PDB_ID|resolution|release_year|ligand_name|comment|Uniprot_ID|protein_name|-logKd/Ki|Kd/Ki|Kd_or_Ki_or_IC50|relation|value|unit|standard_value|standard_unit
2TPI|2.10|1982|2-mer||P00760|TRYPSINOGEN|4.31|Kd=49uM|Kd|=|49|uM|49000|nM
5TLN|2.30|1982|BAN|incomplete ligand structure|P00800|THERMOLYSIN|6.37|Ki=0.43uM|Ki|=|0.43|uM|430|nM
4TLN|2.30|1982|LNO||P00800|THERMOLYSIN|3.72|Ki=190uM|Ki|=|190|uM|190000|nM
4CTS|2.90|1984|OAA||P00889|CITRATE SYNTHASE|5.0|Kd<10uM|Kd|<|10|uM|10000|nM
6RSA|NMR|1986|UVC||P61823|RIBONUCLEASE A|4.4|Ki=40uM|Ki|=|40|uM|40000|nM
1RNT|1.90|1987|2GP||P00651|RIBONUCLEASE T1|5.19|Kd=6.5uM|Kd|=|6.5|uM|6500|nM
6CHA|1.80|1987|PBA|covalent complex|P00766|ALPHA CHYMOTRYPSIN A|4.4|Ki=40uM|Ki|=|40|uM|40000|nM
4TS1|2.50|1989|TYR||P00952|TYROSYL-TRNA SYNTHETASE|4.94|Kd=11.6uM|Kd|=|11.6|uM|11600|nM
4TMN|1.70|1989|0PK||P00800|THERMOLYSIN|10.17|Ki=0.068nM|Ki|=|0.068|nM|0.068|nM
2TMN|1.60|1989|0FA||P00800|THERMOLYSIN|5.89|Ki=1.3uM|Ki|=|1.3|uM|1300|nM
1TLP|2.30|1989|RDF||P00800|THERMOLYSIN|7.55|Ki=28nM|Ki|=|28|nM|28|nM
1TMN|1.90|1989|0ZN||P00800|THERMOLYSIN|7.3|Ki=50nM|Ki|=|50|nM|50|nM
5TMN|1.60|1989|0PJ||P00800|THERMOLYSIN|8.04|Ki=9.1nM|Ki|=|9.1|nM|9.1|nM
4FAB|2.70|1990|FLU||P01865|ANTIBODY IGG2A-KAPPA 4-4-20 FAB (LIGHT CHAIN)|8.06|Kd=8.8nM|Kd|=|8.8|nM|8.8|nM
1P01|2.00|1990|0EG|covalent complex|P00778|ALPHA-LYTIC PROTEASE|9.46|Ki=0.35nM|Ki|=|0.35|nM|0.35|nM
3AT1|2.80|1990|PCT||P0A786|ASPARTATE CARBAMOYLTRANSFERASE (T STATE)|3.18|Ki=0.66mM|Ki|=|0.66|mM|660000|nM
1P05|2.10|1990|5-mer|incomplete ligand structure|P00778|ALPHA-LYTIC PROTEASE|5.96|Ki=1100nM|Ki|=|1100|nM|1100|nM
1P10|2.25|1990|5-mer|incomplete ligand structure|P00778|ALPHA-LYTIC PROTEASE|6.7|Ki=200nM|Ki|=|200|nM|200|nM
6GCH|2.10|1990|APF|covalent complex|P00766|GAMMA CHYMOTRYPSIN A|4.7|Ki=20uM|Ki|=|20|uM|20000|nM
7GCH|1.80|1990|LPF|covalent complex|P00766|GAMMA CHYMOTRYPSIN A|5.7|Ki=2uM|Ki|=|2|uM|2000|nM
1P04|2.55|1990|5-mer|incomplete ligand structure|P00778|ALPHA-LYTIC PROTEASE|7.4|Ki=40nM|Ki|=|40|nM|40|nM
1P06|2.34|1990|5-mer|incomplete ligand structure|P00778|ALPHA-LYTIC PROTEASE|6.27|Ki=540nM|Ki|=|540|nM|540|nM
1P03|2.15|1990|5-mer|incomplete ligand structure|P00778|ALPHA-LYTIC PROTEASE|8.19|Ki=6.4nM|Ki|=|6.4|nM|6.4|nM
1P02|2.00|1990|5-mer|incomplete ligand structure|P00778|ALPHA-LYTIC PROTEASE|7.17|Ki=67nM|Ki|=|67|nM|67|nM
8ABP|1.49|1991|GLA/GLB|isomer|P02924|L-ARABINOSE-BINDING PROTEIN|8.0|Kd=0.010uM|Kd|=|0.01|uM|10|nM
1RBP|2.00|1991|RTL||P02753|RETINOL-BINDING PROTEIN 4|6.72|Kd=0.19uM|Kd|=|0.19|uM|190|nM
7ABP|1.67|1991|FCA/FCB|isomer|P02924|L-ARABINOSE-BINDING PROTEIN|6.46|Kd=0.35uM|Kd|=|0.35|uM|350|nM
6ABP|1.67|1991|ARA/ARB|isomer|P02924|L-ARABINOSE-BINDING PROTEIN|6.36|Kd=0.44uM|Kd|=|0.44|uM|440|nM
1FKF|1.70|1991|FK5||P62942|FK506-BINDING PROTEIN (FKBP)|9.4|Kd=0.4nM|Kd|=|0.4|nM|0.4|nM
9ICD|2.50|1991|NAP||P08200|ISOCITRATE DEHYDROGENASE|3.9|Kd=125uM|Kd|=|125|uM|125000|nM
6APR|2.50|1991|6-mer||P06026|RHIZOPUSPEPSIN|7.77|Ki<=17nM|Ki|<=|17|nM|17|nM
4ER1|2.00|1991|0ZP||P11838|ENDOTHIAPEPSIN|6.62|Ki=0.242uM|Ki|=|0.242|uM|242|nM
5ER2|1.80|1991|0EK||P11838|ENDOTHIAPEPSIN|6.57|Ki=0.27uM|Ki|=|0.27|uM|270|nM
4ER2|2.00|1991|6-mer||P11838|ENDOTHIAPEPSIN|9.3|Ki=0.5nM|Ki|=|0.5|nM|0.5|nM
2YPI|2.50|1991|PGA||P00942|TRIOSEPHOSPHATE ISOMERASE|4.82|Ki=15uM|Ki|=|15|uM|15000|nM
4ER4|2.10|1991|10-mer|incomplete ligand|P11838|ENDOTHIAPEPSIN|6.8|Ki=160nM|Ki|=|160|nM|160|nM
5APR|2.10|1991|9-mer|incomplete ligand structure|P06026|RHIZOPUSPEPSIN|7.77|Ki=17nM|Ki|=|17|nM|17|nM
3ER5|1.80|1991|10-mer||P11838|ENDOTHIAPEPSIN|9.0|Ki=1nM|Ki|=|1|nM|1|nM
4APR|2.50|1991|8-mer|incomplete ligand structure|P06026|RHIZOPUSPEPSIN|6.7|Ki=200nM|Ki|=|200|nM|200|nM
5HVP|2.00|1991|6-mer||Q9WFL7|HIV-1 PROTEASE|7.7|Ki=20nM|Ki|=|20|nM|20|nM
6CPA|2.00|1991|ZAF||P00730|CARBOXYPEPTIDASE A|11.52|Ki=3pM|Ki|=|3|pM|0.003|nM
2ER9|2.20|1991|8-mer|incomplete ligand|P11838|ENDOTHIAPEPSIN|7.4|Ki=40nM|Ki|=|40|nM|40|nM
2ER0|3.00|1991|8-mer||P11838|ENDOTHIAPEPSIN|6.38|Ki=420nM|Ki|=|420|nM|420|nM
4SGA|1.80|1991|5-mer||P00776|PROTEINASE A (SGPA)|7.3|Ki=50nM|Ki|=|50|nM|50|nM
2ER6|2.00|1991|7-mer|redundant to 1gvx|P11838|ENDOTHIAPEPSIN|7.22|Ki=60nM|Ki|=|60|nM|60|nM
3ER3|2.00|1991|0EL|incomplete ligand structure|P11838|ENDOTHIAPEPSIN|7.09|Ki=81nM|Ki|=|81|nM|81|nM
5ER1|2.00|1991|0HT||P11838|ENDOTHIAPEPSIN|6.02|Ki=960nM|Ki|=|960|nM|960|nM
9ABP|1.97|1992|GLA/GLB|isomer|P02924|L-ARABINOSE-BINDING PROTEIN|8.0|Kd=0.01uM|Kd|=|0.01|uM|10|nM
1BAP|1.75|1992|ARA/ARB|isomer|P02924|L-ARABINOSE-BINDING PROTEIN|6.85|Kd=0.14uM|Kd|=|0.14|uM|140|nM
5ABP|1.80|1992|GLA/GLB|isomer|P02924|L-ARABINOSE-BINDING PROTEIN|6.64|Kd=0.23uM|Kd|=|0.23|uM|230|nM
8GPB|2.20|1992|AMP|Kd=0.25-0.7mM|P00489|GLYCOGEN PHOSPHORYLASE B|3.6|Kd=0.25mM|Kd|=|0.25|mM|250000|nM
1APB|1.76|1992|FCA/FCB|isomer|P02924|L-ARABINOSE-BINDING PROTEIN|5.82|Kd=1.51uM|Kd|=|1.51|uM|1510|nM
7GPB|2.90|1992|AMP||P00489|GLYCOGEN PHOSPHORYLASE B|5.52|Kd=3uM|Kd|=|3|uM|3000|nM
1STP|2.60|1992|BTN||P22629|STREPTAVIDIN|13.4|Kd=40fM|Kd|=|40|fM|3.9999999999999996e-05|nM
5EST|2.09|1992|0P2|covalent complex|P00772|ELASTASE|6.52|Ki=0.3uM|Ki|=|0.3|uM|300|nM
6TIM|2.20|1992|G3P||P04789|TRIOSEPHOSPHATE ISOMERASE|3.21|Ki=0.61mM|Ki|=|0.61|mM|610000|nM
6GPB|2.86|1992|H2P||P00489|GLYCOGEN PHOSPHORYLASE B|4.85|Ki=14uM|Ki|=|14|uM|14000|nM
9HVP|2.80|1992|0E9||P12497|HIV-1 PROTEASE|8.35|Ki=4.5nM|Ki|=|4.5|nM|4.5|nM
4TIM|2.40|1992|2PG||P04789|TRIOSEPHOSPHATE ISOMERASE|2.16|Ki=6.9mM|Ki|=|6.9|mM|6900000|nM
4EST|1.78|1992|5-mer|covalent complex|P00772|ELASTASE|5.02|Ki=9.5uM|Ki|=|9.5|uM|9500|nM
2MIP|2.20|1993|7-mer||P04584|HIV-2 PROTEASE|8.46|IC<=3.5nM|IC50|<=|3.5|nM|3.5|nM
4PHV|2.10|1993|VAC||P12497|HIV-1 PROTEASE|9.17|IC=0.67nM|IC50|=|0.67|nM|0.67|nM
1RNE|2.40|1993|C60||P00797|RENIN|8.7|IC=2nM|IC50|=|2|nM|2|nM
1IND|2.20|1993|EOT|Kd for In-EOT|------|IGG1-LAMBDA CHA255 FAB (LIGHT CHAIN)|10.05|Kd=0.09nM|Kd|=|0.09|nM|0.09|nM
1IGJ|2.50|1993|DGX||------|ANTIBODY FAB FRAGMENT|10.0|Kd=0.1nM|Kd|=|0.1|nM|0.1|nM
1FKB|1.70|1993|RAP||P62942|FK506-BINDING PROTEIN (FKBP)|9.7|Kd=0.2nM|Kd|=|0.2|nM|0.2|nM
1GCA|1.70|1993|GAL||P23905|GLUCOSE/GALACTOSE-BINDING PROTEIN|6.7|Kd=0.2uM|Kd|=|0.2|uM|200|nM
1L83|1.70|1993|BNZ||P00720|T4 LYSOZYME|3.4|Kd=0.40mM|Kd|=|0.4|mM|400000|nM
2AVI|3.00|1993|BTN||P02701|AVIDIN|15.22|Kd=0.6fM|Kd|=|0.6|fM|6e-07|nM
1RIN|2.60|1993|MAN||P02867|PEA LECTIN|3.15|Kd=0.7mM|Kd|=|0.7|mM|700000|nM
1DMB|1.80|1993|BCD||P02928|MALTODEXTRIN-BINDING PROTEIN|5.74|Kd=1.80uM|Kd|=|1.8|uM|1800|nM
1ATR|2.34|1993|ADP|Kd by filter binding assay|P19120|HEAT-SHOCK COGNATE 70 KDA PROTEIN|6.96|Kd=110nM|Kd|=|110|nM|110|nM
1DBB|2.70|1993|STR||P01868|IGG1-KAPPA DB3 FAB (LIGHT CHAIN)|9.0|Kd=1nM|Kd|=|1|nM|1|nM
1POP|2.10|1993|4-mer|covalent complex|P00784|PAPAIN|9.0|Kd=1nM|Kd|=|1|nM|1|nM
1GPY|2.40|1993|G6P|Kd=20-30uM|P00489|GLYCOGEN PHOSPHORYLASE B|4.7|Kd=20uM|Kd|=|20|uM|20000|nM
1ABF|1.90|1993|FCA/FCB|isomer|P02924|L-ARABINOSE-BINDING PROTEIN|5.42|Kd=3.8uM|Kd|=|3.8|uM|3800|nM
1RGL|2.00|1993|2GP||P00651|RIBONUCLEASE T1|4.43|Kd=37uM|Kd|=|37|uM|37000|nM
6RNT|1.80|1993|2AM||P00651|RIBONUCLEASE T1|2.37|Kd=4.3mM|Kd|=|4.3|mM|4300000|nM
1RGK|1.87|1993|2AM||P00651|RIBONUCLEASE T1|4.31|Kd=49.1uM|Kd|=|49.1|uM|49100|nM
1HIV|2.00|1993|1ZK||P04585|HIV-1 PROTEASE|9.0|Ki<1.0nM|Ki|<|1|nM|1|nM
1PIP|1.70|1993|7-mer||P00784|PAPAIN|5.0|Ki<10uM|Ki|<|10|uM|10000|nM
8HVP|2.50|1993|7-mer||P03369|HIV-1 PROTEASE|9.0|Ki<1nM|Ki|<|1|nM|1|nM
3GST|1.90|1993|GPR||P04905|GLUTATHIONE S-TRANSFERASE (ISOENZYME 3-3)|6.72|Ki=0.19uM|Ki|=|0.19|uM|190|nM
1CPS|2.25|1993|CPM||P00730|CARBOXYPEPTIDASE A|6.66|Ki=0.22uM|Ki|=|0.22|uM|220|nM
7HVP|2.40|1993|6-mer||P03369|HIV-1 PROTEASE|9.62|Ki=0.24nM|Ki|=|0.24|nM|0.24|nM
2GST|1.80|1993|GPS||P04905|GLUTATHIONE S-TRANSFERASE (ISOENZYME 3-3)|6.07|Ki=0.85uM|Ki|=|0.85|uM|850|nM
2LPR|2.25|1993|5-mer|incomplete ligand structure; covalent complex|P00778|ALPHA-LYTIC PROTEASE|8.89|Ki=1.3nM|Ki|=|1.3|nM|1.3|nM
3LPR|2.15|1993|5-mer|incomplete ligand structure; covalent complex|P00778|ALPHA-LYTIC PROTEASE|5.96|Ki=1100nM|Ki|=|1100|nM|1100|nM
1PPM|1.70|1993|0P1||P00798|PENICILLOPEPSIN|5.8|Ki=1600nM|Ki|=|1600|nM|1600|nM
1HOS|2.30|1993|PHP||P03366|HIV-1 PROTEASE|8.55|Ki=2.8nM|Ki|=|2.8|nM|2.8|nM
1PPL|1.70|1993|1Z7||P00798|PENICILLOPEPSIN|8.55|Ki=2.8nM|Ki|=|2.8|nM|2.8|nM
9LPR|2.20|1993|5-mer|incomplete ligand structure; covalent complex|P00778|ALPHA-LYTIC PROTEASE|5.7|Ki=2000nM|Ki|=|2000|nM|2000|nM
8LPR|2.25|1993|5-mer|incomplete ligand structure; covalent complex|P00778|ALPHA-LYTIC PROTEASE|6.62|Ki=240nM|Ki|=|240|nM|240|nM
5LPR|2.13|1993|5-mer|incomplete ligand structure; covalent complex|P00778|ALPHA-LYTIC PROTEASE|6.57|Ki=270nM|Ki|=|270|nM|270|nM
1BCD|1.90|1993|FMS||P00918|CARBONIC ANHYDRASE 2|8.7|Ki=2nM|Ki|=|2|nM|2|nM
1IVP|2.50|1993|1ZK||P04584|HIV-2 PROTEASE|7.52|Ki=30nM|Ki|=|30|nM|30|nM
1TRD|2.50|1993|PGH||P04789|TRIOSEPHOSPHATE ISOMERASE|5.4|Ki=4uM|Ki|=|4|uM|4000|nM
6LPR|2.10|1993|5-mer|incomplete ligand structure; covalent complex|P00778|ALPHA-LYTIC PROTEASE|7.3|Ki=50nM|Ki|=|50|nM|50|nM
7LPR|2.05|1993|5-mer|incomplete ligand structure; covalent complex|P00778|ALPHA-LYTIC PROTEASE|7.18|Ki=66nM|Ki|=|66|nM|66|nM
1MNS|2.00|1993|APG|covalent complex|P11444|MANDELATE RACEMASE|4.17|Ki=67uM|Ki|=|67|uM|67000|nM
1THS|2.20|1994|11-mer||P00734|THROMBIN ALPHA (SMALL SUBUNIT)|7.54|IC=0.029uM|IC50|=|0.029|uM|29|nM
1HTF|2.20|1994|G26||P03366|HIV-1 PROTEASE|6.83|IC=148nM|IC50|=|148|nM|148|nM
2HMB|2.10|1994|PLM|ligand is PALMITIC ACID|P05413|FATTY ACID-BINDING PROTEIN|5.59|IC=2.6uM|IC50|=|2.6|uM|2600|nM
1HIM|2.90|1994|10-mer|incomplete ligand|I6SHA6|IGG2A-KAPPA 17/9 FAB (HEAVY CHAIN)|7.7|IC=20nM|IC50|=|20|nM|20|nM
1DBJ|2.70|1994|AE2||P01868|IGG1-KAPPA DB3 FAB (LIGHT CHAIN)|7.68|IC=21nM|IC50|=|21|nM|21|nM
1HTE|2.80|1994|G23||P03366|HIV-1 PROTEASE|5.64|IC=2265nM|IC50|=|2265|nM|2265|nM
2DBL|2.90|1994|S5H||P01868|IGG1-KAPPA DB3 FAB (LIGHT CHAIN)|8.7|IC=2nM|IC50|=|2|nM|2|nM
1HTG|2.00|1994|G37||P03366|HIV-1 PROTEASE|8.42|IC=3.8nM|IC50|=|3.8|nM|3.8|nM
1THR|2.30|1994|13-mer|X-ray(human thrombin); IC50=4.2uM(bovine thrombin)|P00734|THROMBIN|5.38|IC=4.2uM|IC50|=|4.2|uM|4200|nM
1ACJ|2.80|1994|THA|ligand is compound tacrine|P04058|ACETYLCHOLINESTERASE|8.09|IC=8.2nM|IC50|=|8.2|nM|8.2|nM
1DBK|3.00|1994|ANO||P01868|IGG1-KAPPA DB3 FAB (LIGHT CHAIN)|8.1|IC=8nM|IC50|=|8|nM|8|nM
1HSL|1.89|1994|HIS||P39182|HISTIDINE-BINDING PROTEIN|7.19|Kd=0.064uM|Kd|=|0.064|uM|64|nM
2DRC|1.90|1994|MTX||P0ABQ4|DIHYDROFOLATE REDUCTASE|9.89|Kd=0.13nM|Kd|=|0.13|nM|0.13|nM
1SRE|1.78|1994|HAB||P22629|STREPTAVIDIN|3.85|Kd=0.14mM|Kd|=|0.14|mM|140000|nM
1SRI|1.65|1994|DMB||P22629|STREPTAVIDIN|6.08|Kd=0.83uM|Kd|=|0.83|uM|830|nM
1TKA|2.70|1994|N3T||P23254|TRANSKETOLASE|6.1|Kd=0.8uM|Kd|=|0.8|uM|800|nM
1ABT|NMR|1994|12-mer|incomplete ligand|P60615|ALPHA-BUNGAROTOXIN|5.85|Kd=1.4uM|Kd|=|1.4|uM|1400|nM
1LST|1.80|1994|LYS||P02911|LYSINE,ARGININE,ORNITHINE-BINDING PROTEIN|7.85|Kd=14nM|Kd|=|14|nM|14|nM
1TKC|2.70|1994|M6T||P23254|TRANSKETOLASE|4.85|Kd=14uM|Kd|=|14|uM|14000|nM
1AVD|2.70|1994|BTN||P02701|AVIDIN|15.0|Kd=1fM|Kd|=|1|fM|1e-06|nM
1CTR|2.45|1994|TFP|Kd in 1-8uM range for the CaM-TFP complex with two, four, and seven TFP molecules bound to CaM|P62158|CALMODULIN|6.0|Kd=1uM|Kd|=|1|uM|1000|nM
1HGI|2.70|1994|ANA||P03437|HEMAGGLUTININ, CHAIN HA1|2.68|Kd=2.1mM|Kd|=|2.1|mM|2100000|nM
1HGJ|2.70|1994|AMN||P03437|HEMAGGLUTININ, CHAIN HA1|1.66|Kd=22mM|Kd|=|22|mM|22000000|nM
1DHJ|1.80|1994|MTX||P0ABQ4|DIHYDROFOLATE REDUCTASE|6.55|Kd=281nM|Kd|=|281|nM|281|nM
1TYS|1.80|1994|TMP||P00470|THYMIDYLATE SYNTHASE|5.49|Kd=3.27uM|Kd|=|3.27|uM|3270|nM
1SPS|2.70|1994|11-mer|incomplete ligand structure|P00524|C-SRC TYROSINE KINASE SH2 DOMAIN|8.52|Kd=3nM|Kd|=|3|nM|3|nM
1PYG|2.87|1994|AMP||P00489|GLYCOGEN PHOSPHORYLASE B|5.52|Kd=3uM|Kd|=|3|uM|3000|nM
1ADL|1.60|1994|ACD||P04117|ADIPOCYTE LIPID-BINDING PROTEIN|5.36|Kd=4.4uM|Kd|=|4.4|uM|4400|nM
1MFD|2.10|1994|3-mer||------|ANTIBODY FAB FRAGMENT|5.31|Kd=4.9uM|Kd|=|4.9|uM|4900|nM
1HGE|2.60|1994|MNA||P03437|HEMAGGLUTININ, CHAIN HA1|2.27|Kd=5.4mM|Kd|=|5.4|mM|5400000|nM
2CGR|2.20|1994|GAS||A2P1G9|ANTIBODY FAB FRAGMENT|7.28|Kd=53nM|Kd|=|53|nM|53|nM
1DHI|1.90|1994|MTX||P0ABQ4|DIHYDROFOLATE REDUCTASE|7.26|Kd=55nM|Kd|=|55|nM|55|nM
1SRG|1.80|1994|MHB||P22629|STREPTAVIDIN|5.3|Kd=5uM|Kd|=|5|uM|5000|nM
1ERB|1.90|1994|ETR|Kd=93nM in phosphate buffer; Kd=8nM in crystallization buffer|P18902|RETINOL BINDING PROTEIN|8.1|Kd=8nM|Kd|=|8|nM|8|nM
1MFA|1.70|1994|3-mer||------|ANTIBODY FV FRAGMENT|5.04|Kd=9.1uM|Kd|=|9.1|uM|9100|nM
1TNI|1.90|1994|PBN||P00760|TRYPSIN|4.0|Ki=0.10mM|Ki|=|0.1|mM|100000|nM
2CTC|1.40|1994|HFA||P00730|CARBOXYPEPTIDASE A|3.89|Ki=0.13mM|Ki|=|0.13|mM|130000|nM
1ADD|2.40|1994|1DA||P03958|ADENOSINE DEAMINASE|6.74|Ki=0.18uM|Ki|=|0.18|uM|180|nM
1TMB|2.30|1994|5-mer||P00734|THROMBIN ALPHA (SMALL SUBUNIT)|6.74|Ki=0.18uM|Ki|=|0.18|uM|180|nM
1ELC|1.75|1994|0Z3||P00772|ELASTASE|6.66|Ki=0.22uM|Ki|=|0.22|uM|220|nM
1WHT|2.00|1994|BZS||P08819|SERINE CARBOXYPEPTIDASE II|3.7|Ki=0.2mM|Ki|=|0.2|mM|200000|nM
1TSI|2.84|1994|4PB||P04789|TRIOSEPHOSPHATE ISOMERASE|3.48|Ki=0.33mM|Ki|=|0.33|mM|330000|nM
1CIL|1.60|1994|ETS||P00918|CARBONIC ANHYDRASE 2|9.43|Ki=0.37nM|Ki|=|0.37|nM|0.37|nM
2SIM|1.60|1994|DAN||P29768|NEURAMINIDASE|3.42|Ki=0.38mM|Ki|=|0.38|mM|380000|nM
1THL|1.70|1994|0DB||P00800|THERMOLYSIN|6.42|Ki=0.38uM|Ki|=|0.38|uM|380|nM
1TNH|1.80|1994|FBA||P00760|TRYPSIN|3.37|Ki=0.43mM|Ki|=|0.43|mM|430000|nM
1ELA|2.00|1994|0Z1||P00772|ELASTASE|6.36|Ki=0.44uM|Ki|=|0.44|uM|440|nM
1CBX|2.00|1994|BZS||P00730|CARBOXYPEPTIDASE A|6.35|Ki=0.45uM|Ki|=|0.45|uM|450|nM
1INC|1.94|1994|ICL|covalent complex|P00772|PORCINE PANCREATIC ELASTASE|9.34|Ki=0.46nM|Ki|=|0.46|nM|0.46|nM
1PPC|1.80|1994|MID||P00760|TRYPSIN|6.16|Ki=0.69uM|Ki|=|0.69|uM|690|nM
1HPS|2.30|1994|RUN||P03366|HIV-1 PROTEASE|9.22|Ki=0.6nM|Ki|=|0.6|nM|0.6|nM
1FIG|3.00|1994|TSA||------|IGG1-KAPPA 1F7 FAB (LIGHT CHAIN)|6.22|Ki=0.6uM|Ki|=|0.6|uM|600|nM
1TET|2.30|1994|15-mer|incomplete ligand structure|P32890|IGG1 TE33 FAB (LIGHT CHAIN)|6.08|Ki=0.83uM|Ki|=|0.83|uM|830|nM
1AZM|2.00|1994|AZM|ligand is compound 2|P00915|CARBONIC ANHYDRASE 1|6.1|Ki=0.8uM|Ki|=|0.8|uM|800|nM
1RPA|3.00|1994|TAR||P20646|PROSTATIC ACID PHOSPHATASE|6.0|Ki=1.0uM|Ki|=|1|uM|1000|nM
1TNG|1.80|1994|AMC||P00760|TRYPSIN|2.93|Ki=1.17mM|Ki|=|1.17|mM|1170000|nM
1PPH|1.90|1994|0ZG||P00760|TRYPSIN|5.92|Ki=1.2uM|Ki|=|1.2|uM|1200|nM
1ETT|2.50|1994|4QQ|X-ray(epsilon-thrombin); Ki(alpha-thrombin)|P00735|THROMBIN EPSILON|5.89|Ki=1.3uM|Ki|=|1.3|uM|1300|nM
1CIM|2.10|1994|PTS||P00918|CARBONIC ANHYDRASE 2|8.82|Ki=1.52nM|Ki|=|1.52|nM|1.52|nM
1CSI|1.70|1994|CMX||P23007|CITRATE SYNTHASE|8.8|Ki=1.6nM|Ki|=|1.6|nM|1.6|nM
1CIN|2.10|1994|MTS||P00918|CARBONIC ANHYDRASE 2|8.73|Ki=1.88nM|Ki|=|1.88|nM|1.88|nM
1FKI|2.20|1994|SB1||P62942|FK506-BINDING PROTEIN (FKBP)|7.0|Ki=100nM|Ki|=|100|nM|100|nM
1RPF|2.20|1994|C3P|ligand is compound 3'-CMP|P61823|RIBONUCLEASE A|3.99|Ki=103uM|Ki|=|103|uM|103000|nM
1GBT|2.00|1994|GBS||P00760|TRYPSIN BETA|2.0|Ki=10mM|Ki|=|10|mM|10000000|nM
1APW|1.80|1994|5-mer||P00798|PENICILLOPEPSIN|8.0|Ki=10nM|Ki|=|10|nM|10|nM
1FKG|2.00|1994|SB3||P62942|FK506-BINDING PROTEIN (FKBP)|8.0|Ki=10nM|Ki|=|10|nM|10|nM
1TKB|2.30|1994|N1T||P23254|TRANSKETOLASE|8.0|Ki=10nM|Ki|=|10|nM|10|nM
1NNB|2.80|1994|DAN||P03472|NEURAMINIDASE|5.0|Ki=10uM|Ki|=|10|uM|10000|nM
1TNJ|1.80|1994|PEA||P00760|TRYPSIN|1.96|Ki=11.0mM|Ki|=|11|mM|11000000|nM
1ENT|1.90|1994|0EM|redundant to 1gvw|P11838|ENDOTHIAPEPSIN|6.96|Ki=110nM|Ki|=|110|nM|110|nM
1HVL|1.80|1994|A76|Ki=112pM (cryst, pH=6.2); Ki=1000pM (soln, pH=4.7)|P03367|HIV-1 PROTEASE|9.95|Ki=112pM|Ki|=|112|pM|0.112|nM
7CPA|2.00|1994|FVF||P00730|CARBOXYPEPTIDASE A|13.96|Ki=11fM|Ki|=|11|fM|1.1e-05|nM
1EPO|2.00|1994|2Z3||P11838|ENDOTHIAPEPSIN|7.96|Ki=11nM|Ki|=|11|nM|11|nM
1HVK|1.80|1994|A79|Ki=11pM (cryst, pH=6.2); Ki=77pM (soln, pH=4.7)|P03366|HIV-1 PROTEASE|10.96|Ki=11pM|Ki|=|11|pM|0.011|nM
1HVI|1.80|1994|A77|Ki=12pM (cryst, pH=6.2); Ki=84pM (soln, pH=4.7)|P03368|HIV-1 PROTEASE|10.92|Ki=12pM|Ki|=|12|pM|0.012|nM
1TNL|1.90|1994|TPA||P00760|TRYPSIN|1.88|Ki=13.3mM|Ki|=|13.3|mM|13300000|nM
1BRA|2.20|1994|BEN||P00763|TRYPSIN BETA|1.82|Ki=15000uM|Ki|=|15000|uM|15000000|nM
1HGT|2.20|1994|12-mer|incomplete ligand structure|P00734|THROMBIN ALPHA (SMALL SUBUNIT)|6.82|Ki=150nM|Ki|=|150|nM|150|nM
1ELS|2.40|1994|PAH|redundant to 1ebg|P00924|ENOLASE|10.82|Ki=15pM|Ki|=|15|pM|0.015|nM
1EED|2.00|1994|0EO|incomplete ligand structure|P11838|ENDOTHIAPEPSIN|4.79|Ki=16.2uM|Ki|=|16.2|uM|16200|nM
1HEG|2.20|1994|PSI||P03366|HIV-1 PROTEASE|7.74|Ki=18nM|Ki|=|18|nM|18|nM
1SBG|2.30|1994|IM1||P03366|HIV-1 PROTEASE|7.74|Ki=18nM|Ki|=|18|nM|18|nM
1APV|1.80|1994|5-mer||P00798|PENICILLOPEPSIN|9.0|Ki=1nM|Ki|=|1|nM|1|nM
1HEF|2.20|1994|5-mer||P03366|HIV-1 PROTEASE|9.0|Ki=1nM|Ki|=|1|nM|1|nM
1AGM|2.30|1994|ACR||P23176|GLUCOAMYLASE-471|12.0|Ki=1pM|Ki|=|1|pM|0.001|nM
1PPK|1.80|1994|IVV||P00798|PENICILLOPEPSIN|7.66|Ki=22nM|Ki|=|22|nM|22|nM
1CSH|1.65|1994|AMX||P23007|CITRATE SYNTHASE|7.55|Ki=28nM|Ki|=|28|nM|28|nM
1IHT|2.10|1994|14-mer|incomplete ligand|P00734|THROMBIN ALPHA|8.46|Ki=3.5nM|Ki|=|3.5|nM|3.5|nM
1LYB|2.50|1994|6-mer||P07339|CATHEPSIN D|11.42|Ki=3.8pM|Ki|=|3.8|pM|0.0038|nM
1TNK|1.80|1994|PRA||P00760|TRYPSIN|1.49|Ki=32.5mM|Ki|=|32.5|mM|32500000|nM
1DWC|3.00|1994|MIT||P00734|THROMBIN ALPHA (SMALL SUBUNIT)|7.41|Ki=39nM|Ki|=|39|nM|39|nM
2CHT|2.20|1994|BAR||P19080|CHORISMATE MUTASE|5.52|Ki=3uM|Ki|=|3|uM|3000|nM
1AAQ|2.50|1994|PSI||Q8Q3J5|HIV-1 PROTEASE|8.4|Ki=4.0nM|Ki|=|4|nM|4|nM
1HVJ|2.00|1994|A78|Ki=4pM (cryst, pH=6.2); Ki=35pM (soln, pH=4.7)|P04587|HIV-1 PROTEASE|11.4|Ki=4pM|Ki|=|4|pM|0.004|nM
1EPQ|1.90|1994|0QF|incomplete ligand structure|P11838|ENDOTHIAPEPSIN|8.19|Ki=6.5nM|Ki|=|6.5|nM|6.5|nM
1DWD|3.00|1994|MID||P00734|THROMBIN ALPHA|8.18|Ki=6.6nM|Ki|=|6.6|nM|6.6|nM
1EPP|1.90|1994|1Z1|incomplete ligand structure|P11838|ENDOTHIAPEPSIN|7.16|Ki=69nM|Ki|=|69|nM|69|nM
1ETS|2.30|1994|MID|X-ray(epsilon-thrombin) while Ki(alpha-thrombin)|P00735|EPSILON THROMBIN|8.22|Ki=6nM|Ki|=|6|nM|6|nM
1ELB|2.10|1994|0Z4||P00772|ELASTASE|7.15|Ki=70nM|Ki|=|70|nM|70|nM
8CPA|2.00|1994|AGF||P00730|CARBOXYPEPTIDASE A|9.15|Ki=710pM|Ki|=|710|pM|0.71|nM
1FKH|1.95|1994|SBX||P62942|FK506-BINDING PROTEIN (FKBP)|8.15|Ki=7nM|Ki|=|7|nM|7|nM
1SIV|2.50|1994|PSI||Q07387|SIV PROTEASE|8.08|Ki=8.4nM|Ki|=|8.4|nM|8.4|nM
1IDA|1.70|1995|0PO||P04584|HIV-2 PROTEASE|8.7|IC<=2.0nM|IC50|<=|2|nM|2|nM
1MNC|2.10|1995|PLH|ligand is compound 2a|P22894|NEUTROPHIL COLLAGENASE|10.34|IC=0.046nM|IC50|=|0.046|nM|0.046|nM
1FTA|2.30|1995|AMP||P09467|FRUCTOSE-1,6-BISPHOSPHATASE 1|6.36|IC=0.44uM|IC50|=|0.44|uM|440|nM
1SHD|2.00|1995|5-mer||P12931|C-SRC TYROSINE KINASE SH2 DOMAIN|6.17|IC=0.67uM|IC50|=|0.67|uM|670|nM
1TPS|1.90|1995|8-mer||P00760|TRYPSIN|8.0|IC=10nM|IC50|=|10|nM|10|nM
1IDB|2.20|1995|0DO||P04584|HIV-2 PROTEASE|7.96|IC=11nM|IC50|=|11|nM|11|nM
1HRN|1.80|1995|03D||P00797|RENIN|8.05|IC=9nM|IC50|=|9|nM|9|nM
1GSF|2.70|1995|EAA||P08263|GLUTATHIONE S-TRANSFERASE A1-1|5.0|IC~10uM|IC50|~|10|uM|10000|nM
1DRJ|2.50|1995|RIP||P02925|D-RIBOSE-BINDING PROTEIN|7.4|Kd=0.040uM|Kd|=|0.04|uM|40|nM
2DRI|1.60|1995|RIP||P02925|D-RIBOSE-BINDING PROTEIN|6.89|Kd=0.13uM|Kd|=|0.13|uM|130|nM
1DRK|2.00|1995|RIP||P02925|D-RIBOSE-BINDING PROTEIN|6.82|Kd=0.15uM|Kd|=|0.15|uM|150|nM
1FLR|1.85|1995|FLU||P01865|ANTIBODY FAB FRAGMENT 4-4-20|10.0|Kd=0.1nM|Kd|=|0.1|nM|0.1|nM
1TYR|1.80|1995|REA||P02766|TRANSTHYRETIN|7.0|Kd=0.1uM|Kd|=|0.1|uM|100|nM
1HMR|1.40|1995|ELA||P05413|FATTY ACID-BINDING PROTEIN|6.55|Kd=0.28uM|Kd|=|0.28|uM|280|nM
1HMS|1.40|1995|OLA||P05413|FATTY ACID-BINDING PROTEIN|6.37|Kd=0.43uM|Kd|=|0.43|uM|430|nM
1CBR|2.90|1995|REA|ligand is (all-E)-RA|P62965|CELLULAR RETINOIC ACID BINDING PROTEIN TYPE I|9.4|Kd=0.4nM|Kd|=|0.4|nM|0.4|nM
1HMT|1.40|1995|STE||P05413|FATTY ACID-BINDING PROTEIN|5.79|Kd=1.64uM|Kd|=|1.64|uM|1640|nM
1CKA|1.50|1995|10-mer|incomplete ligand structure|Q64010|C-CRK N-TERMINAL SH3 DOMAIN|5.72|Kd=1.9uM|Kd|=|1.9|uM|1900|nM
1UTR|NMR|1995|PCB||P17559|UTEROGLOBIN|8.0|Kd=10nM|Kd|=|10|nM|10|nM
1AHX|2.00|1995|HCI||P00509|ASPARTATE AMINOTRANSFERASE|3.92|Kd=120uM|Kd|=|120|uM|120000|nM
1CNY|2.30|1995|EG3||P00918|CARBONIC ANHYDRASE 2|7.85|Kd=14nM|Kd|=|14|nM|14|nM
1LAF|2.06|1995|ARG||P02911|LYSINE,ARGININE,ORNITHINE-BINDING PROTEIN|7.85|Kd=14nM|Kd|=|14|nM|14|nM
186L|1.80|1995|N4B|ligand is compound 38|P00720|T4 LYSOZYME|4.85|Kd=14uM|Kd|=|14|uM|14000|nM
1CNW|2.00|1995|EG1||P00918|CARBONIC ANHYDRASE 2|7.72|Kd=19nM|Kd|=|19|nM|19|nM
184L|1.80|1995|I4B|ligand is compound 39|P00720|T4 LYSOZYME|4.72|Kd=19uM|Kd|=|19|uM|19000|nM
1LCJ|1.80|1995|11-mer||P06239|P56==LCK== TYROSINE KINASE|9.0|Kd=1nM|Kd|=|1|nM|1|nM
1YDA|2.10|1995|AZM||P00918|CARBONIC ANHYDRASE 2|6.55|Kd=280nM|Kd|=|280|nM|280|nM
185L|1.80|1995|IND|ligand is compound 15|P00720|T4 LYSOZYME|3.54|Kd=290uM|Kd|=|290|uM|290000|nM
1PGP|2.50|1995|6PG||P00349|6-PHOSPHOGLUCONATE DEHYDROGENASE (6-PGDH)|5.7|Kd=2uM|Kd|=|2|uM|2000|nM
1LAH|2.06|1995|ORN||P02911|LYSINE,ARGININE,ORNITHINE-BINDING PROTEIN|7.52|Kd=30nM|Kd|=|30|nM|30|nM
187L|1.80|1995|PXY|ligand is compound 18|P00720|T4 LYSOZYME|3.37|Kd=422uM|Kd|=|422|uM|422000|nM
1CNX|1.90|1995|EG2||P00918|CARBONIC ANHYDRASE 2|7.37|Kd=43nM|Kd|=|43|nM|43|nM
1AHY|2.30|1995|MAE||P00509|ASPARTATE AMINOTRANSFERASE|3.36|Kd=440uM|Kd|=|440|uM|440000|nM
188L|1.80|1995|OXE|ligand is compound 4|P00720|T4 LYSOZYME|3.33|Kd=470uM|Kd|=|470|uM|470000|nM
1CKB|1.90|1995|10-mer|incomplete ligand structure|Q64010|C-CRK N-TERMINAL SH3 DOMAIN|5.28|Kd=5.2uM|Kd|=|5.2|uM|5200|nM
1YDB|1.90|1995|AZM||P00918|CARBONIC ANHYDRASE 2|8.24|Kd=5.8nM|Kd|=|5.8|nM|5.8|nM
1LAG|2.06|1995|HIS||P02911|LYSINE,ARGININE,ORNITHINE-BINDING PROTEIN|6.3|Kd=500nM|Kd|=|500|nM|500|nM
1PRL|NMR|1995|9-mer||P00523|C-SRC TYROSINE KINASE SH3 DOMAIN|4.23|Kd=59uM|Kd|=|59|uM|59000|nM
1PRM|NMR|1995|9-mer|redundant to 1prl|P00523|C-SRC TYROSINE KINASE SH3 DOMAIN|4.23|Kd=59uM|Kd|=|59|uM|59000|nM
1RLP|NMR|1995|9-mer||P00523|C-SRC TYROSINE KINASE SH3 DOMAIN|5.1|Kd=8.0uM|Kd|=|8|uM|8000|nM
1RLQ|NMR|1995|9-mer|redundant to 1rlp|P00523|C-SRC TYROSINE KINASE SH3 DOMAIN|5.1|Kd=8.0uM|Kd|=|8|uM|8000|nM
1YDD|2.10|1995|AZM||P00918|CARBONIC ANHYDRASE 2|7.07|Kd=86nM|Kd|=|86|nM|86|nM
1DIS|NMR|1995|BDM||P00381|DIHYDROFOLATE REDUCTASE|11.0|Ki<0.01nM|Ki|<|0.01|nM|0.01|nM
2GYI|1.60|1995|HYA||P15587|XYLOSE ISOMERASE|7.0|Ki<=100nM|Ki|<=|100|nM|100|nM
1CGL|2.40|1995|0ED||P03956|COLLAGENASE 1 (MMP-1)|6.87|Ki=0.135uM|Ki|=|0.135|uM|135|nM
1ELE|2.00|1995|0QN||P00772|ELASTASE|6.85|Ki=0.14uM|Ki|=|0.14|uM|140|nM
2ADA|2.40|1995|HPR||P03958|ADENOSINE DEAMINASE|13.0|Ki=0.1pM|Ki|=|0.1|pM|0.0001|nM
1FPC|2.30|1995|0ZI||P00734|THROMBIN ALPHA|7.0|Ki=0.1uM|Ki|=|0.1|uM|100|nM
1ELD|2.00|1995|0Z0||P00772|ELASTASE|6.7|Ki=0.20uM|Ki|=|0.2|uM|200|nM
1LCP|1.65|1995|PLU||P00727|LEUCINE AMINOPEPTIDASE|6.64|Ki=0.23uM|Ki|=|0.23|uM|230|nM
2SRT|NMR|1995|INH||P08254|STROMELYSIN-1|6.64|Ki=0.23uM|Ki|=|0.23|uM|230|nM
1PDZ|2.20|1995|PGA||P56252|ENOLASE|3.7|Ki=0.2mM|Ki|=|0.2|mM|200000|nM
1TYN|2.00|1995|CTA|covalent complex|P00760|TRYPSIN BETA|9.7|Ki=0.2nM|Ki|=|0.2|nM|0.2|nM
1HVR|1.80|1995|XK2|IC50=0.22uM|P04585|HIV-1 PROTEASE|9.51|Ki=0.31nM|Ki|=|0.31|nM|0.31|nM
1ATL|1.80|1995|SLE-TYR||P15167|ATROLYSIN C|6.28|Ki=0.52uM|Ki|=|0.52|uM|520|nM
1TPW|1.90|1995|PGH||P00940|TRIOSEPHOSPHATE ISOMERASE|3.3|Ki=0.5mM|Ki|=|0.5|mM|500000|nM
1HPV|1.90|1995|478||P04587|HIV-1 PROTEASE|9.22|Ki=0.60nM|Ki|=|0.6|nM|0.6|nM
1CSS|1.70|1995|FCX||P23007|CITRATE SYNTHASE|6.1|Ki=0.8uM|Ki|=|0.8|uM|800|nM
1CTU|2.30|1995|ZEB||P0ABF6|CYTIDINE DEAMINASE|11.92|Ki=1.2pM|Ki|=|1.2|pM|0.0012|nM
1GAR|1.96|1995|U89||P08179|GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMYLASE|10.0|Ki=100pM|Ki|=|100|pM|0.1|nM
1EAT|2.00|1995|TFI|covalent complex|P00772|PORCINE PANCREATIC ELASTASE|7.82|Ki=15nM|Ki|=|15|nM|15|nM
1EBG|2.10|1995|PAH|redundant to 2ptz|P00924|ENOLASE|10.82|Ki=15pM|Ki|=|15|pM|0.015|nM
1HDT|2.60|1995|0E7||P00734|THROMBIN ALPHA|7.76|Ki=17.2nM|Ki|=|17.2|nM|17.2|nM
1BTY|1.50|1995|BEN|ligand is TPB7|P00760|TRYPSIN BETA|4.74|Ki=18.4uM|Ki|=|18.4|uM|18400|nM
1EAS|1.80|1995|TFK|covalent complex|P00772|PORCINE PANCREATIC ELASTASE|7.74|Ki=18nM|Ki|=|18|nM|18|nM
1IBG|2.70|1995|OBN||------|IGG2B-KAPPA 40-50 FAB (LIGHT CHAIN)|8.55|Ki=2.8nM|Ki|=|2.8|nM|2.8|nM
1FIV|2.00|1995|5-mer||P16088|FIV PROTEASE|6.59|Ki=260nM|Ki|=|260|nM|260|nM
1BMA|1.80|1995|0QH||P00772|ELASTASE|4.59|Ki=26uM|Ki|=|26|uM|26000|nM
1CTT|2.20|1995|DHZ||P0ABF6|CYTIDINE DEAMINASE|4.52|Ki=30uM|Ki|=|30|uM|30000|nM
1CSR|1.70|1995|FAM||P23007|CITRATE SYNTHASE|7.38|Ki=42nM|Ki|=|42|nM|42|nM
1HBV|2.30|1995|GAN||P03366|HIV-1 PROTEASE|6.37|Ki=430nM|Ki|=|430|nM|430|nM
1STD|2.90|1995|BFS|ligand is compound 2|P56221|SCYTALONE DEHYDRATASE|10.33|Ki=47pM|Ki|=|47|pM|0.047|nM
1QCA|2.20|1995|FUA||P00484|TYPE III CHLORAMPHENICOL ACETYLTRANSFERASE|5.27|Ki=5.4uM|Ki|=|5.4|uM|5400|nM
1HVS|2.25|1995|A77||P04587|HIV-1 PROTEASE|10.3|Ki=50pM|Ki|=|50|pM|0.05|nM
1HII|2.30|1995|C20||P04584|HIV-2 PROTEASE|7.28|Ki=53nM|Ki|=|53|nM|53|nM
1LAN|1.90|1995|LEU||P00727|LEUCINE AMINOPEPTIDASE|7.22|Ki=60nM|Ki|=|60|nM|60|nM
1HTI|2.80|1995|PGA||P60174|TRIOSEPHOSPHATE ISOMERASE|5.13|Ki=7.4uM|Ki|=|7.4|uM|7400|nM
1PPI|2.20|1995|4-mer||P00690|ALPHA-AMYLASE|5.01|Ki=9.7uM|Ki|=|9.7|uM|9700|nM
1HIH|2.20|1995|C20||P03366|HIV-1 PROTEASE|8.05|Ki=9nM|Ki|=|9|nM|9|nM
1VRT|2.20|1996|NVP||P04585|HIV-1 REVERSE TRANSCRIPTASE|7.1|IC=0.08uM|IC50|=|0.08|uM|80|nM
1VRU|2.40|1996|AAP||P04585|HIV-1 REVERSE TRANSCRIPTASE|7.0|IC=0.1uM|IC50|=|0.1|uM|100|nM
1RTH|2.20|1996|U05||P04585|HIV-1 REVERSE TRANSCRIPTASE|6.4|IC=0.4uM|IC50|=|0.4|uM|400|nM
1BIL|2.40|1996|0IU||P00797|RENIN|9.3|IC=0.5nM|IC50|=|0.5|nM|0.5|nM
1PIG|2.20|1996|8-mer|incomplete ligand structure|P00690|ALPHA-AMYLASE|9.15|IC=0.7nM|IC50|=|0.7|nM|0.7|nM
1BIM|2.80|1996|0QB||P00797|RENIN|8.92|IC=1.2nM|IC50|=|1.2|nM|1.2|nM
1FPI|2.30|1996|AMP|ligand is AMP|P00636|FRUCTOSE-1,6-BISPHOSPHATASE|5.89|IC=1.3uM|IC50|=|1.3|uM|1300|nM
1INF|2.40|1996|ST4||P03474|NEURAMINIDASE|5.0|IC=10uM|IC50|=|10|uM|10000|nM
1CWC|1.86|1996|11-mer||P05092|PEPTIDYL-PROLYL CIS-TRANS ISOMERASE A|7.8|IC=16.0nM|IC50|=|16|nM|16|nM
1RTI|3.00|1996|HEF||P04585|HIV-1 REVERSE TRANSCRIPTASE|4.77|IC=17uM|IC50|=|17|uM|17000|nM
1GYM|2.20|1996|MYG||P14262|PHOSPHATIDYLINOSITOL-SPECIFIC PHOSPHOLIPASE C|2.7|IC=2mM|IC50|=|2|mM|2000000|nM
1CPI|2.05|1996|5-mer||P03369|HIV-1 PROTEASE|7.41|IC=39nM|IC50|=|39|nM|39|nM
1MIK|1.76|1996|11-mer||P05092|PEPTIDYL-PROLYL CIS-TRANS ISOMERASE A|6.35|IC=450nM|IC50|=|450|nM|450|nM
1INH|2.40|1996|ST6|compound 111|P06820|INFLUENZA A SUBTYPE N2 NEURAMINIDASE|2.3|IC=5mM|IC50|=|5|mM|5000000|nM
1ING|2.40|1996|ST5||P06820|INFLUENZA A SUBTYPE N2 NEURAMINIDASE|2.0|IC>10mM|IC50|>|10|mM|10000000|nM
1QWF|NMR|1996|12-mer||P00525|TYROSINE-PROTEIN KINASE TRANSFORMING PROTEIN SRC|6.35|Kd=0.45uM|Kd|=|0.45|uM|450|nM
1NJA|2.50|1996|DCM||P00469|THYMIDYLATE SYNTHASE|6.31|Kd=0.49uM|Kd|=|0.49|uM|490|nM
1QWE|NMR|1996|12-mer||P00525|TYROSINE-PROTEIN KINASE TRANSFORMING PROTEIN SRC|5.92|Kd=1.2uM|Kd|=|1.2|uM|1200|nM
1NJB|2.74|1996|UMP||P00469|THYMIDYLATE SYNTHASE|5.8|Kd=1.6uM|Kd|=|1.6|uM|1600|nM
1GAF|1.95|1996|NPE||P01857|CHIMERIC 48G7 FAB|8.0|Kd=10nM|Kd|=|10|nM|10|nM
1STS|1.95|1996|7-mer|Kd for monomer; incomplete ligand|P22629|STREPTAVIDIN|5.0|Kd=10uM|Kd|=|10|uM|10000|nM
1TSY|2.20|1996|UMP||P00469|THYMIDYLATE SYNTHASE|4.96|Kd=11.0uM|Kd|=|11|uM|11000|nM
1CEA|2.06|1996|ACA||P00747|PLASMINOGEN|4.96|Kd=11uM|Kd|=|11|uM|11000|nM
1DAR|2.40|1996|GDP||Q5SHN5|ELONGATION FACTOR G|4.96|Kd=11uM|Kd|=|11|uM|11000|nM
1SLG|1.76|1996|7-mer|incomplete ligand|P22629|STREPTAVIDIN|3.9|Kd=125uM|Kd|=|125|uM|125000|nM
1LKK|1.00|1996|4-mer||P06239|P56 TYROSINE KINASE|6.85|Kd=140nM|Kd|=|140|nM|140|nM
1LKL|1.80|1996|4-mer||P06239|P56 TYROSINE KINASE|5.81|Kd=1540nM|Kd|=|1540|nM|1540|nM
1TSV|2.90|1996|UMP||P00469|THYMIDYLATE SYNTHASE|4.8|Kd=16.0uM|Kd|=|16|uM|16000|nM
1NJE|2.30|1996|DCM||P00469|THYMIDYLATE SYNTHASE|3.8|Kd=160uM|Kd|=|160|uM|160000|nM
1STR|1.80|1996|6-mer|Kd for monomer|P22629|STREPTAVIDIN|4.77|Kd=17uM|Kd|=|17|uM|17000|nM
1CEB|2.07|1996|AMH||P00747|PLASMINOGEN|6.0|Kd=1uM|Kd|=|1|uM|1000|nM
1NJD|2.20|1996|UMP||P00469|THYMIDYLATE SYNTHASE|5.57|Kd=2.7uM|Kd|=|2.7|uM|2700|nM
1NJC|2.50|1996|DCM||P00469|THYMIDYLATE SYNTHASE|5.55|Kd=2.8uM|Kd|=|2.8|uM|2800|nM
1MAI|1.90|1996|I3P||P10688|PHOSPHOLIPASE C DELTA-1|6.68|Kd=210nM|Kd|=|210|nM|210|nM
1ZSB|2.00|1996|AZM||P00918|CARBONIC ANHYDRASE 2|0.6|Kd=250mM|Kd|=|250|mM|250000000|nM
1SLD|2.50|1996|6-mer||P22629|STREPTAVIDIN|6.57|Kd=270nM|Kd|=|270|nM|270|nM
2OLB|1.40|1996|3-mer||P06202|OLIGO-PEPTIDE BINDING PROTEIN|5.54|Kd=2900nM|Kd|=|2900|nM|2900|nM
1POT|1.80|1996|SPD||P23861|SPERMIDINE/PUTRESCINE-BINDING PROTEIN|5.49|Kd=3.2uM|Kd|=|3.2|uM|3200|nM
1BTN|2.00|1996|I3P|Kd measured on GPIns(4, 5)P2|Q62261|BETA-SPECTRIN|4.4|Kd=40uM|Kd|=|40|uM|40000|nM
1DET|1.80|1996|2GP||P00651|RIBONUCLEASE T1|4.3|Kd=50uM|Kd|=|50|uM|50000|nM
1KEL|1.90|1996|AAH||P01868|ANTIBODY FAB FRAGMENT|7.28|Kd=52nM|Kd|=|52|nM|52|nM
1SLE|2.00|1996|8-mer||P22629|STREPTAVIDIN|6.17|Kd=670nM|Kd|=|670|nM|670|nM
1SWI|2.60|1996|BNZ||P03069|GCN4P1|3.1|Kd=800uM|Kd|=|800|uM|800000|nM
1CYN|1.85|1996|11-mer||P23284|PEPTIDYL-PROLYL CIS-TRANS ISOMERASE B|7.68|Ki<21nM|Ki|<|21|nM|21|nM
1MMQ|1.90|1996|RRS||P09237|MATRILYSIN|7.52|Ki=0.03uM|Ki|=|0.03|uM|30|nM
2UPJ|3.00|1996|U02||P03367|HIV-1 PROTEASE|7.39|Ki=0.041uM|Ki|=|0.041|uM|41|nM
1LHC|1.95|1996|DP7|covalent complex|P00734|THROMBIN ALPHA|10.4|Ki=0.04nM|Ki|=|0.04|nM|0.04|nM
2CSM|2.80|1996|TYR||P32178|CHORISMATE MUTASE|4.3|Ki=0.05mM|Ki|=|0.05|mM|50000|nM
1GRP|2.50|1996|ICT||P08200|ISOCITRATE DEHYDROGENASE|3.72|Ki=0.189mM|Ki|=|0.189|mM|189000|nM
1FMB|1.80|1996|HYB|X-ray(EIAV I54G)while Ki(EIAV wild type)|P32542|EIAV PROTEASE|10.0|Ki=0.1nM|Ki|=|0.1|nM|0.1|nM
1SLN|2.27|1996|INH||P08254|STROMELYSIN-1|6.64|Ki=0.23uM|Ki|=|0.23|uM|230|nM
1LHD|2.35|1996|DI2|covalent complex|P00734|THROMBIN ALPHA|9.62|Ki=0.24nM|Ki|=|0.24|nM|0.24|nM
1LHE|2.25|1996|DI3|covalent complex|P00734|THROMBIN ALPHA|9.54|Ki=0.29nM|Ki|=|0.29|nM|0.29|nM
1HSG|2.00|1996|MK1|redundant to 1hsh but in lower resoluation|P03367|HIV-1 PROTEASE|9.42|Ki=0.38nM|Ki|=|0.38|nM|0.38|nM
1HSH|1.90|1996|MK1||P04584|HIV-2 PROTEASE|9.42|Ki=0.38nM|Ki|=|0.38|nM|0.38|nM
1IGB|2.30|1996|IPO||Q01693|LEUCYL AMINOPEPTIDASE|6.4|Ki=0.4uM|Ki|=|0.4|uM|400|nM
1JRS|1.80|1996|3-mer|covalent complex|P00760|TRYPSIN|6.4|Ki=0.4uM|Ki|=|0.4|uM|400|nM
1AHT|1.60|1996|APA|covalent complex|P00734|THROMBIN ALPHA|6.21|Ki=0.62uM|Ki|=|0.62|uM|620|nM
1MMP|2.30|1996|RSS||P09237|MATRILYSIN|6.07|Ki=0.85uM|Ki|=|0.85|uM|850|nM
1PBK|2.50|1996|RAP||Q00688|FKBP25|9.05|Ki=0.9nM|Ki|=|0.9|nM|0.9|nM
1JAO|2.40|1996|0D3||P22894|NEUTROPHIL COLLAGENASE (MMP-8)|5.92|Ki=1.2uM|Ki|=|1.2|uM|1200|nM
1GAI|1.70|1996|GAC||P22832|GLUCOAMYLASE-471|8.0|Ki=10nM|Ki|=|10|nM|10|nM
1TCX|2.30|1996|IM1||P04587|HIV-1 PROTEASE|6.95|Ki=112nM|Ki|=|112|nM|112|nM
1CWB|2.20|1996|11-mer||P05092|PEPTIDYL-PROLYL CIS-TRANS ISOMERASE A|7.89|Ki=13nM|Ki|=|13|nM|13|nM
1RDN|1.80|1996|MAG||P08661|MANNOSE-BINDING PROTEIN-C|1.84|Ki=14.4mM|Ki|=|14.4|mM|14400000|nM
1AMN|2.80|1996|NAF|covalent complex|P04058|ACETYLCHOLINESTERASE|13.82|Ki=15fM|Ki|=|15|fM|1.4999999999999999e-05|nM
1DUD|2.30|1996|DUD||P06968|DEOXYURIDINE 5'-TRIPHOSPHATE NUCLEOTIDOHYDROLASE|4.82|Ki=15uM|Ki|=|15|uM|15000|nM
1GAH|2.00|1996|ACR||P22832|GLUCOAMYLASE-471|12.0|Ki=1pM|Ki|=|1|pM|0.001|nM
1GNO|2.30|1996|U0E||P03368|HIV-1 PROTEASE|7.7|Ki=20nM|Ki|=|20|nM|20|nM
1RDJ|1.80|1996|MFB||P08661|MANNOSE-BINDING PROTEIN-C|1.66|Ki=21.7mM|Ki|=|21.7|mM|21700000|nM
1GNN|2.30|1996|U0E||P03368|HIV-1 PROTEASE|5.68|Ki=2100nM|Ki|=|2100|nM|2100|nM
1DIF|1.70|1996|A85||P03367|HIV-1 PROTEASE|10.66|Ki=22pM|Ki|=|22|pM|0.022|nM
1BMN|2.80|1996|BM9||P00734|THROMBIN ALPHA|8.44|Ki=3.6nM|Ki|=|3.6|nM|3.6|nM
1REV|2.60|1996|TB9||P04585|HIV-1 REVERSE TRANSCRIPTASE|7.48|Ki=33nM|Ki|=|33|nM|33|nM
1JAQ|2.40|1996|01S||P22894|NEUTROPHIL COLLAGENASE (MMP-8)|4.48|Ki=33uM|Ki|=|33|uM|33000|nM
2CSN|2.50|1996|CKI||P40233|CASEIN KINASE-1|4.41|Ki=39uM|Ki|=|39|uM|39000|nM
1MMR|2.40|1996|SRS||P09237|MATRILYSIN|5.4|Ki=4.0uM|Ki|=|4|uM|4000|nM
1MTR|1.75|1996|PI6||P03369|HIV-1 PROTEASE|8.4|Ki=4nM|Ki|=|4|nM|4|nM
1HPX|2.00|1996|KNI||P03367|HIV-1 PROTEASE|11.26|Ki=5.5pM|Ki|=|5.5|pM|0.0055|nM
1RDL|1.70|1996|MMA||P08661|MANNOSE-BINDING PROTEIN-C|2.24|Ki=5.7mM|Ki|=|5.7|mM|5700000|nM
1GNM|2.30|1996|U0E||P03368|HIV-1 PROTEASE|6.25|Ki=560nM|Ki|=|560|nM|560|nM
1PRO|1.80|1996|A88||P12499|HIV-1 PROTEASE|11.3|Ki=5pM|Ki|=|5|pM|0.005|nM
1NOI|2.50|1996|NTZ|redundant to 1noj|P00489|GLYCOGEN PHOSPHORYLASE|3.15|Ki=700uM|Ki|=|700|uM|700000|nM
1NOJ|2.40|1996|NTZ||P00489|GLYCOGEN PHOSPHORYLASE|3.15|Ki=700uM|Ki|=|700|uM|700000|nM
1NOK|2.40|1996|NTZ|redundant to 1noj|P00489|GLYCOGEN PHOSPHORYLASE|3.15|Ki=700uM|Ki|=|700|uM|700000|nM
1BMM|2.60|1996|BM2||P00734|THROMBIN ALPHA|7.1|Ki=79nM|Ki|=|79|nM|79|nM
1LHG|2.25|1996|DI5|covalent complex|P00734|THROMBIN ALPHA|7.1|Ki=79nM|Ki|=|79|nM|79|nM
1LHF|2.40|1996|DI4|covalent complex|P00734|THROMBIN ALPHA|8.09|Ki=8.1nM|Ki|=|8.1|nM|8.1|nM
1RDI|1.80|1996|MFU||P08661|MANNOSE-BINDING PROTEIN-C|2.06|Ki=8.8mM|Ki|=|8.8|mM|8800000|nM
1MDL|1.85|1996|RMN|ligand is compound (R)-Mandelate|P11444|MANDELATE RACEMASE|3.09|Ki=810uM|Ki|=|810|uM|810000|nM
1RNM|2.00|1996|C5P|ligand is compound 5'-CMP; Ki measured at pH=6.0|P61823|RIBONUCLEASE A|3.07|Ki=844.2uM|Ki|=|844.2|uM|844200|nM
1TCW|2.40|1996|IM1||Q07387|SIV PROTEASE|6.02|Ki=960nM|Ki|=|960|nM|960|nM
1FKW|2.40|1996|PUR||P03958|ADENOSINE DEAMINASE|5.05|Ki=9uM|Ki|=|9|uM|9000|nM
1KVO|2.00|1997|OAP||P14555|PHOSPHOLIPASE A2|7.89|IC=0.013uM|IC50|=|0.013|uM|13|nM
1TZE|2.10|1997|7-mer||P29354|GROWTH FACTOR RECEPTOR-BOUND PROTEIN 2|6.83|IC=0.148uM|IC50|=|0.148|uM|148|nM
1LT6|2.20|1997|GAA||P32890|HEAT-LABILE ENTEROTOXIN B CHAIN|3.3|IC=0.5mM|IC50|=|0.5|mM|500000|nM
1JLX|2.20|1997|3-mer||Q71QF2|AGGLUTININ|5.8|IC=1.6uM|IC50|=|1.6|uM|1600|nM
1BKM|2.00|1997|1C5||P00524|PP60 V-SRC TYROSINE KINASE TRANSFORMING PROTEIN|5.74|IC=1.8uM|IC50|=|1.8|uM|1800|nM
2ROX|2.00|1997|T44|ligand is thyroxine (T4)|P02766|TRANSTHYRETIN|4.98|IC=10.5uM|IC50|=|10.5|uM|10500|nM
1JLD|2.50|1997|0PP||P04584|HIV-2 PROTEASE|6.73|IC=185nM|IC50|=|185|nM|185|nM
1LT5|1.70|1997|TDG||P32890|HEAT-LABILE ENTEROTOXIN B CHAIN|2.7|IC=2mM|IC50|=|2|mM|2000000|nM
1TVR|3.00|1997|TB9||P03366|HIV-1 REVERSE TRANSCRIPTASE|7.48|IC=33nM|IC50|=|33|nM|33|nM
1UWB|3.20|1997|TBO||P03366|HIV-1 REVERSE TRANSCRIPTASE|8.34|IC=4.6nM|IC50|=|4.6|nM|4.6|nM
1DTH|2.00|1997|BAT||P15167|ATROLYSIN C|8.22|IC=6nM|IC50|=|6|nM|6|nM
1RT2|2.55|1997|TNK||P04585|HIV-1 REVERSE TRANSCRIPTASE|8.22|IC=6nM|IC50|=|6|nM|6|nM
1AQ1|2.00|1997|STU||P24941|CYCLIN-DEPENDENT KINASE 2|8.15|IC=7nM|IC50|=|7|nM|7|nM
1RT1|2.55|1997|MKC||P04585|HIV-1 REVERSE TRANSCRIPTASE|8.1|IC=8nM|IC50|=|8|nM|8|nM
1AVN|2.00|1997|HSM||P00918|CARBONIC ANHYDRASE 2|3.9|Kd=0.125mM|Kd|=|0.125|mM|125000|nM
1RBO|2.30|1997|CAP||P00875|RIBULOSE BISPHOSPHATE CARBOXYLASE/OXYGENASE|12.72|Kd=0.19pM|Kd|=|0.19|pM|0.00019|nM
1DRV|2.20|1997|A3D|ligand is 3-Ac-NADH; Kd=0.29+/-0.05uM|P04036|DIHYDRODIPICOLINATE REDUCTASE|6.54|Kd=0.29uM|Kd|=|0.29|uM|290|nM
1AQJ|2.60|1997|SFG||P14385|ADENINE-N6-DNA-METHYLTRANSFERASE TAQI|6.47|Kd=0.34uM|Kd|=|0.34|uM|340|nM
1BXL|NMR|1997|16-mer|Kd=0.34+/-0.03uM|Q07817|BCL-XL|6.47|Kd=0.34uM|Kd|=|0.34|uM|340|nM
1OKL|2.10|1997|MNS||P00918|CARBONIC ANHYDRASE 2|6.03|Kd=0.93uM|Kd|=|0.93|uM|930|nM
1AO0|2.80|1997|ADP||P00497|GLUTAMINE PHOSPHORIBOSYLPYROPHOSPHATE|4.96|Kd=11.0uM|Kd|=|11|uM|11000|nM
1NLP|NMR|1997|8-mer||P00525|C-SRC|4.96|Kd=11uM|Kd|=|11|uM|11000|nM
1AVP|2.60|1997|11-mer|covalent complex|P03252|ADENOVIRAL PROTEINASE|7.92|Kd=12nM|Kd|=|12|nM|12|nM
1JEV|1.30|1997|3-mer||P06202|OLIGO-PEPTIDE BINDING PROTEIN|6.89|Kd=130nM|Kd|=|130|nM|130|nM
1AJ7|2.10|1997|NPE||P01857|IMMUNOGLOBULIN 48G7 GERMLINE FAB|3.87|Kd=135uM|Kd|=|135|uM|135000|nM
1JEU|1.25|1997|3-mer||P06202|OLIGO-PEPTIDE BINDING PROTEIN|6.82|Kd=150nM|Kd|=|150|nM|150|nM
1AG9|1.80|1997|FMN||P61949|FLAVODOXIN|9.0|Kd=1nM|Kd|=|1|nM|1|nM
1ADO|1.90|1997|13P||P00883|ALDOLASE|6.0|Kd=1uM|Kd|=|1|uM|1000|nM
2ADM|2.60|1997|SAM||P14385|ADENINE-N6-DNA-METHYLTRANSFERASE TAQI|5.7|Kd=2.0uM|Kd|=|2|uM|2000|nM
1AQI|2.60|1997|SAH||P14385|ADENINE-N6-DNA-METHYLTRANSFERASE TAQI|5.62|Kd=2.4uM|Kd|=|2.4|uM|2400|nM
2H4N|1.90|1997|AZM||P00918|CARBONIC ANHYDRASE 2|8.7|Kd=2nM|Kd|=|2|nM|2|nM
1NLO|NMR|1997|9-mer||P00525|C-SRC|5.47|Kd=3.4uM|Kd|=|3.4|uM|3400|nM
1GBQ|NMR|1997|10-mer||Q60631|GRB2|2.46|Kd=3.5mM|Kd|=|3.5|mM|3500000|nM
3GBQ|NMR|1997|10-mer|minimized averaged structure|Q60631|GRB2|5.46|Kd=3.5uM|Kd|=|3.5|uM|3500|nM
2MAS|2.30|1997|PIR||Q27546|INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDROLASE|7.52|Kd=30nM|Kd|=|30|nM|30|nM
1RST|1.70|1997|9-mer||P22629|STREPTAVIDIN|4.43|Kd=37uM|Kd|=|37|uM|37000|nM
1AQC|2.30|1997|10-mer||Q02410|X11|5.34|Kd=4.56uM|Kd|=|4.56|uM|4560|nM
1SHC|NMR|1997|12-mer||P29353|SHC|7.28|Kd=53nM|Kd|=|53|nM|53|nM
1JET|1.20|1997|3-mer||P06202|OLIGO-PEPTIDE BINDING PROTEIN|7.25|Kd=56nM|Kd|=|56|nM|56|nM
2HRP|2.20|1997|10-mer|Kd measured on full length HIV-1 protease|P01837|MONOCLONAL ANTIBODY F11.2.32|8.3|Kd=5nM|Kd|=|5|nM|5|nM
2AAC|1.60|1997|FCB||P0A9E0|ARAC|2.22|Kd=6mM|Kd|=|6|mM|6000000|nM
1IRS|NMR|1997|11-mer||P35568|IRS-1|5.22|Kd=6uM|Kd|=|6|uM|6000|nM
1MPA|2.60|1997|9-mer||A2NHM3|MN12H2 IGG2A-KAPPA|8.04|Kd=9.1nM|Kd|=|9.1|nM|9.1|nM
1NOX|1.59|1997|FMN||Q60049|NADH OXIDASE|7.05|Kd=90nM|Kd|=|90|nM|90|nM
1LFO|2.30|1997|OLA|Kd=0.009-0.2uM for site 1; Kd=0.06-4.0uM for site 2|P02692|LIVER FATTY ACID BINDING PROTEIN|6.7|Kd~0.2uM|Kd|~|0.2|uM|200|nM
1UVT|2.50|1997|I48||P00735|THROMBIN|7.64|Ki=0.023uM|Ki|=|0.023|uM|23|nM
1QBT|2.10|1997|146||P04585|HIV-1 PROTEASE|10.62|Ki=0.024nM|Ki|=|0.024|nM|0.024|nM
1QBR|1.80|1997|XV6||P04585|HIV-1 PROTEASE|10.57|Ki=0.027nM|Ki|=|0.027|nM|0.027|nM
1AJQ|2.05|1997|SPA||P06875|PENICILLIN AMIDOHYDROLASE|4.31|Ki=0.049mM|Ki|=|0.049|mM|49000|nM
1QBU|1.80|1997|846||P04585|HIV-1 PROTEASE|10.24|Ki=0.058nM|Ki|=|0.058|nM|0.058|nM
1AI7|2.50|1997|IPH||P06875|PENICILLIN AMIDOHYDROLASE|4.09|Ki=0.082mM|Ki|=|0.082|mM|82000|nM
1AI6|2.55|1997|4HP||P06875|PENICILLIN AMIDOHYDROLASE|3.97|Ki=0.107mM|Ki|=|0.107|mM|107000|nM
4VGC|2.10|1997|SRD|covalent complex|P00766|GAMMA CHYMOTRYPSIN|6.9|Ki=0.127uM|Ki|=|0.127|uM|127|nM
1HXB|2.30|1997|ROC||P04585|HIV-1 PROTEASE|9.92|Ki=0.12nM|Ki|=|0.12|nM|0.12|nM
1SQC|2.85|1997|LDA||P33247|SQUALENE-HOPENE CYCLASE|6.85|Ki=0.14uM|Ki|=|0.14|uM|140|nM
3MBP|1.70|1997|3-mer||P02928|MALTODEXTRIN-BINDING PROTEIN|6.8|Ki=0.16uM|Ki|=|0.16|uM|160|nM
1AI5|2.36|1997|MNP||P06875|PENICILLIN AMIDOHYDROLASE|3.72|Ki=0.189mM|Ki|=|0.189|mM|189000|nM
1AD8|2.00|1997|MDL|covalent complex|P00734|THROMBIN|6.6|Ki=0.25uM|Ki|=|0.25|uM|250|nM
1DMP|2.00|1997|DMQ|IC50=76nM|P04585|HIV-1 PROTEASE|9.55|Ki=0.28nM|Ki|=|0.28|nM|0.28|nM
1QBS|1.80|1997|DMP||P04585|HIV-1 PROTEASE|9.47|Ki=0.34nM|Ki|=|0.34|nM|0.34|nM
1PAU|2.50|1997|5-mer|covalent complex|P42574|APOPAIN|9.46|Ki=0.35nM|Ki|=|0.35|nM|0.35|nM
2KCE|2.20|1997|D16||P0A884|THYMIDYLATE SYNTHASE|6.17|Ki=0.67uM|Ki|=|0.67|uM|670|nM
1HPO|2.50|1997|UNI||P03367|HIV-1 PROTEASE|9.22|Ki=0.6nM|Ki|=|0.6|nM|0.6|nM
1AF2|2.30|1997|__U||P0ABF6|CYTIDINE DEAMINASE|3.1|Ki=0.8mM|Ki|=|0.8|mM|800000|nM
1VGC|1.90|1997|V36|covalent complex|P00766|GAMMA CHYMOTRYPSIN|5.92|Ki=1.20uM|Ki|=|1.2|uM|1200|nM
1YDS|2.20|1997|IQS||P00517|CAMP-DEPENDENT PROTEIN KINASE|5.92|Ki=1.2uM|Ki|=|1.2|uM|1200|nM
3GSS|1.90|1997|2-mer||P09211|GLUTATHIONE S-TRANSFERASE P1-1|5.82|Ki=1.5uM|Ki|=|1.5|uM|1500|nM
1DUB|2.50|1997|CAA||P14604|2-ENOYL-COA HYDRATASE|5.8|Ki=1.6uM|Ki|=|1.6|uM|1600|nM
1UVU|2.80|1997|DCH|incomplete ligand structure|P00735|THROMBIN|5.0|Ki=10uM|Ki|=|10|uM|10000|nM
2GSS|1.90|1997|EAA||P09211|GLUTATHIONE S-TRANSFERASE P1-1|4.94|Ki=11.5uM|Ki|=|11.5|uM|11500|nM
1AJX|2.00|1997|AH1||P03366|HIV-1 PROTEASE|7.91|Ki=12.2nM|Ki|=|12.2|nM|12.2|nM
2RKM|1.80|1997|2-mer||P06202|OLIGO-PEPTIDE BINDING PROTEIN|3.9|Ki=125uM|Ki|=|125|uM|125000|nM
1H4N|2.00|1997|TRS||P00918|CARBONIC ANHYDRASE 2|4.92|Ki=12uM|Ki|=|12|uM|12000|nM
3AID|2.50|1997|ARQ||P03369|HIV-1 PROTEASE|6.86|Ki=137nM|Ki|=|137|nM|137|nM
1AID|2.20|1997|THK||P03369|HIV-1 PROTEASE|4.82|Ki=15uM|Ki|=|15|uM|15000|nM
1AL7|2.60|1997|HST||P05414|GLYCOLATE OXIDASE|7.8|Ki=16nM|Ki|=|16|nM|16|nM
1AJV|2.00|1997|NMB||P03366|HIV-1 PROTEASE|7.72|Ki=19.1nM|Ki|=|19.1|nM|19.1|nM
1AJN|2.36|1997|AAN||P06875|PENICILLIN AMIDOHYDROLASE|2.63|Ki=2.32mM|Ki|=|2.32|mM|2320000|nM
1FWE|2.00|1997|HAE|Ki=1.3mM, total Ki=2.5uM|P18316|UREASE|5.6|Ki=2.5uM|Ki|=|2.5|uM|2500|nM
1VFN|2.15|1997|HPA||P55859|PURINE NUCLEOSIDE PHOSPHORYLASE|5.6|Ki=2.5uM|Ki|=|2.5|uM|2500|nM
1JUY|2.50|1997|H5P||P0A7D4|ADENYLOSUCCINATE SYNTHETASE|7.66|Ki=22nM|Ki|=|22|nM|22|nM
1VOT|2.50|1997|HUP|redundant to 1gpk|P04058|ACETYLCHOLINESTERASE|6.6|Ki=250nM|Ki|=|250|nM|250|nM
1YDR|2.20|1997|IQP||P00517|CAMP-DEPENDENT PROTEIN KINASE|5.52|Ki=3.0uM|Ki|=|3|uM|3000|nM
3VGC|1.67|1997|SRB|covalent complex|P00766|GAMMA CHYMOTRYPSIN|5.51|Ki=3.11uM|Ki|=|3.11|uM|3110|nM
1AI4|2.35|1997|DHY||P06875|PENICILLIN AMIDOHYDROLASE|2.5|Ki=3.13mM|Ki|=|3.13|mM|3130000|nM
7UPJ|2.00|1997|INU||P03367|HIV-1 PROTEASE|8.49|Ki=3.2nM|Ki|=|3.2|nM|3.2|nM
1ANF|1.67|1997|GLC-GLC||P02928|MALTODEXTRIN-BINDING PROTEIN|5.46|Ki=3.5uM|Ki|=|3.5|uM|3500|nM
1AL8|2.20|1997|DHP||P05414|GLYCOLATE OXIDASE|5.32|Ki=4.8uM|Ki|=|4.8|uM|4800|nM
1FAX|3.00|1997|DX9||P00742|COAGULATION FACTOR XA|7.39|Ki=41nM|Ki|=|41|nM|41|nM
6UPJ|2.34|1997|NIU||P04584|HIV-2 PROTEASE|6.32|Ki=480nM|Ki|=|480|nM|480|nM
1YDT|2.30|1997|IQB||P00517|CAMP-DEPENDENT PROTEIN KINASE|7.32|Ki=48nM|Ki|=|48|nM|48|nM
1UVS|2.80|1997|I11||P00734|THROMBIN|5.4|Ki=4uM|Ki|=|4|uM|4000|nM
2VGC|1.80|1997|V35|covalent complex|P00766|GAMMA CHYMOTRYPSIN|5.24|Ki=5.76uM|Ki|=|5.76|uM|5760|nM
1AJP|2.31|1997|OMD||P06875|PENICILLIN AMIDOHYDROLASE|2.23|Ki=5.85mM|Ki|=|5.85|mM|5850000|nM
1AMK|1.83|1997|PGA|Ki=0.050+/-0.003mM|P48499|TRIOSEPHOSPHATE ISOMERASE|4.3|Ki=50uM|Ki|=|50|uM|50000|nM
1ML1|2.60|1997|PGA||P04789|TRIOSEPHOSPHATE ISOMERASE|4.28|Ki=52uM|Ki|=|52|uM|52000|nM
1TOM|1.80|1997|MIN||P00734|THROMBIN ALPHA|8.3|Ki=5nM|Ki|=|5|nM|5|nM
1SME|2.70|1997|6-mer||P46925|PLASMEPSIN-2|11.22|Ki=6pM|Ki|=|6|pM|0.006|nM
5UPJ|2.30|1997|UIN||P04584|HIV-2 PROTEASE|7.12|Ki=75nM|Ki|=|75|nM|75|nM
2JXR|2.40|1997|2Z3||P07267|SACCHAROPEPSIN|7.05|Ki=90nM|Ki|=|90|nM|90|nM
1RTF|2.30|1997|BEN||P00750|TISSUE PLASMINOGEN ACTIVATOR|3.04|Ki=910uM|Ki|=|910|uM|910000|nM
1BM2|2.10|1998|7-mer||P29354|GROWTH FACTOR RECEPTOR-BOUND PROTEIN 2|6.96|IC=0.11uM|IC50|=|0.11|uM|110|nM
2PAX|2.40|1998|4AN||P26446|POLY (ADP-RIBOSE) POLYMERASE|6.74|IC=0.18uM|IC50|=|0.18|uM|180|nM
1VIK|2.40|1998|BAY|redundant to 1vij|P12499|HIV-1 PROTEASE|9.52|IC=0.3nM|IC50|=|0.3|nM|0.3|nM
4AIG|2.00|1998|FLX||P34179|ADAMALYSIN II|6.52|IC=0.3uM|IC50|=|0.3|uM|300|nM
4PAX|2.80|1998|NU1||P26446|POLY (ADP-RIBOSE) POLYMERASE|6.4|IC=0.4uM|IC50|=|0.4|uM|400|nM
1A2C|2.10|1998|4-mer||P00734|THROMBIN ALPHA|6.3|IC=0.5uM|IC50|=|0.5|uM|500|nM
1BMB|1.80|1998|9-mer||P62993|GROWTH FACTOR RECEPTOR-BOUND PROTEIN 2|6.15|IC=0.7uM|IC50|=|0.7|uM|700|nM
1AQ7|2.20|1998|4-mer||P00760|TRYPSIN|6.05|IC=0.9uM|IC50|=|0.9|uM|900|nM
1BL4|1.90|1998|AP1||P62942|FK506-BINDING PROTEIN|8.74|IC=1.8nM|IC50|=|1.8|nM|1.8|nM
1FGI|2.50|1998|SU1|IC50=10-20uM|P11362|FGF RECEPTOR 1|5.0|IC=10uM|IC50|=|10|uM|10000|nM
2AIG|2.60|1998|0GR||P34179|ADAMALYSIN II|5.0|IC=10uM|IC50|=|10|uM|10000|nM
3PAX|2.40|1998|3MB||P26446|POLY (ADP-RIBOSE) POLYMERASE|5.0|IC=10uM|IC50|=|10|uM|10000|nM
3AIG|2.80|1998|0ZC||P34179|ADAMALYSIN II|6.0|IC=1uM|IC50|=|1|uM|1000|nM
1AGW|2.40|1998|SU2|IC50=20-40uM|P11362|FGF RECEPTOR 1|4.7|IC=20uM|IC50|=|20|uM|20000|nM
2QWG|1.80|1998|G28||P03472|NEURAMINIDASE|3.64|IC=230uM|IC50|=|230|uM|230000|nM
1BJI|2.00|1998|DPC||P03472|NEURAMINIDASE|8.7|IC=2nM|IC50|=|2|nM|2|nM
1BMQ|2.50|1998|MNO|covalent complex|P29466|INTERLEUKIN-1 BETA CONVERTASE|7.42|IC=38nM|IC50|=|38|nM|38|nM
1AO8|NMR|1998|MTX|ligand is methotrexate|P00381|DIHYDROFOLATE REDUCTASE|8.22|IC=6nM|IC50|=|6|nM|6|nM
1SKJ|2.00|1998|UR2||P00524|PP60 V-SRC TYROSINE KINASE TRANSFORMING PROTEIN|5.15|IC=7.0uM|IC50|=|7|uM|7000|nM
1ERR|2.60|1998|RAL|ligand is compound 2, RALOXIFENE|P03372|ESTROGEN RECEPTOR|8.11|IC=7.7nM|IC50|=|7.7|nM|7.7|nM
1A5V|1.90|1998|_Y3||P03354|INTEGRASE|3.1|IC=800uM|IC50|=|800|uM|800000|nM
1AKV|2.00|1998|FMN|sq)|P00323|FLAVODOXIN|11.59|Kd=0.0026nM|Kd|=|0.0026|nM|0.0026|nM
1B7H|2.00|1998|3-mer||P06202|OLIGO-PEPTIDE BINDING PROTEIN|8.02|Kd=0.0095uM|Kd|=|0.0095|uM|9.5|nM
1B6H|1.80|1998|3-mer||P06202|OLIGO-PEPTIDE BINDING PROTEIN|7.82|Kd=0.015uM|Kd|=|0.015|uM|15|nM
1A4K|2.40|1998|FRA||P01834|ANTIBODY FAB FRAGMENT|8.0|Kd=0.01uM|Kd|=|0.01|uM|10|nM
3PCJ|2.13|1998|INO||P00436|PROTOCATECHUATE 3,4-DIOXYGENASE|7.22|Kd=0.06uM|Kd|=|0.06|uM|60|nM
1B1H|1.80|1998|3-mer||P06202|OLIGO-PEPTIDE BINDING PROTEIN|7.03|Kd=0.093uM|Kd|=|0.093|uM|93|nM
1AX2|1.95|1998|NAG-GAL||P16404|LECTIN|3.99|Kd=0.103mM|Kd|=|0.103|mM|103000|nM
1B39|2.10|1998|ATP|redundant to 1b38|P24941|CELL DIVISION PROTEIN KINASE 2|6.92|Kd=0.120uM|Kd|=|0.12|uM|120|nM
1BCJ|2.10|1998|NGA||P19999|MANNOSE-BINDING PROTEIN-A|3.7|Kd=0.20mM|Kd|=|0.2|mM|200000|nM
1B0H|1.90|1998|3-mer||P06202|OLIGO-PEPTIDE BINDING PROTEIN|6.7|Kd=0.20uM|Kd|=|0.2|uM|200|nM
1B38|2.00|1998|ATP||P24941|CELL DIVISION PROTEIN KINASE 2|6.6|Kd=0.254uM|Kd|=|0.254|uM|254|nM
1A7X|2.00|1998|FKA||P62942|FK506-BINDING PROTEIN (FKBP)|9.7|Kd=0.2nM|Kd|=|0.2|nM|0.2|nM
1A09|2.00|1998|4-mer|covalent complex|P12931|C-SRC TYROSINE KINASE|6.7|Kd=0.2uM|Kd|=|0.2|uM|200|nM
3PCK|2.13|1998|NNO||P00436|PROTOCATECHUATE 3,4-DIOXYGENASE|6.7|Kd=0.2uM|Kd|=|0.2|uM|200|nM
1X11|2.50|1998|14-mer|incomplete ligand structure|Q02410|X11|6.49|Kd=0.32uM|Kd|=|0.32|uM|320|nM
220L|1.85|1998|BNZ|redundant to 1l83|P00720|T4 LYSOZYME|3.4|Kd=0.4mM|Kd|=|0.4|mM|400000|nM
223L|1.90|1998|BNZ|redundant to 1l83|P00720|T4 LYSOZYME|3.4|Kd=0.4mM|Kd|=|0.4|mM|400000|nM
1A07|2.20|1998|4-mer|incomplete ligand structure|P12931|C-SRC TYROSINE KINASE|6.4|Kd=0.4uM|Kd|=|0.4|uM|400|nM
1A1B|2.20|1998|3-mer||P12931|C-SRC TYROSINE KINASE|6.4|Kd=0.4uM|Kd|=|0.4|uM|400|nM
1A1C|2.40|1998|3-mer||P12931|C-SRC TYROSINE KINASE|6.4|Kd=0.4uM|Kd|=|0.4|uM|400|nM
1AX1|1.95|1998|GLC-GAL||P16404|LECTIN|3.29|Kd=0.515mM|Kd|=|0.515|mM|515000|nM
1BCU|2.00|1998|PRL|Kd=0.53mM in crystal; Kd=10uM in solution|P00734|THROMBIN|3.28|Kd=0.53mM|Kd|=|0.53|mM|530000|nM
2NMB|NMR|1998|7-mer||P16554|NUMB PROTEIN|6.28|Kd=0.53uM|Kd|=|0.53|uM|530|nM
1WDN|1.94|1998|GLN||P10344|GLUTAMINE BINDING PROTEIN|6.3|Kd=0.5uM|Kd|=|0.5|uM|500|nM
1B3H|2.00|1998|3-mer||P06202|OLIGO-PEPTIDE BINDING PROTEIN|6.21|Kd=0.62uM|Kd|=|0.62|uM|620|nM
1AXZ|1.95|1998|GAL||P16404|LECTIN|3.2|Kd=0.637mM|Kd|=|0.637|mM|637000|nM
1A9Q|2.00|1998|HPA|ligand is hypoxanthine|P55859|PURINE NUCLEOSIDE PHOSPHORYLASE|6.17|Kd=0.68uM|Kd|=|0.68|uM|680|nM
1AX0|1.90|1998|A2G||P16404|LECTIN|3.13|Kd=0.746mM|Kd|=|0.746|mM|746000|nM
1AKQ|1.90|1998|FMN|ox)|P00323|FLAVODOXIN|9.1|Kd=0.79nM|Kd|=|0.79|nM|0.79|nM
1AKR|1.58|1998|FMN|ox)|P00323|FLAVODOXIN|9.09|Kd=0.82nM|Kd|=|0.82|nM|0.82|nM
1JMG|2.20|1998|UMP||P00469|THYMIDYLATE SYNTHASE|6.07|Kd=0.85uM|Kd|=|0.85|uM|850|nM
1JMI|2.50|1998|UMP|redundant to 1jmg|P00469|THYMIDYLATE SYNTHASE|6.06|Kd=0.87uM|Kd|=|0.87|uM|870|nM
1B5H|1.90|1998|3-mer||P06202|OLIGO-PEPTIDE BINDING PROTEIN|6.01|Kd=0.97uM|Kd|=|0.97|uM|970|nM
1A4H|2.50|1998|GDM|redundant to 1yet|P02829|HEAT SHOCK PROTEIN HSP90|5.92|Kd=1.2uM|Kd|=|1.2|uM|1200|nM
1AJ6|2.30|1998|NOV|Kd measured at 300K|P06982|GYRASE|5.92|Kd=1.2uM|Kd|=|1.2|uM|1200|nM
1LVK|1.90|1998|MNT-BEF||P08799|MYOSIN|5.92|Kd=1.2uM|Kd|=|1.2|uM|1200|nM
1YET|1.90|1998|GDM|ligand is compound 34(geldanamycin)|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|5.92|Kd=1.2uM|Kd|=|1.2|uM|1200|nM
1BBZ|1.65|1998|11-mer||P00519|ABL TYROSINE KINASE|5.82|Kd=1.5uM|Kd|=|1.5|uM|1500|nM
1VWN|1.85|1998|7-mer|incomplete ligand structure|P22629|STREPTAVIDIN|5.82|Kd=1.5uM|Kd|=|1.5|uM|1500|nM
1JMF|2.50|1998|UMP||P00469|THYMIDYLATE SYNTHASE|5.77|Kd=1.7uM|Kd|=|1.7|uM|1700|nM
1GUX|1.85|1998|9-mer||P06400|RETINOBLASTOMA PROTEIN|6.96|Kd=110nM|Kd|=|110|nM|110|nM
1B3L|2.00|1998|3-mer||P06202|OLIGO-PEPTIDE BINDING PROTEIN|5.89|Kd=1300nM|Kd|=|1300|nM|1300|nM
1B3F|1.80|1998|3-mer||P06202|OLIGO-PEPTIDE BINDING PROTEIN|6.89|Kd=130nM|Kd|=|130|nM|130|nM
1AF6|2.40|1998|GLC-FRU||P02943|MALTOPORIN|1.82|Kd=15mM|Kd|=|15|mM|15000000|nM
1AZG|NMR|1998|14-mer|minimized averaged structure; Kd1=16uM(ITC); Kd2=50uM(NMR); Kd3=28uM(CD);|P27986|PRO-PRO-ARG-PRO-LEU-PRO-VAL-ALA-PRO-GLY-SER-SER|4.8|Kd=16uM|Kd|=|16|uM|16000|nM
1AXS|2.60|1998|HOP||P01857|OXY-COPE CATALYTIC ANTIBODY|7.77|Kd=17nM|Kd|=|17|nM|17|nM
1BR8|2.90|1998|12-mer||P01008|ANTITHROMBIN-III|4.74|Kd=18uM|Kd|=|18|uM|18000|nM
1A1E|2.20|1998|4-mer||P12931|C-SRC TYROSINE KINASE|6.0|Kd=1uM|Kd|=|1|uM|1000|nM
2IZL|1.48|1998|IMI||P22629|STREPTAVIDIN|6.0|Kd=1uM|Kd|=|1|uM|1000|nM
1VWL|1.45|1998|9-mer||P22629|STREPTAVIDIN|5.63|Kd=2.33uM|Kd|=|2.33|uM|2330|nM
1AZL|1.80|1998|FMN|ox)|P00323|FLAVODOXIN|8.62|Kd=2.4nM|Kd|=|2.4|nM|2.4|nM
1A08|2.20|1998|4-mer||P12931|C-SRC TYROSINE KINASE|5.62|Kd=2.4uM|Kd|=|2.4|uM|2400|nM
1AKW|1.75|1998|FMN|ox)|P00323|FLAVODOXIN|8.59|Kd=2.6nM|Kd|=|2.6|nM|2.6|nM
1B3G|2.00|1998|3-mer||P06202|OLIGO-PEPTIDE BINDING PROTEIN|6.7|Kd=200nM|Kd|=|200|nM|200|nM
4TMK|1.98|1998|T5A||P0A720|THYMIDYLATE KINASE|7.7|Kd=20nM|Kd|=|20|nM|20|nM
3PCN|2.40|1998|DHY||P00436|PROTOCATECHUATE 3,4-DIOXYGENASE|3.66|Kd=220uM|Kd|=|220|uM|220000|nM
1AMW|1.85|1998|ADP||P02829|HEAT SHOCK PROTEIN HSP90|4.54|Kd=29uM|Kd|=|29|uM|29000|nM
1B2H|1.90|1998|3-mer||P06202|OLIGO-PEPTIDE BINDING PROTEIN|4.54|Kd=29uM|Kd|=|29|uM|29000|nM
1A99|2.20|1998|PUT||P31133|PUTRESCINE-BINDING PROTEIN|5.7|Kd=2uM|Kd|=|2|uM|2000|nM
1AKT|1.80|1998|FMN|ox)|P00323|FLAVODOXIN|8.49|Kd=3.2nM|Kd|=|3.2|nM|3.2|nM
1B4H|1.90|1998|3-mer||P06202|OLIGO-PEPTIDE BINDING PROTEIN|5.46|Kd=3.44uM|Kd|=|3.44|uM|3440|nM
1A3E|1.85|1998|18-mer|incomplete ligand structure|P00734|THROMBIN ALPHA|8.46|Kd=3.5nM|Kd|=|3.5|nM|3.5|nM
1BM7|2.00|1998|FLF||P02766|TRANSTHYRETIN|7.52|Kd=30nM|Kd|=|30|nM|30|nM
1VWF|1.92|1998|9-mer|Kd for ligand in cyclized form|P22629|STREPTAVIDIN|6.51|Kd=310nM|Kd|=|310|nM|310|nM
5TMP|1.98|1998|Z5A||P0A720|THYMIDYLATE KINASE|7.47|Kd=34nM|Kd|=|34|nM|34|nM
1BHF|1.80|1998|5-mer||P06239|T-LYMPHOCYTE-SPECIFIC PROTEIN TYROSINE KINASE|4.38|Kd=42uM|Kd|=|42|uM|42000|nM
1SWG|1.80|1998|BTN||P22629|CIRCULARLY PERMUTED CORE-STREPTAVIDIN E51/A46|7.36|Kd=43.9nM|Kd|=|43.9|nM|43.9|nM
4RSK|2.10|1998|U3P|Ki=47.4uM (with 0.018M Na+); Ki=153.6uM (with 0.142M Na+)|P61823|RIBONUCLEASE A|4.32|Kd=47.4uM|Kd|=|47.4|uM|47400|nM
1A0T|2.40|1998|SUC||P22340|SUCROSE-SPECIFIC PORIN|1.3|Kd=50mM|Kd|=|50|mM|50000000|nM
1AT5|1.80|1998|3-mer||P00698|LYSOZYME C|4.19|Kd=64uM|Kd|=|64|uM|64000|nM
1AKU|1.90|1998|FMN|hq)|P00323|FLAVODOXIN|6.13|Kd=746nM|Kd|=|746|nM|746|nM
1B05|2.00|1998|3-mer||P06202|OLIGO-PEPTIDE BINDING PROTEIN|7.12|Kd=75nM|Kd|=|75|nM|75|nM
1B32|1.75|1998|3-mer||P06202|OLIGO-PEPTIDE BINDING PROTEIN|7.1|Kd=79nM|Kd|=|79|nM|79|nM
1AT6|1.80|1998|3-mer||P00698|LYSOZYME C|4.07|Kd=85uM|Kd|=|85|uM|85000|nM
1AWI|2.20|1998|10-mer||P07737|PROFILIN|4.05|Kd=90uM|Kd|=|90|uM|90000|nM
1USN|1.80|1998|IN9||P08254|STROMELYSIN-1|7.74|Ki=0.018uM|Ki|=|0.018|uM|18|nM
2QWE|2.00|1998|GNA||P03472|NEURAMINIDASE|7.48|Ki=0.033uM|Ki|=|0.033|uM|33|nM
1BV7|2.00|1998|XV6|complex between HIV-1 PR (I84V mutant) with XV638; Ki mutant/wt ratio=0.5; Ki(wt)=0.1nM|P04585|HIV-1 PROTEASE|10.3|Ki=0.05nM|Ki|=|0.05|nM|0.05|nM
1A5G|2.06|1998|00L|covalent complex|P00734|THROMBIN ALPHA|10.15|Ki=0.071nM|Ki|=|0.071|nM|0.071|nM
1XUG|1.50|1998|BAB||P00760|TRYPSIN|7.05|Ki=0.09uM|Ki|=|0.09|uM|90|nM
1BXO|0.95|1998|PP7||P00798|PENICILLOPEPSIN|10.0|Ki=0.10nM|Ki|=|0.1|nM|0.1|nM
1BV9|2.00|1998|XV6||P04585|HIV-1 PROTEASE|9.96|Ki=0.11nM|Ki|=|0.11|nM|0.11|nM
1A52|2.80|1998|EST|ligand is compound Estradiol (E2)|P03372|ESTROGEN RECEPTOR|9.86|Ki=0.138nM|Ki|=|0.138|nM|0.138|nM
1BHX|2.30|1998|R56||P00734|THROMBIN ALPHA|6.84|Ki=0.145uM|Ki|=|0.145|uM|145|nM
1TBZ|2.30|1998|00Q|covalent complex|P00734|THROMBIN ALPHA|9.8|Ki=0.16nM|Ki|=|0.16|nM|0.16|nM
1BDR|2.80|1998|IM1||P04587|HIV-1 PROTEASE|6.68|Ki=0.21uM|Ki|=|0.21|uM|210|nM
2USN|2.20|1998|IN8||P08254|STROMELYSIN-1|6.51|Ki=0.31uM|Ki|=|0.31|uM|310|nM
1MOQ|1.57|1998|GLP||P17169|GLUCOSAMINE 6-PHOSPHATE SYNTHASE|3.46|Ki=0.35mM|Ki|=|0.35|mM|350000|nM
1ALW|2.03|1998|ISA||P04574|CALPAIN|6.52|Ki=0.3uM|Ki|=|0.3|uM|300|nM
1BDQ|2.50|1998|IM1||P04587|HIV-1 PROTEASE|6.34|Ki=0.46uM|Ki|=|0.46|uM|460|nM
1MET|1.90|1998|DMP||P03366|HIV-1 PROTEASE|9.4|Ki=0.4nM|Ki|=|0.4|nM|0.4|nM
10GS|2.20|1998|VWW||P09211|GLUTATHIONE S-TRANSFERASE P1-1|6.4|Ki=0.4uM|Ki|=|0.4|uM|400|nM
1BR6|2.30|1998|PT1||P02879|RICIN|3.22|Ki=0.6mM|Ki|=|0.6|mM|600000|nM
1AYU|2.20|1998|INA|covalent complex|P43235|CATHEPSIN K|9.15|Ki=0.7nM|Ki|=|0.7|nM|0.7|nM
1TSL|2.50|1998|A15||P00469|THYMIDYLATE SYNTHASE|6.15|Ki=0.7uM|Ki|=|0.7|uM|700|nM
1AWH|3.00|1998|GR3|covalent complex|P00734|THROMBIN ALPHA|6.08|Ki=0.83uM|Ki|=|0.83|uM|830|nM
1MEU|1.90|1998|DMP||P03366|HIV-1 PROTEASE|6.1|Ki=0.8uM|Ki|=|0.8|uM|800|nM
2WED|1.50|1998|PP6||P00798|PENICILLOPEPSIN|6.1|Ki=0.8uM|Ki|=|0.8|uM|800|nM
1AWF|2.20|1998|GR4|covalent complex|P00734|THROMBIN ALPHA|6.01|Ki=0.97uM|Ki|=|0.97|uM|970|nM
3PCF|2.15|1998|FHB||P00436|PROTOCATECHUATE 3,4-DIOXYGENASE|6.05|Ki=0.9uM|Ki|=|0.9|uM|900|nM
1TSM|3.00|1998|MR2||P00469|THYMIDYLATE SYNTHASE|6.0|Ki=1.0uM|Ki|=|1|uM|1000|nM
2PRI|2.30|1998|D6G||P00489|GLYCOGEN PHOSPHORYLASE B|2.91|Ki=1.23mM|Ki|=|1.23|mM|1230000|nM
1A4W|1.80|1998|QWE||P00734|THROMBIN ALPHA|5.92|Ki=1.2uM|Ki|=|1.2|uM|1200|nM
1BDL|2.80|1998|IM1||P04587|HIV-1 PROTEASE|5.85|Ki=1.41uM|Ki|=|1.41|uM|1410|nM
3TLH|2.00|1998|3TL||P03366|HIV-1 PROTEASE|8.82|Ki=1.5nM|Ki|=|1.5|nM|1.5|nM
2AMV|2.30|1998|BIN||P00489|GLYCOGEN PHOSPHORYLASE|8.8|Ki=1.6nM|Ki|=|1.6|nM|1.6|nM
1A8T|2.55|1998|061||P25910|METALLO-BETA-LACTAMASE|5.8|Ki=1.6uM|Ki|=|1.6|uM|1600|nM
3PCE|2.06|1998|3HP||P00436|PROTOCATECHUATE 3,4-DIOXYGENASE|2.0|Ki=10mM|Ki|=|10|mM|10000000|nM
1AYV|2.30|1998|IN6|covalent complex|P43235|CATHEPSIN K|8.0|Ki=10nM|Ki|=|10|nM|10|nM
1B5G|2.07|1998|0ZE|covalent complex|P00734|THROMBIN ALPHA|8.0|Ki=10nM|Ki|=|10|nM|10|nM
1MEM|1.80|1998|0D6|covalent complex|P43235|CATHEPSIN K|7.94|Ki=11.5nM|Ki|=|11.5|nM|11.5|nM
2WEC|1.50|1998|PP5||P00798|PENICILLOPEPSIN|3.96|Ki=110uM|Ki|=|110|uM|110000|nM
1A9M|2.30|1998|U0E||P03368|HIV-1 PROTEASE|6.92|Ki=119nM|Ki|=|119|nM|119|nM
1HVH|1.80|1998|Q82||P04585|HIV-1 PROTEASE|7.96|Ki=11nM|Ki|=|11|nM|11|nM
1AU2|2.60|1998|POS|covalent complex|P43235|CATHEPSIN K|7.89|Ki=13nM|Ki|=|13|nM|13|nM
1ILQ|NMR|1998|19-mer|minimized mean structure; Ki=20uM(CXCR-1 and IL-8)|P10145|INTERLEUKIN-8 PRECURSOR|4.89|Ki=13uM|Ki|=|13|uM|13000|nM
2QWD|2.00|1998|4AM||P03472|NEURAMINIDASE|4.85|Ki=14uM|Ki|=|14|uM|14000|nM
1B4D|2.00|1998|CRA||P00489|GLYCOGEN PHOSPHORYLASE B|4.81|Ki=15.6uM|Ki|=|15.6|uM|15600|nM
1HXW|1.80|1998|RIT||P12499|HIV-1 PROTEASE|10.82|Ki=15pM|Ki|=|15|pM|0.015|nM
1BJU|1.80|1998|GP6|Ki=16+/-2.8uM for ACPU|P00760|TRYPSIN BETA|4.8|Ki=16uM|Ki|=|16|uM|16000|nM
2QWB|2.00|1998|SIA||P03472|NEURAMINIDASE|2.74|Ki=1820uM|Ki|=|1820|uM|1820000|nM
6CGT|2.60|1998|6-mer||P30920|CYCLODEXTRIN GLYCOSYLTRANSFERASE|6.0|Ki=1uM|Ki|=|1|uM|1000|nM
2QWF|1.90|1998|G20||P03472|NEURAMINIDASE|5.67|Ki=2.160uM|Ki|=|2.16|uM|2160|nM
4MBP|1.70|1998|4-mer||P02928|MALTODEXTRIN-BINDING PROTEIN|5.64|Ki=2.3uM|Ki|=|2.3|uM|2300|nM
1A61|2.20|1998|00N|covalent complex|P00734|THROMBIN ALPHA|8.62|Ki=2.4nM|Ki|=|2.4|nM|2.4|nM
1BWA|1.90|1998|XV6||P04585|HIV-1 PROTEASE|8.6|Ki=2.5nM|Ki|=|2.5|nM|2.5|nM
1BJV|1.80|1998|GP8|Ki=2.9+/-0.1uM for APPU|P00760|TRYPSIN BETA|5.54|Ki=2.9uM|Ki|=|2.9|uM|2900|nM
1A46|2.12|1998|00K|covalent complex|P00734|THROMBIN|5.7|Ki=2000nM|Ki|=|2000|nM|2000|nM
1B0F|3.00|1998|SEI|covalent complex|P08246|NEUTROPHIL ELASTASE|7.7|Ki=20nM|Ki|=|20|nM|20|nM
1MES|1.90|1998|DMP||P03366|HIV-1 PROTEASE|7.7|Ki=20nM|Ki|=|20|nM|20|nM
1BJR|2.44|1998|10-mer|covalent complex|P06873|PROTEINASE K|7.68|Ki=21nM|Ki|=|21|nM|21|nM
1AU0|2.60|1998|SDK|covalent complex|P43235|CATHEPSIN K|7.66|Ki=22nM|Ki|=|22|nM|22|nM
5FIV|1.90|1998|3TL||P16088|RETROPEPSIN|7.66|Ki=22nM|Ki|=|22|nM|22|nM
1A7T|1.85|1998|MES||P25910|METALLO-BETA-LACTAMASE|1.64|Ki=23mM|Ki|=|23|mM|23000000|nM
1AFK|1.70|1998|PAP||P61823|RIBONUCLEASE A|6.62|Ki=240nM|Ki|=|240|nM|240|nM
3PCC|1.98|1998|PHB||P00436|PROTOCATECHUATE 3,4-DIOXYGENASE|3.62|Ki=240uM|Ki|=|240|uM|240000|nM
3JDW|2.40|1998|ORN||P50440|L-ARGININE/GLYCINE AMIDINOTRANSFERASE|3.6|Ki=253uM|Ki|=|253|uM|253000|nM
2HPA|2.90|1998|PT3||P15309|PROSTATIC ACID PHOSPHATASE|4.6|Ki=25uM|Ki|=|25|uM|25000|nM
2QWC|1.60|1998|DAN||P03472|NEURAMINIDASE|3.55|Ki=280uM|Ki|=|280|uM|280000|nM
1HFS|1.70|1998|L04||P08254|STROMELYSIN-1|8.7|Ki=2nM|Ki|=|2|nM|2|nM
1OHR|2.10|1998|1UN||Q9Q288|HIV-1 PROTEASE|8.7|Ki=2nM|Ki|=|2|nM|2|nM
1A8I|1.78|1998|GLS||P00489|GLYCOGEN PHOSPHORYLASE|5.52|Ki=3.0uM|Ki|=|3|uM|3000|nM
1BWB|1.80|1998|146||P04585|HIV-1 PROTEASE|8.42|Ki=3.8nM|Ki|=|3.8|nM|3.8|nM
2PRJ|2.30|1998|NBG||P00489|GLYCOGEN PHOSPHORYLASE|4.49|Ki=32uM|Ki|=|32|uM|32000|nM
1LOX|2.40|1998|RS7||P12530|15-LIPOXYGENASE|5.52|Ki=3uM|Ki|=|3|uM|3000|nM
1B11|1.90|1998|3TL||P16088|FIV PROTEASE|7.39|Ki=41nM|Ki|=|41|nM|41|nM
1BXQ|1.41|1998|PP8||P00798|PENICILLOPEPSIN|7.38|Ki=42nM|Ki|=|42|nM|42|nM
3PCB|2.19|1998|3HB||P00436|PROTOCATECHUATE 3,4-DIOXYGENASE|2.4|Ki=4mM|Ki|=|4|mM|4000000|nM
1BQ3|2.70|1998|IHP||P00950|PHOSPHOGLYCERATE MUTASE 1|5.4|Ki=4uM|Ki|=|4|uM|4000|nM
3PCH|2.05|1998|CHB||P00436|PROTOCATECHUATE 3,4-DIOXYGENASE|5.4|Ki=4uM|Ki|=|4|uM|4000|nM
1A28|1.80|1998|STR|ligand is progesterone|P06401|PROGESTERONE RECEPTOR|8.29|Ki=5.1nM|Ki|=|5.1|nM|5.1|nM
1AUJ|2.10|1998|PPB|covalent complex|P00760|TRYPSIN|8.25|Ki=5.6nM|Ki|=|5.6|nM|5.6|nM
1A30|2.00|1998|3-mer||P04585|HIV-1 PROTEASE|4.3|Ki=50uM|Ki|=|50|uM|50000|nM
1AFL|1.70|1998|ATR||P61823|RIBONUCLEASE A|6.28|Ki=520nM|Ki|=|520|nM|520|nM
1AXR|2.30|1998|HTP||P00489|GLYCOGEN PHOSPHORYLASE|3.27|Ki=540uM|Ki|=|540|uM|540000|nM
1IBC|2.73|1998|4-mer|covalent complex|P29466|INTERLEUKIN-1 BETA CONVERTASE|10.25|Ki=56pM|Ki|=|56|pM|0.056|nM
3PCG|1.96|1998|4HP||P00436|PROTOCATECHUATE 3,4-DIOXYGENASE|2.3|Ki=5mM|Ki|=|5|mM|5000000|nM
1A69|2.10|1998|FMB||P0ABP8|PURINE NUCLEOSIDE PHOSPHORYLASE|5.3|Ki=5uM|Ki|=|5|uM|5000|nM
16PK|1.60|1998|BIS|X-ray(Trypanosoma brucei PGK) while Ki(yeast PGK)|P07378|3-PHOSPHOGLYCERATE KINASE|5.22|Ki=6uM|Ki|=|6|uM|6000|nM
1BQ4|2.50|1998|BHC||P00950|PHOSPHOGLYCERATE MUTASE 1|5.22|Ki=6uM|Ki|=|6|uM|6000|nM
3BLS|2.30|1998|APB|covalent complex|P00811|BETA-LACTAMASE|5.14|Ki=7.3uM|Ki|=|7.3|uM|7300|nM
2WEB|1.50|1998|PP4||P00798|PENICILLOPEPSIN|5.12|Ki=7.6uM|Ki|=|7.6|uM|7600|nM
6FIV|1.90|1998|3TL||P16088|RETROPEPSIN|8.08|Ki=8.3nM|Ki|=|8.3|nM|8.3|nM
1AW1|2.70|1998|PGA||P50921|TRIOSEPHOSPHATE ISOMERASE|1.05|Ki=89mM|Ki|=|89|mM|89000000|nM
1STC|2.30|1998|STU||P00517|CAMP-DEPENDENT PROTEIN KINASE|8.1|Ki=8nM|Ki|=|8|nM|8|nM
1JFH|2.03|1998|MA2-MA3||P00690|ALPHA-AMYLASE|2.05|Ki=9mM|Ki|=|9|mM|9000000|nM
1BR5|2.50|1998|NEO||P02879|RICIN|2.7|Ki>2mM|Ki|>|2|mM|2000000|nM
1A4M|1.95|1998|PRH||P03958|ADENOSINE DEAMINASE|13.0|Ki~0.1pM|Ki|~|0.1|pM|0.0001|nM
1A4G|2.20|1999|ZMR||P27907|NEURAMINIDASE|8.4|IC=0.004uM|IC50|=|0.004|uM|4|nM
1BL7|2.50|1999|SB4||Q16539|MITOGEN-ACTIVATED PROTEIN KINASE P38|7.72|IC=0.019uM|IC50|=|0.019|uM|19|nM
1BMK|2.40|1999|SB5||Q16539|MITOGEN-ACTIVATED PROTEIN KINASE P38|7.6|IC=0.025uM|IC50|=|0.025|uM|25|nM
1QF5|2.00|1999|RPL||P0A7D4|ADENYLOSUCCINATE SYNTHETASE|7.37|IC=0.043uM|IC50|=|0.043|uM|43|nM
1BQM|3.10|1999|HBY||P03366|HIV-1 REVERSE TRANSCRIPTASE|7.35|IC=0.045uM|IC50|=|0.045|uM|45|nM
1A9U|2.50|1999|SB2|redundant to 2ewa|Q16539|MITOGEN-ACTIVATED PROTEIN KINASE P38|7.32|IC=0.048uM|IC50|=|0.048|uM|48|nM
1DB4|2.20|1999|8IN|ligand is compound 13d|P14555|PHOSPHOLIPASE A2|7.24|IC=0.057uM|IC50|=|0.057|uM|57|nM
1DB5|2.80|1999|6IN|ligand is compound 7g|P14555|PHOSPHOLIPASE A2|6.82|IC=0.152uM|IC50|=|0.152|uM|152|nM
1BL6|2.50|1999|SB6||Q16539|MITOGEN-ACTIVATED PROTEIN KINASE P38|6.8|IC=0.16uM|IC50|=|0.16|uM|160|nM
1QFS|2.00|1999|ZPR|ligand is compound 59, Z-PRO-PROLINAL|P23687|PROLYL ENDOPEPTIDASE|9.48|IC=0.33nM|IC50|=|0.33|nM|0.33|nM
1QTI|2.50|1999|GNT||P04058|ACETYLCHOLINESTERASE|6.44|IC=0.36uM|IC50|=|0.36|uM|360|nM
1VIJ|2.40|1999|BAY||P12499|HIV-1 PROTEASE|9.52|IC=0.3nM|IC50|=|0.3|nM|0.3|nM
1C3R|2.00|1999|TSN||O67135|HISTONE DEACETYLASE-LIKE PROTEIN, HDLP|6.4|IC=0.4uM|IC50|=|0.4|uM|400|nM
1BQN|3.30|1999|HBY||P03366|HIV-1 REVERSE TRANSCRIPTASE|6.22|IC=0.60uM|IC50|=|0.6|uM|600|nM
1QF4|2.20|1999|RPD||P0A7D4|ADENYLOSUCCINATE SYNTHETASE|6.18|IC=0.665uM|IC50|=|0.665|uM|665|nM
1CJ1|3.00|1999|C78||P62993|GROWTH FACTOR RECEPTOR-BOUND PROTEIN 2|8.8|IC=1.6nM|IC50|=|1.6|nM|1.6|nM
1A86|2.00|1999|0ZB||P22894|MATRIX METALLOPROTEINASE-8|4.0|IC=101uM|IC50|=|101|uM|101000|nM
1BIW|2.50|1999|S80||P08254|STROMELYSIN-1|6.98|IC=104nM|IC50|=|104|nM|104|nM
5PRC|2.35|1999|ATZ||P07173|PHOTOSYNTHETIC REACTION CENTER|4.89|IC=13uM|IC50|=|13|uM|13000|nM
2CBR|2.80|1999|A80||P62964|CRABP-I|6.85|IC=140nM|IC50|=|140|nM|140|nM
1CX9|2.30|1999|NHP||P00929|TRYPTOPHAN SYNTHASE ALPHA CHAIN|6.75|IC=178nM|IC50|=|178|nM|178|nM
6PRC|2.30|1999|CEB|in Complex with the Herbicide Atrazine S(-) enantiomer|P07173|PHOTOSYNTHETIC REACTION CENTER|4.77|IC=17uM|IC50|=|17|uM|17000|nM
1BQO|2.30|1999|N25||P08254|STROMELYSIN-1|7.74|IC=18.4nM|IC50|=|18.4|nM|18.4|nM
3ERK|2.10|1999|SB4||P63086|EXTRACELLULAR REGULATED KINASE 2|4.74|IC=18uM|IC50|=|18|uM|18000|nM
1QS4|2.10|1999|100||Q76353|HIV-1 INTEGRASE|5.64|IC=2.3uM|IC50|=|2.3|uM|2300|nM
1BIO|1.50|1999|SOA||P00746|COMPLEMENT FACTOR D|5.54|IC=2.9uM|IC50|=|2.9|uM|2900|nM
1B9V|2.35|1999|RA2||P03474|NEURAMINIDASE|3.65|IC=224uM|IC50|=|224|uM|224000|nM
1ZFP|1.80|1999|6-mer||P29354|GROWTH FACTOR RECEPTOR-BOUND PROTEIN 2|7.59|IC=26nM|IC50|=|26|nM|26|nM
1QPF|2.50|1999|858||P62942|FK506-BINDING PROTEIN|7.57|IC=27nM|IC50|=|27|nM|27|nM
4ERK|2.20|1999|OLO||P63086|EXTRACELLULAR REGULATED KINASE 2|4.57|IC=27uM|IC50|=|27|uM|27000|nM
1CZQ|1.50|1999|17-mer|IC50=46uM(D10-p1-2k; Syncytia); IC50=85uM(D10-p1-2k, Viral Entry).|------|FUSION PROTEIN BETWEEN THE HYDROPHOBIC POCKET OF HI|4.54|IC=29uM|IC50|=|29|uM|29000|nM
1QPL|2.90|1999|587||P62942|FK506-BINDING PROTEIN|8.51|IC=3.1nM|IC50|=|3.1|nM|3.1|nM
1B2I|NMR|1999|AMH|ligand is compound TXA, Clot-Lysis Buffer and Plasma assay|P00747|PROTEIN (PLASMINOGEN)|5.51|IC=3.1uM|IC50|=|3.1|uM|3100|nM
1A4Q|1.90|1999|DPC||P27907|NEURAMINIDASE|5.44|IC=3.6uM|IC50|=|3.6|uM|3600|nM
1A85|2.00|1999|0DY||P22894|MATRIX METALLOPROTEINASE-8|4.52|IC=30uM|IC50|=|30|uM|30000|nM
1C50|2.30|1999|CHI||P00489|GLYCOGEN PHOSPHORYLASE|6.48|IC=334nM|IC50|=|334|nM|334|nM
1BUG|2.70|1999|URS||Q9ZP19|CATECHOL OXIDASE|4.37|IC=43uM|IC50|=|43|uM|43000|nM
3ZNC|2.80|1999|BZ1||Q64444|CARBONIC ANHYDRASE IV|7.34|IC=45.3nM|IC50|=|45.3|nM|45.3|nM
1C9D|2.30|1999|HF1||P00929|TRYPTOPHAN SYNTHASE ALPHA CHAIN|6.3|IC=499nM|IC50|=|499|nM|499|nM
1EVE|2.50|1999|E20||P04058|ACETYLCHOLINESTERASE|8.24|IC=5.7nM|IC50|=|5.7|nM|5.7|nM
3CBS|2.00|1999|R12||P29373|CRABP-II|7.24|IC=58nM|IC50|=|58|nM|58|nM
7PRC|2.65|1999|CET|in complex with the Herbicide Atrazine R(+) enantiomer|P07173|PHOTOSYNTHETIC REACTION CENTER|5.21|IC=6.2uM|IC50|=|6.2|uM|6200|nM
2CBS|2.10|1999|R13||P29373|CRABP-II|8.22|IC=6nM|IC50|=|6|nM|6|nM
1CW2|2.00|1999|HSP||P00929|TRYPTOPHAN SYNTHASE ALPHA CHAIN|6.15|IC=715nM|IC50|=|715|nM|715|nM
1C5F|2.47|1999|11-mer||Q27450|PEPTIDYL-PROLYL CIS-TRANS ISOMERASE 1|6.07|IC=860nM|IC50|=|860|nM|860|nM
1B9T|2.40|1999|RAI||P03474|NEURAMINIDASE|5.1|IC=8uM|IC50|=|8|uM|8000|nM
1TC1|1.41|1999|FMB|incomplete ligand structure|Q27796|HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE|2.7|IC>2mM|IC50|>|2|mM|2000000|nM
1B9S|2.50|1999|FDI||P03474|NEURAMINIDASE|3.18|IC>667uM|IC50|>|667|uM|667000|nM
1A7C|1.95|1999|6-mer|Kd<=100uM for site 1; Kd=700uM for site 2|P05121|PLASMINOGEN ACTIVATOR INHIBITOR 1|4.0|Kd<=100uM|Kd|<=|100|uM|100000|nM
1BNM|2.60|1999|AL8||P00918|CARBONIC ANHYDRASE 2|10.0|Kd=0.10nM|Kd|=|0.1|nM|0.1|nM
1BNN|2.30|1999|AL1||P00918|CARBONIC ANHYDRASE 2|10.0|Kd=0.10nM|Kd|=|0.1|nM|0.1|nM
1D3V|1.70|1999|ABH||P07824|ARGINASE|6.96|Kd=0.11uM|Kd|=|0.11|uM|110|nM
1SWR|1.90|1999|BTN||P22629|STREPTAVIDIN|6.92|Kd=0.12uM|Kd|=|0.12|uM|120|nM
1A42|2.25|1999|BZU||P00918|CARBONIC ANHYDRASE 2|9.89|Kd=0.13nM|Kd|=|0.13|nM|0.13|nM
1BN3|2.20|1999|AL6||P00918|CARBONIC ANHYDRASE 2|9.89|Kd=0.13nM|Kd|=|0.13|nM|0.13|nM
1BNT|2.15|1999|AL2||P00918|CARBONIC ANHYDRASE 2|9.8|Kd=0.16nM|Kd|=|0.16|nM|0.16|nM
1BKJ|1.80|1999|FMN||Q56691|NADPH-FLAVIN OXIDOREDUCTASE|6.77|Kd=0.17uM|Kd|=|0.17|uM|170|nM
1B2M|2.00|1999|2-mer||P00651|RIBONUCLEASE T1|3.73|Kd=0.185mM|Kd|=|0.185|mM|185000|nM
5FWG|2.00|1999|GPR|structure is GST mutant; Kd measured on GST wild type|P04905|TETRA-(5-FLUOROTRYPTOPHANYL)-GLUTATHIONE|6.72|Kd=0.19uM|Kd|=|0.19|uM|190|nM
2A2G|2.90|1999|LEO||P02761|ALPHA-2U-GLOBULIN|7.0|Kd=0.1uM|Kd|=|0.1|uM|100|nM
1BNU|2.15|1999|AL3||P00918|CARBONIC ANHYDRASE 2|9.7|Kd=0.20nM|Kd|=|0.2|nM|0.2|nM
1A4R|2.50|1999|GNH|Kd=9.4pM for GDP|P60953|G25K GTP-BINDING PROTEIN|6.66|Kd=0.22uM|Kd|=|0.22|uM|220|nM
2AY3|2.40|1999|MPP||P95468|AROMATIC AMINO ACID AMINOTRANSFERASE|3.55|Kd=0.28mM|Kd|=|0.28|mM|280000|nM
1A50|2.30|1999|FIP|Kd=0.2-0.5uM|P00929|TRYPTOPHAN SYNTHASE ALPHA CHAIN|6.7|Kd=0.2uM|Kd|=|0.2|uM|200|nM
1BNQ|2.40|1999|AL4||P00918|CARBONIC ANHYDRASE 2|9.49|Kd=0.32nM|Kd|=|0.32|nM|0.32|nM
1RPJ|1.80|1999|ALL||P39265|PRECURSOR OF PERIPLASMIC SUGAR RECEPTOR|6.48|Kd=0.33uM|Kd|=|0.33|uM|330|nM
1CT8|2.20|1999|TAA||P01837|ANTIBODY FAB FRAGMENT|6.52|Kd=0.3uM|Kd|=|0.3|uM|300|nM
1BN1|2.10|1999|AL5||P00918|CARBONIC ANHYDRASE 2|9.34|Kd=0.46nM|Kd|=|0.46|nM|0.46|nM
1BN4|2.10|1999|AL9||P00918|CARBONIC ANHYDRASE 2|9.31|Kd=0.49nM|Kd|=|0.49|nM|0.49|nM
1AZX|2.90|1999|NTP||P01008|ANTITHROMBIN-III|9.4|Kd=0.4nM|Kd|=|0.4|nM|0.4|nM
1D4P|2.07|1999|BPP||P00734|THROMBIN ALPHA|6.3|Kd=0.5uM|Kd|=|0.5|uM|500|nM
1CZL|1.80|1999|FMN|sq)|P10340|FLAVODOXIN|9.15|Kd=0.71nM|Kd|=|0.71|nM|0.71|nM
2AY6|2.20|1999|3IB||P95468|AROMATIC AMINO ACID AMINOTRANSFERASE|3.11|Kd=0.78mM|Kd|=|0.78|mM|780000|nM
1BNW|2.25|1999|TPD||P00918|CARBONIC ANHYDRASE 2|9.08|Kd=0.83nM|Kd|=|0.83|nM|0.83|nM
1CZR|1.90|1999|FMN|ox)|P10340|FLAVODOXIN|9.0|Kd=1.0nM|Kd|=|1|nM|1|nM
2AY4|2.20|1999|PPT||P95468|AROMATIC AMINO ACID AMINOTRANSFERASE|2.91|Kd=1.24mM|Kd|=|1.24|mM|1240000|nM
2ANS|2.50|1999|2AN||P04117|ADIPOCYTE LIPID-BINDING PROTEIN|5.92|Kd=1.2uM|Kd|=|1.2|uM|1200|nM
1ORK|2.40|1999|ATC||P0ACT4|TETRACYCLINE REPRESSOR|8.81|Kd=1.56nM|Kd|=|1.56|nM|1.56|nM
1BNV|2.40|1999|AL7||P00918|CARBONIC ANHYDRASE 2|8.77|Kd=1.70nM|Kd|=|1.7|nM|1.7|nM
1C12|2.60|1999|TRZ||P01837|ANTIBODY FAB FRAGMENT|8.72|Kd=1.9nM|Kd|=|1.9|nM|1.9|nM
2BOW|2.80|1999|P4P||P39075|MULTIDRUG-EFFLUX TRANSPORTER 1 REGULATOR BMRR|4.0|Kd=100uM|Kd|=|100|uM|100000|nM
1FPP|2.75|1999|FPP|Kd measured on protein from human|Q02293|FARNESYLTRANSFERASE|8.0|Kd=10nM|Kd|=|10|nM|10|nM
1B9J|1.80|1999|3-mer||P06202|OLIGO-PEPTIDE BINDING PROTEIN|5.96|Kd=1100nM|Kd|=|1100|nM|1100|nM
1QKA|1.80|1999|3-mer||P06202|OLIGO-PEPTIDE BINDING PROTEIN|5.92|Kd=1200nM|Kd|=|1200|nM|1200|nM
1A37|3.60|1999|15-mer|incomplete ligand|P63103|14-3-3 PROTEIN ZETA/DELTA|6.92|Kd=120nM|Kd|=|120|nM|120|nM
1D4W|1.80|1999|11-mer|fluorescence polarization binding constant=120nM, data not shown; incomplete ligand|O60880|T CELL SIGNAL TRANSDUCTION MOLECULE SAP|6.92|Kd=120nM|Kd|=|120|nM|120|nM
1VR1|1.90|1999|10-mer|Kd measured on thrombin (S195A, VR1tPA)|P00734|THROMBIN|6.89|Kd=128nM|Kd|=|128|nM|128|nM
2AY2|2.40|1999|CXP||P95468|AROMATIC AMINO ACID AMINOTRANSFERASE|1.88|Kd=13.1mM|Kd|=|13.1|mM|13100000|nM
3TMK|2.00|1999|T5A||P00572|THYMIDYLATE KINASE|6.87|Kd=135nM|Kd|=|135|nM|135|nM
1BKY|2.00|1999|1MC|X-ray(wild type) while Kd(VP39-F180W)|P07617|VP39|3.84|Kd=144uM|Kd|=|144|uM|144000|nM
1BUX|2.80|1999|PPS||P22887|NUCLEOSIDE DIPHOSPHATE KINASE|4.85|Kd=14uM|Kd|=|14|uM|14000|nM
1MXL|NMR|1999|17-mer|Kd=154+/-10uM|P63316|PROTEIN (TROPONIN C)|3.81|Kd=154uM|Kd|=|154|uM|154000|nM
1D2E|1.94|1999|GDP||P49410|ELONGATION FACTOR TU (EF-TU)|6.0|Kd=1uM|Kd|=|1|uM|1000|nM
2AY5|2.40|1999|IOP||P95468|AROMATIC AMINO ACID AMINOTRANSFERASE|2.59|Kd=2.6mM|Kd|=|2.6|mM|2600000|nM
1BGQ|2.50|1999|RDC||P02829|HEAT SHOCK PROTEIN HSP90|8.57|Kd=2.7nM|Kd|=|2.7|nM|2.7|nM
3KIV|1.80|1999|ACA||P08519|APOLIPOPROTEIN|4.7|Kd=20uM|Kd|=|20|uM|20000|nM
1QSC|2.40|1999|7-mer||Q12933|TNF RECEPTOR ASSOCIATED FACTOR 2|3.68|Kd=210uM|Kd|=|210|uM|210000|nM
1SM3|1.95|1999|13-mer|incomplete ligand structure|P01723|SM3 ANTIBODY|4.62|Kd=24uM|Kd|=|24|uM|24000|nM
1D7I|1.90|1999|DSS||P62942|FK506-BINDING PROTEIN (FKBP)|3.6|Kd=250uM|Kd|=|250|uM|250000|nM
5A3H|1.82|1999|FFC|covalent complex|O85465|ENDOGLUCANASE|4.57|Kd=26.7uM|Kd|=|26.7|uM|26700|nM
1B58|1.80|1999|3-mer||P06202|OLIGO-PEPTIDE BINDING PROTEIN|6.59|Kd=260nM|Kd|=|260|nM|260|nM
1D04|1.85|1999|FMN|hq)|P10340|FLAVODOXIN|4.59|Kd=26uM|Kd|=|26|uM|26000|nM
1CZO|1.85|1999|FMN|hq)|P10340|FLAVODOXIN|4.55|Kd=28uM|Kd|=|28|uM|28000|nM
2PCP|2.20|1999|1PC||------|ANTIBODY FAB FRAGMENT|8.7|Kd=2nM|Kd|=|2|nM|2|nM
1BT6|2.40|1999|14-mer|Kd = 2uM for free annexin II; Kd <10 nM when (annexin II)2(p11)2 the complex is formed; incomplete ligand|P60903|S100A10|5.7|Kd=2uM|Kd|=|2|uM|2000|nM
1YEI|1.90|1999|PGG||Q58EU8|ANTIBODY D2.3 (LIGHT CHAIN)|7.46|Kd=35nM|Kd|=|35|nM|35|nM
1YEJ|1.85|1999|PNF||Q58EU8|ANTIBODY D2.3 (LIGHT CHAIN)|7.46|Kd=35nM|Kd|=|35|nM|35|nM
1B5J|1.80|1999|3-mer||P06202|OLIGO-PEPTIDE BINDING PROTEIN|7.43|Kd=37nM|Kd|=|37|nM|37|nM
1BZY|2.00|1999|IMU||P00492|HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE|8.34|Kd=4.6nM|Kd|=|4.6|nM|4.6|nM
1B55|2.40|1999|4IP||Q06187|YROSINE-PROTEIN KINASE BTK|7.4|Kd=40nM|Kd|=|40|nM|40|nM
1QJA|2.00|1999|8-mer||P29312|14-3-3 PROTEIN ZETA/DELTA|6.38|Kd=416nM|Kd|=|416|nM|416|nM
1B51|1.80|1999|3-mer||P06202|OLIGO-PEPTIDE BINDING PROTEIN|7.37|Kd=43nM|Kd|=|43|nM|43|nM
1QKB|1.80|1999|3-mer||P06202|OLIGO-PEPTIDE BINDING PROTEIN|7.35|Kd=45nM|Kd|=|45|nM|45|nM
2AY7|2.40|1999|CLT||P95468|AROMATIC AMINO ACID AMINOTRANSFERASE|2.3|Kd=5.0mM|Kd|=|5|mM|5000000|nM
2AY1|2.20|1999|AHC||P95468|AROMATIC AMINO ACID AMINOTRANSFERASE|2.29|Kd=5.14mM|Kd|=|5.14|mM|5140000|nM
1CLU|1.70|1999|DBG||P01112|TRANSFORMING PROTEIN P21/H-RAS-1|8.27|Kd=5.4nM|Kd|=|5.4|nM|5.4|nM
2AY8|2.20|1999|4TB||P95468|AROMATIC AMINO ACID AMINOTRANSFERASE|2.24|Kd=5.8mM|Kd|=|5.8|mM|5800000|nM
1D7J|1.85|1999|BUQ||P62942|FK506-BINDING PROTEIN (FKBP)|3.3|Kd=500uM|Kd|=|500|uM|500000|nM
1B46|1.80|1999|3-mer||P06202|OLIGO-PEPTIDE BINDING PROTEIN|5.28|Kd=5200nM|Kd|=|5200|nM|5200|nM
1B40|2.20|1999|3-mer||P06202|OLIGO-PEPTIDE BINDING PROTEIN|7.28|Kd=53nM|Kd|=|53|nM|53|nM
1B4Z|1.75|1999|3-mer||P06202|OLIGO-PEPTIDE BINDING PROTEIN|5.23|Kd=5900nM|Kd|=|5900|nM|5900|nM
1BZF|NMR|1999|TMQ||P00381|DIHYDROFOLATE REDUCTASE|8.3|Kd=5nM|Kd|=|5|nM|5|nM
2AY9|2.50|1999|5PV||P95468|AROMATIC AMINO ACID AMINOTRANSFERASE|2.16|Kd=6.9mM|Kd|=|6.9|mM|6900000|nM
1EVH|1.80|1999|7-mer|incomplete ligand structure|Q03173|MENA EVH1 DOMAIN|3.22|Kd=602uM|Kd|=|602|uM|602000|nM
1AZE|NMR|1999|10-mer||P62993|GRB2|4.22|Kd=60uM|Kd|=|60|uM|60000|nM
1QK4|1.90|1999|IMP||Q26997|HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE|4.21|Kd=61uM|Kd|=|61|uM|61000|nM
1D4T|1.10|1999|11-mer|Kd=650nM (FP)|O60880|T CELL SIGNAL TRANSDUCTION MOLECULE SAP|6.19|Kd=650nM|Kd|=|650|nM|650|nM
1QK3|1.65|1999|5GP||Q26997|HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE|5.15|Kd=7.1uM|Kd|=|7.1|uM|7100|nM
1QAW|2.50|1999|TRP||Q9X6J6|TRP RNA-BINDING ATTENUATION PROTEIN|5.12|Kd=7.5uM|Kd|=|7.5|uM|7500|nM
1B52|2.30|1999|3-mer||P06202|OLIGO-PEPTIDE BINDING PROTEIN|7.12|Kd=76nM|Kd|=|76|nM|76|nM
3MCT|2.00|1999|3MC|X-ray(VP39 wild type) while Kd(VP39 F180W)|P07617|VP39|4.07|Kd=85.5uM|Kd|=|85.5|uM|85500|nM
3MAG|1.80|1999|3MA|X-ray(VP39 wild type) while Kd(VP39 F180W)|P07617|VP39|4.07|Kd=86uM|Kd|=|86|uM|86000|nM
1BWN|2.10|1999|4IP||Q06187|BRUTON'S TYROSINE KINASE|7.06|Kd=87nM|Kd|=|87|nM|87|nM
1M6P|1.80|1999|M6P||P11456|CATION-DEPENDENT MANNOSE-6-PHOSPHATE RECEPTOR|5.1|Kd=8uM|Kd|=|8|uM|8000|nM
2MPA|2.60|1999|9-mer||P01837|MN12H2 IGG2A-KAPPA|8.04|Kd=9.1nM|Kd|=|9.1|nM|9.1|nM
1B5I|1.90|1999|3-mer||P06202|OLIGO-PEPTIDE BINDING PROTEIN|7.05|Kd=90nM|Kd|=|90|nM|90|nM
1B42|2.20|1999|M1A|X-ray(wild type) while Kd(VP39-F180W)|P07617|VP39|4.01|Kd=97.9uM|Kd|=|97.9|uM|97900|nM
1SWP|2.00|1999|BTN||P22629|STREPTAVIDIN|11.0|Kd~10pM|Kd|~|10|pM|0.01|nM
1SWK|2.00|1999|BTN||P22629|STREPTAVIDIN|12.0|Kd~1pM|Kd|~|1|pM|0.001|nM
1SWN|2.20|1999|BTN||P22629|STREPTAVIDIN|12.0|Kd~1pM|Kd|~|1|pM|0.001|nM
1D4Y|1.97|1999|TPV||P03367|HIV-1 PROTEASE|11.1|Ki=0.008nM|Ki|=|0.008|nM|0.008|nM
3ERD|2.03|1999|DES|ligand is diethylstilbestrol, affinity in Human Breast Cancer|P03372|ESTROGEN RECEPTOR ALPHA|9.9|Ki=0.126nM|Ki|=|0.126|nM|0.126|nM
2STD|2.10|1999|CRP||P56221|SCYTALONE DEHYDRATASE|9.85|Ki=0.14nM|Ki|=|0.14|nM|0.14|nM
456C|2.40|1999|CBP||P45452|COLLAGENASE 3 (MMP-13)|9.77|Ki=0.17nM|Ki|=|0.17|nM|0.17|nM
1BZH|2.10|1999|7-mer||P18031|PROTEIN-TYROSINE PHOSPHATASE 1B|6.77|Ki=0.17uM|Ki|=|0.17|uM|170|nM
1SFI|1.65|1999|14-mer||P00760|TRYPSIN|10.0|Ki=0.1nM|Ki|=|0.1|nM|0.1|nM
1CH8|2.50|1999|GPX||P0A7D4|ADENYLOSUCCINATE SYNTHETASE|7.0|Ki=0.1uM|Ki|=|0.1|uM|100|nM
1OTH|1.85|1999|PAO|Ki measured at pH=7.0, temp=37C|P00480|PROTEIN (ORNITHINE TRANSCARBAMOYLASE)|7.0|Ki=0.1uM|Ki|=|0.1|uM|100|nM
3ERT|1.90|1999|OHT|ligand is 4-OH-Tamoxifen, affinity in human breast cancer|P03372|ESTROGEN RECEPTOR ALPHA|9.6|Ki=0.249nM|Ki|=|0.249|nM|0.249|nM
1BO5|3.20|1999|FBP||P0A6F3|GLYCEROL KINASE|3.6|Ki=0.25mM|Ki|=|0.25|mM|250000|nM
1DFO|2.40|1999|FFO|Ki=0.2~0.5uM|P0A825|SERINE HYDROXYMETHYLTRANSFERASE|6.7|Ki=0.2uM|Ki|=|0.2|uM|200|nM
1CA8|2.10|1999|0KV|covalent complex|P00734|THROMBIN|9.49|Ki=0.32nM|Ki|=|0.32|nM|0.32|nM
4YAS|2.00|1999|CLX|covalent complex|P52704|HYDROXYNITRILE LYASE|3.41|Ki=0.39mM|Ki|=|0.39|mM|390000|nM
1BXR|2.10|1999|ANP||P00968|CARBAMOYL-PHOSPHATE SYNTHASE|3.4|Ki=0.4mM|Ki|=|0.4|mM|400000|nM
1PME|2.00|1999|SB2||P28482|EXTRACELLULAR REGULATED KINASE 2|9.4|Ki=0.4nM|Ki|=|0.4|nM|0.4|nM
2BPX|2.80|1999|MK1||P04587|HIV-1 PROTEASE|9.4|Ki=0.4nM|Ki|=|0.4|nM|0.4|nM
830C|1.60|1999|RS1||P45452|COLLAGENASE 3 (MMP-13)|9.28|Ki=0.52nM|Ki|=|0.52|nM|0.52|nM
5YAS|2.20|1999|FAC||P52704|HYDROXYNITRILE LYASE|3.26|Ki=0.55mM|Ki|=|0.55|mM|550000|nM
1A5H|2.90|1999|BBA|Ki measured on full lenghth sc-tPA|P00750|TISSUE PLASMINOGEN ACTIVATOR|6.3|Ki=0.5uM|Ki|=|0.5|uM|500|nM
1BA8|1.80|1999|0IT|covalent complex|P00734|THROMBIN|9.0|Ki=1.0nM|Ki|=|1|nM|1|nM
1EKB|2.30|1999|7-mer|incomplete ligand structure; covalent complex|P98072|ENTEROPEPTIDASE|6.0|Ki=1.0uM|Ki|=|1|uM|1000|nM
1CET|2.05|1999|CLQ||Q27743|L-LACTATE DEHYDROGENASE|2.89|Ki=1.3mM|Ki|=|1.3|mM|1300000|nM
2BZA|1.90|1999|ABN||P00760|TRYPSIN|2.8|Ki=1.58mM|Ki|=|1.58|mM|1580000|nM
11GS|2.30|1999|2-mer|redundant to 3gss|P09211|GLUTATHIONE S-TRANSFERASE|5.82|Ki=1.5uM|Ki|=|1.5|uM|1500|nM
1DG9|1.90|1999|EPE||P11064|TYROSINE PHOSPHATASE|2.74|Ki=1.8mM|Ki|=|1.8|mM|1800000|nM
3AMV|2.10|1999|BIN||P00489|GLYCOGEN PHOSPHORYLASE|7.97|Ki=10.8nM|Ki|=|10.8|nM|10.8|nM
1QIN|2.00|1999|GIP||Q04760|LACTOYLGLUTATHIONE LYASE|8.0|Ki=10nM|Ki|=|10|nM|10|nM
1CP6|1.90|1999|BUB|incomplete ligand structure|Q01693|LEUCYL AMINOPEPTIDASE|5.0|Ki=10uM|Ki|=|10|uM|10000|nM
1QF2|2.06|1999|TI3||P00800|THERMOLYSIN|5.92|Ki=1200nM|Ki|=|1200|nM|1200|nM
1BZC|2.35|1999|TPI||P18031|PROTEIN-TYROSINE PHOSPHATASE 1B|4.92|Ki=12uM|Ki|=|12|uM|12000|nM
1XKA|2.30|1999|4PP|IC50=272nM|P00742|COAGULATION FACTOR XA|6.88|Ki=131nM|Ki|=|131|nM|131|nM
1BM6|NMR|1999|3-mer||P08254|STROMELYSIN-1|7.89|Ki=13nM|Ki|=|13|nM|13|nM
1A94|2.00|1999|0Q4||P03367|HIV-1 PROTEASE|7.85|Ki=14nM|Ki|=|14|nM|14|nM
1B8Y|2.00|1999|IN7||P08254|STROMELYSIN-1|7.85|Ki=14nM|Ki|=|14|nM|14|nM
1D5R|2.10|1999|TLA||P60484|PHOSPHOINOSITIDE PHOSPHOTASE PTEN|1.82|Ki=15mM|Ki|=|15|mM|15000000|nM
1CE5|1.90|1999|BEN|redundant to 3gy7|P00760|TRYPSIN|4.74|Ki=18.4uM|Ki|=|18.4|uM|18400|nM
1CAQ|1.80|1999|DPS|redundant to 1ciz|P08254|STROMELYSIN-1|7.72|Ki=19nM|Ki|=|19|nM|19|nM
7STD|1.80|1999|CRP||P56221|SCYTALONE DEHYDRATASE|10.72|Ki=19pM|Ki|=|19|pM|0.019|nM
6STD|1.80|1999|MS2||P56221|SCYTALONE DEHYDRATASE|8.64|Ki=2.3nM|Ki|=|2.3|nM|2.3|nM
1MFI|1.80|1999|FHC||P34884|MACROPHAGE MIGRATION INHIBITORY FACTOR|5.59|Ki=2.6uM|Ki|=|2.6|uM|2600|nM
2SFP|1.90|1999|PPI||P10724|ALANINE RACEMASE|1.7|Ki=20mM|Ki|=|20|mM|20000000|nM
1BAI|2.40|1999|0Q4||O92805|ROUS SARCOMA VIRUS PROTEASE|7.7|Ki=20nM|Ki|=|20|nM|20|nM
2BPV|1.90|1999|1IN||P04587|HIV-1 PROTEASE|7.67|Ki=21.2nM|Ki|=|21.2|nM|21.2|nM
1C3X|2.40|1999|8IG||P81989|PENTOSYLTRANSFERASE|3.68|Ki=210uM|Ki|=|210|uM|210000|nM
1BZJ|2.25|1999|PIC||P18031|PROTEIN-TYROSINE PHOSPHATASE|4.66|Ki=22uM|Ki|=|22|uM|22000|nM
966C|1.90|1999|RS2||P03956|COLLAGENASE 1 (MMP-1)|7.64|Ki=23nM|Ki|=|23|nM|23|nM
1B8O|1.50|1999|IMH||P55859|PURINE NUCLEOSIDE PHOSPHORYLASE|10.64|Ki=23pM|Ki|=|23|pM|0.023|nM
13GS|1.90|1999|SAS||P09211|GLUTATHIONE S-TRANSFERASE|4.62|Ki=24uM|Ki|=|24|uM|24000|nM
1UPF|2.30|1999|URF||Q26998|URACIL PHOSPHORIBOSYLTRANSFERASE|4.6|Ki=25uM|Ki|=|25|uM|25000|nM
1C3E|2.10|1999|NHR||P08179|GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMYLASE|6.59|Ki=260nM|Ki|=|260|nM|260|nM
1A0Q|2.30|1999|HEP||P01837|ANTIBODY FAB FRAGMENT|7.57|Ki=27nM|Ki|=|27|nM|27|nM
1C3B|2.25|1999|BZB|covalent complex|P00811|CEPHALOSPORINASE|7.57|Ki=27nM|Ki|=|27|nM|27|nM
1QHC|1.70|1999|PUA||P61823|RIBONUCLEASE A|7.57|Ki=27nM|Ki|=|27|nM|27|nM
2TSR|2.60|1999|D16||P45352|THYMIDYLATE SYNTHASE|7.54|Ki=29nM|Ki|=|29|nM|29|nM
2FMB|1.80|1999|LP1||P32542|EQUINE INFECTIOUS ANEMIA VIRUS PROTEASE|8.7|Ki=2nM|Ki|=|2|nM|2|nM
1CR6|2.80|1999|CPU||P34914|EPOXIDE HYDROLASE|8.51|Ki=3.1nM|Ki|=|3.1|nM|3.1|nM
1BGO|2.30|1999|I10|covalent complex|P43235|CATHEPSIN K|8.46|Ki=3.5nM|Ki|=|3.5|nM|3.5|nM
4FIV|1.80|1999|LP1||P16088|FIV PROTEASE|6.52|Ki=300nM|Ki|=|300|nM|300|nM
1QCP|1.80|1999|RWJ|covalent complex|P00760|TRYPSIN BETA|7.52|Ki=30nM|Ki|=|30|nM|30|nM
1B8N|2.00|1999|IMG||P55859|PURINE NUCLEOSIDE PHOSPHORYLASE|10.52|Ki=30pM|Ki|=|30|pM|0.03|nM
1D6N|2.70|1999|PPO|Ki measured on HGPRTase wt|P00492|HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE|4.5|Ki=31.5uM|Ki|=|31.5|uM|31500|nM
5STD|1.95|1999|UNN||P56221|SCYTALONE DEHYDRATASE|10.49|Ki=32pM|Ki|=|32|pM|0.032|nM
1CIZ|1.64|1999|DPS||P08254|STROMELYSIN-1|7.44|Ki=36nM|Ki|=|36|nM|36|nM
2BPY|1.90|1999|3IN||P04587|HIV-1 PROTEASE|7.4|Ki=39.8nM|Ki|=|39.8|nM|39.8|nM
1BB0|2.10|1999|0IV|covalent complex|P00734|THROMBIN|8.36|Ki=4.4nM|Ki|=|4.4|nM|4.4|nM
1HWR|1.80|1999|216||P04585|HIV-1 PROTEASE|8.33|Ki=4.70nM|Ki|=|4.7|nM|4.7|nM
7KME|2.10|1999|7-mer|incomplete ligand structure|P00734|THROMBIN|4.4|Ki=40uM|Ki|=|40|uM|40000|nM
1QBV|1.80|1999|PPX||P00734|THROMBIN|5.39|Ki=4100nM|Ki|=|4100|nM|4100|nM
1QJB|2.00|1999|8-mer|Ki for structure mode 2|P29312|14-3-3 PROTEIN ZETA/DELTA|6.38|Ki=416nM|Ki|=|416|nM|416|nM
1QF0|2.20|1999|TI2||P00800|THERMOLYSIN|7.38|Ki=42nM|Ki|=|42|nM|42|nM
2FGI|2.50|1999|PD1||P11362|FIBROBLAST GROWTH FACTOR RECEPTOR 1|7.34|Ki=45.2nM|Ki|=|45.2|nM|45.2|nM
4STD|2.15|1999|BFS||P56221|SCYTALONE DEHYDRATASE|10.33|Ki=47pM|Ki|=|47|pM|0.047|nM
1QF1|2.00|1999|TI1||P00800|THERMOLYSIN|7.32|Ki=48nM|Ki|=|48|nM|48|nM
1QBQ|2.40|1999|HFP||Q04631|FARNESYLTRANSFERASE ALPHA SUBUNIT|8.3|Ki=5nM|Ki|=|5|nM|5|nM
1ICJ|1.90|1999|PGO||P0A6K3|PEPTIDE DEFORMYLASE|2.22|Ki=6mM|Ki|=|6|mM|6000000|nM
3STD|1.65|1999|MQ0||P56221|SCYTALONE DEHYDRATASE|11.11|Ki=7.7pM|Ki|=|7.7|pM|0.0077|nM
4PRG|2.90|1999|072||P37231|PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA|7.15|Ki=70nM|Ki|=|70|nM|70|nM
2TOH|2.30|1999|HBI||P04177|TYROSINE 3-MONOOXYGENASE|4.15|Ki=70uM|Ki|=|70|uM|70000|nM
3USN|NMR|1999|ATT||P08254|STROMELYSIN-1|6.15|Ki=710nM|Ki|=|710|nM|710|nM
1ZZZ|1.90|1999|0IV|incomplete ligand structure; covalent complex|P00760|TRYPSIN|5.14|Ki=7300nM|Ki|=|7300|nM|7300|nM
1B56|2.05|1999|PLM|binding data for E.coli FABP, not human|Q01469|FATTY ACID BINDING PROTEIN|6.1|Ki=802nM|Ki|=|802|nM|802|nM
1YYY|2.10|1999|0KV|incomplete ligand structure; covalent complex|P00760|TRYPSIN|5.09|Ki=8100nM|Ki|=|8100|nM|8100|nM
1ODY|2.00|1999|LP1||P04585|HIV-1 PROTEASE|8.1|Ki=8nM|Ki|=|8|nM|8|nM
1QR3|1.60|2000|8-mer||P00772|ELASTASE 1|6.59|IC=0.26uM|IC50|=|0.26|uM|260|nM
1EEI|2.00|2000|GAA||Q57193|CHOLERA ENTEROTOXIN SUBUNIT B|3.15|IC=0.7mM|IC50|=|0.7|mM|700000|nM
1D5J|2.60|2000|MM3||P08254|STROMELYSIN-1|9.15|IC=0.7nM|IC50|=|0.7|nM|0.7|nM
1E02|2.15|2000|UNA||P81245|ODORANT-BINDING PROTEIN|6.15|IC=0.7uM|IC50|=|0.7|uM|700|nM
1E00|1.83|2000|DHM||P81245|ODORANT-BINDING PROTEIN|6.1|IC=0.8uM|IC50|=|0.8|uM|800|nM
1EEF|1.80|2000|2-mer|ligand is GAL-I06|P32890|HEAT-LABILE ENTEROTOXIN B CHAIN|2.92|IC=1.2mM|IC50|=|1.2|mM|1200000|nM
1DZJ|2.00|2000|SES||P81245|ODORANT-BINDING PROTEIN|5.89|IC=1.3uM|IC50|=|1.3|uM|1300|nM
1C3I|1.83|2000|TR1||P08254|STROMELYSIN-1|5.8|IC=1.6uM|IC50|=|1.6|uM|1600|nM
1BZS|1.70|2000|BSI||P22894|NEUTROPHIL COLLAGENASE|8.0|IC=10nM|IC50|=|10|nM|10|nM
1FV9|3.00|2000|172||P00749|UROKINASE-TYPE PLASMINOGEN ACTIVATOR|5.0|IC=10uM|IC50|=|10|uM|10000|nM
1EFI|1.60|2000|GAT||P32890|HEAT-LABILE ENTEROTOXIN B CHAIN|1.92|IC=12mM|IC50|=|12|mM|12000000|nM
1QHR|2.20|2000|157|covalent complex|P00734|THROMBIN ALPHA|6.89|IC=130nM|IC50|=|130|nM|130|nM
1FTK|1.60|2000|KAI|IC50 measured on S1S2J|P19491|GLUTAMATE RECEPTOR 2|4.84|IC=14.5uM|IC50|=|14.5|uM|14500|nM
1FD7|1.80|2000|AI1||P32890|HEAT-LABILE ENTEROTOXIN B CHAIN|1.85|IC=14mM|IC50|=|14|mM|14000000|nM
1D8F|2.40|2000|SPI||P08254|STROMELYSIN-1 PRECURSOR|7.74|IC=18nM|IC50|=|18|nM|18|nM
1QJ6|2.20|2000|167|covalent complex|P00734|THROMBIN|7.74|IC=18nM|IC50|=|18|nM|18|nM
1C8K|1.76|2000|CPB||P00489|GLYCOGEN PHOSPHORYLASE|6.0|IC=1uM|IC50|=|1|uM|1000|nM
1DI8|2.20|2000|DTQ||P24941|CYCLIN-DEPENDENT KINASE 2|6.0|IC=1uM|IC50|=|1|uM|1000|nM
1CQP|2.60|2000|803||P20701|ANTIGEN CD11A (P180)|5.62|IC=2.4uM|IC50|=|2.4|uM|2400|nM
1FYR|2.40|2000|5-mer||P29354|GROWTH FACTOR RECEPTOR-BOUND PROTEIN 2|5.62|IC=2.4uM|IC50|=|2.4|uM|2400|nM
1E06|2.12|2000|IPB||P81245|ODORANT-BINDING PROTEIN|5.6|IC=2.5uM|IC50|=|2.5|uM|2500|nM
1E1Y|2.23|2000|CPB||P00489|GLYCOGEN PHOSPHORYLASE|5.6|IC=2.5uM|IC50|=|2.5|uM|2500|nM
1QPE|2.00|2000|PP2||P06239|TYROSINE-PROTEIN KINASE LCK|7.7|IC=20nM|IC50|=|20|nM|20|nM
1D8E|3.00|2000|6-mer|FTase complexed with the FPP(FII) anolog and 11-mer KKKSKTKCVIM, IC50 for 11-mer is 50nM. IC50 for TKCVIM 6-mer is 250nM|Q04631|FARNESYLTRANSFERASE ALPHA SUBUNIT|6.6|IC=250nM|IC50|=|250|nM|250|nM
1DMT|2.10|2000|RDF|ligand is Phospho-ramidon|P08473|NEPRILYSIN|8.7|IC=2nM|IC50|=|2|nM|2|nM
1D8M|2.44|2000|BBH||P08254|STROMELYSIN-1 PRECURSOR|8.51|IC=3.1nM|IC50|=|3.1|nM|3.1|nM
1QKN|2.25|2000|RAL|ligand is compound 1, RALOXIFENE|Q62986|ESTROGEN RECEPTOR BETA|8.47|IC=3.4nM|IC50|=|3.4|nM|3.4|nM
1DZP|1.83|2000|BZQ||P81245|ODORANT-BINDING PROTEIN|5.44|IC=3.6uM|IC50|=|3.6|uM|3600|nM
1DZM|1.93|2000|BZM||P81245|ODORANT-BINDING PROTEIN|5.41|IC=3.9uM|IC50|=|3.9|uM|3900|nM
1D7X|2.00|2000|SPC||P08254|STROMELYSIN-1 PRECURSOR|8.52|IC=3nM|IC50|=|3|nM|3|nM
3GWX|2.40|2000|EPA||Q03181|PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR DELTA|5.4|IC=4.0uM|IC50|=|4|uM|4000|nM
1EXV|2.40|2000|700||P06737|GLYCOGEN PHOSPHORYLASE|7.35|IC=45nM|IC50|=|45|nM|45|nM
1C29|2.30|2000|HE1|redundant to 1c8v|P00929|TRYPTOPHAN SYNTHASE ALPHA CHAIN|6.33|IC=472nM|IC50|=|472|nM|472|nM
1C8V|2.20|2000|HE1||P00929|TRYPTOPHAN SYNTHASE ALPHA CHAIN|6.33|IC=472nM|IC50|=|472|nM|472|nM
1QTN|1.20|2000|5-mer|covalent complex|Q14790|CASPASE-8|7.3|IC=50nM|IC50|=|50|nM|50|nM
1EZF|2.15|2000|IN0||P37268|FARNESYL-DIPHOSPHATE FARNESYLTRANSFERASE|7.25|IC=56nM|IC50|=|56|nM|56|nM
1DTT|3.00|2000|FTC||P04585|HIV-1 REVERSE TRANSCRIPTASE, A-CHAIN|8.3|IC=5nM|IC50|=|5|nM|5|nM
1DI9|2.60|2000|MSQ||Q16539|MITOGEN-ACTIVATED PROTEIN KINASE P38|5.3|IC=5uM|IC50|=|5|uM|5000|nM
1C8L|2.30|2000|BIN||P00489|GLYCOGEN PHOSPHORYLASE|8.16|IC=6.9nM|IC50|=|6.9|nM|6.9|nM
1DX6|2.30|2000|GNT||P04058|ACETYLCHOLINESTERASE|6.19|IC=652nM|IC50|=|652|nM|652|nM
1DTQ|2.80|2000|FPT||P04585|HIV-1 REVERSE TRANSCRIPTASE, A-CHAIN|8.22|IC=6nM|IC50|=|6|nM|6|nM
1EM6|2.20|2000|CP4||P06737|GLYCOGEN PHOSPHORYLASE|8.22|IC=6nM|IC50|=|6|nM|6|nM
1DM2|2.10|2000|HMD||P24941|CYCLIN-DEPENDENT KINASE 2|7.15|IC=70nM|IC50|=|70|nM|70|nM
1FTJ|1.90|2000|GLU||P19491|GLUTAMATE RECEPTOR 2|6.09|IC=821nM|IC50|=|821|nM|821|nM
1QJ7|2.20|2000|GR1|covalent complex|P00734|THROMBIN|8.1|IC=8nM|IC50|=|8|nM|8|nM
1FSG|1.05|2000|9DG||Q26997|HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE|5.02|IC=9.5uM|IC50|=|9.5|uM|9500|nM
1FTL|1.80|2000|DNQ||P19491|GLUTAMATE RECEPTOR 2|6.0|IC=998nM|IC50|=|998|nM|998|nM
1QJ1|2.00|2000|166|covalent complex|P00734|THROMBIN|8.05|IC=9nM|IC50|=|9|nM|9|nM
1FAO|1.80|2000|4IP||Q9UN19|DUAL ADAPTOR OF PHOSPHOTYROSINE AND 3|7.37|Kd=0.043uM|Kd|=|0.043|uM|43|nM
1FL3|2.45|2000|SPB||P01867|BLUE FLUORESCENT ANTIBODY 19G2|6.8|Kd=0.16uM|Kd|=|0.16|uM|160|nM
1D2S|1.55|2000|DHT|ligand is compound 1, 5-ALPHA-DIHYDROTESTOSTERONE, pKd=9.74|P04278|SEX HORMONE-BINDING GLOBULIN|9.74|Kd=0.182nM|Kd|=|0.182|nM|0.182|nM
1DF8|1.51|2000|BTN||P22629|STREPTAVIDIN|9.7|Kd=0.20nM|Kd|=|0.2|nM|0.2|nM
1QKU|3.20|2000|EST|WT Kd=0.26+/-0.05nM|P03372|ESTROGEN RECEPTOR|9.59|Kd=0.26nM|Kd|=|0.26|nM|0.26|nM
1G52|1.80|2000|F2B||P00918|CARBONIC ANHYDRASE 2|9.54|Kd=0.29nM|Kd|=|0.29|nM|0.29|nM
1D3Q|2.90|2000|BT2||P00734|THROMBIN ALPHA|6.54|Kd=0.29uM|Kd|=|0.29|uM|290|nM
1C7F|2.00|2000|FMN|ox)|P00323|FLAVODOXIN|9.52|Kd=0.30nM|Kd|=|0.3|nM|0.3|nM
1DL7|2.35|2000|NCH||P01724|ANTIBODY M3C65, LIGHT CHAIN|6.49|Kd=0.32uM|Kd|=|0.32|uM|320|nM
1G1D|2.04|2000|FSB||P00918|CARBONIC ANHYDRASE 2|9.44|Kd=0.36nM|Kd|=|0.36|nM|0.36|nM
1FLM|1.30|2000|FMN||Q46604|FMN-BINDING PROTEIN|9.37|Kd=0.43nM|Kd|=|0.43|nM|0.43|nM
1E03|2.90|2000|NTP||P01008|ANTITHROMBIN-III|9.4|Kd=0.4nM|Kd|=|0.4|nM|0.4|nM
1DB1|1.80|2000|VDX||P11473|VITAMIN D3 RECEPTOR|9.26|Kd=0.55nM|Kd|=|0.55|nM|0.55|nM
1FCZ|1.38|2000|156||P13631|RETINOIC ACID RECEPTOR GAMMA-1|9.22|Kd=0.6nM|Kd|=|0.6|nM|0.6|nM
1FBM|2.70|2000|RTL||P35444|CARTILAGE OLIGOMERIZATION MATRIX PROTEIN|6.22|Kd=0.6uM|Kd|=|0.6|uM|600|nM
1D3D|2.04|2000|BZT||P00734|THROMBIN ALPHA|9.09|Kd=0.81nM|Kd|=|0.81|nM|0.81|nM
1F4Y|2.80|2000|MGU||------|ANTIBODY FAB FRAGMENT, S-20-4, LIGHT CHAIN|6.08|Kd=0.83uM|Kd|=|0.83|uM|830|nM
1DZK|1.48|2000|PRZ||P81245|ODORANT-BINDING PROTEIN|6.1|Kd=0.8uM|Kd|=|0.8|uM|800|nM
1G53|1.94|2000|F6B||P00918|CARBONIC ANHYDRASE 2|9.04|Kd=0.91nM|Kd|=|0.91|nM|0.91|nM
1QKT|2.20|2000|EST||P03372|ESTROGEN RECEPTOR|9.04|Kd=0.92nM|Kd|=|0.92|nM|0.92|nM
1CZC|2.50|2000|GUA||P00509|ASPARTATE AMINOTRANSFERASE|2.82|Kd=1.5mM|Kd|=|1.5|mM|1500000|nM
1CZK|1.90|2000|FMN|ox)|P10340|FLAVODOXIN|8.82|Kd=1.5nM|Kd|=|1.5|nM|1.5|nM
1G54|1.86|2000|FFB||P00918|CARBONIC ANHYDRASE 2|8.82|Kd=1.5nM|Kd|=|1.5|nM|1.5|nM
1G46|1.84|2000|F2B||P00918|CARBONIC ANHYDRASE 2|8.8|Kd=1.6nM|Kd|=|1.6|nM|1.6|nM
1DUV|1.70|2000|PSQ||P04391|ORNITHINE TRANSCARBAMOYLASE|11.8|Kd=1.6pM|Kd|=|1.6|pM|0.0016|nM
1GGD|1.50|2000|FAF|covalent complex|P00766|GAMMA CHYMOTRYPSIN|5.8|Kd=1.6uM|Kd|=|1.6|uM|1600|nM
1QFT|1.25|2000|HSM||O77421|HISTAMINE BINDING PROTEIN 2|8.77|Kd=1.7nM|Kd|=|1.7|nM|1.7|nM
1DDM|NMR|2000|11-mer||P16554|NUMB PROTEIN|5.77|Kd=1.7uM|Kd|=|1.7|uM|1700|nM
1FHR|NMR|2000|7-mer||P22216|PROTEIN KINASE SPK1|4.0|Kd=100uM|Kd|=|100|uM|100000|nM
1F8A|1.84|2000|7-mer||Q13526|PEPTIDYL-PROLYL CIS-TRANS ISOMERASE NIMA|5.0|Kd=10uM|Kd|=|10|uM|10000|nM
1QL7|2.10|2000|ZEN|Kd=10~20uM|P00760|TRYPSIN|5.0|Kd=10uM|Kd|=|10|uM|10000|nM
1C5C|1.61|2000|TK4||------|CHIMERIC DECARBOXYLASE ANTIBODY 21D8|6.96|Kd=110nM|Kd|=|110|nM|110|nM
1ELR|1.90|2000|6-mer||P31948|TPR2A-DOMAIN OF HOP|4.96|Kd=11uM|Kd|=|11|uM|11000|nM
1FF1|NMR|2000|11-mer|Kd=12+/-2uM; incomplete ligand|P42566|EPIDERMAL GROWTH FACTOR RECEPTOR SUBSTRATE 15|4.92|Kd=12uM|Kd|=|12|uM|12000|nM
1QNG|2.10|2000|11-mer||Q25756|PEPTIDYL-PROLYL CIS-TRANS ISOMERASE|7.89|Kd=13nM|Kd|=|13|nM|13|nM
1QIW|2.30|2000|DPD||P02593|CALMODULIN|7.74|Kd=18nM|Kd|=|18|nM|18|nM
1DPU|NMR|2000|16-mer|Kd<1uM; Kd=5uM(binding affinity of RPA32172-270 for XPA1-98)|P15927|REPLICATION PROTEIN A (RPA32) C-TERMINAL DOMAIN|6.0|Kd=1uM|Kd|=|1|uM|1000|nM
1F40|NMR|2000|GPI||P62942|FK506-BINDING PROTEIN|6.0|Kd=1uM|Kd|=|1|uM|1000|nM
1G4J|1.84|2000|FFB||P00918|CARBONIC ANHYDRASE 2|8.7|Kd=2.0nM|Kd|=|2|nM|2|nM
1DKD|2.10|2000|12-mer|incomplete ligand|P0A6F5|GROEL|5.7|Kd=2.0uM|Kd|=|2|uM|2000|nM
1E8H|2.60|2000|ADP||P56216|VANILLYL-ALCOHOL OXIDASE|5.68|Kd=2.1uM|Kd|=|2.1|uM|2100|nM
1G45|1.83|2000|FSB||P00918|CARBONIC ANHYDRASE 2|8.64|Kd=2.3nM|Kd|=|2.3|nM|2.3|nM
1CZE|2.40|2000|SIN||P00509|ASPARTATE AMINOTRANSFERASE|2.62|Kd=2.4mM|Kd|=|2.4|mM|2400000|nM
1F4X|2.30|2000|MGS||------|ANTIBODY FAB FRAGMENT, LIGHT CHAIN|5.59|Kd=2.6uM|Kd|=|2.6|uM|2600|nM
1FO0|2.50|2000|8-mer||P01901|H-2 CLASS I HISTOCOMPATIBILITY ANTIGEN, K-B|5.59|Kd=2.6uM|Kd|=|2.6|uM|2600|nM
1OM2|NMR|2000|11-mer||Q62760|PROTEIN (MITOCHONDRIAL IMPORT RECEPTOR SUBUNIT|4.7|Kd=20uM|Kd|=|20|uM|20000|nM
1E5A|1.80|2000|TBP||P02766|TRANSTHYRETIN|7.64|Kd=23nM|Kd|=|23|nM|23|nM
1FTM|1.70|2000|AMQ||P19491|GLUTAMATE RECEPTOR 2|7.61|Kd=24.8nM|Kd|=|24.8|nM|24.8|nM
1FZQ|1.70|2000|GDP||Q9WUL7|ADP-RIBOSYLATION FACTOR-LIKE PROTEIN 3|7.62|Kd=24nM|Kd|=|24|nM|24|nM
1FJ4|2.35|2000|TLM|redundant to 2vb8|P0A953|BETA-KETOACYL-[ACYL CARRIER PROTEIN] SYNTHASE I|4.59|Kd=26uM|Kd|=|26|uM|26000|nM
1G1E|NMR|2000|16-mer|Kd=15nM(binding affinity of Mad1 1-35 and Sin3)|Q60520|MAD1 PROTEIN|7.54|Kd=29nM|Kd|=|29|nM|29|nM
1E4H|1.80|2000|PBR||P02766|TRANSTHYRETIN|8.41|Kd=3.9nM|Kd|=|3.9|nM|3.9|nM
1G48|1.86|2000|F6B||P00918|CARBONIC ANHYDRASE 2|8.41|Kd=3.9nM|Kd|=|3.9|nM|3.9|nM
1FCY|1.30|2000|564||P13631|RETINOIC ACID RECEPTOR GAMMA-1|8.52|Kd=3nM|Kd|=|3|nM|3|nM
1BP0|2.40|2000|UMP||P00469|THYMIDYLATE SYNTHASE|5.4|Kd=4.0uM|Kd|=|4|uM|4000|nM
1D3P|2.10|2000|BT3||P00734|THROMBIN ALPHA|7.39|Kd=41nM|Kd|=|41|nM|41|nM
1QPB|2.40|2000|PYM||P06169|PYRUVATE DECARBOXYLASE (FORM B)|1.36|Kd=44mM|Kd|=|44|mM|44000000|nM
1G4O|1.96|2000|BSB||P00918|CARBONIC ANHYDRASE 2|8.25|Kd=5.6nM|Kd|=|5.6|nM|5.6|nM
1C7E|2.25|2000|FMN|hq)|P00323|FLAVODOXIN|6.3|Kd=505nM|Kd|=|505|nM|505|nM
1EJ4|2.25|2000|17-mer|incomplete ligand structure|P63073|EUKARYOTIC TRANSLATION INITIATION FACTOR 4E|7.3|Kd=50nM|Kd|=|50|nM|50|nM
1G6G|1.60|2000|13-mer|incomplete ligand structure|P22216|PROTEIN KINASE RAD53|6.28|Kd=530nM|Kd|=|530|nM|530|nM
1G6R|2.80|2000|8-mer||P01738|ALPHA T CELL RECEPTOR|4.27|Kd=54uM|Kd|=|54|uM|54000|nM
1ETZ|2.60|2000|GAS||G0YP42|ANTIBODY FAB NC10.14, LIGHT CHAIN|7.24|Kd=58nM|Kd|=|58|nM|58|nM
1F3J|3.10|2000|14-mer|HEL(11-25) peptide and I-Ag7 complex, Kd=6.0+/-0.7uM|P04228|H-2 CLASS II HISTOCOMPATIBILITY ANTIGEN|5.22|Kd=6.0uM|Kd|=|6|uM|6000|nM
1FCX|1.47|2000|184||P13631|RETINOIC ACID RECEPTOR GAMMA-1|7.19|Kd=64nM|Kd|=|64|nM|64|nM
1D6V|2.00|2000|HOP||P01834|CHIMERIC GERMLINE PRECURSOR OF OXY-COPE|6.17|Kd=670nM|Kd|=|670|nM|670|nM
1FCH|2.20|2000|5-mer||P50542|PEROXISOMAL TARGETING SIGNAL 1 RECEPTOR|7.15|Kd=70nM|Kd|=|70|nM|70|nM
1D6S|2.30|2000|PLP|Kd measured on OASS wt|P12674|O-ACETYLSERINE SULFHYDRYLASE|4.11|Kd=78uM|Kd|=|78|uM|78000|nM
1DVA|3.00|2000|19-mer|incomplete ligan structure|P08709|COAGULATION FACTOR VIIA (HEAVY CHAIN)|8.07|Kd=8.5nM|Kd|=|8.5|nM|8.5|nM
1QNH|2.10|2000|11-mer||Q25756|PEPTIDYL-PROLYL CIS-TRANS ISOMERASE|6.06|Kd=872nM|Kd|=|872|nM|872|nM
1C1U|1.75|2000|BAI||P00734|THROMBIN ALPHA|8.25|Ki=0.0056uM|Ki|=|0.0056|uM|5.6|nM
1C4V|2.10|2000|IH2||P00734|THROMBIN SHORT CHAIN|10.8|Ki=0.016nM|Ki|=|0.016|nM|0.016|nM
1B57|2.00|2000|PGH|ligand is phosphoglycolohydroxamic acid (PGH)|P0AB71|PROTEIN (FRUCTOSE-BISPHOSPHATE ALDOLASE II)|8.0|Ki=0.01uM|Ki|=|0.01|uM|10|nM
1C1R|1.37|2000|BAI||P00760|TRYPSIN|7.63|Ki=0.0235uM|Ki|=|0.0235|uM|23.5|nM
1C1V|1.98|2000|BAB||P00734|THROMBIN|7.64|Ki=0.023uM|Ki|=|0.023|uM|23|nM
1F7B|1.80|2000|NAV|covalent complex|P44539|N-ACETYL-NEURAMINATE LYASE|4.6|Ki=0.025mM|Ki|=|0.025|mM|25000|nM
1C4U|2.10|2000|IH1||P00734|THROMBIN SHORT CHAIN|10.37|Ki=0.043nM|Ki|=|0.043|nM|0.043|nM
1C70|2.50|2000|L75||O92103|HIV-1 PROTEASE|10.3|Ki=0.05nM|Ki|=|0.05|nM|0.05|nM
1FJS|1.92|2000|Z34||P00742|COAGULATION FACTOR XA|9.96|Ki=0.11nM|Ki|=|0.11|nM|0.11|nM
1FH8|1.95|2000|2-mer|ligand is XYP-XIF|P07986|BETA-1,4-XYLANASE|6.89|Ki=0.13uM|Ki|=|0.13|uM|130|nM
1FHD|1.90|2000|2-mer|ligand is XYP-XIM|P07986|BETA-1,4-XYLANASE|6.82|Ki=0.15uM|Ki|=|0.15|uM|150|nM
1GFZ|2.30|2000|CFF|Ki=0.1-0.2mM|P00489|GLYCOGEN PHOSPHORYLASE|4.0|Ki=0.1mM|Ki|=|0.1|mM|100000|nM
1E37|1.75|2000|TPY|covalent complex|P00772|ELASTASE|3.7|Ki=0.20mM|Ki|=|0.2|mM|200000|nM
1C5X|1.75|2000|ESI||P00749|UROKINASE-TYPE PLASMINOGEN ACTIVATOR|6.68|Ki=0.21uM|Ki|=|0.21|uM|210|nM
1D1P|2.20|2000|EPE||P40347|TYROSINE PHOSPHATASE|3.6|Ki=0.25mM|Ki|=|0.25|mM|250000|nM
1F3E|1.85|2000|DPZ||P28720|QUEUINE TRNA-RIBOSYLTRANSFERASE|6.7|Ki=0.2uM|Ki|=|0.2|uM|200|nM
1C6Y|2.50|2000|MK1|X-ray(HIV-1 protease with 9 mutations) while Ki(wild type)|O09893|HIV-1 PROTEASE|9.51|Ki=0.31nM|Ki|=|0.31|nM|0.31|nM
1FH9|1.72|2000|2-mer|ligand is XYP-LOX|P07986|BETA-1,4-XYLANASE|6.43|Ki=0.37uM|Ki|=|0.37|uM|370|nM
1C5Q|1.43|2000|ESI||P00760|TRYPSIN|6.36|Ki=0.44uM|Ki|=|0.44|uM|440|nM
1E6S|1.35|2000|GOX||P29736|MYROSINASE|3.22|Ki=0.6mM|Ki|=|0.6|mM|600000|nM
1D4K|1.85|2000|PI8||P03369|HIV-1 PROTEASE|9.22|Ki=0.6nM|Ki|=|0.6|nM|0.6|nM
1D9I|2.30|2000|00P||P00734|THROMBIN|9.11|Ki=0.78nM|Ki|=|0.78|nM|0.78|nM
1EC9|2.00|2000|XYH||P76637|GLUCARATE DEHYDRATASE|3.1|Ki=0.8mM|Ki|=|0.8|mM|800000|nM
1FQ8|2.80|2000|2Y4||P07267|SACCHAROPEPSIN|6.03|Ki=0.94uM|Ki|=|0.94|uM|940|nM
1F74|1.60|2000|NAY||P44539|N-ACETYL-NEURAMINATE LYASE|3.05|Ki=0.9mM|Ki|=|0.9|mM|900000|nM
1EZQ|2.20|2000|RPR||P00742|COAGULATION FACTOR XA|9.05|Ki=0.9nM|Ki|=|0.9|nM|0.9|nM
1EOC|2.25|2000|4NC||P20371|PROTOCATECHUATE 3,4-DIOXYGENASE ALPHA CHAIN|6.05|Ki=0.9uM|Ki|=|0.9|uM|900|nM
1QON|2.72|2000|I40|Ki measured on AChE (Musca domestica)|P07140|ACETYLCHOLINESTERASE|8.96|Ki=1.09nM|Ki|=|1.09|nM|1.09|nM
1ECQ|2.00|2000|DXG||P76637|GLUCARATE DEHYDRATASE|3.0|Ki=1.0mM|Ki|=|1|mM|1000000|nM
1C5S|1.36|2000|ESX||P00760|TRYPSIN|6.0|Ki=1.0uM|Ki|=|1|uM|1000|nM
1F4E|1.90|2000|TPR||P0A884|THYMIDYLATE SYNTHASE|2.96|Ki=1.1mM|Ki|=|1.1|mM|1100000|nM
1DOJ|1.70|2000|1Z0|covalent complex|P00734|THROMBIN ALPHA|8.96|Ki=1.1nM|Ki|=|1.1|nM|1.1|nM
1E34|1.80|2000|TPX|covalent complex|P00772|ELASTASE|2.88|Ki=1.32mM|Ki|=|1.32|mM|1320000|nM
1QM5|2.00|2000|5-mer||P00490|MALTODEXTRIN PHOSPHORYLASE|5.82|Ki=1.5uM|Ki|=|1.5|uM|1500|nM
1FKN|1.90|2000|7-mer||P56817|BETA-SECRETASE 1|8.8|Ki=1.6nM|Ki|=|1.6|nM|1.6|nM
1D4L|1.75|2000|PI9||P03369|HIV-1 PROTEASE|8.77|Ki=1.7nM|Ki|=|1.7|nM|1.7|nM
1B6K|1.85|2000|PI5||P03369|HIV-1 PROTEASE|8.74|Ki=1.8nM|Ki|=|1.8|nM|1.8|nM
1F0T|1.80|2000|PR1||P00760|TRYPSIN|6.0|Ki=1000nM|Ki|=|1000|nM|1000|nM
1DQN|1.75|2000|IMU||Q24973|GUANINE PHOSPHORIBOSYLTRANSFERASE|8.0|Ki=10nM|Ki|=|10|nM|10|nM
1E2K|1.70|2000|TMC||P03176|THYMIDINE KINASE|4.94|Ki=11.4uM|Ki|=|11.4|uM|11400|nM
1D6W|2.00|2000|00R||P00734|THROMBIN|5.96|Ki=1100nM|Ki|=|1100|nM|1100|nM
1EXW|2.40|2000|HDS|covalent complex|P45478|PALMITOYL PROTEIN THIOESTERASE 1|3.9|Ki=125uM|Ki|=|125|uM|125000|nM
1B6J|1.85|2000|5-mer||P03369|HIV-1 PROTEASE|7.92|Ki=12nM|Ki|=|12|nM|12|nM
1C4Y|2.70|2000|IH3||P00734|THROMBIN SHORT CHAIN|7.92|Ki=12nM|Ki|=|12|nM|12|nM
1FQ6|2.70|2000|0QF||P07267|SACCHAROPEPSIN|7.86|Ki=13.7nM|Ki|=|13.7|nM|13.7|nM
1ERQ|1.90|2000|BJH|covalent complex|P62593|BETA-LACTAMASE TEM-1|7.89|Ki=13nM|Ki|=|13|nM|13|nM
1QBN|1.80|2000|688||P00760|TRYPSIN|5.85|Ki=1400nM|Ki|=|1400|nM|1400|nM
1C83|1.80|2000|OAI||P18031|PROTEIN-TYROSINE PHOSPHATASE 1B|4.85|Ki=14uM|Ki|=|14|uM|14000|nM
1ECV|1.95|2000|878||P18031|PROTEIN-TYROSINE PHOSPHATASE 1B|4.85|Ki=14uM|Ki|=|14|uM|14000|nM
1QJI|2.14|2000|PKF||P07584|ASTACIN|4.85|Ki=14uM|Ki|=|14|uM|14000|nM
1GFW|2.80|2000|MSI|covalent complex|P42574|CASPASE-3|7.82|Ki=15nM|Ki|=|15|nM|15|nM
1QB1|1.80|2000|974||P00760|TRYPSIN|6.77|Ki=170nM|Ki|=|170|nM|170|nM
1EOJ|2.10|2000|14-mer||P00734|THROMBIN ALPHA|13.77|Ki=17fM|Ki|=|17|fM|1.7e-05|nM
1EK1|3.10|2000|CIU||P34914|EPOXIDE HYDROLASE|7.77|Ki=17nM|Ki|=|17|nM|17|nM
1F0S|2.10|2000|PR2||P00742|COAGULATION FACTOR XA|7.74|Ki=18nM|Ki|=|18|nM|18|nM
1QBO|1.80|2000|711||P00760|TRYPSIN|7.74|Ki=18nM|Ki|=|18|nM|18|nM
1QAQ|2.80|2000|SFG||P13956|ERMC' RRNA METHYLTRANSFERASE|4.74|Ki=18uM|Ki|=|18|uM|18000|nM
1YLV|2.15|2000|SHF|covalent complex|P05373|5-AMINOLAEVULINIC ACID DEHYDRATASE|2.7|Ki=2.0mM|Ki|=|2|mM|2000000|nM
1F57|1.75|2000|DCY||P00730|CARBOXYPEPTIDASE A|5.64|Ki=2.3uM|Ki|=|2.3|uM|2300|nM
1HLF|2.26|2000|GL4|Ki measured with phosphate|P00489|GLYCOGEN PHOSPHORYLASE|5.64|Ki=2.3uM|Ki|=|2.3|uM|2300|nM
1EJN|1.80|2000|AGB||P00749|UROKINASE-TYPE PLASMINOGEN ACTIVATOR|5.62|Ki=2.4uM|Ki|=|2.4|uM|2400|nM
1C5N|1.50|2000|ESI||P00734|THROMBIN ALPHA|4.7|Ki=20uM|Ki|=|20|uM|20000|nM
1C86|2.30|2000|OPA||P18031|PROTEIN-TYROSINE PHOSPHATASE 1B|4.7|Ki=20uM|Ki|=|20|uM|20000|nM
1C5P|1.43|2000|BAM||P00760|TRYPSIN|4.68|Ki=21uM|Ki|=|21|uM|21000|nM
1F0R|2.10|2000|815||P00742|COAGULATION FACTOR XA|7.66|Ki=22nM|Ki|=|22|nM|22|nM
1C85|2.72|2000|OBA||P18031|PROTEIN-TYROSINE PHOSPHATASE 1B|4.64|Ki=23uM|Ki|=|23|uM|23000|nM
1F4F|2.00|2000|TP3||P0A884|THYMIDYLATE SYNTHASE|4.62|Ki=24uM|Ki|=|24|uM|24000|nM
1C2T|2.10|2000|NHS|redundant to 1c3e|P08179|GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMYLASE|6.59|Ki=260nM|Ki|=|260|nM|260|nM
1D09|2.10|2000|PAL|ATCase in complex with PALA|P0A786|ASPARTATE CARBAMOYLTRANSFERASE|7.57|Ki=27nM|Ki|=|27|nM|27|nM
1EGH|2.00|2000|PGA||P0A731|METHYLGLYOXAL SYNTHASE|5.7|Ki=2uM|Ki|=|2|uM|2000|nM
1GGN|2.36|2000|GLS||P00489|GLYCOGEN PHOSPHORYLASE|5.51|Ki=3.1uM|Ki|=|3.1|uM|3100|nM
1FQ7|2.80|2000|2Y3||P07267|SACCHAROPEPSIN|5.43|Ki=3.74uM|Ki|=|3.74|uM|3740|nM
1C5O|1.90|2000|BAM||P00734|THROMBIN ALPHA|3.49|Ki=320uM|Ki|=|320|uM|320000|nM
1F4G|1.75|2000|TP4||P0A884|THYMIDYLATE SYNTHASE|6.48|Ki=330nM|Ki|=|330|nM|330|nM
1QAN|2.40|2000|SAH||P13956|ERMC' METHYLTRANSFERASE|4.48|Ki=33uM|Ki|=|33|uM|33000|nM
1FW0|1.90|2000|KAI|ligand is kainate|P19491|GLUTAMATE RECEPTOR 2|5.43|Ki=3690nM|Ki|=|3690|nM|3690|nM
1QB9|1.80|2000|806||P00760|TRYPSIN|7.44|Ki=36nM|Ki|=|36|nM|36|nM
1EOL|2.10|2000|15-mer||P00734|THROMBIN ALPHA|13.42|Ki=38fM|Ki|=|38|fM|3.7999999999999995e-05|nM
1FQ4|2.70|2000|2Y2||P07267|SACCHAROPEPSIN|6.4|Ki=398.0nM|Ki|=|398|nM|398|nM
1B6P|2.00|2000|PI7|incomplete ligand structure|P03369|PROTEASE RETROPEPSIN|8.52|Ki=3nM|Ki|=|3|nM|3|nM
1FQ5|2.40|2000|0GM||P07267|SACCHAROPEPSIN|8.4|Ki=4.0nM|Ki|=|4|nM|4|nM
1F73|1.95|2000|HMN||P44539|N-ACETYL-NEURAMINATE LYASE|2.39|Ki=4.1mM|Ki|=|4.1|mM|4099999.9999999995|nM
1QL9|2.30|2000|ZEN||P00763|TRYPSIN BETA|5.35|Ki=4.45uM|Ki|=|4.45|uM|4450|nM
1QI0|2.10|2000|CBI||P06565|ENDOGLUCANASE B|2.35|Ki=4.5mM|Ki|=|4.5|mM|4500000|nM
1DY4|1.90|2000|SNP||P62694|CELLOBIOHYDROLASE I|4.36|Ki=44uM|Ki|=|44|uM|44000|nM
1B6M|1.85|2000|PI6|redundant to 1mtr|P03369|HIV-1 PROTEASE|8.4|Ki=4nM|Ki|=|4|nM|4|nM
1C88|1.80|2000|OTA||P18031|PROTEIN-TYROSINE PHOSPHATASE 1B|5.29|Ki=5.1uM|Ki|=|5.1|uM|5100|nM
1FH7|1.82|2000|2-mer|ligand is XYP-XDN|P07986|BETA-1,4-XYLANASE|5.24|Ki=5.8uM|Ki|=|5.8|uM|5800|nM
1ERO|2.10|2000|BJP|covalent complex|P62593|BETA-LACTAMASE TEM-1|8.23|Ki=5.9nM|Ki|=|5.9|nM|5.9|nM
1B74|2.30|2000|DGN||P56868|GLUTAMATE RACEMASE|1.3|Ki=50mM|Ki|=|50|mM|50000000|nM
1QM4|2.66|2000|AMB||P13444|METHIONINE ADENOSYLTRANSFERASE, ALPHA FORM|4.3|Ki=50uM|Ki|=|50|uM|50000|nM
1E2L|2.40|2000|TMC||P03176|THYMIDINE KINASE|4.29|Ki=51.5uM|Ki|=|51.5|uM|51500|nM
1B6L|1.75|2000|PI4||P03369|HIV-1 PROTEASE|8.3|Ki=5nM|Ki|=|5|nM|5|nM
1EK2|3.00|2000|CDU||P34914|EPOXIDE HYDROLASE|8.2|Ki=6.3nM|Ki|=|6.3|nM|6.3|nM
1FT7|2.20|2000|PLU|Ki measured at pH=8.0|Q01693|LEUCYL AMINOPEPTIDASE|5.18|Ki=6.6uM|Ki|=|6.6|uM|6600|nM
1C5Y|1.65|2000|ESP||P00749|UROKINASE-TYPE PLASMINOGEN ACTIVATOR|4.2|Ki=63uM|Ki|=|63|uM|63000|nM
1C87|2.10|2000|OPA||P18031|PROTEIN-TYROSINE PHOSPHATASE 1B|4.2|Ki=63uM|Ki|=|63|uM|63000|nM
1F0U|1.90|2000|RPR||P00760|TRYPSIN|7.16|Ki=69nM|Ki|=|69|nM|69|nM
1BSK|3.00|2000|MLN||P0A6K3|PEPTIDE DEFORMYLASE|4.12|Ki=76uM|Ki|=|76|uM|76000|nM
1E55|2.00|2000|2-mer|ligand is BGC-DHR; Ki measured on Glu1 wt|P49235|BETA-GLUCOSIDASE|4.12|Ki=76uM|Ki|=|76|uM|76000|nM
1GFY|2.13|2000|COL|ligand is compound 29; -logKi=5.08|P18031|PROTEIN-TYROSINE PHOSPHATASE 1B|5.08|Ki=8.32uM|Ki|=|8.32|uM|8320|nM
1ENU|1.95|2000|APZ||P28720|TRNA GUANINE TRANSGLYCOSYLASE|5.08|Ki=8.3uM|Ki|=|8.3|uM|8300|nM
1QQ9|1.53|2000|MET||P80561|AMINOPEPTIDASE|2.06|Ki=8.7mM|Ki|=|8.7|mM|8700000|nM
1EIX|2.50|2000|BMQ|redundant to 1x1z|P08244|OROTIDINE 5'-MONOPHOSPHATE DECARBOXYLASE|11.06|Ki=8.8pM|Ki|=|8.8|pM|0.0088|nM
1DGM|1.80|2000|ADN|ligand is adenosine|Q9TVW2|ADENOSINE KINASE|5.05|Ki=8.9uM|Ki|=|8.9|uM|8900|nM
1C5T|1.37|2000|ESP||P00760|TRYPSIN|4.1|Ki=80uM|Ki|=|80|uM|80000|nM
1QB6|1.80|2000|623||P00760|TRYPSIN|6.06|Ki=870nM|Ki|=|870|nM|870|nM
8A3H|0.97|2000|IDC||P06565|ENDOGLUCANASE 5A|4.06|Ki=88uM|Ki|=|88|uM|88000|nM
1C84|2.35|2000|761||P18031|PROTEIN-TYROSINE PHOSPHATASE 1B|5.0|Ki=9.9uM|Ki|=|9.9|uM|9900|nM
1CI7|2.60|2000|CB3||P13100|THYMIDYLATE SYNTHASE|7.05|Ki=90nM|Ki|=|90|nM|90|nM
1C5Z|1.85|2000|BAM||P00749|UROKINASE-TYPE PLASMINOGEN ACTIVATOR|4.01|Ki=97uM|Ki|=|97|uM|97000|nM
1DQX|2.40|2000|BMP|redundant to 1x1z|P03962|OROTIDINE 5'-MONOPHOSPHATE DECARBOXYLASE|11.05|Ki=9pM|Ki|=|9|pM|0.009000000000000001|nM
1JLQ|3.00|2001|SBN||P04585|HIV-1 REVERSE TRANSCRIPTASE, A-CHAIN|8.15|IC=0.007uM|IC50|=|0.007|uM|7|nM
1H8Y|2.00|2001|MER||Q51400|BETA-LACTAMASE|7.7|IC=0.02uM|IC50|=|0.02|uM|20|nM
1JOJ|3.00|2001|7-mer||P02866|CONCANAVALIN A|4.22|IC=0.06mM|IC50|=|0.06|mM|60000|nM
1JBD|NMR|2001|14-mer|lowest-energy structure|P60615|LONG NEUROTOXIN 1|6.92|IC=0.12uM|IC50|=|0.12|uM|120|nM
1G37|2.00|2001|110|covalent complex|P00734|THROMBIN ALPHA|10.0|IC=0.1nM|IC50|=|0.1|nM|0.1|nM
1I7M|2.24|2001|_CG||P17707|S-ADENOSYLMETHIONINE DECARBOXYLASE BETA CHAIN|9.64|IC=0.23nM|IC50|=|0.23|nM|0.23|nM
1FT4|2.90|2001|703||P19438|SOLUBLE TUMOR NECROSIS FACTOR RECEPTOR 1|6.57|IC=0.27uM|IC50|=|0.27|uM|270|nM
1HVY|1.90|2001|D16|ligand is Raltitrexed|P04818|THYMIDYLATE SYNTHASE|6.54|IC=0.29uM|IC50|=|0.29|uM|290|nM
1JIK|2.80|2001|545||A6QHR2|TYROSYL-TRNA SYNTHETASE|9.7|IC=0.2nM|IC50|=|0.2|nM|0.2|nM
1FO3|1.75|2001|KIF||Q9UKM7|ALPHA-1,2-MANNOSIDASE|6.7|IC=0.2uM|IC50|=|0.2|uM|200|nM
1JQ3|1.80|2001|AAT||Q9WZC2|SPERMIDINE SYNTHASE|6.7|IC=0.2uM|IC50|=|0.2|uM|200|nM
1I7C|2.40|2001|MGB||P17707|S-ADENOSYLMETHIONINE DECARBOXYLASE BETA CHAIN|6.4|IC=0.4uM|IC50|=|0.4|uM|400|nM
1K2I|1.80|2001|SN1|covalent complex|P00766|CHYMOTRYPSINOGEN A|3.11|IC=0.78mM|IC50|=|0.78|mM|780000|nM
1I91|2.00|2001|INQ||P00918|CARBONIC ANHYDRASE 2|8.94|IC=1.15nM|IC50|=|1.15|nM|1.15|nM
1I8Z|1.93|2001|INL||P00918|CARBONIC ANHYDRASE 2|8.9|IC=1.27nM|IC50|=|1.27|nM|1.27|nM
1I90|2.00|2001|INM||P00918|CARBONIC ANHYDRASE 2|8.89|IC=1.28nM|IC50|=|1.28|nM|1.28|nM
1JVP|1.53|2001|LIG||P24941|CELL DIVISION PROTEIN KINASE 2|5.8|IC=1.6uM|IC50|=|1.6|uM|1600|nM
1JJ9|2.00|2001|BBT||P22894|MATRIX METALLOPROTEINASE 8|5.77|IC=1.7uM|IC50|=|1.7|uM|1700|nM
1HC9|1.80|2001|13-mer||P60616|ALPHA-BUNGAROTOXIN ISOFORM V31|8.72|IC=1.9nM|IC50|=|1.9|nM|1.9|nM
1IEP|2.10|2001|STI||P00520|TYROSINE-PROTEIN KINASE ABL1|7.0|IC=100nM|IC50|=|100|nM|100|nM
1FVV|2.80|2001|107||P24941|CYCLIN-DEPENDENT KINASE 2|8.0|IC=10nM|IC50|=|10|nM|10|nM
1G2A|1.75|2001|BB2||P0A6K3|PEPTIDE DEFORMYLASE|8.0|IC=10nM|IC50|=|10|nM|10|nM
1K1P|1.90|2001|MEL|ligand is compound Melagatran|P00760|TRYPSIN|7.92|IC=11.9nM|IC50|=|11.9|nM|11.9|nM
1G49|1.90|2001|111||P08254|MATRIX METALLOPROTEINASE-3|7.8|IC=16nM|IC50|=|16|nM|16|nM
1H5U|1.76|2001|CHI|IC50=334nM without glucose|P00489|GLYCOGEN PHOSPHORYLASE|6.75|IC=178nM|IC50|=|178|nM|178|nM
1JII|3.20|2001|383||A6QHR2|TYROSYL-TRNA SYNTHETASE|9.0|IC=1nM|IC50|=|1|nM|1|nM
1F0Q|2.63|2001|EMO||P28523|CASEIN KINASE II, ALPHA SUBUNIT|6.0|IC=1uM|IC50|=|1|uM|1000|nM
1G4K|2.00|2001|HQQ||P08254|STROMELYSIN-1|5.7|IC=2.0uM|IC50|=|2|uM|2000|nM
1IKW|3.00|2001|EFZ||P03366|HIV-1 REVERSE TRANSCRIPTASE|8.6|IC=2.5nM|IC50|=|2.5|nM|2.5|nM
1CS4|2.50|2001|101||P30803|ADENYLATE CYCLASE TYPE 5|5.57|IC=2.7uM|IC50|=|2.7|uM|2700|nM
1FO2|2.38|2001|DMJ||Q9UKM7|ALPHA-1,2-MANNOSIDASE|4.7|IC=20uM|IC50|=|20|uM|20000|nM
1HAA|NMR|2001|13-mer||P01378|ALPHA-BUNGAROTOXIN|8.7|IC=2nM|IC50|=|2|nM|2|nM
1I32|2.60|2001|NMD||Q27890|GLYCERALDEHYDE 3-PHOSPHATE DEHYDROGENASE|5.7|IC=2uM|IC50|=|2|uM|2000|nM
1HBJ|2.50|2001|FBQ|covalent complex|P04058|ACETYLCHOLINESTERASE|8.52|IC=3.0nM|IC50|=|3|nM|3|nM
1G05|2.45|2001|BBH||P08254|STROMELYSIN-1 PRECURSOR|8.51|IC=3.1nM|IC50|=|3.1|nM|3.1|nM
1JJE|1.80|2001|BYS||P52699|BETA-LACTAMASE IMP-1|8.43|IC=3.7nM|IC50|=|3.7|nM|3.7|nM
1FLS|NMR|2001|WAY||P45452|COLLAGENASE 3|7.48|IC=33nM|IC50|=|33|nM|33|nM
1E9H|2.50|2001|INR||P24941|CELL DIVISION PROTEIN KINASE 2|7.46|IC=35nM|IC50|=|35|nM|35|nM
1HYZ|2.30|2001|TTO|incomplete ligand structure|Q76353|INTEGRASE|3.42|IC=380uM|IC50|=|380|uM|380000|nM
1I8J|1.90|2001|DSB||P0ACB2|PORPHOBILINOGEN SYNTHASE|4.41|IC=39uM|IC50|=|39|uM|39000|nM
1JIJ|3.20|2001|629||A6QHR2|TYROSYL-TRNA SYNTHETASE|8.52|IC=3nM|IC50|=|3|nM|3|nM
1JK7|1.90|2001|OKA||P36873|SERINE/THREONINE PROTEIN PHOSPHATASE PP1-GAMMA|8.52|IC=3nM|IC50|=|3|nM|3|nM
1HS6|1.95|2001|BES||P09960|LEUKOTRIENE A-4 HYDROLASE|5.38|IC=4.2uM|IC50|=|4.2|uM|4200|nM
1G5S|2.61|2001|I17||P24941|CELL DIVISION PROTEIN KINASE 2|7.32|IC=48nM|IC50|=|48|nM|48|nM
1JIL|2.20|2001|485||A6QHR2|TYROSYL-TRNA SYNTHETASE|8.4|IC=4nM|IC50|=|4|nM|4|nM
1IKY|3.00|2001|MSD||P03366|HIV-1 REVERSE TRANSCRIPTASE|8.26|IC=5.5nM|IC50|=|5.5|nM|5.5|nM
1IKV|3.00|2001|EFZ||P03366|HIV-1 REVERSE TRANSCRIPTASE|6.28|IC=520nM|IC50|=|520|nM|520|nM
1I72|2.00|2001|MAO|ligand is compound 5|P17707|S-ADENOSYLMETHIONINE DECARBOXYLASE BETA CHAIN|7.26|IC=55nM|IC50|=|55|nM|55|nM
1FVT|2.20|2001|106||P24941|CELL DIVISION PROTEIN KINASE 2|7.22|IC=60nM|IC50|=|60|nM|60|nM
1IKX|2.80|2001|PNU||P03366|HIV-1 REVERSE TRANSCRIPTASE|8.15|IC=7.0nM|IC50|=|7|nM|7|nM
1I33|3.00|2001|TND||Q27890|GLYCERALDEHYDE 3-PHOSPHATE DEHYDROGENASE|4.12|IC=75uM|IC50|=|75|uM|75000|nM
1G27|2.10|2001|BB1||P0A6K3|PEPTIDE DEFORMYLASE|8.15|IC=7nM|IC50|=|7|nM|7|nM
1JJT|1.80|2001|BDS||P52699|BETA-LACTAMASE IMP-1|8.05|IC=9nM|IC50|=|9|nM|9|nM
1HYV|1.70|2001|TTA||Q76353|INTEGRASE|2.3|IC>5mM|IC50|>|5|mM|5000000|nM
1I5D|2.90|2001|128||Q56310|CHEMOTAXIS PROTEIN CHEA|8.0|Kd<0.010uM|Kd|<|0.01|uM|10|nM
1J7Z|2.25|2001|15-mer|X-ray(2M sarcosine); Kd=4.21uM(6.5 Kd=3.38uM(10 Kd=2.00uM(20 Kd=1.30uM(30 Kd=0.70uM(40 Kd=0.38uM(50 Kd=0.18uM(55 Kd=0.02uM(60|P61823|RIBONUCLEASE|7.7|Kd=0.02uM|Kd|=|0.02|uM|20|nM
1JD6|2.70|2001|10-mer||Q24306|APOPTOSIS 1 INHIBITOR|7.39|Kd=0.041uM|Kd|=|0.041|uM|41|nM
1IE9|1.40|2001|VDX|ligand is 1,25(OH)2 vitamin D3|P11473|VITAMIN D3 RECEPTOR|10.19|Kd=0.065nM|Kd|=|0.065|nM|0.065|nM
1J81|2.20|2001|15-mer|Kd=0.53uM(10 Kd=0.30uM(20 Kd=0.08uM(30|P61823|RIBONUCLEASE|7.1|Kd=0.08uM|Kd|=|0.08|uM|80|nM
1HN4|1.50|2001|MJI||P00592|PROPHOSPHOLIPASE A2|3.82|Kd=0.15mM|Kd|=|0.15|mM|150000|nM
1FWV|2.20|2001|3-mer||Q61830|CYSTEINE-RICH DOMAIN OF MANNOSE RECEPTOR|3.72|Kd=0.19mM|Kd|=|0.19|mM|190000|nM
1FWU|1.90|2001|3-mer||Q61830|CYSTEINE-RICH DOMAIN OF MANNOSE RECEPTOR|3.7|Kd=0.20mM|Kd|=|0.2|mM|200000|nM
1JD5|1.90|2001|10-mer||Q24306|APOPTOSIS 1 INHIBITOR|6.62|Kd=0.24uM|Kd|=|0.24|uM|240|nM
1J4Q|NMR|2001|13-mer||P22216|PROTEIN KINASE SPK1|6.44|Kd=0.36uM|Kd|=|0.36|uM|360|nM
1I80|2.00|2001|9HX||P0A538|PURINE NUCLEOSIDE PHOSPHORYLASE|6.41|Kd=0.39uM|Kd|=|0.39|uM|390|nM
1J80|2.10|2001|15-mer|Kd=0.88uM; Kd=0.30uM|P61823|RIBONUCLEASE|6.52|Kd=0.3uM|Kd|=|0.3|uM|300|nM
1K3Q|NMR|2001|13-mer||P22216|PROTEIN KINASE SPK1|6.52|Kd=0.3uM|Kd|=|0.3|uM|300|nM
1G3F|NMR|2001|9-mer||P98170|INHIBITOR OF APOPTOSIS PROTEIN 3|6.37|Kd=0.43uM|Kd|=|0.43|uM|430|nM
1EX8|1.85|2001|A4P|Kd=0.47uM (with Mg2+); Kd=1.93uM (without Mg2+)|P26281|6-HYDROXYMETHYL-7,8-DIHYDROPTERIN PYROPHOSPHOKINASE|6.33|Kd=0.47uM|Kd|=|0.47|uM|470|nM
1G7V|2.40|2001|PAI||P0A715|2-DEHYDRO-3-DEOXYPHOSPHOOCTONATE ALDOLASE|6.4|Kd=0.4uM|Kd|=|0.4|uM|400|nM
1I7Z|2.30|2001|COC||P01834|CHIMERA OF IG KAPPA CHAIN: HUMAN CONSTANT REGION|6.4|Kd=0.4uM|Kd|=|0.4|uM|400|nM
1KA7|NMR|2001|12-mer||O60880|SH2 DOMAIN PROTEIN 1A|6.22|Kd=0.60uM|Kd|=|0.6|uM|600|nM
1H6E|3.60|2001|11-mer|incomplete ligand|P20172|CLATHRIN COAT ASSEMBLY PROTEIN AP50|6.15|Kd=0.7uM|Kd|=|0.7|uM|700|nM
1HIY|2.60|2001|3AN||P22887|NUCLEOSIDE DIPHOSPHATE KINASE|3.08|Kd=0.83mM|Kd|=|0.83|mM|830000|nM
1E3G|2.40|2001|R18|ligand is compound 3 (RU1881)|P10275|ANDROGEN RECEPTOR|9.0|Kd=0.99nM|Kd|=|0.99|nM|0.99|nM
1HN2|1.80|2001|ANC||P07435|ODORANT-BINDING PROTEIN|6.0|Kd=1.0uM|Kd|=|1|uM|1000|nM
1H8S|2.40|2001|AIC||------|MUTANT AL2 6E7P9G|5.81|Kd=1.54uM|Kd|=|1.54|uM|1540|nM
1J4P|NMR|2001|13-mer||P22216|PROTEIN KINASE SPK1|4.99|Kd=10.2uM|Kd|=|10.2|uM|10200|nM
1K3N|NMR|2001|13-mer||P22216|PROTEIN KINASE SPK1|4.99|Kd=10.2uM|Kd|=|10.2|uM|10200|nM
1J4K|NMR|2001|7-mer|redundant to 1fhr|P22216|PROTEIN KINASE SPK1|4.0|Kd=100uM|Kd|=|100|uM|100000|nM
1IH0|NMR|2001|EMD||P63316|TROPONIN C, SLOW SKELETAL AND CARDIAC MUSCLES|5.0|Kd=10uM|Kd|=|10|uM|10000|nM
1F90|2.60|2001|9-mer||------|ANTIBODY FAB FRAGMENT|7.92|Kd=11.9nM|Kd|=|11.9|nM|11.9|nM
1K1L|2.50|2001|FD3||P00760|TRYPSIN|6.9|Kd=125nM|Kd|=|125|nM|125|nM
1FZO|1.80|2001|9-mer||P01901|H-2 CLASS I HISTOCOMPATIBILITY ANTIGEN, K-B|7.89|Kd=13nM|Kd|=|13|nM|13|nM
1H61|1.40|2001|PDN||P71278|PENTAERYTHRITOL TETRANITRATE REDUCTASE|4.89|Kd=13uM|Kd|=|13|uM|13000|nM
1K1N|2.00|2001|CCR||P00760|TRYPSIN|6.82|Kd=153nM|Kd|=|153|nM|153|nM
1H62|1.90|2001|ANB||P71278|PENTAERYTHRITOL TETRANITRATE REDUCTASE|4.77|Kd=17uM|Kd|=|17|uM|17000|nM
1K03|2.70|2001|HBA||Q02899|NADPH DEHYDROGENASE 1|6.0|Kd=1uM|Kd|=|1|uM|1000|nM
1HQ5|2.30|2001|S2C||P07824|ARGINASE 1|5.65|Kd=2.22uM|Kd|=|2.22|uM|2220|nM
1I9N|1.86|2001|IOA||P00918|CARBONIC ANHYDRASE 2|8.66|Kd=2.2nM|Kd|=|2.2|nM|2.2|nM
1HA2|2.50|2001|SWF||P02768|SERUM ALBUMIN|5.54|Kd=2.9uM|Kd|=|2.9|uM|2900|nM
1FZM|1.80|2001|8-mer||P01901|H-2 CLASS I HISTOCOMPATIBILITY ANTIGEN, K-B|7.7|Kd=20nM|Kd|=|20|nM|20|nM
1H60|1.60|2001|STR||P71278|PENTAERYTHRITOL TETRANITRATE REDUCTASE|4.7|Kd=20uM|Kd|=|20|uM|20000|nM
1F47|1.95|2001|17-mer|Kd=21.6uM(binding to immobilized ZipA/M185); Kd=0.2uM(binding to soluble ZipA).|P77173|CELL DIVISION PROTEIN ZIPA|4.67|Kd=21.6uM|Kd|=|21.6|uM|21600|nM
1IF8|1.94|2001|SBS||P00918|CARBONIC ANHYDRASE 2|9.64|Kd=230pM|Kd|=|230|pM|0.23|nM
1II5|1.60|2001|GLU||P73797|HYPOTHETICAL PROTEIN SLR1257|6.62|Kd=240nM|Kd|=|240|nM|240|nM
1JOC|2.20|2001|ITP||Q15075|EARLY ENDOSOMAL AUTOANTIGEN 1|4.62|Kd=24uM|Kd|=|24|uM|24000|nM
1K1I|2.20|2001|FD1||P00760|TRYPSIN BETA|6.58|Kd=264nM|Kd|=|264|nM|264|nM
1K1J|2.20|2001|FD2||P00760|TRYPSIN|7.55|Kd=28nM|Kd|=|28|nM|28|nM
1I8H|NMR|2001|13-mer||P10636|PEPTIDYL-PROLYL CIS-TRANS ISOMERASE NIMA-INTERACTIN|4.54|Kd=29uM|Kd|=|29|uM|29000|nM
1JGL|2.15|2001|EST||Q920E6|ANTIBODY KAPPA-CHAIN|8.7|Kd=2nM|Kd|=|2|nM|2|nM
1I9L|1.93|2001|INV||P00918|CARBONIC ANHYDRASE 2|8.48|Kd=3.3nM|Kd|=|3.3|nM|3.3|nM
1I9M|1.84|2001|INW||P00918|CARBONIC ANHYDRASE 2|8.48|Kd=3.3nM|Kd|=|3.3|nM|3.3|nM
1I9O|1.86|2001|IOC||P00918|CARBONIC ANHYDRASE 2|8.42|Kd=3.8nM|Kd|=|3.8|nM|3.8|nM
1H9Z|2.50|2001|RWF||P02768|SERUM ALBUMIN|5.42|Kd=3.8uM|Kd|=|3.8|uM|3800|nM
1I9P|1.92|2001|IOE||P00918|CARBONIC ANHYDRASE 2|8.41|Kd=3.9nM|Kd|=|3.9|nM|3.9|nM
1I9Q|1.80|2001|IOF||P00918|CARBONIC ANHYDRASE 2|8.41|Kd=3.9nM|Kd|=|3.9|nM|3.9|nM
1IMX|1.82|2001|CPQ||P01343|INSULIN-LIKE GROWTH FACTOR 1A|3.52|Kd=300uM|Kd|=|300|uM|300000|nM
1IF7|1.98|2001|SBR||P00918|CARBONIC ANHYDRASE 2|10.52|Kd=30pM|Kd|=|30|pM|0.03|nM
1EWJ|2.50|2001|BLM||P13081|BLEOMYCIN RESISTANCE DETERMINANT|7.49|Kd=32nM|Kd|=|32|nM|32|nM
1IQ1|2.80|2001|11-mer||P52293|IMPORTIN SUBUNIT ALPHA-2|7.46|Kd=35nM|Kd|=|35|nM|35|nM
1FL6|2.80|2001|AAH||------|ANTIBODY GERMLINE PRECURSOR TO 28B4|7.43|Kd=37nM|Kd|=|37|nM|37|nM
1IKT|1.75|2001|OXN||P51659|ESTRADIOL 17 BETA-DEHYDROGENASE 4|3.4|Kd=400uM|Kd|=|400|uM|400000|nM
1K1M|2.20|2001|FD4||P00760|TRYPSIN|7.4|Kd=40nM|Kd|=|40|nM|40|nM
1JMQ|NMR|2001|10-mer||P46937|65 KDA YES-ASSOCIATED PROTEIN|4.4|Kd=40uM|Kd|=|40|uM|40000|nM
1ILH|2.76|2001|SRL||O75469|ORPHAN NUCLEAR RECEPTOR PXR|7.39|Kd=41nM|Kd|=|41|nM|41|nM
1E3V|2.00|2001|DXC||P07445|STEROID DELTA-ISOMERASE|4.34|Kd=45.74uM|Kd|=|45.74|uM|45740|nM
1FE3|2.80|2001|OLA||O15540|FATTY ACID-BINDING PROTEIN|7.33|Kd=46.7nM|Kd|=|46.7|nM|46.7|nM
1FZK|1.70|2001|9-mer||P01901|H-2 CLASS I HISTOCOMPATIBILITY ANTIGEN, K-B|8.4|Kd=4nM|Kd|=|4|nM|4|nM
1H6H|1.70|2001|PIB||Q15080|NEUTROPHIL CYTOSOL FACTOR 4|5.3|Kd=5.0uM|Kd|=|5|uM|5000|nM
1K9R|NMR|2001|6-mer||P46937|65 KDA YES-ASSOCIATED PROTEIN|3.3|Kd=500uM|Kd|=|500|uM|500000|nM
1FDQ|2.10|2001|HXA||O15540|FATTY ACID-BINDING PROTEIN|7.27|Kd=53.4nM|Kd|=|53.4|nM|53.4|nM
1I5H|NMR|2001|17-mer|Kd=53+/-8uM(150 mM KCl, 10 mM potassium phosphate, pH 7.4); Kd=21+/-3uM(10 mM sodium phosphate, pH 7.4).|Q62940|UBIQUITIN LIGASE NEDD4|4.28|Kd=53uM|Kd|=|53|uM|53000|nM
1IDG|NMR|2001|19-mer|incomplete ligand structure|P60615|ALPHA-BUNGAROTOXIN|7.19|Kd=65nM|Kd|=|65|nM|65|nM
1K9Q|NMR|2001|5-mer||P46937|65 KDA YES-ASSOCIATED PROTEIN|3.15|Kd=700uM|Kd|=|700|uM|700000|nM
1GNY|1.63|2001|5-mer||Q59675|XYLANASE 10C|4.14|Kd=73uM|Kd|=|73|uM|73000|nM
1G6S|1.50|2001|S3P|ligand is SHIKIMATE-3-PHOSPHATE (S3P)|P0A6D3|3-PHOSPHOSHIKIMATE 1-CARBOXYVINYLTRANSFERASE|5.15|Kd=7uM|Kd|=|7|uM|7000|nM
1FZJ|1.90|2001|8-mer||P01901|H-2 CLASS I HISTOCOMPATIBILITY ANTIGEN, K-B|8.1|Kd=8nM|Kd|=|8|nM|8|nM
1I1E|2.50|2001|DM2||P10844|BOTULINUM NEUROTOXIN TYPE B|5.03|Kd=9.4uM|Kd|=|9.4|uM|9400|nM
1J4R|1.80|2001|001||P62942|FK506-BINDING PROTEIN (FKBP)|7.72|Ki=0.019uM|Ki|=|0.019|uM|19|nM
1F8C|1.70|2001|4AM||P03472|NEURAMINIDASE|7.4|Ki=0.04uM|Ki|=|0.04|uM|40|nM
1E66|2.10|2001|HUX||P04058|ACETYLCHOLINESTERASE|9.89|Ki=0.13nM|Ki|=|0.13|nM|0.13|nM
1FSY|1.75|2001|105|covalent complex|P00811|CEPHALOSPORINASE|6.82|Ki=0.15uM|Ki|=|0.15|uM|150|nM
1G7G|2.20|2001|INX||P18031|PROTEIN-TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1|6.6|Ki=0.25uM|Ki|=|0.25|uM|250|nM
1JZS|2.50|2001|MRC||P56690|ISOLEUCYL-TRNA SYNTHETASE|6.6|Ki=0.25uM|Ki|=|0.25|uM|250|nM
1I37|2.00|2001|DHT||P15207|ANDROGEN RECEPTOR|9.57|Ki=0.27nM|Ki|=|0.27|nM|0.27|nM
1HP0|2.10|2001|AD3||Q9GPQ4|IAG-NUCLEOSIDE HYDROLASE|6.7|Ki=0.2uM|Ki|=|0.2|uM|200|nM
1K9S|2.00|2001|FM2||P0ABP8|PURINE NUCLEOSIDE PHOSPHORYLASE|6.52|Ki=0.30uM|Ki|=|0.3|uM|300|nM
1FSW|1.90|2001|CTB|covalent complex|P00811|CEPHALOSPORINASE|6.49|Ki=0.32uM|Ki|=|0.32|uM|320|nM
1I00|2.50|2001|D16||P04818|THYMIDYLATE SYNTHASE|6.34|Ki=0.46uM|Ki|=|0.46|uM|460|nM
1HNN|2.40|2001|SKF||P11086|PHENYLETHANOLAMINE N-METHYLTRANSFERASE|6.24|Ki=0.58uM|Ki|=|0.58|uM|580|nM
1HQH|2.80|2001|NNH||P07824|ARGINASE 1|6.3|Ki=0.5uM|Ki|=|0.5|uM|500|nM
1F92|2.60|2001|UKP||P00749|UROKINASE-TYPE PLASMINOGEN ACTIVATOR|6.19|Ki=0.64uM|Ki|=|0.64|uM|640|nM
1E72|1.60|2001|GOX||P29736|MYROSINASE|3.22|Ki=0.6mM|Ki|=|0.6|mM|600000|nM
1JP5|2.70|2001|9-mer|Ki measured on full length HIV-1 protease; incomplete ligand structure|------|SINGLE-CHAIN FV FRAGMENT 1696|9.22|Ki=0.6nM|Ki|=|0.6|nM|0.6|nM
1H9L|1.67|2001|5-mer|incomplete ligand structure; covalent complex|P00772|ELASTASE|3.12|Ki=0.76mM|Ki|=|0.76|mM|760000|nM
1E6Q|1.35|2001|NTZ||P29736|MYROSINASE|3.15|Ki=0.7mM|Ki|=|0.7|mM|700000|nM
1G42|1.80|2001|CP2|Ki=0.97+/-0.085mM, ligand is 1, 2-DCP|P51698|1,3,4,6-TETRACHLORO-1,4-CYCLOHEXADIENE HYDROLASE|3.01|Ki=0.97mM|Ki|=|0.97|mM|970000|nM
1HQG|2.00|2001|ORN|Ki=880mM for URE|P07824|ARGINASE 1|3.0|Ki=1.0mM|Ki|=|1|mM|1000000|nM
1IIH|2.20|2001|3PG||P04789|TRIOSEPHOSPHATE ISOMERASE|2.89|Ki=1.3mM|Ki|=|1.3|mM|1300000|nM
1E1X|1.85|2001|NW1||P24941|CELL DIVISION PROTEIN KINASE 2|5.89|Ki=1.3uM|Ki|=|1.3|uM|1300|nM
1HDQ|2.30|2001|INF||P00730|CARBOXYPEPTIDASE A|5.82|Ki=1.5uM|Ki|=|1.5|uM|1500|nM
1F1J|2.35|2001|5-mer|covalent complex|P55210|CASPASE-7 (CASP-7)|8.8|Ki=1.6nM|Ki|=|1.6|nM|1.6|nM
1G3C|1.80|2001|109||P00760|TRYPSIN BETA|5.8|Ki=1.6uM|Ki|=|1.6|uM|1600|nM
1G3B|1.80|2001|108|Ki for Mg-108|P00760|TRYPSIN BETA|5.74|Ki=1.8uM|Ki|=|1.8|uM|1800|nM
1EUB|NMR|2001|3-mer||P45452|COLLAGENASE 3|8.72|Ki=1.9nM|Ki|=|1.9|nM|1.9|nM
1E5J|1.85|2001|4-mer||O85465|ENDOGLUCANASE 5A|4.0|Ki=100uM|Ki|=|100|uM|100000|nM
1JUJ|3.00|2001|LYA||P04818|THYMIDYLATE SYNTHASE|6.96|Ki=109nM|Ki|=|109|nM|109|nM
1HLK|2.50|2001|113|IC50=29uM|P25910|BETA-LACTAMASE TYPE II|5.0|Ki=10uM|Ki|=|10|uM|10000|nM
1HQF|2.90|2001|HAR|Ki=10-42uM|P07824|ARGINASE 1|5.0|Ki=10uM|Ki|=|10|uM|10000|nM
1I6V|3.30|2001|RFP||Q9KWU8|DNA-DIRECTED RNA POLYMERASE|5.0|Ki=10uM|Ki|=|10|uM|10000|nM
1G2K|1.95|2001|NM1||P04587|HIV-1 PROTEASE|7.96|Ki=11nM|Ki|=|11|nM|11|nM
1F2O|1.70|2001|LEU|Ki measured with Ca2+|P80561|AMINOPEPTIDASE|1.91|Ki=12.4mM|Ki|=|12.4|mM|12400000|nM
1F2P|1.80|2001|PHE|Ki measured with Ca2+|P80561|AMINOPEPTIDASE|1.9|Ki=12.7mM|Ki|=|12.7|mM|12700000|nM
1E1V|1.95|2001|CMG||P24941|CELL DIVISION PROTEIN KINASE 2|4.92|Ki=12uM|Ki|=|12|uM|12000|nM
1G30|2.00|2001|T87||P00734|PROTHROMBIN|6.85|Ki=140nM|Ki|=|140|nM|140|nM
1F8E|1.40|2001|49A||P03472|NEURAMINIDASE|4.82|Ki=15uM|Ki|=|15|uM|15000|nM
1GA8|2.00|2001|DEL||P96945|GALACTOSYL TRANSFERASE LGTC|1.8|Ki=16mM|Ki|=|16|mM|16000000|nM
1F28|1.90|2001|F89||P13100|THYMIDYLATE SYNTHASE|7.8|Ki=16nM|Ki|=|16|nM|16|nM
1F5K|1.80|2001|BAM||P00749|UROKINASE-TYPE PLASMINOGEN ACTIVATOR|3.74|Ki=180uM|Ki|=|180|uM|180000|nM
1FM9|2.10|2001|570||P19793|PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA|9.0|Ki=1nM|Ki|=|1|nM|1|nM
1FPY|2.89|2001|PPQ||P0A1P6|GLUTAMINE SYNTHETASE|6.0|Ki=1uM|Ki|=|1|uM|1000|nM
1I48|3.25|2001|CCO||Q9ZPL5|CYSTATHIONINE GAMMA-SYNTHASE|5.7|Ki=2.0uM|Ki|=|2|uM|2000|nM
1G5F|1.80|2001|DCE||P51698|1,3,4,6-TETRACHLORO-1,4-CYCLOHEXADIENE HYDROLASE|2.64|Ki=2.31mM|Ki|=|2.31|mM|2310000|nM
1JAK|1.75|2001|IFG||Q9Y691|BETA-N-ACETYLHEXOSAMINIDASE|5.57|Ki=2.7uM|Ki|=|2.7|uM|2700|nM
1G3D|1.80|2001|108|Ki for Cu-108|P00760|TRYPSIN BETA|5.55|Ki=2.8uM|Ki|=|2.8|uM|2800|nM
1I43|3.10|2001|PMC||Q9ZPL5|CYSTATHIONINE GAMMA-SYNTHASE|3.7|Ki=200uM|Ki|=|200|uM|200000|nM
1IEM|2.30|2001|CB4|covalent complex|P00811|BETA-LACTAMASE|7.7|Ki=20nM|Ki|=|20|nM|20|nM
1IEW|2.55|2001|G2F|covalent complex|Q9XEI3|BETA-D-GLUCAN GLUCOHYDROLASE ISOENZYME EXO1|4.59|Ki=25.50uM|Ki|=|25.5|uM|25500|nM
1IIG|2.60|2001|3PP||P04789|TRIOSEPHOSPHATE ISOMERASE|1.57|Ki=27mM|Ki|=|27|mM|27000000|nM
1DXP|2.40|2001|16-mer|Ki=27-67nM; PDBcode:1dy9(binding with inhibitor I; PDBcode:1dy8(binding with inhibitor II); incomplete ligand|Q81755|SERINE PROTEASE NS3 (P70)|7.57|Ki=27nM|Ki|=|27|nM|27|nM
1I41|3.20|2001|HEN||Q9ZPL5|CYSTATHIONINE GAMMA-SYNTHASE|4.57|Ki=27uM|Ki|=|27|uM|27000|nM
1HP5|2.10|2001|NGT||O85361|BETA-N-ACETYLHEXOSAMINIDASE|6.55|Ki=280nM|Ki|=|280|nM|280|nM
1G2O|1.75|2001|IMH||P0A538|PURINE NUCLEOSIDE PHOSPHORYLASE|10.55|Ki=28pM|Ki|=|28|pM|0.028|nM
1F9E|2.90|2001|5-mer|covalent complex|Q14790|CASPASE-8|8.7|Ki=2nM|Ki|=|2|nM|2|nM
1G98|1.90|2001|PA5||Q9N1E2|GLUCOSE-6-PHOSPHATE ISOMERASE|5.7|Ki=2uM|Ki|=|2|uM|2000|nM
1G9R|2.00|2001|UPF||P96945|GLYCOSYL TRANSFERASE|5.7|Ki=2uM|Ki|=|2|uM|2000|nM
1JSV|1.96|2001|U55||P24941|CELL DIVISION PROTEIN KINASE 2|5.7|Ki=2uM|Ki|=|2|uM|2000|nM
1G7F|1.80|2001|INZ||P18031|PROTEIN-TYROSINE PHOSPHATASE 1B|5.47|Ki=3.4uM|Ki|=|3.4|uM|3400|nM
1HI4|1.80|2001|A3P||P10153|EOSINOPHIL-DERIVED NEUROTOXIN|4.49|Ki=32uM|Ki|=|32|uM|32000|nM
1IK4|2.00|2001|PGH||P0A731|METHYLGLYOXAL SYNTHASE|7.41|Ki=39nM|Ki|=|39|nM|39|nM
1F8B|1.80|2001|DAN||P03472|NEURAMINIDASE|5.4|Ki=4.0uM|Ki|=|4|uM|4000|nM
1G3E|1.80|2001|109|Ki for Cu-109|P00760|TRYPSIN BETA|5.38|Ki=4.2uM|Ki|=|4.2|uM|4200|nM
1HEE|1.75|2001|LHY||P00730|CARBOXYPEPTIDASE A|5.34|Ki=4.6uM|Ki|=|4.6|uM|4600|nM
1K06|1.80|2001|BZD||P00489|GLYCOGEN PHOSPHORYLASE|5.34|Ki=4.6uM|Ki|=|4.6|uM|4600|nM
1K08|2.26|2001|BZD|redundant to 1k06|P00489|GLYCOGEN PHOSPHORYLASE|5.34|Ki=4.6uM|Ki|=|4.6|uM|4600|nM
1F8D|1.40|2001|9AM||P03472|NEURAMINIDASE|3.4|Ki=400uM|Ki|=|400|uM|400000|nM
1G2M|3.02|2001|R11||P00742|COAGULATION FACTOR X|7.4|Ki=40nM|Ki|=|40|nM|40|nM
1JH1|2.70|2001|JST||P22894|MATRIX METALLOPROTEINASE-8|4.39|Ki=41uM|Ki|=|41|uM|41000|nM
1JUT|2.70|2001|LYD|Ki measured on human TS|P0A884|THYMIDYLATE SYNTHASE|7.32|Ki=47.7nM|Ki|=|47.7|nM|47.7|nM
1F5L|2.10|2001|AMR||P00749|UROKINASE-TYPE PLASMINOGEN ACTIVATOR|5.28|Ki=5.3uM|Ki|=|5.3|uM|5300|nM
1JD0|1.50|2001|AZM|redundant to 1ydb|O43570|CARBONIC ANHYDRASE 12|8.24|Ki=5.7nM|Ki|=|5.7|nM|5.7|nM
1F9G|2.00|2001|ASC||Q54873|HYALURONATE LYASE|1.28|Ki=53mM|Ki|=|53|mM|53000000|nM
1G2L|1.90|2001|T87||P00742|COAGULATION FACTOR X|7.24|Ki=57nM|Ki|=|57|nM|57|nM
1HV5|2.60|2001|RXP||Q02853|STROMELYSIN 3|8.3|Ki=5nM|Ki|=|5|nM|5|nM
1HI3|1.80|2001|A2P||P10153|EOSINOPHIL-DERIVED NEUROTOXIN|4.19|Ki=64uM|Ki|=|64|uM|64000|nM
1K1O|2.00|2001|IGN||P00760|TRYPSIN|6.17|Ki=675nM|Ki|=|675|nM|675|nM
1G36|1.90|2001|R11||P00760|TRYPSINOGEN|7.17|Ki=67nM|Ki|=|67|nM|67|nM
1EFY|2.20|2001|BZC||P26446|POLY [ADP-RIBOSE] POLYMERASE 1|8.22|Ki=6nM|Ki|=|6|nM|6|nM
1JR1|2.60|2001|MOA|Ki=6-10nM measured on IMPDH human type II|P12269|INOSINE-5'-MONOPHOSPHATE DEHYDROGENASE 2|8.22|Ki=6nM|Ki|=|6|nM|6|nM
1G35|1.80|2001|AHF||P03368|HIV-1 PROTEASE|8.14|Ki=7.3nM|Ki|=|7.3|nM|7.3|nM
1GCZ|1.90|2001|YZ9||P14174|MACROPHAGE MIGRATION INHIBITORY FACTOR|5.13|Ki=7.4uM|Ki|=|7.4|uM|7400|nM
1GAG|2.70|2001|13-mer|incomplete ligand structure|P06213|INSULIN RECEPTOR, TYROSINE KINASE DOMAIN|6.12|Ki=750nM|Ki|=|750|nM|750|nM
1G32|1.90|2001|R11||P00734|PROTHROMBIN|6.11|Ki=780nM|Ki|=|780|nM|780|nM
1JTQ|2.50|2001|LY3|Ki measured on LY3/TS (human)|P0A884|THYMIDYLATE SYNTHASE|8.07|Ki=8.5nM|Ki|=|8.5|nM|8.5|nM
1JJK|3.00|2001|BMP|PH6.0|P08244|OROTIDINE 5'-PHOSPHATE DECARBOXYLASE|11.06|Ki=8.8pM|Ki|=|8.8|pM|0.0088|nM
1IAU|2.00|2001|5-mer|covalent complex|P10144|GRANZYME B|7.1|Ki=80nM|Ki|=|80|nM|80|nM
1GA9|2.10|2001|ETP|covalent complex|P00811|BETA-LACTAMASE|7.08|Ki=83nM|Ki|=|83|nM|83|nM
1HYO|1.30|2001|HBU||P35505|FUMARYLACETOACETATE HYDROLASE|4.07|Ki=84.8uM|Ki|=|84.8|uM|84800|nM
1HI5|1.80|2001|ADP||P10153|EOSINOPHIL-DERIVED NEUROTOXIN|4.04|Ki=92uM|Ki|=|92|uM|92000|nM
1L6Y|1.90|2002|4OX|IC50=0.57mM(94min); IC50=0.22mM(16h)|P0ACB2|PORPHOBILINOGEN SYNTHASE|3.66|IC=0.22mM|IC50|=|0.22|mM|220000|nM
1KKQ|3.00|2002|471||Q07869|PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR ALPHA|6.62|IC=0.24uM|IC50|=|0.24|uM|240|nM
1I7I|2.35|2002|AZ2|IC50 measured on mPPAR-gamma|P37231|PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA|6.7|IC=0.2uM|IC50|=|0.2|uM|200|nM
1IL9|3.10|2002|MOG||P02879|RICIN A CHAIN|3.4|IC=0.40mM|IC50|=|0.4|mM|400000|nM
1M5C|1.65|2002|BRH||P19491|GLUTAMATE RECEPTOR 2|6.3|IC=0.5uM|IC50|=|0.5|uM|500|nM
1KZ8|2.00|2002|PFE||P00636|FRUCTOSE-1,6-BISPHOSPHATASE|6.08|IC=0.83uM|IC50|=|0.83|uM|830|nM
1GZG|1.66|2002|LAF||Q59643|DELTA-AMINOLEVULINIC ACID DEHYDRATASE|3.05|IC=0.9mM|IC50|=|0.9|mM|900000|nM
1H1Q|2.50|2002|2A6||P24941|CELL DIVISION PROTEIN KINASE 2|6.0|IC=1.0uM|IC50|=|1|uM|1000|nM
1I7G|2.20|2002|AZ2||Q07869|PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR ALPHA|6.0|IC=1.0uM|IC50|=|1|uM|1000|nM
1KAT|NMR|2002|19-mer|IC50=0.3uM(VEGF1-109/v107)|P15692|VASCULAR ENDOTHELIAL GROWTH FACTOR|6.0|IC=1.0uM|IC50|=|1|uM|1000|nM
1LD7|2.00|2002|U66||P49354|FARNESYLTRANSFERASE ALPHA SUBUNIT|8.96|IC=1.1nM|IC50|=|1.1|nM|1.1|nM
1IL4|2.60|2002|9DG||P02879|RICIN A CHAIN|2.85|IC=1.4mM|IC50|=|1.4|mM|1400000|nM
1KTT|2.10|2002|C02||P00734|THROMBIN|5.82|IC=1.5uM|IC50|=|1.5|uM|1500|nM
1JYI|2.75|2002|12-mer||P02866|CONCANAVALIN A|4.0|IC=100uM|IC50|=|100|uM|100000|nM
1KMV|1.05|2002|LII|IC50 measured on rat liver DHFR|P00374|DIHYDROFOLATE REDUCTASE|6.95|IC=112nM|IC50|=|112|nM|112|nM
1KLG|2.40|2002|15-mer|mutant TPI23-37(T28I) peptide/HLA-DR1 complexes, IC50=13nM|P01903|HLA CLASS II HISTOCOMPATIBILITY ANTIGEN, DR ALPHA CHAIN|7.89|IC=13nM|IC50|=|13|nM|13|nM
1M5F|1.95|2002|AM1||P19491|GLUTAMATE RECEPTOR 2|7.83|IC=14.8nM|IC50|=|14.8|nM|14.8|nM
1JUF|2.00|2002|9-mer||P01899|H2-DB MAJOR HISTOCOMPATIBILITY ANTIGEN|5.85|IC=1400nM|IC50|=|1400|nM|1400|nM
1IYL|3.20|2002|R64||P30418|MYRISTOYL-COA:PROTEIN N-MYRISTOYLTRANSFERASE|9.0|IC=1nM|IC50|=|1|nM|1|nM
1KE8|2.00|2002|LS4||P24941|CELL DIVISION PROTEIN KINASE 2|6.0|IC=1uM|IC50|=|1|uM|1000|nM
1JIZ|2.60|2002|CGS|IC50 measured on mouse MMP-12|P39900|MACROPHAGE METALLOELASTASE (MMP-12)|8.7|IC=2.0nM|IC50|=|2|nM|2|nM
1IL5|2.80|2002|DDP||P02879|RICIN A CHAIN|2.66|IC=2.2mM|IC50|=|2.2|mM|2200000|nM
1H1R|2.00|2002|6CP||P24941|CELL DIVISION PROTEIN KINASE 2|5.64|IC=2.3uM|IC50|=|2.3|uM|2300|nM
1LEV|2.15|2002|CLI|IC50 measured on human F16Bpase|P00636|FRUCTOSE-1,6-BISPHOSPHATASE|5.6|IC=2.5uM|IC50|=|2.5|uM|2500|nM
1M7Q|2.40|2002|DQO||Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|8.59|IC=2.6nM|IC50|=|2.6|nM|2.6|nM
1IL3|2.80|2002|7DG||P02879|RICIN A CHAIN|2.55|IC=2.8mM|IC50|=|2.8|mM|2800000|nM
1M5E|1.46|2002|AM1||P19491|GLUTAMATE RECEPTOR 2|7.7|IC=20.1nM|IC50|=|20.1|nM|20.1|nM
1HWW|1.87|2002|SWA||Q24451|ALPHA-MANNOSIDASE II|7.7|IC=20nM|IC50|=|20|nM|20|nM
1KLU|1.93|2002|15-mer|wild-type TPI23-37 peptide/HLA-DR1 complexes, IC50=25nM|P01903|HLA CLASS II HISTOCOMPATIBILITY ANTIGEN, DR|7.6|IC=25nM|IC50|=|25|nM|25|nM
1KAK|2.50|2002|FNP||P18031|PROTEIN-TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1|4.59|IC=26uM|IC50|=|26|uM|26000|nM
1LD8|1.80|2002|U49||P49354|FARNESYLTRANSFERASE ALPHA SUBUNIT|8.46|IC=3.5nM|IC50|=|3.5|nM|3.5|nM
1IJR|2.20|2002|CC0|IC50 measured on Src SH2|P06239|PROTO-ONCOGENE TYROSINE-PROTEIN KINASE LCK|5.44|IC=3.6uM|IC50|=|3.6|uM|3600|nM
1EOU|2.10|2002|SMS||P00918|CARBONIC ANHYDRASE 2|7.44|IC=36nM|IC50|=|36|nM|36|nM
1L6S|1.70|2002|DSB||P0ACB2|PORPHOBILINOGEN SYNTHASE|4.41|IC=39uM|IC50|=|39|uM|39000|nM
1HY7|1.50|2002|MBS||P08254|STROMELYSIN-1|5.39|IC=4.09uM|IC50|=|4.09|uM|4090|nM
1KYN|3.50|2002|KTP||P08311|CATHEPSIN G|5.39|IC=4.1uM|IC50|=|4.1|uM|4100|nM
1HXK|1.50|2002|DMJ||Q24451|ALPHA-MANNOSIDASE II|3.4|IC=400uM|IC50|=|400|uM|400000|nM
1HTY|1.40|2002|TRS|tris inhibit dGMII, IC50=40mM|Q24451|ALPHA-MANNOSIDASE II|1.4|IC=40mM|IC50|=|40|mM|40000000|nM
1GMY|1.90|2002|3-mer|covalent complex|P07858|CATHEPSIN B|7.35|IC=45nM|IC50|=|45|nM|45|nM
1ND5|2.90|2002|2BF||P15309|PROSTATIC ACID PHOSPHATASE|8.4|IC=4nM|IC50|=|4|nM|4|nM
1JG0|2.00|2002|DDT||P0A884|THYMIDYLATE SYNTHASE|5.3|IC=5.0uM|IC50|=|5|uM|5000|nM
1KE6|2.00|2002|LS2||P24941|CELL DIVISION PROTEIN KINASE 2|8.24|IC=5.7nM|IC50|=|5.7|nM|5.7|nM
1INQ|2.20|2002|9-mer||P01899|H-2 CLASS I HISTOCOMPATIBILITY ANTIGEN, D-B|6.27|IC=539nM|IC50|=|539|nM|539|nM
1KE5|2.20|2002|LS1||P24941|CELL DIVISION PROTEIN KINASE 2|6.25|IC=560nM|IC50|=|560|nM|560|nM
1JDJ|2.20|2002|CFP||P90551|GLYCEROL-3-PHOSPHATE DEHYDROGENASE|2.3|IC=5mM|IC50|=|5|mM|5000000|nM
1LQF|2.50|2002|BGD||P18031|PROTEIN-TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1|8.3|IC=5nM|IC50|=|5|nM|5|nM
1G9A|2.10|2002|BAB|IC50=5-10uM|P10844|BOTULINUM NEUROTOXIN TYPE B|5.3|IC=5uM|IC50|=|5|uM|5000|nM
1G9B|2.00|2002|BAB|IC50=5-10uM|P10844|BOTULINUM NEUROTOXIN TYPE B|5.3|IC=5uM|IC50|=|5|uM|5000|nM
1G9C|2.35|2002|BAB|IC50=5-10uM|P10844|BOTULINUM NEUROTOXIN TYPE B|5.3|IC=5uM|IC50|=|5|uM|5000|nM
1G9D|2.20|2002|BAB|IC50=5-10uM|P10844|BOTULINUM NEUROTOXIN TYPE B|5.3|IC=5uM|IC50|=|5|uM|5000|nM
1K3T|1.95|2002|BRZ||P22513|GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE|4.19|IC=64uM|IC50|=|64|uM|64000|nM
1KE9|2.00|2002|LS5||P24941|CELL DIVISION PROTEIN KINASE 2|6.18|IC=660nM|IC50|=|660|nM|660|nM
1MZS|2.10|2002|669||P0A6R0|3-OXOACYL-[ACYL-CARRIER-PROTEIN] SYNTHASE 3|5.15|IC=7.0uM|IC50|=|7|uM|7000|nM
1LJT|2.00|2002|HDI|IC50 measured on MIF dopachrome tautomerase|P14174|MACROPHAGE MIGRATION INHIBITORY FACTOR|5.15|IC=7uM|IC50|=|7|uM|7000|nM
1KE7|2.00|2002|LS3||P24941|CELL DIVISION PROTEIN KINASE 2|8.05|IC=8.9nM|IC50|=|8.9|nM|8.9|nM
1M5D|1.73|2002|BRH||P19491|GLUTAMATE RECEPTOR 2|5.04|IC=9.2uM|IC50|=|9.2|uM|9200|nM
1M5B|1.85|2002|BN1||P19491|GLUTAMATE RECEPTOR 2|8.01|IC=9.7nM|IC50|=|9.7|nM|9.7|nM
1LLB|1.72|2002|PCN|covalent complex|P00811|BETA-LACTAMASE|6.05|IC=900nM|IC50|=|900|nM|900|nM
1M7Y|1.60|2002|PPG||P37821|1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYNTHASE|10.96|Kd=0.011nM|Kd|=|0.011|nM|0.011|nM
1LBF|2.05|2002|137||Q06121|INDOLE-3-GLYCEROL PHOSPHATE SYNTHASE|7.85|Kd=0.014uM|Kd|=|0.014|uM|14|nM
1JYC|2.75|2002|15-mer|Kd rang between 0.046 and 0.23 mM (Oldenberg et al., 1992; Kaur et al., 1997).|P02866|CONCANAVALIN A|4.34|Kd=0.046mM|Kd|=|0.046|mM|46000|nM
1N4K|2.20|2002|I3P||P11881|INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR TYPE 1|10.05|Kd=0.09nM|Kd|=|0.09|nM|0.09|nM
1LRH|1.90|2002|NLA||P13689|AUXIN-BINDING PROTEIN 1|6.82|Kd=0.15uM|Kd|=|0.15|uM|150|nM
1LI6|2.00|2002|5MP||P00720|T4 LYSOZYME|3.8|Kd=0.16mM|Kd|=|0.16|mM|160000|nM
1KV2|2.80|2002|B96||Q16539|MITOGEN-ACTIVATED PROTEIN KINASE P38|10.0|Kd=0.1nM|Kd|=|0.1|nM|0.1|nM
1IS0|1.90|2002|4-mer||P00524|C-SRC TYROSINE KINASE|7.0|Kd=0.1uM|Kd|=|0.1|uM|100|nM
1GZ9|1.70|2002|FUC-LAT||P83410|LECTIN|3.51|Kd=0.31mM|Kd|=|0.31|mM|310000|nM
1GZC|1.58|2002|LAT||P83410|LECTIN|3.49|Kd=0.32mM|Kd|=|0.32|mM|320000|nM
1ESZ|2.00|2002|CPO||P07822|FERRICHROME-BINDING PERIPLASMIC PROTEIN|6.52|Kd=0.3uM|Kd|=|0.3|uM|300|nM
1GX8|2.40|2002|RTL|compound retinoids 1, chance of additional binding site in the cases of 1|P02754|BETA-LACTOGLOBULIN|6.37|Kd=0.43uM|Kd|=|0.43|uM|430|nM
1M83|2.20|2002|ATP||P00953|TRYPTOPHANYL-TRNA LIGASE|3.4|Kd=0.4mM|Kd|=|0.4|mM|400000|nM
1G50|2.90|2002|EST||P03372|ESTROGEN RECEPTOR|6.28|Kd=0.53uM|Kd|=|0.53|uM|530|nM
1GUI|1.90|2002|6-mer||Q9WXN1|LAMINARINASE 16A|6.28|Kd=0.53uM|Kd|=|0.53|uM|530|nM
1LHW|1.75|2002|ESM|ligand is compound 12, pKd=9.08|P04278|SEX HORMONE-BINDING GLOBULIN|9.08|Kd=0.832nM|Kd|=|0.832|nM|0.832|nM
1LGT|1.70|2002|BP3|Ki=2.75mM is for steady-state kinetic parameter for DHBD for chlorinated DHBs|P47228|BIPHENYL-2,3-DIOL 1,2-DIOXYGENASE|6.1|Kd=0.8uM|Kd|=|0.8|uM|800|nM
1KDK|1.70|2002|DHT||P04278|SEX HORMONE-BINDING GLOBULIN|9.05|Kd=0.9nM|Kd|=|0.9|nM|0.9|nM
1KL5|1.80|2002|9-mer|incomplete ligand structure|P22629|STREPTAVIDIN|5.99|Kd=1.02uM|Kd|=|1.02|uM|1020|nM
1KV1|2.50|2002|BMU||Q16539|MITOGEN-ACTIVATED PROTEIN KINASE P38|5.94|Kd=1.16uM|Kd|=|1.16|uM|1160|nM
1LHV|2.00|2002|NOG|ligand is D-NORGESTREL, pKd=8.91|P04278|SEX HORMONE-BINDING GLOBULIN|8.91|Kd=1.23nM|Kd|=|1.23|nM|1.23|nM
1KZN|2.30|2002|CBN||P06982|DNA GYRASE SUBUNIT B|8.92|Kd=1.2nM|Kd|=|1.2|nM|1.2|nM
1KYV|2.40|2002|RBF||Q9UUB1|6,7-DIMETHYL-8-RIBITYLLUMAZINE SYNTHASE|5.92|Kd=1.2uM|Kd|=|1.2|uM|1200|nM
1KL3|1.70|2002|9-mer|incomplete ligand structure|P22629|STREPTAVIDIN|5.86|Kd=1.37uM|Kd|=|1.37|uM|1370|nM
1LEK|2.15|2002|8-mer||P01901|H-2 CLASS I HISTOCOMPATIBILITY ANTIGEN, K-B|8.89|Kd=1.3nM|Kd|=|1.3|nM|1.3|nM
1LHU|1.80|2002|EST|ligand is compound 20; -logKd=8.83|P04278|SEX HORMONE-BINDING GLOBULIN|8.83|Kd=1.48nM|Kd|=|1.48|nM|1.48|nM
1GUW|NMR|2002|18-mer|Kd=0.7(HP1/Lys-9-methylated peptide)|P23197|HISTONE H3.1|5.72|Kd=1.9uM|Kd|=|1.9|uM|1900|nM
1M74|3.00|2002|ADP|Kd for Mg-ADP|P28366|PREPROTEIN TRANSLOCASE SECA|7.0|Kd=100nM|Kd|=|100|nM|100|nM
1LGW|1.85|2002|1AN||P00720|T4 LYSOZYME|4.0|Kd=100uM|Kd|=|100|uM|100000|nM
1L5Q|2.25|2002|CFF||P06737|GLYCOGEN PHOSPHORYLASE|3.97|Kd=108uM|Kd|=|108|uM|108000|nM
1JM4|NMR|2002|11-mer|Tat AcK50|Q92831|HIV-1 TAT PEPTIDE|5.0|Kd=10uM|Kd|=|10|uM|10000|nM
1JPL|2.40|2002|12-mer|incomplete ligand structure|Q9NZ52|ADP-RIBOSYLATION FACTOR BINDING PROTEIN GGA3|5.0|Kd=10uM|Kd|=|10|uM|10000|nM
1LEG|1.75|2002|8-mer||P01901|H-2 CLASS I HISTOCOMPATIBILITY ANTIGEN, K-B|7.95|Kd=11.1nM|Kd|=|11.1|nM|11.1|nM
1K6V|2.00|2002|XN2||P35963|HIV-1 PROTEASE|6.92|Kd=120nM|Kd|=|120|nM|120|nM
1MWT|2.45|2002|PNM|ligand is penicillin G|O54286|PBP2A|1.88|Kd=13.3mM|Kd|=|13.3|mM|13300000|nM
1H2T|2.15|2002|GDP-7MG||Q09161|80 KDA NUCLEAR CAP BINDING PROTEIN|7.89|Kd=13nM|Kd|=|13|nM|13|nM
1H2U|2.40|2002|GDP-7MG|redundant to 1h2t|Q09161|80 KDA NUCLEAR CAP BINDING PROTEIN|7.89|Kd=13nM|Kd|=|13|nM|13|nM
1H79|2.90|2002|TTP||Q9T0V5|ANAEROBIC RIBONUCLEOTIDE-TRIPHOSPHATE REDUCTASE|4.89|Kd=13uM|Kd|=|13|uM|13000|nM
1L5R|2.10|2002|RBF||P06737|GLYCOGEN PHOSPHORYLASE|4.77|Kd=17uM|Kd|=|17|uM|17000|nM
1H7A|2.75|2002|DTP||Q9T0V5|ANAEROBIC RIBONUCLEOTIDE-TRIPHOSPHATE REDUCTASE|4.72|Kd=19uM|Kd|=|19|uM|19000|nM
1LVC|3.60|2002|DOT||P40136|CALMODULIN-SENSITIVE ADENYLATE CYCLASE|6.0|Kd=1uM|Kd|=|1|uM|1000|nM
1KNE|2.40|2002|15-mer|incomplete ligand structure|P05205|HETEROCHROMATIN PROTEIN 1|5.6|Kd=2.5uM|Kd|=|2.5|uM|2500|nM
1KF0|2.50|2002|ACP|Kd for Mg-ACP|Q7SIB7|PHOSPHOGLYCERATE KINASE|2.55|Kd=2.80mM|Kd|=|2.8|mM|2800000|nM
1MWN|NMR|2002|12-mer|Kd=200-300nM|P04631|S-100 PROTEIN, BETA CHAIN|6.7|Kd=200nM|Kd|=|200|nM|200|nM
1L2Z|NMR|2002|11-mer||O95400|CD2 ANTIGEN (CYTOPLASMIC TAIL)-BINDING PROTEIN 2|3.69|Kd=203uM|Kd|=|203|uM|203000|nM
1I8I|2.40|2002|12-mer|DSFV MR1 binds to EGFRVIII peptide, Kd=22nM measured at room temperature; incomplete ligand|Q8R028|EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY|7.66|Kd=22nM|Kd|=|22|nM|22|nM
1L0A|2.90|2002|18-mer||Q13114|TNF RECEPTOR ASSOCIATED FACTOR 3|4.62|Kd=23.9uM|Kd|=|23.9|uM|23900|nM
1J5I|NMR|2002|NCZ||P0A3R9|APO-NEOCARZINOSTATIN|3.64|Kd=230uM|Kd|=|230|uM|230000|nM
1K6T|2.25|2002|XN1||P35963|HIV-1 PROTEASE|7.62|Kd=24nM|Kd|=|24|nM|24|nM
1GWR|2.40|2002|12-mer|incomplete ligand structure|P03372|ESTROGEN RECEPTOR|6.6|Kd=250nM|Kd|=|250|nM|250|nM
1MQ1|NMR|2002|12-mer||P04271|S-100 PROTEIN, BETA CHAIN|6.59|Kd=260nM|Kd|=|260|nM|260|nM
1JYQ|2.00|2002|4-mer||P29354|GROWTH FACTOR RECEPTOR-BOUND PROTEIN 2|8.7|Kd=2nM|Kd|=|2|nM|2|nM
1G85|1.80|2002|3OL||P07435|ODORANT-BINDING PROTEIN|5.48|Kd=3.3uM|Kd|=|3.3|uM|3300|nM
1JQ9|1.80|2002|5-mer||P59071|PHOSPHOLIPASE A2|8.45|Kd=3.57nM|Kd|=|3.57|nM|3.57|nM
1LF8|2.30|2002|12-mer|incomplete ligand structure|Q9NZ52|ADP-RIBOSYLATION FACTOR BINDING PROTEIN GGA3|5.46|Kd=3.5uM|Kd|=|3.5|uM|3500|nM
1H0A|1.70|2002|I3P||O88339|EPSIN|5.44|Kd=3.6uM|Kd|=|3.6|uM|3600|nM
1K6C|2.20|2002|MK1||P35963|HIV-1 PROTEASE|7.48|Kd=33nM|Kd|=|33|nM|33|nM
1K2V|1.97|2002|DEF||P07822|FERRICHROME-BINDING PERIPLASMIC PROTEIN|4.44|Kd=36uM|Kd|=|36|uM|36000|nM
1K6P|2.20|2002|XN3||P35963|HIV-1 PROTEASE|7.36|Kd=44nM|Kd|=|44|nM|44|nM
1N5Z|2.70|2002|14-mer|Kd=36uM(Pex13p SH3 domain/Pex5p); incomplete ligand|P80667|PEROXISOMAL MEMBRANE PROTEIN PAS20|4.36|Kd=44uM|Kd|=|44|uM|44000|nM
1JLR|2.45|2002|GTP||Q26998|URACIL PHOSPHORIBOSYLTRANSFERASE|3.33|Kd=465uM|Kd|=|465|uM|465000|nM
1GU3|2.30|2002|5-mer||P14090|ENDOGLUCANASE C|4.32|Kd=47.6uM|Kd|=|47.6|uM|47600|nM
1FD0|1.38|2002|254||P13631|RETINOIC ACID RECEPTOR GAMMA-1|8.4|Kd=4nM|Kd|=|4|nM|4|nM
1L5S|2.10|2002|URC||P06737|GLYCOGEN PHOSPHORYLASE|3.26|Kd=550uM|Kd|=|550|uM|550000|nM
1JUQ|2.20|2002|13-mer|incomplete ligand structure|Q9NZ52|ADP-RIBOSYLATION FACTOR BINDING PROTEIN GGA3|4.25|Kd=56uM|Kd|=|56|uM|56000|nM
1LI3|1.85|2002|3CH||P00720|T4 LYSOZYME|4.25|Kd=56uM|Kd|=|56|uM|56000|nM
1KLL|1.50|2002|_MC||O05205|MITOMYCIN-BINDING PROTEIN|5.2|Kd=6.3uM|Kd|=|6.3|uM|6300|nM
1JIF|1.60|2002|BLM||Q53793|BLEOMYCIN-BINDING PROTEIN|6.2|Kd=630nM|Kd|=|630|nM|630|nM
1LXH|NMR|2002|19-mer|the minimized average structure; incomplete ligand|P01391|LONG NEUROTOXIN 1|7.19|Kd=65nM|Kd|=|65|nM|65|nM
1LBK|1.86|2002|GSH||P09211|GLUTATHIONE S-TRANSFERASE P1-1|3.18|Kd=668uM|Kd|=|668|uM|668000|nM
1LKX|3.00|2002|ADP||Q03479|MYOSIN IE HEAVY CHAIN|5.15|Kd=7.1uM|Kd|=|7.1|uM|7100|nM
1GWQ|2.45|2002|9-mer|incomplete ligand structure|P03372|ESTROGEN RECEPTOR|7.12|Kd=76nM|Kd|=|76|nM|76|nM
1KNA|2.10|2002|15-mer|incomplete ligand structure|P05205|HETEROCHROMATIN PROTEIN 1|5.15|Kd=7uM|Kd|=|7|uM|7000|nM
1M48|1.95|2002|FRG||P60568|INTERLEUKIN-2|5.09|Kd=8.2uM|Kd|=|8.2|uM|8200|nM
1GNI|2.40|2002|OLA||P02768|SERUM ALBUMIN|8.07|Kd=8.5nM|Kd|=|8.5|nM|8.5|nM
1LXF|NMR|2002|BEP|Kd=550uM for 17-mer|P63316|TROPONIN C|4.1|Kd=80uM|Kd|=|80|uM|80000|nM
1LB6|1.80|2002|9-mer||Q9Y4K3|TNF RECEPTOR-ASSOCIATED FACTOR 6|4.08|Kd=84uM|Kd|=|84|uM|84000|nM
1G7Q|1.60|2002|8-mer||P01901|H-2 CLASS I HISTOCOMPATIBILITY ANTIGEN, K-B|6.06|Kd=877nM|Kd|=|877|nM|877|nM
1EZ9|1.90|2002|4-mer||P02928|MALTOSE-BINDING PERIPLASMIC PROTEIN|5.1|Kd=8uM|Kd|=|8|uM|8000|nM
1KMY|2.00|2002|BPY||P47228|BIPHENYL-2,3-DIOL 1,2-DIOXYGENASE|5.1|Kd=8uM|Kd|=|8|uM|8000|nM
1G7P|1.50|2002|9-mer||P01901|H-2 CLASS I HISTOCOMPATIBILITY ANTIGEN, K-B|7.05|Kd=90nM|Kd|=|90|nM|90|nM
1GNJ|2.60|2002|ACD|Kd for the first ACD|P02768|SERUM ALBUMIN|7.04|Kd=91nM|Kd|=|91|nM|91|nM
1LI2|2.00|2002|IPH||P00720|T4 LYSOZYME|4.04|Kd=91uM|Kd|=|91|uM|91000|nM
1L7X|2.30|2002|CFF||P06737|GLYCOGEN PHOSPHORYLASE|4.04|Kd=92uM|Kd|=|92|uM|92000|nM
1KC5|2.50|2002|15-mer|Kd is not exact value|Q8VC55|PC287 IMMUNOGLOBULIN|7.0|Kd~0.1uM|Kd|~|0.1|uM|100|nM
1KCS|2.50|2002|15-mer|Kd is not exact value|P01837|PC282 IMMUNOGLOBULIN|7.0|Kd~0.1uM|Kd|~|0.1|uM|100|nM
1M21|1.80|2002|4-mer||Q8RJN5|PEPTIDE AMIDASE|6.52|Ki<0.3uM|Ki|<|0.3|uM|300|nM
1GHY|1.85|2002|121|Ki for Zn-121|P00734|THROMBIN|8.1|Ki=0.008uM|Ki|=|0.008|uM|8|nM
1GJ7|1.50|2002|132||P00749|UROKINASE-TYPE PLASMINOGEN ACTIVATOR|7.89|Ki=0.013uM|Ki|=|0.013|uM|13|nM
1IZH|1.90|2002|Q50||Q90EB9|HIV-1 PROTEASE|7.7|Ki=0.02uM|Ki|=|0.02|uM|20|nM
1GI4|1.37|2002|122|Ki for Zn-122|P00760|TRYPSIN BETA|7.19|Ki=0.065uM|Ki|=|0.065|uM|65|nM
1D4H|1.81|2002|BEH||P03366|HIV-1 PROTEASE|10.0|Ki=0.10nM|Ki|=|0.1|nM|0.1|nM
1EC2|2.00|2002|BEJ||P03366|HIV-1 PROTEASE|10.0|Ki=0.10nM|Ki|=|0.1|nM|0.1|nM
1GJ6|1.50|2002|132||P00760|TRYPSIN BETA|7.0|Ki=0.10uM|Ki|=|0.1|uM|100|nM
1GJ8|1.64|2002|133||P00749|UROKINASE-TYPE PLASMINOGEN ACTIVATOR|6.96|Ki=0.11uM|Ki|=|0.11|uM|110|nM
1MTO|3.20|2002|F6P||P00512|6-PHOSPHOFRUCTOKINASE|6.96|Ki=0.11uM|Ki|=|0.11|uM|110|nM
1KUK|1.45|2002|3-mer||O57413|METALLOPROTEINASE|3.91|Ki=0.124mM|Ki|=|0.124|mM|124000|nM
1M0Q|2.00|2002|EPC||P16932|2,2-DIALKYLGLYCINE DECARBOXYLASE|3.89|Ki=0.13mM|Ki|=|0.13|mM|130000|nM
1KUG|1.37|2002|3-mer||O57413|METALLOPROTEINASE|3.8|Ki=0.160mM|Ki|=|0.16|mM|160000|nM
1KUI|1.50|2002|3-mer||O57413|METALLOPROTEINASE|3.77|Ki=0.169mM|Ki|=|0.169|mM|169000|nM
1H1B|2.00|2002|151|covalent complex|P08246|LEUKOCYTE ELASTASE|9.8|Ki=0.16nM|Ki|=|0.16|nM|0.16|nM
1IHY|3.00|2002|APR||P56649|GLYCERALDEHYDE 3-PHOSPHATE DEHYDROGENASE|3.74|Ki=0.18mM|Ki|=|0.18|mM|180000|nM
1KQB|1.80|2002|BEZ||Q01234|OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE|4.0|Ki=0.1mM|Ki|=|0.1|mM|100000|nM
1EBY|2.29|2002|BEB||P03366|HIV-1 PROTEASE|9.7|Ki=0.20nM|Ki|=|0.2|nM|0.2|nM
1KE3|2.15|2002|BDB|covalent complex|P00811|BETA-LACTAMASE|6.7|Ki=0.20uM|Ki|=|0.2|uM|200|nM
1IZI|2.15|2002|Q50||Q90EB9|HIV-1 PROTEASE|6.59|Ki=0.26uM|Ki|=|0.26|uM|260|nM
1GZV|3.51|2002|PA5||P08059|GLUCOSE-6-PHOSPHATE ISOMERASE|6.57|Ki=0.27uM|Ki|=|0.27|uM|270|nM
1GZ4|2.20|2002|ATP||P23368|NAD-DEPENDENT MALIC ENZYME|3.7|Ki=0.2mM|Ki|=|0.2|mM|200000|nM
1LOQ|1.50|2002|U||O26232|OROTIDINE 5'-MONOPHOSPHATE DECARBOXYLASE|3.7|Ki=0.2mM|Ki|=|0.2|mM|200000|nM
1KF6|2.70|2002|HQO|E. coli Quinol-Fumarate Reductase with HQNO, Ki=0.2uM|P00363|FUMARATE REDUCTASE FLAVOPROTEIN|6.7|Ki=0.2uM|Ki|=|0.2|uM|200|nM
1KOJ|1.90|2002|PAN||Q9N1E2|GLUCOSE-6-PHOSPHATE ISOMERASE|6.7|Ki=0.2uM|Ki|=|0.2|uM|200|nM
1GPN|2.35|2002|HUB||P04058|ACETYLCHOLINESTERASE|6.48|Ki=0.334uM|Ki|=|0.334|uM|334|nM
1J01|2.00|2002|XIL||P07986|BETA-1,4-XYLANASE|6.47|Ki=0.34uM|Ki|=|0.34|uM|340|nM
1JQE|1.91|2002|QUN|Ki=9.0uM for SAH|P50135|HISTAMINE N-METHYLTRANSFERASE|6.44|Ki=0.36uM|Ki|=|0.36|uM|360|nM
1M4H|2.10|2002|7-mer||P56817|BETA-SECRETASE 1|9.52|Ki=0.3nM|Ki|=|0.3|nM|0.3|nM
1EBZ|2.01|2002|BEC||P03366|HIV-1 PROTEASE|9.4|Ki=0.40nM|Ki|=|0.4|nM|0.4|nM
1LOL|1.90|2002|XMP||O26232|OROTIDINE 5'-MONOPHOSPHATE DECARBOXYLASE|6.39|Ki=0.41uM|Ki|=|0.41|uM|410|nM
1GJB|1.90|2002|130|redundant to 1gjc|P00749|UROKINASE-TYPE PLASMINOGEN ACTIVATOR|6.35|Ki=0.45uM|Ki|=|0.45|uM|450|nM
1GJC|1.73|2002|130||P00749|UROKINASE-TYPE PLASMINOGEN ACTIVATOR|6.35|Ki=0.45uM|Ki|=|0.45|uM|450|nM
1KSN|2.10|2002|FXV||P00742|COAGULATION FACTOR XA|9.4|Ki=0.4nM|Ki|=|0.4|nM|0.4|nM
1GQS|3.00|2002|SAF||P04058|ACETYLCHOLINESTERASE|6.3|Ki=0.5uM|Ki|=|0.5|uM|500|nM
1GI6|1.49|2002|124||P00760|TRYPSIN BETA|6.22|Ki=0.60uM|Ki|=|0.6|uM|600|nM
1EW9|2.00|2002|MMQ||P00634|ALKALINE PHOSPHATASE|3.22|Ki=0.6mM|Ki|=|0.6|mM|600000|nM
1L8G|2.50|2002|DBD|ligand is compound f1; protein is PTPN1|P18031|PROTEIN-TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1|6.22|Ki=0.6uM|Ki|=|0.6|uM|600|nM
1GVK|0.94|2002|4-mer|covalent complex|P00772|ELASTASE|3.05|Ki=0.89mM|Ki|=|0.89|mM|890000|nM
1H22|2.15|2002|E10||P04058|ACETYLCHOLINESTERASE|9.1|Ki=0.8nM|Ki|=|0.8|nM|0.8|nM
1EBW|1.81|2002|BEI||P03366|HIV-1 PROTEASE|9.05|Ki=0.90nM|Ki|=|0.9|nM|0.9|nM
1EC3|1.80|2002|MS3||P03366|HIV-1 PROTEASE|9.04|Ki=0.92nM|Ki|=|0.92|nM|0.92|nM
1JQ8|2.00|2002|5-mer||P59071|PHOSPHOLIPASE A2|6.0|Ki=1.01uM|Ki|=|1.01|uM|1010|nM
1FV0|1.70|2002|9AR||P59071|PHOSPHOLIPASE A2|5.93|Ki=1.18uM|Ki|=|1.18|uM|1180|nM
1EC1|2.10|2002|BEE||P03366|HIV-1 PROTEASE|8.92|Ki=1.20nM|Ki|=|1.2|nM|1.2|nM
1H2K|2.15|2002|OGA|ligand is compound 31|Q969Q7|HYPOXIA-INDUCIBLE FACTOR 1-ALPHA INHIBITOR|2.92|Ki=1.2mM|Ki|=|1.2|mM|1200000|nM
1MUI|2.80|2002|AB1||Q903J0|HIV-1 PROTEASE|11.89|Ki=1.3pM|Ki|=|1.3|pM|0.0013000000000000002|nM
1D4I|1.81|2002|BEG||P03366|HIV-1 PROTEASE|8.85|Ki=1.40nM|Ki|=|1.4|nM|1.4|nM
1K4G|1.70|2002|AIQ||P28720|TRNA GUANINE TRANSGLYCOSYLASE|5.85|Ki=1.4uM|Ki|=|1.4|uM|1400|nM
1KPM|1.80|2002|VIT||P59071|PHOSPHOLIPASE A2|5.8|Ki=1.59uM|Ki|=|1.59|uM|1590|nM
1KAV|2.35|2002|FEP||P18031|PROTEIN-TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1|5.82|Ki=1.5uM|Ki|=|1.5|uM|1500|nM
1KDS|2.15|2002|NPB|covalent complex|P00811|BETA-LACTAMASE|5.77|Ki=1.7uM|Ki|=|1.7|uM|1700|nM
1LF3|2.70|2002|EH5||P46925|PLASMEPSIN-2|7.0|Ki=100nM|Ki|=|100|nM|100|nM
1GVW|1.00|2002|0EM||P11838|ENDOTHIAPEPSIN|6.96|Ki=110nM|Ki|=|110|nM|110|nM
1H5V|1.10|2002|5-mer||O85465|ENDOGLUCANASE 5A|3.93|Ki=117uM|Ki|=|117|uM|117000|nM
1GJ5|1.73|2002|130||P00734|THROMBIN|4.96|Ki=11uM|Ki|=|11|uM|11000|nM
1KM3|1.50|2002|UP6|ligand is compound 3|O26232|OROTIDINE 5'-MONOPHOSPHATE DECARBOXYLASE|4.91|Ki=12.4uM|Ki|=|12.4|uM|12400|nM
1H1P|2.10|2002|CMG|redundant to 1e1v|P24941|CELL DIVISION PROTEIN KINASE 2|4.92|Ki=12uM|Ki|=|12|uM|12000|nM
1JQY|2.14|2002|A32||P32890|HEAT-LABILE ENTEROTOXIN B CHAIN|4.92|Ki=12uM|Ki|=|12|uM|12000|nM
1J15|2.00|2002|BEN|redundant to 1j16|P00763|TRYPSIN BETA|3.84|Ki=143uM|Ki|=|143|uM|143000|nM
1J16|1.60|2002|BEN||P00763|TRYPSIN BETA|3.84|Ki=143uM|Ki|=|143|uM|143000|nM
1ME4|1.20|2002|T10||P25779|CRUZIPAIN|6.84|Ki=146nM|Ki|=|146|nM|146|nM
1JWT|2.50|2002|BLI||P00734|PROTHROMBIN|7.85|Ki=14nM|Ki|=|14|nM|14|nM
1NDE|3.00|2002|MON||Q92731|ESTROGEN RECEPTOR BETA|7.82|Ki=15nM|Ki|=|15|nM|15|nM
1GHZ|1.39|2002|120||P00760|TRYPSIN BETA|4.8|Ki=16uM|Ki|=|16|uM|16000|nM
1LEE|1.90|2002|R36||P46925|PLASMEPSIN-2|7.74|Ki=18nM|Ki|=|18|nM|18|nM
1GVU|0.94|2002|10-mer|incomplete ligand structure|P11838|ENDOTHIAPEPSIN|9.0|Ki=1nM|Ki|=|1|nM|1|nM
1IUP|1.60|2002|ALQ|X-ray(Cumd S103A) while Ki(CumD wild type)|P96965|META-CLEAVAGE PRODUCT HYDROLASE|2.54|Ki=2.9mM|Ki|=|2.9|mM|2900000|nM
1KDW|2.28|2002|4CB|covalent complex|P00811|BETA-LACTAMASE|5.54|Ki=2.9uM|Ki|=|2.9|uM|2900|nM
1H4W|1.70|2002|BEN||P35030|TRYPSIN IVA|4.66|Ki=22uM|Ki|=|22|uM|22000|nM
1M1B|2.25|2002|SPV||P56839|PHOSPHOENOLPYRUVATE PHOSPHOMUTASE|4.66|Ki=22uM|Ki|=|22|uM|22000|nM
1GYY|1.35|2002|FHC||P31992|HYPOTHETICAL PROTEIN YDCE|3.64|Ki=230uM|Ki|=|230|uM|230000|nM
1G9S|2.80|2002|IMP||P0A9M2|HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE|3.61|Ki=247uM|Ki|=|247|uM|247000|nM
1L2S|1.94|2002|STC||P00811|BETA-LACTAMASE|4.59|Ki=26uM|Ki|=|26|uM|26000|nM
1N1M|2.50|2002|A3M||P27487|DIPEPTIDYL PEPTIDASE 4|5.7|Ki=2uM|Ki|=|2|uM|2000|nM
1EC0|1.79|2002|BED||P03366|HIV-1 PROTEASE|8.49|Ki=3.2nM|Ki|=|3.2|nM|3.2|nM
1GYX|1.35|2002|BEZ|Ki=13.9mM for EPE|P31992|HYPOTHETICAL PROTEIN YDCE|2.48|Ki=3.3mM|Ki|=|3.3|mM|3300000|nM
1GI1|1.42|2002|BMZ|Ki measured at pH=7.72|P00760|TRYPSIN BETA|5.47|Ki=3.4uM|Ki|=|3.4|uM|3400|nM
1GJA|1.56|2002|135||P00749|UROKINASE-TYPE PLASMINOGEN ACTIVATOR|5.42|Ki=3.8uM|Ki|=|3.8|uM|3800|nM
1JYS|1.90|2002|ADE||P24247|MTA/SAH NUCLEOSIDASE|3.52|Ki=300uM|Ki|=|300|uM|300000|nM
1LF2|1.80|2002|R37||P46925|PLASMEPSIN-2|7.52|Ki=30nM|Ki|=|30|nM|30|nM
1GU1|1.80|2002|FA1||P15474|3-DEHYDROQUINATE DEHYDRATASE|4.52|Ki=30uM|Ki|=|30|uM|30000|nM
1GI7|1.79|2002|120||P00749|UROKINASE-TYPE PLASMINOGEN ACTIVATOR|4.51|Ki=31uM|Ki|=|31|uM|31000|nM
1J14|2.40|2002|BEN||P00763|TRYPSIN BETA|4.49|Ki=32.2uM|Ki|=|32.2|uM|32200.000000000004|nM
1IIQ|1.83|2002|0ZR||P03367|HIV-1 PROTEASE|7.48|Ki=33nM|Ki|=|33|nM|33|nM
1H8L|2.60|2002|GEM||Q90240|CARBOXYPEPTIDASE GP180 RESIDUES 503-882|7.47|Ki=34nM|Ki|=|34|nM|34|nM
1KTI|1.97|2002|AZC||P00489|GLYCOGEN PHOSPHORYLASE|3.43|Ki=370uM|Ki|=|370|uM|370000|nM
1EB1|1.80|2002|10-mer||P00734|THROMBIN HEAVY CHAIN|10.43|Ki=37pM|Ki|=|37|pM|0.037|nM
1KC7|2.20|2002|PPR||P22983|PYRUVATE PHOSPHATE DIKINASE|5.52|Ki=3uM|Ki|=|3|uM|3000|nM
1IT6|2.00|2002|CYU|incomplete ligand structure|P36873|SERINE/THREONINE PROTEIN PHOSPHATASE PP1-GAMMA|8.39|Ki=4.1nM|Ki|=|4.1|nM|4.1|nM
1K21|1.86|2002|IGN||P00734|PROTHROMBIN|8.38|Ki=4.2nM|Ki|=|4.2|nM|4.2|nM
1KE0|2.30|2002|CVB|covalent complex|P00811|BETA-LACTAMASE|5.38|Ki=4.2uM|Ki|=|4.2|uM|4200|nM
1GPK|2.10|2002|HUP||P04058|ACETYLCHOLINESTERASE|5.37|Ki=4.3uM|Ki|=|4.3|uM|4300|nM
1D4J|1.81|2002|MSC||P03366|HIV-1 PROTEASE|8.36|Ki=4.40nM|Ki|=|4.4|nM|4.4|nM
1H23|2.15|2002|E12||P04058|ACETYLCHOLINESTERASE|8.35|Ki=4.5nM|Ki|=|4.5|nM|4.5|nM
1M0O|2.40|2002|MPM|Ki=0.5mM when preincubated with DGD for 30min|P16932|2,2-DIALKYLGLYCINE DECARBOXYLASE|2.31|Ki=4.9mM|Ki|=|4.9|mM|4900000|nM
1KZK|1.09|2002|JE2||P03369|HIV-1 PROTEASE|10.39|Ki=41pM|Ki|=|41|pM|0.041|nM
1MHW|1.90|2002|5-mer||P07711|CATHEPSIN L|7.35|Ki=45nM|Ki|=|45|nM|45|nM
1GHV|1.85|2002|120||P00734|THROMBIN|4.35|Ki=45uM|Ki|=|45|uM|45000|nM
1I2S|1.70|2002|CIT|ligand is citrate|P00808|BETA-LACTAMASE|3.31|Ki=490uM|Ki|=|490|uM|490000|nM
1K22|1.93|2002|MEL||P00734|PROTHROMBIN|8.4|Ki=4nM|Ki|=|4|nM|4|nM
1KFY|3.60|2002|BRS||P00363|FUMARATE REDUCTASE FLAVOPROTEIN|5.28|Ki=5.2uM|Ki|=|5.2|uM|5200|nM
1EW8|2.20|2002|PAE||P00634|ALKALINE PHOSPHATASE|2.26|Ki=5.5mM|Ki|=|5.5|mM|5500000|nM
1G9T|2.80|2002|5GP||P0A9M2|HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE|3.28|Ki=526uM|Ki|=|526|uM|526000|nM
1J17|2.00|2002|ZEN||P00763|TRYPSIN BETA|5.22|Ki=6.05uM|Ki|=|6.05|uM|6050|nM
1M0N|2.20|2002|HCP||P16932|2,2-DIALKYLGLYCINE DECARBOXYLASE|2.22|Ki=6.0mM|Ki|=|6|mM|6000000|nM
1GI9|1.80|2002|123||P00749|UROKINASE-TYPE PLASMINOGEN ACTIVATOR|5.22|Ki=6.0uM|Ki|=|6|uM|6000|nM
1GJD|1.75|2002|136||P00749|UROKINASE-TYPE PLASMINOGEN ACTIVATOR|5.22|Ki=6.0uM|Ki|=|6|uM|6000|nM
1JQD|2.28|2002|SAH||P50135|HISTAMINE N-METHYLTRANSFERASE|5.16|Ki=6.9uM|Ki|=|6.9|uM|6900|nM
1GVX|1.00|2002|6-mer||P11838|ENDOTHIAPEPSIN|7.22|Ki=60nM|Ki|=|60|nM|60|nM
1LL4|2.80|2002|3-mer||P0CB51|CHITINASE 1|7.22|Ki=60nM|Ki|=|60|nM|60|nM
1KV5|1.65|2002|PGA||P04789|TRIOSEPHOSPHATE ISOMERASE|4.22|Ki=60uM|Ki|=|60|uM|60000|nM
1GHW|1.75|2002|BMZ||P00734|THROMBIN|4.2|Ki=63uM|Ki|=|63|uM|63000|nM
1ME3|1.20|2002|P10||P25779|CRUZIPAIN|7.19|Ki=64.6nM|Ki|=|64.6|nM|64.6|nM
1LOS|1.90|2002|UP6|X-ray(R203A) while Ki(wild type)|O26232|OROTIDINE 5'-MONOPHOSPHATE DECARBOXYLASE|7.19|Ki=64nM|Ki|=|64|nM|64|nM
1H1S|2.00|2002|4SP||P24941|CELL DIVISION PROTEIN KINASE 2|8.22|Ki=6nM|Ki|=|6|nM|6|nM
1H1H|2.00|2002|A2P|Ki=6-7uM|P12724|EOSINOPHIL CATIONIC PROTEIN|5.22|Ki=6uM|Ki|=|6|uM|6000|nM
1JCX|1.80|2002|PAI||O66496|2-DEHYDRO-3-DEOXYPHOSPHOOCTONATE ALDOLASE|5.15|Ki=7.0uM|Ki|=|7|uM|7000|nM
1K4H|1.80|2002|APQ||P28720|TRNA GUANINE TRANSGLYCOSYLASE|5.11|Ki=7.7uM|Ki|=|7.7|uM|7700|nM
1JVU|1.78|2002|C2P|ligand is 2'-CMP|P61823|RIBONUCLEASE A|5.15|Ki=7uM|Ki|=|7|uM|7000|nM
1LOR|1.60|2002|BMP|redundant to 1x1z|O26232|OROTIDINE 5'-MONOPHOSPHATE DECARBOXYLASE|11.06|Ki=8.8pM|Ki|=|8.8|pM|0.0088|nM
1GI8|1.75|2002|BMZ||P00749|UROKINASE-TYPE PLASMINOGEN ACTIVATOR|5.05|Ki=8.9uM|Ki|=|8.9|uM|8900|nM
1GJ4|1.81|2002|132||P00734|THROMBIN|4.07|Ki=85uM|Ki|=|85|uM|85000|nM
1EB2|2.00|2002|BPO||P00760|TRYPSIN|6.01|Ki=980nM|Ki|=|980|nM|980|nM
1OIT|1.60|2003|HDT||P24941|CELL DIVISION PROTEIN KINASE 2|8.52|IC<0.003uM|IC50|<|0.003|uM|3|nM
1NJU|2.70|2003|0FP|covalent complex|P16753|CAPSID PROTEIN P40|7.3|IC<0.05uM|IC50|<|0.05|uM|50|nM
1NKM|2.70|2003|0FP|covalent complex; redundant to 1nju|P16753|CAPSID PROTEIN P40|7.3|IC<0.05uM|IC50|<|0.05|uM|50|nM
1Q6M|2.20|2003|P27||P18031|PROTEIN-TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1|7.89|IC=0.013uM|IC50|=|0.013|uM|13|nM
1Q6J|2.20|2003|335||P18031|PROTEIN-TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1|7.8|IC=0.016uM|IC50|=|0.016|uM|16|nM
1Q6N|2.10|2003|P90||P18031|PROTEIN-TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1|7.64|IC=0.023uM|IC50|=|0.023|uM|23|nM
1J1A|2.20|2003|BHP||P14555|PHOSPHOLIPASE A2|7.54|IC=0.029uM|IC50|=|0.029|uM|29|nM
1ONP|2.50|2003|FOM||P45568|1-DEOXY-D-XYLULOSE 5-PHOSPHATE REDUCTOISOMERASE|7.52|IC=0.030uM|IC50|=|0.03|uM|30|nM
1OIR|1.91|2003|HDY||P24941|CELL DIVISION PROTEIN KINASE 2|7.49|IC=0.032uM|IC50|=|0.032|uM|32|nM
1OGU|2.60|2003|ST8||P24941|CELL DIVISION PROTEIN KINASE 2|7.47|IC=0.034uM|IC50|=|0.034|uM|34|nM
1NQ0|2.40|2003|4HY|ligand is compound 2, -logIC50=10.32|P10828|THYROID HORMONE RECEPTOR BETA-1|10.32|IC=0.048nM|IC50|=|0.048|nM|0.048|nM
1MZC|2.00|2003|BNE||P49354|FARNESYLTRANSFERASE ALPHA SUBUNIT|10.22|IC=0.06nM|IC50|=|0.06|nM|0.06|nM
1NYX|2.65|2003|DRF||P37231|PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA|7.04|IC=0.092uM|IC50|=|0.092|uM|92|nM
1G3M|1.70|2003|PCQ|IC50=0.10-0.19nM|P49888|ESTROGEN SULFOTRANSFERASE|10.0|IC=0.10nM|IC50|=|0.1|nM|0.1|nM
1OUK|2.50|2003|084||Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|9.89|IC=0.13nM|IC50|=|0.13|nM|0.13|nM
1N7T|NMR|2003|7-mer||Q96RT1|99-MER PEPTIDE OF DENSIN-180-LIKE PROTEIN|6.82|IC=0.15uM|IC50|=|0.15|uM|150|nM
1OKX|2.80|2003|8-mer||P00772|ELASTASE 1|6.8|IC=0.16uM|IC50|=|0.16|uM|160|nM
1MQD|1.46|2003|SHI|crystal without zinc|P19491|GLUTAMATE RECEPTOR 2|6.77|IC=0.17uM|IC50|=|0.17|uM|170|nM
1MS7|1.97|2003|SHI|crystal with zinc|P19491|GLUTAMATE RECEPTOR 2|6.77|IC=0.17uM|IC50|=|0.17|uM|170|nM
1PQC|2.80|2003|444|ligand is compound 2, T0901317. scintillation proximity ligand binding assay (SPA)|P55055|OXYSTEROLS RECEPTOR LXR-BETA|7.0|IC=0.1uM|IC50|=|0.1|uM|100|nM
1KWR|2.25|2003|SG2||P00918|CARBONIC ANHYDRASE 2|6.6|IC=0.25uM|IC50|=|0.25|uM|250|nM
1MQH|1.80|2003|BWD||P19491|GLUTAMATE RECEPTOR 2|6.52|IC=0.30uM|IC50|=|0.3|uM|300|nM
1Q9M|2.30|2003|ROL||Q08499|CAMP-SPECIFIC PHOSPHODIESTERASE PDE4D2|6.48|IC=0.33uM|IC50|=|0.33|uM|330|nM
1NL4|2.70|2003|FTL||Q04631|FARNESYLTRANSFERASE ALPHA SUBUNIT|9.41|IC=0.39nM|IC50|=|0.39|nM|0.39|nM
1MQG|2.15|2003|IWD||P19491|GLUTAMATE RECEPTOR 2|6.28|IC=0.52uM|IC50|=|0.52|uM|520|nM
1OL2|2.60|2003|6-mer|IC50=7.2uM for CDK2-cyclin A kinase activity|P24941|CELL DIVISION PROTEIN KINASE 2|6.28|IC=0.53uM|IC50|=|0.53|uM|530|nM
1OYN|2.00|2003|ROL||Q08499|CAMP-SPECIFIC PHOSPHODIESTERASE PDE4D2|6.26|IC=0.55uM|IC50|=|0.55|uM|550|nM
1KWQ|2.60|2003|SG1||P00918|CARBONIC ANHYDRASE 2|9.21|IC=0.62nM|IC50|=|0.62|nM|0.62|nM
1OKV|2.40|2003|6-mer|IC50=7.7uM for CDK2-cyclin A kinase activity|P24941|CELL DIVISION PROTEIN KINASE 2|6.17|IC=0.68uM|IC50|=|0.68|uM|680|nM
1OVE|2.10|2003|358||Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|9.13|IC=0.74nM|IC50|=|0.74|nM|0.74|nM
1PXL|2.50|2003|CK4|IC50 for CDK2-cyclin E kinase inhibition|P24941|CELL DIVISION PROTEIN KINASE 2|6.05|IC=0.9uM|IC50|=|0.9|uM|900|nM
1N94|3.50|2003|TIN||Q04631|FARNESYLTRANSFERASE ALPHA SUBUNIT|8.96|IC=1.1nM|IC50|=|1.1|nM|1.1|nM
1N95|2.30|2003|FTH||Q04631|FARNESYLTRANSFERASE ALPHA SUBUNIT|8.92|IC=1.2nM|IC50|=|1.2|nM|1.2|nM
1O5M|2.30|2003|336||Q04631|FARNESYLTRANSFERASE ALPHA SUBUNIT|8.72|IC=1.9nM|IC50|=|1.9|nM|1.9|nM
1NZQ|2.18|2003|162||P00734|THROMBIN LIGHT CHAIN|7.96|IC=11nM|IC50|=|11|nM|11|nM
1N0T|2.10|2003|AT1||P19491|GLUTAMATE RECEPTOR 2|4.91|IC=12.2uM|IC50|=|12.2|uM|12200|nM
1P2A|2.50|2003|5BN||P24941|CELL DIVISION PROTEIN KINASE 2|7.92|IC=12nM|IC50|=|12|nM|12|nM
1Q6S|2.20|2003|214||P18031|PROTEIN-TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1|7.92|IC=12nM|IC50|=|12|nM|12|nM
1H0W|2.10|2003|207||P24941|CELL DIVISION PROTEIN KINASE 2|4.89|IC=13uM|IC50|=|13|uM|13000|nM
1PXJ|2.30|2003|CK2|IC50 for CDK2-cyclin E kinase inhibition|P24941|CELL DIVISION PROTEIN KINASE 2|4.89|IC=13uM|IC50|=|13|uM|13000|nM
1H3B|2.80|2003|R46||P33247|SQUALENE-HOPENE CYCLASE|6.85|IC=141nM|IC50|=|141|nM|141|nM
1P5E|2.22|2003|TBS|IC50 for TBS/CDK2|P24941|CELL DIVISION PROTEIN KINASE 2|4.81|IC=15.6uM|IC50|=|15.6|uM|15600|nM
1PMV|2.50|2003|537||P53779|MITOGEN-ACTIVATED PROTEIN KINASE 10|6.82|IC=150nM|IC50|=|150|nM|150|nM
1Q3D|2.20|2003|STU||P49841|GLYCOGEN SYNTHASE KINASE-3 BETA|7.82|IC=15nM|IC50|=|15|nM|15|nM
1NJT|2.50|2003|6-mer|covalent complex|P16753|CAPSID PROTEIN P40|4.82|IC=15uM|IC50|=|15|uM|15000|nM
1MKD|2.90|2003|ZAR||Q08499|CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D|6.8|IC=160nM|IC50|=|160|nM|160|nM
1PXI|1.95|2003|CK1|IC50 for CDK2-cyclin E kinase inhibition|P24941|CELL DIVISION PROTEIN KINASE 2|4.77|IC=17uM|IC50|=|17|uM|17000|nM
1M51|2.25|2003|TSX||P35558|PHOSPHOENOLPYRUVATE CARBOXYKINASE|4.73|IC=18.8uM|IC50|=|18.8|uM|18800|nM
1O6H|2.80|2003|W37||P33247|SQUALENE-HOPENE CYCLASE|6.73|IC=186nM|IC50|=|186|nM|186|nM
1H36|2.80|2003|R88||P33247|SQUALENE-HOPENE CYCLASE|7.74|IC=18nM|IC50|=|18|nM|18|nM
1URC|2.60|2003|6-mer||P24941|CELL DIVISION PROTEIN KINASE 2|4.72|IC=19.2uM|IC50|=|19.2|uM|19200|nM
1UOM|2.28|2003|PTI|IC50 measured on full length ERalpha|P03372|ESTROGEN RECEPTOR|7.72|IC=19nM|IC50|=|19|nM|19|nM
1NPW|2.00|2003|LGZ||P03368|POL POLYPROTEIN|8.7|IC=2.0nM|IC50|=|2|nM|2|nM
1NHX|2.10|2003|FTB||P35558|PHOSPHOENOLPYRUVATE CARBOXYKINASE|5.68|IC=2.11uM|IC50|=|2.11|uM|2110|nM
1N9A|3.20|2003|FTI||Q04631|FARNESYLTRANSFERASE ALPHA SUBUNIT|8.66|IC=2.2nM|IC50|=|2.2|nM|2.2|nM
1PXK|2.80|2003|CK3|IC50 for CDK2-cyclin E kinase inhibition|P24941|CELL DIVISION PROTEIN KINASE 2|5.66|IC=2.2uM|IC50|=|2.2|uM|2200|nM
1OIQ|2.31|2003|HDU||P24941|CELL DIVISION PROTEIN KINASE 2|5.54|IC=2.9uM|IC50|=|2.9|uM|2900|nM
1MM6|2.15|2003|QUS|crystal without zinc|P19491|GLUTAMATE RECEPTOR 2|7.7|IC=20nM|IC50|=|20|nM|20|nM
1MM7|1.65|2003|QUS|crystal with zinc|P19491|GLUTAMATE RECEPTOR 2|7.7|IC=20nM|IC50|=|20|nM|20|nM
1PYW|2.10|2003|10-mer||P01903|HLA CLASS II HISTOCOMPATIBILITY ANTIGEN, DR ALPHA CHAIN|7.7|IC=20nM|IC50|=|20|nM|20|nM
1OL1|2.90|2003|6-mer|IC50=37uM for CDK2-cyclin A kinase activity|P24941|CELL DIVISION PROTEIN KINASE 2|4.68|IC=21uM|IC50|=|21|uM|21000|nM
1Q41|2.10|2003|IXM||P49841|GLYCOGEN SYNTHASE KINASE-3 BETA|7.66|IC=22nM|IC50|=|22|nM|22|nM
1H01|1.79|2003|FAL|racemic ligand|P24941|CELL DIVISION PROTEIN KINASE 2|4.66|IC=22uM|IC50|=|22|uM|22000|nM
1MQI|1.35|2003|FWD||P19491|GLUTAMATE RECEPTOR 2|7.63|IC=23.53nM|IC50|=|23.53|nM|23.53|nM
1O6Q|2.80|2003|R17||P33247|SQUALENE-HOPENE CYCLASE|7.64|IC=23nM|IC50|=|23|nM|23|nM
1H3A|2.85|2003|R04||P33247|SQUALENE-HOPENE CYCLASE|6.55|IC=281nM|IC50|=|281|nM|281|nM
1H39|2.80|2003|R03||P33247|SQUALENE-HOPENE CYCLASE|6.54|IC=289nM|IC50|=|289|nM|289|nM
1H08|1.80|2003|BYP|racemic ligand BYP/BWP|P24941|CELL DIVISION PROTEIN KINASE 2|4.55|IC=28uM|IC50|=|28|uM|28000|nM
1H35|2.80|2003|R01||P33247|SQUALENE-HOPENE CYCLASE|7.54|IC=29nM|IC50|=|29|nM|29|nM
1NNK|1.85|2003|CE2||P19491|GLUTAMATE RECEPTOR 2|5.46|IC=3.5uM|IC50|=|3.5|uM|3500|nM
1H3C|2.90|2003|R79||P33247|SQUALENE-HOPENE CYCLASE|6.51|IC=306nM|IC50|=|306|nM|306|nM
1H00|1.60|2003|FCP/FAP|isomer|P24941|CELL DIVISION PROTEIN KINASE 2|4.42|IC=38uM|IC50|=|38|uM|38000|nM
1Q6P|2.30|2003|213||P18031|PROTEIN-TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1|8.52|IC=3nM|IC50|=|3|nM|3|nM
1H07|1.85|2003|MFP/MFQ|isomer|P24941|CELL DIVISION PROTEIN KINASE 2|5.52|IC=3uM|IC50|=|3|uM|3000|nM
1MXU|1.80|2003|BWD||P19491|GLUTAMATE RECEPTOR 2|5.4|IC=4.0uM|IC50|=|4|uM|4000|nM
1MY3|1.75|2003|BWD||P19491|GLUTAMATE RECEPTOR 2|5.4|IC=4.0uM|IC50|=|4|uM|4000|nM
1OUY|2.50|2003|094||Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|8.37|IC=4.3nM|IC50|=|4.3|nM|4.3|nM
1MQJ|1.65|2003|HWD||P19491|GLUTAMATE RECEPTOR 2|5.32|IC=4.76uM|IC50|=|4.76|uM|4760|nM
1RGJ|NMR|2003|13-mer||P60615|LONG NEUROTOXIN 1|8.31|IC=4.9nM|IC50|=|4.9|nM|4.9|nM
1O79|2.80|2003|R23||P33247|SQUALENE-HOPENE CYCLASE|6.39|IC=406nM|IC50|=|406|nM|406|nM
1Q3W|2.30|2003|ATU||P49841|GLYCOGEN SYNTHASE KINASE-3 BETA|8.4|IC=4nM|IC50|=|4|nM|4|nM
1OKW|2.50|2003|7-mer|IC50=31uM for CDK2-cyclin A kinase activity|P24941|CELL DIVISION PROTEIN KINASE 2|5.25|IC=5.6uM|IC50|=|5.6|uM|5600|nM
1NMK|2.10|2003|SFM||P62937|PEPTIDYL-PROLYL CIS-TRANS ISOMERASE A|8.24|IC=5.7nM|IC50|=|5.7|nM|5.7|nM
1NPV|2.00|2003|L27||P03368|POL POLYPROTEIN|8.24|IC=5.7nM|IC50|=|5.7|nM|5.7|nM
1PMU|2.70|2003|9HP||P53779|MITOGEN-ACTIVATED PROTEIN KINASE 10|6.23|IC=590nM|IC50|=|590|nM|590|nM
1H37|2.80|2003|R02||P33247|SQUALENE-HOPENE CYCLASE|7.23|IC=59nM|IC50|=|59|nM|59|nM
1Q6T|2.30|2003|600||P18031|PROTEIN-TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1|8.3|IC=5nM|IC50|=|5|nM|5|nM
1O0D|2.44|2003|163||P00734|THROMBIN LIGHT CHAIN|8.21|IC=6.2nM|IC50|=|6.2|nM|6.2|nM
1ONH|1.38|2003|WY4|covalent complex|Q59401|BETA-LACTAMASE|8.21|IC=6.2nM|IC50|=|6.2|nM|6.2|nM
1OE0|2.40|2003|TTP||Q9XZT6|DEOXYNUCLEOSIDE KINASE|5.16|IC=6.9uM|IC50|=|6.9|uM|6900|nM
1GSZ|2.80|2003|R71||P33247|SQUALENE-HOPENE CYCLASE|7.21|IC=61nM|IC50|=|61|nM|61|nM
1PMN|2.20|2003|984||P53779|MITOGEN-ACTIVATED PROTEIN KINASE 10|8.15|IC=7.1nM|IC50|=|7.1|nM|7.1|nM
1PMX|NMR|2003|16-mer|obtained for wild-type IGF-F1-1 displayed on the gene-3 coat protein (7.2 uM).|P05019|INSULIN-LIKE GROWTH FACTOR IB|5.14|IC=7.2uM|IC50|=|7.2|uM|7200|nM
1PQ6|2.40|2003|965|ligand is compound 2, pIC50=8.1|P55055|OXYSTEROLS RECEPTOR LXR-BETA|8.1|IC=7.94nM|IC50|=|7.94|nM|7.94|nM
1O6R|2.70|2003|R19||P33247|SQUALENE-HOPENE CYCLASE|7.1|IC=80nM|IC50|=|80|nM|80|nM
1ONG|1.10|2003|WY4|covalent complex|P14557|BETA-LACTAMASE SHV-1|8.05|IC=9nM|IC50|=|9|nM|9|nM
1N1G|2.50|2003|BCP||P90551|GLYCEROL-3-PHOSPHATE DEHYDROGENASE|2.3|IC~5mM|IC50|~|5|mM|5000000|nM
1NFS|1.96|2003|DED|Kd measured on IPP isomerase (claviceps purpurea)|Q46822|ISOPENTENYL-DIPHOSPHATE DELTA-ISOMERASE|9.92|Kd<0.12nM|Kd|<|0.12|nM|0.12|nM
1NF8|1.60|2003|ISC||Q7DC80|PHENAZINE BIOSYNTHESIS PROTEIN PHZD|7.82|Kd=0.015uM|Kd|=|0.015|uM|15|nM
1O7O|1.97|2003|UDP||P14769|N-ACETYLLACTOSAMINIDE ALPHA-1,3-GALACTOSYLTRANSFERASE|4.49|Kd=0.032mM|Kd|=|0.032|mM|32000|nM
1GX0|1.80|2003|UDP|ligand is UDP-GAL|P14769|N-ACETYLLACTOSAMINIDE ALPHA-1,3-GALACTOSYLTRANSFERASE|4.22|Kd=0.060mM|Kd|=|0.06|mM|60000|nM
1NZL|1.90|2003|8-mer||P00524|TYROSINE-PROTEIN KINASE SRC|7.15|Kd=0.07uM|Kd|=|0.07|uM|70|nM
1MV0|NMR|2003|14-mer|Kd=0.0933+/-0.0612mM|P01106|MYC PROTO-ONCOGENE PROTEIN|4.03|Kd=0.0933mM|Kd|=|0.0933|mM|93300|nM
1OEB|1.76|2003|13-mer|incomplete ligand|O89100|GRB2-RELATED ADAPTOR PROTEIN 2|6.93|Kd=0.118uM|Kd|=|0.118|uM|118|nM
1Q72|1.70|2003|COC||------|ANTIBODY FAB M82G2, LIGHT CHAIN|6.85|Kd=0.14uM|Kd|=|0.14|uM|140|nM
1QYG|1.81|2003|BCG||------|ANTIBODY FAB M82G2, LIGHT CHAIN|6.85|Kd=0.14uM|Kd|=|0.14|uM|140|nM
1P1N|1.60|2003|KAI||P19491|GLUTAMATE RECEPTOR 2|6.8|Kd=0.16uM|Kd|=|0.16|uM|160|nM
1HK2|2.80|2003|T44||P02768|SERUM ALBUMIN|6.77|Kd=0.17uM|Kd|=|0.17|uM|170|nM
1USI|1.80|2003|PHE||P04816|LEUCINE-SPECIFIC BINDING PROTEIN|6.74|Kd=0.18uM|Kd|=|0.18|uM|180|nM
1UGY|2.40|2003|GAL-GLC||P18670|AGGLUTININ ALPHA CHAIN|3.72|Kd=0.19mM|Kd|=|0.19|mM|190000|nM
1N4M|2.20|2003|18-mer|Kd=0.19+/-0.04uM|Q14209|RETINOBLASTOMA POCKET|6.72|Kd=0.19uM|Kd|=|0.19|uM|190|nM
1OV3|1.80|2003|18-mer|Kd=0.19uM(Isothermal Titration Calorimetry); Kd=0.4uM(Fluorescence Intensity Titrations); incomplete ligand|P14598|NEUTROPHIL CYTOSOL FACTOR 1|6.72|Kd=0.19uM|Kd|=|0.19|uM|190|nM
1O5P|NMR|2003|CHR||P0A3R9|NEOCARZINOSTATIN|10.0|Kd=0.1nM|Kd|=|0.1|nM|0.1|nM
1GWW|1.80|2003|UDP|ligand is UDP-GLC|P14769|N-ACETYLLACTOSAMINIDE ALPHA-1,3-GALACTOSYLTRANSFERASE|3.59|Kd=0.258mM|Kd|=|0.258|mM|258000|nM
1HK3|2.80|2003|T44||P02768|SERUM ALBUMIN|6.59|Kd=0.26uM|Kd|=|0.26|uM|260|nM
1MRW|2.00|2003|K57||P03367|HIV-1 PROTEASE|9.7|Kd=0.2nM|Kd|=|0.2|nM|0.2|nM
1G74|1.70|2003|OLA||P04117|ADIPOCYTE LIPID-BINDING PROTEIN|6.52|Kd=0.30uM|Kd|=|0.3|uM|300|nM
1O9K|2.60|2003|18-mer|Kd=0.34+/-0.02uM|P06400|RETINOBLASTOMA-ASSOCIATED PROTEIN|6.47|Kd=0.34uM|Kd|=|0.34|uM|340|nM
1GT3|1.80|2003|DHM||P07435|ODORANT-BINDING PROTEIN|6.46|Kd=0.35uM|Kd|=|0.35|uM|350|nM
1MS6|1.90|2003|BLN|covalent complex|P25774|CATHEPSIN S|9.52|Kd=0.3nM|Kd|=|0.3|nM|0.3|nM
1GT4|2.10|2003|UNA||P07435|ODORANT-BINDING PROTEIN|6.52|Kd=0.3uM|Kd|=|0.3|uM|300|nM
1H28|2.80|2003|11-mer|11-Mer PEPTIDE of P107 bound to phospho-CDK2/cyclin A, Kd=0.3uM. Ligand in structure has 10-mer, GSAKRRLFGE. Kd(6-mer, RRLFGE)=2.4uM|P24941|CELL DIVISION PROTEIN KINASE 2|6.52|Kd=0.3uM|Kd|=|0.3|uM|300|nM
1NZV|2.10|2003|8-mer||P00524|TYROSINE-PROTEIN KINASE SRC|6.4|Kd=0.40uM|Kd|=|0.4|uM|400|nM
1USK|2.00|2003|LEU||P04816|LEUCINE-SPECIFIC BINDING PROTEIN|6.4|Kd=0.40uM|Kd|=|0.4|uM|400|nM
1M7D|2.30|2003|3-mer||A2NHM3|ANTIBODY FAB FRAGMENT|6.23|Kd=0.59uM|Kd|=|0.59|uM|590|nM
1H24|2.50|2003|9-mer||P24941|CELL DIVISION PROTEIN KINASE 2|6.3|Kd=0.5uM|Kd|=|0.5|uM|500|nM
1MH5|2.10|2003|HAL||P01837|IMMUNOGLOBULIN MS6-164|9.21|Kd=0.61nM|Kd|=|0.61|nM|0.61|nM
1NJF|2.30|2003|AGS|Kd=1.03uM for ADP; Kd=1.36uM for ATP|P06710|DNA POLYMERASE III, GAMMA SUBUNIT|6.21|Kd=0.62uM|Kd|=|0.62|uM|620|nM
1MSN|2.00|2003|JE2||P03367|HIV-1 PROTEASE|9.09|Kd=0.81nM|Kd|=|0.81|nM|0.81|nM
1OGX|2.00|2003|EQU||P07445|STEROID DELTA-ISOMERASE|6.09|Kd=0.81uM|Kd|=|0.81|uM|810|nM
1UGW|1.70|2003|GAL||P18670|AGGLUTININ ALPHA CHAIN|3.09|Kd=0.82mM|Kd|=|0.82|mM|820000|nM
1GT5|2.08|2003|BZQ||P07435|ODORANT-BINDING PROTEIN|6.1|Kd=0.8uM|Kd|=|0.8|uM|800|nM
1OGD|1.95|2003|RIP||P36946|HIGH AFFINITY RIBOSE TRANSPORT PROTEIN RBSD|3.03|Kd=0.93mM|Kd|=|0.93|mM|930000|nM
1N8U|1.80|2003|BDD|redundant to 1n8v|Q9NG96|CHEMOSENSORY PROTEIN|6.03|Kd=0.93uM|Kd|=|0.93|uM|930|nM
1N8V|1.39|2003|BDD||Q9NG96|CHEMOSENSORY PROTEIN|6.03|Kd=0.93uM|Kd|=|0.93|uM|930|nM
1Q8U|1.90|2003|H52||P00517|CAMP-DEPENDENT PROTEIN KINASE|5.96|Kd=1.1uM|Kd|=|1.1|uM|1100|nM
1UGX|1.60|2003|GAL-MGC||P18670|AGGLUTININ ALPHA CHAIN|5.91|Kd=1.24uM|Kd|=|1.24|uM|1240|nM
1OGZ|2.30|2003|EQU|Kd=1.4+/-0.1uM|P00947|STEROID DELTA-ISOMERASE|5.85|Kd=1.4uM|Kd|=|1.4|uM|1400|nM
1OLS|1.85|2003|TDP||P12694|2-OXOISOVALERATE DEHYDROGENASE ALPHA SUBUNIT|5.82|Kd=1.52uM|Kd|=|1.52|uM|1520|nM
1NTV|1.50|2003|14-mer|incomplete ligand structure|P97318|DISABLED HOMOLOG 1|5.82|Kd=1.5uM|Kd|=|1.5|uM|1500|nM
1URG|1.80|2003|MAL||Q9RHZ6|MALTOSE BINDING PROTEIN|5.82|Kd=1.5uM|Kd|=|1.5|uM|1500|nM
1P1O|1.60|2003|QUS||P19491|GLUTAMATE RECEPTOR 2|5.76|Kd=1.74uM|Kd|=|1.74|uM|1740|nM
1MJJ|2.10|2003|HAL||------|IMMUNOGLOBULIN MS6-12|8.74|Kd=1.83nM|Kd|=|1.83|nM|1.83|nM
1H25|2.50|2003|11-mer|11-Mer PEPTIDE of RETINOBLASTOMA bound to phospho-CDK2/cyclin A, Kd=1.8uM. Ligand in structure has 10-mer, PKPLKKLRFD.Kd(6-mer, KKLRFD)=2.3uM; incomplete ligand|P24941|CELL DIVISION PROTEIN KINASE 2|5.74|Kd=1.8uM|Kd|=|1.8|uM|1800|nM
1N7M|1.80|2003|NMP||P01857|GERMLINE METAL CHELATASE CATALYTIC ANTIBODY|5.71|Kd=1.96uM|Kd|=|1.96|uM|1960|nM
1OBX|1.35|2003|8-mer|incomplete ligand|O00560|SYNTENIN 1|5.72|Kd=1.9uM|Kd|=|1.9|uM|1900|nM
1R0P|1.80|2003|KSA||P08581|HEPATOCYTE GROWTH FACTOR RECEPTOR|8.0|Kd=10nM|Kd|=|10|nM|10|nM
1OAI|1.00|2003|9-mer||Q9UBU9|NUCLEAR RNA EXPORT FACTOR|5.0|Kd=10uM|Kd|=|10|uM|10000|nM
1R2B|2.20|2003|17-mer|Kd=11.4+/-1uM(ITC)|P41182|B-CELL LYMPHOMA 6 PROTEIN|4.94|Kd=11.4uM|Kd|=|11.4|uM|11400|nM
1N3W|2.60|2003|MAL||P02928|MALTOSE-BINDING PERIPLASMIC PROTEIN|6.96|Kd=110nM|Kd|=|110|nM|110|nM
1P1Q|2.00|2003|AMQ||P19491|GLUTAMATE RECEPTOR 2|4.89|Kd=12.8uM|Kd|=|12.8|uM|12800|nM
1I3Z|2.15|2003|14-mer|incomplete ligand|O35324|EWS/FLI1 ACTIVATED TRANSCRIPT 2|6.88|Kd=131nM|Kd|=|131|nM|131|nM
1R0X|2.20|2003|ATP||P26361|CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE|3.83|Kd=149uM|Kd|=|149|uM|149000|nM
1R10|3.00|2003|ATP||P26361|CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE|3.83|Kd=149uM|Kd|=|149|uM|149000|nM
1JWS|2.60|2003|13-mer|HLA-DR1(HA peptide 306-318) complex with SEC3 3B1, Kd=14uM|P01903|HLA CLASS II HISTOCOMPATIBILITY ANTIGEN|4.85|Kd=14uM|Kd|=|14|uM|14000|nM
1J19|2.40|2003|16-mer||P26043|RADIXIN|7.79|Kd=16.4nM|Kd|=|16.4|nM|16.4|nM
1Q8T|2.00|2003|Y27||P00517|CAMP-DEPENDENT PROTEIN KINASE|4.76|Kd=17.5uM|Kd|=|17.5|uM|17500|nM
1OIF|2.12|2003|IFM||Q08638|BETA-GLUCOSIDASE A|7.72|Kd=19nM|Kd|=|19|nM|19|nM
1P93|2.70|2003|DEX|ligand is dexamethasone|P04150|GLUCOCORTICOID RECEPTOR|7.72|Kd=19nM|Kd|=|19|nM|19|nM
1GT1|1.71|2003|ANC|Kd=3.3uM for PRZ|P07435|ODORANT-BINDING PROTEIN|6.0|Kd=1uM|Kd|=|1|uM|1000|nM
1LNM|1.90|2003|DTX||P09464|BILIN-BINDING PROTEIN, DIGA16|8.7|Kd=2.0nM|Kd|=|2|nM|2|nM
1OW4|1.60|2003|2AN||Q8MTC1|PHEROMONE BINDING PROTEIN|5.68|Kd=2.1uM|Kd|=|2.1|uM|2100|nM
1HK1|2.65|2003|T44||P02768|SERUM ALBUMIN|5.64|Kd=2.3uM|Kd|=|2.3|uM|2300|nM
1H27|2.20|2003|11-mer|11-Mer PEPTIDE of P27 bound to phospho-CDK2/cyclin A, Kd=0.9uM. Ligand in structure has 6-mer, RNLFGP, Kd(6-mer)=2.5uM; incomplete ligand|P24941|CELL DIVISION PROTEIN KINASE 2|5.6|Kd=2.5uM|Kd|=|2.5|uM|2500|nM
1O9D|2.30|2003|5-mer||P93343|14-3-3-LIKE PROTEIN C|5.6|Kd=2.5uM|Kd|=|2.5|uM|2500|nM
1GWV|2.50|2003|LAT||P14769|N-ACETYLLACTOSAMINIDE ALPHA-1,3-GALACTOSYLTRANSFERASE|2.57|Kd=2.68mM|Kd|=|2.68|mM|2680000|nM
1H26|2.24|2003|11-mer|11-Mer PEPTIDE of P53 bound to phospho-CDK2/cyclin A, Kd=2.9uM.ligand in structure has 9-mer, SRHKKLMFK.Kd(6-mer, KKLMFK)=2.9uM; incomplete ligand|P24941|CELL DIVISION PROTEIN KINASE 2|5.54|Kd=2.9uM|Kd|=|2.9|uM|2900|nM
1NGW|2.60|2003|MMP|Fab 7g12 complexed with N-methylmesoporphyrin, Kd=20.7nM|P06328|MATURE METAL CHELATASE CATALYTIC ANTIBODY, LIGHT|7.68|Kd=20.7nM|Kd|=|20.7|nM|20.7|nM
1OZ0|2.50|2003|MS1||P31335|BIFUNCTIONAL PURINE BIOSYNTHESIS PROTEIN PURH|7.7|Kd=20nM|Kd|=|20|nM|20|nM
1H3H|NMR|2003|11-mer|Kd=220+/-22nM|O89100|GRB2-RELATED ADAPTOR PROTEIN 2|6.66|Kd=220nM|Kd|=|220|nM|220|nM
1OFZ|1.50|2003|FUL||P18891|FUCOSE-SPECIFIC LECTIN|4.62|Kd=24.1uM|Kd|=|24.1|uM|24100|nM
1MN9|2.90|2003|RTP||P22887|NUCLEOSIDE DIPHOSPHATE KINASE|4.62|Kd=24uM|Kd|=|24|uM|24000|nM
1Q9D|2.35|2003|OI1||P00636|FRUCTOSE-1,6-BISPHOSPHATASE|4.6|Kd=25uM|Kd|=|25|uM|25000|nM
1NLI|1.93|2003|ADE||P09989|RIBOSOME-INACTIVATING PROTEIN ALPHA|3.59|Kd=260uM|Kd|=|260|uM|260000|nM
1JWM|2.70|2003|13-mer|HLA-DR1(HA peptide 306-318) complex with SEC3 wt, Kd=270uM|P01903|HLA CLASS II HISTOCOMPATIBILITY ANTIGEN|3.57|Kd=270uM|Kd|=|270|uM|270000|nM
1M13|2.15|2003|HYF||O75469|ORPHAN NUCLEAR RECEPTOR PXR|7.57|Kd=27nM|Kd|=|27|nM|27|nM
1UJ0|1.70|2003|11-mer|incomplete ligand|O88811|SIGNAL TRANSDUCING ADAPTOR MOLECULE (SH3 DOMAIN)|4.57|Kd=27uM|Kd|=|27|uM|27000|nM
1Q4K|2.30|2003|6-mer|incomplete ligand structure|P53350|SERINE/THREONINE-PROTEIN KINASE PLK|6.55|Kd=280nM|Kd|=|280|nM|280|nM
1UMW|1.90|2003|7-mer||P53350|SERINE/THREONINE-PROTEIN KINASE PLK|6.55|Kd=280nM|Kd|=|280|nM|280|nM
1OKO|1.60|2003|GLB||Q05097|PA-I GALACTOPHILIC LECTIN|4.54|Kd=29uM|Kd|=|29|uM|29000|nM
1UH1|2.80|2003|NGA-AMG||P18670|AGGLUTININ ALPHA CHAIN|5.48|Kd=3.3uM|Kd|=|3.3|uM|3300|nM
1LV8|2.30|2003|9PP|redundant to 1lvu|P55859|PURINE NUCLEOSIDE PHOSPHORYLASE|5.46|Kd=3.5uM|Kd|=|3.5|uM|3500|nM
1OBA|2.45|2003|CHT||P15057|LYSOZYME|2.44|Kd=3.6mM|Kd|=|3.6|mM|3600000|nM
1NU8|2.50|2003|3-mer|covalent complex|P27487|DIPEPTIDYL PEPTIDASE 4|5.42|Kd=3.8uM|Kd|=|3.8|uM|3800|nM
1P28|1.70|2003|HBS/HBR|isomer|Q8MTC1|PHEROMONE BINDING PROTEIN|5.42|Kd=3.8uM|Kd|=|3.8|uM|3800|nM
1LKE|1.90|2003|DOG||P09464|BILIN-BINDING PROTEIN, DIGA16|7.52|Kd=30.2nM|Kd|=|30.2|nM|30.2|nM
1OSG|3.00|2003|12-mer|Kd=30+/-10nM (isothermal titration calorimetry); IC50=92nM|Q9Y275|TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER|7.52|Kd=30nM|Kd|=|30|nM|30|nM
1NTK|2.60|2003|AY1|bc1-antimycin A complex, Kd=32pM|P31800|UBIQUINOL-CYTOCHROME-C REDUCTASE COMPLEX CORE|10.49|Kd=32pM|Kd|=|32|pM|0.032|nM
1MSM|2.00|2003|JE2||P03367|HIV-1 PROTEASE|10.48|Kd=33pM|Kd|=|33|pM|0.033|nM
1N0S|2.00|2003|FLU||P09464|BILIN-BINDING PROTEIN|7.45|Kd=35.2nM|Kd|=|35.2|nM|35.2|nM
1R17|1.86|2003|16-mer|Kd=380nM(Isothermal Titration Calorimetry); Kd=379nM(Fluorescence Intensity Titrations); incomplete ligand|Q9KI13|FIBRINOGEN-BINDING PROTEIN SDRG|6.42|Kd=379nM|Kd|=|379|nM|379|nM
1OLU|1.90|2003|TDP||P12694|2-OXOISOVALERATE DEHYDROGENASE ALPHA SUBUNIT|4.41|Kd=39.3uM|Kd|=|39.3|uM|39300|nM
1OE7|1.80|2003|GSH|redundant to 1oe8|P30113|GLUTATHIONE S-TRANSFERASE|5.52|Kd=3uM|Kd|=|3|uM|3000|nM
1OE8|1.65|2003|GSH||P30114|GLUTATHIONE S-TRANSFERASE|5.52|Kd=3uM|Kd|=|3|uM|3000|nM
1M7I|2.50|2003|5-mer||A2NHM3|ANTIBODY FAB FRAGMENT|5.4|Kd=4.0uM|Kd|=|4|uM|4000|nM
1MJ7|2.25|2003|HAL||------|IMMUNOGLOBULIN MS5-393|8.35|Kd=4.50nM|Kd|=|4.5|nM|4.5|nM
1JWU|2.30|2003|13-mer|HLA-DR1(HA peptide 306-318) complex with SEC3 3B2, Kd=4.6uM|P01903|HLA CLASS II HISTOCOMPATIBILITY ANTIGEN|5.34|Kd=4.6uM|Kd|=|4.6|uM|4600|nM
1LVU|2.05|2003|9PP||P55859|PURINE NUCLEOSIDE PHOSPHORYLASE|5.32|Kd=4.8uM|Kd|=|4.8|uM|4800|nM
1OIM|2.15|2003|NOJ|redundant to 2j77|Q08638|BETA-GLUCOSIDASE A|5.32|Kd=4.8uM|Kd|=|4.8|uM|4800|nM
1HK4|2.40|2003|T44||P02768|SERUM ALBUMIN|5.31|Kd=4.9uM|Kd|=|4.9|uM|4900|nM
1Q4L|2.77|2003|679||P49841|GLYCOGEN SYNTHASE KINASE-3 BETA|7.4|Kd=40nM|Kd|=|40|nM|40|nM
1PY1|2.60|2003|7-mer|incomplete ligand structure|Q9UJY5|ADP-RIBOSYLATION FACTOR BINDING PROTEIN GGA1|4.4|Kd=40uM|Kd|=|40|uM|40000|nM
1P7M|NMR|2003|ADK||P05100|DNA-3-METHYLADENINE GLYCOSYLASE I|4.38|Kd=42uM|Kd|=|42|uM|42000|nM
1OLX|2.25|2003|TDP||P12694|2-OXOISOVALERATE DEHYDROGENASE ALPHA SUBUNIT|4.33|Kd=47.1uM|Kd|=|47.1|uM|47100|nM
1OW6|2.35|2003|13-mer|incomplete ligand|Q05397|FOCAL ADHESION KINASE 1|5.4|Kd=4uM|Kd|=|4|uM|4000|nM
1OW7|2.60|2003|13-mer|incomplete ligand|Q05397|FOCAL ADHESION KINASE 1|5.4|Kd=4uM|Kd|=|4|uM|4000|nM
1OW8|2.85|2003|13-mer|incomplete ligand|Q05397|FOCAL ADHESION KINASE 1|5.4|Kd=4uM|Kd|=|4|uM|4000|nM
1PZ5|1.80|2003|8-mer||A2NHM3|ANTIBODY FAB FRAGMENT|5.4|Kd=4uM|Kd|=|4|uM|4000|nM
1HK5|2.70|2003|T44||P02768|SERUM ALBUMIN|5.24|Kd=5.72uM|Kd|=|5.72|uM|5720|nM
1Q8W|2.20|2003|M77||P00517|CAMP-DEPENDENT PROTEIN KINASE|5.24|Kd=5.7uM|Kd|=|5.7|uM|5700|nM
1OQP|NMR|2003|19-mer||P05434|CALTRACTIN|7.3|Kd=50nM|Kd|=|50|nM|50|nM
1MFG|1.25|2003|9-mer||Q96RT1|ERB-B2 INTERACTING PROTEIN|4.3|Kd=50uM|Kd|=|50|uM|50000|nM
1PPX|NMR|2003|8OG||P08337|MUTATOR MUTT PROTEIN|7.28|Kd=52nM|Kd|=|52|nM|52|nM
1PUN|NMR|2003|8OG|redundant to 1ppx|P08337|MUTATOR MUTT PROTEIN|7.28|Kd=52nM|Kd|=|52|nM|52|nM
1PUQ|NMR|2003|8OG|redundant to 1ppx|P08337|MUTATOR MUTT PROTEIN|7.28|Kd=52nM|Kd|=|52|nM|52|nM
1PUS|NMR|2003|8OG|redundant to 1ppx|P08337|MUTATOR MUTT PROTEIN|7.28|Kd=52nM|Kd|=|52|nM|52|nM
1GX4|1.46|2003|UDP|ternary complex; Kd of LacNAc(GAL-NAG) to enzyme-Mn2+-UDP complex is 0.58mM; Kd of UDP to emzyme is 53uM|P14769|N-ACETYLLACTOSAMINIDE ALPHA-1,3-GALACTOSYLTRANSFERASE|4.28|Kd=53uM|Kd|=|53|uM|53000|nM
1M5W|1.96|2003|DXP||P0A794|PYRIDOXAL PHOSPHATE BIOSYNTHETIC PROTEIN PDXJ|4.27|Kd=54uM|Kd|=|54|uM|54000|nM
1MRX|2.00|2003|K57||P03367|HIV-1 PROTEASE|7.26|Kd=55nM|Kd|=|55|nM|55|nM
1MAU|2.15|2003|ATP||P00953|TRYPTOPHANYL-TRNA LIGASE|11.3|Kd=5pM|Kd|=|5|pM|0.005|nM
1P4U|2.20|2003|13-mer|Kd=5+/-1uM; incomplete ligand|Q9NZ52|ADP-RIBOSYLATION FACTOR BINDING PROTEIN GGA3|5.3|Kd=5uM|Kd|=|5|uM|5000|nM
1PDQ|1.76|2003|18-mer|Kd=5+/-1uM; incomplete ligand|P26017|POLYCOMB PROTEIN|5.3|Kd=5uM|Kd|=|5|uM|5000|nM
1UCN|2.00|2003|ADP||P15531|NUCLEOSIDE DIPHOSPHATE KINASE A|5.22|Kd=6.0uM|Kd|=|6|uM|6000|nM
1OX9|2.90|2003|11-mer|incomplete ligand structure|P25663|STRINGENT STARVATION PROTEIN B|5.21|Kd=6.16uM|Kd|=|6.16|uM|6160|nM
1NW5|2.05|2003|SAM||P14751|MODIFICATION METHYLASE RSRI|5.21|Kd=6.1uM|Kd|=|6.1|uM|6100|nM
1Q5L|NMR|2003|7-mer||P0A6Y8|CHAPERONE PROTEIN DNAK|3.22|Kd=600uM|Kd|=|600|uM|600000|nM
1ODI|2.40|2003|ADN||Q5SID9|PURINE NUCLEOSIDE PHOSPHORYLASE|4.21|Kd=62uM|Kd|=|62|uM|62000|nM
1NU1|3.20|2003|QNO|NQNO1 binds to bc1, Kd=64nM|P31800|UBIQUINOL-CYTOCHROME-C REDUCTASE COMPLEX CORE|7.19|Kd=64nM|Kd|=|64|nM|64|nM
1O9E|2.60|2003|FSC||P93343|14-3-3-LIKE PROTEIN C|4.18|Kd=66uM|Kd|=|66|uM|66000|nM
1L6M|2.40|2003|DBH|Kd for Fe-DBH|P80188|NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN|8.1|Kd=7.9nM|Kd|=|7.9|nM|7.9|nM
1OM9|2.50|2003|15-mer|incomplete ligand|Q9UJY5|ADP-RIBOSYLATION FACTOR BINDING PROTEIN GGA1|4.15|Kd=70uM|Kd|=|70|uM|70000|nM
1NW7|2.10|2003|SAH||P14751|MODIFICATION METHYLASE RSRI|5.09|Kd=8.1uM|Kd|=|8.1|uM|8100|nM
1IWQ|2.00|2003|19-mer|Kd=8.8+/-1.6nM; incomplete ligand|P62158|CALMODULIN|8.06|Kd=8.8nM|Kd|=|8.8|nM|8.8|nM
1MAW|3.00|2003|ATP|Kd for the second ATP|P00953|TRYPTOPHANYL-TRNA LIGASE|1.1|Kd=80mM|Kd|=|80|mM|80000000|nM
1GWM|1.15|2003|6-mer||Q9C171|NON-CATALYTIC PROTEIN 1|4.1|Kd=80uM|Kd|=|80|uM|80000|nM
1ODJ|2.40|2003|GMP||Q5SID9|PURINE NUCLEOSIDE PHOSPHORYLASE|4.1|Kd=80uM|Kd|=|80|uM|80000|nM
1JN2|1.90|2003|SFP||P02866|CONCANAVALIN A|4.09|Kd=82uM|Kd|=|82|uM|82000|nM
1ONZ|2.40|2003|968|Ki=17uM|P18031|PROTEIN-TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1|5.1|Kd=8uM|Kd|=|8|uM|8000|nM
1NDJ|1.81|2003|BTN||P22629|STREPTAVIDIN|12.16|Kd~0.69pM|Kd|~|0.69|pM|0.00069|nM
1N9M|1.60|2003|BTN||P22629|STREPTAVIDIN|10.96|Kd~11pM|Kd|~|11|pM|0.011|nM
1N43|1.89|2003|BTN||P22629|STREPTAVIDIN|10.55|Kd~28pM|Kd|~|28|pM|0.028|nM
1O3E|1.64|2003|696|redundant to 1o3f|P00760|TRYPSIN BETA|7.96|Ki=0.011uM|Ki|=|0.011|uM|11|nM
1O3F|1.55|2003|696||P00760|TRYPSIN BETA|7.96|Ki=0.011uM|Ki|=|0.011|uM|11|nM
1O3G|1.55|2003|696|redundant to 1o3f|P00760|TRYPSIN BETA|7.96|Ki=0.011uM|Ki|=|0.011|uM|11|nM
1O2T|1.62|2003|783|pH=7.48|P00760|TRYPSIN BETA|7.85|Ki=0.014uM|Ki|=|0.014|uM|14|nM
1J07|2.35|2003|DCU|Ki measured on TcAChE|P21836|ACETYLCHOLINESTERASE|7.68|Ki=0.021uM|Ki|=|0.021|uM|21|nM
1O2Q|1.50|2003|991||P00760|TRYPSIN BETA|7.68|Ki=0.021uM|Ki|=|0.021|uM|21|nM
1LYX|1.90|2003|PGA||Q07412|TRIOSEPHOSPHATE ISOMERASE|4.54|Ki=0.029mM|Ki|=|0.029|mM|29000|nM
1LZO|2.80|2003|PGA||Q07412|TRIOSEPHOSPHATE ISOMERASE|4.54|Ki=0.029mM|Ki|=|0.029|mM|29000|nM
1PF8|2.51|2003|SU9||P24941|CELL DIVISION PROTEIN KINASE 2|7.51|Ki=0.031uM|Ki|=|0.031|uM|31|nM
1N46|2.20|2003|PFA||P10828|THYROID HORMONE RECEPTOR BETA-1|10.52|Ki=0.03nM|Ki|=|0.03|nM|0.03|nM
1OYT|1.67|2003|FSN||P00734|THROMBIN|7.24|Ki=0.057uM|Ki|=|0.057|uM|57|nM
1NHG|2.43|2003|TCL|Ki=0.05uM pfENR with Triclosan|Q9BH77|ENOYL-ACYL CARRIER REDUCTASE|7.3|Ki=0.05uM|Ki|=|0.05|uM|50|nM
1O3H|1.53|2003|907|redundant to 1o3i|P00760|TRYPSIN BETA|7.3|Ki=0.05uM|Ki|=|0.05|uM|50|nM
1O3I|1.51|2003|907||P00760|TRYPSIN BETA|7.3|Ki=0.05uM|Ki|=|0.05|uM|50|nM
1O2H|1.77|2003|CR3|Ki measured at pH=8.06|P00760|TRYPSIN BETA|7.17|Ki=0.068uM|Ki|=|0.068|uM|68|nM
1O39|1.59|2003|780|redundant to 1o3d|P00760|TRYPSIN BETA|7.13|Ki=0.074uM|Ki|=|0.074|uM|74|nM
1O3B|1.75|2003|780|redundant to 1o3d|P00760|TRYPSIN BETA|7.13|Ki=0.074uM|Ki|=|0.074|uM|74|nM
1O3C|1.64|2003|780|redundant to 1o3d; pH=7.50|P00760|TRYPSIN BETA|7.13|Ki=0.074uM|Ki|=|0.074|uM|74|nM
1O3D|1.33|2003|780||P00760|TRYPSIN BETA|7.13|Ki=0.074uM|Ki|=|0.074|uM|74|nM
1NZ7|2.40|2003|901||P18031|PROTEIN-TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1|7.12|Ki=0.076uM|Ki|=|0.076|uM|76|nM
1NM6|1.80|2003|L86||P00734|THROMBIN|10.05|Ki=0.09nM|Ki|=|0.09|nM|0.09|nM
1M9N|1.93|2003|XMP||P31335|AICAR TRANSFORMYLASE-IMP CYCLOHYDROLASE|6.92|Ki=0.12uM|Ki|=|0.12|uM|120|nM
1O2J|1.65|2003|656||P00760|TRYPSIN BETA|6.92|Ki=0.12uM|Ki|=|0.12|uM|120|nM
1O2K|1.63|2003|656||P00760|TRYPSIN BETA|6.92|Ki=0.12uM|Ki|=|0.12|uM|120|nM
1PVN|2.00|2003|MZP||P50097|INOSINE-5'-MONOPHOSPHATE DEHYDROGENASE|9.82|Ki=0.15nM|Ki|=|0.15|nM|0.15|nM
1NNU|2.50|2003|TCT|Ki=0.15uM pfENR with Triclosan Analogs 2|Q9BH77|ENOYL-ACYL CARRIER REDUCTASE|6.82|Ki=0.15uM|Ki|=|0.15|uM|150|nM
1O37|1.45|2003|653|redundant to 1o38|P00760|TRYPSIN BETA|6.82|Ki=0.15uM|Ki|=|0.15|uM|150|nM
1O38|1.38|2003|653||P00760|TRYPSIN BETA|6.82|Ki=0.15uM|Ki|=|0.15|uM|150|nM
1NLJ|2.40|2003|2CA|covalent complex|P43235|CATHEPSIN K|9.8|Ki=0.16nM|Ki|=|0.16|nM|0.16|nM
1NQ7|1.50|2003|ARL||P45446|NUCLEAR RECEPTOR ROR-BETA|6.8|Ki=0.16uM|Ki|=|0.16|uM|160|nM
1MPL|1.12|2003|RE1|covalent complex|P15555|D-ALANYL-D-ALANINE CARBOXYPEPTIDASE|3.77|Ki=0.17mM|Ki|=|0.17|mM|170000|nM
1O30|1.55|2003|693||P00760|TRYPSIN BETA|6.77|Ki=0.17uM|Ki|=|0.17|uM|170|nM
1O3J|1.40|2003|334||P00760|TRYPSIN BETA|6.77|Ki=0.17uM|Ki|=|0.17|uM|170|nM
1O3K|1.43|2003|334|redundant to 1o3j|P00760|TRYPSIN BETA|6.77|Ki=0.17uM|Ki|=|0.17|uM|170|nM
1ONY|2.15|2003|588||P18031|PROTEIN-TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1|6.77|Ki=0.17uM|Ki|=|0.17|uM|170|nM
1GZ3|2.30|2003|ATP|redundant to 1gz4|P23368|NAD-DEPENDENT MALIC ENZYME|3.7|Ki=0.20mM|Ki|=|0.2|mM|200000|nM
1O3P|1.81|2003|655||P00749|UROKINASE-TYPE PLASMINOGEN ACTIVATOR|6.66|Ki=0.22uM|Ki|=|0.22|uM|220|nM
1N7I|2.80|2003|LY1||P11086|PHENYLETHANOLAMINE N-METHYLTRANSFERASE|6.59|Ki=0.26uM|Ki|=|0.26|uM|260|nM
1O86|2.00|2003|LPR||P22966|ANGIOTENSIN-CONVERTING ENZYME|9.57|Ki=0.27nM|Ki|=|0.27|nM|0.27|nM
1N4H|2.10|2003|REA||P45446|NUCLEAR RECEPTOR ROR-BETA|6.55|Ki=0.28uM|Ki|=|0.28|uM|280|nM
1O3L|1.40|2003|678||P00760|TRYPSIN BETA|6.54|Ki=0.29uM|Ki|=|0.29|uM|290|nM
1NMS|1.70|2003|161|Ki for reversible ligand|P42574|CASPASE-3|6.7|Ki=0.2uM|Ki|=|0.2|uM|200|nM
1M2R|1.70|2003|MNY||P28523|CASEIN KINASE II, ALPHA SUBUNIT|6.46|Ki=0.35uM|Ki|=|0.35|uM|350|nM
1N7J|2.70|2003|IDI||P11086|PHENYLETHANOLAMINE N-METHYLTRANSFERASE|6.43|Ki=0.37uM|Ki|=|0.37|uM|370|nM
1NAX|2.70|2003|IH5|ligand is compound 8|P10828|THYROID HORMONE RECEPTOR BETA-1|6.43|Ki=0.37uM|Ki|=|0.37|uM|370|nM
1O2O|1.63|2003|950||P00760|TRYPSIN BETA|6.36|Ki=0.44uM|Ki|=|0.44|uM|440|nM
1PBQ|1.90|2003|DK1||P35439|N-METHYL-D-ASPARTATE RECEPTOR SUBUNIT 1|6.27|Ki=0.54uM|Ki|=|0.54|uM|540|nM
1OXQ|2.30|2003|9-mer|incomplete ligand structure|Q96CA5|BACULOVIRAL IAP REPEAT-CONTAINING PROTEIN 7|6.3|Ki=0.5uM|Ki|=|0.5|uM|500|nM
1IY7|2.00|2003|CXA||P00730|CARBOXYPEPTIDASE A|6.19|Ki=0.64uM|Ki|=|0.64|uM|640|nM
1O6I|1.70|2003|0HZ||P11797|CHITINASE B|3.19|Ki=0.65mM|Ki|=|0.65|mM|650000|nM
1K1Y|2.40|2003|ACR||O32462|4-ALPHA-GLUCANOTRANSFERASE|3.22|Ki=0.6mM|Ki|=|0.6|mM|600000|nM
1QWU|2.03|2003|GUL|covalent complex|Q24451|ALPHA-MANNOSIDASE II|3.22|Ki=0.6mM|Ki|=|0.6|mM|600000|nM
1NC1|2.00|2003|MTH||P24247|MTA/SAH NUCLEOSIDASE|6.12|Ki=0.75uM|Ki|=|0.75|uM|750|nM
1O2G|1.58|2003|696||P00734|THROMBIN|6.12|Ki=0.76uM|Ki|=|0.76|uM|760|nM
1M2P|2.00|2003|HNA||P28523|CASEIN KINASE II, ALPHA SUBUNIT|6.11|Ki=0.78uM|Ki|=|0.78|uM|780|nM
1O2Z|1.65|2003|312||P00760|TRYPSIN BETA|6.11|Ki=0.78uM|Ki|=|0.78|uM|780|nM
1M2Q|1.79|2003|MNX||P28523|CASEIN KINASE II, ALPHA SUBUNIT|6.1|Ki=0.80uM|Ki|=|0.8|uM|800|nM
1O2N|1.50|2003|762||P00760|TRYPSIN BETA|6.09|Ki=0.81uM|Ki|=|0.81|uM|810|nM
1NHZ|2.30|2003|486|ligand is RU486|P04150|GLUCOCORTICOID RECEPTOR|6.08|Ki=0.84uM|Ki|=|0.84|uM|840|nM
1PU7|1.93|2003|39A||O25323|3-METHYLADENINE DNA GLYCOSYLASE|3.1|Ki=0.8mM|Ki|=|0.8|mM|800000|nM
1PU8|2.13|2003|EA1||O25323|3-METHYLADENINE DNA GLYCOSYLASE|3.1|Ki=0.8mM|Ki|=|0.8|mM|800000|nM
1OS0|2.10|2003|0PQ||P00800|THERMOLYSIN|6.03|Ki=0.93uM|Ki|=|0.93|uM|930|nM
1K27|1.95|2003|MTM|Ki=26nM at initial rate; Ki=1.0nM at equilibrium|Q13126|5'-DEOXY-5'-METHYLTHIOADENOSINE PHOSPHORYLASE|9.0|Ki=1.0nM|Ki|=|1|nM|1|nM
1P6D|2.00|2003|3PC|X-ray(phospholipase C D55N) while Ki(wild type)|P09598|PHOSPHOLIPASE C|2.94|Ki=1.15mM|Ki|=|1.15|mM|1150000|nM
1J37|2.40|2003|X8Z||Q10714|ANGIOTENSIN-CONVERTING ENZYME|8.96|Ki=1.1nM|Ki|=|1.1|nM|1.1|nM
1NFW|2.10|2003|RRR||P00742|COAGULATION FACTOR XA|8.96|Ki=1.1nM|Ki|=|1.1|nM|1.1|nM
1NL9|2.40|2003|989||P18031|PROTEIN-TYROSINE PHOSPHATASE|5.96|Ki=1.1uM|Ki|=|1.1|uM|1100|nM
1O36|1.70|2003|607||P00760|TRYPSIN BETA|5.96|Ki=1.1uM|Ki|=|1.1|uM|1100|nM
1P6E|2.30|2003|PC5|X-ray(phospholipase C D55N) while Ki(wild type)|P09598|PHOSPHOLIPASE C|2.92|Ki=1.21mM|Ki|=|1.21|mM|1210000|nM
1MS0|2.50|2003|DAN|ligand is compound 1|Q26964|TRANS-SIALIDASE|2.91|Ki=1.23mM|Ki|=|1.23|mM|1230000|nM
1O0H|1.20|2003|ADP||P61823|RIBONUCLEASE A|5.92|Ki=1.2uM|Ki|=|1.2|uM|1200|nM
1N3I|1.90|2003|DIH|Ki*=42pM|P0A538|PURINE NUCLEOSIDE PHOSPHORYLASE|8.89|Ki=1.3nM|Ki|=|1.3|nM|1.3|nM
1NFY|2.10|2003|RTR||P00742|COAGULATION FACTOR XA|8.89|Ki=1.3nM|Ki|=|1.3|nM|1.3|nM
1NT1|2.00|2003|T76||P00734|THROMBIN|8.89|Ki=1.3nM|Ki|=|1.3|nM|1.3|nM
1NY0|1.75|2003|NBF|covalent complex|P62593|BETA-LACTAMASE TEM|5.85|Ki=1.4uM|Ki|=|1.4|uM|1400|nM
1O2U|1.41|2003|847|redundant to 1o2w|P00760|TRYPSIN BETA|5.85|Ki=1.4uM|Ki|=|1.4|uM|1400|nM
1O2V|1.50|2003|847|redundant to 1o2w|P00760|TRYPSIN BETA|5.85|Ki=1.4uM|Ki|=|1.4|uM|1400|nM
1O2W|1.38|2003|847||P00760|TRYPSIN BETA|5.85|Ki=1.4uM|Ki|=|1.4|uM|1400|nM
1O2X|1.46|2003|847|redundant to 1o2w|P00760|TRYPSIN BETA|5.85|Ki=1.4uM|Ki|=|1.4|uM|1400|nM
1O2Y|1.45|2003|847|redundant to 1o2w|P00760|TRYPSIN BETA|5.85|Ki=1.4uM|Ki|=|1.4|uM|1400|nM
1Q54|1.93|2003|BHI||Q46822|ISOPENTENYL-DIPHOSPHATE DELTA-ISOMERASE|5.85|Ki=1.4uM|Ki|=|1.4|uM|1400|nM
1NY2|2.30|2003|5-mer|incomplete ligand structure|P00734|THROMBIN|2.76|Ki=1.75mM|Ki|=|1.75|mM|1750000|nM
1LQ2|2.70|2003|IDD|Ki measured on barley beta-d-glucan glucohydrolase|Q9XEI3|BETA-D-GLUCAN GLUCOHYDROLASE ISOENZYME EXO1|8.77|Ki=1.7nM|Ki|=|1.7|nM|1.7|nM
1PXH|2.15|2003|SNA|incomplete ligand structure|P18031|PROTEIN-TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1|8.74|Ki=1.8nM|Ki|=|1.8|nM|1.8|nM
1O32|1.78|2003|801|redundant to 1o33|P00760|TRYPSIN BETA|5.74|Ki=1.8uM|Ki|=|1.8|uM|1800|nM
1O33|1.46|2003|801||P00760|TRYPSIN BETA|5.74|Ki=1.8uM|Ki|=|1.8|uM|1800|nM
1O34|1.50|2003|801|redundant to 1o33|P00760|TRYPSIN BETA|5.74|Ki=1.8uM|Ki|=|1.8|uM|1800|nM
1MF4|1.90|2003|5-mer||P60045|PHOSPHOLIPASE A2|7.99|Ki=10.2nM|Ki|=|10.2|nM|10.2|nM
1P0Y|2.55|2003|MLZ||Q43088|RIBULOSE-1,5 BISPHOSPHATE CARBOXYLASE/OXYGENASE|1.0|Ki=100.8mM|Ki|=|100.8|mM|100800000|nM
1NU3|1.75|2003|VPR||Q9ZAG3|LIMONENE-1,2-EPOXIDE HYDROLASE|4.0|Ki=100uM|Ki|=|100|uM|100000|nM
1MY4|1.90|2003|IWD|ligand is compound (S)-2e|P19491|GLUTAMATE RECEPTOR 2|6.98|Ki=105nM|Ki|=|105|nM|105|nM
1NC6|1.90|2003|ABB|covalent complex|P00760|TRYPSINOGEN|8.0|Ki=10nM|Ki|=|10|nM|10|nM
1KR3|2.50|2003|113|redundant to 1hlk|P25910|BETA-LACTAMASE TYPE II|5.0|Ki=10uM|Ki|=|10|uM|10000|nM
1NC3|2.20|2003|FMC||P24247|MTA/SAH NUCLEOSIDASE|5.0|Ki=10uM|Ki|=|10|uM|10000|nM
1O35|1.41|2003|802||P00760|TRYPSIN BETA|5.0|Ki=10uM|Ki|=|10|uM|10000|nM
1JN4|1.80|2003|139||P61823|RIBONUCLEASE A|4.95|Ki=11.3uM|Ki|=|11.3|uM|11300|nM
1OYQ|1.90|2003|T87||P00760|TRYPSIN|6.96|Ki=110nM|Ki|=|110|nM|110|nM
1MRS|2.00|2003|5HU||O05891|THYMIDYLATE KINASE|3.96|Ki=110uM|Ki|=|110|uM|110000|nM
1NDV|2.30|2003|FR0||P56658|ADENOSINE DEAMINASE|5.92|Ki=1200nM|Ki|=|1200|nM|1200|nM
1PH0|2.20|2003|418|incomplete ligand structure|P18031|PROTEIN-TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1|6.92|Ki=120nM|Ki|=|120|nM|120|nM
1PR5|2.50|2003|TBN||P09743|PURINE NUCLEOSIDE PHOSPHORYLASE|3.92|Ki=120uM|Ki|=|120|uM|120000|nM
1NPZ|2.00|2003|C1P|covalent complex|P25774|CATHEPSIN S|7.89|Ki=13nM|Ki|=|13|nM|13|nM
1NHW|2.35|2003|TCC|Ki=14.3uM pfENR with Triclosan Analogs 1|Q9BH77|ENOYL-ACYL CARRIER REDUCTASE|4.84|Ki=14.3uM|Ki|=|14.3|uM|14300|nM
1N1T|1.60|2003|DAN||O44049|NEURAMINIDASE (SIALIDASE)|3.85|Ki=140uM|Ki|=|140|uM|140000|nM
1N1V|2.10|2003|DAN|redundant to 1n1t|O44049|SIALIDASE|3.85|Ki=140uM|Ki|=|140|uM|140000|nM
1N51|2.30|2003|4-mer||P15034|XAA-PRO AMINOPEPTIDASE|4.85|Ki=14uM|Ki|=|14|uM|14000|nM
1O2P|1.47|2003|972|Ki measured on human trypsin|P00760|TRYPSIN BETA|4.85|Ki=14uM|Ki|=|14|uM|14000|nM
1LQE|2.20|2003|IMA|incomplete ligand structure|P00760|TRYPSIN|5.82|Ki=1507nM|Ki|=|1507|nM|1507|nM
1NJS|1.98|2003|KEU||P22102|PHOSPHORIBOSYL GLYCINAMIDE FORMYLTRANSFERASE|7.82|Ki=15nM|Ki|=|15|nM|15|nM
1NVS|1.80|2003|UCM||O14757|SERINE/THREONINE-PROTEIN KINASE CHK1|7.82|Ki=15nM|Ki|=|15|nM|15|nM
1OSS|1.93|2003|BEN||P00775|TRYPSIN|4.79|Ki=16.4uM|Ki|=|16.4|uM|16400|nM
1MY2|1.80|2003|AMQ|ligand is compound 2, AMPA, data from ref.25|P19491|GLUTAMATE RECEPTOR 2|7.77|Ki=17nM|Ki|=|17|nM|17|nM
1J36|2.40|2003|LPR||Q10714|ANGIOTENSIN-CONVERTING ENZYME|7.74|Ki=18nM|Ki|=|18|nM|18|nM
1NFU|2.05|2003|RRP||P00742|COAGULATION FACTOR XA|7.74|Ki=18nM|Ki|=|18|nM|18|nM
1MCZ|2.80|2003|RMN||P20906|BENZOYLFORMATE DECARBOXYLASE|3.0|Ki=1mM|Ki|=|1|mM|1000000|nM
1MQ5|2.10|2003|XLC||P00742|COAGULATION FACTOR X|9.0|Ki=1nM|Ki|=|1|nM|1|nM
1MXO|1.83|2003|SM2|covalent complex|P00811|BETA-LACTAMASE|9.0|Ki=1nM|Ki|=|1|nM|1|nM
1LF9|2.20|2003|ACR||O85672|GLUCOAMYLASE|12.0|Ki=1pM|Ki|=|1|pM|0.001|nM
1O8B|1.25|2003|ABF||P0A7Z0|RIBOSE-5-PHOSPHATE ISOMERASE|2.68|Ki=2.1mM|Ki|=|2.1|mM|2100000|nM
1OXN|2.20|2003|9-mer|incomplete ligand structure|Q96CA5|BACULOVIRAL IAP REPEAT-CONTAINING PROTEIN 7|5.68|Ki=2.1uM|Ki|=|2.1|uM|2100|nM
1N5R|2.25|2003|PRM||P21836|ACETYLCHOLINESTERASE|5.66|Ki=2.2uM|Ki|=|2.2|uM|2200|nM
1NHU|2.00|2003|153||P26663|RNA-DIRECTED RNA POLYMERASE|5.66|Ki=2.2uM|Ki|=|2.2|uM|2200|nM
1NHV|2.90|2003|154||P26663|HCV NS5B RNA-DEPENDENT RNA POLYMERASE|5.66|Ki=2.2uM|Ki|=|2.2|uM|2200|nM
1LRT|2.20|2003|TAD||P50097|INOSINE-5'-MONOPHOSPHATE DEHYDROGENASE|5.64|Ki=2.3uM|Ki|=|2.3|uM|2300|nM
1H0R|2.10|2003|FA1|ligand is compound 3a|P36918|3-DEHYDROQUINATE DEHYDRATASE|3.7|Ki=200uM|Ki|=|200|uM|200000|nM
1NYY|1.90|2003|105|covalent complex|P62593|BETA-LACTAMASE TEM|4.68|Ki=21uM|Ki|=|21|uM|21000|nM
1NNY|2.40|2003|515||P18031|PROTEIN-TYROSINE PHOSPHATASE 1B|7.66|Ki=22nM|Ki|=|22|nM|22|nM
1OWK|2.80|2003|303||P00749|UROKINASE-TYPE PLASMINOGEN ACTIVATOR|7.63|Ki=23.5nM|Ki|=|23.5|nM|23.5|nM
1PB9|1.60|2003|4AX||P35439|N-METHYL-D-ASPARTATE RECEPTOR SUBUNIT 1|3.62|Ki=241uM|Ki|=|241|uM|241000|nM
1NO9|1.90|2003|4ND|covalent complex|P00734|THROMBIN ALPHA|7.62|Ki=24nM|Ki|=|24|nM|24|nM
1ORW|2.84|2003|2-mer|covalent complex|P22411|DIPEPTIDYL PEPTIDASE 4|7.6|Ki=25.1nM|Ki|=|25.1|nM|25.1|nM
1LPZ|2.40|2003|CMB||P00742|COAGULATION FACTOR XA|7.6|Ki=25nM|Ki|=|25|nM|25|nM
1NJ1|2.55|2003|5CA||O26708|PROLINE-TRNA SYNTHETASE|7.6|Ki=25nM|Ki|=|25|nM|25|nM
1PCG|2.70|2003|9-mer|Ki for ligand in cyclized form|P03372|ESTROGEN RECEPTOR|7.6|Ki=25nM|Ki|=|25|nM|25|nM
1PA9|2.00|2003|CSN||P15273|PROTEIN-TYROSINE PHOSPHATASE YOPH|4.6|Ki=25uM|Ki|=|25|uM|25000|nM
1H46|1.52|2003|RNP||Q09431|CELLULASE|3.57|Ki=270uM|Ki|=|270|uM|270000|nM
1NP0|2.50|2003|NGT|ligand is compound 1a (NAG-thiazoline)|P07686|BETA-HEXOSAMINIDASE BETA CHAIN|3.57|Ki=270uM|Ki|=|270|uM|270000|nM
1OWI|2.93|2003|426||P00749|UROKINASE-TYPE PLASMINOGEN ACTIVATOR|7.55|Ki=28.0nM|Ki|=|28|nM|28|nM
1LPK|2.20|2003|CBB||P00742|COAGULATION FACTOR XA|7.55|Ki=28nM|Ki|=|28|nM|28|nM
1I5R|1.60|2003|HYC||P14061|TYPE 1 17 BETA-HYDROXYSTEROID DEHYDROGENASE|8.52|Ki=3.0nM|Ki|=|3|nM|3|nM
1NFX|2.15|2003|RDR||P00742|COAGULATION FACTOR XA|8.52|Ki=3.0nM|Ki|=|3|nM|3|nM
1PYN|2.20|2003|941||P18031|PROTEIN-TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1|5.49|Ki=3.2uM|Ki|=|3.2|uM|3200|nM
1O2S|1.65|2003|CR4|redundant to 1gi1|P00760|TRYPSIN BETA|5.47|Ki=3.4uM|Ki|=|3.4|uM|3400|nM
1PQ3|2.70|2003|S2C||P78540|ARGINASE-2, MITOCHONDRIAL PRECURSOR|7.52|Ki=30nM|Ki|=|30|nM|30|nM
1MRN|2.45|2003|T5A||O05891|THYMIDYLATE KINASE|4.52|Ki=30uM|Ki|=|30|uM|30000|nM
1MY8|1.72|2003|SM3|covalent complex|P00811|BETA-LACTAMASE|7.46|Ki=35nM|Ki|=|35|nM|35|nM
1OZV|2.65|2003|LYS||Q43088|RIBULOSE-1,5 BISPHOSPHATE CARBOXYLASE/OXYGENASE|1.44|Ki=36.6mM|Ki|=|36.6|mM|36600000|nM
1NO6|2.40|2003|794||P18031|PROTEIN-TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1|4.41|Ki=39uM|Ki|=|39|uM|39000|nM
1NYM|1.20|2003|CXB|covalent complex|P62593|BETA-LACTAMASE TEM|5.4|Ki=4.0uM|Ki|=|4|uM|4000|nM
1NWL|2.40|2003|964||P18031|PROTEIN-TYROSINE PHOSPHATASE 1B|2.39|Ki=4.1mM|Ki|=|4.1|mM|4099999.9999999995|nM
1LZQ|2.20|2003|0ZQ||P03367|HIV-1 PROTEASE|8.39|Ki=4.1nM|Ki|=|4.1|nM|4.1|nM
1OY7|2.70|2003|9-mer|incomplete ligand structure|Q96CA5|BACULOVIRAL IAP REPEAT-CONTAINING PROTEIN 7|5.36|Ki=4.4uM|Ki|=|4.4|uM|4400|nM
1NL6|2.80|2003|750|covalent complex|P43235|CATHEPSIN K|11.32|Ki=4.8pM|Ki|=|4.8|pM|0.0048|nM
1JT1|1.78|2003|MCO||Q9K578|METALLO-BETA-LACTAMASE CLASS B3|3.4|Ki=400uM|Ki|=|400|uM|400000|nM
1OWH|1.61|2003|239||P00749|UROKINASE-TYPE PLASMINOGEN ACTIVATOR|7.4|Ki=40nM|Ki|=|40|nM|40|nM
1OCN|1.31|2003|2-mer|X-ray(CEL6A D416A) while Ki(CEL6A wild type)|Q9C1S9|CELLOBIOHYDROLASE II|6.39|Ki=412nM|Ki|=|412|nM|412|nM
1OWJ|3.10|2003|155||P00749|UROKINASE-TYPE PLASMINOGEN ACTIVATOR|7.32|Ki=48.0nM|Ki|=|48|nM|48|nM
1O1S|2.30|2003|1NH||Q04631|FARNESYLTRANSFERASE ALPHA SUBUNIT|7.31|Ki=49nM|Ki|=|49|nM|49|nM
1PS3|1.80|2003|KIF||Q24451|ALPHA-MANNOSIDASE II|2.28|Ki=5.2mM|Ki|=|5.2|mM|5200000|nM
1NVQ|2.00|2003|UCN||O14757|SERINE/THREONINE-PROTEIN KINASE CHK1|8.25|Ki=5.6nM|Ki|=|5.6|nM|5.6|nM
1NJ5|2.80|2003|P5A||O26708|PROLINE-TRNA SYNTHETASE|7.3|Ki=50nM|Ki|=|50|nM|50|nM
1NQC|1.80|2003|C4P|covalent complex|P25774|CATHEPSIN S|7.3|Ki=50nM|Ki|=|50|nM|50|nM
1NDW|2.00|2003|FR2||P56658|ADENOSINE DEAMINASE|5.23|Ki=5900nM|Ki|=|5900|nM|5900|nM
1O0F|1.50|2003|A3P||P61823|RIBONUCLEASE|5.3|Ki=5uM|Ki|=|5|uM|5000|nM
1PR1|2.30|2003|FMB|redundant to 1a69|P09743|PURINE NUCLEOSIDE PHOSPHORYLASE|5.3|Ki=5uM|Ki|=|5|uM|5000|nM
1H1D|2.00|2003|BIA||P22734|CATECHOL O-METHYLTRANSFERASE|8.22|Ki=6.0nM|Ki|=|6|nM|6|nM
1O2R|1.45|2003|CR9||P00760|TRYPSIN BETA|5.21|Ki=6.1uM|Ki|=|6.1|uM|6100|nM
1OWD|2.32|2003|497||P00749|UROKINASE-TYPE PLASMINOGEN ACTIVATOR|8.2|Ki=6.3nM|Ki|=|6.3|nM|6.3|nM
1OCQ|1.08|2003|IFM-BGC||O85465|ENDOGLUCANASE 5A|5.19|Ki=6.5uM|Ki|=|6.5|uM|6500|nM
1Q1M|2.60|2003|234||P18031|PROTEIN-TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1|5.16|Ki=6.9uM|Ki|=|6.9|uM|6900|nM
1N3Z|1.65|2003|U3P|Ki measured at pH=6.0; redundant to 3djp|P00669|SEMINAL RIBONUCLEASE|4.2|Ki=63.2uM|Ki|=|63.2|uM|63200|nM
1OWE|1.60|2003|675||P00749|UROKINASE-TYPE PLASMINOGEN ACTIVATOR|6.2|Ki=631nM|Ki|=|631|nM|631|nM
1NXY|1.60|2003|SM2|covalent complex|P62593|BETA-LACTAMASE TEM|7.19|Ki=64nM|Ki|=|64|nM|64|nM
1ME7|2.15|2003|RVP||P50097|INOSINE-5'-MONOPHOSPHATE DEHYDROGENASE|7.19|Ki=65nM|Ki|=|65|nM|65|nM
1ME8|1.90|2003|RVP||P50097|INOSINE-5'-MONOPHOSPHATE DEHYDROGENASE|7.19|Ki=65nM|Ki|=|65|nM|65|nM
1NDY|2.00|2003|FR3||P56658|ADENOSINE DEAMINASE|6.17|Ki=680nM|Ki|=|680|nM|680|nM
1PB8|1.45|2003|DSN||P35439|N-METHYL-D-ASPARTATE RECEPTOR SUBUNIT 1|5.15|Ki=7.02uM|Ki|=|7.02|uM|7020|nM
1O0M|1.50|2003|U2P||P61823|RIBONUCLEASE|5.15|Ki=7.1uM|Ki|=|7.1|uM|7100|nM
1P2G|2.30|2003|8-mer||P00489|GLYCOGEN PHOSPHORYLASE|2.13|Ki=7.4mM|Ki|=|7.4|mM|7400000|nM
1QX1|1.30|2003|FMF|covalent complex|Q24451|ALPHA-MANNOSIDASE II|2.12|Ki=7.5mM|Ki|=|7.5|mM|7500000|nM
1NDZ|2.00|2003|FR5||P56658|ADENOSINE DEAMINASE|8.11|Ki=7.7nM|Ki|=|7.7|nM|7.7|nM
1NVR|1.80|2003|STU||O14757|SERINE/THREONINE-PROTEIN KINASE CHK1|8.11|Ki=7.8nM|Ki|=|7.8|nM|7.8|nM
1M2X|1.50|2003|MCO|Ki=70~100uM|O08498|CLASS B CARBAPENEMASE BLAB-1|4.15|Ki=70uM|Ki|=|70|uM|70000|nM
1MQ6|2.10|2003|XLD||P00742|COAGULATION FACTOR XA|11.15|Ki=7pM|Ki|=|7|pM|0.007|nM
1LPG|2.00|2003|IMA||P00742|COAGULATION FACTOR XA|7.09|Ki=82nM|Ki|=|82|nM|82|nM
1O0N|1.50|2003|U3P||P61823|RIBONUCLEASE|4.09|Ki=82uM|Ki|=|82|uM|82000|nM
1N2V|2.10|2003|BDI|redundant to 2z1w|P28720|QUEUINE TRNA-RIBOSYLTRANSFERASE|4.08|Ki=83uM|Ki|=|83|uM|83000|nM
1UI0|1.50|2003|URA||Q7WYV4|URACIL-DNA GLYCOSYLASE|7.06|Ki=88nM|Ki|=|88|nM|88|nM
1NJJ|2.45|2003|GET||Q9TZZ6|ORNITHINE DECARBOXYLASE|2.1|Ki=8mM|Ki|=|8|mM|8000000|nM
1O0O|1.20|2003|A2P||P61823|RIBONUCLEASE|5.1|Ki=8uM|Ki|=|8|uM|8000|nM
1OD8|1.05|2003|XDL-XYP||P26514|ENDO-1,4-BETA-XYLANASE A|5.1|Ki=8uM|Ki|=|8|uM|8000|nM
1QXK|2.30|2003|429||P18031|PROTEIN-TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1|5.05|Ki=9.0uM|Ki|=|9|uM|9000|nM
1LQD|2.70|2003|CMI||P00742|COAGULATION FACTOR XA|8.05|Ki=9nM|Ki|=|9|nM|9|nM
1MX1|2.40|2003|THA||P23141|LIVER CARBOXYLESTERASE I|4.0|Ki>100uM|Ki|>|100|uM|100000|nM
1URW|1.60|2004|I1P||P24941|CELL DIVISION PROTEIN KINASE 2|8.52|IC<0.003uM|IC50|<|0.003|uM|3|nM
1SQI|2.15|2004|869||P32755|4-HYDROXYPHENYLPYRUVIC ACID DIOXYGENASE|7.7|IC<20nM|IC50|<|20|nM|20|nM
1S17|1.95|2004|GNR|IC50 for GNR/PDF-Ni|Q9I7A8|PEPTIDE DEFORMYLASE|8.3|IC<5nM|IC50|<|5|nM|5|nM
1UV5|2.80|2004|BRW|IC50 measured on gsk-3 a/b|P49841|GLYCOGEN SYNTHASE KINASE-3 BETA|8.3|IC=0.005uM|IC50|=|0.005|uM|5|nM
1XOM|1.55|2004|CIO||Q08499|CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D|7.96|IC=0.011uM|IC50|=|0.011|uM|11|nM
1XBC|2.00|2004|STU||P43405|TYROSINE-PROTEIN KINASE SYK|7.92|IC=0.012uM|IC50|=|0.012|uM|12|nM
1VJB|3.20|2004|OHT|ligand is compound 1, (4-OHT)|P62509|ESTROGEN-RELATED RECEPTOR GAMMA|7.89|IC=0.013uM|IC50|=|0.013|uM|13|nM
1XON|1.72|2004|PIL||Q08499|CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D|10.68|IC=0.021nM|IC50|=|0.021|nM|0.021|nM
1VJY|2.00|2004|460||P36897|TGF-BETA RECEPTOR TYPE-1|7.64|IC=0.023uM|IC50|=|0.023|uM|23|nM
1XLX|2.19|2004|CIO||Q07343|CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B|7.6|IC=0.025uM|IC50|=|0.025|uM|25|nM
1Q1Y|1.90|2004|BB2|ligand is actinonin, a hydroxamate peptidic compound, as a positive control was IC50=0.02uM|P68826|PEPTIDE DEFORMYLASE|7.7|IC=0.02uM|IC50|=|0.02|uM|20|nM
1R5G|2.00|2004|AO1||P50579|METHIONINE AMINOPEPTIDASE 2|7.52|IC=0.03uM|IC50|=|0.03|uM|30|nM
1XM4|2.31|2004|PIL||Q07343|CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B|10.39|IC=0.041nM|IC50|=|0.041|nM|0.041|nM
1XDG|2.10|2004|AB8||P20701|INTEGRIN ALPHA-L|7.3|IC=0.05uM|IC50|=|0.05|uM|50|nM
1RS4|2.70|2004|45P||P56740|DIHYDRONEOPTERIN ALDOLASE|7.17|IC=0.068uM|IC50|=|0.068|uM|68|nM
1PY2|2.80|2004|FRH||P60568|INTERLEUKIN-2|7.22|IC=0.06uM|IC50|=|0.06|uM|60|nM
1UNH|2.35|2004|IXM||Q00535|CYCLIN-DEPENDENT KINASE 5|7.0|IC=0.10uM|IC50|=|0.1|uM|100|nM
1R58|1.90|2004|AO5||P50579|METHIONINE AMINOPEPTIDASE 2|6.96|IC=0.11uM|IC50|=|0.11|uM|110|nM
1VJ5|2.35|2004|CIU||P34913|EPOXIDE HYDROLASE 2|6.92|IC=0.12uM|IC50|=|0.12|uM|120|nM
1V0P|2.00|2004|PVB||Q07785|CELL DIVISION CONTROL PROTEIN 2 HOMOLOG|6.89|IC=0.13uM|IC50|=|0.13|uM|130|nM
1RV1|2.30|2004|IMZ||Q00987|E3 UBIQUITIN-PROTEIN LIGASE MDM2|6.85|IC=0.14uM|IC50|=|0.14|uM|140|nM
1UNG|2.30|2004|ALH|IC50=0.16-0.20uM|Q00535|CYCLIN-DEPENDENT KINASE 5|6.8|IC=0.16uM|IC50|=|0.16|uM|160|nM
1R5H|2.40|2004|AO2||P50579|METHIONINE AMINOPEPTIDASE 2|6.74|IC=0.18uM|IC50|=|0.18|uM|180|nM
1RWQ|2.20|2004|5AP||P27487|DIPEPTIDYL PEPTIDASE 4|10.0|IC=0.1nM|IC50|=|0.1|nM|0.1|nM
1UNL|2.20|2004|RRC|ligand is (R)-roscovitine|Q00535|CYCLIN-DEPENDENT KINASE 5|6.7|IC=0.20uM|IC50|=|0.2|uM|200|nM
1OIU|2.00|2004|N76||P24941|CELL DIVISION PROTEIN KINASE 2|6.68|IC=0.21uM|IC50|=|0.21|uM|210|nM
1TKZ|2.81|2004|H16||P04585|HIV-1 REVERSE TRANSCRIPTASE, CHAIN A|6.62|IC=0.24uM|IC50|=|0.24|uM|240|nM
1XNZ|1.52|2004|FCD||P07906|METHIONINE AMINOPEPTIDASE|6.62|IC=0.24uM|IC50|=|0.24|uM|240|nM
1O45|1.80|2004|687|covalent complex|P12931|TYROSINE-PROTEIN KINASE SRC|9.6|IC=0.25nM|IC50|=|0.25|nM|0.25|nM
1SNK|2.40|2004|MYE|covalent complex|P43235|CATHEPSIN K|9.6|IC=0.25nM|IC50|=|0.25|nM|0.25|nM
1SO2|2.40|2004|666||Q13370|CGMP-INHIBITED 3',5'-CYCLIC PHOSPHODIESTERASE B|9.57|IC=0.27nM|IC50|=|0.27|nM|0.27|nM
1XDD|2.20|2004|AAY||P20701|INTEGRIN ALPHA-L|6.7|IC=0.2uM|IC50|=|0.2|uM|200|nM
1RSD|2.50|2004|PSB||P56740|DIHYDRONEOPTERIN ALDOLASE|6.52|IC=0.30uM|IC50|=|0.3|uM|300|nM
1PZJ|1.46|2004|15B||Q57193|CHOLERA ENTEROTOXIN SUBUNIT B|3.49|IC=0.32mM|IC50|=|0.32|mM|320000|nM
1T46|1.60|2004|STI|ligand is compound imatinib|P10721|HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE|6.43|IC=0.37uM|IC50|=|0.37|uM|370|nM
1TL1|2.90|2004|H18||P04585|HIV-1 REVERSE TRANSCRIPTASE, CHAIN A|6.42|IC=0.38uM|IC50|=|0.38|uM|380|nM
1XOR|1.54|2004|ZAR||Q08499|CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D|6.41|IC=0.39uM|IC50|=|0.39|uM|390|nM
1O4D|1.85|2004|262|covalent complex|P12931|TYROSINE-PROTEIN KINASE SRC|3.52|IC=0.3mM|IC50|=|0.3|mM|300000|nM
1O4F|2.00|2004|790||P12931|TYROSINE-PROTEIN KINASE SRC|3.52|IC=0.3mM|IC50|=|0.3|mM|300000|nM
1XM6|1.92|2004|5RM||Q07343|CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B|6.38|IC=0.42uM|IC50|=|0.42|uM|420|nM
1XP6|1.70|2004|AIU||P03372|ESTROGEN RECEPTOR|9.4|IC=0.4nM|IC50|=|0.4|nM|0.4|nM
1TOW|2.00|2004|CRZ||P15090|FATTY ACID-BINDING PROTEIN, ADIPOCYTE|6.24|IC=0.57uM|IC50|=|0.57|uM|570|nM
1XN0|2.31|2004|ROL|racemic ligand|Q07343|CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B|6.24|IC=0.57uM|IC50|=|0.57|uM|570|nM
1O4E|2.00|2004|299|covalent complex|P12931|TYROSINE-PROTEIN KINASE SRC|3.3|IC=0.5mM|IC50|=|0.5|mM|500000|nM
1XP1|1.80|2004|AIH||P03372|ESTROGEN RECEPTOR|9.3|IC=0.5nM|IC50|=|0.5|nM|0.5|nM
1TL3|2.80|2004|H20||P04585|HIV-1 REVERSE TRANSCRIPTASE, CHAIN A|6.2|IC=0.63uM|IC50|=|0.63|uM|630|nM
1X81|3.50|2004|JAN||Q04631|GERANYL-GERANYLTRANSFERASE ALPHA SUBUNIT|9.19|IC=0.65nM|IC50|=|0.65|nM|0.65|nM
1XOQ|1.83|2004|ROF||Q08499|CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D|9.17|IC=0.68nM|IC50|=|0.68|nM|0.68|nM
1TKT|2.60|2004|H12||P04585|HIV-1 REVERSE TRANSCRIPTASE, CHAIN A|6.15|IC=0.71uM|IC50|=|0.71|uM|710|nM
1UU3|1.70|2004|LY4||O15530|3-PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE 1|6.12|IC=0.75uM|IC50|=|0.75|uM|750|nM
1RHK|2.50|2004|6-mer|covalent complex|P42574|CASPASE-3|9.11|IC=0.771nM|IC50|=|0.771|nM|0.771|nM
1TU6|1.75|2004|FSP|covalent complex|P43235|CATHEPSIN K|9.08|IC=0.83nM|IC50|=|0.83|nM|0.83|nM
1XMU|2.30|2004|ROF||Q07343|CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B|9.08|IC=0.84nM|IC50|=|0.84|nM|0.84|nM
1SJ0|1.90|2004|E4D||P03372|ESTROGEN RECEPTOR|9.1|IC=0.8nM|IC50|=|0.8|nM|0.8|nM
1NI1|2.30|2004|2C5||Q04631|FARNESYLTRANSFERASE ALPHA SUBUNIT|9.05|IC=0.90nM|IC50|=|0.9|nM|0.9|nM
1XLZ|2.06|2004|FIL||Q07343|CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B|6.02|IC=0.96uM|IC50|=|0.96|uM|960|nM
1O41|1.70|2004|300|covalent complex|P12931|TYROSINE-PROTEIN KINASE SRC|3.05|IC=0.9mM|IC50|=|0.9|mM|900000|nM
1PUM|2.30|2004|GLB||P81446|LECTIN I A CHAIN|3.05|IC=0.9mM|IC50|=|0.9|mM|900000|nM
1XP0|1.79|2004|VDN||O76074|CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE|9.0|IC=1.0nM|IC50|=|1|nM|1|nM
1UZE|1.82|2004|EAL|ligand is compound 12d, IC50 ref 20. -logIC50=8.4-9.4, +/-0.5 unit|P22966|ANGIOTENSIN-CONVERTING ENZYME|8.9|IC=1.27nM|IC50|=|1.27|nM|1.27|nM
1O4K|1.57|2004|PSN|covalent complex|P12931|TYROSINE-PROTEIN KINASE SRC|2.92|IC=1.2mM|IC50|=|1.2|mM|1200000|nM
1XOZ|1.37|2004|CIA||O76074|CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE|8.92|IC=1.2nM|IC50|=|1.2|nM|1.2|nM
1XP9|1.80|2004|AIJ||P03372|ESTROGEN RECEPTOR|8.89|IC=1.3nM|IC50|=|1.3|nM|1.3|nM
1TQF|1.80|2004|32P||P56817|BETA-SECRETASE 1|5.85|IC=1.4uM|IC50|=|1.4|uM|1400|nM
1UTZ|2.50|2004|PF3|IC50=1.4uM (no AH); IC50=14nM (with AH)|P39900|MACROPHAGE METALLOELASTASE|5.85|IC=1.4uM|IC50|=|1.4|uM|1400|nM
1RRI|2.00|2004|A45||P56740|DIHYDRONEOPTERIN ALDOLASE|5.82|IC=1.5uM|IC50|=|1.5|uM|1500|nM
1ROS|2.00|2004|DEO||P39900|MACROPHAGE METALLOELASTASE|8.77|IC=1.7nM|IC50|=|1.7|nM|1.7|nM
1XPC|1.60|2004|AIT||P03372|ESTROGEN RECEPTOR|8.77|IC=1.7nM|IC50|=|1.7|nM|1.7|nM
1HKM|2.55|2004|3-mer||Q13231|CHITOTRIOSIDASE-1|8.72|IC=1.9nM|IC50|=|1.9|nM|1.9|nM
1S9V|2.22|2004|11-mer|HLA-DQ2 complexed with deamidated gliadin peptide, IC50=100uM|P01909|HLA CLASS II HISTOCOMPATIBILITY ANTIGEN, DQ(3)|4.0|IC=100uM|IC50|=|100|uM|100000|nM
1TLO|1.90|2004|E64|covalent complex|P97571|CALPAIN-1, CATALYTIC SUBUNIT|4.0|IC=100uM|IC50|=|100|uM|100000|nM
1O46|2.00|2004|903||P12931|TYROSINE-PROTEIN KINASE SRC|8.0|IC=10nM|IC50|=|10|nM|10|nM
1SQB|2.69|2004|AZO|azoxystrobin, AZ to bovine bc1 IC50=11.2nM, yeast bc1 IC50=251nM|P31800|UBIQUINOL-CYTOCHROME-C REDUCTASE COMPLEX CORE|7.95|IC=11.2nM|IC50|=|11.2|nM|11.2|nM
1O4A|1.50|2004|197|covalent complex|P12931|TYROSINE-PROTEIN KINASE SRC|6.92|IC=120nM|IC50|=|120|nM|120|nM
1TG5|1.90|2004|645||P93836|4-HYDROXYPHENYLPYRUVATE DIOXYGENASE|7.92|IC=12nM|IC50|=|12|nM|12|nM
1WDY|1.80|2004|25A||Q05823|2-5A-DEPENDENT RIBONUCLEASE|7.89|IC=13nM|IC50|=|13|nM|13|nM
1UYH|2.20|2004|PU0|IC50 measured on full length yeast HSP90-alpha|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|4.84|IC=14.3uM|IC50|=|14.3|uM|14300|nM
1UU7|1.90|2004|BI2||O15530|3-PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE 1|4.85|IC=14uM|IC50|=|14|uM|14000|nM
1UY9|2.00|2004|PU6|IC50 measured on full length yeast HSP90-alpha|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|4.82|IC=15.3uM|IC50|=|15.3|uM|15300|nM
1QXY|1.04|2004|M2C||P0A080|METHIONYL AMINOPEPTIDASE|4.8|IC=16uM|IC50|=|16|uM|16000|nM
1UYK|2.00|2004|PUX|IC50 measured on full length yeast HSP90-alpha|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|4.77|IC=17.1uM|IC50|=|17.1|uM|17100|nM
1RHQ|3.00|2004|0ZZ|covalent complex|P42574|CASPASE-3|7.75|IC=17.7nM|IC50|=|17.7|nM|17.7|nM
1RHM|2.50|2004|NA4|covalent complex|P42574|CASPASE-3|5.76|IC=1735nM|IC50|=|1735|nM|1735|nM
1W22|2.50|2004|NHB||Q9BY41|HISTONE DEACETYLASE 8|6.76|IC=175.5nM|IC50|=|175.5|nM|175.5|nM
1QXZ|1.68|2004|M3C||P0A080|METHIONYL AMINOPEPTIDASE|4.72|IC=19uM|IC50|=|19|uM|19000|nM
1TOU|2.00|2004|B1V||P15090|FATTY ACID-BINDING PROTEIN, ADIPOCYTE|6.0|IC=1uM|IC50|=|1|uM|1000|nM
1UVR|2.81|2004|BI8||O15530|3-PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE 1|6.0|IC=1uM|IC50|=|1|uM|1000|nM
1NPA|2.00|2004|3NH||P03368|POL POLYPROTEIN|8.7|IC=2.0nM|IC50|=|2|nM|2|nM
1TVE|3.00|2004|178||P31116|HOMOSERINE DEHYDROGENASE|5.68|IC=2.1uM|IC50|=|2.1|uM|2100|nM
1O43|1.50|2004|821|covalent complex|P12931|TYROSINE-PROTEIN KINASE SRC|5.66|IC=2.2uM|IC50|=|2.2|uM|2200|nM
1O4I|1.75|2004|219|covalent complex|P12931|TYROSINE-PROTEIN KINASE SRC|2.64|IC=2.3mM|IC50|=|2.3|mM|2300000|nM
1O4P|1.90|2004|791||P12931|TYROSINE-PROTEIN KINASE SRC|2.6|IC=2.5mM|IC50|=|2.5|mM|2500000|nM
1HKJ|2.60|2004|3-mer||Q13231|CHITOTRIOSIDASE-1|8.59|IC=2.6nM|IC50|=|2.6|nM|2.6|nM
1RTL|2.75|2004|CPX|covalent complex|Q91RS4|NS3 PROTEASE/HELICASE|5.59|IC=2.6uM|IC50|=|2.6|uM|2600|nM
1SZM|2.50|2004|BI2||P00517|CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTIC|5.53|IC=2.94uM|IC50|=|2.94|uM|2940|nM
1XOS|2.28|2004|VIA||Q07343|CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B|4.7|IC=20uM|IC50|=|20|uM|20000|nM
1OQ5|1.50|2004|CEL||P00918|CARBONIC ANHYDRASE 2|7.68|IC=21nM|IC50|=|21|nM|21|nM
1UWH|2.95|2004|BAX|ligand is Sorafenib|P15056|B-RAF PROTO-ONCOGENE SERINE/THREONINE-PROTEIN KINASE|7.66|IC=22nM|IC50|=|22|nM|22|nM
1T49|1.90|2004|892||P18031|PROTEIN-TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1|4.66|IC=22uM|IC50|=|22|uM|22000|nM
1SOJ|2.90|2004|IBM||Q13370|CGMP-INHIBITED 3',5'-CYCLIC PHOSPHODIESTERASE B|6.62|IC=242nM|IC50|=|242|nM|242|nM
1V3X|2.20|2004|D76||P00742|COAGULATION FACTOR X (HEAVY CHAIN)|7.62|IC=24nM|IC50|=|24|nM|24|nM
1Q6K|2.10|2004|TCO|covalent complex|P43235|CATHEPSIN K|7.59|IC=26nM|IC50|=|26|nM|26|nM
1VCJ|2.40|2004|IBA||P03474|NEURAMINIDASE|4.59|IC=26uM|IC50|=|26|uM|26000|nM
1RIW|2.04|2004|OSC||P00734|THROMBIN LIGHT CHAIN|7.55|IC=28nM|IC50|=|28|nM|28|nM
1RRW|2.21|2004|9MG||P56740|DIHYDRONEOPTERIN ALDOLASE|4.55|IC=28uM|IC50|=|28|uM|28000|nM
1VYZ|2.21|2004|N5B||P24941|CELL DIVISION PROTEIN KINASE 2|6.54|IC=290nM|IC50|=|290|nM|290|nM
1TKX|2.85|2004|GWB||P04585|HIV-1 REVERSE TRANSCRIPTASE, CHAIN A|7.54|IC=29nM|IC50|=|29|nM|29|nM
1O4B|1.85|2004|876||P12931|TYROSINE-PROTEIN KINASE SRC|5.7|IC=2uM|IC50|=|2|uM|2000|nM
1RHU|2.51|2004|3CY|covalent complex|P42574|CASPASE-3|8.52|IC=3.00nM|IC50|=|3|nM|3|nM
1TL9|1.80|2004|4-mer|covalent complex|P97571|CALPAIN-1, CATALYTIC SUBUNIT|5.52|IC=3.0uM|IC50|=|3|uM|3000|nM
1XH3|1.48|2004|14-mer|alt.M-CSF peptide binds to HLA-B*3501, IC50=3.1uM|P30685|HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-35 ALPHA|5.51|IC=3.1uM|IC50|=|3.1|uM|3100|nM
1O4Q|1.70|2004|256||P12931|TYROSINE-PROTEIN KINASE SRC|2.49|IC=3.2mM|IC50|=|3.2|mM|3200000|nM
1O4O|1.70|2004|HPS||P12931|TYROSINE-PROTEIN KINASE SRC|2.46|IC=3.5mM|IC50|=|3.5|mM|3500000|nM
1O4H|2.25|2004|772||P12931|TYROSINE-PROTEIN KINASE SRC|2.44|IC=3.6mM|IC50|=|3.6|mM|3600000|nM
1XOT|2.34|2004|VDN||Q07343|CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B|5.42|IC=3.8uM|IC50|=|3.8|uM|3800|nM
1O4R|1.50|2004|787||P12931|TYROSINE-PROTEIN KINASE SRC|2.41|IC=3.9mM|IC50|=|3.9|mM|3900000|nM
1UYF|2.00|2004|PU1|IC50 measured on full length yeast HSP90-alpha|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|4.52|IC=30uM|IC50|=|30|uM|30000|nM
1T48|2.20|2004|BB3||P18031|PROTEIN-TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1|3.46|IC=350uM|IC50|=|350|uM|350000|nM
1V1K|2.31|2004|3FP||P24941|CELL DIVISION PROTEIN KINASE 2|4.46|IC=35uM|IC50|=|35|uM|35000|nM
1VYW|2.30|2004|292||P24941|CELL DIVISION PROTEIN KINASE 2|7.43|IC=37nM|IC50|=|37|nM|37|nM
1RSI|2.20|2004|977||P56740|DIHYDRONEOPTERIN ALDOLASE|4.42|IC=38uM|IC50|=|38|uM|38000|nM
1RQ2|1.86|2004|CIT||P64170|CELL DIVISION PROTEIN FTSZ|2.52|IC=3mM|IC50|=|3|mM|3000000|nM
1O44|1.70|2004|852||P12931|TYROSINE-PROTEIN KINASE SRC|8.52|IC=3nM|IC50|=|3|nM|3|nM
1R78|2.00|2004|FMD||P24941|CELL DIVISION PROTEIN KINASE 2|8.52|IC=3nM|IC50|=|3|nM|3|nM
1UYI|2.00|2004|PUZ|IC50 measured on full length yeast HSP90-alpha|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|5.39|IC=4.1uM|IC50|=|4.1|uM|4100|nM
1O4J|1.70|2004|IS2||P12931|TYROSINE-PROTEIN KINASE SRC|2.36|IC=4.4mM|IC50|=|4.4|mM|4400000|nM
1HKK|1.85|2004|3-mer||Q13231|CHITOTRIOSIDASE-1|7.4|IC=40nM|IC50|=|40|nM|40|nM
1UYC|2.00|2004|PU7|IC50 measured on full length yeast HSP90-alpha|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|4.39|IC=41uM|IC50|=|41|uM|41000|nM
1O49|1.70|2004|493||P12931|TYROSINE-PROTEIN KINASE SRC|6.36|IC=437nM|IC50|=|437|nM|437|nM
1O48|1.55|2004|853||P12931|TYROSINE-PROTEIN KINASE SRC|6.35|IC=450nM|IC50|=|450|nM|450|nM
1O47|1.80|2004|822||P12931|TYROSINE-PROTEIN KINASE SRC|8.4|IC=4nM|IC50|=|4|nM|4|nM
1W4L|2.16|2004|GL8||P04058|ACETYLCHOLINESTERASE|8.4|IC=4nM|IC50|=|4|nM|4|nM
1T1R|2.30|2004|IMB||P45568|1-DEOXY-D-XYLULOSE 5-PHOSPHATE REDUCTOISOMERASE|5.4|IC=4uM|IC50|=|4|uM|4000|nM
1TV6|2.80|2004|CP9||P03366|HIV-1 REVERSE TRANSCRIPTASE P66 SUBUNIT|5.4|IC=4uM|IC50|=|4|uM|4000|nM
1UU9|1.95|2004|BI3||O15530|3-PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE 1|5.4|IC=4uM|IC50|=|4|uM|4000|nM
1V0O|1.90|2004|INR||Q07785|CELL DIVISION CONTROL PROTEIN 2 HOMOLOG|5.26|IC=5.50uM|IC50|=|5.5|uM|5500|nM
1XMY|2.40|2004|ROL|ligand is compound (R)-Rolipram, pIC50=7.3|Q07343|CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B|7.3|IC=50.12nM|IC50|=|50.12|nM|50.12|nM
1W51|2.55|2004|L01|ligand is compound 1|P56817|BETA-SECRETASE 1|6.3|IC=500nM|IC50|=|500|nM|500|nM
1PPW|2.21|2004|EIP||Q46822|ISOPENTENYL-DIPHOSPHATE DELTA-ISOMERASE|4.3|IC=50uM|IC50|=|50|uM|50000|nM
1RS2|2.31|2004|209||P56740|DIHYDRONEOPTERIN ALDOLASE|4.3|IC=50uM|IC50|=|50|uM|50000|nM
1PY5|2.30|2004|PY1||P36897|TGF-BETA RECEPTOR TYPE-1|7.29|IC=51nM|IC50|=|51|nM|51|nM
1UYG|2.00|2004|PU2|IC50 measured on full length yeast HSP90-alpha|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|4.27|IC=53.5uM|IC50|=|53.5|uM|53500|nM
1U59|2.30|2004|STU||P43403|TYROSINE-PROTEIN KINASE ZAP-70|7.25|IC=55.8nM|IC50|=|55.8|nM|55.8|nM
1OKZ|2.51|2004|UCN||O15530|3-PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE 1|8.3|IC=5nM|IC50|=|5|nM|5|nM
1V2H|2.70|2004|GUN||P00491|PURINE NUCLEOSIDE PHOSPHORYLASE|5.3|IC=5uM|IC50|=|5|uM|5000|nM
1OKY|2.30|2004|STU||O15530|3-PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE 1|8.19|IC=6.5nM|IC50|=|6.5|nM|6.5|nM
1W6J|2.20|2004|R71|ligand is compound 9|P48449|LANOSTEROL SYNTHASE|8.19|IC=6.5nM|IC50|=|6.5|nM|6.5|nM
1Q0B|1.90|2004|NAT||P52732|KINESIN-LIKE PROTEIN KIF11|5.17|IC=6.7uM|IC50|=|6.7|uM|6700|nM
1UK1|3.00|2004|FRQ||P09874|POLY [ADP-RIBOSE] POLYMERASE 1|7.22|IC=60nM|IC50|=|60|nM|60|nM
1RE1|2.50|2004|NA3|covalent complex|P42574|CASPASE-3|5.21|IC=6117nM|IC50|=|6117|nM|6117|nM
1OIY|2.40|2004|N41||P24941|CELL DIVISION PROTEIN KINASE 2|7.19|IC=64nM|IC50|=|64|nM|64|nM
1OI9|2.10|2004|N20||P24941|CELL DIVISION PROTEIN KINASE 2|7.16|IC=69nM|IC50|=|69|nM|69|nM
1PW6|2.60|2004|FRB||P60568|INTERLEUKIN-2|5.22|IC=6uM|IC50|=|6|uM|6000|nM
1RHR|3.00|2004|CNE|covalent complex|P42574|CASPASE-3|8.1|IC=7.95nM|IC50|=|7.95|nM|7.95|nM
1W6R|2.05|2004|GNT||P04058|ACETYLCHOLINESTERASE|6.15|IC=702nM|IC50|=|702|nM|702|nM
1W76|2.30|2004|GNT|redundant to 1w6r|P04058|ACETYLCHOLINESTERASE|6.15|IC=702nM|IC50|=|702|nM|702|nM
1RXP|1.70|2004|169|covalent complex|P00760|TRYPSIN|7.14|IC=72nM|IC50|=|72|nM|72|nM
1UY8|1.98|2004|PU5|IC50 measured on full length yeast HSP90-alpha|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|4.12|IC=75uM|IC50|=|75|uM|75000|nM
1PFY|1.93|2004|MSP||P00959|METHIONYL-TRNA SYNTHETASE|8.15|IC=7nM|IC50|=|7|nM|7|nM
1TFZ|1.80|2004|869||P93836|4-HYDROXYPHENYLPYRUVATE DIOXYGENASE|8.15|IC=7nM|IC50|=|7|nM|7|nM
1QXW|1.67|2004|M1C||P0A080|METHIONYL AMINOPEPTIDASE|5.15|IC=7uM|IC50|=|7|uM|7000|nM
1T1S|2.40|2004|CBQ||P45568|1-DEOXY-D-XYLULOSE 5-PHOSPHATE REDUCTOISOMERASE|5.15|IC=7uM|IC50|=|7|uM|7000|nM
1RRY|2.70|2004|204||P56740|DIHYDRONEOPTERIN ALDOLASE|4.1|IC=80uM|IC50|=|80|uM|80000|nM
1UK0|3.00|2004|FRM|ligand is compound 4f|P09874|POLY [ADP-RIBOSE] POLYMERASE 1|8.1|IC=8nM|IC50|=|8|nM|8|nM
1T4J|2.70|2004|FRJ||P18031|PROTEIN-TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1|5.1|IC=8uM|IC50|=|8|uM|8000|nM
1RHJ|2.20|2004|PZN|covalent complex|P42574|CASPASE-3|8.04|IC=9.17nM|IC50|=|9.17|nM|9.17|nM
1U32|2.00|2004|OKA||P36873|SERINE/THREONINE PROTEIN PHOSPHATASE PP1-GAMMA|7.01|IC=97nM|IC50|=|97|nM|97|nM
1O42|1.70|2004|843||P12931|TYROSINE-PROTEIN KINASE SRC|8.05|IC=9nM|IC50|=|9|nM|9|nM
1UU8|2.50|2004|BI1||O15530|3-PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE 1|5.05|IC=9uM|IC50|=|9|uM|9000|nM
1UTT|2.20|2004|CP8||P39900|MACROPHAGE METALLOELASTASE|4.0|IC>100uM|IC50|>|100|uM|100000|nM
1UY6|1.90|2004|PU3|IC50 measured on full length yeast HSP90-alpha|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|3.7|IC>200uM|IC50|>|200|uM|200000|nM
1UY7|1.90|2004|PU4|IC50 measured on full length yeast HSP90-alpha|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|3.7|IC>200uM|IC50|>|200|uM|200000|nM
1UYD|2.00|2004|PU8|IC50 measured on full length yeast HSP90-alpha|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|3.7|IC>200uM|IC50|>|200|uM|200000|nM
1UYE|2.00|2004|PU9|IC50 measured on full length yeast HSP90-alpha|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|3.7|IC>200uM|IC50|>|200|uM|200000|nM
1O4L|1.65|2004|CIT||P12931|TYROSINE-PROTEIN KINASE SRC|1.4|IC>40mM|IC50|>|40|mM|40000000|nM
1O4M|1.60|2004|MLA||P12931|TYROSINE-PROTEIN KINASE SRC|1.4|IC>40mM|IC50|>|40|mM|40000000|nM
1O4N|1.60|2004|OXD||P12931|TYROSINE-PROTEIN KINASE SRC|1.4|IC>40mM|IC50|>|40|mM|40000000|nM
1UKT|2.20|2004|4-mer||P05618|CYCLOMALTODEXTRIN GLUCANOTRANSFERASE|2.25|IC>5600uM|IC50|>|5600|uM|5600000|nM
1O4G|1.55|2004|I59||P12931|TYROSINE-PROTEIN KINASE SRC|2.3|IC>5mM|IC50|>|5|mM|5000000|nM
1UYM|2.45|2004|PU3|ligand is compound 19, PU3. IC50=1-2uM|P08238|HEAT SHOCK PROTEIN HSP90-BETA|6.0|IC~1uM|IC50|~|1|uM|1000|nM
1TFQ|NMR|2004|998||P98170|BACULOVIRAL IAP REPEAT-CONTAINING PROTEIN 4|7.92|Kd=0.012uM|Kd|=|0.012|uM|12|nM
1XSC|NMR|2004|ATP||P50583|BIS(5'-NUCLEOSYL)-TETRAPHOSPHATASE|4.3|Kd=0.05mM|Kd|=|0.05|mM|50000|nM
1XZX|2.50|2004|_T3||P10828|THYROID HORMONE RECEPTOR BETA-1|10.22|Kd=0.06nM|Kd|=|0.06|nM|0.06|nM
1SR7|1.46|2004|MOF||P06401|PROGESTERONE RECEPTOR|10.1|Kd=0.08nM|Kd|=|0.08|nM|0.08|nM
1TOI|1.90|2004|HCI||P00509|ASPARTATE AMINOTRANSFERASE|4.05|Kd=0.090mM|Kd|=|0.09|mM|90000|nM
1UTJ|1.83|2004|ABN||P35031|TRYPSIN I|3.84|Kd=0.144mM|Kd|=|0.144|mM|144000|nM
1OS5|2.20|2004|NH1|IC50=0.93uM|P26663|RNA-DIRECTED RNA POLYMERASE|6.85|Kd=0.14uM|Kd|=|0.14|uM|140|nM
1OH4|1.35|2004|7-mer||Q9RIK9|BETA-MANNOSIDASE|3.74|Kd=0.18mM|Kd|=|0.18|mM|180000|nM
1S3K|1.90|2004|4-mer|Fab hu3S193 in complex with the Lewis Y tetrasaccharide, Kd=2.4E-7M|------|ANTIBODY FAB FRAGMENT Hu3s193|6.62|Kd=0.24uM|Kd|=|0.24|uM|240|nM
1VJC|2.10|2004|ATP|Kd for Mg-ATP|Q7SIB7|PHOSPHOGLYCERATE KINASE|3.58|Kd=0.263mM|Kd|=|0.263|mM|263000|nM
1UJK|1.90|2004|12-mer|Kd=0.27+/-0.17uM(SPR); Kd=40uM(ITC); incomplete ligand|Q9UJY5|ADP-RIBOSYLATION FACTOR BINDING PROTEIN GGA1|6.57|Kd=0.27uM|Kd|=|0.27|uM|270|nM
1VJD|1.90|2004|ATP||Q7SIB7|PHOSPHOGLYCERATE KINASE|3.54|Kd=0.286mM|Kd|=|0.286|mM|286000|nM
1NKI|0.95|2004|PPF|Ki=0.41uM|Q9I4K6|PROBABLE FOSFOMYCIN RESISTANCE PROTEIN|6.7|Kd=0.2uM|Kd|=|0.2|uM|200|nM
1S19|2.10|2004|MC9|ligand is MC903(calcipotriol)|P11473|VITAMIN D3 RECEPTOR|9.51|Kd=0.31nM|Kd|=|0.31|nM|0.31|nM
1UTN|1.15|2004|ABN||P00760|TRYPSINOGEN|3.49|Kd=0.321mM|Kd|=|0.321|mM|321000|nM
1RU2|1.48|2004|APC|Kd for Mg-APC|P26281|2-AMINO-4-HYDROXY-6-HYDROXYMETHYLDIHYDROPTERIDINE|6.49|Kd=0.32uM|Kd|=|0.32|uM|320|nM
1Q4X|2.80|2004|G24||P10828|THYROID HORMONE RECEPTOR BETA-1|9.48|Kd=0.33nM|Kd|=|0.33|nM|0.33|nM
1QY1|1.70|2004|PRZ||P11588|MAJOR URINARY PROTEIN|6.52|Kd=0.3uM|Kd|=|0.3|uM|300|nM
1TOJ|1.90|2004|HCI||P00509|ASPARTATE AMINOTRANSFERASE|3.39|Kd=0.41mM|Kd|=|0.41|mM|410000|nM
1UKH|2.35|2004|11-mer|Kd=0.42+/-0.13uM; incomplete ligand|P45983|MITOGEN-ACTIVATED PROTEIN KINASE 8|6.38|Kd=0.42uM|Kd|=|0.42|uM|420|nM
1SQN|1.45|2004|NDR||P06401|PROGESTERONE RECEPTOR|9.4|Kd=0.4nM|Kd|=|0.4|nM|0.4|nM
1XOW|1.80|2004|R18||P10275|ANDROGEN RECEPTOR|9.28|Kd=0.52nM|Kd|=|0.52|nM|0.52|nM
1UDT|2.30|2004|VIA|Kd=0.5~6.6nM|O76074|CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE|9.3|Kd=0.5nM|Kd|=|0.5|nM|0.5|nM
1TPZ|2.00|2004|GDP|redundant to 1tq4|Q9QZ85|INTERFERON-INDUCIBLE GTPASE|6.19|Kd=0.64uM|Kd|=|0.64|uM|640|nM
1TQ4|1.95|2004|GDP||Q9QZ85|INTERFERON-INDUCIBLE GTPASE|6.19|Kd=0.64uM|Kd|=|0.64|uM|640|nM
1TOG|2.31|2004|HCI||P00509|ASPARTATE AMINOTRANSFERASE|3.22|Kd=0.6mM|Kd|=|0.6|mM|600000|nM
1UHO|2.50|2004|VDN|Kd=0.6~0.7nM|O76074|CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE|9.22|Kd=0.6nM|Kd|=|0.6|nM|0.6|nM
1XB7|2.50|2004|12-mer|incomplete ligand|P11474|STEROID HORMONE RECEPTOR ERR1|6.22|Kd=0.6uM|Kd|=|0.6|uM|600|nM
1UOD|1.90|2004|G3H|covalent complex|P76015|DIHYDROXYACETONE KINASE|3.11|Kd=0.78mM|Kd|=|0.78|mM|780000|nM
1XXH|3.45|2004|AGS||P06710|DNA POLYMERASE III, DELTA SUBUNIT|6.11|Kd=0.78uM|Kd|=|0.78|uM|780|nM
1W9U|1.85|2004|5-mer|IC50=0.5uM|Q873X9|CHITINASE|6.09|Kd=0.81uM|Kd|=|0.81|uM|810|nM
1OJ5|2.20|2004|14-mer||O61202|STEROID RECEPTOR COACTIVATOR 1A|6.1|Kd=0.8uM|Kd|=|0.8|uM|800|nM
1UJJ|2.60|2004|12-mer|Kd=0.8+/-0.19uM(SPR); Kd=390uM(ITC); incomplete ligand|Q9UJY5|ADP-RIBOSYLATION FACTOR BINDING PROTEIN GGA1|6.1|Kd=0.8uM|Kd|=|0.8|uM|800|nM
1T7D|2.47|2004|ARY||P00803|SIGNAL PEPTIDASE I|6.03|Kd=0.94uM|Kd|=|0.94|uM|940|nM
1UTM|1.50|2004|PEA||P35031|TRYPSIN I|3.01|Kd=0.972mM|Kd|=|0.972|mM|972000|nM
1UDU|2.83|2004|CIA|Kd=0.9-6.7nM|O76074|CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE|9.05|Kd=0.9nM|Kd|=|0.9|nM|0.9|nM
1T29|2.30|2004|14-mer|incomplete ligand|P38398|BREAST CANCER TYPE 1 SUSCEPTIBILITY PROTEIN|6.05|Kd=0.9uM|Kd|=|0.9|uM|900|nM
1T7R|1.40|2004|15-mer|incomplete ligand; Kd between AR LBD and FxxLF peptide|O97775|ANDROGEN RECEPTOR|5.96|Kd=1.1uM|Kd|=|1.1|uM|1100|nM
1OAY|2.66|2004|FUR||P01751|IMMUNOGLOBULIN E|5.92|Kd=1.2uM|Kd|=|1.2|uM|1200|nM
1OK7|1.65|2004|16-mer|Kd=1.2uM(model1:inhibiton requires two occupied binding sites); Kd2=8.0uM (modle 2: inhibition occurs with only one occupied binding site); incomplete ligand|P00583|DNA POLYMERASE III SUBUNIT BETA|5.92|Kd=1.2uM|Kd|=|1.2|uM|1200|nM
1ULE|2.15|2004|3-mer||Q9P4R8|GALECTIN-2|5.92|Kd=1.2uM|Kd|=|1.2|uM|1200|nM
1U1W|1.35|2004|3HA||Q51792|PHENAZINE BIOSYNTHESIS PROTEIN PHZF|5.85|Kd=1.4uM|Kd|=|1.4|uM|1400|nM
1P17|2.70|2004|IMP||Q27796|HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE|2.82|Kd=1.5mM|Kd|=|1.5|mM|1500000|nM
1RYF|1.75|2004|GDP|Kd for mant-GDP|P63000|RAS-RELATED C3 BOTULINUM TOXIN SUBSTRATE 1|8.8|Kd=1.6nM|Kd|=|1.6|nM|1.6|nM
1QY2|1.75|2004|IPZ||P11588|MAJOR URINARY PROTEIN|5.74|Kd=1.8uM|Kd|=|1.8|uM|1800|nM
1T7F|1.60|2004|15-mer|incomplete ligand structure|O97775|ANDROGEN RECEPTOR|5.74|Kd=1.8uM|Kd|=|1.8|uM|1800|nM
1V11|1.95|2004|TDP||P12694|2-OXOISOVALERATE DEHYDROGENASE ALPHA SUBUNIT|3.98|Kd=104.8uM|Kd|=|104.8|uM|104800|nM
1RMZ|1.34|2004|NGH|Kd=8mM for AHA|P39900|MACROPHAGE METALLOELASTASE (MMP-12)|8.0|Kd=10nM|Kd|=|10|nM|10|nM
1VYG|2.40|2004|ACD||P29498|FATTY ACID-BINDING PROTEIN|8.0|Kd=10nM|Kd|=|10|nM|10|nM
1XWS|1.80|2004|BI1||P11309|SERINE/THREONINE-PROTEIN KINASE PIM-1|8.0|Kd=10nM|Kd|=|10|nM|10|nM
1SBR|2.30|2004|VIB||O34911|YKOF|5.0|Kd=10uM|Kd|=|10|uM|10000|nM
1V1M|2.00|2004|TDP||P12694|2-OXOISOVALERATE DEHYDROGENASE ALPHA SUBUNIT|3.94|Kd=115.0uM|Kd|=|115|uM|115000|nM
1PG2|1.75|2004|MET|Kd=43uM for MET/MetRS|P00959|METHIONYL-TRNA SYNTHETASE|4.96|Kd=11uM|Kd|=|11|uM|11000|nM
1UZ8|1.80|2004|3-mer||P01811|ANTIBODY FAB (IGG3,KAPPA) LIGHT CHAIN 291-2G3-A|4.96|Kd=11uM|Kd|=|11|uM|11000|nM
1NLT|2.70|2004|7-mer||P25491|MITOCHONDRIAL PROTEIN IMPORT PROTEIN MAS5|4.92|Kd=12uM|Kd|=|12|uM|12000|nM
1V16|1.90|2004|TDP||P12694|2-OXOISOVALERATE DEHYDROGENASE ALPHA SUBUNIT|3.87|Kd=134.8uM|Kd|=|134.8|uM|134800|nM
1VKJ|2.50|2004|A3P||O35310|HEPARAN SULFATE (GLUCOSAMINE) 3-O|4.85|Kd=14uM|Kd|=|14|uM|14000|nM
1RD4|2.40|2004|L08||P20701|INTEGRIN ALPHA-L|7.74|Kd=18.3nM|Kd|=|18.3|nM|18.3|nM
1RU1|1.40|2004|APC|Kd=0.32uM for Mg-APC|P26281|2-AMINO-4-HYDROXY-6-HYDROXYMETHYLDIHYDROPTERIDINE|4.74|Kd=18uM|Kd|=|18|uM|18000|nM
1PFU|1.91|2004|MPJ||P00959|METHIONYL-TRNA SYNTHETASE|2.72|Kd=1900uM|Kd|=|1900|uM|1900000|nM
1UX7|1.50|2004|3-mer||P45796|ENDO-1,4-BETA-XYLANASE D|3.0|Kd=1mM|Kd|=|1|mM|1000000|nM
1XT3|2.40|2004|6-mer||P60301|CYTOTOXIN 3|5.7|Kd=2.01uM|Kd|=|2.01|uM|2009.9999999999998|nM
1UTI|1.50|2004|16-mer||O89100|GRB2-RELATED ADAPTOR PROTEIN 2|5.62|Kd=2.4uM|Kd|=|2.4|uM|2400|nM
1Q1G|2.02|2004|MTI||Q8I3X4|URIDINE PHOSPHORYLASE PUTATIVE|8.57|Kd=2.7nM|Kd|=|2.7|nM|2.7|nM
1R5W|2.90|2004|13-mer|IC50=100+/-3nM; EC50=0.023nM|P04224|H-2 CLASS II HISTOCOMPATIBILITY ANTIGEN, E-K ALPHA|5.54|Kd=2.9uM|Kd|=|2.9|uM|2900|nM
1OAU|1.80|2004|SER-DNF||P01724|IMMUNOGLOBULIN E|7.7|Kd=20nM|Kd|=|20|nM|20|nM
1RYH|1.75|2004|GNP|Kd for mant-GNP|P63000|RAS-RELATED C3 BOTULINUM TOXIN SUBSTRATE 1|7.56|Kd=27.6nM|Kd|=|27.6|nM|27.6|nM
1W80|1.90|2004|12-mer|incomplete ligand structure|P17427|ADAPTER-RELATED PROTEIN COMPLEX 2 ALPHA 2|4.54|Kd=28.6uM|Kd|=|28.6|uM|28600|nM
1UTC|2.30|2004|9-mer|incomplete ligand|P49951|CLATHRIN HEAVY CHAIN|4.55|Kd=28uM|Kd|=|28|uM|28000|nM
1SZD|1.50|2004|APR||P53686|NAD-DEPENDENT DEACETYLASE HST2|4.54|Kd=29.16uM|Kd|=|29.16|uM|29160|nM
1XAP|2.10|2004|TTB|Kd=2~9nM|P10826|RETINOIC ACID RECEPTOR BETA|8.7|Kd=2nM|Kd|=|2|nM|2|nM
1Y0X|3.10|2004|T44||P10828|THYROID HORMONE RECEPTOR BETA-1|8.7|Kd=2nM|Kd|=|2|nM|2|nM
1XXI|4.10|2004|ADP||P06710|DNA POLYMERASE III, DELTA SUBUNIT|5.52|Kd=3.0uM|Kd|=|3|uM|3000|nM
1T08|2.10|2004|15-mer|Kd=3.1+/-0.3uM(APC R3- catenin); Kd=10+/-1.3nM(APC pR3- catenin).|P35222|BETA-CATENIN|5.51|Kd=3.1uM|Kd|=|3.1|uM|3100|nM
1UEF|2.50|2004|13-mer|incomplete ligand|P97465|DOCKING PROTEIN 1|5.49|Kd=3.2uM|Kd|=|3.2|uM|3200|nM
1UTL|1.70|2004|PRA||P35031|TRYPSIN I|2.47|Kd=3.41mM|Kd|=|3.41|mM|3410000|nM
1TOK|1.85|2004|MAE||P00509|ASPARTATE AMINOTRANSFERASE|2.47|Kd=3.4mM|Kd|=|3.4|mM|3400000|nM
1R5N|2.90|2004|GDP||O74718|EUKARYOTIC PEPTIDE CHAIN RELEASE FACTOR GTP|5.42|Kd=3.8uM|Kd|=|3.8|uM|3800|nM
1U2R|2.60|2004|GDP||P32324|ELONGATION FACTOR 2|5.41|Kd=3.9uM|Kd|=|3.9|uM|3900|nM
1VEA|2.80|2004|HBN||P10943|HUT OPERON POSITIVE REGULATORY PROTEIN|7.52|Kd=30nM|Kd|=|30|nM|30|nM
1XA5|2.12|2004|KAR||P62157|CALMODULIN|6.5|Kd=316nM|Kd|=|316|nM|316|nM
1OSV|2.50|2004|13-mer|incomplete ligand structure; Kd for bile acid-activated FXR to coactivator peptide NID-3 (KENALLRYLLDKD)|Q62735|BILE ACID RECEPTOR|3.48|Kd=330uM|Kd|=|330|uM|330000|nM
1R5V|2.50|2004|13-mer|IC50=90+/-2nM; EC50=0.13nM|P04224|H-2 CLASS II HISTOCOMPATIBILITY ANTIGEN, E-K ALPHA|4.48|Kd=33uM|Kd|=|33|uM|33000|nM
1QVU|2.96|2004|PRL|ternary complex of QacR with ethidium and proflavine; QacR bind to Pf with Kd=35uM in the presence of 75uM Et|P0A0N4|TRANSCRIPTIONAL REGULATOR QACR|4.46|Kd=35uM|Kd|=|35|uM|35000|nM
1UTP|1.30|2004|PBN||P00760|TRYPSINOGEN|1.44|Kd=36mM|Kd|=|36|mM|36000000|nM
1T2V|3.30|2004|16-mer|incomplete ligand|P38398|BREAST CANCER TYPE 1 SUSCEPTIBILITY PROTEIN|6.4|Kd=400nM|Kd|=|400|nM|400|nM
1UPK|1.85|2004|12-mer|incomplete ligand|Q9Y376|MO25 PROTEIN|6.4|Kd=400nM|Kd|=|400|nM|400|nM
1OAR|2.22|2004|AZN||P01724|IMMUNOGLOBULIN E|7.4|Kd=40nM|Kd|=|40|nM|40|nM
1R6N|2.40|2004|434||P04015|HPV11 REGULATORY PROTEIN E2|7.4|Kd=40nM|Kd|=|40|nM|40|nM
1QVT|2.89|2004|PRL||P0A0N4|TRANSCRIPTIONAL REGULATOR QACR|4.38|Kd=42uM|Kd|=|42|uM|42000|nM
1TD7|2.50|2004|NFL|Ki=1.26uM|P60045|PHOSPHOLIPASE A2, ISOFORM 3|4.37|Kd=43uM|Kd|=|43|uM|43000|nM
1UW6|2.20|2004|NCT||P58154|ACETYLCHOLINE-BINDING PROTEIN|7.34|Kd=45.2nM|Kd|=|45.2|nM|45.2|nM
1TTM|1.95|2004|667||P00918|CARBONIC ANHYDRASE 2|7.35|Kd=45nM|Kd|=|45|nM|45|nM
1SV3|1.35|2004|ANN|Ki=18uM|P59071|PHOSPHOLIPASE A2|4.35|Kd=45uM|Kd|=|45|uM|45000|nM
1T37|2.60|2004|5-mer||P60045|PHOSPHOLIPASE A2, ISOFORM 3|4.35|Kd=45uM|Kd|=|45|uM|45000|nM
1W3J|2.00|2004|OXZ||Q08638|BETA-GLUCOSIDASE A|6.32|Kd=484nM|Kd|=|484|nM|484|nM
1R9L|1.59|2004|BET||P14177|GLYCINE BETAINE-BINDING PERIPLASMIC PROTEIN|5.4|Kd=4uM|Kd|=|4|uM|4000|nM
1S5Q|NMR|2004|16-mer|Kd=5.2+/-1.0uM|Q05195|MAD PROTEIN|5.28|Kd=5.2uM|Kd|=|5.2|uM|5200|nM
1UTO|1.15|2004|PEA||P00760|TRYPSIN BETA|2.27|Kd=5.32mM|Kd|=|5.32|mM|5320000|nM
2BFR|2.50|2004|ADP||O28751|HYPOTHETICAL PROTEIN AF1521|5.25|Kd=5.63uM|Kd|=|5.63|uM|5630|nM
1OPI|NMR|2004|13-mer|Kd=50-100nM|P26368|SPLICING FACTOR U2AF 65 KDA SUBUNIT|7.3|Kd=50nM|Kd|=|50|nM|50|nM
1SW1|1.90|2004|PBE||O29280|OSMOPROTECTION PROTEIN (PROX)|7.3|Kd=50nM|Kd|=|50|nM|50|nM
1U8T|1.50|2004|16-mer|incomplete ligand|P06143|CHEMOTAXIS PROTEIN CHEY|4.26|Kd=55uM|Kd|=|55|uM|55000|nM
1UXA|1.50|2004|SIA-GAL||Q64823|FIBER PROTEIN|2.3|Kd=5mM|Kd|=|5|mM|5000000|nM
1OXR|1.93|2004|AIN||P60045|PHOSPHOLIPASE A2, ISOFORM 3|5.19|Kd=6.4uM|Kd|=|6.4|uM|6400|nM
1SW2|2.10|2004|BET||O29280|OSMOPROTECTION PROTEIN (PROX)|7.22|Kd=60nM|Kd|=|60|nM|60|nM
1PZI|1.99|2004|1DM||P32890|HEAT-LABILE ENTEROTOXIN B CHAIN|4.22|Kd=60uM|Kd|=|60|uM|60000|nM
1ULG|2.20|2004|GAL-NGA||Q9P4R8|GALECTIN-2|4.21|Kd=62.2uM|Kd|=|62.2|uM|62200|nM
1Q7A|1.60|2004|OPB||P59071|PHOSPHOLIPASE A2|7.19|Kd=64nM|Kd|=|64|nM|64|nM
1SJE|2.45|2004|16-mer|HLA-DR1 and Gag[PP16] peptide complex, IC50=29+/-1nM, Kd=6nM; incomplete ligand|P01903|HLA CLASS II HISTOCOMPATIBILITY ANTIGEN, DR ALPHA CHAIN|8.22|Kd=6nM|Kd|=|6|nM|6|nM
1W2X|2.80|2004|RCP||Q00955|ACETYL-COA CARBOXYLASE|5.14|Kd=7.2uM|Kd|=|7.2|uM|7200|nM
1UV6|2.50|2004|CCE||P58154|ACETYLCHOLINE-BINDING PROTEIN|5.12|Kd=7575nM|Kd|=|7575|nM|7575|nM
1P19|2.30|2004|IMP||Q27796|HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE|4.11|Kd=76.8uM|Kd|=|76.8|uM|76800|nM
1UXB|1.75|2004|SIA-GAL||Q64822|FIBER PROTEIN|2.15|Kd=7mM|Kd|=|7|mM|7000000|nM
1RZX|2.10|2004|7-mer||O97111|CG5884-PA|4.1|Kd=80uM|Kd|=|80|uM|80000|nM
1NW4|2.20|2004|IMH||Q8I3X4|URIDINE PHOSPHORYLASE PUTATIVE|9.07|Kd=860pM|Kd|=|860|pM|0.86|nM
1X8S|2.50|2004|12-mer|incomplete ligand|O97111|CG5884-PA|5.1|Kd=8uM|Kd|=|8|uM|8000|nM
1U9L|1.90|2004|13-mer|incomplete ligand structure|P03003|TRANSCRIPTION ELONGATION PROTEIN NUSA|5.02|Kd=9.6uM|Kd|=|9.6|uM|9600|nM
1R4W|2.50|2004|GSH||P24473|GLUTATHIONE S-TRANSFERASE|4.05|Kd=90uM|Kd|=|90|uM|90000|nM
1T79|1.80|2004|15-mer|incomplete ligand structure|O97775|ANDROGEN RECEPTOR|6.04|Kd=920nM|Kd|=|920|nM|920|nM
1SJH|2.25|2004|13-mer|HLA-DR1 and Gag[PG13] peptide complex, IC50=28+/-3nM, Kd=9nM|P01903|HLA CLASS II HISTOCOMPATIBILITY ANTIGEN, DR ALPHA CHAIN|8.05|Kd=9nM|Kd|=|9|nM|9|nM
1VYF|1.85|2004|OLA||P29498|FATTY ACID-BINDING PROTEIN|8.05|Kd=9nM|Kd|=|9|nM|9|nM
1R6Z|2.80|2004|MAL||P02928|CHIMERA OF MALTOSE-BINDING PERIPLASMIC PROTEIN|5.0|Kd>10uM|Kd|>|10|uM|10000|nM
1SYO|2.20|2004|M6P||P08169|CATION-INDEPENDENT MANNOSE 6-PHOSPHATE RECEPTOR|9.0|Kd~1nM|Kd|~|1|nM|1|nM
1SZ0|2.10|2004|M6P||P08169|CATION-INDEPENDENT MANNOSE 6-PHOSPHATE RECEPTOR|9.0|Kd~1nM|Kd|~|1|nM|1|nM
1SM2|2.30|2004|STU||Q08881|TYROSINE-PROTEIN KINASE ITK/TSK|8.0|Ki<10nM|Ki|<|10|nM|10|nM
1RP7|2.09|2004|TZD||P06958|PYRUVATE DEHYDROGENASE E1 COMPONENT|8.52|Ki=0.003uM|Ki|=|0.003|uM|3|nM
1VJA|2.00|2004|7IN||P00749|UROKINASE-TYPE PLASMINOGEN ACTIVATOR|7.7|Ki=0.020uM|Ki|=|0.02|uM|20|nM
1W1G|1.45|2004|4PT||O15530|3-PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE-1|7.68|Ki=0.021uM|Ki|=|0.021|uM|21|nM
1OXG|2.20|2004|14-mer|covalent complex; Ki=2.7+/-0.3 0-11M|P00766|CHYMOTRYPSINOGEN A|10.57|Ki=0.027nM|Ki|=|0.027|nM|0.027|nM
1V0L|0.98|2004|XIF-XYP||P26514|ENDO-1,4-BETA-XYLANASE A|7.55|Ki=0.028uM|Ki|=|0.028|uM|28|nM
1V0N|1.10|2004|XIF-XYP|redundant to 1v0l|P26514|ENDO-1,4-BETA-XYLANASE A|7.55|Ki=0.028uM|Ki|=|0.028|uM|28|nM
1VJ9|2.40|2004|5IN||P00749|UROKINASE-TYPE PLASMINOGEN ACTIVATOR|7.55|Ki=0.028uM|Ki|=|0.028|uM|28|nM
1SQO|1.84|2004|UI2||P00749|UROKINASE-TYPE PLASMINOGEN ACTIVATOR|7.46|Ki=0.035uM|Ki|=|0.035|uM|35|nM
1SC8|2.40|2004|2IN||P00749|UROKINASE-TYPE PLASMINOGEN ACTIVATOR|7.44|Ki=0.036uM|Ki|=|0.036|uM|36|nM
1UA4|1.90|2004|AMP||Q9V2Z6|ADP-DEPENDENT GLUCOKINASE|4.22|Ki=0.06mM|Ki|=|0.06|mM|60000|nM
1PXM|2.53|2004|CK5||P24941|CELL DIVISION PROTEIN KINASE 2|7.22|Ki=0.06uM|Ki|=|0.06|uM|60|nM
1XD0|2.00|2004|ARE||P04746|ALPHA-AMYLASE|7.12|Ki=0.075uM|Ki|=|0.075|uM|75|nM
1PXN|2.50|2004|CK6||P24941|CELL DIVISION PROTEIN KINASE 2|7.15|Ki=0.07uM|Ki|=|0.07|uM|70|nM
1SB1|1.90|2004|165||P00734|PROTHROMBIN|6.89|Ki=0.128uM|Ki|=|0.128|uM|128|nM
1PKX|1.90|2004|XMP||P31939|BIFUNCTIONAL PURINE BIOSYNTHESIS PROTEIN PURH|6.92|Ki=0.12uM|Ki|=|0.12|uM|120|nM
1VCU|2.85|2004|DAN|ligand is compound 4, DANA|Q9Y3R4|SIALIDASE 2|3.85|Ki=0.14mM|Ki|=|0.14|mM|140000|nM
1OM1|1.68|2004|IQA||P28523|CASEIN KINASE II, ALPHA SUBUNIT|6.77|Ki=0.17uM|Ki|=|0.17|uM|170|nM
1NH0|1.03|2004|5-mer||P03367|HIV-1 PROTEASE|9.74|Ki=0.18nM|Ki|=|0.18|nM|0.18|nM
1WC1|1.93|2004|TAT||O32393|ADENYLATE CYCLASE|4.0|Ki=0.1mM|Ki|=|0.1|mM|100000|nM
1WC6|2.51|2004|TAT||O32393|ADENYLATE CYCLASE|4.0|Ki=0.1mM|Ki|=|0.1|mM|100000|nM
1RJK|1.99|2004|VDZ|ligand is compound 4|P13053|VITAMIN D3 RECEPTOR|10.0|Ki=0.1nM|Ki|=|0.1|nM|0.1|nM
1PXP|2.30|2004|CK8||P24941|CELL DIVISION PROTEIN KINASE 2|6.66|Ki=0.22uM|Ki|=|0.22|uM|220|nM
1QW7|1.90|2004|EBP||P0A434|PARATHION HYDROLASE|3.6|Ki=0.25mM|Ki|=|0.25|mM|250000|nM
1UYS|2.80|2004|H1L||Q00955|ACETYL-COA CARBOXYLASE|3.6|Ki=0.25mM|Ki|=|0.25|mM|250000|nM
1W1D|1.50|2004|4IP||O15530|3-PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE-1|6.52|Ki=0.30uM|Ki|=|0.3|uM|300|nM
1S4D|2.70|2004|SAH||P21631|UROPORPHYRIN-III C-METHYLTRANSFERASE|6.49|Ki=0.32uM|Ki|=|0.32|uM|320|nM
1XJD|2.00|2004|STU||Q04759|PROTEIN KINASE C, THETA TYPE|9.48|Ki=0.33nM|Ki|=|0.33|nM|0.33|nM
1Q4W|1.93|2004|DQU|redundant to 1r5y|P28720|QUEUINE TRNA-RIBOSYLTRANSFERASE|6.46|Ki=0.35uM|Ki|=|0.35|uM|350|nM
1R5Y|1.20|2004|DQU||P28720|QUEUINE TRNA-RIBOSYLTRANSFERASE|6.46|Ki=0.35uM|Ki|=|0.35|uM|350|nM
1O5A|1.68|2004|696||P00749|UROKINASE-TYPE PLASMINOGEN ACTIVATOR|6.42|Ki=0.38uM|Ki|=|0.38|uM|380|nM
1RE8|2.10|2004|BD2||P05132|CAMP-DEPENDENT PROTEIN KINASE|9.52|Ki=0.3nM|Ki|=|0.3|nM|0.3|nM
1T69|2.91|2004|SHH|ligand is compound SAHA|Q9BY41|HISTONE DEACETYLASE 8|6.32|Ki=0.48uM|Ki|=|0.48|uM|480|nM
1W3L|1.04|2004|3-mer||O85465|ENDOGLUCANASE 5A|6.28|Ki=0.52uM|Ki|=|0.52|uM|520|nM
1PX4|1.60|2004|IPT||P00722|BETA-GALACTOSIDASE|3.23|Ki=0.59mM|Ki|=|0.59|mM|590000|nM
1PHW|2.36|2004|__N||P0A715|2-DEHYDRO-3-DEOXYPHOSPHOOCTONATE ALDOLASE|3.3|Ki=0.5mM|Ki|=|0.5|mM|500000|nM
1PWP|2.90|2004|NSC||P15917|LETHAL FACTOR|6.3|Ki=0.5uM|Ki|=|0.5|uM|500|nM
1W25|2.70|2004|C2E||Q9A5I5|STALKED-CELL DIFFERENTIATION CONTROLLING PROTEIN|6.3|Ki=0.5uM|Ki|=|0.5|uM|500|nM
1WM1|2.10|2004|PTB||O32449|PROLINE IMINOPEPTIDASE|6.3|Ki=0.5uM|Ki|=|0.5|uM|500|nM
1SQA|2.00|2004|UI1||P00749|UROKINASE-TYPE PLASMINOGEN ACTIVATOR|9.21|Ki=0.62nM|Ki|=|0.62|nM|0.62|nM
1SQT|1.90|2004|UI3||P00749|UROKINASE-TYPE PLASMINOGEN ACTIVATOR|6.2|Ki=0.63uM|Ki|=|0.63|uM|630|nM
1V2K|2.00|2004|ZEN||P00760|TRYPSIN|6.19|Ki=0.65uM|Ki|=|0.65|uM|650|nM
1TA6|1.90|2004|177||P00734|THROMBIN|9.13|Ki=0.74nM|Ki|=|0.74|nM|0.74|nM
1U0G|1.70|2004|E4P||P06745|GLUCOSE-6-PHOSPHATE ISOMERASE|6.15|Ki=0.7uM|Ki|=|0.7|uM|700|nM
1S26|3.00|2004|APC||P40136|CALMODULIN-SENSITIVE ADENYLATE CYCLASE|3.07|Ki=0.85mM|Ki|=|0.85|mM|850000|nM
1O5F|1.78|2004|CR9||P05981|SERINE PROTEASE HEPSIN|6.07|Ki=0.85uM|Ki|=|0.85|uM|850|nM
1UJ5|2.00|2004|5RP||Q72J47|RIBOSE-5-PHOSPHATE ISOMERASE|3.05|Ki=0.89mM|Ki|=|0.89|mM|890000|nM
1UJ6|1.74|2004|A5P||Q72J47|RIBOSE-5-PHOSPHATE ISOMERASE|3.05|Ki=0.89mM|Ki|=|0.89|mM|890000|nM
1XBO|2.50|2004|IX1||P18031|PROTEIN-TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1|6.04|Ki=0.92uM|Ki|=|0.92|uM|920|nM
1S63|1.90|2004|778||P49354|FARNESYLTRANSFERASE|9.05|Ki=0.9nM|Ki|=|0.9|nM|0.9|nM
1UWU|1.95|2004|GOX||P22498|BETA-GALACTOSIDASE|5.98|Ki=1.04uM|Ki|=|1.04|uM|1040|nM
1UWT|1.95|2004|GTL||P22498|BETA-GALACTOSIDASE|5.97|Ki=1.08uM|Ki|=|1.08|uM|1080|nM
1MU8|2.00|2004|CDB||P00734|THROMBIN|9.0|Ki=1.0nM|Ki|=|1|nM|1|nM
1V2N|1.80|2004|BBA||P00760|TRYPSIN|5.9|Ki=1.25uM|Ki|=|1.25|uM|1250|nM
1R1H|1.95|2004|BIR||P08473|NEPRILYSIN|8.92|Ki=1.2nM|Ki|=|1.2|nM|1.2|nM
1U6Q|2.02|2004|745||P00749|UROKINASE-TYPE PLASMINOGEN ACTIVATOR|5.88|Ki=1.31uM|Ki|=|1.31|uM|1310|nM
1UGP|1.63|2004|BUA||Q7SID2|COBALT-CONTAINING NITRILE HYDRATASE SUBUNIT ALPHA|2.89|Ki=1.3mM|Ki|=|1.3|mM|1300000|nM
1SL3|1.81|2004|170||P00734|THROMBIN|11.85|Ki=1.4pM|Ki|=|1.4|pM|0.0014|nM
1Q63|1.85|2004|AIQ|redundant to 1k4g|P28720|QUEUINE TRNA-RIBOSYLTRANSFERASE|5.85|Ki=1.4uM|Ki|=|1.4|uM|1400|nM
1M0B|2.45|2004|0ZQ||P03367|HIV-1 PROTEASE|8.82|Ki=1.53nM|Ki|=|1.53|nM|1.53|nM
1W5W|1.80|2004|BE4||P03366|HIV-1 PROTEASE|8.8|Ki=1.6nM|Ki|=|1.6|nM|1.6|nM
1RQL|2.40|2004|VSO||O31156|PHOSPHONOACETALDEHYDE HYDROLASE|2.75|Ki=1.79mM|Ki|=|1.79|mM|1790000|nM
2BET|2.20|2004|DEZ||Q7D737|CARBOHYDRATE-PHOSPHATE ISOMERASE|2.77|Ki=1.7mM|Ki|=|1.7|mM|1700000|nM
1O5B|1.85|2004|ESI||P00749|UROKINASE-TYPE PLASMINOGEN ACTIVATOR|5.77|Ki=1.7uM|Ki|=|1.7|uM|1700|nM
1Q66|1.75|2004|KMB||P28720|QUEUINE TRNA-RIBOSYLTRANSFERASE|5.77|Ki=1.7uM|Ki|=|1.7|uM|1700|nM
1UR9|1.80|2004|3-mer||Q54276|CHITINASE B|5.77|Ki=1.7uM|Ki|=|1.7|uM|1700|nM
1O5E|1.75|2004|132||P05981|SERINE PROTEASE HEPSIN|5.74|Ki=1.8uM|Ki|=|1.8|uM|1800|nM
1U0H|2.90|2004|ONM||P30803|ADENYLATE CYCLASE TYPE 5|6.96|Ki=110nM|Ki|=|110|nM|110|nM
1QXL|2.25|2004|FR8||P56658|ADENOSINE DEAMINASE|7.96|Ki=11nM|Ki|=|11|nM|11|nM
1O5G|1.75|2004|CR9||P00734|PROTHROMBIN|4.96|Ki=11uM|Ki|=|11|uM|11000|nM
1PWQ|3.52|2004|SD2||P15917|LETHAL FACTOR|4.96|Ki=11uM|Ki|=|11|uM|11000|nM
1T3T|1.90|2004|ADP|X-ray(PurL) while Ki(PurM)|P74881|PHOSPHORIBOSYLFORMYLGLYCINAMIDINE SYNTHASE|4.96|Ki=11uM|Ki|=|11|uM|11000|nM
1TL7|2.80|2004|ONM||P30803|ADENYLATE CYCLASE TYPE 5|7.92|Ki=12nM|Ki|=|12|nM|12|nM
1UZ1|2.00|2004|IFL||Q08638|BETA-GLUCOSIDASE A|6.89|Ki=130nM|Ki|=|130|nM|130|nM
1V79|2.50|2004|FR7|Ki measured on human ADA|P56658|ADENOSINE DEAMINASE|7.89|Ki=13nM|Ki|=|13|nM|13|nM
1XFF|1.80|2004|GLU||P17169|GLUCOSAMINE-FRUCTOSE-6-PHOSPHATE|4.82|Ki=15uM|Ki|=|15|uM|15000|nM
1V48|2.20|2004|HA1||P55859|PURINE NUCLEOSIDE PHOSPHORYLASE|7.8|Ki=16nM|Ki|=|16|nM|16|nM
1PI5|1.49|2004|SM2|covalent complex|P00811|BETA-LACTAMASE|7.77|Ki=17nM|Ki|=|17|nM|17|nM
1V2O|1.62|2004|ANH||P00760|TRYPSIN BETA|4.73|Ki=18.45uM|Ki|=|18.45|uM|18450|nM
1V2P|1.92|2004|ANH|redundant to 1v2o|P00760|TRYPSIN|4.73|Ki=18.45uM|Ki|=|18.45|uM|18450|nM
1SDV|1.40|2004|MK1||P03367|HIV-1 PROTEASE|8.74|Ki=1810pM|Ki|=|1810|pM|1.81|nM
1U2Y|1.95|2004|GOX||P04746|ALPHA-AMYLASE|1.74|Ki=18mM|Ki|=|18|mM|18000000|nM
1TXR|2.00|2004|BES||Q01693|LEUCYL AMINOPEPTIDASE|7.74|Ki=18nM|Ki|=|18|nM|18|nM
1V2T|1.90|2004|ANH||P00760|TRYPSIN|4.71|Ki=19.56uM|Ki|=|19.56|uM|19560|nM
1RM8|1.80|2004|BAT|X-ray(MMP-16) while Ki(MMP-1,-2,-3)|P51512|MATRIX METALLOPROTEINASE-16|9.0|Ki=1nM|Ki|=|1|nM|1|nM
1SSQ|1.85|2004|CYS||P43886|SERINE ACETYLTRANSFERASE|6.0|Ki=1uM|Ki|=|1|uM|1000|nM
1PXO|1.96|2004|CK7||P24941|CELL DIVISION PROTEIN KINASE 2|8.7|Ki=2.0nM|Ki|=|2|nM|2|nM
1PWU|2.70|2004|GM6|Ki measured on LF wt|P15917|LETHAL FACTOR|5.68|Ki=2.1uM|Ki|=|2.1|uM|2100|nM
1MUE|2.00|2004|CDD||P00734|THROMBIN|8.64|Ki=2.3nM|Ki|=|2.3|nM|2.3|nM
1R1J|2.35|2004|OIR||P08473|NEPRILYSIN|8.64|Ki=2.3nM|Ki|=|2.3|nM|2.3|nM
1R1I|2.60|2004|TI1||P08473|NEPRILYSIN|8.54|Ki=2.9nM|Ki|=|2.9|nM|2.9|nM
1RDT|2.40|2004|L79||P19793|PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA|6.7|Ki=200nM|Ki|=|200|nM|200|nM
1REK|2.30|2004|B8L||P05132|CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTIC|6.7|Ki=200nM|Ki|=|200|nM|200|nM
1S39|1.95|2004|AQO|Ki=20~50nM|P28720|TRNA GUANINE TRANSGLYCOSYLASE|7.7|Ki=20nM|Ki|=|20|nM|20|nM
1UOU|2.11|2004|CMU||P19971|THYMIDINE PHOSPHORYLASE|7.7|Ki=20nM|Ki|=|20|nM|20|nM
1V41|2.85|2004|AZG||P00491|PURINE NUCLEOSIDE PHOSPHORYLASE|4.7|Ki=20uM|Ki|=|20|uM|20000|nM
1XS7|2.80|2004|MMI||P56817|BETA-SECRETASE 1|7.6|Ki=25.1nM|Ki|=|25.1|nM|25.1|nM
1W8M|1.65|2004|E1P||P62937|PEPTIDYL-PROLYL CIS-TRANS ISOMERASE A|1.6|Ki=25mM|Ki|=|25|mM|25000000|nM
1U33|1.95|2004|LM2||P04746|ALPHA-AMYLASE|4.6|Ki=25uM|Ki|=|25|uM|25000|nM
1V2R|1.70|2004|ANH||P00760|TRYPSIN|3.55|Ki=278.96uM|Ki|=|278.96|uM|278960|nM
1PK0|3.30|2004|EMA||P40136|CALMODULIN-SENSITIVE ADENYLATE CYCLASE|7.57|Ki=27nM|Ki|=|27|nM|27|nM
1Q95|2.46|2004|PAL||P0A786|ASPARTATE CARBAMOYLTRANSFERASE|7.57|Ki=27nM|Ki|=|27|nM|27|nM
1W5Y|1.90|2004|BE6||P03366|HIV-1 PROTEASE|8.48|Ki=3.3nM|Ki|=|3.3|nM|3.3|nM
1Q65|2.10|2004|BHB||P28720|QUEUINE TRNA-RIBOSYLTRANSFERASE|5.46|Ki=3.5uM|Ki|=|3.5|uM|3500|nM
1T4S|2.80|2004|VAL||P07824|ARGINASE 1|2.44|Ki=3.6mM|Ki|=|3.6|mM|3600000|nM
1XXE|NMR|2004|TUX||O67648|UDP-3-O-[3-HYDROXYMYRISTOYL] N-ACETYLGLUCOSAMINE|5.41|Ki=3.9uM|Ki|=|3.9|uM|3900|nM
1UML|2.50|2004|FR4||P56658|ADENOSINE DEAMINASE|7.52|Ki=30nM|Ki|=|30|nM|30|nM
1W8L|1.80|2004|1P3||P62937|PEPTIDYL-PROLYL CIS-TRANS ISOMERASE A|0.49|Ki=320mM|Ki|=|320|mM|320000000|nM
1RO6|2.00|2004|ROL|Ki=350~400nM|Q07343|CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B|6.46|Ki=350nM|Ki|=|350|nM|350|nM
1PI4|1.39|2004|SM3|covalent complex|P00811|BETA-LACTAMASE|7.43|Ki=37nM|Ki|=|37|nM|37|nM
1PYE|2.00|2004|PM1|IC50=0.32uM|P24941|CELL DIVISION PROTEIN KINASE 2|6.41|Ki=386nM|Ki|=|386|nM|386|nM
1Q5K|1.94|2004|TMU|IC50=104nM|P49841|GLYCOGEN SYNTHASE KINASE-3 BETA|7.42|Ki=38nM|Ki|=|38|nM|38|nM
1TA2|2.30|2004|176||P00734|THROMBIN|8.52|Ki=3nM|Ki|=|3|nM|3|nM
1XKK|2.40|2004|FMM||P00533|EPIDERMAL GROWTH FACTOR RECEPTOR|8.52|Ki=3nM|Ki|=|3|nM|3|nM
1W5X|1.90|2004|BE5||P03366|HIV-1 PROTEASE|8.4|Ki=4.0nM|Ki|=|4|nM|4|nM
1MU6|1.99|2004|CDA||P00734|THROMBIN|8.38|Ki=4.2nM|Ki|=|4.2|nM|4.2|nM
1UZ4|1.71|2004|IFL||Q6QT42|MANNOSIDASE|3.4|Ki=400uM|Ki|=|400|uM|400000|nM
1P57|1.75|2004|CR4||P05981|SERINE PROTEASE HEPSIN|4.4|Ki=40uM|Ki|=|40|uM|40000|nM
1Q83|2.65|2004|TZ5||P21836|ACETYLCHOLINESTERASE|12.39|Ki=410fM|Ki|=|410|fM|0.00041|nM
1SGU|1.90|2004|MK1||P03367|HIV-1 PROTEASE|5.37|Ki=4235nM|Ki|=|4235|nM|4235|nM
1V2U|1.80|2004|BEN||P00760|TRYPSIN|3.37|Ki=427uM|Ki|=|427|uM|427000|nM
1V2V|1.80|2004|BEN|redundant to 1v2u|P00760|TRYPSIN|3.37|Ki=427uM|Ki|=|427|uM|427000|nM
1RWX|1.85|2004|YBH|IL-1 beta , compound 18b, EC50=12.4uM|P29466|INTERLEUKIN-1 BETA CONVERTASE|7.37|Ki=43nM|Ki|=|43|nM|43|nM
1PZO|1.90|2004|CBT||P62593|BETA-LACTAMASE TEM|3.32|Ki=480uM|Ki|=|480|uM|480000|nM
1PZP|1.45|2004|FTA||P62593|BETA-LACTAMASE TEM|3.31|Ki=490uM|Ki|=|490|uM|490000|nM
1S64|2.55|2004|778|Ki in the presence of ATP|Q04631|GERANYL-GERANYLTRANSFERASE ALPHA SUBUNIT|8.4|Ki=4nM|Ki|=|4|nM|4|nM
1XBB|1.57|2004|STI||P43405|TYROSINE-PROTEIN KINASE SYK|5.3|Ki=5.0uM|Ki|=|5|uM|5000|nM
1S89|2.22|2004|PGA||P0A731|METHYLGLYOXAL SYNTHASE|5.24|Ki=5.8uM|Ki|=|5.8|uM|5800|nM
1W3K|1.20|2004|BGC-OXZ||O85465|ENDOGLUCANASE 5A|4.3|Ki=50uM|Ki|=|50|uM|50000|nM
1V2L|1.60|2004|BEN||P00760|TRYPSIN|4.29|Ki=51uM|Ki|=|51|uM|51000|nM
1V2M|1.65|2004|BEN|redundant to 1v2l|P00760|TRYPSIN|4.29|Ki=51uM|Ki|=|51|uM|51000|nM
1SDT|1.30|2004|MK1||P03367|HIV-1 PROTEASE|9.27|Ki=540pM|Ki|=|540|pM|0.54|nM
1V2J|1.90|2004|BEN||P00760|TRYPSIN|3.25|Ki=566uM|Ki|=|566|uM|566000|nM
2BES|2.10|2004|RES||Q7D737|CARBOHYDRATE-PHOSPHATE ISOMERASE|4.24|Ki=57uM|Ki|=|57|uM|57000|nM
1REJ|2.20|2004|B1L||P05132|CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTIC|8.3|Ki=5nM|Ki|=|5|nM|5|nM
1RWW|2.80|2004|OQB|compound 20b|P29466|INTERLEUKIN-1 BETA CONVERTASE|8.3|Ki=5nM|Ki|=|5|nM|5|nM
1O5C|1.63|2004|CR9||P00749|UROKINASE-TYPE PLASMINOGEN ACTIVATOR|5.22|Ki=6.0uM|Ki|=|6|uM|6000|nM
1OGG|1.97|2004|3-mer||P11797|CHITINASE B|5.19|Ki=6.4uM|Ki|=|6.4|uM|6400|nM
1RO7|1.80|2004|CSF||Q9LAK3|ALPHA-2,3/8-SIALYLTRANSFERASE|3.18|Ki=657uM|Ki|=|657|uM|657000|nM
1V2S|1.72|2004|BEN||P00760|TRYPSIN|4.17|Ki=68uM|Ki|=|68|uM|68000|nM
1PL0|2.60|2004|BW2|incomplete ligand structure|P31939|BIFUNCTIONAL PURINE BIOSYNTHESIS PROTEIN PURH|8.22|Ki=6nM|Ki|=|6|nM|6|nM
1S38|1.81|2004|MAQ||P28720|QUEUINE TRNA-RIBOSYLTRANSFERASE|5.15|Ki=7.0uM|Ki|=|7|uM|7000|nM
1W5V|1.80|2004|BE3||P03366|HIV-1 PROTEASE|8.15|Ki=7.1nM|Ki|=|7.1|nM|7.1|nM
1THZ|1.80|2004|326||P31335|BIFUNCTIONAL PURINE BIOSYNTHESIS PROTEIN PURH|5.15|Ki=7.1uM|Ki|=|7.1|uM|7100|nM
1O5R|2.35|2004|FR9||P56658|ADENOSINE DEAMINASE|8.12|Ki=7.5nM|Ki|=|7.5|nM|7.5|nM
1Q91|1.60|2004|DPB||Q9NPB1|5'(3')-DEOXYRIBONUCLEOTIDASE|4.15|Ki=70uM|Ki|=|70|uM|70000|nM
1PF7|2.60|2004|IMH||P00491|PURINE NUCLEOSIDE PHOSPHORYLASE|10.14|Ki=72pM|Ki|=|72|pM|0.07200000000000001|nM
1V2Q|2.30|2004|ANH||P00760|TRYPSIN|4.13|Ki=73.62uM|Ki|=|73.62|uM|73620|nM
1SDU|1.25|2004|MK1||P03367|HIV-1 PROTEASE|10.07|Ki=86pM|Ki|=|86|pM|0.08600000000000001|nM
1Q84|2.45|2004|TZ4||P21836|ACETYLCHOLINESTERASE|11.05|Ki=8900fM|Ki|=|8900|fM|0.0089|nM
1TUF|2.40|2004|AZ1||Q58497|DIAMINOPIMELATE DECARBOXYLASE|4.05|Ki=89uM|Ki|=|89|uM|89000|nM
1P4R|2.55|2004|354||P31939|BIFUNCTIONAL PURINE BIOSYNTHESIS PROTEIN PURH|8.1|Ki=8nM|Ki|=|8|nM|8|nM
1V0K|1.03|2004|XDN-XYP||P26514|ENDO-1,4-BETA-XYLANASE A|5.1|Ki=8uM|Ki|=|8|uM|8000|nM
1V0M|1.07|2004|XDN-XYP|redundant to 1v0k|P26514|ENDO-1,4-BETA-XYLANASE A|5.1|Ki=8uM|Ki|=|8|uM|8000|nM
1V7A|2.50|2004|FRC||P56658|ADENOSINE DEAMINASE|8.01|Ki=9.8nM|Ki|=|9.8|nM|9.8|nM
1PWY|2.80|2004|AC2||P00491|PURINE NUCLEOSIDE PHOSPHORYLASE|4.05|Ki=90uM|Ki|=|90|uM|90000|nM
1SH9|2.50|2004|RIT||P03367|HIV-1 PROTEASE|6.03|Ki=932nM|Ki|=|932|nM|932|nM
1V2W|1.75|2004|ANH||P00760|TRYPSIN|4.01|Ki=97.79uM|Ki|=|97.79|uM|97790|nM
1YT9|3.00|2005|OIS||P03368|POL POLYPROTEIN|8.3|IC=0.005uM|IC50|=|0.005|uM|5|nM
1TT1|1.93|2005|KAI|ligand is KAINATE|P42260|GLUTAMATE RECEPTOR, IONOTROPIC KAINATE 2|8.15|IC=0.007uM|IC50|=|0.007|uM|7|nM
2A5U|2.70|2005|QYT||P48736|PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE|8.1|IC=0.008uM|IC50|=|0.008|uM|8|nM
1Z6J|2.00|2005|PY3||P08709|COAGULATION FACTOR VII|8.03|IC=0.0094uM|IC50|=|0.0094|uM|9.4|nM
1WAW|1.75|2005|5-mer||Q13231|CHITOTRIOSIDASE-1|7.89|IC=0.013uM|IC50|=|0.013|uM|13|nM
1YHS|2.15|2005|STU||P11309|SERINE/THREONINE-PROTEIN KINASE|8.0|IC=0.01uM|IC50|=|0.01|uM|10|nM
2B54|1.85|2005|D05||P24941|CELL DIVISION PROTEIN KINASE 2|7.7|IC=0.020uM|IC50|=|0.02|uM|20|nM
1Y2K|1.36|2005|7DE||Q08499|CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D|7.68|IC=0.021uM|IC50|=|0.021|uM|21|nM
1Y2J|2.55|2005|7DE||Q07343|CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B|7.48|IC=0.033uM|IC50|=|0.033|uM|33|nM
1Y2H|2.40|2005|6DE||Q07343|CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B|7.25|IC=0.056uM|IC50|=|0.056|uM|56|nM
1Y91|2.15|2005|CT9||P24941|CELL DIVISION PROTEIN KINASE 2|7.23|IC=0.059uM|IC50|=|0.059|uM|59|nM
1W83|2.50|2005|L11||Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|7.19|IC=0.065uM|IC50|=|0.065|uM|65|nM
1Z4U|2.80|2005|PH9||O93077|HCV NS5B POLYMERASE|7.15|IC=0.07uM|IC50|=|0.07|uM|70|nM
1YVF|2.50|2005|PH7||O93077|HCV NS5B POLYMERASE|7.0|IC=0.10uM|IC50|=|0.1|uM|100|nM
2A3X|3.00|2005|CPK||P02743|SERUM AMYLOID P-COMPONENT|6.92|IC=0.12uM|IC50|=|0.12|uM|120|nM
1YT7|2.30|2005|3FC|covalent complex|P43235|CATHEPSIN K|9.89|IC=0.13nM|IC50|=|0.13|nM|0.13|nM
1S9T|1.80|2005|QUS|ligand is compound 4|P42260|GLUTAMATE RECEPTOR, IONOTROPIC KAINATE 2|6.82|IC=0.15uM|IC50|=|0.15|uM|150|nM
1Y2E|2.10|2005|5DE||Q08499|CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D|6.8|IC=0.16uM|IC50|=|0.16|uM|160|nM
2AI8|1.70|2005|SB7||P0A6K3|PEPTIDE DEFORMYLASE|6.8|IC=0.16uM|IC50|=|0.16|uM|160|nM
1RW8|2.40|2005|580||P36897|TGF-BETA RECEPTOR TYPE-1|6.76|IC=0.175uM|IC50|=|0.175|uM|175|nM
2C1A|1.95|2005|I5S||P00517|CAMP-DEPENDENT PROTEIN KINASE|6.77|IC=0.17uM|IC50|=|0.17|uM|170|nM
2A4Z|2.90|2005|BYM||P48736|PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE|6.6|IC=0.250uM|IC50|=|0.25|uM|250|nM
2BYH|1.90|2005|2D7||P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|6.59|IC=0.258uM|IC50|=|0.258|uM|258|nM
1Y2C|1.67|2005|3DE||Q08499|CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D|6.57|IC=0.27uM|IC50|=|0.27|uM|270|nM
2C6L|2.30|2005|DT4||P24941|CELL DIVISION PROTEIN KINASE 2|6.57|IC=0.27uM|IC50|=|0.27|uM|270|nM
1ZZ3|1.76|2005|3YP||Q70I53|HISTONE DEACETYLASE-LIKE AMIDOHYDROLASE|6.54|IC=0.290uM|IC50|=|0.29|uM|290|nM
1Z6Q|2.03|2005|195||P00489|GLYCOGEN PHOSPHORYLASE|6.7|IC=0.2uM|IC50|=|0.2|uM|200|nM
1WBT|2.00|2005|WBT||Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|6.47|IC=0.34uM|IC50|=|0.34|uM|340|nM
1WBN|2.40|2005|L09||Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|6.46|IC=0.35uM|IC50|=|0.35|uM|350|nM
2C6M|1.90|2005|DT5||P24941|CELL DIVISION PROTEIN KINASE 2|6.46|IC=0.35uM|IC50|=|0.35|uM|350|nM
2C1B|2.00|2005|CQP||P00517|CAMP-DEPENDENT PROTEIN KINASE|6.4|IC=0.40uM|IC50|=|0.4|uM|400|nM
1Z34|2.40|2005|2FD||------|PURINE NUCLEOSIDE PHOSPHORYLASE|3.38|IC=0.42mM|IC50|=|0.42|mM|420000|nM
2BYI|1.60|2005|2DD||P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|6.34|IC=0.461uM|IC50|=|0.461|uM|461|nM
1XHM|2.70|2005|15-mer|Peptide (SIGK) Bound to a G Protein Beta:Gamma Heterodimer, IC50=0.47uM; incomplete ligand|P62871|GUANINE NUCLEOTIDE-BINDING PROTEIN G(I)/G(S)|6.33|IC=0.47uM|IC50|=|0.47|uM|470|nM
2AI7|2.00|2005|SB7||Q8DP79|PEPTIDE DEFORMYLASE|6.4|IC=0.4uM|IC50|=|0.4|uM|400|nM
1WZY|2.50|2005|F29||P28482|MITOGEN-ACTIVATED PROTEIN KINASE 1|6.25|IC=0.56uM|IC50|=|0.56|uM|560|nM
1ZH7|2.50|2005|11-mer||P45448|ORPHAN NUCLEAR RECEPTOR NR5A2|6.3|IC=0.5uM|IC50|=|0.5|uM|500|nM
1R6G|3.00|2005|442||P10828|THYROID HORMONE RECEPTOR BETA-1|9.21|IC=0.62nM|IC50|=|0.62|nM|0.62|nM
1WBS|1.80|2005|LI2||Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|6.2|IC=0.63uM|IC50|=|0.63|uM|630|nM
2B53|2.00|2005|D23||P24941|CELL DIVISION PROTEIN KINASE 2|6.22|IC=0.6uM|IC50|=|0.6|uM|600|nM
2C6K|1.90|2005|DT2||P24941|CELL DIVISION PROTEIN KINASE 2|6.14|IC=0.73uM|IC50|=|0.73|uM|730|nM
2BZ5|1.90|2005|AB4||P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|6.15|IC=0.7uM|IC50|=|0.7|uM|700|nM
1XO2|2.90|2005|FSE||Q01043|CELL DIVISION PROTEIN KINASE 6|6.07|IC=0.85uM|IC50|=|0.85|uM|850|nM
1YOU|2.30|2005|PFD||P45452|COLLAGENASE 3|9.06|IC=0.87nM|IC50|=|0.87|nM|0.87|nM
2B5J|2.90|2005|3AC||P03366|HIV-1 REVERSE TRANSCRIPTASE P66 SUBUNIT|9.1|IC=0.8nM|IC50|=|0.8|nM|0.8|nM
1ZZ1|1.57|2005|SHH||Q70I53|HISTONE DEACETYLASE-LIKE AMIDOHYDROLASE|6.02|IC=0.95uM|IC50|=|0.95|uM|950|nM
1Z6P|2.40|2005|194||P00489|GLYCOGEN PHOSPHORYLASE|6.05|IC=0.9uM|IC50|=|0.9|uM|900|nM
2A3I|1.95|2005|12-mer|MR bound to the SRC1-4 motif with a highest affinity IC50=0.9uM|P08235|MINERALOCORTICOID RECEPTOR|6.05|IC=0.9uM|IC50|=|0.9|uM|900|nM
1YC5|1.40|2005|NCA||Q9WYW0|NAD-DEPENDENT DEACETYLASE|3.0|IC=1.0mM|IC50|=|1|mM|1000000|nM
2C4G|2.70|2005|514||P24941|CELL DIVISION PROTEIN KINASE 2|5.94|IC=1.15uM|IC50|=|1.15|uM|1150|nM
1W1T|1.90|2005|CHQ||Q54276|CHITINASE B|2.96|IC=1.1mM|IC50|=|1.1|mM|1100000|nM
1U3S|2.50|2005|797||Q92731|ESTROGEN RECEPTOR BETA|8.85|IC=1.4nM|IC50|=|1.4|nM|1.4|nM
2BRO|2.20|2005|DF2||O14757|SERINE/THREONINE-PROTEIN KINASE CHK1|5.85|IC=1.4uM|IC50|=|1.4|uM|1400|nM
1ZYJ|2.00|2005|BI5||Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|5.82|IC=1.5uM|IC50|=|1.5|uM|1500|nM
2BGE|1.80|2005|T2D|ligand is compound 20|P18031|PROTEIN-TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1|2.8|IC=1.6mM|IC50|=|1.6|mM|1600000|nM
1WUG|NMR|2005|NP1||Q92831|HISTONE ACETYLTRANSFERASE PCAF|5.8|IC=1.6uM|IC50|=|1.6|uM|1600|nM
1ZUC|2.00|2005|T98||P06401|PROGESTERONE RECEPTOR|8.77|IC=1.7nM|IC50|=|1.7|nM|1.7|nM
2C68|1.95|2005|CT6||P24941|CELL DIVISION PROTEIN KINASE 2|5.74|IC=1.8uM|IC50|=|1.8|uM|1800|nM
1X76|2.20|2005|697||Q92731|ESTROGEN RECEPTOR BETA|8.72|IC=1.9nM|IC50|=|1.9|nM|1.9|nM
1Z3C|2.20|2005|SA8||Q8SR66|MRNA CAPPING ENZYME|4.0|IC=100uM|IC50|=|100|uM|100000|nM
1X7E|2.80|2005|244||P03372|ESTROGEN RECEPTOR ALPHA|5.97|IC=1062.5nM|IC50|=|1062.5|nM|1062.5|nM
2C6I|1.80|2005|DT1||P24941|CELL DIVISION PROTEIN KINASE 2|4.96|IC=11uM|IC50|=|11|uM|11000|nM
1ZP5|1.80|2005|2NI||P22894|NEUTROPHIL COLLAGENASE (MMP-8)|2.92|IC=1200uM|IC50|=|1200|uM|1200000|nM
1WQV|2.50|2005|PSM||P08709|COAGULATION FACTOR VII|6.89|IC=130nM|IC50|=|130|nM|130|nM
2F6Y|2.15|2005|ENT||P18031|PROTEIN-TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1|3.87|IC=134.8uM|IC50|=|134.8|uM|134800|nM
1YWR|1.95|2005|LI9|IC50 measured on TNF-alpha|P47811|MITOGEN-ACTIVATED PROTEIN KINASE 14|7.89|IC=13nM|IC50|=|13|nM|13|nM
1X78|2.30|2005|244||Q92731|ESTROGEN RECEPTOR BETA|7.85|IC=14.0nM|IC50|=|14|nM|14|nM
1YMX|1.70|2005|CFX|covalent complex|Q9L5C8|BETA-LACTAMASE CTX-M-9|4.85|IC=14.0uM|IC50|=|14|uM|14000|nM
1YW2|2.01|2005|PGJ|IC50 measured on TNF-alpha|P47811|MITOGEN-ACTIVATED PROTEIN KINASE 14|6.85|IC=141nM|IC50|=|141|nM|141|nM
1YHM|2.50|2005|AHD||Q8WS26|FARNESYL PYROPHOSPHATE SYNTHASE|3.83|IC=147uM|IC50|=|147|uM|147000|nM
2A3A|2.10|2005|TEP||Q873X9|CHITINASE|2.82|IC=1500uM|IC50|=|1500|uM|1500000|nM
2B8L|1.70|2005|5HA||P56817|BETA-SECRETASE 1|7.82|IC=15nM|IC50|=|15|nM|15|nM
1TTV|NMR|2005|IMY||P56273|E3 UBIQUITIN-PROTEIN LIGASE MDM2|6.8|IC=160nM|IC50|=|160|nM|160|nM
1WBV|2.00|2005|LI3||Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|3.79|IC=162uM|IC50|=|162|uM|162000|nM
1Y57|1.91|2005|MPZ||P12931|TYROSINE-PROTEIN KINASE SRC|5.79|IC=1633nM|IC50|=|1633|nM|1633|nM
1XH8|1.60|2005|R55||P00517|CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTIC|5.77|IC=1700nM|IC50|=|1700|nM|1700|nM
1WSS|2.60|2005|3CB||P08709|COAGULATION FACTOR VII|7.77|IC=17nM|IC50|=|17|nM|17|nM
1X7Q|1.45|2005|9-mer||P13746|HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-11|6.73|IC=186nM|IC50|=|186|nM|186|nM
1WU1|2.30|2005|D91||P00742|COAGULATION FACTOR X, HEAVY CHAIN|7.74|IC=18nM|IC50|=|18|nM|18|nM
1X70|2.10|2005|715||P27487|DIPEPTIDYL PEPTIDASE 4|7.74|IC=18nM|IC50|=|18|nM|18|nM
1W82|2.20|2005|L10||Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|6.71|IC=196nM|IC50|=|196|nM|196|nM
1YK7|2.50|2005|NBL|covalent complex|P43235|CATHEPSIN K|7.72|IC=19nM|IC50|=|19|nM|19|nM
1WBG|2.20|2005|L03||P00734|THROMBIN|3.0|IC=1mM|IC50|=|1|mM|1000000|nM
1Z9H|2.60|2005|IMN||Q9N0A4|MEMBRANE-ASSOCIATED PROSTAGLANDIN E SYNTHASE-2|3.0|IC=1mM|IC50|=|1|mM|1000000|nM
2BAN|2.95|2005|357||P03366|HIV-1 REVERSE TRANSCRIPTASE P66 SUBUNIT|9.0|IC=1nM|IC50|=|1|nM|1|nM
1ZGV|2.20|2005|501||P00734|THROMBIN|6.0|IC=1uM|IC50|=|1|uM|1000|nM
1Y2D|1.70|2005|4DE||Q08499|CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D|5.7|IC=2.0uM|IC50|=|2|uM|2000|nM
2AIE|1.70|2005|SB9||Q8DP79|PEPTIDE DEFORMYLASE|5.66|IC=2.2uM|IC50|=|2.2|uM|2200|nM
1W1Y|1.85|2005|TYP||Q54276|CHITINASE B|2.62|IC=2.4mM|IC50|=|2.4|mM|2400000|nM
2BBB|1.70|2005|HH1||Q5RZ09|HIV-1 PROTEASE|8.62|IC=2.4nM|IC50|=|2.4|nM|2.4|nM
2F71|1.55|2005|UN7||P18031|PROTEIN-TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1|5.6|IC=2.5uM|IC50|=|2.5|uM|2500|nM
1X0N|NMR|2005|DTF|ligand is compound 4|P62993|GROWTH FACTOR RECEPTOR-BOUND PROTEIN 2|7.7|IC=20nM|IC50|=|20|nM|20|nM
2BTS|1.99|2005|U32||P24941|CELL DIVISION PROTEIN KINASE 2|7.7|IC=20nM|IC50|=|20|nM|20|nM
2BRH|2.10|2005|DFW||O14757|SERINE/THREONINE-PROTEIN KINASE CHK1|4.64|IC=22.9uM|IC50|=|22.9|uM|22900|nM
1Y6A|2.10|2005|AAZ||P35968|VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2|7.66|IC=22nM|IC50|=|22|nM|22|nM
2C69|2.10|2005|CT8||P24941|CELL DIVISION PROTEIN KINASE 2|4.59|IC=26uM|IC50|=|26|uM|26000|nM
2BMC|2.60|2005|MPY||O14965|SERINE THREONINE-PROTEIN KINASE 6|7.57|IC=27nM|IC50|=|27|nM|27|nM
1SVG|2.02|2005|I04||P00517|CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTIC|8.7|IC=2nM|IC50|=|2|nM|2|nM
2BE2|2.43|2005|R22||P03366|HIV-1 REVERSE TRANSCRIPTASE P66 SUBUNIT|8.7|IC=2nM|IC50|=|2|nM|2|nM
2BPM|2.40|2005|529||P24941|CELL DIVISION PROTEIN KINASE 2|8.7|IC=2nM|IC50|=|2|nM|2|nM
2BW7|2.30|2005|ECS||O32393|ADENYLATE CYCLASE|5.7|IC=2uM|IC50|=|2|uM|2000|nM
1U3Q|2.40|2005|272||Q92731|ESTROGEN RECEPTOR BETA|8.46|IC=3.5nM|IC50|=|3.5|nM|3.5|nM
1U9W|2.30|2005|IHI|covalent complex|P43235|CATHEPSIN K|8.46|IC=3.5nM|IC50|=|3.5|nM|3.5|nM
1YND|1.60|2005|SFA||P62937|PEPTIDYL-PROLYL CIS-TRANS ISOMERASE A|8.44|IC=3.6nM|IC50|=|3.6|nM|3.6|nM
2A3W|2.20|2005|CPJ||P02743|SERUM AMYLOID P-COMPONENT|5.42|IC=3.8uM|IC50|=|3.8|uM|3800|nM
2AIA|1.70|2005|SB8||Q8DP79|PEPTIDE DEFORMYLASE|5.41|IC=3.9uM|IC50|=|3.9|uM|3900|nM
1Z5M|2.17|2005|LI8||O15530|3-PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE 1|7.52|IC=30nM|IC50|=|30|nM|30|nM
1ZKN|2.10|2005|IBM||Q08499|CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D|4.51|IC=31uM|IC50|=|31|uM|31000|nM
2F70|2.12|2005|UN6||P18031|PROTEIN-TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1|4.47|IC=33.5uM|IC50|=|33.5|uM|33500|nM
1WOK|3.00|2005|CNQ||P09874|POLY [ADP-RIBOSE] POLYMERASE 1|7.48|IC=33nM|IC50|=|33|nM|33|nM
1WCC|2.20|2005|CIG||P24941|CELL DIVISION PROTEIN KINASE 2|3.46|IC=350uM|IC50|=|350|uM|350000|nM
1W84|2.20|2005|L12||Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|4.46|IC=35uM|IC50|=|35|uM|35000|nM
1SVH|2.30|2005|I08||P00517|CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTIC|6.44|IC=360nM|IC50|=|360|nM|360|nM
2F6V|1.70|2005|SK2||P18031|PROTEIN-TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1|4.43|IC=37uM|IC50|=|37|uM|37000|nM
1Y6B|2.10|2005|AAX||P35968|VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2|7.42|IC=38nM|IC50|=|38|nM|38|nM
1VEB|2.89|2005|I05||P00517|CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTIC|7.41|IC=39nM|IC50|=|39|nM|39|nM
1YI3|2.50|2005|LY2||P11309|SERINE/THREONINE-PROTEIN KINASE|5.4|IC=4.0uM|IC50|=|4|uM|4000|nM
1X7B|2.30|2005|041||Q92731|ESTROGEN RECEPTOR BETA|8.39|IC=4.1nM|IC50|=|4.1|nM|4.1|nM
1YVZ|2.20|2005|JPC||P26660|RNA-DEPENDENT RNA POLYMERASE|5.36|IC=4.4uM|IC50|=|4.4|uM|4400|nM
1WB0|1.65|2005|5-mer||Q13231|CHITOTRIOSIDASE 1|5.35|IC=4.5uM|IC50|=|4.5|uM|4500|nM
1U9Q|2.30|2005|186|covalent complex|P25779|CRUZIPAIN|8.33|IC=4.7nM|IC50|=|4.7|nM|4.7|nM
2F6Z|1.70|2005|UN5||P18031|PROTEIN-TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1|5.32|IC=4.8uM|IC50|=|4.8|uM|4800|nM
1WAY|2.02|2005|L02||P00734|THROMBIN|3.4|IC=400uM|IC50|=|400|uM|400000|nM
1XOG|2.80|2005|ABW||P03472|NEURAMINIDASE|6.39|IC=410nM|IC50|=|410|nM|410|nM
1XOE|2.20|2005|ABX||P03472|NEURAMINIDASE|7.39|IC=41nM|IC50|=|41|nM|41|nM
1WBW|2.41|2005|LI4||Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|4.36|IC=44uM|IC50|=|44|uM|44000|nM
1YRS|2.50|2005|L47|ternary complex of KSP-4-ADP(Mg2+), IC50 for inhibitor 4|P52732|KINESIN-LIKE PROTEIN KIF11|6.35|IC=450nM|IC50|=|450|nM|450|nM
2A3B|1.90|2005|CFF||Q873X9|CHITINASE|3.33|IC=469uM|IC50|=|469|uM|469000|nM
1W1P|2.10|2005|GIO||Q54276|CHITINASE B|2.3|IC=5.0mM|IC50|=|5|mM|5000000|nM
1ZZL|2.00|2005|TZY||Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|8.3|IC=5.0nM|IC50|=|5|nM|5|nM
1WUM|NMR|2005|NP2||Q92831|HISTONE ACETYLTRANSFERASE PCAF|5.29|IC=5.1uM|IC50|=|5.1|uM|5100|nM
2BRN|2.80|2005|DF1||O14757|SERINE/THREONINE-PROTEIN KINASE CHK1|5.26|IC=5.5uM|IC50|=|5.5|uM|5500|nM
1U9E|2.40|2005|397||Q92731|ESTROGEN RECEPTOR BETA|8.24|IC=5.7nM|IC50|=|5.7|nM|5.7|nM
1ZRZ|3.00|2005|BI1||P41743|PROTEIN KINASE C, IOTA|5.24|IC=5.8uM|IC50|=|5.8|uM|5800|nM
1WV7|2.70|2005|5PI||P08709|COAGULATION FACTOR VII|7.26|IC=55nM|IC50|=|55|nM|55|nM
1SVE|2.49|2005|I01||P00517|CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTIC|8.3|IC=5nM|IC50|=|5|nM|5|nM
1U3R|2.21|2005|338||Q92731|ESTROGEN RECEPTOR BETA|8.3|IC=5nM|IC50|=|5|nM|5|nM
1W0X|2.20|2005|OLO|ligand is compound 5, olomoucine|P24941|CYCLIN-DEPENDENT KINASE 2|5.3|IC=5uM|IC50|=|5|uM|5000|nM
1ZZ2|2.00|2005|B11||Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|5.22|IC=6.0uM|IC50|=|6|uM|6000|nM
2BRG|2.10|2005|DFY||O14757|SERINE/THREONINE-PROTEIN KINASE CHK1|5.21|IC=6.1uM|IC50|=|6.1|uM|6100|nM
1W1V|1.85|2005|ALJ||Q54276|CHITINASE B|2.2|IC=6.3mM|IC50|=|6.3|mM|6300000|nM
1SQP|2.70|2005|MYX|myxothiazol to bovine and yeast bc1, similar IC50=6.3nM|P31800|UBIQUINOL-CYTOCHROME-C REDUCTASE COMPLEX CORE|8.2|IC=6.3nM|IC50|=|6.3|nM|6.3|nM
1WUN|2.40|2005|P5B||P08709|COAGULATION FACTOR VII|7.21|IC=62nM|IC50|=|62|nM|62|nM
1XQC|2.05|2005|AEJ||P03372|ESTROGEN RECEPTOR|7.2|IC=63nM|IC50|=|63|nM|63|nM
1XUR|1.85|2005|PB5||P45452|COLLAGENASE 3|5.18|IC=6600nM|IC50|=|6600|nM|6600|nM
1XUO|1.80|2005|LA1||P20701|INTEGRIN ALPHA-L|7.16|IC=69nM|IC50|=|69|nM|69|nM
1U9V|2.20|2005|IHE|covalent complex|P43235|CATHEPSIN K|8.22|IC=6nM|IC50|=|6|nM|6|nM
1XUC|1.70|2005|PB3||P45452|COLLAGENASE 3|7.14|IC=72nM|IC50|=|72|nM|72|nM
1U9X|2.10|2005|IHJ|covalent complex|P43235|CATHEPSIN K|8.15|IC=7nM|IC50|=|7|nM|7|nM
1YVX|2.00|2005|IPC||P26660|RNA-DEPENDENT RNA POLYMERASE|5.1|IC=8.0uM|IC50|=|8|uM|8000|nM
1ZKL|1.67|2005|IBM||Q13946|CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 7A|5.09|IC=8.1uM|IC50|=|8.1|uM|8100|nM
1WXZ|2.80|2005|FRL|IC50 measured on human ADA|P56658|ADENOSINE DEAMINASE|8.07|IC=8.6nM|IC50|=|8.6|nM|8.6|nM
1ZGB|2.30|2005|A1E|IC50 measured on rat AChE/A1E|P04058|ACETYLCHOLINESTERASE|8.06|IC=8.8nM|IC50|=|8.8|nM|8.8|nM
2BRC|1.60|2005|CT5||P02829|ATP-DEPENDENT MOLECULAR CHAPERONE HSP82|5.05|IC=8.9uM|IC50|=|8.9|uM|8900|nM
1Y2B|1.40|2005|DEE||Q08499|CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D|4.09|IC=82uM|IC50|=|82|uM|82000|nM
1WAX|2.20|2005|LO1||P18031|PROTEIN-TYROSINE PHOSPHATASE|4.07|IC=86uM|IC50|=|86|uM|86000|nM
1XUD|1.80|2005|PB4||P45452|COLLAGENASE 3|8.1|IC=8nM|IC50|=|8|nM|8|nM
1ZXC|2.28|2005|IH6||P78536|TNF-ALPHA-CONVERTING ENZYME, ADAM 17|8.1|IC=8nM|IC50|=|8|nM|8|nM
2B52|1.88|2005|D42||P24941|CELL DIVISION PROTEIN KINASE 2|8.1|IC=8nM|IC50|=|8|nM|8|nM
1ZAJ|1.89|2005|M2P|ligand is Mannitol Bis-phosphate (MBP)|P00883|FRUCTOSE-BISPHOSPHATE ALDOLASE A|5.1|IC=8uM|IC50|=|8|uM|8000|nM
1WTG|2.20|2005|3BP||P08709|COAGULATION FACTOR VII|7.03|IC=93nM|IC50|=|93|nM|93|nM
2BTR|1.85|2005|U73||P24941|CELL DIVISION PROTEIN KINASE 2|7.02|IC=95nM|IC50|=|95|nM|95|nM
2B55|1.85|2005|D31||P24941|CELL DIVISION PROTEIN KINASE 2|7.02|IC=96nM|IC50|=|96|nM|96|nM
1X8B|1.81|2005|824|ligand is compound 1|P30291|WEE1-LIKE PROTEIN KINASE|7.01|IC=97nM|IC50|=|97|nM|97|nM
2B8V|1.80|2005|3BN||P56817|BETA-SECRETASE 1|7.01|IC=98nM|IC50|=|98|nM|98|nM
1X7R|2.00|2005|GEN|IC50 measured on estrogen receptor beta|P03372|ESTROGEN RECEPTOR ALPHA|8.05|IC=9nM|IC50|=|9|nM|9|nM
1ZM7|2.20|2005|TTP||Q9XZT6|DEOXYNUCLEOSIDE KINASE|3.0|IC>1000uM|IC50|>|1000|uM|1000000|nM
1W7H|2.21|2005|3IP||Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|3.0|IC>1mM|IC50|>|1|mM|1000000|nM
1WBO|2.16|2005|2CH||Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|3.0|IC>1mM|IC50|>|1|mM|1000000|nM
2BGD|2.40|2005|T1D|IC50=2.47uM|P18031|PROTEIN-TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1|5.0|Kd<10uM|Kd|<|10|uM|10000|nM
1TFT|NMR|2005|997||P98170|BACULOVIRAL IAP REPEAT-CONTAINING PROTEIN 4|8.3|Kd=0.005uM|Kd|=|0.005|uM|5|nM
1T13|2.90|2005|INI||Q44668|6,7-DIMETHYL-8-RIBITYLLUMAZINE SYNTHASE|7.38|Kd=0.042uM|Kd|=|0.042|uM|42|nM
2BFQ|1.50|2005|AR6||O28751|HYPOTHETICAL PROTEIN AF1521|6.89|Kd=0.13uM|Kd|=|0.13|uM|130|nM
1XT8|2.00|2005|CYS||Q0P9S0|PUTATIVE AMINO-ACID TRANSPORTER PERIPLASMIC|6.85|Kd=0.14uM|Kd|=|0.14|uM|140|nM
1TR7|2.10|2005|DEG|redundant to 1uwf|P08191|FIMH PROTEIN|6.82|Kd=0.15uM|Kd|=|0.15|uM|150|nM
1UWF|1.69|2005|DEG||P08191|FIMH PROTEIN|6.82|Kd=0.15uM|Kd|=|0.15|uM|150|nM
2F01|0.85|2005|BTN||P22629|STREPTAVIDIN|13.0|Kd=0.1pM|Kd|=|0.1|pM|0.0001|nM
1TMM|1.25|2005|APC|Kd for Mg-APC|P26281|2-AMINO-4-HYDROXY-6-HYDROXYMETHYLDIHYDROPTERIDINE|6.64|Kd=0.23uM|Kd|=|0.23|uM|230|nM
1ZUB|NMR|2005|11-mer|incomplete ligand|Q9JIR4|REGULATING SYNAPTIC MEMBRANE EXOCYTOSIS PROTEIN|6.57|Kd=0.27uM|Kd|=|0.27|uM|270|nM
2BMZ|2.40|2005|XLM||O22321|RIPENING-ASSOCIATED PROTEIN|3.7|Kd=0.2mM|Kd|=|0.2|mM|200000|nM
1YSG|NMR|2005|4FC||Q07817|APOPTOSIS REGULATOR BCL-X|3.52|Kd=0.30mM|Kd|=|0.3|mM|300000|nM
2AA6|1.95|2005|STR|ligand is Progesterone|P08235|MINERALOCORTICOID RECEPTOR|9.41|Kd=0.39nM|Kd|=|0.39|nM|0.39|nM
2BYS|2.05|2005|LOB||Q8WSF8|ACETYLCHOLINE RECEPTOR|9.52|Kd=0.3nM|Kd|=|0.3|nM|0.3|nM
1W9V|2.00|2005|5-mer|IC50=1.1uM|Q873X9|CHITINASE|6.34|Kd=0.46uM|Kd|=|0.46|uM|460|nM
1Z2B|4.10|2005|VLB||P63043|TUBULIN ALPHA CHAIN|6.4|Kd=0.4uM|Kd|=|0.4|uM|400|nM
2AO6|1.89|2005|R18|redundant to 1xow but in lower resoltuion|P10275|ANDROGEN RECEPTOR|9.28|Kd=0.52nM|Kd|=|0.52|nM|0.52|nM
1S5Z|2.00|2005|SON|Kd=0.62+/-0.05mM; Ki=1.3+/-0.2mM|P22887|NUCLEOSIDE DIPHOSPHATE KINASE|3.21|Kd=0.62mM|Kd|=|0.62|mM|620000|nM
2BT9|0.94|2005|MFU||Q8XXK6|LECTIN|6.19|Kd=0.64uM|Kd|=|0.64|uM|640|nM
1Y8P|2.63|2005|ATP||Q15120|PYRUVATE DEHYDROGENASE [LIPOAMIDE] KINASE|6.08|Kd=0.84uM|Kd|=|0.84|uM|840|nM
1YY6|1.70|2005|10-mer|incomplete ligand|Q93009|UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 7|6.07|Kd=0.86uM|Kd|=|0.86|uM|860|nM
2BYP|2.07|2005|12-mer||Q8WSF8|ACETYLCHOLINE RECEPTOR|9.06|Kd=0.88nM|Kd|=|0.88|nM|0.88|nM
1KJR|1.55|2005|3-mer||P17931|GALECTIN-3|6.06|Kd=0.88uM|Kd|=|0.88|uM|880|nM
1WS5|1.90|2005|MAM||P18670|AGGLUTININ ALPHA CHAIN|3.03|Kd=0.926mM|Kd|=|0.926|mM|926000|nM
1WS4|1.90|2005|GYP||P18670|AGGLUTININ ALPHA CHAIN|3.0|Kd=1.00mM|Kd|=|1|mM|1000000|nM
2ASU|1.85|2005|19-mer|covalent complex; incomplete ligand|P26927|HEPATOCYTE GROWTH FACTOR-LIKE PROTEIN|9.0|Kd=1.0nM|Kd|=|1|nM|1|nM
1XK5|2.40|2005|TPG||O95149|SNURPORTIN-1|6.0|Kd=1.0uM|Kd|=|1|uM|1000|nM
1Y8O|2.48|2005|ADP||Q15120|PYRUVATE DEHYDROGENASE [LIPOAMIDE] KINASE|5.89|Kd=1.30uM|Kd|=|1.3|uM|1300|nM
1YDK|1.95|2005|GTX||P08263|GLUTATHIONE S-TRANSFERASE A1|5.89|Kd=1.3uM|Kd|=|1.3|uM|1300|nM
2A29|NMR|2005|ANP||P03960|POTASSIUM-TRANSPORTING ATPASE B CHAIN|2.85|Kd=1.4mM|Kd|=|1.4|mM|1400000|nM
1WDQ|1.28|2005|MAL||P10538|BETA-AMYLASE|1.98|Kd=10.45mM|Kd|=|10.45|mM|10450000|nM
1VYJ|2.80|2005|16-mer||P12004|PROLIFERATING CELL NUCLEAR ANTIGEN|7.0|Kd=100nM|Kd|=|100|nM|100|nM
1YCM|NMR|2005|NGH||P39900|MACROPHAGE METALLOELASTASE|8.0|Kd=10nM|Kd|=|10|nM|10|nM
1Z3J|NMR|2005|NGH||P39900|MACROPHAGE METALLOELASTASE|8.0|Kd=10nM|Kd|=|10|nM|10|nM
1YID|2.40|2005|ATP|Kd for Mg-ATP|Q9RVD6|TRYPTOPHANYL-TRNA SYNTHETASE|5.0|Kd=10uM|Kd|=|10|uM|10000|nM
1YKP|2.41|2005|DHB||P00436|PROTOCATECHUATE 3,4-DIOXYGENASE ALPHA CHAIN|2.96|Kd=1100uM|Kd|=|1100|uM|1100000|nM
1X9D|1.41|2005|SMD||Q9UKM7|ENDOPLASMIC RETICULUM MANNOSYL-OLIGOSACCHARIDE 1|3.96|Kd=110uM|Kd|=|110|uM|110000|nM
1Z3T|1.70|2005|CBI||Q7LIJ0|CELLULASE|3.94|Kd=115uM|Kd|=|115|uM|115000|nM
2A58|2.80|2005|RBF||Q9UUB1|6,7-DIMETHYL-8-RIBITYLLUMAZINE SYNTHASE|4.92|Kd=12.0uM|Kd|=|12|uM|12000|nM
1Y2F|2.00|2005|WAI||P77173|CELL DIVISION PROTEIN ZIPA|4.92|Kd=12uM|Kd|=|12|uM|12000|nM
1XFV|3.35|2005|3AT||P40136|CALMODULIN-SENSITIVE ADENYLATE CYCLASE|3.89|Kd=130uM|Kd|=|130|uM|130000|nM
1XH7|2.47|2005|R96|IC50=1900nM|P00517|CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTIC|6.82|Kd=150nM|Kd|=|150|nM|150|nM
1SQQ|3.00|2005|OST|MOAS to bovine bc1, Kd=15nM, to yeast bc1, Kd=2nM|P31800|UBIQUINOL-CYTOCHROME-C REDUCTASE COMPLEX CORE|7.82|Kd=15nM|Kd|=|15|nM|15|nM
1Y3P|2.00|2005|4-mer||Q9KWT6|ALGINATE-BINDING PROTEIN, ALGQ1|4.82|Kd=15uM|Kd|=|15|uM|15000|nM
2A0T|NMR|2005|10-mer|Kd by HSQC|P22216|SERINE/THREONINE-PROTEIN KINASE RAD53|4.82|Kd=15uM|Kd|=|15|uM|15000|nM
1YWH|2.70|2005|13-mer||Q9UMV0|UROKINASE PLASMINOGEN ACTIVATOR SURFACE RECEPTOR|7.79|Kd=16.4nM|Kd|=|16.4|nM|16.4|nM
1U1B|2.00|2005|PAX||P61823|RIBONUCLEASE A|7.8|Kd=16nM|Kd|=|16|nM|16|nM
1Y19|2.60|2005|14-mer|Kd=170+/-5nM(for phosphorylated peptide); Kd=271+/-0.6nM(for unphosphorylated peptide); incomplete ligand|O70161|PHOSPHATIDYLINOSITOL-4-PHOSPHATE 5-KINASE, TYPE|6.77|Kd=170nM|Kd|=|170|nM|170|nM
1XH9|1.64|2005|R69||P00517|CAMP-DEPENDENT PROTEIN KINASE|7.77|Kd=17nM|Kd|=|17|nM|17|nM
2B2V|2.65|2005|16-mer|incomplete ligand|O14646|CHROMODOMAIN-HELICASE-DNA-BINDING PROTEIN 1|4.77|Kd=17uM|Kd|=|17|uM|17000|nM
1Y0L|2.50|2005|HAN||------|ANTIBODY FAB 34E4, LIGHT CHAIN|9.0|Kd=1nM|Kd|=|1|nM|1|nM
1T7J|2.20|2005|478||P35963|HIV-1 PROTEASE|8.7|Kd=2.0nM|Kd|=|2|nM|2|nM
2BZ8|2.00|2005|11-mer|Kd=2.5+/-1.0uM|Q96B97|SH3-DOMAIN KINASE BINDING PROTEIN 1|5.6|Kd=2.5uM|Kd|=|2.5|uM|2500|nM
2BYR|2.45|2005|MLK||Q8WSF8|ACETYLCHOLINE RECEPTOR|8.55|Kd=2.8nM|Kd|=|2.8|nM|2.8|nM
1Y3N|1.60|2005|2-mer|ligand is BEM-MAV|Q9KWT6|ALGINATE-BINDING PROTEIN, ALGQ1|5.55|Kd=2.8uM|Kd|=|2.8|uM|2800|nM
2C2L|3.30|2005|10-mer|incomplete ligand structure|Q9DCJ0|CARBOXY TERMINUS OF HSP70-INTERACTING PROTEIN|5.55|Kd=2.8uM|Kd|=|2.8|uM|2800|nM
1XGE|1.90|2005|DOR||P05020|DIHYDROOROTASE|4.68|Kd=20.8uM|Kd|=|20.8|uM|20800|nM
1XR8|2.30|2005|9-mer||P30464|HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-15|6.7|Kd=200nM|Kd|=|200|nM|200|nM
1W70|1.46|2005|15-mer|incomplete ligand structure|Q15080|NEUTROPHIL CYTOSOL FACTOR 4|3.7|Kd=200uM|Kd|=|200|uM|200000|nM
2BJM|2.15|2005|ANF||P01751|ANTIBODY IGE SPE7 LIGHT CHAIN|3.7|Kd=200uM|Kd|=|200|uM|200000|nM
2AGV|2.40|2005|BHQ||P04191|SARCOPLASMIC/ENDOPLASMIC RETICULUM CALCIUM ATPASE 1, SERCA1A|7.7|Kd=20nM|Kd|=|20|nM|20|nM
2ARM|1.23|2005|OIN|Ki=7.4nM|P59071|PHOSPHOLIPASE A2|7.68|Kd=21nM|Kd|=|21|nM|21|nM
2A25|2.20|2005|13-mer|Kd=24+/-4uM; incomplete ligand|Q8IUQ4|E3 UBIQUITIN-PROTEIN LIGASE SIAH1|4.62|Kd=24uM|Kd|=|24|uM|24000|nM
2C3I|1.90|2005|IYZ|ligand is compound imidazo[1,2-b]pyridazine 1|P11309|SERINE/THREONINE-PROTEIN KINASE PIM-1|7.6|Kd=25nM|Kd|=|25|nM|25|nM
1WVA|1.94|2005|S2C|B-containing|P05089|ARGINASE 1|6.57|Kd=270nM|Kd|=|270|nM|270|nM
1YC4|1.81|2005|43P||P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|6.55|Kd=280nM|Kd|=|280|nM|280|nM
1WDR|1.35|2005|MAL||P10538|BETA-AMYLASE|2.52|Kd=3.05mM|Kd|=|3.05|mM|3050000|nM
1Y98|2.50|2005|12-mer||P38398|BREAST CANCER TYPE 1 SUSCEPTIBILITY PROTEIN|5.43|Kd=3.7uM|Kd|=|3.7|uM|3700|nM
1W96|1.80|2005|S1A||Q00955|ACETYL-COA CARBOXYLASE|8.41|Kd=3.9nM|Kd|=|3.9|nM|3.9|nM
1Y3A|2.50|2005|16-mer|ligand is KB752 peptide, Kd=3.9+/-0.6uM, EC50 for GEF activity is 5.6+/-1.1 uM; incomplete ligand|P63096|GUANINE NUCLEOTIDE-BINDING PROTEIN G(I), ALPHA-1|5.41|Kd=3.9uM|Kd|=|3.9|uM|3900|nM
1ZHY|1.60|2005|CLR||P35844|KES1 PROTEIN|6.52|Kd=300nM|Kd|=|300|nM|300|nM
1XZ8|2.80|2005|U5P||P41007|PYRR BIFUNCTIONAL PROTEIN|4.52|Kd=30uM|Kd|=|30|uM|30000|nM
2A4M|2.30|2005|TRP||Q9RVD6|TRYPTOPHANYL-TRNA SYNTHETASE II|4.52|Kd=30uM|Kd|=|30|uM|30000|nM
2BR8|2.40|2005|17-mer|Kd=32.6+/-8.5nM(ITC); IC50=28+/-6nM; EC50calc=21+/-7nM.|Q8WSF8|ACETYLCHOLINE RECEPTOR|7.49|Kd=32.6nM|Kd|=|32.6|nM|32.6|nM
1ZKK|1.45|2005|10-mer|incomplete ligand structure|Q9NQR1|HISTONE-LYSINE N-METHYLTRANSFERASE, H4 LYSINE-20|4.48|Kd=33uM|Kd|=|33|uM|33000|nM
1XH5|2.05|2005|R68|IC50=2400nM|P00517|CAMP-DEPENDENT PROTEIN KINASE|5.47|Kd=3400nM|Kd|=|3400|nM|3400|nM
1XH4|2.45|2005|R69|IC50=30nM|P00517|CAMP-DEPENDENT PROTEIN KINASE|7.47|Kd=34nM|Kd|=|34|nM|34|nM
2BJ4|2.00|2005|11-mer|ER LBD with a 11-mer peptide corresponding to the alpha-II interaction motif (LTSRDFGSWYA)|P03372|ESTROGEN RECEPTOR|4.47|Kd=34uM|Kd|=|34|uM|34000|nM
1ZHK|1.60|2005|13-mer||P30685|HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-35|4.45|Kd=35.2uM|Kd|=|35.2|uM|35200|nM
1YWI|NMR|2005|10-mer|Kd=371+/-22uM; incomplete ligand|O75400|FORMIN-BINDING PROTEIN 3|3.43|Kd=371uM|Kd|=|371|uM|371000|nM
2BAK|2.20|2005|AQZ||Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|7.43|Kd=37nM|Kd|=|37|nM|37|nM
1TJP|1.50|2005|HPF||P00929|TRYPTOPHAN SYNTHASE ALPHA CHAIN|4.42|Kd=38uM|Kd|=|38|uM|38000|nM
2BAJ|2.25|2005|1PP||Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|8.4|Kd=4.0nM|Kd|=|4|nM|4|nM
1W6Y|2.10|2005|EQU||P07445|STEROID DELTA-ISOMERASE|5.36|Kd=4.4uM|Kd|=|4.4|uM|4400|nM
1YVH|2.05|2005|13-mer|incomplete ligand|P22681|CBL E3 UBIQUITIN PROTEIN LIGASE|7.37|Kd=43nM|Kd|=|43|nM|43|nM
1WE2|2.30|2005|DHK||P0A4Z2|SHIKIMATE KINASE|4.36|Kd=44uM|Kd|=|44|uM|44000|nM
1Y2A|2.20|2005|10-mer||P52293|IMPORTIN SUBUNIT ALPHA-2|7.34|Kd=45.8nM|Kd|=|45.8|nM|45.8|nM
1XQ0|1.76|2005|4TR||P00918|CARBONIC ANHYDRASE 2|6.34|Kd=454nM|Kd|=|454|nM|454|nM
1ZM6|2.60|2005|5-mer||P60045|PHOSPHOLIPASE A2, ISOFORM 3|4.35|Kd=45uM|Kd|=|45|uM|45000|nM
1XH6|1.90|2005|R94|IC50=400nM|P00517|CAMP-DEPENDENT PROTEIN KINASE|7.32|Kd=48nM|Kd|=|48|nM|48|nM
2BAL|2.10|2005|PQA||Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|6.31|Kd=490nM|Kd|=|490|nM|490|nM
2AZ5|2.10|2005|307|ligand is SPD304, Kd=5.36+/-0.21uM|P01375|TUMOR NECROSIS FACTOR (TNF-ALPHA)|5.27|Kd=5.36uM|Kd|=|5.36|uM|5360|nM
1X07|2.20|2005|IPE|Kd for Mg-IPE|P60472|UNDECAPRENYL PYROPHOSPHATE SYNTHASE|3.28|Kd=520uM|Kd|=|520|uM|520000|nM
2F8I|1.54|2005|205||P02766|TRANSTHYRETIN|7.26|Kd=55nM|Kd|=|55|nM|55|nM
1RR6|2.50|2005|IMH|Kd=860pM for PfPNP-IMH complex|P00491|PURINE NUCLEOSIDE PHOSPHORYLASE|10.25|Kd=56pM|Kd|=|56|pM|0.056|nM
2AEB|1.29|2005|ABH||P05089|ARGINASE-1|8.3|Kd=5nM|Kd|=|5|nM|5|nM
1X8D|1.80|2005|RNS|Kd=5.91mM measured with minor form of protein|P32156|HYPOTHETICAL PROTEIN YIIL|2.21|Kd=6.16mM|Kd|=|6.16|mM|6160000|nM
1YC1|1.70|2005|4BC||P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|6.17|Kd=680nM|Kd|=|680|nM|680|nM
1XR9|1.79|2005|9-mer||P30464|HLA CLASS I HISTOCOMPATIBILITY ANTIGEN|7.15|Kd=70nM|Kd|=|70|nM|70|nM
1Z3V|1.61|2005|LAT||Q7LIJ0|CELLULASE|4.11|Kd=77uM|Kd|=|77|uM|77000|nM
2C1N|2.00|2005|8-mer|Kd=78.1+/-6.7uM, peptide(ALA-ARG-LYS-SEP-THR-GLY-GLY-LYS)|P63104|14-3-3 PROTEIN ZETA/DELTA|4.11|Kd=78.1uM|Kd|=|78.1|uM|78100|nM
1T4E|2.60|2005|DIZ||Q00987|E3 UBIQUITIN-PROTEIN LIGASE MDM2|7.1|Kd=80nM|Kd|=|80|nM|80|nM
2F7I|1.60|2005|26C||P02766|TRANSTHYRETIN|7.1|Kd=80nM|Kd|=|80|nM|80|nM
1Y2G|1.90|2005|CL3||P77173|CELL DIVISION PROTEIN ZIPA|4.08|Kd=83.1uM|Kd|=|83.1|uM|83100|nM
1XPZ|2.02|2005|4TZ||P00918|CARBONIC ANHYDRASE 2|7.08|Kd=84nM|Kd|=|84|nM|84|nM
1VJ6|NMR|2005|10-mer|PDZ2 complex with C-terminus of APC, Kd=8uM|Q64512|PROTEIN-TYROSINE-PHOSPHATASE|5.1|Kd=8uM|Kd|=|8|uM|8000|nM
1ZHL|1.50|2005|13-mer||P30685|HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-35|5.0|Kd=9.9uM|Kd|=|9.9|uM|9900|nM
2B9A|1.54|2005|FBC||P02766|TRANSTHYRETIN|8.05|Kd=9nM|Kd|=|9|nM|9|nM
1W7X|1.80|2005|413||P08709|COAGULATION FACTOR VIIA|8.4|Ki=0.004uM|Ki|=|0.004|uM|4|nM
1WUQ|2.00|2005|8GT||Q5SH52|GTP CYCLOHYDROLASE I|8.27|Ki=0.0054uM|Ki|=|0.0054|uM|5.4|nM
2AJL|2.50|2005|JNH|covalent complex|P27487|DIPEPTIDYL PEPTIDASE 4|7.89|Ki=0.013uM|Ki|=|0.013|uM|13|nM
1YLY|1.25|2005|CB4|covalent complex|Q9L5C7|BETA-LACTAMASE CTX-M-9|7.82|Ki=0.015uM|Ki|=|0.015|uM|15|nM
1T4V|2.00|2005|14A||P00734|PROTHROMBIN|7.68|Ki=0.021uM|Ki|=|0.021|uM|21|nM
2C3K|2.60|2005|ABO||O14757|SERINE/THREONINE-PROTEIN KINASE CHK1|7.59|Ki=0.026uM|Ki|=|0.026|uM|26|nM
1YSI|NMR|2005|N3B|ligand is compound 1, assay without human serum|Q07817|BCL-2-LIKE PROTEIN 1|7.44|Ki=0.036uM|Ki|=|0.036|uM|36|nM
1XN2|1.90|2005|11-mer|incomplete ligand|P56817|BETA-SECRETASE 1|10.52|Ki=0.03nM|Ki|=|0.03|nM|0.03|nM
1S50|1.65|2005|GLU||P42260|GLUTAMATE RECEPTOR 6|7.2|Ki=0.063uM|Ki|=|0.063|uM|63|nM
1X8J|2.35|2005|AOI|ligand is Androsterone|Q26490|RETINOL DEHYDRATASE|6.96|Ki=0.11uM|Ki|=|0.11|uM|110|nM
1TVO|2.50|2005|FRZ||P28482|MITOGEN-ACTIVATED PROTEIN KINASE 1|6.85|Ki=0.14uM|Ki|=|0.14|uM|140|nM
2ETK|2.96|2005|HFS||Q13464|RHO-ASSOCIATED PROTEIN KINASE 1|6.82|Ki=0.15uM|Ki|=|0.15|uM|150|nM
2ETR|2.60|2005|Y27||Q13464|RHO-ASSOCIATED PROTEIN KINASE 1|6.82|Ki=0.15uM|Ki|=|0.15|uM|150|nM
1WUR|1.82|2005|8DG||Q5SH52|GTP CYCLOHYDROLASE I|6.66|Ki=0.22uM|Ki|=|0.22|uM|220|nM
1W31|1.90|2005|SHO|Ki measured on ALAD (R. spheroides)|P05373|DELTA-AMINOLEVULINIC ACID DEHYDRATASE|3.6|Ki=0.25mM|Ki|=|0.25|mM|250000|nM
1WS1|2.00|2005|BB2||Q819U0|PEPTIDE DEFORMYLASE 1|9.55|Ki=0.28nM|Ki|=|0.28|nM|0.28|nM
2BOK|1.64|2005|784||P00742|COAGULATION FACTOR X|6.55|Ki=0.28uM|Ki|=|0.28|uM|280|nM
2A5S|1.70|2005|GLU||Q00959|N-METHYL-D-ASPARTATE RECEPTOR NMDAR2A SUBUNIT|6.7|Ki=0.2uM|Ki|=|0.2|uM|200|nM
1W2K|3.00|2005|380||P08709|COAGULATION FACTOR VIIA|6.46|Ki=0.35uM|Ki|=|0.35|uM|350|nM
2B07|2.10|2005|598||P18031|PROTEIN-TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1|6.43|Ki=0.37uM|Ki|=|0.37|uM|370|nM
1W0Y|2.50|2005|771||P08709|COAGULATION FACTOR VIIA|6.42|Ki=0.38uM|Ki|=|0.38|uM|380|nM
2AX9|1.65|2005|BHM|ligand is compound R-3|P10275|ANDROGEN RECEPTOR|9.52|Ki=0.3nM|Ki|=|0.3|nM|0.3|nM
1YYS|2.75|2005|SAZ|Ki measured on Trichodiene Synthase wt|P13513|TRICHODIENE SYNTHASE|6.33|Ki=0.47uM|Ki|=|0.47|uM|470|nM
1YVM|1.60|2005|TMG||P07906|METHIONINE AMINOPEPTIDASE|6.4|Ki=0.4uM|Ki|=|0.4|uM|400|nM
2AYR|1.90|2005|L4G||P03372|ESTROGEN RECEPTOR|9.29|Ki=0.51nM|Ki|=|0.51|nM|0.51|nM
1YYR|2.50|2005|SAZ|X-ray(Y305F) while Ki(Trichodiene Synthase wild type)|P13513|TRICHODIENE SYNTHASE|6.29|Ki=0.51uM|Ki|=|0.51|uM|510|nM
2AEL|2.50|2005|SAZ|X-ray(R304K) while Ki(Trichodiene synthase wild type)|P13513|TRICHODIENE SYNTHASE|6.29|Ki=0.51uM|Ki|=|0.51|uM|510|nM
2ESM|3.20|2005|M77||Q13464|RHO-ASSOCIATED PROTEIN KINASE 1|6.28|Ki=0.53uM|Ki|=|0.53|uM|530|nM
1WCQ|2.10|2005|DAN||Q02834|NEURAMINIDASE|6.26|Ki=0.55uM|Ki|=|0.55|uM|550|nM
1YM1|1.12|2005|SM2|covalent complex|Q9L5C8|BETA-LACTAMASE CTX-M-9A|6.24|Ki=0.578uM|Ki|=|0.578|uM|578|nM
2B17|2.71|2005|DIF||P59071|PHOSPHOLIPASE A2, VRV-PL-VIIIA|6.21|Ki=0.62uM|Ki|=|0.62|uM|620|nM
2C3J|2.10|2005|DBQ||O14757|SERINE/THREONINE-PROTEIN KINASE CHK1|6.18|Ki=0.659uM|Ki|=|0.659|uM|659|nM
1Z71|1.80|2005|L17||P00734|THROMBIN|9.18|Ki=0.66nM|Ki|=|0.66|nM|0.66|nM
1X6U|2.70|2005|DO8||P0A715|2-DEHYDRO-3-DEOXYPHOSPHOOCTONATE ALDOLASE|3.22|Ki=0.6mM|Ki|=|0.6|mM|600000|nM
1X39|1.80|2005|IDE||Q9XEI3|BETA-D-GLUCAN EXOHYDROLASE ISOENZYME EXOI|9.22|Ki=0.6nM|Ki|=|0.6|nM|0.6|nM
1Z1R|1.85|2005|HBH|Ki=0.6~12nM|P03369|HIV-1 PROTEASE|9.22|Ki=0.6nM|Ki|=|0.6|nM|0.6|nM
1Y1Z|1.50|2005|192||P35439|N-METHYL-D-ASPARTATE RECEPTOR SUBUNIT 1|3.08|Ki=0.831mM|Ki|=|0.831|mM|831000|nM
1ZXV|2.67|2005|MFM||P15917|LETHAL FACTOR|6.1|Ki=0.8uM|Ki|=|0.8|uM|800|nM
1XGJ|1.97|2005|HTC||P00811|BETA-LACTAMASE|6.0|Ki=1.0uM|Ki|=|1|uM|1000|nM
2BR6|1.70|2005|HSL||Q7B8C3|AIIA-LIKE PROTEIN|2.96|Ki=1.10mM|Ki|=|1.1|mM|1100000|nM
1YMS|1.60|2005|NBF|covalent complex|Q9L5C8|BETA-LACTAMASE CTX-M-9|5.92|Ki=1.2uM|Ki|=|1.2|uM|1200|nM
2BRM|2.20|2005|DFZ||O14757|SERINE/THREONINE-PROTEIN KINASE CHK1|5.89|Ki=1.3uM|Ki|=|1.3|uM|1300|nM
1X38|1.70|2005|IDD||Q9XEI3|BETA-D-GLUCAN EXOHYDROLASE ISOENZYME EXOI|8.77|Ki=1.7nM|Ki|=|1.7|nM|1.7|nM
1ZP8|2.02|2005|AB2|IC50=6nM|P03368|HIV-1 PROTEASE|8.77|Ki=1.7nM|Ki|=|1.7|nM|1.7|nM
1ZDP|1.70|2005|TIO||P00800|THERMOLYSIN|5.74|Ki=1.8uM|Ki|=|1.8|uM|1800|nM
1ZYR|3.00|2005|STD||Q5SHR6|DNA-DIRECTED RNA POLYMERASE SUBUNIT ALPHA|5.74|Ki=1.8uM|Ki|=|1.8|uM|1800|nM
1ZOH|1.81|2005|K44|IC50=740nM|P28523|CASEIN KINASE II, ALPHA SUBUNIT|7.0|Ki=100nM|Ki|=|100|nM|100|nM
1W2H|2.00|2005|ATM||O05891|THYMIDYLATE KINASE TMK|5.0|Ki=10uM|Ki|=|10|uM|10000|nM
2AD5|2.80|2005|CTP||P0A7E5|CTP SYNTHASE|3.96|Ki=110uM|Ki|=|110|uM|110000|nM
2BRB|2.10|2005|PFQ||O14757|SERINE/THREONINE-PROTEIN KINASE CHK1|4.86|Ki=13.7uM|Ki|=|13.7|uM|13700|nM
1X7A|2.90|2005|187||P16293|COAGULATION FACTOR IXA|7.89|Ki=13nM|Ki|=|13|nM|13|nM
1Z6F|1.60|2005|BO9|covalent complex|P04287|PENICILLIN-BINDING PROTEIN 5|4.89|Ki=13uM|Ki|=|13|uM|13000|nM
1XK9|2.10|2005|P34||P11439|EXOTOXIN A|6.85|Ki=140nM|Ki|=|140|nM|140|nM
1XGI|1.96|2005|NST||P00811|BETA-LACTAMASE|4.85|Ki=14uM|Ki|=|14|uM|14000|nM
1YA4|3.20|2005|CTX||P23141|CES1 PROTEIN|4.82|Ki=15.2uM|Ki|=|15.2|uM|15200|nM
1Y1M|1.80|2005|AC5||P35439|N-METHYL-D-ASPARTATE RECEPTOR SUBUNIT 1|1.82|Ki=15.3mM|Ki|=|15.3|mM|15300000|nM
1WKM|2.30|2005|MET||P56218|METHIONINE AMINOPEPTIDASE|0.82|Ki=150mM|Ki|=|150|mM|150000000|nM
1V1J|2.20|2005|FA3||P15474|3-DEHYDROQUINATE DEHYDRATASE|4.82|Ki=15uM|Ki|=|15|uM|15000|nM
1Y3W|1.80|2005|UIP||P00760|TRYPSINOGEN|5.77|Ki=1680nM|Ki|=|1680|nM|1680|nM
1X8T|1.90|2005|RC1||P0A6D3|3-PHOSPHOSHIKIMATE 1-CARBOXYVINYLTRANSFERASE|7.8|Ki=16nM|Ki|=|16|nM|16|nM
1YBG|2.60|2005|TAV||P33038|UDP-N-ACETYLGLUCOSAMINE 1-CARBOXYVINYLTRANSFERASE|4.8|Ki=16uM|Ki|=|16|uM|16000|nM
2AFW|1.56|2005|AHN||Q16769|GLUTAMINYL-PEPTIDE CYCLOTRANSFERASE|4.77|Ki=17uM|Ki|=|17|uM|17000|nM
2AOU|2.30|2005|CQA||P50135|HISTAMINE N-METHYLTRANSFERASE|7.73|Ki=18.6nM|Ki|=|18.6|nM|18.6|nM
1WVJ|1.75|2005|IBC||P19491|GLUTAMATE RECEPTOR 2|6.73|Ki=185nM|Ki|=|185|nM|185|nM
2ADU|1.90|2005|R20||P50579|METHIONINE AMINOPEPTIDASE 2|7.74|Ki=18nM|Ki|=|18|nM|18|nM
1W4P|1.69|2005|UM3||P61823|RIBONUCLEASE A|4.74|Ki=18uM|Ki|=|18|uM|18000|nM
2BVD|1.60|2005|ISX||P16218|ENDOGLUCANASE H|6.0|Ki=1uM|Ki|=|1|uM|1000|nM
2A14|1.70|2005|SAH|ligand is compound SAH|O95050|INDOLETHYLAMINE N-METHYLTRANSFERASE|5.7|Ki=2.0uM|Ki|=|2|uM|2000|nM
2ERZ|2.20|2005|HFS||P05132|CAMP-DEPENDENT PROTEIN KINASE|5.66|Ki=2.2uM|Ki|=|2.2|uM|2200|nM
1T31|1.90|2005|OHH||P23946|CHYMASE|8.64|Ki=2.3nM|Ki|=|2.3|nM|2.3|nM
1Z9G|1.70|2005|RRT||P00800|THERMOLYSIN|5.64|Ki=2.3uM|Ki|=|2.3|uM|2300|nM
1ZE8|2.00|2005|PIU||P00918|CARBONIC ANHYDRASE 2|7.68|Ki=21nM|Ki|=|21|nM|21|nM
1WN6|1.80|2005|BST||P78986|BLASTICIDIN-S DEAMINASE|4.68|Ki=21uM|Ki|=|21|uM|21000|nM
1Y3V|1.60|2005|UIR||P00760|TRYPSIN|5.64|Ki=2300nM|Ki|=|2300|nM|2300|nM
1Y3Y|1.75|2005|UIR|redundant to 1y3v|P00760|TRYPSIN|5.64|Ki=2300nM|Ki|=|2300|nM|2300|nM
2AZR|2.00|2005|982||P18031|PROTEIN-TYROSINE PHOSPHATASE 1B|3.64|Ki=230uM|Ki|=|230|uM|230000|nM
2BO4|1.95|2005|FLC||Q9RFR0|MANNOSYLGLYCERATE SYNTHASE|4.61|Ki=24.6uM|Ki|=|24.6|uM|24600|nM
1YQY|2.30|2005|915||P15917|LETHAL FACTOR|7.62|Ki=24nM|Ki|=|24|nM|24|nM
1T5A|2.80|2005|OXL||P14618|PYRUVATE KINASE ISOZYME M2|4.62|Ki=24uM|Ki|=|24|uM|24000|nM
2F6T|1.70|2005|1C2|IC50=42.5uM|P18031|PROTEIN-TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1|4.62|Ki=24uM|Ki|=|24|uM|24000|nM
2BGR|2.00|2005|9-mer|incomplete ligand structure|P27487|DIPEPTIDYL PEPTIDASE 4|3.6|Ki=250uM|Ki|=|250|uM|250000|nM
1TX7|1.75|2005|4CM||P00760|TRYPSINOGEN|4.6|Ki=25uM|Ki|=|25|uM|25000|nM
1U65|2.61|2005|CP0||P04058|ACETYLCHOLINESTERASE|7.58|Ki=26.4nM|Ki|=|26.4|nM|26.4|nM
2AX6|1.50|2005|HFT|ligand is compound 2b, Ki for hAR in Transiently-Transfected COS-1 Cells|P10275|ANDROGEN RECEPTOR|7.57|Ki=27nM|Ki|=|27|nM|27|nM
1W2G|2.10|2005|THM||O05891|THYMIDYLATE KINASE TMK|4.57|Ki=27uM|Ki|=|27|uM|27000|nM
1Y6Q|2.20|2005|TDI||P24247|MTA/SAH NUCLEOSIDASE|11.7|Ki=2pM|Ki|=|2|pM|0.002|nM
2BGN|3.15|2005|9-mer|incomplete ligand structure|P27487|DIPEPTIDYL PEPTIDASE 4|5.7|Ki=2uM|Ki|=|2|uM|2000|nM
1Z4N|1.97|2005|GL1|redundant to 1z4o|P71447|BETA-PHOSPHOGLUCOMUTASE|4.52|Ki=30uM|Ki|=|30|uM|30000|nM
1Z4O|1.90|2005|GL1||P71447|BETA-PHOSPHOGLUCOMUTASE|4.52|Ki=30uM|Ki|=|30|uM|30000|nM
1U71|2.20|2005|MXA|ligand is compound 4(PTX); Ki=0.025nM in J. Med. Chem., 1996, Vol.39, pp.892-903|P00374|DIHYDROFOLATE REDUCTASE|7.48|Ki=33nM|Ki|=|33|nM|33|nM
1SYI|2.10|2005|CPW||P19491|GLUTAMATE RECEPTOR 2|5.44|Ki=3590nM|Ki|=|3590|nM|3590|nM
1WVC|2.50|2005|CTP||P26396|GLUCOSE-1-PHOSPHATE CYTIDYLYLTRANSFERASE|4.46|Ki=35uM|Ki|=|35|uM|35000|nM
1VZQ|1.54|2005|SHY||P00734|THROMBIN|7.44|Ki=36nM|Ki|=|36|nM|36|nM
2A3C|2.07|2005|PNX|IC50=126uM|Q873X9|CHITINASE|4.43|Ki=37uM|Ki|=|37|uM|37000|nM
2AOW|2.97|2005|THA||P50135|HISTAMINE N-METHYLTRANSFERASE|7.42|Ki=38.2nM|Ki|=|38.2|nM|38.2|nM
2AOX|3.12|2005|THA|redundant to 2aox|P50135|HISTAMINE N-METHYLTRANSFERASE|7.42|Ki=38.2nM|Ki|=|38.2|nM|38.2|nM
1T32|1.85|2005|OHH||P08311|CATHEPSIN G|7.42|Ki=38nM|Ki|=|38|nM|38|nM
1SYH|1.80|2005|CPW||P19491|GLUTAMATE RECEPTOR 2|6.41|Ki=393nM|Ki|=|393|nM|393|nM
1Z6D|1.54|2005|IMP||P61823|RIBONUCLEASE|2.34|Ki=4.6mM|Ki|=|4.6|mM|4600000|nM
1ZGI|2.20|2005|382||P00734|THROMBIN|5.34|Ki=4.6uM|Ki|=|4.6|uM|4600|nM
1Y20|1.40|2005|1AC||P35439|N-METHYL-D-ASPARTATE RECEPTOR SUBUNIT 1|5.32|Ki=4.8uM|Ki|=|4.8|uM|4800|nM
1VYQ|2.40|2005|DUX||Q8II92|DEOXYURIDINE 5'-TRIPHOSPHATE NUCLEOTIDOHYDROLASE|5.3|Ki=4.98uM|Ki|=|4.98|uM|4980|nM
1XN3|2.00|2005|14-mer||P56817|BETA-SECRETASE 1|7.4|Ki=40nM|Ki|=|40|nM|40|nM
1ZOE|1.77|2005|K25||P28523|CASEIN KINASE II, ALPHA SUBUNIT|7.4|Ki=40nM|Ki|=|40|nM|40|nM
1XNX|2.90|2005|ATE|ligand is compound androstenol, pIC50=6.38|O35627|CONSTITUTIVE ANDROSTANE RECEPTOR|6.38|Ki=416nM|Ki|=|416|nM|416|nM
1YFZ|2.20|2005|IMP||Q8R7L0|HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE|4.35|Ki=45uM|Ki|=|45|uM|45000|nM
1Z6S|1.50|2005|AMP||P61823|RIBONUCLEASE|4.34|Ki=46uM|Ki|=|46|uM|46000|nM
1Z1H|1.85|2005|HBB||P03369|HIV-1 PROTEASE|8.4|Ki=4nM|Ki|=|4|nM|4|nM
1ZPA|2.02|2005|A83||P03368|HIV-1 PROTEASE|8.4|Ki=4nM|Ki|=|4|nM|4|nM
2AL5|1.65|2005|FWD|ligand is compound (S)-2b|P19491|GLUTAMATE RECEPTOR 2|8.4|Ki=4nM|Ki|=|4|nM|4|nM
1W4Q|1.68|2005|UMF||P61823|RIBONUCLEASE A|5.26|Ki=5.5uM|Ki|=|5.5|uM|5500|nM
2B7F|2.60|2005|10-mer|Ki=50nM (high-salt buffer); Ki=2.3uM (low-salt buffer)|P10274|HTLV-1 PROTEASE|7.3|Ki=50nM|Ki|=|50|nM|50|nM
1RT9|2.30|2005|IMH|ligand is compound 1, Immucillin-H|P00491|PURINE NUCLEOSIDE PHOSPHORYLASE|10.25|Ki=56pM|Ki|=|56|pM|0.056|nM
1Y4Z|2.00|2005|PCI|competitive Ki=57+/-14nM, noncompetitive Ki=490+/-9nM|P09152|RESPIRATORY NITRATE REDUCTASE 1 ALPHA CHAIN|7.24|Ki=57nM|Ki|=|57|nM|57|nM
1YXD|2.00|2005|LYS|Ki=5-50uM|P0A6L2|DIHYDRODIPICOLINATE SYNTHASE|5.3|Ki=5uM|Ki|=|5|uM|5000|nM
1T5F|2.20|2005|DHH||P07824|ARGINASE 1|4.22|Ki=60uM|Ki|=|60|uM|60000|nM
1XHY|1.85|2005|KAI||P19491|GLUTAMATE RECEPTOR 2|6.18|Ki=662nM|Ki|=|662|nM|662|nM
2C6O|2.10|2005|4SP|redundant to 1h1s|P24941|CELL DIVISION PROTEIN KINASE 2|8.22|Ki=6nM|Ki|=|6|nM|6|nM
1W4O|1.60|2005|UA3||P61823|RIBONUCLEASE A|5.22|Ki=6uM|Ki|=|6|uM|6000|nM
2AFX|1.64|2005|1BN||Q16769|GLUTAMINYL-PEPTIDE CYCLOTRANSFERASE|5.15|Ki=7.1uM|Ki|=|7.1|uM|7100|nM
2BR1|2.00|2005|PFP||O14757|SERINE/THREONINE-PROTEIN KINASE CHK1|5.14|Ki=7.2uM|Ki|=|7.2|uM|7200|nM
1YQJ|2.00|2005|6NP||Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|8.14|Ki=7.3nM|Ki|=|7.3|nM|7.3|nM
1ZOG|2.30|2005|K37|IC50=250nM|P28523|CASEIN KINASE II, ALPHA SUBUNIT|7.15|Ki=70nM|Ki|=|70|nM|70|nM
1Y3X|1.70|2005|UIB||P00760|TRYPSINOGEN|5.14|Ki=7315nM|Ki|=|7315|nM|7315|nM
1X8R|1.50|2005|SC1||P0A6D3|3-PHOSPHOSHIKIMATE 1-CARBOXYVINYLTRANSFERASE|6.12|Ki=750nM|Ki|=|750|nM|750|nM
1Z95|1.80|2005|198||P10275|ANDROGEN RECEPTOR|7.12|Ki=76nM|Ki|=|76|nM|76|nM
1Y6R|2.20|2005|MTM||P24247|MTA/SAH NUCLEOSIDASE|10.11|Ki=77pM|Ki|=|77|pM|0.077|nM
2EXM|1.80|2005|ZIP||P24941|CELL DIVISION PROTEIN KINASE 2|4.11|Ki=78uM|Ki|=|78|uM|78000|nM
2C3L|2.35|2005|IDZ||O14757|SERINE/THREONINE-PROTEIN KINASE CHK1|5.07|Ki=8.58uM|Ki|=|8.58|uM|8580|nM
1X1Z|1.45|2005|BMP||O26232|OROTIDINE 5'-MONOPHOSPHATE DECARBOXYLASE|11.06|Ki=8.8pM|Ki|=|8.8|pM|0.0088|nM
1YQ7|2.20|2005|RIS|ligand is compound 8(risedronate); time-Dependent IC50 initial 452.9nM to final 5.7nM|P14324|FARNESYL PYROPHOSPHATE SYNTHETASE|7.09|Ki=82.2nM|Ki|=|82.2|nM|82.2|nM
2D06|2.30|2005|EST||P50225|SULFOTRANSFERASE 1A1|4.08|Ki=83.2uM|Ki|=|83.2|uM|83200|nM
1YCI|2.70|2005|NDF||Q9NWT6|HYPOXIA-INDUCIBLE FACTOR 1-ALPHA INHIBITOR|4.08|Ki=83uM|Ki|=|83|uM|83000|nM
2AOV|2.48|2005|C2M||P50135|HISTAMINE N-METHYLTRANSFERASE|7.04|Ki=91nM|Ki|=|91|nM|91|nM
2BQV|2.10|2005|A1A||O92139|HIV-1 PROTEASE|8.05|Ki=9nM|Ki|=|9|nM|9|nM
2BUC|2.50|2006|008||P22411|DIPEPTIDYL PEPTIDASE 4|7.0|IC<100nM|IC50|<|100|nM|100|nM
2BED|2.70|2006|736||Q04631|GERANYL-GERANYLTRANSFERASE ALPHA SUBUNIT|8.15|IC=0.007uM|IC50|=|0.007|uM|7|nM
2BU5|2.35|2006|TF1|ligand is compound 3r|Q15119|PYRUVATE DEHYDROGENASE KINASE ISOENZYME 2|7.78|IC=0.0165uM|IC50|=|0.0165|uM|16.5|nM
1YM2|2.05|2006|6-mer||P56817|BETA-SECRETASE 1|8.0|IC=0.01uM|IC50|=|0.01|uM|10|nM
1YM4|2.25|2006|5-mer||P56817|BETA-SECRETASE 1|7.41|IC=0.039uM|IC50|=|0.039|uM|39|nM
2F4B|2.07|2006|EHA||P37231|PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA|7.3|IC=0.05uM|IC50|=|0.05|uM|50|nM
2NSX|2.11|2006|IFM|ligand is compound D-Isofagomine|P04062|GLUCOSYLCERAMIDASE|7.2|IC=0.063uM|IC50|=|0.063|uM|63|nM
2BDF|2.10|2006|24A||P12931|TYROSINE-PROTEIN KINASE SRC|7.17|IC=0.067uM|IC50|=|0.067|uM|67|nM
2EVO|1.70|2006|CT0||P0AE18|METHIONINE AMINOPEPTIDASE|7.17|IC=0.067uM|IC50|=|0.067|uM|67|nM
2BCD|2.10|2006|5-mer||P36873|SERINE/THREONINE PROTEIN PHOSPHATASE PP1-GAMMA|10.22|IC=0.06nM|IC50|=|0.06|nM|0.06|nM
2EWP|2.30|2006|TXF||P62508|ESTROGEN-RELATED RECEPTOR GAMMA|7.1|IC=0.079uM|IC50|=|0.079|uM|79|nM
2FQ6|1.78|2006|P3F|compound 18, IC50=0.079+/-0.02uM, ligand is the product.|P06721|CYSTATHIONINE BETA-LYASE|7.1|IC=0.079uM|IC50|=|0.079|uM|79|nM
2G1Y|2.50|2006|5IG|ligand is compound 19|P00797|RENIN|7.05|IC=0.09uM|IC50|=|0.09|uM|90|nM
2H03|1.65|2006|3UN||Q3MIV7|PROTEIN TYROSINE PHOSPHATASE, RECEPTOR TYPE, B|7.05|IC=0.09uM|IC50|=|0.09|uM|90|nM
2GM1|2.30|2006|2AZ||P52732|KINESIN-RELATED MOTOR PROTEIN EG5|7.0|IC=0.10uM|IC50|=|0.1|uM|100|nM
2HHA|2.35|2006|3TP||Q53TN1|DIPEPTIDYL PEPTIDASE 4|6.91|IC=0.122uM|IC50|=|0.122|uM|122|nM
2AXI|1.40|2006|10-mer||Q9UMT8|UBIQUITIN-PROTEIN LIGASE E3 MDM2|6.85|IC=0.14uM|IC50|=|0.14|uM|140|nM
2IW6|2.30|2006|QQ2||P24941|CELL DIVISION PROTEIN KINASE 2|6.85|IC=0.14uM|IC50|=|0.14|uM|140|nM
2ATH|2.28|2006|3EA||P37231|PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA|6.82|IC=0.152uM|IC50|=|0.152|uM|152|nM
2F3E|2.11|2006|AXQ||P56817|BETA-SECRETASE 1|6.81|IC=0.156uM|IC50|=|0.156|uM|156|nM
2F3F|2.30|2006|AXF||P56817|BETA-SECRETASE 1|6.72|IC=0.19uM|IC50|=|0.19|uM|190|nM
2IE4|2.60|2006|OKA||Q96DH3|PROTEIN PHOSPHATASE 2|10.0|IC=0.1nM|IC50|=|0.1|nM|0.1|nM
2ETM|2.30|2006|7PY|ligand is compound 1|Q05397|FOCAL ADHESION KINASE 1|6.67|IC=0.212uM|IC50|=|0.212|uM|212|nM
1ZEO|2.50|2006|C01||P37231|PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA|6.68|IC=0.21uM|IC50|=|0.21|uM|210|nM
2C5N|2.10|2006|CK8||P24941|CELL DIVISION PROTEIN KINASE 2|6.66|IC=0.22uM|IC50|=|0.22|uM|220|nM
2H96|3.00|2006|893||P45983|MITOGEN-ACTIVATED PROTEIN KINASE 8|6.64|IC=0.23uM|IC50|=|0.23|uM|230|nM
2GTK|2.10|2006|208||P37231|PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA|6.6|IC=0.251uM|IC50|=|0.251|uM|251|nM
1ZPC|2.60|2006|716|covalent complex|P03951|COAGULATION FACTOR XI|6.6|IC=0.254uM|IC50|=|0.254|uM|254|nM
2C5X|2.90|2006|MTW|redundant to 2c5y|P24941|CELL DIVISION PROTEIN KINASE 2|6.6|IC=0.25uM|IC50|=|0.25|uM|250|nM
2C5Y|2.25|2006|MTW||P24941|CELL DIVISION PROTEIN KINASE 2|6.6|IC=0.25uM|IC50|=|0.25|uM|250|nM
2GG2|1.00|2006|U12|compound 3|P0AE18|METHIONINE AMINOPEPTIDASE|6.6|IC=0.25uM|IC50|=|0.25|uM|250|nM
2GG5|2.12|2006|U19|compound 4|P0AE18|METHIONINE AMINOPEPTIDASE|6.6|IC=0.25uM|IC50|=|0.25|uM|250|nM
2CV3|1.90|2006|11-mer|MW>1000|P00772|ELASTASE 1|6.57|IC=0.27uM|IC50|=|0.27|uM|270|nM
2EVC|1.60|2006|FC3||P0AE18|METHIONINE AMINOPEPTIDASE|6.54|IC=0.29uM|IC50|=|0.29|uM|290|nM
2GGX|1.90|2006|NPJ||P35247|PULMONARY SURFACTANT-ASSOCIATED PROTEIN D|3.49|IC=0.32mM|IC50|=|0.32|mM|320000|nM
2H02|2.30|2006|2UN||Q3MIV7|PROTEIN TYROSINE PHOSPHATASE, RECEPTOR TYPE, B|6.49|IC=0.32uM|IC50|=|0.32|uM|320|nM
2AUZ|2.30|2006|CT2|covalent complex|P43235|CATHEPSIN K|9.46|IC=0.35nM|IC50|=|0.35|nM|0.35|nM
2FYV|1.90|2006|W72||Q24451|ALPHA-MANNOSIDASE II|3.52|IC=0.3mM|IC50|=|0.3|mM|300000|nM
2GZ7|1.86|2006|D3F||P59641|REPLICASE POLYPROTEIN 1AB|6.52|IC=0.3uM|IC50|=|0.3|uM|300|nM
2BDJ|2.50|2006|HET||P12931|TYROSINE-PROTEIN KINASE SRC|9.35|IC=0.45nM|IC50|=|0.45|nM|0.45|nM
2F2C|2.80|2006|AP9||Q01043|CYCLIN HOMOLOG|6.35|IC=0.45uM|IC50|=|0.45|uM|450|nM
2FM0|2.00|2006|M98||Q08499|CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D|9.4|IC=0.4nM|IC50|=|0.4|nM|0.4|nM
2A4L|2.40|2006|RRC||P24941|CYCLIN-DEPENDENT KINASE 2|6.4|IC=0.4uM|IC50|=|0.4|uM|400|nM
2FDA|2.00|2006|682|covalent complex|P03951|COAGULATION FACTOR XI|6.3|IC=0.502uM|IC50|=|0.502|uM|502|nM
2AUX|2.40|2006|CT1|covalent complex|P43235|CATHEPSIN K|9.3|IC=0.50nM|IC50|=|0.5|nM|0.5|nM
2HAI|1.58|2006|PFI||P26663|HCV NS5B RNA POLYMERASE|6.28|IC=0.53uM|IC50|=|0.53|uM|530|nM
1YKR|1.80|2006|628||P24941|CELL DIVISION PROTEIN KINASE 2|6.25|IC=0.56uM|IC50|=|0.56|uM|560|nM
2FIX|3.50|2006|870||P09467|FRUCTOSE-1,6-BISPHOSPHATASE 1|6.24|IC=0.57uM|IC50|=|0.57|uM|570|nM
2GG3|1.45|2006|U13|compound 7|P0AE18|METHIONINE AMINOPEPTIDASE|6.24|IC=0.58uM|IC50|=|0.58|uM|580|nM
2F3R|2.50|2006|G5P||P60546|GUANYLATE KINASE|6.3|IC=0.5uM|IC50|=|0.5|uM|500|nM
2I5J|3.15|2006|K05|0.5+/-0.2, DHBNH inhibit RT-RNH|P03366|HIV-1 REVERSE TRANSCRIPTASE/RIBONUCLEASE H|6.3|IC=0.5uM|IC50|=|0.5|uM|500|nM
2EVM|1.70|2006|FC2||P0AE18|METHIONINE AMINOPEPTIDASE|6.16|IC=0.693uM|IC50|=|0.693|uM|693|nM
2G6P|1.90|2006|HM2||P53582|METHIONINE AMINOPEPTIDASE 1|6.22|IC=0.6uM|IC50|=|0.6|uM|600|nM
2CCU|2.70|2006|2D9||P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|6.13|IC=0.74uM|IC50|=|0.74|uM|740|nM
2FDE|2.70|2006|385||P03368|GAG-POL POLYPROTEIN|9.15|IC=0.7nM|IC50|=|0.7|nM|0.7|nM
2EWY|3.10|2006|DBO||Q9Y5Z0|BETA-SECRETASE 2|6.15|IC=0.7uM|IC50|=|0.7|uM|700|nM
2GFS|1.75|2006|PQB||Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|6.15|IC=0.7uM|IC50|=|0.7|uM|700|nM
1ZPB|2.10|2006|995|covalent complex|P03951|COAGULATION FACTOR XI|6.07|IC=0.85uM|IC50|=|0.85|uM|850|nM
2C6E|2.10|2006|HPM|ligand is compound 2h, also is compound 13 in ref.21|O14965|SERINE/THREONINE-PROTEIN KINASE 6|9.1|IC=0.8nM|IC50|=|0.8|nM|0.8|nM
2FUM|2.89|2006|MIX||P0A5S4|PROBABLE SERINE/THREONINE-PROTEIN KINASE PKNB|6.1|IC=0.8uM|IC50|=|0.8|uM|800|nM
2GGU|1.90|2006|MLR||P35247|PULMONARY SURFACTANT-ASSOCIATED PROTEIN D|3.03|IC=0.94mM|IC50|=|0.94|mM|940000|nM
2FES|2.42|2006|3SP||P00734|THROMBIN LIGHT CHAIN|9.01|IC=0.98nM|IC50|=|0.98|nM|0.98|nM
2C0O|2.85|2006|L2G||P08631|TYROSINE-PROTEIN KINASE HCK|5.91|IC=1.22uM|IC50|=|1.22|uM|1220|nM
2G01|3.50|2006|73Q||P45983|MITOGEN-ACTIVATED PROTEIN KINASE 8|5.91|IC=1.22uM|IC50|=|1.22|uM|1220|nM
2EW5|2.20|2006|Y12||Q672W7|PEPTIDE DEFORMYLASE|5.9|IC=1.25uM|IC50|=|1.25|uM|1250|nM
2AA9|1.50|2006|SKM|IC50=1.2mM (with Cl-); IC50=1.7mM (with HCO3-)|P0A6D3|3-PHOSPHOSHIKIMATE 1-CARBOXYVINYLTRANSFERASE|2.92|IC=1.2mM|IC50|=|1.2|mM|1200000|nM
2AAY|1.55|2006|SKM|redundant to 2aa9|P0A6D3|3-PHOSPHOSHIKIMATE 1-CARBOXYVINYLTRANSFERASE|2.92|IC=1.2mM|IC50|=|1.2|mM|1200000|nM
2CM8|2.10|2006|F16||P18031|PROTEIN-TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1|5.87|IC=1.35uM|IC50|=|1.35|uM|1350|nM
2FEQ|2.44|2006|34P||P00734|THROMBIN LIGHT CHAIN|8.86|IC=1.39nM|IC50|=|1.39|nM|1.39|nM
1ZTQ|2.00|2006|033||P45452|COLLAGENASE 3|8.89|IC=1.3nM|IC50|=|1.3|nM|1.3|nM
2J9A|1.73|2006|5-mer||P00727|CYTOSOL AMINOPEPTIDASE|5.89|IC=1.3uM|IC50|=|1.3|uM|1300|nM
1YW7|1.85|2006|A41|ligand is compound 4|P50579|METHIONINE AMINOPEPTIDASE 2|5.85|IC=1.4uM|IC50|=|1.4|uM|1400|nM
2G19|1.70|2006|4HG|ligand is compound 1|Q9GZT9|EGL NINE HOMOLOG 1|5.85|IC=1.4uM|IC50|=|1.4|uM|1400|nM
2I40|2.80|2006|BLZ||P24941|CELL DIVISION PROTEIN KINASE 2|5.8|IC=1.58uM|IC50|=|1.58|uM|1580|nM
2CKM|2.15|2006|AA7|X-ray(TcAChE); IC50(rat AChE)|P04058|ACETYLCHOLINESTERASE|8.82|IC=1.5nM|IC50|=|1.5|nM|1.5|nM
2GIU|2.20|2006|FBR||Q92731|ESTROGEN RECEPTOR BETA|8.82|IC=1.5nM|IC50|=|1.5|nM|1.5|nM
2NQ6|1.50|2006|HM4||P53582|METHIONINE AMINOPEPTIDASE 1|5.82|IC=1.5uM|IC50|=|1.5|uM|1500|nM
2CMC|2.20|2006|DFM||P18031|PROTEIN-TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1|5.76|IC=1.75uM|IC50|=|1.75|uM|1750|nM
2GG7|1.12|2006|U14|compound 1, 2|P0AE18|METHIONINE AMINOPEPTIDASE|5.76|IC=1.75uM|IC50|=|1.75|uM|1750|nM
2CNE|1.80|2006|DFJ||P18031|PROTEIN-TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1|8.77|IC=1.7nM|IC50|=|1.7|nM|1.7|nM
2J7X|2.10|2006|EST|ligand is 17 beta-estradiol|Q62986|ESTROGEN RECEPTOR BETA|8.77|IC=1.7nM|IC50|=|1.7|nM|1.7|nM
2GG0|1.28|2006|U11|compound 12|P0AE18|METHIONINE AMINOPEPTIDASE|5.77|IC=1.7uM|IC50|=|1.7|uM|1700|nM
2H44|1.80|2006|7CA||O76074|CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE|5.77|IC=1.7uM|IC50|=|1.7|uM|1700|nM
2ANM|2.40|2006|CDO||P00734|THROMBIN|8.74|IC=1.8nM|IC50|=|1.8|nM|1.8|nM
2EW6|2.20|2006|Y13||Q672W7|PEPTIDE DEFORMYLASE|4.97|IC=10.8uM|IC50|=|10.8|uM|10800|nM
2F1B|1.45|2006|GB3|compound 10|Q24451|ALPHA-MANNOSIDASE II|3.0|IC=1000uM|IC50|=|1000|uM|1000000|nM
2BRP|2.00|2006|SIE|IC50(SpnHyal)>100uM, IC50(SagHyal)=11uM|Q54873|HYALURONATE LYASE|4.0|IC=100uM|IC50|=|100|uM|100000|nM
2C8Y|2.20|2006|C3M||P00734|THROMBIN|4.0|IC=100uM|IC50|=|100|uM|100000|nM
2IW8|2.30|2006|4SP||P24941|CELL DIVISION PROTEIN KINASE 2|6.99|IC=103nM|IC50|=|103|nM|103|nM
2FME|2.10|2006|3QC||P52732|KINESIN-LIKE PROTEIN KIF11|6.98|IC=104nM|IC50|=|104|nM|104|nM
1YW8|2.65|2006|A75||P50579|METHIONINE AMINOPEPTIDASE 2|8.0|IC=10nM|IC50|=|10|nM|10|nM
2AMA|1.90|2006|DHT|ligand is compound 2, dihydrotestosterone|P10275|ANDROGEN RECEPTOR|8.0|IC=10nM|IC50|=|10|nM|10|nM
2CNG|1.90|2006|IZE||P18031|PROTEIN-TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1|6.96|IC=110nM|IC50|=|110|nM|110|nM
2IGY|2.60|2006|A2T|compound 18, IC50(PM-1)=1123nM, IC50(PM-6)=19440nM, IC50(red blood cell)=126nM|P46925|PLASMEPSIN-2|6.95|IC=113nM|IC50|=|113|nM|113|nM
2HNY|2.50|2006|NVP||P04585|HIV-1 REVERSE TRANSCRIPTASE/RIBONUCLEASE H|5.93|IC=1165nM|IC50|=|1165|nM|1165|nM
2GGA|1.70|2006|GPJ||Q9R4E4|3-PHOSPHOSHIKIMATE 1-CARBOXYVINYLTRANSFERASE|1.96|IC=11mM|IC50|=|11|mM|11000000|nM
2IRZ|1.80|2006|I02||P56817|BETA-SECRETASE 1|7.92|IC=12nM|IC50|=|12|nM|12|nM
2C93|2.20|2006|C4M||P00734|THROMBIN|4.92|IC=12uM|IC50|=|12|uM|12000|nM
2GGB|2.13|2006|U17|compound 14|P0AE18|METHIONINE AMINOPEPTIDASE|4.92|IC=12uM|IC50|=|12|uM|12000|nM
1ZD5|2.60|2006|NC7||P34913|EPOXIDE HYDROLASE 2|4.87|IC=13.4uM|IC50|=|13.4|uM|13400|nM
2CGU|2.50|2006|3A3||O14757|SERINE/THREONINE-PROTEIN KINASE CHK1|4.87|IC=13.4uM|IC50|=|13.4|uM|13400|nM
2F3K|1.60|2006|RO1||P03369|HIV-1 PROTEASE|7.89|IC=13nM|IC50|=|13|nM|13|nM
2J50|3.00|2006|627||O14965|SERINE/THREONINE-PROTEIN KINASE 6|7.89|IC=13nM|IC50|=|13|nM|13|nM
2FJM|2.10|2006|073|IC50=142+/-41nM|P18031|PROTEIN-TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1|6.85|IC=142nM|IC50|=|142|nM|142|nM
2GNH|2.05|2006|H52||P00517|CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTIC|6.83|IC=149nM|IC50|=|149|nM|149|nM
2J87|3.10|2006|TTP|IC50=14+/-4.0uM|O57203|THYMIDINE KINASE|4.85|IC=14uM|IC50|=|14|uM|14000|nM
2CGX|2.20|2006|3D3||O14757|SERINE/THREONINE-PROTEIN KINASE CHK1|4.81|IC=15.6uM|IC50|=|15.6|uM|15600|nM
2BDL|2.00|2006|4PR|covalent complex|P43235|CATHEPSIN K|7.82|IC=15nM|IC50|=|15|nM|15|nM
2EUF|3.00|2006|LQQ||Q01043|VIRAL CYCLIN|7.82|IC=15nM|IC50|=|15|nM|15|nM
2I0V|2.80|2006|6C3|quinolone inhibits cFMS|P07333|CFMS TYROSINE KINASE|6.8|IC=160nM|IC50|=|160|nM|160|nM
2GGD|1.70|2006|GPJ||Q9R4E4|3-PHOSPHOSHIKIMATE 1-CARBOXYVINYLTRANSFERASE|3.8|IC=160uM|IC50|=|160|uM|160000|nM
2CHZ|2.60|2006|093|HUMAN PI-3K GAMMA CATALYTIC SUBUNIT, how get IC50?|P48736|PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE|7.8|IC=16nM|IC50|=|16|nM|16|nM
2CGW|2.20|2006|3C3||O14757|SERINE/THREONINE-PROTEIN KINASE CHK1|4.76|IC=17.3uM|IC50|=|17.3|uM|17300|nM
2BDY|1.61|2006|UNB||P00734|THROMBIN|7.77|IC=17nM|IC50|=|17|nM|17|nM
2CHW|2.60|2006|039|HUMAN PI-3K GAMMA CATALYTIC SUBUNIT|P48736|PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE|4.77|IC=17uM|IC50|=|17|uM|17000|nM
2AZC|2.01|2006|3TL||P03367|PROTEASE RETROPEPSIN|6.74|IC=183nM|IC50|=|183|nM|183|nM
2CMA|2.30|2006|F20||P18031|PROTEIN-TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1|6.73|IC=185nM|IC50|=|185|nM|185|nM
2CHX|2.50|2006|090|HUMAN PI-3K GAMMA CATALYTIC SUBUNIT, how get IC50?|P48736|PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE|7.74|IC=18nM|IC50|=|18|nM|18|nM
2B7A|2.00|2006|IZA||O60674|TYROSINE-PROTEIN KINASE JAK2|9.0|IC=1nM|IC50|=|1|nM|1|nM
2AM1|2.50|2006|1LG||Q8DNV6|UDP-N-ACETYLMURAMOYLALANINE-D-GLUTAMYL-LYSINE-D|6.0|IC=1uM|IC50|=|1|uM|1000|nM
2FL2|2.50|2006|N4T||P52732|KINESIN-LIKE PROTEIN KIF11|8.7|IC=2.0nM|IC50|=|2|nM|2|nM
2CCS|1.79|2006|4BH||P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|5.7|IC=2.0uM|IC50|=|2|uM|2000|nM
2GPP|2.60|2006|1BA|complexed with Nuclear receptor-interacting protein 1|P62508|ESTROGEN-RELATED RECEPTOR GAMMA|5.7|IC=2.0uM|IC50|=|2|uM|2000|nM
2HWH|2.30|2006|RNA||P26663|RNA-DIRECTED RNA POLYMERASE (NS5B) (P68)|5.7|IC=2.0uM|IC50|=|2|uM|2000|nM
2BB7|1.70|2006|QMS||P07906|METHIONINE AMINOPEPTIDASE|5.67|IC=2.14uM|IC50|=|2.14|uM|2140|nM
2GNI|2.27|2006|M77||P00517|CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTIC|5.64|IC=2.28uM|IC50|=|2.28|uM|2280|nM
2I47|1.90|2006|KGY||P78536|TNF-ALPHA-CONVERTING ENZYME, ADAM 17|8.66|IC=2.2nM|IC50|=|2.2|nM|2.2|nM
2F4J|1.91|2006|VX6||P00519|TYROSINE-PROTEIN KINASE ABL1|5.66|IC=2.2uM|IC50|=|2.2|uM|2200|nM
2H42|2.30|2006|VIA||O76074|CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE|8.62|IC=2.4nM|IC50|=|2.4|nM|2.4|nM
1YY4|2.70|2006|4NA||Q9UEV6|ESTROGEN RECEPTOR BETA|8.6|IC=2.52nM|IC50|=|2.52|nM|2.52|nM
2FKY|2.30|2006|N2T||P52732|KINESIN-LIKE PROTEIN KIF11|8.59|IC=2.6nM|IC50|=|2.6|nM|2.6|nM
2IIT|2.35|2006|872||P27487|DIPEPTIDYL PEPTIDASE 4|8.59|IC=2.6nM|IC50|=|2.6|nM|2.6|nM
1YYE|2.03|2006|196||Q9UEV6|ESTROGEN RECEPTOR BETA|8.57|IC=2.7nM|IC50|=|2.7|nM|2.7|nM
2H8H|2.20|2006|H8H||P12931|TYROSINE-PROTEIN KINASE SRC|8.57|IC=2.7nM|IC50|=|2.7|nM|2.7|nM
2NQ7|1.60|2006|HM5||P53582|METHIONINE AMINOPEPTIDASE 1|5.54|IC=2.9uM|IC50|=|2.9|uM|2900|nM
2A2X|2.44|2006|NA9||P00734|THROMBIN LIGHT CHAIN|7.69|IC=20.2nM|IC50|=|20.2|nM|20.2|nM
2FWY|2.10|2006|H64||P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|6.7|IC=200nM|IC50|=|200|nM|200|nM
2IS0|2.20|2006|I03||P56817|BETA-SECRETASE 1|6.7|IC=200nM|IC50|=|200|nM|200|nM
1ZAF|2.20|2006|789||Q92731|ESTROGEN RECEPTOR BETA|7.7|IC=20nM|IC50|=|20|nM|20|nM
2C4F|1.72|2006|GIL||P08709|COAGULATION FACTOR VII PRECURSOR|7.7|IC=20nM|IC50|=|20|nM|20|nM
2G1R|2.42|2006|3IG|ligand is compound 34|P00797|RENIN|7.7|IC=20nM|IC50|=|20|nM|20|nM
2ICA|1.56|2006|2IC||P20701|INTEGRIN ALPHA-L|7.7|IC=20nM|IC50|=|20|nM|20|nM
2CM7|2.10|2006|IZD||P18031|PROTEIN-TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1|6.68|IC=210nM|IC50|=|210|nM|210|nM
2BVE|2.20|2006|PH5|PROP compound|Q62230|SIALOADHESIN|3.67|IC=215uM|IC50|=|215|uM|215000|nM
2CNI|2.00|2006|IZF||P18031|PROTEIN-TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1|7.68|IC=21nM|IC50|=|21|nM|21|nM
2G0H|2.30|2006|SP3||Q86U60|PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA|7.64|IC=22.7nM|IC50|=|22.7|nM|22.7|nM
2C8X|2.17|2006|C5M||P00734|THROMBIN LIGHT CHAIN|6.66|IC=220nM|IC50|=|220|nM|220|nM
2AZ9|2.50|2006|3TL|incomplete structure|P03367|PROTEASE RETROPEPSIN|7.66|IC=22nM|IC50|=|22|nM|22|nM
2FJ0|2.70|2006|TFC|covalent complex|Q7M4E5|JUVENILE HORMONE ESTERASE|7.66|IC=22nM|IC50|=|22|nM|22|nM
2NYR|2.06|2006|SVR||Q9NXA8|NAD-DEPENDENT DEACYLASE SIRTUIN-5|4.66|IC=22uM|IC50|=|22|uM|22000|nM
2EXC|2.75|2006|JNK|ligand is compound 12|P53779|MITOGEN-ACTIVATED PROTEIN KINASE 10|6.63|IC=235nM|IC50|=|235|nM|235|nM
2BKT|2.30|2006|RPF||P00797|RENIN|7.64|IC=23nM|IC50|=|23|nM|23|nM
2CNF|2.20|2006|F32||P18031|PROTEIN-TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1|6.62|IC=240nM|IC50|=|240|nM|240|nM
2I0Y|1.90|2006|5CN|arylamide inhibits cFMS|P07333|CFMS TYROSINE KINASE|7.62|IC=24nM|IC50|=|24|nM|24|nM
2I1M|1.80|2006|5CN|arylamide inhibits cFMS|P07333|MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR|7.62|IC=24nM|IC50|=|24|nM|24|nM
1ZD4|2.70|2006|NC6||P34913|EPOXIDE HYDROLASE 2|3.6|IC=253uM|IC50|=|253|uM|253000|nM
2GG8|1.80|2006|U15|compound 15|P0AE18|METHIONINE AMINOPEPTIDASE|4.6|IC=25uM|IC50|=|25|uM|25000|nM
2CGV|2.60|2006|3B3||O14757|SERINE/THREONINE-PROTEIN KINASE CHK1|4.56|IC=27.3uM|IC50|=|27.3|uM|27300|nM
2CMF|2.50|2006|F11|X-ray(TcAChE); IC50(rat AChE)|P04058|ACETYLCHOLINESTERASE|7.55|IC=28nM|IC50|=|28|nM|28|nM
2HWI|2.00|2006|VRX||P26663|RNA-DIRECTED RNA POLYMERASE (NS5B) (P68)|5.52|IC=3.0uM|IC50|=|3|uM|3000|nM
2GC8|2.20|2006|885||Q99AU2|RNA-DIRECTED RNA POLYMERASE|5.51|IC=3.1uM|IC50|=|3.1|uM|3100|nM
2CN8|2.70|2006|DBQ||O96017|SERINE/THREONINE-PROTEIN KINASE CHK2|5.46|IC=3.5uM|IC50|=|3.5|uM|3500|nM
2FIE|2.81|2006|A74||P09467|FRUCTOSE-1,6-BISPHOSPHATASE 1|5.46|IC=3.5uM|IC50|=|3.5|uM|3500|nM
2GG9|1.05|2006|U16|compound 13|P0AE18|METHIONINE AMINOPEPTIDASE|5.46|IC=3.5uM|IC50|=|3.5|uM|3500|nM
2C8W|1.96|2006|C7M||P00734|THROMBIN LIGHT CHAIN|8.43|IC=3.7nM|IC50|=|3.7|nM|3.7|nM
2AM9|1.64|2006|TES||P10275|ANDROGEN RECEPTOR|8.41|IC=3.9nM|IC50|=|3.9|nM|3.9|nM
1ZOM|2.25|2006|339|compound 36, mutations(S452A, T493A, K455A, C500S)|P03951|COAGULATION FACTOR XI|7.52|IC=30nM|IC50|=|30|nM|30|nM
2C6C|2.00|2006|24I||Q04609|GLUTAMATE CARBOXYPEPTIDASE 2|7.52|IC=30nM|IC50|=|30|nM|30|nM
2BUA|2.56|2006|007||P22411|DIPEPTIDYL PEPTIDASE 4|4.52|IC=30uM|IC50|=|30|uM|30000|nM
2C90|2.25|2006|C1M||P00734|THROMBIN|3.48|IC=330uM|IC50|=|330|uM|330000|nM
2C9T|2.25|2006|13-mer|IC50=33+/-5nM|Q8WSF8|ACETYLCHOLINE RECEPTOR|7.48|IC=33nM|IC50|=|33|nM|33|nM
2BKS|2.20|2006|PZ1||P00797|RENIN|7.43|IC=37nM|IC50|=|37|nM|37|nM
2FL6|2.50|2006|N5T||P52732|KINESIN-LIKE PROTEIN KIF11|7.42|IC=38nM|IC50|=|38|nM|38|nM
2FJN|2.20|2006|073|IC50=39+/-10nM|P18031|PROTEIN-TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1|7.41|IC=39nM|IC50|=|39|nM|39|nM
2B1P|1.90|2006|AIZ|ligand is compound 18|P53779|MITOGEN-ACTIVATED PROTEIN KINASE 10|8.52|IC=3nM|IC50|=|3|nM|3|nM
2HFP|2.00|2006|NSI||Q86U60|PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA|8.52|IC=3nM|IC50|=|3|nM|3|nM
2GCD|2.55|2006|STU||Q9JLS3|SERINE/THREONINE-PROTEIN KINASE TAO2|5.52|IC=3uM|IC50|=|3|uM|3000|nM
2GZ8|1.97|2006|F3F||P59641|REPLICASE POLYPROTEIN 1AB|5.52|IC=3uM|IC50|=|3|uM|3000|nM
2FJP|2.40|2006|S14||P27487|DIPEPTIDYL PEPTIDASE 4|8.37|IC=4.3nM|IC50|=|4.3|nM|4.3|nM
2DQ7|2.80|2006|STU||P06241|PROTO-ONCOGENE TYROSINE-PROTEIN KINASE FYN|8.32|IC=4.8nM|IC50|=|4.8|nM|4.8|nM
2FDD|1.58|2006|385||Q7SPG9|GAG-POL POLYPROTEIN|8.32|IC=4.8nM|IC50|=|4.8|nM|4.8|nM
2DDF|1.70|2006|INN|IC50=41+/-3nM, mutation(S266A, V353G, Q452N), WT IC50=43+/-4nM|P78536|TNF-ALPHA-CONVERTING ENZYME, ADAM 17|7.39|IC=41nM|IC50|=|41|nM|41|nM
2C6G|2.20|2006|GLU|ligand is glutamate, some cofactors in crystal|Q04609|GLUTAMATE CARBOXYPEPTIDASE 2|3.37|IC=428uM|IC50|=|428|uM|428000|nM
2NP8|2.25|2006|CC3|compound 1|O14965|SERINE/THREONINE-PROTEIN KINASE 6|7.38|IC=42nM|IC50|=|42|nM|42|nM
2FM5|2.03|2006|M99||Q08499|CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D|7.37|IC=43nM|IC50|=|43|nM|43|nM
2G1Q|2.51|2006|N9H||P52732|KINESIN-LIKE PROTEIN KIF11|7.36|IC=44nM|IC50|=|44|nM|44|nM
2G9X|2.50|2006|NU5||P24941|CELL DIVISION PROTEIN KINASE 2|7.35|IC=45nM|IC50|=|45|nM|45|nM
2DXS|2.20|2006|JTP||P26663|GENOME POLYPROTEIN|7.34|IC=46nM|IC50|=|46|nM|46|nM
2HK5|2.00|2006|1BM|IC50(Src)=162nM, IC50(Lck)=3nM, IC50(IL-2)=0.549uM|P08631|TYROSINE-PROTEIN KINASE HCK|7.34|IC=46nM|IC50|=|46|nM|46|nM
2ANK|2.46|2006|N12||P00734|THROMBIN HEAVY CHAIN|7.33|IC=47.3nM|IC50|=|47.3|nM|47.3|nM
2BOI|1.10|2006|MFU||Q7NX84|LECTIN CV-IIL|4.32|IC=48uM|IC50|=|48|uM|48000|nM
2G24|1.90|2006|7IG|ligand is compound 11|P00797|RENIN|5.4|IC=4uM|IC50|=|4|uM|4000|nM
2CHM|1.60|2006|3P4||O76074|CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE|8.26|IC=5.5nM|IC50|=|5.5|nM|5.5|nM
2AQ7|2.30|2006|TL5||P0A953|3-OXOACYL-[ACYL-CARRIER-PROTEIN] SYNTHASE I|3.3|IC=500uM|IC50|=|500|uM|500000|nM
2AQB|2.19|2006|TL6||P0A953|3-OXOACYL-[ACYL-CARRIER-PROTEIN] SYNTHASE I|3.3|IC=500uM|IC50|=|500|uM|500000|nM
2HD1|2.23|2006|IBM||Q53Y40|PHOSPHODIESTERASE 9A|3.3|IC=500uM|IC50|=|500|uM|500000|nM
2A0C|1.95|2006|CK9|ligand is olomoucine II|P24941|CELL DIVISION PROTEIN KINASE 2|7.3|IC=50nM|IC50|=|50|nM|50|nM
2FWZ|2.10|2006|H71||P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|7.3|IC=50nM|IC50|=|50|nM|50|nM
2G0G|2.54|2006|SP0||P37231|PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA|6.29|IC=512nM|IC50|=|512|nM|512|nM
2IGX|1.70|2006|A1T|compound 22, ligand structure has some mistakes. IC50(PM-1)=711nM, IC50(PM-6)=3214nM|P46925|PLASMEPSIN-2|7.27|IC=54nM|IC50|=|54|nM|54|nM
2GNL|2.60|2006|H52||P00517|CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTIC|7.24|IC=58nM|IC50|=|58|nM|58|nM
2CNH|1.80|2006|IZB||P18031|PROTEIN-TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1|7.23|IC=59nM|IC50|=|59|nM|59|nM
2GV2|1.80|2006|9-mer|MW>1000|Q9UMT8|E3 UBIQUITIN-PROTEIN LIGASE MDM2|8.3|IC=5nM|IC50|=|5|nM|5|nM
2C5O|2.10|2006|CK2||P24941|CELL DIVISION PROTEIN KINASE 2|5.19|IC=6.50uM|IC50|=|6.5|uM|6500|nM
2IIV|2.15|2006|565||P27487|DIPEPTIDYL PEPTIDASE 4|8.18|IC=6.6nM|IC50|=|6.6|nM|6.6|nM
2BV4|1.00|2006|MMA||Q7NX84|LECTIN CV-IIL|3.22|IC=600uM|IC50|=|600|uM|600000|nM
2FV9|2.02|2006|002|TACE V353G complexed with JMV 390, IC50=60+/-5nM, mutation(S266A, V353G, Q452N), WT IC50=65+/-4nM|P78536|TNF-ALPHA-CONVERTING ENZYME, ADAM 17|7.22|IC=60nM|IC50|=|60|nM|60|nM
2J83|2.00|2006|BAT||Q8TL28|ULILYSIN|4.21|IC=61uM|IC50|=|61|uM|61000|nM
2AZB|2.03|2006|3TL|incomplete structure|P03367|PROTEASE RETROPEPSIN|7.19|IC=64nM|IC50|=|64|nM|64|nM
2CMB|1.70|2006|F17||P18031|PROTEIN-TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1|7.19|IC=65nM|IC50|=|65|nM|65|nM
2J4Z|2.00|2006|626||O14965|SERINE/THREONINE-PROTEIN KINASE 6|7.19|IC=65nM|IC50|=|65|nM|65|nM
2A8H|2.30|2006|4NH||P78536|TNF-ALPHA-CONVERTING ENZYME, ADAM 17|7.17|IC=67nM|IC50|=|67|nM|67|nM
2AZ8|2.00|2006|3TL|incomplete structure|P03367|PROTEASE RETROPEPSIN|8.22|IC=6nM|IC50|=|6|nM|6|nM
2GNF|2.28|2006|Y27||P00517|CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTIC|5.22|IC=6uM|IC50|=|6|uM|6000|nM
2GNJ|2.28|2006|Y27||P00517|CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTIC|5.22|IC=6uM|IC50|=|6|uM|6000|nM
2D1X|1.90|2006|15-mer|IC50=7.9+/-3.12uM; incomplete ligand|Q14247|CORTACTIN ISOFORM A|5.1|IC=7.9uM|IC50|=|7.9|uM|7900|nM
2ALV|1.90|2006|CY6|covalent complex|P59641|REPLICASE POLYPROTEIN 1AB|4.15|IC=70uM|IC50|=|70|uM|70000|nM
2F1A|1.45|2006|GB2|compound 9|Q24451|ALPHA-MANNOSIDASE II|3.14|IC=720uM|IC50|=|720|uM|720000|nM
2GMX|3.50|2006|877||P45983|MITOGEN-ACTIVATED PROTEIN KINASE 8|7.11|IC=77nM|IC50|=|77|nM|77|nM
2B1Z|1.78|2006|17M|PBA(relative binding affinity)=8.1nM; EC50=5.3nM|P03372|ESTROGEN RECEPTOR|7.1|IC=79nM|IC50|=|79|nM|79|nM
2AYP|2.90|2006|43A||O14757|SERINE/THREONINE-PROTEIN KINASE CHK1|8.15|IC=7nM|IC50|=|7|nM|7|nM
2BKZ|2.60|2006|SBC||P24941|CELL DIVISION PROTEIN KINASE 2|8.15|IC=7nM|IC50|=|7|nM|7|nM
2GO4|2.70|2006|TUX|X-ray(source=A.aeolicus); Ki=650nM(source=E.coli)|O67648|UDP-3-O-[3-HYDROXYMYRISTOYL] N-ACETYLGLUCOSAMINE|5.15|IC=7uM|IC50|=|7|uM|7000|nM
2I7C|1.71|2006|AAT|IC50=8.5+/-0.3uM|Q8II73|SPERMIDINE SYNTHASE|5.07|IC=8.5uM|IC50|=|8.5|uM|8500|nM
2IW9|2.00|2006|4SP||P24941|CELL DIVISION PROTEIN KINASE 2|8.05|IC=8.9nM|IC50|=|8.9|nM|8.9|nM
2F18|1.30|2006|GB1|compound 8|Q24451|ALPHA-MANNOSIDASE II|4.1|IC=80uM|IC50|=|80|uM|80000|nM
2AUC|2.60|2006|15-mer|incomplete ligand|D0VWV5|MYOSIN A TAIL INTERACTING PROTEIN|4.08|IC=84uM|IC50|=|84|uM|84000|nM
2AEI|2.52|2006|03R||P08709|COAGULATION FACTOR VII|7.07|IC=86nM|IC50|=|86|nM|86|nM
2HIW|2.20|2006|7MP|IC50(dephosphorylated)=8nM, IC50(phosphorylated)=11nM|P00519|TYROSINE-PROTEIN KINASE ABL1|8.1|IC=8nM|IC50|=|8|nM|8|nM
2AM2|2.80|2006|2LG||Q8DNV6|UDP-N-ACETYLMURAMOYLALANINE-D-GLUTAMYL-LYSINE-D|5.1|IC=8uM|IC50|=|8|uM|8000|nM
2CCT|2.30|2006|2E1||P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|5.02|IC=9.5uM|IC50|=|9.5|uM|9500|nM
2I1R|2.20|2006|VXR||P26663|RNA-DIRECTED RNA POLYMERASE (NS5B) (P68)|5.01|IC=9.7uM|IC50|=|9.7|uM|9700|nM
2BUB|2.66|2006|FPB||P27487|DIPEPTIDYL PEPTIDASE 4|7.05|IC=90nM|IC50|=|90|nM|90|nM
2I0H|2.00|2006|222||Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|8.05|IC=9nM|IC50|=|9|nM|9|nM
1ZD2|3.00|2006|NC3||P34913|EPOXIDE HYDROLASE 2|3.3|IC>500uM|IC50|>|500|uM|500000|nM
1ZD3|2.30|2006|NC4||P34913|EPOXIDE HYDROLASE 2|3.3|IC>500uM|IC50|>|500|uM|500000|nM
2FV5|2.10|2006|541|X-ray(source=human); Ki=0.56nM(source=pig)|P78536|TNF-ALPHA-CONVERTING ENZYME, ADAM 17|11.7|Kd<2pM|Kd|<|2|pM|0.002|nM
2F34|1.74|2006|UBA||P22756|GLUTAMATE RECEPTOR, IONOTROPIC KAINATE 1|6.89|Kd=0.13uM|Kd|=|0.13|uM|130|nM
2C94|1.90|2006|TSF||P66034|6,7-DIMETHYL-8-RIBITYLLUMAZINE SYNTHASE|6.82|Kd=0.15uM|Kd|=|0.15|uM|150|nM
1YBO|2.30|2006|17-mer|Kd=0.16+/-0.01mM; incomplete ligand|O00560|SYNTENIN 1|3.8|Kd=0.16mM|Kd|=|0.16|mM|160000|nM
2FB8|2.90|2006|215|ligand is compound SB-590885|P15056|B-RAF PROTO-ONCOGENE SERINE/THREONINE-PROTEIN KINASE|9.8|Kd=0.16nM|Kd|=|0.16|nM|0.16|nM
2CEO|2.80|2006|T44||P05543|THYROXINE-BINDING GLOBULIN|10.0|Kd=0.1nM|Kd|=|0.1|nM|0.1|nM
2GH7|1.00|2006|BTN||P22629|STREPTAVIDIN|13.0|Kd=0.1pM|Kd|=|0.1|pM|0.0001|nM
2IWX|1.50|2006|M1S|Kd measured by ITC, compound 15h|P02829|HEAT SHOCK PROTEIN HSP82|6.68|Kd=0.21uM|Kd|=|0.21|uM|210|nM
2EWS|2.05|2006|ANP||Q6G7I0|PANTOTHENATE KINASE|6.62|Kd=0.24uM|Kd|=|0.24|uM|240|nM
2EUK|1.85|2006|3-mer||Q9NZD2|GLYCOLIPID TRANSFER PROTEIN|6.6|Kd=0.25uM|Kd|=|0.25|uM|250|nM
2FGH|2.80|2006|ATP||Q28372|GELSOLIN|6.55|Kd=0.28uM|Kd|=|0.28|uM|280|nM
2H21|2.45|2006|SAM||Q43088|RIBULOSE-1,5 BISPHOSPHATE CARBOXYLASE/OXYGENASE|6.54|Kd=0.29uM|Kd|=|0.29|uM|290|nM
2EUM|2.30|2006|3-mer||Q9NZD2|GLYCOLIPID TRANSFER PROTEIN|6.7|Kd=0.2uM|Kd|=|0.2|uM|200|nM
2EVL|2.20|2006|3-mer||Q9NZD2|GLYCOLIPID TRANSFER PROTEIN|6.7|Kd=0.2uM|Kd|=|0.2|uM|200|nM
2CGF|2.20|2006|P2N|Kd measured by ITC, compound 15a|P02829|HEAT SHOCK PROTEIN HSP90|6.41|Kd=0.39uM|Kd|=|0.39|uM|390|nM
2IWS|2.70|2006|NP4|ITC, compound 15f cis, ligand:cis|P02829|ATP-DEPENDENT MOLECULAR CHAPERONE HSP82|6.36|Kd=0.44uM|Kd|=|0.44|uM|440|nM
2C9D|2.80|2006|PHR||P66034|6,7-DIMETHYL-8-RIBITYLLUMAZINE SYNTHASE|6.32|Kd=0.48uM|Kd|=|0.48|uM|480|nM
2IZX|1.30|2006|DTD|Kd(AKAP-IS)=0.4nM|P13861|CAMP-DEPENDENT PROTEIN KINASE TYPE II-ALPHA|9.4|Kd=0.4nM|Kd|=|0.4|nM|0.4|nM
2HDX|2.35|2006|11-mer|Kd=0.55+/-0.010uM; incomplete ligand|Q9WVM5|SH2-B PH DOMAIN CONTAINING SIGNALING MEDIATOR 1|6.26|Kd=0.55uM|Kd|=|0.55|uM|550|nM
2F14|1.71|2006|FL1||P00918|CARBONIC ANHYDRASE 2|9.19|Kd=0.64nM|Kd|=|0.64|nM|0.64|nM
2FGU|2.00|2006|5-mer||O38716|HIV-1 PROTEASE|9.18|Kd=0.66nM|Kd|=|0.66|nM|0.66|nM
1ZC9|2.00|2006|PMP||P16932|2,2-DIALKYLGLYCINE DECARBOXYLASE|3.22|Kd=0.6mM|Kd|=|0.6|mM|600000|nM
2C97|2.00|2006|JCL||P66034|6,7-DIMETHYL-8-RIBITYLLUMAZINE SYNTHASE|6.14|Kd=0.72uM|Kd|=|0.72|uM|720|nM
2CVD|1.45|2006|HQL||O60760|GLUTATHIONE-REQUIRING PROSTAGLANDIN D SYNTHASE|6.1|Kd=0.8uM|Kd|=|0.8|uM|800|nM
2IVZ|2.00|2006|16-mer|Kd=0.92+/-0.03uM; incomplete ligand|P0A855|PROTEIN TOLB|6.04|Kd=0.92uM|Kd|=|0.92|uM|920|nM
2CE9|2.12|2006|5-mer||Q04724|TRANSDUCIN-LIKE ENHANCER PROTEIN 1|6.03|Kd=0.93uM|Kd|=|0.93|uM|930|nM
2DF6|1.30|2006|18-mer|Kd=1.05+/-0.035uM; EC50=0.9+/-0.05uM|O55043|RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 7|5.98|Kd=1.05uM|Kd|=|1.05|uM|1050|nM
2J79|1.94|2006|GTL||Q08638|BETA-GLUCOSIDASE A|5.96|Kd=1.1uM|Kd|=|1.1|uM|1100|nM
2FKF|2.00|2006|G16||P26276|PHOSPHOMANNOMUTASE/PHOSPHOGLUCOMUTASE|2.92|Kd=1.2mM|Kd|=|1.2|mM|1200000|nM
2FW6|1.85|2006|CIT||Q2QJL3|N5-CARBOXYAMINOIMIDAZOLE RIBONUCLEOTIDE MUTASE|2.92|Kd=1.2mM|Kd|=|1.2|mM|1200000|nM
2FWP|1.85|2006|CIT|redundant to 2fw6|Q2QJL3|N5-CARBOXYAMINOIMIDAZOLE RIBONUCLEOTIDE MUTASE|2.92|Kd=1.2mM|Kd|=|1.2|mM|1200000|nM
2IWU|2.80|2006|NP5|ITC, compound 15f trans, ligand:trans|P02829|ATP-DEPENDENT MOLECULAR CHAPERONE HSP82|5.92|Kd=1.2uM|Kd|=|1.2|uM|1200|nM
2G83|2.80|2006|GDP|Kd for GDP with AlF4-|P63096|GUANINE NUCLEOTIDE-BINDING PROTEIN G(I), ALPHA-1|5.92|Kd=1.2uM|Kd|=|1.2|uM|1200|nM
2G6Q|2.00|2006|12-mer|Kd=1.5+/-1uM; incomplete ligand|Q9ESK4|INHIBITOR OF GROWTH PROTEIN 2|5.82|Kd=1.5uM|Kd|=|1.5|uM|1500|nM
2BOJ|1.80|2006|ARW||Q9HYN5|FUCOSE-BINDING LECTIN PA-IIL|5.77|Kd=1.7uM|Kd|=|1.7|uM|1700|nM
2FL5|3.00|2006|RBF||Q5FWF9|IMMUNOGLOBULIN IGG1 LAMBDA LIGHT CHAIN|8.74|Kd=1.8nM|Kd|=|1.8|nM|1.8|nM
2GFA|2.10|2006|10-mer|incomplete ligand|O75164|JUMONJI DOMAIN-CONTAINING PROTEIN 2A|4.98|Kd=10.4uM|Kd|=|10.4|uM|10400|nM
2H2H|2.20|2006|11-mer|Kd=10.5+/-1.4uM; incomplete ligand|Q9WYW0|NAD-DEPENDENT DEACETYLASE|4.98|Kd=10.5uM|Kd|=|10.5|uM|10500|nM
2J7G|1.91|2006|GI4||Q08638|BETA-GLUCOSIDASE A|7.0|Kd=100nM|Kd|=|100|nM|100|nM
2BUV|1.80|2006|DHB||P20371|PROTOCATECHUATE 3,4-DIOXYGENASE ALPHA CHAIN|4.0|Kd=100uM|Kd|=|100|uM|100000|nM
2FLH|1.20|2006|ZEA|Kd(ITC)=106+/-12uM, Kd(ADA)=148+/-14uM|Q9ZWP8|CYTOKININ-SPECIFIC BINDING PROTEIN|3.97|Kd=106uM|Kd|=|106|uM|106000|nM
2BMV|2.11|2006|BEN|FMN calculated Kd=10mM, for holoflavodoxin and benzamidine|O25776|FLAVODOXIN|2.0|Kd=10mM|Kd|=|10|mM|10000000|nM
2EWA|2.10|2006|SB2||P47811|MITOGEN-ACTIVATED PROTEIN KINASE 14|7.94|Kd=11.5nM|Kd|=|11.5|nM|11.5|nM
2H9N|2.00|2006|11-mer|Kd=115+/-13uM; incomplete ligand|P61964|WD REPEAT-CONTAINING PROTEIN 5|3.94|Kd=115uM|Kd|=|115|uM|115000|nM
2A5B|2.49|2006|8HG||P02701|AVIDIN|3.93|Kd=117uM|Kd|=|117|uM|117000|nM
2CBZ|1.50|2006|ATP||P33527|MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 1|3.93|Kd=118uM|Kd|=|118|uM|118000|nM
2J77|2.10|2006|NOJ||Q08638|BETA-GLUCOSIDASE A|4.89|Kd=12.9uM|Kd|=|12.9|uM|12900|nM
2FOY|1.55|2006|B30|Cu-containing|P00915|CARBONIC ANHYDRASE 1|6.92|Kd=120nM|Kd|=|120|nM|120|nM
2HAW|1.75|2006|2PN||P37487|MANGANESE-DEPENDENT INORGANIC PYROPHOSPHATASE|4.92|Kd=12uM|Kd|=|12|uM|12000|nM
2CLV|1.90|2006|8-mer|MW>1000|P01901|H-2 CLASS I HISTOCOMPATIBILITY ANTIGEN, K-B|7.88|Kd=13.2nM|Kd|=|13.2|nM|13.2|nM
2G2R|2.75|2006|TNS||P84751|GREEN-FLUORESCENT ANTIBODY (11G10)-LIGHT CHAIN|7.89|Kd=13nM|Kd|=|13|nM|13|nM
2G97|2.90|2006|DGB||Q80Z29|NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE|6.82|Kd=152nM|Kd|=|152|nM|152|nM
2HU6|1.32|2006|37A||P39900|MACROPHAGE METALLOELASTASE (MMP-12)|3.81|Kd=154uM|Kd|=|154|uM|154000|nM
2O4N|2.00|2006|TPV||P03367|HIV-1 PROTEASE|7.82|Kd=15nM|Kd|=|15|nM|15|nM
2GL0|2.25|2006|ADN||Q8ZVF7|CONSERVED HYPOTHETICAL PROTEIN|4.82|Kd=15uM|Kd|=|15|uM|15000|nM
2GZL|2.50|2006|2AA|IC50=3mM|P62617|2-C-METHYL-D-ERYTHRITOL 2,4-CYCLODIPHOSPHATE SYNTHASE|4.82|Kd=15uM|Kd|=|15|uM|15000|nM
2CCC|1.70|2006|LFN||Q9HPW4|DODECIN, VNG1446H|7.76|Kd=17.57nM|Kd|=|17.57|nM|17.57|nM
2FX9|2.10|2006|14-mer|human fab 4e10 complex with a thioether-linked peptide on gp41, Kd=17nM|P05880|ANTIBODY FAB 4E10|7.77|Kd=17nM|Kd|=|17|nM|17|nM
2B4L|2.00|2006|BET||P46922|GLYCINE BETAINE-BINDING PROTEIN|4.77|Kd=17uM|Kd|=|17|uM|17000|nM
2H9P|1.91|2006|11-mer|Kd=192+/-26uM; incomplete ligand|P61964|WD REPEAT-CONTAINING PROTEIN 5|3.72|Kd=192uM|Kd|=|192|uM|192000|nM
2O4P|1.80|2006|TPV|same as 6dif|P03367|HIV-1 PROTEASE|10.72|Kd=19pM|Kd|=|19|pM|0.019|nM
2HA4|2.56|2006|ACH|Kd=2.0+/-0.2mM, Kd(ambenonium kinetics)=2.0+/-0.2mM, Kd(direct titration)=1.7+/-0.7mM|P21836|ACETYLCHOLINESTERASE|2.7|Kd=2.0mM|Kd|=|2|mM|2000000|nM
2FR3|1.48|2006|REA|wt Kd=2.0+/-1.2nM, Kd(F15W)=40+/-4nM|P29373|CELLULAR RETINOIC ACID-BINDING PROTEIN 2|8.7|Kd=2.0nM|Kd|=|2|nM|2|nM
2C92|1.60|2006|TP6||P66034|6,7-DIMETHYL-8-RIBITYLLUMAZINE SYNTHASE|5.68|Kd=2.11uM|Kd|=|2.11|uM|2110|nM
2CBU|1.85|2006|CTS|Ki=2uM|Q08638|BETA-GLUCOSIDASE A|5.68|Kd=2.1uM|Kd|=|2.1|uM|2100|nM
2AZM|2.41|2006|10-mer|incomplete ligand|Q14676|MEDIATOR OF DNA DAMAGE CHECKPOINT PROTEIN 1|5.66|Kd=2.2uM|Kd|=|2.2|uM|2200|nM
2BMK|2.30|2006|PDD||------|ANTIBODY FAB FRAGMENT|5.62|Kd=2.4uM|Kd|=|2.4|uM|2400|nM
2FUU|NMR|2006|15-mer|NMR structure; Kd1=2.7uM (ITC); Kd2=1.6+/-1.0uM (FP)|P61836|BROMODOMAIN PHD FINGER TRANSCRIPTION FACTOR|5.57|Kd=2.7uM|Kd|=|2.7|uM|2700|nM
2F6J|2.00|2006|15-mer|X-ray structure; Kd1=2.7uM (ITC); Kd2=1.6+/-1.0uM (FP); incomplete ligand|Q7Z7D6|BROMODOMAIN PHD FINGER TRANSCRIPTION FACTOR|5.57|Kd=2.7uM|Kd|=|2.7|uM|2700|nM
2C9B|2.75|2006|PUG||P66034|6,7-DIMETHYL-8-RIBITYLLUMAZINE SYNTHASE|5.54|Kd=2.88uM|Kd|=|2.88|uM|2880|nM
2IDK|2.55|2006|C2F||P13255|GLYCINE N-METHYLTRANSFERASE|5.54|Kd=2.9uM|Kd|=|2.9|uM|2900|nM
2A8G|1.99|2006|GNG||P02701|AVIDIN|3.69|Kd=205uM|Kd|=|205|uM|205000|nM
2FLU|1.50|2006|16-mer||Q16236|KELCH-LIKE ECH-ASSOCIATED PROTEIN 1|7.7|Kd=20nM|Kd|=|20|nM|20|nM
2FX7|1.76|2006|16-mer|human fab 4e10 complex with a 16-residue peptide on gp41, Kd=20nM|P05880|ANTIBODY FAB 4E10|7.7|Kd=20nM|Kd|=|20|nM|20|nM
2HMV|2.20|2006|ADP|Kd=20~70nM|O32080|YUAA PROTEIN|7.7|Kd=20nM|Kd|=|20|nM|20|nM
2HMW|3.00|2006|ATP|20-70, Kd is apparent dissociation constant|O32080|YUAA PROTEIN|7.7|Kd=20nM|Kd|=|20|nM|20|nM
2HMU|2.25|2006|ATP|Kd=20~70nM|O32080|YUAA PROTEIN|7.7|Kd=20nM|Kd|=|20|nM|20|nM
2CEX|2.20|2006|DAN||P44542|PROTEIN HI0146|4.7|Kd=20uM|Kd|=|20|uM|20000|nM
2H23|2.45|2006|SAH|X-ray(pLSMT); Kd(aLSMT)|Q43088|RIBULOSE-1,5 BISPHOSPHATE CARBOXYLASE/OXYGENASE|4.67|Kd=21.2uM|Kd|=|21.2|uM|21200|nM
2FQW|1.71|2006|NOS||P29724|MEMBRANE LIPOPROTEIN TMPC|6.68|Kd=210nM|Kd|=|210|nM|210|nM
2AOJ|1.60|2006|10-mer|Kd=22.1+/-2.8uM|P04587|POL POLYPROTEIN|4.66|Kd=22.1uM|Kd|=|22.1|uM|22100|nM
2J75|1.85|2006|NOY||Q08638|BETA-GLUCOSIDASE A|6.65|Kd=225nM|Kd|=|225|nM|225|nM
2CA8|2.49|2006|GSH||P30113|GLUTATHIONE S-TRANSFERASE|4.66|Kd=22uM|Kd|=|22|uM|22000|nM
2HA2|2.05|2006|SCK|Kd=22+/-1uM, Ki=21+/-2uM, Kd(decidium kinetics)=22+/-1uM|P21836|ACETYLCHOLINESTERASE|4.66|Kd=22uM|Kd|=|22|uM|22000|nM
2J7B|1.87|2006|NTZ||Q08638|BETA-GLUCOSIDASE A|6.62|Kd=240nM|Kd|=|240|nM|240|nM
2A5C|2.50|2006|8DA||P02701|AVIDIN|4.62|Kd=24uM|Kd|=|24|uM|24000|nM
2FSV|2.30|2006|NAD||Q60164|NAD(P) TRANSHYDROGENASE SUBUNIT ALPHA PART 1|4.6|Kd=25uM|Kd|=|25|uM|25000|nM
2FQY|1.90|2006|ADN||P29724|MEMBRANE LIPOPROTEIN TMPC|6.57|Kd=270nM|Kd|=|270|nM|270|nM
2AOF|1.32|2006|11-mer|Kd=28.2+/-4.2uM|P04587|POL POLYPROTEIN|4.55|Kd=28.2uM|Kd|=|28.2|uM|28200|nM
2FOV|1.15|2006|B30|Cu-containing|P00918|CARBONIC ANHYDRASE 2|7.55|Kd=28nM|Kd|=|28|nM|28|nM
2B4M|2.80|2006|PBE||P46922|GLYCINE BETAINE-BINDING PROTEIN|3.53|Kd=295uM|Kd|=|295|uM|295000|nM
2FRD|3.20|2006|NAD|Kd(dI.S138A.)2(dIII)1-NADH)=29uM|Q60164|NAD(P) TRANSHYDROGENASE SUBUNIT ALPHA PART 1|4.54|Kd=29uM|Kd|=|29|uM|29000|nM
2H3E|2.30|2006|6PR||P0A786|ASPARTATE CARBAMOYLTRANSFERASE|5.7|Kd=2uM|Kd|=|2|uM|2000|nM
2G5U|1.80|2006|PCQ||P02766|TRANSTHYRETIN|8.49|Kd=3.2nM|Kd|=|3.2|nM|3.2|nM
2CBV|1.95|2006|CGB|Ki=4uM|Q08638|BETA-GLUCOSIDASE A|5.48|Kd=3.3uM|Kd|=|3.3|uM|3300|nM
2CO0|2.25|2006|15-mer|Kd=3.3+/-0.2uM; incomplete ligand|P61964|WD REPEAT-CONTAINING PROTEIN 5|5.48|Kd=3.3uM|Kd|=|3.3|uM|3300|nM
2HF8|2.10|2006|GSP||Q57884|HYDROGENASE NICKEL INCORPORATION PROTEIN HYPB|5.47|Kd=3.4uM|Kd|=|3.4|uM|3400|nM
2F35|1.87|2006|UBC||P22756|GLUTAMATE RECEPTOR, IONOTROPIC KAINATE 1|5.4|Kd=3.94uM|Kd|=|3.94|uM|3940|nM
2FX8|2.20|2006|12-mer|human fab 4e10 complex with an aib-induced peptide on gp41, Kd=302nM|P05880|ANTIBODY FAB 4E10|6.52|Kd=302nM|Kd|=|302|nM|302|nM
2O4S|1.54|2006|AB1|same as 6dj1|P03367|HIV-1 PROTEASE|10.51|Kd=31pM|Kd|=|31|pM|0.031|nM
2NM1|2.15|2006|17-mer|Kd=34nM(ITC titration at pH 5.7); binding affinity between HCB and the isolated Syt-II is independent of pH.|P10844|BOTULINUM NEUROTOXIN TYPE B|7.47|Kd=34nM|Kd|=|34|nM|34|nM
2CCB|1.65|2006|RBF||Q9HPW4|DODECIN, VNG1446H|7.45|Kd=35.76nM|Kd|=|35.76|nM|35.76|nM
2IKO|1.90|2006|7IG|IC50=6560nM|P00797|RENIN|5.45|Kd=3571nM|Kd|=|3571|nM|3571|nM
2O4K|1.60|2006|DR7||P03367|HIV-1 PROTEASE|10.46|Kd=35pM|Kd|=|35|pM|0.035|nM
2H9M|1.90|2006|11-mer|Kd=35+/-8uM; incomplete ligand|P61964|WD REPEAT-CONTAINING PROTEIN 5|4.46|Kd=35uM|Kd|=|35|uM|35000|nM
2AOH|1.42|2006|10-mer|Kd=36.3+/-5.4uM|P04587|POL POLYPROTEIN|4.44|Kd=36.3uM|Kd|=|36.3|uM|36300|nM
2AMT|2.30|2006|1AA||P62617|2-C-METHYL-D-ERYTHRITOL 2,4-CYCLODIPHOSPHATE SYNTHASE|4.44|Kd=36uM|Kd|=|36|uM|36000|nM
2CIA|1.45|2006|11-mer|incomplete ligand|O43639|CYTOPLASMIC PROTEIN NCK2|6.43|Kd=370nM|Kd|=|370|nM|370|nM
2HA0|2.20|2006|NWA|Kd=37+/-13uM, Ki=23+/-6uM, Kd(ambenonium kinetics)=37+/-13uM, Kd(decidium kinetics)=33+/-2uM. ligand structure, two hydroxyl groups, different from reference.|P21836|ACETYLCHOLINESTERASE|4.43|Kd=37uM|Kd|=|37|uM|37000|nM
2J78|1.65|2006|GOX||Q08638|BETA-GLUCOSIDASE A|6.42|Kd=384nM|Kd|=|384|nM|384|nM
2EZ5|NMR|2006|11-mer||Q9VVI3|E3 UBIQUITIN-PROTEIN LIGASE NEDD4|5.52|Kd=3uM|Kd|=|3|uM|3000|nM
2H6B|2.20|2006|3C4||Q18R04|CHLOROPHENOL REDUCTION GENE K|5.39|Kd=4.1uM|Kd|=|4.1|uM|4100|nM
2H2J|2.45|2006|SFG|X-ray(pLSMT); Kd(aLSMT)|Q43088|RIBULOSE-1,5 BISPHOSPHATE CARBOXYLASE/OXYGENASE|5.38|Kd=4.2uM|Kd|=|4.2|uM|4200|nM
2H2D|1.70|2006|18-mer|Kd=4.3+/-0.5uM; incomplete ligand|Q9WYW0|NAD-DEPENDENT DEACETYLASE|5.37|Kd=4.3uM|Kd|=|4.3|uM|4300|nM
2FXV|2.05|2006|5GP||P42085|XANTHINE PHOSPHORIBOSYLTRANSFERASE|5.35|Kd=4.5uM|Kd|=|4.5|uM|4500|nM
2H13|1.58|2006|10-mer|Kd=4.5+/-0.2uM; incomplete ligand|P61964|WD REPEAT-CONTAINING PROTEIN 5|5.35|Kd=4.5uM|Kd|=|4.5|uM|4500|nM
2C80|2.30|2006|GTX||P30113|GLUTATHIONE S-TRANSFERASE|5.33|Kd=4.7uM|Kd|=|4.7|uM|4700|nM
2EZ7|2.00|2006|DHI||P00918|CARBONIC ANHYDRASE 2|4.36|Kd=43.5uM|Kd|=|43.5|uM|43500|nM
2HA7|2.66|2006|BCH|Kd(ambenonium kinetics)=440+/-50uM, Kd(decidium kinetics)=760+/-320uM|P21836|ACETYLCHOLINESTERASE|3.36|Kd=440uM|Kd|=|440|uM|440000|nM
2J7F|2.28|2006|GI3||Q08638|BETA-GLUCOSIDASE A|6.35|Kd=445nM|Kd|=|445|nM|445|nM
2FYS|2.50|2006|17-mer|incomplete ligand|P63086|MITOGEN-ACTIVATED PROTEIN KINASE 1|4.36|Kd=44uM|Kd|=|44|uM|44000|nM
2HA5|2.15|2006|AT3|Kd(ambenonium kinetics)=46+/-23uM; Kd(decidium kinetics)=160+/-100uM|P21836|ACETYLCHOLINESTERASE|4.34|Kd=46uM|Kd|=|46|uM|46000|nM
2J7E|2.19|2006|GI2||Q08638|BETA-GLUCOSIDASE A|7.32|Kd=48nM|Kd|=|48|nM|48|nM
2HA6|2.25|2006|SCK|Kd(ambenonium kinetics)=48+/-4uM|P21836|ACETYLCHOLINESTERASE|4.32|Kd=48uM|Kd|=|48|uM|48000|nM
2C1P|2.00|2006|FNZ|Kd=4~6uM|Q58EU8|IGK-C PROTEIN|5.4|Kd=4uM|Kd|=|4|uM|4000|nM
2FSA|1.90|2006|15-mer|incomplete ligand|Q7Z7D6|BROMODOMAIN PHD FINGER TRANSCRIPTION FACTOR|5.3|Kd=5.0uM|Kd|=|5|uM|5000|nM
2A4W|1.50|2006|BLM|Kd1=5.1nM; Kd2>1000nM; MW>1000|O05205|MITOMYCIN-BINDING PROTEIN|8.29|Kd=5.1nM|Kd|=|5.1|nM|5.1|nM
2G96|2.90|2006|NMN||Q80Z29|NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE|4.28|Kd=52.8uM|Kd|=|52.8|uM|52800|nM
2CES|2.15|2006|GIM|Ki=138nM at pH=5.8|Q08638|BETA-GLUCOSIDASE A|7.25|Kd=56nM|Kd|=|56|nM|56|nM
2GPH|1.90|2006|16-mer|covalent complex|P63086|MITOGEN-ACTIVATED PROTEIN KINASE 1|5.3|Kd=5uM|Kd|=|5|uM|5000|nM
2GZ2|2.10|2006|A2P|Kd=6.0+/-1.0uM|Q8DQ00|ASPARTATE-SEMIALDEHYDE DEHYDROGENASE|5.22|Kd=6.0uM|Kd|=|6|uM|6000|nM
2F5T|1.45|2006|MAL||Q7LYW4|ARCHAEAL TRANSCRIPTIONAL REGULATOR TRMB|5.17|Kd=6.8uM|Kd|=|6.8|uM|6800|nM
2O4L|1.33|2006|TPV||P03367|HIV-1 PROTEASE|9.22|Kd=608pM|Kd|=|608|pM|0.608|nM
2CI9|1.50|2006|12-mer|incomplete ligand|P16333|CYTOPLASMIC PROTEIN NCK1|7.22|Kd=60nM|Kd|=|60|nM|60|nM
2FO4|2.70|2006|8-mer|Kd=160nM(4oC); Kd=60nM(23oC); Kd=300nM(37oC)|P01901|H-2 CLASS I HISTOCOMPATIBILITY ANTIGEN, K-B|7.22|Kd=60nM|Kd|=|60|nM|60|nM
1YON|1.95|2006|A2R|2P-ADP-ribose, Kd=61+/-8uM at pH=7.7, Kd=250+/-65uM at pH=4.5|P0A9J4|2-DEHYDROPANTOATE 2-REDUCTASE|4.21|Kd=61uM|Kd|=|61|uM|61000|nM
2J7H|1.95|2006|AZF||Q08638|BETA-GLUCOSIDASE A|7.19|Kd=65nM|Kd|=|65|nM|65|nM
2DOO|2.43|2006|C4H|Kd=67+/-14nM; Ki=140+/-10nM; IC50=0.7+/-0.1uM|P52699|BETA-LACTAMASE IMP-1|7.17|Kd=67nM|Kd|=|67|nM|67|nM
1ZEA|1.78|2006|9-mer||A2NHM3|ANTIBODY FAB FRAGMENT|5.22|Kd=6uM|Kd|=|6|uM|6000|nM
2H6Q|1.87|2006|9-mer|incomplete ligand|P61964|WD REPEAT-CONTAINING PROTEIN 5|5.11|Kd=7.8uM|Kd|=|7.8|uM|7800|nM
2FR8|2.60|2006|NAD|Kd(dI.R127A.-NADH)=700uM|Q60164|NAD(P) TRANSHYDROGENASE SUBUNIT ALPHA PART 1|3.15|Kd=700uM|Kd|=|700|uM|700000|nM
2BBA|1.65|2006|15-mer|IC50=15nM; incomplete ligand|P54760|EPHRIN TYPE-B RECEPTOR 4|7.15|Kd=70nM|Kd|=|70|nM|70|nM
2FCI|NMR|2006|14-mer||P08487|DOUBLY PHOSPHORYLATED PEPTIDE DERIVED FROM SYK KINA|7.15|Kd=70nM|Kd|=|70|nM|70|nM
2HMH|2.00|2006|11-mer||O35718|SUPPRESSOR OF CYTOKINE SIGNALING 3|7.15|Kd=70nM|Kd|=|70|nM|70|nM
2FQX|1.70|2006|GMP||P29724|MEMBRANE LIPOPROTEIN TMPC|7.15|Kd=71nM|Kd|=|71|nM|71|nM
2J7D|2.24|2006|GI1||Q08638|BETA-GLUCOSIDASE A|7.13|Kd=74nM|Kd|=|74|nM|74|nM
2FGV|1.50|2006|5-mer||O38716|HIV-1 PROTEASE|6.12|Kd=760nM|Kd|=|760|nM|760|nM
2O9K|1.90|2006|11-mer|Kd=77+/-16uM; incomplete ligand|P61964|WD REPEAT-CONTAINING PROTEIN 5|4.11|Kd=77uM|Kd|=|77|uM|77000|nM
2IKU|2.60|2006|LIY|IC50=58nM|P00797|RENIN|7.1|Kd=79nM|Kd|=|79|nM|79|nM
2IL2|2.24|2006|LIX|IC50=27nM|P00797|RENIN|7.1|Kd=79nM|Kd|=|79|nM|79|nM
2FXU|1.35|2006|BID||P68135|ACTIN-ALPHA-1|8.15|Kd=7nM|Kd|=|7|nM|7|nM
2GTV|NMR|2006|TSA|Kd(overall)=7uM|Q57696|CHORISMATE MUTASE|5.15|Kd=7uM|Kd|=|7|uM|7000|nM
2H6K|1.89|2006|8-mer|MW>1000|P61964|WD REPEAT-CONTAINING PROTEIN 5|5.06|Kd=8.7uM|Kd|=|8.7|uM|8700|nM
2FOU|0.99|2006|B22|Cu-containing|P00918|CARBONIC ANHYDRASE 2|7.1|Kd=80nM|Kd|=|80|nM|80|nM
2HNX|1.50|2006|PLM|Kd=0.083uM for ALB2|P15090|FATTY ACID BINDING PROTEIN, ADIPOCYTE|7.08|Kd=83nM|Kd|=|83|nM|83|nM
1ZSH|2.90|2006|IHP||P17870|BETA-ARRESTIN 1|7.07|Kd=85nM|Kd|=|85|nM|85|nM
2ATE|1.80|2006|NIA|wt PurE with NO2-AIR; Kd=86+/-31nM|P0AG18|PHOSPHORIBOSYL-AMINOIMIDAZOLE CARBOXYLASE|7.07|Kd=86nM|Kd|=|86|nM|86|nM
2H5A|1.72|2006|X1P||P26276|PHOSPHOMANNOMUTASE/PHOSPHOGLUCOMUTASE|5.1|Kd=8uM|Kd|=|8|uM|8000|nM
2H2G|1.63|2006|11-mer|Kd=9.2+/-1.6uM; incomplete ligand|Q9WYW0|NAD-DEPENDENT DEACETYLASE|5.04|Kd=9.2uM|Kd|=|9.2|uM|9200|nM
2D0K|1.90|2006|FOL||P00379|DIHYDROFOLATE REDUCTASE|5.02|Kd=9.51uM|Kd|=|9.51|uM|9510|nM
2CET|1.97|2006|PGI|Ki=7.5nM at pH=5.8|Q08638|BETA-GLUCOSIDASE A|8.02|Kd=9.6nM|Kd|=|9.6|nM|9.6|nM
2CC7|1.80|2006|LUM||Q9HPW4|DODECIN, VNG1446H|8.01|Kd=9.88nM|Kd|=|9.88|nM|9.88|nM
2FTS|2.41|2006|13-mer|Kd=90-120nM|Q03555|GEPHYRIN|7.05|Kd=90nM|Kd|=|90|nM|90|nM
2HA3|2.25|2006|CHT|Kd=930+/-120uM, Kd(ambenonium kinetics)=930+/-120uM, Ki=1.4+/-0.2mM|P21836|ACETYLCHOLINESTERASE|3.03|Kd=930uM|Kd|=|930|uM|930000|nM
2AOI|1.40|2006|11-mer|Kd=96.7+/-12.3uM|P04587|POL POLYPROTEIN|4.01|Kd=96.7uM|Kd|=|96.7|uM|96700|nM
2H2E|2.60|2006|SA8|X-ray(pLSMT); Kd(aLSMT)|Q43088|RIBULOSE-1,5 BISPHOSPHATE CARBOXYLASE/OXYGENASE|3.0|Kd>1000uM|Kd|>|1000|uM|1000000|nM
2EXG|NMR|2006|STF||P55196|AFADIN|4.3|Kd~50uM|Kd|~|50|uM|50000|nM
2CER|2.29|2006|PGI||P22498|BETA-GALACTOSIDASE|9.22|Ki<=0.6nM|Ki|<=|0.6|nM|0.6|nM
2CF8|1.30|2006|ESH||P00734|THROMBIN HEAVY CHAIN|8.1|Ki=0.008uM|Ki|=|0.008|uM|8|nM
2CF9|1.79|2006|348||P00734|THROMBIN HEAVY CHAIN|7.82|Ki=0.015uM|Ki|=|0.015|uM|15|nM
2F0Z|2.80|2006|ZMR|ligand is Zanamivir (compd 1)|Q9Y3R4|SIALIDASE 2|4.77|Ki=0.017mM|Ki|=|0.017|mM|17000|nM
2AOE|1.54|2006|0Q4||P04587|HIV-1 PROTEASE|7.62|Ki=0.024uM|Ki|=|0.024|uM|24|nM
2D1O|2.02|2006|FA4||P08254|STROMELYSIN-1|7.7|Ki=0.02uM|Ki|=|0.02|uM|20|nM
2HH5|1.80|2006|GNQ|redundant to 2hhn|P25774|CATHEPSIN S|7.49|Ki=0.032uM|Ki|=|0.032|uM|32|nM
2F7O|1.43|2006|MSN||Q24451|ALPHA-MANNOSIDASE II|7.44|Ki=0.036uM|Ki|=|0.036|uM|36|nM
2F81|1.25|2006|017||P04587|HIV-1 PROTEASE|10.52|Ki=0.03nM|Ki|=|0.03|nM|0.03|nM
2FZZ|2.20|2006|5QC||P00742|COAGULATION FACTOR X|10.52|Ki=0.03nM|Ki|=|0.03|nM|0.03|nM
2F9U|2.60|2006|5NH|covalent complex|Q91RS4|NS3 PROTEASE/HELICASE|7.39|Ki=0.041uM|Ki|=|0.041|uM|41|nM
2I3H|1.62|2006|4-mer||Q96CA5|BACULOVIRAL IAP REPEAT-CONTAINING PROTEIN 7|7.4|Ki=0.04uM|Ki|=|0.04|uM|40|nM
2I3I|2.30|2006|618||Q96CA5|BACULOVIRAL IAP REPEAT-CONTAINING PROTEIN 7|7.3|Ki=0.05uM|Ki|=|0.05|uM|50|nM
2A4G|2.50|2006|UNH|covalent complex|Q9QP61|NS3 PROTEASE/HELICASE|7.18|Ki=0.066uM|Ki|=|0.066|uM|66|nM
2A4Q|2.45|2006|FNH|covalent complex|Q91RS4|NS3 PROTEASE/HELICASE|7.18|Ki=0.066uM|Ki|=|0.066|uM|66|nM
2BQ6|3.00|2006|IIB||P00742|COAGULATION FACTOR X|10.15|Ki=0.07nM|Ki|=|0.07|nM|0.07|nM
2BZ6|1.60|2006|346||P08709|COAGULATION FACTOR VIIA|7.09|Ki=0.081uM|Ki|=|0.081|uM|81|nM
1ZSF|1.98|2006|0ZS||P03367|HIV-1 PROTEASE|9.92|Ki=0.12nM|Ki|=|0.12|nM|0.12|nM
2D3U|2.00|2006|CCT||Q99AU2|RNA-DIRECTED RNA POLYMERASE|6.92|Ki=0.12uM|Ki|=|0.12|uM|120|nM
1ZSR|2.06|2006|0ZT|redundant to 1zsf|P03367|HIV-1 PROTEASE|9.82|Ki=0.15nM|Ki|=|0.15|nM|0.15|nM
2B1I|2.02|2006|93A|compound 3, include AICAR transformylase and IMP cyclohydrolase|P31335|BIFUNCTIONAL PURINE BIOSYNTHESIS PROTEIN PURH|6.82|Ki=0.15uM|Ki|=|0.15|uM|150|nM
2D41|2.10|2006|SNH||Q99AU2|GENOME POLYPROTEIN|6.82|Ki=0.15uM|Ki|=|0.15|uM|150|nM
2G00|2.10|2006|4QC||P00742|COAGULATION FACTOR X|9.74|Ki=0.18nM|Ki|=|0.18|nM|0.18|nM
1Z6E|1.80|2006|IK8||P00742|COAGULATION FACTOR XA|9.72|Ki=0.19nM|Ki|=|0.19|nM|0.19|nM
2I0G|2.50|2006|I0G||Q92731|ESTROGEN RECEPTOR BETA|9.72|Ki=0.19nM|Ki|=|0.19|nM|0.19|nM
2B1G|2.10|2006|13A|compound 2, include AICAR transformylase and IMP cyclohydrolase|P31335|BIFUNCTIONAL PURINE BIOSYNTHESIS PROTEIN PURH|6.64|Ki=0.23uM|Ki|=|0.23|uM|230|nM
2D3Z|1.80|2006|FIH||Q99AU2|RNA-DIRECTED RNA POLYMERASE|6.64|Ki=0.23uM|Ki|=|0.23|uM|230|nM
2F7P|1.28|2006|2SK||Q24451|ALPHA-MANNOSIDASE II|6.6|Ki=0.249uM|Ki|=|0.249|uM|249|nM
2HWG|2.70|2006|OXL||P08839|PHOSPHOENOLPYRUVATE-PROTEIN PHOSPHOTRANSFERASE|3.55|Ki=0.28mM|Ki|=|0.28|mM|280000|nM
2JBJ|2.19|2006|G88||Q04609|GLUTAMATE CARBOXYPEPTIDASE 2|9.7|Ki=0.2nM|Ki|=|0.2|nM|0.2|nM
2F10|2.90|2006|BCZ|ligand is compound 3, Peramivir|Q9Y3R4|SIALIDASE 2|3.48|Ki=0.33mM|Ki|=|0.33|mM|330000|nM
2BZZ|0.98|2006|AP5||P10153|EOSINOPHIL-DERIVED NEUROTOXIN|6.43|Ki=0.37uM|Ki|=|0.37|uM|370|nM
2FQO|1.87|2006|HYI||O34667|S-RIBOSYLHOMOCYSTEINE LYASE|6.43|Ki=0.37uM|Ki|=|0.37|uM|370|nM
2G94|1.86|2006|ZPQ||P56817|BETA-SECRETASE 1|9.52|Ki=0.3nM|Ki|=|0.3|nM|0.3|nM
2GVJ|2.10|2006|DGB||P43490|NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE|9.52|Ki=0.3nM|Ki|=|0.3|nM|0.3|nM
2HOC|2.10|2006|1CN|ligand is compound 16|P00918|CARBONIC ANHYDRASE 2|9.52|Ki=0.3nM|Ki|=|0.3|nM|0.3|nM
2F9B|2.54|2006|N1H||P08709|COAGULATION FACTOR VII|6.52|Ki=0.3uM|Ki|=|0.3|uM|300|nM
2H4G|2.50|2006|694||P18031|PROTEIN-TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1|6.52|Ki=0.3uM|Ki|=|0.3|uM|300|nM
2AQU|2.00|2006|DR7||P03366|HIV-1 PROTEASE|9.32|Ki=0.48nM|Ki|=|0.48|nM|0.48|nM
2JBK|2.99|2006|QUS||Q04609|GLUTAMATE CARBOXYPEPTIDASE 2|6.4|Ki=0.4uM|Ki|=|0.4|uM|400|nM
2AOG|1.10|2006|2NC||P04587|HIV-1 PROTEASE|6.28|Ki=0.53uM|Ki|=|0.53|uM|530|nM
2AVV|1.50|2006|MK1|redundant to 1sdt|P04587|HIV-1 PROTEASE|9.26|Ki=0.55nM|Ki|=|0.55|nM|0.55|nM
1W6H|2.24|2006|TIT|ligand is compound 5, TIT1330|P46925|PLASMEPSIN-2|9.3|Ki=0.5nM|Ki|=|0.5|nM|0.5|nM
1ZVX|1.87|2006|FIN||P22894|NEUTROPHIL COLLAGENASE (MMP-8)|9.22|Ki=0.6nM|Ki|=|0.6|nM|0.6|nM
2FQT|1.79|2006|H1D||O34667|S-RIBOSYLHOMOCYSTEINE LYASE|6.14|Ki=0.72uM|Ki|=|0.72|uM|720|nM
2G5T|2.30|2006|ACF|covalent complex|P27487|DIPEPTIDYL PEPTIDASE 4|9.09|Ki=0.82nM|Ki|=|0.82|nM|0.82|nM
2I0D|1.95|2006|MUT||O38732|HIV-1 PROTEASE|12.1|Ki=0.8pM|Ki|=|0.8|pM|0.0008|nM
2EWB|1.85|2006|ZED||P00727|LEUCINE AMINOPEPTIDASE|6.1|Ki=0.8uM|Ki|=|0.8|uM|800|nM
2I03|2.40|2006|AXD|covalent complex|P27487|DIPEPTIDYL PEPTIDASE 4|9.0|Ki=1.0nM|Ki|=|1|nM|1|nM
2IEN|1.30|2006|017|redundant to 3tkw; binding data so different from 3tkw|P03368|HIV-1 PROTEASE|9.0|Ki=1.0nM|Ki|=|1|nM|1|nM
2FHY|2.95|2006|A37|IC50=6.6uM|P09467|FRUCTOSE-1,6-BISPHOSPHATASE 1|5.96|Ki=1.1uM|Ki|=|1.1|uM|1100|nM
2H5I|1.69|2006|5-mer|covalent complex|P42574|CASPASE-3, SUBUNIT P17|8.89|Ki=1.3nM|Ki|=|1.3|nM|1.3|nM
2IDW|1.10|2006|017||P03368|HIV-1 PROTEASE|8.89|Ki=1.3nM|Ki|=|1.3|nM|1.3|nM
2AVO|1.10|2006|MK1||P04587|HIV-1 PROTEASE|8.85|Ki=1.40nM|Ki|=|1.4|nM|1.4|nM
1YZ3|2.40|2006|SKA||P11086|PHENYLETHANOLAMINE N-METHYLTRANSFERASE|8.81|Ki=1.55nM|Ki|=|1.55|nM|1.55|nM
2B1V|1.80|2006|458||P03372|ESTROGEN RECEPTOR|5.74|Ki=1.8uM|Ki|=|1.8|uM|1800|nM
2FLB|1.95|2006|6NH||P08709|COAGULATION FACTOR VII|5.74|Ki=1.8uM|Ki|=|1.8|uM|1800|nM
2D2V|2.50|2006|MAL|maltose|P74325|HYPOTHETICAL PROTEIN SLR0953|1.0|Ki=100mM|Ki|=|100|mM|100000000|nM
2GVD|2.90|2006|128|Ki=100+/-30nM, Ki=81+/-27nM in presence of G alpha s|P30803|ADENYLATE CYCLASE TYPE 5|7.0|Ki=100nM|Ki|=|100|nM|100|nM
2B1R|2.20|2006|CBI|cellobiose|P74325|HYPOTHETICAL PROTEIN SLR0953|1.0|Ki=101mM|Ki|=|101|mM|101000000|nM
2G8R|1.70|2006|N3E||P61823|RIBONUCLEASE|3.99|Ki=103uM|Ki|=|103|uM|103000|nM
2HDS|1.16|2006|4MB||P00811|BETA-LACTAMASE|2.0|Ki=10mM|Ki|=|10|mM|10000000|nM
1YPG|1.80|2006|UIR||P00734|THROMBIN LIGHT CHAIN|8.0|Ki=10nM|Ki|=|10|nM|10|nM
2ANL|3.30|2006|JE2||O60990|PLASMEPSIN IV|6.96|Ki=110nM|Ki|=|110|nM|110|nM
2FPZ|2.00|2006|270||P20231|TRYPTASE BETA-2|3.96|Ki=110uM|Ki|=|110|uM|110000|nM
2E1W|2.50|2006|FR6||P56658|ADENOSINE DEAMINASE|7.96|Ki=11nM|Ki|=|11|nM|11|nM
2H5J|2.00|2006|5-mer|covalent complex|P42574|CASPASE-3, SUBUNIT P17|7.91|Ki=12.4nM|Ki|=|12.4|nM|12.4|nM
2GVV|1.73|2006|DI9||Q7SIG4|PHOSPHOTRIESTERASE|3.9|Ki=125uM|Ki|=|125|uM|125000|nM
1ZFK|1.56|2006|NR2|ligand is compound 3|P00918|CARBONIC ANHYDRASE 2|7.92|Ki=12nM|Ki|=|12|nM|12|nM
2GBF|3.10|2006|AIA|covalent complex|P14740|DIPEPTIDYL PEPTIDASE 4|7.92|Ki=12nM|Ki|=|12|nM|12|nM
2AOC|1.30|2006|2NC||P04587|HIV-1 PROTEASE|4.89|Ki=13.0uM|Ki|=|13|uM|13000|nM
2CLX|1.80|2006|F18|IC50=3.5uM|P24941|CELL DIVISION PROTEIN KINASE 2|4.88|Ki=13.3uM|Ki|=|13.3|uM|13300|nM
2GVZ|3.27|2006|ONA|Ki=130+/-11nM, Ki=14+/-3.7nM in presence of G alpha s|P30803|ADENYLATE CYCLASE TYPE 5|6.89|Ki=130nM|Ki|=|130|nM|130|nM
2C6N|3.00|2006|LPR|ligand is lisinopril|Q59GY8|ANGIOTENSIN-CONVERTING ENZYME|6.88|Ki=131.5nM|Ki|=|131.5|nM|131.5|nM
2GV7|2.20|2006|672||Q9Y5Y6|SUPPRESSOR OF TUMORIGENICITY 14|7.85|Ki=14nM|Ki|=|14|nM|14|nM
2A4R|2.40|2006|BNH|covalent complex|Q91RS4|NS3 PROTEASE/HELICASE|7.82|Ki=15nM|Ki|=|15|nM|15|nM
2J34|2.01|2006|GS6||P00742|COAGULATION FACTOR XA|7.82|Ki=15nM|Ki|=|15|nM|15|nM
2HB1|2.00|2006|512||P18031|PROTEIN-TYROSINE PHOSPHATASE 1B|3.8|Ki=160uM|Ki|=|160|uM|160000|nM
2HD6|1.80|2006|BOS||P00918|CARBONIC ANHYDRASE 2|7.8|Ki=16nM|Ki|=|16|nM|16|nM
2I19|2.28|2006|1BY||Q86C09|FARNESYL PYROPHOSPHATE SYNTHASE|7.8|Ki=16nM|Ki|=|16|nM|16|nM
2AJD|2.56|2006|BPR|covalent complex; X-ray(porcine DPIV); Ki(human DPIV); B-containing|P22411|DIPEPTIDYL PEPTIDASE 4|10.8|Ki=16pM|Ki|=|16|pM|0.016|nM
2DUA|2.00|2006|OXL||Q84G06|PHOSPHONOPYRUVATE HYDROLASE|4.77|Ki=17uM|Ki|=|17|uM|17000|nM
2BMG|2.70|2006|I1H||P00742|COAGULATION FACTOR X|7.74|Ki=18nM|Ki|=|18|nM|18|nM
2AM4|1.70|2006|U2F||P27115|ALPHA-1,3-MANNOSYL-GLYCOPROTEIN 2-BETA-N|3.72|Ki=190uM|Ki|=|190|uM|190000|nM
2F94|1.94|2006|BFQ|ligand is compound 6(ibandronate); time-Dependent IC50 initial 1052 nM to final 25.4 nM|P14324|FARNESYL DIPHOSPHATE SYNTHASE|6.71|Ki=195nM|Ki|=|195|nM|195|nM
2FZC|2.10|2006|EOP|IC50=200uM; Ki=2160uM (for substrate CP); Ki=1990uM (for substrate Asp)|P0A786|ASPARTATE CARBAMOYLTRANSFERASE|2.7|Ki=1990uM|Ki|=|1990|uM|1990000|nM
2HDR|2.20|2006|4A3||P00811|BETA-LACTAMASE|1.72|Ki=19mM|Ki|=|19|mM|19000000|nM
2J4I|1.80|2006|GSJ||P00742|COAGULATION FACTOR X|9.0|Ki=1nM|Ki|=|1|nM|1|nM
2F8G|1.22|2006|017||P04587|HIV-1 PROTEASE|8.7|Ki=2.0nM|Ki|=|2|nM|2|nM
2AVM|1.10|2006|2NC||P04587|HIV-1 PROTEASE|5.7|Ki=2.0uM|Ki|=|2|uM|2000|nM
2NW4|3.00|2006|8NH|Ki=2.11+/-0.16nM, EC50(C2C12)=0.44+/-0.03nM, EC50(PEC)=8.66+/-0.22nM|P15207|ANDROGEN RECEPTOR|8.68|Ki=2.11nM|Ki|=|2.11|nM|2.11|nM
2AOD|1.40|2006|2NC||P04587|HIV-1 PROTEASE|5.66|Ki=2.17uM|Ki|=|2.17|uM|2170|nM
2AN5|2.50|2006|TTL||P11086|PHENYLETHANOLAMINE N-METHYLTRANSFERASE|5.68|Ki=2.1uM|Ki|=|2.1|uM|2100|nM
2C4V|2.50|2006|CIT||Q48255|3-DEHYDROQUINATE DEHYDRATASE|2.6|Ki=2.5mM|Ki|=|2.5|mM|2500000|nM
2I0J|2.90|2006|I0G||P03372|ESTROGEN RECEPTOR ALPHA|8.57|Ki=2.68nM|Ki|=|2.68|nM|2.68|nM
2IUZ|1.95|2006|D1H||Q873X9|CHITINASE|5.55|Ki=2.8uM|Ki|=|2.8|uM|2800|nM
2BVR|1.25|2006|4CP||P00734|THROMBIN ALPHA|3.7|Ki=200uM|Ki|=|200|uM|200000|nM
2FX6|1.57|2006|270||P00760|TRYPSIN|3.7|Ki=200uM|Ki|=|200|uM|200000|nM
2C4W|1.55|2006|GAJ||Q48255|3-DEHYDROQUINATE DEHYDRATASE|4.7|Ki=20uM|Ki|=|20|uM|20000|nM
2DW7|2.50|2006|SRT||Q89FH0|BLL6730 PROTEIN|4.7|Ki=20uM|Ki|=|20|uM|20000|nM
2CN0|1.30|2006|F25|Ki for racemic ligand|P00734|PROTHROMBIN|7.66|Ki=22nM|Ki|=|22|nM|22|nM
2FZK|2.50|2006|EOZ|IC50=79uM; Ki=250uM (for substrate CP); Ki=310uM (for substrate Asp)|P0A786|ASPARTATE CARBAMOYLTRANSFERASE|3.6|Ki=250uM|Ki|=|250|uM|250000|nM
2FS8|2.50|2006|C3A|covalent complex|P20231|TRYPTASE BETA-2|7.6|Ki=25nM|Ki|=|25|nM|25|nM
2FXR|2.50|2006|C3A|covalent complex|P20231|TRYPTASE BETA-2|7.6|Ki=25nM|Ki|=|25|nM|25|nM
2GSU|2.00|2006|AMP||Q8PIS1|PHOSPHODIESTERASE-NUCLEOTIDE PYROPHOSPHATASE|3.59|Ki=260uM|Ki|=|260|uM|260000|nM
2B1Q|2.20|2006|TRE|trehalose|P74325|HYPOTHETICAL PROTEIN SLR0953|1.59|Ki=26mM|Ki|=|26|mM|26000000|nM
2FDP|2.50|2006|FRP||P56817|BETA-SECRETASE 1|7.59|Ki=26nM|Ki|=|26|nM|26|nM
2AVS|1.10|2006|MK1||P04587|HIV-1 PROTEASE|7.57|Ki=27.0nM|Ki|=|27|nM|27|nM
2I3V|2.40|2006|GLU|redundant to 2xxr|P19491|GLUTAMATE RECEPTOR 2|6.55|Ki=282nM|Ki|=|282|nM|282|nM
2F1G|1.90|2006|GNF||P25774|CATHEPSIN S|7.54|Ki=29nM|Ki|=|29|nM|29|nM
2B7D|2.24|2006|C1B||P08709|COAGULATION FACTOR VII|8.7|Ki=2nM|Ki|=|2|nM|2|nM
2BVX|3.20|2006|5CB|Structure of ligand is different from reference|P00734|THROMBIN ALPHA|8.7|Ki=2nM|Ki|=|2|nM|2|nM
2I0E|2.60|2006|PDS|IC50=17nM|P05771|PROTEIN KINASE C-BETA II|8.7|Ki=2nM|Ki|=|2|nM|2|nM
2I3Z|2.90|2006|LIR|Ki=2nM (0% plasma); Ki=600nM (18% plasma)|P14740|DIPEPTIDYL PEPTIDASE 4|8.7|Ki=2nM|Ki|=|2|nM|2|nM
2F2H|1.95|2006|XTG||P31434|PUTATIVE FAMILY 31 GLUCOSIDASE YICI|5.7|Ki=2uM|Ki|=|2|uM|2000|nM
2AJB|2.75|2006|0QG|covalent complex|P22411|DIPEPTIDYL PEPTIDASE 4|5.5|Ki=3.14uM|Ki|=|3.14|uM|3140|nM
2IEO|1.53|2006|017|redundant to 2hs1|P03368|HIV-1 PROTEASE|8.49|Ki=3.2nM|Ki|=|3.2|nM|3.2|nM
2IHQ|2.00|2006|LG7||P15207|ANDROGEN RECEPTOR|8.49|Ki=3.2nM|Ki|=|3.2|nM|3.2|nM
2H4K|2.30|2006|509||P18031|PROTEIN-TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1|5.49|Ki=3.2uM|Ki|=|3.2|uM|3200|nM
2IOA|2.80|2006|GGA|Ki*=7.8nM|P0AES0|BIFUNCTIONAL GLUTATHIONYLSPERMIDINE|5.49|Ki=3.2uM|Ki|=|3.2|uM|3200|nM
2HS1|0.84|2006|017||P03368|HIV-1 PROTEASE|8.48|Ki=3.3nM|Ki|=|3.3|nM|3.3|nM
2AEZ|3.05|2006|DQR|for native 1-FEH IIa, Ki=5.9mM. for mutant Ki=3.5mM, data not shown|Q93X60|FRUCTAN 1-EXOHYDROLASE IIA|2.46|Ki=3.5mM|Ki|=|3.5|mM|3500000|nM
2G5P|2.40|2006|ADF|covalent complex|P27487|DIPEPTIDYL PEPTIDASE 4|8.42|Ki=3.8nM|Ki|=|3.8|nM|3.8|nM
2J47|1.98|2006|GDV||Q89ZI2|O-GLCNACASE BT_4395|5.41|Ki=3.9uM|Ki|=|3.9|uM|3900|nM
1ZFQ|1.55|2006|ZEC|ligand is compound 21|P00918|CARBONIC ANHYDRASE 2|7.52|Ki=30nM|Ki|=|30|nM|30|nM
2F89|2.60|2006|210|ligand is compound 2, pamidronate. Time-Dependent Inhibition IC50 initial 1932 nM to final 353 nM|P14324|FARNESYL DIPHOSPHATE SYNTHASE|6.48|Ki=331nM|Ki|=|331|nM|331|nM
2C57|3.10|2006|FA1||Q48255|3-DEHYDROQUINATE DEHYDRATASE|3.43|Ki=370uM|Ki|=|370|uM|370000|nM
2IVU|2.50|2006|ZD6||P07949|PROTO-ONCOGENE TYROSINE-PROTEIN KINASE|6.43|Ki=375nM|Ki|=|375|nM|375|nM
2ISW|1.75|2006|PGH|Ki=37+/-2nM|O97447|PUTATIVE FRUCTOSE-1,6-BISPHOSPHATE ALDOLASE|7.43|Ki=37nM|Ki|=|37|nM|37|nM
2ISV|2.30|2006|PGH|Ki=37+/-2nM; redundant to 2isw|O97447|PUTATIVE FRUCTOSE-1,6-BISPHOSPHATE ALDOLASE|7.43|Ki=37nM|Ki|=|37|nM|37|nM
2CMO|2.65|2006|M1L|X-ray(S-NS1209); Ki(RS-NS1209)|P19491|GLUTAMATE RECEPTOR 2|6.4|Ki=394nM|Ki|=|394|nM|394|nM
2BOH|2.20|2006|IIA||P00742|COAGULATION FACTOR XA|8.52|Ki=3nM|Ki|=|3|nM|3|nM
2BQW|2.95|2006|IIE||P00742|COAGULATION FACTOR X|8.52|Ki=3nM|Ki|=|3|nM|3|nM
2BXT|1.83|2006|C2D|ligand structure is different in reference|P00734|THROMBIN ALPHA|8.52|Ki=3nM|Ki|=|3|nM|3|nM
2FS9|2.30|2006|C4A|covalent complex|P20231|TRYPTASE BETA-2|8.52|Ki=3nM|Ki|=|3|nM|3|nM
2FVD|1.85|2006|LIA||P24941|CELL DIVISION PROTEIN KINASE 2|8.52|Ki=3nM|Ki|=|3|nM|3|nM
2GBI|3.30|2006|XIH||P14740|DIPEPTIDYL PEPTIDASE 4|8.52|Ki=3nM|Ki|=|3|nM|3|nM
2HB3|1.35|2006|GRL||P03366|HIV-1 PROTEASE|11.35|Ki=4.5pM|Ki|=|4.5|pM|0.0045000000000000005|nM
2HS2|1.22|2006|017|redundant to 2hs1|P03368|HIV-1 PROTEASE|8.31|Ki=4.9nM|Ki|=|4.9|nM|4.9|nM
2HDQ|2.10|2006|C21||P00811|BETA-LACTAMASE|1.4|Ki=40mM|Ki|=|40|mM|40000000|nM
1Y3G|2.10|2006|3-mer||P00800|THERMOLYSIN|7.4|Ki=40nM|Ki|=|40|nM|40|nM
2J9H|2.40|2006|GTX|Ki=410+/-26uM , Midpoint concentration 0.06+/-0.01M|P09211|GLUTATHIONE S-TRANSFERASE P|3.39|Ki=410uM|Ki|=|410|uM|410000|nM
2HZY|1.35|2006|DHJ|ligand is compound 1; Ki=41+/-0.4nM|P35505|FUMARYLACETOACETATE HYDROLASE|7.39|Ki=41nM|Ki|=|41|nM|41|nM
2AVQ|1.30|2006|2NC||P04587|HIV-1 PROTEASE|4.39|Ki=41uM|Ki|=|41|uM|41000|nM
2FZG|2.25|2006|EOB|IC50=86uM; Ki=420uM (for substrate CP); Ki=420uM (for substrate Asp)|P0A786|ASPARTATE CARBAMOYLTRANSFERASE|3.38|Ki=420uM|Ki|=|420|uM|420000|nM
2AW1|1.46|2006|COX||P00918|CARBONIC ANHYDRASE 2|7.37|Ki=43nM|Ki|=|43|nM|43|nM
2GV6|2.10|2006|730||Q9Y5Y6|SUPPRESSOR OF TUMORIGENICITY 14|7.34|Ki=46nM|Ki|=|46|nM|46|nM
2J2U|1.90|2006|GSQ||P00742|COAGULATION FACTOR X|7.33|Ki=47nM|Ki|=|47|nM|47|nM
2I0A|1.80|2006|MUI||O38732|HIV-1 PROTEASE|11.4|Ki=4pM|Ki|=|4|pM|0.004|nM
2I80|2.19|2006|G1L||Q5HEB7|D-ALANINE-D-ALANINE LIGASE|5.4|Ki=4uM|Ki|=|4|uM|4000|nM
2CBJ|2.35|2006|OAN|Ki(hOGA-OAN)=70nM for a homologue|Q8XL08|O-GLCNACASE NAGJ|8.27|Ki=5.4nM|Ki|=|5.4|nM|5.4|nM
1ZGE|1.65|2006|SDA|ligand is compound 9|P00918|CARBONIC ANHYDRASE 2|7.3|Ki=50nM|Ki|=|50|nM|50|nM
2AQ9|1.80|2006|15-mer|IC50=60+/-9nM(1uM acyl-ACP); IC50=730+/-107nM(100uM acyl-ACP); incomplete ligand|P0A722|ACYL-[ACYL-CARRIER-PROTEIN]--UDP-N-ACETYLGLUCOSAMIN|7.3|Ki=50nM|Ki|=|50|nM|50|nM
2CEQ|2.14|2006|GIM||P22498|BETA-GALACTOSIDASE|7.28|Ki=53nM|Ki|=|53|nM|53|nM
1ZKY|2.25|2006|689||P03372|ESTROGEN RECEPTOR|6.25|Ki=560nM|Ki|=|560|nM|560|nM
2GBG|3.00|2006|1AD|covalent complex|P14740|DIPEPTIDYL PEPTIDASE 4|7.25|Ki=56nM|Ki|=|56|nM|56|nM
2FAI|2.10|2006|459||P03372|ESTROGEN RECEPTOR|6.24|Ki=570nM|Ki|=|570|nM|570|nM
2GMK|1.65|2006|AMP|Ki=590+/-20uM; IC50=2.5uM|P22069|P-30 PROTEIN|3.23|Ki=590uM|Ki|=|590|uM|590000|nM
2HDU|1.49|2006|F12||P00811|BETA-LACTAMASE|2.3|Ki=5mM|Ki|=|5|mM|5000000|nM
2FF1|2.07|2006|IMH||Q9GPQ4|IAG-NUCLEOSIDE HYDROLASE|8.21|Ki=6.2nM|Ki|=|6.2|nM|6.2|nM
2FF2|2.20|2006|IMH|redundant to 2ff1|Q9GPQ4|IAG-NUCLEOSIDE HYDROLASE|8.21|Ki=6.2nM|Ki|=|6.2|nM|6.2|nM
2H5D|0.90|2006|5-mer|B-containing|P00778|ALPHA-LYTIC PROTEASE|8.19|Ki=6.4nM|Ki|=|6.4|nM|6.4|nM
2H65|2.30|2006|6-mer|covalent complex|P42574|CASPASE-3, SUBUNIT P17|8.19|Ki=6.5nM|Ki|=|6.5|nM|6.5|nM
2F80|1.45|2006|017||P04587|HIV-1 PROTEASE|8.18|Ki=6.6nM|Ki|=|6.6|nM|6.6|nM
2G63|2.00|2006|AAF|covalent complex|P27487|DIPEPTIDYL PEPTIDASE 4|8.17|Ki=6.7nM|Ki|=|6.7|nM|6.7|nM
2HNC|1.55|2006|1SA|ligand is compound 13|P00918|CARBONIC ANHYDRASE 2|7.22|Ki=60nM|Ki|=|60|nM|60|nM
2AJ8|2.11|2006|SC3||P22411|DIPEPTIDYL PEPTIDASE 4|6.2|Ki=638nM|Ki|=|638|nM|638|nM
2G8N|2.15|2006|F83||P11086|PHENYLETHANOLAMINE N-METHYLTRANSFERASE|7.2|Ki=63nM|Ki|=|63|nM|63|nM
1Z9Y|1.66|2006|FUN|ligand is compound 7|P00918|CARBONIC ANHYDRASE 2|7.19|Ki=65nM|Ki|=|65|nM|65|nM
2CJI|2.10|2006|GSK||P00742|COAGULATION FACTOR XA, HEAVY CHAIN|8.22|Ki=6nM|Ki|=|6|nM|6|nM
2HXM|1.30|2006|302||P13051|URACIL-DNA GLYCOSYLASE|5.22|Ki=6uM|Ki|=|6|uM|6000|nM
1ZS0|1.56|2006|EIN||P22894|NEUTROPHIL COLLAGENASE (MMP-8)|6.15|Ki=700nM|Ki|=|700|nM|700|nM
2BXU|2.80|2006|C1D|in PDB database, not aromatic cycle|P00734|THROMBIN ALPHA|7.15|Ki=70nM|Ki|=|70|nM|70|nM
1YP9|2.10|2006|UIZ||P00760|TRYPSIN|5.11|Ki=7700nM|Ki|=|7700|nM|7700|nM
2D1N|2.37|2006|FA4||P45452|COLLAGENASE 3 (MMP-13)|8.15|Ki=7nM|Ki|=|7|nM|7|nM
2FM2|2.70|2006|3BC|covalent complex|Q9ELS8|NS3 PROTEASE/HELICASE|8.15|Ki=7nM|Ki|=|7|nM|7|nM
2BVS|1.40|2006|2CE||P00734|THROMBIN ALPHA|4.1|Ki=80uM|Ki|=|80|uM|80000|nM
2F9K|2.06|2006|ZOL|ligand is compound 7(zoledronate); time-Dependent inhibition; Ki or IC50 increase 100 folds|P14324|FARNESYL DIPHOSPHATE SYNTHASE|7.07|Ki=85.9nM|Ki|=|85.9|nM|85.9|nM
2BQ7|2.20|2006|IID||P00742|COAGULATION FACTOR X|7.05|Ki=89nM|Ki|=|89|nM|89|nM
1YPE|1.81|2006|UIP||P00734|THROMBIN LIGHT CHAIN|8.1|Ki=8nM|Ki|=|8|nM|8|nM
1W7G|1.65|2006|MIU|Ki=8~18uM|P00734|THROMBIN|5.1|Ki=8uM|Ki|=|8|uM|8000|nM
2C02|2.00|2006|ADP|redundant to 1hi5|P10153|EOSINOPHIL-DERIVED NEUROTOXIN|4.04|Ki=92uM|Ki|=|92|uM|92000|nM
1YPJ|1.78|2006|UIB||P00734|THROMBIN LIGHT CHAIN|7.02|Ki=95nM|Ki|=|95|nM|95|nM
2FAH|2.09|2006|MLA||P21642|PHOSPHOENOLPYRUVATE CARBOXYKINASE|1.3|Ki>50mM|Ki|>|50|mM|50000000|nM
2IN6|1.90|2007|839|compound 59|P30291|WEE1-LIKE PROTEIN KINASE|7.64|IC=0.023uM|IC50|=|0.023|uM|23|nM
2J4A|2.20|2007|OEF|ligand is compound 5, -logIC50=10.6|P10828|THYROID HORMONE RECEPTOR BETA-1|10.6|IC=0.025nM|IC50|=|0.025|nM|0.025|nM
2IO6|2.20|2007|330|compound 18|P30291|WEE1-LIKE PROTEIN KINASE|7.52|IC=0.030uM|IC50|=|0.03|uM|30|nM
2UZN|2.30|2007|C96||P24941|CELL DIVISION PROTEIN KINASE 2|7.52|IC=0.03uM|IC50|=|0.03|uM|30|nM
2OBJ|2.50|2007|VRV||P11309|SERINE/THREONINE-PROTEIN KINASE|7.3|IC=0.05uM|IC50|=|0.05|uM|50|nM
2HWP|2.48|2007|DJK|compound 2, S345C|P00523|TYROSINE-PROTEIN KINASE SRC|7.14|IC=0.073uM|IC50|=|0.073|uM|73|nM
2DUV|2.20|2007|371|compound 15a|P24941|CELL DIVISION PROTEIN KINASE 2|7.06|IC=0.087uM|IC50|=|0.087|uM|87|nM
2HWO|2.50|2007|RBS|compound 4, S345C|P00523|TYROSINE-PROTEIN KINASE SRC|6.9|IC=0.126uM|IC50|=|0.126|uM|126|nM
2P3G|3.80|2007|F10||P49137|MAP KINASE-ACTIVATED PROTEIN KINASE 2|6.9|IC=0.126uM|IC50|=|0.126|uM|126|nM
2UZB|2.70|2007|C75||P24941|CELL DIVISION PROTEIN KINASE 2|6.92|IC=0.12uM|IC50|=|0.12|uM|120|nM
2R9S|2.40|2007|255|compound 16a; IC50=0.15+/-0.02uM|P53779|MITOGEN-ACTIVATED PROTEIN KINASE 10|6.82|IC=0.15uM|IC50|=|0.15|uM|150|nM
2JDT|2.15|2007|I5S|PKA-PKB-1, IC50 for PKB- beta -I5S complex is 0.23uM|P00517|CAMP-DEPENDENT PROTEIN KINASE|6.77|IC=0.17uM|IC50|=|0.17|uM|170|nM
2UZD|2.72|2007|C85||P24941|CELL DIVISION PROTEIN KINASE 2|6.74|IC=0.18uM|IC50|=|0.18|uM|180|nM
2RJP|2.80|2007|886||O75173|ADAMTS-4|7.0|IC=0.1uM|IC50|=|0.1|uM|100|nM
2VA7|2.20|2007|C27|measured by FRET|P56817|BETA-SECRETASE 1|6.7|IC=0.20uM|IC50|=|0.2|uM|200|nM
2OF2|2.00|2007|547||P06239|TYROSINE-PROTEIN KINASE LCK|6.68|IC=0.21uM|IC50|=|0.21|uM|210|nM
2J7W|2.60|2007|GTP||Q6DLV0|POLYPROTEIN|6.66|IC=0.22uM|IC50|=|0.22|uM|220|nM
2JDO|1.80|2007|I5S|polymer2:GLYCOGEN SYNTHASE KINASE-3 BETA EC.No.2.7.11.26|P31751|RAC-BETA SERINE/THREONINE-PROTEIN KINASE|6.64|IC=0.23uM|IC50|=|0.23|uM|230|nM
2PGJ|1.71|2007|N1C||P28907|ADP-RIBOSYL CYCLASE 1|3.59|IC=0.26mM|IC50|=|0.26|mM|260000|nM
2PGL|1.76|2007|N1C|incorrect data [protein in crystal is E226Q mutant]|P28907|ADP-RIBOSYL CYCLASE 1|3.59|IC=0.26mM|IC50|=|0.26|mM|260000|nM
2UW6|2.23|2007|GVO|(S)-enantiomer IC50=0.28+/-0.03uM|P00517|CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTIC|6.55|IC=0.28uM|IC50|=|0.28|uM|280|nM
3B8Z|1.40|2007|294||Q9UNA0|PROTEIN ADAMTS-5|6.54|IC=0.29uM|IC50|=|0.29|uM|290|nM
1VSN|2.00|2007|NFT|compound 23, ligand difference: CN -> CH2NH2|P43235|CATHEPSIN K|9.7|IC=0.2nM|IC50|=|0.2|nM|0.2|nM
2OFV|2.00|2007|242||P06239|TYROSINE-PROTEIN KINASE LCK|9.7|IC=0.2nM|IC50|=|0.2|nM|0.2|nM
2GDO|3.00|2007|12C|compound 11|O14757|SERINE/THREONINE-PROTEIN KINASE CHK1|9.49|IC=0.32nM|IC50|=|0.32|nM|0.32|nM
2O64|2.44|2007|MYU||P11309|SERINE/THREONINE-PROTEIN KINASE|6.47|IC=0.34uM|IC50|=|0.34|uM|340|nM
2OHV|2.50|2007|NHL|IC50=0.1ug/mL, MW=287.31|Q9A1B7|GLUTAMATE RACEMASE|6.46|IC=0.35uM|IC50|=|0.35|uM|350|nM
2FW3|2.50|2007|BUI|ligand is compound ST1326|P18886|CARNITINE O-PALMITOYLTRANSFERASE 2|6.42|IC=0.38uM|IC50|=|0.38|uM|380|nM
2OJ9|2.00|2007|BMI||P08069|INSULIN-LIKE GROWTH FACTOR 1 RECEPTOR|6.41|IC=0.39uM|IC50|=|0.39|uM|390|nM
2HOG|1.90|2007|710|compound 21, IC50(Cdk7)=56nM, EC50(CEA)=690nM|O14757|SERINE/THREONINE-PROTEIN KINASE CHK1|9.52|IC=0.3nM|IC50|=|0.3|nM|0.3|nM
2PVW|1.71|2007|G88||Q04609|GLUTAMATE CARBOXYPEPTIDASE 2|9.52|IC=0.3nM|IC50|=|0.3|nM|0.3|nM
2Q6B|2.00|2007|HR2||P04035|3-HYDROXY-3-METHYLGLUTARYL-COENZYME A REDUCTASE|9.52|IC=0.3nM|IC50|=|0.3|nM|0.3|nM
2OFF|2.20|2007|OFF||P00489|GLYCOGEN PHOSPHORYLASE|6.52|IC=0.3uM|IC50|=|0.3|uM|300|nM
2OWB|2.10|2007|626||P53350|SERINE/THREONINE-PROTEIN KINASE PLK1|6.36|IC=0.44uM|IC50|=|0.44|uM|440|nM
2QPJ|2.05|2007|I20||P08473|NEPRILYSIN|6.35|IC=0.45uM|IC50|=|0.45|uM|450|nM
2UYI|2.10|2007|K02|ligand is in the KSP allosteric binding site|P52732|KINESIN-LIKE PROTEIN KIF11|6.32|IC=0.48uM|IC50|=|0.48|uM|480|nM
2V10|3.10|2007|C61||P00797|RENIN|9.4|IC=0.4nM|IC50|=|0.4|nM|0.4|nM
2E98|1.90|2007|B29||P60472|UNDECAPRENYL PYROPHOSPHATE SYNTHASE|6.23|IC=0.59uM|IC50|=|0.59|uM|590|nM
2OG8|2.30|2007|1N8||P06239|TYROSINE-PROTEIN KINASE LCK|9.3|IC=0.5nM|IC50|=|0.5|nM|0.5|nM
2UZL|2.40|2007|C94||P24941|CELL DIVISION PROTEIN KINASE 2|6.21|IC=0.61uM|IC50|=|0.61|uM|610|nM
2GMV|2.30|2007|UN8|compound 16, IC50=0.63+/-0.14uM|P35558|PHOSPHOENOLPYRUVATE CARBOXYKINASE|6.2|IC=0.63uM|IC50|=|0.63|uM|630|nM
2P98|1.70|2007|YE7|IC50=0.64uM at 5uM Mn; IC50=4.31uM at 100uM Mn|P0AE18|METHIONINE AMINOPEPTIDASE|6.19|IC=0.64uM|IC50|=|0.64|uM|640|nM
2HY0|1.70|2007|306|compound 22, IC50 is tested at 0.1mM ATP. EC50(cell)=97nM|O14757|SERINE/THREONINE-PROTEIN KINASE CHK1|9.19|IC=0.65nM|IC50|=|0.65|nM|0.65|nM
2O65|2.85|2007|MYF||P11309|SERINE/THREONINE-PROTEIN KINASE|6.19|IC=0.65uM|IC50|=|0.65|uM|650|nM
2OZR|2.30|2007|GG1||P45452|COLLAGENASE 3|9.17|IC=0.67nM|IC50|=|0.67|nM|0.67|nM
2VA6|2.50|2007|H24|IC50=0.67 uM in SPR assay; IC50=0.38uM in FRET assay; IC50=0.28uM in IGEN assay|P56817|BETA-SECRETASE 1|6.17|IC=0.67uM|IC50|=|0.67|uM|670|nM
2E99|2.00|2007|B08||P60472|UNDECAPRENYL PYROPHOSPHATE SYNTHASE|6.16|IC=0.69uM|IC50|=|0.69|uM|690|nM
2V0Z|2.20|2007|C41||P00797|RENIN|9.22|IC=0.6nM|IC50|=|0.6|nM|0.6|nM
3B2W|2.30|2007|9NH||P06239|TYROSINE-PROTEIN KINASE LCK|9.22|IC=0.6nM|IC50|=|0.6|nM|0.6|nM
2UUE|2.06|2007|MTZ|superseded by 2uue|P24941|CELL DIVISION PROTEIN KINASE 2|6.13|IC=0.74uM|IC50|=|0.74|uM|740|nM
2O63|2.00|2007|MYC||P11309|SERINE/THREONINE-PROTEIN KINASE|6.11|IC=0.78uM|IC50|=|0.78|uM|780|nM
2G9R|2.07|2007|G27|IC50(rabbit muscle)=0.84+/-0.13uM|P00489|GLYCOGEN PHOSPHORYLASE|6.08|IC=0.84uM|IC50|=|0.84|uM|840|nM
2G9U|2.15|2007|G27|ligand is compound 8|P00489|GLYCOGEN PHOSPHORYLASE|6.08|IC=0.84uM|IC50|=|0.84|uM|840|nM
2Q1J|1.90|2007|FXI||P00742|COAGULATION FACTOR XA, HEAVY CHAIN|9.1|IC=0.8nM|IC50|=|0.8|nM|0.8|nM
2PZI|2.40|2007|AXX||P65728|PROBABLE SERINE/THREONINE-PROTEIN KINASE PKNG|6.1|IC=0.8uM|IC50|=|0.8|uM|800|nM
2E9A|2.10|2007|B28||P60472|UNDECAPRENYL PYROPHOSPHATE SYNTHASE|6.04|IC=0.91uM|IC50|=|0.91|uM|910|nM
2O48|2.59|2007|AC6||Q9TQS6|DIMERIC DIHYDRODIOL DEHYDROGENASE|6.01|IC=0.97uM|IC50|=|0.97|uM|970|nM
2I6A|2.20|2007|5I5|compound 1, IC50=0.9+/-0.1nM|Q5VXR3|ADENOSINE KINASE|9.05|IC=0.9nM|IC50|=|0.9|nM|0.9|nM
2V12|3.20|2007|C39||P00797|RENIN|9.05|IC=0.9nM|IC50|=|0.9|nM|0.9|nM
2R0U|1.90|2007|M54||O14757|SERINE/THREONINE-PROTEIN KINASE CHK1|9.0|IC=1.0nM|IC50|=|1|nM|1|nM
2P99|1.80|2007|YE6||P0AE18|METHIONINE AMINOPEPTIDASE|5.94|IC=1.16uM|IC50|=|1.16|uM|1160|nM
2E9C|2.05|2007|B75||P60472|UNDECAPRENYL PYROPHOSPHATE SYNTHASE|5.96|IC=1.1uM|IC50|=|1.1|uM|1100|nM
2O3P|2.24|2007|QUE||P11309|SERINE/THREONINE-PROTEIN KINASE|5.96|IC=1.1uM|IC50|=|1.1|uM|1100|nM
2O7V|2.30|2007|DEP|Ligand structure has missing atoms (covalent inhibition)|Q0ZPV7|CXE CARBOXYLESTERASE|5.96|IC=1.1uM|IC50|=|1.1|uM|1100|nM
2G9V|2.15|2007|IFM|IC50(rabbit muscle)=1.21+/-0.18uM, phosphated of sites|P00489|GLYCOGEN PHOSPHORYLASE|5.92|IC=1.21uM|IC50|=|1.21|uM|1210|nM
2UZV|2.50|2007|SS5|compound 13au, IC50=1360nM|Q3SX13|CAMP-DEPENDENT PROTEIN KINASE,|5.87|IC=1.36uM|IC50|=|1.36|uM|1360|nM
2E9D|2.50|2007|B76||P60472|UNDECAPRENYL PYROPHOSPHATE SYNTHASE|5.89|IC=1.3uM|IC50|=|1.3|uM|1300|nM
2JBL|2.40|2007|SMA||P07173|PHOTOSYNTHETIC REACTION CENTER CYTOCHROME C|5.89|IC=1.3uM|IC50|=|1.3|uM|1300|nM
2OOH|1.85|2007|OX3||P14174|MACROPHAGE MIGRATION INHIBITORY FACTOR|5.89|IC=1.3uM|IC50|=|1.3|uM|1300|nM
2ORK|1.89|2007|IPD||P35247|PULMONARY SURFACTANT-ASSOCIATED PROTEIN D|2.85|IC=1.4mM|IC50|=|1.4|mM|1400000|nM
2GHG|3.50|2007|A53|Z:E>98:1, MTT(F5.12-Akt)IC50=0.2nM. ligand: C=C->C-C|O14757|SERINE/THREONINE-PROTEIN KINASE CHK1|8.82|IC=1.5nM|IC50|=|1.5|nM|1.5|nM
2R9M|1.97|2007|Y11|ligand is compound 1|P25774|CATHEPSIN S|8.82|IC=1.5nM|IC50|=|1.5|nM|1.5|nM
2QE5|2.60|2007|617||Q99AU2|RNA-DIRECTED RNA POLYMERASE|5.79|IC=1.64uM|IC50|=|1.64|uM|1640|nM
2Q2Y|2.50|2007|MKR||P52732|KINESIN-LIKE PROTEIN KIF11|8.8|IC=1.6nM|IC50|=|1.6|nM|1.6|nM
2Q7M|4.25|2007|2CS|ligand is compound MK-0591|P20292|ARACHIDONATE 5-LIPOXYGENASE-ACTIVATING PROTEIN|8.8|IC=1.6nM|IC50|=|1.6|nM|1.6|nM
2P3O|2.76|2007|GTA|IC50=1.7mM for 7MeGpppAC4; IC50=2.52mM for 7MeGpppAC5|Q9WLZ8|TYPE II METHYLTRANSFERASE|2.77|IC=1.7mM|IC50|=|1.7|mM|1700000|nM
2PG2|1.85|2007|K01|ligand is in the KSP allosteric binding site|P52732|KINESIN-LIKE PROTEIN KIF11|5.77|IC=1.7uM|IC50|=|1.7|uM|1700|nM
2VEU|2.40|2007|IZ1|pNPP enzyme assay. compound 4A|P18031|PROTEIN-TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1|7.0|IC=100nM|IC50|=|100|nM|100|nM
2OHR|2.25|2007|8IP||P56817|BETA-SECRETASE 1|4.0|IC=100uM|IC50|=|100|uM|100000|nM
2QCG|1.75|2007|5BU||P11172|URIDINE 5'-MONOPHOSPHATE SYNTHASE (UMP SYNTHASE)|4.0|IC=100uM|IC50|=|100|uM|100000|nM
2P4I|2.50|2007|MR9|Protein synonym: tyrosine-protein kinase receptor tie-2|Q02763|ANGIOPOIETIN-1 RECEPTOR|8.0|IC=10nM|IC50|=|10|nM|10|nM
2QCN|1.85|2007|U5P||P11172|URIDINE 5'-MONOPHOSPHATE SYNTHASE|5.0|IC=10uM|IC50|=|10|uM|10000|nM
2GH6|2.20|2007|CF3|IC50=11.19+/-2.50uM|Q70I53|HISTONE DEACETYLASE-LIKE AMIDOHYDROLASE|4.95|IC=11.19uM|IC50|=|11.19|uM|11190|nM
2IEH|2.70|2007|MOY||P52732|KINESIN-LIKE PROTEIN KIF11|6.96|IC=110nM|IC50|=|110|nM|110|nM
2OJF|2.10|2007|4PY||P00517|CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTIC|6.96|IC=110nM|IC50|=|110|nM|110|nM
2HIZ|2.50|2007|LIJ|compound 32, IC50(Cat-D)=67nM|P56817|BETA-SECRETASE 1|6.95|IC=112nM|IC50|=|112|nM|112|nM
2E2B|2.20|2007|406|compound 8 INNO-406|P00519|TYROSINE-PROTEIN KINASE ABL1|7.96|IC=11nM|IC50|=|11|nM|11|nM
2OAH|1.80|2007|QIN||P56817|BETA-SECRETASE 1|7.96|IC=11nM|IC50|=|11|nM|11|nM
2P83|2.50|2007|MR0||P56817|BETA-SECRETASE 1|7.96|IC=11nM|IC50|=|11|nM|11|nM
2QK8|2.40|2007|MTX||Q81R22|DIHYDROFOLATE REDUCTASE|7.91|IC=12.2nM|IC50|=|12.2|nM|12.2|nM
2Q1L|2.05|2007|882|there is a mistake in ref. (confusing compound 2 and 3)|P04035|3-HYDROXY-3-METHYLGLUTARYL-COENZYME A REDUCTASE|7.91|IC=12.4nM|IC50|=|12.4|nM|12.4|nM
2HXL|1.80|2007|422||O14757|SERINE/THREONINE-PROTEIN KINASE CHK1|7.92|IC=12nM|IC50|=|12|nM|12|nM
2QD9|1.70|2007|LGF||Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|7.89|IC=13nM|IC50|=|13|nM|13|nM
2HXQ|2.00|2007|373||O14757|SERINE/THREONINE-PROTEIN KINASE CHK1|6.84|IC=144nM|IC50|=|144|nM|144|nM
2GFJ|1.80|2007|_VI||P52700|METALLO-BETA-LACTAMASE L1|3.82|IC=150uM|IC50|=|150|uM|150000|nM
2OU7|2.40|2007|ANP||P53350|SERINE/THREONINE-PROTEIN KINASE PLK1|3.81|IC=155uM|IC50|=|155|uM|155000|nM
2O5K|3.20|2007|HBM||P49841|GLYCOGEN SYNTHASE KINASE-3 BETA|7.82|IC=15nM|IC50|=|15|nM|15|nM
2O7N|1.75|2007|2O7|in vitro assay is at cellular level|P20701|INTEGRIN ALPHA-L|7.82|IC=15nM|IC50|=|15|nM|15|nM
3BI6|2.20|2007|396|compound 24|P30291|WEE1-LIKE PROTEIN KINASE|7.82|IC=15nM|IC50|=|15|nM|15|nM
2HB9|1.75|2007|L13||P52700|METALLO-BETA-LACTAMASE L1|4.82|IC=15uM|IC50|=|15|uM|15000|nM
2ILP|1.90|2007|GB5|4-chlorocinnamic hydroxamate|Q7B8V4|BOTULINUM NEUROTOXIN A LIGHT CHAIN|4.82|IC=15uM|IC50|=|15|uM|15000|nM
2Q6C|2.00|2007|HR1||P04035|3-HYDROXY-3-METHYLGLUTARYL-COENZYME A REDUCTASE|7.78|IC=16.7nM|IC50|=|16.7|nM|16.7|nM
2OPH|2.40|2007|277|IC50=16nM (DPP-4, 0% HS); IC50=40nM (DPP-4, 50% HS)|P27487|DIPEPTIDYL PEPTIDASE 4|7.8|IC=16nM|IC50|=|16|nM|16|nM
2HYY|2.40|2007|STI|IC50(WT-Abl)=170+/-23nM, IC50(Bcr-Abl)=231+/-43nM|P00519|TYROSINE-PROTEIN KINASE ABL1|6.77|IC=170nM|IC50|=|170|nM|170|nM
2OSC|2.80|2007|MUH||Q02763|ANGIOPOIETIN-1 RECEPTOR|7.77|IC=17nM|IC50|=|17|nM|17|nM
2QE2|2.90|2007|452||Q99AU2|RNA-DIRECTED RNA POLYMERASE|7.77|IC=17nM|IC50|=|17|nM|17|nM
2VEX|2.20|2007|IZ4|pNPP enzyme assay. compound 4H|P18031|PROTEIN-TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1|6.74|IC=180nM|IC50|=|180|nM|180|nM
2OH0|2.20|2007|2PY||P00517|CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTIC|7.74|IC=18nM|IC50|=|18|nM|18|nM
2UW7|2.10|2007|GVP|IC50=18+/-7nM|P00517|CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTIC|7.74|IC=18nM|IC50|=|18|nM|18|nM
2PJL|2.30|2007|047|ligand is compound 1a|P11474|STEROID HORMONE RECEPTOR ERR1|6.72|IC=190nM|IC50|=|190|nM|190|nM
2IOK|2.40|2007|IOK|compound 1d, IC50(ER beta )=94nM|P03372|ESTROGEN RECEPTOR|9.0|IC=1nM|IC50|=|1|nM|1|nM
2OFU|2.00|2007|1N9||P06239|TYROSINE-PROTEIN KINASE LCK|9.0|IC=1nM|IC50|=|1|nM|1|nM
2OO8|2.20|2007|RAJ||Q02763|ANGIOPOIETIN-1 RECEPTOR|9.0|IC=1nM|IC50|=|1|nM|1|nM
2OW1|2.20|2007|7MR|incorrect data [protein in crystal is E402Q mutant]|P14780|MATRIX METALLOPROTEINASE-9 (MMP-9)|9.0|IC=1nM|IC50|=|1|nM|1|nM
2R6N|1.95|2007|CKE|covalent inhibition|P43235|CATHEPSIN K|9.0|IC=1nM|IC50|=|1|nM|1|nM
2RGU|2.60|2007|356||P27487|DIPEPTIDYL PEPTIDASE 4|9.0|IC=1nM|IC50|=|1|nM|1|nM
2Q72|1.70|2007|IXX||O67854|TRANSPORTER|2.68|IC=2.09mM|IC50|=|2.09|mM|2089999.9999999998|nM
2Q2Z|3.00|2007|MKK||P52732|KINESIN-LIKE PROTEIN KIF11|8.7|IC=2.0nM|IC50|=|2|nM|2|nM
2V0C|1.85|2007|ANZ|incorrect data [ligand in crystal is AMP-AN2690 adduct; IC50=2.1uM is for AN2690]|Q7SIE4|LEUCYL-TRNA SYNTHETASE|5.68|IC=2.1uM|IC50|=|2.1|uM|2100|nM
2R3C|1.73|2007|17-mer|incomplete ligand|------|GP41 N-PEPTIDE|5.66|IC=2.2uM|IC50|=|2.2|uM|2200|nM
2QT9|2.10|2007|524||P27487|DIPEPTIDYL PEPTIDASE 4|8.64|IC=2.3nM|IC50|=|2.3|nM|2.3|nM
2GU8|2.20|2007|796|compound 2aa, IC50(AKT1)=6nM, IC50(AKT2)=23nM|P17612|CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTIC|8.59|IC=2.6nM|IC50|=|2.6|nM|2.6|nM
2J2I|1.90|2007|LY4|ligand is LY333531|P11309|SERINE/THREONINE-PROTEIN KINASE|6.7|IC=200nM|IC50|=|200|nM|200|nM
2OW0|2.00|2007|6MR|incorrect data [protein in crystal is E402Q mutant]|P14780|MATRIX METALLOPROTEINASE-9 (MMP-9)|6.7|IC=201nM|IC50|=|201|nM|201|nM
2QOH|1.95|2007|P3Y||P00520|TYROSINE-PROTEIN KINASE ABL1|7.7|IC=20nM|IC50|=|20|nM|20|nM
2UW0|2.00|2007|GVK||P00517|CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTIC|7.7|IC=20nM|IC50|=|20|nM|20|nM
2H9T|2.40|2007|SVR|Inhibition of alpha Thrombin-induced fibrinogen clotting by SVR, IC50=20uM|P00734|THROMBIN|4.7|IC=20uM|IC50|=|20|uM|20000|nM
2JC0|2.20|2007|699|filtermat assay using full length 1b enzyme|O39930|RNA-DIRECTED RNA POLYMERASE|4.7|IC=20uM|IC50|=|20|uM|20000|nM
2RCU|1.78|2007|BUJ||P18886|CARNITINE O-PALMITOYLTRANSFERASE 2|6.68|IC=210nM|IC50|=|210|nM|210|nM
2P8S|2.20|2007|417||P27487|DIPEPTIDYL PEPTIDASE 4|7.68|IC=21nM|IC50|=|21|nM|21|nM
2VCJ|2.50|2007|2EQ||P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|7.68|IC=21nM|IC50|=|21|nM|21|nM
2VCI|2.00|2007|2GJ||P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|7.68|IC=21nM|IC50|=|21|nM|21|nM
2OQ6|2.00|2007|OGA|ligand is compound 19|O75164|HISTONE DEMETHYLATION PROTEIN|3.6|IC=250uM|IC50|=|250|uM|250000|nM
2Q6H|1.85|2007|CXX||O67854|TRANSPORTER|3.6|IC=250uM|IC50|=|250|uM|250000|nM
2QCH|1.95|2007|5IU||P11172|URIDINE 5'-MONOPHOSPHATE SYNTHASE (UMP SYNTHASE)|3.6|IC=250uM|IC50|=|250|uM|250000|nM
2QOE|2.30|2007|448||P27487|DIPEPTIDYL PEPTIDASE 4|7.6|IC=25nM|IC50|=|25|nM|25|nM
2JAJ|2.00|2007|D20|NG-DIMETHYLARGININE DIMETHYLAMINOHYDROLASE 1 WITH L-257, IC50<25uM|O94760|N(G),N(G)-DIMETHYLARGININE DIMETHYLAMINOHYDROLASE 1|4.6|IC=25uM|IC50|=|25|uM|25000|nM
2OHQ|2.10|2007|7IP||P56817|BETA-SECRETASE 1|4.6|IC=25uM|IC50|=|25|uM|25000|nM
2PH6|2.00|2007|712||P56817|BETA-SECRETASE 1|7.57|IC=27nM|IC50|=|27|nM|27|nM
2UZO|2.30|2007|C62||P24941|CELL DIVISION PROTEIN KINASE 2|4.57|IC=27uM|IC50|=|27|uM|27000|nM
2HVX|2.60|2007|DRX|compound 5f, IC50=29+/-9nM|P23946|CHYMASE|7.54|IC=29nM|IC50|=|29|nM|29|nM
2HM1|2.20|2007|LIQ|compound 13, IC50(Cat-D)=474nM, IC50(HEKcell)=1nM|P56817|BETA-SECRETASE 1|8.7|IC=2nM|IC50|=|2|nM|2|nM
2OVX|2.00|2007|4MR|incorrect data [protein in crystal is E402Q mutant]|P14780|MATRIX METALLOPROTEINASE-9 (MMP-9)|8.7|IC=2nM|IC50|=|2|nM|2|nM
2UYM|2.11|2007|K03|ligand is in the KSP allosteric binding site|P52732|KINESIN-LIKE PROTEIN KIF11|5.51|IC=3.1uM|IC50|=|3.1|uM|3100|nM
2NWW|3.20|2007|TB1|IC50=3.3+/-1.5uM, mutations:D37H, K40H, K125H, K132H, K223H, K264H, K368H|O59010|425AA LONG HYPOTHETICAL PROTON GLUTAMATE SYMPORT|5.48|IC=3.3uM|IC50|=|3.3|uM|3300|nM
2DS1|2.00|2007|1CD|IC50(CDK1)=1.0nM, IC50(CDK4)=6.4nM, IC50(CDK6)=12nM|P24941|CELL DIVISION PROTEIN KINASE 2|8.47|IC=3.4nM|IC50|=|3.4|nM|3.4|nM
2OH4|2.05|2007|GIG||P35968|VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2|8.46|IC=3.5nM|IC50|=|3.5|nM|3.5|nM
2VEV|1.80|2007|IZ2|pNPP enzyme assay. compound 4B|P18031|PROTEIN-TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1|6.52|IC=300nM|IC50|=|300|nM|300|nM
2OW9|1.74|2007|SP6||P45452|COLLAGENASE 3|7.52|IC=30nM|IC50|=|30|nM|30|nM
2GFK|1.90|2007|VII||P52700|METALLO-BETA-LACTAMASE L1|4.52|IC=30uM|IC50|=|30|uM|30000|nM
2H1H|2.40|2007|AFH|ADP-2F-heptose inhibited WaaC with IC50 around 30uM|P24173|LIPOPOLYSACCHARIDE HEPTOSYLTRANSFERASE 1|4.52|IC=30uM|IC50|=|30|uM|30000|nM
2OHM|2.70|2007|8AP||P56817|BETA-SECRETASE 1|3.51|IC=310uM|IC50|=|310|uM|310000|nM
2GJ4|1.60|2007|2TH|compound 17, both (+/-) conformations. IC50(cell)=3.6uM|P00489|GLYCOGEN PHOSPHORYLASE|6.5|IC=319nM|IC50|=|319|nM|319|nM
2UW5|2.14|2007|GVN|(R)-enantiomer IC50=34+/-11nM, (S)-enantiomer IC50=0.28+/-0.03uM|P00517|CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTIC|7.51|IC=31nM|IC50|=|31|nM|31|nM
2QCF|1.22|2007|5FU||P11172|URIDINE 5'-MONOPHOSPHATE SYNTHASE (UMP SYNTHASE)|3.49|IC=320uM|IC50|=|320|uM|320000|nM
2FVC|2.00|2007|888|analogue compound 2|Q99AU2|RNA-DIRECTED RNA POLYMERASE|7.49|IC=32nM|IC50|=|32|nM|32|nM
2HZ0|2.10|2007|GIN|IC50(WT-Abl)=330+/-113nM, IC50(Bcr-Abl)=565+/-60nM|P00519|TYROSINE-PROTEIN KINASE ABL1|6.48|IC=330nM|IC50|=|330|nM|330|nM
2NQG|2.04|2007|NQG|IC50=333+/-95nM|P97571|CALPAIN-1, CATALYTIC SUBUNIT|6.48|IC=333nM|IC50|=|333|nM|333|nM
2HZ4|2.80|2007|4ST|IC50(WT-Abl)=3425+/-1075nM|P00519|TYROSINE-PROTEIN KINASE ABL1|5.47|IC=3425nM|IC50|=|3425|nM|3425|nM
2PZY|2.90|2007|B18||P49137|MAP KINASE-ACTIVATED PROTEIN KINASE 2|7.47|IC=34nM|IC50|=|34|nM|34|nM
2P2I|2.40|2007|608||P35968|VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2|7.42|IC=38nM|IC50|=|38|nM|38|nM
2POQ|2.59|2007|ISD|monkey dimeric DD|Q9TQS6|DIMERIC DIHYDRODIOL DEHYDROGENASE|4.42|IC=38uM|IC50|=|38|uM|38000|nM
2GD8|1.46|2007|PO1|compound 21, IC50(steroid sulfatase)=39nM|P00918|CARBONIC ANHYDRASE 2|7.41|IC=39nM|IC50|=|39|nM|39|nM
2V11|3.10|2007|C80||P00797|RENIN|8.52|IC=3nM|IC50|=|3|nM|3|nM
2VF6|2.10|2007|M0N|ligand is compound 4, MINODRONATE|P14324|FARNESYL PYROPHOSPHATE SYNTHETASE|8.52|IC=3nM|IC50|=|3|nM|3|nM
2GA2|1.95|2007|A19|ligand is A193400, compound 1, HMVEC cell line growth inhibition|P50579|METHIONINE AMINOPEPTIDASE 2|5.52|IC=3uM|IC50|=|3|uM|3000|nM
2OHU|2.35|2007|IP7||P56817|BETA-SECRETASE 1|5.38|IC=4.2uM|IC50|=|4.2|uM|4200|nM
2VD7|2.25|2007|PD2|ligand is compound 1|O75164|LYSINE-SPECIFIC DEMETHYLASE|5.38|IC=4.2uM|IC50|=|4.2|uM|4200|nM
2GQN|1.80|2007|BLP|compound 1, IC50=4.5+/-0.6uM, ligand is the product.|P06721|CYSTATHIONINE BETA-LYASE|5.35|IC=4.5uM|IC50|=|4.5|uM|4500|nM
2QTB|2.25|2007|474||P27487|DIPEPTIDYL PEPTIDASE 4|8.32|IC=4.8nM|IC50|=|4.8|nM|4.8|nM
2JBU|3.00|2007|12-mer|IC50=400+/-100uM; incomplete ligand|Q5T5N2|INSULIN-DEGRADING ENZYME|3.4|IC=400uM|IC50|=|400|uM|400000|nM
2Q8I|2.60|2007|RDC||Q15120|PYRUVATE DEHYDROGENASE [LIPOAMIDE] KINASE|3.4|IC=400uM|IC50|=|400|uM|400000|nM
2QCD|2.03|2007|U5P||P11172|URIDINE 5'-MONOPHOSPHATE SYNTHASE (UMP SYNTHASE)|3.4|IC=400uM|IC50|=|400|uM|400000|nM
2O9I|2.80|2007|444|ligand is Compound 1, T0901317, pIC50=7.4|O75469|ORPHAN NUCLEAR RECEPTOR PXR|7.4|IC=40nM|IC50|=|40|nM|40|nM
2OHS|2.45|2007|9IP||P56817|BETA-SECRETASE 1|4.4|IC=40uM|IC50|=|40|uM|40000|nM
2GM9|2.30|2007|3TH|compound 15, both (+/-) conformations. IC50(cell)=0.69uM|P00489|GLYCOGEN PHOSPHORYLASE|7.39|IC=41nM|IC50|=|41|nM|41|nM
2HZN|2.70|2007|KIN|IC50(WT-Abl)=41nM, IC50(Bcr-Abl)>700nM|Q61258|TYROSINE-PROTEIN KINASE ABL1|7.39|IC=41nM|IC50|=|41|nM|41|nM
2Q9N|2.20|2007|LK5|covalent inhibition|P05364|BETA-LACTAMASE|6.37|IC=430nM|IC50|=|430|nM|430|nM
2PVV|2.11|2007|OSE||Q04609|GLUTAMATE CARBOXYPEPTIDASE 2|3.36|IC=438uM|IC50|=|438|uM|438000|nM
2VEY|2.20|2007|IZ5|pNPP enzyme assay. compound 4I|P18031|PROTEIN-TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1|7.37|IC=43nM|IC50|=|43|nM|43|nM
2QCM|1.67|2007|JW5||P11172|URIDINE 5'-MONOPHOSPHATE SYNTHASE (UMP SYNTHASE)|3.35|IC=450uM|IC50|=|450|uM|450000|nM
2UZE|2.40|2007|C95||P24941|CELL DIVISION PROTEIN KINASE 2|4.33|IC=47uM|IC50|=|47|uM|47000|nM
2OIC|2.40|2007|STU||Q9NWZ3|INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE 4|8.4|IC=4nM|IC50|=|4|nM|4|nM
2PE2|2.13|2007|464|PDK1 mediated AKT2 activation assay (cAKT2)|O15530|3-PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE 1|8.4|IC=4nM|IC50|=|4|nM|4|nM
2UW4|2.00|2007|L15|complex PKA-PKB-3, IC50=5.2+/-3.3uM|P00517|CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTIC|5.28|IC=5.2uM|IC50|=|5.2|uM|5200|nM
2OS9|1.70|2007|INS||P35247|PULMONARY SURFACTANT-ASSOCIATED PROTEIN D|2.24|IC=5.7mM|IC50|=|5.7|mM|5700000|nM
2GDE|2.00|2007|SN3||P00734|THROMBIN LIGHT CHAIN|8.24|IC=5.7nM|IC50|=|5.7|nM|5.7|nM
2PIX|2.40|2007|FLF|FP screening detects IC50~50uM for FLF|P10275|ANDROGEN RECEPTOR|4.3|IC=50uM|IC50|=|50|uM|50000|nM
2P33|2.40|2007|J07||P53779|MITOGEN-ACTIVATED PROTEIN KINASE 10|7.24|IC=57nM|IC50|=|57|nM|57|nM
2R8Q|1.50|2007|IBM||Q6S996|CLASS I PHOSPHODIESTERASE PDEB1|3.24|IC=580uM|IC50|=|580|uM|580000|nM
3BIZ|2.20|2007|61E|compound 14|P30291|WEE1-LIKE PROTEIN KINASE|7.24|IC=58nM|IC50|=|58|nM|58|nM
2IQG|1.70|2007|F2I|compound 6b|P56817|BETA-SECRETASE 1|8.3|IC=5nM|IC50|=|5|nM|5|nM
2NV7|2.10|2007|555|IC50=5+/-2nM, polymer 2: Nuclear receptor coactivator 1, EC. No. 2.3.1.48|Q92731|ESTROGEN RECEPTOR BETA|8.3|IC=5nM|IC50|=|5|nM|5|nM
2PE1|2.14|2007|517|PDK1 mediated AKT2 activation assay (cAKT2)|O15530|3-PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE 1|8.3|IC=5nM|IC50|=|5|nM|5|nM
2RFN|2.50|2007|AM7|IC50=17nM(phosphorylated c-Met); X-ray:unphosphorylated c-Met|P08581|HEPATOCYTE GROWTH FACTOR RECEPTOR|8.3|IC=5nM|IC50|=|5|nM|5|nM
2P9A|1.60|2007|YE6||P0AE18|METHIONINE AMINOPEPTIDASE|5.18|IC=6.56uM|IC50|=|6.56|uM|6560|nM
2IMB|2.41|2007|AHL|L-arginine hydroxamate|Q7B8V4|BOTULINUM NEUROTOXIN A LIGHT CHAIN|4.22|IC=60uM|IC50|=|60|uM|60000|nM
2Q9M|2.05|2007|LK7|covalent inhibition|P05364|BETA-LACTAMASE|7.21|IC=62nM|IC50|=|62|nM|62|nM
2VEW|2.00|2007|IZ3|pNPP enzyme assay. compound 3I|P18031|PROTEIN-TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1|7.19|IC=64nM|IC50|=|64|nM|64|nM
2P2H|1.95|2007|994||P35968|VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2|7.17|IC=68nM|IC50|=|68|nM|68|nM
2OW2|2.90|2007|8MR|incorrect data [protein in crystal is E402Q mutant]|P14780|MATRIX METALLOPROTEINASE-9 (MMP-9)|8.22|IC=6nM|IC50|=|6|nM|6|nM
2I5F|1.35|2007|5IP|bound ligand to be Ins(1, 2, 3, 5, 6)P5, not IP6|P08567|PLECKSTRIN|5.12|IC=7.5uM|IC50|=|7.5|uM|7500|nM
2HZI|1.70|2007|JIN|IC50(WT-Abl)=70+/-32nM, IC50(Bcr-Abl)=22+/-2nM|P00519|TYROSINE-PROTEIN KINASE ABL1|7.15|IC=70nM|IC50|=|70|nM|70|nM
2P8H|1.80|2007|MY9||P56817|BETA-SECRETASE 1|7.15|IC=71nM|IC50|=|71|nM|71|nM
3BCN|2.85|2007|E64||A5YVK8|ERVATAMIN-A|7.12|IC=76.25nM|IC50|=|76.25|nM|76.25|nM
2UW8|2.00|2007|GVQ|IC50=77+/-39.6uM|P00517|CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTIC|4.11|IC=77uM|IC50|=|77|uM|77000|nM
2NQI|2.04|2007|NQI|IC50=784+/-130nM|P97571|CALPAIN-1, CATALYTIC SUBUNIT|6.11|IC=784nM|IC50|=|784|nM|784|nM
2YWP|2.90|2007|A42||O14757|SERINE/THREONINE-PROTEIN KINASE CHK1|8.15|IC=7nM|IC50|=|7|nM|7|nM
2O5D|2.20|2007|VR1||P26663|HCV RNA-DIRECTED RNA POLYMERASE (NS5B)|5.15|IC=7uM|IC50|=|7|uM|7000|nM
2OOZ|1.80|2007|OX5|ligand is compound OXIM6|P14174|MACROPHAGE MIGRATION INHIBITORY FACTOR|5.15|IC=7uM|IC50|=|7|uM|7000|nM
2JBO|3.10|2007|P4O|form-1, PH4.5|P49137|MAP KINASE-ACTIVATED PROTEIN KINASE 2|8.07|IC=8.5nM|IC50|=|8.5|nM|8.5|nM
2JBP|3.31|2007|P4O|form-2, PH7.5|P49137|MAP KINASE-ACTIVATED PROTEIN KINASE 2|8.07|IC=8.5nM|IC50|=|8.5|nM|8.5|nM
2PE0|2.35|2007|39Z|PDK1 mediated AKT2 activation assay (cAKT2)|O15530|3-PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE 1|7.1|IC=80nM|IC50|=|80|nM|80|nM
2QJU|2.90|2007|DSM||O67854|TRANSPORTER|4.1|IC=80uM|IC50|=|80|uM|80000|nM
2UW3|2.19|2007|GVG|complex PKA-PKB-1, IC50=80+/-38uM|P00517|CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTIC|4.1|IC=80uM|IC50|=|80|uM|80000|nM
2OF4|2.70|2007|979||P06239|TYROSINE-PROTEIN KINASE LCK|7.09|IC=81nM|IC50|=|81|nM|81|nM
2OGZ|2.10|2007|U1N||P27487|DIPEPTIDYL PEPTIDASE 4|7.08|IC=84nM|IC50|=|84|nM|84|nM
2VA5|2.75|2007|C8C|IC50=86uM in SPR assay; IC50=130uM in FRET assay|P56817|BETA-SECRETASE 1|4.07|IC=86uM|IC50|=|86|uM|86000|nM
2Q8G|1.90|2007|AZX||Q15118|PYRUVATE DEHYDROGENASE [LIPOAMIDE] KINASE|7.06|IC=87nM|IC50|=|87|nM|87|nM
2IOG|1.60|2007|IOG|compound 11f, IC50(ER beta )=1231nM, IC50(MCF-7)=42.7nM|P03372|ESTROGEN RECEPTOR|8.1|IC=8nM|IC50|=|8|nM|8|nM
2OHT|2.30|2007|IP6||P56817|BETA-SECRETASE 1|5.04|IC=9.1uM|IC50|=|9.1|uM|9100|nM
2OR4|1.62|2007|QUS||Q04609|GLUTAMATE CARBOXYPEPTIDASE 2|5.02|IC=9.5uM|IC50|=|9.5|uM|9500|nM
2PCU|1.60|2007|5-mer||Q9UI42|CARBOXYPEPTIDASE A4|3.04|IC=910uM|IC50|=|910|uM|910000|nM
2OHP|2.25|2007|6IP||P56817|BETA-SECRETASE 1|4.03|IC=94uM|IC50|=|94|uM|94000|nM
2NO3|3.20|2007|859|JNK1 inhibitor 2b, T183E, Y183E|P45983|MITOGEN-ACTIVATED PROTEIN KINASE 8|8.05|IC=9nM|IC50|=|9|nM|9|nM
2Z60|1.95|2007|P3Y||P00520|TYROSINE-PROTEIN KINASE ABL1|8.05|IC=9nM|IC50|=|9|nM|9|nM
2OHK|2.20|2007|1SQ||P56817|BETA-SECRETASE 1|2.7|IC~2000uM|IC50|~|2000|uM|2000000|nM
2V7A|2.50|2007|627|IC50=25nM|P00519|TYROSINE-PROTEIN KINASE ABL1|8.3|Kd=0.005uM|Kd|=|0.005|uM|5|nM
2E7L|2.50|2007|9-mer||A2NTU7|T-CELL RECEPTOR ALPHA CHAIN|7.54|Kd=0.029uM|Kd|=|0.029|uM|29|nM
2GEK|2.40|2007|GDP||A0QWG6|PHOSPHATIDYLINOSITOL MANNOSYLTRANSFERASE (PIMA)|7.52|Kd=0.03uM|Kd|=|0.03|uM|30|nM
2NNV|1.10|2007|M29|Kd=0.03+/-0.001uM, Ki=0.06+/-0.01uM|P00918|CARBONIC ANHYDRASE 2|7.52|Kd=0.03uM|Kd|=|0.03|uM|30|nM
2UXI|2.50|2007|G50|Kd=0.05+/-0.01uM; two independent binding sites|Q9AIU0|HTH-TYPE TRANSCRIPTIONAL REGULATOR TTGR|7.3|Kd=0.05uM|Kd|=|0.05|uM|50|nM
2PL0|2.80|2007|STI|see ref. 8|P06239|TYROSINE-PROTEIN KINASE LCK|7.21|Kd=0.062uM|Kd|=|0.062|uM|62|nM
2R5D|1.66|2007|17-mer|IC50=0.25nM|------|GP41 N-PEPTIDE|10.15|Kd=0.07nM|Kd|=|0.07|nM|0.07|nM
2V8W|2.30|2007|MGO||P06730|EUKARYOTIC TRANSLATION INITIATION FACTOR 4E|6.82|Kd=0.15uM|Kd|=|0.15|uM|150|nM
2JDU|1.50|2007|MFU|G24N/Me-alpha-Fuc; Kd=0.19+/-0.03uM|Q9HYN5|FUCOSE-BINDING LECTIN PA-IIL|6.72|Kd=0.19uM|Kd|=|0.19|uM|190|nM
2C1Q|2.10|2007|BTN||------|BIOTIN-BINDING PROTEIN A|13.0|Kd=0.1pM|Kd|=|0.1|pM|0.0001|nM
2P0D|1.81|2007|I3P||Q9BRR9|RHO GTPASE-ACTIVATING PROTEIN 9|7.0|Kd=0.1uM|Kd|=|0.1|uM|100|nM
2V00|1.55|2007|V15||P11838|ENDOTHIAPEPSIN|3.66|Kd=0.22mM|Kd|=|0.22|mM|220000|nM
2GEJ|2.60|2007|GDD|ligand is GDP-Man; Kd=0.23uM|A0QWG6|PHOSPHATIDYLINOSITOL MANNOSYLTRANSFERASE (PIMA)|6.64|Kd=0.23uM|Kd|=|0.23|uM|230|nM
2OI3|NMR|2007|14-mer|Kd=0.23+/-0.03uM|P08631|TYROSINE-PROTEIN KINASE HCK|6.64|Kd=0.23uM|Kd|=|0.23|uM|230|nM
2JDP|1.30|2007|MFU|S23A/Me-alpha-Fuc; Kd=0.25+/-0.01uM|Q9HYN5|FUCOSE-BINDING LECTIN PA-IIL|6.6|Kd=0.25uM|Kd|=|0.25|uM|250|nM
2JBV|1.86|2007|FAO|Kd=0.29+/-0.01mM|Q7X2H8|CHOLINE OXIDASE|3.54|Kd=0.29mM|Kd|=|0.29|mM|290000|nM
2JDK|1.10|2007|3-mer|ligand 14, Kd(FUC-NAG-T45)=0.29uM|Q9HYN5|FUCOSE-BINDING LECTIN PA-IIL|6.54|Kd=0.29uM|Kd|=|0.29|uM|290|nM
2PY4|1.49|2007|DUP|Kd=1.6uM for human dUTPase with DUP|P0A552|DEOXYURIDINE 5'-TRIPHOSPHATE NUCLEOTIDOHYDROLASE|6.7|Kd=0.2uM|Kd|=|0.2|uM|200|nM
2JDH|1.10|2007|3-mer|ligand 11, Kd(FUC)=2.9uM, Kd(FUC-NAG-TA5)=0.31uM|Q9HYN5|FUCOSE-BINDING LECTIN PA-IIL|6.51|Kd=0.31uM|Kd|=|0.31|uM|310|nM
2QKI|2.40|2007|13-mer||P01024|COMPLEMENT C3|6.41|Kd=0.39uM|Kd|=|0.39|uM|390|nM
2NN7|1.85|2007|M29|Kd=0.3+/-0.01uM, Ki=0.1+/-0.02uM|P00915|CARBONIC ANHYDRASE 1|6.52|Kd=0.3uM|Kd|=|0.3|uM|300|nM
2PFY|1.95|2007|PCA||Q7VXB1|PUTATIVE EXPORTED PROTEIN|6.52|Kd=0.3uM|Kd|=|0.3|uM|300|nM
2QQS|2.82|2007|10-mer|Kd=0.40+/-0.03uM; incomplete ligand|O75164|JMJC DOMAIN-CONTAINING HISTONE DEMETHYLATION|6.4|Kd=0.40uM|Kd|=|0.4|uM|400|nM
2HKF|2.01|2007|9-mer||Q16790|ANTIBODY FAB FRAGMENT|6.38|Kd=0.42uM|Kd|=|0.42|uM|420|nM
2QPQ|1.92|2007|CIT|Kd=0.43+/-0.07uM|Q7W019|PROTEIN BUG27|6.37|Kd=0.43uM|Kd|=|0.43|uM|430|nM
2E27|1.70|2007|AB0|ligand is ciguatoxin 3C; Ka=2.22x10+9M-1|------|ANTI-CIGUATOXIN ANTIBODY, LIGHT CHAIN|9.35|Kd=0.45nM|Kd|=|0.45|nM|0.45|nM
2NNO|1.01|2007|M28|Kd=0.4+/-0.01uM, Ki=0.8+/-0.06uM|P00918|CARBONIC ANHYDRASE 2|6.4|Kd=0.4uM|Kd|=|0.4|uM|400|nM
2GFD|2.30|2007|RDA|GRP94 in complex with radamined; Kd=0.52+/-0.13uM|P41148|ENDOPLASMIN|6.28|Kd=0.52uM|Kd|=|0.52|uM|520|nM
2NXL|2.00|2007|10-mer|Kd=0.54+/-0.20uM; incomplete ligand|O38732|PROTEASE RETROPEPSIN|6.27|Kd=0.54uM|Kd|=|0.54|uM|540|nM
2JNW|NMR|2007|14-mer|incomplete ligand|P07992|DNA EXCISION REPAIR PROTEIN ERCC-1|6.11|Kd=0.78uM|Kd|=|0.78|uM|780|nM
2QX0|1.80|2007|PH2||Q7CKD7|7,8-DIHYDRO-6-HYDROXYMETHYLPTERIN|6.11|Kd=0.78uM|Kd|=|0.78|uM|780|nM
2E7F|2.20|2007|C2F|wide type; equilibrium dialysis: Kd=10uM (pH=4.85-8.5); Tryptophan fluorescence quenching: Kd=0.6uM, Kd=2.1uM (pH=7.6); Isothermal calorimetry: Kd=0.79uM (pH=7.6), Kd=0.29uM (pH=5.1)|Q46389|5-METHYLTETRAHYDROFOLATE CORRINOID/IRON SULFUR|6.1|Kd=0.79uM|Kd|=|0.79|uM|790|nM
2P8N|1.94|2007|ADE||P02879|RICIN A CHAIN|3.15|Kd=0.7mM|Kd|=|0.7|mM|700000|nM
2J3Q|2.80|2007|TFL|AChE (E) complexes with ThT (L) at P site, Fluorescence Determinations Kd=0.7+/-0.2uM|P04058|ACETYLCHOLINESTERASE|6.15|Kd=0.7uM|Kd|=|0.7|uM|700|nM
2PZE|1.70|2007|ATP||P13569|CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE|6.08|Kd=0.84uM|Kd|=|0.84|uM|840|nM
2FXS|2.00|2007|RDA|HSP82 in complex with radamined; Kd=0.87+/-0.14uM|P02829|HEAT SHOCK PROTEIN HSP82|6.06|Kd=0.87uM|Kd|=|0.87|uM|870|nM
2NND|1.60|2007|PRZ|Kd=0.3uM for wt MUP with IBMP|P11589|MAJOR URINARY PROTEIN|6.06|Kd=0.87uM|Kd|=|0.87|uM|870|nM
2NNS|1.03|2007|M25|Kd=0.9+/-0.02uM, Ki=0.9+/-0.03uM|P00918|CARBONIC ANHYDRASE 2|6.05|Kd=0.9uM|Kd|=|0.9|uM|900|nM
2R7G|1.67|2007|10-mer|Kd=0.9+/-0.3uM|P06400|RETINOBLASTOMA-ASSOCIATED PROTEIN|6.05|Kd=0.9uM|Kd|=|0.9|uM|900|nM
2HUG|NMR|2007|14-mer|Kd~1.06uM, Chromo-2 Domain of cpSRP43 complexed with 14-mer cpSRP54 peptide|O22265|SIGNAL RECOGNITION PARTICLE 43 KDA PROTEIN|5.97|Kd=1.06uM|Kd|=|1.06|uM|1060|nM
2Z5O|3.20|2007|10-mer|incomplete ligand structure|Q92973|TRANSPORTIN-1|6.0|Kd=1.0uM|Kd|=|1|uM|1000|nM
2JOA|NMR|2007|7-mer|ligand: ASP-SER-ARG-ILE-TRP-TRP-VAL|Q92743|SERINE PROTEASE HTRA1|5.96|Kd=1.1uM|Kd|=|1.1|uM|1100|nM
2PEH|2.11|2007|10-mer|Kd=1.1+/-0.01uM|Q96I25|SPLICING FACTOR 45|5.96|Kd=1.1uM|Kd|=|1.1|uM|1100|nM
2PV2|1.30|2007|12-mer|Kd=1.23+/-0.15uM|P0ABZ6|CHAPERONE SURA|5.91|Kd=1.23uM|Kd|=|1.23|uM|1230|nM
2OQS|NMR|2007|6-mer|peptide ligand is C-terminal HPV-18 E6 peptide (Chain B) [ARG-ARG-GLU-THR-GLN-VAL]|Q12959|DISKS LARGE HOMOLOG 1|5.89|Kd=1.3uM|Kd|=|1.3|uM|1300|nM
2PH9|2.88|2007|GNT||Q8WSF8|ACETYLCHOLINE RECEPTOR|5.89|Kd=1.3uM|Kd|=|1.3|uM|1300|nM
2QM7|1.85|2007|GDP|Kd1=1.3+/-0.1uM; Kd2=10+/-3uM|Q8RPA0|GTPASE/ATPASE|5.89|Kd=1.3uM|Kd|=|1.3|uM|1300|nM
2E5Y|1.92|2007|ATP|Kd=1.4uM at 36C; Kd=0.67mM at 65C; protein source: Thermophilic bacterium ps-3; Kd(EF1 epsilon)=22+/-1mM at 25C (protein source: E. coli).|P07678|ATP SYNTHASE EPSILON CHAIN|5.85|Kd=1.4uM|Kd|=|1.4|uM|1400|nM
2NN1|1.65|2007|M28|Kd=1.5+/-0.1uM, Ki=2.3+/-0.1uM|P00915|CARBONIC ANHYDRASE 1|5.82|Kd=1.5uM|Kd|=|1.5|uM|1500|nM
2QTA|1.85|2007|TDP|E401K mutant|P0AFG8|PYRUVATE DEHYDROGENASE E1 COMPONENT|5.76|Kd=1.75uM|Kd|=|1.75|uM|1750|nM
2ITT|2.73|2007|AEE|Kd=1.7+/-0.4nM|P00533|EPIDERMAL GROWTH FACTOR RECEPTOR|8.77|Kd=1.7nM|Kd|=|1.7|nM|1.7|nM
2PGZ|1.76|2007|COC||Q8WSF8|ACETYLCHOLINE RECEPTOR|5.74|Kd=1.8uM|Kd|=|1.8|uM|1800|nM
2V25|1.49|2007|ASP||Q0P9X8|MAJOR CELL-BINDING FACTOR|5.72|Kd=1.9uM|Kd|=|1.9|uM|1900|nM
2J6M|3.10|2007|AEE|Kd=10.9+/-3.3nM|P00533|EPIDERMAL GROWTH FACTOR RECEPTOR|7.96|Kd=10.9nM|Kd|=|10.9|nM|10.9|nM
2JA3|3.05|2007|ADP|Kd about 100uM|P51795|CHLORIDE CHANNEL PROTEIN 5|4.0|Kd=100uM|Kd|=|100|uM|100000|nM
2J9L|2.30|2007|ATP|Kd about 100uM|P51795|CHLORIDE CHANNEL PROTEIN 5|4.0|Kd=100uM|Kd|=|100|uM|100000|nM
2Q8Y|2.00|2007|9-mer||P0A2N1|27.5 KDA VIRULENCE PROTEIN|3.99|Kd=102uM|Kd|=|102|uM|102000|nM
2ODD|NMR|2007|17-mer|Kd=109.4+/-0.4uM; incomplete ligand|Q06455|SMRT|3.96|Kd=109.4uM|Kd|=|109.4|uM|109400|nM
2R58|2.00|2007|MLY||Q9VHA0|POLYCOMB PROTEIN SCM|2.0|Kd=10mM|Kd|=|10|mM|10000000|nM
2OIQ|2.07|2007|STI||P00523|TYROSINE-PROTEIN KINASE SRC|5.0|Kd=10uM|Kd|=|10|uM|10000|nM
2ITP|2.74|2007|AEE|Kd=11.3+/-1.5nM|P00533|EPIDERMAL GROWTH FACTOR RECEPTOR|7.95|Kd=11.3nM|Kd|=|11.3|nM|11.3|nM
2G78|1.70|2007|REA|Kd=120+/-5nM, binding data for retinal; ligand in structure is retinoic acid|P29373|CELLULAR RETINOIC ACID-BINDING PROTEIN 2|6.92|Kd=120nM|Kd|=|120|nM|120|nM
2G79|1.69|2007|RET|Kd=120+/-5nM; ligand in structure is retinal|P29373|CELLULAR RETINOIC ACID-BINDING PROTEIN 2|6.92|Kd=120nM|Kd|=|120|nM|120|nM
2ITO|3.25|2007|IRE|Kd=123.6+/-5.9nM|P00533|EPIDERMAL GROWTH FACTOR RECEPTOR|6.91|Kd=123.6nM|Kd|=|123.6|nM|123.6|nM
2OEI|1.35|2007|9-mer||O00213|AMYLOID BETA A4 PROTEIN-BINDING FAMILY B MEMBER|3.91|Kd=124uM|Kd|=|124|uM|124000|nM
2VHJ|1.80|2007|ADP|NTPase P4 PROTEIN S252A MUTANT, Kd=koff/kon=125uM|Q94M05|NTPASE P4|3.9|Kd=125uM|Kd|=|125|uM|125000|nM
2PK6|1.45|2007|O33||P03367|HIV-1 PROTEASE|10.89|Kd=13pM|Kd|=|13|pM|0.013000000000000001|nM
2VHQ|2.15|2007|ATP|Kd=140+/-30uM, NTPase S252A MUTANT IN COMPLEX WITH ATP AND MG2+|Q94M05|NTPASE P4|3.85|Kd=140uM|Kd|=|140|uM|140000|nM
2J4K|2.20|2007|U5P|Kd=14+/-3uM, Ki=17+/-5uM, Kd=70uM in presence of 100uM UTP|Q97ZE2|URIDYLATE KINASE|4.85|Kd=14uM|Kd|=|14|uM|14000|nM
2O9A|1.80|2007|PYR|covalent binding|P16528|ACETATE OPERON REPRESSOR|3.81|Kd=156.2uM|Kd|=|156.2|uM|156200|nM
2JUP|NMR|2007|9-mer|incorrect data [ligand in crystal is GLY-PRO-PRO-LEU-ILE-PRO-PRO-PRO-PRO; Kd=156uM is for PPLIPPPP peptide]|Q8CGF7|TRANSCRIPTION ELONGATION REGULATOR 1|3.81|Kd=156uM|Kd|=|156|uM|156000|nM
2JG0|1.50|2007|TTZ|compound 4; Kd=15nM, Ki=9nM|P13482|PERIPLASMIC TREHALASE|7.82|Kd=15nM|Kd|=|15|nM|15|nM
2HR6|1.84|2007|DUD||P06968|DEOXYURIDINE 5'-TRIPHOSPHATE NUCLEOTIDOHYDROLASE|4.82|Kd=15uM|Kd|=|15|uM|15000|nM
2NSJ|2.31|2007|C2R|H45Q mutant; Kd=16.3+/-2.6uM|P0AG18|PHOSPHORIBOSYL-AMINOIMIDAZOLE CARBOXYLASE|4.79|Kd=16.3uM|Kd|=|16.3|uM|16300|nM
2CLK|1.50|2007|G3H||P00929|TRYPTOPHAN SYNTHASE ALPHA CHAIN|3.79|Kd=164uM|Kd|=|164|uM|164000|nM
2JSD|NMR|2007|NGH||O60882|MATRIX METALLOPROTEINASE-20|7.77|Kd=17nM|Kd|=|17|nM|17|nM
2QM9|2.31|2007|TDZ|Kd value derived from EC50|P04117|ADIPOCYTE LIPID-BINDING PROTEIN|7.77|Kd=17nM|Kd|=|17|nM|17|nM
2DWX|2.55|2007|13-mer|incomplete ligand|Q9UJY5|ADP-RIBOSYLATION FACTOR-BINDING PROTEIN GGA1|3.74|Kd=180uM|Kd|=|180|uM|180000|nM
2OV4|2.50|2007|AQP|Kd1=18uM; Kd2=40uM|P00953|TRYPTOPHANYL-TRNA SYNTHETASE|4.74|Kd=18uM|Kd|=|18|uM|18000|nM
2UXU|2.30|2007|NAR|Kd=18+/-0.3uM|Q9AIU0|HTH-TYPE TRANSCRIPTIONAL REGULATOR TTGR|4.74|Kd=18uM|Kd|=|18|uM|18000|nM
2IG0|1.70|2007|10-mer|Kd=19.7+/-0.7uM; incomplete ligand|Q12888|TUMOR SUPPRESSOR P53-BINDING PROTEIN 1|4.71|Kd=19.7uM|Kd|=|19.7|uM|19700|nM
2I4Z|2.25|2007|DRH|Kd=1978+/-523.5nM|P37231|PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA|5.7|Kd=1978nM|Kd|=|1978|nM|1978|nM
2I4P|2.10|2007|DRH|Kd=1978+/-523.5nM, from apo-form soaked for 30 days|P37231|PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA|5.7|Kd=1978nM|Kd|=|1978|nM|1978|nM
2Q8H|2.00|2007|TF4||Q15118|PYRUVATE DEHYDROGENASE [LIPOAMIDE] KINASE|3.0|Kd=1mM|Kd|=|1|mM|1000000|nM
2R0Y|1.75|2007|13-mer|Kd=1~2mM; incomplete ligand|Q02206|CHROMATIN STRUCTURE-REMODELING COMPLEX PROTEIN|3.0|Kd=1mM|Kd|=|1|mM|1000000|nM
2V3U|1.74|2007|DSN||Q63226|GLUTAMATE RECEPTOR DELTA-2|3.0|Kd=1mM|Kd|=|1|mM|1000000|nM
2GH9|1.95|2007|MLR||Q72I44|MALTOSE/MALTODEXTRIN-BINDING PROTEIN|6.0|Kd=1uM|Kd|=|1|uM|1000|nM
2UYQ|1.80|2007|SAM||Q9CCZ4|HYPOTHETICAL PROTEIN ML2640|5.68|Kd=2.1uM|Kd|=|2.1|uM|2100|nM
2Z5S|2.30|2007|15-mer|Kd=2.20+/-0.30uM; incomplete ligand|Q4V944|MDM4 PROTEIN|5.66|Kd=2.20uM|Kd|=|2.2|uM|2200|nM
2NXD|2.00|2007|10-mer|Kd=2.2+/-0.3uM; incomplete ligand|O38732|PROTEASE RETROPEPSIN|5.66|Kd=2.2uM|Kd|=|2.2|uM|2200|nM
2Z5T|2.30|2007|15-mer|Kd=2.40+/-0.40uM; incomplete ligand|Q4V944|MDM4 PROTEIN|5.62|Kd=2.40uM|Kd|=|2.4|uM|2400|nM
2R5A|2.30|2007|MLZ||Q9VHA0|POLYCOMB PROTEIN SCM|2.6|Kd=2.5mM|Kd|=|2.5|mM|2500000|nM
2R5B|2.00|2007|17-mer|IC50=1.9nM; incomplete ligand|------|GP41 N-PEPTIDE|8.6|Kd=2.5nM|Kd|=|2.5|nM|2.5|nM
2ITZ|2.72|2007|IRE|Kd=2.6+/-0.2nM|P00533|EPIDERMAL GROWTH FACTOR RECEPTOR|8.59|Kd=2.6nM|Kd|=|2.6|nM|2.6|nM
2JDN|1.30|2007|MMA|S22A/Me-alpha-Man; Kd=2.78+/-0.14uM|Q9HYN5|FUCOSE-BINDING LECTIN PA-IIL|5.56|Kd=2.78uM|Kd|=|2.78|uM|2780|nM
2NMX|1.55|2007|M25|Kd=2.7+/-0.1uM, Ki=2.0+/-0.1uM|P00915|CARBONIC ANHYDRASE 1|5.57|Kd=2.7uM|Kd|=|2.7|uM|2700|nM
2NSL|2.00|2007|C2R|H45N mutant; Kd=20.9+/-1.9uM|P0AG18|PHOSPHORIBOSYL-AMINOIMIDAZOLE CARBOXYLASE|4.68|Kd=20.9uM|Kd|=|20.9|uM|20900|nM
2PK5|1.90|2007|075||P03367|HIV-1 PROTEASE|10.7|Kd=20pM|Kd|=|20|pM|0.02|nM
2J9N|1.50|2007|BEN||P00760|TRYPSIN|4.7|Kd=20uM|Kd|=|20|uM|20000|nM
2V5X|2.25|2007|V5X||Q9BY41|HISTONE DEACETYLASE 8|6.66|Kd=220nM|Kd|=|220|nM|220|nM
2PEM|2.95|2007|7-mer||Q44177|ORF134|3.64|Kd=230uM|Kd|=|230|uM|230000|nM
2V87|1.80|2007|13-mer|Kd=25.1+/-3.5uM; incomplete ligand|P21784|VDJ RECOMBINATION-ACTIVATING PROTEIN 2|4.6|Kd=25.1uM|Kd|=|25.1|uM|25100|nM
2VBA|1.36|2007|P4T||P0A953|3-OXOACYL-[ACYL-CARRIER-PROTEIN] SYNTHASE 1|4.6|Kd=25uM|Kd|=|25|uM|25000|nM
2VB8|1.52|2007|TLM||P0A953|3-OXOACYL-[ACYL-CARRIER-PROTEIN] SYNTHASE 1|4.6|Kd=25uM|Kd|=|25|uM|25000|nM
2NN8|1.35|2007|LAT||P17931|GALECTIN-3|3.59|Kd=260uM|Kd|=|260|uM|260000|nM
2HZL|1.40|2007|PYR|Kd=270+/-20nM|Q3J1R2|TRAP-T FAMILY SORBITOL/MANNITOL TRANSPORTER|6.57|Kd=270nM|Kd|=|270|nM|270|nM
2RLY|NMR|2007|8-mer|peptide ligand is PTPPPLPP peptide [PRO-THR-PRO-PRO-PRO-LEU-PRO-PRO]|Q8CGF7|TRANSCRIPTION ELONGATION REGULATOR 1|3.57|Kd=270uM|Kd|=|270|uM|270000|nM
2HRM|1.70|2007|UC5|measured in the presence of Mg2+|P06968|DEOXYURIDINE 5'-TRIPHOSPHATE NUCLEOTIDOHYDROLASE|3.56|Kd=278.5uM|Kd|=|278.5|uM|278500|nM
2CLE|1.50|2007|F6F||P00929|TRYPTOPHAN SYNTHASE ALPHA CHAIN|3.55|Kd=280uM|Kd|=|280|uM|280000|nM
2CLM|1.51|2007|F6F|X-ray(tryptophan synthase in external aldimine state); Kd(internal aldimine state)|P00929|TRYPTOPHAN SYNTHASE ALPHA CHAIN|3.55|Kd=280uM|Kd|=|280|uM|280000|nM
2CLF|1.70|2007|F6F|redundant to 2cle but in lower resulution|P00929|TRYPTOPHAN SYNTHASE ALPHA CHAIN|3.55|Kd=280uM|Kd|=|280|uM|280000|nM
2O9V|1.63|2007|10-mer|Kd=288+/-21uM|A0AED4|PONSIN|3.54|Kd=288uM|Kd|=|288|uM|288000|nM
3B50|1.40|2007|SLB|Kd=28+/-1nM|P44542|SIALIC ACID-BINDING PERIPLASMIC PROTEIN SIAP|7.55|Kd=28nM|Kd|=|28|nM|28|nM
2UYN|1.60|2007|2KT||P0AGL2|PROTEIN TDCF|2.7|Kd=2mM|Kd|=|2|mM|2000000|nM
2NWL|2.96|2007|ASP|Kd=0.002+/-0.002uM, mutations:D37H, K40H, K125H, K132H, K223H, K264H, E368H|O59010|GLUTAMATE SYMPORT PROTEIN|8.7|Kd=2nM|Kd|=|2|nM|2|nM
2OI9|2.35|2007|9-mer||P01897|MAJOR HISTOCOMPATIBILITY COMPLEX PROTEIN|5.7|Kd=2uM|Kd|=|2|uM|2000|nM
2O3Z|2.25|2007|AI7||O67648|UDP-3-O-[3-HYDROXYMYRISTOYL] N-ACETYLGLUCOSAMINE|5.7|Kd=2uM|Kd|=|2|uM|2000|nM
2R3Y|2.50|2007|10-mer|incomplete ligand|P0AEE3|PROTEASE DEGS|5.49|Kd=3.2uM|Kd|=|3.2|uM|3200|nM
2R0Z|2.10|2007|6-mer||A2NHM3|ANTIBODY FAB IGG2A, LIGHT CHAIN|5.47|Kd=3.4uM|Kd|=|3.4|uM|3400|nM
2ISC|2.70|2007|223|compound 3, Ki=3.8+/-0.3pM|A2E7Y6|PURINE NUCLEOSIDE PHOSPHORYLASE|8.42|Kd=3.8nM|Kd|=|3.8|nM|3.8|nM
2JDM|1.70|2007|MFU|S22A/Me-alpha-Fuc; Kd=3.96+/-0.91uM|Q9HYN5|FUCOSE-BINDING LECTIN PA-IIL|5.4|Kd=3.96uM|Kd|=|3.96|uM|3960|nM
2NTF|3.18|2007|OHM||Q0VDX6|MURINE ANTIBODY FAB RS2-1G9 LAMBDA LIGHT CHAIN|6.52|Kd=300nM|Kd|=|300|nM|300|nM
2OPY|2.80|2007|CO9||P98170|BACULOVIRAL IAP REPEAT-CONTAINING PROTEIN 4|4.52|Kd=30uM|Kd|=|30|uM|30000|nM
2PUY|1.43|2007|10-mer||Q96BD5|PHD FINGER PROTEIN 21A|4.52|Kd=30uM|Kd|=|30|uM|30000|nM
2RA6|1.50|2007|ETY|Kd=14uM for 2-naphthol; Kd=30uM for 4-ethylphenol|Q29147|TRICHOSURIN|4.52|Kd=30uM|Kd|=|30|uM|30000|nM
2OGY|2.30|2007|C2F|N199A mutant; equilibrium dialysis: Kd=26.5uM (pH=6.1); Tryptophan fluorescence quenching: Kd=21.3uM (pH=7.6); isothermal calorimetry: Kd=33.2uM (pH=5.1)|Q46389|5-METHYLTETRAHYDROFOLATE CORRINOID/IRON SULFUR|4.48|Kd=33.2uM|Kd|=|33.2|uM|33200|nM
2JQ9|NMR|2007|17-mer|Kd1=33.4+/-0.2uM(20mM Tris-HCl pH 8.0, 100mM NaCl; circles; Kd2=4.61+/-0.02uM (20mM phosphate pH5.5(NMR conditions)); incomplete ligand|Q9UN37|VACUOLAR PROTEIN SORTING-ASSOCIATING PROTEIN 4A|4.48|Kd=33.4uM|Kd|=|33.4|uM|33400|nM
2V83|2.40|2007|9-mer||P21784|VDJ RECOMBINATION-ACTIVATING PROTEIN 2|4.47|Kd=33.8uM|Kd|=|33.8|uM|33800|nM
2V86|2.05|2007|9-mer||P21784|VDJ RECOMBINATION-ACTIVATING PROTEIN 2|4.46|Kd=34.6uM|Kd|=|34.6|uM|34600|nM
2V85|2.00|2007|12-mer|Kd=34.6+/-5.0uM|P21784|VDJ RECOMBINATION-ACTIVATING PROTEIN 2|4.46|Kd=34.6uM|Kd|=|34.6|uM|34600|nM
2J4Q|2.60|2007|TTP|Kd=35+/-3uM, mutation:E138A|P28248|DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE|4.46|Kd=35uM|Kd|=|35|uM|35000|nM
2HJ4|1.80|2007|PNZ|Kd=4.29+/-0.2uM|P84887|AROMATIC AMINE DEHYDROGENASE|5.37|Kd=4.29uM|Kd|=|4.29|uM|4290|nM
2QHD|1.95|2007|DAO||P48650|PHOSPHOLIPASE A2|5.38|Kd=4.2uM|Kd|=|4.2|uM|4200|nM
2NNG|1.20|2007|ZYX|Kd=4.4+/-0.2uM, Ki=8.2+/-0.3uM|P00918|CARBONIC ANHYDRASE 2|5.36|Kd=4.4uM|Kd|=|4.4|uM|4400|nM
2UWD|1.90|2007|2GG|Kd=4.5+/-2.2nM; IC50=21+/-4nM; GI50=78+/-15nM|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|8.35|Kd=4.5nM|Kd|=|4.5|nM|4.5|nM
2GJ5|2.40|2007|VD3|Kd=4.74+/-0.37nM (milk beta-lactoglobulin with VD3); Kd=45.67+/-3.12nM (heated beta-lactoglobulin with VD3 )|P02754|BETA-LACTOGLOBULIN|8.32|Kd=4.74nM|Kd|=|4.74|nM|4.74|nM
2HJB|1.85|2007|PZM|Kd=40.3+/-1.7uM|P84887|AROMATIC AMINE DEHYDROGENASE|4.39|Kd=40.3uM|Kd|=|40.3|uM|40300|nM
2JQK|NMR|2007|19-mer|Kd1=402+/-2uM(20mM Tris-HCl pH 8.0, 100mM NaCl; circles; Kd2=273+/-0.2uM(20mM phosphate pH5.5(NMR conditions)); incomplete ligand|O75351|VACUOLAR PROTEIN SORTING-ASSOCIATING PROTEIN 4B|3.4|Kd=402uM|Kd|=|402|uM|402000|nM
2JDY|1.70|2007|MMA|G24N/Me-alpha-Man; Kd=42.9+/-3.12uM|Q9HYN5|FUCOSE-BINDING LECTIN PA-IIL|4.37|Kd=42.9uM|Kd|=|42.9|uM|42900|nM
2P09|1.65|2007|ATP||------|ATP-BINDING PROTEIN|6.35|Kd=450nM|Kd|=|450|nM|450|nM
2IV9|1.90|2007|12-mer|Kd=46+/-5uM; incomplete ligand|P63010|AP-2 COMPLEX SUBUNIT BETA-2|4.34|Kd=46uM|Kd|=|46|uM|46000|nM
2P0X|NMR|2007|ATP|C58A|------|ABIOTIC ATP-BINDING, FOLDING OPTIMIZED PROTEIN|6.31|Kd=494nM|Kd|=|494|nM|494|nM
2IGW|1.78|2007|2-mer|ligand is GLY-PRO, Kd=49+/-12mM|P52011|PEPTIDYL-PROLYL CIS-TRANS ISOMERASE 3|1.31|Kd=49mM|Kd|=|49|mM|49000000|nM
2V95|1.93|2007|HCY||P31211|CORTICOSTEROID-BINDING GLOBULIN|8.3|Kd=5.0nM|Kd|=|5|nM|5|nM
2PV3|3.39|2007|12-mer|Kd=5.57+/-0.64uM; incomplete ligand|P0ABZ6|CHAPERONE SURA|5.25|Kd=5.57uM|Kd|=|5.57|uM|5570|nM
2E2R|1.60|2007|2OH||P62508|ESTROGEN-RELATED RECEPTOR GAMMA|8.26|Kd=5.5nM|Kd|=|5.5|nM|5.5|nM
2H5E|2.80|2007|GDP||Q2M5U3|PEPTIDE CHAIN RELEASE FACTOR RF-3|8.25|Kd=5.6nM|Kd|=|5.6|nM|5.6|nM
2IGV|1.67|2007|2-mer||P52011|PEPTIDYL-PROLYL CIS-TRANS ISOMERASE 3|2.23|Kd=5.9mM|Kd|=|5.9|mM|5900000|nM
2OI2|2.50|2007|DP6||Q8DR51|MEVALONATE KINASE|6.3|Kd=500nM|Kd|=|500|nM|500|nM
2P15|1.94|2007|EZT||P03372|ESTROGEN RECEPTOR|10.3|Kd=50pM|Kd|=|50|pM|0.05|nM
2CLI|1.70|2007|F9F||P00929|TRYPTOPHAN SYNTHASE ALPHA CHAIN|4.3|Kd=50uM|Kd|=|50|uM|50000|nM
2CLL|1.60|2007|F9F|X-ray(tryptophan synthase in external aldimine state); Kd(internal aldimine state)|P00929|TRYPTOPHAN SYNTHASE ALPHA CHAIN|4.3|Kd=50uM|Kd|=|50|uM|50000|nM
2JO9|NMR|2007|9-mer|Kd=52.1+/-2.14uM|Q8C863|ITCHY E3 UBIQUITIN PROTEIN LIGASE|4.28|Kd=52.1uM|Kd|=|52.1|uM|52100|nM
2ITY|3.42|2007|IRE|Kd=53.5+/-1.8nM|P00533|EPIDERMAL GROWTH FACTOR RECEPTOR|7.27|Kd=53.5nM|Kd|=|53.5|nM|53.5|nM
2PQL|2.20|2007|TSS||Q9BIH3|D7-RELATED 4 PROTEIN, D7R4|7.28|Kd=53nM|Kd|=|53|nM|53|nM
2IMD|1.60|2007|GSH|Selenomethione crystal. Ki(TOH,GSH)=130+/-100uM, GSH is substrate. Kd1(GSH)=5nM; Kd2=2-11uM for second GSH; ternary complex|Q51948|2-HYDROXYCHROMENE-2-CARBOXYLATE ISOMERASE|8.3|Kd=5nM|Kd|=|5|nM|5|nM
2PLL|1.90|2007|ABH||P05089|ARGINASE-1|8.3|Kd=5nM|Kd|=|5|nM|5|nM
2Q7Q|1.60|2007|C2B||P84887|ARALKYLAMINE DEHYDROGENASE LIGHT CHAIN|5.3|Kd=5uM|Kd|=|5|uM|5000|nM
2O1V|2.45|2007|ADP||P41148|ENDOPLASMIN|5.3|Kd=5uM|Kd|=|5|uM|5000|nM
2NXM|2.25|2007|10-mer|Kd=6.4+/-1.3uM; incomplete ligand|O38732|PROTEASE RETROPEPSIN|5.19|Kd=6.4uM|Kd|=|6.4|uM|6400|nM
2I4J|2.10|2007|DRJ|Kd=684.8+/-106.8nM|P37231|PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA|6.16|Kd=684.8nM|Kd|=|684.8|nM|684.8|nM
2I6B|2.30|2007|89I||Q5VXR3|ADENOSINE KINASE|7.17|Kd=68nM|Kd|=|68|nM|68|nM
2QBX|2.30|2007|12-mer|Ephrin type-B receptor 2 complex with antagonistic peptide, IC50~15uM; incomplete ligand|P29323|EPHRIN TYPE-B RECEPTOR 2|5.22|Kd=6uM|Kd|=|6|uM|6000|nM
2HQU|2.20|2007|DUP|measured by ITC|P33316|DEOXYURIDINE 5'-TRIPHOSPHATE NUCLEOTIDOHYDROLASE|5.14|Kd=7.2uM|Kd|=|7.2|uM|7200|nM
2OVQ|2.60|2007|12-mer|CycEdegC doubly phosphorylated at Thr380 and Ser384, Kd=70nM|P63208|S-PHASE KINASE-ASSOCIATED PROTEIN 1A|7.15|Kd=70nM|Kd|=|70|nM|70|nM
2PV1|1.30|2007|7-mer||P0ABZ6|CHAPERONE SURA|7.14|Kd=73nM|Kd|=|73|nM|73|nM
2JF4|2.20|2007|VDM|compound 2; Kd=7nM, Ki=10nM|P13482|PERIPLASMIC TREHALASE|8.15|Kd=7nM|Kd|=|7|nM|7|nM
2R05|2.55|2007|11-mer|Kd=7+/-1uM|Q8WUM4|PROGRAMMED CELL DEATH 6-INTERACTING PROTEIN|5.15|Kd=7uM|Kd|=|7|uM|7000|nM
2R03|2.59|2007|8-mer|Kd=7+/-7uM|Q8WUM4|PROGRAMMED CELL DEATH 6-INTERACTING PROTEIN|5.15|Kd=7uM|Kd|=|7|uM|7000|nM
2IPO|2.60|2007|1IP||P0A786|ASPARTATE CARBAMOYLTRANSFERASE|5.06|Kd=8.8uM|Kd|=|8.8|uM|8800|nM
2V88|2.00|2007|8-mer||P21784|VDJ RECOMBINATION-ACTIVATING PROTEIN 2|4.09|Kd=82.1uM|Kd|=|82.1|uM|82100|nM
2CLH|1.70|2007|F19||P00929|TRYPTOPHAN SYNTHASE ALPHA CHAIN|4.06|Kd=87.6uM|Kd|=|87.6|uM|87600|nM
2CLO|1.50|2007|F19|X-ray(tryptophan synthase in external aldimine state); Kd(internal aldimine state)|P00929|TRYPTOPHAN SYNTHASE ALPHA CHAIN|4.06|Kd=87.6uM|Kd|=|87.6|uM|87600|nM
2R02|2.60|2007|11-mer|Kd=8+/-2uM|Q8WUM4|PROGRAMMED CELL DEATH 6-INTERACTING PROTEIN|5.1|Kd=8uM|Kd|=|8|uM|8000|nM
2JMJ|NMR|2007|10-mer|Kd=9.1+/-1.6uM, ligand: ALA-ARG-THR-M3L-GLN-THR-ALA-ARG-LYS-N-trimethyllysine|Q08465|PROTEIN YNG1|5.04|Kd=9.1uM|Kd|=|9.1|uM|9100|nM
2OHL|2.65|2007|2AQ|ligand is compound 1|P56817|BETA-SECRETASE 1|3.05|Kd=900uM|Kd|=|900|uM|900000|nM
2RM0|NMR|2007|9-mer|peptide ligand is PPPLIPPPP peptide [PRO-PRO-PRO-LEU-ILE-PRO-PRO-PRO-PRO]|Q8CGF7|TRANSCRIPTION ELONGATION REGULATOR 1|4.03|Kd=94uM|Kd|=|94|uM|94000|nM
2E94|2.18|2007|364|IC50=0.03uM|Q12051|GERANYLGERANYL PYROPHOSPHATE SYNTHETASE|8.0|Ki=0.01uM|Ki|=|0.01|uM|10|nM
2I2C|1.85|2007|DTA||Q8Y8D7|INORGANIC POLYPHOSPHATE/ATP-NAD KINASE|4.7|Ki=0.02mM|Ki|=|0.02|mM|20000|nM
2FTD|2.55|2007|ILI|IC50=22nM|P61277|CATHEPSIN K|10.39|Ki=0.041nM|Ki|=|0.041|nM|0.041|nM
2O4J|1.74|2007|VD4||P13053|VITAMIN D3 RECEPTOR|10.1|Ki=0.08nM|Ki|=|0.08|nM|0.08|nM
2P16|2.30|2007|GG2||P00742|COAGULATION FACTOR X|10.1|Ki=0.08nM|Ki|=|0.08|nM|0.08|nM
2E95|2.20|2007|B75|IC50=0.20uM|Q12051|GERANYLGERANYL PYROPHOSPHATE SYNTHETASE|7.1|Ki=0.08uM|Ki|=|0.08|uM|80|nM
2UVM|1.94|2007|GVF|Bz(1, 2, 3, 4)P4 binds to the PKB-alpha PH domain, PIC50=6.35, Ki=0.08uM|P31749|RAC-ALPHA SERINE/THREONINE-PROTEIN KINASE|7.1|Ki=0.08uM|Ki|=|0.08|uM|80|nM
3BGP|2.80|2007|VX1|compound 2|P11309|SERINE/THREONINE-PROTEIN KINASE|7.04|Ki=0.091uM|Ki|=|0.091|uM|91|nM
2E93|2.12|2007|B29|IC50=0.28uM|Q12051|GERANYLGERANYL PYROPHOSPHATE SYNTHETASE|6.96|Ki=0.11uM|Ki|=|0.11|uM|110|nM
2E92|2.31|2007|M0N|IC50=0.34uM|Q12051|GERANYLGERANYL PYROPHOSPHATE SYNTHETASE|6.89|Ki=0.13uM|Ki|=|0.13|uM|130|nM
2IU0|2.53|2007|203||P31335|BIFUNCTIONAL PURINE BIOSYNTHESIS PROTEIN PURH|6.89|Ki=0.13uM|Ki|=|0.13|uM|130|nM
2OXD|2.30|2007|K32||P28523|CASEIN KINASE II, ALPHA SUBUNIT|6.82|Ki=0.15uM|Ki|=|0.15|uM|150|nM
2OT1|2.05|2007|N3P||P00883|FRUCTOSE-BISPHOSPHATE ALDOLASE A|4.0|Ki=0.1mM|Ki|=|0.1|mM|100000|nM
2OXX|2.30|2007|K22||P28523|CASEIN KINASE II, ALPHA SUBUNIT|6.7|Ki=0.20uM|Ki|=|0.2|uM|200|nM
2J4G|2.25|2007|NB1||Q89ZI2|O-GLCNACASE BT_4395|6.6|Ki=0.25uM|Ki|=|0.25|uM|250|nM
2E91|2.14|2007|ZOL|IC50=0.66uM|Q12051|GERANYLGERANYL PYROPHOSPHATE SYNTHETASE|6.59|Ki=0.26uM|Ki|=|0.26|uM|260|nM
2JJ3|2.28|2007|JJ3||Q92731|ESTROGEN RECEPTOR BETA|9.55|Ki=0.28nM|Ki|=|0.28|nM|0.28|nM
2POG|1.84|2007|WST||P03372|ESTROGEN RECEPTOR|9.54|Ki=0.29nM|Ki|=|0.29|nM|0.29|nM
2NT7|2.10|2007|902|compound 49g|P18031|PROTEIN-TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1|6.52|Ki=0.30uM|Ki|=|0.3|uM|300|nM
2OXY|1.81|2007|K17||P28523|CASEIN KINASE II, ALPHA SUBUNIT|6.52|Ki=0.30uM|Ki|=|0.3|uM|300|nM
2OZ5|2.00|2007|7XY|Kd(OMTS1)=73nM, Kd(OMTS2)=1200nM; Ki=0.33+/-0.04uM; IC50=440+/-50nM.|A1QMT0|PHOSPHOTYROSINE PROTEIN PHOSPHATASE PTPB|6.48|Ki=0.33uM|Ki|=|0.33|uM|330|nM
2J27|1.15|2007|PGA|Ki=0.3+/-0.1mM|P04789|TRIOSEPHOSPHATE ISOMERASE|3.52|Ki=0.3mM|Ki|=|0.3|mM|300000|nM
2V3E|2.00|2007|NND||P04062|GLUCOSYLCERAMIDASE|6.52|Ki=0.3uM|Ki|=|0.3|uM|300|nM
2P95|2.20|2007|ME5||P00742|COAGULATION FACTOR XA|9.37|Ki=0.43nM|Ki|=|0.43|nM|0.43|nM
2Z4B|2.34|2007|DC8||Q92731|ESTROGEN RECEPTOR BETA|9.36|Ki=0.44nM|Ki|=|0.44|nM|0.44|nM
2OP3|1.60|2007|TF5|covalent binding|P25774|CATHEPSIN S|6.31|Ki=0.49uM|Ki|=|0.49|uM|490|nM
2O4R|1.98|2007|VD5||P13053|VITAMIN D3 RECEPTOR|9.4|Ki=0.4nM|Ki|=|0.4|nM|0.4|nM
2G9Q|2.50|2007|1AB|ligand is different in reference. IC50=1uM in liver cell glycogenolysis. IC50(rabbit muscle)=0.39+/-0.10uM|P00489|GLYCOGEN PHOSPHORYLASE|6.4|Ki=0.4uM|Ki|=|0.4|uM|400|nM
2O2U|2.45|2007|738||P53779|MITOGEN-ACTIVATED PROTEIN KINASE 10|6.4|Ki=0.4uM|Ki|=|0.4|uM|400|nM
2QTU|2.53|2007|3AS||Q92731|ESTROGEN RECEPTOR BETA|9.28|Ki=0.53nM|Ki|=|0.53|nM|0.53|nM
2OK1|2.40|2007|33A||P53779|MITOGEN-ACTIVATED PROTEIN KINASE 10|6.26|Ki=0.55uM|Ki|=|0.55|uM|550|nM
3BGZ|2.40|2007|VX3|ligand is compound 3|P11309|SERINE/THREONINE-PROTEIN KINASE PIM-1|6.26|Ki=0.55uM|Ki|=|0.55|uM|550|nM
2YXJ|2.20|2007|N3C|Bcl-xl in complex with ABT-737|Q07817|BCL-2-LIKE PROTEIN 1|9.3|Ki=0.5nM|Ki|=|0.5|nM|0.5|nM
2OYL|1.80|2007|IDC||O33853|ENDOGLYCOCERAMIDASE II|6.3|Ki=0.5uM|Ki|=|0.5|uM|500|nM
2V0N|2.71|2007|C2E|IC50=7+/-2uM.|Q9A5I5|RESPONSE REGULATOR PLED|6.3|Ki=0.5uM|Ki|=|0.5|uM|500|nM
2P94|1.80|2007|ME4||P00742|COAGULATION FACTOR XA|9.17|Ki=0.67nM|Ki|=|0.67|nM|0.67|nM
2O7E|1.75|2007|PMI|Ki=0.6uM when substrate is L-Phe|Q3IWB0|PUTATIVE HISTIDINE AMMONIA-LYASE|6.22|Ki=0.6uM|Ki|=|0.6|uM|600|nM
2P2A|2.26|2007|MP9||P19491|GLUTAMATE RECEPTOR 2|6.12|Ki=0.75uM|Ki|=|0.75|uM|750|nM
2Z9G|1.86|2007|BNZ|incomplete ligand structure, Hg-containing|P59641|3C-LIKE PROTEINASE|6.15|Ki=0.7uM|Ki|=|0.7|uM|700|nM
2FLR|2.35|2007|7NH|Ki(fXa)=125uM, Ki(fIIa)=71.5uM, Ki(Trypsin)=46.5uM|P08709|COAGULATION FACTOR VII|6.1|Ki=0.8uM|Ki|=|0.8|uM|800|nM
2QL9|2.14|2007|5-mer|covalent inhibition; ligand is peptide analogue, AC-DQMD-CHO (chain E) [ACE-ASP-GLN-MET-ASA]|P55210|CASPASE-7 (CASP-7)|9.03|Ki=0.94nM|Ki|=|0.94|nM|0.94|nM
2Q54|1.85|2007|MU1||O38732|HIV-1 PROTEASE|9.01|Ki=0.98nM|Ki|=|0.98|nM|0.98|nM
2HW2|1.45|2007|RFP|Ki=1.07+/-0.35mM|O67972|RIFAMPIN ADP-RIBOSYL TRANSFERASE|2.97|Ki=1.07mM|Ki|=|1.07|mM|1070000|nM
2ON3|3.00|2007|XAP||P11926|ORNITHINE DECARBOXYLASE|9.0|Ki=1.0nM|Ki|=|1|nM|1|nM
2P4J|2.50|2007|23I||P56817|BETA-SECRETASE 1|8.96|Ki=1.1nM|Ki|=|1.1|nM|1.1|nM
2ONZ|2.80|2007|TMJ|K57A|P11086|PHENYLETHANOLAMINE N-METHYLTRANSFERASE|8.89|Ki=1.3nM|Ki|=|1.3|nM|1.3|nM
2EG7|2.00|2007|OTD|Ki=1.3+/-0.2uM for HDDP|P05020|DIHYDROOROTASE|5.89|Ki=1.3uM|Ki|=|1.3|uM|1300|nM
2QLB|2.25|2007|5-mer|covalent inhibition; ligand is peptide analogue, AC-ESMD-CHO (chain E) [ACE-GLU-SER-MET-ASA]|P55210|CASPASE-7 (CASP-7)|5.89|Ki=1.3uM|Ki|=|1.3|uM|1300|nM
2OBF|2.30|2007|F83||P11086|PHENYLETHANOLAMINE N-METHYLTRANSFERASE|8.85|Ki=1.4nM|Ki|=|1.4|nM|1.4|nM
2QLF|2.80|2007|5-mer|covalent inhibition; ligand is peptide analogue, AC-DNLD-CHO (chain E) [ACE-ASP-ASN-LEU-ASA]|P55210|CASPASE-7 (CASP-7)|8.85|Ki=1.4nM|Ki|=|1.4|nM|1.4|nM
2OC7|2.70|2007|HU4|covalent inhibition; Ki is Ki*|Q9ELS8|HEPATITIS C VIRUS|5.85|Ki=1.4uM|Ki|=|1.4|uM|1400|nM
2PU1|1.80|2007|FSG|R28K mutant|Q38BV6|ENOLASE|5.85|Ki=1.4uM|Ki|=|1.4|uM|1400|nM
2Z94|1.78|2007|TLD||P59641|REPLICASE POLYPROTEIN 1AB|5.85|Ki=1.4uM|Ki|=|1.4|uM|1400|nM
2HVC|2.10|2007|LGD|ligand is compound 4m (LGD2226), Ki for hAR whole-cell binding|P10275|ANDROGEN RECEPTOR|8.82|Ki=1.5nM|Ki|=|1.5|nM|1.5|nM
2P93|1.90|2007|ME1||P00742|COAGULATION FACTOR XA|8.82|Ki=1.5nM|Ki|=|1.5|nM|1.5|nM
3B7I|1.75|2007|PLU|Ki=1.5+/-0.2uM|Q01693|LEUCYL AMINOPEPTIDASE|5.82|Ki=1.5uM|Ki|=|1.5|uM|1500|nM
2UZ6|2.40|2007|17-mer|SOLUBLE ACETYLCHOLINE RECEPTOR complex with ALPHA-CONOTOXIN TXIA(A10L)|Q8WSF8|ACETYLCHOLINE RECEPTOR|8.77|Ki=1.7nM|Ki|=|1.7|nM|1.7|nM
2PSX|2.30|2007|4-mer|peptide ligand is LEUPEPTIN (chain B) [ACE-LEU-LEU-ARG]|Q9Y337|KALLIKREIN-5|5.77|Ki=1.7uM|Ki|=|1.7|uM|1700|nM
2OPB|2.80|2007|F21|K57A|P11086|PHENYLETHANOLAMINE N-METHYLTRANSFERASE|8.74|Ki=1.8nM|Ki|=|1.8|nM|1.8|nM
2UZ9|2.30|2007|XAN|ligand is Xanthinec|Q9Y2T3|GUANINE DEAMINASE|5.71|Ki=1.96uM|Ki|=|1.96|uM|1960|nM
2I4X|1.55|2007|KGQ|Ki=1.9+/-0.8pM, EC50(MT-2)=0.4+/-0.1nM|P03368|HIV-1 PROTEASE|11.72|Ki=1.9pM|Ki|=|1.9|pM|0.0019|nM
2HOB|1.95|2007|6-mer|Ki=1.9+/-0.1uM, SARS-CoV main protease|P59641|REPLICASE POLYPROTEIN 1AB|5.72|Ki=1.9uM|Ki|=|1.9|uM|1900|nM
2QRL|1.60|2007|OGA||P38998|SACCHAROPINE DEHYDROGENASE|4.0|Ki=100uM|Ki|=|100|uM|100000|nM
3B3C|1.46|2007|PLU|Ki=105+/-11uM|Q01693|LEUCYL AMINOPEPTIDASE|3.98|Ki=105uM|Ki|=|105|uM|105000|nM
2HAH|1.70|2007|3TL|mutations(I37V, N55M, M56I, I57G, V59I, G62F, K63I, L97T, I98P, Q99V, P100N, L101I); Ki(wt FIV)=41nM|P16088|RETROPEPSIN|8.0|Ki=10nM|Ki|=|10|nM|10|nM
3B92|2.00|2007|440||P78536|TNF-ALPHA-CONVERTING ENZYME, ADAM 17|8.0|Ki=10nM|Ki|=|10|nM|10|nM
2OYM|1.86|2007|MNI||O33853|ENDOGLYCOCERAMIDASE II|5.0|Ki=10uM|Ki|=|10|uM|10000|nM
2QE4|2.40|2007|JJ3||P03372|ESTROGEN RECEPTOR|7.96|Ki=11.0nM|Ki|=|11|nM|11|nM
2V3D|1.96|2007|NBV||P04062|GLUCOSYLCERAMIDASE|3.94|Ki=116uM|Ki|=|116|uM|116000|nM
2OC9|2.59|2007|IMH||P00491|PURINE NUCLEOSIDE PHOSPHORYLASE|7.96|Ki=11nM|Ki|=|11|nM|11|nM
2P3A|1.75|2007|3TL||Q6BB74|HIV-1 PROTEASE|7.96|Ki=11nM|Ki|=|11|nM|11|nM
2Q15|2.40|2007|3MR||P56817|BETA-SECRETASE 1|7.96|Ki=11nM|Ki|=|11|nM|11|nM
3BGQ|2.00|2007|VX2|ligand is compound 1|P11309|SERINE/THREONINE-PROTEIN KINASE PIM-1|7.96|Ki=11nM|Ki|=|11|nM|11|nM
2O9J|2.65|2007|CZA||P04191|SARCOPLASMIC/ENDOPLASMIC RETICULUM CALCIUM ATPASE 1, SERCA1A|6.92|Ki=120nM|Ki|=|120|nM|120|nM
2OA0|3.40|2007|CZA||P04191|SARCOPLASMIC/ENDOPLASMIC RETICULUM CALCIUM ATPASE 1, SERCA1A|6.92|Ki=120nM|Ki|=|120|nM|120|nM
2CEM|1.80|2007|2AH|EC50=0.70uM|Q8Q3H0|POL POLYPROTEIN|7.92|Ki=12nM|Ki|=|12|nM|12|nM
2OVV|2.00|2007|PFH||Q9QYJ6|PHOSPHODIESTERASE-10A|7.92|Ki=12nM|Ki|=|12|nM|12|nM
2JNP|NMR|2007|NGH||P08254|MATRIX METALLOPROTEINASE-3|6.89|Ki=130nM|Ki|=|130|nM|130|nM
2OVZ|2.00|2007|5MR|X-ray(E402Q) while Ki(wild type)|P14780|MATRIX METALLOPROTEINASE-9 (MMP-9)|7.89|Ki=13nM|Ki|=|13|nM|13|nM
2FLE|1.90|2007|AI|ligand is compound PC(9); Ki=14+/-3nM|Q9J2R0|HIV-1 PROTEASE|7.85|Ki=14nM|Ki|=|14|nM|14|nM
2OZ7|1.80|2007|CA4|ligand is compound 1, affinity for hAR in Transiently-Transfected COS-1 Cells|P10275|ANDROGEN RECEPTOR|7.85|Ki=14nM|Ki|=|14|nM|14|nM
2P8O|1.50|2007|BVA|Ki=16uM?; covalent binding|P00766|CHYMOTRYPSIN A|4.85|Ki=14uM|Ki|=|14|uM|14000|nM
2UWP|1.75|2007|894||P00742|COAGULATION FACTOR X|6.81|Ki=154nM|Ki|=|154|nM|154|nM
2F9V|2.60|2007|BN6|Ki=0.015uM, ligand difference: C=O -> C-OH|P27958|NS3 PROTEASE/HELICASE|7.82|Ki=15nM|Ki|=|15|nM|15|nM
2OC0|2.30|2007|HU1|covalent inhibition; Ki is Ki*|Q9ELS8|HEPATITIS C VIRUS|7.82|Ki=15nM|Ki|=|15|nM|15|nM
2PTZ|1.65|2007|PAH|R28K mutant|Q38BV6|ENOLASE|7.82|Ki=15nM|Ki|=|15|nM|15|nM
2PU0|1.90|2007|PAH|R28K mutant; redundant to 2ptz|Q38BV6|ENOLASE|7.82|Ki=15nM|Ki|=|15|nM|15|nM
2JAL|1.90|2007|YLL|open ring product|Q08638|BETA-GLUCOSIDASE A|4.82|Ki=15uM|Ki|=|15|uM|15000|nM
2PWG|2.20|2007|CTS||Q2PS28|SUCROSE ISOMERASE|4.82|Ki=15uM|Ki|=|15|uM|15000|nM
2NTA|2.10|2007|521|compound 26c|P18031|PROTEIN-TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1|4.8|Ki=16uM|Ki|=|16|uM|16000|nM
2ON6|2.50|2007|IMH||P00491|PURINE NUCLEOSIDE PHOSPHORYLASE|6.76|Ki=172nM|Ki|=|172|nM|172|nM
2IYF|1.70|2007|ERY|fixed UDP-Glc=1mM, oleandomycin inhibition Ki=177.3uM|Q3HTL6|OLEANDOMYCIN GLYCOSYLTRANSFERASE|3.75|Ki=177.3uM|Ki|=|177.3|uM|177300|nM
2G70|2.40|2007|HNT||P11086|PHENYLETHANOLAMINE N-METHYLTRANSFERASE|7.77|Ki=17nM|Ki|=|17|nM|17|nM
2JH6|2.21|2007|894||P00734|THROMBIN LIGHT CHAIN|7.77|Ki=17nM|Ki|=|17|nM|17|nM
1VSO|1.85|2007|AT1|Ki=18.98+/-1.31uM for R/S racemic; ligand binding to iGluR5 core|P22756|GLUTAMATE RECEPTOR, IONOTROPIC KAINATE 1|4.72|Ki=18.98uM|Ki|=|18.98|uM|18980|nM
2P3D|2.80|2007|3TL||Q7SRY5|POL POLYPROTEIN|6.74|Ki=180nM|Ki|=|180|nM|180|nM
2E2P|2.00|2007|ADP||Q96Y14|HEXOKINASE|4.74|Ki=18uM|Ki|=|18|uM|18000|nM
2O1C|1.80|2007|PPV||P0AFC0|DATP PYROPHOSPHOHYDROLASE|4.72|Ki=19uM|Ki|=|19|uM|19000|nM
2I4T|2.74|2007|UA2|compound 2, Ki=1000pM|A2E7Y6|TRICOMONAS VAGINALIS PURINE NUCLEOSIDE|9.0|Ki=1nM|Ki|=|1|nM|1|nM
2RCX|2.00|2007|SM4|covalent inhibition|P00811|BETA-LACTAMASE|9.0|Ki=1nM|Ki|=|1|nM|1|nM
2Q55|1.90|2007|MU0||O38732|HIV-1 PROTEASE|8.69|Ki=2.04nM|Ki|=|2.04|nM|2.04|nM
2I4D|1.50|2007|QFI|Ki=2.1+/-0.2pM|P03368|HIV-1 PROTEASE|11.68|Ki=2.1pM|Ki|=|2.1|pM|0.0021000000000000003|nM
2OAX|2.29|2007|SNL|ligand is spironolactone|P08235|MINERALOCORTICOID RECEPTOR|8.65|Ki=2.232nM|Ki|=|2.232|nM|2.232|nM
2OP9|1.80|2007|WR1||P59641|REPLICASE POLYPROTEIN 1AB|5.66|Ki=2.2uM|Ki|=|2.2|uM|2200|nM
2OJG|2.00|2007|19A||P28482|MITOGEN-ACTIVATED PROTEIN KINASE 1|5.64|Ki=2.3uM|Ki|=|2.3|uM|2300|nM
2CEJ|2.50|2007|1AH|EC50=1.1uM|Q8Q3H0|HIV-1 PROTEASE|8.62|Ki=2.4nM|Ki|=|2.4|nM|2.4|nM
2I4W|1.55|2007|KGQ|Ki=2.6+/-1.5pM, EC50(PBMC)=2.8+/-0.5nM, EC50(MT-2)=3.5+/-1.5nM, EC50(PM-1)=2.2+/-1.4nM|P03368|HIV-1 PROTEASE|11.59|Ki=2.6pM|Ki|=|2.6|pM|0.0026000000000000003|nM
2R5Q|2.30|2007|1UN|Ki=2.7+/-0.3nM|Q50CM2|PROTEASE RETROPEPSIN|8.57|Ki=2.7nM|Ki|=|2.7|nM|2.7|nM
2I4U|1.50|2007|DJR|Ki=2.7+/-1.6pM, EC50(PBMC)=1.1+/-0.5nM, EC50(MT-2)=0.6+/-0.4nM, EC50(PM-1)=3.5+/-1.1nM|P03368|HIV-1 PROTEASE|11.57|Ki=2.7pM|Ki|=|2.7|pM|0.0027|nM
2NP9|2.45|2007|YE1|Crotonase superfamily|Q8KLK7|DPGC|5.57|Ki=2.7uM|Ki|=|2.7|uM|2700|nM
2ONB|2.70|2007|7PA|Ki=2.7uM (noncompetitive inhibition at higher PDPA concentrations); Ki=0.26uM (uncompetitive inhibition at low concentrations of PDPA)|Q53Y97|THYMIDYLATE SYNTHASE|5.57|Ki=2.7uM|Ki|=|2.7|uM|2700|nM
2ITK|1.45|2007|6-mer|Ki=20.4+/-4.3nM|Q13526|PEPTIDYL-PROLYL CIS-TRANS ISOMERASE NIMA-INTERACTIN|7.69|Ki=20.4nM|Ki|=|20.4|nM|20.4|nM
2JEW|1.40|2007|720|compound 21|P09955|CARBOXYPEPTIDASE B|6.69|Ki=206nM|Ki|=|206|nM|206|nM
2PSJ|1.80|2007|CEI||P27652|RENILLA-LUCIFERIN 2-MONOOXYGENASE|7.7|Ki=20nM|Ki|=|20|nM|20|nM
2FU8|1.80|2007|MCO|Ki measured at neutral pH|P52700|METALLO-BETA-LACTAMASE L1|4.7|Ki=20uM|Ki|=|20|uM|20000|nM
2ONY|2.60|2007|TMJ||P11086|PHENYLETHANOLAMINE N-METHYLTRANSFERASE|6.68|Ki=210nM|Ki|=|210|nM|210|nM
2ZA3|2.65|2007|U5P|ligand is compound 1, UMP|Q8T6J6|OROTIDINE 5'-PHOSPHATE DECARBOXYLASE|3.68|Ki=210uM|Ki|=|210|uM|210000|nM
2H15|1.90|2007|B19|hCA II in complex with compound 8|P00918|CARBONIC ANHYDRASE 2|5.67|Ki=2135nM|Ki|=|2135|nM|2135|nM
2O9R|2.30|2007|TCB||P22505|BETA-GLUCOSIDASE B|1.68|Ki=21mM|Ki|=|21|mM|21000000|nM
2UY4|1.75|2007|AZM|ligand is acetazolamide; Ki=21+/-2uM|P29029|ENDOCHITINASE|4.68|Ki=21uM|Ki|=|21|uM|21000|nM
2HL4|1.55|2007|BO1|ligand is compound 1|P00918|CARBONIC ANHYDRASE 2|7.64|Ki=23nM|Ki|=|23|nM|23|nM
2Z3H|1.50|2007|BLO|deaminohydroxy blasticidin S|P0C2P0|BLASTICIDIN-S DEAMINASE|4.64|Ki=23uM|Ki|=|23|uM|23000|nM
2IT4|2.00|2007|PPF|Isoform hCA I|P00915|CARBONIC ANHYDRASE 1|1.62|Ki=24.1mM|Ki|=|24.1|mM|24100000|nM
2VFZ|2.40|2007|UPF|X-ray(R365K) while Ki(wild type)|P14769|N-ACETYLLACTOSAMINIDE ALPHA-1,3-GALACTOSYLTRANSFERASE|3.61|Ki=245uM|Ki|=|245|uM|245000|nM
2P3C|2.10|2007|3TL||Q6Q004|HIV-1 PROTEASE|7.62|Ki=24nM|Ki|=|24|nM|24|nM
2PSU|1.93|2007|MUU||O38732|HIV-1 PROTEASE|7.62|Ki=24nM|Ki|=|24|nM|24|nM
2IHJ|2.00|2007|CSF||Q15KI8|ALPHA-2,3/2,6-SIALYLTRANSFERASE/SIALIDASE|4.59|Ki=25.7uM|Ki|=|25.7|uM|25700|nM
3B3X|2.50|2007|A33|ligand is compound 4|P94458|BETA-LACTAMASE|3.6|Ki=250uM|Ki|=|250|uM|250000|nM
2GVF|2.50|2007|NHN|compound 38|P26664|POLYPROTEIN|7.6|Ki=25nM|Ki|=|25|nM|25|nM
2O8H|1.80|2007|227||Q9QYJ6|PHOSPHODIESTERASE-10A|7.6|Ki=25nM|Ki|=|25|nM|25|nM
2Q80|2.70|2007|GRG||O95749|GERANYLGERANYL PYROPHOSPHATE SYNTHETASE|4.6|Ki=25uM|Ki|=|25|uM|25000|nM
2JIW|1.95|2007|BEU||Q89ZI2|O-GLCNACASE BT_4395|4.59|Ki=26uM|Ki|=|26|uM|26000|nM
2R9B|2.80|2007|8-mer|ligand is peptide-based inhibitor(compound 1); Ki=271+/-26nM|P46925|PLASMEPSIN-2|6.57|Ki=271nM|Ki|=|271|nM|271|nM
3B3S|1.18|2007|LEU||Q01693|LEUCYL AMINOPEPTIDASE|2.55|Ki=2800uM|Ki|=|2800|uM|2800000|nM
2OI0|2.00|2007|283||P78536|TNF-ALPHA-CONVERTING ENZYME, ADAM 17|7.55|Ki=28nM|Ki|=|28|nM|28|nM
2V96|2.40|2007|CFQ||P04058|ACETYLCHOLINESTERASE|4.54|Ki=29uM|Ki|=|29|uM|29000|nM
2JH0|1.70|2007|701||P00734|THROMBIN LIGHT CHAIN|8.7|Ki=2nM|Ki|=|2|nM|2|nM
2NNQ|1.80|2007|T4B||P15090|ADIPOCYTE LIPID-BINDING PROTEIN|8.7|Ki=2nM|Ki|=|2|nM|2|nM
2OAZ|1.90|2007|I96|compound 102, Co2+ hMetAP2b, Ki=2nM, Mn2+ hMetAP2b, Ki=1500nM|P50579|METHIONINE AMINOPEPTIDASE 2|8.7|Ki=2nM|Ki|=|2|nM|2|nM
2OJJ|2.40|2007|82A||P28482|MITOGEN-ACTIVATED PROTEIN KINASE 1|8.7|Ki=2nM|Ki|=|2|nM|2|nM
2UWO|1.75|2007|701||P00742|COAGULATION FACTOR X|8.7|Ki=2nM|Ki|=|2|nM|2|nM
2OQI|2.80|2007|GGO||P27487|DIPEPTIDYL PEPTIDASE 4|8.49|Ki=3.2nM|Ki|=|3.2|nM|3.2|nM
2O0U|2.10|2007|C0M||P53779|MITOGEN-ACTIVATED PROTEIN KINASE 10|5.49|Ki=3.2uM|Ki|=|3.2|uM|3200|nM
2UY5|1.60|2007|H35|ligand is kinetin; Ki=3.2+/-0.3uM|P29029|ENDOCHITINASE|5.49|Ki=3.2uM|Ki|=|3.2|uM|3200|nM
2P3B|2.10|2007|3TL||P03367|HIV-1 PROTEASE|8.48|Ki=3.3nM|Ki|=|3.3|nM|3.3|nM
2R5P|2.30|2007|MK1|Ki=3.3+/-0.3nM|Q50CM2|HIV-1 PROTEASE|8.48|Ki=3.3nM|Ki|=|3.3|nM|3.3|nM
2OAG|2.30|2007|DLI||P27487|DIPEPTIDYL PEPTIDASE 4|8.47|Ki=3.4nM|Ki|=|3.4|nM|3.4|nM
2I2B|2.10|2007|CC5|incomplete ligand|Q8Y8D7|INORGANIC POLYPHOSPHATE/ATP-NAD KINASE|2.44|Ki=3.6mM|Ki|=|3.6|mM|3600000|nM
2IMA|1.94|2007|GB4|Ki=300+/-12nM|Q7B8V4|BOTULINUM NEUROTOXIN A LIGHT CHAIN|6.52|Ki=300nM|Ki|=|300|nM|300|nM
2O4H|2.70|2007|AS9|Ki 300nM|P45381|ASPARTOACYLASE|6.52|Ki=300nM|Ki|=|300|nM|300|nM
2EG8|2.20|2007|FOT|Ki=31.8+/-1.6uM for FOA|P05020|DIHYDROOROTASE|4.5|Ki=31.8uM|Ki|=|31.8|uM|31800|nM
2G72|2.00|2007|F21||P11086|PHENYLETHANOLAMINE N-METHYLTRANSFERASE|6.5|Ki=315nM|Ki|=|315|nM|315|nM
2CFD|1.60|2007|R4A|Ki=32+/-1nM|P46881|PHENYLETHYLAMINE OXIDASE|7.49|Ki=32nM|Ki|=|32|nM|32|nM
2HHN|1.55|2007|GNQ|ligand is sulfone analog 37|P25774|CATHEPSIN S|7.49|Ki=32nM|Ki|=|32|nM|32|nM
2R2W|2.01|2007|4PG||Q5SWW9|UROKINASE-TYPE PLASMINOGEN ACTIVATOR|4.47|Ki=34uM|Ki|=|34|uM|34000|nM
2G71|2.20|2007|FTS||P11086|PHENYLETHANOLAMINE N-METHYLTRANSFERASE|7.46|Ki=35nM|Ki|=|35|nM|35|nM
2P53|2.10|2007|NNG||P0AF18|N-ACETYLGLUCOSAMINE-6-PHOSPHATE DEACETYLASE|7.46|Ki=35nM|Ki|=|35|nM|35|nM
2JH5|2.50|2007|895||P00734|THROMBIN|6.44|Ki=367nM|Ki|=|367|nM|367|nM
2CFG|1.55|2007|R4A|AGAO IN COMPLEX WITH WC4D3, Ki=36+/-2nM|P46881|PHENYLETHYLAMINE OXIDASE|7.44|Ki=36nM|Ki|=|36|nM|36|nM
2OXN|1.70|2007|OAN||Q9KU37|BETA-HEXOSAMINIDASE|7.44|Ki=36nM|Ki|=|36|nM|36|nM
2I72|2.20|2007|VA1|compound 8, MIC.app=92uM|P00811|BETA-LACTAMASE|7.43|Ki=37nM|Ki|=|37|nM|37|nM
2POU|1.60|2007|I7A||P00918|CARBONIC ANHYDRASE 2|7.42|Ki=38nM|Ki|=|38|nM|38|nM
2OC2|2.25|2007|RX3||P12821|ANGIOTENSIN-CONVERTING ENZYME|8.52|Ki=3nM|Ki|=|3|nM|3|nM
2QU6|2.10|2007|857||P35968|VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2|8.52|Ki=3nM|Ki|=|3|nM|3|nM
2NNK|1.25|2007|ROC|Ki=4.3+/-0.4nM, mutations(Q506K, L532I, L562I, C566A, I583V, C594A), P21212, redundant to 2nnp|P04587|HIV-1 PROTEASE|8.37|Ki=4.3nM|Ki|=|4.3|nM|4.3|nM
2NNP|1.20|2007|ROC|Ki=4.3+/-0.4nM, mutations(Q506K,L532I,L562I,C566A,I583V,C594A); redundant to 2nmz|P04587|HIV-1 PROTEASE|8.37|Ki=4.3nM|Ki|=|4.3|nM|4.3|nM
2NMY|1.10|2007|ROC|Ki=4.3+/-0.7nM, mutations(Q506K, L532I, L562I, C566A, V581A, C594A), P21212, redundant to 2nmz|P04587|HIV-1 PROTEASE|8.37|Ki=4.3nM|Ki|=|4.3|nM|4.3|nM
2NMZ|0.97|2007|ROC|Ki=4.3+/-0.7nM, mutations(Q506K,L532I,L562I,C566A,V581A,C594A), P212121|P04587|HIV-1 PROTEASE|8.37|Ki=4.3nM|Ki|=|4.3|nM|4.3|nM
2GLM|2.60|2007|SCB|compound 2, IC50=47.6+/-0.29uM|Q5G940|(3R)-HYDROXYMYRISTOYL-ACYL CARRIER PROTEIN|5.37|Ki=4.3uM|Ki|=|4.3|uM|4300|nM
2OC1|2.70|2007|HU2|covalent inhibition; Ki is Ki*|Q9ELS8|HEPATITIS C VIRUS|5.37|Ki=4.3uM|Ki|=|4.3|uM|4300|nM
2QLJ|2.60|2007|5-mer|covalent inhibition; ligand is peptide analogue, AC-WEHD-CHO (chain E) [ACE-TRP-GLU-HIS-ASA]|P55210|CASPASE-7 (CASP-7)|5.36|Ki=4.4uM|Ki|=|4.4|uM|4400|nM
2GKL|1.86|2007|PD2|wild type protein; Ki=4.5+/-0.5uM for 4-PDCA(inhibitor 2)|P26918|BETA-LACTAMASE|5.35|Ki=4.5uM|Ki|=|4.5|uM|4500|nM
2J62|2.26|2007|GSZ||Q0TR53|O-GLCNACASE NAGJ|11.34|Ki=4.6pM|Ki|=|4.6|pM|0.0046|nM
2PWD|1.80|2007|NOJ||Q2PS28|SUCROSE ISOMERASE|4.4|Ki=40uM|Ki|=|40|uM|40000|nM
2J95|2.01|2007|GSX|compound 1b|P00742|COAGULATION FACTOR XA|8.4|Ki=4nM|Ki|=|4|nM|4|nM
2OVY|1.80|2007|PFJ||Q9QYJ6|PHOSPHODIESTERASE-10A|8.4|Ki=4nM|Ki|=|4|nM|4|nM
2OQV|2.80|2007|MA9||P27487|DIPEPTIDYL PEPTIDASE 4|8.4|Ki=4nM|Ki|=|4|nM|4|nM
2UWL|1.90|2007|895|ligand is compound 1|P00742|COAGULATION FACTOR X|8.4|Ki=4nM|Ki|=|4|nM|4|nM
2PBW|2.50|2007|DOQ|Ki=5.56+/-0.88nM; ligand binding to iGluR5 core|P22756|GLUTAMATE RECEPTOR, IONOTROPIC KAINATE 1|8.25|Ki=5.56nM|Ki|=|5.56|nM|5.56|nM
2QFT|1.55|2007|GPJ|P101S mutant|P0A6D3|3-PHOSPHOSHIKIMATE 1-CARBOXYVINYLTRANSFERASE|5.26|Ki=5.5uM|Ki|=|5.5|uM|5500|nM
2JFZ|1.86|2007|003|Ki=5.8+/-0.03uM|Q9ZLT0|GLUTAMATE RACEMASE|5.24|Ki=5.8uM|Ki|=|5.8|uM|5800|nM
2NWN|2.15|2007|12-mer||Q53XS3|UROKINASE-TYPE PLASMINOGEN ACTIVATOR|6.3|Ki=500nM|Ki|=|500|nM|500|nM
2UXX|2.74|2007|FAJ|incorrect data [ligand in crystal is FAD-PCNA adduct; Ki(inact)=500uM is for PCNA]|O60341|LYSINE-SPECIFIC HISTONE DEMETHYLASE 1|3.3|Ki=500uM|Ki|=|500|uM|500000|nM
2J94|2.10|2007|G15|compound 1x|P00742|COAGULATION FACTOR X|6.27|Ki=534nM|Ki|=|534|nM|534|nM
2QL7|2.40|2007|5-mer|covalent inhibition; ligand is peptide analogue, AC-IEPD-CHO (chain E) [ACE-ILE-GLU-PRO-ASA]|P55210|CASPASE-7 (CASP-7)|6.26|Ki=550nM|Ki|=|550|nM|550|nM
2QZR|1.95|2007|S79||P28720|QUEUINE TRNA-RIBOSYLTRANSFERASE|7.26|Ki=55nM|Ki|=|55|nM|55|nM
2QRK|1.75|2007|AMP||P38998|SACCHAROPINE DEHYDROGENASE|4.26|Ki=55uM|Ki|=|55|uM|55000|nM
2O4Z|2.10|2007|HSW|ligand is compound 2|P00918|CARBONIC ANHYDRASE 2|6.25|Ki=566nM|Ki|=|566|nM|566|nM
2OBO|2.60|2007|HUD|covalent inhibition; Ki is Ki*|Q91RS4|HEPATITIS C VIRUS|7.24|Ki=57nM|Ki|=|57|nM|57|nM
2PSV|1.75|2007|MUV||O38732|HIV-1 PROTEASE|7.24|Ki=58nM|Ki|=|58|nM|58|nM
2Q38|1.95|2007|LSA|ligand is saccharin|P00918|CARBONIC ANHYDRASE 2|5.23|Ki=5950nM|Ki|=|5950|nM|5950|nM
2CEN|1.70|2007|4AH|EC50=0.18uM|Q8Q3H0|HIV-1 PROTEASE|8.3|Ki=5nM|Ki|=|5|nM|5|nM
2Q5K|1.95|2007|AB1||O38732|HIV-1 PROTEASE|11.3|Ki=5pM|Ki|=|5|pM|0.005|nM
2OYK|1.50|2007|9MR||O33853|ENDOGLYCOCERAMIDASE II|5.3|Ki=5uM|Ki|=|5|uM|5000|nM
2JDS|2.00|2007|L20|Ki=160pM for PKB-alpha-L20 complex|P00517|CAMP-DEPENDENT PROTEIN KINASE|8.2|Ki=6.3nM|Ki|=|6.3|nM|6.3|nM
2JDV|2.08|2007|L20|PKA-PKB-2, Ki=160pM for PKB-alpha-L20 complex|P00517|CAMP-DEPENDENT PROTEIN KINASE|8.2|Ki=6.3nM|Ki|=|6.3|nM|6.3|nM
2I4V|1.50|2007|DJR|Ki=6.3+/-1.3pM, EC50(MT-2)=12.3+/-3.5nM|P03368|HIV-1 PROTEASE|11.2|Ki=6.3pM|Ki|=|6.3|pM|0.0063|nM
2QDT|2.00|2007|I38|Ki=6.5+/-2uM for compound 5a|P52700|METALLO-BETA-LACTAMASE L1|5.19|Ki=6.5uM|Ki|=|6.5|uM|6500|nM
2UY3|1.90|2007|H33|ligand is 8-chlorotheophylline; Ki=600+/-64uM|P29029|ENDOCHITINASE|3.22|Ki=600uM|Ki|=|600|uM|600000|nM
2H6T|1.90|2007|6-mer|Ki for pepA binding to SP3|P43092|CANDIDAPEPSIN-3|7.22|Ki=60nM|Ki|=|60|nM|60|nM
2Q3Z|2.00|2007|7-mer||P21980|TRANSGLUTAMINASE 2|7.22|Ki=60nM|Ki|=|60|nM|60|nM
2POW|1.75|2007|I7C||P00918|CARBONIC ANHYDRASE 2|7.2|Ki=63nM|Ki|=|63|nM|63|nM
3B3W|1.75|2007|LEU||Q01693|LEUCYL AMINOPEPTIDASE|4.19|Ki=65uM|Ki|=|65|uM|65000|nM
2QFU|1.60|2007|GPJ|P101L mutant|P0A6D3|3-PHOSPHOSHIKIMATE 1-CARBOXYVINYLTRANSFERASE|4.18|Ki=66uM|Ki|=|66|uM|66000|nM
2O22|NMR|2007|LIU||P10415|APOPTOSIS REGULATOR BCL-2|7.17|Ki=67nM|Ki|=|67|nM|67|nM
2V2Q|2.30|2007|NVG|ligand is compound 3, Ki=71.2+/-6.2uM, IC50=1.67mM|O67060|4-DIPHOSPHOCYTIDYL-2-C-METHYL-D-ERYTHRITOL KINASE|4.15|Ki=71.2uM|Ki|=|71.2|uM|71200|nM
2POV|1.60|2007|I7B||P00918|CARBONIC ANHYDRASE 2|7.12|Ki=75nM|Ki|=|75|nM|75|nM
2Q1Q|1.90|2007|OSP||P00918|CARBONIC ANHYDRASE 2|8.15|Ki=7nM|Ki|=|7|nM|7|nM
2Q70|1.95|2007|DC8||P03372|ESTROGEN RECEPTOR|8.08|Ki=8.3nM|Ki|=|8.3|nM|8.3|nM
2QU5|2.95|2007|276||P35968|VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2|8.06|Ki=8.7nM|Ki|=|8.7|nM|8.7|nM
2Z1W|1.63|2007|BDI|ligand is compound 6|P28720|QUEUINE TRNA-RIBOSYLTRANSFERASE|4.08|Ki=83uM|Ki|=|83|uM|83000|nM
2V2V|2.40|2007|V12|ligand is compound 1, Ki=85.8+/-9.4uM, IC50=1.99mM|O67060|4-DIPHOSPHOCYTIDYL-2-C-METHYL-D-ERYTHRITOL KINASE|4.07|Ki=85.8uM|Ki|=|85.8|uM|85800|nM
2OC4|2.59|2007|IMH||P00491|PURINE NUCLEOSIDE PHOSPHORYLASE|7.07|Ki=86nM|Ki|=|86|nM|86|nM
2OJI|2.60|2007|33A||P28482|MITOGEN-ACTIVATED PROTEIN KINASE 1|7.07|Ki=86nM|Ki|=|86|nM|86|nM
2JFH|1.97|2007|LK1|compound 2; Ki=870uM; IC50=710uM; ligand is L-Glu|P14900|UDP-N-ACETYLMURAMOYLALANINE-D-GLUTAMATE LIGASE|3.06|Ki=870uM|Ki|=|870|uM|870000|nM
2QL5|2.34|2007|5-mer|covalent inhibition; ligand is peptide analogue, AC-DMQD-CHO (chain E) [ACE-ASP-MET-GLN-ASA]|P55210|CASPASE-7 (CASP-7)|8.1|Ki=8nM|Ki|=|8|nM|8|nM
2GLP|2.42|2007|BDE|ligand is compound 1; IC50=39.8+/-0.35uM|Q5G940|(3R)-HYDROXYMYRISTOYL-ACYL CARRIER PROTEIN|5.01|Ki=9.7uM|Ki|=|9.7|uM|9700|nM
2Q11|2.40|2007|XX4||P56817|BETA-SECRETASE 1|6.05|Ki=900nM|Ki|=|900|nM|900|nM
2Q8M|2.05|2007|AMP|Ki=94uM (with Mg2+); Ki=13uM (without Mg2+)|Q31TG8|FRUCTOSE-BISPHOSPHATASE|4.03|Ki=94uM|Ki|=|94|uM|94000|nM
2JLD|2.35|2008|AG1|Ru containing; IC50<=0.04nM;|P49841|GLYCOGEN SYNTHASE KINASE-3 BETA|10.4|IC<0.04nM|IC50|<|0.04|nM|0.04|nM
3BEA|2.02|2008|IXH|compound 20, Auto-Pi IC50=0.007uM; BMDM IC50=0.003uM|P07333|MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR|8.15|IC=0.007uM|IC50|=|0.007|uM|7|nM
2OW7|1.77|2008|NK2||Q24451|ALPHA-MANNOSIDASE II|4.85|IC=0.014mM|IC50|=|0.014|mM|14000|nM
3BEL|2.30|2008|POX|compound 37|P00533|EPIDERMAL GROWTH FACTOR RECEPTOR|7.85|IC=0.014uM|IC50|=|0.014|uM|14|nM
2VV9|1.90|2008|IM9|compound 2e|P24941|CELL DIVISION PROTEIN KINASE 2|7.77|IC=0.017uM|IC50|=|0.017|uM|17|nM
2VCX|2.10|2008|D26|compound 13|O60760|GLUTATHIONE-REQUIRING PROSTAGLANDIN D SYNTHASE|7.68|IC=0.021uM|IC50|=|0.021|uM|21|nM
3CTJ|2.50|2008|320||P08581|HEPATOCYTE GROWTH FACTOR RECEPTOR|7.46|IC=0.035uM|IC50|=|0.035|uM|35|nM
3CST|3.20|2008|E52||P48736|PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE|7.41|IC=0.039uM|IC50|=|0.039|uM|39|nM
3D4Q|2.80|2008|SM5|compound 18|P15056|B-RAF PROTO-ONCOGENE SERINE/THREONINE-PROTEIN KINASE|10.52|IC=0.03nM|IC50|=|0.03|nM|0.03|nM
2R64|2.30|2008|740||P24941|CELL DIVISION PROTEIN KINASE 2|7.52|IC=0.03uM|IC50|=|0.03|uM|30|nM
2RGP|2.00|2008|HYZ|compound 17|P00533|EPIDERMAL GROWTH FACTOR RECEPTOR|7.52|IC=0.03uM|IC50|=|0.03|uM|30|nM
2W3L|2.10|2008|DRO|ligand is compound 31|P10415|APOPTOSIS REGULATOR BCL-2|7.52|IC=0.03uM|IC50|=|0.03|uM|30|nM
3BMY|1.60|2008|CXZ|compound 13|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|7.52|IC=0.03uM|IC50|=|0.03|uM|30|nM
3C1X|2.17|2008|CKK|compound 10j|P08581|HEPATOCYTE GROWTH FACTOR RECEPTOR|7.35|IC=0.045uM|IC50|=|0.045|uM|45|nM
3CP9|2.50|2008|C19|compound 1|P35968|VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2|7.32|IC=0.048uM|IC50|=|0.048|uM|48|nM
2RC9|1.96|2008|1AC|ligand is compound 1, ACC|Q9R1M7|GLUTAMATE [NMDA] RECEPTOR SUBUNIT 3A|7.4|IC=0.04uM|IC50|=|0.04|uM|40|nM
2VWX|1.65|2008|7X4|compound 1, IC50=0.04+/-0.02uM|P54760|EPHRIN TYPE-B RECEPTOR 4|7.4|IC=0.04uM|IC50|=|0.04|uM|40|nM
3DOG|2.70|2008|NNN||P24941|CELL DIVISION PROTEIN KINASE 2|7.4|IC=0.04uM|IC50|=|0.04|uM|40|nM
3BR9|2.30|2008|DEY|compound 8e|P26663|RNA-DIRECTED RNA POLYMERASE|7.21|IC=0.062uM|IC50|=|0.062|uM|62|nM
3D7H|1.55|2008|YC2|compound 4|Q04609|GLUTAMATE CARBOXYPEPTIDASE 2|10.22|IC=0.06nM|IC50|=|0.06|nM|0.06|nM
2R7B|2.70|2008|253|compound 1|O15530|3-PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE 1|7.22|IC=0.06uM|IC50|=|0.06|uM|60|nM
3DDP|2.70|2008|RC8|phosphorylated Thr160 CDK2, pCDK2|P24941|CELL DIVISION PROTEIN KINASE 2|7.14|IC=0.072uM|IC50|=|0.072|uM|72|nM
2VWY|1.65|2008|7X5|compound 2, IC50=0.09+/-0.05uM|P54760|EPHRIN TYPE-B RECEPTOR 4|7.05|IC=0.09uM|IC50|=|0.09|uM|90|nM
2Z7I|2.10|2008|742|compound 9|Q12051|GERANYLGERANYL PYROPHOSPHATE SYNTHETASE|7.0|IC=0.10uM|IC50|=|0.1|uM|100|nM
3DCT|2.50|2008|064|ligand is compound GW4064|Q96RI1|BILE ACID RECEPTOR|6.95|IC=0.112uM|IC50|=|0.112|uM|112|nM
3BJC|2.00|2008|WAN|compound 12|O76074|CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE|6.96|IC=0.11uM|IC50|=|0.11|uM|110|nM
3CTH|2.30|2008|319||P08581|HEPATOCYTE GROWTH FACTOR RECEPTOR|6.96|IC=0.11uM|IC50|=|0.11|uM|110|nM
3BI1|1.50|2008|3BI|IC50=0.12+/-0.03nM|Q04609|GLUTAMATE CARBOXYPEPTIDASE 2|9.92|IC=0.12nM|IC50|=|0.12|nM|0.12|nM
3CWE|1.60|2008|825||P18031|PROTEIN-TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1|6.92|IC=0.12uM|IC50|=|0.12|uM|120|nM
3EJ1|3.22|2008|5BP|compound 1|P24941|CELL DIVISION PROTEIN KINASE 2|6.92|IC=0.12uM|IC50|=|0.12|uM|120|nM
2VD1|2.25|2008|D28|compound 12|O60760|GLUTATHIONE-REQUIRING PROSTAGLANDIN D SYNTHASE|6.86|IC=0.138uM|IC50|=|0.138|uM|138|nM
3F5P|2.90|2008|741|IC50=0.140+/-0.088uM|P08069|INSULIN-LIKE GROWTH FACTOR 1 RECEPTOR|6.85|IC=0.140uM|IC50|=|0.14|uM|140|nM
2VGP|1.70|2008|AD6||Q6DE08|SERINE/THREONINE-PROTEIN KINASE 12-A|6.85|IC=0.14uM|IC50|=|0.14|uM|140|nM
3E7B|1.70|2008|E7B|IC50=0.16-22nM, see supplement data|P62136|SERINE/THREONINE-PROTEIN PHOSPHATASE PP1-ALPHA|9.8|IC=0.16nM|IC50|=|0.16|nM|0.16|nM
2Q8S|2.30|2008|L92|compound 53A, alpha IC50(R)=0.912uM, gama IC50(S)=0.185uM|P37231|PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA|6.73|IC=0.185uM|IC50|=|0.185|uM|185|nM
3BM9|1.60|2008|BXZ|compound 6|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|6.72|IC=0.19uM|IC50|=|0.19|uM|190|nM
3E7A|1.63|2008|5-mer|IC50=0.1-3nM, see supplement data|P62136|SERINE/THREONINE-PROTEIN PHOSPHATASE PP1-ALPHA|10.0|IC=0.1nM|IC50|=|0.1|nM|0.1|nM
2QC6|1.85|2008|G12||P28523|CASEIN KINASE II, ALPHA SUBUNIT|7.0|IC=0.1uM|IC50|=|0.1|uM|100|nM
3DI6|2.65|2008|PDZ|compound 4c, EC 2.7.7.49/ 2.7.7.7/ 3.1.26.4|P04585|HIV-1 REVERSE TRANSCRIPTASE/RIBONUCLEASE H|7.0|IC=0.1uM|IC50|=|0.1|uM|100|nM
3C45|2.05|2008|317||P27487|DIPEPTIDYL PEPTIDASE 4|9.68|IC=0.21nM|IC50|=|0.21|nM|0.21|nM
3DDQ|1.80|2008|RRC|phosphorylated Thr160 CDK2, pCDK2|P24941|CELL DIVISION PROTEIN KINASE 2|6.68|IC=0.21uM|IC50|=|0.21|uM|210|nM
2VX1|1.65|2008|7X8|compound 5, IC50=0.220+/-0.014uM|P54760|EPHRIN TYPE-B RECEPTOR 4|6.66|IC=0.220uM|IC50|=|0.22|uM|220|nM
3EOC|3.20|2008|T2A|compound 12i|P24941|CELL DIVISION PROTEIN KINASE 2|6.64|IC=0.23uM|IC50|=|0.23|uM|230|nM
2VWW|1.90|2008|7X2|IC50=0.24+/-0.16uM|P54760|EPHRIN TYPE-B RECEPTOR 4|6.62|IC=0.24uM|IC50|=|0.24|uM|240|nM
3DRP|2.60|2008|R8E|IC50=0.2+/-0.1nM, EC 2.7.7.49/ 2.7.7.7/ 3.1.26.4|P04585|HIV-1 REVERSE TRANSCRIPTASE/RIBONUCLEASE H|9.7|IC=0.2nM|IC50|=|0.2|nM|0.2|nM
2VWU|2.00|2008|7X1|IC50=0.35+/-0.13uM|P54760|EPHRIN TYPE-B RECEPTOR 4|6.46|IC=0.35uM|IC50|=|0.35|uM|350|nM
2JDL|2.20|2008|11-mer|incomplete ligand|P09989|RIBOSOME-INACTIVATING PROTEIN ALPHA|9.43|IC=0.37nM|IC50|=|0.37|nM|0.37|nM
2Q94|1.63|2008|A04|compound 6|P0AE18|METHIONINE AMINOPEPTIDASE|6.43|IC=0.37uM|IC50|=|0.37|uM|370|nM
2Z7R|2.00|2008|STU|IC50=0.3-1nM|Q15418|RIBOSOMAL PROTEIN S6 KINASE ALPHA-1|9.52|IC=0.3nM|IC50|=|0.3|nM|0.3|nM
2RC8|1.45|2008|DSN|ligand is D-serine|Q9R1M7|GLUTAMATE [NMDA] RECEPTOR SUBUNIT 3A|6.52|IC=0.3uM|IC50|=|0.3|uM|300|nM
3C10|2.00|2008|TSN|IC50=0.3+/-0.1uM|Q8WUI4|HISTONE DEACETYLASE 7A|6.52|IC=0.3uM|IC50|=|0.3|uM|300|nM
3BV2|2.40|2008|P38|compound 30, TNFa IC50=43nM|Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|9.36|IC=0.44nM|IC50|=|0.44|nM|0.44|nM
3EID|3.15|2008|PO5|compound 41|P24941|CELL DIVISION PROTEIN KINASE 2|6.35|IC=0.45uM|IC50|=|0.45|uM|450|nM
3BV3|2.59|2008|P39|compound 28, TNFa IC50=29nM|Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|9.34|IC=0.46nM|IC50|=|0.46|nM|0.46|nM
3EL7|2.80|2008|PD3|IC50=0.480+/-0.117uM|P00523|TYROSINE-PROTEIN KINASE SRC|6.32|IC=0.48uM|IC50|=|0.48|uM|480|nM
3E2M|2.00|2008|E2M|compound 21a, IC50=0.4nM|P20701|INTEGRIN ALPHA-L|9.4|IC=0.4nM|IC50|=|0.4|nM|0.4|nM
3DRR|2.89|2008|R8E|IC50=0.4+/-0.2nM, EC 2.7.7.49/ 2.7.7.7/ 3.1.26.4|P04585|HIV-1 REVERSE TRANSCRIPTASE/RIBONUCLEASE H|9.4|IC=0.4nM|IC50|=|0.4|nM|0.4|nM
2Q93|1.60|2008|B21|compound 5|P0AE18|METHIONINE AMINOPEPTIDASE|6.25|IC=0.56uM|IC50|=|0.56|uM|560|nM
2QYN|1.57|2008|NPV|IC50=0.57+/-0.04uM|Q08499|CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D|6.24|IC=0.57uM|IC50|=|0.57|uM|570|nM
2VX0|2.10|2008|7X7|Fragment: KINASE DOMAIN, RESIDUES 598-899 Kd=0.58+/-0.12uM;|P54760|EPHRIN TYPE-B RECEPTOR 4|6.24|IC=0.58uM|IC50|=|0.58|uM|580|nM
2QU3|2.00|2008|462||P56817|BETA-SECRETASE 1|6.23|IC=0.59uM|IC50|=|0.59|uM|590|nM
3B8Q|2.75|2008|900||P35968|VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2|9.3|IC=0.5nM|IC50|=|0.5|nM|0.5|nM
3BYS|2.20|2008|AM5||P06239|TYROSINE-PROTEIN KINASE LCK|9.3|IC=0.5nM|IC50|=|0.5|nM|0.5|nM
3D7F|1.54|2008|YBY|compound 2|Q04609|GLUTAMATE CARBOXYPEPTIDASE 2|9.3|IC=0.5nM|IC50|=|0.5|nM|0.5|nM
3DRS|3.15|2008|R8D|IC50=0.5+/-0.2nM, EC 2.7.7.49/ 2.7.7.7/ 3.1.26.4|P04585|HIV-1 REVERSE TRANSCRIPTASE/RIBONUCLEASE H|9.3|IC=0.5nM|IC50|=|0.5|nM|0.5|nM
2W4I|1.87|2008|VGA|Glutamate racemase (MurI) COMPLEX WITH D-GLUTAMATE AND AN INHIBITOR 7|Q9ZLT0|GLUTAMATE RACEMASE|6.3|IC=0.5uM|IC50|=|0.5|uM|500|nM
2QYL|1.95|2008|NPV|IC50=0.65+/-0.01uM|Q5T3Z8|PHOSPHODIESTERASE 4B, CAMP-SPECIFIC|6.19|IC=0.65uM|IC50|=|0.65|uM|650|nM
3DWB|2.38|2008|RDF||P42892|ENDOTHELIN-CONVERTING ENZYME 1|6.19|IC=0.65uM|IC50|=|0.65|uM|650|nM
3B8R|2.70|2008|887||P35968|VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2|9.22|IC=0.6nM|IC50|=|0.6|nM|0.6|nM
2ZE1|2.20|2008|411||P56817|BETA-SECRETASE 1|6.22|IC=0.6uM|IC50|=|0.6|uM|600|nM
2Z4Y|2.10|2008|252|compound 4; Space Group: P 21 21 21|Q12051|GERANYLGERANYL PYROPHOSPHATE SYNTHETASE|6.15|IC=0.71uM|IC50|=|0.71|uM|710|nM
3DB6|2.85|2008|FRS||Q4KMI8|POLO-LIKE KINASE 1|6.14|IC=0.73uM|IC50|=|0.73|uM|730|nM
2Z78|2.10|2008|H86|compound 13|Q12051|GERANYLGERANYL PYROPHOSPHATE SYNTHETASE|6.12|IC=0.76uM|IC50|=|0.76|uM|760|nM
2VWZ|1.65|2008|7X6|compound 3, IC50=0.794+/-0.226uM|P54760|EPHRIN TYPE-B RECEPTOR 4|6.1|IC=0.794uM|IC50|=|0.794|uM|794|nM
3BHX|1.60|2008|BHX|IC50=0.7+/-0.26nM|Q04609|GLUTAMATE CARBOXYPEPTIDASE 2|9.15|IC=0.7nM|IC50|=|0.7|nM|0.7|nM
2ZDZ|2.00|2008|310||P56817|BETA-SECRETASE 1|6.15|IC=0.7uM|IC50|=|0.7|uM|700|nM
3BYU|2.30|2008|AM6||P06239|TYROSINE-PROTEIN KINASE LCK|9.1|IC=0.8nM|IC50|=|0.8|nM|0.8|nM
3DS6|2.90|2008|A17|IC50=0.8+/-0.6nM|Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|9.1|IC=0.8nM|IC50|=|0.8|nM|0.8|nM
2VCQ|1.95|2008|D25|compound 14|O60760|GLUTATHIONE-REQUIRING PROSTAGLANDIN D SYNTHASE|6.04|IC=0.92uM|IC50|=|0.92|uM|920|nM
2Z4W|2.45|2008|749|compound 5|Q12051|GERANYLGERANYL PYROPHOSPHATE SYNTHETASE|6.01|IC=0.98uM|IC50|=|0.98|uM|980|nM
2QA8|1.85|2008|GEN|ligand is compound 5, Genistein|P03372|ESTROGEN RECEPTOR|6.0|IC=0.99uM|IC50|=|0.99|uM|990|nM
3F66|1.40|2008|IHX|compound 28|P08581|HEPATOCYTE GROWTH FACTOR RECEPTOR|6.05|IC=0.9uM|IC50|=|0.9|uM|900|nM
2Q92|1.90|2008|B23|compound 4|P0AE18|METHIONINE AMINOPEPTIDASE|5.96|IC=1.1uM|IC50|=|1.1|uM|1100|nM
2Q96|1.60|2008|A18|compound 8|P0AE18|METHIONINE AMINOPEPTIDASE|5.92|IC=1.2uM|IC50|=|1.2|uM|1200|nM
3C6U|2.70|2008|M22|compound 22|P04585|HIV-1 REVERSE TRANSCRIPTASE|8.87|IC=1.35nM|IC50|=|1.35|nM|1.35|nM
2VIQ|2.00|2008|D55||P00749|UROKINASE-TYPE PLASMINOGEN ACTIVATOR CHAIN B|5.89|IC=1.3uM|IC50|=|1.3|uM|1300|nM
3BG8|1.60|2008|INH|Clavatadine A IC50=1.3uM, Clavatadine B IC50=27uM|P03951|COAGULATION FACTOR XIA|5.89|IC=1.3uM|IC50|=|1.3|uM|1300|nM
2RIB|1.80|2008|GMH|IC50=1.5+/-0.13mM|P35247|PULMONARY SURFACTANT-ASSOCIATED PROTEIN D|2.82|IC=1.5mM|IC50|=|1.5|mM|1500000|nM
2R4F|1.70|2008|RIE|compound 50, IC50=1.5+/-0.2nM|P04035|3-HYDROXY-3-METHYLGLUTARYL-COENZYME A REDUCTASE|8.82|IC=1.5nM|IC50|=|1.5|nM|1.5|nM
3BZ3|2.20|2008|YAM||Q05397|FOCAL ADHESION KINASE 1|8.82|IC=1.5nM|IC50|=|1.5|nM|1.5|nM
2VTR|1.90|2008|LZB|compound 11|P24941|CELL DIVISION PROTEIN KINASE 2|5.82|IC=1.5uM|IC50|=|1.5|uM|1500|nM
3BET|1.85|2008|CTF|compound 15|P00918|CARBONIC ANHYDRASE 2|5.82|IC=1.5uM|IC50|=|1.5|uM|1500|nM
3DPD|2.85|2008|41A||P48736|PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE|5.78|IC=1.66uM|IC50|=|1.66|uM|1660|nM
2VCG|1.90|2008|S17|IC50=1.69+/-0.91uM|Q70I53|HISTONE DEACETYLASE-LIKE AMIDOHYDROLASE|5.77|IC=1.69uM|IC50|=|1.69|uM|1690|nM
2Q95|1.70|2008|A05|compound 7|P0AE18|METHIONINE AMINOPEPTIDASE|5.8|IC=1.6uM|IC50|=|1.6|uM|1600|nM
3E63|1.90|2008|5B2||O60674|TYROSINE-PROTEIN KINASE JAK2|5.8|IC=1.6uM|IC50|=|1.6|uM|1600|nM
3CS8|2.30|2008|12-mer|IC50=1.7+/-0.2uM for PGC-1a ID1, IC50=87+/-20uM for PGC-1a ID2|P37231|PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA|5.77|IC=1.7uM|IC50|=|1.7|uM|1700|nM
2Z4Z|2.09|2008|SC0|compound 12|Q12051|GERANYLGERANYL PYROPHOSPHATE SYNTHETASE|5.73|IC=1.86uM|IC50|=|1.86|uM|1860|nM
3CE3|2.40|2008|1FN|IC50=1.8+/-0.7nM|P08581|HEPATOCYTE GROWTH FACTOR RECEPTOR|8.74|IC=1.8nM|IC50|=|1.8|nM|1.8|nM
2VIY|1.82|2008|VG3|compound 14|P56817|BETA-SECRETASE 1|5.74|IC=1.8uM|IC50|=|1.8|uM|1800|nM
2PJC|1.74|2008|343||P09955|CARBOXYPEPTIDASE B|8.72|IC=1.9nM|IC50|=|1.9|nM|1.9|nM
2VTJ|2.20|2008|LZ4|compound 10|P24941|CELL DIVISION PROTEIN KINASE 2|5.72|IC=1.9uM|IC50|=|1.9|uM|1900|nM
3C4F|2.07|2008|C4F||P11362|BASIC FIBROBLAST GROWTH FACTOR RECEPTOR 1|5.72|IC=1.9uM|IC50|=|1.9|uM|1900|nM
2R3K|1.70|2008|SCQ|compound 7|P24941|CELL DIVISION PROTEIN KINASE 2|7.0|IC=100nM|IC50|=|100|nM|100|nM
2R3L|1.65|2008|SCW|compound 8|P24941|CELL DIVISION PROTEIN KINASE 2|7.0|IC=100nM|IC50|=|100|nM|100|nM
3C4E|1.98|2008|C4E|IC50 100uM|P11309|SERINE/THREONINE-PROTEIN KINASE|4.0|IC=100uM|IC50|=|100|uM|100000|nM
2UUP|1.88|2008|LK4|compound 17l|P14900|UDP-N-ACETYLMURAMOYLALANINE-D-GLUTAMATE LIGASE|3.98|IC=105uM|IC50|=|105|uM|105000|nM
2R3J|1.65|2008|SCJ|compound 5|P24941|CELL DIVISION PROTEIN KINASE 2|8.0|IC=10nM|IC50|=|10|nM|10|nM
2R3M|1.70|2008|SCX|compound 9|P24941|CELL DIVISION PROTEIN KINASE 2|8.0|IC=10nM|IC50|=|10|nM|10|nM
3DEJ|2.60|2008|RXC|IC50=10+/-1nM|P42574|CASPASE-3|8.0|IC=10nM|IC50|=|10|nM|10|nM
3FC1|2.40|2008|52P|ligand is compound VX745|Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|8.0|IC=10nM|IC50|=|10|nM|10|nM
2Z50|2.01|2008|028|compound 10|Q12051|GERANYLGERANYL PYROPHOSPHATE SYNTHETASE|4.95|IC=11.22uM|IC50|=|11.22|uM|11220|nM
3BH8|1.65|2008|10-mer||P01892|HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2|7.95|IC=11.2nM|IC50|=|11.2|nM|11.2|nM
3BPR|2.80|2008|OLP|compound 52, IC50=11.3+/-2.1uM|Q12866|TYROSINE-PROTEIN KINASE MER|4.95|IC=11.3uM|IC50|=|11.3|uM|11300|nM
2RJR|2.10|2008|295||Q8GMG0|TYROSINE AMINOMUTASE|1.94|IC=11.6mM|IC50|=|11.6|mM|11600000|nM
2VD0|2.20|2008|D27||O60760|GLUTATHIONE-REQUIRING PROSTAGLANDIN D SYNTHASE|4.94|IC=11.6uM|IC50|=|11.6|uM|11600|nM
3C0Z|2.10|2008|SHH|IC50=113+/-16uM|Q8WUI4|HISTONE DEACETYLASE 7A|3.95|IC=113uM|IC50|=|113|uM|113000|nM
3BH9|1.70|2008|10-mer||P01892|HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2|6.93|IC=116.9nM|IC50|=|116.9|nM|116.9|nM
2ZVA|2.60|2008|1N1||P25911|TYROSINE-PROTEIN KINASE LYN|7.96|IC=11nM|IC50|=|11|nM|11|nM
2PKS|2.50|2008|G44|compound 20c|P00734|THROMBIN|4.96|IC=11uM|IC50|=|11|uM|11000|nM
3CCN|1.90|2008|LKG|compound 3a, IC50=120+/-18nM|P08581|HEPATOCYTE GROWTH FACTOR RECEPTOR|6.92|IC=120nM|IC50|=|120|nM|120|nM
3E7O|2.14|2008|35F||P45984|MITOGEN-ACTIVATED PROTEIN KINASE 9|6.92|IC=120nM|IC50|=|120|nM|120|nM
2VTH|1.90|2008|LZ2|compound 7|P24941|CELL DIVISION PROTEIN KINASE 2|3.92|IC=120uM|IC50|=|120|uM|120000|nM
2VTE|2.20|2008|IK4|compound 17o|P14900|UDP-N-ACETYLMURAMOYLALANINE-D-GLUTAMATE LIGASE|3.91|IC=122uM|IC50|=|122|uM|122000|nM
3DY6|2.90|2008|DY6|ligand is compound GW9371, pIC50=6.9|Q03181|PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR DELTA|6.9|IC=126nM|IC50|=|126|nM|126|nM
2PJ9|1.56|2008|281||P09955|CARBOXYPEPTIDASE B|7.92|IC=12nM|IC50|=|12|nM|12|nM
2PJ2|1.95|2008|864||P09955|CARBOXYPEPTIDASE B|7.92|IC=12nM|IC50|=|12|nM|12|nM
3CHD|2.00|2008|WRG|IC50=12+/-1uM|Q873X9|CHITINASE|4.92|IC=12uM|IC50|=|12|uM|12000|nM
2ZAS|2.00|2008|1OH|IC50=13.9+/-1.98nM|P62508|ESTROGEN-RELATED RECEPTOR GAMMA|7.86|IC=13.9nM|IC50|=|13.9|nM|13.9|nM
3DDA|1.50|2008|7-mer||A5HZZ9|BOTULINUM NEUROTOXIN A LIGHT CHAIN|3.88|IC=133uM|IC50|=|133|uM|133000|nM
2ONC|2.55|2008|SY1|IC50=13+/-6nM|P27487|DIPEPTIDYL PEPTIDASE 4|7.89|IC=13nM|IC50|=|13|nM|13|nM
2PJ4|2.00|2008|414||P09955|CARBOXYPEPTIDASE B|7.89|IC=13nM|IC50|=|13|nM|13|nM
2VJ6|1.80|2008|VG5|compound 2, IC50=13+/-2nM|P56817|BETA-SECRETASE 1|7.89|IC=13nM|IC50|=|13|nM|13|nM
2VTO|2.19|2008|LZ8|compound 22|P24941|CELL DIVISION PROTEIN KINASE 2|6.85|IC=140nM|IC50|=|140|nM|140|nM
2VTQ|1.90|2008|LZA|compound 28|P24941|CELL DIVISION PROTEIN KINASE 2|6.85|IC=140nM|IC50|=|140|nM|140|nM
3DEH|2.50|2008|RXA|IC50=149+/-15nM|P42574|CASPASE-3|6.83|IC=149nM|IC50|=|149|nM|149|nM
3BI0|1.67|2008|BIX|IC50=14+/-4.2nM|Q04609|GLUTAMATE CARBOXYPEPTIDASE 2|7.85|IC=14nM|IC50|=|14|nM|14|nM
3CIB|1.72|2008|314||P56817|BETA-SECRETASE 1|7.85|IC=14nM|IC50|=|14|nM|14|nM
3D7D|1.69|2008|FBD|compound 3|Q04609|GLUTAMATE CARBOXYPEPTIDASE 2|7.85|IC=14nM|IC50|=|14|nM|14|nM
3EHW|1.80|2008|DUP|ligand is compound 2|Q6FHN1|DUTP PYROPHOSPHATASE|4.82|IC=15.2uM|IC50|=|15.2|uM|15200|nM
3CQU|2.20|2008|CQU|compound 5d, IC50=151+/-32nM|P31749|RAC-ALPHA SERINE/THREONINE-PROTEIN KINASE|6.82|IC=151nM|IC50|=|151|nM|151|nM
3EQB|2.62|2008|LUG||Q02750|DUAL SPECIFICITY MITOGEN-ACTIVATED PROTEIN|1.82|IC=15mM|IC50|=|15|mM|15000000|nM
2PJ5|1.65|2008|11B||P09955|CARBOXYPEPTIDASE B|7.82|IC=15nM|IC50|=|15|nM|15|nM
3C4C|2.57|2008|324||P15056|SERINE/THREONINE-PROTEIN KINASE B-RAF|6.8|IC=160nM|IC50|=|160|nM|160|nM
2VO7|1.98|2008|M05|IC50=168+/-36nM|P00517|CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTIC|6.77|IC=168nM|IC50|=|168|nM|168|nM
2EA2|2.50|2008|F77|compound 9c, enzyme IC50=0.016uM, enzyme IC50=0.016uM w/HSA|P50579|METHIONINE AMINOPEPTIDASE 2|7.8|IC=16nM|IC50|=|16|nM|16|nM
2VWV|1.90|2008|7X3||P54760|EPHRIN TYPE-B RECEPTOR 4|4.8|IC=16uM|IC50|=|16|uM|16000|nM
2JKM|2.31|2008|BII|IC50=17.76+/-1.21nM|Q00944|FOCAL ADHESION KINASE 1|7.75|IC=17.76nM|IC50|=|17.76|nM|17.76|nM
2PIZ|1.60|2008|606||P09955|CARBOXYPEPTIDASE B|6.77|IC=170nM|IC50|=|170|nM|170|nM
2UUO|2.50|2008|LK3|compound 17d|P14900|UDP-N-ACETYLMURAMOYLALANINE-D-GLUTAMATE LIGASE|3.77|IC=170uM|IC50|=|170|uM|170000|nM
2PJ7|1.77|2008|235||P09955|CARBOXYPEPTIDASE B|7.77|IC=17nM|IC50|=|17|nM|17|nM
3CHS|2.55|2008|4BU||P09960|LEUKOTRIENE A-4 HYDROLASE|7.77|IC=17nM|IC50|=|17|nM|17|nM
3D7G|1.75|2008|MUD|compound 1|Q04609|GLUTAMATE CARBOXYPEPTIDASE 2|7.77|IC=17nM|IC50|=|17|nM|17|nM
2QN1|2.40|2008|0AS|X-ray structure(GPb); IC50(GPa)|P00489|GLYCOGEN PHOSPHORYLASE|4.77|IC=17uM|IC50|=|17|uM|17000|nM
2PH8|1.70|2008|35A||P56817|BETA-SECRETASE 1|5.74|IC=1800nM|IC50|=|1800|nM|1800|nM
2VJ9|1.60|2008|VG7|compound 6|P56817|BETA-SECRETASE 1|6.74|IC=180nM|IC50|=|180|nM|180|nM
2VTA|2.00|2008|LZ1|compound 6|P24941|CELL DIVISION PROTEIN KINASE 2|3.73|IC=185uM|IC50|=|185|uM|185000|nM
2PJ8|1.70|2008|17A||P09955|CARBOXYPEPTIDASE B|7.74|IC=18nM|IC50|=|18|nM|18|nM
2VD4|1.90|2008|P21|inhibitor 1|P43889|BIFUNCTIONAL PROTEIN GLMU|4.74|IC=18uM|IC50|=|18|uM|18000|nM
2PJB|1.70|2008|983||P09955|CARBOXYPEPTIDASE B|7.72|IC=19nM|IC50|=|19|nM|19|nM
2ZJF|2.40|2008|BSU||P95276|PROBABLE EPOXIDE HYDROLASE EPHB|7.72|IC=19nM|IC50|=|19|nM|19|nM
3C43|2.30|2008|315||P27487|DIPEPTIDYL PEPTIDASE 4|7.72|IC=19nM|IC50|=|19|nM|19|nM
2VIN|1.90|2008|505|IC50 1mM|P00749|UROKINASE-TYPE PLASMINOGEN ACTIVATOR CHAIN B|3.0|IC=1mM|IC50|=|1|mM|1000000|nM
2VTM|2.25|2008|LZM|compound 8, 54% inhibition IC54=1mM|P24941|CELL DIVISION PROTEIN KINASE 2|3.0|IC=1mM|IC50|=|1|mM|1000000|nM
2R2L|2.23|2008|PB9||Q5RKJ4|FARNESYLTRANSFERASE ALPHA SUBUNIT|9.0|IC=1nM|IC50|=|1|nM|1|nM
2W05|1.90|2008|FRT|compound 5b, IC50=0.001uM|P24941|CELL DIVISION PROTEIN KINASE 2|9.0|IC=1nM|IC50|=|1|nM|1|nM
2QH6|2.70|2008|ODE||P03372|ESTROGEN RECEPTOR|6.0|IC=1uM|IC50|=|1|uM|1000|nM
2R3I|1.28|2008|SCF|compound 4, IC50=1000nM|P24941|CELL DIVISION PROTEIN KINASE 2|6.0|IC=1uM|IC50|=|1|uM|1000|nM
3F69|2.80|2008|XDR|IC50<1uM|P0A5S4|SERINE/THREONINE-PROTEIN KINASE PKNB|6.0|IC=1uM|IC50|=|1|uM|1000|nM
2K31|NMR|2008|35G|IC50=2.0-3.8nM|Q0VBW0|PHOSPHODIESTERASE 5A, CGMP-SPECIFIC|8.7|IC=2.0nM|IC50|=|2|nM|2|nM
3C6T|2.70|2008|M14|compound 14|P04585|HIV-1 REVERSE TRANSCRIPTASE|8.68|IC=2.11nM|IC50|=|2.11|nM|2.11|nM
2PJA|1.70|2008|33Z||P09955|CARBOXYPEPTIDASE B|8.66|IC=2.2nM|IC50|=|2.2|nM|2.2|nM
2RG6|1.72|2008|287||Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|8.66|IC=2.2nM|IC50|=|2.2|nM|2.2|nM
3CJO|2.28|2008|K30|IC50=2.2+/-1.2nM|P52732|KINESIN-LIKE PROTEIN KIF11|8.66|IC=2.2nM|IC50|=|2.2|nM|2.2|nM
3DT1|2.80|2008|P40|IC50=2.4+/-1.3nM|Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|8.62|IC=2.4nM|IC50|=|2.4|nM|2.4|nM
2QNX|2.70|2008|UDT|inhibitor 2, IC50=2.4+/-0.8uM|P0A574|3-OXOACYL-[ACYL-CARRIER-PROTEIN] SYNTHASE 3|5.62|IC=2.4uM|IC50|=|2.4|uM|2400|nM
3BQN|1.80|2008|BQN||P20701|INTEGRIN ALPHA-L|8.6|IC=2.5nM|IC50|=|2.5|nM|2.5|nM
3CBP|1.42|2008|SFG|ligand is compound 4, Sinefungin|Q8WTS6|HISTONE-LYSINE N-METHYLTRANSFERASE SETD7|5.6|IC=2.5uM|IC50|=|2.5|uM|2500|nM
2Z52|2.13|2008|H23|compound 11|Q12051|GERANYLGERANYL PYROPHOSPHATE SYNTHETASE|5.57|IC=2.69uM|IC50|=|2.69|uM|2690|nM
2ZLG|2.52|2008|MRT|IC50=2.6+/-0.1uM|P21524|RIBONUCLEOSIDE-DIPHOSPHATE REDUCTASE LARGE CHAIN|5.59|IC=2.6uM|IC50|=|2.6|uM|2600|nM
2RIA|1.80|2008|289||P35247|PULMONARY SURFACTANT-ASSOCIATED PROTEIN D|2.57|IC=2.7mM|IC50|=|2.7|mM|2700000|nM
2QO1|2.60|2008|VZZ|inhibitor 3, IC50=2.7+/-0.2uM|P0A574|3-OXOACYL-[ACYL-CARRIER-PROTEIN] SYNTHASE 3|5.57|IC=2.7uM|IC50|=|2.7|uM|2700|nM
3DAJ|2.00|2008|FXG|compound 6|Q8C3H8|SERINE/THREONINE KINASE 6|5.54|IC=2.9uM|IC50|=|2.9|uM|2900|nM
3F07|3.30|2008|AGE|IC50=2.9+/-0.6uM, data not shown|Q9BY41|HISTONE DEACETYLASE 8|5.54|IC=2.9uM|IC50|=|2.9|uM|2900|nM
3BWF|2.35|2008|DWC||P11309|SERINE/THREONINE-PROTEIN KINASE|9.7|IC=200pM|IC50|=|200|pM|0.2|nM
2E9O|2.10|2008|A58||O14757|SERINE/THREONINE-PROTEIN KINASE CHK1|7.7|IC=20nM|IC50|=|20|nM|20|nM
2PIY|1.43|2008|528||P09955|CARBOXYPEPTIDASE B|7.7|IC=20nM|IC50|=|20|nM|20|nM
3CHQ|2.09|2008|4BQ||P09960|LEUKOTRIENE A-4 HYDROLASE|7.7|IC=20nM|IC50|=|20|nM|20|nM
2R3H|1.50|2008|SCE|compound 3, IC50=20000nM|P24941|CELL DIVISION PROTEIN KINASE 2|4.7|IC=20uM|IC50|=|20|uM|20000|nM
3C7Q|2.10|2008|XIN|IC50=21+/-13nM, VEGFR-2 (mouse) IC50=13+/-4nM|P35968|VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2|7.68|IC=21nM|IC50|=|21|nM|21|nM
3C72|2.30|2008|CX1|compound 2, IC50=22.7+/-1.8uM|Q08602|GERANYLGERANYL TRANSFERASE TYPE-2 SUBUNIT ALPHA|4.64|IC=22.7uM|IC50|=|22.7|uM|22700|nM
2ZM1|2.10|2008|KSF|compound 3|P06239|TYROSINE-PROTEIN KINASE LCK|6.66|IC=220nM|IC50|=|220|nM|220|nM
3EIO|2.00|2008|AJH||P27487|DIPEPTIDYL PEPTIDASE 4|6.65|IC=223nM|IC50|=|223|nM|223|nM
2PRE|2.70|2008|E64||A8DS38|ERVATAMIN-C|6.65|IC=225nM|IC50|=|225|nM|225|nM
3D14|1.90|2008|AK1||Q8C3H8|SERINE/THREONINE KINASE 6|7.66|IC=22nM|IC50|=|22|nM|22|nM
2QLQ|2.33|2008|SR2|compound 2, IC50=236nM|P00523|TYROSINE-PROTEIN KINASE SRC|6.63|IC=236nM|IC50|=|236|nM|236|nM
3EYL|3.00|2008|SMK|ligand is compound 32a|P98170|BACULOVIRAL IAP REPEAT-CONTAINING PROTEIN 4|6.6|IC=250nM|IC50|=|250|nM|250|nM
2ZP0|2.70|2008|PI0|ligand compound 3 is PI0, benzylsulfonamide-D-ile-gln-P-aminobenzamidine|P08709|COAGULATION FACTOR VII LIGHT CHAIN|7.6|IC=25nM|IC50|=|25|nM|25|nM
3EL8|2.30|2008|PD5|IC50=25+/-2nM|P00523|TYROSINE-PROTEIN KINASE SRC|7.6|IC=25nM|IC50|=|25|nM|25|nM
3CPB|2.70|2008|C92|compound 2, IC50>25uM|P35968|VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2|4.6|IC=25uM|IC50|=|25|uM|25000|nM
2V13|2.80|2008|C40|inhibitor 7, Purified human renin IC50=0.022uM, Plasma human renin IC50=0.026uM|P00797|RENIN|7.59|IC=26nM|IC50|=|26|nM|26|nM
3CGF|3.00|2008|JNF|RCSB is JNF, like analogue 8|P53779|MITOGEN-ACTIVATED PROTEIN KINASE 10|6.57|IC=270nM|IC50|=|270|nM|270|nM
3CM7|3.10|2008|X22|ligand is compound 3a|P98170|BACULOVIRAL IAP REPEAT-CONTAINING PROTEIN 4|6.57|IC=270nM|IC50|=|270|nM|270|nM
2QZK|1.80|2008|I21||P56817|BETA-SECRETASE 1|7.57|IC=27nM|IC50|=|27|nM|27|nM
3DEK|2.40|2008|RXD|IC50=27+/-2nM|P42574|CASPASE-3|7.57|IC=27nM|IC50|=|27|nM|27|nM
3CHO|1.80|2008|4BG||P09960|LEUKOTRIENE A-4 HYDROLASE|6.55|IC=280nM|IC50|=|280|nM|280|nM
2QN2|2.70|2008|0MA|X-ray structure(GPb); IC50(GPa)|P00489|GLYCOGEN PHOSPHORYLASE|4.55|IC=28uM|IC50|=|28|uM|28000|nM
2OW6|1.19|2008|NK1||Q24451|ALPHA-MANNOSIDASE II|2.7|IC=2mM|IC50|=|2|mM|2000000|nM
2VNN|1.87|2008|CM7|compound 8a|P56817|BETA-SECRETASE 1|8.7|IC=2nM|IC50|=|2|nM|2|nM
2W17|2.15|2008|I19|(S)-8b, IC50=0.002uM|P24941|CELL DIVISION PROTEIN KINASE 2|8.7|IC=2nM|IC50|=|2|nM|2|nM
3BE2|1.75|2008|RAJ||P35968|VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2|8.7|IC=2nM|IC50|=|2|nM|2|nM
3CN0|1.52|2008|LJ1|ligand is compound 9|P02766|TRANSTHYRETIN|5.51|IC=3.08uM|IC50|=|3.08|uM|3080|nM
2RG5|2.40|2008|279||Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|8.51|IC=3.1nM|IC50|=|3.1|nM|3.1|nM
2QYK|2.10|2008|NPV|IC50=3.3+/-0.2uM|Q9H3H2|CYCLIC AMP-SPECIFIC PHOSPHODIESTERASE HSPDE4A10|5.48|IC=3.3uM|IC50|=|3.3|uM|3300|nM
3BHB|2.20|2008|10-mer||P01892|HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2|8.47|IC=3.4nM|IC50|=|3.4|nM|3.4|nM
3BX5|2.40|2008|304||Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|8.46|IC=3.5nM|IC50|=|3.5|nM|3.5|nM
2RF2|2.40|2008|MRX|compound 7e|P04585|HIV-1 REVERSE TRANSCRIPTASE/RIBONUCLEASE H|8.44|IC=3.6nM|IC50|=|3.6|nM|3.6|nM
2QU2|2.60|2008|251|ED50=8.9uM|P56817|BETA-SECRETASE 1|5.43|IC=3.7uM|IC50|=|3.7|uM|3700|nM
2QNZ|2.30|2008|DFD|inhibitor 1, IC50=3.8+/-0.5uM|P0A574|3-OXOACYL-[ACYL-CARRIER-PROTEIN] SYNTHASE 3|5.42|IC=3.8uM|IC50|=|3.8|uM|3800|nM
2VTS|1.90|2008|LZC|compound 12|P24941|CELL DIVISION PROTEIN KINASE 2|7.52|IC=30nM|IC50|=|30|nM|30|nM
2ZMJ|2.35|2008|MI4|IC50=3 x 10-8M|P13053|VITAMIN D3 RECEPTOR|7.52|IC=30nM|IC50|=|30|nM|30|nM
3E01|2.95|2008|PZ2|compound 10, EC 2.7.7.49/ 2.7.7.7/ 3.1.26.4|P04585|HIV-1 REVERSE TRANSCRIPTASE|7.52|IC=30nM|IC50|=|30|nM|30|nM
2VL8|2.31|2008|UDP|CTS+UDP IC50~30uM, CTS IC50~100uM, UDP IC50~400uM|Q46342|CYTOTOXIN L|4.52|IC=30uM|IC50|=|30|uM|30000|nM
3CCB|2.49|2008|B2Y|compound 1|P27487|DIPEPTIDYL PEPTIDASE 4|4.52|IC=30uM|IC50|=|30|uM|30000|nM
2ZLF|2.59|2008|7-mer|IC50=31+/-1uM|P21524|RIBONUCLEOSIDE-DIPHOSPHATE REDUCTASE LARGE CHAIN|4.51|IC=31uM|IC50|=|31|uM|31000|nM
3D4L|2.00|2008|605||P27487|DIPEPTIDYL PEPTIDASE 4|7.49|IC=32nM|IC50|=|32|nM|32|nM
2VIE|1.90|2008|VG0|compound 12|P56817|BETA-SECRETASE 1|7.48|IC=33nM|IC50|=|33|nM|33|nM
3BSC|2.65|2008|2PD|compound 3|P26663|RNA-DIRECTED RNA POLYMERASE|4.48|IC=33uM|IC50|=|33|uM|33000|nM
2PT9|2.20|2008|S4M|X-ray(pfSPDS); IC501=35uM(pfSPDS); IC502=1.7uM(rat SPDS).|Q8II73|SPERMIDINE SYNTHASE|4.46|IC=35uM|IC50|=|35|uM|35000|nM
2VQJ|2.10|2008|TFG|IC50=367+/-8nM|P56524|HISTONE DEACETYLASE 4|6.44|IC=367nM|IC50|=|367|nM|367|nM
3DM6|2.60|2008|757||P56817|BETA-SECRETASE 1|7.43|IC=37nM|IC50|=|37|nM|37|nM
3BGM|1.60|2008|9-mer||P01892|HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2|7.41|IC=38.5nM|IC50|=|38.5|nM|38.5|nM
2OW3|2.80|2008|BIM|PDB 2ow3 is for ligand compound 3, not compound 10a, IC50=0.003uM|P49841|GLYCOGEN SYNTHASE KINASE-3 BETA|8.52|IC=3nM|IC50|=|3|nM|3|nM
2QMF|1.75|2008|CS9|inhibitor 2f|P56817|BETA-SECRETASE 1|8.52|IC=3nM|IC50|=|3|nM|3|nM
2VAQ|3.01|2008|VAW|IC50=3+/-0.5nM|P68175|STRICTOSIDINE SYNTHASE|8.52|IC=3nM|IC50|=|3|nM|3|nM
2VNM|1.79|2008|CM8|compound 1|P56817|BETA-SECRETASE 1|8.52|IC=3nM|IC50|=|3|nM|3|nM
2VTP|2.15|2008|LZ9|compound 23|P24941|CELL DIVISION PROTEIN KINASE 2|8.52|IC=3nM|IC50|=|3|nM|3|nM
3CIC|1.75|2008|316||P56817|BETA-SECRETASE 1|8.52|IC=3nM|IC50|=|3|nM|3|nM
3DCV|2.70|2008|55E||P11309|SERINE/THREONINE-PROTEIN KINASE|8.52|IC=3nM|IC50|=|3|nM|3|nM
3DYA|2.30|2008|PZL|compound 6, EC 2.7.7.49/ 2.7.7.7/ 3.1.26.4|P04585|HIV-1 REVERSE TRANSCRIPTASE/RIBONUCLEASE H|8.52|IC=3nM|IC50|=|3|nM|3|nM
3CGO|3.00|2008|JNO|RCSB is JNO, like analogue 2|P53779|MITOGEN-ACTIVATED PROTEIN KINASE 10|5.52|IC=3uM|IC50|=|3|uM|3000|nM
2V22|2.60|2008|C35|IC50=4.1+/-1.4uM, C35 is ligand NCP09|P24941|CELL DIVISION PROTEIN KINASE 2|5.39|IC=4.1uM|IC50|=|4.1|uM|4100|nM
3CHF|1.95|2008|5-mer|IC50=4.3+/-0.2uM|Q873X9|CHITINASE|5.37|IC=4.3uM|IC50|=|4.3|uM|4300|nM
2QAF|1.95|2008|U5P|IC50=4.4+/-1.3uM|Q8T6J6|OROTIDINE 5'-PHOSPHATE DECARBOXYLASE|5.36|IC=4.4uM|IC50|=|4.4|uM|4400|nM
3BGL|2.23|2008|RID|compound 16a in vitro, Rat microsomal HMGCoA reductase inhibition.|P04035|3-HYDROXY-3-METHYLGLUTARYL-COENZYME A REDUCTASE|8.35|IC=4.5nM|IC50|=|4.5|nM|4.5|nM
2QVE|2.00|2008|247||Q8GMG0|TYROSINE AMINOMUTASE|2.32|IC=4.8mM|IC50|=|4.8|mM|4800000|nM
3EQL|2.70|2008|MXP|IC50=4.99+/-0.45uM, dMyx complexed with a Thermus thermophilus RNAP holoenzyme|Q9Z9H6|DNA-DIRECTED RNA POLYMERASE SUBUNIT ALPHA|5.3|IC=4.99uM|IC50|=|4.99|uM|4990|nM
3E62|1.92|2008|5B1||O60674|TYROSINE-PROTEIN KINASE JAK2|4.39|IC=40.9uM|IC50|=|40.9|uM|40900|nM
2VJ7|1.60|2008|VG6|compound 16|P56817|BETA-SECRETASE 1|7.4|IC=40nM|IC50|=|40|nM|40|nM
3CTQ|1.95|2008|337|IC50=40+/-35nM|Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|7.4|IC=40nM|IC50|=|40|nM|40|nM
3DDU|1.56|2008|552|IC50=40+/-0.6nM|P48147|PROLYL ENDOPEPTIDASE|7.4|IC=40nM|IC50|=|40|nM|40|nM
3DEI|2.80|2008|RXB|IC50=40+/-3nM|P42574|CASPASE-3|7.4|IC=40nM|IC50|=|40|nM|40|nM
2VIO|1.80|2008|L1O||P00749|UROKINASE-TYPE PLASMINOGEN ACTIVATOR CHAIN B|4.4|IC=40uM|IC50|=|40|uM|40000|nM
2EI6|2.30|2008|D92|D92(cis) IC50=41nM, (+)D92(cis) IC50=753nM, (-)D92(cis) IC50=16nM, D92(Trans) IC50=13nM|P00742|COAGULATION FACTOR X (HEAVY CHAIN)|7.39|IC=41nM|IC50|=|41|nM|41|nM
3CQW|2.00|2008|CQW|compound 8b, IC50=42+/-30nM|P31749|RAC-ALPHA SERINE/THREONINE-PROTEIN KINASE|7.38|IC=42nM|IC50|=|42|nM|42|nM
3DBD|3.05|2008|3FR||Q4KMI8|POLO-LIKE KINASE 1|7.38|IC=42nM|IC50|=|42|nM|42|nM
2VTT|1.68|2008|LZD|compound 29|P24941|CELL DIVISION PROTEIN KINASE 2|7.36|IC=44nM|IC50|=|44|nM|44|nM
2VRX|1.86|2008|447|ligand is compound ZM447439|Q6DE08|SERINE/THREONINE-PROTEIN KINASE 12-A|7.35|IC=45nM|IC50|=|45|nM|45|nM
2EA4|2.35|2008|F79|compound 17a, enzyme IC50=0.046uM, enzyme IC50=0.12uM w/HSA|P50579|METHIONINE AMINOPEPTIDASE 2|7.34|IC=46nM|IC50|=|46|nM|46|nM
2VU3|1.85|2008|LZE|compound 33|P24941|CELL DIVISION PROTEIN KINASE 2|7.33|IC=47nM|IC50|=|47|nM|47|nM
2PJ6|1.60|2008|059||P09955|CARBOXYPEPTIDASE B|7.31|IC=49nM|IC50|=|49|nM|49|nM
2RL5|2.65|2008|2RL||P35968|VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2|8.4|IC=4nM|IC50|=|4|nM|4|nM
3BL7|2.31|2008|DD1|IC50~4nM; human DcpS|Q96C86|SCAVENGER MRNA-DECAPPING ENZYME DCPS|8.4|IC=4nM|IC50|=|4|nM|4|nM
3EFW|2.29|2008|AK8||O14965|SERINE/THREONINE-PROTEIN KINASE 6|8.4|IC=4nM|IC50|=|4|nM|4|nM
3EKN|2.20|2008|GS3|compound 2 with IGF-1R enzyme IC50 value, data not sure, IC50=4nM|P06213|INSULIN RECEPTOR|8.4|IC=4nM|IC50|=|4|nM|4|nM
2RKU|1.95|2008|R78|compound 1b, IC50=5+/-2.4nM|P53350|SERINE/THREONINE-PROTEIN KINASE PLK1|8.3|IC=5.0nM|IC50|=|5|nM|5|nM
3CHE|2.05|2008|4-mer|IC50=5.1+/-0.2uM|Q873X9|CHITINASE|5.29|IC=5.1uM|IC50|=|5.1|uM|5100|nM
2VIP|1.72|2008|L1R||P00749|UROKINASE-TYPE PLASMINOGEN ACTIVATOR CHAIN B|5.28|IC=5.2uM|IC50|=|5.2|uM|5200|nM
2RJS|2.40|2008|296||Q8GMG0|TYROSINE AMINOMUTASE|2.28|IC=5.3mM|IC50|=|5.3|mM|5300000|nM
2QQ7|2.38|2008|SR2|compound 2, IC50=5710nM|P00523|TYROSINE-PROTEIN KINASE SRC|5.24|IC=5.71uM|IC50|=|5.71|uM|5710|nM
2VVT|1.65|2008|I24|compound 13|Q836J0|GLUTAMATE RACEMASE|5.24|IC=5.8uM|IC50|=|5.8|uM|5800|nM
2R3F|1.50|2008|SC8|compound 1|P24941|CELL DIVISION PROTEIN KINASE 2|6.3|IC=500nM|IC50|=|500|nM|500|nM
2VGO|1.70|2008|AD5|IC50=15nM(Upstate assay conditions); IC50=400nM(Invitrogen assay conditions)|Q6DE08|SERINE/THREONINE-PROTEIN KINASE 12-A|6.3|IC=500nM|IC50|=|500|nM|500|nM
3CH9|2.20|2008|XRG|IC50=500+/-20uM|Q873X9|CHITINASE|3.3|IC=500uM|IC50|=|500|uM|500000|nM
2VIV|1.72|2008|VG2||P00749|UROKINASE-TYPE PLASMINOGEN ACTIVATOR CHAIN B|6.28|IC=520nM|IC50|=|520|nM|520|nM
3CHP|2.10|2008|4BO||P09960|LEUKOTRIENE A-4 HYDROLASE|5.27|IC=5400nM|IC50|=|5400|nM|5400|nM
3D27|2.20|2008|W29|compound 22|P0AE18|METHIONINE AMINOPEPTIDASE|4.25|IC=55.7uM|IC50|=|55.7|uM|55700|nM
3CJ3|1.87|2008|SX4|compound 7c, IC50=17uM|P26663|RNA-DIRECTED RNA POLYMERASE|4.24|IC=57uM|IC50|=|57|uM|57000|nM
2QMD|1.65|2008|CS7|inhibitor 2e|P56817|BETA-SECRETASE 1|8.3|IC=5nM|IC50|=|5|nM|5|nM
3BC5|2.27|2008|ZAA||P37231|PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA|8.3|IC=5nM|IC50|=|5|nM|5|nM
3CID|1.80|2008|318||P56817|BETA-SECRETASE 1|8.3|IC=5nM|IC50|=|5|nM|5|nM
2VJ1|2.25|2008|XP1|IC50<5uM|A7J8L3|SARS CORONAVIRUS MAIN PROTEINASE|5.3|IC=5uM|IC50|=|5|uM|5000|nM
3B9S|1.80|2008|RW1|covalent&nbsp; complex; IC50~5uM, 10~20 fold weak than 475nM, 200nM|P14174|MACROPHAGE MIGRATION INHIBITORY FACTOR|5.3|IC=5uM|IC50|=|5|uM|5000|nM
3CPC|2.40|2008|C52|compound 16, IC50>5uM|P35968|VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2|5.3|IC=5uM|IC50|=|5|uM|5000|nM
3ELJ|1.80|2008|GS7|compound 40 with JNK1, IC50=5010nM|P45983|MITOGEN-ACTIVATED PROTEIN KINASE 8|5.3|IC=5uM|IC50|=|5|uM|5000|nM
2JKK|2.00|2008|BI9|IC50=6.24+/-0.51nM|Q00944|FOCAL ADHESION KINASE 1|8.2|IC=6.24nM|IC50|=|6.24|nM|6.24|nM
2JJR|2.30|2008|TAM|IC50=6.28nM|P09989|RIBOSOME-INACTIVATING PROTEIN ALPHA|8.2|IC=6.28nM|IC50|=|6.28|nM|6.28|nM
2E9N|2.50|2008|76A||O14757|SERINE/THREONINE-PROTEIN KINASE CHK1|8.21|IC=6.2nM|IC50|=|6.2|nM|6.2|nM
2VVO|1.85|2008|A6P|IC50=6.3+/-0.5mM|Q79FD7|RIBOSE-5-PHOSPHATE ISOMERASE B|2.2|IC=6.3mM|IC50|=|6.3|mM|6300000|nM
3CJF|2.15|2008|SAV|indazolylpyrimidine 5a|P35968|VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2|8.2|IC=6.3nM|IC50|=|6.3|nM|6.3|nM
3DCR|1.40|2008|KVS||O38732|HIV-1 PROTEASE|8.2|IC=6.3nM|IC50|=|6.3|nM|6.3|nM
2PMN|2.80|2008|K51|inhibitor K510|Q7YTF7|SER/THR PROTEIN KINASE|5.2|IC=6.3uM|IC50|=|6.3|uM|6300|nM
3C5U|2.80|2008|P41|compound 6a|Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|8.19|IC=6.4nM|IC50|=|6.4|nM|6.4|nM
2PJ3|1.64|2008|86A||P09955|CARBOXYPEPTIDASE B|8.18|IC=6.6nM|IC50|=|6.6|nM|6.6|nM
3EHT|3.40|2008|16-mer|Corticotropin-releasing factor, CRF(27-41); incomplete ligand|P0AEX9|FUSION PROTEIN OF CRFR1 EXTRACELLULAR DOMAIN AND MB|5.17|IC=6.8uM|IC50|=|6.8|uM|6800|nM
2R3O|1.80|2008|2SC|compound 11|P24941|CELL DIVISION PROTEIN KINASE 2|6.22|IC=600nM|IC50|=|600|nM|600|nM
2VIZ|1.60|2008|VG4|compound 21|P56817|BETA-SECRETASE 1|6.22|IC=605nM|IC50|=|605|nM|605|nM
3CY2|2.01|2008|MB9|multiple ligands; close to a 14-mer peptide|P11309|SERINE/THREONINE-PROTEIN KINASE PIM|7.22|IC=60nM|IC50|=|60|nM|60|nM
3CHR|2.20|2008|4BS||P09960|LEUKOTRIENE A-4 HYDROLASE|7.21|IC=61nM|IC50|=|61|nM|61|nM
2ZDX|2.54|2008|P4A|Fragment: Residues 20-411; Mutation: prescission protease site 18, 19;|Q16654|PYRUVATE DEHYDROGENASE KINASE ISOZYME 4|3.19|IC=648uM|IC50|=|648|uM|648000|nM
2RIP|2.90|2008|34Q||P27487|DIPEPTIDYL PEPTIDASE 4|7.19|IC=65nM|IC50|=|65|nM|65|nM
3EE2|1.91|2008|NZO|IC50~65uM|O60760|GLUTATHIONE-REQUIRING PROSTAGLANDIN D SYNTHASE|4.19|IC=65uM|IC50|=|65|uM|65000|nM
2VTI|2.00|2008|LZ3|compound 14|P24941|CELL DIVISION PROTEIN KINASE 2|6.18|IC=660nM|IC50|=|660|nM|660|nM
2R4B|2.40|2008|GW7|compound6, different from GW7, a triple bond to a single bond|Q15303|RECEPTOR TYROSINE-PROTEIN KINASE ERBB-4|7.18|IC=66nM|IC50|=|66|nM|66|nM
3BL9|1.80|2008|DD2|IC50~66nM|Q96C86|SCAVENGER MRNA-DECAPPING ENZYME DCPS|7.18|IC=66nM|IC50|=|66|nM|66|nM
3ECN|2.10|2008|IBM|IC50=698+/-29uM|O60658|HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE|3.16|IC=698uM|IC50|=|698|uM|698000|nM
2QZX|2.50|2008|6-mer|Sap5 complexed with pepstatin A, a 6-mer peptide|P43094|CANDIDAPEPSIN-5|8.22|IC=6nM|IC50|=|6|nM|6|nM
2V16|2.80|2008|C47|inhibitor 3, Purified human renin IC50=0.006uM, Plasma human renin IC50=0.0008uM|P00797|RENIN|8.22|IC=6nM|IC50|=|6|nM|6|nM
3BYM|2.00|2008|AM0||P06239|TYROSINE-PROTEIN KINASE LCK|8.22|IC=6nM|IC50|=|6|nM|6|nM
3BKI|1.87|2008|FQX||P19491|GLUTAMATE RECEPTOR 2|5.12|IC=7.6uM|IC50|=|7.6|uM|7600|nM
2JKO|1.65|2008|BIJ|IC50=7.7+/-1.36nM|Q00944|FOCAL ADHESION KINASE 1|8.11|IC=7.7nM|IC50|=|7.7|nM|7.7|nM
2JKQ|2.60|2008|VG8|can not be reliably determined, but expected to mirror the potency of TAF089|Q00944|FOCAL ADHESION KINASE 1|8.11|IC=7.7nM|IC50|=|7.7|nM|7.7|nM
2R3N|1.63|2008|SCZ|compound 10|P24941|CELL DIVISION PROTEIN KINASE 2|7.15|IC=70nM|IC50|=|70|nM|70|nM
2VIW|2.05|2008|D56||P00749|UROKINASE-TYPE PLASMINOGEN ACTIVATOR CHAIN B|7.14|IC=72nM|IC50|=|72|nM|72|nM
3DBS|2.80|2008|GD9|IC50=0.075uM|P48736|PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE|7.12|IC=75nM|IC50|=|75|nM|75|nM
2ZOF|2.30|2008|BES|X \ray (mouse CN2); Mn2+ containing; IC50(human CN2)|Q9D1A2|CYTOSOLIC NON-SPECIFIC DIPEPTIDASE|8.15|IC=7nM|IC50|=|7|nM|7|nM
3BYO|2.00|2008|AM9||P06239|TYROSINE-PROTEIN KINASE LCK|8.15|IC=7nM|IC50|=|7|nM|7|nM
2PJ0|1.65|2008|922||P09955|CARBOXYPEPTIDASE B|8.09|IC=8.1nM|IC50|=|8.1|nM|8.1|nM
3ENS|2.30|2008|ENS|compound 18|P00742|COAGULATION FACTOR X, LIGHT CHAIN|8.05|IC=8.9nM|IC50|=|8.9|nM|8.9|nM
2R3G|1.55|2008|SC9|compound 2|P24941|CELL DIVISION PROTEIN KINASE 2|6.1|IC=800nM|IC50|=|800|nM|800|nM
2VLE|2.40|2008|DZN||P05091|ALDEHYDE DEHYDROGENASE, MITOCHONDRIAL|7.1|IC=80nM|IC50|=|80|nM|80|nM
2QIQ|1.90|2008|CYV|compound 3|P59641|REPLICASE POLYPROTEIN 1AB|4.1|IC=80uM|IC50|=|80|uM|80000|nM
3CHC|1.90|2008|ZRG|IC50=81+/-4uM|Q873X9|CHITINASE|4.09|IC=81uM|IC50|=|81|uM|81000|nM
2W06|2.04|2008|FRV|compound 5e, IC50=0.083uM|P24941|CELL DIVISION PROTEIN KINASE 2|7.08|IC=83nM|IC50|=|83|nM|83|nM
2VTN|2.20|2008|LZ7|compound 18|P24941|CELL DIVISION PROTEIN KINASE 2|6.07|IC=850nM|IC50|=|850|nM|850|nM
2VTD|1.94|2008|LKM|compound 17n|P14900|UDP-N-ACETYLMURAMOYLALANINE-D-GLUTAMATE LIGASE|4.07|IC=85uM|IC50|=|85|uM|85000|nM
2PJT|2.80|2008|347|IC50=860+/-20nM|P45452|COLLAGENASE 3|6.07|IC=860nM|IC50|=|860|nM|860|nM
2VCW|1.95|2008|ZZA|compound 1|O60760|GLUTATHIONE-REQUIRING PROSTAGLANDIN D SYNTHASE|3.05|IC=890uM|IC50|=|890|uM|890000|nM
2QK5|2.20|2008|CS5|lead inhibitor 1|P56817|BETA-SECRETASE 1|8.1|IC=8nM|IC50|=|8|nM|8|nM
2QP8|1.50|2008|SC7|inhibitor 2q|P56817|BETA-SECRETASE 1|8.1|IC=8nM|IC50|=|8|nM|8|nM
2QZL|1.80|2008|IXS||P56817|BETA-SECRETASE 1|8.1|IC=8nM|IC50|=|8|nM|8|nM
3CCC|2.71|2008|7AC|compound 30, IC50=0.008uM|P27487|DIPEPTIDYL PEPTIDASE 4|8.1|IC=8nM|IC50|=|8|nM|8|nM
2ZDT|2.00|2008|46C|X-ray structure(JNK3/46C); IC50=9.6nM(JNK1/46C).|P53779|MITOGEN-ACTIVATED PROTEIN KINASE 10|8.02|IC=9.6nM|IC50|=|9.6|nM|9.6|nM
2PJ1|1.64|2008|578||P09955|CARBOXYPEPTIDASE B|8.01|IC=9.7nM|IC50|=|9.7|nM|9.7|nM
2R3P|1.66|2008|3SC|compound 12|P24941|CELL DIVISION PROTEIN KINASE 2|6.05|IC=900nM|IC50|=|900|nM|900|nM
3DDB|1.60|2008|7-mer||A5HZZ9|BOTULINUM NEUROTOXIN A LIGHT CHAIN|4.02|IC=95uM|IC50|=|95|uM|95000|nM
2VQM|1.80|2008|HA3|IC50=978+/-62nM|P56524|HISTONE DEACETYLASE 4|6.01|IC=978nM|IC50|=|978|nM|978|nM
2VTL|2.00|2008|LZ5|compound 15|P24941|CELL DIVISION PROTEIN KINASE 2|4.01|IC=97uM|IC50|=|97|uM|97000|nM
2QHN|1.70|2008|582||O14757|SERINE/THREONINE-PROTEIN KINASE CHK1|6.01|IC=980nM|IC50|=|980|nM|980|nM
3DB8|3.15|2008|1FR||Q4KMI8|POLO-LIKE KINASE 1|7.0|IC=99nM|IC50|=|99|nM|99|nM
2JJK|2.00|2008|R15|FBbase complex with compound 7a, IC50=0.009uM|P09467|FRUCTOSE-1,6-BISPHOSPHATASE 1|8.05|IC=9nM|IC50|=|9|nM|9|nM
2ZV9|2.76|2008|PP2||P25911|TYROSINE-PROTEIN KINASE LYN|8.05|IC=9nM|IC50|=|9|nM|9|nM
3CD8|2.00|2008|L5G|compound 4, IC50=9+/-2nM|P08581|HEPATOCYTE GROWTH FACTOR RECEPTOR|8.05|IC=9nM|IC50|=|9|nM|9|nM
2Z8E|1.99|2008|MES||A8W790|GALACTO-N-BIOSE/LACTO-N-BIOSE I TRANSPORTER|8.0|Kd=0.01uM|Kd|=|0.01|uM|10|nM
2Q2A|1.79|2008|ARG||D0VWX8|ARTJ|7.41|Kd=0.039uM|Kd|=|0.039|uM|39|nM
2RKN|1.60|2008|LP3|Kd=0.06+/-0.02uM|Q8W453|DIR1 PROTEIN|7.22|Kd=0.06uM|Kd|=|0.06|uM|60|nM
3E64|1.80|2008|5B3||O60674|TYROSINE-PROTEIN KINASE JAK2|7.11|Kd=0.078uM|Kd|=|0.078|uM|78|nM
2VT3|2.00|2008|ATP||O05521|REDOX-SENSING TRANSCRIPTIONAL REPRESSOR REX|4.15|Kd=0.07mM|Kd|=|0.07|mM|70000|nM
3C49|2.80|2008|KU8|Kd=0.07+/-0.008uM|Q9Y6F1|POLY [ADP-RIBOSE] POLYMERASE 3|7.15|Kd=0.07uM|Kd|=|0.07|uM|70|nM
2ZMD|2.88|2008|537|ligand is compound SP600125|P33981|DUAL SPECIFICITY PROTEIN KINASE TTK|7.01|Kd=0.098uM|Kd|=|0.098|uM|98|nM
3EXE|1.98|2008|TPP|cofactor ThDP binding to wt E1p in presence of Mn2+; Kd=0.11+/-0.01uM is for Mg2+|P08559|PYRUVATE DEHYDROGENASE E1 COMPONENT SUBUNIT|6.96|Kd=0.11uM|Kd|=|0.11|uM|110|nM
3COW|1.80|2008|52H|Kd=0.125+/-0.008uM; Ki=0.22+/-0.03uM|P0A5R0|PANTOTHENATE SYNTHETASE|6.9|Kd=0.125uM|Kd|=|0.125|uM|125|nM
3BU8|2.15|2008|19-mer|Kd=0.12+/-0.03uM; incomplete ligand|Q15554|TELOMERIC REPEAT-BINDING FACTOR 2|6.92|Kd=0.12uM|Kd|=|0.12|uM|120|nM
2VPN|1.55|2008|4CS|Kd=0.19+/-0.02uM|Q8VPB3|PERIPLASMIC SUBSTRATE BINDING PROTEIN|6.72|Kd=0.19uM|Kd|=|0.19|uM|190|nM
3BXZ|3.00|2008|ADP||P10408|PREPROTEIN TRANSLOCASE SUBUNIT SECA|6.72|Kd=0.19uM|Kd|=|0.19|uM|190|nM
3DIW|2.10|2008|10-mer|Kd=0.19+/-0.05uM; incomplete ligand|Q9DBG9|TAX1-BINDING PROTEIN 3|6.72|Kd=0.19uM|Kd|=|0.19|uM|190|nM
2UYW|1.70|2008|BTN||A7YYL1|XENAVIDIN|13.0|Kd=0.1pM|Kd|=|0.1|pM|0.0001|nM
3DAB|1.90|2008|15-mer|Kd=0.21+/-0.05uM; incomplete ligand|O15151|PROTEIN MDM4|6.68|Kd=0.21uM|Kd|=|0.21|uM|210|nM
2QKY|3.10|2008|13Z|IC50=0.022uM|P27487|DIPEPTIDYL PEPTIDASE 4|9.61|Kd=0.247nM|Kd|=|0.247|nM|0.247|nM
2JGS|1.90|2008|BTN|Kd=0.24+/-0.04uM|P02701|CIRCULAR PERMUTANT OF AVIDIN|6.62|Kd=0.24uM|Kd|=|0.24|uM|240|nM
2VWC|2.40|2008|BC2|Kd=0.24uM, IC50=2uM|P02829|HEAT SHOCK PROTEIN HSP82|6.62|Kd=0.24uM|Kd|=|0.24|uM|240|nM
2QPU|1.70|2008|QPU|Kd=0.25+/-0.03mM|P00693|ALPHA-AMYLASE|3.6|Kd=0.25mM|Kd|=|0.25|mM|250000|nM
3BB1|2.80|2008|GNP|Kd=0.25+/-0.05mM|Q41009|TRANSLOCASE OF CHLOROPLAST 34|3.6|Kd=0.25mM|Kd|=|0.25|mM|250000|nM
2P7Z|2.50|2008|OHT||P62508|ESTROGEN-RELATED RECEPTOR GAMMA|6.58|Kd=0.262uM|Kd|=|0.262|uM|262|nM
2P7G|2.10|2008|2OH||P62508|ESTROGEN-RELATED RECEPTOR GAMMA|6.53|Kd=0.297uM|Kd|=|0.297|uM|297|nM
3D0B|1.74|2008|SNX|ligand is compound 16, Kd=0.29uM, IC50=8.9uM|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|6.54|Kd=0.29uM|Kd|=|0.29|uM|290|nM
3EXF|3.00|2008|TPP|Binding of Cofactor ThDP to S-E1p in the Presence of Mg2+ Ions, Kd=0.29+/-0.02uM|P08559|PYRUVATE DEHYDROGENASE E1 COMPONENT SUBUNIT|6.54|Kd=0.29uM|Kd|=|0.29|uM|290|nM
3C7N|3.12|2008|ADP||P32589|HEAT SHOCK PROTEIN HOMOLOG SSE1|6.7|Kd=0.2uM|Kd|=|0.2|uM|200|nM
3BVA|1.05|2008|2NC|Ka=(3.30+/-0.56)e+6M-1|P03367|HIV-1 PROTEASE|6.52|Kd=0.30uM|Kd|=|0.3|uM|300|nM
2JKT|3.40|2008|11-mer|incomplete ligand|P17427|AP-2 COMPLEX SUBUNIT ALPHA-2|6.51|Kd=0.31uM|Kd|=|0.31|uM|310|nM
3CJ4|2.07|2008|SX5|ligand is compound 8e, IC50=1.0uM|P26663|RNA-DIRECTED RNA POLYMERASE|6.51|Kd=0.31uM|Kd|=|0.31|uM|310|nM
2PHB|2.30|2008|230||P00742|COAGULATION FACTOR X, HEAVY CHAIN|9.49|Kd=0.32nM|Kd|=|0.32|nM|0.32|nM
3BUM|2.00|2008|13-mer|incomplete ligand|O43597|PORTEIN SPROUTY HOMOLOG 2|6.49|Kd=0.32uM|Kd|=|0.32|uM|320|nM
2P3I|1.75|2008|MNA|ligand is Neu5Ac-alpha-2Me; Kd measured at 22C|Q91HI9|ROTAVIRUS SPIKE PROTEIN, VP4|3.48|Kd=0.33mM|Kd|=|0.33|mM|330000|nM
2Q2N|1.80|2008|H01|mouse ferrochelatase|P32396|FERROCHELATASE|6.48|Kd=0.33uM|Kd|=|0.33|uM|330|nM
3CPH|2.90|2008|GDP|Kd=0.33+/-0.02uM|P39958|RAB GDP-DISSOCIATION INHIBITOR|6.48|Kd=0.33uM|Kd|=|0.33|uM|330|nM
3D2E|2.35|2008|ATP|Kd=0.38+/-0.097uM(ATP and Sse1p-Hsp70); Kd=0.1uM(full-length proteins)|P32589|HEAT SHOCK PROTEIN HOMOLOG SSE1|6.42|Kd=0.38uM|Kd|=|0.38|uM|380|nM
2JQL|NMR|2008|10-mer||P39009|DNA DAMAGE RESPONSE PROTEIN KINASE DUN1|6.52|Kd=0.3uM|Kd|=|0.3|uM|300|nM
2W0P|1.90|2008|15-mer|Kd=0.3+/-0.05uM, FILAMIN A REPEAT 21 COMPLEXED WITH THE MIGFILIN PEPTIDE; incomplete ligand|P21333|FILAMIN-A|6.52|Kd=0.3uM|Kd|=|0.3|uM|300|nM
2Q2C|2.35|2008|HIS|protein mutant C1G ; Kd=0.42+/-0.08uM;|D0VWX8|ARTJ|6.38|Kd=0.42uM|Kd|=|0.42|uM|420|nM
3C2O|2.30|2008|NTM|Kd(stQAPRTase)=21uM; Kd=0.45+/-0.03mM|P43619|NICOTINATE-NUCLEOTIDE PYROPHOSPHORYLASE|3.35|Kd=0.45mM|Kd|=|0.45|mM|450000|nM
3CJ5|1.92|2008|SX6|ligand is compound 8i, IC50=0.25uM|P26663|RNA-DIRECTED RNA POLYMERASE|6.34|Kd=0.46uM|Kd|=|0.46|uM|460|nM
2ZB1|2.50|2008|GK4|IC50=3uM|Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|6.32|Kd=0.48uM|Kd|=|0.48|uM|480|nM
2PVU|1.79|2008|LYS||D0VWX8|ARTJ|6.31|Kd=0.49uM|Kd|=|0.49|uM|490|nM
2W0S|2.92|2008|BVP|BVdU Kd=0.5+/-0.1mM|P68693|THYMIDYLATE KINASE|3.3|Kd=0.5mM|Kd|=|0.5|mM|500000|nM
2JG8|2.05|2008|SEP|Kd=5 x 10-7M|P02745|COMPLEMENT C1Q SUBCOMPONENT SUBUNIT A|6.3|Kd=0.5uM|Kd|=|0.5|uM|500|nM
2OR9|2.70|2008|11-mer|synthetic epitope peptide of 9E10, Kd1=0.50uM 0.70uM 0.28uM in phosphate, TRISMOPS, buffer|P01106|MONOCLONAL ANTI-C-MYC ANTIBODY 9E10|6.3|Kd=0.5uM|Kd|=|0.5|uM|500|nM
2Q89|2.30|2008|6CS|Kd=0.5+/-0.1uM|Q92WC8|PUTATIVE ABC TRANSPORTER AMINO ACID-BINDING|6.3|Kd=0.5uM|Kd|=|0.5|uM|500|nM
2VRJ|1.90|2008|NCW|ligand is compound 9, Ki=0.28uM|Q08638|BETA-GLUCOSIDASE A|6.3|Kd=0.5uM|Kd|=|0.5|uM|500|nM
3EBL|1.90|2008|GA4||Q6L545|GIBBERELLIN RECEPTOR GID1|6.3|Kd=0.5uM|Kd|=|0.5|uM|500|nM
2ZM3|2.50|2008|575|IC50=2.42uM|P08069|INSULIN-LIKE GROWTH FACTOR 1 RECEPTOR|6.21|Kd=0.614uM|Kd|=|0.614|uM|614|nM
3BUN|2.00|2008|13-mer|incomplete ligand|Q9C004|13-MERIC PEPTIDE FROM PROTEIN SPROUTY HOMOLOG 4|6.21|Kd=0.61uM|Kd|=|0.61|uM|610|nM
2QBU|2.10|2008|SAH|Kd=0.645+/-0.025uM|O27402|PRECORRIN-2 METHYLTRANSFERASE|6.19|Kd=0.645uM|Kd|=|0.645|uM|645|nM
3DXJ|3.00|2008|NE6|IC50=20uM, Kd=0.6+/-0.3uM; ligand is antibiotic myxopyronin (Myx), correspond to code NE6|Q5SHR6|DNA-DIRECTED RNA POLYMERASE SUBUNIT ALPHA|6.22|Kd=0.6uM|Kd|=|0.6|uM|600|nM
3BTI|2.85|2008|BER|Kd=0.72+/-0.08uM|P0A0N3|HTH-TYPE TRANSCRIPTIONAL REGULATOR QACR|6.14|Kd=0.72uM|Kd|=|0.72|uM|720|nM
2P7A|2.30|2008|43M||P62508|ESTROGEN-RELATED RECEPTOR GAMMA|6.1|Kd=0.788uM|Kd|=|0.788|uM|788|nM
3C2R|2.40|2008|PHT|Kd=0.78+/-0.08mM|P43619|NICOTINATE-NUCLEOTIDE PYROPHOSPHORYLASE|3.11|Kd=0.78mM|Kd|=|0.78|mM|780000|nM
3CE0|2.80|2008|P34|Kd=0.7+/-0.15uM|Q9Y6F1|POLY [ADP-RIBOSE] POLYMERASE 3|6.15|Kd=0.7uM|Kd|=|0.7|uM|700|nM
3DST|1.90|2008|GRG|RabGGTase-GGPP complex, co-titration Kd=0.83+/-0.22nM, displacement titration Kd=1.8+/-0.71nM|Q08602|GERANYLGERANYL TRANSFERASE TYPE-2 SUBUNIT ALPHA|9.08|Kd=0.83nM|Kd|=|0.83|nM|0.83|nM
2JKR|2.98|2008|11-mer|incomplete ligand|P17427|AP-2 COMPLEX SUBUNIT ALPHA-2|6.07|Kd=0.85uM|Kd|=|0.85|uM|850|nM
3BUO|2.60|2008|13-mer|incomplete ligand|P00533|13-MERIC PEPTIDE FROM EPIDERMAL GROWTH FACTOR|6.06|Kd=0.88uM|Kd|=|0.88|uM|880|nM
2Z92|2.30|2008|ENE||P01837|ANTI-CIGUATOXIN ANTIBODY 10C9 FAB HEAVY CHAIN|9.1|Kd=0.8nM|Kd|=|0.8|nM|0.8|nM
3CII|4.41|2008|9-mer|Kd=0.8+/-0.055uM|P13747|HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, ALPHA|6.1|Kd=0.8uM|Kd|=|0.8|uM|800|nM
2VMD|1.90|2008|MBG||P42530|DISCOIDIN-2|3.02|Kd=0.95mM|Kd|=|0.95|mM|950000|nM
3COY|2.03|2008|53H|Kd=0.96+/-0.03uM; Ki=4+/-0.6uM|P0A5R0|PANTOTHENATE SYNTHETASE|6.02|Kd=0.96uM|Kd|=|0.96|uM|960|nM
3CFV|2.60|2008|18-mer|Kd1=0.9uM(intrinsic tryptophan fluorescence); Kd2=1uM(surface plasmon resonance, SPR)|Q16576|HISTONE-BINDING PROTEIN RBBP7|6.05|Kd=0.9uM|Kd|=|0.9|uM|900|nM
3CKB|2.30|2008|MLR|Kd=1.04+/-0.017mM|Q8A1G2|SUSD|2.98|Kd=1.04mM|Kd|=|1.04|mM|1040000|nM
3BTL|2.90|2008|MGR|Kd=1.09+/-0.07uM, redundant to 3btk in reference|P0A0N3|HTH-TYPE TRANSCRIPTIONAL REGULATOR QACR|5.96|Kd=1.09uM|Kd|=|1.09|uM|1090|nM
2RCN|2.25|2008|GDP|Kd=1.0+/-0.3uM|Q8ZKB0|GTPASE ENGC|6.0|Kd=1.0uM|Kd|=|1|uM|1000|nM
2Z97|1.80|2008|7HE|one-legged heme-reconstituted P450cam; Kd=1.0+/-0.15uM(putidaredoxin, Pdx)|P00183|CYTOCHROME P450-CAM|6.0|Kd=1.0uM|Kd|=|1|uM|1000|nM
2VMC|1.90|2008|NGA|Kd for GalNAc, N-acetyl-D-galactosamine|P42530|DISCOIDIN-2|2.94|Kd=1.15mM|Kd|=|1.15|mM|1150000|nM
3CFS|2.40|2008|15-mer|Kd1=1.1uM(intrinsic tryptophan fluorescence); Kd2=1uM(surface plasmon resonance, SPR)|Q16576|HISTONE-BINDING PROTEIN RBBP7|5.96|Kd=1.1uM|Kd|=|1.1|uM|1100|nM
2PMK|1.60|2008|128|Kd=1.2+/-0.1uM|P08716|ALPHA-HEMOLYSIN TRANSLOCATION ATP-BINDING|5.92|Kd=1.2uM|Kd|=|1.2|uM|1200|nM
3BIM|2.60|2008|19-mer|BCL6 BTB domain dimer in complex with the BCOR BBD corepressor peptide, Kd=1.32+/-0.02uM; incomplete ligand|P41182|B-CELL LYMPHOMA 6 PROTEIN|5.88|Kd=1.32uM|Kd|=|1.32|uM|1320|nM
2K2R|NMR|2008|10-mer||Q9NVD7|ALPHA-PARVIN|2.89|Kd=1.3mM|Kd|=|1.3|mM|1300000|nM
3BU6|1.95|2008|15-mer|incomplete ligand|P06213|INSULIN RECEPTOR, SUBUNIT BETA|5.89|Kd=1.3uM|Kd|=|1.3|uM|1300|nM
3EEB|2.10|2008|IHP|Kd=1.3+/-0.2uM|Q9KS12|RTX TOXIN RTXA|5.89|Kd=1.3uM|Kd|=|1.3|uM|1300|nM
3BUW|1.45|2008|13-mer|incomplete ligand|P43405|13-MERIC PEPTIDE FROM TYROSINE-PROTEIN KINASE|5.83|Kd=1.49uM|Kd|=|1.49|uM|1490|nM
3E5U|1.83|2008|3C4||Q18R04|CYCLIC NUCLEOTIDE-BINDING PROTEIN|5.85|Kd=1.4uM|Kd|=|1.4|uM|1400|nM
2ZJU|2.58|2008|IM4|Kd=1.57+/-0.21uM, n=3|P58154|ACETYLCHOLINE-BINDING PROTEIN|5.81|Kd=1.557uM|Kd|=|1.557|uM|1557|nM
3E1R|2.00|2008|13-mer|Kd=1.5+/-0.2uM|Q53EZ4|CENTROSOMAL PROTEIN OF 55 KDA|5.82|Kd=1.5uM|Kd|=|1.5|uM|1500|nM
2Q88|1.90|2008|4CS|Kd=1.6+/-0.3uM|Q92WC8|PUTATIVE ABC TRANSPORTER AMINO ACID-BINDING|5.8|Kd=1.6uM|Kd|=|1.6|uM|1600|nM
3BTC|2.90|2008|MGR|Kd=1.77+/-0.17uM|P0A0N3|HTH-TYPE TRANSCRIPTIONAL REGULATOR QACR|5.75|Kd=1.77uM|Kd|=|1.77|uM|1770|nM
3D1E|1.90|2008|10-mer|incomplete ligand|P0A988|DNA POLYMERASE III SUBUNIT BETA|5.77|Kd=1.7uM|Kd|=|1.7|uM|1700|nM
3EG6|1.72|2008|13-mer|Kd=1.7+/-0.1uM, WDR5 bound to MLL1 peptide; incomplete ligand|P61964|WD REPEAT-CONTAINING PROTEIN 5|5.77|Kd=1.7uM|Kd|=|1.7|uM|1700|nM
2VYT|1.90|2008|MLZ|Kd=1.84+/-0.19mM|Q9UQR0|SEX COMB ON MIDLEG-LIKE PROTEIN 2|2.74|Kd=1.84mM|Kd|=|1.84|mM|1840000|nM
3EML|2.60|2008|ZMA|in presence of 1 M NaCl Kd=1+/-0.1nM, in absence of 1 M NaCl Kd=1.8+/-0.2nM|P29274|HUMAN ADENOSINE A2A RECEPTOR/T4 LYSOZYME CHIMERA|8.74|Kd=1.8nM|Kd|=|1.8|nM|1.8|nM
3BZI|2.10|2008|9-mer|incomplete ligand|P53350|SERINE/THREONINE-PROTEIN KINASE PLK1|5.74|Kd=1.8uM|Kd|=|1.8|uM|1800|nM
2PQC|1.60|2008|RC1|Kd=1800+/-600nM|Q9R4E4|3-PHOSPHOSHIKIMATE 1-CARBOXYVINYLTRANSFERASE|5.74|Kd=1.8uM|Kd|=|1.8|uM|1800|nM
3D1F|2.00|2008|9-mer|DNA polymerase III subunit beta bounds to Nonapeptide from polymerase III C-terminal|P0A988|DNA POLYMERASE III SUBUNIT BETA|5.74|Kd=1.8uM|Kd|=|1.8|uM|1800|nM
2OZ2|1.95|2008|D1R|ligand is K11777, Ka=517, 000M-1, Kd=1.93uM|P25779|CRUZIPAIN|5.71|Kd=1.93uM|Kd|=|1.93|uM|1930|nM
3BT9|2.75|2008|DEQ|Kd=1.95+/-0.18uM|P0A0N3|HTH-TYPE TRANSCRIPTIONAL REGULATOR QACR|5.71|Kd=1.95uM|Kd|=|1.95|uM|1950|nM
3C2F|2.35|2008|PRP|Kd=10.1+/-3.3mM|P43619|NICOTINATE-NUCLEOTIDE PYROPHOSPHORYLASE|2.0|Kd=10.1mM|Kd|=|10.1|mM|10100000|nM
3BXG|1.80|2008|BG6|protein from Bacillus subtilis; Kd=10.98+/-1.2uM|O32253|CENTRAL GLYCOLYTIC GENE REGULATOR|4.96|Kd=10.98uM|Kd|=|10.98|uM|10980|nM
3BBB|1.30|2008|2-mer|ligand is dinucleotide d(AG), Kd=100+/-20nM, Ki=280+/-30nM; binding data found in another reference|P22392|NUCLEOSIDE DIPHOSPHATE KINASE B|7.0|Kd=100nM|Kd|=|100|nM|100|nM
2RIN|1.80|2008|ACH|Kd=100+/-12uM|Q92N37|PUTATIVE GLYCINE BETAINE-BINDING ABC TRANSPORTER|4.0|Kd=100uM|Kd|=|100|uM|100000|nM
3CHG|2.80|2008|313|Kd=102+/-11uM|P46922|GLYCINE BETAINE-BINDING PROTEIN|3.99|Kd=102uM|Kd|=|102|uM|102000|nM
2RNW|NMR|2008|15-mer|Kd=1051+/-90uM|Q92831|HISTONE ACETYLTRANSFERASE PCAF|2.98|Kd=1051uM|Kd|=|1051|uM|1051000|nM
3C39|1.85|2008|3PG|ligand is 3-phosphoglycerate|P00558|PHOSPHOGLYCERATE KINASE 1|3.96|Kd=109uM|Kd|=|109|uM|109000|nM
2R6F|3.20|2008|ADP|Kd 10nM|Q5KVB6|EXCINUCLEASE ABC SUBUNIT A|8.0|Kd=10nM|Kd|=|10|nM|10|nM
3C9E|1.80|2008|E64||P43235|CATHEPSIN K|8.0|Kd=10nM|Kd|=|10|nM|10|nM
3DBA|2.57|2008|35G|Kd~10nM|P52731|CONE CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE SUBUNIT|8.0|Kd=10nM|Kd|=|10|nM|10|nM
2JQI|NMR|2008|10-mer|Kd=10-20uM|P22216|SERINE/THREONINE-PROTEIN KINASE RAD53|5.0|Kd=10uM|Kd|=|10|uM|10000|nM
2VPE|1.70|2008|9-mer|hPHD-HD1 and 9-MER H3K4ME2, Kd=11.4+/-1.1uM|Q9Y3Y4|PYGOPUS HOMOLOG 1|4.94|Kd=11.4uM|Kd|=|11.4|uM|11400|nM
2VO4|1.75|2008|4NM|binding of p-nitrophenol to GmGSTU4-4 and Nb-GSH complex; Kd=11.6+/-0.1uM|O49235|GLUTATHIONE S-TRANSFERASE|4.94|Kd=11.6uM|Kd|=|11.6|uM|11600|nM
2EH8|2.60|2008|11-mer|HzKR127 Fab with preS1 peptide, Kd=11+/-1.66nM; incomplete ligand|Q2EID8|HUMANIZED KR127 FAB, LIGHT CHAIN|7.96|Kd=11nM|Kd|=|11|nM|11|nM
2JB6|2.85|2008|T5C|MOR03268:TSC 2:1 complex, Kd2~11pM, Kd1=3.1nM|P01857|ANTIBODY FAB FRAGMENT MOR03268 HEAVY CHAIN|10.96|Kd=11pM|Kd|=|11|pM|0.011|nM
3CD5|2.39|2008|7HI|IC50=5.1nM|P04035|3-HYDROXY-3-METHYLGLUTARYL-COENZYME A REDUCTASE|7.9|Kd=12.7nM|Kd|=|12.7|nM|12.7|nM
2VUK|1.50|2008|P83|Kd=125+/-10uM (ITC); Kd=167+/-12uM (NMR)|P04637|CELLULAR TUMOR ANTIGEN P53|3.9|Kd=125uM|Kd|=|125|uM|125000|nM
3EXH|2.44|2008|TPP|cofactor ThDP binding to phospho-S1-E1p in presence of Mn2+; Kd=13.1+/-1.1uM is for Mg2+|P08559|PYRUVATE DEHYDROGENASE E1 COMPONENT SUBUNIT|4.88|Kd=13.1uM|Kd|=|13.1|uM|13100|nM
2Z6W|0.96|2008|11-mer||P30405|PEPTIDYL-PROLYL CIS-TRANS ISOMERASE F|7.87|Kd=13.4nM|Kd|=|13.4|nM|13.4|nM
3CCW|2.10|2008|4HI|IC50=7.9nM|P04035|3-HYDROXY-3-METHYLGLUTARYL-COENZYME A REDUCTASE|7.87|Kd=13.5nM|Kd|=|13.5|nM|13.5|nM
3C94|2.70|2008|10-mer|Kd=136+/-11nM; incomplete ligand|P04995|EXODEOXYRIBONUCLEASE I|6.87|Kd=136nM|Kd|=|136|nM|136|nM
3CD7|2.05|2008|882|IC50=1.8nM|P04035|3-HYDROXY-3-METHYLGLUTARYL-COENZYME A REDUCTASE|7.84|Kd=14.3nM|Kd|=|14.3|nM|14.3|nM
3DS0|1.60|2008|12-mer|Kd=14.9+/-0.9uM, ligand is Peptide inhibitor of capsid assembly(CAI)|Q72497|HIV-1 CAPSID PROTEIN|4.83|Kd=14.9uM|Kd|=|14.9|uM|14900|nM
2VMF|2.10|2008|MVL|ligand is compound 1a|Q8AAK6|BETA-MANNOSIDASE|5.85|Kd=1400nM|Kd|=|1400|nM|1400|nM
3EMH|1.37|2008|13-mer|WDR5 complex with Mixed-lineage leukemia protein 1, see supplement data; incomplete ligand|P61964|WD REPEAT-CONTAINING PROTEIN 5|6.85|Kd=140nM|Kd|=|140|nM|140|nM
2K4I|NMR|2008|PBU|Kd=143+/-16uM|P04584|HIV-2 MYRISTOYLATED MATRIX PROTEIN|3.84|Kd=143uM|Kd|=|143|uM|143000|nM
3CK8|2.10|2008|BCD|Kd=146+/-5uM|Q8A1G2|SUSD|3.84|Kd=146uM|Kd|=|146|uM|146000|nM
3E6V|1.72|2008|ABH||P05089|ARGINASE-1|6.83|Kd=147nM|Kd|=|147|nM|147|nM
3C84|1.94|2008|TH4|dissociation kinetics Kd=14nM|Q8WSF8|ACETYLCHOLINE RECEPTOR|7.85|Kd=14nM|Kd|=|14|nM|14|nM
3CJ2|1.75|2008|SX3|ligand is compound 7e, IC50=17uM|P26663|RNA-DIRECTED RNA POLYMERASE|4.85|Kd=14uM|Kd|=|14|uM|14000|nM
2JK9|1.79|2008|15-mer|ligand is hPar-4, human prostate apoptosis(sequence is NELNNNLPGGAPAAP), Kd=150+/-12nM; incomplete ligand|Q96BD6|SPRY DOMAIN-CONTAINING SOCS BOX PROTEIN 1|6.82|Kd=150nM|Kd|=|150|nM|150|nM
2PYM|1.90|2008|1UN|Kd=150+/-20nM; Ki=18+/-1nM.|P03367|HIV-1 PROTEASE|6.82|Kd=150nM|Kd|=|150|nM|150|nM
3DNJ|1.15|2008|10-mer|Kd=150-500nM; incomplete ligand|Q9A5I0|ATP-DEPENDENT CLP PROTEASE ADAPTER PROTEIN CLPS|6.82|Kd=150nM|Kd|=|150|nM|150|nM
3BL2|2.30|2008|19-mer|Kd=1580+/-98.3nM|P89884|V-BCL-2|5.8|Kd=1580nM|Kd|=|1580|nM|1580|nM
3CYY|2.40|2008|9-mer|Kd=16.8+/-1.1uM|Q07157|TIGHT JUNCTION PROTEIN ZO-1|4.77|Kd=16.8uM|Kd|=|16.8|uM|16800|nM
2RCB|1.62|2008|DSN|Kd=163+/-45nM|Q8VHN2|GLUTAMATE [NMDA] RECEPTOR SUBUNIT 3B|6.79|Kd=163nM|Kd|=|163|nM|163|nM
2R1X|1.60|2008|2-mer|ligand is KDD-KDA; solution affinity|Q52L64|ANTIBODY FAB FRAGMENT (IGG1K), LIGHT CHAIN|4.8|Kd=16uM|Kd|=|16|uM|16000|nM
2ZPK|1.80|2008|8-mer||Q96RI0|ANTIBODY FAB IGG1-LAMBDA P20.1, LIGHT CHAIN|7.76|Kd=17.5nM|Kd|=|17.5|nM|17.5|nM
3CPJ|2.35|2008|GDP|Kd=18.9+/-2uM; Kd=5.8+/-0.5uM for Ypt31 delta2a|P39958|RAB GDP-DISSOCIATION INHIBITOR|4.72|Kd=18.9uM|Kd|=|18.9|uM|18900|nM
2W68|2.50|2008|3-mer|CBM40 from V. cholerae sialidase with different linkage sialosides, Kd=18uM for 3-SL|P0C6E9|SIALIDASE|4.74|Kd=18uM|Kd|=|18|uM|18000|nM
2R23|1.65|2008|2-mer|ligand is KO1-KDA|Q52L64|ANTIBODY FAB FRAGMENT|3.72|Kd=190uM|Kd|=|190|uM|190000|nM
2VFK|1.50|2008|AMP|Kd=194+/-30uM|Q6JP77|AKAP18 DELTA|3.71|Kd=194uM|Kd|=|194|uM|194000|nM
3D9K|2.20|2008|14-mer|Kd=19+/-2uM, SCAF8 bound to RNA polymerase II CTD phosphorylated at Ser2, Ser5; incomplete ligand|Q9UPN6|RNA-BINDING PROTEIN 16|4.72|Kd=19uM|Kd|=|19|uM|19000|nM
3F9W|1.60|2008|10-mer|Kd=19+/-2uM, SETD8(Y334F) with Histone H4(H4K20)|Q9NQR1|HISTONE-LYSINE N-METHYLTRANSFERASE SETD8|4.72|Kd=19uM|Kd|=|19|uM|19000|nM
3D9O|2.00|2008|14-mer|Kd>1mM, SCAF8(N15M/Y17M) bound to RNA polymerase II CTD unphosphorylated; incomplete ligand|Q9UPN6|RNA-BINDING PROTEIN 16|3.0|Kd=1mM|Kd|=|1|mM|1000000|nM
3BZE|2.50|2008|9-mer||P13747|HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, ALPHA|6.0|Kd=1uM|Kd|=|1|uM|1000|nM
3DS1|1.60|2008|12-mer|Kd=2.0+/-0.1uM, ligand is Peptide inhibitor of capsid assembly(CAI); incomplete ligand|Q72497|HIV-1 CAPSID PROTEIN|5.7|Kd=2.0uM|Kd|=|2|uM|2000|nM
2K0X|NMR|2008|PNS|Kd=2.1+/-0.1uM, 2k0x is not a complex, only act holo-ACP|Q02054|ACTINORHODIN POLYKETIDE SYNTHASE ACYL CARRIER|5.68|Kd=2.1uM|Kd|=|2.1|uM|2100|nM
3B5J|2.00|2008|12D|Kd=2.1+/-0.6uM|P08716|ALPHA-HEMOLYSIN TRANSLOCATION ATP-BINDING|5.68|Kd=2.1uM|Kd|=|2.1|uM|2100|nM
2VPG|1.60|2008|18-mer|Kd=2.1+/-0.1uM; incomplete ligand|Q9Y3Y4|PYGOPUS HOMOLOG 1|5.68|Kd=2.1uM|Kd|=|2.1|uM|2100|nM
3F17|1.10|2008|HS4||P39900|MACROPHAGE METALLOELASTASE (MMP-12)|8.63|Kd=2.36nM|Kd|=|2.36|nM|2.36|nM
3BUX|1.35|2008|13-mer|incomplete ligand|P08581|13-MERIC PEPTIDE FROM HEPATOCYTE GROWTH FACTOR|5.63|Kd=2.36uM|Kd|=|2.36|uM|2360|nM
2QRY|2.25|2008|TPS|Kd=2.3+/-0.6nM|P31550|THIAMINE-BINDING PERIPLASMIC PROTEIN|8.64|Kd=2.3nM|Kd|=|2.3|nM|2.3|nM
2REG|1.90|2008|CHT|Kd=2.3+/-1.0uM|Q92N37|PUTATIVE GLYCINE BETAINE-BINDING ABC TRANSPORTER|5.64|Kd=2.3uM|Kd|=|2.3|uM|2300|nM
3BHO|1.80|2008|B4P|Kd=2.44+/-0.49uM|O43809|CLEAVAGE AND POLYADENYLATION SPECIFICITY FACTOR|5.61|Kd=2.44uM|Kd|=|2.44|uM|2440|nM
3BTJ|2.98|2008|DEQ|Kd=2.4+/-0.2uM|P0A0N3|HTH-TYPE TRANSCRIPTIONAL REGULATOR QACR|5.62|Kd=2.4uM|Kd|=|2.4|uM|2400|nM
3C6W|1.75|2008|12-mer|Kd=2.4+/-1.0uM; incomplete ligand|Q8WYH8|INHIBITOR OF GROWTH PROTEIN 5|5.62|Kd=2.4uM|Kd|=|2.4|uM|2400|nM
2JST|NMR|2008|HLT|Kd=2.6+/-1.7mM|------|FOUR-ALPHA-HELIX BUNDLE|2.59|Kd=2.6mM|Kd|=|2.6|mM|2600000|nM
3BEX|1.51|2008|PAU|TmPanK-III dimer, Kd1=2.7+/-0.16uM; Kd2=6.4+/-0.24uM|Q9WZY5|TYPE III PANTOTHENATE KINASE|5.57|Kd=2.7uM|Kd|=|2.7|uM|2700|nM
3COZ|2.00|2008|54H|Kd=2.7+/-0.1uM; Ki=18+/-3uM|P0A5R0|PANTOTHENATE SYNTHETASE|5.57|Kd=2.7uM|Kd|=|2.7|uM|2700|nM
3BXF|1.70|2008|FBP|protein from Bacillus subtilis; Kd=2.87+/-0.06uM|O32253|CENTRAL GLYCOLYTIC GENE REGULATOR|5.54|Kd=2.87uM|Kd|=|2.87|uM|2870|nM
2RIO|2.40|2008|ADP||P32361|SERINE/THREONINE-PROTEIN KINASE/ENDORIBONUCLEASE|4.69|Kd=20.4uM|Kd|=|20.4|uM|20400|nM
3BRA|2.30|2008|AEF||P56817|BETA-SECRETASE 1|2.7|Kd=2000uM|Kd|=|2000|uM|2000000|nM
2EMT|2.80|2008|18-mer|incomplete ligand|P26043|RADIXIN|6.7|Kd=201nM|Kd|=|201|nM|201|nM
3CLP|2.00|2008|CMP|R307A mutant Kd=205.1+/-10.4uM, R307E was even more severely reduced|Q98GN8|MLL3241 PROTEIN|3.69|Kd=205.1uM|Kd|=|205.1|uM|205100|nM
3F3E|1.80|2008|LEU||O67854|TRANSPORTER|7.7|Kd=20nM|Kd|=|20|nM|20|nM
2K62|NMR|2008|ITL|low Kd to 20uM|P80226|LIVER FATTY ACID-BINDING PROTEIN|4.7|Kd=20uM|Kd|=|20|uM|20000|nM
2QFO|1.68|2008|A13|Kd(A13)=20+/-10uM, Ki(A13)=18+/-1uM; Kd(A51)=150+/-20uM|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|4.7|Kd=20uM|Kd|=|20|uM|20000|nM
3EW2|2.30|2008|BTN|X-ray(Rhizavidin-Biotin) while Kd(2-iminobiotin)|Q8KKW2|RHIZAVIDIN|6.67|Kd=215nM|Kd|=|215|nM|215|nM
2RNY|NMR|2008|15-mer|Kd=213+/-13uM|Q92793|CREB-BINDING PROTEIN|3.66|Kd=218uM|Kd|=|218|uM|218000|nM
2QV7|2.30|2008|ADP|Kd=219+/-34uM|Q6GFF9|DIACYLGLYCEROL KINASE DGKB|3.66|Kd=219uM|Kd|=|219|uM|219000|nM
3F8C|2.20|2008|HT1|Kd=21+/-8nM|A2RI36|TRANSCRIPTIONAL REGULATOR, PADR-LIKE FAMILY|7.68|Kd=21nM|Kd|=|21|nM|21|nM
3FAT|1.90|2008|AMQ|Kd=22.8+/-1.5nM|P19493|GLUTAMATE RECEPTOR 4|7.64|Kd=22.8nM|Kd|=|22.8|nM|22.8|nM
3ERY|1.95|2008|9-mer|Kd=2200+/-260nM(ITC); Kd=1600+/-200nM(SPR equilibrium analysis); Kd=3400+/-500nM (SPR kinetic analysis)|Q02218|H-2 CLASS I HISTOCOMPATIBILITY ANTIGEN|5.66|Kd=2200nM|Kd|=|2200|nM|2200|nM
3BUH|2.30|2008|AED||P56817|BETA-SECRETASE 1|3.66|Kd=220uM|Kd|=|220|uM|220000|nM
3CF1|4.40|2008|ADP|Kd=230-630nM|Q01853|TRANSITIONAL ENDOPLASMIC RETICULUM ATPASE|6.64|Kd=230nM|Kd|=|230|nM|230|nM
3F8F|2.20|2008|DM1|Kd=236+/-53nM|A2RI36|TRANSCRIPTIONAL REGULATOR, PADR-LIKE FAMILY|6.63|Kd=236nM|Kd|=|236|nM|236|nM
2Z4R|3.05|2008|ADP||P46798|CHROMOSOMAL REPLICATION INITIATOR PROTEIN DNAA|7.62|Kd=24nM|Kd|=|24|nM|24|nM
2K00|NMR|2008|15-mer|Kd1=15uM(pH=6.1; stopped-flow fluorescence); Kd2=24uM(pH=6.5; stopped-flow fluorescence); Kd3=23uM(ITC).|P54939|TALIN-1|4.62|Kd=24uM|Kd|=|24|uM|24000|nM
3CWK|1.60|2008|REA|Kd=250+/-19nM|P29373|CELLULAR RETINOIC ACID-BINDING PROTEIN 2|6.6|Kd=250nM|Kd|=|250|nM|250|nM
2PYY|2.10|2008|GLU||D0VWX9|IONOTROPIC GLUTAMATE RECEPTOR BACTERIAL HOMOLOGUE|4.6|Kd=25uM|Kd|=|25|uM|25000|nM
2R1W|1.70|2008|KDB|solution affinity|Q52L64|ANTIBODY FAB FRAGMENT (IGG1K), LIGHT CHAIN|4.6|Kd=25uM|Kd|=|25|uM|25000|nM
3D7K|2.49|2008|D7K||Q9F4L3|BENZALDEHYDE LYASE|4.6|Kd=25uM|Kd|=|25|uM|25000|nM
3CDA|2.07|2008|8HI|IC50=3.0nM|P04035|3-HYDROXY-3-METHYLGLUTARYL-COENZYME A REDUCTASE|7.58|Kd=26.3nM|Kd|=|26.3|nM|26.3|nM
2K46|NMR|2008|NGR|Kd=26.3+/-0.7uM|Q6INX3|MGC80075 PROTEIN|4.58|Kd=26.3uM|Kd|=|26.3|uM|26300|nM
3CD0|2.40|2008|6HI|IC50=2.9nM|P04035|3-HYDROXY-3-METHYLGLUTARYL-COENZYME A REDUCTASE|7.57|Kd=26.9nM|Kd|=|26.9|nM|26.9|nM
2V7D|2.50|2008|10-mer|incomplete ligand|P63103|14-3-3 PROTEIN ZETA/DELTA|6.59|Kd=260nM|Kd|=|260|nM|260|nM
3CCT|2.12|2008|3HI||P04035|3-HYDROXY-3-METHYLGLUTARYL-COENZYME A REDUCTASE|7.56|Kd=27.4nM|Kd|=|27.4|nM|27.4|nM
2JIU|3.05|2008|AEE|Kd=27.6+/-0.7nM|P00533|EPIDERMAL GROWTH FACTOR RECEPTOR|7.56|Kd=27.6nM|Kd|=|27.6|nM|27.6|nM
2PYN|1.85|2008|1UN|Kd=27+/-5nM; Ki=7.0+/-0.4nM.|P03367|HIV-1 PROTEASE|7.57|Kd=27nM|Kd|=|27|nM|27|nM
3B2Q|2.10|2008|ATP|Kd=28+/-2uM|Q60187|V-TYPE ATP SYNTHASE BETA CHAIN|4.55|Kd=28uM|Kd|=|28|uM|28000|nM
3D9P|2.10|2008|14-mer|Kd=29+/-3uM, SCAF8(R112T) bound to RNA polymerase II CTD phosphorylated at Ser2, Ser5; incomplete ligand|Q9UPN6|RNA-BINDING PROTEIN 16|4.54|Kd=29uM|Kd|=|29|uM|29000|nM
3BRN|2.00|2008|SRO|monotonin in complex with (5-HT)serotonin, Kd<=2nM|Q09JR9|LIPOCALIN|8.7|Kd=2nM|Kd|=|2|nM|2|nM
2ZBK|3.56|2008|RDC|Kd=2-2.3uM|O05208|TYPE II DNA TOPOISOMERASE VI SUBUNIT A|5.7|Kd=2uM|Kd|=|2|uM|2000|nM
3C4H|2.10|2008|DRL|Kd=2+/-0.2uM|Q9Y6F1|POLY [ADP-RIBOSE] POLYMERASE 3|5.7|Kd=2uM|Kd|=|2|uM|2000|nM
3EKS|1.80|2008|CY9|Kd=2~20uM|P10987|ACTIN-5C|5.7|Kd=2uM|Kd|=|2|uM|2000|nM
2Q64|2.50|2008|1UN|Kd=3.0+/-0.5nM; Ki=1.4+/-0.2nM.|P03367|HIV-1 PROTEASE|8.52|Kd=3.0nM|Kd|=|3|nM|3|nM
3C1N|2.72|2008|THR|The Allosteric Binding Sites; for the primary binding site, Kd=3.13+/-0.16 uM; for the secondary binding site, Kd=30.5+/-0.03uM|Q57991|PROBABLE ASPARTOKINASE|5.5|Kd=3.13uM|Kd|=|3.13|uM|3130|nM
2QTR|1.70|2008|NXX|Kd=3.2+/-0.8uM, nicotinate adenine dinucleotide (NaAD)|Q6HT60|NICOTINATE (NICOTINAMIDE) NUCLEOTIDE ADENYLYLTRANSFERASE|5.49|Kd=3.2uM|Kd|=|3.2|uM|3200|nM
3BVB|1.30|2008|017|Ka=(3.17+/-0.29)e+5M-1|P03367|HIV-1 PROTEASE|5.49|Kd=3.2uM|Kd|=|3.2|uM|3200|nM
3BXE|1.80|2008|13P|protein from Bacillus subtilis; Kd=3.34+/-0.15uM|O32253|CENTRAL GLYCOLYTIC GENE REGULATOR|5.48|Kd=3.34uM|Kd|=|3.34|uM|3340|nM
2QIC|2.10|2008|12-mer|Kd=3.3+/-1.6uM; incomplete ligand|Q9UK53|INHIBITOR OF GROWTH PROTEIN 1|5.48|Kd=3.3uM|Kd|=|3.3|uM|3300|nM
2ZKJ|2.00|2008|ADP|Kd=3.3+/-0.7uM(without AZD7545); Kd=5.9+/-0.9uM(with AZD7545)|Q16654|PYRUVATE DEHYDROGENASE [LIPOAMIDE] KINASE|5.48|Kd=3.3uM|Kd|=|3.3|uM|3300|nM
3D2R|2.03|2008|ADP|Kd=3.3+/-0.7uM(without AZD7545); Kd=5.9+/-0.9uM(with AZD7545); redundant to 2zkj|Q16654|PYRUVATE DEHYDROGENASE [LIPOAMIDE] KINASE|5.48|Kd=3.3uM|Kd|=|3.3|uM|3300|nM
2VC9|2.36|2008|NOK|Kd=3.6+/-0.3nM; Ki=21nM|Q0TST1|ALPHA-N-ACETYLGLUCOSAMINIDASE|8.44|Kd=3.6nM|Kd|=|3.6|nM|3.6|nM
2VPO|1.80|2008|6CS|Kd=3.80+/-0.07uM|Q8VPB3|PERIPLASMIC SUBSTRATE BINDING PROTEIN|5.42|Kd=3.8uM|Kd|=|3.8|uM|3800|nM
3BZF|2.50|2008|9-mer||P13747|HLA CLASS I HISTOCOMPATIBILITY ANTIGEN|4.52|Kd=30uM|Kd|=|30|uM|30000|nM
2R0H|1.90|2008|CTO|Kd=310+/-4uM|Q206Z5|CGL3 LECTIN|3.51|Kd=310uM|Kd|=|310|uM|310000|nM
2R1Y|1.60|2008|2-mer|ligand is KDO-KDR|Q52L64|ANTIBODY FAB FRAGMENT|4.51|Kd=31uM|Kd|=|31|uM|31000|nM
3F9Y|1.50|2008|10-mer|Kd=32+/-1uM, SETD8(Y334F) with Histone H4(H4K20me1); incomplete ligand|Q9NQR1|HISTONE-LYSINE N-METHYLTRANSFERASE SETD8|4.49|Kd=32uM|Kd|=|32|uM|32000|nM
3D9M|1.75|2008|14-mer|Kd=330+/-50uM, SCAF8 bound to RNA polymerase II CTD phosphorylated at Ser5; incomplete ligand|Q9UPN6|RNA-BINDING PROTEIN 16|3.48|Kd=330uM|Kd|=|330|uM|330000|nM
3D32|1.30|2008|12-mer||O95166|GAMMA-AMINOBUTYRIC ACID RECEPTOR-ASSOCIATED PROTEIN|6.45|Kd=354nM|Kd|=|354|nM|354|nM
2ZIT|3.00|2008|NAD|eEF2-ExoA-NAD+ complex, Kd=35+/-3uM|P32324|ELONGATION FACTOR 2|4.46|Kd=35uM|Kd|=|35|uM|35000|nM
3B82|2.35|2008|NAD|eEF2-ExoA(E546H mutant)-NAD+ complex, relative kd=1.03 fold of 35+/-3uM|P32324|ELONGATION FACTOR 2|4.43|Kd=37uM|Kd|=|37|uM|37000|nM
2QTN|2.40|2008|NCN|Kd=382+/-38uM for nicotinate mononucleotide (NaMN)|Q6HT60|NICOTINATE (NICOTINAMIDE) NUCLEOTIDE ADENYLYLTRANSFERASE|3.42|Kd=382uM|Kd|=|382|uM|382000|nM
2ZDM|1.93|2008|46U|ligand is compound 2b(closed form); Kd=386+/-49nM; Ki=208+/-92nM|P00760|TRYPSIN|6.41|Kd=386nM|Kd|=|386|nM|386|nM
3F18|1.13|2008|HS5||P39900|MACROPHAGE METALLOELASTASE (MMP-12)|7.4|Kd=39.5nM|Kd|=|39.5|nM|39.5|nM
3BF1|2.30|2008|ADP|TmPanK-III-Pan-ADP ternary complex; Kd=3+/-0.5mM|Q9WZY5|TYPE III PANTOTHENATE KINASE|2.52|Kd=3mM|Kd|=|3|mM|3000000|nM
2VW5|1.90|2008|BC6|ligand is compound 5|P02829|HEAT SHOCK PROTEIN HSP82|8.52|Kd=3nM|Kd|=|3|nM|3|nM
2VNF|1.76|2008|10-mer|Kd=3+/-0.6uM, Calorimetric titrations H310K4me3 Kd=6.4+/-0.8uM; incomplete ligand|Q9UNL4|INHIBITOR OF GROWTH PROTEIN 4|5.52|Kd=3uM|Kd|=|3|uM|3000|nM
3B4P|1.70|2008|3B4|Kd=4.0+/-0.6uM|Q396C9|PHENAZINE BIOSYNTHESIS PROTEIN A/B|5.4|Kd=4.0uM|Kd|=|4|uM|4000|nM
3F6E|1.34|2008|8PA||P20906|BENZOYLFORMATE DECARBOXYLASE|2.38|Kd=4.14mM|Kd|=|4.14|mM|4139999.9999999995|nM
2ZDL|1.80|2008|45U|ligand is compound 2a(closed form); Kd=402+/-78nM; Ki=285+/-74nM|P00760|TRYPSIN|6.4|Kd=402nM|Kd|=|402|nM|402|nM
2RNX|NMR|2008|13-mer|Kd=402+/-93uM|Q92831|HISTONE ACETYLTRANSFERASE PCAF|3.4|Kd=402uM|Kd|=|402|uM|402000|nM
2QHR|2.00|2008|11-mer|IC50 .5uM|P01844|13F6-1-2 FAB FRAGMENT HEAVY CHAIN|7.39|Kd=41nM|Kd|=|41|nM|41|nM
3C3R|2.02|2008|13-mer|Kd=41+/-10uM|Q8WUM4|PROGRAMMED CELL DEATH 6-INTERACTING PROTEIN|4.39|Kd=41uM|Kd|=|41|uM|41000|nM
2PR9|2.51|2008|10-mer||P84092|AP-2 COMPLEX SUBUNIT MU-1|7.37|Kd=42.2nM|Kd|=|42.2|nM|42.2|nM
2ZDK|1.67|2008|50U|ligand is compound 3b(closed form); Kd=428+/-38nM; Ki=226+/-119nM|P00760|TRYPSIN|6.37|Kd=428nM|Kd|=|428|nM|428|nM
3DP4|2.11|2008|AMQ|Kd=43+/-5nM|P19492|GLUTAMATE RECEPTOR 3|7.37|Kd=43nM|Kd|=|43|nM|43|nM
2ZIF|2.40|2008|SAM||Q5SL84|PUTATIVE MODIFICATION METHYLASE|4.37|Kd=43uM|Kd|=|43|uM|43000|nM
3C3O|2.15|2008|13-mer|Kd=44+/-6uM|Q8WUM4|PROGRAMMED CELL DEATH 6-INTERACTING PROTEIN|4.36|Kd=44uM|Kd|=|44|uM|44000|nM
3FEG|1.30|2008|HC7|ligand is HC-3; Kd=45+/-5uM; Ki=116+/-15uM|Q9Y259|CHOLINE/ETHANOLAMINE KINASE|4.35|Kd=45uM|Kd|=|45|uM|45000|nM
3C3Q|2.10|2008|18-mer|Kd=48+/-6uM|Q8WUM4|PROGRAMMED CELL DEATH 6-INTERACTING PROTEIN|4.32|Kd=48uM|Kd|=|48|uM|48000|nM
3BBF|1.70|2008|GDP|Kd=5.2+/-0.8uM|P22392|NUCLEOSIDE DIPHOSPHATE KINASE B|5.28|Kd=5.2uM|Kd|=|5.2|uM|5200|nM
3COJ|3.21|2008|13-mer|incomplete ligand|P38398|BREAST CANCER TYPE 1 SUSCEPTIBILITY PROTEIN|5.28|Kd=5.2uM|Kd|=|5.2|uM|5200|nM
2OZ6|2.80|2008|CMP||P55222|VIRULENCE FACTOR REGULATOR|5.26|Kd=5.5uM|Kd|=|5.5|uM|5500|nM
2VCB|2.20|2008|OAN|Ki=6.2+/-0.1uM, Kd=5.5+/-0.3uM|Q0TST1|ALPHA-N-ACETYLGLUCOSAMINIDASE|5.26|Kd=5.5uM|Kd|=|5.5|uM|5500|nM
2K3W|NMR|2008|16-mer|Kd=5.8+/-0.8uM; incomplete ligand|Q9UN37|VACUOLAR PROTEIN SORTING-ASSOCIATING PROTEIN 4A|5.24|Kd=5.8uM|Kd|=|5.8|uM|5800|nM
3F16|1.16|2008|HS3|Kd=5.91nM(D); Kd=41.5nM(L)|P39900|MACROPHAGE METALLOELASTASE (MMP-12)|8.23|Kd=5.91nM|Kd|=|5.91|nM|5.91|nM
2VVN|1.85|2008|NHT||Q89ZI2|O-GLCNACASE BT_4395|7.3|Kd=50nM|Kd|=|50|nM|50|nM
2Q7Y|1.95|2008|IGC||P11609|T-CELL SURFACE GLYCOPROTEIN CD1D1|4.3|Kd=50uM|Kd|=|50|uM|50000|nM
3CCZ|1.70|2008|5HI|IC50=1.1nM|P04035|3-HYDROXY-3-METHYLGLUTARYL-COENZYME A REDUCTASE|7.29|Kd=51.7nM|Kd|=|51.7|nM|51.7|nM
3F48|1.90|2008|ALA||O67854|TRANSPORTER|6.29|Kd=512nM|Kd|=|512|nM|512|nM
3CR4|2.15|2008|PNT|ITC Pnt Kd=53+/-10uM, fluorescence Pnt Kd=39+/-3uM|P02638|PROTEIN S100-B|4.28|Kd=53uM|Kd|=|53|uM|53000|nM
2ZDN|1.98|2008|49U|ligand is compound 3a(closed form); Kd1=562+/-66nM; Kd2=584+/-107nM(Tricine); Kd3=506+/-34M(Hepes); Kd4=416+/-42nM(PPi); Ki=290+/-65nM|P00760|TRYPSIN|6.25|Kd=562nM|Kd|=|562|nM|562|nM
2QBW|1.80|2008|8-mer|Kd=56+/-5nM; IC50=40nM|Q96RT1|PDZ-FIBRONECTIN FUSION PROTEIN|7.25|Kd=56nM|Kd|=|56|nM|56|nM
3BJM|2.35|2008|BJM|ITC Kd<=5nM, while Ki=500pM|P27487|DIPEPTIDYL PEPTIDASE 4|8.3|Kd=5nM|Kd|=|5|nM|5|nM
3BTR|2.60|2008|15-mer|Kd=5+/-0.1uM|P52293|IMPORTIN SUBUNIT ALPHA-2|5.3|Kd=5uM|Kd|=|5|uM|5000|nM
3DS3|2.70|2008|12-mer|Kd=6.0+/-0.4uM, ligand is Peptide inhibitor of capsid assembly(CAI)|Q72497|HIV-1 CAPSID PROTEIN|5.22|Kd=6.0uM|Kd|=|6|uM|6000|nM
3B2T|1.80|2008|M33|Kd=6.21+/-2.1uM|P21802|FIBROBLAST GROWTH FACTOR RECEPTOR 2|5.21|Kd=6.21uM|Kd|=|6.21|uM|6210|nM
2PQJ|2.80|2008|ADE|Kd=6.33+/-0.73nM; IC50=0.37uM|P25891|RIBOSOME-INACTIVATING PROTEIN 3|8.2|Kd=6.33nM|Kd|=|6.33|nM|6.33|nM
3BLR|2.80|2008|CPB|ligand is Flavopiridol|P50750|CYCLIN-DEPENDENT KINASE 9|8.19|Kd=6.4nM|Kd|=|6.4|nM|6.4|nM
3CTR|2.10|2008|MGP|Kd=6.94+/-2.08uM|O95453|POLY(A)-SPECIFIC RIBONUCLEASE PARN|5.16|Kd=6.94uM|Kd|=|6.94|uM|6940|nM
2JB5|2.80|2008|T5C|MOR03268:TSC 1:1 complex, Kd=600+/-300pM|P01857|ANTIBODY FAB FRAGMENT MOR03268 HEAVY CHAIN|9.22|Kd=600pM|Kd|=|600|pM|0.6|nM
3CYU|1.70|2008|0CR|Kd=60+/-20nM|P00918|CARBONIC ANHYDRASE 2|7.22|Kd=60nM|Kd|=|60|nM|60|nM
3F80|1.60|2008|6HN||P05089|ARGINASE-1|4.22|Kd=60uM|Kd|=|60|uM|60000|nM
3F1A|1.25|2008|HS7||P39900|MACROPHAGE METALLOELASTASE (MMP-12)|7.21|Kd=61.1nM|Kd|=|61.1|nM|61.1|nM
3B8H|2.50|2008|NAD|eEF2-ExoA(E546A mutant)-NAD+ complex, relative kd=1.77 fold of 35+/-3uM|P32324|ELONGATION FACTOR 2|4.2|Kd=63.7uM|Kd|=|63.7|uM|63700|nM
2PQB|1.80|2008|GG9|Kd=63+/-15nM|Q9R4E4|3-PHOSPHOSHIKIMATE 1-CARBOXYVINYLTRANSFERASE|7.2|Kd=63nM|Kd|=|63|nM|63|nM
3C79|2.48|2008|IM4|dissociation kinetics Kd=63nM; association kinetics Kd=68+/-23nM|Q8WSF8|ACETYLCHOLINE RECEPTOR|7.2|Kd=63nM|Kd|=|63|nM|63|nM
3EOV|2.60|2008|11-mer|Kd=63nM (Fluorescence), 15.15nM(ITC)|Q9U9R3|PEPTIDYL-PROLYL CIS-TRANS ISOMERASE|7.2|Kd=63nM|Kd|=|63|nM|63|nM
2R2B|1.60|2008|3-mer|ligand is KDA-KDO-KDO|Q52L64|ANTIBODY FAB FRAGMENT|4.2|Kd=63uM|Kd|=|63|uM|63000|nM
3DS4|1.12|2008|12-mer|Kd=64.5+/-21.8uM, ligand is Peptide inhibitor of capsid assembly(CAI)|Q72497|HIV-1 CAPSID PROTEIN|4.19|Kd=64.5uM|Kd|=|64.5|uM|64500|nM
2PMC|2.69|2008|15-mer|X-ray structure:CheY-CheZC15; Kd1=64.7+/-3.1uM(CheY-CheZC15); Kd2=13.2+/-2.1uM(P-CheY-CheZC15); incomplete ligand|P0A2D5|CHEMOTAXIS PROTEIN CHEY|4.19|Kd=64.7uM|Kd|=|64.7|uM|64700|nM
3CR5|1.85|2008|PNT|Kd=64+/-15uM(low salt; ITC); Kd=35+/-12uM(high salt; ITC);|P02638|PROTEIN S100-B|4.19|Kd=64uM|Kd|=|64|uM|64000|nM
3F19|1.13|2008|HS6||P39900|MACROPHAGE METALLOELASTASE (MMP-12)|7.19|Kd=65.1nM|Kd|=|65.1|nM|65.1|nM
2QHM|2.00|2008|7CS||O14757|SERINE/THREONINE-PROTEIN KINASE CHK1|6.18|Kd=660nM|Kd|=|660|nM|660|nM
3BUG|2.50|2008|AEH||P56817|BETA-SECRETASE 1|3.18|Kd=660uM|Kd|=|660|uM|660000|nM
2Q63|2.20|2008|1UN|Kd=66+/-8nM; Ki=9.9+/-0.7nM.|P03367|HIV-1 PROTEASE|7.18|Kd=66nM|Kd|=|66|nM|66|nM
2PL9|2.60|2008|19-mer|X-ray structure:CheY-CheZC19; Kd1=67.4+/-4.5uM(CheY-CheZC19); Kd2=2.2+/-0.2uM(P-CheY-CheZC19).|P0A2D5|CHEMOTAXIS PROTEIN CHEY|4.17|Kd=67.4uM|Kd|=|67.4|uM|67400|nM
2VXJ|1.90|2008|3-mer|Kd by ITC|Q05097|PA-I GALACTOPHILIC LECTIN|4.17|Kd=68uM|Kd|=|68|uM|68000|nM
3D9L|2.20|2008|14-mer|Kd=68+/-8uM, SCAF8 bound to RNA polymerase II CTD phosphorylated at Ser2; incomplete ligand|Q9UPN6|RNA-BINDING PROTEIN 16|4.17|Kd=68uM|Kd|=|68|uM|68000|nM
3F3D|2.30|2008|MET||O67854|TRANSPORTER|7.16|Kd=69nM|Kd|=|69|nM|69|nM
2RFY|1.70|2008|CBI||Q8J0K6|CELLULOSE 1,4-BETA-CELLOBIOSIDASE|5.22|Kd=6uM|Kd|=|6|uM|6000|nM
3BU1|1.40|2008|HSM|Kd=7.1+/-1.0nM|Q09JX9|LIPOCALIN|8.15|Kd=7.1nM|Kd|=|7.1|nM|7.1|nM
2ZJV|2.70|2008|CT4|Kd=7.26+/-1.13uM, n=3|P58154|ACETYLCHOLINE-BINDING PROTEIN|5.14|Kd=7.26uM|Kd|=|7.26|uM|7260|nM
2K2G|NMR|2008|DSV||P39900|MACROPHAGE METALLOELASTASE|8.12|Kd=7.5nM|Kd|=|7.5|nM|7.5|nM
3F15|1.70|2008|HS1||P39900|MACROPHAGE METALLOELASTASE (MMP-12)|8.1|Kd=7.88nM|Kd|=|7.88|nM|7.88|nM
2PNX|1.80|2008|12-mer|PHD finger of ING4 complex with an H3K4Me3 histone peptide, Kd=7.9+/-2uM; incomplete ligand|Q9UNL4|INHIBITOR OF GROWTH PROTEIN 4|5.1|Kd=7.9uM|Kd|=|7.9|uM|7900|nM
2R75|1.40|2008|01G|Kd=714+/-51nM; IC50(Polymerization)=139uM; IC50(GTPase); =179+/-15uM.|O66809|CELL DIVISION PROTEIN FTSZ|6.15|Kd=714nM|Kd|=|714|nM|714|nM
3CGY|2.60|2008|RDC|Kd=715+/-78uM|P14147|VIRULENCE SENSOR HISTIDINE KINASE PHOQ|3.15|Kd=715uM|Kd|=|715|uM|715000|nM
3D2T|1.85|2008|1FL||P02766|TRANSTHYRETIN|7.12|Kd=75nM|Kd|=|75|nM|75|nM
3B95|2.99|2008|15-mer|Kd=7+/-1uM; incomplete ligand|Q5VT56|EUCHROMATIC HISTONE-LYSINE N-METHYLTRANSFERASE 1|5.15|Kd=7uM|Kd|=|7|uM|7000|nM
3E6K|2.10|2008|ABH||P05089|ARGINASE-1|5.15|Kd=7uM|Kd|=|7|uM|7000|nM
2ZG1|2.70|2008|SIA||O15389|SIALIC ACID-BINDING IG-LIKE LECTIN 5|2.1|Kd=8.0mM|Kd|=|8|mM|8000000|nM
2ZG3|3.00|2008|SIA||O15389|SIALIC ACID-BINDING IG-LIKE LECTIN 5|2.06|Kd=8.7mM|Kd|=|8.7|mM|8700000|nM
3D62|2.70|2008|959|Ki=400+/-71nM; incomplete ligand structure|P59641|3C-LIKE PROTEINASE|6.1|Kd=800nM|Kd|=|800|nM|800|nM
3BUF|2.30|2008|AEG||P56817|BETA-SECRETASE 1|3.1|Kd=800uM|Kd|=|800|uM|800000|nM
3B78|2.50|2008|NAD|eEF2-ExoA(R551H mutant)-NAD+ complex, relative kd=2.29 fold of 35+/-3uM|P32324|ELONGATION FACTOR 2|4.1|Kd=80uM|Kd|=|80|uM|80000|nM
3CK7|2.10|2008|ACX|Kd=89+/-4uM|Q8A1G2|SUSD|4.05|Kd=89uM|Kd|=|89|uM|89000|nM
2QT5|2.30|2008|9-mer|Kd=9.4+/-0.3uM; incomplete ligand|P97879|GLUTAMATE RECEPTOR-INTERACTING PROTEIN 1|5.03|Kd=9.4uM|Kd|=|9.4|uM|9400|nM
3D9N|1.60|2008|14-mer|Kd=90+/-4uM, SCAF8 bound to RNA polymerase II CTD phosphorylated at Ser7; incomplete ligand|Q9UPN6|RNA-BINDING PROTEIN 16|4.05|Kd=90uM|Kd|=|90|uM|90000|nM
3BXH|1.85|2008|F6P|protein from Bacillus subtilis; Kd=94.34+/-3.1uM|O32253|CENTRAL GLYCOLYTIC GENE REGULATOR|4.03|Kd=94.34uM|Kd|=|94.34|uM|94340|nM
3DSU|1.90|2008|FPP|RabGGTase-FPP complex, co-titration Kd=94+/-14nM, displacement titration Kd=75+/-10nM|Q08602|GERANYLGERANYL TRANSFERASE TYPE-2 SUBUNIT ALPHA|7.03|Kd=94nM|Kd|=|94|nM|94|nM
3EYF|2.30|2008|11-mer|Kd1=94nM(T=297K; ITC); Kd2=43nM(T=287K; ITC); Kd3=240nM(T=307K; ITC); Kd4=34nM(T=285K; Biacore analysis); Kd5=120nM(T=297K; Biacore analysis); incomplete ligand|P13201|8F9 FAB|7.03|Kd=94nM|Kd|=|94|nM|94|nM
3CDB|2.30|2008|9HI|IC50=5.82nM|P04035|3-HYDROXY-3-METHYLGLUTARYL-COENZYME A REDUCTASE|7.02|Kd=95.7nM|Kd|=|95.7|nM|95.7|nM
2QBP|2.50|2008|527||P18031|PROTEIN-TYROSINE PHOSPHATASE 1B|8.4|Ki=0.004uM|Ki|=|0.004|uM|4|nM
3E0P|1.70|2008|B3C|compound 23|Q16651|PROSTASIN|7.92|Ki=0.012uM|Ki|=|0.012|uM|12|nM
3C56|2.30|2008|PH4|ligand is compound 2|P56109|FRUCTOSE-BISPHOSPHATE ALDOLASE|7.89|Ki=0.013uM|Ki|=|0.013|uM|13|nM
2QI5|1.85|2008|MZ7|ligand is inhibitor 32c|O38732|HIV-1 PROTEASE|10.85|Ki=0.014nM|Ki|=|0.014|nM|0.014|nM
2QI6|1.85|2008|MZ8|ligand is inhibitor 28a|O38732|HIV-1 PROTEASE|10.57|Ki=0.027nM|Ki|=|0.027|nM|0.027|nM
2QI4|1.80|2008|MZ6|ligand is inhibitor 30a|O38732|HIV-1 PROTEASE|10.44|Ki=0.036nM|Ki|=|0.036|nM|0.036|nM
2QBQ|2.10|2008|4B3||P18031|PROTEIN-TYROSINE PHOSPHATASE 1B|7.44|Ki=0.036uM|Ki|=|0.036|uM|36|nM
2R38|1.81|2008|G4G|compound 9 in complex with HIV-1 protease I84V|Q5RZ08|HIV-1 PROTEASE|7.44|Ki=0.036uM|Ki|=|0.036|uM|36|nM
3EKR|2.00|2008|PY9|ligand is compound 14; Ki=0.03uM, IC50=0.06uM, cell IC50=4uM|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|7.52|Ki=0.03uM|Ki|=|0.03|uM|30|nM
2P59|2.90|2008|GG4|Replicon IC50=0.37um|A1Z093|NS3 PROTEASE|7.3|Ki=0.05uM|Ki|=|0.05|uM|50|nM
3C52|2.30|2008|PGH||P56109|FRUCTOSE-BISPHOSPHATE ALDOLASE|7.3|Ki=0.05uM|Ki|=|0.05|uM|50|nM
2QI7|1.85|2008|MZ9|ligand is inhibitor 29b|O38732|HIV-1 PROTEASE|10.21|Ki=0.062nM|Ki|=|0.062|nM|0.062|nM
2QI3|1.95|2008|MZ5|ligand is inhibitor 30d|O38732|HIV-1 PROTEASE|10.2|Ki=0.063nM|Ki|=|0.063|nM|0.063|nM
2QNN|1.48|2008|QN1|ligand is inhibitor 6fg|P03367|HIV-1 PROTEASE|7.15|Ki=0.07uM|Ki|=|0.07|uM|70|nM
2R3W|1.92|2008|G3G|compound 8 in complex with HIV-1 protease I84V|Q5RZ08|HIV-1 PROTEASE|6.89|Ki=0.128uM|Ki|=|0.128|uM|128|nM
2VNP|2.19|2008|DED||Q46822|ISOPENTENYL-DIPHOSPHATE DELTA-ISOMERASE|9.92|Ki=0.12nM|Ki|=|0.12|nM|0.12|nM
3BC3|2.20|2008|OPT|compound 2|P07711|CATHEPSIN L|6.81|Ki=0.155uM|Ki|=|0.155|uM|155|nM
2RFH|1.70|2008|23N||A6H6Y4|CARBOXYPEPTIDASE A|6.82|Ki=0.15uM|Ki|=|0.15|uM|150|nM
2ZQ0|1.60|2008|ACR|Ki=0.15+/-0.03uM|P71094|ALPHA-GLUCOSIDASE SUSB|6.82|Ki=0.15uM|Ki|=|0.15|uM|150|nM
2V2H|1.18|2008|PGA|Ki=0.17+/-0.06mM|P04789|TRIOSEPHOSPHATE ISOMERASE|3.77|Ki=0.17mM|Ki|=|0.17|mM|170000|nM
3E8R|1.90|2008|615||P78536|TNF-ALPHA-CONVERTING ENZYME, ADAM 17|9.74|Ki=0.18nM|Ki|=|0.18|nM|0.18|nM
2QBS|2.10|2008|024||P18031|PROTEIN-TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1|6.68|Ki=0.21uM|Ki|=|0.21|uM|210|nM
2ZA0|1.70|2008|MGI|Ki=0.23+/-0.1uM|A5GZX3|GLYOXALASE I|6.64|Ki=0.23uM|Ki|=|0.23|uM|230|nM
2ZB0|2.10|2008|GK3|IC50=1.5uM|Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|6.62|Ki=0.24uM|Ki|=|0.24|uM|240|nM
2PWR|1.50|2008|G4G|ligand is inhibitor 6fd|P03367|HIV-1 PROTEASE|6.59|Ki=0.26uM|Ki|=|0.26|uM|260|nM
2PVH|2.20|2008|P19||P28523|CASEIN KINASE II, ALPHA SUBUNIT|6.59|Ki=0.26uM|Ki|=|0.26|uM|260|nM
2Z4O|1.60|2008|065|Ki=0.27+/-0.06nM|P03367|HIV-1 PROTEASE|9.57|Ki=0.27nM|Ki|=|0.27|nM|0.27|nM
2PWC|1.78|2008|G3G|ligand is inhibitor 6gd|P03367|HIV-1 PROTEASE|6.57|Ki=0.27uM|Ki|=|0.27|uM|270|nM
3BM8|2.70|2008|PSY|Ki=0.29+/-0.06mM for YopH/PVSN, not D365A mutant|P15273|TYROSINE-PROTEIN PHOSPHATASE YOPH|3.54|Ki=0.29mM|Ki|=|0.29|mM|290000|nM
2VH6|1.95|2008|GSV|ligand is compound 21|P00742|COAGULATION FACTOR XA|9.7|Ki=0.2nM|Ki|=|0.2|nM|0.2|nM
3EKO|1.55|2008|PYU|ligand is compound 1; Ki=0.2uM, IC50=0.4uM, cell IC50 >20uM|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|6.7|Ki=0.2uM|Ki|=|0.2|uM|200|nM
2P4S|2.20|2008|DIH||A4Q998|PURINE NUCLEOSIDE PHOSPHORYLASE|9.51|Ki=0.31nM|Ki|=|0.31|nM|0.31|nM
2R6Y|2.00|2008|LLC|compound LY117018|P03372|ESTROGEN RECEPTOR|9.49|Ki=0.32nM|Ki|=|0.32|nM|0.32|nM
2QF6|3.10|2008|A56|ki=0.32+/-0.04uM|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|6.49|Ki=0.32uM|Ki|=|0.32|uM|320|nM
3BLU|2.00|2008|PVS|Ki=0.35+/-0.06mM|P15273|TYROSINE-PROTEIN PHOSPHATASE YOPH|3.46|Ki=0.35mM|Ki|=|0.35|mM|350000|nM
2PVN|2.00|2008|P63|Ki=0.00035uM|P28523|CASEIN KINASE II, ALPHA SUBUNIT|9.46|Ki=0.35nM|Ki|=|0.35|nM|0.35|nM
3C1K|1.84|2008|T15|compound 15|P00734|PROTHROMBIN|9.44|Ki=0.36nM|Ki|=|0.36|nM|0.36|nM
2PVM|2.00|2008|P29||P28523|CASEIN KINASE II, ALPHA SUBUNIT|6.44|Ki=0.36uM|Ki|=|0.36|uM|360|nM
2V2C|1.89|2008|PGA|Ki=0.39+/-0.14mM|P04789|TRIOSEPHOSPHATE ISOMERASE|3.41|Ki=0.39mM|Ki|=|0.39|mM|390000|nM
2QNP|1.41|2008|QN2|ligand is inhibitor 6af|P03367|HIV-1 PROTEASE|6.41|Ki=0.39uM|Ki|=|0.39|uM|390|nM
2VW1|2.39|2008|DAN||Q54727|SIALIDASE B|3.52|Ki=0.3mM|Ki|=|0.3|mM|300000|nM
3CKP|2.30|2008|012||P56817|BETA-SECRETASE 1|6.35|Ki=0.449uM|Ki|=|0.449|uM|449|nM
2R6W|2.00|2008|LLB|compound LY156681|P03372|ESTROGEN RECEPTOR|9.36|Ki=0.44nM|Ki|=|0.44|nM|0.44|nM
2QBR|2.30|2008|910||P18031|PROTEIN-TYROSINE PHOSPHATASE 1B|6.33|Ki=0.47uM|Ki|=|0.47|uM|470|nM
2W26|2.08|2008|RIV|morpholinone derivative 5, Ki=0.4nM, IC50=0.7nM|P00742|COAGULATION FACTOR XA|9.4|Ki=0.4nM|Ki|=|0.4|nM|0.4|nM
2ZAZ|1.80|2008|GK1|IC50=2.5uM|Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|6.4|Ki=0.4uM|Ki|=|0.4|uM|400|nM
3B65|1.80|2008|3B6|ligand is compound s-24; Ki=0.54+/-0.03nM|P10275|ANDROGEN RECEPTOR|9.27|Ki=0.54nM|Ki|=|0.54|nM|0.54|nM
2VW2|1.70|2008|NHE||Q54727|SIALIDASE B|3.3|Ki=0.5mM|Ki|=|0.5|mM|500000|nM
2OSM|1.60|2008|HTS|compound 4, Ki=0.631+/-0.034uM|P00918|CARBONIC ANHYDRASE 2|6.2|Ki=0.631uM|Ki|=|0.631|uM|631|nM
2QRP|1.86|2008|S06|ligand is compound 4e, Ki=0.63+/-0.02uM|P00489|GLYCOGEN PHOSPHORYLASE|6.2|Ki=0.63uM|Ki|=|0.63|uM|630|nM
3BKL|2.18|2008|KAW||P12821|ANGIOTENSIN-CONVERTING ENZYME|6.17|Ki=0.679uM|Ki|=|0.679|uM|679|nM
2RI9|1.95|2008|LDY||P31723|MANNOSYL-OLIGOSACCHARIDE ALPHA-1,2-MANNOSIDASE|3.22|Ki=0.6mM|Ki|=|0.6|mM|600000|nM
2QNQ|2.30|2008|QN3|ligand is inhibitor 6cd|P03367|HIV-1 PROTEASE|6.11|Ki=0.77uM|Ki|=|0.77|uM|770|nM
2QMG|1.89|2008|SC6|ligand is inhibitor 11; cell line IC50=21nM|P56817|BETA-SECRETASE 1|9.15|Ki=0.7nM|Ki|=|0.7|nM|0.7|nM
3D91|2.20|2008|REM|ligand is compound 12 (remikiren)|P00797|RENIN|9.15|Ki=0.7nM|Ki|=|0.7|nM|0.7|nM
3BH3|2.10|2008|PNH||Q7NSA6|ACETOACETATE DECARBOXYLASE|6.15|Ki=0.7uM|Ki|=|0.7|uM|700|nM
2QD7|1.11|2008|065|Ki=0.80+/-0.06nM|P03367|HIV-1 PROTEASE|9.1|Ki=0.80nM|Ki|=|0.8|nM|0.8|nM
2RKF|1.80|2008|AB1|Ki=0.83+/-0.11nM|A0F7J4|PROTEASE RETROPEPSIN|9.08|Ki=0.83nM|Ki|=|0.83|nM|0.83|nM
3BKK|2.17|2008|KAF||P12821|ANGIOTENSIN-CONVERTING ENZYME|6.08|Ki=0.83uM|Ki|=|0.83|uM|830|nM
2QD8|1.35|2008|065|Ki=0.85+/-0.15nM|P03367|HIV-1 PROTEASE|9.07|Ki=0.85nM|Ki|=|0.85|nM|0.85|nM
3CKE|2.40|2008|FDF||Q9UR08|ARISTOLOCHENE SYNTHASE|6.1|Ki=0.8uM|Ki|=|0.8|uM|800|nM
3BGB|1.90|2008|LJG|ligand is compound 9b|P03367|HIV-1 PROTEASE|6.05|Ki=0.9uM|Ki|=|0.9|uM|900|nM
3D04|2.40|2008|SAK|IC50=2+/-0.1uM, Ki=0.9+/-0.1uM|Q5G940|(3R)-HYDROXYMYRISTOYL-ACYL CARRIER PROTEIN|6.05|Ki=0.9uM|Ki|=|0.9|uM|900|nM
2VQT|2.10|2008|15A|ligand is compound 2a|Q8AAK6|BETA-MANNOSIDASE|6.0|Ki=1.0uM|Ki|=|1|uM|1000|nM
2Z7G|2.52|2008|EH9|ligand is compound 2, (+)-EHNA|P56658|ADENOSINE DEAMINASE|8.95|Ki=1.13nM|Ki|=|1.13|nM|1.13|nM
2QHC|2.80|2008|AB1|Ki=1.1+/-0.3nM|P03367|PROTEASE RETROPEPSIN|8.96|Ki=1.1nM|Ki|=|1.1|nM|1.1|nM
3C2U|1.30|2008|B3P|Ki=1.25+/-0.03mM(pH=8.0)|O52575|XYLOSIDASE/ARABINOSIDASE|2.9|Ki=1.25mM|Ki|=|1.25|mM|1250000|nM
2V6N|1.98|2008|XP1|IC50=0.1uM, Wu et al. (2006) reported a Ki value of 17.4 nM|Q6WGN0|REPLICASE POLYPROTEIN 1AB|5.86|Ki=1.38uM|Ki|=|1.38|uM|1380|nM
3B67|1.90|2008|B67|ligand is compound c-23; Ki=1.4+/-0.3nM|P10275|ANDROGEN RECEPTOR|8.85|Ki=1.4nM|Ki|=|1.4|nM|1.4|nM
3E93|2.00|2008|19B|ligand is compound 19, Ki=1.4nM|Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|8.85|Ki=1.4nM|Ki|=|1.4|nM|1.4|nM
2R3T|1.80|2008|G4G|compound 9 in complex with HIV-1 protease I50V|Q5RZ08|HIV-1 PROTEASE|5.85|Ki=1.4uM|Ki|=|1.4|uM|1400|nM
2ZCQ|2.38|2008|B65|IC50=100~300nM|A9JQL9|DEHYDROSQUALENE SYNTHASE|8.82|Ki=1.5nM|Ki|=|1.5|nM|1.5|nM
3D1Z|1.30|2008|017|Ki=1.6+/-0.1nM|P04587|HIV-1 PROTEASE|8.8|Ki=1.6nM|Ki|=|1.6|nM|1.6|nM
3B5R|1.80|2008|B5R|ligand is compound c-31; Ki=1.7+/-0.2nM|P10275|ANDROGEN RECEPTOR|8.77|Ki=1.7nM|Ki|=|1.7|nM|1.7|nM
3BQC|1.50|2008|EMO|crystal structure in high pH|P68400|CASEIN KINASE II, ALPHA SUBUNIT|5.73|Ki=1.85uM|Ki|=|1.85|uM|1850|nM
2VKM|2.05|2008|BSD|inhibitor 24; IC50=1nM in Chinese hamster cells|P56817|BETA-SECRETASE 1|8.74|Ki=1.8nM|Ki|=|1.8|nM|1.8|nM
2RKD|1.90|2008|3PP|ligand is analogue 12, Ki=1.9+/-0.4mM|P07379|PHOSPHOENOLPYRUVATE CARBOXYKINASE|2.72|Ki=1.9mM|Ki|=|1.9|mM|1900000|nM
3CKZ|1.90|2008|ZMR|relative Ki=1.9*0.1nM|Q6DPL2|NEURAMINIDASE|8.72|Ki=1.9nM|Ki|=|1.9|nM|1.9|nM
2QG0|1.85|2008|A94|Ki=1.9+/-0.2uM|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|5.72|Ki=1.9uM|Ki|=|1.9|uM|1900|nM
2W54|3.30|2008|HHR|Wild-type R.capsulatus XDH complex with pterin-6-aldehyde; Ki=103.57+/-18.96nM|O54050|XANTHINE DEHYDROGENASE|6.98|Ki=103.6nM|Ki|=|103.6|nM|103.6|nM
3CYX|1.20|2008|ROC|Ki=10+/-1nM|P04587|HIV-1 PROTEASE|8.0|Ki=10nM|Ki|=|10|nM|10|nM
3E92|2.00|2008|G6A|ligand is compound 6, Ki=10nM|Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|8.0|Ki=10nM|Ki|=|10|nM|10|nM
3D1G|1.64|2008|322|RU7 compound binds to DNA polymerase III subunit beta|P0A988|DNA POLYMERASE III SUBUNIT BETA|5.0|Ki=10uM|Ki|=|10|uM|10000|nM
2VI5|2.30|2008|Y19|compound 33, Ki =110+/-14uM|P66034|6,7-DIMETHYL-8-RIBITYLLUMAZINE SYNTHASE|3.96|Ki=110uM|Ki|=|110|uM|110000|nM
2Z7H|2.08|2008|GG3|Ki=115nM, IC50=4.17uM|Q12051|GERANYLGERANYL PYROPHOSPHATE SYNTHETASE|6.94|Ki=115nM|Ki|=|115|nM|115|nM
2VJX|1.85|2008|IFL|ligand is compound 6|Q8AAK6|BETA-MANNOSIDASE|4.96|Ki=11uM|Ki|=|11|uM|11000|nM
3D67|3.40|2008|GEM||Q96IY4|CARBOXYPEPTIDASE B2|4.96|Ki=11uM|Ki|=|11|uM|11000|nM
2E9V|2.00|2008|85A|SMILES line in SI file is: pKi_Experiment=7.9, pKi_MMPBSA=44|O14757|SERINE/THREONINE-PROTEIN KINASE CHK1|7.9|Ki=12.59nM|Ki|=|12.59|nM|12.59|nM
3CF8|2.40|2008|QUE|IC50=39.3+/-2.7uM, Ki=12.7+/-0.6uM|Q5G940|(3R)-HYDROXYMYRISTOYL-ACYL CARRIER PROTEIN|4.9|Ki=12.7uM|Ki|=|12.7|uM|12700|nM
2UY0|1.76|2008|HV1|ligand is compound 15|P03366|HIV-1 PROTEASE|6.92|Ki=120nM|Ki|=|120|nM|120|nM
3BL0|1.90|2008|BL0|ligand is compound 5|P00918|CARBONIC ANHYDRASE 2|6.92|Ki=121nM|Ki|=|121|nM|121|nM
2QW1|1.70|2008|3MG|Ki=125+/-15uM|P0AEE5|D-GALACTOSE-BINDING PERIPLASMIC PROTEIN|3.9|Ki=125uM|Ki|=|125|uM|125000|nM
2Q7O|2.90|2008|IMH|compound 2, Ki*=12000pM|P00491|PURINE NUCLEOSIDE PHOSPHORYLASE|7.92|Ki=12nM|Ki|=|12|nM|12|nM
3D7Z|2.10|2008|GK5|ligand is compound 3, IC50=75nM|Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|7.92|Ki=12nM|Ki|=|12|nM|12|nM
3F0R|2.54|2008|TSN|ligand is compound trichostatin A|Q9BY41|HISTONE DEACETYLASE 8|6.89|Ki=130nM|Ki|=|130|nM|130|nM
2ZCR|1.92|2008|B69||A9JQL9|DEHYDROSQUALENE SYNTHASE|6.87|Ki=135nM|Ki|=|135|nM|135|nM
2ZN7|2.10|2008|410||P18031|PROTEIN-TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1|7.89|Ki=13nM|Ki|=|13|nM|13|nM
2VO5|2.30|2008|VBZ|ligand is compound 4a|Q8AAK6|BETA-MANNOSIDASE|4.89|Ki=13uM|Ki|=|13|uM|13000|nM
3D4Z|1.39|2008|GIM||Q24451|ALPHA-MANNOSIDASE II|4.89|Ki=13uM|Ki|=|13|uM|13000|nM
3CF9|2.60|2008|AGI|IC50=11+/-2.5uM, Ki=14.9+/-0.3uM|Q5G940|(3R)-HYDROXYMYRISTOYL-ACYL CARRIER PROTEIN|4.83|Ki=14.9uM|Ki|=|14.9|uM|14900|nM
3EWJ|1.80|2008|642|ligand is compound 21|P78536|TNF-ALPHA-CONVERTING ENZYME, ADAM 17|6.84|Ki=143nM|Ki|=|143|nM|143|nM
2OSF|1.60|2008|TH0|compound 3, Ki(TH0)=148+/-39uM, Ki(S24)=314+/-69uM, IC50(S24)=1.77uM|P00918|CARBONIC ANHYDRASE 2|3.83|Ki=148uM|Ki|=|148|uM|148000|nM
1W12|2.40|2008|SL1||P00749|UROKINASE-TYPE PLASMINOGEN ACTIVATOR|7.85|Ki=14nM|Ki|=|14|nM|14|nM
3DD8|1.90|2008|2C7||P00918|CARBONIC ANHYDRASE 2|7.85|Ki=14nM|Ki|=|14|nM|14|nM
3EFK|2.20|2008|MT4|compound 50, Ki=14+/-1nM|P08581|HEPATOCYTE GROWTH FACTOR RECEPTOR|7.85|Ki=14nM|Ki|=|14|nM|14|nM
2R9X|1.90|2008|WH6||P00811|BETA-LACTAMASE|4.85|Ki=14uM|Ki|=|14|uM|14000|nM
2RA0|2.30|2008|JNJ|ligand is compound 51a|P00742|COAGULATION FACTOR X|7.8|Ki=15.9nM|Ki|=|15.9|nM|15.9|nM
3C88|1.60|2008|5-mer||P10845|BOTULINUM NEUROTOXIN A LIGHT CHAIN|6.8|Ki=157nM|Ki|=|157|nM|157|nM
3D94|2.30|2008|D94|Ki=157nM, IC50=118nm|P08069|INSULIN-LIKE GROWTH FACTOR 1 RECEPTOR|6.8|Ki=157nM|Ki|=|157|nM|157|nM
3CZV|2.00|2008|AZM|Ki=16+/-0.7nM|Q8N1Q1|CARBONIC ANHYDRASE 13|7.8|Ki=16nM|Ki|=|16|nM|16|nM
3FAS|1.40|2008|GLU||P19493|GLUTAMATE RECEPTOR 4|6.77|Ki=171nM|Ki|=|171|nM|171|nM
2PYI|1.88|2008|DL8|Ki=179+/-11uM|P00489|GLYCOGEN PHOSPHORYLASE|3.75|Ki=179uM|Ki|=|179|uM|179000|nM
3CYW|1.40|2008|017|Ki=17+/-2nM|P04587|HIV-1 PROTEASE|7.77|Ki=17nM|Ki|=|17|nM|17|nM
3D50|1.79|2008|OEV||Q24451|ALPHA-MANNOSIDASE II|4.77|Ki=17uM|Ki|=|17|uM|17000|nM
2ZC9|1.58|2008|22U|ligand is compound 2, Ki=180+/-140nM|P00734|THROMBIN LIGHT CHAIN|6.74|Ki=180nM|Ki|=|180|nM|180|nM
2ZGX|1.80|2008|29U|ligand is compound 4, Ki=180+/-30nM|P00734|THROMBIN LIGHT CHAIN|6.74|Ki=180nM|Ki|=|180|nM|180|nM
2JT5|NMR|2008|JT5||P08254|STROMELYSIN-1|7.74|Ki=18nM|Ki|=|18|nM|18|nM
3B7U|1.90|2008|KEL|ligand is KELatorphan|P09960|LEUKOTRIENE A-4 HYDROLASE|7.74|Ki=18nM|Ki|=|18|nM|18|nM
2QRH|1.83|2008|M08|ligand is compound 4c, Ki=19.6+/-0.2uM|P00489|GLYCOGEN PHOSPHORYLASE|4.71|Ki=19.6uM|Ki|=|19.6|uM|19600|nM
3B9G|1.40|2008|IMH|Ki=6.2nM for wt TvNH|Q9GPQ4|IAG-NUCLEOSIDE HYDROLASE|4.72|Ki=19uM|Ki|=|19|uM|19000|nM
2RKA|1.95|2008|PGA|ligand is analogue 13, Ki=1.0+/-0.04mM|P07379|PHOSPHOENOLPYRUVATE CARBOXYKINASE|3.0|Ki=1mM|Ki|=|1|mM|1000000|nM
2P4Y|2.25|2008|C03||P37231|PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA|9.0|Ki=1nM|Ki|=|1|nM|1|nM
2R43|1.58|2008|G3G|compound 8 in complex with HIV-1 protease I50V|Q5RZ08|HIV-1 PROTEASE|6.0|Ki=1uM|Ki|=|1|uM|1000|nM
3DDG|1.74|2008|GB7|ligand is compound 12, measured at 20C|Q24451|ALPHA-MANNOSIDASE II|6.0|Ki=1uM|Ki|=|1|uM|1000|nM
3BAR|1.90|2008|U5P|Mt Ki=0.19+/-0.01uM, Pf Ki=2.0+/-0.1uM|Q8T6J6|OROTIDINE 5'-PHOSPHATE DECARBOXYLASE|5.7|Ki=2.0uM|Ki|=|2|uM|2000|nM
2PQZ|1.55|2008|G0G|ligand is inhibitor 6ad|P03367|HIV-1 PROTEASE|5.67|Ki=2.15uM|Ki|=|2.15|uM|2150|nM
2QD6|1.28|2008|065|Ki=2.1+/-0.4nM|P03367|HIV-1 PROTEASE|8.68|Ki=2.1nM|Ki|=|2.1|nM|2.1|nM
2Q8Z|1.80|2008|NUP|Ki=2.1uM (source pf); Ki=0.84+/-0.025uM (source mt)|Q8IJH3|OROTIDINE 5'-PHOSPHATE DECARBOXYLASE|5.68|Ki=2.1uM|Ki|=|2.1|uM|2100|nM
2VR4|1.80|2008|17B|compound 2c|Q8AAK6|BETA-MANNOSIDASE|5.68|Ki=2.1uM|Ki|=|2.1|uM|2100|nM
3D1X|1.05|2008|ROC|Ki=2.2+/-0.3nM|P04587|HIV-1 PROTEASE|8.66|Ki=2.2nM|Ki|=|2.2|nM|2.2|nM
2QLM|2.10|2008|F68|ligand is compound 25|P00489|GLYCOGEN PHOSPHORYLASE|5.64|Ki=2.3uM|Ki|=|2.3|uM|2300|nM
3BL1|2.10|2008|BL1|ligand is compound 10|P00918|CARBONIC ANHYDRASE 2|5.6|Ki=2.52uM|Ki|=|2.52|uM|2520|nM
3B66|1.65|2008|B66|ligand is compound s-21; Ki=2.5+/-0.2nM|P10275|ANDROGEN RECEPTOR|8.6|Ki=2.5nM|Ki|=|2.5|nM|2.5|nM
2QP6|1.45|2008|MB1|inhibitor 1, Human, recombinant isozymes.|P00918|CARBONIC ANHYDRASE 2|6.68|Ki=208nM|Ki|=|208|nM|208|nM
3B7R|1.81|2008|BIR|Ki=20+/-4nM for inhibitor RB3040|P09960|LEUKOTRIENE A-4 HYDROLASE|7.7|Ki=20nM|Ki|=|20|nM|20|nM
2VES|1.90|2008|GVR||P47205|UDP-3-O-[3-HYDROXYMYRISTOYL] N-ACETYLGLUCOSAMINE DEACETYLASE|7.7|Ki=20nM|Ki|=|20|nM|20|nM
1W0Z|1.90|2008|SI1||P00749|UROKINASE-TYPE PLASMINOGEN ACTIVATOR|7.68|Ki=21nM|Ki|=|21|nM|21|nM
2P1C|2.45|2008|GG3|Ki=21nM, IC50=250nM|Q86C09|FARNESYL PYROPHOSPHATE SYNTHASE|7.68|Ki=21nM|Ki|=|21|nM|21|nM
3CS7|2.20|2008|LG0|ligand is compound 2r|P00742|COAGULATION FACTOR X|10.68|Ki=21pM|Ki|=|21|pM|0.021|nM
2YZ3|2.30|2008|M5P||Q7BJM5|METALLO-BETA-LACTAMASE|6.66|Ki=220nM|Ki|=|220|nM|220|nM
3DDF|1.20|2008|GB6|ligand is compound 11, measured at 20C|Q24451|ALPHA-MANNOSIDASE II|4.66|Ki=22uM|Ki|=|22|uM|22000|nM
3EGK|2.20|2008|M18|compound 5|P00734|THROMBIN|4.66|Ki=22uM|Ki|=|22|uM|22000|nM
2RK8|2.00|2008|PPF|ligand is analogue 10, Ki=230+/-14uM|P07379|PHOSPHOENOLPYRUVATE CARBOXYKINASE|3.64|Ki=230uM|Ki|=|230|uM|230000|nM
3DLN|1.91|2008|GLU|ligand is glutamate|P19492|GLUTAMATE RECEPTOR 3|6.6|Ki=249nM|Ki|=|249|nM|249|nM
2PVL|1.90|2008|P55||P28523|CASEIN KINASE II, ALPHA SUBUNIT|7.62|Ki=24nM|Ki|=|24|nM|24|nM
3BE9|2.00|2008|P04|ligand is compound 10; IC50=0.29uM (HCT116), IC50=0.88uM (PC3)|P28523|CASEIN KINASE II, ALPHA SUBUNIT|7.62|Ki=24nM|Ki|=|24|nM|24|nM
3CL2|2.54|2008|G39|relative Ki=81*0.32nM|Q6DPL2|NEURAMINIDASE|7.59|Ki=25.9nM|Ki|=|25.9|nM|25.9|nM
2JT6|NMR|2008|JT6||P08254|STROMELYSIN-1|7.6|Ki=25nM|Ki|=|25|nM|25|nM
2ZMM|2.10|2008|35B|ligand is compound 8|P18031|PROTEIN-TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1|7.6|Ki=25nM|Ki|=|25|nM|25|nM
2V54|2.40|2008|TYD|Ki=25+/-5uM|P68693|THYMIDYLATE KINASE|4.6|Ki=25uM|Ki|=|25|uM|25000|nM
3DJK|1.00|2008|G55|ligand is compound 3d, Ki=26pM, IC50=5nM|P03367|HIV-1 PROTEASE|10.59|Ki=26pM|Ki|=|26|pM|0.026000000000000002|nM
1W10|2.00|2008|SJ1||P00749|UROKINASE-TYPE PLASMINOGEN ACTIVATOR|7.55|Ki=28nM|Ki|=|28|nM|28|nM
1W13|2.00|2008|SM1||P00749|UROKINASE-TYPE PLASMINOGEN ACTIVATOR|8.7|Ki=2nM|Ki|=|2|nM|2|nM
2VJ8|1.80|2008|HA2|peptidase activity Ki=0.002uM, Epoxide hydrolase activity IC50=0.15uM|Q6IAT6|LEUKOTRIENE A-4 HYDROLASE|8.7|Ki=2nM|Ki|=|2|nM|2|nM
3BLA|2.60|2008|DD3|IC50~2nM|Q96C86|SCAVENGER MRNA-DECAPPING ENZYME DCPS|8.7|Ki=2nM|Ki|=|2|nM|2|nM
3EQR|2.00|2008|T74|ligand is compound 2; Ki=0.002uM; IC50=0.01uM in cell lines|Q07912|ACTIVATED CDC42 KINASE 1|8.7|Ki=2nM|Ki|=|2|nM|2|nM
3D4Y|1.52|2008|MVL||Q24451|ALPHA-MANNOSIDASE II|5.7|Ki=2uM|Ki|=|2|uM|2000|nM
2VH0|1.70|2008|GSI|ligand is compound 15|P00742|COAGULATION FACTOR XA|8.51|Ki=3.1nM|Ki|=|3.1|nM|3.1|nM
3BMQ|1.70|2008|AX5|Pteridine Reductase 1 complex NADP+ and AX5 compound 17, Ki=3.2uM|O76290|PTERIDINE REDUCTASE|5.49|Ki=3.2uM|Ki|=|3.2|uM|3200|nM
2UXZ|1.75|2008|HI1|ligand is compound 12d|P03366|HIV-1 PROTEASE|8.48|Ki=3.3nM|Ki|=|3.3|nM|3.3|nM
2QO8|1.40|2008|3CC|ligand is compound 2|P00918|CARBONIC ANHYDRASE 2|8.47|Ki=3.4nM|Ki|=|3.4|nM|3.4|nM
2Q6F|2.00|2008|6-mer|Ki=3.6+/-0.4uM (IBV Mpro/N3); Ki=2.6+/-0.3uM(IBV Mpro/N27); Ki=2.8+/-0.2uM(IBV Mpro/H16)|Q3Y5H1|INFECTIOUS BRONCHITIS VIRUS (IBV) MAIN PROTEASE|5.44|Ki=3.6uM|Ki|=|3.6|uM|3600|nM
2ZA5|2.30|2008|2FF|Ki=3.7+/-0.5nM; IC50=3.6+/-0.3nM|Q6B052|TRYPTASE BETA-2|8.43|Ki=3.7nM|Ki|=|3.7|nM|3.7|nM
2QLN|2.15|2008|F59|ligand is compound 26|P00489|GLYCOGEN PHOSPHORYLASE|5.43|Ki=3.7uM|Ki|=|3.7|uM|3700|nM
3BFT|2.27|2008|S2P|Ki=323+/-84nM|P19491|GLUTAMATE RECEPTOR 2|6.49|Ki=323nM|Ki|=|323|nM|323|nM
2QHY|1.85|2008|MZ1|ligand is inhibitor 12h|O38732|HIV-1 PROTEASE|7.48|Ki=33nM|Ki|=|33|nM|33|nM
3CM2|2.50|2008|X23|Fluorescence IC50=970+/-120nM, Cheng-Prusoff, Kenakin, Huang get Ki=870, 420, 340nM|P98170|BACULOVIRAL IAP REPEAT-CONTAINING PROTEIN 4|6.47|Ki=340nM|Ki|=|340|nM|340|nM
3BMN|1.98|2008|AX3|Pteridine Reductase 1 complex NADP+ and AX3 compound 15, lack a N atom, Ki>35uM|O76290|PTERIDINE REDUCTASE|4.46|Ki=35uM|Ki|=|35|uM|35000|nM
2Q9Y|2.85|2008|BTM|Ki for BTAC in the presence of PPi and Mg2+ is 36uM|P13513|TRICHODIENE SYNTHASE|4.44|Ki=36uM|Ki|=|36|uM|36000|nM
3E81|1.63|2008|SLB|competitive inhibitors (versus pNPP) for BT1713|Q8A712|ACYLNEURAMINATE CYTIDYLYLTRANSFERASE|1.43|Ki=37mM|Ki|=|37|mM|37000000|nM
2PU2|1.86|2008|DK2|IC50(R)=70uM, Ki(S)=158uM, Ki(R)=140uM|P00811|BETA-LACTAMASE|4.43|Ki=37uM|Ki|=|37|uM|37000|nM
3BGS|2.10|2008|DIH|ligand is compound 4|P00491|PURINE NUCLEOSIDE PHOSPHORYLASE|9.42|Ki=380pM|Ki|=|380|pM|0.38|nM
2VR0|2.80|2008|HQO||Q72EF3|CYTOCHROME C NITRITE REDUCTASE|4.42|Ki=38uM|Ki|=|38|uM|38000|nM
3EFJ|2.60|2008|MT3|compound 7, Ki=39+/-6nM|P08581|HEPATOCYTE GROWTH FACTOR RECEPTOR|7.41|Ki=39nM|Ki|=|39|nM|39|nM
1W14|2.20|2008|SH1||P00749|UROKINASE-TYPE PLASMINOGEN ACTIVATOR|8.52|Ki=3nM|Ki|=|3|nM|3|nM
2QG2|1.80|2008|A91|Ki=4.0+/-1.0uM|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|5.4|Ki=4.0uM|Ki|=|4|uM|4000|nM
3D83|1.90|2008|GK6|ligand is compound 8|Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|8.36|Ki=4.4nM|Ki|=|4.4|nM|4.4|nM
2QN3|1.96|2008|F55|ligand is compound 27|P00489|GLYCOGEN PHOSPHORYLASE|5.36|Ki=4.4uM|Ki|=|4.4|uM|4400|nM
3BV9|1.80|2008|6-mer|Ki=4.4+/-2.4uM; IC50=6.9+/-1.2uM|P00734|THROMBIN|5.36|Ki=4.4uM|Ki|=|4.4|uM|4400|nM
3BC4|1.82|2008|LLG|incomplete ligand structure|P03367|HIV-1 PROTEASE|5.35|Ki=4.5uM|Ki|=|4.5|uM|4500|nM
3E9B|2.15|2008|S2C||P07824|ARGINASE-1|5.35|Ki=4.5uM|Ki|=|4.5|uM|4500|nM
2QCI|1.20|2008|065|Ki=4.6+/-0.7nM|P03367|HIV-1 PROTEASE|8.34|Ki=4.6nM|Ki|=|4.6|nM|4.6|nM
2QNB|1.80|2008|BZD|ligand is compound 15|P00489|GLYCOGEN PHOSPHORYLASE|5.34|Ki=4.6uM|Ki|=|4.6|uM|4600|nM
3DS9|1.76|2008|8-mer|incomplete ligand|A5HZZ9|BOTULINUM NEUROTOXIN A|7.39|Ki=41nM|Ki|=|41|nM|41|nM
2QI0|2.10|2008|MZ3|ligand is inhibitor 11b|O38732|HIV-1 PROTEASE|7.38|Ki=42nM|Ki|=|42|nM|42|nM
2VC7|2.05|2008|HT5|Ki=432.7+/-53.2uM|Q97VT7|ARYLDIALKYLPHOSPHATASE|3.36|Ki=432.7uM|Ki|=|432.7|uM|432700|nM
2VL1|2.15|2008|2-mer|Fragment: RESIDUES 2-455|Q96W94|BETA-ALANINE SYNTHASE|1.35|Ki=45mM|Ki|=|45|mM|45000000|nM
2PNC|2.40|2008|CLU|Ki=466+/-163uM; Kd~1.2mM|Q29437|COPPER AMINE OXIDASE, LIVER ISOZYME|3.33|Ki=466uM|Ki|=|466|uM|466000|nM
2VVS|2.24|2008|OAN||Q89ZI2|O-GLCNACASE BT_4395|7.34|Ki=46nM|Ki|=|46|nM|46|nM
2R2M|2.10|2008|I50|ligand is compound 1|P00734|THROMBIN LIGHT CHAIN|7.33|Ki=47.1nM|Ki|=|47.1|nM|47.1|nM
2Z3Z|1.95|2008|AIO|covalent complex|Q7MUW6|DIPEPTIDYL AMINOPEPTIDASE IV|4.31|Ki=48.8uM|Ki|=|48.8|uM|48800|nM
2QTT|1.93|2008|FMC|Ki=48+/-5uM; ligand in reference is referred to as Formycin A (FMA)|Q9T0I8|5'-METHYLTHIOADENOSINE NUCLEOSIDASE|4.32|Ki=48uM|Ki|=|48|uM|48000|nM
2VSL|2.10|2008|4-mer|Ki=4+/-2nM; IC50=406+/-37nM|P98170|BACULOVIRAL IAP REPEAT-CONTAINING PROTEIN 4|8.4|Ki=4nM|Ki|=|4|nM|4|nM
2ZDA|1.73|2008|32U|ligand is compound 5, Ki=4+/-1.2nM|P00734|THROMBIN|8.4|Ki=4nM|Ki|=|4|nM|4|nM
3B68|1.90|2008|B68|ligand is compound s-4; Ki=4+/-0.7nM|P10275|ANDROGEN RECEPTOR|8.4|Ki=4nM|Ki|=|4|nM|4|nM
3D0E|2.00|2008|G93|IC50=13nM|P31751|RAC-BETA SERINE/THREONINE-PROTEIN KINASE|8.4|Ki=4nM|Ki|=|4|nM|4|nM
3CKR|2.70|2008|009||P56817|BETA-SECRETASE 1|5.3|Ki=5.001uM|Ki|=|5.001|uM|5001|nM
3DYO|1.80|2008|IPT|measured with 0.01mM Mg2+|P00722|BETA-GALACTOSIDASE|2.3|Ki=5.0mM|Ki|=|5|mM|5000000|nM
3BMO|1.60|2008|AX4|Pteridine Reductase 1 complex NADP+ and AX4 compound 16, Ki=5.4uM|O76290|PTERIDINE REDUCTASE|5.27|Ki=5.4uM|Ki|=|5.4|uM|5400|nM
3CEN|1.60|2008|FXA|compound 14|P00742|COAGULATION FACTOR X, HEAVY CHAIN|8.26|Ki=5.5nM|Ki|=|5.5|nM|5.5|nM
3E16|1.60|2008|B4C|compound 12|Q16651|PROSTASIN|5.24|Ki=5.78uM|Ki|=|5.78|uM|5780|nM
3E5A|2.30|2008|VX6||O14965|SERINE/THREONINE-PROTEIN KINASE 6|8.23|Ki=5.9nM|Ki|=|5.9|nM|5.9|nM
2QI1|2.00|2008|MZ4|ligand is inhibitor 11c|O38732|HIV-1 PROTEASE|7.3|Ki=50nM|Ki|=|50|nM|50|nM
3D52|1.60|2008|GHR||Q24451|ALPHA-MANNOSIDASE II|3.28|Ki=520uM|Ki|=|520|uM|520000|nM
2QOA|1.60|2008|MAJ|ligand is compound 1, not compound 3|P00918|CARBONIC ANHYDRASE 2|7.28|Ki=52nM|Ki|=|52|nM|52|nM
3BFU|1.95|2008|R2P|Ki=531+/-98nM|P19491|GLUTAMATE RECEPTOR 2|6.27|Ki=531nM|Ki|=|531|nM|531|nM
2QHZ|1.85|2008|MZ2|ligand is inhibitor 12j|O38732|HIV-1 PROTEASE|7.28|Ki=53nM|Ki|=|53|nM|53|nM
2OLE|2.40|2008|KR2|compound 10f; Ki=56.2nM; IC50=70nM|P27487|DIPEPTIDYL PEPTIDASE 4|7.25|Ki=56.2nM|Ki|=|56.2|nM|56.2|nM
2JKP|1.99|2008|CTS|ligand is castanospermine 2|P71094|ALPHA-GLUCOSIDASE SUSB|4.23|Ki=59uM|Ki|=|59|uM|59000|nM
2JKE|1.70|2008|NOJ|ligand is deoxynojirimycin 1|P71094|ALPHA-GLUCOSIDASE SUSB|4.23|Ki=59uM|Ki|=|59|uM|59000|nM
2PVK|1.90|2008|P45||P28523|CASEIN KINASE II, ALPHA SUBUNIT|8.3|Ki=5nM|Ki|=|5|nM|5|nM
2RD6|2.30|2008|78P|ligand is compound 4a|P09874|POLY [ADP-RIBOSE] POLYMERASE 1|8.3|Ki=5nM|Ki|=|5|nM|5|nM
3D20|1.05|2008|017|Ki=5+/-1nM; redundant to 2hs1|P04587|HIV-1 PROTEASE|8.3|Ki=5nM|Ki|=|5|nM|5|nM
2VK6|1.50|2008|DAN|Ki=5uM(pH=7); Ki=40uM(pH=5)|Q59310|EXO-ALPHA-SIALIDASE|5.3|Ki=5uM|Ki|=|5|uM|5000|nM
3BCS|2.00|2008|CJB|ligand is 1(-D-glucopyranosyl) uracil|P00489|GLYCOGEN PHOSPHORYLASE|5.21|Ki=6.1uM|Ki|=|6.1|uM|6100|nM
2R59|1.89|2008|PH0|Ki=6.5+/-1nM for inhibitor RB3041|P09960|LEUKOTRIENE A-4 HYDROLASE|8.19|Ki=6.5nM|Ki|=|6.5|nM|6.5|nM
2QRG|1.85|2008|M07|ligand is compound 4a, Ki=6.6+/-0.3uM|P00489|GLYCOGEN PHOSPHORYLASE|5.18|Ki=6.6uM|Ki|=|6.6|uM|6600|nM
2ZFP|2.25|2008|19U|ligand is compound 1, Ki=6.8+/-1.5uM|P00734|THROMBIN|5.17|Ki=6.8uM|Ki|=|6.8|uM|6800|nM
3B7J|2.40|2008|JUG|Ki=6.8uM; IC50=30+/-4uM|Q5G940|(3R)-HYDROXYMYRISTOYL-ACYL CARRIER PROTEIN|5.17|Ki=6.8uM|Ki|=|6.8|uM|6800|nM
2EPN|1.61|2008|NGT|Ki=60+/-17nM|Q6ST21|N-ACETYL-BETA-D-GLUCOSAMINIDASE|7.22|Ki=60nM|Ki|=|60|nM|60|nM
2QMJ|1.90|2008|ACR|Ki=62+/-13uM|O43451|MALTASE-GLUCOAMYLASE|4.21|Ki=62uM|Ki|=|62|uM|62000|nM
3F3A|2.00|2008|TRP|Ki=64.8+/-4.67uM|O67854|TRANSPORTER|4.19|Ki=64.8uM|Ki|=|64.8|uM|64800|nM
3C8A|1.52|2008|5-mer||A5HZZ9|BOTULINUM NEUROTOXIN A LIGHT CHAIN|6.18|Ki=660nM|Ki|=|660|nM|660|nM
2JK7|2.82|2008|BI6|Ki=67+/-18nM|P98170|BACULOVIRAL IAP REPEAT-CONTAINING PROTEIN 4|7.17|Ki=67nM|Ki|=|67|nM|67|nM
3D3X|2.25|2008|4-mer|IC50=340uM, Type E botulinum toxin complex with SNAP-25 substrate peptide; incomplete ligand|Q9K395|BOTULINUM TOXIN TYPE E|4.16|Ki=69uM|Ki|=|69|uM|69000|nM
1W11|2.00|2008|SK1||P00749|UROKINASE-TYPE PLASMINOGEN ACTIVATOR|8.22|Ki=6nM|Ki|=|6|nM|6|nM
2ZCS|2.03|2008|B70||A9JQL9|DEHYDROSQUALENE SYNTHASE|8.22|Ki=6nM|Ki|=|6|nM|6|nM
3D1Y|1.05|2008|ROC|Ki=6+/-1nM|P04587|HIV-1 PROTEASE|8.22|Ki=6nM|Ki|=|6|nM|6|nM
3D9V|3.30|2008|H52||Q13464|RHO-ASSOCIATED PROTEIN KINASE 1|8.22|Ki=6nM|Ki|=|6|nM|6|nM
3B4F|1.89|2008|TUO|ligand is compound 5|P00918|CARBONIC ANHYDRASE 2|8.14|Ki=7.2nM|Ki|=|7.2|nM|7.2|nM
2PQ9|1.60|2008|GG9|Ki=7.8+/-0.5nM|P0A6D3|3-PHOSPHOSHIKIMATE 1-CARBOXYVINYLTRANSFERASE|8.11|Ki=7.8nM|Ki|=|7.8|nM|7.8|nM
2E9U|2.00|2008|A25|-logKi=8.1 in in supporting information|O14757|SERINE/THREONINE-PROTEIN KINASE CHK1|8.1|Ki=7.94nM|Ki|=|7.94|nM|7.94|nM
2QRQ|1.80|2008|S13|ligand is compound 4b, Ki=7.9+/-0.1uM|P00489|GLYCOGEN PHOSPHORYLASE|5.1|Ki=7.9uM|Ki|=|7.9|uM|7900|nM
3BBT|2.80|2008|FMM|IC50=1.4+/-0.1uM|Q15303|RECEPTOR TYROSINE-PROTEIN KINASE ERBB-4|6.15|Ki=700nM|Ki|=|700|nM|700|nM
3D51|1.43|2008|GOX||Q24451|ALPHA-MANNOSIDASE II|4.15|Ki=70uM|Ki|=|70|uM|70000|nM
2VOT|1.95|2008|NHV|ligand is compound 1c|Q8AAK6|BETA-MANNOSIDASE|7.14|Ki=72nM|Ki|=|72|nM|72|nM
3C8B|1.47|2008|5-mer||A5HZZ9|BOTULINUM NEUROTOXIN A LIGHT CHAIN|6.1|Ki=786nM|Ki|=|786|nM|786|nM
2RKG|1.80|2008|AB1|Ki=8.2+/-0.7nM|A0F7J4|PROTEASE RETROPEPSIN|8.09|Ki=8.2nM|Ki|=|8.2|nM|8.2|nM
2QTG|1.84|2008|MTH|Ki=8.3+/-1.2uM|Q9T0I8|5'-METHYLTHIOADENOSINE NUCLEOSIDASE|5.08|Ki=8.3uM|Ki|=|8.3|uM|8300|nM
2V77|1.60|2008|PAY||P15085|CARBOXYPEPTIDASE A1|5.06|Ki=8.7uM|Ki|=|8.7|uM|8700|nM
2RKE|1.80|2008|SAT|ligand is analogue 23, Ki =82.5+/-5uM|P07379|PHOSPHOENOLPYRUVATE CARBOXYKINASE|4.08|Ki=82.5uM|Ki|=|82.5|uM|82500|nM
3CL0|2.20|2008|G39|relative Ki=265*0.32nM|Q6DPL2|NEURAMINIDASE|7.07|Ki=84.8nM|Ki|=|84.8|nM|84.8|nM
3C89|1.58|2008|5-mer||P10845|BOTULINUM NEUROTOXIN A LIGHT CHAIN|6.07|Ki=845nM|Ki|=|845|nM|845|nM
2EEP|2.20|2008|AIO|covalent complex|Q7MUW6|DIPEPTIDYL AMINOPEPTIDASE IV|7.06|Ki=88.1nM|Ki|=|88.1|nM|88.1|nM
2RK7|1.90|2008|OXL|ligand is analogue 1, Ki=89+/-4uM|P07379|PHOSPHOENOLPYRUVATE CARBOXYKINASE, CYTOSOLIC|4.05|Ki=89uM|Ki|=|89|uM|89000|nM
2PVJ|1.70|2008|P44||P28523|CASEIN KINASE II, ALPHA SUBUNIT|8.1|Ki=8nM|Ki|=|8|nM|8|nM
2RCW|2.80|2008|AAI|ligand is compound 3, A620223|P09874|POLY [ADP-RIBOSE] POLYMERASE 1|8.1|Ki=8nM|Ki|=|8|nM|8|nM
3CAJ|1.80|2008|EZL|compound 3; redundant to 3dd0|P00918|CARBONIC ANHYDRASE 2|8.1|Ki=8nM|Ki|=|8|nM|8|nM
2R9W|1.80|2008|23C||P00811|BETA-LACTAMASE|5.1|Ki=8uM|Ki|=|8|uM|8000|nM
3BXS|1.60|2008|DRS|products 2, Ki=8uM|P03369|HIV-1 PROTEASE|5.1|Ki=8uM|Ki|=|8|uM|8000|nM
3BGC|1.80|2008|LJH|ligand is compound 6d|P03367|HIV-1 PROTEASE|5.02|Ki=9.6uM|Ki|=|9.6|uM|9600|nM
2VNT|2.20|2008|QGG|compound 33 or 34, preference for the R-isomer, QGG(R) Ki=9.9nM, (S)Ki=111nM|P00749|UROKINASE-TYPE PLASMINOGEN ACTIVATOR|8.0|Ki=9.9nM|Ki|=|9.9|nM|9.9|nM
2QRM|1.90|2008|M09|ligand is compound 4d, Ki=92.5+/-4.2uM|P00489|GLYCOGEN PHOSPHORYLASE|4.03|Ki=92.5uM|Ki|=|92.5|uM|92500|nM
3F3C|2.10|2008|PFF|Ki=950+/-100nM|O67854|TRANSPORTER|6.02|Ki=950nM|Ki|=|950|nM|950|nM
3DC2|2.70|2008|TLA|Ki=950+/-120uM, IC50=36+/-6uM|P0A544|D-3-PHOSPHOGLYCERATE DEHYDROGENASE|3.02|Ki=950uM|Ki|=|950|uM|950000|nM
2VL4|1.90|2008|MNM|ligand is compound 5|Q8AAK6|BETA-MANNOSIDASE|6.01|Ki=975nM|Ki|=|975|nM|975|nM
3EMG|2.60|2008|685|IC50=0.07uM|P43405|TYROSINE-PROTEIN KINASE SYK|8.05|Ki=9nM|Ki|=|9|nM|9|nM
3KF4|1.90|2009|B90|Tyrosine-protein kinase transforming protein Abl complex AP24283|P00520|TYROSINE-PROTEIN KINASE ABL1|9.3|IC<0.5nM|IC50|<|0.5|nM|0.5|nM
3FZ1|1.90|2009|B98|benzthiophene inhibitor bound to human (CDK-2), compound 2 lacks a NH2|P24941|CELL DIVISION PROTEIN KINASE 2|7.92|IC=0.012uM|IC50|=|0.012|uM|12|nM
3H59|2.10|2009|H59|compound 20 bound to C Delta 21 NS5B polymerase, cell activity|P26663|RNA-DIRECTED RNA POLYMERASE|7.89|IC=0.013uM|IC50|=|0.013|uM|13|nM
3G9E|2.30|2009|RO7|PPAR gamma and compound (S)-2Aa|P37231|PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA|7.72|IC=0.019uM|IC50|=|0.019|uM|19|nM
2W1C|3.24|2009|L0C|compound 9|O14965|SERINE/THREONINE-PROTEIN KINASE 6|8.0|IC=0.01uM|IC50|=|0.01|uM|10|nM
2WEV|2.30|2009|CK7||P24941|CELL DIVISION PROTEIN KINASE 2|8.0|IC=0.01uM|IC50|=|0.01|uM|10|nM
3CVK|2.31|2009|N34|IC50<0.01uM, compound 4c|P26663|RNA-DIRECTED RNA POLYMERASE|8.0|IC=0.01uM|IC50|=|0.01|uM|10|nM
3D5M|2.20|2009|4MS|IC50<0.01uM, compound 34|P26663|RNA-DIRECTED RNA POLYMERASE|8.0|IC=0.01uM|IC50|=|0.01|uM|10|nM
3GUR|2.50|2009|BYG|covalent complex; IC50<0.01uM, ligand is N11+GTT|P28161|GLUTATHIONE S-TRANSFERASE MU 2|8.0|IC=0.01uM|IC50|=|0.01|uM|10|nM
2WEZ|1.70|2009|ZYE|compound 17, the -OCH3 group on ligand is wrong as CF3 in reference|P56817|BETA-SECRETASE 1|7.64|IC=0.023uM|IC50|=|0.023|uM|23|nM
3II5|2.79|2009|831|B-Raf wild-type enzyme with compound 10n|P15056|B-RAF PROTO-ONCOGENE SERINE/THREONINE-PROTEIN KINASE|7.62|IC=0.024uM|IC50|=|0.024|uM|24|nM
3HMM|1.70|2009|855|ALK-5 with GW855857(compound 3d), ALK-5 IC50=0.025uM, TGF beta=0.095uM|P36897|TGF-BETA RECEPTOR TYPE-1|7.6|IC=0.025uM|IC50|=|0.025|uM|25|nM
3GXL|1.80|2009|QIG|ALK-5 with GW857175(compound 8d), ALK-5 IC50=0.025uM, TGF beta=0.09uM|P36897|TGF-BETA RECEPTOR TYPE-1|7.6|IC=0.025uM|IC50|=|0.025|uM|25|nM
3IGV|2.60|2009|B80|HCV NS5B polymerase complex compound 29, IC50<0.025uM|P26663|RNA-DIRECTED RNA POLYMERASE|7.6|IC=0.025uM|IC50|=|0.025|uM|25|nM
3IG6|1.83|2009|438|compound 11 bound to uPA|Q5SWW9|UROKINASE-TYPE PLASMINOGEN ACTIVATOR|7.6|IC=0.025uM|IC50|=|0.025|uM|25|nM
3HF6|1.80|2009|LX0|inhibitor 7b co-crystallized with TPH1|P17752|TRYPTOPHAN 5-HYDROXYLASE 1|7.59|IC=0.026uM|IC50|=|0.026|uM|26|nM
3FEI|2.40|2009|CTM||Q07869|PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR ALPHA|7.7|IC=0.02uM|IC50|=|0.02|uM|20|nM
3G8I|2.20|2009|RO7|PPAR alpha and compound (S)-2Aa, IC50=0.038uM|Q07869|PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR ALPHA|7.42|IC=0.038uM|IC50|=|0.038|uM|38|nM
3FYK|3.50|2009|B98|benzthiophene lead bound to MAPKAP Kinase-2 (MK-2), compound 2 lacks a NH2|P49137|MAP KINASE-ACTIVATED PROTEIN KINASE 2|7.4|IC=0.04uM|IC50|=|0.04|uM|40|nM
3GYN|2.15|2009|B42|HCV NS5B polymerase complex compound 49|P26663|RNA-DIRECTED RNA POLYMERASE|7.21|IC=0.061uM|IC50|=|0.061|uM|61|nM
3FF6|3.19|2009|RCP|ligand is compound 2|O00763|ACETYL-COA CARBOXYLASE 2|7.15|IC=0.07uM|IC50|=|0.07|uM|70|nM
3HP5|2.30|2009|52P|p38a in complex with compound 2|Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|7.15|IC=0.07uM|IC50|=|0.07|uM|70|nM
3GOL|2.85|2009|XND|HCV NS5b polymerase in complex with 1, 5 benzodiazepine inhibitor (R)-11d|O92972|RNA-DIRECTED RNA POLYMERASE|7.09|IC=0.081uM|IC50|=|0.081|uM|81|nM
2W3K|2.05|2009|L1D|compound 17|P00742|COAGULATION FACTOR X, HEAVY CHAIN|10.1|IC=0.08nM|IC50|=|0.08|nM|0.08|nM
3FXV|2.26|2009|643|FXR binding to compound 7a|A1L4K5|NR1H4 PROTEIN|7.03|IC=0.094uM|IC50|=|0.094|uM|94|nM
2W6N|1.87|2009|OA2|compound 2c|P24182|BIOTIN CARBOXYLASE|6.9|IC=0.125uM|IC50|=|0.125|uM|125|nM
3JPV|2.35|2009|1DR|human proto-oncogene serine threonine kinase (PIM1) with compound 9|P11309|SERINE/THREONINE-PROTEIN KINASE|6.92|IC=0.12uM|IC50|=|0.12|uM|120|nM
3DU8|2.20|2009|553|IC50=0.146+/-0.045uM, compound 89S|P49841|GLYCOGEN SYNTHASE KINASE-3 BETA|6.84|IC=0.146uM|IC50|=|0.146|uM|146|nM
3KVX|2.40|2009|FMY|compound 9l bind in the ATP pocket of JNK3|P53779|MITOGEN-ACTIVATED PROTEIN KINASE 10|6.83|IC=0.148uM|IC50|=|0.148|uM|148|nM
3G42|2.10|2009|792|compound 11c bound to TACE|P78536|TNF-ALPHA-CONVERTING ENZYME, ADAM 17|6.85|IC=0.14uM|IC50|=|0.14|uM|140|nM
3FUI|2.20|2009|812|compound 14, IC50=0.157+/-0.03uM|P09960|LEUKOTRIENE A-4 HYDROLASE|6.8|IC=0.157uM|IC50|=|0.157|uM|157|nM
3KB3|1.95|2009|A8S|ternary complex of PYL2-ABA-HAB1, (+)-ABA IC50=0.15uM, (-)-ABA IC50=1.7uM|O80992|PUTATIVE UNCHARACTERIZED PROTEIN AT2G26040|6.82|IC=0.15uM|IC50|=|0.15|uM|150|nM
3FV8|2.28|2009|JK3|JNK3 complexed with compound 4g|P53779|MITOGEN-ACTIVATED PROTEIN KINASE 10|6.8|IC=0.16uM|IC50|=|0.16|uM|160|nM
3FUN|1.58|2009|798|compound 18, IC50=0.189+/-0.02uM|P09960|LEUKOTRIENE A-4 HYDROLASE|6.72|IC=0.189uM|IC50|=|0.189|uM|189|nM
3HNG|2.70|2009|8ST|ligand is compound 3|P17948|VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 1|6.74|IC=0.18uM|IC50|=|0.18|uM|180|nM
2W3I|1.90|2009|L1C|compound 26|P00742|COAGULATION FACTOR X, HEAVY CHAIN|10.0|IC=0.1nM|IC50|=|0.1|nM|0.1|nM
3C7P|1.70|2009|POF|compound 4|P00918|CARBONIC ANHYDRASE 2|10.0|IC=0.1nM|IC50|=|0.1|nM|0.1|nM
3HD3|1.75|2009|25B|structure of 8a bound to cruzain|P25779|CRUZIPAIN|7.0|IC=0.1uM|IC50|=|0.1|uM|100|nM
2WF0|1.60|2009|ZY0|compound 22|P56817|BETA-SECRETASE 1|6.68|IC=0.21uM|IC50|=|0.21|uM|210|nM
2WTD|2.75|2009|ZZK|compound 51|O96017|SERINE/THREONINE-PROTEIN KINASE CHK2|6.68|IC=0.21uM|IC50|=|0.21|uM|210|nM
3IEJ|2.18|2009|599|compound 32 bound to Cys25Ser CatS|P25774|CATHEPSIN S|6.66|IC=0.22uM|IC50|=|0.22|uM|220|nM
2WBD|2.40|2009|RO5|compound 4, IC50=0.23uM|P09467|FRUCTOSE-1,6-BISPHOSPHATASE 1|6.64|IC=0.23uM|IC50|=|0.23|uM|230|nM
2WI6|2.18|2009|ZZ6|compound 21e|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|6.64|IC=0.23uM|IC50|=|0.23|uM|230|nM
3KAH|2.30|2009|4DH|Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 with compound 20|Q13526|PEPTIDYL-PROLYL CIS-TRANS ISOMERASE NIMA|6.59|IC=0.26uM|IC50|=|0.26|uM|260|nM
3EJ5|2.50|2009|EJ5|compound 1|P02879|RICIN A CHAIN|3.57|IC=0.27mM|IC50|=|0.27|mM|270000|nM
3IL6|2.50|2009|B83|E. faecalis FabH in complex with compound 23i|Q820T1|3-OXOACYL-[ACYL-CARRIER-PROTEIN] SYNTHASE 3|6.57|IC=0.27uM|IC50|=|0.27|uM|270|nM
3G6Z|2.00|2009|A7T|compound (+)-26g, in buffer IC50=0.2nM, in plasma IC50=19nM|P00797|RENIN|9.7|IC=0.2nM|IC50|=|0.2|nM|0.2|nM
3I06|1.10|2009|QL2|cruzain covalently bound to a purine nitrile, compound 32|P25779|CRUZIPAIN|9.7|IC=0.2nM|IC50|=|0.2|nM|0.2|nM
3K3B|2.40|2009|L31|compound 3 bound to human kinesin Eg5|P52732|KINESIN-LIKE PROTEIN KIF11|6.7|IC=0.2uM|IC50|=|0.2|uM|200|nM
2WTC|3.00|2009|VGM|compound 48|O96017|SERINE/THREONINE-PROTEIN KINASE CHK2|6.51|IC=0.31uM|IC50|=|0.31|uM|310|nM
2W6P|1.85|2009|OA4|compound 3c|P24182|ACETYL-COA CARBOXYLASE|6.48|IC=0.333uM|IC50|=|0.333|uM|333|nM
2W71|1.99|2009|L23|compound 6b|P24182|BIOTIN CARBOXYLASE|6.48|IC=0.334uM|IC50|=|0.334|uM|334|nM
3HR1|1.53|2009|PF9|cAMP and cAMP-inhibited cGMP 3, 5-cyclic phosphodiesterase 10A with compound 9|Q9QYJ6|PHOSPHODIESTERASE|9.43|IC=0.37nM|IC50|=|0.37|nM|0.37|nM
2WAJ|2.40|2009|SNB|compound 16, pIC50=6.4|P53779|MITOGEN-ACTIVATED PROTEIN KINASE 10|6.4|IC=0.398uM|IC50|=|0.398|uM|398|nM
2WMW|2.43|2009|ZYW|Fragment: KINASE DOMAIN, RESIDUES 1-289|O14757|SERINE/THREONINE-PROTEIN KINASE CHK1|6.41|IC=0.39uM|IC50|=|0.39|uM|390|nM
3HQZ|1.70|2009|PF8|cAMP and cAMP-inhibited cGMP 3, 5-cyclic phosphodiesterase 10A with compound 3|Q9QYJ6|PHOSPHODIESTERASE|9.38|IC=0.42nM|IC50|=|0.42|nM|0.42|nM
3FR5|2.20|2009|I4A|compound 30|P15090|FATTY ACID-BINDING PROTEIN, ADIPOCYTE|6.35|IC=0.45uM|IC50|=|0.45|uM|450|nM
3GW5|2.00|2009|72X|compound 21l bound to human renin|P00797|RENIN|9.33|IC=0.47nM|IC50|=|0.47|nM|0.47|nM
3G70|2.00|2009|A5T|compound (+)-26h, in buffer IC50=0.4nM, in plasma IC50=36nM|P00797|RENIN|9.4|IC=0.4nM|IC50|=|0.4|nM|0.4|nM
3G3N|2.40|2009|TC8|PDE7A catalytic domain in complex with compound 15, IC50=0.51+/-0.02uM|Q13946|CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 7A|6.29|IC=0.51uM|IC50|=|0.51|uM|510|nM
2WO8|2.00|2009|077|compound 1|P39900|MACROPHAGE METALLOELASTASE|6.28|IC=0.52uM|IC50|=|0.52|uM|520|nM
2WQB|2.95|2009|QQ1|bound to the TIE2 kinase domain|Q02763|ANGIOPOIETIN-1 RECEPTOR|6.27|IC=0.54uM|IC50|=|0.54|uM|540|nM
3FQH|2.26|2009|057|compound 4|P43405|TYROSINE-PROTEIN KINASE SYK|6.24|IC=0.57uM|IC50|=|0.57|uM|570|nM
3DV1|2.10|2009|AR9|compound 2a|P56817|BETA-SECRETASE 1|6.23|IC=0.59uM|IC50|=|0.59|uM|590|nM
3FR2|2.20|2009|8CA|compound 2a|P15090|FATTY ACID-BINDING PROTEIN, ADIPOCYTE|6.23|IC=0.59uM|IC50|=|0.59|uM|590|nM
2ZV2|2.40|2009|609|ligand is STO-609|Q96RR4|CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE 2|6.3|IC=0.5uM|IC50|=|0.5|uM|500|nM
3G1M|1.70|2009|RF3|ligand is compound 2, BDM31381|P96222|TRANSCRIPTIONAL REGULATORY REPRESSOR PROTEIN|6.3|IC=0.5uM|IC50|=|0.5|uM|500|nM
3FR4|2.16|2009|F8A|compound 26, in reference table 2, n should be 1, not 2|P15090|FATTY ACID-BINDING PROTEIN, ADIPOCYTE|6.19|IC=0.65uM|IC50|=|0.65|uM|650|nM
3HP2|2.15|2009|P36|p38a in complex with compound 1|Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|6.17|IC=0.68uM|IC50|=|0.68|uM|680|nM
3FNU|3.00|2009|006||Q8IM15|HAP PROTEIN|6.16|IC=0.69uM|IC50|=|0.69|uM|690|nM
3GC7|1.80|2009|B45|ligand is compound 1|Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|9.22|IC=0.6nM|IC50|=|0.6|nM|0.6|nM
3FEJ|2.01|2009|CTM||P37231|PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA|6.13|IC=0.74uM|IC50|=|0.74|uM|740|nM
2VPP|2.20|2009|GEO|IC501=0.76+/-0.066uM(ovarian cancer cell line AG6000); IC502=29.89+/-4.27nM(glioblastoma cell line U-87M-G)|Q9XZT6|DEOXYNUCLEOSIDE KINASE|6.12|IC=0.76uM|IC50|=|0.76|uM|760|nM
2WTJ|2.10|2009|WTJ|compound 63|Q9HBS5|SERINE/THREONINE-PROTEIN KINASE CHK2|6.15|IC=0.7uM|IC50|=|0.7|uM|700|nM
3FPD|2.40|2009|Q4A||Q9H9B1|HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-9 SPECIFIC|6.15|IC=0.7uM|IC50|=|0.7|uM|700|nM
3EQ7|2.89|2009|X99|compound 6|P23687|PROLYL ENDOPEPTIDASE|9.09|IC=0.81nM|IC50|=|0.81|nM|0.81|nM
3KAF|2.30|2009|4D9|Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 with compound 18d|Q13526|PEPTIDYL-PROLYL CIS-TRANS ISOMERASE NIMA|6.08|IC=0.83uM|IC50|=|0.83|uM|830|nM
2WMX|2.45|2009|ZY6|Fragment: KINASE DOMAIN, RESIDUES 1-289|O14757|SERINE/THREONINE-PROTEIN KINASE CHK1|6.07|IC=0.86uM|IC50|=|0.86|uM|860|nM
3HW1|2.48|2009|EV2|BACE1-Compound 1 complex, IC50=0.87+/-0.26mM|P56817|BETA-SECRETASE 1|3.06|IC=0.87mM|IC50|=|0.87|mM|870000|nM
3FC2|2.45|2009|IBI|compound BI 6727|P53350|SERINE/THREONINE-PROTEIN KINASE PLK1|9.06|IC=0.87nM|IC50|=|0.87|nM|0.87|nM
3EQ8|2.73|2009|X98|compound 8|P23687|PROLYL ENDOPEPTIDASE|9.06|IC=0.88nM|IC50|=|0.88|nM|0.88|nM
3G72|1.90|2009|A6T|compound (-)-26h, in buffer IC50=0.8nM, in plasma IC50=88nM|P00797|RENIN|9.1|IC=0.8nM|IC50|=|0.8|nM|0.8|nM
3DJF|2.30|2009|BC3|BCX-34, compound 4; IC50=0.8+/-0.05uM|Q9BMI9|PURINE-NUCLEOSIDE PHOSPHORYLASE|6.1|IC=0.8uM|IC50|=|0.8|uM|800|nM
2WI5|2.10|2009|ZZ5|compound 13|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|6.05|IC=0.90uM|IC50|=|0.9|uM|900|nM
2W1D|2.97|2009|L0D|compound 5|O14965|SERINE/THREONINE-PROTEIN KINASE 6|6.04|IC=0.91uM|IC50|=|0.91|uM|910|nM
2WBB|2.22|2009|RO3|compound 1, IC50=0.92uM|P09467|FRUCTOSE-1,6-BISPHOSPHATASE 1|6.04|IC=0.92uM|IC50|=|0.92|uM|920|nM
3JZB|2.01|2009|4HY|TR alpha complex with Triac, IC50=0.97+/-0.09nM|Q6FH41|THRA PROTEIN|9.01|IC=0.97nM|IC50|=|0.97|nM|0.97|nM
2ZOQ|2.39|2009|5ID||P27361|MITOGEN-ACTIVATED PROTEIN KINASE 3|6.05|IC=0.9uM|IC50|=|0.9|uM|900|nM
3EZV|1.99|2009|EZV|inhibitor 9|P24941|CELL DIVISION PROTEIN KINASE 2|5.98|IC=1.04uM|IC50|=|1.04|uM|1040|nM
3FY0|2.35|2009|DW1|PAK1 kinase domain with ruthenium complex rac-DW12, IC50=1090+/-80nM|Q13153|SERINE/THREONINE-PROTEIN KINASE PAK 1|5.96|IC=1.09uM|IC50|=|1.09|uM|1090|nM
2WOA|2.26|2009|576|compound 7a|P39900|MACROPHAGE METALLOELASTASE|5.94|IC=1.15uM|IC50|=|1.15|uM|1150|nM
3FT4|1.90|2009|9-mer|HA-1 peptide|P01892|HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2|5.93|IC=1.17uM|IC50|=|1.17|uM|1170|nM
3JZK|2.10|2009|YIN|structure of compound 1a with human MDM2, IC50=1.23+/-0.82uM|Q00987|E3 UBIQUITIN-PROTEIN LIGASE MDM2|5.91|IC=1.23uM|IC50|=|1.23|uM|1230|nM
2W1I|2.60|2009|L0I|compound 12|O60674|TYROSINE-PROTEIN KINASE JAK2|8.92|IC=1.2nM|IC50|=|1.2|nM|1.2|nM
3HYF|1.70|2009|ON1|p15-Ec in complex with compound 9|Q72547|REVERSE TRANSCRIPTASE/RNASEH|5.92|IC=1.2uM|IC50|=|1.2|uM|1200|nM
3A4O|3.00|2009|STU||P07948|TYROSINE-PROTEIN KINASE LYN|8.89|IC=1.3nM|IC50|=|1.3|nM|1.3|nM
3E0Q|1.90|2009|JFD|compound Sm_VS1; IC50=1.30+/-0.07uM|Q9BMI9|PURINE-NUCLEOSIDE PHOSPHORYLASE|5.89|IC=1.3uM|IC50|=|1.3|uM|1300|nM
3F9N|1.90|2009|38M|compound 38|O14757|SERINE/THREONINE-PROTEIN KINASE CHK1|5.89|IC=1.3uM|IC50|=|1.3|uM|1300|nM
3FCI|1.27|2009|3FI|compound 6|P13051|URACIL-DNA GLYCOSYLASE|5.89|IC=1.3uM|IC50|=|1.3|uM|1300|nM
3DP0|2.50|2009|2BC|compound 3m, IC50=1.42+/-0.28uM|Q5G940|(3R)-HYDROXYMYRISTOYL-ACYL CARRIER PROTEIN|5.85|IC=1.42uM|IC50|=|1.42|uM|1420|nM
3K3G|2.40|2009|MMU|Urea Transporter Bound to 1, 3-dimethylurea, IC50=1.4+/-0.2mM|Q72CX3|UREA TRANSPORTER|2.85|IC=1.4mM|IC50|=|1.4|mM|1400000|nM
3D28|2.30|2009|B34|compound 3|P26663|RNA-DIRECTED RNA POLYMERASE|5.85|IC=1.4uM|IC50|=|1.4|uM|1400|nM
3DUY|1.97|2009|AFJ|compound 1|P56817|BETA-SECRETASE 1|5.85|IC=1.4uM|IC50|=|1.4|uM|1400|nM
3DP2|2.40|2009|4BE|compound 3j, IC50=1.50+/-0.25uM|Q5G940|(3R)-HYDROXYMYRISTOYL-ACYL CARRIER PROTEIN|5.82|IC=1.50uM|IC50|=|1.5|uM|1500|nM
3DOY|2.40|2009|2BE|compound 3i, IC50=1.52+/-0.19uM|Q5G940|(3R)-HYDROXYMYRISTOYL-ACYL CARRIER PROTEIN|5.82|IC=1.52uM|IC50|=|1.52|uM|1520|nM
3DP3|2.30|2009|4BB|compound 3q, IC50=1.52+/-0.11uM|Q5G940|(3R)-HYDROXYMYRISTOYL-ACYL CARRIER PROTEIN|5.82|IC=1.52uM|IC50|=|1.52|uM|1520|nM
2WI4|2.40|2009|ZZ4|compound 12|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|5.81|IC=1.56uM|IC50|=|1.56|uM|1560|nM
3FZS|1.75|2009|B96|compound BIRB796|Q14289|PROTEIN-TYROSINE KINASE 2 BETA|5.82|IC=1.5uM|IC50|=|1.5|uM|1500|nM
3FTW|1.85|2009|11X|ligand is compound 4|P09960|LEUKOTRIENE A-4 HYDROLASE|2.78|IC=1.67mM|IC50|=|1.67|mM|1670000|nM
3EYG|1.90|2009|MI1|JAK1-CP-690, 550 complex|Q59GQ2|TYROSINE-PROTEIN KINASE|8.8|IC=1.6nM|IC50|=|1.6|nM|1.6|nM
3IDP|2.70|2009|L1E|B-Raf V600E kinase domain in complex with compound 1|P15056|B-RAF PROTO-ONCOGENE SERINE/THREONINE-PROTEIN KINASE|8.8|IC=1.6nM|IC50|=|1.6|nM|1.6|nM
3IL5|2.60|2009|B82|E. faecalis FabH in complex with compound 13a|Q820T1|3-OXOACYL-[ACYL-CARRIER-PROTEIN] SYNTHASE 3|5.8|IC=1.6uM|IC50|=|1.6|uM|1600|nM
2ZVJ|2.30|2009|KOM||P22734|CATECHOL O-METHYLTRANSFERASE|5.74|IC=1.8uM|IC50|=|1.8|uM|1800|nM
3HJ0|1.34|2009|A93|compound 4 is a covalent small molecule kinetic stabilizer|P02766|TRANSTHYRETIN|5.71|IC=1.96uM|IC50|=|1.96|uM|1960|nM
3DOZ|2.50|2009|3BE|compound 3k, IC50=1.98+/-0.21uM|Q5G940|(3R)-HYDROXYMYRISTOYL-ACYL CARRIER PROTEIN|5.7|IC=1.98uM|IC50|=|1.98|uM|1980|nM
3K3I|1.70|2009|JZJ|p38 alpha bound to novel DGF-out compound PF-00215955|Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|5.72|IC=1.9uM|IC50|=|1.9|uM|1900|nM
3FMR|2.89|2009|TN4||Q8SR45|METHIONINE AMINOPEPTIDASE 2|7.97|IC=10.6nM|IC50|=|10.6|nM|10.6|nM
3FCK|1.64|2009|FCK|compound 22|P13051|URACIL-DNA GLYCOSYLASE|4.0|IC=100uM|IC50|=|100|uM|100000|nM
3HY7|1.69|2009|097|compound Marimastat|Q9UNA0|A DISINTEGRIN AND METALLOPROTEINASE WITH|6.97|IC=106nM|IC50|=|106|nM|106|nM
3FU6|2.05|2009|80G|compound 9, IC50=106+/-20uM|P09960|LEUKOTRIENE A-4 HYDROLASE|3.97|IC=106uM|IC50|=|106|uM|106000|nM
3H2A|2.40|2009|B57|Dihydropteroate Synthase with compound 7|B1UXN2|DIHYDROPTEROATE SYNTHASE|3.96|IC=108.9uM|IC50|=|108.9|uM|108900|nM
3CO9|2.10|2009|3MS|IC50<10nM, compound 3c|P26663|RNA-DIRECTED RNA POLYMERASE|8.0|IC=10nM|IC50|=|10|nM|10|nM
3CWJ|2.40|2009|321|IC50<10nM, compound 3a|Q99AU2|RNA-DIRECTED RNA POLYMERASE|8.0|IC=10nM|IC50|=|10|nM|10|nM
3EZR|1.90|2009|EZR|inhibitor 17|P24941|CELL DIVISION PROTEIN KINASE 2|5.0|IC=10uM|IC50|=|10|uM|10000|nM
3FMQ|2.50|2009|FUG||Q8SR45|METHIONINE AMINOPEPTIDASE 2|7.95|IC=11.1nM|IC50|=|11.1|nM|11.1|nM
3HQY|2.00|2009|PF6|cAMP and cAMP-inhibited cGMP 3, 5-cyclic phosphodiesterase 10A with compound 2|Q9QYJ6|PHOSPHODIESTERASE|7.94|IC=11.5nM|IC50|=|11.5|nM|11.5|nM
3HHM|2.80|2009|KWT|three quite different data in references|P42336|PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE|7.92|IC=11.9nM|IC50|=|11.9|nM|11.9|nM
3JZQ|1.80|2009|12-mer|ligand is 12-mer peptide inhibitor pDIQ|O15151|PROTEIN MDM4|6.96|IC=110nM|IC50|=|110|nM|110|nM
3FTV|1.70|2009|11X|compound 4, IC50=1167+/-168uM|P09960|LEUKOTRIENE A-4 HYDROLASE|2.93|IC=1167uM|IC50|=|1167|uM|1167000|nM
3E3B|3.20|2009|CCK|compound CC04820 complex with hCK2-alpha2|P19784|CASEIN KINASE II SUBUNIT ALPHA|7.96|IC=11nM|IC50|=|11|nM|11|nM
3FZR|2.70|2009|3JZ|compound PF-431396|Q14289|PROTEIN-TYROSINE KINASE 2 BETA|7.96|IC=11nM|IC50|=|11|nM|11|nM
3HXF|1.90|2009|BD9|Engineered RabGGTase complex with compound 32, IC50=11+/-1.2uM|Q08602|GERANYLGERANYL TRANSFERASE TYPE-2 SUBUNIT ALPHA|4.96|IC=11uM|IC50|=|11|uM|11000|nM
2W70|1.77|2009|L22|compound 6a|P24182|BIOTIN CARBOXYLASE|4.92|IC=12.0uM|IC50|=|12|uM|12000|nM
3DGQ|1.60|2009|EAA|ligand is ethacrynic acid|P09211|GLUTATHIONE S-TRANSFERASE P|4.92|IC=12.0uM|IC50|=|12|uM|12000|nM
3HHA|1.27|2009|NOW|cathepsin L in complex with AZ12878478 compound 26, pIC50=7.9, 1.26x10-8M|P07711|CATHEPSIN L1|7.9|IC=12.6nM|IC50|=|12.6|nM|12.6|nM
2W1E|2.93|2009|L0E|compound 10|O14965|SERINE/THREONINE-PROTEIN KINASE 6|7.92|IC=12nM|IC50|=|12|nM|12|nM
3FI3|2.20|2009|JK2|compound SR3737|P53779|MITOGEN-ACTIVATED PROTEIN KINASE 10|7.92|IC=12nM|IC50|=|12|nM|12|nM
3FXZ|1.64|2009|FLL|PAK1 kinase domain with ruthenium complex lambda-FL172, IC50=130+/-10nM|Q13153|SERINE/THREONINE-PROTEIN KINASE PAK 1|6.89|IC=130nM|IC50|=|130|nM|130|nM
3H03|1.90|2009|UBP|GluR2 AMPA receptor with UBP277, IC50=135+/-12uM|P19491|GLUTAMATE RECEPTOR 2|3.87|IC=135uM|IC50|=|135|uM|135000|nM
2WF4|1.80|2009|ZY4|different ligand structure|P56817|BETA-SECRETASE 1|7.89|IC=13nM|IC50|=|13|nM|13|nM
3A29|2.60|2009|2T0|compound 8L|P09467|FRUCTOSE-1,6-BISPHOSPHATASE 1|7.89|IC=13nM|IC50|=|13|nM|13|nM
3E3U|1.56|2009|NVC||P96275|PEPTIDE DEFORMYLASE|7.89|IC=13nM|IC50|=|13|nM|13|nM
3F8S|2.43|2009|PF2|compound 5, IC50=12.9+/-4.6uM|P27487|DIPEPTIDYL PEPTIDASE 4|7.89|IC=13nM|IC50|=|13|nM|13|nM
3I81|2.08|2009|EBI|compound 9d cocrystallized with IGF-1R|P08069|INSULIN-LIKE GROWTH FACTOR 1 RECEPTOR|7.89|IC=13nM|IC50|=|13|nM|13|nM
3H3C|2.00|2009|P1E|PYK2 in complex with compound 2a, cell IC50=88nM|Q14289|PROTEIN-TYROSINE KINASE 2 BETA|6.85|IC=140nM|IC50|=|140|nM|140|nM
3FU3|2.00|2009|92G|compound 7, IC50=1443+/-63uM|P09960|LEUKOTRIENE A-4 HYDROLASE|2.84|IC=1443uM|IC50|=|1443|uM|1443000|nM
3E51|1.90|2009|N35|compound 2e|P26663|RNA-DIRECTED RNA POLYMERASE|7.85|IC=14nM|IC50|=|14|nM|14|nM
3ETA|2.60|2009|351|compound 19|P06213|INSULIN RECEPTOR, KINASE DOMAIN|7.85|IC=14nM|IC50|=|14|nM|14|nM
2W6Z|1.90|2009|L21|compound 5|P24182|BIOTIN CARBOXYLASE|2.82|IC=1500uM|IC50|=|1500|uM|1500000|nM
2V5A|2.31|2009|LZL|inhibitor 3|P24182|BIOTIN CARBOXYLASE|6.82|IC=150nM|IC50|=|150|nM|150|nM
3FUE|2.38|2009|11S|compound 12, IC50=1510+/-139uM|P09960|LEUKOTRIENE A-4 HYDROLASE|2.82|IC=1510uM|IC50|=|1510|uM|1510000|nM
3DZ6|1.83|2009|M8E|compound 14e|P17707|S-ADENOSYLMETHIONINE DECARBOXYLASE BETA CHAIN|7.82|IC=15nM|IC50|=|15|nM|15|nM
3FT5|1.90|2009|MO8|fragment 1 complex with hsp90|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|4.82|IC=15uM|IC50|=|15|uM|15000|nM
3H0V|2.24|2009|M2T|Human AdoMetDC and MMTA|P17707|S-ADENOSYLMETHIONINE DECARBOXYLASE PROENZYME|4.82|IC=15uM|IC50|=|15|uM|15000|nM
3FAL|2.36|2009|LO2|compound 19|P19793|RETINOIC ACID RECEPTOR RXR-ALPHA|6.78|IC=165nM|IC50|=|165|nM|165|nM
3KBA|2.00|2009|WOW|Progesterone receptor bound to Compound 20|P06401|PROGESTERONE RECEPTOR|7.8|IC=16nM|IC50|=|16|nM|16|nM
3KCE|1.90|2009|4BY|Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 with compound 4|Q13526|PEPTIDYL-PROLYL CIS-TRANS ISOMERASE NIMA|4.8|IC=16uM|IC50|=|16|uM|16000|nM
3FUM|2.15|2009|80A|compound 17, IC50=170+/-5uM|P09960|LEUKOTRIENE A-4 HYDROLASE|3.77|IC=170uM|IC50|=|170|uM|170000|nM
3ET7|2.70|2009|349|PYK2 complexed with compound PF-2318841|Q14289|PROTEIN-TYROSINE KINASE 2 BETA|7.77|IC=17nM|IC50|=|17|nM|17|nM
3HY9|2.02|2009|098|compound 11|Q9UNA0|CATALYTIC DOMAIN OF ADAMTS-5|7.77|IC=17nM|IC50|=|17|nM|17|nM
3H23|2.20|2009|B54|Dihydropteroate Synthase with compound 4|B1UXN2|DIHYDROPTEROATE SYNTHASE|4.71|IC=19.3uM|IC50|=|19.3|uM|19300|nM
3GWU|2.14|2009|SRE|Leucine transporter LeuT in complex with sertraline, IC50=19.7+/-9.2uM|O67854|TRANSPORTER|4.71|IC=19.7uM|IC50|=|19.7|uM|19700|nM
3H21|2.32|2009|B52|Dihydropteroate Synthase with compound 2|B1UXN2|DIHYDROPTEROATE SYNTHASE|4.7|IC=19.8uM|IC50|=|19.8|uM|19800|nM
2WF3|2.08|2009|ZY3|compound 11, in reference, CF3 group is different from O-CH3 in PDB|P56817|BETA-SECRETASE 1|7.72|IC=19nM|IC50|=|19|nM|19|nM
3E8N|2.50|2009|VRA|compound RDEA119|Q02750|DUAL SPECIFICITY MITOGEN-ACTIVATED PROTEIN KINASE|7.72|IC=19nM|IC50|=|19|nM|19|nM
3EKA|3.10|2009|ASC||Q9A0M7|HYALURONIDASE, PHAGE ASSOCIATED|3.0|IC=1mM|IC50|=|1|mM|1000000|nM
3I0S|2.70|2009|RT7|HIV reverse transcriptase in complex with inhibitor 7|P04585|HIV-1 REVERSE TRANSCRIPTASE/RIBONUCLEASE H|9.0|IC=1nM|IC50|=|1|nM|1|nM
2W0D|2.00|2009|CGS||P39900|MACROPHAGE METALLOELASTASE|8.7|IC=2.0nM|IC50|=|2|nM|2|nM
3IK3|1.90|2009|0LI||P00520|TYROSINE-PROTEIN KINASE ABL1|8.7|IC=2.0nM|IC50|=|2|nM|2|nM
3IW4|2.80|2009|LW4|PKC alpha in complex with NVP-AEB071, compound 1, IC50=2.1+/-0.2nM|P17252|PROTEIN KINASE C ALPHA TYPE|8.68|IC=2.1nM|IC50|=|2.1|nM|2.1|nM
3JSI|2.72|2009|WTC|Human phosphodiesterase 9 in complex with inhibitor 2, see support info|O76083|CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE-9|8.68|IC=2.1nM|IC50|=|2.1|nM|2.1|nM
3HA6|2.36|2009|2JZ|compound 10; covalent complex|O14965|SERINE/THREONINE-PROTEIN KINASE 6|5.68|IC=2.1uM|IC50|=|2.1|uM|2100|nM
3F88|2.60|2009|3HT|compound 20x, combine 3 letter code ligand 2HT and 3HT|P49841|GLYCOGEN SYNTHASE KINASE-3 BETA|8.64|IC=2.3nM|IC50|=|2.3|nM|2.3|nM
3GWV|2.35|2009|RFX|Leucine transporter LeuT in complex with R-fluoxetine, IC50=2.54+/-0.41mM|O67854|TRANSPORTER|2.6|IC=2.54mM|IC50|=|2.54|mM|2540000|nM
2WGS|2.55|2009|1AZ|IC50=2.5+/-0.4uM|P0A590|GLUTAMINE SYNTHETASE 1|5.6|IC=2.5uM|IC50|=|2.5|uM|2500|nM
2ZIS|2.60|2009|NH8|compound 8k|Q04631|FARNESYLTRANSFERASE ALPHA SUBUNIT|8.55|IC=2.8nM|IC50|=|2.8|nM|2.8|nM
3G6G|2.31|2009|G6G|Proto-oncogene tyrosine-protein kinase Src and DSA8, IC50=2.8+/-0.3nM|P00523|TYROSINE-PROTEIN KINASE SRC|8.55|IC=2.8nM|IC50|=|2.8|nM|2.8|nM
3KFC|2.40|2009|61X|Compound 7e was cocrystallized with LXRbeta|P55055|OXYSTEROLS RECEPTOR LXR-BETA|8.55|IC=2.8nM|IC50|=|2.8|nM|2.8|nM
3FKT|1.90|2009|SII|inhibitor compound 16, IC50=2.8+/-0.12uM|P56817|BETA-SECRETASE 1|5.55|IC=2.8uM|IC50|=|2.8|uM|2800|nM
3JZC|2.50|2009|4HY|TR beta complex with Triac, IC50=2.94+/-0.52nM|P10828|THYROID HORMONE RECEPTOR BETA-1|8.53|IC=2.94nM|IC50|=|2.94|nM|2.94|nM
3HC8|1.79|2009|PD4|compound 1 Aminopyridiopyrazinones as PDE5 Inhibitors|O76074|CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE|8.54|IC=2.9nM|IC50|=|2.9|nM|2.9|nM
3FUF|2.60|2009|14O|compound 13, IC50>=2000uM|P09960|LEUKOTRIENE A-4 HYDROLASE|2.7|IC=2000uM|IC50|=|2000|uM|2000000|nM
3FUH|1.80|2009|5H1|compound 11 with bestatin, IC50>=2000uM|P09960|LEUKOTRIENE A-4 HYDROLASE|2.7|IC=2000uM|IC50|=|2000|uM|2000000|nM
3FUD|2.20|2009|692|compound 10, IC50>=2000uM|P09960|LEUKOTRIENE A-4 HYDROLASE|2.7|IC=2000uM|IC50|=|2000|uM|2000000|nM
3EX2|1.55|2009|6CN||P11172|OROTIDINE-5'-PHOSPHATE DECARBOXYLASE|3.7|IC=200uM|IC50|=|200|uM|200000|nM
2WHO|2.00|2009|VGI|compound1 with Delta C55-1b NS5B polymerase; IC50=20nM|P26663|RNA-DIRECTED RNA POLYMERASE|7.7|IC=20nM|IC50|=|20|nM|20|nM
2ZYB|2.55|2009|KSL|compound 4|P06239|TYROSINE-PROTEIN KINASE LCK|7.7|IC=20nM|IC50|=|20|nM|20|nM
3EYH|2.00|2009|IZA|JAK1-CMP6 complex|Q59GQ2|TYROSINE-PROTEIN KINASE|7.7|IC=20nM|IC50|=|20|nM|20|nM
3DG8|2.58|2009|RJ6|RJF 00670 with bifunctional quadruple mutant TS-DHFR, IC50=20+/-2uM|Q8I1R6|BIFUNCTIONAL DIHYDROFOLATE REDUCTASE-THYMIDYLATE|4.7|IC=20uM|IC50|=|20|uM|20000|nM
2W6M|2.00|2009|OA1|compound 2|P24182|BIOTIN CARBOXYLASE|4.67|IC=21.5uM|IC50|=|21.5|uM|21500|nM
3FUP|2.40|2009|MI1|JAK2-CP-690, 550 complex|O60674|TYROSINE-PROTEIN KINASE JAK2|7.66|IC=21.7nM|IC50|=|21.7|nM|21.7|nM
3FHR|1.90|2009|P4O||Q16644|MAP KINASE-ACTIVATED PROTEIN KINASE 3|6.68|IC=210nM|IC50|=|210|nM|210|nM
3H2N|2.40|2009|B62|Dihydropteroate Synthase with compound 18|B1UXN2|DIHYDROPTEROATE SYNTHASE|3.67|IC=212.6uM|IC50|=|212.6|uM|212600|nM
3FTS|2.33|2009|STL|compound 2, IC50=212+/-40uM|P09960|LEUKOTRIENE A-4 HYDROLASE|3.67|IC=212uM|IC50|=|212|uM|212000|nM
3H2M|2.31|2009|B61|Dihydropteroate Synthase with compound 17|B1UXN2|DIHYDROPTEROATE SYNTHASE|3.67|IC=215uM|IC50|=|215|uM|215000|nM
3HRB|2.20|2009|I39|unphosphorylated p38 alpha complexed with compound 45, IC50=21+/-1.8nM|Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|7.68|IC=21nM|IC50|=|21|nM|21|nM
2W12|1.46|2009|WR2|X-ray(PH=6.5), where get the PH value|P83512|ZINC METALLOPROTEINASE BAP1|4.65|IC=22.2uM|IC50|=|22.2|uM|22200|nM
3CDE|2.10|2009|N3H||P26663|RNA-DIRECTED RNA POLYMERASE|7.66|IC=22nM|IC50|=|22|nM|22|nM
3D25|1.30|2009|9-mer|VLH/R peptides bound to HLA-A2, IC50=22nM. Kd=35uM is for KP7 TCR/HLA-A2-VLH interaction|P01892|HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2|7.66|IC=22nM|IC50|=|22|nM|22|nM
3DV5|2.10|2009|BAV|compound 3|P56817|BETA-SECRETASE 1|7.66|IC=22nM|IC50|=|22|nM|22|nM
3G76|3.00|2009|CZ3|XIAP-BIR3 in complex with a bivalent compound, IC50=230.8+/-32.8nM|P98170|BACULOVIRAL IAP REPEAT-CONTAINING PROTEIN 4|6.64|IC=230.8nM|IC50|=|230.8|nM|230.8|nM
3HV6|1.95|2009|R39|compound 12; IC501=2300+/-260nM(EFC, enzyme fragment complementation); IC502=5500+/-2800nM(HTRF, homogeneoustime-resolved fluorescence)|Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|5.64|IC=2300nM|IC50|=|2300|nM|2300|nM
3FUJ|1.90|2009|00G|compound 15, wrong N cycle is aromatic in PDB, IC50=234+/-21uM|P09960|LEUKOTRIENE A-4 HYDROLASE|3.63|IC=234uM|IC50|=|234|uM|234000|nM
2W0J|2.05|2009|ZAT||O96017|SERINE/THREONINE-PROTEIN KINASE CHK2|6.62|IC=240nM|IC50|=|240|nM|240|nM
3F7U|2.00|2009|AG4|compound 6d|P22748|CARBONIC ANHYDRASE 4|6.61|IC=246nM|IC50|=|246|nM|246|nM
3FTU|1.90|2009|RE2|compound 3, IC50=247+/-26uM|P09960|LEUKOTRIENE A-4 HYDROLASE|3.61|IC=247uM|IC50|=|247|uM|247000|nM
2W7X|2.07|2009|D1A||O96017|SERINE/THREONINE-PROTEIN KINASE CHK2|7.62|IC=24nM|IC50|=|24|nM|24|nM
3EWU|1.60|2009|UEP|6-acetyl-UMP, covalent adduct; IC50=24+/-13uM|P11172|OROTIDINE-5'-PHOSPHATE DECARBOXYLASE|4.62|IC=24uM|IC50|=|24|uM|24000|nM
3EXO|2.10|2009|5MS||P56817|BETA-SECRETASE 1|4.62|IC=24uM|IC50|=|24|uM|24000|nM
2W6Q|2.05|2009|OA5|compound 4, the author miss a carbon atom in reference|P24182|BIOTIN CARBOXYLASE|4.6|IC=25.4uM|IC50|=|25.4|uM|25400|nM
3H2O|2.70|2009|B63|Dihydropteroate Synthase with compound 19|B1UXN2|DIHYDROPTEROATE SYNTHASE|4.59|IC=25.9uM|IC50|=|25.9|uM|25900|nM
3EJS|1.35|2009|HN5|compound 7|Q24451|ALPHA-MANNOSIDASE II|6.6|IC=250nM|IC50|=|250|nM|250|nM
3EJU|1.32|2009|HN7|compound 5|Q24451|ALPHA-MANNOSIDASE II|6.6|IC=250nM|IC50|=|250|nM|250|nM
3JZP|1.74|2009|12-mer|ligand is 12-mer peptide inhibitor pDI6W|O15151|PROTEIN MDM4|6.6|IC=250nM|IC50|=|250|nM|250|nM
2WCX|2.00|2009|VGC|compound 9a|P26663|RNA-DIRECTED RNA POLYMERASE|7.6|IC=25nM|IC50|=|25|nM|25|nM
3FI2|2.28|2009|JK1|compound SR3451|P53779|MITOGEN-ACTIVATED PROTEIN KINASE 10|7.6|IC=25nM|IC50|=|25|nM|25|nM
3KFA|1.22|2009|B91|Tyrosine-protein kinase transforming protein Abl complex AP24163, IC50=25nM|P00520|TYROSINE-PROTEIN KINASE ABL1|7.6|IC=25nM|IC50|=|25|nM|25|nM
2WF2|1.80|2009|ZY2|compound 10, in reference, CF3 group is different from O-CH3 in PDB|P56817|BETA-SECRETASE 1|7.59|IC=26nM|IC50|=|26|nM|26|nM
3DTC|2.60|2009|VIN|IC50=26+/-12nM, compound 16|P80192|MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9|7.59|IC=26nM|IC50|=|26|nM|26|nM
2WU6|1.92|2009|DKI|Fragment: RESIDUES 127-484 ; IC50=29.2+/-8nM;|P49761|DUAL SPECIFICITY PROTEIN KINASE CLK3|7.53|IC=29.2nM|IC50|=|29.2|nM|29.2|nM
3DGA|2.70|2009|RJ1|PfDHFR-TS complexed with RJF01302, IC50=29.9+/-0.5uM|Q8I1R6|BIFUNCTIONAL DIHYDROFOLATE REDUCTASE-THYMIDYLATE|4.52|IC=29.9uM|IC50|=|29.9|uM|29900|nM
3H06|2.80|2009|VBP|GluR2 AMPA receptor with UBP277, IC50=292+/-26uM|P19491|GLUTAMATE RECEPTOR 2|3.53|IC=292uM|IC50|=|292|uM|292000|nM
3HVG|2.26|2009|EV0|BACE1-Compound 8 complex, IC50=2+/-0.6mM|P56817|BETA-SECRETASE 1|2.7|IC=2mM|IC50|=|2|mM|2000000|nM
2WF1|1.60|2009|ZY1|compound 9, in reference, CF3 group is different from O-CH3 in PDB|P56817|BETA-SECRETASE 1|8.7|IC=2nM|IC50|=|2|nM|2|nM
3DA6|2.00|2009|BZ9|IC501=2+/-0.7nM(Tie-2/BZ9)|P53779|MITOGEN-ACTIVATED PROTEIN KINASE 10|8.7|IC=2nM|IC50|=|2|nM|2|nM
3HWN|2.33|2009|BD3|CATHEPSIN L with AZ13010160, pIC50=8.7, 2nM|P07711|CATHEPSIN L1|8.7|IC=2nM|IC50|=|2|nM|2|nM
3D3P|1.75|2009|20A|compound 20a, pIC50=8.5, IC50=3.16nM, not 2.76nM|Q07343|CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B|8.5|IC=3.16nM|IC50|=|3.16|nM|3.16|nM
3GFE|2.10|2009|P37|p38a Mitogen-Activated Protein Kinase with a Pyrazolopyridinone Inhibitor|Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|8.49|IC=3.2nM|IC50|=|3.2|nM|3.2|nM
3H0B|2.70|2009|B35|aminoheterocycles as a novel beta-secretase inhibitor, IC50 pH 6.4=3.2uM|P56817|BETA-SECRETASE 1|5.49|IC=3.2uM|IC50|=|3.2|uM|3200|nM
2WEI|1.65|2009|VGG|IC50=3.4+/-0.1nM; Fragment: RESIDUES 70-338;|A3FQ16|CALMODULIN-DOMAIN PROTEIN KINASE 1|8.47|IC=3.4nM|IC50|=|3.4|nM|3.4|nM
3KL6|1.45|2009|443|TAK-442|P00742|COAGULATION FACTOR X, HEAVY CHAIN|8.46|IC=3.5nM|IC50|=|3.5|nM|3.5|nM
3GS7|1.80|2009|8BD|Human transthyretin (TTR) complexed inhibitor 13, inhibition rate 51% at 3.6uM|P02766|TRANSTHYRETIN|5.44|IC=3.6uM|IC50|=|3.6|uM|3600|nM
2W6C|2.69|2009|BM4|IC50=3.9+/-1.3nM|P04058|ACETYLCHOLINESTERASE|8.41|IC=3.9nM|IC50|=|3.9|nM|3.9|nM
3KAI|1.90|2009|4FI|Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 with compound 23b|Q13526|PEPTIDYL-PROLYL CIS-TRANS ISOMERASE NIMA|5.41|IC=3.9uM|IC50|=|3.9|uM|3900|nM
3FT8|2.00|2009|MOJ|compound 19|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|7.52|IC=30nM|IC50|=|30|nM|30|nM
2VUR|2.20|2009|YX1|IC50=30uM, but no dose-response curves shows IC50>10mM for cpOGA|Q0TR53|O-GLCNACASE NAGJ|4.52|IC=30uM|IC50|=|30|uM|30000|nM
3G4F|2.65|2009|FPF|incubated with the enzyme and 10uM FPP, 2F-FPP exhibits an IC50 value|Q39761|(+)-DELTA-CADINENE SYNTHASE ISOZYME XC1|4.52|IC=30uM|IC50|=|30|uM|30000|nM
3KSL|2.05|2009|SZH|RnPFTase:4 complexes|Q5RKJ4|FARNESYLTRANSFERASE, CAAX BOX, ALPHA|4.52|IC=30uM|IC50|=|30|uM|30000|nM
3HV4|2.60|2009|L51|compound 21; IC501=310+/-50nM(EFC, enzyme fragment complementation); IC502=290+/-80nM(HTRF, homogeneoustime-resolved fluorescence)|Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|6.51|IC=310nM|IC50|=|310|nM|310|nM
3FCL|1.70|2009|3FL|compound 27|P13051|URACIL-DNA GLYCOSYLASE|3.5|IC=315uM|IC50|=|315|uM|315000|nM
3H26|2.50|2009|B56|Dihydropteroate Synthase with compound 6|B1UXN2|DIHYDROPTEROATE SYNTHASE|4.49|IC=32.4uM|IC50|=|32.4|uM|32400|nM
3FQA|2.35|2009|GAB&PMP|IC50=320+/-0.015mM, GSAMM248I-Gabaculine|P24630|GLUTAMATE-1-SEMIALDEHYDE 2,1-AMINOMUTASE|0.49|IC=320mM|IC50|=|320|mM|320000000|nM
3FDN|1.90|2009|MMH|compound 12w|O14965|SERINE/THREONINE-PROTEIN KINASE 6|7.48|IC=33nM|IC50|=|33|nM|33|nM
3F3W|2.60|2009|1BU|IC50=34+/-12nM|P00523|TYROSINE-PROTEIN KINASE SRC|7.47|IC=34nM|IC50|=|34|nM|34|nM
2WI2|2.09|2009|ZZ3|compound 10, X-ray structure(cocrystal)|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|3.46|IC=350uM|IC50|=|350|uM|350000|nM
2WI3|1.90|2009|ZZ3|compound 10, X-ray structure(soak)|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|3.46|IC=350uM|IC50|=|350|uM|350000|nM
3GWW|2.46|2009|SFX|Leucine transporter LeuT in complex with S-fluoxetine, IC50=355+/-46mM|O67854|TRANSPORTER|0.45|IC=355mM|IC50|=|355|mM|355000000|nM
3HQW|1.70|2009|PF4|cAMP and cAMP-inhibited cGMP 3, 5-cyclic phosphodiesterase 10A with compound 1|Q9QYJ6|PHOSPHODIESTERASE|7.46|IC=35nM|IC50|=|35|nM|35|nM
3JZR|2.10|2009|12-mer|ligand is 12-mer peptide inhibitor pDI6W|Q00987|E3 UBIQUITIN-PROTEIN LIGASE MDM2|7.44|IC=36nM|IC50|=|36|nM|36|nM
3EX3|1.45|2009|U5P|6-azido-UMP, covalent adduct, IC50=36+/-17uM|P11172|OROTIDINE-5'-PHOSPHATE DECARBOXYLASE|4.44|IC=36uM|IC50|=|36|uM|36000|nM
3HFJ|2.02|2009|DZ9|Bacillus anthracis nadD in complex with compound 3_02|Q6HT60|NICOTINATE (NICOTINAMIDE) NUCLEOTIDE ADENYLYLTRANSFERASE|4.44|IC=36uM|IC50|=|36|uM|36000|nM
2JLE|2.90|2009|I15|compound 6, K103N mutant IC50=384+/-30nM, wt IC50=50+/-8.5nM|Q72547|HIV-1 REVERSE TRANSCRIPTASE/RNASEH|6.42|IC=384nM|IC50|=|384|nM|384|nM
2WFG|2.20|2009|ZZB|include special element B|Q5A9A4|CYTOSOLIC LEUCYL-TRNA SYNTHETASE|4.42|IC=38uM|IC50|=|38|uM|38000|nM
3IGB|2.24|2009|454|Beta-secretase 1 complex compound 3|P56817|BETA-SECRETASE 1|4.42|IC=38uM|IC50|=|38|uM|38000|nM
2ZZU|2.50|2009|359|Fragment: UNP RESIDUES 61-212 ; UNP RESIDUES 213-466 ; UNP RESIDUES 33-250 ;|P08709|COAGULATION FACTOR VII LIGHT CHAIN|7.41|IC=39nM|IC50|=|39|nM|39|nM
3FQ7|2.15|2009|PXG|IC50=3+/-0.008mM, GSAMWT-mCPP|P24630|GLUTAMATE-1-SEMIALDEHYDE 2,1-AMINOMUTASE|2.52|IC=3mM|IC50|=|3|mM|3000000|nM
2W1G|2.71|2009|L0G|compound 16|O14965|SERINE/THREONINE-PROTEIN KINASE 6|8.52|IC=3nM|IC50|=|3|nM|3|nM
3H5U|1.95|2009|H5U|structure 5 bound to C Delta 21 NS5B polymerase, IC50=0.003uM|P26663|RNA-DIRECTED RNA POLYMERASE|8.52|IC=3nM|IC50|=|3|nM|3|nM
3I0R|2.98|2009|RT3|HIV reverse transcriptase in complex with inhibitor 3|P04585|HIV-1 REVERSE TRANSCRIPTASE/RIBONUCLEASE H|8.52|IC=3nM|IC50|=|3|nM|3|nM
3IA6|2.31|2009|UNT|nuclear hormone receptor PPAR-gamma with compound 17j, IC50=0.003uM|P37231|PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA|8.52|IC=3nM|IC50|=|3|nM|3|nM
3E37|1.80|2009|ED5|compound 5, IC501=4050nM(Human FTase); IC502=3.0nM(P. falciparum FTase)|P49354|FARNESYLTRANSFERASE|5.39|IC=4.05uM|IC50|=|4.05|uM|4050|nM
3DPK|1.95|2009|8C5||P07333|MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR|8.39|IC=4.1nM|IC50|=|4.1|nM|4.1|nM
3FC8|1.85|2009|IFA|compound 23b|P02766|TRANSTHYRETIN|5.39|IC=4.1uM|IC50|=|4.1|uM|4100|nM
3HXB|2.25|2009|BD5|Engineered RabGGTase complex with compound 6, IC50=4.1+/-0.2uM|Q08602|GERANYLGERANYL TRANSFERASE TYPE-2 SUBUNIT ALPHA|5.39|IC=4.1uM|IC50|=|4.1|uM|4100|nM
3HAB|2.10|2009|677|DPP4 in complex with piperidine fused benzimidazole 25, IC50=0.0042uM|P27487|DIPEPTIDYL PEPTIDASE 4|8.38|IC=4.2nM|IC50|=|4.2|nM|4.2|nM
3H0Z|2.92|2009|45B|Aurora A in complex with a bisanilinopyrimidine, compound 9|O14965|SERINE/THREONINE-PROTEIN KINASE 6|8.37|IC=4.3nM|IC50|=|4.3|nM|4.3|nM
3HXE|1.95|2009|BD8|Engineered RabGGTase complex with compound 37, IC50=4.7+/-0.1uM; dissociation constant(KI)=5.4uM|Q08602|GERANYLGERANYL TRANSFERASE TYPE-2 SUBUNIT ALPHA|5.33|IC=4.7uM|IC50|=|4.7|uM|4700|nM
3FCB|1.80|2009|IFB|compound 22b|P02766|TRANSTHYRETIN|5.31|IC=4.9uM|IC50|=|4.9|uM|4900|nM
3DZ4|1.84|2009|C8M|compound 17d|P17707|S-ADENOSYLMETHIONINE DECARBOXYLASE BETA CHAIN|6.4|IC=400nM|IC50|=|400|nM|400|nM
3HDM|2.60|2009|MMG|serum and glucocorticoid-regulated kinase 1 complex with compound 1|O00141|SERINE/THREONINE-PROTEIN KINASE SGK1|7.4|IC=40nM|IC50|=|40|nM|40|nM
3KF7|2.00|2009|L9G|structure of p38a in complex with compound 61|Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|7.4|IC=40nM|IC50|=|40|nM|40|nM
3FCF|1.84|2009|FCF|compound 14|P13051|URACIL-DNA GLYCOSYLASE|4.4|IC=40uM|IC50|=|40|uM|40000|nM
3ITU|1.58|2009|IBM|hPDE2A catalytic domain complexed with IBMX|O00408|CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE|4.4|IC=40uM|IC50|=|40|uM|40000|nM
3ESS|1.19|2009|18N|IC50=411+/-38nM|Q5EK40|CHOLIX TOXIN|6.39|IC=411nM|IC50|=|411|nM|411|nM
3EQ9|2.47|2009|X97|compound 11|P23687|PROLYL ENDOPEPTIDASE|7.39|IC=41nM|IC50|=|41|nM|41|nM
3FQS|2.10|2009|585||P43405|TYROSINE-PROTEIN KINASE SYK|7.39|IC=41nM|IC50|=|41|nM|41|nM
3HHU|1.59|2009|819|BX-2819 binds to Hsp90, IC50=41nM for inhibition of GM-Bodipy binding|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|7.39|IC=41nM|IC50|=|41|nM|41|nM
2WMU|2.60|2009|ZYU|Fragment: KINASE DOMAIN, RESIDUES 1-289|O14757|SERINE/THREONINE-PROTEIN KINASE CHK1|4.38|IC=42uM|IC50|=|42|uM|42000|nM
3I7G|1.95|2009|732|MMP-13 in complex with a non zinc-chelating inhibitor|P45452|COLLAGENASE 3|6.37|IC=430nM|IC50|=|430|nM|430|nM
3FW3|1.72|2009|ETS|compound dorzolamide|P22748|CARBONIC ANHYDRASE 4|7.37|IC=43nM|IC50|=|43|nM|43|nM
2WOT|1.85|2009|ZZG||P36897|TGF-BETA RECEPTOR TYPE-1|7.36|IC=44nM|IC50|=|44|nM|44|nM
3EJT|1.35|2009|HN6|compound 6|Q24451|ALPHA-MANNOSIDASE II|7.36|IC=44nM|IC50|=|44|nM|44|nM
3FT2|1.80|2009|9-mer|citrulline variant HA-1 peptide, Dissociation rates on cell surface between HA-1 alleles|P01892|HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2|7.36|IC=44nM|IC50|=|44|nM|44|nM
3FT3|1.95|2009|9-mer|histidine variant HA-1 peptide, In vitro TAP translocation of peptide|P01892|HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2|7.36|IC=44nM|IC50|=|44|nM|44|nM
2WIH|2.50|2009|P48|compound 28|P24941|CELL DIVISION PROTEIN KINASE 2|7.35|IC=45nM|IC50|=|45|nM|45|nM
3HV3|2.00|2009|R49|compound 19; IC501=470+/-70nM(EFC, enzyme fragment complementation); IC502=900+/-420nM(HTRF, homogeneoustime-resolved fluorescence)|Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|6.33|IC=470nM|IC50|=|470|nM|470|nM
3COH|2.70|2009|83H|compound 32|O14965|SERINE/THREONINE-PROTEIN KINASE 6|8.4|IC=4nM|IC50|=|4|nM|4|nM
3GZ9|2.00|2009|D32|PPARd Complex with compound 10|Q03181|PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR DELTA|8.4|IC=4nM|IC50|=|4|nM|4|nM
3K9X|1.90|2009|MBM|compound 22 bound to FXa|P00742|COAGULATION FACTOR X|8.4|IC=4nM|IC50|=|4|nM|4|nM
3HXC|1.95|2009|BD6|Engineered RabGGTase complex with compound 8, IC50=5.2+/-0.6uM|Q08602|GERANYLGERANYL TRANSFERASE TYPE-2 SUBUNIT ALPHA|5.28|IC=5.2uM|IC50|=|5.2|uM|5200|nM
3DCQ|1.80|2009|2G0|IC50=5.94+/-1.24uM|Q9HYN5|FUCOSE-BINDING LECTIN PA-IIL|5.23|IC=5.94uM|IC50|=|5.94|uM|5940|nM
2W1F|2.85|2009|L0F|compound 7|O14965|SERINE/THREONINE-PROTEIN KINASE 6|8.23|IC=5.9nM|IC50|=|5.9|nM|5.9|nM
3H2C|2.60|2009|B58|Dihydropteroate Synthase with compound 10, IC50>500uM|B1UXN2|DIHYDROPTEROATE SYNTHASE|3.3|IC=500uM|IC50|=|500|uM|500000|nM
3HDZ|1.80|2009|PD6|compound 1 as PDE5 Inhibitors, structure lack a CH2|O76074|CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE|7.29|IC=51nM|IC50|=|51|nM|51|nM
2W1H|2.15|2009|L0F|compound 7|P24941|CELL DIVISION PROTEIN KINASE 2|7.28|IC=52nM|IC50|=|52|nM|52|nM
2WMR|2.43|2009|ZYR|Fragment: KINASE DOMAIN, RESIDUES 1-289|O14757|SERINE/THREONINE-PROTEIN KINASE CHK1|4.28|IC=52uM|IC50|=|52|uM|52000|nM
3FU0|1.80|2009|22F|compound 6|P09960|LEUKOTRIENE A-4 HYDROLASE|2.28|IC=5308uM|IC50|=|5308|uM|5308000|nM
2WU7|2.25|2009|V25|Fragment: RESIDUES 127-484; IC50=530+/-140nM;|P49761|DUAL SPECIFICITY PROTEIN KINASE CLK3|6.28|IC=530nM|IC50|=|530|nM|530|nM
3FL8|2.29|2009|RAR||Q81R22|DIHYDROFOLATE REDUCTASE|7.27|IC=54nM|IC50|=|54|nM|54|nM
3DPE|1.60|2009|AXB|monoclinic form|P22894|NEUTROPHIL COLLAGENASE|7.24|IC=57nM|IC50|=|57|nM|57|nM
3DPF|2.10|2009|AXB|orthorhombic form|P22894|NEUTROPHIL COLLAGENASE|7.24|IC=57nM|IC50|=|57|nM|57|nM
3F2A|1.90|2009|985|Original dose-response IC50=340nM, resynthesized solid IC50=57+/-1.8nM|P11309|SERINE/THREONINE-PROTEIN KINASE|7.24|IC=57nM|IC50|=|57|nM|57|nM
2WI7|2.50|2009|2KL|compound 34d|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|7.24|IC=58nM|IC50|=|58|nM|58|nM
3FYJ|3.80|2009|B97|benzothiophene inhibitor bound to MAPKAP Kinase-2 (MK-2)|P49137|MAP KINASE-ACTIVATED PROTEIN KINASE 2|8.3|IC=5nM|IC50|=|5|nM|5|nM
3G86|2.20|2009|T18|structure 18 bound to CD21 NS5B polymerase|P26663|RNA-DIRECTED RNA POLYMERASE|8.3|IC=5nM|IC50|=|5|nM|5|nM
3H5S|2.00|2009|H5S|structure 16 bound to C Delta 21 NS5B polymerase, IC50=0.005uM|P26663|RNA-DIRECTED RNA POLYMERASE|8.3|IC=5nM|IC50|=|5|nM|5|nM
3H98|1.90|2009|B5P|HCV NS5b 1b complex with compound 4a, IC50=0.005uM|P26663|RNA-DIRECTED RNA POLYMERASE|8.3|IC=5nM|IC50|=|5|nM|5|nM
3JZF|2.13|2009|JZK|compound 1 bound to AccC ATP-site|P24182|BIOTIN CARBOXYLASE|5.3|IC=5uM|IC50|=|5|uM|5000|nM
3JZI|2.31|2009|JZL|compound 70 bound to biotin carboxylase from E. Coli|P24182|BIOTIN CARBOXYLASE|5.3|IC=5uM|IC50|=|5|uM|5000|nM
3K23|3.00|2009|JZN|Glucocorticoid Receptor with Bound D-prolinamide 11, pIC50=8.2+/-0.1|P04150|GLUCOCORTICOID RECEPTOR|8.2|IC=6.3nM|IC50|=|6.3|nM|6.3|nM
2ZIR|2.40|2009|NH7|compound 8w|Q04631|FARNESYLTRANSFERASE ALPHA SUBUNIT|8.19|IC=6.4nM|IC50|=|6.4|nM|6.4|nM
3G6H|2.35|2009|G6H|Proto-oncogene tyrosine-protein kinase Src T338I mutant and DSA1, IC50=6.4+/-1.2nM|P00523|TYROSINE-PROTEIN KINASE SRC|8.19|IC=6.4nM|IC50|=|6.4|nM|6.4|nM
3KAG|1.90|2009|4D7|Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 with compound 19a|Q13526|PEPTIDYL-PROLYL CIS-TRANS ISOMERASE NIMA|5.18|IC=6.6uM|IC50|=|6.6|uM|6600|nM
3HAC|2.00|2009|361|DPP4 complex with compound 34, 34a IC50=0.0067uM, 34b IC50=0.0083uM|P27487|DIPEPTIDYL PEPTIDASE 4|8.17|IC=6.7nM|IC50|=|6.7|nM|6.7|nM
2W6O|2.50|2009|OA3|compound 3|P24182|BIOTIN CARBOXYLASE|4.22|IC=60.8uM|IC50|=|60.8|uM|60800|nM
3H0W|1.81|2009|N8M|Human AdoMetDC and DMAMA|P17707|S-ADENOSYLMETHIONINE DECARBOXYLASE PROENZYME|6.22|IC=600nM|IC50|=|600|nM|600|nM
3HVC|2.10|2009|GG5|human p38 alpha MAP kinase with 4-FPP|Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|6.22|IC=600nM|IC50|=|600|nM|600|nM
3FTY|2.15|2009|3IP|compound 5, IC50=619+/-131uM|P09960|LEUKOTRIENE A-4 HYDROLASE|3.21|IC=619uM|IC50|=|619|uM|619000|nM
3I7I|2.21|2009|518|MMP-13 in complex with a non zinc-chelating inhibitor|P45452|COLLAGENASE 3|6.21|IC=620nM|IC50|=|620|nM|620|nM
2W0X|2.12|2009|PD2|compound 4|Q9NWT6|HYPOXIA-INDUCIBLE FACTOR 1-ALPHA INHIBITOR|3.2|IC=625uM|IC50|=|625|uM|625000|nM
2WO9|1.70|2009|068|compound 6c|P39900|MACROPHAGE METALLOELASTASE|7.21|IC=62nM|IC50|=|62|nM|62|nM
3KAB|2.19|2009|4BL|Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 with compound 5|Q13526|PEPTIDYL-PROLYL CIS-TRANS ISOMERASE NIMA|3.2|IC=630uM|IC50|=|630|uM|630000|nM
3FZT|1.95|2009|4JZ|compound PF-4618433|Q14289|PROTEIN-TYROSINE KINASE 2 BETA|6.2|IC=637nM|IC50|=|637|nM|637|nM
3HDN|3.10|2009|GMG|serum and glucocorticoid-regulated kinase 1 complex with compound 2|O00141|SERINE/THREONINE-PROTEIN KINASE SGK1|7.2|IC=63nM|IC50|=|63|nM|63|nM
3IG7|1.80|2009|EFP|inhibitor EFP with CDK-2, compound 19, 9nM x 7=63nM|P24941|CELL DIVISION PROTEIN KINASE 2|7.2|IC=63nM|IC50|=|63|nM|63|nM
3F7B|2.05|2009|AG5|compound 6f|P22748|CARBONIC ANHYDRASE 4|7.19|IC=64nM|IC50|=|64|nM|64|nM
3F7Z|2.40|2009|34O|compound 1|P49841|GLYCOGEN SYNTHASE KINASE-3 BETA|7.19|IC=65nM|IC50|=|65|nM|65|nM
3IGG|1.80|2009|EFQ|inhibitor EFQ with CDK-2, compound 15, 95nM x 0.7=66.5nM|P24941|CELL DIVISION PROTEIN KINASE 2|7.18|IC=66.5nM|IC50|=|66.5|nM|66.5|nM
3JSW|2.30|2009|JAR|PDE9A inhibitor 7 bound in PDE9A|O76083|CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE-9|7.18|IC=66nM|IC50|=|66|nM|66|nM
2WUU|1.42|2009|NHW|IC50=68.7+/-4.2nM|A4I7H1|N-MYRISTOYLTRANSFERASE|7.16|IC=68.7nM|IC50|=|68.7|nM|68.7|nM
3EWH|1.60|2009|K11|IC501=69+/-10nM(KDR/K11); IC502=240+/-170nM(Tie-2/K11).|P35968|VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2|7.16|IC=69nM|IC50|=|69|nM|69|nM
3H0Y|2.50|2009|48B|Aurora A in complex with a bisanilinopyrimidine, compound 5|O14965|SERINE/THREONINE-PROTEIN KINASE 6|8.22|IC=6nM|IC50|=|6|nM|6|nM
3HHK|1.70|2009|77Z|compound 11d bound to NS5B (genotype 1b, BK strain, Delta 21 construct)|Q99AU2|HCV NS5B POLYMERASE|8.22|IC=6nM|IC50|=|6|nM|6|nM
3I28|1.95|2009|34N|soluble epoxide hydrolase and inhibitors 24, human IC50=6nM, rats=9nM|P34913|EPOXIDE HYDROLASE 2|8.22|IC=6nM|IC50|=|6|nM|6|nM
3DNG|2.00|2009|AXA|compound 2(S)|P22894|NEUTROPHIL COLLAGENASE|8.13|IC=7.4nM|IC50|=|7.4|nM|7.4|nM
3KAD|1.95|2009|4C0|Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 with compound 18c|Q13526|PEPTIDYL-PROLYL CIS-TRANS ISOMERASE NIMA|5.12|IC=7.5uM|IC50|=|7.5|uM|7500|nM
3H9O|2.30|2009|9BD|Phosphoinositide-dependent protein kinase 1 (PDK-1) in complex with compound 9|O15530|3-PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE 1|7.15|IC=70nM|IC50|=|70|nM|70|nM
3DZ2|1.86|2009|A8M|compound 21c|P17707|S-ADENOSYLMETHIONINE DECARBOXYLASE BETA CHAIN|4.15|IC=70uM|IC50|=|70|uM|70000|nM
2WOU|2.30|2009|ZZF||P36897|TGF-BETA RECEPTOR TYPE-1|7.14|IC=72nM|IC50|=|72|nM|72|nM
3KAC|2.00|2009|4BX|Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 with compound 10|Q13526|PEPTIDYL-PROLYL CIS-TRANS ISOMERASE NIMA|3.13|IC=740uM|IC50|=|740|uM|740000|nM
3F81|1.90|2009|STT|incomplete&nbsp; ligand&nbsp; structure with SA3 in reference|P51452|DUAL SPECIFICITY PROTEIN PHOSPHATASE 3|7.13|IC=74nM|IC50|=|74|nM|74|nM
3FU5|2.30|2009|492|compound 8, IC50=75.2+/-7.3uM|P09960|LEUKOTRIENE A-4 HYDROLASE|4.12|IC=75.2uM|IC50|=|75.2|uM|75200|nM
2WEY|2.80|2009|EV1|ligand is compound 1, papaverine|Q9Y233|CGMP 3',5'-CYCLIC PHOSPHODIESTERASE|7.12|IC=76nM|IC50|=|76|nM|76|nM
3FL9|2.40|2009|TOP||Q81R22|DIHYDROFOLATE REDUCTASE|1.11|IC=77.2mM|IC50|=|77.2|mM|77200000|nM
3EWZ|1.40|2009|CNU|5-cyano-UMP, IC50=79+/-36uM|P11172|OROTIDINE-5'-PHOSPHATE DECARBOXYLASE|4.1|IC=79uM|IC50|=|79|uM|79000|nM
3DZ5|2.43|2009|M8M|compound 12a|P17707|S-ADENOSYLMETHIONINE DECARBOXYLASE BETA CHAIN|8.15|IC=7nM|IC50|=|7|nM|7|nM
3FRZ|1.86|2009|AG0|compound 24|P26663|RNA-DIRECTED RNA POLYMERASE|8.15|IC=7nM|IC50|=|7|nM|7|nM
3H0E|2.00|2009|H0E|caspase-3 complex with compound 3|P42574|CASPASE-3|8.15|IC=7nM|IC50|=|7|nM|7|nM
3I1Y|2.47|2009|33N|soluble epoxide hydrolase and inhibitors 1, human IC50=7nM, rats=4.8nM|P34913|EPOXIDE HYDROLASE 2|8.15|IC=7nM|IC50|=|7|nM|7|nM
3FPM|3.30|2009|793|compound 17|P49137|MAP KINASE-ACTIVATED PROTEIN KINASE 2|5.05|IC=8.9uM|IC50|=|8.9|uM|8900|nM
3FQK|2.20|2009|79Z|compound HCV-796; Kd=71+/-28nM; IC50=81+/-19nM|P26663|RNA-DIRECTED RNA POLYMERASE|7.09|IC=81nM|IC50|=|81|nM|81|nM
3F8W|2.30|2009|ADN|compound adenosine; IC50=82.3+/-0.7uM|Q9BMI9|PURINE-NUCLEOSIDE PHOSPHORYLASE|4.08|IC=82.3uM|IC50|=|82.3|uM|82300|nM
2WD1|2.00|2009|ZZY||P08581|HEPATOCYTE GROWTH FACTOR RECEPTOR|7.09|IC=82nM|IC50|=|82|nM|82|nM
3H2F|2.20|2009|B60|Dihydropteroate Synthase with compound 16|B1UXN2|DIHYDROPTEROATE SYNTHASE|4.06|IC=86.7uM|IC50|=|86.7|uM|86700|nM
3JZS|1.78|2009|12-mer|ligand is 12-mer peptide inhibitor pDIQ|Q00987|E3 UBIQUITIN-PROTEIN LIGASE MDM2|8.1|IC=8nM|IC50|=|8|nM|8|nM
3H22|2.40|2009|B53|Dihydropteroate Synthase with compound 3|B1UXN2|DIHYDROPTEROATE SYNTHASE|5.1|IC=8uM|IC50|=|8|uM|8000|nM
2WMV|2.01|2009|ZYV|Fragment: KINASE DOMAIN, RESIDUES 1-289|O14757|SERINE/THREONINE-PROTEIN KINASE CHK1|5.04|IC=9.2uM|IC50|=|9.2|uM|9200|nM
3DP1|2.30|2009|2RB|compound 3n, IC50=9.92+/-0.59uM|Q5G940|(3R)-HYDROXYMYRISTOYL-ACYL CARRIER PROTEIN|5.0|IC=9.92uM|IC50|=|9.92|uM|9920|nM
2WTI|2.50|2009|WTI|compound 53|Q9HBS5|SERINE/THREONINE-PROTEIN KINASE CHK2|7.04|IC=92nM|IC50|=|92|nM|92|nM
3GNV|2.75|2009|XNZ|NS5B-(R)-1b complex, Kd nd, IC50=0.093uM|O92972|RNA-DIRECTED RNA POLYMERASE|7.03|IC=93nM|IC50|=|93|nM|93|nM
3HYG|1.40|2009|099|compound 8|Q9UNA0|A DISINTEGRIN AND METALLOPROTEINASE WITH|7.03|IC=93nM|IC50|=|93|nM|93|nM
3HV5|2.25|2009|R24|compound 22; IC501=95+/-25nM(EFC, enzyme fragment complementation); IC502=150+/-40nM(HTRF, homogeneoustime-resolved fluorescence)|Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|7.02|IC=95nM|IC50|=|95|nM|95|nM
3FUK|1.95|2009|58Z|compound 16, IC50=966+/-322uM|P09960|LEUKOTRIENE A-4 HYDROLASE|3.02|IC=966uM|IC50|=|966|uM|966000|nM
3HXD|1.95|2009|BD7|Engineered RabGGTase complex with compound 9, IC50=9+/-1uM; dissociation constant(KI)=14.5uM|Q08602|GERANYLGERANYL TRANSFERASE TYPE-2 SUBUNIT ALPHA|5.05|IC=9uM|IC50|=|9|uM|9000|nM
3K3J|2.00|2009|F4C|p38 alpha bound to novel DGF-out compound PF-00416121, IC50>12.5uM|Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|4.9|IC>12.5uM|IC50|>|12.5|uM|12500|nM
2WI1|2.30|2009|ZZ2|compound 11, IC50>4000uM|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|2.4|IC>4000uM|IC50|>|4000|uM|4000000|nM
3K48|2.80|2009|16-mer|peptide 4.2, residues 104-241; not found for peptide 4.2, the IC50 may be 0.49~27 uM|Q9D777|TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13|6.31|IC~0.49uM|IC50|~|0.49|uM|490|nM
3DVP|2.50|2009|10-mer|Kd=0.01~0.1mM; incomplete ligand|Q24117|DYNEIN LIGHT CHAIN 1|5.0|Kd=0.01mM|Kd|=|0.01|mM|10000|nM
3IKC|2.60|2009|2-mer|Fab fragment of S67-27 complex Kdo(2-8)-7-O-Me-Kdo, KME-KDO, Kd=0.35x10-7M|------|IMMUNOGLUBILIN LIGHT CHAIN (IGG3)|7.46|Kd=0.035uM|Kd|=|0.035|uM|35|nM
3CSL|2.70|2009|HEM|Heme bound with HasA-HasR, Kd=0.06uM|Q79AD2|HASR PROTEIN|7.22|Kd=0.06uM|Kd|=|0.06|uM|60|nM
3C8E|1.50|2009|GSH||Q46845|YGHU, GLUTATHIONE S-TRANSFERASE HOMOLOGUE|4.15|Kd=0.07mM|Kd|=|0.07|mM|70000|nM
3GWS|2.20|2009|T3||P10828|THYROID HORMONE RECEPTOR BETA-1|10.09|Kd=0.081nM|Kd|=|0.081|nM|0.081|nM
2WJG|2.20|2009|GDP||Q57986|FERROUS IRON TRANSPORT PROTEIN B HOMOLOG|7.1|Kd=0.08uM|Kd|=|0.08|uM|80|nM
3G15|1.70|2009|HC6|ligand is HC-3; Kd=0.10+/-0.003uM; Ki=0.21+/-0.01uM|P35790|CHOLINE KINASE ALPHA|7.0|Kd=0.10uM|Kd|=|0.1|uM|100|nM
3FSJ|1.37|2009|D7K|Ki=0.38+/-0.04mM|P20906|BENZOYLFORMATE DECARBOXYLASE|3.95|Kd=0.113mM|Kd|=|0.113|mM|113000|nM
3BWK|2.42|2009|C1P|ligand is K11017, Ka=8800M-1, Kd=0.114mM|Q9NBA7|CYSTEINE PROTEASE FALCIPAIN-3|3.94|Kd=0.114mM|Kd|=|0.114|mM|114000|nM
2VK2|1.20|2009|GZL|inferred affinity of YtfQ for galactofuranose is Kd=0.13uM|P39325|ABC TRANSPORTER PERIPLASMIC-BINDING PROTEIN YTFQ|6.89|Kd=0.13uM|Kd|=|0.13|uM|130|nM
3FZY|1.95|2009|IHP|Kd=0.18+/-0.02uM|Q9KS12|RTX TOXIN RTXA|6.74|Kd=0.18uM|Kd|=|0.18|uM|180|nM
3HEG|2.20|2009|BAX|compound sorafenib; IC50=0.057uM|Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|6.74|Kd=0.18uM|Kd|=|0.18|uM|180|nM
2W3O|1.85|2009|8-mer|Kd=0.19+/-0.02uM, HUMAN PNKP FHA DOMAIN with AN XRCC1-DERIVED tri-PHOSPHOPEPTIDE|Q96T60|BIFUNCTIONAL POLYNUCLEOTIDE PHOSPHATASE/KINASE|6.72|Kd=0.19uM|Kd|=|0.19|uM|190|nM
3G7L|2.20|2009|16-mer|Chromodomain of Chp1 in complex with Histone H3K9me3 peptide, Kd=0.19+/-0.02uM; incomplete ligand|Q10103|CHROMO DOMAIN-CONTAINING PROTEIN 1|6.72|Kd=0.19uM|Kd|=|0.19|uM|190|nM
3A1C|1.85|2009|ACP||O29777|PROBABLE COPPER-EXPORTING P-TYPE ATPASE A|4.0|Kd=0.1mM|Kd|=|0.1|mM|100000|nM
2W16|2.71|2009|8-mer|8-mer peptide DSN-ARG-DSN-FHO-LYS-FHO-THR-THR|P48632|FERRIPYOVERDINE RECEPTOR|10.0|Kd=0.1nM|Kd|=|0.1|nM|0.1|nM
3DRF|1.30|2009|8-mer||A2RJ53|OLIGO-PEPTIDE BINDING PROTEIN (OPPA)|7.0|Kd=0.1uM|Kd|=|0.1|uM|100|nM
3DRG|2.50|2009|9-mer||A2RJ53|OLIGO-PEPTIDE BINDING PROTEIN (OPPA)|7.0|Kd=0.1uM|Kd|=|0.1|uM|100|nM
3G2T|2.00|2009|13-mer|human GGA1-VHS complexed with SorLA C-terminal Phosphopeptide, Kd=0.1+/-0.03uM; incomplete ligand|Q9UJY5|ADP-RIBOSYLATION FACTOR-BINDING PROTEIN GGA1|7.0|Kd=0.1uM|Kd|=|0.1|uM|100|nM
3IE3|1.80|2009|N11|Kd=0.21+/-0.06uM|P09211|GLUTATHIONE S-TRANSFERASE P1-1|6.68|Kd=0.21uM|Kd|=|0.21|uM|210|nM
3EL1|1.70|2009|DR7|ligand is atazanavir; Kd=0.23+/-0.12nM|P03369|HIV-1 PROTEASE|9.64|Kd=0.23nM|Kd|=|0.23|nM|0.23|nM
3EKY|1.80|2009|DR7|ligand is atazanavir; Kd=0.23+/-0.12nM; redundant to 3el1|P03369|HIV-1 PROTEASE|9.64|Kd=0.23nM|Kd|=|0.23|nM|0.23|nM
3JVS|1.90|2009|AGY|ligand is compound 3, Kd=0.29+/-0.07uM|O14757|SERINE/THREONINE-PROTEIN KINASE CHK1|6.54|Kd=0.29uM|Kd|=|0.29|uM|290|nM
3IMY|2.55|2009|B72|ligand is compound 7|P10828|THYROID HORMONE RECEPTOR BETA-1|9.7|Kd=0.2nM|Kd|=|0.2|nM|0.2|nM
3BWJ|2.30|2009|ARX|ligand is compound 1; Kd=0.319+/-0.057uM; IC50=2.6+/-0.3uM|P00517|CAMP-DEPENDENT PROTEIN KINASE|6.5|Kd=0.319uM|Kd|=|0.319|uM|319|nM
3GDS|2.85|2009|10-mer|DegS H198P/D320A mutant modified by DFP complex DNRDGNVYYF peptide|P0AEE3|PROTEASE DEGS|6.51|Kd=0.31uM|Kd|=|0.31|uM|310|nM
3D1V|2.70|2009|D1V|2-mercapto(3H)quinazolinone; pKd=3.49, Kd=0.324mM(quinazolinone)|P00491|PURINE NUCLEOSIDE PHOSPHORYLASE|3.49|Kd=0.324mM|Kd|=|0.324|mM|324000|nM
3G3R|2.00|2009|ANP|Vtc4p*-AppNHp-Mn2+, Kd=0.33+/-0.04uM|P47075|VACUOLAR TRANSPORTER CHAPERONE 4|6.48|Kd=0.33uM|Kd|=|0.33|uM|330|nM
3DLA|2.35|2009|NXX|incomplete ligand structure|P0A5L6|GLUTAMINE-DEPENDENT NAD(+) SYNTHETASE|3.46|Kd=0.35mM|Kd|=|0.35|mM|350000|nM
3D7M|2.90|2009|GDP|I56C/Q333C Galpha i1 in complex with GDP-AlF4-, Kd=0.36+/-0.01uM|P10824|GUANINE NUCLEOTIDE-BINDING PROTEIN G(I), ALPHA-1|6.44|Kd=0.36uM|Kd|=|0.36|uM|360|nM
3FFU|2.80|2009|GTP|Kd=0.36uM(for Mg2+) without GTP|Q6MPX4|PROBABLE PYROPHOSPHOHYDROLASE|6.44|Kd=0.36uM|Kd|=|0.36|uM|360|nM
3E8U|2.10|2009|11-mer|Fab 106.3 complex with BNP peptide epitope, Kd=0.38+/-0.07nM|------|ANTIBODY FAB 106.3 HEAVY CHAIN|9.42|Kd=0.38nM|Kd|=|0.38|nM|0.38|nM
3EKX|1.97|2009|1UN|ligand is NFV; Kd=0.39+/-0.07nM|P03369|HIV-1 PROTEASE|9.41|Kd=0.39nM|Kd|=|0.39|nM|0.39|nM
3EKV|1.75|2009|478|ligand is amprenavir; Kd=0.39+/-0.20nM|P03369|HIV-1 PROTEASE|9.41|Kd=0.39nM|Kd|=|0.39|nM|0.39|nM
2W73|1.45|2009|17-mer|A PEPTIDE FROM CALCINEURIN A, Kd1=0.7uM(Temper 35); Kd2=0.3uM(Temper 30)|P62158|CALMODULIN|6.52|Kd=0.3uM|Kd|=|0.3|uM|300|nM
3G2V|2.10|2009|13-mer|VHS:SoP complex, Kd=0.3+/-0.02uM; incomplete ligand|Q9UJY5|ADP-RIBOSYLATION FACTOR-BINDING PROTEIN GGA1|6.52|Kd=0.3uM|Kd|=|0.3|uM|300|nM
3HJO|1.95|2009|EAA|Glutathione Transferase Pi Y108V Mutant Complex with EASG, Kd=0.3+/-0.1uM; multiple ligands|P09211|GLUTATHIONE S-TRANSFERASE P1-1|6.52|Kd=0.3uM|Kd|=|0.3|uM|300|nM
3HIK|1.77|2009|6-mer|Pentamer phosphopeptide-PLHSpT ; Kd=0.445+/-0.180uM|P53350|SERINE/THREONINE-PROTEIN KINASE PLK1|6.35|Kd=0.445uM|Kd|=|0.445|uM|445|nM
3FVH|1.58|2009|7-mer|Kd=0.447+/-0.110uM|P53350|SERINE/THREONINE-PROTEIN KINASE PLK1|6.35|Kd=0.447uM|Kd|=|0.447|uM|447|nM
3ED0|2.30|2009|EMO|Kd=0.45uM(ITC); Kd=4.59uM(SPR); Ki=1.9+/-0.3uM; IC50=9.7+/-1.0uM|Q5G940|(3R)-HYDROXYMYRISTOYL-ACYL CARRIER PROTEIN|6.35|Kd=0.45uM|Kd|=|0.45|uM|450|nM
2ZX5|2.65|2009|ZX5|compound 2; Kd=0.469+/-0.14pM; Ki=0.469pM|Q9WYE2|ALPHA-L-FUCOSIDASE|12.33|Kd=0.469pM|Kd|=|0.469|pM|0.00046899999999999996|nM
3F33|1.70|2009|PFL|ligand is compound 1; binding data in suppl info|P02791|FERRITIN LIGHT CHAIN|3.34|Kd=0.46mM|Kd|=|0.46|mM|460000|nM
3HXI|1.80|2009|GTG|Kd=0.27uM(fluorescence titration); Kd=0.47+/-0.01uM(ITC)|Q13541|EUKARYOTIC TRANSLATION INITIATION 4E|6.33|Kd=0.47uM|Kd|=|0.47|uM|470|nM
2W77|2.90|2009|10-mer|10-mer peptide SER-LYS-GLY-FHO-SER-SER-GLY-LYS-FH7-SER, Kd=0.65+/-0.07nM|P48632|FERRIPYOVERDINE RECEPTOR|9.19|Kd=0.65nM|Kd|=|0.65|nM|0.65|nM
3EU7|2.20|2009|19-mer|19 meric peptide from Breast cancer type 2 susceptibility protein; incomplete ligand|Q86YC2|PARTNER AND LOCALIZER OF BRCA2|6.18|Kd=0.66uM|Kd|=|0.66|uM|660|nM
3F35|1.92|2009|DIE|compound 5(1); binding data in supplementary info; redundant to 3f34|P02791|FERRITIN LIGHT CHAIN|3.16|Kd=0.69mM|Kd|=|0.69|mM|690000|nM
3F34|1.68|2009|DIE|ligand is compound 5(2); binding data in suppl info|P02791|FERRITIN LIGHT CHAIN|3.16|Kd=0.69mM|Kd|=|0.69|mM|690000|nM
3G2S|1.70|2009|13-mer|VHS Domain of human GGA1 complexed with SorLA C-terminal Peptide, Kd=0.6+/-0.02uM; incomplete ligand|Q9UJY5|ADP-RIBOSYLATION FACTOR-BINDING PROTEIN GGA1|6.22|Kd=0.6uM|Kd|=|0.6|uM|600|nM
2ZYM|1.80|2009|ACX|Kd=0.73+/-0.02uM|Q9AJF5|SOLUTE-BINDING PROTEIN|6.14|Kd=0.73uM|Kd|=|0.73|uM|730|nM
2KGI|NMR|2009|9-mer|H3(1-9)K4me3 peptide|P29375|HISTONE DEMETHYLASE JARID1A|6.12|Kd=0.75uM|Kd|=|0.75|uM|750|nM
3GNW|2.39|2009|XNC|NS5B in complex with (S)-4c; Kd=0.79nM, IC50=0.026uM|O92972|RNA-DIRECTED RNA POLYMERASE|9.1|Kd=0.79nM|Kd|=|0.79|nM|0.79|nM
3E73|2.80|2009|GSH||O43813|LANC-LIKE PROTEIN 1|3.15|Kd=0.7mM|Kd|=|0.7|mM|700000|nM
3A3Y|2.80|2009|OBN|X-ray(Na+, K+-ATPase ); Kd=0.7nM(ATPase in E2P-like states).|Q4H132|K-ATPASE ALPHA SUBUNIT|9.15|Kd=0.7nM|Kd|=|0.7|nM|0.7|nM
2K7L|NMR|2009|19-mer|C-terminal domain of human RAP74 with centFCP1-T584PO4 peptide, Kd=0.7+/-0.1uM|P35269|CENTFCP1-T584PO4 PEPTIDE|6.15|Kd=0.7uM|Kd|=|0.7|uM|700|nM
2V58|2.10|2009|LZJ|ligand is inhibitor 1, Kd=0.82+/-0.22nM(SPR); Kd<5.0nM(ITC).|P24182|BIOTIN CARBOXYLASE|9.09|Kd=0.82nM|Kd|=|0.82|nM|0.82|nM
3IW5|2.50|2009|DF3|ligand is compound 14, Kd=0.839+/-0.145uM|Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|6.08|Kd=0.839uM|Kd|=|0.839|uM|839|nM
2W7Y|2.35|2009|3-mer|Ka=(1.2+/-0.3)x10-6M(UV); Ka=(1.01+/-0.16)x10-6M(ITC)|A5LBQ6|PROBABLE SUGAR ABC TRANSPORTER, SUGAR-BINDING|6.08|Kd=0.83uM|Kd|=|0.83|uM|830|nM
3IJY|2.85|2009|2-mer|Fab fragment of S67-27 complex Kdo(2-8)Kdo, KDA-KDO, Kd=9.1x10-7M|------|IMMUNOGLUBILIN LIGHT CHAIN (IGG3)|6.04|Kd=0.91uM|Kd|=|0.91|uM|910|nM
3ESJ|2.70|2009|CC7|compound 7, Kd=0.925+/-0.71mM, temperature is 10 degree|P62617|2-C-METHYL-D-ERYTHRITOL 2,4-CYCLODIPHOSPHATE|3.03|Kd=0.925mM|Kd|=|0.925|mM|925000|nM
3E12|1.70|2009|KD0|Kd=1.02+/-0.01uM(pH=7.5); Kd=1.94+/-0.01uM(pH=5.0)|O66496|2-DEHYDRO-3-DEOXYPHOSPHOOCTONATE ALDOLASE|5.99|Kd=1.02uM|Kd|=|1.02|uM|1020|nM
3DXM|2.85|2009|N24|Kd=1.0+/-0.2uM; IC50=11uM|P61157|ACTIN-RELATED PROTEIN 3|6.0|Kd=1.0uM|Kd|=|1|uM|1000|nM
2KDH|NMR|2009|KDH|Kd=1.1mM|P63316|TROPONIN C, SLOW SKELETAL AND CARDIAC MUSCLES|2.96|Kd=1.1mM|Kd|=|1.1|mM|1100000|nM
2W8J|1.50|2009|PLS|Kd=1.1+/-0.1mM|Q93UV0|SERINE PALMITOYLTRANSFERASE|2.96|Kd=1.1mM|Kd|=|1.1|mM|1100000|nM
3IMG|1.80|2009|BZ3|ligand is compound 33|P0A5R0|PANTOTHENATE SYNTHETASE|2.96|Kd=1.1mM|Kd|=|1.1|mM|1100000|nM
3I9G|1.90|2009|S1P|S1P:LT1009 Fab complex, Kd=1.1+/-0.1nM(50uM Ca2+), Kd=130+/-30nM (without Ca2+)|------|SONEPCIZUMAB ANTIBODY FAB FRAGMENT, HEAVY CHAIN|8.96|Kd=1.1nM|Kd|=|1.1|nM|1.1|nM
2WEQ|2.20|2009|GDM|Kd=1.27+/-0.09uM|P02829|HEAT SHOCK PROTEIN HSP82|5.9|Kd=1.27uM|Kd|=|1.27|uM|1270|nM
2KFG|NMR|2009|12-mer|Rab11-FIP2 DPF peptide FNYESTDPFTAK, Ki=1.2+/-0.1mM|Q9H4M9|EH DOMAIN-CONTAINING PROTEIN 1|2.92|Kd=1.2mM|Kd|=|1.2|mM|1200000|nM
2ZYN|1.70|2009|BCD|Kd=1.2+/-0.1uM|Q9AJF5|SOLUTE-BINDING PROTEIN|5.92|Kd=1.2uM|Kd|=|1.2|uM|1200|nM
3F36|1.70|2009|IP0|compound 7; binding data in supplementary info|P02791|FERRITIN LIGHT CHAIN|2.89|Kd=1.3mM|Kd|=|1.3|mM|1300000|nM
3EKP|2.15|2009|478|ligand is amprenavir; Kd=1.3+/-0.01nM|P03369|HIV-1 PROTEASE|8.89|Kd=1.3nM|Kd|=|1.3|nM|1.3|nM
3GHE|2.40|2009|15-mer|anti-HIV-1 Fab 537-10D complex V3 peptide MN, SUPPLEMENTAL DATA|P88403|ANTIBODY FAB 537-10D, LIGHT CHAIN|5.89|Kd=1.3uM|Kd|=|1.3|uM|1300|nM
3H1X|1.40|2009|IMN|ligand is indomethacin; Kd=1.3+/-0.2uM|P59071|PHOSPHOLIPASE A2, VRV-PL-VIIIA|5.89|Kd=1.3uM|Kd|=|1.3|uM|1300|nM
3FXB|2.90|2009|4CS|the UehA-ectoine complex, Kd=1.4+/-0.1uM|Q5LUA7|TRAP DICARBOXYLATE TRANSPORTER, DCTP SUBUNIT|5.85|Kd=1.4uM|Kd|=|1.4|uM|1400|nM
3H6Z|2.80|2009|6-mer|dSfmbt-4MBT and histone H4K20me1 peptide complex, Kd=1.5+/-0.03uM|Q9VK33|POLYCOMB PROTEIN SFMBT|5.82|Kd=1.5uM|Kd|=|1.5|uM|1500|nM
3IUE|1.73|2009|FG3|ligand is compound 4|P0A5R0|PANTOTHENATE SYNTHETASE|5.82|Kd=1.5uM|Kd|=|1.5|uM|1500|nM
3K8D|1.90|2009|KDO|Kd=1.7+/-0.53uM, incomplete ligand structrue|P04951|3-DEOXY-MANNO-OCTULOSONATE CYTIDYLYLTRANSFERASE|5.77|Kd=1.7uM|Kd|=|1.7|uM|1700|nM
3GPE|2.00|2009|PT5|PKC (alpha)-C2 domain complexed with Ca2+ and PtdIns(4, 5)P2|P05696|PROTEIN KINASE C ALPHA TYPE|5.74|Kd=1.8uM|Kd|=|1.8|uM|1800|nM
3IVX|1.73|2009|FG6|ligand is compound 8|P0A5R0|PANTOTHENATE SYNTHETASE|5.74|Kd=1.8uM|Kd|=|1.8|uM|1800|nM
3HRF|1.90|2009|P47|Human PDK1 kinase domain complex with ATP and PS48|O15530|3-PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE 1|4.99|Kd=10.3uM|Kd|=|10.3|uM|10300|nM
2VR3|1.95|2009|13-mer|Clumping factor A bound to FIBRINOGEN GAMMA-CHAIN; incomplete ligand|Q2G015|CLUMPING FACTOR A|4.98|Kd=10.5uM|Kd|=|10.5|uM|10500|nM
2W47|1.40|2009|UNF|Ka=9.5x10+4M-1|A3DK57|LIPOLYTIC ENZYME, G-D-S-L|4.98|Kd=10.5uM|Kd|=|10.5|uM|10500|nM
3EKW|1.60|2009|DR7|ligand is atazanavir; Kd=10.9+/-1.60nM|P03369|HIV-1 PROTEASE|7.96|Kd=10.9nM|Kd|=|10.9|nM|10.9|nM
2W76|2.80|2009|6-mer|6-mer peptide SDB-FHO-GLN-GLN-FHO-GLY, Kd>10000nM|P48632|FERRIPYOVERDINE RECEPTOR|5.0|Kd=10000nM|Kd|=|10000|nM|10000|nM
2W6U|3.00|2009|7-mer|7-mer peptide SER-ALA-AHO-ORN-ASP-AHO-SER, Kd>10000nM|P48632|FERRIPYOVERDINE RECEPTOR|5.0|Kd=10000nM|Kd|=|10000|nM|10000|nM
2WNL|2.70|2009|AN5|Kd>1000nM|Q8WSF8|ACETYLCHOLINE RECEPTOR|6.0|Kd=1000nM|Kd|=|1000|nM|1000|nM
3IME|2.39|2009|BZ2|ligand is compound 5|P0A5R0|PANTOTHENATE SYNTHETASE|3.0|Kd=1000uM|Kd|=|1000|uM|1000000|nM
2WZF|2.10|2009|UDP-BGC||Q5ZVS2|GLUCOSYLTRANSFERASE|7.0|Kd=100nM|Kd|=|100|nM|100|nM
2KFX|NMR|2009|WW7|P+L-P.L-P.L.L4, two equilirium, Kd1=100uM; Kd2=0.43pM|P63316|TROPONIN C|4.0|Kd=100uM|Kd|=|100|uM|100000|nM
2WHP|2.20|2009|HI6|Ki=31+/-2uM|P21836|ACETYLCHOLINESTERASE|4.0|Kd=100uM|Kd|=|100|uM|100000|nM
3IJH|2.10|2009|KO2|Fab fragment of S67-27 complex Ko, Kd=1000x10-7M|------|IMMUNOGLUBILIN LIGHT CHAIN (IGG3)|4.0|Kd=100uM|Kd|=|100|uM|100000|nM
3HV8|1.45|2009|C2E|ligand is c-di-GMP|Q9HUK6|PROTEIN FIMX|6.98|Kd=104.2nM|Kd|=|104.2|nM|104.2|nM
2K0G|NMR|2009|CMP||Q98GN8|MLL3241 PROTEIN|6.97|Kd=107nM|Kd|=|107|nM|107|nM
3GKZ|1.90|2009|B40|scFv6H4 in complex with METH|------|ANTI-METHAMPHETAMINE SINGLE CHAIN FV|8.0|Kd=10nM|Kd|=|10|nM|10|nM
3GVU|2.05|2009|STI|ligand is imatinib|P42684|TYROSINE-PROTEIN KINASE ABL2|8.0|Kd=10nM|Kd|=|10|nM|10|nM
3HX3|1.69|2009|RET|CRALBP mutant R234W complex 11-cis-retinal|P12271|RETINALDEHYDE-BINDING PROTEIN 1|8.0|Kd=10nM|Kd|=|10|nM|10|nM
2KBS|NMR|2009|8-mer|octameric peptide from Cadherin-23(Cad23-PBM peptide), Kd=10+/-0.2uM|Q9Y6N9|HARMONIN|5.0|Kd=10uM|Kd|=|10|uM|10000|nM
2VXN|0.82|2009|PGH||P48499|TRIOSEPHOSPHATE ISOMERASE|5.0|Kd=10uM|Kd|=|10|uM|10000|nM
3CFN|1.87|2009|2AN||P02766|TRANSTHYRETIN|5.0|Kd=10uM|Kd|=|10|uM|10000|nM
3DOW|2.30|2009|12-mer|Kd=11.5+/-1.1uM, Gamma-aminobutyric acid receptor-associated protein bound to CRT peptide; incomplete ligand|O95166|GAMMA-AMINOBUTYRIC ACID RECEPTOR-ASSOCIATED PROTEIN|4.94|Kd=11.5uM|Kd|=|11.5|uM|11500|nM
3IMC|1.60|2009|BZ3|ligand is compound 1|P0A5R0|PANTOTHENATE SYNTHETASE|2.96|Kd=1100uM|Kd|=|1100|uM|1100000|nM
2WEH|2.10|2009|FB1|ligand is compound 5|P00918|CARBONIC ANHYDRASE 2|5.95|Kd=1125nM|Kd|=|1125|nM|1125|nM
2WEO|1.40|2009|FBW|ligand is compound 3|P00918|CARBONIC ANHYDRASE 2|6.93|Kd=118nM|Kd|=|118|nM|118|nM
3JVK|1.80|2009|8-mer|histone H3.3 peptide(GGK(ac)APRKQ); Kd=118+/-28uM|Q9ESU6|BROMODOMAIN-CONTAINING PROTEIN 4|3.93|Kd=118uM|Kd|=|118|uM|118000|nM
3G5D|2.20|2009|1N1|Kd=11+/-3nM; IC50=0.4+/-0.2nM|P00523|TYROSINE-PROTEIN KINASE SRC|7.96|Kd=11nM|Kd|=|11|nM|11|nM
3JUQ|1.75|2009|AJD&AKD|ligand is compound racemic-1, Kd=12.4+/-0.82uM|Q396C9|PHENAZINE BIOSYNTHESIS PROTEIN A/B|4.91|Kd=12.4uM|Kd|=|12.4|uM|12400|nM
3CX9|2.80|2009|LPX|Kd=5.6uM(in the absence of myristate); Kd=12.9uM(in the presence of myristate)|P02768|SERUM ALBUMIN|4.89|Kd=12.9uM|Kd|=|12.9|uM|12900|nM
3FGC|2.30|2009|FMN|luciferase/FMN complex, Kd is for reduced FMNH2, not FMN|P07740|ALKANAL MONOOXYGENASE ALPHA CHAIN|3.92|Kd=120uM|Kd|=|120|uM|120000|nM
3GK4|1.90|2009|53A|compound SBi523 bound to Ca2+ S100B, Kd=0.12+/-0.03mM|P02638|PROTEIN S100-B|3.92|Kd=120uM|Kd|=|120|uM|120000|nM
3EVD|1.50|2009|GTP|Kd=124+/-6nM; Ki=40+/-10nM|P03314|RNA-DIRECTED RNA POLYMERASE NS5|6.91|Kd=124nM|Kd|=|124|nM|124|nM
3EVC|1.60|2009|GTP|Na+ citrate; Kd=124+/-6nM; Ki=40+/-10nM; redundant to 3evd|P03314|RNA-DIRECTED RNA POLYMERASE NS5|6.91|Kd=124nM|Kd|=|124|nM|124|nM
2WOR|1.70|2009|2AN|S100A7 with 1,8 ANS, Kd=125+/-11uM|P31151|PROTEIN S100-A7|3.9|Kd=125uM|Kd|=|125|uM|125000|nM
2WOS|1.70|2009|6AN|S100A7 with 2,6 ANS, Kd=125+/-11uM|P31151|PROTEIN S100-A7|3.9|Kd=125uM|Kd|=|125|uM|125000|nM
3EHN|2.80|2009|NLC||Q8A8X4|SUSD HOMOLOG|1.92|Kd=12mM|Kd|=|12|mM|12000000|nM
3H9F|2.60|2009|92M|supplementary information; compound Mps1-IN-2; IC50=145nM|P33981|DUAL SPECIFICITY PROTEIN KINASE TTK|7.92|Kd=12nM|Kd|=|12|nM|12|nM
3HV7|2.40|2009|1AU|compound 4; Kd=12+/-2nM|Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|7.92|Kd=12nM|Kd|=|12|nM|12|nM
3IJ0|2.45|2009|11-mer|Eed in complex with a trimethylated histone H3K9 peptide, Kd=13.2+/-1.6uM; incomplete ligand|O75530|POLYCOMB PROTEIN EED|4.88|Kd=13.2uM|Kd|=|13.2|uM|13200|nM
3IW8|2.00|2009|HIZ|compound 25, Kd=13.4+/-2.3uM|Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|4.87|Kd=13.4uM|Kd|=|13.4|uM|13400|nM
3HWX|2.60|2009|TPP|EcMenD ThDP complex, Kd=1.39x10-8M, PH=7.5|P17109|2-SUCCINYL-5-ENOLPYRUVYL-6-HYDROXY-3-CYCLOHEXENE|7.86|Kd=13.9nM|Kd|=|13.9|nM|13.9|nM
3GXZ|2.50|2009|11-mer|ligand is Man-9|P81180|CYANOVIRIN-N|7.89|Kd=13nM|Kd|=|13|nM|13|nM
3A1T|1.80|2009|GDP|crystal form II; Kd=14.8+/-0.4uM|Q9WXQ8|IRON(II) TRANSPORT PROTEIN B|4.83|Kd=14.8uM|Kd|=|14.8|uM|14800|nM
3A1S|1.50|2009|GDP|in crystal form I; Kd=14.8+/-0.4uM|Q9WXQ8|IRON(II) TRANSPORT PROTEIN B|4.83|Kd=14.8uM|Kd|=|14.8|uM|14800|nM
2W4X|2.42|2009|STZ|Kd=14+/-0.4uM|Q89ZI2|O-GLCNACASE BT_4395|4.85|Kd=14uM|Kd|=|14|uM|14000|nM
3F70|2.10|2009|MLZ|L3MBTL2-H4K20me1 complex, Kd=14+/-0.2uM|Q969R5|LETHAL(3)MALIGNANT BRAIN TUMOR-LIKE 2 PROTEIN|4.85|Kd=14uM|Kd|=|14|uM|14000|nM
3H52|2.80|2009|19-mer|binding of NCoR for GR-LBD in the presence of mifepristone; incomplete ligand|P04150|GLUCOCORTICOID RECEPTOR|4.85|Kd=14uM|Kd|=|14|uM|14000|nM
3K41|1.90|2009|M6D|EQKM mutant, wildtype Kd=1mM|P11456|CATION-DEPENDENT MANNOSE-6-PHOSPHATE RECEPTOR|0.82|Kd=150mM|Kd|=|150|mM|150000000|nM
3GCP|2.25|2009|SB2|ligand is SB203580|Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|7.82|Kd=15nM|Kd|=|15|nM|15|nM
3FBR|3.50|2009|9-mer|HipA bound the EF-Tu peptide IREGGRTVGA, Kd=15+/-5uM|P23874|PROTEIN HIPA|4.82|Kd=15uM|Kd|=|15|uM|15000|nM
2ZWZ|2.36|2009|ZWZ|ligand is compound 1; Kd=16.3+/-2.5nM; Ki=16.3nM|Q9WYE2|ALPHA-L-FUCOSIDASE|7.79|Kd=16.3nM|Kd|=|16.3|nM|16.3|nM
3F39|1.85|2009|IPH|compound 9; supplementary information|P02791|FERRITIN LIGHT CHAIN|1.78|Kd=16.5mM|Kd|=|16.5|mM|16500000|nM
3GCU|2.10|2009|R48|ligand is compound 11d; Kd=165+/-58nM|Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|6.78|Kd=165nM|Kd|=|165|nM|165|nM
3BPC|1.85|2009|2-mer|ligand is KDA-KDB|P01837|ANTIBODY FAB FRAGMENT|4.8|Kd=16uM|Kd|=|16|uM|16000|nM
3IIY|2.65|2009|11-mer|Eed in complex with a trimethylated histone H1K26 peptide, Kd=16+/-1uM; incomplete ligand|O75530|POLYCOMB PROTEIN EED|4.8|Kd=16uM|Kd|=|16|uM|16000|nM
3DSZ|2.00|2009|LIZ|Kd=17.1+/-2nM for Tb7.N9 structure, Kd=13.2+/-1.5nM for Tb7.N9.N34|P80188|HUMAN LIPOCALIN 2|7.77|Kd=17.1nM|Kd|=|17.1|nM|17.1|nM
2W10|1.90|2009|12-mer|12-mer TYROSINE-PROTEIN PHOSPHATASE NON-RECEPTOR TYPE 23, Kd=0.17+/-0.06uM|O89100|GRB2-RELATED ADAPTOR PROTEIN 2|6.77|Kd=170nM|Kd|=|170|nM|170|nM
3EKQ|2.20|2009|ROC|ligand is SQV; Kd=176.0+/-4.2nM|P03369|HIV-1 PROTEASE|6.75|Kd=176.0nM|Kd|=|176|nM|176|nM
3GM0|2.40|2009|B41|scFv6H4 in complex with MDMA|------|ANTI-METHAMPHETAMINE SINGLE CHAIN FV|7.77|Kd=17nM|Kd|=|17|nM|17|nM
3ERN|2.10|2009|CAR|AraCMP, Kd=18.91+/-5.8mM, temperature is 10 degree|P62617|2-C-METHYL-D-ERYTHRITOL 2,4-CYCLODIPHOSPHATE|1.72|Kd=18.91mM|Kd|=|18.91|mM|18910000|nM
3EL5|1.60|2009|1UN|ligand is NFV; Kd=18.9+/-0.25nM|P03369|HIV-1 PROTEASE|7.72|Kd=18.9nM|Kd|=|18.9|nM|18.9|nM
3DGO|2.50|2009|ATP|Kd=180+/-30nM|------|ATP-BINDING PROTEIN-DX|6.74|Kd=180nM|Kd|=|180|nM|180|nM
3H91|1.50|2009|15-mer|Protein 1 Fragment: UNP residues 9-62 ; Kd=185+/-20uM;|Q14781|CHROMOBOX PROTEIN HOMOLOG 2|3.73|Kd=185uM|Kd|=|185|uM|185000|nM
3FJG|2.20|2009|3PG||Q0PBL7|MAJOR ANTIGENIC PEPTIDE PEB3|3.73|Kd=187uM|Kd|=|187|uM|187000|nM
2V59|2.40|2009|LZK|ligand is inhibitor 2, Kd=6.53+/-0.64nM(SPR); Kd=18+/-9nM(ITC).|P24182|BIOTIN CARBOXYLASE|7.74|Kd=18nM|Kd|=|18|nM|18|nM
3DNT|1.66|2009|ATP|Kd=18+/-2uM|P23874|PROTEIN HIPA|4.74|Kd=18uM|Kd|=|18|uM|18000|nM
3F3U|2.50|2009|1AW|ligand is compound 1b, Kd=18+/-0.9uM|P00523|TYROSINE-PROTEIN KINASE SRC|4.74|Kd=18uM|Kd|=|18|uM|18000|nM
3HG1|3.00|2009|10-mer|ligand is human leukocyte antigen (HLA)-A*0201-ELA peptide (ELAGIGILTV); Kd=18+/-1uM at temperature 25 degree|Q8WLS4|MHC CLASS I ANTIGEN|4.74|Kd=18uM|Kd|=|18|uM|18000|nM
3FUC|1.45|2009|9D9&9DG|PNP in complex with DFPP-DG, Kd=190+/-90pM|P55859|PURINE NUCLEOSIDE PHOSPHORYLASE|9.72|Kd=190pM|Kd|=|190|pM|0.19|nM
3FJ7|1.70|2009|PEQ|PEP and PEQ are the same ligands|Q0PBL7|MAJOR ANTIGENIC PEPTIDE PEB3|3.71|Kd=195uM|Kd|=|195|uM|195000|nM
3D4F|1.55|2009|LN1|Kd1=19+/-3nM(progress curves); Kd2=27+/-2nM(direct competition reaction.); Ki=0.11+/-0.01uM|P0AD64|BETA-LACTAMASE SHV-1|7.72|Kd=19nM|Kd|=|19|nM|19|nM
2WF5|1.30|2009|BG6||P71447|BETA-PHOSPHOGLUCOMUTASE|6.0|Kd=1uM|Kd|=|1|uM|1000|nM
3ELC|2.50|2009|F01|Kd=2.02+/-0.42mM measured at 10C|P62617|2-C-METHYL-D-ERYTHRITOL 2,4-CYCLODIPHOSPHATE SYNTHASE|2.69|Kd=2.02mM|Kd|=|2.02|mM|2020000|nM
3DKJ|2.00|2009|PRP|human NAMPT complexed benzamide and phosphoribosyl pyrophosphate, Kd=2.0+/-0.2uM(for PRP)|P43490|NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE|5.7|Kd=2.0uM|Kd|=|2|uM|2000|nM
3IUC|2.40|2009|ADP|ITC Kd=3.8uM|B0QZ61|HEAT SHOCK 70KDA PROTEIN 5|5.66|Kd=2.17uM|Kd|=|2.17|uM|2170|nM
3D45|3.00|2009|7MG|Kd=2.1+/-0.07uM|Q8VDG3|POLY(A)-SPECIFIC RIBONUCLEASE PARN|5.68|Kd=2.1uM|Kd|=|2.1|uM|2100|nM
3A1E|1.95|2009|ACP||O29777|PROBABLE COPPER-EXPORTING P-TYPE ATPASE A|2.66|Kd=2.2mM|Kd|=|2.2|mM|2200000|nM
3G2W|2.40|2009|14-mer|VHS Domain of human GGA1 complexed with a DXXLL hinge peptide, Kd=2.2+/-0.4uM; incomplete ligand|Q9UJY5|ADP-RIBOSYLATION FACTOR-BINDING PROTEIN GGA1|5.66|Kd=2.2uM|Kd|=|2.2|uM|2200|nM
3FWV|2.20|2009|6-mer|TPR Protein, T-MOD(VMY) in complex with MEEVF peptide|P31948|HSC70/HSP90-ORGANIZING PROTEIN|5.64|Kd=2.3uM|Kd|=|2.3|uM|2300|nM
3IW7|2.40|2009|IPK|compound 15, Kd=2.3+/-0.57uM; incomplete ligand structure|Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|5.64|Kd=2.3uM|Kd|=|2.3|uM|2300|nM
2KFH|NMR|2009|12-mer|Rab11-FIP2 GPF peptide FNYESTGPFTAK, Ki=2.4+/-0.1mM|Q9H4M9|EH DOMAIN-CONTAINING PROTEIN 1|2.62|Kd=2.4mM|Kd|=|2.4|mM|2400000|nM
3F38|1.75|2009|2MY|compound 8(1); binding data in supplementary info; redundant to 3f37|P02791|FERRITIN LIGHT CHAIN|2.62|Kd=2.4mM|Kd|=|2.4|mM|2400000|nM
3F37|1.54|2009|2MY|ligand is compound 8(2); binding data in suppl info|P02791|FERRITIN LIGHT CHAIN|2.62|Kd=2.4mM|Kd|=|2.4|mM|2400000|nM
3E3C|2.50|2009|HHG||O85638|L0044|5.62|Kd=2.4uM|Kd|=|2.4|uM|2400|nM
2VXA|2.60|2009|RBF|HhDod for RF, Kd=2.5uM|A1WUH0|DODECIN|5.6|Kd=2.5uM|Kd|=|2.5|uM|2500|nM
3E6Y|2.50|2009|CW1|ligand is cotylenin A|P93343|14-3-3-LIKE PROTEIN C|5.6|Kd=2.5uM|Kd|=|2.5|uM|2500|nM
3JUP|1.90|2009|AKD|ligand is compound S-1, Kd=2.63+/-1.1uM|Q396C9|PHENAZINE BIOSYNTHESIS PROTEIN A/B|5.58|Kd=2.63uM|Kd|=|2.63|uM|2630|nM
3GXY|2.40|2009|3-mer||P81180|CYANOVIRIN-N|5.59|Kd=2.6uM|Kd|=|2.6|uM|2600|nM
2W6T|2.90|2009|10-mer|10-mer peptide SER-LYS-GLY-FHO-SER-SER-GLY-ORN-FHO-SER, Kd=2.7+/-0.2nM|P48632|FERRIPYOVERDINE RECEPTOR|8.57|Kd=2.7nM|Kd|=|2.7|nM|2.7|nM
2W78|3.00|2009|7-mer|7-mer peptide SER-LYS-GLY-FHO-LYS-FH7-SER, Kd=2.7+/-0.7nM; incomplete ligand structure|P48632|FERRIPYOVERDINE RECEPTOR|8.57|Kd=2.7nM|Kd|=|2.7|nM|2.7|nM
3KJD|1.95|2009|78P|ligand is inhibitor ABT-888|Q9UGN5|POLY [ADP-RIBOSE] POLYMERASE 2|8.54|Kd=2.9nM|Kd|=|2.9|nM|2.9|nM
3GGW|1.70|2009|12-mer|FAB F22-4 complex a peptide, ITC Kd=2.9+/-0.3uM, SPR Kd=3.3+/-0.2uM; incomplete ligand|------|ANTIBODY FAB F22-4 LIGHT CHAIN|5.54|Kd=2.9uM|Kd|=|2.9|uM|2900|nM
3GL6|1.90|2009|9-mer|unmodified Histone H3 N-terminal residues 1-9|P29375|HISTONE DEMETHYLASE JARID1A|4.68|Kd=20.7uM|Kd|=|20.7|uM|20700|nM
3DP9|2.30|2009|BIG|Kd=208+/-46pM; IC50=6+/-1nM|Q9KPI8|MTA/SAH NUCLEOSIDASE|9.68|Kd=208pM|Kd|=|208|pM|0.20800000000000002|nM
3GF2|1.80|2009|SAL|hypothetical regulator ST1710 complexed with sodium salicylate, Kd=20+/-4.9mM|Q96ZY1|146AA LONG HYPOTHETICAL TRANSCRIPTIONAL|1.7|Kd=20mM|Kd|=|20|mM|20000000|nM
3G0E|1.60|2009|B49|KIT kinase domain in complex with sunitinib, Kd=20+/-13nM|P10721|MAST/STEM CELL GROWTH FACTOR RECEPTOR|7.7|Kd=20nM|Kd|=|20|nM|20|nM
3HY5|3.04|2009|RET|wild type CRALBP complex 11-cis-retinal, two fold weak than R234W mutant|P12271|RETINALDEHYDE-BINDING PROTEIN 1|7.7|Kd=20nM|Kd|=|20|nM|20|nM
3IJ1|2.10|2009|11-mer|Eed in complex with a trimethylated histone H4K20 peptide, Kd=20+/-0.9uM; incomplete ligand|O75530|POLYCOMB PROTEIN EED|4.7|Kd=20uM|Kd|=|20|uM|20000|nM
3K5I|2.00|2009|AIR|Kd=20+/-8uM|A1CII2|PHOSPHORIBOSYL-AMINOIMIDAZOLE CARBOXYLASE|4.7|Kd=20uM|Kd|=|20|uM|20000|nM
3ISJ|2.20|2009|A8D|ligand is compound 2|P0A5R0|PANTOTHENATE SYNTHETASE|3.68|Kd=210uM|Kd|=|210|uM|210000|nM
3IOC|2.50|2009|A5D|ligand is compound PS-14a, Kd=210+/-20uM|P0A5R0|PANTOTHENATE SYNTHETASE|3.68|Kd=210uM|Kd|=|210|uM|210000|nM
3G19|1.85|2009|3-mer|ligand is LLL tripeptide|Q9A5I0|ATP-DEPENDENT CLP PROTEASE ADAPTER PROTEIN CLPS|6.67|Kd=214nM|Kd|=|214|nM|214|nM
2W87|1.60|2009|GCU|Ka=4.5x10+4M-1|Q51815|ESTERASE D|4.65|Kd=22.2uM|Kd|=|22.2|uM|22200|nM
3G0F|2.60|2009|B49|D816H mutant KIT kinase domain in complex with sunitinib, Kd=22+/-15nM|P10721|MAST/STEM CELL GROWTH FACTOR RECEPTOR|7.66|Kd=22nM|Kd|=|22|nM|22|nM
3H1Z|1.83|2009|15-mer|ligand is 15-mer PIPKI gamma-p90 peptide|P62944|AP-2 COMPLEX SUBUNIT BETA-1|4.66|Kd=22uM|Kd|=|22|uM|22000|nM
3JPX|2.05|2009|15-mer|ligand is 15-mer histone peptide H4K20me3; Kd=235+/-66uM; incomplete ligand|O75530|POLYCOMB PROTEIN EED|3.63|Kd=235uM|Kd|=|235|uM|235000|nM
2ZQ1|1.68|2009|11U|compound 1b(closed form); Kd=239+/-26nM; Ki=49+/-15nM|P00760|TRYPSIN|6.62|Kd=239nM|Kd|=|239|nM|239|nM
3D78|1.60|2009|NBB|Kd=23+/-4nM|Q9U9J6|PHEROMONE-BINDING PROTEIN ASP1|7.64|Kd=23nM|Kd|=|23|nM|23|nM
3K5K|1.70|2009|DXQ|compound 8; Kd=23+/-8nM; IC50=15+/-10nM|Q96KQ7|HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-9 SPECIFIC|7.64|Kd=23nM|Kd|=|23|nM|23|nM
3IFP|2.95|2009|7-mer|Amyloid beta A4 protein|P05067|ANTIBODY FAB 12B4, HEAVY CHAIN|7.61|Kd=24.5nM|Kd|=|24.5|nM|24.5|nM
3IQG|1.90|2009|5-mer|Kd=24.9+/-3.6uM; incomplete ligand|P45040|CYSTEINE SYNTHASE|4.6|Kd=24.9uM|Kd|=|24.9|uM|24900|nM
2KFF|NMR|2009|12-mer|Rab11-FIP2 NPF peptide FNYESTNPFTAK, Kd=245+/-35uM|Q9H4M9|EH DOMAIN-CONTAINING PROTEIN 1|3.61|Kd=245uM|Kd|=|245|uM|245000|nM
3EYU|2.71|2009|8-mer|Ror2(518-525)|A2NHM3|IF KAPPA LIGHT CHAIN|7.62|Kd=24nM|Kd|=|24|nM|24|nM
2ROL|NMR|2009|12-mer|Eps8L1 SH3 domain complex 12-mer peptide from T-cell surface glycoprotein CD3 epsilon chain|Q8TE68|EPIDERMAL GROWTH FACTOR RECEPTOR KINASE|4.62|Kd=24uM|Kd|=|24|uM|24000|nM
3IUX|1.65|2009|18-mer|human MDM2 complex with 18-residues inhibitor stingin-1, Kd=25.1+/-5.1nM|Q00987|E3 UBIQUITIN-PROTEIN LIGASE MDM2|7.6|Kd=25.1nM|Kd|=|25.1|nM|25.1|nM
2KBR|NMR|2009|18-mer|harmonin N-terminal complex 18-mer peptide of cadherin23, Kd=25.4+/-0.8uM|Q9Y6N9|HARMONIN|4.6|Kd=25.4uM|Kd|=|25.4|uM|25400|nM
3IQH|1.90|2009|5-mer|Kd=25.8+/-1.7uM; incomplete ligand|P45040|CYSTEINE SYNTHASE|4.59|Kd=25.8uM|Kd|=|25.8|uM|25800|nM
3DGL|1.80|2009|ATP|Kd=250+/-9nM; redundant to 2p09|------|ATP-BINDING PROTEIN-DX|6.6|Kd=250nM|Kd|=|250|nM|250|nM
2WP1|2.10|2009|10-mer|Kd=251+/-62uM, BD2 bound to Histone H3 peptide; incomplete ligand|Q91Y44|BROMODOMAIN TESTIS-SPECIFIC PROTEIN|3.6|Kd=251uM|Kd|=|251|uM|251000|nM
3EKT|1.97|2009|017|ligand is DRV; Kd=26+/-10pM; same as 6dh0|P03369|HIV-1 PROTEASE|10.59|Kd=26pM|Kd|=|26|pM|0.026000000000000002|nM
3F3T|2.50|2009|1AU|ligand is compound 1c, Kd=26+/-1.3uM; IC50=64.1+/-15.3uM|P00523|TYROSINE-PROTEIN KINASE SRC|4.59|Kd=26uM|Kd|=|26|uM|26000|nM
2KHH|NMR|2009|9-mer|ligand is nucleoporin FxFG repeats; Kd=276+/-80nM|Q99257|MRNA EXPORT FACTOR MEX67|6.56|Kd=276nM|Kd|=|276|nM|276|nM
2ZQ2|1.40|2009|13U|ligand is compound 1d(open form); Kd=276+/-76nM; Ki=102+/-18nM|P00760|TRYPSIN|6.56|Kd=276nM|Kd|=|276|nM|276|nM
3GFW|2.74|2009|S22|supplementary information; compound Mps1-IN-1; IC50=367nM|P33981|DUAL SPECIFICITY PROTEIN KINASE TTK|7.57|Kd=27nM|Kd|=|27|nM|27|nM
2UZJ|1.55|2009|E64|CYSTEINE PROTEASE INHIBITOR E64 LINKED TO CYSTEINE 47, Kd=27+/-7uM|Q5X9P3|STREPTOPAIN|4.57|Kd=27uM|Kd|=|27|uM|27000|nM
2ZHD|1.94|2009|12U|compound 1c(open form); Kd=287+/-48nM; Ki=81+/-39nM; redundant to 2zfs|P00760|TRYPSIN|6.54|Kd=287nM|Kd|=|287|nM|287|nM
2ZFS|1.51|2009|12U|ligand is compound 1c(closed form); Kd=287+/-48nM; Ki=81+/-39nM|P00760|TRYPSIN|6.54|Kd=287nM|Kd|=|287|nM|287|nM
2W92|1.65|2009|NGT|Kd=28+/-4uM|Q93HW0|ENDO-BETA-N-ACETYLGLUCOSAMINIDASE D|4.55|Kd=28uM|Kd|=|28|uM|28000|nM
3IUB|1.50|2009|FG2|ligand is compound 3|P0A5R0|PANTOTHENATE SYNTHETASE|4.54|Kd=29uM|Kd|=|29|uM|29000|nM
3GK2|1.98|2009|27A|compound SBi279 bound to Ca2+ S100B, Kd=2+/-1mM|P02638|PROTEIN S100-B|2.7|Kd=2mM|Kd|=|2|mM|2000000|nM
3FHB|2.30|2009|GAB||Q9Y6F1|POLY [ADP-RIBOSE] POLYMERASE 3|5.7|Kd=2uM|Kd|=|2|uM|2000|nM
2WN9|1.75|2009|ZY5|Kd=3.0+/-0.096nM|Q8WSF8|ACETYLCHOLINE RECEPTOR|8.52|Kd=3.0nM|Kd|=|3|nM|3|nM
3DA9|1.80|2009|44U|IC50=18uM|P00734|THROMBIN|5.51|Kd=3.1uM|Kd|=|3.1|uM|3100|nM
3IW6|2.10|2009|PP0|ligand is compound 10, Kd=3.29+/-0.64uM|Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|5.48|Kd=3.29uM|Kd|=|3.29|uM|3290|nM
3GA5|1.87|2009|RGG|Salmonella GBP in complex with GGal; binding data found in another reference|P23905|D-GALACTOSE-BINDING PERIPLASMIC PROTEIN|5.49|Kd=3.2uM|Kd|=|3.2|uM|3200|nM
3EQS|1.65|2009|12-mer|human MDM2 in complex with a 12-mer peptide, Kd1=3.3nM(ITC); Kd2=3.4uM(SPR); incomplete ligand|Q00987|E3 UBIQUITIN-PROTEIN LIGASE MDM2|8.48|Kd=3.3nM|Kd|=|3.3|nM|3.3|nM
3IVV|1.25|2009|10-mer|SPOPMATH-PucSBC1_pep1 complex, Kd=3.7+/-0.03uM; incomplete ligand structure|O43791|SPECKLE-TYPE POZ PROTEIN|5.43|Kd=3.7uM|Kd|=|3.7|uM|3700|nM
2WA8|2.15|2009|10-mer|N-END RULE PEPTIDE Fpep: GRSKGEELFT|P0A8Q6|ATP-DEPENDENT CLP PROTEASE ADAPTER PROTEIN CLPS|5.42|Kd=3.8uM|Kd|=|3.8|uM|3800|nM
3GQO|2.60|2009|APR|macro domain of VEEV virus in complex with ADP-ribose, Kd=3.9+/-0.65uM|P36328|NON-STRUCTURAL PROTEIN 3|5.41|Kd=3.9uM|Kd|=|3.9|uM|3900|nM
2ZFT|1.76|2009|10U|ligand is compound 1a(closed form); Kd1=300+/-34nM(Tris); Kd2=316+/-60nM(Tricine); Kd3=301+/-43M(Hepes); Kd4=245+/-38nM(PPi); Ki=117+/-25nM|P00760|TRYPSIN|6.52|Kd=300nM|Kd|=|300|nM|300|nM
3FDT|2.00|2009|15-mer|Kd=30+/-5uM;|P45973|CHROMOBOX PROTEIN HOMOLOG 5|4.52|Kd=30uM|Kd|=|30|uM|30000|nM
2WL5|1.80|2009|COA|ACETYL-COA ACETYLTRANSFERASE H348N MUTANT WITH COENZYME A, Kd=30+/-2uM|P07097|ACETYL-COA ACETYLTRANSFERASE|4.52|Kd=30uM|Kd|=|30|uM|30000|nM
2WEG|1.10|2009|FBV|ligand is compound 2|P00918|CARBONIC ANHYDRASE 2|6.5|Kd=314nM|Kd|=|314|nM|314|nM
3EU5|2.80|2009|GBO||Q04631|FARNESYLTRANSFERASE|7.49|Kd=32nM|Kd|=|32|nM|32|nM
2WNJ|1.80|2009|ZY7|Kd=330+/-58nM|Q8WSF8|ACETYLCHOLINE RECEPTOR|6.48|Kd=330nM|Kd|=|330|nM|330|nM
3GX0|2.30|2009|GDS|GST-like protein yfcG in complex with GSH, Kd=330+/-10uM|P77526|GST-LIKE PROTEIN YFCG|3.48|Kd=330uM|Kd|=|330|uM|330000|nM
3HEC|2.50|2009|STI|compound imatinib; IC50=70.0uM|Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|4.47|Kd=34.0uM|Kd|=|34|uM|34000|nM
3EL0|2.00|2009|1UN|ligand is NFV; Kd=34.1+/-1.3nM|P03369|HIV-1 PROTEASE|7.47|Kd=34.1nM|Kd|=|34.1|nM|34.1|nM
3GCQ|2.00|2009|1BU|compound 10b, Kd=342+/-39nM|Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|6.47|Kd=342nM|Kd|=|342|nM|342|nM
2W2U|2.20|2009|14-mer|Kd=35.0+/-9.4uM, ligand is a 14-mer peptide of Saci1373 (ESCRT-III); incomplete ligand|Q877H3|HYPOTHETICAL P60 KATANIN|4.46|Kd=35uM|Kd|=|35|uM|35000|nM
3IIW|1.80|2009|11-mer|Eed in complex with a trimethylated histone H3K27 peptide, Kd=36.4+/-2.4uM; incomplete ligand|O75530|POLYCOMB PROTEIN EED|4.44|Kd=36.4uM|Kd|=|36.4|uM|36400|nM
2VX9|1.65|2009|RBF|X-ray(dodecin E45A with RF) while Kd(wild type dodecin with RF)|B0R5M0|DODECIN|7.44|Kd=36nM|Kd|=|36|nM|36|nM
3FEA|1.33|2009|10-mer|Kd=36+/-2nM, p53-peptidomimetic Ac-Phe-Met-Aib-Pmp-6-Cl-Trp-Glu-Ac3c-Leu-NH2|O15151|PROTEIN MDM4|7.44|Kd=36nM|Kd|=|36|nM|36|nM
3GP0|1.90|2009|NIL|ligand is Nilotinib|Q15759|MITOGEN-ACTIVATED PROTEIN KINASE 11|7.44|Kd=36nM|Kd|=|36|nM|36|nM
3K27|1.76|2009|9-mer|H3K9me3; Kd1=24+/-3uM(fluorescence polarization assay); Kd2=36+/-3uM(ITC)|O75530|POLYCOMB PROTEIN EED|4.44|Kd=36uM|Kd|=|36|uM|36000|nM
3DRI|1.80|2009|6-mer||A2RJ53|OLIGO-PEPTIDE BINDING PROTEIN (OPPA)|4.42|Kd=37.7uM|Kd|=|37.7|uM|37700|nM
2WIG|2.15|2009|TC3|nonaged hBChE; compound TA4; Kd=370+/-40uM; Ki=4+/-0.5uM|P06276|CHOLINESTERASE|3.43|Kd=370uM|Kd|=|370|uM|370000|nM
2WE3|2.00|2009|DUT||P03195|DEOXYURIDINE 5'-TRIPHOSPHATE NUCLEOTIDOHYDROLASE|4.43|Kd=37uM|Kd|=|37|uM|37000|nM
3IQI|1.70|2009|5-mer|Kd=38.7+/-2.8uM; incomplete ligand|P45040|CYSTEINE SYNTHASE|4.41|Kd=38.7uM|Kd|=|38.7|uM|38700|nM
2W08|1.70|2009|TPO||P02743|SERUM AMYLOID P-COMPONENT|3.42|Kd=380uM|Kd|=|380|uM|380000|nM
3IOB|1.80|2009|A4D|ligand is compound PS-6, Kd=380+/-30uM|P0A5R0|PANTOTHENATE SYNTHETASE|3.42|Kd=380uM|Kd|=|380|uM|380000|nM
3JZO|1.80|2009|12-mer|pDI peptide; Kd=3nM(FP); IC50=550nM|O15151|PROTEIN MDM4|8.52|Kd=3nM|Kd|=|3|nM|3|nM
3EYS|1.95|2009|6-mer|incomplete ligand|A2NHM3|IF KAPPA LIGHT CHAIN|5.52|Kd=3uM|Kd|=|3|uM|3000|nM
3HQR|2.00|2009|OGA|ligand is compound NOG|Q9GZT9|EGL NINE HOMOLOG 1|5.52|Kd=3uM|Kd|=|3|uM|3000|nM
3EL9|1.60|2009|DR7|ligand is atazanavir; Kd=4.00+/-0.21nM|P03369|HIV-1 PROTEASE|8.4|Kd=4.00nM|Kd|=|4|nM|4|nM
3E85|1.95|2009|BSU|Kd=4.2+/-1.6uM|Q9LLQ2|PATHOGENESIS-RELATED PROTEIN, PR10.2B|5.38|Kd=4.2uM|Kd|=|4.2|uM|4200|nM
3G8E|3.00|2009|IS1|Visfatin with IS001, Kd=4.5+/-0.28uM|Q80Z29|NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE|5.35|Kd=4.5uM|Kd|=|4.5|uM|4500|nM
3EFS|2.30|2009|ATP|Kd=4.6+/-0.5uM|O66837|BIOTIN [ACETYL-COA-CARBOXYLASE] LIGASE|5.34|Kd=4.6uM|Kd|=|4.6|uM|4600|nM
3FTQ|2.90|2009|GNP|see supplement data|P42208|SEPTIN-2|5.33|Kd=4.7uM|Kd|=|4.7|uM|4700|nM
2W9R|1.70|2009|11-mer|DNA Protection During Starvation Protein(Lpep: LVKSKATNLLY)|P0A8Q6|ATP-DEPENDENT CLP PROTEASE ADAPTER PROTEIN CLPS|5.32|Kd=4.8uM|Kd|=|4.8|uM|4800|nM
3K26|1.58|2009|12-mer|ligand is 12-mer trimethylated H3K4 peptide; Kd>400uM; incomplete ligand|O75530|POLYCOMB PROTEIN EED|3.4|Kd=400uM|Kd|=|400|uM|400000|nM
3JZH|2.05|2009|5-mer||O75530|POLYCOMB PROTEIN EED|3.4|Kd=400uM|Kd|=|400|uM|400000|nM
3EOR|2.90|2009|CFV|CDV, Kd~40mM, temperature is 10 degree|P62617|2-C-METHYL-D-ERYTHRITOL 2,4-CYCLODIPHOSPHATE|1.4|Kd=40mM|Kd|=|40|mM|40000000|nM
3FN0|1.80|2009|9-mer|Envelope polyprotein gp160|------|ANTIBODY FAB Z13E1|4.4|Kd=40uM|Kd|=|40|uM|40000|nM
3JZG|2.10|2009|4-mer|H3K27me3; Kd=108+/-17uM(FP); Kd=40+/-6uM(ITC)|O75530|POLYCOMB PROTEIN EED|4.4|Kd=40uM|Kd|=|40|uM|40000|nM
2W9H|1.48|2009|TOP|Kd=430nM(without NADPH); Kd=0.97nM(with 200uM NADPH)|P0A017|DIHYDROFOLATE REDUCTASE|6.37|Kd=430nM|Kd|=|430|nM|430|nM
3DPC|2.30|2009|10-mer|Phosphorylated Peptide P1-P|P00634|ALKALINE PHOSPHATASE|4.36|Kd=44uM|Kd|=|44|uM|44000|nM
2ROK|NMR|2009|2-mer|ligand is 7MG-GDP|Q3TUQ8|POLY(A)-SPECIFIC RIBONUCLEASE|4.35|Kd=45uM|Kd|=|45|uM|45000|nM
3GJD|2.00|2009|LEU|redundant to 3f3e|O67854|TRANSPORTER|7.33|Kd=46.8nM|Kd|=|46.8|nM|46.8|nM
3KV2|1.55|2009|NNH|nor-NOHA (Nx-hydroxy-nor-Larginine), Kd=517nM(SPR), Kd=47.51nM(ITC)|P05089|ARGINASE-1|7.32|Kd=47.51nM|Kd|=|47.51|nM|47.51|nM
3DXK|2.70|2009|N23|Kd=470+/-50nM; IC50=32uM|P61157|ACTIN-RELATED PROTEIN 3|6.33|Kd=470nM|Kd|=|470|nM|470|nM
2WNC|2.20|2009|TKT|Kd=479+/-57nM|Q8WSF8|ACETYLCHOLINE RECEPTOR|6.32|Kd=479nM|Kd|=|479|nM|479|nM
2WKT|2.00|2009|COA|ACETYL-COA ACETYLTRANSFERASE N316A MUTANT WITH COENZYME A, Kd=49+/-3uM|P07097|ACETYL-COA ACETYLTRANSFERASE|4.31|Kd=49uM|Kd|=|49|uM|49000|nM
2WC4|1.70|2009|AMF|ligand is compound 9|Q08638|BETA-GLUCOSIDASE A|5.29|Kd=5.1uM|Kd|=|5.1|uM|5100|nM
3G2U|2.30|2009|13-mer|VHS Domain of human GGA1 complexed with Sotilin C-terminal Peptide, Kd=5.4+/-0.4uM; incomplete ligand|Q9UJY5|ADP-RIBOSYLATION FACTOR-BINDING PROTEIN GGA1|5.27|Kd=5.4uM|Kd|=|5.4|uM|5400|nM
3DPO|2.10|2009|11-mer|E. coli DnaK in complex with a short pyrrhocoricin-derived inhibitor peptide; incomplete ligand|P0A6Y8|CHAPERONE PROTEIN DNAK|8.26|Kd=5.5nM|Kd|=|5.5|nM|5.5|nM
3IVG|1.95|2009|FG5|ligand is compound 7|P0A5R0|PANTOTHENATE SYNTHETASE|4.3|Kd=50uM|Kd|=|50|uM|50000|nM
2WUF|1.90|2009|KEM|ligand is compound DSHA; Kd=51+/-2uM|P96851|2-HYDROXY-6-OXO-6-PHENYLHEXA-2,4-DIENOATE|4.29|Kd=51uM|Kd|=|51|uM|51000|nM
2VZR|1.95|2009|GCU|Ka=1.9x10+4M-1|Q56F26|EXO-BETA-D-GLUCOSAMINIDASE|4.28|Kd=52.6uM|Kd|=|52.6|uM|52600|nM
3A6T|1.96|2009|8OG|MutT in complex with 8-OXO-DGMP|P08337|MUTATOR MUTT PROTEIN|7.28|Kd=52nM|Kd|=|52|nM|52|nM
3JRS|2.05|2009|A8S|(+)-ABA-bound PYL1, Kd=52uM(ITC), Kd=340uM(SPR)|Q8VZS8|PUTATIVE UNCHARACTERIZED PROTEIN AT5G46790|4.28|Kd=52uM|Kd|=|52|uM|52000|nM
3IFO|2.15|2009|7-mer|incomplete ligand|P05067|ANTIBODY FAB 10D5, HEAVY CHAIN|7.26|Kd=54.5nM|Kd|=|54.5|nM|54.5|nM
3IOE|1.95|2009|A7D|ligand is compound PS-14b, Kd=540+/-20uM|P0A5R0|PANTOTHENATE SYNTHETASE|3.27|Kd=540uM|Kd|=|540|uM|540000|nM
3CZ1|1.50|2009|NBB|Kd=55.0+/-8.0nM|Q9U9J6|PHEROMONE-BINDING PROTEIN ASP1|7.26|Kd=55.0nM|Kd|=|55|nM|55|nM
3GCS|2.10|2009|BAX|ligand is sorafenib; Kd=56+/-5nM|Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|7.25|Kd=56nM|Kd|=|56|nM|56|nM
3H78|1.70|2009|BE2|PqsD C112A mutant in complex with 2-AMINOBENZOIC ACID|P20582|PQS BIOSYNTHETIC ENZYME|4.24|Kd=57uM|Kd|=|57|uM|57000|nM
2KE1|NMR|2009|10-mer|H3K4me0 peptide, Kd1=5.3+/-1.2uM(Fluorescence spectroscopy); Kd2=6.5+/-0.2uM(ITC).|O43918|AUTOIMMUNE REGULATOR|5.3|Kd=5uM|Kd|=|5|uM|5000|nM
3EBB|1.90|2009|10-mer|incomplete ligand|Q9Y263|PHOSPHOLIPASE A2-ACTIVATING PROTEIN|5.3|Kd=5uM|Kd|=|5|uM|5000|nM
3GPO|1.90|2009|APR|macro domain of Chikungunya virus in complex with ADP-ribose, Kd=5+/-0.4uM|Q8JUX6|NON-STRUCTURAL PROTEIN 3|5.3|Kd=5uM|Kd|=|5|uM|5000|nM
3G08|1.60|2009|FEE|Kd=6.843+/-3.001nM|P11609|T-CELL SURFACE GLYCOPROTEIN CD1D1|8.16|Kd=6.843nM|Kd|=|6.843|nM|6.843|nM
3CYZ|1.80|2009|9OD|Kd=60.0+/-15.0nM|Q9U9J6|PHEROMONE-BINDING PROTEIN ASP1|7.22|Kd=60.0nM|Kd|=|60|nM|60|nM
3DZT|1.80|2009|EAH|Kd=60.2+/-10.5nM|P18153|D7 PROTEIN|7.22|Kd=60.2nM|Kd|=|60.2|nM|60.2|nM
3DGN|2.70|2009|ADP|Kd=620+/-81nM|------|ATP-BINDING PROTEIN-DX|6.21|Kd=620nM|Kd|=|620|nM|620|nM
3HQH|2.30|2009|15-mer|SPOP-MATHx complex with MacroH2A SBC peptide 1, Kd=63.6+/-0.4uM; incomplete ligand|O43791|SPECKLE-TYPE POZ PROTEIN|4.2|Kd=63.6uM|Kd|=|63.6|uM|63600|nM
2WIJ|2.10|2009|TN7|nonaged hBChE; compound TA5; Kd=630+/-60uM; Ki=8+/-0.6uM|P06276|CHOLINESTERASE|3.2|Kd=630uM|Kd|=|630|uM|630000|nM
2WL4|1.80|2009|COA|ACETYL-COA ACETYLTRANSFERASE H348A MUTANT WITH COENZYME A, Kd=64+/-4uM|P07097|ACETYL-COA ACETYLTRANSFERASE|4.19|Kd=64uM|Kd|=|64|uM|64000|nM
3CFT|1.87|2009|5NS|Kd=64+/-18uM|P02766|TRANSTHYRETIN|4.19|Kd=64uM|Kd|=|64|uM|64000|nM
2WIK|2.10|2009|TC5|nonaged hBChE; compound TA6; Kd=660+/-50uM; Ki=17+/-0.3uM|P06276|CHOLINESTERASE|3.18|Kd=660uM|Kd|=|660|uM|660000|nM
3EL4|2.00|2009|ROC|ligand is SQV; Kd=67.4+/-0.3nM|P03369|HIV-1 PROTEASE|7.17|Kd=67.4nM|Kd|=|67.4|nM|67.4|nM
3H85|2.60|2009|8-mer|PIPKIgamma-p90 peptide|P84092|AP-2 COMPLEX SUBUNIT MU-1|5.22|Kd=6uM|Kd|=|6|uM|6000|nM
2W8W|2.14|2009|PLS|Kd=7.5+/-0.5mM|Q93UV0|SERINE PALMITOYLTRANSFERASE|2.12|Kd=7.5mM|Kd|=|7.5|mM|7500000|nM
2WFJ|0.75|2009|11-mer|Peptidyl-prolyl cis-trans isomerase G complex with CYCLOSPORIN A peptide|Q13427|PEPTIDYL-PROLYL CIS-TRANS ISOMERASE G|7.15|Kd=70nM|Kd|=|70|nM|70|nM
3FQL|1.80|2009|79Z|ligand is compound HCV-796; Kd=71+/-28nM; IC50=81+/-19nM|Q9WMX2|RNA-DIRECTED RNA POLYMERASE|7.15|Kd=71nM|Kd|=|71|nM|71|nM
3F3V|2.60|2009|1BU|Kd=73+/-16nM; IC50=21+/-5nM|P00523|TYROSINE-PROTEIN KINASE SRC|7.14|Kd=73nM|Kd|=|73|nM|73|nM
3GCV|2.30|2009|SS6|compound 10h, Kd=74+/-2nM|Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|7.13|Kd=74nM|Kd|=|74|nM|74|nM
3FE7|1.35|2009|10-mer|Kd=75+/-3nM, p53-peptidomimetic Ac-Phe-Met-Aib-Pmp-Trp-Glu-Ac3c-Leu-NH2|O15151|PROTEIN MDM4|7.12|Kd=75nM|Kd|=|75|nM|75|nM
3HWW|1.95|2009|AKG|EcMenD oxoglutarate complex, Kd=7.5x10-8M (pH=7.5)|P17109|2-SUCCINYL-5-ENOLPYRUVYL-6-HYDROXY-3-CYCLOHEXENE|7.12|Kd=75nM|Kd|=|75|nM|75|nM
3A1D|1.85|2009|ADP||O29777|PROBABLE COPPER-EXPORTING P-TYPE ATPASE A|4.12|Kd=75uM|Kd|=|75|uM|75000|nM
3IVC|2.13|2009|FG4|ligand is compound 6|P0A5R0|PANTOTHENATE SYNTHETASE|4.12|Kd=75uM|Kd|=|75|uM|75000|nM
3IVQ|2.10|2009|12-mer|SPOPMATH-CiSBC2 complex, Kd=76.1+/-0.9uM; incomplete ligand|O43791|SPECKLE-TYPE POZ PROTEIN|4.12|Kd=76.1uM|Kd|=|76.1|uM|76100|nM
2V57|1.90|2009|PRL|one proflavine to homodimer Kd1=79nM, two proflavine to monomer Kd2=4.3uM|Q58L87|TETR FAMILY TRANSCRIPTIONAL REPRESSOR LFRR|7.1|Kd=79nM|Kd|=|79|nM|79|nM
2KNH|NMR|2009|18-mer|ligand is HEB peptide, Kd=7+/-2uM|Q06455|PROTEIN CBFA2T1|5.15|Kd=7uM|Kd|=|7|uM|7000|nM
3EFR|2.55|2009|BTN|Kd=8.3+/-2.1uM|O66837|BIOTIN [ACETYL-COA-CARBOXYLASE] LIGASE|5.08|Kd=8.3uM|Kd|=|8.3|uM|8300|nM
3IFL|1.50|2009|7-mer||P05067|ANTIBODY FAB 12A11, LIGHT CHAIN|8.08|Kd=8.4nM|Kd|=|8.4|nM|8.4|nM
3JUO|2.20|2009|AJD|ligand is compound R-1, Kd=8.55+/-2.6uM|Q396C9|PHENAZINE BIOSYNTHESIS PROTEIN A/B|5.07|Kd=8.55uM|Kd|=|8.55|uM|8550|nM
2VWF|1.58|2009|15-mer|15-mer GRB2-ASSOCIATED-BINDING PROTEIN 2, Kd=8.7+/-0.3uM; incomplete ligand|P62993|GROWTH FACTOR RECEPTOR-BOUND PROTEIN 2|5.06|Kd=8.7uM|Kd|=|8.7|uM|8700|nM
3EQY|1.63|2009|12-mer|human MDMX in complex with a 12-mer peptide, Kd1=8.9nM(ITC); Kd2=4.2uM(SPR)|O15151|PROTEIN MDM4|8.05|Kd=8.9nM|Kd|=|8.9|nM|8.9|nM
3F78|1.60|2009|ICF||P20701|INTEGRIN ALPHA-L|3.1|Kd=800uM|Kd|=|800|uM|800000|nM
3GK1|2.10|2009|32A|ligand is compound SBi132+Ca2+ S100B, Kd=0.08+/-0.02mM|P02638|PROTEIN S100-B|4.1|Kd=80uM|Kd|=|80|uM|80000|nM
3IOD|1.75|2009|A6D|ligand is compound PS-14b, Kd=80+/-10uM|P0A5R0|PANTOTHENATE SYNTHETASE|4.1|Kd=80uM|Kd|=|80|uM|80000|nM
2KMX|NMR|2009|ATP|Ka=1.2x10^4M-1, Kd=8.33x10-5M|Q04656|COPPER-TRANSPORTING ATPASE 1|4.08|Kd=83.3uM|Kd|=|83.3|uM|83300|nM
2WEJ|1.45|2009|FB2|ligand is compound 1|P00918|CARBONIC ANHYDRASE 2|6.08|Kd=839nM|Kd|=|839|nM|839|nM
2WGI|2.85|2009|PNM|X-ray structure(W154A-PenG); Kd1=85+/-5uM(carbon dioxide for W154A OXA-10).|P14489|BETA-LACTAMASE OXA-10|4.07|Kd=85uM|Kd|=|85|uM|85000|nM
2ZSC|1.30|2009|BTN|X-ray(tamavidin-2 with biotin) while Kd=87+/-20nM(tamavidin 2 with 2-iminobiotin)|B9A0T7|TAMAVIDIN2|7.06|Kd=87nM|Kd|=|87|nM|87|nM
3KR8|2.10|2009|XAV|ligand is inhibitor XAV939, Kd=8+/-3nM|Q9H2K2|TANKYRASE-2|8.1|Kd=8nM|Kd|=|8|nM|8|nM
2W85|NMR|2009|12-mer|Peroxisomal Membrane Anchor Protein Pex14 complex Peroxin-19, Kd=9.17+/-0.03uM|O75381|PEROXISOMAL MEMBRANE ANCHOR PROTEIN PEX14|5.04|Kd=9.17uM|Kd|=|9.17|uM|9170|nM
2WJI|1.90|2009|GNP||Q57986|FERROUS IRON TRANSPORT PROTEIN B HOMOLOG|5.02|Kd=9.6uM|Kd|=|9.6|uM|9600|nM
3GUS|1.53|2009|N11|Kd=0.90uM; IC50=0.8uM|P09211|GLUTATHIONE S-TRANSFERASE P|6.05|Kd=900nM|Kd|=|900|nM|900|nM
2WER|1.60|2009|RDC|Kd=90+/-0.007nM|P02829|HEAT SHOCK PROTEIN HSP82|7.05|Kd=90nM|Kd|=|90|nM|90|nM
2W0Z|1.70|2009|9-mer|Gab2a truncated, Kd=93.8+/-3.8uM|P62993|GROWTH FACTOR RECEPTOR-BOUND PROTEIN 2|4.03|Kd=93.8uM|Kd|=|93.8|uM|93800|nM
3FZN|1.62|2009|D7K|BFDC in complex with MBP, Kd=97+/-9uM|P20906|BENZOYLFORMATE DECARBOXYLASE|4.01|Kd=97uM|Kd|=|97|uM|97000|nM
3I90|2.00|2009|11-mer|Protein 1 Fragment: Chromo domain: UNP residues 9-64 ;|O95503|CHROMOBOX PROTEIN HOMOLOG 6|3.3|Kd>500uM|Kd|>|500|uM|500000|nM
3GV6|1.76|2009|15-mer|protein 1 Fragment: UNP residues 8-65 ; protein 2 Fragment: UNP residues 2-16 ;|O95503|CHROMOBOX PROTEIN HOMOLOG 6|3.3|Kd>500uM|Kd|>|500|uM|500000|nM
3I91|1.55|2009|8-mer|protein 1 Fragment: Chromo domain: UNP residues 8-61 ;|Q9HC52|CHROMOBOX PROTEIN HOMOLOG 8|3.3|Kd>500uM|Kd|>|500|uM|500000|nM
3DKG|1.91|2009|SX8|compound SGX532; Ki<10uM; IC50>10uM|A1L467|MET PROTO-ONCOGENE|5.0|Ki<10uM|Ki|<|10|uM|10000|nM
2WGJ|2.00|2009|VGH||P08581|HEPATOCYTE GROWTH FACTOR RECEPTOR|8.7|Ki=0.002uM|Ki|=|0.002|uM|2|nM
3K84|2.25|2009|K84|ligand is compound 4b|P97612|FATTY-ACID AMIDE HYDROLASE 1|8.52|Ki=0.003uM|Ki|=|0.003|uM|3|nM
3IOK|2.10|2009|1P6|tyrosine-protein kinase JAK2 complex compound 42|O60674|TYROSINE-PROTEIN KINASE JAK2|7.96|Ki=0.011uM|Ki|=|0.011|uM|11|nM
3GGV|3.09|2009|GGV|HIV Protease inhibitors with compound 10c|Q9Q2G8|HIV-1 PROTEASE|10.85|Ki=0.014nM|Ki|=|0.014|nM|0.014|nM
3IO7|2.60|2009|1P5|Tyrosine-protein kinase JAK2 complex Compound 12|O60674|TYROSINE-PROTEIN KINASE JAK2|7.77|Ki=0.017uM|Ki|=|0.017|uM|17|nM
3H8C|2.50|2009|NSZ|inhibitors 14|P07711|CATHEPSIN L1|7.72|Ki=0.019uM|Ki|=|0.019|uM|19|nM
3G35|1.41|2009|F13|ligand is compound 12(F13); Ki=0.021mM|Q9L5C8|BETA-LACTAMASE CTX-M-9A|4.68|Ki=0.021mM|Ki|=|0.021|mM|21000|nM
3K83|2.25|2009|F27|ligand is compound 17|P97612|FATTY-ACID AMIDE HYDROLASE 1|7.66|Ki=0.022uM|Ki|=|0.022|uM|22|nM
3H89|2.50|2009|NSX|ligand is inhibitor 4|P07711|CATHEPSIN L1|7.64|Ki=0.023uM|Ki|=|0.023|uM|23|nM
3F5K|1.80|2009|CE5|ligand is compound cellopentaose; Ki=0.024+/-0.02mM|Q42975|BETA-GLUCOSIDASE|4.62|Ki=0.024mM|Ki|=|0.024|mM|24000|nM
3FKV|1.85|2009|BZB|ligand is compound 36, special B atom in ligand|P00811|BETA-LACTAMASE|7.57|Ki=0.027uM|Ki|=|0.027|uM|27|nM
2ZJW|2.40|2009|REF|IC50=0.04uM|P68400|CASEIN KINASE II, ALPHA SUBUNIT|7.7|Ki=0.02uM|Ki|=|0.02|uM|20|nM
3K7F|1.95|2009|F2C|ligand is compound 40|P97612|FATTY-ACID AMIDE HYDROLASE 1|7.7|Ki=0.02uM|Ki|=|0.02|uM|20|nM
3KCF|2.80|2009|JZO|TGFbRI kinase activity of compound 24|P36897|TGF-BETA RECEPTOR TYPE-1|7.46|Ki=0.035uM|Ki|=|0.035|uM|35|nM
2ZY1|1.78|2009|830|IC50=8nM|A9JQL9|DEHYDROSQUALENE SYNTHASE|7.4|Ki=0.04uM|Ki|=|0.04|uM|40|nM
3F5J|1.95|2009|CTT|ligand is compound cellotetraose; Ki=0.052+/-0.06mM|Q42975|BETA-GLUCOSIDASE|4.28|Ki=0.052mM|Ki|=|0.052|mM|52000|nM
3IKG|1.86|2009|J8Z|ligand is compound 22b and Pin1 K77 82Q construct|Q13526|PEPTIDYL-PROLYL CIS-TRANS ISOMERASE NIMA-INTERACTIN|7.24|Ki=0.057uM|Ki|=|0.057|uM|57|nM
3H5B|1.29|2009|031|ligand is compound 19b; Ki=0.099nM; IC50=0.026nM|P03367|HIV-1 PROTEASE|10.0|Ki=0.099nM|Ki|=|0.099|nM|0.099|nM
3JYA|2.10|2009|LWG|ligand is compound 3b|P11309|SERINE/THREONINE-PROTEIN KINASE PIM-1|6.89|Ki=0.1301uM|Ki|=|0.1301|uM|130.1|nM
3FX6|1.85|2009|BPX|CPA-R-5 complex; compound R-5 is incorrect in reference|P00730|CARBOXYPEPTIDASE A1|6.8|Ki=0.16uM|Ki|=|0.16|uM|160|nM
3IKD|2.00|2009|J9Z|ligand is compound 18b and Pin1 K77 82Q construct|Q13526|PEPTIDYL-PROLYL CIS-TRANS ISOMERASE NIMA-INTERACTIN|6.75|Ki=0.179uM|Ki|=|0.179|uM|179|nM
3DK1|1.07|2009|G05|ligand is compound 3; IC50=170nM|P03367|HIV-1 PROTEASE|9.74|Ki=0.18nM|Ki|=|0.18|nM|0.18|nM
3F5L|1.37|2009|LB2|ligand is compound laminaribiose; Ki=0.191+/-0.02mM|Q42975|BETA-GLUCOSIDASE|3.72|Ki=0.191mM|Ki|=|0.191|mM|191000|nM
3G32|1.31|2009|3G3|ligand is compound 6(3G3); Ki=0.194mM|Q9L5C8|BETA-LACTAMASE CTX-M-9A|3.71|Ki=0.194mM|Ki|=|0.194|mM|194000|nM
3ELM|1.90|2009|24F||P45452|COLLAGENASE 3 (MMP-13)|9.72|Ki=0.19nM|Ki|=|0.19|nM|0.19|nM
2ZZ6|1.66|2009|6AZ|native enzyme and 6-N3-UMP complex|O26232|OROTIDINE 5'-MONOPHOSPHATE DECARBOXYLASE|6.72|Ki=0.19uM|Ki|=|0.19|uM|190|nM
2ZO3|1.70|2009|33U|compound 6, Ki=0.1+/-0.2nM|P00734|THROMBIN LIGHT CHAIN|10.0|Ki=0.1nM|Ki|=|0.1|nM|0.1|nM
2WAP|2.80|2009|PIX|covalent&nbsp; complex; ki=0.23+/-0.03uM, ligand is a little different from PF-3845|P97612|FATTY-ACID AMIDE HYDROLASE 1|6.64|Ki=0.23uM|Ki|=|0.23|uM|230|nM
3GS6|2.30|2009|NP6||Q9KU37|BETA-HEXOSAMINIDASE|6.59|Ki=0.26uM|Ki|=|0.26|uM|260|nM
3BLT|2.20|2009|PSY|equilibrium binding constant Ki=0.29+/-0.06mM, covalently bind to Cys of active site|P15273|TYROSINE-PROTEIN PHOSPHATASE YOPH|3.54|Ki=0.29mM|Ki|=|0.29|mM|290000|nM
3EYD|2.30|2009|BE8|compound 17|Q9ELS8|HCV NS3 PROTEASE|9.7|Ki=0.2nM|Ki|=|0.2|nM|0.2|nM
3GSM|2.40|2009|VPU||Q9KU37|BETA-HEXOSAMINIDASE|6.48|Ki=0.33uM|Ki|=|0.33|uM|330|nM
3FV3|1.85|2009|6-mer|Sapp1p in complex with pepstatin A|P32951|SAPP1P-SECRETED ASPARTIC PROTEASE 1|9.52|Ki=0.3nM|Ki|=|0.3|nM|0.3|nM
3G0W|1.95|2009|LGB|ligand is compound 6c, Ki=0.3+/-0.1nM|P15207|ANDROGEN RECEPTOR|9.52|Ki=0.3nM|Ki|=|0.3|nM|0.3|nM
3G5K|1.70|2009|BB2|ligand is compound 1(actinonin)|Q9HBH1|PEPTIDE DEFORMYLASE|9.52|Ki=0.3nM|Ki|=|0.3|nM|0.3|nM
2WCG|2.30|2009|MT5||B2R6A7|GLUCOSYLCERAMIDASE|6.38|Ki=0.42uM|Ki|=|0.42|uM|420|nM
3G90|2.40|2009|J72|Mitogen-activated protein kinase, JNK3 with compound 25|P53779|MITOGEN-ACTIVATED PROTEIN KINASE 10|6.36|Ki=0.44uM|Ki|=|0.44|uM|440|nM
3CTT|2.10|2009|3CU||O43451|MALTASE-GLUCOAMYLASE|6.35|Ki=0.45uM|Ki|=|0.45|uM|450|nM
2WK6|2.50|2009|IUR||P19971|THYMIDINE PHOSPHORYLASE|3.32|Ki=0.48mM|Ki|=|0.48|mM|480000|nM
2ZGA|1.65|2009|YDP|incomplete ligand structure|P03367|HIV-1 PROTEASE|6.32|Ki=0.48uM|Ki|=|0.48|uM|480|nM
3CKT|1.65|2009|YDP|redundant to 2zga|P03367|HIV-1 PROTEASE|6.32|Ki=0.48uM|Ki|=|0.48|uM|480|nM
3JQ9|2.30|2009|AX1|Pteridine Reductase 1 complex NADP+ and AX1 compound 13, Ki=0.4uM|Q581W1|PTERIDINE REDUCTASE 1|6.4|Ki=0.4uM|Ki|=|0.4|uM|400|nM
3H8B|1.80|2009|NSY|ligand is inhibitor 9|P07711|CATHEPSIN L1|6.29|Ki=0.511uM|Ki|=|0.511|uM|511|nM
2ZNT|1.60|2009|DYH|redundant to 3fv1|P39086|GLUTAMATE RECEPTOR, IONOTROPIC KAINATE 1|9.3|Ki=0.5nM|Ki|=|0.5|nM|0.5|nM
2W8F|2.70|2009|BS1|APLYSIA CALIFORNICA ACHBP BOUND TO IN SILICO COMPOUND 31, pKi=6.3+/-0.2|Q8WSF8|ACETYLCHOLINE RECEPTOR|6.3|Ki=0.5uM|Ki|=|0.5|uM|500|nM
3DXH|1.40|2009|UDP|Ki=0.65+/-0.06mM|P61823|RIBONUCLEASE|3.19|Ki=0.65mM|Ki|=|0.65|mM|650000|nM
3HK1|1.70|2009|B64|AFABP/aP2 complexed with 1, Ki=0.67+/-0.18uM|P04117|ADIPOCYTE LIPID-BINDING PROTEIN|6.17|Ki=0.67uM|Ki|=|0.67|uM|670|nM
2K1Q|NMR|2009|5-mer|hepatitis c virus ns3 serine protease complex with 5-mer phenethylamide inhibitor|P90191|SERINE PROTEASE NS3|6.22|Ki=0.6uM|Ki|=|0.6|uM|600|nM
3E9I|2.20|2009|XAH|BsLysRS-LXT-AMP complex; ligand is LXT-AMP; Ki=0.6uM for BsLysRS; Ki=86+/-7uM for EsLysRS|Q9RHV9|LYSYL-TRNA SYNTHETASE|6.22|Ki=0.6uM|Ki|=|0.6|uM|600|nM
2WB5|2.31|2009|VGB|ligand is GlcNAcstatins D; Ki=0.74+/-0.09nM|Q0TR53|O-GLCNACASE NAGJ|9.13|Ki=0.74nM|Ki|=|0.74|nM|0.74|nM
3G9L|2.20|2009|J67|Mitogen-activated protein kinase, JNK3 with compound 47|P53779|MITOGEN-ACTIVATED PROTEIN KINASE 10|6.13|Ki=0.74uM|Ki|=|0.74|uM|740|nM
3IBU|1.41|2009|O48|adducts of sulfamates 2 with hCA II|P00918|CARBONIC ANHYDRASE 2|9.15|Ki=0.7nM|Ki|=|0.7|nM|0.7|nM
2W8Y|1.80|2009|486|Ki=0.82+/-0.01nM; binding data measured with rabbit protein; LBD of rabbit and human proteins are identical|P06401|PROGESTERONE RECEPTOR|9.09|Ki=0.82nM|Ki|=|0.82|nM|0.82|nM
2WC3|2.00|2009|AM3|ligand is compound 8|Q08638|BETA-GLUCOSIDASE A|6.08|Ki=0.83uM|Ki|=|0.83|uM|830|nM
3GBA|1.35|2009|DYH|ligand is compound DH; Ki=0.848+/-0.150nM.|P22756|GLUTAMATE RECEPTOR, IONOTROPIC KAINATE 1|9.07|Ki=0.848nM|Ki|=|0.848|nM|0.848|nM
3FFG|1.54|2009|FFG|ligand is compound 5d|P00742|COAGULATION FACTOR X|9.08|Ki=0.84nM|Ki|=|0.84|nM|0.84|nM
3KCK|2.20|2009|3KC|compound 15a|O60674|TYROSINE-PROTEIN KINASE JAK2|9.1|Ki=0.8nM|Ki|=|0.8|nM|0.8|nM
2ZU3|1.75|2009|ZU3||Q90092|3C PROTEINASE|6.1|Ki=0.8uM|Ki|=|0.8|uM|800|nM
3JQB|2.40|2009|DX6|Pteridine Reductase 1 complex NADP+ and DX6 compound 7, Ki=0.96uM|Q581W1|PTERIDINE REDUCTASE 1|6.02|Ki=0.96uM|Ki|=|0.96|uM|960|nM
3HB4|2.21|2009|E2B|Ki=0.9+/-0.15nM; IC50=42nM|P14061|ESTRADIOL 17-BETA-DEHYDROGENASE 1|9.05|Ki=0.9nM|Ki|=|0.9|nM|0.9|nM
3ISS|2.50|2009|EPU|MurA3 UDP-MurNAc3 phosphite structure|P0A749|UDP-N-ACETYLGLUCOSAMINE 1|6.05|Ki=0.9uM|Ki|=|0.9|uM|900|nM
3G34|1.31|2009|1CE|ligand is compound 11(1CE); Ki=1.1mM|Q9L5C8|BETA-LACTAMASE CTX-M-9A|2.96|Ki=1.1mM|Ki|=|1.1|mM|1100000|nM
3DCC|1.60|2009|D9Z|ligand is inhibitor CHL, Ki=1.1+/-0.2nM|P00918|CARBONIC ANHYDRASE 2|8.96|Ki=1.1nM|Ki|=|1.1|nM|1.1|nM
3G3M|1.40|2009|5FU|Human ODCases with compound 40, 5-fluoro-6-iodo-UMP, but PDB still is 5FU|P11172|URIDINE 5'-MONOPHOSPHATE SYNTHASE|5.96|Ki=1.1uM|Ki|=|1.1|uM|1100|nM
3EBP|2.00|2009|CPB|ligand is Flavopiridol|P00489|GLYCOGEN PHOSPHORYLASE|5.91|Ki=1.24uM|Ki|=|1.24|uM|1240|nM
3EGT|2.00|2009|722||Q86C09|FARNESYL PYROPHOSPHATE SYNTHASE|8.9|Ki=1.26nM|Ki|=|1.26|nM|1.26|nM
3JQ7|1.80|2009|DX2|Pteridine Reductase 1 complex NADP+ and DX2 compound 2, Ki=1.2uM|Q581W1|PTERIDINE REDUCTASE 1|5.92|Ki=1.2uM|Ki|=|1.2|uM|1200|nM
2WOQ|1.75|2009|AYC|covalent complex; IC50=2.1mM|Q59643|DELTA-AMINOLEVULINIC ACID DEHYDRATASE|2.88|Ki=1.33mM|Ki|=|1.33|mM|1330000|nM
3G31|1.70|2009|GF1|ligand is compound 4(GF1); Ki=1.3mM|Q9L5C8|BETA-LACTAMASE CTX-M-9A|2.89|Ki=1.3mM|Ki|=|1.3|mM|1300000|nM
3EHY|1.90|2009|TBL|ligand is compound 2; Ki=1.4+/-0.2uM|P39900|MACROPHAGE METALLOELASTASE (MMP-12)|5.85|Ki=1.4uM|Ki|=|1.4|uM|1400|nM
2ZXG|1.55|2009|S23|crystal structure(E. coli APN); Ki=1.5+/-0.2nM(E. coli APN); Ki=2.2+/-0.5nM(Hog kidney APN)|P04825|AMINOPEPTIDASE N|8.82|Ki=1.5nM|Ki|=|1.5|nM|1.5|nM
3FCQ|1.75|2009|M3S|ligand is compound 9|P00800|THERMOLYSIN|2.77|Ki=1.7mM|Ki|=|1.7|mM|1700000|nM
2WKZ|1.70|2009|5AH||P03366|HIV-1 PROTEASE|8.77|Ki=1.7nM|Ki|=|1.7|nM|1.7|nM
3E4A|2.60|2009|QIX|incomplete ligand structure in RCSB PDB|P14735|INSULIN-DEGRADING ENZYME|8.77|Ki=1.7nM|Ki|=|1.7|nM|1.7|nM
3CSO|2.71|2009|XNI|Ki=1.7+/-1.2uM; IC50=1.8+/-1.1uM|O92972|RNA-DIRECTED RNA POLYMERASE|5.77|Ki=1.7uM|Ki|=|1.7|uM|1700|nM
3JVR|1.76|2009|AGX|ligand is compound 2, Ki=1.89+/-0.32uM|O14757|SERINE/THREONINE-PROTEIN KINASE CHK1|5.72|Ki=1.89uM|Ki|=|1.89|uM|1890|nM
3G9N|2.80|2009|J88|Mitogen-activated protein kinase, JNK3 with compound 41|P53779|MITOGEN-ACTIVATED PROTEIN KINASE 10|5.74|Ki=1.8uM|Ki|=|1.8|uM|1800|nM
2WJ1|1.84|2009|S99|compound 2|P97612|FATTY-ACID AMIDE HYDROLASE 1|8.72|Ki=1.9nM|Ki|=|1.9|nM|1.9|nM
3GJS|1.90|2009|5-mer|Caspase-3 Binds Ac-YVAD-Cho peptide, Ki=10.2+/-0.41uM|P42574|CASPASE-3 SUBUNIT P17|4.99|Ki=10.2uM|Ki|=|10.2|uM|10200|nM
2WD7|1.90|2009|VGD|PTERIDINE REDUCTASE 1 (PTR1) FROM TRYPANOSOMA BRUCEI complex compound 4|O76290|PTERIDINE REDUCTASE|4.97|Ki=10.6uM|Ki|=|10.6|uM|10600|nM
2KAW|NMR|2009|SUZ|Ki=10.7+/-1.2uM.|P51141|SEGMENT POLARITY PROTEIN DISHEVELLED HOMOLOG DVL|4.97|Ki=10.7uM|Ki|=|10.7|uM|10700|nM
3DUX|1.60|2009|64U|compound 7, Ki=100+/-39nM|P00734|THROMBIN LIGHT CHAIN|7.0|Ki=100nM|Ki|=|100|nM|100|nM
3DJQ|1.53|2009|UDP|Ki=1046.4+/-50.2uM|P00669|SEMINAL RIBONUCLEASE|2.98|Ki=1046.4uM|Ki|=|1046.4|uM|1046400.0000000001|nM
3G2Y|1.31|2009|GF4||Q9L5C8|BETA-LACTAMASE CTX-M-9A|2.0|Ki=10mM|Ki|=|10|mM|10000000|nM
2VWN|1.61|2009|H25|ligand is compound 14|P00742|COAGULATION FACTOR XA|8.0|Ki=10nM|Ki|=|10|nM|10|nM
3FUR|2.30|2009|Z12|PPARg with INT131, displace [3H]-rosiglitazone with a Ki of 10 nM|P37231|PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA|8.0|Ki=10nM|Ki|=|10|nM|10|nM
3HS4|1.10|2009|AZM||P00918|CARBONIC ANHYDRASE 2|8.0|Ki=10nM|Ki|=|10|nM|10|nM
3GBE|1.70|2009|NOJ|SmuA in complex with the inhibitor deoxynojirimycin|D0VX20|SUCROSE ISOMERASE SMUA|5.0|Ki=10uM|Ki|=|10|uM|10000|nM
3DCS|1.80|2009|MZM|ligand is inhibitor MZM, Ki=11.4+/-2nM; redundant to 3daz|P00918|CARBONIC ANHYDRASE 2|7.94|Ki=11.4nM|Ki|=|11.4|nM|11.4|nM
3DAZ|1.60|2009|MZM|ligand is inhibitor MZM, Ki=11.8+/-1.8nM|P00918|CARBONIC ANHYDRASE 2|7.93|Ki=11.8nM|Ki|=|11.8|nM|11.8|nM
3IWW|2.30|2009|YZE|GCPII in complex with compound 32d|Q04609|GLUTAMATE CARBOXYPEPTIDASE 2|7.96|Ki=11nM|Ki|=|11|nM|11|nM
2W67|2.25|2009|F34|ligand is compound 5, Ki=11+/-1uM|Q89ZI2|O-GLCNACASE BT_4395|4.96|Ki=11uM|Ki|=|11|uM|11000|nM
3IBC|2.75|2009|5-mer|caspase-7/Ac-YVAD-Cho complex, Ki=12.4+/-0.5uM|P55210|CASPASE-7 (CASP-7)|4.91|Ki=12.4uM|Ki|=|12.4|uM|12400|nM
3GBB|2.10|2009|MS8|ligand is compound MSV-19; Ki=126+/-45nM.|P22756|GLUTAMATE RECEPTOR, IONOTROPIC KAINATE 1|6.9|Ki=126nM|Ki|=|126|nM|126|nM
2JJB|1.90|2009|3CU+GLC|compound 2; casuarine 6-O-a-glucopyranoside|P13482|PERIPLASMIC TREHALASE|7.92|Ki=12nM|Ki|=|12|nM|12|nM
3EFT|1.85|2009|3BS||P00918|CARBONIC ANHYDRASE 2|7.92|Ki=12nM|Ki|=|12|nM|12|nM
3EAX|1.90|2009|LZP|ligand is compound LZP6, Ki=12+/-0.6uM; IC50=16+/-2uM|P18031|PROTEIN-TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1|4.92|Ki=12uM|Ki|=|12|uM|12000|nM
3HFV|2.60|2009|MTY|human mitochondrial phenylalanyl-tRNA synthetase complexed with m-tyrosine|O95363|PHENYLALANYL-TRNA SYNTHETASE, MITOCHONDRIAL|4.87|Ki=13.6uM|Ki|=|13.6|uM|13600|nM
3KHV|2.35|2009|4AL|AMPM inhibitor|P00749|UROKINASE-TYPE PLASMINOGEN ACTIVATOR|1.85|Ki=13.99mM|Ki|=|13.99|mM|13990000|nM
2WKS|2.95|2009|CB6|compound 9d, Ki=130+/-13nM|Q48255|3-DEHYDROQUINATE DEHYDRATASE|6.89|Ki=130nM|Ki|=|130|nM|130|nM
3HIG|2.09|2009|BRN|human diamine oxidase in complex with Berenil, Ki=13+/-1nM|P19801|AMILORIDE-SENSITIVE AMINE OXIDASE|7.89|Ki=13nM|Ki|=|13|nM|13|nM
3HFZ|2.90|2009|MTY|Thermus thermophilus Phenylalanyl-tRNA synthetase comlexed with m-tyrosine|P27001|PHENYLALANYL-TRNA SYNTHETASE ALPHA CHAIN|4.89|Ki=13uM|Ki|=|13|uM|13000|nM
3IBL|1.55|2009|O59|adducts of sulfamates 3 with hCA II|P00918|CARBONIC ANHYDRASE 2|7.84|Ki=14.6nM|Ki|=|14.6|nM|14.6|nM
2WZS|2.25|2009|MVL|ligand is mannoimidazole|Q8A0N1|PUTATIVE ALPHA-1,2-MANNOSIDASE|3.85|Ki=140uM|Ki|=|140|uM|140000|nM
3I7E|1.70|2009|DJR|ligand is compound 2, Ki=14pM, IC50=1.2nM|O38716|HIV-1 PROTEASE|10.85|Ki=14pM|Ki|=|14|pM|0.014|nM
2WW2|1.90|2009|SWA|ligand is swainsonine|Q8A5N9|ALPHA-1,2-MANNOSIDASE|4.85|Ki=14uM|Ki|=|14|uM|14000|nM
3DX2|1.40|2009|MZB|ligand is compound 2|Q24451|ALPHA-MANNOSIDASE II|6.82|Ki=150nM|Ki|=|150|nM|150|nM
3DJX|1.69|2009|C5P|Ki=1557.9+/-84.3uM|P00669|SEMINAL RIBONUCLEASE|2.81|Ki=1557.9uM|Ki|=|1557.9|uM|1557900|nM
3EB1|2.40|2009|LZQ|ligand is compound LZP25, Ki=16.3+/-1.1uM; IC50=20+/-5uM|P18031|PROTEIN-TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1|4.79|Ki=16.3uM|Ki|=|16.3|uM|16300|nM
2ZGM|1.90|2009|LAT||Q6WY08|ANTI-TUMOR LECTIN|1.79|Ki=16.4mM|Ki|=|16.4|mM|16399999.999999998|nM
2WL0|1.90|2009|5AH||P03366|HIV-1 PROTEASE|7.8|Ki=16nM|Ki|=|16|nM|16|nM
3DND|2.26|2009|LL2|ligand B|P00517|CAMP-DEPENDENT PROTEIN KINASE|4.8|Ki=16uM|Ki|=|16|uM|16000|nM
3EVF|1.45|2009|GTA|MPD; Ki=170+/-20nM is for DEN MTase, not yellow fever|P03314|RNA-DIRECTED RNA POLYMERASE NS5|6.77|Ki=170nM|Ki|=|170|nM|170|nM
3GJT|2.20|2009|5-mer|Caspase-3 Binds Ac-IEPD-Cho peptide, Ki=170+/-7nM|P42574|CASPASE-3 SUBUNIT P17|6.77|Ki=170nM|Ki|=|170|nM|170|nM
3GGU|1.80|2009|017|PRDRV5 in complex with darunavir, Ki=170+/-20pM|P03367|HIV-1 PROTEASE|9.77|Ki=170pM|Ki|=|170|pM|0.17|nM
3HAV|2.45|2009|SRY|streptomycin-ATP-APH(2)-IIa ternary complex, competitive inhibitor|Q9EVD7|AMINOGLYCOSIDE PHOSPHOTRANSFERASE|3.77|Ki=170uM|Ki|=|170|uM|170000|nM
3D6Q|1.60|2009|U3S|Ki=172+/-4uM|P61823|RIBONUCLEASE A|3.76|Ki=172uM|Ki|=|172|uM|172000|nM
3GEP|2.60|2009|24H|PH8.5, human HGPRT complex (S)-HPMPG, Ki=176.8+/-10uM|P00492|HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE|3.75|Ki=176.8uM|Ki|=|176.8|uM|176800|nM
3D6P|1.60|2009|U2S|Ki=179+/-3uM|P61823|RIBONUCLEASE|3.75|Ki=179uM|Ki|=|179|uM|179000|nM
3G3D|1.70|2009|5FU|Human ODCases with compound 41, 5-fluoro-6-azido-UMP|P11172|URIDINE 5'-MONOPHOSPHATE SYNTHASE|4.74|Ki=18.2uM|Ki|=|18.2|uM|18200|nM
3JQG|1.90|2009|AX6|Pteridine Reductase 1 complex NADP+ and AX6 compound 18, Ki=18uM|Q581W1|PTERIDINE REDUCTASE 1|4.74|Ki=18uM|Ki|=|18|uM|18000|nM
3GXT|2.70|2009|NOJ|data from ref. 25, for alpha-galactosidase from Aspergillus niger|P06280|ALPHA-GALACTOSIDASE A|4.74|Ki=18uM|Ki|=|18|uM|18000|nM
3EBO|1.90|2009|57D|ligand is Chrysin|P00489|GLYCOGEN PHOSPHORYLASE|4.72|Ki=19.01uM|Ki|=|19.01|uM|19010|nM
3FNM|1.70|2009|AVN|Ki=19.7+/-7.2uM|O25743|GAMMA-GLUTAMYLTRANSPEPTIDASE (GGT) LARGE SUBUNIT|4.71|Ki=19.7uM|Ki|=|19.7|uM|19700|nM
3F6G|2.00|2009|ILE||Q8F3Q1|ALPHA-ISOPROPYLMALATE SYNTHASE|4.72|Ki=19uM|Ki|=|19|uM|19000|nM
3F6H|2.70|2009|ILE|Fragment: Regulatory domain, UNP residues 390-516 ; IC50=86 +/-20uM; Ki=19 +/-5uM;|Q8F3Q1|ALPHA-ISOPROPYLMALATE SYNTHASE|4.72|Ki=19uM|Ki|=|19|uM|19000|nM
3GRJ|2.49|2009|G14|AmpC beta-lactamase with compound 12|P00811|BETA-LACTAMASE|3.0|Ki=1mM|Ki|=|1|mM|1000000|nM
3DD0|1.48|2009|EZL||P00918|CARBONIC ANHYDRASE 2|9.0|Ki=1nM|Ki|=|1|nM|1|nM
3DCW|1.50|2009|EZL|redundant to 3dd0|P00918|CARBONIC ANHYDRASE 2|9.0|Ki=1nM|Ki|=|1|nM|1|nM
3JXW|2.80|2009|LXG|ligand is compound 12b|P11309|SERINE/THREONINE-PROTEIN KINASE|9.0|Ki=1nM|Ki|=|1|nM|1|nM
3JY9|2.10|2009|JZH|compound 9 in complex with JAK2, Ki=0.001uM|O60674|TYROSINE-PROTEIN KINASE JAK2|9.0|Ki=1nM|Ki|=|1|nM|1|nM
2W8G|2.60|2009|BS2|APLYSIA CALIFORNICA ACHBP BOUND TO IN SILICO COMPOUND 35, pKi=6.0+/-0.2|Q8WSF8|ACETYLCHOLINE RECEPTOR|6.0|Ki=1uM|Ki|=|1|uM|1000|nM
3GGJ|2.60|2009|25H|PH7.4, human HGPRT complex PEEHx, Ki=1+/-0.5uM|P00492|HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE|6.0|Ki=1uM|Ki|=|1|uM|1000|nM
3D9Z|1.65|2009|D9Z|ligand is inhibitor CHL, Ki=2.0+/-0.4nM|P00918|CARBONIC ANHYDRASE 2|8.7|Ki=2.0nM|Ki|=|2|nM|2|nM
2WKY|2.20|2009|IBC||P22756|GLUTAMATE RECEPTOR, IONOTROPIC KAINATE 1|8.59|Ki=2.57nM|Ki|=|2.57|nM|2.57|nM
2WCA|2.30|2009|NP6||Q89ZI2|O-GLCNACASE BT_4395|5.6|Ki=2.5uM|Ki|=|2.5|uM|2500|nM
3FA3|2.60|2009|OAF|Ki=2.5+/-0.2uM.|Q2L887|2,3-DIMETHYLMALATE LYASE|5.6|Ki=2.5uM|Ki|=|2.5|uM|2500|nM
3KGP|2.35|2009|4AZ|ligand is inhibitor AMBA|P00749|UROKINASE-TYPE PLASMINOGEN ACTIVATOR|2.57|Ki=2.68mM|Ki|=|2.68|mM|2680000|nM
3GVB|1.80|2009|3GV|ligand is compound 8|P00811|BETA-LACTAMASE|2.59|Ki=2.6mM|Ki|=|2.6|mM|2600000|nM
3IBI|1.93|2009|BOW|adducts of sulfamates 1 with hCA II|P00918|CARBONIC ANHYDRASE 2|8.59|Ki=2.6nM|Ki|=|2.6|nM|2.6|nM
3DKF|1.80|2009|SX8|compound SGX532; Ki1=2.7nM(unphosphorylated form of MET); Ki2=23nM(phosphorylated form of MET); IC50=4nM|A1L467|HEPATOCYTE GROWTH FACTOR RECEPTOR|8.57|Ki=2.7nM|Ki|=|2.7|nM|2.7|nM
3EJQ|1.45|2009|HN3|ligand is compound 3; IC50=29nM|Q24451|ALPHA-MANNOSIDASE II|8.57|Ki=2.7nM|Ki|=|2.7|nM|2.7|nM
3EJR|1.27|2009|HN4|ligand is compound 4; IC50=29nM|Q24451|ALPHA-MANNOSIDASE II|8.57|Ki=2.7nM|Ki|=|2.7|nM|2.7|nM
3EJP|1.32|2009|HN2|ligand is compound 2; IC50=30nM|Q24451|ALPHA-MANNOSIDASE II|8.55|Ki=2.8nM|Ki|=|2.8|nM|2.8|nM
3D7B|1.60|2009|U4S|Ki=203+/-1uM|P61823|RIBONUCLEASE|3.69|Ki=203uM|Ki|=|203|uM|203000|nM
3EWC|2.11|2009|MCF|Ki=20+/-5nM|A5KE01|ADENOSINE DEAMINASE|7.7|Ki=20nM|Ki|=|20|nM|20|nM
3EIG|1.70|2009|MTX|Ki=21+/-11nM; IC50=3100+/-1600nM; compound methotrexate|P00374|DIHYDROFOLATE REDUCTASE|7.68|Ki=21nM|Ki|=|21|nM|21|nM
3EX6|1.30|2009|U5P|ligand is compound 1|P11172|OROTIDINE-5'-PHOSPHATE DECARBOXYLASE|3.66|Ki=220uM|Ki|=|220|uM|220000|nM
3FEE|1.56|2009|QUS|Ki=230+/-24nM|Q9Y3Q0|GLUTAMATE CARBOXYPEPTIDASE 3|6.64|Ki=230nM|Ki|=|230|nM|230|nM
2ZX8|2.33|2009|ZX8||Q9WYE2|ALPHA-L-FUCOSIDASE|9.64|Ki=231.4pM|Ki|=|231.4|pM|0.23140000000000002|nM
3HL7|1.88|2009|I47|ligand is SD-0006, Ki=0.023uM|Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|7.64|Ki=23nM|Ki|=|23|nM|23|nM
3IBN|2.20|2009|O60|adducts of sulfamates 4 with hCA II|P00918|CARBONIC ANHYDRASE 2|7.61|Ki=24.5nM|Ki|=|24.5|nM|24.5|nM
3FK1|1.70|2009|GPF|ligand is glyphosate; Ki=2420+/-87uM; IC50=6600+/-190uM|P0A6D3|3-PHOSPHOSHIKIMATE 1-CARBOXYVINYLTRANSFERASE|2.62|Ki=2420uM|Ki|=|2420|uM|2420000|nM
3IPH|2.10|2009|G11|p38 in complex with inhibitor 11, Ki=25.1nM|Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|7.6|Ki=25.1nM|Ki|=|25.1|nM|25.1|nM
2ZX6|2.42|2009|ZX6||Q9WYE2|ALPHA-L-FUCOSIDASE|10.6|Ki=25.1pM|Ki|=|25.1|pM|0.0251|nM
3G0I|2.10|2009|VPR|Aspergillus niger epoxide hydrolase in complex with valpromide|Q9UR30|EPOXIDE HYDROLASE|3.6|Ki=250uM|Ki|=|250|uM|250000|nM
3EHX|1.90|2009|BDL|ligand is compound 1; Ki=25+/-2nM|P39900|MACROPHAGE METALLOELASTASE (MMP-12)|7.6|Ki=25nM|Ki|=|25|nM|25|nM
3GC4|1.80|2009|AAQ|ligand is compound 11; Ki=25+/-2nM|P28720|QUEUINE TRNA-RIBOSYLTRANSFERASE|7.6|Ki=25nM|Ki|=|25|nM|25|nM
3JWQ|2.87|2009|VIA|chimeric PDE5/PDE6 catalytic domain complex sildenafil, Ki=25+/-2nM|O76074|CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE|7.6|Ki=25nM|Ki|=|25|nM|25|nM
3DX1|1.21|2009|YHO|ligand is compound 3|Q24451|ALPHA-MANNOSIDASE II|3.58|Ki=265uM|Ki|=|265|uM|265000|nM
3BM6|2.10|2009|C9P|compound 11|P00811|BETA-LACTAMASE|7.59|Ki=26nM|Ki|=|26|nM|26|nM
3DJV|1.60|2009|C3P|Ki=27.9+/-1.3uM|P00669|SEMINAL RIBONUCLEASE|4.55|Ki=27.9uM|Ki|=|27.9|uM|27900|nM
3FF3|1.37|2009|GLU||Q9Y3Q0|GLUTAMATE CARBOXYPEPTIDASE 3|3.57|Ki=270uM|Ki|=|270|uM|270000|nM
3E9H|2.10|2009|KAA|BsLysRS-LysSA complex; ligand is LysSA; Ki=28+/-3nM for EsLysRS|Q9RHV9|LYSYL-TRNA SYNTHETASE|7.55|Ki=28nM|Ki|=|28|nM|28|nM
3H30|1.56|2009|RFZ|Ki=29.2uM(competitive); Ki=39.7uM(noncompetitive)|P68400|CASEIN KINASE II, ALPHA SUBUNIT|4.53|Ki=29.2uM|Ki|=|29.2|uM|29200|nM
2ZNS|2.00|2009|GLU|redundant to 3fuz|P39086|GLUTAMATE RECEPTOR, IONOTROPIC KAINATE 1|6.54|Ki=290nM|Ki|=|290|nM|290|nM
3HII|2.15|2009|PNT|human diamine oxidase in complex with Pentamidine, Ki=290+/-19nM|P19801|AMILORIDE-SENSITIVE AMINE OXIDASE|6.54|Ki=290nM|Ki|=|290|nM|290|nM
2W5I|2.40|2009|ATP|ligand is Ap3A; Ki=4.7uM (for p-A3-p); redundant to 2w5g|P61823|RIBONUCLEASE|4.54|Ki=29uM|Ki|=|29|uM|29000|nM
2ZZ1|1.57|2009|6CN|wild type enzyme in complex with 6-CN-UMP|O26232|OROTIDINE 5'-MONOPHOSPHATE DECARBOXYLASE|4.54|Ki=29uM|Ki|=|29|uM|29000|nM
2ZZ2|1.53|2009|6CN|ligand is compound 34|O26232|OROTIDINE 5'-MONOPHOSPHATE DECARBOXYLASE|4.54|Ki=29uM|Ki|=|29|uM|29000|nM
3GSG|2.10|2009|GF1|compound 1|P00811|BETA-LACTAMASE|2.7|Ki=2mM|Ki|=|2|mM|2000000|nM
3GE7|1.50|2009|AFQ|ligand is compound 13; Ki=2+/-1nM|P28720|QUEUINE TRNA-RIBOSYLTRANSFERASE|8.7|Ki=2nM|Ki|=|2|nM|2|nM
3FDM|2.26|2009|17-mer|alpha/beta foldamer in complex with Bcl-xL; incomplete ligand|Q07817|APOPTOSIS REGULATOR BCL-X|8.7|Ki=2nM|Ki|=|2|nM|2|nM
3HVJ|1.79|2009|705|compound 5 is a bisubstrate inhibitor, Ki=2nM, IC50=9nM|P22734|CATECHOL O-METHYLTRANSFERASE|8.7|Ki=2nM|Ki|=|2|nM|2|nM
3G30|1.80|2009|G30|ligand is compound 3(G30); Ki=3.1mM|Q9L5C8|BETA-LACTAMASE CTX-M-9A|2.51|Ki=3.1mM|Ki|=|3.1|mM|3100000|nM
2WQP|1.75|2009|WQP|ligand is compound 1, Ki=3.1+/-0.1uM|Q7DDU0|POLYSIALIC ACID CAPSULE BIOSYNTHESIS PROTEIN|5.51|Ki=3.1uM|Ki|=|3.1|uM|3100|nM
2WR8|1.77|2009|SAH||O58212|PUTATIVE UNCHARACTERIZED PROTEIN PH0463|5.44|Ki=3.6uM|Ki|=|3.6|uM|3600|nM
3GGC|2.78|2009|H26|PH7.4, human HGPRT complex PEEHx, Ki=3.6+/-0.2uM|P00492|HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE|5.44|Ki=3.6uM|Ki|=|3.6|uM|3600|nM
3DX3|1.42|2009|YTB|ligand is compound 4a|Q24451|ALPHA-MANNOSIDASE II|6.52|Ki=300nM|Ki|=|300|nM|300|nM
3HIO|2.00|2009|C2X|Ricin A-chain complex Cyclic G(9-DA)GA 2-OMe, Ki=300nM at PH4.0|P02879|RICIN|6.52|Ki=300nM|Ki|=|300|nM|300|nM
3C14|2.68|2009|POP|AC activity inhibition by PPi-Ca2+, low affinity range 30-300uM|P30803|ADENYLATE CYCLASE TYPE 5|3.52|Ki=300uM|Ki|=|300|uM|300000|nM
2VWO|1.60|2009|LZG|ligand is compound 22|P00742|COAGULATION FACTOR XA|7.51|Ki=31nM|Ki|=|31|nM|31|nM
2ZX7|2.48|2009|ZX7||Q9WYE2|ALPHA-L-FUCOSIDASE|10.49|Ki=32.2pM|Ki|=|32.2|pM|0.032200000000000006|nM
3G1D|1.50|2009|U|ligand is compound 1|O26232|OROTIDINE 5'-MONOPHOSPHATE DECARBOXYLASE|3.48|Ki=330uM|Ki|=|330|uM|330000|nM
3H0A|2.10|2009|D30|PPARgamma, Retinoic Acid Receptor Alpha (RXRa) Complex with compound 21 and peptide|P19793|RETINOIC ACID RECEPTOR RXR-ALPHA|7.48|Ki=33nM|Ki|=|33|nM|33|nM
3FED|1.29|2009|BIX|Ki=34.6+/-5.7nM|Q9Y3Q0|GLUTAMATE CARBOXYPEPTIDASE 3|7.46|Ki=34.6nM|Ki|=|34.6|nM|34.6|nM
3HL5|1.80|2009|9JZ||P98170|BACULOVIRAL IAP REPEAT-CONTAINING PROTEIN 4|4.47|Ki=34uM|Ki|=|34|uM|34000|nM
2WBG|1.85|2009|LGS|ligand is compound 7|Q08638|BETA-GLUCOSIDASE A|4.45|Ki=35.2uM|Ki|=|35.2|uM|35200|nM
3JQF|1.60|2009|AX2|Pteridine Reductase 1 complex NADP+ and AX2 compound 14, lack a N atom, Ki>35uM|Q581W1|PTERIDINE REDUCTASE 1|4.46|Ki=35uM|Ki|=|35|uM|35000|nM
3JQ8|1.95|2009|DX3|Pteridine Reductase 1 complex NADP+ and DX3 compound 3, Ki>35uM|Q581W1|PTERIDINE REDUCTASE 1|4.46|Ki=35uM|Ki|=|35|uM|35000|nM
3JQA|1.90|2009|DX4|Pteridine Reductase 1 complex NADP+ and DX4 compound 5, lack a N atom, Ki>35uM|Q581W1|PTERIDINE REDUCTASE 1|4.46|Ki=35uM|Ki|=|35|uM|35000|nM
3DX0|1.70|2009|MSN|redundant to 2f7o|Q24451|ALPHA-MANNOSIDASE II|7.44|Ki=36nM|Ki|=|36|nM|36|nM
2ZU4|1.93|2009|ZU3||P0C6U8|3C-LIKE PROTEINASE|7.42|Ki=38nM|Ki|=|38|nM|38|nM
3D8Y|1.72|2009|T3S|Ki=396+/-2uM|P61823|RIBONUCLEASE|3.4|Ki=396uM|Ki|=|396|uM|396000|nM
3GR2|1.80|2009|GF4|ligand is compound 3|P00811|BETA-LACTAMASE|2.52|Ki=3mM|Ki|=|3|mM|3000000|nM
2VVC|1.95|2009|LZF|ligand is compound 15|P00742|COAGULATION FACTOR XA|8.52|Ki=3nM|Ki|=|3|nM|3|nM
3HVH|1.30|2009|542|ligand is inhibitor 3; Ki=3nM, IC50=12nM|P22734|CATECHOL O-METHYLTRANSFERASE|8.52|Ki=3nM|Ki|=|3|nM|3|nM
3HVK|1.30|2009|719|ligand is inhibitor 7, Ki=3nM, IC50=15nM|P22734|CATECHOL O-METHYLTRANSFERASE|8.52|Ki=3nM|Ki|=|3|nM|3|nM
3DXG|1.39|2009|U5P|Ki=4.00+/-0.41mM|P61823|RIBONUCLEASE A|2.4|Ki=4.0mM|Ki|=|4|mM|4000000|nM
3HKT|2.36|2009|2SD||P00918|CARBONIC ANHYDRASE 2|5.39|Ki=4.1uM|Ki|=|4.1|uM|4100|nM
2ZXA|2.57|2009|ZXA|compound 7|Q9WYE2|ALPHA-L-FUCOSIDASE|8.35|Ki=4.47nM|Ki|=|4.47|nM|4.47|nM
3G2Z|1.50|2009|GZ2|ligand is compound 2(GZ2); Ki=4.4mM|Q9L5C8|BETA-LACTAMASE CTX-M-9A|2.36|Ki=4.4mM|Ki|=|4.4|mM|4400000|nM
3HKN|1.80|2009|MFS|ligand is compound 4|P00918|CARBONIC ANHYDRASE 2|5.35|Ki=4.51uM|Ki|=|4.51|uM|4510|nM
3HKQ|1.70|2009|1SD|ligand is 1-S-D-Galactopyranosylsulfonamide|P00918|CARBONIC ANHYDRASE 2|5.34|Ki=4.55uM|Ki|=|4.55|uM|4550|nM
3GTC|1.90|2009|GTC|ligand is compound 20|P00811|BETA-LACTAMASE|2.35|Ki=4.5mM|Ki|=|4.5|mM|4500000|nM
3F82|2.50|2009|353|Ki=4.6+/-0.3nM; IC50=3.9+/-0.5uM|P08581|HEPATOCYTE GROWTH FACTOR RECEPTOR|8.34|Ki=4.6nM|Ki|=|4.6|nM|4.6|nM
2WJ2|2.55|2009|OL1|compound 1|P97612|FATTY ACID AMIDE HYDROLASE 1|8.33|Ki=4.7nM|Ki|=|4.7|nM|4.7|nM
3GJQ|2.60|2009|5-mer|Caspase-3 Binds Ac-WEHD-Cho peptide, Ki=4.7+/-0.19uM|P42574|CASPASE-3 SUBUNIT P17|5.33|Ki=4.7uM|Ki|=|4.7|uM|4700|nM
3DC3|1.70|2009|AZM|ligand is inhibitor AZM, Ki=4.9+/-1nM|P00918|CARBONIC ANHYDRASE 2|8.31|Ki=4.9nM|Ki|=|4.9|nM|4.9|nM
3DJO|1.60|2009|U2P|Ki=40.8+/-3.4uM|P00669|SEMINAL RIBONUCLEASE|4.39|Ki=40.8uM|Ki|=|40.8|uM|40800|nM
3KMC|1.80|2009|403|catalytic domain of TACE in complex with inhibitor 2|P78536|TNF-ALPHA-CONVERTING ENZYME, ADAM 17|6.4|Ki=400nM|Ki|=|400|nM|400|nM
3E90|2.45|2009|NKK||P06935|NS2B COFACTOR|7.39|Ki=41nM|Ki|=|41|nM|41|nM
3D8Z|1.98|2009|TXS|Ki=423+/-6uM|P61823|RIBONUCLEASE|3.37|Ki=423uM|Ki|=|423|uM|423000|nM
3F7G|2.30|2009|389|ligand is compound 1|Q96CA5|BACULOVIRAL IAP REPEAT-CONTAINING PROTEIN 7|7.37|Ki=43nM|Ki|=|43|nM|43|nM
3I6O|1.17|2009|GR6|ligand is compound 14c, Ki=45pM, IC50=2nM|P03367|HIV-1 PROTEASE|10.35|Ki=45pM|Ki|=|45|pM|0.045|nM
3F7I|1.90|2009|G13|ligand is compound 14b|Q6R308|BACULOVIRAL IAP REPEAT-CONTAINING PROTEIN 7|7.34|Ki=46nM|Ki|=|46|nM|46|nM
3EBH|1.65|2009|BES|IC50=8~14uM|O96935|M1 FAMILY AMINOPEPTIDASE|6.32|Ki=478.2nM|Ki|=|478.2|nM|478.2|nM
3DHK|1.73|2009|23U|compound 3, Ki=47+/-27nM|P00734|THROMBIN LIGHT CHAIN|7.33|Ki=47nM|Ki|=|47|nM|47|nM
3EOS|1.78|2009|PK2|compound 12, Ki=4+/-2nM|P28720|QUEUINE TRNA-RIBOSYLTRANSFERASE|8.4|Ki=4nM|Ki|=|4|nM|4|nM
2ZXB|2.61|2009|ZXB|compound 8|Q9WYE2|ALPHA-L-FUCOSIDASE|5.3|Ki=5.0uM|Ki|=|5|uM|5000|nM
3IP8|1.50|2009|B85|AMDase in complex with benzylphosphonate, competitive inhibitor Ki=5.2mM|Q05115|ARYLMALONATE DECARBOXYLASE|2.28|Ki=5.2mM|Ki|=|5.2|mM|5200000|nM
3HEK|1.95|2009|BD0|HSP90 N-terminal domain in complex with compound 15, Ki=5.4nM, IC50=112nM|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|8.27|Ki=5.4nM|Ki|=|5.4|nM|5.4|nM
3HLL|1.95|2009|I45|ligand is PH-797804, Ki=5.8+/-0.3nM|Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|8.24|Ki=5.8nM|Ki|=|5.8|nM|5.8|nM
3FL5|2.30|2009|TXQ|IC50=0.11uM|P28523|CASEIN KINASE II, ALPHA SUBUNIT|7.28|Ki=52nM|Ki|=|52|nM|52|nM
3I4A|1.90|2009|LN5|DDAH-1 complex with L-IPO compound 13, Ki=52+/-4uM|O94760|N(G),N(G)-DIMETHYLARGININE DIMETHYLAMINOHYDROLASE 1|4.28|Ki=52uM|Ki|=|52|uM|52000|nM
2ZX9|2.62|2009|ZX9|compound 5, show time-dependent Ki from 1.005nM to 54.2pM|Q9WYE2|ALPHA-L-FUCOSIDASE|10.27|Ki=54.2pM|Ki|=|54.2|pM|0.054200000000000005|nM
3GC5|1.40|2009|2MQ|ligand is compound 8; Ki=55+/-3nM|P28720|QUEUINE TRNA-RIBOSYLTRANSFERASE|7.26|Ki=55nM|Ki|=|55|nM|55|nM
3F8E|2.00|2009|TE1|ligand is compound 4z|P00918|CARBONIC ANHYDRASE 2|7.23|Ki=59nM|Ki|=|59|nM|59|nM
3FQE|2.50|2009|P5C|ligand is compound 3, Ki=5-20nM|P43405|TYROSINE-PROTEIN KINASE SYK|8.3|Ki=5nM|Ki|=|5|nM|5|nM
3HKU|1.80|2009|TOR|ligand is topiramate, Ki=0.005uM|P00918|CARBONIC ANHYDRASE 2|8.3|Ki=5nM|Ki|=|5|nM|5|nM
3HVI|1.20|2009|619|compound 4 is a bisubstrate inhibitor, Ki=5nM, IC50=21nM|P22734|CATECHOL O-METHYLTRANSFERASE|8.3|Ki=5nM|Ki|=|5|nM|5|nM
3JY0|2.40|2009|LYG|ligand is compound 6e|P11309|SERINE/THREONINE-PROTEIN KINASE PIM-1|8.3|Ki=5nM|Ki|=|5|nM|5|nM
2WW0|2.80|2009|SWA|ligand is swainsonine|Q8A0N1|PUTATIVE ALPHA-1,2-MANNOSIDASE|5.3|Ki=5uM|Ki|=|5|uM|5000|nM
2ZXD|2.15|2009|ZXD|ligand is compound 9|Q9WYE2|ALPHA-L-FUCOSIDASE|5.22|Ki=6.0uM|Ki|=|6|uM|6000|nM
3HIT|2.29|2009|DYN|Saporin-L1 complex s3(9-DA)Gs 2-OMe, Ki=6.4+/-1.7nM, in ref.15|Q2QEH4|VACUOLAR SAPORIN|8.19|Ki=6.4nM|Ki|=|6.4|nM|6.4|nM
3HPT|2.19|2009|YET|human FxA in complex with compound 4|P00742|COAGULATION FACTOR X|8.19|Ki=6.5nM|Ki|=|6.5|nM|6.5|nM
2KO7|NMR|2009|JZF|Ki=6.5 +/-1.0uM|Q63J95|PEPTIDYL-PROLYL CIS-TRANS ISOMERASE|5.19|Ki=6.5uM|Ki|=|6.5|uM|6500|nM
3GQZ|1.80|2009|GF7|ligand is compound 5|P00811|BETA-LACTAMASE|2.17|Ki=6.7mM|Ki|=|6.7|mM|6700000|nM
3DJP|1.60|2009|UA3|Ki=63.2+/-4.5uM|P00669|SEMINAL RIBONUCLEASE|4.2|Ki=63.2uM|Ki|=|63.2|uM|63200|nM
3K2F|1.98|2009|NKX|ligand is compound 8|P00918|CARBONIC ANHYDRASE 2|7.2|Ki=63nM|Ki|=|63|nM|63|nM
3G1V|1.30|2009|5FU|ligand is compound 39|O26232|OROTIDINE 5'-MONOPHOSPHATE DECARBOXYLASE|3.19|Ki=645uM|Ki|=|645|uM|645000|nM
3GDT|1.60|2009|UP6||P03962|OROTIDINE 5'-MONOPHOSPHATE DECARBOXYLASE|7.19|Ki=64nM|Ki|=|64|nM|64|nM
3KID|2.71|2009|2BS||P00749|UROKINASE-TYPE PLASMINOGEN ACTIVATOR|3.18|Ki=656uM|Ki|=|656|uM|656000|nM
2VVV|1.73|2009|H21|ligand is compound 10, Ki=0.006uM|P00742|COAGULATION FACTOR XA|8.22|Ki=6nM|Ki|=|6|nM|6|nM
3DNE|2.00|2009|LL1|ligand A|P00517|CAMP-DEPENDENT PROTEIN KINASE|5.22|Ki=6uM|Ki|=|6|uM|6000|nM
3D8W|1.70|2009|D8W|ligand is inhibitor BZM, Ki=7.0+/-0.9nM|P00918|CARBONIC ANHYDRASE 2|8.15|Ki=7.0nM|Ki|=|7|nM|7|nM
3FAA|3.35|2009|55F|compound 2|P36897|TGF-BETA RECEPTOR TYPE-1|8.15|Ki=7.1nM|Ki|=|7.1|nM|7.1|nM
3GV9|1.80|2009|GV9|ligand is compound 21|P00811|BETA-LACTAMASE|2.12|Ki=7.5mM|Ki|=|7.5|mM|7500000|nM
3HIV|2.14|2009|TXN|Saporin-L1 complex G(9-DA)Gs3 2-OMe, Ki=7.5+/-1.6nM, in ref15|Q2QEH4|VACUOLAR SAPORIN|8.12|Ki=7.5nM|Ki|=|7.5|nM|7.5|nM
2ZNU|1.80|2009|NDZ|redundant to 3fv2|P39086|GLUTAMATE RECEPTOR, IONOTROPIC KAINATE 1|8.11|Ki=7.7nM|Ki|=|7.7|nM|7.7|nM
3GPJ|2.70|2009|SY2|yeast 20S proteasome with syringolin B, chymotrypsin-like Ki=7.8uM, trypsin-like Ki=108uM|P23639|PROTEASOME COMPONENT Y7|5.11|Ki=7.8uM|Ki|=|7.8|uM|7800|nM
3A9I|1.80|2009|LYS||O87198|HOMOCITRATE SYNTHASE|4.15|Ki=70.7uM|Ki|=|70.7|uM|70700|nM
3FFP|1.81|2009|LC1|ligand is compound 2|P00918|CARBONIC ANHYDRASE 2|7.14|Ki=72.5nM|Ki|=|72.5|nM|72.5|nM
3KME|1.85|2009|Z59|catalytic domain of TACE with inhibitor 8, lack a NH2 group|P78536|TNF-ALPHA-CONVERTING ENZYME, ADAM 17|6.14|Ki=725nM|Ki|=|725|nM|725|nM
3DX4|1.38|2009|GOO|ligand is compound 5|Q24451|ALPHA-MANNOSIDASE II|7.12|Ki=76nM|Ki|=|76|nM|76|nM
3D6O|1.58|2009|U1S|Ki=77+/-1uM|P61823|RIBONUCLEASE|4.11|Ki=77uM|Ki|=|77|uM|77000|nM
3EBI|2.00|2009|BEY|IC50=24~62uM|O96935|M1 FAMILY AMINOPEPTIDASE|7.1|Ki=79nM|Ki|=|79|nM|79|nM
3FMZ|2.90|2009|2T1|IC501=90nM(human RBP4); IC502=66nM(mouse RBP4).|P02753|RETINOL-BINDING PROTEIN 4|8.08|Ki=8.3nM|Ki|=|8.3|nM|8.3|nM
3JWR|2.99|2009|IBM|chimeric PDE5/PDE6 catalytic domain complex IBMX and peptide, Ki=8.5+/-0.6nM|O76074|CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE|8.07|Ki=8.5nM|Ki|=|8.5|nM|8.5|nM
3HIW|1.80|2009|C2X|Saporin-L1 complex cyclic G(9-DA)GA 2-OMe, Ki=8.7+/-2.3nM, in ref15|Q2QEH4|VACUOLAR SAPORIN|8.06|Ki=8.7nM|Ki|=|8.7|nM|8.7|nM
3F68|1.75|2009|91U|ligand is compound 8, Ki=8.7+/-1.0uM|P00734|PROTHROMBIN|5.06|Ki=8.7uM|Ki|=|8.7|uM|8700|nM
3DBU|1.70|2009|D8W|ligand is inhibitor BZM, Ki=8.8+/-1.2nM|P00918|CARBONIC ANHYDRASE 2|8.06|Ki=8.8nM|Ki|=|8.8|nM|8.8|nM
3F7H|1.80|2009|419|ligand is compound 14a|Q6R308|BACULOVIRAL IAP REPEAT-CONTAINING PROTEIN 7|7.09|Ki=82nM|Ki|=|82|nM|82|nM
2W5G|1.70|2009|ATP|ligand is 5-ATP(pppA)|P61823|RIBONUCLEASE|6.07|Ki=860nM|Ki|=|860|nM|860|nM
2W66|2.27|2009|HQ6||Q89ZI2|O-GLCNACASE BT_4395|4.05|Ki=89uM|Ki|=|89|uM|89000|nM
2VVU|2.30|2009|H22|ligand is compound 12|P00742|COAGULATION FACTOR XA|8.1|Ki=8nM|Ki|=|8|nM|8|nM
3FJZ|1.70|2009|GPF|ligand is glyphosate; Ki=90+/-6uM; IC50=330+/-10uM|P0A6D3|3-PHOSPHOSHIKIMATE 1-CARBOXYVINYLTRANSFERASE|4.05|Ki=90uM|Ki|=|90|uM|90000|nM
2W2I|2.10|2009|PD2|affinity of compound 38 towards JMJD2E, Formaldehyde DeHydrogenase (FDH) coupled assay|B2RXH2|2-OXOGLUTARATE OXYGENASE|6.04|Ki=914nM|Ki|=|914|nM|914|nM
2VWM|1.96|2009|LZI|ligand is compound 26|P00742|COAGULATION FACTOR XA|7.03|Ki=93nM|Ki|=|93|nM|93|nM
2VWL|1.80|2009|LZH|ligand is compound 23|P00742|COAGULATION FACTOR XA|7.02|Ki=95nM|Ki|=|95|nM|95|nM
2WVZ|2.40|2009|KIF|ligand is kifunensine|Q8A0N1|PUTATIVE ALPHA-1,2-MANNOSIDASE|4.02|Ki=96uM|Ki|=|96|uM|96000|nM
3EOU|1.93|2009|PK3|compound 9, Ki=97+/-5nM|P28720|QUEUINE TRNA-RIBOSYLTRANSFERASE|7.01|Ki=97nM|Ki|=|97|nM|97|nM
2ZU5|1.65|2009|ZU5||P0C6U8|3C-LIKE PROTEINASE|7.0|Ki=99nM|Ki|=|99|nM|99|nM
2JKH|1.25|2009|BI7|ligand is compound 3|P00742|COAGULATION FACTOR XA|8.05|Ki=9nM|Ki|=|9|nM|9|nM
2XP2|1.90|2010|VGH|Fragment: TYROSINE KINASE DOMAIN, RESIDUES 105-423;|B6EXY4|ALK TYROSINE KINASE RECEPTOR|9.0|IC<1.0nM|IC50|<|1|nM|1|nM
3OZ1|3.00|2010|BMB|ligand is compound 2a|Q13490|BACULOVIRAL IAP REPEAT-CONTAINING PROTEIN 2|8.7|IC<2nM|IC50|<|2|nM|2|nM
3M2W|2.41|2010|L8I|compound 16A, IC50<3nM|P49137|MAP KINASE-ACTIVATED PROTEIN KINASE 2|8.52|IC<3nM|IC50|<|3|nM|3|nM
3O1G|1.65|2010|O75|compound 7; covalent complex|P43235|CATHEPSIN K|9.0|IC<=1nM|IC50|<=|1|nM|1|nM
3M9F|1.80|2010|595|compound 10b, IC50=0.007+/-0.003 nM|Q9WFL7|HIV-1 PROTEASE|11.15|IC=0.007nM|IC50|=|0.007|nM|0.007|nM
3I7C|1.98|2010|BK2|compound NA-PP2|Q9BJF5|CALMODULIN-DOMAIN PROTEIN KINASE 1|7.74|IC=0.018uM|IC50|=|0.018|uM|18|nM
3MBL|2.60|2010|LSG|compound 19|Q02750|DUAL SPECIFICITY MITOGEN-ACTIVATED PROTEIN KINASE K|7.74|IC=0.018uM|IC50|=|0.018|uM|18|nM
3INH|1.80|2010|569|compound (R)-61, not compound 58; IC50=0.02+/-0.004uM|P56817|BETA-SECRETASE 1|7.7|IC=0.02uM|IC50|=|0.02|uM|20|nM
3LHG|2.10|2010|Z81||P56817|BETA-SECRETASE 1|7.7|IC=0.02uM|IC50|=|0.02|uM|20|nM
3LE6|2.00|2010|2BZ|compound 3a|P24941|CELL DIVISION PROTEIN KINASE 2|7.46|IC=0.035uM|IC50|=|0.035|uM|35|nM
3IN4|2.30|2010|BX2|compoundS- 38; IC50=0.03+/-0.003uM|P56817|BETA-SECRETASE 1|7.52|IC=0.03uM|IC50|=|0.03|uM|30|nM
3INF|1.85|2010|X45|compound 37; IC50=0.04+/-0.01uM|P56817|BETA-SECRETASE 1|7.4|IC=0.04uM|IC50|=|0.04|uM|40|nM
3I6Z|2.19|2010|G6X|compound 3, affinity is measured on recombinant human brain AChe|P04058|ACETYLCHOLINESTERASE|7.3|IC=0.05uM|IC50|=|0.05|uM|50|nM
2XNG|2.60|2010|A0H|compound 17|O14965|SERINE/THREONINE-PROTEIN KINASE 6|7.22|IC=0.060uM|IC50|=|0.06|uM|60|nM
3I7B|1.99|2010|BK1|compound NM-PP1|Q9BJF5|CALMODULIN-DOMAIN PROTEIN KINASE 1|7.18|IC=0.066uM|IC50|=|0.066|uM|66|nM
3IN3|2.00|2010|472|compound 30; IC50=0.06+/-0.01uM|P56817|BETA-SECRETASE 1|7.22|IC=0.06uM|IC50|=|0.06|uM|60|nM
3LP0|2.79|2010|LP7|compound MK1, IC50=0.11 uM (In vitro); IC50=2.8 uM (Antiviral)|P04585|HIV-1 REVERSE TRANSCRIPTASE/RIBONUCLEASE H|6.96|IC=0.11uM|IC50|=|0.11|uM|110|nM
2XCN|3.02|2010|C8D|compound 8d|Q91RS4|NS3 PROTEASE|6.92|IC=0.12uM|IC50|=|0.12|uM|120|nM
3KL8|3.37|2010|18-mer|ligand is 18-mer CaMKII inhibitor; Ca-containing; IC50=0.12uM; incomplete ligand|Q9U6Q0|CALCIUM/CALMODULIN DEPENDENT PROTEIN KINASE II|6.92|IC=0.12uM|IC50|=|0.12|uM|120|nM
3LP1|2.23|2010|LP8|compound MK2, IC50=0.12 uM (In vitro); IC50=3.0uM (Antiviral)|P04585|HIV-1 REVERSE TRANSCRIPTASE/RIBONUCLEASE H|6.92|IC=0.12uM|IC50|=|0.12|uM|120|nM
3KVW|2.28|2010|IRB|ligand is compound 6i|Q92630|DUAL SPECIFICITY TYROSINE-PHOSPHORYLATION-REGULATED|6.89|IC=0.13uM|IC50|=|0.13|uM|130|nM
3AH8|2.90|2010|9-mer|peptide YM-254890 ; IC50=0.15+/-0.04nM|P10824|GUANINE NUCLEOTIDE-BINDING PROTEIN G(I) SUBUNIT ALP|9.82|IC=0.15nM|IC50|=|0.15|nM|0.15|nM
3IPE|1.40|2010|JZE|compound mds84; IC501=0.15+/-0.025uM(Isolated TTR); IC502=12+/-1.4uM(TTR in serum)|P02766|TRANSTHYRETIN|6.82|IC=0.15uM|IC50|=|0.15|uM|150|nM
3KC3|2.90|2010|MK2|ligand is compound 11d, not compound 5d, IC50=0.16uM, not 1.3uM|P49137|MAP KINASE-ACTIVATED PROTEIN KINASE 2|6.8|IC=0.16uM|IC50|=|0.16|uM|160|nM
2X2M|2.50|2010|X2M|compound SU5416; IC50=0.17+/-0.03uM|P07949|PROTO-ONCOGENE TYROSINE-PROTEIN KINASE RECEPTOR RET|6.77|IC=0.17uM|IC50|=|0.17|uM|170|nM
3INE|2.00|2010|X17|compound (S)-34; IC50=0.17+/-0.04uM|P56817|BETA-SECRETASE 1|6.77|IC=0.17uM|IC50|=|0.17|uM|170|nM
2X9E|3.10|2010|SVE|ligand is compound 15|P33981|DUAL SPECIFICITY PROTEIN KINASE TTK|6.74|IC=0.182uM|IC50|=|0.182|uM|182|nM
2XNE|2.80|2010|ASH|compound 15; IC50=0.190+/-0.138uM|O14965|SERINE/THREONINE-PROTEIN KINASE 6|6.72|IC=0.190uM|IC50|=|0.19|uM|190|nM
2X8I|1.92|2010|X8I|compound 4a|O14757|SERINE/THREONINE-PROTEIN KINASE CHK1|6.72|IC=0.19uM|IC50|=|0.19|uM|190|nM
3KYR|2.60|2010|038|ligand is compound (R)-12|P56817|BETA-SECRETASE 1|6.72|IC=0.19uM|IC50|=|0.19|uM|190|nM
3KRY|1.90|2010|3KR|compound 19v, IC50<0.1 nM|P45452|COLLAGENASE 3|10.0|IC=0.1nM|IC50|=|0.1|nM|0.1|nM
3L38|2.10|2010|879|compound 44, IC50=0.1+/-0.02uM|P56817|BETA-SECRETASE 1|7.0|IC=0.1uM|IC50|=|0.1|uM|100|nM
3LP2|2.80|2010|LP9|compound MK3, IC50=0.22 uM (In vitro); IC50=9.0 uM (Antiviral), ligand end is -CH3 or -CH2CH3|P04585|HIV-1 REVERSE TRANSCRIPTASE/RIBONUCLEASE H|6.66|IC=0.22uM|IC50|=|0.22|uM|220|nM
3OAD|2.17|2010|LPO|IC50=0.24nM(buffer); 5.6(human plasma)|P00797|RENIN|9.62|IC=0.24nM|IC50|=|0.24|nM|0.24|nM
3IU9|1.75|2010|T07|compound 8; NI2+ containing|P0A5J2|METHIONINE AMINOPEPTIDASE|6.62|IC=0.24uM|IC50|=|0.24|uM|240|nM
3IPB|1.90|2010|JZD|compound 4ajm15; IC501=0.2+/-0.04uM(Isolated TTR); IC502=27+/-4.9uM(TTR in serum)|P02766|TRANSTHYRETIN|6.7|IC=0.2uM|IC50|=|0.2|uM|200|nM
2X2K|2.60|2010|X2K|compound 33; IC50=0.30+/-0.04uM|P07949|PROTO-ONCOGENE TYROSINE-PROTEIN KINASE RECEPTOR RET|6.52|IC=0.30uM|IC50|=|0.3|uM|300|nM
3OAG|2.30|2010|LPQ|IC50=0.31nM(buffer); 7.5(human plasma)|P00797|RENIN|9.51|IC=0.31nM|IC50|=|0.31|nM|0.31|nM
3IXJ|2.20|2010|586|compound 1d|P56817|BETA-SECRETASE 1|9.49|IC=0.32nM|IC50|=|0.32|nM|0.32|nM
3ARA|1.70|2010|MKH|ligand is compound 16a; IC50=0.32+/-0.018uM|P33316|DEOXYURIDINE 5'-TRIPHOSPHATE NUCLEOTIDOHYDROLASE|6.49|IC=0.32uM|IC50|=|0.32|uM|320|nM
3MJ5|2.63|2010|GRM|compound 15g, EC50=9.1 uM|P0C6U8|REPLICASE POLYPROTEIN 1A|6.49|IC=0.32uM|IC50|=|0.32|uM|320|nM
3ANR|2.60|2010|HRM|compound harmine|Q13627|DUAL SPECIFICITY TYROSINE-PHOSPHORYLATION-REGULATED KINASE|6.46|IC=0.35uM|IC50|=|0.35|uM|350|nM
3I6M|2.26|2010|G3X|compound 2, affinity is measured on recombinant human brain AChe|P04058|ACETYLCHOLINESTERASE|6.46|IC=0.35uM|IC50|=|0.35|uM|350|nM
3KSQ|2.10|2010|Z96|compound 10a|Q5RKJ4|FARNESYLTRANSFERASE ALPHA SUBUNIT|9.42|IC=0.38nM|IC50|=|0.38|nM|0.38|nM
3IS9|2.55|2010|AC7|compound 3; Inhibitory activity versus HIV-1 RT with poly(rC)-oligo(dG) as the template primer.|P03366|HIV-1 REVERSE TRANSCRIPTASE/RIBONUCLEASE H|6.42|IC=0.38uM|IC50|=|0.38|uM|380|nM
3M8Q|2.70|2010|DJZ|compound 5h, not 5d; Antiviral IC50=0.3nM, Enzyme IC50=34 nM|P04585|HIV-1 REVERSE TRANSCRIPTASE/RIBONUCLEASE H|9.52|IC=0.3nM|IC50|=|0.3|nM|0.3|nM
3L3A|2.36|2010|625|compound 32|P56817|BETA-SECRETASE 1|6.38|IC=0.42uM|IC50|=|0.42|uM|420|nM
3KRR|1.80|2010|DQX|Fragment: kinase domain; IC50=0.48 +/-0.02nM, compound NVP-BSK805|O60674|TYROSINE-PROTEIN KINASE JAK2|9.32|IC=0.48nM|IC50|=|0.48|nM|0.48|nM
3LQ8|2.02|2010|88Z||P08581|HEPATOCYTE GROWTH FACTOR RECEPTOR|9.4|IC=0.4nM|IC50|=|0.4|nM|0.4|nM
3LW0|1.79|2010|CCX|compound 10, IC50=0.4+/-0.07um|P08069|INSULIN-LIKE GROWTH FACTOR 1 RECEPTOR|6.4|IC=0.4uM|IC50|=|0.4|uM|400|nM
3G58|2.05|2010|988|supplementary information; compound PMNPQ, also for PDE4D7 IC50=5nM|Q08499|CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D|9.28|IC=0.52nM|IC50|=|0.52|nM|0.52|nM
3IU8|1.85|2010|T03|compound 7; NI2+ containing|P0A5J2|METHIONINE AMINOPEPTIDASE|6.24|IC=0.58uM|IC50|=|0.58|uM|580|nM
2WXK|2.90|2010|RW4|Supplementary information; compound INK666|Q3UDT3|PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE|9.3|IC=0.5nM|IC50|=|0.5|nM|0.5|nM
3KWJ|2.80|2010|23Q|compound 2g|P27487|DIPEPTIDYL PEPTIDASE 4|9.3|IC=0.5nM|IC50|=|0.5|nM|0.5|nM
3MVH|2.01|2010|WFE|compound 42; with GSK3-beta peptide|B2RAM5|V-AKT MURINE THYMOMA VIRAL ONCOGENE HOMOLOG 1|9.3|IC=0.5nM|IC50|=|0.5|nM|0.5|nM
3LMP|1.90|2010|CEK||P37231|PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA|6.21|IC=0.62uM|IC50|=|0.62|uM|620|nM
2XD6|2.20|2010|XD6|compound 20; IC501=0.65uM(FP); IC502=0.90uM(TR-Fret);|P02829|ATP-DEPENDENT MOLECULAR CHAPERONE HSP82|6.19|IC=0.65uM|IC50|=|0.65|uM|650|nM
3L3X|1.55|2010|12-mer|ligand is 12-mer first motif of steroid receptor coactivator 3; IC50=0.71+/-0.1uM, SRC3-1|P10275|ANDROGEN RECEPTOR|6.15|IC=0.71uM|IC50|=|0.71|uM|710|nM
3GEN|1.60|2010|B43||Q06187|TYROSINE-PROTEIN KINASE BTK|9.14|IC=0.72nM|IC50|=|0.72|nM|0.72|nM
2WXG|2.00|2010|ZZN|Supplementary information; compound SW13|Q3UDT3|PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE|9.15|IC=0.7nM|IC50|=|0.7|nM|0.7|nM
3LKZ|2.00|2010|SFG|X-ray(WNV MTase); Bind assay(DENV-2 MTase):IC50=0.7uM(inhibition N7-methylation), 19uM(inhibition 2'-O-methylation); Fragment: West Nile virus methyltransferase (UNP residues 2529-2828)|Q9Q6P4|NON-STRUCTURAL PROTEIN 5|6.15|IC=0.7uM|IC50|=|0.7|uM|700|nM
2XKF|2.35|2010|BX1|compound 2; IC50=0.87+/-0.34uM|P51955|SERINE/THREONINE-PROTEIN KINASE NEK2|6.06|IC=0.87uM|IC50|=|0.87|uM|870|nM
3KRL|2.40|2010|KRL|Fragment: UNP residues 538-678, 753-922; Mutation: C584S;|P07333|MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR|9.1|IC=0.8nM|IC50|=|0.8|nM|0.8|nM
2X8D|1.90|2010|X8D|compound 3|O14757|SERINE/THREONINE-PROTEIN KINASE CHK1|6.1|IC=0.8uM|IC50|=|0.8|uM|800|nM
3LKH|2.05|2010|LT6|compound 44, IC50=0.8uM|O92972|RNA-DIRECTED RNA POLYMERASE|6.1|IC=0.8uM|IC50|=|0.8|uM|800|nM
3MAX|2.05|2010|LLX|IC50=0.90uM (1h), IC50=0.027uM (24h)|Q92769|HISTONE DEACETYLASE 2|6.05|IC=0.90uM|IC50|=|0.9|uM|900|nM
3G4G|2.30|2010|D71|supplementary information; compound RS25344; Space Group: P 21|Q08499|CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D|9.04|IC=0.91nM|IC50|=|0.91|nM|0.91|nM
3G4I|1.90|2010|D71|supplementary information; compound RS25344; Space Group: P 21 21 21|Q08499|CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D|9.04|IC=0.91nM|IC50|=|0.91|nM|0.91|nM
3LJ3|2.43|2010|WYE|mTOR is similar with PI3K gamma, IC50 value is for mTOR|P48736|PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE|9.03|IC=0.94nM|IC50|=|0.94|nM|0.94|nM
2X3T|2.75|2010|9-mer|compound 2, a 9-mer SYNTHETIC GLYCOPEPTIDE, IC50=0.9+/-0.16uM|P10968|AGGLUTININ ISOLECTIN 1|6.05|IC=0.9uM|IC50|=|0.9|uM|900|nM
3IRX|2.80|2010|UDR|compound 4; Inhibitory activity versus HIV-1 RT with poly(rC)-oligo(dG) as the template primer.|P03366|HIV-1 REVERSE TRANSCRIPTASE/RIBONUCLEASE H|9.0|IC=1.0nM|IC50|=|1|nM|1|nM
3M1S|3.13|2010|DW1|(R)-DW12|P49841|GLYCOGEN SYNTHASE KINASE-3 BETA|9.0|IC=1.0nM|IC50|=|1|nM|1|nM
2WZX|1.40|2010|ZX0|compound 2; covalent complex|P24735|BETA-LACTAMASE|6.0|IC=1.0uM|IC50|=|1|uM|1000|nM
3NEF|2.40|2010|PYV|IC50=1.14 +/-0.07uM; Fragment: UNP residues 20-221;|Q8VZS8|ABSCISIC ACID RECEPTOR PYL1|5.94|IC=1.14uM|IC50|=|1.14|uM|1140|nM
3NEG|2.80|2010|PYV|IC50=1.14 +/-0.07uM; Fragment: UNP residues 20-221; redundant to 3nef|Q8VZS8|ABSCISIC ACID RECEPTOR PYL1|5.94|IC=1.14uM|IC50|=|1.14|uM|1140|nM
3KRJ|2.10|2010|KRJ|Fragment: UNP residues 538-678, 753-922; Mutation: C584S;|P07333|MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR|8.96|IC=1.1nM|IC50|=|1.1|nM|1.1|nM
3LPU|1.95|2010|976|IC50=1.37+/-0.36uM, compound 6|Q76353|INTEGRASE|5.86|IC=1.37uM|IC50|=|1.37|uM|1370|nM
3KM4|1.90|2010|22X||P00797|RENIN|8.89|IC=1.3nM|IC50|=|1.3|nM|1.3|nM
3ITZ|2.25|2010|P66|compound 2m|Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|8.85|IC=1.4nM|IC50|=|1.4|nM|1.4|nM
3NZU|2.60|2010|NZU|compound 6; IC50(p110 alpha); X-ray(PI3K gamma)|P48736|PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE|8.85|IC=1.4nM|IC50|=|1.4|nM|1.4|nM
3IND|2.25|2010|593|compound 29; IC50=1.53+/-0.06uM|P56817|BETA-SECRETASE 1|5.82|IC=1.53uM|IC50|=|1.53|uM|1530|nM
2XEZ|2.25|2010|XEZ|compound 24|O14757|SERINE/THREONINE-PROTEIN KINASE CHK1|5.82|IC=1.5uM|IC50|=|1.5|uM|1500|nM
2XK7|1.99|2010|30E|compound 23|P51955|SERINE/THREONINE-PROTEIN KINASE NEK2|5.82|IC=1.5uM|IC50|=|1.5|uM|1500|nM
3OWK|1.80|2010|18E|Fragment: UNP RESIDUES 1-331;|Q5U5J2|CSNK2A1 PROTEIN|5.82|IC=1.5uM|IC50|=|1.5|uM|1500|nM
2XK6|2.20|2010|EQH|compound 36; IC50=1.6+/-0.7uM|P51955|SERINE/THREONINE-PROTEIN KINASE NEK2|5.8|IC=1.6uM|IC50|=|1.6|uM|1600|nM
3PA8|2.00|2010|621|IC50=1.78+/-0.16uM; covalent complex|Q189K3|TOXIN B|5.75|IC=1.78uM|IC50|=|1.78|uM|1780|nM
3NJY|2.60|2010|8XQ|Ni2+ containing; compound 85736331|O75164|LYSINE-SPECIFIC DEMETHYLASE 4A|5.77|IC=1.7uM|IC50|=|1.7|uM|1700|nM
3MKS|2.60|2010|C1C|SCF-I2; IC50=6.2+/-1 uM for Cdc4 substrate inhibition, IC50=1.9+/-1uM is for WT Skp1-Cdc4|P52286|SUPPRESSOR OF KINETOCHORE PROTEIN 1|5.72|IC=1.9uM|IC50|=|1.9|uM|1900|nM
3KX1|1.51|2010|KX1||P43235|CATHEPSIN K|7.0|IC=100nM|IC50|=|100|nM|100|nM
3MB6|1.75|2010|01I|UNP residues 1-331;|P68400|CASEIN KINASE II, ALPHA SUBUNIT|7.0|IC=100nM|IC50|=|100|nM|100|nM
3L6F|2.10|2010|15-mer|ligand is 15-mer phosphopeptide MART-1|P01903|HLA CLASS II HISTOCOMPATIBILITY ANTIGEN, DR ALPHA C|6.99|IC=102nM|IC50|=|102|nM|102|nM
3GZN|3.00|2010|B39|covalent complex of NEDD8-MLN492, inhibitor to NAE enzyme|Q13564|NEDD8-ACTIVATING ENZYME E1 REGULATORY SUBUNIT|8.0|IC=10nM|IC50|=|10|nM|10|nM
3L0E|2.30|2010|G58|ligand is compound 18, pIC50=8.0|P55055|OXYSTEROLS RECEPTOR LXR-BETA|8.0|IC=10nM|IC50|=|10|nM|10|nM
3FXW|2.00|2010|F10|ligand is compound 23|Q16644|MAP KINASE-ACTIVATED PROTEIN KINASE 3|5.96|IC=1100nM|IC50|=|1100|nM|1100|nM
2XVN|2.35|2010|KLS|Fragment: RESIDUES 29-307 ; IC50=112+/-1uM;|Q873Y0|ASPERGILLUS FUMIGATUS CHITINASE A1|3.95|IC=112uM|IC50|=|112|uM|112000|nM
3HO2|2.00|2010|N32|compound 2|P0AAI5|3-OXOACYL-[ACYL-CARRIER-PROTEIN] SYNTHASE 2|6.95|IC=113nM|IC50|=|113|nM|113|nM
3LNK|1.80|2010|74A||P56817|BETA-SECRETASE 1|5.94|IC=1150nM|IC50|=|1150|nM|1150|nM
3NDM|3.30|2010|3ND|compound 31, X-ray(ROCK1); IC50(ROCK2)|Q13464|RHO-ASSOCIATED PROTEIN KINASE 1|7.96|IC=11nM|IC50|=|11|nM|11|nM
3NNX|2.28|2010|EDD|compound 16(PP-p38); IC50=11nM(Fluoroprobe binding assay); 9nM(biochemical analyses)|Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|7.96|IC=11nM|IC50|=|11|nM|11|nM
3LPT|2.00|2010|723|IC50=12.2+/-3.4uM, compound 3|Q76353|INTEGRASE|4.91|IC=12.2uM|IC50|=|12.2|uM|12200|nM
3K22|2.10|2010|JZS|compound 13; pIC50=7.9+/-0.1|P04150|GLUCOCORTICOID RECEPTOR|7.9|IC=12.59nM|IC50|=|12.59|nM|12.59|nM
3OUI|1.70|2010|42Z|Fe2+ containing pIC50=4.9|Q9GZT9|EGL NINE HOMOLOG 1|4.9|IC=12.6uM|IC50|=|12.6|uM|12600|nM
3IPX|2.00|2010|B86|compound 1|P27707|DEOXYCYTIDINE KINASE|6.92|IC=120nM|IC50|=|120|nM|120|nM
3LPJ|1.79|2010|Z75||P56817|BETA-SECRETASE 1|6.92|IC=120nM|IC50|=|120|nM|120|nM
3LOK|2.48|2010|DJK|compound 2c, IC50=120+/-50 nM|P00523|TYROSINE-PROTEIN KINASE SRC|6.92|IC=120nM|IC50|=|120|nM|120|nM
3KBZ|2.45|2010|2T4|compound 6|P09467|FRUCTOSE-1,6-BISPHOSPHATASE 1|6.91|IC=124nM|IC50|=|124|nM|124|nM
3LJT|1.60|2010|LA3|Zn2+ binding; Fragment: Catalytic Domain; Mutation: L282K IC50=129+/-11nM|Q9UNA0|A DISINTEGRIN AND METALLOPROTEINASE WITH THROMBOSPO|6.89|IC=129nM|IC50|=|129|nM|129|nM
2X6D|2.80|2010|X6D|compound 40c|O14965|SERINE/THREONINE-PROTEIN KINASE 6|7.92|IC=12nM|IC50|=|12|nM|12|nM
3IVI|2.20|2010|2LI|compound 56|P56817|BETA-SECRETASE 1|7.92|IC=12nM|IC50|=|12|nM|12|nM
3KC0|2.80|2010|2T5|compound 10b|P09467|FRUCTOSE-1,6-BISPHOSPHATASE 1|7.92|IC=12nM|IC50|=|12|nM|12|nM
3L3Z|2.00|2010|12-mer|ligand is 12-mer third motif of steroid receptor coactivator 3; IC50=13.6+/-2.2uM|P10275|ANDROGEN RECEPTOR|4.87|IC=13.6uM|IC50|=|13.6|uM|13600|nM
2X38|2.20|2010|IC8|Supplementary information; compound IC87114|Q3UDT3|PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE|6.89|IC=130nM|IC50|=|130|nM|130|nM
2XFJ|1.80|2010|VG5|compound 40|P56817|BETA-SECRETASE 1|7.89|IC=13nM|IC50|=|13|nM|13|nM
3MVL|2.80|2010|38P|compound 7k|Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|7.89|IC=13nM|IC50|=|13|nM|13|nM
3LCO|3.40|2010|LC0||P07333|MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR|6.84|IC=143nM|IC50|=|143|nM|143|nM
2X8E|2.50|2010|X8E|compound 28|O14757|SERINE/THREONINE-PROTEIN KINASE CHK1|7.85|IC=14nM|IC50|=|14|nM|14|nM
2XCS|2.10|2010|RXV|S. AUREUS GYRASE COMPLEX WITH GSK299423 AND DNA, IC50=14+/-5nM, not Protein-Nucleic Acid complex|P66937|DNA GYRASE SUBUNIT B, DNA GYRASE SUBUNIT A|7.85|IC=14nM|IC50|=|14|nM|14|nM
3I5N|2.00|2010|B2D|compound 13; IC501=14nM(Cellular); IC502=17nM(Biochemical)|P08581|HEPATOCYTE GROWTH FACTOR RECEPTOR|7.85|IC=14nM|IC50|=|14|nM|14|nM
3IKA|2.90|2010|0UN|compound WZ4002; covalent complex; PC9-GR cell line, EGFR Del E746_A750/T790M|P00533|EPIDERMAL GROWTH FACTOR RECEPTOR|7.85|IC=14nM|IC50|=|14|nM|14|nM
3KQA|2.25|2010|TR9|IC50= 14+/-0.6uM|P33038|UDP-N-ACETYLGLUCOSAMINE 1-CARBOXYVINYLTRANSFERASE|4.85|IC=14uM|IC50|=|14|uM|14000|nM
3NCG|2.49|2010|BK1|IC50= 150 +/- 20nM; Fragment: CpCDPK1, residues 70-538|A3FQ16|CALMODULIN-DOMAIN PROTEIN KINASE 1|6.82|IC=150nM|IC50|=|150|nM|150|nM
3LCE|2.00|2010|LCE|IC50=156+/-6uM; covalent complex|P14489|BETA-LACTAMASE OXA-10|3.81|IC=156uM|IC50|=|156|uM|156000|nM
2X6E|3.35|2010|YM4|compound 51; IC50=15+/-3nM|O14965|SERINE/THREONINE-PROTEIN KINASE 6|7.82|IC=15nM|IC50|=|15|nM|15|nM
2XFI|1.73|2010|XFI|compound 4|P56817|BETA-SECRETASE 1|7.82|IC=15nM|IC50|=|15|nM|15|nM
3KOO|2.79|2010|24D||P34913|EPOXIDE HYDROLASE 2|7.82|IC=15nM|IC50|=|15|nM|15|nM
3L13|3.00|2010|JZW|IC50=1.8(PI3K alpha) IC50=14/1.4/15(PI3K beta/gamma/sigma), compound 14|P48736|PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE|7.82|IC=15nM|IC50|=|15|nM|15|nM
3MJ2|1.90|2010|MJG|BMS-509744, No equilibrium Kd was reached|Q08881|TYROSINE-PROTEIN KINASE ITK/TSK|7.82|IC=15nM|IC50|=|15|nM|15|nM
3N51|2.10|2010|BK3|IC50= 15 +/- 5 nM; Fragment: TgCDPK1, residues 30-507|Q9BJF5|CALMODULIN-DOMAIN PROTEIN KINASE 1|7.82|IC=15nM|IC50|=|15|nM|15|nM
3NCZ|3.00|2010|3NC|compound 22, X-ray(ROCK1); IC50(ROCK2)|Q13464|RHO-ASSOCIATED PROTEIN KINASE 1|7.82|IC=15nM|IC50|=|15|nM|15|nM
2XK4|2.10|2010|OL2|compound 17|P51955|SERINE/THREONINE-PROTEIN KINASE NEK2|4.77|IC=16.9uM|IC50|=|16.9|uM|16900|nM
3IHZ|1.67|2010|FK5|ligand FK506|A5K8X6|70 KDA PEPTIDYLPROLYL ISOMERASE, PUTATIVE|6.8|IC=160nM|IC50|=|160|nM|160|nM
3L0N|1.74|2010|S5P|IC50=1680+/-540uM|P11172|OROTIDINE-5'-PHOSPHATE DECARBOXYLASE|2.77|IC=1680uM|IC50|=|1680|uM|1680000|nM
3G8O|1.90|2010|30X|compound 22, Pyrrolidine 1|P06401|PROGESTERONE RECEPTOR|7.8|IC=16nM|IC50|=|16|nM|16|nM
3HQ5|2.10|2010|GKK|compound 22, Alkylpyrrolidine ligand|P06401|PROGESTERONE RECEPTOR|7.8|IC=16nM|IC50|=|16|nM|16|nM
3PHE|2.20|2010|C9A|compound 16|D0PY27|HCV NS5B RNA-DEPENDENT RNA POLYMERASE|7.8|IC=16nM|IC50|=|16|nM|16|nM
3IU7|1.40|2010|FCD|compound 4; Mn2+ containing|P0A5J2|METHIONINE AMINOPEPTIDASE|4.8|IC=16uM|IC50|=|16|uM|16000|nM
3MLB|1.80|2010|LJZ|inhibitor 1_02_1, IC50=16+/-4 uM|C3L5T6|NICOTINATE-NUCLEOTIDE ADENYLYLTRANSFERASE|4.8|IC=16uM|IC50|=|16|uM|16000|nM
3IOP|2.20|2010|8I1|compound 9i|O15530|3-PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE 1|7.77|IC=17nM|IC50|=|17|nM|17|nM
3K5C|2.12|2010|0BI|compound 3(NB-216)|P56817|BETA-SECRETASE 1|7.77|IC=17nM|IC50|=|17|nM|17|nM
3KWB|2.02|2010|ORH||P43235|CATHEPSIN K|7.77|IC=17nM|IC50|=|17|nM|17|nM
2X4R|2.30|2010|9-mer|CYTOMEGALOVIRUS (CMV, NLVPMVATV); IC50=17+/-2.1uM|P01892|HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2.1|4.77|IC=17uM|IC50|=|17|uM|17000|nM
2X4O|2.30|2010|9-mer|HIV-1 ENVELOPE PEPTIDE (KLTPLCVTL); IC50=17+/-1.0uM|P01892|HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2|4.77|IC=17uM|IC50|=|17|uM|17000|nM
2WXF|1.90|2010|039|Supplementary information; compound PIK-39|Q3UDT3|PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE|6.74|IC=180nM|IC50|=|180|nM|180|nM
3FH8|1.67|2010|27P|compound 5|P09960|LEUKOTRIENE A-4 HYDROLASE|6.74|IC=180nM|IC50|=|180|nM|180|nM
3MV5|2.47|2010|XFE|compound 5; with GSK3-beta peptide|B2RAM5|V-AKT MURINE THYMOMA VIRAL ONCOGENE HOMOLOG 1|6.74|IC=180nM|IC50|=|180|nM|180|nM
2WA4|2.50|2010|069|compound 3|Q9NWT6|HYPOXIA-INDUCIBLE FACTOR 1-ALPHA INHIBITOR|4.74|IC=18uM|IC50|=|18|uM|18000|nM
3KFN|1.77|2010|3TL|IC50=18+/-3uM, inhibitor TL-3 and fragment hit 4D9 by soaking|Q903N5|HIV-1 PROTEASE|4.74|IC=18uM|IC50|=|18|uM|18000|nM
3FUL|2.39|2010|52D|compound 9, 199nM is wrong data in BindingDB|P09960|LEUKOTRIENE A-4 HYDROLASE|3.7|IC=199uM|IC50|=|199|uM|199000|nM
3HNZ|2.75|2010|PMN|compound1|P0AAI5|3-OXOACYL-[ACYL-CARRIER-PROTEIN] SYNTHASE 2|7.72|IC=19nM|IC50|=|19|nM|19|nM
2WA3|2.50|2010|A29|compound 2|Q9NWT6|HYPOXIA-INDUCIBLE FACTOR 1-ALPHA INHIBITOR|3.0|IC=1mM|IC50|=|1|mM|1000000|nM
2WXJ|2.60|2010|RW3|Supplementary information; compound INK654|Q3UDT3|PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE|9.0|IC=1nM|IC50|=|1|nM|1|nM
3IAD|2.65|2010|15X|supplementary information; compound D159153; IC50<1nM; X-ray(human PDE4D); IC50(MICE PDE4D)|Q08499|CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D|9.0|IC=1nM|IC50|=|1|nM|1|nM
3KC1|2.25|2010|2T6|compound 19a|P09467|FRUCTOSE-1,6-BISPHOSPHATASE 1|9.0|IC=1nM|IC50|=|1|nM|1|nM
3KW9|1.80|2010|ORG||P43235|CATHEPSIN K|9.0|IC=1nM|IC50|=|1|nM|1|nM
3PA3|1.40|2010|C70|compound 70|O14757|SERINE/THREONINE-PROTEIN KINASE CHK1|9.0|IC=1nM|IC50|=|1|nM|1|nM
3M8P|2.67|2010|65B|NNRTI TMC-125 Etravirine, Antiviral IC50=2.1 nM (WT, 10%FBS); Antiviral IC50=25.9 nM (WT, 40%HuS)|P04585|HIV-1 REVERSE TRANSCRIPTASE/RIBONUCLEASE H|8.68|IC=2.1nM|IC50|=|2.1|nM|2.1|nM
2XK3|2.20|2010|XK3|compound 35; IC50=2.1+/-1.0uM|P51955|SERINE/THREONINE-PROTEIN KINASE NEK2|5.68|IC=2.1uM|IC50|=|2.1|uM|2100|nM
2X39|1.93|2010|X39|compound 21; IC50=2.2+/-1.2nM|P31751|RAC-BETA SERINE/THREONINE-PROTEIN KINASE|8.66|IC=2.2nM|IC50|=|2.2|nM|2.2|nM
3P1D|1.86|2010|MB3|ligand is compound N-Methyl-2-pyrrolidone (NMP)|Q92793|CREB-BINDING PROTEIN|2.64|IC=2.3mM|IC50|=|2.3|mM|2300000|nM
2XKD|1.96|2010|T3M|compound 12; IC50=2.3+/-0.5uM|P51955|SERINE/THREONINE-PROTEIN KINASE NEK2|5.64|IC=2.3uM|IC50|=|2.3|uM|2300|nM
2XK8|2.00|2010|5R1|compound 15; IC50=2.4+/-0.5uM|P51955|SERINE/THREONINE-PROTEIN KINASE NEK2|5.62|IC=2.4uM|IC50|=|2.4|uM|2400|nM
3FHE|2.16|2010|28P|Leukotriene A4 Hydrolase with inhibitor 2, Bioorg Med Chem Lett. 12: 3383-6 (2002)|P09960|LEUKOTRIENE A-4 HYDROLASE|8.6|IC=2.5nM|IC50|=|2.5|nM|2.5|nM
3K5G|2.00|2010|BJC|compound 25|P56817|BETA-SECRETASE 1|8.6|IC=2.5nM|IC50|=|2.5|nM|2.5|nM
3M6F|1.85|2010|BJZ|IC50=2.5+/-0.4nM|P20701|INTEGRIN ALPHA-L|8.6|IC=2.5nM|IC50|=|2.5|nM|2.5|nM
2XKC|2.50|2010|4VQ|compound 14; IC50=2.6+/-0.5uM|P51955|SERINE/THREONINE-PROTEIN KINASE NEK2|5.59|IC=2.6uM|IC50|=|2.6|uM|2600|nM
2X7D|2.30|2010|EGB|ligand is S-dimethylenastron|P52732|KINESIN-LIKE PROTEIN KIF11|6.7|IC=200nM|IC50|=|200|nM|200|nM
3MB7|1.65|2010|14I|UNP residues 1-331;|P68400|CASEIN KINASE II, ALPHA SUBUNIT|6.7|IC=200nM|IC50|=|200|nM|200|nM
3OYL|2.54|2010|ZZX|PFV S217H mutant intasome bound to magnesium and the INSTI MK2048|P14350|PFV INTEGRASE|6.7|IC=200nM|IC50|=|200|nM|200|nM
2WXN|2.60|2010|DLN|Supplementary information; compound DL07|Q3UDT3|PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE|7.68|IC=21nM|IC50|=|21|nM|21|nM
3K3E|2.70|2010|PDB|compound 1r; IC50=22+/-3nM|O76083|CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE-9|7.66|IC=22nM|IC50|=|22|nM|22|nM
3OW4|2.60|2010|SMY|compound 26; IC50=22+/-3nM; with GSK 3 beta peptide|P31749|RAC-ALPHA SERINE/THREONINE-PROTEIN KINASE|7.66|IC=22nM|IC50|=|22|nM|22|nM
2XG5|2.00|2010|EC2|compound 5d|P15319|CHAPERONE PROTEIN PAPD|4.66|IC=22uM|IC50|=|22|uM|22000|nM
2X6K|3.50|2010|X6K|Supplementary information; compound PI-103|Q9W1M7|PHOSPHOTIDYLINOSITOL 3 KINASE 59F|5.64|IC=2300nM|IC50|=|2300|nM|2300|nM
3KIG|1.39|2010|DA4|Zn2+ binding|P00918|CARBONIC ANHYDRASE 2|6.61|IC=245nM|IC50|=|245|nM|245|nM
3L0K|1.34|2010|6AU|IC50=24+/-13uM|P11172|OROTIDINE-5'-PHOSPHATE DECARBOXYLASE|4.62|IC=24uM|IC50|=|24|uM|24000|nM
2X6F|3.30|2010|3MA|supplementary information; compound 3-MA, IC50=25713nM|Q9W1M7|PHOSPHOTIDYLINOSITOL 3 KINASE 59F|4.59|IC=25.713uM|IC50|=|25.713|uM|25713|nM
3LFS|2.40|2010|A07|inhibitor SAR37|P24941|CELL DIVISION PROTEIN KINASE 2|5.6|IC=2500nM|IC50|=|2500|nM|2500|nM
3KN0|1.90|2010|3TO||P56817|BETA-SECRETASE 1|3.6|IC=250uM|IC50|=|250|uM|250000|nM
3MPT|1.89|2010|1GK|compound 1; pIC50=6.6|Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|6.6|IC=251nM|IC50|=|251|nM|251|nM
3OYN|2.68|2010|ZZX|PFV N224H mutant intasome bound to magnesium and the INSTI MK2048|P14350|PFV INTEGRASE|7.6|IC=25nM|IC50|=|25|nM|25|nM
3KDT|2.70|2010|7HA|compound 2|Q07869|PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR ALPHA|6.59|IC=260nM|IC50|=|260|nM|260|nM
3MSK|2.00|2010|EV4|compound 12b|P56817|BETA-SECRETASE 1|4.59|IC=26uM|IC50|=|26|uM|26000|nM
2XH5|2.72|2010|X37|compound 10; IC50=27+/-18nM|P31751|RAC-BETA SERINE/THREONINE-PROTEIN KINASE|7.57|IC=27nM|IC50|=|27|nM|27|nM
3L5E|1.53|2010|BDW|compound 39|P56817|BETA-SECRETASE 1|7.57|IC=27nM|IC50|=|27|nM|27|nM
3NNV|2.10|2010|437|compound 12|Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|7.57|IC=27nM|IC50|=|27|nM|27|nM
3PJC|2.20|2010|PJC|compound 12; IC50=27+/-7nM|P52333|TYROSINE-PROTEIN KINASE JAK3|7.57|IC=27nM|IC50|=|27|nM|27|nM
3G4K|1.95|2010|ROL|supplementary information; compound R-rolipram; X-ray(human PDE4D); IC50(MICE PDE4D)|Q08499|CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D|6.54|IC=288nM|IC50|=|288|nM|288|nM
3A4P|2.54|2010|DFQ|compound 4|P08581|HEPATOCYTE GROWTH FACTOR RECEPTOR|7.55|IC=28nM|IC50|=|28|nM|28|nM
3KHJ|2.80|2010|C64|IC50=28+/-9nM|Q5CPK7|INOSINE-5'-MONOPHOSPHATE DEHYDROGENASE|7.55|IC=28nM|IC50|=|28|nM|28|nM
2WXV|2.60|2010|WXV|compound 59|P24941|CELL DIVISION PROTEIN KINASE 2|8.7|IC=2nM|IC50|=|2|nM|2|nM
3LVP|3.00|2010|PDR||P08069|INSULIN-LIKE GROWTH FACTOR 1 RECEPTOR|8.7|IC=2nM|IC50|=|2|nM|2|nM
3OOT|2.55|2010|SSR|compound 5k|P00797|RENIN|8.7|IC=2nM|IC50|=|2|nM|2|nM
3OYP|2.76|2010|5-mer|compound 3; covalent complex|P26662|SERINE PROTEASE NS3|8.7|IC=2nM|IC50|=|2|nM|2|nM
3PA5|1.70|2010|C73|compound 1|O14757|SERINE/THREONINE-PROTEIN KINASE CHK1|8.7|IC=2nM|IC50|=|2|nM|2|nM
2X7C|1.90|2010|KZ9|ligand is S-enastron|P52732|KINESIN-LIKE PROTEIN KIF11|5.7|IC=2uM|IC50|=|2|uM|2000|nM
3G0C|2.69|2010|RUF|compound 1|P27487|DIPEPTIDYL PEPTIDASE 4|5.7|IC=2uM|IC50|=|2|uM|2000|nM
3N5H|2.20|2010|GO0|compound 9|P14324|FARNESYL PYROPHOSPHATE SYNTHASE|5.7|IC=2uM|IC50|=|2|uM|2000|nM
2WXD|1.60|2010|E18||P29736|MYROSINASE|5.48|IC=3.3uM|IC50|=|3.3|uM|3300|nM
3MY1|2.80|2010|RFZ|with cyclinT1; X-ray(CDK9 2-330); Bind assay(CDK9 1-330)|P50750|CYCLIN-DEPENDENT KINASE 9|5.45|IC=3.58uM|IC50|=|3.58|uM|3580|nM
3KED|2.30|2010|DAB|Zn2+ binding|P04825|AMINOPEPTIDASE N|2.44|IC=3.6mM|IC50|=|3.6|mM|3600000|nM
3K5F|2.25|2010|AYH|compound 10|P56817|BETA-SECRETASE 1|5.43|IC=3.7uM|IC50|=|3.7|uM|3700|nM
3FRG|1.70|2010|SK4|compound 4; pIC50=8.4|Q07343|CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B|8.4|IC=3.98nM|IC50|=|3.98|nM|3.98|nM
3MVM|2.00|2010|39P|compound 7v|Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|8.41|IC=3.9nM|IC50|=|3.9|nM|3.9|nM
3ARN|1.80|2010|MSJ|ligand is compound 9; IC50=3.9+/-0.63uM|P33316|DEOXYURIDINE 5'-TRIPHOSPHATE NUCLEOTIDOHYDROLASE|5.41|IC=3.9uM|IC50|=|3.9|uM|3900|nM
3K5U|2.35|2010|PFQ|compound 8, find a wrong data IC50=0.309nM in BindingDB|O14965|SERINE/THREONINE-PROTEIN KINASE 6|6.51|IC=309nM|IC50|=|309|nM|309|nM
3MPM|1.95|2010|5LK|compound 1a|P06239|TYROSINE-PROTEIN KINASE LCK|7.52|IC=30nM|IC50|=|30|nM|30|nM
2XF0|2.40|2010|4UB|compound 13|O14757|SERINE/THREONINE-PROTEIN KINASE CHK1|4.52|IC=30uM|IC50|=|30|uM|30000|nM
3LAU|2.10|2010|OFI|IC50=0.044uM is for GSK3beta inhibitor, compound 4 for Aurora2 is IC50>30uM|O14965|SERINE/THREONINE-PROTEIN KINASE 6|4.52|IC=30uM|IC50|=|30|uM|30000|nM
3LFN|2.28|2010|A27|SAR57, an aminoindazole type inhibitor|P24941|CELL DIVISION PROTEIN KINASE 2|5.5|IC=3160nM|IC50|=|3160|nM|3160|nM
2XRU|2.90|2010|400|compound 29, PHA-828300|O14965|SERINE/THREONINE-PROTEIN KINASE 6|7.51|IC=31nM|IC50|=|31|nM|31|nM
3OG7|2.45|2010|032|compound PLX4032|Q5IBP5|AKAP9-BRAF FUSION PROTEIN|7.51|IC=31nM|IC50|=|31|nM|31|nM
3OVX|1.49|2010|O64|compound 5; covalent complex|P25774|CATHEPSIN S|7.51|IC=31nM|IC50|=|31|nM|31|nM
2XCT|3.35|2010|CPF|S. AUREUS GYRASE COMPLEX WITH CIPROFLOXACIN AND DNA, IC50=31+/-10uM, not Protein-Nucleic Acid complex|P66937|DNA GYRASE SUBUNIT B, DNA GYRASE SUBUNIT A|4.51|IC=31uM|IC50|=|31|uM|31000|nM
3MVJ|2.49|2010|XFE|compound 5|P17612|CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTIC|5.49|IC=3200nM|IC50|=|3200|nM|3200|nM
3H0J|2.80|2010|B36|compound 2|Q00955|ACETYL-COA CARBOXYLASE|6.49|IC=325nM|IC50|=|325|nM|325|nM
3NC9|2.40|2010|TR3|compound 6|P50053-2KETOHEXOKINASE||6.48|IC=330nM|IC50|=|330|nM|330|nM
3L16|2.90|2010|JZX|IC50=5.5(PI3K alpha) IC50=60/6.6/33(PI3K beta/gamma/sigma), compound 16|P48736|PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE|7.48|IC=33nM|IC50|=|33|nM|33|nM
2WWJ|2.60|2010|Y28|compound 10a; for JMJD2A, IC502=33uM(MALDI-TOF)|O75164|LYSINE-SPECIFIC DEMETHYLASE 4A|4.48|IC=33uM|IC50|=|33|uM|33000|nM
3KDU|2.07|2010|NKS|compound 12|Q07869|PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR ALPHA|6.46|IC=347nM|IC50|=|347|nM|347|nM
2WXQ|2.70|2010|ZZQ|Supplementary information; compound AS15|Q3UDT3|PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE|7.47|IC=34nM|IC50|=|34|nM|34|nM
2X7O|3.70|2010|ZOP|compound 5; IC50=34+/-30nM|P36897|TGF-BETA RECEPTOR TYPE-1|7.47|IC=34nM|IC50|=|34|nM|34|nM
3GB2|2.40|2010|G3B|compound (S)-9b|P49841|GLYCOGEN SYNTHASE KINASE-3 BETA|7.47|IC=34nM|IC50|=|34|nM|34|nM
3OY3|1.95|2010|XY3|compound AP24589;|P00520|TYROSINE-PROTEIN KINASE ABL1|7.45|IC=35.8nM|IC50|=|35.8|nM|35.8|nM
3KXZ|2.37|2010|925||P06239|TYROSINE-PROTEIN KINASE LCK|7.46|IC=35nM|IC50|=|35|nM|35|nM
2X6J|3.50|2010|093|supplementary information; compound PIK-93|Q9W1M7|PHOSPHOTIDYLINOSITOL 3 KINASE 59F|7.44|IC=36nM|IC50|=|36|nM|36|nM
2XCH|2.00|2010|CKG|compound 2|O15530|3-PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE 1|6.43|IC=374nM|IC50|=|374|nM|374|nM
3L5R|1.94|2010|47X||P14174|MACROPHAGE MIGRATION INHIBITORY FACTOR|7.42|IC=38nM|IC50|=|38|nM|38|nM
2WXP|2.30|2010|GD9|Supplementary information; compound GDC-0941|Q3UDT3|PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE|8.52|IC=3nM|IC50|=|3|nM|3|nM
2XA4|2.04|2010|AZ5|compound 9e; IC50<0.003uM; IC50=58nM(high ATP)|O60674|TYROSINE-PROTEIN KINASE JAK2|8.52|IC=3nM|IC50|=|3|nM|3|nM
2XFK|1.80|2010|AA9|compound 41|P56817|BETA-SECRETASE 1|8.52|IC=3nM|IC50|=|3|nM|3|nM
3NS9|1.78|2010|NS9|compound 4k|P24941|CELL DIVISION PROTEIN KINASE 2|8.52|IC=3nM|IC50|=|3|nM|3|nM
3OCG|2.21|2010|OCG|compound 2f; X-ray(unphosphorylated p38 alpha)|Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|8.52|IC=3nM|IC50|=|3|nM|3|nM
3PA4|1.59|2010|C72|compound 2a|O14757|SERINE/THREONINE-PROTEIN KINASE CHK1|8.52|IC=3nM|IC50|=|3|nM|3|nM
3I97|2.90|2010|8DR|compound 2|O14786|NEUROPILIN-1|5.52|IC=3uM|IC50|=|3|uM|3000|nM
2WZZ|1.57|2010|ZX1|compound 3; covalent complex|P24735|BETA-LACTAMASE|5.4|IC=4.0uM|IC50|=|4|uM|4000|nM
2XKE|2.20|2010|WI2|compound 5|P51955|SERINE/THREONINE-PROTEIN KINASE NEK2|5.38|IC=4.2uM|IC50|=|4.2|uM|4200|nM
3G45|2.63|2010|988|compound PMNPQ|Q07343|CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B|8.36|IC=4.4nM|IC50|=|4.4|nM|4.4|nM
2WXL|1.99|2010|ZS4|compound ZSTK474|Q3UDT3|PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE|8.34|IC=4.6nM|IC50|=|4.6|nM|4.6|nM
3LJ7|2.30|2010|OHO|Carbamate inhibitor URB597, incomplete ligand structure|P97612|FATTY-ACID AMIDE HYDROLASE 1|8.34|IC=4.6nM|IC50|=|4.6|nM|4.6|nM
2WXM|2.80|2010|ZZM|Supplementary information; compound DL06|Q3UDT3|PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE|7.4|IC=40nM|IC50|=|40|nM|40|nM
3LCD|2.50|2010|BDY||P07333|MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR|7.4|IC=40nM|IC50|=|40|nM|40|nM
3OTQ|3.00|2010|MZL|compound 1|P34913|EPOXIDE HYDROLASE 2|7.39|IC=41nM|IC50|=|41|nM|41|nM
3OQK|2.90|2010|S52|compound 2a|P00797|RENIN|6.38|IC=420nM|IC50|=|420|nM|420|nM
3KRX|3.10|2010|BA1|hGRK2-G beta gamma 3 balanol (cocrystal)|P25098|BETA-ADRENERGIC RECEPTOR KINASE 1|7.38|IC=42nM|IC50|=|42|nM|42|nM
3KRW|2.90|2010|BA1|ligand is balanol|P25098|BETA-ADRENERGIC RECEPTOR KINASE 1|7.38|IC=42nM|IC50|=|42|nM|42|nM
3LPB|2.00|2010|NVB||O60674|TYROSINE-PROTEIN KINASE JAK2|7.38|IC=42nM|IC50|=|42|nM|42|nM
3NSH|2.20|2010|957|compound 53|P56817|BETA-SECRETASE 1|6.33|IC=470nM|IC50|=|470|nM|470|nM
3IVH|1.80|2010|1LI|compound 1|P56817|BETA-SECRETASE 1|7.33|IC=47nM|IC50|=|47|nM|47|nM
3NNU|2.40|2010|EDB|compound 19, IC50=48nM(U-p38, Fluoroprobe binding assay); 66nM(PP-p38, Fluoroprobe binding assay); 8nM(PP-p38, biochemical analyses)|Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|7.32|IC=48nM|IC50|=|48|nM|48|nM
2X4U|2.10|2010|9-mer|supplementary information; HIV-1 peptide rt468-476 (ILKEPVHGV); IC50=48+/-1.2uM|P01892|HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2|4.32|IC=48uM|IC50|=|48|uM|48000|nM
3KWZ|1.49|2010|KWZ||P43235|CATHEPSIN K|8.4|IC=4nM|IC50|=|4|nM|4|nM
3NRM|3.05|2010|NRM|IC50<=4nM; compound 1j|O14965|SERINE/THREONINE-PROTEIN KINASE 6|8.4|IC=4nM|IC50|=|4|nM|4|nM
3KEN|2.50|2010|ZZD|Fragment: motor domain of human kinesin Eg5 (residues 1-369)|P52732|KINESIN-LIKE PROTEIN KIF11|5.4|IC=4uM|IC50|=|4|uM|4000|nM
3L17|3.00|2010|JZY|IC50=1.1(PI3K alpha) IC50=6.2/0.7/5.2(PI3K beta/gamma/sigma), compound 20|P48736|PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE|8.28|IC=5.2nM|IC50|=|5.2|nM|5.2|nM
3NW7|2.11|2010|LGV|compound 34|P08069|INSULIN-LIKE GROWTH FACTOR 1 RECEPTOR|8.28|IC=5.3nM|IC50|=|5.3|nM|5.3|nM
2X2L|2.00|2010|X2L|compound 34; IC50=5.3+/-1.3uM|P07949|PROTO-ONCOGENE TYROSINE-PROTEIN KINASE RECEPTOR RET|5.28|IC=5.3uM|IC50|=|5.3|uM|5300|nM
3OKH|2.50|2010|OKH|compound 1r; with incomplete 14-mer coactivator|Q96RI1|BILE ACID RECEPTOR|5.24|IC=5.72uM|IC50|=|5.72|uM|5720|nM
3G4L|2.50|2010|ROF|supplementary information; compound roflumilast; X-ray(human PDE4D); IC50(MICE PDE4D)|Q08499|CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D|8.24|IC=5.8nM|IC50|=|5.8|nM|5.8|nM
3HMV|2.23|2010|HBT|compound 6; pIC50=7.3|Q07343|CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B|7.3|IC=50.12nM|IC50|=|50.12|nM|50.12|nM
3LS4|2.00|2010|TCI||------|ANTIBODY FAB FRAGMENT LIGHT CHAIN|6.3|IC=500nM|IC50|=|500|nM|500|nM
2XML|2.55|2010|OGA|ligand is compound 19|Q9H3R0|LYSINE-SPECIFIC DEMETHYLASE 4C|3.3|IC=500uM|IC50|=|500|uM|500000|nM
3N1V|2.18|2010|3N1||P14324|FARNESYL PYROPHOSPHATE SYNTHASE|3.3|IC=500uM|IC50|=|500|uM|500000|nM
3N46|2.35|2010|3N5|compound 8|P14324|FARNESYL PYROPHOSPHATE SYNTHASE|4.3|IC=50uM|IC50|=|50|uM|50000|nM
3IPY|2.54|2010|B87|compound 9|P27707|DEOXYCYTIDINE KINASE|6.29|IC=510nM|IC50|=|510|nM|510|nM
3OC0|2.70|2010|B2Q|compound 1, supersedes code 3kwh|P27487|DIPEPTIDYL PEPTIDASE 4|6.28|IC=520nM|IC50|=|520|nM|520|nM
3K5D|2.90|2010|XLI|compound 3|P56817|BETA-SECRETASE 1|7.28|IC=53nM|IC50|=|53|nM|53|nM
3MWW|2.80|2010|BIW|compound 8; IC50=57+/-3nM|O92972|GENOME POLYPROTEIN|7.24|IC=57nM|IC50|=|57|nM|57|nM
2X52|1.70|2010|GYT|compound 23, A SYNTHETIC DIVALENT CARBOHYDRATE LIGAND, IC50=57+/-13uM|P10969|AGGLUTININ ISOLECTIN 3|4.24|IC=57uM|IC50|=|57|uM|57000|nM
3O8H|1.90|2010|O8H|compound BDM14950|P96222|TRANSCRIPTIONAL REGULATORY REPRESSOR PROTEIN|6.24|IC=580nM|IC50|=|580|nM|580|nM
3KEC|2.05|2010|3KE|compound 10b; X-ray(catalytic domain); IC501=58nM(MMP-13/CD); IC502=130nM(MMP-13/FL)|P45452|COLLAGENASE 3|7.24|IC=58nM|IC50|=|58|nM|58|nM
3O96|2.70|2010|IQO|inhibitor viii|P31749|RAC-ALPHA SERINE/THREONINE-PROTEIN KINASE|7.24|IC=58nM|IC50|=|58|nM|58|nM
3N4L|2.70|2010|842|compound 19; compound 1 with BACE-1 as PDB 3ivh:IC50=47nM|P56817|BETA-SECRETASE 1|7.23|IC=59nM|IC50|=|59|nM|59|nM
2X81|2.91|2010|ZZL|compound MLN8054|O14965|SERINE/THREONINE-PROTEIN KINASE 6|8.3|IC=5nM|IC50|=|5|nM|5|nM
3G0G|2.45|2010|RUM|compound 13c; IC50=5+/-1nM|P27487|DIPEPTIDYL PEPTIDASE 4|8.3|IC=5nM|IC50|=|5|nM|5|nM
3G0D|2.39|2010|XIH|compound 2|P27487|DIPEPTIDYL PEPTIDASE 4|8.3|IC=5nM|IC50|=|5|nM|5|nM
3LXL|1.74|2010|IZA|ligand is compound 1|P52333|TYROSINE-PROTEIN KINASE JAK3|8.3|IC=5nM|IC50|=|5|nM|5|nM
3LY2|2.60|2010|Z72|IC50=0.005uM|Q07343|CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B|8.3|IC=5nM|IC50|=|5|nM|5|nM
3OCB|2.70|2010|XM1|compound 50; with GSK 3 beta peptide; IC50=5+/-2nM|B2RAM5|V-AKT MURINE THYMOMA VIRAL ONCOGENE HOMOLOG 1|8.3|IC=5nM|IC50|=|5|nM|5|nM
3OCT|1.95|2010|1N1|ligand is compound 1, dasatinib|Q06187|TYROSINE-PROTEIN KINASE BTK|8.3|IC=5nM|IC50|=|5|nM|5|nM
3OT3|1.44|2010|22K|compound 22k|O14757|SERINE/THREONINE-PROTEIN KINASE CHK1|8.3|IC=5nM|IC50|=|5|nM|5|nM
2XEY|2.70|2010|YVQ|compound 31g|O14757|SERINE/THREONINE-PROTEIN KINASE CHK1|5.19|IC=6.5uM|IC50|=|6.5|uM|6500|nM
3IXK|2.50|2010|929|compound 28; IC50=6.6nM for BACE-1 and Ki=210nM for cathepsin D enzyme|P56817|BETA-SECRETASE 1|8.18|IC=6.6nM|IC50|=|6.6|nM|6.6|nM
3KWF|2.40|2010|B1Q|compound 8p|P27487|DIPEPTIDYL PEPTIDASE 4|8.17|IC=6.8nM|IC50|=|6.8|nM|6.8|nM
3L5F|1.70|2010|BDX|compound 40|P56817|BETA-SECRETASE 1|6.22|IC=605nM|IC50|=|605|nM|605|nM
3MA3|2.30|2010|01I|UNP residues 92-403;|P11309|SERINE/THREONINE-PROTEIN KINASE PIM|7.22|IC=60nM|IC50|=|60|nM|60|nM
2X9F|1.75|2010|X9F|enzyme IC50=0.061uM|P54760|EPHRIN TYPE-B RECEPTOR 4|7.21|IC=61nM|IC50|=|61|nM|61|nM
3KGA|2.55|2010|LX9|IC50=0.061+/-0.006uM|P49137|MAP KINASE-ACTIVATED PROTEIN KINASE 2|7.21|IC=61nM|IC50|=|61|nM|61|nM
3H0S|2.43|2010|B38|compound 7|Q00955|ACETYL-COA CARBOXYLASE|6.2|IC=634nM|IC50|=|634|nM|634|nM
2X4S|2.55|2010|9-mer|H5N1 (AVIAN FLU) nucleoprotein (AMDSNTLEL); IC50=63+/-0.1uM|P01892|HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2.1|4.2|IC=63uM|IC50|=|63|uM|63000|nM
3NOK|1.65|2010|DDQ|Mutation: L55F; for detergent additive DDQ, IC50= 64+/-60uM; for another buffer ligand MES, IC50=81+/-5mM;|E7FH78|GLUTAMINYL CYCLASE|4.19|IC=64uM|IC50|=|64|uM|64000|nM
3MY5|2.10|2010|RFZ|with cyclinA|P24941|CELL DIVISION PROTEIN KINASE 2|4.19|IC=65uM|IC50|=|65|uM|65000|nM
3OWL|2.10|2010|19E|Fragment: UNP RESIDUES 1-331;|Q5U5J2|CSNK2A1 PROTEIN|6.17|IC=670nM|IC50|=|670|nM|670|nM
3PUP|2.99|2010|OS1|Ru containing|P49841|GLYCOGEN SYNTHASE KINASE-3 BETA|8.22|IC=6nM|IC50|=|6|nM|6|nM
2XOW|2.09|2010|ISM|covalent complex, IC50~6uM|P09391|RHOMBOID PROTEASE GLPG|5.22|IC=6uM|IC50|=|6|uM|6000|nM
2XWY|2.53|2010|IB8|compound 33; IC50=6+/-3uM|P26663|RNA-DIRECTED RNA POLYMERASE|5.22|IC=6uM|IC50|=|6|uM|6000|nM
3N5J|2.35|2010|GO1|compound 10|P14324|FARNESYL PYROPHOSPHATE SYNTHASE|5.22|IC=6uM|IC50|=|6|uM|6000|nM
3O6T|2.40|2010|PX5|covalent complex; IC50(MtbTrxC)X-ray(MtbTrxCC40S); IC50<6uM|P0A616|THIOREDOXIN|5.22|IC=6uM|IC50|=|6|uM|6000|nM
3LXG|2.30|2010|Z73|ligand WEB-3|Q9QYJ6|PHOSPHODIESTERASE|8.14|IC=7.28nM|IC50|=|7.28|nM|7.28|nM
2X4T|2.30|2010|9-mer|NLVPMVATV peptide|P01892|HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2.1|5.13|IC=7.33uM|IC50|=|7.33|uM|7330|nM
3O8G|1.90|2010|O8G|compound BDM14801|P96222|TRANSCRIPTIONAL REGULATORY REPRESSOR PROTEIN|5.13|IC=7.4uM|IC50|=|7.4|uM|7400|nM
3HNB|1.15|2010|768|compound 005B10|P00451|COAGULATION FACTOR VIII|5.11|IC=7.8uM|IC50|=|7.8|uM|7800|nM
3GWT|1.75|2010|066|compound 4, pIC50=11.1|Q07343|CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B|11.1|IC=7.94pM|IC50|=|7.94|pM|0.007940000000000001|nM
3L5C|1.80|2010|BDQ|compound 31|P56817|BETA-SECRETASE 1|5.15|IC=7000nM|IC50|=|7000|nM|7000|nM
3OKI|2.00|2010|OKI|compound 1a; with incomplete 14-mer coactivator|Q96RI1|BILE ACID RECEPTOR|7.15|IC=70nM|IC50|=|70|nM|70|nM
2XCK|2.30|2010|MH4|compound 4|O15530|3-PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE 1|6.15|IC=713nM|IC50|=|713|nM|713|nM
3ODK|2.30|2010|ODK|compound 3; IC50(Pin1); X-ray(Pin1R14A)|Q13526|PEPTIDYL-PROLYL CIS-TRANS ISOMERASE NIMA-INTERACTIN|3.14|IC=720uM|IC50|=|720|uM|720000|nM
3OW3|1.90|2010|SMY|compound 26; IC50=742+/-69nM|P05132|CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTIC|6.13|IC=742nM|IC50|=|742|nM|742|nM
3NZS|2.75|2010|NZS|compound1d; IC50(PI3K alpha); X-ray(PI3K gamma)|P48736|PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE|7.12|IC=75nM|IC50|=|75|nM|75|nM
3MSJ|1.80|2010|EV3|compound 3|P56817|BETA-SECRETASE 1|3.11|IC=770uM|IC50|=|770|uM|770000|nM
3L5D|1.75|2010|BDV|compound 32|P56817|BETA-SECRETASE 1|4.11|IC=78000nM|IC50|=|78000|nM|78000|nM
3HO9|1.90|2010|N3A|compound 3a, Platencin A1|P0AAI5|3-OXOACYL-[ACYL-CARRIER-PROTEIN] SYNTHASE 2|6.1|IC=789nM|IC50|=|789|nM|789|nM
3OUH|2.51|2010|014|Fe2+ containing pIC50=7.1|Q9GZT9|EGL NINE HOMOLOG 1|7.1|IC=79nM|IC50|=|79|nM|79|nM
2XUC|2.30|2010|XRG|Fragment: RESIDUES 29-337 ; IC50=79+/-8uM;|Q873Y0|CHITINASE|4.1|IC=79uM|IC50|=|79|uM|79000|nM
2WXI|2.80|2010|S30|Supplementary information; compound SW30|Q3UDT3|PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE|8.15|IC=7nM|IC50|=|7|nM|7|nM
3G0B|2.25|2010|T22|compound 27b; IC50=7+/-2nM|P27487|DIPEPTIDYL PEPTIDASE 4|8.15|IC=7nM|IC50|=|7|nM|7|nM
3KB7|2.50|2010|071|compound 49|P53350|SERINE/THREONINE-PROTEIN KINASE PLK1|8.15|IC=7nM|IC50|=|7|nM|7|nM
3L54|2.30|2010|LXX|compound 6; IC50=7nM for PI3K alpha, X-ray: PI3K gamma|P48736|PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE|8.15|IC=7nM|IC50|=|7|nM|7|nM
3NW6|2.20|2010|LGW|compound 11a|P08069|INSULIN-LIKE GROWTH FACTOR 1 RECEPTOR|8.15|IC=7nM|IC50|=|7|nM|7|nM
3NWW|2.09|2010|3NW|compound 41, X-ray(unphosphorylated p38 alpha)|Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|8.15|IC=7nM|IC50|=|7|nM|7|nM
3MSL|2.40|2010|EV5|compound 14i|P56817|BETA-SECRETASE 1|5.15|IC=7uM|IC50|=|7|uM|7000|nM
3N49|2.50|2010|3N4|compound 7|P14324|FARNESYL PYROPHOSPHATE SYNTHASE|5.15|IC=7uM|IC50|=|7|uM|7000|nM
3OXZ|2.20|2010|0LI|compound Ponatinib;|P00520|TYROSINE-PROTEIN KINASE ABL1|8.07|IC=8.6nM|IC50|=|8.6|nM|8.6|nM
3OVZ|2.02|2010|O96|compound 26; covalent complex|P43235|CATHEPSIN K|8.06|IC=8.7nM|IC50|=|8.7|nM|8.7|nM
2X6I|3.40|2010|090|supplementary information; compound PIK-90|Q9W1M7|PHOSPHOTIDYLINOSITOL 3 KINASE 59F|6.08|IC=830nM|IC50|=|830|nM|830|nM
3NW5|2.14|2010|LGX|compound 11b|P08069|INSULIN-LIKE GROWTH FACTOR 1 RECEPTOR|5.08|IC=8400nM|IC50|=|8400|nM|8400|nM
3H0Q|2.50|2010|B37|compound 3|Q00955|ACETYL-COA CARBOXYLASE|6.07|IC=842nM|IC50|=|842|nM|842|nM
2X5O|1.46|2010|VSV|compound (R)-32; IC501=85+/-3uM; IC502=35+/-1uM(Radioactivity assay.)|P14900|UDP-N-ACETYLMURAMOYLALANINE-D-GLUTAMATE LIGASE|4.07|IC=85uM|IC50|=|85|uM|85000|nM
2WD3|1.80|2010|MS4|compound 23; IC50=86+/-8nM|P00918|CARBONIC ANHYDRASE 2|7.07|IC=86nM|IC50|=|86|nM|86|nM
3FH5|1.63|2010|24P|compound 14; IC501=87nM(enzyme); IC502=449nM(HWB)|P09960|LEUKOTRIENE A-4 HYDROLASE|7.06|IC=87nM|IC50|=|87|nM|87|nM
3K3H|2.50|2010|BYE|compound 1s; IC50=88+/-17nM|O76083|CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE-9|7.06|IC=88nM|IC50|=|88|nM|88|nM
2WPA|2.51|2010|889|compound 31|P24941|CELL DIVISION PROTEIN KINASE 2|8.1|IC=8nM|IC50|=|8|nM|8|nM
3ION|2.40|2010|8H1|compound 9h|O15530|3-PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE 1|8.1|IC=8nM|IC50|=|8|nM|8|nM
3L58|1.80|2010|CS5|BACE Bound to SCH589432, compound 1|P56817|BETA-SECRETASE 1|8.1|IC=8nM|IC50|=|8|nM|8|nM
3L8V|2.40|2010|L8V|IC50=0.008uM|P08581|HEPATOCYTE GROWTH FACTOR RECEPTOR|8.1|IC=8nM|IC50|=|8|nM|8|nM
3L9H|2.00|2010|EMQ||P52732|KINESIN-LIKE PROTEIN KIF11|8.1|IC=8nM|IC50|=|8|nM|8|nM
3LXS|1.50|2010|4MC|WRR-483, compound 2, IC50=70+/-30 nM (at PH 5.5), IC50=8+/-2 nM (at PH 8.0)|P25779|CRUZIPAIN|8.1|IC=8nM|IC50|=|8|nM|8|nM
3NIF|2.40|2010|NIF|IC50=6-12uM|P08514|INTEGRIN ALPHAIIB BETA3|5.1|IC=8uM|IC50|=|8|uM|8000|nM
3IIT|1.80|2010|D14|compound 45c; incomplete ligand structure|P00742|COAGULATION FACTOR XA, HEAVY CHAIN|8.02|IC=9.5nM|IC50|=|9.5|nM|9.5|nM
2WXO|2.49|2010|ZZP|Supplementary information; compound AS5|Q3UDT3|PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE|7.05|IC=90nM|IC50|=|90|nM|90|nM
3OQF|2.78|2010|S51|compound 2m|P00797|RENIN|7.04|IC=91nM|IC50|=|91|nM|91|nM
3NZC|2.00|2010|D2O|compound 5; X-ray, IC50(pcDHFR); IC50=170nM(rat DHFR)|P16184|DIHYDROFOLATE REDUCTASE|7.02|IC=96nM|IC50|=|96|nM|96|nM
2WXH|1.90|2010|ZZO|Supplementary information; compound SW14|Q3UDT3|PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE|8.05|IC=9nM|IC50|=|9|nM|9|nM
3MWU|1.98|2010|BK3|IC50= 9 +/- 0.5 nM; Fragment: CpCDPK1; Mutation: N-terminal 69 residues replaced with His tag and linker;|A3FQ16|CALMODULIN-DOMAIN PROTEIN KINASE 1|8.05|IC=9nM|IC50|=|9|nM|9|nM
3NNW|1.89|2010|EDD|compound 16(U-p38)|Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|8.05|IC=9nM|IC50|=|9|nM|9|nM
3OT8|1.65|2010|MI5|compound 17r|O14757|SERINE/THREONINE-PROTEIN KINASE CHK1|8.05|IC=9nM|IC50|=|9|nM|9|nM
3FTZ|2.00|2010|848|compound 8; IC50>2mM|P09960|LEUKOTRIENE A-4 HYDROLASE|2.7|IC>2mM|IC50|>|2|mM|2000000|nM
3N1W|2.56|2010|3N2|IC50>500um; compound 1|P14324|FARNESYL PYROPHOSPHATE SYNTHASE|3.3|IC>500uM|IC50|>|500|uM|500000|nM
3N45|1.88|2010|3N3|IC50>500um; compound 4|P14324|FARNESYL PYROPHOSPHATE SYNTHASE|3.3|IC>500uM|IC50|>|500|uM|500000|nM
3N3L|2.74|2010|MS0|IC50>500um; compound 3|P14324|FARNESYL PYROPHOSPHATE SYNTHASE|3.3|IC>500uM|IC50|>|500|uM|500000|nM
3K98|2.40|2010|1RC|compound 15; Kd<1nM; IC50=0.3uM|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|9.0|Kd<1nM|Kd|<|1|nM|1|nM
3LZS|1.95|2010|017|ligand is Darunavir, Kd=0.0109+/-0.0003nM|Q9QB59|HIV-1 PROTEASE|10.96|Kd=0.0109nM|Kd|=|0.0109|nM|0.0109|nM
3LZV|2.15|2010|017|ligand is Darunavir, Kd=0.026+/-0.005nM; redundant to 3ekt|P03369|HIV-1 PROTEASE|10.59|Kd=0.026nM|Kd|=|0.026|nM|0.026|nM
3MYG|2.40|2010|EML||O14965|SERINE/THREONINE-PROTEIN KINASE 6|10.7|Kd=0.02nM|Kd|=|0.02|nM|0.02|nM
3I02|2.60|2010|KDA&KDO|Kdo(2.4)Kdo(2.4)Kdo, Kd1 = 0.03+/-0.001uM(immobilized glycoconjugates); Kd2 =0.05+/-0.003uM( solution affinity to free oligosaccharides)|------|IMMUNOGLOBULIN LIGHT CHAIN|7.52|Kd=0.03uM|Kd|=|0.03|uM|30|nM
3M5E|1.70|2010|JDR|ligand is compound 7b, affinity at 37C|P00918|CARBONIC ANHYDRASE 2|7.37|Kd=0.043uM|Kd|=|0.043|uM|43|nM
3MHL|1.90|2010|J71|ligand is compound 10b, affinity at 37C|P00918|CARBONIC ANHYDRASE 2|7.25|Kd=0.056uM|Kd|=|0.056|uM|56|nM
3HU2|2.85|2010|AGS|Kd=0.06+/-0.03uM|P55072|TRANSITIONAL ENDOPLASMIC RETICULUM ATPASE|7.22|Kd=0.06uM|Kd|=|0.06|uM|60|nM
3LZU|1.76|2010|017|ligand is Darunavir, Kd=0.087+/-0.062nM|Q9QB59|HIV-1 PROTEASE|10.06|Kd=0.087nM|Kd|=|0.087|nM|0.087|nM
3HU3|2.20|2010|AGS|Kd=0.13+/-0.01uM|P55072|TRANSITIONAL ENDOPLASMIC RETICULUM ATPASE|6.89|Kd=0.13uM|Kd|=|0.13|uM|130|nM
3HU1|2.81|2010|AGS|Kd=0.13+/-0.02uM|P55072|TRANSITIONAL ENDOPLASMIC RETICULUM ATPASE|6.89|Kd=0.13uM|Kd|=|0.13|uM|130|nM
3PSL|1.70|2010|6-mer|N-alpha acetylated form of histone H3, N-alpha-H3, Kd=0.13+/-0.02uM|P61964|WD REPEAT-CONTAINING PROTEIN 5|6.89|Kd=0.13uM|Kd|=|0.13|uM|130|nM
3KDB|1.66|2010|006|ligand is KNI-10006; Kd=0.14+/-0.04nM|P03367|HIV-1 PROTEASE|9.85|Kd=0.14nM|Kd|=|0.14|nM|0.14|nM
3IET|2.20|2010|9-mer|glycopeptide, truly tumor-specific glycopeptide containing the Tn antigen|A8Y5F6|ANTIBODY FAB LIGHT CHAIN (IGG2A)|6.85|Kd=0.14uM|Kd|=|0.14|uM|140|nM
3M3X|1.68|2010|JS7|ligand is compound 10c, affinity at 37C|P00918|CARBONIC ANHYDRASE 2|6.82|Kd=0.15uM|Kd|=|0.15|uM|150|nM
3LXK|2.00|2010|MI1|ligand is compound CP-690550|P52333|TYROSINE-PROTEIN KINASE JAK3|9.8|Kd=0.16nM|Kd|=|0.16|nM|0.16|nM
3M40|1.60|2010|J45|ligand is compound 5a, affinity at 37C|P00918|CARBONIC ANHYDRASE 2|6.77|Kd=0.17uM|Kd|=|0.17|uM|170|nM
3M67|1.80|2010|E36|Kd=0.02uM(thermal shift assay), Kd=0.18uM (ITC)|P00918|CARBONIC ANHYDRASE 2|6.74|Kd=0.18uM|Kd|=|0.18|uM|180|nM
3FSM|1.60|2010|2NC||P03369|COVALENT DIMER [L-ALA51, D-ALA51'] HIV-1 PROTEASE|7.0|Kd=0.1uM|Kd|=|0.1|uM|100|nM
3HZY|2.10|2010|KDA&KDO|Kdo(2.4)Kdo(2.4)Kdo, Kd =0.1+/-0.005uM( solution affinity to free oligosaccharides)|------|ANTIBODY S73-2 FAB (IGG1K), LIGHT CHAIN|7.0|Kd=0.1uM|Kd|=|0.1|uM|100|nM
3KDM|1.50|2010|TES|IC50=900nM|------|IMMUNOGLOBULIN LIGHT CHAIN|7.0|Kd=0.1uM|Kd|=|0.1|uM|100|nM
3MHM|1.50|2010|J75|ligand is compound 8b, affinity at 37C|P00918|CARBONIC ANHYDRASE 2|7.0|Kd=0.1uM|Kd|=|0.1|uM|100|nM
2KPL|NMR|2010|11-mer|ligand is 11-mer C-terminus of HPV16 E6; MAGI-1 PDZ1 / E6CT, Kd=0.23+/-0.02uM|Q96QZ7|MEMBRANE-ASSOCIATED GUANYLATE KINASE, WW AND PDZ DO|6.64|Kd=0.23uM|Kd|=|0.23|uM|230|nM
2XHX|2.80|2010|T5M|compound 24|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|6.6|Kd=0.25uM|Kd|=|0.25|uM|250|nM
3IP6|1.40|2010|PRO||Q7CX36|ABC TRANSPORTER, SUBSTRATE BINDING PROTEIN|6.6|Kd=0.25uM|Kd|=|0.25|uM|250|nM
3KMM|2.80|2010|LHL|ligand is compound 1|P06239|TYROSINE-PROTEIN KINASE LCK|9.7|Kd=0.2nM|Kd|=|0.2|nM|0.2|nM
2KUP|NMR|2010|19-mer|ligand is 19-residue peptide from ALK tyrosine kinase receptor, calculated using the AMBER9 software|O43559|FIBROBLAST GROWTH FACTOR RECEPTOR SUBSTRATE 3|6.7|Kd=0.2uM|Kd|=|0.2|uM|200|nM
3HZK|2.15|2010|KDA&KDO|Kdo(2.4)Kdo, Kd=0.2+/-0.02uM(immobilized glycoconjugates); Kd=0.3+/-0.01uM(solution affinity to free oligosaccharides)|------|ANTIBODY FAB FARGMENT S73-2|6.7|Kd=0.2uM|Kd|=|0.2|uM|200|nM
3MHI|1.70|2010|J90|ligand is compound 11b, affinity at 37C|P00918|CARBONIC ANHYDRASE 2|6.7|Kd=0.2uM|Kd|=|0.2|uM|200|nM
3LHJ|3.31|2010|LHJ|Ki=2.3nM|Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|9.51|Kd=0.31nM|Kd|=|0.31|nM|0.31|nM
2XJJ|1.90|2010|L81|ligand is compound 4; IC50=25uM|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|6.51|Kd=0.31uM|Kd|=|0.31|uM|310|nM
3MHO|1.15|2010|J43|ligand is compound 7a, affinity at 37C|P00918|CARBONIC ANHYDRASE 2|6.49|Kd=0.32uM|Kd|=|0.32|uM|320|nM
3NW3|2.50|2010|MU2|ligand is MDP|Q9GK12|PEPTIDOGLYCAN RECOGNITION PROTEIN 1|6.49|Kd=0.32uM|Kd|=|0.32|uM|320|nM
3OGX|2.80|2010|H1S||Q9GK12|PEPTIDOGLYCAN RECOGNITION PROTEIN 1|6.48|Kd=0.33uM|Kd|=|0.33|uM|330|nM
2XDX|2.42|2010|WOE|ligand is compound 6|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|6.46|Kd=0.35uM|Kd|=|0.35|uM|350|nM
3HZV|1.90|2010|KDA&KDO|Kdo(2.8)Kdo(2.4)Kdo, Kd=0.3+/-0.03uM(immobilized glycoconjugates); Kd=0.2+/-0.003uM( solution affinity to free oligosaccharides)|------|ANTIBODY S73-2 FAB (IGG1K), LIGHT CHAIN|6.52|Kd=0.3uM|Kd|=|0.3|uM|300|nM
2XUP|2.70|2010|TZ5|ligand is compound 101|P21836|ACETYLCHOLINESTERASE|12.39|Kd=0.41pM|Kd|=|0.41|pM|0.00041|nM
3M3R|2.20|2010|BCD|BETA-CYCLODEXTRIN, Kd=0.48+/-0.05uM|P09616|ALPHA-HEMOLYSIN|6.32|Kd=0.48uM|Kd|=|0.48|uM|480|nM
3LNZ|1.95|2010|12-mer|ligand is 12-mer peptide inhibitor PMI (N8A mutant); incomplete ligand|Q00987|E3 UBIQUITIN-PROTEIN LIGASE MDM2|9.31|Kd=0.49nM|Kd|=|0.49|nM|0.49|nM
3FW4|2.30|2010|CAQ|catechol CFe(III), Fe3+ containing Kd=0.4+/-0.2nM; catechol alone Kd=0.20+/-0.06uM|P80188|NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN|9.4|Kd=0.4nM|Kd|=|0.4|nM|0.4|nM
3K1J|2.00|2010|ADP||B6YU74|ATP-DEPENDENT PROTEASE LON|6.4|Kd=0.4uM|Kd|=|0.4|uM|400|nM
3KDC|2.20|2010|JZP|ligand is KNI-10074; Kd=0.52+/-0.24nM|P03367|HIV-1 PROTEASE|9.28|Kd=0.52nM|Kd|=|0.52|nM|0.52|nM
2XGS|2.39|2010|44P|C-UDP; Kd=0.530+/-0.006mM; human OGT IC50=9.0+/-1.0uM|Q8PC69|XCOGT|3.28|Kd=0.530mM|Kd|=|0.53|mM|530000|nM
2XAB|1.90|2010|VHD|ligand is compound 1; Ic50=31nM|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|9.27|Kd=0.54nM|Kd|=|0.54|nM|0.54|nM
3OAP|2.05|2010|11-mer|ligand:Nuclear receptor coactivator 2(GRIP-1); with REA(9cRA); Kd(ITC)=0.55+/-0.02uM(25oC); Kd(CD spectrum)=0.9+/-0.1uM(25oC)|P19793|RETINOIC ACID RECEPTOR RXR-ALPHA|6.26|Kd=0.55uM|Kd|=|0.55|uM|550|nM
3HCM|2.00|2010|S45|ligand is compound SEN205A; Kd=0.5-1.0mM|P04271|PROTEIN S100-B|3.3|Kd=0.5mM|Kd|=|0.5|mM|500000|nM
3K5V|1.74|2010|STJ|GNF-2 binding to the imatinib/Abl complex, Kd=0.5+/-0.1uM; IC50=0.26uM|P00520|TYROSINE-PROTEIN KINASE ABL1|6.3|Kd=0.5uM|Kd|=|0.5|uM|500|nM
3ME9|1.37|2010|11-mer|Histone H3, Kd=0.5+/-0.2uM(ITC), Kd=2+/-0.3uM(FP); SGF29: Fragment: UNP Residues 115-293; H3: Fragment: UNP Residues 2-9|Q96ES7|SAGA-ASSOCIATED FACTOR 29 HOMOLOG|6.3|Kd=0.5uM|Kd|=|0.5|uM|500|nM
3MEA|1.26|2010|11-mer|Histone H3, Kd=0.5+/-0.2uM(ITC), Kd=2+/-0.3uM(FP); SGF29: Fragment: UNP Residues 129-291; H3: Fragment: UNP Residues 2-4|Q96ES7|SAGA-ASSOCIATED FACTOR 29 HOMOLOG|6.3|Kd=0.5uM|Kd|=|0.5|uM|500|nM
3MEU|1.28|2010|14-mer|Histone H3, Kd=0.5+/-0.1uM(ITC); SGF29: Fragment: UNP Residues 115-293; H3: Fragment: UNP Residues 2-14|Q96ES7|SAGA-ASSOCIATED FACTOR 29 HOMOLOG|6.3|Kd=0.5uM|Kd|=|0.5|uM|500|nM
3M55|1.55|2010|11-mer|ligand is TAF10-K189me1 peptide; Kd=0.62+/-0.065uM|Q8WTS6|HISTONE-LYSINE N-METHYLTRANSFERASE SETD7|6.21|Kd=0.62uM|Kd|=|0.62|uM|620|nM
3AD8|2.20|2010|PYC|SO-U96 complex with pyrrole 2-carboxylate, inhibit the enzyme competitively with respect to sarcosine, Kd=0.69+/-0.23mM|Q50LF0|SARCOSINE OXIDASE ALPHA SUBUNIT|3.16|Kd=0.69mM|Kd|=|0.69|mM|690000|nM
3M89|2.00|2010|GSP|ligand is GTP-gamma-S|Q8KNP3|FTSZ/TUBULIN-RELATED PROTEIN|6.16|Kd=0.69uM|Kd|=|0.69|uM|690|nM
3ACL|2.35|2010|3F1|ligand is compound A|O00625|PIRIN|6.22|Kd=0.6uM|Kd|=|0.6|uM|600|nM
3IP5|1.35|2010|ALA||Q7CX36|ABC TRANSPORTER, SUBSTRATE BINDING PROTEIN|6.22|Kd=0.6uM|Kd|=|0.6|uM|600|nM
3IPA|1.55|2010|ALA|redundant to 3ip5|Q7CX36|ABC TRANSPORTER, SUBSTRATE BINDING PROTEIN|6.22|Kd=0.6uM|Kd|=|0.6|uM|600|nM
3P2E|1.68|2010|SAH|ligand is compound AdoHcy|A8C927|16S RRNA METHYLASE|6.22|Kd=0.6uM|Kd|=|0.6|uM|600|nM
3PB3|1.90|2010|SAH|ligand is compound AdoHcy; redundant to 3p2e|A8C927|16S RRNA METHYLASE|6.22|Kd=0.6uM|Kd|=|0.6|uM|600|nM
2XJX|1.66|2010|XJX|ligand is compound 35; IC50=48nM|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|9.15|Kd=0.71nM|Kd|=|0.71|nM|0.71|nM
3IG1|2.80|2010|JTH|Kd1=0.73+/-0.09uM(fluor); Kd2=6+/-1uM(SPR); Ki=0.14uM; IC50=0.21uM|P03366|HIV-1 REVERSE TRANSCRIPTASE P66 SUBUNIT|6.14|Kd=0.73uM|Kd|=|0.73|uM|730|nM
3KTR|1.70|2010|17-mer|ataxin-2|P11940|POLYADENYLATE-BINDING PROTEIN 1|6.15|Kd=0.7uM|Kd|=|0.7|uM|700|nM
3OTF|2.40|2010|CMP||Q9Y3Q4|POTASSIUM/SODIUM HYPERPOLARIZATION-ACTIVATED CYCLIC|6.08|Kd=0.83uM|Kd|=|0.83|uM|830|nM
3MO8|1.69|2010|12-mer|Histone H3.2 TRIMETHYLATED H3K36 PEPTIDE, Kd=0.8+/-0.1mM; BRPF1: PWWP domain; Fragment: UNP residues 1079-1207|P55201|PEREGRIN|3.1|Kd=0.8mM|Kd|=|0.8|mM|800000|nM
3LGL|1.60|2010|11-mer|11-mer DIMETHYLATED p53 LYSINE 382 PEPTIDE, Kd=0.9+/-0.4uM; incomplete ligand|Q12888|TUMOR SUPPRESSOR P53-BINDING PROTEIN 1|6.05|Kd=0.9uM|Kd|=|0.9|uM|900|nM
2XUI|2.60|2010|TZ5|compound syn1; 1-wk|P21836|ACETYLCHOLINESTERASE|15.0|Kd=1.0fM|Kd|=|1|fM|1e-06|nM
3K54|1.94|2010|1N1|X-ray(BTK Y551E) while Kd(wild type)|Q06187|TYROSINE-PROTEIN KINASE BTK|9.0|Kd=1.0nM|Kd|=|1|nM|1|nM
3NEX|1.70|2010|G24|ligand is compound GC-24; Kd=1.0+/-0.2uM|P02766|TRANSTHYRETIN|6.0|Kd=1.0uM|Kd|=|1|uM|1000|nM
2XHT|2.27|2010|C0Y|ligand is compound 21; IC50=22uM in cell lines|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|5.96|Kd=1.1uM|Kd|=|1.1|uM|1100|nM
3KGU|1.85|2010|GEN|ligand is genistein, Kd=1.2+/-0.4uM|P02766|TRANSTHYRETIN|5.92|Kd=1.2uM|Kd|=|1.2|uM|1200|nM
3N5U|3.20|2010|13-mer|ligand:Rb C-terminal peptide 870-882; Kd=1.2+/-0.4uM; imcomplete ligand structure|P62136|SERINE/THREONINE-PROTEIN PHOSPHATASE PP1-ALPHA|5.92|Kd=1.2uM|Kd|=|1.2|uM|1200|nM
3NEO|2.00|2010|G24|ligand is compound GC-24; Kd=1.2+/-0.1uM|P02766|TRANSTHYRETIN|5.92|Kd=1.2uM|Kd|=|1.2|uM|1200|nM
2Y3P|2.62|2010|SM8|IC50=0.6uM|P0AES5|DNA GYRASE SUBUNIT A|5.89|Kd=1.3uM|Kd|=|1.3|uM|1300|nM
3M54|1.60|2010|11-mer|ligand is TAF10-K189 peptide; Kd=1.3+/-0.10uM|Q8WTS6|HISTONE-LYSINE N-METHYLTRANSFERASE SETD7|5.89|Kd=1.3uM|Kd|=|1.3|uM|1300|nM
3LKA|1.80|2010|M4S|ligand is compound PMS|P39900|MACROPHAGE METALLOELASTASE (MMP-12)|2.82|Kd=1.5mM|Kd|=|1.5|mM|1500000|nM
3K00|1.55|2010|MTT|ligand is maltotetraose; Kd=1.7+/-0.2uM|B0B0V1|ACARBOSE/MALTOSE BINDING PROTEIN GACH|5.77|Kd=1.7uM|Kd|=|1.7|uM|1700|nM
3GY2|1.57|2010|BRN|ligand is diminazene; Kd=1.80+/-0.05uM|P00760|TRYPSIN|5.74|Kd=1.80uM|Kd|=|1.8|uM|1800|nM
3KR1|2.30|2010|VGD|compound 15; binding data measured with AdoHcy; Kd=1.8+/-0.3 uM|P11086|PHENYLETHANOLAMINE N-METHYLTRANSFERASE|5.74|Kd=1.8uM|Kd|=|1.8|uM|1800|nM
3O0E|3.01|2010|17-mer|ligand:colicin peptide OBS1; Kd=1.8+/-0.1uM; incomplete ligand|C4ZQ55|OUTER MEMBRANE PORIN 1A (IA;B;F)|5.74|Kd=1.8uM|Kd|=|1.8|uM|1800|nM
3LF0|2.40|2010|ATP||P64249|NITROGEN REGULATORY PROTEIN P-II|5.71|Kd=1.93uM|Kd|=|1.93|uM|1930|nM
3K02|1.55|2010|TXT|ligand is compound 5c; Kd=10.0+/-0.6uM|B0B0V1|ACARBOSE/MALTOSE BINDING PROTEIN GACH|5.0|Kd=10.0uM|Kd|=|10|uM|10000|nM
3LLE|1.85|2010|SGE|compound SC0844, Kd=10.7+/-4.9 uM; IC50=35.9+/-16.4 uM|P02638|PROTEIN S100-B|4.97|Kd=10.7uM|Kd|=|10.7|uM|10700|nM
2KP8|NMR|2010|XIG|compound 1|------|MODEL PEPTIDE|4.0|Kd=100uM|Kd|=|100|uM|100000|nM
3HUC|1.80|2010|G97|ligand is compound 6; Kd=1030+/-180nM|Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|5.99|Kd=1030nM|Kd|=|1030|nM|1030|nM
2KVM|NMR|2010|16-mer|ligand is H3K27me2 peptide; Kd=108.4+/-7.4uM, for H3K27me3 peptide Kd=59+/-4.7uM|Q8VDS3|CHROMOBOX PROTEIN HOMOLOG 7|3.96|Kd=108.4uM|Kd|=|108.4|uM|108400|nM
3L8X|2.40|2010|N4D|compound 2e|Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|8.0|Kd=10nM|Kd|=|10|nM|10|nM
3NGA|2.71|2010|3NG|compound CX-4945; Kd<10nM; IC50=13nM|P68400|CASEIN KINASE II, ALPHA SUBUNIT|8.0|Kd=10nM|Kd|=|10|nM|10|nM
3NEW|2.51|2010|3NE|compound 10; IC50=1.2uM|Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|5.0|Kd=10uM|Kd|=|10|uM|10000|nM
3OMC|1.77|2010|8-mer|incomplete ligand|Q7KZF4|STAPHYLOCOCCAL NUCLEASE DOMAIN-CONTAINING PROTEIN 1|5.0|Kd=10uM|Kd|=|10|uM|10000|nM
3IQJ|1.15|2010|10-mer|Kd=11.7+/-2.5uM; incomplete ligand|P31947|14-3-3 PROTEIN SIGMA|4.93|Kd=11.7uM|Kd|=|11.7|uM|11700|nM
2WIB|2.56|2010|GDP|Kd=11.8+/-1.48uM|A6TF32|FERROUS IRON TRANSPORT PROTEIN B|4.93|Kd=11.8uM|Kd|=|11.8|uM|11800|nM
2W97|2.29|2010|GOL|Kd1 = 110mM(in the presence of 30% NH4SO4); Kd2 =167mM(in the absence of NH4SO4).|P06730|EUKARYOTIC TRANSLATION INITIATION FACTOR 4E|0.96|Kd=110mM|Kd|=|110|mM|110000000|nM
2L1B|NMR|2010|15-mer|protein 1 Fragment: UNP Residues 7-62 ; protein 2 Fragment: UNP Residues 20-34 ; Kd=110+/-17uM;|O95931|CHROMOBOX PROTEIN HOMOLOG 7|3.96|Kd=110uM|Kd|=|110|uM|110000|nM
3KZE|1.80|2010|8-mer|Ac-SSRKEYYA Peptide, Kd=112+/-15uM|Q13009|T-LYMPHOMA INVASION AND METASTASIS-INDUCING PROTEIN 1|3.95|Kd=112uM|Kd|=|112|uM|112000|nM
3LUO|2.55|2010|6-mer|Suc-Ala-Leu-Pro-Phe-pNA, Kd=51+/-21nM(FP), Kd=113+/-20nM(ITC)|Q5SLE7|PEPTIDYL-PROLYL CIS-TRANS ISOMERASE SLYD|6.95|Kd=113nM|Kd|=|113|nM|113|nM
3A5Y|1.90|2010|KAA|ligand is compound LysAMS|C3SGA2|LYSYL-TRNA SYNTHETASE|7.96|Kd=11nM|Kd|=|11|nM|11|nM
3M5A|1.75|2010|11-mer|ligand is TAF10-K189me3 peptide; Kd=11+/-0.28uM|Q8WTS6|HISTONE-LYSINE N-METHYLTRANSFERASE SETD7|4.96|Kd=11uM|Kd|=|11|uM|11000|nM
3MMR|2.14|2010|ABH|Kd=11+/-2 uM(pH=8.0); Ki=11+/-2 uM (pH=7.4); Ki=12+/-2 uM (pH=8.0); Ki=10+/-1 uM (pH=8.5)|Q8I384|ARGINASE|4.96|Kd=11uM|Kd|=|11|uM|11000|nM
3NIN|2.10|2010|5-mer|incomplete ligand structure|P19812|E3 UBIQUITIN-PROTEIN LIGASE UBR1|4.91|Kd=12.4uM|Kd|=|12.4|uM|12400|nM
3JUK|2.30|2010|UPG||O25363|UDP-GLUCOSE PYROPHOSPHORYLASE (GALU)|4.89|Kd=12.9uM|Kd|=|12.9|uM|12900|nM
3M8U|1.85|2010|GDS|glutathione disulfide(GSSG), Kd=12.9+/-0.3uM measured at T=37C|B8F653|HEME-BINDING PROTEIN A|4.89|Kd=12.9uM|Kd|=|12.9|uM|12900|nM
3NIJ|2.10|2010|4-mer|ligand:Peptide HIAA, incomplete ligand structure; Zn-containing; Kd=12.9+/-0.856uM(lower pH ITC2, pH6.5)|P19812|E3 UBIQUITIN-PROTEIN LIGASE UBR1|4.89|Kd=12.9uM|Kd|=|12.9|uM|12900|nM
3IES|2.00|2010|M24|ligand is PTC124-AMP; Kd=120+/-30pM|P08659|LUCIFERIN 4-MONOOXYGENASE|9.92|Kd=120pM|Kd|=|120|pM|0.12|nM
3L5B|1.80|2010|BDO|compound 23|P56817|BETA-SECRETASE 1|3.91|Kd=123uM|Kd|=|123|uM|123000|nM
3LP4|1.90|2010|LYS||P05089|ARGINASE-1|4.88|Kd=13.1uM|Kd|=|13.1|uM|13100|nM
3OBX|1.60|2010|9-mer|Gag PTAP P7A mutant peptide; Kd=130+/-4uM|Q99816|TUMOR SUSCEPTIBILITY GENE 101 PROTEIN|3.89|Kd=130uM|Kd|=|130|uM|130000|nM
3MO5|2.14|2010|E72|Kd=136+/-22nM; IC50=100+/-3nM; structure:with AdoHcy|Q9H9B1|HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-9 SPECIFIC|6.87|Kd=136nM|Kd|=|136|nM|136|nM
3LBZ|2.30|2010|Z89|ligand is inhibitor 79-6, binding data in supporting info, Kd=138+/-31uM, Ki=147uM, IC50=212uM|P41182|B-CELL LYMPHOMA 6 PROTEIN|3.86|Kd=138uM|Kd|=|138|uM|138000|nM
3KQO|2.40|2010|ES4|compound 10; binding data measured with AdoHcy; Kd=140+/-27 uM|P11086|PHENYLETHANOLAMINE N-METHYLTRANSFERASE|3.85|Kd=140uM|Kd|=|140|uM|140000|nM
3LZZ|2.50|2010|GDP|Kd=159+/-51uM (physiological concentration of GDP); Kd=146+/-11uM(radient concentration of GDP)|Q6WRH7|PUTATIVE UNCHARACTERIZED PROTEIN|3.84|Kd=146uM|Kd|=|146|uM|146000|nM
3KPW|2.40|2010|1SQ|compound 3; measured with AdoHcy; Kd=14+/-2 uM|P11086|PHENYLETHANOLAMINE N-METHYLTRANSFERASE|4.85|Kd=14uM|Kd|=|14|uM|14000|nM
3MO0|2.78|2010|E11|Kd=154+/-9nM; IC50=778+/-25nM; X-ray:with AdoHcy|Q9H9B1|HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-9 SPECIFIC|6.81|Kd=154nM|Kd|=|154|nM|154|nM
2XJG|2.25|2010|XJG|ligand is compound 2; IC50=2.5uM|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|7.82|Kd=15nM|Kd|=|15|nM|15|nM
3MJ1|1.72|2010|614|inhibitor RO5191614|Q08881|TYROSINE-PROTEIN KINASE ITK/TSK|7.82|Kd=15nM|Kd|=|15|nM|15|nM
2L0I|NMR|2010|14-mer|ligand is Ser2 diheptad phosphorylated CTD peptide, NMR; Kd=15+/-10uM; incomplete ligand|Q05543|REGULATOR OF TY1 TRANSPOSITION PROTEIN 103|4.82|Kd=15uM|Kd|=|15|uM|15000|nM
2L11|NMR|2010|15-mer|protein 1 Fragment: UNP Residues 29-81 ; protein 2 Fragment: UNP Residues 2-16 ; Kd=15+/-8uM;|Q13185|CHROMOBOX PROTEIN HOMOLOG 3|4.82|Kd=15uM|Kd|=|15|uM|15000|nM
3KMX|1.70|2010|G00|Kd=15+/-7uM|P56817|BETA-SECRETASE 1|4.82|Kd=15uM|Kd|=|15|uM|15000|nM
3KQY|2.20|2010|ES0|compound 13; with AdoHcy; Kd=15+/-1 uM|P11086|PHENYLETHANOLAMINE N-METHYLTRANSFERASE|4.82|Kd=15uM|Kd|=|15|uM|15000|nM
3LXO|1.55|2010|T3P|Kd=15+/-0.9uM|P61823|RIBONUCLEASE|4.82|Kd=15uM|Kd|=|15|uM|15000|nM
2RR4|NMR|2010|10-mer|zf-CW domain and the H3K4me3 peptide, Histone H3 H3K4me3 peptide|Q9H0M4|ZINC FINGER CW-TYPE PWWP DOMAIN PROTEIN 1|4.78|Kd=16.7uM|Kd|=|16.7|uM|16700|nM
3KYF|2.10|2010|5GP|PP4397, Kd=165.0+/-76.9nM|Q88EQ6|PUTATIVE UNCHARACTERIZED PROTEIN|6.78|Kd=165.0nM|Kd|=|165|nM|165|nM
3NQ3|1.90|2010|DKA|ligand is capric acid; Ka=6.0+/-0.5*10^3M-1|P02754|BETA-LACTOGLOBULIN|3.78|Kd=167uM|Kd|=|167|uM|167000|nM
3G5V|2.00|2010|16-mer|Epidermal Growth Factor Receptor peptide; Kd1=16+/-8nM(Pms-serine coupling); Kd2=84+/-3nM(Thiol coupling); Kd3=85+/-0.3nM(Amine coupling)|P00533|806 LIGHT CHAIN|7.8|Kd=16nM|Kd|=|16|nM|16|nM
3IQU|1.05|2010|6-mer|Kd=17.0+/-1.6uM|P31947|14-3-3 PROTEIN SIGMA|4.77|Kd=17.0uM|Kd|=|17|uM|17000|nM
3HDK|1.80|2010|2NC||P03369|[AIB51/51']HIV-1 PROTEASE|4.76|Kd=17.5uM|Kd|=|17.5|uM|17500|nM
3NIM|2.00|2010|4-mer|Zn-containing; Kd=17.7+/-0.325uM (ITC, pH=8)|P19812|E3 UBIQUITIN-PROTEIN LIGASE UBR1|4.75|Kd=17.7uM|Kd|=|17.7|uM|17700|nM
3KQM|2.40|2010|ES3|compound 5; with AdoHcy; Kd=170+/-16 uM|P11086|PHENYLETHANOLAMINE N-METHYLTRANSFERASE|3.77|Kd=170uM|Kd|=|170|uM|170000|nM
2XG3|1.20|2010|3-mer|ligand L2; Kd=18.2+/-0.2uM, 3 separated ligand structures|P17931|GALECTIN-3|4.74|Kd=18.2uM|Kd|=|18.2|uM|18200|nM
3N6K|2.25|2010|BFH|Kd=184+/-25nm(from SI); IC50=0.2+/-0.06um; compound 11|P14324|FARNESYL PYROPHOSPHATE SYNTHASE|6.74|Kd=180nM|Kd|=|180|nM|180|nM
2WQ5|1.65|2010|MIY||P15445|PHOSPHOLIPASE A2|3.74|Kd=180uM|Kd|=|180|uM|180000|nM
3KPV|2.40|2010|ADE|compound 2; with AdoHcy; Kd=180+/-90 uM|P11086|PHENYLETHANOLAMINE N-METHYLTRANSFERASE|3.74|Kd=180uM|Kd|=|180|uM|180000|nM
3LCV|2.00|2010|SAM|ligand is adoMet (S-adenosylmethionine)|Q7M0R2|SISOMICIN-GENTAMICIN RESISTANCE METHYLASE SGM|4.74|Kd=18uM|Kd|=|18|uM|18000|nM
3LLM|2.80|2010|ADP|ligand is mADP|Q08211|ATP-DEPENDENT RNA HELICASE A|4.74|Kd=18uM|Kd|=|18|uM|18000|nM
3NY3|1.60|2010|4-mer|ligand is RIFS; Kd=19.3+/-2.6uM|Q8IWV8|E3 UBIQUITIN-PROTEIN LIGASE UBR2|4.71|Kd=19.3uM|Kd|=|19.3|uM|19300|nM
3LK8|1.80|2010|Z79|ligand is compound 3|P39900|MACROPHAGE METALLOELASTASE (MMP-12)|7.71|Kd=19.7nM|Kd|=|19.7|nM|19.7|nM
2X2C|2.41|2010|11-mer|ligand is cyclosporine; Kd=19+/-2nM; Ki=27+/-5.6nM.|P62937|PEPTIDYL-PROLYL CIS-TRANS ISOMERASE A|7.72|Kd=19nM|Kd|=|19|nM|19|nM
2WZY|2.51|2010|SQX|ligand is SPX (13-desmethyl spirolide C), Kd=0.019nM|Q8WSF8|ACETYLCHOLINE RECEPTOR|10.72|Kd=19pM|Kd|=|19|pM|0.019|nM
3OKP|2.00|2010|GDD|orthorhombic crystal form; Kd=19+/-4.6uM|Q8NNK8|GDP-MANNOSE-DEPENDENT ALPHA-(1-6)-PHOSPHATIDYLINOSI|4.72|Kd=19uM|Kd|=|19|uM|19000|nM
3OKA|2.20|2010|GDD|triclinic crystal form; Kd=19+/-4.6uM; redundant to 3okp|Q8NNK8|ALPHA-MANNOSYLTRANSFERASE|4.72|Kd=19uM|Kd|=|19|uM|19000|nM
3OMG|1.85|2010|8-mer|incomplete ligand|Q7KZF4|STAPHYLOCOCCAL NUCLEASE DOMAIN-CONTAINING PROTEIN 1|4.72|Kd=19uM|Kd|=|19|uM|19000|nM
2XGM|2.55|2010|LXN|compound alloxan, Kd>1mM; human OGT IC50=18+/-1uM|Q8PC69|XCOGT|3.0|Kd=1mM|Kd|=|1|mM|1000000|nM
2XGO|2.60|2010|ZKD|UDP-S-GLCNAC; Kd>1mM; human OGT IC50=93+/-15uM|Q8PC69|XCOGT|3.0|Kd=1mM|Kd|=|1|mM|1000000|nM
3JRX|2.50|2010|S1A|ligand is compound soraphen A|O00763|ACETYL-COA CARBOXYLASE 2|9.0|Kd=1nM|Kd|=|1|nM|1|nM
2L6E|NMR|2010|14-mer||P35963|CAPSID PROTEIN P24|6.0|Kd=1uM|Kd|=|1|uM|1000|nM
3MET|2.00|2010|11-mer|Histone H3, Kd=1+/-0.1uM(ITC), Kd=4+/-1uM(FP); SGF29: Fragment: UNP Residues 115-293; H3: Fragment: UNP Residues 2-12|Q96ES7|SAGA-ASSOCIATED FACTOR 29 HOMOLOG|6.0|Kd=1uM|Kd|=|1|uM|1000|nM
3NYN|2.72|2010|SGV||P43250|G PROTEIN-COUPLED RECEPTOR KINASE 6|6.0|Kd=1uM|Kd|=|1|uM|1000|nM
3AL3|2.15|2010|10-mer|protein 1 Fragment: BRCT7 and BRCT8, UNP residues 1264-1493 ; peptide Fragment: UNP residues 1129-1138 ; Kd=2.1+/-0.1uM;|Q92547|DNA TOPOISOMERASE 2-BINDING PROTEIN 1|5.68|Kd=2.1uM|Kd|=|2.1|uM|2100|nM
3P4F|2.35|2010|11-mer|Retinoblastoma-binding protein 5, RbBP5 (371-381, Y381D), Kd=2.2+/-0.2 uM, WDR5 Fragment: 1-308; X-ray: RbBP5 (371-381, Y381D), Assay: RbBP5 (371-380)|P61964|WD REPEAT-CONTAINING PROTEIN 5|5.66|Kd=2.2uM|Kd|=|2.2|uM|2200|nM
3L1N|1.30|2010|PLM|ligand is palmitoleic acid, Kd=2.34uM for LBD2|O42721|CELL WALL ANTIGEN|5.63|Kd=2.34uM|Kd|=|2.34|uM|2340|nM
3GY3|1.70|2010|PNT|ligand is pentamidine; Kd=2.36+/-0.19uM|P00760|TRYPSIN|5.63|Kd=2.36uM|Kd|=|2.36|uM|2360|nM
3LPL|2.10|2010|TDP||P0AFG9|PYRUVATE DEHYDROGENASE E1 COMPONENT|5.62|Kd=2.39uM|Kd|=|2.39|uM|2390|nM
3HKW|1.55|2010|IX6|ligand is compound 4; 1b_J4 polymerase; Kd=2.3+/1.7nM, PDB is 1a, but reference indicates 1b|P26664|NS5B RNA-DEPENDENT RNA POLYMERASE|8.64|Kd=2.3nM|Kd|=|2.3|nM|2.3|nM
3IP9|1.80|2010|ABU||Q7CX36|ABC TRANSPORTER, SUBSTRATE BINDING PROTEIN|5.62|Kd=2.4uM|Kd|=|2.4|uM|2400|nM
3NES|1.75|2010|B72|ligand is compound GC-1; Kd=2.4+/-1.2uM|P02766|TRANSTHYRETIN|5.62|Kd=2.4uM|Kd|=|2.4|uM|2400|nM
2X4Z|2.10|2010|X4Z|ligand is compound PF-3758309; Kd=2.7+/-0.3nM; Ki=18.7+/-6.6nM;|O96013|SERINE/THREONINE-PROTEIN KINASE PAK 4|8.57|Kd=2.7nM|Kd|=|2.7|nM|2.7|nM
3IQQ|2.01|2010|12-mer|ligand is 12-mer TRTK12 peptide, CapZ protein; Ca2+ containing; Kd=2.9+/-0.5uM; incomplete ligand|P02638|PROTEIN S100-B|5.54|Kd=2.9uM|Kd|=|2.9|uM|2900|nM
3JYR|1.75|2010|ACR|ligand is acarbose; Kd=2.9+/-0.3uM|P19576|MALTOSE BINDING PERIPLASMIC PROTEIN|5.54|Kd=2.9uM|Kd|=|2.9|uM|2900|nM
2KRD|NMR|2010|17-mer|ligan is Switch Region of cardiac Troponin I (147-163); Kd=154+/-30uM, but in the presence of W7, Kd=2000+/-50uM|P63316|TROPONIN C|2.7|Kd=2000uM|Kd|=|2000|uM|2000000|nM
3KD7|2.85|2010|6-mer|Hsp90 MEEVD peptide|Q9H2A1|CTPR390|3.7|Kd=200uM|Kd|=|200|uM|200000|nM
3L59|2.00|2010|BDJ|ligand is compound 10|P56817|BETA-SECRETASE 1|3.7|Kd=200uM|Kd|=|200|uM|200000|nM
3N7S|2.10|2010|3N6||Q16602|CALCITONIN GENE-RELATED PEPTIDE TYPE 1 RECEPTOR|7.7|Kd=20nM|Kd|=|20|nM|20|nM
3N7R|2.90|2010|N7R|CLR/RAMP1 complex with compound 2 telcagepant, Kd<20nM below the limit of detection|Q16602|CALCITONIN GENE-RELATED PEPTIDE TYPE 1 RECEPTOR|7.7|Kd=20nM|Kd|=|20|nM|20|nM
2WVA|2.20|2010|TPU||P06672|PYRUVATE DECARBOXYLASE|10.7|Kd=20pM|Kd|=|20|pM|0.02|nM
3KR0|2.60|2010|172|compound 14; measured with AdoHcy; Kd=20+/-2.5 uM|P11086|PHENYLETHANOLAMINE N-METHYLTRANSFERASE|4.7|Kd=20uM|Kd|=|20|uM|20000|nM
3LM1|2.10|2010|LEC||P18674|AGGLUTININ ALPHA CHAIN|4.7|Kd=20uM|Kd|=|20|uM|20000|nM
3NKK|1.12|2010|JLZ||P00760|TRYPSIN|4.7|Kd=20uM|Kd|=|20|uM|20000|nM
3P2K|2.70|2010|SAM|compound AdoMet|A8C927|16S RRNA METHYLASE|4.7|Kd=20uM|Kd|=|20|uM|20000|nM
3LNJ|2.40|2010|12-mer|ligand is 12-mer D-peptide inhibitor (DPMI-alpha); Kd=219+/-11 nM; incomplete ligand|Q00987|E3 UBIQUITIN-PROTEIN LIGASE MDM2|6.66|Kd=219nM|Kd|=|219|nM|219|nM
3MIY|1.67|2010|B49|ligand is sunitinib|Q08881|TYROSINE-PROTEIN KINASE ITK/TSK|7.68|Kd=21nM|Kd|=|21|nM|21|nM
3OY8|2.19|2010|2-mer|GAL-GCO(LBA); Kd=220+/-75uM; IC50=14.18mM|P09382|GALECTIN-1|3.66|Kd=220uM|Kd|=|220|uM|220000|nM
3MSS|1.95|2010|MS7|ligand is imatinib; compound 2|P00520|TYROSINE-PROTEIN KINASE ABL1|4.66|Kd=22uM|Kd|=|22|uM|22000|nM
2RQU|NMR|2010|19-mer|ligand is 19-mer from Adenomatous polyposis coli protein, Kd=23.6+/-2uM|Q9ULH1|DDEF1_SH3|4.63|Kd=23.6uM|Kd|=|23.6|uM|23600|nM
3LJO|1.50|2010|11U|ligand is compound 1b(open form); Kd=239+/-26nM; Ki=49+/-15nM|P00760|TRYPSIN|6.62|Kd=239nM|Kd|=|239|nM|239|nM
2XS8|2.50|2010|18-mer|SIV agmTan-1 p6 peptide, Kd=24.5+/-0.5uM; incomplete ligand|Q8WUM4|PROGRAMMED CELL DEATH 6-INTERACTING PROTEIN|4.61|Kd=24.5uM|Kd|=|24.5|uM|24500|nM
3LGS|2.20|2010|SAH|Kd=24.8+/-2.6 uM|Q9T0I8|5'-METHYLTHIOADENOSINE NUCLEOSIDASE|4.61|Kd=24.8uM|Kd|=|24.8|uM|24800|nM
3MO2|2.49|2010|E67|Kd=244+/-29nM; IC50=273+/-10nM; structure:with AdoHcy|Q9H9B1|HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-9 SPECIFIC|6.61|Kd=244nM|Kd|=|244|nM|244|nM
3JZJ|1.40|2010|ACR|ligand is acarbose; Kd=248+/-9uM|B0B0V1|ACARBOSE/MALTOSE BINDING PROTEIN GACH|3.61|Kd=248uM|Kd|=|248|uM|248000|nM
3O4K|2.11|2010|LTC|ligand is LTA|Q9GK12|PEPTIDOGLYCAN RECOGNITION PROTEIN 1|7.62|Kd=24nM|Kd|=|24|nM|24|nM
3OB2|2.10|2010|12-mer|ligand:ppEGFR; incomplete ligand structure|P00533|12-MERIC PEPTIDE FROM EPIDERMAL GROWTH FACTOR|4.59|Kd=25.8uM|Kd|=|25.8|uM|25800|nM
3M3O|2.10|2010|3-mer||Q6WY08|ANTI-TUMOR LECTIN|3.6|Kd=250.63uM|Kd|=|250.63|uM|250630|nM
2XDK|1.97|2010|XDK|ligand is compound 1|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|3.6|Kd=250uM|Kd|=|250|uM|250000|nM
3AFK|1.95|2010|3-mer||Q6WY08|ANTI-TUMOR LECTIN|3.6|Kd=251.89uM|Kd|=|251.89|uM|251890|nM
3FH7|2.05|2010|25P|ligand is compound 20; IC50=47nM(enzyme); IC50=37nM(HWB)|P09960|LEUKOTRIENE A-4 HYDROLASE|7.6|Kd=25nM|Kd|=|25|nM|25|nM
2WQ4|1.42|2010|SFU|Kd=2700+/-7uM|B4EH86|LECTIN|2.57|Kd=2700uM|Kd|=|2700|uM|2700000|nM
2L1R|NMR|2010|SXK|dfbp-o for the regulatory domain of cTnC in presence of cTnI, Kd=270+/-30uM|P63316|TROPONIN C|3.57|Kd=270uM|Kd|=|270|uM|270000|nM
3ADT|2.70|2010|HID|compound 5-hydroxy-indole acetate(HIA)|P37231|PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA|4.55|Kd=28.0uM|Kd|=|28|uM|28000|nM
3OQ5|2.50|2010|10-mer|Cellular tumor antigen p53, C-terminal residues 377-386; (p53K382me1), Fragment: MBT Repeats residues 191-530; Kd=28+/-5uM|Q9Y468|LETHAL(3)MALIGNANT BRAIN TUMOR-LIKE PROTEIN|4.55|Kd=28uM|Kd|=|28|uM|28000|nM
3P8P|2.50|2010|LN6|ligand is compound 4; Kd=28+/-2uM|O94760|N(G),N(G)-DIMETHYLARGININE DIMETHYLAMINOHYDROLASE 1|4.55|Kd=28uM|Kd|=|28|uM|28000|nM
3L81|1.60|2010|7-mer|7-mer Amyloid beta A4 protein from ENPTYKFFEQ, Kd=29.6+/-2.4uM, TYKFFEQ peptide|O00189|AP-4 COMPLEX SUBUNIT MU-1|4.53|Kd=29.6uM|Kd|=|29.6|uM|29600|nM
3OBQ|1.40|2010|9-mer|human HRS PSAP peptide; Kd=290+/-42uM|Q99816|TUMOR SUSCEPTIBILITY GENE 101 PROTEIN|3.54|Kd=290uM|Kd|=|290|uM|290000|nM
2X7X|2.64|2010|FRU||Q8A6X1|SENSOR PROTEIN|5.7|Kd=2uM|Kd|=|2|uM|2000|nM
3AD7|2.20|2010|MTG|SO-U96 complex with methylthio acetate, inhibit the enzyme competitively with respect to sarcosine, Kd=3.01+/-0.54mM|Q50LF0|SUBUNIT ALPHA OF SAROCOSINE OXIDASE|2.52|Kd=3.01mM|Kd|=|3.01|mM|3010000|nM
3KGT|1.95|2010|GEN|ligand is genistein, Kd=3.1+/-0.5uM|P02766|TRANSTHYRETIN|5.51|Kd=3.1uM|Kd|=|3.1|uM|3100|nM
3I73|2.40|2010|ADP||O57728|A-TYPE ATP SYNTHASE CATALYTIC SUBUNIT A|5.49|Kd=3.23uM|Kd|=|3.23|uM|3230|nM
3HMP|2.30|2010|CX4|ligand is compound 4; Kd=3.24+/-0.28uM; IC50=38.41+/-4.6uM|P33981|DUAL SPECIFICITY PROTEIN KINASE TTK|5.49|Kd=3.24uM|Kd|=|3.24|uM|3240|nM
3M58|1.40|2010|11-mer|ligand is TAF10-K189me1 peptide; Kd=3.3+/-0.10uM|Q8WTS6|HISTONE-LYSINE N-METHYLTRANSFERASE SETD7|5.48|Kd=3.3uM|Kd|=|3.3|uM|3300|nM
2XDE|1.40|2010|1B0|ligand is compound PF-3450074|Q9IQV5|GAG POLYPROTEIN|5.47|Kd=3.42uM|Kd|=|3.42|uM|3420|nM
3KDD|1.80|2010|JZQ|ligand is KNI-10265; Kd=3.45+/-0.69nM|P03367|HIV-1 PROTEASE|8.46|Kd=3.45nM|Kd|=|3.45|nM|3.45|nM
3PD2|1.86|2010|A3S|Kd=3.4+/-0.3uM; compound Ser3AA|Q9UZ14|THREONYL-TRNA SYNTHETASE|5.47|Kd=3.4uM|Kd|=|3.4|uM|3400|nM
3NAM|3.10|2010|OTK|compound dOTG, Kd= 3.5+/-1.5 nM, The Kd seen like as IC50|B6CAM1|SARCOPLASMIC/ENDOPLASMIC RETICULUM CALCIUM ATPASE 1, SERCA1A|8.46|Kd=3.5nM|Kd|=|3.5|nM|3.5|nM
3PTY|2.00|2010|AFO||P72059|ARABINOSYLTRANSFERASE C|5.44|Kd=3.65uM|Kd|=|3.65|uM|3650|nM
3LP7|2.04|2010|HAR|NOHA (Nx-hydroxy-L-arginine)|P05089|ARGINASE-1|5.44|Kd=3.6uM|Kd|=|3.6|uM|3600|nM
2XBV|1.66|2010|XBV|ligand is compound 27; Ki=7nM|P00742|COAGULATION FACTOR XA|8.43|Kd=3.7nM|Kd|=|3.7|nM|3.7|nM
3NHI|1.43|2010|EAH|ligand is compound LTC4; Kd=3.7+/-0.6nM|Q95NY5|D7 PROTEIN|8.43|Kd=3.7nM|Kd|=|3.7|nM|3.7|nM
3NG4|1.73|2010|2-mer|ligand is GlcNAc-maltose; Affinity for GlcNAc and Beta-maltose separately are in the range of 10^-4M and 10^-5M, while for mixture (MAL-NAG) is 3.7uM|Q9GK12|PEPTIDOGLYCAN RECOGNITION PROTEIN 1|5.43|Kd=3.7uM|Kd|=|3.7|uM|3700|nM
3OB1|2.20|2010|12-mer|ligand:ppSpry2; incomplete ligand structure|O43597|12-MERIC PEPTIDE FROM PROTEIN SPROUTY HOMOLOG 2|5.42|Kd=3.83uM|Kd|=|3.83|uM|3830|nM
2WSX|3.50|2010|NM2|Supplementary information; Kd=3.9+/-0.7mM(detergent solution); Kd=5.3+/-0.8mM(proteoliposomes)|P31553|L-CARNITINE/GAMMA-BUTYROBETAINE ANTIPORTER|2.41|Kd=3.9mM|Kd|=|3.9|mM|3900000|nM
3HMO|2.40|2010|STU|IC50=0.102+/-0.015uM, Kd=0.0305+/-0.001uM; ligand is inhibitor staurosporine|P33981|DUAL SPECIFICITY PROTEIN KINASE TTK|7.52|Kd=30.5nM|Kd|=|30.5|nM|30.5|nM
3LJJ|1.55|2010|10U|compound 1a(open form); Kd1=300+/-34nM(Tris); Kd2=316+/-60nM(Tricine); Kd3=301+/-43M(Hepes); Kd4=245+/-38nM(PPi); Ki=117+/-25nM|P00760|TRYPSIN|6.52|Kd=300nM|Kd|=|300|nM|300|nM
3LCU|2.10|2010|SAH|ligand is adoHcy (S-adenosylhomocysteine)|Q7M0R2|SISOMICIN-GENTAMICIN RESISTANCE METHYLASE SGM|3.52|Kd=300uM|Kd|=|300|uM|300000|nM
3GY7|1.55|2010|BEN|bovine beta-trypsin in complexed with bis-benzamidine|P00760|TRYPSIN|4.52|Kd=30uM|Kd|=|30|uM|30000|nM
3O6L|2.10|2010|15-mer|ligand is 15-mer Tat peptide; Kd=3.1+/-1.9x10-8M|Q98XH7|ANTIBODY FAB 11H6H1, LIGHT CHAIN|7.51|Kd=31nM|Kd|=|31|nM|31|nM
3L2Y|2.70|2010|OPE|Ca2+ binding; Kd=32.07+/-13.4uM|P02741|C-REACTIVE PROTEIN|4.49|Kd=32.07uM|Kd|=|32.07|uM|32070|nM
3KMY|1.90|2010|D8Y||P56817|BETA-SECRETASE 1|4.49|Kd=32uM|Kd|=|32|uM|32000|nM
3PD4|2.40|2010|A3G|Kd=33.3+/-2uM; compound Gly3AA|Q9UZ14|THREONYL-TRNA SYNTHETASE|4.48|Kd=33.2uM|Kd|=|33.2|uM|33200|nM
3O6M|2.40|2010|9-mer|Kd=3.3+/-0.3x10-8M|Q98XH7|ANTIBODY FAB 11H6H1, LIGHT CHAIN|7.48|Kd=33nM|Kd|=|33|nM|33|nM
3KYG|2.10|2010|5GP|Kd=34.3+/-14.6nM for c-di-GMP|Q9KNC3|PUTATIVE UNCHARACTERIZED PROTEIN VCA0042|7.46|Kd=34.3nM|Kd|=|34.3|nM|34.3|nM
3NIL|1.75|2010|4-mer|incomplete ligand structure|P19812|E3 UBIQUITIN-PROTEIN LIGASE UBR1|3.46|Kd=343.2uM|Kd|=|343.2|uM|343200|nM
3O8P|2.10|2010|BMU|ligand is compound M1, wild type protein binding data from ref. 31|Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|6.46|Kd=350nM|Kd|=|350|nM|350|nM
3NIK|1.85|2010|4-mer|Zn-containing; Kd=358.8+/-20.2uM (ITC, pH=8)|P19812|E3 UBIQUITIN-PROTEIN LIGASE UBR1|3.45|Kd=358.8uM|Kd|=|358.8|uM|358800|nM
3G5Y|1.59|2010|16-mer|Epidermal Growth Factor Receptor peptide; Kd1=35+/-6nM(Pms-serine coupling); Kd2=143+/-2nM(Thiol coupling); Kd3=154+/-0.1nM(Amine coupling)|P00533|175 LIGHT CHAIN|7.46|Kd=35nM|Kd|=|35|nM|35|nM
3PD3|1.86|2010|A3T|Kd=36.2+/-10uM; compound Thr3AA|Q9UZ14|THREONYL-TRNA SYNTHETASE|4.44|Kd=36.2uM|Kd|=|36.2|uM|36200|nM
3OKC|2.40|2010|GDP|orthorhombic crystal form; Kd=36.5+/-6.9uM|Q8NNK8|GDP-MANNOSE-DEPENDENT ALPHA-(1-6)-PHOSPHATIDYLINOSI|4.44|Kd=36.5uM|Kd|=|36.5|uM|36500|nM
3KQR|1.50|2010|OPE||P02743|SERUM AMYLOID P-COMPONENT|4.43|Kd=36.8uM|Kd|=|36.8|uM|36800|nM
3M3E|2.10|2010|3-mer||Q6WY08|ANTI-TUMOR LECTIN|4.43|Kd=37.45uM|Kd|=|37.45|uM|37450|nM
2WYF|2.40|2010|GLA-MBG||Q05097|PA-I GALACTOPHILIC LECTIN|4.43|Kd=37uM|Kd|=|37|uM|37000|nM
3KQP|2.40|2010|ES5|compound 11; measured with AdoHcy; Kd=380+/-44 uM|P11086|PHENYLETHANOLAMINE N-METHYLTRANSFERASE|3.42|Kd=380uM|Kd|=|380|uM|380000|nM
3MUK|1.75|2010|8-mer|peptide of Histone H3.3, Fragment: bromodomain, 42-168; X-ray(histone H3 peptide, 22-29), Kd=380+/-105uM|Q9ESU6|BROMODOMAIN-CONTAINING PROTEIN 4|3.42|Kd=380uM|Kd|=|380|uM|380000|nM
3HZM|1.80|2010|KDO|Kd=3+/-0.06uM (solution affinity to free oligosaccharides)|------|ANTIBODY FAB FARGMENT S73-2|5.52|Kd=3uM|Kd|=|3|uM|3000|nM
3M57|1.70|2010|11-mer|ligand is TAF10-K189 peptide; Kd=4.0+/-0.25uM|Q8WTS6|HISTONE-LYSINE N-METHYLTRANSFERASE SETD7|5.4|Kd=4.0uM|Kd|=|4|uM|4000|nM
2XUF|2.55|2010|TZ4|compound anti1; 1-mth|P21836|ACETYLCHOLINESTERASE|14.39|Kd=4.1fM|Kd|=|4.1|fM|4.1e-06|nM
2WIC|2.05|2010|GNP|Kd=4.1+/-0.73uM (with Mg2+)|A6TF32|FERROUS IRON TRANSPORT PROTEIN B|5.39|Kd=4.1uM|Kd|=|4.1|uM|4100|nM
3MF5|2.00|2010|HJZ|Kd=4.32+/-0.555 uM; IC50=0.042uM|P26663|RNA-DIRECTED RNA POLYMERASE|5.36|Kd=4.32uM|Kd|=|4.32|uM|4320|nM
3LQJ|1.90|2010|9-mer|H3(1-9)K4me3 peptide; incomplete ligand|Q03164|MLL1 PHD3-BROMO|5.37|Kd=4.3uM|Kd|=|4.3|uM|4300|nM
3NCQ|1.24|2010|ATP|structure(MgATP); Kd1=4.4uM, Kd2=40.8uM, Kd3=3.8(MgATP); Kd1=3.2uM, Kd2=31.2uM, Kd3=8.8(ATP); diverse binding data at multiple binding sites|O28527|NITROGEN REGULATORY PROTEIN P-II (GLNB-2)|5.36|Kd=4.4uM|Kd|=|4.4|uM|4400|nM
3NPC|2.35|2010|B96|ligand is BIRB796|P45984|MITOGEN-ACTIVATED PROTEIN KINASE 9|8.34|Kd=4.6nM|Kd|=|4.6|nM|4.6|nM
3KQT|2.40|2010|ES7|compound 7; measured with AdoHcy; Kd=4.6+/-0.69 uM|P11086|PHENYLETHANOLAMINE N-METHYLTRANSFERASE|5.34|Kd=4.6uM|Kd|=|4.6|uM|4600|nM
3NEE|1.55|2010|B72|ligand is compound GC-1; Kd=4.6+/-2.1uM|P02766|TRANSTHYRETIN|5.34|Kd=4.6uM|Kd|=|4.6|uM|4600|nM
3NRZ|1.80|2010|HPA|Bovine Xanthine Oxidase in Complex with Hypoxanthine, steady-state and reductive half-reactions, PH=8.5|P80457|XANTHINE DEHYDROGENASE/OXIDASE|5.34|Kd=4.6uM|Kd|=|4.6|uM|4600|nM
2X00|2.40|2010|GYN|ligand is gymnodimine A, Kd=0.0047nM|Q8WSF8|ACETYLCHOLINE RECEPTOR|11.33|Kd=4.7pM|Kd|=|4.7|pM|0.0047|nM
3ML4|2.60|2010|13-mer|ligand is Muscle, skeletal receptor tyrosine-protein kinase (Residues 544-556); incomplete ligand|Q18PE0|PROTEIN DOK-7|5.33|Kd=4.7uM|Kd|=|4.7|uM|4700|nM
2XHR|2.20|2010|C0P|compound 14|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|8.32|Kd=4.8nM|Kd|=|4.8|nM|4.8|nM
3M53|1.85|2010|11-mer|ligand is TAF10-K189 peptide; Kd=4.9+/-0.20uM|Q8WTS6|HISTONE-LYSINE N-METHYLTRANSFERASE SETD7|5.31|Kd=4.9uM|Kd|=|4.9|uM|4900|nM
2XTN|1.90|2010|GTP|Kd=40+/-7nM for GIMAP2(1-260), not GIMAP2(1-234)|Q9UG22|GTPASE IMAP FAMILY MEMBER 2|7.4|Kd=40nM|Kd|=|40|nM|40|nM
3M17|2.60|2010|15-mer|monomeric peptide inhibitor, UNP residues 24-290; deg-shFcRn with peptide1|P55899|IGG RECEPTOR FCRN LARGE SUBUNIT P51|7.4|Kd=40nM|Kd|=|40|nM|40|nM
3I5R|1.70|2010|12-mer|ligand is 12-mer peptide ligand PD1R; incomplete ligand|P27986|PHOSPHATIDYLINOSITOL 3-KINASE REGULATORY SUBUNIT|4.4|Kd=40uM|Kd|=|40|uM|40000|nM
3L6X|2.40|2010|18-mer|ligand is 18-mer E-cadherin; lower affinity|O60716|CATENIN DELTA-1|4.4|Kd=40uM|Kd|=|40|uM|40000|nM
3A73|2.19|2010|PJ2|covalent complex|P02768|SERUM ALBUMIN|3.38|Kd=420uM|Kd|=|420|uM|420000|nM
3GUZ|1.67|2010|PAF||P31663|PANTOTHENATE SYNTHETASE|4.38|Kd=42uM|Kd|=|42|uM|42000|nM
3NM6|1.60|2010|TRS|X-ray(with product ADE); Kd(Tris alone)|Q9ZMY2|MTA/SAH NUCLEOSIDASE|1.35|Kd=45mM|Kd|=|45|mM|45000000|nM
3OGM|3.34|2010|OGK|compound coronatine; ; with JAZ1 degron; Kd=48+/-13nM;|Q39255|SKP1-LIKE PROTEIN 1A|7.32|Kd=48nM|Kd|=|48|nM|48|nM
3NTH|2.80|2010|6-mer|Kd=48uM(ITC), 37uM(SPR); ligand:Aubergine [R13(me2s)]|P25823|MATERNAL PROTEIN TUDOR|4.32|Kd=48uM|Kd|=|48|uM|48000|nM
3HS9|2.15|2010|12-mer|ligand is 12-mer Intersectin 1-peptide; incomplete ligand|P62944|AP-2 COMPLEX SUBUNIT BETA-1|6.31|Kd=490nM|Kd|=|490|nM|490|nM
3MXF|1.60|2010|JQ1|Kd=49+/-2.4nM; IC50=77nM|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|7.31|Kd=49nM|Kd|=|49|nM|49|nM
2XYN|2.81|2010|VX6||P42684|TYROSINE-PROTEIN KINASE ABL2|8.4|Kd=4nM|Kd|=|4|nM|4|nM
3L6H|2.30|2010|BET|ligand is glycine betaine, Kd=4~5uM; redundant to 1r9l|Q7DAU8|GLYCINE BETAINE-BINDING PROTEIN|5.4|Kd=4uM|Kd|=|4|uM|4000|nM
2XZW|1.95|2010|AKG|measured at low 2-OG concentrations; Kd1=5.1+/-4.0uM; Kd2=11.1+/-1.8uM; Kd3=106.7+/-14.8uM; diverse binding data at multiple binding site|P0A3F4|NITROGEN REGULATORY PROTEIN P-II|5.29|Kd=5.1uM|Kd|=|5.1|uM|5100|nM
3K8Q|2.50|2010|22A|ligand is SerMe-Imm-H; Ki=5pM|P00491|PURINE NUCLEOSIDE PHOSPHORYLASE|11.28|Kd=5.2pM|Kd|=|5.2|pM|0.005200000000000001|nM
3N9S|1.85|2010|TD4|ligand is compound 1; IC50=131nM; Zn-containing|D0IR47|FRUCTOSE-BISPHOSPHATE ALDOLASE|5.26|Kd=5.5uM|Kd|=|5.5|uM|5500|nM
2XL3|2.70|2010|14-mer|14-mer peptide Fragment: RESIDUES 369-381 ; 9-mer peptide containing; ternary complex;|P61965|WD REPEAT-CONTAINING PROTEIN 5|5.25|Kd=5.6uM|Kd|=|5.6|uM|5600|nM
2XL2|2.40|2010|14-mer|peptide Fragment: RESIDUES 369-381|P61965|WD REPEAT-CONTAINING PROTEIN 5|5.25|Kd=5.6uM|Kd|=|5.6|uM|5600|nM
3M59|1.70|2010|11-mer|ligand is TAF10-K189me2 peptide; Kd=5.8+/-0.22uM|Q8WTS6|HISTONE-LYSINE N-METHYLTRANSFERASE SETD7|5.24|Kd=5.8uM|Kd|=|5.8|uM|5800|nM
3MLE|2.80|2010|ADP|second crystal form; Mg-containing|O24872|DETHIOBIOTIN SYNTHETASE|5.24|Kd=5.8uM|Kd|=|5.8|uM|5800|nM
3LQ2|1.96|2010|TDP|measured with 0.5mM TDP|P0AFG9|PYRUVATE DEHYDROGENASE E1 COMPONENT|5.22|Kd=5.97uM|Kd|=|5.97|uM|5970|nM
3LQ4|1.98|2010|TDP|redundant to 3lq2, measured with 5mM TDP|P0AFG9|PYRUVATE DEHYDROGENASE E1 COMPONENT|5.22|Kd=5.97uM|Kd|=|5.97|uM|5970|nM
3OBU|1.60|2010|9-mer|Gag PTAP peptide; Kd=50+/-0.7uM|Q99816|TUMOR SUSCEPTIBILITY GENE 101 PROTEIN|4.3|Kd=50uM|Kd|=|50|uM|50000|nM
3L3Q|2.30|2010|15-mer|Fragment:NLS binding domain(71-497); Kd=53.2 +/- 14.9 nM|P52293|IMPORTIN SUBUNIT ALPHA-2|7.27|Kd=53.2nM|Kd|=|53.2|nM|53.2|nM
3IWY|1.93|2010|12-mer|D-PMI-gamma peptide inhibitor, Kd=4.9uM is for MDMX, Kd=53+/-6nM is for MDM2|Q00987|E3 UBIQUITIN-PROTEIN LIGASE MDM2|7.28|Kd=53nM|Kd|=|53|nM|53|nM
3IJG|1.70|2010|AVR|compound (R)-AV1013; Kd=54.0+/-3.1uM; Ki=74.9+/-8.5uM|P14174|MACROPHAGE MIGRATION INHIBITORY FACTOR|4.27|Kd=54.0uM|Kd|=|54|uM|54000|nM
2XIB|2.20|2010|DFU|ligand is compound 3; Kd1=55.1+/-10.1nM(pH=7.0); Kd4=372+/-11.0nM(pH=8.5)|Q8A3I4|ALPHA-L-FUCOSIDASE|7.26|Kd=55.1nM|Kd|=|55.1|nM|55.1|nM
3P5O|1.60|2010|EAM|ligand is compound I-BET; Kd=50.5~61.3nM; IC50=32.5-42.5nM|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|7.26|Kd=55.2nM|Kd|=|55.2|nM|55.2|nM
3LK1|1.79|2010|JKE&EMC|compound SC0322, Kd=55.2+/-5.1uM; IC50=177.7+/-16.5uM; binding data for substrate; complex structure for product|P02638|PROTEIN S100-B|4.26|Kd=55.2uM|Kd|=|55.2|uM|55200|nM
2L12|NMR|2010|15-mer|protein 1 Fragment: UNP Residues 7-62 ; protein 2 Fragment: UNP Residues 2-16 ; Kd=55+/-5uM;|B0QYP2|CHROMOBOX PROTEIN HOMOLOG 7|4.26|Kd=55uM|Kd|=|55|uM|55000|nM
2KSP|NMR|2010|15-mer|ligand is MICAL-L1 like peptide(NPFEEEEED), Kd=57+/-6uM|Q9H4M9|EH DOMAIN-CONTAINING PROTEIN 1|4.24|Kd=57uM|Kd|=|57|uM|57000|nM
3NII|2.10|2010|4-mer|ligand:Peptide KIAA, incomplete ligand structure; Zn-containing; Kd=58.5+/-3.03uM(ITC1, pH8); Kd=18.0+/-1.90uM(lower pH ITC2, pH6.5)|P19812|E3 UBIQUITIN-PROTEIN LIGASE UBR1|4.23|Kd=58.5uM|Kd|=|58.5|uM|58500|nM
3O84|2.10|2010|HTJ|ligand is compound 8; structure and Kd=58+/-11nM for strain AB900; Kd=78+/-7nM(FP), 99+/-13nM(ITC) and Ki=58+/-11nM for strain ATCC|B2HVG8|PEPTIDE ARYLATION ENZYME|7.24|Kd=58nM|Kd|=|58|nM|58|nM
3HS8|1.90|2010|12-mer|ligand is Intersectin 1-peptide|Q6PEE6|ADAPTOR PROTEIN COMPLEX AP-2, ALPHA 2 SUBUNIT|5.3|Kd=5uM|Kd|=|5|uM|5000|nM
3P8H|2.55|2010|P8H|Kd=5+/-1 uM; Fragment: UNP residues 200-522;|Q9Y468|LETHAL(3)MALIGNANT BRAIN TUMOR-LIKE PROTEIN|5.3|Kd=5uM|Kd|=|5|uM|5000|nM
3ILQ|2.05|2010|1O2|compound BbGL-2c; Kd=6.2+/-0.2uM, glycolipid BbGL-2c|P11609|T-CELL SURFACE GLYCOPROTEIN CD1D1|5.21|Kd=6.2uM|Kd|=|6.2|uM|6200|nM
3NSQ|2.60|2010|CHZ|ligand is danthron|Q2NL52|RETINOIC ACID RECEPTOR RXR-ALPHA|5.21|Kd=6.2uM|Kd|=|6.2|uM|6200|nM
3KQS|2.00|2010|AX7|compound 6; with AdoHcy; Kd=6.3+/-0.02 uM|P11086|PHENYLETHANOLAMINE N-METHYLTRANSFERASE|5.2|Kd=6.3uM|Kd|=|6.3|uM|6300|nM
2WTW|3.30|2010|ZZL|ligand is compound MLN-8054|O14965|SERINE/THREONINE-PROTEIN KINASE 6|8.19|Kd=6.5nM|Kd|=|6.5|nM|6.5|nM
3IQV|1.20|2010|6-mer|human 14-3-3 sigma with Raf1 peptide and stabilisator Fusicoccin; Kd=6.6+/-0.8uM; redundant to 3iqu|P31947|14-3-3 PROTEIN SIGMA|5.18|Kd=6.6uM|Kd|=|6.6|uM|6600|nM
3LQI|1.92|2010|9-mer|H3(1-9)K4me2 peptide; incomplete ligand|Q03164|MLL1 PHD3-BROMO|5.16|Kd=6.9uM|Kd|=|6.9|uM|6900|nM
2KZU|NMR|2010|18-mer|ligand is N-terminal residues of the tumor suppressor Rassf1C (23-38)|Q4VX54|DEATH-ASSOCIATED PROTEIN 6|4.22|Kd=60uM|Kd|=|60|uM|60000|nM
3KYQ|2.44|2010|DPV||Q5EGY4|SYNAPTOBREVIN HOMOLOG YKT6|4.22|Kd=60uM|Kd|=|60|uM|60000|nM
3IF7|1.60|2010|SPU|with Ca2+, Kd= 61+/-10 nM in first process, 2.1 +/-0.2 uM in second process|P62157|CALMODULIN|7.21|Kd=61nM|Kd|=|61|nM|61|nM
2WON|2.80|2010|ZZE|Kd=624+/-42.5nM; Fragment: P66, RESIDUES 588-1147; Fragment:P51, RESIDUES 588-1027 ;|P04585|HIV-1 REVERSE TRANSCRIPTASE|6.2|Kd=624nM|Kd|=|624|nM|624|nM
2XII|1.80|2010|TA9|ligand is compound 4; Kd1=63.3+/-12.6nM(pH=7.0); Kd4=157+/-14.3nM(pH=8.5)|Q8A3I4|ALPHA-L-FUCOSIDASE|7.2|Kd=63.3nM|Kd|=|63.3|nM|63.3|nM
2XTO|2.80|2010|GDP|Kd=630+/-40nM is for GIMAP2 (1-260), not GIMAP2 (21-260)|Q9UG22|GTPASE IMAP FAMILY MEMBER 2|6.2|Kd=630nM|Kd|=|630|nM|630|nM
3KPU|2.40|2010|ES1|compound 1; with AdoHcy; Kd=690+/-220 uM|P11086|PHENYLETHANOLAMINE N-METHYLTRANSFERASE|3.16|Kd=690uM|Kd|=|690|uM|690000|nM
3LK0|2.04|2010|Z80|compound SC0067, Kd=696.9+/-427.9 uM; IC50=2222.0+/-1364.3 uM|P02638|PROTEIN S100-B|3.16|Kd=696.9uM|Kd|=|696.9|uM|696900|nM
3NAN|3.10|2010|HZ1|compound Boc-Tg, Kd= 6+/-1 nM, The Kd seen like as IC50|B6CAM1|SARCOPLASMIC/ENDOPLASMIC RETICULUM CALCIUM ATPASE 1, SERCA1A|8.22|Kd=6nM|Kd|=|6|nM|6|nM
2KOH|NMR|2010|16-mer|ligand is VE-Cadherin-5 C-terminus|Q99NH2|PARTITIONING DEFECTIVE 3 HOMOLOG|5.22|Kd=6uM|Kd|=|6|uM|6000|nM
3MS9|1.80|2010|MS9|IC50>100uM, with imatinib; compound 1|P00520|TYROSINE-PROTEIN KINASE ABL1|5.22|Kd=6uM|Kd|=|6|uM|6000|nM
3N1C|2.00|2010|F6P||P06999|6-PHOSPHOFRUCTOKINASE ISOZYME 2|5.22|Kd=6uM|Kd|=|6|uM|6000|nM
3NTI|2.80|2010|13-mer|Kd=6uM(ITC), 14uM(SPR); incomplete ligand structure; ligand:Aubergine [R15(me2s)]|P25823|MATERNAL PROTEIN TUDOR|5.22|Kd=6uM|Kd|=|6|uM|6000|nM
2XI7|2.20|2010|XI7|two independent sites:Kd1=7.20+/-1.73uM; Kd2=159+/-42.9uM; IC50=25-50uM|A5HC98|RNA POLYMERASE L|5.14|Kd=7.20uM|Kd|=|7.2|uM|7200|nM
3KR2|2.30|2010|ET2|compound 16; with AdoHcy; Kd=7.2+/-0.9 uM|P11086|PHENYLETHANOLAMINE N-METHYLTRANSFERASE|5.14|Kd=7.2uM|Kd|=|7.2|uM|7200|nM
2KWN|NMR|2010|15-mer|ligand is Histone H4-Nac peptide|Q92784|HISTONE PEPTIDE|5.13|Kd=7.4uM|Kd|=|7.4|uM|7400|nM
3HB8|2.74|2010|UMP|covalent complex|P04818|THYMIDYLATE SYNTHASE|5.12|Kd=7.5uM|Kd|=|7.5|uM|7500|nM
3NKX|2.40|2010|10-mer|Kd=7.5+/-1.2uM; incomplete ligand|P63104|14-3-3 PROTEIN ZETA/DELTA|5.12|Kd=7.5uM|Kd|=|7.5|uM|7500|nM
3NX7|1.80|2010|NHK|ligand is compound 6|P39900|MACROPHAGE METALLOELASTASE (MMP-12)|8.1|Kd=7.88nM|Kd|=|7.88|nM|7.88|nM
3ADU|2.77|2010|MYI|) compound 5-methoxy-indole acetate(MIA)|P37231|PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA|4.14|Kd=72.8uM|Kd|=|72.8|uM|72800|nM
2WVT|1.80|2010|FHN|ligand is compound 5; Kd=755+/-55nM(pH=6.0) for BtFuc2970; Kd=230+/-7uM for fucose|Q8A3I4|ALPHA-L-FUCOSIDASE|6.12|Kd=755nM|Kd|=|755|nM|755|nM
3NCR|1.44|2010|ADP|structure(MgADP); Kd1=77.5uM, Kd2=18.4uM, Kd3=20.9(MgADP); Kd1=2.4uM, Kd2=9.1uM, Kd3=22.5(ADP); diverse binding data at multiple binding sites|O28527|NITROGEN REGULATORY PROTEIN P-II (GLNB-2)|4.11|Kd=77.5uM|Kd|=|77.5|uM|77500|nM
3OYW|2.50|2010|TDG|Kd=78+/-20uM; IC50=1.156mM|P09382|GALECTIN-1|4.11|Kd=78uM|Kd|=|78|uM|78000|nM
2XDL|1.98|2010|2DL|ligand is compound 3|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|3.1|Kd=790uM|Kd|=|790|uM|790000|nM
3P8E|2.49|2010|LN7|compound 4; covalent complex; Kd=7+/-1uM; Ki=7.5+/-0.4uM|O94760|N(G),N(G)-DIMETHYLARGININE DIMETHYLAMINOHYDROLASE 1|5.15|Kd=7uM|Kd|=|7|uM|7000|nM
3HUB|2.25|2010|469|ligand is compound 7; Kd=8.2+/-2.9nM; IC50=9nM|Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|8.09|Kd=8.2nM|Kd|=|8.2|nM|8.2|nM
3HBO|1.71|2010|2NC||P03369|[D-ALA51/51']HIV-1 PROTEASE|5.09|Kd=8.2uM|Kd|=|8.2|uM|8200|nM
3K8O|2.40|2010|229|ligand is DATMe-Imm-H; Ki=9pM|P00491|PURINE NUCLEOSIDE PHOSPHORYLASE|11.07|Kd=8.6pM|Kd|=|8.6|pM|0.0086|nM
2Y34|2.01|2010|UN9|ligand is compound BIQ|Q9GZT9|EGL NINE HOMOLOG 1|7.1|Kd=80nM|Kd|=|80|nM|80|nM
3HKY|1.90|2010|IX6|ligand is compound 4; 1a_18 polymerase; Kd=80+/-15nM, PDB is 1b, but reference indicates 1a|O92972|RNA-DIRECTED RNA POLYMERASE|7.1|Kd=80nM|Kd|=|80|nM|80|nM
3M3C|2.00|2010|3-mer||Q6WY08|ANTI-TUMOR LECTIN|4.06|Kd=86.21uM|Kd|=|86.21|uM|86210|nM
3LE8|1.70|2010|2B5|compound 6, Ki=5.4uM|P0A5R0|PANTOTHENATE SYNTHETASE|6.07|Kd=860nM|Kd|=|860|nM|860|nM
3NAL|2.65|2010|DBK|compound DTB, Kd= 8+/-1 nM, The Kd seen like as IC50|B6CAM1|SARCOPLASMIC/ENDOPLASMIC RETICULUM CALCIUM ATPASE 1, SERCA1A|8.1|Kd=8nM|Kd|=|8|nM|8|nM
3GY4|1.55|2010|PBZ|ligand is p-aminobenzamidine|P00760|TRYPSIN BETA|5.1|Kd=8uM|Kd|=|8|uM|8000|nM
2XBP|1.20|2010|ATP|Kd=9.6+/-1.3uM|P0A3F4|NITROGEN REGULATORY PROTEIN P-II|5.02|Kd=9.6uM|Kd|=|9.6|uM|9600|nM
3ADS|2.25|2010|IMN|compound indomethacin(IDM); Kd1=9.73uM(SPR); Kd2=17.24uM(ITC); Kd3=934.5uM(ITC)|P37231|PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA|5.01|Kd=9.73uM|Kd|=|9.73|uM|9730|nM
3OUJ|2.30|2010|AKG|ligand is compound 2-Oxoglutarate(2OG)|Q9GZT9|EGL NINE HOMOLOG 1|6.05|Kd=900nM|Kd|=|900|nM|900|nM
3ISW|2.80|2010|18-mer|Cystic fibrosis transmembrane conductance regulator, R21A Fragment:residues 2236-2329; Kd=90 +/-9 uM|P21333|FILAMIN-A|4.05|Kd=90uM|Kd|=|90|uM|90000|nM
3N8K|2.25|2010|D1X||P0A4Z6|3-DEHYDROQUINATE DEHYDRATASE|4.05|Kd=90uM|Kd|=|90|uM|90000|nM
3NQ9|1.90|2010|OCA|ligand is caprylic acid; Ka=10.8+/-1.7*10^3M-1|P02754|BETA-LACTOGLOBULIN|4.03|Kd=92.6uM|Kd|=|92.6|uM|92600|nM
3ADV|2.27|2010|SRO|ligand is compound Serotonin(5-HT)|P37231|PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA|3.03|Kd=933uM|Kd|=|933|uM|933000|nM
3KQW|2.49|2010|ES9|compound 9; with AdoHcy; Kd=97+/-5.9 uM|P11086|PHENYLETHANOLAMINE N-METHYLTRANSFERASE|4.01|Kd=97uM|Kd|=|97|uM|97000|nM
3NHT|1.45|2010|U46|ligand is compound U46619; Kd=98+/-6.8nM|Q95NY5|D7 PROTEIN|7.01|Kd=98nM|Kd|=|98|nM|98|nM
3L8S|2.35|2010|BFF|compound 8; Kd=99.0+/-13.7nM, contain a Cl or Br atom|Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|7.0|Kd=99.0nM|Kd|=|99|nM|99|nM
2XCG|1.90|2010|XCG|Kd=9+/-2nM; Ki=8.3+/-0.6 uM|P27338|AMINE OXIDASE [FLAVIN-CONTAINING] B|8.05|Kd=9nM|Kd|=|9|nM|9|nM
3NK8|1.15|2010|JKZ|compound 2; Kd>1mM|P00760|TRYPSIN|3.0|Kd>1mM|Kd|>|1|mM|1000000|nM
3M56|1.65|2010|11-mer|ligand is TAF10-K189me2 peptide|Q8WTS6|HISTONE-LYSINE N-METHYLTRANSFERASE SETD7|4.15|Kd>70uM|Kd|>|70|uM|70000|nM
3LI2|2.20|2010|SF8|Fragment: UNP residues 38-327; Fe 3+ containing; close conformation; the Kd is not accuracy|A6QJ18|FERRICHROME ABC TRANSPORTER LIPOPROTEIN|9.0|Kd~1nM|Kd|~|1|nM|1|nM
3LHS|1.30|2010|SF8|Fragment: UNP residues 38-327; Fe 3+ containing; open conformation; the Kd is not accuracy|A6QJ18|FERRICHROME ABC TRANSPORTER LIPOPROTEIN|9.0|Kd~1nM|Kd|~|1|nM|1|nM
2XEG|1.59|2010|CI9|ligand is compound ARM-P4(4); Ki=0.020+/-0.008nM; IC50=0.46+/-0.18nM|Q04609|GLUTAMATE CARBOXYPEPTIDASE 2|10.7|Ki=0.020nM|Ki|=|0.02|nM|0.02|nM
2XEI|1.69|2010|ARK|ligand is compound ARM-P2(3); Ki=0.024+/-0.008nM; IC50=0.54+/-0.18nM|Q04609|GLUTAMATE CARBOXYPEPTIDASE 2|10.62|Ki=0.024nM|Ki|=|0.024|nM|0.024|nM
3LIW|2.22|2010|RUP||P00742|COAGULATION FACTOR XA|7.6|Ki=0.025uM|Ki|=|0.025|uM|25|nM
3I51|1.80|2010|45C|ligand is 4, 5-Dichlorocatechol|P95607|CATECHOL 1,2-DIOXYGENASE|7.7|Ki=0.02uM|Ki|=|0.02|uM|20|nM
3HFB|1.92|2010|ML4|ligand is LP-534193; Ki=0.03+/-0.001uM (Trp as the varied substrate); Ki=0.17+/-0.01uM(Trp as the fixed substrate)|P17752|TRYPTOPHAN 5-HYDROXYLASE 1|7.52|Ki=0.03uM|Ki|=|0.03|uM|30|nM
3L4U|1.90|2010|DSK|Ki=0.03+/-0.01uM, compound de-O-sulfonated kotalanol|O43451|MALTASE-GLUCOAMYLASE|7.52|Ki=0.03uM|Ki|=|0.03|uM|30|nM
3MXE|1.85|2010|K54|ligand is compound 18d|P03369|HIV-1 PROTEASE|10.01|Ki=0.097nM|Ki|=|0.097|nM|0.097|nM
3I4Y|1.85|2010|35C|ligand is 3, 5-Dichlorocatechol|P95607|CATECHOL 1,2-DIOXYGENASE|7.05|Ki=0.09uM|Ki|=|0.09|uM|90|nM
3L4Y|1.80|2010|NR4|Ki=0.10+/-0.02uM, compound NR4-8II|O43451|MALTASE-GLUCOAMYLASE|7.0|Ki=0.10uM|Ki|=|0.1|uM|100|nM
3GT9|1.70|2010|516|ligand is compound 11c|Q6R308|BACULOVIRAL IAP REPEAT-CONTAINING PROTEIN 7|3.96|Ki=0.11mM|Ki|=|0.11|mM|110000|nM
2XMY|1.90|2010|CDK|ligand is compound 11; Ki=0.11+/-0.05nM; IC50=221+/-75nM(A2780); IC50=98+/-10nM(MES-SA)|P24941|CELL DIVISION PROTEIN KINASE 2|9.96|Ki=0.11nM|Ki|=|0.11|nM|0.11|nM
3A2C|2.90|2010|PDY|pKi=6.9|P49137|MAP KINASE-ACTIVATED PROTEIN KINASE 2|6.9|Ki=0.126uM|Ki|=|0.126|uM|126|nM
3IAE|2.30|2010|D7K|ligand is compound MBP, ligand structure is not consist with the one in reference|Q9F4L3|BENZALDEHYDE LYASE|3.89|Ki=0.13mM|Ki|=|0.13|mM|130000|nM
3L4X|1.90|2010|NR3|Ki=0.13+/-0.02uM, compound NR4-8|O43451|MALTASE-GLUCOAMYLASE|6.89|Ki=0.13uM|Ki|=|0.13|uM|130|nM
2XEF|1.59|2010|AR8|ligand is compound ARM-P8(6); Ki=0.145+/-0.050nM; IC50=3.29+/-1.14nM|Q04609|GLUTAMATE CARBOXYPEPTIDASE 2|9.84|Ki=0.145nM|Ki|=|0.145|nM|0.145|nM
3M36|2.15|2010|M35|ligand is DPC423|P00742|COAGULATION FACTOR X|9.82|Ki=0.15nM|Ki|=|0.15|nM|0.15|nM
3NU3|1.02|2010|478|Ki=0.15+/-0.04nM|P03366|HIV-1 PROTEASE|9.82|Ki=0.15nM|Ki|=|0.15|nM|0.15|nM
2WK2|2.05|2010|3-mer|ligang is chitotriose thiazoline dithioamide 10; multiple ligand|A6XFF7|CHITINASE A|6.82|Ki=0.15uM|Ki|=|0.15|uM|150|nM
3NUO|1.35|2010|478|Ki=0.16+/-0.01nM|P03366|HIV-1 PROTEASE|9.8|Ki=0.16nM|Ki|=|0.16|nM|0.16|nM
2XHM|1.96|2010|K26||Q10714|ANGIOTENSIN-CONVERTING ENZYME|6.8|Ki=0.16uM|Ki|=|0.16|uM|160|nM
2XB9|2.75|2010|XNW|compound 4a|Q48255|3-DEHYDROQUINATE DEHYDRATASE|6.77|Ki=0.17uM|Ki|=|0.17|uM|170|nM
3ANQ|2.60|2010|EHB|compound INDY; IC50=0.24uM|Q13627|DUAL SPECIFICITY TYROSINE-PHOSPHORYLATION-REGULATED KINASE|6.74|Ki=0.18uM|Ki|=|0.18|uM|180|nM
3L4V|2.10|2010|KTL|Ki=0.19+/-0.03uM, compound kotalanol|O43451|MALTASE-GLUCOAMYLASE|6.72|Ki=0.19uM|Ki|=|0.19|uM|190|nM
3L4Z|2.00|2010|SSD|Ki=0.19+/-0.02uM, compound Salacinol|O43451|MALTASE-GLUCOAMYLASE|6.72|Ki=0.19uM|Ki|=|0.19|uM|190|nM
3M2U|1.40|2010|TXZ|ligand is N-6-mercaptohexanoylthreonine phosphate (CoB6SH) in reference|P11558|METHYL-COENZYME M REDUCTASE I SUBUNIT ALPHA|7.0|Ki=0.1uM|Ki|=|0.1|uM|100|nM
3AAV|1.70|2010|A2C|compound 4; Cu2+ metal containing complex|P00760|TRYPSIN|6.62|Ki=0.24uM|Ki|=|0.24|uM|240|nM
2WLY|2.40|2010|2-mer|ligand is chitotriose thiazoline 4|A6XFF7|CHITINASE A|6.6|Ki=0.25uM|Ki|=|0.25|uM|250|nM
3LC5|2.62|2010|IZX|compound 16|P00740|COAGULATION FACTOR IX|6.57|Ki=0.27uM|Ki|=|0.27|uM|270|nM
3NMQ|2.20|2010|7PP|structure(Hsp90beta); Ki(Hsp90alpha)|P08238|HEAT SHOCK PROTEIN HSP90-BETA|9.7|Ki=0.2nM|Ki|=|0.2|nM|0.2|nM
3HF8|1.85|2010|ML0|ligand is LP-533401; Ki=0.31+/-0.01uM (Trp as the varied substrate); Ki=0.81+/-0.03uM(Trp as the fixed substrate)|P17752|TRYPTOPHAN 5-HYDROXYLASE 1|6.51|Ki=0.31uM|Ki|=|0.31|uM|310|nM
2XD9|1.95|2010|XD9||Q48255|3-DEHYDROQUINATE DEHYDRATASE|6.46|Ki=0.35uM|Ki|=|0.35|uM|350|nM
3P4Q|3.35|2010|OAA|Escherichia coli menaquinol:fumarate reductase (QFR) in complex with oxaloacetate, Ki=0.0003mM|D3GV56|FUMARATE REDUCTASE FLAVOPROTEIN|6.52|Ki=0.3uM|Ki|=|0.3|uM|300|nM
3KQD|2.75|2010|LGL|compound 5e|P00742|COAGULATION FACTOR XA, HEAVY CHAIN|9.4|Ki=0.40nM|Ki|=|0.4|nM|0.4|nM
3NUJ|1.50|2010|478|Ki=0.41+/-0.05nM|P03366|HIV-1 PROTEASE|9.39|Ki=0.41nM|Ki|=|0.41|nM|0.41|nM
3IUT|1.20|2010|KB2|tetrafluorophenoxymethyl ketone inhibitor 2; RCSB ligand structure no F atom, Ki=0.46+/-0.4uM; IC50=5.1uM|P25779|CRUZIPAIN|6.34|Ki=0.46uM|Ki|=|0.46|uM|460|nM
3IOI|1.45|2010|1GW|compound 2; Ki=0.53uM(UDP-Gal as donor); Ki=0.52uM(UDP-GalNAc as donor)|P16442|HISTO-BLOOD GROUP ABO SYSTEM TRANSFERASE|6.28|Ki=0.53uM|Ki|=|0.53|uM|530|nM
3AAQ|2.00|2010|ARU|ligand is compound ARL 67156, poor Ki=0.5mM, data not shown|Q5ZUA2|ECTONUCLEOSIDE TRIPHOSPHATE DIPHOSPHOHYDROLASE I|3.3|Ki=0.5mM|Ki|=|0.5|mM|500000|nM
3L7G|2.70|2010|M44|ligand name M44 is DDP, binding of DDFP as an inhibitor or DDP as a product|Q44238|XAA-PRO DIPEPTIDASE|3.3|Ki=0.5mM|Ki|=|0.5|mM|500000|nM
3FV1|1.50|2010|DYH||P39086|GLUTAMATE RECEPTOR, IONOTROPIC KAINATE 1|9.3|Ki=0.5nM|Ki|=|0.5|nM|0.5|nM
3KQB|2.25|2010|LGJ|compound 4b|P00742|COAGULATION FACTOR XA, HEAVY CHAIN|9.3|Ki=0.5nM|Ki|=|0.5|nM|0.5|nM
3NU6|1.16|2010|478|Ki=0.50+/-0.06nM|P03366|HIV-1 PROTEASE|9.3|Ki=0.5nM|Ki|=|0.5|nM|0.5|nM
3LPP|2.15|2010|KTL||P14410|SUCRASE-ISOMALTASE|6.22|Ki=0.60uM|Ki|=|0.6|uM|600|nM
2XB7|2.50|2010|GUI|ligand is compound NVP-TAE684; Ki=0.65+/-0.07nM; IC50=17nM|Q9UM73|ALK TYROSINE KINASE RECEPTOR|9.19|Ki=0.65nM|Ki|=|0.65|nM|0.65|nM
3MN8|2.70|2010|GEM|ligand GEMSA, Ki=0.67+/-0.08 uM|D3DME3|LP15968P|6.17|Ki=0.67uM|Ki|=|0.67|uM|670|nM
3OF8|2.20|2010|I0Y|compound 1; covalent complex|P07711|CATHEPSIN L1|9.22|Ki=0.6nM|Ki|=|0.6|nM|0.6|nM
2XDA|1.85|2010|JPS||Q48255|3-DEHYDROQUINATE DEHYDRATASE|6.22|Ki=0.6uM|Ki|=|0.6|uM|600|nM
3AGM|2.00|2010|8-mer|compound ARC-670; IC50=42nM|P17612|CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTIC|9.09|Ki=0.82nM|Ki|=|0.82|nM|0.82|nM
3P8Z|1.70|2010|36A||C1KBQ3|NON-STRUCTURAL PROTEIN 5|6.09|Ki=0.82uM|Ki|=|0.82|uM|820|nM
3A2O|0.88|2010|KNJ|ligand is compound 13k|Q9EKL4|HIV-1 PROTEASE|9.08|Ki=0.83nM|Ki|=|0.83|nM|0.83|nM
3FVL|1.85|2010|BHK|ligand is compound L-1|P00730|CARBOXYPEPTIDASE A1|6.07|Ki=0.86uM|Ki|=|0.86|uM|860|nM
3OWJ|1.85|2010|1EL||Q5U5J2|CASEIN KINASE II, ALPHA SUBUNIT|6.07|Ki=0.86uM|Ki|=|0.86|uM|860|nM
3LEA|2.00|2010|Z93|ligand is compound 27|P78536|DISINTEGRIN AND METALLOPROTEINASE DOMAIN-CONTAINING|9.1|Ki=0.8nM|Ki|=|0.8|nM|0.8|nM
3LPK|1.93|2010|Z76|IC50=7.0nM in cell lines|P56817|BETA-SECRETASE 1|9.1|Ki=0.8nM|Ki|=|0.8|nM|0.8|nM
3MDZ|2.32|2010|EZL|ligand is compound 3|P43166|CARBONIC ANHYDRASE 7|9.1|Ki=0.8nM|Ki|=|0.8|nM|0.8|nM
3M37|1.90|2010|M37|ligand is DPC602, compound 40c|P00742|COAGULATION FACTOR X|9.04|Ki=0.91nM|Ki|=|0.91|nM|0.91|nM
3NU9|1.85|2010|478|Ki=0.9+/-0.2nM|P03366|HIV-1 PROTEASE|9.05|Ki=0.9nM|Ki|=|0.9|nM|0.9|nM
3L4W|2.00|2010|MIG|Ki=1.0+/-0.1uM, compound miglitol|O43451|MALTASE-GLUCOAMYLASE|6.0|Ki=1.0uM|Ki|=|1|uM|1000|nM
3LMK|2.44|2010|GLU||P41594|METABOTROPIC GLUTAMATE RECEPTOR 5|5.94|Ki=1.16uM|Ki|=|1.16|uM|1160|nM
2XAQ|3.20|2010|M84|ligand is 13b; incomplete ligand structure|O60341|LYSINE-SPECIFIC HISTONE DEMETHYLASE 1|5.96|Ki=1.1uM|Ki|=|1.1|uM|1100|nM
3IAF|2.80|2010|TPP|compound BP, ligand structure is not consist with reference|Q9F4L3|BENZALDEHYDE LYASE|2.92|Ki=1.2mM|Ki|=|1.2|mM|1200000|nM
3K8C|2.10|2010|RES||A1BTJ7|RIBOSE-5-PHOSPHATE ISOMERASE|2.92|Ki=1.2mM|Ki|=|1.2|mM|1200000|nM
3K37|2.00|2010|BCZ|ligand is Peramivir; Ki=1.2nM(no preincubation); Ki=0.6nM(preincubation); IC501=27.8nM(no preincubation); IC502=2.8nM(preincubation)|Q3S340|NEURAMINIDASE|8.92|Ki=1.2nM|Ki|=|1.2|nM|1.2|nM
3KJQ|1.80|2010|B94|covalent inhibitor, incomplete ligand structure compound 4, Ki=1.32+/-0.12 uM|Q14790|CASPASE-8|5.88|Ki=1.32uM|Ki|=|1.32|uM|1320|nM
2XEJ|1.78|2010|OKD|ligand is compound MeO-P4 (10); Ki=1.34+/-0.64nM; IC50=30.2+/-14.4nM|Q04609|GLUTAMATE CARBOXYPEPTIDASE 2|8.87|Ki=1.34nM|Ki|=|1.34|nM|1.34|nM
2WPB|2.05|2010|ZZI|compound THB|P0A6L4|N-ACETYLNEURAMINATE LYASE|2.89|Ki=1.3mM|Ki|=|1.3|mM|1300000|nM
2WTX|2.20|2010|VDO|compound 4; Ki=1.3+/-0.2mM; IC50=5.3+/-1.4mM, IC50=41uM at 0.15 mM UDP|P31677|ALPHA-TREHALOSE-PHOSPHATE SYNTHASE|2.89|Ki=1.3mM|Ki|=|1.3|mM|1300000|nM
2XAS|3.20|2010|M80|ligand is 14e; incomplete ligand structure|O60341|LYSINE-SPECIFIC HISTONE DEMETHYLASE 1|5.89|Ki=1.3uM|Ki|=|1.3|uM|1300|nM
3MXD|1.95|2010|K53|ligand is compound 17c|P03369|HIV-1 PROTEASE|8.83|Ki=1.47nM|Ki|=|1.47|nM|1.47|nM
3FVK|1.50|2010|8DX||P39086|GLUTAMATE RECEPTOR, IONOTROPIC KAINATE 1|8.82|Ki=1.5nM|Ki|=|1.5|nM|1.5|nM
3NU4|1.20|2010|478|Ki=1.5+/-0.2nM|P03366|HIV-1 PROTEASE|8.82|Ki=1.5nM|Ki|=|1.5|nM|1.5|nM
3FYZ|2.10|2010|MXC|compound 3; incomplete ligand structure; IC50 in supplementary information; Ki=1.6+/-0.3uM; IC50=22+/-1nM(NCF); IC50=187+/-17nM(CENTA)|Q8RLA6|BETA-LACTAMASE OXA-24|5.8|Ki=1.6uM|Ki|=|1.6|uM|1600|nM
3K16|3.00|2010|4-mer|pSPTF-COO-; Ki=1.6+/-0.3uM|P38398|BREAST CANCER TYPE 1 SUSCEPTIBILITY PROTEIN|5.8|Ki=1.6uM|Ki|=|1.6|uM|1600|nM
2WTV|2.40|2010|ZZL|ligand is compound MLN8054; Ki=1.8+/-0.2nM|O14965|SERINE/THREONINE-PROTEIN KINASE 6|8.74|Ki=1.8nM|Ki|=|1.8|nM|1.8|nM
3JYJ|1.87|2010|JZI|compound 23a|Q13526|PEPTIDYL-PROLYL CIS-TRANS ISOMERASE NIMA|5.74|Ki=1.8uM|Ki|=|1.8|uM|1800|nM
3LIK|1.80|2010|EEG|redundant to 3ts4|P39900|MACROPHAGE METALLOELASTASE (MMP-12)|8.72|Ki=1.92nM|Ki|=|1.92|nM|1.92|nM
3P4R|3.05|2010|GUA|Escherichia coli menaquinol:fumarate reductase (QFR) in complex with glutarate, Ki=0.0003mM|D3GV56|FUMARATE REDUCTASE FLAVOPROTEIN|2.72|Ki=1.9mM|Ki|=|1.9|mM|1900000|nM
3I3D|2.20|2010|IPT|Fragment: Residues 10-1024; Mutation: M543A;|B8LFD6|BETA-GALACTOSIDASE|1.99|Ki=10.3mM|Ki|=|10.3|mM|10300000|nM
3LDW|2.47|2010|ZOL|with IPP; binding with Mg2+; Ki=10.7+/- 1.2 nM|A5K4U6|FARNESYL PYROPHOSPHATE SYNTHASE|7.97|Ki=10.7nM|Ki|=|10.7|nM|10.7|nM
2XBW|1.72|2010|455|ligand is compound 10|P00742|COAGULATION FACTOR XA|8.0|Ki=10nM|Ki|=|10|nM|10|nM
3K97|1.95|2010|4CD|ligand is compound 2a; IC50=1uM|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|8.0|Ki=10nM|Ki|=|10|nM|10|nM
2X95|1.96|2010|X95|ligand is lisW-S; Ki=7uM(for C-domain of sACE)|Q10714|ANGIOTENSIN-CONVERTING ENZYME|4.95|Ki=11.3uM|Ki|=|11.3|uM|11300|nM
3MXR|1.30|2010|CZ8|compound 1, Ki=11.3+/-0.6 uM|P0AD64|BETA-LACTAMASE SHV-1|4.95|Ki=11.3uM|Ki|=|11.3|uM|11300|nM
3PP7|2.35|2010|SVR|ligand is suramin; Ki=115.6+/-2.6uM, incomplete ligand structure|Q27686|PYRUVATE KINASE|3.94|Ki=115.6uM|Ki|=|115.6|uM|115600|nM
3LIR|1.90|2010|EEC||P39900|MACROPHAGE METALLOELASTASE (MMP-12)|6.92|Ki=119nM|Ki|=|119|nM|119|nM
2X8Z|1.98|2010|X8Z|ligand is L-captopril; Ki1=14nM for C-domains of sACE; Ki2=8.9nM for N-domains of sACE|Q10714|ANGIOTENSIN-CONVERTING ENZYME|7.96|Ki=11nM|Ki|=|11|nM|11|nM
3MHC|1.70|2010|ARZ||P00918|CARBONIC ANHYDRASE 2|7.96|Ki=11nM|Ki|=|11|nM|11|nM
3LBJ|1.50|2010|WW8|IC50=19.7+/-3.8uM, compound WK298|O15151|PROTEIN MDM4|4.96|Ki=11uM|Ki|=|11|uM|11000|nM
3FVG|1.50|2010|MS8||P39086|GLUTAMATE RECEPTOR, IONOTROPIC KAINATE 1|6.89|Ki=128nM|Ki|=|128|nM|128|nM
3I6C|1.30|2010|GIA|compound 3f|Q13526|PEPTIDYL-PROLYL CIS-TRANS ISOMERASE NIMA|4.92|Ki=12uM|Ki|=|12|uM|12000|nM
3K15|2.80|2010|5-mer|pSPTF-CONH2; Ki=12+/-2uM|P38398|BREAST CANCER TYPE 1 SUSCEPTIBILITY PROTEIN|4.92|Ki=12uM|Ki|=|12|uM|12000|nM
3KJF|2.00|2010|B92|covalent inhibitor, incomplete ligand structure compound 1, Ki=13.4+/-3.7 uM|P42574|CASPASE-3|4.87|Ki=13.4uM|Ki|=|13.4|uM|13400|nM
3G2I|2.00|2010|RUG|ligand is compound 3d; Ki=13.7+/-1uM|P00489|GLYCOGEN PHOSPHORYLASE|4.86|Ki=13.7uM|Ki|=|13.7|uM|13700|nM
3G2L|2.30|2010|LEW|ligand is compound 3b; Ki=135.9+/-9.5uM|P00489|GLYCOGEN PHOSPHORYLASE|3.87|Ki=135.9uM|Ki|=|135.9|uM|135900|nM
3KR5|2.56|2010|BEY||Q8IL11|M17 LEUCYL AMINOPEPTIDASE|7.89|Ki=13nM|Ki|=|13|nM|13|nM
3N2U|1.81|2010|D3X|ligand is compound 4; Ki=14.3+/-7.0nM; Zn-containing|P39900|MACROPHAGE METALLOELASTASE (MMP-12)|7.84|Ki=14.3nM|Ki|=|14.3|nM|14.3|nM
3MZ3|3.20|2010|B3N|compound M344; with Co2+; Ki=14.8+/-0.8nM|Q9BY41|HISTONE DEACETYLASE 8|7.83|Ki=14.8nM|Ki|=|14.8|nM|14.8|nM
3MOH|2.10|2010|PGA|measured with Mn2+, GDP; Ki=1460+/-48uM(A467G); Ki=2530+/-13uM(WT)|P07379|PHOSPHOENOLPYRUVATE CARBOXYKINASE, CYTOSOLIC|2.84|Ki=1460uM|Ki|=|1460|uM|1460000|nM
2XNB|1.85|2010|Y8L|ligand is ompound 14; Ki=149+/-40nM; IC50=131+/-9nM(A2780); IC50=150+/-16nM(MES-SA)|P24941|CELL DIVISION PROTEIN KINASE 2|6.83|Ki=149nM|Ki|=|149|nM|149|nM
3H9K|2.65|2010|UFP|ligand is FdUMP, the active metabolite of 5-FU|P04818|THYMIDYLATE SYNTHASE|7.85|Ki=14nM|Ki|=|14|nM|14|nM
3IK1|2.25|2010|20C|ligand is compound 20A|P00469|THYMIDYLATE SYNTHASE|4.85|Ki=14uM|Ki|=|14|uM|14000|nM
3K05|1.33|2010|5-mer|5-mer phospho peptide pSQEY-CONH2; Ki=14+/-2uM|Q14676|MEDIATOR OF DNA DAMAGE CHECKPOINT PROTEIN 1|4.85|Ki=14uM|Ki|=|14|uM|14000|nM
3G2H|2.03|2010|KOT|ligand is compound 3a; Ki=151.3+/-2.3uM|P00489|GLYCOGEN PHOSPHORYLASE|3.82|Ki=151.3uM|Ki|=|151.3|uM|151300|nM
2XBX|1.85|2010|RR8|ligand is compound 2|P00742|COAGULATION FACTOR XA|7.82|Ki=15nM|Ki|=|15|nM|15|nM
3G2K|2.00|2010|SKY|ligand is compound 3c; Ki=16.1+/-1.3uM|P00489|GLYCOGEN PHOSPHORYLASE|4.79|Ki=16.1uM|Ki|=|16.1|uM|16100.000000000002|nM
2X7S|1.64|2010|WZC|compound 5; Ki=1660+/-177nM; IC50=549nM(end point); IC50=770+/-51nM(initial rate)|P00918|CARBONIC ANHYDRASE 2|5.78|Ki=1660nM|Ki|=|1660|nM|1660|nM
2XAJ|3.30|2010|TCA|ligand is (-)-tPCPA HCl ; incomplete ligand structure|O60341|LYSINE-SPECIFIC HISTONE DEMETHYLASE 1|3.77|Ki=168uM|Ki|=|168|uM|168000|nM
3FVN|1.50|2010|9DX||P39086|GLUTAMATE RECEPTOR, IONOTROPIC KAINATE 1|6.77|Ki=169nM|Ki|=|169|nM|169|nM
3AGL|2.10|2010|A03|ligand is compound ARC-1039; IC50=97nM|P17612|CAMP-DEPENDENT PROTEIN KINASE|7.8|Ki=16nM|Ki|=|16|nM|16|nM
3GI4|1.85|2010|K60|ligand is SAR-KB60, Ki=0.016nM|O38732|HIV-1 PROTEASE|10.8|Ki=16pM|Ki|=|16|pM|0.016|nM
3ACW|1.63|2010|651|ligand is compound BPH-651|A9JQL9|DEHYDROSQUALENE SYNTHASE|4.76|Ki=17.5uM|Ki|=|17.5|uM|17500|nM
3G2J|2.14|2010|9GP|ligand is compound 5d; Ki=17.9+/-0.4uM|P00489|GLYCOGEN PHOSPHORYLASE|4.75|Ki=17.9uM|Ki|=|17.9|uM|17900|nM
2X09|2.40|2010|X09|ligand is compound 4; Ki=175+/-8uM|Q56F26|EXO-BETA-D-GLUCOSAMINIDASE|3.76|Ki=175uM|Ki|=|175|uM|175000|nM
3MI2|1.20|2010|PFU|ligand is compound 8, Ki=1.7x10-5mM|P11172|URIDINE 5'-MONOPHOSPHATE SYNTHASE|7.77|Ki=17nM|Ki|=|17|nM|17|nM
3ABT|3.20|2010|2PF|too big incomplete ligand structure; compound 2-PFPA; Ki=17+/-4.9uM; IC50=8.9uM|O60341|LYSINE-SPECIFIC HISTONE DEMETHYLASE 1|4.77|Ki=17uM|Ki|=|17|uM|17000|nM
3MKF|1.33|2010|CZ7|cefoperazone BATSI, Ki=17+/-2 uM|P0AD64|BETA-LACTAMASE SHV-1|4.77|Ki=17uM|Ki|=|17|uM|17000|nM
3LJG|1.31|2010|EEF||P39900|MACROPHAGE METALLOELASTASE (MMP-12)|7.73|Ki=18.6nM|Ki|=|18.6|nM|18.6|nM
2X91|1.98|2010|LPR|ligand is lisinopril; Ki1=2.4nM for C-domains of sACE; Ki2=44nM for N-domains of sACE|Q10714|ANGIOTENSIN-CONVERTING ENZYME|6.74|Ki=180nM|Ki|=|180|nM|180|nM
2WYI|2.60|2010|SWA||Q99YP5|ALPHA-MANNOSIDASE|4.74|Ki=18uM|Ki|=|18|uM|18000|nM
3G6M|1.65|2010|CFF|Fragment: residues 21-426; Ki=19.7+/-0.3 mM|A9LI60|CHITINASE|1.71|Ki=19.7mM|Ki|=|19.7|mM|19700000|nM
2XC0|2.05|2010|8NC|ligand is compound 35|P00742|COAGULATION FACTOR XA|6.72|Ki=192nM|Ki|=|192|nM|192|nM
2WYJ|2.38|2010|898|ligand is compound 22|P00742|COAGULATION FACTOR XA|9.0|Ki=1nM|Ki|=|1|nM|1|nM
3LVW|2.50|2010|GSH||P32477|GLUTAMATE-CYSTEINE LIGASE|2.67|Ki=2.12mM|Ki|=|2.12|mM|2120000|nM
3KQC|2.20|2010|LGK|compound 5a|P00742|COAGULATION FACTOR XA, HEAVY CHAIN|8.66|Ki=2.2nM|Ki|=|2.2|nM|2.2|nM
3NOX|2.34|2010|6A5|ligand is compound 24c|Q53TN1|DIPEPTIDYL PEPTIDASE 4|8.66|Ki=2.2nM|Ki|=|2.2|nM|2.2|nM
3MKE|1.75|2010|CB4|ceftazidime BATSI, Ki=2.2+/-0.2 uM|P0AD64|BETA-LACTAMASE SHV-1|5.66|Ki=2.2uM|Ki|=|2.2|uM|2200|nM
3FV7|2.00|2010|MXS|compound 2; incomplete ligand structure; IC50 in supplementary information; Ki=2.3+/-0.3uM; IC50=27+/-1nM(NCF)|Q8RLA6|BETA-LACTAMASE OXA-24|5.64|Ki=2.3uM|Ki|=|2.3|uM|2300|nM
3ABU|3.10|2010|12F|incomplete ligand structure; compound S1201; Ki=2.4+/-0.63uM; IC50=8.1uM|O60341|LYSINE-SPECIFIC HISTONE DEMETHYLASE 1|5.62|Ki=2.4uM|Ki|=|2.4|uM|2400|nM
3OE0|2.90|2010|16-mer|cyclic peptide ligand CVX15; Ki=2.5+/-1.0nM(SPA), 55.3+/-7.0nM(Filter plate); ; IC50=0.6nM(CXCR4)|P61073|C-X-C CHEMOKINE RECEPTOR TYPE 4, LYSOZYME CHIMERA|8.6|Ki=2.5nM|Ki|=|2.5|nM|2.5|nM
2WYN|2.10|2010|2-mer|compound 6|P13482|PERIPLASMIC TREHALASE|5.55|Ki=2.8uM|Ki|=|2.8|uM|2800|nM
3LPF|2.26|2010|Z77|inhibitor 2; Ki=208+/-25.4nM; IC50=369+/-31.1nM|P05804|BETA-GLUCURONIDASE|6.68|Ki=208nM|Ki|=|208|nM|208|nM
2X97|1.85|2010|RX4|ligand is RXP407; Ki=12nM for N-domain of sACE|Q10714|ANGIOTENSIN-CONVERTING ENZYME|5.66|Ki=2200nM|Ki|=|2200|nM|2200|nM
2XJ7|2.00|2010|GC2|ligand is compound 6-Ac-Cas|Q89ZI2|O-GLCNACASE BT_4395|6.66|Ki=220nM|Ki|=|220|nM|220|nM
2XBA|1.95|2010|571|compound PHA-E429; Ki=23.68+/-2.35nM; IC50=91nM|Q9UM73|ALK TYROSINE KINASE RECEPTOR|7.63|Ki=23.68nM|Ki|=|23.68|nM|23.68|nM
2X7T|1.89|2010|WZB|ligand is compound 4; Ki=232+/-57nM; IC50=290nM(end point); IC50=169+/-31nM(initial rate)|P00918|CARBONIC ANHYDRASE 2|6.63|Ki=232nM|Ki|=|232|nM|232|nM
3L0V|1.75|2010|724|ligand is compound 3|P78536|TNF-ALPHA-CONVERTING ENZYME, ADAM 17|7.64|Ki=23nM|Ki|=|23|nM|23|nM
2XAF|3.25|2010|TCF|ligand is (+)-Br-cPCPA HCl; incomplete ligand structure|O60341|LYSINE-SPECIFIC HISTONE DEMETHYLASE 1|4.64|Ki=23uM|Ki|=|23|uM|23000|nM
3LXE|1.90|2010|TOR|ligand is topiramate|P00915|CARBONIC ANHYDRASE 1|6.6|Ki=250nM|Ki|=|250|nM|250|nM
3ITC|1.70|2010|CIT|compound citrate; Ki=25+/-15mM, competitive inhibitors of Sco3058|Q93J45|RENAL DIPEPTIDASE|1.6|Ki=25mM|Ki|=|25|mM|25000000|nM
3KR4|2.00|2010|BES||Q8IL11|M17 LEUCYL AMINOPEPTIDASE|7.6|Ki=25nM|Ki|=|25|nM|25|nM
3O87|1.78|2010|BSG|compound 9; IC50=130nM; covalent complex; B-containing|P00811|BETA-LACTAMASE|7.6|Ki=25nM|Ki|=|25|nM|25|nM
2WLZ|1.82|2010|2-mer|ligang is chitotriose thiazoline 3|A6XFF7|CHITINASE A|4.6|Ki=25uM|Ki|=|25|uM|25000|nM
2X0Y|2.25|2010|X0T|Ki=25+/-2uM; IC50=60+/-10uM|Q0TR53|O-GLCNACASE NAGJ|4.6|Ki=25uM|Ki|=|25|uM|25000|nM
3K0H|2.70|2010|5-mer|pSPTF-CONH2; Ki=25+/-5uM|P38398|BREAST CANCER TYPE 1 SUSCEPTIBILITY PROTEIN|4.6|Ki=25uM|Ki|=|25|uM|25000|nM
2XB8|2.40|2010|XNW|ligand is compound 4a|P0A4Z6|3-DEHYDROQUINATE DEHYDRATASE|7.59|Ki=26nM|Ki|=|26|nM|26|nM
3HP9|1.60|2010|CF1|ligand is compound CFAM; Ki=26+/-4uM; IC50=8+/-1nM|P04995|EXODEOXYRIBONUCLEASE I|4.59|Ki=26uM|Ki|=|26|uM|26000|nM
3IPQ|2.00|2010|965|ligand is compound GW3965; Ki=27+/-4nM|Q13133|OXYSTEROLS RECEPTOR LXR-ALPHA|7.57|Ki=27nM|Ki|=|27|nM|27|nM
3IXG|2.14|2010|BZB||P00811|BETA-LACTAMASE|7.57|Ki=27nM|Ki|=|27|nM|27|nM
2XAH|3.10|2010|3PL|ligand is (+)-tPCPA HCl ; incomplete ligand structure|O60341|LYSINE-SPECIFIC HISTONE DEMETHYLASE 1|3.55|Ki=284uM|Ki|=|284|uM|284000|nM
2XAG|3.10|2010|TCF|ligand is (-)-Br-tPCPA HCl; incomplete ligand structure|O60341|LYSINE-SPECIFIC HISTONE DEMETHYLASE 1|4.55|Ki=28uM|Ki|=|28|uM|28000|nM
3FUZ|1.65|2010|GLU||P39086|GLUTAMATE RECEPTOR, IONOTROPIC KAINATE 1|6.54|Ki=290nM|Ki|=|290|nM|290|nM
3MWE|2.20|2010|TLA|Truncated Human ATP-Citrate Lyase (UNP residues 1-425) and Truncated Human ATP-Citrate Lyase (UNP residues 487-821)|P53396|ATP-CITRATE SYNTHASE|1.54|Ki=29mM|Ki|=|29|mM|29000000|nM
2WYG|1.88|2010|461|ligand is compound 21|P00742|COAGULATION FACTOR XA|8.7|Ki=2nM|Ki|=|2|nM|2|nM
3I60|2.50|2010|E86||P28482|MITOGEN-ACTIVATED PROTEIN KINASE 1|8.7|Ki=2nM|Ki|=|2|nM|2|nM
3I5Z|2.20|2010|Z48||P28482|MITOGEN-ACTIVATED PROTEIN KINASE 1|8.7|Ki=2nM|Ki|=|2|nM|2|nM
3L1S|2.90|2010|Z92|compound 46, Ki<2nM|P49841|GLYCOGEN SYNTHASE KINASE-3 BETA|8.7|Ki=2nM|Ki|=|2|nM|2|nM
3LGP|1.90|2010|50X|compound 3i, Ki=2nM|P78536|DISINTEGRIN AND METALLOPROTEINASE DOMAIN-CONTAINING|8.7|Ki=2nM|Ki|=|2|nM|2|nM
3ACX|1.31|2010|673|ligand is compound BPH-673|A9JQL9|DEHYDROSQUALENE SYNTHASE|5.7|Ki=2uM|Ki|=|2|uM|2000|nM
3KKU|1.28|2010|B95|ligand is compound 27|P25779|CRUZIPAIN|5.7|Ki=2uM|Ki|=|2|uM|2000|nM
3I25|2.10|2010|MV7|ligand is compound 2c|P56817|BETA-SECRETASE 1|8.51|Ki=3.1nM|Ki|=|3.1|nM|3.1|nM
3L79|1.86|2010|DKX|ligand is compound DK1|P00489|GLYCOGEN PHOSPHORYLASE|2.46|Ki=3.46mM|Ki|=|3.46|mM|3460000|nM
3MI3|2.38|2010|LYS||Q9Y823|HOMOCITRATE SYNTHASE, MITOCHONDRIAL|5.45|Ki=3.56uM|Ki|=|3.56|uM|3560|nM
3L7C|1.93|2010|DK4||P00489|GLYCOGEN PHOSPHORYLASE|2.44|Ki=3.67mM|Ki|=|3.67|mM|3670000|nM
3MJL|1.90|2010|2AI|2-Aminoimidazole is a weak noncompetitive inhibitor|P05089|ARGINASE-1|2.44|Ki=3.6mM|Ki|=|3.6|mM|3600000|nM
3K0K|2.70|2010|4-mer|phospho peptide pSPTF-COOH; Ki=3.7+/-0.3uM|P38398|BREAST CANCER TYPE 1 SUSCEPTIBILITY PROTEIN|5.43|Ki=3.7uM|Ki|=|3.7|uM|3700|nM
3L4T|1.90|2010|BJ1|KI=3.8+/-0.8uM, compound BJ2661|O43451|MALTASE-GLUCOAMYLASE|5.42|Ki=3.8uM|Ki|=|3.8|uM|3800|nM
3OXC|1.16|2010|ROC|Ki=3.9+/-0.8nM, mutations(Q506K, L532I, L562I, C566A, C594A), P212121|Q7SSI0|HIV-1 PROTEASE|8.41|Ki=3.9nM|Ki|=|3.9|nM|3.9|nM
3MFV|1.90|2010|Z70|ligand is compound AHH, Ki=3000+/-10uM|P05089|ARGINASE-1|2.52|Ki=3000uM|Ki|=|3000|uM|3000000|nM
3MFW|1.47|2010|B3U|ligand is compound 2AH, Ki=300+/-9uM|P05089|ARGINASE-1|3.52|Ki=300uM|Ki|=|300|uM|300000|nM
2WM0|1.90|2010|3-mer|ligand is chitobiose thiazoline thioamide 9|A6XFF7|CHITINASE A|4.52|Ki=30uM|Ki|=|30|uM|30000|nM
3N2V|1.55|2010|JT5|ligand is compound 30; Ki=31+/-4.8nM; Zn-containing|P39900|MACROPHAGE METALLOELASTASE (MMP-12)|7.51|Ki=31nM|Ki|=|31|nM|31|nM
3AAS|1.75|2010|GUS|ligand is compound 1; Cu-containing complex|P00760|TRYPSIN|4.51|Ki=31uM|Ki|=|31|uM|31000|nM
2XDM|2.40|2010|BO8|compound 3; Ki=32+/-6nM|P39045|D-ALANYL-D-ALANINE CARBOXYPEPTIDASE|7.49|Ki=32nM|Ki|=|32|nM|32|nM
3NYX|2.50|2010|TZ1|ligand is compound 1|P29597|NON-RECEPTOR TYROSINE-PROTEIN KINASE TYK2|7.49|Ki=32nM|Ki|=|32|nM|32|nM
3HL8|1.55|2010|BBP|ligand is compound BCBP; Ki=32+/-4uM; IC50=23+/-3nM|P04995|EXODEOXYRIBONUCLEASE I|4.49|Ki=32uM|Ki|=|32|uM|32000|nM
3IEO|2.00|2010|AMJ|compound 7|P00918|CARBONIC ANHYDRASE 2|6.48|Ki=331nM|Ki|=|331|nM|331|nM
3L3L|2.50|2010|L3L|ligand is compound 4e|P09874|POLY [ADP-RIBOSE] POLYMERASE 1|7.48|Ki=33nM|Ki|=|33|nM|33|nM
3PD8|2.48|2010|HA7|ligand is compound 5(S); Ki for GluA2(R); structure for GluA2-S1S2|P19491|GLUTAMATE RECEPTOR 2|6.46|Ki=348nM|Ki|=|348|nM|348|nM
3OWN|2.00|2010|3OX||P00797|RENIN|7.47|Ki=34nM|Ki|=|34|nM|34|nM
3LBL|1.60|2010|MI6|IC50=0.18+/-0.015uM, compound MI-63|Q00987|E3 UBIQUITIN-PROTEIN LIGASE MDM2|7.44|Ki=36nM|Ki|=|36|nM|36|nM
3NBA|2.68|2010|APC|compound AMPcPP; Ki=388+/-49uM; Mg containing|P0A530|PHOSPHOPANTETHEINE ADENYLYLTRANSFERASE|3.41|Ki=388uM|Ki|=|388|uM|388000|nM
3K5X|1.40|2010|P8D|ligand is compound 1; Ki=390+/-21nM|Q93J45|DIPEPTIDASE|6.41|Ki=390nM|Ki|=|390|nM|390|nM
3LPI|2.05|2010|Z74|IC50=5nM|P56817|BETA-SECRETASE 1|8.52|Ki=3nM|Ki|=|3|nM|3|nM
3IOG|1.41|2010|SDF|ligand is compound 18|P26918|BETA-LACTAMASE|5.52|Ki=3uM|Ki|=|3|uM|3000|nM
3L7B|2.00|2010|DKZ|ligand is compound DK3|P00489|GLYCOGEN PHOSPHORYLASE|2.4|Ki=4.01mM|Ki|=|4.01|mM|4010000|nM
3FZC|2.00|2010|MXF|compound 5; incomplete ligand structure; IC50 in supplementary information; Ki=4.1+/-0.6uM; IC50=55+/-5nM(NCF); IC50=237+/-7nM(CENTA)|Q8RLA6|BETA-LACTAMASE OXA-24|5.39|Ki=4.1uM|Ki|=|4.1|uM|4100|nM
3M1K|1.35|2010|BEW|ligand is compound 4|P00918|CARBONIC ANHYDRASE 2|5.39|Ki=4.1uM|Ki|=|4.1|uM|4100|nM
2XDW|1.35|2010|3-mer|covalent complex|P23687|PROLYL ENDOPEPTIDASE|8.37|Ki=4.3nM|Ki|=|4.3|nM|4.3|nM
3KEK|1.97|2010|3EK|ligand is compound 29b; structure(catalytic domain); Ki=4.4+/-0.15nM(MMP-13/FL)|P45452|COLLAGENASE 3 (MMP-13)|8.36|Ki=4.4nM|Ki|=|4.4|nM|4.4|nM
3NU5|1.29|2010|478|Ki=4.5+/-0.6nM|P03366|HIV-1 PROTEASE|8.35|Ki=4.5nM|Ki|=|4.5|nM|4.5|nM
3K4Q|2.20|2010|IHS||P34752|3-PHYTASE A|5.34|Ki=4.6uM|Ki|=|4.6|uM|4600|nM
3O88|1.64|2010|BSH|compound 17; covalent complex; B-containing|P00811|BETA-LACTAMASE|6.37|Ki=430nM|Ki|=|430|nM|430|nM
3L7A|1.90|2010|DKY|ligand is compound DK2, IC50=250uM|P00489|GLYCOGEN PHOSPHORYLASE|4.33|Ki=46.42uM|Ki|=|46.42|uM|46420|nM
3IPU|2.40|2010|O40|ligand is compound benzisoxazole urea; Ki=48+/-4nM|Q13133|OXYSTEROLS RECEPTOR LXR-ALPHA|7.32|Ki=48nM|Ki|=|48|nM|48|nM
3MNU|1.80|2010|BON||P00918|CARBONIC ANHYDRASE 2|7.32|Ki=48nM|Ki|=|48|nM|48|nM
3MHW|1.45|2010|ABV||P00749|UROKINASE-TYPE PLASMINOGEN ACTIVATOR|2.3|Ki=5.03mM|Ki|=|5.03|mM|5030000|nM
3O5X|2.00|2010|JZG|ligand is compound 9; Ki=5.2+/-0.3uM; IC50=5.5+/-0.4uM|Q06124|TYROSINE-PROTEIN PHOSPHATASE, NON-RECEPTOR TYPE 11|5.28|Ki=5.2uM|Ki|=|5.2|uM|5200|nM
3I3B|2.20|2010|149||B8LFD6|BETA-GALACTOSIDASE|2.23|Ki=5.9mM|Ki|=|5.9|mM|5900000|nM
3OK9|1.27|2010|G52|ligand is compound 4; Ki=5.9pM; IC50=1.8nM|P03366|HIV-1 PROTEASE|11.23|Ki=5.9pM|Ki|=|5.9|pM|0.005900000000000001|nM
3LC3|1.90|2010|IYX||P00740|COAGULATION FACTOR IX|5.23|Ki=5.9uM|Ki|=|5.9|uM|5900|nM
3MOE|1.25|2010|SPV|measured with Mn2+, GTP; Ki=50+/-3uM(A467G); Ki=26+/-1uM(WT)|P07379|PHOSPHOENOLPYRUVATE CARBOXYKINASE, CYTOSOLIC|4.3|Ki=50uM|Ki|=|50|uM|50000|nM
2X7U|2.12|2010|WZA|ligand is compound 3; Ki=5340+/-833nM; IC50=376nM(end point); IC50=2113+/-256nM(initial rate)|P00918|CARBONIC ANHYDRASE 2|5.27|Ki=5340nM|Ki|=|5340|nM|5340|nM
3GTA|1.70|2010|851|ligand is compound 26d|Q6R308|BACULOVIRAL IAP REPEAT-CONTAINING PROTEIN 7|4.28|Ki=53uM|Ki|=|53|uM|53000|nM
3N3G|1.60|2010|93N|ligand is compound 18|P25774|CATHEPSIN S|7.24|Ki=58nM|Ki|=|58|nM|58|nM
3KGQ|1.70|2010|CIT||P00730|CARBOXYPEPTIDASE A|2.3|Ki=5mM|Ki|=|5|mM|5000000|nM
3GJW|2.30|2010|GJW|ligand is compound 9c|P09874|POLY [ADP-RIBOSE] POLYMERASE 1|8.3|Ki=5nM|Ki|=|5|nM|5|nM
3GN7|2.50|2010|3GN|ligand is compound 3a; redundant to 2rd6|P09874|POLY [ADP-RIBOSE] POLYMERASE 1|8.3|Ki=5nM|Ki|=|5|nM|5|nM
2WZM|1.64|2010|NA7|Ki=6.0+/-1.2uM, INH-NADPH adducts inhibit activity of AKR5H1|A0QV09|ALDO-KETO REDUCTASE|5.22|Ki=6.0uM|Ki|=|6|uM|6000|nM
3KJN|1.80|2010|B93|covalent inhibitor, incomplete ligand structure compound 9, Ki=6.44+/-0.29 uM|Q14790|CASPASE-8|5.19|Ki=6.44uM|Ki|=|6.44|uM|6440|nM
3L7D|2.00|2010|DK5||P00489|GLYCOGEN PHOSPHORYLASE|2.18|Ki=6.55mM|Ki|=|6.55|mM|6550000|nM
3L3N|2.30|2010|LSW||P12821|ANGIOTENSIN-CONVERTING ENZYME|8.18|Ki=6.6nM|Ki|=|6.6|nM|6.6|nM
3OE9|3.10|2010|ITD|X-ray:in P1 spacegroup with 2 molecules per asymmetric unit; Ki=6.6+/-1.4nM(SPA), 19.8+/-5.0nM(Filter plate); IC50=8nM(CXCR4)|P61073|C-X-C CHEMOKINE RECEPTOR TYPE 4, LYSOZYME CHIMERA|8.18|Ki=6.6nM|Ki|=|6.6|nM|6.6|nM
3KRD|2.50|2010|FEB|Fellutamide B, Ki=6.8+/-0.2 nM|O33244|PROTEASOME SUBUNIT ALPHA|8.17|Ki=6.8nM|Ki|=|6.8|nM|6.8|nM
3PD9|2.10|2010|HA5|ligand is compound 4(R); Ki for GluA2(R); structure for GluA2-S1S2|P19491|GLUTAMATE RECEPTOR 2|6.22|Ki=600nM|Ki|=|600|nM|600|nM
3K99|2.10|2010|PFT|ligand is compound 2b; IC50=7uM|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|7.22|Ki=60nM|Ki|=|60|nM|60|nM
3M35|2.20|2010|M35|ligand is DPC423|P00760|TRYPSIN|7.22|Ki=60nM|Ki|=|60|nM|60|nM
3L08|2.70|2010|ZIG|compound 1; Pi3K gamma|P48736|PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE|10.22|Ki=60pM|Ki|=|60|pM|0.06|nM
3NF3|2.40|2010|8-mer|inhibitor JTH-NB72-39; Ki=638.1+/-92.0nM; Zn2+, Ni2+ containing|Q7B8V4|BOTULINUM NEUROTOXIN A|6.2|Ki=638.1nM|Ki|=|638.1|nM|638.1|nM
3MZ6|2.00|2010|B3N|ligand is compound M344; with Fe2+; Ki=63+/-2nM(HDAC8); structure(D101L HDAC8); Kd(metal)=1.1+/-0.3uM(Fe2+ with HDAC8)|Q9BY41|HISTONE DEACETYLASE 8|7.2|Ki=63nM|Ki|=|63|nM|63|nM
3IPS|2.26|2010|O90|compound f3methylAA; Ki=64+/-6nM|Q13133|OXYSTEROLS RECEPTOR LXR-ALPHA|7.19|Ki=64nM|Ki|=|64|nM|64|nM
3NSN|2.10|2010|TMX-CTO||Q06GJ0|N-ACETYLGLUCOSAMINIDASE|7.19|Ki=65nM|Ki|=|65|nM|65|nM
3LPG|2.42|2010|Z78|inhibitor 3; Ki=684+/-81.6nM; IC50=586+/-31.1nM|P05804|BETA-GLUCURONIDASE|6.16|Ki=684nM|Ki|=|684|nM|684|nM
2XE4|1.65|2010|4-mer|4-mer;|Q4QHU7|OLIGOPEPTIDASE B|7.16|Ki=69nM|Ki|=|69|nM|69|nM
3L3M|2.50|2010|A92|ligand is compound 25b|P09874|POLY [ADP-RIBOSE] POLYMERASE 1|8.22|Ki=6nM|Ki|=|6|nM|6|nM
3LE9|1.85|2010|727|ligand is compound 1|P78536|DISINTEGRIN AND METALLOPROTEINASE DOMAIN-CONTAINING|8.22|Ki=6nM|Ki|=|6|nM|6|nM
3GI6|1.84|2010|D78|ligand is SAR-AD78, Ki=0.006nM|O38732|HIV-1 PROTEASE|11.22|Ki=6pM|Ki|=|6|pM|0.006|nM
3GI5|1.80|2010|K62|ligand is SAR-KB62, Ki=0.006nM|O38732|HIV-1 PROTEASE|11.22|Ki=6pM|Ki|=|6|pM|0.006|nM
3IOF|1.44|2010|IFS|ligand is compound 10a|P26918|BETA-LACTAMASE|5.22|Ki=6uM|Ki|=|6|uM|6000|nM
3IJZ|2.21|2010|15C|ligand is compound 23A|P00469|THYMIDYLATE SYNTHASE|5.22|Ki=6uM|Ki|=|6|uM|6000|nM
3ODU|2.50|2010|ITD|Ki=7.3+/-1.4nM(SPA), 25.6+/-4.8nM(Filter plate); IC50=8nM(CXCR4)|P61073|C-X-C CHEMOKINE RECEPTOR TYPE 4, LYSOZYME CHIMERA|8.14|Ki=7.3nM|Ki|=|7.3|nM|7.3|nM
3OE8|3.10|2010|ITD|X-ray:in P1 spacegroup with 3 molecules per asymmetric unit; Ki=7.3+/-1.4nM(SPA), 25.6+/-4.8nM(Filter plate); IC50=8nM(CXCR4)|P61073|C-X-C CHEMOKINE RECEPTOR TYPE 4, LYSOZYME CHIMERA|8.14|Ki=7.3nM|Ki|=|7.3|nM|7.3|nM
3N2C|2.81|2010|LWY|Ki=7.5+/-1.0uM; modified colorimetric Cd-ninhydrin assay; Zn-containing|Q393A1|PROLIDASE|5.12|Ki=7.5uM|Ki|=|7.5|uM|7500|nM
3FV2|1.50|2010|NDZ||P39086|GLUTAMATE RECEPTOR, IONOTROPIC KAINATE 1|8.11|Ki=7.7nM|Ki|=|7.7|nM|7.7|nM
3N9R|1.80|2010|TD3|ligand is compound 2; Zn-containing|D0IR47|FRUCTOSE-BISPHOSPHATE ALDOLASE|7.15|Ki=70nM|Ki|=|70|nM|70|nM
3O86|1.60|2010|BSF|compound 4; IC50=380nM; covalent complex; B-containing|P00811|BETA-LACTAMASE|7.15|Ki=70nM|Ki|=|70|nM|70|nM
2XG9|1.80|2010|GLC-NOJ|ligand is G1M|P16098|BETA-AMYLASE|4.15|Ki=70uM|Ki|=|70|uM|70000|nM
3N7O|1.80|2010|N7O|ligand is compound JNJ-18054478|P23946|CHYMASE|7.14|Ki=72nM|Ki|=|72|nM|72|nM
3KEJ|2.30|2010|3EJ|compound 17a; structure(catalytic domain); Ki=75.9+/-21.1nM(MMP-13/FL)|P45452|COLLAGENASE 3 (MMP-13)|7.12|Ki=75.9nM|Ki|=|75.9|nM|75.9|nM
2KSB|NMR|2010|11-mer|Substance P in isotropic q=0.25 DMPC/CHAPS/GM1 bicelles as a ligand|P25103|SUBSTANCE-P RECEPTOR|3.12|Ki=754uM|Ki|=|754|uM|754000|nM
3MKN|2.00|2010|DNB|competitive inhibitor DAPIR, Ki=76+/-8uM|C3T3U2|PUTATIVE UNCHARACTERIZED PROTEIN YEIK|4.12|Ki=76uM|Ki|=|76|uM|76000|nM
3K4D|2.39|2010|EVA|ligand is Glucaro-d-lactam; Ki=7750+/-475nM; IC50=26400+/-483nM|P05804|BETA-GLUCURONIDASE|5.11|Ki=7750nM|Ki|=|7750|nM|7750|nM
3I4B|2.30|2010|Z48|ligand is compound 2|P49841|GLYCOGEN SYNTHASE KINASE-3 BETA|8.15|Ki=7nM|Ki|=|7|nM|7|nM
3NXQ|1.99|2010|RX4|ligand is analogue 21 (RXP407)|P12821|ANGIOTENSIN-CONVERTING ENZYME|8.15|Ki=7nM|Ki|=|7|nM|7|nM
3OAW|2.75|2010|OAW|Ki=7nM(PI3K alpha); X-ray(PI3K gamma)|P48736|PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE|8.15|Ki=7nM|Ki|=|7|nM|7|nM
3KQE|2.35|2010|LGM|compound 5f|P00742|COAGULATION FACTOR XA, HEAVY CHAIN|8.09|Ki=8.1nM|Ki|=|8.1|nM|8.1|nM
3OE6|3.20|2010|ITD|X-ray:in I222 spacegroup; Ki=8.2+/-1.0nM(SPA), 14+/-1.7nM(Filter plate); IC50=8nM(CXCR4)|P61073|C-X-C CHEMOKINE RECEPTOR TYPE 4, LYSOZYME CHIMERA|8.09|Ki=8.2nM|Ki|=|8.2|nM|8.2|nM
3K39|2.54|2010|BCZ|compound 3 Peramivir; Ki1=8.3nM(no preincubation); Ki2=8.2nM(preincubation); IC501=75.2nM(no preincubation); IC502=41.5nM(preincubation)|Q3S340|NEURAMINIDASE|8.08|Ki=8.3nM|Ki|=|8.3|nM|8.3|nM
3LIL|1.80|2010|EEA||P39900|MACROPHAGE METALLOELASTASE (MMP-12)|8.08|Ki=8.3nM|Ki|=|8.3|nM|8.3|nM
3G2N|2.10|2010|OAK|ligand is compound 5a|P00489|GLYCOGEN PHOSPHORYLASE|4.09|Ki=81uM|Ki|=|81|uM|81000|nM
3K3A|2.59|2010|G39|compound 2 Oseltamivir; Ki1=84.0nM(no preincubation); Ki2=82.0nM(preincubation); IC501=659.7nM(no preincubation); IC502=708.0nM(preincubation)|Q3S340|NEURAMINIDASE|7.08|Ki=84.0nM|Ki|=|84|nM|84|nM
3KWA|2.00|2010|SPM|Ki=84+/-2uM|P00918|CARBONIC ANHYDRASE 2|4.08|Ki=84uM|Ki|=|84|uM|84000|nM
3MOF|1.75|2010|OXL|measured with Mn2+, GDP; Ki=860+/-33uM(A467G); Ki=106+/-6uM(WT)|P07379|PHOSPHOENOLPYRUVATE CARBOXYKINASE|3.07|Ki=860uM|Ki|=|860|uM|860000|nM
2KSA|NMR|2010|11-mer|Substance P in DMPC/CHAPS isotropic q=0.25 bicelles as a ligand|P25103|SUBSTANCE-P RECEPTOR|3.06|Ki=871uM|Ki|=|871|uM|871000|nM
3AHO|1.88|2010|3A2|Zn-containing|Q4W803|OLIGOPEPTIDASE|7.05|Ki=88.9nM|Ki|=|88.9|nM|88.9|nM
3ITH|2.80|2010|EDM|compound DAVP-1; Space Group: P 21|P03366|HIV-1 REVERSE TRANSCRIPTASE/RIBONUCLEASE H|8.1|Ki=8nM|Ki|=|8|nM|8|nM
2KS9|NMR|2010|11-mer|11-mer Substance P, Ki=9020uM|P25103|SUBSTANCE-P RECEPTOR|2.04|Ki=9.02mM|Ki|=|9.02|mM|9020000|nM
3AAU|1.80|2010|GZC|ligand is compound 2; Cu-containing complex|P00760|TRYPSIN|5.05|Ki=9.0uM|Ki|=|9|uM|9000|nM
3MXS|1.24|2010|CZ9|compound 2, Ki=9.8+/-0.5 uM|P0AD64|BETA-LACTAMASE SHV-1|5.01|Ki=9.8uM|Ki|=|9.8|uM|9800|nM
3AHN|1.80|2010|3A1|Zn-containing|Q4W803|OLIGOPEPTIDASE|7.05|Ki=90.1nM|Ki|=|90.1|nM|90.1|nM
3LBK|2.30|2010|K23|IC50=1.71+/-1.1027uM, compound WK23|Q00987|E3 UBIQUITIN-PROTEIN LIGASE MDM2|6.04|Ki=916nM|Ki|=|916|nM|916|nM
3MTW|1.70|2010|M3R|ligand is compound 8; Zn2+ containing; Ki=92+/-10nM(L-Ala-L-Arg as substrate)|Q9A4Z9|L-ARGININE CARBOXYPEPTIDASE CC2672|7.04|Ki=92nM|Ki|=|92|nM|92|nM
3IGP|1.65|2010|DT7|ligand is compound 2|P00918|CARBONIC ANHYDRASE 2|7.02|Ki=94.5nM|Ki|=|94.5|nM|94.5|nM
2X96|1.85|2010|RX3|ligand is RXPA380; Ki=3nM for C-domain of sACE|Q10714|ANGIOTENSIN-CONVERTING ENZYME|4.03|Ki=94uM|Ki|=|94|uM|94000|nM
2XZ5|2.80|2010|ACH|Fragment: RESIDUES 20-236 ; mutant Y53C-MMTS; Ki=98.3+/-0.8uM;|Q8WSF8|ACETYLCHOLINE RECEPTOR|4.01|Ki=98.3uM|Ki|=|98.3|uM|98300|nM
2XC4|1.67|2010|IVK|ligand is compound 11|P00742|COAGULATION FACTOR XA|8.05|Ki=9nM|Ki|=|9|nM|9|nM
3AG9|2.00|2010|A02|ligand is compound ARC-1012; IC50=54nM|P00517|CAMP-DEPENDENT PROTEIN KINASE|8.05|Ki=9nM|Ki|=|9|nM|9|nM
3PPJ|3.70|2011|FOI|Fragment: Kinase domain, UNP residues 432-726;|P15056|SERINE/THREONINE-PROTEIN KINASE B-RAF|8.7|IC<2nM|IC50|<|2|nM|2|nM
2XVD|1.70|2011|AS6|Fragment: KINASE DOMAIN, RESIDUES 598-899; Mutation: YES;|P54760|EPHRIN TYPE-B RECEPTOR 4|8.7|IC=0.002uM|IC50|=|0.002|uM|2|nM
2YAC|2.20|2011|937|IC50=0.002+/-0.001uM; Fragment: KINASE DOMAIN RESIDUES 36-345;|P53350|SERINE/THREONINE-PROTEIN KINASE PLK1|8.7|IC=0.002uM|IC50|=|0.002|uM|2|nM
2XBJ|2.30|2011|XBJ|Fragment: KINASE DOMAIN, RESIDUES 210-531|O96017|SERINE/THREONINE-PROTEIN KINASE CHK2|8.52|IC=0.003uM|IC50|=|0.003|uM|3|nM
2YJ8|1.30|2011|YJ8|Fragment: CATALYTIC DOMAIN, RESIDUES 114-333;|P07711|CATHEPSIN L1|8.19|IC=0.0065uM|IC50|=|0.0065|uM|6.5|nM
2XM9|2.50|2011|LWH|Fragment: KINASE DOMAIN, RESIDUES 210-531|O96017|SERINE/THREONINE-PROTEIN KINASE CHK2|8.05|IC=0.009uM|IC50|=|0.009|uM|9|nM
2YJ2|1.15|2011|YJ2|Fragment: CATALYTIC DOMAIN, RESIDUES 114-333;|P07711|CATHEPSIN L1|7.92|IC=0.012uM|IC50|=|0.012|uM|12|nM
3P7B|1.90|2011|P7B||P47811|MITOGEN-ACTIVATED PROTEIN KINASE 14|7.74|IC=0.018uM|IC50|=|0.018|uM|18|nM
3TWD|1.90|2011|GOB|compound 3|P0ACC7|BIFUNCTIONAL PROTEIN GLMU|7.74|IC=0.018uM|IC50|=|0.018|uM|18|nM
3S7M|2.20|2011|532|ligand is compound (S)-63; IC50=0.01+/-0.01uM|P56817|BETA-SECRETASE 1|8.0|IC=0.01uM|IC50|=|0.01|uM|10|nM
2XU1|1.45|2011|424|Fragment: CATALYTIC DOMAIN, RESIDUES 114-333 ;|P07711|CATHEPSIN L1|7.66|IC=0.022uM|IC50|=|0.022|uM|22|nM
2YJC|1.14|2011|424|Fragment: CATALYTIC DOMAIN, RESIDUES 114-333;|P07711|CATHEPSIN L1|7.66|IC=0.022uM|IC50|=|0.022|uM|22|nM
3P7C|2.30|2011|P7C||P47811|MITOGEN-ACTIVATED PROTEIN KINASE 14|7.66|IC=0.022uM|IC50|=|0.022|uM|22|nM
2Y1X|2.40|2011|845|Fragment: CATALYTIC DOMAIN, RESIDUES 135-482; IC50=0.027+/-0.009uM, use full length protein|Q86X55|HISTONE-ARGININE METHYLTRANSFERASE CARM1|7.57|IC=0.027uM|IC50|=|0.027|uM|27|nM
2YC5|1.60|2011|6BC|IC50=0.035+/-0.007uM; Fragment: RESIDUES 76-302;|P69834|2-C-METHYL-D-ERYTHRITOL 4-PHOSPHATE CYTIDYLYLTRANSFERASE|7.46|IC=0.035uM|IC50|=|0.035|uM|35|nM
3APC|2.54|2011|MMD|Fragment: residues 144-1102;|P48736|PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE|7.44|IC=0.036uM|IC50|=|0.036|uM|36|nM
2YCF|1.77|2011|YCF|IC50=0.03+/-0.03nM; Fragment: CATALYTIC DOMAIN, RESIDUES 210-530;|O96017|SERINE/THREONINE-PROTEIN KINASE CHK2|10.52|IC=0.03nM|IC50|=|0.03|nM|0.03|nM
3PJ8|1.96|2011|404|ligand is compound 7|P24941|CELL DIVISION PROTEIN KINASE 2|7.4|IC=0.04uM|IC50|=|0.04|uM|40|nM
2XX2|1.85|2011|13C|Fragment: N-TERMINAL DOMAIN, RESIDUES 1-214;|P02829|ATP-DEPENDENT MOLECULAR CHAPERONE HSP82|7.3|IC=0.05uM|IC50|=|0.05|uM|50|nM
3P5K|2.09|2011|P5K||P47811|MITOGEN-ACTIVATED PROTEIN KINASE 14|7.12|IC=0.076uM|IC50|=|0.076|uM|76|nM
2XK9|2.35|2011|XK9|Fragment: CATALYTIC KINASE DOMAIN, RESIDUES 210-531; IC50=0.07+/-0.03nM;|A8JZZ5|SERINE/THREONINE-PROTEIN KINASE CHK2|10.15|IC=0.07nM|IC50|=|0.07|nM|0.07|nM
3TGE|1.96|2011|TGE|ligand is compound 1|O76074|CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE|10.15|IC=0.07nM|IC50|=|0.07|nM|0.07|nM
2XX4|2.20|2011|13I|Fragment: N-TERMINAL DOMAIN, RESIDUES 1-214;|P02829|ATP-DEPENDENT MOLECULAR CHAPERONE HSP82|7.1|IC=0.08uM|IC50|=|0.08|uM|80|nM
3S7L|2.16|2011|591|ligand is compound 28; IC50=0.08+/-0.02uM|P56817|BETA-SECRETASE 1|7.1|IC=0.08uM|IC50|=|0.08|uM|80|nM
3UO9|2.30|2011|04A|ligand is BPTES; IC50=0.08+/-0.02uM|O94925|GLUTAMINASE KIDNEY ISOFORM, MITOCHONDRIAL|7.1|IC=0.08uM|IC50|=|0.08|uM|80|nM
2YJ9|1.35|2011|YJ9|Fragment: CATALYTIC DOMAIN, RESIDUES 114-333;|P07711|CATHEPSIN L1|7.02|IC=0.095uM|IC50|=|0.095|uM|95|nM
2YJB|1.40|2011|YJ9|Fragment: CATALYTIC DOMAIN, RESIDUES 114-333;|P07711|CATHEPSIN L1|7.02|IC=0.095uM|IC50|=|0.095|uM|95|nM
3R7Q|2.50|2011|FAV|ligand is compound 1f|P48736|PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE|6.97|IC=0.108uM|IC50|=|0.108|uM|108|nM
3QAQ|2.90|2011|QAQ|ligand is compound 1|P48736|PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE|7.0|IC=0.10uM|IC50|=|0.1|uM|100|nM
3QJ9|2.30|2011|QJ9|ligand is compound 2|P97612|FATTY-ACID AMIDE HYDROLASE 1|7.0|IC=0.10uM|IC50|=|0.1|uM|100|nM
3ZYA|1.90|2011|2A8|ligand is compound 3|Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|7.0|IC=0.10uM|IC50|=|0.1|uM|100|nM
3LQ5|3.00|2011|SLQ|with CyclinT|P50750|CYCLIN-DEPENDENT KINASE 9|6.96|IC=0.11uM|IC50|=|0.11|uM|110|nM
3P78|2.30|2011|P78||P47811|MITOGEN-ACTIVATED PROTEIN KINASE 14|6.96|IC=0.11uM|IC50|=|0.11|uM|110|nM
3QTF|1.57|2011|05S|ligand is compound 19|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|6.96|IC=0.11uM|IC50|=|0.11|uM|110|nM
3R04|1.70|2011|UNQ|ligand is compound 21|P11309|SERINE/THREONINE-PROTEIN KINASE PIM|6.92|IC=0.12uM|IC50|=|0.12|uM|120|nM
3R0I|2.10|2011|C0K|ligand is compound 20b; IC50=0.12+/-0.07uM|P45568|1-DEOXY-D-XYLULOSE 5-PHOSPHATE REDUCTOISOMERASE|6.92|IC=0.12uM|IC50|=|0.12|uM|120|nM
2XU5|1.60|2011|XU5|Fragment: CATALYTIC DOMAIN, RESIDUES 114-333|P07711|CATHEPSIN L1|6.89|IC=0.13uM|IC50|=|0.13|uM|130|nM
3ZRK|2.37|2011|ZRK|compound 11, pIC50=6.9|P49841|GLYCOGEN SYNTHASE KINASE-3 BETA|6.89|IC=0.13uM|IC50|=|0.13|uM|130|nM
3ZRM|2.49|2011|ZRM|compound 13, pIC50=6.9|P49841|GLYCOGEN SYNTHASE KINASE-3 BETA|6.89|IC=0.13uM|IC50|=|0.13|uM|130|nM
2YCQ|2.05|2011|UPX|IC50=0.14+/-0.02nM; Fragment: CATALYTIC DOMAIN, RESIDUES 210-531;|O96017|SERINE/THREONINE-PROTEIN KINASE CHK2|9.85|IC=0.14nM|IC50|=|0.14|nM|0.14|nM
2YC3|1.40|2011|MW5|IC50=0.14+/-0.01uM; Fragment: RESIDUES 76-302;|P69834|2-C-METHYL-D-ERYTHRITOL 4-PHOSPHATE CYTIDYLYLTRANSFERASE|6.85|IC=0.14uM|IC50|=|0.14|uM|140|nM
3QCQ|2.50|2011|3Q0|ligand is compound 12f; PIC50=6.8|O15530|3-PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE 1|6.8|IC=0.158uM|IC50|=|0.158|uM|158|nM
2Y1D|2.05|2011|34F|IC50=0.15+/-0.02uM; Fragment: RESIDUES 24-412; Mn binding|A2VLK3|1-DEOXY-D-XYLULOSE 5-PHOSPHATE REDUCTOISOMERASE|6.82|IC=0.15uM|IC50|=|0.15|uM|150|nM
2XM8|3.40|2011|B4W|Fragment: KINASE DOMAIN, RESIDUES 210-531 ;|O96017|SERINE/THREONINE-PROTEIN KINASE CHK2|6.8|IC=0.16uM|IC50|=|0.16|uM|160|nM
2XNM|1.85|2011|WGZ|Fragment: KINASE DOMAIN, RESIDUES 1-271; IC50=0.16+/-0.02uM|P51955|SERINE/THREONINE-PROTEIN KINASE NEK2|6.8|IC=0.16uM|IC50|=|0.16|uM|160|nM
2XU3|0.90|2011|XU3|Fragment: CATALYTIC DOMAIN, RESIDUES 114-333 ;|P07711|CATHEPSIN L1|6.8|IC=0.16uM|IC50|=|0.16|uM|160|nM
3ZRL|2.48|2011|ZRL|compound 12, pIC50=6.8|P49841|GLYCOGEN SYNTHASE KINASE-3 BETA|6.8|IC=0.16uM|IC50|=|0.16|uM|160|nM
2YIR|2.10|2011|YIR|Fragment: CATALYTIC KINASE DOMAIN, RESIDUES 210-531; IC50=0.17+/-0.01nM|O96017|SERINE/THREONINE-PROTEIN KINASE CHK2|9.77|IC=0.17nM|IC50|=|0.17|nM|0.17|nM
3R21|2.90|2011|D36|ligand is compound 10e|O14965|SERINE/THREONINE-PROTEIN KINASE 6|6.74|IC=0.18uM|IC50|=|0.18|uM|180|nM
3PIX|1.85|2011|027|Fragment: unp residues 387-659;|Q06187|TYROSINE-PROTEIN KINASE BTK|7.0|IC=0.1uM|IC50|=|0.1|uM|100|nM
2XX5|2.00|2011|13N|Fragment: N-TERMINAL DOMAIN, RESIDUES 1-214;|P02829|ATP-DEPENDENT MOLECULAR CHAPERONE HSP82|6.7|IC=0.20uM|IC50|=|0.2|uM|200|nM
3O9L|2.40|2011|LPN|IC50=0.22nM(Buffer), 12.3(Plasma); Fragment: unp residues 67-232;|P00797|RENIN|9.66|IC=0.22nM|IC50|=|0.22|nM|0.22|nM
2Y5K|2.10|2011|YCU||P09467|FRUCTOSE-1,6-BISPHOSPHATASE 1|6.66|IC=0.22uM|IC50|=|0.22|uM|220|nM
3OW6|1.80|2011|MEX||P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|6.66|IC=0.22uM|IC50|=|0.22|uM|220|nM
3OPM|2.72|2011|LUI|Fragment: DPP4; Mutation: N-terminal His tag;|P27487|DIPEPTIDYL PEPTIDASE 4|6.62|IC=0.24uM|IC50|=|0.24|uM|240|nM
2YIT|2.20|2011|YIT|IC50=0.29+/-0.14nM; Fragment: CHK2 CATALYTIC DOMAIN, RESIDUES 210-531;|O96017|SERINE/THREONINE-PROTEIN KINASE CHK2|9.54|IC=0.29nM|IC50|=|0.29|nM|0.29|nM
3PIY|2.55|2011|585|Fragment: unp residues 387-659;|Q06187|TYROSINE-PROTEIN KINASE BTK|6.54|IC=0.29uM|IC50|=|0.29|uM|290|nM
3SL8|2.60|2011|JN7|ligand is compound 10o|Q08499|CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D|6.54|IC=0.29uM|IC50|=|0.29|uM|290|nM
3N5K|2.20|2011|TG1|ligand is compound 1a, thapsigargin|P04191|SARCOPLASMIC/ENDOPLASMIC RETICULUM CALCIUM ATPASE 1, SERCA1A|9.7|IC=0.2nM|IC50|=|0.2|nM|0.2|nM
3ZS0|2.30|2011|ZS0||P05164|MYELOPEROXIDASE LIGHT CHAIN|6.7|IC=0.2uM|IC50|=|0.2|uM|200|nM
3QCS|2.49|2011|3Q1|ligand is compound 12k; PIC50=6.5|O15530|3-PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE 1|6.5|IC=0.316uM|IC50|=|0.316|uM|316|nM
3U6A|2.20|2011|18P|R-18a, isomer compound|P56817|BETA-SECRETASE 1|6.49|IC=0.324uM|IC50|=|0.324|uM|324|nM
3P3U|1.50|2011|3M4|ligand is compound 9|P02766|TRANSTHYRETIN|6.48|IC=0.3291uM|IC50|=|0.3291|uM|329.1|nM
3QAR|2.65|2011|QAR|ligand is compound 32|P48736|PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE|6.49|IC=0.32uM|IC50|=|0.32|uM|320|nM
2X24|2.40|2011|X24||------|ACETYL-COA CARBOXYLASE|6.48|IC=0.33uM|IC50|=|0.33|uM|330|nM
2Y5L|2.20|2011|RO8||P09467|FRUCTOSE-1,6-BISPHOSPHATASE 1|6.48|IC=0.33uM|IC50|=|0.33|uM|330|nM
2XU4|1.12|2011|DJT|Fragment: CATALYTIC DOMAIN, RESIDUES 114-333|P07711|CATHEPSIN L1|6.47|IC=0.34uM|IC50|=|0.34|uM|340|nM
2XNP|1.98|2011|WCX|IC50=0.36+/-0.06uM; Fragment: KINASE DOMAIN, RESIDUES 1-271;|P51955|SERINE/THREONINE-PROTEIN KINASE NEK2|6.44|IC=0.36uM|IC50|=|0.36|uM|360|nM
3QKK|2.30|2011|SMH|ligand is compound 21|P31749|RAC-ALPHA SERINE/THREONINE-PROTEIN KINASE|6.52|IC=0.3uM|IC50|=|0.3|uM|300|nM
3QUP|1.90|2011|LUN|ligand is compound 11|P55144|TYROSINE-PROTEIN KINASE RECEPTOR TYRO3|6.32|IC=0.476uM|IC50|=|0.476|uM|476|nM
3Q4B|2.19|2011|RX5|compound 9, fragment: UNP residues 70-406; IC50=0.47 nM(0.3nM renin), 0.30 nM(36 pM renin) and 1.1 nM (plasma)|P00797|RENIN|9.33|IC=0.47nM|IC50|=|0.47|nM|0.47|nM
3SFI|2.31|2011|3SF|ligand is compound 42|P96222|TRANSCRIPTIONAL REGULATORY REPRESSOR PROTEIN|6.4|IC=0.4uM|IC50|=|0.4|uM|400|nM
3ZS1|2.60|2011|PVW||P05164|MYELOPEROXIDASE LIGHT CHAIN|6.4|IC=0.4uM|IC50|=|0.4|uM|400|nM
3P7A|2.31|2011|P7A||P47811|MITOGEN-ACTIVATED PROTEIN KINASE 14|6.28|IC=0.52uM|IC50|=|0.52|uM|520|nM
3TI6|1.69|2011|G39|ligand is oseltamivir|C3W5S3|NEURAMINIDASE|9.27|IC=0.54nM|IC50|=|0.54|nM|0.54|nM
3Q5H|2.16|2011|RX6|compound 3, fragment: UNP residues 67-406; IC50=0.56 nM(0.3nM renin), 0.42 nM(36 pM renin) and 0.48 nM (plasma)|P00797|RENIN|6.25|IC=0.56uM|IC50|=|0.56|uM|560|nM
3RO4|2.60|2011|LJ9|ligand is compound 20f|P50053|KETOHEXOKINASE|6.23|IC=0.59uM|IC50|=|0.59|uM|590|nM
3O23|2.10|2011|MQY|Fragment: Kinase domain; Mutation: Y987F;|P08069|INSULIN-LIKE GROWTH FACTOR 1 RECEPTOR|6.3|IC=0.5uM|IC50|=|0.5|uM|500|nM
3QCJ|2.26|2011|NX4|ligand is compound 15|P23470|RECEPTOR-TYPE TYROSINE-PROTEIN PHOSPHATASE GAMMA|6.3|IC=0.5uM|IC50|=|0.5|uM|500|nM
2YKJ|1.46|2011|YKJ|Fragment: N-DOMAIN, RESIDUES 18-233;|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|6.21|IC=0.61uM|IC50|=|0.61|uM|610|nM
2YB9|2.40|2011|HA0|Zn-containing; Fragment: RESIDUES 55-750;|P08473|NEPRILYSIN|9.22|IC=0.6nM|IC50|=|0.6|nM|0.6|nM
2YE9|2.20|2011|2D4|ligand is compound 13, FP enzyme IC50=0.6uM|P07900|HEAT SHOCK PROTEIN HSP 90-ALPHA|6.22|IC=0.6uM|IC50|=|0.6|uM|600|nM
3S1Y|1.40|2011|S1Y|ligand is compound 6, structure is a little diffrent from PDB|P24735|BETA-LACTAMASE|6.22|IC=0.6uM|IC50|=|0.6|uM|600|nM
3QG6|2.50|2011|8-mer|8-mer autoinducing peptides (AIPs) group 4|Q9F6Z3|AP4-24H11 LIGHT CHAIN|9.14|IC=0.73nM|IC50|=|0.73|nM|0.73|nM
2XYR|2.50|2011|SFG|Fragment: RESIDUES 6776-7067; ternary complex|P0C6X7|PUTATIVE 2'-O-METHYL TRANSFERASE|6.13|IC=0.74uM|IC50|=|0.74|uM|740|nM
3R2A|3.00|2011|RHN|ligand is Rhein|P19793|RETINOIC ACID RECEPTOR RXR-ALPHA|6.12|IC=0.75uM|IC50|=|0.75|uM|750|nM
2YKC|1.67|2011|YKC|Fragment: N-DOMAIN, RESIDUES 18-233;|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|6.11|IC=0.78uM|IC50|=|0.78|uM|780|nM
3RSV|2.50|2011|3RS|ligand is compound 57|P56817|BETA-SECRETASE 1|9.15|IC=0.7nM|IC50|=|0.7|nM|0.7|nM
3SN7|1.82|2011|540|ligand is compound 96; IC50=0.7+/-0.03nM|Q9Y233|CGMP 3',5'-CYCLIC PHOSPHODIESTERASE|9.15|IC=0.7nM|IC50|=|0.7|nM|0.7|nM
3SNL|2.40|2011|548|ligand is compound 115; IC50=0.7+/-0.03nM|Q9Y233|CGMP 3',5'-CYCLIC PHOSPHODIESTERASE|9.15|IC=0.7nM|IC50|=|0.7|nM|0.7|nM
2Y1G|1.95|2011|FM5|IC50=0.7+/-0.1uM; Fragment: RESIDUES 24-412; Mn binding|A2VLK3|1-DEOXY-D-XYLULOSE 5-PHOSPHATE REDUCTOISOMERASE|6.15|IC=0.7uM|IC50|=|0.7|uM|700|nM
3OSW|2.55|2011|XDI|Fragment: ligand binding domain;|P37231|PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA|6.15|IC=0.7uM|IC50|=|0.7|uM|700|nM
3RM8|1.80|2011|RM8|ligand is compound 2|Q9BZP6|ACIDIC MAMMALIAN CHITINASE|6.15|IC=0.7uM|IC50|=|0.7|uM|700|nM
3MW1|2.80|2011|MIH|IC50=0.82+/-1.98nM|Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|9.09|IC=0.82nM|IC50|=|0.82|nM|0.82|nM
3RHX|2.01|2011|3RH|ligand is ARQ 069; IC50=0.84+/-0.15uM|P11362|BASIC FIBROBLAST GROWTH FACTOR RECEPTOR 1|6.08|IC=0.84uM|IC50|=|0.84|uM|840|nM
2YIW|2.00|2011|YIW||Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|9.1|IC=0.8nM|IC50|=|0.8|nM|0.8|nM
3QRI|2.10|2011|919|ligand is DCC-2036|P00519|TYROSINE-PROTEIN KINASE ABL1|9.1|IC=0.8nM|IC50|=|0.8|nM|0.8|nM
3RCJ|1.70|2011|3RC|ligand is compound 8f|O15530|3-PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE 1|6.1|IC=0.8uM|IC50|=|0.8|uM|800|nM
3TI8|1.60|2011|LNV|ligand is laninamivir|A1ILL9|NEURAMINIDASE|9.05|IC=0.90nM|IC50|=|0.9|nM|0.9|nM
3R0T|1.75|2011|FU9|CK2:Fragment: unp residues 1-337;|P68400|CASEIN KINASE II, ALPHA SUBUNIT|9.04|IC=0.91nM|IC50|=|0.91|nM|0.91|nM
2YG2|1.70|2011|FLC||O95445|APOLIPOPROTEIN M|6.05|IC=0.9uM|IC50|=|0.9|uM|900|nM
3SKH|2.50|2011|058|ligand is compound 1|O92972|RNA-DIRECTED RNA POLYMERASE|6.05|IC=0.9uM|IC50|=|0.9|uM|900|nM
3TJD|2.90|2011|6TP|ligand is compound 19|O60674|TYROSINE-PROTEIN KINASE JAK2|9.0|IC=1.0nM|IC50|=|1|nM|1|nM
3TI5|1.90|2011|ZMR|ligand is zanamivir|C3W5S3|NEURAMINIDASE|8.95|IC=1.11nM|IC50|=|1.11|nM|1.11|nM
2XNO|1.98|2011|ED8|Fragment: RESIDUES 1-271; IC50=1.18+/-0.16uM|P51955|SERINE/THREONINE-PROTEIN KINASE NEK2|5.93|IC=1.18uM|IC50|=|1.18|uM|1180|nM
3S7A|1.80|2011|684|ligand is PT684, Human dihydrofolate reductase binary complex with PT684|P00374|DIHYDROFOLATE REDUCTASE|8.96|IC=1.1nM|IC50|=|1.1|nM|1.1|nM
2YKB|1.93|2011|YKB|Fragment: N-DOMAIN, RESIDUES 18-233;|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|5.96|IC=1.1uM|IC50|=|1.1|uM|1100|nM
2YKE|1.43|2011|YKE|Fragment: N-DOMAIN, RESIDUES 18-233;|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|5.96|IC=1.1uM|IC50|=|1.1|uM|1100|nM
3MG8|2.59|2011|L3T|multi component!!compound 16; IC50=1.2+/-0.35nM for S20 beta5c(substrate Ac-WLA-AMC); Ki below 0.25nM(substrate Suc-LLVY-AMC)|P23639|PROTEASOME COMPONENT Y7|8.92|IC=1.2nM|IC50|=|1.2|nM|1.2|nM
3QO9|2.60|2011|QO9|ligand is compound 7(TSAO-T); IC50=1.2+/-0.14uM|P03366|HIV-1 REVERSE TRANSCRIPTASE/RIBONUCLEASE H|5.92|IC=1.2uM|IC50|=|1.2|uM|1200|nM
2YCS|2.35|2011|NXP|IC50=1.36+/-0.71nM; Fragment: CATALYTIC DOMAIN, RESIDUES 210-531;|O96017|SERINE/THREONINE-PROTEIN KINASE CHK2|8.87|IC=1.36nM|IC50|=|1.36|nM|1.36|nM
3TIC|1.89|2011|ZMR|ligand is zanamivir|Q194T1|NEURAMINIDASE|8.87|IC=1.36nM|IC50|=|1.36|nM|1.36|nM
4A23|2.40|2011|C56|ligand is c5685, mixed isomer ligand code is C56 or C57; IC50=1.3+/-0.1uM|P21836|ACETYLCHOLINESTERASE|5.89|IC=1.3uM|IC50|=|1.3|uM|1300|nM
3RXA|1.70|2011|SZ1|Kinetic study using fluorescence-based substrate|P00760|TRYPSIN|2.85|IC=1.4mM|IC50|=|1.4|mM|1400000|nM
3PPK|3.00|2011|FNI|Fragment: Kinase domain, UNP residues 432-726;|P15056|SERINE/THREONINE-PROTEIN KINASE B-RAF|8.85|IC=1.4nM|IC50|=|1.4|nM|1.4|nM
3PRF|2.90|2011|FP3|Fragment: Kinase domain, UNP residues 432-726;|P15056|SERINE/THREONINE-PROTEIN KINASE B-RAF|8.85|IC=1.4nM|IC50|=|1.4|nM|1.4|nM
3R2F|2.53|2011|PB0|ligand is compound 28a; IC50=1.4nM(HPLC)|P56817|BETA-SECRETASE 1|8.85|IC=1.4nM|IC50|=|1.4|nM|1.4|nM
3NZW|2.50|2011|5-mer|TMC-95A mimic ligand 2b, IC50=1.5+/-0.1uM|P23639|PROTEASOME COMPONENT Y7|5.82|IC=1.5uM|IC50|=|1.5|uM|1500|nM
3SJO|1.70|2011|AG7||E0WWC7|3C PROTEASE|5.78|IC=1.65uM|IC50|=|1.65|uM|1650|nM
3QFV|2.65|2011|NM7|IC50=1.69+/-0.13uM|Q86XZ8|CDC42BPB PROTEIN|5.77|IC=1.69uM|IC50|=|1.69|uM|1690|nM
3SKC|3.20|2011|BR2|ligand is compound 64|P15056|SERINE/THREONINE-PROTEIN KINASE B-RAF|8.8|IC=1.6nM|IC50|=|1.6|nM|1.6|nM
3S3Q|1.80|2011|C1P|ligand is K11017; IC50=1.71+/-0.13nM; covalent complex|Q8MNY2|CATHEPSIN B-LIKE PEPTIDASE (C01 FAMILY)|8.77|IC=1.71nM|IC50|=|1.71|nM|1.71|nM
3RZ3|2.30|2011|U94|IC50=1.72+/-0.36uM|P49427|UBIQUITIN-CONJUGATING ENZYME E2 R1|5.76|IC=1.72uM|IC50|=|1.72|uM|1720|nM
2YIS|2.00|2011|YIS||Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|8.77|IC=1.7nM|IC50|=|1.7|nM|1.7|nM
3TI3|1.80|2011|LNV|ligand is laninamivir|C3W5S3|NEURAMINIDASE|8.74|IC=1.83nM|IC50|=|1.83|nM|1.83|nM
3Q32|2.50|2011|J2I|Fragment: protein kinase 2 domain (UNP residues 839-1132);|O60674|TYROSINE-PROTEIN KINASE JAK2|8.74|IC=1.8nM|IC50|=|1.8|nM|1.8|nM
3R7R|2.90|2011|FAZ|ligand is compound 6|P48736|PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE|8.74|IC=1.8nM|IC50|=|1.8|nM|1.8|nM
2XK1|2.80|2011|EWB|covalent complex, B containing, IC50 = 1.8+/-0.1 uM ; assay method in SI|P39045|D-ALANYL-D-ALANINE CARBOXYPEPTIDASE|5.74|IC=1.8uM|IC50|=|1.8|uM|1800|nM
3TKU|2.15|2011|M77|IC50=1.92+/-0.36uM|Q9Y5S2|SERINE/THREONINE-PROTEIN KINASE MRCK BETA|5.72|IC=1.92uM|IC50|=|1.92|uM|1920|nM
3T9T|1.65|2011|IAQ|ligand is compound 36|Q08881|TYROSINE-PROTEIN KINASE ITK/TSK|8.71|IC=1.93nM|IC50|=|1.93|nM|1.93|nM
3B1U|2.10|2011|YFF|IC50=1.9+/-0.21uM;|Q9UM07|PROTEIN-ARGININE DEIMINASE TYPE-4|5.72|IC=1.9uM|IC50|=|1.9|uM|1900|nM
3RV3|1.91|2011|ADP|Mg2+ containing|P24182|BIOTIN CARBOXYLASE|2.0|IC=10mM|IC50|=|10|mM|10000000|nM
3QD3|2.00|2011|3Q5|ligand is compound (3R, 6S)-37c; PIC50=8.0|O15530|3-PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE 1|8.0|IC=10nM|IC50|=|10|nM|10|nM
2Y6C|1.70|2011|TQI|Zn-containing; Fragment: RESIDUES 95-258; pIC50=5.0|P09237|MATRILYSIN|5.0|IC=10uM|IC50|=|10|uM|10000|nM
3R5J|1.77|2011|6-mer|ligand is peptide (ACE)ADVAD-CHO|P42575|CASPASE-2 SUBUNIT P18|6.96|IC=110nM|IC50|=|110|nM|110|nM
3TV4|3.40|2011|TV4|compound 5, crystal is wildtype, affinity assay is for B-Raf V600E mutant|P15056|SERINE/THREONINE-PROTEIN KINASE B-RAF|6.96|IC=110nM|IC50|=|110|nM|110|nM
3SVV|2.20|2011|VSP|ligand is compound 9|P00523|TYROSINE-PROTEIN KINASE SRC|6.94|IC=114nM|IC50|=|114|nM|114|nM
3QI4|2.50|2011|IBM|IC50=117.2+/-1.2uM|O76083|CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE-9|3.93|IC=117.2uM|IC50|=|117.2|uM|117200|nM
3NWB|1.30|2011|659|compound 5, with Mg2+; radiochemical assay|P22734|CATECHOL O-METHYLTRANSFERASE|7.96|IC=11nM|IC50|=|11|nM|11|nM
3PP0|2.25|2011|03Q|ligand is SYR127063|P04626|RECEPTOR TYROSINE-PROTEIN KINASE ERBB-2|7.96|IC=11nM|IC50|=|11|nM|11|nM
3RVI|2.65|2011|RVI|ligand is compound 50|P56817|BETA-SECRETASE 1|7.96|IC=11nM|IC50|=|11|nM|11|nM
3SNI|1.90|2011|546|ligand is compound 74; IC50=11+/-1.1nM|Q9Y233|CGMP 3',5'-CYCLIC PHOSPHODIESTERASE|7.96|IC=11nM|IC50|=|11|nM|11|nM
2XSB|2.11|2011|GDL||Q2CEE3|HYALURONOGLUCOSAMINIDASE|4.96|IC=11uM|IC50|=|11|uM|11000|nM
2YIQ|1.89|2011|YIQ|Fragment: CATALYTIC KINASE DOMAIN, RESIDUES 210-531; IC50=12.67+/-11.90nM;|O96017|SERINE/THREONINE-PROTEIN KINASE CHK2|7.9|IC=12.67nM|IC50|=|12.67|nM|12.67|nM
2XEL|2.50|2011|IA2|IC50=126.6+/-21 uM; Fragment: MOTOR DOMAIN, RESUDES 2-761;|P08799|MYOSIN-2 HEAVY CHAIN|3.9|IC=126.6uM|IC50|=|126.6|uM|126600|nM
3TIB|2.20|2011|LVO|ligand is laninamivir octanoate(CS-8958)|Q194T1|NEURAMINIDASE|6.89|IC=129nM|IC50|=|129|nM|129|nM
2Y0J|2.43|2011|AXC|Fragment: CATALYTIC DOMAIN, RESIDUES 432-764;|Q9Y233|CGMP 3',5'-CYCLIC PHOSPHODIESTERASE|7.92|IC=12nM|IC50|=|12|nM|12|nM
3O0U|1.80|2011|O47|Covalent complex; Fragment: UNP Residues 115-329;|P43235|CATHEPSIN K|7.92|IC=12nM|IC50|=|12|nM|12|nM
3QPP|1.80|2011|PFW|ligand is compound 16|Q9QYJ6|PHOSPHODIESTERASE|7.92|IC=12nM|IC50|=|12|nM|12|nM
3SZB|1.51|2011|I1E|ligand is Aldi-1; IC50=12+/-1.0uM; covalent complex; ligand undergoes a beta-elimination progress|P30838|ALDEHYDE DEHYDROGENASE|4.92|IC=12uM|IC50|=|12|uM|12000|nM
2YLO|2.50|2011|YLO|Fragment: LIGAND-BINDING DOMAIN, RESIDUES 664-919; IC50=13.1+/-1.2uM;|P10275|ANDROGEN RECEPTOR|4.88|IC=13.1uM|IC50|=|13.1|uM|13100|nM
3SIE|1.93|2011|5BO|ligand is compound 4; IC50=13.3+/-4.5nM|O76074|CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE|7.88|IC=13.3nM|IC50|=|13.3|nM|13.3|nM
2YIU|2.70|2011|SMA|Paracoccus denitrificans dimeric CYTOCHROME BC1 complex with stigmatellin A|P05418|CYTOCHROME B|6.89|IC=130nM|IC50|=|130|nM|130|nM
3PY0|1.75|2011|SU9||P24941|CELL DIVISION PROTEIN KINASE 2|6.89|IC=130nM|IC50|=|130|nM|130|nM
3PY1|2.05|2011|SU9||P24941|CELL DIVISION PROTEIN KINASE 2|6.89|IC=130nM|IC50|=|130|nM|130|nM
2XIZ|2.21|2011|XIZ|Fragment: KINASE DOMAIN, RESIDUES 14-313;|P11309|SERINE/THREONINE PROTEIN KINASE PIM|3.89|IC=130uM|IC50|=|130|uM|130000|nM
3SRC|2.00|2011|28N|ligand is NS2028|Q9I194|ACYL-HOMOSERINE LACTONE ACYLASE PVDQ|3.89|IC=130uM|IC50|=|130|uM|130000|nM
3NPA|1.97|2011|Z57|IC50=136.4+/-4.9uM|P00489|GLYCOGEN PHOSPHORYLASE|3.87|IC=136.4uM|IC50|=|136.4|uM|136400|nM
3MG7|2.78|2011|L2T|multi component!!compound 8; IC50=13nM for 20S beta5c site(substrate Ac-WLA-AMC)|P23639|PROTEASOME COMPONENT Y7|7.89|IC=13nM|IC50|=|13|nM|13|nM
3ATK|1.74|2011|SZ1||P00760|TRYPSIN|2.85|IC=1400uM|IC50|=|1400|uM|1400000|nM
3PZ3|2.00|2011|PZ3|Zn2+ binding; IC50=141+/-26 nM; PDB error;|Q08602|GERANYLGERANYL TRANSFERASE TYPE-2 SUBUNIT ALPHA|6.85|IC=141nM|IC50|=|141|nM|141|nM
3OOZ|1.80|2011|ZOO||P56817|BETA-SECRETASE 1|7.85|IC=14nM|IC50|=|14|nM|14|nM
3QTI|2.00|2011|3QT||P08581|HEPATOCYTE GROWTH FACTOR RECEPTOR|7.85|IC=14nM|IC50|=|14|nM|14|nM
3TL5|2.79|2011|980|ligand is compound 2|P48736|PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE|7.85|IC=14nM|IC50|=|14|nM|14|nM
2YEM|2.30|2011|WSH|Fragment: C-TERMINAL BROMODOMAIN, RESIDUES 333-460; IC50=15.5+/-1.9nM|O60885|BROMODOMAIN-CONTAINING PROTEIN 2|7.81|IC=15.5nM|IC50|=|15.5|nM|15.5|nM
3RXH|1.70|2011|HSM||P00760|TRYPSIN|1.8|IC=15.7mM|IC50|=|15.7|mM|15700000|nM
2XJ0|3.10|2011|XJ0|Fragment: KINASE DOMAIN, RESIDUES 14-313;|P11309|SERINE/THREONINE PROTEIN KINASE PIM|2.82|IC=1500uM|IC50|=|1500|uM|1500000|nM
2YC0|2.15|2011|2HG|Fe-containing; IC50=1500+/-400uM|Q9NWT6|HYPOXIA-INDUCIBLE FACTOR 1-ALPHA INHIBITOR|2.82|IC=1500uM|IC50|=|1500|uM|1500000|nM
3QBH|2.24|2011|QBH||P56817|BETA-SECRETASE 1|6.82|IC=150nM|IC50|=|150|nM|150|nM
3TPP|1.60|2011|5HA||P56817|BETA-SECRETASE 1|7.82|IC=15nM|IC50|=|15|nM|15|nM
2XP8|2.10|2011|4FY||Q13526|PEPTIDYL-PROLYL CIS-TRANS ISOMERASE NIMA-INTERACTIN|4.82|IC=15uM|IC50|=|15|uM|15000|nM
3AS3|2.40|2011|I5I|P21-A; ligand is 2-(imidazolin-2-yl)-5-isothiocyanatobenzofuran, IMI;IC50=160+/-78uM(pNP assay)|Q9AMP1|CHITINASE A|3.8|IC=160uM|IC50|=|160|uM|160000|nM
3QI3|2.30|2011|PDB|ligand is (S)-BAY73-6691; IC50=164.2+/-1.2uM|O76083|CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE-9|3.78|IC=164.2uM|IC50|=|164.2|uM|164200|nM
2XTK|2.00|2011|AZM|ligand is acetazolamide; IC50=164+/-75uM|B0Y2Y2|CLASS III CHITINASE CHIA1|3.79|IC=164uM|IC50|=|164|uM|164000|nM
3L9L|2.00|2011|L9L|compound 36; IC50=167+/-50nM|P17612|CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTIC|6.78|IC=167nM|IC50|=|167|nM|167|nM
3S0J|2.00|2011|Z15|IC50=169.9+/-10uM|P00489|GLYCOGEN PHOSPHORYLASE|3.77|IC=169.9uM|IC50|=|169.9|uM|169900|nM
3NUU|1.98|2011|JOZ|compound 11|Q9UPJ8|PKB-LIKE|3.77|IC=169uM|IC50|=|169|uM|169000|nM
3OY1|1.70|2011|589||P53779|MITOGEN-ACTIVATED PROTEIN KINASE 10|7.8|IC=16nM|IC50|=|16|nM|16|nM
3T07|3.30|2011|09C|IC50=16+/-9nM|Q6GG09|PYRUVATE KINASE|7.8|IC=16nM|IC50|=|16|nM|16|nM
2Y2J|2.06|2011|ZA4|Fragment: TRANSPEPTIDASE DOMAIN, RESIDUES 101-125, 323-791; Mutation: YES; IC50=16+/-1uM; B containing, covalent complex|Q7CRA4|PENICILLIN-BINDING PROTEIN 1B|4.8|IC=16uM|IC50|=|16|uM|16000|nM
3Q3B|2.70|2011|55E||P49841|GLYCOGEN SYNTHASE KINASE-3 BETA|7.76|IC=17.2nM|IC50|=|17.2|nM|17.2|nM
3ATL|1.74|2011|BEN||P00760|TRYPSIN|4.76|IC=17.2uM|IC50|=|17.2|uM|17200|nM
3RXE|1.70|2011|BEN|Kinetic study using fluorescence-based substrate|P00760|TRYPSIN|4.76|IC=17.2uM|IC50|=|17.2|uM|17200|nM
3QPN|2.00|2011|PFK|ligand is compound 24|Q9QYJ6|PHOSPHODIESTERASE|7.77|IC=17nM|IC50|=|17|nM|17|nM
3R22|2.90|2011|D37|ligand is compound 2|O14965|SERINE/THREONINE-PROTEIN KINASE 6|7.77|IC=17nM|IC50|=|17|nM|17|nM
3RCD|3.21|2011|03P|ligand is 34e|P04626|RECEPTOR TYROSINE-PROTEIN KINASE ERBB-2|7.77|IC=17nM|IC50|=|17|nM|17|nM
3RQ7|1.55|2011|7-mer|ligand is C6H5(CH2)8-derivatized peptide inhibitor(4j)|P53350|SERINE/THREONINE-PROTEIN KINASE PLK1|7.77|IC=17nM|IC50|=|17|nM|17|nM
3SKE|1.97|2011|054|ligand is compound 7r|O92972|HCV NS5B RNA_DEPENDENT RNA POLYMERASE|7.77|IC=17nM|IC50|=|17|nM|17|nM
3PDQ|1.99|2011|KC6|Ni binding; Fragment: Catalytic domain, residues 1-359;|O75164|LYSINE-SPECIFIC DEMETHYLASE 4A|6.74|IC=180nM|IC50|=|180|nM|180|nM
3S0N|1.95|2011|0BB|ligand is compound 2|P23946|CHYMASE|6.74|IC=180nM|IC50|=|180|nM|180|nM
2XP4|1.80|2011|G14||Q13526|PEPTIDYL-PROLYL CIS-TRANS ISOMERASE NIMA-INTERACTIN|3.74|IC=180uM|IC50|=|180|uM|180000|nM
3MRV|1.94|2011|16F|IC50=180+/-7.8 uM|P00489|GLYCOGEN PHOSPHORYLASE|3.74|IC=180uM|IC50|=|180|uM|180000|nM
3ATI|1.71|2011|SZ4||P00760|TRYPSIN|3.73|IC=188uM|IC50|=|188|uM|188000|nM
3RXD|1.70|2011|SZ4|Kinetic study using fluorescence-based substrate, ligand structure in reference is a little different from PDB|P00760|TRYPSIN|3.73|IC=188uM|IC50|=|188|uM|188000|nM
2YDE|2.28|2011|S2G|Fe-containing; IC50=189+/-34uM|Q9NWT6|HYPOXIA-INDUCIBLE FACTOR 1-ALPHA INHIBITOR|3.72|IC=189uM|IC50|=|189|uM|189000|nM
3O9V|2.75|2011|10T|IC50=17-19 nM|P27487|DIPEPTIDYL PEPTIDASE 4|7.74|IC=18nM|IC50|=|18|nM|18|nM
3OHH|2.01|2011|3HH||P56817|BETA-SECRETASE 1|7.74|IC=18nM|IC50|=|18|nM|18|nM
3QK5|2.20|2011|QK5|ligand is compound 45|P97612|FATTY-ACID AMIDE HYDROLASE 1|7.74|IC=18nM|IC50|=|18|nM|18|nM
2XZG|1.70|2011|VH1|Fragment: N-TERMINAL DOMAIN, RESIDUES 1-364;|Q00610|CLATHRIN HEAVY CHAIN 1|4.74|IC=18uM|IC50|=|18|uM|18000|nM
3TPR|2.55|2011|5HA|ligand is compound IV|P56817|BETA-SECRETASE 1|7.7|IC=19.9nM|IC50|=|19.9|nM|19.9|nM
3MS2|2.10|2011|18S|IC50=192.4+/-5.8 uM|P00489|GLYCOGEN PHOSPHORYLASE|3.72|IC=192.4uM|IC50|=|192.4|uM|192400|nM
3ZST|2.30|2011|ACX|alpha CD, not a common ligand|Q9L1K2|PUTATIVE GLUCANOHYDROLASE PEP1A GLGE ISOFORM 1|1.72|IC=19mM|IC50|=|19|mM|19000000|nM
3OWB|2.05|2011|BSM|IC50=19+/-2 nM|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|7.72|IC=19nM|IC50|=|19|nM|19|nM
3R02|1.95|2011|UNM|ligand is compound 38|P11309|SERINE/THREONINE-PROTEIN KINASE PIM|9.0|IC=1nM|IC50|=|1|nM|1|nM
3SJI|1.80|2011|AG7|ligand is rupintrivir|C8CIL7|3C PROTEASE|5.69|IC=2.06uM|IC50|=|2.06|uM|2060|nM
3S3R|2.64|2011|0IW|ligand is K11777; IC50=2.09+/-0.08nM; covalent complex|Q8MNY2|CATHEPSIN B-LIKE PEPTIDASE (C01 FAMILY)|8.68|IC=2.09nM|IC50|=|2.09|nM|2.09|nM
2XPB|2.00|2011|4GE||Q13526|PEPTIDYL-PROLYL CIS-TRANS ISOMERASE NIMA-INTERACTIN|5.7|IC=2.0uM|IC50|=|2|uM|2000|nM
3RXK|1.60|2011|SZ8|Kinetic study using fluorescence-based substrate|P00760|TRYPSIN|2.68|IC=2.1mM|IC50|=|2.1|mM|2100000|nM
3P76|1.93|2011|P76|Zn binding; Fragment: UNP residues 1-271; X-ray:AaLpxc, Assay:eeLpxc|O67648|UDP-3-O-[3-HYDROXYMYRISTOYL] N-ACETYLGLUCOSAMINE|8.68|IC=2.1nM|IC50|=|2.1|nM|2.1|nM
3RXB|1.70|2011|ALG|Kinetic study using fluorescence-based substrate|P00760|TRYPSIN|2.66|IC=2.2mM|IC50|=|2.2|mM|2200000|nM
3B1T|2.50|2011|YCL|IC50=2.2+/-0.31uM;|Q9UM07|PROTEIN-ARGININE DEIMINASE TYPE-4|5.66|IC=2.2uM|IC50|=|2.2|uM|2200|nM
3OXI|2.20|2011|SYY|Fragment: UNP residues 40 to 401; with JIP1 peptide|P53779|MITOGEN-ACTIVATED PROTEIN KINASE 10|5.66|IC=2.2uM|IC50|=|2.2|uM|2200|nM
3P79|2.10|2011|P79||P47811|MITOGEN-ACTIVATED PROTEIN KINASE 14|5.64|IC=2.3uM|IC50|=|2.3|uM|2300|nM
3QZQ|1.70|2011|AG7|not a good affinity data|E7E815|3C PROTEASE|5.64|IC=2.3uM|IC50|=|2.3|uM|2300|nM
3RXL|1.70|2011|SZ9|Kinetic study using fluorescence-based substrate|P00760|TRYPSIN|2.62|IC=2.4mM|IC50|=|2.4|mM|2400000|nM
3QQU|2.90|2011|01P|ligand is pyrimidine 8|P08069|INSULIN-LIKE GROWTH FACTOR 1 RECEPTOR|8.62|IC=2.4nM|IC50|=|2.4|nM|2.4|nM
3RXF|1.70|2011|4AP|Kinetic study using fluorescence-based substrate|P00760|TRYPSIN|2.6|IC=2.5mM|IC50|=|2.5|mM|2500000|nM
3NZI|2.75|2011|7-mer|covalent complex; Peptide: B containing; HTRA1: Fragment: unp residues 158-480;|Q92743|SERINE PROTEASE HTRA1|5.59|IC=2.6uM|IC50|=|2.6|uM|2600|nM
3SO9|2.87|2011|017|IC50=2.76+/-0.16nM|Q000H7|HIV-1 PROTEASE|8.56|IC=2.76nM|IC50|=|2.76|nM|2.76|nM
3SDG|1.87|2011|3SE|ligand is compound 5|P96222|HTH-TYPE TRANSCRIPTIONAL REGULATOR ETHR|5.55|IC=2.8uM|IC50|=|2.8|uM|2800|nM
3Q96|3.10|2011|0NF|ligand is compound 24; Flash Plate Assay|P15056|SERINE/THREONINE-PROTEIN KINASE B-RAF|8.54|IC=2.9nM|IC50|=|2.9|nM|2.9|nM
3SFF|2.00|2011|0DI|ligand is compound 3|Q9BY41|HISTONE DEACETYLASE 8|6.7|IC=200nM|IC50|=|200|nM|200|nM
3MRT|1.98|2011|12E|IC50=200+/-17 uM|P00489|GLYCOGEN PHOSPHORYLASE|3.7|IC=200uM|IC50|=|200|uM|200000|nM
3ASX|2.00|2011|D99|Fragment: UNP residues 31-370;|P37268|SQUALENE SYNTHASE|7.7|IC=20nM|IC50|=|20|nM|20|nM
3OLF|1.90|2011|OLF|compound 7i, SPA method, mutation E281A, E354A|Q96RI1|BILE ACID RECEPTOR|7.7|IC=20nM|IC50|=|20|nM|20|nM
3Q0Z|2.29|2011|23E||Q9WMX2|RNA-DIRECTED RNA POLYMERASE|7.7|IC=20nM|IC50|=|20|nM|20|nM
3QCY|2.20|2011|3Q3|ligand is compound (S)-21a; PIC50=7.7|O15530|3-PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE 1|7.7|IC=20nM|IC50|=|20|nM|20|nM
2XP6|1.90|2011|4G2||Q13526|PEPTIDYL-PROLYL CIS-TRANS ISOMERASE NIMA-INTERACTIN|4.7|IC=20uM|IC50|=|20|uM|20000|nM
2Y2P|1.62|2011|Z10|IC50=20+/-2uM; Fragment: TRANSPEPTIDASE DOMAIN, RESIDUES 101-125, 323-791; Mutation: YES; B containing, covalent complex|Q7CRA4|PENICILLIN-BINDING PROTEIN 1B|4.7|IC=20uM|IC50|=|20|uM|20000|nM
2YBT|2.22|2011|DW0|IC50=20+/-1uM; Fragment: CATALYTIC DOMAIN, RESIDUES 21-398;|Q9BZP6|ACIDIC MAMMALIAN CHITINASE|4.7|IC=20uM|IC50|=|20|uM|20000|nM
3SL5|2.65|2011|J25|ligand is compound 10d|Q08499|CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D|7.66|IC=22nM|IC50|=|22|nM|22|nM
3RME|1.80|2011|RME|ligand is compound 5|Q9BZP6|ACIDIC MAMMALIAN CHITINASE|4.66|IC=22uM|IC50|=|22|uM|22000|nM
3MTB|1.95|2011|23V|IC50=23.2+/-0.5 uM|P00489|GLYCOGEN PHOSPHORYLASE|4.63|IC=23.2uM|IC50|=|23.2|uM|23200|nM
3PX8|1.29|2011|JP2|Fragment: UNP residues 18-275;|D6MWP9|PREPRORICIN|3.64|IC=230uM|IC50|=|230|uM|230000|nM
3RXM|1.70|2011|SW1|Kinetic study using fluorescence-based substrate|P00760|TRYPSIN|3.63|IC=232uM|IC50|=|232|uM|232000|nM
3OS3|2.80|2011|3OS|Fragment: UNP RESIDUES 62-270, 303-393;|Q02750|MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1 (MERK 1)|6.63|IC=235nM|IC50|=|235|nM|235|nM
3POZ|1.50|2011|03P|ligand is compound TAK-285|P00533|EPIDERMAL GROWTH FACTOR RECEPTOR|7.64|IC=23nM|IC50|=|23|nM|23|nM
3RJM|2.55|2011|6-mer|ligand is compound 33c, ligand is 6-mer peptide, 3PX is just a modified residue|P42575|CASPASE-2 SUBUNIT P18|6.61|IC=246nM|IC50|=|246|nM|246|nM
3QPO|1.80|2011|PFR|ligand is compound 13|Q9QYJ6|PHOSPHODIESTERASE|6.61|IC=247nM|IC50|=|247|nM|247|nM
2YBP|2.02|2011|2HG|Fragment: CATALYTIC DOMAIN, RESIDUES 1-359; Ni-containing; IC50=24+/-2uM; 12-mer peptide substrate containing; IC50=17+/-4uM when 10 fold Fe2+ concentration|O75164|LYSINE-SPECIFIC DEMETHYLASE 4A|4.62|IC=24uM|IC50|=|24|uM|24000|nM
2YBK|2.40|2011|2HG|Fragment: CATALYTIC DOMAIN, RESIDUES 1-359; Ni-containing; IC50=24+/-2uM; IC50=17+/-4uM when 10 fold Fe2+ concentration;|O75164|LYSINE-SPECIFIC DEMETHYLASE 4A|4.62|IC=24uM|IC50|=|24|uM|24000|nM
3P50|3.30|2011|PFL|IC50=24+/-6.3uM; electrophysiological assay|Q7NDN8|GLR4197 PROTEIN|4.62|IC=24uM|IC50|=|24|uM|24000|nM
3MT9|2.05|2011|18O|IC50=25.7+/-0.9 uM|P00489|GLYCOGEN PHOSPHORYLASE|4.59|IC=25.7uM|IC50|=|25.7|uM|25700|nM
2Y68|1.49|2011|T04|IC50=253+/-27uM|P14900|UDP-N-ACETYLMURAMOYLALANINE-D-GLUTAMATE LIGASE|3.6|IC=253uM|IC50|=|253|uM|253000|nM
2Y6O|1.54|2011|1N1|Fragment: KINASE DOMAIN, RESIDUES 606-896;|Q03137|EPHRIN TYPE-A RECEPTOR 4|7.6|IC=25nM|IC50|=|25|nM|25|nM
3NWE|1.50|2011|662|mutation: M91I, Y95C; compound 6, with Mg2+; radiochemical assay|P22734|CATECHOL O-METHYLTRANSFERASE|7.6|IC=25nM|IC50|=|25|nM|25|nM
3PTG|2.43|2011|932||P53779|MITOGEN-ACTIVATED PROTEIN KINASE 10|7.6|IC=25nM|IC50|=|25|nM|25|nM
3R6G|2.07|2011|6-mer|ligand is Peptide Inhibitor (ACE)VDVAD-CHO|P42575|CASPASE-2 SUBUNIT P18|7.6|IC=25nM|IC50|=|25|nM|25|nM
3LKJ|2.50|2011|LKJ|Fragment: UNP residues 121-261;|P29965|CD40 LIGAND|4.6|IC=25uM|IC50|=|25|uM|25000|nM
3NC4|2.07|2011|26O|IC50=26.6+/-3.3 uM|P00489|GLYCOGEN PHOSPHORYLASE|4.58|IC=26.6uM|IC50|=|26.6|uM|26600|nM
2Y2I|1.78|2011|ZA3|IC50=26+/-3uM; Fragment: TRANSPEPTIDASE DOMAIN, RESIDUES 101-125, 323-791; Mutation: YES; B containing, covalent complex|Q7CRA4|PENICILLIN-BINDING PROTEIN 1B|4.59|IC=26uM|IC50|=|26|uM|26000|nM
2YBS|2.32|2011|S2G|protein Fragment: CATALYTIC DOMAIN, RESIDUES 1-359; 12-mer peptide substrate containing; Ni-containing; IC50=26+/-3uM; IC50=33+/-5uM when 10 fold Fe2+ concentration|O75164|LYSINE-SPECIFIC DEMETHYLASE 4A|4.59|IC=26uM|IC50|=|26|uM|26000|nM
2YCM|1.80|2011|30A|IC50=274+/-15uM; Fragment: CYTIDYLTRANSFERASE DOMAIN, RESIDUES 76-302;|P69834|2-C-METHYL-D-ERYTHRITOL 4-PHOSPHATE CYTIDYLYLTRANSFERASE|3.56|IC=274uM|IC50|=|274|uM|274000|nM
3S3O|2.55|2011|DLU|in vitro strand transfer assay, ligand is Dolutegravir (S/GSK1349572)|P14350|PFV INTEGRASE|7.57|IC=27nM|IC50|=|27|nM|27|nM
3SL4|1.90|2011|JN4|ligand is compound 12d|Q08499|CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D|7.57|IC=27nM|IC50|=|27|nM|27|nM
2Y2N|2.07|2011|E07|IC50=27+/-2uM; Fragment: TRANSPEPTIDASE DOMAIN, RESIDUES 101-125, 323-791; Mutation: YES; B containing, covalent complex|Q7CRA4|PENICILLIN-BINDING PROTEIN 1B|4.57|IC=27uM|IC50|=|27|uM|27000|nM
2Y2H|1.96|2011|ZA2|IC50=27+/-1uM; Fragment: TRANSPEPTIDASE DOMAIN, RESIDUES 101-125, 323-791; Mutation: YES; B containing, covalent complex|Q7CRA4|PENICILLIN-BINDING PROTEIN 1B|4.57|IC=27uM|IC50|=|27|uM|27000|nM
3P4W|3.20|2011|DSF|IC50=27+/-13uM; electrophysiological assay|Q7NDN8|GLR4197 PROTEIN|4.57|IC=27uM|IC50|=|27|uM|27000|nM
3SOQ|1.90|2011|9-mer|ligand is DKK1 peptide;IC501=27+/-5uM(for E1)|O75581|LOW-DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN 6|4.57|IC=27uM|IC50|=|27|uM|27000|nM
3MT8|2.00|2011|17T|IC50=28.3+/-1.7 uM|P00489|GLYCOGEN PHOSPHORYLASE|4.55|IC=28.3uM|IC50|=|28.3|uM|28300|nM
3OTX|1.55|2011|AP5|IC50=29.4+/-0.2uM; Mutation: S2A;|Q584S0|ADENOSINE KINASE, PUTATIVE|4.53|IC=29.4uM|IC50|=|29.4|uM|29400|nM
3PVU|2.48|2011|QRW|ligand is CMPD101; IC50=290+/-98nM|P21146|BETA-ADRENERGIC RECEPTOR KINASE 1|6.54|IC=290nM|IC50|=|290|nM|290|nM
3NF9|1.95|2011|CD9|ligand is compound 8|Q76353|INTEGRASE|3.54|IC=290uM|IC50|=|290|uM|290000|nM
2Y67|1.85|2011|N21|IC50=292+/-6uM;|P14900|UDP-N-ACETYLMURAMOYLALANINE-D-GLUTAMATE LIGASE|3.53|IC=292uM|IC50|=|292|uM|292000|nM
3NF6|1.90|2011|IMV|ligand is compound 3|Q76353|INTEGRASE|3.53|IC=295uM|IC50|=|295|uM|295000|nM
2YAK|2.20|2011|OSV|Fragment: AA, RESIDUES 1-285;|P53355|DEATH-ASSOCIATED PROTEIN KINASE 1|8.7|IC=2nM|IC50|=|2|nM|2|nM
3QC4|1.80|2011|MP7|IC50=2nM for Phosphorylated PDK-AKT; IC50<13nM for Unphosphorylated PDK-AKT; Fragment: kinase domain (UNP residues 51-359); Mutation: E303A, K304A;|O15530|3-PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE 1|8.7|IC=2nM|IC50|=|2|nM|2|nM
3THB|2.50|2011|3TA|ligand is compound 12b; Zn2+containing; IC50=2+/-0.8nM|P53350|SERINE/THREONINE-PROTEIN KINASE PLK1|8.7|IC=2nM|IC50|=|2|nM|2|nM
3B0W|2.20|2011|DGX|ligand is digoxin|P51449|NUCLEAR RECEPTOR ROR-GAMMA|5.7|IC=2uM|IC50|=|2|uM|2000|nM
3SPK|1.24|2011|TPV|IC50=3.02+/-0.10nM|Q000H7|HIV-1 PROTEASE|8.52|IC=3.02nM|IC50|=|3.02|nM|3.02|nM
3ZXH|1.30|2011|E41|ligand is compound 12|P45452|COLLAGENASE 3|8.52|IC=3.0nM|IC50|=|3|nM|3|nM
3TIA|1.80|2011|LNV|ligand is laninamivir|Q194T1|NEURAMINIDASE|8.51|IC=3.12nM|IC50|=|3.12|nM|3.12|nM
3QD0|1.99|2011|3Q4|ligand is compound (3S, 6R)-28a; PIC50=8.5|O15530|3-PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE 1|8.5|IC=3.16nM|IC50|=|3.16|nM|3.16|nM
3PP1|2.70|2011|IZG|Fragment: kinase domain;|Q02750|DUAL SPECIFICITY MITOGEN-ACTIVATED PROTEIN KINASE K|8.49|IC=3.2nM|IC50|=|3.2|nM|3.2|nM
4A22|1.90|2011|TD4|inhibitor 1|P67475|FRUCTOSE-BISPHOSPHATE ALDOLASE|8.49|IC=3.2nM|IC50|=|3.2|nM|3.2|nM
3QCH|2.40|2011|NX2|ligand is compound 12|P23470|RECEPTOR-TYPE TYROSINE-PROTEIN PHOSPHATASE GAMMA|5.48|IC=3.3uM|IC50|=|3.3|uM|3300|nM
3Q2G|2.30|2011|QGF|Zn binding; X-ray:ADAM-TS1, Assay: ADAM-TS4; Fragment: residues in UNP 256-548;|Q9UHI8|A DISINTEGRIN AND METALLOPROTEINASE WITH THROMBOSPO|8.46|IC=3.5nM|IC50|=|3.5|nM|3.5|nM
3PIZ|2.21|2011|03C|Fragment: unp residues 387-659;|Q06187|TYROSINE-PROTEIN KINASE BTK|5.46|IC=3.5uM|IC50|=|3.5|uM|3500|nM
3S22|1.65|2011|3S2||P24735|BETA-LACTAMASE|5.46|IC=3.5uM|IC50|=|3.5|uM|3500|nM
3QCI|2.27|2011|NX3|ligand is compound 14|P23470|RECEPTOR-TYPE TYROSINE-PROTEIN PHOSPHATASE GAMMA|5.42|IC=3.8uM|IC50|=|3.8|uM|3800|nM
3OGQ|1.80|2011|AB1|mutation:I37V, N55M, V59I, I98S, Q99V, P100N; binding data from other paper|P16088|FIV PROTEASE|7.52|IC=30nM|IC50|=|30|nM|30|nM
3OWD|1.63|2011|MEY||P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|7.52|IC=30nM|IC50|=|30|nM|30|nM
3Q7J|2.91|2011|FBO|ligand is D24|O93655|TRICORN PROTEASE-INTERACTING FACTOR F3|4.52|IC=30uM|IC50|=|30|uM|30000|nM
3PEQ|2.40|2011|3EQ|pIC50=7.5; Fragment: unp residues 171-441;|Q03181|PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR DELTA|7.5|IC=31.6nM|IC50|=|31.6|nM|31.6|nM
3SRV|1.95|2011|S19|ligand is compound 20, pIC50=7.5|P43405|TYROSINE-PROTEIN KINASE SYK|7.5|IC=31.6nM|IC50|=|31.6|nM|31.6|nM
3RO0|1.50|2011|TPT|ligand is compound 5; IC50=31.89+/-0.64 uM|P46107|PYRROLIDONE-CARBOXYLATE PEPTIDASE|4.5|IC=31.89uM|IC50|=|31.89|uM|31890|nM
3NUS|2.75|2011|JNZ|compound 8|Q9UPJ8|PHOSPHOINOSITIDE-DEPENDENT KINASE-1|3.51|IC=311uM|IC50|=|311|uM|311000|nM
3OEU|2.60|2011|OEU||P23639|PROTEASOME COMPONENT Y7|7.51|IC=31nM|IC50|=|31|nM|31|nM
3P9J|2.80|2011|P9J|Fragment: unp residues 124-391; Mutation: K124A, T287A, T288A;|O14965|SERINE/THREONINE-PROTEIN KINASE 6|7.51|IC=31nM|IC50|=|31|nM|31|nM
3TJC|2.40|2011|0TP|ligand is compound 8|O60674|TYROSINE-PROTEIN KINASE JAK2|7.51|IC=31nM|IC50|=|31|nM|31|nM
3PDC|2.60|2011|ZYI|Fragment: Hydrolase domain (UNP residues 226 to 548);|P34913|EPOXIDE HYDROLASE 2|7.49|IC=32nM|IC50|=|32|nM|32|nM
3SKA|1.73|2011|053|ligand is compound 7q|O92972|HCV NS5B RNA_DEPENDENT RNA POLYMERASE|7.49|IC=32nM|IC50|=|32|nM|32|nM
2XLN|2.40|2011|EWA|covalent complex, B containing, assay method in SI|P39045|D-ALANYL-D-ALANINE CARBOXYPEPTIDASE|4.48|IC=33uM|IC50|=|33|uM|33000|nM
3MTD|2.10|2011|25E|IC50=340.5+/-21.7 uM|P00489|GLYCOGEN PHOSPHORYLASE|3.47|IC=340.5uM|IC50|=|340.5|uM|340500|nM
3NF7|1.80|2011|CIW|ligand is compound 4|Q76353|INTEGRASE|3.47|IC=340uM|IC50|=|340|uM|340000|nM
3NUY|2.10|2011|JPZ|compound 17|Q9UPJ8|PKB-LIKE|3.46|IC=345uM|IC50|=|345|uM|345000|nM
3ZW3|2.80|2011|ZW3|ligand is compound 12, HTRF based assay|P48736|PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE|7.47|IC=34nM|IC50|=|34|nM|34|nM
3SHZ|2.45|2011|5CO|ligand is compound 3; IC50=35.9+/-11.5nM|O76074|CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE|7.44|IC=35.9nM|IC50|=|35.9|nM|35.9|nM
3NLB|1.90|2011|5BE||O14757|SERINE/THREONINE-PROTEIN KINASE CHK1|7.46|IC=35nM|IC50|=|35|nM|35|nM
2YDM|2.44|2011|SLC|IC50=36.4+/-1.5nM; Fragment: EXTRACELLULAR DOMAIN, RESIDUES 68-656; Se containing; Zn binding|P12821|ANGIOTENSIN CONVERTING ENZYME|7.44|IC=36.4nM|IC50|=|36.4|nM|36.4|nM
2XIY|2.20|2011|XIY|Fragment: KINASE DOMAIN, RESIDUES 14-313;|P11309|SERINE/THREONINE PROTEIN KINASE PIM|2.44|IC=3600uM|IC50|=|3600|uM|3600000|nM
2XP5|1.90|2011|4FF||Q13526|PEPTIDYL-PROLYL CIS-TRANS ISOMERASE NIMA-INTERACTIN|3.44|IC=360uM|IC50|=|360|uM|360000|nM
3AS2|1.80|2011|POY|ligand is Propentofylline, PRO;IC50=360+/-42uM(pNP assay)|Q9AMP1|CHITINASE A|3.44|IC=360uM|IC50|=|360|uM|360000|nM
3OGP|1.70|2011|017|mutation:I37V, N55M, V59I, I98S, Q99V, P100N; binding data from other paper|P16088|FIV PROTEASE|7.44|IC=36nM|IC50|=|36|nM|36|nM
3QKV|3.10|2011|QKV||P97612|FATTY-ACID AMIDE HYDROLASE 1|7.44|IC=36nM|IC50|=|36|nM|36|nM
3Q4C|3.20|2011|RSW|Ru containing|P15056|SERINE/THREONINE-PROTEIN KINASE B-RAF|6.43|IC=370nM|IC50|=|370|nM|370|nM
3MS7|1.95|2011|22S|IC50=370+/-9.7 uM|P00489|GLYCOGEN PHOSPHORYLASE|3.43|IC=370uM|IC50|=|370|uM|370000|nM
3OMM|2.10|2011|OMM|compound 7g, SPA method, mutation E281A, E354A|Q96RI1|BILE ACID RECEPTOR|7.43|IC=37nM|IC50|=|37|nM|37|nM
3Q3T|2.60|2011|RX0|Fragment: UNP residues 67-406;|P00797|RENIN|7.43|IC=37nM|IC50|=|37|nM|37|nM
3ZQT|2.29|2011|30Z|IC50=38.8+/-1.3uM; Fragment: LIGAND BINDING DOMAIN, RESIDUES 664-919;|P10275|ANDROGEN RECEPTOR|4.41|IC=38.8uM|IC50|=|38.8|uM|38800|nM
3RL4|1.29|2011|5GP|IC50=3800+/-800nM|B1WBP0|METALLOPHOSPHOESTERASE MPPED2|5.42|IC=3800nM|IC50|=|3800|nM|3800|nM
3PX9|1.89|2011|JP3|Fragment: UNP residues 18-275;|D6MWP9|PREPRORICIN|3.42|IC=380uM|IC50|=|380|uM|380000|nM
3QKM|2.20|2011|SM9|ligand is compound 5|P31749|RAC-ALPHA SERINE/THREONINE-PROTEIN KINASE|7.42|IC=38nM|IC50|=|38|nM|38|nM
3P23|2.70|2011|ADP|IC50=38+/-17uM; Mg2+ binding; Fragment: UNP residues 547-977;|O75460|SERINE/THREONINE-PROTEIN KINASE/ENDORIBONUCLEASE IR|4.42|IC=38uM|IC50|=|38|uM|38000|nM
4A7B|2.20|2011|3W5|ligand is diastereoisomers 21/22, ligand code is 3W4 or 3W5; IC501=39.8nM(21); IC502=10nM(22)|P45452|COLLAGENASE 3|7.4|IC=39.8nM|IC50|=|39.8|nM|39.8|nM
3NP9|2.00|2011|Z2T|IC50=39.8+/-0.3uM|P00489|GLYCOGEN PHOSPHORYLASE|4.4|IC=39.8uM|IC50|=|39.8|uM|39800|nM
3U4R|2.00|2011|08F|ligand is compound 7q, IC50=0.039uM|O92972|RNA-DIRECTED RNA POLYMERASE|7.41|IC=39nM|IC50|=|39|nM|39|nM
3PSB|3.40|2011|SM6|Fragment: UNP residues 432-726;|P15056|B-RAF PROTO-ONCOGENE SERINE/THREONINE-PROTEIN KINASE|8.52|IC=3nM|IC50|=|3|nM|3|nM
3PSD|3.60|2011|SM7|Fragment: UNP residues 432-726;|P15056|B-RAF PROTO-ONCOGENE SERINE/THREONINE-PROTEIN KINASE|8.52|IC=3nM|IC50|=|3|nM|3|nM
3SFC|2.10|2011|S53|ligand is compound 7d|P00797|RENIN|8.52|IC=3nM|IC50|=|3|nM|3|nM
3QCL|2.40|2011|NXV|ligand is compound 20|P23470|RECEPTOR-TYPE TYROSINE-PROTEIN PHOSPHATASE GAMMA|5.4|IC=4.0uM|IC50|=|4|uM|4000|nM
2XPA|1.90|2011|4G5||Q13526|PEPTIDYL-PROLYL CIS-TRANS ISOMERASE NIMA-INTERACTIN|5.39|IC=4.1uM|IC50|=|4.1|uM|4100|nM
2XYU|2.12|2011|Q9G|IC50=4.5+/-0.5uM; Fragment: KINASE DOMAIN, RESIDUES 1548-1832;|Q03137|EPHRIN TYPE-A RECEPTOR 4|5.35|IC=4.5uM|IC50|=|4.5|uM|4500|nM
3TV6|3.30|2011|B0R|compound 17, crystal is wildtype, affinity assay is for B-Raf V600E mutant|P15056|SERINE/THREONINE-PROTEIN KINASE B-RAF|8.32|IC=4.8nM|IC50|=|4.8|nM|4.8|nM
3MRX|1.95|2011|17S|IC50=406.5+/-40.6 uM|P00489|GLYCOGEN PHOSPHORYLASE|3.39|IC=406.5uM|IC50|=|406.5|uM|406500|nM
3S3M|2.49|2011|DLU|in vitro strand transfer assay, ligand is Dolutegravir (S/GSK1349572)|P14350|PFV INTEGRASE|7.4|IC=40nM|IC50|=|40|nM|40|nM
3SC1|2.70|2011|3S1|ligand is compound 16|O15530|3-PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE 1|4.38|IC=41.4uM|IC50|=|41.4|uM|41400|nM
2XNI|3.30|2011|TR8|ligand is compound 9a; covalent complex|C1KHZ7|NS3 PROTEASE|7.37|IC=43nM|IC50|=|43|nM|43|nM
3M11|2.75|2011|AKI|Fragment: catalytic domain; Mutation: T288D; compound 3|O14965|SERINE/THREONINE-PROTEIN KINASE 6|7.37|IC=43nM|IC50|=|43|nM|43|nM
2XO8|2.40|2011|H70|Fragment: MOTOR DOMAIN, RESIDUES 3-761; IC50=47.2+/-3.2uM;|P08799|MYOSIN-2 HEAVY CHAIN|4.33|IC=47.2uM|IC50|=|47.2|uM|47200|nM
3MSC|1.95|2011|24S|IC50=484.2+/-23.3 uM|P00489|GLYCOGEN PHOSPHORYLASE|3.31|IC=484.2uM|IC50|=|484.2|uM|484200|nM
3PJ1|2.00|2011|LHL|Fragment: unp residues 387-659;|Q06187|TYROSINE-PROTEIN KINASE BTK|7.32|IC=48nM|IC50|=|48|nM|48|nM
3VHU|2.11|2011|SNL|ligand is spironolactone|P08235|MINERALOCORTICOID RECEPTOR|7.31|IC=49nM|IC50|=|49|nM|49|nM
3OOK|2.29|2011|OOK|compound 7l, SPA method, mutation E281A, E354A|Q96RI1|BILE ACID RECEPTOR|8.4|IC=4nM|IC50|=|4|nM|4|nM
3QRJ|1.82|2011|919|ligand is DCC-2036|P00519|TYROSINE-PROTEIN KINASE ABL1|8.4|IC=4nM|IC50|=|4|nM|4|nM
3R2B|2.90|2011|05B|ligand is compound 5b; EC50=4nM|P49137|MAP KINASE-ACTIVATED PROTEIN KINASE 2|8.4|IC=4nM|IC50|=|4|nM|4|nM
3TTZ|1.63|2011|07N|ligand is compound 26, IC50=0.004uM|P0A0K8|DNA GYRASE SUBUNIT B|8.4|IC=4nM|IC50|=|4|nM|4|nM
3O95|2.85|2011|01T|IC50=5.1-5.4 nM|P27487|DIPEPTIDYL PEPTIDASE 4|8.28|IC=5.3nM|IC50|=|5.3|nM|5.3|nM
3TDC|2.41|2011|0EU|ligand is compound 26h|Q59GJ9|ACETYL-COA CARBOXYLASE 2|8.27|IC=5.4nM|IC50|=|5.4|nM|5.4|nM
3SZ9|2.10|2011|I3E|ligand is Aldi-3; IC50=5.4+/-1.3uM; covalent complex; ligand undergoes a beta-elimination progress|P05091|ALDEHYDE DEHYDROGENASE, MITOCHONDRIAL|5.27|IC=5.4uM|IC50|=|5.4|uM|5400|nM
3PJ3|1.85|2011|04L|Fragment: unp residues 387-659;|Q06187|TYROSINE-PROTEIN KINASE BTK|5.25|IC=5.6uM|IC50|=|5.6|uM|5600|nM
3AW0|2.30|2011|6-mer|ligand 6-mer peptide; Mutation: R188I;|P0C6U8|3C-LIKE PROTEINASE|5.24|IC=5.7uM|IC50|=|5.7|uM|5700|nM
3MQF|1.95|2011|20X|IC50=5.7+/-0.4 uM|P00489|GLYCOGEN PHOSPHORYLASE|5.24|IC=5.7uM|IC50|=|5.7|uM|5700|nM
3QCK|2.05|2011|NX5|ligand is compound 17|P23470|RECEPTOR-TYPE TYROSINE-PROTEIN PHOSPHATASE GAMMA|5.24|IC=5.8uM|IC50|=|5.8|uM|5800|nM
3R01|2.60|2011|UNE|ligand is compound 11|P11309|SERINE/THREONINE-PROTEIN KINASE PIM|5.24|IC=5.8uM|IC50|=|5.8|uM|5800|nM
3PXY|1.80|2011|JWS||P24941|CELL DIVISION PROTEIN KINASE 2|5.23|IC=5.9uM|IC50|=|5.9|uM|5900|nM
3PXZ|1.70|2011|JWS||P24941|CELL DIVISION PROTEIN KINASE 2|5.23|IC=5.9uM|IC50|=|5.9|uM|5900|nM
3MTA|2.23|2011|22O|IC50=50.4+/-1.9 uM|P00489|GLYCOGEN PHOSPHORYLASE|4.3|IC=50.4uM|IC50|=|50.4|uM|50400|nM
3L9M|1.90|2011|L9M|mutation V123A, L173M, Q181K; X-ray(PKAB3 mutation), binding assay(PKA WT); compound 18; IC50= 50+/- 8.7nM|P17612|CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTIC|7.3|IC=50nM|IC50|=|50|nM|50|nM
3OOF|2.29|2011|OOF|compound 7d, SPA method, mutation E281A, E354A|Q96RI1|BILE ACID RECEPTOR|7.3|IC=50nM|IC50|=|50|nM|50|nM
3VHV|1.35|2011|LD1|ligand is compound 1d, LD1 or LD2 isomer|P08235|MINERALOCORTICOID RECEPTOR|6.29|IC=510nM|IC50|=|510|nM|510|nM
3MS4|2.07|2011|21N|IC50=524.3+/-11.4 uM|P00489|GLYCOGEN PHOSPHORYLASE|3.28|IC=524.3uM|IC50|=|524.3|uM|524300|nM
3U4O|1.77|2011|08E|ligand is compound 1|O92972|RNA-DIRECTED RNA POLYMERASE|7.28|IC=53nM|IC50|=|53|nM|53|nM
3PKA|1.25|2011|Y02|Mn binding|P0A5J2|METHIONINE AMINOPEPTIDASE|6.27|IC=540nM|IC50|=|540|nM|540|nM
3RHK|1.94|2011|M97|ligand is ARQ 197; IC50=548+/-120nM(the first 20 min)|P08581|HEPATOCYTE GROWTH FACTOR RECEPTOR|6.26|IC=548nM|IC50|=|548|nM|548|nM
3PVW|2.49|2011|QRX|ligand is CMPD103A; IC50=54+/-14nM|P21146|BETA-ADRENERGIC RECEPTOR KINASE 1|7.27|IC=54nM|IC50|=|54|nM|54|nM
3ANS|1.98|2011|S38|Fragment: hydrolase domain, UNP residues 230-555 ;|P34913|EPOXIDE HYDROLASE 2|6.25|IC=565nM|IC50|=|565|nM|565|nM
3QRK|2.30|2011|9DP|ligand is compound 1|P00519|TYROSINE-PROTEIN KINASE ABL1|7.24|IC=57nM|IC50|=|57|nM|57|nM
3SKF|3.00|2011|PB7|ligand is compound 5|P56817|BETA-SECRETASE 1|8.3|IC=5nM|IC50|=|5|nM|5|nM
3VHE|1.55|2011|42Q|ligand is compound 20d; enzyme Cinhibitor dilution assay|P35968|VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2|8.21|IC=6.2nM|IC50|=|6.2|nM|6.2|nM
3QD4|2.30|2011|3Q6|ligand is compound 43a; PIC50=8.2|O15530|3-PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE 1|8.2|IC=6.31nM|IC50|=|6.31|nM|6.31|nM
3NZX|2.70|2011|5-mer|TMC-95A mimic ligand 2c, IC50=6.8+/-0.1uM|P23639|PROTEASOME COMPONENT Y7|5.17|IC=6.8uM|IC50|=|6.8|uM|6800|nM
2Y2K|2.09|2011|ZA5|Fragment: TRANSPEPTIDASE DOMAIN, RESIDUES 101-125, 323-791; Mutation: YES; IC50=6.9+/-0.1uM; B containing, covalent complex|Q7CRA4|PENICILLIN-BINDING PROTEIN 1B|5.16|IC=6.9uM|IC50|=|6.9|uM|6900|nM
3SOV|1.27|2011|9-mer|ligand is SOST peptide;IC501=61+/-10uM(for E1)|O75581|LOW-DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN 6|4.21|IC=61uM|IC50|=|61|uM|61000|nM
3PKB|1.25|2011|Y16|Mn binding|P0A5J2|METHIONINE AMINOPEPTIDASE|6.21|IC=620nM|IC50|=|620|nM|620|nM
3QSD|1.30|2011|074|ligand is CA074; IC50=63.9+/-2.8nM; covalent complex|Q8MNY2|CATHEPSIN B-LIKE PEPTIDASE (C01 FAMILY)|7.19|IC=63.9nM|IC50|=|63.9|nM|63.9|nM
3LZB|2.70|2011|ITI|Fragment:696-1022; Mutation: V924R; compound 21|P00533|EPIDERMAL GROWTH FACTOR RECEPTOR|7.2|IC=63nM|IC50|=|63|nM|63|nM
3QCX|2.30|2011|3Q2|ligand is compound (R)-18a; PIC50=7.2|O15530|3-PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE 1|7.2|IC=63nM|IC50|=|63|nM|63|nM
3AVZ|2.46|2011|6-mer|ligand 6-mer peptide; Mutation: R188I;|P0C6U8|3C-LIKE PROTEINASE|7.19|IC=65nM|IC50|=|65|nM|65|nM
3SRB|1.80|2011|28S|ligand is SMER28|Q9I194|ACYL-HOMOSERINE LACTONE ACYLASE PVDQ|4.19|IC=65uM|IC50|=|65|uM|65000|nM
3RL3|1.42|2011|5GP|IC50=67+/-1.6nM|B1WBP0|METALLOPHOSPHOESTERASE MPPED2|7.17|IC=67nM|IC50|=|67|nM|67|nM
3S2P|2.30|2011|PMU||P24941|CYCLIN-DEPENDENT KINASE 2|7.17|IC=68nM|IC50|=|68|nM|68|nM
2YCR|2.20|2011|HCW|IC50=69.60+/-40.22nM; Fragment: CATALYTIC DOMAIN, RESIDUES 210-531;|O96017|SERINE/THREONINE-PROTEIN KINASE CHK2|7.16|IC=69.60nM|IC50|=|69.6|nM|69.6|nM
3Q2H|2.33|2011|QHF|Zn binding; X-ray:ADAM-TS1, Assay: ADAM-TS4; Fragment: residues in UNP 256-548;|Q9UHI8|A DISINTEGRIN AND METALLOPROTEINASE WITH THROMBOSPO|9.16|IC=690pM|IC50|=|690|pM|0.6900000000000001|nM
3PZ4|2.10|2011|3PZ|Zn2+ binding; IC50=6+/-3 nM; X-ray:BMS3:FTase:FPP|Q04631|FARNESYLTRANSFERASE/GERANYLGERANYLTRANSFERA|8.22|IC=6nM|IC50|=|6|nM|6|nM
3Q77|2.00|2011|2HY||P08246|NEUTROPHIL ELASTASE|8.22|IC=6nM|IC50|=|6|nM|6|nM
3OSI|2.70|2011|XDH|Fragment: ligand binding domain;|P37231|PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA|5.22|IC=6uM|IC50|=|6|uM|6000|nM
3RXG|1.70|2011|SZ3|Kinetic study using fluorescence-based substrate|P00760|TRYPSIN|2.15|IC=7.1mM|IC50|=|7.1|mM|7100000|nM
3PJ2|1.75|2011|04K|Fragment: unp residues 387-659;|Q06187|TYROSINE-PROTEIN KINASE BTK|5.14|IC=7.2uM|IC50|=|7.2|uM|7200|nM
3OEV|2.85|2011|3OE||P23639|PROTEASOME COMPONENT Y7|8.13|IC=7.4nM|IC50|=|7.4|nM|7.4|nM
3Q3K|2.00|2011|D90|Fragment: UNP RESIDUES 125-178|P00742|COAGULATION FACTOR XA, HEAVY CHAIN|8.13|IC=7.4nM|IC50|=|7.4|nM|7.4|nM
3TU9|2.09|2011|5MM|IC50=7.5+/-0.5uM|P00883|FRUCTOSE-BISPHOSPHATE ALDOLASE A|5.12|IC=7.5uM|IC50|=|7.5|uM|7500|nM
2YJW|1.61|2011|YJW|Fragment: N-DOMAIN, RESIDUES 18-233;|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|5.12|IC=7.6uM|IC50|=|7.6|uM|7600|nM
2YJX|1.83|2011|YJX|Fragment: N-DOMAIN, RESIDUES 18-233;|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|5.12|IC=7.6uM|IC50|=|7.6|uM|7600|nM
3R7B|1.80|2011|5-mer|ligand is Peptide Inhibitor (ACE)DVAD-CHO|P42575|CASPASE-2 SUBUNIT P18|6.15|IC=710nM|IC50|=|710|nM|710|nM
3R7N|2.33|2011|5-mer|ligand is two copies of Peptide Inhibitor (ACE)DVAD-CHO|P42575|CASPASE-2 SUBUNIT P18|6.15|IC=710nM|IC50|=|710|nM|710|nM
3PZ1|1.95|2011|3PZ|Zn2+ binding; IC50=724+/-321 nM; PDB error|Q08602|GERANYLGERANYL TRANSFERASE TYPE-2 SUBUNIT ALPHA|6.14|IC=724nM|IC50|=|724|nM|724|nM
3PZ2|2.35|2011|3PZ|Zn2+ binding; IC50=724+/-321 nM; PDB error; X-ray: BMS3:RabGGTase:GGPP|Q08602|GERANYLGERANYL TRANSFERASE TYPE-2 SUBUNIT ALPHA|6.14|IC=724nM|IC50|=|724|nM|724|nM
3RTN|2.70|2011|RTN|ligand is compound 42|P56817|BETA-SECRETASE 1|7.13|IC=74nM|IC50|=|74|nM|74|nM
3PKD|1.47|2011|Y10|Mn binding|P0A5J2|METHIONINE AMINOPEPTIDASE|6.12|IC=760nM|IC50|=|760|nM|760|nM
2YIG|1.70|2011|5EL|Fragment: CATALYTIC DOMAIN, RESIDUES 104-274; pIC50=7.1|P45452|COLLAGENASE 3|7.1|IC=79.4nM|IC50|=|79.4|nM|79.4|nM
3O57|2.00|2011|ZG2|pIC50=10.1, Fragment: Catalytic domain, 324-675; Mutation: S482A, S487A, S489A;|Q07343|CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B|10.1|IC=79.4pM|IC50|=|79.4|pM|0.07940000000000001|nM
2Y6D|1.60|2011|TQJ|Zn-containing; pIC50=7.1|P09237|MATRILYSIN|7.1|IC=79nM|IC50|=|79|nM|79|nM
3AT4|2.20|2011|CCK|Fragment: residues 1-335;|P68400|CASEIN KINASE II, ALPHA SUBUNIT|8.1|IC=8.0nM|IC50|=|8|nM|8|nM
3S2A|2.55|2011|2NQ|ligand is compound 16d; IC50=8.1+/-3nM|P48736|PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE|8.09|IC=8.1nM|IC50|=|8.1|nM|8.1|nM
2YK9|1.32|2011|YK9|Fragment: N-DOMAIN, RESIDUES 18-223;|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|5.09|IC=8.1uM|IC50|=|8.1|uM|8100|nM
2Y1O|1.49|2011|T26|ligand is compound 9; IC50=8.2+/-0.6uM|P14900|UDP-N-ACETYLMURAMOYLALANINE-D-GLUTAMATE LIGASE|5.09|IC=8.2uM|IC50|=|8.2|uM|8200|nM
3RXP|1.60|2011|SW3|Kinetic study using fluorescence-based substrate|P00760|TRYPSIN|2.08|IC=8.3mM|IC50|=|8.3|mM|8300000.000000001|nM
3QSB|1.90|2011|743|ligand is compound 4|P0A988|DNA POLYMERASE III SUBUNIT BETA|5.08|IC=8.3uM|IC50|=|8.3|uM|8300|nM
3ANT|2.40|2011|S82|Fragment: hydrolase domain, UNP residues 230-555|P34913|EPOXIDE HYDROLASE 2|8.07|IC=8.5nM|IC50|=|8.5|nM|8.5|nM
3R2Y|3.00|2011|P4O|ligand is compound 16|P49137|MAP KINASE-ACTIVATED PROTEIN KINASE 2|8.07|IC=8.5nM|IC50|=|8.5|nM|8.5|nM
3R00|2.10|2011|UNJ|ligand is compound 10|P11309|SERINE/THREONINE-PROTEIN KINASE PIM|5.07|IC=8.5uM|IC50|=|8.5|uM|8500|nM
3L9N|2.00|2011|L9N|mutation V123A, L173M, Q181K; X-ray(PKAB3 mutation), binding assay(PKA WT); compound 27; IC50= 8.6+/-0.8nM|P17612|CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTIC|8.07|IC=8.6nM|IC50|=|8.6|nM|8.6|nM
3S2O|2.60|2011|EV6|compound 14m|P56817|BETA-SECRETASE 1|5.05|IC=8.9uM|IC50|=|8.9|uM|8900|nM
3TY0|2.00|2011|082|ligand is compound 51|P37231|PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA|7.08|IC=83.1nM|IC50|=|83.1|nM|83.1|nM
3RXO|1.60|2011|SW2|Kinetic study using fluorescence-based substrate|P00760|TRYPSIN|4.08|IC=83.3uM|IC50|=|83.3|uM|83300|nM
3RKZ|1.57|2011|06T|ligand is compound 21|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|7.08|IC=83nM|IC50|=|83|nM|83|nM
3ATM|1.72|2011|TSS||P00760|TRYPSIN|3.06|IC=873uM|IC50|=|873|uM|873000|nM
3RXI|1.60|2011|TSS|Kinetic study using fluorescence-based substrate|P00760|TRYPSIN|3.06|IC=873uM|IC50|=|873|uM|873000|nM
3RXJ|1.70|2011|GBS|Kinetic study using fluorescence-based substrate|P00760|TRYPSIN|3.06|IC=873uM|IC50|=|873|uM|873000|nM
3S3N|2.49|2011|DLU|in vitro strand transfer assay, ligand is Dolutegravir (S/GSK1349572)|P14350|PFV INTEGRASE|7.06|IC=88nM|IC50|=|88|nM|88|nM
3SKG|2.88|2011|PB8|ligand is compound 14c|P56817|BETA-SECRETASE 1|8.1|IC=8nM|IC50|=|8|nM|8|nM
3AT3|2.60|2011|ATK|Fragment: residues 1-335;|P68400|CASEIN KINASE II, ALPHA SUBUNIT|8.04|IC=9.2nM|IC50|=|9.2|nM|9.2|nM
3RDH|2.39|2011|3RD|ligand is FOBISIN101|P63104|14-3-3 PROTEIN ZETA/DELTA|5.03|IC=9.3uM|IC50|=|9.3|uM|9300|nM
3N4C|1.90|2011|EF3|Fragment: UNP residues 115 to 331; compound 46|P25774|CATHEPSIN S|8.02|IC=9.5nM|IC50|=|9.5|nM|9.5|nM
3SHY|2.65|2011|5FO|ligand is compound 2; IC50=90.9+/-22.4nM|O76074|CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE|7.04|IC=90.9nM|IC50|=|90.9|nM|90.9|nM
3SFH|2.70|2011|1DI|ligand is compound 4|Q9BY41|HISTONE DEACETYLASE 8|7.05|IC=90nM|IC50|=|90|nM|90|nM
3THD|1.79|2011|DGJ|ligand is 1-deoxygalactonojirimycin (D-galacto-DNJ)|P16278|BETA-GALACTOSIDASE|4.05|IC=90uM|IC50|=|90|uM|90000|nM
3ZVV|2.50|2011|XAZ|ligand is compound 1|P48736|PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE|3.04|IC=915uM|IC50|=|915|uM|915000|nM
3R91|1.58|2011|06H|ligand is compound 40|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|7.04|IC=92nM|IC50|=|92|nM|92|nM
3MT7|2.00|2011|16O|IC50=93.2+/-5.1 uM|P00489|GLYCOGEN PHOSPHORYLASE|4.03|IC=93.2uM|IC50|=|93.2|uM|93200|nM
3TI4|1.60|2011|LVO|ligand is laninamivir octanoate(CS-8958)|C3W5S3|NEURAMINIDASE|6.02|IC=947nM|IC50|=|947|nM|947|nM
3OHF|2.10|2011|3HF|Fragment: UNP residues 14-454;|P56817|BETA-SECRETASE 1|7.03|IC=94nM|IC50|=|94|nM|94|nM
3PI5|2.40|2011|3P5|Fragment: UNP residues 48-447|P56817|BETA-SECRETASE 1|6.02|IC=950nM|IC50|=|950|nM|950|nM
3AS1|2.00|2011|CTI|ligand is Chelerythrine, CHE; IC50=95+/-34uM(pNP assay)|Q9AMP1|CHITINASE A|4.02|IC=95uM|IC50|=|95|uM|95000|nM
3NP7|2.05|2011|Z15|complex with compound 3 and 4; IC50=95uM for compound4, IC50=169.9+/-10uM for compound 3, IC50=140+/-10uM for compound 3-4 mixture|P00489|GLYCOGEN PHOSPHORYLASE|4.02|IC=95uM|IC50|=|95|uM|95000|nM
3PKC|1.47|2011|Y08|Mn binding|P0A5J2|METHIONINE AMINOPEPTIDASE|6.02|IC=960nM|IC50|=|960|nM|960|nM
3R92|1.58|2011|06J|ligand is compound 10|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|7.02|IC=96nM|IC50|=|96|nM|96|nM
3ATW|2.36|2011|5-mer|ligand 5-mer peptide; Mutation: R188I;|P0C6U8|3C-LIKE PROTEINASE|7.01|IC=98nM|IC50|=|98|nM|98|nM
3QKL|1.90|2011|SMR|ligand is compound 38|P31749|RAC-ALPHA SERINE/THREONINE-PROTEIN KINASE|8.05|IC=9nM|IC50|=|9|nM|9|nM
3TXO|2.05|2011|07U|ligand is compound 12|P24723|PROTEIN KINASE C ETA TYPE|8.05|IC=9nM|IC50|=|9|nM|9|nM
2XP3|2.00|2011|B21||Q13526|PEPTIDYL-PROLYL CIS-TRANS ISOMERASE NIMA-INTERACTIN|3.0|IC>1000uM|IC50|>|1000|uM|1000000|nM
3NF8|1.90|2011|CDQ|ligand is compound 5|Q76353|INTEGRASE|3.0|IC>1000uM|IC50|>|1000|uM|1000000|nM
3PKE|1.60|2011|Y10|Ni binding|P0A5J2|METHIONINE AMINOPEPTIDASE|3.6|IC>250uM|IC50|>|250|uM|250000|nM
2XIX|2.40|2011|XIX|Fragment: KINASE DOMAIN, RESIDUES 14-313;|P11309|SERINE/THREONINE-PROTEIN KINASE PIM|2.3|IC>5000uM|IC50|>|5000|uM|5000000|nM
2XNN|2.50|2011|430|Fragment: KINASE DOMAIN, RESIDUES 1-271;|P51955|SERINE/THREONINE-PROTEIN KINASE NEK2|4.3|IC>50uM|IC50|>|50|uM|50000|nM
3OB0|2.85|2011|2M6|IC50 estimated from figS5|P0DOX7|ANTIBODY FAB 2G12, LIGHT CHAIN|3.0|IC~1mM|IC50|~|1|mM|1000000|nM
3OAY|1.95|2011|BDF|not accuraacy, IC50~20mM (substrate tetrasaccharide), ~0.1M (substrate monosaccharide)|P0DOX7|ANTIBODY FAB 2G12, LIGHT CHAIN|1.7|IC~20mM|IC50|~|20|mM|20000000|nM
2YLP|2.30|2011|056|IC50=50-100 uM; Fragment: LIGAND-BINDING DOMAIN, RESIDUES 664-919;|P10275|ANDROGEN RECEPTOR|4.3|IC~50uM|IC50|~|50|uM|50000|nM
2YLQ|2.40|2011|YLQ|IC50=50-100 uM; Fragment: LIGAND-BINDING DOMAIN, RESIDUES 664-919;|P10275|ANDROGEN RECEPTOR|4.3|IC~50uM|IC50|~|50|uM|50000|nM
2XN7|1.43|2011|T44-F6Z|2-mer ligand, Fragment: RESIDUES 32-380; Mutation:RESIDUES 346-355 OF TBG WERE REPLACED BY GAMFLEAIPRS|P05543|THYROXINE-BINDING GLOBULIN|10.0|Kd<0.1nM|Kd|<|0.1|nM|0.1|nM
2YCH|2.20|2011|ATP|Mg-containing|Q5SIJ0|COMPETENCE PROTEIN PILM|3.0|Kd<1mM|Kd|<|1|mM|1000000|nM
2L65|NMR|2011|6-mer|ligand is Calicheamicin-Gamma, consists of 6 fragments, MTC-DAG-MRP-EMP-HIB-DSR|Q8KNF0|CALC|4.22|Kd<60uM|Kd|<|60|uM|60000|nM
3B28|1.35|2011|B2X||P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|8.47|Kd=0.0034uM|Kd|=|0.0034|uM|3.4|nM
2YLN|1.12|2011|CYS||Q5F9M1|PUTATIVE ABC TRANSPORTER, PERIPLASMIC BINDING PROTE|7.68|Kd=0.021uM|Kd|=|0.021|uM|21|nM
3UVM|1.57|2011|10-mer|ligand is 10-mer WDR5-interacting motif of MLL4, Kd=0.03+/-0.004uM|P61964|WD REPEAT-CONTAINING PROTEIN 5|7.52|Kd=0.03uM|Kd|=|0.03|uM|30|nM
3B24|1.70|2011|B2J||P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|4.38|Kd=0.042mM|Kd|=|0.042|mM|42000|nM
2XUZ|1.90|2011|EB4||P40409|IRON-UPTAKE SYSTEM-BINDING PROTEIN|7.4|Kd=0.04uM|Kd|=|0.04|uM|40|nM
3Q8D|2.30|2011|10-mer|ligand is 10-mer Single-stranded DNA-binding protein; Kd=0.06+/-0.01uM(50mM NaCl), Kd=0.34+/-0.02uM(200mM NaCl)|D5CXR1|DNA REPAIR PROTEIN RECO|7.22|Kd=0.06uM|Kd|=|0.06|uM|60|nM
2X6W|1.35|2011|4-mer|ligand is hexasaccharide,Kd=0.079+/-0.016uM|Q9AYY6|TAIL SPIKE PROTEIN|7.1|Kd=0.079uM|Kd|=|0.079|uM|79|nM
3ARP|1.55|2011|DEQ|ligand is Dequalinlium, DEQ; IC50=0.4+/-0.1uM(pNP assay)|Q9AMP1|CHITINASE A|7.15|Kd=0.07uM|Kd|=|0.07|uM|70|nM
3QX9|2.00|2011|ATP||Q9UKV8|PROTEIN ARGONAUTE 2|4.05|Kd=0.09mM|Kd|=|0.09|mM|90000|nM
3U0D|2.51|2011|DBH|ligand is 2,3-DHBA;containing Fe3+;Kd=0.101+/-0.002nM|P80188|NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN|10.0|Kd=0.101nM|Kd|=|0.101|nM|0.101|nM
3T2V|2.51|2011|KKJ|ligand is mycolic acid;Kd=0.13+/-0.05uM|Q9GK12|PEPTIDOGLYCAN RECOGNITION PROTEIN 1|6.99|Kd=0.103uM|Kd|=|0.103|uM|103|nM
3UVO|2.20|2011|11-mer|ligand is 11-mer WDR5-interacting motif of SET1B, Kd=0.10+/-0.01uM|P61964|WD REPEAT-CONTAINING PROTEIN 5|7.0|Kd=0.10uM|Kd|=|0.1|uM|100|nM
3AP4|2.33|2011|LBT|ligand is LACTOSE|O00214|GALECTIN-8|3.92|Kd=0.12mM|Kd|=|0.12|mM|120000|nM
3R1V|2.19|2011|AZB||Q7PXT9|ODORANT-BINDING PROTEIN|6.92|Kd=0.12uM|Kd|=|0.12|uM|120|nM
3UEX|2.10|2011|STE|complex between LGB and STE; Kd=0.12uM(fluorescence); Kd=0.63uM(ESI-MS); Kd=2.59uM(EPA)|P02754|BETA-LACTOGLOBULIN|6.92|Kd=0.12uM|Kd|=|0.12|uM|120|nM
2Y57|3.30|2011|V37|Fragment: RESIDUES 20-236; pKd=6.9+/-0.1 by SPR; pKd=7.3+/-0.2 by ITC; pKi=7.5+/-0.1|Q8WSF8|ACETYLCHOLINE RECEPTOR|6.89|Kd=0.13uM|Kd|=|0.13|uM|130|nM
3RDO|1.40|2011|BTN||P22629|STREPTAVIDIN|9.85|Kd=0.14nM|Kd|=|0.14|nM|0.14|nM
3S8O|1.85|2011|5-mer||P62993|GROWTH FACTOR RECEPTOR-BOUND PROTEIN 2|6.85|Kd=0.14uM|Kd|=|0.14|uM|140|nM
3QO2|2.49|2011|15-mer|ligand is H3(1-15)K9me3; Kd=0.14+/-0.01uM|Q99549|M-PHASE PHOSPHOPROTEIN 8|6.85|Kd=0.14uM|Kd|=|0.14|uM|140|nM
3T5I|2.10|2011|9-mer|ligand is C-terminal Farnesylated Rheb peptide CSQQGKSS(CMT), Fluorescence polarization measurements|O43924|RETINAL ROD RHODOPSIN-SENSITIVE CGMP 3',5'-CYCLIC|6.82|Kd=0.15uM|Kd|=|0.15|uM|150|nM
3TDZ|2.00|2011|13-mer|ligand is stapled acetylated Ubc12N, 5:9S refers to helical staple|Q96GG9|DCN1-LIKE PROTEIN 1|6.82|Kd=0.15uM|Kd|=|0.15|uM|150|nM
3UVK|1.40|2011|11-mer|ligand is 11-mer WDR5-interacting motif of MLL2, Kd=0.16+/-0.01uM|P61964|WD REPEAT-CONTAINING PROTEIN 5|6.8|Kd=0.16uM|Kd|=|0.16|uM|160|nM
3AO2|1.80|2011|AVX||Q72498|HIV-1 INTEGRASE|3.77|Kd=0.17mM|Kd|=|0.17|mM|170000|nM
3Q6S|1.93|2011|19-mer|ligand is a peptide from Shugoshin-like 1|P83916|CHROMOBOX PROTEIN HOMOLOG 1|6.74|Kd=0.18uM|Kd|=|0.18|uM|180|nM
3AQT|2.50|2011|RCO||Q8NR95|BACTERIAL REGULATORY PROTEINS, TETR FAMILY|6.72|Kd=0.19uM|Kd|=|0.19|uM|190|nM
3POA|2.01|2011|12-mer|synthetic phosphopeptide (pThr), Fragment: FHA domain; TPO mutation in phosphopeptide ; incomplete ligand|P71590|PUTATIVE UNCHARACTERIZED PROTEIN TB39.8|7.0|Kd=0.1uM|Kd|=|0.1|uM|100|nM
3RSE|2.65|2011|3-mer|ligand is 3-mer CA fragment of Bos taurus N-WASP peptide; Kd1=0.1+/-0.04uM(site 1); Kd2=10.1+/-1.1uM(site 2);|P61157|ACTIN-RELATED PROTEIN 3|7.0|Kd=0.1uM|Kd|=|0.1|uM|100|nM
3ZYU|1.50|2011|1GH||O60885|BROMODOMAIN-CONTAINING PROTEIN 4|7.0|Kd=0.1uM|Kd|=|0.1|uM|100|nM
3SHV|2.10|2011|10-mer|ligand is 10-mer Histone H2A.x peptide, Kd=0.22+/-0.02uM|Q8NEM0|MICROCEPHALIN|6.66|Kd=0.22uM|Kd|=|0.22|uM|220|nM
3UAT|2.70|2011|18-mer|ligand is 18-mer phosphor-LGN peptide, Kd=0.22+/-0.01uM|Q62696|DISKS LARGE HOMOLOG 1|6.66|Kd=0.22uM|Kd|=|0.22|uM|220|nM
3B26|2.10|2011|B2L||P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|6.64|Kd=0.23uM|Kd|=|0.23|uM|230|nM
3ZY5|1.96|2011|GFB||Q18014|PUTATIVE GDP-FUCOSE PROTEIN O-FUCOSYLTRANSFERASE 1|6.64|Kd=0.23uM|Kd|=|0.23|uM|230|nM
3ORN|2.80|2011|3OR|with MgAMP-PNP, Assay: with ATP; Fragment: UNP RESIDUES 62-270, 303-393;|Q02750|MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1 (MERK 1)|9.62|Kd=0.24nM|Kd|=|0.24|nM|0.24|nM
3KA2|1.40|2011|2NC||P03369|L-ALA51;GLY51']HIV-1 PROTEASE|6.62|Kd=0.24uM|Kd|=|0.24|uM|240|nM
3M93|2.90|2011|M7G|Kd=0.24+/-0.04uM(ITC), Kd=0.161+/-0.005uM(Fluorescent titration)|Q6PKX2|TRANSLATION INITIATION FACTOR 4E|6.62|Kd=0.24uM|Kd|=|0.24|uM|240|nM
2XZQ|2.40|2011|12-mer|peptide Fragment: PEPTIDE, RESIDUES 1-12|------|ANTI-NP MURINE GERMLINE MONOCLONAL ANTIBODY BBE6.12|6.59|Kd=0.26uM|Kd|=|0.26|uM|260|nM
3TL0|2.05|2011|10-mer|ligand is RLNpYAQLWHR peptide ; Kd=0.26+/-0.02uM|Q06124|TYROSINE-PROTEIN PHOSPHATASE, NON-RECEPTOR TYPE 11|6.59|Kd=0.26uM|Kd|=|0.26|uM|260|nM
3UVN|1.79|2011|11-mer|ligand is 11-mer WDR5-interacting motif of SET1A, Kd=0.26+/-0.02uM|P61964|WD REPEAT-CONTAINING PROTEIN 5|6.59|Kd=0.26uM|Kd|=|0.26|uM|260|nM
2LBM|NMR|2011|15-mer|protein Fragment: UNP residues 159-296;|P46100|TRANSCRIPTIONAL REGULATOR ATRX|6.57|Kd=0.27uM|Kd|=|0.27|uM|270|nM
3OVE|1.82|2011|5-mer||P62993|GROWTH FACTOR RECEPTOR-BOUND PROTEIN 2|6.57|Kd=0.27uM|Kd|=|0.27|uM|270|nM
3S0E|1.60|2011|EOL||Q1W640|OBP14|6.55|Kd=0.28uM|Kd|=|0.28|uM|280|nM
3PGU|1.70|2011|OLA||P10384|LONG-CHAIN FATTY ACID TRANSPORT PROTEIN|6.7|Kd=0.2uM|Kd|=|0.2|uM|200|nM
2Y56|3.59|2011|V11|Fragment: RESIDUES 20-236; pKd=6.5+/-0.1 by SPR; pKd=7.4+/-0.1 by ITC; pKi=7+/-0.1|Q8WSF8|ACETYLCHOLINE RECEPTOR|6.51|Kd=0.31uM|Kd|=|0.31|uM|310|nM
3R93|2.06|2011|15-mer||Q99549|M-PHASE PHOSPHOPROTEIN 8|6.51|Kd=0.31uM|Kd|=|0.31|uM|310|nM
2YGU|2.60|2011|HP6|1/Kd=3.1uM-1|P35775|VENOM ALLERGEN 2|6.49|Kd=0.322uM|Kd|=|0.322|uM|322|nM
3MUF|2.30|2011|S3P|ligand is shikimate-3-phosphate (S3P); Kd=0.32+/-0.07uM|P56073|SHIKIMATE KINASE|6.49|Kd=0.32uM|Kd|=|0.32|uM|320|nM
3S0B|1.22|2011|FNA||Q1W640|OBP14|6.49|Kd=0.32uM|Kd|=|0.32|uM|320|nM
2Y4M|2.70|2011|GDX|Mg2+ containing|D0MI02|MANNOSYLGLYCERATE SYNTHASE|6.46|Kd=0.345uM|Kd|=|0.345|uM|345|nM
2YKI|1.67|2011|YKI||P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|9.46|Kd=0.35nM|Kd|=|0.35|nM|0.35|nM
3ZY2|1.54|2011|GDP||Q18014|PUTATIVE GDP-FUCOSE PROTEIN O-FUCOSYLTRANSFERASE 1|6.46|Kd=0.35uM|Kd|=|0.35|uM|350|nM
2Y36|2.70|2011|12-mer||------|ANTI-NP MURINE GERMLINE MONOCLONAL ANTIBODY BBE6.12|6.42|Kd=0.38uM|Kd|=|0.38|uM|380|nM
2XXN|1.60|2011|15-mer|protein Fragment: TRAF DOMAIN, RESIDUES 63-205 ;|Q93009|UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 7|6.41|Kd=0.39uM|Kd|=|0.39|uM|390|nM
3O9P|2.07|2011|MHI||P77348|PERIPLASMIC MUREIN PEPTIDE-BINDING PROTEIN|6.52|Kd=0.3uM|Kd|=|0.3|uM|300|nM
3TF6|2.35|2011|DBH|ligand is 2,3-DHBA; Kd=0.40+/-0.01uM|P80188|NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN|6.4|Kd=0.40uM|Kd|=|0.4|uM|400|nM
3HAU|1.30|2011|2NC||P03369|HIV-1 PROTEASE|6.38|Kd=0.42uM|Kd|=|0.42|uM|420|nM
3QLM|2.50|2011|PLM||P00592|PHOSPHOLIPASE A2|6.37|Kd=0.431uM|Kd|=|0.431|uM|431|nM
2Y1W|2.10|2011|849|Fragment: CATALYTIC DOMAIN, RESIDUES 135-482; cofactor SFG-containing; IC50 assay use full length protein, IC50=0.03+/-0.015uM|Q86X55|HISTONE-ARGININE METHYLTRANSFERASE CARM1|6.33|Kd=0.465uM|Kd|=|0.465|uM|465|nM
4A4E|NMR|2011|2MR|ligand is sDMA|Q16637|SURVIVAL MOTOR NEURON PROTEIN|3.32|Kd=0.476mM|Kd|=|0.476|mM|476000|nM
3RDQ|1.60|2011|DTB||P22629|STREPTAVIDIN|9.31|Kd=0.49nM|Kd|=|0.49|nM|0.49|nM
3UEW|2.00|2011|PLM|complex between LGB and PLM; Kd=0.49uM(ITC); Kd=0.10uM(fluorescence); Kd=2.63uM(ESI-MS); Kd=2.56uM(EPA)|P02754|BETA-LACTOGLOBULIN|6.31|Kd=0.49uM|Kd|=|0.49|uM|490|nM
3ARQ|1.50|2011|DM5|ligand is Idarubicin, IDA; Kd=0.4+/-0.02uM|Q9AMP1|CHITINASE A|6.4|Kd=0.4uM|Kd|=|0.4|uM|400|nM
3LL8|2.00|2011|11-mer|ligand is AKAP79 peptide|P24588|AKAP79 PEPTIDE|6.4|Kd=0.4uM|Kd|=|0.4|uM|400|nM
3RSB|2.80|2011|GTP|Kd=0.4+/-0.04uM|Q58517|ADENOSYLCOBINAMIDE-PHOSPHATE GUANYLYLTRANSFERASE|6.4|Kd=0.4uM|Kd|=|0.4|uM|400|nM
3SZM|2.63|2011|10-mer|Kd=0.4+/-0.2uM|Q8NEM0|MICROCEPHALIN|6.4|Kd=0.4uM|Kd|=|0.4|uM|400|nM
3RUX|1.70|2011|BS5||P96884|BIFUNCTIONAL LIGASE/REPRESSOR BIRA|9.28|Kd=0.53nM|Kd|=|0.53|nM|0.53|nM
3RBQ|2.00|2011|11-mer|ligand is a 11-mer Guanine nucleotide-binding protein G(t) subunit alpha-1 peptide; Kd=0.54+/-0.28uM|Q13432|PROTEIN UNC-119 HOMOLOG A|6.27|Kd=0.54uM|Kd|=|0.54|uM|540|nM
3T1L|1.60|2011|MQT||P17931|GALECTIN-3|3.26|Kd=0.55mM|Kd|=|0.55|mM|550000|nM
2L6J|NMR|2011|5-mer|ligand is C-terminus Hsp90 chaperone peptide MEEVD; Kd=0.55+/-0.06uM|P25638|TPR REPEAT-CONTAINING PROTEIN ASSOCIATED WITH HSP90|6.26|Kd=0.55uM|Kd|=|0.55|uM|550|nM
2Y4L|2.80|2011|GDP|Mn2+ containing|Q9RFR0|MANNOSYLGLYCERATE SYNTHASE|6.3|Kd=0.5uM|Kd|=|0.5|uM|500|nM
3QL9|0.93|2011|15-mer|monoclinic form, histone H3K9me3 peptide|P46100|TRANSCRIPTIONAL REGULATOR ATRX|6.3|Kd=0.5uM|Kd|=|0.5|uM|500|nM
3S7B|2.42|2011|NH5|ligand is AZ505|Q9NRG4|N-LYSINE METHYLTRANSFERASE SMYD2|6.3|Kd=0.5uM|Kd|=|0.5|uM|500|nM
3HLO|1.60|2011|2NC||P03369|COVALENT DIMER [GLY51/D-ALA51'] HIV-1 PROTEASE|6.21|Kd=0.61uM|Kd|=|0.61|uM|610|nM
3S8N|1.71|2011|5-mer||P62993|GROWTH FACTOR RECEPTOR-BOUND PROTEIN 2|6.21|Kd=0.62uM|Kd|=|0.62|uM|620|nM
3P9T|2.02|2011|TCL||Q8KLP4|REPRESSOR|6.2|Kd=0.63uM|Kd|=|0.63|uM|630|nM
3U5L|1.39|2011|08K||O60885|BROMODOMAIN-CONTAINING PROTEIN 4|6.19|Kd=0.64uM|Kd|=|0.64|uM|640|nM
2Y07|2.40|2011|12-mer||------|ANTI-NP MURINE GERMLINE MONOCLONAL ANTIBODY BBE6.12|6.22|Kd=0.6uM|Kd|=|0.6|uM|600|nM
3QMK|2.21|2011|4-mer|Kd=0.787+/-0.124uM, ligand is heparin hexasaccharide|P51693|AMYLOID-LIKE PROTEIN 1|6.1|Kd=0.787uM|Kd|=|0.787|uM|787|nM
2Y4S|2.10|2011|BCD|protein Fragment: RESIDUES 22-904 ;|O48541|LIMIT DEXTRINASE|6.15|Kd=0.7uM|Kd|=|0.7|uM|700|nM
3ARW|1.50|2011|CTI|ligand is Chelerythrine, CHE; Kd=0.7+/-0.03uM(Fluorescence)|Q9AMP1|CHITINASE A|6.15|Kd=0.7uM|Kd|=|0.7|uM|700|nM
3QXD|2.30|2011|15-mer|ligand is 15-mer CLIP peptide|P01903|HLA CLASS II HISTOCOMPATIBILITY ANTIGEN, DR ALPHA C|6.15|Kd=0.7uM|Kd|=|0.7|uM|700|nM
2Y06|2.50|2011|12-mer||------|ANTI-NP MURINE GERMLINE MONOCLONAL ANTIBODY BBE6.12|6.1|Kd=0.80uM|Kd|=|0.8|uM|800|nM
3B25|1.75|2011|B2K||P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|6.07|Kd=0.86uM|Kd|=|0.86|uM|860|nM
3SJT|1.60|2011|5AB|Kd=0.88+/-0.02uM; Mn binding;|P05089|ARGINASE-1|6.06|Kd=0.88uM|Kd|=|0.88|uM|880|nM
3QC9|2.70|2011|ADP|Kd=0.88+/-0.30uM|P28327|RHODOPSIN KINASE|6.06|Kd=0.88uM|Kd|=|0.88|uM|880|nM
3PWM|1.46|2011|017||P03367|HIV-1 PROTEASE|9.1|Kd=0.8nM|Kd|=|0.8|nM|0.8|nM
2YAY|1.86|2011|DUP|ligand is DUPNPP; Ca-containing|O15826|DUTPASE|6.1|Kd=0.8uM|Kd|=|0.8|uM|800|nM
3MP1|2.60|2011|5-mer|H3K4me3 peptide, Kd=0.8+/-0.2 uM(SPR), Kd=4+/-1 uM(FP), Kd=2.3+/-0.3 uM(ITC); X-ray:5-mer, binding assay:11-mer|P0AEX9|MALTOSE-BINDING PERIPLASMIC PROTEIN, LINKER, SAGA|6.1|Kd=0.8uM|Kd|=|0.8|uM|800|nM
3T1N|2.60|2011|4-mer|ligand is Cdc27 peptide; Kd=0.8+/-0.1uM|Q8NEM0|MICROCEPHALIN|6.1|Kd=0.8uM|Kd|=|0.8|uM|800|nM
3T1M|1.55|2011|DQT||P17931|GALECTIN-3|3.04|Kd=0.91mM|Kd|=|0.91|mM|910000|nM
3SHB|1.80|2011|12-mer|ligand is 12-mer Histone H3 peptide|Q96T88|E3 UBIQUITIN-PROTEIN LIGASE UHRF1|6.03|Kd=0.93uM|Kd|=|0.93|uM|930|nM
3AP7|1.53|2011|3-mer|ligand is 3'-SL|O00214|GALECTIN-8|3.0|Kd=0.99mM|Kd|=|0.99|mM|990000|nM
2XHS|2.80|2011|9-mer||P33244|NUCLEAR HORMONE RECEPTOR FTZ-F1|6.0|Kd=0.99uM|Kd|=|0.99|uM|990|nM
2L75|NMR|2011|14-mer|ligand is H3K9me3; Kd=0.9+/-0.4 uM|Q14839|CHROMODOMAIN-HELICASE-DNA-BINDING PROTEIN 4|6.05|Kd=0.9uM|Kd|=|0.9|uM|900|nM
3HAW|1.30|2011|2NC||P03369|[L-ALA51/51']HIV-1 PROTEASE|6.0|Kd=1.01uM|Kd|=|1.01|uM|1010|nM
4A4G|NMR|2011|DA2|ligand is aDMA|Q16637|SURVIVAL MOTOR NEURON PROTEIN|2.99|Kd=1.025mM|Kd|=|1.025|mM|1024999.9999999999|nM
2XV1|2.15|2011|ECA||P40409|IRON-UPTAKE SYSTEM-BINDING PROTEIN|5.99|Kd=1.03uM|Kd|=|1.03|uM|1030|nM
3RL8|2.20|2011|11-mer|ligand is 11-mer peptide from Adenomatous polyposis coli protein; Kd=1.05+/-0.22uM|Q12959|DISKS LARGE HOMOLOG 1|5.98|Kd=1.05uM|Kd|=|1.05|uM|1050|nM
3ARZ|1.82|2011|I5I|P21-A; ligand is 2-(imidazolin-2-yl)-5-isothiocyanatobenzofuran, IMI; Kd=1.0+/-0.1uM(Fluorescence)|Q9AMP1|CHITINASE A|6.0|Kd=1.0uM|Kd|=|1|uM|1000|nM
3ARY|1.35|2011|I5I|space group P21; ligand is IMI; Kd=1.0+/-0.1uM(Fluorescence)|Q9AMP1|CHITINASE A|6.0|Kd=1.0uM|Kd|=|1|uM|1000|nM
3QNJ|2.28|2011|19-mer|ligand is antimicrobial peptide oncocin|P0A6Y8|CHAPERONE PROTEIN DNAK|6.0|Kd=1.0uM|Kd|=|1|uM|1000|nM
4A0J|2.80|2011|6-mer|ligand is HISTONE H3 PEPTIDE C2 form; Kd=1.0+/-0.1uM|O15392|BACULOVIRAL IAP REPEAT-CONTAINING PROTEIN 5|6.0|Kd=1.0uM|Kd|=|1|uM|1000|nM
3PM1|2.80|2011|ET|Kd=1.18+/-0.04 uM, Mutation: K67S, C72A, E90Q, C141S;|P0A0N3|HTH-TYPE TRANSCRIPTIONAL REGULATOR QACR|5.93|Kd=1.18uM|Kd|=|1.18|uM|1180|nM
3ALT|2.50|2011|MLB|ligand is Melibiose; Ca-containing|Q7M4F9|LECTIN CEL-IV, C-TYPE|2.92|Kd=1.19mM|Kd|=|1.19|mM|1190000|nM
3RZ7|1.80|2011|RZ7||P00918|CARBONIC ANHYDRASE 2|8.96|Kd=1.1nM|Kd|=|1.1|nM|1.1|nM
3MP6|1.48|2011|4-mer|X-ray(H3K4me2) while Kd(H3(1-11)K4me2); whether ligand is 4-mer or 11-mer not clear|P0AEX9|MALTOSE-BINDING PERIPLASMIC PROTEIN, LINKER, SAGA|5.96|Kd=1.1uM|Kd|=|1.1|uM|1100|nM
3RW9|2.00|2011|DSH||P19623|SPERMIDINE SYNTHASE|5.96|Kd=1.1uM|Kd|=|1.1|uM|1100|nM
3UEV|1.90|2011|MYR|complex between LGB and MYR; Kd=1.29uM(ITC); Kd=0.33uM(fluorescence); Kd=5.26uM(ESI-MS)|P02754|BETA-LACTOGLOBULIN|5.89|Kd=1.29uM|Kd|=|1.29|uM|1290|nM
3R0H|2.60|2011|9-mer|The measured binding affinities of the NG2 peptides to PDZ5 and PDZ45 are essentially the same.|Q24008|INACTIVATION-NO-AFTER-POTENTIAL D PROTEIN|5.92|Kd=1.2uM|Kd|=|1.2|uM|1200|nM
3TKZ|1.80|2011|10-mer|ligand is RVIpYFVPLNR peptide; Kd=1.2+/-0.3uM|Q06124|TYROSINE-PROTEIN PHOSPHATASE, NON-RECEPTOR TYPE 11|5.92|Kd=1.2uM|Kd|=|1.2|uM|1200|nM
4A4F|NMR|2011|2MR|ligand is sDMA|O75940|SURVIVAL OF MOTOR NEURON-RELATED-SPLICING FACTOR 30|2.88|Kd=1.317mM|Kd|=|1.317|mM|1317000|nM
3TCG|2.00|2011|3-mer||P23843|PERIPLASMIC OLIGOPEPTIDE-BINDING PROTEIN|5.87|Kd=1.36uM|Kd|=|1.36|uM|1360|nM
3QX8|2.30|2011|GTG||Q9UKV8|PROTEIN ARGONAUTE 2|2.86|Kd=1.37mM|Kd|=|1.37|mM|1370000|nM
2Y8I|3.13|2011|ADP|Fragment: MOTOR DOMAIN, RESIDUES 2-759; Mutation: G680A; Mg binding|P08799|MYOSIN-2 HEAVY CHAIN|5.89|Kd=1.3uM|Kd|=|1.3|uM|1300|nM
3AX5|2.20|2011|11-mer|protein Fragment: CYTOSOLIC DOMAIN, UNP RESIDUES 59-126; peptide Fragment: C-TERMINAL HALF, UNP RESIDUES 12-20 ; peptide Mutation: P13C, S16C; Kd=1.4+/-0.5uM|Q62760|MITOCHONDRIAL IMPORT RECEPTOR SUBUNIT TOM20 HOMOLOG|5.85|Kd=1.4uM|Kd|=|1.4|uM|1400|nM
3IAW|1.61|2011|2NC||P03369|GLY51;AIB51]HIV-1 PROTEASE|5.8|Kd=1.57uM|Kd|=|1.57|uM|1570|nM
3PPR|2.10|2011|4CS||O32243|GLYCINE BETAINE/CARNITINE/CHOLINE-BINDING PROTEIN|2.82|Kd=1.5mM|Kd|=|1.5|mM|1500000|nM
2Y8L|2.50|2011|ADP||P54645|5'-AMP-ACTIVATED PROTEIN KINASE CATALYTIC SUBUNIT A|5.82|Kd=1.5uM|Kd|=|1.5|uM|1500|nM
2Y8Q|2.80|2011|ADP||P54645|5'-AMP-ACTIVATED PROTEIN KINASE CATALYTIC SUBUNIT A|5.82|Kd=1.5uM|Kd|=|1.5|uM|1500|nM
3QQA|2.20|2011|TCH||Q7B8P6|CMER|5.82|Kd=1.5uM|Kd|=|1.5|uM|1500|nM
3PLU|1.40|2011|19-mer|66 kDa U4/U6.U5 small nuclear ribonucleoprotein component HINDI domain, Kd=1.69+/-0.27uM; Hub-1: Mutation: A20G|Q6Q546|UBIQUITIN-LIKE MODIFIER HUB1|5.77|Kd=1.69uM|Kd|=|1.69|uM|1690|nM
3RM4|1.90|2011|3RM||Q9BZP6|ACIDIC MAMMALIAN CHITINASE|5.77|Kd=1.69uM|Kd|=|1.69|uM|1690|nM
2XN6|1.29|2011|F6Y-T44|Kd=1.6+/-0.1nM; dimer ligand; Fragment: RESIDUES 32-380; Mutation: RESIDUES 346-355 OF TBG WERE REPLACED BY GAMFLEAIPRS;|P05543|THYROXINE-BINDING GLOBULIN|8.8|Kd=1.6nM|Kd|=|1.6|nM|1.6|nM
3RT4|1.70|2011|LP5|ligand is LPS|Q9GK12|PEPTIDOGLYCAN RECOGNITION PROTEIN 1|8.8|Kd=1.6nM|Kd|=|1.6|nM|1.6|nM
4A4H|NMR|2011|DA2|ligand is aDMA|O75940|SURVIVAL OF MOTOR NEURON-RELATED-SPLICING FACTOR 30|2.77|Kd=1.706mM|Kd|=|1.706|mM|1706000|nM
2XP7|2.00|2011|4F8||Q13526|PEPTIDYL-PROLYL CIS-TRANS ISOMERASE NIMA-INTERACTIN|5.77|Kd=1.7uM|Kd|=|1.7|uM|1700|nM
3QXC|1.34|2011|ATP|Mg-containing|O24872|DETHIOBIOTIN SYNTHETASE|5.77|Kd=1.7uM|Kd|=|1.7|uM|1700|nM
3RZ1|1.51|2011|RZ1||P00918|CARBONIC ANHYDRASE 2|8.74|Kd=1.8nM|Kd|=|1.8|nM|1.8|nM
3O1D|2.40|2011|13-mer|with Gemini-0072; Kd=1.8+/-0.07uM. note that the ligand G72 only EC50 data=0.15+/-0.1nM, it increase the Kd of NR2 to receptor|Q9PTN2|VITAMIN D3 RECEPTOR A|5.74|Kd=1.8uM|Kd|=|1.8|uM|1800|nM
3O1E|2.50|2011|13-mer|with Gemini-0097; Kd=1.8+/-0.08uM. note that the ligand H97 only EC50 data=0.25+/-0.1nM, it increase the Kd of NR2 to receptor|Q9PTN2|VITAMIN D3 RECEPTOR A|5.74|Kd=1.8uM|Kd|=|1.8|uM|1800|nM
3PWH|3.30|2011|ZMA|ligand is ZM241385|P29274|ADENOSINE RECEPTOR A2A|8.72|Kd=1.9nM|Kd|=|1.9|nM|1.9|nM
2Y7W|2.89|2011|SAL|Kd=10.38+/-0.17uM; Fragment: INDUCER BINDING DOMAIN, RESIDUES 80-301; Mutation: YES;|Q7WT50|LYSR-TYPE REGULATORY PROTEIN|4.98|Kd=10.38uM|Kd|=|10.38|uM|10380|nM
2L7U|NMR|2011|7-mer|7-mer peptide; Kd = 104+/-5 uM; protein Fragment: Ig-like V-type domain residues 23-125; peptide Fragment: Sequence database residues 148-154|Q15109|ADVANCED GLYCOSYLATION END PRODUCT-SPECIFIC RECEPTOR|3.98|Kd=104uM|Kd|=|104|uM|104000|nM
3REY|3.31|2011|XAC||P29274|ADENOSINE RECEPTOR A2A|8.0|Kd=10nM|Kd|=|10|nM|10|nM
3P9M|2.00|2011|8-mer||P01901|H-2 CLASS I HISTOCOMPATIBILITY ANTIGEN, K-B|5.0|Kd=10uM|Kd|=|10|uM|10000|nM
2Y7K|1.95|2011|SAL||Q7WT50|LYSR-TYPE REGULATORY PROTEIN|4.93|Kd=11.80uM|Kd|=|11.8|uM|11800|nM
2XN3|2.09|2011|ID8||P05543|THYROXINE-BINDING GLOBULIN|5.92|Kd=1198nM|Kd|=|1198|nM|1198|nM
3N2E|2.53|2011|OSA|ligand is NSC162535; Kd=11+/-4uM|P56073|SHIKIMATE KINASE|4.96|Kd=11uM|Kd|=|11|uM|11000|nM
3RDV|1.75|2011|8-mer||P30622|CAP-GLY DOMAIN-CONTAINING LINKER PROTEIN 1|4.91|Kd=12.3uM|Kd|=|12.3|uM|12300|nM
3TE5|2.50|2011|NAI||P06782|CARBON CATABOLITE-DEREPRESSING PROTEIN KINASE|4.91|Kd=12.3uM|Kd|=|12.3|uM|12300|nM
3N75|2.00|2011|G4P|Kd1=12.8+/-6.6 nM; Kd2=684.9+/-314.3nM|P0A9H3|LYSINE DECARBOXYLASE|7.89|Kd=12.8nM|Kd|=|12.8|nM|12.8|nM
3QS6|2.80|2011|TRP|Kd=12.8+/-1.3uM|O67854|NA(+):NEUROTRANSMITTER SYMPORTER (SNF FAMILY)|4.89|Kd=12.8uM|Kd|=|12.8|uM|12800|nM
2XXY|3.00|2011|KAI|Kd = 12.9+/-1.7 nM; protein mutant D776K; Fragment: LIGAND BINDING DOMAIN, RESIDUES 429-544, 667-806|P42260|GLUTAMATE RECEPTOR, IONOTROPIC KAINATE 2|7.89|Kd=12.9nM|Kd|=|12.9|nM|12.9|nM
3RZ9|2.29|2011|13-mer|Kd=120+/-9nM; Solid-phase binding assays|P52293|IMPORTIN SUBUNIT ALPHA-2|6.92|Kd=120nM|Kd|=|120|nM|120|nM
3RLB|2.00|2011|VIB||D8KFM5|THIT|9.92|Kd=120pM|Kd|=|120|pM|0.12|nM
3QIP|2.09|2011|P4Y|ligand is compound 2; Kd=129+/-43nM|P04585|HIV-1 REVERSE TRANSCRIPTASE P66|6.89|Kd=129nM|Kd|=|129|nM|129|nM
2X85|1.50|2011|4-mer|ligand is hexasaccharide;Kd=129+/-11uM|Q9AYY6|TAILSPIKE PROTEIN HK620|3.89|Kd=129uM|Kd|=|129|uM|129000|nM
3OD0|2.90|2011|PCG|Kd=12+/-1.6nM; Fragment: Cyclic nucleotie binding domain;|Q6P5T7|PRKG1 PROTEIN|7.92|Kd=12nM|Kd|=|12|nM|12|nM
3PJU|2.50|2011|C2E||Q3KK31|CYCLIC DIMERIC GMP BINDING PROTEIN|4.88|Kd=13.1uM|Kd|=|13.1|uM|13100|nM
3PJT|2.52|2011|C2E|Kd=13.1+/-0.9 uM; Fragment: UNP Residues 400-648;|Q3KK31|CYCLIC DIMERIC GMP BINDING PROTEIN|4.88|Kd=13.1uM|Kd|=|13.1|uM|13100|nM
3QIN|1.70|2011|P1Y||Q72547|GAG-POL POLYPROTEIN|6.87|Kd=136nM|Kd|=|136|nM|136|nM
3PYY|1.85|2011|3YY||Q59FK4|TYROSINE-PROTEIN KINASE ABL1|6.86|Kd=137nM|Kd|=|137|nM|137|nM
3RTX|2.81|2011|18-mer|ligand is a 18-mer RNA Polymerase II C-terminal domain peptide|O55236|MRNA-CAPPING ENZYME|3.86|Kd=139uM|Kd|=|139|uM|139000|nM
2YLC|1.30|2011|U||P0A1R0|PROTEIN HFQ|7.89|Kd=13nM|Kd|=|13|nM|13|nM
3RZ5|1.65|2011|RZ5||P00918|CARBONIC ANHYDRASE 2|7.89|Kd=13nM|Kd|=|13|nM|13|nM
3NJQ|2.00|2011|NJQ||P88911|ORF 17|4.89|Kd=13uM|Kd|=|13|uM|13000|nM
3ZYF|1.94|2011|147|ligand is NPG; Kd=14.1+/-0.2uM|Q05097|PA-I GALACTOPHILIC LECTIN|4.85|Kd=14.1uM|Kd|=|14.1|uM|14100|nM
3RU1|2.30|2011|3RU||P56817|BETA-SECRETASE 1|4.85|Kd=14.2uM|Kd|=|14.2|uM|14200|nM
2YB0|2.28|2011|DUR||O15826|DUTPASE|3.85|Kd=140uM|Kd|=|140|uM|140000|nM
3QIO|1.40|2011|QID|ligand is compound 3; Kd=144+/-11nM|Q72547|GAG-POL POLYPROTEIN|6.84|Kd=144nM|Kd|=|144|nM|144|nM
3QND|2.40|2011|SIA||Q64823|FIBER PROTEIN|4.85|Kd=14uM|Kd|=|14|uM|14000|nM
2XQQ|1.31|2011|7-mer||Q96FJ2|DYNEIN LIGHT CHAIN 2|4.82|Kd=15.2uM|Kd|=|15.2|uM|15200|nM
3S75|1.50|2011|EVG||P00918|CARBONIC ANHYDRASE 2|6.82|Kd=150nM|Kd|=|150|nM|150|nM
3N5E|2.26|2011|8-mer|ligand is LR; Kd1=151nM(first binding site)|P04818|THYMIDYLATE SYNTHASE|6.82|Kd=151nM|Kd|=|151|nM|151|nM
3Q72|1.66|2011|GNP||P55042|GTP-BINDING PROTEIN RAD|5.8|Kd=1574nM|Kd|=|1574|nM|1574|nM
3Q7P|2.50|2011|GNP|redundant to 3q7q|P55042|GTP-BINDING PROTEIN RAD|5.8|Kd=1574nM|Kd|=|1574|nM|1574|nM
3ODI|2.20|2011|11-mer|Voclosporin, E-ISA247, Kd=15+/-4nM|A8K220|CYCLOPHILIN A|7.82|Kd=15nM|Kd|=|15|nM|15|nM
3NFK|1.43|2011|13-mer|Glycoprotein G, Cyto13-att, PTPN4 PDZ: Fragment: PDZ domain (UNP residues 499-604); ligand: Fragment: UNP residues 512-524|P29074|TYROSINE-PROTEIN PHOSPHATASE NON-RECEPTOR TYPE 4|3.8|Kd=160uM|Kd|=|160|uM|160000|nM
3RYJ|1.39|2011|RYJ||P00918|CARBONIC ANHYDRASE 2|7.8|Kd=16nM|Kd|=|16|nM|16|nM
3O2M|2.70|2011|46A|Fragment: unp residues 1-364; Mutation: T183E, Y185E; The unactuvated protein|P45983|MITOGEN-ACTIVATED PROTEIN KINASE 8|4.8|Kd=16uM|Kd|=|16|uM|16000|nM
3STJ|2.60|2011|7-mer|ligand is PDZ1 peptide|P39099|PROTEASE DEGQ|4.8|Kd=16uM|Kd|=|16|uM|16000|nM
3TWV|2.30|2011|16-mer|ligand is 16-mer human NUMA1 peptide, chimeric, Kd=17.2+/-3.2uM|Q9H2K2|TANKYRASE-2|4.76|Kd=17.2uM|Kd|=|17.2|uM|17200|nM
2Y9G|1.67|2011|LAT|([LSL150:(lactose)beta, gamma] binary lactose complex, either LAT or LBT|Q7Z8V1|HEMOLYTIC LECTIN LSLA|3.77|Kd=170uM|Kd|=|170|uM|170000|nM
3ARD|3.01|2011|3GH|ternary complexes; another protein CD1d containing|P11609|ANTIGEN-PRESENTING GLYCOPROTEIN CD1D1|6.76|Kd=175nM|Kd|=|175|nM|175|nM
3RM9|2.10|2011|613||Q9BZP6|ACIDIC MAMMALIAN CHITINASE|4.77|Kd=17uM|Kd|=|17|uM|17000|nM
3RQE|2.80|2011|14-mer|ligand is Paxillin LD1 peptide; Kd=17+/-3uM|Q9BUL8|PROGRAMMED CELL DEATH PROTEIN 10|4.77|Kd=17uM|Kd|=|17|uM|17000|nM
3RL7|2.30|2011|11-mer|ligand is 11-mer peptide from Adenomatous polyposis coli protein; Kd=18.2+/-7.6uM|Q12959|DISKS LARGE HOMOLOG 1|4.74|Kd=18.2uM|Kd|=|18.2|uM|18200|nM
3PDH|1.80|2011|18-mer|Cellular tumor antigen p53 18-residue peptide, propionylated p53 18-residue peptide, Temperature at 25 degree, Kd=183+/-17 nM|Q9WYW0|NAD-DEPENDENT DEACETYLASE|6.74|Kd=183nM|Kd|=|183|nM|183|nM
3PUK|3.05|2011|10-mer|Syntaxin-4 N-terminal peptide, Fragment: UNP residues 1-10; Kd=18+/-7 uM|Q60770|SYNTAXIN-BINDING PROTEIN 3|4.74|Kd=18uM|Kd|=|18|uM|18000|nM
3QS5|2.60|2011|TRP|Kd=19.6+/-2.0uM|O67854|NA(+):NEUROTRANSMITTER SYMPORTER (SNF FAMILY)|4.71|Kd=19.6uM|Kd|=|19.6|uM|19600|nM
3P7I|1.71|2011|P7I||Q1R3F7|PHND, SUBUNIT OF ALKYLPHOSPHONATE ABC TRANSPORTER|7.7|Kd=19.9nM|Kd|=|19.9|nM|19.9|nM
3Q6Z|2.23|2011|APR|Kd=192+/-7uM|Q460N5|POLY [ADP-RIBOSE] POLYMERASE 14|3.72|Kd=192uM|Kd|=|192|uM|192000|nM
2L84|NMR|2011|J28|Fragment: Bromo domain residues 1081-1197;|Q92793|CREB-BINDING PROTEIN|7.72|Kd=19nM|Kd|=|19|nM|19|nM
3UVL|2.20|2011|11-mer|ligand is 11-mer WDR5-interacting motif of MLL3, Kd=2.03+/-0.11uM|P61964|WD REPEAT-CONTAINING PROTEIN 5|5.69|Kd=2.03uM|Kd|=|2.03|uM|2029.9999999999998|nM
2LKO|NMR|2011|4IP|Kd=2.12+/-0.19uM|Q96AC1|FERMITIN FAMILY HOMOLOG 2|5.67|Kd=2.12uM|Kd|=|2.12|uM|2120|nM
3TDU|1.50|2011|16-mer|ligand is NEDD8-conjugating enzyme Ubc12|Q96GG9|DCN1-LIKE PROTEIN 1|5.67|Kd=2.15uM|Kd|=|2.15|uM|2150|nM
3SOU|1.80|2011|9-mer|ligand is H3(1-9) peptide|Q96T88|E3 UBIQUITIN-PROTEIN LIGASE UHRF1|5.68|Kd=2.1uM|Kd|=|2.1|uM|2100|nM
3T6R|1.95|2011|7-mer|unmodified Histone H3.1 tail N-terminal peptide|Q96T88|E3 UBIQUITIN-PROTEIN LIGASE UHRF1|5.66|Kd=2.20uM|Kd|=|2.2|uM|2200|nM
3TD4|1.79|2011|API||Q6RYW5|OUTER MEMBRANE PROTEIN OMP38|5.66|Kd=2.2uM|Kd|=|2.2|uM|2200|nM
3S71|1.25|2011|EVD||P00918|CARBONIC ANHYDRASE 2|8.64|Kd=2.3nM|Kd|=|2.3|nM|2.3|nM
2XZC|1.36|2011|XOP|Kd3=6.2+/-0.4uM|------|ANTIBODY FAB A.17 LIGHT CHAIN|5.64|Kd=2.3uM|Kd|=|2.3|uM|2300|nM
3ARV|1.50|2011|SAU|ligand is Sanguinarine(SAN); IC50=2.3+/-0.3uM(pNP assay)|Q9AMP1|CHITINASE A|5.64|Kd=2.3uM|Kd|=|2.3|uM|2300|nM
3S8L|1.71|2011|5-mer||P62993|GROWTH FACTOR RECEPTOR-BOUND PROTEIN 2|5.64|Kd=2.3uM|Kd|=|2.3|uM|2300|nM
3LDP|2.20|2011|3P1||P11021|78 KDA GLUCOSE-REGULATED PROTEIN|5.62|Kd=2.41uM|Kd|=|2.41|uM|2410|nM
3U5J|1.60|2011|08H||O60885|BROMODOMAIN-CONTAINING PROTEIN 4|5.61|Kd=2.46uM|Kd|=|2.46|uM|2460|nM
3RYZ|1.37|2011|RYZ||P00918|CARBONIC ANHYDRASE 2|8.62|Kd=2.4nM|Kd|=|2.4|nM|2.4|nM
3TWU|1.80|2011|16-mer|ligand is 16-mer human MCL1 peptide, Kd=2.4+/-0.2uM;|Q9H2K2|TANKYRASE-2|5.62|Kd=2.4uM|Kd|=|2.4|uM|2400|nM
3QPS|2.35|2011|CHD||Q7B8P6|CMER|5.6|Kd=2.5uM|Kd|=|2.5|uM|2500|nM
3T8S|3.77|2011|I3P|ligand is compound 1 (IP3), full-length Kd=12.5nM. similar to code 3uj0|P29994|INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR TYPE 1|8.55|Kd=2.82nM|Kd|=|2.82|nM|2.82|nM
3OVN|1.95|2011|MPV||Q72498|HIV-1 INTEGRASE|2.55|Kd=2.8mM|Kd|=|2.8|mM|2800000|nM
2Y7I|1.90|2011|ARG||Q8ZKA9|STM4351|5.54|Kd=2.9uM|Kd|=|2.9|uM|2900|nM
3UJD|1.50|2011|PC|complex between PfPMT-Y19F and pCho; Kd=20.2+/-6.8uM|Q6T755|PHOSPHOETHANOLAMINE N-METHYLTRANSFERASE|4.69|Kd=20.2uM|Kd|=|20.2|uM|20200|nM
2XN5|1.70|2011|FUN||P05543|THYROXINE-BINDING GLOBULIN|6.69|Kd=205nM|Kd|=|205|nM|205|nM
3O75|2.30|2011|F1X|Kd=209+/-20nM|Q88PQ6|FRUCTOSE TRANSPORT SYSTEM REPRESSOR FRUR|6.68|Kd=209nM|Kd|=|209|nM|209|nM
2Y54|3.65|2011|V63|pKd=4.7+/-0.1; Fragment: RESIDUES 20-236; pKd=5.9+/-0.2 by ITC; pKi=5.3+/-0.1|Q8WSF8|ACETYLCHOLINE RECEPTOR|4.7|Kd=20uM|Kd|=|20|uM|20000|nM
3PAB|2.20|2011|8-mer|Ovalbumin epitope, EIINFEKL, (S1E), Kd=20-22uM; Fragment: Extracellular domain|P01901|H-2 CLASS I HISTOCOMPATIBILITY ANTIGEN, K-B ALPHA C|4.7|Kd=20uM|Kd|=|20|uM|20000|nM
3TG5|2.30|2011|11-mer|ligand is peptide from p53(365-375); incomplete liagnd|Q9NRG4|N-LYSINE METHYLTRANSFERASE SMYD2|4.7|Kd=20uM|Kd|=|20|uM|20000|nM
3QS4|2.63|2011|TRP|Kd=21.0+/-2.7uM|O67854|NA(+):NEUROTRANSMITTER SYMPORTER (SNF FAMILY)|4.68|Kd=21.0uM|Kd|=|21|uM|21000|nM
3TIW|1.80|2011|19-mer|Kd=21.3+/-0.3 nM|P55072|TRANSITIONAL ENDOPLASMIC RETICULUM ATPASE|7.67|Kd=21.3nM|Kd|=|21.3|nM|21.3|nM
3OOB|1.89|2011|KDH|Mutation: R14A;|Q13526|PEPTIDYL-PROLYL CIS-TRANS ISOMERASE NIMA-INTERACTIN|4.67|Kd=21.6uM|Kd|=|21.6|uM|21600|nM
2X6X|1.48|2011|6-mer|ligand is hexasaccharide; Kd=210+/-7uM|Q9AYY6|TAILSPIKE PROTEIN HK620|3.68|Kd=210uM|Kd|=|210|uM|210000|nM
3INY|2.75|2011|7DG|Kd=217 +/-14 uM; IC50=251+/-2 uM(data in other paper)|P00491|PURINE NUCLEOSIDE PHOSPHORYLASE|3.66|Kd=217uM|Kd|=|217|uM|217000|nM
3Q7Q|2.30|2011|GNP||P55042|GTP-BINDING PROTEIN RAD|5.65|Kd=2256nM|Kd|=|2256|nM|2256|nM
2YDF|2.75|2011|IO3|binding assay method by biosensor|P02768|SERUM ALBUMIN|7.66|Kd=22nM|Kd|=|22|nM|22|nM
2L3R|NMR|2011|11-mer|ligand is H3K4me0/H3K9me3 peptide; Kd=22+/-6uM|Q96T88|E3 UBIQUITIN-PROTEIN LIGASE UHRF1|4.66|Kd=22uM|Kd|=|22|uM|22000|nM
3PKN|1.80|2011|14-mer|La-related protein 4 LARP4: PABP-binding region (UNP residues 13-26); PABP MLLE domain (UNP residues 544-626) with PAM2 motif of LARP4(13-26)|P11940|POLYADENYLATE-BINDING PROTEIN 1|4.66|Kd=22uM|Kd|=|22|uM|22000|nM
3UJ9|1.24|2011|PC|complex between PfPMT and pCho; Kd=23.4+/-1.6uM|Q6T755|PHOSPHOETHANOLAMINE N-METHYLTRANSFERASE|4.63|Kd=23.4uM|Kd|=|23.4|uM|23400|nM
3ARB|2.70|2011|FEE|ternary complexes; another protein CD1d containing|P11609|ANTIGEN-PRESENTING GLYCOPROTEIN CD1D1|6.63|Kd=234nM|Kd|=|234|nM|234|nM
3RQG|2.50|2011|13-mer|ligand is Paxillin LD4 peptide; Kd=23+/-6uM|Q9BUL8|PROGRAMMED CELL DEATH PROTEIN 10|4.64|Kd=23uM|Kd|=|23|uM|23000|nM
2YGA|2.37|2011|GDM||P02829|ATP-DEPENDENT MOLECULAR CHAPERONE HSP82|4.61|Kd=24.5uM|Kd|=|24.5|uM|24500|nM
2L98|NMR|2011|STL|Fragment: EF-hand domains 3 and 4, residues 91-161 ; binding assay method by NMR|P63316|TROPONIN C, SLOW SKELETAL AND CARDIAC MUSCLES|3.61|Kd=243uM|Kd|=|243|uM|243000|nM
3SK2|1.01|2011|GRI||Q8GPH6|EHPR|3.61|Kd=244uM|Kd|=|244|uM|244000|nM
3UBX|3.10|2011|09N|ligand is C20:2;Kd=25.2+/-0.9nM|P11609|ANTIGEN-PRESENTING GLYCOPROTEIN CD1D1|7.6|Kd=25.2nM|Kd|=|25.2|nM|25.2|nM
3T2C|1.30|2011|13P|calorimetric titration; Mg2+ containing; the enzyme can bind its first substrate, DHAP|B1YAL1|FRUCTOSE-1,6-BISPHOSPHATE ALDOLASE/PHOSPHATASE|4.6|Kd=25uM|Kd|=|25|uM|25000|nM
3SL1|1.90|2011|FB6|Ki=260+/-20uM; Mn binding; Fragment: UNP residues 22-411;|Q8I384|ARGINASE|3.59|Kd=260uM|Kd|=|260|uM|260000|nM
3P3S|1.60|2011|3M2|ligand is compound 14|P02766|TRANSTHYRETIN|7.59|Kd=26nM|Kd|=|26|nM|26|nM
2X6Y|1.35|2011|4-mer|ligand is hexasaccharide,kd=26+/-3uM|Q9AYY6|TAIL SPIKE PROTEIN|4.59|Kd=26uM|Kd|=|26|uM|26000|nM
3UJC|1.19|2011|PC|ligand is H132A-pCho; Kd=26.0+/-11.3uM|Q6T755|PHOSPHOETHANOLAMINE N-METHYLTRANSFERASE|4.59|Kd=26uM|Kd|=|26|uM|26000|nM
3OCP|2.49|2011|CMP||Q6P5T7|PRKG1 PROTEIN|7.57|Kd=27nM|Kd|=|27|nM|27|nM
3Q6W|1.75|2011|Q6W|lignad is compound 1; Kd=27+/-7nM|P08581|HEPATOCYTE GROWTH FACTOR RECEPTOR|7.57|Kd=27nM|Kd|=|27|nM|27|nM
3RJW|2.56|2011|CIQ|ligand is UNC0638(3)|Q96KQ7|HISTONE-LYSINE N-METHYLTRANSFERASE EHMT2|7.57|Kd=27nM|Kd|=|27|nM|27|nM
3MXC|2.00|2011|9-mer|acid peptide, Kd=286.1+/-11.9nM|P62993|GROWTH FACTOR RECEPTOR-BOUND PROTEIN 2|6.54|Kd=286.1nM|Kd|=|286.1|nM|286.1|nM
2XJ1|2.13|2011|XJ1||P11309|SERINE/THREONINE-PROTEIN KINASE PIM-1|7.55|Kd=28nM|Kd|=|28|nM|28|nM
3RZ0|1.80|2011|RZ0||P00918|CARBONIC ANHYDRASE 2|7.55|Kd=28nM|Kd|=|28|nM|28|nM
3AQA|2.30|2011|BYH|compound BIC1|P25440|BROMODOMAIN-CONTAINING PROTEIN 2|4.55|Kd=28uM|Kd|=|28|uM|28000|nM
3AS0|2.00|2011|SAU|ligand is Sanguinarine, SAN|Q9AMP1|CHITINASE A|4.55|Kd=28uM|Kd|=|28|uM|28000|nM
3PPQ|1.91|2011|CHT||O32243|GLYCINE BETAINE/CARNITINE/CHOLINE-BINDING PROTEIN|4.55|Kd=28uM|Kd|=|28|uM|28000|nM
3S73|1.75|2011|EVF||P00918|CARBONIC ANHYDRASE 2|8.7|Kd=2nM|Kd|=|2|nM|2|nM
3PXE|2.85|2011|10-mer|Kd=2+/-0.1uM; BRCA1:Fragment: BRCT domain, UNP residues 1646-1859; Mutation: E1836K;|P38398|BREAST CANCER TYPE 1 SUSCEPTIBILITY PROTEIN|5.7|Kd=2uM|Kd|=|2|uM|2000|nM
3TWS|1.70|2011|16-mer|ligand is 16-mer human TERF1 peptide, Kd=3.0+/-0.5uM|Q9H2K2|TANKYRASE-2|5.52|Kd=3.0uM|Kd|=|3|uM|3000|nM
2Y58|3.25|2011|V38|Fragment: RESIDUES 20-236; pKd=5.5+/-0.1 by SPR; pKd=6.0+/-0.4 by ITC; pKi=6+/-0.1|Q8WSF8|ACETYLCHOLINE RECEPTOR|5.5|Kd=3.16uM|Kd|=|3.16|uM|3160|nM
2YIX|2.30|2011|YIX||Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|8.48|Kd=3.3nM|Kd|=|3.3|nM|3.3|nM
2Y7P|1.85|2011|SAL|DNTR inducer binding domain in complex with salicylate|Q7WT50|LYSR-TYPE REGULATORY PROTEIN|5.47|Kd=3.4uM|Kd|=|3.4|uM|3400|nM
2Y4K|2.45|2011|GDP|Mg2+ containing|Q9RFR0|MANNOSYLGLYCERATE SYNTHASE|5.46|Kd=3.5uM|Kd|=|3.5|uM|3500|nM
3P2H|2.00|2011|NOO|Kd=3.6-4.1 uM; Mutation: F42M, I149M, L152M, deletion H91, deletion P92;|Q4VSJ8|AHL SYNTHASE|5.44|Kd=3.6uM|Kd|=|3.6|uM|3600|nM
3U10|2.30|2011|CMP|complex between cAMP and MBP-HCN2; Kd by ITC|Q9UL51|POTASSIUM/SODIUM HYPERPOLARIZATION-ACTIVATED CYCLIC|5.44|Kd=3.6uM|Kd|=|3.6|uM|3600|nM
3QLB|3.26|2011|2-mer|ligand is CIT-EFE; Kd=3.7+/-2.1nM|C5I2D9|ENANTIO-PYOCHELIN RECEPTOR|8.43|Kd=3.7nM|Kd|=|3.7|nM|3.7|nM
3QLC|2.50|2011|15-mer||P46100|TRANSCRIPTIONAL REGULATOR ATRX|5.43|Kd=3.7uM|Kd|=|3.7|uM|3700|nM
3S7F|2.85|2011|13-mer|ligand is p53 substrate peptide|Q9NRG4|N-LYSINE METHYLTRANSFERASE SMYD2|5.43|Kd=3.7uM|Kd|=|3.7|uM|3700|nM
3TJH|2.12|2011|9-mer|ligand is in 9-mer p3A1-H2-Ld peptide format|P01897|H2-LD SBM2|5.41|Kd=3.9uM|Kd|=|3.9|uM|3900|nM
3R6U|1.61|2011|CHT||Q45462|CHOLINE-BINDING PROTEIN|4.52|Kd=30.5uM|Kd|=|30.5|uM|30500|nM
3MYQ|1.35|2011|E27||P00918|CARBONIC ANHYDRASE 2|7.52|Kd=30nM|Kd|=|30|nM|30|nM
3N7H|1.60|2011|DE3||Q8T6S0|ODORANT-BINDING PROTEIN|4.5|Kd=31.3uM|Kd|=|31.3|uM|31300|nM
3PUJ|3.31|2011|10-mer|Syntaxin-4 N-terminal peptide, Fragment: UNP residues 1-10; Kd=31+/-8 uM|P61765|SYNTAXIN-BINDING PROTEIN 1|4.51|Kd=31uM|Kd|=|31|uM|31000|nM
3QEL|2.60|2011|QEL|ligand is ifenprodil|Q91977|NMDA GLUTAMATE RECEPTOR SUBUNIT|6.49|Kd=320nM|Kd|=|320|nM|320|nM
3M6R|2.40|2011|BB2||Q9FUZ2|PEPTIDE DEFORMYLASE 1B|7.49|Kd=32nM|Kd|=|32|nM|32|nM
3TA0|2.30|2011|ATP|Kd measured with Mg2+|O28524|NITROGEN REGULATORY PROTEIN P-II (GLNB-3)|3.47|Kd=338uM|Kd|=|338|uM|338000|nM
3S78|1.98|2011|EVJ||P00918|CARBONIC ANHYDRASE 2|6.47|Kd=340nM|Kd|=|340|nM|340|nM
3SKK|1.70|2011|4U7|Kd=34+/-2uM; Mn binding;|P05089|ARGINASE-1|4.47|Kd=34uM|Kd|=|34|uM|34000|nM
3ATP|2.50|2011|SER||P02942|METHYL-ACCEPTING CHEMOTAXIS PROTEIN I|4.45|Kd=35.6uM|Kd|=|35.6|uM|35600|nM
3PQZ|2.41|2011|11-mer|cyclic peptide, G7-18NATE, Grb7: Fragment: SH2 domain|Q14451|GROWTH FACTOR RECEPTOR-BOUND PROTEIN 7|4.46|Kd=35uM|Kd|=|35|uM|35000|nM
3TSZ|2.50|2011|12-mer|ligans is JAM-A_12 peptide|Q07157|TIGHT JUNCTION PROTEIN ZO-1|4.46|Kd=35uM|Kd|=|35|uM|35000|nM
3TVW|2.80|2011|07H|ligand is compound 4; Kd=37.0+/-6.0 uM|Q00955|ACETYL-COA CARBOXYLASE|4.43|Kd=37.0uM|Kd|=|37|uM|37000|nM
3AXZ|2.25|2011|ADN||P43912|TRNA (GUANINE-N(1)-)-METHYLTRANSFERASE|3.43|Kd=372uM|Kd|=|372|uM|372000|nM
3ART|2.23|2011|DEQ|ligand is Dequalinlium, DEQ|Q9AMP1|CHITINASE A|4.43|Kd=37uM|Kd|=|37|uM|37000|nM
3PXF|1.80|2011|2AN||P24941|CELL DIVISION PROTEIN KINASE 2|4.43|Kd=37uM|Kd|=|37|uM|37000|nM
3PXQ|1.90|2011|2AN|redundant to 3pxf|P24941|CELL DIVISION PROTEIN KINASE 2|4.43|Kd=37uM|Kd|=|37|uM|37000|nM
3RTM|2.76|2011|RTM|ligand is compound 40|P56817|BETA-SECRETASE 1|4.42|Kd=38.4uM|Kd|=|38.4|uM|38400|nM
3RSX|2.48|2011|RSV||P56817|BETA-SECRETASE 1|4.41|Kd=38.8uM|Kd|=|38.8|uM|38800|nM
3MXY|2.30|2011|9-mer|aicd peptide E683V variant, Kd=384.8+/-37.7nM|P62993|GROWTH FACTOR RECEPTOR-BOUND PROTEIN 2|6.41|Kd=384.8nM|Kd|=|384.8|nM|384.8|nM
3RYY|1.16|2011|RYY||P00918|CARBONIC ANHYDRASE 2|7.42|Kd=38nM|Kd|=|38|nM|38|nM
3RQF|2.70|2011|13-mer|ligand is Paxillin LD2 peptide; Kd=39+/-2uM|Q9BUL8|PROGRAMMED CELL DEATH PROTEIN 10|4.41|Kd=39uM|Kd|=|39|uM|39000|nM
3N23|4.60|2011|OBN|Kd=3nM(no KCl, also in crystral); 130 nM(10mM KCl), 420nM(50 mM KCl)|P05024|SODIUM/POTASSIUM-TRANSPORTING ATPASE SUBUNIT ALPHA|8.52|Kd=3nM|Kd|=|3|nM|3|nM
2L8J|NMR|2011|18-mer||Q9H0R8|GAMMA-AMINOBUTYRIC ACID RECEPTOR-ASSOCIATED PROTEIN|5.52|Kd=3uM|Kd|=|3|uM|3000|nM
3ARR|1.65|2011|PNX|ligand is pentoxifyllin(PEN); IC50=3.5+/-0.5uM(pNP assay)|Q9AMP1|CHITINASE A|5.4|Kd=4.0uM|Kd|=|4|uM|4000|nM
3QKD|2.02|2011|HI0||Q07817|BCL-2-LIKE PROTEIN 1|8.38|Kd=4.2nM|Kd|=|4.2|nM|4.2|nM
3SW9|3.05|2011|12-mer|ligand is 12-mer peptide mDnmt3aK44me0-Sinefungin, Kd=4.2+/-0.3uM|Q9H9B1|HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1|5.38|Kd=4.2uM|Kd|=|4.2|uM|4200|nM
3TWW|2.00|2011|16-mer|ligand is 16-mer human LNPEP peptide, chimeric, Kd=4.2+/-0.3uM|Q9H2K2|TANKYRASE-2|5.38|Kd=4.2uM|Kd|=|4.2|uM|4200|nM
3ZYB|2.29|2011|4-mer|ligand GalBG0 (GalB-KPL-NH2); Kd=51.5+/-6.7uM|Q05097|PA-I GALACTOPHILIC LECTIN|5.38|Kd=4.2uM|Kd|=|4.2|uM|4200|nM
3Q6K|2.52|2011|SRO|Kd=4.3+/-1.1nM|Q5WPU9|43.2 KDA SALIVARY PROTEIN|8.37|Kd=4.3nM|Kd|=|4.3|nM|4.3|nM
3OJ8|1.90|2011|OJ8|Fragment: UNP residues 30-579; Mutation: L192F, F194Y, A377T, S435N, I491V, V495M;|P97612|FATTY-ACID AMIDE HYDROLASE 1|8.36|Kd=4.4nM|Kd|=|4.4|nM|4.4|nM
3AY9|1.75|2011|ADP|binding data measured with Mg2+|P08107|HEAT SHOCK 70 KDA PROTEIN 1A/1B|8.34|Kd=4.55nM|Kd|=|4.55|nM|4.55|nM
3M6P|2.00|2011|BB2||Q9FUZ2|PEPTIDE DEFORMYLASE 1B|8.35|Kd=4.5nM|Kd|=|4.5|nM|4.5|nM
3ARX|1.16|2011|POY|ligand is propentofylline(PRO); Kd=4.7+/-0.5uM(Fluorescence)|Q9AMP1|CHITINASE A|5.33|Kd=4.7uM|Kd|=|4.7|uM|4700|nM
3TV5|2.80|2011|RCP|ligand is compound 1; Kd=4.8+/-2.0uM|Q00955|ACETYL-COA CARBOXYLASE|5.32|Kd=4.8uM|Kd|=|4.8|uM|4800|nM
3S72|1.60|2011|EVE||P00918|CARBONIC ANHYDRASE 2|6.4|Kd=400nM|Kd|=|400|nM|400|nM
3NFL|1.91|2011|16-mer|Glutamate [NMDA] receptor subunit epsilon-1, GluN2A16 PTPN4 PDZ: Fragment: PDZ domain (UNP residues 499-604); ligand: Fragment: UNP residues 1449-1464;|P29074|TYROSINE-PROTEIN PHOSPHATASE NON-RECEPTOR TYPE 4|4.38|Kd=42uM|Kd|=|42|uM|42000|nM
3N35|2.00|2011|A2G||P16404|LECTIN|3.37|Kd=431uM|Kd|=|431|uM|431000|nM
3ZXE|1.67|2011|PGZ|ligand is compound 6|P47929|GALECTIN-7|3.35|Kd=450uM|Kd|=|450|uM|450000|nM
3LRH|2.60|2011|14-mer|huntingtin, alpha-Htt-VL: Fragment: anti-huntingtin VL domain; Mutation: G112A; Htt:Fragment: huntingtin peptide;|P42858|ANTI-HUNTINGTIN VL DOMAIN|7.35|Kd=45nM|Kd|=|45|nM|45|nM
2YDW|1.90|2011|WSH||P25440|BROMODOMAIN-CONTAINING PROTEIN 2|7.34|Kd=46.0nM|Kd|=|46|nM|46|nM
3RY8|1.40|2011|FLC|Kd=460+/-80uM|Q5F4T5|CAPSID PROTEIN|3.34|Kd=460uM|Kd|=|460|uM|460000|nM
3ATV|1.58|2011|ADP|binding data measured without Mg2+|P08107|HEAT SHOCK 70 KDA PROTEIN 1A/1B|5.34|Kd=4610nM|Kd|=|4610|nM|4610|nM
3AYA|2.00|2011|3-mer|THR-A2G-GAL; Fragment: C-TERMINAL DOMAIN, UNP residues 117-250;|P17931|GALECTIN-3|4.33|Kd=47uM|Kd|=|47|uM|47000|nM
3Q5U|2.50|2011|13-mer|ligand is Phospholipid scramblase 4 peptide; Kd=48.7+/-6.5uM; incomplete ligand|P52293|IMPORTIN SUBUNIT ALPHA-2|4.31|Kd=48.7uM|Kd|=|48.7|uM|48700|nM
3M6Q|2.40|2011|BB2||Q9FUZ2|PEPTIDE DEFORMYLASE 1B|7.32|Kd=48nM|Kd|=|48|nM|48|nM
3TPU|3.10|2011|9-mer|ligand is in 9-mer p5E8-H2-Ld peptide format|P01897|42F3 ALPHA|4.32|Kd=48uM|Kd|=|48|uM|48000|nM
3QT7|2.20|2011|FM0|ligand is FMVAPP; Ki=49+/-5nM|Q9FD73|MEVALONATE DIPHOSPHATE DECARBOXYLASE|7.31|Kd=49nM|Kd|=|49|nM|49|nM
3QXV|2.50|2011|MTX||------|ANTI-METHOTREXATE CDR1-4 GRAFT VHH|8.4|Kd=4nM|Kd|=|4|nM|4|nM
3S74|1.40|2011|03T||P00918|CARBONIC ANHYDRASE 2|8.4|Kd=4nM|Kd|=|4|nM|4|nM
3PMA|2.20|2011|SCR|Kd=4+/-0.4uM;|P00735|THROMBIN LIGHT CHAIN|5.4|Kd=4uM|Kd|=|4|uM|4000|nM
3ATU|1.65|2011|ADP|binding data measured with ADP, Mg2+, Na+|P08107|HEAT SHOCK 70 KDA PROTEIN 1A/1B|8.3|Kd=5.00nM|Kd|=|5|nM|5|nM
3PCU|2.00|2011|LX8|Kd(Rut binding to RXR-alpha-LBD), X-ray(RXR-alpha-LBD complexed with Rut and SRC1 peptide)|P19793|RETINOIC ACID RECEPTOR RXR-ALPHA|5.29|Kd=5.08uM|Kd|=|5.08|uM|5080|nM
3R24|2.00|2011|SAM||P0C6X7|2'-O-METHYL TRANSFERASE|5.25|Kd=5.59uM|Kd|=|5.59|uM|5590|nM
3AO1|1.90|2011|BZX||Q72498|HIV-1 INTEGRASE|2.26|Kd=5.5mM|Kd|=|5.5|mM|5500000|nM
3TWX|1.80|2011|16-mer|ligand is 16-mer human FNBP1 peptide, Kd=5.5+/-1.3uM; chimeric peptide|Q9H2K2|TANKYRASE-2|5.26|Kd=5.5uM|Kd|=|5.5|uM|5500|nM
3TDJ|1.95|2011|3TJ|ligand is BPAM-97; Kd=5.6+/-0.9uM|P19491|GLUTAMATE RECEPTOR 2|5.25|Kd=5.6uM|Kd|=|5.6|uM|5600|nM
3UEU|2.10|2011|DAO|complex between LGB and DAO; Kd=5.81uM(ITC); Kd=0.71uM(fluorescence); Kd=24.4uM(ESI-MS); Kd=24.4uM(EPA)|P02754|BETA-LACTOGLOBULIN|5.24|Kd=5.81uM|Kd|=|5.81|uM|5810|nM
3QXH|1.36|2011|ADP|Mg-containing|O24872|DETHIOBIOTIN SYNTHETASE|5.24|Kd=5.8uM|Kd|=|5.8|uM|5800|nM
3AO5|1.80|2011|BBY||Q72498|HIV-1 INTEGRASE|2.23|Kd=5.9mM|Kd|=|5.9|mM|5900000|nM
3ZYH|1.50|2011|G0S|ligand is GALBG0; Kd=51.5+/-6.7uM|Q05097|PA-I GALACTOPHILIC LECTIN|4.29|Kd=51.5uM|Kd|=|51.5|uM|51500|nM
2YEL|1.65|2011|WSH|Kd for BRD4-BD1,2|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|7.28|Kd=52.5nM|Kd|=|52.5|nM|52.5|nM
3ARG|3.00|2011|DB6|ternary complexes; another protein CD1d containing|P11609|ANTIGEN-PRESENTING GLYCOPROTEIN CD1D1|7.26|Kd=55nM|Kd|=|55|nM|55|nM
3Q4L|1.95|2011|6-mer|ligand is pentapeptide P14;Kd=55nM(N=0.90)|P0A988|DNA POLYMERASE III SUBUNIT BETA|7.26|Kd=55nM|Kd|=|55|nM|55|nM
3TDH|2.30|2011|AMP||P06782|CARBON CATABOLITE-DEREPRESSING PROTEIN KINASE|4.26|Kd=55uM|Kd|=|55|uM|55000|nM
3P3R|1.25|2011|3M1|ligand is Ro41-0960; Kd=56.05+/-4.14nM; IC50=0.755uM(in supp info)|P02766|TRANSTHYRETIN|7.25|Kd=56.05nM|Kd|=|56.05|nM|56.05|nM
3TA1|1.90|2011|ADP|Kd measured with Mg2+|O28524|NITROGEN REGULATORY PROTEIN P-II (GLNB-3)|3.25|Kd=568uM|Kd|=|568|uM|568000|nM
3P3T|1.45|2011|3M3|ligand is compound 7; Kd=57.91+/-13.2nM; IC50=0.296uM(in supp info)|P02766|TRANSTHYRETIN|7.24|Kd=57.91nM|Kd|=|57.91|nM|57.91|nM
3AYC|1.80|2011|5-mer|Fragment: C-TERMINAL DOMAIN, UNP residues 117-250;|P17931|GALECTIN-3|4.24|Kd=57uM|Kd|=|57|uM|57000|nM
3ZQE|2.19|2011|DXC||P41784|PROTEIN PRGI, CELL INVASION PROTEIN SIPD|4.23|Kd=59.0uM|Kd|=|59|uM|59000|nM
3P9L|2.00|2011|8-mer||P01901|H-2 CLASS I HISTOCOMPATIBILITY ANTIGEN, K-B|5.3|Kd=5uM|Kd|=|5|uM|5000|nM
3PPO|2.70|2011|DCK||O32243|GLYCINE BETAINE/CARNITINE/CHOLINE-BINDING PROTEIN|5.3|Kd=5uM|Kd|=|5|uM|5000|nM
3RI1|2.10|2011|3RH|ligand is ARQ 069; Kd=5+/-1.4uM|P21802|FIBROBLAST GROWTH FACTOR RECEPTOR 2|5.3|Kd=5uM|Kd|=|5|uM|5000|nM
3Q71|2.20|2011|AR6|Kd=6.0+/-0.1uM|Q460N5|POLY [ADP-RIBOSE] POLYMERASE 14|5.22|Kd=6.0uM|Kd|=|6|uM|6000|nM
3RTH|2.70|2011|RTH|ligand is compound 39|P56817|BETA-SECRETASE 1|5.21|Kd=6.1uM|Kd|=|6.1|uM|6100|nM
3OV1|1.60|2011|5-mer||P62993|GROWTH FACTOR RECEPTOR-BOUND PROTEIN 2|5.2|Kd=6.25uM|Kd|=|6.25|uM|6250|nM
3T7G|2.08|2011|17-mer|ligand is Autophagy-related protein 3|P38862|UBIQUITIN-LIKE MODIFIER-ACTIVATING ENZYME ATG7|5.2|Kd=6.32uM|Kd|=|6.32|uM|6320|nM
3TWR|1.55|2011|16-mer|ligand is 16-mer peptide from human SH3 domain-binding protein 2, Kd=6.4+/-0.6uM|Q9H2K2|TANKYRASE-2|5.19|Kd=6.4uM|Kd|=|6.4|uM|6400|nM
3RZ8|1.70|2011|RZ8||P00918|CARBONIC ANHYDRASE 2|8.17|Kd=6.7nM|Kd|=|6.7|nM|6.7|nM
3TC5|1.40|2011|3T5||Q13526|PEPTIDYL-PROLYL CIS-TRANS ISOMERASE NIMA-INTERACTIN|5.17|Kd=6.8uM|Kd|=|6.8|uM|6800|nM
3B27|1.50|2011|B2T||P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|5.16|Kd=6.9uM|Kd|=|6.9|uM|6900|nM
3ARU|1.90|2011|PNX|ligand is pentoxifyllin(PEN)|Q9AMP1|CHITINASE A|3.22|Kd=600uM|Kd|=|600|uM|600000|nM
3I8T|2.10|2011|LBT|Kd1=600+/-70uM, Kd2=28+/-10mM; Fragment: Galectin 1 domain|Q8K419|GALECTIN-4|3.22|Kd=600uM|Kd|=|600|uM|600000|nM
3M96|1.40|2011|E38||P00918|CARBONIC ANHYDRASE 2|7.22|Kd=60nM|Kd|=|60|nM|60|nM
3QEM|3.00|2011|QEM|ligand is Ro|Q91977|NMDA GLUTAMATE RECEPTOR SUBUNIT|7.22|Kd=60nM|Kd|=|60|nM|60|nM
2YEK|1.98|2011|EAM|ligand is compound I-BET|P25440|BROMODOMAIN-CONTAINING PROTEIN 2|7.21|Kd=61.3nM|Kd|=|61.3|nM|61.3|nM
3Q4J|2.30|2011|6-mer|ligand is pentapeptide P6;Kd=613nM(N=1.14)|P0A988|DNA POLYMERASE III SUBUNIT BETA|6.21|Kd=613nM|Kd|=|613|nM|613|nM
3ARE|2.80|2011|4GH|ternary complexes; another protein CD1d containing|P11609|ANTIGEN-PRESENTING GLYCOPROTEIN CD1D1|6.21|Kd=617nM|Kd|=|617|nM|617|nM
3ODL|2.31|2011|11-mer|Kd=61+/-9nM,|A8K220|CYCLOPHILIN A|7.21|Kd=61nM|Kd|=|61|nM|61|nM
3S77|1.86|2011|EVI||P00918|CARBONIC ANHYDRASE 2|7.21|Kd=61nM|Kd|=|61|nM|61|nM
3ARF|2.90|2011|DB3|ternary complexes; another protein CD1d containing|P11609|ANTIGEN-PRESENTING GLYCOPROTEIN CD1D1|7.19|Kd=64nM|Kd|=|64|nM|64|nM
3ZQI|1.50|2011|16-mer|ligand is inducer peptide-TIP2, Kd=64+/-3nM|P04483|TETRACYCLINE REPRESSOR PROTEIN CLASS B FROM TRANSPO|7.19|Kd=64nM|Kd|=|64|nM|64|nM
2LH8|NMR|2011|VIB|Fragment: UNP residues 125-228;|P04273|MAJOR PRION PROTEIN|4.18|Kd=65.36uM|Kd|=|65.36|uM|65360|nM
3AYD|1.90|2011|3-mer|Fragment: C-TERMINAL DOMAIN, UNP residues 117-250;|P17931|GALECTIN-3|4.19|Kd=65uM|Kd|=|65|uM|65000|nM
2XJ2|2.20|2011|985||P11309|SERINE/THREONINE-PROTEIN KINASE PIM-1|7.18|Kd=66nM|Kd|=|66|nM|66|nM
3QFD|1.68|2011|9-mer|ligand is Mart-1 peptide(27-35); Kd=68+/-4uM|P01892|HLA CLASS I HISTOCOMPATIBILITY ANTIGEN|4.17|Kd=68uM|Kd|=|68|uM|68000|nM
3QZV|2.00|2011|11-mer|ligand is histone H4K12ac; Kd69+/-1uM|Q12830|NUCLEOSOME-REMODELING FACTOR SUBUNIT BPTF|4.16|Kd=69uM|Kd|=|69|uM|69000|nM
3PPP|2.40|2011|BET||O32243|GLYCINE BETAINE/CARNITINE/CHOLINE-BINDING PROTEIN|5.22|Kd=6uM|Kd|=|6|uM|6000|nM
3QXT|1.70|2011|MTX||------|ANTI-METHOTREXATE CDR1-3 GRAFT VHH|5.22|Kd=6uM|Kd|=|6|uM|6000|nM
2XRW|1.33|2011|14-mer|ligand is pepNFAT4|A1L4K2|MITOGEN-ACTIVATED PROTEIN KINASE 8|5.15|Kd=7.1uM|Kd|=|7.1|uM|7100|nM
2XS0|2.60|2011|14-mer|ligand is pepNFAT4|P45983|MITOGEN-ACTIVATED PROTEIN KINASE 8|5.15|Kd=7.1uM|Kd|=|7.1|uM|7100|nM
2LCT|NMR|2011|13-mer|ligand is Syk-derived doubly phosphorylated peptide(pYpY); Kd=7.27+/-0.04uM|P15498|PROTO-ONCOGENE VAV|5.14|Kd=7.27uM|Kd|=|7.27|uM|7270|nM
3TAO|1.45|2011|PGH||P66940|TRIOSEPHOSPHATE ISOMERASE|5.14|Kd=7.28uM|Kd|=|7.28|uM|7280|nM
3RYX|1.60|2011|RYX||P00918|CARBONIC ANHYDRASE 2|8.14|Kd=7.3nM|Kd|=|7.3|nM|7.3|nM
2YAZ|2.40|2011|UMP|ligand is DUMP; Mg-containing|O15826|DUTPASE|5.14|Kd=7.3uM|Kd|=|7.3|uM|7300|nM
3SOW|1.95|2011|9-mer|ligand is H3(1-9)K4me3 peptide|Q96T88|E3 UBIQUITIN-PROTEIN LIGASE UHRF1|5.14|Kd=7.3uM|Kd|=|7.3|uM|7300|nM
2YK1|1.85|2011|NCT||------|ANTIBODY FAB FRAGMENT, HEAVY CHAIN|8.13|Kd=7.4nM|Kd|=|7.4|nM|7.4|nM
3OZJ|2.10|2011|BGV||P19793|RETINOIC ACID RECEPTOR RXR-ALPHA|5.11|Kd=7.7uM|Kd|=|7.7|uM|7700|nM
3UJB|1.52|2011|SAH|complex between PfPMT and AdoCys; Kd=7.9+/-0.8uM|Q6T755|PHOSPHOETHANOLAMINE N-METHYLTRANSFERASE|5.1|Kd=7.9uM|Kd|=|7.9|uM|7900|nM
3ZVY|1.95|2011|8-mer|ligand is 8-mer H3 peptide, Kd=7.9+/-0.3uM|Q96T88|E3 UBIQUITIN-PROTEIN LIGASE UHRF1|5.1|Kd=7.9uM|Kd|=|7.9|uM|7900|nM
3Q8H|1.75|2011|AO9|ligand is compound 5|Q63T71|2-C-METHYL-D-ERYTHRITOL 2,4-CYCLODIPHOSPHATE SYNTHASE|4.15|Kd=70uM|Kd|=|70|uM|70000|nM
3T4N|2.30|2011|ADP||P06782|CARBON CATABOLITE-DEREPRESSING PROTEIN KINASE|4.14|Kd=72uM|Kd|=|72|uM|72000|nM
3MAM|1.80|2011|BET||O29280|OSMOPROTECTION PROTEIN (PROX)|4.12|Kd=76uM|Kd|=|76|uM|76000|nM
3O56|2.42|2011|ZG1||Q07343|CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B|9.1|Kd=794pM|Kd|=|794|pM|0.794|nM
2YGF|2.00|2011|GDM||P02829|HEAT SHOCK PROTEIN HSP82|5.09|Kd=8.06uM|Kd|=|8.06|uM|8060.000000000001|nM
3O4L|2.54|2011|9-mer|BSLF2/BMLF1 protein (Fragment: residues 286-294)|Q8WLS4|MHC CLASS I ANTIGEN|5.09|Kd=8.1uM|Kd|=|8.1|uM|8100|nM
3QYY|1.90|2011|C2E||Q8P559|RESPONSE REGULATOR|5.08|Kd=8.26uM|Kd|=|8.26|uM|8260|nM
3M94|2.05|2011|M7M||Q6PKX2|TRANSLATION INITIATION FACTOR 4E|5.08|Kd=8.4uM|Kd|=|8.4|uM|8400|nM
3AO4|1.95|2011|833||Q72498|HIV-1 INTEGRASE|2.07|Kd=8.5mM|Kd|=|8.5|mM|8500000|nM
2XM1|2.00|2011|LTM||Q89ZI2|O-GLCNACASE BT_4395|5.07|Kd=8.5uM|Kd|=|8.5|uM|8500|nM
2YGE|1.96|2011|GDM||P02829|HEAT SHOCK PROTEIN HSP82|5.06|Kd=8.62uM|Kd|=|8.62|uM|8620|nM
3SXU|1.85|2011|5-mer|5-mer SSB peptide; Kd=8.9+/-0.7uM|P28905|DNA POLYMERASE III SUBUNIT CHI|5.05|Kd=8.9uM|Kd|=|8.9|uM|8900|nM
2LK1|NMR|2011|AQN|Fragment: RanBP2-type zinc finger residues 181-210; Kd=82+/-5uM|P52756|RNA-BINDING PROTEIN 5|4.09|Kd=82uM|Kd|=|82|uM|82000|nM
3RLP|1.70|2011|3RP||P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|7.08|Kd=84nM|Kd|=|84|nM|84|nM
3P0G|3.50|2011|P0G||P07550|BETA-2 ADRENERGIC RECEPTOR, LYSOZYME|10.08|Kd=84pM|Kd|=|84|pM|0.084|nM
3R42|1.87|2011|9-mer|ligand is a 9-mer vps27 PSDP1 peptide; Kd=84+/-5uM|P25604|SUPPRESSOR PROTEIN STP22 OF TEMPERATURE-SENSITIVE A|4.08|Kd=84uM|Kd|=|84|uM|84000|nM
3RYV|1.20|2011|RYV||P00918|CARBONIC ANHYDRASE 2|7.07|Kd=86nM|Kd|=|86|nM|86|nM
3Q4K|2.60|2011|6-mer|ligand is pentapeptide P12;Kd=89nM(N=1.02)|P0A988|DNA POLYMERASE III SUBUNIT BETA|7.05|Kd=89nM|Kd|=|89|nM|89|nM
2XXT|1.90|2011|KAI||P42260|GLUTAMATE RECEPTOR, IONOTROPIC KAINATE 2|8.05|Kd=9.0nM|Kd|=|9|nM|9|nM
3AJE|1.80|2011|THR|Kd=9.3+/-0.3 uM;|Q970S6|PUTATIVE UNCHARACTERIZED PROTEIN ST1526|5.03|Kd=9.3uM|Kd|=|9.3|uM|9300|nM
3SMQ|2.00|2011|TDU|ligand is compound 1;Kd=9.5+/-0.5uM|O60678|PROTEIN ARGININE N-METHYLTRANSFERASE 3|5.02|Kd=9.5uM|Kd|=|9.5|uM|9500|nM
3TFK|2.75|2011|9-mer|ligand is in 9-mer p4B10-H2-Ld peptide format|P01897|H2-LD SBM2|5.01|Kd=9.7uM|Kd|=|9.7|uM|9700|nM
3S76|1.60|2011|EVH||P00918|CARBONIC ANHYDRASE 2|5.05|Kd=9000nM|Kd|=|9000|nM|9000|nM
3S0D|1.24|2011|CTV||Q1W640|OBP14|7.05|Kd=90nM|Kd|=|90|nM|90|nM
3AY0|3.05|2011|ADN|Kd=910+/-58uM|Q58293|UNCHARACTERIZED PROTEIN MJ0883|3.04|Kd=910uM|Kd|=|910|uM|910000|nM
3PO1|1.65|2011|MKY|ligand is compound 2; Kd=95+/-4uM (by spectrophotometric assay)|P00734|THROMBIN|4.02|Kd=95uM|Kd|=|95|uM|95000|nM
3S3K|3.20|2011|CSN|ligand is PNC; Kd=97.69+/-5.58uM|P35992|TYROSINE-PROTEIN PHOSPHATASE 10D|4.01|Kd=97.69uM|Kd|=|97.69|uM|97690|nM
3QZT|1.50|2011|10-mer|ligand is histone H4K16ac; Kd=99+/-7uM; Form 2|Q12830|NUCLEOSOME-REMODELING FACTOR SUBUNIT BPTF|4.0|Kd=99uM|Kd|=|99|uM|99000|nM
3T2T|1.90|2011|MQT|ligand is compound 1; Kd=0.55+/-0.15mM|P09382|GALECTIN-1|2.4|Kd>4mM|Kd|>|4|mM|4000000|nM
2LAS|NMR|2011|13-mer|ligand is M-IR2_peptide|P63165|SMALL UBIQUITIN-RELATED MODIFIER 1|5.74|Kd~1.8uM|Kd|~|1.8|uM|1800|nM
3TF7|2.75|2011|9-mer|ligand is in 9-mer QL9-H2-Ld peptide format|Q60597|H2-LD SBM2|3.52|Kd~300uM|Kd|~|300|uM|300000|nM
2XAE|2.60|2011|2XA|IC50=53.3+/-1.5 nM; Fragment: MOTOR DOMAIN, RESIDUES 1-368;|P52732|KINESIN-LIKE PROTEIN KIF11|7.3|Ki<50.0nM|Ki|<|50|nM|50|nM
3ZXZ|1.80|2011|KRW|ligand is compound 2|P08581|HEPATOCYTE GROWTH FACTOR RECEPTOR|8.4|Ki=0.004uM|Ki|=|0.004|uM|4|nM
2XPK|2.40|2011|Z0M||Q0TR53|O-GLCNACASE NAGJ|11.3|Ki=0.005nM|Ki|=|0.005|nM|0.005|nM
3RTI|2.80|2011|FMP||P02879|RICIN|7.37|Ki=0.043uM|Ki|=|0.043|uM|43|nM
3U8N|2.35|2011|09S|lignad is compound 5; Ki=0.067+/-0.026nM|P58154|ACETYLCHOLINE-BINDING PROTEIN|10.17|Ki=0.067nM|Ki|=|0.067|nM|0.067|nM
3PBB|1.95|2011|PBD|ligand is PBD150; Ki=0.095+/-0.003uM; Zn-containing|Q16769|GLUTAMINYL-PEPTIDE CYCLOTRANSFERASE|7.02|Ki=0.095uM|Ki|=|0.095|uM|95|nM
2XWD|2.66|2011|LGS|Ki1=0.11+/-0.02uM at pH7.3; Ki2=8.7+/-0.3uM at pH5.5|P04062|GLUCOSYLCERAMIDASE|6.96|Ki=0.11uM|Ki|=|0.11|uM|110|nM
3R4N|2.00|2011|FU5||P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|6.89|Ki=0.13uM|Ki|=|0.13|uM|130|nM
3MV0|2.20|2011|149||B8LFD6|BETA-GALACTOSIDASE|3.85|Ki=0.14mM|Ki|=|0.14|mM|140000|nM
3N76|1.90|2011|CA2||P0A4Z6|3-DEHYDROQUINATE DEHYDRATASE|6.85|Ki=0.14uM|Ki|=|0.14|uM|140|nM
3PE2|1.90|2011|E1B||P68400|CASEIN KINASE II, ALPHA SUBUNIT|9.76|Ki=0.175nM|Ki|=|0.175|nM|0.175|nM
3PE1|1.60|2011|3NG||P68400|CASEIN KINASE II, ALPHA SUBUNIT|9.65|Ki=0.223nM|Ki|=|0.223|nM|0.223|nM
3PWD|2.20|2011|CZ0||P28523|CASEIN KINASE II, ALPHA SUBUNIT|6.66|Ki=0.22uM|Ki|=|0.22|uM|220|nM
3OZP|2.00|2011|OAN||Q06GJ0|N-ACETYLGLUCOSAMINIDASE|6.62|Ki=0.24uM|Ki|=|0.24|uM|240|nM
3TU1|1.60|2011|07G||Q00987|E3 UBIQUITIN-PROTEIN LIGASE MDM2|6.6|Ki=0.25uM|Ki|=|0.25|uM|250|nM
3PB9|1.12|2011|1BN|ligand is 1-benzylimidazole; Ki=0.262+/-0.062uM; Zn-containing|Q9NXS2|GLUTAMINYL-PEPTIDE CYCLOTRANSFERASE-LIKE PROTEIN|6.58|Ki=0.262uM|Ki|=|0.262|uM|262|nM
3OPR|1.65|2011|SA2|Ki=0.26+/-0.01 uM; Mutation: R164H|P0AD64|BETA-LACTAMASE SHV-1|6.59|Ki=0.26uM|Ki|=|0.26|uM|260|nM
3QOX|2.30|2011|SAH||Q8TEK3|HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-79 SPECIFIC|6.57|Ki=0.27uM|Ki|=|0.27|uM|270|nM
3AMA|1.75|2011|SKE||P17612|CAMP-DEPENDENT PROTEIN KINASE|6.53|Ki=0.297uM|Ki|=|0.297|uM|297|nM
3PPM|1.78|2011|JG1||P97612|FATTY-ACID AMIDE HYDROLASE 1|9.54|Ki=0.29nM|Ki|=|0.29|nM|0.29|nM
3PR0|2.20|2011|JG2|Covalently bound mode; Fragment: deltaTM-FAAH, UNP residues 30-579; Mutation: L192F, F194Y, A377T, S435N, I491V, V495M|P97612|FATTY ACID AMIDE HYDROLASE 1|9.54|Ki=0.29nM|Ki|=|0.29|nM|0.29|nM
3SR4|2.50|2011|TT8||Q8TEK3|HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-79 SPECIFIC|6.54|Ki=0.29uM|Ki|=|0.29|uM|290|nM
3SM2|1.75|2011|478||Q9E7M1|GAG-PRO-POL POLYPROTEIN|9.7|Ki=0.2nM|Ki|=|0.2|nM|0.2|nM
3O9F|1.70|2011|K2D|ligand is compound 11b;Ki=0.2+/-2pM|Q90K99|HIV-1 PROTEASE|12.7|Ki=0.2pM|Ki|=|0.2|pM|0.0002|nM
3MUZ|1.90|2011|IPT||B8LFD6|BETA-GALACTOSIDASE|3.46|Ki=0.35mM|Ki|=|0.35|mM|350000|nM
2Y59|2.50|2011|ZA3|Ki=0.36+/-0.06uM; covalent complex, B-containing|P39045|D-ALANYL-D-ALANINE CARBOXYPEPTIDASE|6.44|Ki=0.36uM|Ki|=|0.36|uM|360|nM
2XOG|1.72|2011|SFB||P61823|RIBONUCLEASE|3.43|Ki=0.37mM|Ki|=|0.37|mM|370000|nM
2YBU|2.25|2011|CX9||Q9BZP6|ACIDIC MAMMALIAN CHITINASE|6.38|Ki=0.42uM|Ki|=|0.42|uM|420|nM
2XOI|1.72|2011|SFB|redundant to 2xog|P61823|RIBONUCLEASE|3.34|Ki=0.46mM|Ki|=|0.46|mM|460000|nM
3O64|1.88|2011|786||P78536|TNF-ALPHA-CONVERTING ENZYME, ADAM 17|9.4|Ki=0.4nM|Ki|=|0.4|nM|0.4|nM
3MG4|3.11|2011|LXT|multi component of protein; Ki=0.50+/-0.12nM for 20S beta5 site(substrate Suc-LLVY-AMC)|P23639|PROTEASOME COMPONENT Y7|9.3|Ki=0.50nM|Ki|=|0.5|nM|0.5|nM
3P8N|1.90|2011|L4T|ligand is BI201335; Ki=0.53+/-0.05nM|P26662|HCV SERINE PROTEASE NS3|9.28|Ki=0.53nM|Ki|=|0.53|nM|0.53|nM
3OPP|1.80|2011|SA2|Ki=0.53+/-0.02uM; Mutation: R164S|P0AD64|BETA-LACTAMASE SHV-1|6.28|Ki=0.53uM|Ki|=|0.53|uM|530|nM
3NZK|1.80|2011|C90||A1JJJ9|UDP-3-O-[3-HYDROXYMYRISTOYL] N-ACETYLGLUCOSAMINE|9.27|Ki=0.54nM|Ki|=|0.54|nM|0.54|nM
3MG0|2.68|2011|BO2|B containing; covalent complex; multi component of protein; Ki=0.56+/-0.072nM; substrate Suc-LLVY-AMC, 20S beta5 site|P23639|PROTEASOME COMPONENT Y7|9.25|Ki=0.56nM|Ki|=|0.56|nM|0.56|nM
3RF4|1.80|2011|FUN||A4GRE3|MACROPHAGE MIGRATION INHIBITORY FACTOR|6.25|Ki=0.56uM|Ki|=|0.56|uM|560|nM
3O9G|1.65|2011|F53|ligand is compound 11c;Ki=0.5+/-17pM|Q90K99|HIV-1 PROTEASE|12.3|Ki=0.5pM|Ki|=|0.5|pM|0.0005|nM
3O9B|1.50|2011|K2A|ligand is compound 10c;Ki=0.5+/-9pM|Q90K99|POL POLYPROTEIN|12.3|Ki=0.5pM|Ki|=|0.5|pM|0.0005|nM
2XY9|1.97|2011|3ES||P12821|ANGIOTENSIN-CONVERTING ENZYME|9.19|Ki=0.65nM|Ki|=|0.65|nM|0.65|nM
3OZG|1.99|2011|SSI|ligand is compound 3; Ki=0.65+/-0.04nM by spectrophotometric assay|P20035|HYPOXANTHINE-GUANINE-XANTHINE PHOSPHORIBOSYLTRANSFE|9.19|Ki=0.65nM|Ki|=|0.65|nM|0.65|nM
3AMB|2.25|2011|VX6||P17612|CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTIC|6.18|Ki=0.66uM|Ki|=|0.66|uM|660|nM
3RWP|1.92|2011|ABQ||O15530|3-PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE 1|9.22|Ki=0.6nM|Ki|=|0.6|nM|0.6|nM
3O0G|1.95|2011|3O0||Q00535|CYCLIN-DEPENDENT KINASE 5|6.22|Ki=0.6uM|Ki|=|0.6|uM|600|nM
2YA7|1.89|2011|ZMR||B2DJD9|NEURAMINIDASE A|3.14|Ki=0.72mM|Ki|=|0.72|mM|720000|nM
3QFY|2.30|2011|IFM-SO4||O66264|CELLOBIOSE PHOSPHORYLASE|6.12|Ki=0.75uM|Ki|=|0.75|uM|750|nM
3AOX|1.75|2011|EMH||Q9UM73|ALK TYROSINE KINASE RECEPTOR|9.08|Ki=0.83nM|Ki|=|0.83|nM|0.83|nM
3O9H|1.70|2011|K2E|ligand is compound 11d;Ki=0.8+/-2pM|Q90K99|HIV-1 PROTEASE|12.1|Ki=0.8pM|Ki|=|0.8|pM|0.0008|nM
2XWE|2.31|2011|AMF||P04062|GLUCOSYLCERAMIDASE|6.02|Ki=0.95uM|Ki|=|0.95|uM|950|nM
3ZQ9|1.86|2011|NOY-BGC|ligand is Glc-noeuromycin|Q1A2D0|XYLOGLUCANASE|6.02|Ki=0.95uM|Ki|=|0.95|uM|950|nM
3O9C|1.85|2011|K20|ligand is compound 10d;Ki=0.9+/-4pM|Q90K99|POL POLYPROTEIN|12.05|Ki=0.9pM|Ki|=|0.9|pM|0.0009000000000000001|nM
3R4M|1.70|2011|WOE||P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|5.92|Ki=1.2uM|Ki|=|1.2|uM|1200|nM
2Y7X|1.90|2011|MZA||P00742|COAGULATION FACTOR XA|8.89|Ki=1.3nM|Ki|=|1.3|nM|1.3|nM
3U8M|2.70|2011|09R|lignad is compound 4; Ki=1.3+/-0.9nM|P58154|ACETYLCHOLINE-BINDING PROTEIN|8.89|Ki=1.3nM|Ki|=|1.3|nM|1.3|nM
3ZZE|1.87|2011|6XP|ligand is compound 10|P08581|HEPATOCYTE GROWTH FACTOR RECEPTOR|8.89|Ki=1.3nM|Ki|=|1.3|nM|1.3|nM
3QGW|2.10|2011|L7A||Q08881|TYROSINE-PROTEIN KINASE ITK/TSK|5.89|Ki=1.3uM|Ki|=|1.3|uM|1300|nM
3O9I|1.45|2011|A61|ligand is compound 11e; Ki=1.5+/-1pM|Q90K99|HIV-1 PROTEASE|11.82|Ki=1.5pM|Ki|=|1.5|pM|0.0015|nM
3OAF|1.70|2011|OAG|ligand is OAAG324; Ki=1.6+/-0.06nM|P00374|DIHYDROFOLATE REDUCTASE|8.8|Ki=1.6nM|Ki|=|1.6|nM|1.6|nM
3MBZ|2.60|2011|MXC|Fragment: UNP residues 32-275; Ki=1.6 +/- 0.3uM(compound 3); ligand not complete in X-ray(hydrolysis product)|Q8RLA6|BETA-LACTAMASE OXA24|5.8|Ki=1.6uM|Ki|=|1.6|uM|1600|nM
2YA8|1.75|2011|G39||B2DJD9|NEURAMINIDASE A|5.75|Ki=1.77uM|Ki|=|1.77|uM|1770|nM
3PB7|1.40|2011|PBD|ligand is PBD150; Ki=1.817+/-0.154uM; Zn-containing|Q9NXS2|GLUTAMINYL-PEPTIDE CYCLOTRANSFERASE-LIKE PROTEIN|5.74|Ki=1.817uM|Ki|=|1.817|uM|1817|nM
3M3Z|2.10|2011|3F5||P11142|HEAT SHOCK COGNATE 71 KDA PROTEIN|5.73|Ki=1.85uM|Ki|=|1.85|uM|1850|nM
3P8O|2.30|2011|L5T|ligand is analog 1; Ki=1.89+/-0.06nM|P26662|HCV SERINE PROTEASE NS3|8.72|Ki=1.89nM|Ki|=|1.89|nM|1.89|nM
3OY0|1.60|2011|OY0||P00918|CARBONIC ANHYDRASE 2|8.0|Ki=10.1nM|Ki|=|10.1|nM|10.1|nM
3OYQ|1.47|2011|OYQ||P00918|CARBONIC ANHYDRASE 2|7.99|Ki=10.3nM|Ki|=|10.3|nM|10.3|nM
3T82|2.00|2011|SG4||P00918|CARBONIC ANHYDRASE 2|7.0|Ki=101nM|Ki|=|101|nM|101|nM
3SLZ|1.40|2011|3TL||Q9E7M1|GAG-PRO-POL POLYPROTEIN|6.99|Ki=102nM|Ki|=|102|nM|102|nM
3T83|1.80|2011|MG5&SG5||P00918|CARBONIC ANHYDRASE 2|6.98|Ki=105nM|Ki|=|105|nM|105|nM
3T84|2.00|2011|SG6||P00918|CARBONIC ANHYDRASE 2|6.97|Ki=106nM|Ki|=|106|nM|106|nM
3SIO|2.32|2011|MLK||Q8WSF8|ACETYLCHOLINE RECEPTOR|8.0|Ki=10nM|Ki|=|10|nM|10|nM
3QS1|3.10|2011|006||P39898|PLASMEPSIN-1|7.96|Ki=11.0nM|Ki|=|11|nM|11|nM
3T85|2.40|2011|SG7||P00918|CARBONIC ANHYDRASE 2|7.95|Ki=11.3nM|Ki|=|11.3|nM|11.3|nM
3PN1|2.00|2011|IVH||P43813|DNA LIGASE|6.96|Ki=110nM|Ki|=|110|nM|110|nM
3SVJ|1.55|2011|4LI||Q939R9|PEPTIDE DEFORMYLASE 3|6.93|Ki=117nM|Ki|=|117|nM|117|nM
2L8R|NMR|2011|APR|Ki=119.3+/4.5uM|Q9Y530|UNCHARACTERIZED PROTEIN C6ORF130|3.92|Ki=119.3uM|Ki|=|119.3|uM|119300|nM
3R4P|1.70|2011|FU7||P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|7.96|Ki=11nM|Ki|=|11|nM|11|nM
3N87|2.40|2011|N87||P0A4Z6|3-DEHYDROQUINATE DEHYDRATASE|4.96|Ki=11uM|Ki|=|11|uM|11000|nM
3OLD|2.00|2011|6-mer||P04746|ALPHA-AMYLASE|5.9|Ki=1254.9nM|Ki|=|1254.9|nM|1254.9|nM
2XPC|1.49|2011|051||Q8X9Y9|UDP-N-ACETYLMURAMOYLALANINE-D-GLUTAMATE LIGASE|3.9|Ki=125uM|Ki|=|125|uM|125000|nM
3P3J|1.60|2011|498|Ru containing, Zn binding|P00918|CARBONIC ANHYDRASE 2|7.92|Ki=12nM|Ki|=|12|nM|12|nM
2YDV|2.60|2011|NEC|pKi=7.86+/-0.06; Fragment: RESIDUES 1-317; Mutation: YES;|P29274|ADENOSINE RECEPTOR A2A|7.86|Ki=13.8nM|Ki|=|13.8|nM|13.8|nM
3OE5|1.52|2011|611||P22734|CATECHOL O-METHYLTRANSFERASE|6.88|Ki=132nM|Ki|=|132|nM|132|nM
2Y55|2.60|2011|FP5|Ki=134+/-16uM; covalent complex, B-containing|P39045|D-ALANYL-D-ALANINE CARBOXYPEPTIDASE|3.87|Ki=134uM|Ki|=|134|uM|134000|nM
3MG6|2.60|2011|LZT|multi component!!compound 6; Ki=13+/-1.4nM for 20S beta5 site(substrate Suc-LLVY-AMC)|P23639|PROTEASOME COMPONENT Y7|7.89|Ki=13nM|Ki|=|13|nM|13|nM
3OLG|2.30|2011|7-mer|HSD-G6D-GLC-HSD-G6D-GLC-BGC; Ki=14.3+/-0.2 nM|P04746|ALPHA-AMYLASE|7.84|Ki=14.3nM|Ki|=|14.3|nM|14.3|nM
3OLE|1.55|2011|7-mer|ACI-G6D-GLC-ACI-G6D-GLC-GLC; Ki=14.7+/-1.2 nM|P04746|ALPHA-AMYLASE|7.83|Ki=14.7nM|Ki|=|14.7|nM|14.7|nM
3PN4|1.90|2011|BB2|AtPDF1B in complex with actinonin|Q9FUZ2|PEPTIDE DEFORMYLASE 1B|6.85|Ki=140nM|Ki|=|140|nM|140|nM
3SM1|1.50|2011|6-mer|ligand is pepstatin A; HPLC-based assay with oligopeptide substrate|Q9E7M1|GAG-PRO-POL POLYPROTEIN|5.84|Ki=1442nM|Ki|=|1442|nM|1442|nM
2Y5G|1.29|2011|FJD||P00742|COAGULATION FACTOR XA|6.84|Ki=146nM|Ki|=|146|nM|146|nM
3OHI|2.30|2011|HDX||O97447|PUTATIVE FRUCTOSE-1,6-BISPHOSPHATE ALDOLASE|4.85|Ki=14uM|Ki|=|14|uM|14000|nM
2XYD|2.15|2011|3ES||P12821|ANGIOTENSIN-CONVERTING ENZYME|6.82|Ki=150nM|Ki|=|150|nM|150|nM
3AI8|2.11|2011|HNQ||P07858|CATHEPSIN B|3.81|Ki=154.4uM|Ki|=|154.4|uM|154400|nM
3S2V|2.50|2011|3HU||P22756|GLUTAMATE RECEPTOR, IONOTROPIC KAINATE 1|6.8|Ki=157nM|Ki|=|157|nM|157|nM
3Q2M|2.90|2011|CKI|Ki=159+/-11 uM|E1XXQ2|SPECTINOMYCIN PHOSPHOTRANSFERASE|3.8|Ki=159uM|Ki|=|159|uM|159000|nM
3PRS|1.38|2011|RIT||P11838|ENDOTHIAPEPSIN|7.82|Ki=15nM|Ki|=|15|nM|15|nM
3N2P|1.65|2011|AYX||P00918|CARBONIC ANHYDRASE 2|7.82|Ki=15nM|Ki|=|15|nM|15|nM
3O99|1.95|2011|K13|ligand is compound 10a; Ki=15+/-8pM|Q90K99|HIV-1 PROTEASE|10.82|Ki=15pM|Ki|=|15|pM|0.015|nM
2Y5H|1.33|2011|Y5H||P00742|COAGULATION FACTOR XA|5.79|Ki=1620nM|Ki|=|1620|nM|1620|nM
3QGY|2.10|2011|L7O||Q08881|TYROSINE-PROTEIN KINASE ITK/TSK|7.8|Ki=16nM|Ki|=|16|nM|16|nM
3O5N|1.83|2011|BR0||Q4ACU6|SH3 AND MULTIPLE ANKYRIN REPEAT DOMAINS PROTEIN 3|4.76|Ki=17.2uM|Ki|=|17.2|uM|17200|nM
3OIM|1.45|2011|VZ5|ligand is compound 16; Ki=180+/-10nM by membrane-inlet mass spectrometry; Zn-containing|P00918|CARBONIC ANHYDRASE 2|6.74|Ki=180nM|Ki|=|180|nM|180|nM
3P3G|1.65|2011|3P3||D5CV28|UDP-3-O-[3-HYDROXYMYRISTOYL] N-ACETYLGLUCOSAMINE|9.74|Ki=180pM|Ki|=|180|pM|0.18|nM
3NB5|1.80|2011|R21||P00918|CARBONIC ANHYDRASE 2|7.74|Ki=18nM|Ki|=|18|nM|18|nM
3PS6|2.60|2011|3PS|x-ray:PI3Kgamma; assay:PI3Kalpha|P48736|PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE|7.74|Ki=18nM|Ki|=|18|nM|18|nM
3O9D|1.85|2011|K19|ligand is compound 10e; Ki=19+/-23pM|Q90K99|HIV-1 PROTEASE|10.72|Ki=19pM|Ki|=|19|pM|0.019|nM
3NW9|1.65|2011|637||P22734|CATECHOL O-METHYLTRANSFERASE|9.0|Ki=1nM|Ki|=|1|nM|1|nM
3UI7|2.28|2011|C1L||Q9Y233|CGMP 3',5'-CYCLIC PHOSPHODIESTERASE|9.0|Ki=1nM|Ki|=|1|nM|1|nM
3UCJ|1.85|2011|AZM|ligand is Co-CA-AZM|Q96554|CARBONIC ANHYDRASE|6.0|Ki=1uM|Ki|=|1|uM|1000|nM
3QK0|2.85|2011|QK0|ligand is compound 82; ATP-based cell viability assay|P48736|PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE|8.7|Ki=2.0nM|Ki|=|2|nM|2|nM
3SN8|1.99|2011|S89|ligand is Cm-FF-H; Ki=2.24+/-0.58uM|P0C6U8|3C-LIKE PROTEINASE|5.65|Ki=2.24uM|Ki|=|2.24|uM|2240|nM
3T19|2.60|2011|5MA|ligand is compound 5; a standard SPA assay|P04585|HIV-1 REVERSE TRANSCRIPTASE|8.66|Ki=2.2nM|Ki|=|2.2|nM|2.2|nM
3U8K|2.47|2011|09P|lignad is compound 2; Ki=2.2+/-0.1nM|P58154|ACETYLCHOLINE-BINDING PROTEIN|8.66|Ki=2.2nM|Ki|=|2.2|nM|2.2|nM
3RF5|2.10|2011|FUZ||A4GRE3|MACROPHAGE MIGRATION INHIBITORY FACTOR|5.63|Ki=2.37uM|Ki|=|2.37|uM|2370|nM
3N86|1.90|2011|RJP||P0A4Z6|3-DEHYDROQUINATE DEHYDRATASE|5.64|Ki=2.3uM|Ki|=|2.3|uM|2300|nM
3QCE|2.10|2011|NXY||P23470|RECEPTOR-TYPE TYROSINE-PROTEIN PHOSPHATASE GAMMA|5.6|Ki=2.5uM|Ki|=|2.5|uM|2500|nM
3QCF|2.50|2011|NXY|ligand is compound 1|P23470|RECEPTOR-TYPE TYROSINE-PROTEIN PHOSPHATASE GAMMA|5.6|Ki=2.5uM|Ki|=|2.5|uM|2500|nM
3QAA|1.40|2011|G04||P03366|HIV-1 PROTEASE|11.54|Ki=2.9pM|Ki|=|2.9|pM|0.0029|nM
3N7A|2.00|2011|FA1||P0A4Z6|3-DEHYDROQUINATE DEHYDRATASE|3.7|Ki=200uM|Ki|=|200|uM|200000|nM
3TH9|1.34|2011|9Y9||P0C6F2|HIV-1 PROTEASE|7.7|Ki=20nM|Ki|=|20|nM|20|nM
3O9A|1.90|2011|K14|ligand is compound 10b; Ki=20+/-15pM|Q90K99|HIV-1 PROTEASE|10.7|Ki=20pM|Ki|=|20|pM|0.02|nM
3OIL|1.50|2011|VZ5|ligand is compound 16; Ki=2100+/-220nM by membrane-inlet mass spectrometry; Zn-containing|P00918|CARBONIC ANHYDRASE 2|5.68|Ki=2100nM|Ki|=|2100|nM|2100|nM
3TSD|2.65|2011|XMP|Ki=218+/-6uM|Q81W29|INOSINE-5'-MONOPHOSPHATE DEHYDROGENASE|3.66|Ki=218uM|Ki|=|218|uM|218000|nM
3MZC|1.50|2011|S6I||P00918|CARBONIC ANHYDRASE 2|6.65|Ki=226nM|Ki|=|226|nM|226|nM
2YHD|2.20|2011|AV6||P10275|ANDROGEN RECEPTOR|4.64|Ki=23.0uM|Ki|=|23|uM|23000|nM
3SJF|1.65|2011|JRG||Q04609|GLUTAMATE CARBOXYPEPTIDASE 2|7.64|Ki=23nM|Ki|=|23|nM|23|nM
2XM2|1.95|2011|LOG||Q89ZI2|O-GLCNACASE BT_4395|4.62|Ki=24uM|Ki|=|24|uM|24000|nM
3P58|1.49|2011|P58||P00918|CARBONIC ANHYDRASE 2|7.6|Ki=25.4nM|Ki|=|25.4|nM|25.4|nM
2Y77|1.50|2011|CB8||P0A4Z6|3-DEHYDROQUINATE DEHYDRATASE|6.6|Ki=250nM|Ki|=|250|nM|250|nM
3T8V|1.80|2011|BTJ||O96935|M1 FAMILY AMINOPEPTIDASE|6.59|Ki=260nM|Ki|=|260|nM|260|nM
3PRZ|2.60|2011|3RZ|x-ray:PI3Kgamma; assay:PI3Kalpha|P48736|PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE|7.59|Ki=26nM|Ki|=|26|nM|26|nM
3RUP|1.99|2011|ADP|Ca2+ containing; Ki=27.0+/-2.0mM|P24182|BIOTIN CARBOXYLASE|1.57|Ki=27.0mM|Ki|=|27|mM|27000000|nM
3N8N|2.50|2011|N88||P0A4Z6|3-DEHYDROQUINATE DEHYDRATASE|4.57|Ki=27uM|Ki|=|27|uM|27000|nM
2XXR|1.60|2011|GLU|GluR6 wt LBD dimer in complex with glutamate|P42260|GLUTAMATE RECEPTOR, IONOTROPIC KAINATE 2|6.55|Ki=280nM|Ki|=|280|nM|280|nM
3PJG|2.70|2011|UGA||C4XAX5|UDP-GLUCOSE 6-DEHYDROGENASE|3.55|Ki=283uM|Ki|=|283|uM|283000|nM
3QVU|2.50|2011|NPO|ligand is pNP; Ki=283+/-100uM; Human SULT1A1 variant b9+PAP+pNP|P50225|SULFOTRANSFERASE 1A1|3.55|Ki=283uM|Ki|=|283|uM|283000|nM
3NI5|2.10|2011|C1H||P00918|CARBONIC ANHYDRASE 2|7.55|Ki=28nM|Ki|=|28|nM|28|nM
3T8W|2.00|2011|DGZ|ligand is PNAP|Q8IL11|M17 LEUCYL AMINOPEPTIDASE|7.54|Ki=29nM|Ki|=|29|nM|29|nM
3SL0|2.00|2011|FB5|Ki=2000+/-200uM; Mn binding; Fragment: UNP residues 22-411;|Q8I384|ARGINASE|2.7|Ki=2mM|Ki|=|2|mM|2000000|nM
2X2I|2.60|2011|QPS|ligand is acarbose|Q9STC1|ALPHA-1,4-GLUCAN LYASE ISOZYME 1|8.7|Ki=2nM|Ki|=|2|nM|2|nM
2Y5F|1.29|2011|XWG||P00742|COAGULATION FACTOR XA|8.7|Ki=2nM|Ki|=|2|nM|2|nM
2Y81|1.70|2011|931||P00742|COAGULATION FACTOR XA|8.7|Ki=2nM|Ki|=|2|nM|2|nM
2Y7Z|1.84|2011|C0Z||P00742|COAGULATION FACTOR XA|8.7|Ki=2nM|Ki|=|2|nM|2|nM
2YA6|2.00|2011|DAN||B2DJD9|NEURAMINIDASE A|5.7|Ki=2uM|Ki|=|2|uM|2000|nM
3ML5|2.05|2011|AZM|ligand is acetazolamide|P43166|CARBONIC ANHYDRASE 7|8.52|Ki=3.0nM|Ki|=|3|nM|3|nM
2YDT|1.60|2011|EDG-AHR||B8ZY56|EXO-1,5-ALPHA-L-ARABINOFURANOBIOSIDASE|5.52|Ki=3.0uM|Ki|=|3|uM|3000|nM
3TZA|1.90|2011|TZG||P19491|GLUTAMATE RECEPTOR 2|5.5|Ki=3.15uM|Ki|=|3.15|uM|3150|nM
3U8J|2.35|2011|09O|lignad is compound 1; Ki=3.1+/-0.9nM|P58154|ACETYLCHOLINE-BINDING PROTEIN|8.51|Ki=3.1nM|Ki|=|3.1|nM|3.1|nM
3B1M|1.60|2011|KRC||P37231|PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA|8.48|Ki=3.3nM|Ki|=|3.3|nM|3.3|nM
3N3J|1.50|2011|WWV||P00918|CARBONIC ANHYDRASE 2|8.48|Ki=3.3nM|Ki|=|3.3|nM|3.3|nM
2XYF|1.80|2011|G40|ligand is compound 9d|P03366|HIV-1 PROTEASE|8.44|Ki=3.6nM|Ki|=|3.6|nM|3.6|nM
3TAM|2.51|2011|M06|ligand is compound 6|P04585|HIV-1 REVERSE TRANSCRIPTASE/RIBONUCLEASE H|8.43|Ki=3.7nM|Ki|=|3.7|nM|3.7|nM
3STR|1.75|2011|3LI||Q939R9|PEPTIDE DEFORMYLASE 3|8.4|Ki=3.96nM|Ki|=|3.96|nM|3.96|nM
2YDO|3.00|2011|ADN|Fragment: RESIDUES 1-317; Mutation: YES; pKi=7.51+/-0.08|P29274|ADENOSINE RECEPTOR A2A|7.51|Ki=30.9nM|Ki|=|30.9|nM|30.9|nM
3RLR|1.70|2011|3RR||P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|7.52|Ki=30nM|Ki|=|30|nM|30|nM
3SW8|1.70|2011|5LI||Q939R9|PEPTIDE DEFORMYLASE 3|4.5|Ki=31.72uM|Ki|=|31.72|uM|31720|nM
3P17|1.43|2011|99P|ligand is compound 2; Ki=33.4+/-19.0uM|P00734|THROMBIN|4.48|Ki=33.4uM|Ki|=|33.4|uM|33400|nM
3NYD|1.23|2011|3NY|ligand is TSA 5-NBT|P23360|ENDO-1,4-BETA-XYLANASE A|3.48|Ki=330uM|Ki|=|330|uM|330000|nM
3QXM|1.65|2011|NDZ||Q13002|GLUTAMATE RECEPTOR, IONOTROPIC KAINATE 2|7.48|Ki=33nM|Ki|=|33|nM|33|nM
3T01|1.60|2011|PPF||Q92UV8|PHOSPHONOACETATE HYDROLASE|4.48|Ki=33uM|Ki|=|33|uM|33000|nM
3OE4|1.49|2011|610||P22734|CATECHOL O-METHYLTRANSFERASE|7.47|Ki=34nM|Ki|=|34|nM|34|nM
3SHJ|2.80|2011|H10|ligand is compound 10; Ki=0.034+/-0.004uM|P23639|PROTEASOME COMPONENT Y7|7.47|Ki=34nM|Ki|=|34|nM|34|nM
3OCZ|1.35|2011|SRA||P26093|LIPOPROTEIN E|7.46|Ki=35nM|Ki|=|35|nM|35|nM
3RWQ|2.55|2011|3RW|ligand is compound 15|O15530|3-PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE 1|7.46|Ki=35nM|Ki|=|35|nM|35|nM
3ZUK|2.60|2011|RDF|Ki=35+/-5nM; PH=8; T=37C|O53649|ENDOPEPTIDASE, PEPTIDASE FAMILY M13|7.46|Ki=35nM|Ki|=|35|nM|35|nM
3PFP|2.35|2011|035-036|ligands are compound (R)-4 and (S)-4; Ki1=360+/-50nM((R)-4); Ki2=620+/-110nM((S)-4); Mn-containing|O53512|3-DEOXY-D-ARABINO-HEPTULOSONATE 7-PHOSPHAT|6.44|Ki=360nM|Ki|=|360|nM|360|nM
3P3H|1.50|2011|84A|Fe containing, Zn binding|P00918|CARBONIC ANHYDRASE 2|7.44|Ki=36nM|Ki|=|36|nM|36|nM
3MMF|1.50|2011|D9H||P00918|CARBONIC ANHYDRASE 2|7.43|Ki=37nM|Ki|=|37|nM|37|nM
2XYS|1.91|2011|SY9||Q8WSF8|ACETYLCHOLINE RECEPTOR|7.42|Ki=38nM|Ki|=|38|nM|38|nM
3QVV|2.35|2011|3QV|ligand is 3CYC; Ki=38+/-12uM; Human SULT1A1 variant b9+PAP+3CyC|P50225|SULFOTRANSFERASE 1A1|4.42|Ki=38uM|Ki|=|38|uM|38000|nM
2XXW|2.30|2011|GLU||P42260|GLUTAMATE RECEPTOR, IONOTROPIC KAINATE 2|6.41|Ki=390nM|Ki|=|390|nM|390|nM
2XXX|2.10|2011|GLU|GluR6 D776K LBD dimer in complex with glutamate (P21 21 21)|P42260|GLUTAMATE RECEPTOR, IONOTROPIC KAINATE 2|6.41|Ki=390nM|Ki|=|390|nM|390|nM
3R17|1.70|2011|5UM||P00918|CARBONIC ANHYDRASE 2|6.41|Ki=390nM|Ki|=|390|nM|390|nM
3SX4|2.60|2011|KXA|ligand is compound (+)-3f|P27487|DIPEPTIDYL PEPTIDASE 4|8.52|Ki=3nM|Ki|=|3|nM|3|nM
3LDQ|1.90|2011|3P1||P11142|HEAT SHOCK COGNATE 71 KDA PROTEIN|5.36|Ki=4.32uM|Ki|=|4.32|uM|4320|nM
3T1A|2.40|2011|5MA||P04585|HIV-1 REVERSE TRANSCRIPTASE|8.37|Ki=4.3nM|Ki|=|4.3|nM|4.3|nM
3QT6|2.05|2011|2P0|ligand is DOGP; Ki=4.3+/-1.0uM; X-ray(S-DPGP), Ki(RS-DPGP)|Q9FD73|MEVALONATE DIPHOSPHATE DECARBOXYLASE|5.37|Ki=4.3uM|Ki|=|4.3|uM|4300|nM
3NS7|2.60|2011|3NS|covalent complex; compound 9s; Fragment: UNP residues 136-297;|P29466|CASPASE-1|8.33|Ki=4.68nM|Ki|=|4.68|nM|4.68|nM
2XYE|2.00|2011|CXG|ligand is compound 9a|P03366|HIV-1 PROTEASE|8.34|Ki=4.6nM|Ki|=|4.6|nM|4.6|nM
3QIY|2.30|2011|QI1||A5HZZ9|BOTULINUM NEUROTOXIN A|5.34|Ki=4.6uM|Ki|=|4.6|uM|4600|nM
3SW2|2.42|2011|FI1||P00742|COAGULATION FACTOR X|8.33|Ki=4.71nM|Ki|=|4.71|nM|4.71|nM
3QAK|2.71|2011|UKA|Ki=4.75+/-0.73nM (in the absence of NaCl)|P29274|ADENOSINE RECEPTOR A2A,LYSOZYME CHIMERA|8.32|Ki=4.75nM|Ki|=|4.75|nM|4.75|nM
3Q1X|1.59|2011|SER||Q9U8X2|SERINE ACETYLTRANSFERASE|5.33|Ki=4.7uM|Ki|=|4.7|uM|4700|nM
3P5L|1.50|2011|IT5||P00918|CARBONIC ANHYDRASE 2|7.39|Ki=40.8nM|Ki|=|40.8|nM|40.8|nM
3SNC|2.58|2011|6-mer|ligand is Peptide aldehyde inhibitor Ac-NSTSQ-H; Ki=40.98+/-2.63uM|P0C6U8|3C-LIKE PROTEINASE|4.39|Ki=40.98uM|Ki|=|40.98|uM|40980|nM
3O3J|3.00|2011|BB4|mutation R118K; compound 6b, Ki=400+/-35nM; X-ray: AtPDF(R118K), Binding assay: AtPDF(WT)|Q9FUZ2|PEPTIDE DEFORMYLASE 1B|6.4|Ki=400nM|Ki|=|400|nM|400|nM
3PN3|1.30|2011|PN3||Q9FUZ2|PEPTIDE DEFORMYLASE 1B|6.4|Ki=400nM|Ki|=|400|nM|400|nM
3RLQ|1.90|2011|3RQ||P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|7.4|Ki=40nM|Ki|=|40|nM|40|nM
3SNB|2.40|2011|6-mer|ligand is Peptide aldehyde inhibitor Ac-DSFDQ-H; Ki=41.24+/-2.25uM|P0C6U8|3C-LIKE PROTEINASE|4.38|Ki=41.24uM|Ki|=|41.24|uM|41240|nM
3U9Q|1.52|2011|DKA|complex between PPAR gamma and decanoic acid and PGC-1a peptide|P37231|PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA|4.38|Ki=41.7uM|Ki|=|41.7|uM|41700|nM
3MNA|1.50|2011|DWH|ligand is compound 7|P00918|CARBONIC ANHYDRASE 2|7.39|Ki=41nM|Ki|=|41|nM|41|nM
3SH1|2.90|2011|MLK|Ki=41+/-14nM|Q8WSF8|ACETYLCHOLINE RECEPTOR|7.39|Ki=41nM|Ki|=|41|nM|41|nM
2Y71|1.50|2011|CB6||P0A4Z6|3-DEHYDROQUINATE DEHYDRATASE|7.37|Ki=42.5nM|Ki|=|42.5|nM|42.5|nM
2Y4A|2.70|2011|BH6|Fragment: RESIDUES 50-515 ; Ki=42+/-7uM; covalent complex, B-containing|P39045|D-ALANYL-D-ALANINE CARBOXYPEPTIDASE|4.38|Ki=42uM|Ki|=|42|uM|42000|nM
3Q43|1.80|2011|D66||O96935|M1 FAMILY AMINOPEPTIDASE|7.37|Ki=43nM|Ki|=|43|nM|43|nM
2Y76|2.50|2011|CB7||P0A4Z6|3-DEHYDROQUINATE DEHYDRATASE|6.36|Ki=440nM|Ki|=|440|nM|440|nM
3OKU|1.45|2011|VZ4|ligand is compound 15; Ki=440+/-50nM by membrane-inlet mass spectrometry; Zn-containing|P00918|CARBONIC ANHYDRASE 2|6.36|Ki=440nM|Ki|=|440|nM|440|nM
3RT8|2.43|2011|CWD|ligand is compound (S)-2c|P19492|GLUTAMATE RECEPTOR 3|6.35|Ki=451nM|Ki|=|451|nM|451|nM
3RTF|1.70|2011|CWD|ligand is compound (S)-2c|P19491|GLUTAMATE RECEPTOR 2|7.35|Ki=45nM|Ki|=|45|nM|45|nM
3OZS|1.44|2011|OZS||P22734|CATECHOL O-METHYLTRANSFERASE|5.33|Ki=4645nM|Ki|=|4645|nM|4645|nM
3PWW|1.22|2011|ROC||P11838|ENDOTHIAPEPSIN|7.32|Ki=48nM|Ki|=|48|nM|48|nM
3Q44|1.80|2011|D50||O96935|M1 FAMILY AMINOPEPTIDASE|6.31|Ki=490nM|Ki|=|490|nM|490|nM
2Y82|2.20|2011|930||P00742|COAGULATION FACTOR XA|8.4|Ki=4nM|Ki|=|4|nM|4|nM
3SWW|2.00|2011|KXB||P27487|DIPEPTIDYL PEPTIDASE 4|8.4|Ki=4nM|Ki|=|4|nM|4|nM
2YJQ|2.25|2011|3-mer|ligand is Glc-Glc-oxazine|Q1A2D0|CEL44C|5.28|Ki=5.2uM|Ki|=|5.2|uM|5200|nM
3U1I|2.30|2011|5-mer|Dengue virus protease covalently bound to a peptide inhibitor, benzoyl-norleucine-Lys-Arg-Argaldehyde (Bz-nKRR-H)|Q5UB51|SERINE PROTEASE SUBUNIT NS2B|5.25|Ki=5.6uM|Ki|=|5.6|uM|5600|nM
3PB8|1.13|2011|AHN|ligand is N-w-Acetylhistamine; Ki=5.748+/-0.366uM; Zn-containing|Q9NXS2|GLUTAMINYL-PEPTIDE CYCLOTRANSFERASE-LIKE PROTEIN|5.24|Ki=5.748uM|Ki|=|5.748|uM|5748|nM
2XYT|2.05|2011|TC9||Q8WSF8|ACETYLCHOLINE RECEPTOR|6.29|Ki=509.2nM|Ki|=|509.2|nM|509.2|nM
3N0N|1.50|2011|P9B||P00918|CARBONIC ANHYDRASE 2|7.3|Ki=50nM|Ki|=|50|nM|50|nM
3R16|1.60|2011|5UN||P00918|CARBONIC ANHYDRASE 2|7.3|Ki=50nM|Ki|=|50|nM|50|nM
4A1W|2.50|2011|19-mer|ligand is ALPHA-BETA-FOLDAMER 4C|Q07817|BCL-2-LIKE PROTEIN 1|7.3|Ki=50nM|Ki|=|50|nM|50|nM
3TFU|1.94|2011|PL8||P0A4X6|ADENOSYLMETHIONINE-8-AMINO-7-OXONONANOATE AMINOTRAN|3.28|Ki=520uM|Ki|=|520|uM|520000|nM
3O7U|1.71|2011|O7U||Q53ZC8|CYTOSINE DEAMINASE|7.28|Ki=52nM|Ki|=|52|nM|52|nM
3RX5|1.99|2011|G2I|ligand is compound 2; Ki=540+/-11nM|Q9AJS0|CELLULASE|6.27|Ki=540nM|Ki|=|540|nM|540|nM
3QFZ|2.39|2011|NOJ-SO4||O66264|CELLOBIOSE PHOSPHORYLASE|3.24|Ki=570uM|Ki|=|570|uM|570000|nM
3OKV|1.45|2011|VZ4|ligand is compound 15; Ki=590+/-30nM by membrane-inlet mass spectrometry; Zn-containing|P00918|CARBONIC ANHYDRASE 2|6.23|Ki=590nM|Ki|=|590|nM|590|nM
3S3V|1.53|2011|TOP||P00374|DIHYDROFOLATE REDUCTASE|6.23|Ki=593nM|Ki|=|593|nM|593|nM
3RV4|1.98|2011|ADP|Ca2+ and Mg2+ containing; Ki=5~20mM|P24182|BIOTIN CARBOXYLASE|2.3|Ki=5mM|Ki|=|5|mM|5000000|nM
3O9E|1.50|2011|A60|ligand is compound 11a; Ki=5+/-6pM|Q90K99|HIV-1 PROTEASE|11.3|Ki=5pM|Ki|=|5|pM|0.005|nM
3ST5|1.45|2011|G89||P03367|HIV-1 PROTEASE|11.3|Ki=5pM|Ki|=|5|pM|0.005|nM
3PGL|2.35|2011|RZX||Q9GZU7|CARBOXY-TERMINAL DOMAIN RNA POLYMERASE II POLYPEPTI|5.3|Ki=5uM|Ki|=|5|uM|5000|nM
3QIZ|2.00|2011|QI2||A5HZZ9|BOTULINUM NEUROTOXIN A|5.21|Ki=6.1uM|Ki|=|6.1|uM|6100|nM
3TJM|1.48|2011|7FA||P49327|FATTY ACID SYNTHASE|5.2|Ki=6.36uM|Ki|=|6.36|uM|6360|nM
3QJ0|2.30|2011|QI3||A5HZZ9|BOTULINUM NEUROTOXIN A|5.2|Ki=6.3uM|Ki|=|6.3|uM|6300|nM
3ROC|1.70|2011|29A||Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|8.19|Ki=6.4nM|Ki|=|6.4|nM|6.4|nM
3RX8|2.56|2011|9MR|ligand is compound 1; Ki=610+/-14nM|Q9AJS0|CELLULASE|6.21|Ki=610nM|Ki|=|610|nM|610|nM
3N0H|1.92|2011|TOP|redundant to 3s3v|P00374|DIHYDROFOLATE REDUCTASE|6.21|Ki=617nM|Ki|=|617|nM|617|nM
3O0J|1.95|2011|3OJ|ligand is AN2898; Ki=65+/-9.8nM; Mg-containing; Zn-containing|Q07343|CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B|7.19|Ki=65nM|Ki|=|65|nM|65|nM
3Q2J|2.15|2011|CKI||P0A3Y5|AMINOGLYCOSIDE 3'-PHOSPHOTRANSFERASE|4.18|Ki=66.1uM|Ki|=|66.1|uM|66100|nM
3PS1|1.85|2011|ZH2||D5CV28|UDP-3-O-[3-HYDROXYMYRISTOYL] N-ACETYLGLUCOSAMINE|10.17|Ki=67pM|Ki|=|67|pM|0.067|nM
3OIK|1.50|2011|WZB|ligand is compound 14; Ki=680+/-40nM; membrane-inlet mass spectrometry; Zn-containing; incomplete ligand structure|P00918|CARBONIC ANHYDRASE 2|6.17|Ki=680nM|Ki|=|680|nM|680|nM
3LJZ|2.00|2011|LA3||P45452|COLLAGENASE 3 (MMP-13)|8.14|Ki=7.3nM|Ki|=|7.3|nM|7.3|nM
3S9E|1.60|2011|GLU||P42264|GLUTAMATE RECEPTOR, IONOTROPIC KAINATE 3|5.13|Ki=7.43uM|Ki|=|7.43|uM|7430|nM
3OZR|1.73|2011|OZR||P22734|CATECHOL O-METHYLTRANSFERASE|5.15|Ki=7022nM|Ki|=|7022|nM|7022|nM
3RT6|2.84|2011|FWD||P19492|GLUTAMATE RECEPTOR 3|7.15|Ki=70nM|Ki|=|70|nM|70|nM
3SNA|3.05|2011|6-mer|ligand is Peptide aldehyde inhibitor Ac-NSFSQ-H; Ki=72.73+/-3.60uM|P0C6U8|3C-LIKE PROTEINASE|4.14|Ki=72.73uM|Ki|=|72.73|uM|72730|nM
3OZT|1.48|2011|OZZ||P22734|CATECHOL O-METHYLTRANSFERASE|4.13|Ki=74.9uM|Ki|=|74.9|uM|74900|nM
2X2R|2.20|2011|X2O||P52732|KINESIN-LIKE PROTEIN KIF11|7.12|Ki=76.2nM|Ki|=|76.2|nM|76.2|nM
3R4O|2.65|2011|FU3|compound 16; Enzymatic Ki was calculated from enzymatic IC50 using the Cheng-Prusoff equation|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|8.15|Ki=7nM|Ki|=|7|nM|7|nM
3TU7|2.49|2011|0BM||P00734|PROTHROMBIN|8.09|Ki=8.17nM|Ki|=|8.17|nM|8.17|nM
3SND|1.89|2011|6-mer|ligand is Peptide aldehyde inhibitor Ac-ESTLQ-H; Ki=8.27+/-1.52uM; Cocrystallization|P0C6U8|3C-LIKE PROTEINASE|5.08|Ki=8.27uM|Ki|=|8.27|uM|8270|nM
2YFX|1.70|2011|VGH|ligand is crizotinid|B6EXY4|ALK TYROSINE KINASE RECEPTOR|8.09|Ki=8.2nM|Ki|=|8.2|nM|8.2|nM
3P9H|1.80|2011|11-mer|Gag polyprotein, Ki=8.7+/-3.5uM; Fragment: N-terminal UEV domain (UNP residues 2 to 145); Mutation: Mutation of 43VFNDGS48 to GG|Q99816|TUMOR SUSCEPTIBILITY GENE 101 PROTEIN|5.06|Ki=8.7uM|Ki|=|8.7|uM|8700|nM
3U8L|2.32|2011|09Q|lignad is compound 3; Ki=8.9+/-0.9nM|P58154|ACETYLCHOLINE-BINDING PROTEIN|8.05|Ki=8.9nM|Ki|=|8.9|nM|8.9|nM
3P55|2.00|2011|670|Fe containing, Zn binding|P00918|CARBONIC ANHYDRASE 2|7.1|Ki=80nM|Ki|=|80|nM|80|nM
3LOO|2.00|2011|B4P||------|ANOPHELES GAMBIAE ADENOSINE KINASE|6.07|Ki=860nM|Ki|=|860|nM|860|nM
3PO6|1.47|2011|DT9||P00918|CARBONIC ANHYDRASE 2|7.06|Ki=87.3nM|Ki|=|87.3|nM|87.3|nM
3LOX|2.65|2011|MCX||Q9ELS8|HCV NS3 PROTEASE|8.1|Ki=8nM|Ki|=|8|nM|8|nM
3P4V|2.00|2011|PMX||P00918|CARBONIC ANHYDRASE 2|5.1|Ki=8uM|Ki|=|8|uM|8000|nM
3P44|2.20|2011|067|Ru containing, Zn binding|P00918|CARBONIC ANHYDRASE 2|8.01|Ki=9.7nM|Ki|=|9.7|nM|9.7|nM
3RX7|2.02|2011|G3I|ligand is compound 3; Ki=940+/-12nM|Q9AJS0|CELLULASE|6.03|Ki=940nM|Ki|=|940|nM|940|nM
3N4B|1.60|2011|WWZ||P00918|CARBONIC ANHYDRASE 2|7.02|Ki=96nM|Ki|=|96|nM|96|nM
2Y80|1.90|2011|439||P00742|COAGULATION FACTOR XA|8.05|Ki=9nM|Ki|=|9|nM|9|nM
3ML2|1.80|2011|SU0||P00918|CARBONIC ANHYDRASE 2|8.05|Ki=9nM|Ki|=|9|nM|9|nM
3OYS|1.54|2011|OYS||P00918|CARBONIC ANHYDRASE 2|8.05|Ki=9nM|Ki|=|9|nM|9|nM
2XLC|2.70|2011|DEP|covalent complex|Q9K5F2|ACETYL XYLAN ESTERASE|2.3|Ki~5mM|Ki|~|5|mM|5000000|nM
3Q2A|1.99|2011|PAB||Q6Q8Q7|TOLUENE-4-MONOOXYGENASE SYSTEM PROTEIN A|5.3|Ki~5uM|Ki|~|5|uM|5000|nM
4DMY|1.63|2012|0LC|incomplete ligand structure|P43235|CATHEPSIN K|9.0|IC<0.001uM|IC50|<|0.001|uM|1|nM
4DTK|1.86|2012|7LI|IC50<0.003 uM ([ATP at Km])|P11309|SERINE/THREONINE-PROTEIN KINASE PIM-1|8.52|IC<0.003uM|IC50|<|0.003|uM|3|nM
3U4W|1.90|2012|5-mer|compound 4b|P00523|TYROSINE-PROTEIN KINASE SRC|8.4|IC<0.004uM|IC50|<|0.004|uM|4|nM
4AXA|1.90|2012|RKD|ligand is AT13148|P00517|CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTIC|8.0|IC<10nM|IC50|<|10|nM|10|nM
3U1Y|2.00|2012|03I|compound 1t; IC50<2.13+/-1.72nM|P47205|UDP-3-O-[3-HYDROXYMYRISTOYL] N-ACETYLGLUCOSAMINE DEACETYLASE|8.67|IC<2.13nM|IC50|<|2.13|nM|2.13|nM
3U4U|2.20|2012|LNH|compound 5f|P68400|CASEIN KINASE II, ALPHA SUBUNIT|8.52|IC<3nM|IC50|<|3|nM|3|nM
4E1Z|2.50|2012|0MX|X-ray(Mouse), IC50(human)|Q9R117|NON-RECEPTOR TYROSINE-PROTEIN KINASE TYK2|8.52|IC<3nM|IC50|<|3|nM|3|nM
3VAP|2.66|2012|0FY|compound 56|O14965|AURORA KINASE A|8.4|IC<4nM|IC50|<|4|nM|4|nM
4GTQ|2.60|2012|7TQ|Zn-containing|Q04631|FARNESYLTRANSFERASE/GERANYLGERANYLTRANSFERA|8.3|IC<5nM|IC50|<|5|nM|5|nM
4GTR|2.20|2012|7TR|Zn-containing|Q04631|FARNESYLTRANSFERASE/GERANYLGERANYLTRANSFERA|8.3|IC<5nM|IC50|<|5|nM|5|nM
4D89|1.65|2012|BXD|compound 60n; soak|P56817|BETA-SECRETASE 1|8.7|IC=0.002uM|IC50|=|0.002|uM|2|nM
4AT3|1.77|2012|LTI|complex TrkB and Cpd5n|Q16620|BDNF/NT-3 GROWTH FACTORS RECEPTOR|8.4|IC=0.004uM|IC50|=|0.004|uM|4|nM
4AZ3|2.04|2012|S35|compound 15a|P10619|LYSOSOMAL PROTECTIVE PROTEIN 32 KDA CHAIN|8.3|IC=0.005uM|IC50|=|0.005|uM|5|nM
4EMV|1.70|2012|0R9||G6TGY9|TOPOISOMERASE IV, SUBUNIT B|8.3|IC=0.005uM|IC50|=|0.005|uM|5|nM
4A7C|2.30|2012|E46|compound 6b|P11309|PROTO-ONCOGENE SERINE/THREONINE-PROTEIN KINASE PIM|8.22|IC=0.006uM|IC50|=|0.006|uM|6|nM
3TYV|1.65|2012|HI3|compound 56|O92972|RNA-DIRECTED RNA POLYMERASE|8.1|IC=0.008uM|IC50|=|0.008|uM|8|nM
4A4O|2.70|2012|664|compound 25|P53350|SERINE/THREONINE-PROTEIN KINASE PLK1|8.05|IC=0.009uM|IC50|=|0.009|uM|9|nM
3UH4|2.00|2012|XAV|compound TNKS1-XAV939|O95271|TANKYRASE-1|7.96|IC=0.011uM|IC50|=|0.011|uM|11|nM
3VW9|1.47|2012|HPJ|compound 3d|Q04760|LACTOYLGLUTATHIONE LYASE|7.96|IC=0.011uM|IC50|=|0.011|uM|11|nM
4AT4|2.36|2012|T6E|complex TrkB and EX429|Q16620|BDNF/NT-3 GROWTH FACTORS RECEPTOR|7.92|IC=0.012uM|IC50|=|0.012|uM|12|nM
4A4L|2.35|2012|939|compound 13|P53350|SERINE/THREONINE-PROTEIN KINASE PLK1|7.82|IC=0.015uM|IC50|=|0.015|uM|15|nM
4FNY|2.45|2012|I3K||Q9UM73|ALK TYROSINE KINASE RECEPTOR|7.8|IC=0.016uM|IC50|=|0.016|uM|16|nM
4FNZ|2.60|2012|NZF||Q9UM73|ALK TYROSINE KINASE RECEPTOR|7.8|IC=0.016uM|IC50|=|0.016|uM|16|nM
3VQS|1.90|2012|JT1|complex HCVBK and JTK-853; IC50=0.0178+/-0.0008uM|D0PY27|RNA-DIRECTED RNA POLYMERASE|7.75|IC=0.0178uM|IC50|=|0.0178|uM|17.8|nM
4HCU|1.43|2012|13L|covalent complex|Q08881|TYROSINE-PROTEIN KINASE ITK/TSK|8.0|IC=0.01uM|IC50|=|0.01|uM|10|nM
4GH6|2.70|2012|LUO|IC50=0.021+/-0.005uM|O76083|CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE-9|7.68|IC=0.021uM|IC50|=|0.021|uM|21|nM
3VRV|1.90|2012|YSD|compound 5a|P13053|VITAMIN D3 RECEPTOR|10.54|IC=0.029nM|IC50|=|0.029|nM|0.029|nM
2YER|1.83|2012|TQ1|ligand is compound 16e|O14757|SERINE/THREONINE-PROTEIN KINASE CHK1|7.7|IC=0.02uM|IC50|=|0.02|uM|20|nM
3QU0|1.95|2012|X40|ligand is compound 42|P24941|CYCLIN-DEPENDENT KINASE 2|7.7|IC=0.02uM|IC50|=|0.02|uM|20|nM
3QXP|1.75|2012|X64|ligand is compound 51|P24941|CYCLIN-DEPENDENT KINASE 2|7.7|IC=0.02uM|IC50|=|0.02|uM|20|nM
4GCJ|1.42|2012|X64|ligand is compound 51|P24941|CYCLIN-DEPENDENT KINASE 2|7.7|IC=0.02uM|IC50|=|0.02|uM|20|nM
3ZXR|2.15|2012|IQ1|compound 3|P0A590|GLUTAMINE SYNTHETASE 1|7.7|IC=0.02uM|IC50|=|0.02|uM|20|nM
4DFN|2.48|2012|0K1||P43405|TYROSINE-PROTEIN KINASE SYK|7.7|IC=0.02uM|IC50|=|0.02|uM|20|nM
4DK7|2.45|2012|0KS|Ca-containing, the crystal contains Nuclear receptor coactivator 1|P55055|OXYSTEROLS RECEPTOR LXR-BETA|7.7|IC=0.02uM|IC50|=|0.02|uM|20|nM
4B1D|1.95|2012|6TG|compound 1m; IC50(FRET assay); IC50=0.049uM(SH-SY5Y assay)|P56817|BETA-SECRETASE 1|7.49|IC=0.032uM|IC50|=|0.032|uM|32|nM
3RDE|1.89|2012|OYP|ligand is compound 3d|P16469|ARACHIDONATE 12-LIPOXYGENASE, 12S-TYPE|7.46|IC=0.035uM|IC50|=|0.035|uM|35|nM
3UVP|2.40|2012|048|compound 45; IC50=0.035+/-0.002uM|Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|7.46|IC=0.035uM|IC50|=|0.035|uM|35|nM
4AT5|1.71|2012|MUJ|complex TrkB and GW2580|Q16620|BDNF/NT-3 GROWTH FACTORS RECEPTOR|7.42|IC=0.038uM|IC50|=|0.038|uM|38|nM
4AZ0|2.17|2012|S61|compound 8a|P10619|LYSOSOMAL PROTECTIVE PROTEIN 32 KDA CHAIN|7.42|IC=0.038uM|IC50|=|0.038|uM|38|nM
3U2K|1.64|2012|087|ligand is compound 10|P0A0K8|DNA GYRASE SUBUNIT B|7.52|IC=0.03uM|IC50|=|0.03|uM|30|nM
4DIJ|1.90|2012|BLF||Q00987|E3 UBIQUITIN-PROTEIN LIGASE MDM2|7.52|IC=0.03uM|IC50|=|0.03|uM|30|nM
4D88|1.70|2012|BXQ|compound 48|P56817|BETA-SECRETASE 1|7.31|IC=0.049uM|IC50|=|0.049|uM|49|nM
3ZXV|2.26|2012|MXI|compound 11a; IC50=0.049+/-0.006uM|P0A590|GLUTAMINE SYNTHETASE 1|7.31|IC=0.049uM|IC50|=|0.049|uM|49|nM
3V5Q|2.20|2012|0F4|compound 20; IC50=0.004uM for cellular Ba/F3 assay; IC50=0.04uM(biochemical assay)|Q16288|NT-3 GROWTH FACTOR RECEPTOR|7.4|IC=0.04uM|IC50|=|0.04|uM|40|nM
4HGT|1.80|2012|15G||P48730|CASEIN KINASE I ISOFORM DELTA|7.4|IC=0.04uM|IC50|=|0.04|uM|40|nM
3VG1|1.77|2012|0GT|compound 32a; Racemate; soak|P56817|BETA-SECRETASE 1|7.26|IC=0.055uM|IC50|=|0.055|uM|55|nM
4D83|2.40|2012|0GT|ligand is compound 32a|P56817|BETA-SECRETASE 1|7.26|IC=0.055uM|IC50|=|0.055|uM|55|nM
4A4X|2.40|2012|JUP|compound rac-17j|P51955|SERINE/THREONINE-PROTEIN KINASE NEK2|7.23|IC=0.059uM|IC50|=|0.059|uM|59|nM
3TKI|1.60|2012|S25|ligand is compound 25|O14757|SERINE/THREONINE-PROTEIN KINASE CHK1|10.3|IC=0.05nM|IC50|=|0.05|nM|0.05|nM
3QTZ|2.00|2012|X42|ligand is compound 52|P24941|CYCLIN-DEPENDENT KINASE 2|7.3|IC=0.05uM|IC50|=|0.05|uM|50|nM
4AVG|2.20|2012|SL6|compound R05-2; IC50=0.06+/-0.02uM|C3W5S0|POLYMERASE PA|7.22|IC=0.06uM|IC50|=|0.06|uM|60|nM
4AFE|2.60|2012|GGY|compound rac-21|P51955|SERINE/THREONINE-PROTEIN KINASE NEK2|7.14|IC=0.073uM|IC50|=|0.073|uM|73|nM
4HCT|1.48|2012|18R|X-ray(R-52), IC50(RS-52)|Q08881|TYROSINE-PROTEIN KINASE ITK/TSK|7.14|IC=0.073uM|IC50|=|0.073|uM|73|nM
4B1C|1.95|2012|1B1|compound 1t; IC50(FRET assay); IC50=0.19uM(SH-SY5Y assay)|P56817|BETA-SECRETASE 1|7.1|IC=0.079uM|IC50|=|0.079|uM|79|nM
3RPV|1.80|2012|26Z|ligand is compound 55|P24941|CYCLIN-DEPENDENT KINASE 2|7.15|IC=0.07uM|IC50|=|0.07|uM|70|nM
3QTX|1.95|2012|X43|ligand is compound 54|P24941|CYCLIN-DEPENDENT KINASE 2|7.15|IC=0.07uM|IC50|=|0.07|uM|70|nM
3QTU|1.82|2012|X44|ligand is compound 53|P24941|CYCLIN-DEPENDENT KINASE 2|7.15|IC=0.07uM|IC50|=|0.07|uM|70|nM
3TV8|2.64|2012|DGJ|ligand is 1-deoxygalactonojirimycin (D-galacto-DNJ), IC50=45uM for L-galacto-DNJ|P06280|ALPHA-GALACTOSIDASE A|7.15|IC=0.07uM|IC50|=|0.07|uM|70|nM
4ENY|2.80|2012|J19|compound 2|P11309|SERINE/THREONINE-PROTEIN KINASE PIM-1|7.05|IC=0.089uM|IC50|=|0.089|uM|89|nM
4AOF|3.30|2012|7L0|compound 45|P48736|PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE|7.1|IC=0.08uM|IC50|=|0.08|uM|80|nM
4HEU|2.00|2012|15J||Q9Y233|PHOSPHODIESTERASE-10A|10.01|IC=0.097nM|IC50|=|0.097|nM|0.097|nM
3VRU|2.00|2012|YS3|compound 4a|P13053|VITAMIN D3 RECEPTOR|10.0|IC=0.10nM|IC50|=|0.1|nM|0.1|nM
2YM7|1.81|2012|YM7|ligand is compound 20; IC50=0.13+/-0.051uM|O14757|SERINE/THREONINE-PROTEIN KINASE CHK1|6.89|IC=0.13uM|IC50|=|0.13|uM|130|nM
3RAK|1.75|2012|03Z|ligand is compound 57|P24941|CYCLIN-DEPENDENT KINASE 2|6.89|IC=0.13uM|IC50|=|0.13|uM|130|nM
4AWK|1.90|2012|CI1|compound R05-1; IC50=0.13+/-0.04uM|C3W5S0|POLYMERASE PA|6.89|IC=0.13uM|IC50|=|0.13|uM|130|nM
4D85|2.65|2012|0GU|compound 39a|P56817|BETA-SECRETASE 1|6.85|IC=0.14uM|IC50|=|0.14|uM|140|nM
3VOZ|2.40|2012|04A|complex KGA and BPTES; IC50=0.14+/-0.03uM|O94925|GLUTAMINASE KIDNEY ISOFORM, MITOCHONDRIAL|6.85|IC=0.14uM|IC50|=|0.14|uM|140|nM
4HKI|2.15|2012|FLN||Q9H2K2|TANKYRASE-2|6.85|IC=0.14uM|IC50|=|0.14|uM|140|nM
3UIX|2.20|2012|Q17|compound 1; IC50=0.151+/-0.001uM|P11309|SERINE/THREONINE-PROTEIN KINASE PIM|6.82|IC=0.151uM|IC50|=|0.151|uM|151|nM
2YDI|1.60|2012|YDI|ligand is compound 1|O14757|SERINE/THREONINE-PROTEIN KINASE CHK1|6.82|IC=0.15uM|IC50|=|0.15|uM|150|nM
3UFL|1.90|2012|508|compound 9|P56817|BETA-SECRETASE 1|6.82|IC=0.15uM|IC50|=|0.15|uM|150|nM
4G2F|1.70|2012|C07||Q6P4R6|EPH RECEPTOR A3|6.8|IC=0.16uM|IC50|=|0.16|uM|160|nM
4DCE|2.03|2012|0JF|IC50=0.174+/-0.012uM|Q9UM73|ALK TYROSINE KINASE RECEPTOR|6.76|IC=0.174uM|IC50|=|0.174|uM|174|nM
4B4G|2.50|2012|KKT|compound 8j; IC50=0.175+/-0.067uM|Q9HU22|GLUCOSE-1-PHOSPHATE THYMIDYLYLTRANSFERASE|6.76|IC=0.175uM|IC50|=|0.175|uM|175|nM
4HLM|1.95|2012|16S||Q9H2K2|TANKYRASE-2|6.77|IC=0.17uM|IC50|=|0.17|uM|170|nM
4DVI|1.90|2012|2IW|ligand is compound 2, IWR2|O95271|TANKYRASE-1|6.72|IC=0.192uM|IC50|=|0.192|uM|192|nM
2YEX|1.30|2012|YEX|ligand is compound 5a|O14757|SERINE/THREONINE-PROTEIN KINASE CHK1|10.0|IC=0.1nM|IC50|=|0.1|nM|0.1|nM
3RAL|1.75|2012|04Z|ligand is compound 56|P24941|CYCLIN-DEPENDENT KINASE 2|7.0|IC=0.1uM|IC50|=|0.1|uM|100|nM
4B4M|2.35|2012|JWT|compound 8k; IC50=0.205+/-0.009uM|Q9HU22|GLUCOSE-1-PHOSPHATE THYMIDYLYLTRANSFERASE|6.69|IC=0.205uM|IC50|=|0.205|uM|205|nM
3TTJ|2.10|2012|JBI|ligand is compound 1; IC50=0.21+/-0.06uM|P53779|MITOGEN-ACTIVATED PROTEIN KINASE 10|6.68|IC=0.21uM|IC50|=|0.21|uM|210|nM
4H39|1.99|2012|10-mer|ligand is pepJIP1; IC50=0.21+/-0.02uM(Protein Substrate: His-SAB (1 C390)), IC50=0.30+/-0.07uM(Protein Substrate: FLAG-ATF2 (2 C115))|P53779|MITOGEN-ACTIVATED PROTEIN KINASE 10|6.68|IC=0.21uM|IC50|=|0.21|uM|210|nM
4E96|1.92|2012|0NS|IC50 (AlphaScreen assay)|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|6.66|IC=0.22uM|IC50|=|0.22|uM|220|nM
4E8Z|3.05|2012|IHC|K-containing, IC50(myelin basic protein)|B4EB35|D-BETA-D-HEPTOSE 7-PHOSPHATE KINASE|6.64|IC=0.23uM|IC50|=|0.23|uM|230|nM
3UMX|2.55|2012|Q18|compound 1|P11309|SERINE/THREONINE-PROTEIN KINASE PIM|6.62|IC=0.24uM|IC50|=|0.24|uM|240|nM
4EFU|2.00|2012|EFU||P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|6.6|IC=0.25uM|IC50|=|0.25|uM|250|nM
4EA3|3.01|2012|0NN||P0ABE7|FUSION PROTEIN OF NOCICEPTIN RECEPTOR AND CYTOCHROM|9.57|IC=0.27nM|IC50|=|0.27|nM|0.27|nM
4GE5|2.00|2012|A89|IC50=0.27+/-0.07uM|P43378|TYROSINE-PROTEIN PHOSPHATASE NON-RECEPTOR TYPE 9|6.57|IC=0.27uM|IC50|=|0.27|uM|270|nM
4EOX|1.78|2012|0S5|Na-containing|Q8DP79|PEPTIDE DEFORMYLASE|9.55|IC=0.28nM|IC50|=|0.28|nM|0.28|nM
4FCD|2.02|2012|0T6||Q9Y233|CGMP 3',5'-CYCLIC PHOSPHODIESTERASE|9.55|IC=0.28nM|IC50|=|0.28|nM|0.28|nM
4FRJ|1.95|2012|DWB|IC50=0.28+/-0.10uM|P56817|BETA-SECRETASE 1|6.55|IC=0.28uM|IC50|=|0.28|uM|280|nM
3RK7|1.80|2012|08Z|ligand is compound 43|P24941|CYCLIN-DEPENDENT KINASE 2|6.7|IC=0.2uM|IC50|=|0.2|uM|200|nM
4HLG|2.00|2012|20B||Q9H2K2|TANKYRASE-2|6.51|IC=0.31uM|IC50|=|0.31|uM|310|nM
3U8H|2.30|2012|BHP|ligand is KH064;IC50=0.32+/-0.09uM|P14555|PHOSPHOLIPASE A2|6.49|IC=0.32uM|IC50|=|0.32|uM|320|nM
3TNH|3.20|2012|F18|ligand is CAN508|P50750|CYCLIN-DEPENDENT KINASE 9|6.46|IC=0.35uM|IC50|=|0.35|uM|350|nM
4DGN|1.75|2012|LU2|IC50=0.35+/-0.04uM|P28523|CASEIN KINASE II, ALPHA SUBUNIT|6.46|IC=0.35uM|IC50|=|0.35|uM|350|nM
3VJK|2.49|2012|M51|compound 8g; IC50(Human); IC50=0.29nM(Rat)|P27487|DIPEPTIDYL PEPTIDASE 4|9.43|IC=0.37nM|IC50|=|0.37|nM|0.37|nM
3VJM|2.10|2012|W61|compound 8g; IC50(human); IC50=0.59nM(rat)|P27487|DIPEPTIDYL PEPTIDASE 4|9.43|IC=0.37nM|IC50|=|0.37|nM|0.37|nM
4B5B|2.06|2012|BBE|compound 8p; IC50=0.387+/-0.065uM|Q9HU22|GLUCOSE-1-PHOSPHATE THYMIDYLYLTRANSFERASE|6.41|IC=0.387uM|IC50|=|0.387|uM|387|nM
3RKB|2.00|2012|12Z|ligand is compound 45|P24941|CYCLIN-DEPENDENT KINASE 2|6.42|IC=0.38uM|IC50|=|0.38|uM|380|nM
3V8T|2.00|2012|477|compound 7|Q08881|TYROSINE-PROTEIN KINASE ITK/TSK|9.52|IC=0.3nM|IC50|=|0.3|nM|0.3|nM
4HCV|1.48|2012|13J|covalent complex|Q08881|TYROSINE-PROTEIN KINASE ITK/TSK|6.4|IC=0.40uM|IC50|=|0.4|uM|400|nM
3VRW|2.40|2012|YS5|compound 5c|P13053|VITAMIN D3 RECEPTOR|9.39|IC=0.41nM|IC50|=|0.41|nM|0.41|nM
4A16|2.65|2012|H34|ligand is huprine 4;IC50=0.43+/-0.04nM|P21836|ACETYLCHOLINESTERASE|9.37|IC=0.43nM|IC50|=|0.43|nM|0.43|nM
2YM5|2.03|2012|YM5|ligand is compound 6|O14757|SERINE/THREONINE-PROTEIN KINASE CHK1|6.37|IC=0.43uM|IC50|=|0.43|uM|430|nM
4E5H|2.16|2012|0N8|Mn-containing, IC50(in vitro transcription assay)|Q5EP34|POLYMERASE PROTEIN PA|6.37|IC=0.43uM|IC50|=|0.43|uM|430|nM
3ZZH|2.10|2012|ARG|complex between AAK domain and Arg; IC50=0.44+/-0.05mM|Q01217|ACETYLGLUTAMATE KINASE|3.36|IC=0.44mM|IC50|=|0.44|mM|440000|nM
3UWO|1.70|2012|0DJ|compound 17; IC50=0.44+/-0.13uM|Q9HZN8|THYMIDYLATE KINASE|6.36|IC=0.44uM|IC50|=|0.44|uM|440|nM
4HL5|2.20|2012|15W||Q9H2K2|TANKYRASE-2|6.35|IC=0.45uM|IC50|=|0.45|uM|450|nM
3U8D|1.80|2012|U8D|ligand is LY311727;IC50=0.47+/-0.2uM|P14555|PHOSPHOLIPASE A2|6.33|IC=0.47uM|IC50|=|0.47|uM|470|nM
3UR9|1.65|2012|K36|covalent bound;ligand is GC376;IC50=0.49+/-0.05uM|Q83883|3C-LIKE PROTEASE|6.31|IC=0.49uM|IC50|=|0.49|uM|490|nM
4G31|2.28|2012|0WH|IC50=0.4+/-0.32nM|Q9NZJ5|EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 3|9.4|IC=0.4nM|IC50|=|0.4|nM|0.4|nM
4E26|2.55|2012|734||P15056|SERINE/THREONINE-PROTEIN KINASE B-RAF|6.4|IC=0.4uM|IC50|=|0.4|uM|400|nM
4ALG|1.60|2012|1GH|compound 14; IC50=0.20-1.23uM; pIC50=6.3|P25440|BROMODOMAIN-CONTAINING PROTEIN 2|6.3|IC=0.50uM|IC50|=|0.5|uM|500|nM
4H3A|1.98|2012|0YY|ligand is compound 15; a continuous spectrophotometric assay|P60472|UNDECAPRENYL PYROPHOSPHATE SYNTHASE|6.29|IC=0.51uM|IC50|=|0.51|uM|510|nM
3RK9|1.85|2012|09Z|ligand is compound 44|P24941|CYCLIN-DEPENDENT KINASE 2|6.28|IC=0.52uM|IC50|=|0.52|uM|520|nM
4ABU|1.86|2012|FT1|compound C2|P02766|TRANSTHYRETIN|6.28|IC=0.52uM|IC50|=|0.52|uM|520|nM
4ENX|2.80|2012|Z20|compound 3|P11309|SERINE/THREONINE-PROTEIN KINASE PIM-1|6.26|IC=0.550uM|IC50|=|0.55|uM|550|nM
3V9B|2.10|2012|IHM|ligand is compound 1s|Q08499|CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D|9.3|IC=0.5nM|IC50|=|0.5|nM|0.5|nM
4HLD|2.00|2012|16T||Q6GJI9|THYMIDYLATE KINASE|9.3|IC=0.5nM|IC50|=|0.5|nM|0.5|nM
3T4V|1.73|2012|MD3|ligand is compound 18; Fe-containing|P05050|ALPHA-KETOGLUTARATE-DEPENDENT DIOXYGENASE ALKB|6.3|IC=0.5uM|IC50|=|0.5|uM|500|nM
4A9M|2.06|2012|P9M|compound 6a|P25440|BROMODOMAIN-CONTAINING PROTEIN 2|6.3|IC=0.5uM|IC50|=|0.5|uM|500|nM
4AAW|2.20|2012|R84|compound 37; IC50=0.25uM(Ecoil); IC50=0.5uM(H.in); IC50=0.5uM(S.pn); IC50>200uM(S.au)|Q8DQ18|BIFUNCTIONAL PROTEIN GLMU|6.3|IC=0.5uM|IC50|=|0.5|uM|500|nM
4F63|2.55|2012|0S7|pIC50=6.3|P11362|FIBROBLAST GROWTH FACTOR RECEPTOR 1|6.3|IC=0.5uM|IC50|=|0.5|uM|500|nM
4B14|1.50|2012|4XB|complex PvNMT-NHM-26; IC50(fluorescent-activity cell sorting (FACS) assay)|A5K1A2|GLYCYLPEPTIDE N-TETRADECANOYLTRANSFERASE|6.22|IC=0.60uM|IC50|=|0.6|uM|600|nM
4HMH|2.30|2012|F94||Q9H2K2|TANKYRASE-2|6.21|IC=0.62uM|IC50|=|0.62|uM|620|nM
3VJS|1.93|2012|10S|compound S10|P13053|VITAMIN D3 RECEPTOR|6.19|IC=0.64uM|IC50|=|0.64|uM|640|nM
3QTW|1.85|2012|X3A|ligand is compound 30|P24941|CYCLIN-DEPENDENT KINASE 2|6.19|IC=0.65uM|IC50|=|0.65|uM|650|nM
3V8S|2.29|2012|0HD|compound 18; IC50=0.65+/-0.03uM(ROCK1); IC50=0.67+/-0.12uM(ROCK2)|Q13464|RHO-ASSOCIATED PROTEIN KINASE 1|6.19|IC=0.65uM|IC50|=|0.65|uM|650|nM
4DFL|1.98|2012|0K0||P43405|TYROSINE-PROTEIN KINASE SYK|6.17|IC=0.67uM|IC50|=|0.67|uM|670|nM
4AN3|2.10|2012|5Y0|compound 2|Q02750|MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1 (MERK 1)|9.22|IC=0.6nM|IC50|=|0.6|nM|0.6|nM
4F4P|2.37|2012|0SB||P43405|TYROSINE-PROTEIN KINASE SYK|9.22|IC=0.6nM|IC50|=|0.6|nM|0.6|nM
3S9Z|1.79|2012|I92|ligand is compound 4; Mg-containing|P0A5J4|MALATE SYNTHASE G|6.22|IC=0.6uM|IC50|=|0.6|uM|600|nM
4E5D|2.20|2012|0NJ|ligand is compound e|P08659|LUCIFERIN 4-MONOOXYGENASE|6.22|IC=0.6uM|IC50|=|0.6|uM|600|nM
3TN8|2.95|2012|F18|ligand is CAN508|P50750|CYCLIN-DEPENDENT KINASE 9|6.13|IC=0.74uM|IC50|=|0.74|uM|740|nM
3V6S|2.97|2012|0F0|compound JNK-IN7; covalent complex; IC50=1.54nM(JNK1); IC50=1.99nM(JNK2)|P53779|MITOGEN-ACTIVATED PROTEIN KINASE 10|9.12|IC=0.75nM|IC50|=|0.75|nM|0.75|nM
4AKN|1.82|2012|S5B|compound 1; IC50=0.41-1.51uM; pIC50=6.1|P25440|BROMODOMAIN-CONTAINING PROTEIN 2|6.1|IC=0.79uM|IC50|=|0.79|uM|790|nM
3U18|1.90|2012|Y0X|ligand is p425|P14174|MACROPHAGE MIGRATION INHIBITORY FACTOR|6.09|IC=0.81uM|IC50|=|0.81|uM|810|nM
4E8W|2.87|2012|IHA|K-containing, IC50(myelin basic protein)|B4EB35|D-BETA-D-HEPTOSE 7-PHOSPHATE KINASE|6.09|IC=0.81uM|IC50|=|0.81|uM|810|nM
4F49|2.25|2012|K36|covalent bound;ligand is GC376;IC50=0.82+/-0.;Porcine transmissible gastroenteritis coronavirus strain Purdue|P0C6V2|3C-LIKE PROTEINASE|6.09|IC=0.82uM|IC50|=|0.82|uM|820|nM
4ABV|1.80|2012|FT2|compound C3|P02766|TRANSTHYRETIN|6.07|IC=0.85uM|IC50|=|0.85|uM|850|nM
4HLF|2.15|2012|15Z||Q9H2K2|TANKYRASE-2|6.06|IC=0.87uM|IC50|=|0.87|uM|870|nM
2YM6|2.01|2012|YM6|ligand is compound 8; IC50=0.88+/-0.21uM|O14757|SERINE/THREONINE-PROTEIN KINASE CHK1|6.06|IC=0.88uM|IC50|=|0.88|uM|880|nM
4GW8|2.00|2012|3RA||P11309|SERINE/THREONINE-PROTEIN KINASE PIM-1|6.06|IC=0.88uM|IC50|=|0.88|uM|880|nM
3UOK|2.95|2012|0C6|compound 10|O14965|AURORA KINASE A|9.1|IC=0.8nM|IC50|=|0.8|nM|0.8|nM
3SAZ|2.04|2012|043|ligand is compound 7; Mg-containing|P0A5J4|MALATE SYNTHASE G|6.1|IC=0.8uM|IC50|=|0.8|uM|800|nM
4GE2|1.80|2012|75A|IC50=0.90+/-0.02uM|P43378|TYROSINE-PROTEIN PHOSPHATASE NON-RECEPTOR TYPE 9|6.05|IC=0.90uM|IC50|=|0.9|uM|900|nM
4H38|1.95|2012|0YX|ligand is compound 13; a continuous spectrophotometric assay|P60472|UNDECAPRENYL PYROPHOSPHATE SYNTHASE|6.04|IC=0.92uM|IC50|=|0.92|uM|920|nM
4GG5|2.42|2012|0J3|IC50=0.93+/-0.18nM|P08581|HEPATOCYTE GROWTH FACTOR RECEPTOR|9.03|IC=0.93nM|IC50|=|0.93|nM|0.93|nM
3QTR|1.85|2012|X36|ligand is compound 16|P24941|CYCLIN-DEPENDENT KINASE 2|6.03|IC=0.93uM|IC50|=|0.93|uM|930|nM
3UGC|1.34|2012|046||O60674|TYROSINE-PROTEIN KINASE JAK2|6.02|IC=0.947uM|IC50|=|0.947|uM|947|nM
3TT0|2.80|2012|07J|ligand is compound 1h|P11362|FIBROBLAST GROWTH FACTOR RECEPTOR 1|9.05|IC=0.9nM|IC50|=|0.9|nM|0.9|nM
4AN2|2.50|2012|EUI|compound 1|Q02750|MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1 (MERK 1)|9.05|IC=0.9nM|IC50|=|0.9|nM|0.9|nM
4AQC|1.90|2012|88A|complex JAK2 and cmp 28; IC50=0.9+/-0.1nM; IC50=61+/-16nM(cell assay)|O60674|TYROSINE-PROTEIN KINASE JAK2|9.05|IC=0.9nM|IC50|=|0.9|nM|0.9|nM
3U8W|2.15|2012|09J|compound 3j; IC50=1.0+/-0.3nM|Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|9.0|IC=1.0nM|IC50|=|1|nM|1|nM
2YM3|2.01|2012|YM3|ligand is compound 2|O14757|SERINE/THREONINE-PROTEIN KINASE CHK1|6.0|IC=1.0uM|IC50|=|1|uM|1000|nM
3UDQ|2.73|2012|09E|compound 13|P56817|BETA-SECRETASE 1|6.0|IC=1.0uM|IC50|=|1|uM|1000|nM
3UH2|2.00|2012|P34|compound TNKS1-PJ34|O95271|TANKYRASE-1|6.0|IC=1.0uM|IC50|=|1|uM|1000|nM
3UE4|2.42|2012|DB8|ligand is compound 1|P00519|TYROSINE-PROTEIN KINASE ABL1|8.96|IC=1.1nM|IC50|=|1.1|nM|1.1|nM
3SAD|1.82|2012|040|ligand is compound 1; Mg-containing|P0A5J4|MALATE SYNTHASE G|5.96|IC=1.1uM|IC50|=|1.1|uM|1100|nM
4AWG|2.60|2012|CI3|compound R05-3; IC50=1.1+/-0.5uM|C3W5S0|POLYMERASE PA|5.96|IC=1.1uM|IC50|=|1.1|uM|1100|nM
4HLH|1.75|2012|20D||Q9H2K2|TANKYRASE-2|5.96|IC=1.1uM|IC50|=|1.1|uM|1100|nM
4HLK|2.00|2012|431||Q9H2K2|TANKYRASE-2|5.96|IC=1.1uM|IC50|=|1.1|uM|1100|nM
4HKN|2.05|2012|LU2||Q9H2K2|TANKYRASE-2|5.96|IC=1.1uM|IC50|=|1.1|uM|1100|nM
4FOD|2.00|2012|0UV|IC50=0.0012+/-0.0002uM|Q9UM73|ALK TYROSINE KINASE RECEPTOR|8.92|IC=1.2nM|IC50|=|1.2|nM|1.2|nM
4HDC|2.05|2012|13Y||P65249|THYMIDYLATE KINASE|8.92|IC=1.2nM|IC50|=|1.2|nM|1.2|nM
3VQH|1.95|2012|IQB|ligand is H-89, luminescence based assay|P17612|CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTIC|5.92|IC=1.2uM|IC50|=|1.2|uM|1200|nM
4DGM|1.65|2012|AGI|IC50=1.2+/-0.15uM|P28523|CASEIN KINASE II, ALPHA SUBUNIT|5.92|IC=1.2uM|IC50|=|1.2|uM|1200|nM
3R6T|1.20|2012|LU1|ligand is compound 4; Mg-containing|P22734|CATECHOL O-METHYLTRANSFERASE|5.86|IC=1.368uM|IC50|=|1.368|uM|1368|nM
3VF3|1.48|2012|0GS|compound 14d|P56817|BETA-SECRETASE 1|5.86|IC=1.37uM|IC50|=|1.37|uM|1370|nM
3RIN|2.20|2012|I2O|ligand is compound 16; IC50=1.3+/-0.05nM|Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|8.89|IC=1.3nM|IC50|=|1.3|nM|1.3|nM
3V66|1.80|2012|D3A|compound (4R, 6S)-15a; cell-based assay|P37268|SQUALENE SYNTHASE|8.89|IC=1.3nM|IC50|=|1.3|nM|1.3|nM
4B71|2.50|2012|DJL|IC50=1.3+/-0.1uM|P26663|SERINE PROTEASE NS3|5.89|IC=1.3uM|IC50|=|1.3|uM|1300|nM
3VSX|2.80|2012|R32|compound 17; IC50(human); IC50=7.0nM(monkey plasma)|P00797|RENIN|8.85|IC=1.4nM|IC50|=|1.4|nM|1.4|nM
3R9N|1.75|2012|Z68|ligand is compound 26|P24941|CYCLIN-DEPENDENT KINASE 2|5.85|IC=1.4uM|IC50|=|1.4|uM|1400|nM
4EHM|2.20|2012|PJA|covalent complex, IC50=1.4+/-0.1uM|Q08602|GERANYLGERANYL TRANSFERASE TYPE-2 SUBUNIT ALPHA|5.85|IC=1.4uM|IC50|=|1.4|uM|1400|nM
2YM4|2.35|2012|4YM|ligand is compound 4|O14757|SERINE/THREONINE-PROTEIN KINASE CHK1|5.82|IC=1.5uM|IC50|=|1.5|uM|1500|nM
4A9N|1.85|2012|A9N|compound 5|P25440|BROMODOMAIN-CONTAINING PROTEIN 2|5.82|IC=1.5uM|IC50|=|1.5|uM|1500|nM
3VYF|2.80|2012|VYF|compound 9; IC50(human); IC50=10nM(monkey plasma)|P00797|RENIN|8.8|IC=1.6nM|IC50|=|1.6|nM|1.6|nM
4F6V|2.30|2012|ZYM|ligand is compound 7; Mg-containing|A9JQL9|DEHYDROSQUALENE SYNTHASE|5.8|IC=1.6uM|IC50|=|1.6|uM|1600|nM
4ACF|2.00|2012|46B|compound 5b; IC50=1.6+/-0.3uM|P0A590|GLUTAMINE SYNTHETASE 1|5.8|IC=1.6uM|IC50|=|1.6|uM|1600|nM
4DCD|1.69|2012|K36|covalent bound;ligand is GC376;IC50=1.77+/-0.31uM|P03300|GENOME POLYPROTEIN|5.75|IC=1.77uM|IC50|=|1.77|uM|1770|nM
3QW7|1.50|2012|5-mer|ligand is peptide RRFC; IC50=1.8+/-0.1uM; Zn-containing|A5HZZ9|BOTULINUM NEUROTOXIN A|5.74|IC=1.8uM|IC50|=|1.8|uM|1800|nM
4D8N|1.68|2012|0HM|compound 9, 9a and 9b are two possible structures for the same compound registration 9|Q92876|KALLIKREIN-6|5.74|IC=1.8uM|IC50|=|1.8|uM|1800|nM
4DK8|2.75|2012|0KT|Ca-containing, the crystal contains Nuclear receptor coactivator 1|P55055|OXYSTEROLS RECEPTOR LXR-BETA|5.74|IC=1.8uM|IC50|=|1.8|uM|1800|nM
4GZ3|1.90|2012|UDP||O15294|UDP-N-ACETYLGLUCOSAMINE--PEPTIDE|5.74|IC=1.8uM|IC50|=|1.8|uM|1800|nM
3VF9|2.30|2012|477|compound 3|P43405|TYROSINE-PROTEIN KINASE SYK|8.72|IC=1.9nM|IC50|=|1.9|nM|1.9|nM
4H3C|1.93|2012|0YZ|ligand is compound 14; a continuous spectrophotometric assay|P60472|UNDECAPRENYL PYROPHOSPHATE SYNTHASE|5.72|IC=1.9uM|IC50|=|1.9|uM|1900|nM
4A6W|1.46|2012|5C1|Mn2+ containing;ligand is HA7|C6EAB7|METHIONINE AMINOPEPTIDASE|5.72|IC=1.9uM|IC50|=|1.9|uM|1900|nM
4A6V|1.46|2012|IKY|Mn2+ containing;ligand is HA5|C6EAB7|METHIONINE AMINOPEPTIDASE|5.72|IC=1.9uM|IC50|=|1.9|uM|1900|nM
4AWM|2.60|2012|KDH|compound EGCG; IC50=1.9+/-0.4uM|C3W5S0|POLYMERASE PA|5.72|IC=1.9uM|IC50|=|1.9|uM|1900|nM
4HBX|1.62|2012|14X|IC50 measured in AlphaScreen assay|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|5.72|IC=1.9uM|IC50|=|1.9|uM|1900|nM
4B12|1.79|2012|C23|complex PvNMT-NHM-22; IC50(fluorescent-activity cell sorting (FACS) assay)|A5K1A2|GLYCYLPEPTIDE N-TETRADECANOYLTRANSFERASE|4.99|IC=10.2uM|IC50|=|10.2|uM|10200|nM
4GTO|2.15|2012|7TO|IC50=10.5+/-3.9nM, Zn-containing|Q04631|FARNESYLTRANSFERASE/GERANYLGERANYLTRANSFERA|7.98|IC=10.5nM|IC50|=|10.5|nM|10.5|nM
3V5J|2.59|2012|0F2|compound 5|Q08881|TYROSINE-PROTEIN KINASE ITK/TSK|7.96|IC=10.9nM|IC50|=|10.9|nM|10.9|nM
4FHI|2.40|2012|0S4||Q9PTN2|VITAMIN D3 RECEPTOR A|7.0|IC=100nM|IC50|=|100|nM|100|nM
3VBV|2.08|2012|0FK|compound 2b|P11309|SERINE/THREONINE-PROTEIN KINASE PIM-1|5.0|IC=10uM|IC50|=|10|uM|10000|nM
3VP3|2.70|2012|BP8|inhibitor 3, IC50=11.1+/-1.96uM|O94925|GLUTAMINASE KIDNEY ISOFORM, MITOCHONDRIAL|4.95|IC=11.1uM|IC50|=|11.1|uM|11100|nM
4GTP|2.75|2012|7TP|IC50=11.4+/-10nM, Zn-containing|Q04631|FARNESYLTRANSFERASE/GERANYLGERANYLTRANSFERA|7.94|IC=11.4nM|IC50|=|11.4|nM|11.4|nM
4G34|2.70|2012|924||Q9NZJ5|EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 3|7.93|IC=11.7nM|IC50|=|11.7|nM|11.7|nM
4AC3|2.10|2012|R83|compound 33; IC50>200uM(Ecoil); IC50=120uM(H.in); IC50=110uM(S.pn); IC50>200uM(S.au)|Q8DQ18|BIFUNCTIONAL PROTEIN GLMU|3.96|IC=110uM|IC50|=|110|uM|110000|nM
4HV3|1.54|2012|19L||P02879|RICIN|3.94|IC=115uM|IC50|=|115|uM|115000|nM
3RWI|2.01|2012|10-mer|ligand is Vif GW10 peptide from Virion infectivity factor|Q9GJ77|MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I|6.94|IC=116nM|IC50|=|116|nM|116|nM
3T0M|1.62|2012|2CT|ligand is compound A2|P31947|14-3-3 PROTEIN SIGMA|3.94|IC=116uM|IC50|=|116|uM|116000|nM
4E93|1.84|2012|GUI|IC50(Z'-Lyte Assays)|P07332|TYROSINE-PROTEIN KINASE FES/FPS|6.93|IC=118nM|IC50|=|118|nM|118|nM
3UDR|1.95|2012|09F|compound 14|P56817|BETA-SECRETASE 1|4.96|IC=11uM|IC50|=|11|uM|11000|nM
3UNJ|1.90|2012|0BX|complex CDK2 with compound 1|P24941|CYCLIN-DEPENDENT KINASE 2|4.96|IC=11uM|IC50|=|11|uM|11000|nM
4A9I|2.25|2012|P9I|compound 4; IC50(fluorescence anisotropy assay); IC50=2.0uM(TR-FRET)|P25440|BROMODOMAIN-CONTAINING PROTEIN 2|4.9|IC=12.6uM|IC50|=|12.6|uM|12600|nM
4GTS|2.45|2012|7TP|Zn-containing, IC50=12.8+/-8.8nM|Q08602|GERANYLGERANYL TRANSFERASE TYPE-2 SUBUNIT ALPHA|7.89|IC=12.8nM|IC50|=|12.8|nM|12.8|nM
4H1J|2.00|2012|0YH|IC50=1200+/-55nM|Q14289|PROTEIN-TYROSINE KINASE 2 BETA|5.92|IC=1200nM|IC50|=|1200|nM|1200|nM
4GSY|1.71|2012|0Y5||P65249|THYMIDYLATE KINASE|6.92|IC=120nM|IC50|=|120|nM|120|nM
4HN2|1.90|2012|0EJ|IC50=129+/-7nM|O43314|INOSITOL HEXAKISPHOSPHATE AND DIPHOSPHOINOSITOL|6.89|IC=129nM|IC50|=|129|nM|129|nM
3U4I|2.12|2012|CVR|ligand is cADPcR ;IC50=129+/-12uM|P28907|ADP-RIBOSYL CYCLASE 1|3.89|IC=129uM|IC50|=|129|uM|129000|nM
3Q92|2.80|2012|XNB|ligand is compound 8; IC50=12+/-6nM|P50053-2KETOHEXOKINASE||7.92|IC=12nM|IC50|=|12|nM|12|nM
3RAH|1.75|2012|O1Z|ligand is compound 28|P24941|CYCLIN-DEPENDENT KINASE 2|7.92|IC=12nM|IC50|=|12|nM|12|nM
4AEL|2.20|2012|4HN|compound 5|Q9Y233|CGMP 3',5'-CYCLIC PHOSPHODIESTERASE|7.92|IC=12nM|IC50|=|12|nM|12|nM
4G55|1.69|2012|VH2|Fragment: N TERMINAL DOMAIN, RESIDUES 1-364|Q00610|CLATHRIN HEAVY CHAIN 1|4.92|IC=12uM|IC50|=|12|uM|12000|nM
3AZB|2.60|2012|KM1|ligand is NAS91-11|Q965D7|BETA-HYDROXYACYL-ACP DEHYDRATASE|4.92|IC=12uM|IC50|=|12|uM|12000|nM
3NTP|1.76|2012|RZD|ligand is inhibitor 2; IC50=12+/-2uM|Q13526|PEPTIDYL-PROLYL CIS-TRANS ISOMERASE NIMA-INTERACTIN|4.92|IC=12uM|IC50|=|12|uM|12000|nM
3S00|1.80|2012|Z60|ligand is compound 5|P24941|CYCLIN-DEPENDENT KINASE 2|4.92|IC=12uM|IC50|=|12|uM|12000|nM
3VSW|3.00|2012|R31|compound rac-7; IC50(human); IC50=2800nM(Monkey plasma)|P00797|RENIN|6.89|IC=130nM|IC50|=|130|nM|130|nM
3TI1|1.99|2012|B49|ligand is compound 1; IC50=130+/-17uM|P24941|CYCLIN-DEPENDENT KINASE 2|3.89|IC=130uM|IC50|=|130|uM|130000|nM
4FGZ|1.99|2012|CQA|IC50=1350+/-43uM|Q6T755|PHOSPHOETHANOLAMINE N-METHYLTRANSFERASE|2.87|IC=1350uM|IC50|=|1350|uM|1350000|nM
4AJW|2.80|2012|VWN|complex PI3K delta and cmp 8|O35904|PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE|5.86|IC=1395nM|IC50|=|1395|nM|1395|nM
2YM8|2.07|2012|YM8|ligand is compound (R)-3; IC50=13+/-1.3nM|O14757|SERINE/THREONINE-PROTEIN KINASE CHK1|7.89|IC=13nM|IC50|=|13|nM|13|nM
3UZP|1.94|2012|0CK|ligand is compound PF670462|P48730|CASEIN KINASE I ISOFORM DELTA|7.89|IC=13nM|IC50|=|13|nM|13|nM
3V04|2.70|2012|V04|compound 1|Q02750|DUAL SPECIFICITY MITOGEN-ACTIVATED PROTEIN KINASE K|7.89|IC=13nM|IC50|=|13|nM|13|nM
4EG4|3.15|2012|0OT||Q38C91|METHIONYL-TRNA SYNTHETASE|7.89|IC=13nM|IC50|=|13|nM|13|nM
4EHR|2.09|2012|0Q5||Q07817|BCL-2-LIKE PROTEIN 1|7.89|IC=13nM|IC50|=|13|nM|13|nM
3TWJ|2.90|2012|07R|ligand is RKI-1447|Q13464|RHO-ASSOCIATED PROTEIN KINASE 1|7.84|IC=14.5nM|IC50|=|14.5|nM|14.5|nM
4D9P|2.26|2012|Z17|X-ray((R)-compound 17), IC50((RS)-compound 17)|C3P9L8|DIHYDROPTEROATE SYNTHASE|3.84|IC=145uM|IC50|=|145|uM|145000|nM
3RIL|2.40|2012|3RK|ligand is compound 1; IC50=146+/-7uM|P04062|GLUCOSYLCERAMIDASE|3.84|IC=146uM|IC50|=|146|uM|146000|nM
4EDY|1.72|2012|9PQ||O60760|HEMATOPOIETIC PROSTAGLANDIN D SYNTHASE|5.83|IC=1480nM|IC50|=|1480|nM|1480|nM
3UA8|1.90|2012|08W|compound 21; IC50=14+/-2nM. [3H]-CNQX binding affinitya for ligands, AMPA. Maybe wrong data|P42262|GLUTAMATE RECEPTOR 2|7.85|IC=14nM|IC50|=|14|nM|14|nM
3VW6|2.40|2012|IM6|compound 10|Q99683|MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 5|7.85|IC=14nM|IC50|=|14|nM|14|nM
4AVU|2.40|2012|LDR|ligand is compound 16|Q9H2K2|TANKYRASE-2|7.85|IC=14nM|IC50|=|14|nM|14|nM
4DFW|1.55|2012|7-mer|Cl-containing, IC50=0.014+/-0.001uM|P53350|SERINE/THREONINE-PROTEIN KINASE PLK1|7.85|IC=14nM|IC50|=|14|nM|14|nM
4FS3|1.80|2012|0WE|different ligand structure(double bond)|Q6GI75|ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTASE [NADPH] FABI|7.85|IC=14nM|IC50|=|14|nM|14|nM
4E5F|2.39|2012|0N7|Mn-containing, IC50(in vitro transcription assay)|Q5EP34|POLYMERASE PROTEIN PA|4.82|IC=15.0uM|IC50|=|15|uM|15000|nM
3VF8|2.08|2012|0JE|compound 2|P43405|TYROSINE-PROTEIN KINASE SYK|6.82|IC=150nM|IC50|=|150|nM|150|nM
3SGT|1.85|2012|P09|ligand is compound 8; a continuous spectrophotometric assay|P60473|UNDECAPRENYL PYROPHOSPHATE SYNTHASE|3.82|IC=150uM|IC50|=|150|uM|150000|nM
4EGI|1.79|2012|B2J|IC50 = 150 +/- 37 uM; incomplete ligand structure|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|3.82|IC=150uM|IC50|=|150|uM|150000|nM
4EH4|2.50|2012|0OL|IC50=1534+/-128uM; another ligand is IRG|Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|2.81|IC=1534uM|IC50|=|1534|uM|1534000|nM
3VV6|2.05|2012|B00|compound 6|P56817|BETA-SECRETASE 1|3.8|IC=157uM|IC50|=|157|uM|157000|nM
3UPH|2.00|2012|0C1|compound 26|O92972|RNA-DIRECTED RNA POLYMERASE|7.82|IC=15nM|IC50|=|15|nM|15|nM
3QQK|1.86|2012|X02|ligand is compound 1|P24941|CYCLIN-DEPENDENT KINASE 2|4.82|IC=15uM|IC50|=|15|uM|15000|nM
3UNK|2.10|2012|0BY|complex CDK2 with compound 7|P24941|CYCLIN-DEPENDENT KINASE 2|4.82|IC=15uM|IC50|=|15|uM|15000|nM
4HUP|1.70|2012|19M||P02879|RICIN|4.82|IC=15uM|IC50|=|15|uM|15000|nM
4DH6|2.50|2012|0KN|iodide-containing|P56817|BETA-SECRETASE 1|7.77|IC=16.8nM|IC50|=|16.8|nM|16.8|nM
3SDK|2.70|2012|P3N|ligand is compound34; there is an error in PDB's ligand structrue|P23639|PROTEASOME COMPONENT Y7|6.8|IC=160nM|IC50|=|160|nM|160|nM
3RWJ|2.70|2012|8-mer|ligand is Vif HW8 peptide from Virion infectivity factor|Q9GJ77|MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I|7.8|IC=16nM|IC50|=|16|nM|16|nM
3S3I|1.80|2012|CQ0|ligand is compound 1;IC50=16+/-7.2nM|Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|7.8|IC=16nM|IC50|=|16|nM|16|nM
4A9R|2.85|2012|RU5|compound 30; IC50=16+/-6.9nM|O96017|SERINE/THREONINE-PROTEIN KINASE CHK2|7.8|IC=16nM|IC50|=|16|nM|16|nM
4AA5|2.38|2012|NQB|compound 33|Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|7.8|IC=16nM|IC50|=|16|nM|16|nM
3VV8|2.50|2012|B02|compound 36|P56817|BETA-SECRETASE 1|4.77|IC=17.1uM|IC50|=|17.1|uM|17100|nM
3VI2|2.10|2012|HMZ|ligand is HMOA|Q8T6J6|OROTIDINE 5'-PHOSPHATE DECARBOXYLASE|3.77|IC=170uM|IC50|=|170|uM|170000|nM
4HLC|1.55|2012|T05||Q6GJI9|THYMIDYLATE KINASE|6.76|IC=174nM|IC50|=|174|nM|174|nM
3S1H|1.75|2012|56Z|ligand is compound 66|P24941|CYCLIN-DEPENDENT KINASE 2|4.77|IC=17uM|IC50|=|17|uM|17000|nM
3TIY|1.84|2012|TIY|ligand is compound 2; IC50=17+/-13.uM|P24941|CYCLIN-DEPENDENT KINASE 2|4.77|IC=17uM|IC50|=|17|uM|17000|nM
3VBX|2.03|2012|0FO|compound 2c|P11309|SERINE/THREONINE-PROTEIN KINASE PIM-1|4.77|IC=17uM|IC50|=|17|uM|17000|nM
3ZTX|1.95|2012|ZTX|complex Aurora B/INCENP and cmp 1, IC50 is not 5.6nM|Q6DE08|SERINE/THREONINE-PROTEIN KINASE 12-A|7.74|IC=18.4nM|IC50|=|18.4|nM|18.4|nM
3VP4|2.45|2012|BP9|inhibitor 4, IC50=18.6+/-2.30uM|O94925|GLUTAMINASE KIDNEY ISOFORM, MITOCHONDRIAL|4.73|IC=18.6uM|IC50|=|18.6|uM|18600|nM
4ANX|2.73|2012|534|compound 4; Bradford assay|P48736|PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE|7.74|IC=18nM|IC50|=|18|nM|18|nM
4ANW|2.31|2012|O92|compound 31; Bradford assay|P48736|PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE|7.74|IC=18nM|IC50|=|18|nM|18|nM
4AZY|1.79|2012|7F3|compound 10|P56817|BETA-SECRETASE 1|6.7|IC=198nM|IC50|=|198|nM|198|nM
4FZG|3.00|2012|4-mer|covalent complex, ligand is Glidobactin|P23639|PROTEASOME COMPONENT Y7|7.72|IC=19nM|IC50|=|19|nM|19|nM
3TKM|1.95|2012|GW0|ligand is compound GW0742|Q03181|PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR DELTA|9.0|IC=1nM|IC50|=|1|nM|1|nM
4DEI|2.05|2012|0JL||P08581|HEPATOCYTE GROWTH FACTOR RECEPTOR|9.0|IC=1nM|IC50|=|1|nM|1|nM
3S9I|1.90|2012|XI7|ligand is PDKA; Mg-containing|P0A5J4|MALATE SYNTHASE G|5.7|IC=2.0uM|IC50|=|2|uM|2000|nM
3UDY|2.00|2012|09G|compound 11|P56817|BETA-SECRETASE 1|5.7|IC=2.0uM|IC50|=|2|uM|2000|nM
4B13|1.58|2012|X25|complex PvNMT-NHM-25; IC50(fluorescent-activity cell sorting (FACS) assay)|A5K1A2|GLYCYLPEPTIDE N-TETRADECANOYLTRANSFERASE|5.7|IC=2.0uM|IC50|=|2|uM|2000|nM
3VI5|2.00|2012|M4M|compound APAS; IC50=2.1+/-0.31uM(without CA); IC50=3.2+/-0.27uM(with CA)|O60760|HEMATOPOIETIC PROSTAGLANDIN D SYNTHASE|5.68|IC=2.1uM|IC50|=|2.1|uM|2100|nM
3S68|1.85|2012|TCW|ligand is compound 1, Tolcapone. Inhibition of Rat Brain COMT|P22734|CATECHOL O-METHYLTRANSFERASE|8.66|IC=2.2nM|IC50|=|2.2|nM|2.2|nM
3VNT|1.64|2012|0JA|compound 6d; IC50=2.0-2.4nM|P35968|VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2|8.66|IC=2.2nM|IC50|=|2.2|nM|2.2|nM
4BBF|2.00|2012|O19||O60674|TYROSINE-PROTEIN KINASE JAK2|8.66|IC=2.2nM|IC50|=|2.2|nM|2.2|nM
3SH0|1.84|2012|SAX|ligand is compound 11; a continuous spectrophotometric assay|P60472|UNDECAPRENYL PYROPHOSPHATE SYNTHASE|5.66|IC=2.2uM|IC50|=|2.2|uM|2200|nM
4EE0|1.75|2012|0O4||O60760|HEMATOPOIETIC PROSTAGLANDIN D SYNTHASE|8.63|IC=2.34nM|IC50|=|2.34|nM|2.34|nM
3UPY|1.80|2012|FOM|ligand is FSM;IC50=2.39+/-0.62uM|Q2YIM3|OXIDOREDUCTASE|5.62|IC=2.39uM|IC50|=|2.39|uM|2390|nM
4G9C|3.50|2012|0WP|IC50(B-RafV(600E)), X-ray(B-Raf)|P15056|SERINE/THREONINE-PROTEIN KINASE B-RAF|8.64|IC=2.3nM|IC50|=|2.3|nM|2.3|nM
4B11|1.59|2012|7I1|complex PvNMT-NHM-13; IC50(fluorescent-activity cell sorting (FACS) assay)|A5K1A2|GLYCYLPEPTIDE N-TETRADECANOYLTRANSFERASE|5.64|IC=2.3uM|IC50|=|2.3|uM|2300|nM
4DMN|2.45|2012|0L9|IC50 = 2.3+/- 0.1 uM|P12497|HIV-1 INTEGRASE|5.64|IC=2.3uM|IC50|=|2.3|uM|2300|nM
4B00|1.83|2012|I6X|compound R-41|P56817|BETA-SECRETASE 1|8.61|IC=2.44nM|IC50|=|2.44|nM|2.44|nM
4F65|2.26|2012|0S9|pIC50=8.6|P11362|FIBROBLAST GROWTH FACTOR RECEPTOR 1|8.6|IC=2.5nM|IC50|=|2.5|nM|2.5|nM
3VRT|2.40|2012|YS2|compound 3a|P13053|VITAMIN D3 RECEPTOR|8.57|IC=2.7nM|IC50|=|2.7|nM|2.7|nM
4AWF|2.30|2012|XI7|compound DPBA; Ic50=2.7+/-0.3uM|C3W5S0|POLYMERASE PA|5.57|IC=2.7uM|IC50|=|2.7|uM|2700|nM
4FRI|2.30|2012|DWA|IC50=2.85+/-0.17uM|P56817|BETA-SECRETASE 1|5.55|IC=2.85uM|IC50|=|2.85|uM|2850|nM
3RWG|2.10|2012|9-mer|ligand is Nef MW9 peptide from Protein Nef|Q9GJ77|MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I|8.55|IC=2.8nM|IC50|=|2.8|nM|2.8|nM
4FCB|2.10|2012|0T7||Q9Y233|CGMP 3',5'-CYCLIC PHOSPHODIESTERASE|8.54|IC=2.9nM|IC50|=|2.9|nM|2.9|nM
3R8V|1.90|2012|Z62|ligand is compound 2|P24941|CYCLIN-DEPENDENT KINASE 2|5.54|IC=2.9uM|IC50|=|2.9|uM|2900|nM
4HKK|1.95|2012|AGI||Q9H2K2|TANKYRASE-2|5.54|IC=2.9uM|IC50|=|2.9|uM|2900|nM
3UPF|2.60|2012|0BU|complex MNV RdRp and NF023; IC50=200+/-2nM|Q80J95|RNA-DEPENDENT RNA POLYMERASE|6.7|IC=200nM|IC50|=|200|nM|200|nM
4D8I|1.38|2012|5-mer|covalent complex|E0PTS8|STREPTOPAIN|6.69|IC=205nM|IC50|=|205|nM|205|nM
3UXM|1.95|2012|0DN|compound dFTM; IC50=20+/-4uM|Q9HZN8|THYMIDYLATE KINASE|4.7|IC=20uM|IC50|=|20|uM|20000|nM
4HUO|1.52|2012|RS8||P02879|RICIN|4.7|IC=20uM|IC50|=|20|uM|20000|nM
4E5G|2.65|2012|XI7|Mn-containing, IC50(in vitro transcription assay)|Q5EP34|POLYMERASE PROTEIN PA|4.67|IC=21.3uM|IC50|=|21.3|uM|21300|nM
3SZ1|2.30|2012|LU2|ligand is luteolin|P37231|PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA|4.66|IC=21.8uM|IC50|=|21.8|uM|21800|nM
3QA2|2.52|2012|XNA|ligand is compound 3; IC50=210+/-88nM|P50053-2KETOHEXOKINASE||6.68|IC=210nM|IC50|=|210|nM|210|nM
3V1R|2.80|2012|JTH|full-length RNase H; IC50=21-67nM|Q2F7J3|REVERSE TRANSCRIPTASE/RIBONUCLEASE H P80|7.68|IC=21nM|IC50|=|21|nM|21|nM
4ANU|2.81|2012|EM7|compound 2; Bradford assay|P48736|PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE|7.68|IC=21nM|IC50|=|21|nM|21|nM
3QI1|2.30|2012|C6A|ligand is compound 50|P56817|BETA-SECRETASE 1|7.66|IC=22nM|IC50|=|22|nM|22|nM
4HBV|1.63|2012|15E|IC50 measured in AlphaScreen assay|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|4.64|IC=23uM|IC50|=|23|uM|23000|nM
4A9C|2.10|2012|B5F|IC50=24.8+/-3.0uM, BiPh(2, 3', 4, 5', 6)P5 is not a SHIP2 substrate but inhibits Ins(1, 3, 4, 5)P4 hydrolysis|O15357|PHOSPHATIDYLINOSITOL-3,4,5-TRISPHOSPHATE 5-PHOSPHAT|4.61|IC=24.8uM|IC50|=|24.8|uM|24800|nM
4HEJ|2.00|2012|14D|IC50(racemic-16), X-ray((S)-16)|P65249|THYMIDYLATE KINASE|4.62|IC=24000nM|IC50|=|24000|nM|24000|nM
3UDJ|1.80|2012|092|compound 5|P56817|BETA-SECRETASE 1|3.62|IC=242uM|IC50|=|242|uM|242000|nM
3VC4|2.23|2012|0FS|compound 3|P11309|SERINE/THREONINE-PROTEIN KINASE PIM-1|7.62|IC=24nM|IC50|=|24|nM|24|nM
4AVW|2.15|2012|G18|ligand is compound 18|Q9H2K2|TANKYRASE-2|7.62|IC=24nM|IC50|=|24|nM|24|nM
4AWO|1.70|2012|99B|compound 12i|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|7.62|IC=24nM|IC50|=|24|nM|24|nM
4EC4|3.30|2012|0O6|IC50=25.4+/-0.1nM|P98170|BACULOVIRAL IAP REPEAT-CONTAINING PROTEIN 4|7.6|IC=25.4nM|IC50|=|25.4|nM|25.4|nM
4DEA|2.45|2012|NHI|compound 3i; IC50=256+/-38nM|O14965|AURORA KINASE A|6.59|IC=256nM|IC50|=|256|nM|256|nM
3V01|2.71|2012|3V0|compound 3|Q02750|DUAL SPECIFICITY MITOGEN-ACTIVATED PROTEIN KINASE K|7.6|IC=25nM|IC50|=|25|nM|25|nM
4G19|2.00|2012|GSH|IC50 = 261.5 +/- 39.8 uM|I6ZUH3|GLUTATHIONE TRANSFERASE GTE1|3.58|IC=261.5uM|IC50|=|261.5|uM|261500|nM
3SD5|3.20|2012|SD5|Filter binding assay; IC50=262+/-94 nM|P48736|PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE|6.58|IC=262nM|IC50|=|262|nM|262|nM
4HKP|1.75|2012|16B|IC50=28.3+/-1.5uM|P11172|URIDINE 5'-MONOPHOSPHATE SYNTHASE|4.55|IC=28.3uM|IC50|=|28.3|uM|28300|nM
4ANM|1.70|2012|WUL|compound 3|P28523|CASEIN KINASE II, ALPHA SUBUNIT|7.55|IC=28nM|IC50|=|28|nM|28|nM
4DEM|1.85|2012|YS4|Mg-containing, IC50(without preincubation)=1390nM, IC50(with 10 min of preincubation)=28nM|P14324|FARNESYL PYROPHOSPHATE SYNTHASE|7.55|IC=28nM|IC50|=|28|nM|28|nM
4DHF|2.80|2012|0K6|Mg-containing|O14965|AURORA KINASE A|7.55|IC=28nM|IC50|=|28|nM|28|nM
4H5D|2.02|2012|YS4|ligand is compound 13k|P14324|FARNESYL PYROPHOSPHATE SYNTHASE|7.55|IC=28nM|IC50|=|28|nM|28|nM
4H5C|2.02|2012|YS4|ligand is compound 13k, YS0470. Time-Dependent Inhibition IC50 initial 1390 nM to final 28 nM|P14324|FARNESYL PYROPHOSPHATE SYNTHASE|7.55|IC=28nM|IC50|=|28|nM|28|nM
3VBY|2.27|2012|0FR|compound 2d|P11309|SERINE/THREONINE-PROTEIN KINASE PIM-1|4.55|IC=28uM|IC50|=|28|uM|28000|nM
4EH3|2.40|2012|NAR|IC50=292+/-54uM; another ligand is IRG|Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|3.53|IC=292uM|IC50|=|292|uM|292000|nM
3AVF|1.70|2012|8-mer|ligand is peptide 10; IC50=295.0+/-95.9uM|P12497|INTEGRASE|3.53|IC=295.0uM|IC50|=|295|uM|295000|nM
4D8C|2.07|2012|BXD|ligand is compound 60n|P56817|BETA-SECRETASE 1|8.7|IC=2nM|IC50|=|2|nM|2|nM
4AA7|2.00|2012|R82|compound 1; IC50=2uM(Ecoli); IC50=8uM(H.in.); IC50>200uM(S.pn.); IC50>200uM(S.au.)|P0ACC7|BIFUNCTIONAL PROTEIN GLMU|5.7|IC=2uM|IC50|=|2|uM|2000|nM
4H4M|2.85|2012|494||P03366|HIV-1 REVERSE TRANSCRIPTASE/RIBONUCLEASE H|8.52|IC=3.0nM|IC50|=|3|nM|3|nM
4H2O|2.14|2012|0YW|ligand is compound 12; a continuous spectrophotometric assay|P60472|UNDECAPRENYL PYROPHOSPHATE SYNTHASE|5.52|IC=3.0uM|IC50|=|3|uM|3000|nM
3UOL|2.40|2012|0C7|compound 11|O14965|AURORA KINASE A|8.51|IC=3.1nM|IC50|=|3.1|nM|3.1|nM
3QTQ|1.80|2012|X35|ligand is compound 3|P24941|CYCLIN-DEPENDENT KINASE 2|5.51|IC=3.1uM|IC50|=|3.1|uM|3100|nM
3QTS|1.90|2012|X46|ligand is compound 34|P24941|CYCLIN-DEPENDENT KINASE 2|5.51|IC=3.1uM|IC50|=|3.1|uM|3100|nM
3SGX|2.45|2012|0FW|ligand is compound 10; a continuous spectrophotometric assay|P60472|UNDECAPRENYL PYROPHOSPHATE SYNTHASE|5.49|IC=3.2uM|IC50|=|3.2|uM|3200|nM
3VP1|2.30|2012|04A|ligand is compound 3|O94925|GLUTAMINASE KIDNEY ISOFORM, MITOCHONDRIAL|5.48|IC=3.3uM|IC50|=|3.3|uM|3300|nM
3RIK|2.48|2012|3RI|ligand is compound 2; IC50=3.4+/-0.2mM|P04062|GLUCOSYLCERAMIDASE|2.47|IC=3.4mM|IC50|=|3.4|mM|3400000|nM
3T3Y|2.00|2012|MD6|ligand is compound 22; Fe-containing|P05050|ALPHA-KETOGLUTARATE-DEPENDENT DIOXYGENASE ALKB|5.47|IC=3.4uM|IC50|=|3.4|uM|3400|nM
4FLI|1.55|2012|Y16|Mn-containing|P53582|METHIONINE AMINOPEPTIDASE 1|5.44|IC=3.59uM|IC50|=|3.59|uM|3590|nM
3UHM|1.26|2012|RFN|compound 2a; IC50=3.6+/-0.8nM|P47205|UDP-3-O-[3-HYDROXYMYRISTOYL] N-ACETYLGLUCOSAMINE DEACETYLASE|8.44|IC=3.6nM|IC50|=|3.6|nM|3.6|nM
4BBE|1.90|2012|3O4||O60674|TYROSINE-PROTEIN KINASE JAK2|8.44|IC=3.6nM|IC50|=|3.6|nM|3.6|nM
4DRP|1.80|2012|0MD|IC50=3.9+/-0.6uM,|Q13451|PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5|5.41|IC=3.9uM|IC50|=|3.9|uM|3900|nM
4DRO|1.10|2012|0MD|IC50=3.9+/-0.6uM, incomplete ligand structure|Q13451|PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5|5.41|IC=3.9uM|IC50|=|3.9|uM|3900|nM
3R0W|1.70|2012|RSY|ligand is compound 2; IC50=30.3+/-1.97uM|Q000H7|MDR 769 HIV-1 PROTEASE|4.52|IC=30.0uM|IC50|=|30|uM|30000|nM
3QW6|1.60|2012|5-mer|ligand is peptide RYGC; IC50=300.0+/-3.5uM; Zn-containing|A5HZZ9|BOTULINUM NEUROTOXIN A|3.52|IC=300uM|IC50|=|300|uM|300000|nM
4HV7|1.87|2012|19J||P02879|RICIN|3.52|IC=300uM|IC50|=|300|uM|300000|nM
3RWF|2.60|2012|9-mer|ligand is Nef QW9 peptide from Protein Nef|Q9GJ77|MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I|6.52|IC=305nM|IC50|=|305|nM|305|nM
3TV7|2.75|2012|07Q|ligand is compound (R)-14f; IC50=30+/-22nM|Q13464|RHO-ASSOCIATED PROTEIN KINASE 1|7.52|IC=30nM|IC50|=|30|nM|30|nM
3T0L|1.60|2012|1CT|ligand is compound A1|P31947|14-3-3 PROTEIN SIGMA|4.52|IC=30uM|IC50|=|30|uM|30000|nM
4AF3|2.75|2012|VX6|complex Aurora B and inhibitor 1; IC50(Human); IC50=19nM(X.laevis)|Q96GD4|AURORA KINASE B|7.51|IC=31nM|IC50|=|31|nM|31|nM
4HNI|2.74|2012|16W||P49674|CASEIN KINASE I ISOFORM EPSILON|7.49|IC=32nM|IC50|=|32|nM|32|nM
3UDK|2.51|2012|095|compound 6|P56817|BETA-SECRETASE 1|4.49|IC=32uM|IC50|=|32|uM|32000|nM
3VBG|2.80|2012|03M|complex MDM2 and RO-2443|Q00987|E3 UBIQUITIN-PROTEIN LIGASE MDM2|7.48|IC=33nM|IC50|=|33|nM|33|nM
3S0O|2.00|2012|50Z|ligand is compound 6|P24941|CYCLIN-DEPENDENT KINASE 2|4.48|IC=33uM|IC50|=|33|uM|33000|nM
3UDM|1.94|2012|09A|compound 8|P56817|BETA-SECRETASE 1|4.48|IC=33uM|IC50|=|33|uM|33000|nM
4EH6|2.10|2012|0ON|IC50=3471+/-796uM; another ligand is IRG|Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|2.46|IC=3471uM|IC50|=|3471|uM|3471000|nM
4H71|1.93|2012|PXE|IC50 (Incubation time is 4 min) come from the supporting information|P53350|SERINE/THREONINE-PROTEIN KINASE PLK1|4.45|IC=35.57uM|IC50|=|35.57|uM|35570|nM
4AA0|1.80|2012|AA0|compound 2|Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|7.46|IC=35nM|IC50|=|35|nM|35|nM
4FHH|2.33|2012|0U3||Q9PTN2|VITAMIN D3 RECEPTOR A|7.46|IC=35nM|IC50|=|35|nM|35|nM
3SGV|1.61|2012|2BJ|ligand is comound 9; a continuous spectrophotometric assay|P60472|UNDECAPRENYL PYROPHOSPHATE SYNTHASE|4.46|IC=35uM|IC50|=|35|uM|35000|nM
4DEB|3.05|2012|NHJ|compound 13|O14965|AURORA KINASE A|6.43|IC=371nM|IC50|=|371|nM|371|nM
4D8A|2.18|2012|0HY|X-ray((R)-compound 21), IC50((RS)-compound 21)|C3P9L8|DIHYDROPTEROATE SYNTHASE|3.42|IC=376uM|IC50|=|376|uM|376000|nM
3VQU|2.40|2012|O22|compound 9|P33981|DUAL SPECIFICITY PROTEIN KINASE TTK|7.43|IC=37nM|IC50|=|37|nM|37|nM
4AQ3|2.40|2012|398|complex Bcl-2 and cmp 18; IC50=47nM(complex Bcl-xl and cmp 18)|P10415|APOPTOSIS REGULATOR BCL-2|7.43|IC=37nM|IC50|=|37|nM|37|nM
3VBT|2.23|2012|0F9|compound 2e|P11309|SERINE/THREONINE-PROTEIN KINASE PIM-1|4.43|IC=37uM|IC50|=|37|uM|37000|nM
4DED|3.05|2012|NHU|compound 3g; IC50=38.2+/-8.8nM|O14965|AURORA KINASE A|7.42|IC=38.2nM|IC50|=|38.2|nM|38.2|nM
4FPF|2.23|2012|JKK|IC50=38.9+/-0.8uM|Q54727|SIALIDASE B|4.41|IC=38.9uM|IC50|=|38.9|uM|38900|nM
4GTV|1.95|2012|7TR|IC50=38+/-7nM (fluorometric assay), IC50=123+/-22nM (radiometric assay), Zn-containing|Q08602|GERANYLGERANYL TRANSFERASE TYPE-2 SUBUNIT ALPHA|7.42|IC=38nM|IC50|=|38|nM|38|nM
3AVA|1.70|2012|8-mer|ligand is peptide 4; IC50=39.7+/-7.1uM|P12497|INTEGRASE|4.4|IC=39.7uM|IC50|=|39.7|uM|39700|nM
4AFJ|1.98|2012|SJJ|compound 11, pIC50=6.4|P49841|GLYCOGEN SYNTHASE KINASE-3 BETA|6.4|IC=398nM|IC50|=|398|nM|398|nM
3VB6|2.50|2012|7-mer|covalent bond; IC50=39+/-1uM|P0C6U8|3C-LIKE PROTEINASE|4.41|IC=39uM|IC50|=|39|uM|39000|nM
4E3F|1.50|2012|GRE|IC50=3+/-1mM (a standard esterase activity assay)|P00918|CARBONIC ANHYDRASE 2|2.52|IC=3mM|IC50|=|3|mM|3000000|nM
3UMW|2.08|2012|596|compound 14|P11309|SERINE/THREONINE-PROTEIN KINASE PIM|8.52|IC=3nM|IC50|=|3|nM|3|nM
4FOC|1.70|2012|0UU|IC50=0.003+/-0.001uM|Q9UM73|ALK TYROSINE KINASE RECEPTOR|8.52|IC=3nM|IC50|=|3|nM|3|nM
3RK5|2.00|2012|07Z|ligand is compound 48|P24941|CYCLIN-DEPENDENT KINASE 2|5.4|IC=4.0uM|IC50|=|4|uM|4000|nM
3VJT|2.00|2012|10R|compound R10|P13053|VITAMIN D3 RECEPTOR|5.39|IC=4.1uM|IC50|=|4.1|uM|4100|nM
4ERE|1.80|2012|0R2|IC50=4.2+/-0.9nM(human serum free)|Q00987|E3 UBIQUITIN-PROTEIN LIGASE MDM2|8.38|IC=4.2nM|IC50|=|4.2|nM|4.2|nM
4EBV|1.67|2012|0O7|IC50=3.8-4.6 uM|Q05397|FOCAL ADHESION KINASE 1|5.38|IC=4.2uM|IC50|=|4.2|uM|4200|nM
4EL9|1.55|2012|AFE|ligand is afzelin|P18654|RIBOSOMAL PROTEIN S6 KINASE ALPHA-3|5.36|IC=4.37uM|IC50|=|4.37|uM|4370|nM
4HBY|1.59|2012|13F|IC50 measured in AlphaScreen assay|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|5.36|IC=4.4uM|IC50|=|4.4|uM|4400|nM
3V3V|2.70|2012|MYU||P45983|MITOGEN-ACTIVATED PROTEIN KINASE 8|5.34|IC=4.6uM|IC50|=|4.6|uM|4600|nM
3VB5|1.95|2012|5-mer|covalent bond; IC50=4.6+/-0.2uM|P0C6U8|3C-LIKE PROTEINASE|5.34|IC=4.6uM|IC50|=|4.6|uM|4600|nM
3VV7|2.10|2012|0B1|compound 33|P56817|BETA-SECRETASE 1|5.34|IC=4.6uM|IC50|=|4.6|uM|4600|nM
3SDI|2.65|2012|3SD|ligand is compound20; X-ray(Saccharomyces cerevisiae S288c), IC50(human)|P23639|PROTEASOME COMPONENT Y7|8.33|IC=4.7nM|IC50|=|4.7|nM|4.7|nM
4B3U|1.80|2012|NWL|compound 12b; IC50=4.7+/-4.0uM|Q9HU22|GLUCOSE-1-PHOSPHATE THYMIDYLYLTRANSFERASE|5.33|IC=4.7uM|IC50|=|4.7|uM|4700|nM
3RPY|1.90|2012|27Z|ligand is compound 61|P24941|CYCLIN-DEPENDENT KINASE 2|5.32|IC=4.8uM|IC50|=|4.8|uM|4800|nM
3SQQ|1.85|2012|99Z|ligand is compound 62|P24941|CYCLIN-DEPENDENT KINASE 2|5.32|IC=4.8uM|IC50|=|4.8|uM|4800|nM
4H2J|1.81|2012|0YU|ligand is compound 16; a continuous spectrophotometric assay|P60472|UNDECAPRENYL PYROPHOSPHATE SYNTHASE|5.32|IC=4.8uM|IC50|=|4.8|uM|4800|nM
4HBW|1.69|2012|14Z|IC50 measured in AlphaScreen assay|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|5.32|IC=4.8uM|IC50|=|4.8|uM|4800|nM
4DDL|2.07|2012|0JQ|Zn-containing|Q9Y233|CGMP 3',5'-CYCLIC PHOSPHODIESTERASE|8.31|IC=4.9nM|IC50|=|4.9|nM|4.9|nM
3VI7|2.00|2012|CBD|compound Cibacron Blue; IC50=40.4+/-2.6nM(without CA); IC50=150+/-11nM(with CA)|O60760|HEMATOPOIETIC PROSTAGLANDIN D SYNTHASE|7.39|IC=40.4nM|IC50|=|40.4|nM|40.4|nM
4ACU|1.75|2012|QN7|compound 14, pIC50=7.39|P56817|BETA-SECRETASE 1|7.39|IC=40.7nM|IC50|=|40.7|nM|40.7|nM
4DPF|1.80|2012|0LG||P56817|BETA-SECRETASE 1|6.4|IC=400nM|IC50|=|400|nM|400|nM
3VYD|2.81|2012|VYD|compound 6; IC50(human); IC50>1000nM(monkey plasma)|P00797|RENIN|6.39|IC=406nM|IC50|=|406|nM|406|nM
3RWH|2.60|2012|8-mer|ligand is Pol MF8 peptide from Pol protein|Q9GJ77|MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I|7.4|IC=40nM|IC50|=|40|nM|40|nM
3V4V|3.10|2012|0DU|ligand is compound 28, a4b7 RPMI cells/MadCAM IC50 nM|P13612|INTEGRIN ALPHA-4|7.38|IC=42nM|IC50|=|42|nM|42|nM
3AV9|1.70|2012|8-mer|ligand is peptide 12; IC50=435+/-91.9uM|P12497|INTEGRASE|3.36|IC=435uM|IC50|=|435|uM|435000|nM
3RWE|2.40|2012|9-mer|ligand is Pol FW9 peptide from Pol protei|Q9GJ77|MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I|7.37|IC=43nM|IC50|=|43|nM|43|nM
4EG6|2.90|2012|0P5||Q38C91|METHIONYL-TRNA SYNTHETASE|7.37|IC=43nM|IC50|=|43|nM|43|nM
4ANV|2.13|2012|751|compound 1; Bradford assay|P48736|PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE|6.36|IC=441nM|IC50|=|441|nM|441|nM
4AN9|2.80|2012|2P7|compound 7|Q02750|MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1 (MERK 1)|7.36|IC=44nM|IC50|=|44|nM|44|nM
4EWO|1.80|2012|996|IC50(Protein binding in mouse serum, free unbound = 10%), IC50((S):(R)=79:21 at the C4 of the bicyclic ring), X-ray((S)-configuration at the C4 of the bicyclic ring)|P56817|BETA-SECRETASE 1|7.36|IC=44nM|IC50|=|44|nM|44|nM
4EZ3|2.00|2012|0S0|ligand is compound 4; IC50=45+/-8.3uM|P24941|CYCLIN-DEPENDENT KINASE 2|4.35|IC=45uM|IC50|=|45|uM|45000|nM
4EEH|1.60|2012|HH6||P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|4.35|IC=45uM|IC50|=|45|uM|45000|nM
4EG7|2.75|2012|0P4||Q38C91|METHIONYL-TRNA SYNTHETASE|7.34|IC=46nM|IC50|=|46|nM|46|nM
4HCO|2.75|2012|IMW|IC50 (Incubation time is 6 min) come from the supporting information|P53350|SERINE/THREONINE-PROTEIN KINASE PLK1|4.32|IC=47.38uM|IC50|=|47.38|uM|47380|nM
3VBQ|1.85|2012|0F5|compound 6|P11309|SERINE/THREONINE-PROTEIN KINASE PIM-1|9.33|IC=470pM|IC50|=|470|pM|0.47000000000000003|nM
4AWQ|1.60|2012|592|compound 1|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|6.32|IC=479nM|IC50|=|479|nM|479|nM
3TKH|1.79|2012|07S|ligand is compound 1|O14757|SERINE/THREONINE-PROTEIN KINASE CHK1|7.33|IC=47nM|IC50|=|47|nM|47|nM
3UQP|1.77|2012|8-mer|compound 11|P56817|BETA-SECRETASE 1|7.31|IC=48.8nM|IC50|=|48.8|nM|48.8|nM
3R8Z|1.85|2012|Z63|ligand is compound 10|P24941|CYCLIN-DEPENDENT KINASE 2|4.31|IC=49uM|IC50|=|49|uM|49000|nM
3VB4|2.20|2012|5-mer|covalent bond; IC50=49+/-2uM|P0C6U8|3C-LIKE PROTEINASE|4.31|IC=49uM|IC50|=|49|uM|49000|nM
3VB7|1.95|2012|5-mer|covalent bond; IC50=49+/-2uM|P0C6U8|3C-LIKE PROTEINASE|4.31|IC=49uM|IC50|=|49|uM|49000|nM
3S4Q|2.27|2012|NK0|ligand is compound 24|Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|8.4|IC=4nM|IC50|=|4|nM|4|nM
4FZC|2.80|2012|4-mer|covalent complex; ligand is Cepafungin I|P23639|PROTEASOME COMPONENT Y7|8.4|IC=4nM|IC50|=|4|nM|4|nM
4DUS|2.50|2012|0MP|IC50=5.0+/-3.0nM, Compound 16 is mixture of diastereomers (1:1, 2S, 3R and 2R, 3S)|P56817|BETA-SECRETASE 1|8.3|IC=5.0nM|IC50|=|5|nM|5|nM
4FLL|1.50|2012|YZ6|Mn-containing|P53582|METHIONINE AMINOPEPTIDASE 1|5.29|IC=5.14uM|IC50|=|5.14|uM|5140|nM
3T4H|1.65|2012|MD5|ligand is compound 15; Fe-containing|P05050|ALPHA-KETOGLUTARATE-DEPENDENT DIOXYGENASE ALKB|5.28|IC=5.2uM|IC50|=|5.2|uM|5200|nM
4EB9|2.60|2012|0O6|IC50=5.4+/-0.1nM|Q13490|BACULOVIRAL IAP REPEAT-CONTAINING PROTEIN 2|8.27|IC=5.4nM|IC50|=|5.4|nM|5.4|nM
4FLK|1.47|2012|Y10|Mn-containing|P53582|METHIONINE AMINOPEPTIDASE 1|5.25|IC=5.58uM|IC50|=|5.58|uM|5580|nM
4DI2|2.00|2012|0K9||P56817|BETA-SECRETASE 1|8.26|IC=5.5nM|IC50|=|5.5|nM|5.5|nM
3SB0|2.20|2012|I93|ligand is compound 11; Mg-containing|P0A5J4|MALATE SYNTHASE G|5.26|IC=5.5uM|IC50|=|5.5|uM|5500|nM
3VJL|2.39|2012|W94|compound 9b; IC50(Human); IC50=2.5nM(Rat)|P27487|DIPEPTIDYL PEPTIDASE 4|8.25|IC=5.6nM|IC50|=|5.6|nM|5.6|nM
3RJC|1.85|2012|06Z|ligand is compound 19|P24941|CYCLIN-DEPENDENT KINASE 2|5.24|IC=5.7uM|IC50|=|5.7|uM|5700|nM
4DRM|1.48|2012|0MC|IC50=5.8+/-0.6uM|Q13451|PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5|5.24|IC=5.8uM|IC50|=|5.8|uM|5800|nM
4DRN|1.07|2012|0MC|IC50=5.8+/-0.6uM|Q13451|PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5|5.24|IC=5.8uM|IC50|=|5.8|uM|5800|nM
3QBN|3.50|2012|E9Z|ligand is compound 1; IC50=5.9+/-1.4nM; X-ray(Homo sapiens), IC50(U. maydis)|O14965|SERINE/THREONINE-PROTEIN KINASE 6|8.23|IC=5.9nM|IC50|=|5.9|nM|5.9|nM
4EHV|1.60|2012|0SJ|IC50=5103+/-544uM; another ligand is IRG|Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|2.29|IC=5103uM|IC50|=|5103|uM|5103000|nM
4EH7|2.10|2012|0OO|IC50=520+/-192uM; another ligand is IRG|Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|3.28|IC=520uM|IC50|=|520|uM|520000|nM
4B95|2.80|2012|UCK|IC50=52+/-2uM|Q15370|TRANSCRIPTION ELONGATION FACTOR B POLYPEPTIDE 2|4.28|IC=52uM|IC50|=|52|uM|52000|nM
4H36|3.00|2012|8-mer|ligand is pepATF2; IC50=53.4+/-5uM(Protein Substrate: His-SAB (1 C390)), IC50=136.9+/-41uM (Protein Substrate: FLAG-ATF2 (2 C115))|P53779|MITOGEN-ACTIVATED PROTEIN KINASE 10|4.27|IC=53.4uM|IC50|=|53.4|uM|53400|nM
4GB9|2.44|2012|0WR|ligand is compound 14|P48736|PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE|6.27|IC=540nM|IC50|=|540|nM|540|nM
4EH9|2.10|2012|0OQ|IC50=5453+/-513uM; another ligand is IRG|Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|2.26|IC=5453uM|IC50|=|5453|uM|5453000|nM
4EGH|1.60|2012|0OY|IC50 = 550+/-200 uM; Mg-containing|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|3.26|IC=550uM|IC50|=|550|uM|550000|nM
3VEU|1.52|2012|0GO|compound 3|P56817|BETA-SECRETASE 1|7.26|IC=55nM|IC50|=|55|nM|55|nM
4E1M|1.90|2012|TQ2|IC50 = 55+/-3 nM (Strand transfer);|P12497|HIV-1 INTEGRASE|7.26|IC=55nM|IC50|=|55|nM|55|nM
3TH8|2.11|2012|TH9|ligand is compound 9|P60472|UNDECAPRENYL PYROPHOSPHATE SYNTHASE|6.25|IC=560nM|IC50|=|560|nM|560|nM
3UA9|2.15|2012|IWR|compound 2, IC50 is 56nM, not 56uM|Q9H2K2|TANKYRASE-2|7.25|IC=56nM|IC50|=|56|nM|56|nM
3U4H|1.88|2012|C8R|ligand is 8-amino cIDPR;IC50=56+/-9uM|P28907|ADP-RIBOSYL CYCLASE 1|4.25|IC=56uM|IC50|=|56|uM|56000|nM
3UQR|3.06|2012|7-mer|compound 13|P56817|BETA-SECRETASE 1|7.24|IC=57.2nM|IC50|=|57.2|nM|57.2|nM
4FPK|2.40|2012|IJ1|IC50=57.4+/-6.0uM|Q54727|SIALIDASE B|4.24|IC=57.4uM|IC50|=|57.4|uM|57400|nM
3UWK|1.91|2012|0DF|compound 1; IC50=58+/-11uM|Q9HZN8|THYMIDYLATE KINASE|4.24|IC=58uM|IC50|=|58|uM|58000|nM
4F8H|2.99|2012|RKE||Q7NDN8|PROTON-GATED ION CHANNEL|4.24|IC=58uM|IC50|=|58|uM|58000|nM
4DT6|2.60|2012|6LI|IC50=0.059+/-0.02uM|P06730|EUKARYOTIC TRANSLATION INITIATION FACTOR 4E|7.23|IC=59nM|IC50|=|59|nM|59|nM
4E3D|1.60|2012|GTQ|IC50=5+/-2mM (a standard esterase activity assay)|P00918|CARBONIC ANHYDRASE 2|2.3|IC=5mM|IC50|=|5|mM|5000000|nM
2YDJ|1.85|2012|YDJ|ligand is compound 4|O14757|SERINE/THREONINE-PROTEIN KINASE CHK1|8.3|IC=5nM|IC50|=|5|nM|5|nM
3RVG|2.50|2012|17P|ligand is compound 38|O60674|TYROSINE-PROTEIN KINASE JAK2|8.3|IC=5nM|IC50|=|5|nM|5|nM
3TYQ|1.60|2012|HI4|compound 47; covalent complex|O92972|RNA-DIRECTED RNA POLYMERASE|8.3|IC=5nM|IC50|=|5|nM|5|nM
4EJN|2.19|2012|0R4|IC50 measured in Thermal Shift Assay (TSA)|P31749|RAC-ALPHA SERINE/THREONINE-PROTEIN KINASE|8.3|IC=5nM|IC50|=|5|nM|5|nM
4FOB|1.90|2012|0US|IC50=0.005+/-0.002uM|Q9UM73|ALK TYROSINE KINASE RECEPTOR|8.3|IC=5nM|IC50|=|5|nM|5|nM
4HGS|2.40|2012|15G||Q9Y6M4|CASEIN KINASE I ISOFORM GAMMA-3|8.3|IC=5nM|IC50|=|5|nM|5|nM
3R8U|2.00|2012|Z31|ligand is compound 4|P24941|CYCLIN-DEPENDENT KINASE 2|5.3|IC=5uM|IC50|=|5|uM|5000|nM
3UDP|1.95|2012|09D|compound 12|P56817|BETA-SECRETASE 1|5.22|IC=6.0uM|IC50|=|6|uM|6000|nM
3UP7|3.05|2012|0C9|compound 1; IC50=6.1+/-1.0nM(in vitro); IC50>100uM(in vivo)|O14965|AURORA KINASE A|8.21|IC=6.1nM|IC50|=|6.1|nM|6.1|nM
4H2M|1.78|2012|0YV|ligand is compound 18; a continuous spectrophotometric assay|P60472|UNDECAPRENYL PYROPHOSPHATE SYNTHASE|5.21|IC=6.1uM|IC50|=|6.1|uM|6100|nM
3U6J|2.15|2012|03X|complex VEGFR-2 and cmp 26|P35968|VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2|8.21|IC=6.2nM|IC50|=|6.2|nM|6.2|nM
4ANB|2.20|2012|YQY|compound 8|Q02750|MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1 (MERK 1)|8.18|IC=6.6nM|IC50|=|6.6|nM|6.6|nM
4H3B|2.08|2012|10-mer|ligand is pepSAB; IC50=6.76+/-0.94uM(Protein Substrate: His-SAB (1 C390)), IC50=7.56+/-1.74uM(Protein Substrate: FLAG-ATF2 (2 C115))|P53779|MITOGEN-ACTIVATED PROTEIN KINASE 10|5.17|IC=6.76uM|IC50|=|6.76|uM|6760|nM
4AAC|2.50|2012|AAV|compound 29|Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|8.17|IC=6.7nM|IC50|=|6.7|nM|6.7|nM
3RNI|1.95|2012|21Z|ligand is compound 82|P24941|CYCLIN-DEPENDENT KINASE 2|5.17|IC=6.7uM|IC50|=|6.7|uM|6700|nM
4ASK|1.86|2012|K0I|ligand is GSK-J1; Co2+ containing|O15054|LYSINE-SPECIFIC DEMETHYLASE 6B|7.22|IC=60nM|IC50|=|60|nM|60|nM
4A9U|2.48|2012|A9U|compound 47; IC50=60+/-8nM|O96017|SERINE/THREONINE-PROTEIN KINASE CHK2|7.22|IC=60nM|IC50|=|60|nM|60|nM
4DEH|2.00|2012|0JK||P08581|HEPATOCYTE GROWTH FACTOR RECEPTOR|6.21|IC=612nM|IC50|=|612|nM|612|nM
4A9S|2.66|2012|RU9|compound 19; IC50=61+/-31nM|O96017|SERINE/THREONINE-PROTEIN KINASE CHK2|7.21|IC=61nM|IC50|=|61|nM|61|nM
3VID|2.30|2012|4TT|compound A; phosphorylated VEGFR2; IC50=860nM(phosphorylated VEGFR2)|P35968|VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2|6.21|IC=620nM|IC50|=|620|nM|620|nM
4EYJ|2.10|2012|N61||O15264|MITOGEN-ACTIVATED PROTEIN KINASE 13|6.21|IC=620nM|IC50|=|620|nM|620|nM
4EH8|2.20|2012|0OP|IC50=6247+/-358uM; another ligand is IRG|Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|2.2|IC=6247uM|IC50|=|6247|uM|6247000|nM
4F64|2.05|2012|0S8|pIC50=7.2|P11362|FIBROBLAST GROWTH FACTOR RECEPTOR 1|7.2|IC=63.1nM|IC50|=|63.1|nM|63.1|nM
3AVL|1.88|2012|8-mer|ligand is peptide 6; IC50=65.8+/-31.7uM|P12497|INTEGRASE|4.18|IC=65.8uM|IC50|=|65.8|uM|65800|nM
4EGA|2.70|2012|0P8||Q38C91|METHIONYL-TRNA SYNTHETASE|7.19|IC=65nM|IC50|=|65|nM|65|nM
4E1N|2.00|2012|TQX|IC50 = 67+/-4 nM (Strand transfer);|P12497|HIV-1 INTEGRASE|7.17|IC=67nM|IC50|=|67|nM|67|nM
4AZT|2.34|2012|LY2|compound LY294002|Q47592|METHYLTRANSFERASE WBDD|4.17|IC=68uM|IC50|=|68|uM|68000|nM
4EH2|2.00|2012|0OK|IC50=692+/-252uM; another ligand is IRG|Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|3.16|IC=692uM|IC50|=|692|uM|692000|nM
3TTI|2.20|2012|KBI|ligand is compound 1; IC50=6+/-2 nM|P53779|MITOGEN-ACTIVATED PROTEIN KINASE 10|8.22|IC=6nM|IC50|=|6|nM|6|nM
3UPI|2.00|2012|0C2|compound 27|O92972|RNA-DIRECTED RNA POLYMERASE|8.22|IC=6nM|IC50|=|6|nM|6|nM
4DEG|2.00|2012|0JJ||P08581|HEPATOCYTE GROWTH FACTOR RECEPTOR|8.22|IC=6nM|IC50|=|6|nM|6|nM
4E20|2.60|2012|0MY|IC50=6+/-1nM, X-ray(Mouse), IC50(human)|Q9R117|NON-RECEPTOR TYROSINE-PROTEIN KINASE TYK2|8.22|IC=6nM|IC50|=|6|nM|6|nM
4GTT|2.05|2012|7TQ|IC50=6+/-4nM (radiometric assay), IC50=72+/-2nM(fluorometric assay), Zn-containing|Q08602|GERANYLGERANYL TRANSFERASE TYPE-2 SUBUNIT ALPHA|8.22|IC=6nM|IC50|=|6|nM|6|nM
3VBW|2.48|2012|0FN|compound 2a|P11309|SERINE/THREONINE-PROTEIN KINASE PIM-1|5.22|IC=6uM|IC50|=|6|uM|6000|nM
3V5L|1.86|2012|0G1|compound 6|Q08881|TYROSINE-PROTEIN KINASE ITK/TSK|8.15|IC=7.0nM|IC50|=|7|nM|7|nM
4DBN|3.15|2012|0JA|compound 6d; IC50=6.0-8.3nM|P15056|SERINE/THREONINE-PROTEIN KINASE B-RAF|8.15|IC=7.0nM|IC50|=|7|nM|7|nM
3UDN|2.19|2012|09B|compound 9|P56817|BETA-SECRETASE 1|5.15|IC=7.0uM|IC50|=|7|uM|7000|nM
4FLJ|1.74|2012|Y08|Mn-containing|P53582|METHIONINE AMINOPEPTIDASE 1|5.13|IC=7.45uM|IC50|=|7.45|uM|7450|nM
3AZA|2.70|2012|KM0|ligand is NAS91-10|Q965D7|BETA-HYDROXYACYL-ACP DEHYDRATASE|5.13|IC=7.4uM|IC50|=|7.4|uM|7400|nM
3RWC|2.50|2012|9-mer|ligand is Nef IW9 peptide from Protein Nef|Q9GJ77|MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I|8.12|IC=7.6nM|IC50|=|7.6|nM|7.6|nM
3VYE|2.70|2012|VYE|compound 7; IC50(human); IC50=54nM(monkey plasma)|P00797|RENIN|8.11|IC=7.7nM|IC50|=|7.7|nM|7.7|nM
4EM7|1.90|2012|0RA||G6TGY9|TOPOISOMERASE IV, SUBUNIT B|5.11|IC=7.7uM|IC50|=|7.7|uM|7700|nM
4HAI|2.55|2012|I23||P34913|EPOXIDE HYDROLASE 2|8.1|IC=7.9nM|IC50|=|7.9|nM|7.9|nM
3V6R|2.60|2012|CQQ|compound JNK-IN2; covalent complex; IC50=809nM(JNK1); IC50=1140nM(JNK2)|P53779|MITOGEN-ACTIVATED PROTEIN KINASE 10|6.15|IC=709nM|IC50|=|709|nM|709|nM
3UR0|2.45|2012|SVR|complex MNV RdRp and Suramin; IC50=70+/-3nM|Q80J95|RNA-DEPENDENT RNA POLYMERASE|7.15|IC=70nM|IC50|=|70|nM|70|nM
4A9T|2.70|2012|A9T|author says compound 44; IC50=70+/-3nM; true structure is compound 43; IC50=14+/-8nM, add a Cl atom|O96017|SERINE/THREONINE-PROTEIN KINASE CHK2|7.15|IC=70nM|IC50|=|70|nM|70|nM
4ESI|1.87|2012|0RB||P02879|RICIN|4.15|IC=70uM|IC50|=|70|uM|70000|nM
4HNF|2.07|2012|16W||P48730|CASEIN KINASE I ISOFORM DELTA|6.15|IC=711nM|IC50|=|711|nM|711|nM
3R9D|1.95|2012|X6B|ligand is compound 87|P24941|CYCLIN-DEPENDENT KINASE 2|4.15|IC=71uM|IC50|=|71|uM|71000|nM
4AW5|2.33|2012|30K|complex EphB4 and 7i|P54760|EPHRIN TYPE-B RECEPTOR 4|6.12|IC=765nM|IC50|=|765|nM|765|nM
4ACX|2.00|2012|S8Z|compound 23, pIC50=7.11|P56817|BETA-SECRETASE 1|7.11|IC=77.6nM|IC50|=|77.6|nM|77.6|nM
4DPI|1.90|2012|0N1||P56817|BETA-SECRETASE 1|7.11|IC=78nM|IC50|=|78|nM|78|nM
4H1M|1.99|2012|0YJ||Q14289|PROTEIN-TYROSINE KINASE 2 BETA|7.11|IC=78nM|IC50|=|78|nM|78|nM
2YDK|1.90|2012|YDK|ligand is compound 3b|O14757|SERINE/THREONINE-PROTEIN KINASE CHK1|8.15|IC=7nM|IC50|=|7|nM|7|nM
4ERW|2.00|2012|STU|ligand is Staurosporine|P24941|CYCLIN-DEPENDENT KINASE 2|8.15|IC=7nM|IC50|=|7|nM|7|nM
4E4X|3.60|2012|T1Q|X-ray(B-Raf(WT)), IC50=7 nM (B-Raf(V600E))|P15056|SERINE/THREONINE-PROTEIN KINASE B-RAF|8.15|IC=7nM|IC50|=|7|nM|7|nM
3VP2|2.70|2012|BP0|inhibitor 2, IC50=8.02+/-1.47uM|O94925|GLUTAMINASE KIDNEY ISOFORM, MITOCHONDRIAL|5.1|IC=8.02uM|IC50|=|8.02|uM|8020|nM
3QAI|2.70|2012|XNN|ligand is compound 47; IC50=8.0+/-7.1nM|P50053-2KETOHEXOKINASE||8.1|IC=8.0nM|IC50|=|8|nM|8|nM
3QW8|1.60|2012|5-mer|ligand is peptide CRGC; IC50=8.0+/-1.2uM; Zn-containing|A5HZZ9|BOTULINUM NEUROTOXIN A|5.1|IC=8.0uM|IC50|=|8|uM|8000|nM
4EDZ|2.00|2012|0O5||O60760|HEMATOPOIETIC PROSTAGLANDIN D SYNTHASE|8.08|IC=8.26nM|IC50|=|8.26|nM|8.26|nM
4F6X|1.98|2012|ZYL|ligand is compound 41; Mg-containing|A9JQL9|DEHYDROSQUALENE SYNTHASE|5.09|IC=8.2uM|IC50|=|8.2|uM|8200|nM
4DRK|1.50|2012|I63|IC50=8.36+/-0.98uM|Q13451|PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5|5.08|IC=8.36uM|IC50|=|8.36|uM|8360|nM
4EXG|1.80|2012|916|IC50(Ratios of (S):(R)-configurations (diastereomeric mixture) at the C4 of the bicyclic ring(75:25)), X-ray((S)-configuration at the C4 of the bicyclic ring)|P56817|BETA-SECRETASE 1|8.07|IC=8.5nM|IC50|=|8.5|nM|8.5|nM
3V8W|2.27|2012|0G2|compound 8|Q08881|TYROSINE-PROTEIN KINASE ITK/TSK|8.07|IC=8.6nM|IC50|=|8.6|nM|8.6|nM
4EBW|2.65|2012|0PF|IC50=7.4-10.3 uM|Q05397|FOCAL ADHESION KINASE 1|5.06|IC=8.7uM|IC50|=|8.7|uM|8700|nM
4DGG|2.65|2012|I76|IC50=800+/-160nM|P00523|TYROSINE-PROTEIN KINASE SRC|6.1|IC=800nM|IC50|=|800|nM|800|nM
4EH5|2.00|2012|0OM|IC50=818+/-80uM; another ligand is IRG|Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|3.09|IC=818uM|IC50|=|818|uM|818000|nM
4AWP|1.82|2012|99A|compound 7e|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|7.09|IC=81nM|IC50|=|81|nM|81|nM
3RMF|1.75|2012|20Z|ligand is compound 69|P24941|CYCLIN-DEPENDENT KINASE 2|4.09|IC=82uM|IC50|=|82|uM|82000|nM
4DAW|2.00|2012|0H2|X-ray(the racemic complex 1), IC50((R)-1), IC50=0.083+/-0.02uM|Q13153|SERINE/THREONINE-PROTEIN KINASE PAK 1|7.08|IC=83nM|IC50|=|83|nM|83|nM
4EC0|1.85|2012|7PQ||O60760|HEMATOPOIETIC PROSTAGLANDIN D SYNTHASE|6.07|IC=845nM|IC50|=|845|nM|845|nM
4GDY|2.89|2012|0X1|compound 4 inhibits KAT II irreversibly via formation of an imine adduct with the aldehyde group of the enzyme co-factor pyridoxal phosphate (PLP), followed by tautomerization to an enamine.|Q8N5Z0|KYNURENINE/ALPHA-AMINOADIPATE AMINOTRANSFERASE|7.08|IC=84nM|IC50|=|84|nM|84|nM
3AVB|1.85|2012|8-mer|ligand is peptide 2; IC50=85.2+/-24.5uM|P12497|INTEGRASE|4.07|IC=85.2uM|IC50|=|85.2|uM|85200|nM
4EFT|2.12|2012|EFT||P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|4.07|IC=85uM|IC50|=|85|uM|85000|nM
4AML|1.60|2012|GYU|compound 20, monovalent IC50=8000+/-1000uM|P10968|AGGLUTININ ISOLECTIN 1|2.1|IC=8mM|IC50|=|8|mM|8000000|nM
4EG5|3.10|2012|0OU||Q38C91|METHIONYL-TRNA SYNTHETASE|8.1|IC=8nM|IC50|=|8|nM|8|nM
4FRK|2.10|2012|DWD|IC50=0.008+/-0.0003uM|P56817|BETA-SECRETASE 1|8.1|IC=8nM|IC50|=|8|nM|8|nM
4HGL|2.40|2012|0YO|SO4-containing|Q9Y6M4|CASEIN KINASE I ISOFORM GAMMA-3|8.1|IC=8nM|IC50|=|8|nM|8|nM
4EJF|2.65|2012|18-mer|ligand is phage-derived peptide 419|P55212|CASPASE-6|5.1|IC=8uM|IC50|=|8|uM|8000|nM
4AA4|2.30|2012|QC0|compound 22|Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|8.05|IC=9.0nM|IC50|=|9|nM|9|nM
3V4J|2.04|2012|PQR|compound MN30|Q9HC16|DNA DC->DU-EDITING ENZYME APOBEC-3G|5.04|IC=9.1uM|IC50|=|9.1|uM|9100|nM
4DGR|1.55|2012|3LV|IC50=9.1+/-2.2uM, Ca-containing, K-containing|P03472|NEURAMINIDASE|5.04|IC=9.1uM|IC50|=|9.1|uM|9100|nM
4GTM|2.20|2012|7TM|IC50=9.2+/-4.2nM, Zn-containing|Q04631|FARNESYLTRANSFERASE/GERANYLGERANYLTRANSFERA|8.04|IC=9.2nM|IC50|=|9.2|nM|9.2|nM
3V49|1.70|2012|PK0|compound +/-11b|P10275|ANDROGEN RECEPTOR|8.02|IC=9.6nM|IC50|=|9.6|nM|9.6|nM
3RWD|2.60|2012|11-mer|ligand is Nef IW11 peptide from Protein Nef|Q9GJ77|MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I|8.0|IC=9.9nM|IC50|=|9.9|nM|9.9|nM
3T0T|3.10|2012|I30||Q6GG09|PYRUVATE KINASE|7.04|IC=91nM|IC50|=|91|nM|91|nM
4DUM|2.95|2012|HLI|IC50=0.095+/-0.004uM|P06730|EUKARYOTIC TRANSLATION INITIATION FACTOR 4E|7.02|IC=95nM|IC50|=|95|nM|95|nM
4EYM|2.35|2012|0RX||O15264|MITOGEN-ACTIVATED PROTEIN KINASE 13|4.01|IC=98747nM|IC50|=|98747|nM|98747|nM
4D8E|1.50|2012|E64|covalent complex|E0PTS8|STREPTOPAIN|7.01|IC=98nM|IC50|=|98|nM|98|nM
4E4A|1.45|2012|JKE|IC50=9+/-5mM (a standard esterase activity assay)|P00918|CARBONIC ANHYDRASE 2|2.05|IC=9mM|IC50|=|9|mM|9000000|nM
4G11|3.40|2012|0W7||P48736|PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE|5.0|IC>10000nM|IC50|>|10000|nM|10000|nM
3RZB|1.90|2012|02Z|ligand is compound 41|P24941|CYCLIN-DEPENDENT KINASE 2|4.0|IC>100uM|IC50|>|100|uM|100000|nM
3RPR|1.75|2012|25Z|ligand is compound 37|P24941|CYCLIN-DEPENDENT KINASE 2|4.0|IC>100uM|IC50|>|100|uM|100000|nM
3R9H|2.10|2012|Z67|ligand is compound 90|P24941|CYCLIN-DEPENDENT KINASE 2|4.0|IC>100uM|IC50|>|100|uM|100000|nM
3R9O|1.90|2012|Z71|ligand is compound 88|P24941|CYCLIN-DEPENDENT KINASE 2|4.0|IC>100uM|IC50|>|100|uM|100000|nM
4AI8|2.40|2012|DZA|complex FIH and Daminozide; IC50(MALDI assay)|Q9NWT6|HYPOXIA-INDUCIBLE FACTOR 1-ALPHA INHIBITOR|4.0|IC>100uM|IC50|>|100|uM|100000|nM
4GXS|1.96|2012|0YS|Zn-containing|P19491|GLUTAMATE RECEPTOR 2|4.0|IC>100uM|IC50|>|100|uM|100000|nM
3TIZ|2.02|2012|3TI|ligand is compound 3|P24941|CYCLIN-DEPENDENT KINASE 2|3.82|IC>150uM|IC50|>|150|uM|150000|nM
3AVM|1.88|2012|8-mer|ligand is peptide 13|P12497|INTEGRASE|3.3|IC>500uM|IC50|>|500|uM|500000|nM
3AVN|2.10|2012|8-mer|ligand is peptide 14|P12497|INTEGRASE|3.3|IC>500uM|IC50|>|500|uM|500000|nM
3AVI|1.70|2012|8-mer|ligand is peptide 23|P12497|INTEGRASE|3.3|IC>500uM|IC50|>|500|uM|500000|nM
3AVK|1.75|2012|8-mer|ligand is peptide 24|P12497|INTEGRASE|3.3|IC>500uM|IC50|>|500|uM|500000|nM
3AVJ|1.70|2012|8-mer|ligand is peptide 27|P12497|INTEGRASE|3.3|IC>500uM|IC50|>|500|uM|500000|nM
3AVH|1.88|2012|8-mer|ligand is peptide 7|P12497|INTEGRASE|3.3|IC>500uM|IC50|>|500|uM|500000|nM
3AVG|1.70|2012|8-mer|ligand is peptide 8|P12497|INTEGRASE|3.3|IC>500uM|IC50|>|500|uM|500000|nM
4B6E|2.46|2012|10L||P26663|SERINE PROTEASE NS3|2.3|IC>5mM|IC50|>|5|mM|5000000|nM
4ASY|2.30|2012|N5Y|compound 8f|G3XCK4|GLUCOSE-1-PHOSPHATE THYMIDYLYLTRANSFERASE|4.22|IC>60uM|IC50|>|60|uM|60000|nM
3UYT|2.00|2012|0CK|IC50=8-14nM(CK1 delta), IC50=7.7+/-2.2nM(CKI epsilon)|P48730|CASEIN KINASE I ISOFORM DELTA|7.85|IC~14nM|IC50|~|14|nM|14|nM
4B6F|2.89|2012|20L|IC50(55 3% I at 500), Where it was not possible to measure a full IC50 curve, the percent inhibition (% I) at the given concentration is indicated.|P26663|SERINE PROTEASE NS3|3.3|IC~500uM|IC50|~|500|uM|500000|nM
3TVL|2.30|2012|3PO||Q9BU02|THIAMINE-TRIPHOSPHATASE|4.0|Kd<0.1mM|Kd|<|0.1|mM|100000|nM
2LL6|NMR|2012|17-mer|ligand is iNOS peptide|P62158|CALMODULIN|10.0|Kd<0.1nM|Kd|<|0.1|nM|0.1|nM
3U9N|1.85|2012|09H|compound 1|O14757|SERINE/THREONINE-PROTEIN KINASE CHK1|7.0|Kd<100nM|Kd|<|100|nM|100|nM
4AP0|2.59|2012|G7X|complex Eg5-ADP-ispinesib|P52732|KINESIN-LIKE PROTEIN KIF11|8.0|Kd<10nM|Kd|<|10|nM|10|nM
4B74|2.18|2012|1LH||P26663|SERINE PROTEASE NS3|7.66|Kd=0.022uM|Kd|=|0.022|uM|22|nM
4ASJ|2.25|2012|N6A|ligand is compound 8a; Kd=0.028+/-0.003uM; IC50=0.073+/-0.01uM|G3XCK4|GLUCOSE-1-PHOSPHATE THYMIDYLYLTRANSFERASE|7.55|Kd=0.028uM|Kd|=|0.028|uM|28|nM
3UUG|1.75|2012|BDP||P25548|MULTIPLE SUGAR-BINDING PERIPLASMIC RECEPTOR CHVE|4.51|Kd=0.031mM|Kd|=|0.031|mM|31000|nM
4DY6|2.20|2012|A22||Q8Y8D7|INORGANIC POLYPHOSPHATE/ATP-NAD KINASE 1|4.4|Kd=0.04mM|Kd|=|0.04|mM|40000|nM
3S8X|1.30|2012|E59|ligand is compound 2a; Zn-containing; Kd by ITC (37C,pH=7.0)|P00918|CARBONIC ANHYDRASE 2|7.3|Kd=0.05uM|Kd|=|0.05|uM|50|nM
4B73|2.50|2012|4VA||P26663|SERINE PROTEASE NS3|7.21|Kd=0.062uM|Kd|=|0.062|uM|62|nM
4AJN|2.10|2012|88V|compound 29|P04642|L-LACTATE DEHYDROGENASE A CHAIN|7.16|Kd=0.069uM|Kd|=|0.069|uM|69|nM
4ARW|2.20|2012|HNR|ligand is compound 1; Kd=0.074+/-0.006uM; IC50=0.21+/-0.03uM|G3XCK4|GLUCOSE-1-PHOSPHATE THYMIDYLYLTRANSFERASE|7.13|Kd=0.074uM|Kd|=|0.074|uM|74|nM
4DAF|2.50|2012|0J4|X-ray((R)-compound 19), Kd((RS)-compound 19)|C3P9L8|DIHYDROPTEROATE SYNTHASE|7.12|Kd=0.076uM|Kd|=|0.076|uM|76|nM
3U15|1.80|2012|03M|complex between MDMX and RO-2443|O15151|PROTEIN MDM4|7.11|Kd=0.078uM|Kd|=|0.078|uM|78|nM
4AJO|1.96|2012|88N|compound 33|P04642|L-LACTATE DEHYDROGENASE A CHAIN|7.03|Kd=0.093uM|Kd|=|0.093|uM|93|nM
4FCQ|2.15|2012|2N6||P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|7.0|Kd=0.101uM|Kd|=|0.101|uM|101|nM
4EKI|2.85|2012|0QK|Kd=0.10+/-0.02nM|Q8TEK3|HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-79 SPECIFIC|10.0|Kd=0.10nM|Kd|=|0.1|nM|0.1|nM
4DEW|1.90|2012|LU2|Kd=0.10+/-0.01uM (Model:Independent)|P02766|TRANSTHYRETIN|7.0|Kd=0.10uM|Kd|=|0.1|uM|100|nM
4I47|2.65|2012|MY6||D9J2T9|RRNA N-GLYCOSIDASE|6.92|Kd=0.12uM|Kd|=|0.12|uM|120|nM
4AL4|1.78|2012|W7E|compound 26|P04642|L-LACTATE DEHYDROGENASE A CHAIN|6.89|Kd=0.13uM|Kd|=|0.13|uM|130|nM
3RUL|2.50|2012|7-mer|ligand is Dalbavancin; Kd=0.14+/-0.02uM; covalent complex|P0CG48|UBIQUITIN|6.85|Kd=0.14uM|Kd|=|0.14|uM|140|nM
3S9T|1.30|2012|E49|ligand is compound 1f; Zn-containing; Kd by ITC (37C,pH=7.0)|P00918|CARBONIC ANHYDRASE 2|6.82|Kd=0.15uM|Kd|=|0.15|uM|150|nM
4GY5|2.96|2012|17-mer|ligand is H3K9me3 prptide; Zn-containing, Kd=0.15uM(TTD-PHD of UHRF1 robustly bound to H3K9me3 peptide), Kd=0.97uM(TTD domain of UHRF1 binds to H3K9me3)|Q96T88|E3 UBIQUITIN-PROTEIN LIGASE UHRF1|6.82|Kd=0.15uM|Kd|=|0.15|uM|150|nM
3UIB|2.65|2012|SB2|compound LmaMPK10deltaC; Kd=0.16+/-0.015uM|Q4QHJ8|MITOGEN-ACTIVATED PROTEIN KINASE|6.8|Kd=0.16uM|Kd|=|0.16|uM|160|nM
4A7J|1.90|2012|16-mer|compound WDR5-H3R2me2s; Kd=0.1+/-0.01uM; incomplete ligand|P61964|WD REPEAT-CONTAINING PROTEIN 5|7.0|Kd=0.1uM|Kd|=|0.1|uM|100|nM
4B2D|2.30|2012|SER|X-ray(human PKM2 with L-serine and FBP bound), Kd was measured in the presence of FBP|P14618|PYRUVATE KINASE ISOZYMES M1/M2|3.7|Kd=0.20mM|Kd|=|0.2|mM|200000|nM
4GUI|1.78|2012|QIC|Kd=0.23+/-0.04 mM (K170M DHQD), X-ray (WT DHQD)|P58687|3-DEHYDROQUINATE DEHYDRATASE|3.64|Kd=0.23mM|Kd|=|0.23|mM|230000|nM
3UZC|3.34|2012|T4E|compound 4e|P29274|ADENOSINE A2A RECEPTOR|9.61|Kd=0.248nM|Kd|=|0.248|nM|0.248|nM
3V3Q|2.22|2012|TMY||P22736|NUCLEAR RECEPTOR SUBFAMILY 4 GROUP A MEMBER 1|6.6|Kd=0.25uM|Kd|=|0.25|uM|250|nM
4DKQ|1.89|2012|0LK||Q0ED31|HIV-1 GP120 CORE|6.6|Kd=0.25uM|Kd|=|0.25|uM|250|nM
4H75|2.10|2012|8-mer|Kd=0.25+/-0.03uM; ligand is peptide H3K4(me3)|Q9Y657|SPINDLIN-1|6.6|Kd=0.25uM|Kd|=|0.25|uM|250|nM
4DB7|2.50|2012|Z25||C3P9L8|DIHYDROPTEROATE SYNTHASE|6.56|Kd=0.273uM|Kd|=|0.273|uM|273|nM
3SAX|1.10|2012|E50|ligand is compound 1g; Zn-containing; Kd by ITC (37C,pH=7.0)|P00918|CARBONIC ANHYDRASE 2|6.57|Kd=0.27uM|Kd|=|0.27|uM|270|nM
4A4V|2.00|2012|YFD|ligand is amorfrutin 2|P37231|PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA|6.54|Kd=0.287uM|Kd|=|0.287|uM|287|nM
4AQH|2.40|2012|TB7|ligand is AZ3976; Kd1=0.29+/-0.05uM(latent PAI-1,ITC),Kd2=0.38+/-0.05uM(Active PAI-1,ITC),Kd3=0.24+/-0.03uM(Active PAI-1,SPR),Kd4=0.19+/-0.01uM(latent PAI-1,SPR);IC501=26uM(enzymatic chromogenic assay),IC502=16uM(plasma clot lysis assay)|P05121|PLASMINOGEN ACTIVATOR INHIBITOR 1|6.54|Kd=0.29uM|Kd|=|0.29|uM|290|nM
2LCS|NMR|2012|16-mer|ligand is a peptide from Serine/threonine-protein kinase STE20|Q12163|NAP1-BINDING PROTEIN 2|6.7|Kd=0.2uM|Kd|=|0.2|uM|200|nM
2LKK|NMR|2012|OLA|ligand is compound oleate|P07148|FATTY ACID-BINDING PROTEIN, LIVER|6.7|Kd=0.2uM|Kd|=|0.2|uM|200|nM
4EWN|1.90|2012|0VR||Q9X0C6|IMIDAZOLE GLYCEROL PHOSPHATE SYNTHASE SUBUNIT HISF|6.7|Kd=0.2uM|Kd|=|0.2|uM|200|nM
4DKR|1.80|2012|0LJ||Q0ED31|HIV-1 GP120 CORE|6.52|Kd=0.30uM|Kd|=|0.3|uM|300|nM
4FUT|2.00|2012|ATP|Mg-containing, Kd=0.31+/-0.09uM|Q6ND88|MALONYL COA SYNTHETASE|6.51|Kd=0.31uM|Kd|=|0.31|uM|310|nM
4B5S|1.68|2012|PYR|ligand is pyruvate; Kd=0.32+/-0.02mM|B1IS70|4-HYDROXY-2-OXO-HEPTANE-1,7-DIOATE ALDOLASE|3.49|Kd=0.32mM|Kd|=|0.32|mM|320000|nM
4GBY|2.81|2012|XYP|Kd=0.35+/-0.03mM|P0AGF4|D-XYLOSE-PROTON SYMPORTER|3.46|Kd=0.35mM|Kd|=|0.35|mM|350000|nM
4GLR|1.90|2012|18-mer|incomplete ligand structure|P10636|PHOSPHO-PEPTIDE|9.46|Kd=0.35nM|Kd|=|0.35|nM|0.35|nM
3ASK|2.90|2012|13-mer|ligand is H3K9me3; Kd=0.37+/-0.01uM|Q96T88|E3 UBIQUITIN-PROTEIN LIGASE UHRF1|6.43|Kd=0.37uM|Kd|=|0.37|uM|370|nM
3V3L|1.65|2012|V3L|Kd=0.37+/-0.02uM|Q9NTX7|E3 UBIQUITIN-PROTEIN LIGASE RNF146|6.43|Kd=0.37uM|Kd|=|0.37|uM|370|nM
3U0T|2.50|2012|11-mer|ligand in assay is Amyloid beta 17-40 fragments; ligand in crystal is Amyloid beta A4 C-terminal residues 30-40|P05067|PONEZUMAB LC FAB|9.52|Kd=0.3nM|Kd|=|0.3|nM|0.3|nM
4DVE|2.09|2012|BTN||A2RMJ9|BIOTIN TRANSPORTER BIOY|9.52|Kd=0.3nM|Kd|=|0.3|nM|0.3|nM
4DKO|1.98|2012|0LM||Q0ED31|HIV-1 GP120 CORE|6.52|Kd=0.3uM|Kd|=|0.3|uM|300|nM
3V7D|2.31|2012|19-mer|complex Cdc4 and Sic1; Kd=0.41+/-0.007uM. ScSkp1-ScCdc4-pSic1 peptide complex; incomplete ligand|P52286|SUPPRESSOR OF KINETOCHORE PROTEIN 1|6.39|Kd=0.41uM|Kd|=|0.41|uM|410|nM
3TAY|1.85|2012|MN0|Kd=0.42+/-0.095mM|P0C6Y8|OUTER CAPSID PROTEIN VP4|3.38|Kd=0.42mM|Kd|=|0.42|mM|420000|nM
4F3H|2.50|2012|C2E|covalent complex|Q8P8F1|PUTATIVE UNCHARACTERIZED PROTEIN|6.38|Kd=0.42uM|Kd|=|0.42|uM|420|nM
3UI2|3.18|2012|13-mer|Kd=0.39uM is for full-length cpSRP43, correct Kd=0.43uM for cpSRP43 Delta CD3|O22265|SIGNAL RECOGNITION PARTICLE 43 KDA PROTEIN, CHLOROP|6.37|Kd=0.43uM|Kd|=|0.43|uM|430|nM
3T6B|2.40|2012|5-mer|ligand is peptide tynorphin; Kd=0.44+/-0.02uM (at 25C); Kd=0.22+/-0.03uM (at 35C)|Q9NY33|DIPEPTIDYL PEPTIDASE 3|6.36|Kd=0.44uM|Kd|=|0.44|uM|440|nM
3T6J|2.98|2012|5-mer|ligand is opioid peptide tynorphin; Kd=0.44+/-0.02uM (at 25C); Kd=0.22+/-0.03uM (at 35C)|Q9NY33|DIPEPTIDYL PEPTIDASE 3|6.36|Kd=0.44uM|Kd|=|0.44|uM|440|nM
3TPX|1.80|2012|12-mer|ligand is D-peptide inhibitor DPMI-delta; Kd=0.45+/-0.41nM|Q00987|E3 UBIQUITIN-PROTEIN LIGASE MDM2|9.35|Kd=0.45nM|Kd|=|0.45|nM|0.45|nM
4B0B|1.90|2012|54F|fragment 2; Ka=2140+/-31.8M(ITC)|O33877|3-HYDROXYDECANOYL-[ACYL-CARRIER-PROTEIN] DEHYDRATASE|3.33|Kd=0.47mM|Kd|=|0.47|mM|470000|nM
4B5T|1.92|2012|2KT|ligand is ketobutyrate; Kd=0.47+/-0.02mM|B1IS70|4-HYDROXY-2-OXO-HEPTANE-1,7-DIOATE ALDOLASE|3.33|Kd=0.47mM|Kd|=|0.47|mM|470000|nM
4B5W|1.79|2012|PYR|ligand is pyruvate; Kd=0.47+/-0.001mM (with 0.5mM Co2+)|B1IS70|4-HYDROXY-2-OXO-HEPTANE-1,7-DIOATE ALDOLASE|3.33|Kd=0.47mM|Kd|=|0.47|mM|470000|nM
4DER|1.90|2012|AGI|Kd=0.49+/-0.13uM (Model:Independent)|P02766|TRANSTHYRETIN|6.31|Kd=0.49uM|Kd|=|0.49|uM|490|nM
4ERF|2.00|2012|0R3|IC50=1.1+/-0.5nM(0% human serum), IC50=4.2+/-1.8nM(15% human serum)|Q00987|E3 UBIQUITIN-PROTEIN LIGASE MDM2|9.4|Kd=0.4nM|Kd|=|0.4|nM|0.4|nM
4FCR|1.70|2012|0TM||P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|9.4|Kd=0.4nM|Kd|=|0.4|nM|0.4|nM
4EU0|1.70|2012|C2E|one molecule (c-di-GMP) in the asymmetric unit|Q9HZE7|PELD|6.4|Kd=0.4uM|Kd|=|0.4|uM|400|nM
4F20|2.50|2012|13-mer|ligand is peptide from Dermokine; incomplete ligand|Q6GDH2|CLUMPING FACTOR B|3.29|Kd=0.5083mM|Kd|=|0.5083|mM|508300|nM
4D8Z|2.20|2012|0J2|X-ray((R)-compound 24), Kd((RS)-compound 24)|C3P9L8|DIHYDROPTEROATE SYNTHASE|6.29|Kd=0.51uM|Kd|=|0.51|uM|510|nM
3VHD|1.52|2012|VHE|ligand is compound 16|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|9.28|Kd=0.52nM|Kd|=|0.52|nM|0.52|nM
4AY5|3.15|2012|UDP|complex hOGT and UDP; Kd=0.54+/-0.01uM|O15294|UDP-N-ACETYLGLUCOSAMINE--PEPTIDE|6.27|Kd=0.54uM|Kd|=|0.54|uM|540|nM
4DJ7|2.81|2012|3-mer|ligand is SIA-NAG-GAL|Q6VMK1|HEMAGGLUTININ|6.3|Kd=0.5uM|Kd|=|0.5|uM|500|nM
4EUV|2.00|2012|C2E|1 molecule (c-di-GMP) in the asymmetric unit|Q9HZE7|PELD|6.3|Kd=0.5uM|Kd|=|0.5|uM|500|nM
4ETZ|2.05|2012|C2E|two molecules (c-di-GMP) in the asymmetric unit|Q9HZE7|PELD|6.3|Kd=0.5uM|Kd|=|0.5|uM|500|nM
4DMA|2.30|2012|15-mer|ligand is peptide from Nuclear receptor coactivator 1; The SRC-2 RID binds to liganded ER-alpha LBD dimers with a stoichiometry of 1 coactivator per homodimer and a Kd of 0.65 uM.Kd=0.65+/-0.005uM|P03372|ESTROGEN RECEPTOR|6.19|Kd=0.65uM|Kd|=|0.65|uM|650|nM
4AQ4|1.80|2012|G3P|complex between UgpB and G3P; Kd=0.68+/-0.02uM|P0AG81|SN-GLYCEROL-3-PHOSPHATE-BINDING PERIPLASMIC PROTEIN|6.17|Kd=0.68uM|Kd|=|0.68|uM|680|nM
4GBZ|2.89|2012|BGC|Kd=0.77+/-0.01mM|P0AGF4|D-XYLOSE-PROTON SYMPORTER|3.11|Kd=0.77mM|Kd|=|0.77|mM|770000|nM
2Y9Q|1.55|2012|18-mer|ligand is pepMNK1|P28482|MITOGEN-ACTIVATED PROTEIN KINASE 1|6.15|Kd=0.7uM|Kd|=|0.7|uM|700|nM
4E8Y|2.60|2012|IHA|K-containing, IC50(myelin basic protein), the complex include ligand M7B|B4EB35|D-BETA-D-HEPTOSE 7-PHOSPHATE KINASE|6.09|Kd=0.81uM|Kd|=|0.81|uM|810|nM
3SFG|2.21|2012|2TU|Kd=0.865+/-0.4uM|Q80J95|RNA-DEPENDENT RNA POLYMERASE|6.06|Kd=0.865uM|Kd|=|0.865|uM|865|nM
4H5E|2.04|2012|IPR|Kd=0.86+/-0.06uM; another ligand is YS4|P14324|FARNESYL PYROPHOSPHATE SYNTHASE|6.07|Kd=0.86uM|Kd|=|0.86|uM|860|nM
4EUC|2.64|2012|0RQ||B3EY95|SUCCINYL-COA:ACETATE COENZYME A TRANSFERASE|6.1|Kd=0.8uM|Kd|=|0.8|uM|800|nM
4GAH|2.30|2012|0ET|Kd=0.8+/-0.1uM|Q5T1C6|THIOESTERASE SUPERFAMILY MEMBER 4|6.1|Kd=0.8uM|Kd|=|0.8|uM|800|nM
4GLW|2.00|2012|0XT||C1CKI0|DNA LIGASE|6.1|Kd=0.8uM|Kd|=|0.8|uM|800|nM
4E34|1.40|2012|10-mer|Kd (F*-iCAL36 (F*-ANSRWPTSII) for CALP)|Q9HD26|GOLGI-ASSOCIATED PDZ AND COILED-COIL MOTIF-CONTAINI|6.01|Kd=0.97uM|Kd|=|0.97|uM|970|nM
4G0P|1.80|2012|U5P|Kd=0.98+/-0.01mM|O04379|PROTEIN ARGONAUTE 1|3.01|Kd=0.98mM|Kd|=|0.98|mM|980000|nM
4GUJ|1.50|2012|SKM|Kd=0.9+/-0.2 mM (K170M DHQD), X-ray (WT DHQD)|P58687|3-DEHYDROQUINATE DEHYDRATASE|3.05|Kd=0.9mM|Kd|=|0.9|mM|900000|nM
4ARA|2.50|2012|C56|complex between Mus musculus AChE and R-6|P21836|ACETYLCHOLINESTERASE|6.05|Kd=0.9uM|Kd|=|0.9|uM|900|nM
4G69|2.00|2012|11-mer|Kd=1.05+/-0.22uM; ligand is from Adenomatous polyposis coli protein|Q12959|DISKS LARGE HOMOLOG 1|5.98|Kd=1.05uM|Kd|=|1.05|uM|1050|nM
4FM8|1.90|2012|0UQ|ligand is compound 12a; binding free energy = -8.15 kcal/mol (ITC); IC50=2.4uM|P56817|BETA-SECRETASE 1|5.97|Kd=1.06uM|Kd|=|1.06|uM|1060|nM
3UIL|2.20|2012|DAO|ligand is lauric acid; Kd=1.0+/-0.63uM|Q9GK12|PEPTIDOGLYCAN RECOGNITION PROTEIN 1|6.0|Kd=1.0uM|Kd|=|1|uM|1000|nM
3UZA|3.27|2012|T4G|compound 4g|P29274|ADENOSINE RECEPTOR A2A|8.94|Kd=1.16nM|Kd|=|1.16|nM|1.16|nM
4DST|2.30|2012|9LI|Kd=1.1+/-0.5mM; Mg-containing|P01116|GTPASE KRAS, ISOFORM 2B|2.96|Kd=1.1mM|Kd|=|1.1|mM|1100000|nM
4AI5|2.22|2012|ADK|complex between Y16F-mutant and 3-MeA|Q6G8R1|DNA-3-METHYLADENINE GLYCOSYLASE I|2.92|Kd=1.2mM|Kd|=|1.2|mM|1200000|nM
3VHC|1.41|2012|VHC|ligand is compound 11|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|8.89|Kd=1.3nM|Kd|=|1.3|nM|1.3|nM
4ARB|2.25|2012|C57|complex between Mus musculus AChE and S-6|P21836|ACETYLCHOLINESTERASE|5.89|Kd=1.3uM|Kd|=|1.3|uM|1300|nM
2LNW|NMR|2012|9-mer|ligand is pY1408; Kd=1.40+/-0.05uM|P52735|GUANINE NUCLEOTIDE EXCHANGE FACTOR VAV2|5.85|Kd=1.40uM|Kd|=|1.4|uM|1400|nM
4DES|1.75|2012|57D|Kd=1.40+/-0.06uM (Model:Independent); IC50=12.16+/-1.08uM|P02766|TRANSTHYRETIN|5.85|Kd=1.40uM|Kd|=|1.4|uM|1400|nM
3UDH|1.70|2012|091|ligand is compound 1|P56817|BETA-SECRETASE 1|2.85|Kd=1.4mM|Kd|=|1.4|mM|1400000|nM
2LIQ|NMR|2012|3-mer||B3GA02|CCL2 LECTIN|5.85|Kd=1.4uM|Kd|=|1.4|uM|1400|nM
3UAL|1.80|2012|14-mer|Kd=1.55+/-0.06uM(WT); Kd=4.99+/-0.59uM(F33A); Kd=1.53+/-0.05uM(E35A); Kd=1.55+/-0.29uM(F37A); incomplete ligand|P62258|14-3-3 PROTEIN EPSILON|5.81|Kd=1.55uM|Kd|=|1.55|uM|1550|nM
4DSU|1.70|2012|BZI|Kd=1.5+/-0.3mM; Mg-containing|P01116|GTPASE KRAS, ISOFORM 2B|2.82|Kd=1.5mM|Kd|=|1.5|mM|1500000|nM
3QUE|2.70|2012|3FF||Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|8.82|Kd=1.5nM|Kd|=|1.5|nM|1.5|nM
2LLO|NMR|2012|19-mer|ligand is ER alpha peptide; Kd=1.5+/-0.2uM(CaM:ER=1:2)|P62155|CALMODULIN|5.82|Kd=1.5uM|Kd|=|1.5|uM|1500|nM
2LLQ|NMR|2012|19-mer|ligand is ER alpha peptide; Kd=1.5+/-0.2uM(CaM:ER=1:1)|P62155|CALMODULIN|5.82|Kd=1.5uM|Kd|=|1.5|uM|1500|nM
3R5N|2.00|2012|MLO||P37231|PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA|5.78|Kd=1.67uM|Kd|=|1.67|uM|1670|nM
2LL7|NMR|2012|17-mer|ligand is eNOS peptide|P62158|CALMODULIN|8.8|Kd=1.6nM|Kd|=|1.6|nM|1.6|nM
3V31|1.57|2012|18-mer|complex ANKRA2 and HDAC4; Kd=1.6+/-0.2uM|Q9H9E1|ANKYRIN REPEAT FAMILY A PROTEIN 2|5.8|Kd=1.6uM|Kd|=|1.6|uM|1600|nM
3ASL|1.41|2012|11-mer|Kd=1.73+/-0.09uM|Q96T88|E3 UBIQUITIN-PROTEIN LIGASE UHRF1|5.76|Kd=1.73uM|Kd|=|1.73|uM|1730|nM
4B4Q|2.00|2012|6-mer|Kd=1.76+/-0.78uM (back scattering interferometry (BSI))|Q47212|F18 FIMBRIAL ADHESIN AC|5.75|Kd=1.76uM|Kd|=|1.76|uM|1760|nM
4EKG|2.80|2012|0QJ|Kd=1.7+/-0.2nM|Q8TEK3|HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-79 SPECIFIC|8.77|Kd=1.7nM|Kd|=|1.7|nM|1.7|nM
3RUM|1.85|2012|7-mer|ligand is Ristocetin; Kd=1.7+/-0.3uM; covalent complex|P0AEX9|MALTOSE-BINDING PERIPLASMIC PROTEIN|5.77|Kd=1.7uM|Kd|=|1.7|uM|1700|nM
4FXQ|1.96|2012|G9L|Kd=1.7+/-0.2uM, Ki=1.8+/-0.4uM, IC50=6.1+/-1.2uM;|Q4MV79|PUTATIVE ADP-RIBOSYLTRANSFERASE CERTHRAX|5.77|Kd=1.7uM|Kd|=|1.7|uM|1700|nM
3UT5|2.73|2012|4-mer|complex sT2R-ustiloxin; Kd=1.8+/-0.6uM|D0VWZ0|TUBULIN ALPHA CHAIN|5.74|Kd=1.8uM|Kd|=|1.8|uM|1800|nM
4GAO|3.28|2012|12-mer|ligand is UBC12(NAc1-21)|Q6PH85|DCN1-LIKE PROTEIN 2|5.74|Kd=1.8uM|Kd|=|1.8|uM|1800|nM
4ABK|1.60|2012|AR6|Kd=1.9+/-0.1uM|Q460N5|POLY [ADP-RIBOSE] POLYMERASE 14|5.72|Kd=1.9uM|Kd|=|1.9|uM|1900|nM
4DKP|1.80|2012|0LL||Q0ED31|HIV-1 GP120 CORE|5.72|Kd=1.9uM|Kd|=|1.9|uM|1900|nM
4DN0|2.30|2012|C2E|Na-containing; Kd = 1.9 +/- 0.1 uM|Q02PM6|PUTATIVE UNCHARACTERIZED PROTEIN PELD|5.72|Kd=1.9uM|Kd|=|1.9|uM|1900|nM
3UII|2.60|2012|10-mer|Kd=10.0+/-1.4uM; incomplete ligand|O15392|BACULOVIRAL IAP REPEAT-CONTAINING PROTEIN 5|5.0|Kd=10.0uM|Kd|=|10|uM|10000|nM
3UIK|2.70|2012|10-mer|complex K62Y/H80W mutated Survivin and H3; Kd=10.6+/-0.7uM; incomplete ligand|O15392|BACULOVIRAL IAP REPEAT-CONTAINING PROTEIN 5|4.97|Kd=10.6uM|Kd|=|10.6|uM|10600|nM
3QBC|1.65|2012|B55|Kd=10.8+/-0.4uM(SPR)|Q99W87|2-AMINO-4-HYDROXY-6-HYDROXYMETHYLDIHYDROPTERIDINE|4.97|Kd=10.8uM|Kd|=|10.8|uM|10800|nM
3ZSQ|1.70|2012|O4N|ligand is compound 10; Kd=10.9+/-2.7uM(Core3H); Kd=74+/-16uM(Core4H)|Q76353|HIV-1 INTEGRASE|4.96|Kd=10.9uM|Kd|=|10.9|uM|10900|nM
4AZA|2.16|2012|14-mer|ligand is EIF4G1_D5S PEPTIDE;Kd=103.0+/-2.3nM|P06730|EUKARYOTIC TRANSLATION INITIATION FACTOR 4E|6.99|Kd=103.0nM|Kd|=|103|nM|103|nM
2Y6S|2.80|2012|17-mer|ligand is peptide from ENVELOPE GLYCOPROTEIN; Kd=103+/-47nM|P87666|LIGHT CHAIN|6.99|Kd=103nM|Kd|=|103|nM|103|nM
4ES0|1.82|2012|14-mer|ligand is Histone-lysine N-methyltransferase SETD1B|P61964|WD REPEAT-CONTAINING PROTEIN 5|6.99|Kd=103nM|Kd|=|103|nM|103|nM
4AV0|2.10|2012|HNV|ligand is compound 6; Kd=104.6+/-21.9nM|A2IC68|FIMH PROTEIN|6.98|Kd=104.6nM|Kd|=|104.6|nM|104.6|nM
4AGM|1.52|2012|P86|ligand is compound 4; Kd=105uM(ITC); Kd=104+/-23uM(NMR)|P04637|CELLULAR TUMOR ANTIGEN P53|3.98|Kd=105uM|Kd|=|105|uM|105000|nM
4AGN|1.60|2012|NXG|ligand is compound 9; Kd=107uM(ITC); Kd=114+/-8uM(NMR)|P04637|CELLULAR TUMOR ANTIGEN P53|3.97|Kd=107uM|Kd|=|107|uM|107000|nM
3UXG|1.85|2012|17-mer|complex RFXANK and HDAC4; Kd=109+/-23uM; incomplete ligand|O14593|DNA-BINDING PROTEIN RFXANK|3.96|Kd=109uM|Kd|=|109|uM|109000|nM
3T0X|1.96|2012|DIW||------|IMMUNOGLOBULIN VARIABLE LAMBDA DOMAIN M8VLA4(S55P)|8.0|Kd=10nM|Kd|=|10|nM|10|nM
4G8L|2.80|2012|25A||Q05823|2-5A-DEPENDENT RIBONUCLEASE|8.0|Kd=10nM|Kd|=|10|nM|10|nM
4F1Q|2.80|2012|0RZ||Q460N5|POLY [ADP-RIBOSE] POLYMERASE 14|4.95|Kd=11.2uM|Kd|=|11.2|uM|11200|nM
4DMW|2.50|2012|UDP|Kd=11.4+/-0.9uM; Mn-containing; Kd by nonradioactive glycotransferase assay, Kd(UDP-glucose-Mn-Tcd); X-ray(UDP-Mn-TcdA)|P16154|TOXIN A|4.94|Kd=11.4uM|Kd|=|11.4|uM|11400|nM
4E9C|1.70|2012|11-mer|incomplete ligand structure, ligand is LDPPLHSpTA phosphopeptide|P53350|SERINE/THREONINE-PROTEIN KINASE PLK1|5.96|Kd=1100nM|Kd|=|1100|nM|1100|nM
4DAI|2.50|2012|0J5|Kd = 110 +/- 1 nM|C3P9L8|DIHYDROPTEROATE SYNTHASE|6.96|Kd=110nM|Kd|=|110|nM|110|nM
2LO6|NMR|2012|14-mer|ligand is pSer5 CTD; Kd=113+/-5uM|P53617|PROTEIN NRD1|3.95|Kd=113uM|Kd|=|113|uM|113000|nM
4HBM|1.90|2012|0Y7|Kd=12.0+/-0.1nM|Q00987|E3 UBIQUITIN-PROTEIN LIGASE MDM2|7.92|Kd=12.0nM|Kd|=|12|nM|12|nM
4G8M|2.05|2012|G8M||P19491|GLUTAMATE RECEPTOR 2|7.89|Kd=12.8nM|Kd|=|12.8|nM|12.8|nM
4F14|1.20|2012|13-mer|Kd = 12.93 +/- 0.84 uM; incomplete ligand|O76041|NEBULETTE|4.89|Kd=12.93uM|Kd|=|12.93|uM|12930|nM
3U6W|2.21|2012|KIV|compound KIV-MtuLeuA425; Kd=120+/-15nM|P96420|2-ISOPROPYLMALATE SYNTHASE|6.92|Kd=120nM|Kd|=|120|nM|120|nM
2YIM|1.41|2012|MC4||O06543|PROBABLE ALPHA-METHYLACYL-COA RACEMASE MCR|3.92|Kd=120uM|Kd|=|120|uM|120000|nM
3UIH|2.40|2012|15-mer|Kd=121+/-15uM; incomplete ligand|O15392|BACULOVIRAL IAP REPEAT-CONTAINING PROTEIN 5|3.92|Kd=121uM|Kd|=|121|uM|121000|nM
3UYR|1.70|2012|8-mer|ligand is pC35-55Ld; Kd=127+/-1.4nM|P01897|ANTIBODY FAB HEAVY CHAIN|6.9|Kd=127nM|Kd|=|127|nM|127|nM
3AU6|3.30|2012|DG3|complex of ttPolX and Mg-dGTP. Kd=12+/-1.6nM|Q5SJ64|DNA POLYMERASE BETA FAMILY (X FAMILY)|7.92|Kd=12nM|Kd|=|12|nM|12|nM
3SBI|1.40|2012|E90|ligand is compound 2j; Zn-containing; Kd by ITC (37C,pH=7.0)|P00918|CARBONIC ANHYDRASE 2|7.92|Kd=12nM|Kd|=|12|nM|12|nM
4G68|1.80|2012|3-mer|Kd=12+/-1nM|J9PBT4|ABC TRANSPORTER|7.92|Kd=12nM|Kd|=|12|nM|12|nM
4AJ4|1.90|2012|VAB|ligand is compound 18|P04642|L-LACTATE DEHYDROGENASE A CHAIN|3.89|Kd=130uM|Kd|=|130|uM|130000|nM
4DGB|1.70|2012|6-mer|ligand is peptide from capsid protein; Kd measured with DTT; no binding to HIV-2 without DTT|B0LJC8|PEPTIDYL-PROLYL CIS-TRANS ISOMERASE A|3.89|Kd=130uM|Kd|=|130|uM|130000|nM
3U3U|2.50|2012|EAH|ligand is compound LTE4; Kd=133.3+/-23.3nM|F8QQG5|TABLYSIN 15|6.88|Kd=133.3nM|Kd|=|133.3|nM|133.3|nM
4AB8|1.60|2012|VXU|ligand is CC 00413|P00760|TRYPSIN|3.87|Kd=136uM|Kd|=|136|uM|136000|nM
3ZT3|1.95|2012|ZT4|ligand is compound 2; Kd=1375+/-149uM(Core3H); Kd=763+/-372uM(Core4H)|Q76353|HIV-1 INTEGRASE|2.86|Kd=1375uM|Kd|=|1375|uM|1375000|nM
3UOH|2.80|2012|0C4|compound 8; Kd=13+/-2.2nM; IC50=2.1+/-0.4nM|O14965|AURORA KINASE A|7.89|Kd=13nM|Kd|=|13|nM|13|nM
4DJS|3.03|2012|17-mer|incomplete ligand structure; Kd=13+/-2nM|P35222|BETA-CATENIN|7.89|Kd=13nM|Kd|=|13|nM|13|nM
2LSK|NMR|2012|16-mer||Q9UBZ9|DNA REPAIR PROTEIN REV1|4.89|Kd=13uM|Kd|=|13|uM|13000|nM
3TTN|2.00|2012|SPD||Q9I6J0|POLYAMINE TRANSPORT PROTEIN|7.84|Kd=14.3nM|Kd|=|14.3|nM|14.3|nM
3R0Y|1.65|2012|RSZ|ligand is compound 1; IC50=14.53+/-1.65uM|Q000H7|HIV-1 PROTEASE|4.84|Kd=14.53uM|Kd|=|14.53|uM|14530|nM
3ZT2|1.70|2012|ZT2|ligand is compound 3; Kd=1435+/-304uM(Core3H); Kd=724+/-347uM(Core4H)|Q76353|HIV-1 INTEGRASE|2.84|Kd=1435uM|Kd|=|1435|uM|1435000|nM
4AGO|1.45|2012|P74|ligand is compound 11; Kd by ITC|P04637|CELLULAR TUMOR ANTIGEN P53|4.81|Kd=15.5uM|Kd|=|15.5|uM|15500|nM
4GKC|1.30|2012|RET|Kd=150+/-12nM, covalent complex|P50120|RETINOL-BINDING PROTEIN 2|6.82|Kd=150nM|Kd|=|150|nM|150|nM
4FL3|1.90|2012|ANP|Kd=150+/-30uM, Mg-containing|P43405|TYROSINE-PROTEIN KINASE SYK|3.82|Kd=150uM|Kd|=|150|uM|150000|nM
4ABA|1.25|2012|SW1|ligand is CC 11513|P00760|TRYPSIN|3.82|Kd=153uM|Kd|=|153|uM|153000|nM
4EQF|3.00|2012|7-mer|Kd=155+/-31nM; ligand is peptide from Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2|Q8C437|PEX5-RELATED PROTEIN|6.81|Kd=155nM|Kd|=|155|nM|155|nM
3ZT4|2.20|2012|ZT2|compound 1; Kd=1570+/-337uM(Core3H); Kd=750+/-311uM(Core4H); redundant to 3zt2|Q76353|INTEGRASE|2.8|Kd=1570uM|Kd|=|1570|uM|1570000|nM
3QN7|1.90|2012|17-mer|ligand is Bicyclic peptide inhibitor;Kd157+/-39nM|P00749|UROKINASE-TYPE PLASMINOGEN ACTIVATOR|6.8|Kd=157nM|Kd|=|157|nM|157|nM
4AHV|1.80|2012|Z5P|ligand is compound 64|P12497|INTEGRASE|1.82|Kd=15mM|Kd|=|15|mM|15000000|nM
3UO6|2.80|2012|0BY|compound 7; Kd=15+/-1.5nM; IC50=2.5+/-0.3nM|O14965|AURORA KINASE A|7.82|Kd=15nM|Kd|=|15|nM|15|nM
4E6C|2.39|2012|0O8|Kd=15+/-5uM, incomplete ligand structure|Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|4.82|Kd=15uM|Kd|=|15|uM|15000|nM
4FYS|2.01|2012|6-mer|Kd=15+/-4.0 uM|P15144|AMINOPEPTIDASE N|4.82|Kd=15uM|Kd|=|15|uM|15000|nM
2LZG|NMR|2012|13Q|Kd=16.9+/-0.2nM; NMR Structure|Q00987|E3 UBIQUITIN-PROTEIN LIGASE MDM2|7.77|Kd=16.9nM|Kd|=|16.9|nM|16.9|nM
4AJL|1.77|2012|88W|ligand is compound 24|P04642|L-LACTATE DEHYDROGENASE A CHAIN|3.8|Kd=160uM|Kd|=|160|uM|160000|nM
3UNZ|2.80|2012|0BZ|compound 6; Kd=16+/-1.6nM; IC50=3.7+/-0.7nM|O14965|AURORA KINASE A|7.8|Kd=16nM|Kd|=|16|nM|16|nM
4GLX|1.90|2012|0XS|compound 20a, but has 26-mer DNA in crystal on RCSB PDB website, Kd(S. pneumoniae LigA), X-ray(E. coli LigA), IC50(E. coli LigA)|P15042|DNA (26-MER)|7.8|Kd=16nM|Kd|=|16|nM|16|nM
4DE7|3.00|2012|UDP|Kd = 16 +/- 1 uM; incomplete ligand structure|O05309|GLUCOSYL-3-PHOSPHOGLYCERATE SYNTHASE (GPGS)|4.8|Kd=16uM|Kd|=|16|uM|16000|nM
4DS1|1.85|2012|11-mer|Kd = 17.9+/-3.8 uM; incomplete ligand|Q02647|DYNEIN LIGHT CHAIN 1|4.75|Kd=17.9uM|Kd|=|17.9|uM|17900|nM
4FN5|2.90|2012|8-mer|ligand is peptide from Argyrin B|Q9HWD2|ELONGATION FACTOR G 1|6.76|Kd=173nM|Kd|=|173|nM|173|nM
3UVQ|2.20|2012|FS8|compound 16e|Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|7.77|Kd=17nM|Kd|=|17|nM|17|nM
2Y1N|2.00|2012|12-mer|ligand is ZAP-70 peptide; Kd=17+/-0.4uM|P22681|E3 UBIQUITIN-PROTEIN LIGASE|4.77|Kd=17uM|Kd|=|17|uM|17000|nM
3UD7|2.80|2012|GNS-IDY|compound 89|P05230|HEPARIN-BINDING GROWTH FACTOR 1|4.74|Kd=18.1uM|Kd|=|18.1|uM|18100|nM
4AUY|2.10|2012|HNW|compound 4; Kd=18.3+/-5.9nM|A2IC68|FIMH PROTEIN|7.74|Kd=18.3nM|Kd|=|18.3|nM|18.3|nM
3VJC|1.89|2012|ZGA|ligand is ZA-A; Kd=18.9+/-0.4nM|P37268|SQUALENE SYNTHASE|7.72|Kd=18.9nM|Kd|=|18.9|nM|18.9|nM
3V30|1.57|2012|17-mer|complex RFXANK and RFX5; Kd=184+/-44uM; incomplete ligand|O14593|DNA-BINDING PROTEIN RFXANK|3.74|Kd=184uM|Kd|=|184|uM|184000|nM
3UIJ|2.71|2012|15-mer|complex K62Y/H80W mutated Survivin and SmacN; Kd=19.8+/-2.3uM; incomplete ligand|O15392|BACULOVIRAL IAP REPEAT-CONTAINING PROTEIN 5|4.7|Kd=19.8uM|Kd|=|19.8|uM|19800|nM
4FLP|2.23|2012|JQ1|Kd=190.1+/-7.6nM; K-containing|Q58F21|BROMODOMAIN TESTIS-SPECIFIC PROTEIN|6.72|Kd=190.1nM|Kd|=|190.1|nM|190.1|nM
4A4W|2.00|2012|YFB|ligand is amorfrutin B|P37231|PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA|7.72|Kd=19nM|Kd|=|19|nM|19|nM
4EGK|1.69|2012|RDC|Kd value from ref.28|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|7.72|Kd=19nM|Kd|=|19|nM|19|nM
4FVQ|1.75|2012|ATP|Mg-containing|O60674|TYROSINE-PROTEIN KINASE JAK2|6.0|Kd=1uM|Kd|=|1|uM|1000|nM
4FVR|2.00|2012|ATP|Mg-containing|O60674|TYROSINE-PROTEIN KINASE JAK2|6.0|Kd=1uM|Kd|=|1|uM|1000|nM
4DET|2.05|2012|KMP|Kd=2.10+/-0.63uM (Model:Independent); IC50=8.26+/-1.06uM|P02766|TRANSTHYRETIN|5.68|Kd=2.10uM|Kd|=|2.1|uM|2100|nM
3U0P|2.80|2012|LSC|lipid, not good drugs; Kd=2.1+/-1.1uM|P15813|ANTIGEN-PRESENTING GLYCOPROTEIN CD1D|5.68|Kd=2.1uM|Kd|=|2.1|uM|2100|nM
4DEU|1.60|2012|NAR|Kd=2.29+/-0.18uM (Model:Independent); IC50=12.39+/-1.16uM|P02766|TRANSTHYRETIN|5.64|Kd=2.29uM|Kd|=|2.29|uM|2290|nM
4FT2|3.20|2012|15-mer|Intermolecular interaction between the chromodomain of ZMET2 and H3(1 C15)K9me2 peptide|Q9AXT8|DNA (CYTOSINE-5)-METHYLTRANSFERASE 1|5.64|Kd=2.3uM|Kd|=|2.3|uM|2300|nM
4DRU|2.10|2012|0LN||O92972|RNA-DIRECTED RNA POLYMERASE|8.62|Kd=2.4nM|Kd|=|2.4|nM|2.4|nM
4F9G|2.95|2012|C2E|Kd=2.4+/-0.5uM|Q86WV6|TRANSMEMBRANE PROTEIN 173|5.62|Kd=2.4uM|Kd|=|2.4|uM|2400|nM
4HTP|2.25|2012|11-mer|ligand is cArt-Pep|P49917|DNA LIGASE 4|5.62|Kd=2.4uM|Kd|=|2.4|uM|2400|nM
4EQJ|1.80|2012|8-mer|Kd = 2.52 +/- 0.4 uM; X-ray(Pr-3), Kd(the D25N (inactive) variants of Pr-3); incomplete ligand structure|P03369|PROTEASE, TETHERED DIMER|5.6|Kd=2.52uM|Kd|=|2.52|uM|2520|nM
3UDV|1.88|2012|J1C|compound HPPK-19; Kd=2.55+/-0.15uM; IC50=3.16+/-0.34uM|P26281|2-AMINO-4-HYDROXY-6-HYDROXYMETHYLDIHYDROPTERIDINE|5.59|Kd=2.55uM|Kd|=|2.55|uM|2550|nM
2YHW|1.64|2012|BM3|ligand is N-acetylmannosamine|Q9Y223|BIFUNCTIONAL UDP-N-ACETYLGLUCOSAMINE|5.6|Kd=2.5uM|Kd|=|2.5|uM|2500|nM
2YHY|1.82|2012|BM3|ligand is N-acetylmannosamine;ADP containing; redundant to 2yhw|Q9Y223|BIFUNCTIONAL UDP-N-ACETYLGLUCOSAMINE|5.6|Kd=2.5uM|Kd|=|2.5|uM|2500|nM
3R5T|1.45|2012|VBN|Fe-containing; Kd=2.65+/-0.63nM|Q9RCF6|FERRIC VIBRIOBACTIN ABC TRANSPORTER|8.58|Kd=2.65nM|Kd|=|2.65|nM|2.65|nM
2LGF|NMR|2012|15-mer|ligand is L-selectin;Ca2+ containing, Kd=2.7+/-1.2 uM|P62158|CALMODULIN|5.57|Kd=2.7uM|Kd|=|2.7|uM|2700|nM
3UBD|1.53|2012|SL0|ligand is compound SL0101|P18654|RIBOSOMAL PROTEIN S6 KINASE ALPHA-3|5.54|Kd=2.9uM|Kd|=|2.9|uM|2900|nM
3V78|2.30|2012|ET|complex between Rv3066 and ethidium; Kd=2.9+/-0.2uM|P95092|PROBABLE TRANSCRIPTIONAL REGULATORY PROTEIN|5.54|Kd=2.9uM|Kd|=|2.9|uM|2900|nM
4AGP|1.50|2012|P51|ligand is compound 12; Kd by ITC|P04637|CELLULAR TUMOR ANTIGEN P53|4.69|Kd=20.6uM|Kd|=|20.6|uM|20600|nM
4GWI|1.60|2012|BDZ|Kd=202+/-31uM, Mg-containing, Ca-containing|Q2PHL4|PLATELET AGGREGATION FACTOR SM-HPAF|3.69|Kd=202uM|Kd|=|202|uM|202000|nM
4E9D|2.75|2012|10-mer|incomplete ligand structure, ligand is 3-(1-benzothiophen-2-yl)propanoyl-derivatized DPPLHSpTA peptide|P53350|SERINE/THREONINE-PROTEIN KINASE PLK1|7.7|Kd=20nM|Kd|=|20|nM|20|nM
3UEF|2.45|2012|12-mer|hs wt H3T3(1-12); Kd=21.0+/-1.8uM; incomplete ligand|O15392|BACULOVIRAL IAP REPEAT-CONTAINING PROTEIN 5|4.68|Kd=21.0uM|Kd|=|21|uM|21000|nM
3UD9|2.34|2012|SGN-IDY|compound 91|P05230|HEPARIN-BINDING GROWTH FACTOR 1|4.67|Kd=21.2uM|Kd|=|21.2|uM|21200|nM
4AJE|2.35|2012|2B4|ligand is compound 20|P04642|L-LACTATE DEHYDROGENASE A CHAIN|3.68|Kd=210uM|Kd|=|210|uM|210000|nM
4AIA|1.80|2012|ADK|Kd=220uM(pH=7.8,ITC); Kd=470uM(pH=5.8,ITC); Kd=78uM(pH=7.8,fluorescence); Kd=165uM(pH=5.8,fluorescence)|Q6G8R1|DNA-3-METHYLADENINE GLYCOSYLASE I|3.66|Kd=220uM|Kd|=|220|uM|220000|nM
4FL2|2.19|2012|ANP|Kd=220+/-30uM; Mg-containing|P43405|TYROSINE-PROTEIN KINASE SYK|3.66|Kd=220uM|Kd|=|220|uM|220000|nM
4AGL|1.70|2012|P84|ligand is compound 3; Kd=225uM(ITC); Kd=184+/-23uM(NMR)|P04637|CELLULAR TUMOR ANTIGEN P53|3.65|Kd=225uM|Kd|=|225|uM|225000|nM
2YME|2.40|2012|CWB||Q8WSF8|ACETYLCHOLINE RECEPTOR|7.66|Kd=22nM|Kd|=|22|nM|22|nM
4FBX|2.33|2012|7-mer|Kd measured in FA displacement assay; ligand is bisubstrate inhibitor; incomplete ligand|P68400|CASEIN KINASE II, ALPHA SUBUNIT|7.66|Kd=22nM|Kd|=|22|nM|22|nM
4GQ4|1.27|2012|0RT||O00255|MENIN|7.66|Kd=22nM|Kd|=|22|nM|22|nM
3V43|1.47|2012|18-mer|peptide H3(1-18)K14ac; incomplete ligand|Q92794|HISTONE ACETYLTRANSFERASE KAT6A|4.63|Kd=23.3uM|Kd|=|23.3|uM|23300|nM
4AVI|2.40|2012|XNS|ligand is compound 2; Kd=23.6+/-3.6nM|A2IC68|FIMH PROTEIN|7.63|Kd=23.6nM|Kd|=|23.6|nM|23.6|nM
3UMQ|2.20|2012|BUA|ligand is butyric acid; Kd=24.1+/-2.0uM|Q9GK12|PEPTIDOGLYCAN RECOGNITION PROTEIN 1|4.62|Kd=24.1uM|Kd|=|24.1|uM|24100|nM
4A4C|2.70|2012|12-mer|Kd=244+/-7uM|P22681|E3 UBIQUITIN-PROTEIN LIGASE CBL|3.61|Kd=244uM|Kd|=|244|uM|244000|nM
4DBM|2.30|2012|0J0|Kd=24+/-6.8nM|Q8WSF8|ACETYLCHOLINE RECEPTOR|7.62|Kd=24nM|Kd|=|24|nM|24|nM
3TCY|1.55|2012|PHE|Phe-soaked cPAH; Kd=24+/-1.1uM; redundant to 3tk2|P30967|PHENYLALANINE-4-HYDROXYLASE|4.62|Kd=24uM|Kd|=|24|uM|24000|nM
3TK2|1.35|2012|PHE|cPAH co-crystallized with Phe; Kd=24+/-1.1uM|P30967|PHENYLALANINE-4-HYDROXYLASE|4.62|Kd=24uM|Kd|=|24|uM|24000|nM
3U90|1.90|2012|SDS|complex between apoferritin and SDS; Kd=24+/-9uM(at 293K)|P02791|FERRITIN LIGHT CHAIN|4.62|Kd=24uM|Kd|=|24|uM|24000|nM
4ABF|1.30|2012|513|ligand is CC 33513|P00760|TRYPSIN|4.62|Kd=24uM|Kd|=|24|uM|24000|nM
4AD3|2.00|2012|GLC-DMJ||D6D1V7|GLYCOSYL HYDROLASE FAMILY 71|4.62|Kd=24uM|Kd|=|24|uM|24000|nM
4G0A|2.10|2012|3-mer|incomplete ligand|Q03243|NON-STRUCTURAL PROTEIN 2|7.6|Kd=25.3nM|Kd|=|25.3|nM|25.3|nM
4DCV|2.60|2012|GCP|Kd=25.7+/-2.8uM (no salt), nucleotide binding content (GD1/GD2):empty/GMPPCP|P50743|GTP-BINDING PROTEIN ENGA|4.59|Kd=25.7uM|Kd|=|25.7|uM|25700|nM
2LBV|NMR|2012|ACD||Q9I9P7|EXTRACELLULAR FATTY ACID-BINDING PROTEIN|7.59|Kd=26nM|Kd|=|26|nM|26|nM
3SAP|1.75|2012|E2I|ligand is compound 2i; Zn-containing; Kd by ITC (37C,pH=7.0)|P00918|CARBONIC ANHYDRASE 2|7.59|Kd=26nM|Kd|=|26|nM|26|nM
4FNN|2.24|2012|STE|ligand is stearic acid; Kd=27.2+/-7.4nM|Q9GK12|PEPTIDOGLYCAN RECOGNITION PROTEIN 1|7.57|Kd=27.2nM|Kd|=|27.2|nM|27.2|nM
3UW9|2.30|2012|11-mer|ligand is H4K8K12; Kd=27.4+/-0.9uM|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|4.56|Kd=27.4uM|Kd|=|27.4|uM|27400|nM
3ZTC|2.65|2012|TR0|compound 2; Kd=27.7+/-0.2uM|Q15370|TRANSCRIPTION ELONGATION FACTOR B POLYPEPTIDE 2|4.56|Kd=27.7uM|Kd|=|27.7|uM|27700|nM
4ABG|1.52|2012|91B|ligand is CC 35913|P00760|TRYPSIN BETA|3.57|Kd=271uM|Kd|=|271|uM|271000|nM
4ESG|1.70|2012|17-mer|peptide in crystal is Ac-EPPLPNPHGSARAEVHLRK-NH2, peptide in assay is Ac-LNPHGSARAEVHLR-NH2|P61964|WD REPEAT-CONTAINING PROTEIN 5|5.56|Kd=2762nM|Kd|=|2762|nM|2762|nM
4AJI|1.93|2012|88R|ligand is compound 21|P04642|L-LACTATE DEHYDROGENASE A CHAIN|3.55|Kd=280uM|Kd|=|280|uM|280000|nM
3UED|2.70|2012|12-mer|hs wt H3T3ph(1-12); Kd=29.6+/-5.4uM; incomplete ligand|O15392|BACULOVIRAL IAP REPEAT-CONTAINING PROTEIN 5|4.53|Kd=29.6uM|Kd|=|29.6|uM|29600|nM
3UO4|2.45|2012|0C0|ligand is compound 3; Kd=299+/-27nM; IC50=149+/-23nM|O14965|SERINE/THREONINE-PROTEIN KINASE 6|6.52|Kd=299nM|Kd|=|299|nM|299|nM
4EXZ|1.61|2012|RET|Kd=29+/-5nM, covalent complex|P50120|RETINOL-BINDING PROTEIN 2|7.54|Kd=29nM|Kd|=|29|nM|29|nM
4B76|2.14|2012|PW1||P26663|SERINE PROTEASE NS3|4.54|Kd=29uM|Kd|=|29|uM|29000|nM
4BD3|NMR|2012|11-mer|ligand is H3K36me3 peptide; Kd=29+/-5uM|Q5T6S3|PHD FINGER PROTEIN 19|4.54|Kd=29uM|Kd|=|29|uM|29000|nM
3RQW|2.91|2012|ACH||E0SJQ4|ELIC PENTAMERIC LIGAND GATED ION CHANNEL FROM ERWIN|2.7|Kd=2mM|Kd|=|2|mM|2000000|nM
4EO6|1.79|2012|0S2|Kd(HCV NS5B GT-1b delta21); IC50(RNA dependent HCV GT-1b NS5B polymerase)|P26663|RNA-DIRECTED RNA POLYMERASE|8.7|Kd=2nM|Kd|=|2|nM|2|nM
4G0Q|1.80|2012|C5P|Kd=3.00+/-0.48mM|O04379|PROTEIN ARGONAUTE 1|2.52|Kd=3.00mM|Kd|=|3|mM|3000000|nM
3TTM|2.00|2012|PUT||Q9I6J1|POLYAMINE TRANSPORT PROTEIN|8.52|Kd=3.0nM|Kd|=|3|nM|3|nM
3U51|2.24|2012|6-mer|compound 1; IC50=25+/-3.0uM|P00523|TYROSINE-PROTEIN KINASE SRC|5.51|Kd=3.1uM|Kd|=|3.1|uM|3100|nM
3TZ4|2.25|2012|03H|with ADP; ligand is compound 4; Kd=3.2+/-0.6uM|Q00972|3-METHYL-2-OXOBUTANOATE DEHYDROGENASE|5.49|Kd=3.2uM|Kd|=|3.2|uM|3200|nM
4AH9|1.70|2012|0MB|ligand is compound 68|P12497|INTEGRASE|2.46|Kd=3.5mM|Kd|=|3.5|mM|3500000|nM
3RUN|1.40|2012|7-mer|ligand is VANCOMYCIN; Kd=3.6+/-0.7uM; covalent complex|P00720|T4 LYSOZYME|5.44|Kd=3.6uM|Kd|=|3.6|uM|3600|nM
4F5Y|2.40|2012|C2E|a dimeric receptor-ligand complex with 2:1 stoichiometry, Ca-containing|Q86WV6|TRANSMEMBRANE PROTEIN 173|5.43|Kd=3.70uM|Kd|=|3.7|uM|3700|nM
2LYW|NMR|2012|13-mer|Kd=30+/-10uM|P30989|NEUROTENSIN RECEPTOR TYPE 1|4.52|Kd=30.0uM|Kd|=|30|uM|30000|nM
4GZW|2.45|2012|3-mer|ligand is SIA-NAG-GAL; Kd=30.0+/-5.5uM|K7N5N3|NEURAMINIDASE|4.52|Kd=30.0uM|Kd|=|30|uM|30000|nM
4DCY|2.00|2012|L2M|Kd=30.2+/-1.6uM|P33590|NICKEL-BINDING PERIPLASMIC PROTEIN|4.52|Kd=30.2uM|Kd|=|30.2|uM|30200|nM
2LP8|NMR|2012|18-mer|ligand is BakI81F; Kd=30.5+/-5.7nM|Q07817|BCL-2-LIKE PROTEIN 1|7.52|Kd=30.5nM|Kd|=|30.5|nM|30.5|nM
4DCX|2.00|2012|L2D|Kd=31.4+/-2.7uM|P33590|NICKEL-BINDING PERIPLASMIC PROTEIN|4.5|Kd=31.4uM|Kd|=|31.4|uM|31400|nM
4ABB|1.25|2012|K9S|ligand is CC 12313|P00760|TRYPSIN|4.51|Kd=31uM|Kd|=|31|uM|31000|nM
4EMR|1.75|2012|MGP||D9J2T9|RRNA N-GLYCOSIDASE|7.49|Kd=32.1nM|Kd|=|32.1|nM|32.1|nM
4E67|2.10|2012|8-mer|ligand is PLHSpTA peptide|P53350|SERINE/THREONINE-PROTEIN KINASE PLK1|6.48|Kd=330nM|Kd|=|330|nM|330|nM
4EPY|1.80|2012|0QY||P01116|GTPASE KRAS, ISOFORM 2B|3.47|Kd=340uM|Kd|=|340|uM|340000|nM
4AFT|3.20|2012|QMR|complex AcAChBP and Varenicline|Q8WSF8|ACETYLCHOLINE RECEPTOR|6.47|Kd=342nM|Kd|=|342|nM|342|nM
3T2W|1.50|2012|BTN||Q12QS6|AVIDIN/STREPTAVIDIN|7.46|Kd=35nM|Kd|=|35|nM|35|nM
4F3I|1.40|2012|0S6|ligand is MS417;Kd=36.1+/-7.8nM|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|7.44|Kd=36.1nM|Kd|=|36.1|nM|36.1|nM
4AVJ|2.10|2012|J73|ligand is compound 5; Kd=36.5+/-6.4nM|A2IC68|FIMH PROTEIN|7.44|Kd=36.5nM|Kd|=|36.5|nM|36.5|nM
4FMU|2.10|2012|0UM|Kd=360+/-15nM|Q9BYW2|HISTONE-LYSINE N-METHYLTRANSFERASE SETD2|6.44|Kd=360nM|Kd|=|360|nM|360|nM
4B4N|1.81|2012|15-mer|ligand is CLEAVAGE AND POLYADENYLATION SPECIFICITY FACTOR SUBUNIT 6|A9PKC6|GAG PROTEIN|3.44|Kd=362uM|Kd|=|362|uM|362000|nM
4FFS|1.90|2012|BIG||Q9ZMY2|AMINODEOXYFUTALOSINE NUCLEOSIDASE|10.44|Kd=36pM|Kd|=|36|pM|0.036000000000000004|nM
4HCZ|1.85|2012|10-mer|ligand is H3K36me3 peptide, Kd=36+/-4uM|O43189|PHD FINGER PROTEIN 1|4.44|Kd=36uM|Kd|=|36|uM|36000|nM
4AXD|2.05|2012|ANP|ligand is AMPPNP, Kd=37+/-9 uM|Q93YN9|INOSITOL-PENTAKISPHOSPHATE 2-KINASE|4.43|Kd=37uM|Kd|=|37|uM|37000|nM
2YI5|2.50|2012|YI5|ligand is ICPD 34|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|7.41|Kd=39nM|Kd|=|39|nM|39|nM
3UO5|2.70|2012|0BX|compound 1; Kd=39+/-5.9nM; IC50=10+/-1.6nM|O14965|SERINE/THREONINE-PROTEIN KINASE 6|7.41|Kd=39nM|Kd|=|39|nM|39|nM
3TCT|1.30|2012|3MI|Kd4=154nM for the second binding site|P02766|TRANSTHYRETIN|8.52|Kd=3nM|Kd|=|3|nM|3|nM
3UD8|2.37|2012|GNX-IDY|compound 90|P05230|HEPARIN-BINDING GROWTH FACTOR 1|5.38|Kd=4.13uM|Kd|=|4.13|uM|4130|nM
4F7V|1.73|2012|J1D|Kd=4.16+/-0.25uM|P26281|2-AMINO-4-HYDROXY-6-HYDROXYMETHYLDIHYDROPTERIDINE|5.38|Kd=4.16uM|Kd|=|4.16|uM|4160|nM
2LTX|NMR|2012|15-mer|Kd=4.1+/-0.1uM|Q9HCE7|E3 UBIQUITIN-PROTEIN LIGASE SMURF1|5.39|Kd=4.1uM|Kd|=|4.1|uM|4100|nM
3SO6|1.37|2012|14-mer|ligand is LDLR tail peptide; Kd=4.1+/-134uM|D3ZAR1|LDL RECEPTOR ADAPTOR PROTEIN|5.39|Kd=4.1uM|Kd|=|4.1|uM|4100|nM
3TGS|2.70|2012|03G|ligand is NBD-556|C6G099|HIV-1 CLADE C1086 GP120 CORE|5.39|Kd=4.1uM|Kd|=|4.1|uM|4100|nM
2LTY|NMR|2012|15-mer|Kd=4.2+/-0.1uM|Q96PU5|E3 UBIQUITIN-PROTEIN LIGASE NEDD4-LIKE|5.38|Kd=4.2uM|Kd|=|4.2|uM|4200|nM
3TIF|1.80|2012|ADP|Kd=4.2+/-0.6uM|Q58206|UNCHARACTERIZED ABC TRANSPORTER ATP-BINDING PROTEIN|5.38|Kd=4.2uM|Kd|=|4.2|uM|4200|nM
4G0K|2.56|2012|0VS||P42620|PROTEIN YQJG|5.37|Kd=4.3uM|Kd|=|4.3|uM|4300|nM
4EF4|2.15|2012|C2E|Ca-containing; Kd = 4.42 +/- 0.02 uM|Q86WV6|TRANSMEMBRANE PROTEIN 173|5.35|Kd=4.42uM|Kd|=|4.42|uM|4420|nM
4EP2|1.90|2012|8-mer|Kd = 4.43 +/- 0.9 uM; X-ray(WT protease), Kd(the D25N (inactive) variants of WT protease); incomplete ligand structure|P03369|PROTEASE, TETHERED DIMER|5.35|Kd=4.43uM|Kd|=|4.43|uM|4430|nM
3R7O|2.30|2012|M61|lignad is compound 1 (MK-2461)|P08581|HEPATOCYTE GROWTH FACTOR RECEPTOR|8.36|Kd=4.4nM|Kd|=|4.4|nM|4.4|nM
3U3Z|1.50|2012|4-mer|Kd=4.4+/-0.3uM|Q8NEM0|MICROCEPHALIN|5.36|Kd=4.4uM|Kd|=|4.4|uM|4400|nM
2LTZ|NMR|2012|15-mer|Kd=4.5+/-0.2uM|Q9HAU4|E3 UBIQUITIN-PROTEIN LIGASE SMURF2|5.35|Kd=4.5uM|Kd|=|4.5|uM|4500|nM
3R8I|2.30|2012|XCX|ligand is compound 2|P37231|PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA|5.35|Kd=4.5uM|Kd|=|4.5|uM|4500|nM
3V2X|1.85|2012|11-mer|complex Megalin and ANKRA2; Kd=4.5+/-0.5uM|Q9H9E1|ANKYRIN REPEAT FAMILY A PROTEIN 2|5.35|Kd=4.5uM|Kd|=|4.5|uM|4500|nM
3ZYR|1.65|2012|8-mer|ligand is compound H|G1EUI6|LECTIN|5.34|Kd=4.6uM|Kd|=|4.6|uM|4600|nM
3RZI|1.95|2012|TRP|Kd=21+/-1uM (Phe only); Kd=4.7+/-0.1uM (Trp only); Kd=5.0+/-0.1uM (Phe to Trp-bound protein); Kd=1.08+/-0.03uM (Trp to Phe-bound protein)|O53512|PROBABLE 3-DEOXY-D-ARABINO-HEPTULOSONATE 7-PHOSPHAT|5.33|Kd=4.7uM|Kd|=|4.7|uM|4700|nM
2YI7|1.40|2012|BZ8|ligand is ICPD 47|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|8.32|Kd=4.8nM|Kd|=|4.8|nM|4.8|nM
3UIG|2.40|2012|15-mer|complex Survivin and H3T3ph; Kd=4.80+/-1.13uM; incomplete ligand|O15392|BACULOVIRAL IAP REPEAT-CONTAINING PROTEIN 5|5.32|Kd=4.8uM|Kd|=|4.8|uM|4800|nM
4G0Y|1.65|2012|AMP|Kd=4.99+/-0.67mM|O04379|PROTEIN ARGONAUTE 1|2.3|Kd=4.99mM|Kd|=|4.99|mM|4990000|nM
3V2O|1.89|2012|19-mer|complex Megalin and ANKRA2; Kd=4.9+/-0.6uM; incomplete ligand|Q9H9E1|ANKYRIN REPEAT FAMILY A PROTEIN 2|5.31|Kd=4.9uM|Kd|=|4.9|uM|4900|nM
4ABE|1.30|2012|913|ligand is CC 32913|P00760|TRYPSIN|3.4|Kd=400uM|Kd|=|400|uM|400000|nM
3RE4|2.00|2012|TO1||O28471|RIO-TYPE SERINE/THREONINE-PROTEIN KINASE RIO1|7.4|Kd=40nM|Kd|=|40|nM|40|nM
3UP2|2.30|2012|0C8|ligand is compound 5; Kd=40+/-5.6nM; IC50=28+/-4.8nM|O14965|SERINE/THREONINE-PROTEIN KINASE 6|7.4|Kd=40nM|Kd|=|40|nM|40|nM
3VHA|1.39|2012|VHA|ligand is compound 8|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|7.4|Kd=40nM|Kd|=|40|nM|40|nM
3UNN|1.70|2012|8-mer|Kd=40+/-3uM, ligand is phospho-T4 peptide from Mediator of DNA damage checkpoint protein 1|Q14676|MEDIATOR OF DNA DAMAGE CHECKPOINT PROTEIN 1|4.4|Kd=40uM|Kd|=|40|uM|40000|nM
3VA4|1.54|2012|11-mer|incomplete ligand|Q5PSV9|MEDIATOR OF DNA DAMAGE CHECKPOINT PROTEIN 1|4.4|Kd=40uM|Kd|=|40|uM|40000|nM
4ABD|1.25|2012|SW2|ligand is CC 21913|P00760|TRYPSIN|4.4|Kd=40uM|Kd|=|40|uM|40000|nM
4AJ2|1.75|2012|52C|compound 14|P04642|L-LACTATE DEHYDROGENASE A CHAIN|2.38|Kd=4200uM|Kd|=|4200|uM|4200000|nM
3UVU|2.38|2012|19-mer|Kd=42+/-6.5nM|P39748|FLAP ENDONUCLEASE 1 (FEN1) PEPTIDE|7.38|Kd=42nM|Kd|=|42|nM|42|nM
4EDE|1.40|2012|RET|Kd=42+/-6nM, covalent complex, incomplete ligand|P50120|RETINOL-BINDING PROTEIN 2|7.38|Kd=42nM|Kd|=|42|nM|42|nM
3RSR|2.30|2012|N5P|Kd1=44uM(S-site), Kd2=5mM(A-site)|P21524|RIBONUCLEOSIDE-DIPHOSPHATE REDUCTASE LARGE CHAIN|4.36|Kd=44uM|Kd|=|44|uM|44000|nM
4FI9|3.05|2012|14-mer||Q9UH99|SUN DOMAIN-CONTAINING PROTEIN 2|7.34|Kd=45.6nM|Kd|=|45.6|nM|45.6|nM
3R5M|2.80|2012|MLO||P19793|RETINOIC ACID RECEPTOR RXR-ALPHA|4.34|Kd=45.7uM|Kd|=|45.7|uM|45700|nM
4AZF|2.55|2012|3RA||Q92630|DYRK2 DUAL-SPECIFICITY TYROSINE-PHOSPHORYLATION REG|6.35|Kd=450nM|Kd|=|450|nM|450|nM
2YQ6|1.80|2012|19-mer|ligand is BimSAHB|Q07817|BCL-2-LIKE PROTEIN 1|7.35|Kd=45nM|Kd|=|45|nM|45|nM
4A2A|1.80|2012|16-mer|complex FtsA and Ftsz; Kd=45-58uM; incomplte ligand|Q9WZU0|CELL DIVISION PROTEIN FTSA, PUTATIVE|4.35|Kd=45uM|Kd|=|45|uM|45000|nM
3UVX|1.91|2012|11-mer|ligand is H4K12K16; Kd=46.1+/-0.9uM; incomplete ligand|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|4.34|Kd=46.1uM|Kd|=|46.1|uM|46100|nM
4GWK|1.53|2012|3PG|Kd=460+/-40uM|P52209|6-PHOSPHOGLUCONATE DEHYDROGENASE, DECARBOXYLATING|3.34|Kd=460uM|Kd|=|460|uM|460000|nM
4AB9|1.20|2012|VXQ|ligand is CC 00813|P00760|TRYPSIN|3.33|Kd=466uM|Kd|=|466|uM|466000|nM
3UOD|2.50|2012|0C3|ligand is compound 4; Kd=49+/-5.2nM; IC50=35+/-4.1nM|O14965|SERINE/THREONINE-PROTEIN KINASE 6|7.31|Kd=49nM|Kd|=|49|nM|49|nM
4AHU|1.90|2012|ICO|ligand is compound 67|P12497|HIV-1 INTEGRASE|2.27|Kd=5.4mM|Kd|=|5.4|mM|5400000|nM
3TKW|1.55|2012|017|ligand is DRV; Kd=5.4+/-1.4uM|P03367|HIV-1 PROTEASE|5.27|Kd=5.4uM|Kd|=|5.4|uM|5400|nM
3ZRC|2.90|2012|L8B|compound 15; Kd=5.4+/-0.uM;|Q15370|TRANSCRIPTION ELONGATION FACTOR B POLYPEPTIDE 2|5.27|Kd=5.4uM|Kd|=|5.4|uM|5400|nM
3UG2|2.50|2012|IRE|Kd=5.6nM(G719S/T790M); Kd=31.9nM(G719S); Kd=14.2nM(WT)|P00533|EPIDERMAL GROWTH FACTOR RECEPTOR|8.25|Kd=5.6nM|Kd|=|5.6|nM|5.6|nM
2LSR|NMR|2012|16-mer|ligand is 16-mer peptide from Cadherin-23; Kd=5.7+/-0.6uM|Q9Y6N9|HARMONIN|5.24|Kd=5.7uM|Kd|=|5.7|uM|5700|nM
3TZ2|2.85|2012|CLT|ligand is compound 4;Kd=5.7+/-0.7uM|Q00972|3-METHYL-2-OXOBUTANOATE DEHYDROGENASE|5.24|Kd=5.7uM|Kd|=|5.7|uM|5700|nM
4E81|1.90|2012|10-mer|Kd=5.8+/-1.7uM; ligand is apidaecin peptide fragment; incomplete ligand|P0A6Y8|CHAPERONE PROTEIN DNAK|5.24|Kd=5.8uM|Kd|=|5.8|uM|5800|nM
4FK7|1.78|2012|P34|Kd = 5.8 +/- 2.6 uM, Ki = 9.6 +/- 0.3 uM, IC50 = 32.3 +/- 1.1 uM; incomplete ligand structure; X-ray(the catalytic domain of Certhrax ), Kd,Ki,IC50 (full length Certhrax)|Q4MV79|PUTATIVE ADP-RIBOSYLTRANSFERASE CERTHRAX|5.24|Kd=5.8uM|Kd|=|5.8|uM|5800|nM
4B1J|2.08|2012|A1R|complex between hPARG26 and ADP-HPD; Kd=50.0+/-6.4nM; IC50=1.10+/-0.22uM|Q86W56|POLY(ADP-RIBOSE) GLYCOHYDROLASE|7.3|Kd=50.0nM|Kd|=|50|nM|50|nM
3T0W|1.50|2012|DIW||------|IMMUNOGLOBULIN VARIABLE LAMBDA DOMAIN|7.3|Kd=50nM|Kd|=|50|nM|50|nM
3UPK|2.00|2012|UD1|ligand is UNAG|P33038|UDP-N-ACETYLGLUCOSAMINE 1-CARBOXYVINYLTRANSFERASE|4.3|Kd=50uM|Kd|=|50|uM|50000|nM
4I3Z|2.05|2012|ADP|Kd=51.3+/-1.1uM([Mg2+]=10mM,[ADP]=5mM), Mg-containing|P24941|CELL DIVISION PROTEIN KINASE 2|4.29|Kd=51.3uM|Kd|=|51.3|uM|51300|nM
3ZSX|1.95|2012|N44|ligand is compound 9; Kd=519+/-49uM(Core3H); Kd=880+/-99uM(Core4H)|Q76353|HIV-1 INTEGRASE|3.28|Kd=519uM|Kd|=|519|uM|519000|nM
3UOJ|2.90|2012|0C5|compound 9; Kd=51+/-5.5nM; IC50=43+/-8.0nM|O14965|AURORA KINASE A|7.29|Kd=51nM|Kd|=|51|nM|51|nM
4FL1|1.79|2012|ANP|Kd=520+/-60uM; Mg-containing|P43405|TYROSINE-PROTEIN KINASE SYK|3.28|Kd=520uM|Kd|=|520|uM|520000|nM
3SBH|1.65|2012|E65|ligand is compound 2f; Zn-containing; Kd by ITC (37C,pH=7.0)|P00918|CARBONIC ANHYDRASE 2|7.28|Kd=52nM|Kd|=|52|nM|52|nM
3TZD|1.81|2012|19-mer|complex Cbx3-H1K26me2; incomplete ligand|Q13185|CHROMOBOX PROTEIN HOMOLOG 3|4.28|Kd=52uM|Kd|=|52|uM|52000|nM
4FAK|1.70|2012|SAM|Kd1=52+/-0.4 uM, Kd2=606+/-2 uM; each monomer of OrfX bound AdoMet but with different binding affinities|P0C1V0|RIBOSOMAL RNA LARGE SUBUNIT METHYLTRANSFERASE H|4.28|Kd=52uM|Kd|=|52|uM|52000|nM
4AOC|2.70|2012|A1Q||Q1BKJ8|BC2L-A LECTIN|4.27|Kd=53.8uM|Kd|=|53.8|uM|53800|nM
4GQ6|1.55|2012|12-mer||O00255|MENIN|7.28|Kd=53nM|Kd|=|53|nM|53|nM
4EWR|1.50|2012|14-mer|ligand is Histone-lysine N-methyltransferase SETD1A|P61964|WD REPEAT-CONTAINING PROTEIN 5|6.27|Kd=541nM|Kd|=|541|nM|541|nM
4ERY|1.30|2012|14-mer|ligand is Histone-lysine N-methyltransferase MLL3, Win motif peptide|P61964|WD REPEAT-CONTAINING PROTEIN 5|7.27|Kd=54nM|Kd|=|54|nM|54|nM
3V3B|2.00|2012|16-mer|peptide SAH-p53-8; incomplete ligand|Q00987|E3 UBIQUITIN-PROTEIN LIGASE MDM2|7.26|Kd=55nM|Kd|=|55|nM|55|nM
4EFG|1.58|2012|RET|Kd=55+/-5nM, covalent complex|P50120|RETINOL-BINDING PROTEIN 2|7.26|Kd=55nM|Kd|=|55|nM|55|nM
4FM7|1.56|2012|0UP|ligand is compound 14g; binding free energy = -9.88 kcal/mol (ITC); IC50=0.10uM|P56817|BETA-SECRETASE 1|7.24|Kd=57nM|Kd|=|57|nM|57|nM
4AVH|2.10|2012|FK9|ligand is compound 1; Kd=59.5+/-4.7nM|A2IC68|FIMH PROTEIN|7.23|Kd=59.5nM|Kd|=|59.5|nM|59.5|nM
2LTW|NMR|2012|14-mer|Kd=59.8+/-3.4uM|P46937|YORKIE HOMOLOG|4.22|Kd=59.8uM|Kd|=|59.8|uM|59800|nM
3ZSY|2.20|2012|OM3|ligand is compound 7; Kd=595+/-16uM(Core3H); Kd=1180+/-198uM(Core4H)|Q76353|HIV-1 INTEGRASE|3.23|Kd=595uM|Kd|=|595|uM|595000|nM
3UPV|1.60|2012|7-mer|ligand is PTVEEVD; Kd=5+/-0.4uM|P15705|HEAT SHOCK PROTEIN STI1|5.3|Kd=5uM|Kd|=|5|uM|5000|nM
4G0Z|1.75|2012|5GP|Kd=6.13+/-1.03mM|O04379|PROTEIN ARGONAUTE 1|2.21|Kd=6.13mM|Kd|=|6.13|mM|6130000|nM
4A6S|2.15|2012|GS9|ligand is compound 11; Kd=6.3+/-0.4uM|Q05097|PA-I GALACTOPHILIC LECTIN|5.2|Kd=6.3uM|Kd|=|6.3|uM|6300|nM
3T4P|1.77|2012|4-mer|Kd=6.43+/-0.9uM|G1C2I2|O-ACETYL SERINE SULFHYDRYLASE|5.19|Kd=6.43uM|Kd|=|6.43|uM|6430|nM
4AHS|1.75|2012|AKH|ligand is compound 66|P12497|HIV-1 INTEGRASE|2.19|Kd=6.4mM|Kd|=|6.4|mM|6400000|nM
2LHA|NMR|2012|IHP||P21579|SYNAPTOTAGMIN-1|5.19|Kd=6.4uM|Kd|=|6.4|uM|6400|nM
4AHR|1.90|2012|I2E|ligand is compound 63|P12497|HIV-1 INTEGRASE|2.19|Kd=6.5mM|Kd|=|6.5|mM|6500000|nM
4G0L|2.62|2012|GSH||P42620|PROTEIN YQJG|5.19|Kd=6.5uM|Kd|=|6.5|uM|6500|nM
4DUH|1.50|2012|RLI|Kd=6.6+/-2.0uM|P0AES6|DNA GYRASE SUBUNIT B|5.18|Kd=6.6uM|Kd|=|6.6|uM|6600|nM
2YNN|1.78|2012|8-mer|Kd=6.8+/-2.6uM|P41811|COATOMER SUBUNIT BETA|5.17|Kd=6.8uM|Kd|=|6.8|uM|6800|nM
3UVW|1.37|2012|12-mer|ligand is H4K5K8; Kd=6.8+/-0.1uM|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|5.17|Kd=6.8uM|Kd|=|6.8|uM|6800|nM
2LTV|NMR|2012|12-mer|Kd=6.9+/-0.3uM|P46937|YORKIE HOMOLOG|5.16|Kd=6.9uM|Kd|=|6.9|uM|6900|nM
4FQO|1.65|2012|AZ3|Kd=6.9+/-0.9uM|P02638|PROTEIN S100-B|5.16|Kd=6.9uM|Kd|=|6.9|uM|6900|nM
4AV5|1.40|2012|FYZ|ligand is compound 8; Kd=61.0+/-9.6nM|A2IC68|FIMH PROTEIN|7.21|Kd=61.0nM|Kd|=|61|nM|61|nM
3UEC|2.18|2012|4-mer|ligand is N-TERMINAL FRAGMENT OF HISTONE H3, Kd=61.7+/-8.5uM|O15392|BACULOVIRAL IAP REPEAT-CONTAINING PROTEIN 5|4.21|Kd=61.7uM|Kd|=|61.7|uM|61700|nM
4AD2|2.10|2012|GLC-IFM||D6D1V7|GLYCOSYL HYDROLASE FAMILY 71|6.2|Kd=625nM|Kd|=|625|nM|625|nM
4G8N|2.30|2012|G8M||P42264|GLUTAMATE RECEPTOR, IONOTROPIC KAINATE 3|7.2|Kd=63nM|Kd|=|63|nM|63|nM
3RG2|3.10|2012|2-mer|ligand is SVS-PNS (compound 1); Kd=63+/-4.8uM; covalent complex|P10378|ENTEROBACTIN SYNTHASE COMPONENT E (ENTE)|4.2|Kd=63uM|Kd|=|63|uM|63000|nM
4GZX|2.45|2012|2-mer|ligand is SIA-GAL; Kd=645+/-55uM|K7N5N3|NEURAMINIDASE|3.19|Kd=645uM|Kd|=|645|uM|645000|nM
3TSK|2.00|2012|QEG|ligand is compound 8|P39900|MACROPHAGE METALLOELASTASE (MMP-12)|7.17|Kd=67nM|Kd|=|67|nM|67|nM
4B9W|2.10|2012|13-mer|Kd=68+/-6uM; ligand is peptide from PIWI-LIKE PROTEIN 2; incomplete ligand|Q99MV1|TUDOR DOMAIN-CONTAINING PROTEIN 1|4.17|Kd=68.0uM|Kd|=|68|uM|68000|nM
2YMD|1.96|2012|SRO|Kd=693+/-29uM|Q8WSF8|ACETYLCHOLINE RECEPTOR|3.16|Kd=693uM|Kd|=|693|uM|693000|nM
4ACI|1.65|2012|CIT|Mg-containing; Crystal Form II|Q8NQ97|HTH-TYPE TRANSCRIPTIONAL REPRESSOR ACNR|2.22|Kd=6mM|Kd|=|6|mM|6000000|nM
3U2Q|2.70|2012|12-mer|compound LFF571(4)|P0CE47|ELONGATION FACTOR TU 1|8.22|Kd=6nM|Kd|=|6|nM|6|nM
4B0J|2.50|2012|3MQ|fragment 1, ITC K=141+/-3.68|O33877|3-HYDROXYDECANOYL-[ACYL-CARRIER-PROTEIN] DEHYDRATAS|2.15|Kd=7.1mM|Kd|=|7.1|mM|7100000|nM
2YI0|1.60|2012|YI0|ligand is ICPD 26|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|8.12|Kd=7.5nM|Kd|=|7.5|nM|7.5|nM
2Y8O|1.95|2012|14-mer|ligand is pepMKK6|Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|5.12|Kd=7.5uM|Kd|=|7.5|uM|7500|nM
4AY6|3.30|2012|12V|complex hOGT and UDP-55-GlcNac; Kd=7.5+/-0.1uM|O15294|UDP-N-ACETYLGLUCOSAMINE--PEPTIDE|5.12|Kd=7.5uM|Kd|=|7.5|uM|7500|nM
3ZSO|1.75|2012|O2N|ligand is compound 11; Kd=7.6+/-1.2uM(Core3H); Kd=76+/-11uM(Core4H)|Q76353|HIV-1 INTEGRASE|5.12|Kd=7.6uM|Kd|=|7.6|uM|7600|nM
4F1L|1.90|2012|0RY||Q460N5|POLY [ADP-RIBOSE] POLYMERASE 14|5.12|Kd=7.6uM|Kd|=|7.6|uM|7600|nM
4AZE|3.15|2012|3RA||Q13627|DUAL SPECIFICITY TYROSINE-PHOSPHORYLATION-REGULATED KINASE|8.11|Kd=7.8nM|Kd|=|7.8|nM|7.8|nM
4EEJ|1.50|2012|RET|Kd=70+/-6nM, covalent complex|P50120|RETINOL-BINDING PROTEIN 2|7.15|Kd=70nM|Kd|=|70|nM|70|nM
4ABH|1.25|2012|7Z3|ligand is CC 38513|P00760|TRYPSIN|4.15|Kd=71uM|Kd|=|71|uM|71000|nM
3TH0|1.75|2012|5-mer|ITC assay, T=22.5C, ligand is P22 TSP|P12528|BIFUNCTIONAL TAIL PROTEIN|4.12|Kd=75.8uM|Kd|=|75.8|uM|75800|nM
3TTP|2.23|2012|017|ligand is darunavir|P03367|HIV-1 PROTEASE|9.12|Kd=750pM|Kd|=|750|pM|0.75|nM
4ERQ|1.91|2012|14-mer|ligand is Histone-lysine N-methyltransferase MLL2, Win motif peptide|P61964|WD REPEAT-CONTAINING PROTEIN 5|7.12|Kd=75nM|Kd|=|75|nM|75|nM
4AJK|2.03|2012|88S|compound 22|P04642|L-LACTATE DEHYDROGENASE A CHAIN|3.11|Kd=770uM|Kd|=|770|uM|770000|nM
4AJ1|1.87|2012|AJ1|compound 12, SPR Kd=770uM, NMR Kd=1000uM|P04642|L-LACTATE DEHYDROGENASE A CHAIN|3.11|Kd=770uM|Kd|=|770|uM|770000|nM
3V4T|2.50|2012|UD1|ligand is UNAG|P33038|UDP-N-ACETYLGLUCOSAMINE 1-CARBOXYVINYLTRANSFERASE|4.11|Kd=77uM|Kd|=|77|uM|77000|nM
3UDD|1.95|2012|34M|ligand is compound 24|O95271|TANKYRASE-1|7.1|Kd=79nM|Kd|=|79|nM|79|nM
4EO8|1.80|2012|0S3|Kd(HCV NS5B GT-1b delta21); IC50(RNA dependent HCV GT-1b NS5B polymerase)|P26663|RNA-DIRECTED RNA POLYMERASE|8.15|Kd=7nM|Kd|=|7|nM|7|nM
4DCS|2.25|2012|GDP|Kd=8.0+/-1.0uM (no salt)|P50743|GTP-BINDING PROTEIN ENGA|5.1|Kd=8.0uM|Kd|=|8|uM|8000|nM
3TB6|2.21|2012|ARB|Kd=8.4+/-0.4uM|P96711|ARABINOSE METABOLISM TRANSCRIPTIONAL REPRESSOR|5.08|Kd=8.4uM|Kd|=|8.4|uM|8400|nM
4B0C|2.70|2012|C9H|fragment 3, ITC K=118+/-2.98|O33877|3-HYDROXYDECANOYL-[ACYL-CARRIER-PROTEIN] DEHYDRATAS|2.07|Kd=8.5mM|Kd|=|8.5|mM|8500000|nM
2YFA|1.80|2012|LMR||Q88E10|METHYL-ACCEPTING CHEMOTAXIS TRANSDUCER|5.07|Kd=8.5uM|Kd|=|8.5|uM|8500|nM
4F8J|1.60|2012|HC4|ligand is COU|Q6N8W4|PUTATIVE BRANCHED-CHAIN AMINO ACID TRANSPORT SYSTEM|5.07|Kd=8.6uM|Kd|=|8.6|uM|8600|nM
4FXP|1.95|2012|ADX|Kd1=80.4+/-5.2uM(first site); Kd2=460+/-99uM(second site)|Q43295|ADENYLYL-SULFATE KINASE 1|4.09|Kd=80.4uM|Kd|=|80.4|uM|80400|nM
4EMF|1.77|2012|M7G||D9J2T9|RRNA N-GLYCOSIDASE|7.08|Kd=83.9nM|Kd|=|83.9|nM|83.9|nM
4AOM|1.94|2012|18-mer|ligand is MYOSIN-A;Kd=85+/-6nM|Q8I4W8|MYOSIN A TAIL DOMAIN INTERACTING PROTEIN|7.07|Kd=85nM|Kd|=|85|nM|85|nM
2LOZ|NMR|2012|14-mer|ligand is Rho GTPase-activating protein 7.|Q63HR2|TENSIN-LIKE C1 DOMAIN-CONTAINING PHOSPHATASE|4.06|Kd=86.5uM|Kd|=|86.5|uM|86500|nM
4FEM|2.50|2012|ACX|Kd = 86.96 +/- 19.7 uM;|G8JZT0|OUTER MEMBRANE PROTEIN SUSE|4.06|Kd=86.96uM|Kd|=|86.96|uM|86960|nM
4DXG|2.50|2012|4-mer|Kd=87.0+/-4.5nM|A6QE81|STAPHYLOCOCCAL ENTEROTOXIN-LIKE TOXIN|7.06|Kd=87.0nM|Kd|=|87|nM|87|nM
4ERZ|1.75|2012|14-mer|ligand is Histone-lysine N-methyltransferase MLL4, Win motif peptide|P61964|WD REPEAT-CONTAINING PROTEIN 5|7.06|Kd=88nM|Kd|=|88|nM|88|nM
3U3F|3.10|2012|17-mer|ligand is paxillin LD4 motifs peptide|Q14289|PROTEIN-TYROSINE KINASE 2-BETA|5.1|Kd=8uM|Kd|=|8|uM|8000|nM
3TZ0|2.50|2012|03H|ligand is compound 2; Kd=9.2+/-1.4uM|Q00972|3-METHYL-2-OXOBUTANOATE DEHYDROGENASE|5.04|Kd=9.2uM|Kd|=|9.2|uM|9200|nM
3USX|2.28|2012|MYR|ligand is Myristic Acid; Kd=9.53+/-0.10uM|Q9GK12|PEPTIDOGLYCAN RECOGNITION PROTEIN 1|5.02|Kd=9.53uM|Kd|=|9.53|uM|9530|nM
4DOW|1.95|2012|12-mer|ligandis H4K20me2 peptide|Q9Z1N2|ORIGIN RECOGNITION COMPLEX SUBUNIT 1|5.02|Kd=9.6uM|Kd|=|9.6|uM|9600|nM
3UDA|2.51|2012|SUS-IDY|compound 92|P05230|HEPARIN-BINDING GROWTH FACTOR 1|5.01|Kd=9.71uM|Kd|=|9.71|uM|9710|nM
3VJE|2.12|2012|ZGA|ligand is ZA-A; Kd=9.7+/-0.4nM|A9JQL9|DEHYDROSQUALENE SYNTHASE|8.01|Kd=9.7nM|Kd|=|9.7|nM|9.7|nM
4AGQ|1.42|2012|P96|ligand is compound 13; Kd by ITC|P04637|CELLULAR TUMOR ANTIGEN P53|5.01|Kd=9.7uM|Kd|=|9.7|uM|9700|nM
4AV4|1.90|2012|FVQ|ligand is compound 7; Kd=94.3+/-18.1nM|A2IC68|FIMH PROTEIN|7.03|Kd=94.3nM|Kd|=|94.3|nM|94.3|nM
4FXZ|2.60|2012|LEU|Kd=99.4+/-51.nM(detergents: C12M)|O67854|TRANSPORTER|7.03|Kd=94.3nM|Kd|=|94.3|nM|94.3|nM
3ZTD|2.79|2012|ZTD|compound 1; Kd=86.1+/-1.6uM(FP); Kd=96.2+/-4.6uM(ITC)|Q15370|TRANSCRIPTION ELONGATION FACTOR B POLYPEPTIDE 2|4.02|Kd=96.2uM|Kd|=|96.2|uM|96200|nM
4FE9|2.00|2012|MTT|Kd = 990.1 +/- 107.8 uM; Na-cnotaining|G8JZS6|OUTER MEMBRANE PROTEIN SUSF|3.0|Kd=990.1uM|Kd|=|990.1|uM|990100|nM
4B8Y|1.90|2012|6-mer|Fe-containing; Kd=9+/-0.5nM; ligand is peptide from VIRULENCE FACTOR|Q2FVW9|FHUD2|8.05|Kd=9nM|Kd|=|9|nM|9|nM
4FMQ|2.10|2012|17-mer|ligand is pepSynth-revD|P28482|MITOGEN-ACTIVATED PROTEIN KINASE 1|5.05|Kd=9uM|Kd|=|9|uM|9000|nM
3UZD|1.86|2012|17-mer|complex 14-3-3 gamma and pHDAC4; Kd=9+/-2uM; incomplete ligand|P61981|14-3-3 PROTEIN GAMMA|5.05|Kd=9uM|Kd|=|9|uM|9000|nM
4EUO|1.28|2012|ABU|Kd=9+/-2uM|A9CGA5|ABC TRANSPORTER, SUBSTRATE BINDING PROTEIN|5.05|Kd=9uM|Kd|=|9|uM|9000|nM
3UD5|2.00|2012|J1A|compound HPPK-17|P26281|2-AMINO-4-HYDROXY-6-HYDROXYMETHYLDIHYDROPTERIDINE|3.82|Kd>150uM|Kd|>|150|uM|150000|nM
3ZT1|1.75|2012|OM1|compound 4; Kd(Core3H); Kd>2000uM(Core4H)|Q76353|INTEGRASE|2.7|Kd>2000uM|Kd|>|2000|uM|2000000|nM
3ZSZ|2.00|2012|OM2|compound 6; Kd(Core3H); Kd>2000uM(Core4H)|Q76353|INTEGRASE|2.7|Kd>2000uM|Kd|>|2000|uM|2000000|nM
3ZSW|1.80|2012|ZSW|compound 8; Kd(Core3H); Kd>2000uM(Core4H)|Q76353|INTEGRASE|2.7|Kd>2000uM|Kd|>|2000|uM|2000000|nM
4AWJ|2.50|2012|V6F|compound 13|Q15370|TRANSCRIPTION ELONGATION FACTOR B POLYPEPTIDE 2|2.0|Kd~10000uM|Kd|~|10000|uM|10000000|nM
4EDU|2.58|2012|16-mer|ligand is H2AK36mel peptide|Q9UQR0|SEX COMB ON MIDLEG-LIKE PROTEIN 2|3.99|Kd~102uM|Kd|~|102|uM|102000|nM
3QO3|2.15|2012|ATP||P0A6X3|PROTEIN HFQ|6.9|Kd~125nM|Kd|~|125|nM|125|nM
3AZ9|2.75|2012|K91|ligand is NAS91|Q965D7|BETA-HYDROXYACYL-ACP DEHYDRATASE|6.0|Kd~1uM|Kd|~|1|uM|1000|nM
3AZ8|3.10|2012|S21|ligand is NAS21|Q965D7|BETA-HYDROXYACYL-ACP DEHYDRATASE|6.0|Kd~1uM|Kd|~|1|uM|1000|nM
4EMT|1.50|2012|C2E||Q86WV6|TRANSMEMBRANE PROTEIN 173|5.3|Kd~5uM|Kd|~|5|uM|5000|nM
4HXJ|2.00|2012|3-mer||P12931|TYROSINE-PROTEIN KINASE SRC|4.13|Kd~74.3uM|Kd|~|74.3|uM|74300|nM
4BB2|2.48|2012|STR||P08185|CORTICOSTEROID-BINDING GLOBULIN|7.07|Kd~85nM|Kd|~|85|nM|85|nM
4FE6|2.00|2012|0TQ||P03367|HIV-1 PROTEASE|10.0|Ki<0.10nM|Ki|<|0.1|nM|0.1|nM
4A7I|2.40|2012|A7I|ligand is compound 1a|P00742|COAGULATION FACTOR X|8.7|Ki=0.002uM|Ki|=|0.002|uM|2|nM
4DJR|1.55|2012|0KJ||Q90K99|HIV-1 PROTEASE|11.52|Ki=0.003nM|Ki|=|0.003|nM|0.003|nM
4AOI|1.90|2012|4K0|ligand is compound 24|P08581|HEPATOCYTE GROWTH FACTOR RECEPTOR|8.4|Ki=0.004uM|Ki|=|0.004|uM|4|nM
4AP7|1.80|2012|F47|ligand is compound 12|P08581|HEPATOCYTE GROWTH FACTOR RECEPTOR|7.96|Ki=0.011uM|Ki|=|0.011|uM|11|nM
3VDC|2.55|2012|IPT|complex N460T and IPTG; Ki=0.012+/-0.001mM|P00722|BETA-GALACTOSIDASE|4.92|Ki=0.012mM|Ki|=|0.012|mM|12000|nM
3UTU|1.55|2012|1TS|ligand is compound 65|P00734|THROMBIN|10.92|Ki=0.012nM|Ki|=|0.012|nM|0.012|nM
3UW5|1.71|2012|4-mer||Q96CA5|BACULOVIRAL IAP REPEAT-CONTAINING PROTEIN 7|7.85|Ki=0.014uM|Ki|=|0.014|uM|14|nM
3VD4|2.00|2012|IPT|complex between N460D and IPTG; Ki=0.015+/-0.001mM|P00722|BETA-GALACTOSIDASE|4.82|Ki=0.015mM|Ki|=|0.015|mM|15000|nM
4AMY|2.00|2012|2P2|covalent complex; compound IC-1; Ki=0.015+/-0.005nM; IC50=0.26+/-0.09nM|P23687|PROLYL ENDOPEPTIDASE|10.82|Ki=0.015nM|Ki|=|0.015|nM|0.015|nM
4GID|2.00|2012|0GH||P56817|BETA-SECRETASE 1|10.77|Ki=0.017nM|Ki|=|0.017|nM|0.017|nM
3UW4|1.79|2012|4-mer||Q13490|BACULOVIRAL IAP REPEAT-CONTAINING PROTEIN 2|7.77|Ki=0.017uM|Ki|=|0.017|uM|17|nM
4ASE|1.83|2012|AV9|complex between tivozanib and plus-JM|P35968|VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2|11.0|Ki=0.01nM|Ki|=|0.01|nM|0.01|nM
4AGC|2.00|2012|AXI|complex between axitinib and plus-JM|P35968|VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2|10.7|Ki=0.020nM|Ki|=|0.02|nM|0.02|nM
3T5U|1.75|2012|A09|ligand is compound 53|P00918|CARBONIC ANHYDRASE 2|7.59|Ki=0.026uM|Ki|=|0.026|uM|26|nM
4DJP|1.40|2012|M73||Q90K99|HIV-1 PROTEASE|10.55|Ki=0.028nM|Ki|=|0.028|nM|0.028|nM
4AN0|2.20|2012|2P6|covalent complex; compound IC-3; Ki=0.02+/-0.005nM; IC50=0.2+/-0.04nM|P23687|PROLYL ENDOPEPTIDASE|10.7|Ki=0.02nM|Ki|=|0.02|nM|0.02|nM
4E7R|2.25|2012|0NW||P00734|THROMBIN LIGHT CHAIN|7.7|Ki=0.02uM|Ki|=|0.02|uM|20|nM
3VD7|2.87|2012|GTZ|complex N460S and GTZ; Ki=0.033+/-0.005mM|P00722|BETA-GALACTOSIDASE|4.48|Ki=0.033mM|Ki|=|0.033|mM|33000|nM
4DQ2|2.50|2012|BTX|ligand is compound 2; Ki=0.03+/-0.01uM|E5R5T0|BIOTIN-[ACETYL-COA-CARBOXYLASE] LIGASE|7.52|Ki=0.03uM|Ki|=|0.03|uM|30|nM
4AZ2|2.60|2012|9MU|ligand is compound 3b or 3c, but RS chiral bond not identical|P00734|THROMBIN LIGHT CHAIN|7.33|Ki=0.047uM|Ki|=|0.047|uM|47|nM
4DJQ|1.40|2012|M86||Q90K99|HIV-1 PROTEASE|10.32|Ki=0.048nM|Ki|=|0.048|nM|0.048|nM
4AN1|1.90|2012|2P8|covalent complex; compound IC-4; IC50=0.83+/-0.09nM|P23687|PROLYL ENDOPEPTIDASE|10.26|Ki=0.055nM|Ki|=|0.055|nM|0.055|nM
3T0B|2.40|2012|IPT|ligand is IPTG; Na-containing|P00722|BETA-GALACTOSIDASE|4.3|Ki=0.05mM|Ki|=|0.05|mM|50000|nM
4E3N|1.49|2012|0NE|covalent complex|P00811|BETA-LACTAMASE|10.3|Ki=0.05nM|Ki|=|0.05|nM|0.05|nM
4APP|2.20|2012|N53|ligand is compound 3; Ki(SDS-PAGE and autoradiography, ref 13)|O96013|SERINE/THREONINE-PROTEIN KINASE PAK 4|7.19|Ki=0.064uM|Ki|=|0.064|uM|64|nM
3UZ5|1.90|2012|0CU|complex between R13-3/11H and 5,7-Cl; Ki=0.06+/-0.02uM|------|KEMP ELIMINASE KE59 R13 3/11H|7.22|Ki=0.06uM|Ki|=|0.06|uM|60|nM
3TFV|3.00|2012|2CN|ligand is compound 16|A9JQL9|DEHYDROSQUALENE SYNTHASE|7.1|Ki=0.08uM|Ki|=|0.08|uM|80|nM
4BBH|1.63|2012|YBN||A5K1A2|GLYCYLPEPTIDE N-TETRADECANOYLTRANSFERASE|7.1|Ki=0.08uM|Ki|=|0.08|uM|80|nM
3V7S|3.10|2012|36F|ligand is compound 14;Ki=0.09+/-0.01uM|C8N5A9|BIOTIN LIGASE|7.05|Ki=0.09uM|Ki|=|0.09|uM|90|nM
3VD9|2.05|2012|IPT|complex between N460S and IPTG; Ki=0.10+/-0.01mM|P00722|BETA-GALACTOSIDASE|4.0|Ki=0.10mM|Ki|=|0.1|mM|100000|nM
3SUD|1.96|2012|SUE|ligand is MK-5172; Ki=0.14+/-0.02nM|A8DG50|NS3/4A PROTEASE|9.85|Ki=0.14nM|Ki|=|0.14|nM|0.14|nM
4AMZ|2.00|2012|2P4|covalent complex; compound IC-2; Ki=0.15+/-0.08nM; IC50=0.3+/-0.15nM|P23687|PROLYL ENDOPEPTIDASE|9.82|Ki=0.15nM|Ki|=|0.15|nM|0.15|nM
3T09|1.75|2012|149|ligand is D-galactonolactone; Na-containing|P00722|BETA-GALACTOSIDASE|3.8|Ki=0.16mM|Ki|=|0.16|mM|160000|nM
4B7Q|2.73|2012|ZMR|Ki=0.18+/-0.03nM|C7FH46|NEURAMINIDASE|9.74|Ki=0.18nM|Ki|=|0.18|nM|0.18|nM
4DJV|1.73|2012|0KM|ligand is R-4b in crystal structure|P56817|BETA-SECRETASE 1|6.72|Ki=0.19uM|Ki|=|0.19|uM|190|nM
4AYW|3.30|2012|ANP|plate form|Q9NRK6|ATP-BINDING CASSETTE SUB-FAMILY B MEMBER 10|4.0|Ki=0.1mM|Ki|=|0.1|mM|100000|nM
3T2Q|2.40|2012|149|ligand is D-galactonolactone; Na-containing|P00722|BETA-GALACTOSIDASE|3.66|Ki=0.22mM|Ki|=|0.22|mM|220000|nM
4ACG|2.60|2012|6LQ|compound 25|P49841|GLYCOGEN SYNTHASE KINASE-3 BETA|9.66|Ki=0.22nM|Ki|=|0.22|nM|0.22|nM
2YFE|2.00|2012|YFE|ligand is Amorfrutin 1|P37231|PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA|6.63|Ki=0.236uM|Ki|=|0.236|uM|236|nM
3S54|1.42|2012|017|ligand is DRV; in space group P21212|Q7SSI0|HIV-1 PROTEASE|9.64|Ki=0.23nM|Ki|=|0.23|nM|0.23|nM
3S53|1.50|2012|017|ligand is DRV; in space group P212121; redundant to 3s54|Q7SSI0|HIV-1 PROTEASE|9.64|Ki=0.23nM|Ki|=|0.23|nM|0.23|nM
4B7R|1.90|2012|G39|Ki=0.23+/-0.12nM|C7FH46|NEURAMINIDASE|9.64|Ki=0.23nM|Ki|=|0.23|nM|0.23|nM
3S56|1.88|2012|ROC|ligand is SQV|Q7SSI0|HIV-1 PROTEASE|9.62|Ki=0.24nM|Ki|=|0.24|nM|0.24|nM
3T2P|2.60|2012|IPT|the ligand is IPTG; Na-containing|P00722|BETA-GALACTOSIDASE|3.6|Ki=0.25mM|Ki|=|0.25|mM|250000|nM
4AX9|1.90|2012|N5N|ligand is compound 19f|P00734|PROTHROMBIN|9.57|Ki=0.27nM|Ki|=|0.27|nM|0.27|nM
3TFN|2.07|2012|2CJ|ligand is compound 6|A9JQL9|DEHYDROSQUALENE SYNTHASE|6.57|Ki=0.27uM|Ki|=|0.27|uM|270|nM
4AFH|1.88|2012|L0B|complex between Ct-AChBP and lobeline; Ki=0.29+/-0.06nM|I6L8L2|CAPITELLA TELETA ACHBP|9.54|Ki=0.29nM|Ki|=|0.29|nM|0.29|nM
4AYT|2.85|2012|ACP|rod form A|Q9NRK6|ATP-BINDING CASSETTE SUB-FAMILY B MEMBER 10|3.7|Ki=0.2mM|Ki|=|0.2|mM|200000|nM
4AYX|2.90|2012|ACP|rod form B|Q9NRK6|ATP-BINDING CASSETTE SUB-FAMILY B MEMBER 10|3.7|Ki=0.2mM|Ki|=|0.2|mM|200000|nM
4E3M|1.44|2012|0ND|covalent complex|P00811|BETA-LACTAMASE|9.7|Ki=0.2nM|Ki|=|0.2|nM|0.2|nM
4FK6|2.20|2012|0UJ||P23458|TYROSINE-PROTEIN KINASE JAK1|9.7|Ki=0.2nM|Ki|=|0.2|nM|0.2|nM
3T64|1.65|2012|DU3|ligand is compound 15a|Q8II92|DEOXYURIDINE 5'-TRIPHOSPHATE NUCLEOTIDOHYDROLASE|6.7|Ki=0.2uM|Ki|=|0.2|uM|200|nM
3T60|2.40|2012|DUA|lignad is compound 24|Q8II92|DEOXYURIDINE 5'-TRIPHOSPHATE NUCLEOTIDOHYDROLASE|6.7|Ki=0.2uM|Ki|=|0.2|uM|200|nM
4FNS|2.60|2012|DGJ|Ki = 0.2 +/- 0.03 uM|Q9ALJ4|ALPHA-GALACTOSIDASE AGAA|6.7|Ki=0.2uM|Ki|=|0.2|uM|200|nM
4DJH|2.90|2012|JDC||P41145|KAPPA-TYPE OPIOID RECEPTOR, LYSOZYME|9.49|Ki=0.32nM|Ki|=|0.32|nM|0.32|nM
4GFD|1.80|2012|0YB||P65249|THYMIDYLATE KINASE|9.48|Ki=0.33nM|Ki|=|0.33|nM|0.33|nM
3TFP|2.00|2012|03L|ligand is compound 8 (the Cl atom is missing in the reference)|A9JQL9|DEHYDROSQUALENE SYNTHASE|6.47|Ki=0.34uM|Ki|=|0.34|uM|340|nM
4FEA|3.79|2012|0TE|Ki (the specific velocity plot)|P55210|CASPASE-7 (CASP-7)|6.47|Ki=0.34uM|Ki|=|0.34|uM|340|nM
3S9Y|1.70|2012|FNU|ligand is compound 41; Ki=0.36+/-0.03uM(Mt ODCases), X-ray(Hs ODCases)|Q8IJH3|OROTIDINE 5'-PHOSPHATE DECARBOXYLASE|6.44|Ki=0.36uM|Ki|=|0.36|uM|360|nM
4EA1|2.46|2012|3RX|ligand is compound E-3; redundant to 4ea2|A9JQL9|DEHYDROSQUALENE SYNTHASE|6.44|Ki=0.36uM|Ki|=|0.36|uM|360|nM
4EA2|2.05|2012|RWZ|ligand is compound Z-3|A9JQL9|DEHYDROSQUALENE SYNTHASE|6.44|Ki=0.36uM|Ki|=|0.36|uM|360|nM
4EWH|2.50|2012|T77||Q07912|ACTIVATED CDC42 KINASE 1|9.52|Ki=0.3nM|Ki|=|0.3|nM|0.3|nM
3PWK|1.50|2012|L14||A5MTN0|ASPARTATE-SEMIALDEHYDE DEHYDROGENASE|3.35|Ki=0.45mM|Ki|=|0.45|mM|450000|nM
3VF5|1.25|2012|031|Ki=0.46+/-0.04nM|P03367|HIV-1 PROTEASE|9.34|Ki=0.46nM|Ki|=|0.46|nM|0.46|nM
4A4Q|1.80|2012|UX9|ligand is compound 13i|Q8Q3H0|HIV-1 PROTEASE|9.4|Ki=0.4nM|Ki|=|0.4|nM|0.4|nM
2Y8C|2.10|2012|DUQ|ligand is compound 4c|Q8II92|DEOXYURIDINE 5'-TRIPHOSPHATE NUCLEOTIDOHYDROLASE|6.4|Ki=0.4uM|Ki|=|0.4|uM|400|nM
4ASD|2.03|2012|BAX|complex between sorafenib and plus-JM|P35968|VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2|9.28|Ki=0.52nM|Ki|=|0.52|nM|0.52|nM
4DJW|1.90|2012|0KP|ligand is R-4j in crystal structure|P56817|BETA-SECRETASE 1|6.28|Ki=0.53uM|Ki|=|0.53|uM|530|nM
4DV8|1.63|2012|0LX|Zn-containing|P15917|LETHAL FACTOR|9.24|Ki=0.58nM|Ki|=|0.58|nM|0.58|nM
3VH9|1.29|2012|HQY|ligand is compound 9|Q01693|LEUCYL AMINOPEPTIDASE|6.24|Ki=0.58uM|Ki|=|0.58|uM|580|nM
4FKK|2.60|2012|BES|ligand is bestatin|P15145|AMINOPEPTIDASE N|9.3|Ki=0.5nM|Ki|=|0.5|nM|0.5|nM
3T70|1.80|2012|DU4|ligand is compound 15g|Q8II92|DEOXYURIDINE 5'-TRIPHOSPHATE NUCLEOTIDOHYDROLASE|6.3|Ki=0.5uM|Ki|=|0.5|uM|500|nM
3VFA|1.43|2012|031|Ki=0.65+/-0.05nM|P0C6F2|HIV-1 PROTEASE|9.19|Ki=0.65nM|Ki|=|0.65|nM|0.65|nM
4B9K|2.00|2012|TG0||Q15370|TRANSCRIPTION ELONGATION FACTOR B POLYPEPTIDE 2|6.17|Ki=0.67uM|Ki|=|0.67|uM|670|nM
4AYV|2.80|2012|9MQ|compound 19g|P00734|THROMBIN LIGHT CHAIN|9.17|Ki=0.68nM|Ki|=|0.68|nM|0.68|nM
3SU3|1.30|2012|SU3|ligand is Vaniprevir; Ki=0.74+/-0.07nM|A8DG50|NS3/4A PROTEASE|9.13|Ki=0.74nM|Ki|=|0.74|nM|0.74|nM
3VF7|1.30|2012|031|Ki=0.80+/-0.08nM|P03367|HIV-1 PROTEASE|9.1|Ki=0.80nM|Ki|=|0.8|nM|0.8|nM
3SUE|2.20|2012|SUE|ligand is MK-5172; Ki=0.84+/-0.05nM|A8DG50|NS3/4A PROTEASE|9.08|Ki=0.84nM|Ki|=|0.84|nM|0.84|nM
4E3K|1.43|2012|0NA|covalent complex|P00811|BETA-LACTAMASE|9.1|Ki=0.8nM|Ki|=|0.8|nM|0.8|nM
3T08|2.00|2012|IPT|ligand is IPTG; Na-containing|P00722|BETA-GALACTOSIDASE|3.04|Ki=0.91mM|Ki|=|0.91|mM|910000|nM
3VFB|1.55|2012|031|Ki=0.92+/-0.10nM|P03367|HIV-1 PROTEASE|9.04|Ki=0.92nM|Ki|=|0.92|nM|0.92|nM
4E4N|1.90|2012|0NL||P23458|TYROSINE-PROTEIN KINASE JAK1|9.05|Ki=0.9nM|Ki|=|0.9|nM|0.9|nM
4E3B|1.50|2012|10-mer|Ki = 0.9 +/- 0.4 uM; incomplete ligand|O14907|TAX1-BINDING PROTEIN 3|6.05|Ki=0.9uM|Ki|=|0.9|uM|900|nM
3T3E|2.15|2012|GPQ|ligand is GlcClU;Ki=1.02+/-0.15uM|P00489|GLYCOGEN PHOSPHORYLASE|5.99|Ki=1.02uM|Ki|=|1.02|uM|1020|nM
3U6H|2.00|2012|03X|Ki=1.0+/-0.3nM; IC50=20+/-7.5nM(PC3), compound 26|P08581|HEPATOCYTE GROWTH FACTOR RECEPTOR|9.0|Ki=1.0nM|Ki|=|1|nM|1|nM
3V5P|2.10|2012|C88|ligand is compound 12; Ki by nonradioactive luciferase assay|Q9BJF5|CALMODULIN-DOMAIN PROTEIN KINASE 1|8.96|Ki=1.1nM|Ki|=|1.1|nM|1.1|nM
4AG8|1.95|2012|AXI|complex between axitinib and minus-JM|P35968|VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2|8.96|Ki=1.1nM|Ki|=|1.1|nM|1.1|nM
4DE1|1.26|2012|0J6||Q9L5C8|BETA-LACTAMASE CTX-M-9A|5.96|Ki=1.1uM|Ki|=|1.1|uM|1100|nM
4E3J|1.80|2012|0N4|covalent complex|P00811|BETA-LACTAMASE|8.92|Ki=1.2nM|Ki|=|1.2|nM|1.2|nM
4E6D|2.22|2012|0NU||O60674|TYROSINE-PROTEIN KINASE JAK2|8.92|Ki=1.2nM|Ki|=|1.2|nM|1.2|nM
3ZVT|3.10|2012|B07|Ki=1.2+/-0.2uM; Ki2=1.5+/-0.2uM; covalent complex; B-containing|P39045|D-ALANYL-D-ALANINE CARBOXYPEPTIDASE|5.92|Ki=1.2uM|Ki|=|1.2|uM|1200|nM
3ZV7|2.26|2012|NHG|ligand is compound 2a; Ki=1.2+/-0.24uM|P04058|ACETYLCHOLINESTERASE|5.92|Ki=1.2uM|Ki|=|1.2|uM|1200|nM
4GQQ|1.35|2012|0XR|Ki=1.3+/-0.1mM (uncompetitive)|P04746|ALPHA-AMYLASE|2.89|Ki=1.3mM|Ki|=|1.3|mM|1300000|nM
3SX9|2.65|2012|BK7|ligand is compound 3b; nonradioactive Kinaseglo luciferase assay|Q9BJF5|CALMODULIN-DOMAIN PROTEIN KINASE 1|8.89|Ki=1.3nM|Ki|=|1.3|nM|1.3|nM
4E3I|1.60|2012|0N3|covalent complex|P00811|BETA-LACTAMASE|8.89|Ki=1.3nM|Ki|=|1.3|nM|1.3|nM
3U9C|3.20|2012|04G|complex CK2 alpha and resorufin|P68400|CASEIN KINASE II, ALPHA SUBUNIT|5.89|Ki=1.3uM|Ki|=|1.3|uM|1300|nM
4DE0|1.12|2012|0JB||Q9L5C8|BETA-LACTAMASE CTX-M-9A|5.89|Ki=1.3uM|Ki|=|1.3|uM|1300|nM
4E28|2.30|2012|0MZ||P04818|THYMIDYLATE SYNTHASE|5.89|Ki=1.3uM|Ki|=|1.3|uM|1300|nM
4DO5|1.51|2012|DGJ|Ki=1.48+/-0.15uM|P17050|ALPHA-N-ACETYLGALACTOSAMINIDASE|5.83|Ki=1.48uM|Ki|=|1.48|uM|1480|nM
3QQS|1.97|2012|17C|ligand is ACS172; Ki=1.5+/-0.1uM|P66992|ANTHRANILATE PHOSPHORIBOSYLTRANSFERASE|5.82|Ki=1.5uM|Ki|=|1.5|uM|1500|nM
4DLD|2.00|2012|TZG|Ki=1.5+/-0.2uM|P22756|GLUTAMATE RECEPTOR, IONOTROPIC KAINATE 1|5.82|Ki=1.5uM|Ki|=|1.5|uM|1500|nM
4E9U|2.10|2012|RWY|Mg-containing|A9JQL9|DEHYDROSQUALENE SYNTHASE|5.82|Ki=1.5uM|Ki|=|1.5|uM|1500|nM
4B7N|2.84|2012|ZMR|Ki=1.65+/-0.40nM, Influenza A virus (A/Netherlands/2631_1202/2010(H1N1))|F8UU09|NEURAMINIDASE|8.78|Ki=1.65nM|Ki|=|1.65|nM|1.65|nM
2YIV|1.28|2012|NBN|ligand is n-BIC|Q9F8A8|CARBON MONOXIDE DEHYDROGENASE 2|2.78|Ki=1.66mM|Ki|=|1.66|mM|1660000|nM
4GE9|2.43|2012|0L0|compound 4 inhibits KAT II irreversibly via formation of an imine adduct with the aldehyde group of the enzyme co-factor pyridoxal phosphate (PLP), followed by tautomerization to an enamine.|Q8N5Z0|KYNURENINE/ALPHA-AMINOADIPATE AMINOTRANSFERASE|8.8|Ki=1.6nM|Ki|=|1.6|nM|1.6|nM
4G8V|1.70|2012|0EY|Ki=1.6+/-0.2uM|P61823|RIBONUCLEASE|5.8|Ki=1.6uM|Ki|=|1.6|uM|1600|nM
4A95|1.55|2012|9MT|ligand is compound 1; Ki=1.73+/-0.16uM(PvNMT); Ki=1.69+/-0.22uM(HsNMT1); Ki=11.39+/-2.11(HsNMT2)|A5K1A2|GLYCYLPEPTIDE N-TETRADECANOYLTRANSFERASE|5.76|Ki=1.73uM|Ki|=|1.73|uM|1730|nM
3QDD|1.79|2012|94M|ligand is compound 14|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|8.77|Ki=1.7nM|Ki|=|1.7|nM|1.7|nM
4E4L|2.00|2012|0NH||P23458|TYROSINE-PROTEIN KINASE JAK1|8.77|Ki=1.7nM|Ki|=|1.7|nM|1.7|nM
4FRS|1.70|2012|0V6||P56817|BETA-SECRETASE 1|8.77|Ki=1.7nM|Ki|=|1.7|nM|1.7|nM
3V7C|2.70|2012|C77|ligand is compound 7;Ki=1.83+/-0.33uM|C8N5A9|BIOTIN LIGASE|5.74|Ki=1.83uM|Ki|=|1.83|uM|1830|nM
4EI4|2.22|2012|0Q2||P23458|TYROSINE-PROTEIN KINASE JAK1|8.74|Ki=1.8nM|Ki|=|1.8|nM|1.8|nM
4DFG|1.23|2012|0JV||P03367|HIV-1 PROTEASE|11.74|Ki=1.8pM|Ki|=|1.8|pM|0.0018000000000000002|nM
3T3H|2.60|2012|GPV|ligand is GlcIU; Ki=1.94+/-0.09uM|P00489|GLYCOGEN PHOSPHORYLASE|5.71|Ki=1.94uM|Ki|=|1.94|uM|1940|nM
3TS4|1.59|2012|EEG|ligand is compound 3|P39900|MACROPHAGE METALLOELASTASE (MMP-12)|8.72|Ki=1.9nM|Ki|=|1.9|nM|1.9|nM
3SHC|1.90|2012|B01|ligand is compound 8; Ki=1.9+/-0.8uM|P00734|THROMBIN|5.72|Ki=1.9uM|Ki|=|1.9|uM|1900|nM
3TNE|2.40|2012|RIT|data from ref 11|B8YPM3|SECRETED ASPARTIC PROTEASE|5.72|Ki=1.9uM|Ki|=|1.9|uM|1900|nM
4E3G|1.55|2012|PHB|Ki measured in CO2 hydration assay|P00918|CARBONIC ANHYDRASE 2|4.97|Ki=10.6uM|Ki|=|10.6|uM|10600|nM
4B6O|2.00|2012|3DQ||P0A4Z6|3-DEHYDROQUINATE DEHYDRATASE|7.0|Ki=100nM|Ki|=|100|nM|100|nM
4FAI|1.65|2012|PBD|Ki=101.3+/-0.2nM(pH=7); Zn-containing|Q86PD7|CG5976, ISOFORM B|6.99|Ki=101.3nM|Ki|=|101.3|nM|101.3|nM
4FBE|1.88|2012|PBD|Ki=101.3+/-0.2nM(pH=7); Zn-containing; redundant to 4fai|Q86PD7|CG5976, ISOFORM B|6.99|Ki=101.3nM|Ki|=|101.3|nM|101.3|nM
3UMP|1.85|2012|ATP|Ki=1026+/-100uM|P06999|6-PHOSPHOFRUCTOKINASE ISOZYME 2|2.99|Ki=1026uM|Ki|=|1026|uM|1026000|nM
4AA2|1.99|2012|11-mer|complex AnCE and BPPb; incomplete ligand|Q10714|ANGIOTENSIN-CONVERTING ENZYME|3.97|Ki=107uM|Ki|=|107|uM|107000|nM
4A6L|2.05|2012|P43|ligand is compound 2|Q15661|TRYPTASE ALPHA/BETA-1|8.0|Ki=10nM|Ki|=|10|nM|10|nM
4EHZ|2.17|2012|JAK||P23458|TYROSINE-PROTEIN KINASE JAK1|8.0|Ki=10nM|Ki|=|10|nM|10|nM
4B7J|2.42|2012|G39|Ki=11.1+/-1.10nM|F8UU09|NEURAMINIDASE|7.95|Ki=11.1nM|Ki|=|11.1|nM|11.1|nM
3U7N|2.30|2012|UHF|ligand is PMT1067; Ki=11.2+/-1.6nM (T=303K;pH=7;50mM HEPES buffer)|Q5HGZ3|PEPTIDE DEFORMYLASE|7.95|Ki=11.2nM|Ki|=|11.2|nM|11.2|nM
3UXK|2.20|2012|BHO|ligand is compound BzH; Ki=11.7+/-1.2uM|P11444|MANDELATE RACEMASE|4.93|Ki=11.7uM|Ki|=|11.7|uM|11700|nM
4HGE|2.30|2012|15V||O60674|TYROSINE-PROTEIN KINASE JAK2|7.92|Ki=11.9nM|Ki|=|11.9|nM|11.9|nM
4GQR|1.20|2012|MYC|Ki=110+/-15uM (competitive binding)|P04746|ALPHA-AMYLASE|3.96|Ki=110uM|Ki|=|110|uM|110000|nM
3TWP|1.83|2012|SAL|ligand is ACS10; Ki=119+/-20uM|P66992|ANTHRANILATE PHOSPHORIBOSYLTRANSFERASE|3.92|Ki=119uM|Ki|=|119|uM|119000|nM
3UUO|2.11|2012|0CV|ligand is compound 1|Q9Y233|CGMP 3',5'-CYCLIC PHOSPHODIESTERASE|7.96|Ki=11nM|Ki|=|11|nM|11|nM
3VEH|2.00|2012|0GA|ligand is methyl-AMT; Ki=11+/-1uM; Ki(Z/E=9:1) while X-ray(Z-form)|Q7D785|ISOCHORISMATE SYNTHASE/ISOCHORISMATE-PYRUVATE LYASE|4.96|Ki=11uM|Ki|=|11|uM|11000|nM
3SV8|2.50|2012|SV6|ligand is Telaprevir; Ki=12.2+/-0.9nM; covalent complex|A8DG50|NS3/4A PROTEASE|7.91|Ki=12.2nM|Ki|=|12.2|nM|12.2|nM
4A50|2.75|2012|DQ6/DQ7|compound 29; Ki=12.2+/-3.8nM(rac-29); Ki=11.1+/-3.9nM(S-29); Ki=6.4+/-3.9nM(R-29)|P52732|KINESIN-LIKE PROTEIN KIF11|7.91|Ki=12.2nM|Ki|=|12.2|nM|12.2|nM
3T3D|2.50|2012|CJB|ligand is GlcU; Ki=12.39+/-0.94uM|P00489|GLYCOGEN PHOSPHORYLASE|4.91|Ki=12.39uM|Ki|=|12.39|uM|12390|nM
4GK7|2.80|2012|4-mer|Ki=12.5+/-1.5nM (GlbA inhibited the CT-L activity)|P23639|PROTEASOME COMPONENT Y7|7.9|Ki=12.5nM|Ki|=|12.5|nM|12.5|nM
4B5D|2.20|2012|SW4|Ki=12.8+/-0.4nM|I6L8L2|CAPITELLA TELETA ACHBP|7.89|Ki=12.8nM|Ki|=|12.8|nM|12.8|nM
3ZVW|2.00|2012|FP5|Ki=125+/-8uM; covalent complex, B-containing|P39045|D-ALANYL-D-ALANINE CARBOXYPEPTIDASE|3.9|Ki=125uM|Ki|=|125|uM|125000|nM
3UMO|1.70|2012|ATP|Ki=129+/-55uM; measured with 50mM KCl|P06999|6-PHOSPHOFRUCTOKINASE ISOZYME 2|3.89|Ki=129uM|Ki|=|129|uM|129000|nM
4A6C|1.50|2012|QG9|ligand is compound 19b|Q8Q3H0|HIV-1 PROTEASE|7.92|Ki=12nM|Ki|=|12|nM|12|nM
4G0C|2.00|2012|AZM|Zn-containing|P00918|CARBONIC ANHYDRASE 2|7.92|Ki=12nM|Ki|=|12|nM|12|nM
3RV8|2.29|2012|RVC/VCE|ligand is (Z/E)-cyclopropyl-AMT; Ki=12+/-1uM;|Q7D785|ISOCHORISMATE SYNTHASE/ISOCHORISMATE-PYRUVATE LYASE|4.92|Ki=12uM|Ki|=|12|uM|12000|nM
3RV9|2.14|2012|RVD|ligand is ethyl-AMT; Ki=12+/-2uM; Ki(Z/E=10:3), X-ray(Z)|Q7D785|ISOCHORISMATE SYNTHASE/ISOCHORISMATE-PYRUVATE LYASE|4.92|Ki=12uM|Ki|=|12|uM|12000|nM
3SI4|1.27|2012|B04|ligand is compound 5; Ki=132.2+/-35.3uM|P00734|THROMBIN|3.88|Ki=132.2uM|Ki|=|132.2|uM|132200|nM
3SPF|1.70|2012|B50|ligand is compound 4; Ki=138+/-7.6uM|Q07817|BCL-2-LIKE PROTEIN 1|3.86|Ki=138uM|Ki|=|138|uM|138000|nM
4GZP|2.30|2012|G39|Ki=14.3+/-2.3nM; Ca-containing|K7N5N3|NEURAMINIDASE|7.84|Ki=14.3nM|Ki|=|14.3|nM|14.3|nM
4B6R|2.00|2012|3DQ||Q48255|3-DEHYDROQUINATE DEHYDRATASE|5.85|Ki=1420nM|Ki|=|1420|nM|1420|nM
3SUT|1.90|2012|OAN|ligand is PUGNAc; Ki=14+/-2nM|D0VX21|BETA-HEXOSAMINIDASE|7.85|Ki=14nM|Ki|=|14|nM|14|nM
3RV7|2.50|2012|RVB|ligand is (Z)-isopropyl-AMT; Ki=14+/-2uM; Ki(Z/E=4:1), X-ray(Z)|Q7D785|ISOCHORISMATE SYNTHASE/ISOCHORISMATE-PYRUVATE LYASE|4.85|Ki=14uM|Ki|=|14|uM|14000|nM
4EU3|1.58|2012|CIT|Ki=150+/-20mM (LCR assays)|B3EY95|SUCCINYL-COA:ACETATE COENZYME A TRANSFERASE|0.82|Ki=150mM|Ki|=|150|mM|150000000|nM
3R88|1.73|2012|14F|ligand is ACS145; Ki=15+/-4uM|P66992|ANTHRANILATE PHOSPHORIBOSYLTRANSFERASE|4.82|Ki=15uM|Ki|=|15|uM|15000|nM
3T03|2.10|2012|3T0|ligand is GQ-16; another ligand is nuclear receptor coactivator 1(18-mer)|P37231|PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA|6.8|Ki=160nM|Ki|=|160|nM|160|nM
3SU0|1.16|2012|TSV|ligand is Danoprevir; Ki=162+/-16nM|A8DG50|NS3/4A PROTEASE|6.79|Ki=162nM|Ki|=|162|nM|162|nM
4DKT|2.98|2012|5-mer|ligand is peptide from TDFA; Ki=16+/-10uM|Q9UM07|PROTEIN-ARGININE DEIMINASE TYPE-4|4.8|Ki=16uM|Ki|=|16|uM|16000|nM
3T3I|2.65|2012|GPW|ligand is GlcCF3U;Ki=17.00+/-1.28uM|P00489|GLYCOGEN PHOSPHORYLASE|4.77|Ki=17.00uM|Ki|=|17|uM|17000|nM
4GZT|2.19|2012|G39|Ki=17.0+/-1.5nM; Ca-containing|K7N5N3|NEURAMINIDASE|7.77|Ki=17.0nM|Ki|=|17|nM|17|nM
3TZM|1.70|2012|085|ligand is compound SB-431542|P36897|TGF-BETA RECEPTOR TYPE-1|7.77|Ki=17nM|Ki|=|17|nM|17|nM
4E5J|2.35|2012|581|Mn-containing|Q5EP34|POLYMERASE PROTEIN PA|4.73|Ki=18.7uM|Ki|=|18.7|uM|18700|nM
4A51|2.75|2012|DQ8|compound 25; Ki=185.8+/-30.4nM|P52732|KINESIN-LIKE PROTEIN KIF11|6.73|Ki=185.8nM|Ki|=|185.8|nM|185.8|nM
3TVC|2.43|2012|E3P|ligand is compound 18|P45452|COLLAGENASE 3 (MMP-13)|7.74|Ki=18nM|Ki|=|18|nM|18|nM
3QS8|2.00|2012|17D|ligand is ACS174; Ki=18+/-2uM|P66992|ANTHRANILATE PHOSPHORIBOSYLTRANSFERASE|4.74|Ki=18uM|Ki|=|18|uM|18000|nM
4F39|1.83|2012|KAI||P19492|GLUTAMATE RECEPTOR 3|5.7|Ki=1980nM|Ki|=|1980|nM|1980|nM
3R6C|1.83|2012|17N|ligand is ACS179; Ki=19+/-5uM|P66992|ANTHRANILATE PHOSPHORIBOSYLTRANSFERASE|4.72|Ki=19uM|Ki|=|19|uM|19000|nM
3U6I|2.10|2012|044|ligand is compound (R)-58a|P08581|HEPATOCYTE GROWTH FACTOR RECEPTOR|9.0|Ki=1nM|Ki|=|1|nM|1|nM
3URI|2.10|2012|8-mer|complex between endothiapepsin and DB5 peptide|P11838|ENDOTHIAPEPSIN|9.0|Ki=1nM|Ki|=|1|nM|1|nM
4FLH|2.60|2012|14K|Ki(a modified in vitro AlphaScreen assay)|P48736|PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE|9.0|Ki=1nM|Ki|=|1|nM|1|nM
4H3F|1.70|2012|10O||P56817|BETA-SECRETASE 1|9.0|Ki=1nM|Ki|=|1|nM|1|nM
4H4B|2.90|2012|11H|Ki=2.0+/-0.2mM|P49902|CYTOSOLIC PURINE 5'-NUCLEOTIDASE|2.7|Ki=2.0mM|Ki|=|2|mM|2000000|nM
4F1S|3.00|2012|F1S|Ki=2.0+/-0.7nM nM(PI3K-alpha), X-ray(PI3K-gamma)|P48736|PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE|8.7|Ki=2.0nM|Ki|=|2|nM|2|nM
4FCF|1.09|2012|MA4|Ki=2.4+/-0.2nM|P0AD64|BETA-LACTAMASE SHV-1|8.62|Ki=2.4nM|Ki|=|2.4|nM|2.4|nM
4HF4|2.00|2012|15H||Q9Y233|PHOSPHODIESTERASE-10A|8.62|Ki=2.4nM|Ki|=|2.4|nM|2.4|nM
4DDY|1.36|2012|DN6||Q9L5C8|BETA-LACTAMASE|5.62|Ki=2.4uM|Ki|=|2.4|uM|2400|nM
3S43|1.26|2012|478|ligand is amprenavir|Q7SSE3|HIV-1 PROTEASE|8.6|Ki=2.53nM|Ki|=|2.53|nM|2.53|nM
3SXF|2.04|2012|BK5|ligand is compound 3a; Ki by nonradioactive luciferase assay|Q9BJF5|CALMODULIN-DOMAIN PROTEIN KINASE 1|8.6|Ki=2.5nM|Ki|=|2.5|nM|2.5|nM
3T3U|2.10|2012|BK6|ligand is compound 2b; Ki by nonradioactive luciferase assay|Q9BJF5|CALMODULIN-DOMAIN PROTEIN KINASE 1|8.6|Ki=2.5nM|Ki|=|2.5|nM|2.5|nM
4EFS|1.63|2012|E37|ligand is compound 16|P39900|MACROPHAGE METALLOELASTASE (MMP-12)|8.6|Ki=2.5nM|Ki|=|2.5|nM|2.5|nM
3U78|2.69|2012|E67|compound E67-KIAA1718; IC50=3.7+/-0.3uM|Q6ZMT4|LYSINE-SPECIFIC DEMETHYLASE 7|5.6|Ki=2.5uM|Ki|=|2.5|uM|2500|nM
3SHA|1.52|2012|P97|ligand is compound 10; Ki=2.6+/-1.1uM|P00734|THROMBIN|5.59|Ki=2.6uM|Ki|=|2.6|uM|2600|nM
3V7X|1.03|2012|D7A|complex between compound I and hCAII; Ki=2.7+/-0.1nM|P00918|CARBONIC ANHYDRASE 2|8.57|Ki=2.7nM|Ki|=|2.7|nM|2.7|nM
3UXL|2.20|2012|CFI|ligand is compound CfN|P11444|MANDELATE RACEMASE|5.57|Ki=2.7uM|Ki|=|2.7|uM|2700|nM
3UZJ|1.69|2012|0CT|complex between R13-3/11H and benzotriazole; Ki=2.82+/-0.19uM|------|KEMP ELIMINASE KE59 R13 3/11H|5.55|Ki=2.82uM|Ki|=|2.82|uM|2820|nM
3V51|1.95|2012|I76|ligand is compound 11; Ki by nonradioactive luciferase assay|Q9BJF5|CALMODULIN-DOMAIN PROTEIN KINASE 1|8.55|Ki=2.8nM|Ki|=|2.8|nM|2.8|nM
4F09|2.40|2012|JAK||O60674|TYROSINE-PROTEIN KINASE JAK2|6.7|Ki=200nM|Ki|=|200|nM|200|nM
3SU1|1.40|2012|TSV|ligand is Danoprevir; Ki=208+/-66nM|A8DG50|NS3/4A PROTEASE|6.68|Ki=208nM|Ki|=|208|nM|208|nM
3UWL|2.07|2012|FOZ|complex EfTS and 5-FTHF; Ki=208+/-15uM|Q834R3|THYMIDYLATE SYNTHASE|3.68|Ki=208uM|Ki|=|208|uM|208000|nM
4ACC|2.21|2012|7YG|ligand is compound 23|P49841|GLYCOGEN SYNTHASE KINASE-3 BETA|7.7|Ki=20nM|Ki|=|20|nM|20|nM
4FSL|2.50|2012|0VB|I-containig|P56817|BETA-SECRETASE 1|7.7|Ki=20nM|Ki|=|20|nM|20|nM
3SUW|1.90|2012|GC2|ligand is NHAc-CAS; Ki=20+/-3uM|D0VX21|BETA-HEXOSAMINIDASE|4.7|Ki=20uM|Ki|=|20|uM|20000|nM
4GKH|1.86|2012|0J9|Ki=21.5+/-1.7uM|B0VD92|AMINOGLYCOSIDE 3'-PHOSPHOTRANSFERASE APHA1-IAB|4.67|Ki=21.5uM|Ki|=|21.5|uM|21500|nM
4ACM|1.63|2012|7YG|compound 23 with CDK2|P24941|CYCLIN-DEPENDENT KINASE 2|6.68|Ki=210nM|Ki|=|210|nM|210|nM
3RV6|2.04|2012|RVA/VAE|ligand is (Z/E)-phenyl-AMT; Ki=21+/-1uM; RVA(Z)/VAE(E)|Q7D785|ISOCHORISMATE SYNTHASE/ISOCHORISMATE-PYRUVATE LYASE|4.68|Ki=21uM|Ki|=|21|uM|21000|nM
3QTV|1.63|2012|06P|ligand is compound 7; Ki=22.5+/-13.2uM|P00734|THROMBIN|4.65|Ki=22.5uM|Ki|=|22.5|uM|22500|nM
4ACH|2.60|2012|KDI|compound 51|P49841|GLYCOGEN SYNTHASE KINASE-3 BETA|7.66|Ki=22nM|Ki|=|22|nM|22|nM
4E5W|1.86|2012|0NT||P23458|TYROSINE-PROTEIN KINASE JAK1|7.66|Ki=22nM|Ki|=|22|nM|22|nM
3ST6|1.75|2012|RVE|ligand is AMT; Ki=240+/-40uM|Q7D785|ISOCHORISMATE SYNTHASE/ISOCHORISMATE-PYRUVATE LYASE|3.62|Ki=240uM|Ki|=|240|uM|240000|nM
4E35|1.40|2012|10-mer|Ki = 24 +/- 2 uM; incomplete ligand|Q9HD26|GOLGI-ASSOCIATED PDZ AND COILED-COIL MOTIF-CONTAINI|4.62|Ki=24uM|Ki|=|24|uM|24000|nM
4DFU|1.98|2012|QUE||O68183|"APH(2"")-ID"|4.6|Ki=25.1uM|Ki|=|25.1|uM|25100|nM
3RJ7|1.20|2012|RCS|ligand is compound 4|P00918|CARBONIC ANHYDRASE 2|7.6|Ki=25.3nM|Ki|=|25.3|nM|25.3|nM
4G8Y|1.80|2012|0FT|Ki=25.8+/-2.4uM|P61823|RIBONUCLEASE|4.59|Ki=25.8uM|Ki|=|25.8|uM|25800|nM
4F08|2.82|2012|1RS||O60674|TYROSINE-PROTEIN KINASE JAK2|6.6|Ki=250nM|Ki|=|250|nM|250|nM
4DFB|1.95|2012|KAN|Ki for Kanamycin A is referred to Kinase inhibitor Quercetin|O68183|"APH(2"")-ID"|4.6|Ki=25uM|Ki|=|25|uM|25000|nM
3VHK|2.49|2012|BPK|ligand is compound E|P35968|VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2|4.6|Ki=25uM|Ki|=|25|uM|25000|nM
4BC5|1.98|2012|5FX|Ki=25+/-2uM|O75191|XYLULOSE KINASE|4.6|Ki=25uM|Ki|=|25|uM|25000|nM
4B05|1.80|2012|32D|ligand is AZD3839|P56817|BETA-SECRETASE 1|7.58|Ki=26.1nM|Ki|=|26.1|nM|26.1|nM
3SU5|1.55|2012|SU3|ligand is Vaniprevir; Ki=2635+/-702nM|A8DG50|NS3/4A PROTEASE|5.58|Ki=2635nM|Ki|=|2635|nM|2635|nM
3SYM|2.40|2012|GP0|ligang is compound 5; Ki=27.1+/-1.4uM|P00489|GLYCOGEN PHOSPHORYLASE|4.57|Ki=27.1uM|Ki|=|27.1|uM|27100|nM
3SUF|2.19|2012|SUE|ligand is MK-5172; Ki=27.8+/-12.1nM|A8DG50|NS3/4A PROTEASE|7.56|Ki=27.8nM|Ki|=|27.8|nM|27.8|nM
3RBM|2.61|2012|B73|ligand is BPH-703; Mg-containing|A5K4U6|FARNESYL PYROPHOSPHATE SYNTHASE|6.57|Ki=270nM|Ki|=|270|nM|270|nM
4FS4|1.74|2012|H24|ligand is compound 4, ligand structure is diffrent: -NH2 and =NH|P56817|BETA-SECRETASE 1|6.57|Ki=270nM|Ki|=|270|nM|270|nM
2LSP|NMR|2012|13-mer|ligand is NF-kB-K310ac peptide|Q04206|NF-KB-K310AC PEPTIDE|3.56|Ki=274uM|Ki|=|274|uM|274000|nM
3RR4|1.68|2012|HRD|ligand is compound 11a; Ki=28.05+/-11.97uM|P28720|QUEUINE TRNA-RIBOSYLTRANSFERASE|4.55|Ki=28.05uM|Ki|=|28.05|uM|28050|nM
4B6Q|1.54|2012|BZ5||P0A4Z6|3-DEHYDROQUINATE DEHYDRATASE|7.55|Ki=28nM|Ki|=|28|nM|28|nM
3SUV|1.60|2012|NOK|ligand is NHAc-DNJ; Ki=28+/-4uM|D0VX21|BETA-HEXOSAMINIDASE|4.55|Ki=28uM|Ki|=|28|uM|28000|nM
3VDB|2.05|2012|149|complex between N460T and galactonolactone; Ki=3.03+/-0.20mM|P00722|BETA-GALACTOSIDASE|2.52|Ki=3.03mM|Ki|=|3.03|mM|3030000|nM
4E3L|1.43|2012|0NB|covalent complex|P00811|BETA-LACTAMASE|8.52|Ki=3.0nM|Ki|=|3|nM|3|nM
3T6Y|2.60|2012|DU2|ligand is compound 15f|Q8II92|DEOXYURIDINE 5'-TRIPHOSPHATE NUCLEOTIDOHYDROLASE|5.52|Ki=3.0uM|Ki|=|3|uM|3000|nM
4DE3|1.44|2012|DN8||Q9L5C8|BETA-LACTAMASE|5.52|Ki=3.0uM|Ki|=|3|uM|3000|nM
3S45|1.51|2012|478|ligand is amprenavir|Q9W9R3|HIV-2 PROTEASE|8.49|Ki=3.24nM|Ki|=|3.24|nM|3.24|nM
3T3G|2.40|2012|GPU|ligna is GlcBrU; Ki=3.27+/-0.44uM|P00489|GLYCOGEN PHOSPHORYLASE|5.49|Ki=3.27uM|Ki|=|3.27|uM|3270|nM
4DJU|1.80|2012|0KK||P56817|BETA-SECRETASE 1|5.44|Ki=3.6uM|Ki|=|3.6|uM|3600|nM
3U7S|2.05|2012|017|complex between PRDRV1 and darunavir; Ki=3700+/-300pM|Q993Q5|HIV-1 PROTEASE|8.43|Ki=3.7nM|Ki|=|3.7|nM|3.7|nM
4G3G|2.50|2012|0WA|X-ray(mNIK V408(m)L) while Ki(hNIK)|Q9WUL6|NF-KAPPA-BETA-INDUCING KINASE|8.43|Ki=3.7nM|Ki|=|3.7|nM|3.7|nM
4FEV|1.89|2012|PP1|Ki=3.8+/-0.4uM|B0VD92|AMINOGLYCOSIDE 3'-PHOSPHOTRANSFERASE APHA1-IAB|5.42|Ki=3.8uM|Ki|=|3.8|uM|3800|nM
4AGD|2.81|2012|B49|complex Sunitinib/plus-JM|P35968|VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2|8.41|Ki=3.9nM|Ki|=|3.9|nM|3.9|nM
4G90|1.90|2012|0G0|Ki=30.8+/-4.4uM|P61823|RIBONUCLEASE|4.51|Ki=30.8uM|Ki|=|30.8|uM|30800|nM
4EKY|2.45|2012|D1J|Ki=303.0+/-6.7uM|P00489|GLYCOGEN PHOSPHORYLASE|3.52|Ki=303.0uM|Ki|=|303|uM|303000|nM
4E3O|1.60|2012|0NG|covalent complex|P00811|BETA-LACTAMASE|6.51|Ki=310nM|Ki|=|310|nM|310|nM
4EL0|2.40|2012|D1K|Ki=32.4+/-0.5uM|P00489|GLYCOGEN PHOSPHORYLASE|4.49|Ki=32.4uM|Ki|=|32.4|uM|32400|nM
3U92|1.90|2012|KAI|ligand is kainate|P42264|GLUTAMATE RECEPTOR, IONOTROPIC KAINATE 3|7.48|Ki=32.8nM|Ki|=|32.8|nM|32.8|nM
4EJ2|2.65|2012|D1F|Ki=3204+/-144uM|P00489|GLYCOGEN PHOSPHORYLASE|2.49|Ki=3204uM|Ki|=|3204|uM|3204000|nM
4EKE|2.60|2012|D1I|Ki=33.4+/-4.0uM|P00489|GLYCOGEN PHOSPHORYLASE|4.48|Ki=33.4uM|Ki|=|33.4|uM|33400|nM
4E0W|2.35|2012|KAI|redundant to 3u92|P42264|GLUTAMATE RECEPTOR, IONOTROPIC KAINATE 3|7.48|Ki=33nM|Ki|=|33|nM|33|nM
4DHL|2.30|2012|0K7|Ki=33+/-10uM; Zn-containing|O24319|PURPLE ACID PHOSPHATASE|4.48|Ki=33uM|Ki|=|33|uM|33000|nM
3SV6|1.40|2012|SV6|ligand is Telaprevir; Ki=34.4+/-3.0nM; covalent complex|A8DG50|NS3/4A PROTEASE|7.46|Ki=34.4nM|Ki|=|34.4|nM|34.4|nM
4GKI|1.88|2012|0JN|Ki=34.4+/-1.9uM|B0VD92|AMINOGLYCOSIDE 3'-PHOSPHOTRANSFERASE APHA1-IAB|4.46|Ki=34.4uM|Ki|=|34.4|uM|34400|nM
4ABJ|1.45|2012|13-mer|compound 3; Ki=34+/-5nM; incomplete ligand|P00760|TRYPSIN|7.47|Ki=34nM|Ki|=|34|nM|34|nM
4GE6|1.40|2012|B26|Ki=32-36 nM|P43378|TYROSINE-PROTEIN PHOSPHATASE NON-RECEPTOR TYPE 9|7.47|Ki=34nM|Ki|=|34|nM|34|nM
3U7M|2.15|2012|FHF|ligand is PMT1039(15e); Ki=35.1+/-3.1nM(T=303K;pH=7;50mM HEPES buffer)|Q5HGZ3|PEPTIDE DEFORMYLASE|7.45|Ki=35.1nM|Ki|=|35.1|nM|35.1|nM
3QW5|1.60|2012|5-mer|ligand is peptide RRGF; Zn-containing|A5HZZ9|BOTULINUM NEUROTOXIN A LIGHT CHAIN|6.45|Ki=358nM|Ki|=|358|nM|358|nM
4DFF|2.11|2012|0JP|Zn-containing; Mg-containing|Q9Y233|CGMP 3',5'-CYCLIC PHOSPHODIESTERASE|7.46|Ki=35nM|Ki|=|35|nM|35|nM
4I8N|2.50|2012|1CG||P18031|PROTEIN-TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1|4.46|Ki=35uM|Ki|=|35|uM|35000|nM
3U81|1.13|2012|SAH||P22734|CATECHOL O-METHYLTRANSFERASE|4.44|Ki=36uM|Ki|=|36|uM|36000|nM
3RBU|1.60|2012|G88|Ki=370+/-80pM(HPLC assay); Zn-containing|Q04609|GLUTAMATE CARBOXYPEPTIDASE 2|9.43|Ki=370pM|Ki|=|370|pM|0.37|nM
4DSY|2.30|2012|0LO|Ki=37+/-16uM; Zn-containing; Fe-containing|O24319|PURPLE ACID PHOSPHATASE|4.43|Ki=37uM|Ki|=|37|uM|37000|nM
4EK9|2.50|2012|EP4||Q8TEK3|HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-79 SPECIFIC|4.42|Ki=38000nM|Ki|=|38000|nM|38000|nM
4EXS|2.40|2012|X8Z|Zn-containing|C7C422|METALLO-BETA-LACTAMASE NDM-1|4.41|Ki=39.0uM|Ki|=|39|uM|39000|nM
3S5Y|2.10|2012|DGJ|Ki=39.1+/-1.9 nM|P06280|ALPHA-GALACTOSIDASE A|7.41|Ki=39.1nM|Ki|=|39.1|nM|39.1|nM
3UXD|1.80|2012|0CU|complex between R1-7/10H and 5,7-Cl; Ki=39.3+/-0.2uM|------|KEMP ELIMINASE KE59 R1 7/10H|4.41|Ki=39.3uM|Ki|=|39.3|uM|39300|nM
3SUU|1.60|2012|OGN|ligand is Gal-PUGNAc; Ki=3+/-2nM|D0VX21|BETA-HEXOSAMINIDASE|8.52|Ki=3nM|Ki|=|3|nM|3|nM
3T3V|2.04|2012|BK4|ligand is compound 2a; nonradioactive Kinaseglo luciferase assay|Q9BJF5|CALMODULIN-DOMAIN PROTEIN KINASE 1|8.52|Ki=3nM|Ki|=|3|nM|3|nM
4H1E|1.90|2012|10J||P56817|BETA-SECRETASE 1|8.52|Ki=3nM|Ki|=|3|nM|3|nM
4H3I|1.96|2012|10V||P56817|BETA-SECRETASE 1|8.52|Ki=3nM|Ki|=|3|nM|3|nM
4DJO|1.78|2012|MK5||Q90K99|HIV-1 PROTEASE|11.52|Ki=3pM|Ki|=|3|pM|0.003|nM
4EN4|2.15|2012|GT0||O00764|PYRIDOXAL KINASE|5.52|Ki=3uM|Ki|=|3|uM|3000|nM
4APH|1.99|2012|8-mer|complex between C-domain of ACE and Ang II peptide; incomplete ligand|P12821|ANGIOTENSIN-CONVERTING ENZYME|5.4|Ki=4.0uM|Ki|=|4|uM|4000|nM
4A6B|1.80|2012|QG8|ligand is compound 19d|Q8Q3H0|HIV-1 PROTEASE|8.38|Ki=4.2nM|Ki|=|4.2|nM|4.2|nM
4G3E|2.50|2012|0WC|X-ray(mNIK) while Ki(hNIK)|Q9WUL6|NF-KAPPA-BETA-INDUCING KINASE|8.38|Ki=4.2nM|Ki|=|4.2|nM|4.2|nM
3T0D|1.93|2012|149|ligand is D-galactonolactone; Na-containing|P00722|BETA-GALACTOSIDASE|2.37|Ki=4.3mM|Ki|=|4.3|mM|4300000|nM
3TCP|2.69|2012|CKJ|ligand is compound 43|Q12866|TYROSINE-PROTEIN KINASE MER|8.37|Ki=4.3nM|Ki|=|4.3|nM|4.3|nM
4DU8|2.10|2012|2P0|Ki(protein=S.epidermidis MDD,ligand=DPGP) while X-ray(protein=D283A MDD, ligand=DPGP)|Q9FD73|MEVALONATE DIPHOSPHATE DECARBOXYLASE|5.37|Ki=4.3uM|Ki|=|4.3|uM|4300|nM
4DPY|2.14|2012|2P0|Ki(protein=S.epidermidis MDD,ligand=DPGP) while X-ray(protein=S192A MDD, ligand=DPGP)|Q9FD73|MEVALONATE DIPHOSPHATE DECARBOXYLASE|5.37|Ki=4.3uM|Ki|=|4.3|uM|4300|nM
4EL5|2.00|2012|D1M|Ki=4.3~5.1uM|P00489|GLYCOGEN PHOSPHORYLASE|5.37|Ki=4.3uM|Ki|=|4.3|uM|4300|nM
4E6Q|1.95|2012|0NV||O60674|TYROSINE-PROTEIN KINASE JAK2|8.36|Ki=4.4nM|Ki|=|4.4|nM|4.4|nM
4G3F|1.64|2012|0WB|X-ray(mNIK) while Ki(hNIK)|Q9WUL6|NF-KAPPA-BETA-INDUCING KINASE|8.36|Ki=4.4nM|Ki|=|4.4|nM|4.4|nM
4ACD|2.60|2012|GR9|compound 18|P49841|GLYCOGEN SYNTHASE KINASE-3 BETA|8.31|Ki=4.9nM|Ki|=|4.9|nM|4.9|nM
3TLL|1.37|2012|62D|ligand is compound 11b; Ki=40.83+/-4.27uM|P28720|QUEUINE TRNA-RIBOSYLTRANSFERASE|4.39|Ki=40.83uM|Ki|=|40.83|uM|40830|nM
3ZZF|2.20|2012|NLG|complex between AAK domain and NAG; Ki=400+/-55mM|Q01217|ACETYLGLUTAMATE KINASE|0.4|Ki=400mM|Ki|=|400|mM|400000000|nM
4FSE|2.65|2012|0VA|I-containig|P56817|BETA-SECRETASE 1|7.4|Ki=40nM|Ki|=|40|nM|40|nM
4DT2|2.70|2012|0LV|Ki=43+/-14uM, the equilibrium dissociation constant for competitive inhibitor binding|O24319|PURPLE ACID PHOSPHATASE|4.37|Ki=43uM|Ki|=|43|uM|43000|nM
3SU2|1.50|2012|TSV|ligand is Danoprevir; Ki=44.8+/-3.6nM|A8DG50|NS3/4A PROTEASE|7.35|Ki=44.8nM|Ki|=|44.8|nM|44.8|nM
4EO4|2.87|2012|SSA|apparent Ki = 450 +/- 145 nM; Zn-containing|P07236|THREONINE--TRNA LIGASE, MITOCHONDRIAL|6.35|Ki=450nM|Ki|=|450|nM|450|nM
3S6T|2.30|2012|OAN||Q06GJ0|N-ACETYLGLUCOSAMINIDASE|7.35|Ki=45nM|Ki|=|45|nM|45|nM
3U93|1.88|2012|GLU|ligand is glutamate|P42264|GLUTAMATE RECEPTOR, IONOTROPIC KAINATE 3|6.31|Ki=494nM|Ki|=|494|nM|494|nM
4DK5|2.95|2012|0KO||P48736|PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE|8.4|Ki=4nM|Ki|=|4|nM|4|nM
4E5I|2.94|2012|0N9|Mn-containing|Q5EP34|POLYMERASE PROTEIN PA|5.3|Ki=5.01uM|Ki|=|5.01|uM|5010|nM
3TT4|1.88|2012|E1S|ligand is compound 17|P22894|NEUTROPHIL COLLAGENASE (MMP-8)|8.28|Ki=5.3nM|Ki|=|5.3|nM|5.3|nM
4DJY|1.86|2012|0KR|ligand is R-24 in crystal structure|P56817|BETA-SECRETASE 1|8.27|Ki=5.4nM|Ki|=|5.4|nM|5.4|nM
4FJZ|3.00|2012|4FJ|incomplete ligand structure|P48736|PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE|6.29|Ki=509nM|Ki|=|509|nM|509|nM
4DPT|2.19|2012|FM0|Ki (Protein: S. epidermidis MDD, Ligand: FMVAPP), X-ray(Protein: MDD, Ligand: FMVAPP, ATP-gamma-S)|Q9FD73|MEVALONATE DIPHOSPHATE DECARBOXYLASE|7.3|Ki=50nM|Ki|=|50|nM|50|nM
4DPU|1.90|2012|FM0|Ki (Protein: S. epidermidis MDD, Ligand: FMVAPP), X-ray(Protein: S192A MDD, Ligand: FMVAPP, ATP-gamma-S)|Q9FD73|MEVALONATE DIPHOSPHATE DECARBOXYLASE|7.3|Ki=50nM|Ki|=|50|nM|50|nM
4EOH|2.10|2012|TEP||O00764|PYRIDOXAL KINASE|4.3|Ki=50uM|Ki|=|50|uM|50000|nM
4DO4|1.40|2012|DJN|Ki=51+/-6nM|P17050|ALPHA-N-ACETYLGALACTOSAMINIDASE|7.29|Ki=51nM|Ki|=|51|nM|51|nM
3U7L|2.01|2012|UDB|ligand is PMT497; Ki=52.4+/-6.5nM(T=303K;pH=7;50mM HEPES buffer)|Q5HGZ3|PEPTIDE DEFORMYLASE|7.28|Ki=52.4nM|Ki|=|52.4|nM|52.4|nM
4ALX|2.30|2012|IZN|complex between DHbetaE and Ls-AChBP; Ki=52+/-5nM|P58154|ACETYLCHOLINE-BINDING PROTEIN|7.28|Ki=52nM|Ki|=|52|nM|52|nM
3QWC|1.75|2012|98P|ligand is compound 11; Ki=55.4+/-21.4uM|P00734|THROMBIN|4.26|Ki=55.4uM|Ki|=|55.4|uM|55400|nM
3SU4|2.25|2012|SU3|ligand is Vaniprevir; Ki=554+/-64nM|A8DG50|NS3/4A PROTEASE|6.26|Ki=554nM|Ki|=|554|nM|554|nM
3RYW|2.90|2012|K9H|ligand is BPH-811; Mg-containing|A5K4U6|FARNESYL PYROPHOSPHATE SYNTHASE|6.24|Ki=570nM|Ki|=|570|nM|570|nM
4HA5|1.83|2012|13W||P56817|BETA-SECRETASE 1|7.24|Ki=58nM|Ki|=|58|nM|58|nM
4DJX|1.50|2012|0KQ|liagnd is R-17h in crystal structure|P56817|BETA-SECRETASE 1|7.23|Ki=59nM|Ki|=|59|nM|59|nM
3T3C|2.10|2012|017|ligand is DRV; Ki=59+/-7pM|P03367|HIV-1 PROTEASE|10.23|Ki=59pM|Ki|=|59|pM|0.059000000000000004|nM
4AFG|2.00|2012|QMR|complex between Ct-AChBP and varenicline; Ki=5+/-1nM|I6L8L2|CAPITELLA TELETA ACHBP|8.3|Ki=5nM|Ki|=|5|nM|5|nM
4FEW|1.98|2012|PP2|Ki=6.2+/-0.5uM|B0VD92|AMINOGLYCOSIDE 3'-PHOSPHOTRANSFERASE APHA1-IAB|5.21|Ki=6.2uM|Ki|=|6.2|uM|6200|nM
4ABI|1.55|2012|13-mer|compound 6; /ki=6.3+/-1.8nM; incomplete ligand|P00760|TRYPSIN|8.2|Ki=6.3nM|Ki|=|6.3|nM|6.3|nM
4GG7|2.27|2012|0J8||P08581|HEPATOCYTE GROWTH FACTOR RECEPTOR|8.2|Ki=6.3nM|Ki|=|6.3|nM|6.3|nM
3UU1|1.82|2012|14B|ligand is ACS142; Ki=6.3+/-0.8uM|P66992|ANTHRANILATE PHOSPHORIBOSYLTRANSFERASE|5.2|Ki=6.3uM|Ki|=|6.3|uM|6300|nM
3S1G|1.82|2012|ITE|ligand is compound 8a; Ki=6.5+/-2.9uM|P28720|QUEUINE TRNA-RIBOSYLTRANSFERASE|5.19|Ki=6.5uM|Ki|=|6.5|uM|6500|nM
4AYY|2.60|2012|9MX|compound 19d|P00734|THROMBIN LIGHT CHAIN|8.17|Ki=6.7nM|Ki|=|6.7|nM|6.7|nM
3SUG|1.80|2012|SUE|ligand is MK-5172; Ki=620+/-71nM|A8DG50|NS3/4A PROTEASE|6.21|Ki=620nM|Ki|=|620|nM|620|nM
3V7T|2.09|2012|0GX|ligand is compound 2|Q6NZY1|TRYPTASE BETA-2|7.21|Ki=62nM|Ki|=|62|nM|62|nM
3QX5|1.35|2012|02P|ligand is compound 9; Ki=63.5+/-13.6uM|P00734|THROMBIN|4.2|Ki=63.5uM|Ki|=|63.5|uM|63500|nM
3SV2|1.30|2012|P05|ligand is compound 6; Ki=64.0+/-20.0uM|P00734|THROMBIN|4.19|Ki=64.0uM|Ki|=|64|uM|64000|nM
3SI3|1.55|2012|B03|ligand is compound 4; Ki=69.3+/-0.1uM|P00734|THROMBIN|4.16|Ki=69.3uM|Ki|=|69.3|uM|69300|nM
3V5T|2.13|2012|UW9|ligand is compound 13; Ki by nonradioactive luciferase assay|Q9BJF5|CALMODULIN-DOMAIN PROTEIN KINASE 1|8.22|Ki=6nM|Ki|=|6|nM|6|nM
4H3G|1.85|2012|10Q||P56817|BETA-SECRETASE 1|8.22|Ki=6nM|Ki|=|6|nM|6|nM
4GE7|2.10|2012|0K5|compound 3 inhibits KAT II irreversibly via formation of an imine adduct with the aldehyde group of the enzyme co-factor pyridoxal phosphate (PLP), followed by tautomerization to an enamine.|Q8N5Z0|KYNURENINE/ALPHA-AMINOADIPATE AMINOTRANSFERASE|8.15|Ki=7.1nM|Ki|=|7.1|nM|7.1|nM
3UPX|2.27|2012|B6A|ligand is compound 10; nonradioactive Kinaseglo luciferase assay|Q9BJF5|CALMODULIN-DOMAIN PROTEIN KINASE 1|8.12|Ki=7.5nM|Ki|=|7.5|nM|7.5|nM
3UF9|2.68|2012|FST|Ki=7.78+/-1.23mM|Q97VT7|ARYLDIALKYLPHOSPHATASE|2.11|Ki=7.78mM|Ki|=|7.78|mM|7780000|nM
4GE4|2.41|2012|0KE|compound 2 inhibits KAT II irreversibly via formation of an imine adduct with the aldehyde group of the enzyme co-factor pyridoxal phosphate (PLP), followed by tautomerization to an enamine.|Q8N5Z0|KYNURENINE/ALPHA-AMINOADIPATE AMINOTRANSFERASE|8.11|Ki=7.7nM|Ki|=|7.7|nM|7.7|nM
4E49|1.45|2012|RCO|Ki measured in CO2 hydration assay|P00918|CARBONIC ANHYDRASE 2|5.11|Ki=7.7uM|Ki|=|7.7|uM|7700|nM
3SYR|2.40|2012|GPK|ligand is GLcFU; Ki=7.9+/-0.3uM|P00489|GLYCOGEN PHOSPHORYLASE|5.1|Ki=7.9uM|Ki|=|7.9|uM|7900|nM
3V4X|1.95|2012|F24|Ki=700+/-18.5nM(nonlinear fit method); Ki=606nM(graphical method); Ki=53.7nM(human HMGCS)|Q9FD71|HMG-COA SYNTHASE|6.15|Ki=700nM|Ki|=|700|nM|700|nM
3AXK|1.90|2012|NDP||P0C512|RIBULOSE BISPHOSPHATE CARBOXYLASE LARGE CHAIN|4.15|Ki=70uM|Ki|=|70|uM|70000|nM
3SUR|1.90|2012|NGT|ligand is NAG-thiazoline; Ki=70+/-4uM|D0VX21|BETA-HEXOSAMINIDASE|4.15|Ki=70uM|Ki|=|70|uM|70000|nM
4EXH|2.00|2012|6-mer|Ki=712+/-39nM, covalent complex|Q9E7M1|GAG-PRO-POL POLYPROTEIN|6.15|Ki=712nM|Ki|=|712|nM|712|nM
3SUS|1.80|2012|GNL|ligand is Gal-NAG-thiazoline; Ki=71+/-5uM|D0VX21|BETA-HEXOSAMINIDASE|4.15|Ki=71uM|Ki|=|71|uM|71000|nM
3TVX|2.84|2012|PNX|ligand is pentoxifylline|P27815|CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4A|4.14|Ki=72uM|Ki|=|72|uM|72000|nM
3QTO|1.52|2012|10P|ligand is compound 3; Ki=74.8+/-20.5uM|P00734|THROMBIN|4.13|Ki=74.8uM|Ki|=|74.8|uM|74800|nM
3SM0|1.57|2012|AEK|ligand is compound 10a; Ki=740+/-170nM|P28720|QUEUINE TRNA-RIBOSYLTRANSFERASE|6.13|Ki=740nM|Ki|=|740|nM|740|nM
3V5G|1.50|2012|0F3|compound 1; IC50(stopped-flow assay); IC50=123nM(Spectrophotometric Esterase Assay)|P00918|CARBONIC ANHYDRASE 2|7.13|Ki=74nM|Ki|=|74|nM|74|nM
4B6P|2.30|2012|2HN||P0A4Z6|3-DEHYDROQUINATE DEHYDRATASE|7.13|Ki=74nM|Ki|=|74|nM|74|nM
4DE2|1.40|2012|DN3||Q9L5C8|BETA-LACTAMASE CTX-M-9A|4.12|Ki=76.0uM|Ki|=|76|uM|76000|nM
4E0X|2.00|2012|KAI||P22756|GLUTAMATE RECEPTOR, IONOTROPIC KAINATE 1|7.12|Ki=76nM|Ki|=|76|nM|76|nM
4AA1|1.99|2012|8-mer|ligand is Ang II peptide; incomplete ligand|Q10714|ANGIOTENSIN-CONVERTING ENZYME|4.12|Ki=76uM|Ki|=|76|uM|76000|nM
3V2W|3.35|2012|ML5|ligand is compound 2a|P21453|SPHINGOSINE 1-PHOSPHATE RECEPTOR 1, LYSOZYME CHIMER|7.11|Ki=77nM|Ki|=|77|nM|77|nM
3AXM|1.65|2012|6PG|Mg-containing|P0C512|RIBULOSE BISPHOSPHATE CARBOXYLASE LARGE CHAIN|5.07|Ki=8.5uM|Ki|=|8.5|uM|8500|nM
3VBD|1.05|2012|0FZ|ligand is compound 2a; Ki=8.6+/-0.6nM|P00918|CARBONIC ANHYDRASE 2|8.07|Ki=8.6nM|Ki|=|8.6|nM|8.6|nM
4B9Z|2.00|2012|ACR|ligand is Acarbose|B3PEE6|ALPHA-GLUCOSIDASE, ADG31B|4.09|Ki=81.4uM|Ki|=|81.4|uM|81400|nM
3SV7|1.55|2012|SV6|ligand is Telaprevir; Ki=823+/-60nM; covalent complex|A8DG50|NS3/4A PROTEASE|6.08|Ki=823nM|Ki|=|823|nM|823|nM
3U7K|1.90|2012|MDB|ligand is PMT387(7a); Ki=84.9+/-12.8nM (T=303K;pH=7.0;50mM HEPES buffer)|Q5HGZ3|PEPTIDE DEFORMYLASE|7.07|Ki=84.9nM|Ki|=|84.9|nM|84.9|nM
3VW7|2.20|2012|VPX|ligand is compound 4|P25116|PROTEINASE-ACTIVATED RECEPTOR 1, LYSOZYME|8.1|Ki=8nM|Ki|=|8|nM|8|nM
4DDS|1.36|2012|0J7||Q9L5C8|BETA-LACTAMASE|5.01|Ki=9.7uM|Ki|=|9.7|uM|9700|nM
4E3H|1.50|2012|HQE|Ki measured in CO2 hydration assay|P00918|CARBONIC ANHYDRASE 2|7.05|Ki=90nM|Ki|=|90|nM|90|nM
4H3J|1.60|2012|10W||P56817|BETA-SECRETASE 1|7.05|Ki=90nM|Ki|=|90|nM|90|nM
4F9U|1.80|2012|PBD|Ki=944+/-93nM(pH=7); Zn-containing|Q9VRQ9|CG32412|6.03|Ki=944nM|Ki|=|944|nM|944|nM
4F9V|2.10|2012|PBD|Ki=944+/-93nM(pH=7); Zn-containing; redundant to 4f9u|Q9VRQ9|CG32412|6.03|Ki=944nM|Ki|=|944|nM|944|nM
3SU6|1.10|2012|SU3|ligand is Vaniprevir; Ki=958+/-162nM|A8DG50|NS3/4A PROTEASE|6.02|Ki=958nM|Ki|=|958|nM|958|nM
4B6S|1.90|2012|2HN||Q48255|3-DEHYDROQUINATE DEHYDRATASE|6.01|Ki=970nM|Ki|=|970|nM|970|nM
3SV9|1.60|2012|SV6|ligand is Telaprevir|A8DG50|NS3/4A PROTEASE|5.0|Ki>10000nM|Ki|>|10000|nM|10000|nM
3UQG|2.20|2012|B5A|ligand is compound 7b|P00523|TYROSINE-PROTEIN KINASE SRC|5.0|Ki>10uM|Ki|>|10|uM|10000|nM
3UPZ|2.20|2012|B5A|ligand is compound 7b; nonradioactive Kinaseglo luciferase assay|Q9BJF5|CALMODULIN-DOMAIN PROTEIN KINASE 1|5.6|Ki>2.5uM|Ki|>|2.5|uM|2500|nM
3UQF|2.27|2012|BK5|ligand is compound 3a|P00523|TYROSINE-PROTEIN KINASE SRC|4.7|Ki>20uM|Ki|>|20|uM|20000|nM
3SRG|2.19|2012|OCH|Ca-containing|------|SERUM PARAOXONASE|5.7|Ki~2uM|Ki|~|2|uM|2000|nM
4FCK|1.90|2012|GPA|Co-containing|P05089|ARGINASE-1|1.26|Ki~55mM|Ki|~|55|mM|55000000|nM
4FCI|1.82|2012|GPA|Mn-containing|P05089|ARGINASE-1|1.26|Ki~55mM|Ki|~|55|mM|55000000|nM
4LP0|1.95|2013|1YM|ligand is compound 31|Q8DQB5|TOPOISOMERASE IV, SUBUNIT B|8.0|IC<0.01uM|IC50|<|0.01|uM|10|nM
4LPB|1.75|2013|1YP|ligand is compound 35|Q8DQB5|TOPOISOMERASE IV, SUBUNIT B|8.0|IC<0.01uM|IC50|<|0.01|uM|10|nM
4JG8|3.10|2013|1LE|Covalent complex, Different ligand structure(double bond)|P51812|RIBOSOMAL PROTEIN S6 KINASE ALPHA-3|8.6|IC<2.5nM|IC50|<|2.5|nM|2.5|nM
4GJD|2.65|2013|0N0|IC50 = 0.003 +/- 0.002 uM|P00797|RENIN|8.52|IC=0.003uM|IC50|=|0.003|uM|3|nM
4JSR|1.70|2013|1NQ|mass spectrometry assay|Q9NTG7|NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-3|8.4|IC=0.004uM|IC50|=|0.004|uM|4|nM
4C4G|2.65|2013|7RO|IC50 = 0.006 +/- 0.003 uM, different ligand structure|P33981|DUAL SPECIFICITY PROTEIN KINASE TTK|8.22|IC=0.006uM|IC50|=|0.006|uM|6|nM
4I7C|2.80|2013|14-mer|covalent complex; DELFIA TRF assay|Q8IUQ4|E3 UBIQUITIN-PROTEIN LIGASE SIAH1|8.22|IC=0.006uM|IC50|=|0.006|uM|6|nM
4JT9|2.24|2013|1NS|mass spectrometry assay|Q9NTG7|NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-3|8.14|IC=0.0072uM|IC50|=|0.0072|uM|7.2|nM
4JR5|1.91|2013|1LS|A mass spectrometry-based assay|P43490|NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE|8.15|IC=0.007uM|IC50|=|0.007|uM|7|nM
4I1C|2.00|2013|1BE|AlphaScreen assay|P56817|BETA-SECRETASE 1|8.1|IC=0.008uM|IC50|=|0.008|uM|8|nM
4I9I|2.40|2013|1DY|Enzymatic TNKS1 autoparsylation assay|O95271|TANKYRASE-1|8.1|IC=0.008uM|IC50|=|0.008|uM|8|nM
4BKY|1.83|2013|82B||Q14680|MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE|7.92|IC=0.012uM|IC50|=|0.012|uM|12|nM
4MQ1|2.35|2013|2C3|The ligand in crystal is not equal to the ligand in literature(4mq1 4mq2 swap).|Q13627|DUAL SPECIFICITY TYROSINE-PHOSPHORYLATION-REGULATED KINASE|7.92|IC=0.012uM|IC50|=|0.012|uM|12|nM
4BZO|2.10|2013|676||P11309|SERINE/THREONINE-PROTEIN KINASE PIM-1|7.89|IC=0.013uM|IC50|=|0.013|uM|13|nM
4MZ4|1.63|2013|2F3|ligand is compound 2e|O92972|RNA-DIRECTED RNA POLYMERASE|7.89|IC=0.013uM|IC50|=|0.013|uM|13|nM
4HVS|1.90|2013|647||P10721|MAST/STEM CELL GROWTH FACTOR RECEPTOR KIT|7.8|IC=0.016uM|IC50|=|0.016|uM|16|nM
4IJP|2.25|2013|1EH|MS-based biochemical assay|Q13523|SERINE/THREONINE-PROTEIN KINASE PRP4 HOMOLOG|7.8|IC=0.016uM|IC50|=|0.016|uM|16|nM
4GMC|2.70|2013|1BI|X-ray(HCV NS5B), IC50(HCV NS5B_delta21)|O92972|HCV NS5B POLYMERASE|7.74|IC=0.018uM|IC50|=|0.018|uM|18|nM
4JIK|1.90|2013|1KO||O14757|SERINE/THREONINE-PROTEIN KINASE CHK1|7.74|IC=0.018uM|IC50|=|0.018|uM|18|nM
4HHZ|2.72|2013|15S||P09874|POLY [ADP-RIBOSE] POLYMERASE 1|7.72|IC=0.019uM|IC50|=|0.019|uM|19|nM
4BTY|3.10|2013|JWF|IC50 = 0.020 +/- 0.002 uM|Q16853|MEMBRANE PRIMARY AMINE OXIDASE|7.7|IC=0.020uM|IC50|=|0.02|uM|20|nM
4C4I|2.65|2013|X20|IC50 = 0.022 +/- 0.001 uM|P33981|DUAL SPECIFICITY PROTEIN KINASE TTK|7.66|IC=0.022uM|IC50|=|0.022|uM|22|nM
4JJE|1.48|2013|6-mer||P42574|CASPASE-3|7.64|IC=0.023uM|IC50|=|0.023|uM|23|nM
4C4E|2.60|2013|4T9|IC50 = 0.025 +/- 0.012 uM|P33981|DUAL SPECIFICITY PROTEIN KINASE TTK|7.6|IC=0.025uM|IC50|=|0.025|uM|25|nM
4HYF|2.80|2013|1AK|IC50 = 0.025 +/- 0.006 uM|Q9H2K2|TANKYRASE-2|7.6|IC=0.025uM|IC50|=|0.025|uM|25|nM
4C4F|2.36|2013|7CE|IC50 = 0.026 +/- 0.010 uM|P33981|DUAL SPECIFICITY PROTEIN KINASE TTK|7.59|IC=0.026uM|IC50|=|0.026|uM|26|nM
4BKZ|2.20|2013|1WS||Q14680|MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE|7.57|IC=0.027uM|IC50|=|0.027|uM|27|nM
4G17|2.10|2013|0VN|X-ray(CK1-gamma-3), IC50(CK1-gamma)|Q9Y6M4|CASEIN KINASE I ISOFORM GAMMA-3|7.54|IC=0.029uM|IC50|=|0.029|uM|29|nM
4BNU|2.00|2013|9KQ|IC50 = 0.02 uM (AcAcCoA as substrate), IC50 = 0.5 uM (3-OH decanoyl-NAC as substrate)|O54438|3-OXOACYL-[ACYL-CARRIER-PROTEIN] REDUCTASE FABG|7.7|IC=0.02uM|IC50|=|0.02|uM|20|nM
4BNX|2.30|2013|O74|IC50 = 0.02 uM (AcAcCoA as substrate), IC50 = 0.6 uM (3-OH decanoyl-NAC as substrate)|O54438|3-OXOACYL-[ACYL-CARRIER-PROTEIN] REDUCTASE FABG|7.7|IC=0.02uM|IC50|=|0.02|uM|20|nM
4CBY|2.72|2013|KEE|Zn-containing; IC50(HDAC4 WT), X-ray(HDAC4 L728A)|P56524|HISTONE DEACETYLASE 4|7.7|IC=0.02uM|IC50|=|0.02|uM|20|nM
4L02|2.75|2013|1V2|ligand is compound 23|Q9NYA1|SPHINGOSINE KINASE 1|7.7|IC=0.02uM|IC50|=|0.02|uM|20|nM
4BQW|1.79|2013|QNM|Mn-containing|Q9GZT9|EGL NINE HOMOLOG 1|7.48|IC=0.033uM|IC50|=|0.033|uM|33|nM
4JT8|2.26|2013|1NR|mass spectrometry assay|Q9NTG7|NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-3|7.48|IC=0.033uM|IC50|=|0.033|uM|33|nM
4I6Q|1.85|2013|1DT|ligand is compound 1h;IC50=0.03+/-0.004uM|P52333|TYROSINE-PROTEIN KINASE JAK3|7.52|IC=0.03uM|IC50|=|0.03|uM|30|nM
4BNV|2.50|2013|Q7U|IC50 = 0.03 uM (AcAcCoA as substrate), IC50 = 1.0 uM (3-OH decanoyl-NAC as substrate)|O54438|3-OXOACYL-[ACYL-CARRIER-PROTEIN] REDUCTASE FABG|7.52|IC=0.03uM|IC50|=|0.03|uM|30|nM
4IVS|2.64|2013|VSI|IC50=0.044+/-0.005uM|P56817|BETA-SECRETASE 1|7.36|IC=0.044uM|IC50|=|0.044|uM|44|nM
4IDV|2.90|2013|13V|NIK biochemical chemiluminescent assay|Q99558|MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 14|7.4|IC=0.04uM|IC50|=|0.04|uM|40|nM
4K69|1.50|2013|1P9|ligand is compound 15; IC50 = 0.04 +/- 0.01 uM|P23946|CHYMASE|7.4|IC=0.04uM|IC50|=|0.04|uM|40|nM
4HYS|2.42|2013|1BJ||A1L4K2|MITOGEN-ACTIVATED PROTEIN KINASE 8|7.26|IC=0.055uM|IC50|=|0.055|uM|55|nM
4BO2|1.90|2013|36K|IC50 = 0.05 uM (AcAcCoA as substrate), IC50 = 2.1 uM (3-OH decanoyl-NAC as substrate)|O54438|3-OXOACYL-[ACYL-CARRIER-PROTEIN] REDUCTASE FABG|7.3|IC=0.05uM|IC50|=|0.05|uM|50|nM
4BO1|2.20|2013|NKH|IC50 = 0.05 uM (AcAcCoA as substrate), IC50 = 2.0 uM (3-OH decanoyl-NAC as substrate)|O54438|3-OXOACYL-[ACYL-CARRIER-PROTEIN] REDUCTASE FABG|7.3|IC=0.05uM|IC50|=|0.05|uM|50|nM
4CBT|3.03|2013|9F4|Zn-containing|P56524|HISTONE DEACETYLASE 4|7.3|IC=0.05uM|IC50|=|0.05|uM|50|nM
4NB6|2.85|2013|444|ligand is compound 1|P51449|NUCLEAR RECEPTOR ROR-GAMMA|7.22|IC=0.060uM|IC50|=|0.06|uM|60|nM
4HW7|2.90|2013|64M||P07333|MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR|7.21|IC=0.062uM|IC50|=|0.062|uM|62|nM
3ZOV|2.10|2013|WZV|ligand is RO5464694|P56817|BETA-SECRETASE 1|7.22|IC=0.06uM|IC50|=|0.06|uM|60|nM
4LYN|2.00|2013|1YG|ligand is compound 33|P24941|CYCLIN-DEPENDENT KINASE 2|7.22|IC=0.06uM|IC50|=|0.06|uM|60|nM
4BTW|2.80|2013|JW7|IC50 = 0.071 +/- 0.007 uM|Q16853|MEMBRANE PRIMARY AMINE OXIDASE|7.15|IC=0.071uM|IC50|=|0.071|uM|71|nM
4JU3|2.00|2013|1O1|IC50=0.085+/-0.02uM, RdRp assay, Scintillation Proximity Assay|O92972|GENOME POLYPROTEIN|7.07|IC=0.085uM|IC50|=|0.085|uM|85|nM
4JVE|2.30|2013|1MQ|IC50=0.086+/-0.009uM, Different ligand structure(double bond)|Q00987|E3 UBIQUITIN-PROTEIN LIGASE MDM2|7.07|IC=0.086uM|IC50|=|0.086|uM|86|nM
4J3E|1.91|2013|NUT||P56273|E3 UBIQUITIN-PROTEIN LIGASE MDM2|7.06|IC=0.088uM|IC50|=|0.088|uM|88|nM
4LXM|2.30|2013|1YU|ligand is compound 12a|P56817|BETA-SECRETASE 1|7.06|IC=0.088uM|IC50|=|0.088|uM|88|nM
3W55|3.00|2013|1FM||P28482|MITOGEN-ACTIVATED PROTEIN KINASE 1|7.1|IC=0.08uM|IC50|=|0.08|uM|80|nM
4BO5|2.60|2013|WI4|IC50 = 0.08 uM (AcAcCoA as substrate), IC50 = 2.9 uM (3-OH decanoyl-NAC as substrate)|O54438|3-OXOACYL-[ACYL-CARRIER-PROTEIN] REDUCTASE FABG|7.1|IC=0.08uM|IC50|=|0.08|uM|80|nM
4MQ2|2.80|2013|2C4|IC50 = 0.097 +/- 0.06 uM,the ligand in crystal is not equal to the ligand in literature(4mq1 4mq2 swap).|Q13627|DUAL SPECIFICITY TYROSINE-PHOSPHORYLATION-REGULATED KINASE|7.01|IC=0.097uM|IC50|=|0.097|uM|97|nM
4GJC|2.40|2013|0MJ|IC50 = 0.09 +/-0.05 uM; X-ray((3S,5R)-9), IC50(rac-9)|P00797|RENIN|7.05|IC=0.09uM|IC50|=|0.09|uM|90|nM
4LI6|2.05|2013|1XO|ligand is compound 19;The protein in crystal(Tankyrase-1) and in binding data(Tankyrase-2) is not identical.|O95271|TANKYRASE-1|6.97|IC=0.106uM|IC50|=|0.106|uM|106|nM
4BO7|2.60|2013|J2T|IC50 = 0.10 uM (AcAcCoA as substrate), IC50 = 1.9 uM (3-OH decanoyl-NAC as substrate)|O54438|3-OXOACYL-[ACYL-CARRIER-PROTEIN] REDUCTASE FABG|7.0|IC=0.10uM|IC50|=|0.1|uM|100|nM
4BFY|2.30|2013|ZVY|IC50 = 0.12 uM (IC50 at Km for ATP), IC50 = 0.12 uM (IC50 at 50xKm for ATP)|P63810|PANTOTHENATE KINASE|6.92|IC=0.12uM|IC50|=|0.12|uM|120|nM
4BO8|2.70|2013|34X|IC50 = 0.12 uM (AcAcCoA as substrate), IC50 = 3.9 uM (3-OH decanoyl-NAC as substrate)|O54438|3-OXOACYL-[ACYL-CARRIER-PROTEIN] REDUCTASE FABG|6.92|IC=0.12uM|IC50|=|0.12|uM|120|nM
4JG7|3.00|2013|1LC|IC50=0.12+/-0.02uM, covalent complex, Different ligand structure(double bond)|P51812|RIBOSOMAL PROTEIN S6 KINASE ALPHA-3|6.92|IC=0.12uM|IC50|=|0.12|uM|120|nM
4BO4|2.70|2013|36G|IC50 = 0.13 uM (AcAcCoA as substrate), IC50 = 3.1 uM (3-OH decanoyl-NAC as substrate)|O54438|3-OXOACYL-[ACYL-CARRIER-PROTEIN] REDUCTASE FABG|6.89|IC=0.13uM|IC50|=|0.13|uM|130|nM
4G16|2.30|2013|0VM|X-ray(CK1-gamma-3), IC50(CK1-gamma)|Q9Y6M4|CASEIN KINASE I ISOFORM GAMMA-3|6.85|IC=0.14uM|IC50|=|0.14|uM|140|nM
4H4D|1.35|2013|10E|covalent complex|P62623|4-HYDROXY-3-METHYLBUT-2-ENYL DIPHOSPHATE REDUCTASE|6.82|IC=0.15uM|IC50|=|0.15|uM|150|nM
4N3R|1.90|2013|2GU|ligand is compound 2|O95271|TANKYRASE-1|6.82|IC=0.15uM|IC50|=|0.15|uM|150|nM
4J0A|2.40|2013|1JL||O92972|GENOME POLYPROTEIN|6.8|IC=0.16uM|IC50|=|0.16|uM|160|nM
4L7F|1.95|2013|1V5||P45983|MITOGEN-ACTIVATED PROTEIN KINASE 8|6.8|IC=0.16uM|IC50|=|0.16|uM|160|nM
4JZF|1.84|2013|1NL|ligand is compound 21a|P08709|COAGULATION FACTOR VIIA (HEAVY CHAIN)|6.76|IC=0.175uM|IC50|=|0.175|uM|175|nM
4GJ7|2.80|2013|0LT||P00797|RENIN|6.77|IC=0.17uM|IC50|=|0.17|uM|170|nM
4I10|2.07|2013|1BS||P56817|BETA-SECRETASE 1|6.77|IC=0.17uM|IC50|=|0.17|uM|170|nM
4J0T|2.05|2013|6T9|ligand is compound 14i|P56817|BETA-SECRETASE 1|6.74|IC=0.184uM|IC50|=|0.184|uM|184|nM
3ZM5|2.94|2013|IGM|ligand is compound 22n; Malachite green assay|Q8DNV6|UDP-N-ACETYLMURAMOYL-TRIPEPTIDE-D-ALANYL-D-ALANINE|6.74|IC=0.18uM|IC50|=|0.18|uM|180|nM
4BO6|2.80|2013|36P|IC50 = 0.18 uM (AcAcCoA as substrate), IC50 = 1.6 uM (3-OH decanoyl-NAC as substrate)|O54438|3-OXOACYL-[ACYL-CARRIER-PROTEIN] REDUCTASE FABG|6.74|IC=0.18uM|IC50|=|0.18|uM|180|nM
4H58|3.10|2013|10Z|ligand is compound 48|P15056|SERINE/THREONINE-PROTEIN KINASE B-RAF|6.72|IC=0.192uM|IC50|=|0.192|uM|192|nM
4MSG|1.80|2013|2C6|ligand is compound 22|O95271|TANKYRASE-1|10.0|IC=0.1nM|IC50|=|0.1|nM|0.1|nM
4MT9|2.00|2013|2D6|ligand is compound 49|O95271|TANKYRASE-1|10.0|IC=0.1nM|IC50|=|0.1|nM|0.1|nM
4GS8|2.99|2013|MGJ|ligand is bdm43079, compound 5|P14735|INSULIN-DEGRADING ENZYME|7.0|IC=0.1uM|IC50|=|0.1|uM|100|nM
4I7D|2.40|2013|14-mer|covalent complex; DELFIA TRF assay|Q8IUQ4|E3 UBIQUITIN-PROTEIN LIGASE SIAH1|7.0|IC=0.1uM|IC50|=|0.1|uM|100|nM
4IDT|2.40|2013|T28|NIK biochemical chemiluminescent assay|Q99558|MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 14|7.0|IC=0.1uM|IC50|=|0.1|uM|100|nM
4BO0|2.40|2013|FXE|IC50 = 0.20 uM (AcAcCoA as substrate), IC50 = 5.4 uM (3-OH decanoyl-NAC as substrate)|O54438|3-OXOACYL-[ACYL-CARRIER-PROTEIN] REDUCTASE FABG|6.7|IC=0.20uM|IC50|=|0.2|uM|200|nM
4K4F|2.90|2013|K4F|ligand is compound 18|O95271|TANKYRASE-1|6.7|IC=0.20uM|IC50|=|0.2|uM|200|nM
4LH5|2.19|2013|LF0|ligand is Mut101|Q9WJM2|INTEGRASE|6.7|IC=0.20uM|IC50|=|0.2|uM|200|nM
4H4E|1.70|2013|10G|covalent complex|P62623|4-HYDROXY-3-METHYLBUT-2-ENYL DIPHOSPHATE REDUCTASE|6.68|IC=0.21uM|IC50|=|0.21|uM|210|nM
4J08|2.10|2013|1JH||O92972|GENOME POLYPROTEIN|6.66|IC=0.22uM|IC50|=|0.22|uM|220|nM
4J51|2.30|2013|N75|IC50=0.259+/-0.007uM|Q9Y2R2|TYROSINE-PROTEIN PHOSPHATASE NON-RECEPTOR TYPE 22|6.59|IC=0.259uM|IC50|=|0.259|uM|259|nM
4BIE|2.36|2013|IE6|ligand is compound 4;PIC501=6.6+/-1.1(ASk1 Full length N-terminal GST tag),PIC502=6.8+/-0.4(ASk1 Full length N-terminal 6HisAvi tag)|Q99683|MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 5|6.6|IC=0.25uM|IC50|=|0.25|uM|250|nM
4BIB|2.43|2013|IEO|ligand is compound 1;PIC501=6.6+/-0.4(ASk1 Full length N-terminal GST tag),PIC502=6.2+/-0.1(ASk1 Full length N-terminal 6HisAvi tag)|Q99683|MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 5|6.6|IC=0.25uM|IC50|=|0.25|uM|250|nM
4BNZ|2.50|2013|8M5|IC50 = 0.26 uM (AcAcCoA as substrate), IC50 = 3.7 uM (3-OH decanoyl-NAC as substrate)|O54438|3-OXOACYL-[ACYL-CARRIER-PROTEIN] REDUCTASE FABG|6.59|IC=0.26uM|IC50|=|0.26|uM|260|nM
4BYJ|2.75|2013|FH5|IC50 = 0.27 +/- 0.008 uM|O14965|AURORA KINASE A|6.57|IC=0.27uM|IC50|=|0.27|uM|270|nM
4KRS|2.29|2013|1SX|ligand is compound 4|O95271|TANKYRASE-1|6.52|IC=0.299uM|IC50|=|0.299|uM|299|nM
3W54|2.30|2013|RNB|ligand is CCB|Q26710|ALTERNATIVE OXIDASE, MITOCHONDRIAL|9.7|IC=0.2nM|IC50|=|0.2|nM|0.2|nM
4BTI|2.29|2013|7R9||P00742|COAGULATION FACTOR X LIGHT CHAIN|9.7|IC=0.2nM|IC50|=|0.2|nM|0.2|nM
4JJS|2.20|2013|1M9||O92972|GENOME POLYPROTEIN|6.7|IC=0.2uM|IC50|=|0.2|uM|200|nM
3ZM6|1.84|2013|2GN|ligand is compound 22m; Malachite green assay|Q8DNV6|UDP-N-ACETYLMURAMOYL-TRIPEPTIDE-D-ALANYL-D-ALANINE|6.52|IC=0.30uM|IC50|=|0.3|uM|300|nM
4BO3|2.50|2013|U98|IC50 = 0.30 uM (AcAcCoA as substrate), IC50 = 4.1 uM (3-OH decanoyl-NAC as substrate)|O54438|3-OXOACYL-[ACYL-CARRIER-PROTEIN] REDUCTASE FABG|6.52|IC=0.30uM|IC50|=|0.3|uM|300|nM
4BO9|2.90|2013|3X3|IC50 = 0.31 uM (AcAcCoA as substrate), IC50 = 7.8 uM (3-OH decanoyl-NAC as substrate)|O54438|3-OXOACYL-[ACYL-CARRIER-PROTEIN] REDUCTASE FABG|6.51|IC=0.31uM|IC50|=|0.31|uM|310|nM
4BRX|2.05|2013|KGW|IC50 = 0.32 +/- 0.09 uM|Q00944|FOCAL ADHESION KINASE 1|6.49|IC=0.32uM|IC50|=|0.32|uM|320|nM
4D8S|2.40|2013|0HX|Ca-containing; the method of getting IC50 from supporting information S9|Q07599|NEURAMINIDASE|6.49|IC=0.32uM|IC50|=|0.32|uM|320|nM
4JU4|2.40|2013|1O3|IC50=0.34+/-0.18uM, RdRp assay, Scintillation Proximity Assay|O92972|GENOME POLYPROTEIN|6.47|IC=0.34uM|IC50|=|0.34|uM|340|nM
4JG6|2.60|2013|1LB|IC50=0.36+/-0.01uM, Covalent complex, Different ligand structure(double bond)|P51812|RIBOSOMAL PROTEIN S6 KINASE ALPHA-3|6.44|IC=0.36uM|IC50|=|0.36|uM|360|nM
4I5P|1.74|2013|1D1||Q9NYY3|SERINE/THREONINE-PROTEIN KINASE PLK2|6.42|IC=0.377uM|IC50|=|0.377|uM|377|nM
4J0S|1.84|2013|1H3|IC50=0.382(0.346-0.420)uM, AlphaScreen Peptide Displacement Assay (ALPHA Assay)|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|6.42|IC=0.382uM|IC50|=|0.382|uM|382|nM
4J0R|1.72|2013|1H2|IC50=0.386(0.345-0.420)uM, AlphaScreen Peptide Displacement Assay (ALPHA Assay)|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|6.41|IC=0.386uM|IC50|=|0.386|uM|386|nM
4M5O|2.00|2013|X48|ligand is compound 4|F0TRT1|POLYMERASE PA|6.42|IC=0.38uM|IC50|=|0.38|uM|380|nM
4BQX|1.79|2013|UN9|Mn-containing|Q9GZT9|EGL NINE HOMOLOG 1|6.52|IC=0.3uM|IC50|=|0.3|uM|300|nM
4EZ5|2.70|2013|0RS|IC50=0.3+/-0.1uM; IC50(TR-FRET method come from Supporting Information)|Q00534|CYCLIN-DEPENDENT KINASE 6|6.52|IC=0.3uM|IC50|=|0.3|uM|300|nM
4I12|1.78|2013|1BC|AlphaScreen assay|P56817|BETA-SECRETASE 1|6.39|IC=0.406uM|IC50|=|0.406|uM|406|nM
4MWV|2.00|2013|BCZ|ligand is Peramivir;IC50 = 0.40(0.25-0.67) nM|R4JGE3|NEURAMINIDASE|9.4|IC=0.40nM|IC50|=|0.4|nM|0.4|nM
4FF8|2.40|2013|14S||P55144|TYROSINE-PROTEIN KINASE RECEPTOR TYRO3|6.4|IC=0.40uM|IC50|=|0.4|uM|400|nM
4MWR|1.80|2013|ZMR|ligand is Zanamivir;IC50 = 0.41(0.10-1.72) nM|R4JGE3|NEURAMINIDASE|9.39|IC=0.41nM|IC50|=|0.41|nM|0.41|nM
4J0Y|1.77|2013|1H6|ligand is compound 67|P56817|BETA-SECRETASE 1|6.36|IC=0.435uM|IC50|=|0.435|uM|435|nM
3VS3|2.17|2013|VSE|ligand is RK-20449|P08631|TYROSINE-PROTEIN KINASE HCK|9.37|IC=0.43nM|IC50|=|0.43|nM|0.43|nM
4I0F|1.80|2013|1BF|AlphaScreen assay|P56817|BETA-SECRETASE 1|6.35|IC=0.45uM|IC50|=|0.45|uM|450|nM
4MK5|1.90|2013|28A|ligand is compound 5|M9V5A4|POLYMERASE PA|6.35|IC=0.45uM|IC50|=|0.45|uM|450|nM
4LKM|2.00|2013|8-mer|ligand is PL-74|P53350|SERINE/THREONINE-PROTEIN KINASE PLK1|6.34|IC=0.46uM|IC50|=|0.46|uM|460|nM
4I0Z|1.80|2013|1BB||P56817|BETA-SECRETASE 1|6.33|IC=0.47uM|IC50|=|0.47|uM|470|nM
3VVA|2.59|2013|CHW|ligand is AF2779OH|Q26710|ALTERNATIVE OXIDASE, MITOCHONDRIAL|9.32|IC=0.48nM|IC50|=|0.48|nM|0.48|nM
4I31|1.93|2013|17-mer|IC50=0.48+/-0.27nM; incomplete ligand|P26662|GENOME POLYPROTEIN|9.32|IC=0.48nM|IC50|=|0.48|nM|0.48|nM
4JJ7|1.18|2013|6-mer||Q14790|CASPASE-8|6.4|IC=0.4uM|IC50|=|0.4|uM|400|nM
4KIO|2.18|2013|G5K|pIC50 = 6.3|Q08881|TYROSINE-PROTEIN KINASE ITK/TSK|6.3|IC=0.501uM|IC50|=|0.501|uM|501|nM
4BW3|1.50|2013|9BM||O60885|BROMODOMAIN-CONTAINING PROTEIN 4|6.3|IC=0.50uM|IC50|=|0.5|uM|500|nM
4JDA|2.65|2013|A9S|ligand is (-)-ABA|Q9SSM7|ABSCISIC ACID RECEPTOR PYL3|6.29|IC=0.51uM|IC50|=|0.51|uM|510|nM
4CFW|2.45|2013|SQ9|IC50 = 0.51 +/- 0.05 uM|P24941|CYCLIN-DEPENDENT KINASE 2|6.29|IC=0.51uM|IC50|=|0.51|uM|510|nM
4JJU|1.91|2013|1MB||O92972|GENOME POLYPROTEIN|6.29|IC=0.51uM|IC50|=|0.51|uM|510|nM
3WIX|1.90|2013|LC3|ligand is compound 4|Q07820|INDUCED MYELOID LEUKEMIA CELL DIFFERENTIATION PROTEIN MCL|6.27|IC=0.54uM|IC50|=|0.54|uM|540|nM
3ZJV|2.31|2013|AN3213|The crystal structure is a ternary complex of leucyl-tRNA synthetase, RNA and AN3213.|P07813|LEUCYL-TRNA SYNTHETASE|6.27|IC=0.54uM|IC50|=|0.54|uM|540|nM
4L6Q|2.79|2013|1WU|ligand is compound 4|O75116|RHO-ASSOCIATED PROTEIN KINASE 2|6.27|IC=0.54uM|IC50|=|0.54|uM|540|nM
4INU|3.10|2013|1G6|Different ligand structure(double bond)|P23639|PROTEASOME COMPONENT Y7|9.26|IC=0.55nM|IC50|=|0.55|nM|0.55|nM
4BFZ|2.10|2013|ZVZ||P63810|PANTOTHENATE KINASE|6.26|IC=0.55uM|IC50|=|0.55|uM|550|nM
4LI5|2.64|2013|1WY|covalent complex|P00533|EPIDERMAL GROWTH FACTOR RECEPTOR|6.26|IC=0.55uM|IC50|=|0.55|uM|550|nM
4C35|2.19|2013|NU3|IC50 = 0.56 +/- 0.05 uM (AlphaScreen kinase assay)|P00517|CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTIC|6.25|IC=0.56uM|IC50|=|0.56|uM|560|nM
4MCC|1.95|2013|21X|ligand is compound 27|P43912|TRNA (GUANINE-N(1)-)-METHYLTRANSFERASE|6.25|IC=0.56uM|IC50|=|0.56|uM|560|nM
3WD2|2.20|2013|A1L|ligand is Azide 2|P11797|CHITINASE B|6.24|IC=0.58uM|IC50|=|0.58|uM|580|nM
4IQU|2.40|2013|1FQ|compound 4b, IC50 value|P09838|DNA NUCLEOTIDYLEXOTRANSFERASE|6.24|IC=0.58uM|IC50|=|0.58|uM|580|nM
4IKR|1.78|2013|PVP|IC50=0.59+/-0.04uM, Co-contained|P53582|METHIONINE AMINOPEPTIDASE 1|6.23|IC=0.59uM|IC50|=|0.59|uM|590|nM
3VTB|2.00|2013|TKA|ligand is compound 4b, ADTK1|P13053|VITAMIN D3 RECEPTOR|9.3|IC=0.5nM|IC50|=|0.5|nM|0.5|nM
4BTU|2.37|2013|6XS||P00742|COAGULATION FACTOR X HEAVY CHAIN|9.3|IC=0.5nM|IC50|=|0.5|nM|0.5|nM
4HZX|2.20|2013|G39||A9YN63|NEURAMINIDASE|9.3|IC=0.5nM|IC50|=|0.5|nM|0.5|nM
4I4E|1.55|2013|1BQ||Q05397|FOCAL ADHESION KINASE 1|6.3|IC=0.5uM|IC50|=|0.5|uM|500|nM
4KIL|1.75|2013|1R5|ligand is compound 9|F0TRT1|POLYMERASE PA|6.3|IC=0.5uM|IC50|=|0.5|uM|500|nM
3WIY|2.15|2013|LC6|ligand is compound 10|Q07820|INDUCED MYELOID LEUKEMIA CELL DIFFERENTIATION PROTEIN MCL|6.21|IC=0.61uM|IC50|=|0.61|uM|610|nM
4I0D|1.91|2013|1B7|AlphaScreen assay|P56817|BETA-SECRETASE 1|6.21|IC=0.61uM|IC50|=|0.61|uM|610|nM
4IR5|1.70|2013|IR5|compound 17|Q9UIF8|BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN PROTEIN 2B|6.21|IC=0.61uM|IC50|=|0.61|uM|610|nM
4JWR|2.35|2013|1MY||Q00987|E3 UBIQUITIN-PROTEIN LIGASE MDM2|6.21|IC=0.61uM|IC50|=|0.61|uM|610|nM
4B72|1.60|2013|2FB|ligand is compound 41|P56817|BETA-SECRETASE 1|6.2|IC=0.63uM|IC50|=|0.63|uM|630|nM
4BW4|1.67|2013|9B6||O60885|BROMODOMAIN-CONTAINING PROTEIN 4|6.2|IC=0.63uM|IC50|=|0.63|uM|630|nM
4GW6|2.65|2013|LF2|IC50 = 0.63 +/- 0.3 uM|P12497|GAG-POL POLYPROTEIN|6.2|IC=0.63uM|IC50|=|0.63|uM|630|nM
4I4F|1.75|2013|1BR||Q05397|FOCAL ADHESION KINASE 1|6.19|IC=0.64uM|IC50|=|0.64|uM|640|nM
4IKT|1.60|2013|TFV|IC50=0.67+/-0.03uM, Co-contained|P53582|METHIONINE AMINOPEPTIDASE 1|6.17|IC=0.67uM|IC50|=|0.67|uM|670|nM
4JU6|2.20|2013|1O6|IC50=0.67+/-0.26uM, RdRp assay, Scintillation Proximity Assay|O92972|GENOME POLYPROTEIN|6.17|IC=0.67uM|IC50|=|0.67|uM|670|nM
4JU7|2.20|2013|1O6|IC50=0.67+/-0.26uM, RdRp assay, Scintillation Proximity Assay|O92972|GENOME POLYPROTEIN|6.17|IC=0.67uM|IC50|=|0.67|uM|670|nM
4B6C|2.20|2013|B5U|ligand is compound 6|P0C559|DNA GYRASE SUBUNIT B|6.16|IC=0.69uM|IC50|=|0.69|uM|690|nM
3ZC6|2.42|2013|VFC|ligand is compound 6d;IC50=0.6+/-0.3nM|P52333|TYROSINE-PROTEIN KINASE JAK3|9.22|IC=0.6nM|IC50|=|0.6|nM|0.6|nM
4DWK|3.00|2013|MGK|ligand is bdm41671, compound 3|P14735|INSULIN-DEGRADING ENZYME|6.22|IC=0.6uM|IC50|=|0.6|uM|600|nM
4JJ8|2.94|2013|6-mer||P55210|CASPASE-7 (CASP-7)|6.14|IC=0.73uM|IC50|=|0.73|uM|730|nM
4MK2|1.85|2013|28B|ligand is compound 3|M9V5A4|POLYMERASE PA|6.14|IC=0.73uM|IC50|=|0.73|uM|730|nM
3ZEB|2.20|2013|SV1|IC50=0.74+/-0.13uM, the ring is open|P09391|RHOMBOID PROTEASE GLPG|6.13|IC=0.74uM|IC50|=|0.74|uM|740|nM
4HZT|1.80|2013|0ZA||P56817|BETA-SECRETASE 1|6.12|IC=0.75uM|IC50|=|0.75|uM|750|nM
4LI7|2.20|2013|1XP|ligand is compound 33;The protein in crystal(Tankyrase-1) and in binding data(Tankyrase-2) is not identical.|O95271|TANKYRASE-1|6.11|IC=0.770uM|IC50|=|0.77|uM|770|nM
4J1H|2.20|2013|1HJ|ligand is compound 109|P56817|BETA-SECRETASE 1|6.11|IC=0.776uM|IC50|=|0.776|uM|776|nM
4GVM|2.16|2013|LF2|IC50 = 0.78 +/- 0.06 uM|P12497|GAG-POL POLYPROTEIN|6.11|IC=0.78uM|IC50|=|0.78|uM|780|nM
4IQT|2.60|2013|1FO|ligand is compound 4c|P09838|DNA NUCLEOTIDYLEXOTRANSFERASE|6.11|IC=0.78uM|IC50|=|0.78|uM|780|nM
4MWQ|2.00|2013|G39|ligand is Oseltamivir Carboxylate; IC50 = 0.79(0.51-1.23) nM|R4JGE3|NEURAMINIDASE|9.1|IC=0.79nM|IC50|=|0.79|nM|0.79|nM
4HXM|1.50|2013|1A8|IC50 = 0.79 +/- 0.8 uM|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|6.1|IC=0.79uM|IC50|=|0.79|uM|790|nM
4BSQ|1.96|2013|QQV|covalent complex|O70370|CATHEPSIN S|9.15|IC=0.7nM|IC50|=|0.7|nM|0.7|nM
4KP6|1.50|2013|1S1|ligand is compounf 44|Q07343|CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B|9.09|IC=0.81nM|IC50|=|0.81|nM|0.81|nM
4LKL|1.58|2013|8-mer|ligand is PL-55|P53350|SERINE/THREONINE-PROTEIN KINASE PLK1|6.09|IC=0.82uM|IC50|=|0.82|uM|820|nM
4IR6|1.80|2013|IR6|compound 20|Q9UIF8|BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN PROTEIN 2B|6.08|IC=0.84uM|IC50|=|0.84|uM|840|nM
4INB|1.80|2013|1F6|HIV-1 capsid assembly assay (CAA)|Q79791|GAG PROTEIN|6.05|IC=0.89uM|IC50|=|0.89|uM|890|nM
3ZLQ|2.10|2013|6T9|ligand is compound 14i|Q9Y5Z0|BETA-SECRETASE 2|6.04|IC=0.904uM|IC50|=|0.904|uM|904|nM
4II9|1.66|2013|8-mer|IC50=0.93+/-0.07uM|Q9EY50|FEMX|6.03|IC=0.93uM|IC50|=|0.93|uM|930|nM
3VUC|2.60|2013|HHE|ligand is compound 5|P00797|RENIN|9.05|IC=0.9nM|IC50|=|0.9|nM|0.9|nM
4IVT|1.60|2013|VTI|IC50=1.01+/-0.091uM|P56817|BETA-SECRETASE 1|6.0|IC=1.01uM|IC50|=|1.01|uM|1010|nM
4JV7|2.20|2013|1MN|IC50=1.0+/-0.1uM|Q00987|E3 UBIQUITIN-PROTEIN LIGASE MDM2|6.0|IC=1.0uM|IC50|=|1|uM|1000|nM
3ZMI|2.20|2013|L6C|L29 data set 1;IC50=1.117+/-0.05uM, covalent complex|P09391|RHOMBOID PROTEASE GLPG|5.95|IC=1.117uM|IC50|=|1.117|uM|1117|nM
3ZOT|2.40|2013|L6C|L29 data set 2;IC50=1.117+/-0.05uM; covalent complex|P09391|RHOMBOID PROTEASE GLPG|5.95|IC=1.117uM|IC50|=|1.117|uM|1117|nM
4I6B|1.80|2013|11G||Q9NYY3|SERINE/THREONINE-PROTEIN KINASE PLK2|5.93|IC=1.17uM|IC50|=|1.17|uM|1170|nM
4K3L|1.50|2013|2-mer|ligand is AcLF|P0A988|DNA POLYMERASE III SUBUNIT BETA|2.96|IC=1.1mM|IC50|=|1.1|mM|1100000|nM
4BDT|3.10|2013|HUW|ligand is huprine W|P22303|ACETYLCHOLINESTERASE|8.96|IC=1.1nM|IC50|=|1.1|nM|1.1|nM
3ZM4|2.37|2013|22T|ligand is fragment 1|Q02750|DUAL SPECIFICITY MITOGEN-ACTIVATED PROTEIN KINASE K|5.96|IC=1.1uM|IC50|=|1.1|uM|1100|nM
4BQY|1.53|2013|FNT|Fe-containing|Q9GZT9|EGL NINE HOMOLOG 1|5.96|IC=1.1uM|IC50|=|1.1|uM|1100|nM
4FEQ|2.20|2013|0T8||P55144|TYROSINE-PROTEIN KINASE RECEPTOR TYRO3|5.96|IC=1.1uM|IC50|=|1.1|uM|1100|nM
4AZP|2.10|2013|A9M|ligand is AEA; binding affinity=1.26+/-0.18uM|Q497I3|FATTY ACID-BINDING PROTEIN, EPIDERMAL|5.9|IC=1.26uM|IC50|=|1.26|uM|1260|nM
4BW1|1.40|2013|S5B||O60885|BROMODOMAIN-CONTAINING PROTEIN 4|5.9|IC=1.26uM|IC50|=|1.26|uM|1260|nM
4MTI|2.15|2013|2DX|ligand is compound 63;IC50 = 1.2(1.1-1.3) nM|Q13490|BACULOVIRAL IAP REPEAT-CONTAINING PROTEIN 2|8.92|IC=1.2nM|IC50|=|1.2|nM|1.2|nM
4MXA|3.00|2013|BK7|ligand is inhibitor RM-1-132, compound 15n|F0V9W9|CALMODULIN-DOMAIN PROTEIN KINASE ISOENZYME GAM|8.92|IC=1.2nM|IC50|=|1.2|nM|1.2|nM
3ZKI|2.40|2013|WZV|ligand is RO5464694|Q9Y5Z0|BETA-SECRETASE 2|5.92|IC=1.2uM|IC50|=|1.2|uM|1200|nM
4GJA|2.60|2013|0M3|X-ray((3S,5R)-5), IC50 = 1.2 +/- 0.5 uM ((rac)-5)|P00797|RENIN|5.92|IC=1.2uM|IC50|=|1.2|uM|1200|nM
4L3P|2.68|2013|1UH|ligand is compound 1b; Binding assay method is ALPHAScreen.|O43318|MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 7|5.92|IC=1.2uM|IC50|=|1.2|uM|1200|nM
4HZW|1.70|2013|LNV||A9YN63|NEURAMINIDASE|8.88|IC=1.31nM|IC50|=|1.31|nM|1.31|nM
3ZLK|1.95|2013|Y46|compound 15a; IC50=1.32+/-3.7uM|G3XCK4|GLUCOSE-1-PHOSPHATE THYMIDYLYLTRANSFERASE|5.88|IC=1.32uM|IC50|=|1.32|uM|1320|nM
4HY5|1.75|2013|1AQ|Zn-containing; IC50 = 1.2~1.5 nM|Q13490|BACULOVIRAL IAP REPEAT-CONTAINING PROTEIN 2|8.89|IC=1.3nM|IC50|=|1.3|nM|1.3|nM
4MCV|2.73|2013|29K|IC50 = 1.3 +/- 0.2 nM|P00523|TYROSINE-PROTEIN KINASE SRC|8.89|IC=1.3nM|IC50|=|1.3|nM|1.3|nM
4BTT|2.59|2013|VYR|different ligand structure|P00742|COAGULATION FACTOR X LIGHT CHAIN|8.84|IC=1.43nM|IC50|=|1.43|nM|1.43|nM
4BZN|1.90|2013|UGX||P11309|SERINE/THREONINE-PROTEIN KINASE PIM-1|5.84|IC=1.441uM|IC50|=|1.441|uM|1441|nM
3VO3|1.52|2013|0KF|ligand is compound 19|P35968|VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2|8.85|IC=1.4nM|IC50|=|1.4|nM|1.4|nM
4HVD|1.85|2013|933|IC50 = 1.4 +/- 0.3 nM (a kinasefiltration assay)|P52333|TYROSINE-PROTEIN KINASE JAK3|8.85|IC=1.4nM|IC50|=|1.4|nM|1.4|nM
4J6I|2.90|2013|1JV||P48736|PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE|8.85|IC=1.4nM|IC50|=|1.4|nM|1.4|nM
4MU7|1.79|2013|2DY|ligand is compound 48;IC50 = 1.4(1.3-1.6) nM|Q13490|BACULOVIRAL IAP REPEAT-CONTAINING PROTEIN 2|8.85|IC=1.4nM|IC50|=|1.4|nM|1.4|nM
4GSC|2.81|2013|MGW|ligand is bdm41559, compound 2|P14735|INSULIN-DEGRADING ENZYME|5.85|IC=1.4uM|IC50|=|1.4|uM|1400|nM
3ZLO|2.60|2013|X8U|ligand is compound 6;IC50=1.5+/-0.4nM|Q07817|BCL-2-LIKE PROTEIN 1|8.82|IC=1.5nM|IC50|=|1.5|nM|1.5|nM
4MCB|1.94|2013|21W|ligand is compound 38|P43912|TRNA (GUANINE-N(1)-)-METHYLTRANSFERASE|5.82|IC=1.5uM|IC50|=|1.5|uM|1500|nM
4GHT|1.96|2013|AG7|covalent complex|A9XG43|3C PROTEINASE|5.78|IC=1.67uM|IC50|=|1.67|uM|1670|nM
4G2W|2.28|2013|NI0|Zn-containing, Mg-containing|O76074|CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE|8.8|IC=1.6nM|IC50|=|1.6|nM|1.6|nM
4GK2|2.19|2013|L66||Q6P4R6|EPH RECEPTOR A3|8.8|IC=1.6nM|IC50|=|1.6|nM|1.6|nM
4INT|2.90|2013|1G5|Different ligand structure(double bond)|P23639|PROTEASOME COMPONENT Y7|5.8|IC=1.6uM|IC50|=|1.6|uM|1600|nM
4MZJ|1.47|2013|19-mer|ligand is pGly[801,805], a stapled myoA tail peptide|Q8I4W8|MYOSIN A TAIL DOMAIN INTERACTING PROTEIN|5.8|IC=1.6uM|IC50|=|1.6|uM|1600|nM
4IKU|1.30|2013|SHX|IC50=1.79+/-0.08uM, Co-contained|P53582|METHIONINE AMINOPEPTIDASE 1|5.75|IC=1.79uM|IC50|=|1.79|uM|1790|nM
4IBM|1.80|2013|IR1||P06213|INSULIN RECEPTOR|5.74|IC=1.8uM|IC50|=|1.8|uM|1800|nM
4JV9|2.50|2013|1MO|IC50=1.8+/-0.1uM|Q00987|E3 UBIQUITIN-PROTEIN LIGASE MDM2|5.74|IC=1.8uM|IC50|=|1.8|uM|1800|nM
4HHY|2.36|2013|15R||P09874|POLY [ADP-RIBOSE] POLYMERASE 1|8.72|IC=1.92nM|IC50|=|1.92|nM|1.92|nM
4JHT|1.18|2013|8XQ|a formaldehyde dehydrogenase based assay; Mn-containing|P05050|ALPHA-KETOGLUTARATE-DEPENDENT DIOXYGENASE ALKB|4.99|IC=10.2uM|IC50|=|10.2|uM|10200|nM
4M5R|1.40|2013|MSR|ligand is compound 1|F0TRT1|POLYMERASE PA|3.0|IC=1000uM|IC50|=|1000|uM|1000000|nM
4I7F|2.50|2013|NVE||P04585|HIV-1 REVERSE TRANSCRIPTASE|7.0|IC=100nM|IC50|=|100|nM|100|nM
4IZ0|2.22|2013|2BI||O92972|RNA-DIRECTED RNA POLYMERASE|4.0|IC=100uM|IC50|=|100|uM|100000|nM
4DR9|1.90|2013|BB2|ligand is actinonin|Q5N5L5|PEPTIDE DEFORMYLASE|8.0|IC=10nM|IC50|=|10|nM|10|nM
4KFP|1.84|2013|1R7|ligand is compound 29|P43490|NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE|8.0|IC=10nM|IC50|=|10|nM|10|nM
4MB9|1.85|2013|28F|ligand is compound 20|G6TGY9|TOPOISOMERASE IV, SUBUNIT B|8.0|IC=10nM|IC50|=|10|nM|10|nM
4B78|1.50|2013|KGG|ligand is compound 91|P56817|BETA-SECRETASE 1|5.0|IC=10uM|IC50|=|10|uM|10000|nM
3ZMJ|2.30|2013|L61|IC50=11.71+/-0.75uM, covalent complex|P09391|RHOMBOID PROTEASE GLPG|4.93|IC=11.71uM|IC50|=|11.71|uM|11710|nM
4BDC|3.00|2013|ODH|ligand is compound 13 IC50=11.7+/-2.0uM;Mobility Shift Assay|O96017|SERINE/THREONINE-PROTEIN KINASE CHK2|4.93|IC=11.7uM|IC50|=|11.7|uM|11700|nM
4LC7|1.70|2013|1WP|ligand is compound 40|P56817|BETA-SECRETASE-1|4.93|IC=11.8uM|IC50|=|11.8|uM|11800|nM
4L34|1.80|2013|1VG|Zn-contained|Q9H2K2|TANKYRASE-2|6.94|IC=114nM|IC50|=|114|nM|114|nM
4DHO|1.70|2013|Y09|ligand is compound B9|P31947|14-3-3 PROTEIN SIGMA|3.93|IC=118uM|IC50|=|118|uM|118000|nM
3W5E|2.30|2013|NVW|ligand is compound 31e|Q07343|CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B|7.96|IC=11nM|IC50|=|11|nM|11|nM
4G2J|2.40|2013|0WF|Zn-containing, Mg-containing;|O76083|CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE-9|7.96|IC=11nM|IC50|=|11|nM|11|nM
4JBS|2.79|2013|P52|IC50=11+/-2nM, Zn-contained|Q6P179|ENDOPLASMIC RETICULUM AMINOPEPTIDASE 2|7.96|IC=11nM|IC50|=|11|nM|11|nM
4M4Q|2.50|2013|21A|ligand is compound 7|F0TRT1|POLYMERASE PA|7.96|IC=11nM|IC50|=|11|nM|11|nM
4M5U|2.20|2013|20F|ligand is compound 16;IC50 = 0.011 0.0005 uM|F0TRT1|POLYMERASE PA|7.96|IC=11nM|IC50|=|11|nM|11|nM
4J04|2.00|2013|1JF||O92972|GENOME POLYPROTEIN|4.96|IC=11uM|IC50|=|11|uM|11000|nM
4KB8|1.95|2013|1QN|ligand is compound 4|P48730|CASEIN KINASE I ISOFORM DELTA|7.89|IC=12.9nM|IC50|=|12.9|nM|12.9|nM
3WFG|1.40|2013|WFG|ligand is compound 2e|P08235|MINERALOCORTICOID RECEPTOR|6.92|IC=120nM|IC50|=|120|nM|120|nM
4KC1|1.50|2013|WS1|ligand is 8-GLC|P16442|FUCOSYLGLYCOPROTEIN ALPHA-N|2.91|IC=1220uM|IC50|=|1220|uM|1220000|nM
4JX7|2.40|2013|1N6|IC50 = 123 +/- 14 nM|P11309|SERINE/THREONINE-PROTEIN KINASE PIM-1|6.91|IC=123nM|IC50|=|123|nM|123|nM
4J4O|1.73|2013|D44|IC50=125+/-2.9nM|A5K8X6|70 KDA PEPTIDYLPROLYL ISOMERASE, PUTATIVE|6.9|IC=125nM|IC50|=|125|nM|125|nM
4MEN|1.81|2013|25K|ligand is compound 3; 33% inhibition|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|3.9|IC=125uM|IC50|=|125|uM|125000|nM
4KQQ|2.10|2013|VPP|ligand is (5S)-penicilloic acid;IC50 = 126 +/- 18 uM;co-crystallization|G3XD46|PENICILLIN-BINDING PROTEIN 3|3.9|IC=126uM|IC50|=|126|uM|126000|nM
4KQR|2.01|2013|VPP|ligand is (5S)-penicilloic acid;IC50 = 126 +/- 18 uM;co-crystallization; soaking|G3XD46|PENICILLIN-BINDING PROTEIN 3|3.9|IC=126uM|IC50|=|126|uM|126000|nM
4FZ6|1.85|2013|0VG||P43405|TYROSINE-PROTEIN KINASE SYK|6.9|IC=127nM|IC50|=|127|nM|127|nM
4DVF|1.80|2013|7-mer||P56817|BETA-SECRETASE 1|6.89|IC=128nM|IC50|=|128|nM|128|nM
4DHN|1.80|2013|0KC|ligand is compound B10|P31947|14-3-3 PROTEIN SIGMA|3.89|IC=128uM|IC50|=|128|uM|128000|nM
4LQY|1.54|2013|AMP|IC50 = 129 +/- 73 uM|Q9Y6X5|BIS(5'-ADENOSYL)-TRIPHOSPHATASE ENPP4|3.89|IC=129uM|IC50|=|129|uM|129000|nM
3VTD|2.70|2013|TKD|ligand is compound 5b, ADTK4|P13053|VITAMIN D3 RECEPTOR|7.92|IC=12nM|IC50|=|12|nM|12|nM
4J1F|2.25|2013|1HL|ligand is compound 89|P56817|BETA-SECRETASE 1|7.92|IC=12nM|IC50|=|12|nM|12|nM
4KMU|3.85|2013|RFP|ligand is RMP|P0A7Z4|DNA-DIRECTED RNA POLYMERASE SUBUNIT ALPHA|7.92|IC=12nM|IC50|=|12|nM|12|nM
3UKR|2.48|2013|CKH|ligand is compound 1;IC50=12+/-1uM|P61157|ACTIN-RELATED PROTEIN 3|4.92|IC=12uM|IC50|=|12|uM|12000|nM
4B81|2.80|2013|ZN4|ligand is compound 5;Ellman assay|P21836|ACETYLCHOLINESTERASE|4.92|IC=12uM|IC50|=|12|uM|12000|nM
4J4N|2.75|2013|D44|IC50=132+/-1.09nM|Q8I4V8|FK506-BINDING PROTEIN (FKBP)-TYPE PEPTIDYL-PROPYL|6.88|IC=132nM|IC50|=|132|nM|132|nM
4BNT|2.30|2013|36E||O54438|3-OXOACYL-[ACYL-CARRIER-PROTEIN] REDUCTASE FABG|3.86|IC=137.69uM|IC50|=|137.69|uM|137690|nM
3VTC|1.50|2013|TK3|ligand is compound 5a, ADTK3|P13053|VITAMIN D3 RECEPTOR|7.89|IC=13nM|IC50|=|13|nM|13|nM
3WAX|1.90|2013|DWX|ligand is 3BoA;IC50=13+/-2.4nM|Q9R1E6|ECTONUCLEOTIDE PYROPHOSPHATASE/PHOSPHODIESTERASE|7.89|IC=13nM|IC50|=|13|nM|13|nM
4J1K|2.18|2013|1HG|ligand is compound 111|P56817|BETA-SECRETASE 1|7.89|IC=13nM|IC50|=|13|nM|13|nM
4DZW|3.05|2013|0MQ|Mg-containing|Q95WL3|FARNESYL PYROPHOSPHATE SYNTHASE|7.89|IC=13nM|IC50|=|13|nM|13|nM
4KBC|1.98|2013|1QJ|ligand is compound 3|P48730|CASEIN KINASE I ISOFORM DELTA|7.85|IC=14.2nM|IC50|=|14.2|nM|14.2|nM
4GYE|2.27|2013|6-mer||Q9QM22|HIV-1 PROTEASE|6.85|IC=142nM|IC50|=|142|nM|142|nM
4L0S|1.90|2013|1UZ|Zn-contained|Q9H2K2|TANKYRASE-2|6.84|IC=145nM|IC50|=|145|nM|145|nM
4L32|1.85|2013|1VF|Zn-contained|Q9H2K2|TANKYRASE-2|6.84|IC=146nM|IC50|=|146|nM|146|nM
3ZO4|1.65|2013|QWI|ligand is compound 41|P00517|CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTIC|6.83|IC=149nM|IC50|=|149|nM|149|nM
4BJC|2.20|2013|RPB|Zn-containing; IC50(Fluorescence method come from ref. 7.)|Q9H2K2|TANKYRASE-2|7.85|IC=14nM|IC50|=|14|nM|14|nM
4GK4|2.10|2013|L90||Q6P4R6|EPH RECEPTOR A3|7.85|IC=14nM|IC50|=|14|nM|14|nM
4I0R|2.10|2013|1B4||P43405|TYROSINE-PROTEIN KINASE SYK|7.85|IC=14nM|IC50|=|14|nM|14|nM
4JZR|2.10|2013|4JR|ligand is compound 4b; pIC50 = 7.8|Q9GZT9|EGL NINE HOMOLOG 1|7.8|IC=15.8nM|IC50|=|15.8|nM|15.8|nM
4BDE|2.55|2013|CWS|ligand is compound 15 IC50=15.9+/-9.0uM;Mobility Shift Assay|O96017|SERINE/THREONINE-PROTEIN KINASE CHK2|4.8|IC=15.9uM|IC50|=|15.9|uM|15900|nM
3ZLX|2.20|2013|5EZ|ligand is fragment 18|Q02750|DUAL SPECIFICITY MITOGEN-ACTIVATED PROTEIN KINASE K|3.8|IC=157uM|IC50|=|157|uM|157000|nM
4B0G|2.50|2013|VEK|ligand is compound 21a|O14965|AURORA KINASE A|7.82|IC=15nM|IC50|=|15|nM|15|nM
4BFP|2.40|2013|SWY||Q9H2K2|TANKYRASE-2|7.82|IC=15nM|IC50|=|15|nM|15|nM
4BGG|2.56|2013|844|ligand is compound 26, LDN-213844, assay for ACVRLK2|Q04771|ACTIVIN RECEPTOR TYPE-1|7.82|IC=15nM|IC50|=|15|nM|15|nM
4DHT|1.80|2013|0KG|ligand is compound B2|P31947|14-3-3 PROTEIN SIGMA|4.82|IC=15uM|IC50|=|15|uM|15000|nM
4IE5|1.95|2013|MD6|IC50=15+/-1.1uM, Zn-contained|Q9C0B1|ALPHA-KETOGLUTARATE-DEPENDENT DIOXYGENASE FTO|4.82|IC=15uM|IC50|=|15|uM|15000|nM
4L31|2.00|2013|F08|Zn-contained|Q9H2K2|TANKYRASE-2|6.79|IC=162nM|IC50|=|162|nM|162|nM
4DHM|1.70|2013|0KB|ligand is compound B11|P31947|14-3-3 PROTEIN SIGMA|3.78|IC=165uM|IC50|=|165|uM|165000|nM
4KQO|2.31|2013|JPP|IC50 = 166 +/- 62 nM, the ligand in the crystal is not complete.|G3XD46|PENICILLIN-BINDING PROTEIN 3|6.78|IC=166nM|IC50|=|166|nM|166|nM
2LY0|NMR|2013|A2Y|ligand is M2WJ332|Q6XT21|MEMBRANE ION CHANNEL M2|4.8|IC=16uM|IC50|=|16|uM|16000|nM
4DHS|1.74|2013|Y03|ligand is compound B3|P31947|14-3-3 PROTEIN SIGMA|4.8|IC=16uM|IC50|=|16|uM|16000|nM
4MK1|1.85|2013|27Y|ligand is comound 2|M9V5A4|POLYMERASE PA|4.8|IC=16uM|IC50|=|16|uM|16000|nM
4HVG|2.75|2013|19Q|IC50 = 17.0 +/- 3.4 nM (a kinasefiltration assay)|P52333|TYROSINE-PROTEIN KINASE JAK3|7.77|IC=17.0nM|IC50|=|17|nM|17|nM
4C38|1.58|2013|VUP|IC50 = 17.4 +/- 6.0 nM (AlphaScreen kinase assay)|P00517|CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTIC|7.76|IC=17.4nM|IC50|=|17.4|nM|17.4|nM
4ALU|2.60|2013|79O|ligand is compound 3|P11309|SERINE/THREONINE-PROTEIN KINASE PIM-1|7.77|IC=17nM|IC50|=|17|nM|17|nM
4G1F|2.90|2013|0WG||P27487|DIPEPTIDYL PEPTIDASE 4|7.77|IC=17nM|IC50|=|17|nM|17|nM
4KE0|2.30|2013|1R8|ligand is compound 13|P56817|BETA-SECRETASE 1|7.77|IC=17nM|IC50|=|17|nM|17|nM
4M3Q|2.72|2013|24K|ligand is compound 3|Q12866|TYROSINE-PROTEIN KINASE MER|7.77|IC=17nM|IC50|=|17|nM|17|nM
3WAV|1.80|2013|DWV|ligand is compound 10|Q9R1E6|ECTONUCLEOTIDE PYROPHOSPHATASE/PHOSPHODIESTERASE|6.74|IC=180nM|IC50|=|180|nM|180|nM
4MX0|2.10|2013|BCZ|ligand is Peramivir;IC50 = 184.7(129-264) nM|R4RZI6|NEURAMINIDASE|6.73|IC=184.7nM|IC50|=|184.7|nM|184.7|nM
4DWB|2.10|2013|0M7|Mg-containing|Q95WL3|FARNESYL PYROPHOSPHATE SYNTHASE|5.74|IC=1840nM|IC50|=|1840|nM|1840|nM
4DV9|2.08|2013|8-mer||P56817|BETA-SECRETASE 1|6.72|IC=189nM|IC50|=|189|nM|189|nM
4IPF|1.70|2013|1F0|IC50=18+/-11nM|P56273|E3 UBIQUITIN-PROTEIN LIGASE MDM2|7.74|IC=18nM|IC50|=|18|nM|18|nM
4JHQ|1.99|2013|B6F|IC50=18+/-2.0nM, Fe-containing|P02701|AVIDIN|7.74|IC=18nM|IC50|=|18|nM|18|nM
4KJV|1.70|2013|1RK|ligand is compound 36|P98170|E3 UBIQUITIN-PROTEIN LIGASE XIAP|7.74|IC=18nM|IC50|=|18|nM|18|nM
4HVH|2.30|2013|19R|IC50 = 19.0 +/- 6.2 nM (a kinasefiltration assay)|P52333|TYROSINE-PROTEIN KINASE JAK3|7.72|IC=19.0nM|IC50|=|19|nM|19|nM
4C37|1.70|2013|Z21|IC50 = 19.7 +/- 2.6 nM (AlphaScreen kinase assay)|P00517|CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTIC|7.71|IC=19.7nM|IC50|=|19.7|nM|19.7|nM
4C36|1.98|2013|ZO9|IC50 (AlphaScreen kinase assay)|P00517|CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTIC|7.7|IC=19.8nM|IC50|=|19.8|nM|19.8|nM
4BB4|1.65|2013|32W|Mg2+ containing;ligand is compound 3|P54760|EPHRIN TYPE-B RECEPTOR 4|6.72|IC=190nM|IC50|=|190|nM|190|nM
4JRG|1.90|2013|I09||P56273|E3 UBIQUITIN-PROTEIN LIGASE MDM2|6.71|IC=196nM|IC50|=|196|nM|196|nM
3ZLW|2.12|2013|MT8|ligand is fragment 3|Q02750|DUAL SPECIFICITY MITOGEN-ACTIVATED PROTEIN KINASE K|3.7|IC=198uM|IC50|=|198|uM|198000|nM
3W2R|2.05|2013|W2R|ligand is compound 4|P00533|EPIDERMAL GROWTH FACTOR RECEPTOR|7.72|IC=19nM|IC50|=|19|nM|19|nM
4J1E|1.78|2013|1HM|ligand is compound 88|P56817|BETA-SECRETASE 1|7.72|IC=19nM|IC50|=|19|nM|19|nM
4IM0|2.40|2013|1FV|Immunoprecipitation kinase assay|Q9UHD2|SERINE/THREONINE-PROTEIN KINASE TBK1|7.72|IC=19nM|IC50|=|19|nM|19|nM
4HYH|1.70|2013|1AM||O14757|SERINE/THREONINE-PROTEIN KINASE CHK1|9.0|IC=1nM|IC50|=|1|nM|1|nM
4IWD|1.99|2013|1JC||P08581|HEPATOCYTE GROWTH FACTOR RECEPTOR|9.0|IC=1nM|IC50|=|1|nM|1|nM
4KTC|2.30|2013|1X3|ligand is compound 6; IC50=1nM, EC50=6nM|P26662|HCV SERINE PROTEASE NS3|9.0|IC=1nM|IC50|=|1|nM|1|nM
4L8M|2.10|2013|F46|ligand is compound 32a; IC50 = 0.001 +/- 0.0002 uM|Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|9.0|IC=1nM|IC50|=|1|nM|1|nM
4MK8|2.09|2013|28Q|ligand is compound 4|P26663|RNA-DIRECTED RNA POLYMERASE|9.0|IC=1nM|IC50|=|1|nM|1|nM
4MKA|2.05|2013|2AY|ligand is compound 13|P26663|RNA-DIRECTED RNA POLYMERASE|9.0|IC=1nM|IC50|=|1|nM|1|nM
3ZO1|2.00|2013|SIJ|ligand is compound 12|P00517|CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTIC|6.0|IC=1uM|IC50|=|1|uM|1000|nM
4AWI|1.91|2013|AQ2|ligand is compound 4, PIC50=6.0|P45983|MITOGEN-ACTIVATED PROTEIN KINASE 8|6.0|IC=1uM|IC50|=|1|uM|1000|nM
4JQL|1.72|2013|VJ6||P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|6.0|IC=1uM|IC50|=|1|uM|1000|nM
3WC5|1.70|2013|DDK|ligand is compound 1a|P09955|CARBOXYPEPTIDASE B|8.7|IC=2.0nM|IC50|=|2|nM|2|nM
4JLG|1.90|2013|1L8|ligand is (R)-PFI-2|Q8WTS6|HISTONE-LYSINE N-METHYLTRANSFERASE SETD7|8.7|IC=2.0nM|IC50|=|2|nM|2|nM
4LGU|2.00|2013|1YH|ligand is compound A|Q13490|BACULOVIRAL IAP REPEAT-CONTAINING PROTEIN 2|8.68|IC=2.1nM|IC50|=|2.1|nM|2.1|nM
3ZJU|2.40|2013|AN3016|The crystal structure is a ternary complex of leucyl-tRNA synthetase, RNA and AN3016.|P07813|LEUCYL-TRNA SYNTHETASE|5.68|IC=2.1uM|IC50|=|2.1|uM|2100|nM
4HXL|1.52|2013|1A9|IC50 = 2.2 +/- 0.1 uM|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|5.66|IC=2.2uM|IC50|=|2.2|uM|2200|nM
3ZJT|2.20|2013|AN3017|The crystal structure is a ternary complex of leucyl-tRNA synthetase, RNA and AN3017.|P07813|LEUCYL-TRNA SYNTHETASE|5.64|IC=2.3uM|IC50|=|2.3|uM|2300|nM
4LNF|2.95|2013|GLN||P12425|GLUTAMINE SYNTHETASE|2.62|IC=2.4mM|IC50|=|2.4|mM|2400000|nM
4MZL|2.01|2013|18-mer|ligand is hydrogen bond surrogate (HBS) myoA helix mimetic peptide|Q8I4W8|MYOSIN A TAIL DOMAIN INTERACTING PROTEIN|5.62|IC=2.4uM|IC50|=|2.4|uM|2400|nM
4KE1|1.91|2013|1R6|ligand is compound 19|P56817|BETA-SECRETASE 1|8.6|IC=2.5nM|IC50|=|2.5|nM|2.5|nM
4BTL|2.50|2013|5GZ|ligand is compound 24; Ellman assay|P21836|ACETYLCHOLINESTERASE|5.6|IC=2.5uM|IC50|=|2.5|uM|2500|nM
4EZL|2.94|2013|0SE||P48736|PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE|8.59|IC=2.6nM|IC50|=|2.6|nM|2.6|nM
4MX9|3.10|2013|2E8|inhibitor UW1294|F0V9W9|CALMODULIN-DOMAIN PROTEIN KINASE ISOENZYME GAM|8.59|IC=2.6nM|IC50|=|2.6|nM|2.6|nM
4INR|2.70|2013|1G1|Different ligand structure(double bond); covalent complex|P23639|PROTEASOME COMPONENT Y7|5.59|IC=2.6uM|IC50|=|2.6|uM|2600|nM
4HY4|1.25|2013|1BG|IC50 = 2.5~2.9 nM; Zn-containing|Q13490|BACULOVIRAL IAP REPEAT-CONTAINING PROTEIN 2|8.57|IC=2.7nM|IC50|=|2.7|nM|2.7|nM
4BDA|2.60|2013|VFB|ligand is compound 11 IC50=2.7+/-0.2uM;Mobility Shift Assay|O96017|SERINE/THREONINE-PROTEIN KINASE CHK2|5.57|IC=2.7uM|IC50|=|2.7|uM|2700|nM
4IE6|2.50|2013|UN9|IC50=2.8+/-0.9uM, Zn-contained|Q9C0B1|ALPHA-KETOGLUTARATE-DEPENDENT DIOXYGENASE FTO|5.55|IC=2.8uM|IC50|=|2.8|uM|2800|nM
4MBL|2.60|2013|26L|ligand is compound 9g|P11309|SERINE/THREONINE-PROTEIN KINASE PIM-1|8.54|IC=2.9nM|IC50|=|2.9|nM|2.9|nM
4DTT|3.22|2013|I41|IDE-CF-(1), ligand is compund 41367, hits 1|P14735|INSULIN-DEGRADING ENZYME|5.54|IC=2.9uM|IC50|=|2.9|uM|2900|nM
4HY0|2.84|2013|1AQ|Zn-containing; IC50 = 140~280 nM|P98170|E3 UBIQUITIN-PROTEIN LIGASE XIAP|6.7|IC=200nM|IC50|=|200|nM|200|nM
4NIE|2.01|2013|NBH|ligand is compound 2;IC50 = 20 nM(dual FRET)|P51449|NUCLEAR RECEPTOR ROR-GAMMA|7.7|IC=20nM|IC50|=|20|nM|20|nM
4FIC|2.50|2013|0UL||P00523|TYROSINE-PROTEIN KINASE SRC|4.7|IC=20uM|IC50|=|20|uM|20000|nM
4L2G|2.05|2013|1V4|Zn-contained|Q9H2K2|TANKYRASE-2|6.68|IC=210nM|IC50|=|210|nM|210|nM
4MWW|1.90|2013|G39|ligand is Oseltamivir Carboxylate; IC50 = 214770(126699-364063) nM|R4RZI6|NEURAMINIDASE|3.67|IC=214770nM|IC50|=|214770|nM|214770|nM
4JR3|2.70|2013|KJR||P00533|EPIDERMAL GROWTH FACTOR RECEPTOR|6.66|IC=218nM|IC50|=|218|nM|218|nM
4BJB|2.30|2013|P34|Zn-containing; IC50(Fluorescence method come from ref. 7.)|Q9H2K2|TANKYRASE-2|6.66|IC=219nM|IC50|=|219|nM|219|nM
4J3M|1.90|2013|AJ8|ligand is compound 15|Q9H2K2|TANKYRASE-2|7.68|IC=21nM|IC50|=|21|nM|21|nM
4HWW|1.30|2013|X7A|Mn-containing|P05089|ARGINASE-1|6.65|IC=223nM|IC50|=|223|nM|223|nM
4BDI|2.32|2013|HAU|ligand is compound 19 IC50=227.7+/-22.2uM;Mobility Shift Assay|O96017|SERINE/THREONINE-PROTEIN KINASE CHK2|3.64|IC=227.7uM|IC50|=|227.7|uM|227700|nM
3WAY|1.75|2013|DWY|ligand is 4BoA;IC50=22+/-5.4nM|Q9R1E6|ECTONUCLEOTIDE PYROPHOSPHATASE/PHOSPHODIESTERASE|7.66|IC=22nM|IC50|=|22|nM|22|nM
3WD1|2.30|2013|ST7|ligand is Syn-triazole 4|P11797|CHITINASE B|7.66|IC=22nM|IC50|=|22|nM|22|nM
3ZEP|2.35|2013|1NX|ligand is compound 12a;IC50=22+/-9nM|P52333|TYROSINE-PROTEIN KINASE JAK3|7.66|IC=22nM|IC50|=|22|nM|22|nM
4BJX|1.59|2013|73B|ligand is I-BET726|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|7.66|IC=22nM|IC50|=|22|nM|22|nM
4B84|2.60|2013|Z5K|ligand is compound 12;Ellman assay|P21836|ACETYLCHOLINESTERASE|4.66|IC=22uM|IC50|=|22|uM|22000|nM
4L0V|1.70|2013|1V1|Zn-contained|Q9H2K2|TANKYRASE-2|6.63|IC=233nM|IC50|=|233|nM|233|nM
4EYR|1.80|2013|RIT|IC50 = 237 +/- 5.6 nM|Q000H7|HIV-1 PROTEASE|6.63|IC=237nM|IC50|=|237|nM|237|nM
3ZMG|1.74|2013|6Z0|ligand is compound 14d|P56817|BETA-SECRETASE 1|7.64|IC=23nM|IC50|=|23|nM|23|nM
4IXU|1.90|2013|38I|measuring urea levels in a colorimetric assay, B-contained; Mn-containing|P78540|ARGINASE-2, MITOCHONDRIAL PRECURSON|7.64|IC=23nM|IC50|=|23|nM|23|nM
4KIQ|2.50|2013|1RA|ligand is compound 9d|Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|7.64|IC=23nM|IC50|=|23|nM|23|nM
3WBL|2.00|2013|PDY|ligand is TEI-I01800|P24941|CYCLIN-DEPENDENT KINASE 2|4.64|IC=23uM|IC50|=|23|uM|23000|nM
4IXV|2.30|2013|XA1|measuring urea levels in a colorimetric assay, B-contained; Mn-containing|P78540|ARGINASE-2, MITOCHONDRIAL PRECURSON|6.62|IC=240nM|IC50|=|240|nM|240|nM
4FXJ|2.90|2013|PHE|IC50 = 240 +/- 0.1 uM (the standard lactate dehydrogenase coupled assay)|P14618|PYRUVATE KINASE ISOZYMES M1/M2|3.62|IC=240uM|IC50|=|240|uM|240000|nM
4NRC|1.86|2013|2LY|ligand is compound 3; IC50= 241+/-28uM; AlphaLISA binding assay|Q9UIF8|BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN PROTEIN 2B|3.62|IC=241uM|IC50|=|241|uM|241000|nM
4JBO|2.49|2013|WPH||O14965|AURORA KINASE A|7.62|IC=24nM|IC50|=|24|nM|24|nM
4JP9|1.80|2013|1M5||P56817|BETA-SECRETASE 1|7.62|IC=24nM|IC50|=|24|nM|24|nM
4K4E|2.30|2013|K4E|ligand is compound 52,but the structure of the ligand is not correct|O95271|TANKYRASE-1|7.62|IC=24nM|IC50|=|24|nM|24|nM
4KN7|3.69|2013|1RM|ligand is bxRIF2c|P0A7Z4|DNA-DIRECTED RNA POLYMERASE SUBUNIT ALPHA|7.62|IC=24nM|IC50|=|24|nM|24|nM
4MEQ|1.77|2013|25O|lgand is compound 4; 32% inhibition|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|3.6|IC=250uM|IC50|=|250|uM|250000|nM
4MEO|1.72|2013|25V|ligand is compound 5; 31% inhibition|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|3.6|IC=250uM|IC50|=|250|uM|250000|nM
4LA7|1.98|2013|A1O|ligand is Quinabactin|O80992|ABSCISIC ACID RECEPTOR PYL2|6.57|IC=267nM|IC50|=|267|nM|267|nM
4I0T|1.70|2013|1B6||P43405|TYROSINE-PROTEIN KINASE SYK|7.59|IC=26nM|IC50|=|26|nM|26|nM
4I11|1.89|2013|1CH||P56817|BETA-SECRETASE 1|4.57|IC=27.2uM|IC50|=|27.2|uM|27200|nM
4L0I|2.30|2013|1UW|Zn-contained|Q9H2K2|TANKYRASE-2|6.57|IC=272nM|IC50|=|272|nM|272|nM
4ALW|1.92|2013|HY7|ligand is compound 6d|P11309|SERINE/THREONINE-PROTEIN KINASE PIM|7.57|IC=27nM|IC50|=|27|nM|27|nM
4DHR|1.40|2013|Y04|ligand is compound B4|P31947|14-3-3 PROTEIN SIGMA|4.57|IC=27uM|IC50|=|27|uM|27000|nM
4J0V|1.94|2013|1H7|ligand is compound 66|P56817|BETA-SECRETASE 1|7.55|IC=28nM|IC50|=|28|nM|28|nM
4L53|2.55|2013|1UO|ligand is compound 13a|O43318|MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 7|7.55|IC=28nM|IC50|=|28|nM|28|nM
3W2T|2.36|2013|LF7||P27487|DIPEPTIDYL PEPTIDASE 4|7.53|IC=29.2nM|IC50|=|29.2|nM|29.2|nM
4JOA|2.70|2013|3DK||Q9UM73|ALK TYROSINE KINASE RECEPTOR|7.54|IC=29nM|IC50|=|29|nM|29|nM
4JRV|2.80|2013|KJV||P00533|EPIDERMAL GROWTH FACTOR RECEPTOR|7.54|IC=29nM|IC50|=|29|nM|29|nM
4LWW|1.64|2013|LWW|ligand is compound 4|P43490|NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE|7.54|IC=29nM|IC50|=|29|nM|29|nM
4J53|2.50|2013|1J4||P53350|SERINE/THREONINE-PROTEIN KINASE PLK1|8.7|IC=2nM|IC50|=|2|nM|2|nM
4LGH|2.84|2013|0JN|ligand is 1NM-PP1|P00523|TYROSINE-PROTEIN KINASE SRC|8.7|IC=2nM|IC50|=|2|nM|2|nM
4LXA|1.95|2013|1YS|ligand is compound 11a|P56817|BETA-SECRETASE 1|8.7|IC=2nM|IC50|=|2|nM|2|nM
4N4V|2.00|2013|2GY|ligand is compound 4|O95271|TANKYRASE-1|8.7|IC=2nM|IC50|=|2|nM|2|nM
4I7B|3.00|2013|14-mer|covalent complex; DELFIA TRF assay; incomplete ligand|Q8IUQ4|E3 UBIQUITIN-PROTEIN LIGASE SIAH1|5.7|IC=2uM|IC50|=|2|uM|2000|nM
4BCB|1.70|2013|4I4|ligand is compound 13;IC50=3.0+/-0.3nM|P23687|PROLYL ENDOPEPTIDASE|8.52|IC=3.0nM|IC50|=|3|nM|3|nM
4MWU|1.80|2013|LNV|ligand is Laninamivir;IC50 = 3.24(2.48-4.23) nM|R4JGE3|NEURAMINIDASE|8.49|IC=3.24nM|IC50|=|3.24|nM|3.24|nM
4EHE|3.30|2013|RI8|X-ray (B-Raf), IC50 (B-Raf_V600E); IC50 (method radioactivity come from supporting information)|P15056|SERINE/THREONINE-PROTEIN KINASE B-RAF|8.49|IC=3.2nM|IC50|=|3.2|nM|3.2|nM
4IE4|2.50|2013|8XQ|IC50=3.3+/-1.1uM, Zn-contained|Q9C0B1|ALPHA-KETOGLUTARATE-DEPENDENT DIOXYGENASE FTO|5.48|IC=3.3uM|IC50|=|3.3|uM|3300|nM
4JMU|2.00|2013|1ML||P12497|GAG-POL POLYPROTEIN|5.47|IC=3.4uM|IC50|=|3.4|uM|3400|nM
4LGE|1.55|2013|1Y0|ligand is compound 2|Q13490|BACULOVIRAL IAP REPEAT-CONTAINING PROTEIN 2|8.46|IC=3.5nM|IC50|=|3.5|nM|3.5|nM
3W1F|2.70|2013|1O5|ligand is compound 23d|P33981|DUAL SPECIFICITY PROTEIN KINASE TTK|8.44|IC=3.67nM|IC50|=|3.67|nM|3.67|nM
4BDK|3.30|2013|RQQ|ligand is compound 22 IC50=3.6+/-1.2uM;Mobility Shift Assay|O96017|SERINE/THREONINE-PROTEIN KINASE CHK2|5.44|IC=3.6uM|IC50|=|3.6|uM|3600|nM
4EZJ|2.67|2013|0SC||P48736|PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE|8.42|IC=3.8nM|IC50|=|3.8|nM|3.8|nM
4HBP|2.91|2013|17J|covalent complex|P97612|FATTY-ACID AMIDE HYDROLASE 1|8.42|IC=3.8nM|IC50|=|3.8|nM|3.8|nM
3ZLY|2.11|2013|YSO|ligand is fragment 8|Q02750|DUAL SPECIFICITY MITOGEN-ACTIVATED PROTEIN KINASE K|3.52|IC=300uM|IC50|=|300|uM|300000|nM
3ZLV|2.50|2013|HI6|IC50=300+/-48uM|P21836|ACETYLCHOLINESTERASE|3.52|IC=300uM|IC50|=|300|uM|300000|nM
3ZBF|2.20|2013|VGH|ligand is crizotinib|P08922|PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ROS|7.52|IC=30nM|IC50|=|30|nM|30|nM
4GVU|1.55|2013|8-mer|IC50 = 30 +/- 6.8 nM|P00772|CHYMOTRYPSIN-LIKE ELASTASE FAMILY MEMBER 1|7.52|IC=30nM|IC50|=|30|nM|30|nM
3W5T|2.29|2013|LHP|ligand is LCA propionate|P13053|VITAMIN D3 RECEPTOR|4.52|IC=30uM|IC50|=|30|uM|30000|nM
4ITH|2.25|2013|RCM||Q13546|RECEPTOR-INTERACTING SERINE/THREONINE-PROTEIN KINASE 1|6.5|IC=316.9nM|IC50|=|316.9|nM|316.9|nM
4G2L|3.00|2013|0WL|Zn-containing, Mg-containing|O76083|CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE-9|7.49|IC=32nM|IC50|=|32|nM|32|nM
4KBI|2.06|2013|1C0|ligand is compound 4|P26663|HCV POLYMERASE|7.49|IC=32nM|IC50|=|32|nM|32|nM
4KB7|1.85|2013|690|ligand is compound 32|P26663|HCV POLYMERASE|7.49|IC=32nM|IC50|=|32|nM|32|nM
4DHQ|1.75|2013|Y06|ligand is compound B6|P31947|14-3-3 PROTEIN SIGMA|4.49|IC=32uM|IC50|=|32|uM|32000|nM
4BCD|1.50|2013|TDV|ligand is compound 9i;IC50=33+/-4nM|P23687|PROLYL ENDOPEPTIDASE|7.48|IC=33nM|IC50|=|33|nM|33|nM
3WAB|2.15|2013|DDW|ligand is compound 2|P09955|CARBOXYPEPTIDASE B|7.47|IC=34nM|IC50|=|34|nM|34|nM
4LH7|1.90|2013|1X8|ligand is compound 5c|Q837V6|DNA LIGASE|4.47|IC=34uM|IC50|=|34|uM|34000|nM
4JOO|1.80|2013|1M4||P56817|BETA-SECRETASE 1|4.43|IC=36.83uM|IC50|=|36.83|uM|36830|nM
4BDD|2.67|2013|Z0O|ligand is compound 14 IC50=36.9+/-9.0uM;Mobility Shift Assay|O96017|SERINE/THREONINE-PROTEIN KINASE CHK2|4.43|IC=36.9uM|IC50|=|36.9|uM|36900|nM
4L2K|2.10|2013|1V8|Zn-contained|Q9H2K2|TANKYRASE-2|6.44|IC=360nM|IC50|=|360|nM|360|nM
3W33|1.70|2013|W19|ligand is compound 19b|P00533|EPIDERMAL GROWTH FACTOR RECEPTOR|7.44|IC=36nM|IC50|=|36|nM|36|nM
4I0S|1.98|2013|1B5||P43405|TYROSINE-PROTEIN KINASE SYK|7.44|IC=36nM|IC50|=|36|nM|36|nM
4K8S|2.39|2013|1QT|ligand is compound 14|P56817|BETA-SECRETASE 1|7.44|IC=36nM|IC50|=|36|nM|36|nM
4DHP|1.75|2013|Y07|ligand is compound B7|P31947|14-3-3 PROTEIN SIGMA|4.44|IC=36uM|IC50|=|36|uM|36000|nM
4KW6|3.00|2013|QDO|covalent complex.|J7HJM3|PEROXIREDOXIN-1|3.43|IC=374uM|IC50|=|374|uM|374000|nM
4ITJ|1.80|2013|1HX||Q13546|RECEPTOR-INTERACTING SERINE/THREONINE-PROTEIN KINASE 1|6.42|IC=377.2nM|IC50|=|377.2|nM|377.2|nM
4DXJ|2.35|2013|0M9|Mg-containing|Q95WL3|FARNESYL PYROPHOSPHATE SYNTHASE|7.42|IC=38.0nM|IC50|=|38|nM|38|nM
4NRB|2.08|2013|2LX|ligand is compound 1; IC50= 38+/-4uM; AlphaLISA binding assay|Q9UIF8|BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN PROTEIN 2B|4.42|IC=38uM|IC50|=|38|uM|38000|nM
3ZLS|2.50|2013|92P|ligand is fragment 6|Q02750|DUAL SPECIFICITY MITOGEN-ACTIVATED PROTEIN KINASE K|4.4|IC=39.4uM|IC50|=|39.4|uM|39400|nM
4JQ7|2.73|2013|KJQ||P00533|EPIDERMAL GROWTH FACTOR RECEPTOR|6.41|IC=393nM|IC50|=|393|nM|393|nM
4BAE|2.35|2013|RWX|ligand is compound 4|P0C559|DNA GYRASE SUBUNIT B|8.52|IC=3nM|IC50|=|3|nM|3|nM
4C4J|2.50|2013|X21|IC50 = 3 +/- 2 nM|P33981|DUAL SPECIFICITY PROTEIN KINASE TTK|8.52|IC=3nM|IC50|=|3|nM|3|nM
4GV1|1.49|2013|0XZ||P31749|RAC-ALPHA SERINE/THREONINE-PROTEIN KINASE|8.52|IC=3nM|IC50|=|3|nM|3|nM
4HYI|1.40|2013|1AO||O14757|SERINE/THREONINE-PROTEIN KINASE CHK1|8.52|IC=3nM|IC50|=|3|nM|3|nM
4IZY|2.30|2013|1J2|X-ray( JNK1-beta); IC50( JNK1)|A1L4K2|MITOGEN-ACTIVATED PROTEIN KINASE 8|8.52|IC=3nM|IC50|=|3|nM|3|nM
4J52|2.30|2013|1J3||P53350|SERINE/THREONINE-PROTEIN KINASE PLK1|8.52|IC=3nM|IC50|=|3|nM|3|nM
4JNC|1.96|2013|1LF||P34913|EPOXIDE HYDROLASE 2|8.52|IC=3nM|IC50|=|3|nM|3|nM
4JNM|2.20|2013|1LJ|A mass spectrometry-based assay|P43490|NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE|8.52|IC=3nM|IC50|=|3|nM|3|nM
4L6S|2.20|2013|1WQ|ligand is compound 3j|P09874|POLY [ADP-RIBOSE] POLYMERASE 1|8.52|IC=3nM|IC50|=|3|nM|3|nM
4LGG|2.41|2013|VGG|ligand is 3MB-PP1|P00523|TYROSINE-PROTEIN KINASE SRC|8.52|IC=3nM|IC50|=|3|nM|3|nM
4JLH|2.09|2013|0L9|IC50 = 4.0 +/- 0.6 uM|P12497|HIV-1 INTEGRASE|5.4|IC=4.0uM|IC50|=|4|uM|4000|nM
4HXS|1.43|2013|1A3|IC50 = 4.1 +/- 0.4 uM|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|5.39|IC=4.1uM|IC50|=|4.1|uM|4100|nM
4HXR|1.53|2013|1A4|IC50 = 4.1 +/- 0.5 uM|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|5.39|IC=4.1uM|IC50|=|4.1|uM|4100|nM
4HLW|2.50|2013|17W||P10275|ANDROGEN RECEPTOR|5.38|IC=4.2uM|IC50|=|4.2|uM|4200|nM
4KZ0|2.87|2013|1UJ|ligand is compound 2|P48736|PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE|5.38|IC=4.2uM|IC50|=|4.2|uM|4200|nM
4K3K|1.85|2013|SFK|ligand is 4MF|P0A988|DNA POLYMERASE III SUBUNIT BETA|2.35|IC=4.44mM|IC50|=|4.44|mM|4440000|nM
3WIZ|2.45|2013|LC6|ligand is compound 10|Q07817|BCL-2-LIKE PROTEIN 1|8.36|IC=4.4nM|IC50|=|4.4|nM|4.4|nM
4GZF|2.05|2013|6-mer|IC50 = 4.4 +/- 0.2 nM|Q9QM22|HIV-1 PROTEASE|8.36|IC=4.4nM|IC50|=|4.4|nM|4.4|nM
4LTS|1.69|2013|LTS|ligand is compound 15|P43490|NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE|8.36|IC=4.4nM|IC50|=|4.4|nM|4.4|nM
4MVH|2.50|2013|2F5|ligadn is compound 26; IC50 = 4.5 +/- 0.44 nM|Q9Y233|CGMP 3',5'-CYCLIC PHOSPHODIESTERASE|8.35|IC=4.5nM|IC50|=|4.5|nM|4.5|nM
4IE2|2.21|2013|1EC|measuring urea levels in a colorimetric assay; Mn-containing|P78540|ARGINASE-2, MITOCHONDRIAL PRECURSON|5.35|IC=4.5uM|IC50|=|4.5|uM|4500|nM
4J06|2.00|2013|1JG||O92972|GENOME POLYPROTEIN|5.34|IC=4.6uM|IC50|=|4.6|uM|4600|nM
4EEV|1.80|2013|L1X||P08581|HEPATOCYTE GROWTH FACTOR RECEPTOR|8.33|IC=4.7nM|IC50|=|4.7|nM|4.7|nM
4HTX|1.90|2013|19F||O00408|CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE|8.33|IC=4.7nM|IC50|=|4.7|nM|4.7|nM
4I33|1.90|2013|17-mer|IC50=4.7+/-1.6nM; incomplete ligand|P26662|GENOME POLYPROTEIN|8.33|IC=4.7nM|IC50|=|4.7|nM|4.7|nM
3WI6|2.99|2013|YRZ|ligand is TEI-L03090|P49137|MAP KINASE-ACTIVATED PROTEIN KINASE 2|5.33|IC=4.7uM|IC50|=|4.7|uM|4700|nM
4MCD|1.55|2013|22L|ligand is compound 1|P43912|TRNA (GUANINE-N(1)-)-METHYLTRANSFERASE|5.33|IC=4.7uM|IC50|=|4.7|uM|4700|nM
4MEP|1.85|2013|24Y|ligand is compound 1|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|5.33|IC=4.7uM|IC50|=|4.7|uM|4700|nM
4KIN|1.97|2013|1M8|ligand is compound 5c|Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|8.32|IC=4.8nM|IC50|=|4.8|nM|4.8|nM
3V3M|1.96|2013|0EN|ligand is compound 16;IC50=4.8+/-0.9uM|P0C6U8|3C-LIKE PROTEINASE|5.32|IC=4.8uM|IC50|=|4.8|uM|4800|nM
4MZK|1.82|2013|19-mer|ligand is pGly[807,811], a stapled myoA tail peptide|Q8I4W8|MYOSIN A TAIL DOMAIN INTERACTING PROTEIN|5.31|IC=4.9uM|IC50|=|4.9|uM|4900|nM
4MBC|1.75|2013|28G|ligand is compound 11|G6TGY9|TOPOISOMERASE IV, SUBUNIT B|6.4|IC=400nM|IC50|=|400|nM|400|nM
4J1I|2.05|2013|1HH|ligand is compound 110|P56817|BETA-SECRETASE 1|7.4|IC=40nM|IC50|=|40|nM|40|nM
4B80|2.50|2013|A36|ligand is compound 4; Ellman assay|P21836|ACETYLCHOLINESTERASE|4.4|IC=40uM|IC50|=|40|uM|40000|nM
4BEK|2.39|2013|XK0|ligand is compound 1|P56817|BETA-SECRETASE 1|4.39|IC=41.2uM|IC50|=|41.2|uM|41200|nM
4JBP|2.45|2013|YPH||O14965|AURORA KINASE A|7.39|IC=41nM|IC50|=|41|nM|41|nM
4LN7|1.73|2013|1ZQ|ligand is compound 6|F0TRT1|POLYMERASE PA|7.39|IC=41nM|IC50|=|41|nM|41|nM
4B82|2.10|2013|B3Z|ligand is compound 10;Ellman assay|P21836|ACETYLCHOLINESTERASE|4.39|IC=41uM|IC50|=|41|uM|41000|nM
4MK7|2.80|2013|28O|ligand is compound 2|P26663|RNA-DIRECTED RNA POLYMERASE|6.36|IC=435nM|IC50|=|435|nM|435|nM
4ITI|2.86|2013|1HW||Q13546|RECEPTOR-INTERACTING SERINE/THREONINE-PROTEIN KINASE 1|6.36|IC=439.5nM|IC50|=|439.5|nM|439.5|nM
4IDZ|2.46|2013|OGA|IC50=44+/-1.1uM, Ni-containing|Q9C0B1|ALPHA-KETOGLUTARATE-DEPENDENT DIOXYGENASE FTO|4.36|IC=44uM|IC50|=|44|uM|44000|nM
4BJ9|2.05|2013|UHB|Zn-containing; IC50(Fluorescence method come from ref. 7.)|Q9H2K2|TANKYRASE-2|7.35|IC=45nM|IC50|=|45|nM|45|nM
4JIB|1.72|2013|1L6||O00408|CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE|7.35|IC=45nM|IC50|=|45|nM|45|nM
4K2Y|2.30|2013|ES2|ligand is compound 2;IC50 = 470 +/- 180 uM|P23946|CHYMASE|3.33|IC=470uM|IC50|=|470|uM|470000|nM
4FYO|1.40|2013|0VF||P43405|TYROSINE-PROTEIN KINASE SYK|7.33|IC=47nM|IC50|=|47|nM|47|nM
4JPE|1.80|2013|1M7||P56817|BETA-SECRETASE 1|7.32|IC=48nM|IC50|=|48|nM|48|nM
4E1E|2.65|2013|0MW|Mg-containing|Q95WL3|FARNESYL PYROPHOSPHATE SYNTHASE|6.31|IC=490nM|IC50|=|490|nM|490|nM
4KC2|1.70|2013|WS2|ligand is 8-Gal|P16442|FUCOSYLGLYCOPROTEIN ALPHA-N-ACETYLGALACTOSAMINYLTRA|3.31|IC=493uM|IC50|=|493|uM|493000|nM
4J1C|2.01|2013|1HO|ligand is compound 70|P56817|BETA-SECRETASE 1|7.31|IC=49nM|IC50|=|49|nM|49|nM
4KSQ|3.30|2013|1SW|ligand is compound 5B|P15056|SERINE/THREONINE-PROTEIN KINASE B-RAF|7.31|IC=49nM|IC50|=|49|nM|49|nM
4M84|2.00|2013|21E|ligand is compound 35|Q9BJF5|CALMODULIN-DOMAIN PROTEIN KINASE 1|7.31|IC=49nM|IC50|=|49|nM|49|nM
4N4T|2.31|2013|2GV|ligand is compound 3|Q6PFX9|TANKYRASE-1|7.31|IC=49nM|IC50|=|49|nM|49|nM
4B7Z|2.30|2013|Q4Q|ligand is compound 3; Ellman assay|P21836|ACETYLCHOLINESTERASE|4.31|IC=49uM|IC50|=|49|uM|49000|nM
4BGH|1.95|2013|3I6||P24941|CYCLIN-DEPENDENT KINASE 2|8.4|IC=4nM|IC50|=|4|nM|4|nM
4JAI|3.20|2013|XU2||O14965|AURORA KINASE A|8.4|IC=4nM|IC50|=|4|nM|4|nM
4L52|2.54|2013|1UL|ligand is compound 12az; Binding assay method is ALPHAScreen.|O43318|MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 7|8.4|IC=4nM|IC50|=|4|nM|4|nM
4LXK|2.05|2013|1YT|ligand is compound 11d|P56817|BETA-SECRETASE 1|8.4|IC=4nM|IC50|=|4|nM|4|nM
3ZMH|2.30|2013|L62|IC50=5.267+/-0.08uM; covalent complex|P09391|RHOMBOID PROTEASE GLPG|5.28|IC=5.267uM|IC50|=|5.267|uM|5267|nM
4J3D|2.00|2013|1JS|Zn-containing|P47205|UDP-3-O-[3-HYDROXYMYRISTOYL] N-ACETYLGLUCOSAMINE DEACETYLASE|8.28|IC=5.3nM|IC50|=|5.3|nM|5.3|nM
4JAJ|2.70|2013|XU1||O14965|AURORA KINASE A|5.26|IC=5.54uM|IC50|=|5.54|uM|5540|nM
3WC7|1.90|2013|EF1|ligand is EF6265|P09955|CARBOXYPEPTIDASE B|8.26|IC=5.5nM|IC50|=|5.5|nM|5.5|nM
4J70|2.80|2013|1KR|IC50=5.7+/-1.2uM; covalent complex|P23639|PROTEASOME COMPONENT Y7|5.24|IC=5.7uM|IC50|=|5.7|uM|5700|nM
4BIC|2.62|2013|IE4|ligand is compound 2;PIC501=7.3+/-0.4(ASk1 Full length N-terminal GST tag),PIC502=7.1+/-0.03(ASk1 Full length N-terminal 6HisAvi tag)|Q99683|MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 5|7.3|IC=50.12nM|IC50|=|50.12|nM|50.12|nM
4FGY|2.84|2013|11-mer||P37231|PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA|6.3|IC=500nM|IC50|=|500|nM|500|nM
4HZE|1.60|2013|X7A|Mn-containing|P78540|ARGINASE-2, MITOCHONDRIAL PRECURSON|6.29|IC=509nM|IC50|=|509|nM|509|nM
4KAI|2.30|2013|1PV|ligand is compound 3|P26663|HCV POLYMERASE|7.3|IC=50nM|IC50|=|50|nM|50|nM
4MOT|1.75|2013|2B7|ligand is compound 21|Q8DQB5|TOPOISOMERASE IV, SUBUNIT B|7.3|IC=50nM|IC50|=|50|nM|50|nM
4J0P|1.97|2013|1H8|ligand is compound 1b|P56817|BETA-SECRETASE 1|7.29|IC=51nM|IC50|=|51|nM|51|nM
4BHZ|2.85|2013|Z0B|binding data from a mobility shift microfluidics assay|P33981|DUAL SPECIFICITY PROTEIN KINASE TTK|4.27|IC=53.5uM|IC50|=|53.5|uM|53500|nM
4J17|1.81|2013|1HQ|ligand is compound 69|P56817|BETA-SECRETASE 1|7.27|IC=54nM|IC50|=|54|nM|54|nM
4L0L|2.10|2013|PFV|ligand is compound 17; IC50 = 54 +/- 44 nM|Q51504|PENICILLIN-BINDING PROTEIN 3|7.27|IC=54nM|IC50|=|54|nM|54|nM
4M6P|1.75|2013|20R|ligand is compound 14|P43490|NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE|7.27|IC=54nM|IC50|=|54|nM|54|nM
4AU8|1.90|2013|Z3R|ligand is compound 4a|Q00535|CYCLIN-DEPENDENT KINASE 5|6.26|IC=551nM|IC50|=|551|nM|551|nM
4GK3|1.90|2013|L87||Q6P4R6|EPH RECEPTOR A3|7.25|IC=56nM|IC50|=|56|nM|56|nM
4K60|1.50|2013|1P8|ligand is compound 3; IC50 = 570 +/- 330 uM|P23946|CHYMASE|3.24|IC=570uM|IC50|=|570|uM|570000|nM
4KN4|3.96|2013|1RL|ligand is bxRIF2b|P0A7Z4|DNA-DIRECTED RNA POLYMERASE SUBUNIT ALPHA|7.24|IC=57nM|IC50|=|57|nM|57|nM
4DWG|2.01|2013|0M8|Mg-containing|Q95WL3|FARNESYL PYROPHOSPHATE SYNTHASE|7.24|IC=58.0nM|IC50|=|58|nM|58|nM
4BI0|2.84|2013|Z0W|binding data from a mobility shift microfluidics assay|P33981|DUAL SPECIFICITY PROTEIN KINASE TTK|4.23|IC=58.6uM|IC50|=|58.6|uM|58600|nM
3WAW|1.95|2013|DWW|ligand is 2BoA;IC50=580+/-120nM|Q9R1E6|ECTONUCLEOTIDE PYROPHOSPHATASE/PHOSPHODIESTERASE|6.24|IC=580nM|IC50|=|580|nM|580|nM
4KC4|1.60|2013|WS3|compound 17|P16442|FUCOSYLGLYCOPROTEIN ALPHA-N|3.23|IC=584uM|IC50|=|584|uM|584000|nM
3W69|1.90|2013|LTZ|ligand is compound 35|Q00987|E3 UBIQUITIN-PROTEIN LIGASE MDM2|7.24|IC=58nM|IC50|=|58|nM|58|nM
4I32|2.30|2013|17-mer|IC50=58+/-15nM; incomplete ligand|P26662|GENOME POLYPROTEIN|7.24|IC=58nM|IC50|=|58|nM|58|nM
4L2F|2.05|2013|1V3|Zn-contained|Q9H2K2|TANKYRASE-2|6.23|IC=595nM|IC50|=|595|nM|595|nM
2YOJ|1.76|2013|8Y6|ligand is compound 11|O92972|RNA-DIRECTED RNA POLYMERASE|8.3|IC=5nM|IC50|=|5|nM|5|nM
4I6F|2.90|2013|1C7||Q9NYY3|SERINE/THREONINE-PROTEIN KINASE PLK2|8.3|IC=5nM|IC50|=|5|nM|5|nM
4I6H|1.91|2013|1C8||Q9NYY3|SERINE/THREONINE-PROTEIN KINASE PLK2|8.3|IC=5nM|IC50|=|5|nM|5|nM
4JZD|2.20|2013|1NJ|ligand is compound 1|P08709|COAGULATION FACTOR VIIA (HEAVY CHAIN)|8.3|IC=5nM|IC50|=|5|nM|5|nM
4DHU|1.67|2013|0KH|ligand is compound B1|P31947|14-3-3 PROTEIN SIGMA|5.3|IC=5uM|IC50|=|5|uM|5000|nM
4JVI|2.90|2013|QZN|IC50=5.0+/-1.6uM|Q02IG8|TRANSCRIPTIONAL REGULATOR MVFR|5.3|IC=5uM|IC50|=|5|uM|5000|nM
4KBA|1.98|2013|1QM|ligand is compound 5|P48730|CASEIN KINASE I ISOFORM DELTA|8.22|IC=6.0nM|IC50|=|6|nM|6|nM
4IXH|2.10|2013|Q21|IC50=6.1+/-0.5nM|Q8T6T2|INOSINE-5'-MONOPHOSPHATE DEHYDROGENASE|8.21|IC=6.1nM|IC50|=|6.1|nM|6.1|nM
4M6Q|2.41|2013|20T|ligand is compound 26; The ligand in crystal is not equal to the ligand in binding assay|P43490|NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE|8.21|IC=6.1nM|IC50|=|6.1|nM|6.1|nM
4IFH|3.29|2013|1EF|compound 10; BDM44619;|P14735|INSULIN-DEGRADING ENZYME|5.21|IC=6.1uM|IC50|=|6.1|uM|6100|nM
4HYU|2.15|2013|1BK||A1L4K2|MITOGEN-ACTIVATED PROTEIN KINASE 8|8.21|IC=6.2nM|IC50|=|6.2|nM|6.2|nM
4MDS|1.60|2013|23H||P0C6U8|3C-LIKE PROTEINASE|5.21|IC=6.2uM|IC50|=|6.2|uM|6200|nM
4BHN|2.30|2013|BH9|ligand is compound 5;PIC501=8.2+/-0.1(ASk1 Full length N-terminal GST tag),PIC502=8.3+/-0.1(ASk1 Full length N-terminal 6HisAvi tag)|Q99683|MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 5|8.2|IC=6.31nM|IC50|=|6.31|nM|6.31|nM
4BW2|1.92|2013|UTH||O60885|BROMODOMAIN-CONTAINING PROTEIN 4|5.2|IC=6.31uM|IC50|=|6.31|uM|6310|nM
4EZK|2.80|2013|0SD||P48736|PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE|8.2|IC=6.3nM|IC50|=|6.3|nM|6.3|nM
4B70|1.60|2013|WM9|ligand is compound 19b|P56817|BETA-SECRETASE 1|5.2|IC=6.3uM|IC50|=|6.3|uM|6300|nM
4FXF|2.55|2013|FBP|IC50 = 6.5 +/- 0.3 uM (the standard lactate dehydrogenase coupled assay)|P14618|PYRUVATE KINASE ISOZYMES M1/M2|5.19|IC=6.5uM|IC50|=|6.5|uM|6500|nM
4KBK|2.10|2013|1QG|ligand is compound 6|P48730|CASEIN KINASE I ISOFORM DELTA|8.18|IC=6.6nM|IC50|=|6.6|nM|6.6|nM
3ZIM|2.85|2013|KKR|ligand is compound 3|P42336|PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE|8.17|IC=6.8nM|IC50|=|6.8|nM|6.8|nM
3W2S|1.90|2013|W2R|ligand is compound 4|P00533|EPIDERMAL GROWTH FACTOR RECEPTOR|8.16|IC=6.9nM|IC50|=|6.9|nM|6.9|nM
4ANQ|1.76|2013|VGH|ligand is crizotinid|Q9UM73|ALK TYROSINE KINASE RECEPTOR|6.22|IC=605nM|IC50|=|605|nM|605|nM
4HXQ|1.45|2013|X8A|Mn-containing|P05089|ARGINASE-1|7.22|IC=60nM|IC50|=|60|nM|60|nM
4MBJ|3.60|2013|DFS|ligand is compound 4|P15056|SERINE/THREONINE-PROTEIN KINASE B-RAF|7.21|IC=61nM|IC50|=|61|nM|61|nM
4IS6|2.50|2013|16-mer|ligand is GP100 peptide|P01903|HLA CLASS II HISTOCOMPATIBILITY ANTIGEN, DR ALPHA CHAIN|6.2|IC=627nM|IC50|=|627|nM|627|nM
4ARK|2.60|2013|M3K|ligand is compound 1|Q02750|DUAL SPECIFICITY MITOGEN-ACTIVATED PROTEIN KINASE K|7.2|IC=63nM|IC50|=|63|nM|63|nM
4MSK|2.30|2013|2C8|ligand is compound 34|O95271|TANKYRASE-1|7.2|IC=63nM|IC50|=|63|nM|63|nM
4EHG|3.50|2013|RI9|IC50 (method radioactivity come from supporting information)|P15056|SERINE/THREONINE-PROTEIN KINASE B-RAF|7.19|IC=64nM|IC50|=|64|nM|64|nM
3WFF|2.05|2013|WFF|ligand is compound 2b|P08235|MINERALOCORTICOID RECEPTOR|6.18|IC=660nM|IC50|=|660|nM|660|nM
3W2Q|2.20|2013|HKI|ligand is neratinib(3)|P00533|EPIDERMAL GROWTH FACTOR RECEPTOR|7.18|IC=66nM|IC50|=|66|nM|66|nM
4L0T|2.10|2013|1V0|Zn-contained|Q9H2K2|TANKYRASE-2|7.18|IC=66nM|IC50|=|66|nM|66|nM
4L0B|1.80|2013|1UT|Zn-contained|Q9H2K2|TANKYRASE-2|7.17|IC=67nM|IC50|=|67|nM|67|nM
4I06|1.80|2013|X8A|Mn-containing|P78540|ARGINASE-2, MITOCHONDRIAL PRECURSON|7.17|IC=67nM|IC50|=|67|nM|67|nM
4KLB|2.62|2013|1RV|IC50 = 68.5 +/- 3.0uM|P25779|CRUZIPAIN|4.16|IC=68.5uM|IC50|=|68.5|uM|68500|nM
4HVI|2.40|2013|19S|IC50 = 68.9 +/- 23.3 nM (a kinasefiltration assay)|P52333|TYROSINE-PROTEIN KINASE JAK3|7.16|IC=68.9nM|IC50|=|68.9|nM|68.9|nM
4BI1|2.70|2013|ZO6|binding data from a mobility shift microfluidics assay|P33981|DUAL SPECIFICITY PROTEIN KINASE TTK|4.16|IC=69.1uM|IC50|=|69.1|uM|69100|nM
4BS4|1.89|2013|A64|Zn-contained|Q9H2K2|TANKYRASE-2|8.22|IC=6nM|IC50|=|6|nM|6|nM
4BS5|1.25|2013|MG2|covalent complex|O70370|CATHEPSIN S|8.22|IC=6nM|IC50|=|6|nM|6|nM
4C4H|2.80|2013|7RO|IC50 = 6 +/- 3 nM|P33981|DUAL SPECIFICITY PROTEIN KINASE TTK|8.22|IC=6nM|IC50|=|6|nM|6|nM
4KJU|1.60|2013|1RH|ligand is compound 21j;IC50 = 0.006 +/- 0.002 uM|P98170|E3 UBIQUITIN-PROTEIN LIGASE XIAP|8.22|IC=6nM|IC50|=|6|nM|6|nM
4IKS|1.70|2013|TFD|IC50=7.23+/-0.02uM, Co=contained, Different ligand structures (methyl)|P53582|METHIONINE AMINOPEPTIDASE 1|5.14|IC=7.23uM|IC50|=|7.23|uM|7230|nM
4AUA|2.31|2013|4AU|ligand is fragment A|Q00534|CYCLIN-DEPENDENT KINASE 6|5.14|IC=7.2uM|IC50|=|7.2|uM|7200|nM
4BDJ|3.01|2013|Z2M|ligand is compound 20 IC50=7.2+/-2.9uM;Mobility Shift Assay|O96017|SERINE/THREONINE-PROTEIN KINASE CHK2|5.14|IC=7.2uM|IC50|=|7.2|uM|7200|nM
4LI8|2.52|2013|1XQ|ligand is compound 35; The protein in crystal(Tankyrase-1) and in binding data(Tankyrase-2) is not identical.|O95271|TANKYRASE-1|8.12|IC=7.5nM|IC50|=|7.5|nM|7.5|nM
4BIO|2.45|2013|8XQ|Fe-containing; IC50 (MS-based assay)|Q9NWT6|HYPOXIA-INDUCIBLE FACTOR 1-ALPHA INHIBITOR|5.12|IC=7.6uM|IC50|=|7.6|uM|7600|nM
4GJ6|2.58|2013|0LS||P00797|RENIN|5.12|IC=7.6uM|IC50|=|7.6|uM|7600|nM
3VRY|2.48|2013|B43|ligand is RK-24466|P08631|TYROSINE-PROTEIN KINASE HCK|8.11|IC=7.7nM|IC50|=|7.7|nM|7.7|nM
4BID|2.80|2013|IE8|ligand is compound 3;PIC501=8.1+/-0.1(ASk1 Full length N-terminal GST tag),PIC502=8.2+/-0.1(ASk1 Full length N-terminal 6HisAvi tag)|Q99683|MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 5|8.1|IC=7.94nM|IC50|=|7.94|nM|7.94|nM
4B77|1.80|2013|54M|ligand is compound 83|P56817|BETA-SECRETASE 1|5.1|IC=7.9uM|IC50|=|7.9|uM|7900|nM
4KZL|2.00|2013|20D|Zn-contained|Q9H2K2|TANKYRASE-2|6.15|IC=700nM|IC50|=|700|nM|700|nM
3ULI|2.00|2013|1N3|ligand is compound 4g|P24941|CYCLIN-DEPENDENT KINASE 2|7.15|IC=70nM|IC50|=|70|nM|70|nM
4L10|1.70|2013|A63|Zn-contained|Q9H2K2|TANKYRASE-2|7.15|IC=71nM|IC50|=|71|nM|71|nM
4FGX|1.59|2013|7-mer||P56817|BETA-SECRETASE 1|7.14|IC=73nM|IC50|=|73|nM|73|nM
4JSC|2.50|2013|1OY||P56273|E3 UBIQUITIN-PROTEIN LIGASE MDM2|7.13|IC=74nM|IC50|=|74|nM|74|nM
4MWX|1.80|2013|ZMR|ligand is Zanamivir; IC50 = 75.7(57.4-99.7) nM|R4RZI6|NEURAMINIDASE|7.12|IC=75.7nM|IC50|=|75.7|nM|75.7|nM
3W32|1.80|2013|W32|ligand is compound 20a|P00533|EPIDERMAL GROWTH FACTOR RECEPTOR|7.12|IC=75nM|IC50|=|75|nM|75|nM
4MGV|1.72|2013|D5I|ligand is compound 4a;IC50 = 75 6.32 nM|A5K8X6|70 KDA PEPTIDYLPROLYL ISOMERASE, PUTATIVE|7.12|IC=75nM|IC50|=|75|nM|75|nM
4BDG|2.84|2013|P3J|ligand is compound 17 IC50=76.2+/-3.3uM;Mobility Shift Assay|O96017|SERINE/THREONINE-PROTEIN KINASE CHK2|4.12|IC=76.2uM|IC50|=|76.2|uM|76200|nM
4BDH|2.70|2013|WVI|ligand is compound 18 IC50=76.8+/-1.4uM;Mobility Shift Assay|O96017|SERINE/THREONINE-PROTEIN KINASE CHK2|4.11|IC=76.8uM|IC50|=|76.8|uM|76800|nM
4K9H|2.29|2013|1QU|ligand is compound 7|P56817|BETA-SECRETASE 1|7.12|IC=76nM|IC50|=|76|nM|76|nM
4J0Z|2.13|2013|1H5|ligand is compound 68|P56817|BETA-SECRETASE 1|7.11|IC=77nM|IC50|=|77|nM|77|nM
4LH6|1.65|2013|1X7|ligand is compound 1|Q837V6|DNA LIGASE|4.11|IC=77uM|IC50|=|77|uM|77000|nM
4C66|1.87|2013|H4C||O60885|BROMODOMAIN-CONTAINING PROTEIN 4|4.1|IC=79.4uM|IC50|=|79.4|uM|79400|nM
4DO3|2.25|2013|0LA|IC50 = 79 +/- 20 uM (PH=7.4), IC50 = 15.5 +/- 0.1 uM (PH=6.0)|P97612|FATTY-ACID AMIDE HYDROLASE 1|4.1|IC=79uM|IC50|=|79|uM|79000|nM
3RTP|2.40|2013|34I|ligand is compound 2|P53779|MITOGEN-ACTIVATED PROTEIN KINASE 10|8.15|IC=7nM|IC50|=|7|nM|7|nM
4ALV|2.59|2013|R9P|ligand is compound 5m|P11309|SERINE/THREONINE-PROTEIN KINASE PIM-1|8.15|IC=7nM|IC50|=|7|nM|7|nM
4L33|2.10|2013|F70|Zn-contained|Q9H2K2|TANKYRASE-2|8.15|IC=7nM|IC50|=|7|nM|7|nM
4JZE|1.52|2013|1NK|ligand is compound 1|P08709|COAGULATION FACTOR VIIA (HEAVY CHAIN)|8.15|IC=7nM|IC50|=|7|nM|7|nM
4KIP|2.27|2013|1R9|ligand is compound 8|Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|8.15|IC=7nM|IC50|=|7|nM|7|nM
4MBI|2.30|2013|26K|ligand is compound 11o|P11309|SERINE/THREONINE-PROTEIN KINASE PIM-1|8.15|IC=7nM|IC50|=|7|nM|7|nM
4B83|2.40|2013|B3V|ligand is compound 11;Ellman assay|P21836|ACETYLCHOLINESTERASE|5.15|IC=7uM|IC50|=|7|uM|7000|nM
4KZC|3.25|2013|1UK|ligand is compound 17|P48736|PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE|8.09|IC=8.2nM|IC50|=|8.2|nM|8.2|nM
4HZZ|1.60|2013|G39||A9YN63|NEURAMINIDASE|8.08|IC=8.31nM|IC50|=|8.31|nM|8.31|nM
3WD9|2.50|2013|QPC|ligand is compound 10f|Q07343|CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B|8.08|IC=8.3nM|IC50|=|8.3|nM|8.3|nM
4IE0|2.53|2013|PD2|IC50=8.3+/-1.1uM, Zn-contained|Q9C0B1|ALPHA-KETOGLUTARATE-DEPENDENT DIOXYGENASE FTO|5.08|IC=8.3uM|IC50|=|8.3|uM|8300|nM
4I5M|1.80|2013|R78||Q9NYY3|SERINE/THREONINE-PROTEIN KINASE PLK2|8.06|IC=8.8nM|IC50|=|8.8|nM|8.8|nM
4JKT|2.77|2013|04A|IC50=80.4+/-7.2nM|D3Z7P3|GLUTAMINASE KIDNEY ISOFORM, MITOCHONDRIAL|7.09|IC=80.4nM|IC50|=|80.4|nM|80.4|nM
3ZO2|1.98|2013|15I|ligand is compound 14|P00517|CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTIC|7.1|IC=80nM|IC50|=|80|nM|80|nM
4BDF|2.70|2013|H3R|ligand is compound 16 IC50=81.1+/-24.5uM;Mobility Shift Assay|O96017|SERINE/THREONINE-PROTEIN KINASE CHK2|4.09|IC=81.1uM|IC50|=|81.1|uM|81100|nM
3W2P|2.05|2013|W2P|ligand is compound 2, convalent bond|P00533|EPIDERMAL GROWTH FACTOR RECEPTOR|5.09|IC=8100nM|IC50|=|8100|nM|8100|nM
3W2O|2.35|2013|03P|ligand is TAK-285(1)|P00533|EPIDERMAL GROWTH FACTOR RECEPTOR|5.08|IC=8400nM|IC50|=|8400|nM|8400|nM
4BDB|2.50|2013|ODO|ligand is compound 12 IC50=85.6+/-7.9uM;Mobility Shift Assay|O96017|SERINE/THREONINE-PROTEIN KINASE CHK2|4.07|IC=85.6uM|IC50|=|85.6|uM|85600|nM
4L09|2.05|2013|1UR|Zn-contained|Q9H2K2|TANKYRASE-2|6.07|IC=850nM|IC50|=|850|nM|850|nM
4B85|2.10|2013|B3W|ligand is compound 17;Ellman assay|P21836|ACETYLCHOLINESTERASE|4.06|IC=88uM|IC50|=|88|uM|88000|nM
4MWY|1.80|2013|LNV|ligand is Laninamivir;IC50 = 89.6(71.1-113) nM|R4RZI6|NEURAMINIDASE|7.05|IC=89.6nM|IC50|=|89.6|nM|89.6|nM
4E90|2.50|2013|7RG|Zn-containing, Mg-containing;|O76083|CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE-9|8.1|IC=8nM|IC50|=|8|nM|8|nM
4EQC|2.01|2013|XR1||Q13153|SERINE/THREONINE-PROTEIN KINASE PAK 1|8.1|IC=8nM|IC50|=|8|nM|8|nM
4JQ8|2.83|2013|KJ8||P00533|EPIDERMAL GROWTH FACTOR RECEPTOR|8.1|IC=8nM|IC50|=|8|nM|8|nM
4IE7|2.60|2013|RHN|IC50=9.0+/-1.1uM, Zn-contained, Different ligand structure(carboxyl)|Q9C0B1|ALPHA-KETOGLUTARATE-DEPENDENT DIOXYGENASE FTO|5.05|IC=9.0uM|IC50|=|9|uM|9000|nM
3VZV|2.80|2013|VZV|ligand is compound 14b|Q00987|E3 UBIQUITIN-PROTEIN LIGASE MDM2|8.04|IC=9.2nM|IC50|=|9.2|nM|9.2|nM
4MUW|2.64|2013|2F4|ligand is compound 1; IC50 = 9.7 +/- 0.86 nM|Q9Y233|CGMP 3',5'-CYCLIC PHOSPHODIESTERASE|8.01|IC=9.7nM|IC50|=|9.7|nM|9.7|nM
4HG7|1.60|2013|NUT||Q00987|E3 UBIQUITIN-PROTEIN LIGASE MDM2|7.05|IC=90nM|IC50|=|90|nM|90|nM
3WI2|2.26|2013|P98|ligand is compound 7g|Q9Y233|CGMP 3',5'-CYCLIC PHOSPHODIESTERASE|7.04|IC=92nM|IC50|=|92|nM|92|nM
4BI2|3.11|2013|ZO8|binding data from a mobility shift microfluidics assay|P33981|DUAL SPECIFICITY PROTEIN KINASE TTK|4.03|IC=94.1uM|IC50|=|94.1|uM|94100|nM
4JPC|1.80|2013|1M6||P56817|BETA-SECRETASE 1|7.03|IC=94nM|IC50|=|94|nM|94|nM
4BFD|2.30|2013|8T3|ligand is compound 18|P56817|BETA-SECRETASE 1|7.02|IC=96nM|IC50|=|96|nM|96|nM
4IE3|2.35|2013|1EE|measuring urea levels in a colorimetric assay; Mn-containing|P78540|ARGINASE-2, MITOCHONDRIAL PRECURSON|6.01|IC=980nM|IC50|=|980|nM|980|nM
4L7G|1.38|2013|1W0|ligand is compound 34|P56817|BETA-SECRETASE 1|4.0|IC=99.3uM|IC50|=|99.3|uM|99300|nM
4BCC|1.65|2013|JKT|ligand is compound 14;IC50=9.0+/-0.1nM|P23687|PROLYL ENDOPEPTIDASE|8.05|IC=9nM|IC50|=|9|nM|9|nM
4BYI|2.60|2013|FH3|IC50 = 9 +/- 3 nM|O14965|AURORA KINASE A|8.05|IC=9nM|IC50|=|9|nM|9|nM
4MK9|2.05|2013|28R|ligand is compound 12|P26663|RNA-DIRECTED RNA POLYMERASE|8.05|IC=9nM|IC50|=|9|nM|9|nM
4G2Y|2.40|2013|NI5|Zn-containing, Mg-containing|O76074|CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE|6.0|IC>1000nM|IC50|>|1000|nM|1000|nM
4K5Z|1.80|2013|1P7|ligand is compound 11|P23946|CHYMASE|3.0|IC>1000uM|IC50|>|1000|uM|1000000|nM
4GJB|2.75|2013|0ME|X-ray(S-6), IC50(rac-6)|P00797|RENIN|4.0|IC>100uM|IC50|>|100|uM|100000|nM
4L7H|1.85|2013|1W1|ligand is Compound S1|P56817|BETA-SECRETASE 1|3.7|IC>200uM|IC50|>|200|uM|200000|nM
4L7J|1.65|2013|1W2|ligand is Compound S2|P56817|BETA-SECRETASE 1|3.7|IC>200uM|IC50|>|200|uM|200000|nM
3VZD|2.30|2013|UUL|ligand is SKI-II;with Mg and ADP|Q9NYA1|SPHINGOSINE KINASE 1|6.3|IC~0.5uM|IC50|~|0.5|uM|500|nM
4GA3|2.39|2013|4GA|IC50 (a continuous spectrophotometric assay); Mg-containing|P14324|FARNESYL PYROPHOSPHATE SYNTHASE|7.52|IC~30nM|IC50|~|30|nM|30|nM
4BXN|2.79|2013|6LX|ligand is compound 1|P52732|KINESIN-LIKE PROTEIN KIF11|8.0|Kd<10nM|Kd|<|10|nM|10|nM
4MDT|2.59|2013|24G||K0BGQ2|UDP-3-O-[3-HYDROXYMYRISTOYL] N-ACETYLGLUCOSAMINE|5.0|Kd<10uM|Kd|<|10|uM|10000|nM
4J9A|3.20|2013|DOG||Q9HYR3|ENGINEERED DIGOXIGENIN BINDER PROTEIN DIG10.3|8.22|Kd<6nM|Kd|<|6|nM|6|nM
4LOP|2.05|2013|SB4||P47811|MITOGEN-ACTIVATED PROTEIN KINASE 14|8.15|Kd=0.007uM|Kd|=|0.007|uM|7|nM
4LOQ|2.32|2013|SB4||P47811|MITOGEN-ACTIVATED PROTEIN KINASE 14|8.15|Kd=0.007uM|Kd|=|0.007|uM|7|nM
4AVT|3.20|2013|GHE|ligand is CPHPC, assay with calcium ions|P02743|SERUM AMYLOID P-COMPONENT|8.06|Kd=0.0088uM|Kd|=|0.0088|uM|8.8|nM
4F7L|2.90|2013|0SO|compound 2|P49336|CYCLIN-DEPENDENT KINASE 8|8.0|Kd=0.01uM|Kd|=|0.01|uM|10|nM
2YNS|2.10|2013|12-mer|ligand is B54NLS; Kd=0.025+/-0.004uM; incomplete ligand|Q71VM4|IMPORTIN SUBUNIT ALPHA-1A|7.6|Kd=0.025uM|Kd|=|0.025|uM|25|nM
4KLN|2.62|2013|AGS|Kd = 0.02 +/- 0.001 uM|P55072|TRANSITIONAL ENDOPLASMIC RETICULUM ATPASE|7.7|Kd=0.02uM|Kd|=|0.02|uM|20|nM
4FIL|2.40|2013|0UE|Kd=0.034+/-0.009 uM|Q7BGA5|FERRIC HYDROXAMATE RECEPTOR 2|7.47|Kd=0.034uM|Kd|=|0.034|uM|34|nM
4F6W|2.39|2013|0SS|compound 1|P49336|CYCLIN-DEPENDENT KINASE 8|7.52|Kd=0.03uM|Kd|=|0.03|uM|30|nM
4GPK|3.20|2013|8-mer|Kd = 0.03 +/- 0.01 uM|G5DDY8|NPRR|7.52|Kd=0.03uM|Kd|=|0.03|uM|30|nM
3ZI0|1.90|2013|FM8|Mn-containing; ligand is compound 14i|P64012|1-DEOXY-D-XYLULOSE 5-PHOSPHATE REDUCTOISOMERASE|7.4|Kd=0.04uM|Kd|=|0.04|uM|40|nM
4LY1|1.57|2013|20Y|ligand is compound 1|Q92769|HISTONE DEACETYLASE 2|7.26|Kd=0.0552uM|Kd|=|0.0552|uM|55.199999999999996|nM
4GGZ|1.75|2013|BTN|Kd=0.066+/-0.015nM|Q89U61|BRADAVIDIN 2|10.18|Kd=0.066nM|Kd|=|0.066|nM|0.066|nM
4I9H|2.17|2013|1E4|IC50=0.440uM|P13491|L-LACTATE DEHYDROGENASE A CHAIN|7.17|Kd=0.068uM|Kd|=|0.068|uM|68|nM
4BG6|2.30|2013|10-mer|Kd = 0.069 +/- 0.025 uM; incomplete ligand|P63104|14-3-3 PROTEIN ZETA/DELTA|7.16|Kd=0.069uM|Kd|=|0.069|uM|69|nM
4CFE|3.02|2013|992|Kd = 0.06 +/- 0.013 uM (biolayer interferometry), Kd = 0.085 +/- 0.03 uM (circular dichroism)|P54646|5'-AMP-ACTIVATED PROTEIN KINASE CATALYTIC SUBUNIT A|7.22|Kd=0.06uM|Kd|=|0.06|uM|60|nM
4FR3|1.90|2013|6-mer|ligand is TASK3 PHOSPHOPEPTIDE;bond with 16-O-Me-FC-H|P31947|14-3-3 PROTEIN SIGMA|7.15|Kd=0.07uM|Kd|=|0.07|uM|70|nM
4KO8|1.98|2013|AGS|Kd=0.07+/-0.01 uM|P55072|TRANSITIONAL ENDOPLASMIC RETICULUM ATPASE|7.15|Kd=0.07uM|Kd|=|0.07|uM|70|nM
4HY9|1.55|2013|12-mer|Kd = 0.08 +/- 0.03 uM; incomplete ligand|P0A6Y8|CHAPERONE PROTEIN DNAK|7.1|Kd=0.08uM|Kd|=|0.08|uM|80|nM
4F7N|2.65|2013|0SV|compound 11|P49336|CYCLIN-DEPENDENT KINASE 8|7.1|Kd=0.08uM|Kd|=|0.08|uM|80|nM
3ZHZ|2.25|2013|FM7|ligand is compound 14f|P64012|1-DEOXY-D-XYLULOSE 5-PHOSPHATE REDUCTOISOMERASE|7.05|Kd=0.09uM|Kd|=|0.09|uM|90|nM
4KOM|2.60|2013|4-mer||V5IRU3|HEMAGGLUTININ HA1|7.0|Kd=0.10uM|Kd|=|0.1|uM|100|nM
4K9Y|2.00|2013|K9Y|ligand is compound 13|Q05397|FOCAL ADHESION KINASE 1|6.95|Kd=0.111uM|Kd|=|0.111|uM|111|nM
4I54|2.50|2013|1C1|Kd=0.11+/-0.03uM|Q0ED31|HIV-1 GLYCOPROTEIN|6.96|Kd=0.11uM|Kd|=|0.11|uM|110|nM
4JYB|2.10|2013|GNP|ligand is GMPPNP; Kd=0.11+/-0.01 uM|C5AP93|METHYLMALONYL-COA MUTASE ACCESSORY PROTEIN|6.96|Kd=0.11uM|Kd|=|0.11|uM|110|nM
4LOH|2.25|2013|1SY|ligand is c[G(2',5')pA(3',5')p]|Q86WV6|STIMULATOR OF INTERFERON GENES PROTEIN|6.96|Kd=0.11uM|Kd|=|0.11|uM|110|nM
4HPY|1.50|2013|19-mer|incomplete ligand|Q9WLG7|CH59 FAB HEAVY CHAIN|9.92|Kd=0.12nM|Kd|=|0.12|nM|0.12|nM
3WDZ|2.60|2013|14-mer|ligand is Peptide from Sequestosome-1;Ka=8.5+/-2.4 106M-1; incomplete ligand|Q9Z2X8|KELCH-LIKE ECH-ASSOCIATED PROTEIN 1|6.92|Kd=0.12uM|Kd|=|0.12|uM|120|nM
4G4P|1.50|2013|GLN|Kd=0.13+/-0.01uM|Q837S0|AMINO ACID ABC TRANSPORTER, AMINO ACID-BINDING/PERM|6.89|Kd=0.13uM|Kd|=|0.13|uM|130|nM
4BCQ|2.40|2013|TJF|ligand is comound 6|P24941|CYCLIN-DEPENDENT KINASE 2|6.83|Kd=0.147uM|Kd|=|0.147|uM|147|nM
4B8P|2.30|2013|12-mer|ligand is A89NLS; Kd=0.14+/-0.023uM; incomplete ligand|Q71VM4|IMPORTIN SUBUNIT ALPHA-1A|6.85|Kd=0.14uM|Kd|=|0.14|uM|140|nM
3ZKE|2.20|2013|11-mer|ligand is NEK9 peptide|P63167|DYNEIN LIGHT CHAIN 1|6.8|Kd=0.16uM|Kd|=|0.16|uM|160|nM
4LKG|2.99|2013|3-mer||V5IRU7|HEMAGGLUTININ|6.8|Kd=0.16uM|Kd|=|0.16|uM|160|nM
4LOI|1.89|2013|1YC|ligand is c[G(2',5')pA(2',5')p]|Q86WV6|STIMULATOR OF INTERFERON GENES PROTEIN|6.77|Kd=0.17uM|Kd|=|0.17|uM|170|nM
4LXZ|1.85|2013|SHH|ligand is SAHA|Q92769|HISTONE DEACETYLASE 2|6.74|Kd=0.182uM|Kd|=|0.182|uM|182|nM
4LG6|1.80|2013|17-mer|ligand is CCDC8 peptide|Q9H9E1|ANKYRIN REPEAT FAMILY A PROTEIN 2|6.74|Kd=0.18uM|Kd|=|0.18|uM|180|nM
4LRH|2.80|2013|FOL||P15328|FOLATE RECEPTOR ALPHA|9.72|Kd=0.19nM|Kd|=|0.19|nM|0.19|nM
2RT5|NMR|2013|8-mer|ligand is peptide from Silencing mediator of retinoic acid and thyroid hormone receptor;Kd=0.19+/-0.18uM,ITC|Q96T58|MSX2-INTERACTING PROTEIN|6.72|Kd=0.19uM|Kd|=|0.19|uM|190|nM
4LWC|1.61|2013|1XU|ligand is compound 8; incomplete ligand|P27694|REPLICATION PROTEIN A 70 KDA DNA-BINDING SUBUNIT|6.72|Kd=0.19uM|Kd|=|0.19|uM|190|nM
4LHV|1.95|2013|GDP||P61006|RAS-RELATED PROTEIN RAB-8A|10.0|Kd=0.1nM|Kd|=|0.1|nM|0.1|nM
4JYC|2.20|2013|GDP|Kd=0.20+/-0.01 uM|C5AP93|METHYLMALONYL-COA MUTASE ACCESSORY PROTEIN|6.7|Kd=0.20uM|Kd|=|0.2|uM|200|nM
4LKJ|2.80|2013|3-mer||V5IRV2|HEMAGGLUTININ|6.7|Kd=0.20uM|Kd|=|0.2|uM|200|nM
3ZHX|2.00|2013|FM6|Mn-containing; ligand is compound 14a|P64012|1-DEOXY-D-XYLULOSE 5-PHOSPHATE REDUCTOISOMERASE|6.68|Kd=0.21uM|Kd|=|0.21|uM|210|nM
4IAW|2.40|2013|LIZ|Different ligand structure; Y-containing|P80188|NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN|9.63|Kd=0.234nM|Kd|=|0.234|nM|0.234|nM
4IUO|1.80|2013|QIC|Kd=0.23+/-0.04mM|P58687|3-DEHYDROQUINATE DEHYDRATASE|3.64|Kd=0.23mM|Kd|=|0.23|mM|230000|nM
4BTK|2.00|2013|DTQ|Kd=0.46 uM(Phosphorylated TTBK1), Kd=0.24 uM(Nonphosphorylated TTBK1)|Q5TCY1|TAU-TUBULIN KINASE 1|6.62|Kd=0.24uM|Kd|=|0.24|uM|240|nM
4GQP|2.00|2013|B40|Kd=0.25+/-0.014nM|------|ANTI-METHAMPHETAMINE SINGLE CHAIN FV|9.6|Kd=0.25nM|Kd|=|0.25|nM|0.25|nM
4LI0|3.30|2013|GDP||P61006|RAS-RELATED PROTEIN RAB-8A|6.59|Kd=0.26uM|Kd|=|0.26|uM|260|nM
4IAX|1.90|2013|LIZ|Different ligand structure; Y-containing|P80188|NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN|9.56|Kd=0.273nM|Kd|=|0.273|nM|0.273|nM
2M3Z|NMR|2013|1HF|ligand is compound 3;Kd=0.27+/-0.07uM|P12497|NUCLEOCAPSID PROTEIN P7|6.57|Kd=0.27uM|Kd|=|0.27|uM|270|nM
4JGV|3.01|2013|T94|Kd=0.27+/-0.03uM|P22736|NUCLEAR RECEPTOR SUBFAMILY 4 GROUP A MEMBER 1|6.57|Kd=0.27uM|Kd|=|0.27|uM|270|nM
4IUE|2.38|2013|AJ4|ligand is compound 11|Q9H2K2|TANKYRASE-2|6.55|Kd=0.28uM|Kd|=|0.28|uM|280|nM
4IO2|1.37|2013|GLU|Kd=0.2+/-0.02uM|E9P5T5|GLUTAMATE RECEPTOR 1|6.7|Kd=0.2uM|Kd|=|0.2|uM|200|nM
4NJ3|1.85|2013|2KD||P24941|CYCLIN-DEPENDENT KINASE 2|6.52|Kd=0.30uM|Kd|=|0.3|uM|300|nM
4GV8|2.10|2013|DUP|Mg-containing|Q8SDV3|DUTPASE|6.49|Kd=0.32uM|Kd|=|0.32|uM|320|nM
4KON|2.60|2013|SIA-GAL||V5IRU3|HEMAGGLUTININ HA1|6.48|Kd=0.33uM|Kd|=|0.33|uM|330|nM
3ZH8|2.74|2013|C58|ligand is CRT0066854|P41743|PROTEIN KINASE C, IOTA|6.47|Kd=0.341uM|Kd|=|0.341|uM|341|nM
4B7P|1.70|2013|9UN|ligand is NMS-E973|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|9.46|Kd=0.346nM|Kd|=|0.346|nM|0.346|nM
4HYB|1.70|2013|11-mer|Kd = 0.35 +/- 0.01 uM; incomplete ligand|P0A6Y8|CHAPERONE PROTEIN DNAK|6.46|Kd=0.35uM|Kd|=|0.35|uM|350|nM
4N07|1.87|2013|2J9|ligand is compound 3; Kd=0.35+/-0.02 uM|P19491|GLUTAMATE RECEPTOR 2|6.46|Kd=0.35uM|Kd|=|0.35|uM|350|nM
4JFK|1.15|2013|JFK|Kd=0.36+/-0.1uM|Q13451|PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5|6.44|Kd=0.36uM|Kd|=|0.36|uM|360|nM
3ZLL|2.00|2013|4WF|ligand is compound 2; Kd=0.395+/-0.02uM; IC50=1.14+/-0.19uM|G3XCK4|GLUCOSE-1-PHOSPHATE THYMIDYLYLTRANSFERASE|6.4|Kd=0.395uM|Kd|=|0.395|uM|395|nM
4EZO|1.90|2013|15-mer|Kd = 0.3 +/- 0.1 uM; incomplete ligand|P0A6Y8|CHAPERONE PROTEIN DNAK|6.52|Kd=0.3uM|Kd|=|0.3|uM|300|nM
4LOJ|1.77|2013|1SY|ligand is c[G(2',5')pA(3',5')p]|Q3TBT3|STIMULATOR OF INTERFERON GENES PROTEIN|6.52|Kd=0.3uM|Kd|=|0.3|uM|300|nM
4CFF|3.92|2013|C1V|Kd = 0.40 +/- 0.15 uM|P54646|5'-AMP-ACTIVATED PROTEIN KINASE CATALYTIC SUBUNIT A|6.4|Kd=0.40uM|Kd|=|0.4|uM|400|nM
3W07|1.03|2013|U5P|Kd=0.42+/-0.02mM|O26232|OROTIDINE 5'-MONOPHOSPHATE DECARBOXYLASE|3.38|Kd=0.42mM|Kd|=|0.42|mM|420000|nM
4B33|1.50|2013|1NP|ligand is compound 9|O74036|DNA REPAIR AND RECOMBINATION PROTEIN RADA|3.37|Kd=0.43mM|Kd|=|0.43|mM|430000|nM
3V2P|1.87|2013|STE|Kd=0.44+/-0.06uM|Q9R0G6|CARTILAGE OLIGOMERIZATION MATRIX PROTEIN|6.36|Kd=0.44uM|Kd|=|0.44|uM|440|nM
4J4V|2.30|2013|SVR|Kd=0.44+/-0.095uM; incomplete ligand structure|I6WJ72|NUCLEOCAPSID PROTEIN|6.36|Kd=0.44uM|Kd|=|0.44|uM|440|nM
4I67|2.33|2013|4-mer|Kd=0.45+/-0.036uM|Q72GF3|HEAT RESISTANT RNA DEPENDENT ATPASE|6.35|Kd=0.45uM|Kd|=|0.45|uM|450|nM
4B32|1.50|2013|03V|ligand is compound 10|O74036|DNA REPAIR AND RECOMBINATION PROTEIN RADA|3.34|Kd=0.46mM|Kd|=|0.46|mM|460000|nM
3ZK6|2.48|2013|H1I|ligand is compound 2; Kd=230+/-20nM|Q07817|BCL-2-LIKE PROTEIN 1|6.34|Kd=0.46uM|Kd|=|0.46|uM|460|nM
3W9K|1.80|2013|MYR|Kd=0.48+/-0.05uM|Q973T5|FATTY ACID BINDING PROTEIN|6.32|Kd=0.48uM|Kd|=|0.48|uM|480|nM
3V2Q|2.20|2013|PLM|Kd=0.51+/-0.07uM|Q9R0G6|CARTILAGE OLIGOMERIZATION MATRIX PROTEIN|6.29|Kd=0.51uM|Kd|=|0.51|uM|510|nM
4N6H|1.80|2013|EJ4||P0ABE7|SOLUBLE CYTOCHROME B562, DELTA-TYPE OPIOID RECEPTOR|9.28|Kd=0.52nM|Kd|=|0.52|nM|0.52|nM
4JBL|2.00|2013|MET|Kd=0.54+/-0.03mM|O15570|CYSTEINE SYNTHASE|3.27|Kd=0.54mM|Kd|=|0.54|mM|540000|nM
4F0C|1.90|2013|GDS|ligand is GSSG|I7B368|GLUTATHIONE TRANSFERASE|6.27|Kd=0.54uM|Kd|=|0.54|uM|540|nM
3ZLR|2.03|2013|X0B|ligand is WEHI-539|Q07817|BCL-2-LIKE PROTEIN 1|9.26|Kd=0.55nM|Kd|=|0.55|nM|0.55|nM
3UX0|1.75|2013|6-mer|ligand is TASK3 PHOSPHOPEPTIDE;bond with FC-H|P31947|14-3-3 PROTEIN SIGMA|6.26|Kd=0.55uM|Kd|=|0.55|uM|550|nM
4B2L|1.50|2013|TR7|ligand is compound 8|O74036|DNA REPAIR AND RECOMBINATION PROTEIN RADA|3.24|Kd=0.57mM|Kd|=|0.57|mM|570000|nM
4HWB|2.61|2013|NHE|Kd = 0.57 +/- 0.01 nM|P78552|INTERLEUKIN-13 RECEPTOR SUBUNIT ALPHA-1|9.24|Kd=0.57nM|Kd|=|0.57|nM|0.57|nM
4KII|1.85|2013|RHL|Rh-containing|P02754|BETA-LACTOGLOBULIN|6.23|Kd=0.59uM|Kd|=|0.59|uM|590|nM
4DDH|2.07|2013|MS0|Kd=0.5+/-0.01 mM|P0A5R0|PANTOTHENATE SYNTHETASE|3.3|Kd=0.5mM|Kd|=|0.5|mM|500000|nM
4E1K|2.00|2013|0N5||P43889|BIFUNCTIONAL PROTEIN GLMU|6.3|Kd=0.5uM|Kd|=|0.5|uM|500|nM
4BQG|1.90|2013|50Q||Q2VPJ6|HEAT SHOCK PROTEIN HSP90-ALPHA|6.22|Kd=0.60uM|Kd|=|0.6|uM|600|nM
4MJO|2.40|2013|2C1|ligand is compound 3; Kd=0.60+/-0.03uM|P09467|FRUCTOSE-1,6-BISPHOSPHATASE 1|6.22|Kd=0.60uM|Kd|=|0.6|uM|600|nM
4K6I|2.10|2013|9RA|ligand is Targretin; Ka=1.59+/-0.04 uM^(-1)(25 C)|P19793|RETINOIC ACID RECEPTOR RXR-ALPHA|6.2|Kd=0.629uM|Kd|=|0.629|uM|629|nM
3ZCW|1.69|2013|4A2|ligand is BI8;ADP containing;Kd1=0.65+/-0.01uM(BJ8, 1st site)|P52732|KINESIN-LIKE PROTEIN KIF11|6.19|Kd=0.65uM|Kd|=|0.65|uM|650|nM
4NMX|1.85|2013|15-mer|ligand is peptide 2-8;Kd = 0.66 +/- 0.11 uM|Q8NBP7|PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9|6.18|Kd=0.66uM|Kd|=|0.66|uM|660|nM
4FHT|2.15|2013|DHB|Kd=0.67+/-0.01uM|Q9XAM6|PCAV TRANSCRIPTIONAL REGULATOR|6.17|Kd=0.67uM|Kd|=|0.67|uM|670|nM
4JFF|2.43|2013|10-mer||P01892|HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA CHAIN|9.22|Kd=0.6nM|Kd|=|0.6|nM|0.6|nM
4F6U|2.10|2013|0SR|compound 5|P49336|CYCLIN-DEPENDENT KINASE 8|6.15|Kd=0.70uM|Kd|=|0.7|uM|700|nM
4B34|1.55|2013|ABV|ligand is compound 6|O74036|DNA REPAIR AND RECOMBINATION PROTEIN RADA|3.14|Kd=0.73mM|Kd|=|0.73|mM|730000|nM
4K4J|2.00|2013|1O8|ligand is 9cUAB30; Ka=1.33+/-0.04 uM^(-1)(25 C)|P19793|RETINOIC ACID RECEPTOR RXR-ALPHA|6.12|Kd=0.752uM|Kd|=|0.752|uM|752|nM
4M7C|2.05|2013|13-mer|ligand is Peptide from Structure-specific endonuclease subunit SLX4;Kd = 0.75 +/- 0.12 uM|Q15554|TELOMERIC REPEAT-BINDING FACTOR 2|6.12|Kd=0.75uM|Kd|=|0.75|uM|750|nM
4HP0|1.19|2013|4-mer||P00698|LYSOZYME C|6.12|Kd=0.76uM|Kd|=|0.76|uM|760|nM
4IRX|1.45|2013|INS|Kd=0.76+/-0.08uM|Q9A9V2|SUGAR ABC TRANSPORTER, PERIPLASMIC SUGAR-BINDING PR|6.12|Kd=0.76uM|Kd|=|0.76|uM|760|nM
4KAO|2.39|2013|KAO|ligand is compound 27|Q05397|FOCAL ADHESION KINASE 1|6.11|Kd=0.77uM|Kd|=|0.77|uM|770|nM
4HMK|3.00|2013|LEU|Na-containing, Br-containing; Kd = 0.79 +/- 0.05 uM|O67854|TRANSPORTER|6.1|Kd=0.79uM|Kd|=|0.79|uM|790|nM
4HOD|3.30|2013|LEU|Na-containing, Cl-containing; Kd = 0.79 +/- 0.05 uM|O67854|TRANSPORTER|6.1|Kd=0.79uM|Kd|=|0.79|uM|790|nM
4MZ5|2.10|2013|13-mer|ligand is peptide from dUTPase;Kd = 0.79 +/- 0.26 uM; incomplete ligand|P33316|DEOXYURIDINE 5'-TRIPHOSPHATE NUCLEOTIDOHYDROLASE|6.1|Kd=0.79uM|Kd|=|0.79|uM|790|nM
4DE5|2.25|2013|0JD|Kd=0.7+/-0.02 mM|P0A5R0|PANTOTHENATE SYNTHETASE|3.15|Kd=0.7mM|Kd|=|0.7|mM|700000|nM
4FZJ|1.63|2013|0W1|Kd=0.7+/-0.02 mM|P0A5R0|PANTOTHENATE SYNTHETASE|3.15|Kd=0.7mM|Kd|=|0.7|mM|700000|nM
4FMN|2.69|2013|9-mer|Kd = 0.80 +/- 0.02 uM; incomplete ligand|P38920|DNA MISMATCH REPAIR PROTEIN MLH1|6.1|Kd=0.80uM|Kd|=|0.8|uM|800|nM
4JNJ|1.90|2013|BTN|Kd=0.85+/-0.02nM|------|STREPTAVIDIN/RHIZAVIDIN HYBRID|9.07|Kd=0.85nM|Kd|=|0.85|nM|0.85|nM
4IO3|1.66|2013|ASP|Kd=0.87+/-0.08uM|E9P5T5|AVGLUR1 LIGAND BINDING DOMAIN|6.06|Kd=0.87uM|Kd|=|0.87|uM|870|nM
4L50|2.10|2013|D8X|ligand is D8P; Kd=0.88+/-0.14uM|P76141|TRANSCRIPTIONAL REGULATOR LSRR|6.06|Kd=0.88uM|Kd|=|0.88|uM|880|nM
3V2N|1.80|2013|MYR|Kd=0.8+/-0.1uM|Q9R0G6|CARTILAGE OLIGOMERIZATION MATRIX PROTEIN|6.1|Kd=0.8uM|Kd|=|0.8|uM|800|nM
4C4N|2.36|2013|6-mer||Q62226|SONIC HEDGEHOG PROTEIN|6.1|Kd=0.8uM|Kd|=|0.8|uM|800|nM
4HBN|2.60|2013|CMP|Kd = 0.8 +/- 0.05 uM|Q9Y3Q4|POTASSIUM/SODIUM HYPERPOLARIZATION-ACTIVATED CYCLIC|6.1|Kd=0.8uM|Kd|=|0.8|uM|800|nM
4KM0|1.30|2013|CP6|ligand is PYR|P0A546|DIHYDROFOLATE REDUCTASE|6.04|Kd=0.91uM|Kd|=|0.91|uM|910|nM
3ZKF|2.60|2013|11-mer|ligand is P-NEK9 peptide; incomplete ligand|P63167|DYNEIN LIGHT CHAIN 1|6.02|Kd=0.96uM|Kd|=|0.96|uM|960|nM
4G5F|2.33|2013|0JD|Kd=0.9+/-0.04 mM|P0A5R0|PANTOTHENATE SYNTHETASE|3.05|Kd=0.9mM|Kd|=|0.9|mM|900000|nM
4KQP|0.95|2013|GLN|Kd=0.9+/-0.2uM|Q9CES5|GLUTAMINE ABC TRANSPORTER PERMEASE AND SUBSTRATE BI|6.05|Kd=0.9uM|Kd|=|0.9|uM|900|nM
4AZ5|1.73|2013|NGW|ligand is NGT; Kd=1.02+/-0.14uM|P49610|BETA-N-ACETYLHEXOSAMINIDASE|5.99|Kd=1.02uM|Kd|=|1.02|uM|1020|nM
4CH2|1.60|2013|14-mer|Kd = 1.03 +/- 0.05 uM; incomplete ligand|P00734|THROMBIN|5.99|Kd=1.03uM|Kd|=|1.03|uM|1030|nM
4CH8|1.75|2013|14-mer|Kd = 1.03 +/- 0.05 uM; incomplete ligand|P00734|THROMBIN|5.99|Kd=1.03uM|Kd|=|1.03|uM|1030|nM
4NKT|1.90|2013|2KH|Kd=1.08+/-0.02 uM|O13833|POLY(A) RNA POLYMERASE PROTEIN CID1|5.97|Kd=1.08uM|Kd|=|1.08|uM|1080|nM
4B2I|1.30|2013|LZ1|ligand is compound 5|O74036|DNA REPAIR AND RECOMBINATION PROTEIN RADA|3.0|Kd=1.0mM|Kd|=|1|mM|1000000|nM
4EZW|1.80|2013|7-mer|Kd = 1.0 +/- 0.3 uM; incomplete ligand|P0A6Y8|CHAPERONE PROTEIN DNAK|6.0|Kd=1.0uM|Kd|=|1|uM|1000|nM
4BGY|2.68|2013|3-mer|Kd = 1.1 +/- 0.2 mM (MST)|Q6DQ34|HEMAGGLUTININ|2.96|Kd=1.1mM|Kd|=|1.1|mM|1100000|nM
4DLJ|2.60|2013|6RG|Kd = 1.20 +/- 0.30 uM|Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|5.92|Kd=1.20uM|Kd|=|1.2|uM|1200|nM
4LKK|2.49|2013|2-mer||V5IRV5|HEMAGGLUTININ|5.92|Kd=1.20uM|Kd|=|1.2|uM|1200|nM
4KNE|2.00|2013|1CY|ligand is CYC|P0A546|DIHYDROFOLATE REDUCTASE|5.9|Kd=1.26uM|Kd|=|1.26|uM|1260|nM
4EF6|1.94|2013|I2E|Kd=1.2+/-0.01 mM|P0A5R0|PANTOTHENATE SYNTHETASE|2.92|Kd=1.2mM|Kd|=|1.2|mM|1200000|nM
4AZC|2.09|2013|NGW|ligand is NGT; Kd=1.38+/-0.04uM|P49610|BETA-N-ACETYLHEXOSAMINIDASE|5.86|Kd=1.38uM|Kd|=|1.38|uM|1380|nM
4JN4|2.30|2013|ATP|Kd=1.38+/-0.06uM; Mg-containing|P0A6Y8|CHAPERONE PROTEIN DNAK|5.86|Kd=1.38uM|Kd|=|1.38|uM|1380|nM
4JNE|1.96|2013|ATP|Kd=1.38+/-0.06uM; Mg-containing|P0A6Y8|CHAPERONE PROTEIN DNAK|5.86|Kd=1.38uM|Kd|=|1.38|uM|1380|nM
4B35|1.40|2013|4ME|ligand is compound 4|O74036|DNA REPAIR AND RECOMBINATION PROTEIN RADA|2.89|Kd=1.3mM|Kd|=|1.3|mM|1300000|nM
3ZOS|1.92|2013|0LI|ligand is ponatinib|Q08345|EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1|8.89|Kd=1.3nM|Kd|=|1.3|nM|1.3|nM
4HVA|2.07|2013|4HV||P55212|CASPASE-6|5.89|Kd=1.3uM|Kd|=|1.3|uM|1300|nM
4JV8|1.45|2013|1M1|Kd=1.42+/-0.48uM|O43924|RETINAL ROD RHODOPSIN-SENSITIVE CGMP 3',5'-CYCLIC|5.85|Kd=1.42uM|Kd|=|1.42|uM|1420|nM
4KM2|1.40|2013|TOP|ligand is TMP|P0A546|DIHYDROFOLATE REDUCTASE|5.84|Kd=1.43uM|Kd|=|1.43|uM|1430|nM
4L4V|1.90|2013|1VY|ligand is rRL-6-CH2OH; Kd =1.65+/-0.16 uM|Q95460|HLA CLASS I HISTOCOMPATIBILITY ANTIGEN|5.78|Kd=1.65uM|Kd|=|1.65|uM|1650|nM
4KSP|2.93|2013|1SU|ligand is compound 8B|P15056|SERINE/THREONINE-PROTEIN KINASE B-RAF|8.8|Kd=1.6nM|Kd|=|1.6|nM|1.6|nM
4EZX|1.70|2013|7-mer|Kd=1.6+/-0.5 uM|P0A6Y8|CHAPERONE PROTEIN DNAK|5.8|Kd=1.6uM|Kd|=|1.6|uM|1600|nM
4K3P|2.15|2013|6-mer|ligand is AcQLALF|P0A988|DNA POLYMERASE III SUBUNIT BETA|5.8|Kd=1.6uM|Kd|=|1.6|uM|1600|nM
2YNR|2.30|2013|12-mer|ligand is B54NLS; Kd=1.70+/-0.23uM|Q52L97|IMPORTIN SUBUNIT ALPHA|5.77|Kd=1.70uM|Kd|=|1.7|uM|1700|nM
4G5Y|1.80|2013|0OC|Kd = 1.7 +/- 0.08 mM|P0A5R0|PANTOTHENATE SYNTHETASE|2.77|Kd=1.7mM|Kd|=|1.7|mM|1700000|nM
4F70|3.00|2013|0ST|compound 4|P49336|CYCLIN-DEPENDENT KINASE 8|5.74|Kd=1.82uM|Kd|=|1.82|uM|1820|nM
4I60|2.50|2013|B1R|Ru-contained|P02701|AVIDIN|5.73|Kd=1.87uM|Kd|=|1.87|uM|1870|nM
4LPS|2.00|2013|GDP|Ni2+ containing; Kd=1.8+/-0.6 uM|O25560|HYDROGENASE/UREASE NICKEL INCORPORATION PROTEIN HYP|5.74|Kd=1.8uM|Kd|=|1.8|uM|1800|nM
4BKJ|1.70|2013|STI|ligand is lmatinib|Q08345|EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1|8.72|Kd=1.9nM|Kd|=|1.9|nM|1.9|nM
4BR3|2.20|2013|U85||P35790|CHOLINE KINASE ALPHA|5.72|Kd=1.9uM|Kd|=|1.9|uM|1900|nM
4I9O|2.00|2013|KI1|covalent complex|P45481|CREB-BINDING PROTEIN|5.72|Kd=1.9uM|Kd|=|1.9|uM|1900|nM
4IUT|2.70|2013|15-mer|Kd=1.9+/-0.06uM; incomplete ligand|Q9XI47|SAWADEE HOMEODOMAIN HOMOLOG 1|5.72|Kd=1.9uM|Kd|=|1.9|uM|1900|nM
4IUV|2.80|2013|15-mer|Kd=1.9+/-0.16uM; incomplete ligand|Q9XI47|SAWADEE HOMEODOMAIN HOMOLOG 1|5.72|Kd=1.9uM|Kd|=|1.9|uM|1900|nM
4KNM|1.90|2013|E1E|ligand is compound 2f|Q8N1Q1|CARBONIC ANHYDRASE 13|8.0|Kd=10.0nM|Kd|=|10|nM|10|nM
4JFL|1.20|2013|1KY|Kd=10.5+/-2.3uM|Q13451|PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5|4.98|Kd=10.5uM|Kd|=|10.5|uM|10500|nM
4BXU|NMR|2013|15-mer||O75381|PEROXISOMAL MEMBRANE ANCHOR PROTEIN PEX14|7.0|Kd=100nM|Kd|=|100|nM|100|nM
4BCS|1.80|2013|BTN|Kd at PH=7 by ITC|P56734|CHIMERIC AVIDIN|6.99|Kd=103nM|Kd|=|103|nM|103|nM
4I7L|1.52|2013|IPH||P00720|LYSOZYME|3.99|Kd=103uM|Kd|=|103|uM|103000|nM
4ATT|1.25|2013|HNV|ligand is 1OMe; Kd=53+/-2.3nM(SPR); Kd=104.6+/-21.9nM(ITC)|A2IC68|FIMH PROTEIN|6.98|Kd=104.6nM|Kd|=|104.6|nM|104.6|nM
2M0V|NMR|2013|5-mer|lgand is C-terminal CFTR peptide;Kd=1079+/-79nM|O14745|NA(+)/H(+) EXCHANGE REGULATORY COFACTOR NHE-RF1|5.97|Kd=1079nM|Kd|=|1079|nM|1079|nM
4CEB|1.75|2013|ZSV|Kd=1080+/-123 uM|Q76353|HIV-1 INTEGRASE|2.97|Kd=1080uM|Kd|=|1080|uM|1080000|nM
4HT0|1.60|2013|V50|Zn-containing|P00918|CARBONIC ANHYDRASE 2|8.0|Kd=10nM|Kd|=|10|nM|10|nM
4KNJ|2.00|2013|E1F|ligand is compound 2j|P00918|CARBONIC ANHYDRASE 2|7.95|Kd=11.1nM|Kd|=|11.1|nM|11.1|nM
4BUP|2.17|2013|SAM|Kd=11.2+/-1uM|Q3U8K7|HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1|4.95|Kd=11.2uM|Kd|=|11.2|uM|11200|nM
4LBP|1.87|2013|1WG||Q45075|5-CHLORO-2-HYDROXYHYDROQUINONE DEHYDROCHLORINASE|4.94|Kd=11.4uM|Kd|=|11.4|uM|11400|nM
4IDO|2.09|2013|GDP|Kd=11.63+/-1.18uM; Mg-containing|Q8WXF7|ATLASTIN-1|4.93|Kd=11.63uM|Kd|=|11.63|uM|11630|nM
4I9R|2.60|2013|RET|Kd=112+/-17nM, Covalent binding|P29373|CELLULAR RETINOIC ACID-BINDING PROTEIN 2|6.95|Kd=112nM|Kd|=|112|nM|112|nM
4BI6|1.45|2013|PGA|Ki=560+/-59uM, Kd=113.3+/-41.7uM|P36186|TRIOSEPHOSPHATE ISOMERASE|3.95|Kd=113.3uM|Kd|=|113.3|uM|113300|nM
4MR4|1.66|2013|1K0|ligand is RVX-208; Kd = 1142 +/- 46 nM|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|5.94|Kd=1142nM|Kd|=|1142|nM|1142|nM
4MR3|1.68|2013|1K0|ligand is RVX-208; Kd=1142+/-46 nM|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|5.94|Kd=1142nM|Kd|=|1142|nM|1142|nM
4K3Q|1.85|2013|6-mer|ligand is AcQLDAF|P0A988|DNA POLYMERASE III SUBUNIT BETA|3.94|Kd=115.1uM|Kd|=|115.1|uM|115100|nM
4FCM|2.69|2013|9-mer|Kd = 115 +/- 3 uM; incomplete ligand|Q13283|RAS GTPASE-ACTIVATING PROTEIN-BINDING PROTEIN 1|3.94|Kd=115uM|Kd|=|115|uM|115000|nM
4J2T|3.20|2013|1HT|Kd=11+/-1nM|B6CAM1|SARCOPLASMIC/ENDOPLASMIC RETICULUM CALCIUM ATPASE 1, SERCA1A|7.96|Kd=11nM|Kd|=|11|nM|11|nM
4C73|1.80|2013|TLH|Ki = 12.1 +/- 0.6 uM|I6Y8T4|3-OXOACYL-[ACYL-CARRIER-PROTEIN] SYNTHASE 1|4.92|Kd=12.1uM|Kd|=|12.1|uM|12100|nM
4C0R|1.55|2013|GDS|Kd = 12.2 +/- 0.6 uM; Cd-containing|M2L4D8|PUTATIVE AMINO ACID BINDING PROTEIN|4.91|Kd=12.2uM|Kd|=|12.2|uM|12200|nM
4APO|1.90|2013|6-mer|ligand is TOMM20;Kd=12.3+/-0.5uM|O00170|AH RECEPTOR-INTERACTING PROTEIN|4.91|Kd=12.3uM|Kd|=|12.3|uM|12300|nM
4LIL|2.60|2013|UTP|Kd = 12.5 +/- 0.72 uM|P49642|DNA PRIMASE SMALL SUBUNIT|4.9|Kd=12.5uM|Kd|=|12.5|uM|12500|nM
4IGT|1.24|2013|3ZA||P19491|GLUTAMATE RECEPTOR 2|7.89|Kd=12.8nM|Kd|=|12.8|nM|12.8|nM
4I2W|3.60|2013|10-mer||G5EG62|PROTEIN UNC-45|3.92|Kd=120.8uM|Kd|=|120.8|uM|120800|nM
3ZHF|1.70|2013|9-mer|ligand is preS1 Site 1 peptide;Kd=120+/-10uM; incomplete ligand|O75843|AP-1 COMPLEX SUBUNIT GAMMA-LIKE 2|3.92|Kd=120uM|Kd|=|120|uM|120000|nM
3WDE|1.44|2013|7-mer|ligand is Cyclomarin A;Kd=124+/-12nM|P0A522|PROBABLE ATP-DEPENDENT CLP PROTEASE ATP-BINDING SUB|6.91|Kd=124nM|Kd|=|124|nM|124|nM
4BH3|2.00|2013|3-mer|Kd = 12 +/- 2.5 mM (MST)|Q5EP31|HEMAGGLUTININ|1.92|Kd=12mM|Kd|=|12|mM|12000000|nM
3WDC|1.18|2013|7-mer|ligand is Cyclomarin A;Kd=12+/-3nM|P0A522|PROBABLE ATP-DEPENDENT CLP PROTEASE ATP-BINDING SUB|7.92|Kd=12nM|Kd|=|12|nM|12|nM
4HS8|2.60|2013|16-mer|incomplete ligand|Q9YK84|E2-PEPTIDE|7.92|Kd=12nM|Kd|=|12|nM|12|nM
4I2Z|2.90|2013|10-mer|incomplete ligand|G5EG62|PROTEIN UNC-45|4.87|Kd=13.5uM|Kd|=|13.5|uM|13500|nM
4IPJ|2.15|2013|LMR|Kd=13.5+/-0.4uM, Mn-containing|Q7DDU0|POLYSIALIC ACID CAPSULE BIOSYNTHESIS PROTEIN SIAC|4.87|Kd=13.5uM|Kd|=|13.5|uM|13500|nM
3W5N|1.80|2013|RAM||Q82PP4|PUTATIVE RHAMNOSIDASE|3.87|Kd=135uM|Kd|=|135|uM|135000|nM
4IJL|1.70|2013|1EK||P27694|REPLICATION PROTEIN A 70 KDA DNA-BINDING SUBUNIT|3.87|Kd=135uM|Kd|=|135|uM|135000|nM
4I9U|2.50|2013|1E7|IC50=770uM|P13491|L-LACTATE DEHYDROGENASE A CHAIN|3.86|Kd=137uM|Kd|=|137|uM|137000|nM
4HPI|1.19|2013|3-mer||P00698|LYSOZYME C|4.85|Kd=14.2uM|Kd|=|14.2|uM|14200|nM
4AIF|2.01|2013|7-mer|ligand is peptide from HSP90-beta;Kd=14.4+/-1.0uM(N=1.1),Kd2=18.6+/-2.0uM(N=1.2)|O00170|AH RECEPTOR-INTERACTING PROTEIN|4.84|Kd=14.4uM|Kd|=|14.4|uM|14400|nM
3VVY|1.63|2013|ET|ligand is Ethidium bromide; Kd=14.6+/-0.10uM|D0ZP76|PUTATIVE REGULATORY PROTEIN|4.84|Kd=14.6uM|Kd|=|14.6|uM|14600|nM
4LUV|1.40|2013|1XS|ligand is compound 2; 1XS in Site-2, 1DZ in Site-1|P27694|REPLICATION PROTEIN A 70 KDA DNA-BINDING SUBUNIT|2.85|Kd=1400uM|Kd|=|1400|uM|1400000|nM
4K3H|2.45|2013|1OM||------|IMMUNOGLOBULIN LAMBDA VARIABLE DOMAIN L5(L89S)|6.85|Kd=140nM|Kd|=|140|nM|140|nM
4BT9|1.90|2013|9-mer|Kd = 143.5 +/- 10.5 uM|P13674|PROLYL 4-HYDROXYLASE SUBUNIT ALPHA-1|3.84|Kd=143.5uM|Kd|=|143.5|uM|143500|nM
4KN1|2.30|2013|04J|ligand is Aminopterin; Kd=144+/-5 nM(pH 7.4),crystal(pH 8.0)|P14207|FOLATE RECEPTOR BETA|6.84|Kd=144nM|Kd|=|144|nM|144|nM
4CGJ|2.15|2013|NZL|Kd=1460+/-89 uM|Q76353|INTEGRASE|2.84|Kd=1460uM|Kd|=|1460|uM|1460000|nM
4IEH|2.10|2013|1E9|Bcl-2/BAK complex, IC50=17nM|P10415|APOPTOSIS REGULATOR BCL-2|7.85|Kd=14nM|Kd|=|14|nM|14|nM
4IKN|1.85|2013|6-mer|Kd=14.0+/-2.8uM; incomplete ligand|P53676|AP-3 COMPLEX SUBUNIT MU-1|4.85|Kd=14uM|Kd|=|14|uM|14000|nM
4J7E|1.63|2013|I29||P56273|E3 UBIQUITIN-PROTEIN LIGASE MDM2|4.85|Kd=14uM|Kd|=|14|uM|14000|nM
4IO6|1.60|2013|MET|Kd=15.1+/-2.5uM|E9P5T5|AVGLUR1 LIGAND BINDING DOMAIN|4.82|Kd=15.1uM|Kd|=|15.1|uM|15100|nM
4C1M|2.00|2013|NIH|ligand is compound HX1, Kd=0.0158uM|P05164|MYELOPEROXIDASE LIGHT CHAIN|7.8|Kd=15.8nM|Kd|=|15.8|nM|15.8|nM
4AQ6|1.98|2013|OMD|Fe-containing; Kd=15.8+/-1.4uM|Q88E47|HOMOGENTISATE 1,2-DIOXYGENASE|4.8|Kd=15.8uM|Kd|=|15.8|uM|15800|nM
4BKS|2.20|2013|X6C|Kd=150+/-9uM|Q15370|TRANSCRIPTION ELONGATION FACTOR B POLYPEPTIDE 2|3.82|Kd=150uM|Kd|=|150|uM|150000|nM
4EAR|1.70|2013|IM5|Ki = 151 +/- 16 pM|P00491|PURINE NUCLEOSIDE PHOSPHORYLASE|9.82|Kd=151pM|Kd|=|151|pM|0.151|nM
3VX3|2.10|2013|ADP|Kd=15+/-1.8nM|Q5JIH4|ATPASE INVOLVED IN CHROMOSOME PARTITIONING, PARA/MI|7.82|Kd=15nM|Kd|=|15|nM|15|nM
3ZP9|1.31|2013|9TH|ligand is compound 9; Kd=15+/-2nM|P00918|CARBONIC ANHYDRASE 2|7.82|Kd=15nM|Kd|=|15|nM|15|nM
4J8B|1.88|2013|6-mer|Kd=16.1+/-0.6uM|Q96WV5|COATOMER ALPHA SUBUNIT|4.79|Kd=16.1uM|Kd|=|16.1|uM|16100.000000000002|nM
4AS9|2.71|2013|4QS||P02829|ATP-DEPENDENT MOLECULAR CHAPERONE HSP82|4.79|Kd=16.3uM|Kd|=|16.3|uM|16300|nM
4KNI|1.80|2013|E1E|ligand is compound 2f|P00918|CARBONIC ANHYDRASE 2|7.78|Kd=16.7nM|Kd|=|16.7|nM|16.7|nM
4KNN|1.40|2013|E1F|ligand is compound 2j|Q8N1Q1|CARBONIC ANHYDRASE 13|7.78|Kd=16.7nM|Kd|=|16.7|nM|16.7|nM
4AD6|1.85|2013|GSY|ligand is compound 21a; Kd=16.7+/-3.5uM|C8MLE4|7,8-DIHYDRO-6-HYDROXYMETHYLPTERIN-PYROPHOSPHOKINASE|4.78|Kd=16.7uM|Kd|=|16.7|uM|16700|nM
4KOX|1.80|2013|CLS|ligand is Cephalothin; Kd = 16.9 +/- 1.2 uM|Q9HV14|UNCHARACTERIZED PROTEIN|4.77|Kd=16.9uM|Kd|=|16.9|uM|16900|nM
4I9S|2.58|2013|RET|Kd=162+/-30nM, Covalent binding|P29373|CELLULAR RETINOIC ACID-BINDING PROTEIN 2|6.79|Kd=162nM|Kd|=|162|nM|162|nM
4BQT|2.88|2013|C5E|complex AcAChBP and Cytisine|Q8WSF8|ACETYLCHOLINE RECEPTOR|5.79|Kd=1640nM|Kd|=|1640|nM|1640|nM
4KLV|1.30|2013|KLV|ligand is 4-Methylumbelliferyl phosphate; Kd = 165.3 +/- 9.5 uM|Q9HV14|UNCHARACTERIZED PROTEIN|3.78|Kd=165.3uM|Kd|=|165.3|uM|165300|nM
4J8T|2.05|2013|DOG|Kd=168+/-59nM|Q9HYR3|ENGINEERED DIGOXIGENIN BINDER PROTEIN DIG10.2|6.77|Kd=168nM|Kd|=|168|nM|168|nM
4J3L|2.09|2013|AJ5|ligand is compound 17|Q9H2K2|TANKYRASE-2|7.8|Kd=16nM|Kd|=|16|nM|16|nM
4AU7|2.07|2013|SAH|Kd=17.2+/-7uM|Q6Q783|HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H2|4.76|Kd=17.2uM|Kd|=|17.2|uM|17200|nM
3VW2|2.34|2013|BER|ligand is berberine; Kd=17.9+/-0.03uM|D0ZP76|PUTATIVE REGULATORY PROTEIN|4.75|Kd=17.9uM|Kd|=|17.9|uM|17900|nM
4J86|1.48|2013|6-mer|Kd=170.9+/-10.2uM|P41811|COATOMER SUBUNIT BETA|3.77|Kd=170.9uM|Kd|=|170.9|uM|170900|nM
4JG0|1.81|2013|12-mer|incomplete ligand|------|ANTIBODY FAB LIGHT CHAIN|6.76|Kd=172nM|Kd|=|172|nM|172|nM
4KOV|1.60|2013|KOV|ligand is Cefuroxime; Kd = 176.7 +/- 6.2 uM|Q9HV14|UNCHARACTERIZED PROTEIN|3.75|Kd=176.7uM|Kd|=|176.7|uM|176700|nM
4BGX|2.48|2013|SIA-GAL|Kd = 17 +/- 3 mM (MST)|Q6DQ34|HEMAGGLUTININ|1.77|Kd=17mM|Kd|=|17|mM|17000000|nM
4KAX|1.85|2013|GTP||P62330|ADP-RIBOSYLATION FACTOR 6|4.77|Kd=17uM|Kd|=|17|uM|17000|nM
4AUJ|1.53|2013|HNW|ligand is 2OH; Kd=18.3+/-5.9nM(ITC); Kd=36.9+/-3.0nM(SPR)|A2IC68|FIMH PROTEIN|7.74|Kd=18.3nM|Kd|=|18.3|nM|18.3|nM
4AYU|1.50|2013|N8P|ligand is N-Acetyl-D-Proline|P02743|SERUM AMYLOID P-COMPONENT|4.73|Kd=18.6uM|Kd|=|18.6|uM|18600|nM
4FZ3|2.10|2013|6-mer|Kd=184.3+/-9.8 uM|Q9NTG7|NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-3|3.73|Kd=184.3uM|Kd|=|184.3|uM|184300|nM
4F9Y|1.85|2013|LM3||Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|6.74|Kd=184nM|Kd|=|184|nM|184|nM
4KBY|2.36|2013|C2E|Ka/Kd = 5.39*10^6/1.86*10^(-7)|Q3TBT3|STIMULATOR OF INTERFERON GENES PROTEIN|6.73|Kd=186nM|Kd|=|186|nM|186|nM
4J22|2.12|2013|AJ7|ligand is compound 16|Q9H2K2|TANKYRASE-2|7.74|Kd=18nM|Kd|=|18|nM|18|nM
4MM5|3.20|2013|SRE|ligand is sertraline; Kd = 18 +/- 2 nM|O67854|TRANSPORTER|7.74|Kd=18nM|Kd|=|18|nM|18|nM
4IH6|2.20|2013|1EP||P26663|RNA-DIRECTED RNA POLYMERASE|4.74|Kd=18uM|Kd|=|18|uM|18000|nM
4GVC|1.54|2013|8-mer|ligand is phosphorylated Syndecan1 Peptide|Q13009|T-LYMPHOMA INVASION AND METASTASIS-INDUCING PROTEIN 1|4.71|Kd=19.3uM|Kd|=|19.3|uM|19300|nM
4LJH|1.45|2013|GAL-MHD|ligand is compound 15; Kd=19.4+/-1.5 uM|Q05097|PA-I GALACTOPHILIC LECTIN|4.71|Kd=19.4uM|Kd|=|19.4|uM|19400|nM
4HFZ|2.69|2013|15-mer|Kd = 1900 +/- 200 nM; incomplete ligand|Q00987|E3 UBIQUITIN-PROTEIN LIGASE MDM2|5.72|Kd=1900nM|Kd|=|1900|nM|1900|nM
3VZG|2.70|2013|2-mer|ligand is O-(alpha-D-mannosyl)-L-threonine|O60844|ZYMOGEN GRANULE MEMBRANE PROTEIN 16|1.72|Kd=19mM|Kd|=|19|mM|19000000|nM
4K0O|2.15|2013|NAG-MBG||Q47200|F17B-G FIMBRIAL ADHESIN|3.0|Kd=1mM|Kd|=|1|mM|1000000|nM
4BB9|1.47|2013|F1P||Q14397|GLUCOKINASE REGULATORY PROTEIN|6.0|Kd=1uM|Kd|=|1|uM|1000|nM
4B3C|1.90|2013|5H1|ligand is compound 1|O74036|DNA REPAIR AND RECOMBINATION PROTEIN RADA|2.68|Kd=2.1mM|Kd|=|2.1|mM|2100000|nM
4B3D|1.59|2013|5MI|ligand is compound 2|O74036|DNA REPAIR AND RECOMBINATION PROTEIN RADA|2.68|Kd=2.1mM|Kd|=|2.1|mM|2100000|nM
4JN2|1.71|2013|4CC|ligand is dabigatran|------|ANTI DABIGATRAN FAB|11.68|Kd=2.1pM|Kd|=|2.1|pM|0.0021000000000000003|nM
4L4Z|2.30|2013|D5X|ligand is D5P; Kd=2.1+/-0.3 uM|P76141|TRANSCRIPTIONAL REGULATOR LSRR|5.68|Kd=2.1uM|Kd|=|2.1|uM|2100|nM
4IUU|2.70|2013|15-mer|Kd=2.22+/-0.2uM; incomplete ligand|Q9XI47|SAWADEE HOMEODOMAIN HOMOLOG 1|5.65|Kd=2.22uM|Kd|=|2.22|uM|2220|nM
4EZY|1.85|2013|7-mer|Kd = 2.26 +/- 0.01 uM; incomplete ligand|P0A6Y8|CHAPERONE PROTEIN DNAK|5.65|Kd=2.26uM|Kd|=|2.26|uM|2260|nM
4JIN|2.10|2013|1L7|Kd=2.28+/-0.03uM, other binding data: Kd=6.1+/-0.4uM, ATP 10uM; Kd=10.1+/-0.9uM, ATP 30uM|O28471|RIO-TYPE SERINE/THREONINE-PROTEIN KINASE RIO1|5.64|Kd=2.28uM|Kd|=|2.28|uM|2280|nM
3ZI8|1.50|2013|FU4|ligand is alpha-MeFuc-fucose|D8NA05|PUTATIVE FUCOSE-BINDING LECTIN PROTEIN|5.66|Kd=2.2uM|Kd|=|2.2|uM|2200|nM
4GS9|1.72|2013|0XB||Q99814|ENDOTHELIAL PAS DOMAIN-CONTAINING PROTEIN 1|5.66|Kd=2.2uM|Kd|=|2.2|uM|2200|nM
4I8X|2.23|2013|6P3|IC50>2mM|P13491|L-LACTATE DEHYDROGENASE A CHAIN|2.64|Kd=2.3mM|Kd|=|2.3|mM|2300000|nM
4DLI|1.91|2013|IRG|Kd=2.40+/-1.90uM|Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|5.62|Kd=2.40uM|Kd|=|2.4|uM|2400|nM
4LNO|2.90|2013|GLN||P12425|GLUTAMINE SYNTHETASE|2.62|Kd=2.4mM|Kd|=|2.4|mM|2400000|nM
4JX9|1.40|2013|URI|ligand is Uridine; Kd=3.11*10^(-9) M(fluorescence), 2.4*10^(-9) M(SPR)|D0C9L6|PEPTIDYL-TRNA HYDROLASE|8.62|Kd=2.4nM|Kd|=|2.4|nM|2.4|nM
4DZY|2.10|2013|WJ1|Kd=2.4+/-0.4uM; IC50=6.3 uM; Mg-containing; K-containing|Q00972|3-METHYL-2-OXOBUTANOATE DEHYDROGENASE|5.62|Kd=2.4uM|Kd|=|2.4|uM|2400|nM
4JIZ|2.10|2013|8-mer||Q9H8S9|MOB KINASE ACTIVATOR 1A|5.62|Kd=2.4uM|Kd|=|2.4|uM|2400|nM
4BQH|1.75|2013|9VU|Kd=2.58+/-0.07uM|Q386Q8|UDP-N-ACETYLGLUCOSAMINE PYROPHOSPHORYLASE|5.59|Kd=2.58uM|Kd|=|2.58|uM|2580|nM
4IUR|2.50|2013|15-mer|Kd=2.63+/-0.2uM; incomplete ligand|Q9XI47|SAWADEE HOMEODOMAIN HOMOLOG 1|5.58|Kd=2.63uM|Kd|=|2.63|uM|2630|nM
4KMZ|2.30|2013|FOL|ligand is Folic acid; Kd=2.7+/-1.5 nM(pH 7.4), 23+/-5 nM(pH 6.5),crystal(pH 8.0)|P14207|FOLATE RECEPTOR BETA|8.57|Kd=2.7nM|Kd|=|2.7|nM|2.7|nM
4FMO|3.04|2013|8-mer|Kd = 2.94 +/- 0.03 uM; incomplete ligand|P38920|DNA MISMATCH REPAIR PROTEIN MLH1|5.53|Kd=2.94uM|Kd|=|2.94|uM|2940|nM
4HJ2|2.10|2013|LZ6|Kd=2.95+/-0.5mM, Kd=6.05+/-0.8mM (for fast and slow reactions, respectively)|P08263|GLUTATHIONE S-TRANSFERASE A1|2.53|Kd=2.95mM|Kd|=|2.95|mM|2950000|nM
4BA3|2.10|2013|12-mer|ligand is A89NLS; Kd=2.9+/-0.36uM; incomplete ligand|P52293|IMPORTIN SUBUNIT ALPHA-2|5.54|Kd=2.9uM|Kd|=|2.9|uM|2900|nM
4NXU|2.30|2013|ADP|Kd=2.9+/-0.8uM|Q9NQG6|MITOCHONDRIAL DYNAMIC PROTEIN MID51|5.54|Kd=2.9uM|Kd|=|2.9|uM|2900|nM
4J84|1.47|2013|5-mer|Kd=20.4+/-0.7uM|P41811|COATOMER SUBUNIT BETA|4.69|Kd=20.4uM|Kd|=|20.4|uM|20400|nM
4LAR|2.38|2013|1WE||------|SINGLE HEAVY CHAIN VARIABLE FRAGMENT|4.68|Kd=20.7uM|Kd|=|20.7|uM|20700|nM
4J8R|2.30|2013|16-mer|incomplete ligand|P04925|LIGHT CHAIN OF POM2 FAB|7.7|Kd=20nM|Kd|=|20|nM|20|nM
4J7D|1.25|2013|I31||P56273|E3 UBIQUITIN-PROTEIN LIGASE MDM2|4.7|Kd=20uM|Kd|=|20|uM|20000|nM
4J93|1.74|2013|1JR||Q79791|GAG PROTEIN|4.7|Kd=20uM|Kd|=|20|uM|20000|nM
4LUZ|1.90|2013|1XT|ligand is compound 7|P27694|REPLICATION PROTEIN A 70 KDA DNA-BINDING SUBUNIT|4.7|Kd=20uM|Kd|=|20|uM|20000|nM
4DEL|1.58|2013|PGH|Zn-containing; Kd=21.1+/-0.2 nM|P67475|FRUCTOSE-BISPHOSPHATE ALDOLASE|7.68|Kd=21.1nM|Kd|=|21.1|nM|21.1|nM
3VW1|2.21|2013|CVI|ligand is violet; Kd=21.2+/-0.52uM|D0ZP76|PUTATIVE REGULATORY PROTEIN|4.67|Kd=21.2uM|Kd|=|21.2|uM|21200|nM
3VW0|2.60|2013|DEQ|ligand is dequalinium; Kd=21.2+/-0.42uM|D0ZP76|PUTATIVE REGULATORY PROTEIN|4.67|Kd=21.2uM|Kd|=|21.2|uM|21200|nM
4NKU|1.94|2013|2-mer|Kd=21.3+/-3.2 uM; ligand is A-U|O13833|POLY(A) RNA POLYMERASE PROTEIN CID1|4.67|Kd=21.3uM|Kd|=|21.3|uM|21300|nM
4IO7|1.92|2013|PHE|Kd=211+/-45uM|E9P5T5|AVGLUR1 LIGAND BINDING DOMAIN|3.68|Kd=211uM|Kd|=|211|uM|211000|nM
4JV6|1.87|2013|18F||O43924|RETINAL ROD RHODOPSIN-SENSITIVE CGMP 3',5'-CYCLIC|6.66|Kd=217nM|Kd|=|217|nM|217|nM
2YPO|2.00|2013|PHE|Kd=21+/-1uM|O53512|PHOSPHO-2-DEHYDRO-3-DEOXYHEPTONATE ALDOLASE AROG|4.68|Kd=21uM|Kd|=|21|uM|21000|nM
4L58|1.48|2013|12-mer|ligand is H3K4me3; Kd = 21 +/- 9 uM; incomplete ligand|Q8IZD2|HISTONE-LYSINE N-METHYLTRANSFERASE MLL5|4.68|Kd=21uM|Kd|=|21|uM|21000|nM
4J78|1.48|2013|5-mer|Kd=22.5+/-1.3uM|P41811|COATOMER SUBUNIT BETA|4.65|Kd=22.5uM|Kd|=|22.5|uM|22500|nM
4I1R|2.70|2013|LZU|Kd=22.6+/-0.5uM|Q9UDY8|MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOC|4.65|Kd=22.6uM|Kd|=|22.6|uM|22600|nM
4IZM|4.50|2013|ASP||O59010|425AA LONG HYPOTHETICAL PROTON GLUTAMATE SYMPORT|6.66|Kd=220nM|Kd|=|220|nM|220|nM
3VWS|2.10|2013|VWS|ligand is NITD107|Q6DLV0|NON-STRUCTURAL PROTEIN 5|3.65|Kd=225uM|Kd|=|225|uM|225000|nM
4IO8|2.58|2013|3FD|Kd=228+/-16nM|Q59EJ3|HEAT SHOCK 70 KDA PROTEIN 1A|6.64|Kd=228nM|Kd|=|228|nM|228|nM
4AW8|2.00|2013|ZN|Zn2+ containing; Kd=22+/-2nM|B5MZR0|METAL-BINDING PROTEIN YODA|7.66|Kd=22nM|Kd|=|22|nM|22|nM
4G8O|2.71|2013|96P|Kd = 22 +/- 6 nM|P05121|PLASMINOGEN ACTIVATOR INHIBITOR 1|7.66|Kd=22nM|Kd|=|22|nM|22|nM
4G8R|2.19|2013|96P|Kd = 22 +/- 6 nM|P05121|PLASMINOGEN ACTIVATOR INHIBITOR 1|7.66|Kd=22nM|Kd|=|22|nM|22|nM
4HSO|2.10|2013|TYR|Kd = 22 +/- 2 uM|Q9K169|3-DEOXY-D-ARABINO-HEPTULOSONATE 7-PHOSPHATE SYNTHAS|4.66|Kd=22uM|Kd|=|22|uM|22000|nM
4JG1|1.55|2013|12-mer|incomplete ligand|------|ANTIBODY FAB LIGHT CHAIN|6.63|Kd=232nM|Kd|=|232|nM|232|nM
4M1D|1.80|2013|14-mer|Kd = 0.023 +/- 0.001 uM|A2NUT2|ANTIBODY FAB MAB 447-52D LIGHT CHAIN|7.64|Kd=23nM|Kd|=|23|nM|23|nM
4IO4|1.94|2013|SER|Kd=24.5+/-1.9uM|E9P5T5|AVGLUR1 LIGAND BINDING DOMAIN|4.61|Kd=24.5uM|Kd|=|24.5|uM|24500|nM
4BKT|2.35|2013|QD0|Kd=240+/-17uM|Q15370|TRANSCRIPTION ELONGATION FACTOR B POLYPEPTIDE 2|3.62|Kd=240uM|Kd|=|240|uM|240000|nM
4C6V|2.70|2013|TLG|Kd = 25.6 +/- 0.5 uM|I6Y8T4|3-OXOACYL-[ACYL-CARRIER-PROTEIN] SYNTHASE 1|4.59|Kd=25.6uM|Kd|=|25.6|uM|25600|nM
4C6U|2.40|2013|TLG|Kd=25.6+/-0.5uM|I6Y8T4|3-OXOACYL-[ACYL-CARRIER-PROTEIN] SYNTHASE 1|4.59|Kd=25.6uM|Kd|=|25.6|uM|25600|nM
4B3B|1.19|2013|6-mer|ligand is FHTA peptide; Kd=250+/-50uM|O74036|DNA REPAIR AND RECOMBINATION PROTEIN RADA|3.6|Kd=250uM|Kd|=|250|uM|250000|nM
4MR5|1.63|2013|1K0|ligand in PDB is RVX-208, Kd=251+/-17 nM(Ligand in PDB is wrong)|P25440|BROMODOMAIN-CONTAINING PROTEIN 2|6.6|Kd=251nM|Kd|=|251|nM|251|nM
4MR6|1.67|2013|1K0|ligand is RVX-208; Kd=251+/-17 nM|P25440|BROMODOMAIN-CONTAINING PROTEIN 2|6.6|Kd=251nM|Kd|=|251|nM|251|nM
4K3R|1.86|2013|6-mer|ligand is AcQLDLA|P0A988|DNA POLYMERASE III SUBUNIT BETA|3.59|Kd=259.1uM|Kd|=|259.1|uM|259100.00000000003|nM
4JAL|2.00|2013|SAH||P0AGJ7|TRNA (CYTIDINE(34)-2'-O)-METHYLTRANSFERASE|4.6|Kd=25uM|Kd|=|25|uM|25000|nM
3VVZ|2.51|2013|RHQ|ligand is rhodamine 6G;Kd=26.4+/-0.08uM|D0ZP76|PUTATIVE REGULATORY PROTEIN|4.58|Kd=26.4uM|Kd|=|26.4|uM|26400|nM
4BI7|1.60|2013|PGA|Kd=26.4+/-2.6uM, Ki=87+/-15uM|P36186|TRIOSEPHOSPHATE ISOMERASE|4.58|Kd=26.4uM|Kd|=|26.4|uM|26400|nM
3WB5|2.50|2013|0B4|ligand is compound 6|P56817|BETA-SECRETASE 1|4.57|Kd=26.8uM|Kd|=|26.8|uM|26800|nM
4GVD|1.85|2013|8-mer|ligand is Syndecan1 Peptide|Q13009|T-LYMPHOMA INVASION AND METASTASIS-INDUCING PROTEIN 1|4.57|Kd=26.9uM|Kd|=|26.9|uM|26900|nM
4J74|1.20|2013|I18||P56273|E3 UBIQUITIN-PROTEIN LIGASE MDM2|4.59|Kd=26uM|Kd|=|26|uM|26000|nM
4J73|1.44|2013|7-mer|Kd=27.7+/-2.5uM; incomplete ligand|P41811|COATOMER SUBUNIT BETA|4.56|Kd=27.7uM|Kd|=|27.7|uM|27700|nM
4JJM|2.09|2013|11-mer|ligand is cyclosporin A peptide|D0ELH5|PEPTIDYL-PROLYL CIS-TRANS ISOMERASE|7.57|Kd=27nM|Kd|=|27|nM|27|nM
4IGK|1.75|2013|7-mer|Kd=28.2+/-2uM|P38398|BREAST CANCER TYPE 1 SUSCEPTIBILITY PROTEIN|4.55|Kd=28.2uM|Kd|=|28.2|uM|28200|nM
4K3M|1.85|2013|5-mer|ligand is AcALDLF; incomplete ligand|P0A988|DNA POLYMERASE III SUBUNIT BETA|3.55|Kd=281.2uM|Kd|=|281.2|uM|281200|nM
4HT2|1.45|2013|V50|Zn-containing|O43570|CARBONIC ANHYDRASE 12|6.54|Kd=290nM|Kd|=|290|nM|290|nM
4GNG|1.73|2013|15-mer|Kd = 290 +/- 8 uM; Zn-containing; incomplete ligand structure|Q9BZ95|HISTONE-LYSINE N-METHYLTRANSFERASE NSD3|3.54|Kd=290uM|Kd|=|290|uM|290000|nM
4MMF|2.70|2013|29Q|ligand is mazindol; Kd = 295 +/- 7 nM|O67854|TRANSPORTER|6.53|Kd=295nM|Kd|=|295|nM|295|nM
4HU1|1.95|2013|V13|Zn-containing|Q8N1Q1|CARBONIC ANHYDRASE 13|7.54|Kd=29nM|Kd|=|29|nM|29|nM
4HNN|2.40|2013|LYS|Kd=2+/-0.3 uM (the first lysine), Kd=0.38+/-0.14 mM (the second lysine)|D7U7T8|DIHYDRODIPICOLINATE SYNTHASE|5.7|Kd=2uM|Kd|=|2|uM|2000|nM
4K55|1.91|2013|H6P||O00481|BUTYROPHILIN SUBFAMILY 3 MEMBER A1|5.51|Kd=3.06uM|Kd|=|3.06|uM|3060|nM
4NK9|2.57|2013|2K5|ligand is compound 1|P11362|FIBROBLAST GROWTH FACTOR RECEPTOR 1|8.51|Kd=3.1nM|Kd|=|3.1|nM|3.1|nM
4I9C|3.10|2013|5-mer|SDS-PAGE|P71002|RESPONSE REGULATOR ASPARTATE PHOSPHATASE F|5.51|Kd=3.1uM|Kd|=|3.1|uM|3100|nM
4F6S|2.60|2013|0SQ|compound 7|P49336|CYCLIN-DEPENDENT KINASE 8|5.49|Kd=3.24uM|Kd|=|3.24|uM|3240|nM
4EFK|1.70|2013|0OC|Kd=3.2+/-0.2 mM|P0A5R0|PANTOTHENATE SYNTHETASE|2.49|Kd=3.2mM|Kd|=|3.2|mM|3200000|nM
4IFI|2.20|2013|6-mer|Kd=3.34+/-0.2uM|P38398|BREAST CANCER TYPE 1 SUSCEPTIBILITY PROTEIN|5.48|Kd=3.34uM|Kd|=|3.34|uM|3340|nM
3ZDV|1.41|2013|F1A-MMA|ligand is compound 5e|Q9HYN5|FUCOSE-BINDING LECTIN PA-IIL|5.48|Kd=3.3uM|Kd|=|3.3|uM|3300|nM
4JFM|1.02|2013|1KZ|Kd=3.3+/-0.5uM|Q13451|PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5|5.48|Kd=3.3uM|Kd|=|3.3|uM|3300|nM
4GNE|1.47|2013|7-mer|Zn-containing; Kd = 3.4 +/- 0.12 mM; incomplete ligand structure|Q9BZ95|HISTONE-LYSINE N-METHYLTRANSFERASE NSD3|2.47|Kd=3.4mM|Kd|=|3.4|mM|3400000|nM
3ZLN|2.29|2013|H0Y|ligand is compound 3|Q07817|BCL-2-LIKE PROTEIN 1|8.47|Kd=3.4nM|Kd|=|3.4|nM|3.4|nM
4J77|1.76|2013|6-mer|Kd=3.4+/-0.3uM; incomplete ligand|P41811|WBP1|5.47|Kd=3.4uM|Kd|=|3.4|uM|3400|nM
4N7J|1.67|2013|2GQ|The ligand structure in PDB is wrong.|P55212|CASPASE-6|5.47|Kd=3.4uM|Kd|=|3.4|uM|3400|nM
4N7M|2.12|2013|2GQ|ligand is compound 5|P55212|CASPASE-6|5.47|Kd=3.4uM|Kd|=|3.4|uM|3400|nM
4DDM|1.83|2013|0HO|Kd=3.5+/-0.04 mM|P0A5R0|PANTOTHENATE SYNTHETASE|2.46|Kd=3.5mM|Kd|=|3.5|mM|3500000|nM
4GW5|2.20|2013|12-mer|Kd = 3.5 +/- 0.1 uM|P01834|CETUXIMAB FAB, LIGHT CHAIN|5.46|Kd=3.5uM|Kd|=|3.5|uM|3500|nM
4KOT|1.55|2013|CE3|ligand is Cefotaxime; Kd = 3.5 +/- 0.2 uM|Q9HV14|UNCHARACTERIZED PROTEIN|5.46|Kd=3.5uM|Kd|=|3.5|uM|3500|nM
4KSY|1.88|2013|1SY||Q86WV6|STIMULATOR OF INTERFERON GENES PROTEIN|8.42|Kd=3.79nM|Kd|=|3.79|nM|3.79|nM
4B60|1.83|2013|17-mer|ligand is FIBRINOGEN GAMMA CHAIN;Kd=3.7+/-0.1uM; incomplete ligand|P14738|FIBRONECTIN-BINDING PROTEIN A|5.43|Kd=3.7uM|Kd|=|3.7|uM|3700|nM
4KMD|1.70|2013|17-mer|Kd = 3.86 +/- 0.62 uM; incomplete ligand|Q9UMX1|SUFU|5.41|Kd=3.86uM|Kd|=|3.86|uM|3860|nM
4NXV|2.30|2013|GDP|Kd=3.8+/-0.9uM|Q9NQG6|MITOCHONDRIAL DYNAMIC PROTEIN MID51|5.42|Kd=3.8uM|Kd|=|3.8|uM|3800|nM
4FGT|2.00|2013|4-mer|ligand is 4-mer CG peptide, ITC Ka=2.55 x 10 E5 M-1|P04818|THYMIDYLATE SYNTHASE|5.41|Kd=3.92uM|Kd|=|3.92|uM|3920|nM
4IGQ|2.35|2013|3-mer||Q53WJ1|OS05G0196500 PROTEIN|4.52|Kd=30.1uM|Kd|=|30.1|uM|30100|nM
4G93|4.20|2013|0YP||P03147|CAPSID PROTEIN|3.52|Kd=300uM|Kd|=|300|uM|300000|nM
4HS6|1.53|2013|16-mer|incomplete ligand|Q9YK84|MRCT10.V362 FAB LIGHT CHAIN|7.52|Kd=30nM|Kd|=|30|nM|30|nM
4J81|1.75|2013|5-mer|Kd=31.9+/-2.6uM|P41811|COATOMER SUBUNIT BETA|4.5|Kd=31.9uM|Kd|=|31.9|uM|31900|nM
4NKA|2.19|2013|2K7|ligand is compound 2|P11362|FIBROBLAST GROWTH FACTOR RECEPTOR 1|6.51|Kd=311.4nM|Kd|=|311.4|nM|311.4|nM
4I7P|1.60|2013|ES3||P00720|LYSOZYME|3.5|Kd=317uM|Kd|=|317|uM|317000|nM
4MME|2.50|2013|29Q|ligand is mazindol; Kd=318+/-10nM|O67854|TRANSPORTER|6.5|Kd=318nM|Kd|=|318|nM|318|nM
4JFE|2.70|2013|10-mer||P01892|HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA CHAIN|4.51|Kd=31uM|Kd|=|31|uM|31000|nM
4AVS|1.40|2013|N7P|ligand is N-acetyl-L-proline|P02743|SERUM AMYLOID P-COMPONENT|3.49|Kd=322uM|Kd|=|322|uM|322000|nM
4EOY|2.22|2013|8-mer|Mg-containing|Q8IJK2|MICROTUBULE-ASSOCIATED PROTEIN 1 LIGHT CHAIN 3|6.49|Kd=326nM|Kd|=|326|nM|326|nM
4BH4|1.90|2013|3-mer|Kd = 32 +/- 8 mM (MST)|Q5EP31|HEMAGGLUTININ|1.49|Kd=32mM|Kd|=|32|mM|32000000|nM
4L6T|1.86|2013|5-mer|ligand is GM1;Kd=32+/-2 nM|Q8GAV4|ECXA|7.49|Kd=32nM|Kd|=|32|nM|32|nM
4KP8|1.80|2013|E1G|ligand is compound 3j|O43570|CARBONIC ANHYDRASE 12|5.48|Kd=3330nM|Kd|=|3330|nM|3330|nM
4AZI|1.98|2013|OAN|ligand is PUGNAc; Kd=35.56+/-2.27nM|P49610|BETA-N-ACETYLHEXOSAMINIDASE|7.45|Kd=35.56nM|Kd|=|35.56|nM|35.56|nM
2LYB|NMR|2013|8SP|ligand is di-C8-PS;Kd=35+/-1uM|P12497|MATRIX PROTEIN P17|4.46|Kd=35uM|Kd|=|35|uM|35000|nM
3WB4|2.25|2013|0B3|ligand is (R)-3|P56817|BETA-SECRETASE 1|4.44|Kd=36.6uM|Kd|=|36.6|uM|36600|nM
4K3O|2.00|2013|6-mer|ligand is AcQADLF|P0A988|DNA POLYMERASE III SUBUNIT BETA|4.44|Kd=36.7uM|Kd|=|36.7|uM|36700|nM
4JFX|1.95|2013|12-mer|incomplete ligand|------|ANTIBODY FAB LIGHT CHAIN|6.44|Kd=360nM|Kd|=|360|nM|360|nM
2M0U|NMR|2013|5-mer|ligand is C-terminal CFTR peptide;Kd=365+/-35nM|O14745|NA(+)/H(+) EXCHANGE REGULATORY COFACTOR NHE-RF1|6.44|Kd=365nM|Kd|=|365|nM|365|nM
4JFD|2.46|2013|10-mer||P01892|HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA CHAIN|4.44|Kd=36uM|Kd|=|36|uM|36000|nM
4GE1|2.15|2013|TSS||Q86PT9|BIOGENIC AMINE-BINDING PROTEIN|6.43|Kd=370nM|Kd|=|370|nM|370|nM
4K67|2.70|2013|3-mer|incomplete ligand structure|A8HWY8|HEMAGGLUTININ|3.43|Kd=372uM|Kd|=|372|uM|372000|nM
4JPY|2.13|2013|PHE|Fe3+ and Phe-bound cPAH; Kd=37+/-0.3uM|P30967|PHENYLALANINE-4-HYDROXYLASE|4.43|Kd=37uM|Kd|=|37|uM|37000|nM
4KCX|2.00|2013|1QK||Q58F21|BROMODOMAIN TESTIS-SPECIFIC PROTEIN|4.43|Kd=37uM|Kd|=|37|uM|37000|nM
4MNQ|2.74|2013|9-mer|Kd = 37 +/-5 uM|P01892|HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA CHAIN|4.43|Kd=37uM|Kd|=|37|uM|37000|nM
3ZM9|1.90|2013|QMQ|ligand is compound 1; Kd1=38nM for the first monomer; Kd2=190nM for the second monomer|P35790|CHOLINE KINASE ALPHA|7.42|Kd=38nM|Kd|=|38|nM|38|nM
4J21|1.93|2013|AJ6|ligand is compound 14|Q9H2K2|TANKYRASE-2|7.41|Kd=39nM|Kd|=|39|nM|39|nM
4JVB|1.75|2013|1M0|Kd=39+/-11nM|O43924|RETINAL ROD RHODOPSIN-SENSITIVE CGMP 3',5'-CYCLIC|7.41|Kd=39nM|Kd|=|39|nM|39|nM
2YPP|2.30|2013|TYR|Kd=39+/-1uM|O53512|PHOSPHO-2-DEHYDRO-3-DEOXYHEPTONATE ALDOLASE AROG|4.41|Kd=39uM|Kd|=|39|uM|39000|nM
4B8O|2.08|2013|11-mer|ligand is SV40TAGNLS;Kd=4.0+/-0.2nM|Q71VM4|IMPORTIN SUBUNIT ALPHA-1A|8.4|Kd=4.0nM|Kd|=|4|nM|4|nM
4BTM|2.54|2013|F8E|Kd = 30 uM(Phosphorylated TTBK1), Kd = 4.1 uM(Nonphosphorylated TTBK1)|Q5TCY1|TAU-TUBULIN KINASE 1|5.39|Kd=4.1uM|Kd|=|4.1|uM|4100|nM
4EJ8|2.35|2013|1F1|Kd=4.1+/-1.4uM|P12499|HIV-1 PROTEASE|5.39|Kd=4.1uM|Kd|=|4.1|uM|4100|nM
2M0O|NMR|2013|11-mer|ligand is H3K36me3 peptide;Kd=4.2+/-0.3uM|O43189|PHD FINGER PROTEIN 1|5.38|Kd=4.2uM|Kd|=|4.2|uM|4200|nM
4KOD|2.96|2013|ADP|Kd = 4.37 +/- 0.96 uM|P55072|TRANSITIONAL ENDOPLASMIC RETICULUM ATPASE|5.36|Kd=4.37uM|Kd|=|4.37|uM|4370|nM
4JCK|1.15|2013|1LL||P17931|GALECTIN-3|2.37|Kd=4.3mM|Kd|=|4.3|mM|4300000|nM
4LKF|1.64|2013|4-mer|ligand is peptide WKYL; Kd = 4.3 +/- 1.1 uM|Q05097|PA-I GALACTOPHILIC LECTIN|5.37|Kd=4.3uM|Kd|=|4.3|uM|4300|nM
4LKE|1.65|2013|4-mer|ligand is peptide WRIA; Kd = 4.3 +/- 0.2 uM; incomplete ligand|Q05097|PA-I GALACTOPHILIC LECTIN|5.37|Kd=4.3uM|Kd|=|4.3|uM|4300|nM
4BLB|2.80|2013|17-mer|Kd = 4.47 +/- 0.417 uM; incomplete ligand|P0AEX9|MALTOSE-BINDING PERIPLASMIC PROTEIN|5.35|Kd=4.47uM|Kd|=|4.47|uM|4470|nM
4K19|2.74|2013|1OD|ligand is &#64258;uvibactin; Fe3+ containing; Fe-Kd = 4.4(8) nM|P80188|NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN|8.36|Kd=4.4nM|Kd|=|4.4|nM|4.4|nM
4B9H|2.10|2013|4-mer|ligand is chitin tetramer (GlcNAc)4;Kd for Ecp6 binds chitin with 1:1 stoichiometry|B3VBK9|EXTRACELLULAR PROTEIN 6|5.35|Kd=4.5uM|Kd|=|4.5|uM|4500|nM
4LKD|2.31|2013|4-mer|ligand is peptide QRSA; Kd = 4.5 +/- 0.5 uM; incomplete ligand|Q05097|PA-I GALACTOPHILIC LECTIN|5.35|Kd=4.5uM|Kd|=|4.5|uM|4500|nM
4JWK|1.87|2013|CTN|ligand is Cytidine; Kd= 4.79*10^(-9) M(fluorescence), 5.3*10^(-9) M(SPR)|D0C9L6|PEPTIDYL-TRNA HYDROLASE|8.32|Kd=4.79nM|Kd|=|4.79|nM|4.79|nM
4IPI|1.75|2013|LMR|Kd=4.8+/-0.1uM, Mn-containing|Q7DDU0|POLYSIALIC ACID CAPSULE BIOSYNTHESIS PROTEIN SIAC|5.32|Kd=4.8uM|Kd|=|4.8|uM|4800|nM
4IPN|2.41|2013|1FT|Kd=408.7+/-9.3uM|Q97S37|6-PHOSPHO-BETA-GLUCOSIDASE|3.39|Kd=408.7uM|Kd|=|408.7|uM|408700|nM
4KN0|2.10|2013|MTX|ligand is Methotrexate; Kd=40+/-7 nM(pH 7.4), 332+/-64 nM(pH 6.5),crystal(pH 8.0)|P14207|FOLATE RECEPTOR BETA|7.4|Kd=40nM|Kd|=|40|nM|40|nM
4HFP|2.40|2013|15U|Kd=42+/-2nM|P00734|PROTHROMBIN|7.38|Kd=42nM|Kd|=|42|nM|42|nM
4GW1|2.24|2013|12-mer|Kd = 430 +/- 30 nM|P01834|CETUXIMAB FAB, LIGHT CHAIN|6.37|Kd=430nM|Kd|=|430|nM|430|nM
4MM4|2.89|2013|8PR|ligand is paroxetine;Kd = 431 +/- 24 nM|O67854|TRANSPORTER|6.37|Kd=431nM|Kd|=|431|nM|431|nM
4GU9|2.40|2013|4GU||Q05397|FOCAL ADHESION KINASE 1|4.37|Kd=43uM|Kd|=|43|uM|43000|nM
4J82|1.46|2013|5-mer|Kd=44.2+/-1.6uM|P41811|COATOMER SUBUNIT BETA|4.35|Kd=44.2uM|Kd|=|44.2|uM|44200|nM
4GU6|1.95|2013|10N||Q05397|FOCAL ADHESION KINASE 1|7.36|Kd=44nM|Kd|=|44|nM|44|nM
4NBN|1.75|2013|2J7|ligand is compound 14|P55212|CASPASE-6|4.36|Kd=44uM|Kd|=|44|uM|44000|nM
4GNF|1.55|2013|15-mer|Kd = 450 +/- 20 uM; Zn-containing; incomplete ligand structure|Q9BZ95|HISTONE-LYSINE N-METHYLTRANSFERASE NSD3|3.35|Kd=450uM|Kd|=|450|uM|450000|nM
4CC2|1.55|2013|12-mer||Q6XZF7|DYNAMIN-BINDING PROTEIN|4.33|Kd=46.5uM|Kd|=|46.5|uM|46500|nM
4AYQ|1.10|2013|MVL|ligand is compound 2|B0SWV2|MANNOSYL-OLIGOSACCHARIDE 1,2-ALPHA-MANNOSIDASE|7.33|Kd=47nM|Kd|=|47|nM|47|nM
4IJH|1.50|2013|1EJ||P27694|REPLICATION PROTEIN A 70 KDA DNA-BINDING SUBUNIT|4.33|Kd=47uM|Kd|=|47|uM|47000|nM
4I7J|1.67|2013|BNZ||P00720|LYSOZYME|3.32|Kd=480uM|Kd|=|480|uM|480000|nM
4KOW|1.45|2013|CFX|ligand is Cefoxitin; Kd=49.3+/-2.9 uM|Q9HV14|UNCHARACTERIZED PROTEIN|4.31|Kd=49.3uM|Kd|=|49.3|uM|49300|nM
4BEA|2.57|2013|13-mer|ligand is STAPLED EIF4E INTERACTING PEPTIDE;Kd=5.+/-0.7nM|P06730|EUKARYOTIC TRANSLATION INITIATION FACTOR 4E|8.3|Kd=5.0nM|Kd|=|5|nM|5|nM
4DX9|2.99|2013|15-mer|Kd = 5.0 +/- 0.15 uM; incomplete ligand|O14713|INTEGRIN BETA-1-BINDING PROTEIN 1|5.3|Kd=5.0uM|Kd|=|5|uM|5000|nM
4BJ8|2.40|2013|BTN|Kd=5.13+/-2.36nM|E7F650|ZEBAVIDIN|8.29|Kd=5.13nM|Kd|=|5.13|nM|5.13|nM
4DDK|1.75|2013|0HN|Kd=5.1+/-0.2 mM|P0A5R0|PANTOTHENATE SYNTHETASE|2.29|Kd=5.1mM|Kd|=|5.1|mM|5100000|nM
4E70|1.61|2013|N7I||A6XNE6|CONIFERYL ALCOHOL 9-O-METHYLTRANSFERASE|5.28|Kd=5.26uM|Kd|=|5.26|uM|5260|nM
4GXL|2.02|2013|14-mer|Kd(NDP52 371-381), X-ray(NDP52 368-381); incomplete ligand|O00214|GALECTIN-8|5.28|Kd=5.2uM|Kd|=|5.2|uM|5200|nM
4LP6|2.15|2013|Q4I|ligand is compound 5|P00918|CARBONIC ANHYDRASE 2|8.27|Kd=5.36nM|Kd|=|5.36|nM|5.36|nM
2LSV|NMR|2013|9-mer|ligand is ATP-dependent molecular chaperone HSP82;Kd=5.41+/-0.33uM|P25638|TPR REPEAT-CONTAINING PROTEIN ASSOCIATED WITH HSP90|5.27|Kd=5.41uM|Kd|=|5.41|uM|5410|nM
4L1U|2.42|2013|13-mer|ligand is peptide from Transcription elongation factor SPT5; Kd = 5.45 +/- 0.38 uM; incomplete ligand|Q92541|RNA POLYMERASE-ASSOCIATED PROTEIN RTF1 HOMOLOG|5.26|Kd=5.45uM|Kd|=|5.45|uM|5450|nM
4J2C|1.80|2013|17-mer|Kd=5.6+/-0.7uM; incomplete ligand|O43752|SYNTAXIN-6|5.25|Kd=5.6uM|Kd|=|5.6|uM|5600|nM
4IDN|2.25|2013|GNP|Kd=5.77+/-0.479uM; Mg-containing|Q8WXF7|ATLASTIN-1|5.24|Kd=5.77uM|Kd|=|5.77|uM|5770|nM
4F7J|2.60|2013|0SU|compound 3|P49336|CYCLIN-DEPENDENT KINASE 8|5.24|Kd=5.82uM|Kd|=|5.82|uM|5820|nM
4KFQ|2.20|2013|KFQ|ligand is TK40|P35439|GLUTAMATE RECEPTOR IONOTROPIC, NMDA 1|8.23|Kd=5.86nM|Kd|=|5.86|nM|5.86|nM
4HMQ|2.10|2013|FCE|Kd = 5.8 +/- 1.4 nM|Q97R09|IRON-COMPOUND ABC TRANSPORTER, IRON COMPOUND-BINDIN|8.24|Kd=5.8nM|Kd|=|5.8|nM|5.8|nM
4GUE|1.80|2013|QCT||P18654|RIBOSOMAL PROTEIN S6 KINASE ALPHA-3|5.24|Kd=5.8uM|Kd|=|5.8|uM|5800|nM
4IH7|2.30|2013|1ER||P26663|RNA-DIRECTED RNA POLYMERASE|5.24|Kd=5.8uM|Kd|=|5.8|uM|5800|nM
4JC1|1.50|2013|TDG||P17931|GALECTIN-3|4.3|Kd=50uM|Kd|=|50|uM|50000|nM
4KN2|2.60|2013|LYA|ligand is Pemetrexed; Kd = 54 +/- 17 nM(pH 7.4), 323 nM(pH 6.5),crystal(pH 8.2)|P14207|FOLATE RECEPTOR BETA|7.27|Kd=54nM|Kd|=|54|nM|54|nM
4K66|3.00|2013|4-mer|incomplete ligand structure|A8HWY8|HEMAGGLUTININ|3.26|Kd=554uM|Kd|=|554|uM|554000|nM
4IB5|2.20|2013|13-mer|Kd=559.67+/-256.70nM|P68400|CASEIN KINASE II, ALPHA SUBUNIT|6.25|Kd=559.67nM|Kd|=|559.67|nM|559.67|nM
4K0U|2.15|2013|15-mer|Kd=55+/-20nM|Q01567|LIPOPROTEIN|7.26|Kd=55nM|Kd|=|55|nM|55|nM
4AZB|2.10|2013|OAN|ligand is PUGNAc; Kd=57.69+/-10.84nM|P49610|BETA-N-ACETYLHEXOSAMINIDASE|7.24|Kd=57.69nM|Kd|=|57.69|nM|57.69|nM
4LUO|1.54|2013|1DZ|ligand is compound 4;Kd of Same ligand in two site: 580 uM(Site-1),>2000 uM(Site-2)|P27694|REPLICATION PROTEIN A 70 KDA DNA-BINDING SUBUNIT|3.24|Kd=580uM|Kd|=|580|uM|580000|nM
4HIQ|1.18|2013|16V|Kd1=6.2+/-2.0 nM, Kd2=139+/-80 nM (for the first and the second binding sites of V122I-TTR)|P02766|TRANSTHYRETIN|8.21|Kd=6.2nM|Kd|=|6.2|nM|6.2|nM
4JR0|1.80|2013|6-mer|Kd=6.3+/-0.6nM; incomplete ligand|P42574|PROCASPASE-3|8.2|Kd=6.3nM|Kd|=|6.3|nM|6.3|nM
4EZR|1.90|2013|8-mer|Kd=6.3+/-0.3 uM|P0A6Y8|CHAPERONE PROTEIN DNAK|5.2|Kd=6.3uM|Kd|=|6.3|uM|6300|nM
4EZQ|2.00|2013|9-mer|Kd = 6.3 +/- 0.3 uM; incomplete ligand|P0A6Y8|CHAPERONE PROTEIN DNAK|5.2|Kd=6.3uM|Kd|=|6.3|uM|6300|nM
4LK6|2.86|2013|GAL-LRD|ligand is compound 17; Kd = 6.3 +/- 0.2 uM|Q05097|PA-I GALACTOPHILIC LECTIN|5.2|Kd=6.3uM|Kd|=|6.3|uM|6300|nM
4JDF|1.69|2013|SPD|Kd=6.4+/-1.2mM|P31133|PUTRESCINE-BINDING PROTEIN|2.19|Kd=6.4mM|Kd|=|6.4|mM|6400000|nM
3VFQ|2.80|2013|AR6|First,Kd1=6.4+/-0.2uM;Second, Kd2=261+/-30uM|Q460N5|POLY [ADP-RIBOSE] POLYMERASE 14|5.19|Kd=6.4uM|Kd|=|6.4|uM|6400|nM
4EZZ|2.05|2013|7-mer|Kd=6.4+/-0.6 uM|P0A6Y8|CHAPERONE PROTEIN DNAK|5.19|Kd=6.4uM|Kd|=|6.4|uM|6400|nM
4K5Y|2.98|2013|1Q5|Kd = 6.7(2.5) nM|P34998|CORTICOTROPIN-RELEASING FACTOR RECEPTOR 1|8.17|Kd=6.7nM|Kd|=|6.7|nM|6.7|nM
4N5D|2.06|2013|2FQ|ligand is compound 1|P55212|CASPASE-6|3.22|Kd=607uM|Kd|=|607|uM|607000|nM
4GNY|1.64|2013|SDS|Kd=52uM(ITC, 15C, pH=7.0), Kd=60uM(ITC, 25C, pH=7.0)|P02754|BETA-LACTOGLOBULIN|4.22|Kd=60uM|Kd|=|60|uM|60000|nM
4K63|3.10|2013|4-mer|incomplete ligand structure|A8HWY8|HEMAGGLUTININ|4.22|Kd=60uM|Kd|=|60|uM|60000|nM
4JMX|2.55|2013|IM2|Kd=62.1+/-11.2nM, Different ligand structures (ring); covalent complex|L0T5Q5|PROBABLE L,D-TRANSPEPTIDASE LDTA|7.21|Kd=62.1nM|Kd|=|62.1|nM|62.1|nM
4HT6|1.90|2013|11-mer|Kd = 620 +/- 270 nM|Q02647|DYNEIN LIGHT CHAIN 1|6.21|Kd=620nM|Kd|=|620|nM|620|nM
4IGR|2.65|2013|3ZA||P42264|GLUTAMATE RECEPTOR, IONOTROPIC KAINATE 3|7.2|Kd=63nM|Kd|=|63|nM|63|nM
4J8G|1.90|2013|11-mer|Kd=64.5+/-5.4uM|Q96WV5|COATOMER SUBUNIT ALPHA|4.19|Kd=64.5uM|Kd|=|64.5|uM|64500|nM
2LYA|NMR|2013|PC8|ligand is di-C8-PC;Kd=65+/-2uM|P12497|MATRIX PROTEIN P17|4.19|Kd=65uM|Kd|=|65|uM|65000|nM
4NRA|1.85|2013|2LW|ligand is compound 6|Q9UIF8|BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN PROTEIN 2B|4.19|Kd=65uM|Kd|=|65|uM|65000|nM
4NKS|2.50|2013|2M2|ligand is compound 3|P11362|FIBROBLAST GROWTH FACTOR RECEPTOR 1|7.17|Kd=67.9nM|Kd|=|67.9|nM|67.9|nM
4JKW|2.01|2013|IPE||O00481|BUTYROPHILIN SUBFAMILY 3 MEMBER A1|4.16|Kd=69.9uM|Kd|=|69.9|uM|69900|nM
4JPX|1.55|2013|PHE|Kd=7.0+/-0.3uM|P30967|PHENYLALANINE-4-HYDROXYLASE|5.15|Kd=7.0uM|Kd|=|7|uM|7000|nM
4H85|2.10|2013|HRI|Kd=7.0+/-1.5uM; K-containing, Mg-containing|Q00972|3-METHYL-2-OXOBUTANOATE DEHYDROGENASE|5.15|Kd=7.0uM|Kd|=|7|uM|7000|nM
4EJL|2.44|2013|IOP|Kd=7.2+/-1.7uM|P12499|HIV-1 PROTEASE|5.14|Kd=7.2uM|Kd|=|7.2|uM|7200|nM
4EZT|2.00|2013|9-mer|Kd = 7.4 +/- 0.4 uM; incomplete ligand|P0A6Y8|CHAPERONE PROTEIN DNAK|5.13|Kd=7.4uM|Kd|=|7.4|uM|7400|nM
4H81|2.05|2013|WJ2|Kd=7.5 +/-2.2uM; K-containing, Mg-containing|Q00972|3-METHYL-2-OXOBUTANOATE DEHYDROGENASE|5.12|Kd=7.5uM|Kd|=|7.5|uM|7500|nM
4B6U|NMR|2013|M7G|ligand is m7GDP;Kd=7.7+/-0.3uM|Q9DBB5|EUKARYOTIC TRANSLATION INITIATION FACTOR 4E TYPE 3|5.11|Kd=7.7uM|Kd|=|7.7|uM|7700|nM
4CDR|3.15|2013|9-mer|covalent complex|O15294|UDP-N-ACETYLGLUCOSAMINE--PEPTIDE|5.1|Kd=7.9uM|Kd|=|7.9|uM|7900|nM
4C1T|2.39|2013|4-mer||C6A6Z1|SUGAR TRANSPORTER SOLUTE-BINDING PROTEIN|7.15|Kd=70.8nM|Kd|=|70.8|nM|70.8|nM
4LW1|1.63|2013|1XS|ligand is compound 2; Kd=710uM(site 1), Kd>1400uM(site 2)|P27694|REPLICATION PROTEIN A 70 KDA DNA-BINDING SUBUNIT|3.15|Kd=710uM|Kd|=|710|uM|710000|nM
4JFZ|1.75|2013|12-mer|incomplete ligand|------|ANTIBODY FAB LIGHT CHAIN|7.15|Kd=71nM|Kd|=|71|nM|71|nM
2MC1|NMR|2013|13-mer|ligand is Tyrosine-protein kinase SYK|P15498|PROTO-ONCOGENE VAV|4.15|Kd=71uM|Kd|=|71|uM|71000|nM
4CC3|1.97|2013|12-mer||Q6XZF7|DYNAMIN-BINDING PROTEIN|4.14|Kd=72.5uM|Kd|=|72.5|uM|72500|nM
4I7M|1.48|2013|2LP||P00720|LYSOZYME|4.14|Kd=72uM|Kd|=|72|uM|72000|nM
4CGI|2.07|2013|NZL|Kd=752+/-158 uM|Q76353|HIV-1 INTEGRASE|3.12|Kd=752uM|Kd|=|752|uM|752000|nM
4AYP|0.85|2013|SMD|ligand is compound 1|B0SWV2|MANNOSYL-OLIGOSACCHARIDE 1,2-ALPHA-MANNOSIDASE|6.12|Kd=755nM|Kd|=|755|nM|755|nM
2LTO|NMR|2013|13-mer|ligand is DNA-directed RNA polymerase II subunit RPB1;Kd1=770+/-30uM(NMR);Kd2=900+/-200uM(fluoresence)|Q9H7E2|TUDOR DOMAIN-CONTAINING PROTEIN 3|3.11|Kd=770uM|Kd|=|770|uM|770000|nM
3WDD|1.18|2013|7-mer|ligand is Cyclomarin A;Kd=780+/-80nM|P0A522|PROBABLE ATP-DEPENDENT CLP PROTEASE ATP-BINDING SUB|6.11|Kd=780nM|Kd|=|780|nM|780|nM
4KZQ|2.25|2013|DFL|Zn-containing|Q9H2K2|TANKYRASE-2|6.1|Kd=788nM|Kd|=|788|nM|788|nM
4IH5|1.90|2013|12R||P26663|RNA-DIRECTED RNA POLYMERASE|4.11|Kd=78uM|Kd|=|78|uM|78000|nM
4AZG|2.40|2013|OAN|ligand is PUGNAc; Kd=79.05+/-0.44nM|P49610|BETA-N-ACETYLHEXOSAMINIDASE|7.1|Kd=79.05nM|Kd|=|79.05|nM|79.05|nM
4LOO|1.95|2013|SB4|in monoclinic crystal form|P47811|MITOGEN-ACTIVATED PROTEIN KINASE 14|8.15|Kd=7nM|Kd|=|7|nM|7|nM
4LY9|2.35|2013|1YY||Q14397|GLUCOKINASE REGULATORY PROTEIN|8.15|Kd=7nM|Kd|=|7|nM|7|nM
4HIS|1.20|2013|3MI|Kd1=8.1+/-0.8 nM, Kd2~1 uM (for the first and the second binding sites of V122I-TTR)|P02766|TRANSTHYRETIN|8.09|Kd=8.1nM|Kd|=|8.1|nM|8.1|nM
4H7Q|2.10|2013|COI|Kd=8.8+/-0.5uM; K-containing, Mg-containing|Q00972|3-METHYL-2-OXOBUTANOATE DEHYDROGENASE|5.06|Kd=8.8uM|Kd|=|8.8|uM|8800|nM
4C94|3.00|2013|KXN|Kd1 = 8.9 +/- 1.8 uM, Kd2 = 399.1 +/- 10.6 uM ( two distinct ligand binding sites )|D0E0C7|FRA A 3 ALLERGEN|5.05|Kd=8.9uM|Kd|=|8.9|uM|8900|nM
4C1U|2.00|2013|3-mer||C6A6Z1|SUGAR TRANSPORTER SOLUTE-BINDING PROTEIN|7.09|Kd=81nM|Kd|=|81|nM|81|nM
4GHI|1.50|2013|0X3||Q99814|ENDOTHELIAL PAS DOMAIN-CONTAINING PROTEIN 1|7.09|Kd=81nM|Kd|=|81|nM|81|nM
4KP5|1.45|2013|E1F|ligand is compound 2j|O43570|CARBONIC ANHYDRASE 12|6.08|Kd=833nM|Kd|=|833|nM|833|nM
2M41|NMR|2013|15-mer|ligand is peptide from Capicua|Q96RK0|PROTEIN CAPICUA HOMOLOG|5.1|Kd=8uM|Kd|=|8|uM|8000|nM
4H3Q|2.20|2013|13-mer|incomplete ligand|P28482|MITOGEN-ACTIVATED PROTEIN KINASE 1|5.1|Kd=8uM|Kd|=|8|uM|8000|nM
4IHO|2.80|2013|9-mer||P01899|H-2 CLASS I HISTOCOMPATIBILITY ANTIGEN, D-B ALPHA C|5.1|Kd=8uM|Kd|=|8|uM|8000|nM
4JYM|1.35|2013|KKN|Kd=9.05+/-2.03 uM|Q9SZU7|HYDROLASE, ALPHA/BETA FOLD FAMILY PROTEIN|5.04|Kd=9.05uM|Kd|=|9.05|uM|9050|nM
4LK7|1.76|2013|2-mer|ligand is 04G-GAL (compound 16); Kd=9.1+/-0.6 uM|Q05097|PA-I GALACTOPHILIC LECTIN|5.04|Kd=9.1uM|Kd|=|9.1|uM|9100|nM
4IO5|1.72|2013|ALA|Kd=9.27+/-1.24uM|E9P5T5|AVGLUR1 LIGAND BINDING DOMAIN|5.03|Kd=9.27uM|Kd|=|9.27|uM|9270|nM
4JJQ|1.95|2013|10-mer|Kd=9.4+/-2.1uM; incomplete ligand|Q93009|UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 7|5.03|Kd=9.4uM|Kd|=|9.4|uM|9400|nM
4NP9|1.92|2013|I3P|Kd=9.4+/-1.4 uM|P47709|RABPHILIN-3A|5.03|Kd=9.4uM|Kd|=|9.4|uM|9400|nM
4MZ6|1.88|2013|13-mer|Kd = 9.62 +/- 1.54 uM; incomplete ligand|P33316|DEOXYURIDINE 5'-TRIPHOSPHATE NUCLEOTIDOHYDROLASE|5.02|Kd=9.62uM|Kd|=|9.62|uM|9620|nM
2M3M|NMR|2013|11-mer|ligand is Protein E6;(E6CT11);Kd=9.63+/-0.02uM|Q12959|DISKS LARGE HOMOLOG 1|5.02|Kd=9.63uM|Kd|=|9.63|uM|9630|nM
4BTB|1.90|2013|9-mer|Kd = 9.8 +/- 0.2 uM|P13674|PROLYL 4-HYDROXYLASE SUBUNIT ALPHA-1|5.01|Kd=9.8uM|Kd|=|9.8|uM|9800|nM
4I7K|1.72|2013|MBN||P00720|LYSOZYME|3.04|Kd=905uM|Kd|=|905|uM|905000|nM
3VFJ|2.05|2013|7-mer|ligand is MonodeChloro- Teicoplanin A2-2;Kd=91+/-7nM|P0AEX9|MALTOSE-BINDING PERIPLASMIC PROTEIN|7.04|Kd=91nM|Kd|=|91|nM|91|nM
4KAB|2.71|2013|4KA|ligand si compound 6|Q05397|FOCAL ADHESION KINASE 1|4.03|Kd=93uM|Kd|=|93|uM|93000|nM
3UEO|2.60|2013|12-mer|Kd=94+/-15uM; incomplete ligand|Q92547|DNA TOPOISOMERASE 2-BINDING PROTEIN 1|4.03|Kd=94uM|Kd|=|94|uM|94000|nM
3W0L|2.92|2013|F6R|Kd=95+/-25nM|Q91753|GLUCOKINASE|7.02|Kd=95nM|Kd|=|95|nM|95|nM
4K8A|2.91|2013|K8A|ligand is compound 3|Q05397|FOCAL ADHESION KINASE 1|4.02|Kd=95uM|Kd|=|95|uM|95000|nM
4L51|1.90|2013|HSX|ligand is R5P; Kd=995+/-50 uM|P76141|TRANSCRIPTIONAL REGULATOR LSRR|3.0|Kd=995uM|Kd|=|995|uM|995000|nM
4AYR|1.10|2013|IFL||B0SWV2|MANNOSYL-OLIGOSACCHARIDE 1,2-ALPHA-MANNOSIDASE|7.0|Kd=99nM|Kd|=|99|nM|99|nM
3ZJC|3.15|2013|GNP|Kd=9+/-1uM|Q8NHV1|GTPASE IMAP FAMILY MEMBER 7|5.05|Kd=9uM|Kd|=|9|uM|9000|nM
4LKH|3.10|2013|SIA-NAG||V5IRU7|HEMAGGLUTININ|3.0|Kd>1.0mM|Kd|>|1|mM|1000000|nM
4BV2|3.30|2013|13-mer|Kd(microscale thermophoresis); incomplete ligand|Q9WYW0|NAD-DEPENDENT DEACETYLASE|3.74|Kd>180uM|Kd|>|180|uM|180000|nM
4K64|2.60|2013|3-mer|incomplete ligand structure|A8HWY8|HEMAGGLUTININ|3.0|Kd>1mM|Kd|>|1|mM|1000000|nM
4GJ8|2.50|2013|0LU/0LW||P00797|RENIN|3.3|Kd>500uM|Kd|>|500|uM|500000|nM
4GJ9|2.60|2013|0M2|X-ray(R-4), Kd,IC50(rac-4)|P00797|RENIN|3.3|Kd>500uM|Kd|>|500|uM|500000|nM
4J79|1.56|2013|6-mer||P41811|COATOMER SUBUNIT BETA|3.1|Kd>800uM|Kd|>|800|uM|800000|nM
2YMT|1.80|2013|9-mer|ligand is a phage peptide; incomplete ligand|O75843|AP-1 COMPLEX SUBUNIT GAMMA-LIKE 2|8.0|Kd~10nM|Kd|~|10|nM|10|nM
4ARO|1.59|2013|IHS|ligand is MIHS|G9Y2J2|HISTIDINE ACID PHOSPHATASE|6.8|Kd~160nM|Kd|~|160|nM|160|nM
4L5J|2.60|2013|HSX|ligand is R5P|P76141|TRANSCRIPTIONAL REGULATOR LSRR|3.0|Kd~1mM|Kd|~|1|mM|1000000|nM
3ZHA|2.55|2013|19-mer|ligand is COLLAGEN MODEL PEPTIDE 18-T8R11|C7C419|HSP47|6.0|Kd~1uM|Kd|~|1|uM|1000|nM
4J8S|1.55|2013|15-mer|incomplete ligand|A5YKK6|CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1|5.7|Kd~2uM|Kd|~|2|uM|2000|nM
2M3O|NMR|2013|11-mer|ligand is alpha-hENaC peptide|P46934|E3 UBIQUITIN-PROTEIN LIGASE NEDD4|5.3|Kd~5uM|Kd|~|5|uM|5000|nM
4J24|2.10|2013|19-mer|incomplete ligand|Q92731|ESTROGEN RECEPTOR BETA|7.3|Ki<0.05uM|Ki|<|0.05|uM|50|nM
4GEE|1.70|2013|0WT|Ki (the coupled spectrophotometric Enzchek assay)|Q839Z1|DNA GYRASE SUBUNIT B|9.0|Ki<1nM|Ki|<|1|nM|1|nM
4GGL|1.69|2013|CJC|Ki (the coupled spectrophotometric Enzchek assay)|Q839Z1|DNA GYRASE SUBUNIT B|9.0|Ki<1nM|Ki|<|1|nM|1|nM
4GM8|2.60|2013|5-mer|IC50 = 2.4 +/- 1.7 nM|P61964|WD REPEAT-CONTAINING PROTEIN 5|9.0|Ki<1nM|Ki|<|1|nM|1|nM
4GM3|3.39|2013|5-mer|IC50 = 2.9 +/- 1.4 nM|P61964|WD REPEAT-CONTAINING PROTEIN 5|9.0|Ki<1nM|Ki|<|1|nM|1|nM
4I5H|1.90|2013|G17||P63086|MITOGEN-ACTIVATED PROTEIN KINASE 1|8.7|Ki<2nM|Ki|<|2|nM|2|nM
4K1B|2.08|2013|1OC|ligand is compound 17|P11309|SERINE/THREONINE-PROTEIN KINASE PIM-1|11.52|Ki=0.003nM|Ki|=|0.003|nM|0.003|nM
4GBD|1.98|2013|MCF|Zn-containing; Ki=0.0048+/-0.0005nM|Q9HZ64|PUTATIVE UNCHARACTERIZED PROTEIN|11.32|Ki=0.0048nM|Ki|=|0.0048|nM|0.0048|nM
4GIH|2.00|2013|0X5||P29597|NON-RECEPTOR TYROSINE-PROTEIN KINASE TYK2|8.32|Ki=0.0048uM|Ki|=|0.0048|uM|4.8|nM
4KB9|1.29|2013|G79|ligand is compound 16a|Q7SSI0|HIV-1 PROTEASE|11.0|Ki=0.01nM|Ki|=|0.01|nM|0.01|nM
4FP1|1.68|2013|BFM|Ki=0.027+/-0.004mM|P11444|MANDELATE RACEMASE|4.57|Ki=0.027mM|Ki|=|0.027|mM|27000|nM
4GMY|2.40|2013|0X5||O60674|TYROSINE-PROTEIN KINASE JAK2|7.55|Ki=0.028uM|Ki|=|0.028|uM|28|nM
4JK5|1.55|2013|18-mer|Ki=0.028+/-0.004uM|P00749|UROKINASE-TYPE PLASMINOGEN ACTIVATOR|7.55|Ki=0.028uM|Ki|=|0.028|uM|28|nM
4FXY|2.80|2013|0W2|ligand is compound R2, inhibition respect to fluororgenic substrate: dynorphin|P42676|NEUROLYSIN, MITOCHONDRIAL|7.54|Ki=0.029uM|Ki|=|0.029|uM|29|nM
4IJQ|2.00|2013|SV2|Ki=0.03+/-0.002uM; Mg-containing|P00492|HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE|7.52|Ki=0.03uM|Ki|=|0.03|uM|30|nM
4GD6|1.53|2013|17K|Ki = 0.042 +/- 0.004 uM; covalent complex|P0AD64|BETA-LACTAMASE SHV-1|7.38|Ki=0.042uM|Ki|=|0.042|uM|42|nM
4HW2|2.80|2013|19H|Ki = 0.055 +/- 0.018 uM|Q07820|INDUCED MYELOID LEUKEMIA CELL DIFFERENTIATION PROTEIN MCL|7.26|Ki=0.055uM|Ki|=|0.055|uM|55|nM
4LMN|2.80|2013|EUI|Ki = 262.5 nM(-ATP), 0.05 nM(+ATP)|Q02750|DUAL SPECIFICITY MITOGEN-ACTIVATED PROTEIN KINASE K|10.3|Ki=0.05nM|Ki|=|0.05|nM|0.05|nM
4JK6|2.20|2013|18-mer|Ki=0.064+/-0.005uM|P00749|UROKINASE-TYPE PLASMINOGEN ACTIVATOR|7.19|Ki=0.064uM|Ki|=|0.064|uM|64|nM
4GFM|2.30|2013|0X2||O60674|TYROSINE-PROTEIN KINASE JAK2|7.22|Ki=0.06uM|Ki|=|0.06|uM|60|nM
4GS6|2.20|2013|1FM|Ki = 0.071 +/- 0.032 uM; covalent complex|O43318|TAK1-TAB1 FUSION PROTEIN|7.15|Ki=0.071uM|Ki|=|0.071|uM|71|nM
4HRA|3.15|2013|EP6|Ki =0.08 +/- 0.03nM|Q8TEK3|HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-79 SPECIFIC|10.1|Ki=0.08nM|Ki|=|0.08|nM|0.08|nM
4BNY|1.80|2013|36I|IC50= 0.08 uM (AcAcCoA as substrate), IC50=2.7uM (3-OH decanoyl-NAC as substrate)|O54438|3-OXOACYL-[ACYL-CARRIER-PROTEIN] REDUCTASE FABG|7.1|Ki=0.08uM|Ki|=|0.08|uM|80|nM
4HVB|2.35|2013|19P|Ki (displacement fluorescence polarization (FP) assay come from ref 5)|P48736|PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE|9.95|Ki=0.111nM|Ki|=|0.111|nM|0.111|nM
4BCM|2.45|2013|T7Z|ligand is compound 4|P24941|CELL DIVISION PROTEIN KINASE 2|6.91|Ki=0.123uM|Ki|=|0.123|uM|123|nM
4IMZ|1.70|2013|4-mer|covalent complex|Q83883|GENOME POLYPROTEIN|6.92|Ki=0.12uM|Ki|=|0.12|uM|120|nM
4BCO|2.05|2013|T6Q|ligand is compound 12t|P24941|CELL DIVISION PROTEIN KINASE 2|6.88|Ki=0.131uM|Ki|=|0.131|uM|131|nM
2YOL|3.20|2013|EBN|ligand is compound 40|P06935|SERINE PROTEASE SUBUNIT NS2B, SERINE PROTEASE NS3|6.89|Ki=0.13uM|Ki|=|0.13|uM|130|nM
3ZCZ|2.60|2013|TFR|ligand is compound 12;K-=0.17+/-0.02uM|P39045|D-ALANYL-D-ALANINE CARBOXYPEPTIDASE|6.77|Ki=0.17uM|Ki|=|0.17|uM|170|nM
4EW3|1.70|2013|DXZ||P22102|TRIFUNCTIONAL PURINE BIOSYNTHETIC PROTEIN ADENOSINE|6.74|Ki=0.18uM|Ki|=|0.18|uM|180|nM
4HGC|1.29|2013|14-mer|incomplete ligand|P00760|TRYPSIN|10.0|Ki=0.1nM|Ki|=|0.1|nM|0.1|nM
4IVC|2.35|2013|1J6||P23458|TYROSINE-PROTEIN KINASE JAK1|10.0|Ki=0.1nM|Ki|=|0.1|nM|0.1|nM
4M1J|1.80|2013|B0S|Ki = 0.20 +/- 0.04 nM, B-containing|Q9I194|ACYL-HOMOSERINE LACTONE ACYLASE PVDQ|9.7|Ki=0.20nM|Ki|=|0.2|nM|0.2|nM
4ISU|2.30|2013|IKM|Ki=0.21+/-0.02mM by radioactive binding assay|P19491|GLUTAMATE RECEPTOR 2|3.68|Ki=0.21mM|Ki|=|0.21|mM|210000|nM
4EW2|1.60|2013|DXY||P22102|TRIFUNCTIONAL PURINE BIOSYNTHETIC PROTEIN ADENOSINE|6.68|Ki=0.21uM|Ki|=|0.21|uM|210|nM
4GFO|2.30|2013|0X2||P29597|NON-RECEPTOR TYROSINE-PROTEIN KINASE TYK2|6.62|Ki=0.24uM|Ki|=|0.24|uM|240|nM
4GQL|1.15|2013|R47|Zn-containing|P39900|MACROPHAGE METALLOELASTASE (MMP-12)|9.59|Ki=0.26nM|Ki|=|0.26|nM|0.26|nM
4GR0|1.50|2013|R4B|Zn-containing|P39900|MACROPHAGE METALLOELASTASE (MMP-12)|9.55|Ki=0.28nM|Ki|=|0.28|nM|0.28|nM
4BTX|2.78|2013|WF8|IC50 = 0.29 +/- 0.06 uM|Q16853|MEMBRANE PRIMARY AMINE OXIDASE|6.54|Ki=0.29uM|Ki|=|0.29|uM|290|nM
4HW3|2.40|2013|19G|Ki=0.32+/-0.01uM|Q07820|INDUCED MYELOID LEUKEMIA CELL DIFFERENTIATION PROTEIN MCL|6.49|Ki=0.32uM|Ki|=|0.32|uM|320|nM
4DA5|2.40|2013|0H7|Ki=0.36+/-0.01 uM, IC50=0.47+/-0.08 uM (coupled spectrophotometric assay)|P35790|CHOLINE KINASE ALPHA|6.44|Ki=0.36uM|Ki|=|0.36|uM|360|nM
4IVD|1.93|2013|15T||P23458|TYROSINE-PROTEIN KINASE JAK1|9.52|Ki=0.3nM|Ki|=|0.3|nM|0.3|nM
4CA5|1.85|2013|3EF|Ki=0.41+/-0.03nM; Zn-containing|P12821|ANGIOTENSIN-CONVERTING ENZYME|9.39|Ki=0.41nM|Ki|=|0.41|nM|0.41|nM
4BT4|1.60|2013|QFH|Ki=0.46+/-0.18 mM; Zn-containing|P23616|ALPHA-ACETOLACTATE DECARBOXYLASE|3.34|Ki=0.46mM|Ki|=|0.46|mM|460000|nM
4KS2|2.60|2013|1SJ|ligand is compound 5|Q0A480|NEURAMINIDASE|9.34|Ki=0.46nM|Ki|=|0.46|nM|0.46|nM
4HEV|2.50|2013|AXM|Zn-containing|P10845|BOTULINUM NEUROTOXIN A LIGHT CHAIN|6.34|Ki=0.46uM|Ki|=|0.46|uM|460|nM
4JFW|2.10|2013|H58|Different ligand structures (double bond)|Q8A3I4|ALPHA-L-FUCOSIDASE|6.34|Ki=0.46uM|Ki|=|0.46|uM|460|nM
4MSS|1.80|2013|2CZ||B4EA43|BETA-HEXOSAMINIDASE 1|6.4|Ki=0.4uM|Ki|=|0.4|uM|400|nM
4JFV|1.88|2013|H57|Different ligand structures (double bond)|Q8A3I4|ALPHA-L-FUCOSIDASE|6.28|Ki=0.52uM|Ki|=|0.52|uM|520|nM
3V0P|1.90|2013|4GW|ligand is compound 1; bound with HAA|P16442|HISTO-BLOOD GROUP ABO SYSTEM TRANSFERASE|6.28|Ki=0.53uM|Ki|=|0.53|uM|530|nM
4INH|1.70|2013|4-mer|covalent complex|Q83883|GENOME POLYPROTEIN|6.25|Ki=0.56uM|Ki|=|0.56|uM|560|nM
4HNC|1.89|2013|0UT|Ki=0.67+/-0.12 mM(WT MR), X-ray(tmMR); Mg-containing|P11444|MANDELATE RACEMASE|3.17|Ki=0.67mM|Ki|=|0.67|mM|670000|nM
4JIA|1.85|2013|1K3||O60674|TYROSINE-PROTEIN KINASE JAK2|9.22|Ki=0.6nM|Ki|=|0.6|nM|0.6|nM
4M0E|2.00|2013|1YL|Ki=0.6+/-0.8uM|P22303|ACETYLCHOLINESTERASE|6.22|Ki=0.6uM|Ki|=|0.6|uM|600|nM
4MDN|1.91|2013|Y30||Q00987|E3 UBIQUITIN-PROTEIN LIGASE MDM2|6.22|Ki=0.6uM|Ki|=|0.6|uM|600|nM
3ZMM|2.51|2013|F9J|ligand is compond 6; Ki=0.72+/-0.005nM|O60674|TYROSINE-PROTEIN KINASE JAK2|9.14|Ki=0.72nM|Ki|=|0.72|nM|0.72|nM
4BT3|1.10|2013|WTZ|Ki=0.76+/-0.40 mM; Zn-containing|P23616|ALPHA-ACETOLACTATE DECARBOXYLASE|3.12|Ki=0.76mM|Ki|=|0.76|mM|760000|nM
4MF1|2.11|2013|29Y|ligand is compound (S,S)-13b|Q08881|TYROSINE-PROTEIN KINASE ITK/TSK|9.15|Ki=0.7nM|Ki|=|0.7|nM|0.7|nM
4EOS|2.57|2013|1RO|Ki = 0.89 +/- 0.26 uM|P24941|CYCLIN-DEPENDENT KINASE 2|6.05|Ki=0.89uM|Ki|=|0.89|uM|890|nM
4EOL|2.40|2013|1RO|Ki=0.89+/-0.26 uM; X-ray(Cyclin-dependent kinase 2 (H84S, Q85M, K89D mutation)), Ki(Cyclin-dependent kinase 2)|P24941|CYCLIN-DEPENDENT KINASE 2|6.05|Ki=0.89uM|Ki|=|0.89|uM|890|nM
4EON|2.40|2013|1RO|Ki=0.89+/-0.26 uM; X-ray(Cyclin-dependent kinase 2 (H84S, Q85M, Q131E mutation)), Ki(Cyclin-dependent kinase 2); Mg-containing|P24941|CYCLIN-DEPENDENT KINASE 2|6.05|Ki=0.89uM|Ki|=|0.89|uM|890|nM
4EOI|2.00|2013|1RO|Ki=0.89+/-0.26 uM; X-ray(Cyclin-dependent kinase 2 (K89D, Q131E mutation)), Ki(Cyclin-dependent kinase 2)|P24941|CYCLIN-DEPENDENT KINASE 2|6.05|Ki=0.89uM|Ki|=|0.89|uM|890|nM
4EOP|1.99|2013|1RO|Ki=0.89+/-0.26 uM; X-ray(Cyclin-dependent kinase 2 (Q131E mutation)), Ki(Cyclin-dependent kinase 2); Mg-containing|P24941|CYCLIN-DEPENDENT KINASE 2|6.05|Ki=0.89uM|Ki|=|0.89|uM|890|nM
4AZ6|1.36|2013|OAN|ligand is PUGNAc; Ki=0.8+/-0.1nM|P49610|BETA-N-ACETYLHEXOSAMINIDASE|9.1|Ki=0.8nM|Ki|=|0.8|nM|0.8|nM
4HWS|1.70|2013|1B3|Zn-containing; Ki by a coupled spectrophotometric assay|P0A8M3|THREONINE-TRNA LIGASE|9.1|Ki=0.8nM|Ki|=|0.8|nM|0.8|nM
4JH0|2.35|2013|1MD|Ki=0.94+/-0.18nM|P27487|DIPEPTIDYL PEPTIDASE 4|9.03|Ki=0.94nM|Ki|=|0.94|nM|0.94|nM
4BAQ|1.89|2013|M4Z|ligand is compound 4; Ki=0.98+/-0.02nM|P00734|THROMBIN LIGHT CHAIN|9.01|Ki=0.98nM|Ki|=|0.98|nM|0.98|nM
4I72|2.05|2013|UA2|Ca-containing|Q57ZL6|INOSINE-ADENOSINE-GUANOSINE-NUCLEOSIDE HYDROLASE|9.05|Ki=0.9nM|Ki|=|0.9|nM|0.9|nM
4HXZ|2.70|2013|19Y|Ki (the coupled spectrophotometric Enzchek assay)|Q2A1P5|TOPOISOMERASE IV, SUBUNIT B|6.05|Ki=0.9uM|Ki|=|0.9|uM|900|nM
4BPS|1.08|2013|3EB|Ki=1.02+/-0.22 mM(by spectrophotometric assay )|Q9KID9|FKBO|2.99|Ki=1.02mM|Ki|=|1.02|mM|1020000|nM
4BAM|1.88|2013|MM9|ligand is compound 3; Ki=1.14+/-0.02nM|P00734|THROMBIN LIGHT CHAIN|8.94|Ki=1.14nM|Ki|=|1.14|nM|1.14|nM
4K18|2.05|2013|1OB|ligand is compound 2|P11309|SERINE/THREONINE-PROTEIN KINASE PIM-1|8.96|Ki=1.1nM|Ki|=|1.1|nM|1.1|nM
4HEG|1.46|2013|G52|Ki=1.20+/-0.08nM|P03367|HIV-1 PROTEASE|8.92|Ki=1.20nM|Ki|=|1.2|nM|1.2|nM
4BAK|1.94|2013|M67|ligand is compound 5; Ki=1.22+/-0.08nM|P00734|THROMBIN LIGHT CHAIN|8.91|Ki=1.22nM|Ki|=|1.22|nM|1.22|nM
4HZ5|2.70|2013|19Y|Ki (the coupled spectrophotometric Enzchek assay)|H7C794|DNA TOPOISOMERASE IV, B SUBUNIT|5.92|Ki=1.2uM|Ki|=|1.2|uM|1200|nM
4KYH|2.50|2013|ZST|ligand is zopolrestat|Q9CPU0|LACTOYLGLUTATHIONE LYASE|5.92|Ki=1.2uM|Ki|=|1.2|uM|1200|nM
4MDQ|2.12|2013|28W||Q00987|E3 UBIQUITIN-PROTEIN LIGASE MDM2|5.92|Ki=1.2uM|Ki|=|1.2|uM|1200|nM
4GPL|3.00|2013|7-mer|Ki = 1.3 +/- 0.6 uM|P22681|ACE-PTR-THR-PRO-GLU-PRO, PEPTIDE INHIBITOR|5.89|Ki=1.3uM|Ki|=|1.3|uM|1300|nM
4IU0|1.77|2013|ABH|Measure the urea colorimetrically, B-contained; Mn-containing|Q6TUJ5|ARGINASE|5.89|Ki=1.3uM|Ki|=|1.3|uM|1300|nM
4GJ3|2.50|2013|0XP||P29597|NON-RECEPTOR TYROSINE-PROTEIN KINASE TYK2|8.85|Ki=1.4nM|Ki|=|1.4|nM|1.4|nM
4I5C|2.10|2013|C5I||P23458|TYROSINE-PROTEIN KINASE JAK1|8.82|Ki=1.5nM|Ki|=|1.5|nM|1.5|nM
4KS1|2.20|2013|2H8|ligand is compound 4|Q0A480|NEURAMINIDASE|8.82|Ki=1.5nM|Ki|=|1.5|nM|1.5|nM
4F3C|1.93|2013|BIG|Ki=1.5+/-0.4 pM|E8NLP5|MTA/SAH NUCLEOSIDASE|11.82|Ki=1.5pM|Ki|=|1.5|pM|0.0015|nM
4IMQ|1.50|2013|4-mer|covalent complex|Q83883|3C-LIKE PROTEASE|5.82|Ki=1.5uM|Ki|=|1.5|uM|1500|nM
4BT5|1.10|2013|23B|Ki=1.72+/-0.98 mM; Zn-containing|P23616|ALPHA-ACETOLACTATE DECARBOXYLASE|2.76|Ki=1.72mM|Ki|=|1.72|mM|1720000|nM
4M0F|2.30|2013|1YK||P22303|ACETYLCHOLINESTERASE|8.77|Ki=1.7nM|Ki|=|1.7|nM|1.7|nM
4J45|1.48|2013|4-mer||P98170|E3 UBIQUITIN-PROTEIN LIGASE XIAP|5.77|Ki=1.7uM|Ki|=|1.7|uM|1700|nM
4J44|1.30|2013|4-mer||P98170|E3 UBIQUITIN-PROTEIN LIGASE XIAP|5.73|Ki=1.87uM|Ki|=|1.87|uM|1870|nM
4GII|2.31|2013|0X6||P29597|NON-RECEPTOR TYROSINE-PROTEIN KINASE TYK2|8.74|Ki=1.8nM|Ki|=|1.8|nM|1.8|nM
4ISH|1.82|2013|1GE||P08709|COAGULATION FACTOR VII|8.72|Ki=1.9nM|Ki|=|1.9|nM|1.9|nM
4IVB|1.90|2013|1J5||P23458|TYROSINE-PROTEIN KINASE JAK1|8.72|Ki=1.9nM|Ki|=|1.9|nM|1.9|nM
3ZCL|1.40|2013|5TF|ligand is compound 28f|P08581|HEPATOCYTE GROWTH FACTOR RECEPTOR|8.0|Ki=10.1nM|Ki|=|10.1|nM|10.1|nM
4MO8|1.85|2013|2VQ|ligand is compound 7|P00918|CARBONIC ANHYDRASE 2|8.0|Ki=10.1nM|Ki|=|10.1|nM|10.1|nM
3ZN0|2.80|2013|6-mer|ligand is peptide PRSFAA|O60341|LYSINE-SPECIFIC HISTONE DEMETHYLASE 1A|4.97|Ki=10.7uM|Ki|=|10.7|uM|10700|nM
4IN9|1.55|2013|4-mer||D0EM77|KARILYSIN PROTEASE|4.97|Ki=10.7uM|Ki|=|10.7|uM|10700|nM
4K5O|1.90|2013|1OT|ligand is compound 6|O96935|M1 FAMILY AMINOPEPTIDASE|3.98|Ki=104uM|Ki|=|104|uM|104000|nM
4JJF|2.20|2013|2-mer|ligand is FE9-N2I; Fe-contained; covalent complex|P32440|5,10-METHENYLTETRAHYDROMETHANOPTERIN HYDROGENASE|8.0|Ki=10nM|Ki|=|10|nM|10|nM
4JYU|1.80|2013|1OK|ligand is compound (R)-2|P08709|COAGULATION FACTOR VII LIGHT CHAIN|8.0|Ki=10nM|Ki|=|10|nM|10|nM
3UFA|1.80|2013|VPF|ligand is compound 41|Q2FXC2|SERINE PROTEASE SPLA|5.0|Ki=10uM|Ki|=|10|uM|10000|nM
4BXK|2.20|2013|1IU|Ki=11.21+/-0.74 nM; Zn-containing; different ligand structure|P12821|ANGIOTENSIN-CONVERTING ENZYME|7.95|Ki=11.21nM|Ki|=|11.21|nM|11.21|nM
4F9W|2.00|2013|LM4||Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|6.94|Ki=114nM|Ki|=|114|nM|114|nM
4BCJ|3.16|2013|T9N|lignad is compound 3|P50750|CYCLIN-DEPENDENT KINASE 9|7.96|Ki=11nM|Ki|=|11|nM|11|nM
4K3N|2.00|2013|1OT|ligand is compound 6|Q8IL11|M17 LEUCYL AMINOPEPTIDASE|7.96|Ki=11nM|Ki|=|11|nM|11|nM
2YOH|1.60|2013|WMJ|ligand is compound 30|Q8I4S1|THYMIDYLATE KINASE|4.96|Ki=11uM|Ki|=|11|uM|11000|nM
4JSA|1.50|2013|FB2|Ki=11+/-2uM; Hg-containing|P00918|CARBONIC ANHYDRASE 2|4.96|Ki=11uM|Ki|=|11|uM|11000|nM
4K5L|1.91|2013|19N|ligand is compound 1|O96935|M1 FAMILY AMINOPEPTIDASE|4.96|Ki=11uM|Ki|=|11|uM|11000|nM
4J47|1.35|2013|4-mer||P98170|E3 UBIQUITIN-PROTEIN LIGASE XIAP|4.92|Ki=12.02uM|Ki|=|12.02|uM|12020|nM
4I8W|1.96|2013|G07||P0C6F2|HIV-1 PROTEASE|10.9|Ki=12.7pM|Ki|=|12.7|pM|0.0127|nM
4K5N|1.91|2013|1OU|ligand is compound 5|O96935|M1 FAMILY AMINOPEPTIDASE|3.9|Ki=127uM|Ki|=|127|uM|127000|nM
4BCN|2.10|2013|T9N|ligand is compound 3|P24941|CELL DIVISION PROTEIN KINASE 2|7.92|Ki=12nM|Ki|=|12|nM|12|nM
4J5P|2.30|2013|BR1|covalent complex; Ki=77nM (3h preincubation of inhibitor); Ki=12nM (6h preincubation of inhibitor)|P97612|FATTY-ACID AMIDE HYDROLASE 1|7.92|Ki=12nM|Ki|=|12|nM|12|nM
4ELE|2.35|2013|31I|Ki = 13.2 +/- 0.5 nM; Ca-containing|Q81R22|DIHYDROFOLATE REDUCTASE|7.88|Ki=13.2nM|Ki|=|13.2|nM|13.2|nM
4KS5|2.70|2013|1SO|ligand is compound 8|Q0A480|NEURAMINIDASE|6.89|Ki=130nM|Ki|=|130|nM|130|nM
4MJP|1.85|2013|27O|ligand is (R)-Vedaprofen|P0A988|DNA POLYMERASE III SUBUNIT BETA|3.88|Ki=131uM|Ki|=|131|uM|131000|nM
3WJW|1.59|2013|U6M|ligand is 6-methyl-UMP; Ki=134+/-5uM|O26232|OROTIDINE 5'-MONOPHOSPHATE DECARBOXYLASE|3.87|Ki=134uM|Ki|=|134|uM|134000|nM
4AXM|2.80|2013|V65|ligand is compound 19, ligand is wrong(-CN-->-CONH2)|P07711|CATHEPSIN L1|7.89|Ki=13nM|Ki|=|13|nM|13|nM
4GR8|1.30|2013|R4C|Zn-containing|P39900|MACROPHAGE METALLOELASTASE (MMP-12)|7.83|Ki=14.7nM|Ki|=|14.7|nM|14.7|nM
4IVK|1.80|2013|CEP|covalent complex|K4HQE7|CARBOXYLESTERASES|3.85|Ki=140uM|Ki|=|140|uM|140000|nM
4IIC|1.90|2013|IFM|Ki=14+/-2uM|P48825|BETA-GLUCOSIDASE 1|4.85|Ki=14uM|Ki|=|14|uM|14000|nM
4GR3|1.49|2013|R45|Zn-containing|P39900|MACROPHAGE METALLOELASTASE (MMP-12)|7.81|Ki=15.5nM|Ki|=|15.5|nM|15.5|nM
4EB8|2.30|2013|IM5|Ki=151+/-16 pM|P00491|PURINE NUCLEOSIDE PHOSPHORYLASE|9.82|Ki=151pM|Ki|=|151|pM|0.151|nM
4M48|2.96|2013|21B||Q9NB97|TRANSPORTER|6.81|Ki=156nM|Ki|=|156|nM|156|nM
4K0Y|1.95|2013|1OA|ligand is compound 1|P11309|SERINE/THREONINE-PROTEIN KINASE PIM-1|7.82|Ki=15nM|Ki|=|15|nM|15|nM
4N6Z|2.20|2013|2HW|ligand is compound 3f|P11309|SERINE/THREONINE-PROTEIN KINASE PIM-1|7.8|Ki=16nM|Ki|=|16|nM|16|nM
4HLA|1.95|2013|017||P03367|HIV-1 PROTEASE|10.8|Ki=16pM|Ki|=|16|pM|0.016|nM
4HWP|1.81|2013|X16|Zn-containing; Ki by a coupled spectrophotometric assay|P0A8M3|THREONINE-TRNA LIGASE|7.76|Ki=17.2nM|Ki|=|17.2|nM|17.2|nM
4C6X|1.95|2013|TLM|Ki = 175.4 +/- 3.0 uM|I6Y8T4|3-OXOACYL-[ACYL-CARRIER-PROTEIN] SYNTHASE 1|3.76|Ki=175.4uM|Ki|=|175.4|uM|175400|nM
4JYV|2.19|2013|1OJ|ligand is compound (R)-26|P08709|COAGULATION FACTOR VII LIGHT CHAIN|7.77|Ki=17nM|Ki|=|17|nM|17|nM
4JFI|1.05|2013|1KT|Ki=18.1+/-1.2uM|Q13451|PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5|4.74|Ki=18.1uM|Ki|=|18.1|uM|18100|nM
4CA6|1.91|2013|3EF|Ki=180+/-25nM; Zn-containing|P12821|ANGIOTENSIN-CONVERTING ENZYME|6.74|Ki=180nM|Ki|=|180|nM|180|nM
4HWR|1.90|2013|1B2|Zn-containing; Ki(a coupled spectrophotometric assay)|P0A8M3|THREONINE-TRNA LIGASE|6.74|Ki=182nM|Ki|=|182|nM|182|nM
4I71|1.28|2013|AGV|Ca-containing|Q57ZL6|INOSINE-ADENOSINE-GUANOSINE-NUCLEOSIDE HYDROLASE|7.74|Ki=18nM|Ki|=|18|nM|18|nM
3ZMZ|3.00|2013|6-mer|ligand is peptide PRSFAV|O60341|LYSINE-SPECIFIC HISTONE DEMETHYLASE 1A|4.74|Ki=18uM|Ki|=|18|uM|18000|nM
4KYK|2.00|2013|IMN|ligand is indomethacin|Q9CPU0|LACTOYLGLUTATHIONE LYASE|4.74|Ki=18uM|Ki|=|18|uM|18000|nM
4I73|2.18|2013|MBY|Ca-containing|Q57ZL6|INOSINE-ADENOSINE-GUANOSINE-NUCLEOSIDE HYDROLASE|6.72|Ki=190nM|Ki|=|190|nM|190|nM
4I74|1.68|2013|MBY|Ca-containing|Q57ZL6|INOSINE-ADENOSINE-GUANOSINE-NUCLEOSIDE HYDROLASE|6.72|Ki=190nM|Ki|=|190|nM|190|nM
4K5M|1.75|2013|1OV|ligand is compound 2|O96935|M1 FAMILY AMINOPEPTIDASE|3.71|Ki=193uM|Ki|=|193|uM|193000|nM
4MJQ|1.73|2013|27R|ligand is Bromfenac|P0A988|DNA POLYMERASE III SUBUNIT BETA|3.71|Ki=193uM|Ki|=|193|uM|193000|nM
4N70|2.10|2013|2HX|ligand is compound 5c|P11309|SERINE/THREONINE-PROTEIN KINASE PIM-1|12.0|Ki=1pM|Ki|=|1|pM|0.001|nM
4BAH|1.94|2013|MEL|ligand is Melagatran; Ki=2.01+/-0.09nM|P00734|THROMBIN LIGHT CHAIN|8.7|Ki=2.01nM|Ki|=|2.01|nM|2.01|nM
4J28|1.73|2013|EAT|Ki=2.0+/-0.1uM|Q8A3I4|ALPHA-L-FUCOSIDASE|5.7|Ki=2.0uM|Ki|=|2|uM|2000|nM
4JFJ|1.08|2013|1KU|Ki=2.1+/-0.2uM|Q13451|PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5|5.68|Ki=2.1uM|Ki|=|2.1|uM|2100|nM
4KP0|2.80|2013|KPK||P23946|CHYMASE|8.65|Ki=2.24nM|Ki|=|2.24|nM|2.24|nM
4J48|2.10|2013|4-mer||P98170|E3 UBIQUITIN-PROTEIN LIGASE XIAP|5.62|Ki=2.41uM|Ki|=|2.41|uM|2410|nM
4BAN|1.87|2013|M6S|ligand is compound 2; Ki=2.43+/-0.07nM|P00734|THROMBIN LIGHT CHAIN|8.61|Ki=2.43nM|Ki|=|2.43|nM|2.43|nM
4IID|2.30|2013|NOJ|Ki=2.4+/-0.3uM|P48825|BETA-GLUCOSIDASE 1|5.62|Ki=2.4uM|Ki|=|2.4|uM|2400|nM
4GJ2|2.40|2013|0XH||P29597|NON-RECEPTOR TYROSINE-PROTEIN KINASE TYK2|8.6|Ki=2.5nM|Ki|=|2.5|nM|2.5|nM
3VTR|2.50|2013|TCG||Q06GJ0|N-ACETYLGLUCOSAMINIDASE|5.57|Ki=2.714uM|Ki|=|2.714|uM|2714|nM
4KWW|2.55|2013|PHT|Ki = 2.8 +/- 0.4 uM|Q15274|NICOTINATE-NUCLEOTIDE PYROPHOSPHORYLASE|5.55|Ki=2.8uM|Ki|=|2.8|uM|2800|nM
4HWO|1.91|2013|409|Zn-containing; Ki by a coupled spectrophotometric assay|P0A8M3|THREONINE-TRNA LIGASE|8.54|Ki=2.9nM|Ki|=|2.9|nM|2.9|nM
4MM6|3.10|2013|29E|ligand is duloxetine;Ki = 205 +/- 15 nM|O67854|TRANSPORTER|6.69|Ki=205nM|Ki|=|205|nM|205|nM
4MM9|2.90|2013|FVX|ligand is fluvoxamine;Ki = 2070 +/- 272 nM|O67854|TRANSPORTER|5.68|Ki=2070nM|Ki|=|2070|nM|2070|nM
4CA8|1.99|2013|3ES|Zn-containing; Ki=210nM, 95% confidence interval 180-246 nM|Q10714|ANGIOTENSIN-CONVERTING ENZYME|6.68|Ki=210nM|Ki|=|210|nM|210|nM
4N99|2.30|2013|2J1|ligand is compound 7|P0A988|DNA POLYMERASE III SUBUNIT BETA|3.67|Ki=216uM|Ki|=|216|uM|216000|nM
3ZPR|2.70|2013|3WC|ligand is compound 20; pKi=6.65|P07700|BETA-1 ADRENERGIC RECEPTOR|6.65|Ki=224nM|Ki|=|224|nM|224|nM
4BCH|2.96|2013|T7Z|ligand is compound 4|P50750|CYCLIN-DEPENDENT KINASE 9|7.66|Ki=22nM|Ki|=|22|nM|22|nM
4HZM|1.45|2013|1BW||Q8ZQ06|BETA-HEXOSAMINIDASE|4.63|Ki=23.2uM|Ki|=|23.2|uM|23200|nM
4I80|3.10|2013|9-mer||O00255|MENIN|7.62|Ki=23.8nM|Ki|=|23.8|nM|23.8|nM
4MM7|2.85|2013|29J|ligand is desvenlafaxine;Ki = 235500 +/- 82352 nM|O67854|TRANSPORTER|3.63|Ki=235.5uM|Ki|=|235.5|uM|235500|nM
4K77|2.40|2013|1Q4|ligand is compound 6|P23458|TYROSINE-PROTEIN KINASE JAK1|6.63|Ki=235nM|Ki|=|235|nM|235|nM
4LCH|1.60|2013|1WN|ligand is compound 24c; Ki=0.024+/-0.004 nM (EcLpxC)|P47205|UDP-3-O-[3-HYDROXYMYRISTOYL] N-ACETYLGLUCOSAMINE DEACETYLASE|10.62|Ki=24pM|Ki|=|24|pM|0.024|nM
4BDS|2.10|2013|THA|ligand is tacrine|P06276|CHOLINESTERASE|7.6|Ki=25nM|Ki|=|25|nM|25|nM
2YOF|1.82|2013|74W|ligand is compound 53|Q8I4S1|THYMIDYLATE KINASE|4.6|Ki=25uM|Ki|=|25|uM|25000|nM
4J03|2.92|2013|FVS|Ki=26+/-3nM|P34913|EPOXIDE HYDROLASE 2|7.59|Ki=26nM|Ki|=|26|nM|26|nM
4AMW|1.90|2013|5DI|Ki=28.3+/-2.1mM|Q9STC1|ALPHA-1,4-GLUCAN LYASE ISOZYME 1|1.55|Ki=28.3mM|Ki|=|28.3|mM|28300000|nM
3ZMT|3.10|2013|6-mer|ligand is peptide PRSFLV|O60341|LYSINE-SPECIFIC HISTONE DEMETHYLASE 1A|4.55|Ki=28.4uM|Ki|=|28.4|uM|28400|nM
4N98|1.70|2013|4FC|ligand is compound 5|P0A988|DNA POLYMERASE III SUBUNIT BETA|3.55|Ki=280uM|Ki|=|280|uM|280000|nM
4MJR|1.62|2013|0LA|(S)-Carprofen|P0A988|DNA POLYMERASE III SUBUNIT BETA|3.55|Ki=283uM|Ki|=|283|uM|283000|nM
3ZN1|3.10|2013|6-mer|ligand is peptide PRLYLV|O60341|LYSINE-SPECIFIC HISTONE DEMETHYLASE 1A|4.54|Ki=29.1uM|Ki|=|29.1|uM|29100|nM
4HY1|1.90|2013|19X|Ki by coupled spectrophotometric Enzchek assay|Q2A1P5|TOPOISOMERASE IV, SUBUNIT B|8.7|Ki=2nM|Ki|=|2|nM|2|nM
4HXW|1.69|2013|1A0|Ki (the coupled spectrophotometric Enzchek assay)|Q839Z1|DNA GYRASE SUBUNIT B|8.7|Ki=2nM|Ki|=|2|nM|2|nM
4JJG|2.50|2013|2-mer|ligand is FE9-IC9; Fe-contained, Different ligand structures (number of carbon); covalent complex|P32440|5,10-METHENYLTETRAHYDROMETHANOPTERIN HYDROGENASE|8.7|Ki=2nM|Ki|=|2|nM|2|nM
4K6Z|2.73|2013|1Q3|ligand is compound 37|P23458|TYROSINE-PROTEIN KINASE JAK1|8.7|Ki=2nM|Ki|=|2|nM|2|nM
4BS0|1.09|2013|6NT||P23360|KEMP ELIMINASE HG3.17|5.7|Ki=2uM|Ki|=|2|uM|2000|nM
3V0L|1.75|2013|2GW|ligand is compound 2|P16442|HISTO-BLOOD GROUP ABO SYSTEM TRANSFERASE|5.52|Ki=3.0uM|Ki|=|3|uM|3000|nM
3ZPT|1.54|2013|M8Y|ligand is (R)-19a|P03366|HIV-1 PROTEASE|8.51|Ki=3.1nM|Ki|=|3.1|nM|3.1|nM
4HDF|1.29|2013|G52|Ki=3.2+/-0.2nM|P03367|HIV-1 PROTEASE|8.49|Ki=3.2nM|Ki|=|3.2|nM|3.2|nM
4M2R|1.99|2013|BZ1|ligand is BRZ|P00918|CARBONIC ANHYDRASE 2|8.49|Ki=3.2nM|Ki|=|3.2|nM|3.2|nM
4HE9|1.06|2013|G52|Na-containing; Ki = 3.5 +/- 0.2 nM; covalent complex|P03367|HIV-1 PROTEASE|8.46|Ki=3.5nM|Ki|=|3.5|nM|3.5|nM
4JFT|2.10|2013|1KN||Q8A3I4|ALPHA-L-FUCOSIDASE|5.46|Ki=3.5uM|Ki|=|3.5|uM|3500|nM
4J26|2.30|2013|12-mer|Ki=3.64+/-0.21uM|Q92731|ESTROGEN RECEPTOR BETA|5.44|Ki=3.64uM|Ki|=|3.64|uM|3640|nM
4HDP|1.22|2013|G52|Na-containing; Ki=30.9+/-0.6nM|P03367|HIV-1 PROTEASE|7.51|Ki=30.9nM|Ki|=|30.9|nM|30.9|nM
4C70|1.75|2013|TLJ|Ki = 305.0 +/- 8.0 uM|I6Y8T4|3-OXOACYL-[ACYL-CARRIER-PROTEIN] SYNTHASE 1|3.52|Ki=305uM|Ki|=|305|uM|305000|nM
4LH3|1.81|2013|GUA|ligand is Glutarate; Ki = 30 +/- 3 mM|Q8CHT0|DELTA-1-PYRROLINE-5-CARBOXYLATE DEHYDROGENASE|1.52|Ki=30mM|Ki|=|30|mM|30000000|nM
4LPF|2.30|2013|3TR|ki=310+/-30uM|I6XBW5|IMIDAZOLEGLYCEROL-PHOSPHATE DEHYDRATASE|3.51|Ki=310uM|Ki|=|310|uM|310000|nM
4KZU|2.10|2013|A73|Zn-containing|Q9H2K2|TANKYRASE-2|6.5|Ki=313nM|Ki|=|313|nM|313|nM
2YOG|1.50|2013|74X|ligand is compound 28|Q8I4S1|THYMIDYLATE KINASE|4.51|Ki=31uM|Ki|=|31|uM|31000|nM
4CCD|1.97|2013|2DG|Ki = 32 +/- 1.8 uM; covalent complex|P54818|GALACTOCEREBROSIDASE|4.49|Ki=32uM|Ki|=|32|uM|32000|nM
4BVB|2.00|2013|OCZ|Ki = 33.4 +/- 4.4 uM|Q9NTG7|NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-3|4.48|Ki=33.4uM|Ki|=|33.4|uM|33400|nM
4H42|2.01|2013|11E||P00749|UROKINASE-TYPE PLASMINOGEN ACTIVATOR|3.47|Ki=341uM|Ki|=|341|uM|341000|nM
4K5P|1.85|2013|1OS|ligand is compound 7|O96935|M1 FAMILY AMINOPEPTIDASE|3.46|Ki=345uM|Ki|=|345|uM|345000|nM
4C6Z|1.80|2013|TLE|Ki = 357.0 +/- 35.0 uM|I6Y8T4|3-OXOACYL-[ACYL-CARRIER-PROTEIN] SYNTHASE 1|3.45|Ki=357.0uM|Ki|=|357|uM|357000|nM
3ZNR|2.40|2013|NU9|ligand is TMP269,1|Q8WUI4|HISTONE DEACETYLASE 7|7.44|Ki=36nM|Ki|=|36|nM|36|nM
4M2V|1.72|2013|BZ1|ligand is BRZ|P00918|CARBONIC ANHYDRASE 2|7.44|Ki=36nM|Ki|=|36|nM|36|nM
4C71|1.80|2013|7RD|Ki = 384.0 +/- 12.0 uM|I6Y8T4|3-OXOACYL-[ACYL-CARRIER-PROTEIN] SYNTHASE 1|3.42|Ki=384.0uM|Ki|=|384|uM|384000|nM
3ZNS|2.45|2013|NU7|ligand is TMP942,3|Q8WUI4|HISTONE DEACETYLASE 7|7.41|Ki=39nM|Ki|=|39|nM|39|nM
4BAO|1.87|2013|MVF|ligand is compound 1; Ki=4.29+/-0.10nM|P00734|THROMBIN LIGHT CHAIN|8.37|Ki=4.29nM|Ki|=|4.29|nM|4.29|nM
3ZPU|1.80|2013|M8B|ligand is (R)-19b|P03366|HIV-1 PROTEASE|8.38|Ki=4.2nM|Ki|=|4.2|nM|4.2|nM
4IIE|2.00|2013|CGB|Ki=4.6+/-1.0mM|P48825|BETA-GLUCOSIDASE 1|2.34|Ki=4.6mM|Ki|=|4.6|mM|4600000|nM
4GIU|1.67|2013|636|ligand is compound 34, Uncompetitive Ki value|P66992|ANTHRANILATE PHOSPHORIBOSYLTRANSFERASE|5.33|Ki=4.7uM|Ki|=|4.7|uM|4700|nM
4BBG|2.75|2013|V02|ligand is compound 46;Ki=4.8+/-1.2nM|P52732|KINESIN-LIKE PROTEIN KIF11|8.32|Ki=4.8nM|Ki|=|4.8|nM|4.8|nM
4KS3|2.60|2013|1SL|ligand is compound 6|Q0A480|NEURAMINIDASE|6.37|Ki=430nM|Ki|=|430|nM|430|nM
4CA7|1.82|2013|3EF|Zn-containing|Q10714|ANGIOTENSIN-CONVERTING ENZYME|7.36|Ki=44nM|Ki|=|44|nM|44|nM
4LVT|2.05|2013|1XJ|ligand is Navitoclax(1); Ki=0.044nM(TR-FRET)|P10415|APOPTOSIS REGULATOR BCL-2|10.36|Ki=44pM|Ki|=|44|pM|0.044|nM
3ZDH|2.20|2013|XRS|ligand is compound 7|P58154|ACETYLCHOLINE-BINDING PROTEIN|7.35|Ki=45nM|Ki|=|45|nM|45|nM
3ZMU|3.20|2013|6-mer|ligand is peptide PKSFLV|O60341|LYSINE-SPECIFIC HISTONE DEMETHYLASE 1A|4.3|Ki=49.6uM|Ki|=|49.6|uM|49600|nM
4BCK|2.05|2013|T3E|ligand is compound 12c|P24941|CELL DIVISION PROTEIN KINASE 2|8.4|Ki=4nM|Ki|=|4|nM|4|nM
4IJ1|1.79|2013|17C|ligand is compound ACS172, Competitive Ki value|P66992|ANTHRANILATE PHOSPHORIBOSYLTRANSFERASE|5.4|Ki=4uM|Ki|=|4|uM|4000|nM
3ZPS|1.55|2013|EQM|ligand is (R)-17b, ring of ligand is opening in the crystal.|P03366|HIV-1 PROTEASE|8.3|Ki=5.0nM|Ki|=|5|nM|5|nM
4ELB|2.60|2013|34R/34S|Ki = 5.0 +/- 0.6 nM; Ca-containing|Q81R22|DIHYDROFOLATE REDUCTASE|8.3|Ki=5.0nM|Ki|=|5|nM|5|nM
4F2W|2.00|2013|TDI|Ki=5.0+/-0.4 pM|E8NLP5|MTA/SAH NUCLEOSIDASE|11.3|Ki=5.0pM|Ki|=|5|pM|0.005|nM
4J46|1.42|2013|4-mer||P98170|E3 UBIQUITIN-PROTEIN LIGASE XIAP|5.28|Ki=5.24uM|Ki|=|5.24|uM|5240|nM
4MFE|2.61|2013|3PY|ligand is 3-Hydroxypyruvate|Q2K340|PYRUVATE CARBOXYLASE|2.27|Ki=5.4mM|Ki|=|5.4|mM|5400000|nM
4JFS|2.00|2013|16Z||Q8A3I4|ALPHA-L-FUCOSIDASE|5.27|Ki=5.4uM|Ki|=|5.4|uM|5400|nM
4JSZ|1.90|2013|FB2|Ki=5000+/-1100uM; Zn-containing|P00918|CARBONIC ANHYDRASE 2|2.3|Ki=5000uM|Ki|=|5000|uM|5000000|nM
4EOR|2.20|2013|4SP|Ki=500+/-30nM|P24941|CELL DIVISION PROTEIN KINASE 2|6.3|Ki=500nM|Ki|=|500|nM|500|nM
4JSS|1.50|2013|BEW|Ki=500+/-60uM; Zn-containing|P00918|CARBONIC ANHYDRASE 2|3.3|Ki=500uM|Ki|=|500|uM|500000|nM
4IWZ|1.60|2013|1GO|Ki=51+/-3.1nM by stopped-flow CO2 hydrase assay; Zn-containing|P00918|CARBONIC ANHYDRASE 2|7.29|Ki=51nM|Ki|=|51|nM|51|nM
4M2W|1.66|2013|ETS|ligand is DRZ|P00918|CARBONIC ANHYDRASE 2|7.28|Ki=52nM|Ki|=|52|nM|52|nM
3ZMV|3.00|2013|6-mer|ligand is peptide PLSFLV|O60341|LYSINE-SPECIFIC HISTONE DEMETHYLASE 1A|4.26|Ki=55uM|Ki|=|55|uM|55000|nM
4BCP|2.26|2013|T3C|ligand is compound 12u|P24941|CELL DIVISION PROTEIN KINASE 2|6.25|Ki=568nM|Ki|=|568|nM|568|nM
4LH2|1.67|2013|SIN|ligand is Succinate; Ki = 58 +/- 4 mM|Q8CHT0|DELTA-1-PYRROLINE-5-CARBOXYLATE DEHYDROGENASE|1.24|Ki=58mM|Ki|=|58|mM|58000000|nM
4IQ6|3.12|2013|IQ6||P49841|GLYCOGEN SYNTHASE KINASE-3 BETA|7.24|Ki=58nM|Ki|=|58|nM|58|nM
4LXD|1.90|2013|1XV|ligand is compound 2|P10415|APOPTOSIS REGULATOR BCL-2|7.23|Ki=59nM|Ki|=|59|nM|59|nM
4GFN|1.90|2013|SUY|Ki (the coupled spectrophotometric Enzchek assay)|Q839Z1|DNA GYRASE SUBUNIT B|8.3|Ki=5nM|Ki|=|5|nM|5|nM
4LKO|2.43|2013|1WH||P27487|DIPEPTIDYL PEPTIDASE 4|8.22|Ki=6.0nM|Ki|=|6|nM|6|nM
4AMX|2.10|2013|5GF|ligand is 5FGlcF|Q9STC1|ALPHA-1,4-GLUCAN LYASE ISOZYME 1|2.19|Ki=6.5mM|Ki|=|6.5|mM|6500000|nM
3W37|1.70|2013|ACR||L0N7E5|ALPHA-GLUCOSIDASE|5.18|Ki=6.68uM|Ki|=|6.68|uM|6680|nM
4IIF|2.45|2013|CTS|Ki=6.6+/-0.6uM|P48825|BETA-GLUCOSIDASE 1|5.18|Ki=6.6uM|Ki|=|6.6|uM|6600|nM
4GKM|1.67|2013|683|ligand is compound 14|P66992|ANTHRANILATE PHOSPHORIBOSYLTRANSFERASE|5.17|Ki=6.8uM|Ki|=|6.8|uM|6800|nM
4ELG|2.10|2013|52I/52J|Ki=6.9+/-0.5 nM; Ca-containing|Q81R22|DIHYDROFOLATE REDUCTASE|8.16|Ki=6.9nM|Ki|=|6.9|nM|6.9|nM
4BQS|2.15|2013|K2Q|Ki=62+/-1uM|P0A4Z2|SHIKIMATE KINASE|4.21|Ki=62uM|Ki|=|62|uM|62000|nM
4N9A|1.90|2013|2J2|ligand is compound 8|P0A988|DNA POLYMERASE III SUBUNIT BETA|4.19|Ki=64uM|Ki|=|64|uM|64000|nM
3ZPQ|2.80|2013|XF5|ligand is compound 19; pKi=7.17|P07700|BETA-1 ADRENERGIC RECEPTOR|7.17|Ki=67.6nM|Ki|=|67.6|nM|67.6|nM
4IVA|1.50|2013|1J5|Ki=1.9nM(when protein is JAK1); Ki(JAK2)/Ki(JAK1)=36|O60674|TYROSINE-PROTEIN KINASE JAK2|7.16|Ki=68.4nM|Ki|=|68.4|nM|68.4|nM
4F3K|1.85|2013|HCE|Ki=69.0+/-12.1 pM|E8NLP5|MTA/SAH NUCLEOSIDASE|10.16|Ki=69.0pM|Ki|=|69|pM|0.069|nM
3ZBX|2.20|2013|6XE|ligand is compound 7|P08581|HEPATOCYTE GROWTH FACTOR RECEPTOR|8.22|Ki=6nM|Ki|=|6|nM|6|nM
4BCI|3.10|2013|T3E|ligand is compound 12c|P50750|CYCLIN-DEPENDENT KINASE 9|8.22|Ki=6nM|Ki|=|6|nM|6|nM
4HYM|1.90|2013|CJC|Ki by coupled spectrophotometric Enzchek assay|Q2A1P5|TOPOISOMERASE IV, SUBUNIT B|8.22|Ki=6nM|Ki|=|6|nM|6|nM
4LRR|2.41|2013|CF9|ligand is compound 3; Ki=6+/-0.2 uM|P0A886|THYMIDYLATE SYNTHASE|5.22|Ki=6uM|Ki|=|6|uM|6000|nM
4ISI|1.94|2013|1GG||P08709|COAGULATION FACTOR VII|8.14|Ki=7.3nM|Ki|=|7.3|nM|7.3|nM
4GLY|1.52|2013|14-mer||P00749|UROKINASE-TYPE PLASMINOGEN ACTIVATOR|5.11|Ki=7.7uM|Ki|=|7.7|uM|7700|nM
4KS4|2.50|2013|1SN|ligand is compound 7|Q0A480|NEURAMINIDASE|7.14|Ki=72nM|Ki|=|72|nM|72|nM
3ZC5|2.20|2013|W9Z|ligand is compound 8|P08581|HEPATOCYTE GROWTH FACTOR RECEPTOR|7.13|Ki=74nM|Ki|=|74|nM|74|nM
4KX8|2.40|2013|4-mer|ligand is peptide from amastatin (L20-VAL-VAL-SAP)|Q07075|GLUTAMYL AMINOPEPTIDASE|7.13|Ki=74nM|Ki|=|74|nM|74|nM
4KXB|2.40|2013|BES|ligand is bestatin|Q07075|GLUTAMYL AMINOPEPTIDASE|4.12|Ki=75uM|Ki|=|75|uM|75000|nM
2LWI|NMR|2013|KOB|ligand is Kobe2601;Ki=77+/-49uM|P01112|GTPASE HRAS|3.11|Ki=773uM|Ki|=|773|uM|773000|nM
4MM8|3.31|2013|RFX|ligand is fluoxetine;Ki = 778 +/- 76 nM|O67854|TRANSPORTER|6.11|Ki=778nM|Ki|=|778|nM|778|nM
3ZDG|2.48|2013|XRX|ligand is compound 4|P58154|ACETYLCHOLINE-BINDING PROTEIN|7.1|Ki=79nM|Ki|=|79|nM|79|nM
4BCF|3.01|2013|T6Q|ligand is compound 12t|P50750|CYCLIN-DEPENDENT KINASE 9|8.15|Ki=7nM|Ki|=|7|nM|7|nM
4BCG|3.08|2013|T3C|ligand is compound 12u|P50750|CYCLIN-DEPENDENT KINASE 9|8.15|Ki=7nM|Ki|=|7|nM|7|nM
4N5T|1.70|2013|15-mer||Q7ZUW7|PROTEIN MDM4|8.15|Ki=7nM|Ki|=|7|nM|7|nM
4ELH|2.10|2013|53I/53J|Ki=8.2+/-0.5 nM; Ca-containing|Q81R22|DIHYDROFOLATE REDUCTASE|8.09|Ki=8.2nM|Ki|=|8.2|nM|8.2|nM
4C72|1.50|2013|TLG|Ki = 8.2 +/- 0.8 uM|I6Y8T4|3-OXOACYL-[ACYL-CARRIER-PROTEIN] SYNTHASE 1|5.09|Ki=8.2uM|Ki|=|8.2|uM|8200|nM
4MF0|2.67|2013|29Z|ligand is compound 13a|Q08881|TYROSINE-PROTEIN KINASE ITK/TSK|8.08|Ki=8.4nM|Ki|=|8.4|nM|8.4|nM
4HDB|1.49|2013|G52|Na-containing; Kd=8.9+/-0.4nM|P03367|HIV-1 PROTEASE|8.05|Ki=8.9nM|Ki|=|8.9|nM|8.9|nM
4I8Z|1.75|2013|G08||P0C6F2|HIV-1 PROTEASE|11.05|Ki=8.9pM|Ki|=|8.9|pM|0.0089|nM
4KVM|2.60|2013|5-mer|Ki = 8.9 +/- 0.1 uM|O74985|N-TERMINAL ACETYLTRANSFERASE A COMPLEX SUBUNIT NAT1|5.05|Ki=8.9uM|Ki|=|8.9|uM|8900|nM
4EOK|2.57|2013|4SP|Ki = 8600 +/- 3200 nM|P24941|CYCLIN-DEPENDENT KINASE 2|5.07|Ki=8600nM|Ki|=|8600|nM|8600|nM
4M2U|2.00|2013|ETS|ligand is DRZ|P00918|CARBONIC ANHYDRASE 2|8.04|Ki=9.1nM|Ki|=|9.1|nM|9.1|nM
4ELF|2.30|2013|35I|Ca-containing; Ki=9.4+/-0.5 nM|Q81R22|DIHYDROFOLATE REDUCTASE|8.03|Ki=9.4nM|Ki|=|9.4|nM|9.4|nM
4MMA|3.30|2013|CXX|ligand is clomipramine;Ki = 920 +/- 76 nM|O67854|TRANSPORTER|6.04|Ki=920nM|Ki|=|920|nM|920|nM
4N6Y|2.60|2013|2HV|ligand is compound 1a|P11309|SERINE/THREONINE-PROTEIN KINASE PIM-1|7.04|Ki=92nM|Ki|=|92|nM|92|nM
4JHZ|2.83|2013|1KV|ligand is inhibitor 8|P05804|BETA-GLUCURONIDASE|6.02|Ki=957nM|Ki|=|957|nM|957|nM
4BCW|1.50|2013|TU0|ligand is compound 9,the ring is open.|P00918|CARBONIC ANHYDRASE 2|4.0|Ki>100uM|Ki|>|100|uM|100000|nM
4HWT|2.30|2013|1B2|Zn-containing; Ki(a coupled spectrophotometric assay)|P26639|THREONINE--TRNA LIGASE, CYTOPLASMIC|4.3|Ki>50000nM|Ki|>|50000|nM|50000|nM
4IU4|1.80|2013|S2C|Measure the urea colorimetrically, B-contained; Mn-containing|Q6TUJ5|ARGINASE|5.0|Ki~10uM|Ki|~|10|uM|10000|nM
4FYH|2.44|2013|TR5||O35820|DEOXYRIBONUCLEOSIDE 5'-MONOPHOSPHATE N-GLYCOSIDASE|4.85|Ki~14uM|Ki|~|14|uM|14000|nM
4IU1|1.95|2013|NNH|Measure the urea colorimetrically; Mn-containing|Q6TUJ5|ARGINASE|4.3|Ki~50uM|Ki|~|50|uM|50000|nM
4WHZ|1.79|2014|3NL|ligand is compound 26k|P53779|MITOGEN-ACTIVATED PROTEIN KINASE 10|9.0|IC<1nM|IC50|<|1|nM|1|nM
4URO|2.59|2014|NOV|ligand is Novobiocin|P0A0K8|DNA GYRASE SUBUNIT B|8.4|IC<4nM|IC50|<|4|nM|4|nM
4KQL|2.31|2014|1SG|ligand is compound 24a, WG578|P43889|BIFUNCTIONAL PROTEIN GLMU|8.77|IC=0.0017uM|IC50|=|0.0017|uM|1.7|nM
4O12|2.50|2014|2QG|ligand is compound GMX1778|P43490|NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE|8.7|IC=0.002uM|IC50|=|0.002|uM|2|nM
4C61|2.45|2014|LMM|ligand is compound 23b|O60674|TYROSINE-PROTEIN KINASE JAK2|8.4|IC=0.004uM|IC50|=|0.004|uM|4|nM
4MQU|2.22|2014|MG9|ligand is compound 27|Q14397|GLUCOKINASE REGULATORY PROTEIN|8.4|IC=0.004uM|IC50|=|0.004|uM|4|nM
4MHA|2.59|2014|4MH|ligand is compound 22|Q12866|TYROSINE-PROTEIN KINASE MER|8.28|IC=0.0052uM|IC50|=|0.0052|uM|5.2|nM
4JPS|2.20|2014|1LT|ligand is compound 8|P42336|PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE|8.3|IC=0.005uM|IC50|=|0.005|uM|5|nM
4L4L|2.12|2014|1XC|ligand is compound PRib-GNE-617, PRPP adduct of GNE-617. affinity is for GNE-617|P43490|NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE|8.3|IC=0.005uM|IC50|=|0.005|uM|5|nM
4LWU|1.14|2014|20U|ligand is RO5499252, compound 20, HTRF binding assay|P56273|E3 UBIQUITIN-PROTEIN LIGASE MDM2|8.3|IC=0.005uM|IC50|=|0.005|uM|5|nM
4D0X|1.82|2014|953|ligand is compound 28|O60674|TYROSINE-PROTEIN KINASE JAK2|8.1|IC=0.008uM|IC50|=|0.008|uM|8|nM
4NCG|2.58|2014|2KW|ligand is compound 36|P04585|HIV-1 REVERSE TRANSCRIPTASE/RIBONUCLEASE H|7.96|IC=0.011uM|IC50|=|0.011|uM|11|nM
4MZS|1.85|2014|2EV|covalent ligand, compound 57, IC50 is for human Cathepsin S|O70370|CATHEPSIN S|7.92|IC=0.012uM|IC50|=|0.012|uM|12|nM
4N9E|1.72|2014|2HL|ligand is compound 63|P43490|NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE|7.82|IC=0.015uM|IC50|=|0.015|uM|15|nM
3WCB|3.00|2014|8PH|BPH-1237/TcSQS|Q4CWB4|FARNESYLTRANSFERASE, PUTATIVE|7.74|IC=0.018uM|IC50|=|0.018|uM|18|nM
4N9D|1.70|2014|2HJ|ligand is compound 51|P43490|NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE|7.72|IC=0.019uM|IC50|=|0.019|uM|19|nM
4L4M|2.44|2014|1XD|ligand is GNE-643|P43490|NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE|8.0|IC=0.01uM|IC50|=|0.01|uM|10|nM
4U45|2.58|2014|3DC|ligand is compound 25|O95819|MITOGEN-ACTIVATED PROTEIN KINASE 4|8.0|IC=0.01uM|IC50|=|0.01|uM|10|nM
4N8E|2.30|2014|2KV|ligand is compound 12a|P27487|DIPEPTIDYL PEPTIDASE 4|7.7|IC=0.020uM|IC50|=|0.02|uM|20|nM
4D1S|1.66|2014|BJG|ligand is compound 24|O60674|TYROSINE-PROTEIN KINASE JAK2|7.66|IC=0.022uM|IC50|=|0.022|uM|22|nM
4LWI|1.70|2014|FJ6|compound 60|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|7.64|IC=0.023uM|IC50|=|0.023|uM|23|nM
4LWH|1.70|2014|FJ5|compound 93|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|7.57|IC=0.027uM|IC50|=|0.027|uM|27|nM
4D0W|1.77|2014|VVQ|ligand is compound 6|O60674|TYROSINE-PROTEIN KINASE JAK2|7.7|IC=0.02uM|IC50|=|0.02|uM|20|nM
4K2G|2.30|2014|1OQ|ligand is compound 4, BRD-A33442372|Q9I194|ACYL-HOMOSERINE LACTONE ACYLASE PVDQ|7.7|IC=0.02uM|IC50|=|0.02|uM|20|nM
4NLD|2.75|2014|2N7|ligand is compound 2|Q9WMX2|RNA-DIRECTED RNA POLYMERASE|7.7|IC=0.02uM|IC50|=|0.02|uM|20|nM
4NW5|1.94|2014|2NR|ligand is compound 8|P51812|RIBOSOMAL PROTEIN S6 KINASE ALPHA-3|7.7|IC=0.02uM|IC50|=|0.02|uM|20|nM
4TW9|2.40|2014|386|ligand is compound 1; IC50=0.02+/-0.02uM|P48730|CASEIN KINASE I ISOFORM DELTA|7.7|IC=0.02uM|IC50|=|0.02|uM|20|nM
4TYT|1.80|2014|S3C|ligand is ML302F; IC50=0.02+/-0.07uM|P04190|BETA-LACTAMASE 2|7.7|IC=0.02uM|IC50|=|0.02|uM|20|nM
4OON|3.20|2014|2U4|ligand is compound 17|Q07806|PENICILLIN-BINDING PROTEIN 1A|7.52|IC=0.030uM|IC50|=|0.03|uM|30|nM
4J3J|3.20|2014|D3C|ligand is compound 21r, but two N atoms are different|P27487|DIPEPTIDYL PEPTIDASE 4|7.51|IC=0.031uM|IC50|=|0.031|uM|31|nM
4KWP|1.25|2014|EXX|ligand is compound K164|P68400|CASEIN KINASE II, ALPHA SUBUNIT|7.49|IC=0.032uM|IC50|=|0.032|uM|32|nM
4D2V|2.45|2014|45R|ligand is compound 7|Q14680|MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE|7.43|IC=0.037uM|IC50|=|0.037|uM|37|nM
4WWO|2.30|2014|3VD|ligand is compound 16|P48736|PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE|7.42|IC=0.0380uM|IC50|=|0.038|uM|38|nM
4TWC|1.70|2014|37J|ligand is compound 5;|P48730|CASEIN KINASE I ISOFORM DELTA|7.4|IC=0.040uM|IC50|=|0.04|uM|40|nM
4NXS|2.55|2014|2OZ|DGJ-pFPhT; IC50=0.043+/-0.0062uM (PH=7)|P06280|ALPHA-GALACTOSIDASE A|7.37|IC=0.043uM|IC50|=|0.043|uM|43|nM
4KNB|2.40|2014|1RU|ligand is compound R-(5a)|P08581|HEPATOCYTE GROWTH FACTOR RECEPTOR|7.33|IC=0.047uM|IC50|=|0.047|uM|47|nM
4K2F|1.99|2014|A08|ligand is compound 3, BRD-A08522488|Q9I194|ACYL-HOMOSERINE LACTONE ACYLASE PVDQ|7.4|IC=0.04uM|IC50|=|0.04|uM|40|nM
4OTY|2.35|2014|LUR|ligand is compound 1(lumiracoxib); IC50= 0.04+/-0.01uM (substrate 2-AG);|Q05769|PROSTAGLANDIN G/H SYNTHASE 2|7.4|IC=0.04uM|IC50|=|0.04|uM|40|nM
4WHH|1.90|2014|5-mer|ligand is peptide 22|P53350|SERINE/THREONINE-PROTEIN KINASE PLK1|7.4|IC=0.04uM|IC50|=|0.04|uM|40|nM
3WCF|2.22|2014|BH8|ligand is BPH1218|P37268|SQUALENE SYNTHASE|7.28|IC=0.053uM|IC50|=|0.053|uM|53|nM
4O0Z|2.05|2014|2RM|ligand is compound GNE-200|P43490|NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE|7.24|IC=0.057uM|IC50|=|0.057|uM|57|nM
4CL9|1.40|2014|IES|ligand is DUAL946 (1), IC50=0.05uM|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|7.3|IC=0.05uM|IC50|=|0.05|uM|50|nM
4KPX|2.21|2014|1SE|ligand is compound 14b, WG766|P43889|BIFUNCTIONAL PROTEIN GLMU|7.3|IC=0.05uM|IC50|=|0.05|uM|50|nM
4PIS|2.10|2014|3FU|ligand is inhibitor 14|B9A5C1|PROTEASE|7.22|IC=0.06uM|IC50|=|0.06|uM|60|nM
4C1E|1.40|2014|MCO|ligand is D-captopril|Q9K2N0|BETA-LACTAMASE CLASS B VIM-2|7.14|IC=0.072uM|IC50|=|0.072|uM|72|nM
4O10|1.55|2014|2QF|ligand is compound GNE-201|P43490|NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE|7.11|IC=0.078uM|IC50|=|0.078|uM|78|nM
4LWE|1.50|2014|FJ2|compound 24|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|7.15|IC=0.07uM|IC50|=|0.07|uM|70|nM
4MRO|2.20|2014|MG0|ligand is compound 23|Q14397|GLUCOKINASE REGULATORY PROTEIN|7.06|IC=0.087uM|IC50|=|0.087|uM|87|nM
3WCH|2.50|2014|8PH|ligand is BPH1237|P37268|SQUALENE SYNTHASE|7.05|IC=0.089uM|IC50|=|0.089|uM|89|nM
4PIQ|2.07|2014|3FS|ligand is inhibitor 9|B9A5C1|PROTEASE|7.1|IC=0.08uM|IC50|=|0.08|uM|80|nM
4J1P|1.08|2014|1K0|target is BRD2(BD2)|Q658Y7|BROMODOMAIN-CONTAINING PROTEIN 2|7.05|IC=0.09uM|IC50|=|0.09|uM|90|nM
4OAS|1.70|2014|2SW|ligand is compound 25; IC50=0.10+/-0.04nM (biochemical potency HTRF IC50)|Q00987|E3 UBIQUITIN-PROTEIN LIGASE MDM2|10.0|IC=0.10nM|IC50|=|0.1|nM|0.1|nM
4PKB|2.09|2014|MAY|ligand is MAFP; IC50=0.116+/-0.0046uM|Q8LPW4|PATATIN-17|6.94|IC=0.116uM|IC50|=|0.116|uM|116|nM
4PZW|1.80|2014|2X4|ligand is compound 13|P56817|BETA-SECRETASE 1|6.96|IC=0.11uM|IC50|=|0.11|uM|110|nM
4OP1|2.39|2014|2UW|ligand is compound 59; IC50=0.129+/-0.030uM|Q14397|GLUCOKINASE REGULATORY PROTEIN|6.89|IC=0.129uM|IC50|=|0.129|uM|129|nM
4TN2|2.70|2014|33J|ligand is compound 5g|P26663|GENOME POLYPROTEIN|6.92|IC=0.12uM|IC50|=|0.12|uM|120|nM
4WWP|2.40|2014|3VE|ligand is compound 27|P48736|PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE|6.92|IC=0.12uM|IC50|=|0.12|uM|120|nM
4UVC|3.10|2014|D52|ligand is compound 21d|O60341|LYSINE-SPECIFIC HISTONE DEMETHYLASE 1A|6.88|IC=0.131uM|IC50|=|0.131|uM|131|nM
4O76|1.70|2014|1M3|ligand is TG101209|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|6.89|IC=0.13uM|IC50|=|0.13|uM|130|nM
4TKG|1.95|2014|09L|ligand is AZD2281|Q9H2K2|TANKYRASE-2|6.85|IC=0.140uM|IC50|=|0.14|uM|140|nM
3WCG|2.80|2014|BH3|ligand is BPH-1344|Q4CWB4|FARNESYLTRANSFERASE, PUTATIVE|6.85|IC=0.14uM|IC50|=|0.14|uM|140|nM
4NZM|2.00|2014|0EJ|ligand is 5-PA-InsP5|O43314|INOSITOL HEXAKISPHOSPHATE AND DIPHOSPHOINOSITOL|6.85|IC=0.14uM|IC50|=|0.14|uM|140|nM
4OOL|2.30|2014|2U2|ligand is compound 14|U6AVY0|CELL DIVISION PROTEIN FTSI [PEPTIDOGLYCAN SYNTHETASE]|6.85|IC=0.14uM|IC50|=|0.14|uM|140|nM
4CKU|1.85|2014|P2F|ligand is compound 1SR|P46925|PLASMEPSIN-2|6.82|IC=0.15uM|IC50|=|0.15|uM|150|nM
4OW0|2.10|2014|S88|ligand is compound 3k; IC50=0.15+/- 0.01uM; modified residues ipeptidelinking|P0C6U8|PAPAIN-LIKE PROTEASE|6.82|IC=0.15uM|IC50|=|0.15|uM|150|nM
4W9S|1.80|2014|3K1|ligand is compound 11|P13166|POLYMERASE ACIDIC PROTEIN|6.82|IC=0.15uM|IC50|=|0.15|uM|150|nM
4WLB|1.70|2014|3QQ|ligand is compound 48|P51449|NUCLEAR RECEPTOR ROR-GAMMA|6.74|IC=0.18uM|IC50|=|0.18|uM|180|nM
4USJ|2.85|2014|ARG|ligand is arginine; Kd=0.1~1mM|Q9SCL7|ACETYLGLUTAMATE KINASE, CHLOROPLASTIC|4.0|IC=0.1mM|IC50|=|0.1|mM|100000|nM
4ODE|1.80|2014|2U0|ligand is compound 4; HTRF IC50=0.1+/-0.01nM; biochemical assay using serum free buffer|Q00987|E3 UBIQUITIN-PROTEIN LIGASE MDM2|10.0|IC=0.1nM|IC50|=|0.1|nM|0.1|nM
4ODF|2.20|2014|2U1|ligand is compound 47; HTRF IC50=0.1+/-0.01nM; biochemical assay using serum free buffer|Q00987|E3 UBIQUITIN-PROTEIN LIGASE MDM2|10.0|IC=0.1nM|IC50|=|0.1|nM|0.1|nM
4OGN|1.38|2014|2U5|ligand is compound 3; HTRF IC50=0.1+/-0.01nM; biochemical assay using serum free buffer|Q00987|E3 UBIQUITIN-PROTEIN LIGASE MDM2|10.0|IC=0.1nM|IC50|=|0.1|nM|0.1|nM
4OGT|1.54|2014|2U6|ligand is compound 46; HTRF IC50=0.1+/-0.05nM; biochemical assay using serum free buffer|Q00987|E3 UBIQUITIN-PROTEIN LIGASE MDM2|10.0|IC=0.1nM|IC50|=|0.1|nM|0.1|nM
4PHW|2.50|2014|2W1|ligand is compound 4|Q9Y233|CGMP 3',5'-CYCLIC PHOSPHODIESTERASE|10.0|IC=0.1nM|IC50|=|0.1|nM|0.1|nM
4O1L|2.50|2014|HO4|ligand is compound 1a; IC50=0.20+/-0.02uM|P55263|ADENOSINE KINASE|6.7|IC=0.20uM|IC50|=|0.2|uM|200|nM
4Q6R|2.40|2014|30J|ligand is compound 31; IC50=0.21+/-0.04uM|O95470|SPHINGOSINE-1-PHOSPHATE LYASE 1|6.68|IC=0.21uM|IC50|=|0.21|uM|210|nM
4CC6|2.01|2014|L5Y|ligand is compound 12|Q9AIU7|DNA LIGASE|6.64|IC=0.23uM|IC50|=|0.23|uM|230|nM
4PNK|2.56|2014|KZQ|GRK2-G-belta-gamma ; GSK180736A; log IC50 = -6.6|P25098|BETA-ADRENERGIC RECEPTOR KINASE 1|6.6|IC=0.25uM|IC50|=|0.25|uM|250|nM
3WCL|2.24|2014|BH3|ligand is BPH1344|P37268|SQUALENE SYNTHASE|6.59|IC=0.26uM|IC50|=|0.26|uM|260|nM
4MZO|1.47|2014|2EW|covalent ligand, compound 56, IC50 is for human Cathepsin S|O70370|CATHEPSIN S|6.57|IC=0.271uM|IC50|=|0.271|uM|271|nM
3WCI|2.30|2014|BH5|ligand is BPH1325|P37268|SQUALENE SYNTHASE|6.57|IC=0.27uM|IC50|=|0.27|uM|270|nM
4TKF|2.60|2014|33C|ligand is IWR-1|Q9H2K2|TANKYRASE-2|6.55|IC=0.285uM|IC50|=|0.285|uM|285|nM
4CLB|1.60|2014|83T|ligand is I-BET295|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|6.55|IC=0.28uM|IC50|=|0.28|uM|280|nM
4O9S|2.30|2014|2RY|ligand is compound 15; IC50=0.28+/-0.07uM; hRBP4 SPA|P02753|RETINOL-BINDING PROTEIN 4|6.55|IC=0.28uM|IC50|=|0.28|uM|280|nM
3WT5|1.90|2014|YA1|ligand is compound 8a, crystal form 1|P13053|VITAMIN D3 RECEPTOR|9.54|IC=0.29nM|IC50|=|0.29|nM|0.29|nM
4PS5|1.40|2014|2TA|ligand is TG101348; was PDB entry 4O73(superseded)|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|6.54|IC=0.29uM|IC50|=|0.29|uM|290|nM
4PL3|2.90|2014|31J|MKC9989 inhibitor; Mouse IRE1-alpha IC50=0.29+/-0.04uM|Q9EQY0|SERINE/THREONINE-PROTEIN KINASE/ENDORIBONUCLEASE IR|6.54|IC=0.29uM|IC50|=|0.29|uM|290|nM
4MIB|2.30|2014|28M|ligand is compound 48|P26663|RNA-DIRECTED RNA POLYMERASE|9.7|IC=0.2nM|IC50|=|0.2|nM|0.2|nM
4Q1N|2.09|2014|2Y9|ligand is compound 31|P00797|RENIN|9.7|IC=0.2nM|IC50|=|0.2|nM|0.2|nM
4M7B|1.95|2014|28C|ligand is compound 12|Q9H2K2|TANKYRASE-2|6.7|IC=0.2uM|IC50|=|0.2|uM|200|nM
4MEX|3.90|2014|9-mer|ligand is 9-mer Salinamide A peptide|P0A7Z4|DNA-DIRECTED RNA POLYMERASE SUBUNIT ALPHA|6.7|IC=0.2uM|IC50|=|0.2|uM|200|nM
4U5T|3.30|2014|3CG|NSC13778; Sb-containing|------|VBP LEUCINE ZIPPER|6.7|IC=0.2uM|IC50|=|0.2|uM|200|nM
3WYM|2.00|2014|3K9|ligand is compound 27h|Q9Y233|CGMP 3',5'-CYCLIC PHOSPHODIESTERASE|9.52|IC=0.30nM|IC50|=|0.3|nM|0.3|nM
4UV8|2.80|2014|D69|LSD1(KDM1A)-CoREST; ligand is compound 20e|O60341|LYSINE-SPECIFIC HISTONE DEMETHYLASE 1A|6.47|IC=0.335uM|IC50|=|0.335|uM|335|nM
4TJY|1.90|2014|3GN|ligand is ABT-888|Q9H2K2|TANKYRASE-2|6.44|IC=0.367uM|IC50|=|0.367|uM|367|nM
3ZMQ|3.30|2014|10-mer|ligand is 10-mer Src-derived peptide inhibitor: AC-4|P18031|PROTEIN-TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1|6.44|IC=0.36uM|IC50|=|0.36|uM|360|nM
4OYA|2.03|2014|1VE|ligand is compound 8|Q96PN6|ADENYLATE CYCLASE TYPE 10|6.44|IC=0.36uM|IC50|=|0.36|uM|360|nM
4CIK|1.78|2014|XO3|ligand is compound 17, clotlysis IC50 value|P00747|PLASMINOGEN|6.43|IC=0.37uM|IC50|=|0.37|uM|370|nM
4M8T|3.00|2014|RMM|ligand is compound 24|P18654|RIBOSOMAL PROTEIN S6 KINASE ALPHA-3|6.43|IC=0.37uM|IC50|=|0.37|uM|370|nM
4O1B|1.65|2014|DGB|ligand is compound 11(APO866); biochemical IC50 =0.385+/-0.224 uM|P43490|NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE|6.41|IC=0.385uM|IC50|=|0.385|uM|385|nM
4PVT|2.00|2014|S3C|ligand is ML302F; IC50=0.3+/-0.09uM|Q9K2N0|BETA-LACTAMASE CLASS B VIM-2|6.52|IC=0.3uM|IC50|=|0.3|uM|300|nM
4M3B|2.00|2014|2B2|ligand is compound 19|P96222|HTH-TYPE TRANSCRIPTIONAL REGULATOR ETHR|6.4|IC=0.40uM|IC50|=|0.4|uM|400|nM
4WHL|2.71|2014|5-mer|ligand is peptide 8|P53350|SERINE/THREONINE-PROTEIN KINASE PLK1|6.4|IC=0.40uM|IC50|=|0.4|uM|400|nM
4U79|2.23|2014|3EL|ligand is comppound 19|P53779|MITOGEN-ACTIVATED PROTEIN KINASE 10|6.4|IC=0.40uM|IC50|=|0.4|uM|400|nM
4TKI|2.15|2014|33E|ligand is BSI-201|Q9H2K2|TANKYRASE-2|6.38|IC=0.416uM|IC50|=|0.416|uM|416|nM
4CQG|2.57|2014|OT5|ligand is OTSSP167, MPK38 also known as maternal embryonic leucine zipper kinase (MELK)|Q61846|MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE|9.39|IC=0.41nM|IC50|=|0.41|nM|0.41|nM
4NZN|1.75|2014|2OU|ligand is 2-O-Bn-5-PA-InsP4|O43314|INOSITOL HEXAKISPHOSPHATE AND DIPHOSPHOINOSITOL|6.38|IC=0.42uM|IC50|=|0.42|uM|420|nM
4PSQ|2.40|2014|2WL|ligand is compound 1; IC50=0.44+/-0.18uM; hRBP4 SPA|P02753|RETINOL-BINDING PROTEIN 4|6.36|IC=0.44uM|IC50|=|0.44|uM|440|nM
4PNR|1.71|2014|G18|ligand is TIQ-A|Q9H2K2|TANKYRASE-2|6.34|IC=0.456uM|IC50|=|0.456|uM|456|nM
4LQ3|2.60|2014|20V|ligand is PPNDS|Q2N379|RNA-DEPENDENT RNA-POLYMERASE|6.35|IC=0.45uM|IC50|=|0.45|uM|450|nM
4OKG|2.06|2014|2SZ|compound B|P47205|UDP-3-O-[3-HYDROXYMYRISTOYL] N-ACETYLGLUCOSAMINE DEACETYLASE|9.32|IC=0.48nM|IC50|=|0.48|nM|0.48|nM
4BG1|1.89|2014|IVL|ligand is compound 26|O75936|GAMMA-BUTYROBETAINE DIOXYGENASE|6.31|IC=0.49uM|IC50|=|0.49|uM|490|nM
4OVZ|2.50|2014|P85|ligand is compound 3j; IC50=0.49+/- 0.01uM; modified residues ipeptidelinking|P0C6U8|PAPAIN-LIKE PROTEINASE|6.31|IC=0.49uM|IC50|=|0.49|uM|490|nM
4PVO|1.48|2014|SVB|IC50=0.49+/-0.18uM; ML302 undergoes hydrolysis to give ML302M, revealing binding of ML302M (ML302 + ML302F) Chain A and ML302F Chain B|Q9K2N0|BETA-LACTAMASE CLASS B VIM-2|6.31|IC=0.49uM|IC50|=|0.49|uM|490|nM
4OBA|1.60|2014|2TW|ligand is compound 4; HTRF IC50=0.4+/-0.1nM (serum free)|Q00987|E3 UBIQUITIN-PROTEIN LIGASE MDM2|9.4|IC=0.4nM|IC50|=|0.4|nM|0.4|nM
4C7T|2.05|2014|5RI|ligand is compound PHM16|Q00944|FOCAL ADHESION KINASE 1|6.4|IC=0.4uM|IC50|=|0.4|uM|400|nM
4UYH|1.73|2014|9S3|ligand is compound 28; BRD2 N-terminal bromodomain|P25440|BROMODOMAIN-CONTAINING PROTEIN 2|6.3|IC=0.50uM|IC50|=|0.5|uM|500|nM
4QT0|3.20|2014|38Q|ligand is compound 1; IC50=0.51 +/-0.14uM|P00338|L-LACTATE DEHYDROGENASE A CHAIN|6.29|IC=0.51uM|IC50|=|0.51|uM|510|nM
4WJ5|1.65|2014|10-mer|ligand is [am-phg][NVA]AGIGILT[PRG]; IC50=0.51+/-0.01uM|P01892|HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA CHAIN|6.29|IC=0.51uM|IC50|=|0.51|uM|510|nM
3WNT|2.07|2014|9BE|[Covalent complex] compound 2; rhMIF covalently modified with 2 binding in the downwards orientation|P14174|MACROPHAGE MIGRATION INHIBITORY FACTOR|6.28|IC=0.53uM|IC50|=|0.53|uM|530|nM
3WNR|2.01|2014|9BE|[Covalent complex] compound 2; rhMIF covalently modified with 2 binding in the upwards orientation|P14174|MACROPHAGE MIGRATION INHIBITORY FACTOR|6.28|IC=0.53uM|IC50|=|0.53|uM|530|nM
4M3G|2.30|2014|2G1|ligand is compound 17|P96222|HTH-TYPE TRANSCRIPTIONAL REGULATOR ETHR|6.26|IC=0.55uM|IC50|=|0.55|uM|550|nM
4M3E|2.11|2014|2B3|ligand is compound 20|P96222|HTH-TYPE TRANSCRIPTIONAL REGULATOR ETHR|6.25|IC=0.56uM|IC50|=|0.56|uM|560|nM
4PJT|2.35|2014|2YQ|ligand is BMN 673|P09874|POLY [ADP-RIBOSE] POLYMERASE 1|9.24|IC=0.57nM|IC50|=|0.57|nM|0.57|nM
4OQ5|2.86|2014|2UU|ligand is compound 17|Q07820|INDUCED MYELOID LEUKEMIA CELL DIFFERENTIATION PROTEIN MCL|6.3|IC=0.5uM|IC50|=|0.5|uM|500|nM
4BGM|2.40|2014|DLT|ligand is compound 24|O75936|GAMMA-BUTYROBETAINE DIOXYGENASE|6.21|IC=0.61uM|IC50|=|0.61|uM|610|nM
4LP9|1.35|2014|7-mer||P11838|ENDOTHIAPEPSIN|6.21|IC=0.62uM|IC50|=|0.62|uM|620|nM
4JVQ|2.40|2014|1ML|ligand is compound 9|O92972|GENOME POLYPROTEIN|6.2|IC=0.63uM|IC50|=|0.63|uM|630|nM
4OLC|2.60|2014|DCD|ligand is Disulfiram; on page 10506, Fig2|A8BB85|CARBAMATE KINASE|6.19|IC=0.64uM|IC50|=|0.64|uM|640|nM
4UMU|2.02|2014|0V0|ligand is compound 4; Astex|Q14680|MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE|6.19|IC=0.65uM|IC50|=|0.65|uM|650|nM
4C68|1.38|2014|EN5|ternay complex of PvNMT-NHM-compound 10|A5K1A2|GLYCYLPEPTIDE N-TETRADECANOYLTRANSFERASE|6.17|IC=0.68uM|IC50|=|0.68|uM|680|nM
4UZD|3.20|2014|QMN|ligand is compound 47|O14965|AURORA KINASE A|9.22|IC=0.6nM|IC50|=|0.6|nM|0.6|nM
4J5B|2.01|2014|6B4|compound 27|P30405|PEPTIDYL-PROLYL CIS-TRANS ISOMERASE F|6.22|IC=0.6uM|IC50|=|0.6|uM|600|nM
4UMT|1.98|2014|47W|ligand is compound 5; Astex|Q14680|MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE|6.14|IC=0.72uM|IC50|=|0.72|uM|720|nM
4L7D|2.25|2014|1VX|ligand is compound 59|Q14145|KELCH-LIKE ECH-ASSOCIATED PROTEIN 1|6.12|IC=0.75uM|IC50|=|0.75|uM|750|nM
4CXW|3.10|2014|6MK|ligand is compound 12|Q9C0B1|ALPHA-KETOGLUTARATE-DEPENDENT DIOXYGENASE FTO|6.09|IC=0.81uM|IC50|=|0.81|uM|810|nM
4PNI|1.85|2014|KQQ|GSK2163632A; log IC50 = -6.09|P28327|RHODOPSIN KINASE|6.09|IC=0.81uM|IC50|=|0.81|uM|810|nM
4QN7|2.30|2014|G39||Q20R18|NEURAMINIDASE|9.08|IC=0.84nM|IC50|=|0.84|nM|0.84|nM
4PV0|2.00|2014|CG4|ligand is compound 9|P43405|TYROSINE-PROTEIN KINASE SYK|9.07|IC=0.85nM|IC50|=|0.85|nM|0.85|nM
4WWN|2.70|2014|3VC|ligand is compound 1|P48736|PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE|6.07|IC=0.85uM|IC50|=|0.85|uM|850|nM
4NAU|2.33|2014|2W3|ligand is compound D|P63820|PHOSPHOPANTETHEINE ADENYLYLTRANSFERASE|9.06|IC=0.87nM|IC50|=|0.87|nM|0.87|nM
4O4R|2.40|2014|20V|compound PPNDS; IC50=0.88+/-0.03uM|S4V9Y7|RNA-DEPENDENT RNA POLYMERASE|6.06|IC=0.88uM|IC50|=|0.88|uM|880|nM
4N1T|1.60|2014|2GD|ligand is TH287, ligand 2|P36639|7,8-DIHYDRO-8-OXOGUANINE TRIPHOSPHATASE|9.1|IC=0.8nM|IC50|=|0.8|nM|0.8|nM
4TJW|1.70|2014|P34|ligand is PJ-34|Q9H2K2|TANKYRASE-2|6.02|IC=0.963uM|IC50|=|0.963|uM|963|nM
4UV9|3.00|2014|D70|ligand is compound 20b|O60341|LYSINE-SPECIFIC HISTONE DEMETHYLASE 1A|6.01|IC=0.975uM|IC50|=|0.975|uM|975|nM
4M3M|2.10|2014|22N|ligand is compound 2, IC50=0.9nM for H3N2, IC50=0.7nM for H1N1, Crystal is H3N8|Q0A480|NEURAMINIDASE|9.05|IC=0.9nM|IC50|=|0.9|nM|0.9|nM
4W7T|1.80|2014|3JC|ligand is compound 1|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|6.05|IC=0.9uM|IC50|=|0.9|uM|900|nM
4URK|2.90|2014|A82|ligand is compound 2 (AZD6482)|P48736|PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE|5.96|IC=1.09uM|IC50|=|1.09|uM|1090|nM
4D2T|2.70|2014|3I7|ligand is compound 4|Q14680|MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE|6.0|IC=1.0uM|IC50|=|1|uM|1000|nM
4O72|1.40|2014|2R4|ligand is NU7441|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|6.0|IC=1.0uM|IC50|=|1|uM|1000|nM
4PZX|1.80|2014|2X5|ligand is compound 18|P56817|BETA-SECRETASE 1|6.0|IC=1.0uM|IC50|=|1|uM|1000|nM
4OP2|2.24|2014|2UX|ligand is compound 4; IC50=1.176+/-0.073uM|Q14397|GLUCOKINASE REGULATORY PROTEIN|5.93|IC=1.176uM|IC50|=|1.176|uM|1176|nM
3WNS|1.66|2014|9AI|[Covalent complex] compound 3|P14174|MACROPHAGE MIGRATION INHIBITORY FACTOR|5.96|IC=1.1uM|IC50|=|1.1|uM|1100|nM
4J5D|1.32|2014|728|compound 26|P30405|PEPTIDYL-PROLYL CIS-TRANS ISOMERASE F|5.96|IC=1.1uM|IC50|=|1.1|uM|1100|nM
4N1B|2.55|2014|2FS|ligand is compound 43|Q14145|KELCH-LIKE ECH-ASSOCIATED PROTEIN 1|5.96|IC=1.1uM|IC50|=|1.1|uM|1100|nM
4P0W|2.41|2014|1XH|liand is compound 13|P14324|FARNESYL PYROPHOSPHATE SYNTHASE|5.96|IC=1.1uM|IC50|=|1.1|uM|1100|nM
4HRC|2.80|2014|OV2|ligand is compound 3|P23639|PROTEASOME COMPONENT Y7|8.92|IC=1.2nM|IC50|=|1.2|nM|1.2|nM
4P0V|2.40|2014|1WO|ligand is compound 11|P14324|FARNESYL PYROPHOSPHATE SYNTHASE|5.92|IC=1.2uM|IC50|=|1.2|uM|1200|nM
4P0X|2.50|2014|1WO|ligand is compound 11|P14324|FARNESYL PYROPHOSPHATE SYNTHASE|5.92|IC=1.2uM|IC50|=|1.2|uM|1200|nM
4QYE|2.05|2014|3DL|ligand is compound 1|O14757|SERINE/THREONINE-PROTEIN KINASE CHK1|5.92|IC=1.2uM|IC50|=|1.2|uM|1200|nM
4UX6|3.00|2014|YWO|ligand is compound 2|P29477|NITRIC OXIDE SYNTHASE, INDUCIBLE|5.92|IC=1.2uM|IC50|=|1.2|uM|1200|nM
3WKE|2.75|2014|AUB|ligand is compound t-AUCB|P34913|EPOXIDE HYDROLASE 2|8.89|IC=1.3nM|IC50|=|1.3|nM|1.3|nM
4CLI|2.05|2014|5P8|ligand is compound 8K|Q9UM73|ALK TYROSINE KINASE RECEPTOR|8.89|IC=1.3nM|IC50|=|1.3|nM|1.3|nM
4LQG|1.77|2014|CTW|compound 4|Q04609|GLUTAMATE CARBOXYPEPTIDASE 2|8.89|IC=1.3nM|IC50|=|1.3|nM|1.3|nM
4QYH|1.90|2014|3DX|ligand is compound 16|O14757|SERINE/THREONINE-PROTEIN KINASE CHK1|8.89|IC=1.3nM|IC50|=|1.3|nM|1.3|nM
3WGW|2.80|2014|T2B|compound T2AA, PCNA/PIP-box interaction inhibition is IC50=1.3uM|P12004|PROLIFERATING CELL NUCLEAR ANTIGEN|5.89|IC=1.3uM|IC50|=|1.3|uM|1300|nM
4MSU|2.50|2014|2EU|ligand is compound 1|Q14397|GLUCOKINASE REGULATORY PROTEIN|5.85|IC=1.42uM|IC50|=|1.42|uM|1420|nM
3WYL|2.68|2014|3KB|ligand is compound 20a|Q9Y233|CGMP 3',5'-CYCLIC PHOSPHODIESTERASE|8.85|IC=1.4nM|IC50|=|1.4|nM|1.4|nM
4BIS|2.49|2014|8HQ|in table IC50=1.4uM, in text of pp. 3112, IC50=4uM|O75164|LYSINE-SPECIFIC DEMETHYLASE 4A|5.85|IC=1.4uM|IC50|=|1.4|uM|1400|nM
4J59|1.92|2014|671|compound 28|P30405|PEPTIDYL-PROLYL CIS-TRANS ISOMERASE F|5.85|IC=1.4uM|IC50|=|1.4|uM|1400|nM
4NAK|1.80|2014|PBQ|ligand is compound 4a, assay with 40uM Cd2+|P69834|2-C-METHYL-D-ERYTHRITOL 4-PHOSPHATE CYTIDYLYLTRANSFERASE|5.85|IC=1.4uM|IC50|=|1.4|uM|1400|nM
4PNM|2.19|2014|NU1|ligand is Nu1025|Q9H2K2|TANKYRASE-2|5.85|IC=1.4uM|IC50|=|1.4|uM|1400|nM
4HRD|2.80|2014|OV1|ligand is compound 1|P23639|PROTEASOME COMPONENT Y7|8.82|IC=1.5nM|IC50|=|1.5|nM|1.5|nM
4K9G|1.55|2014|1Q1|ligand is ISO-66, named 1Q1|P14174|MACROPHAGE MIGRATION INHIBITORY FACTOR|5.82|IC=1.5uM|IC50|=|1.5|uM|1500|nM
4PNT|1.60|2014|IQD|ligand is 1,5-IQD|Q9H2K2|TANKYRASE-2|5.82|IC=1.5uM|IC50|=|1.5|uM|1500|nM
4U03|2.04|2014|TLL|ligand is 5MTHFGLU2|Q9KVG7|CYCLIC AMP-GMP SYNTHASE|5.77|IC=1.69uM|IC50|=|1.69|uM|1690|nM
4U0M|2.30|2014|TLL|ligand is 5MTHFGLU2|Q9KVG7|CYCLIC AMP-GMP SYNTHASE|5.77|IC=1.69uM|IC50|=|1.69|uM|1690|nM
4U0N|2.10|2014|TLL|ligand is 5MTHFGLU2|Q9KVG7|CYCLIC AMP-GMP SYNTHASE|5.77|IC=1.69uM|IC50|=|1.69|uM|1690|nM
4OYB|1.70|2014|1VJ|ligand is compound 7|Q96PN6|ADENYLATE CYCLASE TYPE 10|5.8|IC=1.6uM|IC50|=|1.6|uM|1600|nM
4UVA|2.90|2014|D73|ligand is compound 20a|O60341|LYSINE-SPECIFIC HISTONE DEMETHYLASE 1A|5.75|IC=1.78uM|IC50|=|1.78|uM|1780|nM
3WT7|2.40|2014|YA2|ligand is compound 9a|P13053|VITAMIN D3 RECEPTOR|8.75|IC=1.79nM|IC50|=|1.79|nM|1.79|nM
4D09|2.50|2014|788|ligand is compound 3|O00408|CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE|8.77|IC=1.7nM|IC50|=|1.7|nM|1.7|nM
4J3I|1.24|2014|1K0|target is BRD4(BD1)|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|5.74|IC=1.8uM|IC50|=|1.8|uM|1800|nM
4KNR|2.10|2014|1S8|ligand is compound 5c, WG188|P43889|BIFUNCTIONAL PROTEIN GLMU|5.74|IC=1.8uM|IC50|=|1.8|uM|1800|nM
4NHX|2.10|2014|OGA|ligand is N-oxalylglycine (NOG)|Q8N543|2-OXOGLUTARATE AND IRON-DEPENDENT OXYGENASE DOMAIN|5.72|IC=1.9uM|IC50|=|1.9|uM|1900|nM
4OBZ|2.90|2014|2S4|ligand is compound 7|P07339|CATHEPSIN D LIGHT CHAIN|5.72|IC=1.9uM|IC50|=|1.9|uM|1900|nM
4C1C|1.18|2014|MCO|ligand is D-captopril|P04190|BETA-LACTAMASE 2|4.97|IC=10.7uM|IC50|=|10.7|uM|10700|nM
4BPJ|1.60|2014|19-mer|ligand is alpha beta Puma BH3 peptide 3|P97287|FUSION PROTEIN CONSISTING OF INDUCED MYELOID LEUKEM|6.0|IC=1000nM|IC50|=|1000|nM|1000|nM
4NRT|2.02|2014|2NG|ligand is compound 6; IC50=1000+/-90nM|A0ZNP5|HNV-RDRP|6.0|IC=1000nM|IC50|=|1000|nM|1000|nM
4RFY|1.70|2014|3OU|ligand is compound 1b; Human Whole Blood IC50|Q06187|TYROSINE-PROTEIN KINASE BTK|7.0|IC=100nM|IC50|=|100|nM|100|nM
4CKR|2.20|2014|DI1|ligand is compound DDR1-IN-1|Q08345|EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1|6.98|IC=105nM|IC50|=|105|nM|105|nM
4QTD|1.50|2014|38Z|SCH772984|P45983|MITOGEN-ACTIVATED PROTEIN KINASE 8|5.97|IC=1080nM|IC50|=|1080|nM|1080|nM
4D08|1.90|2014|Q2T|ligand is compound 12|O00408|CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE|8.0|IC=10nM|IC50|=|10|nM|10|nM
4O2E|1.98|2014|9-mer|ligand is SL9|P30475|HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-39 ALPHA CHAIN|8.0|IC=10nM|IC50|=|10|nM|10|nM
4QG7|1.67|2014|32K|ligand is compound 18|Q6GJI9|THYMIDYLATE KINASE|8.0|IC=10nM|IC50|=|10|nM|10|nM
4LV4|2.08|2014|8HC|ligand is HCA|P67475|FRUCTOSE-BISPHOSPHATE ALDOLASE|5.0|IC=10uM|IC50|=|10|uM|10000|nM
4O7C|1.55|2014|2RK|ligand is SB614067-R|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|5.0|IC=10uM|IC50|=|10|uM|10000|nM
4P74|2.70|2014|2U9|ligand is compound 3a|Q9I0A4|PHENYLALANINE-TRNA LIGASE BETA SUBUNIT|5.0|IC=10uM|IC50|=|10|uM|10000|nM
4PNQ|1.85|2014|32X|ligand is 5-AIQ|Q9H2K2|TANKYRASE-2|5.0|IC=10uM|IC50|=|10|uM|10000|nM
4J5E|.99|2014|7B7|compound 24|P30405|PEPTIDYL-PROLYL CIS-TRANS ISOMERASE F|4.94|IC=11.4uM|IC50|=|11.4|uM|11400|nM
4CXY|2.65|2014|DGR|ligand is compound 21|Q9C0B1|ALPHA-KETOGLUTARATE-DEPENDENT DIOXYGENASE FTO|4.93|IC=11.8uM|IC50|=|11.8|uM|11800|nM
4N8D|1.65|2014|2KS|ligand is compound syn-7aa|P27487|DIPEPTIDYL PEPTIDASE 4|4.92|IC=11.9uM|IC50|=|11.9|uM|11900|nM
4OG7|2.08|2014|2SE|ligand is compound 20 (MIV-7); IC50= 114+/-2nM|O00255|MENIN|6.94|IC=114nM|IC50|=|114|nM|114|nM
4NRU|2.30|2014|2NG|ligand compound 6; IC50=115+/-15nM|S4V9Y7|RNA-DEPENDENT RNA POLYMERASE|6.94|IC=115nM|IC50|=|115|nM|115|nM
4PP7|3.40|2014|2VX|ligand is compound 18; crystal is compound 18 in complex with wt B-Raf; IC50 is V600E mutant B-Raf|P15056|SERINE/THREONINE-PROTEIN KINASE B-RAF|7.96|IC=11nM|IC50|=|11|nM|11|nM
4OYM|1.70|2014|1ZC|ligand is compound 6|Q96PN6|ADENYLATE CYCLASE TYPE 10|4.96|IC=11uM|IC50|=|11|uM|11000|nM
4PL5|3.40|2014|31L|OICR573 inhibitor; Mouse IRE1-alpha IC50=11+/-9.9uM|Q9EQY0|SERINE/THREONINE-PROTEIN KINASE/ENDORIBONUCLEASE IR|4.96|IC=11uM|IC50|=|11|uM|11000|nM
4OT6|2.05|2014|2V1|ligand is compound 15|Q06187|TYROSINE-PROTEIN KINASE BTK|5.92|IC=1200nM|IC50|=|1200|nM|1200|nM
4NA4|2.50|2014|A1R|ligand is ADD-HPD|O88622|POLY(ADP-RIBOSE) GLYCOHYDROLASE|6.92|IC=120nM|IC50|=|120|nM|120|nM
4MWE|2.45|2014|2EN|ligand is chem1475|Q38C91|METHIONYL-TRNA SYNTHETASE|5.91|IC=1231nM|IC50|=|1231|nM|1231|nM
3WK7|2.20|2014|S0D|ligand is compound 4|P34913|EPOXIDE HYDROLASE 2|3.9|IC=127uM|IC50|=|127|uM|127000|nM
4P6E|1.80|2014|2FC|ligand is compound 7; IC50=1290+/-453nM|P25774|CATHEPSIN S|5.89|IC=1290nM|IC50|=|1290|nM|1290|nM
3WV2|2.30|2014|WGG|ligand is compound 44|P45452|COLLAGENASE 3|7.92|IC=12nM|IC50|=|12|nM|12|nM
4QGA|1.94|2014|31Z|ligand is compound 19|Q6GJI9|THYMIDYLATE KINASE|7.92|IC=12nM|IC50|=|12|nM|12|nM
4L7O|2.00|2014|1VD|ligand is compound 18i|Q9Y6F1|POLY [ADP-RIBOSE] POLYMERASE 3|4.88|IC=13.2uM|IC50|=|13.2|uM|13200|nM
4MWC|2.65|2014|2EM|ligand is chem1540|Q38C91|METHIONYL-TRNA SYNTHETASE|5.87|IC=1360nM|IC50|=|1360|nM|1360|nM
4U93|1.55|2014|990|ligand is compound 9|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|7.89|IC=13nM|IC50|=|13|nM|13|nM
4O0J|2.05|2014|LF8|ligand is KF115; I N-LEDGF/75 binding IC50=13+/-1.5uM|P12497|INTEGRASE|4.89|IC=13uM|IC50|=|13|uM|13000|nM
4O7F|1.80|2014|2RQ|ligand is SB251527|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|4.89|IC=13uM|IC50|=|13|uM|13000|nM
4NJD|2.50|2014|NJD|KY-04031; LNCap cells Viability IC50=14.47+/-1.26uM; LNCap cells AR luciferase IC50=2.50+/-0.28uM|O96013|SERINE/THREONINE-PROTEIN KINASE PAK 4|4.84|IC=14.47uM|IC50|=|14.47|uM|14470|nM
4L7N|1.80|2014|1VB|ligand is compound 18h|Q9Y6F1|POLY [ADP-RIBOSE] POLYMERASE 3|4.84|IC=14.4uM|IC50|=|14.4|uM|14400|nM
4PKT|2.40|2014|30O|ligand is compound 13; IC50=14.9+/-2.4uM|P15917|LETHAL FACTOR|4.83|IC=14.9uM|IC50|=|14.9|uM|14900|nM
4W9Q|1.08|2014|3JP|ligand is compound 10|Q13451|PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5|6.85|IC=140nM|IC50|=|140|nM|140|nM
4O91|2.39|2014|NG2|ligand is compound 1|O43318|MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 7|6.83|IC=149nM|IC50|=|149|nM|149|nM
4U6R|2.50|2014|3E4|ligand is compound 16|O75460|SERINE/THREONINE-PROTEIN KINASE/ENDORIBONUCLEASE IR|7.85|IC=14nM|IC50|=|14|nM|14|nM
4LQ9|2.04|2014|21D|ligand is NAF2|Q2N379|RNA-DEPENDENT RNA-POLYMERASE|4.85|IC=14uM|IC50|=|14|uM|14000|nM
4OK6|2.40|2014|2T7|ligand is compound 13|K4KA16|SERINE PROTEASE NS3|4.85|IC=14uM|IC50|=|14|uM|14000|nM
4PKR|2.20|2014|2ZL|ligand is compound 10; IC50=15.2+/-0.5uM|P15917|LETHAL FACTOR|4.82|IC=15.2uM|IC50|=|15.2|uM|15200|nM
4PKS|2.30|2014|30H|ligand is compound 11; IC50=15.2+/-0.9uM|P15917|LETHAL FACTOR|4.82|IC=15.2uM|IC50|=|15.2|uM|15200|nM
4M7X|1.42|2014|27Q|ligand is compound N7-Pan (7)|Q8NVG0|TYPE II PANTOTHENATE KINASE|4.8|IC=15.7uM|IC50|=|15.7|uM|15700|nM
4LM5|2.25|2014|Q17|ligand is compound 1|P11309|SERINE/THREONINE-PROTEIN KINASE PIM-1|6.82|IC=150nM|IC50|=|150|nM|150|nM
4C8R|2.82|2014|6YT||O75936|GAMMA-BUTYROBETAINE DIOXYGENASE|6.82|IC=153nM|IC50|=|153|nM|153|nM
4Q9S|2.07|2014|30G|ligand is compound 1; TR-FRET|Q05397|FOCAL ADHESION KINASE 1|3.81|IC=156uM|IC50|=|156|uM|156000|nM
3WE4|2.00|2014|5FI|ligand is compound PF4078671|P23443|RIBOSOMAL PROTEIN S6 KINASE BETA-1|7.82|IC=15nM|IC50|=|15|nM|15|nM
4NO9|2.90|2014|2L0|ligand is compound 3|P23639|PROTEASOME SUBUNIT ALPHA TYPE-2|7.82|IC=15nM|IC50|=|15|nM|15|nM
4O13|1.75|2014|2P1|ligand is compound 1(GNE-618); biochemical IC50 =0.015+/-0.004 uMol; NAMPT WT|P43490|NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE|7.82|IC=15nM|IC50|=|15|nM|15|nM
3WK5|2.77|2014|S0C|ligand is compound 2|P34913|EPOXIDE HYDROLASE 2|4.82|IC=15uM|IC50|=|15|uM|15000|nM
4JLN|2.15|2014|18V|ligand is compound F4|P27707|DEOXYCYTIDINE KINASE|7.78|IC=16.7nM|IC50|=|16.7|nM|16.7|nM
4UMR|3.00|2014|QBB|ligand is compound 1|Q14680|MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE|3.8|IC=160uM|IC50|=|160|uM|160000|nM
4HNP|2.80|2014|ONK|ligand is compound 4|P23639|PROTEASOME COMPONENT Y7|6.78|IC=164.5nM|IC50|=|164.5|nM|164.5|nM
4MW6|2.56|2014|2EE|ligand is chem1476|Q38C91|METHIONYL-TRNA SYNTHETASE|5.78|IC=1678nM|IC50|=|1678|nM|1678|nM
4P7E|2.40|2014|2HB|ligand is compound 65(GLPG0634); Human Whole Blood Potency|O60674|TYROSINE-PROTEIN KINASE JAK2|4.76|IC=17.5uM|IC50|=|17.5|uM|17500|nM
4L23|2.50|2014|X6K|ligand is PI103|P42336|PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE|7.75|IC=17.9nM|IC50|=|17.9|nM|17.9|nM
3WKD|2.48|2014|S0K|ligand is compound 10|P34913|EPOXIDE HYDROLASE 2|3.77|IC=171uM|IC50|=|171|uM|171000|nM
4MD6|2.00|2014|24E|ligand is compound 57|O76074|CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE|7.77|IC=17nM|IC50|=|17|nM|17|nM
4OBP|2.27|2014|2QU|ligand is compound 29|O95819|MITOGEN-ACTIVATED PROTEIN KINASE 4|7.77|IC=17nM|IC50|=|17|nM|17|nM
4OHO|2.58|2014|2TG|ligand is compound 24|Q14397|GLUCOKINASE REGULATORY PROTEIN|7.77|IC=17nM|IC50|=|17|nM|17|nM
4I9Z|2.08|2014|5BA|ligand is compound 10a|O76074|CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE|7.74|IC=18.2nM|IC50|=|18.2|nM|18.2|nM
4CFM|2.85|2014|4QE|ligand is compound 29|P24941|CYCLIN-DEPENDENT KINASE 2|4.74|IC=18.2uM|IC50|=|18.2|uM|18200|nM
4PH4|2.80|2014|2UG|ligand is PIK-III|Q8NEB9|PHOSPHATIDYLINOSITOL 3-KINASE CATALYTIC SUBUNIT TYP|7.74|IC=18nM|IC50|=|18|nM|18|nM
4O71|1.36|2014|CPB|ligand is Flavopiridol|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|4.74|IC=18uM|IC50|=|18|uM|18000|nM
4KPZ|2.09|2014|1SF|ligand is compound 39|P43889|BIFUNCTIONAL PROTEIN GLMU|2.71|IC=1950uM|IC50|=|1950|uM|1950000|nM
3WKC|2.20|2014|S0J|ligand is compound 9|P34913|EPOXIDE HYDROLASE 2|3.71|IC=195uM|IC50|=|195|uM|195000|nM
4OG6|1.49|2014|2S9|ligand is compound 13 (MIV-4); IC50= 197+/-24nM|O00255|MENIN|6.71|IC=197nM|IC50|=|197|nM|197|nM
4MW2|2.30|2014|2E9|ligand is chem1472|Q38C91|METHIONYL-TRNA SYNTHETASE|6.7|IC=198nM|IC50|=|198|nM|198|nM
4MW1|2.49|2014|44F|ligand is chem1444|Q38C91|METHIONYL-TRNA SYNTHETASE|7.72|IC=19nM|IC50|=|19|nM|19|nM
4NAN|1.80|2014|2JM|ligand is compound 4e, assay with 40uM Cd2+|P69834|2-C-METHYL-D-ERYTHRITOL 4-PHOSPHATE CYTIDYLYLTRANSFERASE|4.72|IC=19uM|IC50|=|19|uM|19000|nM
4O70|1.55|2014|1QK|ligand is Dinaciclib|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|4.72|IC=19uM|IC50|=|19|uM|19000|nM
4O7A|1.34|2014|2RF|ligand is SB409514|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|4.72|IC=19uM|IC50|=|19|uM|19000|nM
4OYI|1.70|2014|1VK|ligand is compound 4|Q96PN6|ADENYLATE CYCLASE TYPE 10|4.72|IC=19uM|IC50|=|19|uM|19000|nM
4WH9|1.50|2014|3M8|ligand is compound 7|P30305|M-PHASE INDUCER PHOSPHATASE 2|3.0|IC=1mM|IC50|=|1|mM|1000000|nM
4O6E|1.95|2014|2SH|ligand is compound 28|P28482|MITOGEN-ACTIVATED PROTEIN KINASE 1|9.0|IC=1nM|IC50|=|1|nM|1|nM
4QGG|1.62|2014|32C|ligand is compound 46|Q6GJI9|THYMIDYLATE KINASE|9.0|IC=1nM|IC50|=|1|nM|1|nM
4QGH|1.78|2014|32E|ligand is compound 47|Q6GJI9|THYMIDYLATE KINASE|9.0|IC=1nM|IC50|=|1|nM|1|nM
4RIO|2.69|2014|3QX|ligand is compound 5g|P52333|TYROSINE-PROTEIN KINASE JAK3|9.0|IC=1nM|IC50|=|1|nM|1|nM
4UWK|2.83|2014|UJB|ligand is compound 15|Q8NEB9|PHOSPHATIDYLINOSITOL 3-KINASE CATALYTIC SUBUNIT TYP|9.0|IC=1nM|IC50|=|1|nM|1|nM
4L7L|2.10|2014|1VA|ligand is compound 6j|Q9Y6F1|POLY [ADP-RIBOSE] POLYMERASE 3|6.0|IC=1uM|IC50|=|1|uM|1000|nM
4OCC|1.80|2014|2TZ|ligand is compound 48; HTRF IC50 biochemical assay, buffer containing 15% human serum|Q00987|E3 UBIQUITIN-PROTEIN LIGASE MDM2|8.7|IC=2.0nM|IC50|=|2|nM|2|nM
4CXX|2.76|2014|640|ligand is compound 16|Q9C0B1|ALPHA-KETOGLUTARATE-DEPENDENT DIOXYGENASE FTO|5.68|IC=2.11uM|IC50|=|2.11|uM|2110|nM
3ZMP|2.62|2014|10-mer|ligand is 10-mer Src-derived peptide inhibitor: AC-1|P18031|PROTEIN-TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1|5.67|IC=2.13uM|IC50|=|2.13|uM|2130|nM
4D2P|2.55|2014|6Z7|ligand is compound 2|Q14680|MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE|5.68|IC=2.1uM|IC50|=|2.1|uM|2100|nM
4P0N|2.08|2014|1IR/1IS|ligand is compound 24 racemic; IC50=2,2+/-0.1nM|Q9Y233|CGMP 3',5'-CYCLIC PHOSPHODIESTERASE|8.66|IC=2.2nM|IC50|=|2.2|nM|2.2|nM
4L70|2.00|2014|1V9|ligand is compoiund 6a|Q9Y6F1|POLY [ADP-RIBOSE] POLYMERASE 3|5.66|IC=2.2uM|IC50|=|2.2|uM|2200|nM
4L7U|2.80|2014|1VC|ligand is compound 19e|Q9Y6F1|POLY [ADP-RIBOSE] POLYMERASE 3|5.66|IC=2.2uM|IC50|=|2.2|uM|2200|nM
4NAL|1.80|2014|H70|ligand is compound 4b, assay with 40uM Cd2+|P69834|2-C-METHYL-D-ERYTHRITOL 4-PHOSPHATE CYTIDYLYLTRANSFERASE|5.66|IC=2.2uM|IC50|=|2.2|uM|2200|nM
4L7B|2.41|2014|1VV|ligand is compound (S,R,S)-1a|Q14145|KELCH-LIKE ECH-ASSOCIATED PROTEIN 1|5.64|IC=2.3uM|IC50|=|2.3|uM|2300|nM
4NHY|2.60|2014|PD2|ligand is 2,4-PDCA|Q8N543|2-OXOGLUTARATE AND IRON-DEPENDENT OXYGENASE DOMAIN|5.64|IC=2.3uM|IC50|=|2.3|uM|2300|nM
4TPM|2.77|2014|35E|ligand is compound 8; IC50=2.4+/-0.7nM|Q9Y233|CGMP 3',5'-CYCLIC PHOSPHODIESTERASE|8.62|IC=2.4nM|IC50|=|2.4|nM|2.4|nM
4TXE|1.80|2014|38F|ligand is compound 5|P29029|ENDOCHITINASE|5.62|IC=2.4uM|IC50|=|2.4|uM|2400|nM
4QLT|2.80|2014|39V|ligand is compound 2; belta-5i|P23639|PROTEASOME SUBUNIT ALPHA TYPE-2|8.6|IC=2.5nM|IC50|=|2.5|nM|2.5|nM
4O77|2.00|2014|2RE|ligand is SB202190|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|5.6|IC=2.5uM|IC50|=|2.5|uM|2500|nM
4TPP|2.65|2014|35D|ligand is compound 47; IC50=2.6+/-0.6nM|Q9Y233|CGMP 3',5'-CYCLIC PHOSPHODIESTERASE|8.59|IC=2.6nM|IC50|=|2.6|nM|2.6|nM
4TX6|1.90|2014|38B|ligand is compound 1|B0Y2Y2|CLASS III CHITINASE CHIA1|5.59|IC=2.6uM|IC50|=|2.6|uM|2600|nM
4TK0|1.65|2014|32Z|ligand is DPQ|Q9H2K2|TANKYRASE-2|5.55|IC=2.8uM|IC50|=|2.8|uM|2800|nM
4U5J|2.26|2014|RXT|C-src|P00523|TYROSINE-PROTEIN KINASE SRC|5.53|IC=2.93uM|IC50|=|2.93|uM|2930|nM
4X7I|1.77|2014|3YS|ligand is LY2886721|P56817|BETA-SECRETASE 1|7.69|IC=20.3nM|IC50|=|20.3|nM|20.3|nM
4PYV|2.65|2014|2XF|ligand is compound 4|P00797|RENIN|6.7|IC=200nM|IC50|=|200|nM|200|nM
4O4K|2.10|2014|2PK|ligand is Mirin; IC50 is estimated to be 200-300 uM chromatin bound RPA;|Q9X1X0|EXONUCLEASE, PUTATIVE|3.7|IC=200uM|IC50|=|200|uM|200000|nM
3WF7|1.85|2014|FS9|ligand is compound F179|P23443|RIBOSOMAL PROTEIN S6 KINASE BETA-1|6.69|IC=206nM|IC50|=|206|nM|206|nM
4MX1|1.59|2014|1MX|ligand is compound 13|P02879|RICIN A CHAIN|3.68|IC=209uM|IC50|=|209|uM|209000|nM
4O7B|1.50|2014|2RJ|ligand is SB284847-BT|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|4.7|IC=20uM|IC50|=|20|uM|20000|nM
4UY1|2.20|2014|TJM|ligand is compound 7|O15496|GROUP 10 SECRETORY PHOSPHOLIPASE A2|4.7|IC=20uM|IC50|=|20|uM|20000|nM
3WS8|2.60|2014|X4C|ligand is compound 14c|Q9Y233|CGMP 3',5'-CYCLIC PHOSPHODIESTERASE|6.68|IC=210nM|IC50|=|210|nM|210|nM
4RRS|1.80|2014|3UY|ligand is compound 51|P56817|BETA-SECRETASE 1|6.68|IC=210nM|IC50|=|210|nM|210|nM
4R17|2.10|2014|3K4|compound 1; IC50=21+/-2nM; incubated 2h|P23639|PROTEASOME SUBUNIT ALPHA TYPE-2|7.68|IC=21nM|IC50|=|21|nM|21|nM
4R18|2.40|2014|ABA|ligand is compound 1; incubated 6h at PH 6.8; IC50=21+/-2nM|P23639|PROTEASOME SUBUNIT ALPHA TYPE-2|7.68|IC=21nM|IC50|=|21|nM|21|nM
4O75|1.55|2014|2RC|ligand is Fostamatinib|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|4.68|IC=21uM|IC50|=|21|uM|21000|nM
4PKW|1.75|2014|GM6|ligand is compound 17; IC50=22.5+/-1.6uM|P15917|LETHAL FACTOR|4.65|IC=22.5uM|IC50|=|22.5|uM|22500|nM
4JLM|2.18|2014|1NN|ligand is compound F3|P27707|DEOXYCYTIDINE KINASE|7.64|IC=22.7nM|IC50|=|22.7|nM|22.7|nM
4JVJ|2.80|2014|1MV|ligand is compound 6f, optimized M2 assay|P14324|FARNESYL PYROPHOSPHATE SYNTHASE|7.66|IC=22nM|IC50|=|22|nM|22|nM
4P73|3.03|2014|GAX|ligand is compound 1a|Q9I0A4|PHENYLALANINE-TRNA LIGASE BETA SUBUNIT|7.66|IC=22nM|IC50|=|22|nM|22|nM
4C1F|2.01|2014|X8Z|ligand is L-captopril|P52699|BETA-LACTAMASE IMP-1|4.63|IC=23.3uM|IC50|=|23.3|uM|23300|nM
4K6V|1.50|2014|1P4-18D|compound 12b; consist of 1P4 and three 18D; cell binding assay|Q64823|FIBER PROTEIN|4.63|IC=23.4uM|IC50|=|23.4|uM|23400|nM
4CFV|2.00|2014|75X|ligand is compound 36|P24941|CYCLIN-DEPENDENT KINASE 2|4.63|IC=23.6uM|IC50|=|23.6|uM|23600|nM
3WF8|1.98|2014|F76|ligand is compound F176|P23443|RIBOSOMAL PROTEIN S6 KINASE BETA-1|6.63|IC=232nM|IC50|=|232|nM|232|nM
4NW7|2.15|2014|2O5|ligand is compound 8|Q07343|CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B|6.63|IC=237nM|IC50|=|237|nM|237|nM
3WYK|2.50|2014|3KG|ligand is compound 1|Q9Y233|CGMP 3',5'-CYCLIC PHOSPHODIESTERASE|7.64|IC=23nM|IC50|=|23|nM|23|nM
4BFR|2.80|2014|J82|ligand is compound 28|Q8BTI9|PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE CATA|7.64|IC=23nM|IC50|=|23|nM|23|nM
4LNG|1.91|2014|JAN|FPP-tipifarnib|Q4WP27|CAAX FARNESYLTRANSFERASE ALPHA SUBUNIT RAM2|5.62|IC=2400nM|IC50|=|2400|nM|2400|nM
4NNW|2.60|2014|2MK|ligand is compound 2|P23639|PROTEASOME SUBUNIT ALPHA TYPE-2|6.61|IC=244nM|IC50|=|244|nM|244|nM
3W8O|1.85|2014|WPC|ligand is Iron Phthalocyanine, FE-Pc, include metal atom|G3XD33|HEME ACQUISITION PROTEIN HASAP|7.62|IC=24nM|IC50|=|24|nM|24|nM
3WV3|1.60|2014|WLL|ligand is compound 7a|P45452|COLLAGENASE 3|7.62|IC=24nM|IC50|=|24|nM|24|nM
4O1D|1.71|2014|DGB|ligand is compound 11(APO866); biochemical IC50 =0.024+/-0.021 uM|P43490|NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE|7.62|IC=24nM|IC50|=|24|nM|24|nM
4PID|1.59|2014|2UQ|ligand is inhibitor 2|P03252|PROTEASE|4.62|IC=24uM|IC50|=|24|uM|24000|nM
4NRP|1.80|2014|OGA|Mn2+ containing;ligand is N-oxalylglycine|Q6P6C2|RNA DEMETHYLASE ALKBH5|4.59|IC=25.85uM|IC50|=|25.85|uM|25850|nM
4MUK|1.90|2014|2DV|compound 20|P0A5R0|PANTOTHENATE SYNTHETASE|6.6|IC=253nM|IC50|=|253|nM|253|nM
4BZR|1.84|2014|K26|ligand is compound 1, K-26. data is for aRabbit lung sACE|P12821|ANGIOTENSIN-CONVERTING ENZYME|7.6|IC=25nM|IC50|=|25|nM|25|nM
4O74|1.45|2014|R78|ligand is BI2536|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|7.6|IC=25nM|IC50|=|25|nM|25|nM
4OTG|2.60|2014|2V9|ligand is Lestaurtinib; IC50=26+/-0.7nM; PRK1 wild-type|Q16512|SERINE/THREONINE-PROTEIN KINASE N1|7.59|IC=26nM|IC50|=|26|nM|26|nM
4RRO|1.80|2014|3UX|ligand is compound 48|P56817|BETA-SECRETASE 1|7.59|IC=26nM|IC50|=|26|nM|26|nM
4NNN|2.50|2014|ALD|ligand is compound 1|P23639|PROTEASOME SUBUNIT ALPHA TYPE-2|6.57|IC=270nM|IC50|=|270|nM|270|nM
4LNB|1.75|2014|ED5|FPP-ED5|Q4WP27|CAAX FARNESYLTRANSFERASE ALPHA SUBUNIT RAM2|6.56|IC=275nM|IC50|=|275|nM|275|nM
4NO1|2.50|2014|CIX|ligand is compound 4|P23639|PROTEASOME SUBUNIT ALPHA TYPE-2|7.57|IC=27nM|IC50|=|27|nM|27|nM
4MVW|2.90|2014|43E|ligand is chem1433|Q38C91|METHIONYL-TRNA SYNTHETASE|7.55|IC=28nM|IC50|=|28|nM|28|nM
4OHM|2.40|2014|2TF|ligand is compound 51|Q14397|GLUCOKINASE REGULATORY PROTEIN|7.55|IC=28nM|IC50|=|28|nM|28|nM
4MX5|1.52|2014|5MX|ligand is compound 15|P02879|RICIN A CHAIN|4.55|IC=28uM|IC50|=|28|uM|28000|nM
4OZ3|1.70|2014|1Z8|ligand is compound 5; IC50=28+/-3.8uM|Q96PN6|ADENYLATE CYCLASE TYPE 10|4.55|IC=28uM|IC50|=|28|uM|28000|nM
4MVY|2.31|2014|387|ligand is chem1387|Q38C91|METHIONYL-TRNA SYNTHETASE|7.54|IC=29nM|IC50|=|29|nM|29|nM
4O28|2.00|2014|1QS|ligand is compound 8(GNE-617); biochemical IC50 =0.029+/-0.010 uM|P43490|NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE|7.54|IC=29nM|IC50|=|29|nM|29|nM
3WKA|2.01|2014|S0G|ligand is compound 7|P34913|EPOXIDE HYDROLASE 2|4.54|IC=29uM|IC50|=|29|uM|29000|nM
4NWK|1.62|2014|2R8|ligand is compound 35(BMS-605339); GT-1a screen IC50|A8DG50|NS3/4A PROTEASE|8.7|IC=2nM|IC50|=|2|nM|2|nM
4O15|1.80|2014|2P1|ligand is compound 1(GNE-618); biochemical IC50 =2+/-0.2nM; NAMPT mutant|P43490|NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE|8.7|IC=2nM|IC50|=|2|nM|2|nM
4RCE|2.40|2014|3LN|ligand is compound 2; IC50=2+/-1nM|P56817|BETA-SECRETASE 1|8.7|IC=2nM|IC50|=|2|nM|2|nM
4J5C|1.03|2014|7I6|compound 30|P30405|PEPTIDYL-PROLYL CIS-TRANS ISOMERASE F|5.52|IC=3.0uM|IC50|=|3|uM|3000|nM
4PNL|1.50|2014|DRL|ligand is DR-2313|Q9H2K2|TANKYRASE-2|5.52|IC=3.0uM|IC50|=|3|uM|3000|nM
4CTJ|1.47|2014|3A9|fragment 217 (3A9)|A9LIE0|NON-STRUCTURAL PROTEIN 5|2.51|IC=3.12mM|IC50|=|3.12|mM|3120000|nM
4UVB|2.80|2014|D51|ligand is compound 21a|O60341|LYSINE-SPECIFIC HISTONE DEMETHYLASE 1A|5.49|IC=3.26uM|IC50|=|3.26|uM|3260|nM
4KNX|1.90|2014|1S9|ligand is compound 7b, WG176|P43889|BIFUNCTIONAL PROTEIN GLMU|5.49|IC=3.2uM|IC50|=|3.2|uM|3200|nM
4JPA|2.00|2014|AZ6|ligand is compound 5b|P45452|COLLAGENASE 3|8.48|IC=3.3nM|IC50|=|3.3|nM|3.3|nM
4NVQ|2.03|2014|2OD|ligand is compound 12(A-366)|Q96KQ7|HISTONE-LYSINE N-METHYLTRANSFERASE EHMT2|8.48|IC=3.3nM|IC50|=|3.3|nM|3.3|nM
4C5W|1.70|2014|NM3|ligand is compound 14|O75936|GAMMA-BUTYROBETAINE DIOXYGENASE|5.48|IC=3.3uM|IC50|=|3.3|uM|3300|nM
4OQ6|1.81|2014|2UV|ligand is compound 36|Q07820|INDUCED MYELOID LEUKEMIA CELL DIFFERENTIATION PROTEIN MCL|5.48|IC=3.3uM|IC50|=|3.3|uM|3300|nM
4OSF|1.62|2014|4MT|[Covalent complex] compound 8|P14174|MACROPHAGE MIGRATION INHIBITORY FACTOR|5.44|IC=3.6uM|IC50|=|3.6|uM|3600|nM
4TJU|1.57|2014|CNQ|ligand is 3,4-CPQ-5-C|Q9H2K2|TANKYRASE-2|5.44|IC=3.6uM|IC50|=|3.6|uM|3600|nM
4CQE|2.30|2014|CQE|ligand is compound 20|D7PBN4|SLC45A3-BRAF FUSION PROTEIN|8.43|IC=3.7nM|IC50|=|3.7|nM|3.7|nM
4P2T|2.15|2014|24Q|ligand is compound 3; IC50=3.7+/-0.7uM|O36607|KSHV PROTEASE|5.43|IC=3.7uM|IC50|=|3.7|uM|3700|nM
4PNC|1.54|2014|7NP|ligand is compound 1; IC50=3.7+/-0.3uM|C3TPN7|METHIONINE AMINOPEPTIDASE|5.43|IC=3.7uM|IC50|=|3.7|uM|3700|nM
4LWT|1.60|2014|20Q|ligand is RO5027344, compound 5|P56273|E3 UBIQUITIN-PROTEIN LIGASE MDM2|5.41|IC=3.9uM|IC50|=|3.9|uM|3900|nM
4M3D|1.90|2014|2H2|ligand is compound 21|P96222|HTH-TYPE TRANSCRIPTIONAL REGULATOR ETHR|5.41|IC=3.9uM|IC50|=|3.9|uM|3900|nM
4PKU|2.40|2014|30P|ligand is compound 15; IC50=30.0+/-1.0uM|P15917|LETHAL FACTOR|4.52|IC=30.0uM|IC50|=|30|uM|30000|nM
4OG5|1.63|2014|2S7|ligand is compound 16 (MIV-5); IC50= 302+/-49nM|O00255|MENIN|6.52|IC=302nM|IC50|=|302|nM|302|nM
4NGH|2.68|2014|17-mer|ligand is 17-mer SAH-MPER(671-683KKK)(q)pSer peptide|P05880|ANTIBODY FAB LIGHT CHAIN|7.52|IC=30nM|IC50|=|30|nM|30|nM
4MW4|2.50|2014|2EB|ligand is chem1473|Q38C91|METHIONYL-TRNA SYNTHETASE|6.5|IC=316nM|IC50|=|316|nM|316|nM
4D2W|1.92|2014|NF5|ligand is compound 5|Q14680|MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE|4.51|IC=31uM|IC50|=|31|uM|31000|nM
4OK5|2.15|2014|2T2|ligand is compound 9|K4KA16|SERINE PROTEASE NS3|4.51|IC=31uM|IC50|=|31|uM|31000|nM
4MWB|2.31|2014|2EK|ligand is chem1509|Q38C91|METHIONYL-TRNA SYNTHETASE|6.49|IC=324nM|IC50|=|324|nM|324|nM
4MYQ|1.90|2014|19T|ligand is A-33|Q07343|CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B|7.49|IC=32nM|IC50|=|32|nM|32|nM
4TK5|2.02|2014|UHB|ligand is EB47|Q9H2K2|TANKYRASE-2|7.49|IC=32nM|IC50|=|32|nM|32|nM
4W7P|2.80|2014|3J7|ligand is compound 6|Q13464|RHO-ASSOCIATED PROTEIN KINASE 1|7.49|IC=32nM|IC50|=|32|nM|32|nM
4MRA|2.34|2014|QUE|ligand is QUERCETIN, IC50=20.9, 33.5 or 34.8 uM for GPb from refs|P00489|GLYCOGEN PHOSPHORYLASE|4.47|IC=33.5uM|IC50|=|33.5|uM|33500|nM
4N7E|2.70|2014|2JQ|ligand is AF38469|Q99523|SORTILIN|6.48|IC=330nM|IC50|=|330|nM|330|nM
4NAT|1.72|2014|2W5|ligand is compound A|P63820|PHOSPHOPANTETHEINE ADENYLYLTRANSFERASE|6.48|IC=330nM|IC50|=|330|nM|330|nM
3WF6|2.03|2014|FZ9|ligand is compound F109|P23443|RIBOSOMAL PROTEIN S6 KINASE BETA-1|7.48|IC=33nM|IC50|=|33|nM|33|nM
4D2D|2.52|2014|3-mer|ligand is tri-Alanine peptide|Q5M4H8|DI-OR TRIPEPTIDE\:H+ SYMPORTER|3.47|IC=340uM|IC50|=|340|uM|340000|nM
4BHF|2.05|2014|MZT|ligand is compound 64|O75936|GAMMA-BUTYROBETAINE DIOXYGENASE|3.46|IC=343uM|IC50|=|343|uM|343000|nM
4NRQ|2.50|2014|PD2|Mn2+ containing;ligand is pyridine-2,4-dicarboxylate|Q6P6C2|RNA DEMETHYLASE ALKBH5|3.46|IC=347.2uM|IC50|=|347.2|uM|347200|nM
4R6V|2.35|2014|FI3|ligand is FIIN-3|P22455|FIBROBLAST GROWTH FACTOR RECEPTOR 4|7.45|IC=35.3nM|IC50|=|35.3|nM|35.3|nM
4NPV|2.40|2014|0NK|ligand is compound 7a|Q01064|CALCIUM/CALMODULIN-DEPENDENT 3',5'-CYCLIC NUCLEOTIDE|7.46|IC=35nM|IC50|=|35|nM|35|nM
4OHP|2.40|2014|2TJ|ligand is compound 15|Q14397|GLUCOKINASE REGULATORY PROTEIN|7.46|IC=35nM|IC50|=|35|nM|35|nM
4URN|2.30|2014|NOV|ligand is Novobiocin|X5EN43|DNA TOPOISOMERASE IV, B SUBUNIT|4.46|IC=35uM|IC50|=|35|uM|35000|nM
4OV5|2.20|2014|14-mer|ligand is A1L9 peptide; IC50=36.9+/-2.9nM|P01903|HLA CLASS II HISTOCOMPATIBILITY ANTIGEN, DR ALPHA C|7.43|IC=36.9nM|IC50|=|36.9|nM|36.9|nM
4QLS|2.80|2014|37Y|ligand is compound 11; belta-5i|P23639|PROTEASOME SUBUNIT ALPHA TYPE-2|7.44|IC=36nM|IC50|=|36|nM|36|nM
4WSK|1.92|2014|3U2|[Covalent complex] [Incomplete ligand] [Nonstandard assay: Temp 37, pH=4.5, McIlvaine buffer=150mM, 0.1% (w/v) BSA] [Different protein in assay: human] compound 4; Structure differs;|Q8A3I4|ALPHA-L-FUCOSIDASE|6.43|IC=371.6nM|IC50|=|371.6|nM|371.6|nM
4O2F|1.90|2014|8-mer|ligand is HL8|P30475|HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-39 ALPHA|6.41|IC=387nM|IC50|=|387|nM|387|nM
4OAR|2.41|2014|2S0|ligand is UPA-SMRT; IC50=0.038+/-0.011nM|P06401|PROGESTERONE RECEPTOR|10.42|IC=38pM|IC50|=|38|pM|0.038|nM
4PL0|2.70|2014|ANP|ligand is AMP-PNP; IC50=39.5+/-0.6uM|Q9X2W0|MICROCIN-J25 EXPORT ATP-BINDING/PERMEASE PROTEIN|4.4|IC=39.5uM|IC50|=|39.5|uM|39500|nM
4QTC|1.40|2014|38Z|SCH772984|Q8TF76|SERINE/THREONINE-PROTEIN KINASE HASPIN|6.4|IC=398nM|IC50|=|398|nM|398|nM
4L2X|2.55|2014|YL2|ligand is compound 6m, optimized M2 assay|P14324|FARNESYL PYROPHOSPHATE SYNTHASE|7.41|IC=39nM|IC50|=|39|nM|39|nM
4MW0|2.20|2014|392|ligand is chem1392|Q38C91|METHIONYL-TRNA SYNTHETASE|7.41|IC=39nM|IC50|=|39|nM|39|nM
4QSM|3.00|2014|38K|ligand is compound 2; IC50=0.039+/-0.007uM|P00338|L-LACTATE DEHYDROGENASE A CHAIN|7.41|IC=39nM|IC50|=|39|nM|39|nM
4R02|2.50|2014|3E5|ligand is compound 6a; BSc4999 (alpha-Keto Phenylamide); intracellular inhibition|P23639|PROTEASOME SUBUNIT ALPHA TYPE-2|7.41|IC=39nM|IC50|=|39|nM|39|nM
4TLR|1.86|2014|33H|ligand is compound 22a|------|HCV NS5B RNA-DEPENDENT RNA POLYMERASE|8.52|IC=3nM|IC50|=|3|nM|3|nM
4UWH|1.93|2014|JXM|ligand is compound 4|Q8NEB9|PHOSPHATIDYLINOSITOL 3-KINASE CATALYTIC SUBUNIT TYP|8.52|IC=3nM|IC50|=|3|nM|3|nM
4WCU|2.35|2014|3KQ|ligand is compound 15|Q08499|CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D|8.52|IC=3nM|IC50|=|3|nM|3|nM
4P1R|2.24|2014|2KR|ligand is compound 7; IC50=4.1+/-1.5nM|Q9Y233|CGMP 3',5'-CYCLIC PHOSPHODIESTERASE|8.39|IC=4.1nM|IC50|=|4.1|nM|4.1|nM
4QYG|1.75|2014|3DW|ligand is compound 14|O14757|SERINE/THREONINE-PROTEIN KINASE CHK1|8.39|IC=4.1nM|IC50|=|4.1|nM|4.1|nM
4UMQ|2.60|2014|B5S|ligand is compound 3|Q14680|MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE|5.38|IC=4.2uM|IC50|=|4.2|uM|4200|nM
4OOW|2.57|2014|CAQ|quercetagetin; strain J4 (genotype 1b); IC50=4.3+/-0.7uM|O92972|RNA-DIRECTED RNA POLYMERASE|5.37|IC=4.3uM|IC50|=|4.3|uM|4300|nM
4RCP|1.60|2014|5-mer|ligand is peptide 2(PL-2)|P53350|SERINE/THREONINE-PROTEIN KINASE PLK1|5.35|IC=4.42uM|IC50|=|4.42|uM|4420|nM
4C1D|1.20|2014|X8Z|ligand is L-captopril|Q9K2N0|BETA-LACTAMASE CLASS B VIM-2|5.36|IC=4.4uM|IC50|=|4.4|uM|4400|nM
4PYQ|1.39|2014|2X1|ligand is ureido-benzamidine|P22734|CATECHOL O-METHYLTRANSFERASE|5.36|IC=4.4uM|IC50|=|4.4|uM|4400|nM
4K6W|1.50|2014|1P0-18D|trivalent sialic acid inhibitor ME0408, compound 12a; consist of 1P0 and three 18D; cell-binding assay|Q64823|FIBER PROTEIN|5.35|IC=4.5uM|IC50|=|4.5|uM|4500|nM
4WGI|1.85|2014|3M6|ligand is compound 7|P0AEY0|MALTOSE-BINDING PERIPLASMIC PROTEIN,INDUCED MYELOID|5.35|IC=4.5uM|IC50|=|4.5|uM|4500|nM
4O78|1.34|2014|SAV|ligand is GW612286X|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|5.34|IC=4.6uM|IC50|=|4.6|uM|4600|nM
4M7Y|1.80|2014|2GH|ligand is compound N5-Pan (6)|Q8NVG0|TYPE II PANTOTHENATE KINASE|5.32|IC=4.8uM|IC50|=|4.8|uM|4800|nM
4QAG|1.71|2014|F95|ligand is F3284-8495; IC50 measured at pH=7.4 with 1 mM Mg2+|P03366|HIV-1 REVERSE TRANSCRIPTASE/RIBONUCLEASE H|5.32|IC=4.8uM|IC50|=|4.8|uM|4800|nM
4CSJ|2.30|2014|NN7|ligand is compound 30|P04150|GLUCOCORTICOID RECEPTOR|8.31|IC=4.9nM|IC50|=|4.9|nM|4.9|nM
4M3F|2.00|2014|2D1|ligand is compound 8|P96222|HTH-TYPE TRANSCRIPTIONAL REGULATOR ETHR|5.31|IC=4.9uM|IC50|=|4.9|uM|4900|nM
4RFZ|1.17|2014|3OV|ligand is compound 4b; Human Whole Blood IC50|Q06187|TYROSINE-PROTEIN KINASE BTK|7.4|IC=40nM|IC50|=|40|nM|40|nM
4U6X|1.68|2014|15-mer|ALQDA peptide, ALQDAGDSSRKEYFI; incomplete ligand structure|P01892|HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA CHAIN|6.38|IC=414nM|IC50|=|414|nM|414|nM
4OTI|1.93|2014|MI1|ligand is Tofacitinib; IC50=43+/-4nM; PRK1 wild-type|Q16512|SERINE/THREONINE-PROTEIN KINASE N1|7.37|IC=43nM|IC50|=|43|nM|43|nM
4CLZ|1.90|2014|4DS|ligand is compound DIDS|Q96PN6|ADENYLATE CYCLASE TYPE 10|4.37|IC=43uM|IC50|=|43|uM|43000|nM
4QQC|2.40|2014|37O|ligand is FIIN-2|P22455|FIBROBLAST GROWTH FACTOR RECEPTOR 4|7.34|IC=45.3nM|IC50|=|45.3|nM|45.3|nM
4QRC|1.90|2014|0LI|ligand is Ponatinib; BaF3 Cell Viability Assay|P22455|FIBROBLAST GROWTH FACTOR RECEPTOR 4|6.34|IC=452nM|IC50|=|452|nM|452|nM
4MW5|2.35|2014|415|ligand is chem1415|Q38C91|METHIONYL-TRNA SYNTHETASE|7.35|IC=45nM|IC50|=|45|nM|45|nM
4PM0|2.10|2014|32V|ligand is compound 24|Q13946|CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 7A|7.35|IC=45nM|IC50|=|45|nM|45|nM
4WSJ|1.64|2014|3U3|[Covalent complex] [Incomplete ligand] [Nonstandard assay: Temp 37, pH=4.5, McIlvaine buffer=150mM, 0.1% (w/v) BSA] [Different protein in assay: human] compound 5; Structure differs;|Q8A3I4|ALPHA-L-FUCOSIDASE|7.33|IC=46.8nM|IC50|=|46.8|nM|46.8|nM
4NK3|1.90|2014|MK7|ligand is compound 3 (MK-7655)|P24735|BETA-LACTAMASE|6.33|IC=465nM|IC50|=|465|nM|465|nM
4NHC|2.91|2014|17-mer|ligand is 17-mer SAH-MPER(671-683KKK)(q)) peptide|P05880|ANTIBODY FAB LIGHT CHAIN|7.34|IC=46nM|IC50|=|46|nM|46|nM
4MAO|2.60|2014|28D|ligand is compound 20, RMM58|P18654|RIBOSOMAL PROTEIN S6 KINASE ALPHA-3|7.33|IC=47nM|IC50|=|47|nM|47|nM
4QQ5|2.20|2014|37O|ligand is FIN-2; BaF3 Cell Viability Assay|P22455|FIBROBLAST GROWTH FACTOR RECEPTOR 4|6.32|IC=482nM|IC50|=|482|nM|482|nM
4J8M|1.85|2014|CJ5|ligand is compound CD532|O14965|AURORA KINASE A|7.32|IC=48nM|IC50|=|48|nM|48|nM
4RRN|1.80|2014|3UW|ligand is compound 45|P56817|BETA-SECRETASE 1|7.32|IC=48nM|IC50|=|48|nM|48|nM
4NAH|2.38|2014|2VJ|ligand is compound B; multiple ligands|P63820|PHOSPHOPANTETHEINE ADENYLYLTRANSFERASE|6.31|IC=490nM|IC50|=|490|nM|490|nM
3WK8|2.20|2014|S0E|ligand is compound 5|P34913|EPOXIDE HYDROLASE 2|4.31|IC=49uM|IC50|=|49|uM|49000|nM
4NW6|1.74|2014|2NS|ligand is compound 27|P51812|RIBOSOMAL PROTEIN S6 KINASE ALPHA-3|8.4|IC=4nM|IC50|=|4|nM|4|nM
4PX6|1.60|2014|2X6|ligand is compound 3b|P43405|TYROSINE-PROTEIN KINASE SYK|8.4|IC=4nM|IC50|=|4|nM|4|nM
4RA5|2.61|2014|3L0|ligand is compound11a|Q04759|HUMAN PROTEIN KINASE C THETA|8.4|IC=4nM|IC50|=|4|nM|4|nM
4RCF|1.78|2014|3LO|ligand is compound 40; IC50=4+/-1nM; human embryonic kidney cells|P56817|BETA-SECRETASE 1|8.4|IC=4nM|IC50|=|4|nM|4|nM
4UYN|1.90|2014|Y3M|ligand is compound 16|O14965|AURORA KINASE A|8.4|IC=4nM|IC50|=|4|nM|4|nM
4O5B|2.37|2014|LF9|ligand is KF116; I N-LEDGF/75 binding IC50=5.03+/-0.36uM|P12497|INTEGRASE|8.3|IC=5.03nM|IC50|=|5.03|nM|5.03|nM
4O55|2.24|2014|LF9|ligand is KF116; I N-LEDGF/75 binding IC50=5.03+/-0.36uM|P12497|INTEGRASE|5.3|IC=5.03uM|IC50|=|5.03|uM|5030|nM
4N1U|1.60|2014|2GE|ligand is TH588, compound 3|P36639|7,8-DIHYDRO-8-OXOGUANINE TRIPHOSPHATASE|8.3|IC=5.0nM|IC50|=|5|nM|5|nM
4WN1|3.13|2014|3SJ|ligand is compound 42b|Q9Y233|CGMP 3',5'-CYCLIC PHOSPHODIESTERASE|8.29|IC=5.1nM|IC50|=|5.1|nM|5.1|nM
4U0G|3.20|2014|7-mer|ligand is ADEP-2B5Me; IC50=5.1+/-0.5uM|P9WPC3|ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2|5.29|IC=5.1uM|IC50|=|5.1|uM|5100|nM
4L1A|1.90|2014|AB1|ligand is Lopinavir|Q000H7|MDR 769 HIV-1 PROTEASE|8.27|IC=5.39nM|IC50|=|5.39|nM|5.39|nM
4PL4|3.00|2014|31K|OICR464 inhibitor; Mouse IRE1-alpha IC50=5.4+/-5.2uM|Q9EQY0|SERINE/THREONINE-PROTEIN KINASE/ENDORIBONUCLEASE IR|5.27|IC=5.4uM|IC50|=|5.4|uM|5400|nM
4PKV|2.50|2014|30R|ligand is compound 16; IC50=5.6+/-3.0uM|P15917|LETHAL FACTOR|5.25|IC=5.6uM|IC50|=|5.6|uM|5600|nM
4O7E|1.85|2014|2RN|ligand is SB610251-B|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|5.24|IC=5.7uM|IC50|=|5.7|uM|5700|nM
4MH7|2.51|2014|MH7|ligand is compound 7|Q12866|TYROSINE-PROTEIN KINASE MER|5.23|IC=5.9uM|IC50|=|5.9|uM|5900|nM
4URL|2.29|2014|XAM|ligand is Kibdelomycin;|X5EN43|DNA TOPOISOMERASE IV, B SUBUNIT|6.3|IC=500nM|IC50|=|500|nM|500|nM
4OJQ|2.25|2014|2SX|ligand is compound 1|K4KA16|SERINE PROTEASE NS3|3.3|IC=500uM|IC50|=|500|uM|500000|nM
4RG0|2.50|2014|3P0|ligand is compound 5b; Human Whole Blood IC50|Q06187|TYROSINE-PROTEIN KINASE BTK|7.3|IC=50nM|IC50|=|50|nM|50|nM
4CQF|2.30|2014|9Z8|ligand is compound 1a|A5H660|HISTONE DEACETYLASE 8|4.3|IC=50uM|IC50|=|50|uM|50000|nM
4O5G|2.30|2014|2PV|ligand is PFM39; IC50 is estimated to be 50-75 uM chromatin bound RPA;|Q9X1X0|EXONUCLEASE, PUTATIVE|4.3|IC=50uM|IC50|=|50|uM|50000|nM
4O43|2.40|2014|2PW|ligand is PFM03; IC50 is estimated to be 50-75 uM chromatin bound RPA;|Q9X1X0|EXONUCLEASE, PUTATIVE|4.3|IC=50uM|IC50|=|50|uM|50000|nM
4O24|2.30|2014|2Q0|ligand is PFM01; IC50 is estimated to be 50-75 uM chromatin bound RPA;|Q9X1X0|EXONUCLEASE, PUTATIVE|4.3|IC=50uM|IC50|=|50|uM|50000|nM
4PF3|1.10|2014|HFN|ligand is compound 37a|P08235|MINERALOCORTICOID RECEPTOR|7.29|IC=51nM|IC50|=|51|nM|51|nM
4BGK|2.18|2014|RTK|ligand is compound 78|O75936|GAMMA-BUTYROBETAINE DIOXYGENASE|6.28|IC=520nM|IC50|=|520|nM|520|nM
4W9N|1.84|2014|TCL|IC50=54.7+/-1.2uM|P49327|ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTASE|4.26|IC=54.7uM|IC50|=|54.7|uM|54700|nM
4LMU|2.38|2014|QUE|ligand is quercetin|P11309|SERINE/THREONINE-PROTEIN KINASE PIM-1|7.26|IC=55nM|IC50|=|55|nM|55|nM
4Q9Z|2.60|2014|PZW|ligand is compound 35|Q04759|HUMAN PROTEIN KINASE C THETA|7.26|IC=55nM|IC50|=|55|nM|55|nM
4TO8|2.10|2014|FLC|CITRATE ANION; IC50=56.9+/-3.5mM|W8TRN9|FRUCTOSE-1,6-BISPHOSPHATE ALDOLASE, CLASS II|1.24|IC=56.9mM|IC50|=|56.9|mM|56900000|nM
3WF9|2.04|2014|FS7|ligand is compound F177|P23443|RIBOSOMAL PROTEIN S6 KINASE BETA-1|6.25|IC=567nM|IC50|=|567|nM|567|nM
4OG8|1.53|2014|2SF|ligand is compound 19b (MIV-6R); IC50= 56+/-3nM|O00255|MENIN|7.25|IC=56nM|IC50|=|56|nM|56|nM
4MVX|2.55|2014|C13|ligand is chem1356|Q38C91|METHIONYL-TRNA SYNTHETASE|7.24|IC=57nM|IC50|=|57|nM|57|nM
4OD9|1.90|2014|2RZ|ligand is compound 24|P07339|CATHEPSIN D LIGHT CHAIN|7.24|IC=58nM|IC50|=|58|nM|58|nM
4KCG|2.09|2014|1QC|IC50 for the DI-39 inhibitor|P27707|DEOXYCYTIDINE KINASE|8.3|IC=5nM|IC50|=|5|nM|5|nM
4NUS|2.39|2014|2NK|ligand is LJH685|P51812|RIBOSOMAL PROTEIN S6 KINASE ALPHA-3|8.3|IC=5nM|IC50|=|5|nM|5|nM
4OHK|2.80|2014|2TE|ligand is compound 65|Q14397|GLUCOKINASE REGULATORY PROTEIN|8.3|IC=5nM|IC50|=|5|nM|5|nM
4OLH|2.40|2014|2TO|ligand is compound 51|Q14397|GLUCOKINASE REGULATORY PROTEIN|8.3|IC=5nM|IC50|=|5|nM|5|nM
4QO4|1.70|2014|35S|ligand is compound 16; HTRF IC50 human serum|Q00987|E3 UBIQUITIN-PROTEIN LIGASE MDM2|8.3|IC=5nM|IC50|=|5|nM|5|nM
4WKI|1.60|2014|3PW|ligand is compound 11|O75173|A DISINTEGRIN AND METALLOPROTEINASE WITH THROMBOSPO|8.3|IC=5nM|IC50|=|5|nM|5|nM
4NUF|2.80|2014|16-mer|EID1 bound to SHP: IC50 ~5-10 uM|K0BGG6|MALTOSE ABC TRANSPORTER PERIPLASMIC PROTEIN|5.3|IC=5uM|IC50|=|5|uM|5000|nM
2MLM|NMR|2014|2W7|ligand is compound 1a, structure in PDB is an open ring|R9YTM5|SORTASE FAMILY PROTEIN|5.21|IC=6.11uM|IC50|=|6.11|uM|6110|nM
3WK6|2.10|2014|S0B|ligand is compound 3|P34913|EPOXIDE HYDROLASE 2|5.2|IC=6.3uM|IC50|=|6.3|uM|6300|nM
4MK0|2.40|2014|29X|ligand is benzolactam derivative CCG-206584, plogIC50=5.2|P25098|BETA-ADRENERGIC RECEPTOR KINASE 1|5.2|IC=6.3uM|IC50|=|6.3|uM|6300|nM
4QLQ|2.40|2014|38N|ligand is compound 8; belta-5i|P23639|PROTEASOME SUBUNIT ALPHA TYPE-2|8.18|IC=6.6nM|IC50|=|6.6|nM|6.6|nM
4MXC|1.63|2014|DWF|compound 3h|P08581|HEPATOCYTE GROWTH FACTOR RECEPTOR|8.17|IC=6.7nM|IC50|=|6.7|nM|6.7|nM
4LTE|2.71|2014|5-mer|ligand is 5-mer macrocyclic Inhibitor|P14735|INSULIN-DEGRADING ENZYME|7.22|IC=60nM|IC50|=|60|nM|60|nM
3WKB|2.20|2014|S0I|ligand is compound 8|P34913|EPOXIDE HYDROLASE 2|4.21|IC=61uM|IC50|=|61|uM|61000|nM
4NRM|2.17|2014|FLC|Mn2+ containing;ligand is acetate|Q6P6C2|RNA DEMETHYLASE ALKBH5|3.2|IC=627.9uM|IC50|=|627.9|uM|627900|nM
4WZ8|2.23|2014|3W7|ligand is compound 6|Q00955|ACETYL-COA CARBOXYLASE|7.21|IC=62nM|IC50|=|62|nM|62|nM
4WBO|2.81|2014|ANW|ligand is Amlexanox; pIC50=4.2|P28327|RHODOPSIN KINASE|4.2|IC=63.10uM|IC50|=|63.1|uM|63100|nM
4P90|2.49|2014|2K0|ligand is compound 15|Q13153|SERINE/THREONINE-PROTEIN KINASE PAK 1|7.19|IC=64nM|IC50|=|64|nM|64|nM
4PY1|2.16|2014|2YK|ligand is compound 15; IC50 of LRRK2.;tyrosine kinase 2 (Tyk2) ATP-binding site residues are 74% similar to those in LRRK2|P29597|NON-RECEPTOR TYROSINE-PROTEIN KINASE TYK2|7.19|IC=64nM|IC50|=|64|nM|64|nM
4OBQ|2.19|2014|2QT|ligand is compound 31|O95819|MITOGEN-ACTIVATED PROTEIN KINASE 4|7.19|IC=65nM|IC50|=|65|nM|65|nM
4Q1S|2.60|2014|2YD|ligand is KM; for y-belta 5 activity|P23639|PROTEASOME SUBUNIT ALPHA TYPE-2|4.17|IC=67.9uM|IC50|=|67.9|uM|67900|nM
4BPI|1.98|2014|19-mer|ligand is alpha beta Puma BH3 peptide 2|P97287|FUSION PROTEIN CONSISTING OF INDUCED MYELOID LEUKEM|6.17|IC=670nM|IC50|=|670|nM|670|nM
4FC0|2.95|2014|0T2|ligand is compound 5|P15056|SERINE/THREONINE-PROTEIN KINASE B-RAF|7.16|IC=69nM|IC50|=|69|nM|69|nM
4QGF|1.83|2014|32B|ligand is compound 38|Q6GJI9|THYMIDYLATE KINASE|7.16|IC=69nM|IC50|=|69|nM|69|nM
3WHW|2.70|2014|RUX|Ruthenium-based inhibitor, compound 4|P36639|7,8-DIHYDRO-8-OXOGUANINE TRIPHOSPHATASE|8.22|IC=6nM|IC50|=|6|nM|6|nM
4LWV|2.32|2014|20W|ligand is compound 16, RO5545353|P56273|E3 UBIQUITIN-PROTEIN LIGASE MDM2|8.22|IC=6nM|IC50|=|6|nM|6|nM
4U0I|2.00|2014|0LI|ligand is ponatinib; IC50 in vitro|P10721|MAST/STEM CELL GROWTH FACTOR RECEPTOR|8.22|IC=6nM|IC50|=|6|nM|6|nM
4PCE|1.29|2014|2N0|ligand is compound 2|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|5.15|IC=7.0uM|IC50|=|7|uM|7000|nM
4C1G|1.71|2014|MCO|ligand is D-captopril|P52699|BETA-LACTAMASE IMP-1|5.14|IC=7.2uM|IC50|=|7.2|uM|7200|nM
3WK4|2.11|2014|S0A|ligand is compound 1|P34913|EPOXIDE HYDROLASE 2|5.13|IC=7.4uM|IC50|=|7.4|uM|7400|nM
4L7C|2.40|2014|1VW|ligand is compound 22|Q14145|KELCH-LIKE ECH-ASSOCIATED PROTEIN 1|5.13|IC=7.4uM|IC50|=|7.4|uM|7400|nM
4PCI|1.25|2014|2NJ|ligand is compound 3|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|5.12|IC=7.5uM|IC50|=|7.5|uM|7500|nM
4P6G|1.58|2014|2FZ|ligand is compound 5; IC50=7.70+/-5.85|P25774|CATHEPSIN S|8.11|IC=7.70nM|IC50|=|7.7|nM|7.7|nM
4PUZ|2.08|2014|CG9|ligand is compound 68(GS-9973)|P43405|TYROSINE-PROTEIN KINASE SYK|8.11|IC=7.7nM|IC50|=|7.7|nM|7.7|nM
4NO8|2.70|2014|2LV|ligand is compound 6|P23639|PROTEASOME SUBUNIT ALPHA TYPE-2|7.15|IC=70nM|IC50|=|70|nM|70|nM
3WK9|2.20|2014|S0F|ligand is compound 6|P34913|EPOXIDE HYDROLASE 2|4.15|IC=70uM|IC50|=|70|uM|70000|nM
4OK3|2.30|2014|2SY|ligand is compound 7|K4KA16|SERINE PROTEASE NS3|4.15|IC=71uM|IC50|=|71|uM|71000|nM
4JLJ|2.00|2014|1NM|ligand is compound F1|P27707|DEOXYCYTIDINE KINASE|6.13|IC=745.7nM|IC50|=|745.7|nM|745.7|nM
4WK7|1.24|2014|3PQ|ligand is compound 1|O75173|A DISINTEGRIN AND METALLOPROTEINASE WITH THROMBOSPO|7.13|IC=74nM|IC50|=|74|nM|74|nM
4R5N|1.80|2014|3J9|ligand is compound 50|P56817|BETA-SECRETASE 1|7.12|IC=76nM|IC50|=|76|nM|76|nM
4RJ6|2.70|2014|3R0|ligand is compound 4|P00533|EPIDERMAL GROWTH FACTOR RECEPTOR|7.12|IC=76nM|IC50|=|76|nM|76|nM
4IA0|2.17|2014|5BB|ligand is compound 2e|O76074|CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE|7.11|IC=77nM|IC50|=|77|nM|77|nM
4OBO|2.10|2014|2QV|ligand is compound 22|O95819|MITOGEN-ACTIVATED PROTEIN KINASE 4|7.11|IC=77nM|IC50|=|77|nM|77|nM
4NO6|3.00|2014|2M1|ligand is compound 5|P23639|PROTEASOME SUBUNIT ALPHA TYPE-2|6.11|IC=780nM|IC50|=|780|nM|780|nM
4UYD|1.37|2014|V1T|ligand is compound 1; pIC50=4.1|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|4.1|IC=79.43uM|IC50|=|79.43|uM|79430|nM
4LXB|1.61|2014|7R9|ligand is compound 58|P00734|THROMBIN LIGHT CHAIN|8.15|IC=7nM|IC50|=|7|nM|7|nM
4ONA|2.40|2014|UW1|ligand is compound 26|Q9BJF5|CALMODULIN-DOMAIN PROTEIN KINASE 1|8.15|IC=7nM|IC50|=|7|nM|7|nM
4OP3|2.82|2014|2UY|ligand is compound 39; IC50=0.007+/-0.002uM|Q14397|GLUCOKINASE REGULATORY PROTEIN|8.15|IC=7nM|IC50|=|7|nM|7|nM
4UWF|2.99|2014|EUT|ligand is compound 2|Q8NEB9|PHOSPHATIDYLINOSITOL 3-KINASE CATALYTIC SUBUNIT TYP|8.15|IC=7nM|IC50|=|7|nM|7|nM
4UWG|2.70|2014|RBQ|ligand is compound 3|Q8NEB9|PHOSPHATIDYLINOSITOL 3-KINASE CATALYTIC SUBUNIT TYP|8.15|IC=7nM|IC50|=|7|nM|7|nM
4QLU|2.80|2014|38X|ligand is compound 9; belta-5i|P23639|PROTEASOME SUBUNIT ALPHA TYPE-2|8.08|IC=8.3nM|IC50|=|8.3|nM|8.3|nM
4TWD|3.20|2014|377|ligand is Memantine|P0C7B7|CYS-LOOP LIGAND-GATED ION CHANNEL|5.08|IC=8.3uM|IC50|=|8.3|uM|8300|nM
4CFX|3.50|2014|G6T|ligand is compound 44|P24941|CYCLIN-DEPENDENT KINASE 2|5.06|IC=8.7uM|IC50|=|8.7|uM|8700|nM
4C1H|1.10|2014|X8Z|ligand is L-captopril|P04190|BETA-LACTAMASE 2|4.09|IC=80.4uM|IC50|=|80.4|uM|80400|nM
4P75|2.96|2014|2NM|ligand is compound 4a|Q9I0A4|PHENYLALANINE-TRNA LIGASE BETA SUBUNIT|4.1|IC=80uM|IC50|=|80|uM|80000|nM
3WF5|2.10|2014|FZ8|ligand is compound F108|P23443|RIBOSOMAL PROTEIN S6 KINASE BETA-1|7.09|IC=81nM|IC50|=|81|nM|81|nM
4P72|2.62|2014|2NL|ligand is compound 2a|Q9I0A4|PHENYLALANINE-TRNA LIGASE BETA SUBUNIT|4.09|IC=82uM|IC50|=|82|uM|82000|nM
4U6Y|1.47|2014|15-mer|FLNKD peptide, FLNKDLEVDGHFVTM|P01892|HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA CHAIN|7.08|IC=83nM|IC50|=|83|nM|83|nM
4V25|2.60|2014|SZ6|ligand is VER-246608|Q15119|PYRUVATE DEHYDROGENASE (ACETYL-TRANSFERRING) KINASE|7.08|IC=84nM|IC50|=|84|nM|84|nM
4OC6|2.64|2014|2S1|ligand is compound 2|P07339|CATHEPSIN D LIGHT CHAIN|7.07|IC=85nM|IC50|=|85|nM|85|nM
4NWM|2.03|2014|2P5|ligand is compound 20|Q06187|TYROSINE-PROTEIN KINASE BTK|8.1|IC=8nM|IC50|=|8|nM|8|nM
4OQ3|2.30|2014|2V8|ligand is compound 7; TR-FRET IC50|Q00987|E3 UBIQUITIN-PROTEIN LIGASE MDM2|8.1|IC=8nM|IC50|=|8|nM|8|nM
4P10|2.00|2014|2B8|ligand is compound 5; wild type TAFIa for biological experiments|Q96IY4|CARBOXYPEPTIDASE B2|8.1|IC=8nM|IC50|=|8|nM|8|nM
4U44|2.43|2014|3D9|ligand is compound 16|O95819|MITOGEN-ACTIVATED PROTEIN KINASE 4|8.1|IC=8nM|IC50|=|8|nM|8|nM
4OGV|2.20|2014|2U7|ligand is compound 49; HTRF IC50, buffer containing 15% human serum|Q00987|E3 UBIQUITIN-PROTEIN LIGASE MDM2|8.05|IC=9.0nM|IC50|=|9|nM|9|nM
4N00|1.80|2014|2EX|ligand is compound 62|P56817|BETA-SECRETASE 1|8.02|IC=9.5nM|IC50|=|9.5|nM|9.5|nM
4RLK|1.24|2014|E91||P28523|CASEIN KINASE II, ALPHA SUBUNIT|5.02|IC=9.5uM|IC50|=|9.5|uM|9500|nM
4RLL|1.85|2014|E91||P68400|CASEIN KINASE II, ALPHA SUBUNIT|5.02|IC=9.5uM|IC50|=|9.5|uM|9500|nM
4L7R|2.20|2014|M00|ligand is compound 19c|Q9Y6F1|POLY [ADP-RIBOSE] POLYMERASE 3|5.02|IC=9.6uM|IC50|=|9.6|uM|9600|nM
4BHI|2.15|2014|RUJ|ligand is compound 98|O75936|GAMMA-BUTYROBETAINE DIOXYGENASE|7.05|IC=90nM|IC50|=|90|nM|90|nM
3WS9|2.99|2014|X4D|ligand is compound 14d|Q9Y233|CGMP 3',5'-CYCLIC PHOSPHODIESTERASE|7.04|IC=92nM|IC50|=|92|nM|92|nM
4TPT|2.60|2014|35H|ligand is compound 22|P53671|LIM DOMAIN KINASE 2|7.04|IC=92nM|IC50|=|92|nM|92|nM
4RJ3|1.63|2014|3QS|ligand is compound 8|P24941|CYCLIN-DEPENDENT KINASE 2|7.03|IC=93nM|IC50|=|93|nM|93|nM
4MW9|2.65|2014|2EJ|ligand is chem1478|Q38C91|METHIONYL-TRNA SYNTHETASE|7.02|IC=96nM|IC50|=|96|nM|96|nM
4UZH|2.00|2014|JVE|ligand is compound 1|O14965|AURORA 2 KINASE DOMAIN|5.01|IC=9800nM|IC50|=|9800|nM|9800|nM
4PMT|2.10|2014|31Y|ligand is compound 1|P04629|HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR|6.0|IC=997nM|IC50|=|997|nM|997|nM
4OTH|1.80|2014|DRN|ligand is Ro-31-8220; IC50=9+/-3nM; PRK1 wild-type|Q16512|SERINE/THREONINE-PROTEIN KINASE N1|8.05|IC=9nM|IC50|=|9|nM|9|nM
4URM|2.94|2014|XAM|ligand is Kibdelomycin;|P0A0K8|DNA GYRASE SUBUNIT B|8.05|IC=9nM|IC50|=|9|nM|9|nM
4MW7|2.75|2014|2EF|ligand is chem1469|Q38C91|METHIONYL-TRNA SYNTHETASE|5.0|IC>10000nM|IC50|>|10000|nM|10000|nM
4OZ2|2.10|2014|1Z6|ligand is compound 1|Q96PN6|ADENYLATE CYCLASE TYPE 10|3.0|IC>1000uM|IC50|>|1000|uM|1000000|nM
4OYP|2.28|2014|BZ2|ligand is compound 2|Q96PN6|ADENYLATE CYCLASE TYPE 10|3.0|IC>1000uM|IC50|>|1000|uM|1000000|nM
4CFU|2.20|2014|2WC|ligand is compound 37|P24941|CYCLIN-DEPENDENT KINASE 2|4.0|IC>100uM|IC50|>|100|uM|100000|nM
4TUH|1.80|2014|38H|ligand is compound 10|Q07817|BCL-2-LIKE PROTEIN 1|4.0|IC>100uM|IC50|>|100|uM|100000|nM
4CTK|1.53|2014|SVN|fragment 97 (2A4)|A9LIE0|POLYPROTEIN|2.0|IC>10mM|IC50|>|10|mM|10000000|nM
4OYO|1.75|2014|1WC|ligand is compound 3|Q96PN6|ADENYLATE CYCLASE TYPE 10|3.52|IC>300uM|IC50|>|300|uM|300000|nM
4PNS|1.65|2014|32Y|ligand is INH2BP|Q9H2K2|TANKYRASE-2|4.52|IC>30uM|IC50|>|30|uM|30000|nM
4PML|1.87|2014|3AB|ligand is 3-AB|Q9H2K2|TANKYRASE-2|4.52|IC>30uM|IC50|>|30|uM|30000|nM
4PNN|1.65|2014|JPZ|ligand is 4-HQN|Q9H2K2|TANKYRASE-2|4.52|IC>30uM|IC50|>|30|uM|30000|nM
4J58|1.28|2014|53Z|compound 23|P30405|PEPTIDYL-PROLYL CIS-TRANS ISOMERASE F|3.3|IC>500uM|IC50|>|500|uM|500000|nM
4WH7|1.62|2014|8H8|ligand is compound 1|P30305|M-PHASE INDUCER PHOSPHATASE 2|2.3|IC>5mM|IC50|>|5|mM|5000000|nM
4WAF|2.39|2014|3K6|ligand is compound 4; IC50>=10uM|P42336|PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE|5.0|IC>=10uM|IC50|>=|10|uM|10000|nM
4N8R|2.03|2014|K08|ligand is K8008, IC50 is estimated value|P19793|RETINOIC ACID RECEPTOR RXR-ALPHA|5.0|IC~10uM|IC50|~|10|uM|10000|nM
4N5G|2.11|2014|K09|ligand is K8012, IC50 is estimated value|P19793|RETINOIC ACID RECEPTOR RXR-ALPHA|5.0|IC~10uM|IC50|~|10|uM|10000|nM
4O7D|2.30|2014|ONL|ligand is DON|O94925|GLUTAMINASE KIDNEY ISOFORM, MITOCHONDRIAL|3.0|IC~1mM|IC50|~|1|mM|1000000|nM
4PYN|1.20|2014|SAH||P22734|CATECHOL O-METHYLTRANSFERASE|4.52|IC~30uM|IC50|~|30|uM|30000|nM
4PYO|2.10|2014|SAH||P22734|CATECHOL O-METHYLTRANSFERASE|4.52|IC~30uM|IC50|~|30|uM|30000|nM
4OJR|1.82|2014|2SQ|ligand is GSK1264; IN F815K mutant|P03366|HIV-1 INTEGRASE|7.42|IC~38nM|IC50|~|38|nM|38|nM
4P1U|2.52|2014|21G|ligand is compound 2, VX787|P31345|POLYMERASE BASIC PROTEIN 2|8.52|Kd<0.003uM|Kd|<|0.003|uM|3|nM
4LJ3|1.70|2014|C2E|substrate c-di-GMP and Ca++, MST assay, Kd <=1nM|P21514|CYCLIC DI-GMP PHOSPHODIESTERASE YAHA|9.0|Kd<1nM|Kd|<|1|nM|1|nM
4NB3|1.35|2014|15-mer|ligand is 3,4 dichlorophenylalanine ATRIP derived peptide 33|P27694|REPLICATION PROTEIN A 70 KDA DNA-BINDING SUBUNIT|7.66|Kd=0.022uM|Kd|=|0.022|uM|22|nM
4QYY|1.65|2014|3G7|compound 4; unphosphorylated ERK2 (apo ERK2); TdF|P63086|MITOGEN-ACTIVATED PROTEIN KINASE 1|7.3|Kd=0.05uM|Kd|=|0.05|uM|50|nM
4MO4|1.67|2014|ACP||Q9I5Q5|ANHYDRO-N-ACETYLMURAMIC ACID KINASE|4.22|Kd=0.06mM|Kd|=|0.06|mM|60000|nM
4W97|1.60|2014|UCA|ligand is HIP-CoA; Kd=0.08+/-0.01uM|P9WMB9|HTH-TYPE TRANSCRIPTIONAL REPRESSOR KSTR2|7.1|Kd=0.08uM|Kd|=|0.08|uM|80|nM
4NCM|2.82|2014|704|ligand is compound 3|P31345|POLYMERASE BASIC PROTEIN 2|7.0|Kd=0.10uM|Kd|=|0.1|uM|100|nM
4CG8|1.75|2014|G8S|compound14|P35790|CHOLINE KINASE ALPHA|6.96|Kd=0.11uM|Kd|=|0.11|uM|110|nM
4PO0|2.73|2014|NPS|Kd=0.12-0.20uM; fluorometric assay|G1U9S2|SERUM ALBUMIN|6.92|Kd=0.12uM|Kd|=|0.12|uM|120|nM
4U0E|2.04|2014|1B0|PF74; -DTT|P12493|CAPSID PROTEIN P24|6.92|Kd=0.12uM|Kd|=|0.12|uM|120|nM
4WM9|2.40|2014|NXL|ligand is avibactam|Q8RLA6|BETA-LACTAMASE|6.92|Kd=0.12uM|Kd|=|0.12|uM|120|nM
4U0S|2.49|2014|ADP|Kd=0.158+/-0.021uM|Q9BVA6|ADENOSINE MONOPHOSPHATE-PROTEIN TRANSFERASE FICD|6.8|Kd=0.158uM|Kd|=|0.158|uM|158|nM
4NZO|1.90|2014|2OV|ligand is 2,5-di-O-Bn-InsP4|O43314|INOSITOL HEXAKISPHOSPHATE AND DIPHOSPHOINOSITOL|6.77|Kd=0.17uM|Kd|=|0.17|uM|170|nM
4W9H|2.10|2014|3JF|ligand is 7; Kd=0.185+/-0.006uM|Q15370|TRANSCRIPTION ELONGATION FACTOR B POLYPEPTIDE 2|6.73|Kd=0.185uM|Kd|=|0.185|uM|185|nM
4OYK|2.00|2014|19-mer|ligand is a Ubiquitin thioesterase peptide(49-67); binding to HOIP wt; Kd=0.18+/-0.084uM|Q96EP0|E3 UBIQUITIN-PROTEIN LIGASE RNF31|6.74|Kd=0.18uM|Kd|=|0.18|uM|180|nM
4O0A|1.20|2014|2P9|ligand is compound 8|P27694|REPLICATION PROTEIN A 70 KDA DNA-BINDING SUBUNIT|6.72|Kd=0.19uM|Kd|=|0.19|uM|190|nM
4TXC|1.95|2014|38G|ligand is compound 6; Kd=0.24+/-0.09uM|P53355|DEATH-ASSOCIATED PROTEIN KINASE 1|6.62|Kd=0.24uM|Kd|=|0.24|uM|240|nM
4Q3S|2.11|2014|X7A|SmARG-ABHPE; Kd=0.26+/-0.02uM; PH=8.5|Q6WVP6|ARGINASE|6.59|Kd=0.26uM|Kd|=|0.26|uM|260|nM
4QNB|2.00|2014|1B0|ligand is PF74; Kd=0.26+/-0.09uM|P12497|CAPSID PROTEIN P24|6.59|Kd=0.26uM|Kd|=|0.26|uM|260|nM
4W9K|2.10|2014|3JO|ligand is 14; Kd=0.291+/-0.02uM|Q15370|TRANSCRIPTION ELONGATION FACTOR B POLYPEPTIDE 2|6.54|Kd=0.291uM|Kd|=|0.291|uM|291|nM
4P0B|2.70|2014|10-mer|Injectant:HOIP PUB 550uM ; Cell:OTULIN 50 uM;|Q96EP0|E3 UBIQUITIN-PROTEIN LIGASE RNF31|6.54|Kd=0.29uM|Kd|=|0.29|uM|290|nM
4UU8|2.90|2014|9-mer|ligand is 3,3-dimethyl- succinylated CPS1-peptide 5c; Kd=0.29+/-0.04uM|Q6DHI5|NAD-DEPENDENT PROTEIN DEACYLASE SIRTUIN-5|6.54|Kd=0.29uM|Kd|=|0.29|uM|290|nM
4QAB|2.98|2014|KK2|ligand is compound 32; Kd=0.0002+/-0.0001uM|P58154|ACETYLCHOLINE-BINDING PROTEIN|9.7|Kd=0.2nM|Kd|=|0.2|nM|0.2|nM
4V05|2.57|2014|66T|ligand is AZD4547; Kd=0.2+/-0.01nM|D3DSX2|FIBROBLAST GROWTH FACTOR RECEPTOR 1|9.7|Kd=0.2nM|Kd|=|0.2|nM|0.2|nM
4M13|1.85|2014|1E0|ligand is compound 8, Kd1: allosteric pocket, Kd2: ATP pocket|Q08881|TYROSINE-PROTEIN KINASE ITK/TSK|6.7|Kd=0.2uM|Kd|=|0.2|uM|200|nM
4M14|1.55|2014|QWS|ligand is compound 9, Kd1: allosteric pocket, Kd2: ATP pocket|Q08881|TYROSINE-PROTEIN KINASE ITK/TSK|6.7|Kd=0.2uM|Kd|=|0.2|uM|200|nM
4TZM|2.30|2014|16-mer|ligand is HTP-3 closure motif1|Q95XC8|PROTEIN HTP-2|6.7|Kd=0.2uM|Kd|=|0.2|uM|200|nM
4MG8|1.85|2014|27J|ligand is compound alpha-zearalanol|P03372|ESTROGEN RECEPTOR|6.48|Kd=0.33uM|Kd|=|0.33|uM|330|nM
4PVV|2.50|2014|HO4|ligand is compound 1a; IC50=0.33+/-0.02uM|P83734|ADENOSINE KINASE|6.48|Kd=0.33uM|Kd|=|0.33|uM|330|nM
4Q0A|1.90|2014|4OA|ligand is LCA; Kd=0.33+/-0.26uM; direct titration: Kd 0.3 and 9.5 uM for the first and the second binding events|Q9PTN2|VITAMIN D3 RECEPTOR A|6.48|Kd=0.33uM|Kd|=|0.33|uM|330|nM
4Q3T|2.14|2014|HAR|SmARG-NOAH; Kd=0.33+/-0.09uM; PH=8.5;the first binding site|Q6WVP6|ARGINASE|6.48|Kd=0.33uM|Kd|=|0.33|uM|330|nM
4PSX|2.51|2014|15-mer||Q12341|HISTONE ACETYLTRANSFERASE TYPE B CATALYTIC SUBUNIT|6.47|Kd=0.34uM|Kd|=|0.34|uM|340|nM
4M0Y|1.70|2014|M0Y|ligand is compound 1, Kd1: allosteric pocket, Kd2: ATP pocket|Q08881|TYROSINE-PROTEIN KINASE ITK/TSK|6.46|Kd=0.35uM|Kd|=|0.35|uM|350|nM
4Q3U|2.50|2014|NNH|SmARG-nor NOAH; Kd=0.36+/-0.08uM; PH=8.5|Q6WVP6|ARGINASE|6.44|Kd=0.36uM|Kd|=|0.36|uM|360|nM
4QAA|2.70|2014|KK1|ligand is compound 15; Kd=0.36+/-0.03uM|P58154|ACETYLCHOLINE-BINDING PROTEIN|6.44|Kd=0.36uM|Kd|=|0.36|uM|360|nM
4D3H|2.00|2014|2BA|ligand is compound c-di-AMP|Q99WC0|PSTA|6.43|Kd=0.37uM|Kd|=|0.37|uM|370|nM
4C1W|1.84|2014|SLT||Q4LB86|NEURAMINIDASE|9.41|Kd=0.39nM|Kd|=|0.39|nM|0.39|nM
4TZN|3.12|2014|16-mer|ligand is HTP-3 motif-6|Q95XC8|PROTEIN HTP-2|6.52|Kd=0.3uM|Kd|=|0.3|uM|300|nM
4TZQ|2.30|2014|17-mer|ligand is HTP-3 motif-1|Q20305|PROTEIN HTP-1|6.52|Kd=0.3uM|Kd|=|0.3|uM|300|nM
4QNU|2.60|2014|GEK|ligand is Cx-SaM; crystal space P21212|A1AC32|TRNA (MO5U34)-METHYLTRANSFERASE|6.4|Kd=0.40uM|Kd|=|0.4|uM|400|nM
4MG7|2.15|2014|27H|ligand is compound ferutinine|P03372|ESTROGEN RECEPTOR|6.36|Kd=0.44uM|Kd|=|0.44|uM|440|nM
4NBL|1.76|2014|2J6|ligand is compound 12|P55212|CASPASE-6|6.33|Kd=0.47uM|Kd|=|0.47|uM|470|nM
3WHA|1.30|2014|WHA|ligand is compound 16l|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|9.32|Kd=0.48nM|Kd|=|0.48|nM|0.48|nM
4MGC|2.15|2014|27M|ligand is compound benzophenone-2, BP-2|P03372|ESTROGEN RECEPTOR|6.32|Kd=0.48uM|Kd|=|0.48|uM|480|nM
4QAC|2.10|2014|KK3|ligand is compound 33; Kd=0.0004+/-0.0002uM|P58154|ACETYLCHOLINE-BINDING PROTEIN|9.4|Kd=0.4nM|Kd|=|0.4|nM|0.4|nM
4CGA|1.74|2014|QLW|ligand is compound 5|P35790|CHOLINE KINASE ALPHA|6.4|Kd=0.4uM|Kd|=|0.4|uM|400|nM
4O3U|3.04|2014|15-mer|ZAP2.3; Kd=0.4+/-0.3uM|P14210|HEPATOCYTE GROWTH FACTOR|6.4|Kd=0.4uM|Kd|=|0.4|uM|400|nM
4P00|3.20|2014|C2E|UDP-bound complex; c-di-GMP binds to WT BcsA-B; Kd=0.4+/-0.04uM|Q3J125|CELLULOSE SYNTHASE SUBUNIT A|6.4|Kd=0.4uM|Kd|=|0.4|uM|400|nM
4P02|2.65|2014|C2E|UDP-free complex; c-di-GMP binds to WT BcsA-B; Kd=0.4+/-0.04uM|Q3J125|CELLULOSE SYNTHASE SUBUNIT A|6.4|Kd=0.4uM|Kd|=|0.4|uM|400|nM
4LJ5|2.40|2014|ADP||Q9RA63|CHAPERONE PROTEIN CLPB|6.29|Kd=0.51uM|Kd|=|0.51|uM|510|nM
4N84|2.50|2014|10-mer|ligand is a 12-carbon-linker cyclic peptide derived from ExoS, Beta-SS-12|P63104|14-3-3 PROTEIN ZETA/DELTA|6.29|Kd=0.51uM|Kd|=|0.51|uM|510|nM
4N7U|1.46|2014|2JA|ligand is compound cHDMAPP|O00481|BUTYROPHILIN SUBFAMILY 3 MEMBER A1|6.29|Kd=0.51uM|Kd|=|0.51|uM|510|nM
2MKR|NMR|2014|13-mer|ligand is 13-mer Acidic Transactivation Domain of Epstein-Barr nuclear antigen 2 (EBNA2)|P32776|RNA POLYMERASE II TRANSCRIPTION FACTOR B SUBUNIT 1|6.27|Kd=0.54uM|Kd|=|0.54|uM|540|nM
4Q3R|2.17|2014|XA2|SmARG-ABHDP; Kd=0.54+/-0.08uM; PH=8.5|Q6WVP6|ARGINASE|6.27|Kd=0.54uM|Kd|=|0.54|uM|540|nM
4R4I|1.40|2014|3HV|ligand is compound 7j; Kd= 0.54+/- 0.2uM|P27694|REPLICATION PROTEIN A 70 KDA DNA-BINDING SUBUNIT|6.27|Kd=0.54uM|Kd|=|0.54|uM|540|nM
4N7Y|2.16|2014|11-mer|ligand is a 8-carbon-linker cyclic peptide derived from ExoS, Beta-RS-8|P63104|14-3-3 PROTEIN ZETA/DELTA|6.26|Kd=0.55uM|Kd|=|0.55|uM|550|nM
4R4T|1.28|2014|3J0|ligand is compound 7f; Kd= 0.55+/- 0.1uM|P27694|REPLICATION PROTEIN A 70 KDA DNA-BINDING SUBUNIT|6.26|Kd=0.55uM|Kd|=|0.55|uM|550|nM
4W9J|2.20|2014|3JH|ligand is 13; Kd=0.588+/-0.04uM|Q15370|TRANSCRIPTION ELONGATION FACTOR B POLYPEPTIDE 2|6.23|Kd=0.588uM|Kd|=|0.588|uM|588|nM
4NP3|1.61|2014|2L2|ligand is compound 5a|P15379|CD44 ANTIGEN|3.3|Kd=0.5mM|Kd|=|0.5|mM|500000|nM
4OAG|2.00|2014|ADP|Kd=0.5+/-0.008uM|Q8BGV8|MITOCHONDRIAL DYNAMIC PROTEIN MID51|6.3|Kd=0.5uM|Kd|=|0.5|uM|500|nM
4POW|1.55|2014|OP1|ligand is pyronopaline; Kd=0.5+/-0.07uM|P35120|NOPALINE-BINDING PERIPLASMIC PROTEIN|6.3|Kd=0.5uM|Kd|=|0.5|uM|500|nM
4CG9|1.83|2014|GQG|ligand is compound 12|P35790|CHOLINE KINASE ALPHA|6.21|Kd=0.62uM|Kd|=|0.62|uM|620|nM
4Q6E|1.12|2014|KR5|ligand is compound 18|P00918|CARBONIC ANHYDRASE 2|6.18|Kd=0.667uM|Kd|=|0.667|uM|667|nM
3W9R|1.90|2014|A8S|ligand is (+)-ABA|Q84MC7|ABSCISIC ACID RECEPTOR PYL9|6.18|Kd=0.66uM|Kd|=|0.66|uM|660|nM
4PFU|2.05|2014|MAB|ligand is Mannobiose|G4FEC0|ABC TRANSPORTER SUBSTRATE-BINDING PROTEIN|6.17|Kd=0.67uM|Kd|=|0.67|uM|670|nM
4KTU|1.35|2014|14-mer|ligand is microviridin J peptide, at PH 6.5|P00760|TRYPSIN|6.16|Kd=0.685uM|Kd|=|0.685|uM|685|nM
4PN1|2.80|2014|18-mer|ligand is from Spt5 CTD; Kd=0.68+/-0.10uM|Q9P6Q6|MRNA-CAPPING ENZYME SUBUNIT BETA|6.17|Kd=0.68uM|Kd|=|0.68|uM|680|nM
4KXL|1.69|2014|6C6|ligand is compound 7|O35820|2'-DEOXYNUCLEOSIDE 5'-PHOSPHATE N-HYDROLASE 1|6.22|Kd=0.6uM|Kd|=|0.6|uM|600|nM
4MSL|2.70|2014|2ET|ligand is compound AF40431|Q99523|SORTILIN|6.15|Kd=0.70uM|Kd|=|0.7|uM|700|nM
4UTR|2.90|2014|9-mer|ligand is glutarylated CPS1-peptide 6a; Kd=0.70+/-0.11uM|Q6DHI5|NAD-DEPENDENT PROTEIN DEACYLASE SIRTUIN-5|6.15|Kd=0.70uM|Kd|=|0.7|uM|700|nM
4UTN|3.00|2014|9-mer|ligand is succinylated CPS1-peptide 5a; Kd=0.71+/-0.05uM|Q6DHI5|NAD-DEPENDENT PROTEIN DEACYLASE SIRTUIN-5|6.15|Kd=0.71uM|Kd|=|0.71|uM|710|nM
4M7J|1.95|2014|3-mer|ligand is Kdo(2.8)Kdo(2.4)Kdo trisaccharide|------|ANTIBODY FAB IGG1K, S25-26|6.11|Kd=0.781uM|Kd|=|0.781|uM|781|nM
2MG5|NMR|2014|16-mer|ligand is eNOSpThr495 Peptide, assay with 0.225 uM free Ca2+|P62158|CALMODULIN|6.15|Kd=0.7uM|Kd|=|0.7|uM|700|nM
4UU7|3.00|2014|9-mer|ligand is 3-methyl- succinylated CPS1-peptide 5b; Kd=0.83+/-0.17uM|Q6DHI5|NAD-DEPENDENT PROTEIN DEACYLASE SIRTUIN-5|6.08|Kd=0.83uM|Kd|=|0.83|uM|830|nM
4OO9|2.60|2014|2U8|Kd=0.86+/-0.04nM|P41594|METABOTROPIC GLUTAMATE RECEPTOR 5, LYSOZYME|9.07|Kd=0.86nM|Kd|=|0.86|nM|0.86|nM
4PXF|2.75|2014|11-mer|ligand is ArrFL-1; light-activated Rhodopsin meta II|P02699|RHODOPSIN|3.1|Kd=0.8mM|Kd|=|0.8|mM|800000|nM
4KXN|1.90|2014|6K6|ligand is compound 5|O35820|2'-DEOXYNUCLEOSIDE 5'-PHOSPHATE N-HYDROLASE 1|6.1|Kd=0.8uM|Kd|=|0.8|uM|800|nM
4OCP|1.94|2014|ADP|ligand is ADP; Kd=0.8+/-0.1uM|T2I3Q3|N-ACETYLHEXOSAMINE 1-PHOSPHATE KINASE|6.1|Kd=0.8uM|Kd|=|0.8|uM|800|nM
4PD8|2.75|2014|P0C|ligand is pyrrolo-cytidine; Kd=0.94+/-0.17uM|Q9KPL5|NUPC FAMILY PROTEIN|6.03|Kd=0.94uM|Kd|=|0.94|uM|940|nM
4QXR|2.37|2014|1YE|ligand is DMXAA; hSTING(S162A/G230I/Q266I)|Q86WV6|STIMULATOR OF INTERFERON GENES PROTEIN|6.0|Kd=0.99uM|Kd|=|0.99|uM|990|nM
2MWP|NMR|2014|12-mer|ligand is a 12-mer p53K382me2 peptide|Q12888|TUMOR SUPPRESSOR P53-BINDING PROTEIN 1|6.05|Kd=0.9uM|Kd|=|0.9|uM|900|nM
4M12|2.15|2014|1YZ|ligand is compound 7, Kd1: allosteric pocket, Kd2: ATP pocket|Q08881|TYROSINE-PROTEIN KINASE ITK/TSK|6.05|Kd=0.9uM|Kd|=|0.9|uM|900|nM
4QFS|3.55|2014|32H|ligand is Br2-A769662 core; Kd=900+/-200nM|P54645|5'-AMP-ACTIVATED PROTEIN KINASE CATALYTIC SUBUNIT A|6.05|Kd=0.9uM|Kd|=|0.9|uM|900|nM
2MOW|NMR|2014|12-mer|ligand is 12-mer Trf4p NIM peptide|P53617|PROTEIN NRD1|5.96|Kd=1.09uM|Kd|=|1.09|uM|1090|nM
4L3O|2.52|2014|16-mer|ligand is 16-mer cyclic peptide S2iL5, assay temp=10C|Q8IXJ6|NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-2|6.0|Kd=1.0uM|Kd|=|1|uM|1000|nM
4P3H|1.45|2014|25G|ligand is compound 2; IC50=1.0+/-0.1uM|O36607|KSHV PROTEASE|6.0|Kd=1.0uM|Kd|=|1|uM|1000|nM
4W9I|2.40|2014|3JS|ligand is 10; Kd=1.10+/-0.07uM|Q15370|TRANSCRIPTION ELONGATION FACTOR B POLYPEPTIDE 2|5.96|Kd=1.10uM|Kd|=|1.1|uM|1100|nM
4QH7|1.83|2014|12-mer|Ana2 peptide 1; Kd=1.14+/-0.07uM|Q24117|DYNEIN LIGHT CHAIN 1|5.94|Kd=1.14uM|Kd|=|1.14|uM|1140|nM
4PZ8|3.10|2014|18-mer|ligand is Spt5-CDT; Kd=1.19+/-0.37uM|P40997|MRNA-CAPPING ENZYME SUBUNIT ALPHA|5.92|Kd=1.19uM|Kd|=|1.19|uM|1190|nM
4MRG|1.69|2014|24W|ligand is compound 3|P15379|CD44 ANTIGEN|2.96|Kd=1.1mM|Kd|=|1.1|mM|1100000|nM
4CKI|2.12|2014|ADN|ligand is ADENOSINE|P07949|PROTO-ONCOGENE TYROSINE-PROTEIN KINASE RECEPTOR RET|5.96|Kd=1.1uM|Kd|=|1.1|uM|1100|nM
4CSD|1.35|2014|MFU|ligand is alpha-MeFuc|Q8XXK6|FUCOSE-BINDING LECTIN PROTEIN|5.91|Kd=1.23uM|Kd|=|1.23|uM|1230|nM
4ONF|2.00|2014|7-mer|ligand is Amyloid belta1-10 peptide|P05067|3D6 FAB ANTIBODY HEAVY CHAIN|8.92|Kd=1.2nM|Kd|=|1.2|nM|1.2|nM
4RDN|2.10|2014|6MD|Kd=1.2+/-0.1uM|Q9Y5A9|YTH DOMAIN-CONTAINING FAMILY PROTEIN 2|5.92|Kd=1.2uM|Kd|=|1.2|uM|1200|nM
4U0F|2.22|2014|3A8|BI-2; -DTT|P12493|CAPSID PROTEIN P24|5.92|Kd=1.2uM|Kd|=|1.2|uM|1200|nM
4CFL|1.32|2014|8DQ|ligand is compound LY303511|Q6NXE4|BROMODOMAIN-CONTAINING PROTEIN 4|5.88|Kd=1.33uM|Kd|=|1.33|uM|1330|nM
4MGA|1.80|2014|27L|ligand is compound 4-tert-octylphenol, 4-OP|P03372|ESTROGEN RECEPTOR|5.86|Kd=1.37uM|Kd|=|1.37|uM|1370|nM
4OUJ|1.46|2014|LBT|ligand is B-lactose; Kd=1.39+/-0.17mM, PH=8.0|B1INP8|HEMAGGLUTININ COMPONENT HA33|2.86|Kd=1.39mM|Kd|=|1.39|mM|1390000|nM
4PSH|2.60|2014|ARG|Kd= 1.3+/-0.9nM|Q9WZ62|ABC-TYPE TRANSPORTER, PERIPLASMIC SUBUNIT FAMILY 3|8.89|Kd=1.3nM|Kd|=|1.3|nM|1.3|nM
2MPM|NMR|2014|16-mer|ligand is 16-mer peptide of 8-23 of CCR3, Su1617|P51671|EOTAXIN|5.89|Kd=1.3uM|Kd|=|1.3|uM|1300|nM
4Q3Q|2.00|2014|ABH|SmARG-ABH; Kd=1.3+/-0.2uM; PH=8.5|Q6WVP6|ARGINASE|5.89|Kd=1.3uM|Kd|=|1.3|uM|1300|nM
4TKN|3.00|2014|19-mer|KRIT1- NPXF2;ligand is 19-mer peptide from Krev interaction trapped protein 1; Kd=1.3+/-0.3uM|Q15036|SORTING NEXIN-17|5.89|Kd=1.3uM|Kd|=|1.3|uM|1300|nM
4WK1|1.98|2014|2BA|ligand is c-di-AMP; Kd=1.3+/-0.07uM|Q5HIJ4|PSTA|5.89|Kd=1.3uM|Kd|=|1.3|uM|1300|nM
4QDK|1.70|2014|SAH|ligand is SAH;Kd=1.4+/-0.1uM(wild-type); Kd=8.1+/-0.2uM(H139N mutant);Kd=31.0+/-1.7uM(H139Q mutant)|Q55467|MAGNESIUM-PROTOPORPHYRIN O-METHYLTRANSFERASE|5.85|Kd=1.4uM|Kd|=|1.4|uM|1400|nM
4RWW|1.60|2014|2BA|ligand is Cyclic-di-AMP (c-di-AMP)|Q8Y3Y7|LMO2692 PROTEIN|5.85|Kd=1.4uM|Kd|=|1.4|uM|1400|nM
4OYS|2.90|2014|1TT|ligand is compound SAR405; Kd=1.52+/-0.77nM|Q8NEB9|PHOSPHATIDYLINOSITOL 3-KINASE CATALYTIC SUBUNIT TYP|8.82|Kd=1.52nM|Kd|=|1.52|nM|1.52|nM
4U0U|2.98|2014|ADP|protein is wild type; Kd=1.52+/-0.14uM|Q9BVA6|ADENOSINE MONOPHOSPHATE-PROTEIN TRANSFERASE FICD|5.82|Kd=1.52uM|Kd|=|1.52|uM|1520|nM
4JMG|1.40|2014|13-mer|ligand is Ptpn11_pY580 peptide|Q06124|CLAMP PTPN11_PY580|8.82|Kd=1.5nM|Kd|=|1.5|nM|1.5|nM
4LJ8|2.10|2014|ADP||Q9RA63|CHAPERONE PROTEIN CLPB|5.82|Kd=1.5uM|Kd|=|1.5|uM|1500|nM
4R4O|1.33|2014|3HW|ligand is compound 7e; Kd= 1.5+/- 0.3uM|P27694|REPLICATION PROTEIN A 70 KDA DNA-BINDING SUBUNIT|5.82|Kd=1.5uM|Kd|=|1.5|uM|1500|nM
4RQK|1.55|2014|R1S|ligand is RS1|O15530|3-PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE 1|5.82|Kd=1.5uM|Kd|=|1.5|uM|1500|nM
4OEE|1.50|2014|GNX-IDY|ligand is S3I2; Kd=1.73+/-0.31uM|P09038|FIBROBLAST GROWTH FACTOR 2|5.76|Kd=1.73uM|Kd|=|1.73|uM|1730|nM
4MN3|1.54|2014|7-mer|ligand is compound 11|O95931|CHROMOBOX PROTEIN HOMOLOG 7|5.75|Kd=1.77uM|Kd|=|1.77|uM|1770|nM
4LBO|1.65|2014|3-mer|ligand is GM3: SIA-2-3-Gal-beta-1-4-Glc|P17931|GALECTIN-3|5.77|Kd=1.7uM|Kd|=|1.7|uM|1700|nM
4Q9O|2.20|2014|2ZW|ligand is UK-106051; Kd=1.7+/-0.3 uM|Q8DRB3|ISOPRENYL TRANSFERASE|5.77|Kd=1.7uM|Kd|=|1.7|uM|1700|nM
4NDU|1.30|2014|AMG|ligand is alpha-methylgalactoside, data from Goldstein et al. 2007|A7UNK4|ALPHA-GALACTOSYL-BINDING LECTIN|2.74|Kd=1.8mM|Kd|=|1.8|mM|1800000|nM
4D1D|3.70|2014|5ND/5NL|ligand is D-NMH, R-S mixture in crystal structure 5ND and 5NL|D6R8X8|HYDANTOIN TRANSPORT PROTEIN|5.74|Kd=1.8uM|Kd|=|1.8|uM|1800|nM
4O2A|2.50|2014|2RR|ligand is BAL27862; Kd=1.8+/-0.5uM|P81947|TUBULIN ALPHA-1B CHAIN|5.74|Kd=1.8uM|Kd|=|1.8|uM|1800|nM
4QQ4|1.75|2014|16-mer|ligand is peptide H3K4me3|Q14149|MORC FAMILY CW-TYPE ZINC FINGER PROTEIN 3|5.74|Kd=1.8uM|Kd|=|1.8|uM|1800|nM
4QXQ|2.42|2014|1YE|ligand is DMXAA; hSTING(S162A/Q266I)|Q86WV6|STIMULATOR OF INTERFERON GENES PROTEIN|5.7|Kd=1.99uM|Kd|=|1.99|uM|1990|nM
4TV3|2.85|2014|ML9|PIK3-alpha isolated delta-ABD-LBS subunit; PF-04691502; Kd=1.9+/-0.1nM; Temp 10|P42336|PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE|8.72|Kd=1.9nM|Kd|=|1.9|nM|1.9|nM
3WP0|2.04|2014|15-mer|ligand is a phosphor-Lgl2a peptide|P31016|DISKS LARGE HOMOLOG 4|4.99|Kd=10.2uM|Kd|=|10.2|uM|10200|nM
4W9D|2.20|2014|3JK|ligand is 3; Kd=10.2+/-0.50uM|Q15370|TRANSCRIPTION ELONGATION FACTOR B POLYPEPTIDE 2|4.99|Kd=10.2uM|Kd|=|10.2|uM|10200|nM
4QC1|1.99|2014|11-mer|ligand is H3K14ac peptide|Q9UIF8|BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN PROTEIN 2B|4.99|Kd=10.35uM|Kd|=|10.35|uM|10350|nM
4TSX|1.94|2014|LF0|BI-D; Kd=10.3+/-2.3uM|F2WR39|INTEGRASE|4.99|Kd=10.3uM|Kd|=|10.3|uM|10300|nM
4C3K|3.10|2014|ADP|ITC Kd for binding site 1|P0A3F4|NITROGEN REGULATORY PROTEIN P-II|4.97|Kd=10.6uM|Kd|=|10.6|uM|10600|nM
4OZL|1.49|2014|AMP||B8ZYW1|NITROGEN REGULATORY PROTEIN P-II|4.97|Kd=10.6uM|Kd|=|10.6|uM|10600|nM
4IBC|1.75|2014|12G|ligand is compound GA246, estimate Kd value|Q05127|POLYMERASE COFACTOR VP35|2.98|Kd=1049uM|Kd|=|1049|uM|1049000|nM
4IBG|1.41|2014|1D6|ligand is compound VPL48|Q05127|POLYMERASE COFACTOR VP35|3.97|Kd=108.0uM|Kd|=|108|uM|108000|nM
4NJ9|1.95|2014|2M9|ligand is MPTS|Q7TS98|8B10 LIGHT CHAIN|6.97|Kd=108nM|Kd|=|108|nM|108|nM
4QSU|1.90|2014|TDR|ligand is Thymine|Q6PL18|ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 2|2.0|Kd=10mM|Kd|=|10|mM|10000000|nM
4QSV|1.90|2014|THM|ligand is Thymidine|Q6PL18|ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 2|2.0|Kd=10mM|Kd|=|10|mM|10000000|nM
4O2C|1.80|2014|10-mer|ligand is NAc-SL9|P30475|HLA CLASS I HISTOCOMPATIBILITY ANTIGEN|8.0|Kd=10nM|Kd|=|10|nM|10|nM
4POH|2.30|2014|2VR|ligand is compound 4; Kd=10+/-1nM|P19793|RETINOIC ACID RECEPTOR RXR-ALPHA|8.0|Kd=10nM|Kd|=|10|nM|10|nM
4OI6|2.04|2014|CIT||Q9FCE4|NICKEL RESPONSIVE PROTEIN|5.0|Kd=10uM|Kd|=|10|uM|10000|nM
4C16|1.93|2014|4-mer|ligand is GAL-FUC-Q6Z-4WC, glycomimetic compound 1|P16581|E-SELECTIN|4.96|Kd=11.04uM|Kd|=|11.04|uM|11040|nM
4NMV|1.40|2014|10-mer|ligand is peptide iCAL36(BRB-K-1); Kd=11.1+/-3.9uM|Q9HD26|GOLGI-ASSOCIATED PDZ AND COILED-COIL MOTIF-CONTAINI|4.95|Kd=11.1uM|Kd|=|11.1|uM|11100|nM
4MRF|1.55|2014|2CK|ligand is compound 2|P15379|CD44 ANTIGEN|1.95|Kd=11.2mM|Kd|=|11.2|mM|11200000|nM
4NMS|1.70|2014|10-mer|ligand is peptide iCAL36(FLB-K-1); Kd=11.4+/-3.7uM|Q9HD26|GOLGI-ASSOCIATED PDZ AND COILED-COIL MOTIF-CONTAINI|4.94|Kd=11.4uM|Kd|=|11.4|uM|11400|nM
4P4S|3.30|2014|GCP|ligand is GMPPCP|P20591|INTERFERON-INDUCED GTP-BINDING PROTEIN MX1|4.94|Kd=11.5uM|Kd|=|11.5|uM|11500|nM
4QHT|2.56|2014|ANP|ligand is AMP-PNP|A5F6D4|FLAGELLAR REGULATORY PROTEIN C|4.94|Kd=11.5uM|Kd|=|11.5|uM|11500|nM
4RPN|2.27|2014|PCI|ligand is PCP; Kd1=110nM|P52679|PCP DEGRADATION TRANSCRIPTIONAL ACTIVATION PROTEIN|6.96|Kd=110nM|Kd|=|110|nM|110|nM
4CE3|2.31|2014|L4V|ligand is compound 27d|P02829|ATP-DEPENDENT MOLECULAR CHAPERONE HSP82|3.96|Kd=110uM|Kd|=|110|uM|110000|nM
4Q4S|1.25|2014|S98|ligand is compound 4a; Kd=111.6+/-11.8nM|P28720|QUEUINE TRNA-RIBOSYLTRANSFERASE|6.95|Kd=111.6nM|Kd|=|111.6|nM|111.6|nM
4WK2|2.50|2014|6-mer|binding data measured in 5 mM Mg2+ and absence of Ca2+, ligand is GRGDSP linear peptide|P08648|INTEGRIN ALPHA-5|6.94|Kd=115nM|Kd|=|115|nM|115|nM
4KVA|2.14|2014|GTP|1,15 or 1.15 x 10-4M, author's problem|G4VFI8|SEPTIN|3.94|Kd=115uM|Kd|=|115|uM|115000|nM
4K10|2.30|2014|NI9|ligand is 46I, complex is LmFPPS-46I-Mg2+|Q4QBL1|FARNESYL PYROPHOSPHATE SYNTHASE|6.92|Kd=119.5nM|Kd|=|119.5|nM|119.5|nM
4R7M|2.85|2014|3MW|ligand is compound 13m|Q8IL11|M17 LEUCYL AMINOPEPTIDASE|7.96|Kd=11nM|Kd|=|11|nM|11|nM
4LBL|1.58|2014|3-mer|ligand is GM3: SIA-2-3-Gal-beta-1-4-Glc|P17931|GALECTIN-3|4.96|Kd=11uM|Kd|=|11|uM|11000|nM
4PHU|2.33|2014|2YB|TAK-875; hGPR40 mutant L42A,F88A,G103A,Y202F with GS linker Kd=12.04+/-0.9nM|O14842|FREE FATTY ACID RECEPTOR 1,LYSOZYME|7.92|Kd=12.04nM|Kd|=|12.04|nM|12.04|nM
4MRH|1.12|2014|2CQ|ligand is compound 4|P15379|CD44 ANTIGEN|1.9|Kd=12.6mM|Kd|=|12.6|mM|12600000|nM
4QH8|1.90|2014|13-mer|Ana2 peptide 2; Kd=12.8+/-1.5uM|Q24117|DYNEIN LIGHT CHAIN 1|4.89|Kd=12.8uM|Kd|=|12.8|uM|12800|nM
4U4S|1.90|2014|3C1|ligand is compound 6; Kd=1200+/-40uM|P19491|GLUTAMATE RECEPTOR 2|2.92|Kd=1200uM|Kd|=|1200|uM|1200000|nM
4PD7|2.91|2014|ZE8|ligand is zebularine; Kd=120+/-5uM|Q9KPL5|NUPC FAMILY PROTEIN|3.92|Kd=120uM|Kd|=|120|uM|120000|nM
4PZ5|1.96|2014|16-mer|Fibronectin-binding protein BBK32; Kd=121+/-26.3nM|P02751|FIBRONECTIN|6.92|Kd=121nM|Kd|=|121|nM|121|nM
4N9C|1.75|2014|2ZM|ligand is compound 24|P43490|NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE|3.9|Kd=126uM|Kd|=|126|uM|126000|nM
4Q0K|1.34|2014|GA3|Kd=13.4+/-0.5uM (pH=5.5)|G7J032|PHYTOHORMONE BINDING PROTEIN MTPHBP|4.87|Kd=13.4uM|Kd|=|13.4|uM|13400|nM
4NL1|2.30|2014|Z13|ligand is compound 11; Kd= 130+/-1uM|Q81VW8|DIHYDROPTEROATE SYNTHASE|3.89|Kd=130uM|Kd|=|130|uM|130000|nM
4PRB|1.75|2014|11-mer|HPVG-A4; Kd=131.5+/-0.5uM|C5MK56|MHC CLASS I ANTIGEN|3.88|Kd=131.5uM|Kd|=|131.5|uM|131500|nM
4WVL|2.41|2014|3US|ligand is compound 1|Q8TEK3|HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-79 SPECIFIC|6.88|Kd=131nM|Kd|=|131|nM|131|nM
4K43|2.90|2014|1PO|ligand is compound GC-04|P68135|ACTIN, ALPHA SKELETAL MUSCLE|6.88|Kd=132nM|Kd|=|132|nM|132|nM
4RVR|1.98|2014|3WQ|compound 19, GSK2801, ITC data is available|Q9UIF8|BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN PROTEIN 2B|6.87|Kd=136nM|Kd|=|136|nM|136|nM
4NBK|1.94|2014|2J5|ligand is compound 6|P55212|CASPASE-6|3.87|Kd=136uM|Kd|=|136|uM|136000|nM
4PD5|2.91|2014|GEO|ligand is gemcitabine; Kd=1370+/-430uM|Q9KPL5|NUPC FAMILY PROTEIN|2.86|Kd=1370uM|Kd|=|1370|uM|1370000|nM
4M8E|2.40|2014|29V|ligand is (S)-1|P19793|RETINOIC ACID RECEPTOR RXR-ALPHA|7.89|Kd=13nM|Kd|=|13|nM|13|nM
4L9I|2.32|2014|8PR|ligand is paroxetine, biolayer interferometry|P28327|RHODOPSIN KINASE|4.89|Kd=13uM|Kd|=|13|uM|13000|nM
4PNU|1.90|2014|2VD|compound 5l; ITC data is available|U6NCW5|DNA POLYMERASE III SUBUNIT BETA|4.89|Kd=13uM|Kd|=|13|uM|13000|nM
4PGH|2.80|2014|SAM|Kd=13+/-2uM (pH=6.5)|C5YH12|CAFFEIC ACID O-METHYLTRANSFERASE|4.89|Kd=13uM|Kd|=|13|uM|13000|nM
4WJ7|2.75|2014|13-mer|ligand is KRIT1 NPxY/F3; Kd=13+/-2.5uM|Q9BSQ5|MALCAVERNIN|4.89|Kd=13uM|Kd|=|13|uM|13000|nM
3WP1|2.80|2014|17-mer|ligand is a phosphor-Lgl2c peptide|P31016|DISKS LARGE HOMOLOG 4|4.85|Kd=14.1uM|Kd|=|14.1|uM|14100|nM
4NMT|1.40|2014|10-mer|ligand is peptide iCAL36(TFA-K-1); Kd=14.1+/-2.0uM|Q9HD26|GOLGI-ASSOCIATED PDZ AND COILED-COIL MOTIF-CONTAINI|4.85|Kd=14.1uM|Kd|=|14.1|uM|14100|nM
4CKJ|1.65|2014|ADN|ligand is ADENOSINE|P07949|PROTO-ONCOGENE TYROSINE-PROTEIN KINASE RECEPTOR RET|4.84|Kd=14.3uM|Kd|=|14.3|uM|14300|nM
4M5J|1.70|2014|YH5|ligand is compound 7|P26281|2-AMINO-4-HYDROXY-6-HYDROXYMETHYLDIHYDROPTERIDINE|4.84|Kd=14.5uM|Kd|=|14.5|uM|14500|nM
4KIF|2.50|2014|PPY|ligand is phenylpyruvic acid|Q643C8|METHYLTRANSFERASE MPPJ|4.84|Kd=14.6uM|Kd|=|14.6|uM|14600|nM
4UOF|2.10|2014|DAT|ligand is dADP|A5J299|NUCLEOSIDE DIPHOSPHATE KINASE|4.84|Kd=14.6uM|Kd|=|14.6|uM|14600|nM
4NMO|1.40|2014|10-mer|ligand is iCAL36(Ac-K-1) peptide; Kd=14.9+/-5.8uM|Q9HD26|GOLGI-ASSOCIATED PDZ AND COILED-COIL MOTIF-CONTAINI|4.83|Kd=14.9uM|Kd|=|14.9|uM|14900|nM
4W50|2.42|2014|12-mer|ligand is APY peptide|P54764|EPHRIN TYPE-A RECEPTOR 4|5.85|Kd=1400nM|Kd|=|1400|nM|1400|nM
4QTN|2.80|2014|NNR|Kd=142+/-96nM|D2ZZC1|NICOTINAMIDE RIBOSIDE TRANSPORTER PNUC|6.85|Kd=142nM|Kd|=|142|nM|142|nM
4CE2|2.38|2014|BO5|ligand is compound 27b|P02829|ATP-DEPENDENT MOLECULAR CHAPERONE HSP82|3.84|Kd=144uM|Kd|=|144|uM|144000|nM
4PUL|1.65|2014|2WU|ligand is compound 2; Kd=146.1+/-25.6nM; TGT mutant Asp102Asn|P28720|QUEUINE TRNA-RIBOSYLTRANSFERASE|6.84|Kd=146.1nM|Kd|=|146.1|nM|146.1|nM
4KV9|1.93|2014|GDP|1,46 or 1.46 x 10-4M, author's problem|G4VFI8|SEPTIN|3.84|Kd=146uM|Kd|=|146|uM|146000|nM
4U91|2.00|2014|11-mer|ligand is 3d; Kd=149+/-23nM|Q03555|GEPHYRIN|6.83|Kd=149nM|Kd|=|149|nM|149|nM
4PG3|2.70|2014|KRS|ligand is cladosporin; Kd=14+/-1.4nM|Q8IDJ8|LYSINE-TRNA LIGASE|7.85|Kd=14nM|Kd|=|14|nM|14|nM
4QLV|2.90|2014|39Q|ligand is compound 17; belta-5i|P23639|PROTEASOME SUBUNIT ALPHA TYPE-2|7.85|Kd=14nM|Kd|=|14|nM|14|nM
4OVH|2.25|2014|2VE|compound 5b; ITC data is available|U6NCW5|DNA POLYMERASE III SUBUNIT BETA|4.85|Kd=14uM|Kd|=|14|uM|14000|nM
4O4Y|1.85|2014|14-mer|ligand is IDES hinge peptide (TCPPCPAPELLG)|P01857|2095-2 LIGHT CHAIN|7.81|Kd=15.5nM|Kd|=|15.5|nM|15.5|nM
4K7I|2.25|2014|CAQ|ligand is compound 1, CATECHOL, 15N-HSQC experiments|P30044|PEROXIREDOXIN-5|2.82|Kd=1500uM|Kd|=|1500|uM|1500000|nM
4MMM|1.47|2014|BP7|ligand is compound 4|P30044|PEROXIREDOXIN-5|3.82|Kd=150uM|Kd|=|150|uM|150000|nM
4PB1|2.80|2014|RBV|ligand is ribavirin; Kd=1530+/-350uM|Q9KPL5|NUPC FAMILY PROTEIN|2.82|Kd=1530uM|Kd|=|1530|uM|1530000|nM
4CI3|3.50|2014|Y70|ligand is compound pomalidomide|Q16531|DNA DAMAGE-BINDING PROTEIN 1|6.81|Kd=156.6nM|Kd|=|156.6|nM|156.6|nM
4PP3|2.00|2014|2VZ|ligand is compound 2 ; Kd=15+/-2nM|P19793|RETINOIC ACID RECEPTOR RXR-ALPHA|7.82|Kd=15nM|Kd|=|15|nM|15|nM
4UXQ|1.85|2014|0LI|ligand is Ponatinib; Kd=16.0+/-0.04nM|P22455|FIBROBLAST GROWTH FACTOR RECEPTOR 4|7.8|Kd=16.0nM|Kd|=|16|nM|16|nM
4Q4Q|1.41|2014|SAQ|ligand is compound 4b; Kd=1638.9+/-204.7nM|P28720|QUEUINE TRNA-RIBOSYLTRANSFERASE|5.79|Kd=1638.9nM|Kd|=|1638.9|nM|1638.9|nM
4OGJ|1.65|2014|2TA|ligand is TG-101348; Kd=164+/-10nM|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|6.79|Kd=164nM|Kd|=|164|nM|164|nM
4QEM|1.20|2014|HC4|ligand is (i) p-Coumaric acid|D0VX11|PHOSPHOLIPASE A2, VRV-PL-VIIIA|7.8|Kd=16nM|Kd|=|16|nM|16|nM
4LZS|2.20|2014|L46|ligand is compound XD46|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|4.8|Kd=16uM|Kd|=|16|uM|16000|nM
4PB2|2.30|2014|5UD|ligand is 5-fluorouridine; Kd=16+/-1uM|Q9KPL5|NUPC FAMILY PROTEIN|4.8|Kd=16uM|Kd|=|16|uM|16000|nM
4LOV|1.50|2014|KGM|ligand is Heptylmannoside|P08191|FIMH PROTEIN|7.77|Kd=17.1nM|Kd|=|17.1|nM|17.1|nM
4OEF|1.80|2014|SGN-IDY|ligand is S6I2; Kd=17.5+/-1.8uM|P09038|FIBROBLAST GROWTH FACTOR 2|4.76|Kd=17.5uM|Kd|=|17.5|uM|17500|nM
4K8O|2.65|2014|ATP||P36370|ANTIGEN PEPTIDE TRANSPORTER 1|3.77|Kd=170uM|Kd|=|170|uM|170000|nM
4MUV|1.25|2014|PCG|ligand is cyclic-GMP|Q98GN8|CYCLIC NUCLEOTIDE-GATED POTASSIUM CHANNEL MLL3241|5.76|Kd=1731nM|Kd|=|1731|nM|1731|nM
4TU4|1.73|2014|37N|ligand is compound 2; Kd=175+/-3uM|Q6PL18|ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 2|3.76|Kd=175uM|Kd|=|175|uM|175000|nM
4CI2|2.95|2014|LVY|ligand is compound lenalidomide|Q16531|DNA DAMAGE-BINDING PROTEIN 1|6.75|Kd=177.8nM|Kd|=|177.8|nM|177.8|nM
4J09|1.90|2014|6-mer|ligand is RJPXD33 peptide (TNLYMLPKWDIP-NH2)|P0A722|ACYL-[ACYL-CARRIER-PROTEIN]--UDP-N-ACETYLGLUCOSAMIN|4.77|Kd=17uM|Kd|=|17|uM|17000|nM
4UOH|2.01|2014|ADP|ligand is ADP|A5J299|NUCLEOSIDE DIPHOSPHATE KINASE|4.77|Kd=17uM|Kd|=|17|uM|17000|nM
4M5L|1.09|2014|YH4|ligand is compound 9|P26281|2-AMINO-4-HYDROXY-6-HYDROXYMETHYLDIHYDROPTERIDINE|4.72|Kd=18.9uM|Kd|=|18.9|uM|18900|nM
4PRE|1.65|2014|11-mer|HPVG-Q5; Kd=180.5+/-5.5uM|C5MK56|MHC CLASS I ANTIGEN|3.74|Kd=180.5uM|Kd|=|180.5|uM|180500|nM
4CY1|1.50|2014|15-mer|ligand is KAT8 REGULATORY NSL COMPLEX SUBUNIT 1, KANSL1 peptide|P61964|WD REPEAT-CONTAINING PROTEIN 5|6.74|Kd=181nM|Kd|=|181|nM|181|nM
4MP7|1.80|2014|PFT|ligand is PA7|Q15119|PYRUVATE DEHYDROGENASE [LIPOAMIDE] KINASE ISOZYME|5.74|Kd=1827nM|Kd|=|1827|nM|1827|nM
4PUM|1.93|2014|2WU|ligand is compound 2; Kd=188.1+/-59.1nM; TGT mutant Asp156Asn|P28720|QUEUINE TRNA-RIBOSYLTRANSFERASE|6.73|Kd=188.1nM|Kd|=|188.1|nM|188.1|nM
4QSX|1.93|2014|38S|ligand is 3'-deoxy thymidine|Q6PL18|ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 2|1.74|Kd=18mM|Kd|=|18|mM|18000000|nM
4PP5|2.00|2014|2W0|ligand is compound 1 ; Kd=18+/-3nM|P19793|RETINOIC ACID RECEPTOR RXR-ALPHA|7.74|Kd=18nM|Kd|=|18|nM|18|nM
4M5M|1.12|2014|DX4|ligand is compound 18|P26281|2-AMINO-4-HYDROXY-6-HYDROXYMETHYLDIHYDROPTERIDINE|4.74|Kd=18uM|Kd|=|18|uM|18000|nM
4CU1|1.89|2014|71S|ligand is compound 8S|P29473|NITRIC OXIDE SYNTHASE, ENDOTHELIAL|4.71|Kd=19.4uM|Kd|=|19.4|uM|19400|nM
4MMP|1.57|2014|SLB|ligand is compound Neu5Ac|K0Y3H9|SIALIC ACID BINDING PROTEIN|7.71|Kd=19.7nM|Kd|=|19.7|nM|19.7|nM
4TK1|2.70|2014|11-mer|GABAA receptor alpha3(alpha-11 WT) ; Kd=190+/-30uM; space group P21212|Q03555|GEPHYRIN|3.72|Kd=190uM|Kd|=|190|uM|190000|nM
4TK2|4.10|2014|11-mer|GABAA receptor alpha3(alpha-11 WT) ; Kd=190+/-30uM; space group P61|Q03555|GEPHYRIN|3.72|Kd=190uM|Kd|=|190|uM|190000|nM
4D1A|3.40|2014|I5H|ligand is compound L-IMH, Kd assay by stopped-flow spectrophotofluorimetry|D6R8X8|HYDANTOIN TRANSPORT PROTEIN|4.72|Kd=19uM|Kd|=|19|uM|19000|nM
4USW|2.05|2014|ATP|Kd=2.03+/-0.42mM|Q96PN6|ADENYLATE CYCLASE TYPE 10|2.69|Kd=2.03mM|Kd|=|2.03|mM|2029999.9999999998|nM
4PZV|1.70|2014|J1D|HP-26; Kd=2.0+/-0.3uM|Q5NGA7|2-AMINO-4-HYDROXY-6-HYDROXYMETHYLDIHYDROPTERIDINE|5.7|Kd=2.0uM|Kd|=|2|uM|2000|nM
4MG9|2.00|2014|27K|ligand is compound butylparaben|P03372|ESTROGEN RECEPTOR|5.68|Kd=2.11uM|Kd|=|2.11|uM|2110|nM
4NCN|1.87|2014|GTP||G0S8G9|EUKARYOTIC TRANSLATION INITIATION FACTOR 5B-LIKE PR|5.67|Kd=2.12uM|Kd|=|2.12|uM|2120|nM
4U7T|2.90|2014|12-mer|peptide from Histone H3; Kd=2.14+/-0.13uM without dsDNA|Q9Y6K1|DNA (CYTOSINE-5)-METHYLTRANSFERASE 3A|5.67|Kd=2.14uM|Kd|=|2.14|uM|2140|nM
4JMH|2.41|2014|13-mer|ligand is Shc-PY239/240 peptide|P29353|CLAMP SHC1_PY239/240|8.68|Kd=2.1nM|Kd|=|2.1|nM|2.1|nM
4C52|2.05|2014|X0D|ligand is compound 39b|Q07817|BCL-2-LIKE PROTEIN 1|5.68|Kd=2.1uM|Kd|=|2.1|uM|2100|nM
4N7G|2.25|2014|11-mer|ligand is a peptide derived from ExoS, 420-QGLLDALDLAS-430, ESp|P63104|14-3-3 PROTEIN ZETA/DELTA|5.66|Kd=2.2uM|Kd|=|2.2|uM|2200|nM
4PRN|1.65|2014|11-mer|HPVG-A4; TK3 TCR|P30685|HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-35 ALPHA|5.66|Kd=2.2uM|Kd|=|2.2|uM|2200|nM
4PR5|1.80|2014|11-mer|HPVG-D5; TK3 TCR|P30685|HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-35 ALPHA|5.66|Kd=2.2uM|Kd|=|2.2|uM|2200|nM
4PRA|1.85|2014|11-mer|HPVG-Q5; TK3 TCR|C5MK56|MHC CLASS I ANTIGEN|5.66|Kd=2.2uM|Kd|=|2.2|uM|2200|nM
4PRP|2.50|2014|11-mer|HPVG-Q5; TK3 TCR-HLA-B 35:01|C5MK56|MHC CLASS I ANTIGEN|5.66|Kd=2.2uM|Kd|=|2.2|uM|2200|nM
3WIG|2.70|2014|CHU|ligand is compound CH5126766|Q02750|MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1 (MERK 1)|8.64|Kd=2.30nM|Kd|=|2.3|nM|2.3|nM
3ZEV|3.00|2014|8-mer|ligand is NEUROTENSIN peptide|P20789|NEUROTENSIN RECEPTOR 1 TM86V|8.64|Kd=2.3nM|Kd|=|2.3|nM|2.3|nM
4PFT|1.75|2014|MAB|ligand is Mannobiose|Q9X0V0|ABC TRANSPORTER PERIPLASMIC PEPTIDE-BINDING PROTEIN|8.64|Kd=2.3nM|Kd|=|2.3|nM|2.3|nM
4MG6|2.10|2014|27G|ligand is compound benzylbutylphtalate, BBP|P03372|ESTROGEN RECEPTOR|5.62|Kd=2.42uM|Kd|=|2.42|uM|2420|nM
4NRL|2.72|2014|SIA|ligand is Neu5Ac-alpha-(2,3)Gal receptor analogues, 6 SLN-LN; Kd=2.4+/-0.4nM|P03460|HEMAGGLUTININ HA1 CHAIN|8.62|Kd=2.4nM|Kd|=|2.4|nM|2.4|nM
4MY6|1.70|2014|3VH|compound 4a|Q8N8S7|PROTEIN ENABLED HOMOLOG|5.62|Kd=2.4uM|Kd|=|2.4|uM|2400|nM
4Q6F|1.91|2014|5-mer|ligand is unmodified H3K4 histone peptide|Q9UIF9|BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN PROTEIN 2A|5.6|Kd=2.50uM|Kd|=|2.5|uM|2500|nM
4UP5|1.65|2014|94W|ligand is CF4|Q9BRQ0|PYGOPUS HOMOLOG 2, B-CELL CLL/LYMPHOMA 9-LIKE PROTEIN|2.6|Kd=2.5mM|Kd|=|2.5|mM|2500000|nM
4QF7|1.48|2014|C0R|ligand is (iv) Corticosterone|D0VX11|PHOSPHOLIPASE A2, VRV-PL-VIIIA|8.6|Kd=2.5nM|Kd|=|2.5|nM|2.5|nM
4KXM|2.24|2014|6IA|ligand is compound 1, a C=C bond is different|O35820|2'-DEOXYNUCLEOSIDE 5'-PHOSPHATE N-HYDROLASE 1|5.59|Kd=2.6uM|Kd|=|2.6|uM|2600|nM
4O3F|2.11|2014|TZN|Kd=2.78+/-0.90uM|P09411|PHOSPHOGLYCERATE KINASE 1|5.56|Kd=2.78uM|Kd|=|2.78|uM|2780|nM
4UWL|2.80|2014|7A5|ligand is compound 31; Kd=2.7+/-0.9nM|Q8NEB9|PHOSPHATIDYLINOSITOL 3-KINASE CATALYTIC SUBUNIT TYP|8.57|Kd=2.7nM|Kd|=|2.7|nM|2.7|nM
4LL3|1.95|2014|017|ligand is darunavir|Q9WFL7|HIV-1 PROTEASE|11.57|Kd=2.7pM|Kd|=|2.7|pM|0.0027|nM
4QIJ|2.20|2014|1HA|1-hydroxy-2-naphthoyl-CoA(HNA-CoA); Kd=2.9+/-0.3uM|P9WNP5|1,4-DIHYDROXY-2-NAPHTHOYL-COA SYNTHASE|5.54|Kd=2.9uM|Kd|=|2.9|uM|2900|nM
4R4C|1.40|2014|3HS|ligand is compound 7i; Kd=2.9+/- 0.8uM|P27694|REPLICATION PROTEIN A 70 KDA DNA-BINDING SUBUNIT|5.54|Kd=2.9uM|Kd|=|2.9|uM|2900|nM
4MGD|1.90|2014|27N|ligand is compound HPTE|P03372|ESTROGEN RECEPTOR|4.69|Kd=20.19uM|Kd|=|20.19|uM|20190|nM
4TPW|1.50|2014|33R|ligand is 4EGI1-1E; m7GTP-eIF4E; Kd=20.5+/-2.2uM|P06730|EUKARYOTIC TRANSLATION INITIATION FACTOR 4E|4.69|Kd=20.5uM|Kd|=|20.5|uM|20500|nM
4MUE|2.06|2014|2DH|compound 11|P0A5R0|PANTOTHENATE SYNTHETASE|6.7|Kd=200nM|Kd|=|200|nM|200|nM
4TTE|1.80|2014|36Z|ligand is compound 1; Kd=202+/-5uM|Q6PL18|ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 2|3.69|Kd=202uM|Kd|=|202|uM|202000|nM
2MWO|NMR|2014|15-mer|ligand is a 15-mer p53K370me2 peptide|Q12888|TUMOR SUPPRESSOR P53-BINDING PROTEIN 1|4.7|Kd=20uM|Kd|=|20|uM|20000|nM
4LZR|1.85|2014|LOC|ligand is compound XD25|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|4.7|Kd=20uM|Kd|=|20|uM|20000|nM
4ORU|1.55|2014|PEU|ligand is polyethylene glycol; Kd by fluorometric titration (30% PEG 4000 solution)|P41222|PROSTAGLANDIN-H2 D-ISOMERASE|3.68|Kd=210uM|Kd|=|210|uM|210000|nM
4IBD|1.84|2014|1DL|ligand is compound VPL27|Q05127|POLYMERASE COFACTOR VP35|3.67|Kd=214.6uM|Kd|=|214.6|uM|214600|nM
4CIG|1.70|2014|X0P|ligand is compound 101121|Q76353|HIV-1 INTEGRASE|3.67|Kd=214uM|Kd|=|214|uM|214000|nM
4LNP|1.41|2014|10-mer|ligand is 10-mer proline rich peptide from Vinculin, prr2|Q9BX66|SORBIN AND SH3 DOMAIN-CONTAINING PROTEIN 1|3.67|Kd=214uM|Kd|=|214|uM|214000|nM
4V27|1.90|2014|2-mer|ManIFG(24); mannose-alpha-1,3-isofagomine; wild type protein|D6D1V7|GLYCOSYL HYDROLASE FAMILY 71|6.66|Kd=217nM|Kd|=|217|nM|217|nM
4QSW|1.80|2014|38T|ligand is 5-methyl uridine|Q6PL18|ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 2|1.68|Kd=21mM|Kd|=|21|mM|21000000|nM
4W9C|2.20|2014|3JG|ligand is 2; 2-pVHL-Elo B-EloC; Kd=22.2+/-1.46uM|Q15370|TRANSCRIPTION ELONGATION FACTOR B POLYPEPTIDE 2|4.65|Kd=22.2uM|Kd|=|22.2|uM|22200|nM
4RPO|1.95|2014|T6C|ligand is TCP; 2,4,6-trichlorophenol|P52679|PCP DEGRADATION TRANSCRIPTIONAL ACTIVATION PROTEIN|7.64|Kd=22.8nM|Kd|=|22.8|nM|22.8|nM
4OEU|2.20|2014|HIS|YpYntA binds to Ni(L-His)2; Kd=22+/-6nM|Q0P844|PUTATIVE PEPTIDE ABC-TRANSPORT SYSTEM PERIPLASMIC P|7.66|Kd=22nM|Kd|=|22|nM|22|nM
4OFL|2.70|2014|HIS|YpYntA binds to Ni(L-His)2; Kd=22+/-6nM|Q7CJS8|EXTRACYTOPLASMIC NICKEL-BINDING PROTEIN YPYNTA|7.66|Kd=22nM|Kd|=|22|nM|22|nM
4QEV|1.80|2014|31O|ligand is ME|P25440|BROMODOMAIN-CONTAINING PROTEIN 2|7.66|Kd=22nM|Kd|=|22|nM|22|nM
4O42|1.87|2014|15-mer|NS1K229me2; Kd=22+/-1.1uM|O14646|CHROMODOMAIN-HELICASE-DNA-BINDING PROTEIN 1|4.66|Kd=22uM|Kd|=|22|uM|22000|nM
4TT2|2.50|2014|6-mer|ligand is H4(1-20)K5Ac peptide|Q6PL18|ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 2|4.66|Kd=22uM|Kd|=|22|uM|22000|nM
4LYW|1.95|2014|21Q|ligand is compound XD14|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|6.63|Kd=237nM|Kd|=|237|nM|237|nM
4MPN|1.75|2014|PV0|ligand is PS10|Q15119|PYRUVATE DEHYDROGENASE [LIPOAMIDE] KINASE ISOZYME|6.62|Kd=239nM|Kd|=|239|nM|239|nM
4MYH|3.38|2014|GSH||P40416|IRON-SULFUR CLUSTERS TRANSPORTER ATM1, MITOCHONDRIA|4.64|Kd=23uM|Kd|=|23|uM|23000|nM
4PSB|1.42|2014|GA3|Kd=23+/-1uM (pH=7.4)|Q9ZWP8|CYTOKININ-SPECIFIC BINDING PROTEIN|4.64|Kd=23uM|Kd|=|23|uM|23000|nM
4OCQ|1.88|2014|A2G|ligand is GalNAc; Kd=24.7+/-1.5uM|T2I3Q3|N-ACETYLHEXOSAMINE 1-PHOSPHATE KINASE|4.61|Kd=24.7uM|Kd|=|24.7|uM|24700|nM
4OZ1|1.74|2014|10-mer|UHM/SF3b155 ULM5; Kd=2400+/-1nM|Q14498|RNA-BINDING PROTEIN 39|5.62|Kd=2400nM|Kd|=|2400|nM|2400|nM
4LN2|1.00|2014|11-mer|ligand is 11-mer proline rich peptide from Vinculin, prr1|Q9BX66|SORBIN AND SH3 DOMAIN-CONTAINING PROTEIN 1|3.61|Kd=248uM|Kd|=|248|uM|248000|nM
4CI1|2.98|2014|EF2|ligand is compound thalidomide|Q16531|DNA DAMAGE-BINDING PROTEIN 1|6.6|Kd=249.2nM|Kd|=|249.2|nM|249.2|nM
4NRK|2.63|2014|SIA|ligand is Neu5Ac-alpha-(2,6)Gal receptor analogues, 3 SLN-LN;Kd=24+/-17nM|P03460|HEMAGGLUTININ HA1 CHAIN|7.62|Kd=24nM|Kd|=|24|nM|24|nM
4PRD|1.75|2014|11-mer|HPVG-D5; Kd=25.4+/-8.1uM|C5MK56|MHC CLASS I ANTIGEN|4.6|Kd=25.4uM|Kd|=|25.4|uM|25400|nM
4PRH|2.50|2014|11-mer|HPVG-D5; Kd=25.4+/-8.1uM; TK3 TCR-HLA-B 35:08|C5MK56|MHC CLASS I ANTIGEN|4.6|Kd=25.4uM|Kd|=|25.4|uM|25400|nM
4QK4|2.81|2014|PIK|ligand is PI(4.5)P2; Kd=250+/-25nM|Q13285|STEROIDOGENIC FACTOR 1|6.6|Kd=250nM|Kd|=|250|nM|250|nM
4C1Y|2.23|2014|MFB|ligand is b-methylfucoside, Beta MeFuc|Q4WW81|FUCOSE-SPECIFIC LECTIN FLEA|3.6|Kd=251uM|Kd|=|251|uM|251000|nM
4CJQ|1.70|2014|VXO|ligand is compound 40812|Q76353|HIV-1 INTEGRASE|3.59|Kd=256uM|Kd|=|256|uM|256000|nM
4M8H|2.20|2014|R4M|ligand is (R)-1|P19793|RETINOIC ACID RECEPTOR RXR-ALPHA|7.6|Kd=25nM|Kd|=|25|nM|25|nM
4UYF|1.60|2014|73B|ligand is compound 47; Kd=25+/-8nM|P25440|BROMODOMAIN-CONTAINING PROTEIN 2|7.6|Kd=25nM|Kd|=|25|nM|25|nM
4UYG|2.50|2014|73B|ligand is compound 47; Kd=25+/-8nM; redundant to 4uyf|P25440|BROMODOMAIN-CONTAINING PROTEIN 2|7.6|Kd=25nM|Kd|=|25|nM|25|nM
4QBM|1.65|2014|9-mer|ligand is H4K16acK20ac|Q9UIF9|BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN PROTEIN 2A|4.58|Kd=26.08uM|Kd|=|26.08|uM|26080|nM
4CK3|1.79|2014|K1T|ligand is compound 17650|Q76353|HIV-1 INTEGRASE|3.57|Kd=268uM|Kd|=|268|uM|268000|nM
4CU7|2.20|2014|GIF|ligand is compound GIF|I6L8R4|BETA-GALACTOSIDASE|7.59|Kd=26nM|Kd|=|26|nM|26|nM
4IBB|1.75|2014|1DK|ligand is compound GA-017|Q05127|POLYMERASE COFACTOR VP35|3.57|Kd=270.7uM|Kd|=|270.7|uM|270700|nM
4LBU|1.17|2014|1WJ|ligand is compound 6b|P28720|QUEUINE TRNA-RIBOSYLTRANSFERASE|6.56|Kd=276nM|Kd|=|276|nM|276|nM
4NYM|3.55|2014|RND|ligand is compound 2; to K-RasG12D|P01112|GTPASE HRAS|3.55|Kd=279uM|Kd|=|279|uM|279000|nM
4NVP|2.50|2014|7CH|ligand is 7-CH-cAMP; Kd=27+/-7nM|Q9Y3Q4|POTASSIUM/SODIUM HYPERPOLARIZATION-ACTIVATED CYCLIC|7.57|Kd=27nM|Kd|=|27|nM|27|nM
4PMM|2.00|2014|31V|ligand is compound 2|P04629|HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR|7.57|Kd=27nM|Kd|=|27|nM|27|nM
4K42|2.90|2014|NWM|ligand is compound SF-01|P68135|ACTIN, ALPHA SKELETAL MUSCLE|6.55|Kd=285nM|Kd|=|285|nM|285|nM
4OG3|2.01|2014|2S6|ligand is compound 11 (MIV-3)R isome|O00255|MENIN|6.55|Kd=285nM|Kd|=|285|nM|285|nM
4LEQ|1.41|2014|1WK|ligand is compound 6a|P28720|QUEUINE TRNA-RIBOSYLTRANSFERASE|6.54|Kd=288nM|Kd|=|288|nM|288|nM
4U90|2.00|2014|10-mer|ligand is 3v; Kd=288+/-86nM|Q03555|GEPHYRIN|6.54|Kd=288nM|Kd|=|288|nM|288|nM
4UAC|1.60|2014|ACR|ligand is acarbose; Kd=288+/-5.9nM|D6E1Y1|CARBOHYDRATE ABC TRANSPORTER SUBSTRATE-BINDING PROT|6.54|Kd=288nM|Kd|=|288|nM|288|nM
4MYD|1.37|2014|164|ligand is compound SHCHC|P37355|2-SUCCINYL-6-HYDROXY-2,4-CYCLOHEXADIENE-1-CARBOXYLA|4.55|Kd=28uM|Kd|=|28|uM|28000|nM
4ORX|1.60|2014|PEU|ligand is polyethylene glycol|P41222|PROSTAGLANDIN-H2 D-ISOMERASE|3.53|Kd=297uM|Kd|=|297|uM|297000|nM
4ORY|1.80|2014|PEU|ligand is polyethylene glycol|P41222|PROSTAGLANDIN-H2 D-ISOMERASE|3.53|Kd=297uM|Kd|=|297|uM|297000|nM
4NMR|1.55|2014|10-mer|ligand is peptide iCAL36(Ac-K-5) ; Kd=298+/-5uM|Q9HD26|GOLGI-ASSOCIATED PDZ AND COILED-COIL MOTIF-CONTAINI|3.53|Kd=298uM|Kd|=|298|uM|298000|nM
4QER|1.20|2014|STL|ligand is (ii) Resveratrol|D0VX11|PHOSPHOLIPASE A2, VRV-PL-VIIIA|7.54|Kd=29nM|Kd|=|29|nM|29|nM
4RUU|1.40|2014|RET|Kd=29+/-5nM|P50120|RETINOL-BINDING PROTEIN 2|7.54|Kd=29nM|Kd|=|29|nM|29|nM
4M5H|1.11|2014|YH2|ligand is compound 2|P26281|2-AMINO-4-HYDROXY-6-HYDROXYMETHYLDIHYDROPTERIDINE|4.54|Kd=29uM|Kd|=|29|uM|29000|nM
4NW2|1.90|2014|15-mer|NS1K229me3; Kd=29+/-1.2uM; incomplete ligand structure|O14646|CHROMODOMAIN-HELICASE-DNA-BINDING PROTEIN 1|4.54|Kd=29uM|Kd|=|29|uM|29000|nM
4D1C|3.70|2014|B5H|ligand is compound BVH|D6R8X8|HYDANTOIN TRANSPORT PROTEIN|5.7|Kd=2uM|Kd|=|2|uM|2000|nM
4PIO|1.51|2014|AVI|ligand is N-alpha-dimethylhistidine; Kd=2+/-1uM; EgtD solution contained 7 mM SAH|A0R5M8|HISTIDINE-SPECIFIC METHYLTRANSFERASE EGTD|5.7|Kd=2uM|Kd|=|2|uM|2000|nM
4QQI|2.03|2014|17-mer|ligand is DNA-binding protein RFX7|Q9H9E1|ANKYRIN REPEAT FAMILY A PROTEIN 2|5.52|Kd=3.0uM|Kd|=|3|uM|3000|nM
4QXO|1.88|2014|1YE|ligand is DMXAA; hSTING(group2)|Q86WV6|STIMULATOR OF INTERFERON GENES PROTEIN|5.51|Kd=3.12uM|Kd|=|3.12|uM|3120|nM
4NNI|2.64|2014|VGL|ligand is POA, the active form of PZA|P9WH43|30S RIBOSOMAL PROTEIN S1|5.5|Kd=3.13uM|Kd|=|3.13|uM|3130|nM
4W9F|2.10|2014|3JU|ligand is 5; Kd=3.27+/-0.22uM|Q15370|TRANSCRIPTION ELONGATION FACTOR B POLYPEPTIDE 2|5.49|Kd=3.27uM|Kd|=|3.27|uM|3270|nM
4TQ3|2.41|2014|GPP|Kd=3.2+/-0.1uM; with Mg2+|O28625|PRENYLTRANSFERASE|5.49|Kd=3.2uM|Kd|=|3.2|uM|3200|nM
4N7H|1.70|2014|13-mer|ligand is 1st PPXY Motif of ARRDC3|P46934|E3 UBIQUITIN-PROTEIN LIGASE NEDD4|5.48|Kd=3.3uM|Kd|=|3.3|uM|3300|nM
4PF5|2.04|2014|M3N|Ps.Man9(5); a synthetic derivative of high-mannose chain|P02866|CONCANAVALIN-A|5.48|Kd=3.3uM|Kd|=|3.3|uM|3300|nM
4QFG|3.46|2014|AMP|Kd=3300+/-1000nM|P54645|5'-AMP-ACTIVATED PROTEIN KINASE CATALYTIC SUBUNIT A|5.48|Kd=3.3uM|Kd|=|3.3|uM|3300|nM
4N6G|2.14|2014|2GQ|ligand is compound 5|P55212|CASPASE-6|5.47|Kd=3.4uM|Kd|=|3.4|uM|3400|nM
4MGB|1.85|2014|XDH|ligand is compound TCBPA|P03372|ESTROGEN RECEPTOR|5.44|Kd=3.67uM|Kd|=|3.67|uM|3670|nM
4POX|2.29|2014|2W2|ligand is nopaline;Kd=3.7+/-0.6uM|P35120|NOPALINE-BINDING PERIPLASMIC PROTEIN|5.43|Kd=3.7uM|Kd|=|3.7|uM|3700|nM
4TMP|2.30|2014|11-mer|ligand is H3K9ac peptide|P42568|PROTEIN AF-9|5.43|Kd=3.7uM|Kd|=|3.7|uM|3700|nM
4TUN|1.93|2014|MVH||P00698|LYSOZYME C|5.41|Kd=3.87uM|Kd|=|3.87|uM|3870|nM
4P0A|2.30|2014|10-mer|Injectant:P97 peptide 2mM; Cell:HOIP PUB 150 uM|Q96EP0|E3 UBIQUITIN-PROTEIN LIGASE RNF31|4.52|Kd=30.3uM|Kd|=|30.3|uM|30300|nM
4W4Z|2.41|2014|13-mer|ligand is APY-bAla8.am peptide|P54764|EPHRIN TYPE-A RECEPTOR 4|7.52|Kd=30nM|Kd|=|30|nM|30|nM
4TRC|2.40|2014|ADE|ligand is adenine|Q97W95|PURINE PHOSPHORIBOSYLTRANSFERASE (GPT-1)|4.52|Kd=30uM|Kd|=|30|uM|30000|nM
4QF8|1.65|2014|SPD|ligand is (iii) Spermidine|D0VX11|PHOSPHOLIPASE A2, VRV-PL-VIIIA|7.51|Kd=31nM|Kd|=|31|nM|31|nM
4NMQ|1.40|2014|10-mer|ligand is peptide iCAL36(Ac-K-4)|Q9HD26|GOLGI-ASSOCIATED PDZ AND COILED-COIL MOTIF-CONTAINI|4.49|Kd=32.3uM|Kd|=|32.3|uM|32299.999999999996|nM
4NYJ|2.85|2014|2PZ|ligand is compound 1; to K-RasG12D|P01112|GTPASE HRAS|3.49|Kd=322uM|Kd|=|322|uM|322000|nM
4W9W|1.72|2014|YDJ|ligand is AZD7762|Q9NSY1|BMP-2-INDUCIBLE PROTEIN KINASE|7.48|Kd=33.1nM|Kd|=|33.1|nM|33.1|nM
4K7N|2.30|2014|MCT|ligand is compound 2, 4-METHYLCATECHOL, 15N-HSQC experiments|P30044|PEROXIREDOXIN-5|3.48|Kd=330uM|Kd|=|330|uM|330000|nM
4OKS|2.25|2014|2T9|ligand is compound 19; IC50=3uM|K4KA16|SERINE PROTEASE NS3|4.48|Kd=33uM|Kd|=|33|uM|33000|nM
4Q4O|1.35|2014|2YM|ligand is compound 3a; Kd=34.3+/-6.5nM|P28720|QUEUINE TRNA-RIBOSYLTRANSFERASE|7.46|Kd=34.3nM|Kd|=|34.3|nM|34.3|nM
4MQ6|1.70|2014|29W|compound 10|P0A5R0|PANTOTHENATE SYNTHETASE|6.47|Kd=340nM|Kd|=|340|nM|340|nM
4JZB|1.90|2014|P2H|ligand is 300B, complex is LmFPPS-300B-IPP-Ca2+|Q4QBL1|FARNESYL PYROPHOSPHATE SYNTHASE|6.47|Kd=342.5nM|Kd|=|342.5|nM|342.5|nM
4PUJ|1.42|2014|CKR|ligand is compound 1; Kd=35+/-6.9nM|P28720|QUEUINE TRNA-RIBOSYLTRANSFERASE|7.46|Kd=35.0nM|Kd|=|35|nM|35|nM
4G2R|2.28|2014|H1L|ligand is compound haloxyfop-R|P63407|ACCD6, CARBOXYLTRANSFERASE BETA-SUBUNIT OF ACYL-COA|4.45|Kd=35.8uM|Kd|=|35.8|uM|35800|nM
4TZ2|1.70|2014|39R|ligand is compound 5|Q6PL18|ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 2|3.46|Kd=350uM|Kd|=|350|uM|350000|nM
4MP2|1.75|2014|PV1|ligand is PA1|Q15119|PYRUVATE DEHYDROGENASE [LIPOAMIDE] KINASE ISOZYME|5.45|Kd=3570nM|Kd|=|3570|nM|3570|nM
4OR0|2.58|2014|NPS|ligand is NPS;using microcalorimetry|P02769|SERUM ALBUMIN|7.46|Kd=35nM|Kd|=|35|nM|35|nM
4IBF|2.29|2014|1D5|ligand is compound VPL42|Q05127|POLYMERASE COFACTOR VP35|4.43|Kd=36.8uM|Kd|=|36.8|uM|36800|nM
4Q4R|1.45|2014|SQO|ligand is compound 2b; Kd=369.2+/-25.3nM|P28720|QUEUINE TRNA-RIBOSYLTRANSFERASE|6.43|Kd=369.2nM|Kd|=|369.2|nM|369.2|nM
4D1B|3.80|2014|5FH|ligand is compound L-BH|D6R8X8|HYDANTOIN TRANSPORT PROTEIN|4.44|Kd=36uM|Kd|=|36|uM|36000|nM
4PD6|2.08|2014|URI|ligand is uridine; Kd=36+/-3uM|Q9KPL5|NUPC FAMILY PROTEIN|4.44|Kd=36uM|Kd|=|36|uM|36000|nM
4OGI|1.73|2014|R78|ligand is BI-2536; Kd=37+/-3nM|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|7.43|Kd=37nM|Kd|=|37|nM|37|nM
4QGD|1.80|2014|PZZ|ligand is (v) Gramine derivative|D0VX11|PHOSPHOLIPASE A2, VRV-PL-VIIIA|7.43|Kd=37nM|Kd|=|37|nM|37|nM
4USI|1.45|2014|AKG|ligand is 2-oxoglutarate|A8JI83|NITROGEN REGULATORY PROTEIN PII|4.41|Kd=38.9uM|Kd|=|38.9|uM|38900|nM
4WT2|1.42|2014|3UD|ligand is compound 25(AM-7209)|Q00987|E3 UBIQUITIN-PROTEIN LIGASE MDM2|10.42|Kd=38pM|Kd|=|38|pM|0.038|nM
4CC5|1.88|2014|L5V|ligand is compound 3|Q9AIU7|DNA LIGASE|4.42|Kd=38uM|Kd|=|38|uM|38000|nM
4P5Z|2.00|2014|Q7M|ligand is compound 7m|P29320|EPH RECEPTOR A3|7.41|Kd=39.3nM|Kd|=|39.3|nM|39.3|nM
4W9X|2.14|2014|3JW|ligand is Baricitinib|Q9NSY1|BMP-2-INDUCIBLE PROTEIN KINASE|7.4|Kd=39.8nM|Kd|=|39.8|nM|39.8|nM
3WGG|2.10|2014|8NA|ligand is compound alpha-NAD+|D5KM69|REDOX-SENSING TRANSCRIPTIONAL REPRESSOR REX|4.4|Kd=39.9uM|Kd|=|39.9|uM|39900|nM
4PP0|1.57|2014|OP1|ligand is pyronopaline; Kd=39.9+/-7uM|P35120|NOPALINE-BINDING PERIPLASMIC PROTEIN|4.4|Kd=39.9uM|Kd|=|39.9|uM|39900|nM
4JE7|2.10|2014|BB2|ligand is actinonin|Q9FV53|PEPTIDE DEFORMYLASE 1A|6.4|Kd=395nM|Kd|=|395|nM|395|nM
4QPL|1.90|2014|V3L|iso-ADPr; Kd=39+/-7nM|Q9CZW6|E3 UBIQUITIN-PROTEIN LIGASE RNF146|7.41|Kd=39nM|Kd|=|39|nM|39|nM
4O6W|1.45|2014|7-mer|ligand is compound 3m|P53350|SERINE/THREONINE-PROTEIN KINASE PLK1|8.52|Kd=3nM|Kd|=|3|nM|3|nM
4C5D|2.30|2014|X0R|ligand is compound 41|Q07817|BCL-2-LIKE PROTEIN 1|5.4|Kd=4.0uM|Kd|=|4|uM|4000|nM
4NYT|2.25|2014|PC|ligand is Phosphocholine|Q15485|FICOLIN-2|2.39|Kd=4.1mM|Kd|=|4.1|mM|4099999.9999999995|nM
4MG5|2.05|2014|27E|ligand is compound chlordecone|P03372|ESTROGEN RECEPTOR|5.34|Kd=4.53uM|Kd|=|4.53|uM|4530|nM
4US3|2.10|2014|TRP|ligand is HiLiDe; L-Trp Kd=4.8+/-0.6uM|Q9KDT3|TRANSPORTER|5.32|Kd=4.8uM|Kd|=|4.8|uM|4800|nM
4US4|2.60|2014|TRP|ligand is MhsT LCP; L-Trp Kd=4.8+/-0.6uM|Q9KDT3|TRANSPORTER|5.32|Kd=4.8uM|Kd|=|4.8|uM|4800|nM
4MDR|1.85|2014|10-mer|ligand is a sorting peptide from the amyloid precursor protein (APP)|O00189|AP-4 COMPLEX SUBUNIT MU-1|4.39|Kd=40.6uM|Kd|=|40.6|uM|40600|nM
4Q4P|1.54|2014|2YO|ligand is compound 3b; Kd=407.4+/-46.0nM|P28720|QUEUINE TRNA-RIBOSYLTRANSFERASE|6.39|Kd=407.4nM|Kd|=|407.4|nM|407.4|nM
2MOV|NMR|2014|IOR|ligand is compound MG-H1|Q15109|ADVANCED GLYCOSYLATION END PRODUCT-SPECIFIC RECEPTOR|7.4|Kd=40nM|Kd|=|40|nM|40|nM
4RRV|1.41|2014|15-mer|ligand is PIFtide|O15530|3-PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE 1|7.4|Kd=40nM|Kd|=|40|nM|40|nM
4P4T|2.30|2014|GDP|ligand is GDP|P20591|INTERFERON-INDUCED GTP-BINDING PROTEIN MX1|4.39|Kd=41.0uM|Kd|=|41|uM|41000|nM
4CE1|2.01|2014|7FK|ligand is compound 27c|P02829|ATP-DEPENDENT MOLECULAR CHAPERONE HSP82|4.38|Kd=41.8uM|Kd|=|41.8|uM|41800|nM
4MPE|1.95|2014|PV8|ligand is PS8|Q15119|PYRUVATE DEHYDROGENASE [LIPOAMIDE] KINASE ISOZYME|6.37|Kd=426nM|Kd|=|426|nM|426|nM
4MRD|2.55|2014|NAG-BDP|ligand is HA oligosaccharide 4|P15379|CD44 ANTIGEN|3.37|Kd=428uM|Kd|=|428|uM|428000|nM
4Q6D|1.12|2014|WW3|ligand is compound 31|P00918|CARBONIC ANHYDRASE 2|7.36|Kd=43.5nM|Kd|=|43.5|nM|43.5|nM
4R91|1.58|2014|3KT|ligand is compound 41|P56817|BETA-SECRETASE 1|6.37|Kd=430nM|Kd|=|430|nM|430|nM
4CJ4|1.80|2014|S3G|ligand is compound GL5243104|Q76353|HIV-1 INTEGRASE|3.36|Kd=432uM|Kd|=|432|uM|432000|nM
4O36|1.22|2014|15-mer|Ribonuclease pancreatic, S-peptide 2;Kd=436+/-32nM|P61823|RIBONUCLEASE|6.36|Kd=436nM|Kd|=|436|nM|436|nM
4O3T|2.99|2014|11-mer|ZAP14; Kd=43+/-28uM|P14210|HEPATOCYTE GROWTH FACTOR|4.37|Kd=43uM|Kd|=|43|uM|43000|nM
4MNP|2.50|2014|SLB|ligand is compound Neu5Ac|Q8RDN9|N-ACETYLNEURAMINATE-BINDING PROTEIN|7.34|Kd=45.5nM|Kd|=|45.5|nM|45.5|nM
4MZF|2.10|2014|9-mer|ligand is histone H3(K4me3-R8me2a) peptide|Q71DI3|PEPTIDE FROM HISTONE H3.2|7.35|Kd=45nM|Kd|=|45|nM|45|nM
4MUF|2.50|2014|2DJ|compound 12|P0A5R0|PANTOTHENATE SYNTHETASE|6.34|Kd=460nM|Kd|=|460|nM|460|nM
4LYS|1.83|2014|2SJ|ligand is compound XD1|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|4.34|Kd=46uM|Kd|=|46|uM|46000|nM
4IBJ|1.54|2014|1D9|ligand is compound VPL58|Q05127|POLYMERASE COFACTOR VP35|4.33|Kd=47.0uM|Kd|=|47|uM|47000|nM
4PD9|3.10|2014|ADN|ligand is adenosine; Kd=470+/-100uM|Q9KPL5|NUPC FAMILY PROTEIN|3.33|Kd=470uM|Kd|=|470|uM|470000|nM
4CJP|2.00|2014|4D2|ligand is compound 40811|Q76353|HIV-1 INTEGRASE|3.32|Kd=481uM|Kd|=|481|uM|481000|nM
4D1J|1.80|2014|DGJ|Kd=485+/-42 nM|B3PBE0|BETA-GALACTOSIDASE, BGL35A|6.31|Kd=485nM|Kd|=|485|nM|485|nM
4C9X|1.20|2014|VHS|ligand is S-crizotinib|P36639|7,8-DIHYDRO-8-OXOGUANINE TRIPHOSPHATASE|7.32|Kd=48nM|Kd|=|48|nM|48|nM
4U43|2.18|2014|3D8|ligand is compound 6|O95819|MITOGEN-ACTIVATED PROTEIN KINASE 4|4.32|Kd=48uM|Kd|=|48|uM|48000|nM
4NY3|1.80|2014|6-mer|PPP2CA C-terminal peptide(TPDYFL peptides); Kd=49.5+/-1.8uM|Q15257|SERINE/THREONINE-PROTEIN PHOSPHATASE 2A ACTIVATOR|4.31|Kd=49.5uM|Kd|=|49.5|uM|49500|nM
4NYF|1.90|2014|4BI|ligand is compound 16|P0C6F2|HIV-1 INTEGRASE|7.31|Kd=49nM|Kd|=|49|nM|49|nM
4U0C|1.77|2014|17-mer|ligand in crystal is (1407-TNNSPSGVFTFGANSST-1423) peptide|P12493|CAPSID PROTEIN P24|4.31|Kd=49uM|Kd|=|49|uM|49000|nM
4U0D|3.00|2014|17-mer|ligand in crystal is (1407-TNNSPSGVFTFGANSST-1423) peptide|P12493|GAG POLYPROTEIN|4.31|Kd=49uM|Kd|=|49|uM|49000|nM
4M3P|1.90|2014|HCS|ligand is Homocysteine, Kd in presence of potassium ion|Q93088|BETAINE--HOMOCYSTEINE S-METHYLTRANSFERASE 1|5.4|Kd=4uM|Kd|=|4|uM|4000|nM
4OZJ|1.45|2014|ADP||B8ZYW1|NITROGEN REGULATORY PROTEIN P-II|5.4|Kd=4uM|Kd|=|4|uM|4000|nM
4OZN|2.60|2014|ATP||B8ZYW1|NITROGEN REGULATORY PROTEIN P-II|5.4|Kd=4uM|Kd|=|4|uM|4000|nM
4PIN|1.90|2014|AVI|ligand is N-alpha-dimethylhistidine; Kd=4+/-2uM|A0R5M8|HISTIDINE-SPECIFIC METHYLTRANSFERASE EGTD|5.4|Kd=4uM|Kd|=|4|uM|4000|nM
4POV|2.20|2014|2VY|[Incomplete ligand] compound 7; RCSB wrongly save functional group -C-OH as -C=O, same as compound 9, 2VY in PDB code 4pop|A2RI47|THIAMINE TRANSPORTER THIT|8.28|Kd=5.21nM|Kd|=|5.21|nM|5.21|nM
4N9B|2.86|2014|2HH|ligand is compound 7|P43490|NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE|5.28|Kd=5.2uM|Kd|=|5.2|uM|5200|nM
4R6W|1.59|2014|SAH|AdoHcy with pCho; AdoHcy Kd=5.4+/-0.1uM for SAH|Q6T755|PHOSPHOETHANOLAMINE N-METHYLTRANSFERASE|5.27|Kd=5.4uM|Kd|=|5.4|uM|5400|nM
4R6X|2.55|2014|SAH|AdoHcy with pEA; Kd=5.4+/-0.1uM for SAH|Q6T755|PHOSPHOETHANOLAMINE N-METHYLTRANSFERASE|5.27|Kd=5.4uM|Kd|=|5.4|uM|5400|nM
4W9G|2.70|2014|3JV|ligand is 6; Kd=6.53+/-0.59uM|Q15370|TRANSCRIPTION ELONGATION FACTOR B POLYPEPTIDE 2|5.26|Kd=5.53uM|Kd|=|5.53|uM|5530|nM
4NP2|1.75|2014|2L1|ligand is compound 5|P15379|CD44 ANTIGEN|2.26|Kd=5.5mM|Kd|=|5.5|mM|5500000|nM
4NON|2.50|2014|GDP|Kd=5.71+/-0.59uM|Q5M586|FERROUS IRON UPTAKE TRANSPORTER PROTEIN B|5.24|Kd=5.71uM|Kd|=|5.71|uM|5710|nM
4UTX|3.10|2014|9-mer|ligand is 3-nitro- propionylated CPS1-peptide 5i; Kd=5.78+/-2.36uM|Q6DHI5|NAD-DEPENDENT PROTEIN DEACYLASE SIRTUIN-5|5.24|Kd=5.78uM|Kd|=|5.78|uM|5780|nM
4UUA|2.80|2014|9-mer|ligand is 3S-Z-amino- succinylated CPS1-peptide 5i; Kd=5.78+/-2.36uM|Q6DHI5|NAD-DEPENDENT PROTEIN DEACYLASE SIRTUIN-5|5.24|Kd=5.78uM|Kd|=|5.78|uM|5780|nM
3WQW|2.00|2014|6-mer|ligand is (GlcN)x6|Q2V6H4|CHITINASE|5.23|Kd=5.9uM|Kd|=|5.9|uM|5900|nM
4M5K|1.30|2014|YH3|ligand is compound 8|P26281|2-AMINO-4-HYDROXY-6-HYDROXYMETHYLDIHYDROPTERIDINE|5.23|Kd=5.9uM|Kd|=|5.9|uM|5900|nM
4IBK|1.85|2014|1DE|ligand is compound VPL60|Q05127|POLYMERASE COFACTOR VP35|4.3|Kd=50.4uM|Kd|=|50.4|uM|50400|nM
4TZ8|2.15|2014|39U|ligand is compound 12|Q6PL18|ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 2|3.3|Kd=500uM|Kd|=|500|uM|500000|nM
4K7O|1.98|2014|EKZ|ligand is compound 3, 4-tert-butylbenzene-1,2-diol, 15N-HSQC experiments|P30044|PEROXIREDOXIN-5|4.3|Kd=50uM|Kd|=|50|uM|50000|nM
4O61|1.90|2014|CIT|ligand is citrate|Q6P6C2|RNA DEMETHYLASE ALKBH5|4.3|Kd=50uM|Kd|=|50|uM|50000|nM
4U0B|2.80|2014|15-mer|CPSF6 peptide, P212121 crystal form; -DTT|P12493|CAPSID PROTEIN P24|4.3|Kd=50uM|Kd|=|50|uM|50000|nM
4U0A|2.05|2014|15-mer|CPSF6 peptide, P6 crystal form; -DTT|P12493|CAPSID PROTEIN P24|4.3|Kd=50uM|Kd|=|50|uM|50000|nM
4PUK|1.49|2014|2WU|ligand is compound 2; Kd=52.4+/-6.9nM|P28720|QUEUINE TRNA-RIBOSYLTRANSFERASE|7.28|Kd=52.4nM|Kd|=|52.4|nM|52.4|nM
4R1E|1.98|2014|15-mer|peptide-fragment chimera 3; Kd=52+/-8nM|Q8I4W8|MYOSIN A TAIL DOMAIN INTERACTING PROTEIN|7.28|Kd=52nM|Kd|=|52|nM|52|nM
4CLP|1.90|2014|CMP|Kd=54.2+/-13.4 mM|Q96PN6|ADENYLATE CYCLASE TYPE 10|1.27|Kd=54.2mM|Kd|=|54.2|mM|54200000|nM
4LPG|2.35|2014|1MV|ligand is compound 6a, CL01131|P14324|FARNESYL PYROPHOSPHATE SYNTHASE|4.25|Kd=55.6uM|Kd|=|55.6|uM|55600|nM
4UA8|1.54|2014|MLR|ligand is maltotriose; Kd=550+/-14nM|D6E1Y1|CARBOHYDRATE ABC TRANSPORTER SUBSTRATE-BINDING PROT|6.26|Kd=550nM|Kd|=|550|nM|550|nM
4WIV|1.56|2014|3P2|ligand is compound 32|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|6.26|Kd=550nM|Kd|=|550|nM|550|nM
4NNR|1.98|2014|FK5||P26885|PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP2|7.26|Kd=55nM|Kd|=|55|nM|55|nM
2MJI|NMR|2014|KTR|ligand is Ketorolac, ITC data|P12104|FATTY ACID-BINDING PROTEIN, INTESTINAL|4.25|Kd=56.7uM|Kd|=|56.7|uM|56700|nM
3WQM|2.10|2014|B29|inhibitor BPH-629|O50407|DITERPENE SYNTHASE|6.25|Kd=560nM|Kd|=|560|nM|560|nM
4W5J|1.65|2014|AP5|Kd1=57+/-2nM; Kd2=177+/-53nM|Q04ML5|ADENYLATE KINASE|7.24|Kd=57nM|Kd|=|57|nM|57|nM
4U0X|2.03|2014|ZXM|ligand is compound S02030|Q6DRA1|ADC-7 BETA-LACTAMASE|6.23|Kd=590nM|Kd|=|590|nM|590|nM
4R5G|3.45|2014|3JE|ligand PET-16 binding to wt Dna-ADP; Kd=6.0+/-1.8uM|P0A6Y8|CHAPERONE PROTEIN DNAK|5.22|Kd=6.0uM|Kd|=|6|uM|6000|nM
3WQV|2.04|2014|5-mer|ligand is (GlcN)x5|Q2V6H4|CHITINASE|5.21|Kd=6.2uM|Kd|=|6.2|uM|6200|nM
4MRE|1.58|2014|2C9|ligand is compound 1|P15379|CD44 ANTIGEN|2.19|Kd=6.4mM|Kd|=|6.4|mM|6400000|nM
2MNZ|NMR|2014|10-mer|ligand is H3K4me0(1-10aa) peptide|Q9UGL1|LYSINE-SPECIFIC DEMETHYLASE 5B|5.19|Kd=6.4uM|Kd|=|6.4|uM|6400|nM
4M0Z|2.00|2014|M0Z|ligand is compound 5, Kd1: allosteric pocket, Kd2: ATP pocket|Q08881|TYROSINE-PROTEIN KINASE ITK/TSK|5.19|Kd=6.4uM|Kd|=|6.4|uM|6400|nM
4QOK|3.00|2014|10-mer|HLA-A*0201 restricted Melan-A/MART-1 26-35 (EAAGIGILTV) antigen (A2-EAA); Kd=6.4+/-0.2uM|P01892|HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA CHAIN|5.19|Kd=6.4uM|Kd|=|6.4|uM|6400|nM
4ONO|2.71|2014|PMK|Kd1=24.7+/-3.4uM(1.6TCRs),Kd2=7.3+/-2.0uM(1.22TCRs),Kd3= 6.5+/-2.0uM(2.4TCRs),Kd4=16.0+/-2.4uM(22.2TCRs)|P61769|BETA-2-MICROGLOBULIN/T-CELL SURFACE GLYCOPROTEIN CD|5.19|Kd=6.5uM|Kd|=|6.5|uM|6500|nM
4M5I|1.08|2014|YH6|ligand is compound 3|P26281|2-AMINO-4-HYDROXY-6-HYDROXYMETHYLDIHYDROPTERIDINE|5.17|Kd=6.7uM|Kd|=|6.7|uM|6700|nM
4KP4|3.00|2014|ANP|ligand is non-hydrolysable ATP analogue AMPPNP|P0AEJ4|OSMOLARITY SENSOR PROTEIN ENVZ, HISTIDINE KINASE|5.17|Kd=6.8uM|Kd|=|6.8|uM|6800|nM
4NJA|2.20|2014|2M9|ligand is MPTS|P01660|6C8 LIGHT CHAIN|6.22|Kd=600nM|Kd|=|600|nM|600|nM
4TYL|1.85|2014|39O|ligand is compound 1|Q6PL18|ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 2|3.22|Kd=600uM|Kd|=|600|uM|600000|nM
4JE8|2.40|2014|3-mer|ligand is Met-Ala-Ser|Q9FV53|PEPTIDE DEFORMYLASE 1A|5.21|Kd=6100nM|Kd|=|6100|nM|6100|nM
4MUL|1.75|2014|2DW|compound 13|P0A5R0|PANTOTHENATE SYNTHETASE|6.21|Kd=610nM|Kd|=|610|nM|610|nM
4PDA|2.61|2014|CTN|ligand is cytidine; Kd=61+/-5uM|Q9KPL5|NUPC FAMILY PROTEIN|4.21|Kd=61uM|Kd|=|61|uM|61000|nM
4UMN|1.99|2014|13-mer|ligand is M06; Kd=63.13+/-17.81nM|Q00987|E3 UBIQUITIN-PROTEIN LIGASE MDM2|7.2|Kd=63.13nM|Kd|=|63.13|nM|63.13|nM
4CA4|2.84|2014|KGM||A2IC68|FIMH PROTEIN|7.18|Kd=65.5nM|Kd|=|65.5|nM|65.5|nM
4MZH|2.20|2014|9-mer|ligand is histone H3(K4me3-R8me2s) peptide|Q9Y657|SPINDLIN-1|7.18|Kd=66nM|Kd|=|66|nM|66|nM
4Q9M|2.06|2014|2ZW|ligand is UK-106051 with FPP; Kd=66+/-7 nM|Q8DRB3|ISOPRENYL TRANSFERASE|7.18|Kd=66nM|Kd|=|66|nM|66|nM
4O9W|1.69|2014|6-mer|Kd=69.91+/-15.95nM|P53350|SERINE/THREONINE-PROTEIN KINASE PLK1|7.16|Kd=69.91nM|Kd|=|69.91|nM|69.91|nM
4O37|1.40|2014|15-mer|Ribonuclease pancreatic, S-peptide 3; Kd=694+/-57nM|P61823|RIBONUCLEASE|6.16|Kd=694nM|Kd|=|694|nM|694|nM
4W9E|2.60|2014|3JT|ligand is 4; Kd=7.09+/-0.59uM|Q15370|TRANSCRIPTION ELONGATION FACTOR B POLYPEPTIDE 2|5.15|Kd=7.09uM|Kd|=|7.09|uM|7090|nM
4BUQ|2.20|2014|KGM|ligand is compound HM|A2IC68|FIMH PROTEIN|8.14|Kd=7.3nM|Kd|=|7.3|nM|7.3|nM
4POP|2.20|2014|2VY|compound 9;|A2RI47|THIAMINE TRANSPORTER THIT|8.13|Kd=7.44nM|Kd|=|7.44|nM|7.44|nM
4QFR|3.34|2014|32J|ligand is Cl-A769662; Kd=7.4+/-0.1nM|P54645|5'-AMP-ACTIVATED PROTEIN KINASE CATALYTIC SUBUNIT A|8.13|Kd=7.4nM|Kd|=|7.4|nM|7.4|nM
4M5N|2.00|2014|YH7|ligand is compound 21|P26281|2-AMINO-4-HYDROXY-6-HYDROXYMETHYLDIHYDROPTERIDINE|5.12|Kd=7.5uM|Kd|=|7.5|uM|7500|nM
4V04|2.12|2014|0LI|ligand is Ponatinib; Kd=7.7+/-0.03nM|D3DSX2|FIBROBLAST GROWTH FACTOR RECEPTOR 1|8.11|Kd=7.7nM|Kd|=|7.7|nM|7.7|nM
4V01|2.33|2014|0LI|ligand is ponatinib; Kd=7.7+/-0.03nM|D3DSX2|FIBROBLAST GROWTH FACTOR RECEPTOR 1|8.11|Kd=7.7nM|Kd|=|7.7|nM|7.7|nM
4PMS|2.80|2014|31X|ligand is compound 4|P04629|HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR|8.1|Kd=7.9nM|Kd|=|7.9|nM|7.9|nM
4WHT|2.22|2014|12-mer|E2 antigenic region 412-423 Epitope peptide; Glasgow; P1 crystal form; Kd=7.9+/-0.7nM|Q9WJJ4|HEAVY CHAIN OF THE FAB FRAGMENT DERIVED FROM NEUTRA|8.1|Kd=7.9nM|Kd|=|7.9|nM|7.9|nM
4WHY|2.62|2014|12-mer|Epitope peptide; ntigenic region 412-423 Epitope peptide; Glasgow; P21 crystal form; Kd=7.9+/-0.7nM|Q9WJJ4|EPITOPE PEPTIDE|8.1|Kd=7.9nM|Kd|=|7.9|nM|7.9|nM
4IBE|1.95|2014|11Y|ligand is compound VPL-029|Q05127|POLYMERASE COFACTOR VP35|4.15|Kd=70.6uM|Kd|=|70.6|uM|70600|nM
4O45|1.87|2014|15-mer|NS1; Kd=70+/-5uM|P61964|WD REPEAT-CONTAINING PROTEIN 5|4.15|Kd=70uM|Kd|=|70|uM|70000|nM
4MPC|1.70|2014|PV2|ligand is PS2|Q15119|PYRUVATE DEHYDROGENASE [LIPOAMIDE] KINASE ISOZYME|6.15|Kd=711nM|Kd|=|711|nM|711|nM
4K6U|1.90|2014|1P4-SIA|compound 11b; consist of 1P4 and three SIA; SPR data is available|Q64823|FIBER PROTEIN|4.14|Kd=72.8uM|Kd|=|72.8|uM|72800|nM
4IBI|1.47|2014|1D8|ligand is compound VPL57|Q05127|POLYMERASE COFACTOR VP35|4.14|Kd=73.0uM|Kd|=|73|uM|73000|nM
4D1Y|2.60|2014|RBF|ligand is RIBOFLAVIN|Q8A8A4|PUTATIVE PROTEASE I|7.13|Kd=74nM|Kd|=|74|nM|74|nM
4WHS|1.35|2014|3N8|ligand is 4CF, PH=8.5; ITC PH=7,5|P00436|PROTOCATECHUATE 3,4-DIOXYGENASE|4.12|Kd=75uM|Kd|=|75|uM|75000|nM
4WHQ|1.78|2014|3N8|ligand is 4CF, with O2, PH=6.5; ITC PH=7.5; redundant to 4whs|P00436|PROTOCATECHUATE 3,4-DIOXYGENASE ALPHA CHAIN|4.12|Kd=75uM|Kd|=|75|uM|75000|nM
4WHR|1.58|2014|3N8|ligand is 4CF, with O2, PH=8.5; ITC PH=7.5; redundant to 4whs|P00436|PROTOCATECHUATE 3,4-DIOXYGENASE ALPHA CHAIN|4.12|Kd=75uM|Kd|=|75|uM|75000|nM
4K6T|2.00|2014|1P0-SIA|compound 11a; consist of 1P0 and three SIA; SPR data is available|Q64823|FIBER PROTEIN|4.1|Kd=78.6uM|Kd|=|78.6|uM|78600|nM
4C9W|1.65|2014|VGH|ligand is R-crizotinib|P36639|7,8-DIHYDRO-8-OXOGUANINE TRIPHOSPHATASE|6.11|Kd=781nM|Kd|=|781|nM|781|nM
4CJR|1.80|2014|FYM|ligand is compound 101119|Q76353|HIV-1 INTEGRASE|3.1|Kd=793uM|Kd|=|793|uM|793000|nM
4WF2|2.31|2014|BTX|ligand is biotinol-5'-AMP|P06709|BIFUNCTIONAL LIGASE/REPRESSOR BIRA|8.1|Kd=8.03nM|Kd|=|8.03|nM|8.03|nM
4UTV|2.40|2014|9-mer|ligand is 3-phenyl- succinylated CPS1-peptide 5h; Kd=8.20+/-0.55uM|Q6DHI5|NAD-DEPENDENT PROTEIN DEACYLASE SIRTUIN-5|5.09|Kd=8.20uM|Kd|=|8.2|uM|8200|nM
4R4Q|1.35|2014|3HZ|ligand is compound 7b; Kd= 8.2+/- 2.6uM|P27694|REPLICATION PROTEIN A 70 KDA DNA-BINDING SUBUNIT|5.09|Kd=8.2uM|Kd|=|8.2|uM|8200|nM
4OCK|1.72|2014|ANP|ligand is AMPPNP; Kd=8.3+/-0.5uM|T2I3Q3|N-ACETYLHEXOSAMINE 1-PHOSPHATE KINASE|5.08|Kd=8.3uM|Kd|=|8.3|uM|8300|nM
4OCV|1.47|2014|ANP|ligand is AMPPNP; Kd=8.3+/-0.5uM|B7GN78|N-ACETYLHEXOSAMINE 1-PHOSPHATE KINASE|5.08|Kd=8.3uM|Kd|=|8.3|uM|8300|nM
4OD7|1.60|2014|9-mer|PWATCDS; Kd=8.3+/-0.4uM|B4EZ68|THIOL:DISULFIDE INTERCHANGE PROTEIN|5.08|Kd=8.3uM|Kd|=|8.3|uM|8300|nM
4UM9|2.50|2014|13-mer|transforming growth factor beta 3 peptide; Kd calculated from IC50 value|P06756|INTEGRIN ALPHA-V|8.07|Kd=8.5nM|Kd|=|8.5|nM|8.5|nM
4J7I|2.56|2014|11-mer|ligand is Transcription initiation factor TFIID subunit 10 peptide|Q8WTS6|HISTONE-LYSINE N-METHYLTRANSFERASE SETD7|5.06|Kd=8.8uM|Kd|=|8.8|uM|8800|nM
4QKD|1.35|2014|AKG|Kd=80.9+/-8.12nM; modification of ALKBH7 Leu-110;Mn2+ containing|Q9BT30|ALPHA-KETOGLUTARATE-DEPENDENT DIOXYGENASE ALKB HOMO|4.09|Kd=80.9uM|Kd|=|80.9|uM|80900|nM
4QJR|2.40|2014|PIZ|ligand is PIP3; Kd=80+/-12nM|Q13285|STEROIDOGENIC FACTOR 1|7.1|Kd=80nM|Kd|=|80|nM|80|nM
4MJI|2.99|2014|8-mer||P18464|HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-51 ALPHA CHAIN|4.09|Kd=81.8uM|Kd|=|81.8|uM|81800|nM
4PO7|2.66|2014|13-mer|incomplete ligand structure|Q99523|SORTILIN|7.07|Kd=85nM|Kd|=|85|nM|85|nM
4NYI|2.96|2014|2PX|ligand is compound 3; to K-RasG12D|P01112|GTPASE HRAS|3.06|Kd=868uM|Kd|=|868|uM|868000|nM
4QEW|1.70|2014|31P|ligand is ET|P25440|BROMODOMAIN-CONTAINING PROTEIN 2|7.07|Kd=86nM|Kd|=|86|nM|86|nM
4CSY|2.41|2014|SIA-MAG-GAL-FUC|ligand is Sialyl Lewis X, consist of SIA-MAG-GAL-FUC|P16581|E-SELECTIN|3.06|Kd=878uM|Kd|=|878|uM|878000|nM
4QZS|1.45|2014|JQ1|ligand is (+)-JQ1; Kd=89=/-5nM|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|7.05|Kd=89nM|Kd|=|89|nM|89|nM
4CS9|2.01|2014|AMP|fluorescence-based thermal shift assays (TSA)|Q8QN58|M2-1|2.1|Kd=8mM|Kd|=|8|mM|8000000|nM
4POJ|2.00|2014|2VP|ligand is compound 3 ; Kd=8+/-2nM|P19793|RETINOIC ACID RECEPTOR RXR-ALPHA|8.1|Kd=8nM|Kd|=|8|nM|8|nM
4WKE|1.62|2014|3PU|ligand is compound 10|O75173|A DISINTEGRIN AND METALLOPROTEINASE WITH THROMBOSPO|8.1|Kd=8nM|Kd|=|8|nM|8|nM
4RN6|3.00|2014|15U|active site inhibitor S-argatroban, ITC Kd=8+/-0.1uM|P00734|THROMBIN|5.1|Kd=8uM|Kd|=|8|uM|8000|nM
4QSK|2.70|2014|2BA|ligand is c-di-AMP; Kd=8+/-0.2uM; space group C2|W6G6F5|PYRUVATE CARBOXYLASE|5.1|Kd=8uM|Kd|=|8|uM|8000|nM
4QSH|2.51|2014|2BA|ligand is c-di-AMP; Kd=8+/-0.2uM; space group P21|W6G6F5|PYRUVATE CARBOXYLASE|5.1|Kd=8uM|Kd|=|8|uM|8000|nM
4TK3|2.70|2014|11-mer|GABAA receptor alpha3(alpha-11 SL) ; Kd=8+/-1uM; space group P21212|Q03555|GEPHYRIN|5.1|Kd=8uM|Kd|=|8|uM|8000|nM
4TK4|3.60|2014|11-mer|GABAA receptor alpha3(alpha-11 SL) ; Kd=8+/-1uM; space group P61|Q03555|GEPHYRIN|5.1|Kd=8uM|Kd|=|8|uM|8000|nM
4OEG|1.60|2014|SUS-IDY|ligand is S9I2; Kd=9.01+/-0.23uM|P09038|FIBROBLAST GROWTH FACTOR 2|5.05|Kd=9.01uM|Kd|=|9.01|uM|9010|nM
4JAZ|2.85|2014|STL|ITC Ka=1.09x10E5M-1, Kd=9.17uM|P37231|PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA|5.04|Kd=9.17uM|Kd|=|9.17|uM|9170|nM
4LPH|2.30|2014|YL3|ligand is compound 7, CL03093|P14324|FARNESYL PYROPHOSPHATE SYNTHASE|5.04|Kd=9.2uM|Kd|=|9.2|uM|9200|nM
4W9L|2.20|2014|3JJ|ligand is 15; Kd=9.52+/-1.02uM|Q15370|TRANSCRIPTION ELONGATION FACTOR B POLYPEPTIDE 2|5.02|Kd=9.52uM|Kd|=|9.52|uM|9520|nM
4UYE|1.65|2014|9F9|ligand is compound 3; IC50=79.43nM; for cellular protein interaction assay, IC50=0.98uM|P55201|PEREGRIN|8.02|Kd=9.54nM|Kd|=|9.54|nM|9.54|nM
4M5G|1.31|2014|YH1|ligand is compound 1|P26281|2-AMINO-4-HYDROXY-6-HYDROXYMETHYLDIHYDROPTERIDINE|5.01|Kd=9.7uM|Kd|=|9.7|uM|9700|nM
4U4X|1.56|2014|3C2|ligand is compound 5; Kd=9.8+/-0.7uM|P19491|GLUTAMATE RECEPTOR 2|5.01|Kd=9.8uM|Kd|=|9.8|uM|9800|nM
4O62|1.78|2014|11-mer|ligand is peptide H3K4me3|Q504Y3|ZINC FINGER CW-TYPE PWWP DOMAIN PROTEIN 2|5.0|Kd=9.9uM|Kd|=|9.9|uM|9900|nM
4LNW|1.90|2014|T3|ligand is T3|P10827|THYROID HORMONE RECEPTOR ALPHA|7.04|Kd=90.9nM|Kd|=|90.9|nM|90.9|nM
4NMP|1.30|2014|10-mer|peptide iCAL36(Ac-K-3)|Q9HD26|GOLGI-ASSOCIATED PDZ AND COILED-COIL MOTIF-CONTAINI|4.04|Kd=91.9uM|Kd|=|91.9|uM|91900|nM
4PRI|2.40|2014|11-mer|HPVG; Kd=93.2+/-3.8uM; TK3 TCR-HLA-B 35:08|C5MK56|MHC CLASS I ANTIGEN|4.03|Kd=93.2uM|Kd|=|93.2|uM|93200|nM
4QL1|1.50|2014|35Q|ligand is compound OICR-9429|P61964|WD REPEAT-CONTAINING PROTEIN 5|7.03|Kd=93nM|Kd|=|93|nM|93|nM
4OG4|1.45|2014|2VK|ligand is compound 11 (MIV-3)S isomer|O00255|MENIN|6.02|Kd=952nM|Kd|=|952|nM|952|nM
4WYM|2.60|2014|17-mer|Kd by AUC, analytical ultracentrifugation; Kd=83.3uM by FP|P12497|CAPSID PROTEIN P24|4.0|Kd=99.8uM|Kd|=|99.8|uM|99800|nM
4TSZ|2.00|2014|6-mer|ligand is peptide P14(AcQChaDLdiClF); PaSC; Kd=99+/-18nM|V4MZL6|DNA POLYMERASE III SUBUNIT BETA|7.0|Kd=99nM|Kd|=|99|nM|99|nM
4WMC|2.30|2014|NXL|ligand is avibactam|Q6XEC0|BETA-LACTAMASE|8.05|Kd=9nM|Kd|=|9|nM|9|nM
4OCT|2.28|2014|AKG|ligand is 2OG; ALKBH5 wild-type|Q6P6C2|RNA DEMETHYLASE ALKBH5|5.05|Kd=9uM|Kd|=|9|uM|9000|nM
4PNW|2.00|2014|2VM|compound 5m|U6NCW5|DNA POLYMERASE III SUBUNIT BETA|5.05|Kd=9uM|Kd|=|9|uM|9000|nM
4RQV|1.50|2014|R2S||O15530|3-PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE 1|5.05|Kd=9uM|Kd|=|9|uM|9000|nM
4PJI|2.50|2014|30W||Q95460|MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I-RELATED GE|3.7|Kd>200uM|Kd|>|200|uM|200000|nM
4OAZ|2.25|2014|C2E|ligand is cyclic dinucleotide c-di-GMP|Q7AKQ8|PUTATIVE DNA-BINDING PROTEIN|5.77|Kd~1.7uM|Kd|~|1.7|uM|1700|nM
4QTA|1.45|2014|38Z|SCH772984|P28482|MITOGEN-ACTIVATED PROTEIN KINASE 1|6.7|Kd~200nM|Kd|~|200|nM|200|nM
4QTB|1.40|2014|38Z|SCH772984|P27361|MITOGEN-ACTIVATED PROTEIN KINASE 3|6.7|Kd~200nM|Kd|~|200|nM|200|nM
4OCX|2.39|2014|MT1||A2NHM3|ANTIBODY FAB ADD056 HEAVY CHAIN|11.44|Kd~3.6pM|Kd|~|3.6|pM|0.0036000000000000003|nM
4PMP|1.80|2014|31W|compound 3|P04629|HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR|6.4|Kd~400nM|Kd|~|400|nM|400|nM
4CIZ|3.40|2014|RET|ligand is 9-cis-retinal|P12271|RETINALDEHYDE-BINDING PROTEIN 1|7.29|Kd~51nM|Kd|~|51|nM|51|nM
4LED|2.37|2014|XXR|ligand is D-rhamnose, estimated ITC Kd=5~10mM|T2LG16|PYOCIN L1|2.3|Kd~5mM|Kd|~|5|mM|5000000|nM
4NRO|2.30|2014|AKG|Mn2+ containing;ligand is alpha-ketoglutarate|Q6P6C2|RNA DEMETHYLASE ALKBH5|5.02|Kd~9.6uM|Kd|~|9.6|uM|9600|nM
4MAN|2.07|2014|1Y1|ligand is ABT-199|P10415|APOPTOSIS REGULATOR BCL-2|11.0|Ki<0.01nM|Ki|<|0.01|nM|0.01|nM
4NUD|1.20|2014|NUD|ligand is compound 27(MS436)|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|7.07|Ki<0.0845uM|Ki|<|0.0845|uM|84.5|nM
4CMT|1.73|2014|GWH|ligand is compound 6i|Q9UM73|ALK TYROSINE KINASE RECEPTOR|9.7|Ki<0.2nM|Ki|<|0.2|nM|0.2|nM
4CMU|1.80|2014|IV7|ligand is compound 8a|Q9UM73|ALK TYROSINE KINASE RECEPTOR|9.7|Ki<0.2nM|Ki|<|0.2|nM|0.2|nM
4KZ5|1.35|2014|1U3|ligand is fragment compound 5|P00811|BETA-LACTAMASE|2.0|Ki<10mM|Ki|<|10|mM|10000000|nM
4OKP|1.37|2014|2V0|ligand is compound 46|P00811|BETA-LACTAMASE|2.7|Ki<2mM|Ki|<|2|mM|2000000|nM
4L2L|1.65|2014|1V6|ligand is compound 4 (ARM1)|P09960|LEUKOTRIENE A-4 HYDROLASE|5.7|Ki=0.002mM|Ki|=|0.002|mM|2000|nM
4CWR|2.00|2014|HAJ|ligand is compound 7o|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|8.3|Ki=0.005uM|Ki|=|0.005|uM|5|nM
4CWS|2.30|2014|G3R|ligand is compound 12b|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|7.92|Ki=0.012uM|Ki|=|0.012|uM|12|nM
4LV2|1.65|2014|N95|ligand is compound 7|P00811|BETA-LACTAMASE|8.0|Ki=0.01uM|Ki|=|0.01|uM|10|nM
4QBB|1.60|2014|E69|ligand is E64-R-P-NH2; Ki=0.03+/-0.002uM|P03305|LEADER PROTEASE|7.52|Ki=0.03uM|Ki|=|0.03|uM|30|nM
4R6T|2.60|2014|R5T|ligand is compound 7|Q8IL11|M17 LEUCYL AMINOPEPTIDASE|7.52|Ki=0.03uM|Ki|=|0.03|uM|30|nM
4NGM|1.84|2014|JB7|ligand is compound 22a|Q04609|GLUTAMATE CARBOXYPEPTIDASE 2|10.35|Ki=0.0449nM|Ki|=|0.0449|nM|0.0449|nM
4JYT|2.00|2014|N4A|ligand is compound 10, Ki=0.04uM|Q9Y5Y6|SUPPRESSOR OF TUMORIGENICITY 14|7.4|Ki=0.04uM|Ki|=|0.04|uM|40|nM
4JZI|2.00|2014|N4C|ligand is compound 24|Q9Y5Y6|SUPPRESSOR OF TUMORIGENICITY 14|7.4|Ki=0.04uM|Ki|=|0.04|uM|40|nM
4LEN|1.50|2014|2GK|ligand is compound 5|Q9L5C8|BETA-LACTAMASE|7.4|Ki=0.04uM|Ki|=|0.04|uM|40|nM
4LV1|1.74|2014|NL9|ligand is compound 3|P00811|BETA-LACTAMASE|7.4|Ki=0.04uM|Ki|=|0.04|uM|40|nM
4M8X|2.05|2014|KGQ|ligand is GS-8374, with PR2|Q90JJ9|PROTEASE RETROPEPSIN|10.2|Ki=0.063nM|Ki|=|0.063|nM|0.063|nM
4KZ4|1.42|2014|4A1|ligand is fragment compound 60|P00811|BETA-LACTAMASE|4.15|Ki=0.07mM|Ki|=|0.07|mM|70000|nM
4CWQ|2.00|2014|W2D|ligand is compound 7n|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|7.06|Ki=0.088uM|Ki|=|0.088|uM|88|nM
4TYO|1.75|2014|39X|ligand is compound 7|Q13526|PEPTIDYL-PROLYL CIS-TRANS ISOMERASE NIMA-INTERACTIN|7.1|Ki=0.08uM|Ki|=|0.08|uM|80|nM
4M8Y|2.22|2014|KGQ|ligand is GS-8374, with PR1|Q90JJ9|PROTEASE RETROPEPSIN|9.96|Ki=0.11nM|Ki|=|0.11|nM|0.11|nM
4MHZ|1.95|2014|PBD|Apo-ls-QC-PBD150, without Zn2+|B7QK46|GLUTAMINYL CYCLASE, PUTATIVE|6.87|Ki=0.134uM|Ki|=|0.134|uM|134|nM
4NUE|1.30|2014|NUE|ligand is compound 28(MS267)|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|6.82|Ki=0.15uM|Ki|=|0.15|uM|150|nM
4QY3|1.50|2014|3G1|ligand is compound 3|P00918|CARBONIC ANHYDRASE 2|6.82|Ki=0.15uM|Ki|=|0.15|uM|150|nM
4WKV|2.14|2014|3QK|ligand is C8-B(OH)2; B-containing; Ki=1.61+/-0.03x10-7M|Q9I194|ACYL-HOMOSERINE LACTONE ACYLASE PVDQ|6.79|Ki=0.161uM|Ki|=|0.161|uM|161|nM
4CWP|1.95|2014|TV2|ligand is compound 7l|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|6.77|Ki=0.170uM|Ki|=|0.17|uM|170|nM
4CWT|1.90|2014|IK9|ligand is compound 18a|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|6.75|Ki=0.179uM|Ki|=|0.179|uM|179|nM
4PPB|2.82|2014|2VV|ligand is compound 28|Q08881|TYROSINE-PROTEIN KINASE ITK/TSK|10.0|Ki=0.1nM|Ki|=|0.1|nM|0.1|nM
4NA7|2.80|2014|1T5|ligand is compound 1|P03951|COAGULATION FACTOR XI|9.7|Ki=0.20nM|Ki|=|0.2|nM|0.2|nM
4OS2|1.79|2014|14-mer|bicyclic peptide UK602 (bicyclic 1); Ki=0.20+/-0.01uM|P00749|UROKINASE-TYPE PLASMINOGEN ACTIVATOR|6.7|Ki=0.20uM|Ki|=|0.2|uM|200|nM
3ZJ6|2.40|2014|VM2|ligand is compound 1|Q9SPP9|RAUCAFFRICINE-O-BETA-D-GLUCOSIDASE|6.66|Ki=0.22uM|Ki|=|0.22|uM|220|nM
4JIT|2.80|2014|3ZF|ligand is compound 2|H0Q6L9|XANTHINE PHOSPHORIBOSYLTRANSFERASE|6.64|Ki=0.23uM|Ki|=|0.23|uM|230|nM
4LSJ|2.35|2014|LSJ|ligand is compound 10|P04150|GLUCOCORTICOID RECEPTOR|9.57|Ki=0.268nM|Ki|=|0.268|nM|0.268|nM
4CD6|1.64|2014|2-mer|ligand is compound 3, ManIFG|A5H1I6|ENDO-BETA-1,4-MANNANASE|3.59|Ki=0.26mM|Ki|=|0.26|mM|260000|nM
4MC6|1.31|2014|23K|ligand is compound 48|P0C6F2|HIV-1 PROTEASE|9.59|Ki=0.26nM|Ki|=|0.26|nM|0.26|nM
4KZA|1.60|2014|NZ9|ligand is fragment compound 48|P00811|BETA-LACTAMASE|3.7|Ki=0.2mM|Ki|=|0.2|mM|200000|nM
4CD0|2.23|2014|AWJ||Q9UM73|ALK TYROSINE KINASE RECEPTOR|9.7|Ki=0.2nM|Ki|=|0.2|nM|0.2|nM
4JZ1|1.90|2014|F4D|ligand is compound 8|Q9Y5Y6|SUPPRESSOR OF TUMORIGENICITY 14|6.7|Ki=0.2uM|Ki|=|0.2|uM|200|nM
3WMC|2.10|2014|NF6|ligand is naphthalimide derivative Q2|Q06GJ0|N-ACETYLGLUCOSAMINIDASE|6.51|Ki=0.31uM|Ki|=|0.31|uM|310|nM
4MHY|1.38|2014|PBD|Zn-ls-QC-PBD150, with Zn2+|B7QK46|GLUTAMINYL CYCLASE, PUTATIVE|6.47|Ki=0.342uM|Ki|=|0.342|uM|342|nM
4MC9|1.19|2014|23L|ligand is compound 47|P0C6F2|HIV-1 PROTEASE|9.44|Ki=0.36nM|Ki|=|0.36|nM|0.36|nM
4OS6|1.75|2014|14-mer|bicyclic peptide UK604 (bicyclic 2); Ki=0.36+/-0.03uM|P00749|UROKINASE-TYPE PLASMINOGEN ACTIVATOR|6.44|Ki=0.36uM|Ki|=|0.36|uM|360|nM
4TY7|2.09|2014|39F|ligand is compound 16b|P03951|COAGULATION FACTOR XI|9.52|Ki=0.3nM|Ki|=|0.3|nM|0.3|nM
4LHM|1.52|2014|AZZ|Ki measured at 0.8mM AZT concentration|P07650|THYMIDINE PHOSPHORYLASE|3.39|Ki=0.41mM|Ki|=|0.41|mM|410000|nM
4J3U|1.70|2014|9-mer|ligand is G2S beta CD, combined with SGD and GLC|Q9FYY0|LIMIT DEXTRINASE|6.34|Ki=0.46uM|Ki|=|0.46|uM|460|nM
4WKT|1.78|2014|BUB|ligand is C4-B(OH)2; B-containing; Ki=5.5+/-0.9x10-4M|Q9I194|ACYL-HOMOSERINE LACTONE ACYLASE PVDQ|3.26|Ki=0.55mM|Ki|=|0.55|mM|550000|nM
4QGE|2.00|2014|35O|ligand is compound 3r|K7AGW3|PHOSPHODIESTERASE 9A|9.3|Ki=0.5nM|Ki|=|0.5|nM|0.5|nM
4OB2|1.52|2014|BUB|PtNHase-BuBA soaking; Ki=0.5+/-0.1uM|Q7SID2|COBALT-CONTAINING NITRILE HYDRATASE SUBUNIT ALPHA|6.3|Ki=0.5uM|Ki|=|0.5|uM|500|nM
4OB1|1.63|2014|BUB|ligand is BuBA; Ki=0.5+/-0.1uM|Q7SID2|COBALT-CONTAINING NITRILE HYDRATASE SUBUNIT ALPHA|6.3|Ki=0.5uM|Ki|=|0.5|uM|500|nM
4R8Y|1.90|2014|3KO|ligand is compound 38|P56817|BETA-SECRETASE 1|6.19|Ki=0.64uM|Ki|=|0.64|uM|640|nM
4MLX|1.65|2014|TM7|ligand is compound ATM|P00918|CARBONIC ANHYDRASE 2|3.19|Ki=0.65mM|Ki|=|0.65|mM|650000|nM
4OCZ|2.94|2014|2RU|ligand is inhibitor 4; Ki=0.66+/-0.10nM|P34913|EPOXIDE HYDROLASE 2|9.18|Ki=0.66nM|Ki|=|0.66|nM|0.66|nM
4MSE|2.81|2014|2ZU|ligand is compound ZT1597|Q9Y233|CGMP 3',5'-CYCLIC PHOSPHODIESTERASE|6.16|Ki=0.69uM|Ki|=|0.69|uM|690|nM
4O04|1.82|2014|2Q8|ligand is compound 8; Ki=0.58+/-0.13uM|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|6.16|Ki=0.69uM|Ki|=|0.69|uM|690|nM
4CLJ|1.66|2014|5P8|ligand is compound 8k|Q9UM73|ALK TYROSINE KINASE RECEPTOR|9.15|Ki=0.70nM|Ki|=|0.7|nM|0.7|nM
4N1Z|2.35|2014|N1Z|ligand is BPH-1222|P14324|FARNESYL PYROPHOSPHATE SYNTHASE|9.14|Ki=0.72nM|Ki|=|0.72|nM|0.72|nM
4P6W|1.95|2014|MOF|ligand is MOF|P04150|GLUCOCORTICOID RECEPTOR|9.15|Ki=0.7nM|Ki|=|0.7|nM|0.7|nM
4PQN|1.71|2014|2W6|ligand is compound 28(GNE-9822)|Q08881|TYROSINE-PROTEIN KINASE ITK/TSK|9.15|Ki=0.7nM|Ki|=|0.7|nM|0.7|nM
4R5V|2.10|2014|R5V|ligand is compound 13d|O96935|M1 FAMILY AMINOPEPTIDASE|6.15|Ki=0.7uM|Ki|=|0.7|uM|700|nM
4O3B|1.91|2014|GLU|7.5 mM L-Asp; L-Glu being present in one subunit, and neither L-Asp nor L-Glu being present in the other subunit|P19491|GLUTAMATE RECEPTOR 2|6.09|Ki=0.82uM|Ki|=|0.82|uM|820|nM
4CMO|1.83|2014|YPW|ligand is compound 6h|Q9UM73|ALK TYROSINE KINASE RECEPTOR|9.07|Ki=0.85nM|Ki|=|0.85|nM|0.85|nM
4KZ6|1.68|2014|ZB6|ligand is fragment compound 13|P00811|BETA-LACTAMASE|3.1|Ki=0.8mM|Ki|=|0.8|mM|800000|nM
4PPA|2.67|2014|2VU|ligand is compound 11|Q08881|TYROSINE-PROTEIN KINASE ITK/TSK|9.1|Ki=0.8nM|Ki|=|0.8|nM|0.8|nM
4L19|1.66|2014|1UA|ligand is compound 2 (Q1)|P45452|COLLAGENASE 3 (MMP-13)|6.1|Ki=0.8uM|Ki|=|0.8|uM|800|nM
4R5T|1.98|2014|R5T|ligand is compound 7|O96935|M1 FAMILY AMINOPEPTIDASE|6.1|Ki=0.8uM|Ki|=|0.8|uM|800|nM
4OD0|2.92|2014|2RV|ligand is inhibitor 18; Ki=0.91+/-0.13nM|P34913|EPOXIDE HYDROLASE 2|9.04|Ki=0.91nM|Ki|=|0.91|nM|0.91|nM
4NUC|1.40|2014|435|ligand is compound 4(MS435)|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|6.04|Ki=0.91uM|Ki|=|0.91|uM|910|nM
4PPC|2.95|2014|2VW|ligand is compound 27|Q08881|TYROSINE-PROTEIN KINASE ITK/TSK|9.03|Ki=0.93nM|Ki|=|0.93|nM|0.93|nM
4R3W|1.91|2014|A2P|2,5-ADP; Ki=1.0+/-0.08mM|A5MTN0|ASPARTATE-SEMIALDEHYDE DEHYDROGENASE|3.0|Ki=1.0mM|Ki|=|1|mM|1000000|nM
4KWG|2.10|2014|2AK|ligand is compound 1, competitive Inhibition Data versus Varied Aldehyde|P05091|ALDEHYDE DEHYDROGENASE|6.0|Ki=1.0uM|Ki|=|1|uM|1000|nM
4MSC|2.47|2014|2ZT|ligand is compound ZT1595|Q9Y233|CGMP 3',5'-CYCLIC PHOSPHODIESTERASE|5.96|Ki=1.1uM|Ki|=|1.1|uM|1100|nM
4LKT|2.57|2014|EIC||Q01469|FATTY ACID-BINDING PROTEIN|5.9|Ki=1.26uM|Ki|=|1.26|uM|1260|nM
4CD8|1.47|2014|2-mer|ligand is compound 4|A5H1I6|ENDO-BETA-1,4-MANNANASE|2.89|Ki=1.3mM|Ki|=|1.3|mM|1300000|nM
4KZB|1.37|2014|NZ2|ligand is fragment compound 50, R-S mixture, ligand name could be NZ2 or NZ3|P00811|BETA-LACTAMASE|2.89|Ki=1.3mM|Ki|=|1.3|mM|1300000|nM
4MLT|2.00|2014|TM4|ligand is compound TM|P00918|CARBONIC ANHYDRASE 2|2.85|Ki=1.4mM|Ki|=|1.4|mM|1400000|nM
4NA8|2.30|2014|1T6|ligand is compound 16|P03951|COAGULATION FACTOR XI|8.82|Ki=1.50nM|Ki|=|1.5|nM|1.5|nM
4OYT|2.40|2014|FON|(6R)-5FTHF|A5K8L9|SERINE HYDROXYMETHYLTRANSFERASE|2.81|Ki=1.55mM|Ki|=|1.55|mM|1550000|nM
4NGQ|2.08|2014|J37|ligand is compound 22b;Kd=1.570=+/-0.071nM|Q04609|GLUTAMATE CARBOXYPEPTIDASE 2|8.8|Ki=1.570nM|Ki|=|1.57|nM|1.57|nM
4P5D|2.11|2014|N6P|ligand is compound 1a; Ki=1.5+/-0.1uM|O35820|2'-DEOXYNUCLEOSIDE 5'-PHOSPHATE N-HYDROLASE 1|5.82|Ki=1.5uM|Ki|=|1.5|uM|1500|nM
4KZ8|2.28|2014|1U6|ligand is fragment compound 20|P00811|BETA-LACTAMASE|2.8|Ki=1.6mM|Ki|=|1.6|mM|1600000|nM
4MNW|1.49|2014|14-mer|ligand is bicyclic peptide TBMB(UK749)|P00749|UROKINASE-TYPE PLASMINOGEN ACTIVATOR CHAIN B|5.76|Ki=1.72uM|Ki|=|1.72|uM|1720|nM
4NWC|2.01|2014|2QE|ligand is compound 1; Ki=1.74+/-0.29uM|P42264|GLUTAMATE RECEPTOR, IONOTROPIC KAINATE 3|5.76|Ki=1.74uM|Ki|=|1.74|uM|1740|nM
4KZ3|1.67|2014|1U1|ligand is fragment compound 44|P00811|BETA-LACTAMASE|2.77|Ki=1.7mM|Ki|=|1.7|mM|1700000|nM
4MBF|1.54|2014|2AW|ligand is compound PSR-4-157, miss a ring bond in PDB website|P0AD64|BETA-LACTAMASE SHV-1|5.77|Ki=1.7uM|Ki|=|1.7|uM|1700|nM
4M6U|1.80|2014|TTN|tartronate was a competitive inhibitor of MR|P11444|MANDELATE RACEMASE|2.74|Ki=1.8mM|Ki|=|1.8|mM|1800000|nM
4O2B|2.30|2014|LOC|ligand is colchicine;Ki=1.8+/-0.15uM|P81947|TUBULIN ALPHA-1B CHAIN|5.74|Ki=1.8uM|Ki|=|1.8|uM|1800|nM
4MNY|1.70|2014|14-mer|ligand is bicyclic peptide TBAB(UK903)|P00749|UROKINASE-TYPE PLASMINOGEN ACTIVATOR CHAIN B|5.71|Ki=1.96uM|Ki|=|1.96|uM|1960|nM
4MQP|1.83|2014|2B1|ligand is compound 2, competitive reversible inhibitor of BioA with respect to SAM. But structure is different from that in PDB|P0A4X6|ADENOSYLMETHIONINE-8-AMINO-7-OXONONANOATE AMINOTRAN|4.98|Ki=10.4uM|Ki|=|10.4|uM|10400|nM
4NGP|1.63|2014|J31|ligand is compound 20(H)b;Kd=10.97+/-0.57nM|Q04609|GLUTAMATE CARBOXYPEPTIDASE 2|7.96|Ki=10.97nM|Ki|=|10.97|nM|10.97|nM
4OC4|1.66|2014|2QN|ligand is compound 4|Q04609|GLUTAMATE CARBOXYPEPTIDASE 2|6.98|Ki=105nM|Ki|=|105|nM|105|nM
4OWM|1.99|2014|3F0|substrate is compound 3FA|P66992|ANTHRANILATE PHOSPHORIBOSYLTRANSFERASE|2.96|Ki=1090uM|Ki|=|1090|uM|1090000|nM
4O9V|1.90|2014|NT4|ligand is compound 15|Q9Y5Y6|SUPPRESSOR OF TUMORIGENICITY 14|8.0|Ki=10nM|Ki|=|10|nM|10|nM
4CFT|1.79|2014|M48|ligand is compound 7|P29473|ENDOTHELIAL NITRIC OXIDE SYNTHASE|4.95|Ki=11.16uM|Ki|=|11.16|uM|11160|nM
4CIV|2.90|2014|48P|ligand is compound 5|P0A4Z6|3-DEHYDROQUINATE DEHYDRATASE|4.95|Ki=11.2uM|Ki|=|11.2|uM|11200|nM
4MNV|1.80|2014|14-mer|ligand is bicyclic peptide TBMB(UK729), 10+4=14 mer; incomplete ligand structure|P00749|UROKINASE-TYPE PLASMINOGEN ACTIVATOR CHAIN B|4.94|Ki=11.56uM|Ki|=|11.56|uM|11560|nM
4JOJ|1.20|2014|10-mer|ligand is peptide F-iCAL36 (ANSRFPTSII)|Q9HD26|GOLGI-ASSOCIATED PDZ AND COILED-COIL MOTIF-CONTAINI|3.96|Ki=110uM|Ki|=|110|uM|110000|nM
4QIR|1.70|2014|379|ligand is compound 11; Ki=112+/-16nM|Q9JYV4|AMINOPEPTIDASE N|6.95|Ki=112nM|Ki|=|112|nM|112|nM
4R59|1.65|2014|3J3|ligand is compound 5d|P00918|CARBONIC ANHYDRASE 2|7.96|Ki=11nM|Ki|=|11|nM|11|nM
4CD1|2.00|2014|8E9|ligand is compound PSB-071, data from ref (Baqi et al., 2009)|O35795|ECTONUCLEOSIDE TRIPHOSPHATE DIPHOSPHOHYDROLASE 2|4.89|Ki=12.8uM|Ki|=|12.8|uM|12800|nM
4LM3|1.49|2014|9ZE|ligand is compound ZT0464 (4)|Q9Y233|CGMP 3',5'-CYCLIC PHOSPHODIESTERASE|2.92|Ki=1200uM|Ki|=|1200|uM|1200000|nM
4QGI|1.90|2014|ROC|Saquinavir(SQV); Ki=125+/-15uM|P0C6F2|HIV-1 PROTEASE|3.9|Ki=125uM|Ki|=|125|uM|125000|nM
3ZJ8|3.01|2014|LR1|ligand is compound 3|Q8GU20|STRICTOSIDINE-O-BETA-D-GLUCOSIDASE|3.9|Ki=127uM|Ki|=|127|uM|127000|nM
4QUO|1.65|2014|3DZ|ligand is compound 35; Ki=12+/-7nM|E6MUM9|AMINOPEPTIDASE N|7.92|Ki=12nM|Ki|=|12|nM|12|nM
4OS4|2.00|2014|15-mer|bicyclic peptide UK603 (bicyclic 1); Ki=13.6+/-0.5uM|P00749|UROKINASE-TYPE PLASMINOGEN ACTIVATOR|4.87|Ki=13.6uM|Ki|=|13.6|uM|13600|nM
4LLX|1.75|2014|5ZE|ligand is compound ZT0434 (18)|Q9Y233|CGMP 3',5'-CYCLIC PHOSPHODIESTERASE|2.89|Ki=1300uM|Ki|=|1300|uM|1300000|nM
4N4S|2.20|2014|2H1|ligand is compound 3|P63086|MITOGEN-ACTIVATED PROTEIN KINASE 1|6.88|Ki=133nM|Ki|=|133|nM|133|nM
4K6Y|1.48|2014|10-mer|ligand is peptide iCAL36-Q (ANSRWQTSII)|Q9HD26|GOLGI-ASSOCIATED PDZ AND COILED-COIL MOTIF-CONTAINI|4.83|Ki=14.8uM|Ki|=|14.8|uM|14800|nM
3WQ5|1.80|2014|VPA|[Nonstandard assay: Temp 40,PH=4.0,Tris Hcl=10mM] ligand is PhPA|Q7X9A9|BETA-PRIMEVEROSIDASE|3.85|Ki=140uM|Ki|=|140|uM|140000|nM
4KIU|2.40|2014|KIU|ligand is compound 49d|P0A4Z6|3-DEHYDROQUINATE DEHYDRATASE|3.85|Ki=140uM|Ki|=|140|uM|140000|nM
4OZO|2.60|2014|OTN|ligand is oNPTG; Ki=147+/-59 uM|Q8A5P6|PUTATIVE LIPOPROTEIN|3.83|Ki=147uM|Ki|=|147|uM|147000|nM
4MC1|1.39|2014|526|ligand is compound 52|P0C6F2|HIV-1 PROTEASE|7.85|Ki=14nM|Ki|=|14|nM|14|nM
4O44|2.89|2014|2RS|ligand is compound 2; Ki=14+/-4nM|P03366|HIV-1 REVERSE TRANSCRIPTASE P66 SUBUNIT|7.85|Ki=14nM|Ki|=|14|nM|14|nM
4PCS|1.77|2014|2M7|ligand is compound 5|Q8A3I4|ALPHA-L-FUCOSIDASE|7.85|Ki=14nM|Ki|=|14|nM|14|nM
4R76|2.50|2014|R5X|ligand is compound 13l|Q8IL11|M17 LEUCYL AMINOPEPTIDASE|7.85|Ki=14nM|Ki|=|14|nM|14|nM
4R95|1.99|2014|3KW|ligand is compound 54|P56817|BETA-SECRETASE 1|7.85|Ki=14nM|Ki|=|14|nM|14|nM
4RAK|2.04|2014|652|ligand is compound 18|P55055|OXYSTEROLS RECEPTOR LXR-BETA|7.85|Ki=14nM|Ki|=|14|nM|14|nM
4CIW|2.20|2014|XH2|ligand is compound 6|P0A4Z6|3-DEHYDROQUINATE DEHYDRATASE|4.82|Ki=15.0uM|Ki|=|15|uM|15000|nM
4IH3|2.49|2014|PDC||Q8TDX5|2-AMINO-3-CARBOXYMUCONATE-6-SEMIALDEHYDE DECARBOXYL|4.82|Ki=15.2uM|Ki|=|15.2|uM|15200|nM
4KEQ|2.28|2014|5PN||Q988B9|4-PYRIDOXOLACTONASE|3.82|Ki=150uM|Ki|=|150|uM|150000|nM
4KWF|2.31|2014|3AK|ligand is compound 3, competitive Inhibition Data versus Varied Aldehyde|P05091|ALDEHYDE DEHYDROGENASE|4.82|Ki=15uM|Ki|=|15|uM|15000|nM
4K78|1.80|2014|10-mer|ligand is peptide iCAL36-QDTRL (ANSRWQDTRL)|Q9HD26|GOLGI-ASSOCIATED PDZ AND COILED-COIL MOTIF-CONTAINI|4.79|Ki=16.2uM|Ki|=|16.2|uM|16200|nM
4OMC|2.30|2014|5-mer|ligand is inhibitor I1: meta-guanidinomethyl- Phac-RVR-Amba; Ki=16.7+/-0.6pM|P09958|FURIN|10.78|Ki=16.7pM|Ki|=|16.7|pM|0.0167|nM
4R93|1.71|2014|779|ligand is compound 46|P56817|BETA-SECRETASE 1|7.8|Ki=16nM|Ki|=|16|nM|16|nM
4RJ4|2.78|2014|3QW|ligand is compound 6|P00533|EPIDERMAL GROWTH FACTOR RECEPTOR|7.8|Ki=16nM|Ki|=|16|nM|16|nM
4W9P|1.50|2014|3JR|ligand is (S)-19|Q13451|PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5|7.8|Ki=16nM|Ki|=|16|nM|16|nM
4LLP|1.75|2014|4ZE|ligand is compound ZT0401(NA)|Q9Y233|CGMP 3',5'-CYCLIC PHOSPHODIESTERASE|4.8|Ki=16uM|Ki|=|16|uM|16000|nM
4UUB|2.90|2014|9-mer|ligand is 2R-butyl- succinylated CPS1-peptide 5j; Ki=17.2+/-1.31uM|Q6DHI5|NAD-DEPENDENT PROTEIN DEACYLASE SIRTUIN-5|4.76|Ki=17.2uM|Ki|=|17.2|uM|17200|nM
4MNX|1.85|2014|14-mer|ligand is bicyclic peptide TATA(UK811)|P00749|UROKINASE-TYPE PLASMINOGEN ACTIVATOR CHAIN B|4.75|Ki=17.73uM|Ki|=|17.73|uM|17730|nM
4OBV|2.84|2014|2SU|ligand is alpha-FMT; Ki=178+/-73mM|A7B1V0|PYRIDOXAL-DEPENDENT DECARBOXYLASE DOMAIN PROTEIN|0.75|Ki=178mM|Ki|=|178|mM|178000000|nM
4CPX|1.85|2014|V78|ligand is compound 10e|P03366|HIV-1 PROTEASE|7.77|Ki=17nM|Ki|=|17|nM|17|nM
4NGA|2.15|2014|2KF|ligand is compound 7j|P08709|COAGULATION FACTOR VIIA (HEAVY CHAIN)|7.77|Ki=17nM|Ki|=|17|nM|17|nM
4RJ8|2.50|2014|3QS|ligand is compound 8|P00533|EPIDERMAL GROWTH FACTOR RECEPTOR|7.77|Ki=17nM|Ki|=|17|nM|17|nM
4W9O|1.27|2014|3JQ|ligand is (R)-19|Q13451|PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5|7.77|Ki=17nM|Ki|=|17|nM|17|nM
4R5B|1.50|2014|3J4|ligand is compound 5e|P00918|CARBONIC ANHYDRASE 2|6.73|Ki=185nM|Ki|=|185|nM|185|nM
4CAE|1.46|2014|3F3|ligand is compound 20b|A5K1A2|GLYCYLPEPTIDE N-TETRADECANOYLTRANSFERASE|7.74|Ki=18nM|Ki|=|18|nM|18|nM
4CPQ|2.35|2014|9MW|ligand is compound 9b|P03366|HIV-1 PROTEASE|7.74|Ki=18nM|Ki|=|18|nM|18|nM
4JXS|1.90|2014|18U|ligand is compound 4|P00811|BETA-LACTAMASE|4.74|Ki=18uM|Ki|=|18|uM|18000|nM
4JOG|1.47|2014|10-mer|ligand is peptide V-iCAL36 (ANSRVPTSII)|Q9HD26|GOLGI-ASSOCIATED PDZ AND COILED-COIL MOTIF-CONTAINI|3.72|Ki=190uM|Ki|=|190|uM|190000|nM
4CD5|1.10|2014|2-mer|ligand is compound 4|B3PGI1|ENDO-1,4-BETA MANNANASE, PUTATIVE, MAN26C|6.71|Ki=194nM|Ki|=|194|nM|194|nM
4JXW|2.30|2014|1MW|ligand is compound 6|P00811|BETA-LACTAMASE|4.72|Ki=19uM|Ki|=|19|uM|19000|nM
4C2V|1.49|2014|YJA||Q6DE08|AURORA KINASE B-A|9.0|Ki=1nM|Ki|=|1|nM|1|nM
4PS8|2.99|2014|2WK|ligand is compound 10|P48736|PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE|9.0|Ki=1nM|Ki|=|1|nM|1|nM
4Q1C|2.00|2014|2XM|ligand is compound 8; Ki=2.0+/-0.6nM|P27707|DEOXYCYTIDINE KINASE|8.7|Ki=2.0nM|Ki|=|2|nM|2|nM
4WKU|2.00|2014|3QJ|ligand is C6-B(OH)2; B-containing; Ki=2.1+/-0.4x10-6M|Q9I194|ACYL-HOMOSERINE LACTONE ACYLASE PVDQ|5.68|Ki=2.1uM|Ki|=|2.1|uM|2100|nM
4JLS|2.20|2014|3ZE|ligand is compound 8|H0Q6L9|XANTHINE PHOSPHORIBOSYLTRANSFERASE|5.66|Ki=2.2uM|Ki|=|2.2|uM|2200|nM
4BF1|1.35|2014|9FK|ligand is compound 10|P00918|CARBONIC ANHYDRASE 2|8.62|Ki=2.4nM|Ki|=|2.4|nM|2.4|nM
4O3A|1.80|2014|ASP|250 mM L-Asp; Ki= 2.57+/-0.13mM; redundant to 4o3c|P19491|GLUTAMATE RECEPTOR 2|2.59|Ki=2.57mM|Ki|=|2.57|mM|2570000|nM
4O3C|1.50|2014|ASP|50 mM L-Asp; Ki= 2.57+/-0.13mM|P19491|GLUTAMATE RECEPTOR 2|2.59|Ki=2.57mM|Ki|=|2.57|mM|2570000|nM
4OS1|2.20|2014|15-mer|bicyclic peptide UK601 (bicyclic 1); Ki=2.5+/-0.1uM|P00749|UROKINASE-TYPE PLASMINOGEN ACTIVATOR|5.6|Ki=2.5uM|Ki|=|2.5|uM|2500|nM
4TW8|3.00|2014|37M|ligand is iFit-FL; Ki=2611+/-340nM|Q02790|PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP4|5.58|Ki=2.611uM|Ki|=|2.611|uM|2611|nM
4CWN|1.80|2014|6LV|ligand is compound 7h|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|5.59|Ki=2.6uM|Ki|=|2.6|uM|2600|nM
4TPK|2.70|2014|3F9|ligand is compound (+)-1|P06276|CHOLINESTERASE|8.57|Ki=2.71nM|Ki|=|2.71|nM|2.71|nM
2YNE|1.72|2014|YNE|ligand is compound 2a|A5K1A2|GLYCYLPEPTIDE N-TETRADECANOYLTRANSFERASE|8.57|Ki=2.7nM|Ki|=|2.7|nM|2.7|nM
4P5E|1.35|2014|N6P|ligand is compound 1a; Ki=2.8+/-0.1uM|O43598|2'-DEOXYNUCLEOSIDE 5'-PHOSPHATE N-HYDROLASE 1|5.55|Ki=2.8uM|Ki|=|2.8|uM|2800|nM
4PQA|1.78|2014|X8Z|ZnZn(NmDapE)|Q9JYL2|SUCCINYL-DIAMINOPIMELATE DESUCCINYLASE|5.55|Ki=2.8uM|Ki|=|2.8|uM|2800|nM
4O0T|2.60|2014|2OL|ligand is compound 17|Q13153|SERINE/THREONINE-PROTEIN KINASE PAK 1|5.54|Ki=2.9uM|Ki|=|2.9|uM|2900|nM
4CPZ|2.20|2014|ZMR|ligand is Zanamivir|U5XBU0|NEURAMINIDASE|7.68|Ki=20.85nM|Ki|=|20.85|nM|20.85|nM
4OVG|1.90|2014|2VF|compound 2a|U6NCW5|DNA POLYMERASE III SUBUNIT BETA|3.69|Ki=204uM|Ki|=|204|uM|204000|nM
4CPT|1.70|2014|1T8|ligand is compound 10b|P03366|HIV-1 PROTEASE|7.7|Ki=20nM|Ki|=|20|nM|20|nM
4O09|1.96|2014|2R6|ligand is compound 30; Ki=0.020+/-0.004uM|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|7.7|Ki=20nM|Ki|=|20|nM|20|nM
4Q93|2.10|2014|STL|Resveratrol(RSV)|P54577|TYROSINE--TRNA LIGASE, CYTOPLASMIC|4.65|Ki=22.3uM|Ki|=|22.3|uM|22300|nM
4RJ7|2.55|2014|3R1|ligand is compound 1|P00533|EPIDERMAL GROWTH FACTOR RECEPTOR|7.66|Ki=22nM|Ki|=|22|nM|22|nM
4OS5|2.26|2014|15-mer|bicyclic peptide UK603 (bicyclic 2); Ki=23.7+/-0.6uM|P00749|UROKINASE-TYPE PLASMINOGEN ACTIVATOR|4.63|Ki=23.7uM|Ki|=|23.7|uM|23700|nM
4G95|1.35|2014|OAG|ligand is OAAG324|P00374|DIHYDROFOLATE REDUCTASE|7.61|Ki=24.4nM|Ki|=|24.4|nM|24.4|nM
4OS7|2.00|2014|15-mer|bicyclic peptide UK607 (bicyclic); Ki=24+/-2uM|P00749|UROKINASE-TYPE PLASMINOGEN ACTIVATOR|4.62|Ki=24uM|Ki|=|24|uM|24000|nM
4OC1|1.75|2014|2QS|ligand is compound 5|Q04609|GLUTAMATE CARBOXYPEPTIDASE 2|6.6|Ki=254nM|Ki|=|254|nM|254|nM
4P58|2.06|2014|2F6|ligand is compound 6|P22734|CATECHOL O-METHYLTRANSFERASE|4.6|Ki=25uM|Ki|=|25|uM|25000|nM
4CD4|1.20|2014|2-mer|ligand is compound 3|B3PGI1|ENDO-1,4-BETA MANNANASE, PUTATIVE, MAN26C|6.58|Ki=263nM|Ki|=|263|nM|263|nM
4TW7|1.25|2014|37K|ligand is iFit4; Ki=26+/-4nM|Q13451|PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5|7.59|Ki=26nM|Ki|=|26|nM|26|nM
3WQ6|1.80|2014|ZPA|[Nonstandard assay: Temp 40 ,PH=4.0,Tris Hcl 10 mM ] ligand is BsPA|Q7X9A9|BETA-PRIMEVEROSIDASE|4.59|Ki=26uM|Ki|=|26|uM|26000|nM
4CIY|2.10|2014|NDY|ligand is compound 8|P0A4Z6|3-DEHYDROQUINATE DEHYDRATASE|4.57|Ki=27.0uM|Ki|=|27|uM|27000|nM
4JOE|1.14|2014|10-mer|ligand is peptide A-iCAL36 (ANSRAPTSII)|Q9HD26|GOLGI-ASSOCIATED PDZ AND COILED-COIL MOTIF-CONTAINI|3.56|Ki=275uM|Ki|=|275|uM|275000|nM
4NGN|1.64|2014|J96|ligand in paper is compound 20a(Br), ligand in RCSB PDB is compound 9b (for code 4NGR in paper)|Q04609|GLUTAMATE CARBOXYPEPTIDASE 2|7.55|Ki=28.1nM|Ki|=|28.1|nM|28.1|nM
4NGR|1.90|2014|J21|ligand is compound 9b;Kd=28.1+/-1.5nM|Q04609|GLUTAMATE CARBOXYPEPTIDASE 2|7.55|Ki=28.1nM|Ki|=|28.1|nM|28.1|nM
4CPU|1.82|2014|V78|ligand is compound 10d|P03366|HIV-1 PROTEASE|7.53|Ki=29.5nM|Ki|=|29.5|nM|29.5|nM
4WKS|1.63|2014|3QD|ligand is C2-B(OH)2; B-containing; Ki=2+/-0.4x10-3M|Q9I194|ACYL-HOMOSERINE LACTONE ACYLASE PVDQ|2.7|Ki=2mM|Ki|=|2|mM|2000000|nM
4PS3|2.90|2014|2WH|ligand is compound 22|P48736|PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE|8.7|Ki=2nM|Ki|=|2|nM|2|nM
4R5A|1.64|2014|3J4|ligand is compound 5e|P00918|CARBONIC ANHYDRASE 2|8.7|Ki=2nM|Ki|=|2|nM|2|nM
4KZ7|1.43|2014|1U5|ligand is fragment compound 16|P00811|BETA-LACTAMASE|2.49|Ki=3.2mM|Ki|=|3.2|mM|3200000|nM
4LV3|1.42|2014|25N|ligand is compound 14|P00811|BETA-LACTAMASE|5.49|Ki=3.2uM|Ki|=|3.2|uM|3200|nM
4O0V|2.80|2014|2OL|ligand is compound 17; PAK4 Ser residue modified|O96013|SERINE/THREONINE-PROTEIN KINASE PAK 4|8.48|Ki=3.3nM|Ki|=|3.3|nM|3.3|nM
4K1E|1.30|2014|14-mer|ligand is modified peptide SFTI inhibitor FCQR|Q9Y5K2|KALLIKREIN-4|8.44|Ki=3.59nM|Ki|=|3.59|nM|3.59|nM
4MVN|1.70|2014|I1S|ligand is compound 31, incorrect structure, different from that in PDB|Q2FXC2|SERINE PROTEASE SPLA|5.46|Ki=3.5uM|Ki|=|3.5|uM|3500|nM
4NGT|2.31|2014|J42|ligand is compound 28b;Kd=3.88+/-0.35nM|Q04609|GLUTAMATE CARBOXYPEPTIDASE 2|8.41|Ki=3.88nM|Ki|=|3.88|nM|3.88|nM
4NWD|2.60|2014|2QD|ligand is compound 2; Ki=3.96+/-0.99uM|P42264|GLUTAMATE RECEPTOR, IONOTROPIC KAINATE 3|5.4|Ki=3.96uM|Ki|=|3.96|uM|3960|nM
4UMA|1.76|2014|GZ3|ligand is vinyl phosphonate 6; Ki=3.9+/-0.4uM|Q9K169|PHOSPHO-2-DEHYDRO-3-DEOXYHEPTONATE ALDOLASE|5.41|Ki=3.9uM|Ki|=|3.9|uM|3900|nM
4MRZ|1.58|2014|2ZV|ligand is compound ZT0429 (10)|Q9Y233|CGMP 3',5'-CYCLIC PHOSPHODIESTERASE|3.52|Ki=300uM|Ki|=|300|uM|300000|nM
4QME|1.60|2014|37B|ligand is compound (R,S)-1|Q9JYV4|AMINOPEPTIDASE N|6.52|Ki=302nM|Ki|=|302|nM|302|nM
4TY6|1.85|2014|39D|ligand is compound 11h|P03951|COAGULATION FACTOR XI|7.52|Ki=30nM|Ki|=|30|nM|30|nM
4CPW|1.70|2014|V78|ligand is compound 11d|P03366|HIV-1 PROTEASE|7.5|Ki=31.5nM|Ki|=|31.5|nM|31.5|nM
4N3W|1.90|2014|15-mer|ligand is Acetylated Histone 4 Peptide (H4K20ac)|Q92793|CREB-BINDING PROTEIN|3.5|Ki=315uM|Ki|=|315|uM|315000|nM
4OC0|1.85|2014|2R7|ligand is compound 3|Q04609|GLUTAMATE CARBOXYPEPTIDASE 2|6.5|Ki=318nM|Ki|=|318|nM|318|nM
4JXV|1.76|2014|1MU|ligand is compound 5|P00811|BETA-LACTAMASE|4.51|Ki=31uM|Ki|=|31|uM|31000|nM
4CWF|2.00|2014|H05|ligand is compound 3|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|4.49|Ki=32.4uM|Ki|=|32.4|uM|32400|nM
2YND|1.89|2014|646|ligand is compound 1a|A5K1A2|GLYCYLPEPTIDE N-TETRADECANOYLTRANSFERASE|7.49|Ki=32nM|Ki|=|32|nM|32|nM
4CU8|2.50|2014|DGJ|ligand is compound DGJ|I6L8R4|GLYCOSIDE HYDROLASE 2|4.47|Ki=33.9uM|Ki|=|33.9|uM|33900|nM
4Q2K|2.20|2014|5BF|ligand is compound 5b|P00766|CHYMOTRYPSINOGEN A|7.48|Ki=33nM|Ki|=|33|nM|33|nM
4CIX|2.90|2014|W4N|ligand is compound 7|P0A4Z6|3-DEHYDROQUINATE DEHYDRATASE|4.47|Ki=34.0uM|Ki|=|34|uM|34000|nM
4OWO|1.99|2014|6F0|substrate is compound 6FA|P66992|ANTHRANILATE PHOSPHORIBOSYLTRANSFERASE|4.47|Ki=34uM|Ki|=|34|uM|34000|nM
4KWO|1.32|2014|1UD|ligand is compound beta 6c|P28720|QUEUINE TRNA-RIBOSYLTRANSFERASE|6.45|Ki=353nM|Ki|=|353|nM|353|nM
4CPR|1.80|2014|378|ligand is compound 9e|P03366|HIV-1 PROTEASE|7.46|Ki=35nM|Ki|=|35|nM|35|nM
4UMC|2.34|2014|PEQ|ligand is (S)-phospholactate 8; Ki=360+/-30uM|Q9K169|PHOSPHO-2-DEHYDRO-3-DEOXYHEPTONATE ALDOLASE|3.44|Ki=360uM|Ki|=|360|uM|360000|nM
4O0R|2.40|2014|X4Z|ligand is compound 1|Q13153|SERINE/THREONINE-PROTEIN KINASE PAK 1|7.44|Ki=36nM|Ki|=|36|nM|36|nM
4NH9|2.77|2014|2LC|ligand is SNX0723|P14625|ENDOPLASMIN|6.43|Ki=375nM|Ki|=|375|nM|375|nM
4MI9|1.85|2014|26W|ligand is compound S20|P00489|GLYCOGEN PHOSPHORYLASE|3.42|Ki=376.87uM|Ki|=|376.87|uM|376870|nM
4O05|1.79|2014|2Q9|ligand is compound 23; Ki=0.037+/-0.017uM|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|7.43|Ki=37nM|Ki|=|37|nM|37|nM
4OU3|1.95|2014|6-mer|CNGRCG tumor-homing peptide|P15145|AMINOPEPTIDASE N|4.41|Ki=38.7uM|Ki|=|38.7|uM|38700|nM
4LLJ|1.56|2014|1XN|ligand is compound ZT0214 (11)|Q9Y233|CGMP 3',5'-CYCLIC PHOSPHODIESTERASE|3.42|Ki=380uM|Ki|=|380|uM|380000|nM
4N8Q|2.08|2014|FA0|substrate is compound 4FA|P66992|ANTHRANILATE PHOSPHORIBOSYLTRANSFERASE|3.42|Ki=380uM|Ki|=|380|uM|380000|nM
4P7S|2.87|2014|2OK|ligand is compound 2; Ki=38+/-9nM|Q6Q3H7|MACROPHAGE MIGRATION INHIBITORY FACTOR-LIKE PROTEIN|7.42|Ki=38nM|Ki|=|38|nM|38|nM
4P7M|3.02|2014|2OE|ligand is compound 1; Ki=39+/-8nM|Q6Q3H7|MACROPHAGE MIGRATION INHIBITORY FACTOR-LIKE PROTEIN|7.41|Ki=39nM|Ki|=|39|nM|39|nM
4PS7|2.69|2014|2WJ|ligand is compound 3|P48736|PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE|7.41|Ki=39nM|Ki|=|39|nM|39|nM
4R92|1.71|2014|3KU|ligand is compound 44|P56817|BETA-SECRETASE 1|7.41|Ki=39nM|Ki|=|39|nM|39|nM
4NH8|1.65|2014|2LC|ligand is SNX0723|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|8.52|Ki=3nM|Ki|=|3|nM|3|nM
4O97|2.20|2014|NTX|ligand is compound 43|Q9Y5Y6|SUPPRESSOR OF TUMORIGENICITY 14|8.52|Ki=3nM|Ki|=|3|nM|3|nM
4CNH|1.90|2014|3U9|ligand is compound 6b|Q9UM73|ALK TYROSINE KINASE RECEPTOR|8.4|Ki=4.0nM|Ki|=|4|nM|4|nM
3WMB|2.70|2014|NF1|ligand is naphthalimide derivative Q1|Q06GJ0|BETA-HEXOSAMINIDASE|5.37|Ki=4.28uM|Ki|=|4.28|uM|4280|nM
4V24|1.80|2014|GYR|ligand is PF-543 (compound 1)|Q9NYA1|SPHINGOSINE KINASE 1|8.37|Ki=4.3nM|Ki|=|4.3|nM|4.3|nM
4BF6|1.82|2014|X0Q|ligand is compound 13|P00918|CARBONIC ANHYDRASE 2|8.35|Ki=4.5nM|Ki|=|4.5|nM|4.5|nM
4K76|1.75|2014|10-mer|ligand is peptide iCAL36-TRL (ANSRWPTTRL)|Q9HD26|GOLGI-ASSOCIATED PDZ AND COILED-COIL MOTIF-CONTAINI|5.35|Ki=4.5uM|Ki|=|4.5|uM|4500|nM
4PEE|1.95|2014|2OX|ligand is compound 4|Q8A3I4|ALPHA-L-FUCOSIDASE|8.32|Ki=4.8nM|Ki|=|4.8|nM|4.8|nM
4MIC|2.45|2014|26Y|ligand is compound S6|P00489|GLYCOGEN PHOSPHORYLASE|5.3|Ki=4.98uM|Ki|=|4.98|uM|4980|nM
4MS0|1.79|2014|2ZX|ligand is compound ZT0443 (5)|Q9Y233|CGMP 3',5'-CYCLIC PHOSPHODIESTERASE|3.39|Ki=410uM|Ki|=|410|uM|410000|nM
4NA9|2.24|2014|1T7|ligand is compound 29, Ki for Factor VIIa is 41nM|P08709|COAGULATION FACTOR VII|7.39|Ki=41nM|Ki|=|41|nM|41|nM
4O07|1.86|2014|FGH|ligand is compound 28; Ki=0.042+/-0.012uM|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|7.38|Ki=42nM|Ki|=|42|nM|42|nM
4NTJ|2.62|2014|AZJ|ligand is ADZ1283; P2Y12R D294 mutant+ BRIL; Ki= 43.9+/-10.0nM|Q9H244|P2Y PURINOCEPTOR 12, SOLUBLE CYTOCHROME B562|7.36|Ki=43.9nM|Ki|=|43.9|nM|43.9|nM
4PP9|2.58|2014|2VT|ligand is compound 1|Q08881|TYROSINE-PROTEIN KINASE ITK/TSK|7.37|Ki=43nM|Ki|=|43|nM|43|nM
4JOH|1.47|2014|10-mer|ligand is peptide H-iCAL36 (ANSRHPTSII)|Q9HD26|GOLGI-ASSOCIATED PDZ AND COILED-COIL MOTIF-CONTAINI|3.35|Ki=450uM|Ki|=|450|uM|450000|nM
4LKQ|1.62|2014|1XM|ligand is compound ZT0017 (1)|Q9Y233|CGMP 3',5'-CYCLIC PHOSPHODIESTERASE|3.35|Ki=450uM|Ki|=|450|uM|450000|nM
4OWV|1.90|2014|BE2|ligand is anthranilate|P66992|ANTHRANILATE PHOSPHORIBOSYLTRANSFERASE|4.35|Ki=45uM|Ki|=|45|uM|45000|nM
4MI6|1.90|2014|26V|ligand is compound S2|P00489|GLYCOGEN PHOSPHORYLASE|4.31|Ki=48.68uM|Ki|=|48.68|uM|48680|nM
4CPY|1.80|2014|G39|ligand is Oseltamivir|U5XBU0|NEURAMINIDASE|6.31|Ki=491.35nM|Ki|=|491.35|nM|491.35|nM
4NH7|2.00|2014|E0G|ligand is SNX2112|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|8.4|Ki=4nM|Ki|=|4|nM|4|nM
4UAL|1.71|2014|3FV|ligand is BDP5290|Q9Y5S2|SERINE/THREONINE-PROTEIN KINASE MRCK BETA|8.4|Ki=4nM|Ki|=|4|nM|4|nM
4OB0|1.20|2014|PBC|ligand is PBA; Ki=5.0+/-0.9uM|Q7SID2|COBALT-CONTAINING NITRILE HYDRATASE SUBUNIT ALPHA|5.3|Ki=5.0uM|Ki|=|5|uM|5000|nM
4MHS|2.00|2014|26Q|ligand is compound S1|P00489|GLYCOGEN PHOSPHORYLASE|5.29|Ki=5.14uM|Ki|=|5.14|uM|5140|nM
4OC3|1.79|2014|2QP|ligand is compound 1|Q04609|GLUTAMATE CARBOXYPEPTIDASE 2|8.28|Ki=5.3nM|Ki|=|5.3|nM|5.3|nM
4OC2|1.65|2014|2QQ|ligand is compound 6|Q04609|GLUTAMATE CARBOXYPEPTIDASE 2|8.28|Ki=5.3nM|Ki|=|5.3|nM|5.3|nM
4CPS|1.55|2014|1T8|ligand is compound 10a|P03366|HIV-1 PROTEASE|8.27|Ki=5.4nM|Ki|=|5.4|nM|5.4|nM
4R5X|1.85|2014|R5X|ligand is compound 13l|O96935|M1 FAMILY AMINOPEPTIDASE|5.26|Ki=5.5uM|Ki|=|5.5|uM|5500|nM
4U8W|1.30|2014|G10|ligand is inhibitor 4|P03366|HIV-1 PROTEASE|11.24|Ki=5.8pM|Ki|=|5.8|pM|0.0058|nM
4MSA|1.62|2014|2ZM|ligand is compound ZT0449 (6)|Q9Y233|CGMP 3',5'-CYCLIC PHOSPHODIESTERASE|3.3|Ki=500uM|Ki|=|500|uM|500000|nM
4MRW|1.96|2014|MRW|ligand is compound ZT0120 (b) (3)|Q9Y233|CGMP 3',5'-CYCLIC PHOSPHODIESTERASE|3.3|Ki=500uM|Ki|=|500|uM|500000|nM
4KIJ|2.80|2014|KIJ|ligand is compound 35c|P0A4Z6|3-DEHYDROQUINATE DEHYDRATASE|4.3|Ki=50uM|Ki|=|50|uM|50000|nM
4NQ6|1.80|2014|3R9|Ki = 53 +/- 5 uM|P04190|BETA-LACTAMASE 2|4.28|Ki=53uM|Ki|=|53|uM|53000|nM
4ITP|1.70|2014|1GD||P00918|CARBONIC ANHYDRASE 2|7.27|Ki=54nM|Ki|=|54|nM|54|nM
4K75|1.50|2014|10-mer|ligand is peptide iCAL36-QDTRL (ANSRWQDTRL)|Q9HD26|GOLGI-ASSOCIATED PDZ AND COILED-COIL MOTIF-CONTAINI|4.25|Ki=56.2uM|Ki|=|56.2|uM|56200|nM
4LM0|1.66|2014|5NI|ligand is compound ZT0448 (c)(8)|Q9Y233|CGMP 3',5'-CYCLIC PHOSPHODIESTERASE|3.25|Ki=560uM|Ki|=|560|uM|560000|nM
4OAK|2.00|2014|2-mer|ligand is D-Alanine-D-Alanine|Q9JN36|D,D-DIPEPTIDASE/D,D-CARBOXYPEPTIDASE|4.22|Ki=59.7uM|Ki|=|59.7|uM|59700|nM
4LM1|1.60|2014|7ZE|ligand is compound ZT0450 (19)|Q9Y233|CGMP 3',5'-CYCLIC PHOSPHODIESTERASE|3.23|Ki=590uM|Ki|=|590|uM|590000|nM
4O0B|1.93|2014|2QA|ligand is compound 31; Ki=0.005+/-0.002uM|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|8.3|Ki=5nM|Ki|=|5|nM|5|nM
4CWO|2.31|2014|T62|ligand is compound 8b|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|5.21|Ki=6.1uM|Ki|=|6.1|uM|6100|nM
4M0R|1.96|2014|644|ligand is compound 38|P66992|ANTHRANILATE PHOSPHORIBOSYLTRANSFERASE|5.21|Ki=6.2uM|Ki|=|6.2|uM|6200|nM
4MC2|1.56|2014|525|ligand is compound 50|P0C6F2|HIV-1 PROTEASE|8.19|Ki=6.4nM|Ki|=|6.4|nM|6.4|nM
4Q1E|1.85|2014|2Y7/2Y8|ligand is compound 10; Ki=6.8+/-1.6nM; R,S|P27707|DEOXYCYTIDINE KINASE|8.17|Ki=6.8nM|Ki|=|6.8|nM|6.8|nM
4O0Y|2.20|2014|2OO|ligand is compound 13; PAK4 Ser residue modified|O96013|SERINE/THREONINE-PROTEIN KINASE PAK 4|7.22|Ki=60nM|Ki|=|60|nM|60|nM
4OWN|2.11|2014|5RG|substrate is compound 5FA|P66992|ANTHRANILATE PHOSPHORIBOSYLTRANSFERASE|4.22|Ki=60uM|Ki|=|60|uM|60000|nM
4TW6|1.40|2014|37L|ligand is iFit|Q13451|PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5|4.21|Ki=61uM|Ki|=|61|uM|61000|nM
4RJ5|3.10|2014|3QY|ligand is compound 5|P00533|EPIDERMAL GROWTH FACTOR RECEPTOR|7.18|Ki=66nM|Ki|=|66|nM|66|nM
4O0X|2.48|2014|2OQ|ligand is compound 8; PAK4 Ser residue modified|O96013|SERINE/THREONINE-PROTEIN KINASE PAK 4|7.17|Ki=68nM|Ki|=|68|nM|68|nM
4JOF|1.20|2014|10-mer|ligand is peptide L-iCAL36 (ANSRLPTSII)|Q9HD26|GOLGI-ASSOCIATED PDZ AND COILED-COIL MOTIF-CONTAINI|4.17|Ki=68uM|Ki|=|68|uM|68000|nM
4OMA|1.60|2014|LCS|ligand is L-cycloserine; Ki=0.068+/-0.07mM|R1FPL7|METHIONINE GAMMA-LYASE|4.17|Ki=68uM|Ki|=|68|uM|68000|nM
4KUP|1.31|2014|1TZ|ligand is compound (S)-H4-A4, prepare crystal with 20mM acylhydrazone inhibitor|P11838|ENDOTHIAPEPSIN|5.22|Ki=6uM|Ki|=|6|uM|6000|nM
4KIW|2.57|2014|KIW|ligand is compound 49e|P0A4Z6|3-DEHYDROQUINATE DEHYDRATASE|5.12|Ki=7.5uM|Ki|=|7.5|uM|7500|nM
4NGS|1.68|2014|J34|ligand is compound 13b;Kd=7.6+/-1.2nM|Q04609|GLUTAMATE CARBOXYPEPTIDASE 2|8.12|Ki=7.6nM|Ki|=|7.6|nM|7.6|nM
4CP7|1.80|2014|9MW|ligand is compound 9a|P03366|HIV-1 PROTEASE|8.11|Ki=7.8nM|Ki|=|7.8|nM|7.8|nM
4PCT|2.10|2014|H76|ligand is compound 11|Q8A3I4|ALPHA-L-FUCOSIDASE|7.15|Ki=70nM|Ki|=|70|nM|70|nM
4PRJ|2.80|2014|2VU|ligand is compound 2|O14965|AURORA KINASE A|7.14|Ki=72nM|Ki|=|72|nM|72|nM
4Q18|2.00|2014|2XJ|ligand is compound 4; Ki=735+/-55nM|P27707|DEOXYCYTIDINE KINASE|6.13|Ki=735nM|Ki|=|735|nM|735|nM
4OVF|2.05|2014|2VG|compound 1e|U6NCW5|DNA POLYMERASE III SUBUNIT BETA|4.13|Ki=74uM|Ki|=|74|uM|74000|nM
4MI3|2.15|2014|26R|ligand is compound S21|P00489|GLYCOGEN PHOSPHORYLASE|4.12|Ki=75.29uM|Ki|=|75.29|uM|75290|nM
4BZS|2.10|2014|K26|ligand is compound 1, K-26. data is for N-domain|P12821|ANGIOTENSIN-CONVERTING ENZYME|7.12|Ki=75nM|Ki|=|75|nM|75|nM
4CAF|1.70|2014|370|ligand is compound 34a|A5K1A2|GLYCYLPEPTIDE N-TETRADECANOYLTRANSFERASE|7.12|Ki=75nM|Ki|=|75|nM|75|nM
4NG9|2.20|2014|2KE|ligand is compound 7d|P08709|COAGULATION FACTOR VIIA (HEAVY CHAIN)|7.12|Ki=75nM|Ki|=|75|nM|75|nM
4LOY|1.77|2014|6XS|ligand is Compound 15 (SAR107375)|P00734|THROMBIN HEAVY CHAIN|8.09|Ki=8.1nM|Ki|=|8.1|nM|8.1|nM
4MHO|2.00|2014|26M|ligand is compound S3|P00489|GLYCOGEN PHOSPHORYLASE|5.08|Ki=8.25uM|Ki|=|8.25|uM|8250|nM
4Q19|2.09|2014|2XL|ligand is compound 5; Ki=8.9+/-0.9nM|P27707|DEOXYCYTIDINE KINASE|8.05|Ki=8.9nM|Ki|=|8.9|nM|8.9|nM
4CQ0|1.45|2014|SXS|ligand is compound 5b, but structure is different from that in PDB|P00918|CARBONIC ANHYDRASE 2|5.09|Ki=8106nM|Ki|=|8106|nM|8106|nM
4JOK|1.09|2014|10-mer|ligand is peptide Y-iCAL36 (ANSRYPTSII)|Q9HD26|GOLGI-ASSOCIATED PDZ AND COILED-COIL MOTIF-CONTAINI|4.07|Ki=85.3uM|Ki|=|85.3|uM|85300|nM
4OC5|1.70|2014|2QM|ligand is compound 2|Q04609|GLUTAMATE CARBOXYPEPTIDASE 2|7.07|Ki=85nM|Ki|=|85|nM|85|nM
4QKX|3.30|2014|35V|ligand is compound 2; Ki=85+/-29nM|D9IEF7|BETA-2 ADRENERGIC RECEPTOR|7.07|Ki=85nM|Ki|=|85|nM|85|nM
4QHP|1.60|2014|32Q/32R|ligand is compound 36; Ki=9.0+/-3nM|Q9JYV4|AMINOPEPTIDASE N|8.05|Ki=9.0nM|Ki|=|9|nM|9|nM
4Q1F|2.10|2014|2XN|ligand is compound 12R; Ki=9.2+/-1.1nM|P27707|DEOXYCYTIDINE KINASE|8.04|Ki=9.2nM|Ki|=|9.2|nM|9.2|nM
4LM4|1.48|2014|JPZ|ligand is compound ZT0902 (25)|Q9Y233|CGMP 3',5'-CYCLIC PHOSPHODIESTERASE|3.04|Ki=910uM|Ki|=|910|uM|910000|nM
4P6X|2.50|2014|HCY|ligand is cortisol|P04150|GLUCOCORTICOID RECEPTOR|7.04|Ki=91nM|Ki|=|91|nM|91|nM
4LM2|1.55|2014|8ZE|ligand is compound ZT0462 (14)|Q9Y233|CGMP 3',5'-CYCLIC PHOSPHODIESTERASE|3.03|Ki=940uM|Ki|=|940|uM|940000|nM
4MSN|2.30|2014|2ZQ|ligand is compound ZT0451 (7)|Q9Y233|CGMP 3',5'-CYCLIC PHOSPHODIESTERASE|4.03|Ki=94uM|Ki|=|94|uM|94000|nM
4OMD|2.70|2014|5-mer|ligand is iInhbitor I2: Phac-RVR-Amba ; Ki=977+/-196pM|P09958|FURIN|9.01|Ki=977pM|Ki|=|977|pM|0.977|nM
4LLK|1.55|2014|MEW|ligand is compound ZT0217 (60)|Q9Y233|CGMP 3',5'-CYCLIC PHOSPHODIESTERASE|3.0|Ki=990uM|Ki|=|990|uM|990000|nM
4UMB|2.17|2014|0V5|ligand is (R)-phospholactate 7; Ki=99+/-16uM|Q9K169|PHOSPHO-2-DEHYDRO-3-DEOXYHEPTONATE ALDOLASE|4.0|Ki=99uM|Ki|=|99|uM|99000|nM
4O4G|2.71|2014|2RT|ligand is compound 1; Ki=9+/-2nM|P03366|HIV-1 REVERSE TRANSCRIPTASE P66 SUBUNIT|8.05|Ki=9nM|Ki|=|9|nM|9|nM
4K72|1.90|2014|10-mer|ligand is peptide iCAL36-VQD (ANSRVQDSII)|Q9HD26|GOLGI-ASSOCIATED PDZ AND COILED-COIL MOTIF-CONTAINI|3.0|Ki>1000uM|Ki|>|1000|uM|1000000|nM
4OLD|1.48|2014|2UZ|ligand is compound 45|P00811|BETA-LACTAMASE|2.7|Ki>2mM|Ki|>|2|mM|2000000|nM
4OUE|2.35|2014|IPT|ligand is IPTG|Q8A5P6|PUTATIVE LIPOPROTEIN|3.3|Ki>500uM|Ki|>|500|uM|500000|nM
4UAT|1.30|2014|XBP|ligand is XuBP; Crystal form I, 25% PEG-550MME, 0.1 M MES-NaOH pH 6.5; RsCbbY mutant D10N Mg2+ containing|P95649|PROTEIN CBBY|5.89|Ki~1.3uM|Ki|~|1.3|uM|1300|nM
4UAU|1.45|2014|XBP|Crystal form II, 25% PEG- 1000, 0.1 M MES-NaOH pH 6.5; RsCbbY mutant D10N|P95649|PROTEIN CBBY|5.89|Ki~1.3uM|Ki|~|1.3|uM|1300|nM
4TNW|3.20|2014|POV|ligand is POPS|G5EBR3|AVERMECTIN-SENSITIVE GLUTAMATE-GATED CHLORIDE CHANN|3.78|Ki~167uM|Ki|~|167|uM|167000|nM
4NZB|2.68|2014|NSE||P58154|ACETYLCHOLINE-BINDING PROTEIN|4.17|Ki~67uM|Ki|~|67|uM|67000|nM
4WX6|2.15|2015|3VK|[Covalent complex] compound 6|B9A5C1|PROTEASE|9.0|IC<0.001uM|IC50|<|0.001|uM|1|nM
5ALH|1.90|2015|4UA|compound 29|P34913|EPOXIDE HYDROLASE 2|7.07|IC<0.086uM|IC50|<|0.086|uM|86|nM
5AKL|2.00|2015|6N8|compound 20|P34913|EPOXIDE HYDROLASE 2|7.07|IC<0.086uM|IC50|<|0.086|uM|86|nM
5ALR|2.60|2015|8TM|compound 39|P34913|EPOXIDE HYDROLASE 2|7.07|IC<0.086uM|IC50|<|0.086|uM|86|nM
5ALI|1.85|2015|Q3B|compound 30|P34913|EPOXIDE HYDROLASE 2|7.07|IC<0.086uM|IC50|<|0.086|uM|86|nM
5ALP|2.06|2015|QYD|compound 37|P34913|EPOXIDE HYDROLASE 2|7.07|IC<0.086uM|IC50|<|0.086|uM|86|nM
5AKJ|2.03|2015|6N4|compound 18|P34913|EPOXIDE HYDROLASE 2|5.86|IC<1.37uM|IC50|<|1.37|uM|1370|nM
4YFF|3.07|2015|4CV|[Nonstandard assay: 20 mM Tris, 15 mM MgCl2] compound 53;|Q59H18|SERINE/THREONINE-PROTEIN KINASE TNNI3K|8.0|IC<10nM|IC50|<|10|nM|10|nM
5DL1|3.00|2015|5C2|ligand is compound AV145, IC50 value between 2-10uM|Q2YSF8|ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT|5.0|IC<10uM|IC50|<|10|uM|10000|nM
4WUY|1.63|2015|3UJ|[Nonstandard assay: p53(361-380) peptide as a substrate] LLY-507|Q9NRG4|N-LYSINE METHYLTRANSFERASE SMYD2|7.82|IC<15nM|IC50|<|15|nM|15|nM
4R1V|1.20|2015|3E8|compound 22|P08581|HEPATOCYTE GROWTH FACTOR RECEPTOR|9.0|IC<1nM|IC50|<|1|nM|1|nM
4WX4|1.03|2015|3VF|compound 3a|B9A5C1|PROTEASE|9.22|IC=0.0006uM|IC50|=|0.0006|uM|0.6|nM
5EW3|2.50|2015|5T2|ligand is compound AAL993, cellular assays, CHO cells|P35968|VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2|8.92|IC=0.0012uM|IC50|=|0.0012|uM|1.2|nM
5BVW|1.94|2015|1N1|ligand is compound dasatinib, 0.0015uM at 40% inhibition, not exact IC50 value|Q08345|EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1|8.82|IC=0.0015uM|IC50|=|0.0015|uM|1.5|nM
5BVN|2.21|2015|4VD|ligand is compound 4, 0.0015uM at 54% inhibition, not exact IC50 value|Q08345|EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1|8.82|IC=0.0015uM|IC50|=|0.0015|uM|1.5|nM
4UIB|1.94|2015|GWX|compound 3p|P09955|CARBOXYPEPTIDASE B|9.0|IC=0.001uM|IC50|=|0.001|uM|1|nM
4YS7|2.50|2015|4GK|[Nonstandard assay: Temp 37, 2.5mM Tris-HCl, 2mM MgCl2] compound 39|Q9Y233|CAMP AND CAMP-INHIBITED CGMP 3',5'-CYCLIC PHOSPHODIESTERASE|9.0|IC=0.001uM|IC50|=|0.001|uM|1|nM
5BPA|1.79|2015|4UF|ligand is compound 15|P45452|COLLAGENASE 3|9.0|IC=0.001uM|IC50|=|0.001|uM|1|nM
4UNR|1.98|2015|QZE|compound 23|F2GKC3|THYMIDYLATE KINASE|8.7|IC=0.002uM|IC50|=|0.002|uM|2|nM
4ZG7|1.75|2015|4O0|[Nonstandard assay: Temp 37] compound PAT-347; LPC substrate;|Q13822|ECTONUCLEOTIDE PYROPHOSPHATASE/PHOSPHODIESTERASE|8.7|IC=0.002uM|IC50|=|0.002|uM|2|nM
4U01|2.80|2015|39W|[Different protein in assay: full length 1b Con1 HCV NS3/4A protease] compound 16c|A6N4J4|NON-STRUCTURAL 3 PROTEASE|8.46|IC=0.0035uM|IC50|=|0.0035|uM|3.5|nM
3WV1|1.98|2015|WHH|[Nonstandard assay: Temp=37,50 mM Tris-HCl (pH 7.5), 10 mM CaCl2, 150 mM NaCl] compound 21k|P45452|COLLAGENASE 3|11.41|IC=0.0039nM|IC50|=|0.0039|nM|0.0039|nM
5AK2|2.19|2015|85Z|ligand is compound 24|P03372|ESTROGEN RECEPTOR|8.41|IC=0.0039uM|IC50|=|0.0039|uM|3.9|nM
4QMN|2.09|2015|DB8|ligand is Bosutinib|Q9Y6E0|SERINE/THREONINE-PROTEIN KINASE 24|8.52|IC=0.003uM|IC50|=|0.003|uM|3|nM
4YNE|2.02|2015|4EK|racemic 14 in assay, compound 14(R) in crystal;|P04629|HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR|8.52|IC=0.003uM|IC50|=|0.003|uM|3|nM
5AM1|2.15|2015|I5T|compound 49|P34913|EPOXIDE HYDROLASE 2|8.52|IC=0.003uM|IC50|=|0.003|uM|3|nM
5BUE|2.40|2015|4V8|ligand is compoud 10|P28482|MITOGEN-ACTIVATED PROTEIN KINASE 1|8.52|IC=0.003uM|IC50|=|0.003|uM|3|nM
4XV1|2.47|2015|904|PLX7904;|P15056|SERINE/THREONINE-PROTEIN KINASE B-RAF|8.38|IC=0.0042uM|IC50|=|0.0042|uM|4.2|nM
4QMY|1.88|2015|STU|ligand is Staurosporine|Q9Y6E0|SERINE/THREONINE-PROTEIN KINASE 24|8.4|IC=0.004uM|IC50|=|0.004|uM|4|nM
5A3T|1.90|2015|MMK|ligand is KDM5-C49|Q9UGL1|LYSINE-SPECIFIC DEMETHYLASE 5B|8.4|IC=0.004uM|IC50|=|0.004|uM|4|nM
5CS2|1.65|2015|7-mer|ligand is the cyclic peptide cyclomarinA (1)|Q8IL97|HISTIDINE TRIAD PROTEIN|8.4|IC=0.004uM|IC50|=|0.004|uM|4|nM
5D9K|2.55|2015|584|ligand is compound 25|P51812|RIBOSOMAL PROTEIN S6 KINASE ALPHA-3|8.4|IC=0.004uM|IC50|=|0.004|uM|4|nM
4XV2|2.50|2015|P06|ligand is dabrafenib;|P15056|SERINE/THREONINE-PROTEIN KINASE B-RAF|8.27|IC=0.0054uM|IC50|=|0.0054|uM|5.4|nM
5AM3|2.20|2015|AUB|compound 51|P34913|EPOXIDE HYDROLASE 2|8.3|IC=0.005uM|IC50|=|0.005|uM|5|nM
5BUJ|1.85|2015|4VB|ligand is compound 19|P28482|MITOGEN-ACTIVATED PROTEIN KINASE 1|8.3|IC=0.005uM|IC50|=|0.005|uM|5|nM
5BVO|1.98|2015|4VE|ligand is compound 9, 0.005uM at 59% inhibition, not exact IC50 value|Q08345|EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1|8.3|IC=0.005uM|IC50|=|0.005|uM|5|nM
4OTF|1.95|2015|2VL|compound 2, GDC0834|Q06187|TYROSINE-PROTEIN KINASE BTK|8.22|IC=0.006uM|IC50|=|0.006|uM|6|nM
4YL0|1.52|2015|4DZ|ligand is MF63;|O14684|PROSTAGLANDIN E SYNTHASE|8.22|IC=0.006uM|IC50|=|0.006|uM|6|nM
4YLJ|2.58|2015|4E1|[Nonstandard assay: Temp 30, ATP=15uM] compound 5j|Q13627|DUAL SPECIFICITY TYROSINE-PHOSPHORYLATION-REGULATED KINASE|8.22|IC=0.006uM|IC50|=|0.006|uM|6|nM
5ALZ|2.30|2015|XQ9|compound 47|P34913|EPOXIDE HYDROLASE 2|8.22|IC=0.006uM|IC50|=|0.006|uM|6|nM
4YL3|1.41|2015|4U9|compound 5;|O14684|PROSTAGLANDIN E SYNTHASE|8.15|IC=0.007uM|IC50|=|0.007|uM|7|nM
4RYG|2.65|2015|3ZJ|compound 54a|P00797|RENIN|8.1|IC=0.008uM|IC50|=|0.008|uM|8|nM
4ZYI|1.67|2015|4TH|compound 2|Q00987|E3 UBIQUITIN-PROTEIN LIGASE MDM2|8.1|IC=0.008uM|IC50|=|0.008|uM|8|nM
4YQH|2.31|2015|4F7|[Nonstandard assay: Temp 37, 2.5mM Tris-HCl, 2mM MgCl2] compound 14|Q9Y233|CAMP AND CAMP-INHIBITED CGMP 3',5'-CYCLIC PHOSPHODIESTERASE|8.05|IC=0.009uM|IC50|=|0.009|uM|9|nM
5BVE|2.00|2015|4VG|ligand is compound 11|P28482|MITOGEN-ACTIVATED PROTEIN KINASE 1|11.0|IC=0.010nM|IC50|=|0.01|nM|0.01|nM
4QMT|1.50|2015|H1N|ligand is Hesperadin|Q9Y6E0|SERINE/THREONINE-PROTEIN KINASE 24|8.0|IC=0.010uM|IC50|=|0.01|uM|10|nM
5AJX|2.58|2015|FD9|ligand is compound 67|Q16875|6-PHOSPHOFRUCTO-2-KINASE/FRUCTOSE-2,6-BISPHOSPHATAS|7.96|IC=0.011uM|IC50|=|0.011|uM|11|nM
4WT6|2.30|2015|3U6|compound 18|P11309|SERINE/THREONINE-PROTEIN KINASE PIM-1|7.92|IC=0.012uM|IC50|=|0.012|uM|12|nM
4XV3|2.80|2015|P02|ligand is PLX7922;|P15056|SERINE/THREONINE-PROTEIN KINASE B-RAF|7.92|IC=0.012uM|IC50|=|0.012|uM|12|nM
5D7R|1.55|2015|57Y|ligand is compound 28|P0A0K8|DNA GYRASE SUBUNIT B|7.89|IC=0.013uM|IC50|=|0.013|uM|13|nM
4QMP|2.00|2015|DKI|ligand is CDK1/2 Inhibitor III|Q9Y6E0|SERINE/THREONINE-PROTEIN KINASE 24|7.85|IC=0.014uM|IC50|=|0.014|uM|14|nM
4X9V|1.43|2015|6-mer|phosphopeptide macrocycle 3c|P53350|SERINE/THREONINE-PROTEIN KINASE PLK1|7.85|IC=0.014uM|IC50|=|0.014|uM|14|nM
4X9R|1.40|2015|6-mer|phosphopeptide macrocycle 3b|P53350|SERINE/THREONINE-PROTEIN KINASE PLK1|7.82|IC=0.015uM|IC50|=|0.015|uM|15|nM
4Z1Q|1.40|2015|558|[Nonstandard assay: NaCl=40mM] compound 3;|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|7.82|IC=0.015uM|IC50|=|0.015|uM|15|nM
5AKE|2.26|2015|6N0|compoud 14|P34913|EPOXIDE HYDROLASE 2|7.82|IC=0.015uM|IC50|=|0.015|uM|15|nM
5CTE|2.34|2015|57L|[Different protein in assay: rat ACC1 used in assay] ligand is compound 3.5.1, IC50 for rat ACC1|Q00955|ACETYL-COA CARBOXYLASE|7.8|IC=0.016uM|IC50|=|0.016|uM|16|nM
4WSY|2.30|2015|3U5|compound 1|P11309|SERINE/THREONINE-PROTEIN KINASE PIM-1|7.77|IC=0.017uM|IC50|=|0.017|uM|17|nM
4QMO|1.90|2015|34L|ligand is C16|Q9Y6E0|SERINE/THREONINE-PROTEIN KINASE 24|7.72|IC=0.019uM|IC50|=|0.019|uM|19|nM
5ALS|2.57|2015|5DQ|compound 40|P34913|EPOXIDE HYDROLASE 2|7.72|IC=0.019uM|IC50|=|0.019|uM|19|nM
4PRY|1.70|2015|5-mer|[Different ligand in assay: Ac-LETD-AOMK] ligand is unnatural peptide Ac-LETD-CHO|P42574|CASPASE-3|7.7|IC=0.020uM|IC50|=|0.02|uM|20|nM
5AK0|2.03|2015|8V1|ligand is compound 43|Q16875|6-PHOSPHOFRUCTO-2-KINASE/FRUCTOSE-2,6-BISPHOSPHATAS|7.68|IC=0.021uM|IC50|=|0.021|uM|21|nM
5ALU|1.87|2015|HD2|compound 42|P34913|EPOXIDE HYDROLASE 2|7.66|IC=0.022uM|IC50|=|0.022|uM|22|nM
5E1E|2.30|2015|5JG|ligand is compound 30|P23458|TYROSINE-PROTEIN KINASE JAK1|7.66|IC=0.022uM|IC50|=|0.022|uM|22|nM
4QMV|2.40|2015|34W|ligand is PF-03814735|Q9Y6E0|SERINE/THREONINE-PROTEIN KINASE 24|7.64|IC=0.023uM|IC50|=|0.023|uM|23|nM
4YK5|1.42|2015|4DV|compound 30;|O14684|PROSTAGLANDIN E SYNTHASE|7.64|IC=0.023uM|IC50|=|0.023|uM|23|nM
5D9L|2.15|2015|583|ligand is compound 1|P51812|RIBOSOMAL PROTEIN S6 KINASE ALPHA-3|7.62|IC=0.024uM|IC50|=|0.024|uM|24|nM
4ZG9|2.95|2015|4O2|[Nonstandard assay: Temp 37] compound PAT-352; LPC substrate;|Q13822|ECTONUCLEOTIDE PYROPHOSPHATASE/PHOSPHODIESTERASE|7.59|IC=0.026uM|IC50|=|0.026|uM|26|nM
5D11|2.30|2015|56G|ligand is compound 5b|P00523|TYROSINE-PROTEIN KINASE SRC|7.55|IC=0.028uM|IC50|=|0.028|uM|28|nM
4ZJR|2.70|2015|4P3|[Incomplete ligand] compound 48|P51449|NUCLEAR RECEPTOR ROR-GAMMA|7.54|IC=0.029uM|IC50|=|0.029|uM|29|nM
4D2S|2.50|2015|DYK|compound 23|P33981|DUAL SPECIFICITY PROTEIN KINASE TTK|7.7|IC=0.02uM|IC50|=|0.02|uM|20|nM
4ZGA|2.60|2015|4O3|[Nonstandard assay: Temp 37] compound PAT-494; LPC substrate;|Q13822|ECTONUCLEOTIDE PYROPHOSPHATASE/PHOSPHODIESTERASE|7.7|IC=0.02uM|IC50|=|0.02|uM|20|nM
5AAE|3.11|2015|7HD|compound 14d|O14965|AURORA KINASE A|7.46|IC=0.035uM|IC50|=|0.035|uM|35|nM
4Z2I|2.00|2015|M6B|compound 30|P11797|CHITINASE B|7.44|IC=0.036uM|IC50|=|0.036|uM|36|nM
5AAF|2.78|2015|NL4|compound 14a|O14965|AURORA KINASE A|7.44|IC=0.036uM|IC50|=|0.036|uM|36|nM
4QPA|2.85|2015|35W|compound 39; SAR IC50 data|P28482|MITOGEN-ACTIVATED PROTEIN KINASE 1|7.43|IC=0.037uM|IC50|=|0.037|uM|37|nM
5ALG|2.40|2015|R4N|compound 28|P34913|EPOXIDE HYDROLASE 2|7.52|IC=0.03uM|IC50|=|0.03|uM|30|nM
5D12|3.00|2015|G97|ligand is compound 1a|P00523|TYROSINE-PROTEIN KINASE SRC|7.37|IC=0.043uM|IC50|=|0.043|uM|43|nM
5AAG|2.85|2015|6F2|compound 14b|O14965|AURORA KINASE A|7.34|IC=0.046uM|IC50|=|0.046|uM|46|nM
4Q4I|2.31|2015|4-mer|ligand is Amastatin|P04825|AMINOPEPTIDASE N|7.33|IC=0.047uM|IC50|=|0.047|uM|47|nM
4RZ1|2.60|2015|3ZN|compound 24|P00797|RENIN|7.4|IC=0.04uM|IC50|=|0.04|uM|40|nM
4WX7|2.40|2015|3VJ|[Covalent complex] compound 2c|B9A5C1|PROTEASE|7.4|IC=0.04uM|IC50|=|0.04|uM|40|nM
5APJ|2.08|2015|76E|ligand is compound 15, IC50 is displacement of tritiated T0901317 from human RORg LBD|P51449|NUCLEAR RECEPTOR ROR-GAMMA|7.4|IC=0.04uM|IC50|=|0.04|uM|40|nM
4YV2|2.17|2015|4K3|[Covalent complex] [Incomplete ligand] fragment 6; open circle in RCSB; code is 4yu2 in paper|Q4DA73|SPERMIDINE SYNTHASE, PUTATIVE|7.29|IC=0.051uM|IC50|=|0.051|uM|51|nM
4ZPG|2.00|2015|4QF|compound 10;|P56817|BETA-SECRETASE 1|7.26|IC=0.055uM|IC50|=|0.055|uM|55|nM
4YBS|1.83|2015|4BK|compound 7g;|O15164|TRANSCRIPTION INTERMEDIARY FACTOR 1-ALPHA|7.24|IC=0.057uM|IC50|=|0.057|uM|57|nM
4ZUR|1.13|2015|7XA|[Nonstandard assay: pH=8.2, 25 mM Tris, 137 mM NaCl, 2.7 mM KCl, 1 mM MgCl2] compound 6;|Q48935|ACETYLPOLYAMINE AMINOHYDROLASE|7.17|IC=0.068uM|IC50|=|0.068|uM|68|nM
5AEP|1.95|2015|QUP|compound 15|O60674|TYROSINE-PROTEIN KINASE JAK2|7.17|IC=0.068uM|IC50|=|0.068|uM|68|nM
4Y6P|1.90|2015|R77|compound 8d;|Q8IKG4|1-DEOXY-D-XYLULOSE 5-PHOSPHATE REDUCTOISOMERASE|7.16|IC=0.069uM|IC50|=|0.069|uM|69|nM
4NXO|2.73|2015|2H7|compound 1; BDM44768|P14735|INSULIN-DEGRADING ENZYME|7.22|IC=0.06uM|IC50|=|0.06|uM|60|nM
4QR5|1.41|2015|BNM|compound 40a|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|7.22|IC=0.06uM|IC50|=|0.06|uM|60|nM
5AEN|1.86|2015|DP8|[Nonstandard assay: 50 mM Tris-HCl, 50 mM NaCl, 0.01% Triton-X 100] compound 23|P09960|LEUKOTRIENE A-4 HYDROLASE|7.22|IC=0.06uM|IC50|=|0.06|uM|60|nM
5APH|1.54|2015|VYI|ligand is compound 25, IC50 is displacement of tritiated T0901317 from human RORg LBD|P51449|NUCLEAR RECEPTOR ROR-GAMMA|7.22|IC=0.06uM|IC50|=|0.06|uM|60|nM
5CT7|3.17|2015|55J|ligand is compound 1, RAF265|P15056|SERINE/THREONINE-PROTEIN KINASE B-RAF|7.15|IC=0.070uM|IC50|=|0.07|uM|70|nM
4QP9|2.00|2015|35X|compound 34; SAR IC50 data|P28482|MITOGEN-ACTIVATED PROTEIN KINASE 1|7.15|IC=0.071uM|IC50|=|0.071|uM|71|nM
5D10|2.70|2015|563|ligand is compound 5c|P00523|TYROSINE-PROTEIN KINASE SRC|7.14|IC=0.072uM|IC50|=|0.072|uM|72|nM
4YPS|2.10|2015|4F6|racemic 10 in assay, compound 10(R) in crystal;|P04629|HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR|7.12|IC=0.075uM|IC50|=|0.075|uM|75|nM
5DJV|2.30|2015|5BL|ligand is biaryl compound 8e|P14324|FARNESYL PYROPHOSPHATE SYNTHASE|7.11|IC=0.077uM|IC50|=|0.077|uM|77|nM
4Y6M|2.27|2015|48Q|ligand is PG418|P46925|PLASMEPSIN-2|7.15|IC=0.07uM|IC50|=|0.07|uM|70|nM
5AXQ|1.77|2015|4LP|ligand is compound 19e|Q9Y233|CGMP 3',5'-CYCLIC PHOSPHODIESTERASE|10.1|IC=0.080nM|IC50|=|0.08|nM|0.08|nM
4WAG|3.41|2015|3K7|compound 49|Q9UBF8|PHOSPHATIDYLINOSITOL 4-KINASE BETA,PHOSPHATIDYLINOS|7.08|IC=0.083uM|IC50|=|0.083|uM|83|nM
4QMW|1.60|2015|KS1|ligand is pp-121|Q9Y6E0|SERINE/THREONINE-PROTEIN KINASE 24|7.07|IC=0.086uM|IC50|=|0.086|uM|86|nM
5AK5|2.22|2015|V2Z|compound 12|P34913|EPOXIDE HYDROLASE 2|7.07|IC=0.086uM|IC50|=|0.086|uM|86|nM
5BUI|2.12|2015|4V9|ligand is compound 2|P28482|MITOGEN-ACTIVATED PROTEIN KINASE 1|7.05|IC=0.089uM|IC50|=|0.089|uM|89|nM
5AI5|2.28|2015|BSU|compound 3|P34913|EPOXIDE HYDROLASE 2|7.03|IC=0.093uM|IC50|=|0.093|uM|93|nM
5AJW|2.50|2015|S6L|ligand is compound 49|Q16875|6-PHOSPHOFRUCTO-2-KINASE/FRUCTOSE-2,6-BISPHOSPHATAS|6.98|IC=0.104uM|IC50|=|0.104|uM|104|nM
4WQ3|1.79|2015|3SU-3SU|compound 4, dual compound 3 linked;|P04632|CALPAIN SMALL SUBUNIT 1|7.0|IC=0.10uM|IC50|=|0.1|uM|100|nM
4QW4|2.80|2015|3BV|carfizomib|P23639|PROTEASOME SUBUNIT ALPHA TYPE-2|6.95|IC=0.113uM|IC50|=|0.113|uM|113|nM
5AM4|1.87|2015|MVJ|compound 52|P34913|EPOXIDE HYDROLASE 2|6.95|IC=0.113uM|IC50|=|0.113|uM|113|nM
4Y67|1.60|2015|RC5|compound 8c;|Q8IKG4|1-DEOXY-D-XYLULOSE 5-PHOSPHATE REDUCTOISOMERASE|6.93|IC=0.117uM|IC50|=|0.117|uM|117|nM
4QOC|1.70|2015|35T|compound 16|Q00987|E3 UBIQUITIN-PROTEIN LIGASE MDM2|9.92|IC=0.12nM|IC50|=|0.12|nM|0.12|nM
4YLL|1.40|2015|4E3|[Nonstandard assay: Temp 30, ATP=15uM] compound 5t|Q13627|DUAL SPECIFICITY TYROSINE-PHOSPHORYLATION-REGULATED KINASE|6.92|IC=0.12uM|IC50|=|0.12|uM|120|nM
4ZUQ|1.22|2015|6XA|[Nonstandard assay: pH=8.2, 25 mM Tris, 137 mM NaCl, 2.7 mM KCl, 1 mM MgCl2] compound 5;|Q48935|ACETYLPOLYAMINE AMINOHYDROLASE|6.89|IC=0.13uM|IC50|=|0.13|uM|130|nM
4X9W|1.80|2015|5-mer|phosphopeptide macrocycle 4c|P53350|SERINE/THREONINE-PROTEIN KINASE PLK1|6.85|IC=0.14uM|IC50|=|0.14|uM|140|nM
4YBM|1.46|2015|4BJ|compound 7b;|O15164|TRANSCRIPTION INTERMEDIARY FACTOR 1-ALPHA|6.85|IC=0.14uM|IC50|=|0.14|uM|140|nM
5D7C|1.55|2015|57W|ligand is compound 12|P0A0K8|DNA GYRASE SUBUNIT B|6.85|IC=0.14uM|IC50|=|0.14|uM|140|nM
5A83|2.09|2015|YD3|compound 42|Q14CR1|ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 2|6.8|IC=0.158uM|IC50|=|0.158|uM|158|nM
5BVD|1.90|2015|4VF|ligand is compound 3|P28482|MITOGEN-ACTIVATED PROTEIN KINASE 1|9.8|IC=0.16nM|IC50|=|0.16|nM|0.16|nM
4QO9|2.20|2015|627|ligand is Danusertib (wrong code 4QMR in paper)|Q9Y6E0|SERINE/THREONINE-PROTEIN KINASE 24|6.8|IC=0.16uM|IC50|=|0.16|uM|160|nM
4XT9|2.25|2015|43V|compound 2c; pIC50=6.8;|P51449|NUCLEAR RECEPTOR ROR-GAMMA|6.8|IC=0.16uM|IC50|=|0.16|uM|160|nM
5C83|2.33|2015|4YN|ligand is compound 21|P98170|E3 UBIQUITIN-PROTEIN LIGASE XIAP|6.8|IC=0.16uM|IC50|=|0.16|uM|160|nM
4ZUP|1.42|2015|5XA|[Nonstandard assay: pH=8.2, 25 mM Tris, 137 mM NaCl, 2.7 mM KCl, 1 mM MgCl2] compound 4;|Q48935|ACETYLPOLYAMINE AMINOHYDROLASE|6.77|IC=0.17uM|IC50|=|0.17|uM|170|nM
5C26|1.95|2015|50H|ligand is compound 1|P43405|TYROSINE-PROTEIN KINASE SYK|6.77|IC=0.17uM|IC50|=|0.17|uM|170|nM
5ALY|1.90|2015|B7H|compound 46|P34913|EPOXIDE HYDROLASE 2|6.73|IC=0.1845uM|IC50|=|0.1845|uM|184.5|nM
4YLK|1.40|2015|4E2|[Nonstandard assay: Temp 30, ATP=15uM] compound 5s|Q13627|DUAL SPECIFICITY TYROSINE-PHOSPHORYLATION-REGULATED KINASE|6.74|IC=0.18uM|IC50|=|0.18|uM|180|nM
4ZPF|1.80|2015|4QD|[Different ligand in assay: ] compound 6; Ligand in binding assay is racemic|P56817|BETA-SECRETASE 1|6.74|IC=0.18uM|IC50|=|0.18|uM|180|nM
5BVF|1.90|2015|4VJ|ligand is compound 19|P28482|MITOGEN-ACTIVATED PROTEIN KINASE 1|9.72|IC=0.19nM|IC50|=|0.19|nM|0.19|nM
4Q4E|1.90|2015|BB2|ligand is Actinonin|P04825|AMINOPEPTIDASE N|6.72|IC=0.19uM|IC50|=|0.19|uM|190|nM
4UIA|2.18|2015|FH9|compound 3a|P09955|CARBOXYPEPTIDASE B|6.72|IC=0.19uM|IC50|=|0.19|uM|190|nM
4XV9|2.00|2015|1OO|ligand is PLX5568;|P15056|SERINE/THREONINE-PROTEIN KINASE B-RAF|6.72|IC=0.19uM|IC50|=|0.19|uM|190|nM
4UCO|2.50|2015|D41|compound 10|P43813|DNA LIGASE|7.0|IC=0.1uM|IC50|=|0.1|uM|100|nM
4YBT|1.82|2015|4BV|compound 7l;|O15164|TRANSCRIPTION INTERMEDIARY FACTOR 1-ALPHA|7.0|IC=0.1uM|IC50|=|0.1|uM|100|nM
4YMJ|2.00|2015|4EJ|compound 1|Q16288|NT-3 GROWTH FACTOR RECEPTOR|7.0|IC=0.1uM|IC50|=|0.1|uM|100|nM
5ALF|2.32|2015|OE1|compound 27|P34913|EPOXIDE HYDROLASE 2|6.69|IC=0.204uM|IC50|=|0.204|uM|204|nM
5AAD|3.10|2015|5GX|compound 7a;|O14965|AURORA KINASE A|6.67|IC=0.212uM|IC50|=|0.212|uM|212|nM
4YL1|1.41|2015|4U8|compound 3;|O14684|PROSTAGLANDIN E SYNTHASE|6.67|IC=0.216uM|IC50|=|0.216|uM|216|nM
4Z2G|2.60|2015|M6V|compound 26|P11797|CHITINASE B|6.66|IC=0.217uM|IC50|=|0.217|uM|217|nM
5AWJ|2.20|2015|YSL|ligand is compound 5|P13053|VITAMIN D3 RECEPTOR|9.68|IC=0.21nM|IC50|=|0.21|nM|0.21|nM
4QMZ|1.88|2015|B49|ligand is sunitinib|Q9Y6E0|SERINE/THREONINE-PROTEIN KINASE 24|6.68|IC=0.21uM|IC50|=|0.21|uM|210|nM
4ZJW|2.50|2015|4P1|compound 16|P51449|NUCLEAR RECEPTOR ROR-GAMMA|6.66|IC=0.22uM|IC50|=|0.22|uM|220|nM
4QW3|2.90|2015|BO2|bortezomib|P23639|PROTEASOME SUBUNIT ALPHA TYPE-2|6.61|IC=0.243uM|IC50|=|0.243|uM|243|nM
5AI9|1.80|2015|K78|compound 6|P34913|EPOXIDE HYDROLASE 2|6.61|IC=0.244uM|IC50|=|0.244|uM|244|nM
4UNQ|2.30|2015|H6D|compound 36|F2GKC3|THYMIDYLATE KINASE|6.62|IC=0.24uM|IC50|=|0.24|uM|240|nM
5ALK|2.33|2015|WMR|compound 32|P34913|EPOXIDE HYDROLASE 2|6.6|IC=0.252uM|IC50|=|0.252|uM|252|nM
5AKH|2.10|2015|6NM|compound 16|P34913|EPOXIDE HYDROLASE 2|6.59|IC=0.256uM|IC50|=|0.256|uM|256|nM
4QR4|1.28|2015|BNK|compound 18c|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|6.6|IC=0.25uM|IC50|=|0.25|uM|250|nM
4WPF|2.20|2015|3SN|compound 3|P51449|NUCLEAR RECEPTOR ROR-GAMMA|6.6|IC=0.25uM|IC50|=|0.25|uM|250|nM
5ALN|2.00|2015|5ZM|compound 35|P34913|EPOXIDE HYDROLASE 2|6.57|IC=0.267uM|IC50|=|0.267|uM|267|nM
4QMQ|1.77|2015|34U|ligand is CP-673451|Q9Y6E0|SERINE/THREONINE-PROTEIN KINASE 24|6.59|IC=0.26uM|IC50|=|0.26|uM|260|nM
4PY2|2.15|2015|43E|ligand is compound 1433; aminoacylation enzyme inhibition assay|Q2YQ76|METHIONINE--TRNA LIGASE|6.57|IC=0.272uM|IC50|=|0.272|uM|272|nM
4ZUM|1.42|2015|FKS|compound 1;|Q48935|ACETYLPOLYAMINE AMINOHYDROLASE|6.57|IC=0.27uM|IC50|=|0.27|uM|270|nM
4QP8|2.45|2015|362|compound 24; SAR IC50 data|P28482|MITOGEN-ACTIVATED PROTEIN KINASE 1|6.55|IC=0.28uM|IC50|=|0.28|uM|280|nM
5ALM|2.00|2015|7GM|compound 34|P34913|EPOXIDE HYDROLASE 2|6.53|IC=0.294uM|IC50|=|0.294|uM|294|nM
4QVL|2.80|2015|BO2|bortezomib|P23639|PROTEASOME SUBUNIT ALPHA TYPE-2|6.53|IC=0.298uM|IC50|=|0.298|uM|298|nM
4UIT|1.30|2015|N1D|compound 17; pIC50=6.7|A6NFY8|BROMODOMAIN-CONTAINING PROTEIN 9|6.7|IC=0.2uM|IC50|=|0.2|uM|200|nM
4UNS|2.18|2015|QZ3|compound 33|F2GKC3|THYMIDYLATE KINASE|6.7|IC=0.2uM|IC50|=|0.2|uM|200|nM
4QPS|1.80|2015|37Q|[Covalent complex] compound 4, covalent|P52333|TYROSINE-PROTEIN KINASE JAK3|6.52|IC=0.30uM|IC50|=|0.3|uM|300|nM
4QWS|3.00|2015|3BV|carfilzomib|P23639|PROTEASOME SUBUNIT ALPHA TYPE-2|6.5|IC=0.316uM|IC50|=|0.316|uM|316|nM
4YOI|1.82|2015|4F4|compound 1A;|P0C6W3|3C-LIKE PROTEINASE|6.48|IC=0.33uM|IC50|=|0.33|uM|330|nM
4X2I|1.20|2015|3X0|ligand is CPI-13; AlphaLISA assay|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|6.46|IC=0.35uM|IC50|=|0.35|uM|350|nM
3WYJ|2.10|2015|H78|compound 19|P60472|UNDECAPRENYL PYROPHOSPHATE SYNTHASE|6.44|IC=0.36uM|IC50|=|0.36|uM|360|nM
4WZ4|1.05|2015|3VU|[Covalent complex] [Uncommon element] [Nonstandard assay: TEMP 37] compound 37 (rac)|P24735|BETA-LACTAMASE|6.44|IC=0.36uM|IC50|=|0.36|uM|360|nM
4Z2J|2.60|2015|M6G|[Incomplete ligand] compound 31|P11797|CHITINASE B|6.43|IC=0.374uM|IC50|=|0.374|uM|374|nM
4WNK|2.42|2015|453|ligand is CCG215022|P43249|G PROTEIN-COUPLED RECEPTOR KINASE 5|6.42|IC=0.38uM|IC50|=|0.38|uM|380|nM
4ZYC|1.95|2015|4SS|compound 5;|Q00987|E3 UBIQUITIN-PROTEIN LIGASE MDM2|6.42|IC=0.38uM|IC50|=|0.38|uM|380|nM
4ZUO|1.33|2015|XS6|compound 3;|Q48935|ACETYLPOLYAMINE AMINOHYDROLASE|6.41|IC=0.39uM|IC50|=|0.39|uM|390|nM
4WTU|1.85|2015|3UT|[Nonstandard assay: pH=4.5, 50 mM acetate] compound 15|P56817|BETA-SECRETASE 1|9.52|IC=0.3nM|IC50|=|0.3|nM|0.3|nM
4Y73|2.14|2015|XPY|compound 18|Q9NWZ3|INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE 4|9.52|IC=0.3nM|IC50|=|0.3|nM|0.3|nM
4YOJ|1.90|2015|RFM|compound 2A;|P0C6W3|3C-LIKE PROTEINASE|6.39|IC=0.41uM|IC50|=|0.41|uM|410|nM
4UNN|2.50|2015|QZZ|compound 8|F2GKC3|THYMIDYLATE KINASE|6.38|IC=0.42uM|IC50|=|0.42|uM|420|nM
4WZV|1.65|2015|E40|[Nonstandard assay: Temp 37, Tris 50 mM, NaCl 150 mM, CaCl2 10 mM, Brij 35 0.05%, DMSO 1%] compound 3|P14780|MATRIX METALLOPROTEINASE-9 (MMP-9)|9.37|IC=0.43nM|IC50|=|0.43|nM|0.43|nM
5FDG|2.10|2015|0N8|compound 3, same structure as L-742001|P03433|POLYMERASE ACIDIC PROTEIN|6.37|IC=0.43uM|IC50|=|0.43|uM|430|nM
4QVM|2.80|2015|BO2|bortezomib|P23639|PROTEASOME SUBUNIT ALPHA TYPE-2|6.35|IC=0.446uM|IC50|=|0.446|uM|446|nM
4QW5|3.00|2015|3BV|carfilzomib|P23639|PROTEASOME SUBUNIT ALPHA TYPE-2|6.35|IC=0.449uM|IC50|=|0.449|uM|449|nM
4ZPE|1.70|2015|4QA|compound 5;|P56817|BETA-SECRETASE 1|6.35|IC=0.45uM|IC50|=|0.45|uM|450|nM
5CTC|2.70|2015|57K|[Different protein in assay: rat ACC1 used in assay] ligand is compound 1.4, IC50 for rat ACC1|Q00955|ACETYL-COA CARBOXYLASE|6.35|IC=0.45uM|IC50|=|0.45|uM|450|nM
4QMM|1.85|2015|35R|Ligand is AT9283|Q9Y6E0|SERINE/THREONINE-PROTEIN KINASE 24|6.34|IC=0.46uM|IC50|=|0.46|uM|460|nM
4ZG6|1.80|2015|4NY|[Nonstandard assay: Temp 37] compound PAT-078; LPC substrate|Q13822|ECTONUCLEOTIDE PYROPHOSPHATASE/PHOSPHODIESTERASE|6.33|IC=0.472uM|IC50|=|0.472|uM|472|nM
4QT2|1.44|2015|RAP|ligand is rapamycin; oxidized crystal form; another reduced crystal form deposited as code 4qt3|Q8I4V8|FK506-BINDING PROTEIN (FKBP)-TYPE PEPTIDYL-PROPYL|6.32|IC=0.48uM|IC50|=|0.48|uM|480|nM
5AJY|2.37|2015|87T|ligand is compound 69|Q16875|6-PHOSPHOFRUCTO-2-KINASE/FRUCTOSE-2,6-BISPHOSPHATAS|6.3|IC=0.496uM|IC50|=|0.496|uM|496|nM
4UFZ|2.33|2015|IA7|compound 22g|P43813|DNA LIGASE|6.31|IC=0.49uM|IC50|=|0.49|uM|490|nM
5EY8|3.50|2015|5SV|AMPC20|A0R618|ACYL-COA SYNTHASE|6.31|IC=0.49uM|IC50|=|0.49|uM|490|nM
4WRS|2.20|2015|3U1|compound 13o|P11309|SERINE/THREONINE-PROTEIN KINASE PIM-1|9.4|IC=0.4nM|IC50|=|0.4|nM|0.4|nM
4XBD|1.45|2015|M40|[Incomplete ligand] [Nonstandard assay: pH=8, Tris buffer] compound 44-o(Orthorhombic P Form)|Q83883|3C-LIKE PROTEASE|6.4|IC=0.4uM|IC50|=|0.4|uM|400|nM
4YV9|1.95|2015|11-mer|ligand is Cyclosporin A|A0A0J9|TRANSCRIPTIONAL REGULATOR|6.4|IC=0.4uM|IC50|=|0.4|uM|400|nM
4Y2X|2.50|2015|4A0|fragment 9|P34913|EPOXIDE HYDROLASE 2|6.29|IC=0.51uM|IC50|=|0.51|uM|510|nM
4QW7|2.70|2015|3BV|carfilzomib|P23639|PROTEASOME SUBUNIT ALPHA TYPE-2|6.28|IC=0.521uM|IC50|=|0.521|uM|521|nM
4QWX|2.90|2015|04C|ONX0914|P23639|PROTEASOME SUBUNIT ALPHA TYPE-2|6.27|IC=0.540uM|IC50|=|0.54|uM|540|nM
4QWK|2.80|2015|3BV|carfilzomib|P23639|PROTEASOME SUBUNIT ALPHA TYPE-2|6.27|IC=0.543uM|IC50|=|0.543|uM|543|nM
5A0C|2.10|2015|JJV|ligand is compound 28|P08246|NEUTROPHIL ELASTASE|9.27|IC=0.54nM|IC50|=|0.54|nM|0.54|nM
4WVS|2.09|2015|5-mer|ligand is linear 7|P98170|E3 UBIQUITIN-PROTEIN LIGASE XIAP|6.27|IC=0.54uM|IC50|=|0.54|uM|540|nM
4QZX|2.60|2015|04C|ONX0914|P23639|PROTEASOME SUBUNIT ALPHA TYPE-2|6.26|IC=0.553uM|IC50|=|0.553|uM|553|nM
5AJV|3.01|2015|8R2|ligand is compound 44|Q16875|HUMAN PFKFB3|6.24|IC=0.575uM|IC50|=|0.575|uM|575|nM
4WF6|2.65|2015|407|compound 3r; MK-31; MSA assay data|P15917|LETHAL FACTOR|6.3|IC=0.5uM|IC50|=|0.5|uM|500|nM
4WQ2|1.64|2015|3SU|compound 3|P04632|CALPAIN SMALL SUBUNIT 1|6.3|IC=0.5uM|IC50|=|0.5|uM|500|nM
5C84|2.36|2015|4YL|ligand is compound 20|P98170|E3 UBIQUITIN-PROTEIN LIGASE XIAP|6.19|IC=0.64uM|IC50|=|0.64|uM|640|nM
4QWL|2.60|2015|3BV|carfilzomib|P23639|PROTEASOME SUBUNIT ALPHA TYPE-2|6.18|IC=0.661uM|IC50|=|0.661|uM|661|nM
4ZRO|2.06|2015|5-mer|[Covalent complex] compound 6|Q98VG9|3C-LIKE PROTEINASE|6.16|IC=0.69uM|IC50|=|0.69|uM|690|nM
5ALO|2.00|2015|A0J|compound 36|P34913|EPOXIDE HYDROLASE 2|6.13|IC=0.738uM|IC50|=|0.738|uM|738|nM
5AKI|1.81|2015|6NF|compound 17|P34913|EPOXIDE HYDROLASE 2|6.12|IC=0.754uM|IC50|=|0.754|uM|754|nM
4QW1|2.90|2015|BO2|bortezomib|P23639|PROTEASOME SUBUNIT ALPHA TYPE-2|6.11|IC=0.773uM|IC50|=|0.773|uM|773|nM
4Z1S|1.06|2015|559|[Nonstandard assay: NaCl=40mM] compound 15|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|6.1|IC=0.79uM|IC50|=|0.79|uM|790|nM
4QL8|2.10|2015|JAD|compound 26, whole cell radioligand competition binding assay|P10275|ANDROGEN RECEPTOR|9.15|IC=0.7nM|IC50|=|0.7|nM|0.7|nM
4RCD|1.90|2015|3LL|[Different protein in assay: R-5K, R-4K] compound 42|P56817|BETA-SECRETASE 1|9.15|IC=0.7nM|IC50|=|0.7|nM|0.7|nM
4UDB|2.36|2015|CV7|ligand is dibC, desisobutyrylciclesonide|P08235|MINERALOCORTICOID RECEPTOR|9.15|IC=0.7nM|IC50|=|0.7|nM|0.7|nM
4XG9|2.91|2015|X9G|ligand is O282|P43405|TYROSINE-PROTEIN KINASE SYK|9.15|IC=0.7nM|IC50|=|0.7|nM|0.7|nM
4WP7|1.80|2015|3SR|ligand is CM026|P00352|RETINAL DEHYDROGENASE 1|6.1|IC=0.80uM|IC50|=|0.8|uM|800|nM
4YRS|2.75|2015|4JS|ligand is Chem 1698|Q4DA54|HISTIDYL-TRNA SYNTHETASE|3.07|IC=0.85mM|IC50|=|0.85|mM|850000|nM
4QVP|2.30|2015|BO2|bortezomib|P23639|PROTEASOME SUBUNIT ALPHA TYPE-2|6.05|IC=0.891uM|IC50|=|0.891|uM|891|nM
4YA8|3.30|2015|49W|ligand is PG394|P46925|PLASMEPSIN-2|6.1|IC=0.8uM|IC50|=|0.8|uM|800|nM
5AXP|1.95|2015|4LK|ligand is compound 1|Q9Y233|CGMP 3',5'-CYCLIC PHOSPHODIESTERASE|9.03|IC=0.94nM|IC50|=|0.94|nM|0.94|nM
5F5I|2.63|2015|5V1|compound 30b|O75164|LYSINE-SPECIFIC DEMETHYLASE 4A|6.02|IC=0.95uM|IC50|=|0.95|uM|950|nM
4XKX|1.80|2015|43K|compound 28|P56817|BETA-SECRETASE 1|9.05|IC=0.9nM|IC50|=|0.9|nM|0.9|nM
4QWG|2.60|2015|3BV|carfilzomib|P23639|PROTEASOME SUBUNIT ALPHA TYPE-2|5.97|IC=1.069uM|IC50|=|1.069|uM|1069|nM
4WY6|2.10|2015|3VP|[Nonstandard assay: Temp 37, PH=4.5, 100 mM sodium acetate] compound 36|P56817|BETA-SECRETASE 1|5.97|IC=1.07uM|IC50|=|1.07|uM|1070|nM
4XUB|1.98|2015|43D|compound 7|Q9UIF8|BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN PROTEIN 2B|5.97|IC=1.07uM|IC50|=|1.07|uM|1070|nM
5ALD|2.26|2015|FCW|compound 25|P34913|EPOXIDE HYDROLASE 2|5.97|IC=1.08uM|IC50|=|1.08|uM|1080|nM
4RVM|1.86|2015|3X7|compound 19|O14757|SERINE/THREONINE-PROTEIN KINASE CHK1|9.0|IC=1.0nM|IC50|=|1|nM|1|nM
5ALE|1.95|2015|ONR|compound 26|P34913|EPOXIDE HYDROLASE 2|5.95|IC=1.132uM|IC50|=|1.132|uM|1132|nM
5BPE|2.70|2015|E22|ligand is compound 9|A0A0X1|EV71 3CPRO|5.95|IC=1.13uM|IC50|=|1.13|uM|1130|nM
4QWR|2.90|2015|3BV|carfilzomib|P23639|PROTEASOME SUBUNIT ALPHA TYPE-2|5.93|IC=1.184uM|IC50|=|1.184|uM|1184|nM
4PTC|2.71|2015|2WE|compound 3|P49841|GLYCOGEN SYNTHASE KINASE-3 BETA|8.96|IC=1.1nM|IC50|=|1.1|nM|1.1|nM
5CF8|1.80|2015|50V|ligand is compound 11(BMS-911543)|O60674|TYROSINE-PROTEIN KINASE JAK2|8.96|IC=1.1nM|IC50|=|1.1|nM|1.1|nM
4QXS|1.90|2015|WC1|compound 9i, WC01088|P14324|FARNESYL PYROPHOSPHATE SYNTHASE|5.96|IC=1.1uM|IC50|=|1.1|uM|1100|nM
4UXH|2.40|2015|T5A|ligand is Ap5DT|Q4QC75|THYMIDINE KINASE|5.96|IC=1.1uM|IC50|=|1.1|uM|1100|nM
5D1U|2.85|2015|56P|compound 5c; MSA assay data|P15917|LETHAL FACTOR|5.96|IC=1.1uM|IC50|=|1.1|uM|1100|nM
4QXJ|2.80|2015|04C|ONX 0914|P23639|PROTEASOME SUBUNIT ALPHA TYPE-2|5.9|IC=1.265uM|IC50|=|1.265|uM|1265|nM
5A5R|2.01|2015|NP8|compound 60|Q6PL18|ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 2|5.9|IC=1.26uM|IC50|=|1.26|uM|1260|nM
5A5S|1.36|2015|NP8|compound 60|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|5.9|IC=1.26uM|IC50|=|1.26|uM|1260|nM
4ZTL|2.39|2015|4S1|compound 1|Q9NWZ3|INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE 4|5.92|IC=1.2uM|IC50|=|1.2|uM|1200|nM
5AFX|2.39|2015|PVZ|compound 37;|Q86C09|FARNESYL PYROPHOSPHATE SYNTHASE|5.92|IC=1.2uM|IC50|=|1.2|uM|1200|nM
5AM0|1.88|2015|LWS|compound 48|P34913|EPOXIDE HYDROLASE 2|5.88|IC=1.32uM|IC50|=|1.32|uM|1320|nM
4QW6|2.90|2015|3BV|carfilzomib|P23639|PROTEASOME SUBUNIT ALPHA TYPE-2|5.85|IC=1.397uM|IC50|=|1.397|uM|1397|nM
3WZU|3.01|2015|1FM|ligand is 5Z7O|O14733|DUAL SPECIFICITY MITOGEN-ACTIVATED PROTEIN KINASE K|5.89|IC=1.3uM|IC50|=|1.3|uM|1300|nM
4QMU|1.55|2015|SKE|ligand is JNJ-7706621|Q9Y6E0|SERINE/THREONINE-PROTEIN KINASE 24|5.89|IC=1.3uM|IC50|=|1.3|uM|1300|nM
4QR3|1.37|2015|BNJ|compound 12a|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|5.85|IC=1.40uM|IC50|=|1.4|uM|1400|nM
4X47|2.00|2015|DAN|[Nonstandard assay: Temp 37, PH=6.5] Neu5Ac2en|V8BWT1|ANHYDROSIALIDASE|2.85|IC=1.41mM|IC50|=|1.41|mM|1410000|nM
4Z2L|2.30|2015|M6F|compound 33|P11797|CHITINASE B|5.85|IC=1.41uM|IC50|=|1.41|uM|1410|nM
4XS2|2.73|2015|42P|compound 1|Q9NWZ3|INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE 4|5.82|IC=1.52uM|IC50|=|1.52|uM|1520|nM
5A3W|2.00|2015|PD2|ligand is 2,4-PDCA|Q9UGL1|LYSINE-SPECIFIC DEMETHYLASE 5B|5.82|IC=1.5uM|IC50|=|1.5|uM|1500|nM
4YAX|2.25|2015|4AE|compound 5g;|O15164|TRANSCRIPTION INTERMEDIARY FACTOR 1-ALPHA|5.82|IC=1.5uM|IC50|=|1.5|uM|1500|nM
4YRT|2.05|2015|781|ligand is Chem 1781|Q4DA54|HISTIDYL-TRNA SYNTHETASE|2.78|IC=1.65mM|IC50|=|1.65|mM|1650000|nM
4Z2K|2.30|2015|M6E|compound 32|P11797|CHITINASE B|5.78|IC=1.66uM|IC50|=|1.66|uM|1660|nM
4QWJ|2.90|2015|3BV|carfilzomib|P23639|PROTEASOME SUBUNIT ALPHA TYPE-2|5.77|IC=1.686uM|IC50|=|1.686|uM|1686|nM
4PY4|2.76|2015|XL2|ligand is compound 8|Q460N5|POLY [ADP-RIBOSE] POLYMERASE 14|5.77|IC=1.69uM|IC50|=|1.69|uM|1690|nM
4Z9L|2.10|2015|880||P53779|MITOGEN-ACTIVATED PROTEIN KINASE 10|8.8|IC=1.6nM|IC50|=|1.6|nM|1.6|nM
5AUY|2.00|2015|MRI|ligand is compound 9, morin|P53355|DEATH-ASSOCIATED PROTEIN KINASE 1|5.8|IC=1.6uM|IC50|=|1.6|uM|1600|nM
4RSS|1.83|2015|4MG|compound 16h|P43405|TYROSINE-PROTEIN KINASE SYK|8.77|IC=1.7nM|IC50|=|1.7|nM|1.7|nM
5D1T|2.20|2015|56R|compound 5a; MSA assay data|P15917|LETHAL FACTOR|5.77|IC=1.7uM|IC50|=|1.7|uM|1700|nM
4YUW|1.97|2015|4JU|ligand is 4MCHA|Q4DA73|SPERMIDINE SYNTHASE, PUTATIVE|5.77|IC=1.7uM|IC50|=|1.7|uM|1700|nM
5AM5|2.26|2015|6NZ|compound 53|P34913|EPOXIDE HYDROLASE 2|5.74|IC=1.82uM|IC50|=|1.82|uM|1820|nM
4ZSP|1.91|2015|4RZ|compound 6|P56817|BETA-SECRETASE 1|5.74|IC=1.83uM|IC50|=|1.83|uM|1830|nM
4RXA|2.20|2015|3F2|compound 7|P14324|FARNESYL PYROPHOSPHATE SYNTHASE|5.74|IC=1.8uM|IC50|=|1.8|uM|1800|nM
4YOG|2.00|2015|4F5|compound 3B;|P0C6W3|3C-LIKE PROTEINASE|5.74|IC=1.8uM|IC50|=|1.8|uM|1800|nM
4WVU|2.02|2015|5-mer|compound 8;|P98170|E3 UBIQUITIN-PROTEIN LIGASE XIAP|5.71|IC=1.97uM|IC50|=|1.97|uM|1970|nM
4XG8|2.40|2015|X8G|ligand is O272|P43405|TYROSINE-PROTEIN KINASE SYK|8.72|IC=1.9nM|IC50|=|1.9|nM|1.9|nM
5C4U|2.08|2015|4Y7|MRL-367;|P51449|NUCLEAR RECEPTOR ROR-GAMMA|8.72|IC=1.9nM|IC50|=|1.9|nM|1.9|nM
5C42|3.50|2015|29T|ligand is compound 3, JLJ555|P03366|HIV-1 REVERSE TRANSCRIPTASE P66 SUBUNIT|8.72|IC=1.9nM|IC50|=|1.9|nM|1.9|nM
4U82|1.66|2015|FPS|ligand is FSPP|P60477|ISOPRENYL TRANSFERASE|5.72|IC=1.9uM|IC50|=|1.9|uM|1900|nM
4RVT|2.40|2015|3XM|compound 11e|O95819|MITOGEN-ACTIVATED PROTEIN KINASE 4|5.72|IC=1.9uM|IC50|=|1.9|uM|1900|nM
5C7E|3.10|2015|11-mer|ligand is 11-mer Arabidopsis IAA10 peptide|Q5NBT9|ASPR2 PROTEIN|5.0|IC=10.0uM|IC50|=|10|uM|10000|nM
5AP5|2.80|2015|7RO|ligand is compound 1, with ATP present at 21uM|P33981|DUAL SPECIFICITY PROTEIN KINASE TTK|7.97|IC=10.8nM|IC50|=|10.8|nM|10.8|nM
5AP1|2.05|2015|O38|ligand is compound ONCOII, with ATP present at 10.7uM|P33981|DUAL SPECIFICITY PROTEIN KINASE TTK|7.97|IC=10.8nM|IC50|=|10.8|nM|10.8|nM
4UXB|3.22|2015|P34|complex is PARP1/PJ34|P09874|POLY [ADP-RIBOSE] POLYMERASE 1|7.96|IC=10.9nM|IC50|=|10.9|nM|10.9|nM
4RS0|2.81|2015|IBP|ligand is S-ibuprofen|Q05769|PROSTAGLANDIN G/H SYNTHASE 2|6.0|IC=1000nM|IC50|=|1000|nM|1000|nM
4ZLZ|2.00|2015|4RV|compound 8;|Q06187|TYROSINE-PROTEIN KINASE BTK|7.0|IC=100nM|IC50|=|100|nM|100|nM
5A5P|2.03|2015|JTF|compound 11|Q6PL18|ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 2|4.0|IC=100uM|IC50|=|100|uM|100000|nM
4W4X|2.65|2015|3HN|ligand is SR12327|P53779|C-JUN N-TERMINAL KINASE 3|6.99|IC=102.8nM|IC50|=|102.8|nM|102.8|nM
4U2Y|2.48|2015|RZM|ligand is DDGIM|Q9L1K2|ALPHA-1,4-GLUCAN:MALTOSE-1-PHOSPHATE MALTOSYLTRANSFERASE 1|3.99|IC=102uM|IC50|=|102|uM|102000|nM
5C7F|2.70|2015|11-mer|ligand is 11-mer Arabidopsis IAA1 peptide|Q5NBT9|ASPR2 PROTEIN|3.98|IC=105.6uM|IC50|=|105.6|uM|105600|nM
4TWY|1.60|2015|3BL|compound 40|P0C6X7|3C-LIKE PROTEINASE|3.97|IC=108uM|IC50|=|108|uM|108000|nM
4YKN|2.90|2015|4EL|compound 5e|P27986|PHOSPHATIDYLINOSITOL 3-KINASE REGULATORY SUBUNIT AL|8.0|IC=10nM|IC50|=|10|nM|10|nM
4ZH2|4.20|2015|4OB|[Nonstandard assay: Temp 37, pH=8, 50 mM Tris-HCl, 100 mM KCl, 10 mM MgCl2] ligand is CBR703; for gram-negative enteric bacterial RNAP|P0A7Z4|DNA-DIRECTED RNA POLYMERASE SUBUNIT ALPHA|5.0|IC=10uM|IC50|=|10|uM|10000|nM
5AUX|1.50|2015|KMP|ligand is compound 6, kaempferol|P53355|DEATH-ASSOCIATED PROTEIN KINASE 1|5.0|IC=10uM|IC50|=|10|uM|10000|nM
4XUC|1.80|2015|43G|compound 18|P21964|CATECHOL O-METHYLTRANSFERASE|5.96|IC=1100nM|IC50|=|1100|nM|1100|nM
5C3K|2.02|2015|4XF|ligand is compound 4|P98170|E3 UBIQUITIN-PROTEIN LIGASE XIAP|3.96|IC=110uM|IC50|=|110|uM|110000|nM
4WYO|2.89|2015|3W2|compound 1;|Q00955|ACETYL-COA CARBOXYLASE|6.95|IC=111nM|IC50|=|111|nM|111|nM
4Y62|1.60|2015|48E|compoud 16a|P16442|HISTO-BLOOD GROUP ABO SYSTEM TRANSFERASE|2.95|IC=1133uM|IC50|=|1133|uM|1133000|nM
4W4V|2.01|2015|3H8|ligand is SR-11165|P53779|C-JUN N-TERMINAL KINASE 3|6.94|IC=115nM|IC50|=|115|nM|115|nM
4UVX|1.95|2015|H2W|compound 14f|Q9H2K2|TANKYRASE-2|7.96|IC=11nM|IC50|=|11|nM|11|nM
4Y46|2.04|2015|4F2|compound 22|P53779|MITOGEN-ACTIVATED PROTEIN KINASE 10|7.96|IC=11nM|IC50|=|11|nM|11|nM
4Y8C|2.70|2015|49D|[Nonstandard assay: pH=8, 50 mM Tris-HCl, 10 mM MgCl2] (S)-C33;|O76083|CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE-9|7.96|IC=11nM|IC50|=|11|nM|11|nM
4QMX|1.88|2015|H8H|ligand is Saracatinib|Q9Y6E0|SERINE/THREONINE-PROTEIN KINASE 24|4.96|IC=11uM|IC50|=|11|uM|11000|nM
5AL3|1.75|2015|TGW|ligand is compound 11|Q9H2K2|TANKYRASE-2|4.96|IC=11uM|IC50|=|11|uM|11000|nM
4RE9|2.91|2015|3M9|compound 16|P14735|INSULIN-DEGRADING ENZYME|4.92|IC=12.1uM|IC50|=|12.1|uM|12100|nM
4TVJ|2.10|2015|09L|complex is PARP1/Olaparib|Q9UGN5|POLY [ADP-RIBOSE] POLYMERASE 2|7.91|IC=12.3nM|IC50|=|12.3|nM|12.3|nM
4UIU|1.64|2015|TVU|compound 32; pIC50=7.9|A6NFY8|BROMODOMAIN-CONTAINING PROTEIN 9|7.9|IC=12.6nM|IC50|=|12.6|nM|12.6|nM
4UVU|1.95|2015|U1T|compound 13n|Q9H2K2|TANKYRASE-2|5.92|IC=1200nM|IC50|=|1200|nM|1200|nM
5C0K|2.20|2015|4WK|ligand is compound 3|P98170|E3 UBIQUITIN-PROTEIN LIGASE XIAP|2.92|IC=1200uM|IC50|=|1200|uM|1200000|nM
5CI7|1.74|2015|51W|ligand is compound 3|O75385|SERINE/THREONINE-PROTEIN KINASE ULK1|6.92|IC=120nM|IC50|=|120|nM|120|nM
5AI8|1.85|2015|K2T|compound 5|P34913|EPOXIDE HYDROLASE 2|3.9|IC=125.6uM|IC50|=|125.6|uM|125600|nM
4YJN|2.60|2015|UW4|compound 37;|Q9BJF5|CALMODULIN-DOMAIN PROTEIN KINASE 1|7.92|IC=12nM|IC50|=|12|nM|12|nM
4ZLO|2.50|2015|4PV|compound 1|Q13153|SERINE/THREONINE-PROTEIN KINASE PAK 1|4.92|IC=12uM|IC50|=|12|uM|12000|nM
5ALT|2.15|2015|9XZ|compound 41|P34913|EPOXIDE HYDROLASE 2|4.88|IC=13.1uM|IC50|=|13.1|uM|13100|nM
5AP6|2.10|2015|PWU|ligand is compound 2, with ATP present at 125uM|P33981|DUAL SPECIFICITY PROTEIN KINASE TTK|7.88|IC=13.3nM|IC50|=|13.3|nM|13.3|nM
4RVK|1.85|2015|3XK|compound 8|O14757|SERINE/THREONINE-PROTEIN KINASE CHK1|7.87|IC=13.5nM|IC50|=|13.5|nM|13.5|nM
5DJR|2.40|2015|5BK|ligand is biaryl compound 6|P14324|FARNESYL PYROPHOSPHATE SYNTHASE|4.86|IC=13.9uM|IC50|=|13.9|uM|13900|nM
4UCV|2.60|2015|I6G|compound 5|P43813|DNA LIGASE|2.88|IC=1310uM|IC50|=|1310|uM|1310000|nM
5AFK|2.46|2015|5VU|fragment 2;|P36544|ACETYLCHOLINE-BINDING PROTEIN|3.88|IC=132uM|IC50|=|132|uM|132000|nM
4RX9|1.75|2015|3YT|compound 1; enzyme assay|P43405|TYROSINE-PROTEIN KINASE SYK|7.89|IC=13nM|IC50|=|13|nM|13|nM
4Y85|2.33|2015|499|[Nonstandard assay: Temp 30, 50 mM HEPES, 1 mM DTT, 0.02% (w/v) Tween 20, 0.02% (w/v) BSA] compound 2|P41279|MITOGEN-ACTIVATED PROTEIN KINASE 8|7.89|IC=13nM|IC50|=|13|nM|13|nM
4YP8|2.64|2015|4GF|compound 30|Q9NWZ3|INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE 4|7.89|IC=13nM|IC50|=|13|nM|13|nM
4P4B|1.93|2015|2G2|[Nonstandard assay: Temp 37, pH=7.4, 50 mM Tris-HCl, 1% Triton X-100 ] inhibitor CTT54|Q04609|GLUTAMATE CARBOXYPEPTIDASE 2|7.85|IC=14nM|IC50|=|14|nM|14|nM
4X7Q|2.33|2015|3YR|compound 1s|Q9P1W9|SERINE/THREONINE-PROTEIN KINASE PIM-2|7.85|IC=14nM|IC50|=|14|nM|14|nM
4YZN|1.55|2015|4K5|[Nonstandard assay: Temp 30, 50 mM Tris-HCl, 0.1 mM EGTA, 25 uM [gamma-32P]ATP (~300 cpm/pmol), 10 mM MgCl2, 2 mM DTT, 150 uM LRRKtide] compound 19;|Q6XHB2|PROBABLE SERINE/THREONINE-PROTEIN KINASE ROCO4|4.81|IC=15.4uM|IC50|=|15.4|uM|15400|nM
5CQJ|2.15|2015|53Q|ligand is clomiphene|P60472|UNDECAPRENYL PYROPHOSPHATE SYNTHASE|4.81|IC=15.4uM|IC50|=|15.4|uM|15400|nM
4UIV|1.72|2015|XZB|compound 44; pIC50=7.8|Q9H8M2|BROMODOMAIN-CONTAINING PROTEIN 9|7.8|IC=15.8nM|IC50|=|15.8|nM|15.8|nM
4RN2|2.39|2015|L7G|compound 3|Q9BY41|HISTONE DEACETYLASE 8|5.82|IC=1500nM|IC50|=|1500|nM|1500|nM
5AKU|1.80|2015|29F|ligand is compound 37|Q9H2K2|TANKYRASE-2|6.82|IC=150nM|IC50|=|150|nM|150|nM
4Y2T|2.40|2015|49Q|fragment 6|P34913|EPOXIDE HYDROLASE 2|3.82|IC=150uM|IC50|=|150|uM|150000|nM
4Y5H|2.06|2015|519|compound 13|P53779|MITOGEN-ACTIVATED PROTEIN KINASE 10|7.82|IC=15nM|IC50|=|15|nM|15|nM
4ZSA|2.00|2015|4UT|[Nonstandard assay: Temp 37, 50 mM HEPES, 50 mM MgCl2, 0.5 mM MnCl2] compound 7n;|P11362|FIBROBLAST GROWTH FACTOR RECEPTOR 1|7.82|IC=15nM|IC50|=|15|nM|15|nM
5BQ0|1.57|2015|4US|ligand is compound 13, BMS-824171|Q06187|TYROSINE-PROTEIN KINASE BTK|7.82|IC=15nM|IC50|=|15|nM|15|nM
5C6V|3.10|2015|11-mer|ligand is 11-mer Arabidopsis NINJA peptide|Q5NBT9|ASPR2 PROTEIN|4.8|IC=16.0uM|IC50|=|16|uM|16000|nM
4R6E|2.20|2015|3JD|complex is PARP1/Niraparib|P09874|POLY [ADP-RIBOSE] POLYMERASE 1|7.78|IC=16.7nM|IC50|=|16.7|nM|16.7|nM
4WNO|1.56|2015|3RF|compound 1|O75385|SERINE/THREONINE-PROTEIN KINASE ULK1|6.8|IC=160nM|IC50|=|160|nM|160|nM
5AIB|1.95|2015|KJU|compound 8|P34913|EPOXIDE HYDROLASE 2|3.8|IC=160uM|IC50|=|160|uM|160000|nM
5DDA|1.83|2015|59M|ligand is compound MI-333|O00255|MENIN|5.78|IC=1653nM|IC50|=|1653|nM|1653|nM
4P4F|1.86|2015|2GB|[Nonstandard assay: Temp 37, pH=7.4, 50 mM Tris-HCl, 1% Triton X-100 ] inhibitor NC-2-40|Q04609|GLUTAMATE CARBOXYPEPTIDASE 2|6.77|IC=168nM|IC50|=|168|nM|168|nM
4P44|1.75|2015|2F7|[Nonstandard assay: Temp 37, pH=7.4, 50 mM Tris-HCl, 1% Triton X-100 ] inhibitor JRB-4-81|Q04609|GLUTAMATE CARBOXYPEPTIDASE 2|7.8|IC=16nM|IC50|=|16|nM|16|nM
4P45|1.87|2015|2F9|[Nonstandard assay: Temp 37, pH=7.4, 50 mM Tris-HCl, 1% Triton X-100 ] inhibitor JRB-4-73|Q04609|GLUTAMATE CARBOXYPEPTIDASE 2|7.8|IC=16nM|IC50|=|16|nM|16|nM
5CY3|1.76|2015|55Y|ligand is compound 12|P43405|TYROSINE-PROTEIN KINASE SYK|7.8|IC=16nM|IC50|=|16|nM|16|nM
4XG3|2.30|2015|X3G|ligand is G206|P43405|TYROSINE-PROTEIN KINASE SYK|7.76|IC=17.5nM|IC50|=|17.5|nM|17.5|nM
4UUH|2.52|2015|T40|compound 23|O95271|TANKYRASE-1|7.77|IC=17nM|IC50|=|17|nM|17|nM
4Y83|2.89|2015|49B|[Nonstandard assay: Temp 30, 50 mM HEPES, 1 mM DTT] compound 3|P41279|MITOGEN-ACTIVATED PROTEIN KINASE 8|7.77|IC=17nM|IC50|=|17|nM|17|nM
5ABW|1.60|2015|WQQ|[Incomplete ligand] ligand is compound 12|P08246|NEUTROPHIL ELASTASE|7.77|IC=17nM|IC50|=|17|nM|17|nM
5CCL|1.50|2015|4ZW|ligand is screening hit compound 1, not EPZ031686|Q9H7B4|HISTONE-LYSINE N-METHYLTRANSFERASE SMYD3|4.77|IC=17uM|IC50|=|17|uM|17000|nM
5CWA|2.10|2015|0GA|ligand is methyl-AMT|P9WFX2|ANTHRANILATE SYNTHASE COMPONENT 1|4.77|IC=17uM|IC50|=|17|uM|17000|nM
4P4D|1.65|2015|2GR|[Nonstandard assay: Temp 37, pH=7.4, 50 mM Tris-HCl, 1% Triton X-100 ] inhibitor MP1C|Q04609|GLUTAMATE CARBOXYPEPTIDASE 2|5.74|IC=1800nM|IC50|=|1800|nM|1800|nM
4P4E|1.67|2015|2G4|[Nonstandard assay: Temp 37, pH=7.4, 50 mM Tris-HCl, 1% Triton X-100 ] inhibitor MP1D|Q04609|GLUTAMATE CARBOXYPEPTIDASE 2|6.74|IC=180nM|IC50|=|180|nM|180|nM
4YUX|1.60|2015|4JT|ligand is fragment 1|Q4DA73|SPERMIDINE SYNTHASE, PUTATIVE|3.74|IC=180uM|IC50|=|180|uM|180000|nM
4X6Y|2.10|2015|S94|[Different ligand in assay: Ligand in binding assay is racemic compound] compound 1|P34913|EPOXIDE HYDROLASE 2|7.72|IC=19.1nM|IC50|=|19.1|nM|19.1|nM
4UIZ|1.19|2015|N1D|compound 17; pIC50=4.7|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|4.7|IC=19.95uM|IC50|=|19.95|uM|19950|nM
4UVW|2.10|2015|NYJ|compound 17|Q9H2K2|TANKYRASE-2|7.72|IC=19nM|IC50|=|19|nM|19|nM
4UW1|3.37|2015|92R|compound 12|O95271|TANKYRASE-1|7.72|IC=19nM|IC50|=|19|nM|19|nM
4XE0|2.43|2015|40L|ligand is Idelalisib|O35904|PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE|7.72|IC=19nM|IC50|=|19|nM|19|nM
4ZTN|2.23|2015|4S3|compound 19|Q9NWZ3|INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE 4|7.72|IC=19nM|IC50|=|19|nM|19|nM
5A3N|2.00|2015|LQT|ligand is KDOAM-25|Q9UGL1|LYSINE-SPECIFIC DEMETHYLASE 5B|7.72|IC=19nM|IC50|=|19|nM|19|nM
5C7B|2.68|2015|4YD|ligand is compound 5, 52% inhibition at 1mM|P98170|E3 UBIQUITIN-PROTEIN LIGASE XIAP|3.0|IC=1mM|IC50|=|1|mM|1000000|nM
4XYF|1.85|2015|44X|ligand is (S)-21f|P08581|HEPATOCYTE GROWTH FACTOR RECEPTOR|9.0|IC=1nM|IC50|=|1|nM|1|nM
4QWF|3.00|2015|3BV|carfilzomib|P23639|PROTEASOME SUBUNIT ALPHA TYPE-2|6.0|IC=1uM|IC50|=|1|uM|1000|nM
4WYY|1.28|2015|3VT|[Covalent complex] [Uncommon element] [Nonstandard assay: Temp 37] compound 11 (rac)|P24735|BETA-LACTAMASE|6.0|IC=1uM|IC50|=|1|uM|1000|nM
4X8G|3.29|2015|3Z0|ligand is GSK199|Q9UM07|PROTEIN-ARGININE DEIMINASE TYPE-4|6.0|IC=1uM|IC50|=|1|uM|1000|nM
5AJZ|2.35|2015|MJP|ligand is compound 51|Q16875|6-PHOSPHOFRUCTO-2-KINASE/FRUCTOSE-2,6-BISPHOSPHATAS|5.7|IC=2.01uM|IC50|=|2.01|uM|2009.9999999999998|nM
4ZSQ|2.30|2015|4RX|compound 7|P56817|BETA-SECRETASE 1|5.65|IC=2.25uM|IC50|=|2.25|uM|2250|nM
4QZ7|2.80|2015|04C|ONX0914|P23639|PROTEASOME SUBUNIT ALPHA TYPE-2|5.65|IC=2.262uM|IC50|=|2.262|uM|2262|nM
4YO6|2.32|2015|4GD|compound 1|Q9NWZ3|INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE 4|5.66|IC=2.2uM|IC50|=|2.2|uM|2200|nM
4X6X|1.80|2015|S74|[Different ligand in assay: Ligand in binding assay is racemic compound] compound 14|P34913|EPOXIDE HYDROLASE 2|8.64|IC=2.3nM|IC50|=|2.3|nM|2.3|nM
4ZIM|2.65|2015|4OK|compound 1|O60674|TYROSINE-PROTEIN KINASE JAK2|8.62|IC=2.4nM|IC50|=|2.4|nM|2.4|nM
4UIY|1.30|2015|5V2|compound 44; pIC50=5.6|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|5.6|IC=2.51uM|IC50|=|2.51|uM|2510|nM
5A82|1.86|2015|YEJ|compound 30|Q14CR1|ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 2|5.6|IC=2.51uM|IC50|=|2.51|uM|2510|nM
5CF5|2.45|2015|50W|ligand is compound 18|O60674|TYROSINE-PROTEIN KINASE JAK2|8.6|IC=2.5nM|IC50|=|2.5|nM|2.5|nM
4XSZ|3.68|2015|42U|[Nonstandard assay: Temp 37, PH=8, 20 mM NaCl] CBR 9393|A7ZSI4|DNA-DIRECTED RNA POLYMERASE SUBUNIT ALPHA|5.6|IC=2.5uM|IC50|=|2.5|uM|2500|nM
4YAD|1.73|2015|4A7|compound 3b;|O15164|TRANSCRIPTION INTERMEDIARY FACTOR 1-ALPHA|5.6|IC=2.5uM|IC50|=|2.5|uM|2500|nM
5BOY|2.03|2015|4UE|ligand is compound 11|P45452|COLLAGENASE 3|5.6|IC=2.5uM|IC50|=|2.5|uM|2500|nM
5D6P|2.05|2015|57U|ligand is compound 1f|P0A0K8|DNA GYRASE SUBUNIT B|5.6|IC=2.5uM|IC50|=|2.5|uM|2500|nM
5DJ5|2.40|2015|GR2|ligand is synthetic strigolactone GR24|Q10QA5|PROBABLE STRIGOLACTONE ESTERASE D14|5.6|IC=2.5uM|IC50|=|2.5|uM|2500|nM
5ALL|2.20|2015|II6|compound 33|P34913|EPOXIDE HYDROLASE 2|5.57|IC=2.678uM|IC50|=|2.678|uM|2678|nM
4XH6|2.04|2015|HUL|hispidulin|P11309|SERINE/THREONINE-PROTEIN KINASE PIM-1|5.57|IC=2.71uM|IC50|=|2.71|uM|2710|nM
5ALJ|2.10|2015|T5J|compound 31|P34913|EPOXIDE HYDROLASE 2|5.56|IC=2.737uM|IC50|=|2.737|uM|2737|nM
4UMJ|1.85|2015|BFQ|ligand is ibandronate|Q9HWY4|GERANYLTRANSTRANSFERASE|5.57|IC=2.7uM|IC50|=|2.7|uM|2700|nM
5EDS|2.80|2015|5MT|ligand is compound 5|P48736|PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE|5.54|IC=2.88uM|IC50|=|2.88|uM|2880|nM
4YND|2.79|2015|4GQ|[Nonstandard assay: PH=9, 20 mM Tris, 2.5mM DTT, 0.01% Triton X-100] compound 23a|Q9NRG4|N-LYSINE METHYLTRANSFERASE SMYD2|8.55|IC=2.8nM|IC50|=|2.8|nM|2.8|nM
4QZ6|2.90|2015|04C|ONX0914|P23639|PROTEASOME SUBUNIT ALPHA TYPE-2|5.53|IC=2.979uM|IC50|=|2.979|uM|2979|nM
4YAY|2.90|2015|ZD7|ZD7155|P0ABE7|SOLUBLE CYTOCHROME B562,TYPE-1 ANGIOTENSIN II RECEP|8.54|IC=2.9nM|IC50|=|2.9|nM|2.9|nM
5AR4|2.70|2015|SB2|ligand is compound 2, SB-203580|O43353|RECEPTOR-INTERACTING SERINE/THREONINE-PROTEIN KINASE 2|6.7|IC=200nM|IC50|=|200|nM|200|nM
5AI0|1.75|2015|JF6|compound 1|P34913|EPOXIDE HYDROLASE 2|3.69|IC=206.4uM|IC50|=|206.4|uM|206400|nM
4TTV|2.80|2015|BC9|ligand is BC194|P26639|THREONINE--TRNA LIGASE, CYTOPLASMIC|6.68|IC=209nM|IC50|=|209|nM|209|nM
4YZ9|2.46|2015|4K7|GSK2850163|O75460|SERINE/THREONINE-PROTEIN KINASE/ENDORIBONUCLEASE IR|7.7|IC=20nM|IC50|=|20|nM|20|nM
5A0A|1.78|2015|JJS|ligand is compound 20|P08246|NEUTROPHIL ELASTASE|7.7|IC=20nM|IC50|=|20|nM|20|nM
4XUM|2.40|2015|IMN|ligand is indomethacin|P37231|PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA|4.67|IC=21.3uM|IC50|=|21.3|uM|21300|nM
4XG4|2.30|2015|X4G|ligand is G207|P43405|TYROSINE-PROTEIN KINASE SYK|7.67|IC=21.5nM|IC50|=|21.5|nM|21.5|nM
5C4T|1.77|2015|4Y6|MRL-673;|P51449|NUCLEAR RECEPTOR ROR-GAMMA|7.66|IC=21.8nM|IC50|=|21.8|nM|21.8|nM
4Z90|3.00|2015|4LE|ligand is isoflurane;|E0SJQ4|GAMMA-AMINOBUTYRIC-ACID RECEPTOR SUBUNIT BETA-1|4.66|IC=21.9uM|IC50|=|21.9|uM|21900|nM
4WPN|1.95|2015|3ST|ligand is CM053;|P00352|RETINAL DEHYDROGENASE 1|6.68|IC=210nM|IC50|=|210|nM|210|nM
4Z7H|2.90|2015|4L5|[Nonstandard assay: Temp 37, 40 mM Tris, 20 mM MgCl2, 1mM DTT] compound 3(Imidazopyridine);|O75460|SERINE/THREONINE-PROTEIN KINASE/ENDORIBONUCLEASE IR|6.66|IC=218nM|IC50|=|218|nM|218|nM
5AUU|1.70|2015|LU2|ligand is compound 1, luteolin|P53355|DEATH-ASSOCIATED PROTEIN KINASE 1|4.68|IC=21uM|IC50|=|21|uM|21000|nM
4Y2P|2.05|2015|3C5|fragment 2|P34913|BIFUNCTIONAL EPOXIDE HYDROLASE 2|2.66|IC=2200uM|IC50|=|2200|uM|2200000|nM
4X69|1.42|2015|OP0|[Nonstandard assay: Temp 30] ligand is OP0595|Q47066|BETA-LACTAMASE TOHO-1|7.66|IC=22nM|IC50|=|22|nM|22|nM
4RXE|2.50|2015|3YQ|compound 9|Q86C09|FARNESYL PYROPHOSPHATE SYNTHASE|6.64|IC=230nM|IC50|=|230|nM|230|nM
4PV7|3.24|2015|CJP|compound 1|P27487|DIPEPTIDYL PEPTIDASE 4|6.63|IC=232.8nM|IC50|=|232.8|nM|232.8|nM
4RSC|1.80|2015|A3V|ligand is emixustate|Q28175|RETINOID ISOMEROHYDROLASE|6.63|IC=232nM|IC50|=|232|nM|232|nM
5CTB|2.40|2015|57J|[Different protein in assay: rat ACC1 used in assay] ligand is compound I, IC50 for rat ACC1|Q00955|ACETYL-COA CARBOXYLASE|7.64|IC=23nM|IC50|=|23|nM|23|nM
4QNA|1.85|2015|X11|ligand is TP fragment|Q6P0Y1|SERINE/THREONINE-PROTEIN KINASE 24|4.64|IC=23uM|IC50|=|23|uM|23000|nM
5A1F|2.10|2015|OGA|ligand is NOG|Q9UGL1|LYSINE-SPECIFIC DEMETHYLASE 5B|4.61|IC=24.5uM|IC50|=|24.5|uM|24500|nM
4WY3|1.89|2015|3X5|compound 44|P0C6X7|3C-LIKE PROTEINASE|3.62|IC=240uM|IC50|=|240|uM|240000|nM
4YBI|1.84|2015|4B2|ligand is LY2811376;|P56817|BETA-SECRETASE 1|6.6|IC=249nM|IC50|=|249|nM|249|nM
4RN0|1.76|2015|L6G|compound 1|Q9BY41|HISTONE DEACETYLASE 8|6.59|IC=255nM|IC50|=|255|nM|255|nM
4ZTM|2.66|2015|4S2|compound 4|Q9NWZ3|INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE 4|7.6|IC=25nM|IC50|=|25|nM|25|nM
4UDA|2.03|2015|DEX|ligand is Dexa, dexamethasone;|P08235|MINERALOCORTICOID RECEPTOR|7.59|IC=26.0nM|IC50|=|26|nM|26|nM
5DDD|2.14|2015|59X|ligand is compound MI-836|O00255|MENIN|6.59|IC=260nM|IC50|=|260|nM|260|nM
4XM7|2.70|2015|41S|compound 4;|P15917|LETHAL FACTOR|3.57|IC=267uM|IC50|=|267|uM|267000|nM
5AB0|2.50|2015|10-mer|DG025 peptide|Q6P179|ENDOPLASMIC RETICULUM AMINOPEPTIDASE 2|7.59|IC=26nM|IC50|=|26|nM|26|nM
4XUA|1.75|2015|43C|compound 1|Q9UIF8|BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN PROTEIN 2B|4.59|IC=26uM|IC50|=|26|uM|26000|nM
4ZUN|1.40|2015|SS9|compound 2;|Q48935|ACETYLPOLYAMINE AMINOHYDROLASE|4.59|IC=26uM|IC50|=|26|uM|26000|nM
4X68|1.68|2015|OP0|[Nonstandard assay: Temp 30] ligand is OP0595|P24735|BETA-LACTAMASE|6.57|IC=271nM|IC50|=|271|nM|271|nM
5AV0|1.85|2015|47X|ligand is compound 15, 7,3',4'-trihydroxyisoflavone|P53355|DEATH-ASSOCIATED PROTEIN KINASE 1|3.55|IC=280uM|IC50|=|280|uM|280000|nM
4X49|2.01|2015|G39|[Nonstandard assay: Temp 37, PH=6.5] Oseltamivir carboxylate|V8BWT1|ANHYDROSIALIDASE|4.53|IC=29.6uM|IC50|=|29.6|uM|29600|nM
4UUQ|2.36|2015|64D|ligand is SAR127303|Q99685|MONOGLYCERIDE LIPASE|7.54|IC=29nM|IC50|=|29|nM|29|nM
4X7O|2.65|2015|3Z6|compound 52;|Q9NZJ5|EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 3|8.7|IC=2nM|IC50|=|2|nM|2|nM
4XMO|1.75|2015|46G|ligand is (R)-20c|P08581|HEPATOCYTE GROWTH FACTOR RECEPTOR|8.7|IC=2nM|IC50|=|2|nM|2|nM
4QZ3|2.80|2015|04C|ONX 0914|P23639|PROTEASOME SUBUNIT ALPHA TYPE-2|5.51|IC=3.085uM|IC50|=|3.085|uM|3085|nM
4QWU|3.00|2015|BO2|bortezomib|P23639|PROTEASOME SUBUNIT ALPHA TYPE-2|5.51|IC=3.120uM|IC50|=|3.12|uM|3120|nM
4URA|2.23|2015|LEL|ligand is compound 14a|O75164|LYSINE-SPECIFIC DEMETHYLASE 4A|5.5|IC=3.16uM|IC50|=|3.16|uM|3160|nM
4WZ5|1.60|2015|3VU|[Covalent complex] [Uncommon element] [Nonstandard assay: TEMP=37, KHCO3=3mM] compound 37 (rac)|P14489|BETA-LACTAMASE OXA-10|5.51|IC=3.1uM|IC50|=|3.1|uM|3100|nM
4ZS2|2.16|2015|FLU|[Nonstandard assay: in ssRNA, Temp 37, 50 mM HEPES ] ligand is fluorescein; IC50 value against FTO demethylation|Q9C0B1|ALPHA-KETOGLUTARATE-DEPENDENT DIOXYGENASE FTO|5.49|IC=3.23uM|IC50|=|3.23|uM|3230|nM
5ALX|2.23|2015|DUL|compound 45|P34913|EPOXIDE HYDROLASE 2|5.48|IC=3.277uM|IC50|=|3.277|uM|3277|nM
3WYY|3.05|2015|O17|compound 19c|P33981|DUAL SPECIFICITY PROTEIN KINASE TTK|8.49|IC=3.2nM|IC50|=|3.2|nM|3.2|nM
3WQH|2.85|2015|SKK|ligand is Anagliptin|P27487|DIPEPTIDYL PEPTIDASE 4|8.48|IC=3.3nM|IC50|=|3.3|nM|3.3|nM
5AP2|2.80|2015|PWU|ligand is compound 2, with ATP present at 10.7uM|P33981|DUAL SPECIFICITY PROTEIN KINASE TTK|8.48|IC=3.3nM|IC50|=|3.3|nM|3.3|nM
4D2R|2.10|2015|DYK|compound 23|P08069|INSULIN-LIKE GROWTH FACTOR 1 RECEPTOR|5.48|IC=3.3uM|IC50|=|3.3|uM|3300|nM
4TMF|2.05|2015|JS2|[Different ligand in assay: compound 7] ligand is compound 7a, hydrolysis at N1 of compound 7|P28907|ADP-RIBOSYL CYCLASE/CYCLIC ADP-RIBOSE HYDROLASE 1|5.48|IC=3.3uM|IC50|=|3.3|uM|3300|nM
4Y6R|1.90|2015|RF7|compound 7a;|Q8IKG4|1-DEOXY-D-XYLULOSE 5-PHOSPHATE REDUCTOISOMERASE|5.48|IC=3.3uM|IC50|=|3.3|uM|3300|nM
4QZ0|3.00|2015|04C|ONX 0914|P23639|PROTEASOME SUBUNIT ALPHA TYPE-2|5.46|IC=3.502uM|IC50|=|3.502|uM|3502|nM
5A09|1.81|2015|JJD|ligand is compound 19|P08246|NEUTROPHIL ELASTASE|8.46|IC=3.5nM|IC50|=|3.5|nM|3.5|nM
4ZLY|1.65|2015|4RU|compound 2|Q06187|TYROSINE-PROTEIN KINASE BTK|5.46|IC=3.5uM|IC50|=|3.5|uM|3500|nM
4QZ1|3.00|2015|04C|ONX 0914|P23639|PROTEASOME SUBUNIT ALPHA TYPE-2|5.44|IC=3.658uM|IC50|=|3.658|uM|3658|nM
4ZK5|2.89|2015|4P4|compound 13;|O95819|MITOGEN-ACTIVATED PROTEIN KINASE 4|8.43|IC=3.7nM|IC50|=|3.7|nM|3.7|nM
4XTA|2.50|2015|DIF|ligand is diclofenac|P37231|PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA|5.43|IC=3.7uM|IC50|=|3.7|uM|3700|nM
5C4S|2.23|2015|4Y5|MRL-299;|P51449|NUCLEAR RECEPTOR ROR-GAMMA|8.42|IC=3.8nM|IC50|=|3.8|nM|3.8|nM
4UXJ|3.00|2015|TTP|ligand is dTTP|Q4QC75|THYMIDINE KINASE|5.42|IC=3.8uM|IC50|=|3.8|uM|3800|nM
4RXD|2.00|2015|RIS|compound 2|Q86C09|FARNESYL PYROPHOSPHATE SYNTHASE|6.52|IC=300nM|IC50|=|300|nM|300|nM
5AL4|1.90|2015|WLH|ligand is compound 6|Q9H2K2|TANKYRASE-2|6.52|IC=300nM|IC50|=|300|nM|300|nM
4XYC|3.30|2015|2K9|compound 3|P9WN38|GLUTAMINE SYNTHETASE 1|7.51|IC=31nM|IC50|=|31|nM|31|nM
5AUV|1.50|2015|AGI|ligand is compound 2, apigenin|P53355|DEATH-ASSOCIATED PROTEIN KINASE 1|4.51|IC=31uM|IC50|=|31|uM|31000|nM
4XG7|1.76|2015|X7G|ligand is O259|P43405|TYROSINE-PROTEIN KINASE SYK|7.49|IC=32.6nM|IC50|=|32.6|nM|32.6|nM
5AR7|2.71|2015|SR8|ligand is compound 3, Biaryl Urea|O43353|RECEPTOR-INTERACTING SERINE/THREONINE-PROTEIN KINASE 2|6.49|IC=320nM|IC50|=|320|nM|320|nM
5AK6|2.15|2015|YPN|compound 13|P34913|EPOXIDE HYDROLASE 2|3.49|IC=326.4uM|IC50|=|326.4|uM|326400|nM
4UVV|1.90|2015|W8L|compound 13h|Q9H2K2|TANKYRASE-2|7.49|IC=32nM|IC50|=|32|nM|32|nM
5AI4|1.93|2015|4VY|compound 2|P34913|EPOXIDE HYDROLASE 2|3.47|IC=337.1uM|IC50|=|337.1|uM|337100|nM
4W4W|1.90|2015|3HJ|ligand is SR12326|P53779|C-JUN N-TERMINAL KINASE 3|7.46|IC=34.7nM|IC50|=|34.7|nM|34.7|nM
5AKG|2.51|2015|6N6|compound 15|P34913|EPOXIDE HYDROLASE 2|4.46|IC=34.81uM|IC50|=|34.81|uM|34810|nM
4W4Y|2.30|2015|3HQ|ligand is SR12130|P53779|C-JUN N-TERMINAL KINASE 3|6.46|IC=344.8nM|IC50|=|344.8|nM|344.8|nM
5AFN|2.22|2015|OJD|fragment 5;|P36544|ACETYLCHOLINE-BINDING PROTEIN|4.47|IC=34uM|IC50|=|34|uM|34000|nM
5AP4|2.85|2015|O38|ligand is compound ONCOII, with ATP present at 21uM|P33981|DUAL SPECIFICITY PROTEIN KINASE TTK|6.46|IC=350nM|IC50|=|350|nM|350|nM
4P4I|1.87|2015|2G5|[Nonstandard assay: Temp 37, pH=7.4, 50 mM Tris-HCl, 1% Triton X-100 ] inhibitor T33|Q04609|GLUTAMATE CARBOXYPEPTIDASE 2|7.46|IC=35nM|IC50|=|35|nM|35|nM
4RX8|1.59|2015|3YX|compound 11; enzyme assay|P43405|TYROSINE-PROTEIN KINASE SYK|7.46|IC=35nM|IC50|=|35|nM|35|nM
4ZSR|1.65|2015|4RY|compound 8|P56817|BETA-SECRETASE 1|4.44|IC=36.1uM|IC50|=|36.1|uM|36100|nM
5AL2|1.90|2015|O53|ligand is compound 34|Q9H2K2|TANKYRASE-2|6.44|IC=360nM|IC50|=|360|nM|360|nM
4X2L|2.55|2015|3WP|[Nonstandard assay: Temp 37, PH=4.5, 100 mM sodium acetate] compound 6;|P56817|BETA-SECRETASE 1|4.44|IC=36uM|IC50|=|36|uM|36000|nM
4RSE|2.39|2015|A6V|ligand is MB-001|Q28175|RETINOID ISOMEROHYDROLASE|6.4|IC=396nM|IC50|=|396|nM|396|nM
5AFL|2.35|2015|FHV|fragment 3;|P36544|ACETYLCHOLINE-BINDING PROTEIN|3.4|IC=398uM|IC50|=|398|uM|398000|nM
5BOT|1.85|2015|4UM|ligand is compound 1|P45452|COLLAGENASE 3|4.41|IC=39uM|IC50|=|39|uM|39000|nM
4RPV|3.05|2015|3UR|compound 3|P11309|SERINE/THREONINE-PROTEIN KINASE PIM-1|8.52|IC=3nM|IC50|=|3|nM|3|nM
4RX5|1.36|2015|3YO|[Nonstandard assay: Temp 37] compound 23|Q06187|TYROSINE-PROTEIN KINASE BTK|8.52|IC=3nM|IC50|=|3|nM|3|nM
4YZC|2.49|2015|STU|Nonstandard assay: ligand is staurosporine, STS; inhibit pIRE1a kinase enzymatic activity|O75460|SERINE/THREONINE-PROTEIN KINASE/ENDORIBONUCLEASE IR|8.52|IC=3nM|IC50|=|3|nM|3|nM
4ZOM|2.27|2015|4Q3|compound 4j|P51449|NUCLEAR RECEPTOR ROR-GAMMA|8.52|IC=3nM|IC50|=|3|nM|3|nM
4YVZ|2.50|2015|3AT|[Incomplete ligand] [Nonstandard assay: pH 9.5, 50 mM glycine/NaOH, 50 mM NaCl, 10 mM MgCl2, 0.3mM ATP] 3'-dATP|Q9WY43|DNA INTEGRITY SCANNING PROTEIN DISA|5.52|IC=3uM|IC50|=|3|uM|3000|nM
4QVW|3.00|2015|BO2|bortezomib|P23639|PROTEASOME SUBUNIT ALPHA TYPE-2|5.38|IC=4.138uM|IC50|=|4.138|uM|4138|nM
3WYX|2.90|2015|O38|compound 33|P33981|DUAL SPECIFICITY PROTEIN KINASE TTK|8.37|IC=4.3nM|IC50|=|4.3|nM|4.3|nM
4QWI|2.60|2015|3BV|carfilzomib|P23639|PROTEASOME SUBUNIT ALPHA TYPE-2|5.36|IC=4.401uM|IC50|=|4.401|uM|4401|nM
4Y2B|2.20|2015|EPK|compound 22|Q13946|HIGH AFFINITY CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIE|8.36|IC=4.4nM|IC50|=|4.4|nM|4.4|nM
5DLS|2.15|2015|5CV|ligand is compound VER-00158411|O14757|SERINE/THREONINE-PROTEIN KINASE CHK1|8.36|IC=4.4nM|IC50|=|4.4|nM|4.4|nM
4YHF|2.20|2015|4C9|[Covalent complex] [Incomplete ligand] compound 3; reversible covalent inhibitor;|Q06187|TYROSINE-PROTEIN KINASE BTK|8.34|IC=4.6nM|IC50|=|4.6|nM|4.6|nM
5ES1|2.80|2015|5RC|ligand is compound 1|Q96L34|MAP/MICROTUBULE AFFINITY-REGULATING KINASE 4|8.34|IC=4.6nM|IC50|=|4.6|nM|4.6|nM
4WVT|1.96|2015|6-mer|compound 5;|P98170|E3 UBIQUITIN-PROTEIN LIGASE XIAP|5.31|IC=4.87uM|IC50|=|4.87|uM|4870|nM
4X6K|1.94|2015|3XR|[Nonstandard assay: Temp 37, PH=6.5] Siastatin B|V8BWT1|ANHYDROSIALIDASE|5.31|IC=4.87uM|IC50|=|4.87|uM|4870|nM
5A3U|3.30|2015|R8J|compound 1|Q9GZT9|EGL NINE HOMOLOG 1|8.32|IC=4.8nM|IC50|=|4.8|nM|4.8|nM
4XJR|3.00|2015|OEL|[Covalent complex] [Incomplete ligand] [Nonstandard assay: pH 4.6, NaOAc 50 mM, CaCl2 5 mM] compound 5; Miss a F atom in PDB;|G8G134|HEMAGGLUTININ-NEURAMINIDASE|5.32|IC=4.8uM|IC50|=|4.8|uM|4800|nM
5AI6|2.30|2015|4XH|compound 4|P34913|EPOXIDE HYDROLASE 2|4.4|IC=40.19uM|IC50|=|40.19|uM|40190|nM
4R1Y|2.00|2015|3EH|compound 1|P08581|HEPATOCYTE GROWTH FACTOR RECEPTOR|6.4|IC=400nM|IC50|=|400|nM|400|nM
5CF4|2.38|2015|50Y|ligand is compound 12|O60674|TYROSINE-PROTEIN KINASE JAK2|7.4|IC=40nM|IC50|=|40|nM|40|nM
4ZH3|4.08|2015|4OD|[Nonstandard assay: Temp 37, pH=8, 50 mM Tris-HCl, 100 mM KCl, 10 mM MgCl2, 1mMDTT, 10 mg/ml BSA, 5% methanol, 5.5% glycero] ligand is CBRH16-Br; for gram-negative enteric bacterial RNAP|P0A7Z4|DNA-DIRECTED RNA POLYMERASE SUBUNIT ALPHA|4.4|IC=40uM|IC50|=|40|uM|40000|nM
4RVL|1.85|2015|3XL|compound 7|O14757|SERINE/THREONINE-PROTEIN KINASE CHK1|7.38|IC=41.7nM|IC50|=|41.7|nM|41.7|nM
5AKW|2.07|2015|NKI|ligand is compound 29|Q9H2K2|TANKYRASE-2|6.39|IC=410nM|IC50|=|410|nM|410|nM
4X7J|2.30|2015|3Z1|compound 7;|Q9NZJ5|EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 3|7.39|IC=41nM|IC50|=|41|nM|41|nM
4X7H|2.00|2015|3Z2|compound 10b|Q9NZJ5|EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 3|7.38|IC=42nM|IC50|=|42|nM|42|nM
5AFJ|2.22|2015|42R|fragment 1;|P36544|ACETYLCHOLINE-BINDING PROTEIN|4.38|IC=42uM|IC50|=|42|uM|42000|nM
5ALV|1.80|2015|6TZ|compound 43|P34913|EPOXIDE HYDROLASE 2|4.36|IC=43.48uM|IC50|=|43.48|uM|43480|nM
4UCU|2.10|2015|8HC|compound 6|P43813|DNA LIGASE|3.35|IC=447uM|IC50|=|447|uM|447000|nM
5CLM|2.61|2015|52K|ligand is compound 3R-6a|P56817|BETA-SECRETASE 1|7.36|IC=44nM|IC50|=|44|nM|44|nM
3WPN|2.80|2015|B4S|ligand is PVZB1194|P52732|KINESIN-LIKE PROTEIN KIF11|4.36|IC=44uM|IC50|=|44|uM|44000|nM
4YUY|1.58|2015|1SQ|ligand is fragment 2|Q4DA73|SPERMIDINE SYNTHASE, PUTATIVE|3.34|IC=460uM|IC50|=|460|uM|460000|nM
4V0I|2.54|2015|J82|compound 3(S)|O35904|PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE|6.33|IC=468nM|IC50|=|468|nM|468|nM
4TN4|2.20|2015|33G|ligand is pyrazolopyran (+)-16|A5K8L9|SERINE HYDROXYMETHYLTRANSFERASE|6.33|IC=470nM|IC50|=|470|nM|470|nM
5D1J|1.80|2015|56H|ligand is compound 21|P24941|CYCLIN-DEPENDENT KINASE 2|7.32|IC=48nM|IC50|=|48|nM|48|nM
5AIC|1.89|2015|TGX|compound 9|P34913|EPOXIDE HYDROLASE 2|4.3|IC=49.6uM|IC50|=|49.6|uM|49600|nM
4ZLA|1.90|2015|BES|BESTATIN;|O25294|CYTOSOL AMINOPEPTIDASE|7.3|IC=49.9nM|IC50|=|49.9|nM|49.9|nM
5C7A|2.36|2015|4YE|ligand is compound 7, 52% inhibition at 495uM|P98170|E3 UBIQUITIN-PROTEIN LIGASE XIAP|3.31|IC=495uM|IC50|=|495|uM|495000|nM
4X7K|1.80|2015|3Z3|compound 34;|Q9NZJ5|EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 3|8.4|IC=4nM|IC50|=|4|nM|4|nM
4Z3V|1.60|2015|4L6|compound 11;|Q06187|TYROSINE-PROTEIN KINASE BTK|8.4|IC=4nM|IC50|=|4|nM|4|nM
5CCM|2.30|2015|4ZX|ligand is compound EPZ030456, cell IC50=48nm|Q9H7B4|HISTONE-LYSINE N-METHYLTRANSFERASE SMYD3|8.4|IC=4nM|IC50|=|4|nM|4|nM
5A85|1.72|2015|78J|compound 13|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|5.3|IC=5.01uM|IC50|=|5.01|uM|5010|nM
4WY1|1.98|2015|3VO|[Nonstandard assay: Temp 37, PH=4.5, 100 mM sodium acetate] compound 24b;|P56817|BETA-SECRETASE 1|5.29|IC=5.1uM|IC50|=|5.1|uM|5100|nM
4YZM|3.00|2015|4K4|[Nonstandard assay: Temp 30, 50 mM Tris-HCl, 0.1 mM EGTA] ligand is LRRK2-In1|Q6XHB2|PROBABLE SERINE/THREONINE-PROTEIN KINASE ROCO4|5.27|IC=5.38uM|IC50|=|5.38|uM|5380|nM
4QZ5|2.80|2015|04C|ONX 0914|P23639|PROTEASOME SUBUNIT ALPHA TYPE-2|5.26|IC=5.452uM|IC50|=|5.452|uM|5452|nM
5AKZ|2.18|2015|6NX|compound 24|P34913|EPOXIDE HYDROLASE 2|5.26|IC=5.49uM|IC50|=|5.49|uM|5490|nM
4UVY|1.95|2015|SGW|compound 15e|Q9H2K2|TANKYRASE-2|8.26|IC=5.5nM|IC50|=|5.5|nM|5.5|nM
5AP0|2.15|2015|AU5|[Nonstandard assay: with ATP present at its Km concentration 10.7uM] ligand is compound AZ3146, with ATP present at 10.7uM|P33981|DUAL SPECIFICITY PROTEIN KINASE TTK|8.26|IC=5.5nM|IC50|=|5.5|nM|5.5|nM
5C7C|2.32|2015|4YC|ligand is compound 18|P98170|E3 UBIQUITIN-PROTEIN LIGASE XIAP|5.26|IC=5.5uM|IC50|=|5.5|uM|5500|nM
5D6Q|1.50|2015|57V|ligand is compound 7|P0A0K8|DNA GYRASE SUBUNIT B|5.24|IC=5.8uM|IC50|=|5.8|uM|5800|nM
4PTG|2.36|2015|2WG|compound 24|P49841|GLYCOGEN SYNTHASE KINASE-3 BETA|8.23|IC=5.9nM|IC50|=|5.9|nM|5.9|nM
5AHJ|2.80|2015|7IM|ligand is macyranone A|P23639|PROTEASOME SUBUNIT ALPHA TYPE-2|8.23|IC=5.9nM|IC50|=|5.9|nM|5.9|nM
4QP7|2.25|2015|363|compound 17; SAR IC50 data|P28482|MITOGEN-ACTIVATED PROTEIN KINASE 1|5.23|IC=5.9uM|IC50|=|5.9|uM|5900|nM
4UIX|1.58|2015|TVU|compound 32; pIC50=7.3|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|7.3|IC=50.1nM|IC50|=|50.1|nM|50.1|nM
4YFI|2.70|2015|4CW|compound 1;|Q59H18|SERINE/THREONINE-PROTEIN KINASE TNNI3K|6.3|IC=500nM|IC50|=|500|nM|500|nM
5AR5|2.66|2015|IQ7|ligand is compound 5, Benzimidazole|O43353|RECEPTOR-INTERACTING SERINE/THREONINE-PROTEIN KINASE 2|6.3|IC=500nM|IC50|=|500|nM|500|nM
4UIW|1.73|2015|H1B|compound 45; pIC50=7.3|A6NFY8|BROMODOMAIN-CONTAINING PROTEIN 9|7.3|IC=50nM|IC50|=|50|nM|50|nM
5AP7|2.45|2015|SVE|ligand is compound NMS-P715, with ATP present at 125uM|P33981|MONOPOLAR SPINDLE KINASE 1|6.29|IC=510nM|IC50|=|510|nM|510|nM
4XXS|1.86|2015|SI5|[Nonstandard assay: Temp 37, PH=4.5, 100 mM sodium acetate] compound 5|P56817|BETA-SECRETASE 1|7.28|IC=52nM|IC50|=|52|nM|52|nM
4Y2S|2.30|2015|49P|fragment 5|P34913|EPOXIDE HYDROLASE 2|4.28|IC=52uM|IC50|=|52|uM|52000|nM
5A6N|1.70|2015|U7E|compound 2;|O43293|DEATH-ASSOCIATED PROTEIN KINASE 3|4.28|IC=52uM|IC50|=|52|uM|52000|nM
4YV0|1.95|2015|4JW|fragment 4; code is 4yu0 in paper|Q4DA73|SPERMIDINE SYNTHASE, PUTATIVE|3.28|IC=530uM|IC50|=|530|uM|530000|nM
5AL1|1.75|2015|GN5|ligand is compound 36|Q9H2K2|TANKYRASE-2|4.28|IC=53uM|IC50|=|53|uM|53000|nM
5CXZ|1.70|2015|55U|ligand is compound 6|P43405|TYROSINE-PROTEIN KINASE SYK|6.26|IC=552nM|IC50|=|552|nM|552|nM
4Y29|1.98|2015|CTI|ligand is chelerythrine|P37231|PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA|6.25|IC=566nM|IC50|=|566|nM|566|nM
4S3F|1.70|2015|43W|compound 8|Q5SLI8|4-HYDROXY-3-METHYLBUT-2-EN-1-YL DIPHOSPHATE SYNTHAS|6.24|IC=580nM|IC50|=|580|nM|580|nM
4Y2U|2.75|2015|49R|fragment 7|P34913|BIFUNCTIONAL EPOXIDE HYDROLASE 2|3.24|IC=580uM|IC50|=|580|uM|580000|nM
3WZK|2.30|2015|O23|compound 11f|P33981|DUAL SPECIFICITY PROTEIN KINASE TTK|7.24|IC=58nM|IC50|=|58|nM|58|nM
4Y87|3.10|2015|49E|[Nonstandard assay: pH=8, 50 mM Tris-HCl, 10 mM MgCl2] (R)-C33;|O76083|CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE-9|7.24|IC=58nM|IC50|=|58|nM|58|nM
5AK4|1.79|2015|GVG|compound 11|P34913|EPOXIDE HYDROLASE 2|4.23|IC=59.2uM|IC50|=|59.2|uM|59200|nM
4RX7|1.80|2015|3YV|compound 10; enzyme assay|P43405|TYROSINE-PROTEIN KINASE SYK|8.3|IC=5nM|IC50|=|5|nM|5|nM
4XHK|1.90|2015|3YR|compound 1s|P11309|SERINE/THREONINE-PROTEIN KINASE PIM-1|8.3|IC=5nM|IC50|=|5|nM|5|nM
5A0B|2.23|2015|JJX|ligand is compound 24|P08246|NEUTROPHIL ELASTASE|8.3|IC=5nM|IC50|=|5|nM|5|nM
5CXH|1.90|2015|55M|ligand is compound 11|P43405|TYROSINE-PROTEIN KINASE SYK|8.3|IC=5nM|IC50|=|5|nM|5|nM
4QZ2|2.70|2015|04C|ONX 0914|P23639|PROTEASOME SUBUNIT ALPHA TYPE-2|5.21|IC=6.167uM|IC50|=|6.167|uM|6167|nM
5C4O|2.24|2015|4F1|MRL-871; space group P 61 2 2|P51449|NUCLEAR RECEPTOR ROR-GAMMA|8.21|IC=6.1nM|IC50|=|6.1|nM|6.1|nM
5AIA|2.26|2015|KWB|compound 7|P34913|EPOXIDE HYDROLASE 2|5.2|IC=6.268uM|IC50|=|6.268|uM|6268|nM
4QVQ|2.60|2015|BO2|bortezomib|P23639|PROTEASOME SUBUNIT ALPHA TYPE-2|5.2|IC=6.366uM|IC50|=|6.366|uM|6366|nM
4ZS3|2.45|2015|A4F|[Nonstandard assay: in ssRNA, Temp 37, 50 mM HEPES ] ligand is 5-aminofluorescein; IC50 value against FTO demethylation|Q9C0B1|ALPHA-KETOGLUTARATE-DEPENDENT DIOXYGENASE FTO|5.18|IC=6.55uM|IC50|=|6.55|uM|6550|nM
3WZJ|2.75|2015|O43|compound 27b|P33981|DUAL SPECIFICITY PROTEIN KINASE TTK|8.18|IC=6.6nM|IC50|=|6.6|nM|6.6|nM
4XCT|1.30|2015|N73|[Nonstandard assay: Temp 37, Tris 50 mM, NaCl 150 mM, CaCl2 10 mM, Brij 35 0.05%, DMSO 1%] compound 1|P14780|MATRIX METALLOPROTEINASE-9 (MMP-9)|8.17|IC=6.7nM|IC50|=|6.7|nM|6.7|nM
5DIQ|2.10|2015|5B9|ligand is salicylic acid derivative 3a|P14324|FARNESYL PYROPHOSPHATE SYNTHASE|5.17|IC=6.8uM|IC50|=|6.8|uM|6800|nM
4TMR|2.70|2015|99S|ligand is pyrazolopyran (+)-1|A5K8L9|SERINE HYDROXYMETHYLTRANSFERASE|7.22|IC=60nM|IC50|=|60|nM|60|nM
4ZH4|3.99|2015|4OE|[Nonstandard assay: Temp 37, pH=8, 50 mM Tris-HCl, 100 mM KCl, 10 mM MgCl2, 1mMDTT, 10 mg/ml BSA, 5% methanol, 5.5% glycero] ligand is CBRH18; for gram-negative enteric bacterial RNAP|P0A7Z4|DNA-DIRECTED RNA POLYMERASE SUBUNIT ALPHA|4.22|IC=60uM|IC50|=|60|uM|60000|nM
4UCS|1.90|2015|9MJ|compound 4|P43813|DNA LIGASE|4.21|IC=61uM|IC50|=|61|uM|61000|nM
5FDD|2.51|2015|4P8|compound 1|P03433|POLYMERASE ACIDIC PROTEIN|4.2|IC=63.30uM|IC50|=|63.3|uM|63300|nM
4TWW|2.42|2015|3A7|compound 41|P0C6X7|3C-LIKE PROTEINASE|4.2|IC=63uM|IC50|=|63|uM|63000|nM
5DDE|1.78|2015|5A0|ligand is compound MI-859|O00255|MENIN|7.19|IC=65nM|IC50|=|65|nM|65|nM
5DDF|1.66|2015|5A1|ligand is compound MI-273|O00255|MENIN|6.17|IC=674nM|IC50|=|674|nM|674|nM
4X7N|2.35|2015|3Z5|compound 44;|Q9NZJ5|EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 3|8.22|IC=6nM|IC50|=|6|nM|6|nM
4QVV|2.80|2015|BO2|bortezomib|P23639|PROTEASOME SUBUNIT ALPHA TYPE-2|5.15|IC=7.010uM|IC50|=|7.01|uM|7010|nM
5ALW|2.20|2015|JQN|compound 44|P34913|EPOXIDE HYDROLASE 2|5.15|IC=7.05uM|IC50|=|7.05|uM|7050|nM
4QZW|3.00|2015|04C|ONX0914|P23639|PROTEASOME SUBUNIT ALPHA TYPE-2|5.15|IC=7.155uM|IC50|=|7.155|uM|7155|nM
4QW0|2.90|2015|BO2|bortezomib|P23639|PROTEASOME SUBUNIT ALPHA TYPE-2|5.14|IC=7.192uM|IC50|=|7.192|uM|7192|nM
5DJP|2.40|2015|5BJ|ligand is biaryl compound 5|P14324|FARNESYL PYROPHOSPHATE SYNTHASE|5.15|IC=7.1uM|IC50|=|7.1|uM|7100|nM
4RLP|2.79|2015|72B|[Uncommon element] ligand is FL772|P23443|P70S6K1|8.14|IC=7.3nM|IC50|=|7.3|nM|7.3|nM
4QMS|1.88|2015|1N1|Ligand is Dasatinib (wrong code 4QO9 in paper)|Q9Y6E0|SERINE/THREONINE-PROTEIN KINASE 24|5.13|IC=7.4uM|IC50|=|7.4|uM|7400|nM
4Z7I|3.31|2015|10-mer|[Incomplete ligand] [Nonstandard assay: Temp 37, 50 mM HEPES, 100 mM NaCl ] ligand is DG025 peptide|Q9UIQ6|LEUCYL-CYSTINYL AMINOPEPTIDASE|8.11|IC=7.7nM|IC50|=|7.7|nM|7.7|nM
5C7D|2.25|2015|4YF|ligand is compound 17|P98170|E3 UBIQUITIN-PROTEIN LIGASE XIAP|5.11|IC=7.7uM|IC50|=|7.7|uM|7700|nM
4QVN|2.90|2015|BO2|bortezomib|P23639|PROTEASOME SUBUNIT ALPHA TYPE-2|5.1|IC=7.925uM|IC50|=|7.925|uM|7925|nM
5AR8|2.79|2015|XYW|ligand is compound 4, Biphenylsulfonamide|O43353|RECEPTOR-INTERACTING SERINE/THREONINE-PROTEIN KINASE 2|8.1|IC=7.9nM|IC50|=|7.9|nM|7.9|nM
4P4J|1.66|2015|2H9|[Nonstandard assay: Temp 37, pH=7.4, 50 mM Tris-HCl, 1% Triton X-100 ] inhibitor T33D|Q04609|GLUTAMATE CARBOXYPEPTIDASE 2|6.15|IC=700nM|IC50|=|700|nM|700|nM
5AFM|2.85|2015|9Z0|fragment 4;|P36544|ACETYLCHOLINE-BINDING PROTEIN|4.15|IC=70uM|IC50|=|70|uM|70000|nM
5AL5|2.05|2015|JL9|ligand is compound 5|Q9H2K2|TANKYRASE-2|7.15|IC=71nM|IC50|=|71|nM|71|nM
4XJT|2.60|2015|41Z|[Nonstandard assay: pH=4.5] [Different protein in assay: Protein in binding assay is Wild Type] compound 1a;|P28907|ADP-RIBOSYL CYCLASE/CYCLIC ADP-RIBOSE HYDROLASE 1|5.14|IC=7200nM|IC50|=|7200|nM|7200|nM
4TRW|2.85|2015|4-mer|inhibitor R-26|P56817|BETA-SECRETASE 1|4.14|IC=72uM|IC50|=|72|uM|72000|nM
4R5W|2.84|2015|XAV|complex is PARP1/XAV939|P09874|POLY [ADP-RIBOSE] POLYMERASE 1|7.13|IC=74.1nM|IC50|=|74.1|nM|74.1|nM
4PTE|2.03|2015|2WF|compound 14|P49841|GLYCOGEN SYNTHASE KINASE-3 BETA|7.13|IC=74nM|IC50|=|74|nM|74|nM
4UCT|2.10|2015|5U1|compound 7|P43813|DNA LIGASE|3.12|IC=767uM|IC50|=|767|uM|767000|nM
4XJS|2.80|2015|733|[Nonstandard assay: pH=4.5, 50 mM HEPES, 2 mM EDTA, 1 mM CHAPS, 2.5 mM sodium acetate, 100 uM NAD, 250 uM GW323434X, and 0.4 nM CD38] compound 1bf;|P28907|ADP-RIBOSYL CYCLASE/CYCLIC ADP-RIBOSE HYDROLASE 1|7.12|IC=76nM|IC50|=|76|nM|76|nM
4S3E|1.35|2015|0CG|compound 7|Q5SLI8|4-HYDROXY-3-METHYLBUT-2-EN-1-YL DIPHOSPHATE SYNTHAS|6.11|IC=770nM|IC50|=|770|nM|770|nM
5DD9|1.62|2015|59K|ligand is compound MI-326|O00255|MENIN|6.11|IC=779nM|IC50|=|779|nM|779|nM
4QT1|2.40|2015|3C9|compound 12|P52333|TYROSINE-PROTEIN KINASE JAK3|8.15|IC=7nM|IC50|=|7|nM|7|nM
4QVY|2.51|2015|BO2|bortezomib|P23639|PROTEASOME SUBUNIT ALPHA TYPE-2|5.09|IC=8.037uM|IC50|=|8.037|uM|8037.000000000001|nM
4X3U|1.63|2015|SVR|ligand is Suramin|Q8VDS3|CHROMOBOX PROTEIN HOMOLOG 7|5.09|IC=8.1uM|IC50|=|8.1|uM|8100|nM
5CF6|2.50|2015|50O|ligand is compound 3|O60674|TYROSINE-PROTEIN KINASE JAK2|8.09|IC=8.2nM|IC50|=|8.2|nM|8.2|nM
4Z2H|2.35|2015|M6A|compound 29|P11797|CHITINASE B|5.08|IC=8.3uM|IC50|=|8.3|uM|8300|nM
5AK3|2.28|2015|XM0|compound 10|P34913|EPOXIDE HYDROLASE 2|5.07|IC=8.49uM|IC50|=|8.49|uM|8490|nM
4YAB|1.90|2015|4CN|compound 1;|O15164|TRANSCRIPTION INTERMEDIARY FACTOR 1-ALPHA|5.07|IC=8.5uM|IC50|=|8.5|uM|8500|nM
5AUW|1.50|2015|QUE|ligand is compound 4, quercetin|P53355|DEATH-ASSOCIATED PROTEIN KINASE 1|5.05|IC=8.9uM|IC50|=|8.9|uM|8900|nM
4Y2J|2.15|2015|49G|fragment 1|P34913|BIFUNCTIONAL EPOXIDE HYDROLASE 2|3.1|IC=800uM|IC50|=|800|uM|800000|nM
4RYC|2.45|2015|3ZK|eutomers compound 47a; ligand in assay is 47;|P00797|RENIN|7.1|IC=80nM|IC50|=|80|nM|80|nM
5DDB|1.54|2015|59Q|ligand is compound MI-319|O00255|MENIN|7.09|IC=82nM|IC50|=|82|nM|82|nM
4YV1|1.85|2015|4K2|fragment 5; code is 4yu1 in paper|Q4DA73|SPERMIDINE SYNTHASE, PUTATIVE|3.08|IC=830uM|IC50|=|830|uM|830000|nM
4XDO|1.97|2015|OGA|[Nonstandard assay: PH=8, 50 mM HEPES, 100 uM sodium ascorbate, 20 mM NaCl] N-oxaylglycine|Q9H3R0|LYSINE-SPECIFIC DEMETHYLASE 4C|4.08|IC=84uM|IC50|=|84|uM|84000|nM
5A5Z|2.60|2015|WJZ|[Nonstandard assay: HEPES 50 mM, pH 7.5] compound 11|C7C422|BETA-LACTAMASE NDM-1|4.08|IC=84uM|IC50|=|84|uM|84000|nM
4WNP|1.88|2015|3RJ|compound 6|O75385|SERINE/THREONINE-PROTEIN KINASE ULK1|8.1|IC=8nM|IC50|=|8|nM|8|nM
4XY2|2.03|2015|490|compound 38b|Q9Y233|CGMP 3',5'-CYCLIC PHOSPHODIESTERASE|8.1|IC=8nM|IC50|=|8|nM|8|nM
4YUZ|1.97|2015|4JV|ligand is fragment 3|Q4DA73|SPERMIDINE SYNTHASE, PUTATIVE|5.04|IC=9.1uM|IC50|=|9.1|uM|9100|nM
4Y6S|2.10|2015|48S|compound 7b;|Q8IKG4|1-DEOXY-D-XYLULOSE 5-PHOSPHATE REDUCTOISOMERASE|5.03|IC=9.3uM|IC50|=|9.3|uM|9300|nM
4YAT|2.18|2015|4A8|compound 5b;|O15164|TRANSCRIPTION INTERMEDIARY FACTOR 1-ALPHA|5.03|IC=9.3uM|IC50|=|9.3|uM|9300|nM
4TRZ|3.25|2015|4-mer|inhibitor R-27|P56817|BETA-SECRETASE 1|5.03|IC=9.4uM|IC50|=|9.4|uM|9400|nM
4W4S|2.00|2015|B29|ligand is BPH-629|Q45222|UNCHARACTERIZED PROTEIN BLR2150|5.02|IC=9.5uM|IC50|=|9.5|uM|9500|nM
5AM2|1.70|2015|KUF|compound 50|P34913|EPOXIDE HYDROLASE 2|5.01|IC=9.685uM|IC50|=|9.685|uM|9685|nM
5D1S|2.10|2015|56Q|compound 3a; MSA assay data|P15917|LETHAL FACTOR|5.02|IC=9.6uM|IC50|=|9.6|uM|9600|nM
4XG6|2.40|2015|X6G|ligand is O194|P43405|TYROSINE-PROTEIN KINASE SYK|8.01|IC=9.7nM|IC50|=|9.7|nM|9.7|nM
4YYL|1.91|2015|4KN|[Nonstandard assay: Temp 37, 20 mM Tris-HCl, 100 mM NaCl, 10 mM beta-mercaptoethanol, 1.0 mM MgCl2, 1.0 mM MnCl2] compound 1|P03433|POLYMERASE ACIDIC PROTEIN|5.01|IC=9.7uM|IC50|=|9.7|uM|9700|nM
4QZ4|3.00|2015|04C|ONX 0914|P23639|PROTEASOME SUBUNIT ALPHA TYPE-2|5.01|IC=9.830uM|IC50|=|9.83|uM|9830|nM
4Y32|1.70|2015|7-mer|analogue compound 1b;|P31947|14-3-3 PROTEIN SIGMA|4.05|IC=90.1uM|IC50|=|90.1|uM|90100|nM
4XM6|2.35|2015|41R|compound 3;|P15917|LETHAL FACTOR|4.05|IC=90uM|IC50|=|90|uM|90000|nM
4Y2V|2.40|2015|4A5|fragment 8|P34913|EPOXIDE HYDROLASE 2|4.04|IC=91uM|IC50|=|91|uM|91000|nM
5AP3|2.70|2015|AU5|ligand is compound AZ3146, with ATP present at 21uM|P33981|DUAL SPECIFICITY PROTEIN KINASE TTK|7.03|IC=93nM|IC50|=|93|nM|93|nM
4XM8|2.70|2015|41T|compound 5;|P15917|LETHAL FACTOR|3.02|IC=950uM|IC50|=|950|uM|950000|nM
4UX4|1.80|2015|E9L|compound 17a|Q9H2K2|TANKYRASE-2|7.01|IC=97nM|IC50|=|97|nM|97|nM
5AUZ|1.60|2015|GEN|ligand is compound 13, genistein|P53355|DEATH-ASSOCIATED PROTEIN KINASE 1|4.01|IC=98uM|IC50|=|98|uM|98000|nM
5AKK|1.90|2015|1P8|compound 19|P34913|EPOXIDE HYDROLASE 2|4.0|IC=99.3uM|IC50|=|99.3|uM|99300|nM
4X7L|1.90|2015|3Z4|compound 39;|Q9NZJ5|EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 3|8.05|IC=9nM|IC50|=|9|nM|9|nM
5ECE|2.20|2015|5N2|ligand is Phthalazinone 1, AZ9482 (compound 1)|O95271|TANKYRASE-1|8.05|IC=9nM|IC50|=|9|nM|9|nM
4Y2Y|2.30|2015|49Z|fragment 10|P34913|EPOXIDE HYDROLASE 2|5.05|IC=9uM|IC50|=|9|uM|9000|nM
4YLU|2.10|2015|R30|compound 11|V9TU12|ORF1A PROTEIN|4.0|IC>100uM|IC50|>|100|uM|100000|nM
5BVK|2.29|2015|4VC|ligand is compound 1|Q08345|EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1|4.0|IC>100uM|IC50|>|100|uM|100000|nM
4XBB|1.85|2015|3ZR|[Incomplete ligand] [Nonstandard assay: pH=8, Tris buffer] compound 17|Q83883|3C-LIKE PROTEASE|5.0|IC>10uM|IC50|>|10|uM|10000|nM
5A5O|2.04|2015|J5I|fragment 5|Q6PL18|ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 2|3.0|IC>1mM|IC50|>|1|mM|1000000|nM
4YPF|2.20|2015|4FS|ligand is Chem 84|Q4DA54|HISTIDYL-TRNA SYNTHETASE|2.7|IC>2mM|IC50|>|2|mM|2000000|nM
4YRC|2.10|2015|0P6|ligand is Chem 89|Q4DA54|HISTIDYL-TRNA SYNTHETASE|2.7|IC>2mM|IC50|>|2|mM|2000000|nM
4YRG|2.15|2015|4HU|ligand is Chem 149|Q4DA54|HISTIDYL-TRNA SYNTHETASE|2.7|IC>2mM|IC50|>|2|mM|2000000|nM
4YRR|2.30|2015|691|ligand is Chem 1691|Q4DA54|HISTIDYL-TRNA SYNTHETASE|2.7|IC>2mM|IC50|>|2|mM|2000000|nM
4XUE|2.30|2015|43J|compound 27b|P21964|CATECHOL O-METHYLTRANSFERASE|5.3|IC>5000nM|IC50|>|5000|nM|5000|nM
4UCR|2.15|2015|JCF|compound 3|P43813|DNA LIGASE|3.3|IC>500uM|IC50|>|500|uM|500000|nM
5AES|2.75|2015|5B0|compound 3|P60487|PYRIDOXAL PHOSPHATE PHOSPHATASE|2.89|IC~1.3mM|IC50|~|1.3|mM|1300000|nM
4RN1|2.18|2015|L8G|compound 2|Q9BY41|HISTONE DEACETYLASE 8|5.0|IC~10000nM|IC50|~|10000|nM|10000|nM
4XSX|3.71|2015|42S|[Nonstandard assay: Temp 37, PH=8, 20 mM NaCl] CBR 703; range 10~20uM|A7ZSI4|DNA-DIRECTED RNA POLYMERASE SUBUNIT ALPHA|5.0|IC~10uM|IC50|~|10|uM|10000|nM
4V1F|1.70|2015|BQ1|ligand is BDQ, IC50 is 20-25nM|I0RTF3|F0F1 ATP SYNTHASE SUBUNIT C|7.7|IC~20nM|IC50|~|20|nM|20|nM
4RXC|2.31|2015|HRX|compound 8|Q86C09|FARNESYL PYROPHOSPHATE SYNTHASE|4.48|IC~33uM|IC50|~|33|uM|33000|nM
4ZSM|1.96|2015|4RW|compound 3|P56817|BETA-SECRETASE 1|2.4|IC~4mM|IC50|~|4|mM|4000000|nM
5A00|2.75|2015|D7N|compound 20by|P09874|POLY [ADP-RIBOSE] POLYMERASE 1|7.52|Kd<0.03uM|Kd|<|0.03|uM|30|nM
4XHE|1.90|2015|40P|A-AChBP in complex with pinnatoxin A|Q8WSF8|ACETYLCHOLINE RECEPTOR|10.3|Kd<0.05nM|Kd|<|0.05|nM|0.05|nM
4PZH|1.06|2015|V13|[Nonstandard assay: Temp 37 , pH =7.0,] compound 5|P00918|CARBONIC ANHYDRASE 2|8.0|Kd<10nM|Kd|<|10|nM|10|nM
4X61|2.85|2015|3XV|EPZ015666|O14744|PROTEIN ARGININE N-METHYLTRANSFERASE 5|9.0|Kd<1nM|Kd|<|1|nM|1|nM
4X60|2.35|2015|3XV|EPZ015666;|O14744|PROTEIN ARGININE N-METHYLTRANSFERASE 5|9.0|Kd<1nM|Kd|<|1|nM|1|nM
4S2I|1.60|2015|NXL|ligand is Avibactam|G3G192|BETA-LACTAMASE|9.0|Kd=0.001uM|Kd|=|0.001|uM|1|nM
4WR7|1.50|2015|3TV|[Nonstandard assay: Temp 37,50 mM sodium phosphate] compound 3e|P00915|CARBONIC ANHYDRASE 1|11.7|Kd=0.002nM|Kd|=|0.002|nM|0.002|nM
4Y8D|2.10|2015|49J|[Different protein in assay: GAK-specific NbGAK_4 nanobody] compound 12i|O14976|CYCLIN-G-ASSOCIATED KINASE|8.05|Kd=0.0089uM|Kd|=|0.0089|uM|8.9|nM
5BS4|1.29|2015|4UX|ligand is entry7(compound 25g)|P03366|HIV-1 PROTEASE|11.0|Kd=0.0099nM|Kd|=|0.0099|nM|0.0099|nM
5AIX|2.10|2015|KRX|compound 2|O60760|HEMATOPOIETIC PROSTAGLANDIN D SYNTHASE|7.92|Kd=0.012uM|Kd|=|0.012|uM|12|nM
4XTX|2.30|2015|590|compound 57;|I6YFP0|BIFUNCTIONAL LIGASE/REPRESSOR BIRA|10.57|Kd=0.027nM|Kd|=|0.027|nM|0.027|nM
4WW6|1.06|2015|3TV|[Nonstandard assay: Temp 37,50 mM sodium phosphate] compound 3e|P00918|CARBONIC ANHYDRASE 2|10.21|Kd=0.062nM|Kd|=|0.062|nM|0.062|nM
4WW8|1.42|2015|VD9|[Nonstandard assay: Temp 37,50 mM sodium phosphate] compound 4e|O43570|CARBONIC ANHYDRASE 12|10.17|Kd=0.067nM|Kd|=|0.067|nM|0.067|nM
5AH2|2.13|2015|11-mer|ligand is GRISELIMYCIN peptide|A0QND6|DNA POLYMERASE III SUBUNIT BETA|10.08|Kd=0.083nM|Kd|=|0.083|nM|0.083|nM
4ZZZ|1.90|2015|FSU|compound 10b|P09874|POLY [ADP-RIBOSE] POLYMERASE 1|7.06|Kd=0.087uM|Kd|=|0.087|uM|87|nM
3WTN|2.09|2015|N2Y|ligand is DN-IMI|P58154|ACETYLCHOLINE-BINDING PROTEIN|7.04|Kd=0.091uM|Kd|=|0.091|uM|91|nM
3WTL|2.30|2015|N1Y|ligand is CH-IMI|P58154|ACETYLCHOLINE-BINDING PROTEIN|7.04|Kd=0.092uM|Kd|=|0.092|uM|92|nM
5EPL|1.81|2015|6-mer|peptide inhibitor UNC3866|O00257|E3 SUMO-PROTEIN LIGASE CBX4|7.03|Kd=0.094uM|Kd|=|0.094|uM|94|nM
3WTM|2.48|2015|N1Y|ligand is CH-IMI|P58154|ACETYLCHOLINE-BINDING PROTEIN|7.0|Kd=0.100uM|Kd|=|0.1|uM|100|nM
3WZN|1.30|2015|BTN|ligand is BTN|P22629|STREPTAVIDIN|7.0|Kd=0.10uM|Kd|=|0.1|uM|100|nM
4ODL|2.92|2015|16-mer|[Multiple sites: site1: Kd=0.113+/-0.012uM; site 2: Kd=2.93+/-0.12uM] TtSlyDFL:S2|Q5SLE7|PEPTIDYL-PROLYL CIS-TRANS ISOMERASE SLYD|6.95|Kd=0.113uM|Kd|=|0.113|uM|113|nM
3WTO|2.25|2015|N2Y|ligand is DN-IMI|P58154|ACETYLCHOLINE-BINDING PROTEIN|6.92|Kd=0.119uM|Kd|=|0.119|uM|119|nM
4ZZX|1.65|2015|FSU|compound 10b|Q9UGN5|POLY [ADP-RIBOSE] POLYMERASE 2|6.9|Kd=0.125uM|Kd|=|0.125|uM|125|nM
4X1S|1.90|2015|10-mer|[Incomplete ligand] [Nonstandard assay: NaCl=140mM, sodium phosphate=20mM] ligand is Mupain-1-16 D9A;|P00749|MUPAIN-1-16|6.87|Kd=0.134uM|Kd|=|0.134|uM|134|nM
4XTZ|1.90|2015|594|compound 69|I6YFP0|BIFUNCTIONAL LIGASE/REPRESSOR BIRA|9.82|Kd=0.153nM|Kd|=|0.153|nM|0.153|nM
4WUP|1.75|2015|3UF|[Nonstandard assay: Temp 37,50 mM sodium phosphate] compound 4c|P00915|CARBONIC ANHYDRASE 1|9.82|Kd=0.15nM|Kd|=|0.15|nM|0.15|nM
3WZP|1.20|2015|ZOF|ligand is iminobiotin long tail (IMNtail)|P22629|STREPTAVIDIN|6.82|Kd=0.15uM|Kd|=|0.15|uM|150|nM
4YOZ|2.25|2015|9-mer|[Nonstandard assay: Temp 15, pH=8.0, 25 mM Tris, 200 mM NaCl, and 5 mM BME] ligand is HPV E7 peptide|P28749|RETINOBLASTOMA-LIKE PROTEIN 1,RETINOBLASTOMA-LIKE P|6.8|Kd=0.16uM|Kd|=|0.16|uM|160|nM
4ODN|1.60|2015|17-mer|[Multiple sites: site1: Kd=0.183+/-0.018uM; site 2: Kd=5.68+/-0.27uM] TtSlyDFL:S2-plus2|Q5SLE7|PEPTIDYL-PROLYL CIS-TRANS ISOMERASE SLYD|6.74|Kd=0.183uM|Kd|=|0.183|uM|183|nM
4WMU|1.55|2015|19H|compound 2|P0AEX9|MBP-MCL1 CHIMERA PROTEIN,INDUCED MYELOID LEUKEMIA C|6.74|Kd=0.18uM|Kd|=|0.18|uM|180|nM
5AGU|2.17|2015|11-mer|ligand is GRISELIMYCIN peptide|I6XU56|DNA POLYMERASE III SUBUNIT BETA|10.0|Kd=0.1nM|Kd|=|0.1|nM|0.1|nM
4XRQ|1.95|2015|1B0|ligand is PF-3450074|P12493|CAPSID PROTEIN P24|6.63|Kd=0.232uM|Kd|=|0.232|uM|232|nM
4RD0|1.71|2015|GDP|ligand is GDP|Q980A5|TRANSLATION INITIATION FACTOR 2 SUBUNIT GAMMA|6.62|Kd=0.24uM|Kd|=|0.24|uM|240|nM
4X8N|2.10|2015|10-mer|[Incomplete ligand] [Nonstandard assay: PH=8, NaCl=150mM, Tris-HCl =25mM, BME=5mM] ligand is phosphorylated RbBP5;|Q9UBL3|SET1/ASH2 HISTONE METHYLTRANSFERASE COMPLEX SUBUNIT|6.62|Kd=0.24uM|Kd|=|0.24|uM|240|nM
4XII|2.70|2015|40V|compound 8g|P06276|CHOLINESTERASE|6.6|Kd=0.25uM|Kd|=|0.25|uM|250|nM
4ZZD|2.35|2015|RBF|[Nonstandard assay: pH=8, 20 mM Tris-HCl, 150 mM NaCl, 1 mMEDTA] RIBOFLAVIN;|A2RI36|TRANSCRIPTIONAL REGULATOR, PADR-LIKE FAMILY|6.6|Kd=0.25uM|Kd|=|0.25|uM|250|nM
5E0A|2.60|2015|NAG||Q9GK12|PEPTIDOGLYCAN RECOGNITION PROTEIN 1|6.59|Kd=0.26uM|Kd|=|0.26|uM|260|nM
5C7N|1.75|2015|BMF|compound 20|P55201|PEREGRIN|6.57|Kd=0.27uM|Kd|=|0.27|uM|270|nM
5CFA|1.45|2015|15-mer|ligand is 15-mer peptide from Fibrinogen alpha chain|Q14U76|BONE SIALOPROTEIN-BINDING PROTEIN|6.54|Kd=0.290uM|Kd|=|0.29|uM|290|nM
3WTK|2.69|2015|TH4|ligand is Thiacloprid|P58154|ACETYLCHOLINE-BINDING PROTEIN|6.53|Kd=0.294uM|Kd|=|0.294|uM|294|nM
3WTJ|2.24|2015|TH4|ligand is Thiacloprid|P58154|ACETYLCHOLINE-BINDING PROTEIN|6.53|Kd=0.297uM|Kd|=|0.297|uM|297|nM
5AGV|1.93|2015|11-mer|ligand is CYCLOHEXYL GRISELIMYCIN peptide|I6XU56|DNA POLYMERASE III SUBUNIT BETA|9.7|Kd=0.2nM|Kd|=|0.2|nM|0.2|nM
4XU3|2.24|2015|44R|compound 90;|I6YFP0|BIFUNCTIONAL LIGASE/REPRESSOR BIRA|9.5|Kd=0.315nM|Kd|=|0.315|nM|0.315|nM
5CP9|1.90|2015|6O5|ligand is compound MB605; Kd=0.31+/-0.04mM|P14210|HEPATOCYTE GROWTH FACTOR|3.51|Kd=0.31mM|Kd|=|0.31|mM|310000|nM
4XU1|1.70|2015|44O|compound 82;|I6YFP0|BIFUNCTIONAL LIGASE/REPRESSOR BIRA|9.49|Kd=0.324nM|Kd|=|0.324|nM|0.324|nM
4YEE|2.00|2015|4CQ|gBCD;|Q9QZH4|5'-AMP-ACTIVATED PROTEIN KINASE SUBUNIT BETA-2|6.49|Kd=0.32uM|Kd|=|0.32|uM|320|nM
4Z68|1.86|2015|12-mer|[Nonstandard assay: TEMP 4, NaCl=110mM, TCEP=1mM] [Different protein in assay: ] ligand is HsArpinCt peptide;|Q9H2K2|TANKYRASE-2|6.49|Kd=0.32uM|Kd|=|0.32|uM|320|nM
4RD3|1.69|2015|GDP|ligand is GDP|Q980A5|TRANSLATION INITIATION FACTOR 2 SUBUNIT GAMMA|6.47|Kd=0.34uM|Kd|=|0.34|uM|340|nM
4ZHL|2.06|2015|10-mer|[Nonstandard assay: Temp 37, 10 mM Hepes, 140 mM NaCl, 0.1% BSA] ligand is mupain-1-IG peptide|P00749|UROKINASE-TYPE PLASMINOGEN ACTIVATOR|6.47|Kd=0.34uM|Kd|=|0.34|uM|340|nM
5AI1|2.10|2015|EQU|amino acid ID is Y30F/Y55F/Y115F/D38N in paper;|P07445|KETOSTEROID ISOMERASE|6.47|Kd=0.34uM|Kd|=|0.34|uM|340|nM
5C11|2.80|2015|10-mer|ligand is 10-mer histone H3C4me3 peptide|P29375|LYSINE-SPECIFIC DEMETHYLASE 5A|6.47|Kd=0.34uM|Kd|=|0.34|uM|340|nM
4YMH|1.88|2015|SAH|higher affinity in presence of Mg2+;|Q9HGR1|PUTATIVE SAM-DEPENDENT O-METHYLTRANFERASE|6.46|Kd=0.35uM|Kd|=|0.35|uM|350|nM
4X1N|1.80|2015|10-mer|[Incomplete ligand] [Nonstandard assay: NaCl=140mM, sodium phosphate=20mM] ligand is Mupain-1-16;|P00749|MUPAIN-1-16|6.42|Kd=0.38uM|Kd|=|0.38|uM|380|nM
5CVD|1.30|2015|9-mer|ligand is 9-mer alpha-N-dimethylated human CENP-A peptide|Q9BV86|N-TERMINAL XAA-PRO-LYS N-METHYLTRANSFERASE 1|6.41|Kd=0.39uM|Kd|=|0.39|uM|390|nM
4ZEB|1.89|2015|AGR|ligand is agrocinopine A; another lower resolution structure is 4ze9|Q7D2F4|ABC TRANSPORTER, SUBSTRATE BINDING PROTEIN|6.52|Kd=0.3uM|Kd|=|0.3|uM|300|nM
5A2K|1.70|2015|6-mer|[Incomplete ligand] [Nonstandard assay: 10 mM sodium phosphate buffer containing 150 mM NaCl] ligand is glycopeptide m1*|P01801|IG LAMBDA-1 CHAIN V REGION S43|6.35|Kd=0.45uM|Kd|=|0.45|uM|450|nM
4ZVI|2.20|2015|4S4|compound 18a;|P0AES7|DNA GYRASE SUBUNIT B|6.33|Kd=0.47uM|Kd|=|0.47|uM|470|nM
4X1R|2.10|2015|10-mer|[Incomplete ligand] [Nonstandard assay: NaCl=140mM, sodium phosphate=20mM] ligand is Mupain-1-12;|P00749|MUPAIN-1-12|6.4|Kd=0.4uM|Kd|=|0.4|uM|400|nM
5E0L|1.31|2015|14-mer|ligand is 14-mer Protein Chica peptide, Chica (415-424)|Q24117|DYNEIN LIGHT CHAIN 1|6.4|Kd=0.4uM|Kd|=|0.4|uM|400|nM
3WTH|2.54|2015|IM4|ligand is imidacloprid|P58154|ACETYLCHOLINE-BINDING PROTEIN|6.29|Kd=0.514uM|Kd|=|0.514|uM|514|nM
4RD6|1.94|2015|GDP|ligand is GDP|Q980A5|TRANSLATION INITIATION FACTOR 2 SUBUNIT GAMMA|6.28|Kd=0.52uM|Kd|=|0.52|uM|520|nM
4ZB6|1.80|2015|GDS|ligand is GSSG|A0A0R4|PCURE2P4|6.28|Kd=0.53uM|Kd|=|0.53|uM|530|nM
4XTV|1.45|2015|44K|compound 36;|I6YFP0|BIFUNCTIONAL LIGASE/REPRESSOR BIRA|9.27|Kd=0.54nM|Kd|=|0.54|nM|0.54|nM
5AIS|1.85|2015|CWC|compound 7|O60760|HEMATOPOIETIC PROSTAGLANDIN D SYNTHASE|6.24|Kd=0.57uM|Kd|=|0.57|uM|570|nM
4XU2|1.85|2015|44Q|compound 87;|I6YFP0|BIFUNCTIONAL LIGASE/REPRESSOR BIRA|9.23|Kd=0.592nM|Kd|=|0.592|nM|0.592|nM
3WZQ|1.70|2015|ZOF|ligand is iminobiotin long tail (IMNtail)|P22629|STREPTAVIDIN|6.23|Kd=0.59uM|Kd|=|0.59|uM|590|nM
4X13|2.00|2015|5-mer|[Nonstandard assay: Temp 37, SVGA cells] ligand is LSTc pentasaccharide|P90498|MAJOR CAPSID PROTEIN|3.3|Kd=0.5mM|Kd|=|0.5|mM|500000|nM
4XTY|1.80|2015|44L|compound 63;|I6YFP0|BIFUNCTIONAL LIGASE/REPRESSOR BIRA|9.21|Kd=0.614nM|Kd|=|0.614|nM|0.614|nM
5D9P|1.80|2015|NBG|Kd=0.63+/-0.03mM; ligand is compound 1|O06842|B-1,4-ENDOGLUCANASE|3.2|Kd=0.63mM|Kd|=|0.63|mM|630000|nM
5AIV|2.04|2015|M1W|compound 9|O60760|HEMATOPOIETIC PROSTAGLANDIN D SYNTHASE|6.19|Kd=0.65uM|Kd|=|0.65|uM|650|nM
4PLI|1.65|2015|11-mer|ligand is H3K36me3 peptide|Q4V3E2|AT1G02740|3.16|Kd=0.69mM|Kd|=|0.69|mM|690000|nM
4YV5|1.90|2015|SVR|[Multiple sites: site 1: Kd=0.6uM; site 2=6.2uM] ligand is Suramin|Q9I834|BASIC PHOSPHOLIPASE A2 HOMOLOG 2|6.22|Kd=0.6uM|Kd|=|0.6|uM|600|nM
4RT1|1.70|2015|C2E|ligand is c-di-GMP|Q9HY69|ALGINATE BIOSYNTHESIS PROTEIN ALG44|6.14|Kd=0.73uM|Kd|=|0.73|uM|730|nM
4XU0|1.60|2015|44N|compound 73;|I6YFP0|BIFUNCTIONAL LIGASE/REPRESSOR BIRA|9.11|Kd=0.769nM|Kd|=|0.769|nM|0.769|nM
4X34|1.80|2015|10-mer|[Incomplete ligand] ligand is p53K381acK382me2 peptide;|Q12888|TUMOR SUPPRESSOR P53-BINDING PROTEIN 1|6.12|Kd=0.76uM|Kd|=|0.76|uM|760|nM
4TQN|1.70|2015|UL4|compound 10, UL04|Q92793|CREB-BINDING PROTEIN|6.11|Kd=0.77uM|Kd|=|0.77|uM|770|nM
5C13|2.10|2015|10-mer|ligand is histone H3C4me3 peptide|Q5VWG9|TRANSCRIPTION INITIATION FACTOR TFIID SUBUNIT 3|6.1|Kd=0.79uM|Kd|=|0.79|uM|790|nM
4X0Z|1.85|2015|4-mer|[Nonstandard assay: Temp 37, SVGA cells] GM1 oligosaccharide|P90498|MAJOR CAPSID PROTEIN|3.15|Kd=0.7mM|Kd|=|0.7|mM|700000|nM
5AGJ|2.00|2015|ANZ|[Nonstandard assay: pH=8, 50 mM HEPES-KOH, 30 mM KCl, 30 mM MgCl2] ligand is AN2690-AMP;|Q5A9A4|POTENTIAL CYTOSOLIC LEUCYL TRNA SYNTHETASE|6.15|Kd=0.7uM|Kd|=|0.7|uM|700|nM
4CWB|1.56|2015|X6L|compound 7|C8MLE4|7,8-DIHYDRO-6-HYDROXYMETHYLPTERIN-PYROPHOSPHOKINASE|6.09|Kd=0.81uM|Kd|=|0.81|uM|810|nM
3X00|1.30|2015|ZOF|ligand is bis iminobiotin long tail (Bis-IMNtail)|P22629|STREPTAVIDIN|9.08|Kd=0.83nM|Kd|=|0.83|nM|0.83|nM
4ODM|1.75|2015|16-mer|[Multiple sites: site1: Kd=0.855+/-0.332uM; site 2: Kd=18.83+/-6.2uM] TtSlyDFL:S2-W23A|Q5SLE7|PEPTIDYL-PROLYL CIS-TRANS ISOMERASE SLYD|6.07|Kd=0.855uM|Kd|=|0.855|uM|855|nM
4XK9|2.20|2015|41J|A-AChBP in complex with pinnatoxin G|Q8WSF8|ACETYLCHOLINE RECEPTOR|9.07|Kd=0.86nM|Kd|=|0.86|nM|0.86|nM
4XQU|3.25|2015|SIA-NAG-GAL|ligand is 3'-SLN|A0A059|HEMAGGLUTININ HA1|6.07|Kd=0.86uM|Kd|=|0.86|uM|860|nM
4PL6|1.68|2015|11-mer|ligand is H3K4me3 peptide|Q4V3E2|AT1G02740|3.1|Kd=0.8mM|Kd|=|0.8|mM|800000|nM
4XKB|1.50|2015|DE9|[Nonstandard assay: Temp 20, pH=7.6,Tris-HCl=100mM, NaCl=100mM] ligand is Deuteroporphyrin IX;|P72583|YCF53-LIKE PROTEIN|6.1|Kd=0.8uM|Kd|=|0.8|uM|800|nM
4TKJ|.87|2015|PLM|[Nonstandard assay: 20 mM Tris-HCl, pH 8.0, and 100 mM NaCl, or 20 mM potassium phosphate, pH 7.0, and 100 mM NaCl] ligand is palmitic acid|P05413|FATTY ACID-BINDING PROTEIN|6.04|Kd=0.913uM|Kd|=|0.913|uM|913|nM
4XTW|2.30|2015|44M|compound 46;|I6YFP0|BIFUNCTIONAL LIGASE/REPRESSOR BIRA|9.03|Kd=0.933nM|Kd|=|0.933|nM|0.933|nM
4ZB8|2.00|2015|GDS|ligand is GSSG|A0A0R4|PCURE2P6|6.03|Kd=0.94uM|Kd|=|0.94|uM|940|nM
4WRI|1.40|2015|OKA|[Different protein in assay: OABP2 is a mixture of homologues, OABP2.1, OABP2.2, and OABP2.3] crystal is OABP2.1|Q2MHR1|OKADAIC ACID BINDING PROTEIN 2-ALPHA|9.01|Kd=0.97nM|Kd|=|0.97|nM|0.97|nM
4U5V|1.97|2015|RH2|[Nonstandard assay: Temp=25,PH=6.0;100 mM citrate, 200 mM NaCl, 10% DMSO] compound 17|P52293|IMPORTIN SUBUNIT ALPHA-1|3.05|Kd=0.9mM|Kd|=|0.9|mM|900000|nM
4RIS|2.30|2015|18-mer|ligand is gp120 (165-182) L179A/I181A peptide|K7Z4Z0|ENVELOPE GLYCOPROTEIN|6.05|Kd=0.9uM|Kd|=|0.9|uM|900|nM
4TXS|2.78|2015|3AQ|fragement 114|D0PY27|POLYPROTEIN|3.0|Kd=1.01mM|Kd|=|1.01|mM|1010000|nM
4TJZ|.87|2015|DKA|[Nonstandard assay: 20 mM Tris-HCl, pH 8.0, and 100 mM NaCl, or 20 mM potassium phosphate, pH 7.0, and 100 mM NaCl] ligand is capric acid, DKA|P05413|FATTY ACID-BINDING PROTEIN|5.97|Kd=1.07uM|Kd|=|1.07|uM|1070|nM
4RR6|1.88|2015|A3S|ligand is L-Ser3AA|Q9YFY3|PROBABLE THREONINE--TRNA LIGASE 2|6.0|Kd=1.0uM|Kd|=|1|uM|1000|nM
4RA1|1.75|2015|ALX-BNX|ligand is D-Glucose-2-phosphate; mixture of alpha ALX and beta BNX|Q7D2F4|ABC TRANSPORTER, SUBSTRATE BINDING PROTEIN|5.94|Kd=1.16uM|Kd|=|1.16|uM|1160|nM
4UND|2.20|2015|2YQ|complex is PARP1/Talazoparib|P09874|POLY [ADP-RIBOSE] POLYMERASE 1|8.96|Kd=1.1nM|Kd|=|1.1|nM|1.1|nM
4CRJ|2.00|2015|YH5|compound 3|C8MLE4|7,8-DIHYDRO-6-HYDROXYMETHYLPTERIN-PYROPHOSPHOKINASE|5.96|Kd=1.1uM|Kd|=|1.1|uM|1100|nM
4D4D|1.40|2015|MAN-IFM|ligand is compound 3; 1,6-ManIFG, two combined units|Q9Z4P9|ALPHA-1,6-MANNANASE|5.96|Kd=1.1uM|Kd|=|1.1|uM|1100|nM
4RME|2.30|2015|13-mer|ligand is coactivator peptide GRIP-1|P19793|RETINOIC ACID RECEPTOR RXR-ALPHA|5.92|Kd=1.21uM|Kd|=|1.21|uM|1210|nM
4RXH|1.76|2015|8-mer|[Multiple sites: site1: Kd=1.23uM; site2: 1.69uM] ligand is SV40 NLS (125-PPKKKRKV-132) peptide|Q9C2K9|IMPORTIN SUBUNIT ALPHA|5.91|Kd=1.23uM|Kd|=|1.23|uM|1230|nM
3WTI|2.68|2015|CT4|ligand is Clothianidin|P58154|ACETYLCHOLINE-BINDING PROTEIN|5.9|Kd=1.27uM|Kd|=|1.27|uM|1270|nM
4X14|2.30|2015|4-mer|[Nonstandard assay: Temp 37, SVGA cells] ligand is GM1 oligosaccharide|P03089|MAJOR CAPSID PROTEIN VP1|2.92|Kd=1.2mM|Kd|=|1.2|mM|1200000|nM
5CT2|2.00|2015|CXS|ligand is compound CAPS|P14210|HEPATOCYTE GROWTH FACTOR|2.92|Kd=1.2mM|Kd|=|1.2|mM|1200000|nM
4Y5D|1.20|2015|MT6|ligand is ALiS-2|P22629|STREPTAVIDIN|5.92|Kd=1.2uM|Kd|=|1.2|uM|1200|nM
5EQ0|1.18|2015|6-mer|peptide inhibitor UNC3866|Q9HC52|CHROMOBOX PROTEIN HOMOLOG 8|5.92|Kd=1.2uM|Kd|=|1.2|uM|1200|nM
5CYI|2.00|2015|55S|[Covalent complex] [Incomplete ligand] CDK2/Cyclin A covalent complex with ligand NU6300, but RCSB used structure of NU6310|P24941|CYCLIN-DEPENDENT KINASE 2|5.88|Kd=1.31uM|Kd|=|1.31|uM|1310|nM
4ZEI|2.30|2015|LAO|ligand is L-arabinose-2-phosphate|Q7D2F4|ABC TRANSPORTER, SUBSTRATE BINDING PROTEIN|5.88|Kd=1.33uM|Kd|=|1.33|uM|1330|nM
4XKC|2.00|2015|MD9|[Nonstandard assay: Temp 20, pH=7.6,Tris-HCl=100mM, NaCl=100mM] ligand is Magnesium Deuteroporphyrin IX;|P72583|YCF53-LIKE PROTEIN|5.87|Kd=1.36uM|Kd|=|1.36|uM|1360|nM
4U5U|1.96|2015|3D2|[Nonstandard assay: Temp=25,PH=6.0;100 mM citrate, 200 mM NaCl, 10% DMSO] compound 16|P52293|IMPORTIN SUBUNIT ALPHA-1|2.89|Kd=1.3mM|Kd|=|1.3|mM|1300000|nM
4URX|2.49|2015|HXY|compound 4a|P01112|GTPASE HRAS|2.89|Kd=1.3mM|Kd|=|1.3|mM|1300000|nM
4CST|1.10|2015|CWK|compound 10j|P08191|FIMH PROTEIN|8.89|Kd=1.3nM|Kd|=|1.3|nM|1.3|nM
4PXM|1.90|2015|EST|radioligand binding assays|P03372|ESTROGEN RECEPTOR|8.89|Kd=1.3nM|Kd|=|1.3|nM|1.3|nM
4YC9|1.82|2015|4C1|compound 8i|O15164|TRANSCRIPTION INTERMEDIARY FACTOR 1-ALPHA|8.89|Kd=1.3nM|Kd|=|1.3|nM|1.3|nM
4X3S|1.60|2015|10-mer|[Incomplete ligand] [Different ligand in assay: Kd: binding assay SETDB1 peptide] ligand is SETDB1-K1170me3 peptide|Q8VDS3|CHROMOBOX PROTEIN HOMOLOG 7|5.89|Kd=1.3uM|Kd|=|1.3|uM|1300|nM
4XYN|2.55|2015|15-mer|[Incomplete ligand] ligand is human RAGE-derived W61 peptide;|P04271|RECEPTOR FOR ADVANCED GLYCATION ENDPRODUCTS-DERIVED PEPTIDE|5.89|Kd=1.3uM|Kd|=|1.3|uM|1300|nM
4OEX|2.14|2015|5EO|compound 1|O76074|CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE|5.84|Kd=1.45uM|Kd|=|1.45|uM|1450|nM
4YZ5|2.27|2015|SLT|[Incomplete ligand] [Nonstandard assay: PH=8, 20mM Tris, 50 mM NaCl] 3'-SL|Q97Q99|PUTATIVE NEURAMINIDASE|2.83|Kd=1.48mM|Kd|=|1.48|mM|1480000|nM
5A2J|1.65|2015|6-mer|[Nonstandard assay: 10 mM sodium phosphate buffer containing 150 mM NaCl] ligand is glycopeptide m1|P01801|SCFV-SM3|5.85|Kd=1.4uM|Kd|=|1.4|uM|1400|nM
5C0M|1.60|2015|10-mer|SGF29-HC4me3, ligand is a Carba containing peptide|Q96ES7|SAGA-ASSOCIATED FACTOR 29 HOMOLOG|5.85|Kd=1.4uM|Kd|=|1.4|uM|1400|nM
4Z46|1.85|2015|1PT|[Uncommon element] [Nonstandard assay: 10 mM Hepes, 150 mM NaCl, 3 mM EDTA] ligand is OXALIPLATIN; also contains Cisplatin in crystal|P00698|LYSOZYME C|2.82|Kd=1.51mM|Kd|=|1.51|mM|1510000|nM
4ZEC|2.15|2015|C84|ligand is agrocin 84|Q7D2F4|ABC TRANSPORTER, SUBSTRATE BINDING PROTEIN|5.82|Kd=1.5uM|Kd|=|1.5|uM|1500|nM
4YCV|3.41|2015|KRS|[Nonstandard assay: PH=8, 20 mM Tris-HCl, 200 mM NaCl, 5 mM DTT] ligand is cladosporin, Thermal Shift Assay|W7JP72|LYSINE-TRNA LIGASE|5.82|Kd=1.5uM|Kd|=|1.5|uM|1500|nM
4URW|2.76|2015|DXO|compound 3|P01112|GTPASE HRAS|2.8|Kd=1.6mM|Kd|=|1.6|mM|1600000|nM
4YW2|2.00|2015|2-mer|[Incomplete ligand] [Nonstandard assay: PH=8, 20mM Tris, 50 mM NaCl] ligand is 6'-SL|A0A0H2|SIALIDASE B|2.8|Kd=1.6mM|Kd|=|1.6|mM|1600000|nM
4WPH|2.92|2015|11-mer|ligand is ICP0 peptide|Q93009|UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 7|5.8|Kd=1.6uM|Kd|=|1.6|uM|1600|nM
4YMQ|2.00|2015|ZBD|compound 14|P51449|NUCLEAR RECEPTOR ROR-GAMMA|5.8|Kd=1.6uM|Kd|=|1.6|uM|1600|nM
4YSL|1.46|2015|GSH|ligand is glutathione;|A5VWI3|BETA-LACTAMASE DOMAIN PROTEIN|5.8|Kd=1.6uM|Kd|=|1.6|uM|1600|nM
4URV|2.58|2015|UMK|compound 2|P01112|GTPASE HRAS|2.77|Kd=1.7mM|Kd|=|1.7|mM|1700000|nM
5EA3|2.75|2015|5NK|ligand is compound JNJ-2408068|P03420|FUSION GLYCOPROTEIN F0|8.77|Kd=1.7nM|Kd|=|1.7|nM|1.7|nM
4ZDU|2.30|2015|16-mer|[Different protein in assay: delta-IBB importin-alpha(70-529)] NP ncNLS peptide;|P52293|IMPORTIN SUBUNIT ALPHA-1|5.77|Kd=1.7uM|Kd|=|1.7|uM|1700|nM
5CBR|2.00|2015|4ZK|ligand is compound (S)-37, functional Kb value|P19491|GLUTAMATE RECEPTOR 2|5.74|Kd=1.80uM|Kd|=|1.8|uM|1800|nM
4TKH|.93|2015|MYR|[Nonstandard assay: 20 mM Tris-HCl, pH 8.0, and 100 mM NaCl, or 20 mM potassium phosphate, pH 7.0, and 100 mM NaCl] ligand is myristic acid|P05413|FATTY ACID-BINDING PROTEIN|5.74|Kd=1.84uM|Kd|=|1.84|uM|1840|nM
5EPK|1.80|2015|6-mer|peptide inhibitor UNC3866|Q14781|CHROMOBOX PROTEIN HOMOLOG 2|5.74|Kd=1.8uM|Kd|=|1.8|uM|1800|nM
3WVM|.88|2015|STE|[Nonstandard assay: 20 mM Tris-HCl, pH 8.0, and 100 mM NaCl, or 20 mM potassium phosphate, pH 7.0, and 100 mM NaCl] ligand is stearic acid, STE|P05413|FATTY ACID-BINDING PROTEIN|5.71|Kd=1.95uM|Kd|=|1.95|uM|1950|nM
4CZS|1.73|2015|5-mer|ligand is 5-mer Man-WYD|P81461|CONCANAVALIN-A|5.0|Kd=10.0uM|Kd|=|10|uM|10000|nM
4XQA|1.41|2015|423|compound 17a; SPR data is available|Q64823|FIBER PROTEIN|4.99|Kd=10.3uM|Kd|=|10.3|uM|10300|nM
4WV6|1.75|2015|14-mer|[Nonstandard assay: PH=8, NaCl=150mM, Tris-HCl=25mM, belta-mercaptoethanol=1mM] ligand is TAF8-NLS peptide;|P52292|IMPORTIN SUBUNIT ALPHA-1|4.98|Kd=10.4uM|Kd|=|10.4|uM|10400|nM
4X1F|2.00|2015|3WF|[Nonstandard assay: pH 8.5, Tris-HCl 20 mM, NaCl 200 mM, TCEP 1mM, 0.05% Tween 20, 5% DMSO] ligand is Ethinyl estradiol, EE2;|O75469|NUCLEAR RECEPTOR SUBFAMILY 1 GROUP I MEMBER 2|7.97|Kd=10.8nM|Kd|=|10.8|nM|10.8|nM
4RLT|2.05|2015|FSE|ligand is Fisetin, this pdf is protected|I6Y8B9|(3R)-HYDROXYACYL-ACP DEHYDRATASE SUBUNIT HADA|4.96|Kd=10.9uM|Kd|=|10.9|uM|10900|nM
5BOJ|1.75|2015|4TX|ligand is compound GEM, Gemfibrozil|P02766|TRANSTHYRETIN|7.0|Kd=100nM|Kd|=|100|nM|100|nM
4UCD|2.66|2015|M81|compound M81|P03418|NUCLEOPROTEIN|4.0|Kd=100uM|Kd|=|100|uM|100000|nM
4X0F|3.22|2015|ROL|[Different ligand in assay: Ligand in binding assay is racemic] ligand is R-rolipram|Q07343|CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B|7.0|Kd=101nM|Kd|=|101|nM|101|nM
4W53|1.56|2015|MBN|ligand is Toluene|P00720|ENDOLYSIN|3.99|Kd=102uM|Kd|=|102|uM|102000|nM
5ABA|1.62|2015|UL7|compound 5;|P04637|CELLULAR TUMOR ANTIGEN P53|2.98|Kd=1040uM|Kd|=|1040|uM|1040000|nM
4TWT|2.85|2015|12-mer|ligand is peptide macrocycle (M21)|P01375|TUMOR NECROSIS FACTOR (TNF-ALPHA)|8.0|Kd=10nM|Kd|=|10|nM|10|nM
4XXH|2.40|2015|T6P||P36673|HTH-TYPE TRANSCRIPTIONAL REGULATOR TRER|5.0|Kd=10uM|Kd|=|10|uM|10000|nM
5CST|1.78|2015|CDP|ligand is cytidine diphosphate (CDP)|D9J2T9|RIBOSOME INACTIVATING PROTEIN|6.96|Kd=110nM|Kd|=|110|nM|110|nM
4YYN|1.85|2015|11-mer|H4(1-11) K5cr/K8cr peptide;|P21675|TRANSCRIPTION INITIATION FACTOR TFIID SUBUNIT 1|3.96|Kd=110uM|Kd|=|110|uM|110000|nM
4ZMF|2.39|2015|AMP||P42527|MYOSIN HEAVY CHAIN KINASE A|3.96|Kd=110uM|Kd|=|110|uM|110000|nM
4RGD|1.20|2015|CIT|quantitative lipid cosedimentation assays|Q47765|BACTERIOCIN AS-48|3.94|Kd=113.9uM|Kd|=|113.9|uM|113900|nM
4PGD|2.70|2015|9-mer|ligand is peptide FAPGNYPAF|P01901|H-2 CLASS I HISTOCOMPATIBILITY ANTIGEN, K-B ALPHA C|6.92|Kd=119nM|Kd|=|119|nM|119|nM
5EA7|2.85|2015|5NO|ligand is compound BMS-433771|P03420|FUSION GLYCOPROTEIN F0|7.96|Kd=11nM|Kd|=|11|nM|11|nM
5AJO|1.48|2015|17-mer|ligand is glycopeptide MUC5AC-3,13|Q10471|POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 2|4.96|Kd=11uM|Kd|=|11|uM|11000|nM
5CYV|1.52|2015|WCA|ligand is p-coumaroyl-CoA|Q0S6D0|TRANSCRIPTIONAL REGULATOR|4.96|Kd=11uM|Kd|=|11|uM|11000|nM
5FJX|2.45|2015|8-mer|ligand is Gcs1 WxxF peptide|P43621|COATOMER SUBUNIT DELTA|4.96|Kd=11uM|Kd|=|11|uM|11000|nM
4Y2Q|2.40|2015|49N|fragment 3|P34913|BIFUNCTIONAL EPOXIDE HYDROLASE 2|2.92|Kd=1200uM|Kd|=|1200|uM|1200000|nM
4QTL|1.80|2015|WWO|compound 10d|P00918|CARBONIC ANHYDRASE 2|6.92|Kd=120nM|Kd|=|120|nM|120|nM
4RH5|1.60|2015|9-mer|ligand is Eps15 pTyr849 peptide (846-854)|P26045|TYROSINE-PROTEIN PHOSPHATASE NON-RECEPTOR TYPE 3|6.9|Kd=127.3nM|Kd|=|127.3|nM|127.3|nM
5AOM|1.74|2015|FY8|compound 12;|P04637|CELLULAR TUMOR ANTIGEN P53|2.9|Kd=1270uM|Kd|=|1270|uM|1270000|nM
5E1S|2.26|2015|5JA|Inhibitor BI 885578|P06213|INSULIN RECEPTOR|7.92|Kd=12nM|Kd|=|12|nM|12|nM
4RLW|2.20|2015|BUN|ligand is Butein|I6Y8B9|(3R)-HYDROXYACYL-ACP DEHYDRATASE SUBUNIT HADA|4.87|Kd=13.4uM|Kd|=|13.4|uM|13400|nM
4RRA|1.70|2015|A3T|ligand is L-Thr3AA|Q9YFY3|PROBABLE THREONINE--TRNA LIGASE 2|4.87|Kd=13.4uM|Kd|=|13.4|uM|13400|nM
4Y3B|1.80|2015|7-mer|analogue compound 3b; ITC data for 3b is available|P31947|14-3-3 PROTEIN SIGMA|4.87|Kd=13.4uM|Kd|=|13.4|uM|13400|nM
4ZL4|2.37|2015|4PK|WEHI-842|Q6PRR9|ASPARTIC PROTEASE PM5|7.86|Kd=13.8nM|Kd|=|13.8|nM|13.8|nM
4YW7|1.82|2015|4J0|ligand is 5u3;|Q05097|PA-I GALACTOPHILIC LECTIN|6.89|Kd=130nM|Kd|=|130|nM|130|nM
4PGC|2.30|2015|9-mer|ligand is peptide FAPGN(3,5-diiodotyrosine)PAL|P01901|H-2 CLASS I HISTOCOMPATIBILITY ANTIGEN, K-B ALPHA C|5.88|Kd=1311nM|Kd|=|1311|nM|1311|nM
4XYA|2.05|2015|43S|[Nonstandard assay: NaCl=150mM, HEPES=50mM, pH=7.5(Temp 25)] compound 11;|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|5.86|Kd=1370nM|Kd|=|1370|nM|1370|nM
4WMX|2.00|2015|3R7|compound 6|P0AEX9|MBP-MCL1 CHIMERA PROTEIN|4.85|Kd=14.1uM|Kd|=|14.1|uM|14100|nM
5EFC|1.90|2015|GTP|ligand is GTP|Q9QLL6|POLYMERASE BASIC PROTEIN 2|4.85|Kd=14.1uM|Kd|=|14.1|uM|14100|nM
5E1B|1.65|2015|6-mer|ligand is SPKRIA peptide, RCC1, ITC Kd1 and kd2 is quite different|Q9BV86|N-TERMINAL XAA-PRO-LYS N-METHYLTRANSFERASE 1|4.84|Kd=14.3uM|Kd|=|14.3|uM|14300|nM
5D1R|2.00|2015|56S|ligand is compound Isopropyl laurate|P9WMC8|RV1816 TRANSCRIPTIONAL REGULATOR|4.84|Kd=14.4uM|Kd|=|14.4|uM|14400|nM
5EFA|1.90|2015|MGT|ligand is m7GTP|Q9QLL6|POLYMERASE BASIC PROTEIN 2|4.83|Kd=14.7uM|Kd|=|14.7|uM|14700|nM
4YM2|2.10|2015|SGA-BGC|ligand is lactose-3'-sulfate|P56470|GALECTIN-4|2.85|Kd=1400uM|Kd|=|1400|uM|1400000|nM
5ACW|1.80|2015|RHU|compound 1|Q9K2N0|BETA-LACTAMASE|3.84|Kd=145uM|Kd|=|145|uM|145000|nM
4RES|3.41|2015|BUF|ligand is bufalin|P05024|SODIUM/POTASSIUM-TRANSPORTING ATPASE SUBUNIT ALPHA|7.85|Kd=14nM|Kd|=|14|nM|14|nM
4X5R|1.65|2015|3XO|compound 6; Direct ITC assay|P08191|FIMH PROTEIN|7.85|Kd=14nM|Kd|=|14|nM|14|nM
4W57|1.68|2015|N4B|ligand is n-Butylbenzene|P00720|ENDOLYSIN|4.85|Kd=14uM|Kd|=|14|uM|14000|nM
4RLU|2.20|2015|HCC|ligand is HCC, 2',4,4'-TRIHYDROXYCHALCONE|I6Y8B9|(3R)-HYDROXYACYL-ACP DEHYDRATASE SUBUNIT HADA|4.82|Kd=15.2uM|Kd|=|15.2|uM|15200|nM
5D7E|1.90|2015|8-mer|ligand is H3K9ac peptide|P35189|TRANSCRIPTION INITIATION FACTOR TFIID SUBUNIT 14|3.82|Kd=150.6uM|Kd|=|150.6|uM|150600|nM
4OEW|2.44|2015|5IO|compound 5|O76074|CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE|6.82|Kd=152nM|Kd|=|152|nM|152|nM
4RRG|1.93|2015|A3T|[Multiple sites: site 1: Kd=1538.5uM; site 2: Kd=3875.9uM] ligand is L-Thr3AA|Q58597|THREONINE--TRNA LIGASE|2.81|Kd=1538.5uM|Kd|=|1538.5|uM|1538500|nM
4ODK|1.40|2015|16-mer|[Multiple sites: site 2: Kd=158+/-19uM] TtSlyDFL:T1|Q5SLE7|PEPTIDYL-PROLYL CIS-TRANS ISOMERASE SLYD|3.8|Kd=158uM|Kd|=|158|uM|158000|nM
4QPD|2.10|2015|THG|ligand is tetrahydrofolate|E3NZ06|10-FORMYLTETRAHYDROFOLATE DEHYDROGENASE|7.82|Kd=15nM|Kd|=|15|nM|15|nM
2MS4|NMR|2015|9-mer|ligand is 9-mer CrkII peptide|P62937|PEPTIDYL-PROLYL CIS-TRANS ISOMERASE A|4.82|Kd=15uM|Kd|=|15|uM|15000|nM
4XQB|1.60|2015|425|compound 17b; SPR data is available|Q64823|FIBER PROTEIN|3.79|Kd=163.4uM|Kd|=|163.4|uM|163400|nM
4WY7|2.10|2015|16-mer||P05880|FAB 4E10 HEAVY CHAIN|6.78|Kd=167nM|Kd|=|167|nM|167|nM
5AHU|2.69|2015|G76|compound 51;|C9ZSP7|FARNESYL PYROPHOSPHATE SYNTHASE|6.78|Kd=167nM|Kd|=|167|nM|167|nM
4Q46|1.80|2015|GDP||A0A0J9|POLYMERASE BASIC PROTEIN 2|3.77|Kd=169uM|Kd|=|169|uM|169000|nM
4PG9|2.40|2015|9-mer|ligand is peptide FAPGNYPAL|P01901|H-2 CLASS I HISTOCOMPATIBILITY ANTIGEN, K-B|7.8|Kd=16nM|Kd|=|16|nM|16|nM
4QJW|1.55|2015|WWO|compound 10d|O43570|CARBONIC ANHYDRASE 12|7.8|Kd=16nM|Kd|=|16|nM|16|nM
4QXT|1.58|2015|19-mer|ligand is FC27-MSP2 (14-30)|Q03643|FV FRAGMENT(MAB6D8) HEAVY CHAIN|7.8|Kd=16nM|Kd|=|16|nM|16|nM
4ODP|1.75|2015|16-mer|[Multiple sites: site 2: Kd=17.06+/-1.13uM] TtSlyD delta IF:S2-W23A|Q5SLE7|PEPTIDYL-PROLYL CIS-TRANS ISOMERASE SLYD, PEPTIDYL-PROLYL|4.77|Kd=17.06uM|Kd|=|17.06|uM|17060|nM
4WOP|2.39|2015|CTP|ligand is CTP|A5U2S7|ATP-DEPENDENT DETHIOBIOTIN SYNTHETASE BIOD|4.76|Kd=17.2uM|Kd|=|17.2|uM|17200|nM
4Z8A|1.76|2015|17-mer|[Nonstandard assay: 10 mM Tris-HCl, 100 mM NaCl] Cacophony derived peptide|P91645|RIM-BINDING PROTEIN, ISOFORM F|4.76|Kd=17.3uM|Kd|=|17.3|uM|17300|nM
4CJN|1.95|2015|QNZ|compound 2; Binding to PBP2a allosteric site; 6.9ug/mL and MW=393.39 means Kd=17.54uM|Q54113|PENICILLIN BINDING PROTEIN 2 PRIME|4.76|Kd=17.54uM|Kd|=|17.54|uM|17540|nM
4X50|2.00|2015|3X8|compound 2; Direct ITC assay|P08191|FIMH PROTEIN|7.75|Kd=17.7nM|Kd|=|17.7|nM|17.7|nM
4W5A|2.60|2015|11-mer|ligand is H3K9me3S10ph peptide|P46100|TRANSCRIPTIONAL REGULATOR ATRX|3.77|Kd=170uM|Kd|=|170|uM|170000|nM
4X63|3.05|2015|3XV|EPZ015666|O14744|PROTEIN ARGININE N-METHYLTRANSFERASE 5|6.77|Kd=171nM|Kd|=|171|nM|171|nM
4PVX|2.18|2015|YS1|ligand is YS05035|P14324|FARNESYL PYROPHOSPHATE SYNTHASE|6.76|Kd=172nM|Kd|=|172|nM|172|nM
4W52|1.50|2015|BNZ|ligand is benzene|P00720|T4 LYSOZYME|3.76|Kd=175uM|Kd|=|175|uM|175000|nM
4PGE|2.00|2015|9-mer|ligand is peptide FAPGNYPAW|P01901|H-2 CLASS I HISTOCOMPATIBILITY ANTIGEN, K-B ALPHA C|7.77|Kd=17nM|Kd|=|17|nM|17|nM
5CSZ|1.80|2015|11-mer|gantenerumab fab bind to synthetic A 40 monomers|P05067|GANTENERUMAB FAB FRAGMENT HEAVY CHAIN|7.77|Kd=17nM|Kd|=|17|nM|17|nM
5A3O|1.60|2015|DH6-MMA|[Incomplete ligand] compound 3; miss a carbon atom;|Q9HYN5|FUCOSE-BINDING LECTIN PA-IIL|4.73|Kd=18.5uM|Kd|=|18.5|uM|18500|nM
4RXZ|1.55|2015|12-mer|ligand is PMI peptide|O15151|PROTEIN MDM4|6.74|Kd=181nM|Kd|=|181|nM|181|nM
5AM6|1.96|2015|38O|ligand is TKI258, e.g. dovitinib|P11362|FIBROBLAST GROWTH FACTOR RECEPTOR 1|6.73|Kd=185nM|Kd|=|185|nM|185|nM
5E1M|1.75|2015|6-mer|ligand is PPKRIA peptide, RCC1, ITC Kd1 and kd2 is quite different|Q9BV86|N-TERMINAL XAA-PRO-LYS N-METHYLTRANSFERASE 1|6.72|Kd=189nM|Kd|=|189|nM|189|nM
5CIN|1.70|2015|15-mer|Loop+4E10ep|P05880|FAB 4E10 HEAVY CHAIN|7.74|Kd=18nM|Kd|=|18|nM|18|nM
4NXQ|2.10|2015|8-mer|Kd=18+/-1uM, QM PDZ/Caspr4;|Q13009|T-LYMPHOMA INVASION AND METASTASIS-INDUCING PROTEIN 1|4.74|Kd=18uM|Kd|=|18|uM|18000|nM
4W55|1.64|2015|3H0|ligand is n-Propylbenzene|P00720|ENDOLYSIN|4.74|Kd=18uM|Kd|=|18|uM|18000|nM
5ALB|2.16|2015|TIQ|ligand is compound ticagrelor|------|MEDI2452 HEAVY CHAIN|10.71|Kd=19.6pM|Kd|=|19.6|pM|0.019600000000000003|nM
4TYB|2.93|2015|3B1|fragement 328|D0PY27|POLYPROTEIN|1.7|Kd=19.99mM|Kd|=|19.99|mM|19990000|nM
4CRL|2.40|2015|C1I|ligand is cortistatin A|P49336|CYCLIN-DEPENDENT KINASE 8|9.71|Kd=195pM|Kd|=|195|pM|0.195|nM
4PVY|2.05|2015|JD1|ligand is JDS05119|P14324|FARNESYL PYROPHOSPHATE SYNTHASE|6.71|Kd=197nM|Kd|=|197|nM|197|nM
4U0W|2.00|2015|16G|GlcNAc-6-P (NagR), data from ref 7|O34817|HTH-TYPE TRANSCRIPTIONAL REPRESSOR YVOA|3.0|Kd=1mM|Kd|=|1|mM|1000000|nM
4X5Q|1.12|2015|3XN|compound 5; Competitive ITC assay|P08191|FIMH PROTEIN|9.0|Kd=1nM|Kd|=|1|nM|1|nM
4TKY|2.50|2015|7-mer|[Different protein in assay: wild type Escherichia coli DsbA] ligand is peptide 3: PFATCDS|P0AEG4|THIOL:DISULFIDE INTERCHANGE PROTEIN DSBA|5.7|Kd=2.0uM|Kd|=|2|uM|2000|nM
4Z0U|2.00|2015|10-mer|H1/SSB|A7ZHV1|RIBONUCLEASE H|5.7|Kd=2.0uM|Kd|=|2|uM|2000|nM
4YCW|2.90|2015|KRS|[Nonstandard assay: with LYS; Thermal Shift Assay] ligand is cladosporin|Q15046|LYSINE--TRNA LIGASE|5.68|Kd=2.1uM|Kd|=|2.1|uM|2100|nM
4ZEK|2.09|2015|LAH|ligand is L-arabinose-2-isopropylphosphate|Q52012|ABC TRANSPORTER, SUBSTRATE BINDING PROTEIN|5.66|Kd=2.2uM|Kd|=|2.2|uM|2200|nM
4XEK|1.79|2015|19-mer|[Multiple sites: site 1: Kd=2.2 uM; site 2: Kd=33 uM] ligand is Leupaxin-LD4 peptide|Q14289|PROTEIN-TYROSINE KINASE 2-BETA|5.66|Kd=2.2uM|Kd|=|2.2|uM|2200|nM
4YDN|1.35|2015|2WN|[Multiple sites: Kd1=2.3 nM; Kd2=719 nM] ligand is probe 4, protein is two T4-binding sites TTR;|P02766|TRANSTHYRETIN|8.64|Kd=2.3nM|Kd|=|2.3|nM|2.3|nM
4ZYF|1.80|2015|4T4|compound 1;|Q00987|E3 UBIQUITIN-PROTEIN LIGASE MDM2|8.64|Kd=2.3nM|Kd|=|2.3|nM|2.3|nM
5E8F|2.10|2015|5-mer|ligand is 5-mer fully modified geranylgeranylated PDE6C Peptide|O43924|RETINAL ROD RHODOPSIN-SENSITIVE CGMP 3',5'-CYCLIC PHOSPHODIESTERASE|8.64|Kd=2.3nM|Kd|=|2.3|nM|2.3|nM
4TKB|.86|2015|DAO|[Nonstandard assay: 20 mM Tris-HCl, pH 8.0, and 100 mM NaCl, or 20 mM potassium phosphate, pH 7.0, and 100 mM NaCl] ligand is lauric acid|P05413|FATTY ACID-BINDING PROTEIN|5.59|Kd=2.56uM|Kd|=|2.56|uM|2560|nM
4QJP|1.62|2015|V1F|[Nonstandard assay: Temp 37, pH 7.0] compound 9d|Q8N1Q1|CARBONIC ANHYDRASE 13|8.6|Kd=2.5nM|Kd|=|2.5|nM|2.5|nM
4WZ6|2.05|2015|ATP||P13569|CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR|5.6|Kd=2.5uM|Kd|=|2.5|uM|2500|nM
4ZZY|2.20|2015|D7N|compound 20by|Q9UGN5|POLY [ADP-RIBOSE] POLYMERASE 2|5.6|Kd=2.5uM|Kd|=|2.5|uM|2500|nM
5AFV|2.25|2015|JH5|[Nonstandard assay: NaCl=150mM; Tris/HCl=25mM] ligand is hit 10;|P35790|CHOLINE KINASE ALPHA|5.59|Kd=2.6uM|Kd|=|2.6|uM|2600|nM
5A81|2.03|2015|78J|compound 13|Q6PL18|ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 2|5.54|Kd=2.9uM|Kd|=|2.9|uM|2900|nM
5AZG|1.81|2015|10-mer|ligand is UNC-51 peptide|Q09490|PROTEIN LGG-1|5.54|Kd=2.9uM|Kd|=|2.9|uM|2900|nM
4Z89|2.64|2015|17-mer|[Incomplete ligand] Cacophony derived peptide|P91645|RIM-BINDING PROTEIN, ISOFORM F|4.69|Kd=20.2uM|Kd|=|20.2|uM|20200|nM
4Q0L|2.00|2015|V14|[Nonstandard assay: Temp=37, pH =7.0,] compound 3|O43570|CARBONIC ANHYDRASE 12|7.7|Kd=20nM|Kd|=|20|nM|20|nM
4YMG|1.90|2015|SAM|higher affinity in presence of Mg2+;|Q9HGR1|PUTATIVE SAM-DEPENDENT O-METHYLTRANFERASE|4.68|Kd=21uM|Kd|=|21|uM|21000|nM
5A5Q|1.97|2015|6XC|compound 25|Q6PL18|ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 2|4.68|Kd=21uM|Kd|=|21|uM|21000|nM
5AOJ|1.47|2015|Y0V|compound 9|P04637|CELLULAR TUMOR ANTIGEN P53|4.68|Kd=21uM|Kd|=|21|uM|21000|nM
5DHF|2.29|2015|13-mer||P62826|GTP-BINDING NUCLEAR PROTEIN RAN|5.66|Kd=2200nM|Kd|=|2200|nM|2200|nM
4Y4V|2.04|2015|DAL|[Nonstandard assay: pH=7.9, 20 mM HEPES, 150 mM sodium chloride] ligand is D-Ala|O25255|CONSERVED HYPOTHETICAL SECRETED PROTEIN|3.65|Kd=224uM|Kd|=|224|uM|224000|nM
4Q06|1.15|2015|V90|[Nonstandard assay: Temp 37 , pH =7.0,] [Different protein in assay: A65S, N67Q, I91L, F130V, V134L, L203A] compound 1|P00918|CARBONIC ANHYDRASE 2|7.66|Kd=22nM|Kd|=|22|nM|22|nM
5A46|2.63|2015|38O|ligand is dovitinib|D3DSX2|FIBROBLAST GROWTH FACTOR RECEPTOR 1|7.66|Kd=22nM|Kd|=|22|nM|22|nM
4X5Z|1.86|2015|3XY|ligand is MI-136|O00255|MENIN|7.63|Kd=23.6nM|Kd|=|23.6|nM|23.6|nM
5DQE|2.18|2015|5E4|ligand is bromo-fenamic acid, ITC Kd for TEAD2 or TEAD4 is not clear|Q15562|TRANSCRIPTIONAL ENHANCER FACTOR TEF-4|3.63|Kd=234uM|Kd|=|234|uM|234000|nM
4Y94|2.40|2015|IHP|[Nonstandard assay: 150 mM NaCl, 25 mM Tris, 5% glycerol] ligand is IP6|Q3ZC95|NON-SPECIFIC PROTEIN-TYROSINE KINASE|6.62|Kd=238nM|Kd|=|238|nM|238|nM
4RRF|1.70|2015|A3S|[Multiple sites: site 1: Kd=239.2uM; site 2: Kd=555.6uM] ligand is L-Ser3AA|Q58597|THREONINE--TRNA LIGASE|3.62|Kd=239.2uM|Kd|=|239.2|uM|239200|nM
4R73|1.60|2015|G6P|ligand is endogenous G6P/M6P mixture in crystal|A3N294|ABC-TYPE FE3+ TRANSPORT SYSTEM|7.64|Kd=23nM|Kd|=|23|nM|23|nM
5E4W|2.80|2015|9-mer|ligand is the A3CT motif IV peptide|P0AA27|THIOREDOXIN-1|4.64|Kd=23uM|Kd|=|23|uM|23000|nM
5E73|1.71|2015|UO1|ligand is compound 47|Q9UIF8|BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN PROTEIN 2B|4.64|Kd=23uM|Kd|=|23|uM|23000|nM
4YYM|1.50|2015|11-mer|H4(1-11) K5bu/K8bu peptide;|P21675|TRANSCRIPTION INITIATION FACTOR TFIID SUBUNIT 1|3.62|Kd=240uM|Kd|=|240|uM|240000|nM
4QP1|2.70|2015|EMU|compound 1|P28482|MITOGEN-ACTIVATED PROTEIN KINASE 1|3.61|Kd=247uM|Kd|=|247|uM|247000|nM
4UIN|2.50|2015|QI9|ligand is quinine|------|FAB 314.3|7.62|Kd=24nM|Kd|=|24|nM|24|nM
4XGZ|2.50|2015|19-mer|ligand is human paxillin LD2 motif|P49023|FAB HEAVY CHAIN|7.62|Kd=24nM|Kd|=|24|nM|24|nM
4YNL|2.10|2015|6-mer|ligand is Heterocyst inhibition-signaling peptide, PatS6|P27709|HETEROCYST DIFFERENTIATION CONTROL PROTEIN|4.62|Kd=24uM|Kd|=|24|uM|24000|nM
4X8O|2.10|2015|AP5|inhibitor Ap5a|P69441|ADENYLATE KINASE|6.6|Kd=250nM|Kd|=|250|nM|250|nM
5DQF|2.15|2015|CZE|ligand is Cetirizine, RS mixture in crystal (CZE/LCR)|P35747|SERUM ALBUMIN|3.6|Kd=253uM|Kd|=|253|uM|253000|nM
3X1K|2.55|2015|ANP|ligand is AMP-PNP; RCSB confused code 3x1k and 3x1m|A3LHH1|PHOSPHOPANTETHEINE ADENYLYLTRANSFERASE|3.59|Kd=256uM|Kd|=|256|uM|256000|nM
4Z2P|1.60|2015|12-mer|[Incomplete ligand] ligand is hoef-peptide(L9F)|A9D857|AVIDIN FAMILY|4.6|Kd=25uM|Kd|=|25|uM|25000|nM
5CS5|1.90|2015|PIN|ligand is compound PIPES|P14210|HEPATOCYTE GROWTH FACTOR|1.58|Kd=26.6mM|Kd|=|26.6|mM|26600000|nM
4OR4|2.21|2015|M7G|[Nonstandard assay: Temp 20] ligand is m7GDP,|A0A0J9|POLYMERASE BASIC PROTEIN 2|4.57|Kd=26.8uM|Kd|=|26.8|uM|26800|nM
4RET|4.00|2015|DGX|[Incomplete ligand] [Different ligand in assay: ligand in assay is digitoxigenin, differs for a carbon and oxygen atom] ligand is digoxin, named DGX|P05024|SODIUM/POTASSIUM-TRANSPORTING ATPASE SUBUNIT ALPHA|7.59|Kd=26nM|Kd|=|26|nM|26|nM
4XBO|2.60|2015|SAH||P0AE01|TRNA (CYTIDINE/URIDINE-2'-O-)-METHYLTRANSFERASE TRM|4.59|Kd=26uM|Kd|=|26|uM|26000|nM
4X3K|1.45|2015|7-mer|ligand is H3K27me3 peptide|Q8VDS3|CHROMOBOX PROTEIN HOMOLOG 7|4.56|Kd=27.7uM|Kd|=|27.7|uM|27700|nM
5A7B|1.40|2015|KMN|compound 3|P04637|CELLULAR TUMOR ANTIGEN P53|3.57|Kd=271uM|Kd|=|271|uM|271000|nM
4YRD|2.44|2015|3IT|3-isopropenyl-tropolone;|Q99X63|CAPSULAR POLYSACCHARIDE SYNTHESIS ENZYME CAP5F|4.57|Kd=27uM|Kd|=|27|uM|27000|nM
4X3T|2.14|2015|45E|ligand is MS37452|Q8VDS3|CHROMOBOX PROTEIN HOMOLOG 7|4.54|Kd=28.9uM|Kd|=|28.9|uM|28900|nM
5BTX|2.10|2015|CMP|ligand is CYCLIC AMP, CAMP|G8UY02|LPG1496|3.55|Kd=280uM|Kd|=|280|uM|280000|nM
4X2S|4.21|2015|ASP|[Nonstandard assay: NaCl=100mM]|O59010|425AA LONG HYPOTHETICAL PROTON GLUTAMATE SYMPORT|6.55|Kd=285nM|Kd|=|285|nM|285|nM
4YWA|1.19|2015|4J9|3u3;|Q05097|PA-I GALACTOPHILIC LECTIN|7.55|Kd=28nM|Kd|=|28|nM|28|nM
5DMS|1.90|2015|9-mer|ligand is 9-mer F-box only protein 43|Q07832|SERINE/THREONINE-PROTEIN KINASE PLK1|4.53|Kd=29.58uM|Kd|=|29.58|uM|29580|nM
4Z7F|3.19|2015|FOL|[Nonstandard assay: PH=8, 20mM Tris-HCl, 100mM NaCl, 0.018% (w/v) n-Dodecyl-beta-D-Maltopyranoside] FOLIC ACID;|Q837A3|FOLATE ECF TRANSPORTER|7.53|Kd=29.8nM|Kd|=|29.8|nM|29.8|nM
5CQU|2.35|2015|JRJ|compound 14, final deposition|P68400|CASEIN KINASE II, ALPHA SUBUNIT|6.54|Kd=290nM|Kd|=|290|nM|290|nM
4RWJ|2.49|2015|66T|ligand is AZD4547|P11362|FIBROBLAST GROWTH FACTOR RECEPTOR 1|8.7|Kd=2nM|Kd|=|2|nM|2|nM
5BNJ|2.64|2015|4TV|ligand is compound 1|P49336|CYCLIN-DEPENDENT KINASE 8|8.7|Kd=2nM|Kd|=|2|nM|2|nM
5E8R|2.55|2015|5L6|ligand is compound MS023|Q96LA8|PROTEIN ARGININE N-METHYLTRANSFERASE 6|8.7|Kd=2nM|Kd|=|2|nM|2|nM
4ZBA|1.50|2015|GDS|ligand is GSSG|A0A0R4|PCURE2P8|5.51|Kd=3.09uM|Kd|=|3.09|uM|3090|nM
4URZ|2.24|2015|VJP|compound 6|P01112|GTPASE HRAS|2.52|Kd=3.0mM|Kd|=|3|mM|3000000|nM
4RT0|1.80|2015|C2E|[Different protein in assay: L69M in crystal, wildtype in assay] ligand is c-di-GMP|Q9HY69|ALGINATE BIOSYNTHESIS PROTEIN ALG44|5.5|Kd=3.13uM|Kd|=|3.13|uM|3130|nM
4U5N|2.31|2015|3D4|[Nonstandard assay: Temp=25,PH=6.0;100 mM citrate, 200 mM NaCl, 10% DMSO] compound 12;|P52293|IMPORTIN SUBUNIT ALPHA-1|2.48|Kd=3.3mM|Kd|=|3.3|mM|3300000|nM
4UC5|2.19|2015|PHE|[Multiple sites: site 1: Kd=3.3 uM; site 2: Kd=11 uM] ligand is allosteric inhibitor phe, two binding site|Q9K169|PHOSPHO-2-DEHYDRO-3-DEOXYHEPTONATE ALDOLASE|5.48|Kd=3.3uM|Kd|=|3.3|uM|3300|nM
4X8P|2.20|2015|12-mer|[Nonstandard assay: PH=8, NaCl=150mM, Tris-HCl =25mM, BME=5mM] ligand is RbBP5;|Q9UBL3|SET1/ASH2 HISTONE METHYLTRANSFERASE COMPLEX SUBUNIT|5.48|Kd=3.3uM|Kd|=|3.3|uM|3300|nM
4YCU|2.10|2015|KRS|[Nonstandard assay: with LYS; Thermal Shift Assay] ligand is cladosporin|Q15046|LYSINE--TRNA LIGASE|5.48|Kd=3.3uM|Kd|=|3.3|uM|3300|nM
4QB3|.94|2015|30M|compound 4b, Olinone|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|5.47|Kd=3.4uM|Kd|=|3.4|uM|3400|nM
4RRQ|1.79|2015|A3S|[Different protein in assay: Protein in binding assay is wild type] ligand is L-Ser3AA|Q9UZ14|THREONYL-TRNA LIGASE|5.47|Kd=3.4uM|Kd|=|3.4|uM|3400|nM
4X3E|2.30|2015|13-mer|[Incomplete ligand] ligand is trimethylated Jarid2K116me3 peptide;|O75530|POLYCOMB PROTEIN EED|5.47|Kd=3.4uM|Kd|=|3.4|uM|3400|nM
4XCB|1.60|2015|HY0|ligand is hygromycin B;|Q2MFS1|OXIDASE/HYDROXYLASE|5.47|Kd=3.4uM|Kd|=|3.4|uM|3400|nM
4CSS|1.07|2015|CWX|compound 10e|P08191|FIMH PROTEIN|8.46|Kd=3.5nM|Kd|=|3.5|nM|3.5|nM
4D62|2.50|2015|SIA|[Nonstandard assay: pH=6.0, 10 mM MES-NaOH] ligand is 3-sialyllactose, also named as SIA in RCSB|Q2TLC1|FIBER KNOB DOMAIN|2.44|Kd=3.64mM|Kd|=|3.64|mM|3640000|nM
4OFB|3.05|2015|14-mer|ligand is nonphosphopeptide inhibitor 8.6 3-14|P38398|BREAST CANCER TYPE 1 SUSCEPTIBILITY PROTEIN|5.43|Kd=3.7uM|Kd|=|3.7|uM|3700|nM
5E1O|2.00|2015|6-mer|ligand is RPKRIA peptide, RCC1, ITC Kd1 and kd2 is quite different|Q9BV86|N-TERMINAL XAA-PRO-LYS N-METHYLTRANSFERASE 1|5.43|Kd=3.7uM|Kd|=|3.7|uM|3700|nM
5EY9|2.50|2015|5SV|[Incomplete ligand] ligand is AMPC12; But still find AMPC20 in RCSB PDB; MST Kd data|B2HMK0|LONG-CHAIN-FATTY-ACID--AMP LIGASE FADD32|5.41|Kd=3.87uM|Kd|=|3.87|uM|3870|nM
4U5O|2.00|2015|3D5|[Nonstandard assay: Temp=25,PH=6.0;100 mM citrate, 200 mM NaCl, 10% DMSO] compound 15|P52293|IMPORTIN SUBUNIT ALPHA-1|2.42|Kd=3.8mM|Kd|=|3.8|mM|3800000|nM
5CBS|1.80|2015|E42|ligand is compound (R)-38, functional Kb value|P19491|GLUTAMATE RECEPTOR 2|5.41|Kd=3.90uM|Kd|=|3.9|uM|3900|nM
4U5S|2.12|2015|3D0|[Nonstandard assay: Temp=25,PH=6.0;100 mM citrate, 200 mM NaCl, 10% DMSO] compound 13|P52293|IMPORTIN SUBUNIT ALPHA-1|2.41|Kd=3.9mM|Kd|=|3.9|mM|3900000|nM
2MPS|NMR|2015|16-mer|ligand is Tumor protein p73 TAD(10-25)|Q00987|E3 UBIQUITIN-PROTEIN LIGASE MDM2|5.41|Kd=3.9uM|Kd|=|3.9|uM|3900|nM
5CT1|2.00|2015|NHE|ligand is compound CHES|P14210|HEPATOCYTE GROWTH FACTOR|1.52|Kd=30.2mM|Kd|=|30.2|mM|30200000|nM
4WEY|1.55|2015|EG6|compound 41|C5WBA2|THIOL:DISULFIDE INTERCHANGE PROTEIN|3.5|Kd=318uM|Kd|=|318|uM|318000|nM
4ZPH|2.80|2015|PRL|[Nonstandard assay: pH=8, 20mM Tris, 400mM NaCl] ligand is Proflavine|P53762|ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR|7.51|Kd=31nM|Kd|=|31|nM|31|nM
4Z2O|1.17|2015|12-mer|Hoef-peptide; high resolution|A9D857|AVIDIN FAMILY|4.51|Kd=31uM|Kd|=|31|uM|31000|nM
3WUT|2.30|2015|14-mer|ligand is TEX14 (792-804) peptide|Q53EZ4|CENTROSOMAL PROTEIN OF 55 KDA|6.49|Kd=323nM|Kd|=|323|nM|323|nM
4V11|1.95|2015|10-mer|ligand is SV2A peptide phosphorylated at Thr84, SV2A pT84|P21579|SYNAPTOTAGMIN-1|6.49|Kd=324nM|Kd|=|324|nM|324|nM
4YM4|3.12|2015|12-mer|Thr9 phosphorylated N-terminal peptide 1-15;|Q96CG3|TRAF-INTERACTING PROTEIN WITH FHA DOMAIN-CONTAINING|4.47|Kd=33.6uM|Kd|=|33.6|uM|33600|nM
4PGB|2.80|2015|9-mer|ligand is peptide FAPGNWPAL|P01901|H-2 CLASS I HISTOCOMPATIBILITY ANTIGEN, K-B ALPHA C|7.48|Kd=33nM|Kd|=|33|nM|33|nM
4ODQ|2.00|2015|16-mer|[Multiple sites: site 2: Kd=34.25+/-3.40uM] TtSlyD delta IF:S3|Q5SLE7|PEPTIDYL-PROLYL CIS-TRANS ISOMERASE SLYD, PEPTIDYL-PROLYL|4.47|Kd=34.25uM|Kd|=|34.25|uM|34250|nM
5C3P|2.10|2015|AKG|ligand is compound alpha-KG|Q7RYZ9|THYMINE DIOXYGENASE|4.46|Kd=34.4uM|Kd|=|34.4|uM|34400|nM
4ZJI|1.99|2015|4OQ|compound 11|Q13153|SERINE/THREONINE-PROTEIN KINASE PAK 1|6.47|Kd=340nM|Kd|=|340|nM|340|nM
4QP6|3.10|2015|36N|compound 3|P28482|MITOGEN-ACTIVATED PROTEIN KINASE 1|3.46|Kd=343uM|Kd|=|343|uM|343000|nM
5DTJ|2.71|2015|5G8|ligand is reactivator compound SP134|P21836|ACETYLCHOLINESTERASE|4.47|Kd=34uM|Kd|=|34|uM|34000|nM
5EAY|1.55|2015|13-mer|ligand is 13-mer human Dna2 peptide (residues 1 to 20) containing the alpha 1 helix|P27694|REPLICATION PROTEIN A 70 KDA DNA-BINDING SUBUNIT|4.47|Kd=34uM|Kd|=|34|uM|34000|nM
5AZF|1.60|2015|4-mer|ligand is 4-mer WEEL peptide|Q09490|PROTEIN LGG-1|4.44|Kd=36.1uM|Kd|=|36.1|uM|36100|nM
4RRR|1.86|2015|A3T|[Different protein in assay: Protein in binding assay is wild type] ligand is L-Thr3AA|Q9UZ14|THREONYL-TRNA LIGASE|4.44|Kd=36.2uM|Kd|=|36.2|uM|36200|nM
4X21|1.95|2015|3WH|compound 7d;|P53779|MITOGEN-ACTIVATED PROTEIN KINASE 10|7.44|Kd=36nM|Kd|=|36|nM|36|nM
4Z8M|2.95|2015|19-mer|MAVS T6BM2 peptide|Q9Y4K3|TNF RECEPTOR-ASSOCIATED FACTOR 6|7.44|Kd=36nM|Kd|=|36|nM|36|nM
4Y16|2.60|2015|48G|NC-alphaGC;|P11609|ANTIGEN-PRESENTING GLYCOPROTEIN CD1D1|7.43|Kd=37.1nM|Kd|=|37.1|nM|37.1|nM
4QN9|2.65|2015|DXC|ligand is detergent sodium deoxycholate (DC)|Q6IQ20|N-ACYL-PHOSPHATIDYLETHANOLAMINE-HYDROLYZING PHOSPHO|4.41|Kd=38.5uM|Kd|=|38.5|uM|38500|nM
5AEL|2.60|2015|QAF|compound 5|Q86C09|FARNESYL PYROPHOSPHATE SYNTHASE|7.41|Kd=39.2nM|Kd|=|39.2|nM|39.2|nM
5C5H|2.40|2015|4YB|ligand is OSB-AMS|P37353|2-SUCCINYLBENZOATE--COA LIGASE|6.4|Kd=394nM|Kd|=|394|nM|394|nM
4XY8|1.70|2015|43U|[Nonstandard assay: NaCl=150mM, HEPES=50mM, pH=7.5(Temp 25)] compound 7d;|Q9H8M2|BROMODOMAIN-CONTAINING PROTEIN 9|6.4|Kd=397nM|Kd|=|397|nM|397|nM
4WN5|1.15|2015|MVC|ligand is 18:1-1-monoacylglycerol;|Q9Y2N7|HYPOXIA-INDUCIBLE FACTOR 3-ALPHA|7.41|Kd=39nM|Kd|=|39|nM|39|nM
5EA6|2.75|2015|5NP|ligand is compound BTA-9881|P03420|FUSION GLYCOPROTEIN F0|7.41|Kd=39nM|Kd|=|39|nM|39|nM
5E74|1.78|2015|5KH|ligand is compound 50|Q9UIF8|BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN PROTEIN 2B|4.41|Kd=39uM|Kd|=|39|uM|39000|nM
4TYA|2.94|2015|3AE|fragment 204|D0PY27|POLYPROTEIN|2.39|Kd=4.04mM|Kd|=|4.04|mM|4040000|nM
4CL6|2.41|2015|7SB|[Nonstandard assay: Temp 20, pH=7.5, 100 mM sodium phosphate, 7.5% DMSO] ligand is N42FTA|O33877|3-HYDROXYDECANOYL-[ACYL-CARRIER-PROTEIN] DEHYDRATASE|5.39|Kd=4.05uM|Kd|=|4.05|uM|4050|nM
4U5L|2.53|2015|3D6|[Nonstandard assay: Temp=25,PH=6.0;100 mM citrate, 200 mM NaCl, 10% DMSO] compound 11|P52293|IMPORTIN SUBUNIT ALPHA-1|2.4|Kd=4.0mM|Kd|=|4|mM|4000000|nM
4RQZ|2.40|2015|10-mer|ligand is 10-mer activating peptide|H9UXC8|PROTEASE DEGS|5.4|Kd=4.0uM|Kd|=|4|uM|4000|nM
4Z88|2.09|2015|17-mer|[Incomplete ligand] Aplip1 peptide|Q9W0K0|RIM-BINDING PROTEIN, ISOFORM F|5.39|Kd=4.1uM|Kd|=|4.1|uM|4100|nM
5E1D|1.45|2015|6-mer|ligand is YPKRIA peptide, RCC1, ITC Kd1 and kd2 is quite different|Q9BV86|N-TERMINAL XAA-PRO-LYS N-METHYLTRANSFERASE 1|5.39|Kd=4.1uM|Kd|=|4.1|uM|4100|nM
5D21|1.90|2015|56N|ligand is compound GalAxPSG3|A0A073|LECA|8.38|Kd=4.2nM|Kd|=|4.2|nM|4.2|nM
4XC2|1.90|2015|11-mer|[Different protein in assay: 15N-labeled GABARAPL1] KBTBD6 AIM peptide;|Q6IAW1|GABA(A) RECEPTOR-ASSOCIATED PROTEIN|5.37|Kd=4.3uM|Kd|=|4.3|uM|4300|nM
4YEF|1.72|2015|4CQ|gBCD;|P80386|5'-AMP-ACTIVATED PROTEIN KINASE SUBUNIT BETA-1|5.35|Kd=4.44uM|Kd|=|4.44|uM|4440|nM
4WRQ|2.41|2015|18-mer|[Incomplete ligand] ligand is Chibby peptide|P63104|14-3-3 PROTEIN ZETA/DELTA|5.34|Kd=4.6uM|Kd|=|4.6|uM|4600|nM
4R07|2.00|2015|UCG|[Nonstandard assay: Temp=298K,pH =5.5, NaCL=100 mM ] ligand is ORN06|Q9NR97|TOLL-LIKE RECEPTOR 8|5.32|Kd=4.8uM|Kd|=|4.8|uM|4800|nM
4OR6|2.29|2015|GDP|[Nonstandard assay: Temp 20] ligand is GDP,|A0A0J9|POLYMERASE BASIC PROTEIN 2|5.31|Kd=4.9uM|Kd|=|4.9|uM|4900|nM
4OMK|1.75|2015|SQL|ligand is squalene|O76054|SEC14-LIKE PROTEIN 2|4.4|Kd=40.10uM|Kd|=|40.1|uM|40100|nM
4QJO|1.80|2015|V1F|[Nonstandard assay: Temp 37, pH 7.0] compound 9d|O43570|CARBONIC ANHYDRASE 12|7.4|Kd=40nM|Kd|=|40|nM|40|nM
5AER|2.19|2015|14-mer|D2 Receptor peptide; 1:2 two-site binding model|P62168|NEURONAL CALCIUM SENSOR 1|4.4|Kd=40uM|Kd|=|40|uM|40000|nM
5CIL|1.81|2015|13-mer|WDWD+4E10ep|P05880|FAB 4E10 HEAVY CHAIN|7.39|Kd=41nM|Kd|=|41|nM|41|nM
4ZT8|1.98|2015|CYT|ligand is CYS; SPR Kd=41uM, fluorescence Kd=0.23mM|D9J2T9|RIBOSOME INACTIVATING PROTEIN|4.39|Kd=41uM|Kd|=|41|uM|41000|nM
4XTT|2.71|2015|2BA||J9USJ9|PUTATIVE POTASSIUM TRANSPORT PROTEIN|7.37|Kd=43.1nM|Kd|=|43.1|nM|43.1|nM
4Z93|1.27|2015|4LD|compound 18|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|7.35|Kd=44.6nM|Kd|=|44.6|nM|44.6|nM
4WYP|1.50|2015|AMP|[Nonstandard assay: PH=6.4, 20mM MES] ligand is 5'AMP|P61823|RIBONUCLEASE|3.36|Kd=440uM|Kd|=|440|uM|440000|nM
3WSY|3.11|2015|15-mer|ligand is propeptide fragment: pro14-28|Q92673|SORTILIN-RELATED RECEPTOR|6.36|Kd=441nM|Kd|=|441|nM|441|nM
4WET|1.63|2015|WEF|compound 40|C5WBA2|THIOL:DISULFIDE INTERCHANGE PROTEIN|3.35|Kd=444uM|Kd|=|444|uM|444000|nM
4XMB|2.43|2015|41P|compound 12e|Q14145|KELCH-LIKE ECH-ASSOCIATED PROTEIN 1|7.36|Kd=44nM|Kd|=|44|nM|44|nM
4U7O|2.40|2015|AN2|AMPPNP|C6VIM1|HISTIDINE PROTEIN KINASE|3.35|Kd=450uM|Kd|=|450|uM|450000|nM
4CP5|2.32|2015|EOI|ligand is compound 6, S-PMPApp|P22887|NUCLEOSIDE DIPHOSPHATE KINASE|3.34|Kd=452uM|Kd|=|452|uM|452000|nM
4XY9|1.83|2015|43U|[Nonstandard assay: NaCl=150mM, HEPES=50mM, pH=7.5(Temp 25)] compound 7d;|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|5.33|Kd=4651nM|Kd|=|4651|nM|4651|nM
4NXR|1.90|2015|8-mer|Kd=46+/-2uM, QM PDZ/NRXN1|Q13009|T-LYMPHOMA INVASION AND METASTASIS-INDUCING PROTEIN 1|4.34|Kd=46uM|Kd|=|46|uM|46000|nM
5AGI|1.47|2015|ANZ|[Nonstandard assay: pH=8, 50 mM HEPES-KOH, 30 mM KCl, 30 mM MgCl2] ligand is AN2690-AMP;|Q5A9A4|POTENTIAL CYTOSOLIC LEUCYL TRNA SYNTHETASE|4.34|Kd=46uM|Kd|=|46|uM|46000|nM
5AB9|1.36|2015|92O|compound 2;|P04637|CELLULAR TUMOR ANTIGEN P53|6.33|Kd=470nM|Kd|=|470|nM|470|nM
5AOL|1.50|2015|UFV|compound 11;|P04637|CELLULAR TUMOR ANTIGEN P53|2.32|Kd=4800uM|Kd|=|4800|uM|4800000|nM
4QJ0|1.55|2015|WWX|compound 10p|O43570|CARBONIC ANHYDRASE 12|7.32|Kd=48nM|Kd|=|48|nM|48|nM
4UCC|2.05|2015|ZKW|compound M76|P03418|NUCLEOPROTEIN|4.32|Kd=48uM|Kd|=|48|uM|48000|nM
4U68|1.80|2015|11-mer|Rhi-CD structure with H3K9me3 peptide|Q7JXA8|RHINO|4.31|Kd=49.3uM|Kd|=|49.3|uM|49300|nM
4Z6I|1.95|2015|4L3|[Nonstandard assay: Temp 15, 20 mM HEPES, 150 mM NaCl, 0.5 mM TCEP] compound (2R,3S)-24|Q9H8M2|BROMODOMAIN-CONTAINING PROTEIN 9|6.31|Kd=493nM|Kd|=|493|nM|493|nM
5FJW|2.80|2015|9-mer|ligand is Dsl1 WxWx(MSE) peptide|P43621|COATOMER SUBUNIT DELTA|5.4|Kd=4uM|Kd|=|4|uM|4000|nM
4X1Q|2.28|2015|10-mer|[Incomplete ligand] [Nonstandard assay: NaCl=140mM, sodium phosphate=20mM] ligand is Mupain-1;|P00749|MUPAIN-1|5.3|Kd=5.04uM|Kd|=|5.04|uM|5040|nM
5E0M|1.65|2015|13-mer|ligand is 13-mer Protein Chica peptide, Chica (468-476)|Q24117|DYNEIN LIGHT CHAIN 1|5.28|Kd=5.2uM|Kd|=|5.2|uM|5200|nM
4OMJ|1.60|2015|2TX|ligand is 2,3-oxidosqualene|O76054|SEC14-LIKE PROTEIN 2|5.26|Kd=5.44uM|Kd|=|5.44|uM|5440|nM
5A4C|2.09|2015|XOJ|ligand is PDA|P11362|FIBROBLAST GROWTH FACTOR RECEPTOR 1|8.24|Kd=5.7nM|Kd|=|5.7|nM|5.7|nM
4X6S|2.55|2015|11-mer|peptide 2;|Q14451|GROWTH FACTOR RECEPTOR-BOUND PROTEIN 7|5.24|Kd=5.7uM|Kd|=|5.7|uM|5700|nM
4Y59|1.22|2015|T21|ligand is ALiS-1|P22629|STREPTAVIDIN|5.24|Kd=5.8uM|Kd|=|5.8|uM|5800|nM
4Z7Q|2.70|2015|5-mer|AGDV-NH2 peptide;|P08514|INTEGRIN ALPHA-IIB|4.29|Kd=50.9uM|Kd|=|50.9|uM|50900|nM
4Q08|1.07|2015|V90|compound 1|P00918|CARBONIC ANHYDRASE 2|6.3|Kd=500nM|Kd|=|500|nM|500|nM
4QIY|1.30|2015|WWX|[Nonstandard assay: Temp 37, pH=7] compound 10p|P00918|CARBONIC ANHYDRASE 2|7.3|Kd=50nM|Kd|=|50|nM|50|nM
5A14|2.00|2015|LQ5|[Nonstandard assay: Temp=10 or 15C, 50 mM HEPES, 300 mM NaCl, 1 mM DTT] compound 1;|P24941|CYCLIN-DEPENDENT KINASE 2|7.3|Kd=50nM|Kd|=|50|nM|50|nM
4WYZ|1.45|2015|U3P|[Nonstandard assay: PH=6.4, 20mM MES] ligand is 3'UMP;|P61823|RIBONUCLEASE|4.3|Kd=50uM|Kd|=|50|uM|50000|nM
4XHV|1.23|2015|10-mer|Nrx-1 C-term peptide|D1Z359|LP20995P|4.3|Kd=50uM|Kd|=|50|uM|50000|nM
4ZME|1.98|2015|ADN|Adenosine;|P42527|MYOSIN HEAVY CHAIN KINASE A|4.3|Kd=50uM|Kd|=|50|uM|50000|nM
4QJX|1.95|2015|WWO|compound 10d|Q8N1Q1|CARBONIC ANHYDRASE 13|7.28|Kd=52nM|Kd|=|52|nM|52|nM
5CFB|3.04|2015|SY9|ligand is Strychnine|O75311|GLYCINE RECEPTOR SUBUNIT ALPHA-3,GLYCINE RECEPTOR|7.28|Kd=52nM|Kd|=|52|nM|52|nM
4QFO|2.30|2015|2-mer|ligand is Met-Leu|A7Y7W1|ABC TRANSPORTER PERIPLASMIC PEPTIDE-BINDING PROTEIN|4.27|Kd=53.4uM|Kd|=|53.4|uM|53400|nM
4RYL|2.10|2015|3ZG|ligand is SGC707, binds an allosteric site at the interface of the two PRMT3 subunits|Q8WUV3|PRMT3 PROTEIN|7.28|Kd=53nM|Kd|=|53|nM|53|nM
4R0A|1.90|2015|URI|ligand is uridine|Q9NR97|TOLL-LIKE RECEPTOR 8|4.26|Kd=55uM|Kd|=|55|uM|55000|nM
4R75|1.28|2015|S7P|ligand is S7P|A3N294|ABC-TYPE FE3+ TRANSPORT SYSTEM|7.24|Kd=57nM|Kd|=|57|nM|57|nM
4QFP|1.90|2015|2-mer|ligand is Val-Thr|A7Y7W1|ABC TRANSPORTER PERIPLASMIC PEPTIDE-BINDING PROTEIN|4.23|Kd=58.6uM|Kd|=|58.6|uM|58600|nM
4UIL|2.85|2015|QI9|ligand is quinine|------|FAB 314.1|7.24|Kd=58nM|Kd|=|58|nM|58|nM
4X3H|2.40|2015|9-mer|[Nonstandard assay: PH=8, 10 mM Tris-Cl, 0.5% NP-40, 100 mM NaCl] TARPgamma2 peptide|Q63053|ACTIVITY-REGULATED CYTOSKELETON-ASSOCIATED PROTEIN|4.23|Kd=59.4uM|Kd|=|59.4|uM|59400|nM
5DIF|2.09|2015|15-mer||P62826|GTP-BINDING NUCLEAR PROTEIN RAN|6.23|Kd=590nM|Kd|=|590|nM|590|nM
4UNP|2.30|2015|TXW|compound 28, Kd data available|P9WKE0|THYMIDYLATE KINASE|3.23|Kd=590uM|Kd|=|590|uM|590000|nM
4PYY|1.75|2015|V14|[Nonstandard assay: Temp 37 , pH =7.0,] compound 3|P00918|CARBONIC ANHYDRASE 2|7.23|Kd=59nM|Kd|=|59|nM|59|nM
5AJP|1.65|2015|17-mer|ligand is glycopeptide MUC5AC-13, assay with UDP and Mn2+|Q10471|POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 2|5.3|Kd=5uM|Kd|=|5|uM|5000|nM
5DAH|2.61|2015|11-mer|[Different ligand in assay: ligand is Histone H3 peptide (15-34)] ligand in paper is Histone H3 peptide (1-36), but only 11-mer in PDB|P55197|PROTEIN AF-10|5.3|Kd=5uM|Kd|=|5|uM|5000|nM
4URU|2.83|2015|6W2|compound 1|P01112|GTPASE HRAS|2.22|Kd=6.0mM|Kd|=|6|mM|6000000|nM
4URY|2.47|2015|RV1|compound 5|P01112|GTPASE HRAS|2.22|Kd=6.0mM|Kd|=|6|mM|6000000|nM
4X5P|1.00|2015|3XJ|compound 7; Direct ITC assay|P08191|FIMH PROTEIN|8.21|Kd=6.2nM|Kd|=|6.2|nM|6.2|nM
5ACY|2.01|2015|9S3|I-BET858|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|8.19|Kd=6.4nM|Kd|=|6.4|nM|6.4|nM
4Q09|1.20|2015|V14|compound 3|P00918|CARBONIC ANHYDRASE 2|8.17|Kd=6.7nM|Kd|=|6.7|nM|6.7|nM
4QJM|1.75|2015|V1F|[Nonstandard assay: Temp 37, pH 7.0] compound 9d|P00918|CARBONIC ANHYDRASE 2|8.17|Kd=6.7nM|Kd|=|6.7|nM|6.7|nM
3WUV|2.79|2015|14-mer|ligand is ALIXN-TEX14C chimera peptide 2|Q53EZ4|CENTROSOMAL PROTEIN OF 55 KDA|5.17|Kd=6.7uM|Kd|=|6.7|uM|6700|nM
5AUT|1.70|2015|2AN|ligand is compound ANS|P53355|DEATH-ASSOCIATED PROTEIN KINASE 1|5.17|Kd=6.7uM|Kd|=|6.7|uM|6700|nM
5AHW|2.15|2015|CMP||A0QYW6|UNIVERSAL STRESS PROTEIN|5.17|Kd=6.82uM|Kd|=|6.82|uM|6820|nM
4ZUD|2.80|2015|OLM|ligand is olmesartan;|P0ABE7|CHIMERA PROTEIN OF SOLUBLE CYTOCHROME B562 AND TYPE|8.16|Kd=6.9nM|Kd|=|6.9|nM|6.9|nM
4YY6|1.45|2015|11-mer|butyryllysine peptide H4(1-11) K5bu/K8bu|Q9H8M2|BROMODOMAIN-CONTAINING PROTEIN 9|4.22|Kd=60uM|Kd|=|60|uM|60000|nM
4Z6H|1.80|2015|4L2|[Nonstandard assay: Temp 15, 20 mM HEPES, 150 mM NaCl, 0.5 mM TCEP] compound 6|Q9H8M2|BROMODOMAIN-CONTAINING PROTEIN 9|6.21|Kd=612nM|Kd|=|612|nM|612|nM
4X1P|1.60|2015|10-mer|[Incomplete ligand] [Nonstandard assay: PH=5, 10 mM sodium acetate] ligand is mupain-1-17; 4x0w is lower resolution structure;|P00749|UROKINASE-TYPE PLASMINOGEN ACTIVATOR|4.2|Kd=62.8uM|Kd|=|62.8|uM|62800|nM
5AM7|1.96|2015|38O|ligand is TKI258, e.g. dovitinib|P11362|FIBROBLAST GROWTH FACTOR RECEPTOR 1|7.19|Kd=64.5nM|Kd|=|64.5|nM|64.5|nM
4QY8|1.35|2015|19-mer|ligand is 3D7-MSP2 (14-30)|P50498|FV FRAGMENT(MAB6D8) HEAVY CHAIN|7.19|Kd=64nM|Kd|=|64|nM|64|nM
4RWK|2.98|2015|66T|ligand is AZD4547|P11362|FIBROBLAST GROWTH FACTOR RECEPTOR 1|7.19|Kd=64nM|Kd|=|64|nM|64|nM
4YYI|1.50|2015|11-mer|H4(1-11) K5ac/K8ac peptide;|Q9H8M2|BROMODOMAIN-CONTAINING PROTEIN 9|4.19|Kd=64uM|Kd|=|64|uM|64000|nM
4UCE|2.95|2015|MZS|compound M72|P03418|NUCLEOPROTEIN|3.17|Kd=680uM|Kd|=|680|uM|680000|nM
5BV3|2.25|2015|M7G|ligand is m7GDP, Kd=68nM for close site|Q06151|M7GPPPX DIPHOSPHATASE|7.17|Kd=68nM|Kd|=|68|nM|68|nM
4W54|1.79|2015|PYJ|ligand is Ethylbenzene|P00720|ENDOLYSIN|4.17|Kd=68uM|Kd|=|68|uM|68000|nM
5F2K|1.60|2015|SAH||B2HHT4|FATTY ACID O-METHYLTRANSFERASE|6.16|Kd=697nM|Kd|=|697|nM|697|nM
4X11|2.30|2015|SIA|[Nonstandard assay: Temp 37, SVGA cells] ligand is GD1a oligosaccharide|P90498|MAJOR CAPSID PROTEIN|2.22|Kd=6mM|Kd|=|6|mM|6000000|nM
4PDK|2.80|2015|3VV|[Multiple sites: site 1: Kd=6nM; site 2: Kd=88nM]|Q9KQU8|FATTY ACID METABOLISM REGULATOR PROTEIN|8.22|Kd=6nM|Kd|=|6|nM|6|nM
4QYO|1.21|2015|11-mer|ligand is peptide MSP2 (14-22)|Q03643|FV FRAGMENT(MAB6D8) HEAVY CHAIN|8.22|Kd=6nM|Kd|=|6|nM|6|nM
4R3S|1.70|2015|15-mer|ligand is peptide MSP2 (11-23)|Q9GQZ3|FV FRAGMENT(MAB6D8) HEAVY CHAIN|8.22|Kd=6nM|Kd|=|6|nM|6|nM
4XCU|1.71|2015|40M|[Covalent complex] BLU9931|P22455|FIBROBLAST GROWTH FACTOR RECEPTOR 4|8.22|Kd=6nM|Kd|=|6|nM|6|nM
4XH2|2.00|2015|18-mer|ligand is human paxillin LD4 motif|P49023|FAB HEAVY CHAIN|8.22|Kd=6nM|Kd|=|6|nM|6|nM
5CGJ|3.36|2015|51M|ligand is RA839|Q9Z2X8|KELCH-LIKE ECH-ASSOCIATED PROTEIN 1|5.22|Kd=6uM|Kd|=|6|uM|6000|nM
5CS3|2.50|2015|EP1|ligand is compound (H)EPPS|P14210|HEPATOCYTE GROWTH FACTOR|2.15|Kd=7.0mM|Kd|=|7|mM|7000000|nM
4QIZ|1.55|2015|WWX|[Nonstandard assay: Temp 37, pH=7] compound 10p|Q8N1Q1|CARBONIC ANHYDRASE 13|8.15|Kd=7.1nM|Kd|=|7.1|nM|7.1|nM
4Q07|1.15|2015|V14|[Nonstandard assay: Temp=37] [Different protein in assay: A65S, N67Q, I91L, F130V, V134L, L203A] compound 3|P00918|CARBONIC ANHYDRASE 2|8.14|Kd=7.3nM|Kd|=|7.3|nM|7.3|nM
3WUU|2.90|2015|14-mer|ligand is TEX14N-ALIXC chimera peptide 1|Q53EZ4|CENTROSOMAL PROTEIN OF 55 KDA|5.14|Kd=7.3uM|Kd|=|7.3|uM|7300|nM
5BTR|3.20|2015|5-mer|[Nonstandard assay: in the presence of 0.5 mM resveratrol]|Q96EB6|NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-1,NAD-DEP|5.14|Kd=7.3uM|Kd|=|7.3|uM|7300|nM
5ALC|1.70|2015|TIQ|ligand is compound ticagrelor|------|ANTI-TICAGRELOR FAB 72, HEAVY CHAIN|8.13|Kd=7.4nM|Kd|=|7.4|nM|7.4|nM
4ZED|1.75|2015|AGW|ligand is agrocinopine-3'-O-benzoate|Q7D2F4|ABC TRANSPORTER, SUBSTRATE BINDING PROTEIN|5.12|Kd=7.5uM|Kd|=|7.5|uM|7500|nM
5D1W|3.59|2015|PLM|ligand is compound PALMITIC ACID|O05892|RV3249C TRANSCRIPTIONAL REGULATOR|5.12|Kd=7.5uM|Kd|=|7.5|uM|7500|nM
4QFL|1.75|2015|2-mer|ligand is peptide Ala-Phe|A7Y7W1|ABC TRANSPORTER PERIPLASMIC PEPTIDE-BINDING PROTEIN|5.11|Kd=7.7uM|Kd|=|7.7|uM|7700|nM
5EA4|2.30|2015|5NM|ligand is compound JNJ-49153390|P03420|FUSION GLYCOPROTEIN F0|8.11|Kd=7.8nM|Kd|=|7.8|nM|7.8|nM
4UX9|2.34|2015|12-mer|JNK1 binds to MKK7 residues 37-48|P45983|MITOGEN-ACTIVATED PROTEIN KINASE 8|5.1|Kd=7.9uM|Kd|=|7.9|uM|7900|nM
4XT2|1.70|2015|43L|(S,R)-24|P27540|ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR|7.15|Kd=70nM|Kd|=|70|nM|70|nM
4PYX|1.80|2015|V90|[Nonstandard assay: Temp 37 , pH =7.0,] compound 1|P00918|CARBONIC ANHYDRASE 2|6.14|Kd=730nM|Kd|=|730|nM|730|nM
5DQ8|2.31|2015|FLF|ligand is FA, flufenamic acid|Q15562|TRANSCRIPTIONAL ENHANCER FACTOR TEF-4|4.14|Kd=73uM|Kd|=|73|uM|73000|nM
5C5T|1.60|2015|AKG|Kd under 520 nm absorbance measurements|Q84406|PROLYL 4-HYDROXYLASE|3.13|Kd=746uM|Kd|=|746|uM|746000|nM
4ZOW|2.45|2015|CLM|ligand is chloramphenicol|P0AEY8|MULTIDRUG TRANSPORTER MDFA|4.12|Kd=75uM|Kd|=|75|uM|75000|nM
4QFN|2.30|2015|2-mer|ligand is Gly-Glu|A7Y7W1|ABC TRANSPORTER PERIPLASMIC PEPTIDE-BINDING PROTEIN|4.12|Kd=76uM|Kd|=|76|uM|76000|nM
4D52|1.76|2015|GIV|ligand is L-Gal; name GIV for beta L-Gal and GXL for alpha L-Gal|Q4WW81|FUCOSE-SPECIFIC LECTIN FLEA|3.11|Kd=775uM|Kd|=|775|uM|775000|nM
4WF4|1.70|2015|WF4|compound 4|C5WBA2|THIOL:DISULFIDE INTERCHANGE PROTEIN|3.11|Kd=777uM|Kd|=|777|uM|777000|nM
4YMX|1.48|2015|ARG|[Nonstandard assay: 20 mM Hepes, 200 mM NaCl] ligand is ARGININE|Q8RCC4|ABC-TYPE AMINO ACID TRANSPORT SYSTEM|7.1|Kd=79nM|Kd|=|79|nM|79|nM
4YCL|3.25|2015|CZA||P04191|SARCOPLASMIC/ENDOPLASMIC RETICULUM CALCIUM ATPASE 1|8.15|Kd=7nM|Kd|=|7|nM|7|nM
4QIP|2.00|2015|SDS|[Multiple sites: inner SDS binding site (Kd=7uM), outer SDS binding site (Kd=100uM] two binding sites|P15494|MAJOR POLLEN ALLERGEN BET V 1-A|5.15|Kd=7uM|Kd|=|7|uM|7000|nM
4OIV|1.70|2015|XX9|ligand is NDB|Q96RI1|BILE ACID RECEPTOR|5.08|Kd=8.29uM|Kd|=|8.29|uM|8290|nM
4XX9|1.40|2015|RF4|[Different protein in assay: in binding assay is wild type protein] RF4|O15530|3-PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE 1|5.08|Kd=8.4uM|Kd|=|8.4|uM|8400|nM
4U54|2.41|2015|3C5|[Nonstandard assay: Temp=25,PH=6.0;100 mM citrate, 200 mM NaCl, 10% DMSO] compound 1|P52293|IMPORTIN SUBUNIT ALPHA-1|2.06|Kd=8.7mM|Kd|=|8.7|mM|8700000|nM
5EA5|3.05|2015|TM3|ligand is compound TMC-353121|P03420|FUSION GLYCOPROTEIN F0|8.06|Kd=8.7nM|Kd|=|8.7|nM|8.7|nM
5A2I|1.88|2015|6-mer|[Nonstandard assay: 10 mM sodium phosphate buffer containing 150 mM NaCl] ligand is glycopeptide m2*|P01801|IG LAMBDA-1 CHAIN V REGION S43|5.06|Kd=8.8uM|Kd|=|8.8|uM|8800|nM
4TY9|2.78|2015|3B0|fragement 162|D0PY27|POLYPROTEIN|2.05|Kd=8.96mM|Kd|=|8.96|mM|8960000|nM
4X8T|2.20|2015|3Z8|compound 7|P08709|COAGULATION FACTOR VIIA (HEAVY CHAIN)|2.05|Kd=8.9mM|Kd|=|8.9|mM|8900000|nM
4WCI|1.65|2015|16-mer|ligand is proline-rich peptide (aa 378-393) from human RIN3e1|Q9Y5K6|CD2-ASSOCIATED PROTEIN|5.05|Kd=8.9uM|Kd|=|8.9|uM|8900|nM
5CC2|2.50|2015|CKA|ligand is compound 7-CKA|Q63226|GLUTAMATE RECEPTOR DELTA-2|4.1|Kd=80uM|Kd|=|80|uM|80000|nM
4YW6|1.40|2015|G0P|ligand is GalAG1;|Q05097|PA-I GALACTOPHILIC LECTIN|7.08|Kd=83nM|Kd|=|83|nM|83|nM
4WMY|1.60|2015|3S6|ligand is allyl-beta-galactofuranose|Q8WWA0|INTELECTIN-1|7.07|Kd=85nM|Kd|=|85|nM|85|nM
4XMR|1.30|2015|ILE|isoleucine;|Q0P864|PUTATIVE METHYL-ACCEPTING CHEMOTAXIS SIGNAL TRANSDU|4.07|Kd=86uM|Kd|=|86|uM|86000|nM
4R74|1.93|2015|F6P|ligand is F6P|A3N294|ABC-TYPE FE3+ TRANSPORT SYSTEM|8.1|Kd=8nM|Kd|=|8|nM|8|nM
4RWL|2.19|2015|3ZC|ligand is E3810|P11362|FIBROBLAST GROWTH FACTOR RECEPTOR 1|8.1|Kd=8nM|Kd|=|8|nM|8|nM
4Z7N|2.60|2015|4-mer|AGDV peptide;|P08514|INTEGRIN ALPHA-IIB|5.04|Kd=9.03uM|Kd|=|9.03|uM|9030|nM
4YP1|2.65|2015|2BA|[Nonstandard assay: pH=8, 20 mM Tris-HCl, 80 mM NaCl] ligand is Cyclic di-AMP (c-di-AMP)|Q3TBT3|STIMULATOR OF INTERFERON GENES PROTEIN|5.04|Kd=9.1uM|Kd|=|9.1|uM|9100|nM
4UU5|1.23|2015|17-mer|ligand is Crb-17-peptide|Q8N3R9|MAGUK P55 SUBFAMILY MEMBER 5|5.04|Kd=9.2uM|Kd|=|9.2|uM|9200|nM
4TY8|2.78|2015|3AV|fragement 117|D0PY27|POLYPROTEIN|2.03|Kd=9.31mM|Kd|=|9.31|mM|9310000|nM
4X5Y|1.59|2015|3XW|ligand is MI-503|O00255|MENIN|8.03|Kd=9.3nM|Kd|=|9.3|nM|9.3|nM
4RCG|2.60|2015|GDP|ligand is GDP|I6Y334|PHOSPHOENOLPYRUVATE CARBOXYKINASE|5.03|Kd=9.3uM|Kd|=|9.3|uM|9300|nM
4Y7R|1.90|2015|8-mer|[Nonstandard assay: PH=6, 200 mM phosphate, 300 mM NaCl] MYC MbIIIb peptide;|P61964|WD REPEAT-CONTAINING PROTEIN 5|5.03|Kd=9.3uM|Kd|=|9.3|uM|9300|nM
4ZJJ|2.20|2015|4OR|compound 2|Q13153|SERINE/THREONINE-PROTEIN KINASE PAK 1|8.0|Kd=9.9nM|Kd|=|9.9|nM|9.9|nM
4WMV|2.40|2015|3R4|compound 4, named 3R4|P0AEX9|MBL-MCL1 CHIMERA PROTEIN|4.03|Kd=93uM|Kd|=|93|uM|93000|nM
5CSO|1.78|2015|CTN|ligand is cytidine|D9J2T9|RIBOSOME INACTIVATING PROTEIN|6.03|Kd=940nM|Kd|=|940|nM|940|nM
4QP2|2.23|2015|36R|compound 2|P28482|MITOGEN-ACTIVATED PROTEIN KINASE 1|3.03|Kd=940uM|Kd|=|940|uM|940000|nM
5AOI|1.78|2015|RZH|compound 6;|P04637|CELLULAR TUMOR ANTIGEN P53|3.03|Kd=940uM|Kd|=|940|uM|940000|nM
5ACX|1.80|2015|WL3|compound 2|Q9K2N0|BETA-LACTAMASE|5.05|Kd=9uM|Kd|=|9|uM|9000|nM
4U58|2.56|2015|3C6|[Nonstandard assay: Temp=25,PH=6.0;100 mM citrate, 200 mM NaCl, 10% DMSO] compound 14|P52293|IMPORTIN SUBUNIT ALPHA-1|2.0|Kd>10.0mM|Kd|>|10|mM|10000000|nM
5AOK|1.35|2015|GOH|compound 10|P04637|CELLULAR TUMOR ANTIGEN P53|2.7|Kd>2000uM|Kd|>|2000|uM|2000000|nM
4Y5S|2.54|2015|AKG|[Nonstandard assay: Temp 37] alpha-Ketoglutarate;|Q4WAW9|VERRUCULOGEN SYNTHASE|3.73|Kd~185uM|Kd|~|185|uM|185000|nM
4D63|2.20|2015|SIA|ligand is 6-sialyllactose, also named as SIA in RCSB|Q2TLC1|FIBER KNOB DOMAIN|1.64|Kd~23mM|Kd|~|23|mM|23000000|nM
4ZYR|3.31|2015|9PG|alpha-NPG|P02920|LACTOSE PERMEASE|5.7|Kd~2uM|Kd|~|2|uM|2000|nM
4YDQ|2.30|2015|HFG|HF; Kd in the presence of AMPPNP is 9nM;|Q8I5R7|PROLINE--TRNA LIGASE|6.52|Kd~300nM|Kd|~|300|nM|300|nM
4PDE|2.80|2015|GDP|GDP; estimated Kd value|J7QY30|PROTEIN FDHD|6.44|Kd~364nM|Kd|~|364|nM|364|nM
4XPJ|2.61|2015|LPY|ligand is lysophosphatidylinositol|P01139|BETA-NERVE GROWTH FACTOR|5.09|Kd~8.11uM|Kd|~|8.11|uM|8109.999999999999|nM
5CEO|2.28|2015|50D|ligand is compound 2|Q12852|MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 12|9.3|Ki<0.0005uM|Ki|<|0.0005|uM|0.5|nM
4QVX|2.10|2015|3CQ|compound 17|Q07817|BCL-2-LIKE PROTEIN 1|11.0|Ki<0.01nM|Ki|<|0.01|nM|0.01|nM
4UXL|2.40|2015|5P8|ligand is PF-06463922|P08922|PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ROS|10.6|Ki<0.025nM|Ki|<|0.025|nM|0.025|nM
5BRY|1.34|2015|4UY|ligand is entry 6(compoud 25f)|P03366|HIV-1 PROTEASE|11.82|Ki=0.0015nM|Ki|=|0.0015|nM|0.0015|nM
4CRC|1.60|2015|OTM|compound 10|P03951|COAGULATION FACTOR XI|8.72|Ki=0.0019uM|Ki|=|0.0019|uM|1.9|nM
4YTH|2.04|2015|467|compound 44|O60674|TYROSINE-PROTEIN KINASE JAK2|8.7|Ki=0.002uM|Ki|=|0.002|uM|2|nM
5DGU|1.22|2015|5B7|ligand is compound 30b|Q8Q3H0|HIV-1 PROTEASE|11.35|Ki=0.0045nM|Ki|=|0.0045|nM|0.0045|nM
5EM6|2.78|2015|5Q3|ligand is compound 19|P00533|EPIDERMAL GROWTH FACTOR RECEPTOR|8.4|Ki=0.004uM|Ki|=|0.004|uM|4|nM
4YTF|1.78|2015|4HZ|compound 22|O60674|TYROSINE-PROTEIN KINASE JAK2|8.15|Ki=0.007uM|Ki|=|0.007|uM|7|nM
5DGW|1.62|2015|5B5|ligand is compound 30j|Q8Q3H0|HIV-1 PROTEASE|11.05|Ki=0.009nM|Ki|=|0.009|nM|0.009|nM
4ZHM|1.90|2015|10-mer|[Nonstandard assay: Temp 37, 10 mM Hepes, 140 mM NaCl, 0.1% BSA] ligand is mupain-16-IG peptide|P00749|UROKINASE-TYPE PLASMINOGEN ACTIVATOR|8.05|Ki=0.009uM|Ki|=|0.009|uM|9|nM
4YTC|2.16|2015|4HW|compound 1|O60674|TYROSINE-PROTEIN KINASE JAK2|7.89|Ki=0.013uM|Ki|=|0.013|uM|13|nM
5EM7|2.81|2015|5Q4|ligand is compound 13|P00533|EPIDERMAL GROWTH FACTOR RECEPTOR|7.72|Ki=0.019uM|Ki|=|0.019|uM|19|nM
4CRB|1.85|2015|7P0|compound 9|P03951|COAGULATION FACTOR XI|7.57|Ki=0.027uM|Ki|=|0.027|uM|27|nM
4YO8|2.10|2015|4EZ|compound 54|Q9ZMY2|AMINODEOXYFUTALOSINE NUCLEOSIDASE|10.52|Ki=0.030nM|Ki|=|0.03|nM|0.03|nM
5DIA|1.96|2015|5E6|ligand is compound 36|P11309|SERINE/THREONINE-PROTEIN KINASE PIM-1|10.46|Ki=0.035nM|Ki|=|0.035|nM|0.035|nM
4RAC|2.05|2015|3L4|compound 7b|P00492|HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE|7.52|Ki=0.03uM|Ki|=|0.03|uM|30|nM
5CEQ|1.91|2015|50F|ligand is compound 11|Q12852|MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 12|7.38|Ki=0.042uM|Ki|=|0.042|uM|42|nM
4YNB|2.00|2015|4EH|compound 32|Q9ZMY2|AMINODEOXYFUTALOSINE NUCLEOSIDASE|10.37|Ki=0.043nM|Ki|=|0.043|nM|0.043|nM
4XUZ|1.50|2015|4D6|[Uncommon element] [Nonstandard assay: 50 mM Na phosphate, 0.1 mg/mL BSA] [Different protein in assay: recombinant E. coli strains] compound 9f|S5LVN3|BETA-LACTAMASE|7.36|Ki=0.044uM|Ki|=|0.044|uM|44|nM
4Y8Z|2.20|2015|4CE|compoud 13|P03951|COAGULATION FACTOR XIA|10.4|Ki=0.04nM|Ki|=|0.04|nM|0.04|nM
4RAB|2.26|2015|3L3|compound 10c|P00492|HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE|7.4|Ki=0.04uM|Ki|=|0.04|uM|40|nM
4X0U|1.95|2015|3W9|[Covalent complex] ligand is DEAB; covalent inactivation of ALDH7A1 by DEAB;|P49419|ALPHA-AMINOADIPIC SEMIALDEHYDE DEHYDROGENASE|7.4|Ki=0.04uM|Ki|=|0.04|uM|40|nM
5BWC|2.45|2015|HBP|ligand is compound ORTHO-7|P04058|ACETYLCHOLINESTERASE|7.21|Ki=0.061uM|Ki|=|0.061|uM|61|nM
4CRA|1.80|2015|XJ8|compound 8|P03951|COAGULATION FACTOR XI|7.22|Ki=0.06uM|Ki|=|0.06|uM|60|nM
4ZBF|2.20|2015|4M7|compound 24|Q07820|INDUCED MYELOID LEUKEMIA CELL DIFFERENTIATION PROTEIN MCL|7.13|Ki=0.074uM|Ki|=|0.074|uM|74|nM
4RAN|2.55|2015|3L6|compound 11a|P00492|HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE|7.15|Ki=0.07uM|Ki|=|0.07|uM|70|nM
4CRD|2.10|2015|OTJ|compound 11|P03951|COAGULATION FACTOR XI|7.1|Ki=0.08uM|Ki|=|0.08|uM|80|nM
4RAD|2.00|2015|3L5|compound 7c|P00492|HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE|7.1|Ki=0.08uM|Ki|=|0.08|uM|80|nM
4YIK|1.48|2015|2O2|[Nonstandard assay: Temp 37, 2-4 nM enzyme in 20 mM Tris.HCl, 20 mM MgCl2, 2 mM EDTA and 2 mM DTT, pH 7.5] compound 3: mdN|Q9NPB1|5'(3')-DEOXYRIBONUCLEOTIDASE|6.89|Ki=0.128uM|Ki|=|0.128|uM|128|nM
5CEP|1.99|2015|50E|ligand is compound 3|Q12852|MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 12|6.84|Ki=0.145uM|Ki|=|0.145|uM|145|nM
4ZO5|2.50|2015|4Q0|compound 8j|Q9Y233|CAMP AND CAMP-INHIBITED CGMP 3',5'-CYCLIC PHOSPHODIESTERASE|9.82|Ki=0.15nM|Ki|=|0.15|nM|0.15|nM
4YUR|2.65|2015|4J7|[Nonstandard assay: pH=8.0, 20mM MgCl2, 1 mM DTT] ligand is centrinone|O00444|SERINE/THREONINE-PROTEIN KINASE PLK4|9.8|Ki=0.16nM|Ki|=|0.16|nM|0.16|nM
4WKN|2.00|2015|TDI|compound 2|Q9ZMY2|AMINODEOXYFUTALOSINE NUCLEOSIDASE|9.72|Ki=0.19nM|Ki|=|0.19|nM|0.19|nM
4RAQ|2.53|2015|3L8|compound 6b|P00492|HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE|6.72|Ki=0.19uM|Ki|=|0.19|uM|190|nM
4OEL|1.40|2015|2-mer|ligand is Ser-Tyr|P53634|DIPEPTIDYL PEPTIDASE 1 HEAVY CHAIN|7.0|Ki=0.1uM|Ki|=|0.1|uM|100|nM
4O2P|2.10|2015|11V|ligand is compound 3-R|P00523|TYROSINE-PROTEIN KINASE SRC|6.7|Ki=0.20uM|Ki|=|0.2|uM|200|nM
4ZIP|1.11|2015|G64|compound 5o|P03366|HIV-1 PROTEASE|9.68|Ki=0.21nM|Ki|=|0.21|nM|0.21|nM
4WKC|1.64|2015|BIG|ligand is BuTDIA|A7ZHQ1|5'-METHYLTHIOADENOSINE/S-ADENOSYLHOMOCYSTEINE NUCLE|12.68|Ki=0.21pM|Ki|=|0.21|pM|0.00021|nM
5EM5|2.65|2015|5Q2|ligand is compound 2|P00533|EPIDERMAL GROWTH FACTOR RECEPTOR|6.58|Ki=0.262uM|Ki|=|0.262|uM|262|nM
5CJF|1.83|2015|520|ligand is compound 20|Q9ULX7|CARBONIC ANHYDRASE 14|9.59|Ki=0.26nM|Ki|=|0.26|nM|0.26|nM
4WKP|1.58|2015|3QA|compound 36|Q9ZMY2|AMINODEOXYFUTALOSINE NUCLEOSIDASE|9.55|Ki=0.28nM|Ki|=|0.28|nM|0.28|nM
4PV5|2.30|2015|CBW|ligand is 18-beta-glycyrrhetinic acid (GA)|Q9CPU0|LACTOYLGLUTATHIONE LYASE|6.54|Ki=0.29uM|Ki|=|0.29|uM|290|nM
4QHC|1.90|2015|33V|[Covalent complex] ligand is Penem 2|P9WKD3|BETA-LACTAMASE|6.7|Ki=0.2uM|Ki|=|0.2|uM|200|nM
5DHJ|2.46|2015|5E5|ligand is compound 4|P11309|SERINE/THREONINE-PROTEIN KINASE PIM-1|6.7|Ki=0.2uM|Ki|=|0.2|uM|200|nM
4ZBI|2.50|2015|4M6|compound 20|Q07820|INDUCED MYELOID LEUKEMIA CELL DIFFERENTIATION PROTEIN MCL|6.51|Ki=0.31uM|Ki|=|0.31|uM|310|nM
4WKO|1.90|2015|HCE|compound 22|Q9ZMY2|AMINODEOXYFUTALOSINE NUCLEOSIDASE|9.47|Ki=0.34nM|Ki|=|0.34|nM|0.34|nM
4XJ0|2.58|2015|41B|ligand is (S)-14k|P28482|MITOGEN-ACTIVATED PROTEIN KINASE 1|9.52|Ki=0.3nM|Ki|=|0.3|nM|0.3|nM
4R0I|1.90|2015|3KM|compound 6|Q9Y5Y6|SUPPRESSOR OF TUMORIGENICITY 14|6.52|Ki=0.3uM|Ki|=|0.3|uM|300|nM
4QLL|1.85|2015|CTT|ligand is cellotetraose|Q75I93|BETA-GLUCOSIDASE 7|3.38|Ki=0.42mM|Ki|=|0.42|mM|420000|nM
4Z0K|1.41|2015|4LN|compound 14a|P00740|COAGULATION FACTOR IX|6.34|Ki=0.462uM|Ki|=|0.462|uM|462|nM
4Q99|1.50|2015|HT4|ligand is 4-CH3-2mp|P00918|CARBONIC ANHYDRASE 2|6.28|Ki=0.52uM|Ki|=|0.52|uM|520|nM
4TY1|2.70|2015|38W|compound 29|P11309|SERINE/THREONINE-PROTEIN KINASE PIM-1|9.26|Ki=0.55nM|Ki|=|0.55|nM|0.55|nM
4R3B|1.37|2015|3GE|[Incomplete ligand] ligand is PSR-3-283A, named 3GE, ligand is open circle in RCSB|P0AD64|BETA-LACTAMASE SHV-1|6.25|Ki=0.56uM|Ki|=|0.56|uM|560|nM
4QLK|1.83|2015|CTT|ligand is cellotetraose|Q75I93|BETA-GLUCOSIDASE 7|3.24|Ki=0.57mM|Ki|=|0.57|mM|570000|nM
4WR8|2.60|2015|3TX|[Nonstandard assay: PH=6, 500 mM boric acid] compound 3a|P14174|MACROPHAGE MIGRATION INHIBITORY FACTOR|6.23|Ki=0.59uM|Ki|=|0.59|uM|590|nM
4CRF|2.30|2015|R9B|compound 13|P03951|COAGULATION FACTOR XI|9.3|Ki=0.5nM|Ki|=|0.5|nM|0.5|nM
4Q1A|1.90|2015|2XZ|compound 6|P27707|DEOXYCYTIDINE KINASE|9.3|Ki=0.5nM|Ki|=|0.5|nM|0.5|nM
5CGC|3.10|2015|51D|PKi=9.3; PIC50=8.6; ligand is compound 14|P41594|METABOTROPIC GLUTAMATE RECEPTOR 5, ENDOLYSIN|9.3|Ki=0.5nM|Ki|=|0.5|nM|0.5|nM
5CGD|2.60|2015|51E|PKi=9.3; PIC50=9.2; ligand is compound 25|P41594|METABOTROPIC GLUTAMATE RECEPTOR 5, ENDOLYSIN|9.3|Ki=0.5nM|Ki|=|0.5|nM|0.5|nM
5BRN|2.30|2015|4X2|ligand is compound 25|P00492|HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE|6.3|Ki=0.5uM|Ki|=|0.5|uM|500|nM
4YMB|1.93|2015|4E7|compound 2f;|P22756|GLUTAMATE RECEPTOR, IONOTROPIC KAINATE 1|6.21|Ki=0.62uM|Ki|=|0.62|uM|620|nM
4WRB|1.81|2015|3TW|[Nonstandard assay: PH=6, 500 mM boric acid] compound 3b|P14174|MACROPHAGE MIGRATION INHIBITORY FACTOR|6.19|Ki=0.65uM|Ki|=|0.65|uM|650|nM
5DHH|3.00|2015|DGW|pKi=9.18; ligand is SB-612111|C8TP59|GPCR-BRIL CHIMERA|9.18|Ki=0.66nM|Ki|=|0.66|nM|0.66|nM
4RHU|2.57|2015|45T-3QE|compound 5, RS mixture of 45T and 3QE|I6YCM5|HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE HPT|6.16|Ki=0.69uM|Ki|=|0.69|uM|690|nM
4S1G|2.10|2015|43T|compound 12|P00797|RENIN|9.22|Ki=0.6nM|Ki|=|0.6|nM|0.6|nM
5BSK|2.61|2015|4X7|ligand is compound 26|P00492|HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE|6.22|Ki=0.6uM|Ki|=|0.6|uM|600|nM
5DHG|3.00|2015|DGV|pKi=9.14, ligand is compound 35, C-35|C8TP59|NOCICEPTIN RECEPTOR-CYTOCHROME B562 CHIMERA|9.14|Ki=0.72nM|Ki|=|0.72|nM|0.72|nM
4Y8Y|2.60|2015|4D5|compound 9|P03951|COAGULATION FACTOR XIA|9.15|Ki=0.7nM|Ki|=|0.7|nM|0.7|nM
5AML|1.36|2015|51J|ligand is compound 3e|P00918|CARBONIC ANHYDRASE 2|9.15|Ki=0.7nM|Ki|=|0.7|nM|0.7|nM
5DIT|2.25|2015|5B8|ligand is compound 41|Q13451|PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5|6.15|Ki=0.7uM|Ki|=|0.7|uM|700|nM
4ZLS|1.53|2015|G61|compound 17a|P03366|HIV-1 PROTEASE|9.09|Ki=0.82nM|Ki|=|0.82|nM|0.82|nM
5AVI|2.70|2015|4KM|ligand is compound 4|Q13133|OXYSTEROLS RECEPTOR LXR-ALPHA|6.06|Ki=0.87uM|Ki|=|0.87|uM|870|nM
5EM8|2.80|2015|5Q4|ligand is compound 13|P00533|EPIDERMAL GROWTH FACTOR RECEPTOR|5.96|Ki=1.090uM|Ki|=|1.09|uM|1090|nM
4RHY|2.32|2015|3QG|compound 14|A5U8U8|HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE|5.95|Ki=1.13uM|Ki|=|1.13|uM|1130|nM
5A69|2.20|2015|OGN|[Nonstandard assay: Temp 37] Ki=1.1+/-0.1nM, ligand is Gal-PUGNAc|C1CH75|N-ACETYL-BETA-D-GLUCOSAMINIDASE|8.96|Ki=1.1nM|Ki|=|1.1|nM|1.1|nM
3WZ6|1.40|2015|IXZ|compound 5|P11838|ENDOTHIAPEPSIN|5.96|Ki=1.1uM|Ki|=|1.1|uM|1100|nM
4YVC|3.20|2015|4KH|[Nonstandard assay: Temp 30, 100 mM HEPES, 10 mM MgCl2, 25 mM NaCl, 2 mM DTT,1.5% DMSO] compound 4|Q13464|RHO-ASSOCIATED PROTEIN KINASE 1|5.96|Ki=1.1uM|Ki|=|1.1|uM|1100|nM
5CAS|2.10|2015|4ZQ|ligand is compound 41a|P00533|EPIDERMAL GROWTH FACTOR RECEPTOR|8.85|Ki=1.4nM|Ki|=|1.4|nM|1.4|nM
4X6N|2.10|2015|3Y5|compound 26|P03951|COAGULATION FACTOR XI|8.82|Ki=1.5nM|Ki|=|1.5|nM|1.5|nM
3WZ8|1.45|2015|IXV|compound 8|P11838|ENDOTHIAPEPSIN|5.82|Ki=1.5uM|Ki|=|1.5|uM|1500|nM
5CAU|2.25|2015|4ZR|ligand is compound 41b|P00533|EPIDERMAL GROWTH FACTOR RECEPTOR|8.8|Ki=1.6nM|Ki|=|1.6|nM|1.6|nM
5E2P|2.11|2015|7P0|ligand is compound 27|P03951|COAGULATION FACTOR XIA|8.8|Ki=1.6nM|Ki|=|1.6|nM|1.6|nM
4RHX|2.03|2015|3QF|compound 9|A5U8U8|HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE|5.8|Ki=1.6uM|Ki|=|1.6|uM|1600|nM
4YKK|1.38|2015|DSN|D-serine;|A0A0R4|ML032222A IGLUR|2.77|Ki=1.7mM|Ki|=|1.7|mM|1700000|nM
4YHQ|1.30|2015|G10|[Nonstandard assay: Temp 37, pH=5.6, 100 mM MES, 400 mM sodium chloride] GRL-5010A;|P03366|PROTEASE|8.77|Ki=1.7nM|Ki|=|1.7|nM|1.7|nM
4YT7|2.30|2015|4K1|compound 35|P08709|COAGULATION FACTOR VII (HEAVY CHAIN)|8.77|Ki=1.7nM|Ki|=|1.7|nM|1.7|nM
5ABH|1.95|2015|YWN|[Nonstandard assay: Temp 37, 1X PBS buffer (0.03% BSA)] [Different protein in assay: Protein in binding assay is human OGA] compound 31;|Q89ZI2|O-GLCNACASE BT_4395|8.77|Ki=1.7nM|Ki|=|1.7|nM|1.7|nM
3WZ7|1.90|2015|IXY|compound 6|P11838|ENDOTHIAPEPSIN|5.74|Ki=1.8uM|Ki|=|1.8|uM|1800|nM
4Q1B|2.15|2015|2Y0|compound 7|P27707|DEOXYCYTIDINE KINASE|8.72|Ki=1.9nM|Ki|=|1.9|nM|1.9|nM
4X6O|2.10|2015|3Y4|compound 30|P03951|COAGULATION FACTOR XI|8.72|Ki=1.9nM|Ki|=|1.9|nM|1.9|nM
4RE2|2.00|2015|MVL|[Nonstandard assay: Temp 30, PH=5.0 ] ligand is mannoimidazole;|B5ABY0|BETA-MANNOSIDASE/BETA-GLUCOSIDASE|4.98|Ki=10.4uM|Ki|=|10.4|uM|10400|nM
4U2W|1.00|2015|16-mer|[Different ligand in assay: ] ligand is HV-BBI(3-18), Ki=1000nM is for HV-BBI(5-15)|B1VC43|BOWMAN-BIRK TRYPSIN INHIBITOR|6.0|Ki=1000nM|Ki|=|1000|nM|1000|nM
4ZZ3|2.50|2015|4DW|[Nonstandard assay: Temp 37, pH=7.5, 0.1 M Hepes] ligand is PMX;|P22102|TRIFUNCTIONAL PURINE BIOSYNTHETIC PROTEIN ADENOSINE|6.0|Ki=1000nM|Ki|=|1000|nM|1000|nM
4RIV|1.63|2015|LSA|ligand is SAC|P00918|CARBONIC ANHYDRASE 2|7.0|Ki=100nM|Ki|=|100|nM|100|nM
4YVE|3.40|2015|4KK|[Nonstandard assay: Temp 30, 100 mM HEPES, 10 mM MgCl2, 25 mM NaCl, 2 mM DTT,1.5% DMSO] compound 10|Q13464|RHO-ASSOCIATED PROTEIN KINASE 1|7.0|Ki=100nM|Ki|=|100|nM|100|nM
4TWP|2.40|2015|AXI|ligand is axitinib|P00519|TYROSINE-PROTEIN KINASE ABL1|10.0|Ki=100pM|Ki|=|100|pM|0.1|nM
4P6C|1.86|2015|RES|ligand is 4PEH|Q9KKP2|3,4-DIHYDROXY-2-BUTANONE 4-PHOSPHATE SYNTHASE|4.0|Ki=100uM|Ki|=|100|uM|100000|nM
4R3C|2.06|2015|3GF|ligand is MW150|Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|7.0|Ki=101nM|Ki|=|101|nM|101|nM
5FL4|1.82|2015|9FK|ligand is compound 2|Q16790|CARBONIC ANHYDRASE 9|7.0|Ki=101nM|Ki|=|101|nM|101|nM
4XAR|2.26|2015|40F|[Nonstandard assay: pH=7.6, K3PO4=10mM, KBr=100mM] compound 1;|Q14832|METABOTROPIC GLUTAMATE RECEPTOR 3|6.97|Ki=107nM|Ki|=|107|nM|107|nM
4X6I|1.87|2015|3Y1|[Nonstandard assay: Temp 37, PH=6] compound 6;|P43235|CATHEPSIN K|8.0|Ki=10nM|Ki|=|10|nM|10|nM
5BML|2.95|2015|4TW|[Nonstandard assay: Temp 30, 100 mM HEPES, 10 mM MgCl2, 25 mM NaCl, 2 mM DTT,1.5% DMSO] compound 37|Q13464|RHO-ASSOCIATED PROTEIN KINASE 1|8.0|Ki=10nM|Ki|=|10|nM|10|nM
4ZX0|1.60|2015|5L2|compound 623|P00918|CARBONIC ANHYDRASE 2|8.0|Ki=10nM|Ki|=|10|nM|10|nM
5A6K|2.10|2015|NSG|ligand is Gal-NGT|C1CH75|GH20C|5.95|Ki=1130nM|Ki|=|1130|nM|1130|nM
4RN4|1.53|2015|3T7|compound 3|P00918|CARBONIC ANHYDRASE 2|6.94|Ki=114nM|Ki|=|114|nM|114|nM
4XIR|1.70|2015|40X|[Nonstandard assay: 50 mMKCl, 5 mMMgCl2, 20 mMHEPES, 0.1% CHAPS (Sigma C5070), 0.1% bovine gamma-globulin (Sigma G7516), and 2 mM dithiothreitol (Sigma 646563)] compound 13;|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|6.94|Ki=115nM|Ki|=|115|nM|115|nM
4Y79|2.10|2015|4O6|[Nonstandard assay: NaCl=150mM, CaCl2=5mM, HEPESa=50mM] compound 1c;|P00742|COAGULATION FACTOR X|7.96|Ki=11nM|Ki|=|11|nM|11|nM
4YT6|2.07|2015|4JY|compound 19|P08709|COAGULATION FACTOR VII (HEAVY CHAIN)|7.96|Ki=11nM|Ki|=|11|nM|11|nM
4RUY|1.14|2015|3W6|compound 2b|P00918|CARBONIC ANHYDRASE 2|7.89|Ki=12.8nM|Ki|=|12.8|nM|12.8|nM
5CAN|2.80|2015|4ZB|ligand is compound 27|P00533|EPIDERMAL GROWTH FACTOR RECEPTOR|6.91|Ki=124nM|Ki|=|124|nM|124|nM
4RUX|1.14|2015|3W3|compound 2d|P00918|CARBONIC ANHYDRASE 2|7.92|Ki=12nM|Ki|=|12|nM|12|nM
4X8V|2.50|2015|3Z9|compound 18|P08709|COAGULATION FACTOR VIIA|6.89|Ki=130nM|Ki|=|130|nM|130|nM
4UFK|2.40|2015|LDU|ligand is DIL|P54818|GALACTOCEREBROSIDASE|3.89|Ki=130uM|Ki|=|130|uM|130000|nM
4RE4|2.29|2015|IFM|[Nonstandard assay: Temp 30, PH=5.0 ] ligand is isofagomine|B5ABY0|BETA-MANNOSIDASE/BETA-GLUCOSIDASE|6.87|Ki=135nM|Ki|=|135|nM|135|nM
4X8S|2.10|2015|3Z7|compound 6|P08709|COAGULATION FACTOR VIIA (HEAVY CHAIN)|1.89|Ki=13mM|Ki|=|13|mM|13000000|nM
4YTI|2.52|2015|VJK|ligand is VX-509;|O60674|TYROSINE-PROTEIN KINASE JAK2|7.89|Ki=13nM|Ki|=|13|nM|13|nM
4ZZ1|1.35|2015|3YF|[Nonstandard assay: Temp 37, pH=7.5, 0.1 M Hepes] compound 5;|P22102|TRIFUNCTIONAL PURINE BIOSYNTHETIC PROTEIN ADENOSINE|7.89|Ki=13nM|Ki|=|13|nM|13|nM
5CNJ|2.65|2015|52Q|ligand is compound 14a|Q14416|METABOTROPIC GLUTAMATE RECEPTOR 2|6.84|Ki=144nM|Ki|=|144|nM|144|nM
5DGZ|2.50|2015|L20|ligand is compound 1|P11309|SERINE/THREONINE-PROTEIN KINASE PIM-1|7.85|Ki=14nM|Ki|=|14|nM|14|nM
4Q87|1.55|2015|4FH|ligand is 4-CF3-1,2-HOPTO|P00918|CARBONIC ANHYDRASE 2|4.85|Ki=14uM|Ki|=|14|uM|14000|nM
5ABF|2.10|2015|XRJ|[Nonstandard assay: Temp 37, 1X PBS buffer (0.03% BSA)] [Different protein in assay: Protein in binding assay is human OGA] compound 25;|Q89ZI2|O-GLCNACASE BT_4395|4.85|Ki=14uM|Ki|=|14|uM|14000|nM
4Z84|1.55|2015|NVX|ligand is (+)-1c|P00517|CAMP-DEPENDENT PROTEIN KINASE|5.82|Ki=1500nM|Ki|=|1500|nM|1500|nM
5CNM|2.84|2015|52Q|ligand is compound 14a|Q14832|METABOTROPIC GLUTAMATE RECEPTOR 3|6.81|Ki=156nM|Ki|=|156|nM|156|nM
4Q1D|2.00|2015|2Y1|compound 9|P27707|DEOXYCYTIDINE KINASE|7.78|Ki=16.6nM|Ki|=|16.6|nM|16.6|nM
4XNV|2.20|2015|BUR|ligand is BPTU;|P47900|P2Y PURINOCEPTOR 1, RUBREDOXIN, P2Y PURINOCEPTOR 1|6.79|Ki=161nM|Ki|=|161|nM|161|nM
4X24|1.50|2015|TDI|ligand is MTDIA|A5F5R2|5'-METHYLTHIOADENOSINE/S-ADENOSYLHOMOCYSTEINE NUCLEOSIDASE|9.78|Ki=166pM|Ki|=|166|pM|0.166|nM
4X6J|1.59|2015|3Y2|[Covalent complex] [Nonstandard assay: Temp 37, PH=6] compound 5;|P43235|CATHEPSIN K|7.8|Ki=16nM|Ki|=|16|nM|16|nM
5C1M|2.10|2015|4VO|ligand is BU72, Ki in presence of nanobody 39|P42866|MU-TYPE OPIOID RECEPTOR|10.8|Ki=16pM|Ki|=|16|pM|0.016|nM
4Z2B|1.80|2015|4LC|compound 3;|Q6L8Q7|2',5'-PHOSPHODIESTERASE 12|7.76|Ki=17.5nM|Ki|=|17.5|nM|17.5|nM
4UM1|2.83|2015|09P|ligand is NS3573|P58154|ACETYLCHOLINE-BINDING PROTEIN|5.77|Ki=1700nM|Ki|=|1700|nM|1700|nM
4X48|1.89|2015|XPF|compound 3|P19491|GLUTAMATE RECEPTOR 2|6.77|Ki=170nM|Ki|=|170|nM|170|nM
5CBM|2.30|2015|4ZN|compound 12; S isomer|A0A024|M17 LEUCYL AMINOPEPTIDASE|7.77|Ki=17nM|Ki|=|17|nM|17|nM
4XNW|2.70|2015|2ID|ligand is MRS-2500;|P47900|P2Y PURINOCEPTOR 1, RUBREDOXIN, P2Y PURINOCEPTOR 1|7.74|Ki=18.4nM|Ki|=|18.4|nM|18.4|nM
4U7Q|1.70|2015|3EM|compound 1|Q9Q2G4|HIV-1 PROTEASE|9.74|Ki=180pM|Ki|=|180|pM|0.18|nM
4UFM|2.40|2015|DGJ|ligand is DGJ|P54818|GALACTOCEREBROSIDASE|3.72|Ki=190uM|Ki|=|190|uM|190000|nM
4RAO|1.87|2015|3L7|compound 6c|P00492|HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE|6.0|Ki=1uM|Ki|=|1|uM|1000|nM
5C2E|2.10|2015|4Y1|ligand is compound 15d|Q9Y233|CGMP 3',5'-CYCLIC PHOSPHODIESTERASE|8.7|Ki=2.0nM|Ki|=|2|nM|2|nM
5DK4|1.90|2015|5BX|ligand is indolmycin|P00953|TRYPTOPHANYL-TRNA LIGASE|8.7|Ki=2.0nM|Ki|=|2|nM|2|nM
5E2O|2.08|2015|5JM|ligand is compound 6|P03951|COAGULATION FACTOR XIA|8.7|Ki=2.0nM|Ki|=|2|nM|2|nM
4Q9Y|1.55|2015|M3T|ligand is 3-CH3-TP|P00918|CARBONIC ANHYDRASE 2|5.68|Ki=2.1uM|Ki|=|2.1|uM|2100|nM
5C28|1.56|2015|4XV|ligand is compound 6|Q9Y233|CGMP 3',5'-CYCLIC PHOSPHODIESTERASE|5.66|Ki=2.2uM|Ki|=|2.2|uM|2200|nM
4UFL|2.40|2015|DZX|ligand is DGN|P54818|GALACTOCEREBROSIDASE|2.64|Ki=2.3mM|Ki|=|2.3|mM|2300000|nM
4QD6|2.45|2015|30T|compound 4b|Q08881|TYROSINE-PROTEIN KINASE ITK/TSK|8.64|Ki=2.3nM|Ki|=|2.3|nM|2.3|nM
4ZQT|1.98|2015|4QP|[Incomplete ligand] compound 12; R isomer|O96935|M1 FAMILY AMINOPEPTIDASE|5.64|Ki=2.3uM|Ki|=|2.3|uM|2300|nM
5EGM|1.84|2015|5NY|ligand is compound 82|P00740|COAGULATION FACTOR IX|8.62|Ki=2.4nM|Ki|=|2.4|nM|2.4|nM
4RE3|2.55|2015|GIM|[Nonstandard assay: Temp 30, PH=5.0] ligand is glucoimidazole|B5ABY0|BETA-MANNOSIDASE/BETA-GLUCOSIDASE|8.57|Ki=2.7nM|Ki|=|2.7|nM|2.7|nM
5CAQ|2.50|2015|4ZJ|ligand is compound 33|P00533|EPIDERMAL GROWTH FACTOR RECEPTOR|8.57|Ki=2.7nM|Ki|=|2.7|nM|2.7|nM
4WKB|1.37|2015|TDI|ligand is MTDIA|A5F5R2|5'-METHYLTHIOADENOSINE/S-ADENOSYLHOMOCYSTEINE NUCLEOSIDASE|11.57|Ki=2.7pM|Ki|=|2.7|pM|0.0027|nM
4WBG|1.90|2015|AZR|[Covalent complex] ligand is aztorenam|Q51578|BETA-LACTAMASE|5.55|Ki=2.85uM|Ki|=|2.85|uM|2850|nM
5AMD|1.50|2015|45I|ligand is compound 3i|P00918|CARBONIC ANHYDRASE 2|8.55|Ki=2.8nM|Ki|=|2.8|nM|2.8|nM
5EK0|3.53|2015|5P2|ligand is compound GX-936|A8EVM5|CHIMERA OF BACTERIAL ION TRANSPORT PROTEIN AND HUMA|7.68|Ki=20.7nM|Ki|=|20.7|nM|20.7|nM
5C8K|3.00|2015|4YV|ligand is compound 1|P00533|EPIDERMAL GROWTH FACTOR RECEPTOR|7.7|Ki=20nM|Ki|=|20|nM|20|nM
4YIH|1.82|2015|2O2|[Nonstandard assay: Temp 37, 2-4 nM enzyme in 20 mM Tris.HCl, 20 mM MgCl2, 2 mM EDTA and 2 mM DTT, pH 7.5] compound 3: cdN|Q8TCD5|5'(3')-DEOXYRIBONUCLEOTIDASE, CYTOSOLIC TYPE|4.66|Ki=21.7uM|Ki|=|21.7|uM|21700|nM
5CAV|2.73|2015|4ZQ|ligand is compound 41a|P00533|EPIDERMAL GROWTH FACTOR RECEPTOR|6.67|Ki=216nM|Ki|=|216|nM|216|nM
4YGF|2.00|2015|AZM|ligand is acetazolamide (AAZ)|K4NGD4|ALPHA-CARBONIC ANHYDRASE|7.68|Ki=21nM|Ki|=|21|nM|21|nM
4PS1|1.73|2015|5-mer|ligand is unnatural (BAL)LQ(HYP)(1U8) PEPTIDE, HYP CV8/9-AOMK|Q14790|CASPASE-8|6.66|Ki=220nM|Ki|=|220|nM|220|nM
4YHA|2.20|2015|MZM|methazolamide (MZA)|K4NGD4|ALPHA-CARBONIC ANHYDRASE|6.65|Ki=225nM|Ki|=|225|nM|225|nM
4X6H|1.00|2015|2-mer|ligand is 3XT-I37; covalent complex; Nonstandard assay: Temp 37, PH=6; compound 9|P43235|CATHEPSIN K|7.66|Ki=22nM|Ki|=|22|nM|22|nM
4ZY4|2.60|2015|4T3|compound 4|Q13153|SERINE/THREONINE-PROTEIN KINASE PAK 1|7.66|Ki=22nM|Ki|=|22|nM|22|nM
5CAL|2.70|2015|4Z8|ligand is compound 24|P00533|EPIDERMAL GROWTH FACTOR RECEPTOR|7.66|Ki=22nM|Ki|=|22|nM|22|nM
4RUZ|1.63|2015|3W8|compound 2a|P00918|CARBONIC ANHYDRASE 2|7.64|Ki=23.1nM|Ki|=|23.1|nM|23.1|nM
4Q7W|1.45|2015|6MH|ligand is 6-CH3-1,2-HOPTO|P00918|CARBONIC ANHYDRASE 2|2.64|Ki=2300uM|Ki|=|2300|uM|2300000|nM
4Q8Y|1.45|2015|HQT|ligand is 2,1-HIQTO|P00918|CARBONIC ANHYDRASE 2|2.64|Ki=2300uM|Ki|=|2300|uM|2300000|nM
4XIP|1.70|2015|40W|compound 5|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|6.63|Ki=235nM|Ki|=|235|nM|235|nM
5C91|2.44|2015|4YU|[Covalent complex] ligand is compound 1, Ki=245.8+/-54.8uM for disrupting Nedd4-1:Ub binding|P46934|E3 UBIQUITIN-PROTEIN LIGASE NEDD4|3.61|Ki=245.8uM|Ki|=|245.8|uM|245800|nM
4WEF|2.50|2015|DF4|[Nonstandard assay: IC50 kinetics assay using a pH 4.5 acetate buffer and 0.5 mM MUNANA] ligand is difluorosialic acid; without preincubation|Q6WJ03|HEMAGGLUTININ-NEURAMINIDASE GLYCOPROTEIN|2.59|Ki=2577uM|Ki|=|2577|uM|2577000|nM
4XAS|2.35|2015|40H|[Nonstandard assay: pH=7.6, K3PO4=10mM, KBr=100mM] compound 5;|Q14416|METABOTROPIC GLUTAMATE RECEPTOR 2|6.59|Ki=260nM|Ki|=|260|nM|260|nM
4Q7V|1.60|2015|5MH|ligand is 5-CH3-1,2-HOPTO|P00918|CARBONIC ANHYDRASE 2|3.59|Ki=260uM|Ki|=|260|uM|260000|nM
4Y63|1.30|2015|48O|[Incomplete ligand] compound 15; structure differs;|P16442|HISTO-BLOOD GROUP ABO SYSTEM TRANSFERASE|3.58|Ki=261uM|Ki|=|261|uM|261000|nM
4ZY5|2.35|2015|4T5|compound 17|Q13153|SERINE/THREONINE-PROTEIN KINASE PAK 1|7.59|Ki=26nM|Ki|=|26|nM|26|nM
4Q8X|1.55|2015|7FH|ligand is 5-CF3-1,2-HOPTO|P00918|CARBONIC ANHYDRASE 2|3.57|Ki=270uM|Ki|=|270|uM|270000|nM
4NCT|2.60|2015|2K2|ligand is PKC412|Q13627|DUAL SPECIFICITY TYROSINE-PHOSPHORYLATION-REGULATED KINASE|7.55|Ki=28.4nM|Ki|=|28.4|nM|28.4|nM
5C8N|2.40|2015|4YX|ligand is compound 23|P00533|EPIDERMAL GROWTH FACTOR RECEPTOR|7.55|Ki=28nM|Ki|=|28|nM|28|nM
5A0E|1.25|2015|11-mer|CsA analogue, JW47|P30405|PEPTIDYL-PROLYL CIS-TRANS ISOMERASE F|6.53|Ki=298nM|Ki|=|298|nM|298|nM
4UM3|2.70|2015|09R|ligand is NS3920|P58154|ACETYLCHOLINE BINDING PROTEIN|7.54|Ki=29nM|Ki|=|29|nM|29|nM
4ZWY|1.50|2015|4SN|[Incomplete ligand] compound 625; seems RCSB confused these pdb codes|P00918|CARBONIC ANHYDRASE 2|8.7|Ki=2nM|Ki|=|2|nM|2|nM
4ZWZ|1.62|2015|510|compound 626|P00918|CARBONIC ANHYDRASE 2|8.7|Ki=2nM|Ki|=|2|nM|2|nM
4ZWX|1.70|2015|5KZ|compound 623|P00918|CARBONIC ANHYDRASE 2|8.7|Ki=2nM|Ki|=|2|nM|2|nM
5EDQ|2.80|2015|5N3|ligand is compound 15|P00533|EPIDERMAL GROWTH FACTOR RECEPTOR|8.7|Ki=2nM|Ki|=|2|nM|2|nM
4Q1W|1.85|2015|017||V5Y949|HIV-1 PROTEASE|11.7|Ki=2pM|Ki|=|2|pM|0.002|nM
4U7V|1.38|2015|3EN|compound 2|Q9Q2G4|HIV-1 PROTEASE|5.49|Ki=3.2uM|Ki|=|3.2|uM|3200|nM
4X8U|2.10|2015|3ZB|compound 15|P08709|COAGULATION FACTOR VIIA|2.46|Ki=3.5mM|Ki|=|3.5|mM|3500000|nM
4ZAE|1.86|2015|4M1|compound 13|P00740|COAGULATION FACTOR IX|8.44|Ki=3.6nM|Ki|=|3.6|nM|3.6|nM
4RSP|1.62|2015|5-mer|[Covalent complex] compound 6; Peptidomimetic compound|V9TU12|ORF1A PROTEIN|5.44|Ki=3.6uM|Ki|=|3.6|uM|3600|nM
4Y8X|1.90|2015|4GR|compound 3|P03951|COAGULATION FACTOR XIA|8.43|Ki=3.7nM|Ki|=|3.7|nM|3.7|nM
4U6Z|1.80|2015|Q07|compound 19|P53582|METHIONINE AMINOPEPTIDASE 1|5.41|Ki=3.9uM|Ki|=|3.9|uM|3900|nM
5BYI|1.15|2015|4WA|ligand is compound 1d|P00918|CARBONIC ANHYDRASE 2|7.51|Ki=30.7nM|Ki|=|30.7|nM|30.7|nM
5EDR|2.60|2015|5N4|ligand is compound 27|P00533|EPIDERMAL GROWTH FACTOR RECEPTOR|7.46|Ki=34.3nM|Ki|=|34.3|nM|34.3|nM
4QF9|2.28|2015|35K|compound 1b|P22756|GLUTAMATE RECEPTOR, IONOTROPIC KAINATE 1|4.43|Ki=37.1uM|Ki|=|37.1|uM|37100|nM
4YKJ|1.40|2015|ALA|ligand is alanine|A0A0R4|ML032222A IGLUR|4.43|Ki=37uM|Ki|=|37|uM|37000|nM
4WA9|2.20|2015|AXI|ligand is axitinib|P00519|TYROSINE-PROTEIN KINASE ABL1|8.42|Ki=3800pM|Ki|=|3800|pM|3.8000000000000003|nM
4UFH|2.16|2015|GIF|ligand is IGF|P54818|GALACTOCEREBROSIDASE|6.42|Ki=380nM|Ki|=|380|nM|380|nM
5CAO|2.60|2015|4ZG|ligand is compound 29|P00533|EPIDERMAL GROWTH FACTOR RECEPTOR|7.42|Ki=38nM|Ki|=|38|nM|38|nM
4Q7S|1.80|2015|2YU|ligand is 4-CH3-1,2-HOPTO|P00918|CARBONIC ANHYDRASE 2|4.42|Ki=38uM|Ki|=|38|uM|38000|nM
4U3F|3.23|2015|Y52|compound 18|D0VX31|MITOCHONDRIAL UBIQUINOL-CYTOCHROME-C REDUCTASE COMPLEX CORE|8.39|Ki=4.1nM|Ki|=|4.1|nM|4.1|nM
4YE3|1.35|2015|G04|[Nonstandard assay: Temp 37, pH=5.6, 100 mM MES, 400 mM sodium chloride] ligand is GRL-4410A;|P03366|PROTEASE|8.37|Ki=4.3nM|Ki|=|4.3|nM|4.3|nM
4YML|1.75|2015|4F0|compound 2|P0AF12|5'-METHYLTHIOADENOSINE/S-ADENOSYLHOMOCYSTEINE NUCLEOSIDASE|8.35|Ki=4.5nM|Ki|=|4.5|nM|4.5|nM
4YX9|1.75|2015|4HY|tiratricol, compound 3|Q02P97|CFTR INHIBITORY FACTOR (CIF)|5.35|Ki=4.5uM|Ki|=|4.5|uM|4500|nM
4Z1K|1.35|2015|4KB|compound 4b|P00918|CARBONIC ANHYDRASE 2|8.33|Ki=4.7nM|Ki|=|4.7|nM|4.7|nM
5C2A|2.00|2015|4Y2|ligand is compound 9s|Q9Y233|CGMP 3',5'-CYCLIC PHOSPHODIESTERASE|8.32|Ki=4.8nM|Ki|=|4.8|nM|4.8|nM
4U1B|1.89|2015|Q08|compound 20|P53582|METHIONINE AMINOPEPTIDASE 1|5.31|Ki=4.9uM|Ki|=|4.9|uM|4900|nM
4ZXY|2.06|2015|4T1|compound (R)-4|P08709|COAGULATION FACTOR VIIA (HEAVY CHAIN)|6.4|Ki=400nM|Ki|=|400|nM|400|nM
4Z83|1.80|2015|4L7|ligand is (+)-1p|P00517|CAMP-DEPENDENT PROTEIN KINASE|7.4|Ki=40nM|Ki|=|40|nM|40|nM
5FL6|1.95|2015|Y0R|ligand is compound 3|Q16790|CARBONIC ANHYDRASE 9|7.36|Ki=43.6nM|Ki|=|43.6|nM|43.6|nM
4XX4|2.40|2015|70Y|[Different protein in assay: Rat AUC 2037nM hr at 10 mpk p.o.] compound 4|P00797|RENIN|7.36|Ki=44nM|Ki|=|44|nM|44|nM
5BMS|2.90|2015|4T6|compound 29|O96013|SERINE/THREONINE-PROTEIN KINASE PAK 4|6.34|Ki=455nM|Ki|=|455|nM|455|nM
4Q1Y|1.50|2015|017||V5Y949|HIV-1 PROTEASE|10.35|Ki=45pM|Ki|=|45|pM|0.045|nM
4Q7P|1.65|2015|3MH|ligand is 3-CH3-1,2-HOPTO|P00918|CARBONIC ANHYDRASE 2|4.32|Ki=48uM|Ki|=|48|uM|48000|nM
4Y0A|1.91|2015|SKM|ligand is shikimate|B7GVP4|SHIKIMATE KINASE|2.31|Ki=4950uM|Ki|=|4950|uM|4950000|nM
4OEM|1.52|2015|2-mer|ligand is Gly-Lys|P53634|DIPEPTIDYL PEPTIDASE 1 HEAVY CHAIN|5.3|Ki=5.0uM|Ki|=|5|uM|5000|nM
4RYD|2.15|2015|5-mer|compound 19; para-guanidinomethyl-Phac-R-Tle-R-Amba|P09958|FURIN|11.26|Ki=5.5pM|Ki|=|5.5|pM|0.0055|nM
4RFC|1.65|2015|3O1|compound 4c|P00918|CARBONIC ANHYDRASE 2|8.24|Ki=5.7nM|Ki|=|5.7|nM|5.7|nM
4Z1E|2.01|2015|DF5|comopound 5c|P00918|CARBONIC ANHYDRASE 2|8.24|Ki=5.7nM|Ki|=|5.7|nM|5.7|nM
4Z1N|1.47|2015|4KD|[Incomplete ligand] compound 4a|P00918|CARBONIC ANHYDRASE 2|8.23|Ki=5.89nM|Ki|=|5.89|nM|5.89|nM
4X6M|2.40|2015|3Y3|compound 25|P03951|COAGULATION FACTOR XI|8.24|Ki=5.8nM|Ki|=|5.8|nM|5.8|nM
4RIU|1.65|2015|3QR|compound 1|P00918|CARBONIC ANHYDRASE 2|7.3|Ki=50nM|Ki|=|50|nM|50|nM
5CAP|2.40|2015|4ZH|ligand is compound 30|P00533|EPIDERMAL GROWTH FACTOR RECEPTOR|7.28|Ki=52nM|Ki|=|52|nM|52|nM
4UFJ|2.20|2015|IF7|ligand is IGL|P54818|GALACTOCEREBROSIDASE|4.28|Ki=52uM|Ki|=|52|uM|52000|nM
4WCF|1.93|2015|3KN|compound III|O76290|PTERIDINE REDUCTASE|4.28|Ki=53uM|Ki|=|53|uM|53000|nM
4U69|1.60|2015|Q07|compound 19|P53582|METHIONINE AMINOPEPTIDASE 1|4.26|Ki=54.8uM|Ki|=|54.8|uM|54800|nM
4XIT|1.86|2015|40Z|compound 26|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|7.27|Ki=54nM|Ki|=|54|nM|54|nM
4XX3|2.40|2015|70X|[Different protein in assay: Rat AUC 31nM hr at 10 mpk p.o.] compound 3|P00797|RENIN|7.25|Ki=56nM|Ki|=|56|nM|56|nM
5E13|1.34|2015|5J9|ligand is compound 11c|P10153|EOSINOPHIL-DERIVED NEUROTOXIN|4.24|Ki=57.8uM|Ki|=|57.8|uM|57800|nM
4X6P|1.93|2015|3YU|[Nonstandard assay: Temp 37] compound 33|P03951|COAGULATION FACTOR XI|8.3|Ki=5nM|Ki|=|5|nM|5|nM
4ZY6|2.15|2015|4T6|compound 29|Q13153|SERINE/THREONINE-PROTEIN KINASE PAK 1|8.3|Ki=5nM|Ki|=|5|nM|5|nM
5BWB|2.57|2015|4VV|ligand is compound 2BIM-7, double bond position is different|P04058|ACETYLCHOLINESTERASE|5.3|Ki=5uM|Ki|=|5|uM|5000|nM
5AMG|1.55|2015|IW7|ligand is compound 3d|P00918|CARBONIC ANHYDRASE 2|8.22|Ki=6.0nM|Ki|=|6|nM|6|nM
4U71|1.80|2015|Q03|compound 15|P53582|METHIONINE AMINOPEPTIDASE 1|5.22|Ki=6.0uM|Ki|=|6|uM|6000|nM
5FL5|2.05|2015|82E|ligand is compound 1|Q16790|CARBONIC ANHYDRASE 9|8.19|Ki=6.4nM|Ki|=|6.4|nM|6.4|nM
4U73|1.80|2015|Q02|compound 2|P53582|METHIONINE AMINOPEPTIDASE 1|5.18|Ki=6.6uM|Ki|=|6.6|uM|6600|nM
4Z0Q|1.45|2015|4K9|compound 5e|P00918|CARBONIC ANHYDRASE 2|8.17|Ki=6.8nM|Ki|=|6.8|nM|6.8|nM
5A6A|2.69|2015|NGT|[Nonstandard assay: Temp 37] Ki=60.6+/-3.0nM, ligand is NGT|C1CH75|N-ACETYL-BETA-D-GLUCOSAMINIDASE|7.22|Ki=60.6nM|Ki|=|60.6|nM|60.6|nM
4U6W|1.83|2015|Q08|compound 20|P53582|METHIONINE AMINOPEPTIDASE 1|4.21|Ki=61.3uM|Ki|=|61.3|uM|61300|nM
4UFI|2.40|2015|AGK|ligand is AGF|P54818|GALACTOCEREBROSIDASE|6.2|Ki=630nM|Ki|=|630|nM|630|nM
5C8M|2.90|2015|4YW|ligand is compound 17|P00533|EPIDERMAL GROWTH FACTOR RECEPTOR|7.19|Ki=64nM|Ki|=|64|nM|64|nM
4Q83|1.55|2015|3FH|ligand is 3-CF3-1,2-HOPTO|P00918|CARBONIC ANHYDRASE 2|4.19|Ki=64uM|Ki|=|64|uM|64000|nM
4X3I|1.80|2015|7-mer|[Nonstandard assay: PH=8, 10 mM Tris-Cl, 0.5% NP-40, 100 mM NaCl] CaMKIIalpha peptide;|Q63053|ACTIVITY-REGULATED CYTOSKELETON-ASSOCIATED PROTEIN|3.17|Ki=671uM|Ki|=|671|uM|671000|nM
5DWR|2.00|2015|5H7|ligand is compound 8|P11309|SERINE/THREONINE-PROTEIN KINASE PIM-1|11.22|Ki=6pM|Ki|=|6|pM|0.006|nM
4Q90|1.54|2015|4H2|ligand is 4-CH3-2MPyr|P00918|CARBONIC ANHYDRASE 2|2.15|Ki=7.0mM|Ki|=|7|mM|7000000|nM
4QRH|1.65|2015|0O2|ligand is (p)ppGpp|W6E076|GUANYLATE KINASE|5.15|Ki=7.0uM|Ki|=|7|uM|7000|nM
4Z1J|1.27|2015|4KC|compound 4e|P00918|CARBONIC ANHYDRASE 2|8.11|Ki=7.7nM|Ki|=|7.7|nM|7.7|nM
5A6B|1.77|2015|OAN|[Nonstandard assay: Temp 37] Ki=7.9+/-0.7nM, ligand is PUGNAc|C1CH75|N-ACETYL-BETA-D-GLUCOSAMINIDASE|8.1|Ki=7.9nM|Ki|=|7.9|nM|7.9|nM
4CR5|2.00|2015|0TU|compound 5|P03951|COAGULATION FACTOR XIA|4.15|Ki=70uM|Ki|=|70|uM|70000|nM
4XAQ|2.21|2015|40F|[Nonstandard assay: pH=7.6, K3PO4=10mM, KBr=100mM] compound 1;|Q14416|METABOTROPIC GLUTAMATE RECEPTOR 2|7.14|Ki=71.7nM|Ki|=|71.7|nM|71.7|nM
4ZX1|1.50|2015|5L3|compound 625|P00918|CARBONIC ANHYDRASE 2|6.14|Ki=725nM|Ki|=|725|nM|725|nM
4WOV|1.80|2015|3SM|ligand is BMS066|P29597|NON-RECEPTOR TYROSINE-PROTEIN KINASE TYK2|7.14|Ki=72nM|Ki|=|72|nM|72|nM
4YC0|1.50|2015|5OF|ligand is M6;|A3UNN4|PUTATIVE NAD(+)--ARGININE ADP-RIBOSYLTRANSFERASE VI|4.13|Ki=74uM|Ki|=|74|uM|74000|nM
4XE1|1.80|2015|IL5|[Nonstandard assay: CO2 hydration reaction, 20 mM Hepes, 20 mM NaClO4] ligand is compound 2|P00918|CARBONIC ANHYDRASE 2|7.11|Ki=77.3nM|Ki|=|77.3|nM|77.3|nM
4Y64|1.60|2015|48C|[Incomplete ligand] compound 13e; structure differs;|P16442|HISTO-BLOOD GROUP ABO SYSTEM TRANSFERASE|3.1|Ki=790uM|Ki|=|790|uM|790000|nM
4Q1X|1.90|2015|017||V5Y949|HIV-1 PROTEASE|11.15|Ki=7pM|Ki|=|7|pM|0.007|nM
5C2H|2.09|2015|4XU|ligand is compound 15h|Q9Y233|CGMP 3',5'-CYCLIC PHOSPHODIESTERASE|11.09|Ki=8.2pM|Ki|=|8.2|pM|0.008199999999999999|nM
4WXI|2.60|2015|3VM|ligand is (S)-23;|P03951|COAGULATION FACTOR XI|8.08|Ki=8.4nM|Ki|=|8.4|nM|8.4|nM
4X3R|1.86|2015|686|[Nonstandard assay: pH=7.4, 25 mM Bis-Tris propane, 150 mM NaCl, 100 uM ZnCl2, 0.001% (w/w) octaethylene glycol monododecyl] compound 7;|Q04609|GLUTAMATE CARBOXYPEPTIDASE 2|11.07|Ki=8.6pM|Ki|=|8.6|pM|0.0086|nM
5C1W|1.70|2015|4XS|ligand is compound 5|Q9Y233|CGMP 3',5'-CYCLIC PHOSPHODIESTERASE|5.06|Ki=8.7uM|Ki|=|8.7|uM|8700|nM
4RFD|1.63|2015|3O5|compound 5c|P00918|CARBONIC ANHYDRASE 2|8.05|Ki=8.9nM|Ki|=|8.9|nM|8.9|nM
4CR9|1.70|2015|OTW|compound 6|P03951|COAGULATION FACTOR XI|4.1|Ki=80uM|Ki|=|80|uM|80000|nM
5E2R|1.60|2015|520|ligand is compound 20|P00918|CARBONIC ANHYDRASE 2|7.06|Ki=86.2nM|Ki|=|86.2|nM|86.2|nM
4XIQ|1.84|2015|40Y|compound 6;|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|7.07|Ki=86nM|Ki|=|86|nM|86|nM
5C29|2.05|2015|4XY|ligand is compound 9h|Q9Y233|CGMP 3',5'-CYCLIC PHOSPHODIESTERASE|6.06|Ki=880nM|Ki|=|880|nM|880|nM
5ABE|2.00|2015|XQO|[Nonstandard assay: Temp 37, 1X PBS buffer (0.03% BSA)] [Different protein in assay: Protein in binding assay is human OGA] compound 21|Q89ZI2|O-GLCNACASE BT_4395|3.05|Ki=890uM|Ki|=|890|uM|890000|nM
4ZXX|2.60|2015|4T0|compound 1|P08709|COAGULATION FACTOR VIIA HEAVY CHAIN|8.1|Ki=8nM|Ki|=|8|nM|8|nM
4RKX|1.59|2015|3S9|ligand is compound 2477|E0PTS8|STREPTOPAIN|5.1|Ki=8uM|Ki|=|8|uM|8000|nM
4ZZ2|1.45|2015|3YG|[Nonstandard assay: Temp 37, pH=7.5, 0.1 M Hepes] compound 7;|P22102|TRIFUNCTIONAL PURINE BIOSYNTHETIC PROTEIN ADENOSINE|8.04|Ki=9.1nM|Ki|=|9.1|nM|9.1|nM
4U70|1.60|2015|Q04|compound 16|P53582|METHIONINE AMINOPEPTIDASE 1|5.02|Ki=9.5uM|Ki|=|9.5|uM|9500|nM
4YES|1.50|2015|45S|compound 10|P00734|THROMBIN LIGHT CHAIN|8.02|Ki=9.6nM|Ki|=|9.6|nM|9.6|nM
4U6C|1.91|2015|Q06|compound 18|P53582|METHIONINE AMINOPEPTIDASE 1|5.0|Ki=9.9uM|Ki|=|9.9|uM|9900|nM
4RFM|2.10|2015|3P6|compound 28|Q08881|TYROSINE-PROTEIN KINASE ITK/TSK|10.05|Ki=90pM|Ki|=|90|pM|0.09|nM
4PS0|1.63|2015|5-mer|ligand is (BAL)LQ(HYP)(1U8) PEPTIDE, HYP CV8/9-AOMK|P42574|CASPASE-3|4.04|Ki=92000nM|Ki|=|92000|nM|92000|nM
4Q81|1.55|2015|7MH|ligand is 4,6-CH3-1,2-HOPTO|P00918|CARBONIC ANHYDRASE 2|3.02|Ki=950uM|Ki|=|950|uM|950000|nM
5ABG|2.00|2015|V0N|[Nonstandard assay: Temp 37, 1X PBS buffer (0.03% BSA)] [Different protein in assay: Protein in binding assay is human OGA] compound 34;|Q89ZI2|O-GLCNACASE BT_4395|8.05|Ki=9nM|Ki|=|9|nM|9|nM
4YZU|1.41|2015|4K6|compound 1|P00740|COAGULATION FACTOR IX|5.05|Ki=9uM|Ki|=|9|uM|9000|nM
5C6O|3.00|2015|4YH|ligand is verapamil|Q9KAX3|BH2163 PROTEIN|3.7|Ki>200uM|Ki|>|200|uM|200000|nM
5C6P|3.00|2015|4YH|ligand is verapamil|Q5F9J8|PROTEIN C|3.7|Ki>200uM|Ki|>|200|uM|200000|nM
4U6E|1.90|2015|Q02|compound 15|P53582|METHIONINE AMINOPEPTIDASE 1|3.3|Ki>500uM|Ki|>|500|uM|500000|nM
4XSY|4.01|2015|42T|[Nonstandard assay: pH=8, 50 mM Tris-Cl, 20 mM NaCl, 10 mM MgCl2, 0.1 mM EDTA, 2.5 ug acetylated BSA/mL] CBR 9379|A7ZSI4|DNA-DIRECTED RNA POLYMERASE SUBUNIT ALPHA|5.3|Ki~5uM|Ki|~|5|uM|5000|nM
5BMM|2.50|2016|5-mer|ligand is DNA-templated macrocyclic inhibitor MC25b|P00523|TYROSINE-PROTEIN KINASE SRC|8.4|IC<0.004uM|IC50|<|0.004|uM|4|nM
4ZT7|2.40|2016|4RC|compound 13|Q38C91|METHIONYL-TRNA SYNTHETASE|8.0|IC<10nM|IC50|<|10|nM|10|nM
4ZT6|2.25|2016|4RD|compound 11|Q38C91|METHIONYL-TRNA SYNTHETASE|8.0|IC<10nM|IC50|<|10|nM|10|nM
4ZT5|2.35|2016|4RN|compound 8|Q38C91|METHIONYL-TRNA SYNTHETASE|8.0|IC<10nM|IC50|<|10|nM|10|nM
4ZT4|2.30|2016|4RO|compound 7|Q38C91|METHIONYL-TRNA SYNTHETASE|8.0|IC<10nM|IC50|<|10|nM|10|nM
4ZT2|2.70|2016|4RP|compound 5|Q38C91|METHIONYL-TRNA SYNTHETASE|8.0|IC<10nM|IC50|<|10|nM|10|nM
4ZT3|2.80|2016|4RQ|compound 6|Q38C91|METHIONYL-TRNA SYNTHETASE|8.0|IC<10nM|IC50|<|10|nM|10|nM
4YEC|1.12|2016|5-mer|[Nonstandard assay: Temp 37] PmC11 and Ac-VLTK-AOMK|A7A9N3|CLOSTRIPAIN FAMILY|7.6|IC<25nM|IC50|<|25|nM|25|nM
5BQH|1.60|2016|4UK|compound 5|O14684|PROSTAGLANDIN E SYNTHASE|8.52|IC<3nM|IC50|<|3|nM|3|nM
5JAU|1.95|2016|6HU|ligand is compound 16,Thio-PAF Assay|Q13093|PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE|8.85|IC=0.0014uM|IC50|=|0.0014|uM|1.4|nM
5J8X|2.53|2016|OK3|[Uncommon element] compound 2|P0AEB2|D-ALANYL-D-ALANINE CARBOXYPEPTIDASE DACA|8.8|IC=0.0016uM|IC50|=|0.0016|uM|1.6|nM
5K0I|1.30|2016|6PW|ligand is compound 14|O14684|PROSTAGLANDIN E SYNTHASE|8.7|IC=0.002uM|IC50|=|0.002|uM|2|nM
5HLN|3.10|2016|65C|ligand is CHIR99021|P49841|GLYCOGEN SYNTHASE KINASE-3 BETA|11.52|IC=0.003nM|IC50|=|0.003|nM|0.003|nM
5FQC|1.45|2016|OK3|[Uncommon element] compound 2|Q9K2N0|BETA-LACTAMASE|8.52|IC=0.003uM|IC50|=|0.003|uM|3|nM
5JYO|2.10|2016|63J|ligand is CB-839|O94925|GLUTAMINASE KIDNEY ISOFORM, MITOCHONDRIAL|8.52|IC=0.003uM|IC50|=|0.003|uM|3|nM
5E91|2.42|2016|5L4|compound 1; HTRF assay|P37173|TGF-BETA RECEPTOR TYPE-2|8.4|IC=0.004uM|IC50|=|0.004|uM|4|nM
5JOG|2.46|2016|6LT|ligand is CNS5i-3|Q92905|COP9 SIGNALOSOME COMPLEX SUBUNIT 5|8.24|IC=0.0058uM|IC50|=|0.0058|uM|5.8|nM
5K0S|2.45|2016|0OU|ligand is compound 1312; aminoacylation enzyme inhibition assay|P59078|METHIONINE--TRNA LIGASE|8.22|IC=0.006uM|IC50|=|0.006|uM|6|nM
5LGO|1.12|2016|6VZ|[Different protein in assay: protein in assay is human cationic trypsin] ligand is compound 15|P00760|TRYPSIN|8.22|IC=0.006uM|IC50|=|0.006|uM|6|nM
5HMH|1.79|2016|62R|compound 21|Q00987|E3 UBIQUITIN-PROTEIN LIGASE MDM2|8.15|IC=0.007uM|IC50|=|0.007|uM|7|nM
5TKD|1.92|2016|7GL|ligand is compound 18|P29597|NON-RECEPTOR TYROSINE-PROTEIN KINASE TYK2|8.15|IC=0.007uM|IC50|=|0.007|uM|7|nM
5EI8|2.17|2016|5OE|compound 24c|P33981|DUAL SPECIFICITY PROTEIN KINASE TTK|8.1|IC=0.008uM|IC50|=|0.008|uM|8|nM
5LCK|1.89|2016|6TT|[Covalent complex] ligand is compound 3; covalent inhibitor|P28482|MITOGEN-ACTIVATED PROTEIN KINASE 1|8.1|IC=0.008uM|IC50|=|0.008|uM|8|nM
5CZB|1.96|2016|55W|compound 31|O92972|HCV NS5B POLYMERASE|8.0|IC=0.0099uM|IC50|=|0.0099|uM|9.9|nM
5FXS|1.90|2016|OZN|ligand is compound 24|P08069|INSULIN-LIKE GROWTH FACTOR 1 RECEPTOR|8.05|IC=0.009uM|IC50|=|0.009|uM|9|nM
5IHA|1.96|2016|6BE|ligand is compound 8f; IC50=0.009uM at ATP=20uM, IC50=0.41uM at ATP=2mM|Q14680|MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE|8.05|IC=0.009uM|IC50|=|0.009|uM|9|nM
5FTQ|1.70|2016|U4W|compoudn 17|Q9UM73|ALK TYROSINE KINASE RECEPTOR|8.0|IC=0.010uM|IC50|=|0.01|uM|10|nM
5HEX|2.73|2016|604|compound 30|P52789|HEXOKINASE-2|8.0|IC=0.010uM|IC50|=|0.01|uM|10|nM
5JI6|2.15|2016|6KN|ligand is compound 21|P50579|METHIONINE AMINOPEPTIDASE 2|7.96|IC=0.011uM|IC50|=|0.011|uM|11|nM
5G3N|1.80|2016|X28|compound 4|P14555|PHOSPHOLIPASE A2|7.92|IC=0.012uM|IC50|=|0.012|uM|12|nM
5KJK|1.93|2016|6T1|ligand is compound 48 (AZ370)|Q9NRG4|N-LYSINE METHYLTRANSFERASE SMYD2|7.92|IC=0.012uM|IC50|=|0.012|uM|12|nM
5FWJ|2.10|2016|MMK|ligand is KDM5-C49|P41229|HISTONE DEMETHYLASE JARID1C|7.89|IC=0.013uM|IC50|=|0.013|uM|13|nM
5HKM|2.10|2016|61Y|compound 34|O15530|3-PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE 1|7.89|IC=0.013uM|IC50|=|0.013|uM|13|nM
5IHC|2.14|2016|6BB|ligand is compound 12b; assay at ATP=20uM|Q14680|MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE|7.89|IC=0.013uM|IC50|=|0.013|uM|13|nM
5KIT|1.60|2016|6TA|ligand is compound 41; RCSB PDB maked with wrong compound 37 in title|P43490|NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE|7.89|IC=0.013uM|IC50|=|0.013|uM|13|nM
5TKB|2.16|2016|7DJ|ligand is compound 30|Q08499|CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D|7.89|IC=0.013uM|IC50|=|0.013|uM|13|nM
5E90|2.05|2016|5L4|compound 1; HTRF assay|P36897|TGF-BETA RECEPTOR TYPE-1|7.85|IC=0.014uM|IC50|=|0.014|uM|14|nM
5FXQ|2.30|2016|GD5|ligand is compound 12|P08069|INSULIN-LIKE GROWTH FACTOR 1 RECEPTOR|7.85|IC=0.014uM|IC50|=|0.014|uM|14|nM
5HMI|1.74|2016|62T|compound 10|Q00987|E3 UBIQUITIN-PROTEIN LIGASE MDM2|7.82|IC=0.015uM|IC50|=|0.015|uM|15|nM
5IU2|2.70|2016|6DA|ligand is compound 28|P41279|MITOGEN-ACTIVATED PROTEIN KINASE 8|7.8|IC=0.016uM|IC50|=|0.016|uM|16|nM
5JJR|1.99|2016|68E|compound 29|Q6DLV0|GENOME POLYPROTEIN|7.8|IC=0.016uM|IC50|=|0.016|uM|16|nM
5FP0|2.35|2016|SZC|compound 16|P34913|BIFUNCTIONAL EPOXIDE HYDROLASE 2|7.77|IC=0.017uM|IC50|=|0.017|uM|17|nM
5KJN|2.72|2016|6TL|ligand is compound 47|Q9NRG4|N-LYSINE METHYLTRANSFERASE SMYD2|7.77|IC=0.017uM|IC50|=|0.017|uM|17|nM
5EH0|2.18|2016|5NW|compound 34e|------|MONOPOLAR SPINDLE KINASE 1 (MPS1)|7.74|IC=0.018uM|IC50|=|0.018|uM|18|nM
5I2R|2.50|2016|67A|compound 26|Q9Y233|CAMP AND CAMP-INHIBITED CGMP 3',5'-CYCLIC PHOSPHODIESTERASE|7.72|IC=0.019uM|IC50|=|0.019|uM|19|nM
5LH8|1.54|2016|6WH|[Different protein in assay: protein in assay is human cationic trypsin] ligand is compound 8|P00760|TRYPSIN|7.72|IC=0.019uM|IC50|=|0.019|uM|19|nM
5B0X|2.30|2016|HCK|compound 1|P68400|CASEIN KINASE II, ALPHA SUBUNIT|7.7|IC=0.020uM|IC50|=|0.02|uM|20|nM
5T68|2.93|2016|77V|ligand is compound 19|P43405|TYROSINE-PROTEIN KINASE SYK|7.64|IC=0.023uM|IC50|=|0.023|uM|23|nM
5FUN|2.30|2016|GZA|ligand is GSK467|Q9UGL1|LYSINE-SPECIFIC DEMETHYLASE 5B|7.59|IC=0.026uM|IC50|=|0.026|uM|26|nM
4WNM|2.50|2016|3RT|ligand is CC-509|P43405|TYROSINE-PROTEIN KINASE SYK|7.59|IC=0.026uM|IC50|=|0.026|uM|26|nM
5DRI|2.80|2016|5EQ|compound 23|A5U3K4|MALATE SYNTHASE G|7.7|IC=0.02uM|IC50|=|0.02|uM|20|nM
5KTX|1.27|2016|6XH|ligand is compound 59|Q92793|CREB-BINDING PROTEIN|7.7|IC=0.02uM|IC50|=|0.02|uM|20|nM
5I89|1.07|2016|69B|ligand is compound 27|Q92793|CREB-BINDING PROTEIN|7.48|IC=0.033uM|IC50|=|0.033|uM|33|nM
5AEH|1.85|2016|8IR|compound 6|Q9H2K2|TANKYRASE-2|7.43|IC=0.037uM|IC50|=|0.037|uM|37|nM
5FXR|2.40|2016|8LN|ligand is compound 10|P08069|INSULIN-LIKE GROWTH FACTOR 1 RECEPTOR|7.42|IC=0.038uM|IC50|=|0.038|uM|38|nM
5HLS|2.18|2016|62G|compound 10 (CPI-0610)|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|7.41|IC=0.039uM|IC50|=|0.039|uM|39|nM
5KTW|1.09|2016|6XG|ligand is compound 44|Q92793|CREB-BINDING PROTEIN|7.52|IC=0.03uM|IC50|=|0.03|uM|30|nM
5J1V|2.52|2016|6FD|ligand is compound 13|P49759|DUAL SPECIFICITY PROTEIN KINASE CLK1|7.39|IC=0.041uM|IC50|=|0.041|uM|41|nM
5BYZ|1.65|2016|4WE|compound 3|Q13164|MITOGEN-ACTIVATED PROTEIN KINASE 7|7.38|IC=0.042uM|IC50|=|0.042|uM|42|nM
5G3W|1.60|2016|C65|ligand is compound E-1a|Q70I53|HISTONE DEACETYLASE-LIKE AMIDOHYDROLASE|7.38|IC=0.042uM|IC50|=|0.042|uM|42|nM
5EI2|2.67|2016|5O7|compound 24b|P33981|DUAL SPECIFICITY PROTEIN KINASE TTK|7.34|IC=0.046uM|IC50|=|0.046|uM|46|nM
5JJS|1.65|2016|6L2|ligand is compound 27|Q6DLV0|GENOME POLYPROTEIN|7.32|IC=0.048uM|IC50|=|0.048|uM|48|nM
5HMK|2.17|2016|62Q|compound 3|Q00987|E3 UBIQUITIN-PROTEIN LIGASE MDM2|7.4|IC=0.04uM|IC50|=|0.04|uM|40|nM
5LI3|2.40|2016|9RB|ligand is compound E-4a; PDB code is 5G14 in paper, but 5LI3 in RCSB|------|ACETOIN UTILIZATION PROTEIN|7.28|IC=0.053uM|IC50|=|0.053|uM|53|nM
5HLP|2.45|2016|65A|ligand is BRD3937|P49841|GLYCOGEN SYNTHASE KINASE-3 BETA|7.27|IC=0.054uM|IC50|=|0.054|uM|54|nM
5ETH|2.80|2016|5RT|compound 3|P51449|NUCLEAR RECEPTOR ROR-GAMMA|7.25|IC=0.056uM|IC50|=|0.056|uM|56|nM
5KRE|2.00|2016|6WG|[Covalent complex] ligand is covalent inhibitor 2|Q5VWZ2|LYSOPHOSPHOLIPASE-LIKE PROTEIN 1|7.23|IC=0.059uM|IC50|=|0.059|uM|59|nM
5JO0|1.80|2016|L56|ligand is compound 6b|Q8IKG4|1-DEOXY-D-XYLULOSE 5-PHOSPHATE REDUCTOISOMERASE|7.3|IC=0.05uM|IC50|=|0.05|uM|50|nM
5K4L|3.18|2016|6QN|ligand is compound 18|P29375|LYSINE-SPECIFIC DEMETHYLASE 5A|7.3|IC=0.05uM|IC50|=|0.05|uM|50|nM
5HZN|2.20|2016|66A|compound 1 (NVP-AEW541)|P08069|INSULIN-LIKE GROWTH FACTOR 1 RECEPTOR|7.21|IC=0.061uM|IC50|=|0.061|uM|61|nM
5KJM|2.19|2016|6TM|[Incomplete ligand] ligand is compound 30 (AZ931); 7 N-atoms in RCSB PDB, but 6 N-atoms in paper|Q9NRG4|N-LYSINE METHYLTRANSFERASE SMYD2|7.19|IC=0.065uM|IC50|=|0.065|uM|65|nM
5JMP|1.70|2016|LC7|ligand is compound 6f|Q8IKG4|1-DEOXY-D-XYLULOSE 5-PHOSPHATE REDUCTOISOMERASE|7.17|IC=0.067uM|IC50|=|0.067|uM|67|nM
5K0J|1.94|2016|6P2|ligand is compound 24|P22734|CATECHOL O-METHYLTRANSFERASE|7.12|IC=0.075uM|IC50|=|0.075|uM|75|nM
5DW1|1.55|2016|5GD|ligand is compound RVX-297|P25440|BROMODOMAIN-CONTAINING PROTEIN 2|7.1|IC=0.08uM|IC50|=|0.08|uM|80|nM
5EEC|1.87|2016|ZXM|[Uncommon element] ligand is compound S02030|Q9F663|CARBAPENEM-HYDROLYZING BETA-LACTAMASE KPC|7.1|IC=0.08uM|IC50|=|0.08|uM|80|nM
5F3I|2.24|2016|5UJ|compound 54j|O75164|LYSINE-SPECIFIC DEMETHYLASE 4A|7.1|IC=0.08uM|IC50|=|0.08|uM|80|nM
5BNS|2.20|2016|4VM|compound 36|P0A6R0|3-OXOACYL-[ACYL-CARRIER-PROTEIN] SYNTHASE 3|7.02|IC=0.095uM|IC50|=|0.095|uM|95|nM
5BYY|2.79|2016|4WG|compound 2|Q13164|MITOGEN-ACTIVATED PROTEIN KINASE 7|7.01|IC=0.098uM|IC50|=|0.098|uM|98|nM
5EI6|2.01|2016|5OQ|compound 15b|P33981|DUAL SPECIFICITY PROTEIN KINASE TTK|7.0|IC=0.099uM|IC50|=|0.099|uM|99|nM
5JYP|2.74|2016|ZBS|ligand is trans-CBTBP(1S, 3S-CBTBP); 1S, 3S or 1R, 3R|O94925|GLUTAMINASE KIDNEY ISOFORM, MITOCHONDRIAL|7.0|IC=0.10uM|IC50|=|0.1|uM|100|nM
5I8B|1.52|2016|69F|ligand is compound 23|Q92793|CREB-BINDING PROTEIN|6.96|IC=0.11uM|IC50|=|0.11|uM|110|nM
5F3G|2.50|2016|5UL|compound 53a|O75164|LYSINE-SPECIFIC DEMETHYLASE 4A|6.9|IC=0.126uM|IC50|=|0.126|uM|126|nM
5F2F|1.67|2016|5U7|compound 7; biofilm assay|P08191|FIMH PROTEIN|6.92|IC=0.12uM|IC50|=|0.12|uM|120|nM
5JBI|1.70|2016|6J8|ligand is compound 6c|Q8IKG4|1-DEOXY-D-XYLULOSE 5-PHOSPHATE REDUCTOISOMERASE|6.92|IC=0.12uM|IC50|=|0.12|uM|120|nM
5LZ9|2.06|2016|7BR|ligand is compound (S)-23|Q13093|PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE|6.92|IC=0.12uM|IC50|=|0.12|uM|120|nM
5F3E|2.16|2016|5UO|compound 54a|O75164|LYSINE-SPECIFIC DEMETHYLASE 4A|6.86|IC=0.138uM|IC50|=|0.138|uM|138|nM
5JIC|1.40|2016|N7E|ligand is compound MeO-N5-PanAm (11)|Q8NVG0|TYPE II PANTOTHENATE KINASE|6.89|IC=0.13uM|IC50|=|0.13|uM|130|nM
5EE8|1.54|2016|ZXM|[Uncommon element] ligand is compound S02030|P0AD64|BETA-LACTAMASE SHV-1|6.89|IC=0.13uM|IC50|=|0.13|uM|130|nM
5HE2|2.79|2016|F0S|compound 12n|P21146|BETA-ADRENERGIC RECEPTOR KINASE 1|6.89|IC=0.13uM|IC50|=|0.13|uM|130|nM
5HFU|2.92|2016|603|compound 27|P52789|HEXOKINASE-2|6.89|IC=0.13uM|IC50|=|0.13|uM|130|nM
5G1C|1.81|2016|9RB|ligand is compound E-4a|Q70I53|HISTONE DEACETYLASE-LIKE AMIDOHYDROLASE|6.85|IC=0.14uM|IC50|=|0.14|uM|140|nM
5EUD|2.24|2016|5S6|compound 2|Q67PY4|PUTATIVE SPHINGOSINE-1-PHOSPHATE LYASE|6.82|IC=0.15uM|IC50|=|0.15|uM|150|nM
5HE0|2.56|2016|453|compound 12h|P21146|BETA-ADRENERGIC RECEPTOR KINASE 1|6.82|IC=0.15uM|IC50|=|0.15|uM|150|nM
5JC1|1.65|2016|6JB|ligand is compound 6d|Q8IKG4|1-DEOXY-D-XYLULOSE 5-PHOSPHATE REDUCTOISOMERASE|6.82|IC=0.15uM|IC50|=|0.15|uM|150|nM
5KR8|2.12|2016|6WE|ligand is compound 5|P56817|BETA-SECRETASE 1|6.82|IC=0.15uM|IC50|=|0.15|uM|150|nM
5DY5|1.95|2016|5GR|compound 9|Q8IXJ6|NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-2|6.79|IC=0.163uM|IC50|=|0.163|uM|163|nM
5JMW|1.55|2016|L50|ligand is compound 6a|Q8IKG4|1-DEOXY-D-XYLULOSE 5-PHOSPHATE REDUCTOISOMERASE|6.76|IC=0.175uM|IC50|=|0.175|uM|175|nM
5A8Y|1.90|2016|VBM|ligand is compound 13|P08246|NEUTROPHIL ELASTASE|9.77|IC=0.17nM|IC50|=|0.17|nM|0.17|nM
5ECV|2.09|2016|5M2|compound 25|P9WK17|MALATE SYNTHASE G|6.77|IC=0.17uM|IC50|=|0.17|uM|170|nM
5EUE|2.83|2016|5S5|compound 1|Q67PY4|PUTATIVE SPHINGOSINE-1-PHOSPHATE LYASE|6.77|IC=0.17uM|IC50|=|0.17|uM|170|nM
5IH8|1.85|2016|6BJ|ligand is compound 1a; IC50=0.18uM at ATP=20uM, IC50=18.8uM at ATP=2mM|Q14680|MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE|6.74|IC=0.18uM|IC50|=|0.18|uM|180|nM
5ENH|1.95|2016|5QB|compound 12|Q8WWQ0|PH-INTERACTING PROTEIN|3.72|IC=0.19mM|IC50|=|0.19|mM|190000|nM
5J1W|2.42|2016|6FB|ligand is compound 14|P49759|DUAL SPECIFICITY PROTEIN KINASE CLK1|6.72|IC=0.19uM|IC50|=|0.19|uM|190|nM
5HX8|2.20|2016|66P|compound 10|P23458|TYROSINE-PROTEIN KINASE JAK1|10.0|IC=0.1nM|IC50|=|0.1|nM|0.1|nM
5KZI|2.10|2016|6YN|ligand is compound 8b|P11309|SERINE/THREONINE-PROTEIN KINASE PIM-1|10.0|IC=0.1nM|IC50|=|0.1|nM|0.1|nM
5EJV|2.58|2016|444|ligand is compound T090131718|P51449|NUCLEAR RECEPTOR ROR-GAMMA|6.69|IC=0.204uM|IC50|=|0.204|uM|204|nM
5LC0|2.70|2016|6T8|[Uncommon element] ligand is cn-716; ring closed in RCSB PDB|------|NS2B-NS3 PROTEASE,NS2B-NS3 PROTEASE|6.7|IC=0.20uM|IC50|=|0.2|uM|200|nM
4YQU|1.94|2016|4GB|[Covalent complex] covalent inhibitor C1-31|P78417|GLUTATHIONE S-TRANSFERASE OMEGA-1|6.66|IC=0.221uM|IC50|=|0.221|uM|221|nM
5CLS|1.75|2016|52T|inhibitor (+)-31a|P50579|METHIONINE AMINOPEPTIDASE 2|6.66|IC=0.22uM|IC50|=|0.22|uM|220|nM
5JAT|2.04|2016|6HR|ligand is compound 12,Thio-PAF Assay|Q13093|PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE|6.64|IC=0.23uM|IC50|=|0.23|uM|230|nM
5JAP|2.46|2016|6HZ|ligand is compound 8,Thio-PAF Assay|Q13093|PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE|6.64|IC=0.23uM|IC50|=|0.23|uM|230|nM
5LCJ|1.78|2016|6TS|[Covalent complex] ligand is compound 1; covalent inhibitor|P28482|MITOGEN-ACTIVATED PROTEIN KINASE 1|6.64|IC=0.23uM|IC50|=|0.23|uM|230|nM
5EOB|1.75|2016|5QQ|Compound 23|P08581|HEPATOCYTE GROWTH FACTOR RECEPTOR|9.62|IC=0.24nM|IC50|=|0.24|nM|0.24|nM
5M55|2.40|2016|7GG|ligand is compound 71|P51955|SERINE/THREONINE-PROTEIN KINASE NEK2|6.62|IC=0.24uM|IC50|=|0.24|uM|240|nM
5LMA|1.43|2016|6ZG|ligand is compound 1; pIC50=6.6|P43405|TYROSINE-PROTEIN KINASE SYK|6.6|IC=0.25uM|IC50|=|0.25|uM|250|nM
5ITD|3.02|2016|6CY|ligand is compound 11|P42336|PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE|6.58|IC=0.262uM|IC50|=|0.262|uM|262|nM
5ENF|1.37|2016|5Q7|ligand is compound 4|Q8WWQ0|PH-INTERACTING PROTEIN|3.57|IC=0.27mM|IC50|=|0.27|mM|270000|nM
5FBN|1.80|2016|5WF|compound 1|Q06187|TYROSINE-PROTEIN KINASE BTK|9.57|IC=0.27nM|IC50|=|0.27|nM|0.27|nM
5JNL|1.60|2016|L54|ligand is compound 6g|Q8IKG4|1-DEOXY-D-XYLULOSE 5-PHOSPHATE REDUCTOISOMERASE|6.57|IC=0.27uM|IC50|=|0.27|uM|270|nM
5HE3|2.74|2016|FF1|compound 12i|P21146|BETA-ADRENERGIC RECEPTOR KINASE 1|6.55|IC=0.28uM|IC50|=|0.28|uM|280|nM
5HE1|3.15|2016|ZS2|compound 12k|P25098|BETA-ADRENERGIC RECEPTOR KINASE 1|6.55|IC=0.28uM|IC50|=|0.28|uM|280|nM
5JAZ|1.40|2016|LC5|ligand is compound 6h|Q8IKG4|1-DEOXY-D-XYLULOSE 5-PHOSPHATE REDUCTOISOMERASE|6.55|IC=0.28uM|IC50|=|0.28|uM|280|nM
5HK9|1.80|2016|64O|ligand is compound 8h|Q02P97|CFTR INHIBITORY FACTOR (CIF)|6.54|IC=0.29uM|IC50|=|0.29|uM|290|nM
5LSY|1.62|2016|76M|ligand is compound 4|Q9BYW2|HISTONE-LYSINE N-METHYLTRANSFERASE SETD2|6.54|IC=0.29uM|IC50|=|0.29|uM|290|nM
5KE0|1.68|2016|6S9|ligand is compound 11|P63086|MITOGEN-ACTIVATED PROTEIN KINASE 1|9.7|IC=0.2nM|IC50|=|0.2|nM|0.2|nM
5F2S|2.08|2016|5TZ|compound 15|O75164|LYSINE-SPECIFIC DEMETHYLASE 4A|6.7|IC=0.2uM|IC50|=|0.2|uM|200|nM
5I5X|1.65|2016|68C|ligand is compound 27; pIC50 = 6.7|O15382|BRANCHED-CHAIN-AMINO-ACID AMINOTRANSFERASE, MITOCHONDRIAL|6.7|IC=0.2uM|IC50|=|0.2|uM|200|nM
5FBO|1.89|2016|5WH|compound 3|Q06187|TYROSINE-PROTEIN KINASE BTK|9.51|IC=0.31nM|IC50|=|0.31|nM|0.31|nM
5KQF|1.98|2016|6WD|ligand is compound 12|P56817|BETA-SECRETASE 1|6.51|IC=0.31uM|IC50|=|0.31|uM|310|nM
5FQ9|1.50|2016|C6S|[Uncommon element] compound 1|P14489|BETA-LACTAMASE OXA-10|6.48|IC=0.33uM|IC50|=|0.33|uM|330|nM
5TOZ|1.98|2016|7H4|[Covalent complex] ligand is covalent inhibitor PF-06651600|P52333|TYROSINE-PROTEIN KINASE JAK3|9.46|IC=0.346nM|IC50|=|0.346|nM|0.346|nM
5HKA|2.05|2016|64N|ligand is compound 8c|Q02P97|CFTR INHIBITORY FACTOR (CIF)|6.46|IC=0.35uM|IC50|=|0.35|uM|350|nM
5C20|2.75|2016|GHZ|compound 2|A9XG43|3C PROTEINASE|6.41|IC=0.3883uM|IC50|=|0.3883|uM|388.29999999999995|nM
5K4X|1.37|2016|6Q9|ligand is compound 1|G7CNL4|INOSINE-5'-MONOPHOSPHATE DEHYDROGENASE,INOSINE-5|6.42|IC=0.38uM|IC50|=|0.38|uM|380|nM
5EDI|2.20|2016|5M9|compound 24|Q9Y233|CAMP AND CAMP-INHIBITED CGMP 3',5'-CYCLIC PHOSPHODIESTERASE|9.52|IC=0.3nM|IC50|=|0.3|nM|0.3|nM
5EOL|2.20|2016|5QO|ligand is compound 9c|P11309|SERINE/THREONINE-PROTEIN KINASE PIM-1|9.52|IC=0.3nM|IC50|=|0.3|nM|0.3|nM
5FCW|1.98|2016|5YA|compound 6|Q9BY41|HISTONE DEACETYLASE 8|6.52|IC=0.3uM|IC50|=|0.3|uM|300|nM
5FQB|1.90|2016|OK3|[Uncommon element] compound 2|P04190|BETA-LACTAMASE 2|6.52|IC=0.3uM|IC50|=|0.3|uM|300|nM
5T4B|1.76|2016|75N|ligand is compound 34a|P27487|DIPEPTIDYL PEPTIDASE 4|9.38|IC=0.42nM|IC50|=|0.42|nM|0.42|nM
5B5B|2.00|2016|AKX|compound 3a|P13053|VITAMIN D3 RECEPTOR|9.37|IC=0.43nM|IC50|=|0.43|nM|0.43|nM
5K5E|2.80|2016|6QS|ligand is compound 16|P06276|CHOLINESTERASE|6.35|IC=0.443uM|IC50|=|0.443|uM|443|nM
5DP8|2.40|2016|5ED|compound 8|A9XG43|3C PROTEINASE|6.36|IC=0.44uM|IC50|=|0.44|uM|440|nM
5HM0|1.40|2016|62V|compound 3|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|6.36|IC=0.44uM|IC50|=|0.44|uM|440|nM
5B4K|2.90|2016|6DT|compound 2|Q9Y233|CGMP 3',5'-CYCLIC PHOSPHODIESTERASE|9.34|IC=0.46nM|IC50|=|0.46|nM|0.46|nM
5F9E|2.00|2016|5VS|ligand is compound 10|Q04759|PROTEIN KINASE C, THETA TYPE|9.34|IC=0.46nM|IC50|=|0.46|nM|0.46|nM
5ELZ|1.80|2016|3V9|ligand is compound N-Pip-PanAm (12)|Q8NVG0|TYPE II PANTOTHENATE KINASE|6.34|IC=0.46uM|IC50|=|0.46|uM|460|nM
4ZTQ|2.80|2016|4RM|compound 77|O14965|AURORA KINASE A|6.32|IC=0.48uM|IC50|=|0.48|uM|480|nM
5LSS|1.79|2016|76H|ligand is compound 3|Q9BYW2|HISTONE-LYSINE N-METHYLTRANSFERASE SETD2|6.31|IC=0.49uM|IC50|=|0.49|uM|490|nM
5LYH|2.17|2016|7B8|inhibitor H10,IC50=0.49+/-0.07uM|Q460N5|POLY [ADP-RIBOSE] POLYMERASE 14|6.31|IC=0.49uM|IC50|=|0.49|uM|490|nM
5A4E|2.68|2016|7QQ|compound 5|Q13627|DUAL SPECIFICITY TYROSINE-PHOSPHORYLATION-REGULATED KINASE|6.4|IC=0.4uM|IC50|=|0.4|uM|400|nM
5DGM|2.86|2016|59Z|compound 7|P14324|FARNESYL PYROPHOSPHATE SYNTHASE|6.4|IC=0.4uM|IC50|=|0.4|uM|400|nM
5BNR|1.89|2016|4VL|compound 23|P0A6R0|3-OXOACYL-[ACYL-CARRIER-PROTEIN] SYNTHASE 3|6.28|IC=0.53uM|IC50|=|0.53|uM|530|nM
5I86|1.05|2016|69A|ligand is compound 14|Q92793|CREB-BINDING PROTEIN|6.28|IC=0.53uM|IC50|=|0.53|uM|530|nM
5JIY|1.48|2016|11-mer|ligand is Histone H3K9norLeucine mutant peptide, K9Nle|Q96KQ7|HISTONE-LYSINE N-METHYLTRANSFERASE EHMT2|6.27|IC=0.54uM|IC50|=|0.54|uM|540|nM
5FPU|2.24|2016|K0I|ligand is GSKJ1|Q9UGL1|LYSINE-SPECIFIC DEMETHYLASE 5B|6.26|IC=0.55uM|IC50|=|0.55|uM|550|nM
4Z22|2.62|2016|4KG|[Different protein in assay: M205S protein in crystal, wild-type in assay] inhibitor DR718A|W7FL77|PLASMEPSIN-2|6.24|IC=0.57uM|IC50|=|0.57|uM|570|nM
5KOQ|2.70|2016|6VR|ligand is compound 14|P00797|RENIN|9.24|IC=0.58nM|IC50|=|0.58|nM|0.58|nM
5ENE|1.49|2016|5Q8|ligand is compound 3|Q8WWQ0|PH-INTERACTING PROTEIN|3.23|IC=0.59mM|IC50|=|0.59|mM|590000|nM
5DCZ|2.23|2016|59B|ligand is compound 23|Q9H2K2|TANKYRASE-2|9.3|IC=0.5nM|IC50|=|0.5|nM|0.5|nM
5EAK|2.80|2016|24R|compound 19|Q7KZI7|SERINE/THREONINE-PROTEIN KINASE MARK2|9.3|IC=0.5nM|IC50|=|0.5|nM|0.5|nM
5HMY|2.10|2016|LNY|compound 15|Q6DLV0|RNA-DIRECTED RNA POLYMERASE NS5|6.3|IC=0.5uM|IC50|=|0.5|uM|500|nM
5IH5|2.25|2016|AUE|Epiblastin A (compound 15)|P48730|CASEIN KINASE I ISOFORM DELTA|6.3|IC=0.5uM|IC50|=|0.5|uM|500|nM
5KQD|2.60|2016|PKZ|ligand is Palmitoyl-CoA|Q9H999|PANTOTHENATE KINASE 3|6.3|IC=0.5uM|IC50|=|0.5|uM|500|nM
5KTU|1.38|2016|6XB|ligand is compound 7|Q92793|CREB-BINDING PROTEIN|6.21|IC=0.62uM|IC50|=|0.62|uM|620|nM
5M53|1.90|2016|7GJ|ligand is compound 11|P51955|SERINE/THREONINE-PROTEIN KINASE NEK2|6.21|IC=0.62uM|IC50|=|0.62|uM|620|nM
4WN0|2.20|2016|G3P|ligand is D-glycerol-1-phosphate (GroP)|Q5PPM0|XEEL PROTEIN|3.22|IC=0.6mM|IC50|=|0.6|mM|600000|nM
4YHT|3.05|2016|4EF|[Different protein in assay: Bra-f in bioassay has v600e mutation] compound 11|P15056|SERINE/THREONINE-PROTEIN KINASE B-RAF|9.22|IC=0.6nM|IC50|=|0.6|nM|0.6|nM
5B4L|2.40|2016|6DW|compound 16f|Q9Y233|CGMP 3',5'-CYCLIC PHOSPHODIESTERASE|9.12|IC=0.76nM|IC50|=|0.76|nM|0.76|nM
5LXP|2.07|2016|7AG|inhibitor H5|Q460N5|POLY [ADP-RIBOSE] POLYMERASE 14|6.12|IC=0.76uM|IC50|=|0.76|uM|760|nM
5ENB|1.73|2016|5Q5|ligand is compound thiourea 1|Q8WWQ0|PH-INTERACTING PROTEIN|3.11|IC=0.78mM|IC50|=|0.78|mM|780000|nM
5ISM|2.00|2016|6DG|ligand is compound 30|P27487|DIPEPTIDYL PEPTIDASE 4|9.15|IC=0.7nM|IC50|=|0.7|nM|0.7|nM
5A54|2.63|2016|5PW|compound 15|Q13627|DUAL SPECIFICITY TYROSINE-PHOSPHORYLATION-REGULATED KINASE|6.15|IC=0.7uM|IC50|=|0.7|uM|700|nM
5FAH|1.10|2016|5VT|[Nonstandard assay: pH 5.6, 150mM NaCl] compound 1|P49862|KALLIKREIN-7|6.15|IC=0.7uM|IC50|=|0.7|uM|700|nM
5EHY|2.26|2016|5O4|compound 39|P33981|DUAL SPECIFICITY PROTEIN KINASE TTK|6.09|IC=0.81uM|IC50|=|0.81|uM|810|nM
5DP9|1.90|2016|5EX|compound 9|A9XG43|3C PROTEINASE|6.08|IC=0.84uM|IC50|=|0.84|uM|840|nM
5K0F|1.81|2016|6P1|ligand is compound 22+23; racemate; , IC50=0.86uM for comp 22, IC50=0.47uM for comp 23|P22734|CATECHOL O-METHYLTRANSFERASE|6.07|IC=0.86uM|IC50|=|0.86|uM|860|nM
5IVT|1.15|2016|6EE|ligand is compound 9t(MK-8718)|C8B467|HIV-1 PROTEASE|9.1|IC=0.8nM|IC50|=|0.8|nM|0.8|nM
5A3X|2.26|2016|QIV|compound 2|Q13627|DUAL SPECIFICITY TYROSINE-PHOSPHORYLATION-REGULATED KINASE|6.1|IC=0.8uM|IC50|=|0.8|uM|800|nM
5LZ8|2.11|2016|7BP|ligand is compound ( +/-)-18|Q13093|PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE|6.01|IC=0.98uM|IC50|=|0.98|uM|980|nM
5BQI|1.88|2016|4UL|compound 8|O14684|PROSTAGLANDIN E SYNTHASE|9.05|IC=0.9nM|IC50|=|0.9|nM|0.9|nM
5I5Z|2.60|2016|68U|ligand is compound 7|P49336|CYCLIN-DEPENDENT KINASE 8|9.05|IC=0.9nM|IC50|=|0.9|nM|0.9|nM
5F3C|2.06|2016|5U8|compound 52d|O75164|LYSINE-SPECIFIC DEMETHYLASE 4A|6.05|IC=0.9uM|IC50|=|0.9|uM|900|nM
5J4Y|2.59|2016|6JG|ligand is compound 12h|P03072|LARGE T ANTIGEN|6.05|IC=0.9uM|IC50|=|0.9|uM|900|nM
5K0B|2.36|2016|6PS|ligand is compound 18|P22734|CATECHOL O-METHYLTRANSFERASE|6.05|IC=0.9uM|IC50|=|0.9|uM|900|nM
5DRC|2.18|2016|5ER|compound 9|P9WK17|MALATE SYNTHASE G|5.98|IC=1.05uM|IC50|=|1.05|uM|1050|nM
5K09|2.70|2016|6PQ|ligand is compound 15|P22734|CATECHOL O-METHYLTRANSFERASE|6.0|IC=1.0uM|IC50|=|1|uM|1000|nM
5HO8|2.70|2016|63E|compound 16|O15530|3-PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE 1|5.96|IC=1.1uM|IC50|=|1.1|uM|1100|nM
5JOH|1.99|2016|6M3|ligand is CNS5i-1b|Q92905|COP9 SIGNALOSOME COMPLEX SUBUNIT 5|5.96|IC=1.1uM|IC50|=|1.1|uM|1100|nM
5K0C|1.95|2016|6OZ|ligand is compound 20|P22734|CATECHOL O-METHYLTRANSFERASE|5.96|IC=1.1uM|IC50|=|1.1|uM|1100|nM
5T6G|2.45|2016|N40|ligand is compound 7m|Q83883|GENOME POLYPROTEIN|5.96|IC=1.1uM|IC50|=|1.1|uM|1100|nM
5E8Z|1.51|2016|5L4|compound 1; HTRF assay|P36897|TGF-BETA RECEPTOR TYPE-1|5.91|IC=1.243uM|IC50|=|1.243|uM|1243|nM
5C1Y|1.97|2016|GHY|compound 1|A9XG43|3C PROTEINASE|5.9|IC=1.246uM|IC50|=|1.246|uM|1246|nM
5AX3|2.98|2016|5ID|ternary complex with a peptide PEP in allosteric site and 5-IOD in ATP site, IC50 for PEP is 9.8uM|P28482|MITOGEN-ACTIVATED PROTEIN KINASE 1|5.92|IC=1.2uM|IC50|=|1.2|uM|1200|nM
5CUQ|1.70|2016|NSC|ligand is NSC12155|C0LMU0|NONSTRUCTURAL PROTEIN NS5|5.92|IC=1.2uM|IC50|=|1.2|uM|1200|nM
5LSX|2.90|2016|76O|ligand is compound 9|Q9BYW2|HISTONE-LYSINE N-METHYLTRANSFERASE SETD2|5.92|IC=1.2uM|IC50|=|1.2|uM|1200|nM
5TRJ|2.57|2016|7HO|ligand is compound 9b|Q9WMX2|RNA-DEPENDENT RNA POLYMERASE|5.92|IC=1.2uM|IC50|=|1.2|uM|1200|nM
5A4T|2.15|2016|AJG|compound 14|Q13627|DUAL SPECIFICITY TYROSINE-PHOSPHORYLATION-REGULATED KINASE|5.89|IC=1.3uM|IC50|=|1.3|uM|1300|nM
5J4V|2.94|2016|6JH|ligand is compound 12g|P03072|LARGE T ANTIGEN|5.85|IC=1.4uM|IC50|=|1.4|uM|1400|nM
5KOS|2.41|2016|6VS|ligand is compound 8 (TAK-272)|P00797|RENIN|8.82|IC=1.5nM|IC50|=|1.5|nM|1.5|nM
5LRK|2.30|2016|6-mer|ligand is compound 3|P09955|CARBOXYPEPTIDASE B|8.82|IC=1.5nM|IC50|=|1.5|nM|1.5|nM
5LRG|2.02|2016|6-mer|ligand is peptide compound 1|P09955|CARBOXYPEPTIDASE B|8.82|IC=1.5nM|IC50|=|1.5|nM|1.5|nM
5JLZ|1.99|2016|15-mer|ligand is modified alpha-enolase peptide 26-40 with citrulline at the position 32 (CIT26)|P01903|HLA CLASS II HISTOCOMPATIBILITY ANTIGEN, DR ALPHA CHAIN|5.82|IC=1.5uM|IC50|=|1.5|uM|1500|nM
5K0T|2.60|2016|415|ligand is compound 1415; aminoacylation enzyme inhibition assay|P59078|METHIONINE--TRNA LIGASE|5.78|IC=1.657uM|IC50|=|1.657|uM|1657|nM
5HA9|4.01|2016|TP0|IC50=1.65+/-0.25uM, ligand is 11d, PA-10|P09874|POLY [ADP-RIBOSE] POLYMERASE 1|5.78|IC=1.65uM|IC50|=|1.65|uM|1650|nM
5E0G|1.20|2016|5LG|compound 1|Q83883|NOROVIRUS 3C-LIKE PROTEASE|5.8|IC=1.6uM|IC50|=|1.6|uM|1600|nM
5T6F|1.90|2016|N38|ligand is compound 7l; orthorhombic crystal|Q83883|GENOME POLYPROTEIN|5.8|IC=1.6uM|IC50|=|1.6|uM|1600|nM
5C1X|1.86|2016|GHX|compound VIII|A9XG43|3C PROTEINASE|5.75|IC=1.767uM|IC50|=|1.767|uM|1767|nM
5FGK|2.36|2016|5XG|compound 25|P49336|CYCLIN-DEPENDENT KINASE 8|8.77|IC=1.7nM|IC50|=|1.7|nM|1.7|nM
5I7U|1.95|2016|6AJ|ligand is compound 17c|P27487|DIPEPTIDYL PEPTIDASE 4|8.77|IC=1.7nM|IC50|=|1.7|nM|1.7|nM
5F37|2.22|2016|N5J|compound 58|O75164|LYSINE-SPECIFIC DEMETHYLASE 4A|5.77|IC=1.7uM|IC50|=|1.7|uM|1700|nM
5JAS|2.06|2016|6HW|ligand is compound 11,Thio-PAF Assay|Q13093|PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE|5.77|IC=1.7uM|IC50|=|1.7|uM|1700|nM
4XUH|2.22|2016|SFI|ligand is sulindac sulfide|P37231|PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA|5.73|IC=1.87uM|IC50|=|1.87|uM|1870|nM
5DUF|1.50|2016|G7A|ligand is GSK729A|P9WNP1|PROBABLE ENOYL-COA HYDRATASE ECHA6|5.74|IC=1.8uM|IC50|=|1.8|uM|1800|nM
5IEG|1.82|2016|6A9|ligand is N-9'-methoxynonyl-1-deoxynojirimycin (MON-DNJ)|Q8BHN3|NEUTRAL ALPHA-GLUCOSIDASE AB|5.74|IC=1.8uM|IC50|=|1.8|uM|1800|nM
4YQV|2.06|2016|4GG|[Covalent complex] covalent inhibitor C4-10|P78417|GLUTATHIONE S-TRANSFERASE OMEGA-1|5.71|IC=1.95uM|IC50|=|1.95|uM|1950|nM
5LRJ|2.20|2016|6-mer|ligand is peptide compound 2|P09955|CARBOXYPEPTIDASE B|8.72|IC=1.9nM|IC50|=|1.9|nM|1.9|nM
5DLV|2.00|2016|5D5|ligand is TUDCA|Q64610|ECTONUCLEOTIDE PYROPHOSPHATASE/PHOSPHODIESTERASE|4.98|IC=10.4uM|IC50|=|10.4|uM|10400|nM
5LXC|2.15|2016|7AA|comp.1 (EHT 5372)|Q92630|DUAL SPECIFICITY TYROSINE-PHOSPHORYLATION-REGULATED KINASE|7.97|IC=10.8nM|IC50|=|10.8|nM|10.8|nM
5KBQ|2.58|2016|IPV|ligand is compound 1|Q13153|SERINE/THREONINE-PROTEIN KINASE PAK 1|7.0|IC=100nM|IC50|=|100|nM|100|nM
5JIM|1.26|2016|P8S|ligand is Perfluoroktansulfonsyra (PFOS)|P02766|TRANSTHYRETIN|3.99|IC=103uM|IC50|=|103|uM|103000|nM
5F2W|2.60|2016|5UP|compound 16|O75164|LYSINE-SPECIFIC DEMETHYLASE 4A|3.98|IC=104.2uM|IC50|=|104.2|uM|104200|nM
5JDC|1.78|2016|6JP|ligand is NP-13|O76290|PTERIDINE REDUCTASE|3.98|IC=104.2uM|IC50|=|104.2|uM|104200|nM
5JZN|2.85|2016|GUI|ligand is NVP-TAE684|O15075|SERINE/THREONINE-PROTEIN KINASE DCLK1|5.96|IC=1084nM|IC50|=|1084|nM|1084|nM
4UFU|2.10|2016|2ZI|compound 18c (TA-12)|Q9H2K2|TANKYRASE-2|8.0|IC=10nM|IC50|=|10|nM|10|nM
5CEH|3.14|2016|50P|ligand is CPI-455, inhibition of full-length KDM5A|P29375|LYSINE-SPECIFIC DEMETHYLASE 5A|8.0|IC=10nM|IC50|=|10|nM|10|nM
5DSX|2.41|2016|5EW|compound 10|Q8TEK3|HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-79 SPECIFIC|8.0|IC=10nM|IC50|=|10|nM|10|nM
5HX6|2.23|2016|65U|[Different protein in assay: wild type protein in assay] compound 14|Q13546|RECEPTOR-INTERACTING SERINE/THREONINE-PROTEIN KINASE 1|8.0|IC=10nM|IC50|=|10|nM|10|nM
5LJ0|1.82|2016|6XX|ligand is compound 16; pIC50=8.0|Q6PL18|ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 2|8.0|IC=10nM|IC50|=|10|nM|10|nM
5T4F|1.90|2016|75M|ligand is compound 34p|P27487|DIPEPTIDYL PEPTIDASE 4|8.0|IC=10nM|IC50|=|10|nM|10|nM
5LJ2|1.19|2016|6XW|ligand is compound 4; pIC50=5.0|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|5.0|IC=10uM|IC50|=|10|uM|10000|nM
5IEE|1.92|2016|NOJ|ligand is 1-deoxynojirimycin (DNJ)|Q8BHN3|NEUTRAL ALPHA-GLUCOSIDASE AB|4.94|IC=11.4uM|IC50|=|11.4|uM|11400|nM
5F32|2.05|2016|5V7|compound 40|O75164|LYSINE-SPECIFIC DEMETHYLASE 4A|4.94|IC=11.5uM|IC50|=|11.5|uM|11500|nM
5J5T|2.85|2016|6G2|ligand is compound 1|Q8IVH8|MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE KINASE 3|6.96|IC=110nM|IC50|=|110|nM|110|nM
5I59|2.25|2016|67Q|ligand is MPX-007; assay at 1uM glycine|P35439|GLUTAMATE RECEPTOR IONOTROPIC, NMDA 1|6.95|IC=112nM|IC50|=|112|nM|112|nM
5I58|2.52|2016|67R|ligand is MPX-004; assay at 1uM glycine|P35439|GLUTAMATE RECEPTOR IONOTROPIC, NMDA 1|6.92|IC=119nM|IC50|=|119|nM|119|nM
4Q15|2.35|2016|HFG|ligand is Halofuginone|Q8I5R7|PROLINE--TRNA LIGASE|7.96|IC=11nM|IC50|=|11|nM|11|nM
5JGD|3.10|2016|6KD|ligand is compound 12|O43318|TAK1 KINASE - TAB1 CHIMERA FUSION PROTEIN|7.96|IC=11nM|IC50|=|11|nM|11|nM
5K05|2.14|2016|6P5|ligand is compound 8|P22734|CATECHOL O-METHYLTRANSFERASE|4.96|IC=11uM|IC50|=|11|uM|11000|nM
5SXN|2.10|2016|74U|ligand is compound 4|P00797|RENIN|4.96|IC=11uM|IC50|=|11|uM|11000|nM
5SY2|2.25|2016|74V|ligand is compound 7|P00797|RENIN|4.96|IC=11uM|IC50|=|11|uM|11000|nM
5GHV|2.80|2016|X5G|ligand is O178|P43405|TYROSINE-PROTEIN KINASE SYK|7.92|IC=12.1nM|IC50|=|12.1|nM|12.1|nM
5DXG|1.86|2016|13-mer|SRC2-P5|P03372|ESTROGEN RECEPTOR|5.92|IC=1200nM|IC50|=|1200|nM|1200|nM
5I12|1.59|2016|H27|compound 2|P14780|MATRIX METALLOPROTEINASE-9 (MMP-9)|5.92|IC=1200nM|IC50|=|1200|nM|1200|nM
5KKR|3.51|2016|6U7|ligand is APS-2-79|Q6VAB6|KINASE SUPPRESSOR OF RAS 2|6.92|IC=120nM|IC50|=|120|nM|120|nM
5AXI|2.50|2016|5-mer|ligand is 5-mer peptide Cblin|Q3TTA7|E3 UBIQUITIN-PROTEIN LIGASE CBL-B|3.92|IC=120uM|IC50|=|120|uM|120000|nM
5HN7|2.15|2016|04M|ligand is BPH-1158|A5K4U6|FARNESYL PYROPHOSPHATE SYNTHASE|3.92|IC=120uM|IC50|=|120|uM|120000|nM
5B1S|1.58|2016|BSX|TcSpdSyn in complex with dcSAM and compound 1|Q4DA73|SPERMIDINE SYNTHASE, PUTATIVE|3.91|IC=124uM|IC50|=|124|uM|124000|nM
5DV2|2.07|2016|C5P|ligand is cytidine-5'-monophosphate (CMP)|Q96LI5|CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 6-LIKE|2.9|IC=1250uM|IC50|=|1250|uM|1250000|nM
5DB3|1.71|2016|58Q|compound 31 (MI-574)|O00255|MENIN|7.92|IC=12nM|IC50|=|12|nM|12|nM
5EWM|2.76|2016|5SM|ligand is EVT-101|Q91977|NMDA GLUTAMATE RECEPTOR SUBUNIT|7.92|IC=12nM|IC50|=|12|nM|12|nM
5EHP|1.85|2016|5OA|compound 2 (SHP836); Allosteric Inhibitor|Q06124|TYROSINE-PROTEIN PHOSPHATASE, NON-RECEPTOR TYPE 11|4.92|IC=12uM|IC50|=|12|uM|12000|nM
5M57|2.30|2016|4SP|ligand is compound 6|P51955|SERINE/THREONINE-PROTEIN KINASE NEK2|4.92|IC=12uM|IC50|=|12|uM|12000|nM
5I40|1.04|2016|67N|compound 1|Q9H8M2|BROMODOMAIN-CONTAINING PROTEIN 9|4.86|IC=13.7uM|IC50|=|13.7|uM|13700|nM
5EWJ|2.77|2016|QEL|ligand is Ifenprodil|Q91977|NMDA GLUTAMATE RECEPTOR SUBUNIT|6.89|IC=130nM|IC50|=|130|nM|130|nM
5KDE|2.65|2016|6RT|ligand is compound 1|P9WI55|INORGANIC PYROPHOSPHATASE|3.89|IC=130uM|IC50|=|130|uM|130000|nM
4UI3|2.00|2016|06R|compound 13c (TA-26)|Q9H2K2|TANKYRASE-2|6.88|IC=133nM|IC50|=|133|nM|133|nM
5DTQ|2.61|2016|5F6|compound 3|Q8TEK3|HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-79 SPECIFIC|3.86|IC=139uM|IC50|=|139|uM|139000|nM
5EMK|2.52|2016|5QH|[Different protein in assay: IC50 for protein PRMT5] compound 9|O14744|PROTEIN ARGININE N-METHYLTRANSFERASE 5|7.89|IC=13nM|IC50|=|13|nM|13|nM
5JGB|2.80|2016|6JV|ligand is compound 10|O43318|TAK1 KINASE - TAB1 CHIMERA FUSION PROTEIN|7.89|IC=13nM|IC50|=|13|nM|13|nM
5T1A|2.81|2016|VT5|ligand is CCR2-RA-[R]; the presence of allosteric BMS-681 increased total binding|P41597|CHIMERA PROTEIN OF CC CHEMOKINE RECEPTOR TYPE 2 ISOFORM B|7.89|IC=13nM|IC50|=|13|nM|13|nM
5TT7|1.77|2016|7KF|ligand is compound 1|P43405|TYROSINE-PROTEIN KINASE SYK|7.89|IC=13nM|IC50|=|13|nM|13|nM
5KU3|1.14|2016|6XH|ligand is compound 59|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|4.89|IC=13uM|IC50|=|13|uM|13000|nM
5DP6|3.01|2016|5EB|compound 7|A9XG43|3C PROTEINASE|4.83|IC=14.71uM|IC50|=|14.71|uM|14710|nM
5EZZ|2.10|2016|5T6|compound 19; cell data|P56817|BETA-SECRETASE 1|6.84|IC=145nM|IC50|=|145|nM|145|nM
5KHX|2.40|2016|6TE|ligand is PF-4950736|P23458|TYROSINE-PROTEIN KINASE JAK1|7.85|IC=14nM|IC50|=|14|nM|14|nM
5FBE|1.43|2016|5W5|compound 2|P00746|COMPLEMENT FACTOR D|4.85|IC=14uM|IC50|=|14|uM|14000|nM
5LYY|2.17|2016|7BJ|ligand is compound 5|Q13093|PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE|4.85|IC=14uM|IC50|=|14|uM|14000|nM
5BPP|2.03|2016|A4Z|LTA4H and bufexamac complex|P09960|LEUKOTRIENE A-4 HYDROLASE|4.8|IC=15.86uM|IC50|=|15.86|uM|15860|nM
5LMB|1.95|2016|6ZF|ligand is compound 6; pIC50=7.8|P43405|TYROSINE-PROTEIN KINASE SYK|7.8|IC=15.8nM|IC50|=|15.8|nM|15.8|nM
5DT2|2.30|2016|5EV|compound 11|Q8TEK3|HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-79 SPECIFIC|6.82|IC=150nM|IC50|=|150|nM|150|nM
5J75|2.00|2016|6GQ|[Nonstandard assay: Temp 4 C] ligand is ML342; Kd not given|------|SCFV AM2.2|6.82|IC=150nM|IC50|=|150|nM|150|nM
5TJX|1.41|2016|GBT|ligand is compound 30; tans-isomer in crystal|P03952|PLASMA KALLIKREIN|6.82|IC=153nM|IC50|=|153|nM|153|nM
5EKO|2.00|2016|N17|compound 117; Kd not determined|O15264|MITOGEN-ACTIVATED PROTEIN KINASE 13|4.8|IC=15785nM|IC50|=|15785|nM|15785|nM
5ACB|2.70|2016|5I1|[Covalent complex] ligand is THZ531; covalent inhibitor|G3V5E1|CYCLIN-K|6.8|IC=158nM|IC50|=|158|nM|158|nM
5L72|3.06|2016|6PF|ligand is compound 3; pIC50=6.8|Q3UDT3|PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE|6.8|IC=158nM|IC50|=|158|nM|158|nM
5LG3|3.57|2016|Z80|ligand is chlorpromazine (CPZ)|E0SJQ4|GAMMA-AMINOBUTYRIC-ACID RECEPTOR SUBUNIT BETA-1|3.8|IC=158uM|IC50|=|158|uM|158000|nM
5BNM|1.70|2016|4VK|compound 6|P0A6R0|3-OXOACYL-[ACYL-CARRIER-PROTEIN] SYNTHASE 3|4.82|IC=15uM|IC50|=|15|uM|15000|nM
5KGW|2.34|2016|7SK|ligand is compound 5c|Q76353|INTEGRASE|4.79|IC=16.1uM|IC50|=|16.1|uM|16100.000000000002|nM
5FWA|1.80|2016|J7C|compound 1 (CP1)|Q3UKX1|PROTEIN ARGININE N-METHYLTRANSFERASE 2|4.79|IC=16.3uM|IC50|=|16.3|uM|16300|nM
5FQT|2.00|2016|7QN|compound 16|P03372|ESTROGEN RECEPTOR ALPHA|6.8|IC=160nM|IC50|=|160|nM|160|nM
4UI5|1.65|2016|BJ4|compound 20b (TA-41)|Q9H2K2|TANKYRASE-2|6.78|IC=167nM|IC50|=|167|nM|167|nM
5JRQ|2.29|2016|6N9|ligand is VEM-6-VEM|P15056|SERINE/THREONINE-PROTEIN KINASE B-RAF|6.77|IC=169nM|IC50|=|169|nM|169|nM
5KGX|2.67|2016|7SK|ligand is compound 5c|Q76353|INTEGRASE|4.8|IC=16uM|IC50|=|16|uM|16000|nM
5HVY|2.39|2016|66X|compound 20|P49336|CYCLIN-DEPENDENT KINASE 8|7.76|IC=17.4nM|IC50|=|17.4|nM|17.4|nM
5BQG|1.44|2016|4UJ|compound 4|O14684|PROSTAGLANDIN E SYNTHASE|4.76|IC=17.4uM|IC50|=|17.4|uM|17400|nM
5H7H|1.95|2016|5-mer|ligand is F1324(10-13) peptide|P41182|B-CELL LYMPHOMA 6 PROTEIN|3.77|IC=170uM|IC50|=|170|uM|170000|nM
5JID|1.20|2016|8PF|ligand is Perfluorooctanoic acid (PFOA)|P02766|TRANSTHYRETIN|3.76|IC=175uM|IC50|=|175|uM|175000|nM
5L4H|3.30|2016|6JW|ligand is brominated barbiturate|Q7NDN8|PROTON-GATED ION CHANNEL|3.75|IC=177uM|IC50|=|177|uM|177000|nM
5LWN|1.60|2016|79R|ligand is compound 5 (FM409)|P52333|TYROSINE-PROTEIN KINASE JAK3|7.77|IC=17nM|IC50|=|17|nM|17|nM
5HO7|3.00|2016|63L|compound 9|O15530|3-PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE 1|4.77|IC=17uM|IC50|=|17|uM|17000|nM
5FUL|1.89|2016|SAH|ligand is SAH; protein is mPRMT (21-445) in paper|Q3UKX1|PROTEIN ARGININE N-METHYLTRANSFERASE 2|4.74|IC=18.3uM|IC50|=|18.3|uM|18300|nM
5DGJ|1.00|2016|V64|compound 21|Q83883|3C-LIKE PROTEASE|4.73|IC=18.5uM|IC50|=|18.5|uM|18500|nM
5DP5|2.03|2016|5E9|compound 4|A9XG43|3C PROTEASE|4.73|IC=18.70uM|IC50|=|18.7|uM|18700|nM
5A7C|1.90|2016|5D4|ligand is HMBA; AlphaScreen assay|Q15059|BROMODOMAIN-CONTAINING PROTEIN 3|3.74|IC=180uM|IC50|=|180|uM|180000|nM
5EMM|2.37|2016|5QL|[Different protein in assay: IC50 for protein PRMT5] compound 15|O14744|PROTEIN ARGININE N-METHYLTRANSFERASE 5|7.74|IC=18nM|IC50|=|18|nM|18|nM
5I0L|2.45|2016|H27|compound 2; the PDB code in paper is 5IOL, not 5I0L|P39900|MACROPHAGE METALLOELASTASE|7.74|IC=18nM|IC50|=|18|nM|18|nM
5FUM|2.50|2016|SOF|compound 2|P21836|ACETYLCHOLINESTERASE|4.74|IC=18uM|IC50|=|18|uM|18000|nM
5KLS|3.30|2016|6UC|ligand is UK-59811|A8EVM5|ION TRANSPORT PROTEIN|6.71|IC=194nM|IC50|=|194|nM|194|nM
5FQP|1.88|2016|GQD|compound 12|P03372|ESTROGEN RECEPTOR ALPHA|7.72|IC=19nM|IC50|=|19|nM|19|nM
5J3S|3.40|2016|6FQ|ligand is compound 163|O95551|TYROSYL-DNA PHOSPHODIESTERASE 2|7.72|IC=19nM|IC50|=|19|nM|19|nM
5M51|1.90|2016|NU6|ligand is compound 8|P51955|SERINE/THREONINE-PROTEIN KINASE NEK2|4.72|IC=19uM|IC50|=|19|uM|19000|nM
5EYD|1.85|2016|5T1|compound 23|P08581|HEPATOCYTE GROWTH FACTOR RECEPTOR|9.0|IC=1nM|IC50|=|1|nM|1|nM
5ADQ|2.10|2016|A95|compound 1|Q9H2K2|TANKYRASE-2|5.7|IC=2.01uM|IC50|=|2.01|uM|2009.9999999999998|nM
5K5S|2.60|2016|TRP|ligand is L-Trp; IC50 in presence of 2 mM Ca2+|P41180|EXTRACELLULAR CALCIUM-SENSING RECEPTOR|2.69|IC=2.04mM|IC50|=|2.04|mM|2040000|nM
5ANS|1.60|2016|RX8|compound 25|P36639|7,8-DIHYDRO-8-OXOGUANINE TRIPHOSPHATASE|5.69|IC=2.056uM|IC50|=|2.056|uM|2056|nM
5JAR|2.11|2016|6HV|ligand is compound 10,Thio-PAF Assay|Q13093|PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE|5.7|IC=2.0uM|IC50|=|2|uM|2000|nM
5ADS|1.80|2016|QNS|compound 4|Q9H2K2|TANKYRASE-2|5.67|IC=2.15uM|IC50|=|2.15|uM|2150|nM
5F1Z|2.65|2016|5U3|compound 20|P29597|NON-RECEPTOR TYROSINE-PROTEIN KINASE TYK2|8.68|IC=2.1nM|IC50|=|2.1|nM|2.1|nM
5ADT|2.15|2016|1TC|compound 5|Q9H2K2|TANKYRASE-2|5.65|IC=2.23uM|IC50|=|2.23|uM|2230|nM
5F4N|1.91|2016|5UY|ligand is compound 12|O14757|SERINE/THREONINE-PROTEIN KINASE CHK1|8.66|IC=2.2nM|IC50|=|2.2|nM|2.2|nM
5G3M|1.85|2016|9JH|compound 1|O15496|GROUP 10 SECRETORY PHOSPHOLIPASE A2|5.66|IC=2.2uM|IC50|=|2.2|uM|2200|nM
5HBE|2.38|2016|5Y6|compound 42|P49336|CYCLIN-DEPENDENT KINASE 8|8.64|IC=2.3nM|IC50|=|2.3|nM|2.3|nM
5HBJ|3.00|2016|5Y8|compound 109|P49336|CYCLIN-DEPENDENT KINASE 8|8.64|IC=2.3nM|IC50|=|2.3|nM|2.3|nM
5JGA|2.00|2016|6KC|ligand is compound 11c|O43318|TAK1 KINASE - TAB1 CHIMERA FUSION PROTEIN|8.64|IC=2.3nM|IC50|=|2.3|nM|2.3|nM
5BQS|1.90|2016|4VN|compound 29|C1CIR8|3-OXOACYL-[ACYL-CARRIER-PROTEIN] SYNTHASE 3|5.64|IC=2.3uM|IC50|=|2.3|uM|2300|nM
4ZS0|3.00|2016|4QV|compound 6|O14965|AURORA KINASE A|5.64|IC=2.3uM|IC50|=|2.3|uM|2300|nM
4ZSJ|2.48|2016|4R0|compound 5|Q13164|MITOGEN-ACTIVATED PROTEIN KINASE 7|5.64|IC=2.3uM|IC50|=|2.3|uM|2300|nM
5ADR|2.10|2016|QS5|compound 3|Q9H2K2|TANKYRASE-2|5.64|IC=2.3uM|IC50|=|2.3|uM|2300|nM
5JIN|1.85|2016|11-mer|ligand is Histone H3K9M mutant peptide|Q96KQ7|HISTONE-LYSINE N-METHYLTRANSFERASE EHMT2|5.64|IC=2.3uM|IC50|=|2.3|uM|2300|nM
5E0H|1.95|2016|5LH|compound 3|Q83883|NOROVIRUS 3C-LIKE PROTEASE|5.62|IC=2.4uM|IC50|=|2.4|uM|2400|nM
5ICV|1.53|2016|5-mer|ligand is CoA-Ac-MKAVQAD-NH2 (CoA-Ac-MKAV7)|Q9H7X0|N-ALPHA-ACETYLTRANSFERASE 60|5.62|IC=2.4uM|IC50|=|2.4|uM|2400|nM
5IH6|2.30|2016|AUG|ligand is compound 18|P48730|CASEIN KINASE I ISOFORM DELTA|5.6|IC=2.5uM|IC50|=|2.5|uM|2500|nM
5IDN|2.26|2016|6A7|ligand is compound 25|P49336|CYCLIN-DEPENDENT KINASE 8|8.59|IC=2.6nM|IC50|=|2.6|nM|2.6|nM
5HKB|1.65|2016|64L|ligand is compound 1a|Q02P97|CFTR INHIBITORY FACTOR (CIF)|5.59|IC=2.6uM|IC50|=|2.6|uM|2600|nM
5EIF|1.50|2016|4M0|compound 1; DENV 2'O-MTase activity|P27915|GENOME POLYPROTEIN|2.55|IC=2.8mM|IC50|=|2.8|mM|2800000|nM
5HZX|1.90|2016|2GE|ligand is TH588|Q7ZWC3|NUDIX (NUCLEOSIDE DIPHOSPHATE LINKED MOIETY X)-TYPE MOTIF|8.55|IC=2.8nM|IC50|=|2.8|nM|2.8|nM
5A4Q|2.37|2016|Y3L|compound 11|Q13627|DUAL SPECIFICITY TYROSINE-PHOSPHORYLATION-REGULATED KINASE|5.54|IC=2.9uM|IC50|=|2.9|uM|2900|nM
5JR6|2.30|2016|5-mer|ligand is 5-mer peptide Apstatin|Q8IKT5|PEPTIDASE, PUTATIVE|4.69|IC=20.2uM|IC50|=|20.2|uM|20200|nM
5HO6|1.97|2016|63K|compound 12 (SAR125844)|P08581|HEPATOCYTE GROWTH FACTOR RECEPTOR|6.69|IC=204nM|IC50|=|204|nM|204|nM
5DRY|2.41|2016|5EK|compound 3|Q8TEK3|HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-79 SPECIFIC|7.7|IC=20nM|IC50|=|20|nM|20|nM
5LSC|1.50|2016|752|ligand is compound 1|B8QIQ9|METALLO-BETA-LACTAMASE VIM-2-LIKE PROTEIN|4.7|IC=20uM|IC50|=|20|uM|20000|nM
5FUS|1.87|2016|DAO|ligand is dodecanoic acid (Lauric acid)|B4EKM5|PUTATIVE ENOYL COA HYDRATASE|4.68|IC=21.1uM|IC50|=|21.1|uM|21100|nM
5D7A|2.90|2016|58C|ligand is NCB-0846|Q9UKE5|TRAF2 AND NCK-INTERACTING PROTEIN KINASE|7.68|IC=21nM|IC50|=|21|nM|21|nM
5DI1|2.90|2016|5DF|compound 13|O95819|MITOGEN-ACTIVATED PROTEIN KINASE 4|7.68|IC=21nM|IC50|=|21|nM|21|nM
5F1L|2.30|2016|5U2|compound 11|Q9H8M2|BROMODOMAIN-CONTAINING PROTEIN 9|7.68|IC=21nM|IC50|=|21|nM|21|nM
5J5D|2.40|2016|6GT||P9WP25|4-HYDROXY-TETRAHYDRODIPICOLINATE SYNTHASE|4.68|IC=21uM|IC50|=|21|uM|21000|nM
5DPA|2.06|2016|5F2|compound 6|A9XG43|3C PROTEINASE|4.65|IC=22.46uM|IC50|=|22.46|uM|22460|nM
5JQ9|2.10|2016|6MB|[Different protein in assay: protein in assay is BaDHPS from Bacillus anthracis] ligand is compound 16|------|DIHYDROPTEROATE SYNTHASE|4.65|IC=22.5uM|IC50|=|22.5|uM|22500|nM
5DB1|1.86|2016|58O|compound 18 (MI-336)|O00255|MENIN|7.66|IC=22nM|IC50|=|22|nM|22|nM
5HLD|2.31|2016|63V|ligand is CENTA, not MOENOMYCIN that exists in all crystals|P02919|PENICILLIN-BINDING PROTEIN 1B|4.66|IC=22uM|IC50|=|22|uM|22000|nM
5HL9|2.70|2016|AIX|ligand is ampicillin, not MOENOMYCIN that exists in all crystals|P02919|PENICILLIN-BINDING PROTEIN 1B|4.66|IC=22uM|IC50|=|22|uM|22000|nM
4XWK|3.50|2016|4C8|ligand is PBDE-100|P21447|MULTIDRUG RESISTANCE PROTEIN 1A|4.63|IC=23.2uM|IC50|=|23.2|uM|23200|nM
4R5Y|3.50|2016|3K3|ligand is BGB-283|P15056|SERINE/THREONINE-PROTEIN KINASE B-RAF|7.64|IC=23nM|IC50|=|23|nM|23|nM
5EML|2.39|2016|5QK|[Different protein in assay: IC50 for protein PRMT5] compound 10|O14744|PROTEIN ARGININE N-METHYLTRANSFERASE 5|7.64|IC=23nM|IC50|=|23|nM|23|nM
5HLW|1.97|2016|62E|compound 14|P08581|HEPATOCYTE GROWTH FACTOR RECEPTOR|7.64|IC=23nM|IC50|=|23|nM|23|nM
5L4E|3.50|2016|EDP|ligand is Thiopental|Q7NDN8|PROTON-GATED ION CHANNEL|4.61|IC=24.4uM|IC50|=|24.4|uM|24400|nM
5CUH|1.83|2016|LTQ|compound 3|P14780|MATRIX METALLOPROTEINASE-9 (MMP-9)|4.62|IC=24uM|IC50|=|24|uM|24000|nM
5KMH|3.20|2016|6U8|ligand is Br-verapamil|A8EVM5|ION TRANSPORT PROTEIN|4.62|IC=24uM|IC50|=|24|uM|24000|nM
5F00|1.95|2016|5T8|compound 21; cell data|P56817|BETA-SECRETASE 1|6.6|IC=250nM|IC50|=|250|nM|250|nM
4UI8|2.05|2016|IY5|compound 21c (TA-55)|Q9H2K2|TANKYRASE-2|7.6|IC=25nM|IC50|=|25|nM|25|nM
4ZTS|2.90|2016|4RK|compound 88|O14965|AURORA KINASE A|7.6|IC=25nM|IC50|=|25|nM|25|nM
5DB2|1.54|2016|58R|compound 7 (MI-389)|O00255|MENIN|7.6|IC=25nM|IC50|=|25|nM|25|nM
5DYT|2.55|2016|5HB|IC50=25+/-3.8nM, ligand is compound 8|P06276|CHOLINESTERASE|7.6|IC=25nM|IC50|=|25|nM|25|nM
5E7R|2.11|2016|5KW|[Covalent complex] TAK1-10|O43318|TAK1 KINASE - TAB1 CHIMERA FUSION PROTEIN|7.6|IC=25nM|IC50|=|25|nM|25|nM
5EYM|2.70|2016|5U5|ligand is compound BI 847325|Q02750|DUAL SPECIFICITY MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1|7.6|IC=25nM|IC50|=|25|nM|25|nM
5EI4|1.05|2016|5NV|compound 7; ITC Kd not determined|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|4.58|IC=26.4uM|IC50|=|26.4|uM|26400|nM
5GJF|2.89|2016|6V4|compound 3|O43318|TAK1 KINASE - TAB1 CHIMERA FUSION PROTEIN|6.59|IC=260nM|IC50|=|260|nM|260|nM
5JSM|2.19|2016|6NB|ligand is VEM-3-VEM|P15056|SERINE/THREONINE-PROTEIN KINASE B-RAF|6.59|IC=260nM|IC50|=|260|nM|260|nM
5KBR|2.36|2016|IPW|ligand is compound 2|Q13153|SERINE/THREONINE-PROTEIN KINASE PAK 1|6.59|IC=260nM|IC50|=|260|nM|260|nM
5FQR|1.88|2016|QHG|compound 10a|P03372|ESTROGEN RECEPTOR|7.59|IC=26nM|IC50|=|26|nM|26|nM
4YH3|1.60|2016|Y80|compound 16a with BRD4(1)|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|4.59|IC=26uM|IC50|=|26|uM|26000|nM
4YH4|1.33|2016|Y81|compound 19d|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|4.59|IC=26uM|IC50|=|26|uM|26000|nM
5DP7|2.08|2016|5EC|compound 5|A9XG43|3C PROTEINASE|4.56|IC=27.57uM|IC50|=|27.57|uM|27570|nM
5L8T|1.85|2016|6RR|ligand is compound 2|Q9UIF8|BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN PROTEIN 2B|3.55|IC=279uM|IC50|=|279|uM|279000|nM
5ARG|1.99|2016|H41|ligand is compound S-4|Q9NRG4|N-LYSINE METHYLTRANSFERASE SMYD2|7.57|IC=27nM|IC50|=|27|nM|27|nM
5A8Z|2.00|2016|IUL|ligand is compound 24|P08246|NEUTROPHIL ELASTASE|7.55|IC=28nM|IC50|=|28|nM|28|nM
5IZQ|3.60|2016|83A|ligand is compound 4|P15328|FOLATE RECEPTOR ALPHA|8.52|IC=3.04nM|IC50|=|3.04|nM|3.04|nM
5LXD|2.58|2016|7A7|comp.2 (EHT 1610)|Q92630|DUAL SPECIFICITY TYROSINE-PHOSPHORYLATION-REGULATED KINASE|8.5|IC=3.16nM|IC50|=|3.16|nM|3.16|nM
5K4I|1.76|2016|6QB|ligand is compound 22|P28482|MITOGEN-ACTIVATED PROTEIN KINASE 1|8.51|IC=3.1nM|IC50|=|3.1|nM|3.1|nM
5TO8|1.98|2016|7FM|ligand is compound 10a|Q14289|PROTEIN-TYROSINE KINASE 2 BETA|8.51|IC=3.1nM|IC50|=|3.1|nM|3.1|nM
5H8X|1.30|2016|5XT|ligand is compound 14|P22894|NEUTROPHIL COLLAGENASE (MMP-8)|5.51|IC=3.1uM|IC50|=|3.1|uM|3100|nM
5TR6|1.93|2016|7KG|ligand is TAK-659|P43405|TYROSINE-PROTEIN KINASE SYK|8.49|IC=3.2nM|IC50|=|3.2|nM|3.2|nM
5LKR|2.52|2016|6YC|ligand is compound 3|P06276|CHOLINESTERASE|5.48|IC=3.306uM|IC50|=|3.306|uM|3306|nM
5IV4|1.79|2016|LRI|ligand is RU-0204277 (LRE1)|Q96PN6|ADENYLATE CYCLASE TYPE 10|5.48|IC=3.3uM|IC50|=|3.3|uM|3300|nM
5F94|2.51|2016|3UO|compound 15|P49841|GLYCOGEN SYNTHASE KINASE-3 BETA|8.47|IC=3.4nM|IC50|=|3.4|nM|3.4|nM
5ICP|2.18|2016|69Z|ligand is compound 6|P49336|CYCLIN-DEPENDENT KINASE 8|8.42|IC=3.8nM|IC50|=|3.8|nM|3.8|nM
5AB1|1.96|2016|4-mer|compound 18; competitive enzyme-linked lectinosorbent assay (ELLSA)|Q6JKW3|FIMH PROTEIN|5.42|IC=3.8uM|IC50|=|3.8|uM|3800|nM
5ANQ|2.00|2016|5YQ|compound 9a ; in vitro LANCE assay|O75164|LYSINE-SPECIFIC DEMETHYLASE 4A|5.4|IC=3.98uM|IC50|=|3.98|uM|3980|nM
5A4L|2.73|2016|ZC3|compound 8|Q13627|DUAL SPECIFICITY TYROSINE-PHOSPHORYLATION-REGULATED KINASE|5.41|IC=3.9uM|IC50|=|3.9|uM|3900|nM
5LT6|2.05|2016|76J|ligand is compound 8|Q9BYW2|HISTONE-LYSINE N-METHYLTRANSFERASE SETD2|5.41|IC=3.9uM|IC50|=|3.9|uM|3900|nM
4Y5I|1.40|2016|9-mer|compound 2a|P31947|14-3-3 PROTEIN SIGMA|3.52|IC=301.3uM|IC50|=|301.3|uM|301300|nM
5FDP|2.25|2016|5WR|compound 6c|Q08345|EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1|6.51|IC=309nM|IC50|=|309|nM|309|nM
5F20|2.91|2016|5U4|compound 8|P29597|NON-RECEPTOR TYROSINE-PROTEIN KINASE TYK2|7.52|IC=30nM|IC50|=|30|nM|30|nM
5FI6|2.52|2016|5XY|compound 7e|O94925|GLUTAMINASE KIDNEY ISOFORM, MITOCHONDRIAL|7.52|IC=30nM|IC50|=|30|nM|30|nM
5I94|2.98|2016|69V|compound 14d|O94925|GLUTAMINASE KIDNEY ISOFORM, MITOCHONDRIAL|7.52|IC=30nM|IC50|=|30|nM|30|nM
4YQM|2.38|2016|4G9|[Covalent complex] covalent inhibitor C1-27|P78417|GLUTATHIONE S-TRANSFERASE OMEGA-1|7.51|IC=31nM|IC50|=|31|nM|31|nM
5ETY|2.90|2016|K56|ligand is compound K-756|O95271|TANKYRASE-1|7.51|IC=31nM|IC50|=|31|nM|31|nM
5JT2|2.70|2016|6NC|ligand is VEM-BISAMIDE-2|P15056|SERINE/THREONINE-PROTEIN KINASE B-RAF|7.47|IC=33.5nM|IC50|=|33.5|nM|33.5|nM
5DV4|1.80|2016|NMY|ligand is neomycin|Q96LI5|CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 6-LIKE|2.47|IC=3370uM|IC50|=|3370|uM|3370000|nM
5EMJ|2.27|2016|5QJ|[Different protein in assay: IC50 for protein PRMT5] compound 8|O14744|PROTEIN ARGININE N-METHYLTRANSFERASE 5|7.48|IC=33nM|IC50|=|33|nM|33|nM
5TOL|2.51|2016|7H3|ligand is compound 2e|P56817|BETA-SECRETASE 1|7.48|IC=33nM|IC50|=|33|nM|33|nM
5F0H|1.99|2016|5TC|compound 28|P9WMC0|HTH-TYPE TRANSCRIPTIONAL REGULATOR ETHR|4.48|IC=33uM|IC50|=|33|uM|33000|nM
5LAY|2.71|2016|6SS|ligand is compound 6g|Q00987|E3 UBIQUITIN-PROTEIN LIGASE MDM2|7.47|IC=34nM|IC50|=|34|nM|34|nM
5IFU|2.45|2016|GBM|ligand is Glyburide; ATP depletion assay|Q8I5R7|PROLINE--TRNA LIGASE|4.47|IC=34uM|IC50|=|34|uM|34000|nM
5EHG|2.02|2016|5O0|compound 29; DENV 2'O-MTase activity|P27915|GENOME POLYPROTEIN|3.43|IC=369uM|IC50|=|369|uM|369000|nM
5F02|1.43|2016|5T9|compound 15|P07711|CATHEPSIN L1|7.44|IC=36nM|IC50|=|36|nM|36|nM
5KX7|2.80|2016|6YD|ligand is compound 37|Q9NWZ3|INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE 4|7.44|IC=36nM|IC50|=|36|nM|36|nM
5I24|1.85|2016|66U|[Incomplete ligand] compound 1(CF021); -NH2-OH- merged into NH in PDB site|B3PEE6|OLIGOSACCHARIDE 4-ALPHA-D-GLUCOSYLTRANSFERASE|7.42|IC=37.8nM|IC50|=|37.8|nM|37.8|nM
5DB0|1.50|2016|58P|mixture of 3-(RS), ligand name is 58P or 6E6; IC50 is 46nM for 3-(R), 42nM for 3-(S)|O00255|MENIN|7.43|IC=37nM|IC50|=|37|nM|37|nM
4XHL|3.01|2016|CKI|[Different protein in assay: IC50 assay for wt HRR25 (1-394)] IC50 assay for wt HRR25 (1-394), not K38R mutant|P29295|CASEIN KINASE I HOMOLOG HRR25|4.43|IC=37uM|IC50|=|37|uM|37000|nM
5DH3|2.47|2016|5BS|ligand is XMU-MP-1|Q13188|SERINE/THREONINE-PROTEIN KINASE 3|7.42|IC=38.1nM|IC50|=|38.1|nM|38.1|nM
5KX8|2.67|2016|6YE|ligand is compound 1|Q9NWZ3|INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE 4|7.42|IC=38nM|IC50|=|38|nM|38|nM
5JCJ|1.76|2016|6JM|ligand is compound 7|O76290|PTERIDINE REDUCTASE|4.42|IC=38uM|IC50|=|38|uM|38000|nM
5SZ9|2.85|2016|74Y|ligand is compound 3|P00797|RENIN|4.42|IC=38uM|IC50|=|38|uM|38000|nM
5DXE|1.50|2016|13-mer|ligand is Stapled Peptide SRC2-SP4|P03372|ESTROGEN RECEPTOR|6.41|IC=390nM|IC50|=|390|nM|390|nM
5DTR|2.34|2016|5F7|compound 5|Q8TEK3|HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-79 SPECIFIC|4.41|IC=39uM|IC50|=|39|uM|39000|nM
5F6U|1.55|2016|5VK|ligand is compound 8|P63279|SUMO-CONJUGATING ENZYME UBC9|2.52|IC=3mM|IC50|=|3|mM|3000000|nM
5EYC|1.80|2016|5SZ|compound 5|P08581|HEPATOCYTE GROWTH FACTOR RECEPTOR|8.52|IC=3nM|IC50|=|3|nM|3|nM
5EYK|1.93|2016|5U5|ligand is compound BI 847325|Q6DE08|AURORA KINASE B-A|8.52|IC=3nM|IC50|=|3|nM|3|nM
5J79|2.69|2016|6GE|ligand is compound 3|O43353|RECEPTOR-INTERACTING SERINE/THREONINE-PROTEIN KINASE 2|8.52|IC=3nM|IC50|=|3|nM|3|nM
5I83|1.35|2016|68Y|ligand is compound 12|Q92793|CREB-BINDING PROTEIN|5.39|IC=4.1uM|IC50|=|4.1|uM|4100|nM
5JDI|1.38|2016|6JO|ligand is compound 2|O76290|PTERIDINE REDUCTASE|5.37|IC=4.3uM|IC50|=|4.3|uM|4300|nM
5DRT|2.69|2016|5EG|compound 2|Q8TEK3|HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-79 SPECIFIC|5.36|IC=4.4uM|IC50|=|4.4|uM|4400|nM
5AMN|2.57|2016|DTQ|compound 6|P07949|PROTO-ONCOGENE TYROSINE-PROTEIN KINASE RECEPTOR RET|8.35|IC=4.5nM|IC50|=|4.5|nM|4.5|nM
4Z16|2.90|2016|4LH|[Covalent complex] compound 9|P52333|TYROSINE-PROTEIN KINASE JAK3|8.32|IC=4.8nM|IC50|=|4.8|nM|4.8|nM
5J47|1.99|2016|6JJ|ligand is compound 5d|P03072|LARGE T ANTIGEN|5.31|IC=4.9uM|IC50|=|4.9|uM|4900|nM
5F1U|2.35|2016|3VN|potent allosteric inhibitor bislysine|Q9PPB4|4-HYDROXY-TETRAHYDRODIPICOLINATE SYNTHASE|6.4|IC=400nM|IC50|=|400|nM|400|nM
5IUH|2.10|2016|34Y|ligand is compound 5d|Q9UM73|ALK TYROSINE KINASE RECEPTOR|6.4|IC=402nM|IC50|=|402|nM|402|nM
5FI7|2.50|2016|5XZ|compound 14b|O94925|GLUTAMINASE KIDNEY ISOFORM, MITOCHONDRIAL|7.4|IC=40nM|IC50|=|40|nM|40|nM
5I3M|2.17|2016|67F|[Different protein in assay: Protein in binding assay is WT] compound 3|P39900|MACROPHAGE METALLOELASTASE|7.4|IC=40nM|IC50|=|40|nM|40|nM
5L44|1.75|2016|K26|ligand is K-26 tripeptide|------|K-26 DIPEPTIDYL CARBOXYPEPTIDASE|4.4|IC=40uM|IC50|=|40|uM|40000|nM
5E8W|1.86|2016|STU|[Different protein in assay: wildtype protein in bioassay] ligand is staurosporine; HTRF assay|P36897|TGF-BETA RECEPTOR TYPE-1|4.39|IC=41uM|IC50|=|41|uM|41000|nM
5CUU|2.96|2016|4GA|ligand is BPH-1260|Q4JH30|ACIDOCALCISOMAL PYROPHOSPHATASE|4.37|IC=42.3uM|IC50|=|42.3|uM|42300|nM
4ZCW|1.99|2016|4NG|ligand is SF2312|P09104|GAMMA-ENOLASE|7.37|IC=42.5nM|IC50|=|42.5|nM|42.5|nM
5F01|1.52|2016|5T7|compound 22; cell data|P56817|BETA-SECRETASE 1|6.38|IC=420nM|IC50|=|420|nM|420|nM
5T4E|1.77|2016|75L|ligand is compound 19a|P27487|DIPEPTIDYL PEPTIDASE 4|5.36|IC=4376nM|IC50|=|4376|nM|4376|nM
5D6F|1.55|2016|57R|inhibitor (+)-31b|P50579|METHIONINE AMINOPEPTIDASE 2|4.37|IC=43uM|IC50|=|43|uM|43000|nM
5SY3|2.30|2016|74Z|ligand is compound 2|P00797|RENIN|4.37|IC=43uM|IC50|=|43|uM|43000|nM
4UI7|1.80|2016|VT3|compound 21b (TA-49)|Q9H2K2|TANKYRASE-2|7.36|IC=44nM|IC50|=|44|nM|44|nM
5ELY|1.81|2016|5PU|ligand is compound (R)-1|Q04609|GLUTAMATE CARBOXYPEPTIDASE 2|7.36|IC=44nM|IC50|=|44|nM|44|nM
5FQS|1.94|2016|J0W|compound 11a|P03372|ESTROGEN RECEPTOR|7.36|IC=44nM|IC50|=|44|nM|44|nM
4YXD|3.00|2016|FTN|ligand is flutolanil, has some cofactors in crystal|Q0QF01|SUCCINATE DEHYDROGENASE [UBIQUINONE] FLAVOPROTEIN SUBUNIT|4.34|IC=45.9uM|IC50|=|45.9|uM|45900|nM
5JNN|2.30|2016|6LM|ligand is Phaseic acid (PA)|O80992|ABSCISIC ACID RECEPTOR PYL2|5.35|IC=4504nM|IC50|=|4504|nM|4504|nM
5EHI|1.30|2016|5O3|compound 28; DENV 2'O-MTase activity|P27915|NS5 METHYLTRANSFERASE DENGUE VIRUS|3.34|IC=452uM|IC50|=|452|uM|452000|nM
4UI4|2.40|2016|RJN|compound 38 (TA-29)|Q9H2K2|TANKYRASE-2|7.35|IC=45nM|IC50|=|45|nM|45|nM
5IDP|2.65|2016|6A6|ligand is compound 17|P49336|CYCLIN-DEPENDENT KINASE 8|7.35|IC=45nM|IC50|=|45|nM|45|nM
5K8V|2.25|2016|6RE|compound 1 (CP1); Why add a H atom compared to CP1 in code 5fwa|Q9WVG6|HISTONE-ARGININE METHYLTRANSFERASE CARM1|6.34|IC=460nM|IC50|=|460|nM|460|nM
5FUE|2.20|2016|UV4|[Nonstandard assay: assay at Temp 30C] compound 13a|A5H660|HISTONE DEACETYLASE 8|6.33|IC=468.2nM|IC50|=|468.2|nM|468.2|nM
5L99|2.00|2016|6S0|ligand is compound 6|Q9UIF8|BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN PROTEIN 2B|3.32|IC=481uM|IC50|=|481|uM|481000|nM
5I56|2.28|2016|67P|ligand is TCN-201; assay at 1uM glycine|P35439|GLUTAMATE RECEPTOR IONOTROPIC, NMDA 1|7.32|IC=48nM|IC50|=|48|nM|48|nM
5HBH|2.50|2016|5Y7|compound 54|P49336|CYCLIN-DEPENDENT KINASE 8|7.31|IC=49.2nM|IC50|=|49.2|nM|49.2|nM
5L98|2.26|2016|6RY|ligand is compound 4|Q9UIF8|BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN PROTEIN 2B|3.31|IC=490uM|IC50|=|490|uM|490000|nM
5JRS|1.97|2016|6MV|ligand is compound 23|Q06187|TYROSINE-PROTEIN KINASE BTK|8.4|IC=4nM|IC50|=|4|nM|4|nM
5LAZ|1.66|2016|6ST|ligand is compound 3|Q00987|E3 UBIQUITIN-PROTEIN LIGASE MDM2|8.4|IC=4nM|IC50|=|4|nM|4|nM
5JIQ|1.45|2016|27M|ligand is 2,2',4,4'-tetrahydroxybenzophenone (BP2)|P02766|TRANSTHYRETIN|5.4|IC=4uM|IC50|=|4|uM|4000|nM
5LAX|2.60|2016|15-mer|ligand is alpha-enolase peptide 26-40 (26)|P01903|HLA CLASS II HISTOCOMPATIBILITY ANTIGEN, DR ALPHA CHAIN|5.4|IC=4uM|IC50|=|4|uM|4000|nM
5IEF|2.38|2016|NBV|ligand is N-butyl-1-deoxynojirimycin (NB-DNJ)|Q8BHN3|NEUTRAL ALPHA-GLUCOSIDASE AB|5.28|IC=5.2uM|IC50|=|5.2|uM|5200|nM
5CEI|2.24|2016|50R|compound 22|P49336|CYCLIN-DEPENDENT KINASE 8|8.28|IC=5.3nM|IC50|=|5.3|nM|5.3|nM
5A7I|2.89|2016|B6K|ligand is biphenyl 3,3',4,4',5,5'- hexakisphosphate|P32019|TYPE II INOSITOL 1,4,5-TRISPHOSPHATE 5-PHOSPHATASE|5.26|IC=5.5uM|IC50|=|5.5|uM|5500|nM
5F6V|1.49|2016|5VL|ligand is compound 1; cocktail soak crystal|P63279|SUMO-CONJUGATING ENZYME UBC9|2.24|IC=5.8mM|IC50|=|5.8|mM|5800000|nM
5KMF|3.20|2016|6U9|ligand is nimodipine|A8EVM5|ION TRANSPORT PROTEIN|6.29|IC=508nM|IC50|=|508|nM|508|nM
5HN9|2.12|2016|04W|ligand is BPH-1186|A5K4U6|FARNESYL PYROPHOSPHATE SYNTHASE|4.3|IC=50uM|IC50|=|50|uM|50000|nM
5I23|1.95|2016|66V|compound 2(CF022)|B3PEE6|OLIGOSACCHARIDE 4-ALPHA-D-GLUCOSYLTRANSFERASE|7.29|IC=51.7nM|IC50|=|51.7|nM|51.7|nM
5I4O|2.05|2016|V28|[Different protein in assay: Protein in binding assay is WT] compound 7|P39900|MACROPHAGE METALLOELASTASE|7.28|IC=53nM|IC50|=|53|nM|53|nM
4UHG|1.70|2016|SZ5|compound 13b (TA-21)|Q9H2K2|TANKYRASE-2|6.27|IC=540nM|IC50|=|540|nM|540|nM
5KDF|2.45|2016|6RU|ligand is compound 6|P9WI55|INORGANIC PYROPHOSPHATASE|3.27|IC=540uM|IC50|=|540|uM|540000|nM
5L6P|2.26|2016|6P8|[Covalent complex] ligand is compound 6; covalent inhibitor|P54753|EPHRIN TYPE-B RECEPTOR 3|7.26|IC=55nM|IC50|=|55|nM|55|nM
5HNA|2.69|2016|63D|ligand is BPH-1251|A5K4U6|FARNESYL PYROPHOSPHATE SYNTHASE|4.23|IC=59uM|IC50|=|59|uM|59000|nM
4YNK|2.30|2016|YW2|compound 5b|P13053|VITAMIN D3 RECEPTOR|8.3|IC=5nM|IC50|=|5|nM|5|nM
5J7B|2.53|2016|6GD|ligand is compound 27|O43353|RECEPTOR-INTERACTING SERINE/THREONINE-PROTEIN KINASE 2|8.3|IC=5nM|IC50|=|5|nM|5|nM
5JFR|1.60|2016|6KP|ligand is compound 10; pIC50=8.3|P50579|METHIONINE AMINOPEPTIDASE 2|8.3|IC=5nM|IC50|=|5|nM|5|nM
5KCV|2.70|2016|6S1|ligand is compound 21a; allosteric inhibitor; IC50 for phosphorylation AKT1|P31749|RAC-ALPHA SERINE/THREONINE-PROTEIN KINASE|8.3|IC=5nM|IC50|=|5|nM|5|nM
4WI1|1.65|2016|3O6|ligand is TCMDC-124506|Q8I5R7|PROLINE--TRNA LIGASE|5.3|IC=5uM|IC50|=|5|uM|5000|nM
5IVS|1.46|2016|6EF|ligand is compound 9a|Q77VV3|HIV-1 PROTEASE|8.21|IC=6.1nM|IC50|=|6.1|nM|6.1|nM
5E0J|1.20|2016|5LJ|compound 10|Q83883|NOROVIRUS 3C-LIKE PROTEASE|5.21|IC=6.1uM|IC50|=|6.1|uM|6100|nM
5TRK|2.06|2016|7HH|ligand is compound 12d|Q9WMX2|GENOME POLYPROTEIN|5.21|IC=6.2uM|IC50|=|6.2|uM|6200|nM
5A7J|2.90|2016|K2Y|ligand is benzene 1,2,4,5- tetrakisphosphate|P32019|TYPE II INOSITOL 1,4,5-TRISPHOSPHATE 5-PHOSPHATASE|5.2|IC=6.3uM|IC50|=|6.3|uM|6300|nM
5HG1|2.76|2016|62C|compound 1|P52789|HEXOKINASE-2|5.2|IC=6.3uM|IC50|=|6.3|uM|6300|nM
5A8X|2.23|2016|IUY|ligand is compound 5|P08246|NEUTROPHIL ELASTASE|8.19|IC=6.5nM|IC50|=|6.5|nM|6.5|nM
5HM3|2.25|2016|649|ligand is PhU-AMS|O53580|LONG-CHAIN-FATTY-ACID--AMP LIGASE FADD32|5.17|IC=6.8uM|IC50|=|6.8|uM|6800|nM
5TH7|1.95|2016|75P|ligand is compound 3|Q9NQR1|N-LYSINE METHYLTRANSFERASE KMT5A|5.16|IC=6.9uM|IC50|=|6.9|uM|6900|nM
5FQV|1.74|2016|VQI|compound 15|P03372|ESTROGEN RECEPTOR ALPHA|6.21|IC=610nM|IC50|=|610|nM|610|nM
5GJG|2.61|2016|6V5|compound 4|O43318|TAK1 KINASE - TAB1 CHIMERA FUSION PROTEIN|6.21|IC=610nM|IC50|=|610|nM|610|nM
4ZA0|2.31|2016|PAH|ligand is Phosphonoacetohydroxamate (PhAH)|P09104|GAMMA-ENOLASE|7.21|IC=62.3nM|IC50|=|62.3|nM|62.3|nM
5DP4|2.21|2016|5E8|compound 3|A9XG43|3C PROTEINASE|4.2|IC=62.88uM|IC50|=|62.88|uM|62880|nM
5G11|2.48|2016|7H1|ligand is PFSAHA|Q9HXM1|HDAH|7.21|IC=62nM|IC50|=|62|nM|62|nM
5I43|1.95|2016|67M|[Different protein in assay: Protein in binding assay is WT] compound 8|P39900|MACROPHAGE METALLOELASTASE|7.2|IC=63nM|IC50|=|63|nM|63|nM
5HOA|2.14|2016|63K|compound 12 (SAR125844)|P08581|HEPATOCYTE GROWTH FACTOR RECEPTOR|7.19|IC=64nM|IC50|=|64|nM|64|nM
5HOR|2.20|2016|63K|compound 12 (SAR125844)|P08581|HEPATOCYTE GROWTH FACTOR RECEPTOR|8.22|IC=6nM|IC50|=|6|nM|6|nM
5J6D|1.90|2016|6H5|ligand is compound 51|P17752|TRYPTOPHAN 5-HYDROXYLASE 1|8.22|IC=6nM|IC50|=|6|nM|6|nM
5L6O|1.88|2016|6P6|[Covalent complex] ligand is compound 3; covalent inhibitor|P54753|EPHRIN TYPE-B RECEPTOR 3|8.22|IC=6nM|IC50|=|6|nM|6|nM
4Z8D|2.00|2016|4LB|compound 9|P0A6R2|3-OXOACYL-[ACYL-CARRIER-PROTEIN] SYNTHASE 3|5.22|IC=6uM|IC50|=|6|uM|6000|nM
5KQG|1.50|2016|6VX|ligand is compound 7|P24666|LOW MOLECULAR WEIGHT PHOSPHOTYROSINE PROTEIN PHOSPHATASE|5.15|IC=7.1uM|IC50|=|7.1|uM|7100|nM
5KUP|1.39|2016|6XL|ligand is compound 9|Q06187|TYROSINE-PROTEIN KINASE BTK|8.14|IC=7.2nM|IC50|=|7.2|nM|7.2|nM
5ENM|1.98|2016|5QU|Compound 10|P56817|BETA-SECRETASE 1|7.15|IC=70nM|IC50|=|70|nM|70|nM
5FI2|2.50|2016|5XX|compound 7d|O94925|GLUTAMINASE KIDNEY ISOFORM, MITOCHONDRIAL|7.15|IC=70nM|IC50|=|70|nM|70|nM
5I2Z|2.30|2016|V24|[Different protein in assay: Protein in binding assay is WT] compound 6|P39900|MACROPHAGE METALLOELASTASE|7.14|IC=72nM|IC50|=|72|nM|72|nM
5K4J|1.60|2016|6QB|ligand is compound 22; IC50 ratio of CDK2/ERK2=25|P24941|CYCLIN-DEPENDENT KINASE 2|7.11|IC=77.5nM|IC50|=|77.5|nM|77.5|nM
4UFY|1.70|2016|M3W|compound 18b (TA-13)|Q9H2K2|TANKYRASE-2|8.15|IC=7nM|IC50|=|7|nM|7|nM
5I13|2.15|2016|4P9|compound 2|P03433|POLYMERASE ACIDIC PROTEIN|5.08|IC=8.26uM|IC50|=|8.26|uM|8260|nM
5TRH|2.70|2016|7HL|ligand is compound 5|Q9WMX2|NS5B RNA-DEPENDENT RNA POLYMERASE|5.08|IC=8.4uM|IC50|=|8.4|uM|8400|nM
5DG6|2.35|2016|V66|compound 22|Q83883|3C-LIKE PROTEASE|5.07|IC=8.6uM|IC50|=|8.6|uM|8600|nM
5EGA|2.15|2016|GK0|ligand is compound 23|C3W5S0|POLYMERASE ACIDIC PROTEIN|5.06|IC=8.7uM|IC50|=|8.7|uM|8700|nM
5I0B|3.09|2016|67U|ligand is KY-04045; radiometric assay|O96013|SERINE/THREONINE-PROTEIN KINASE PAK 4|5.06|IC=8.7uM|IC50|=|8.7|uM|8700|nM
5TRI|2.30|2016|7HM|ligand is compound 7|Q9WMX2|NS5B RNA-DEPENDENT RNA POLYMERASE|5.06|IC=8.7uM|IC50|=|8.7|uM|8700|nM
5DA3|1.70|2016|58V|ligand is compound IPA|Q13882|PROTEIN-TYROSINE KINASE 6|7.1|IC=80nM|IC50|=|80|nM|80|nM
5LAW|1.64|2016|6SJ|ligand is compound 14; in crystal is eutomer 14, but in assay is rac-14|Q00987|E3 UBIQUITIN-PROTEIN LIGASE MDM2|7.1|IC=80nM|IC50|=|80|nM|80|nM
5LAV|1.73|2016|6SK|ligand is compound 6b|Q00987|E3 UBIQUITIN-PROTEIN LIGASE MDM2|6.09|IC=819nM|IC50|=|819|nM|819|nM
5LQQ|2.40|2016|72P|ligand is compound 51|Q64610|ECTONUCLEOTIDE PYROPHOSPHATASE/PHOSPHODIESTERASE|7.09|IC=81nM|IC50|=|81|nM|81|nM
4UI6|1.80|2016|ECZ|compound 20c (TA-47)|Q9H2K2|TANKYRASE-2|7.06|IC=87nM|IC50|=|87|nM|87|nM
5EZX|1.90|2016|5T5|compound 20; cell data|P56817|BETA-SECRETASE 1|7.06|IC=87nM|IC50|=|87|nM|87|nM
5AX9|2.40|2016|4KT|compound 9|Q9UKE5|TRAF2 AND NCK-INTERACTING PROTEIN KINASE|8.1|IC=8nM|IC50|=|8|nM|8|nM
5ENK|2.11|2016|5QV|Compound 18|P56817|BETA-SECRETASE 1|8.1|IC=8nM|IC50|=|8|nM|8|nM
5JYY|2.10|2016|6PY|ligand is compound 1|R4NFR6|NEURAMINIDASE|8.1|IC=8nM|IC50|=|8|nM|8|nM
5F39|2.65|2016|5UB|compound 37|O75164|LYSINE-SPECIFIC DEMETHYLASE 4A|5.1|IC=8uM|IC50|=|8|uM|8000|nM
5LOH|3.10|2016|STU|ligand is staurosporine (STU)|Q96GX5|SERINE/THREONINE-PROTEIN KINASE GREATWALL,SERINE/THREONINE|5.04|IC=9.1uM|IC50|=|9.1|uM|9100|nM
5K1I|2.61|2016|6PT|ligand is compound 6|Q08499|CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D|8.04|IC=9.2nM|IC50|=|9.2|nM|9.2|nM
5T4H|2.61|2016|75J|ligand is compound 34n|P27487|DIPEPTIDYL PEPTIDASE 4|8.03|IC=9.31nM|IC50|=|9.31|nM|9.31|nM
5EKX|1.76|2016|2CQ|compound 2; DENV 2'O-MTase activity|P27915|NS5 METHYLTRANSFERASE|2.03|IC=9.3mM|IC50|=|9.3|mM|9300000|nM
5G10|1.71|2016|6DK|ligand is SATFMK|Q9HXM1|HDAH|8.01|IC=9.7nM|IC50|=|9.7|nM|9.7|nM
5F95|2.53|2016|3UP|compound 18|P49841|GLYCOGEN SYNTHASE KINASE-3 BETA|8.01|IC=9.8nM|IC50|=|9.8|nM|9.8|nM
5FD2|2.89|2016|5XJ|ligand is compound 6a|P15056|SERINE/THREONINE-PROTEIN KINASE B-RAF|7.05|IC=90nM|IC50|=|90|nM|90|nM
5DDC|1.62|2016|59V|ligand is compound MI-2-3|O00255|MENIN|7.04|IC=92nM|IC50|=|92|nM|92|nM
5HNG|3.01|2016|62O|compound 10|O15530|3-PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE 1|4.03|IC=93uM|IC50|=|93|uM|93000|nM
5G2N|2.68|2016|6E2|compound 39i (Copanlisib)|P48736|PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE|7.03|IC=94nM|IC50|=|94|nM|94|nM
5D29|1.80|2016|5Q1|ligand is compound (S)-1|Q04609|GLUTAMATE CARBOXYPEPTIDASE 2|7.01|IC=97nM|IC50|=|97|nM|97|nM
5HN8|2.70|2016|HXK|ligand is BPH-1182|A5K4U6|FARNESYL PYROPHOSPHATE SYNTHASE|4.01|IC=97uM|IC50|=|97|uM|97000|nM
5HLB|2.42|2016|AZR|ligand is aztreonam, not MOENOMYCIN that exists in all crystals|P02919|PENICILLIN-BINDING PROTEIN 1B|4.01|IC=98.5uM|IC50|=|98.5|uM|98500|nM
5EIW|1.61|2016|X0V|compound 3; DENV 2'O-MTase activity|P27915|NS5 METHYLTRANSFERASE|2.05|IC=9mM|IC50|=|9|mM|9000000|nM
5K5N|2.20|2016|6QH|ligand is PF-367 (PF-04802367); mobility shift assay|P49841|GLYCOGEN SYNTHASE KINASE-3 BETA|8.05|IC=9nM|IC50|=|9|nM|9|nM
5IUI|1.88|2016|45Q|ligand is compound 4|Q9UM73|ALK TYROSINE KINASE RECEPTOR|5.0|IC>10000nM|IC50|>|10000|nM|10000|nM
5FNQ|1.91|2016|S0W|compound 1; ITC Kd not determined|Q9Z2X8|KELCH-LIKE ECH-ASSOCIATED PROTEIN 1|3.0|IC>1000uM|IC50|>|1000|uM|1000000|nM
5L97|2.05|2016|6RW|ligand is compound 3|Q9UIF8|BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN PROTEIN 2B|3.0|IC>1000uM|IC50|>|1000|uM|1000000|nM
5F04|1.84|2016|5TB|compound 3|P9WMC0|HTH-TYPE TRANSCRIPTIONAL REGULATOR ETHR|4.0|IC>100uM|IC50|>|100|uM|100000|nM
5F0C|1.87|2016|5TE|compound 4|P9WMC0|HTH-TYPE TRANSCRIPTIONAL REGULATOR ETHR|4.0|IC>100uM|IC50|>|100|uM|100000|nM
5F27|1.68|2016|5TT|compound 2|P9WMC0|HTH-TYPE TRANSCRIPTIONAL REGULATOR ETHR|4.0|IC>100uM|IC50|>|100|uM|100000|nM
5KQL|1.45|2016|6VY|ligand is compound 9; IC50>>100uM|P24666|LOW MOLECULAR WEIGHT PHOSPHOTYROSINE PROTEIN PHOSPHATASE|4.0|IC>100uM|IC50|>|100|uM|100000|nM
4ZSG|1.79|2016|4QX|compound 4|Q13164|MITOGEN-ACTIVATED PROTEIN KINASE 7|5.0|IC>10uM|IC50|>|10|uM|10000|nM
4ZSL|2.25|2016|4QZ|compound 6|Q13164|MITOGEN-ACTIVATED PROTEIN KINASE 7|5.0|IC>10uM|IC50|>|10|uM|10000|nM
5JAH|2.06|2016|6HQ|ligand is compound 3|Q13093|PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE|3.0|IC>1mM|IC50|>|1|mM|1000000|nM
5LJ1|1.90|2016|6XX|ligand is compound 16; pIC50<=4.5|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|4.5|IC>31.6uM|IC50|>|31.6|uM|31600|nM
5F6D|1.55|2016|5VJ|ligand is compound 6|P63279|SUMO-CONJUGATING ENZYME UBC9|2.52|IC>3mM|IC50|>|3|mM|3000000|nM
5L96|2.15|2016|6RZ|ligand is compound 1|Q9UIF8|BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN PROTEIN 2B|3.3|IC>500uM|IC50|>|500|uM|500000|nM
5D6E|1.49|2016|94A|inhibitor (-)-31b|P50579|METHIONINE AMINOPEPTIDASE 2|4.3|IC>50uM|IC50|>|50|uM|50000|nM
5ENC|1.59|2016|5QD|ligand is compound 2|Q8WWQ0|PH-INTERACTING PROTEIN|2.3|IC>5mM|IC50|>|5|mM|5000000|nM
5ENI|1.69|2016|5QA|compound 13|Q8WWQ0|PH-INTERACTING PROTEIN|2.3|IC>5mM|IC50|>|5|mM|5000000|nM
5ENJ|1.63|2016|5Q9|compound 14|Q8WWQ0|PH-INTERACTING PROTEIN|2.3|IC>5mM|IC50|>|5|mM|5000000|nM
5JAO|2.06|2016|6HX|ligand is compound 6,Thio-PAF Assay|Q13093|PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE|4.0|IC~100uM|IC50|~|100|uM|100000|nM
5LZ2|2.10|2016|7BX|ligand is compound 4|Q13093|PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE|3.0|IC~1mM|IC50|~|1|mM|1000000|nM
5A5D|1.74|2016|5LC|CFe-5-Lic|Q0P8Q4|ENTEROCHELIN UPTAKE PERIPLASMIC BINDING PROTEIN|8.0|Kd<10nM|Kd|<|10|nM|10|nM
5ANU|1.80|2016|58T|compound 15|P36639|7,8-DIHYDRO-8-OXOGUANINE TRIPHOSPHATASE|9.4|Kd=0.0004uM|Kd|=|0.0004|uM|0.4|nM
5ANV|1.16|2016|RGJ|compound 19|P36639|7,8-DIHYDRO-8-OXOGUANINE TRIPHOSPHATASE|9.3|Kd=0.0005uM|Kd|=|0.0005|uM|0.5|nM
5FNU|1.78|2016|L6I|compound 7|Q9Z2X8|KELCH-LIKE ECH-ASSOCIATED PROTEIN 1|8.89|Kd=0.0013uM|Kd|=|0.0013|uM|1.3|nM
5IH9|1.79|2016|6BF|ligand is compound 8a; has SPR derived KD data|Q14680|MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE|8.7|Kd=0.002uM|Kd|=|0.002|uM|2|nM
5IZJ|1.85|2016|4-mer|ligand is compound ARC-1411 (6J9-AZ1-DAR-DAR)|P17612|CAMP-DEPENDENT PROTEIN KINASE|11.52|Kd=0.003nM|Kd|=|0.003|nM|0.003|nM
5ANW|1.37|2016|9CQ|compound 24|P36639|7,8-DIHYDRO-8-OXOGUANINE TRIPHOSPHATASE|8.52|Kd=0.003uM|Kd|=|0.003|uM|3|nM
5FA7|1.67|2016|5VR|ligand is FPI-1523|Q9EXV5|BETA-LACTAMASE|8.4|Kd=0.004uM|Kd|=|0.004|uM|4|nM
5FCK|1.86|2016|5WC|compound 6; SPR data available|P00746|COMPLEMENT FACTOR D|8.22|Kd=0.006uM|Kd|=|0.006|uM|6|nM
5J5X|2.60|2016|7-mer|ligand is compound ARC-1416 (6J9-AZ1-DAL-DAR-DAR-DAR-DAR)|P17612|CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTIC|11.02|Kd=0.0095nM|Kd|=|0.0095|nM|0.0095|nM
4ZAM|1.42|2016|MA4|KRC-2|P0AD64|BETA-LACTAMASE SHV-1|7.96|Kd=0.011uM|Kd|=|0.011|uM|11|nM
5FAO|3.01|2016|5VW|ligand is FPI-1465|Q9EXV5|BETA-LACTAMASE|7.96|Kd=0.011uM|Kd|=|0.011|uM|11|nM
5E89|1.50|2016|TD2|compound 4|P17931|GALECTIN-3|7.85|Kd=0.014uM|Kd|=|0.014|uM|14|nM
5G1N|2.10|2016|PAL|[Nonstandard assay: pH 8.3, 150 mM NaCl] [Multiple sites: site 1: Kd=0.017 uM; site 2: Kd=0.027 uM; site 3: Kd=1.4 uM] ligand is PALA; three non-equivalent binding sites|P27708|CAD PROTEIN|7.77|Kd=0.017uM|Kd|=|0.017|uM|17|nM
5FAP|2.70|2016|602|ligand is FPI-1602|Q9EXV5|BETA-LACTAMASE|8.0|Kd=0.01uM|Kd|=|0.01|uM|10|nM
5F4L|2.70|2016|5VE|ligand is compound (R,R)-JP-III-048 (4)|------|ENVELOPE GLYCOPROTEIN GP120 OF HIV-1 CLADE C|7.62|Kd=0.024uM|Kd|=|0.024|uM|24|nM
5I22|NMR|2016|17-mer|ligand is CHIKV nsP3 peptide|O00499|MYC BOX-DEPENDENT-INTERACTING PROTEIN 1|7.62|Kd=0.024uM|Kd|=|0.024|uM|24|nM
5IVE|1.78|2016|6E8|ligand is compound N8|P29375|LYSINE-SPECIFIC DEMETHYLASE 5A|7.57|Kd=0.027uM|Kd|=|0.027|uM|27|nM
5A2S|2.65|2016|OTF|compound 14|P56524|HISTONE DEACETYLASE 4|7.7|Kd=0.02uM|Kd|=|0.02|uM|20|nM
5EL2|1.75|2016|KBR|[Multiple sites: site 1: Kd1=0.034 mM; site 2: Kd2=0.714 mM] ligand is Icaridin; two binding sites|Q8I8T0|AGAP003309-PA|4.47|Kd=0.034mM|Kd|=|0.034|mM|34000|nM
5E8A|1.50|2016|5KS|compound 5|P17931|GALECTIN-3|7.47|Kd=0.034uM|Kd|=|0.034|uM|34|nM
5FAS|1.74|2016|5VR|FPI-1523|Q6XEC0|BETA-LACTAMASE|7.47|Kd=0.034uM|Kd|=|0.034|uM|34|nM
5I8G|1.41|2016|69E|Compound 28 (CPI-637); has Kd for this compound|Q92793|CREB-BINDING PROTEIN|7.52|Kd=0.03uM|Kd|=|0.03|uM|30|nM
5AGS|1.47|2016|38Y|[Uncommon element] compound 11|P9WFV1|LEUCINE--TRNA LIGASE|7.4|Kd=0.040uM|Kd|=|0.04|uM|40|nM
5L7K|2.10|2016|6-mer|ligand is 6-mer myristoylated NPHP3 peptide (myrGTASSL); stopped flow assay|Q13432|PROTEIN UNC-119 HOMOLOG A|10.37|Kd=0.043nM|Kd|=|0.043|nM|0.043|nM
5IVJ|1.57|2016|6ED|ligand is compound N11|P29375|LYSINE-SPECIFIC DEMETHYLASE 5A|7.34|Kd=0.046uM|Kd|=|0.046|uM|46|nM
5F4P|2.60|2016|5VG|ligand is (R,R)-BNM-III-170 (compound 5)|------|ENVELOPE GLYCOPROTEIN GP120 OF HIV-1 CLADE C|7.33|Kd=0.047uM|Kd|=|0.047|uM|47|nM
5TBM|1.85|2016|79A|ligand is PT2385|Q99814|ENDOTHELIAL PAS DOMAIN-CONTAINING PROTEIN 1|7.31|Kd=0.049uM|Kd|=|0.049|uM|49|nM
5ISL|1.69|2016|MMK|ligand is compound KDM5-C49|P29375|LYSINE-SPECIFIC DEMETHYLASE 5A|7.28|Kd=0.052uM|Kd|=|0.052|uM|52|nM
5IZU|2.49|2016|15-mer|ligand is SAPAP3 E-PBM peptide (963-977)|Q4ACU6|SH3 AND MULTIPLE ANKYRIN REPEAT DOMAINS PROTEIN 3|7.27|Kd=0.054uM|Kd|=|0.054|uM|54|nM
5HVT|1.75|2016|NVS|ligand is compound NVS-2|P14174|MACROPHAGE MIGRATION INHIBITORY FACTOR|7.26|Kd=0.055uM|Kd|=|0.055|uM|55|nM
5E88|1.60|2016|5KT|compound 12|P17931|GALECTIN-3|7.19|Kd=0.065uM|Kd|=|0.065|uM|65|nM
5H9P|2.04|2016|TD2|ligand is TD-139|P17931|GALECTIN-3|7.17|Kd=0.068uM|Kd|=|0.068|uM|68|nM
5IW0|1.63|2016|6EP|ligand is compound N19|P29375|LYSINE-SPECIFIC DEMETHYLASE 5A|7.22|Kd=0.06uM|Kd|=|0.06|uM|60|nM
5HVS|1.75|2016|65V|compound 3i|P14174|MACROPHAGE MIGRATION INHIBITORY FACTOR|7.15|Kd=0.071uM|Kd|=|0.071|uM|71|nM
5AGT|1.45|2016|A2H|[Uncommon element] compound 13|P9WFV1|LEUCINE--TRNA LIGASE|7.12|Kd=0.075uM|Kd|=|0.075|uM|75|nM
5IJP|2.75|2016|I6P|ligand is inositol hexakisphosphate (InsP6)|G0SCH1|PUTATIVE UNCHARACTERIZED PROTEIN|7.15|Kd=0.07uM|Kd|=|0.07|uM|70|nM
5HVA|2.10|2016|DUP|ligand is dUMPNPP|Q9RS96|DR2231|7.07|Kd=0.086uM|Kd|=|0.086|uM|86|nM
5F4R|2.80|2016|5VF|ligand is (R,R)-BNM-IV-147 (compound 6)|------|ENVELOPE GLYCOPROTEIN GP120 OF HIV-1 CLADE C|7.02|Kd=0.095uM|Kd|=|0.095|uM|95|nM
5F4U|3.10|2016|5VH|ligand is (R,R)-BNM-IV-197 (compound 7)|------|ENVELOPE GLYCOPROTEIN GP120 OF HIV-1 CLADE C|7.02|Kd=0.095uM|Kd|=|0.095|uM|95|nM
5LWE|2.80|2016|79K|ligand is vercirnon|P51686|C-C CHEMOKINE RECEPTOR TYPE 9|9.96|Kd=0.11nM|Kd|=|0.11|nM|0.11|nM
5FAT|2.09|2016|602|ligand is FPI-1602|Q6XEC0|BETA-LACTAMASE|6.96|Kd=0.11uM|Kd|=|0.11|uM|110|nM
5CQT|1.60|2016|EB3|compound 28|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|6.91|Kd=0.124uM|Kd|=|0.124|uM|124|nM
5DX4|2.30|2016|E0C|compound 85|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|6.86|Kd=0.137uM|Kd|=|0.137|uM|137|nM
5TEG|1.30|2016|8-mer|ligand is histone H4K20 norleucine mutant peptide (2)|Q9NQR1|N-LYSINE METHYLTRANSFERASE KMT5A|6.85|Kd=0.14uM|Kd|=|0.14|uM|140|nM
5ECH|2.14|2016|JAA|ligand is JA|Q9SKE2|JASMONIC ACID-AMIDO SYNTHETASE JAR1|3.8|Kd=0.16mM|Kd|=|0.16|mM|160000|nM
5ECI|1.56|2016|JAA|ligand is JA|Q9SKE2|JASMONIC ACID-AMIDO SYNTHETASE JAR1|3.8|Kd=0.16mM|Kd|=|0.16|mM|160000|nM
5ELV|1.92|2016|5PX|compound 5 (BPAM-521)|P19491|GLUTAMATE RECEPTOR 2|6.8|Kd=0.16uM|Kd|=|0.16|uM|160|nM
5KHI|2.10|2016|6SX|[Multiple sites: site 1: Kd=0.17 uM; site 2: Kd=2.76 uM] ligand is purine riboside-3', 5'-cyclic monophosphate (cPuMP)|O88703|POTASSIUM/SODIUM HYPERPOLARIZATION-ACTIVATED CYCLIC|6.77|Kd=0.17uM|Kd|=|0.17|uM|170|nM
5JS3|1.16|2016|6MG|ligand is compound 3|P00800|THERMOLYSIN|6.73|Kd=0.185uM|Kd|=|0.185|uM|185|nM
5IZF|2.10|2016|6-mer|ligand is compound ARC-1408 (6J9-AZ1-DAR-ACA-DAR-NH2)|P17612|CAMP-DEPENDENT PROTEIN KINASE|9.74|Kd=0.18nM|Kd|=|0.18|nM|0.18|nM
5IZK|3.25|2016|GDP|ligand is GDP|P57772|SELENOCYSTEINE-SPECIFIC ELONGATION FACTOR|6.72|Kd=0.19uM|Kd|=|0.19|uM|190|nM
5CY9|1.55|2016|E0A|compound 58|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|6.66|Kd=0.218uM|Kd|=|0.218|uM|218|nM
5GGN|1.21|2016|LEC|ligand is pNP-beta-GlcNAc|Q8WZA1|PROTEIN O-LINKED-MANNOSE BETA-1,2-N|3.66|Kd=0.22mM|Kd|=|0.22|mM|220000|nM
4Y24|2.32|2016|TD2|ligand is TD-139|P09382|GALECTIN-1|6.66|Kd=0.22uM|Kd|=|0.22|uM|220|nM
5JT9|1.26|2016|7AF|ligand is compound 2|P00800|THERMOLYSIN|6.63|Kd=0.233uM|Kd|=|0.233|uM|233|nM
5I2E|1.60|2016|67D|ligand is compound 7|P49773|HISTIDINE TRIAD NUCLEOTIDE-BINDING PROTEIN 1|6.64|Kd=0.23uM|Kd|=|0.23|uM|230|nM
5L3J|2.83|2016|6G9|ligand is compound 24|P0AES6|DNA GYRASE SUBUNIT B|6.64|Kd=0.23uM|Kd|=|0.23|uM|230|nM
4ZNX|2.10|2016|12-mer|ligand is peptide APP12|P06241|TYROSINE-PROTEIN KINASE FYN|6.62|Kd=0.24uM|Kd|=|0.24|uM|240|nM
5EJL|2.30|2016|C2E|ligand is c-di-GMP|G3FT00|KLEBSIELLA PNEUMONIAE GENOME ASSEMBLY NOVST|6.62|Kd=0.24uM|Kd|=|0.24|uM|240|nM
5T1L|2.48|2016|12-mer|ligand is CQA(Ph)2DLSTRRLKC peptide|P01834|CETUXIMAB FAB, LIGHT CHAIN|6.62|Kd=0.24uM|Kd|=|0.24|uM|240|nM
5IGQ|3.90|2016|11-mer|ligand is 11-mer Trib1 peptide|Q8NHY2|E3 UBIQUITIN-PROTEIN LIGASE RFWD2|6.6|Kd=0.25uM|Kd|=|0.25|uM|250|nM
5J19|2.00|2016|15-mer|ligand is Phosphorylated peptide from Partner of Numb (pPon)|P53350|SERINE/THREONINE-PROTEIN KINASE PLK1|6.6|Kd=0.25uM|Kd|=|0.25|uM|250|nM
5L4I|1.45|2016|6J3|ligand is Clonixin|P02766|TRANSTHYRETIN|6.59|Kd=0.26uM|Kd|=|0.26|uM|260|nM
5IJJ|1.95|2016|I6P|ligand is inositol hexakisphosphate (InsP6)|G0RY29|SPX DOMAIN|6.55|Kd=0.28uM|Kd|=|0.28|uM|280|nM
5GGK|1.30|2016|MBE|ligand is pNP-beta-Man|Q8WZA1|PROTEIN O-LINKED-MANNOSE BETA-1,2-N|3.54|Kd=0.29mM|Kd|=|0.29|mM|290000|nM
5E2N|1.53|2016|V14|[Nonstandard assay: Temp 37] CA XIII-10h|Q8N1Q1|CARBONIC ANHYDRASE 13|9.54|Kd=0.29nM|Kd|=|0.29|nM|0.29|nM
4RFR|1.50|2016|RHN|ligand is rhein|P05050|ALPHA-KETOGLUTARATE-DEPENDENT DIOXYGENASE ALKB|6.54|Kd=0.29uM|Kd|=|0.29|uM|290|nM
5ETR|1.32|2016|5RW|ligand is compound 34|Q99W87|2-AMINO-4-HYDROXY-6-HYDROXYMETHYLDIHYDROPTERIDINE|6.52|Kd=0.30uM|Kd|=|0.3|uM|300|nM
5KAU|1.95|2016|RHQ|ligand is RHODAMINE 6G (RH6G)|------|SA2223 PROTEIN|6.52|Kd=0.30uM|Kd|=|0.3|uM|300|nM
5AQT|1.90|2016|5P7|[Different protein in assay: crystal: HSC70/BAG1, binding assay:HSC70] kd=0.31+/-0.01mM, HSC70/BAG1 Compound 23|P11142|HEAT SHOCK COGNATE 71 KDA PROTEIN|3.51|Kd=0.31mM|Kd|=|0.31|mM|310000|nM
5J31|2.40|2016|10-mer|ligand is alkyne cross-linked cyclic peptide H derived from ExoS|P63104|14-3-3 PROTEIN ZETA/DELTA|6.51|Kd=0.31uM|Kd|=|0.31|uM|310|nM
5JVI|1.12|2016|6QC|ligand is compound 5|P00800|THERMOLYSIN|6.51|Kd=0.31uM|Kd|=|0.31|uM|310|nM
5CU4|1.56|2016|54S|ligand is compound CAM4066 (7)|P68400|CASEIN KINASE II, ALPHA SUBUNIT|6.49|Kd=0.320uM|Kd|=|0.32|uM|320|nM
5I2F|1.25|2016|BS5|ligand is Bio-AMS|P49773|HISTIDINE TRIAD NUCLEOTIDE-BINDING PROTEIN 1|6.49|Kd=0.32uM|Kd|=|0.32|uM|320|nM
5ETQ|1.96|2016|YH2|ligand is compound 40|Q99W87|2-AMINO-4-HYDROXY-6-HYDROXYMETHYLDIHYDROPTERIDINE|6.48|Kd=0.33uM|Kd|=|0.33|uM|330|nM
5JSS|1.19|2016|6NG|ligand is compound 6|P00800|THERMOLYSIN|6.45|Kd=0.354uM|Kd|=|0.354|uM|354|nM
5DBM|1.86|2016|58N|ligand is CPI703|Q92793|CREB-BINDING PROTEIN|6.46|Kd=0.35uM|Kd|=|0.35|uM|350|nM
5IVY|1.45|2016|6EO|ligand is compound N16|P29375|LYSINE-SPECIFIC DEMETHYLASE 5A|6.44|Kd=0.36uM|Kd|=|0.36|uM|360|nM
5AQV|1.75|2016|KC7|[Different protein in assay: crystal: HSC70/BAG1, binding assay:HSC70] Kd=0.37+/-0.03mM, HSC70/BAG1 Compound 28|P11142|HEAT SHOCK COGNATE 71 KDA PROTEIN|3.43|Kd=0.37mM|Kd|=|0.37|mM|370000|nM
5JXN|1.38|2016|6NN|ligand is compound 4|P00800|THERMOLYSIN|6.41|Kd=0.388uM|Kd|=|0.388|uM|388|nM
5EOM|2.55|2016|CTP||Q13394|PROTEIN MAB-21-LIKE 1|6.39|Kd=0.41uM|Kd|=|0.41|uM|410|nM
5KHK|2.07|2016|6SZ|[Multiple sites: site 1: Kd=0.41 uM; site 2: Kd=3.08 uM] ligand is 2-NH2-cPuMP|O88703|POTASSIUM/SODIUM HYPERPOLARIZATION-ACTIVATED CYCLIC|6.39|Kd=0.41uM|Kd|=|0.41|uM|410|nM
5D0R|2.24|2016|B1T||Q96PN6|ADENYLATE CYCLASE TYPE 10|6.37|Kd=0.43uM|Kd|=|0.43|uM|430|nM
5ANT|2.00|2016|RJE|compound 27|P36639|7,8-DIHYDRO-8-OXOGUANINE TRIPHOSPHATASE|6.36|Kd=0.440uM|Kd|=|0.44|uM|440|nM
5IN9|2.60|2016|6C0|ligand is compound 48|P41148|ENDOPLASMIN|6.36|Kd=0.44uM|Kd|=|0.44|uM|440|nM
5DUC|2.70|2016|G51|ligand is GSK951A|P9WNP1|PROBABLE ENOYL-COA HYDRATASE ECHA6|6.35|Kd=0.45uM|Kd|=|0.45|uM|450|nM
5IVV|1.85|2016|6EN|ligand is compound N12|P29375|LYSINE-SPECIFIC DEMETHYLASE 5A|6.35|Kd=0.45uM|Kd|=|0.45|uM|450|nM
5LZ5|2.05|2016|7K4|ligand is compound (s)-15; ITC data available|Q13093|PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE|6.35|Kd=0.45uM|Kd|=|0.45|uM|450|nM
5EWZ|2.34|2016|11-mer|ligand is diphosphorylated Gab2-pS210pT391 peptide|P63104|14-3-3 PROTEIN ZETA/DELTA|6.34|Kd=0.46uM|Kd|=|0.46|uM|460|nM
5KBE|2.50|2016|IPH|ligand is phenol|Q43965|MOPR|6.34|Kd=0.46uM|Kd|=|0.46|uM|460|nM
5EKM|1.33|2016|TG5|compound 4|P00918|CARBONIC ANHYDRASE 2|6.32|Kd=0.48uM|Kd|=|0.48|uM|480|nM
5K8N|3.23|2016|6R6|ligand is 5-nitroanthranilic acid (5NAA)|D3WZ85|5-NITROANTHRANILIC ACID AMINOHYDROLASE|6.32|Kd=0.48uM|Kd|=|0.48|uM|480|nM
5GMH|2.20|2016|RX8|[Nonstandard assay: pH 5.5, 150 mM NaCl] ligand is R848|B3Y653|TOLL-LIKE RECEPTOR 7|6.31|Kd=0.49uM|Kd|=|0.49|uM|490|nM
5IX1|2.60|2016|15-mer|ligand is H3(1-15)K4me3 peptide|F7BJB9|MORC FAMILY CW-TYPE ZINC FINGER PROTEIN 3|6.31|Kd=0.49uM|Kd|=|0.49|uM|490|nM
5I3Y|2.15|2016|68K|ligand is compound 9|P56817|BETA-SECRETASE 1|9.4|Kd=0.4nM|Kd|=|0.4|nM|0.4|nM
5D25|1.70|2016|56M|compound 2|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|6.3|Kd=0.50uM|Kd|=|0.5|uM|500|nM
5T52|1.70|2016|A2G/NGA|[Different ligand in assay: Kd=0.54 nM, beta-GalNAc] alpha-GalNAc + beta-GalNAc, App Kd|P86993|LECTIN|9.28|Kd=0.52nM|Kd|=|0.52|nM|0.52|nM
4YBJ|2.61|2016|4A9|ligand is DAS-DFGO-I; assay by KINOMEscan service|P00523|TYROSINE-PROTEIN KINASE SRC|9.28|Kd=0.53nM|Kd|=|0.53|nM|0.53|nM
5LZ7|2.10|2016|7BK|ligand is compound (R)-15; ITC data available|Q13093|PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE|6.28|Kd=0.53uM|Kd|=|0.53|uM|530|nM
5T1K|2.48|2016|12-mer|ligand is CQFDA(Ph)2STRRLKC peptide|P01834|CETUXIMAB FAB, LIGHT CHAIN|6.28|Kd=0.53uM|Kd|=|0.53|uM|530|nM
5K6S|2.79|2016|19-mer|ligand is 19-mer cpS-BubR1 peptide; 663-TLSIKKL(pS)PIIEDDREADH-681|Q13362|SERINE/THREONINE-PROTEIN PHOSPHATASE 2A 56 KDA REGULATORY|6.26|Kd=0.55uM|Kd|=|0.55|uM|550|nM
5SWF|2.82|2016|9-mer|ligand is 9-mer dpSpS-BubR1 peptide; 668-KL(pS)PIIED(pS)-676|Q13362|SERINE/THREONINE-PROTEIN PHOSPHATASE 2A 56 KDA REGULATORY|6.26|Kd=0.55uM|Kd|=|0.55|uM|550|nM
5KBH|2.55|2016|3CH|ligand is 3-chlorophenol|Q43965|MOPR|6.26|Kd=0.55uM|Kd|=|0.55|uM|550|nM
5H7G|1.85|2016|13-mer|ligand is F1324 peptide; SPR data available|P41182|B-CELL LYMPHOMA 6 PROTEIN|9.24|Kd=0.57nM|Kd|=|0.57|nM|0.57|nM
5ETV|1.72|2016|5RZ|ligand is compound 13|Q99W87|2-AMINO-4-HYDROXY-6-HYDROXYMETHYLDIHYDROPTERIDINE|6.24|Kd=0.57uM|Kd|=|0.57|uM|570|nM
5LWD|1.23|2016|79E|ligand is compound 6|P00800|THERMOLYSIN|6.24|Kd=0.57uM|Kd|=|0.57|uM|570|nM
5ETT|1.55|2016|5RY|ligand is compound 50|Q99W87|2-AMINO-4-HYDROXY-6-HYDROXYMETHYLDIHYDROPTERIDINE|6.23|Kd=0.59uM|Kd|=|0.59|uM|590|nM
5GGP|1.60|2016|12-mer|ligand includes 2-mer monosaccharide and 10-mer peptide, GlcNAc-beta1,2-Man-peptide|Q8WZA1|PROTEIN O-LINKED-MANNOSE BETA-1,2-N|3.3|Kd=0.5mM|Kd|=|0.5|mM|500000|nM
4ZFI|2.00|2016|4NJ|compound 1a; MST assay|Q00987|E3 UBIQUITIN-PROTEIN LIGASE MDM2|6.3|Kd=0.5uM|Kd|=|0.5|uM|500|nM
5HFF|1.75|2016|9-mer|ligand is a mutant C-terminal peptide derived from CRIPT (T-2F)|P31016|DISKS LARGE HOMOLOG 4|6.3|Kd=0.5uM|Kd|=|0.5|uM|500|nM
5HTL|1.37|2016|C2E|ligand is c-di-GMP|------|MSHA BIOGENESIS PROTEIN MSHE|6.3|Kd=0.5uM|Kd|=|0.5|uM|500|nM
5H5R|1.20|2016|15-mer|ligand is GXpep-2 peptide|P36969|PHOSPHOLIPID HYDROPEROXIDE GLUTATHIONE PEROXIDASE|6.21|Kd=0.61uM|Kd|=|0.61|uM|610|nM
5EE7|2.50|2016|5MV|[Different ligand in assay: ligand in binding assay is Tritium-labelled] ligand is antagonist MK-0893; pKd=9.21|P47871|GLUCAGON RECEPTOR,ENDOLYSIN,GLUCAGON RECEPTOR|9.21|Kd=0.62nM|Kd|=|0.62|nM|0.62|nM
5SVX|1.56|2016|11-mer|ligand is H3K4me3 peptide|Q14149|MORC FAMILY CW-TYPE ZINC FINGER PROTEIN 3|6.19|Kd=0.64uM|Kd|=|0.64|uM|640|nM
5FNT|1.79|2016|0PL|compound 6|Q9Z2X8|KELCH-LIKE ECH-ASSOCIATED PROTEIN 1|6.17|Kd=0.67uM|Kd|=|0.67|uM|670|nM
5I3W|2.15|2016|68L|ligand is compound 2|P56817|BETA-SECRETASE 1|9.22|Kd=0.6nM|Kd|=|0.6|nM|0.6|nM
5J18|NMR|2016|6FS|ligand is Rigosertib; MST assay|P15056|SERINE/THREONINE-PROTEIN KINASE B-RAF|9.15|Kd=0.71nM|Kd|=|0.71|nM|0.71|nM
5AR0|1.90|2016|GB8|ligand is compoud 17|P0DMV8|HEAT SHOCK 70 KDA PROTEIN 1A|6.14|Kd=0.72uM|Kd|=|0.72|uM|720|nM
5F1C|2.90|2016|ATP||G3MM57|PUTATIVE UNCHARACTERIZED PROTEIN|6.13|Kd=0.745uM|Kd|=|0.745|uM|745|nM
5SVY|1.05|2016|11-mer|ligand is H3K4me1 peptide|Q14149|MORC FAMILY CW-TYPE ZINC FINGER PROTEIN 3|6.13|Kd=0.74uM|Kd|=|0.74|uM|740|nM
5KAX|2.00|2016|RHQ|ligand is RHODAMINE 6G (RH6G)|Q8KFZ1|CTR107 PROTEIN|6.11|Kd=0.78uM|Kd|=|0.78|uM|780|nM
5KBG|2.80|2016|JZ0|ligand is o-cresol|Q43965|MOPR|6.11|Kd=0.78uM|Kd|=|0.78|uM|780|nM
5ETP|1.05|2016|5RZ|ligand is compound 13|P26281|2-AMINO-4-HYDROXY-6-HYDROXYMETHYLDIHYDROPTERIDINE|6.15|Kd=0.7uM|Kd|=|0.7|uM|700|nM
5FTG|1.45|2016|NBR|compound 10a|P35790|CHOLINE KINASE ALPHA|6.15|Kd=0.7uM|Kd|=|0.7|uM|700|nM
5K4Z|1.64|2016|6Q8|ligand is compound 6; Kd is available for comp 6|G7CNL4|INOSINE-5'-MONOPHOSPHATE DEHYDROGENASE,INOSINE-5|6.15|Kd=0.7uM|Kd|=|0.7|uM|700|nM
5L0C|3.10|2016|PIO|[Multiple sites: site 1: Kd=0.7uM; site 2: Kd=0.59uM] ligand is PIP2|P18206|VINCULIN|6.15|Kd=0.7uM|Kd|=|0.7|uM|700|nM
5D26|1.82|2016|L28|compound 3|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|6.09|Kd=0.81uM|Kd|=|0.81|uM|810|nM
5E7N|1.21|2016|5KR|compound 20c|P27694|REPLICATION PROTEIN A 70 KDA DNA-BINDING SUBUNIT|6.09|Kd=0.81uM|Kd|=|0.81|uM|810|nM
5EEL|2.47|2016|9-mer|ligand is Bicyclic Peptide Inhibitor (G7-B4)|Q14451|GROWTH FACTOR RECEPTOR-BOUND PROTEIN 7|6.08|Kd=0.83uM|Kd|=|0.83|uM|830|nM
5H9R|1.58|2016|TGZ|ligand is TAZTDG|P17931|GALECTIN-3|6.08|Kd=0.84uM|Kd|=|0.84|uM|840|nM
5T54|1.65|2016|3-mer|[Different ligand in assay: ] ligand is BG-A, oligosaccharide|P86993|LECTIN|9.06|Kd=0.87nM|Kd|=|0.87|nM|0.87|nM
5D3L|1.50|2016|57F|compound 13|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|6.06|Kd=0.88uM|Kd|=|0.88|uM|880|nM
5AQQ|2.72|2016|BBW|[Different protein in assay: crystal: HSC70/BAG1, binding assay:HSC70] Kd=0.8+/-0.5mM, HSC70/BAG1 Compound 13|P11142|HEAT SHOCK COGNATE 71 KDA PROTEIN|3.1|Kd=0.8mM|Kd|=|0.8|mM|800000|nM
5GGO|1.50|2016|2-mer|ligand is GalNAc-beta1,3-GlcNAc-beta-pNP (2-mer of LEC+NGA)|Q8WZA1|PROTEIN O-LINKED-MANNOSE BETA-1,2-N|3.1|Kd=0.8mM|Kd|=|0.8|mM|800000|nM
5HEB|1.65|2016|9-mer|ligand is a C-terminal peptide derived from CRIPT|P31016|DISKS LARGE HOMOLOG 4|6.1|Kd=0.8uM|Kd|=|0.8|uM|800|nM
5EKG|2.80|2016|19-mer|[Multiple sites: major site Kd=0.91uM; minor site Kd=140uM] ligand is XPG2 peptide|P52293|XPG2 PEPTIDE|6.04|Kd=0.91uM|Kd|=|0.91|uM|910|nM
5EGS|2.15|2016|5NR|fragment 7|Q96LA8|PROTEIN ARGININE N-METHYLTRANSFERASE 6|6.01|Kd=0.97uM|Kd|=|0.97|uM|970|nM
5K7H|2.35|2016|IVC|ligand is isovaleryl coenzyme A; MST assay|Q1D4I5|TRANSCRIPTIONAL REGULATOR, TETR FAMILY|6.0|Kd=0.99uM|Kd|=|0.99|uM|990|nM
5KCB|2.10|2016|ET|ligand is ethidium bromide (ET)|------|SA2223 PROTEIN|6.0|Kd=0.99uM|Kd|=|0.99|uM|990|nM
5G2G|1.60|2016|EQU|ligand is equilenin|P07445|STEROID DELTA-ISOMERASE|6.05|Kd=0.9uM|Kd|=|0.9|uM|900|nM
5HIP|1.99|2016|61O|compound 1|P20581|PQSE|6.05|Kd=0.9uM|Kd|=|0.9|uM|900|nM
5AQU|1.92|2016|UX0|[Different protein in assay: crystal: HSC70/BAG1, binding assay:HSC70] Kd=1.04+/-0.55mM, HSC70/BAG1 Compound 26|P11142|HEAT SHOCK COGNATE 71 KDA PROTEIN|2.98|Kd=1.04mM|Kd|=|1.04|mM|1040000|nM
5K8O|2.89|2016|6R7|ligand is compound 5NSA; Kd for 5NSA with Mn2+ ion is 0.59uM|D3WZ85|5-NITROANTHRANILIC ACID AMINOHYDROLASE|5.96|Kd=1.09uM|Kd|=|1.09|uM|1090|nM
5EKH|1.34|2016|5RD|compound 1|P00918|CARBONIC ANHYDRASE 2|5.95|Kd=1.11uM|Kd|=|1.11|uM|1110|nM
4XO8|1.70|2016|KGM||P08191|FIMH PROTEIN|8.96|Kd=1.1nM|Kd|=|1.1|nM|1.1|nM
5AEI|1.83|2016|10-mer|ligand is peptide (KR)5|------|DESIGNED ARMADILLO REPEAT PROTEIN YIIIM5AII|8.96|Kd=1.1nM|Kd|=|1.1|nM|1.1|nM
5DRS|1.10|2016|5EF|[Nonstandard assay: Temp 37] CAII-10n|P00918|CARBONIC ANHYDRASE 2|8.96|Kd=1.1nM|Kd|=|1.1|nM|1.1|nM
4YJL|2.10|2016|13-mer|ligand is peptide Amer1-A2 (496-508)|P25054|ADENOMATOUS POLYPOSIS COLI PROTEIN|5.96|Kd=1.1uM|Kd|=|1.1|uM|1100|nM
5HJA|1.65|2016|XA2|[Different ligand in assay: racemic] inhibitor ABHDP; affinity is for ABHDP, racemic (DL)|Q6TUJ5|ARGINASE|5.96|Kd=1.1uM|Kd|=|1.1|uM|1100|nM
5HV0|1.63|2016|AKG|ligand is cofactor 2-OXOGLUTARIC ACID|Q81LZ8|PROLYL 4-HYDROXYLASE|5.96|Kd=1.1uM|Kd|=|1.1|uM|1100|nM
5CP5|1.79|2016|EB0|compound 17|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|5.91|Kd=1.234uM|Kd|=|1.234|uM|1234|nM
5ETS|1.95|2016|5RX|ligand is compound 35|Q99W87|2-AMINO-4-HYDROXY-6-HYDROXYMETHYLDIHYDROPTERIDINE|5.91|Kd=1.24uM|Kd|=|1.24|uM|1240|nM
5LVL|1.40|2016|537|ligand is PS653|O15530|3-PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE 1|5.9|Kd=1.25uM|Kd|=|1.25|uM|1250|nM
5KBF|2.00|2016|CMP|ligand is cAMP|Q7KQK0|CAMP-DEPENDENT PROTEIN KINASE REGULATORY SUBUNIT|8.92|Kd=1.2nM|Kd|=|1.2|nM|1.2|nM
5FB1|2.10|2016|15-mer|ligand is 15-mer histone H3 K9me3 peptide|P23497|NUCLEAR AUTOANTIGEN SP-100|5.92|Kd=1.2uM|Kd|=|1.2|uM|1200|nM
5FH6|2.30|2016|5XM|ligand is compound 10|Q86U86|PROTEIN POLYBROMO-1|5.92|Kd=1.2uM|Kd|=|1.2|uM|1200|nM
5IVC|1.57|2016|6E7|ligand is compound N3|P29375|LYSINE-SPECIFIC DEMETHYLASE 5A|5.92|Kd=1.2uM|Kd|=|1.2|uM|1200|nM
5IZM|3.40|2016|GNP|ligand is GDPNP|P57772|SELENOCYSTEINE-SPECIFIC ELONGATION FACTOR|5.92|Kd=1.2uM|Kd|=|1.2|uM|1200|nM
5SVZ|2.00|2016|15-mer|[Nonstandard assay: boiled] +/-0.2, Tat|P52293|IMPORTIN SUBUNIT ALPHA-1|5.92|Kd=1.2uM|Kd|=|1.2|uM|1200|nM
5LWM|1.55|2016|79T|ligand is compound 4 (FM381); commercial displacement assay|P52333|TYROSINE-PROTEIN KINASE JAK3|8.87|Kd=1.34nM|Kd|=|1.34|nM|1.34|nM
5LIF|1.31|2016|6XO|ligand is compound 5|P00800|THERMOLYSIN|5.87|Kd=1.34uM|Kd|=|1.34|uM|1340|nM
5EH5|1.21|2016|XCZ|compound 1|P00918|CARBONIC ANHYDRASE 2|5.87|Kd=1.35uM|Kd|=|1.35|uM|1350|nM
5IPJ|2.10|2016|6CD|ligand is compound 17; DiscoveRx assay|P11309|SERINE/THREONINE-PROTEIN KINASE PIM-1|8.89|Kd=1.3nM|Kd|=|1.3|nM|1.3|nM
5D3S|1.75|2016|579|compound 12|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|5.89|Kd=1.3uM|Kd|=|1.3|uM|1300|nM
5FSY|1.70|2016|AR6|ligand is ADP-ribose|C9ZP98|MACRODOMAIN|5.89|Kd=1.3uM|Kd|=|1.3|uM|1300|nM
5FYQ|3.00|2016|13-mer|ligand is 13-mer trifluoroacetylated Ran peptide, Ran(31-43) TfAcK37|Q8IXJ6|NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-2|5.89|Kd=1.3uM|Kd|=|1.3|uM|1300|nM
5L4F|1.48|2016|6J1|ligand is 2,6-Dinitro-p-cresol (DNPC)|P02766|TRANSTHYRETIN|5.89|Kd=1.3uM|Kd|=|1.3|uM|1300|nM
5T5G|2.10|2016|75P|Kd = 1.3 +/- 0.3 uM, ligand is compound 2.|Q9NQR1|N-LYSINE METHYLTRANSFERASE KMT5A|5.89|Kd=1.3uM|Kd|=|1.3|uM|1300|nM
5DW2|1.12|2016|5GD|ligand is compound RVX-297|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|5.84|Kd=1.44uM|Kd|=|1.44|uM|1440|nM
5AQO|2.12|2016|CWS|[Different protein in assay: crystal: HSC70/BAG1, binding assay:HSC70] Kd=1.4+/-0.1mM, HSC70/BAG1 Compound 8|P11142|HEAT SHOCK COGNATE 71 KDA PROTEIN|2.85|Kd=1.4mM|Kd|=|1.4|mM|1400000|nM
5IVN|1.00|2016|12-mer|ligand is Cadherin derived peptide (BC2)|G9GAG7|BC2-NANOBODY|8.85|Kd=1.4nM|Kd|=|1.4|nM|1.4|nM
5EGU|2.21|2016|5NQ|compound 1|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|5.85|Kd=1.4uM|Kd|=|1.4|uM|1400|nM
5ENG|1.30|2016|5QN|ligand is compound 12|Q92793|CREB-BINDING PROTEIN|5.85|Kd=1.4uM|Kd|=|1.4|uM|1400|nM
5LSO|2.22|2016|6-mer|ligand is cyclic peptide inhibitor compound 3|Q96I25|SPLICING FACTOR 45|5.85|Kd=1.4uM|Kd|=|1.4|uM|1400|nM
5TB6|1.79|2016|77X|Kd=1.53+/-0.01uM; CREBBP(1)/CPD-A|Q92793|CREB-BINDING PROTEIN|5.82|Kd=1.53uM|Kd|=|1.53|uM|1530|nM
4Z5W|2.20|2016|5-mer|complex of PSK and DcPSKR-LRR; MST assay|Q8LPB4|PHYTOSULFOKINE RECEPTOR 1|5.81|Kd=1.55uM|Kd|=|1.55|uM|1550|nM
5EZ0|2.35|2016|11-mer|ligand is peptide p38 gamma-KETPL|P29074|TYROSINE-PROTEIN PHOSPHATASE NON-RECEPTOR TYPE 4|5.8|Kd=1.58uM|Kd|=|1.58|uM|1580|nM
5IAY|NMR|2016|16-mer|ligand is 16-mer Spacer peptide|Q96T88|E3 UBIQUITIN-PROTEIN LIGASE UHRF1|5.8|Kd=1.59uM|Kd|=|1.59|uM|1590|nM
5AIP|2.30|2016|4HP|ligand is 4-hydroxyphenylacetate (4-HPA)|Q7DD70|TRANSCRIPTIONAL REGULATOR, MARR FAMILY|2.82|Kd=1.5mM|Kd|=|1.5|mM|1500000|nM
5EEQ|1.60|2016|12-mer|ligand is Bicyclic Peptide Inhibitor (G7-B1)|Q14451|GROWTH FACTOR RECEPTOR-BOUND PROTEIN 7|5.82|Kd=1.5uM|Kd|=|1.5|uM|1500|nM
5ETK|1.09|2016|5RU|ligand is compound 18|P26281|2-AMINO-4-HYDROXY-6-HYDROXYMETHYLDIHYDROPTERIDINE|5.82|Kd=1.5uM|Kd|=|1.5|uM|1500|nM
5IL1|1.71|2016|SAM|ligand is AdoMet (SAM)|Q86U44|METTL3|5.82|Kd=1.5uM|Kd|=|1.5|uM|1500|nM
5T1M|2.53|2016|12-mer|ligand is CQYDLSTRRLKC|P01834|CETUXIMAB FAB, LIGHT CHAIN|5.82|Kd=1.5uM|Kd|=|1.5|uM|1500|nM
5E2Q|2.40|2016|8-mer|ligand is peptide angiotensin-II|Q9NY33|DIPEPTIDYL PEPTIDASE 3|5.79|Kd=1.64uM|Kd|=|1.64|uM|1640|nM
5ETA|2.80|2016|16-mer|ligand is KIM domain of the Toxoplasma protein GRA24 (GRA24 KIM1 peptide)|Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|5.8|Kd=1.6uM|Kd|=|1.6|uM|1600|nM
5IH2|1.80|2016|12-mer|ligand is proline-rich motifs in cAbl peptide (PRM758)|Q64010|ADAPTER MOLECULE CRK|5.76|Kd=1.72uM|Kd|=|1.72|uM|1720|nM
5AQN|2.45|2016|JG8|[Different protein in assay: crystal: HSC70/BAG1, binding assay:HSC70] Kd=1.7+/-0.6mM, HSC70/BAG1 Compound 7|P11142|HEAT SHOCK COGNATE 71 KDA PROTEIN|2.77|Kd=1.7mM|Kd|=|1.7|mM|1700000|nM
4Z0F|2.30|2016|13-mer|ligand is RON2hp [Phe2038(6CW)] peptide, sequence #11|------|APICAL MEMBRANE ANTIGEN 1|5.77|Kd=1.7uM|Kd|=|1.7|uM|1700|nM
5FSN|1.69|2016|6Q3|ligand is compound 6|P36639|7,8-DIHYDRO-8-OXOGUANINE TRIPHOSPHATASE|5.77|Kd=1.7uM|Kd|=|1.7|uM|1700|nM
5IZL|2.72|2016|GCP|ligand is GDPCP|P57772|SELENOCYSTEINE-SPECIFIC ELONGATION FACTOR|5.73|Kd=1.85uM|Kd|=|1.85|uM|1850|nM
5DLZ|1.70|2016|5D1|compound 1|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|5.74|Kd=1.8uM|Kd|=|1.8|uM|1800|nM
5EIS|1.60|2016|5OU|compound 5|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|5.74|Kd=1.8uM|Kd|=|1.8|uM|1800|nM
5FOS|1.35|2016|17-mer|ligand is RadA-OP peptide|O74036|DNA REPAIR AND RECOMBINATION PROTEIN RADA|5.74|Kd=1.8uM|Kd|=|1.8|uM|1800|nM
5H5Q|1.10|2016|15-mer|ligand is GXpep-1 peptide|P36969|PHOSPHOLIPID HYDROPEROXIDE GLUTATHIONE PEROXIDASE|5.74|Kd=1.8uM|Kd|=|1.8|uM|1800|nM
5HF1|1.75|2016|9-mer|ligand is a mutant C-terminal peptide derived from CRIPT (T-2F)|P31016|DISKS LARGE HOMOLOG 4|5.74|Kd=1.8uM|Kd|=|1.8|uM|1800|nM
5ITF|2.51|2016|12-mer|ligand is GQ(2-Br-F)DLSTRRLKG meditope peptide|P01834|CETUXIMAB FAB, LIGHT CHAIN|5.74|Kd=1.8uM|Kd|=|1.8|uM|1800|nM
5FSX|2.00|2016|ADP|ligand is ADP|C9ZP98|MACRODOMAIN|2.72|Kd=1.9mM|Kd|=|1.9|mM|1900000|nM
5IKB|2.05|2016|KAI|ligand is kainate|Q01812|GLUTAMATE RECEPTOR IONOTROPIC, KAINATE 4,GLUTAMATE RECEPTOR|8.72|Kd=1.9nM|Kd|=|1.9|nM|1.9|nM
5J74|2.70|2016|6GN|ligand is TO1-2p; Flow cytometry results|------|SCFV AM2.2|8.72|Kd=1.9nM|Kd|=|1.9|nM|1.9|nM
5DU8|2.23|2016|5FK|ligand is GSK572A|P9WNP1|PROBABLE ENOYL-COA HYDRATASE ECHA6|5.72|Kd=1.9uM|Kd|=|1.9|uM|1900|nM
5EKN|2.59|2016|N58|compound 58; assay by differential scanning fluorimetry (DSF)|O15264|MITOGEN-ACTIVATED PROTEIN KINASE 13|5.72|Kd=1.9uM|Kd|=|1.9|uM|1900|nM
5HFC|1.85|2016|9-mer|ligand is a mutant C-terminal peptide derived from CRIPT (T-2F)|P31016|DISKS LARGE HOMOLOG 4|5.72|Kd=1.9uM|Kd|=|1.9|uM|1900|nM
4Z07|2.50|2016|PCG|PKG1beta; Kd = 10.3 +/- 0.5 nM|Q13976|CGMP-DEPENDENT PROTEIN KINASE 1|7.99|Kd=10.3nM|Kd|=|10.3|nM|10.3|nM
5EHW|1.39|2016|5OO|compound 10|P00918|CARBONIC ANHYDRASE 2|3.0|Kd=1005uM|Kd|=|1005|uM|1005000|nM
5FPP|2.40|2016|HI6||P21836|ACETYLCHOLINESTERASE|4.0|Kd=100uM|Kd|=|100|uM|100000|nM
5G4N|1.35|2016|O83|compound 3|P04637|CELLULAR TUMOR ANTIGEN P53|4.0|Kd=101uM|Kd|=|101|uM|101000|nM
5J3V|3.05|2016|17-mer|[Different ligand in assay: Histone H3 (1-28) in assay] Histone H3 (11-27) in crystal, Histone H3 (1-28) in assay|Q92973|TRANSPORTIN-1,TRANSPORTIN-1|6.98|Kd=104.5nM|Kd|=|104.5|nM|104.5|nM
5JEK|2.40|2016|18-mer|pMAVS/IRF-3 complex, ligand is 18-mer pMAVS peptide|Q14653|INTERFERON REGULATORY FACTOR 3|3.98|Kd=104uM|Kd|=|104|uM|104000|nM
5C85|1.70|2016|4YO|compound 8|P55201|PEREGRIN|3.98|Kd=105uM|Kd|=|105|uM|105000|nM
4YX4|1.01|2016|FB2|compound 1|P00918|CARBONIC ANHYDRASE 2|5.97|Kd=1073.4nM|Kd|=|1073.4|nM|1073.4|nM
5FLQ|1.70|2016|IO2|compound 4|P00918|CARBONIC ANHYDRASE 2|2.97|Kd=1080uM|Kd|=|1080|uM|1080000|nM
5EQY|2.50|2016|5RA|compound 65|P35790|CHOLINE KINASE ALPHA|8.0|Kd=10nM|Kd|=|10|nM|10|nM
5T6J|1.75|2016|13-mer|ligand is protein DSN1 (560-572)|Q04477|KINETOCHORE PROTEIN SPC24|4.93|Kd=11.63uM|Kd|=|11.63|uM|11630|nM
5FNG|2.05|2016|YIE|compound 40|P00918|CARBONIC ANHYDRASE 2|2.96|Kd=1105uM|Kd|=|1105|uM|1105000|nM
5ICX|2.60|2016|16-mer|ligand is (AcN)-CQFDLSTRRLRCGGSK peptide|P01834|CETUXIMAB FAB, LIGHT CHAIN|6.96|Kd=110nM|Kd|=|110|nM|110|nM
5FOU|1.50|2016|6-mer|[Nonstandard assay: pH 6.0, 100 mM NaCl] ligand is FHPA TETRAPEPTIDE|O74036|DNA REPAIR AND RECOMBINATION PROTEIN RADA|3.95|Kd=113uM|Kd|=|113|uM|113000|nM
5KNJ|2.88|2016|6UX|ligand is compound 1|Q8NB16|MIXED LINEAGE KINASE DOMAIN-LIKE PROTEIN|6.94|Kd=116nM|Kd|=|116|nM|116|nM
4ZV2|1.43|2016|GLN|L-glutamine|------|ANCQR|2.93|Kd=1170uM|Kd|=|1170|uM|1170000|nM
4ZKI|3.40|2016|ADP|ADP|C6VIM1|HISTIDINE PROTEIN KINASE|2.92|Kd=1195uM|Kd|=|1195|uM|1195000|nM
4YHZ|2.30|2016|12-mer|ligand is H3K4me3 peptide|------|FAB HEAVY CHAIN|7.96|Kd=11nM|Kd|=|11|nM|11|nM
4RQI|2.44|2016|18-mer|ligand is peptide RAP1-YLP 89-106|Q15554|TELOMERIC REPEAT-BINDING FACTOR 2|4.91|Kd=12.3uM|Kd|=|12.3|uM|12300|nM
5HBN|1.60|2016|RPI|ligand is phospho-arginine (pArgAA)|P37571|NEGATIVE REGULATOR OF GENETIC COMPETENCE CLPC/MECB|4.89|Kd=12.9uM|Kd|=|12.9|uM|12900|nM
5II2|2.10|2016|LU2|compound 15, according to structure in RCSB PDB|Q86U86|PROTEIN POLYBROMO-1|4.89|Kd=12.9uM|Kd|=|12.9|uM|12900|nM
5T1I|1.60|2016|15-mer|+/-36.2, HP1gamma_110-176/H3(38-52)|Q13185|CHROMOBOX PROTEIN HOMOLOG 3|3.92|Kd=121.5uM|Kd|=|121.5|uM|121500|nM
5FLT|1.67|2016|VJJ|compound 3|P00918|CARBONIC ANHYDRASE 2|2.89|Kd=1280uM|Kd|=|1280|uM|1280000|nM
5GJD|2.79|2016|6V3|compound 2; SPR Kd available|O43318|TAK1 KINASE - TAB1 CHIMERA FUSION PROTEIN|7.92|Kd=12nM|Kd|=|12|nM|12|nM
5I1Q|1.50|2016|67C|compound 5; BROMOscan bromodomain selectivity data|P21675|TRANSCRIPTION INITIATION FACTOR TFIID SUBUNIT 1|7.92|Kd=12nM|Kd|=|12|nM|12|nM
5D3T|1.93|2016|56Y|compound 16|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|4.92|Kd=12uM|Kd|=|12|uM|12000|nM
5EZG|1.84|2016|5T4|compound 22|P9WMC0|HTH-TYPE TRANSCRIPTIONAL REGULATOR ETHR|4.92|Kd=12uM|Kd|=|12|uM|12000|nM
5F1J|1.63|2016|5TO|compound 1|P9WMC0|HTH-TYPE TRANSCRIPTIONAL REGULATOR ETHR|4.92|Kd=12uM|Kd|=|12|uM|12000|nM
5ETU|2.53|2016|12-mer|ligand is L5E meditope variant, CQFDESTRRLKC|P01834|CETUXIMAB FAB, LIGHT CHAIN|3.89|Kd=130uM|Kd|=|130|uM|130000|nM
5EQE|2.40|2016|5R8|compound 11|P35790|CHOLINE KINASE ALPHA|3.88|Kd=132uM|Kd|=|132|uM|132000|nM
5J0D|1.05|2016|6F9|ligand is compound 102|Q92793|CREB-BINDING PROTEIN|6.87|Kd=134nM|Kd|=|134|nM|134|nM
5IYV|2.56|2016|12-mer|ligand is peptide hormone IDL1|P47735|RECEPTOR-LIKE PROTEIN KINASE 5|3.87|Kd=135uM|Kd|=|135|uM|135000|nM
5FH7|1.47|2016|5XL|ligand is compound 18|Q86U86|PROTEIN POLYBROMO-1|6.86|Kd=137nM|Kd|=|137|nM|137|nM
5G4M|1.38|2016|O82|compound 2|P04637|CELLULAR TUMOR ANTIGEN P53|3.86|Kd=138uM|Kd|=|138|uM|138000|nM
5CSD|1.45|2016|ACD|[Multiple sites: site 1:13nM; site 2: 2.3uM] Mp1p-LBD2-1AA|------|ENVELOPE GLYCOPROTEIN|7.89|Kd=13nM|Kd|=|13|nM|13|nM
5FB7|1.50|2016|ACD|[Multiple sites: site 1:13nM; site 2: 2.3uM] Mp1p-LBD2-2AA|------|ENVELOPE GLYCOPROTEIN|7.89|Kd=13nM|Kd|=|13|nM|13|nM
5L3A|1.98|2016|6DP|ligand is compound 1|O60674|TYROSINE-PROTEIN KINASE JAK2|4.89|Kd=13uM|Kd|=|13|uM|13000|nM
5F1H|1.82|2016|5U6|compound 2 (BI-9564)|Q9H8M2|BROMODOMAIN-CONTAINING PROTEIN 9|7.85|Kd=14.1nM|Kd|=|14.1|nM|14.1|nM
4YJE|1.90|2016|11-mer|ligand is peptide Amer1-A1 (325-335)|P25054|ADENOMATOUS POLYPOSIS COLI PROTEIN|4.84|Kd=14.4uM|Kd|=|14.4|uM|14400|nM
5IE1|2.30|2016|6BS|ligand is compound 5|P56817|BETA-SECRETASE 1|6.85|Kd=140nM|Kd|=|140|nM|140|nM
5BTV|1.70|2016|4-mer|ligand is a 4-mer Tau-pS324 peptide; MST assays|P31947|14-3-3 PROTEIN SIGMA|3.85|Kd=140uM|Kd|=|140|uM|140000|nM
5THA|1.80|2016|GP3|kd=140+/-30uM, ligand is GpppG.|Q8TEQ6|GEM-ASSOCIATED PROTEIN 5|3.85|Kd=140uM|Kd|=|140|uM|140000|nM
4YC8|2.90|2016|4B7|ligand is DAS-CHO-I; assay by KINOMEscan service|P00519|TYROSINE-PROTEIN KINASE ABL1|7.85|Kd=14nM|Kd|=|14|nM|14|nM
5EWK|1.60|2016|P34|inhibitor PJ34|C9Z6T8|PUTATIVE ADP-RIBOSYLTRANSFERASE SCABIN|4.85|Kd=14uM|Kd|=|14|uM|14000|nM
5F90|1.64|2016|4-mer|ligand is Gb3 allyl; ligand name is GAL-BGC-GLA-5VQ|H2FH31|GALNAC/GAL-SPECIFIC LECTIN|4.85|Kd=14uM|Kd|=|14|uM|14000|nM
5EU1|1.60|2016|5SW|compound 1 (BI-7273)|Q9H8M2|BROMODOMAIN-CONTAINING PROTEIN 9|7.81|Kd=15.4nM|Kd|=|15.4|nM|15.4|nM
5IY4|2.95|2016|16-mer|ligand is PIP box of DVC1 peptide|P12004|PROLIFERATING CELL NUCLEAR ANTIGEN|4.81|Kd=15.55uM|Kd|=|15.55|uM|15550|nM
5JEO|1.72|2016|19-mer|ligand is 19-mer Phosphorylated Rotavirus NSP1 peptide|Q14653|ROTAVIRUS NSP1 PEPTIDE|4.8|Kd=15.8uM|Kd|=|15.8|uM|15800|nM
5EXW|1.90|2016|7DT|ligand is 7-deazaATP|P11021|78 KDA GLUCOSE-REGULATED PROTEIN|6.82|Kd=150nM|Kd|=|150|nM|150|nM
5HTC|1.50|2016|66M|inhibitor ARC-3372|Q8TF76|SERINE/THREONINE-PROTEIN KINASE HASPIN|6.82|Kd=150nM|Kd|=|150|nM|150|nM
5HYQ|2.48|2016|12-mer|ligand is amidated meditope; CQFDLSTRRLKC-(Am)|P01834|CETUXIMAB FAB, LIGHT CHAIN|6.82|Kd=150nM|Kd|=|150|nM|150|nM
5ETX|2.35|2016|5RS|ligand is compound 5172-Linear|C1KIK8|NS3 PROTEASE|6.81|Kd=154.3nM|Kd|=|154.3|nM|154.3|nM
4YB7|2.20|2016|ATP|[Multiple sites: ] Kd = 158 +/- 13 uMligand is His|Q5HSJ4|ATP PHOSPHORIBOSYLTRANSFERASE|3.8|Kd=158uM|Kd|=|158|uM|158000|nM
5FOV|1.74|2016|6-mer|[Nonstandard assay: pH 6.0, 100 mM NaCl] ligand is FHTG TETRAPEPTIDE|O74036|DNA REPAIR AND RECOMBINATION PROTEIN RADA|2.8|Kd=1590uM|Kd|=|1590|uM|1590000|nM
4YBK|2.50|2016|4B7|ligand is DAS-CHO-I; assay by KINOMEscan service|P00523|TYROSINE-PROTEIN KINASE SRC|7.82|Kd=15nM|Kd|=|15|nM|15|nM
5I29|1.21|2016|67B|compound 2; BROMOscan bromodomain selectivity data|P21675|TRANSCRIPTION INITIATION FACTOR TFIID SUBUNIT 1|7.82|Kd=15nM|Kd|=|15|nM|15|nM
5D7X|1.35|2016|XZ8|compound 1b; BROMOscan assays|P55201|PEREGRIN|4.82|Kd=15uM|Kd|=|15|uM|15000|nM
5GGL|1.27|2016|6ZC|ligand is pNP-alpha-GlcNAc|Q8WZA1|PROTEIN O-LINKED-MANNOSE BETA-1,2-N|1.78|Kd=16.52mM|Kd|=|16.52|mM|16520000|nM
5A3R|3.05|2016|DL5|Ligand is TNP-AMPPCP|P04191|SARCOPLASMIC/ENDOPLASMIC RETICULUM CALCIUM ATPASE 1|7.78|Kd=16.7nM|Kd|=|16.7|nM|16.7|nM
5ESQ|2.55|2016|12-mer|ligand is Cyclic beta-alanine-linked meditope, AQFDLSTRRLKA|P01834|CETUXIMAB FAB, LIGHT CHAIN|5.8|Kd=1600nM|Kd|=|1600|nM|1600|nM
5FBI|1.47|2016|5WD|compound 4; NMR Kd available|P00746|COMPLEMENT FACTOR D|2.8|Kd=1600uM|Kd|=|1600|uM|1600000|nM
5ETF|2.40|2016|15-mer|[Different protein in assay: protein in bindng assay is wild type] ligand is KIM domain of MKK6|Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|3.79|Kd=161.5uM|Kd|=|161.5|uM|161500|nM
5AQF|1.88|2016|ADN|[Different protein in assay: crystal: HSC70/BAG1, binding assay:HSC70] Kd=165+/-37uM, HSC70/BAG1 Adenosine|P11142|HEAT SHOCK COGNATE 71 KDA PROTEIN|3.78|Kd=165uM|Kd|=|165|uM|165000|nM
5I3V|1.62|2016|68M|ligand is compound 1|P56817|BETA-SECRETASE 1|7.8|Kd=16nM|Kd|=|16|nM|16|nM
5JQ7|2.69|2016|T0R|[Nonstandard assay: assay at PH=5.2] ligand is toremifene; Kd by thermal-shift assay|Q05320|ENVELOPE GLYCOPROTEIN 1|4.8|Kd=16uM|Kd|=|16|uM|16000|nM
5CKR|2.95|2016|57M|ligand is Muraymycin D2|O66465|PHOSPHO-N-ACETYLMURAMOYL-PENTAPEPTIDE-TRANSFERASE|7.76|Kd=17.2nM|Kd|=|17.2|nM|17.2|nM
5LP6|2.90|2016|71P|[Different protein in assay: crystal: tubulin:RB3:TTL, binding assay:tubulin] Kd=17.2+/-2.5uM, T2ReTTL in complex with TH|P81947|TUBULIN ALPHA-1B CHAIN|4.76|Kd=17.2uM|Kd|=|17.2|uM|17200|nM
5LNE|2.20|2016|2-mer|ligand is Thomsen-Friedenreich (TF) antigen; also named Gal-beta1-3GalNAc (A2G-GAL)|Q1RBS0|PUTATIVE FML FIMBRIAL ADHESIN FMLD|4.76|Kd=17.43uM|Kd|=|17.43|uM|17430|nM
5GGJ|1.42|2016|PNA|ligand is pNP-alpha-Man|Q8WZA1|PROTEIN O-LINKED-MANNOSE BETA-1,2-N|1.75|Kd=17.78mM|Kd|=|17.78|mM|17780000|nM
5FWR|2.13|2016|3X8|same as 4x50|I6BD60|FIMH PROTEIN|7.75|Kd=17.7nM|Kd|=|17.7|nM|17.7|nM
5ID0|2.48|2016|11-mer|ligand is (AHA)QFDLSTRRLK peptide|P01834|CETUXIMAB FAB, LIGHT CHAIN|5.77|Kd=1700nM|Kd|=|1700|nM|1700|nM
5FH8|1.55|2016|5XK|ligand is compound 28|Q86U86|PROTEIN POLYBROMO-1|6.77|Kd=170nM|Kd|=|170|nM|170|nM
5HTB|1.70|2016|6L5|inhibitor ARC-3353|Q8TF76|SERINE/THREONINE-PROTEIN KINASE HASPIN|6.77|Kd=170nM|Kd|=|170|nM|170|nM
5EWH|1.63|2016|5SG|compound 7|P55201|PEREGRIN|3.77|Kd=170uM|Kd|=|170|uM|170000|nM
4YHM|2.16|2016|4CC|aDabi-Fab2b: Dabigatran complex|------|ADABI-FAB2B HEAVY CHAIN|9.76|Kd=173pM|Kd|=|173|pM|0.17300000000000001|nM
5ER4|1.81|2016|5RL|ligand is compound SC0025|P02638|PROTEIN S100-B|2.76|Kd=1752uM|Kd|=|1752|uM|1752000|nM
5KLT|2.60|2016|16-mer|Kd = 175 +/- 35 nM. ligand is peptide P4[M]|P52293|IMPORTIN SUBUNIT ALPHA-1|6.76|Kd=175nM|Kd|=|175|nM|175|nM
5HBS|.89|2016|RTL|ligand is all-trans-retinol|P09455|RETINOL-BINDING PROTEIN 1|7.73|Kd=18.5nM|Kd|=|18.5|nM|18.5|nM
5TCA|3.15|2016|J55|ligand is JH3; BLI assay|P00746|COMPLEMENT FACTOR D|7.72|Kd=18.85nM|Kd|=|18.85|nM|18.85|nM
4YK0|1.65|2016|98|ligand is CPI098|Q92793|CREB-BINDING PROTEIN|3.74|Kd=181uM|Kd|=|181|uM|181000|nM
5FV7|2.84|2016|R3Z|compound 1|P39748|FLAP ENDONUCLEASE 1|6.74|Kd=182nM|Kd|=|182|nM|182|nM
5KHJ|2.01|2016|6SY|ligand is uridine-3', 5'-cyclic monophosphate (cUMP)|O88703|POTASSIUM/SODIUM HYPERPOLARIZATION-ACTIVATED CYCLIC|3.74|Kd=183.8uM|Kd|=|183.8|uM|183800|nM
5I8P|2.37|2016|VQ7|ligand is compound 1|Q13093|PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE|6.73|Kd=185nM|Kd|=|185|nM|185|nM
5IA0|1.95|2016|A5B|ligand is alisertib (MLN8237)|P29317|EPHRIN TYPE-A RECEPTOR 2|6.73|Kd=187nM|Kd|=|187|nM|187|nM
4YHO|1.82|2016|4CC|ligand is Dabigatran|------|ADABI-FAB3 HEAVY CHAIN|10.74|Kd=18pM|Kd|=|18|pM|0.018000000000000002|nM
5K03|1.81|2016|6P4|ligand is compound 2|P22734|CATECHOL O-METHYLTRANSFERASE|4.74|Kd=18uM|Kd|=|18|uM|18000|nM
4YB5|2.24|2016|HIS|[Multiple sites: Kd = 19.3 +/- 0.2 uM, 14.5 +/- 0.2 uM, 36 +/-1 uM, 50 +/- 1 uM, 47 +/- 1 uM. sequential binding model (five events)] ligand is His|Q5HSJ4|ATP PHOSPHORIBOSYLTRANSFERASE|4.71|Kd=19.3uM|Kd|=|19.3|uM|19300|nM
5HIS|1.77|2016|60P|compound 3|P20581|PQSE|4.71|Kd=19.6uM|Kd|=|19.6|uM|19600|nM
5L9G|1.75|2016|MO0|ligand is mannopine|------|PERIPLASMIC BINDING PROTEIN|7.7|Kd=19.8nM|Kd|=|19.8|nM|19.8|nM
5IA2|1.62|2016|L66|ligand is compound 66|P29317|EPHRIN TYPE-A RECEPTOR 2|7.72|Kd=19nM|Kd|=|19|nM|19|nM
5KLR|2.20|2016|16-mer|Kd = 19 +/- 4 nM. ligand is peptide P4[R]|P52293|IMPORTIN SUBUNIT ALPHA-1|7.72|Kd=19nM|Kd|=|19|nM|19|nM
5HJQ|2.30|2016|I3P|ligand is inositol(1,4,5)triphosphate; IP3|Q9VIH7|LD10117P|4.72|Kd=19uM|Kd|=|19|uM|19000|nM
5AQR|1.91|2016|N8Y|[Different protein in assay: crystal: HSC70/BAG1, binding assay:HSC70] Kd=1.0+/-0.09mM, HSC70/BAG1 Compound 16|P11142|HEAT SHOCK COGNATE 71 KDA PROTEIN|3.0|Kd=1mM|Kd|=|1|mM|1000000|nM
5EKJ|1.13|2016|TG4|compound 3|P00918|CARBONIC ANHYDRASE 2|6.0|Kd=1uM|Kd|=|1|uM|1000|nM
5F0F|1.76|2016|5TD|compound 15|P9WMC0|HTH-TYPE TRANSCRIPTIONAL REGULATOR ETHR|6.0|Kd=1uM|Kd|=|1|uM|1000|nM
5EYZ|2.09|2016|13-mer|ligand is tailored peptide Cyto8-RETEV|P29074|TYROSINE-PROTEIN PHOSPHATASE NON-RECEPTOR TYPE 4|6.0|Kd=1uM|Kd|=|1|uM|1000|nM
5F1R|2.25|2016|42O|compound 1|P22262|LISTERIOLYSIN REGULATORY PROTEIN|6.0|Kd=1uM|Kd|=|1|uM|1000|nM
4YK6|1.70|2016|11-mer|ligand is peptide Amer1-A4 (365-375)|Q5JTC6|APC MEMBRANE RECRUITMENT PROTEIN 1|5.7|Kd=2.0uM|Kd|=|2|uM|2000|nM
4YSI|1.02|2016|8-mer|ligand is 8-mer WT vIRF1 peptide|Q93009|UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 7|5.7|Kd=2.0uM|Kd|=|2|uM|2000|nM
5ELD|1.40|2016|5-mer|ligand is A-penta-BGA (A2G-NDG-NAG-GAL-FUC)|Q57193|CHOLERA ENTEROTOXIN SUBUNIT B|2.66|Kd=2.19mM|Kd|=|2.19|mM|2190000|nM
5AQP|2.08|2016|1LQ|[Different protein in assay: crystal: HSC70/BAG1, binding assay:HSC70] Kd=2.1+/-0.6mM, HSC70/BAG1 Compound 10|P11142|HEAT SHOCK COGNATE 71 KDA PROTEIN|2.68|Kd=2.1mM|Kd|=|2.1|mM|2100000|nM
5A3S|3.30|2016|128|ligand is TNP-ATP; another ligand thapsigargin in crystal|P04191|SARCOPLASMIC/ENDOPLASMIC RETICULUM CALCIUM ATPASE 1|8.68|Kd=2.1nM|Kd|=|2.1|nM|2.1|nM
5HJB|2.70|2016|8-mer|ligand is H3K9cr peptide|P42568|PROTEIN AF-9|5.68|Kd=2.1uM|Kd|=|2.1|uM|2100|nM
5TCC|3.37|2016|J56|ligand is JH4; BLI assay|P00746|COMPLEMENT FACTOR D|5.66|Kd=2.21uM|Kd|=|2.21|uM|2210|nM
5EY0|1.60|2016|GTP||A7X1N2|GTP-SENSING TRANSCRIPTIONAL PLEIOTROPIC REPRESSOR CODY|2.65|Kd=2.26mM|Kd|=|2.26|mM|2260000|nM
5EPN|2.30|2016|5R2|ligand is compound 5172-mcP1P3|C1KIK8|NS3/4A PROTEASE|8.66|Kd=2.2nM|Kd|=|2.2|nM|2.2|nM
5HGC|2.43|2016|HCY|ligand is cortisol|H0ZQY2|SERPIN|8.66|Kd=2.2nM|Kd|=|2.2|nM|2.2|nM
5D6Y|2.29|2016|10-mer|ligand is peptide histone H3K23me3|O75164|LYSINE-SPECIFIC DEMETHYLASE 4A|5.66|Kd=2.2uM|Kd|=|2.2|uM|2200|nM
5HEY|1.50|2016|9-mer|ligand is a C-terminal peptide derived from CRIPT|P31016|DISKS LARGE HOMOLOG 4|5.66|Kd=2.2uM|Kd|=|2.2|uM|2200|nM
5D0C|1.49|2016|E0B|compound 42|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|5.63|Kd=2.340uM|Kd|=|2.34|uM|2340|nM
5C4L|2.35|2016|SIS|ligand is sisomicin|O68183|"APH(2"")-ID"|5.64|Kd=2.3uM|Kd|=|2.3|uM|2300|nM
5L0H|2.90|2016|PIO|ligand is PIP2|P18206|VINCULIN|5.64|Kd=2.3uM|Kd|=|2.3|uM|2300|nM
5G46|1.76|2016|6VD|ligand is CT49|P51449|NUCLEAR RECEPTOR ROR-GAMMA|2.6|Kd=2.5mM|Kd|=|2.5|mM|2500000|nM
5A3Q|3.05|2016|DL5|ligand is TNP-AMPPCP; another ligand thapsigargin in crystal|P04191|SARCOPLASMIC/ENDOPLASMIC RETICULUM CALCIUM ATPASE 1|8.6|Kd=2.5nM|Kd|=|2.5|nM|2.5|nM
5EJE|1.90|2016|AP5|[Multiple sites: site1:Kd=2.5uM; site2:Kd=250uM] Ap5a-bound AdKcc,ox|A7ZIN4|ADENYLATE KINASE|5.6|Kd=2.5uM|Kd|=|2.5|uM|2500|nM
5KHD|1.75|2016|C2E|ligans is c-di-GMP|F2RCL8|DNA-BINDING PROTEIN|5.6|Kd=2.5uM|Kd|=|2.5|uM|2500|nM
5D1N|2.71|2016|SAH|ligand is SAH|C7Q5P8|UNCHARACTERIZED PROTEIN|5.57|Kd=2.7uM|Kd|=|2.7|uM|2700|nM
5EM9|1.60|2016|8-mer|ligand is phosphorylated C-terminal 5HT4(a)R PDZ binding motif; p5-HT4(a)R|Q8K4V4|SORTING NEXIN-27|5.57|Kd=2.7uM|Kd|=|2.7|uM|2700|nM
5ETO|1.07|2016|5RY|ligand is compound 50|P26281|2-AMINO-4-HYDROXY-6-HYDROXYMETHYLDIHYDROPTERIDINE|5.57|Kd=2.7uM|Kd|=|2.7|uM|2700|nM
5I9Y|1.23|2016|1N1|ligand is Dasatinib|P29317|EPHRIN TYPE-A RECEPTOR 2|8.55|Kd=2.8nM|Kd|=|2.8|nM|2.8|nM
5SVL|2.90|2016|ATP|ligand is ATP; scintillation proximity assays (SPA)|P56373|P2X PURINOCEPTOR 3|8.55|Kd=2.8nM|Kd|=|2.8|nM|2.8|nM
5DUS|1.43|2016|APR|ligand is ADP-ribose|T2B9G2|ORF1A|5.53|Kd=2.95uM|Kd|=|2.95|uM|2950|nM
5SXM|2.00|2016|8-mer||P61964|WD REPEAT-CONTAINING PROTEIN 5|8.54|Kd=2.9nM|Kd|=|2.9|nM|2.9|nM
5KHG|2.24|2016|CC7|ligand is cytidine-3', 5'-cyclic monophosphate (cCMP)|O88703|POTASSIUM/SODIUM HYPERPOLARIZATION-ACTIVATED CYCLIC|4.69|Kd=20.23uM|Kd|=|20.23|uM|20230|nM
5FE9|2.35|2016|5WS|[Nonstandard assay: ITC at Temp 15C] compound SL1122 (compound 13)|Q92831|HISTONE ACETYLTRANSFERASE KAT2B|4.68|Kd=20.98uM|Kd|=|20.98|uM|20980|nM
5G43|2.58|2016|5IM|ligand is CT16|P51449|NUCLEAR RECEPTOR ROR-GAMMA|3.7|Kd=200uM|Kd|=|200|uM|200000|nM
5DKN|1.53|2016|B7I|compound 5a (SBi4225); Kd calculated from fluorescent polarization competition assay (FPCA) IC50 data|P02638|PROTEIN S100-B|3.69|Kd=202.6uM|Kd|=|202.6|uM|202600|nM
5A6X|1.55|2016|MFU|ligand is alpha-methyl-fucoside, compound 2|U8MRX2|FUCOSE-BINDING LECTIN PA-IIL|6.69|Kd=202nM|Kd|=|202|nM|202|nM
5FS5|1.42|2016|KGM|ligand is HM|A2IC68|FIMH PROTEIN|6.69|Kd=206.4nM|Kd|=|206.4|nM|206.4|nM
5IXQ|1.86|2016|12-mer|ligand is peptide hormone IDA; Kd=20+/-0.9 uM|P47735|RECEPTOR-LIKE PROTEIN KINASE 5|4.7|Kd=20uM|Kd|=|20|uM|20000|nM
5LVN|1.38|2016|ADN|ligand is Adenosine|O15530|3-PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE 1|4.7|Kd=20uM|Kd|=|20|uM|20000|nM
5TDW|1.70|2016|11-mer|ligand is H3K4me3 peptide|P36124|SET DOMAIN-CONTAINING PROTEIN 3|4.7|Kd=20uM|Kd|=|20|uM|20000|nM
5AQJ|1.96|2016|Q88|[Different protein in assay: crystal: HSC70/BAG1, binding assay:HSC70] Kd=2100+/-170uM, HSC70/BAG1 Compound 6|P11142|HEAT SHOCK COGNATE 71 KDA PROTEIN|2.68|Kd=2100uM|Kd|=|2100|uM|2100000|nM
5L2W|2.80|2016|1QK|ligand is compound Dinaciclib|P24941|CYCLIN-DEPENDENT KINASE 2|6.68|Kd=210nM|Kd|=|210|nM|210|nM
5F3T|2.05|2016|5UH|[Nonstandard assay: SPR at Temp 4C] ligand is compound JF-31-MG46|Q6DLV0|RNA-DEPENDENT RNA POLYMERASE|3.68|Kd=210uM|Kd|=|210|uM|210000|nM
5FOG|2.30|2016|VRT|ligand is Nva2AA|B6AA20|LEUCYL-TRNA SYNTHETASE|3.67|Kd=213uM|Kd|=|213|uM|213000|nM
5ER5|1.26|2016|ET|ligand is SC1990; should has a Br- iron in ligand|P02638|PROTEIN S100-B|3.67|Kd=215.4uM|Kd|=|215.4|uM|215400|nM
5FOL|1.77|2016|SO8|ligand is Ile2AA|B6AA20|LEUCYL-TRNA SYNTHETASE|3.67|Kd=215uM|Kd|=|215|uM|215000|nM
4D7B|1.15|2016|TCW|[Multiple sites: site 1: Kd=21 nM; site 2: Kd=58 nM] ligand is tolcapone; two ligand-binding sites|P02766|TRANSTHYRETIN|7.68|Kd=21nM|Kd|=|21|nM|21|nM
5EQ1|1.55|2016|BEA|compound 1|P55201|PEREGRIN|4.68|Kd=21uM|Kd|=|21|uM|21000|nM
5AWU|2.70|2016|11-mer|ligand is 11-mer peptide Eps15-645-654|Q9BQI5|SH3-CONTAINING GRB2-LIKE PROTEIN 3-INTERACTING PROTEIN 1|4.65|Kd=22.4uM|Kd|=|22.4|uM|22400|nM
5KLP|2.00|2016|IHP|[Different protein in assay: ten mutations in protein] ligand is IP6; ten mutations to facilitate crystal-packing interactions|Q6VE93|ORF34|4.64|Kd=22.7uM|Kd|=|22.7|uM|22700|nM
5KH7|1.70|2016|6T7|Kd = 220 +/- 20 uM. ligand is compound 3|Q9UBN7|HISTONE DEACETYLASE 6|3.66|Kd=220uM|Kd|=|220|uM|220000|nM
5AQK|2.09|2016|GDP|[Different protein in assay: crystal: HSC70/BAG1, binding assay:HSC70] HSC70/BAG1 GDP|P11142|HEAT SHOCK COGNATE 71 KDA PROTEIN|3.65|Kd=223uM|Kd|=|223|uM|223000|nM
5JI8|1.42|2016|6KT|ligand is compound 1, pKd=4.63|Q9H8M2|BROMODOMAIN-CONTAINING PROTEIN 9|4.63|Kd=23.4uM|Kd|=|23.4|uM|23400|nM
5KO1|2.16|2016|6UY|ligand is compound 4|Q8NB16|MIXED LINEAGE KINASE DOMAIN-LIKE PROTEIN|6.64|Kd=230nM|Kd|=|230|nM|230|nM
5HOG|3.09|2016|17-mer|ligand is CIP-Box Motif of the Dna2 Nuclease (207-223)|Q01454|DNA POLYMERASE ALPHA-BINDING PROTEIN|3.64|Kd=230uM|Kd|=|230|uM|230000|nM
5ETL|1.82|2016|5RV|ligand is compound 24|P26281|2-AMINO-4-HYDROXY-6-HYDROXYMETHYLDIHYDROPTERIDINE|4.64|Kd=23uM|Kd|=|23|uM|23000|nM
5HU9|1.53|2016|66K|ligand is CHMFL-074; MST assay|P00519|TYROSINE-PROTEIN KINASE ABL1|7.62|Kd=24.2nM|Kd|=|24.2|nM|24.2|nM
5SYN|1.64|2016|71T|ligand is ML349; FP Kd data available|O95372|ACYL-PROTEIN THIOESTERASE 2|6.62|Kd=240nM|Kd|=|240|nM|240|nM
5EZH|1.70|2016|841|compound 21|P9WMC0|HTH-TYPE TRANSCRIPTIONAL REGULATOR ETHR|4.62|Kd=24uM|Kd|=|24|uM|24000|nM
5FSL|1.25|2016|UAN|Kd=24+/-0.4uM, ligand is compound 3|P36639|7,8-DIHYDRO-8-OXOGUANINE TRIPHOSPHATASE|4.62|Kd=24uM|Kd|=|24|uM|24000|nM
5I88|1.40|2016|69G|compound 4; BROMOscan bromodomain selectivity data|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|6.6|Kd=250nM|Kd|=|250|nM|250|nM
5LVR|2.05|2016|78Y|Kd=250+/-10uM; PCAF/CPD-E|Q92831|HISTONE ACETYLTRANSFERASE KAT2B|3.6|Kd=250uM|Kd|=|250|uM|250000|nM
5D2A|2.13|2016|12-mer|ligand is (Het2G1-Cys)2 dendrimer|Q9HYN5|FUCOSE-BINDING LECTIN PA-IIL|5.59|Kd=2570nM|Kd|=|2570|nM|2570|nM
5I8C|1.54|2016|9-mer|ligand is HIV-1 Clade A BG505 Fusion Peptide (residue 512-520)|------|VRC34.01 FAB HEAVY CHAIN|7.6|Kd=25nM|Kd|=|25|nM|25|nM
5IA5|1.78|2016|GV0|ligand is golvatinib (E7050)|P29317|EPHRIN TYPE-A RECEPTOR 2|7.6|Kd=25nM|Kd|=|25|nM|25|nM
5IXT|1.94|2016|17-mer|ligand is N-terminal extended IDA peptide hormone PKGV-IDA|P47735|RECEPTOR-LIKE PROTEIN KINASE 5|4.6|Kd=25uM|Kd|=|25|uM|25000|nM
4XTM|2.70|2016|A2G|GalNAc; Kd = 26.97 +/- 0.89 uM|P81371|SEED LECTIN|4.57|Kd=26.97uM|Kd|=|26.97|uM|26970|nM
5HFB|1.62|2016|9-mer|ligand is a C-terminal peptide derived from CRIPT|P31016|DISKS LARGE HOMOLOG 4|4.57|Kd=26.9uM|Kd|=|26.9|uM|26900|nM
5C4K|3.05|2016|GET|ligand is G418|O68183|"APH(2"")-ID"|4.56|Kd=27.5uM|Kd|=|27.5|uM|27500|nM
5IQL|2.10|2016|8-mer|[Different ligand in assay: ITC assay use H3(15-39)K27cr peptide] ligand is H3(24-31)K27cr peptide, ITC assay is for H3(15-39)K27cr peptide|Q9ULM3|YEATS DOMAIN-CONTAINING PROTEIN 2|4.56|Kd=27.5uM|Kd|=|27.5|uM|27500|nM
5EVZ|1.85|2016|ADP|ligand is ADP|P11021|78 KDA GLUCOSE-REGULATED PROTEIN|6.57|Kd=270nM|Kd|=|270|nM|270|nM
5CSH|1.59|2016|54E|compound 4|P68400|CASEIN KINASE II, ALPHA SUBUNIT|3.57|Kd=270uM|Kd|=|270|uM|270000|nM
5JR2|1.75|2016|13-mer|ligand is APYd3 peptide inhibitor (17)|P54764|EPHRIN TYPE-A RECEPTOR 4|7.57|Kd=27nM|Kd|=|27|nM|27|nM
4ZS9|1.37|2016|RAF|Kd=27+/-2uM, complex is BlG16BP/raffinose|C6A9Y6|SUGAR BINDING PROTEIN OF ABC TRANSPORTER SYSTEM|4.57|Kd=27uM|Kd|=|27|uM|27000|nM
5C2O|2.35|2016|TTP|dTTP|Q8DSE5|PUTATIVE DEOXYCYTIDYLATE DEAMINASE|4.55|Kd=28.2uM|Kd|=|28.2|uM|28200|nM
5CXI|2.00|2016|5TW|ligand is 4-BNC-CoA|P96856|HTH-TYPE TRANSCRIPTIONAL REPRESSOR KSTR|6.55|Kd=280nM|Kd|=|280|nM|280|nM
5DTS|1.94|2016|5F8|compound 2|Q6XEC0|BETA-LACTAMASE|3.55|Kd=280uM|Kd|=|280|uM|280000|nM
5DVA|2.50|2016|5FL|compound 1|Q6XEC0|BETA-LACTAMASE|3.55|Kd=280uM|Kd|=|280|uM|280000|nM
5FPK|1.34|2016|6-mer|[Nonstandard assay: pH 6.0, 100 mM NaCl] ligand is FATA TETRAPEPTIDE|O74036|DNA REPAIR AND RECOMBINATION PROTEIN RADA|3.55|Kd=280uM|Kd|=|280|uM|280000|nM
5B56|2.30|2016|12-mer|[Multiple sites: site 1: Kd=29.1 uM; site 2: Kd=3.2 mM] ligand is HIV-1 VPR C-Terminal domain (85-96)|P52293|IMPORTIN SUBUNIT ALPHA-1|4.54|Kd=29.1uM|Kd|=|29.1|uM|29100|nM
5HES|2.14|2016|032|[Nonstandard assay: ITC at Temp 37C] ligand is Vemurafenib|Q9NYL2|MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE MLT|7.54|Kd=29nM|Kd|=|29|nM|29|nM
5ETB|1.33|2016|5RO|compound 15|P55201|PEREGRIN|4.54|Kd=29uM|Kd|=|29|uM|29000|nM
5F3Z|2.00|2016|5V5|[Nonstandard assay: SPR at Temp 4C] ligand is compound PC-79-SH52|Q6DLV0|GENOME POLYPROTEIN|4.54|Kd=29uM|Kd|=|29|uM|29000|nM
5IOP|2.50|2016|12-mer|ligand is GQ(4-Br-F)DLSTRRLKG meditope peptide|P01834|CETUXIMAB FAB, LIGHT CHAIN|4.54|Kd=29uM|Kd|=|29|uM|29000|nM
5TDR|1.42|2016|11-mer|ligand is H3K4me2 peptide; Kd data from ref.16|P36124|SET DOMAIN-CONTAINING PROTEIN 3|4.54|Kd=29uM|Kd|=|29|uM|29000|nM
4YHP|2.53|2016|16-mer|ligand is H3K9me3 peptide, use peptide IP assay.|------|H3K9ME3 PEPTIDE|8.7|Kd=2nM|Kd|=|2|nM|2|nM
5DLX|1.90|2016|5D2|compound 2|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|5.7|Kd=2uM|Kd|=|2|uM|2000|nM
5ELQ|1.10|2016|8-mer|ligand is 8-mer C-terminal DGKzeta PDZ binding motif|Q8K4V4|SORTING NEXIN-27|5.7|Kd=2uM|Kd|=|2|uM|2000|nM
5LZ4|2.07|2016|7BW|ligand is compound 13; ITC data available|Q13093|PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE|5.7|Kd=2uM|Kd|=|2|uM|2000|nM
4ZGK|2.00|2016|4NX|compound 2a; MST assay|Q00987|E3 UBIQUITIN-PROTEIN LIGASE MDM2|5.51|Kd=3.1uM|Kd|=|3.1|uM|3100|nM
5CKS|2.12|2016|52L|ligand is DAHP Oxime|P0AB91|PHOSPHO-2-DEHYDRO-3-DEOXYHEPTONATE ALDOLASE, PHE-SENSITIVE|5.51|Kd=3.1uM|Kd|=|3.1|uM|3100|nM
5AVF|1.95|2016|TAU|ligand is taurine|------|METHYL-ACCEPTING CHEMOTAXIS (MCP) SIGNALING DOMAIN PROTEIN|5.49|Kd=3.2uM|Kd|=|3.2|uM|3200|nM
4ZE6|1.17|2016|011|fragment compound 39|P11838|ENDOTHIAPEPSIN|2.48|Kd=3.3mM|Kd|=|3.3|mM|3300000|nM
5SVK|2.77|2016|ATP|ligand is ATP; scintillation proximity assays (SPA)|P56373|P2X PURINOCEPTOR 3|8.48|Kd=3.3nM|Kd|=|3.3|nM|3.3|nM
5AQZ|1.65|2016|SGV|ligand is compound sangivamycin 10|P0DMV8|HEAT SHOCK 70 KDA PROTEIN 1A|5.48|Kd=3.3uM|Kd|=|3.3|uM|3300|nM
5HRW|1.80|2016|64E|compound 11, according to structure in RCSB PDB|Q86U86|PROTEIN POLYBROMO-1|5.48|Kd=3.3uM|Kd|=|3.3|uM|3300|nM
5II1|2.02|2016|6BL|compound 9, according to structure in RCSB PDB|Q86U86|PROTEIN POLYBROMO-1|5.48|Kd=3.3uM|Kd|=|3.3|uM|3300|nM
4Y4J|1.03|2016|LNR|fragment compound 97|P11838|ENDOTHIAPEPSIN|2.47|Kd=3.4mM|Kd|=|3.4|mM|3400000|nM
5FB0|2.70|2016|15-mer|ligand is 15-mer H31-15T3ph peptide|P23497|NUCLEAR AUTOANTIGEN SP-100|5.47|Kd=3.4uM|Kd|=|3.4|uM|3400|nM
5GU4|1.55|2016|9-mer|ligand is C9 2 (DDMGFGLFD) peptide|P02879|RICIN|5.47|Kd=3.4uM|Kd|=|3.4|uM|3400|nM
5AQH|2.00|2016|ZVO|[Different protein in assay: crystal: HSC70/BAG1, binding assay:HSC70] Kd=3.5+/-0.6mM, HSC70/BAG1 Compound 3|P11142|HEAT SHOCK COGNATE 71 KDA PROTEIN|2.46|Kd=3.5mM|Kd|=|3.5|mM|3500000|nM
5B4W|2.60|2016|18-mer|ligand is (PlxnB1)-binding macrocyclic peptide PB1m6|O43157|PLEXIN-B1|8.46|Kd=3.5nM|Kd|=|3.5|nM|3.5|nM
5DTW|2.44|2016|5F9|ligand is C20-CoA|P9WNP1|PROBABLE ENOYL-COA HYDRATASE ECHA6|5.46|Kd=3.5uM|Kd|=|3.5|uM|3500|nM
5AVE|1.80|2016|SER|ligand is L-serine|------|METHYL-ACCEPTING CHEMOTAXIS (MCP) SIGNALING DOMAIN PROTEIN|5.44|Kd=3.6uM|Kd|=|3.6|uM|3600|nM
5E3A|2.05|2016|5-mer|ligand is opioid peptide leu-enkephalin|Q9NY33|DIPEPTIDYL PEPTIDASE 3|5.44|Kd=3.6uM|Kd|=|3.6|uM|3600|nM
5TBN|NMR|2016|12-mer|ligand is histone H3K4me2 peptide|Q9BVI0|PHD FINGER PROTEIN 20|5.44|Kd=3.6uM|Kd|=|3.6|uM|3600|nM
5F2U|1.85|2016|4-mer|ligand is 4-mer fully modified farnesylated INPP5E Peptide|O43924|RETINAL ROD RHODOPSIN-SENSITIVE CGMP 3',5'-CYCLIC PHOSPHODIESTERASE|8.43|Kd=3.7nM|Kd|=|3.7|nM|3.7|nM
5AGR|1.30|2016|A52|[Uncommon element] compound 2|P9WFV1|LEUCINE--TRNA LIGASE|5.43|Kd=3.7uM|Kd|=|3.7|uM|3700|nM
5ETM|1.46|2016|5RW|ligand is compound 34|P26281|2-AMINO-4-HYDROXY-6-HYDROXYMETHYLDIHYDROPTERIDINE|5.41|Kd=3.9uM|Kd|=|3.9|uM|3900|nM
5AWT|2.70|2016|11-mer|ligand is 11-mer peptide Eps15-640-649|Q9BQI5|SH3-CONTAINING GRB2-LIKE PROTEIN 3-INTERACTING PROTEIN 1|4.52|Kd=30.2uM|Kd|=|30.2|uM|30200|nM
5EOC|1.98|2016|14-mer|ligand is Cyclic variant of Hepatitis C Virus E2 epitope I|------|FAB FRAGMENT (HEAVY CHAIN)|7.52|Kd=30.3nM|Kd|=|30.3|nM|30.3|nM
5I9X|1.43|2016|DB8|ligand is bosutinib (SKI-606); Kinobeads binding assay|P29317|EPHRIN TYPE-A RECEPTOR 2|7.52|Kd=30nM|Kd|=|30|nM|30|nM
5TH2|1.84|2016|12-mer|ligand is CQFDQSTRRLKC peptide|P01834|CETUXIMAB FAB, LIGHT CHAIN|4.52|Kd=30uM|Kd|=|30|uM|30000|nM
5DTT|2.10|2016|5F5|compound 3|Q6XEC0|BETA-LACTAMASE|3.51|Kd=310uM|Kd|=|310|uM|310000|nM
5KEW|2.10|2016|6SB|ligand is bile salt taurodeoxycholate (TDC)|Q87GI4|VTRA PROTEIN|6.5|Kd=315.4nM|Kd|=|315.4|nM|315.4|nM
4YXI|.96|2016|4J8|compound 2|P00918|CARBONIC ANHYDRASE 2|6.5|Kd=318.8nM|Kd|=|318.8|nM|318.8|nM
5E2W|1.50|2016|18-mer|ligand is peptide-12, i.e. triply phosphorylated TAU peptide TPP-2|------|AT8 LIGHT CHAIN|7.51|Kd=31nM|Kd|=|31|nM|31|nM
5LY3|1.60|2016|16-mer|ligand is 16-mer arcadin-2 C-terminal peptide|A3MWN5|ACTIN/ACTIN FAMILY PROTEIN|7.51|Kd=31nM|Kd|=|31|nM|31|nM
5AQG|2.24|2016|ZJB|[Different protein in assay: crystal: HSC70/BAG1, binding assay:HSC70] Kd=31+/-11uM, HSC70/BAG1 Compound 2|P11142|HEAT SHOCK COGNATE 71 KDA PROTEIN|4.51|Kd=31uM|Kd|=|31|uM|31000|nM
5L8N|2.12|2016|6RQ|ligand is compound 1|P51161|GASTROTROPIN|4.51|Kd=31uM|Kd|=|31|uM|31000|nM
5EOK|2.80|2016|9-mer|peptide P39|P03951|COAGULATION FACTOR XI|3.49|Kd=320uM|Kd|=|320|uM|320000|nM
5FND|2.00|2016|IQ5|compound 2|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|3.49|Kd=320uM|Kd|=|320|uM|320000|nM
5I25|2.85|2016|8-mer|peptide HKP|P03951|COAGULATION FACTOR XI|3.49|Kd=324uM|Kd|=|324|uM|324000|nM
5DOH|1.05|2016|5DU|[Nonstandard assay: Temp 37] CAII-2m|P00918|CARBONIC ANHYDRASE 2|7.49|Kd=32nM|Kd|=|32|nM|32|nM
5GIC|2.35|2016|DLC|ligand is DLAM-2P|P13053|VITAMIN D3 RECEPTOR|6.48|Kd=330.9nM|Kd|=|330.9|nM|330.9|nM
5EH7|1.43|2016|5O5|compound 37|P00918|CARBONIC ANHYDRASE 2|3.48|Kd=330uM|Kd|=|330|uM|330000|nM
5FNI|1.60|2016|YIH|compound 37; redundant to 5eh7|P00918|CARBONIC ANHYDRASE 2|3.48|Kd=330uM|Kd|=|330|uM|330000|nM
5A5V|2.04|2016|PXJ|CFe-6-Lic|Q0P8Q4|ENTEROCHELIN UPTAKE PERIPLASMIC BINDING PROTEIN|7.48|Kd=33nM|Kd|=|33|nM|33|nM
5GR9|2.77|2016|12-mer|ligand is 12-mer TDIF/CLE41 peptide|Q9FII5|LEUCINE-RICH REPEAT RECEPTOR-LIKE PROTEIN KINASE TDR|7.48|Kd=33nM|Kd|=|33|nM|33|nM
5A7Y|2.50|2016|SAH|same as 1qan|Q4J894|TRNA (ADENINE(9)-N1)-METHYLTRANSFERASE|4.48|Kd=33uM|Kd|=|33|uM|33000|nM
5JAL|2.06|2016|6HO|[Incomplete ligand] PDB use ligand structure of fragment 5 in paper, should be fragment 4|Q13093|PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE|2.47|Kd=3400uM|Kd|=|3400|uM|3400000|nM
5EB3|2.40|2016|UEG|ligand is compound VB6; SPR data|Q9I4L4|YFIR|1.45|Kd=35.2mM|Kd|=|35.2|mM|35200000|nM
5FUT|1.60|2016|PQ7|ligand is compound BR25|P35790|CHOLINE KINASE ALPHA|6.45|Kd=352nM|Kd|=|352|nM|352|nM
5JOX|1.80|2016|EDG|ligand is AraDNJ|A7LXT8|NON-REDUCING END ALPHA-L-ARABINOFURANOSIDASE BOGH43A|4.46|Kd=35uM|Kd|=|35|uM|35000|nM
5D6J|2.25|2016|ATP||A0R618|ACYL-COA SYNTHASE|4.44|Kd=36uM|Kd|=|36|uM|36000|nM
5HED|1.70|2016|9-mer|ligand is a mutant C-terminal peptide derived from CRIPT (T-2F)|P31016|DISKS LARGE HOMOLOG 4|4.44|Kd=36uM|Kd|=|36|uM|36000|nM
5F2P|1.80|2016|5TY|compound 3|Q9H8M2|BROMODOMAIN-CONTAINING PROTEIN 9|4.43|Kd=37.5uM|Kd|=|37.5|uM|37500|nM
5I38|2.60|2016|KOJ|ligand is kojic acid (KA); MST assay|B2ZB02|TYROSINASE|3.42|Kd=377uM|Kd|=|377|uM|377000|nM
5G4O|1.48|2016|O80|compound 6|P04637|CELLULAR TUMOR ANTIGEN P53|4.43|Kd=37uM|Kd|=|37|uM|37000|nM
5H9Q|1.93|2016|TD2|ligand is TD-139|P47929|GALECTIN-7|4.42|Kd=38.0uM|Kd|=|38|uM|38000|nM
5EPS|1.47|2016|5QX|compound 11|P55201|PEREGRIN|4.42|Kd=38uM|Kd|=|38|uM|38000|nM
5EPY|2.30|2016|5R2|ligand is compound 5172-mcP1P3|C1KIK8|NS3 PROTEASE|7.4|Kd=39.9nM|Kd|=|39.9|nM|39.9|nM
5IHH|1.35|2016|6B5|ligand is 7-MeO-Lut; MST assay|P02766|TRANSTHYRETIN|6.41|Kd=390nM|Kd|=|390|nM|390|nM
5DX3|2.09|2016|13-mer|ligand is Stapled Peptide SRC2-SP3|P03372|ESTROGEN RECEPTOR|7.41|Kd=39nM|Kd|=|39|nM|39|nM
4XOC|1.42|2016|KGM|FimHL F18 .HM|Q0T8Y8|FIMH PROTEIN|8.52|Kd=3nM|Kd|=|3|nM|3|nM
5F08|1.92|2016|5TG|compound 14|P9WMC0|HTH-TYPE TRANSCRIPTIONAL REGULATOR ETHR|5.52|Kd=3uM|Kd|=|3|uM|3000|nM
5IXF|NMR|2016|14-mer|ligand is AMSH-P2 derived peptide|O75886|SIGNAL TRANSDUCING ADAPTER MOLECULE 2|5.52|Kd=3uM|Kd|=|3|uM|3000|nM
5TEF|1.95|2016|GTG|kd=4.0+/-0.5uM; ligand is m7GpppG.|Q8TEQ6|GEM-ASSOCIATED PROTEIN 5|5.4|Kd=4.0uM|Kd|=|4|uM|4000|nM
5CHK|2.20|2016|55R|avidin-HABA, MST assay|P02701|AVIDIN|5.39|Kd=4.12uM|Kd|=|4.12|uM|4120|nM
5KBI|2.90|2016|CAQ|ligand is catechol|Q43965|MOPR|5.39|Kd=4.12uM|Kd|=|4.12|uM|4120|nM
5EXX|3.31|2016|C2E|[Different protein in assay: full-length PaFleQ used for bioassay] ligand is c-di-GMP|G3XCV0|TRANSCRIPTIONAL REGULATOR FLEQ|5.39|Kd=4.1uM|Kd|=|4.1|uM|4100|nM
5DPW|2.19|2016|14-mer|complex is PLEKHM1-LIR/LC3A|Q9BXW4|MICROTUBULE-ASSOCIATED PROTEINS 1A/1B LIGHT CHAIN 3C|5.37|Kd=4.22uM|Kd|=|4.22|uM|4220|nM
5EOU|2.40|2016|ATP|[Nonstandard assay: ITC assay at Temp 10C]|G3XD28|TYPE 4 FIMBRIAL BIOGENESIS PROTEIN PILM,TYPE 4 FIMBRIAL|5.36|Kd=4.37uM|Kd|=|4.37|uM|4370|nM
5ETN|1.40|2016|5RX|ligand is compound 35|P26281|2-AMINO-4-HYDROXY-6-HYDROXYMETHYLDIHYDROPTERIDINE|5.37|Kd=4.3uM|Kd|=|4.3|uM|4300|nM
5ELF|1.55|2016|5-mer|ligand is A-penta-HMO (A2G-GAL-BGC-GLC-FUC)|P01556|CHOLERA ENTEROTOXIN SUBUNIT B|2.34|Kd=4.57mM|Kd|=|4.57|mM|4570000|nM
4Y3Y|1.35|2016|DCL|fragment compound 42|P11838|ENDOTHIAPEPSIN|2.35|Kd=4.5mM|Kd|=|4.5|mM|4500000|nM
5EDL|1.95|2016|VIB|ligand is thiamine|O34738|PUTATIVE HMP/THIAMINE PERMEASE PROTEIN YKOE|8.35|Kd=4.5nM|Kd|=|4.5|nM|4.5|nM
5L4M|1.58|2016|SBK|ligand is 3,5,6-Trichloro-2-pyridinyloxyacetic acid (Triclopyr)|P02766|TRANSTHYRETIN|5.34|Kd=4.6uM|Kd|=|4.6|uM|4600|nM
5CQX|1.63|2016|15-mer|ligand is MazE residues 68-82|P0AE70|ENDORIBONUCLEASE MAZF|5.33|Kd=4.7uM|Kd|=|4.7|uM|4700|nM
5CZM|1.30|2016|R47|compound 1; delta G=-11.6 kcal/mol|P39900|MACROPHAGE METALLOELASTASE (MMP-12)|8.32|Kd=4.8nM|Kd|=|4.8|nM|4.8|nM
5EHE|1.50|2016|WWO|[Nonstandard assay: Temp 37] CA II-10d|P00918|CARBONIC ANHYDRASE 2|8.32|Kd=4.8nM|Kd|=|4.8|nM|4.8|nM
4YB6|1.98|2016|HIS|[Multiple sites: Kd = 4.8 +/- 0.7 uM, 2.3 +/- 0.1 uM. sequential binding model (two events)] ligand is His/AMP|Q5HSJ4|ATP PHOSPHORIBOSYLTRANSFERASE|5.32|Kd=4.8uM|Kd|=|4.8|uM|4800|nM
5AYY|3.09|2016|NTM|ligand is Quinolinate, QA|V9HWJ5|NICOTINATE-NUCLEOTIDE PYROPHOSPHORYLASE|5.32|Kd=4.8uM|Kd|=|4.8|uM|4800|nM
5KS7|2.90|2016|2BA|ligand is cyclic-di-AMP|Q9KHT9|CARNITINE TRANSPORT ATP-BINDING PROTEIN OPUCA|5.32|Kd=4.8uM|Kd|=|4.8|uM|4800|nM
5H8B|2.55|2016|5Y2|compound 2|P68400|CASEIN KINASE II, ALPHA SUBUNIT|11.31|Kd=4.91pM|Kd|=|4.91|pM|0.00491|nM
5D0J|2.60|2016|9-mer|ligand is G7-TEdFP peptide (G7-B4NS)|Q14451|GROWTH FACTOR RECEPTOR-BOUND PROTEIN 7|5.31|Kd=4.93uM|Kd|=|4.93|uM|4930|nM
5L2I|2.75|2016|LQQ|ligand is Palbociclib|Q00534|CYCLIN-DEPENDENT KINASE 6|7.4|Kd=40.1nM|Kd|=|40.1|nM|40.1|nM
5D3C|1.31|2016|56O|compound 2; delta G=-14.2 kcal/mol|P39900|MACROPHAGE METALLOELASTASE (MMP-12)|10.4|Kd=40pM|Kd|=|40|pM|0.04|nM
5IGM|1.60|2016|BMF|ligand is bromosporine (BSP)|Q9H8M2|BROMODOMAIN-CONTAINING PROTEIN 9|7.38|Kd=41.7nM|Kd|=|41.7|nM|41.7|nM
5IGK|1.70|2016|BMF|ligand is bromosporine (BSP)|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|7.38|Kd=41.8nM|Kd|=|41.8|nM|41.8|nM
5L8O|2.39|2016|CHD|ligand is cholate|P51161|GASTROTROPIN|3.38|Kd=415uM|Kd|=|415|uM|415000|nM
4YYT|1.07|2016|S2O|compound 5|P00918|CARBONIC ANHYDRASE 2|6.38|Kd=418.3nM|Kd|=|418.3|nM|418.3|nM
5HFJ|3.10|2016|SAM|ligand is cofactor SAM (AdoMet); MST assay|O24891|ADENINE SPECIFIC DNA METHYLTRANSFERASE (DPNA)|4.39|Kd=41uM|Kd|=|41|uM|41000|nM
5IGL|2.10|2016|BMF|ligand is bromosporine (BSP)|Q8IZX4|TRANSCRIPTION INITIATION FACTOR TFIID SUBUNIT 1-LIKE|7.37|Kd=42.7nM|Kd|=|42.7|nM|42.7|nM
5HYR|2.27|2016|13-mer|ligand is Stapled Peptide SRC2-SP2|P03372|ESTROGEN RECEPTOR|7.38|Kd=42nM|Kd|=|42|nM|42|nM
5ERG|2.20|2016|SAM|ligand is SAM|P41814|TRNA (ADENINE(58)-N(1))-METHYLTRANSFERASE NON-CATALYTIC|4.35|Kd=44.33uM|Kd|=|44.33|uM|44330|nM
5D3X|1.69|2016|4IP|ITC Kd=391nM in figure S2, but 440nM in page 5|Q8TCU6|PHOSPHATIDYLINOSITOL 3,4,5-TRISPHOSPHATE-DEPENDENT RAC|6.36|Kd=440nM|Kd|=|440|nM|440|nM
5MF6|1.87|2016|7M2|ligand is compound 7 (UBCS039); MST assay|Q8N6T7|NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-6|4.36|Kd=44uM|Kd|=|44|uM|44000|nM
5HGQ|3.28|2016|KRS|ligand is cladosporin|E1FQP0|LYSINE--TRNA LIGASE|7.34|Kd=45.2nM|Kd|=|45.2|nM|45.2|nM
5HJC|2.60|2016|9-mer|ligand is histone H3 peptide acetylation at K18 (H3K18ac)|Q15059|BROMODOMAIN-CONTAINING PROTEIN 3|4.35|Kd=45uM|Kd|=|45|uM|45000|nM
5IUG|1.93|2016|729|ligand is compound 5a; SPR Kd calculated from Kon Koff|Q9UM73|ALK TYROSINE KINASE RECEPTOR|7.33|Kd=46.4nM|Kd|=|46.4|nM|46.4|nM
5L3F|3.50|2016|11-mer|ligand is 11-mer peptide polymyxin B|O60341|LYSINE-SPECIFIC HISTONE DEMETHYLASE 1A|6.33|Kd=463nM|Kd|=|463|nM|463|nM
5IA3|1.79|2016|P17|ligand is PD173955|P29317|EPHRIN TYPE-A RECEPTOR 2|7.34|Kd=46nM|Kd|=|46|nM|46|nM
5EK9|2.08|2016|5P4|[Nonstandard assay: Temp 10] 9 bound to BRD2-BD2|P25440|BROMODOMAIN-CONTAINING PROTEIN 2|7.33|Kd=47nM|Kd|=|47|nM|47|nM
4ZCS|2.45|2016|CDC|Kd = 47 +/ -5 uM. ligand is CDPCho|Q8IEE9|CHOLINE-PHOSPHATE CYTIDYLYLTRANSFERASE|4.33|Kd=47uM|Kd|=|47|uM|47000|nM
5H8G|2.00|2016|5Y4|compound 7b|P68400|CASEIN KINASE II, ALPHA SUBUNIT|10.32|Kd=48.2pM|Kd|=|48.2|pM|0.04820000000000001|nM
5MEH|0.95|2016|DMJ|ligand is DMJ|B0SWV2|MANNOSYL-OLIGOSACCHARIDE 1,2-ALPHA-MANNOSIDASE|6.32|Kd=481nM|Kd|=|481|nM|481|nM
5FE7|2.08|2016|5WU|fragment ZB2216 (fragment 11)|Q92831|HISTONE ACETYLTRANSFERASE KAT2B|3.31|Kd=488uM|Kd|=|488|uM|488000|nM
5KHH|1.77|2016|6SW|ligand is inosine-3', 5'-cyclic monophosphate (cIMP)|O88703|POTASSIUM/SODIUM HYPERPOLARIZATION-ACTIVATED CYCLIC|4.31|Kd=49.32uM|Kd|=|49.32|uM|49320|nM
5I9I|2.70|2016|5HV|ligand is Darapladib|Q13093|PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE|7.3|Kd=49.7nM|Kd|=|49.7|nM|49.7|nM
4Y38|1.10|2016|0A9|ligand is fragment compound 29|P11838|ENDOTHIAPEPSIN|2.4|Kd=4mM|Kd|=|4|mM|4000000|nM
5CSW|2.66|2016|P06|ligand is dabrafenib|P15056|SERINE/THREONINE-PROTEIN KINASE B-RAF|8.4|Kd=4nM|Kd|=|4|nM|4|nM
5EP7|1.20|2016|5QR|ligand is compound 3|Q92793|CREB-BINDING PROTEIN|5.4|Kd=4uM|Kd|=|4|uM|4000|nM
5EQP|2.35|2016|5R9|compound 37|P35790|CHOLINE KINASE ALPHA|5.4|Kd=4uM|Kd|=|4|uM|4000|nM
5FNS|1.79|2016|XYY|compound 5|Q9Z2X8|KELCH-LIKE ECH-ASSOCIATED PROTEIN 1|5.4|Kd=4uM|Kd|=|4|uM|4000|nM
5L9O|1.84|2016|GOP|ligand is glucopine|Q7D447|DEOXYFRUCTOSYL-AMINO ACID TRANSPORTER PERIPLASMIC BINDING|5.4|Kd=4uM|Kd|=|4|uM|4000|nM
5HRV|1.70|2016|64C|compound 10, according to structure in RCSB PDB|Q86U86|PROTEIN POLYBROMO-1|5.29|Kd=5.1uM|Kd|=|5.1|uM|5100|nM
5HRX|1.73|2016|64F|compound 12, according to structure in RCSB PDB|Q86U86|PROTEIN POLYBROMO-1|5.29|Kd=5.1uM|Kd|=|5.1|uM|5100|nM
5ECT|1.30|2016|DUP|ligand is dUPNPP; assay by near-UV CD titration|P9WNS5|DEOXYURIDINE 5'-TRIPHOSPHATE NUCLEOTIDOHYDROLASE|5.28|Kd=5.2uM|Kd|=|5.2|uM|5200|nM
5HWU|2.10|2016|DUP|ligand is dUMPNPP|Q9RS96|UNCHARACTERIZED PROTEIN|5.27|Kd=5.35uM|Kd|=|5.35|uM|5350|nM
5FAQ|1.96|2016|5VW|FPI-1465|Q6XEC0|BETA-LACTAMASE|5.28|Kd=5.3uM|Kd|=|5.3|uM|5300|nM
5KXC|1.80|2016|6Y2|ligand is LacdiNAc-pNP|------|ISTERIA FLORIBUNDA AGGLUTININ|5.26|Kd=5.45uM|Kd|=|5.45|uM|5450|nM
5GS9|2.50|2016|ARG|ligand is arginine|Q8WTX7|GATS-LIKE PROTEIN 3|5.26|Kd=5.5uM|Kd|=|5.5|uM|5500|nM
5IQ6|3.00|2016|6CJ|ligand is HeE1-2Tyr|Q6DLV0|RNA DEPENDENT RNA POLYMERASE|5.26|Kd=5.5uM|Kd|=|5.5|uM|5500|nM
5DU4|1.70|2016|5FF|ligand is GSK366A|P9WNP1|PROBABLE ENOYL-COA HYDRATASE ECHA6|5.25|Kd=5.6uM|Kd|=|5.6|uM|5600|nM
4ZV1|1.52|2016|ARG|ligand is L-argnine|------|ANCQR|5.24|Kd=5.73uM|Kd|=|5.73|uM|5730|nM
5D3J|1.70|2016|L33|compound 6|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|5.24|Kd=5.7uM|Kd|=|5.7|uM|5700|nM
5EDD|1.97|2016|DUP|ligand is dUPNPP; assay by near-UV CD titration|A5U649|DEOXYURIDINE 5'-TRIPHOSPHATE NUCLEOTIDOHYDROLASE|5.24|Kd=5.7uM|Kd|=|5.7|uM|5700|nM
5HJD|2.81|2016|7-mer|ligand is histone H3 peptide Crotonylation at K18 (H3K18cr)|P42568|PROTEIN AF-9|5.24|Kd=5.7uM|Kd|=|5.7|uM|5700|nM
5D24|1.65|2016|L26|compound 14|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|5.24|Kd=5.8uM|Kd|=|5.8|uM|5800|nM
5EMA|1.32|2016|8-mer|ligand is phosphorylated C-terminal LRRC3B PDZ binding motif (pLRRC3B)|Q8K4V4|SORTING NEXIN-27|5.23|Kd=5.9uM|Kd|=|5.9|uM|5900|nM
5ICZ|2.55|2016|12-mer|ligand is GQFDLSTRRLKG peptide|P01834|CETUXIMAB FAB, LIGHT CHAIN|5.3|Kd=5000nM|Kd|=|5000|nM|5000|nM
5EJW|2.60|2016|5PZ|ligand is compound MS351|Q8VDS3|CHROMOBOX PROTEIN HOMOLOG 7|3.3|Kd=500uM|Kd|=|500|uM|500000|nM
5G45|2.07|2016|A7W|ligand is CT24|P51449|NUCLEAR RECEPTOR ROR-GAMMA|3.3|Kd=500uM|Kd|=|500|uM|500000|nM
5DTK|1.60|2016|5F3|compound 17|Q6XEC0|BETA-LACTAMASE|4.3|Kd=50uM|Kd|=|50|uM|50000|nM
5EWY|1.40|2016|5TQ|inhibitor P6E|C9Z6T8|PUTATIVE ADP-RIBOSYLTRANSFERASE SCABIN|4.3|Kd=50uM|Kd|=|50|uM|50000|nM
5DUW|1.70|2016|5GO|ligand is lactose-3'-sulfate|P56470|GALECTIN-4|3.29|Kd=510uM|Kd|=|510|uM|510000|nM
4R06|2.22|2016|3E7|ligand is SR2067|P37231|PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA|6.29|Kd=513nM|Kd|=|513|nM|513|nM
5FNJ|1.67|2016|YI6|compound 33|P00918|CARBONIC ANHYDRASE 2|2.29|Kd=5150uM|Kd|=|5150|uM|5150000|nM
5I7Y|1.45|2016|69G|compound 4; BROMOscan bromodomain selectivity data|Q9H8M2|BROMODOMAIN-CONTAINING PROTEIN 9|7.28|Kd=52nM|Kd|=|52|nM|52|nM
5IA4|1.80|2016|88Z|ligand is foretinib (XL880)|P29317|EPHRIN TYPE-A RECEPTOR 2|7.28|Kd=52nM|Kd|=|52|nM|52|nM
5F2R|2.15|2016|ACP|ligand is AMPPCP|P11021|78 KDA GLUCOSE-REGULATED PROTEIN|4.28|Kd=52uM|Kd|=|52|uM|52000|nM
5L4J|1.62|2016|6JD|ligand is 4,4'-Dihydroxydiphenyl sulfone (Bisphenol S, BPS)|P02766|TRANSTHYRETIN|4.28|Kd=52uM|Kd|=|52|uM|52000|nM
5DXB|2.08|2016|13-mer|ligand is Stapled Peptide SRC2-SP1|P03372|ESTROGEN RECEPTOR|6.28|Kd=530nM|Kd|=|530|nM|530|nM
5IA1|2.04|2016|ZZL|ligand is MLN8054|P29317|EPHRIN TYPE-A RECEPTOR 2|6.28|Kd=530nM|Kd|=|530|nM|530|nM
5I7X|1.18|2016|67B|compound 2; BROMOscan bromodomain selectivity data|Q9H8M2|BROMODOMAIN-CONTAINING PROTEIN 9|7.28|Kd=53nM|Kd|=|53|nM|53|nM
5F9B|2.25|2016|5VN|compound 19 (caulophyllogenin)|P37231|PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA|4.26|Kd=54.82uM|Kd|=|54.82|uM|54820|nM
5ARF|1.92|2016|I9H|compound 6|Q9NRG4|N-LYSINE METHYLTRANSFERASE SMYD2|6.27|Kd=540nM|Kd|=|540|nM|540|nM
4XTP|1.97|2016|TNR|TN; Kd = 55.40 +/- 2.84 uM|P81371|SEED LECTIN|4.26|Kd=55.40uM|Kd|=|55.4|uM|55400|nM
5EI3|1.71|2016|5O8|compound 7a|P06730|EUKARYOTIC TRANSLATION INITIATION FACTOR 4E|4.25|Kd=56.5uM|Kd|=|56.5|uM|56500|nM
5ID1|2.49|2016|12-mer|ligand is (MPT)QFDLSTRRLKC peptide|P01834|CETUXIMAB FAB, LIGHT CHAIN|6.25|Kd=560nM|Kd|=|560|nM|560|nM
4ZIJ|1.78|2016|SFQ|ligand is sulfonamide 1|P0AEG4|THIOL:DISULFIDE INTERCHANGE PROTEIN DSBA|3.25|Kd=565uM|Kd|=|565|uM|565000|nM
5A6I|1.86|2016|TCW|[Multiple sites: site 1: Kd=56 nM; site 2: Kd=1.1 uM] ligand is tolcapone; two ligand-binding sites|P02766|TRANSTHYRETIN|7.25|Kd=56nM|Kd|=|56|nM|56|nM
5B2D|2.18|2016|SLT|ligand is 3-sialyllactose|Q9WAF5|HN PROTEIN|4.25|Kd=56uM|Kd|=|56|uM|56000|nM
4YXU|1.08|2016|4JE|compound 4|P00918|CARBONIC ANHYDRASE 2|7.24|Kd=57.4nM|Kd|=|57.4|nM|57.4|nM
5F8Y|1.70|2016|X6X|ligand is galactosamine; BLI assay|H2FH31|GALNAC/GAL-SPECIFIC LECTIN|4.24|Kd=57uM|Kd|=|57|uM|57000|nM
5HUW|1.95|2016|12-mer|[Multiple sites: site 1: Kd=588.2 nM; site 2: Kd=100 uM] ligand is 12-mer HSV-1 Large Terminase NLS peptide; nano-ITC data|P52293|IMPORTIN SUBUNIT ALPHA-1|6.23|Kd=588.2nM|Kd|=|588.2|nM|588.2|nM
5AD1|1.32|2016|8LC|ligand is CFe-8-Lic|Q0P8Q4|ENTEROCHELIN UPTAKE PERIPLASMIC BINDING PROTEIN|7.24|Kd=58nM|Kd|=|58|nM|58|nM
5AJC|1.70|2016|4-mer|ligand is sialyl lewis X tetrasaccharide (SLex), include Gal-GlcNac-Fuc-NueAc|D8NA05|PUTATIVE FUCOSE-BINDING LECTIN PROTEIN|4.24|Kd=58uM|Kd|=|58|uM|58000|nM
5CSP|1.50|2016|54G|compound 5|P68400|CASEIN KINASE II, ALPHA SUBUNIT|4.24|Kd=58uM|Kd|=|58|uM|58000|nM
5CU2|1.71|2016|54G|[Nonstandard assay: PH=8] 19 and 9 (PDB: 5CU2), co-soaked into CK2 alpha|P68400|CASEIN KINASE II, ALPHA SUBUNIT|4.24|Kd=58uM|Kd|=|58|uM|58000|nM
5L3G|3.10|2016|11-mer|ligand is 11-mer peptide polymyxin E (colistin)|O60341|LYSINE-SPECIFIC HISTONE DEMETHYLASE 1A|6.23|Kd=594nM|Kd|=|594|nM|594|nM
5E2M|1.41|2016|V14|[Nonstandard assay: Temp 37] CA I-10h|P00915|CARBONIC ANHYDRASE 1|7.23|Kd=59nM|Kd|=|59|nM|59|nM
5FNR|1.89|2016|XMS|compound 4|Q9Z2X8|KELCH-LIKE ECH-ASSOCIATED PROTEIN 1|4.23|Kd=59uM|Kd|=|59|uM|59000|nM
4ZTR|2.85|2016|4RJ|compound 9|O14965|AURORA KINASE A|8.3|Kd=5nM|Kd|=|5|nM|5|nM
5E80|2.60|2016|5KP|ligand is compound 2a|O43924|RETINAL ROD RHODOPSIN-SENSITIVE CGMP 3',5'-CYCLIC|8.3|Kd=5nM|Kd|=|5|nM|5|nM
4Z0E|1.90|2016|13-mer|ligand is RON2hp [Phe2038TRN] peptide, sequence #9|------|APICAL MEMBRANE ANTIGEN 1|5.3|Kd=5uM|Kd|=|5|uM|5000|nM
4Z0D|2.10|2016|13-mer|ligand is RON2hp [Phe2038Trp] peptide, sequence #2|------|APICAL MEMBRANE ANTIGEN 1|5.3|Kd=5uM|Kd|=|5|uM|5000|nM
5EYR|1.57|2016|5T0|compound 5|P9WMC1|HTH-TYPE TRANSCRIPTIONAL REGULATOR ETHR|5.3|Kd=5uM|Kd|=|5|uM|5000|nM
5DKR|1.74|2016|5CZ|compound 17 (SBi29); Kd calculated from fluorescent polarization competition assay (FPCA) IC50 data|P02638|PROTEIN S100-B|5.22|Kd=6.0uM|Kd|=|6|uM|6000|nM
5HHX|3.00|2016|16-mer|ligand is a high affinity IL-17A peptide antagonist (HAP)|Q16552|INTERLEUKIN-17A|8.21|Kd=6.16nM|Kd|=|6.16|nM|6.16|nM
5H8E|2.15|2016|5Y3|compound 7h|P68400|CASEIN KINASE II, ALPHA SUBUNIT|11.2|Kd=6.33pM|Kd|=|6.33|pM|0.0063300000000000006|nM
5EMB|.85|2016|8-mer|ligand is C-terminal phosphorylated PTHR PDZ binding motif (pPTHR)|Q8K4V4|SORTING NEXIN-27|5.2|Kd=6.3uM|Kd|=|6.3|uM|6300|nM
5G1P|3.19|2016|CP|[Nonstandard assay: pH 8.3, 150 mM NaCl] ligand is CP (carbamoyl phosphate); equivalent binding sites per huATCase trimer|P27708|CAD PROTEIN|5.2|Kd=6.3uM|Kd|=|6.3|uM|6300|nM
5EQQ|1.65|2016|5RS|ligand is compound 5172-Linear|C1KIK8|NS3 PROTEASE|8.17|Kd=6.7nM|Kd|=|6.7|nM|6.7|nM
4Y3J|1.31|2016|HIC|compound 30|P11838|ENDOTHIAPEPSIN|2.17|Kd=6.8mM|Kd|=|6.8|mM|6800000|nM
5FDZ|2.40|2016|5X0|[Nonstandard assay: ITC at Temp 15C] compound 14|Q92831|HISTONE ACETYLTRANSFERASE KAT2B|5.17|Kd=6.8uM|Kd|=|6.8|uM|6800|nM
5SVI|1.61|2016|8-mer|ligand is H3K4me0 peptide|Q14149|MORC FAMILY CW-TYPE ZINC FINGER PROTEIN 3|5.17|Kd=6.8uM|Kd|=|6.8|uM|6800|nM
5CW8|2.60|2016|55X|ligand is 3och-CoA|P96856|HTH-TYPE TRANSCRIPTIONAL REPRESSOR KSTR|7.22|Kd=60nM|Kd|=|60|nM|60|nM
5KH3|1.60|2016|6U6|Kd = 60 +/- 3 uM. ligand is compound 3|Q9UBN7|HISTONE DEACETYLASE 6|4.22|Kd=60uM|Kd|=|60|uM|60000|nM
5TTF|1.72|2016|7KZ|Kd = 610 +/- 68 nM. complex is G9a/compound 18|Q96KQ7|HISTONE-LYSINE N-METHYLTRANSFERASE EHMT2|6.21|Kd=610nM|Kd|=|610|nM|610|nM
5DYO|2.36|2016|FLU|ligand is flourescein|------|FAB 43.1 HEAVY CHAIN|10.21|Kd=61pM|Kd|=|61|pM|0.061|nM
5EN3|1.25|2016|7LU|ligand is compound 7-Cl-Lut; MST assay|P02766|TRANSTHYRETIN|6.21|Kd=620nM|Kd|=|620|nM|620|nM
5I80|1.45|2016|67B|compound 2; BROMOscan bromodomain selectivity data|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|7.21|Kd=62nM|Kd|=|62|nM|62|nM
5LJJ|3.00|2016|AD5|ligand is Reversine|P33981|DUAL SPECIFICITY PROTEIN KINASE TTK|7.21|Kd=62nM|Kd|=|62|nM|62|nM
5CS6|1.88|2016|K82|compound 3|P68400|CASEIN KINASE II, ALPHA SUBUNIT|3.2|Kd=630uM|Kd|=|630|uM|630000|nM
5FLP|1.71|2016|6J5|compound 5|P00918|CARBONIC ANHYDRASE 2|3.2|Kd=631uM|Kd|=|631|uM|631000|nM
5HA1|1.35|2016|RNE|ligand is retinylamine|P09455|RETINOL-BINDING PROTEIN 1|7.19|Kd=64.1nM|Kd|=|64.1|nM|64.1|nM
5L2T|2.37|2016|6ZZ|ligand is compound Ribociclib|Q00534|CYCLIN-DEPENDENT KINASE 6|6.19|Kd=650nM|Kd|=|650|nM|650|nM
5L3E|2.80|2016|E11|[Multiple sites: site 1: Kd=28 uM; site 2: Kd=660 nM] ITC identify two types of binding sites for E11|O60341|LYSINE-SPECIFIC HISTONE DEMETHYLASE 1A|6.18|Kd=660nM|Kd|=|660|nM|660|nM
5FOX|1.30|2016|6-mer|[Nonstandard assay: pH 6.0, 100 mM NaCl] ligand is FHAA TETRAPEPTIDE|O74036|DNA REPAIR AND RECOMBINATION PROTEIN RADA|3.17|Kd=675uM|Kd|=|675|uM|675000|nM
5F41|2.00|2016|5V6|[Nonstandard assay: SPR at Temp 4C] ligand is compound FD-83-KI26|Q6DLV0|GENOME POLYPROTEIN|4.17|Kd=67uM|Kd|=|67|uM|67000|nM
5EPP|1.88|2016|15-mer|ligand is 15-mer VBM Motif in Rhomboid Protease, RHBDL4|P55072|TRANSITIONAL ENDOPLASMIC RETICULUM ATPASE|4.16|Kd=68.9uM|Kd|=|68.9|uM|68900|nM
5ITO|2.35|2016|6DB|ligand is octopine|P35120|NOPALINE-BINDING PERIPLASMIC PROTEIN|4.16|Kd=68.9uM|Kd|=|68.9|uM|68900|nM
5FOT|1.19|2016|6-mer|[Nonstandard assay: pH 6.0, 100 mM NaCl] ligand is FHTU TETRAPEPTIDE|O74036|DNA REPAIR AND RECOMBINATION PROTEIN RADA|3.17|Kd=680uM|Kd|=|680|uM|680000|nM
5BW4|2.10|2016|SAM|ligand is SAM|C7Q5P8|16S RRNA (ADENINE(1408)-N(1))-METHYLTRANSFERASE|4.17|Kd=68uM|Kd|=|68|uM|68000|nM
5FE6|1.77|2016|5WZ|fragment ZB1916 (fragment 10)|Q92831|HISTONE ACETYLTRANSFERASE KAT2B|2.16|Kd=6910uM|Kd|=|6910|uM|6910000|nM
5JQB|2.68|2016|IBP|[Nonstandard assay: assay at PH=5.2] ligand is ibuprofen; Kd by thermal-shift assay|Q05320|ENVELOPE GLYCOPROTEIN 1|2.22|Kd=6mM|Kd|=|6|mM|6000000|nM
5CSX|2.51|2016|54J|ligand is BI 882370|P15056|SERINE/THREONINE-PROTEIN KINASE B-RAF|8.22|Kd=6nM|Kd|=|6|nM|6|nM
5K8S|1.15|2016|CMP|ligand is cAMP|Q7KQK0|CAMP-DEPENDENT PROTEIN KINASE REGULATORY SUBUNIT|8.22|Kd=6nM|Kd|=|6|nM|6|nM
5BRZ|2.62|2016|9-mer|ligand is 9-mer peptide A1-MAGE-A3|P30443|HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-1 ALPHA CHAIN|8.15|Kd=7.1nM|Kd|=|7.1|nM|7.1|nM
5U4X|1.88|2016|7VM|[Nonstandard assay: binding only occurred in the presence of SAM, SAM = 50 uM] Kd = 7.1 +/- 1.8 nM. ligand is TP-064|Q86X55|HISTONE-ARGININE METHYLTRANSFERASE CARM1|8.15|Kd=7.1nM|Kd|=|7.1|nM|7.1|nM
5KVA|1.83|2016|SAM|ITC Kd=8.6uM in Fig. 4a, but 7.32uM in table 2; mad author|C5Z4W3|CAFFEOYL-COA O-METHYLTRANSFERASE|5.14|Kd=7.32uM|Kd|=|7.32|uM|7320|nM
4UD7|1.60|2016|16-mer|Kd=7.4+/-1.5nM, ligand is compound YS-2(peptide)|Q00987|MDM2|8.13|Kd=7.4nM|Kd|=|7.4|nM|7.4|nM
5D3P|1.95|2016|57E|compound 10|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|5.13|Kd=7.4uM|Kd|=|7.4|uM|7400|nM
5HDA|2.39|2016|9-mer|ligand is Epstein-Barr nuclear antigen 2, EBNA2 PXLXP motif|Q15326|ZINC FINGER MYND DOMAIN-CONTAINING PROTEIN 11|5.13|Kd=7.4uM|Kd|=|7.4|uM|7400|nM
5F74|2.35|2016|AMP||Q9CQV8|14-3-3 PROTEIN BETA/ALPHA|5.12|Kd=7.6uM|Kd|=|7.6|uM|7600|nM
5LBQ|3.30|2016|767|ligand is MC3767|O60341|LYSINE-SPECIFIC HISTONE DEMETHYLASE 1A|5.11|Kd=7.78uM|Kd|=|7.78|uM|7780|nM
5D3H|1.70|2016|57G|compound 4|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|5.1|Kd=7.9uM|Kd|=|7.9|uM|7900|nM
5E5G|1.95|2016|DTR|ligand is D-Trp|------|3-DEOXY-D-ARABINOHEPTULOSONATE-7-PHOSPHATE SYNTHASE|3.15|Kd=700uM|Kd|=|700|uM|700000|nM
5FNF|2.10|2016|TQL|compound 3|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|3.15|Kd=700uM|Kd|=|700|uM|700000|nM
5FLO|1.66|2016|J4K|compound 6|P00918|CARBONIC ANHYDRASE 2|3.15|Kd=709uM|Kd|=|709|uM|709000|nM
5FPI|2.77|2016|8-mer|ligand is Integrin alpha4 internalisation peptide QYKSILQE|P84092|AP-2 COMPLEX SUBUNIT MU|4.14|Kd=72uM|Kd|=|72|uM|72000|nM
5EHR|1.70|2016|5OD|Allosteric Inhibitor SHP099|Q06124|TYROSINE-PROTEIN PHOSPHATASE, NON-RECEPTOR TYPE 11|7.14|Kd=73nM|Kd|=|73|nM|73|nM
5LVQ|2.05|2016|2LX|Kd=73+/-1uM; PCAF/CPD-D|Q92831|HISTONE ACETYLTRANSFERASE KAT2B|4.14|Kd=73uM|Kd|=|73|uM|73000|nM
5LOM|1.50|2016|SNW|ligand is Deoxyfructosylglutamine (DFG)|Q7D447|DEOXYFRUCTOSYL-AMINO ACID TRANSPORTER PERIPLASMIC BINDING|7.13|Kd=74.1nM|Kd|=|74.1|nM|74.1|nM
5HPM|2.67|2016|11-mer|ligand is Cyclic amidated, acetylated linked meditope; (AcN)-CQFDLSTRRLKC-(Am)|P01834|CETUXIMAB FAB, LIGHT CHAIN|7.13|Kd=74nM|Kd|=|74|nM|74|nM
5EY4|1.86|2016|DTP|ligand is 2'-deoxyATP|P11021|78 KDA GLUCOSE-REGULATED PROTEIN|3.12|Kd=750uM|Kd|=|750|uM|750000|nM
5BS0|2.40|2016|9-mer|ligand is 9-mer peptide titin|P30443|HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-1 ALPHA CHAIN|7.12|Kd=76.7nM|Kd|=|76.7|nM|76.7|nM
5EB2|2.71|2016|TRP|ligand is L-Trp; SPR data|Q9I4L4|YFIR|1.11|Kd=76.9mM|Kd|=|76.9|mM|76900000|nM
5E6O|1.80|2016|4-mer|peptide Trp-Glu-Glu-Leu (WEEL)|Q23536|PROTEIN LGG-2|4.11|Kd=76.9uM|Kd|=|76.9|uM|76900|nM
5GID|2.15|2016|VDP|ligand is DLAM-4P; crystal in C2 form|P13053|VITAMIN D3 RECEPTOR|6.11|Kd=769.2nM|Kd|=|769.2|nM|769.2|nM
5DNU|1.20|2016|KKN|ligand is karrikin (KAR1)|------|SHKAI2IB|4.11|Kd=77.6uM|Kd|=|77.6|uM|77600|nM
5FNC|2.20|2016|IEE|compound 1|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|4.11|Kd=77uM|Kd|=|77|uM|77000|nM
5KAT|2.10|2016|P4P|ligand is tetraphenylphosphonium (TPP)|------|SA2223 PROTEIN|4.1|Kd=78.7uM|Kd|=|78.7|uM|78700|nM
5F1X|1.90|2016|ATP|ligand is ATP|P11021|78 KDA GLUCOSE-REGULATED PROTEIN|6.11|Kd=780nM|Kd|=|780|nM|780|nM
5L9L|1.80|2016|GOP|ligand is glucopine|------|PERIPLASMIC BINDING PROTEIN|7.1|Kd=79.4nM|Kd|=|79.4|nM|79.4|nM
5HV1|3.10|2016|RFP|ligand is RIFAMPICIN (RIF)|------|PHOSPHOENOLPYRUVATE SYNTHASE|4.1|Kd=79.4uM|Kd|=|79.4|uM|79400|nM
5EH8|1.38|2016|5O6|compound 19|P00918|CARBONIC ANHYDRASE 2|3.1|Kd=791uM|Kd|=|791|uM|791000|nM
5HKH|2.55|2016|9-mer|ligand is 9-mer UBA5 LIR/UFIM peptide|P61960|UBIQUITIN-FOLD MODIFIER 1|5.09|Kd=8.1uM|Kd|=|8.1|uM|8100|nM
5H5S|1.85|2016|14-mer|ligand is GXpep-3 peptide|P36969|PHOSPHOLIPID HYDROPEROXIDE GLUTATHIONE PEROXIDASE|5.09|Kd=8.2uM|Kd|=|8.2|uM|8200|nM
5J32|1.93|2016|IPM|[Nonstandard assay: ITC assay at Temp 15C] ligand is isopropylmalate|P93832|3-ISOPROPYLMALATE DEHYDROGENASE 2, CHLOROPLASTIC|5.08|Kd=8.3uM|Kd|=|8.3|uM|8300|nM
5HWV|1.65|2016|MBN|ligand is toluene;|A5W4E3|SENSOR HISTIDINE KINASE TODS|5.07|Kd=8.5uM|Kd|=|8.5|uM|8500|nM
5LUU|1.61|2016|77X|Kd=8.63+/-0.05uM, BRD4(1)/CPD-A|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|5.06|Kd=8.63uM|Kd|=|8.63|uM|8630|nM
5EHV|1.21|2016|5ON|compound 35|P00918|CARBONIC ANHYDRASE 2|3.08|Kd=826uM|Kd|=|826|uM|826000|nM
5DD0|2.49|2016|13-mer|ligand is MPER peptide, kd measured by Bio-Layer Interferometry|------|ANTI-HIV ANTIBODY DH570 FAB HEAVY CHAIN|7.08|Kd=83.7nM|Kd|=|83.7|nM|83.7|nM
5E2V|1.64|2016|18-mer|ligand is peptide-6, i.e. doubly phosphorylated TAU peptide TPP-1|------|AT8 LIGHT CHAIN|6.08|Kd=831nM|Kd|=|831|nM|831|nM
5L2S|2.27|2016|6ZV|ligand is compound Abemaciclib|Q00534|CYCLIN-DEPENDENT KINASE 6|7.08|Kd=83nM|Kd|=|83|nM|83|nM
5ICY|2.50|2016|12-mer|ligand is SQFDLSTRRLKS peptide|P01834|CETUXIMAB FAB, LIGHT CHAIN|5.06|Kd=8700nM|Kd|=|8700|nM|8700|nM
5H9S|1.82|2016|TGZ|ligand is TAZTDG|P47929|GALECTIN-7|4.06|Kd=87uM|Kd|=|87|uM|87000|nM
5I3X|1.85|2016|68J|ligand is compound 6|P56817|BETA-SECRETASE 1|8.1|Kd=8nM|Kd|=|8|nM|8|nM
4Z7O|2.85|2016|4-mer|[Different protein in assay: 10E5 Fab in crystal was not mentioned in bioassay] ligand is AGDV peptide|P08514|INTEGRIN ALPHA-IIB|5.04|Kd=9.03uM|Kd|=|9.03|uM|9030|nM
5KQ5|3.41|2016|STU|ligand is compound 7|P54645|5'-AMP-ACTIVATED PROTEIN KINASE CATALYTIC SUBUNIT A|8.05|Kd=9.0nM|Kd|=|9|nM|9|nM
5T3N|2.40|2016|75G|ligand is Sp-2Cl-cAMPS|Q7KQK0|CAMP-DEPENDENT PROTEIN KINASE REGULATORY SUBUNIT|8.04|Kd=9.1nM|Kd|=|9.1|nM|9.1|nM
5F25|1.68|2016|5TU|compound 4|Q9H8M2|BROMODOMAIN-CONTAINING PROTEIN 9|5.04|Kd=9.1uM|Kd|=|9.1|uM|9100|nM
5D3N|2.15|2016|L40|compound 7|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|5.04|Kd=9.2uM|Kd|=|9.2|uM|9200|nM
5HUY|1.98|2016|12-mer|[Multiple sites: site 1: Kd=9.4 uM; site 2: Kd=66.9 uM] ligand is 16-mer HCMV pUL56 NLS peptide; nano-ITC data|P52293|IMPORTIN SUBUNIT ALPHA-1|5.03|Kd=9.4uM|Kd|=|9.4|uM|9400|nM
5FF6|2.50|2016|12-mer|ligand is L10Q meditope variant, CQFDLSTRRQKC|P01834|CETUXIMAB FAB, LIGHT CHAIN|5.02|Kd=9.5uM|Kd|=|9.5|uM|9500|nM
5IOK|2.22|2016|8-mer|ligand is histone H3K9cr peptide|P35189|TRANSCRIPTION INITIATION FACTOR TFIID SUBUNIT 14|5.02|Kd=9.5uM|Kd|=|9.5|uM|9500|nM
5DU6|2.61|2016|G59|ligand is GSK059A|P9WNP1|PROBABLE ENOYL-COA HYDRATASE ECHA6|5.02|Kd=9.6uM|Kd|=|9.6|uM|9600|nM
5FOM|2.10|2016|A2H|[Uncommon element] ligand is AN6426-AMP|B6AA20|LEUCYL-TRNA SYNTHETASE|5.01|Kd=9.8uM|Kd|=|9.8|uM|9800|nM
4UE1|1.45|2016|16-mer|Kd=9.9+/-1.5nM, ligand is compound YS-1(peptide)|Q00987|E3 UBIQUITIN-PROTEIN LIGASE MDM2|8.0|Kd=9.9nM|Kd|=|9.9|nM|9.9|nM
4XOE|2.40|2016|KGM||Q0T8Y8|FIMH PROTEIN|5.0|Kd=9.9uM|Kd|=|9.9|uM|9900|nM
5ITP|1.85|2016|6DB|ligand is octopine|P35120|NOPALINE-BINDING PERIPLASMIC PROTEIN|5.0|Kd=9.9uM|Kd|=|9.9|uM|9900|nM
5FLS|1.67|2016|6ZX|compound 2|P00918|CARBONIC ANHYDRASE 2|3.04|Kd=905uM|Kd|=|905|uM|905000|nM
4ZSH|1.80|2016|4XW|PxR-LBD with 9CDHRA|P19793|RETINOIC ACID RECEPTOR RXR-ALPHA|7.05|Kd=90nM|Kd|=|90|nM|90|nM
5LLI|2.40|2016|6Z3|ligand is VH298; SPR Kd=10nM; FP Kd=80nM|Q15370|TRANSCRIPTION ELONGATION FACTOR B POLYPEPTIDE 2|7.05|Kd=90nM|Kd|=|90|nM|90|nM
4YXO|1.06|2016|4JC|compound 3|P00918|CARBONIC ANHYDRASE 2|7.04|Kd=91.4nM|Kd|=|91.4|nM|91.4|nM
5EPR|1.65|2016|5QY|compound 12|P55201|PEREGRIN|4.04|Kd=91uM|Kd|=|91|uM|91000|nM
5E2L|2.50|2016|DPN|ligand is D-Phe|------|3-DEOXY-D-ARABINOHEPTULOSONATE-7-PHOSPHATE SYNTHASE|4.03|Kd=93uM|Kd|=|93|uM|93000|nM
5FOW|1.80|2016|6-mer|[Nonstandard assay: pH 6.0, 100 mM NaCl] ligand is WHTA TETRAPEPTIDE|O74036|DNA REPAIR AND RECOMBINATION PROTEIN RADA|4.03|Kd=93uM|Kd|=|93|uM|93000|nM
5E3D|1.71|2016|5JL|compound 4|P55201|PEREGRIN|4.02|Kd=95uM|Kd|=|95|uM|95000|nM
5GLU|2.10|2016|3-mer|ligand is SiaLac; 3-mer of SIA-GAL-GLC|------|GALECTIN|4.02|Kd=96uM|Kd|=|96|uM|96000|nM
5JAN|2.12|2016|6HP|[Incomplete ligand] PDB use ligand structure of fragment 2 in paper, should be fragment 5|Q13093|PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE|3.01|Kd=980uM|Kd|=|980|uM|980000|nM
5L9I|1.90|2016|SNW|ligand is DFG|------|PERIPLASMIC BINDING PROTEIN|7.0|Kd=99nM|Kd|=|99|nM|99|nM
5CXA|1.30|2016|55L|compound 3; delta G=-11.2 kcal/mol|P39900|MACROPHAGE METALLOELASTASE (MMP-12)|8.05|Kd=9nM|Kd|=|9|nM|9|nM
5I9Z|1.70|2016|627|ligand is danusertib (PHA739358)|P29317|EPHRIN TYPE-A RECEPTOR 2|8.05|Kd=9nM|Kd|=|9|nM|9|nM
5LD8|2.13|2016|6U5|ligand is GSK3011724A; chemoproteomic affinities, also has SPR Kd in the 10-20nM range|P9WQD9|3-OXOACYL-[ACYL-CARRIER-PROTEIN] SYNTHASE 1|8.05|Kd=9nM|Kd|=|9|nM|9|nM
5I3A|2.20|2016|HQE|ligand is hydroquinone (HQ) in configuration A|B2ZB02|TYROSINASE|5.05|Kd=9uM|Kd|=|9|uM|9000|nM
4Y4G|1.44|2016|GGB|fragment compound 53|P11838|ENDOTHIAPEPSIN|2.0|Kd>10.0mM|Kd|>|10|mM|10000000|nM
5C87|1.55|2016|4YS|compound 5|P55201|PEREGRIN|3.7|Kd>200uM|Kd|>|200|uM|200000|nM
5DY7|1.69|2016|5GT|compound 10|P55201|PEREGRIN|3.7|Kd>200uM|Kd|>|200|uM|200000|nM
5DYA|1.65|2016|5GV|compound 14|P55201|PEREGRIN|3.7|Kd>200uM|Kd|>|200|uM|200000|nM
5EM3|1.40|2016|5Q0|compound 6|P55201|PEREGRIN|3.7|Kd>200uM|Kd|>|200|uM|200000|nM
5EVA|1.45|2016|5S9|compound 19|P55201|PEREGRIN|3.7|Kd>200uM|Kd|>|200|uM|200000|nM
5EWD|1.58|2016|5SH|compound 2|P55201|PEREGRIN|3.7|Kd>200uM|Kd|>|200|uM|200000|nM
5HN0|2.05|2016|LNN|[Nonstandard assay: ITC assay at Temp 4C] compound 4; IC50=769 uM|Q6DLV0|RNA-DIRECTED RNA POLYMERASE NS5|3.7|Kd>200uM|Kd|>|200|uM|200000|nM
5ELE|1.60|2016|5-mer|ligand is A-penta-BGA (A2G-NDG-NAG-GAL-FUC)|P01556|CHOLERA ENTEROTOXIN SUBUNIT B|1.52|Kd>30mM|Kd|>|30|mM|30000000|nM
5FSM|1.67|2016|N91|ligand is compound 5|P36639|7,8-DIHYDRO-8-OXOGUANINE TRIPHOSPHATASE|4.4|Kd>40uM|Kd|>|40|uM|40000|nM
5IVF|1.68|2016|6EB|ligand is compound N10|P29375|LYSINE-SPECIFIC DEMETHYLASE 5A|4.4|Kd>40uM|Kd|>|40|uM|40000|nM
5IR1|2.48|2016|12-mer|ligand is GQ(3-Br-F)-DLSTRRLKG meditope peptide|P01834|CETUXIMAB FAB, LIGHT CHAIN|5.27|Kd>5.4uM|Kd|>|5.4|uM|5400|nM
5E3G|1.65|2016|5JQ|compound 3|P55201|PEREGRIN|4.3|Kd>50uM|Kd|>|50|uM|50000|nM
5EUK|2.50|2016|12-mer|ligand is F3H meditope variant, CQHDLSTRRLKC|P01834|CETUXIMAB FAB, LIGHT CHAIN|4.3|Kd>50uM|Kd|>|50|uM|50000|nM
5F88|2.48|2016|12-mer|ligand is L5Y meditope variant, CQFDYSTRRLKC|P01834|CETUXIMAB FAB, LIGHT CHAIN|4.3|Kd>50uM|Kd|>|50|uM|50000|nM
5I2I|2.55|2016|12-mer|ligand is cyclic F3Q variant of the meditope; CQQDLSTRRLKG|P01834|CETUXIMAB FAB, LIGHT CHAIN|4.3|Kd>50uM|Kd|>|50|uM|50000|nM
5IVZ|2.48|2016|12-mer|ligand is GQFDLST(Cit)RLKG meditope peptide|P01834|CETUXIMAB FAB, LIGHT CHAIN|4.3|Kd>50uM|Kd|>|50|uM|50000|nM
5G42|1.72|2016|4TU|ligand is CT6|P51449|NUCLEAR RECEPTOR ROR-GAMMA|2.3|Kd>5mM|Kd|>|5|mM|5000000|nM
5IV2|2.48|2016|12-mer|ligand is GQFDLSTR(Cit)LKG meditope peptide|P01834|CETUXIMAB FAB, LIGHT CHAIN|5.1|Kd>8.0uM|Kd|>|8|uM|8000|nM
5F67|1.76|2016|19-mer|ligand is TRP channel tail (TRPCT)|Q24008|INACTIVATION-NO-AFTER-POTENTIAL D PROTEIN|6.89|Kd~0.13uM|Kd|~|0.13|uM|130|nM
5IM3|2.30|2016|DTP|bind approximately three dATP per polypeptide|Q9I4I1|RIBONUCLEOSIDE-DIPHOSPHATE REDUCTASE|5.82|Kd~1.5uM|Kd|~|1.5|uM|1500|nM
5JER|2.91|2016|19-mer|ligand is 19-mer Rotavirus NSP1 peptide|Q14653|ROTAVIRUS NSP1 PEPTIDE|3.7|Kd~200uM|Kd|~|200|uM|200000|nM
5DTM|2.20|2016|5F4|compound 1|Q8TEK3|HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-79 SPECIFIC|4.3|Kd~50uM|Kd|~|50|uM|50000|nM
5IIS|2.10|2016|6CB|ligand is compound 3a|P11309|SERINE/THREONINE-PROTEIN KINASE PIM-1|9.0|Ki<0.001uM|Ki|<|0.001|uM|1|nM
5EW9|2.18|2016|5VC|ligand is MK-5108|O14965|AURORA KINASE A|11.0|Ki<0.01nM|Ki|<|0.01|nM|0.01|nM
4ZY1|2.50|2016|4U5|pfa-m17,compound 10r|------|PROBABLE M17 FAMILY AMINOPEPTIDASE|8.14|Ki=0.0072uM|Ki|=|0.0072|uM|7.2|nM
4ZY0|2.20|2016|4TM|pfa-m17,compound 10q|------|PROBABLE M17 FAMILY AMINOPEPTIDASE|8.04|Ki=0.0091uM|Ki|=|0.0091|uM|9.1|nM
4ZYQ|2.60|2016|4U6|compound 10s|------|PROBABLE M17 FAMILY AMINOPEPTIDASE|8.01|Ki=0.0097uM|Ki|=|0.0097|uM|9.700000000000001|nM
4YDG|3.25|2016|G3G|compound 10|P03362|HTLV-1 PROTEASE|7.82|Ki=0.015uM|Ki|=|0.015|uM|15|nM
5HZ6|1.14|2016|65Y|compound 11|P15090|FATTY ACID-BINDING PROTEIN, ADIPOCYTE|7.8|Ki=0.016uM|Ki|=|0.016|uM|16|nM
5EDC|1.29|2016|5M7|compound 13|P15090|FATTY ACID-BINDING PROTEIN, ADIPOCYTE|7.66|Ki=0.022uM|Ki|=|0.022|uM|22|nM
5HCT|1.36|2016|61P|compound 13; +/-0.0002|P11838|ENDOTHIAPEPSIN|7.6|Ki=0.0254uM|Ki|=|0.0254|uM|25.4|nM
4ZW3|1.80|2016|4S9|PfA-M1, compound 9b|O96935|M1 FAMILY AMINOPEPTIDASE|7.57|Ki=0.027uM|Ki|=|0.027|uM|27|nM
5D48|1.81|2016|L96|compound 1|P15090|FATTY ACID-BINDING PROTEIN, ADIPOCYTE|7.52|Ki=0.03uM|Ki|=|0.03|uM|30|nM
4ZX9|2.60|2016|4TK|pfa-m17,compound 10b|------|PROBABLE M17 FAMILY AMINOPEPTIDASE|7.39|Ki=0.041uM|Ki|=|0.041|uM|41|nM
5DIU|1.30|2016|5BG|compound 3|Q13451|PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5|7.37|Ki=0.043uM|Ki|=|0.043|uM|43|nM
5J7P|1.85|2016|6H1|[Covalent complex] [Incomplete ligand] RDR03785 (compound 3); Miss a ring in PDB|P14174|MACROPHAGE MIGRATION INHIBITORY FACTOR|7.28|Ki=0.052uM|Ki|=|0.052|uM|52|nM
5B25|1.90|2016|4QJ|compound 3|Q01064|CALCIUM/CALMODULIN-DEPENDENT 3',5'-CYCLIC NUCLEOTIDE|10.24|Ki=0.058nM|Ki|=|0.058|nM|0.058|nM
4ZY2|2.10|2016|4TL|compound 10o|------|PROBABLE M17 FAMILY AMINOPEPTIDASE|7.22|Ki=0.060uM|Ki|=|0.06|uM|60|nM
4ZX3|2.00|2016|4TK|pfa-m1, compound10b|O96935|M1 FAMILY AMINOPEPTIDASE|7.19|Ki=0.065uM|Ki|=|0.065|uM|65|nM
5L2Z|1.79|2016|70C|[Nonstandard assay: assay at temp 37C] ligand is compound 56|P08709|COAGULATION FACTOR VII (HEAVY CHAIN)|10.22|Ki=0.06nM|Ki|=|0.06|nM|0.06|nM
4ZX4|1.90|2016|4TL|pfa-m1, compound 10o|O96935|M1 FAMILY AMINOPEPTIDASE|7.11|Ki=0.078uM|Ki|=|0.078|uM|78|nM
4ZX8|2.70|2016|4TY|pfa-m17, compound9b|------|PROBABLE M17 FAMILY AMINOPEPTIDASE|7.1|Ki=0.080uM|Ki|=|0.08|uM|80|nM
5K0H|2.20|2016|6PK|ligand is compound 2|P00742|COAGULATION FACTOR X|7.09|Ki=0.081uM|Ki|=|0.081|uM|81|nM
5A9U|1.60|2016|5P8|ligand is lorlatinib|Q9UM73|ALK TYROSINE KINASE RECEPTOR|10.1|Ki=0.08nM|Ki|=|0.08|nM|0.08|nM
5HZ9|2.30|2016|5M8|compound 6|P05413|FATTY ACID-BINDING PROTEIN|7.03|Ki=0.093uM|Ki|=|0.093|uM|93|nM
5D47|1.70|2016|L19|compound 2; author gives wrong compound 3|P15090|FATTY ACID-BINDING PROTEIN, ADIPOCYTE|7.0|Ki=0.10uM|Ki|=|0.1|uM|100|nM
5D45|1.65|2016|57P|compound 3; author gives wrong compound 2|P15090|FATTY ACID-BINDING PROTEIN, ADIPOCYTE|6.92|Ki=0.12uM|Ki|=|0.12|uM|120|nM
5L2Y|1.82|2016|70D|[Nonstandard assay: assay at temp 37C] ligand is compound 54|P08709|COAGULATION FACTOR VII (HEAVY CHAIN)|9.85|Ki=0.14nM|Ki|=|0.14|nM|0.14|nM
5DIV|1.65|2016|5BH|compound 29|Q13451|PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5|6.85|Ki=0.14uM|Ki|=|0.14|uM|140|nM
5LXB|2.34|2016|7A9|[Different protein in assay: assay use wildtype 5-HTBP protein] ligand is palonosetron|Q8WSF8|ACETYLCHOLINE RECEPTOR|9.77|Ki=0.17nM|Ki|=|0.17|nM|0.17|nM
5AYT|1.40|2016|L6Y||P02766|TRANSTHYRETIN|6.77|Ki=0.17uM|Ki|=|0.17|uM|170|nM
5EDB|1.18|2016|5M8|compound 10|P15090|FATTY ACID-BINDING PROTEIN, ADIPOCYTE|7.0|Ki=0.1uM|Ki|=|0.1|uM|100|nM
5FHO|2.30|2016|5XN|compound 7|P19491|GLUTAMATE RECEPTOR 2|6.67|Ki=0.213uM|Ki|=|0.213|uM|213|nM
4UFD|1.43|2016|S49|compound 5|P00734|THROMBIN LIGHT CHAIN|9.68|Ki=0.21nM|Ki|=|0.21|nM|0.21|nM
5DH5|2.00|2016|5AY|ligand is Pyp-1|Q9Y233|CGMP 3',5'-CYCLIC PHOSPHODIESTERASE|9.64|Ki=0.23nM|Ki|=|0.23|nM|0.23|nM
5L7E|1.86|2016|6Q0|ligand is compound 1; pKi=6.6, pIC50=5.9|P08235|MINERALOCORTICOID RECEPTOR|6.6|Ki=0.25uM|Ki|=|0.25|uM|250|nM
5EW0|1.30|2016|3C7|compound 1a (L-CS319)|Q9RMI1|BETA-LACTAMASE|6.59|Ki=0.26uM|Ki|=|0.26|uM|260|nM
5DXT|2.25|2016|5H5|compound 4|P42336|PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE|9.7|Ki=0.2nM|Ki|=|0.2|nM|0.2|nM
5SZ4|1.60|2016|72D|ligand is compound 4a|P00918|CARBONIC ANHYDRASE 2|9.7|Ki=0.2nM|Ki|=|0.2|nM|0.2|nM
5SZ7|1.78|2016|72H|ligand is compound 4p|P00918|CARBONIC ANHYDRASE 2|9.7|Ki=0.2nM|Ki|=|0.2|nM|0.2|nM
5KR1|1.60|2016|017|ligand is DRV|V5YAB1|PROTEASE PR5-DRV|9.49|Ki=0.32nM|Ki|=|0.32|nM|0.32|nM
5IWG|1.66|2016|IWX|ligand is compound BRD4884|Q92769|HISTONE DEACETYLASE 2|6.46|Ki=0.346uM|Ki|=|0.346|uM|346|nM
5CGV|2.17|2016|0N8|ligand is L-742,001|C3W5S0|POLYMERASE ACIDIC PROTEIN|6.47|Ki=0.34uM|Ki|=|0.34|uM|340|nM
5IUB|2.10|2016|6DV|ligand is compound 12x|P29274|ADENOSINE RECEPTOR A2A,SOLUBLE CYTOCHROME B562,ADENOSINE|9.46|Ki=0.35nM|Ki|=|0.35|nM|0.35|nM
5FDR|2.60|2016|5X3|compound 60|Q07820|INDUCED MYELOID LEUKEMIA CELL DIFFERENTIATION PROTEIN MCL|9.44|Ki=0.36nM|Ki|=|0.36|nM|0.36|nM
5AAA|1.73|2016|VGH|ligand is crizotinib|Q9UM73|ALK TYROSINE KINASE RECEPTOR|9.42|Ki=0.38nM|Ki|=|0.38|nM|0.38|nM
5JFP|1.49|2016|6KK|ligand is compound 15d|C8B467|HIV-1 PROTEASE|9.32|Ki=0.48nM|Ki|=|0.48|nM|0.48|nM
5HZ8|1.12|2016|65Z|compound 9|P15090|FATTY ACID-BINDING PROTEIN|6.4|Ki=0.4uM|Ki|=|0.4|uM|400|nM
5IX0|1.72|2016|6EZ|ligand is compound BRD7232|Q92769|HISTONE DEACETYLASE 2|6.28|Ki=0.519uM|Ki|=|0.519|uM|519|nM
5KQY|1.65|2016|017|ligand is DRV|C8BD48|HIV-1 PROTEASE E35D-DRV|9.29|Ki=0.51nM|Ki|=|0.51|nM|0.51|nM
5IU4|1.72|2016|ZMA|ligand is compound ZM241385|P29274|ADENOSINE RECEPTOR A2A,SOLUBLE CYTOCHROME B562,ADENOSINE|9.28|Ki=0.53nM|Ki|=|0.53|nM|0.53|nM
4ZJ8|2.75|2016|SUV|ligand is suvorexant|O43613|HUMAN OX1R FUSION PROTEIN TO P.ABYSII GLYCOGEN SYNTHASE|9.26|Ki=0.55nM|Ki|=|0.55|nM|0.55|nM
5DHU|2.33|2016|5A8|compound 11q|Q8Y8D7|NAD KINASE 1|6.3|Ki=0.5uM|Ki|=|0.5|uM|500|nM
4ZX5|1.95|2016|4TM|compound 10q|O96935|M1 FAMILY AMINOPEPTIDASE|6.19|Ki=0.64uM|Ki|=|0.64|uM|640|nM
5EEI|1.32|2016|SHH|ligand is SAHA|A7YT55|HDAC6 PROTEIN|9.22|Ki=0.6nM|Ki|=|0.6|nM|0.6|nM
5KR0|1.80|2016|478|ligand is APV|C8BD48|HIV-1 PROTEASE E35D-APV|9.15|Ki=0.71nM|Ki|=|0.71|nM|0.71|nM
5L30|1.73|2016|70A|ligand is compound 59|P08709|COAGULATION FACTOR VII|9.14|Ki=0.72nM|Ki|=|0.72|nM|0.72|nM
5CR7|2.90|2016|5WO|compound 2c|P49902|CYTOSOLIC PURINE 5'-NUCLEOTIDASE|3.1|Ki=0.79mM|Ki|=|0.79|mM|790000|nM
5AAB|2.20|2016|VGH|ligand is crizotinib|Q9UM73|ALK TYROSINE KINASE RECEPTOR|9.06|Ki=0.88nM|Ki|=|0.88|nM|0.88|nM
5TRF|2.10|2016|7HC|ligand is SAR405838 (MI-77301)|Q00987|E3 UBIQUITIN-PROTEIN LIGASE MDM2|9.06|Ki=0.88nM|Ki|=|0.88|nM|0.88|nM
5EEK|1.59|2016|TSN|ligand is trichostatin A(TSA)|A7YT55|HDAC6 PROTEIN|9.1|Ki=0.8nM|Ki|=|0.8|nM|0.8|nM
5SZ0|1.63|2016|72D|ligand is compound 4a|P00918|CARBONIC ANHYDRASE 2|9.1|Ki=0.8nM|Ki|=|0.8|nM|0.8|nM
5L7F|1.80|2016|2-mer|ligand is compound probe 1; consist of R47-6PJ|P39900|MACROPHAGE METALLOELASTASE|9.05|Ki=0.90nM|Ki|=|0.9|nM|0.9|nM
5E2S|1.50|2016|5CX|compound 4c|P00918|CARBONIC ANHYDRASE 2|9.01|Ki=0.98nM|Ki|=|0.98|nM|0.98|nM
4UJA|1.93|2016|4L7|compound 1p|P17612|CAMP-DEPENDENT PROTEIN KINASE|9.05|Ki=0.9nM|Ki|=|0.9|nM|0.9|nM
4ZJC|2.83|2016|4OT|ligand is SB-674042|O43613|HUMAN OX1R FUSION PROTEIN TO P.ABYSII GLYCOGEN SYNTHASE|8.96|Ki=1.1nM|Ki|=|1.1|nM|1.1|nM
5EEN|1.86|2016|5OG|ligand is Belinostat|A7YT55|HDAC6 PROTEIN|8.96|Ki=1.1nM|Ki|=|1.1|nM|1.1|nM
5IU7|1.90|2016|6DY|ligand is compound 12c|P29274|ADENOSINE RECEPTOR A2A,SOLUBLE CYTOCHROME B562,ADENOSINE|8.96|Ki=1.1nM|Ki|=|1.1|nM|1.1|nM
4ZW8|2.00|2016|4T2|pfa-m1,compound 9r|O96935|M1 FAMILY AMINOPEPTIDASE|5.96|Ki=1.1uM|Ki|=|1.1|uM|1100|nM
5FHN|1.60|2016|5XO|compound 8|P19491|GLUTAMATE RECEPTOR 2|5.9|Ki=1.27uM|Ki|=|1.27|uM|1270|nM
5HCY|2.46|2016|60D|compound 13|P00533|EPIDERMAL GROWTH FACTOR RECEPTOR|8.92|Ki=1.2nM|Ki|=|1.2|nM|1.2|nM
5SZ1|1.55|2016|72E|ligand is compound 4b|P00918|CARBONIC ANHYDRASE 2|8.92|Ki=1.2nM|Ki|=|1.2|nM|1.2|nM
5AAC|1.70|2016|VGH|ligand is crizotinib|Q9UM73|ALK TYROSINE KINASE RECEPTOR|8.89|Ki=1.3nM|Ki|=|1.3|nM|1.3|nM
5EF8|2.60|2016|LBH|ligand is panobinostat|A7YT55|HDAC6 PROTEIN|8.85|Ki=1.4nM|Ki|=|1.4|nM|1.4|nM
5HJ9|1.28|2016|X7A|[Uncommon element] [Different ligand in assay: S-isomer] inhibitor ABHPE; affinity is for ABHPE, S-isomer (L)|Q6TUJ5|ARGINASE|5.85|Ki=1.4uM|Ki|=|1.4|uM|1400|nM
5IUA|2.20|2016|6DX|ligand is compound 12b|P29274|ADENOSINE RECEPTOR A2A,SOLUBLE CYTOCHROME B562,ADENOSINE|8.82|Ki=1.5nM|Ki|=|1.5|nM|1.5|nM
5KBY|2.24|2016|6RL|ligand is trelagliptin (SYR-472)|P27487|DIPEPTIDYL PEPTIDASE 4|8.82|Ki=1.5nM|Ki|=|1.5|nM|1.5|nM
5D2R|1.90|2016|56W|ligand is inhibitor 1|B5ZAD9|CONSERVED HYPOTHETICAL SECRETED PROTEIN|5.82|Ki=1.5uM|Ki|=|1.5|uM|1500|nM
5K13|1.85|2016|6Q7|ligand is compound 2|P10276|RETINOIC ACID RECEPTOR ALPHA|8.74|Ki=1.8nM|Ki|=|1.8|nM|1.8|nM
5JG1|1.16|2016|6KR|ligand is compound 15i|C8B467|HIV-1 PROTEASE|8.72|Ki=1.9nM|Ki|=|1.9|nM|1.9|nM
4ZW6|1.90|2016|4SY|compound 9q|O96935|M1 FAMILY AMINOPEPTIDASE|5.72|Ki=1.9uM|Ki|=|1.9|uM|1900|nM
4ZYU|1.95|2016|3YA|[Nonstandard assay: Temp 37] Ki=1067+/-271nM, GARFTase / AGF50|P22102|TRIFUNCTIONAL PURINE BIOSYNTHETIC PROTEIN ADENOSINE-3|5.97|Ki=1067nM|Ki|=|1067|nM|1067|nM
4UJB|1.95|2016|8BQ|compound 1b|P17612|CAMP-DEPENDENT PROTEIN KINASE|8.0|Ki=10nM|Ki|=|10|nM|10|nM
5EVB|1.84|2016|3R9|compound 1b (D-CS319)|P52700|METALLO-BETA-LACTAMASE L1|5.0|Ki=10uM|Ki|=|10|uM|10000|nM
5EVD|1.80|2016|VC2|compound 2b (D-VC26)|P52700|METALLO-BETA-LACTAMASE L1|5.0|Ki=10uM|Ki|=|10|uM|10000|nM
5F5B|2.30|2016|5-mer|Ac-VRMA-CHO; +/-4|------|RHOMBOID PROTEASE GLPG|3.95|Ki=113uM|Ki|=|113|uM|113000|nM
4UFF|1.55|2016|6V2|compound 3|P00734|THROMBIN LIGHT CHAIN|7.96|Ki=11nM|Ki|=|11|nM|11|nM
4YV8|2.00|2016|5-mer|[Covalent complex] ligand is 5-mer covalent inhibitor lichostatinal|P43235|CATHEPSIN K|7.96|Ki=11nM|Ki|=|11|nM|11|nM
5E28|1.30|2016|BC5|compound 4h|P00918|CARBONIC ANHYDRASE 2|7.91|Ki=12.3nM|Ki|=|12.3|nM|12.3|nM
5JY3|2.40|2016|6OX|ligand is compound 15 (BMS-852927)|P55055|OXYSTEROLS RECEPTOR LXR-BETA|7.92|Ki=12nM|Ki|=|12|nM|12|nM
5DRQ|1.63|2016|5EM|ligand is LPC-040|P47205|UDP-3-O-[3-HYDROXYMYRISTOYL] N-ACETYLGLUCOSAMINE DEACETYLASE|10.92|Ki=12pM|Ki|=|12|pM|0.012|nM
5EVK|1.63|2016|3C7|compound 1a (L-CS319)|P52700|METALLO-BETA-LACTAMASE L1|4.92|Ki=12uM|Ki|=|12|uM|12000|nM
5J5R|1.60|2016|6G1|inhibitor VCC234718|G7CNL4|INOSINE-5'-MONOPHOSPHATE DEHYDROGENASE,INOSINE-5|6.89|Ki=130nM|Ki|=|130|nM|130|nM
5JF2|2.00|2016|SF7|ligand is AT002|Q8E378|PEPTIDE DEFORMYLASE|7.89|Ki=13nM|Ki|=|13|nM|13|nM
5KYJ|2.80|2016|6Y8|[Different protein in assay: assay use only LXRbeta] ligand is compound 14|P55055|OXYSTEROLS RECEPTOR LXR-BETA|7.89|Ki=13nM|Ki|=|13|nM|13|nM
5J7W|2.50|2016|MTX|ligand is methotrexate|Q834R3|THYMIDYLATE SYNTHASE|4.89|Ki=13uM|Ki|=|13|uM|13000|nM
5F1V|2.20|2016|3VN|potent allosteric inhibitor bislysine|Q9PPB4|4-HYDROXY-TETRAHYDRODIPICOLINATE SYNTHASE|6.85|Ki=140nM|Ki|=|140|nM|140|nM
5DHP|2.27|2016|5AQ|compound 12a|Q8Y8D7|NAD KINASE 1|3.85|Ki=140uM|Ki|=|140|uM|140000|nM
5JF8|1.80|2016|PN3|ligand is inhibitor RAS358 (21)|Q8E378|PEPTIDE DEFORMYLASE|5.85|Ki=1428nM|Ki|=|1428|nM|1428|nM
5ELW|1.40|2016|5LD|ligand is (R)-C348|O23346|IMIDAZOLEGLYCEROL-PHOSPHATE DEHYDRATASE 2, CHLOROPLASTIC|7.85|Ki=14nM|Ki|=|14|nM|14|nM
5HI7|2.15|2016|62X|ligand is GSK2807|Q9H7B4|HISTONE-LYSINE N-METHYLTRANSFERASE SMYD3|7.85|Ki=14nM|Ki|=|14|nM|14|nM
5K51|2.96|2016|6QD|ligand is compound 6|Q07010|HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE|4.8|Ki=15.8uM|Ki|=|15.8|uM|15800|nM
5HDV|1.71|2016|60V|compound 11|P56817|BETA-SECRETASE 1|7.82|Ki=15nM|Ki|=|15|nM|15|nM
5AYF|2.01|2016|C7H|ligand is cyproheptadine|Q8WTS6|HISTONE-LYSINE N-METHYLTRANSFERASE SETD7|4.82|Ki=15uM|Ki|=|15|uM|15000|nM
5EWA|2.30|2016|9BZ|compound 2a (L-VC26)|P52699|BETA-LACTAMASE IMP-1|4.82|Ki=15uM|Ki|=|15|uM|15000|nM
5J9Z|2.50|2016|6HJ|[Different protein in assay: Protein in binding assay is mutant T790M / L858R] ligand is compound 1a|P00533|EPIDERMAL GROWTH FACTOR RECEPTOR|7.8|Ki=16nM|Ki|=|16|nM|16|nM
5L7G|2.01|2016|6QE|ligand is compound 25d; pKi=7.8, pIC50=6.3|P08235|MINERALOCORTICOID RECEPTOR|7.8|Ki=16nM|Ki|=|16|nM|16|nM
4YCN|3.50|2016|7BL|BLLB; coupled enzyme assay|P04191|SARCOPLASMIC/ENDOPLASMIC RETICULUM CALCIUM ATPASE 1|7.77|Ki=17nM|Ki|=|17|nM|17|nM
4ZYT|1.70|2016|3Y9|[Nonstandard assay: Temp 37] Ki=17+/-3nM, GARFTase / AGF23|P22102|TRIFUNCTIONAL PURINE BIOSYNTHETIC PROTEIN ADENOSINE-3|7.77|Ki=17nM|Ki|=|17|nM|17|nM
5KXI|3.94|2016|NCT|ligand is nicotine.|P43681|NEURONAL ACETYLCHOLINE RECEPTOR SUBUNIT ALPHA-4|7.74|Ki=18.2nM|Ki|=|18.2|nM|18.2|nM
5FDI|1.85|2016|5WM|compound 4|P00918|CARBONIC ANHYDRASE 2|7.73|Ki=18.5nM|Ki|=|18.5|nM|18.5|nM
5IU8|2.00|2016|6DZ|ligand is compound 12f|P29274|ADENOSINE RECEPTOR A2A,SOLUBLE CYTOCHROME B562,ADENOSINE|7.74|Ki=18nM|Ki|=|18|nM|18|nM
5J41|1.19|2016|2-mer|ligand is 3LF-GSH, hydrolyzed Piperlongumine (hPL)|P09211|GLUTATHIONE S-TRANSFERASE P1-1|3.7|Ki=199uM|Ki|=|199|uM|199000|nM
4YCM|3.20|2016|7BS|BLS; coupled enzyme assay|P04191|SARCOPLASMIC/ENDOPLASMIC RETICULUM CALCIUM ATPASE 1|7.72|Ki=19nM|Ki|=|19|nM|19|nM
4ZW7|1.95|2016|4SZ|pfa-m1;compound 9m|O96935|M1 FAMILY AMINOPEPTIDASE|4.72|Ki=19uM|Ki|=|19|uM|19000|nM
5DXH|3.00|2016|5H2|compound 5|P42336|PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE|9.0|Ki=1nM|Ki|=|1|nM|1|nM
5EF7|1.90|2016|5OJ|ligand is HPOB|A7YT55|HDAC6 PROTEIN|9.0|Ki=1nM|Ki|=|1|nM|1|nM
5HDU|1.58|2016|60W|compound 8|P56817|BETA-SECRETASE 1|9.0|Ki=1nM|Ki|=|1|nM|1|nM
5DHT|2.59|2016|5A9|compound 11c|Q8Y8D7|NAD KINASE 1|6.0|Ki=1uM|Ki|=|1|uM|1000|nM
5CJ6|2.07|2016|51Y|compound 6|P10275|ANDROGEN RECEPTOR|8.69|Ki=2.03nM|Ki|=|2.03|nM|2.03|nM
5SZ2|1.63|2016|72G|ligand is compound 4e|P00918|CARBONIC ANHYDRASE 2|8.7|Ki=2.0nM|Ki|=|2|nM|2|nM
5EDU|2.79|2016|TSN|ligand is trichostatin A(TSA)|P0AEY0|MALTOSE-BINDING PERIPLASMIC PROTEIN, HISTONE DEACETYLASE 6|8.66|Ki=2.2nM|Ki|=|2.2|nM|2.2|nM
5HU1|1.50|2016|66F|compound 3|P56817|BETA-SECRETASE 1|8.66|Ki=2.2nM|Ki|=|2.2|nM|2.2|nM
5EHN|2.60|2016|5NZ|ligand is syn-TZ2PA5|P21836|ACETYLCHOLINESTERASE|11.64|Ki=2.3pM|Ki|=|2.3|pM|0.0023|nM
5FOO|2.10|2016|JAZ|ligand is 6-phospho-cyclophellitol|Q99YP9|6-PHOSPHO-BETA-D GLYCOSIDASE|2.62|Ki=2.4mM|Ki|=|2.4|mM|2400000|nM
5HTZ|1.95|2016|66J|compound 9|P56817|BETA-SECRETASE 1|8.62|Ki=2.4nM|Ki|=|2.4|nM|2.4|nM
5SZ3|1.69|2016|72H|ligand is compound 4p|P00918|CARBONIC ANHYDRASE 2|8.6|Ki=2.5nM|Ki|=|2.5|nM|2.5|nM
5HK2|3.20|2016|61V|ligand is 4-IBP|Q99720|SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1|8.59|Ki=2.6nM|Ki|=|2.6|nM|2.6|nM
5D75|1.83|2016|FK5|ligand is FK506|Q00688|PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP3|6.7|Ki=200nM|Ki|=|200|nM|200|nM
5HE4|1.53|2016|60T|compound 23|P56817|BETA-SECRETASE 1|7.7|Ki=20nM|Ki|=|20|nM|20|nM
5SZ5|1.27|2016|72E|ligand is compound 4b|P00918|CARBONIC ANHYDRASE 2|7.7|Ki=20nM|Ki|=|20|nM|20|nM
5JSQ|1.50|2016|6MS|ligand is compound 3|Q07010|HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE|4.67|Ki=21.3uM|Ki|=|21.3|uM|21300|nM
5EG4|1.32|2016|5N7|compound 31|P00760|TRYPSIN|7.68|Ki=21nM|Ki|=|21|nM|21|nM
5DEX|2.40|2016|5E0|ligand is FRA-19|P35439|GLUTAMATE RECEPTOR IONOTROPIC, NMDA 1|7.65|Ki=22.6nM|Ki|=|22.6|nM|22.6|nM
4ZYV|2.05|2016|G71|[Nonstandard assay: Temp 37] Ki=22+/-3nM, GARFTase / AGF71|P22102|TRIFUNCTIONAL PURINE BIOSYNTHETIC PROTEIN ADENOSINE-3|7.66|Ki=22nM|Ki|=|22|nM|22|nM
5DFP|2.20|2016|59U|compound 1 (FRAX1036)|Q13153|SERINE/THREONINE-PROTEIN KINASE PAK 1|7.66|Ki=22nM|Ki|=|22|nM|22|nM
5KZ0|2.30|2016|6YL|ligand is compound 6f|Q9UM73|ALK TYROSINE KINASE RECEPTOR|7.66|Ki=22nM|Ki|=|22|nM|22|nM
5FKJ|3.13|2016|G0W|ligand is C-547|P21836|ACETYLCHOLINESTERASE|10.66|Ki=22pM|Ki|=|22|pM|0.022|nM
5EL9|1.10|2016|5DL|ligand is (S)-C348|O23346|IMIDAZOLEGLYCEROL-PHOSPHATE DEHYDRATASE 2, CHLOROPLASTIC|7.64|Ki=23.0nM|Ki|=|23|nM|23|nM
5EIE|2.10|2016|TZ2|ligand is TZ2|P21836|ACETYLCHOLINESTERASE|7.64|Ki=23nM|Ki|=|23|nM|23|nM
5EXN|1.49|2016|5SU|ligand is compound (S)-24|P03951|COAGULATION FACTOR XIA|7.64|Ki=23nM|Ki|=|23|nM|23|nM
5DHR|2.31|2016|5AJ|compound 11o|Q8Y8D7|NAD KINASE 1|4.64|Ki=23uM|Ki|=|23|uM|23000|nM
5J7Q|2.05|2016|6H2|ligand is compound 14|P14174|MACROPHAGE MIGRATION INHIBITORY FACTOR|4.58|Ki=26.6uM|Ki|=|26.6|uM|26600|nM
5DRO|2.01|2016|ZH2|[Different protein in assay: C181A] ligand is LPC-011|O67648|UDP-3-O-[3-HYDROXYMYRISTOYL] N-ACETYLGLUCOSAMINE|10.59|Ki=26pM|Ki|=|26|pM|0.026000000000000002|nM
5SYM|1.55|2016|71Q|ligand is ML348|O75608|ACYL-PROTEIN THIOESTERASE 1|6.55|Ki=280nM|Ki|=|280|nM|280|nM
4UJ9|1.87|2016|S3N|compound 1l|P17612|CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTIC|8.7|Ki=2nM|Ki|=|2|nM|2|nM
5HCV|2.50|2016|60R|compound 21|P08235|MINERALOCORTICOID RECEPTOR|8.7|Ki=2nM|Ki|=|2|nM|2|nM
5HG5|1.52|2016|633|[Covalent complex] compound 10; Ki estimated|P00533|EPIDERMAL GROWTH FACTOR RECEPTOR|8.7|Ki=2nM|Ki|=|2|nM|2|nM
5DHQ|2.29|2016|5AK|compound 12c|Q8Y8D7|NAD KINASE 1|5.7|Ki=2uM|Ki|=|2|uM|2000|nM
5IJ7|2.62|2016|6BN|inhibitor 1|G1KPH4|ENHANCER OF ZESTE HOMOLOG 2 (EZH2),HISTONE-LYSINE N|8.51|Ki=3.10nM|Ki|=|3.1|nM|3.1|nM
5FL1|1.95|2016|DV1|[Different protein in assay: binding data for hOGA protein] compound 11b|Q89ZI2|O-GLCNACASE BT_4395|8.49|Ki=3.2nM|Ki|=|3.2|nM|3.2|nM
5KR2|1.78|2016|ROC|ligand is SQV|V5YAB1|PROTEASE PR5-SQV|8.48|Ki=3.3nM|Ki|=|3.3|nM|3.3|nM
5DRR|1.59|2016|5EN|ligand is LPC-058|P47205|UDP-3-O-[3-HYDROXYMYRISTOYL] N-ACETYLGLUCOSAMINE DEACETYLASE|11.46|Ki=3.5pM|Ki|=|3.5|pM|0.0035|nM
5KQX|2.40|2016|ROC|ligand is SQV|C8BD48|HIV-1 PROTEASE E35D-SQV|8.44|Ki=3.6nM|Ki|=|3.6|nM|3.6|nM
5DEY|2.10|2016|59T|compound 12 (G-5555)|Q13153|SERINE/THREONINE-PROTEIN KINASE PAK 1|8.43|Ki=3.7nM|Ki|=|3.7|nM|3.7|nM
5EXL|2.30|2016|5SS|ligand is compound (S)-10|P03951|COAGULATION FACTOR XIA|8.43|Ki=3.7nM|Ki|=|3.7|nM|3.7|nM
4UJ1|1.77|2016|NVX|compound 1c|P17612|CAMP-DEPENDENT PROTEIN KINASE|6.52|Ki=300nM|Ki|=|300|nM|300|nM
5HE5|1.55|2016|60S|compound 17|P56817|BETA-SECRETASE 1|6.47|Ki=336nM|Ki|=|336|nM|336|nM
5EHQ|2.50|2016|5O2|ligand is anti-TZ2PA5|P21836|ACETYLCHOLINESTERASE|10.48|Ki=33pM|Ki|=|33|pM|0.033|nM
5FDC|1.75|2016|5WN|compound 1|P00918|CARBONIC ANHYDRASE 2|7.46|Ki=34.8nM|Ki|=|34.8|nM|34.8|nM
5EFJ|1.73|2016|4-mer|ligand is HC toxin, a peptide-like inhibitor|A7YT55|HDAC6 PROTEIN|6.46|Ki=350nM|Ki|=|350|nM|350|nM
5FL0|1.95|2016|71I|[Different protein in assay: binding data for hOGA protein] compound 15e|Q89ZI2|O-GLCNACASE BT_4395|6.46|Ki=350nM|Ki|=|350|nM|350|nM
5HG9|2.15|2016|63A|[Covalent complex] compound 14; Ki estimated|P00533|EPIDERMAL GROWTH FACTOR RECEPTOR|7.46|Ki=35nM|Ki|=|35|nM|35|nM
5FDO|2.80|2016|5X2|compound 49|Q07820|INDUCED MYELOID LEUKEMIA CELL DIFFERENTIATION PROTEIN MCL|6.44|Ki=361nM|Ki|=|361|nM|361|nM
4ZW5|1.80|2016|4SA|pfa-m1; compoud 9f|O96935|M1 FAMILY AMINOPEPTIDASE|4.43|Ki=37uM|Ki|=|37|uM|37000|nM
5JF3|1.60|2016|SF5|ligand is AT018|Q8E378|PEPTIDE DEFORMYLASE|7.42|Ki=38nM|Ki|=|38|nM|38|nM
5HG8|1.42|2016|634|[Covalent complex] compound 12; Ki estimated|P00533|EPIDERMAL GROWTH FACTOR RECEPTOR|8.52|Ki=3nM|Ki|=|3|nM|3|nM
5I4V|2.61|2016|67S|[Different protein in assay: assay for ligand binding domain of human LXR Beta] ligand is compound 17|P55055|OXYSTEROLS RECEPTOR LXR-BETA|8.52|Ki=3nM|Ki|=|3|nM|3|nM
5HCX|2.60|2016|60B|compound 7|P00533|EPIDERMAL GROWTH FACTOR RECEPTOR|8.39|Ki=4.1nM|Ki|=|4.1|nM|4.1|nM
5EFB|2.54|2016|5OK|ligand is Oxamflatin|A7YT55|HDAC6 PROTEIN|8.37|Ki=4.3nM|Ki|=|4.3|nM|4.3|nM
5HK1|2.51|2016|61W|ligand is PD144418|Q99720|SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1|8.37|Ki=4.3nM|Ki|=|4.3|nM|4.3|nM
5CDH|2.00|2016|TLA|[Nonstandard assay: Temp 37 C and pH 5.5 with 6.4 pmoles of enzyme] competitive inhibition, L(+)-tartrate as the inhibitor and pNPP as the substrate|Q9APF7|MAJOR ACID PHOSPHATASE|5.37|Ki=4.3uM|Ki|=|4.3|uM|4300|nM
5IME|2.22|2016|6BZ|ligand is compound 9|Q13153|SERINE/THREONINE-PROTEIN KINASE PAK 1|8.34|Ki=4.6nM|Ki|=|4.6|nM|4.6|nM
5FKY|1.80|2016|2J4|[Nonstandard assay: Temp 37] ligand is compound 11a|Q89ZI2|O-GLCNACASE BT_4395|8.33|Ki=4.7nM|Ki|=|4.7|nM|4.7|nM
5EEF|2.15|2016|TSN|ligand is trichostatin A(TSA)|F8W4B7|HDAC6|8.32|Ki=4.8nM|Ki|=|4.8|nM|4.8|nM
5G53|3.40|2016|NEC|ligand is agonist NECA; assay at 100mM NaCl|P29274|ADENOSINE RECEPTOR A2A|6.37|Ki=430nM|Ki|=|430|nM|430|nM
5DQC|2.47|2016|5E7|compound 2|P56817|BETA-SECRETASE 1|7.34|Ki=45.6nM|Ki|=|45.6|nM|45.6|nM
5HDZ|1.49|2016|954|compound 16|P56817|BETA-SECRETASE 1|7.35|Ki=45nM|Ki|=|45|nM|45|nM
5EIJ|1.99|2016|5OT|ligand is compound 3|P00918|CARBONIC ANHYDRASE 2|5.31|Ki=4860nM|Ki|=|4860|nM|4860|nM
5HDX|1.60|2016|60U|compound 15|P56817|BETA-SECRETASE 1|7.32|Ki=48nM|Ki|=|48|nM|48|nM
5DXU|2.64|2016|5H5|compound 4|O00329|PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE|8.4|Ki=4nM|Ki|=|4|nM|4|nM
5HD0|1.65|2016|60Y|compound 6|P56817|BETA-SECRETASE 1|8.4|Ki=4nM|Ki|=|4|nM|4|nM
5HG7|1.85|2016|630|[Covalent complex] compound 1; Ki estimated|P00533|EPIDERMAL GROWTH FACTOR RECEPTOR|8.4|Ki=4nM|Ki|=|4|nM|4|nM
5J8Z|1.70|2016|FC4|ligand is racemic compound D; ligand codes are FC4 and 6KE|P00918|CARBONIC ANHYDRASE 2|8.3|Ki=5.0nM|Ki|=|5|nM|5|nM
5KZQ|2.80|2016|6YS|ligand is compound 19f|Q14416|METABOTROPIC GLUTAMATE RECEPTOR 2|8.28|Ki=5.3nM|Ki|=|5.3|nM|5.3|nM
4ZX6|2.05|2016|4U6|compound 10s|O96935|M1 FAMILY AMINOPEPTIDASE|5.27|Ki=5.4uM|Ki|=|5.4|uM|5400|nM
5L7H|1.84|2016|6QG|ligand is compound 44; pKi=7.3, pIC50=6.6|P08235|MINERALOCORTICOID RECEPTOR|7.3|Ki=50nM|Ki|=|50|nM|50|nM
5J4N|2.59|2016|AG2|ligand is agmatine|P60063|ARGININE/AGMATINE ANTIPORTER|4.25|Ki=56uM|Ki|=|56|uM|56000|nM
5KAP|2.95|2016|6RH|ligand is compound 5|Q07010|HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE|4.23|Ki=58.6uM|Ki|=|58.6|uM|58600|nM
5DH4|2.20|2016|5AV|compound 6|Q9Y233|CGMP 3',5'-CYCLIC PHOSPHODIESTERASE|7.24|Ki=58nM|Ki|=|58|nM|58|nM
5J9Y|2.80|2016|6HL|[Different protein in assay: Protein in binding assay is mutant T790M / L858R] ligand is compound 1b|P00533|EPIDERMAL GROWTH FACTOR RECEPTOR|7.24|Ki=58nM|Ki|=|58|nM|58|nM
5HU0|1.83|2016|66H|ligand is compound (R)-13|P56817|BETA-SECRETASE 1|6.23|Ki=595nM|Ki|=|595|nM|595|nM
5J9F|2.10|2016|83A|ligand is compound 4|P22102|TRIFUNCTIONAL PURINE BIOSYNTHETIC PROTEIN ADENOSINE-3|7.23|Ki=59nM|Ki|=|59|nM|59|nM
5HE7|1.71|2016|60X|compound 9|P56817|BETA-SECRETASE 1|8.3|Ki=5nM|Ki|=|5|nM|5|nM
5KDR|2.60|2016|YT5|ligand is moiramide B|Q2FG38|ACETYL-COENZYME A CARBOXYLASE CARBOXYL TRANSFERASE SUBUNIT|8.3|Ki=5nM|Ki|=|5|nM|5|nM
5KHM|1.48|2016|XNH|ligand is compound 13; pKi=8.3|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|8.3|Ki=5nM|Ki|=|5|nM|5|nM
5FTO|2.22|2016|YMX|compound 2, Entrectinib; Ki calculated from IC50|Q9UM73|ALK TYROSINE KINASE RECEPTOR|8.21|Ki=6.2nM|Ki|=|6.2|nM|6.2|nM
5EXM|2.09|2016|5ST|ligand is compound (S)-17|P03951|COAGULATION FACTOR XIA|8.2|Ki=6.3nM|Ki|=|6.3|nM|6.3|nM
5F91|2.00|2016|5WJ|compound 7|P9WN92|FUMARATE HYDRATASE CLASS II|5.2|Ki=6.3uM|Ki|=|6.3|uM|6300|nM
5AA9|1.93|2016|5P8|ligand is loratinib|Q9UM73|ALK TYROSINE KINASE RECEPTOR|8.19|Ki=6.4nM|Ki|=|6.4|nM|6.4|nM
5JF6|1.70|2016|BB4|ligand is inhibitor 6b (AB47)|Q8E378|PEPTIDE DEFORMYLASE|7.21|Ki=62nM|Ki|=|62|nM|62|nM
5JF5|1.80|2016|7JT|ligand is AT020|Q8E378|PEPTIDE DEFORMYLASE|7.2|Ki=63nM|Ki|=|63|nM|63|nM
5FCZ|2.45|2016|TNX|ligand is NTA-glucal|O85361|B-N-ACETYLHEXOSAMINIDASE|4.2|Ki=63uM|Ki|=|63|uM|63000|nM
5JF1|2.00|2016|BB2|ligand is actinonin|Q8E378|PEPTIDE DEFORMYLASE|7.19|Ki=64nM|Ki|=|64|nM|64|nM
5JF4|2.40|2016|6JT|ligand is AT019|Q8E378|PEPTIDE DEFORMYLASE|7.19|Ki=65nM|Ki|=|65|nM|65|nM
5ETJ|2.30|2016|IM5|ligand is DADMe-ImmG; inhibition assay, should be Ki data, not Kd data|P00491|PURINE NUCLEOSIDE PHOSPHORYLASE|10.18|Ki=66pM|Ki|=|66|pM|0.066|nM
5M1Z|2.00|2016|2-mer|[Nonstandard assay: Temp 40] +/-4, comp.2|B8ZY56|EXO-1,5-ALPHA-L-ARABINOFURANOBIOSIDASE|4.18|Ki=66uM|Ki|=|66|uM|66000|nM
4ZYZ|1.60|2016|3YD|[Nonstandard assay: Temp 37] Ki=67+/-10nM, GARFTase / AGF145|P22102|TRIFUNCTIONAL PURINE BIOSYNTHETIC PROTEIN ADENOSINE-3|7.17|Ki=67nM|Ki|=|67|nM|67|nM
4ZYW|2.05|2016|G94|[Nonstandard assay: Temp 37] Ki=68+/-11nM, GARFTase / AGF94|P22102|TRIFUNCTIONAL PURINE BIOSYNTHETIC PROTEIN ADENOSINE-3|7.17|Ki=68nM|Ki|=|68|nM|68|nM
5KYA|2.60|2016|6Y4|[Different protein in assay: assay use only LXRbeta] ligand is compound 7|P55055|OXYSTEROLS RECEPTOR LXR-BETA|8.22|Ki=6nM|Ki|=|6|nM|6|nM
5DHS|2.62|2016|5AG|compound 11j|Q8Y8D7|NAD KINASE 1|5.22|Ki=6uM|Ki|=|6|uM|6000|nM
5EV8|2.30|2016|3R9|compound 1b (D-CS319)|P52699|BETA-LACTAMASE IMP-1|5.22|Ki=6uM|Ki|=|6|uM|6000|nM
4YDF|2.80|2016|4B1|compound 9|Q82134|HTLV-1 PROTEASE|5.1|Ki=7.9uM|Ki|=|7.9|uM|7900|nM
5KAM|2.48|2016|IMP|ligand is compound IMP|Q07010|HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE|4.11|Ki=77.3uM|Ki|=|77.3|uM|77300|nM
4UFE|1.59|2016|3ZD|compound 2|P00734|THROMBIN LIGHT CHAIN|8.15|Ki=7nM|Ki|=|7|nM|7|nM
4UFG|1.65|2016|D6J|compound 4|P00734|THROMBIN LIGHT CHAIN|8.15|Ki=7nM|Ki|=|7|nM|7|nM
4ZYX|1.65|2016|3YB|[Nonstandard assay: Temp 37] Ki=7+/-1nM, GARFTase / AGF117|P22102|TRIFUNCTIONAL PURINE BIOSYNTHETIC PROTEIN ADENOSINE-3|8.15|Ki=7nM|Ki|=|7|nM|7|nM
5JXQ|1.20|2016|6OK|ligand is compound 6b|P28720|QUEUINE TRNA-RIBOSYLTRANSFERASE|8.15|Ki=7nM|Ki|=|7|nM|7|nM
5FHM|1.55|2016|5XP|compound 6|P19491|GLUTAMATE RECEPTOR 2|5.09|Ki=8.15uM|Ki|=|8.15|uM|8150|nM
5JFU|1.70|2016|6KQ|ligand is compound 15h|C8B467|HIV-1 PROTEASE|8.07|Ki=8.5nM|Ki|=|8.5|nM|8.5|nM
5AA8|1.86|2016|5P8|ligand is lorlatinib|Q9UM73|ALK TYROSINE KINASE RECEPTOR|8.07|Ki=8.6nM|Ki|=|8.6|nM|8.6|nM
5EFH|2.16|2016|FKS|ligand is trifluoroketone inhibitor|A7YT55|HDAC6 PROTEIN|6.1|Ki=800nM|Ki|=|800|nM|800|nM
4UJ2|2.02|2016|NVV|compound 1e|P17612|CAMP-DEPENDENT PROTEIN KINASE|7.1|Ki=80nM|Ki|=|80|nM|80|nM
5A6H|1.57|2016|OE2|ligand is Psammaplin C (NP-6)|P00918|CARBONIC ANHYDRASE 2|7.06|Ki=88.0nM|Ki|=|88|nM|88|nM
5E2K|1.40|2016|BX4|compound 4g|P00918|CARBONIC ANHYDRASE 2|8.03|Ki=9.3nM|Ki|=|9.3|nM|9.3|nM
5JF7|2.10|2016|6JU|ligand is inhibitor SMP289|Q8E378|PEPTIDE DEFORMYLASE|6.04|Ki=909nM|Ki|=|909|nM|909|nM
4ZZ0|1.65|2016|3YE|[Nonstandard assay: Temp 37] Ki=99+/-13nM, GARFTase / AGF147|P22102|TRIFUNCTIONAL PURINE BIOSYNTHETIC PROTEIN ADENOSINE-3|7.0|Ki=99nM|Ki|=|99|nM|99|nM
5SZ6|1.15|2016|72G|ligand is compound 4e|P00918|CARBONIC ANHYDRASE 2|7.0|Ki=99nM|Ki|=|99|nM|99|nM
4ZYY|1.85|2016|3YC|[Nonstandard assay: Temp 37] Ki=9+/-1nM, GARFTase / AGF118|P22102|TRIFUNCTIONAL PURINE BIOSYNTHETIC PROTEIN ADENOSINE-3|8.05|Ki=9nM|Ki|=|9|nM|9|nM
5D4A|1.70|2016|57Q|compound 4|P15090|FATTY ACID-BINDING PROTEIN, ADIPOCYTE|5.85|Ki>1.4uM|Ki|>|1.4|uM|1400|nM
5LS6|3.47|2017|74D|[Nonstandard assay: PH 8.5] Human PRC2 complex with compound 10|Q15910|HISTONE-LYSINE N-METHYLTRANSFERASE EZH2,HISTONE-LYSINE N|9.0|IC<0.001uM|IC50|<|0.001|uM|1|nM
5UAC|3.80|2017|RFP|ligand is Rifampin|P0A7Z4|DNA-DIRECTED RNA POLYMERASE SUBUNIT ALPHA|8.3|IC<0.005uM|IC50|<|0.005|uM|5|nM
5MMN|1.90|2017|O54|[Different protein in assay: Protein in bingding assay is gyrase] ATPase inhibition assay, comp.27|P0AES7|DNA GYRASE SUBUNIT B|6.7|IC<0.2uM|IC50|<|0.2|uM|200|nM
5NHF|2.14|2017|8X5|KM ATP, comp.8|P28482|MITOGEN-ACTIVATED PROTEIN KINASE 1|9.49|IC<0.32nM|IC50|<|0.32|nM|0.32|nM
5NHL|2.07|2017|8XB|KM ATP, comp.17|P28482|MITOGEN-ACTIVATED PROTEIN KINASE 1|9.52|IC<0.3nM|IC50|<|0.3|nM|0.3|nM
5NHO|2.24|2017|8XN|KM ATP, comp.18|P28482|MITOGEN-ACTIVATED PROTEIN KINASE 1|9.52|IC<0.3nM|IC50|<|0.3|nM|0.3|nM
5NHH|1.94|2017|8XH|KM ATP, comp.12|P28482|MITOGEN-ACTIVATED PROTEIN KINASE 1|8.95|IC<1.13nM|IC50|<|1.13|nM|1.13|nM
5TQU|2.60|2017|I53|ligand is compound 1|Q38C91|METHIONYL-TRNA SYNTHETASE|7.6|IC<25nM|IC50|<|25|nM|25|nM
5MW2|2.35|2017|U52|ligand is BI-3802|P41182|B-CELL LYMPHOMA 6 PROTEIN|8.52|IC<3nM|IC50|<|3|nM|3|nM
5J58|2.80|2017|N56|ligand is compound 16|Q38C91|METHIONYL-TRNA SYNTHETASE|7.3|IC<50nM|IC50|<|50|nM|50|nM
5J59|2.40|2017|N93|ligand is compound 31|Q38C91|METHIONYL-TRNA SYNTHETASE|7.3|IC<50nM|IC50|<|50|nM|50|nM
5V49|2.30|2017|8WA|ligand is compound 13|Q38C91|METHIONYL-TRNA SYNTHETASE|7.3|IC<50nM|IC50|<|50|nM|50|nM
6B8U|2.68|2017|8EN|ligand is compound 2|P15056|SERINE/THREONINE-PROTEIN KINASE B-RAF|9.7|IC=0.0002uM|IC50|=|0.0002|uM|0.2|nM
5TZA|1.70|2017|7OG|[Different protein in assay: Protein in binding assay is full length PDE2a enzymes. Protein in crystal is residues 579 to 918.] ligand is compound 9.|O00408|CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE|9.0|IC=0.001uM|IC50|=|0.001|uM|1|nM
6BFA|2.80|2017|UW5|compound is 32 not the 33.|Q9BJF5|CALMODULIN-DOMAIN PROTEIN KINASE 1|9.0|IC=0.001uM|IC50|=|0.001|uM|1|nM
5NHV|2.00|2017|8QB|KM ATP, comp.23|P28482|MITOGEN-ACTIVATED PROTEIN KINASE 1|8.55|IC=0.0028uM|IC50|=|0.0028|uM|2.8|nM
5U00|1.41|2017|7OV|[Different protein in assay: Protein in binding assay is full length PDE2a enzymes. Protein in crystal is residues 579 to 918.] ligand is compound 34.|O00408|CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE|8.7|IC=0.002uM|IC50|=|0.002|uM|2|nM
5VGO|1.62|2017|9B1|ligand is G-744.|Q06187|TYROSINE-PROTEIN KINASE BTK|8.7|IC=0.002uM|IC50|=|0.002|uM|2|nM
5NHJ|2.12|2017|8XE|KM ATP, comp.14|P28482|MITOGEN-ACTIVATED PROTEIN KINASE 1|8.27|IC=0.0054uM|IC50|=|0.0054|uM|5.4|nM
5K76|2.74|2017|6R1|28|Q9NWZ3|INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE 4|8.3|IC=0.005uM|IC50|=|0.005|uM|5|nM
5XS2|2.04|2017|8D6|compound 17|P49336|CYCLIN-DEPENDENT KINASE 8|8.3|IC=0.005uM|IC50|=|0.005|uM|5|nM
6B4W|2.90|2017|CQ7|23 bound in the TTK ATP pocket,|P33981|DUAL SPECIFICITY PROTEIN KINASE TTK|8.3|IC=0.005uM|IC50|=|0.005|uM|5|nM
6B8J|2.60|2017|65C|GSK3:compound 1|P49841|GLYCOGEN SYNTHASE KINASE-3 BETA|8.3|IC=0.005uM|IC50|=|0.005|uM|5|nM
6BFD|1.62|2017|DJS|5b;+/-0.0003|P56817|BETA-SECRETASE 1|8.3|IC=0.005uM|IC50|=|0.005|uM|5|nM
5NOB|1.85|2017|92T|comp.16|Q9H2K2|TANKYRASE-2|8.2|IC=0.0063uM|IC50|=|0.0063|uM|6.3|nM
5NB7|1.33|2017|8NQ|comp.2|P00746|COMPLEMENT FACTOR D|8.22|IC=0.006uM|IC50|=|0.006|uM|6|nM
5Q0M|2.20|2017|9L1|comp.34|Q96RI1|BILE ACID RECEPTOR|8.1|IC=0.0079uM|IC50|=|0.0079|uM|7.9|nM
5Q1C|2.30|2017|9NA|comp.31|Q96RI1|BILE ACID RECEPTOR|8.08|IC=0.0084uM|IC50|=|0.0084|uM|8.4|nM
5Q0N|2.40|2017|9L4|comp.27|Q96RI1|BILE ACID RECEPTOR|8.06|IC=0.0087uM|IC50|=|0.0087|uM|8.7|nM
5Q15|1.90|2017|9MP|comp.22|Q96RI1|BILE ACID RECEPTOR|8.05|IC=0.0089uM|IC50|=|0.0089|uM|8.9|nM
5TZC|2.36|2017|7OJ|[Different protein in assay: Protein in binding assay is full length PDE2a enzymes. Protein in crystal is residues 579 to 918.] ligand is compound 27.|O00408|CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE|8.1|IC=0.008uM|IC50|=|0.008|uM|8|nM
5W5O|2.89|2017|9XA|7F|O43353|RECEPTOR-INTERACTING SERINE/THREONINE-PROTEIN KINASE 2|8.1|IC=0.008uM|IC50|=|0.008|uM|8|nM
5WG3|2.90|2017|AFM|CCG258748|P25098|BETA-ADRENERGIC RECEPTOR KINASE 1|8.1|IC=0.008uM|IC50|=|0.008|uM|8|nM
5Q1A|2.00|2017|9N4|comp.14|Q96RI1|BILE ACID RECEPTOR|8.02|IC=0.0096uM|IC50|=|0.0096|uM|9.6|nM
5TRS|3.08|2017|7HZ|IC50=0.010+/-0.002uM, ligand is PKS2144.|A5U4D5|PROTEASOME SUBUNIT ALPHA|8.0|IC=0.010uM|IC50|=|0.01|uM|10|nM
5O83|2.90|2017|9NQ|comp.3h (CDZ173/leniolisib)|O35904|PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE|7.96|IC=0.011uM|IC50|=|0.011|uM|11|nM
5Q16|2.00|2017|9MS|comp.20|Q96RI1|BILE ACID RECEPTOR|7.87|IC=0.0135uM|IC50|=|0.0135|uM|13.5|nM
5TZZ|1.60|2017|7OJ|[Different protein in assay: Protein in binding assay is full length PDE2a enzymes. Protein in crystal is residues 579 to 918.] ligand is compound 33.|O00408|CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE|7.85|IC=0.014uM|IC50|=|0.014|uM|14|nM
5TRG|2.80|2017|7HJ|ligand is DPLG-2.|A5U4D5|PROTEASOME SUBUNIT ALPHA|7.82|IC=0.015uM|IC50|=|0.015|uM|15|nM
5TRY|3.00|2017|7J0|IC50=0.016+/-0.001uM, ligand is PKS2206.|A5U4D5|PROTEASOME SUBUNIT ALPHA|7.8|IC=0.016uM|IC50|=|0.016|uM|16|nM
5TS0|2.85|2017|7J1|IC50=0.016+/-0.002uM, ligand is PKS2208.|A5U4D5|PROTEASOME SUBUNIT ALPHA|7.8|IC=0.016uM|IC50|=|0.016|uM|16|nM
5TX5|2.56|2017|7MJ|[Different protein in assay: protein in crystal is C34A, C127A, C233A, and C240A mutant.] ligand is compound 5.|Q13546|RECEPTOR-INTERACTING SERINE/THREONINE-PROTEIN KINASE 1|7.8|IC=0.016uM|IC50|=|0.016|uM|16|nM
5TYS|2.01|2017|7OA|IC50=0.019+/-0.017nM, ligand is GRL-142|C8B467|HIV-1 PROTEASE|10.72|IC=0.019nM|IC50|=|0.019|nM|0.019|nM
5NGB|2.90|2017|8WH|+/-0.004, comp.37|Q3UDT3|PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE|7.72|IC=0.019uM|IC50|=|0.019|uM|19|nM
5Q0V|1.87|2017|9LS|comp.24|Q96RI1|BILE ACID RECEPTOR|7.69|IC=0.0205uM|IC50|=|0.0205|uM|20.5|nM
5Q14|1.85|2017|9MM|comp.28|Q96RI1|BILE ACID RECEPTOR|7.68|IC=0.021uM|IC50|=|0.021|uM|21|nM
5LGU|3.20|2017|6W1|ligand is compound 34|O60341|LYSINE-SPECIFIC HISTONE DEMETHYLASE 1A|7.66|IC=0.022uM|IC50|=|0.022|uM|22|nM
5NHP|1.99|2017|8XK|KM ATP, comp.22|P28482|MITOGEN-ACTIVATED PROTEIN KINASE 1|7.64|IC=0.023uM|IC50|=|0.023|uM|23|nM
5THO|3.00|2017|7C7|IC50=0.023+/-0.002uM, ligand is PKS2205.|A5U4D5|PROTEASOME SUBUNIT ALPHA|7.64|IC=0.023uM|IC50|=|0.023|uM|23|nM
5Q0O|1.90|2017|9L7|comp.13|Q96RI1|BILE ACID RECEPTOR|7.61|IC=0.0244uM|IC50|=|0.0244|uM|24.400000000000002|nM
5UOY|1.82|2017|8HM|ligand is compound 16j.|Q01064|CALCIUM/CALMODULIN-DEPENDENT 3',5'-CYCLIC NUCLEOTIDE|7.57|IC=0.027uM|IC50|=|0.027|uM|27|nM
5V88|1.60|2017|8ZD|IC50=0.028+/-0.003uM, ligand is NAcM-COV|D9IEF7|LYSOZYME,DCN1-LIKE PROTEIN 1|7.55|IC=0.028uM|IC50|=|0.028|uM|28|nM
5OX6|1.99|2017|A1Z|ligand is vadadustat|Q9GZT9|EGL NINE HOMOLOG 1|7.54|IC=0.029uM|IC50|=|0.029|uM|29|nM
5V1B|2.49|2017|8UY|ligand is compound 17.|Q96KS0|EGL NINE HOMOLOG 2|7.47|IC=0.034uM|IC50|=|0.034|uM|34|nM
5NGU|2.74|2017|8X2|KM ATP, comp.4|P28482|MITOGEN-ACTIVATED PROTEIN KINASE 1|7.44|IC=0.036uM|IC50|=|0.036|uM|36|nM
5OHJ|1.60|2017|9VE|[Different protein in assay: PDE4] +-0.022, (S*,S**)-18e, cell-free|Q07343|CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B|10.42|IC=0.0378nM|IC50|=|0.0378|nM|0.0378|nM
5LMK|2.40|2017|6ZK|ligand is compound 1l|P24941|CYCLIN-DEPENDENT KINASE 2|7.43|IC=0.037uM|IC50|=|0.037|uM|37|nM
5LYX|1.90|2017|7BF|+/-0.001, comp.27|P50579|METHIONINE AMINOPEPTIDASE 2|7.42|IC=0.038uM|IC50|=|0.038|uM|38|nM
5Q0P|1.80|2017|9LA|comp.29|Q96RI1|BILE ACID RECEPTOR|7.41|IC=0.039uM|IC50|=|0.039|uM|39|nM
5MMP|2.05|2017|G3Z|[Different protein in assay: Protein in bingding assay is gyrase] Supercoiling inhibition assay., comp.36|P0AES7|DNA GYRASE SUBUNIT B|7.52|IC=0.03uM|IC50|=|0.03|uM|30|nM
5UKM|3.03|2017|T0E|IC50=0.03+/-0.001uM, ligand is 14as.|P21146|BETA-ADRENERGIC RECEPTOR KINASE 1|7.52|IC=0.03uM|IC50|=|0.03|uM|30|nM
5PZN|2.25|2017|8XP|comp.18|Q9WMX2|RNA-DIRECTED RNA POLYMERASE|7.39|IC=0.041uM|IC50|=|0.041|uM|41|nM
5TRR|3.10|2017|7HY|IC50=0.041+/-0.006uM, ligand is PKS2169.|A5U4D5|PROTEASOME SUBUNIT ALPHA|7.39|IC=0.041uM|IC50|=|0.041|uM|41|nM
5NEV|2.97|2017|72L|complex is CDK2-cyclin A/compound73|P24941|CYCLIN-DEPENDENT KINASE 2|7.36|IC=0.044uM|IC50|=|0.044|uM|44|nM
5Q0X|2.26|2017|643|comp.33|Q96RI1|BILE ACID RECEPTOR|7.35|IC=0.045uM|IC50|=|0.045|uM|45|nM
5Q1B|2.30|2017|9N7|comp.36|Q96RI1|BILE ACID RECEPTOR|7.31|IC=0.0487uM|IC50|=|0.0487|uM|48.7|nM
5Q19|1.98|2017|9N1|comp.6|Q96RI1|BILE ACID RECEPTOR|7.32|IC=0.048uM|IC50|=|0.048|uM|48|nM
5TZX|1.90|2017|7OY|[Different protein in assay: Protein in binding assay is full length PDE2a enzymes. Protein in crystal is residues 579 to 918.] ligand is compound 32.|O00408|CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE|7.28|IC=0.052uM|IC50|=|0.052|uM|52|nM
5N4S|1.20|2017|R38|comp.3|Q9K2N0|BETA-LACTAMASE VIM-2|7.26|IC=0.055uM|IC50|=|0.055|uM|55|nM
5GGZ|2.02|2017|6TN|IC50=0.056+/-0.002uM, compound 50 bound to the active site of Hsp90|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|7.25|IC=0.056uM|IC50|=|0.056|uM|56|nM
5J7G|1.85|2017|6GG|[Different protein in assay: assay MDM2 1 ?25, x-ray MDM2 18 ?25] MDM2 18-125|Q00987|E3 UBIQUITIN-PROTEIN LIGASE MDM2|7.24|IC=0.058uM|IC50|=|0.058|uM|58|nM
5J7F|2.00|2017|6GG|[Nonstandard assay: PH=8] MDM2 1-125; ligand is 19|Q00987|E3 UBIQUITIN-PROTEIN LIGASE MDM2|7.24|IC=0.058uM|IC50|=|0.058|uM|58|nM
5Q0W|1.90|2017|9LV|comp.12|Q96RI1|BILE ACID RECEPTOR|7.24|IC=0.058uM|IC50|=|0.058|uM|58|nM
5UWF|1.87|2017|8Q7|ligand is compound 16d.|Q9Y233|CGMP 3',5'-CYCLIC PHOSPHODIESTERASE|7.23|IC=0.059uM|IC50|=|0.059|uM|59|nM
5NAW|1.25|2017|8RZ|comp.13|P00746|COMPLEMENT FACTOR D|7.3|IC=0.05uM|IC50|=|0.05|uM|50|nM
5NBA|1.87|2017|8S5|comp.14|P00746|COMPLEMENT FACTOR D|7.3|IC=0.05uM|IC50|=|0.05|uM|50|nM
5Q0S|2.50|2017|9LJ|comp.25|Q96RI1|BILE ACID RECEPTOR|7.21|IC=0.062uM|IC50|=|0.062|uM|62|nM
5WG5|3.10|2017|ZSO|CCG224061|P25098|BETA-ADRENERGIC RECEPTOR KINASE 1|7.18|IC=0.066uM|IC50|=|0.066|uM|66|nM
5Q18|1.90|2017|9MY|comp.32|Q96RI1|BILE ACID RECEPTOR|7.17|IC=0.0675uM|IC50|=|0.0675|uM|67.5|nM
5T1U|1.78|2017|P6U|[Nonstandard assay: Temp 37, pH=4.5] comp.6u|P56817|BETA-SECRETASE 1|7.16|IC=0.069uM|IC50|=|0.069|uM|69|nM
5Q1F|2.30|2017|9NJ|comp.30|Q96RI1|BILE ACID RECEPTOR|7.14|IC=0.0725uM|IC50|=|0.0725|uM|72.5|nM
5T1W|2.96|2017|74B|[Nonstandard assay: Temp 37, pH=4.5] comp.16|P56817|BETA-SECRETASE 1|7.11|IC=0.077uM|IC50|=|0.077|uM|77|nM
5V86|1.37|2017|8ZA|IC50=0.079+/-0.013uM, ligand is NAcM-OPT|D9IEF7|LYSOZYME,DCN1-LIKE PROTEIN 1|7.1|IC=0.079uM|IC50|=|0.079|uM|79|nM
5Y3N|2.40|2017|8MF|[Different protein in assay: Protein in binding assay is full-length] 12b|Q12931|HEAT SHOCK PROTEIN 75 KDA, MITOCHONDRIAL|7.1|IC=0.079uM|IC50|=|0.079|uM|79|nM
6BFX|1.99|2017|DKJ|29;+/-0.0004|P56817|BETA-SECRETASE 1|7.1|IC=0.079uM|IC50|=|0.079|uM|79|nM
5LGR|2.00|2017|12-mer|CARM1-Compound 5|Q9WVG6|HISTONE-ARGININE METHYLTRANSFERASE CARM1|7.09|IC=0.0817uM|IC50|=|0.0817|uM|81.69999999999999|nM
5LGS|2.10|2017|9-mer|CARM1-Compound 6|Q9WVG6|HISTONE-ARGININE METHYLTRANSFERASE CARM1|7.06|IC=0.0876uM|IC50|=|0.0876|uM|87.6|nM
5LGQ|2.11|2017|11-mer|CARM1-Compound 4|Q9WVG6|HISTONE-ARGININE METHYLTRANSFERASE CARM1|7.05|IC=0.0901uM|IC50|=|0.0901|uM|90.1|nM
5Q13|1.90|2017|9MD|comp.19|Q96RI1|BILE ACID RECEPTOR|7.04|IC=0.091uM|IC50|=|0.091|uM|91|nM
5LGP|2.04|2017|13-mer|CARM1-Compound 3|Q9WVG6|HISTONE-ARGININE METHYLTRANSFERASE CARM1|7.04|IC=0.092uM|IC50|=|0.092|uM|92|nM
5M5Q|2.20|2017|7K1|comp.4|Q92905|COP9 SIGNALOSOME COMPLEX SUBUNIT 5|7.05|IC=0.09uM|IC50|=|0.09|uM|90|nM
6B3E|3.06|2017|CJM|5 in yellow bound to CDK12|Q9NYV4|CYCLIN-DEPENDENT KINASE 12|6.99|IC=0.103uM|IC50|=|0.103|uM|103|nM
5WG4|2.31|2017|AFV|CCG257284|P25098|BETA-ADRENERGIC RECEPTOR KINASE 1|7.0|IC=0.10uM|IC50|=|0.1|uM|100|nM
5OFX|1.75|2017|RAF|+/-0.01, Raffinose (25)|Q7N561|PLLA|3.96|IC=0.11mM|IC50|=|0.11|mM|110000|nM
5GSO|2.60|2017|5GI|[Nonstandard assay: Temp 30] WT EV71 3C-NK-1.8k|E7E815|3C PROTEIN|6.96|IC=0.11uM|IC50|=|0.11|uM|110|nM
5L13|2.40|2017|6ZE|ALDH2 in complex with compound 2|P05091|ALDEHYDE DEHYDROGENASE, MITOCHONDRIAL|6.96|IC=0.11uM|IC50|=|0.11|uM|110|nM
5MHQ|1.30|2017|8QT|IC50 = 0.11 +/- 0.02; binding assay is CDK2/A; CDK2-CCT068127 complex|P24941|CYCLIN-DEPENDENT KINASE 2|6.96|IC=0.11uM|IC50|=|0.11|uM|110|nM
5Q1E|1.85|2017|9NG|comp.11|Q96RI1|BILE ACID RECEPTOR|6.92|IC=0.12uM|IC50|=|0.12|uM|120|nM
5Y3O|2.70|2017|8M9|[Different protein in assay: Protein in binding assay is full-length] 21|Q12931|HEAT SHOCK PROTEIN 75 KDA, MITOCHONDRIAL|6.86|IC=0.138uM|IC50|=|0.138|uM|138|nM
5L2M|1.70|2017|6ZY|ALDH1A1 in complex with 15|P00352|RETINAL DEHYDROGENASE 1|6.89|IC=0.13uM|IC50|=|0.13|uM|130|nM
5X9P|1.86|2017|80L|5 bound to BCL6|P41182|B-CELL LYMPHOMA 6 PROTEIN|6.89|IC=0.13uM|IC50|=|0.13|uM|130|nM
5TZ3|1.72|2017|7OM|[Different protein in assay: Protein in binding assay is full length PDE2a enzymes. Protein in crystal is residues 579 to 918.] ligand is compound 7.|O00408|CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE|6.85|IC=0.14uM|IC50|=|0.14|uM|140|nM
5QC4|2.00|2017|BC7|compound 36|P25774|CATHEPSIN S|6.82|IC=0.15uM|IC50|=|0.15|uM|150|nM
5Q0U|1.90|2017|9LP|comp.35|Q96RI1|BILE ACID RECEPTOR|6.76|IC=0.175uM|IC50|=|0.175|uM|175|nM
5NGS|1.85|2017|8WW|comp.1a|P36639|7,8-DIHYDRO-8-OXOGUANINE TRIPHOSPHATASE|6.77|IC=0.17uM|IC50|=|0.17|uM|170|nM
5V3Y|1.98|2017|5V8|IC50=0.19+/-0.01uM, ligand is TAM16.|------|POLYKETIDE SYNTHASE PKS13|6.72|IC=0.19uM|IC50|=|0.19|uM|190|nM
5G0Q|1.65|2017|IF6|[Covalent complex] [Nonstandard assay: Temp 37] AcGH79(wt)-5 complex|C1F2K5|BETA-GLUCURONIDASE|10.0|IC=0.1nM|IC50|=|0.1|nM|0.1|nM
5WO4|1.84|2017|B7V|28 in JAK1|P23458|TYROSINE-PROTEIN KINASE JAK1|10.0|IC=0.1nM|IC50|=|0.1|nM|0.1|nM
5M0S|2.10|2017|7CW|COM.5|Q64610|ECTONUCLEOTIDE PYROPHOSPHATASE/PHOSPHODIESTERASE|6.69|IC=0.202uM|IC50|=|0.202|uM|202|nM
5V84|2.70|2017|96V|ligand is compound 6.|Q9BXF3|CAT EYE SYNDROME CRITICAL REGION PROTEIN 2|6.7|IC=0.20uM|IC50|=|0.2|uM|200|nM
5O11|2.40|2017|3NG|CX-4945|P11309|SERINE/THREONINE-PROTEIN KINASE PIM-1|6.67|IC=0.216uM|IC50|=|0.216|uM|216|nM
5T90|2.80|2017|18-mer|IC50=0.21+/-0.04uM, LsIA-LsAChBP complex|P58154|ACETYLCHOLINE-BINDING PROTEIN|6.68|IC=0.21uM|IC50|=|0.21|uM|210|nM
5MZ3|2.15|2017|8EN|comp.2|Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|6.66|IC=0.22uM|IC50|=|0.22|uM|220|nM
6BFW|1.84|2017|DK7|24;+/-0.011|P56817|BETA-SECRETASE 1|6.66|IC=0.22uM|IC50|=|0.22|uM|220|nM
5Q0J|2.00|2017|9KV|comp.7|Q96RI1|BILE ACID RECEPTOR|6.62|IC=0.239uM|IC50|=|0.239|uM|239|nM
5T37|1.76|2017|758|comp.4|O14684|PROSTAGLANDIN E SYNTHASE|6.62|IC=0.241uM|IC50|=|0.241|uM|241|nM
5L6H|2.30|2017|6O2|[Covalent complex] Uba1-Ub-ABPA3|P22515|UBIQUITIN-ACTIVATING ENZYME E1 1|6.62|IC=0.24uM|IC50|=|0.24|uM|240|nM
5UGD|1.38|2017|89S|IC50=0.24+/-0.004uM, ligand is YO-2|P00747|PLASMINOGEN|6.62|IC=0.24uM|IC50|=|0.24|uM|240|nM
5V42|1.99|2017|I66|IC50=0.24+/-0.02uM, ligand is TAM3.|------|POLYKETIDE SYNTHASE PKS13|6.62|IC=0.24uM|IC50|=|0.24|uM|240|nM
5YJP|1.80|2017|8W6|human chymase/O-ethylamidoxime 5b|P23946|CHYMASE|6.62|IC=0.24uM|IC50|=|0.24|uM|240|nM
5LQF|2.06|2017|4SP|[Different protein in assay: crystal:CDK1-cyclinB-CKS2, binding assay:CDK1] complex is CDK1-cyclinB-CKS2/compound3|P06493|CYCLIN-DEPENDENT KINASE 1|6.6|IC=0.25uM|IC50|=|0.25|uM|250|nM
5TYR|1.80|2017|7O7|IC50=0.26+/-0.05nM, ligand is GRL-121|C8B467|HIV-1 PROTEASE|9.59|IC=0.26nM|IC50|=|0.26|nM|0.26|nM
5V3X|1.94|2017|I28|IC50=0.26+/-0.03uM, ligand is TAM1.|------|POLYKETIDE SYNTHASE PKS13|6.59|IC=0.26uM|IC50|=|0.26|uM|260|nM
5JZ9|2.68|2017|6OR|[Nonstandard assay: Temp 21] HsaD-27|P9WNH4|4,5:9,10-DISECO-3-HYDROXY-5,9,17-TRIOXOANDROSTA-1(10),2|3.57|IC=0.27mM|IC50|=|0.27|mM|270000|nM
5L15|2.40|2017|G39|NA/Ose|R4NFR6|NEURAMINIDASE|9.57|IC=0.27nM|IC50|=|0.27|nM|0.27|nM
5B5P|1.60|2017|WNN|[Nonstandard assay: Temp 37] ligand is compound 23|P45452|COLLAGENASE 3|9.7|IC=0.2nM|IC50|=|0.2|nM|0.2|nM
5UIU|2.02|2017|8CG|ligand is compound 40.|Q9NWZ3|INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE 4|9.7|IC=0.2nM|IC50|=|0.2|nM|0.2|nM
5KCX|2.20|2017|6S3|24 PIM1|P11309|SERINE/THREONINE-PROTEIN KINASE PIM-1|6.7|IC=0.2uM|IC50|=|0.2|uM|200|nM
5L6J|2.68|2017|61T|[Covalent complex] Uba1-Ub-MLN7243|P22515|UBIQUITIN-ACTIVATING ENZYME E1 1|6.7|IC=0.2uM|IC50|=|0.2|uM|200|nM
5WYS|3.00|2017|7V6|[Uncommon element] [Different ligand in assay: ligand in binding assay is Br] comp.3i PDB file is wrong, chemical formula is wrong|P08659|LUCIFERIN 4-MONOOXYGENASE|6.7|IC=0.2uM|IC50|=|0.2|uM|200|nM
5UYU|1.90|2017|8QV|ligand is compound 13|P56817|BETA-SECRETASE 1|9.51|IC=0.31nM|IC50|=|0.31|nM|0.31|nM
5LGT|3.00|2017|6W3|ligand is compound 15|O60341|LYSINE-SPECIFIC HISTONE DEMETHYLASE 1A|6.51|IC=0.31uM|IC50|=|0.31|uM|310|nM
5H19|1.90|2017|LQF|[Nonstandard assay: pH 8] EED-EBD-EED162|O75530|POLYCOMB PROTEIN EED|6.49|IC=0.32uM|IC50|=|0.32|uM|320|nM
5NSP|2.30|2017|97E|comp.14|Q9H2K2|TANKYRASE-2|6.47|IC=0.34uM|IC50|=|0.34|uM|340|nM
5VFD|1.93|2017|9CM|ligand is compound 3.|Q8RLA6|BETA-LACTAMASE|6.44|IC=0.36uM|IC50|=|0.36|uM|360|nM
6EQS|1.32|2017|BV8|[Different protein in assay: ] hSIRT5/29;+/- 0.10|Q9NXA8|NAD-DEPENDENT DEACYLASE SIRTUIN-5|6.43|IC=0.37uM|IC50|=|0.37|uM|370|nM
6EO0|2.40|2017|BVT|[Different protein in assay: protein in binding assay is human specis] zSIRT5/29;+/- 0.10|Q6DHI5|NAD-DEPENDENT PROTEIN DEACYLASE SIRTUIN-5|6.43|IC=0.37uM|IC50|=|0.37|uM|370|nM
6AX1|2.26|2017|C0S|3|Q99685|MONOGLYCERIDE LIPASE|9.42|IC=0.38nM|IC50|=|0.38|nM|0.38|nM
5MM9|1.55|2017|8SH|comp.2b|B5KVR9|METALLO-BETA-LACTAMASE VIM-17|6.42|IC=0.38uM|IC50|=|0.38|uM|380|nM
5UGG|1.20|2017|89M|IC50=0.38+/-0.010uM, ligand is PSI-112|P00747|PLASMINOGEN|6.42|IC=0.38uM|IC50|=|0.38|uM|380|nM
5LP1|1.91|2017|71H||Q13093|PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE|9.4|IC=0.398nM|IC50|=|0.398|nM|0.398|nM
5WBZ|2.40|2017|A4J|Compound 12;hKHK-A IC50;|P50053|KETOHEXOKINASE|6.41|IC=0.39uM|IC50|=|0.39|uM|390|nM
5WRE|1.95|2017|7TL|[Different protein in assay: protein in binding assay is wild type] HAP_R01;|L7R9I1|CORE PROTEIN|6.41|IC=0.39uM|IC50|=|0.39|uM|390|nM
5JZB|2.10|2017|6OT|[Nonstandard assay: Temp 21] HsaD-2|P9WNH5|4,5:9,10-DISECO-3-HYDROXY-5,9,17-TRIOXOANDROSTA-1(10),2|3.39|IC=0.41mM|IC50|=|0.41|mM|410000|nM
5VQZ|2.23|2017|9HY|[Covalent complex] K103N/Y181C:3;+/-0.07; 24h|P03366|REVERSE TRANSCRIPTASE/RIBONUCLEASE H|6.39|IC=0.41uM|IC50|=|0.41|uM|410|nM
5XQX|2.30|2017|8CC|compound 4|P49336|CYCLIN-DEPENDENT KINASE 8|6.39|IC=0.41uM|IC50|=|0.41|uM|410|nM
5QBV|1.80|2017|N2D|compound 12; Ki(human CatS); X-ray(CatS C25S)|P25774|CATHEPSIN S|6.37|IC=0.43uM|IC50|=|0.43|uM|430|nM
5UQV|2.84|2017|8JM|IC50=0.43+/-0.07uM, ligand is GNE-6640|Q93009|UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 7|6.37|IC=0.43uM|IC50|=|0.43|uM|430|nM
5TUQ|2.71|2017|J63|[Different protein in assay: protein in crystal is C280S mutant.] IC50=0.45+/-0.07uM, pol assay. ligand is compound 4a.|P03366|HIV-1 REVERSE TRANSCRIPTASE|6.35|IC=0.45uM|IC50|=|0.45|uM|450|nM
5UP0|2.04|2017|8HP|ligand is compound 3.|Q01064|CALCIUM/CALMODULIN-DEPENDENT 3',5'-CYCLIC NUCLEOTIDE|6.34|IC=0.46uM|IC50|=|0.46|uM|460|nM
5VQX|2.40|2017|9HY|[Covalent complex] Y181C-3;+/-0.03; 24h|P03366|REVERSE TRANSCRIPTASE/RIBONUCLEASE H|6.32|IC=0.48uM|IC50|=|0.48|uM|480|nM
5NCY|1.90|2017|8TK|[Different protein in assay: Protein in binding assay is recombinant human PI3Kd] comp.13|O35904|PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE|9.4|IC=0.4nM|IC50|=|0.4|nM|0.4|nM
5TEX|2.15|2017|7AU|23 PIM1|P11309|SERINE/THREONINE-PROTEIN KINASE PIM-1|6.4|IC=0.4uM|IC50|=|0.4|uM|400|nM
5VQV|2.58|2017|9J1|[Covalent complex] Y181C-5;+/-0.04; 24h|P03366|REVERSE TRANSCRIPTASE/RIBONUCLEASE H|6.4|IC=0.4uM|IC50|=|0.4|uM|400|nM
5N3W|2.30|2017|8KW|+/-0.04, comp.9 IC50: epoxide hydrolase|P09960|LEUKOTRIENE A-4 HYDROLASE|6.3|IC=0.50uM|IC50|=|0.5|uM|500|nM
5NAR|1.55|2017|8RW|comp.7|P00746|COMPLEMENT FACTOR D|6.3|IC=0.50uM|IC50|=|0.5|uM|500|nM
5NB6|1.75|2017|8S2|comp.18|P00746|COMPLEMENT FACTOR D|6.3|IC=0.50uM|IC50|=|0.5|uM|500|nM
6AYD|3.00|2017|C2J|comp.1|P11309|SERINE/THREONINE-PROTEIN KINASE PIM-1|6.3|IC=0.50uM|IC50|=|0.5|uM|500|nM
5VP1|1.86|2017|9GA|20 Bound in the PDE2A|O00408|CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE|9.29|IC=0.51nM|IC50|=|0.51|nM|0.51|nM
5VQY|2.35|2017|9J1|[Covalent complex] K103N/Y181C:5;+/-0.05; 24h|P03366|REVERSE TRANSCRIPTASE/RIBONUCLEASE H|6.29|IC=0.51uM|IC50|=|0.51|uM|510|nM
5ODU|1.56|2017|AMG|+/-0.07, Me-alpha-Gal (12)|Q7N561|PLLA|3.28|IC=0.52mM|IC50|=|0.52|mM|520000|nM
5TYN|1.53|2017|7NS|[Covalent complex] [Uncommon element] compound is 3|Q25252|CARBOXYLIC ESTER HYDROLASE|9.28|IC=0.52nM|IC50|=|0.52|nM|0.52|nM
5JZS|2.27|2017|FGZ|[Nonstandard assay: Temp 21] HsaD-32|------|2-HYDROXY-6-OXO-6-PHENYLHEXA-2,4-DIENOATE HYDROLASE BPHD|3.27|IC=0.54mM|IC50|=|0.54|mM|540000|nM
5U9D|1.33|2017|83P|ligand is compound 3|Q06187|TYROSINE-PROTEIN KINASE BTK|9.26|IC=0.55nM|IC50|=|0.55|nM|0.55|nM
5Q1I|1.95|2017|9O1|comp.23|Q96RI1|BILE ACID RECEPTOR|6.24|IC=0.57uM|IC50|=|0.57|uM|570|nM
5MAT|2.07|2017|7KJ|+/-0.02, comp.29c|Q8IXJ6|NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-2|6.24|IC=0.58uM|IC50|=|0.58|uM|580|nM
6AUD|2.02|2017|BWY|[Different protein in assay: Protein in binding assay is PI3Kgamma, crystal is PI3Kgamma_K802T mutant.] S-isomer 8|P48736|PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE|6.22|IC=0.596uM|IC50|=|0.596|uM|596|nM
5L17|2.40|2017|ZMR|NA/Zan|R4NFR6|NEURAMINIDASE|9.3|IC=0.5nM|IC50|=|0.5|nM|0.5|nM
5U7D|1.75|2017|19F|ligand is compound 1.|O00408|CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE|9.3|IC=0.5nM|IC50|=|0.5|nM|0.5|nM
5VP0|2.20|2017|9GJ|36 bound in the PDE2A|O00408|CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE|9.21|IC=0.61nM|IC50|=|0.61|nM|0.61|nM
5UKK|2.60|2017|8DJ|IC50=0.61+/-0.12uM, ligand is 14ak.|P25098|BETA-ADRENERGIC RECEPTOR KINASE 1|6.21|IC=0.61uM|IC50|=|0.61|uM|610|nM
5UQX|2.23|2017|8JP|IC50=0.61+/-0.15uM, ligand is GNE-6776|Q93009|UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 7|6.21|IC=0.61uM|IC50|=|0.61|uM|610|nM
5GUB|1.78|2017|2-mer|Smon0123/C delta 0S|D1AWE0|EXTRACELLULAR SOLUTE-BINDING PROTEIN FAMILY 1|6.2|IC=0.635uM|IC50|=|0.635|uM|635|nM
5T2M|2.80|2017|74N|[Different protein in assay: Protein in binding assay is human] comp.7m|O35904|PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE|9.2|IC=0.63nM|IC50|=|0.63|nM|0.63|nM
5UKL|2.15|2017|SIX|IC50=0.63+/-0.33uM, ligand is 14bd.|P25098|BETA-ADRENERGIC RECEPTOR KINASE 1|6.2|IC=0.63uM|IC50|=|0.63|uM|630|nM
5N1V|2.52|2017|8GQ|comp.11|P68400|CASEIN KINASE II, ALPHA SUBUNIT|6.19|IC=0.64uM|IC50|=|0.64|uM|640|nM
5TZH|1.60|2017|7OP|[Different protein in assay: Protein in binding assay is full length PDE2a enzymes. Protein in crystal is residues 579 to 918.] ligand is compound 30.|O00408|CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE|6.17|IC=0.679uM|IC50|=|0.679|uM|679|nM
5USF|2.75|2017|YSA|ligand is TyrSA.|E9BC28|TYROSYL-TRNA SYNTHETASE, PUTATIVE|9.16|IC=0.69nM|IC50|=|0.69|nM|0.69|nM
5NTW|1.64|2017|98N|comp.7|P51449|NUCLEAR RECEPTOR ROR-GAMMA|9.22|IC=0.6nM|IC50|=|0.6|nM|0.6|nM
5NQE|2.71|2017|94Z|comp.4s|Q460N5|POLY [ADP-RIBOSE] POLYMERASE 14|6.15|IC=0.70uM|IC50|=|0.7|uM|700|nM
5V41|2.05|2017|J24|IC50=0.71+/-0.05uM, ligand is TAM5.|------|POLYKETIDE SYNTHASE PKS13|6.15|IC=0.71uM|IC50|=|0.71|uM|710|nM
5T8E|2.71|2017|77U|IC50=0.72+/-0.25nM, ligand is compound B.|P10275|ANDROGEN RECEPTOR|9.14|IC=0.72nM|IC50|=|0.72|nM|0.72|nM
5L2O|2.05|2017|6ZW|ALDH1A1 in complex with compound 32|P00352|RETINAL DEHYDROGENASE 1|6.12|IC=0.76uM|IC50|=|0.76|uM|760|nM
5Q1D|1.89|2017|9ND|comp.21|Q96RI1|BILE ACID RECEPTOR|6.12|IC=0.76uM|IC50|=|0.76|uM|760|nM
5Q0Q|2.60|2017|9LD|comp.17|Q96RI1|BILE ACID RECEPTOR|6.11|IC=0.785uM|IC50|=|0.785|uM|785|nM
5T2D|2.90|2017|74L|[Different protein in assay: Protein in binding assay is human] comp.7j|O35904|PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE|9.1|IC=0.794nM|IC50|=|0.794|nM|0.794|nM
5URK|2.95|2017|8LP|[Different protein in assay: crystal:395-2129, binding assay:full-length] ligand is compound 6.|O75643|U5 SMALL NUCLEAR RIBONUCLEOPROTEIN 200 KDA HELICASE|6.1|IC=0.79uM|IC50|=|0.79|uM|790|nM
5VOM|1.67|2017|9GY|8;|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|6.1|IC=0.79uM|IC50|=|0.79|uM|790|nM
5NTP|1.70|2017|98E|comp.5|P51449|NUCLEAR RECEPTOR ROR-GAMMA|9.15|IC=0.7nM|IC50|=|0.7|nM|0.7|nM
5LUB|2.10|2017|3Y7|apo-AEP +compound 11|Q99538|LEGUMAIN|6.15|IC=0.7uM|IC50|=|0.7|uM|700|nM
5LYW|1.69|2017|7BH|+/-0.2, comp.16|P50579|METHIONINE AMINOPEPTIDASE 2|6.15|IC=0.7uM|IC50|=|0.7|uM|700|nM
5M0D|2.40|2017|7C8|COM.11|Q64610|ECTONUCLEOTIDE PYROPHOSPHATASE/PHOSPHODIESTERASE|6.09|IC=0.814uM|IC50|=|0.814|uM|814|nM
5WUU|1.72|2017|7UU|DCBD-005, +/- 0.03; Alpha screen assay|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|6.09|IC=0.81uM|IC50|=|0.81|uM|810|nM
5YJK|2.40|2017|8VX|compound 34 in the active site of human KLK7|P49862|KALLIKREIN-7|6.09|IC=0.82uM|IC50|=|0.82|uM|820|nM
6ENX|1.95|2017|BJW|[Different protein in assay: protein in binding assay is human specis] zSIRT5/10;+/- 0.10|Q6DHI5|NAD-DEPENDENT PROTEIN DEACYLASE SIRTUIN-5|6.08|IC=0.83uM|IC50|=|0.83|uM|830|nM
5VLP|2.90|2017|17-mer|[Different protein in assay: crystal:PCSK9-P-CRD, binding assay:PCSK9-P] IC50=0.84+/-0.08uM, ligand is MESFPGWNLV(hR)IGLLR|Q8NBP7|PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9|6.08|IC=0.84uM|IC50|=|0.84|uM|840|nM
5JV1|2.30|2017|YL6|ligand is compound 42|P14324|FARNESYL PYROPHOSPHATE SYNTHASE|6.07|IC=0.86uM|IC50|=|0.86|uM|860|nM
5H17|2.30|2017|LQE|[Nonstandard assay: pH 8] EED-EBD-EED210|O75530|POLYCOMB PROTEIN EED|6.05|IC=0.89uM|IC50|=|0.89|uM|890|nM
5GMP|2.80|2017|F62|[Different protein in assay: Protein in binding assay has another mutation, L858R] compound 8 binding with EGFRT790M|P00533|EPIDERMAL GROWTH FACTOR RECEPTOR|9.1|IC=0.8nM|IC50|=|0.8|nM|0.8|nM
5NCZ|1.94|2017|8TN|[Different protein in assay: Protein in binding assay is recombinant human PI3Kd] comp.15c|O35904|PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE|9.1|IC=0.8nM|IC50|=|0.8|nM|0.8|nM
5VFC|1.64|2017|9BA|IC50=0.90+/-0.20nM, ligand is compound 18.|P61964|WD REPEAT-CONTAINING PROTEIN 5|9.05|IC=0.90nM|IC50|=|0.9|nM|0.9|nM
5KGN|1.95|2017|13-mer|iPGM/Ce-2d|G5EFZ1|2,3-BISPHOSPHOGLYCERATE-INDEPENDENT PHOSPHOGLYCERATE|9.03|IC=0.933nM|IC50|=|0.933|nM|0.933|nM
5TZW|1.59|2017|7P4|[Different protein in assay: Protein in binding assay is full length PDE2a enzymes. Protein in crystal is residues 579 to 918.] ligand is compound 31.|O00408|CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE|6.01|IC=0.987uM|IC50|=|0.987|uM|987|nM
5Y1Y|1.91|2017|HNQ|BRD4_BD1 in complex with nitroxoline;+/- 0.04|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|6.01|IC=0.98uM|IC50|=|0.98|uM|980|nM
5VO6|2.65|2017|9J4|compund2/JAK3;|P52333|TYROSINE-PROTEIN KINASE JAK3|9.05|IC=0.9nM|IC50|=|0.9|nM|0.9|nM
5TUR|2.95|2017|7LK|4 PIM1|P11309|SERINE/THREONINE-PROTEIN KINASE PIM-1|6.05|IC=0.9uM|IC50|=|0.9|uM|900|nM
5UR1|2.20|2017|YY9|[Covalent complex] ligand is compound 2l.|P11362|FIBROBLAST GROWTH FACTOR RECEPTOR 1|8.97|IC=1.06nM|IC50|=|1.06|nM|1.06|nM
5N4T|1.16|2017|R59|comp.4|Q9K2N0|BETA-LACTAMASE VIM-2|5.97|IC=1.06uM|IC50|=|1.06|uM|1060|nM
5GSW|3.19|2017|5GI|[Nonstandard assay: Temp 30] N69S EV71 3C-NK-1.8k|E7E815|3C PROTEIN|5.94|IC=1.15uM|IC50|=|1.15|uM|1150|nM
5WR7|2.76|2017|RCH|ligand is CH7057288,IC50=1.1+/-0.12nM|P04629|HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR|8.96|IC=1.1nM|IC50|=|1.1|nM|1.1|nM
5JV0|2.40|2017|YL5|ligand is compound 38|P14324|FARNESYL PYROPHOSPHATE SYNTHASE|5.96|IC=1.1uM|IC50|=|1.1|uM|1100|nM
5PZM|2.54|2017|8XS|comp.8|Q9WMX2|RNA-DIRECTED RNA POLYMERASE|5.96|IC=1.1uM|IC50|=|1.1|uM|1100|nM
5VQR|2.55|2017|9KG|[Covalent complex] WT-5;+/-0.2; 24h|P03366|REVERSE TRANSCRIPTASE/RIBONUCLEASE H|5.92|IC=1.2uM|IC50|=|1.2|uM|1200|nM
5V8V|2.60|2017|90D|ligand is compound 3p|P00797|RENIN|8.89|IC=1.3nM|IC50|=|1.3|nM|1.3|nM
5VRP|3.22|2017|9JD|ligand is compound 3n|P00797|RENIN|8.89|IC=1.3nM|IC50|=|1.3|nM|1.3|nM
5WFJ|2.48|2017|9Z4|JAK3 kinase domain bound with compound 13a|P52333|TYROSINE-PROTEIN KINASE JAK3|8.89|IC=1.3nM|IC50|=|1.3|nM|1.3|nM
5NGT|1.54|2017|8WZ|comp.4b|P36639|7,8-DIHYDRO-8-OXOGUANINE TRIPHOSPHATASE|5.89|IC=1.3uM|IC50|=|1.3|uM|1300|nM
5OXG|2.13|2017|B4B|LDN-212854|Q04771|ACTIVIN RECEPTOR TYPE-1|5.89|IC=1.3uM|IC50|=|1.3|uM|1300|nM
5U5H|1.80|2017|7VV|ligand is compound 19.|O75530|POLYCOMB PROTEIN EED|5.89|IC=1.3uM|IC50|=|1.3|uM|1300|nM
5U62|1.90|2017|7WD|ligand is compound 16.|O75530|POLYCOMB PROTEIN EED|5.89|IC=1.3uM|IC50|=|1.3|uM|1300|nM
6BFE|1.51|2017|DJV|11;+/-0.144|P56817|BETA-SECRETASE 1|5.85|IC=1.40uM|IC50|=|1.4|uM|1400|nM
5Q0Z|2.26|2017|9M1|comp.5|Q96RI1|BILE ACID RECEPTOR|5.85|IC=1.42uM|IC50|=|1.42|uM|1420|nM
5WBQ|2.40|2017|A3J|Compound 7|P50053|KETOHEXOKINASE|5.83|IC=1.47uM|IC50|=|1.47|uM|1470|nM
5KU9|2.20|2017|6XJ|compound 1 bound to Mcl-1|------|INDUCED MYELOID LEUKEMIA CELL DIFFERENTIATION PROTEIN MCL|5.83|IC=1.49uM|IC50|=|1.49|uM|1490|nM
5J9K|2.55|2017|15-mer|[Different ligand in assay: assay: 11-mer]|Q5NBT9|PROTEIN TPR1|5.85|IC=1.4uM|IC50|=|1.4|uM|1400|nM
5KV9|2.00|2017|I57|[Nonstandard assay: Temp 37, pH=4.6] hPIV-3 HN in complex with inhibitors 5|G8G134|HEMAGGLUTININ-NEURAMINIDASE|5.85|IC=1.4uM|IC50|=|1.4|uM|1400|nM
5H15|2.27|2017|LQD|EED-EBD-EED709|O75530|POLYCOMB PROTEIN EED|5.8|IC=1.57uM|IC50|=|1.57|uM|1570|nM
5V40|1.99|2017|JS1|IC50=1.57+/-0.15uM, ligand is TAM6.|------|POLYKETIDE SYNTHASE PKS13|5.8|IC=1.57uM|IC50|=|1.57|uM|1570|nM
5TA6|2.50|2017|79D|ligand is compound 8.|P53350|SERINE/THREONINE-PROTEIN KINASE PLK1|8.82|IC=1.5nM|IC50|=|1.5|nM|1.5|nM
5TOB|2.12|2017|YAM|ligand is compound PF-562271.|Q14289|PROTEIN-TYROSINE KINASE 2 BETA|8.82|IC=1.5nM|IC50|=|1.5|nM|1.5|nM
5U3B|2.00|2017|7TD|ligand is compound 1(-)|P47205|UDP-3-O-ACYL-N-ACETYLGLUCOSAMINE DEACETYLASE|8.82|IC=1.5nM|IC50|=|1.5|nM|1.5|nM
5TBJ|2.32|2017|LHD|Table 3, IC50=1.5+/-0.5uM|Q9WVG6|HISTONE-ARGININE METHYLTRANSFERASE CARM1|5.82|IC=1.5uM|IC50|=|1.5|uM|1500|nM
5TG1|1.40|2017|V56|[Covalent complex] ligand is compound 13.|Q83883|3C-LIKE PROTEASE|5.82|IC=1.5uM|IC50|=|1.5|uM|1500|nM
5W5J|2.85|2017|9WS|1|O43353|RECEPTOR-INTERACTING SERINE/THREONINE-PROTEIN KINASE 2|5.82|IC=1.5uM|IC50|=|1.5|uM|1500|nM
5K32|1.99|2017|6Q2|ligand is compound 21|Q08499|CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D|8.8|IC=1.6nM|IC50|=|1.6|nM|1.6|nM
5VPM|2.90|2017|9G7|ligand is compound 4e|P00797|RENIN|8.8|IC=1.6nM|IC50|=|1.6|nM|1.6|nM
5GX6|1.81|2017|2-mer|Smon0123/C delta 4S|D1AWE0|EXTRACELLULAR SOLUTE-BINDING PROTEIN FAMILY 1|5.8|IC=1.6uM|IC50|=|1.6|uM|1600|nM
5T23|2.78|2017|74F|comp.5d|P48736|PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE|5.8|IC=1.6uM|IC50|=|1.6|uM|1600|nM
5Y5N|2.30|2017|8NO|compound 6. +/- 0.26|Q8IXJ6|NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-2|5.76|IC=1.74uM|IC50|=|1.74|uM|1740|nM
5TD7|2.85|2017|FKS|[Different protein in assay: crystal:zHDAC10 (Y307F), binding assay:zHDAC10] Ki=0.7+/-0.2uM, ligand is AAT.|Q803K0|ZGC:55652|5.77|IC=1.7uM|IC50|=|1.7|uM|1700|nM
5XAF|2.55|2017|84F|[Nonstandard assay: Temp 37] 14c|P81947|TUBULIN ALPHA-1B CHAIN|5.77|IC=1.7uM|IC50|=|1.7|uM|1700|nM
5Q0Y|2.20|2017|9LY|comp.26|Q96RI1|BILE ACID RECEPTOR|5.73|IC=1.87uM|IC50|=|1.87|uM|1870|nM
5NI0|1.67|2017|8XW|comp.10c|Q9K2N0|BETA-LACTAMASE CLASS B VIM-2|5.74|IC=1.8uM|IC50|=|1.8|uM|1800|nM
5VQT|2.56|2017|9K7|[Covalent complex] WT-3;+/-0.2; 24h|P03366|REVERSE TRANSCRIPTASE/RIBONUCLEASE H|5.74|IC=1.8uM|IC50|=|1.8|uM|1800|nM
5T2P|1.69|2017|K89|[Different protein in assay: Protein in binding assay is WT] +/-0.22, SBA_R01|L7R9I1|CORE PROTEIN|5.72|IC=1.9uM|IC50|=|1.9|uM|1900|nM
5Y9L|2.15|2017|8R3|compound 25 in the active site of human KLK7|P49862|KALLIKREIN-7|5.72|IC=1.9uM|IC50|=|1.9|uM|1900|nM
5TWL|2.42|2017|H91|complex is MELK(2-333)/HTH-01-091|Q14680|MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE|7.98|IC=10.5nM|IC50|=|10.5|nM|10.5|nM
5LE1|1.40|2017|6UW|VIM-2 in complex with compound 16|Q9K2N0|METALLO-BETA-LACTAMASE VIM-2|4.97|IC=10.6uM|IC50|=|10.6|uM|10600|nM
5USQ|2.55|2017|8LY|ligand is compound 32.|P36897|TGF-BETA RECEPTOR TYPE-1|7.0|IC=100nM|IC50|=|100|nM|100|nM
5GN5|2.85|2017|6XZ|compound is 17, IC50=104+/-7nM|D3KVM3|GLYCEROL KINASE|6.98|IC=104nM|IC50|=|104|nM|104|nM
5VGI|2.07|2017|9DJ|IC50=104+/-10nM, ligand is compound 6|O75164|LYSINE-SPECIFIC DEMETHYLASE 4A|6.98|IC=104nM|IC50|=|104|nM|104|nM
5UL5|2.20|2017|8D7|[Nonstandard assay: Temp 37] IC50=106+/-16nM, ligand is (R)-MB-004|Q28175|RETINOID ISOMEROHYDROLASE|6.97|IC=106nM|IC50|=|106|nM|106|nM
5ML5|1.90|2017|1VI|comp.11b|Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|8.0|IC=10nM|IC50|=|10|nM|10|nM
5W85|2.25|2017|9YS|10 in IRAK4|Q9NWZ3|INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE 4|8.0|IC=10nM|IC50|=|10|nM|10|nM
5H13|1.90|2017|LQA|[Nonstandard assay: pH 8] EED-EED396|O75530|POLYCOMB PROTEIN EED|4.94|IC=11.58uM|IC50|=|11.58|uM|11580|nM
5H0G|1.80|2017|OOU|RK- 21252|P08631|TYROSINE-PROTEIN KINASE HCK|6.95|IC=111nM|IC50|=|111|nM|111|nM
5IZC|1.92|2017|6F4|compound 4c|O76290|PTERIDINE REDUCTASE|3.95|IC=112uM|IC50|=|112|uM|112000|nM
5H0B|1.65|2017|OOQ|RK-21060|P08631|TYROSINE-PROTEIN KINASE HCK|7.96|IC=11nM|IC50|=|11|nM|11|nM
5WQA|2.30|2017|J20|selaginpulvilins K;|Q08499|CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D|7.96|IC=11nM|IC50|=|11|nM|11|nM
5TI7|1.65|2017|7CQ|IC50=11+/-0.181uM, ligand is 8302.|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|4.96|IC=11uM|IC50|=|11|uM|11000|nM
5UP3|2.95|2017|8GS|ligand is compound 6.|Q99683|MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 5|7.9|IC=12.59nM|IC50|=|12.59|nM|12.59|nM
5GN6|2.50|2017|6Y0|compound is 17b, IC50=120+/-8nM|D3KVM3|GLYCEROL KINASE|6.92|IC=120nM|IC50|=|120|nM|120|nM
5TQ6|2.06|2017|7GV|ligand is compound 3.|O60674|TYROSINE-PROTEIN KINASE JAK2|6.91|IC=123.6nM|IC50|=|123.6|nM|123.6|nM
5MLI|1.63|2017|82I|pIC50 = 3.9 +/- 0.55, complex is BRD4 BD1/15|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|3.9|IC=125.9uM|IC50|=|125.9|uM|125900|nM
5LZJ|1.20|2017|7BT|comp.1|P01556|CHOLERA ENTEROTOXIN SUBUNIT B|3.9|IC=125uM|IC50|=|125|uM|125000|nM
5LY2|2.43|2017|14-mer|R6Kme|O75164|LYSINE-SPECIFIC DEMETHYLASE 4A|7.92|IC=12nM|IC50|=|12|nM|12|nM
5GMI|2.71|2017|19-mer|JAM-C|Q99JX3|GOLGI REASSEMBLY-STACKING PROTEIN 2|4.92|IC=12uM|IC50|=|12|uM|12000|nM
5MXV|1.63|2017|K3T|comp.1|P9WMC1|HTH-TYPE TRANSCRIPTIONAL REGULATOR ETHR|4.92|IC=12uM|IC50|=|12|uM|12000|nM
5X79|1.90|2017|GF5|[Covalent complex] 1 bound to GSTP1-1|P09211|GLUTATHIONE S-TRANSFERASE P|4.92|IC=12uM|IC50|=|12|uM|12000|nM
5TWZ|2.63|2017|45R|Z'-LYTE assay|Q14680|MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE|7.87|IC=13.5nM|IC50|=|13.5|nM|13.5|nM
5MYD|2.30|2017|DUP|dUPPNP|------|DUTPASE|4.86|IC=13.9uM|IC50|=|13.9|uM|13900|nM
5KJ0|1.51|2017|6TB|ligand is compound 2;DB-1-264|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|6.89|IC=130nM|IC50|=|130|nM|130|nM
5H09|1.95|2017|OOO|RK-21058|P08631|TYROSINE-PROTEIN KINASE HCK|5.88|IC=1323nM|IC50|=|1323|nM|1323|nM
5NE3|1.35|2017|NXL|[Uncommon element] [Nonstandard assay: Temp 37] avibactam|B2FRP5|BETA-LACTAMASE|7.84|IC=14.36nM|IC50|=|14.36|nM|14.36|nM
5KV8|1.95|2017|6Y6|[Nonstandard assay: Temp 37, pH=4.6] hPIV-3 HN in complex with inhibitors 6|G8G134|HEMAGGLUTININ-NEURAMINIDASE|4.84|IC=14.5uM|IC50|=|14.5|uM|14500|nM
6EKS|1.87|2017|G39|[Nonstandard assay: Temp 37] oseltamivir carboxylate;+/-1|P0C6E9|SIALIDASE|3.84|IC=144uM|IC50|=|144|uM|144000|nM
5UIS|2.50|2017|8C1|ligand is compound 14.|Q9NWZ3|INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE 4|6.84|IC=146nM|IC50|=|146|nM|146|nM
5TPG|1.50|2017|7H5|17a bound to TPH1|P17752|TRYPTOPHAN 5-HYDROXYLASE 1|7.85|IC=14nM|IC50|=|14|nM|14|nM
5WEJ|1.95|2017|V45|[Nonstandard assay: TEMP 37;] NVPro/8B|Q83883|GENOME POLYPROTEIN|4.82|IC=15.3uM|IC50|=|15.3|uM|15300|nM
5IAW|2.58|2017|10-mer|FXR LBD bound to tschimgine with SRC2-3|Q96RI1|BILE ACID RECEPTOR|4.81|IC=15.44uM|IC50|=|15.44|uM|15440|nM
5M6H|2.50|2017|7J6|comp.9|P98170|E3 UBIQUITIN-PROTEIN LIGASE XIAP|6.82|IC=150nM|IC50|=|150|nM|150|nM
5TYL|1.75|2017|7N7|compound is 4|Q25252|CARBOXYLIC ESTER HYDROLASE|7.82|IC=15nM|IC50|=|15|nM|15|nM
5WBR|2.58|2017|A3Y|Compound 8|P50053|KETOHEXOKINASE|4.77|IC=16.79uM|IC50|=|16.79|uM|16790|nM
5T92|2.22|2017|77W|ligand is compound 9.|P03372|ESTROGEN RECEPTOR|7.8|IC=16nM|IC50|=|16|nM|16|nM
5LCF|1.86|2017|6TJ|VIM-2 in complex with 30|Q9K2N0|METALLO-BETA-LACTAMASE VIM-2|4.75|IC=17.8uM|IC50|=|17.8|uM|17800|nM
5T97|3.00|2017|782|ligand is compound 40.|P03372|ESTROGEN RECEPTOR|7.77|IC=17nM|IC50|=|17|nM|17|nM
5MW6|1.65|2017|RC0|comp.1|P41182|B-CELL LYMPHOMA 6 PROTEIN|4.73|IC=18648nM|IC50|=|18648|nM|18648|nM
5ULG|2.10|2017|8E4|[Nonstandard assay: Temp 37] IC50=189+/-31nM, ligand is MB-008|Q28175|RETINOID ISOMEROHYDROLASE|6.72|IC=189nM|IC50|=|189|nM|189|nM
5UUU|2.70|2017|QRW|ligand is compound 115h.|P25098|BETA-ADRENERGIC RECEPTOR KINASE 1|7.74|IC=18nM|IC50|=|18|nM|18|nM
5GTY|3.14|2017|816|CHMFL-EGFR-26 in complex with EGFR T790M protein|P00533|EPIDERMAL GROWTH FACTOR RECEPTOR|7.72|IC=19.01nM|IC50|=|19.01|nM|19.01|nM
5LX6|1.25|2017|78P|complex is PARP10/veliparib|Q53GL7|POLY [ADP-RIBOSE] POLYMERASE 10|5.72|IC=1900nM|IC50|=|1900|nM|1900|nM
5B5O|1.20|2017|WMM|[Nonstandard assay: Temp 37] ligand is compound 2|P45452|COLLAGENASE 3|5.72|IC=1900nM|IC50|=|1900|nM|1900|nM
5MWD|1.85|2017|TJ3|comp.2|P41182|B-CELL LYMPHOMA 6 PROTEIN|5.72|IC=1918nM|IC50|=|1918|nM|1918|nM
5U2F|2.53|2017|82Y|ligand is SF2558HA.|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|6.71|IC=193nM|IC50|=|193|nM|193|nM
5NU1|1.85|2017|8YB|comp.8|P51449|NUCLEAR RECEPTOR ROR-GAMMA|9.0|IC=1nM|IC50|=|1|nM|1|nM
5TL9|1.20|2017|7DN|comp.16|O14684|PROSTAGLANDIN E SYNTHASE|9.0|IC=1nM|IC50|=|1|nM|1|nM
5T8J|2.70|2017|77T|IC50=1+/-0.3nM, ligand is compound 1c.|P10275|ANDROGEN RECEPTOR|9.0|IC=1nM|IC50|=|1|nM|1|nM
5INH|1.84|2017|6C1|[Uncommon element] [Nonstandard assay: PH=8] [Different protein in assay: Protein in binding assay is human] mouse ATX. Crystal structure of 16|Q9R1E6|ECTONUCLEOTIDE PYROPHOSPHATASE/PHOSPHODIESTERASE|6.0|IC=1uM|IC50|=|1|uM|1000|nM
5T2I|2.30|2017|74J|[Different protein in assay: Protein in binding assay is human] comp.7k|O35904|PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE|8.7|IC=2.0nM|IC50|=|2|nM|2|nM
5TW3|2.85|2017|7N1|IC50=2.0+/-0.4nM, ligand is compound 2.|P03366|HIV-1 REVERSE TRANSCRIPTASE P66 SUBUNIT|8.7|IC=2.0nM|IC50|=|2|nM|2|nM
5VQS|2.50|2017|9KD|[Covalent complex] WT-4;+/-0.3; 24h|P03366|REVERSE TRANSCRIPTASE/RIBONUCLEASE H|5.7|IC=2.0uM|IC50|=|2|uM|2000|nM
5VQW|2.50|2017|9KD|[Covalent complex] Y181C-4;+/-0.4; 24h|P03366|REVERSE TRANSCRIPTASE/RIBONUCLEASE H|5.7|IC=2.0uM|IC50|=|2|uM|2000|nM
5TD2|2.68|2017|7AE|[Different protein in assay: Protein in binding assay is Axl. Protein in crystal is Mer(I650M).] ligand is compound 21.|Q12866|TYROSINE-PROTEIN KINASE MER|8.66|IC=2.2nM|IC50|=|2.2|nM|2.2|nM
5TQ3|2.69|2017|7GZ|ligand is compound 5.|O60674|TYROSINE-PROTEIN KINASE JAK2|8.66|IC=2.2nM|IC50|=|2.2|nM|2.2|nM
5OV9|2.40|2017|CVI|crystal violet|P21836|ACETYLCHOLINESTERASE|5.66|IC=2.2uM|IC50|=|2.2|uM|2200|nM
5T2Y|1.94|2017|753|+/-0.4, comp.17|Q0P9D1|UDP-N-ACETYLBACILLOSAMINE N-ACETYLTRANSFERASE|5.66|IC=2.2uM|IC50|=|2.2|uM|2200|nM
5NHY|1.72|2017|8XT|+/-0.8, BAY-707|P36639|7,8-DIHYDRO-8-OXOGUANINE TRIPHOSPHATASE|8.64|IC=2.3nM|IC50|=|2.3|nM|2.3|nM
5UBT|2.83|2017|85S|ligand is compound 9.|O00329|PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE|8.62|IC=2.4nM|IC50|=|2.4|nM|2.4|nM
5TOE|2.30|2017|7GK|3 PIM1|P11309|SERINE/THREONINE-PROTEIN KINASE PIM-1|5.6|IC=2.5uM|IC50|=|2.5|uM|2500|nM
5LHG|3.34|2017|6X3|ligand is compound 17|O60341|LYSINE-SPECIFIC HISTONE DEMETHYLASE 1A|5.6|IC=2.5uM|IC50|=|2.5|uM|2500|nM
5OX5|2.25|2017|B2E|CCT6|Q9GZT9|EGL NINE HOMOLOG 1|5.59|IC=2.6uM|IC50|=|2.6|uM|2600|nM
5GX7|1.99|2017|2-mer|Smon0123/C delta 6S|D1AWE0|EXTRACELLULAR SOLUTE-BINDING PROTEIN FAMILY 1|5.56|IC=2.76uM|IC50|=|2.76|uM|2760|nM
5L2N|1.70|2017|6ZU|ALDH1A1 in complex with 34|P00352|RETINAL DEHYDROGENASE 1|5.55|IC=2.8uM|IC50|=|2.8|uM|2800|nM
5LGN|3.20|2017|6W0|ligand is compound 19|O60341|LYSINE-SPECIFIC HISTONE DEMETHYLASE 1A|5.54|IC=2.9uM|IC50|=|2.9|uM|2900|nM
5LCH|1.94|2017|6TU|[Different ligand in assay: Ligand in binding assay is racemic.] VIM-2 in complex with 42|Q9K2N0|METALLO-BETA-LACTAMASE VIM-2|4.69|IC=20.3uM|IC50|=|20.3|uM|20300|nM
5XMV|2.16|2017|8AU|[Different protein in assay: source of protein in binding assay is Arabidopsis thaliana ] [Different ligand in assay: lligand in binding assay is racemates] (+)-5|A5K8L9|SERINE HYDROXYMETHYLTRANSFERASE|7.68|IC=20.9nM|IC50|=|20.9|nM|20.9|nM
5H6V|2.42|2017|7HS|ligand is compound 1|H8XX12|GENOME POLYPROTEIN|6.68|IC=208nM|IC50|=|208|nM|208|nM
5MKX|1.68|2017|82I|pIC50 = 4.7 +/- 0.1, complex is PCAF/15|Q92831|HISTONE ACETYLTRANSFERASE KAT2B|4.7|IC=20uM|IC50|=|20|uM|20000|nM
5MKZ|1.62|2017|RNK|pIC50 = 4.7 +/-0= 0.27, complex is BDR4 BD1/12|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|4.7|IC=20uM|IC50|=|20|uM|20000|nM
5SXK|3.55|2017|71K|+/-4, frag.18|P42336|PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE|4.7|IC=20uM|IC50|=|20|uM|20000|nM
5TQ7|2.10|2017|7GT|ligand is compound 4.|O60674|TYROSINE-PROTEIN KINASE JAK2|7.67|IC=21.2nM|IC50|=|21.2|nM|21.2|nM
5H0E|2.10|2017|OOS|RK-21107|P08631|TYROSINE-PROTEIN KINASE HCK|6.68|IC=210nM|IC50|=|210|nM|210|nM
5U6V|1.78|2017|7WY|ligand is compound 20, AlphaScreen Assay|P25440|BROMODOMAIN-CONTAINING PROTEIN 2|7.68|IC=21nM|IC50|=|21|nM|21|nM
5OP6|2.45|2017|A0W|GSK128863|Q9NWT6|HYPOXIA-INDUCIBLE FACTOR 1-ALPHA INHIBITOR|4.68|IC=21uM|IC50|=|21|uM|21000|nM
5TI6|1.70|2017|7CO|IC50=21+/-0.254uM, ligand is 8236.|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|4.68|IC=21uM|IC50|=|21|uM|21000|nM
5TYK|1.65|2017|7N4|[Covalent complex] [Uncommon element] compound is 5|Q25252|CARBOXYLIC ESTER HYDROLASE|7.65|IC=22.4nM|IC50|=|22.4|nM|22.4|nM
5M6F|2.39|2017|7HU|comp.7|P98170|E3 UBIQUITIN-PROTEIN LIGASE XIAP|6.66|IC=220nM|IC50|=|220|nM|220|nM
5MJA|2.14|2017|7O3|[Covalent complex] +/-18, EphB1/comp.1|P54762|EPHRIN TYPE-B RECEPTOR 1|6.66|IC=220nM|IC50|=|220|nM|220|nM
5N9T|1.73|2017|8QQ|comp.5|Q93009|UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 7|6.66|IC=220nM|IC50|=|220|nM|220|nM
5LHU|2.02|2017|HIS|L-His-bound ATP-PRT|P9WMN1|ATP PHOSPHORIBOSYLTRANSFERASE|4.66|IC=22uM|IC50|=|22|uM|22000|nM
5MYR|1.83|2017|UDY|comp.6|P9WMC1|HTH-TYPE TRANSCRIPTIONAL REGULATOR ETHR|4.66|IC=22uM|IC50|=|22|uM|22000|nM
5TQ8|1.59|2017|7GS|ligand is compound 2|O60674|TYROSINE-PROTEIN KINASE JAK2|7.64|IC=23.1nM|IC50|=|23.1|nM|23.1|nM
5VEX|3.00|2017|97V|ligand is NNC0640|P43220|GLUCAGON-LIKE PEPTIDE 1 RECEPTOR, ENDOLYSIN CHIMERA|4.63|IC=23.44uM|IC50|=|23.44|uM|23440|nM
5U2C|3.30|2017|82Y|ligand is SF2558HA|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|6.63|IC=235nM|IC50|=|235|nM|235|nM
5XMR|2.55|2017|8AO|[Different protein in assay: source of protein in binding assay is Arabidopsis thaliana ] [Different ligand in assay: lligand in binding assay is racemates] (+)-20;|A5K8L9|SERINE HYDROXYMETHYLTRANSFERASE|7.61|IC=24.5nM|IC50|=|24.5|nM|24.5|nM
5MW3|2.09|2017|5JT|ligand is compound 2|Q8TEK3|HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-79 SPECIFIC|6.62|IC=240nM|IC50|=|240|nM|240|nM
5K5C|1.85|2017|TRE|trehalose|------|ALPHA,ALPHA-TREHALOSE-PHOSPHATE SYNTHASE|1.62|IC=24mM|IC50|=|24|mM|24000000|nM
5XKM|2.16|2017|87R|38a bound in the PDE2A|O00408|CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE|7.62|IC=24nM|IC50|=|24|nM|24|nM
5M39|1.38|2017|7EA|comp.1|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|4.62|IC=24uM|IC50|=|24|uM|24000|nM
5NGR|2.20|2017|8WT|comp.2|P36639|7,8-DIHYDRO-8-OXOGUANINE TRIPHOSPHATASE|4.62|IC=24uM|IC50|=|24|uM|24000|nM
5TI2|1.65|2017|7CJ|IC50=24+/-0.322uM, ligand is 8110.|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|4.62|IC=24uM|IC50|=|24|uM|24000|nM
5TC0|2.24|2017|79Y|[Different protein in assay: Protein in binding assay is Axl. Protein in crystal is Mer(I650M).] ligand is compound 19.|Q12866|TYROSINE-PROTEIN KINASE MER|7.6|IC=25nM|IC50|=|25|nM|25|nM
5TYP|1.88|2017|7NJ|[Covalent complex] [Uncommon element] compound is 1|Q25252|CARBOXYLIC ESTER HYDROLASE|7.6|IC=25nM|IC50|=|25|nM|25|nM
5XMT|2.55|2017|8B0|[Different protein in assay: source of protein in binding assay is Arabidopsis thaliana ] [Different ligand in assay: lligand in binding assay is racemates] (+)-7|A5K8L9|SERINE HYDROXYMETHYLTRANSFERASE|7.58|IC=26.2nM|IC50|=|26.2|nM|26.2|nM
5Q1G|2.00|2017|9NM|comp.3|Q96RI1|BILE ACID RECEPTOR|3.58|IC=263uM|IC50|=|263|uM|263000|nM
5UAL|3.89|2017|RFP|ligand is Rifampin|P0A7Z4|DNA-DIRECTED RNA POLYMERASE SUBUNIT ALPHA|3.58|IC=263uM|IC50|=|263|uM|263000|nM
5SWH|2.50|2017|71D|[Different protein in assay: crystal: SrcCD V284C, assay: Src3D V284C] IC50(Src3D V284C)=26+/-2nM|P00523|PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC|7.59|IC=26nM|IC50|=|26|nM|26|nM
5TI4|1.62|2017|7CM|IC50=26+/-0.202uM, ligand is 8200.|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|4.59|IC=26uM|IC50|=|26|uM|26000|nM
5WPB|1.55|2017|B8P|IC50(FP,11a)=270+/-80uM|Q9UBN7|HISTONE DEACETYLASE 6|3.57|IC=270uM|IC50|=|270|uM|270000|nM
5U2E|1.99|2017|837|ligand is ligand is SF2535.|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|6.56|IC=277nM|IC50|=|277|nM|277|nM
5Q0R|1.91|2017|9LG|comp.15|Q96RI1|BILE ACID RECEPTOR|4.57|IC=27uM|IC50|=|27|uM|27000|nM
5TEH|2.99|2017|S56|[Different protein in assay: crystal: SrcCD V284C, assay: Src3D V284C] IC50(Src3D V284C)=28+/-3nM|P00523|PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC|7.55|IC=28nM|IC50|=|28|nM|28|nM
5TTV|1.93|2017|7KX|[Covalent complex] ligand is compound 6, ATP=1mM|P52333|TYROSINE-PROTEIN KINASE JAK3|7.54|IC=29nM|IC50|=|29|nM|29|nM
5OPC|2.30|2017|A1Z|Vadadustat|Q9NWT6|HYPOXIA-INDUCIBLE FACTOR 1-ALPHA INHIBITOR|4.54|IC=29uM|IC50|=|29|uM|29000|nM
5Q0T|2.14|2017|9LM|comp.16|Q96RI1|BILE ACID RECEPTOR|4.54|IC=29uM|IC50|=|29|uM|29000|nM
5W86|2.61|2017|9YV|7 in IRAK4|P52333|TYROSINE-PROTEIN KINASE JAK3|8.7|IC=2nM|IC50|=|2|nM|2|nM
5X8I|1.90|2017|SQZ|compound 25|P49759|DUAL SPECIFICITY PROTEIN KINASE CLK1|8.7|IC=2nM|IC50|=|2|nM|2|nM
5K1V|2.90|2017|6PX|ligand is compound 1|Q6P179|ENDOPLASMIC RETICULUM AMINOPEPTIDASE 2|5.7|IC=2uM|IC50|=|2|uM|2000|nM
5M3A|1.65|2017|7E7|comp.2|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|5.7|IC=2uM|IC50|=|2|uM|2000|nM
5MKY|1.67|2017|I0D|pIC50 = 5.7 +/- 0.11, complex is BRD9/20|Q9H8M2|BROMODOMAIN-CONTAINING PROTEIN 9|5.7|IC=2uM|IC50|=|2|uM|2000|nM
5MJB|2.23|2017|7O3|[Covalent complex] +/-1.2, EphB1_G703C/comp.1|P54762|EPHRIN TYPE-B RECEPTOR 1|8.52|IC=3.0nM|IC50|=|3|nM|3|nM
6B1O|1.91|2017|C8S|ligand is Saxagliptin M2, IC50=3.1 +/- 0.3 nmol/L|P27487|DIPEPTIDYL PEPTIDASE 4|8.51|IC=3.1nM|IC50|=|3.1|nM|3.1|nM
5XZR|2.80|2017|8J6|[Nonstandard assay: PH=5] SHP2 in complex with compound 10|Q06124|TYROSINE-PROTEIN PHOSPHATASE, NON-RECEPTOR TYPE 11|5.49|IC=3.27uM|IC50|=|3.27|uM|3270|nM
5T28|2.80|2017|74Q|[Different protein in assay: Protein in binding assay is human] comp.5k|O35904|PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE|8.49|IC=3.2nM|IC50|=|3.2|nM|3.2|nM
5TG2|1.75|2017|V69|ligand is compound 21.|Q83883|3C-LIKE PROTEASE|5.49|IC=3.2uM|IC50|=|3.2|uM|3200|nM
5JH6|2.37|2017|T92|[Covalent complex] TAK1-7|O43318|MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 7|8.48|IC=3.3nM|IC50|=|3.3|nM|3.3|nM
5V8Q|1.44|2017|97A|ligand is compound 2f.|P10275|ANDROGEN RECEPTOR|8.44|IC=3.6nM|IC50|=|3.6|nM|3.6|nM
5T66|1.95|2017|C6S|[Covalent complex] [Uncommon element] [Nonstandard assay: preincubation time = 30 min] +/-0.1, cyclic boronate 1|G3G192|BETA-LACTAMASE|8.43|IC=3.7nM|IC50|=|3.7|nM|3.7|nM
5KSX|2.65|2017|7AM|ligand is compound 29|P14324|FARNESYL PYROPHOSPHATE SYNTHASE|5.43|IC=3.7uM|IC50|=|3.7|uM|3700|nM
5MYM|2.28|2017|HYV|comp.3|P9WMC1|HTH-TYPE TRANSCRIPTIONAL REGULATOR ETHR|5.41|IC=3.9uM|IC50|=|3.9|uM|3900|nM
5U5T|1.60|2017|7W7|ligand is compound 14.|O75530|POLYCOMB PROTEIN EED|5.41|IC=3.9uM|IC50|=|3.9|uM|3900|nM
5XMU|2.39|2017|8A0|[Different protein in assay: source of protein in binding assay is Arabidopsis thaliana ] [Different ligand in assay: lligand in binding assay is racemates] (+)-4|A5K8L9|SERINE HYDROXYMETHYLTRANSFERASE|7.51|IC=30.9nM|IC50|=|30.9|nM|30.9|nM
5ORX|1.88|2017|A6H|comp.10, refers to Aurora-ACA alone|O14965|AURORA KINASE A|3.51|IC=308uM|IC50|=|308|uM|308000|nM
5TWX|2.55|2017|7P7|ligand is compound 3.|Q9H8M2|BROMODOMAIN-CONTAINING PROTEIN 9|7.52|IC=30nM|IC50|=|30|nM|30|nM
5MYN|1.56|2017|ZUF|comp.5|P9WMC1|HTH-TYPE TRANSCRIPTIONAL REGULATOR ETHR|4.52|IC=30uM|IC50|=|30|uM|30000|nM
5MXX|1.75|2017|W4A|comp.1|------|SERINE-ARGININE (SR) PROTEIN KINASE 1|7.51|IC=31nM|IC50|=|31|nM|31|nM
5MYV|2.90|2017|W4A|comp.1|P78362|SRSF PROTEIN KINASE 2,SRSF PROTEIN KINASE 2|7.51|IC=31nM|IC50|=|31|nM|31|nM
5K6A|1.70|2017|6QT|ligand is compound 1, in vitro enzyme reporter assay|O76290|PTERIDINE REDUCTASE|4.51|IC=31uM|IC50|=|31|uM|31000|nM
5LCA|1.93|2017|B06|VIM-2 in complex with 17|Q9K2N0|METALLO-BETA-LACTAMASE VIM-2|4.48|IC=32.8uM|IC50|=|32.8|uM|32800|nM
5VND|2.20|2017|9ES|[Different protein in assay: Protein in binding assay is WT] ligand is H3B-6527|P11362|FIBROBLAST GROWTH FACTOR RECEPTOR 1|6.49|IC=320nM|IC50|=|320|nM|320|nM
5NTQ|2.26|2017|444|comp.6|P51449|NUCLEAR RECEPTOR ROR-GAMMA|7.47|IC=33.8nM|IC50|=|33.8|nM|33.8|nM
5L01|1.90|2017|6Z4|15a bound to TPH1|P17752|TRYPTOPHAN 5-HYDROXYLASE 1|7.48|IC=33nM|IC50|=|33|nM|33|nM
5SWG|3.11|2017|CAQ|[Multiple sites] ligand in crystal is Frag.5 and Frag.21, binding assay is Frag.21|P42336|PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE|4.48|IC=33uM|IC50|=|33|uM|33000|nM
5J9L|2.75|2017|6HF|[Covalent complex] TAK1-10|O43318|MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 7|7.47|IC=34nM|IC50|=|34|nM|34|nM
6B1E|1.77|2017|LF7|[Nonstandard assay: Tem 37] ligand is Vildagliptin,IC50=34+/-7.7nM/L|P27487|DIPEPTIDYL PEPTIDASE 4|7.47|IC=34nM|IC50|=|34|nM|34|nM
5UWM|1.62|2017|8OA|IC50=356+/-95nM, ligand is compound (R)-17a|P45452|COLLAGENASE 3|6.45|IC=356nM|IC50|=|356|nM|356|nM
5M7M|2.70|2017|7HR|[Nonstandard assay: Temp 37, pH=8.5, NaCl=500mM] +/-53, comp.9, LPC 16:0 as substrate|Q13822|ECTONUCLEOTIDE PYROPHOSPHATASE/PHOSPHODIESTERASE|6.45|IC=357nM|IC50|=|357|nM|357|nM
5TYJ|1.75|2017|7ND|[Covalent complex] [Uncommon element] compound is 3.10|Q25252|CARBOXYLIC ESTER HYDROLASE|7.46|IC=35nM|IC50|=|35|nM|35|nM
5MRD|1.41|2017|S26|[Different protein in assay: ] +/-0.8, PS267|O15530|3-PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE 1|4.44|IC=36.4uM|IC50|=|36.4|uM|36400|nM
5W84|2.90|2017|9YY|4 in IRAK4|Q9NWZ3|INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE 4|6.44|IC=360nM|IC50|=|360|nM|360|nM
5H22|1.50|2017|7FT|IC50=36+/-3.9nM|A0PJ91|HSP90AA1 PROTEIN|7.44|IC=36nM|IC50|=|36|nM|36|nM
5U7J|1.90|2017|7XV|ligand is compound 3.|O00408|CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE|6.41|IC=389.6nM|IC50|=|389.6|nM|389.6|nM
5NPD|1.95|2017|94B|[Nonstandard assay: Temp 37] [Different protein in assay: protein in binding assay is WT] +/-3, GAA, comp.4|B3PEE6|OLIGOSACCHARIDE 4-ALPHA-D-GLUCOSYLTRANSFERASE|7.42|IC=38nM|IC50|=|38|nM|38|nM
6ALZ|2.21|2017|BKM|PP1:TTN|P62136|SERINE/THREONINE-PROTEIN PHOSPHATASE PP1-ALPHA|10.42|IC=38pM|IC50|=|38|pM|0.038|nM
6EZ6|2.04|2017|C5Z|[Covalent complex] 8;PIC50=7.4;|O35904|PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE|7.4|IC=39.81nM|IC50|=|39.81|nM|39.81|nM
5UAH|4.10|2017|RFP|ligand is Rifampin|P0A7Z4|DNA-DIRECTED RNA POLYMERASE SUBUNIT ALPHA|3.4|IC=398uM|IC50|=|398|uM|398000|nM
5VLR|2.80|2017|9EM|IC50=3+/-1nM, ligand is compound 22.|O00329|PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE|8.52|IC=3nM|IC50|=|3|nM|3|nM
5JUZ|2.40|2017|YL4|ligand is compound 33|P14324|FARNESYL PYROPHOSPHATE SYNTHASE|5.52|IC=3uM|IC50|=|3|uM|3000|nM
5V5E|2.30|2017|8N4|IC50=2.8+/-3uM, ligand is compound 4.|O40922|ORF 17|5.52|IC=3uM|IC50|=|3|uM|3000|nM
5TQ4|2.30|2017|7GY|ligand is compound 13.|O60674|TYROSINE-PROTEIN KINASE JAK2|8.38|IC=4.2nM|IC50|=|4.2|nM|4.2|nM
5Q0L|2.50|2017|9KY|comp.8|Q96RI1|BILE ACID RECEPTOR|5.36|IC=4.36uM|IC50|=|4.36|uM|4360|nM
5M6U|2.85|2017|7KA|comp.11|O00329|PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE CATALYTIC|8.37|IC=4.3nM|IC50|=|4.3|nM|4.3|nM
5K0X|2.23|2017|K0X|11 in complex with Mer|Q12866|TYROSINE-PROTEIN KINASE MER|8.36|IC=4.4nM|IC50|=|4.4|nM|4.4|nM
5LLM|3.25|2017|6Z6||P43003|EXCITATORY AMINO ACID TRANSPORTER 1,NEUTRAL AMINO ACID|5.35|IC=4.5uM|IC50|=|4.5|uM|4500|nM
5Q12|2.00|2017|9MA|comp.2|Q96RI1|BILE ACID RECEPTOR|5.33|IC=4.64uM|IC50|=|4.64|uM|4640|nM
5UIT|1.84|2017|8CD|ligand is compound 20.|Q9NWZ3|INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE 4|8.34|IC=4.6nM|IC50|=|4.6|nM|4.6|nM
5NHZ|1.85|2017|8XZ|comp.10b|Q9K2N0|BETA-LACTAMASE CLASS B VIM-2|5.33|IC=4.7uM|IC50|=|4.7|uM|4700|nM
5DYW|2.50|2017|5HF|IC50=4.9+/-0.3nM, ligand is compound 2|P06276|CHOLINESTERASE|8.31|IC=4.9nM|IC50|=|4.9|nM|4.9|nM
5TNT|1.40|2017|7GQ|ligand is compound 16.|P00740|COAGULATION FACTOR IX|8.31|IC=4.9nM|IC50|=|4.9|nM|4.9|nM
5V24|2.50|2017|8V7|ligand is compound 13.|Q99683|MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 5|6.4|IC=400nM|IC50|=|400|nM|400|nM
5QBY|2.25|2017|N2A|compound 27; Ki(human CatS); X-ray(CatS C25S)|P25774|CATHEPSIN S|7.4|IC=40nM|IC50|=|40|nM|40|nM
5MRI|2.00|2017|Q9Y|comp.18|Q99523|SORTILIN|4.4|IC=40uM|IC50|=|40|uM|40000|nM
5MAR|1.89|2017|7KE|+/-11.9, comp.48|Q8IXJ6|NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-2|4.39|IC=41.2uM|IC50|=|41.2|uM|41200|nM
5MXK|1.93|2017|ZHA|against EthR-DNA106, comp.4|P9WMC1|HTH-TYPE TRANSCRIPTIONAL REGULATOR ETHR|3.39|IC=410uM|IC50|=|410|uM|410000|nM
5TI5|1.83|2017|7CN|IC50=41+/-0.811uM, ligand is 8228.|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|4.39|IC=41uM|IC50|=|41|uM|41000|nM
5U7L|2.38|2017|7Y4|ligand is compound 56.|O00408|CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE|6.37|IC=423nM|IC50|=|423|nM|423|nM
5GVL|2.50|2017|GI8|[Different protein in assay: assay uses PfSHMT]|A5K8L9|SERINE HYDROXYMETHYLTRANSFERASE|7.38|IC=42nM|IC50|=|42|nM|42|nM
5XMP|2.40|2017|8A3|[Different protein in assay: source of protein in binding assay is Arabidopsis thaliana ] [Different ligand in assay: lligand in binding assay is racemates] COMPOUND 11|A5K8L9|SERINE HYDROXYMETHYLTRANSFERASE|7.37|IC=43.0nM|IC50|=|43|nM|43|nM
5T36|1.40|2017|755|comp.5|O14684|PROSTAGLANDIN E SYNTHASE|7.37|IC=43nM|IC50|=|43|nM|43|nM
5UE4|1.80|2017|5XQ|[Nonstandard assay: Temp 37] [Different protein in assay: crystal:proMMP-9desFnII ,bindingassay:proMMP-9] ligand is JNJ0966|P14780|MATRIX METALLOPROTEINASE-9 (MMP-9)|6.36|IC=440nM|IC50|=|440|nM|440|nM
5M6M|2.37|2017|7H8|comp.12|P98170|E3 UBIQUITIN-PROTEIN LIGASE XIAP|7.36|IC=44nM|IC50|=|44|nM|44|nM
5SYS|2.80|2017|72F|[Different protein in assay: crystal: SrcCD V284C, assay: Src3D V284C] IC50(Src3D V284C)=44+/-7nM|P00523|PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC|7.36|IC=44nM|IC50|=|44|nM|44|nM
5TI3|1.70|2017|7CG|IC50=44+/-1.363uM, ligand is 8152.|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|4.36|IC=44uM|IC50|=|44|uM|44000|nM
5UJO|1.35|2017|LSI|[Covalent complex] [Uncommon element] [Different protein in assay: Protein in binding assay is wildtype, protein in crystal is E166A mutant] IC50=44+/-4uM, ligand is compound 3|Q9L5C8|BETA-LACTAMASE|4.36|IC=44uM|IC50|=|44|uM|44000|nM
5V9T|3.05|2017|90V|ligand is compound 50.|P29375|LYSINE-SPECIFIC DEMETHYLASE 5A|7.35|IC=45nM|IC50|=|45|nM|45|nM
5L6I|2.76|2017|B39|[Covalent complex] Uba1-Ub-MLN4924|P22515|UBIQUITIN-ACTIVATING ENZYME E1 1|4.35|IC=45uM|IC50|=|45|uM|45000|nM
5N49|1.94|2017|8LW|comp.7/ BRPF2 BD|O95696|BROMODOMAIN-CONTAINING PROTEIN 1|6.33|IC=470nM|IC50|=|470|nM|470|nM
5TTU|1.72|2017|7KV|[Covalent complex] ligand is compound 7, ATP=1mM|P52333|TYROSINE-PROTEIN KINASE JAK3|7.33|IC=47nM|IC50|=|47|nM|47|nM
5MKJ|2.50|2017|4CU|+/-4.6, comp.9|P19793|RETINOIC ACID RECEPTOR RXR-ALPHA|4.31|IC=48.5uM|IC50|=|48.5|uM|48500|nM
5T4U|1.50|2017|12Q|comp.5b|P55201|PEREGRIN|5.32|IC=4800nM|IC50|=|4800|nM|4800|nM
5UOX|2.50|2017|8GY|ligand is compound 19.|Q99683|MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 5|8.3|IC=5.01nM|IC50|=|5.01|nM|5.01|nM
5T2B|2.30|2017|74O|[Different protein in assay: Protein in binding assay is human] comp.7e|O35904|PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE|8.3|IC=5.0nM|IC50|=|5|nM|5|nM
5J8I|2.40|2017|6H4|[Covalent complex] TAK1-2|O43318|MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 7|8.29|IC=5.1nM|IC50|=|5.1|nM|5.1|nM
5NE1|2.09|2017|OK3|[Uncommon element] [Nonstandard assay: Temp 37] cyclic boronate 2|Q9RBQ1|BETA-LACTAMASE|8.28|IC=5.25nM|IC50|=|5.25|nM|5.25|nM
5GNK|1.80|2017|80U|EGFR T790M in complex with compound 21|P00533|EPIDERMAL GROWTH FACTOR RECEPTOR|8.28|IC=5.3nM|IC50|=|5.3|nM|5.3|nM
5URJ|2.75|2017|8LS|[Different protein in assay: crystal:395-2129, binding assay:full-length] ligand is compound 3.|O75643|U5 SMALL NUCLEAR RIBONUCLEOPROTEIN 200 KDA HELICASE|5.28|IC=5.3uM|IC50|=|5.3|uM|5300|nM
5URM|2.80|2017|8LV|[Different protein in assay: crystal:395-2129, binding assay:full-length] ligand is compound 12.|O75643|U5 SMALL NUCLEAR RIBONUCLEOPROTEIN 200 KDA HELICASE|5.28|IC=5.3uM|IC50|=|5.3|uM|5300|nM
5VQQ|2.55|2017|9JP|[Covalent complex] WT-2;+/-1.0; 24h|P03366|REVERSE TRANSCRIPTASE/RIBONUCLEASE H|5.28|IC=5.3uM|IC50|=|5.3|uM|5300|nM
5V5D|2.10|2017|8OY|IC50=5.4+/-0.6uM, ligand is compound 1.|O40922|ORF 17|5.27|IC=5.4uM|IC50|=|5.4|uM|5400|nM
5VLK|2.20|2017|11-mer|[Different protein in assay: crystal:PCSK9-P-CRD, binding assay:PCSK9-P] IC50=5.55+/-0.36uM, ligand is WNLV(hR)IGLLR|Q8NBP7|PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9|5.26|IC=5.55uM|IC50|=|5.55|uM|5550|nM
5Q17|2.10|2017|9MV|comp.10|Q96RI1|BILE ACID RECEPTOR|5.25|IC=5.64uM|IC50|=|5.64|uM|5640|nM
5V19|3.10|2017|8V4|ligand is compound 7.|Q99683|MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 5|3.3|IC=500uM|IC50|=|500|uM|500000|nM
5ML0|1.64|2017|P2L|[Different protein in assay: Protein in binding assay is Human] pIC50 = 6.3 +/- 0.04. complex is mouse PCAF/(R)-23|Q9JHD1|HISTONE ACETYLTRANSFERASE KAT2B|6.3|IC=501nM|IC50|=|501|nM|501|nM
5J7S|2.37|2017|6H3|[Covalent complex] TAK1-5|O43318|MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 7|7.3|IC=50nM|IC50|=|50|nM|50|nM
5MYS|1.59|2017|YP6|comp.7|P9WMC1|HTH-TYPE TRANSCRIPTIONAL REGULATOR ETHR|4.3|IC=50uM|IC50|=|50|uM|50000|nM
5ONE|2.60|2017|9YQ|+/-3.0|O14965|AURORA KINASE A|7.28|IC=52nM|IC50|=|52|nM|52|nM
6EKU|1.75|2017|ZMR|[Nonstandard assay: Temp 37] zanamivir;+/-2|P0C6E9|SIALIDASE|4.28|IC=52uM|IC50|=|52|uM|52000|nM
5UIQ|2.64|2017|8BV|ligand is compound 51.|Q9NWZ3|INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE 4|4.26|IC=55.056uM|IC50|=|55.056|uM|55056|nM
5Q0I|1.70|2017|0X0|comp.1|Q96RI1|BILE ACID RECEPTOR|4.25|IC=56.1uM|IC50|=|56.1|uM|56100|nM
5DYY|2.65|2017|5HH|IC50=56.9+/-9.8nM, ligand is compound 7|P06276|CHOLINESTERASE|7.24|IC=56.9nM|IC50|=|56.9|nM|56.9|nM
5LVX|2.20|2017|7E4/79B|[Covalent complex] ligand is JZ-5907|P04062|GLUCOSYLCERAMIDASE|7.25|IC=56nM|IC50|=|56|nM|56|nM
5TTS|2.34|2017|7KU|[Covalent complex] ligand is compound 4, ATP=1mM|P52333|TYROSINE-PROTEIN KINASE JAK3|7.25|IC=56nM|IC50|=|56|nM|56|nM
5TQ5|2.30|2017|7GX|ligand is compound 16.|O60674|TYROSINE-PROTEIN KINASE JAK2|7.23|IC=58.8nM|IC50|=|58.8|nM|58.8|nM
5T1T|2.34|2017|76P|comp.3|Q9NWZ3|INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE 4|7.24|IC=58nM|IC50|=|58|nM|58|nM
5NPF|1.38|2017|945|[Covalent complex] [Nonstandard assay: Temp 37] [Different ligand in assay: ligand in binding assay is unreacted and ligand in crystal is ring-opened] +/-4.5, GBA2, comp.6, reacted|F6BL85|GLUCOSYLCERAMIDASE|4.24|IC=58uM|IC50|=|58|uM|58000|nM
5O0S|1.16|2017|9FQ|[Nonstandard assay: Temp 37] +/-4.5, GBA2, comp.6, unreacted|F6BL85|GLUCOSYLCERAMIDASE|4.24|IC=58uM|IC50|=|58|uM|58000|nM
5TIU|1.49|2017|7CU|ligand is compound 8.|P43405|TYROSINE-PROTEIN KINASE SYK|8.3|IC=5nM|IC50|=|5|nM|5|nM
5X5O|1.87|2017|7Z0|3g;+/-0.62|Q9NYL2|MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE MLT|8.3|IC=5nM|IC50|=|5|nM|5|nM
5TYO|1.57|2017|7NM|[Covalent complex] [Uncommon element] compound is 2|Q25252|CARBOXYLIC ESTER HYDROLASE|8.21|IC=6.1nM|IC50|=|6.1|nM|6.1|nM
5UVC|2.65|2017|8PV|ligand is compound 30i.|P25098|BETA-ADRENERGIC RECEPTOR KINASE 1|8.21|IC=6.1nM|IC50|=|6.1|nM|6.1|nM
5Q10|2.20|2017|9M4|comp.18|Q96RI1|BILE ACID RECEPTOR|5.2|IC=6.28uM|IC50|=|6.28|uM|6280|nM
5UOR|2.75|2017|8GV|ligand is compound 17.|Q99683|MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 5|8.2|IC=6.31nM|IC50|=|6.31|nM|6.31|nM
5T2L|2.55|2017|74H|[Different protein in assay: Protein in binding assay is human] comp.7l|O35904|PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE|8.2|IC=6.3nM|IC50|=|6.3|nM|6.3|nM
5H21|1.59|2017|RMR|ligand is compound DC-BD-29|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|5.19|IC=6.4uM|IC50|=|6.4|uM|6400|nM
5LHH|3.05|2017|6X0|ligand is compound 49|O60341|LYSINE-SPECIFIC HISTONE DEMETHYLASE 1A|8.17|IC=6.7nM|IC50|=|6.7|nM|6.7|nM
5UBG|1.90|2017|PRT|IC50=6.8+/-0.7uM, ligand is PR-ATP|Q5HSJ4|ATP PHOSPHORIBOSYLTRANSFERASE|5.17|IC=6.8uM|IC50|=|6.8|uM|6800|nM
5V83|2.00|2017|8Z7|IC50=6.91+/-0.442uM, ligand is NAcM-HIT|D9IEF7|LYSOZYME,DCN1-LIKE PROTEIN 1 CHIMERA|5.16|IC=6.91uM|IC50|=|6.91|uM|6910|nM
5T4V|1.65|2017|N48|comp.22|P55201|PEREGRIN|7.22|IC=60nM|IC50|=|60|nM|60|nM
5V3O|3.20|2017|8W7|ligand is compound 6.|Q16531|DNA DAMAGE-BINDING PROTEIN 1|7.22|IC=60nM|IC50|=|60|nM|60|nM
5V7T|2.30|2017|91V|ligand is compound 3.|Q460N5|POLY [ADP-RIBOSE] POLYMERASE 14|6.21|IC=610nM|IC50|=|610|nM|610|nM
5MWO|1.96|2017|J6W|against EthR-DNA106, comp.7|P9WMC1|HTH-TYPE TRANSCRIPTIONAL REGULATOR ETHR|3.21|IC=610uM|IC50|=|610|uM|610000|nM
5N20|1.38|2017|8GN|comp.1|P41182|B-CELL LYMPHOMA 6 PROTEIN|4.21|IC=61uM|IC50|=|61|uM|61000|nM
5MRH|2.50|2017|Q9Z|comp.1|Q99523|SORTILIN|4.2|IC=63uM|IC50|=|63|uM|63000|nM
5MIH|1.80|2017|7NU|+/-42, comp.3|Q05097|PA-I GALACTOPHILIC LECTIN|4.19|IC=64uM|IC50|=|64|uM|64000|nM
5U7I|2.00|2017|7XS|ligand is compound 4.|O00408|CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE|7.18|IC=66.6nM|IC50|=|66.6|nM|66.6|nM
5V7I|2.47|2017|8Z1|ligand is racemic compound 2|P34897|SERINE HYDROXYMETHYLTRANSFERASE, MITOCHONDRIAL|7.18|IC=66nM|IC50|=|66|nM|66|nM
5OP8|2.30|2017|A1H|Molidustat|Q9NWT6|HYPOXIA-INDUCIBLE FACTOR 1-ALPHA INHIBITOR|4.18|IC=66uM|IC50|=|66|uM|66000|nM
5H0H|1.72|2017|OOV|RK-21253|P08631|TYROSINE-PROTEIN KINASE HCK|6.16|IC=686nM|IC50|=|686|nM|686|nM
5HCL|1.50|2017|5Y9|BRD4-BD1/DMA|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|2.22|IC=6mM|IC50|=|6|mM|6000000|nM
5H3Q|2.10|2017|7HF|A1 bound to TrkA with the JM region;without JM region IC50=37163.3nM|P04629|HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR|8.22|IC=6nM|IC50|=|6|nM|6|nM
5KSV|2.20|2017|15-mer|ligand is CLIP2|O19705|MHC CLASS II HLA-DQ-ALPHA CHAIN|5.22|IC=6uM|IC50|=|6|uM|6000|nM
5VEW|2.70|2017|97Y|ligand is PF-06372222.|P43220|GLUCAGON-LIKE PEPTIDE 1 RECEPTOR, ENDOLYSIN CHIMERA|5.15|IC=7.08uM|IC50|=|7.08|uM|7080|nM
5Q11|2.20|2017|9M7|comp.4|Q96RI1|BILE ACID RECEPTOR|5.14|IC=7.19uM|IC50|=|7.19|uM|7190|nM
5U7K|2.06|2017|7Y1|ligand is compound 39.|O00408|CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE|8.15|IC=7.1nM|IC50|=|7.1|nM|7.1|nM
5JK3|2.37|2017|6L4|[Covalent complex] TAK1-22|O43318|MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 7|8.14|IC=7.3nM|IC50|=|7.3|nM|7.3|nM
5XMS|2.45|2017|8B3|[Different protein in assay: source of protein in binding assay is Arabidopsis thaliana ] [Different ligand in assay: lligand in binding assay is racemates] (+)-3|A5K8L9|SERINE HYDROXYMETHYLTRANSFERASE|8.14|IC=7.3nM|IC50|=|7.3|nM|7.3|nM
5LM6|1.17|2017|H32|VIM-2 in complex with 35|Q9K2N0|METALLO-BETA-LACTAMASE VIM-2|5.11|IC=7.7uM|IC50|=|7.7|uM|7700|nM
5OGK|3.60|2017|GDD|+/-0.4 GDP-M|P40107|GDP-MANNOSE TRANSPORTER 1|5.11|IC=7.7uM|IC50|=|7.7|uM|7700|nM
5LHI|3.40|2017|6X5|ligand is compound 50|O60341|LYSINE-SPECIFIC HISTONE DEMETHYLASE 1|8.11|IC=7.8nM|IC50|=|7.8|nM|7.8|nM
5VQU|2.60|2017|9JP|[Covalent complex] Y181C-2;+/-2.5; 24h|P03366|REVERSE TRANSCRIPTASE/RIBONUCLEASE H|5.11|IC=7.8uM|IC50|=|7.8|uM|7800|nM
6EYZ|2.20|2017|C5W|[Covalent complex] 4;PIC50=8.1;|Q3UDT3|PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE|8.1|IC=7.94nM|IC50|=|7.94|nM|7.94|nM
5Q1H|2.20|2017|9NP|comp.9|Q96RI1|BILE ACID RECEPTOR|5.1|IC=7.95uM|IC50|=|7.95|uM|7950|nM
5T2G|2.55|2017|74K|[Different protein in assay: Protein in binding assay is human] comp.7i|O35904|PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE|8.1|IC=7.9nM|IC50|=|7.9|nM|7.9|nM
5MTS|2.60|2017|XKA|comp.2|P08191|FIMH PROTEIN|7.15|IC=70nM|IC50|=|70|nM|70|nM
5UIR|2.64|2017|8BY|ligand is compound 12.|Q9NWZ3|INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE 4|7.14|IC=71.9nM|IC50|=|71.9|nM|71.9|nM
5OY3|2.14|2017|17-mer|enzyme assay|O15054|LYSINE-SPECIFIC DEMETHYLASE 6B|4.15|IC=71uM|IC50|=|71|uM|71000|nM
5V9P|3.00|2017|90S|ligand is compound 35.|P29375|LYSINE-SPECIFIC DEMETHYLASE 5A|6.14|IC=727nM|IC50|=|727|nM|727|nM
5UR5|1.93|2017|8KP|[Incomplete ligand] IC50=72+/-15nM, ligand is compound 4m|O49686|ABSCISIC ACID RECEPTOR PYR1|7.14|IC=72nM|IC50|=|72|nM|72|nM
5V7W|2.65|2017|91J|ligand is compound 4.|Q460N5|POLY [ADP-RIBOSE] POLYMERASE 14|7.12|IC=76nM|IC50|=|76|nM|76|nM
5VEE|2.50|2017|981|ligand is FRAX486|O96013|SERINE/THREONINE-PROTEIN KINASE PAK 4|6.11|IC=779nM|IC50|=|779|nM|779|nM
5T27|2.60|2017|74F|comp.5d|O35904|PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE|7.1|IC=79nM|IC50|=|79|nM|79|nM
5H2U|2.24|2017|1N1|PTK6 in complex with Dasatinib|Q13882|PROTEIN-TYROSINE KINASE 6|8.15|IC=7nM|IC50|=|7|nM|7|nM
5K00|1.77|2017|6PV|MELK/5|Q14680|MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE|8.15|IC=7nM|IC50|=|7|nM|7|nM
5O4Y|2.30|2017|16-mer|peptide 57|Q9NZQ7|PROGRAMMED CELL DEATH 1 LIGAND 1|8.15|IC=7nM|IC50|=|7|nM|7|nM
5XG4|3.00|2017|QUE|uPA-quercetin|P00749|UROKINASE-TYPE PLASMINOGEN ACTIVATOR|5.15|IC=7uM|IC50|=|7|uM|7000|nM
5JMX|1.44|2017|DZ5|IC50 = 8.2 +/- 0.1 uM, ligand is 6c|P04190|BETA-LACTAMASE 2|5.09|IC=8.2uM|IC50|=|8.2|uM|8200|nM
5TYH|2.10|2017|7O4|comp.1|Q0P9D1|UDP-N-ACETYLBACILLOSAMINE N-ACETYLTRANSFERASE|2.08|IC=8.4mM|IC50|=|8.4|mM|8400000|nM
5GMJ|2.99|2017|19-mer|[Nonstandard assay: Temp 4] JAM-B|Q99JX3|GOLGI REASSEMBLY-STACKING PROTEIN 2|5.08|IC=8.4uM|IC50|=|8.4|uM|8400|nM
5H14|1.90|2017|LQB|[Nonstandard assay: pH 8] EED-EBD-EED666|O75530|POLYCOMB PROTEIN EED|5.06|IC=8.76uM|IC50|=|8.76|uM|8760|nM
5N2F|1.70|2017|8HW|comp.2a|Q9NZQ7|PROGRAMMED CELL DEATH 1 LIGAND 1|7.1|IC=80nM|IC50|=|80|nM|80|nM
5KSU|2.73|2017|15-mer|ligand is CLIP1|P01909|HLA CLASS II HISTOCOMPATIBILITY ANTIGEN, DQ ALPHA 1 CHAIN|4.08|IC=82.5uM|IC50|=|82.5|uM|82500|nM
5NPB|1.90|2017|93Z|[Covalent complex] [Nonstandard assay: Temp 37] +/-1, GAA, comp.5|B3PEE6|OLIGOSACCHARIDE 4-ALPHA-D-GLUCOSYLTRANSFERASE|7.09|IC=82nM|IC50|=|82|nM|82|nM
5T1S|2.30|2017|76Q|comp.1|Q9NWZ3|INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE 4|7.08|IC=84nM|IC50|=|84|nM|84|nM
5UR6|1.63|2017|8KM|[Incomplete ligand] IC50=87+/-3nM, ligand is compound 4i|O49686|ABSCISIC ACID RECEPTOR PYR1|7.06|IC=87nM|IC50|=|87|nM|87|nM
5OR9|2.00|2017|JR5|comp.13|Q9UIF8|BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN PROTEIN 2B|4.06|IC=88uM|IC50|=|88|uM|88000|nM
5MQV|2.15|2017|D5Q|+/-1. comp.16b|P48730|CASEIN KINASE I ISOFORM DELTA|8.1|IC=8nM|IC50|=|8|nM|8|nM
5W4W|1.99|2017|9WG|inhibitor 9|P48730|CASEIN KINASE I ISOFORM DELTA|8.1|IC=8nM|IC50|=|8|nM|8|nM
6BFN|2.26|2017|DL1|JH-I-25/IRAK1|P51617|INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE 1|8.03|IC=9.3nM|IC50|=|9.3|nM|9.3|nM
5UWL|2.55|2017|8OJ|IC50=9.4+/-1.7nM, ligand is compound (S)-17a|P45452|COLLAGENASE 3|8.03|IC=9.4nM|IC50|=|9.4|nM|9.4|nM
5V5N|2.01|2017|EDH|ligand is Takinib EDHS-206 1|O43318|MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 7|8.02|IC=9.5nM|IC50|=|9.5|nM|9.5|nM
5ICK|2.47|2017|11-mer|FXR LBD bound to feroline with SRC2-3|Q96RI1|BILE ACID RECEPTOR|5.01|IC=9.786uM|IC50|=|9.786|uM|9786|nM
5NTK|1.90|2017|99N|comp.2|P51449|NUCLEAR RECEPTOR ROR-GAMMA|8.01|IC=9.7nM|IC50|=|9.7|nM|9.7|nM
5MYL|1.72|2017|Q2N|comp.2|P9WMC1|HTH-TYPE TRANSCRIPTIONAL REGULATOR ETHR|5.0|IC=9.9uM|IC50|=|9.9|uM|9900|nM
5GN7|3.20|2017|6XZ|compound is 17, IC50=900+/-77nM|Q26710|ALTERNATIVE OXIDASE, MITOCHONDRIAL|6.05|IC=900nM|IC50|=|900|nM|900|nM
5GN9|3.20|2017|6Y0|compound is 17b, IC50=90+/-7nM|Q26710|ALTERNATIVE OXIDASE, MITOCHONDRIAL|7.05|IC=90nM|IC50|=|90|nM|90|nM
5U5K|2.33|2017|7VY|ligand is compound 2.|O75530|POLYCOMB PROTEIN EED|4.02|IC=95uM|IC50|=|95|uM|95000|nM
5GVK|2.24|2017|G45|[Different protein in assay: assay uses PfSHMT]|A5K8L9|SERINE HYDROXYMETHYLTRANSFERASE|7.0|IC=99nM|IC50|=|99|nM|99|nM
5O45|0.99|2017|15-mer|peptide 71|Q9NZQ7|PROGRAMMED CELL DEATH 1 LIGAND 1|8.05|IC=9nM|IC50|=|9|nM|9|nM
5XVK|1.88|2017|8GC|[Nonstandard assay: Temp 37] moNNMT-MNA-SAH Complex|O55239|NICOTINAMIDE N-METHYLTRANSFERASE|5.05|IC=9uM|IC50|=|9|uM|9000|nM
5XVQ|2.29|2017|8GC|[Nonstandard assay: Temp 37] moNNMT-MNA-SAH Complex|F7ERX8|NICOTINAMIDE N-METHYLTRANSFERASE (NNMT)|5.05|IC=9uM|IC50|=|9|uM|9000|nM
5J6S|2.80|2017|6GA|ligand is compound 2|Q6P179|ENDOPLASMIC RETICULUM AMINOPEPTIDASE 2|4.0|IC>100uM|IC50|>|100|uM|100000|nM
5NPE|1.95|2017|948|[Covalent complex] [Nonstandard assay: Temp 37] +/-1, GAA, comp.2|B3PEE6|OLIGOSACCHARIDE 4-ALPHA-D-GLUCOSYLTRANSFERASE|4.0|IC>100uM|IC50|>|100|uM|100000|nM
5NPC|1.96|2017|94E|[Nonstandard assay: Temp 37] [Different protein in assay: protein in binding assay is WT] +/-1, GAA, comp.6|B3PEE6|OLIGOSACCHARIDE 4-ALPHA-D-GLUCOSYLTRANSFERASE|4.0|IC>100uM|IC50|>|100|uM|100000|nM
5VT1|1.90|2017|9JS|ligand is compound 2|Q96RR4|CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE 2|4.3|IC>50uM|IC50|>|50|uM|50000|nM
5ORB|2.10|2017|JR6|comp.30|Q9UIF8|BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN PROTEIN 2B|4.29|IC>51uM|IC50|>|51|uM|51000|nM
5LZG|1.13|2017|7BN|comp.2|P01556|CHOLERA ENTEROTOXIN SUBUNIT B|3.1|IC~0.8mM|IC50|~|0.8|mM|800000|nM
5LZH|1.13|2017|7BN|comp.2|Q57193|CHOLERA ENTEROTOXIN SUBUNIT B|3.1|IC~0.8mM|IC50|~|0.8|mM|800000|nM
5TX3|2.90|2017|7MY|IC50 = 1.4 ~ 3.3 nM. complex is MELK(1-340)/MRT199665|Q14680|MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE|8.85|IC~1.4nM|IC50|~|1.4|nM|1.4|nM
5JV2|2.30|2017|6O3|[Nonstandard assay: Temp 37] ligand is compound 49|P14324|FARNESYL PYROPHOSPHATE SYNTHASE|4.0|IC~100uM|IC50|~|100|uM|100000|nM
5N2D|2.35|2017|8J8|comp.1a|Q9NZQ7|PROGRAMMED CELL DEATH 1 LIGAND 1|8.22|IC~6nM|IC50|~|6|nM|6|nM
5ML4|2.40|2017|RRQ|comp.7|O43924|RETINAL ROD RHODOPSIN-SENSITIVE CGMP 3',5'-CYCLIC|8.7|Kd<2nM|Kd|<|2|nM|2|nM
5UFR|2.07|2017|88J|ligand is compound S-12, TF binding assay|P51449|NUCLEAR RECEPTOR ROR-GAMMA|8.7|Kd=0.002uM|Kd|=|0.002|uM|2|nM
5JUR|2.93|2017|6NS|cap-binding domain of PB2/compound 4|Q30NP1|POLYMERASE BASIC PROTEIN 2|8.52|Kd=0.003uM|Kd|=|0.003|uM|3|nM
5ORG|1.99|2017|6DB|+/-0.0001, octopine|P0A4F8|OCTOPINE-BINDING PERIPLASMIC PROTEIN|8.4|Kd=0.004uM|Kd|=|0.004|uM|4|nM
5N1Z|1.81|2017|8GQ|ligand is compound 11|P41182|B-CELL LYMPHOMA 6 PROTEIN|8.19|Kd=0.0065uM|Kd|=|0.0065|uM|6.5|nM
5UL6|1.45|2017|15-mer|Kd=0.006+/-0.002uM, complex is nSH3CrkII RMNS1.|P46108|ADAPTER MOLECULE CRK|8.22|Kd=0.006uM|Kd|=|0.006|uM|6|nM
5LLG|1.12|2017|VD9|ligand is compound 1|P00918|CARBONIC ANHYDRASE 2|11.13|Kd=0.0074nM|Kd|=|0.0074|nM|0.0074|nM
5UHI|3.20|2017|8A4|ligand is compound 28, TF binding assay|P51449|NUCLEAR RECEPTOR ROR-GAMMA|8.04|Kd=0.0092uM|Kd|=|0.0092|uM|9.2|nM
5LYR|1.14|2017|2-mer|+/-0.002, ligand is compound 9|D6D1V7|GLYCOSYL HYDROLASE FAMILY 71|7.89|Kd=0.013uM|Kd|=|0.013|uM|13|nM
6EUW|1.00|2017|BYB|A/H5N1 PB2 cap-binding/ VX-787N;+/- 0.004|Q2LG68|POLYMERASE BASIC PROTEIN 2|7.77|Kd=0.017uM|Kd|=|0.017|uM|17|nM
5H1E|2.60|2017|13-mer|rat VDR-LBD/1,25D3/SRC2-3(peptide) complex|P13053|VITAMIN D3 RECEPTOR|7.54|Kd=0.029uM|Kd|=|0.029|uM|29|nM
5UFO|2.80|2017|87J|ligand is compound 20, TF binding assay|P51449|NUCLEAR RECEPTOR ROR-GAMMA|7.43|Kd=0.037uM|Kd|=|0.037|uM|37|nM
5NMF|2.89|2017|9-mer|A2-SLYNTIATL|P01892|HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA CHAIN|7.42|Kd=0.038uM|Kd|=|0.038|uM|38|nM
5N8B|1.03|2017|13-mer|[Nonstandard assay: pH=5.0] AFPDYLAEYHGG|P22629|STREPTAVIDIN|7.37|Kd=0.043uM|Kd|=|0.043|uM|43|nM
5LLE|1.90|2017|V51|ligand is compound 2|P00918|CARBONIC ANHYDRASE 2|10.22|Kd=0.060nM|Kd|=|0.06|nM|0.06|nM
5KLY|1.30|2017|6UR||P49773|HISTIDINE TRIAD NUCLEOTIDE-BINDING PROTEIN 1|7.21|Kd=0.061uM|Kd|=|0.061|uM|61|nM
5LLH|1.90|2017|V49|ligand is compound 4|P00918|CARBONIC ANHYDRASE 2|10.17|Kd=0.067nM|Kd|=|0.067|nM|0.067|nM
5UKJ|2.80|2017|3K6|ligand is compound 1.|P42336|PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE|7.16|Kd=0.069uM|Kd|=|0.069|uM|69|nM
5X4Q|2.00|2017|7Z6|BCL6/7|P41182|B-CELL LYMPHOMA 6 PROTEIN|7.11|Kd=0.078uM|Kd|=|0.078|uM|78|nM
6AXL|2.40|2017|14-mer|Fab317-(NPNA)3;+/-0.016|------|FAB317 LIGHT CHAINS|7.11|Kd=0.078uM|Kd|=|0.078|uM|78|nM
5NME|2.94|2017|9-mer|A2-SLYNTVATL|P01892|HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA CHAIN|7.09|Kd=0.082uM|Kd|=|0.082|uM|82|nM
5M63|2.74|2017|7-mer|DP2|------|H CHAIN OF FAB NVS-1-19-5|6.96|Kd=0.11uM|Kd|=|0.11|uM|110|nM
5KM5|2.10|2017|TR5|[Different protein in assay: Protein in binding assay is H112N, and wt in crystal.] Structure is a catalytic product complex with hHint2|Q9BX68|HISTIDINE TRIAD NUCLEOTIDE-BINDING PROTEIN 2|6.92|Kd=0.121uM|Kd|=|0.121|uM|121|nM
5M3B|1.50|2017|CBY|[Uncommon element] +/- 0.02 Cbi|P37028|VITAMIN B12-BINDING PROTEIN|6.92|Kd=0.12uM|Kd|=|0.12|uM|120|nM
5VR8|2.00|2017|UDX|ligand is UDX|O60701|UDP-GLUCOSE 6-DEHYDROGENASE|6.87|Kd=0.135uM|Kd|=|0.135|uM|135|nM
5TYI|2.15|2017|9-mer|[Nonstandard assay: PO4(3-), 1mM and 50mM] Kd(1mM, PO4(3-))=0.13+/-0.0004uM, Kd(50mM,PO4(3-))=0.83+/-0.001uM|Q14451|GROWTH FACTOR RECEPTOR-BOUND PROTEIN 7|6.89|Kd=0.13uM|Kd|=|0.13|uM|130|nM
5M34|1.60|2017|CBY|[Uncommon element] +/- 0.03 Cbi|P37028|VITAMIN B12-BINDING PROTEIN|6.82|Kd=0.15uM|Kd|=|0.15|uM|150|nM
5H1T|1.95|2017|7FF|[Nonstandard assay: PH=8] ligand is compound 1|O15164|TRANSCRIPTION INTERMEDIARY FACTOR 1-ALPHA|3.8|Kd=0.16mM|Kd|=|0.16|mM|160000|nM
5VLH|2.86|2017|14-mer|[Different protein in assay: crystal:PCSK9-P-CRD, binding assay:PCSK9-P] kd=0.16+/-0.004uM, ligand is pep1, CRLPWNLQRIGLPC|Q8NBP7|PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9|6.8|Kd=0.16uM|Kd|=|0.16|uM|160|nM
5WA9|1.15|2017|9ZD||P49773|HISTIDINE TRIAD NUCLEOTIDE-BINDING PROTEIN 1|6.76|Kd=0.175uM|Kd|=|0.175|uM|175|nM
5NA0|2.90|2017|8QZ|comp.5|P33981|DUAL SPECIFICITY PROTEIN KINASE TTK|9.77|Kd=0.17nM|Kd|=|0.17|nM|0.17|nM
5YU9|1.95|2017|1E8|[Covalent complex] [Different protein in assay: Protein in binding assay is L858R/T790M.] Ibrutinib;|P00533|EPIDERMAL GROWTH FACTOR RECEPTOR|6.74|Kd=0.18uM|Kd|=|0.18|uM|180|nM
5H1V|2.00|2017|7FU|ligand is compound 6|O15164|TRANSCRIPTION INTERMEDIARY FACTOR 1-ALPHA|4.0|Kd=0.1mM|Kd|=|0.1|mM|100000|nM
5MEV|2.94|2017|7LW|ligand is compound 21|P97287|INDUCED MYELOID LEUKEMIA CELL DIFFERENTIATION PROTEIN MCL-1|7.0|Kd=0.1uM|Kd|=|0.1|uM|100|nM
6AYI|2.09|2017|C3G|EcGusR/PNPG|P0ACT8|HTH-TYPE TRANSCRIPTIONAL REGULATOR UIDR|6.68|Kd=0.21uM|Kd|=|0.21|uM|210|nM
5U06|2.10|2017|9-mer|[Nonstandard assay: PO4(3-), 1mM and 50mM] Kd(1mM, PO4(3-))=0.22+/-0.0004uM, Kd(50mM,PO4(3-))=2.94+/-0.008uM|Q14451|GROWTH FACTOR RECEPTOR-BOUND PROTEIN 7|6.66|Kd=0.22uM|Kd|=|0.22|uM|220|nM
5WYX|2.40|2017|CU8|[Nonstandard assay: PH=5.5] CU-CPT8m|Q9NR97|TOLL-LIKE RECEPTOR 8|6.66|Kd=0.22uM|Kd|=|0.22|uM|220|nM
5IZ6|2.15|2017|9-mer||P25054|ADENOMATOUS POLYPOSIS COLI PROTEIN|6.64|Kd=0.23uM|Kd|=|0.23|uM|230|nM
5NU3|1.75|2017|99E|[Nonstandard assay: Temp 4] CBP bound to XDM-CBP:|Q92793|CREB-BINDING PROTEIN|6.64|Kd=0.23uM|Kd|=|0.23|uM|230|nM
5UL1|3.00|2017|8DY|ligand is compound 7.|P42336|PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE|6.64|Kd=0.23uM|Kd|=|0.23|uM|230|nM
5UNJ|1.96|2017|14-mer|Kd=0.24+/-0.04uM for RJW100 bound LRH-1 LBD interact with coactivator PGC1, Kd is not 0.24uM for full-length LRH-1|O00482|NUCLEAR RECEPTOR SUBFAMILY 5 GROUP A MEMBER 2|6.62|Kd=0.24uM|Kd|=|0.24|uM|240|nM
5W10|2.15|2017|CMP|Lcd1GAF in complex with cAMP|Q72MQ6|CGMP-SPECIFIC PHOSPHODIESTERASE|6.62|Kd=0.24uM|Kd|=|0.24|uM|240|nM
5K48|1.74|2017|S5Z|Kd = 0.251 +/- 0.221 uM, ligand is compound 1|Q9K2N0|BETA-LACTAMASE VIM-2|6.6|Kd=0.251uM|Kd|=|0.251|uM|251|nM
5MB1|1.65|2017|7KT|[Incomplete ligand] ligand is compound 7a, 7KT-FUL in PDB|U8MRX2|FUCOSE-BINDING LECTIN PA-IIL|6.6|Kd=0.253uM|Kd|=|0.253|uM|253|nM
5WTT|2.70|2017|8-mer|ligand is CCN1 epitope, steady-state analysis|------|HEAVY CHAIN OF 093G9 FAB|6.6|Kd=0.25uM|Kd|=|0.25|uM|250|nM
5MXF|1.90|2017|MFU|+/-0.6, n=4 Me-alpha-L-Fuc|C7BLE4|PHOTORHABDUS ASYMBIOTICA LECTIN PHL|3.59|Kd=0.26mM|Kd|=|0.26|mM|260000|nM
5G1A|1.42|2017|7H1|[Nonstandard assay: Temp 30, PH=8] PFSAHA bound to HDAHbo|Q70I53|HISTONE DEACETYLASE-LIKE AMIDOHYDROLASE|6.57|Kd=0.27uM|Kd|=|0.27|uM|270|nM
5NWK|3.30|2017|5-mer|+/-0.02, CPP, +FC|Q5KTN5|14-3-3 C-1 PROTEIN|6.57|Kd=0.27uM|Kd|=|0.27|uM|270|nM
5TWH|2.50|2017|17-mer|Kd=0.68+/-0.1uM, ligand is pT353 peptide.|Q9H8S9|MOB KINASE ACTIVATOR 1A|6.55|Kd=0.28uM|Kd|=|0.28|uM|280|nM
5N69|2.45|2017|2OW|[Nonstandard assay: Temp 10] +/-0.04, OM, MgADP.VO4|Q9BE39|MYOSIN-7|6.54|Kd=0.29uM|Kd|=|0.29|uM|290|nM
5U98|2.00|2017|9-mer|ligand is SPT5a|P18465|HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-57 ALPHA CHAIN|9.7|Kd=0.2nM|Kd|=|0.2|nM|0.2|nM
5G17|1.51|2017|6DK|[Nonstandard assay: Temp 30, PH=8] HDAHbo T101A - SATFMK.|Q70I53|HISTONE DEACETYLASE-LIKE AMIDOHYDROLASE|6.7|Kd=0.2uM|Kd|=|0.2|uM|200|nM
6AXK|2.10|2017|14-mer|Fab311-(NPNA)3;+/-0.06|------|FAB311 HEAVY CHAIN|6.52|Kd=0.305uM|Kd|=|0.305|uM|305|nM
5H1U|1.90|2017|6KT|ligand is compound 2|O15164|TRANSCRIPTION INTERMEDIARY FACTOR 1-ALPHA|3.51|Kd=0.31mM|Kd|=|0.31|mM|310000|nM
5MAY|1.65|2017|PK6|[Incomplete ligand] ligand is compound 7b, PK6-FUL in PDB|U8MRX2|FUCOSE-BINDING LECTIN PA-IIL|6.48|Kd=0.328uM|Kd|=|0.328|uM|328|nM
5NXQ|2.41|2017|19-mer|+/-0.02, A2|Q01454|DNA POLYMERASE ALPHA-BINDING PROTEIN|6.49|Kd=0.32uM|Kd|=|0.32|uM|320|nM
5XG5|1.54|2017|A2G|N-acetyl-D-galactosamine|------|MITSUBA-1|3.48|Kd=0.33mM|Kd|=|0.33|mM|330000|nM
5MES|2.24|2017|7LT|ligand is compound 29|P97287|INDUCED MYELOID LEUKEMIA CELL DIFFERENTIATION PROTEIN MCL-1|6.47|Kd=0.34uM|Kd|=|0.34|uM|340|nM
5VB5|2.23|2017|92A|Kd=0.35+/-0.22uM, ligand is compound 2|P51449|NUCLEAR RECEPTOR ROR-GAMMA|6.46|Kd=0.35uM|Kd|=|0.35|uM|350|nM
5WBL|3.35|2017|16-mer|[Different protein in assay: Assay:Human, X-ray: Arabidopsis thaliana] PRAS40;|Q93YQ1|REGULATORY-ASSOCIATED PROTEIN OF TOR 1|6.44|Kd=0.36uM|Kd|=|0.36|uM|360|nM
5JOP|1.75|2017|4-mer|ligand is tetrasaccharide, TS14 glycan; ITC Kd=51nM|------|FAB 14.22 LIGHT CHAIN|9.41|Kd=0.39nM|Kd|=|0.39|nM|0.39|nM
5V79|2.25|2017|8Y4|Kd=2.05+/-0.02uM, ligand is compound 62|P0AC14|DIHYDROPTEROATE SYNTHASE|6.41|Kd=0.39uM|Kd|=|0.39|uM|390|nM
5LLC|1.10|2017|V26|ligand is compound 13|P00918|CARBONIC ANHYDRASE 2|9.52|Kd=0.3nM|Kd|=|0.3|nM|0.3|nM
5G60|1.99|2017|NYT|complex is FusA/nystose|------|ABC TRANSPORTER, SUBSTRATE-BINDING PROTEIN|6.52|Kd=0.3uM|Kd|=|0.3|uM|300|nM
5LSH|1.06|2017|KTS||P61626|LYSOZYME C|3.39|Kd=0.41mM|Kd|=|0.41|mM|410000|nM
5WYR|2.45|2017|DFG|Ki=0.41+/-0.07uM,SAM for substrate|Q02RL6|TRNA (GUANINE-N(1)-)-METHYLTRANSFERASE|6.39|Kd=0.41uM|Kd|=|0.41|uM|410|nM
5KLZ|1.50|2017|AMP|[Different protein in assay: Protein in binding assay is H112N, and wt in crystal.]|P49773|HISTIDINE TRIAD NUCLEOTIDE-BINDING PROTEIN 1|6.37|Kd=0.423uM|Kd|=|0.423|uM|423|nM
5V7A|2.35|2017|8Y7|Kd=0.42+/-0.04uM, ligand is compound 61|P0AC14|DIHYDROPTEROATE SYNTHASE|6.38|Kd=0.42uM|Kd|=|0.42|uM|420|nM
5VB6|2.04|2017|927|Kd=0.43+/-0.18uM, ligand is compound 2|P51449|NUCLEAR RECEPTOR ROR-GAMMA|6.37|Kd=0.43uM|Kd|=|0.43|uM|430|nM
5VLL|2.37|2017|14-mer|[Different protein in assay: crystal:PCSK9-P-CRD, binding assay:PCSK9-P] kd=0.43+/-0.05uM, ligand is pep3, CFIPWNLQRIGLLC|Q8NBP7|PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9|6.37|Kd=0.43uM|Kd|=|0.43|uM|430|nM
5U4A|1.90|2017|7VG|[Uncommon element] Kd=0.44+/-0.01uM, ligand is compound 4.|P02766|TRANSTHYRETIN|6.36|Kd=0.44uM|Kd|=|0.44|uM|440|nM
5U4E|1.45|2017|XLB|[Uncommon element] Kd=0.45+/-0.01uM, ligand is compound 8.|P02766|TRANSTHYRETIN|6.35|Kd=0.45uM|Kd|=|0.45|uM|450|nM
5M04|1.85|2017|GDP||P42641|GTPASE OBGE/CGTA|6.34|Kd=0.46uM|Kd|=|0.46|uM|460|nM
5NU5|1.60|2017|99E|[Nonstandard assay: Temp 4] p300 bound to XDM-CBP:|Q09472|HISTONE ACETYLTRANSFERASE P300|6.33|Kd=0.47uM|Kd|=|0.47|uM|470|nM
5N8W|1.10|2017|14-mer|[Nonstandard assay: pH=5.0] GGwhdeatwkpG|P22629|STREPTAVIDIN|6.33|Kd=0.47uM|Kd|=|0.47|uM|470|nM
5U4F|1.50|2017|IWW|[Covalent complex] [Uncommon element] Kd=0.47+/-0.03uM, ligand is compound 10.|P02766|TRANSTHYRETIN|6.33|Kd=0.47uM|Kd|=|0.47|uM|470|nM
5U48|1.50|2017|S4B|[Uncommon element] Kd=0.47+/-0.02uM, ligand is compound 2.|P02766|TRANSTHYRETIN|6.33|Kd=0.47uM|Kd|=|0.47|uM|470|nM
5U4D|1.55|2017|XLO|Kd=0.47+/-0.01uM, ligand is compound 7|P02766|TRANSTHYRETIN|6.33|Kd=0.47uM|Kd|=|0.47|uM|470|nM
5LLO|1.60|2017|5EF|ligand is compound 12|O43570|CARBONIC ANHYDRASE 12|9.4|Kd=0.4nM|Kd|=|0.4|nM|0.4|nM
5G61|2.40|2017|FNY|complex is FusA/fructofuranosyl-nystose|------|ABC TRANSPORTER, SUBSTRATE-BINDING PROTEIN|6.4|Kd=0.4uM|Kd|=|0.4|uM|400|nM
5UK8|2.50|2017|8DV|ligand is compound 5|P42336|PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE|6.4|Kd=0.4uM|Kd|=|0.4|uM|400|nM
5GUT|2.10|2017|SAH|Kd(AdoHcy, N1248A)=0.51uM|P13864|DNA (CYTOSINE-5)-METHYLTRANSFERASE 1|6.29|Kd=0.51uM|Kd|=|0.51|uM|510|nM
5T2T|1.97|2017|0N8|[Nonstandard assay: with ions] Kd = 0.51 +/- 0.11 uM. ligand is L-742,001|------|RNA-DIRECTED RNA POLYMERASE L|6.29|Kd=0.51uM|Kd|=|0.51|uM|510|nM
6AOL|2.76|2017|VC1|30;+/- 0.05|P41148|ENDOPLASMIN|6.27|Kd=0.54uM|Kd|=|0.54|uM|540|nM
5OKU|2.07|2017|0L1|+/-0.49; adipate|Q6N193|UNCHARACTERIZED PROTEIN FAMILY UPF0065:TAT PATHWAY SIGNAL|6.26|Kd=0.55uM|Kd|=|0.55|uM|550|nM
5N87|2.29|2017|N66|NTRC 0060-0|P33981|DUAL SPECIFICITY PROTEIN KINASE TTK|9.25|Kd=0.56nM|Kd|=|0.56|nM|0.56|nM
5VQI|2.50|2017|13-mer|[Multiple sites: site 1:kd=0.56uM;site 2: kd=9.90uM] NIT-2 NLS|Q9C2K9|IMPORTIN SUBUNIT ALPHA|6.25|Kd=0.56uM|Kd|=|0.56|uM|560|nM
5WA8|1.30|2017|9ZA||P49773|HISTIDINE TRIAD NUCLEOTIDE-BINDING PROTEIN 1|6.23|Kd=0.587uM|Kd|=|0.587|uM|587|nM
5O0A|1.81|2017|9FH|frag.1|B1MDL6|PHOSPHOPANTETHEINE ADENYLYLTRANSFERASE|3.24|Kd=0.58mM|Kd|=|0.58|mM|580000|nM
5LLP|1.48|2017|6Z9|ligand is compound 16|O43570|CARBONIC ANHYDRASE 12|9.24|Kd=0.58nM|Kd|=|0.58|nM|0.58|nM
5YBE|2.11|2017|19-mer|KANK1/KIF21A;+/-0.05|Q6AXG6|KANK1 PROTEIN|6.24|Kd=0.58uM|Kd|=|0.58|uM|580|nM
5GMV|2.25|2017|8-mer|Kd=0.59+/-0.06uM, LC3B-FUNDC1 pS17 peptide complex|Q9GZQ8|MICROTUBULE-ASSOCIATED PROTEINS 1A/1B LIGHT CHAIN 3B|6.23|Kd=0.59uM|Kd|=|0.59|uM|590|nM
5T18|1.50|2017|73T|+/-0.2, comp.14f|Q06187|TYROSINE-PROTEIN KINASE BTK|9.3|Kd=0.5nM|Kd|=|0.5|nM|0.5|nM
5BJT|3.20|2017|19-mer|[Nonstandard assay: pH=6]|P55899|IGG RECEPTOR FCRN LARGE SUBUNIT P51|6.3|Kd=0.5uM|Kd|=|0.5|uM|500|nM
5WQK|1.70|2017|7NC|[Nonstandard assay: PH=9] compound 3|Q505N7|SULFURTRANSFERASE|6.3|Kd=0.5uM|Kd|=|0.5|uM|500|nM
6AWN|3.62|2017|8PR|ligand is paroxetine,Kd=0.63+/-0.07nM|P31645|SODIUM-DEPENDENT SEROTONIN TRANSPORTER|9.2|Kd=0.63nM|Kd|=|0.63|nM|0.63|nM
6AOM|2.87|2017|VC5|6;+/- 0.05|P41148|ENDOPLASMIN|6.2|Kd=0.63uM|Kd|=|0.63|uM|630|nM
5U0Z|2.29|2017|7PM|Kd=0.65+/-0.03uM, ligand is compound 59|P0AC14|DIHYDROPTEROATE SYNTHASE|6.19|Kd=0.65uM|Kd|=|0.65|uM|650|nM
5KM1|1.65|2017|5GP|[Different protein in assay: Protein in binding assay is H112N, and wt in crystal.]|P49773|HISTIDINE TRIAD NUCLEOTIDE-BINDING PROTEIN 1|6.18|Kd=0.663uM|Kd|=|0.663|uM|663|nM
5WL0|2.40|2017|21G|PB2LONG-VX787|Q67296|POLYMERASE BASIC PROTEIN 2|9.17|Kd=0.67nM|Kd|=|0.67|nM|0.67|nM
5TWG|2.30|2017|15-mer|Kd=0.28+/-0.1uM, ligand is pT367 peptide.|Q9H8S9|MOB KINASE ACTIVATOR 1A|6.17|Kd=0.68uM|Kd|=|0.68|uM|680|nM
5NWI|2.35|2017|5-mer|+/-0.05, CPP, -FC|Q5KTN5|14-3-3 C-1 PROTEIN|6.16|Kd=0.69uM|Kd|=|0.69|uM|690|nM
5J20|1.76|2017|6FJ|ligand is compound 20|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|9.14|Kd=0.72nM|Kd|=|0.72|nM|0.72|nM
5U49|2.22|2017|S2L|Kd=0.73+/-0.02uM, ligand is compound 3|P02766|TRANSTHYRETIN|6.14|Kd=0.73uM|Kd|=|0.73|uM|730|nM
5NKB|1.50|2017|8ZT|ligand is compound 4a|P29317|EPHRIN TYPE-A RECEPTOR 2|9.12|Kd=0.76nM|Kd|=|0.76|nM|0.76|nM
5VAD|2.36|2017|91Y|ligand is compound B, ATP/PPi exchange enzymatic assay|P07814|BIFUNCTIONAL GLUTAMATE/PROLINE--TRNA LIGASE|9.12|Kd=0.76nM|Kd|=|0.76|nM|0.76|nM
5NFB|1.59|2017|8VT|comp.4|P17931|GALECTIN-3|6.11|Kd=0.77uM|Kd|=|0.77|uM|770|nM
5U4G|1.80|2017|7UV|[Uncommon element] Kd=0.79+/-0.03uM, ligand is compound 11.|P02766|TRANSTHYRETIN|6.1|Kd=0.79uM|Kd|=|0.79|uM|790|nM
5WXH|1.30|2017|7-mer||Q5VWG9|TRANSCRIPTION INITIATION FACTOR TFIID SUBUNIT 3|6.15|Kd=0.7uM|Kd|=|0.7|uM|700|nM
5FSO|1.67|2017|S76|ligand is compound 7|P36639|7,8-DIHYDRO-8-OXOGUANINE TRIPHOSPHATASE|6.09|Kd=0.81uM|Kd|=|0.81|uM|810|nM
5U0Y|1.88|2017|7PJ|Kd=0.83+/-0.01uM, ligand is compound 58|P0AC14|DIHYDROPTEROATE SYNTHASE|6.08|Kd=0.83uM|Kd|=|0.83|uM|830|nM
5N2X|1.21|2017|8KN|[Nonstandard assay: buffer is Cacodylate] +/-0.27, comp.6|P00800|THERMOLYSIN|6.06|Kd=0.87uM|Kd|=|0.87|uM|870|nM
5NAI|1.15|2017|93W|VIM-5(Oxidized):comp.1|Q8GKX2|CLASS B METALLO-BETA-LACTAMASE|6.1|Kd=0.8uM|Kd|=|0.8|uM|800|nM
5N58|1.96|2017|93W|VIM-5:comp.1|Q8GKX2|CLASS B METALLO-BETA-LACTAMASE|6.1|Kd=0.8uM|Kd|=|0.8|uM|800|nM
5W7J|2.20|2017|10-mer|[Different ligand in assay: ligand in binding assay is Snap25b] ANK17-E89A/Snap25111-1;+/-0.3|Q8IUH5|PALMITOYLTRANSFERASE ZDHHC17|6.1|Kd=0.8uM|Kd|=|0.8|uM|800|nM
5Y5W|3.30|2017|9-mer|Kd(H4K20Me3)=0.8+/-0.04uM|Q9Y657|SPINDLIN-1|6.1|Kd=0.8uM|Kd|=|0.8|uM|800|nM
5N0F|1.69|2017|7K2|+/-0.03, ManSIFG 2|Q9Z4P9|ALPHA-1,6-MANNANASE|6.05|Kd=0.90uM|Kd|=|0.9|uM|900|nM
5TVN|2.90|2017|7LD|ligand id LSD.|P41595|CHIMERA PROTEIN OF HUMAN 5-HYDROXYTRYPTAMINE RECEPTOR 2B|9.04|Kd=0.91nM|Kd|=|0.91|nM|0.91|nM
5WBK|3.11|2017|14-mer|[Different protein in assay: Assay:Human, X-ray: Arabidopsis thaliana] S6K1;|Q93YQ1|REGULATORY-ASSOCIATED PROTEIN OF TOR 1|6.03|Kd=0.94uM|Kd|=|0.94|uM|940|nM
5MMG|1.23|2017|UT0|ligand is compound 10|Q92793|CREB-BINDING PROTEIN|6.01|Kd=0.970uM|Kd|=|0.97|uM|970|nM
5MYK|1.60|2017|16-mer|[Different ligand in assay: Ligand in binding assay is hAbetapE3-18] +/-0.31, mAbetapE3-18 PEGb|P12023|FAB C#17 LIGHT CHAIN|9.0|Kd=0.99nM|Kd|=|0.99|nM|0.99|nM
5U4C|1.70|2017|XBS|[Uncommon element] Kd=0.99+/-0.02uM, ligand is compound 6.|P02766|TRANSTHYRETIN|6.0|Kd=0.99uM|Kd|=|0.99|uM|990|nM
5N55|1.99|2017|8NN|VIM-5(Oxidized):comp.2|Q8GKX2|CLASS B METALLO-BETA-LACTAMASE|5.99|Kd=1.03uM|Kd|=|1.03|uM|1030|nM
5XYF|2.20|2017|18-mer|TIN2TRFH-TPP1TBM/TRF2TBM;+/- 0.17|Q9BSI4|TERF1-INTERACTING NUCLEAR FACTOR 2|5.98|Kd=1.05uM|Kd|=|1.05|uM|1050|nM
5TBE|2.44|2017|78L|ligand is compound 3, Kd=(1.06+-4.40)nM|Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|8.97|Kd=1.06nM|Kd|=|1.06|nM|1.06|nM
5TPC|2.00|2017|6-mer|Kd=1.0+/-0.1mM, ligand is GD1a. ligand is glycan.|P10845|BOTULINUM NEUROTOXIN TYPE A|3.0|Kd=1.0mM|Kd|=|1|mM|1000000|nM
5V4B|2.60|2017|15-mer|Kd=1.0+/-0.2uM, the Skp1-FBXW7 complex bound to DISC1 193 ?07/pT198/pS202|P63208|S-PHASE KINASE-ASSOCIATED PROTEIN 1|6.0|Kd=1.0uM|Kd|=|1|uM|1000|nM
5NAD|2.80|2017|8RH|BAY 1217389|P33981|DUAL SPECIFICITY PROTEIN KINASE TTK|8.96|Kd=1.1nM|Kd|=|1.1|nM|1.1|nM
5H08|2.53|2017|7WL|human PTPRZ1-D1 complexed with NAZ2329|P23471|RECEPTOR-TYPE TYROSINE-PROTEIN PHOSPHATASE ZETA|5.96|Kd=1.1uM|Kd|=|1.1|uM|1100|nM
5N21|1.58|2017|8HN|comp.7|P41182|B-CELL LYMPHOMA 6 PROTEIN|5.96|Kd=1.1uM|Kd|=|1.1|uM|1100|nM
5TTW|1.74|2017|5-mer|[Nonstandard assay: PH=8] Kd=1.1+/-0.27uM, ligand is compound 3|O75530|POLYCOMB PROTEIN EED|5.96|Kd=1.1uM|Kd|=|1.1|uM|1100|nM
5U1Q|2.10|2017|9-mer|[Nonstandard assay: PO4(3-), 1mM] Kd(1mM, PO4(3-))=1.1+/-0.01uM|Q14451|GROWTH FACTOR RECEPTOR-BOUND PROTEIN 7|5.96|Kd=1.1uM|Kd|=|1.1|uM|1100|nM
6EQP|2.35|2017|BUW|ethropropazine/hBChE; +/-0.1|P06276|CHOLINESTERASE|5.96|Kd=1.1uM|Kd|=|1.1|uM|1100|nM
5HLM|2.50|2017|B9F|[Uncommon element] Kd=1.27+/-0.06uM, ligand is compound 7|P02701|AVIDIN|5.9|Kd=1.27uM|Kd|=|1.27|uM|1270|nM
5H63|1.92|2017|UD1|[Different protein in assay: Protein in binding assay is WT] ligand is UDP-GlcNAc|------|TRANSFERASE|5.92|Kd=1.2uM|Kd|=|1.2|uM|1200|nM
5LTO|3.46|2017|GLN|[Covalent complex] Data is from a reference|------|METHYL-ACCEPTING CHEMOTAXIS PROTEIN PCTB|5.92|Kd=1.2uM|Kd|=|1.2|uM|1200|nM
5U2J|1.60|2017|16-mer|Kd=1.2+/-0.4uM, ligand is H3K14bu peptide.|Q8WYB5|HISTONE H3K14BU|5.92|Kd=1.2uM|Kd|=|1.2|uM|1200|nM
6EUX|2.05|2017|BYB|B/Memphis PB2 cap-midlink/VX-787N; +/-0.2|Q5V8X3|POLYMERASE BASIC PROTEIN 2|5.92|Kd=1.2uM|Kd|=|1.2|uM|1200|nM
5LO5|1.44|2017|70M|Kd(69)=1.34+/-0.2uM, kon=1.75E+5, koff=4.29E-1|P07900|HEAT SHOCK PROTEIN HSP 90-ALPHA|5.87|Kd=1.34uM|Kd|=|1.34|uM|1340|nM
5TQS|1.88|2017|11-mer|Kd=1.39+/-0.03uM, ligand is ErbB2-pep.|P08487|1-PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE PHOSPHODIESTERASE|5.86|Kd=1.39uM|Kd|=|1.39|uM|1390|nM
5NGZ|2.40|2017|2BG||Q9NPD8|UBIQUITIN-CONJUGATING ENZYME E2 T|2.89|Kd=1.3mM|Kd|=|1.3|mM|1300000|nM
5MTY|2.31|2017|HB9|comp.6j|Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|8.89|Kd=1.3nM|Kd|=|1.3|nM|1.3|nM
5WA4|2.65|2017|16-mer|TbtD/N-terminal region of the leader peptide|D6Y504|PYRIDINE SYNTHASE TBTD|5.89|Kd=1.3uM|Kd|=|1.3|uM|1300|nM
5KK8|2.11|2017|ADP|[Nonstandard assay: in presence of ATPgammaS]|G4VJY9|NUCLEOSIDE DIPHOSPHATE KINASE|5.84|Kd=1.45uM|Kd|=|1.45|uM|1450|nM
5TDB|1.10|2017|4-mer|ligand is ADMA-RIFS peptide.|Q8IWV8|E3 UBIQUITIN-PROTEIN LIGASE UBR2|5.84|Kd=1.45uM|Kd|=|1.45|uM|1450|nM
5MME|1.35|2017|8Q6|ligand is compound 9|Q92793|CREB-BINDING PROTEIN|5.85|Kd=1.4uM|Kd|=|1.4|uM|1400|nM
5MQL|3.25|2017|G65|[Multiple sites: site 1: Kd =1.4 +/- 0.1 uM, site 2: Kd =36 +/- 8 uM] [Different protein in assay: Protein in binding assay is S74E] +/-0.1, masitinib|P27707|DEOXYCYTIDINE KINASE|5.85|Kd=1.4uM|Kd|=|1.4|uM|1400|nM
5Y48|1.70|2017|URA||D9J2T9|RIBOSOME INACTIVATING PROTEIN|5.85|Kd=1.4uM|Kd|=|1.4|uM|1400|nM
5K0M|1.83|2017|6PU|Kd = 1.5 +/- 0.1 nM. ligand is A395(5)|O75530|POLYCOMB PROTEIN EED|8.82|Kd=1.5nM|Kd|=|1.5|nM|1.5|nM
5GG4|3.11|2017|13-mer|[Nonstandard assay: Temp 20] USP7-RNF169|Q93009|UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 7|5.82|Kd=1.5uM|Kd|=|1.5|uM|1500|nM
5OEI|1.78|2017|OOG|+/-0.67; 2-oxoadipate|Q6N193|UNCHARACTERIZED PROTEIN FAMILY UPF0065:TAT PATHWAY SIGNAL|5.8|Kd=1.60uM|Kd|=|1.6|uM|1600|nM
5N31|1.37|2017|8LB|[Nonstandard assay: buffer is Cacodylate] +/-0.22, compd 5|P00800|THERMOLYSIN|5.79|Kd=1.61uM|Kd|=|1.61|uM|1610|nM
5MO8|1.82|2017|C98|[Nonstandard assay: PH=8] ligand is compound 21|P68400|CASEIN KINASE II, ALPHA SUBUNIT|5.79|Kd=1.64uM|Kd|=|1.64|uM|1640|nM
5HKI|2.40|2017|6ZJ|[Uncommon element] MtOPRT-FDC|P9WHK9|OROTATE PHOSPHORIBOSYLTRANSFERASE|2.8|Kd=1.6mM|Kd|=|1.6|mM|1600000|nM
5OFW|1.50|2017|9TW|[Different protein in assay: crystal:PHGDH-93, binding assay: sPHGDH] +/-0.2, frag.5|O43175|D-3-PHOSPHOGLYCERATE DEHYDROGENASE|2.8|Kd=1.6mM|Kd|=|1.6|mM|1600000|nM
5LRQ|1.70|2017|4WG|compound 2|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|5.8|Kd=1.6uM|Kd|=|1.6|uM|1600|nM
5M9D|NMR|2017|16-mer|+/-0.1, pS2pS7-CTD|Q05543|REGULATOR OF TY1 TRANSPOSITION PROTEIN 103|5.8|Kd=1.6uM|Kd|=|1.6|uM|1600|nM
5TZF|2.40|2017|C2E|Kd=1.6+/-0.5uM, ligand is c-di-GMP, BldD CTD (D116A)-(c-di-GMP)2 form1|F2RCL8|DNA-BINDING PROTEIN|5.8|Kd=1.6uM|Kd|=|1.6|uM|1600|nM
5TZG|2.50|2017|C2E|Kd=1.8+/-0.5uM, ligand is c-di-GMP, BldD CTD (D116A)-(c-di-GMP)2 form2|F2RCL8|DNA-BINDING PROTEIN|5.8|Kd=1.6uM|Kd|=|1.6|uM|1600|nM
5NMG|2.75|2017|9-mer|A2-SLFNTIAVL|P01892|HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA CHAIN|5.75|Kd=1.77uM|Kd|=|1.77|uM|1770|nM
5N7V|2.52|2017|8PT|MPI-0479605|P33981|DUAL SPECIFICITY PROTEIN KINASE TTK|8.77|Kd=1.7nM|Kd|=|1.7|nM|1.7|nM
5VSK|3.33|2017|9HS|USP7/8;+/- 0.895|Q93009|UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 7|5.74|Kd=1.838uM|Kd|=|1.838|uM|1838|nM
5N8T|1.61|2017|13-mer|[Nonstandard assay: pH=5.0] Gdlwqheatwkkq; incomplete ligand structure|P22629|STREPTAVIDIN|5.74|Kd=1.84uM|Kd|=|1.84|uM|1840|nM
5OTA|2.10|2017|AQQ|+/-0.3, octopinic acid|P35120|NOPALINE-BINDING PERIPLASMIC PROTEIN|5.74|Kd=1.8uM|Kd|=|1.8|uM|1800|nM
5SVE|2.60|2017|18-mer|+/-0.1, NFATc1 LxVP|Q08209|SERINE/THREONINE-PROTEIN PHOSPHATASE 2B CATALYTIC SUBUNIT|5.74|Kd=1.8uM|Kd|=|1.8|uM|1800|nM
5TZD|1.75|2017|C2E|Kd=1.8+/-0.5uM, ligand is c-di-GMP. BldD CTD -(c-di-GMP)2|F2RCL8|DNA-BINDING PROTEIN|5.74|Kd=1.8uM|Kd|=|1.8|uM|1800|nM
5U4B|1.45|2017|XOS|Kd=1.8+/-0.1uM, ligand is compound 5|P02766|TRANSTHYRETIN|5.74|Kd=1.8uM|Kd|=|1.8|uM|1800|nM
5WLE|1.95|2017|12-mer|H3K4me3;+/- 0.7;pH=7.5|Q9VG78|PROTEIN PARTNER OF SNF, ISOFORM A|5.72|Kd=1.9uM|Kd|=|1.9|uM|1900|nM
5LPJ|1.65|2017|XDM|[Nonstandard assay: Temp 4] CBP bound to XDM1|Q92793|CREB-BINDING PROTEIN|5.0|Kd=10.1uM|Kd|=|10.1|uM|10100|nM
5GJ9|2.10|2017|VGL|Kd=10.2+/-0.5uM, ligand is POA|Q41931|1-AMINOCYCLOPROPANE-1-CARBOXYLATE OXIDASE 2|4.99|Kd=10.2uM|Kd|=|10.2|uM|10200|nM
5J82|2.17|2017|6GV|Kd = 1000 +/- 40 nM, ligand is compound 8|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|6.0|Kd=1000nM|Kd|=|1000|nM|1000|nM
5MGK|2.30|2017|7MW|ligand is compound 2|Q9UIF9|BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN PROTEIN 2A|4.0|Kd=100uM|Kd|=|100|uM|100000|nM
5T70|2.10|2017|10-mer|Kd=102+/-15.8uM, ligand is peptide T3N.|P18465|HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-57 ALPHA CHAIN|3.99|Kd=102uM|Kd|=|102|uM|102000|nM
5VS6|2.27|2017|9QD|USP7/1;+/- 15|Q93009|UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 7|6.98|Kd=104nM|Kd|=|104|nM|104|nM
5USZ|2.10|2017|SKE|ligand is JNJ-7706621.|O60674|TYROSINE-PROTEIN KINASE JAK2|6.97|Kd=106nM|Kd|=|106|nM|106|nM
5VSE|1.60|2017|9HG|G9a-SAM-17;+/- 80|Q96KQ7|HISTONE-LYSINE N-METHYLTRANSFERASE EHMT2|5.97|Kd=1070nM|Kd|=|1070|nM|1070|nM
5MRA|3.74|2017|DM2|[Multiple sites: site1:10nM; site2: 1uM] doxorubicin, Kd1, in the presence of Ca2+|P30626|SORCIN|8.0|Kd=10nM|Kd|=|10|nM|10|nM
5NKK|2.64|2017|GDP||O62301|PROTEIN SMG-8|5.0|Kd=10uM|Kd|=|10|uM|10000|nM
5X54|2.30|2017|5-mer|EWWW|Q14145|KELCH-LIKE ECH-ASSOCIATED PROTEIN 1|5.0|Kd=10uM|Kd|=|10|uM|10000|nM
6AXJ|2.38|2017|11-mer|Yaf9 YEATS/H3K27ac;+/-2|P53930|PROTEIN AF-9 HOMOLOG|5.0|Kd=10uM|Kd|=|10|uM|10000|nM
5VC5|1.93|2017|96M|[Nonstandard assay: Temp 15] Kd=11.0+/-1.6nM, ligand is PD166285(compound 3)|P30291|WEE1-LIKE PROTEIN KINASE|7.96|Kd=11.0nM|Kd|=|11|nM|11|nM
5W7I|2.11|2017|10-mer|ANK17/Snap25111-120;+/-2.1|Q8IUH5|PALMITOYLTRANSFERASE ZDHHC17|4.95|Kd=11.2uM|Kd|=|11.2|uM|11200|nM
5NN4|1.83|2017|SC2|+/-0.74, NAC|P10253|LYSOSOMAL ALPHA-GLUCOSIDASE|1.94|Kd=11.57mM|Kd|=|11.57|mM|11570000|nM
6AZL|2.48|2017|11-mer|(AHA)QFDLST R(EtCOOH)RLK|P01834|CETUXIMAB FAB, LIGHT CHAIN|4.93|Kd=11.8uM|Kd|=|11.8|uM|11800|nM
5VCW|2.25|2017|93J|Kd=1105+/-82.9nM, ligand is Pelitinib|Q99640|MEMBRANE-ASSOCIATED TYROSINE- AND THREONINE-SPECIFIC CDC2|5.96|Kd=1105nM|Kd|=|1105|nM|1105|nM
5J71|1.65|2017|P35|PDK2 + 5|Q15119|PYRUVATE DEHYDROGENASE (ACETYL-TRANSFERRING) KINASE|6.96|Kd=110nM|Kd|=|110|nM|110|nM
5V35|2.50|2017|FAR|[Incomplete ligand] Kd=110+/-9nM, ligand is FC, AIPL1-FKBP V71F:FC complex|Q9NZN9|ARYL HYDROCARBON RECEPTOR-INTERACTING PROTEIN-LIKE 1|6.96|Kd=110nM|Kd|=|110|nM|110|nM
5M5D|1.07|2017|2-mer|+/-11, ligand is compound 7|D6D1V7|GLYCOSYL HYDROLASE FAMILY 71|3.95|Kd=111uM|Kd|=|111|uM|111000|nM
5LWS|1.03|2017|7B2|EP-1-2|P11838|ENDOTHIAPEPSIN|3.94|Kd=115uM|Kd|=|115|uM|115000|nM
5N84|2.30|2017|8Q5|Mps-BAY2b|P33981|DUAL SPECIFICITY PROTEIN KINASE TTK|7.96|Kd=11nM|Kd|=|11|nM|11|nM
5TA2|1.48|2017|78X|ligand is compound 7|P62937|PEPTIDYL-PROLYL CIS-TRANS ISOMERASE A|7.96|Kd=11nM|Kd|=|11|nM|11|nM
5IOZ|2.02|2017|6C4|amide 4 bound to subpocket II of EthR.|A5U9I4|TETR-FAMILY TRANSCRIPTIONAL REGULATORY REPRESSOR PROTEIN|4.96|Kd=11uM|Kd|=|11|uM|11000|nM
5XW6|3.10|2017|128|[Nonstandard assay: Temp 4;] TNP-ATP-bound ckP2X7; +/- 2.64|E1C6P3|P2X PURINOCEPTOR|4.91|Kd=12.26uM|Kd|=|12.26|uM|12260|nM
5X4M|1.65|2017|7ZF|BCL6/1|P41182|B-CELL LYMPHOMA 6 PROTEIN|2.92|Kd=1200uM|Kd|=|1200|uM|1200000|nM
5W6I|3.10|2017|12-mer|[Different protein in assay: protein in binding assay is H1N1 A/California/07/ 2009 (H1/Cal)] P3;+/- 20;|P03452|HEMAGGLUTININ|6.9|Kd=125nM|Kd|=|125|nM|125|nM
6B7B|1.98|2017|CWJ|CoaD in complex with compound 2; +/-402|P0A6I6|PHOSPHOPANTETHEINE ADENYLYLTRANSFERASE|2.89|Kd=1280uM|Kd|=|1280|uM|1280000|nM
5ORV|1.88|2017|A65|ligand is compound 8|O14965|AURORA KINASE A|2.89|Kd=1297uM|Kd|=|1297|uM|1297000|nM
5F63|1.45|2017|5W2|ligand is compound 5|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|7.92|Kd=12nM|Kd|=|12|nM|12|nM
5LPL|1.65|2017|71X|[Nonstandard assay: Temp 4] CBP bound to XDM3c:|Q92793|CREB-BINDING PROTEIN|4.92|Kd=12uM|Kd|=|12|uM|12000|nM
5V5Y|1.90|2017|8X7|[Nonstandard assay: Temp 15] Kd=13.4+/-1.2nM, ligand is MK1775|P30291|WEE1-LIKE PROTEIN KINASE|7.87|Kd=13.4nM|Kd|=|13.4|nM|13.4|nM
5VC6|2.00|2017|P48|[Nonstandard assay: Temp 15] Kd=13.6+/-2.0nM, ligand is PHA-848125|P30291|WEE1-LIKE PROTEIN KINASE|7.87|Kd=13.6nM|Kd|=|13.6|nM|13.6|nM
5UT0|2.10|2017|35R|ligand is AT9283.|O60674|TYROSINE-PROTEIN KINASE JAK2|5.88|Kd=1323nM|Kd|=|1323|nM|1323|nM
5TCI|2.45|2017|79V|ligand is BRD4592.|P9WFY1|TRYPTOPHAN SYNTHASE ALPHA CHAIN|6.88|Kd=132nM|Kd|=|132|nM|132|nM
5MK1|2.50|2017|18-mer|ligand is CHMP4A peptide|Q9H3S7|TYROSINE-PROTEIN PHOSPHATASE NON-RECEPTOR TYPE 23|3.88|Kd=132uM|Kd|=|132|uM|132000|nM
5WKF|2.95|2017|10-mer|D30 TCR/GTS1;+/-7.0|P13746|HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-11 ALPHA CHAIN|3.87|Kd=136uM|Kd|=|136|uM|136000|nM
6B7F|2.56|2017|CW4|CoaD in complex with compound 15;+/- 23|P0A6I6|PHOSPHOPANTETHEINE ADENYLYLTRANSFERASE|3.87|Kd=136uM|Kd|=|136|uM|136000|nM
5WXG|1.70|2017|7-mer|H3K4ac|Q5VWG9|TRANSCRIPTION INITIATION FACTOR TFIID SUBUNIT 3|3.86|Kd=137uM|Kd|=|137|uM|137000|nM
5LDM|2.46|2017|2AM|LigT/2'-AMP|------|RNA 2',3'-CYCLIC PHOSPHODIESTERASE|3.86|Kd=139uM|Kd|=|139|uM|139000|nM
5J6L|1.75|2017|6GC|ligand is compound 16|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|7.89|Kd=13nM|Kd|=|13|nM|13|nM
5ML2|1.60|2017|NH6|+/-4, comp.3|O43924|RETINAL ROD RHODOPSIN-SENSITIVE CGMP 3',5'-CYCLIC|7.89|Kd=13nM|Kd|=|13|nM|13|nM
5IPC|1.30|2017|6CE|complex (ES1) of H112N-3|P49773|HISTIDINE TRIAD NUCLEOTIDE-BINDING PROTEIN 1|4.89|Kd=13uM|Kd|=|13|uM|13000|nM
5JSG|2.50|2017|6P9|Spindlin1 bound to compound EML405(2)|Q9Y657|SPINDLIN-1|4.85|Kd=14.2uM|Kd|=|14.2|uM|14200|nM
5WYQ|2.16|2017|SAM|Kd=14.4+/-3.1uM|Q02RL6|TRNA (GUANINE-N(1)-)-METHYLTRANSFERASE|4.84|Kd=14.4uM|Kd|=|14.4|uM|14400|nM
5VWI|1.75|2017|8-mer|PDZ3/beta-PIX;+/- 2.1|Q14160|PROTEIN SCRIBBLE HOMOLOG|4.84|Kd=14.5uM|Kd|=|14.5|uM|14500|nM
5J64|1.38|2017|6G7|Kd = 140 +/- 17 nM, ligand is compound 1|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|6.85|Kd=140nM|Kd|=|140|nM|140|nM
5WKH|3.20|2017|10-mer|D30 TCR/GTS3/4; +/-2.5|P13746|HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-11 ALPHA CHAIN|3.85|Kd=142.5uM|Kd|=|142.5|uM|142500|nM
5KU6|1.80|2017|MZM|fluorescent thermal shift assay|P22748|CARBONIC ANHYDRASE 4|6.84|Kd=143nM|Kd|=|143|nM|143|nM
5MI3|2.80|2017|GDP|[Multiple sites: site 1: Kd =146 +/1 nM; site 2: Kd = 5.7 +/- 0.5 nM; site 3: Kd = 1.64 +/- 0.02 nM] Kd = 146 +/- 1 nM|P0CE47|ELONGATION FACTOR TU 1|6.84|Kd=146nM|Kd|=|146|nM|146|nM
5UC1|2.35|2017|486|[Nonstandard assay: in the presence of NCoR] Kd = 14 +/- 2 nM, ligand is RU-486|------|GLUCOCORTICOID RECEPTOR|7.85|Kd=14nM|Kd|=|14|nM|14|nM
5WUK|2.03|2017|73K|EED226; +/-8|O75530|POLYCOMB PROTEIN EED|7.85|Kd=14nM|Kd|=|14|nM|14|nM
5U5L|2.55|2017|7VA|ligand is rivoglitazone.|P37231|PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA|4.85|Kd=14uM|Kd|=|14|uM|14000|nM
5VCV|1.92|2017|1N1|Kd=150+/-9.1nM, ligand is Dasatinib|Q99640|MEMBRANE-ASSOCIATED TYROSINE- AND THREONINE-SPECIFIC CDC2|6.82|Kd=150nM|Kd|=|150|nM|150|nM
5VFM|2.06|2017|HC4|Kd=150+/-20uM, ligand is CuA. Microscale thermophoresis (MST) assays|Q9IAT9|BASIC PHOSPHOLIPASE A2 HOMOLOG BNSP-7|3.82|Kd=150uM|Kd|=|150|uM|150000|nM
5WBF|2.19|2017|LAC|TlpC LBD/lactate|O24911|METHYL-ACCEPTING CHEMOTAXIS TRANSDUCER (TLPC)|3.81|Kd=155uM|Kd|=|155|uM|155000|nM
5NK6|1.27|2017|90W|ligand is compound 2d|P29317|EPHRIN TYPE-A RECEPTOR 2|6.8|Kd=158nM|Kd|=|158|nM|158|nM
6BNH|NMR|2017|13-mer|BRD4 ET domain/JMJD6 peptide; +/- 14|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|3.8|Kd=158uM|Kd|=|158|uM|158000|nM
5KJ2|1.95|2017|6TF|Kd=15+/-0.1nM|Q09472|HISTONE ACETYLTRANSFERASE P300|7.82|Kd=15nM|Kd|=|15|nM|15|nM
5ORL|1.69|2017|A4W|comp.1|O14965|AURORA KINASE A|4.82|Kd=15uM|Kd|=|15|uM|15000|nM
5JN9|2.10|2017|EZL|fluorescent thermal shift assay|P22748|CARBONIC ANHYDRASE 4|7.79|Kd=16.2nM|Kd|=|16.2|nM|16.2|nM
5UWI|2.14|2017|18-mer|ligand is HDAC5 NES Peptide|P62826|GTP-BINDING NUCLEAR PROTEIN RAN|5.8|Kd=1600nM|Kd|=|1600|nM|1600|nM
5UWP|2.05|2017|19-mer|ligand is mDia2 NES Peptide|P62826|GTP-BINDING NUCLEAR PROTEIN RAN|5.8|Kd=1600nM|Kd|=|1600|nM|1600|nM
5J8M|1.90|2017|6DL|ligand is compound 6|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|6.8|Kd=160nM|Kd|=|160|nM|160|nM
5GVP|2.26|2017|GCF|[Different protein in assay: assay uses PfSHMT]|A5K8L9|SERINE HYDROXYMETHYLTRANSFERASE|6.78|Kd=165nM|Kd|=|165|nM|165|nM
5OS4|1.88|2017|A8H|ligand is compound 17|O14965|AURORA KINASE A|2.78|Kd=1665uM|Kd|=|1665|uM|1665000|nM
5NJZ|1.77|2017|8ZH|ligand is compound 1g|P29317|EPHRIN TYPE-A RECEPTOR 2|7.8|Kd=16nM|Kd|=|16|nM|16|nM
5J3L|1.66|2017|6FR|ligand is compound 5|P9WMC0|HTH-TYPE TRANSCRIPTIONAL REGULATOR ETHR|4.8|Kd=16uM|Kd|=|16|uM|16000|nM
5JZI|2.50|2017|10-mer|HCV1406-NS3/A2 complex|P01892|HLA CLASS I HISTOCOMPATIBILITY ANTIGEN|4.8|Kd=16uM|Kd|=|16|uM|16000|nM
5MTX|1.80|2017|FJI|comp.8m|Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|7.75|Kd=17.7nM|Kd|=|17.7|nM|17.7|nM
5OUG|2.57|2017|9Z0|+/-627.74, fragment.4, crystal is fragment4+lobeline|------|HUMANIZED ALPHA-ACHBP|2.77|Kd=1703.44uM|Kd|=|1703.44|uM|1703440|nM
5MI5|2.15|2017|OAN|+/-10, PUGNAc|Q89ZI2|O-GLCNACASE BT_4395|6.77|Kd=170nM|Kd|=|170|nM|170|nM
5NVZ|2.70|2017|9BN|+/-30, comp.16|Q15370|ELONGIN-B|6.77|Kd=170nM|Kd|=|170|nM|170|nM
5NVW|2.20|2017|9BW|+/-30, ligand is compound 6|Q15370|TRANSCRIPTION ELONGATION FACTOR B POLYPEPTIDE 2|6.77|Kd=170nM|Kd|=|170|nM|170|nM
5UGH|2.06|2017|8AJ|Kd=170+/-1.1nM, ligand is PF-9366.|P31153|S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2|6.77|Kd=170nM|Kd|=|170|nM|170|nM
5ORR|2.09|2017|A5Q|comp.5|O14965|AURORA KINASE A|3.77|Kd=170uM|Kd|=|170|uM|170000|nM
5V8O|3.10|2017|8ZM|ligand is compound 15.|Q8N884|CYCLIC GMP-AMP SYNTHASE|3.77|Kd=171uM|Kd|=|171|uM|171000|nM
5X9H|3.60|2017|ATP|full-length MgtE in complex with ATP AND MG2+|Q5SMG8|MAGNESIUM TRANSPORTER MGTE|3.76|Kd=172uM|Kd|=|172|uM|172000|nM
6BHH|1.85|2017|18-mer|3TD(W358A)- H3K9me2/K14ac;+/-12|Q15047|HISTONE-LYSINE N-METHYLTRANSFERASE SETDB1|3.76|Kd=174uM|Kd|=|174|uM|174000|nM
5NTT|2.75|2017|SVE|+/-204, NMS-P715|P33981|DUAL SPECIFICITY PROTEIN KINASE TTK|5.75|Kd=1764nM|Kd|=|1764|nM|1764|nM
5LDO|2.75|2017|3AM|LigT/3'-AMP|------|RNA 2',3'-CYCLIC PHOSPHODIESTERASE|3.75|Kd=177uM|Kd|=|177|uM|177000|nM
5J6N|1.90|2017|6FF|ligand is compound 14|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|7.77|Kd=17nM|Kd|=|17|nM|17|nM
5J9X|1.80|2017|6GC|Kd = 17 +/- 1.8 nM, ligand is compound 16|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|7.77|Kd=17nM|Kd|=|17|nM|17|nM
5J6A|2.05|2017|P46|PDK2 + 17|Q15119|PYRUVATE DEHYDROGENASE (ACETYL-TRANSFERRING) KINASE|7.77|Kd=17nM|Kd|=|17|nM|17|nM
5MG2|1.75|2017|7M8|compound 5/ TAF1 BD2|P21675|TRANSCRIPTION INITIATION FACTOR TFIID SUBUNIT 1|7.77|Kd=17nM|Kd|=|17|nM|17|nM
5W5S|2.28|2017|12-mer|[Different protein in assay: protein in binding assay is H1N1 A/California/07/ 2009 (H1/Cal)] P5;+/- 4;|P03452|HEMAGGLUTININ|7.77|Kd=17nM|Kd|=|17|nM|17|nM
5IYY|1.60|2017|R40|Kd = 17 +/- 1 uM, ligand is R7|O14786|NEUROPILIN-1|4.77|Kd=17uM|Kd|=|17|uM|17000|nM
5WQD|3.00|2017|16-mer|wide type;|Q15554|TELOMERIC REPEAT-BINDING FACTOR 2|4.77|Kd=17uM|Kd|=|17|uM|17000|nM
5Y62|3.00|2017|5GP|YfiR-GMP|Q9I4L4|YFIR|1.74|Kd=18.4mM|Kd|=|18.4|mM|18400000|nM
5GMN|1.80|2017|949|protein is CA II, ligand is Polmacoxib|P00918|CARBONIC ANHYDRASE 2|4.73|Kd=18.8uM|Kd|=|18.8|uM|18800|nM
5LLA|1.50|2017|6YQ|[Nonstandard assay: Temp 37] complex is CA XIII-2 a|Q8N1Q1|CARBONIC ANHYDRASE 13|7.72|Kd=18.9nM|Kd|=|18.9|nM|18.9|nM
5J27|1.70|2017|6FF|Kd = 180 +/- 61 nM, ligand is compound 14|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|6.74|Kd=180nM|Kd|=|180|nM|180|nM
5U7M|3.03|2017|83G|ligand is BMS-378806.|Q2N0S5|ENVELOPE GLYCOPROTEIN GP160|6.74|Kd=180nM|Kd|=|180|nM|180|nM
5OS2|1.92|2017|A7K|compound 15|O14965|AURORA KINASE A|2.74|Kd=1821uM|Kd|=|1821|uM|1821000|nM
5NK2|1.65|2017|8ZZ|compound 2b|P29317|EPHRIN TYPE-A RECEPTOR 2|6.74|Kd=182nM|Kd|=|182|nM|182|nM
5X73|2.50|2017|P59|complex with R-1;|O43924|RETINAL ROD RHODOPSIN-SENSITIVE CGMP 3',5'-CYCLIC|6.74|Kd=184nM|Kd|=|184|nM|184|nM
5GVM|2.24|2017|G57|[Different protein in assay: assay uses PfSHMT]|A5K8L9|SERINE HYDROXYMETHYLTRANSFERASE|6.73|Kd=186nM|Kd|=|186|nM|186|nM
5J2X|1.22|2017|6DL|Kd = 18 +/- 4.2 nM, ligand is compound 6|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|7.74|Kd=18nM|Kd|=|18|nM|18|nM
5Y61|2.99|2017|5GP|YfiBL43P-YfiR-GMP|Q9I4L4|YFIR|1.72|Kd=19.1mM|Kd|=|19.1|mM|19100000|nM
5OTC|2.20|2017|AQK|+/-1.37,noroctipinic acid|P35120|NOPALINE-BINDING PERIPLASMIC PROTEIN|4.71|Kd=19.3uM|Kd|=|19.3|uM|19300|nM
5KMA|1.55|2017|777||P49773|HISTIDINE TRIAD NUCLEOTIDE-BINDING PROTEIN 1|4.71|Kd=19.6uM|Kd|=|19.6|uM|19600|nM
5WIP|2.62|2017|XXO|239852;+/-1.2|Q17U16|CONJUGAL TRANSFER PROTEIN|4.71|Kd=19.6uM|Kd|=|19.6|uM|19600|nM
5O58|1.55|2017|2-mer|+/-36, 5'-pApG, 2-mer RNA|Q9X1T1|PHOSPHODIESTERASE TM1595|6.72|Kd=191nM|Kd|=|191|nM|191|nM
5NKI|1.68|2017|8ZW|ligand is compound 4b|P29317|EPHRIN TYPE-A RECEPTOR 2|7.72|Kd=19nM|Kd|=|19|nM|19|nM
5NKC|1.45|2017|90T|ligand is compound 2h|P29317|EPHRIN TYPE-A RECEPTOR 2|7.72|Kd=19nM|Kd|=|19|nM|19|nM
6ASZ|1.52|2017|6-mer||P05205|HETEROCHROMATIN PROTEIN 1|4.72|Kd=19uM|Kd|=|19|uM|19000|nM
5WLG|2.10|2017|9-mer|Kd(WT)=19.0+/-0.3uM,|P01899|H-2 CLASS I HISTOCOMPATIBILITY ANTIGEN, D-B ALPHA CHAIN|4.72|Kd=19uM|Kd|=|19|uM|19000|nM
5NK4|1.45|2017|90E|ligand is compound 2c|P29317|EPHRIN TYPE-A RECEPTOR 2|8.7|Kd=2.0nM|Kd|=|2|nM|2|nM
5MRO|1.80|2017|Q9P|+/-0.1, compound 1|P69834|2-C-METHYL-D-ERYTHRITOL 4-PHOSPHATE CYTIDYLYLTRANSFERASE|5.7|Kd=2.0uM|Kd|=|2|uM|2000|nM
5OUH|2.50|2017|L0B|+/-1.06, alpha-lobeline|P36544|ACETYLCHOLINE BINDING PROTEIN|5.67|Kd=2.14uM|Kd|=|2.14|uM|2140|nM
5N18|1.45|2017|8HZ|+/-0.2, compound 1|Q5A4W8|BROMODOMAIN-CONTAINING FACTOR 1|5.68|Kd=2.1uM|Kd|=|2.1|uM|2100|nM
5O2D|1.60|2017|9HH|MnK2-13|Q460N5|POLY [ADP-RIBOSE] POLYMERASE 14|5.68|Kd=2.1uM|Kd|=|2.1|uM|2100|nM
6ESJ|2.98|2017|PRM|propidium/hBChE;+/- 0.4|P06276|CHOLINESTERASE|5.68|Kd=2.1uM|Kd|=|2.1|uM|2100|nM
5GV2|2.06|2017|ARG|Kd=2.23+/-0.20uM|Q8WTX7|GATS-LIKE PROTEIN 3|5.65|Kd=2.23uM|Kd|=|2.23|uM|2230|nM
5N93|2.10|2017|8QE|TC-Mps1-12|P33981|DUAL SPECIFICITY PROTEIN KINASE TTK|8.66|Kd=2.2nM|Kd|=|2.2|nM|2.2|nM
5G5Z|2.01|2017|DQR|complex is FusA/kestose|------|ABC TRANSPORTER, SUBSTRATE-BINDING PROTEIN|5.66|Kd=2.2uM|Kd|=|2.2|uM|2200|nM
5X74|2.25|2017|JAY|complex with 2c; +/-0.8|O43924|RETINAL ROD RHODOPSIN-SENSITIVE CGMP 3',5'-CYCLIC PHOSPHODIESTERASE|8.64|Kd=2.3nM|Kd|=|2.3|nM|2.3|nM
6AZK|2.48|2017|11-mer|(AHA)QFDLST R(PrOH)RLK|P01834|CETUXIMAB FAB, LIGHT CHAIN|5.64|Kd=2.3uM|Kd|=|2.3|uM|2300|nM
5LVD|1.25|2017|79F|TLN-5|P00800|THERMOLYSIN|2.62|Kd=2.4mM|Kd|=|2.4|mM|2400000|nM
5N9S|2.30|2017|8QW|BAY 1161909|P33981|DUAL SPECIFICITY PROTEIN KINASE TTK|8.62|Kd=2.4nM|Kd|=|2.4|nM|2.4|nM
6EUV|2.70|2017|21G|A/Victoria(H3N2) PB2 cap-midlink;+/- 1.3|P31345|POLYMERASE BASIC PROTEIN 2|8.62|Kd=2.4nM|Kd|=|2.4|nM|2.4|nM
5TPB|2.60|2017|3-mer|Kd=2.6+/-0.5mM, ligand is sialyl-T. ligand is glycan.|P10845|BOTULINUM NEUROTOXIN TYPE A|2.59|Kd=2.6mM|Kd|=|2.6|mM|2600000|nM
5NBW|2.40|2017|8SK|Benzo[a]pyrene|------|FAB 22F12 (L,H)|8.59|Kd=2.6nM|Kd|=|2.6|nM|2.6|nM
5MGX|2.18|2017|8-mer|[Different ligand in assay: full length Hsp90beta] +/-0.2, Hsp90 MEEVD|Q14318|YEAST HSP90 C-TERMINUS|5.59|Kd=2.6uM|Kd|=|2.6|uM|2600|nM
5N9R|2.23|2017|8RN|+/-0.1, compound 2|Q93009|UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 7|5.59|Kd=2.6uM|Kd|=|2.6|uM|2600|nM
5LPM|1.50|2017|71Y|[Nonstandard assay: Temp 4] p300 bound to XDM3d:|Q09472|HISTONE ACETYLTRANSFERASE P300|5.56|Kd=2.77uM|Kd|=|2.77|uM|2770|nM
5J6M|1.64|2017|6FJ|ligand is compound 20|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|8.57|Kd=2.7nM|Kd|=|2.7|nM|2.7|nM
6AU5|2.48|2017|11-mer|(AHA)QFDLST R(nBu)RLK|P01834|CETUXIMAB FAB, LIGHT CHAIN|5.57|Kd=2.7uM|Kd|=|2.7|uM|2700|nM
6AYH|2.05|2017|C3G|SeGusR/PNPG|------|TETR FAMILY TRANSCRIPTIONAL REGULATOR|5.57|Kd=2.7uM|Kd|=|2.7|uM|2700|nM
5N8J|1.05|2017|12-mer|[Nonstandard assay: pH=5.0] GyGlanvdessG, code in paper is 5N8S|P22629|STREPTAVIDIN|5.54|Kd=2.87uM|Kd|=|2.87|uM|2870|nM
5N53|1.48|2017|8NB|[Different protein in assay: crystal:PHGDH-93, binding assay: sPHGDH] +/-1.6, frag.15|O43175|D-3-PHOSPHOGLYCERATE DEHYDROGENASE|2.55|Kd=2.8mM|Kd|=|2.8|mM|2800000|nM
5GJA|2.10|2017|6PC|Kd=2.8+/-0.2uM, ligand is 2-PA|Q41931|1-AMINOCYCLOPROPANE-1-CARBOXYLATE OXIDASE 2|5.55|Kd=2.8uM|Kd|=|2.8|uM|2800|nM
5JY0|2.60|2017|4-mer|PeDPP11:LDVW; incomplete ligand structure|F8WQK8|ASP/GLU-SPECIFIC DIPEPTIDYL-PEPTIDASE|5.55|Kd=2.8uM|Kd|=|2.8|uM|2800|nM
6BW3|2.20|2017|12-mer|Kd(PRDM3)=2.96+/-0.34uM|Q09028|HISTONE-BINDING PROTEIN RBBP4|5.53|Kd=2.96uM|Kd|=|2.96|uM|2960|nM
5SZC|1.19|2017|18-mer|Kd(H3K4me1)=20.4+/-2.3uM|Q92784|ZINC FINGER PROTEIN DPF3|4.69|Kd=20.4uM|Kd|=|20.4|uM|20400|nM
5UWJ|2.22|2017|15-mer|ligand is FMRP NES Peptide|P62826|GTP-BINDING NUCLEAR PROTEIN RAN|5.7|Kd=2000nM|Kd|=|2000|nM|2000|nM
5NVV|2.10|2017|9BT|+/-30, compound 3|Q15370|TRANSCRIPTION ELONGATION FACTOR B POLYPEPTIDE 2|6.7|Kd=200nM|Kd|=|200|nM|200|nM
5TGC|3.25|2017|ATP|ligand is ATP|Q12406|ACTIN-RELATED PROTEIN 7|6.7|Kd=200nM|Kd|=|200|nM|200|nM
5ML3|1.40|2017|DL3|+/-31, comp.5|O43924|RETINAL ROD RHODOPSIN-SENSITIVE CGMP 3',5'-CYCLIC|9.69|Kd=203pM|Kd|=|203|pM|0.203|nM
5H85|1.70|2017|5XS|ligand is compound 20|Q92793|CREB-BINDING PROTEIN|4.7|Kd=20uM|Kd|=|20|uM|20000|nM
5IPA|1.78|2017|6C8|ligand is compound 7|A5U9I4|TETR-FAMILY TRANSCRIPTIONAL REGULATORY REPRESSOR PROTEIN|4.7|Kd=20uM|Kd|=|20|uM|20000|nM
5VFJ|2.08|2017|DHC|Kd=20+/-10uM, ligand is CaA. Microscale thermophoresis (MST) assays|Q9IAT9|BASIC PHOSPHOLIPASE A2 HOMOLOG BNSP-7|4.7|Kd=20uM|Kd|=|20|uM|20000|nM
5WBM|2.16|2017|A4G|ligand is compound 3|P50053|KETOHEXOKINASE|4.7|Kd=20uM|Kd|=|20|uM|20000|nM
5VDQ|3.25|2017|9BG|Kd=215+/-81uM, ligand is 2',5'-cGpAp, complex is cGAS161/2',5'-cGpAp|Q8N884|CYCLIC GMP-AMP SYNTHASE|3.67|Kd=215uM|Kd|=|215|uM|215000|nM
5NKG|1.10|2017|8ZK|ligand is compound 3d|P29317|EPHRIN TYPE-A RECEPTOR 2|7.68|Kd=21nM|Kd|=|21|nM|21|nM
5WYZ|2.30|2017|7VF|[Nonstandard assay: PH=5.5] CU-CPT9b|Q9NR97|TOLL-LIKE RECEPTOR 8|7.68|Kd=21nM|Kd|=|21|nM|21|nM
5YJM|1.90|2017|8W3|human chymase/O-phenylamidoxime 5f|P23946|CHYMASE|7.68|Kd=21nM|Kd|=|21|nM|21|nM
5KAB|1.97|2017|OTA|PTP1B delta7 P185G:TCS401|P18031|TYROSINE-PROTEIN PHOSPHATASE, NON-RECEPTOR TYPE 1|4.68|Kd=21uM|Kd|=|21|uM|21000|nM
5VDT|2.58|2017|4BW|Kd=21+/-5uM, ligand is 3',3'-cGAMP, complex is cGAS161/3',3'-cGAMP|Q8N884|CYCLIC GMP-AMP SYNTHASE|4.68|Kd=21uM|Kd|=|21|uM|21000|nM
5W99|1.59|2017|A1V|PbtD-TSP;+/-3|U5Q3T2|PBTD|4.68|Kd=21uM|Kd|=|21|uM|21000|nM
5XVU|3.00|2017|ATP|[Nonstandard assay: in the absence of Mg2+]|Q8IIR9|CASEIN KINASE 2, ALPHA SUBUNIT|4.65|Kd=22.3uM|Kd|=|22.3|uM|22300|nM
5W94|3.19|2017|6-mer|Scc2/4 complex bound to the Ctf19 phosphorylated peptide;+/- 3.0|P40090|MAU2 CHROMATID COHESION FACTOR HOMOLOG|4.65|Kd=22.6uM|Kd|=|22.6|uM|22600|nM
5B6C|1.55|2017|11-mer|Kd=221+/-36uM, N-terminal domain of p97 and the SHP box of Ufd1|P55072|TRANSITIONAL ENDOPLASMIC RETICULUM ATPASE|3.66|Kd=221uM|Kd|=|221|uM|221000|nM
5M17|1.03|2017|2-mer|+/-11, ligand is compound 5|D6D1V7|GLYCOSYL HYDROLASE FAMILY 71|3.66|Kd=221uM|Kd|=|221|uM|221000|nM
5NK8|1.76|2017|90Z|ligand is compound 2f|P29317|EPHRIN TYPE-A RECEPTOR 2|6.64|Kd=229nM|Kd|=|229|nM|229|nM
5TCY|1.90|2017|5LC|ligand is H227L-5-Lic|Q0P8Q4|ENTEROCHELIN UPTAKE PERIPLASMIC BINDING PROTEIN|7.66|Kd=22nM|Kd|=|22|nM|22|nM
5J1R|1.92|2017|6FG|ligand is compound 8|------|ETHR|4.66|Kd=22uM|Kd|=|22|uM|22000|nM
6EZQ|2.39|2017|C7K|ligand is compound 3f; +/- 3|P02768|SERUM ALBUMIN|4.66|Kd=22uM|Kd|=|22|uM|22000|nM
5N34|1.22|2017|8JQ|[Nonstandard assay: buffer is Cacodylate] +/-1.74, compound 3|P00800|THERMOLYSIN|4.63|Kd=23.27uM|Kd|=|23.27|uM|23270|nM
5V13|1.84|2017|JH3|[Different ligand in assay: x-ray:The protein sample contained a 10-fold molar excess of racemic JH III] ligand is 10-R JH III.|Q16Y94|AAEL008620-PA ODORANT-BINDING PROTEIN|7.63|Kd=23.3nM|Kd|=|23.3|nM|23.3|nM
5MOC|1.80|2017|12-mer|[Different ligand in assay: p53 CTD (15-mer)] +/-2.2|P31947|14-3-3 PROTEIN SIGMA|4.63|Kd=23.6uM|Kd|=|23.6|uM|23600|nM
6BHE|1.35|2017|18-mer|3TDH3K9me3/K14ac;+/-0.9|Q15047|HISTONE-LYSINE N-METHYLTRANSFERASE SETDB1|4.62|Kd=23.9uM|Kd|=|23.9|uM|23900|nM
5JQ5|1.94|2017|I74|CDK2/ICEC0942|P24941|CELL DIVISION PROTEIN KINASE 2|5.63|Kd=2341nM|Kd|=|2341|nM|2341|nM
5JHK|1.80|2017|6K8|Kd = 23 +/- 1 uM, ligand is R8|O14786|NEUROPILIN-1|4.64|Kd=23uM|Kd|=|23|uM|23000|nM
5WIC|2.55|2017|FOA|1E6;+/-1.9|Q17U16|CONJUGAL TRANSFER PROTEIN|4.64|Kd=23uM|Kd|=|23|uM|23000|nM
5ULP|1.55|2017|KB1|ligand is MS2042|B3U3M3|MRNA CAP 0-1 NS5-TYPE METHYLTRANSFERASE|4.61|Kd=24.3uM|Kd|=|24.3|uM|24300|nM
5M77|1.46|2017|2-mer|+/-7.9, (ManS)2IFG 3|Q9Z4P9|ALPHA-1,6-MANNANASE|7.61|Kd=24.7nM|Kd|=|24.7|nM|24.7|nM
5MWJ|2.04|2017|EBU|[Multiple sites: Kd2=522+/-39.6 nM second binding, not multiple sites] +/-24.2, comp.18, Kd1|Q04724|TRANSDUCIN-LIKE ENHANCER PROTEIN 1|7.61|Kd=24.7nM|Kd|=|24.7|nM|24.7|nM
5KM3|1.20|2017|U5P|[Different protein in assay: Protein in binding assay is H112N, and wt in crystal.]|P49773|HISTIDINE TRIAD NUCLEOTIDE-BINDING PROTEIN 1|4.6|Kd=24.9uM|Kd|=|24.9|uM|24900|nM
5LUD|1.25|2017|76X||V9HWF5|PEPTIDYL-PROLYL CIS-TRANS ISOMERASE A|3.61|Kd=248uM|Kd|=|248|uM|248000|nM
5UJV|2.70|2017|A8S|Kd=249+/-14.1uM, ligand is ABA|------|ABSCISIC ACID RECEPTOR|3.6|Kd=249uM|Kd|=|249|uM|249000|nM
5TA4|1.50|2017|838|ligand is compound 8|P62937|PEPTIDYL-PROLYL CIS-TRANS ISOMERASE A|7.62|Kd=24nM|Kd|=|24|nM|24|nM
5JGQ|1.60|2017|6JY|Kd = 24 +/- 0 uM, ligand is R6|O14786|NEUROPILIN-1|4.62|Kd=24uM|Kd|=|24|uM|24000|nM
5YCO|2.20|2017|17-mer|PCNA-UHRF2PIP|P12004|PROLIFERATING CELL NUCLEAR ANTIGEN|4.59|Kd=25.7uM|Kd|=|25.7|uM|25700|nM
5NW1|2.10|2017|9BH|+/-50, ligand is compound 18|Q15370|TRANSCRIPTION ELONGATION FACTOR B POLYPEPTIDE 2|6.6|Kd=250nM|Kd|=|250|nM|250|nM
5OQ4|2.70|2017|A3W|comp.1|P48736|PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE|7.6|Kd=25nM|Kd|=|25|nM|25|nM
5T9U|2.30|2017|7HG|ligand is compound 3|P62937|PEPTIDYL-PROLYL CIS-TRANS ISOMERASE A|7.6|Kd=25nM|Kd|=|25|nM|25|nM
5OFV|1.50|2017|9TZ|[Different protein in assay: crystal:PHGDH-93, binding assay: sPHGDH] +/-31.8, frag.14|O43175|D-3-PHOSPHOGLYCERATE DEHYDROGENASE|1.58|Kd=26.2mM|Kd|=|26.2|mM|26200000|nM
5U0G|1.54|2017|7QY|ligand is compound 17|P00918|CARBONIC ANHYDRASE 2|4.58|Kd=26.2uM|Kd|=|26.2|uM|26200|nM
5N7G|2.95|2017|7-mer|+/-7.3|Q96QZ7|MEMBRANE-ASSOCIATED GUANYLATE KINASE, WW AND PDZ DOMAIN|4.58|Kd=26.3uM|Kd|=|26.3|uM|26300|nM
5T9W|2.00|2017|78E|ligand is compound 5|P62937|PEPTIDYL-PROLYL CIS-TRANS ISOMERASE A|5.59|Kd=2600nM|Kd|=|2600|nM|2600|nM
5NKH|1.29|2017|8ZQ|compound 3e|P29317|EPHRIN TYPE-A RECEPTOR 2|7.59|Kd=26nM|Kd|=|26|nM|26|nM
5NKD|1.41|2017|91K|compound 2i|P29317|EPHRIN TYPE-A RECEPTOR 2|7.59|Kd=26nM|Kd|=|26|nM|26|nM
5KA3|2.14|2017|OTA|PTP1B YAYA:TCS401; redundant to 5k9w|P18031|TYROSINE-PROTEIN PHOSPHATASE, NON-RECEPTOR TYPE 1|4.59|Kd=26uM|Kd|=|26|uM|26000|nM
5K9W|2.01|2017|OTA|PTP1B:TCS401|P18031|TYROSINE-PROTEIN PHOSPHATASE, NON-RECEPTOR TYPE 1|4.59|Kd=26uM|Kd|=|26|uM|26000|nM
5VDK|2.70|2017|8X7|Kd=27.0+/-3.6nM, ligand is MK1775|P0C1S8|WEE1-LIKE PROTEIN KINASE 2|7.57|Kd=27.0nM|Kd|=|27|nM|27|nM
5OVR|2.15|2017|AXK|+/-0.6, compound 2|P54829|TYROSINE-PROTEIN PHOSPHATASE NON-RECEPTOR TYPE 5|4.57|Kd=27.2uM|Kd|=|27.2|uM|27200|nM
5CPR|2.22|2017|539|A-196/UV420H1-SAM complex|Q4FZB7|HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1|7.56|Kd=27.5nM|Kd|=|27.5|nM|27.5|nM
5VCY|1.56|2017|DB8|Kd=270+/-17.2nM, ligand is Bosutinib|Q99640|MEMBRANE-ASSOCIATED TYROSINE- AND THREONINE-SPECIFIC CDC2|6.57|Kd=270nM|Kd|=|270|nM|270|nM
5H5O|2.12|2017|PCG|Ka/Kd = 3.65*10^6/2.74*10(-7)|B0RM05|DIGUANYLATE CYCLASE|6.56|Kd=274nM|Kd|=|274|nM|274|nM
5OS0|1.74|2017|A6Z|comp.13|O14965|AURORA KINASE A|2.55|Kd=2792uM|Kd|=|2792|uM|2792000|nM
5W6R|2.73|2017|12-mer|[Different protein in assay: protein in binding assay is H1N1 A/California/07/ 2009 (H1/Cal)] P6;+/- 9;|P03452|HEMAGGLUTININ|7.57|Kd=27nM|Kd|=|27|nM|27|nM
5W6T|2.59|2017|12-mer|[Different protein in assay: protein in binding assay is H1N1 A/California/07/ 2009 (H1/Cal)] P7;+/- 7;|P03452|HEMAGGLUTININ|7.57|Kd=27nM|Kd|=|27|nM|27|nM
5KO5|1.36|2017|CYT|Kd = 27 +/- 3 uM. ligand is cytosine|------|PURINE NUCLEOSIDE PHOSPHORYLASE|4.57|Kd=27uM|Kd|=|27|uM|27000|nM
5U0D|1.59|2017|7R7|ligand is compound 14|P00918|CARBONIC ANHYDRASE 2|4.54|Kd=28.6uM|Kd|=|28.6|uM|28600|nM
5HYX|2.60|2017|13-mer|[Nonstandard assay: Temp 20, pH 6.0, NaCl 100 mM] ligand is RGF1(peptide)|C0LGR3|PROBABLE LRR RECEPTOR-LIKE SERINE/THREONINE-PROTEIN KINASE|6.55|Kd=280nM|Kd|=|280|nM|280|nM
5TPX|2.10|2017|7H7|ligand is L-45|Q8IB67|HISTONE ACETYLTRANSFERASE GCN5|6.55|Kd=280nM|Kd|=|280|nM|280|nM
5VCX|2.70|2017|H8H|Kd=2817+/-144.4nM, ligand is Saracatinib|Q99640|MEMBRANE-ASSOCIATED TYROSINE- AND THREONINE-SPECIFIC CDC2|5.55|Kd=2817nM|Kd|=|2817|nM|2817|nM
5VD3|1.80|2017|H8H|Kd=2817+/-144.4nM, ligand is Saracatinib|Q99640|MEMBRANE-ASSOCIATED TYROSINE- AND THREONINE-SPECIFIC CDC2|5.55|Kd=2817nM|Kd|=|2817|nM|2817|nM
5VKM|2.20|2017|2-mer|[Incomplete ligand] [Different protein in assay: x-ray:(5A: N67A, N112A, N135A, N164A, N231A), assay:wt] Kd=281+/-10uM, ligand is alpha-2-6 sialyllactose|P20273|B-CELL RECEPTOR CD22|3.55|Kd=281uM|Kd|=|281|uM|281000|nM
5V2L|2.10|2017|ATP|Kd=288+/-36uM, ligand is ATP.|Q9FD68|MEVALONATE DIPHOSPHATE DECARBOXYLASE|3.54|Kd=288uM|Kd|=|288|uM|288000|nM
6B7E|2.10|2017|CWA|CoaD in complex with compound 14;+/- 4|P0A6I6|PHOSPHOPANTETHEINE ADENYLYLTRANSFERASE|4.55|Kd=28uM|Kd|=|28|uM|28000|nM
5GMM|2.00|2017|949|protein is CA I, ligand is Polmacoxib|P00915|CARBONIC ANHYDRASE 1|4.54|Kd=29.1uM|Kd|=|29.1|uM|29100|nM
5MYO|1.59|2017|10-mer|AbetapE3-12 PEGb, octamers|P05067|FAB C#6 LIGHT CHAIN|10.53|Kd=29.3pM|Kd|=|29.3|pM|0.0293|nM
5LY1|2.50|2017|14-mer||O75164|LYSINE-SPECIFIC DEMETHYLASE 4A|7.53|Kd=29.8nM|Kd|=|29.8|nM|29.8|nM
5TZY|3.22|2017|7OS|Kd=2+/-0.3nM; ternary complex of GPR40/MK-8666/AgoPAM-AP8|O14842|FREE FATTY ACID RECEPTOR 1,ENDOLYSIN,FREE FATTY ACID|8.7|Kd=2nM|Kd|=|2|nM|2|nM
5MQT|3.20|2017|STI|[Multiple sites: site 1: Kd = 2 +/- 0.8 uM, site 2: Kd =36 +/- 6 uM] [Different protein in assay: Protein in binding assay is S74E] +/-0.8, imatinib|P27707|DEOXYCYTIDINE KINASE|5.7|Kd=2uM|Kd|=|2|uM|2000|nM
5LPK|2.10|2017|XDM|[Nonstandard assay: Temp 4] p300 bound to XDM1:|Q09472|HISTONE ACETYLTRANSFERASE P300|5.51|Kd=3.06uM|Kd|=|3.06|uM|3060|nM
5MRP|1.90|2017|6BC|+/-0.3, compound 2|P69834|2-C-METHYL-D-ERYTHRITOL 4-PHOSPHATE CYTIDYLYLTRANSFERASE|5.52|Kd=3.0uM|Kd|=|3|uM|3000|nM
5NN6|2.00|2017|MIG|NHE-DNJ|P10253|LYSOSOMAL ALPHA-GLUCOSIDASE|5.52|Kd=3.0uM|Kd|=|3|uM|3000|nM
5W1W|3.10|2017|9-mer|GF4 TCR-HLA-E-LVL;+/- 0.2|P13747|HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, ALPHA CHAIN|5.52|Kd=3.0uM|Kd|=|3|uM|3000|nM
6BW4|2.00|2017|12-mer|Kd(PRDM16)=3.15+/-0.36uM|Q09028|HISTONE-BINDING PROTEIN RBBP4|5.5|Kd=3.15uM|Kd|=|3.15|uM|3150|nM
5TQ1|1.49|2017|11-mer|Kd=3.21+/-0.36uM, ligand is IR-pep.|P08487|1-PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE PHOSPHODIESTERASE|5.49|Kd=3.21uM|Kd|=|3.21|uM|3210|nM
5VZY|2.32|2017|15-mer|[Different ligand in assay: ligand in binding assay is 18-mer] Abeta11-28;|P0DOX5|CRENEZUMAB FAB HEAVY CHAIN,IMMUNOGLOBULIN GAMMA-1 HEAVY|8.49|Kd=3.2nM|Kd|=|3.2|nM|3.2|nM
5MN1|0.79|2017|2AP|+/-1.0|P00760|TRYPSIN|2.48|Kd=3.3mM|Kd|=|3.3|mM|3300000|nM
5MNB|0.94|2017|2AP|"+/-1.0, Determined by ""low c value"" ITC, 2-Aminopyridine"|P00760|TRYPSIN|2.48|Kd=3.3mM|Kd|=|3.3|mM|3300000|nM
5MNX|1.42|2017|2AP|"+/-1.0, Determined by ""low c value"" ITC, 2-Aminopyridine"|P00760|TRYPSIN|2.48|Kd=3.3mM|Kd|=|3.3|mM|3300000|nM
5MON|0.94|2017|2AP|"+/-1.0, Determined by ""low c value"" ITC, 2-Aminopyridine"|P00760|TRYPSIN|2.48|Kd=3.3mM|Kd|=|3.3|mM|3300000|nM
5JNC|2.00|2017|6LH|fluorescent thermal shift assay|P22748|CARBONIC ANHYDRASE 4|5.48|Kd=3.3uM|Kd|=|3.3|uM|3300|nM
5MAV|2.58|2017|19-mer|+/-0.4, PARG peptide|P12004|PROLIFERATING CELL NUCLEAR ANTIGEN|5.48|Kd=3.3uM|Kd|=|3.3|uM|3300|nM
5VWK|2.35|2017|8-mer|PDZ1/beta-PIX;+/- 0.3|Q14160|PROTEIN SCRIBBLE HOMOLOG|5.48|Kd=3.3uM|Kd|=|3.3|uM|3300|nM
5MNR|1.25|2017|JC2|[Nonstandard assay: buffer is Cacodylate] +/-1.26, compound 7|P00800|THERMOLYSIN|5.46|Kd=3.44uM|Kd|=|3.44|uM|3440|nM
5U0F|1.21|2017|7R1|ligand is compound 25|P00918|CARBONIC ANHYDRASE 2|5.47|Kd=3.4uM|Kd|=|3.4|uM|3400|nM
5NKA|1.38|2017|91H|ligand is compound 2g|P29317|EPHRIN TYPE-A RECEPTOR 2|5.46|Kd=3.5uM|Kd|=|3.5|uM|3500|nM
5TXY|1.21|2017|7Q1|ligand is compound 10|P00918|CARBONIC ANHYDRASE 2|5.46|Kd=3.5uM|Kd|=|3.5|uM|3500|nM
5TY8|1.45|2017|7Q1|ligand is compound 10|P00918|CARBONIC ANHYDRASE 2|5.46|Kd=3.5uM|Kd|=|3.5|uM|3500|nM
5U13|1.95|2017|YH5|Kd=3.9+/-0.2uM, ligand is compound 36|P0AC14|DIHYDROPTEROATE SYNTHASE|5.41|Kd=3.9uM|Kd|=|3.9|uM|3900|nM
5JJM|2.15|2017|8-mer|DHT-bound human AR-LBD with UBA3 59S-72V peptide|P10275|ANDROGEN RECEPTOR|7.51|Kd=30.6nM|Kd|=|30.6|nM|30.6|nM
5NW0|2.30|2017|9BK|+/-40, compound 17|Q15370|TRANSCRIPTION ELONGATION FACTOR B POLYPEPTIDE 2|6.52|Kd=300nM|Kd|=|300|nM|300|nM
5MOD|2.08|2017|86L|[Nonstandard assay: PH=8] ligand is compound 3|P68400|CASEIN KINASE II, ALPHA SUBUNIT|3.52|Kd=300uM|Kd|=|300|uM|300000|nM
5VFN|2.39|2017|HCI|Kd=300+/-50uM, ligand is CiA. Microscale thermophoresis (MST) assays|Q9IAT9|BASIC PHOSPHOLIPASE A2 HOMOLOG BNSP-7|3.52|Kd=300uM|Kd|=|300|uM|300000|nM
5M2Q|1.70|2017|CBY|[Uncommon element] +/- 7 Cbi|P0A910|OUTER MEMBRANE PROTEIN A,VITAMIN B12-BINDING PROTEIN|7.52|Kd=30nM|Kd|=|30|nM|30|nM
5JHD|2.46|2017|9-mer|ligand is peptide LS10|P01892|HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA CHAIN|4.52|Kd=30uM|Kd|=|30|uM|30000|nM
5OVX|2.10|2017|AY5|[Nonstandard assay: Temp 30] +/-0.8, compound 3|P54829|TYROSINE-PROTEIN PHOSPHATASE NON-RECEPTOR TYPE 5|4.5|Kd=31.4uM|Kd|=|31.4|uM|31400|nM
5MYG|2.30|2017|LS8|[Nonstandard assay: Temp 15] comp.16|P55201|PEREGRIN|7.51|Kd=31nM|Kd|=|31|nM|31|nM
5USY|2.00|2017|SKE|ligand is JNJ-7706621.|O60674|TYROSINE-PROTEIN KINASE JAK2|7.51|Kd=31nM|Kd|=|31|nM|31|nM
5TYA|1.50|2017|7QS|ligand is compound 13|P00918|CARBONIC ANHYDRASE 2|4.48|Kd=32.9uM|Kd|=|32.9|uM|32900|nM
5NW2|2.20|2017|9B8|+/-20, compound 19|Q15370|TRANSCRIPTION ELONGATION FACTOR B POLYPEPTIDE 2|6.49|Kd=320nM|Kd|=|320|nM|320|nM
5W6U|2.88|2017|12-mer|[Different protein in assay: protein in binding assay is H1N1 A/California/07/ 2009 (H1/Cal)] P2;+/- 311;|P03452|HEMAGGLUTININ|5.49|Kd=3230nM|Kd|=|3230|nM|3230|nM
5VD0|2.13|2017|8X7|Kd=324+/-27.3nM, ligand is MK1775|Q99640|MEMBRANE-ASSOCIATED TYROSINE- AND THREONINE-SPECIFIC CDC2|6.49|Kd=324nM|Kd|=|324|nM|324|nM
5ISZ|2.06|2017|9-mer|ligand is peptide LS01|P01892|HLA CLASS I HISTOCOMPATIBILITY ANTIGEN|4.49|Kd=32uM|Kd|=|32|uM|32000|nM
5WII|2.79|2017|AO4|4H10;+/-1.8|Q17U16|CONJUGAL TRANSFER PROTEIN|4.49|Kd=32uM|Kd|=|32|uM|32000|nM
6B7A|1.99|2017|CWM|CoaD in complex with compound 1; +/-4|P0A6I6|PHOSPHOPANTETHEINE ADENYLYLTRANSFERASE|4.49|Kd=32uM|Kd|=|32|uM|32000|nM
5MA7|1.30|2017|7K0|TLN-6|P00800|THERMOLYSIN|3.47|Kd=336uM|Kd|=|336|uM|336000|nM
5W4R|3.00|2017|9WD|compound 24b|P51449|NUCLEAR RECEPTOR ROR-GAMMA|7.48|Kd=33nM|Kd|=|33|nM|33|nM
5KA1|1.84|2017|OTA|PTP1B delta 7:TCS401|P18031|TYROSINE-PROTEIN PHOSPHATASE, NON-RECEPTOR TYPE 1|4.48|Kd=33uM|Kd|=|33|uM|33000|nM
5J8U|1.75|2017|6DL|ligand is compound 1|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|6.47|Kd=340nM|Kd|=|340|nM|340|nM
5NDD|2.80|2017|8TZ|+/-740, AZ8838|D9IEF7|LYSOZYME,PROTEINASE-ACTIVATED RECEPTOR 2,SOLUBLE CYTOCHROME|6.46|Kd=344nM|Kd|=|344|nM|344|nM
5O91|3.20|2017|C5N|+/-81, comp.5|P33981|DUAL SPECIFICITY PROTEIN KINASE TTK|6.46|Kd=349nM|Kd|=|349|nM|349|nM
5ORY|1.99|2017|AY4|comp.11|O14965|AURORA KINASE A|3.45|Kd=357uM|Kd|=|357|uM|357000|nM
5ML6|1.87|2017|9GD|+/-36, comp.8|O43924|RETINAL ROD RHODOPSIN-SENSITIVE CGMP 3',5'-CYCLIC|9.45|Kd=358pM|Kd|=|358|pM|0.358|nM
5F61|1.45|2017|5W0|ligand is compound 3|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|7.46|Kd=35nM|Kd|=|35|nM|35|nM
5B6G|1.99|2017|9-mer||P25054|ADENOMATOUS POLYPOSIS COLI PROTEIN|7.44|Kd=36nM|Kd|=|36|nM|36|nM
5H5F|1.70|2017|SAM|Kd=37.2+/-3.59uM, Sfm1-SAM|Q12314|PROTEIN ARGININE N-METHYLTRANSFERASE SFM1|4.43|Kd=37.2uM|Kd|=|37.2|uM|37200|nM
5TUS|2.66|2017|7LL|Kd=37.4+/-4.7uM, ligand is NSAH.|P23921|RIBONUCLEOSIDE-DIPHOSPHATE REDUCTASE LARGE SUBUNIT|4.43|Kd=37.4uM|Kd|=|37.4|uM|37400|nM
5W1V|3.31|2017|9-mer|GF4 TCR-HLA-E-LIL;+/- 3.9|P13747|HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, ALPHA CHAIN|4.43|Kd=37.4uM|Kd|=|37.4|uM|37400|nM
5OS3|1.81|2017|A7N|comp.16|O14965|AURORA KINASE A|2.43|Kd=3753uM|Kd|=|3753|uM|3753000|nM
5X62|2.20|2017|SAH|SAH-bound YNL092W|P53934|CARNOSINE N-METHYLTRANSFERASE|6.42|Kd=379nM|Kd|=|379|nM|379|nM
5KAD|1.90|2017|OTA|PTP1B N193A :TCS401|P18031|TYROSINE-PROTEIN PHOSPHATASE, NON-RECEPTOR TYPE 1|4.43|Kd=37uM|Kd|=|37|uM|37000|nM
5TW5|1.85|2017|7LM|ligand is compound 23.|P11609|ANTIGEN-PRESENTING GLYCOPROTEIN CD1D1|7.42|Kd=38.1nM|Kd|=|38.1|nM|38.1|nM
5JM4|2.34|2017|11-mer|[Different ligand in assay: Ligand in binding assay is FITC-labeled] ligand is peptide 22|P63104|14-3-3 PROTEIN ZETA/DELTA|7.42|Kd=38nM|Kd|=|38|nM|38|nM
5NK3|1.59|2017|92Q|ligand is compound 1l|P29317|EPHRIN TYPE-A RECEPTOR 2|7.42|Kd=38nM|Kd|=|38|nM|38|nM
5MK9|0.92|2017|BCD|+/-0.4, beta-cyclodextrin|B0L7B0|MALE1|4.42|Kd=38uM|Kd|=|38|uM|38000|nM
5KM2|1.25|2017|C5P|[Different protein in assay: Protein in binding assay is H112N, and wt in crystal.]|P49773|HISTIDINE TRIAD NUCLEOTIDE-BINDING PROTEIN 1|4.41|Kd=39.1uM|Kd|=|39.1|uM|39100|nM
5NE5|1.05|2017|KIF|Kifunensine (compound 1)|B0SWV2|MANNOSYL-OLIGOSACCHARIDE 1,2-ALPHA-MANNOSIDASE|7.41|Kd=39nM|Kd|=|39|nM|39|nM
5KA9|2.07|2017|OTA|PTP1B L192A:TCS401|P18031|TYROSINE-PROTEIN PHOSPHATASE, NON-RECEPTOR TYPE 1|4.41|Kd=39uM|Kd|=|39|uM|39000|nM
5N70|1.81|2017|8-mer|ligand is peptide [1-8]|V5HCK7|PUTATIVE CATHEPSIN D|8.52|Kd=3nM|Kd|=|3|nM|3|nM
5VI6|1.24|2017|4-mer|Kd=3+/-1nM, ligand is Trapoxin A|Q9BY41|HISTONE DEACETYLASE 8|8.52|Kd=3nM|Kd|=|3|nM|3|nM
5J1X|2.10|2017|AR5|Kd = 3 +/- 1 uM, ligand is R5|O14786|NEUROPILIN-1|5.52|Kd=3uM|Kd|=|3|uM|3000|nM
5WQJ|1.20|2017|7N3|[Nonstandard assay: PH=9] compound 1|Q505N7|SULFURTRANSFERASE|5.52|Kd=3uM|Kd|=|3|uM|3000|nM
5WRS|2.75|2017|ATP|apparent dissociation constant values|Q96MK3|PSEUDOKINASE FAM20A|5.52|Kd=3uM|Kd|=|3|uM|3000|nM
5MEK|1.74|2017|A3P|+/-2.6, PAP|Q9C9C9|CYTOSOLIC SULFOTRANSFERASE 18|5.38|Kd=4.2uM|Kd|=|4.2|uM|4200|nM
5FSC|1.95|2017|G8Z|Kd = 4.4 +/- 1.5 mM, ligand is All4MeMan|B0CZL6|TECTONIN 2|2.36|Kd=4.4mM|Kd|=|4.4|mM|4400000|nM
5MI9|3.30|2017|GDP|nonphosphorylated protein|A8A5E6|ELONGATION FACTOR TU 1|8.35|Kd=4.5nM|Kd|=|4.5|nM|4.5|nM
5L26|3.40|2017|URI||G4CRQ5|NUCLEOSIDE PERMEASE|5.35|Kd=4.5uM|Kd|=|4.5|uM|4500|nM
5U11|1.99|2017|7PS|Kd=4.5+/-0.1uM, ligand is compound 41|P0AC14|DIHYDROPTEROATE SYNTHASE|5.35|Kd=4.5uM|Kd|=|4.5|uM|4500|nM
5U14|1.95|2017|7PV|Kd=4.6+/-0.1uM, ligand is compound 60|P0AC14|DIHYDROPTEROATE SYNTHASE|5.34|Kd=4.6uM|Kd|=|4.6|uM|4600|nM
5WP5|1.50|2017|SAH|AtPMT2/SAH|Q944H0|PHOSPHOMETHYLETHANOLAMINE N-METHYLTRANSFERASE 2|5.34|Kd=4.6uM|Kd|=|4.6|uM|4600|nM
5N8E|1.10|2017|13-mer|[Nonstandard assay: pH=5.0] RDPAPAWAHGGG|P22629|STREPTAVIDIN|5.33|Kd=4.7uM|Kd|=|4.7|uM|4700|nM
5NF9|1.87|2017|8VW|comp.2|P17931|GALECTIN-3|5.33|Kd=4.7uM|Kd|=|4.7|uM|4700|nM
5MLO|1.96|2017|15-mer|ZRANB3 PIP box peptide|P12004|PROLIFERATING CELL NUCLEAR ANTIGEN|5.32|Kd=4.8uM|Kd|=|4.8|uM|4800|nM
5N17|1.60|2017|8FK|+/-1.0, compound 1|Q5A4W8|BROMODOMAIN-CONTAINING FACTOR 1|5.32|Kd=4.8uM|Kd|=|4.8|uM|4800|nM
5MZ8|2.20|2017|SIN|+/-0.7, succinate, by MST|A9SS48|ALDEHYDE DEHYDROGENASE 21|2.31|Kd=4.9mM|Kd|=|4.9|mM|4900000|nM
5KM0|1.53|2017|IMP|[Different protein in assay: Protein in binding assay is H112N, and wt in crystal.]|P49773|HISTIDINE TRIAD NUCLEOTIDE-BINDING PROTEIN 1|5.31|Kd=4.9uM|Kd|=|4.9|uM|4900|nM
5N2Z|1.37|2017|8JH|[Nonstandard assay: buffer is Cacodylate] +/-0.32, compound 1|P00800|THERMOLYSIN|5.31|Kd=4.9uM|Kd|=|4.9|uM|4900|nM
5M29|1.50|2017|CBY|[Uncommon element] +/- 10 Cbi|P37028|VITAMIN B12-BINDING PROTEIN|7.4|Kd=40nM|Kd|=|40|nM|40|nM
5TUZ|1.95|2017|7L6|[Nonstandard assay: PH=8] Kd=40+/-5nM, ligand is compound 4.|Q9H9B1|HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1|7.4|Kd=40nM|Kd|=|40|nM|40|nM
5OS5|1.74|2017|A8K|compound 18|O14965|AURORA KINASE A|3.39|Kd=410uM|Kd|=|410|uM|410000|nM
5UFP|1.90|2017|86D|ligand is PT2399|Q99814|ENDOTHELIAL PAS DOMAIN-CONTAINING PROTEIN 1|7.37|Kd=42.5nM|Kd|=|42.5|nM|42.5|nM
5LNY|1.88|2017|70K|Kd = 42 +/- 5.7 nM. ligand is compound 3b|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|7.38|Kd=42nM|Kd|=|42|nM|42|nM
5TCJ|2.40|2017|79V|ligand is BRD4592|P9WFY1|TRYPTOPHAN SYNTHASE ALPHA CHAIN|7.38|Kd=42nM|Kd|=|42|nM|42|nM
5UT4|2.00|2017|DQX|Kd=42+/-3.5uM, ligand is 2.|O60674|TYROSINE-PROTEIN KINASE JAK2|4.38|Kd=42uM|Kd|=|42|uM|42000|nM
5VC4|2.10|2017|XZN|[Nonstandard assay: Temp 15] Kd=43.7+/-10nM, ligand is Bos.isomer|P30291|WEE1-LIKE PROTEIN KINASE|7.36|Kd=43.7nM|Kd|=|43.7|nM|43.7|nM
5ORZ|1.92|2017|A6W|comp.12|O14965|AURORA KINASE A|3.36|Kd=432uM|Kd|=|432|uM|432000|nM
5F60|1.35|2017|5VZ|ligand is compound 2|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|7.37|Kd=43nM|Kd|=|43|nM|43|nM
5T78|2.20|2017|8-mer|Kd=43+/-3.6nM, ligand id MUC1 Glycopeptide.|------|FAB FRAGMENT AR20.5 - LIGHT CHAIN|7.37|Kd=43nM|Kd|=|43|nM|43|nM
5VCZ|1.50|2017|XZN|Kd=444+/-41.0nM, ligand is Bos. isomer|Q99640|MEMBRANE-ASSOCIATED TYROSINE- AND THREONINE-SPECIFIC CDC2|6.35|Kd=444nM|Kd|=|444|nM|444|nM
5TUY|2.60|2017|7L6|[Nonstandard assay: PH=8] Kd=445+/-40nM, ligand is compound 4.|Q96KQ7|HISTONE-LYSINE N-METHYLTRANSFERASE EHMT2|6.35|Kd=445nM|Kd|=|445|nM|445|nM
5WBP|2.74|2017|A2J|Compound 5|P50053|KETOHEXOKINASE|4.36|Kd=44uM|Kd|=|44|uM|44000|nM
5N3V|1.12|2017|8L5|[Nonstandard assay: buffer is Cacodylate] +/-3.41, compound 4|P00800|THERMOLYSIN|4.34|Kd=45.24uM|Kd|=|45.24|uM|45240|nM
5GOE|1.80|2017|GDP|GDPbound MFN1IMC(T109A)|Q8IWA4|MITOFUSIN-1|4.34|Kd=45.7uM|Kd|=|45.7|uM|45700|nM
5JNA|2.00|2017|TOR|fluorescent thermal shift assay|P22748|CARBONIC ANHYDRASE 4|7.35|Kd=45nM|Kd|=|45|nM|45|nM
5TGY|NMR|2017|7BU|[Uncommon element] [Nonstandard assay: Temp 50] Kd=45+/-4nM, ligand is (CF3)4PZn|------|PS1|7.35|Kd=45nM|Kd|=|45|nM|45|nM
5KA7|2.06|2017|OTA|PTP1B T178A:TCS401|P18031|TYROSINE-PROTEIN PHOSPHATASE, NON-RECEPTOR TYPE 1|4.35|Kd=45uM|Kd|=|45|uM|45000|nM
5YC1|2.51|2017|5-mer|GPIbbeta|Q9BUZ4|TNF RECEPTOR-ASSOCIATED FACTOR 4|4.34|Kd=46.1uM|Kd|=|46.1|uM|46100|nM
5W38|1.80|2017|7-mer|[Covalent complex] [Different ligand in assay: ligand in crystal is 3-mer] Man5-IgG3 Fc|P01860|IMMUNOGLOBULIN HEAVY CONSTANT GAMMA 3|7.33|Kd=46.5nM|Kd|=|46.5|nM|46.5|nM
5X72|1.95|2017|P59/P69|complex with R-1 AND S-1;+/- 65|O43924|RETINAL ROD RHODOPSIN-SENSITIVE CGMP 3',5'-CYCLIC|6.33|Kd=467nM|Kd|=|467|nM|467|nM
5NK7|1.89|2017|8ZZ|compound 2a|P29317|EPHRIN TYPE-A RECEPTOR 2|6.33|Kd=468nM|Kd|=|468|nM|468|nM
5TTG|1.66|2017|7KZ|Kd = 46 +/- 15 nM. complex is GLP/compound 18|Q9H9B1|HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1|7.34|Kd=46nM|Kd|=|46|nM|46|nM
5MRB|2.20|2017|C5N|+/-50, compound 5/Mps1 C604Y|P33981|DUAL SPECIFICITY PROTEIN KINASE TTK|6.33|Kd=471nM|Kd|=|471|nM|471|nM
5MNC|0.92|2017|ANL|"+/-7.3, Determined by ""low c value"" ITC, Aniline"|P00760|CATIONIC TRYPSIN|1.31|Kd=48.5mM|Kd|=|48.5|mM|48500000|nM
5MNY|1.43|2017|WOT|"+/-7.3, Determined by ""low c value"" ITC, Aniline"|P00760|CATIONIC TRYPSIN|1.31|Kd=48.5mM|Kd|=|48.5|mM|48500000|nM
5MOO|1.44|2017|WOT|"+/-7.3, Determined by ""low c value"" ITC, Aniline"|P00760|CATIONIC TRYPSIN|1.31|Kd=48.5mM|Kd|=|48.5|mM|48500000|nM
5OGL|2.70|2017|9UB|(omegaZZZ)-PPC-GlcNAc|B9KDD4|UNDECAPRENYL-DIPHOSPHOOLIGOSACCHARIDE--PROTEIN|4.31|Kd=48.5uM|Kd|=|48.5|uM|48500|nM
5GMU|1.80|2017|7LH||P39912|PROTEIN AROA(G)|3.32|Kd=480uM|Kd|=|480|uM|480000|nM
5M28|1.08|2017|MLR|+/-1.9, maltotriose|B0L7B0|MALE1|4.32|Kd=48uM|Kd|=|48|uM|48000|nM
5TW2|1.75|2017|7LP|ligand is compound 5.|P11609|ANTIGEN-PRESENTING GLYCOPROTEIN CD1D1|7.3|Kd=49.7nM|Kd|=|49.7|nM|49.7|nM
5OS1|1.90|2017|A7H|comp.14|O14965|AURORA KINASE A|3.31|Kd=494uM|Kd|=|494|uM|494000|nM
5U9I|2.30|2017|FAR|[Incomplete ligand] Kd=49+/-8nM, ligand is FC, AIPL1-FKBP:FC complex|Q9NZN9|ARYL HYDROCARBON RECEPTOR-INTERACTING PROTEIN-LIKE 1|7.31|Kd=49nM|Kd|=|49|nM|49|nM
5MKA|1.15|2017|RCD|+/-1.3, gamma-cyclodextrin|B0L7B0|MALE1|4.31|Kd=49uM|Kd|=|49|uM|49000|nM
5LL4|1.12|2017|6YH|[Nonstandard assay: Temp 37] complex is CA II-1 a|P00918|CARBONIC ANHYDRASE 2|8.4|Kd=4nM|Kd|=|4|nM|4|nM
5JSJ|2.35|2017|6PD|Spindlin1 bound to compound EML631(6)|Q9Y657|SPINDLIN-1|5.4|Kd=4uM|Kd|=|4|uM|4000|nM
5LSG|2.00|2017|QZQ|PPAR gamma /BA|P37231|PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA|5.4|Kd=4uM|Kd|=|4|uM|4000|nM
5MQE|1.65|2017|PKU|ligand is compound 1|Q92793|CREB-BINDING PROTEIN|5.4|Kd=4uM|Kd|=|4|uM|4000|nM
5V2P|2.00|2017|19-mer|[Nonstandard assay: Temp 15] Kd=5.1+/-1.6nM, ligand is peptide AID-CAP.|Q8VGC3|VOLTAGE-DEPENDENT L-TYPE CALCIUM CHANNEL SUBUNIT BETA-2|8.29|Kd=5.1nM|Kd|=|5.1|nM|5.1|nM
5Y59|2.40|2017|12-mer|[Nonstandard assay: Tem 16 C,PH=8] ligand is Sir4 peptide,Kd=5.1+/-0.9uM|Q04437|ATP-DEPENDENT DNA HELICASE II SUBUNIT 2|5.29|Kd=5.1uM|Kd|=|5.1|uM|5100|nM
5V2Q|1.70|2017|19-mer|[Nonstandard assay: Temp 15] Kd=5.2+/-1.5nM, ligand is peptide AID-CEN.|Q8VGC3|VOLTAGE-DEPENDENT L-TYPE CALCIUM CHANNEL SUBUNIT BETA-2|8.28|Kd=5.2nM|Kd|=|5.2|nM|5.2|nM
5G5F|2.30|2017|GSH|GSH-MiGSTU|------|TAU CLASS GLUTATHIONE S-TRANSFERASE|5.28|Kd=5.2uM|Kd|=|5.2|uM|5200|nM
5LTN|1.88|2017|XI7|[Nonstandard assay: with ions] Kd = 5.38 +/- 2.06 uM. ligand is DPBA|------|RNA-DIRECTED RNA POLYMERASE L|5.27|Kd=5.38uM|Kd|=|5.38|uM|5380|nM
5IRR|2.04|2017|GSP||A8IYS5|SEPTIN-LIKE PROTEIN|5.27|Kd=5.4uM|Kd|=|5.4|uM|5400|nM
5MXO|1.20|2017|3-mer|[Nonstandard assay: FC-A 1 mM] [Different ligand in assay: p53 CTD (15-mer)] +/-0.84|P31947|14-3-3 PROTEIN SIGMA|5.27|Kd=5.4uM|Kd|=|5.4|uM|5400|nM
5TWJ|2.30|2017|SAM|Kd=5.58+/-0.31uM, ligand is SAM|B7MFQ9|RIBOSOMAL RNA LARGE SUBUNIT METHYLTRANSFERASE H|5.25|Kd=5.58uM|Kd|=|5.58|uM|5580|nM
5J86|1.87|2017|6GW|Kd = 5.5 +/- 3.2 nM, ligand is compound 18|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|8.26|Kd=5.5nM|Kd|=|5.5|nM|5.5|nM
5B5F|1.20|2017|6F3|ligand is compound ALiS3|P22629|STREPTAVIDIN|5.25|Kd=5.6uM|Kd|=|5.6|uM|5600|nM
5B5G|1.50|2017|6FX|ligand is compound ALiS4|P22629|STREPTAVIDIN|5.25|Kd=5.6uM|Kd|=|5.6|uM|5600|nM
5NFA|1.59|2017|8VQ|comp.2|P17931|GALECTIN-3|5.25|Kd=5.6uM|Kd|=|5.6|uM|5600|nM
5XUP|2.10|2017|12-mer|[Different ligand in assay: ligand in binding assay is 15-mer] TRF1TRFH-TERB1TBM;+/- 0.69|P54274|TELOMERIC REPEAT-BINDING FACTOR 1|5.25|Kd=5.6uM|Kd|=|5.6|uM|5600|nM
5M9W|1.21|2017|7GR|TLN-1|P00800|THERMOLYSIN|2.24|Kd=5.7mM|Kd|=|5.7|mM|5700000|nM
5N7X|1.12|2017|12-mer|[Nonstandard assay: pH=5.0] +/-0.29;EWVHPQFEQKAK|P22629|STREPTAVIDIN|5.24|Kd=5.7uM|Kd|=|5.7|uM|5700|nM
5NZO|1.29|2017|9EZ|[Different protein in assay: crystal:PHGDH-93, binding assay: sPHGDH] +/-2.0, frag.3|O43175|D-3-PHOSPHOGLYCERATE DEHYDROGENASE|2.24|Kd=5.8mM|Kd|=|5.8|mM|5800000|nM
5W1E|2.06|2017|PHB|+/-0.5uM|Q9Z4X2|PUTATIVE TRANSCRIPTIONAL REGULATOR|5.24|Kd=5.8uM|Kd|=|5.8|uM|5800|nM
5TZO|1.67|2017|7V7|ligand is Fentanyl.|P18429|ENDO-1,4-BETA-XYLANASE A|5.23|Kd=5.9uM|Kd|=|5.9|uM|5900|nM
5JN8|1.85|2017|AZM|fluorescent thermal shift assay|P22748|CARBONIC ANHYDRASE 4|7.3|Kd=50nM|Kd|=|50|nM|50|nM
5MI6|2.00|2017|NHT|Kd=50+/-7.6nM; ligand is thiamet-G(2)|Q89ZI2|O-GLCNACASE BT_4395|7.3|Kd=50nM|Kd|=|50|nM|50|nM
5JGI|1.38|2017|AAG|Kd = 50 +/- 3 uM, ligand is R4|O14786|NEUROPILIN-1|4.3|Kd=50uM|Kd|=|50|uM|50000|nM
5VSC|1.40|2017|9HJ|G9a-SAM-13; +/- 62|Q96KQ7|HISTONE-LYSINE N-METHYLTRANSFERASE EHMT2|6.29|Kd=510nM|Kd|=|510|nM|510|nM
5MGJ|2.10|2017|7MX|ligand is compound 1|Q9UIF9|BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN PROTEIN 2A|4.29|Kd=51uM|Kd|=|51|uM|51000|nM
5T8R|2.40|2017|10-mer|Kd=51+/-2uM, peptide sequence is ARTKQTARKS.|Q9UIF9|BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN PROTEIN 2A|4.29|Kd=51uM|Kd|=|51|uM|51000|nM
5MOE|1.89|2017|OQC|[Nonstandard assay: PH=8] ligand is compound 6|P68400|CASEIN KINASE II, ALPHA SUBUNIT|3.28|Kd=520uM|Kd|=|520|uM|520000|nM
6B7D|1.80|2017|CWG|CoaD in complex with compound 9;+/- 12|P0A6I6|PHOSPHOPANTETHEINE ADENYLYLTRANSFERASE|4.28|Kd=52uM|Kd|=|52|uM|52000|nM
5LO6|2.40|2017|70O|Kd(36)=53.9+/-9.3nM, kon=2.53E+4, koff=1.39E-3|P07900|HEAT SHOCK PROTEIN HSP 90-ALPHA|7.27|Kd=53.9nM|Kd|=|53.9|nM|53.9|nM
5MGF|1.90|2017|7MW|ligand is compound 2|Q9UIF8|BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN PROTEIN 2B|4.27|Kd=54uM|Kd|=|54|uM|54000|nM
6BHI|1.40|2017|16-mer|3TD(W358A)- H3K9me3/K14ac;+/-5.5|Q15047|HISTONE-LYSINE N-METHYLTRANSFERASE SETDB1|4.25|Kd=55.6uM|Kd|=|55.6|uM|55600|nM
5KM9|1.45|2017|ADN|complex with hHint2|Q9BX68|HISTIDINE TRIAD NUCLEOTIDE-BINDING PROTEIN 2|4.25|Kd=55.9uM|Kd|=|55.9|uM|55900|nM
5UFF|2.14|2017|8B7|ligand is 2'-Fucosyllactose|------|RBC36|4.24|Kd=57.1uM|Kd|=|57.1|uM|57100|nM
5UT6|1.65|2017|8MY|Kd=57.3+/-2.8uM, ligand is compound 8|O60674|TYROSINE-PROTEIN KINASE JAK2|4.24|Kd=57.3uM|Kd|=|57.3|uM|57300|nM
5TV1|2.40|2017|IHP|site1, ligand is IP6,domain, MST-measured fluorescence binding isotherm|P32120|BETA-ARRESTIN-2|7.24|Kd=57nM|Kd|=|57|nM|57|nM
5VSD|1.85|2017|9HJ|GLP-SAM-13;+/- 8|Q9H9B1|HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1|7.24|Kd=57nM|Kd|=|57|nM|57|nM
5U0W|1.97|2017|9MG|Kd=58+/-8uM, ligand is compound 7|P0AC14|DIHYDROPTEROATE SYNTHASE|4.24|Kd=58uM|Kd|=|58|uM|58000|nM
5IF6|2.50|2017|3QZ|Kd = 59 +/- 7.5 nM. complex is OHP9_1c/17-OHP|------|OHP9_1C|7.23|Kd=59nM|Kd|=|59|nM|59|nM
6AU2|1.63|2017|CGJ|compound 2|Q15047|HISTONE-LYSINE N-METHYLTRANSFERASE SETDB1|2.3|Kd=5mM|Kd|=|5|mM|5000000|nM
5N16|1.76|2017|8FN|+/-2.5, comp.1|Q5A4W8|BROMODOMAIN-CONTAINING FACTOR 1|5.3|Kd=5uM|Kd|=|5|uM|5000|nM
5X9O|1.58|2017|80R|1a with BCL6|P41182|B-CELL LYMPHOMA 6 PROTEIN|5.3|Kd=5uM|Kd|=|5|uM|5000|nM
5FSB|1.65|2017|6YR|Kd = 6.0 +/- 0.3 mM, ligand is 2MeSeFuc|B0CZL6|TECTONIN 2|2.22|Kd=6.0mM|Kd|=|6|mM|6000000|nM
5TY1|1.60|2017|7QV|ligand is compound 11|P00918|CARBONIC ANHYDRASE 2|5.21|Kd=6.1uM|Kd|=|6.1|uM|6100|nM
5TY9|1.53|2017|7QV|ligand is compound 11|P00918|CARBONIC ANHYDRASE 2|5.21|Kd=6.1uM|Kd|=|6.1|uM|6100|nM
5X13|1.70|2017|HC4|[Nonstandard assay: TEMP 4] ligand is p-coumaric acid|E0TW95|TRANSCRIPTIONAL REGULATOR|5.21|Kd=6.2uM|Kd|=|6.2|uM|6200|nM
5XXK|1.66|2017|12-mer|apled peptide (M011) bound to Mdm2-M62A|Q00987|E3 UBIQUITIN-PROTEIN LIGASE MDM2|8.2|Kd=6.337nM|Kd|=|6.337|nM|6.337|nM
5LU2|2.50|2017|13-mer|Correct Kd=6.3uM for pHSPB6(11-23) phosphopeptide; wrong Kd=0.56uM is for full length pHSPB6|P31947|14-3-3 PROTEIN SIGMA|5.2|Kd=6.3uM|Kd|=|6.3|uM|6300|nM
5TCO|2.10|2017|79Q|ligand is compound 2, Kd=(6.46+3.14)/2nM|Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|8.19|Kd=6.46nM|Kd|=|6.46|nM|6.46|nM
5NZP|1.30|2017|9EW|[Different protein in assay: crystal:PHGDH-93, binding assay: sPHGDH] +/-4.7, frag.16|O43175|D-3-PHOSPHOGLYCERATE DEHYDROGENASE|2.19|Kd=6.5mM|Kd|=|6.5|mM|6500000|nM
5TBP|2.60|2017|7A4|ligand is K-80003.|P19793|RETINOIC ACID RECEPTOR RXR-ALPHA|5.18|Kd=6.67uM|Kd|=|6.67|uM|6670|nM
5MYX|1.49|2017|16-mer|+/-1.56, mAbetapE3-18 PEGb|------|FAB C#24 LIGHT CHAIN|8.16|Kd=6.85nM|Kd|=|6.85|nM|6.85|nM
5F62|1.35|2017|5W1|ligand is compound 4|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|8.17|Kd=6.8nM|Kd|=|6.8|nM|6.8|nM
5UFC|1.89|2017|3-mer|ligand is H-trisaccharide|------|TN4-22|5.16|Kd=6.9uM|Kd|=|6.9|uM|6900|nM
5GO2|1.91|2017|CIT||P39912|PROTEIN AROA(G)|3.22|Kd=600uM|Kd|=|600|uM|600000|nM
5N99|1.50|2017|5-mer|[Nonstandard assay: pH=5.0] NQpWQ|P22629|STREPTAVIDIN|4.21|Kd=61.3uM|Kd|=|61.3|uM|61300|nM
5OSD|1.99|2017|A9B|comp.20|O14965|AURORA KINASE A|3.21|Kd=619uM|Kd|=|619|uM|619000|nM
5JCB|2.30|2017|NV4|tubulin-1S|Q2XVP4|TUBULIN ALPHA-1B CHAIN|4.21|Kd=62.04uM|Kd|=|62.04|uM|62040|nM
5T6Z|2.00|2017|10-mer|Kd=62.1+/-6.57uM, ligand is peptide TW10.|P18465|HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-57 ALPHA CHAIN|4.21|Kd=62.1uM|Kd|=|62.1|uM|62100|nM
5OFI|2.00|2017|9TQ|+/-3.8, flurescent ligand 1|Q7N561|PIIA|4.2|Kd=62.7uM|Kd|=|62.7|uM|62700|nM
5WBO|2.25|2017|A1Y|ligand is compound 4|P50053|KETOHEXOKINASE|4.21|Kd=62uM|Kd|=|62|uM|62000|nM
5OT8|2.35|2017|6DB|+/-13.8, octopine|P35120|NOPALINE-BINDING PERIPLASMIC PROTEIN|4.2|Kd=63.8uM|Kd|=|63.8|uM|63800|nM
5IJR|1.52|2017|HRG|Kd = 637 +/- 70 uM, ligand is R9|O14786|NEUROPILIN-1|3.2|Kd=637uM|Kd|=|637|uM|637000|nM
5T9Z|1.40|2017|78R|ligand is compound 6|P62937|PEPTIDYL-PROLYL CIS-TRANS ISOMERASE A|7.19|Kd=64nM|Kd|=|64|nM|64|nM
5W5U|2.46|2017|12-mer|[Different protein in assay: protein in binding assay is H1N1 A/California/07/ 2009 (H1/Cal)] P4;+/- 19;|P03452|HEMAGGLUTININ|7.19|Kd=64nM|Kd|=|64|nM|64|nM
5LT9|3.00|2017|ARG|[Covalent complex] Data is from a reference|------|METHYL-ACCEPTING CHEMOTAXIS PROTEIN PCTB|4.19|Kd=64uM|Kd|=|64|uM|64000|nM
5VGY|1.39|2017|9AA|ligand is compound 27'|P00918|CARBONIC ANHYDRASE 2|4.18|Kd=65.5uM|Kd|=|65.5|uM|65500|nM
5NGE|2.35|2017|8WK|FT671|Q93009|UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 7|7.19|Kd=65nM|Kd|=|65|nM|65|nM
5T35|2.70|2017|759|[Multiple sites: BRD4BD2-MZ1: Kd=15+/-1 nM; VCB-(MZ1-BRD4BD2): Kd=3.7+/-0.7 nM] +/-6, MZ1, PROTAC|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|7.18|Kd=66nM|Kd|=|66|nM|66|nM
5O0B|1.74|2017|9FE|frag.2|B1MDL6|PHOSPHOPANTETHEINE ADENYLYLTRANSFERASE|4.18|Kd=66uM|Kd|=|66|uM|66000|nM
5XN3|1.34|2017|8-mer|cR8-SPSB2; +/-109|Q99619|SPRY DOMAIN-CONTAINING SOCS BOX PROTEIN 2|6.17|Kd=671nM|Kd|=|671|nM|671|nM
5GTR|2.80|2017|10-mer|[Nonstandard assay: PH=8] [Different ligand in assay: FITC labeled] ER alpha LBD in complex with 6|P03372|ESTROGEN RECEPTOR|7.17|Kd=67nM|Kd|=|67|nM|67|nM
5U28|1.80|2017|82V|Kd=67+/-7nM, ligand is SF2523|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|7.17|Kd=67nM|Kd|=|67|nM|67|nM
5LDK|2.10|2017|ATP|LigT/ATP|------|RNA 2',3'-CYCLIC PHOSPHODIESTERASE|4.17|Kd=67uM|Kd|=|67|uM|67000|nM
5LDP|1.80|2017|ATP|LigT/ATP|------|RNA 2',3'-CYCLIC PHOSPHODIESTERASE|4.17|Kd=67uM|Kd|=|67|uM|67000|nM
5OSE|1.90|2017|A98|compound 21|O14965|AURORA KINASE A|3.17|Kd=681uM|Kd|=|681|uM|681000|nM
5N1X|1.72|2017|8HH|comp.2|P41182|B-CELL LYMPHOMA 6 PROTEIN|3.16|Kd=689uM|Kd|=|689|uM|689000|nM
5X4N|1.94|2017|7ZL|BCL6/4|P41182|B-CELL LYMPHOMA 6 PROTEIN|4.17|Kd=68uM|Kd|=|68|uM|68000|nM
5FYX|1.80|2017|FD6|dNCS-1 bound to penothiazine FD16|Q9VWX8|FREQUENIN 2|4.16|Kd=69.6uM|Kd|=|69.6|uM|69600|nM
6AWP|3.80|2017|FVX|ligand is fluvoxamine,Ki=69+/-9nM,ligand in binding assay is possitive,in PDB is neutral|P31645|SODIUM-DEPENDENT SEROTONIN TRANSPORTER|7.16|Kd=69nM|Kd|=|69|nM|69|nM
5T8Q|2.63|2017|76Y|ligand is fragment 17.|Q9WUL6|MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 14|4.16|Kd=69uM|Kd|=|69|uM|69000|nM
5IOY|1.77|2017|6C5|[Nonstandard assay: pH = 8.0] urea 3 bound to EthR|A5U9I4|TETR-FAMILY TRANSCRIPTIONAL REGULATORY REPRESSOR PROTEIN|5.22|Kd=6uM|Kd|=|6|uM|6000|nM
5JA0|1.90|2017|FPP|ligand is FPP, titrated in presence of Mg2+|P14324|FARNESYL PYROPHOSPHATE SYNTHASE|5.22|Kd=6uM|Kd|=|6|uM|6000|nM
5U6K|2.60|2017|13-mer|Kd=6+/-2uM, ligand is pSer304 BLM peptide|Q6ZQF0|DNA TOPOISOMERASE 2-BINDING PROTEIN 1|5.22|Kd=6uM|Kd|=|6|uM|6000|nM
5GP7|1.50|2017|10-mer|[Different ligand in assay: Ligand in binding assay is USP25 (1049-1055), ] TNKS1 ARC5 in complex with the tankyrase-binding motif of USP25|O95271|TANKYRASE-1|5.15|Kd=7.1uM|Kd|=|7.1|uM|7100|nM
6B7C|1.56|2017|CWP|CoaD in complex with compound 3;+/- 4.5|P0A6I6|PHOSPHOPANTETHEINE ADENYLYLTRANSFERASE|5.14|Kd=7.2uM|Kd|=|7.2|uM|7200|nM
5KWW|2.50|2017|6YA|RSV F in complex with fusion inhibitor JNJ-53718678|W8RJF9|FUSION GLYCOPROTEIN F0|8.13|Kd=7.4nM|Kd|=|7.4|nM|7.4|nM
5VSB|1.85|2017|9QA|USP7/1;+/- 3.216|Q93009|UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 7|5.12|Kd=7.614uM|Kd|=|7.614|uM|7614|nM
6F0Y|NMR|2017|15-mer|Rtt109(419-433 )and Asf1;+/-1.23|P32447|HISTONE CHAPERONE ASF1|5.11|Kd=7.78uM|Kd|=|7.78|uM|7780|nM
5U0E|1.27|2017|7R4|ligand is compound 24|P00918|CARBONIC ANHYDRASE 2|5.11|Kd=7.7uM|Kd|=|7.7|uM|7700|nM
5KEJ|2.35|2017|GTX|GSX-MiGSTU|------|TAU CLASS GLUTATHIONE S-TRANSFERASE|5.11|Kd=7.8uM|Kd|=|7.8|uM|7800|nM
5NGF|2.33|2017|8WN|[Covalent complex] FT827|Q93009|UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 7|5.11|Kd=7.8uM|Kd|=|7.8|uM|7800|nM
5SZB|1.20|2017|18-mer|Kd(H3K4me0)=7.8+/-0.5uM|Q92784|ZINC FINGER PROTEIN DPF3|5.11|Kd=7.8uM|Kd|=|7.8|uM|7800|nM
5OW1|2.05|2017|AY8|[Nonstandard assay: Temp 30] +/-4.7, comp.1|P54829|TYROSINE-PROTEIN PHOSPHATASE NON-RECEPTOR TYPE 5|4.15|Kd=70.4uM|Kd|=|70.4|uM|70400|nM
5KZP|2.26|2017|15-mer|cyclic C1 immunogen bound to HCV1|------|HCV1-C1 ANTIBODY FAB HEAVY CHAIN|7.15|Kd=70nM|Kd|=|70|nM|70|nM
5W4V|2.65|2017|9WA|compound 19b|P51449|NUCLEAR RECEPTOR ROR-GAMMA|7.15|Kd=70nM|Kd|=|70|nM|70|nM
5NJX|2.49|2017|16-mer|[Different protein in assay: Protein in binding assay is TPR domain of FKBP51] +/-32|Q13451|PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5|4.15|Kd=70uM|Kd|=|70|uM|70000|nM
5AAN|1.60|2017|XOC|dNCS-1 bound to penothiazine FD44|Q9VWX8|CG5907-PA, ISOFORM A|4.15|Kd=71uM|Kd|=|71|uM|71000|nM
5NK9|1.59|2017|912|compound 2e|P29317|EPHRIN TYPE-A RECEPTOR 2|6.14|Kd=724nM|Kd|=|724|nM|724|nM
5MY8|1.70|2017|RXZ|+/-5, SPHINX31|Q96SB4|SRSF PROTEIN KINASE 1,SRSF PROTEIN KINASE 1|7.14|Kd=72nM|Kd|=|72|nM|72|nM
5U7O|3.03|2017|83J|ligand is BMS-626529.|Q2N0S5|ENVELOPE GLYCOPROTEIN GP160|7.14|Kd=73nM|Kd|=|73|nM|73|nM
5WIR|2.10|2017|15-mer|hTRF1TRFH TERB1TBM;+/-9.0|P54274|TERB1-TBM|7.12|Kd=75.1nM|Kd|=|75.1|nM|75.1|nM
5UMZ|1.90|2017|13-mer|[Nonstandard assay: Temp 4] Kd=75.62+/-21.1nM, ligand is TNRC6A cNLS|P52293|IMPORTIN SUBUNIT ALPHA-1|7.12|Kd=75.62nM|Kd|=|75.62|nM|75.62|nM
5NVY|2.90|2017|9B5|+/-20, comp.11|Q15370|ELONGIN-B|6.12|Kd=760nM|Kd|=|760|nM|760|nM
5VC3|1.97|2017|DB8|[Nonstandard assay: Temp 15] Kd=77.5+/-6.0nM, ligand is Bosutinib|P30291|WEE1-LIKE PROTEIN KINASE|7.11|Kd=77.5nM|Kd|=|77.5|nM|77.5|nM
5MI7|2.10|2017|OAN|+/-7.7, PUGNAc|Q89ZI2|O-GLCNACASE BT_4395|7.11|Kd=77nM|Kd|=|77|nM|77|nM
5MTV|2.79|2017|AGS||Q9EQP2|EH DOMAIN-CONTAINING PROTEIN 4|4.11|Kd=77uM|Kd|=|77|uM|77000|nM
5VD2|2.05|2017|34W|[Nonstandard assay: Temp 15] Kd=78.7+/-8.3nM, ligand is PF-03814735|P30291|WEE1-LIKE PROTEIN KINASE|7.1|Kd=78.7nM|Kd|=|78.7|nM|78.7|nM
5ORW|2.00|2017|A6E|compound 9|O14965|AURORA KINASE A|3.1|Kd=796uM|Kd|=|796|uM|796000|nM
5T7S|1.90|2017|LBT|ligand is lactose|O00214|GALECTIN-8|4.1|Kd=79uM|Kd|=|79|uM|79000|nM
5N2T|1.38|2017|8KK|[Nonstandard assay: buffer is Cacodylate] +/-0.35, compound 2|P00800|THERMOLYSIN|5.08|Kd=8.40uM|Kd|=|8.4|uM|8400|nM
5U12|1.84|2017|5RU|Kd=8.5+/-2.1uM, ligand is compound 13|P0AC14|DIHYDROPTEROATE SYNTHASE|5.07|Kd=8.5uM|Kd|=|8.5|uM|8500|nM
6AXP|2.48|2017|11-mer|(AHA)QFDLST R(nOc)RLK|P01834|CETUXIMAB FAB, LIGHT CHAIN|5.07|Kd=8.5uM|Kd|=|8.5|uM|8500|nM
5GSA|2.49|2017|73K|EED226 compound bound EED|O75530|POLYCOMB PROTEIN EED|7.09|Kd=82nM|Kd|=|82|nM|82|nM
5LL9|1.45|2017|6YQ|[Nonstandard assay: Temp 37] complex is CA XII-2a|O43570|CARBONIC ANHYDRASE 12|6.08|Kd=833nM|Kd|=|833|nM|833|nM
5OT9|2.45|2017|AOZ|+/-6.7, histopine|P35120|NOPALINE-BINDING PERIPLASMIC PROTEIN|4.07|Kd=84.4uM|Kd|=|84.4|uM|84400|nM
5GS4|2.40|2017|10-mer|[Nonstandard assay: PH=8] [Different ligand in assay: FITC-labeled] ER alpha LBD in complex with 2|P03372|ESTROGEN RECEPTOR|7.07|Kd=85nM|Kd|=|85|nM|85|nM
5MPZ|1.40|2017|4I8|compound 3|Q92793|CREB-BINDING PROTEIN|4.07|Kd=85uM|Kd|=|85|uM|85000|nM
5O4Z|1.70|2017|A|+/-94, 5'-pApA|Q9X1T1|DHH/DHHA1-TYPE PHOSPHODIESTERASE TM1595|6.07|Kd=860nM|Kd|=|860|nM|860|nM
5F5Z|1.76|2017|5VY|ligand is compound 1|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|7.07|Kd=86nM|Kd|=|86|nM|86|nM
5JHB|2.48|2017|6K5|p110 gamma PIKiN3|P48736|PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE|6.06|Kd=873nM|Kd|=|873|nM|873|nM
5UXF|1.50|2017|2BA|ligand is c-di-AMP|Q54A37|DIHYDRODIOL DEHYDROGENASE|7.06|Kd=87nM|Kd|=|87|nM|87|nM
5MGE|1.95|2017|7MX|ligand is compound 1|Q9UIF8|BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN PROTEIN 2B|4.06|Kd=87uM|Kd|=|87|uM|87000|nM
5T6P|1.97|2017|8-mer|Kd=880+/-123nM, ligand id MUC1 peptide.|------|FAB FRAGMENT AR20.5 - LIGHT CHAIN|6.06|Kd=880nM|Kd|=|880|nM|880|nM
5X4O|2.05|2017|YAM|BCL6/5|P41182|B-CELL LYMPHOMA 6 PROTEIN|4.06|Kd=88uM|Kd|=|88|uM|88000|nM
5ORT|2.56|2017|A5Z|comp.7|O14965|AURORA KINASE A|3.05|Kd=894uM|Kd|=|894|uM|894000|nM
5MK3|2.00|2017|18-mer|ligand is CHMP4C peptide|Q9H3S7|TYROSINE-PROTEIN PHOSPHATASE NON-RECEPTOR TYPE 23|4.05|Kd=89uM|Kd|=|89|uM|89000|nM
5VDP|2.30|2017|1SY|Kd=89+/-6uM, ligand is 2',3'-cGAMP, complex is cGAS161/2',3'-cGAMP|Q8N884|CYCLIC GMP-AMP SYNTHASE|4.05|Kd=89uM|Kd|=|89|uM|89000|nM
5ML8|2.60|2017|V98|+/-2, comp.4|O43924|RETINAL ROD RHODOPSIN-SENSITIVE CGMP 3',5'-CYCLIC|8.1|Kd=8nM|Kd|=|8|nM|8|nM
5LYN|2.00|2017|7-mer|+/-0.05, PTVEEVD|Q12118|SMALL GLUTAMINE-RICH TETRATRICOPEPTIDE REPEAT-CONTAINING|5.04|Kd=9.04uM|Kd|=|9.04|uM|9040|nM
5MLW|2.45|2017|11-mer|ZRANB3 APIM peptide|P12004|PROLIFERATING CELL NUCLEAR ANTIGEN|5.03|Kd=9.24uM|Kd|=|9.24|uM|9240|nM
6AYN|2.48|2017|11-mer|(AHA)QFDLST R(PrNH2)RLK|P01834|CETUXIMAB FAB, LIGHT CHAIN|5.04|Kd=9.2uM|Kd|=|9.2|uM|9200|nM
5N3Y|1.34|2017|8L2|[Nonstandard assay: buffer is Cacodylate] +/-0.28, compound 8|P00800|THERMOLYSIN|5.03|Kd=9.32uM|Kd|=|9.32|uM|9320|nM
5NZQ|1.50|2017|5AO|[Different protein in assay: crystal:PHGDH-93, binding assay: sPHGDH] +/-3.8, frag.10|O43175|D-3-PHOSPHOGLYCERATE DEHYDROGENASE|2.03|Kd=9.3mM|Kd|=|9.3|mM|9300000|nM
5MRM|1.80|2017|Q9T|+/-0.6, compound 4|P69834|2-C-METHYL-D-ERYTHRITOL 4-PHOSPHATE CYTIDYLYLTRANSFERASE|5.03|Kd=9.3uM|Kd|=|9.3|uM|9300|nM
5WIO|2.52|2017|XXE|105055;+/-0.4|Q17U16|CONJUGAL TRANSFER PROTEIN|5.03|Kd=9.3uM|Kd|=|9.3|uM|9300|nM
5X4P|2.06|2017|7ZO|BCL6/6|P41182|B-CELL LYMPHOMA 6 PROTEIN|5.03|Kd=9.3uM|Kd|=|9.3|uM|9300|nM
6B27|1.73|2017|14-mer|STAC2/CaV1.1(747-760)|Q6ZMT1|SH3 AND CYSTEINE-RICH DOMAIN-CONTAINING PROTEIN 2|5.03|Kd=9.3uM|Kd|=|9.3|uM|9300|nM
6BHD|1.25|2017|18-mer|3TD H3K9me2/K14ac;+/-0.2|Q15047|HISTONE-LYSINE N-METHYLTRANSFERASE SETDB1|5.03|Kd=9.3uM|Kd|=|9.3|uM|9300|nM
5NYZ|2.50|2017|DUP||A4ZF98|DUTPASE|5.03|Kd=9.4uM|Kd|=|9.4|uM|9400|nM
5NZ2|2.85|2017|DUP||A4ZF98|DUTPASE|5.03|Kd=9.4uM|Kd|=|9.4|uM|9400|nM
5GOF|1.60|2017|GTP|GTP-bound MFN1IMC(T109A)|Q8IWA4|MITOFUSIN-1|4.05|Kd=90.1uM|Kd|=|90.1|uM|90100|nM
5LL5|1.42|2017|6YH|[Nonstandard assay: Temp 37] complex is CA XII-1a|O43570|CARBONIC ANHYDRASE 12|6.04|Kd=909nM|Kd|=|909|nM|909|nM
5GVN|2.30|2017|G6F|[Different protein in assay: assay uses PfSHMT]|A5K8L9|SERINE HYDROXYMETHYLTRANSFERASE|7.05|Kd=90nM|Kd|=|90|nM|90|nM
5NVX|2.20|2017|4YY|+/-10, compound 10|Q15370|TRANSCRIPTION ELONGATION FACTOR B POLYPEPTIDE 2|7.05|Kd=90nM|Kd|=|90|nM|90|nM
5MOB|1.67|2017|A8S|[Nonstandard assay: Temp 5] +/-10, ABA, absence of phosphatase|K4CN56|SLPYL1_ABA|4.05|Kd=90uM|Kd|=|90|uM|90000|nM
6AT0|1.29|2017|6-mer||P05205|HETEROCHROMATIN PROTEIN 1|4.04|Kd=91.7uM|Kd|=|91.7|uM|91700|nM
5OUI|3.10|2017|AVB|+/-35.08, CU2017|P36544|ACETYLCHOLINE BINDING PROTEIN|4.03|Kd=93.57uM|Kd|=|93.57|uM|93570|nM
5VSF|1.70|2017|9HG|GLP-SAM-17; +/- 14|Q9H9B1|HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1|7.03|Kd=94nM|Kd|=|94|nM|94|nM
5XO2|2.20|2017|7-mer|[Covalent complex] ligand is Deoxy-GlcNAc-type glycopeptide,Kd =94+/-26 uM|Q9UKJ1|PAIRED IMMUNOGLOBULIN-LIKE TYPE 2 RECEPTOR ALPHA|4.03|Kd=94uM|Kd|=|94|uM|94000|nM
5XOF|1.96|2017|7-mer|[Covalent complex] ligand is GlcNAc-type glycopeptide,Kd =98+/-1.0uM|Q9UKJ1|PAIRED IMMUNOGLOBULIN-LIKE TYPE 2 RECEPTOR ALPHA|4.01|Kd=98uM|Kd|=|98|uM|98000|nM
5VD1|1.70|2017|P48|Kd=990+/-55.2nM, ligand is PHA-848125|Q99640|MEMBRANE-ASSOCIATED TYROSINE- AND THREONINE-SPECIFIC CDC2|6.0|Kd=990nM|Kd|=|990|nM|990|nM
5LB7|1.50|2017|9-mer|ligand is 9-mer peptide derived from ASPM|Q8BG40|KATANIN P80 WD40 REPEAT-CONTAINING SUBUNIT B1|5.05|Kd=9uM|Kd|=|9|uM|9000|nM
6EWW|2.68|2017|8-mer|[Different protein in assay: protein in binding assay is 14-3-3 gamma] ligand is peptide pepS100; kd = 1+/-0.5uM|P63104|14-3-3 PROTEIN ZETA/DELTA|5.05|Kd=9uM|Kd|=|9|uM|9000|nM
5LM4|3.10|2017|6Z6||P43003|EXCITATORY AMINO ACID TRANSPORTER 1,NEUTRAL AMINO ACID|3.88|Kd>131uM|Kd|>|131|uM|131000|nM
5JQ8|1.94|2017|I73|CDK2/ICEC0943|P24941|CYCLIN-DEPENDENT KINASE 2|5.7|Kd>2000nM|Kd|>|2000|nM|2000|nM
5JPT|2.94|2017|CDP|Prp43/CDP|P53131|PRE-MRNA-SPLICING FACTOR ATP-DEPENDENT RNA HELICASE PRP43|4.6|Kd>25uM|Kd|>|25|uM|25000|nM
5MGL|2.65|2017|7MU|[Incomplete ligand] comp.3|Q9UIF9|BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN PROTEIN 2A|3.3|Kd>500uM|Kd|>|500|uM|500000|nM
5MGG|2.10|2017|7MU|comp.3|Q9UIF8|BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN PROTEIN 2B|3.3|Kd>500uM|Kd|>|500|uM|500000|nM
5MGM|2.80|2017|7MZ|comp.4|Q9UIF9|BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN PROTEIN 2A|3.3|Kd>500uM|Kd|>|500|uM|500000|nM
5VDO|3.22|2017|1YC|ligand is 2',2'-cGAMP, complex is cGAS161/2',2'-cGAMP|Q8N884|CYCLIC GMP-AMP SYNTHASE|3.3|Kd>500uM|Kd|>|500|uM|500000|nM
5VDR|3.04|2017|9B7|ligand is 3',3'-cdIMP, complex is cGAS161/3',3'-cdIMP|Q8N884|CYCLIC GMP-AMP SYNTHASE|3.3|Kd>500uM|Kd|>|500|uM|500000|nM
5VDS|2.77|2017|9BJ|ligand is 3',3'-cdUMP, complex is cGAS161/3',3'-cdUMP|Q8N884|CYCLIC GMP-AMP SYNTHASE|3.3|Kd>500uM|Kd|>|500|uM|500000|nM
5XXF|3.10|2017|17-mer|Rap1PBM-Poz1-Tpz1PBM|O13852|PROTECTION OF TELOMERES PROTEIN POZ1|5.74|Kd~1.8uM|Kd|~|1.8|uM|1800|nM
5IEO|1.85|2017|VDY||------|CDL2.3A|7.0|Kd~100nM|Kd|~|100|nM|100|nM
5IEP|1.89|2017|VDY||------|CDL2.3B|7.0|Kd~100nM|Kd|~|100|nM|100|nM
5U51|2.80|2017|G4P|ligand is ppGpp|------|STRINGENT STARVATION PROTEIN A|4.92|Kd~12uM|Kd|~|12|uM|12000|nM
5WHC|2.55|2017|AJJ|2 in complex with USP7-CD|Q93009|UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 7|4.92|Kd~12uM|Kd|~|12|uM|12000|nM
5IER|2.01|2017|3QZ|complex is OHP9/17-OHP|------|OHP9|4.89|Kd~13uM|Kd|~|13|uM|13000|nM
5U66|1.70|2017|15-mer|Kd~1+/-0.5mM, ligand is peptide LH1.|Q6MZV7|STAPLED PEPTIDE FROM DOMAIN B OF PROTEIN A|3.0|Kd~1mM|Kd|~|1|mM|1000000|nM
5VDU|2.73|2017|9BS|Kd=100~300uM, ligand is ligand is F2, complex is cGAS161/F2|Q8N884|CYCLIC GMP-AMP SYNTHASE|3.7|Kd~200uM|Kd|~|200|uM|200000|nM
5VDV|3.00|2017|9BV|Kd=100~300uM, ligand is F3, complex is cGAS161/F3|Q8N884|CYCLIC GMP-AMP SYNTHASE|3.7|Kd~200uM|Kd|~|200|uM|200000|nM
5VDW|2.71|2017|9BY|Kd=100~300uM, ligand is F1, complex is cGAS161/F1|Q8N884|CYCLIC GMP-AMP SYNTHASE|3.7|Kd~200uM|Kd|~|200|uM|200000|nM
5IEN|2.09|2017|VDY||------|CDL2.2|6.52|Kd~300nM|Kd|~|300|nM|300|nM
5MT4|1.65|2017|M7O|comp.9|P00746|COMPLEMENT FACTOR D|3.3|Kd~500uM|Kd|~|500|uM|500000|nM
5MT0|1.29|2017|QJS|comp.8|P00746|COMPLEMENT FACTOR D|3.3|Kd~500uM|Kd|~|500|uM|500000|nM
5N1Y|1.39|2017|10-mer|A2-MVW peptide|P01892|HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA CHAIN|3.22|Kd~600uM|Kd|~|600|uM|600000|nM
5F29|1.82|2017|2BA|ligand is c-di-AMP. ligand:protein ratio is 0.5|------|NA+/H+ ANTIPORTER-LIKE PROTEIN|5.05|Kd~9uM|Kd|~|9|uM|9000|nM
5WFZ|2.35|2017|KU0|E119D mutant)/8e (SRI-30049);|C3W5S0|POLYMERASE ACIDIC PROTEIN|8.0|Ki<0.01uM|Ki|<|0.01|uM|10|nM
5U6C|2.10|2017|7YS|ligand is compound 1.|Q12866|TYROSINE-PROTEIN KINASE MER|10.3|Ki<0.05nM|Ki|<|0.05|nM|0.05|nM
5IF4|2.39|2017|6AK|ligand is compound 5|Q07820|INDUCED MYELOID LEUKEMIA CELL DIFFERENTIATION PROTEIN MCL|9.0|Ki<1nM|Ki|<|1|nM|1|nM
5KKT|2.80|2017|6U2|ligand is compound 37|Q13464|RHO-ASSOCIATED PROTEIN KINASE 1|9.0|Ki<1nM|Ki|<|1|nM|1|nM
5TQF|1.85|2017|7KR|[Different protein in assay: Protein in binding assay is TF/FVIIa.] ligand is compound 7.|P08709|COAGULATION FACTOR VIIA (HEAVY CHAIN)|8.3|Ki<5nM|Ki|<|5|nM|5|nM
5WAL|2.45|2017|9ZS|ligand is compound 6-TYK2|P29597|NON-RECEPTOR TYROSINE-PROTEIN KINASE TYK2|8.77|Ki=0.0017uM|Ki|=|0.0017|uM|1.7|nM
5MW4|2.19|2017|5JU|comp.7|Q8TEK3|HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-79 SPECIFIC|11.7|Ki=0.002nM|Ki|=|0.002|nM|0.002|nM
5VO1|2.45|2017|9FS|10 bound to the DLK kinase domain|Q12852|MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 12|8.15|Ki=0.007uM|Ki|=|0.007|uM|7|nM
5W7U|2.20|2017|GY8|8f (SRI-29928);+/-0.007|C3W5S0|POLYMERASE ACIDIC PROTEIN|8.05|Ki=0.009uM|Ki|=|0.009|uM|9|nM
5ULT|1.53|2017|8FM|ligand is compound 25|C8B467|HIV-1 PROTEASE|10.85|Ki=0.014nM|Ki|=|0.014|nM|0.014|nM
5WLO|1.27|2017|GR7|ligand is inhibitor 5j|Q5RZ08|HIV-1 PROTEASE|10.82|Ki=0.015nM|Ki|=|0.015|nM|0.015|nM
5OQ5|1.40|2017|4K4|comp.2|O14757|SERINE/THREONINE-PROTEIN KINASE CHK1|7.7|Ki=0.0200uM|Ki|=|0.02|uM|20|nM
5UV5|3.00|2017|Y55|Ki=0.020+/-0.004uM, ligand is YLC2-155.|P03366|REVERSE TRANSCRIPTASE/RIBONUCLEASE H|7.7|Ki=0.020uM|Ki|=|0.02|uM|20|nM
5OPB|1.55|2017|A1N|comp.7|O14757|SERINE/THREONINE-PROTEIN KINASE CHK1|7.62|Ki=0.0241uM|Ki|=|0.0241|uM|24.1|nM
5UOV|1.33|2017|8FP|ligand is compound 4b|C8B467|HIV-1 PROTEASE|10.6|Ki=0.025nM|Ki|=|0.025|nM|0.025|nM
5OQ6|1.95|2017|4K4|comp.2|O14757|SERINE/THREONINE-PROTEIN KINASE CHK1|7.56|Ki=0.0277uM|Ki|=|0.0277|uM|27.7|nM
5OOT|2.10|2017|4K4|ligand is compound 2|O14757|SERINE/THREONINE-PROTEIN KINASE CHK1|7.55|Ki=0.0285uM|Ki|=|0.0285|uM|28.5|nM
5NEE|1.70|2017|8V5|ligand is compound 8|P00918|CARBONIC ANHYDRASE 2|10.7|Ki=0.02nM|Ki|=|0.02|nM|0.02|nM
5WB6|2.35|2017|9ZM|[Nonstandard assay: Temp 37] 14|P03951|COAGULATION FACTOR XI|10.7|Ki=0.02nM|Ki|=|0.02|nM|0.02|nM
5XP7|2.01|2017|8C6|kinase inhibition assay,|P00523|PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC|4.42|Ki=0.038mM|Ki|=|0.038|mM|38000|nM
5MIM|1.90|2017|1N|[Different ligand in assay: Ligand in binding assay is racemate.] comp.1|P09958|FURIN|7.34|Ki=0.046uM|Ki|=|0.046|uM|46|nM
5OPV|1.90|2017|A3H|comp.23|O14757|SERINE/THREONINE-PROTEIN KINASE CHK1|7.29|Ki=0.0515uM|Ki|=|0.0515|uM|51.5|nM
5OPU|1.55|2017|A3K|comp.22|O14757|SERINE/THREONINE-PROTEIN KINASE CHK1|7.28|Ki=0.0530uM|Ki|=|0.053|uM|53|nM
5NEA|1.30|2017|8V8|ligand is compound 7|P00918|CARBONIC ANHYDRASE 2|10.3|Ki=0.05nM|Ki|=|0.05|nM|0.05|nM
5WE9|1.80|2017|GY7|7b (SRI-29731); +/-0.01|C3W5S0|POLYMERASE ACIDIC PROTEIN|7.22|Ki=0.06uM|Ki|=|0.06|uM|60|nM
5MQY|1.13|2017|GH4|[Covalent complex] comp.35|P07711|CATHEPSIN L1|7.11|Ki=0.077uM|Ki|=|0.077|uM|77|nM
5LPD|1.50|2017|71U|compound 3|P00734|THROMBIN LIGHT CHAIN|10.15|Ki=0.07nM|Ki|=|0.07|nM|0.07|nM
5V82|1.89|2017|96Y|ligand is compound 19|P11309|SERINE/THREONINE-PROTEIN KINASE PIM-1|10.15|Ki=0.07nM|Ki|=|0.07|nM|0.07|nM
5HZ5|1.40|2017|65X|human FABP5 with compound 12|Q01469|FATTY ACID-BINDING PROTEIN|7.07|Ki=0.086uM|Ki|=|0.086|uM|86|nM
5IU6|2.51|2017|7HX|Ki = 0.13 +/- 0.04 mM|P0ABP8|PURINE NUCLEOSIDE PHOSPHORYLASE DEOD-TYPE|3.89|Ki=0.13mM|Ki|=|0.13|mM|130000|nM
5Q0F|2.12|2017|9FA|[Nonstandard assay: Temp 37] comp.14|P03951|COAGULATION FACTOR XI|9.89|Ki=0.13nM|Ki|=|0.13|nM|0.13|nM
5U6B|2.84|2017|7YS|Ki=0.13+/-0.01nM, ligand is compound 1.|P30530|TYROSINE-PROTEIN KINASE RECEPTOR UFO|9.89|Ki=0.13nM|Ki|=|0.13|nM|0.13|nM
5H4J|1.80|2017|FKM|[Nonstandard assay: Temp 37] ligand is TAS-114|P33316|DEOXYURIDINE 5'-TRIPHOSPHATE NUCLEOTIDOHYDROLASE|6.89|Ki=0.13uM|Ki|=|0.13|uM|130|nM
5VO2|2.96|2017|9FV|7;|Q12852|MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 12|6.81|Ki=0.154uM|Ki|=|0.154|uM|154|nM
5JZY|1.27|2017|6OV|compound 1|P00734|PROTHROMBIN|9.82|Ki=0.15nM|Ki|=|0.15|nM|0.15|nM
5W9G|2.10|2017|KU2|9k (SRI-30023);+/-0.003|C3W5S0|POLYMERASE ACIDIC PROTEIN|6.82|Ki=0.15uM|Ki|=|0.15|uM|150|nM
5WEV|1.85|2017|9ZS|compound 6- JAK2;|O60674|TYROSINE-PROTEIN KINASE JAK2|6.82|Ki=0.15uM|Ki|=|0.15|uM|150|nM
5TKU|2.12|2017|7DK|[Nonstandard assay: Temp 37] ligand is compound 16.|P03951|COAGULATION FACTOR XIA|9.8|Ki=0.16nM|Ki|=|0.16|nM|0.16|nM
5Q0G|2.60|2017|9F7|[Nonstandard assay: Temp 37] comp.20|P03951|COAGULATION FACTOR XI|9.74|Ki=0.18nM|Ki|=|0.18|nM|0.18|nM
5TDI|1.40|2017|7AS|[Covalent complex] [Nonstandard assay: PH=5.5] Ki=0.18+/-0.06nM, ligand is ODN.|P43235|CATHEPSIN K|9.74|Ki=0.18nM|Ki|=|0.18|nM|0.18|nM
5OP4|2.00|2017|A0T|ligand is compound 4a|O14757|SERINE/THREONINE-PROTEIN KINASE CHK1|6.71|Ki=0.194uM|Ki|=|0.194|uM|194|nM
5VB7|2.34|2017|921|ligand is compound 3|P51449|NUCLEAR RECEPTOR ROR-GAMMA|6.72|Ki=0.19uM|Ki|=|0.19|uM|190|nM
5G22|2.32|2017|YN4|26 (cyan carbons) in complex with PvNMT and non-hydrolizable MyrCoA|A5K1A2|GLYCYLPEPTIDE N-TETRADECANOYLTRANSFERASE|7.0|Ki=0.1uM|Ki|=|0.1|uM|100|nM
5N8V|1.55|2017|KZZ|PEX14-5|Q8IEW2|PEROXIN 14|6.68|Ki=0.207uM|Ki|=|0.207|uM|207|nM
5OP5|1.90|2017|3FE|ligand is compound 5|O14757|SERINE/THREONINE-PROTEIN KINASE CHK1|6.67|Ki=0.216uM|Ki|=|0.216|uM|216|nM
6B97|1.76|2017|CZY|ligand is compound 9|O00408|CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE|6.63|Ki=0.237uM|Ki|=|0.237|uM|237|nM
5OP2|1.90|2017|A0Q|comp.3b|O14757|SERINE/THREONINE-PROTEIN KINASE CHK1|6.62|Ki=0.240uM|Ki|=|0.24|uM|240|nM
5TQG|1.90|2017|7KS|[Different protein in assay: Protein in binding assay is TF/FVIIa.] ligand is compound 26.|P08709|COAGULATION FACTOR VIIA (HEAVY CHAIN)|9.62|Ki=0.24nM|Ki|=|0.24|nM|0.24|nM
5JFD|1.46|2017|2TS|compound 7|P00734|PROTHROMBIN|9.54|Ki=0.29nM|Ki|=|0.29|nM|0.29|nM
5M4Q|1.73|2017|PRO|Ki=0.31+/-0.04 mM; same as 5mby|P12955|XAA-PRO DIPEPTIDASE|3.51|Ki=0.31mM|Ki|=|0.31|mM|310000|nM
5MBY|1.55|2017|PRO|Ki=0.31+/-0.04 mM|P12955|XAA-PRO DIPEPTIDASE|3.51|Ki=0.31mM|Ki|=|0.31|mM|310000|nM
5T8O|2.41|2017|76Z|Ki=0.31+/-0.11uM, ligand is compound 3|Q9WUL6|MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 14|6.51|Ki=0.31uM|Ki|=|0.31|uM|310|nM
5OQ7|2.10|2017|A0Q|comp.3b|O14757|SERINE/THREONINE-PROTEIN KINASE CHK1|6.49|Ki=0.322uM|Ki|=|0.322|uM|322|nM
5UNF|2.80|2017|8ES|ligand is compound 1, crystal: monoclinic|P0ABE7|CHIMERA PROTEIN OF TYPE-2 ANGIOTENSIN II RECEPTOR|9.47|Ki=0.34nM|Ki|=|0.34|nM|0.34|nM
5UNG|2.80|2017|8ES|ligand is compound 1, crystal: orthorhombic|P0ABE7|CHIMERA PROTEIN OF TYPE-2 ANGIOTENSIN II RECEPTOR|9.47|Ki=0.34nM|Ki|=|0.34|nM|0.34|nM
6B4L|2.25|2017|CJY|ligand is compound 5|Q07820|INDUCED MYELOID LEUKEMIA CELL DIFFERENTIATION PROTEIN MCL|6.47|Ki=0.34uM|Ki|=|0.34|uM|340|nM
5UNH|2.90|2017|8EM|ligand is compound 2.|P0ABE7|SOLUBLE CYTOCHROME B562,TYPE-2 ANGIOTENSIN II RECEPTOR|9.46|Ki=0.35nM|Ki|=|0.35|nM|0.35|nM
5WEF|2.00|2017|GY6|mutant/inhibitor 7a (SRI-29770);+/-0.01|C3W5S0|POLYMERASE ACIDIC PROTEIN|6.44|Ki=0.36uM|Ki|=|0.36|uM|360|nM
5WAF|2.03|2017|A0Y|[Uncommon element] [Different ligand in assay: ligand in crystal is covalently bound phosphate ion] CR192|Q6DRA1|BETA-LACTAMASE|9.35|Ki=0.45nM|Ki|=|0.45|nM|0.45|nM
5HH6|1.80|2017|60N|inhibition assay, Ki=0.4+/-0.1uM|P52700|METALLO-BETA-LACTAMASE L1|6.4|Ki=0.4uM|Ki|=|0.4|uM|400|nM
5URA|1.85|2017|8KS|[Different ligand in assay: crystal:SBFI-26 as S enantiomer] ligand is SBFI- 26.|O15540|FATTY ACID-BINDING PROTEIN|6.4|Ki=0.4uM|Ki|=|0.4|uM|400|nM
5HH5|1.80|2017|60M|inhibition assay, Ki=0.5+/-0.1uM|P52700|METALLO-BETA-LACTAMASE L1|6.3|Ki=0.5uM|Ki|=|0.5|uM|500|nM
5UPZ|1.27|2017|8HD|ligand is compound 3b|C8B467|HIV-1 PROTEASE|9.2|Ki=0.63nM|Ki|=|0.63|nM|0.63|nM
5Q0E|2.12|2017|9FD|[Nonstandard assay: Temp 37] comp.8|P03951|COAGULATION FACTOR XI|9.16|Ki=0.69nM|Ki|=|0.69|nM|0.69|nM
5KNS|2.79|2017|3L7|[Nonstandard assay: MgCl2 12mM] Ki=0.75+/-0.04uM, ligand is compound 5|------|HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE|6.12|Ki=0.75uM|Ki|=|0.75|uM|750|nM
5KNX|2.40|2017|6WC|[Nonstandard assay: MgCl2 12mM] Ki=0.8+/-0.08uM, ligand is compound 7|------|HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE|6.1|Ki=0.8uM|Ki|=|0.8|uM|800|nM
5M7S|2.40|2017|NHT|Thiamet-G|O60502|PROTEIN O-GLCNACASE|9.05|Ki=0.9nM|Ki|=|0.9|nM|0.9|nM
5UR9|2.20|2017|8KS|[Different ligand in assay: crystal:SBFI-26 as S enantiomer] ligand is SBFI- 26.|Q01469|FATTY ACID-BINDING PROTEIN|6.05|Ki=0.9uM|Ki|=|0.9|uM|900|nM
5VP9|1.86|2017|9H7|18f/WT NS3 4A; +/- 0.13|A8DG50|NS3/4A PROTEASE|8.99|Ki=1.03nM|Ki|=|1.03|nM|1.03|nM
5Q0D|2.12|2017|9EY|[Nonstandard assay: Temp 37] comp.1|P03951|COAGULATION FACTOR XI|9.0|Ki=1.0nM|Ki|=|1|nM|1|nM
5UW5|2.94|2017|19-mer|Ki=1.10+/-0.22uM, ligand is presegetalin A1 [14-32].|R4P353|PEPTIDE CYCLASE 1|5.96|Ki=1.10uM|Ki|=|1.1|uM|1100|nM
5WQC|1.96|2017|7MA|OX2R-EMPA (cryocooled crystal structur/Synchrotron)|O43614|OREXIN RECEPTOR TYPE 2,GLGA GLYCOGEN SYNTHASE,OREXIN|8.96|Ki=1.1nM|Ki|=|1.1|nM|1.1|nM
5WS3|2.30|2017|7MA|[Different protein in assay: Protein in binding assay is human] ligand is EMPA; same as 5wqc|O43614|OREXIN RECEPTOR TYPE 2,GLGA GLYCOGEN SYNTHASE,OREXIN|8.96|Ki=1.1nM|Ki|=|1.1|nM|1.1|nM
5HH4|2.00|2017|60M|inhibition assay, Ki=1.1+/-0.2uM|P52699|BETA-LACTAMASE IMP-1|5.96|Ki=1.1uM|Ki|=|1.1|uM|1100|nM
5M23|1.97|2017|7DC|+/-0.36, peptidomimetic 7 trans|P61964|WD REPEAT-CONTAINING PROTEIN 5|8.9|Ki=1.25nM|Ki|=|1.25|nM|1.25|nM
5T8P|2.32|2017|774|Ki=1.28+/-0.3uM, ligand is compound 2|Q9WUL6|MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 14|5.89|Ki=1.28uM|Ki|=|1.28|uM|1280|nM
5LJT|1.00|2017|A6N|hCAII/compound13|P00918|CARBONIC ANHYDRASE 2|8.92|Ki=1.2nM|Ki|=|1.2|nM|1.2|nM
5N24|1.50|2017|8HE|ligand is compound 1|P00918|CARBONIC ANHYDRASE 2|8.92|Ki=1.2nM|Ki|=|1.2|nM|1.2|nM
5OQ8|2.00|2017|A0Q|ligand is compound 3b|O14757|SERINE/THREONINE-PROTEIN KINASE CHK1|5.85|Ki=1.41uM|Ki|=|1.41|uM|1410|nM
5X5G|2.00|2017|OP0|[Covalent complex] Ki=1.49+/-0.05uM, enzyme kinetic assay|------|BETA-LACTAMASE|5.83|Ki=1.49uM|Ki|=|1.49|uM|1490|nM
5MLJ|1.80|2017|9ST|complex is GCN5 / (R,R)-32|Q92830|HISTONE ACETYLTRANSFERASE KAT2A|8.85|Ki=1.4nM|Ki|=|1.4|nM|1.4|nM
5UOO|1.69|2017|8FV|Ki=1.4+/-0.4nM, ligand is compound 31|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|8.85|Ki=1.4nM|Ki|=|1.4|nM|1.4|nM
5KNR|2.86|2017|3L5|[Nonstandard assay: MgCl2 12mM] Ki=1.4+/-0.2uM, ligand is compound 6|------|HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE|5.85|Ki=1.4uM|Ki|=|1.4|uM|1400|nM
5NDF|2.30|2017|LU2|+/-0.05 Luteolin|Q10471|POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 2|5.85|Ki=1.4uM|Ki|=|1.4|uM|1400|nM
5UEX|2.29|2017|89D|Ki=1.5+/-0.2nM, ligand is compound 61a.|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|8.82|Ki=1.5nM|Ki|=|1.5|nM|1.5|nM
5KYK|2.70|2017|6ZD|[Covalent complex] KRAS G12C-Compound 47|P01116|GTPASE KRAS|5.8|Ki=1.6uM|Ki|=|1.6|uM|1600|nM
5W3I|1.95|2017|GY5|inhibitor 6e (SRI-29685)|C3W5S0|POLYMERASE ACIDIC PROTEIN|5.8|Ki=1.6uM|Ki|=|1.6|uM|1600|nM
5GWA|1.59|2017|NXL|[Covalent complex] Ki = 1.71 +/- 0.10uM; The compound is a covalent inhibitor and reacts with S47 residue|------|BETA-LACTAMASE|5.77|Ki=1.71uM|Ki|=|1.71|uM|1710|nM
5VKC|2.31|2017|9EA|ligand is compound 33|Q07820|INDUCED MYELOID LEUKEMIA CELL DIFFERENTIATION PROTEIN MCL|8.74|Ki=1.8nM|Ki|=|1.8|nM|1.8|nM
5N1S|1.30|2017|8GE|lgiand is compound 4|P00918|CARBONIC ANHYDRASE 2|7.99|Ki=10.2nM|Ki|=|10.2|nM|10.2|nM
5V8P|2.50|2017|90G|[Nonstandard assay: Temp 37] ligand is ABS-143.|P10845|BOTULINUM NEUROTOXIN A|4.99|Ki=10.2uM|Ki|=|10.2|uM|10200|nM
6EO8|1.94|2017|2FN|ligand is compound 3|P00734|PROTHROMBIN|7.0|Ki=100nM|Ki|=|100|nM|100|nM
5G2B|1.83|2017|LQY|pKi = 7, ligand is compound NPD-008(8)|Q8WQX9|CLASS 1 PHOSPHODIESTERASE PDEB1|7.0|Ki=100nM|Ki|=|100|nM|100|nM
5WCM|1.20|2017|4NZ||Q89GW5|BLR6230 PROTEIN|4.0|Ki=100uM|Ki|=|100|uM|100000|nM
5N1R|1.30|2017|8GH|lgiand is compound 2|P00918|CARBONIC ANHYDRASE 2|7.95|Ki=11.1nM|Ki|=|11.1|nM|11.1|nM
5UIG|3.50|2017|8D1|ligand is cmpd-1, pKi=7.95+/-0.06|P29274|ADENOSINE RECEPTOR A2A,SOLUBLE CYTOCHROME B562,ADENOSINE|7.95|Ki=11.2nM|Ki|=|11.2|nM|11.2|nM
5GWY|2.85|2017|PRD|[Covalent complex] Ki=11.3+/-1.0uM|P0C6U6|MAIN PROTEASE|4.95|Ki=11.3uM|Ki|=|11.3|uM|11300|nM
6EN5|1.75|2017|BJ2|N-domain of ACE bound to 16; Ki=11.45+/-1.37nM|P12821|ANGIOTENSIN-CONVERTING ENZYME|7.94|Ki=11.45nM|Ki|=|11.45|nM|11.45|nM
5QCM|2.20|2017|BVJ|[Nonstandard assay: Temp 37] comp.21|P03951|COAGULATION FACTOR XI|6.96|Ki=110nM|Ki|=|110|nM|110|nM
5VTB|2.40|2017|15-mer|Ki=(BCL11A2-16)=110nM, Ki(BCL11A2-12)=268nM|Q09028|HISTONE-BINDING PROTEIN RBBP4|6.96|Ki=110nM|Ki|=|110|nM|110|nM
5QCL|2.11|2017|BUY|[Nonstandard assay: Temp 37] comp.6|P03951|COAGULATION FACTOR XI|7.96|Ki=11nM|Ki|=|11|nM|11|nM
5U8F|1.34|2017|82G|[Different protein in assay: crystal: EED residues D77 to 441, binding assay: full length] ligand is compound 15.|O75530|POLYCOMB PROTEIN EED|7.96|Ki=11nM|Ki|=|11|nM|11|nM
5L8A|1.57|2017|6RB|PEX14-3|Q8IEW2|PEROXIN 14|4.91|Ki=12.3uM|Ki|=|12.3|uM|12300|nM
5JHA|2.51|2017|6K7|p110 gamma PIKiN2|P48736|PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE|5.9|Ki=1264nM|Ki|=|1264|nM|1264|nM
5Q0H|2.50|2017|9F1|[Nonstandard assay: Temp 37] comp.28|P03951|COAGULATION FACTOR XI|7.92|Ki=12nM|Ki|=|12|nM|12|nM
5KNV|2.86|2017|6W9|[Nonstandard assay: MgCl2 12mM] Ki=13.4+/-1.0uM, ligand is compound 3|------|HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE|4.87|Ki=13.4uM|Ki|=|13.4|uM|13400|nM
5UWN|3.20|2017|8O7|Ki=13.5+/-3.7nM, ligand is compound 10d|P45452|COLLAGENASE 3|7.87|Ki=13.5nM|Ki|=|13.5|nM|13.5|nM
5NIH|1.30|2017|8VE|+/-43, LM-12b|P19491|GLUTAMATE RECEPTOR 2|6.87|Ki=134nM|Ki|=|134|nM|134|nM
5THJ|1.50|2017|0TR|Ki=1350+/-40uM, ligand is Tropolone.|P00918|CARBONIC ANHYDRASE 2|2.87|Ki=1350uM|Ki|=|1350|uM|1350000|nM
5HVU|2.80|2017|65R|ligand is comound 30|Q13464|RHO-ASSOCIATED PROTEIN KINASE 1|7.89|Ki=13nM|Ki|=|13|nM|13|nM
5M4F|1.52|2017|7FC|[Different protein in assay: Protein in binding assay is CK2alpha2beta2] FLC21|P68400|CASEIN KINASE II, ALPHA SUBUNIT|7.89|Ki=13nM|Ki|=|13|nM|13|nM
5M4I|2.22|2017|7FC|[Different protein in assay: Protein in binding assay is CK2alpha2beta2] FLC21|P68400|CASEIN KINASE II, ALPHA SUBUNIT|7.89|Ki=13nM|Ki|=|13|nM|13|nM
5M56|2.24|2017|7FC|[Different protein in assay: Protein in binding assay is CK2alpha2beta2] FLC21|P19784|CASEIN KINASE II SUBUNIT ALPHA|7.89|Ki=13nM|Ki|=|13|nM|13|nM
5U8A|1.45|2017|82D|[Different protein in assay: crystal: EED residues D77 to 441, binding assay: full length] ligand is compound 10.|O75530|POLYCOMB PROTEIN EED|7.89|Ki=13nM|Ki|=|13|nM|13|nM
5UGC|1.58|2017|8BS|[Covalent complex] [Different protein in assay: protein in crystal is L858R, T790M, V948R mutant.] ligand is compound 21.|P00533|EPIDERMAL GROWTH FACTOR RECEPTOR|7.89|Ki=13nM|Ki|=|13|nM|13|nM
5M4U|2.20|2017|7FC|[Different protein in assay: Protein in binding assay is CK2alpha2beta2] FLC21|P19784|CASEIN KINASE II SUBUNIT ALPHA|4.89|Ki=13uM|Ki|=|13|uM|13000|nM
5ULN|1.35|2017|8JS|ligand is compound 22(S)|P00918|CARBONIC ANHYDRASE 2|7.85|Ki=14.2nM|Ki|=|14.2|nM|14.2|nM
6B96|1.88|2017|CZV|ligand is compound 16|O00408|CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE|7.84|Ki=14.3nM|Ki|=|14.3|nM|14.3|nM
5VJP|1.98|2017|IR9|Ki=14.9+/-2.9uM, ligand is L-DIAB|P49435|ADENINE PHOSPHORIBOSYLTRANSFERASE 1|4.83|Ki=14.9uM|Ki|=|14.9|uM|14900|nM
5TH4|1.47|2017|BEW|Ki=1420+/-30uM, ligand is 1,2-HOPTO.|P00918|CARBONIC ANHYDRASE 2|2.85|Ki=1420uM|Ki|=|1420|uM|1420000|nM
5MAE|1.00|2017|7KN|comp.23|P07711|CATHEPSIN L1|6.84|Ki=146nM|Ki|=|146|nM|146|nM
5NF5|2.85|2017|8VN|+/-31, CIP-AS|P22756|GLUTAMATE RECEPTOR, IONOTROPIC KAINATE 1|6.82|Ki=152nM|Ki|=|152|nM|152|nM
5MHP|2.43|2017|7NB|[Nonstandard assay: Temp 37] comp.11|Q13822|ECTONUCLEOTIDE PYROPHOSPHATASE/PHOSPHODIESTERASE|7.82|Ki=15nM|Ki|=|15|nM|15|nM
5K1F|1.94|2017|IMP|ligand is IMP|Q99QC1|BETA-LACTAMASE|4.79|Ki=16.2uM|Ki|=|16.2|uM|16200|nM
5OBJ|2.90|2017|9QK|comp.2|O14965|AURORA KINASE A|4.78|Ki=16.5uM|Ki|=|16.5|uM|16500|nM
5N25|1.40|2017|8HK|ligand is compound 3|P00918|CARBONIC ANHYDRASE 2|7.78|Ki=16.6nM|Ki|=|16.6|nM|16.6|nM
5UEU|2.26|2017|0S6|ligand is compound 2a|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|7.78|Ki=16.7nM|Ki|=|16.7|nM|16.7|nM
6EO9|1.84|2017|2OJ|ligand is compound 2|P00734|PROTHROMBIN|6.8|Ki=160nM|Ki|=|160|nM|160|nM
5WAE|1.80|2017|A1J|[Uncommon element] [Different ligand in assay: ligand in crystal is covalently bound phosphate ion] CR167|Q6DRA1|BETA-LACTAMASE|6.8|Ki=160nM|Ki|=|160|nM|160|nM
5UF0|1.35|2017|89J|ligand is fragment 1|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|3.8|Ki=160uM|Ki|=|160|uM|160000|nM
5UGA|1.82|2017|8BM|[Different protein in assay: protein in crystal is L858R, T790M, V948R mutant.] ligand is compound 18.|P00533|EPIDERMAL GROWTH FACTOR RECEPTOR|6.79|Ki=161nM|Ki|=|161|nM|161|nM
5UGB|2.53|2017|8BM|ligand is compound 18.|P00533|EPIDERMAL GROWTH FACTOR RECEPTOR|6.79|Ki=161nM|Ki|=|161|nM|161|nM
5MTE|1.40|2017|BB2|[Nonstandard assay: Temp 37] +/-10, arabinose|Q6VT21|PUTATIVE UNCHARACTERIZED PROTEIN ORF60T|6.78|Ki=167nM|Ki|=|167|nM|167|nM
5NEB|2.05|2017|8VE|+/-5, LM-12b|P22756|GLUTAMATE RECEPTOR, IONOTROPIC KAINATE 1|7.77|Ki=17nM|Ki|=|17|nM|17|nM
5MKR|1.87|2017|TI8|ligand is compound 8|P0DMV8|HEAT SHOCK 70 KDA PROTEIN 1A|4.77|Ki=17uM|Ki|=|17|uM|17000|nM
5MKS|1.99|2017|TI8|ligand is compound 8|P0DMV8|HEAT SHOCK 70 KDA PROTEIN 1A|4.77|Ki=17uM|Ki|=|17|uM|17000|nM
5NFH|2.80|2017|8W2|[Different protein in assay: Protein in binding assay is LdMetRS] DDD806905|Q38C91|METHIONYL-TRNA SYNTHETASE|7.74|Ki=18nM|Ki|=|18|nM|18|nM
5GWZ|2.44|2017|6-mer|[Covalent complex] compound 1 bound to PEDV Mpro|P0C6V6|PEDV MAIN PROTEASE|4.71|Ki=19.4uM|Ki|=|19.4|uM|19400|nM
5TQE|1.90|2017|7KQ|[Different protein in assay: Protein in binding assay is TF/FVIIa.] ligand is compound 4.|P08709|COAGULATION FACTOR VIIA (HEAVY CHAIN)|6.72|Ki=190nM|Ki|=|190|nM|190|nM
5NG9|1.15|2017|8VN|+/-50, CIP-AS|P19491|GLUTAMATE RECEPTOR 2|6.72|Ki=191nM|Ki|=|191|nM|191|nM
5TT3|2.20|2017|EZL|ligand is EZA|K4NGD4|ALPHA-CARBONIC ANHYDRASE|6.71|Ki=193nM|Ki|=|193|nM|193|nM
5LJQ|1.05|2017|ANV|hCAII/compound3|P00918|CARBONIC ANHYDRASE 2|9.0|Ki=1nM|Ki|=|1|nM|1|nM
6AWO|3.53|2017|SRE|ligand is Sertraline,Ki=2.0+/-0.2nM,ligand in binding assay is possitive,in PDB is neutral|P31645|SODIUM-DEPENDENT SEROTONIN TRANSPORTER|8.7|Ki=2.0nM|Ki|=|2|nM|2|nM
5M4K|2.60|2017|7F9|comp.10|Q15119|PYRUVATE DEHYDROGENASE (ACETYL-TRANSFERRING) KINASE|5.66|Ki=2.17uM|Ki|=|2.17|uM|2170|nM
5UWK|1.60|2017|8OM|ligand is compound (S)-10a|P45452|COLLAGENASE 3|8.64|Ki=2.3nM|Ki|=|2.3|nM|2.3|nM
5IZ8|3.06|2017|9-mer|Ki(FP)=2.41+/-0.88uM|P25054|ADENOMATOUS POLYPOSIS COLI PROTEIN|5.62|Ki=2.41uM|Ki|=|2.41|uM|2410|nM
5UV1|2.40|2017|0FV|Ki=2.4+/-0.5uM, ligand is FGPP.|------|(+)-LIMONENE SYNTHASE|5.62|Ki=2.4uM|Ki|=|2.4|uM|2400|nM
5OPR|1.95|2017|A3E|comp.8|O14757|SERINE/THREONINE-PROTEIN KINASE CHK1|5.59|Ki=2.56uM|Ki|=|2.56|uM|2560|nM
5UPF|1.69|2017|8HV|ligand is compound 53|P43490|NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE|8.6|Ki=2.5nM|Ki|=|2.5|nM|2.5|nM
5OSK|2.11|2017|A9Q|+/-0.1, comp.7j|P81947|TUBULIN ALPHA-1B CHAIN|5.6|Ki=2.5uM|Ki|=|2.5|uM|2500|nM
5U6D|1.64|2017|7XG|[Different protein in assay: crystal: EED residues D77 to 441, binding assay: full length] ligand is compound 35.|O75530|POLYCOMB PROTEIN EED|8.59|Ki=2.6nM|Ki|=|2.6|nM|2.6|nM
6ESY|2.80|2017|TFX|thioflavin T/hBChE;+/- 0.5|P06276|CHOLINESTERASE|5.59|Ki=2.6uM|Ki|=|2.6|uM|2600|nM
5V4Q|2.20|2017|8WY|[Covalent complex] [Nonstandard assay: Temp 37] [Different ligand in assay: ] Ki=2.7+/-0.7mM, ligand is DON.|P19440|GAMMA-GLUTAMYLTRANSPEPTIDASE 1 HEAVY CHAIN|2.57|Ki=2.7mM|Ki|=|2.7|mM|2700000|nM
5KNU|2.81|2017|6WA|[Nonstandard assay: MgCl2 12mM] Ki=2.8+/-0.3uM, ligand is compound 8|------|HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE|5.55|Ki=2.8uM|Ki|=|2.8|uM|2800|nM
5MJN|1.17|2017|7O8|ligand is compound 17|P00918|CARBONIC ANHYDRASE 2|8.54|Ki=2.9nM|Ki|=|2.9|nM|2.9|nM
5K1D|1.94|2017|5GP|ligand is GMP|Q99QC1|BETA-LACTAMASE|4.68|Ki=20.8uM|Ki|=|20.8|uM|20800|nM
5O4F|2.10|2017|8VE|+/-55, LM-12b|P42264|GLUTAMATE RECEPTOR, IONOTROPIC KAINATE 3|6.68|Ki=208nM|Ki|=|208|nM|208|nM
5Y7W|2.25|2017|16-mer|yl-2 and NCOA1 complex;+/- 4|P70365|NUCLEAR RECEPTOR COACTIVATOR 1|7.7|Ki=20nM|Ki|=|20|nM|20|nM
5UN9|2.50|2017|NHT|[Nonstandard assay: Temp 37] ligand is thiamet-G.|O60502|PROTEIN O-GLCNACASE|7.68|Ki=21nM|Ki|=|21|nM|21|nM
6B4U|1.95|2017|CN7|ligand is compound 14; Ki=21+/-7.9nM|Q07820|INDUCED MYELOID LEUKEMIA CELL DIFFERENTIATION PROTEIN MCL|7.68|Ki=21nM|Ki|=|21|nM|21|nM
6B98|1.97|2017|D07|ligand is compound 1|O00408|CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE|4.65|Ki=22.4uM|Ki|=|22.4|uM|22400|nM
5W13|1.95|2017|SM2|[Uncommon element] SM23;+/- 2|Q6DRA1|BETA-LACTAMASE|7.66|Ki=22nM|Ki|=|22|nM|22|nM
5IEZ|2.60|2017|6AL|ligand is compound 2|Q07820|INDUCED MYELOID LEUKEMIA CELL DIFFERENTIATION PROTEIN MCL|7.64|Ki=23nM|Ki|=|23|nM|23|nM
5QCK|2.64|2017|BUV|[Nonstandard assay: Temp 37] comp.4|P03951|COAGULATION FACTOR XI|7.64|Ki=23nM|Ki|=|23|nM|23|nM
5U6J|2.30|2017|82J|ligand is compound 14|P08709|COAGULATION FACTOR VII|7.64|Ki=23nM|Ki|=|23|nM|23|nM
5VIJ|2.11|2017|5DX|ligand is ST1|P35439|GLUTAMATE RECEPTOR IONOTROPIC, NMDA 1|7.61|Ki=24.3nM|Ki|=|24.3|nM|24.3|nM
5THI|1.50|2017|0TR|Ki=245+/-14uM, ligand is Tropolone.|P00918|CARBONIC ANHYDRASE 2|3.61|Ki=245uM|Ki|=|245|uM|245000|nM
6B4N|1.30|2017|G53|inhibitor 3g (GRL-5311) with wild-type HIV-1 protease|Q6QK01|HIV-1 PROTEASE|10.55|Ki=27.9pM|Ki|=|27.9|pM|0.027899999999999998|nM
5TG6|1.78|2017|J4W|[Covalent complex] [Uncommon element] ligand is BA4.|Q8RLA6|BETA-LACTAMASE|4.55|Ki=28.3uM|Ki|=|28.3|uM|28300|nM
5U8C|1.60|2017|84J|Ki=29.58+/-0.24nM; ligand is NVP-AAM077|P35439|GLUTAMATE RECEPTOR IONOTROPIC, NMDA 1|7.53|Ki=29.58nM|Ki|=|29.58|nM|29.58|nM
5TG7|2.28|2017|JW3|[Covalent complex] [Uncommon element] ligand is BA3.|Q8RLA6|BETA-LACTAMASE|4.53|Ki=29.8uM|Ki|=|29.8|uM|29800|nM
5KKS|3.30|2017|6U1|Ligand is compound 28|Q13464|RHO-ASSOCIATED PROTEIN KINASE 1|8.7|Ki=2nM|Ki|=|2|nM|2|nM
5UG8|1.46|2017|8BP|[Covalent complex] [Different protein in assay: protein in crystal is L858R, T790M, V948R mutant.] ligand is compound 7.|P00533|EPIDERMAL GROWTH FACTOR RECEPTOR|8.7|Ki=2nM|Ki|=|2|nM|2|nM
5WEI|2.25|2017|GY6|E119D mutant/inhibitor 7a (SRI-29770); +/-2|C3W5S0|POLYMERASE ACIDIC PROTEIN|5.7|Ki=2uM|Ki|=|2|uM|2000|nM
5IZA|1.50|2017|9-mer|Ki(FP)=3.12+/-0.70uM|P25054|ADENOMATOUS POLYPOSIS COLI PROTEIN|5.51|Ki=3.12uM|Ki|=|3.12|uM|3120|nM
5NX2|3.70|2017|10-mer|[Different protein in assay: Protein in binding assay is WT] Peptide 5|P43220|GLUCAGON-LIKE PEPTIDE 1 RECEPTOR|8.49|Ki=3.2nM|Ki|=|3.2|nM|3.2|nM
5TKT|2.12|2017|7DS|[Nonstandard assay: Temp 37] ligand is compound 13.|P03951|COAGULATION FACTOR XIA|8.49|Ki=3.2nM|Ki|=|3.2|nM|3.2|nM
5UFS|2.12|2017|1TA|ligand is TA|------|ANCESTRAL GLUCOCORTICOID RECEPTOR2|8.49|Ki=3.2nM|Ki|=|3.2|nM|3.2|nM
5N0D|1.70|2017|8F2|ligand is compound 30a|P00918|CARBONIC ANHYDRASE 2|8.48|Ki=3.3nM|Ki|=|3.3|nM|3.3|nM
5NN5|2.00|2017|NOJ|DNJ|P10253|LYSOSOMAL ALPHA-GLUCOSIDASE|5.47|Ki=3.4uM|Ki|=|3.4|uM|3400|nM
5TP0|1.25|2017|BRN|Ki=3.66+/-0.08uM; ligand is diminazene|P35030|TRYPSIN-3|5.44|Ki=3.66uM|Ki|=|3.66|uM|3660|nM
5N0E|1.75|2017|8F3|compound 30b|P00918|CARBONIC ANHYDRASE 2|8.44|Ki=3.6nM|Ki|=|3.6|nM|3.6|nM
5VOJ|1.80|2017|9H4|19b/WT NS3 4A; +/- 0.04|A8DG50|NS3/4A PROTEASE|8.44|Ki=3.6nM|Ki|=|3.6|nM|3.6|nM
5IZ9|2.93|2017|9-mer|Ki(FP)=3.80+/-0.72uM|P25054|ADENOMATOUS POLYPOSIS COLI PROTEIN|5.42|Ki=3.80uM|Ki|=|3.8|uM|3800|nM
5G57|1.73|2017|6M5|pKi = 8.4, ligand is compound NPD-001(1)|Q8WQX9|PHOSPHODIESTERASE B1|8.4|Ki=3.98nM|Ki|=|3.98|nM|3.98|nM
5M7T|2.60|2017|GDV|PugNAc-imidazole|O60502|PROTEIN O-GLCNACASE|5.41|Ki=3.9uM|Ki|=|3.9|uM|3900|nM
6F3F|2.42|2017|ADP|[Different protein in assay: Protein in binding assay is SrcdeltaC] Src in complex with ADP;+/-8|Q3UKD6|TYROSINE-PROTEIN KINASE|4.52|Ki=30uM|Ki|=|30|uM|30000|nM
5TT8|2.40|2017|D8W|ligand is BZA.|K4NGD4|ALPHA-CARBONIC ANHYDRASE|6.5|Ki=315nM|Ki|=|315|nM|315|nM
5VIH|2.40|2017|5DZ|ligand is ST6|P35439|GLUTAMATE RECEPTOR IONOTROPIC, NMDA 1|7.49|Ki=32.2nM|Ki|=|32.2|nM|32.2|nM
5TUO|2.50|2017|1SA|ligand is compound 1|K4NGD4|ALPHA-CARBONIC ANHYDRASE|6.49|Ki=323nM|Ki|=|323|nM|323|nM
6B16|2.29|2017|C7Y|compound 5;|Q13153|SERINE/THREONINE-PROTEIN KINASE PAK 1|7.49|Ki=32nM|Ki|=|32|nM|32|nM
5T19|2.10|2017|73U|ligand is compound 5b|P18031|TYROSINE-PROTEIN PHOSPHATASE, NON-RECEPTOR TYPE 1|4.49|Ki=32uM|Ki|=|32|uM|32000|nM
5O07|1.80|2017|1VQ|ligand is compound 3|P00918|CARBONIC ANHYDRASE 2|7.47|Ki=33.8nM|Ki|=|33.8|nM|33.8|nM
5MFS|1.57|2017|7ML|[Incomplete ligand] +/-40, I2|P04825|AMINOPEPTIDASE N|6.48|Ki=330nM|Ki|=|330|nM|330|nM
5MFT|1.59|2017|7MF|[Incomplete ligand] +/-7, I3|P04825|AMINOPEPTIDASE N|7.47|Ki=34nM|Ki|=|34|nM|34|nM
5MAJ|1.00|2017|7KH|com.30|P07711|CATHEPSIN L1|7.46|Ki=35nM|Ki|=|35|nM|35|nM
5NF6|2.55|2017|8VN|+/-7, CIP-AS|P42264|GLUTAMATE RECEPTOR, IONOTROPIC KAINATE 3|7.46|Ki=35nM|Ki|=|35|nM|35|nM
5DPX|1.85|2017|L3B||P52700|METALLO-BETA-LACTAMASE L1|4.46|Ki=35uM|Ki|=|35|uM|35000|nM
5KNT|2.55|2017|6WB|[Nonstandard assay: MgCl2 12mM] Ki=37+/-2uM, ligand is compound 1|------|HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE|4.43|Ki=37uM|Ki|=|37|uM|37000|nM
5WAC|2.06|2017|A1M|[Uncommon element] [Different ligand in assay: ligand in crystal is covalently bound phosphate ion] CR157|Q6DRA1|BETA-LACTAMASE|7.42|Ki=38nM|Ki|=|38|nM|38|nM
5UV2|2.20|2017|LA6|Ki=39.5+/-5.2uM; ligand is FNPP|------|(+)-LIMONENE SYNTHASE|4.4|Ki=39.5uM|Ki|=|39.5|uM|39500|nM
5UFI|2.58|2017|8B1|ligand is DI-591|Q96GG9|DCN1-LIKE PROTEIN 1|8.4|Ki=4.0nM|Ki|=|4|nM|4|nM
5M2V|3.18|2017|7E5|comp.1b|P22756|GLUTAMATE RECEPTOR, IONOTROPIC KAINATE 1|5.4|Ki=4.0uM|Ki|=|4|uM|4000|nM
5OBR|2.62|2017|9QT|comp.5|O14965|AURORA KINASE A|5.36|Ki=4.4uM|Ki|=|4.4|uM|4400|nM
6EP4|2.30|2017|DME|decamethonium/hBChE; +/-0.2uM|P06276|CHOLINESTERASE|5.35|Ki=4.5uM|Ki|=|4.5|uM|4500|nM
5G1Z|1.50|2017|U53|quinoline 1 in a ternary complex with P. vivax NMT and S-(2- oxo)pentadecylCoA (NHM)|A5K1A2|GLYCYLPEPTIDE N-TETRADECANOYLTRANSFERASE|5.32|Ki=4.74uM|Ki|=|4.74|uM|4740|nM
5M44|2.71|2017|7EY|[Different protein in assay: Protein in binding assay is CK2alpha2beta2] TTP22|P68400|CASEIN KINASE II, ALPHA SUBUNIT|7.4|Ki=40nM|Ki|=|40|nM|40|nM
5M4C|1.94|2017|7EY|[Different protein in assay: Protein in binding assay is CK2alpha2beta2] TTP22|P68400|CASEIN KINASE II, ALPHA SUBUNIT|7.4|Ki=40nM|Ki|=|40|nM|40|nM
6EQU|1.65|2017|BVE|hCA II/2|P00918|CARBONIC ANHYDRASE 2|6.38|Ki=419nM|Ki|=|419|nM|419|nM
5VT4|3.21|2017|9KJ|compound 5;+/- 4|Q9L1K2|ALPHA-1,4-GLUCAN:MALTOSE-1-PHOSPHATE MALTOSYLTRANSFERASE 1|4.35|Ki=45uM|Ki|=|45|uM|45000|nM
5W14|1.88|2017|9TJ|[Uncommon element] 3c;+/- 3|Q6DRA1|BETA-LACTAMASE|7.34|Ki=46nM|Ki|=|46|nM|46|nM
5TG4|1.44|2017|JW1|[Covalent complex] [Uncommon element] ligand is BA16! not BA3!|Q8RLA6|BETA-LACTAMASE|3.32|Ki=475uM|Ki|=|475|uM|475000|nM
5UEY|2.41|2017|88M|Ki=5.1+/-0.1nM, ligand is compound 25e.|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|8.29|Ki=5.1nM|Ki|=|5.1|nM|5.1|nM
5MFR|1.40|2017|7MK|[Incomplete ligand] +/-3000, I1|P04825|AMINOPEPTIDASE N|4.3|Ki=50000nM|Ki|=|50000|nM|50000|nM
5VII|1.95|2017|5DY|ST3|P35439|GLUTAMATE RECEPTOR IONOTROPIC, NMDA 1|7.29|Ki=51.8nM|Ki|=|51.8|nM|51.8|nM
5WZR|2.79|2017|DJN|Gal-NHAc-DNJ|G5ELM1|ALPHA-N-ACETYLGALACTOSAMINIDASE|7.29|Ki=51nM|Ki|=|51|nM|51|nM
5W12|1.88|2017|9TG|[Uncommon element] EC04|Q6DRA1|BETA-LACTAMASE|7.28|Ki=53nM|Ki|=|53|nM|53|nM
5V6U|2.80|2017|8YM|Ki=5470+/-398uM, ligand is compound 1, Ac-DEVD-AFC cleavage assays|P55210|CASPASE-7 (CASP-7)|2.26|Ki=5470uM|Ki|=|5470|uM|5470000|nM
5OM9|1.80|2017|O2S|[Covalent complex] [Nonstandard assay: Temp 37, NaCl=500 mM] +/-5, comp.11|P15085|CARBOXYPEPTIDASE A1|4.25|Ki=56uM|Ki|=|56|uM|56000|nM
5M25|2.43|2017|7DU|+/-0.36, peptidomimetic 7 cis|P61964|WD REPEAT-CONTAINING PROTEIN 5|8.19|Ki=6.50nM|Ki|=|6.5|nM|6.5|nM
5TFX|1.50|2017|7B1|ligand is compound 13|P00918|CARBONIC ANHYDRASE 2|7.22|Ki=60.9nM|Ki|=|60.9|nM|60.9|nM
5U69|1.28|2017|LQD|[Different protein in assay: crystal: EED residues D77 to 441, binding assay: full length] ligand is compound 1.|O75530|POLYCOMB PROTEIN EED|6.22|Ki=600nM|Ki|=|600|nM|600|nM
5WAG|1.93|2017|A0V|[Uncommon element] [Different ligand in assay: ligand in crystal is covalently bound phosphate ion] S06017|Q6DRA1|BETA-LACTAMASE|5.21|Ki=6110nM|Ki|=|6110|nM|6110|nM
5TI0|1.42|2017|7CZ|Ki=61+/-5uM, ligand is Thiotropolone.|P00918|CARBONIC ANHYDRASE 2|4.21|Ki=61uM|Ki|=|61|uM|61000|nM
5OFU|2.62|2017|AMP|[Nonstandard assay: Temp 37]|O97193|FBP PROTEIN|4.2|Ki=63.8uM|Ki|=|63.8|uM|63800|nM
5U94|2.20|2017|G93|kinase assay, Ki=64+/-23nM|P9WI81|SERINE/THREONINE-PROTEIN KINASE PKNB|7.19|Ki=64nM|Ki|=|64|nM|64|nM
5WEX|1.26|2017|8JS|ligand is compound 10(Se)|P00918|CARBONIC ANHYDRASE 2|7.18|Ki=66.3nM|Ki|=|66.3|nM|66.3|nM
5V0N|2.16|2017|8W4|ligand is compound 5g|P56817|BETA-SECRETASE 1|7.17|Ki=67.1nM|Ki|=|67.1|nM|67.1|nM
5TKS|1.55|2017|7DL|[Nonstandard assay: Temp 37] ligand is compound 9.|P03951|COAGULATION FACTOR XI|7.17|Ki=68nM|Ki|=|68|nM|68|nM
5M0M|2.10|2017|7CF|+/-2, comp.17|Q64610|ECTONUCLEOTIDE PYROPHOSPHATASE/PHOSPHODIESTERASE|8.22|Ki=6nM|Ki|=|6|nM|6|nM
5QCN|2.30|2017|BVM|[Nonstandard assay: Temp 37] comp.38|P03951|COAGULATION FACTOR XI|8.22|Ki=6nM|Ki|=|6|nM|6|nM
5W8V|2.35|2017|9YP|human HGPRT in complex with compound 20|P00492|HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE|8.22|Ki=6nM|Ki|=|6|nM|6|nM
5V1Y|1.42|2017|16-mer|Ki=7.1+/-0.9nM, ligand is RPN2(940-953)|Q16186|PROTEASOMAL UBIQUITIN RECEPTOR ADRM1|8.15|Ki=7.1nM|Ki|=|7.1|nM|7.1|nM
5WAD|2.09|2017|QQZ|[Uncommon element] CR161|Q6DRA1|BETA-LACTAMASE|8.11|Ki=7.8nM|Ki|=|7.8|nM|7.8|nM
5XHR|1.80|2017|PXH|[Covalent complex] MPC-1 with P99|P05364|BETA-LACTAMASE|5.1|Ki=7.9uM|Ki|=|7.9|uM|7900|nM
5NIN|1.70|2017|16-mer|[Different protein in assay: Protein in binding assay is biotinylated CaM] +/-8, AKAP79(77-92)|P62158|CALMODULIN|7.12|Ki=75nM|Ki|=|75|nM|75|nM
5ULA|1.50|2017|5MJ|ligand is MS402|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|7.11|Ki=77nM|Ki|=|77|nM|77|nM
5KEZ|1.83|2017|11-mer|HPA/piHA-Dm complex|P04746|ALPHA-AMYLASE|8.15|Ki=7nM|Ki|=|7|nM|7|nM
5TWO|1.93|2017|7MV|ligand is VSP-51.|P37231|PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA|8.09|Ki=8.06nM|Ki|=|8.06|nM|8.06|nM
5N6S|2.10|2017|8P5|ligand is compound 5|Q08638|BETA-GLUCOSIDASE A|8.09|Ki=8.2nM|Ki|=|8.2|nM|8.2|nM
5TV3|2.90|2017|7L3|ligand is 3.|K4NGD4|ALPHA-CARBONIC ANHYDRASE|8.09|Ki=8.2nM|Ki|=|8.2|nM|8.2|nM
5L87|0.87|2017|6RD|PEX14-2|Q8IEW2|PEROXIN 14|5.07|Ki=8.43uM|Ki|=|8.43|uM|8430|nM
5OPS|2.00|2017|A3Q|comp.9|O14757|SERINE/THREONINE-PROTEIN KINASE CHK1|5.06|Ki=8.63uM|Ki|=|8.63|uM|8630|nM
5VJN|1.78|2017|IR8|Ki=8.7+/-1.5uM, ligand is D-DIAB|P49435|ADENINE PHOSPHORIBOSYLTRANSFERASE 1|5.06|Ki=8.7uM|Ki|=|8.7|uM|8700|nM
5J87|1.59|2017|N42|[Covalent complex] 9 in complex with BTK|Q06187|TYROSINE-PROTEIN KINASE BTK|8.05|Ki=8.9nM|Ki|=|8.9|nM|8.9|nM
5M7U|2.30|2017|XHA|ligand is VV347|O60502|PROTEIN O-GLCNACASE|8.1|Ki=8nM|Ki|=|8|nM|8|nM
5UG9|1.33|2017|8AM|[Covalent complex] ligand is compound 16.|P00533|EPIDERMAL GROWTH FACTOR RECEPTOR|8.1|Ki=8nM|Ki|=|8|nM|8|nM
5LCE|1.39|2017|6TH|compound 2|P00734|PROTHROMBIN|8.04|Ki=9.2nM|Ki|=|9.2|nM|9.2|nM
5VSJ|2.46|2017|9HV|ligand is compound 6; +/-16|Q9L1K2|ALPHA-1,4-GLUCAN:MALTOSE-1-PHOSPHATE MALTOSYLTRANSFERASE 1|4.02|Ki=95uM|Ki|=|95|uM|95000|nM
5THN|1.33|2017|7CZ|Ki=96+/-13uM, ligand is Thiotropolone.|P00918|CARBONIC ANHYDRASE 2|4.02|Ki=96uM|Ki|=|96|uM|96000|nM
5TG5|1.75|2017|JW8|[Covalent complex] [Uncommon element] ligand is BA8.|Q8RLA6|BETA-LACTAMASE|4.01|Ki=97.3uM|Ki|=|97.3|uM|97300|nM
5UEZ|1.51|2017|89G|Ki=970+/-200nM; ligand is compound 11|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|6.01|Ki=970nM|Ki|=|970|nM|970|nM
5UPE|1.93|2017|8HY|ligand is compound 5|P43490|NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE|8.05|Ki=9nM|Ki|=|9|nM|9|nM
5ZA1|2.52|2018|9A0|ligand is compound 6|P51449|NUCLEAR RECEPTOR ROR-GAMMA|7.52|IC<0.030uM|IC50|<|0.03|uM|30|nM
6BSL|1.45|2018|EVV|ligand is compound 22|P13497|BONE MORPHOGENETIC PROTEIN 1|9.0|IC<1nM|IC50|<|1|nM|1|nM
5OQW|2.31|2018|A4E|ligand is ASTX660|P98170|E3 UBIQUITIN-PROTEIN LIGASE XIAP|7.4|IC<40nM|IC50|<|40|nM|40|nM
5UY8|2.39|2018|8UM|ligand is compound 32b|P31939|BIFUNCTIONAL PURINE BIOSYNTHESIS PROTEIN PURH|8.3|IC<5nM|IC50|<|5|nM|5|nM
6HD4|2.03|2018|FYW|ligand is compound 7; IC50=0.0023+/-0.0009uM|P00520|TYROSINE-PROTEIN KINASE ABL1|8.64|IC=0.0023uM|IC50|=|0.0023|uM|2.3|nM
6F22|1.55|2018|C9B|ligand is compound 29|P36639|7,8-DIHYDRO-8-OXOGUANINE TRIPHOSPHATASE|8.7|IC=0.002uM|IC50|=|0.002|uM|2|nM
5QIL|1.98|2018|J2V|ligand is compound 2b|P36897|TGF-BETA RECEPTOR TYPE-1|11.52|IC=0.003nM|IC50|=|0.003|nM|0.003|nM
6CCY|2.18|2018|EX4|ligand is compound 5|P31749|RAC-ALPHA SERINE/THREONINE-PROTEIN KINASE,PIFTIDE|8.52|IC=0.003uM|IC50|=|0.003|uM|3|nM
6F3D|2.38|2018|CJT|ligand is compound 2|Q9NWZ3|INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE 4|8.4|IC=0.004uM|IC50|=|0.004|uM|4|nM
5KPK|2.40|2018|6VK|IC50 = 0.005 +/- 0.003 uM. ligand is BRD0209|P49841|GLYCOGEN SYNTHASE KINASE-3 BETA|8.3|IC=0.005uM|IC50|=|0.005|uM|5|nM
6C6O|2.30|2018|ENG|[Incomplete ligand] [Different ligand in assay: tautomer] ligand is PDKA-substituent 2-Br-4-OH|A5U3K4|MALATE SYNTHASE G|8.3|IC=0.005uM|IC50|=|0.005|uM|5|nM
6C4G|2.39|2018|EQG|ligand is compound 27; IC50 = 0.005+/-0.001uM|Q6PRR9|ASPARTIC PROTEASE PM5|8.3|IC=0.005uM|IC50|=|0.005|uM|5|nM
6F23|1.84|2018|C8Z|ligand is compound 16|P36639|7,8-DIHYDRO-8-OXOGUANINE TRIPHOSPHATASE|8.3|IC=0.005uM|IC50|=|0.005|uM|5|nM
5QIM|1.75|2018|J2Y|ligand is compound 3e|P36897|TGF-BETA RECEPTOR TYPE-1|11.22|IC=0.006nM|IC50|=|0.006|nM|0.006|nM
6FFN|1.75|2018|D8K|[Covalent complex] ligand is compound 6|P04936|3C PROTEASE|8.22|IC=0.006uM|IC50|=|0.006|uM|6|nM
6BA7|2.50|2018|D1Y|[Incomplete ligand] [Different ligand in assay: tautomer] ligand is PDKA-substituent 2-Cl-4-OH|A5U3K4|MALATE SYNTHASE G|8.15|IC=0.007uM|IC50|=|0.007|uM|7|nM
5XYZ|2.64|2018|GYL|[Covalent complex][Incomplete ligand] ligand is 8,IC50=0.008+/-0.004uM|Q06187|TYROSINE-PROTEIN KINASE BTK|8.1|IC=0.008uM|IC50|=|0.008|uM|8|nM
6DO3|2.17|2018|7-mer|[Incomplete ligand] [Different ligand in assay: Ligand in binding assay is SPPPMAGG] ligand is peptide SPPPMAGG. AlphaScreen competition assay, IC50 = 0.0083-0.0110uM (95% CI)|Q9Y2U9|KELCH DOMAIN-CONTAINING PROTEIN 2|8.03|IC=0.0094uM|IC50|=|0.0094|uM|9.4|nM
5NI5|2.30|2018|8YB|ligand is compound 1|P51449|NUCLEAR RECEPTOR ROR-GAMMA|8.05|IC=0.009uM|IC50|=|0.009|uM|9|nM
6ESN|1.84|2018|BWE|ligand is compound 32|P51449|NUCLEAR RECEPTOR ROR-GAMMA|8.05|IC=0.009uM|IC50|=|0.009|uM|9|nM
5O7E|1.87|2018|9NB|IC50 = 0.010 +/- 0.002. ligand is compound 3|Q46085|COLH PROTEIN|8.0|IC=0.010uM|IC50|=|0.01|uM|10|nM
6DF7|2.00|2018|G9V|Ligand is compound 27; bingind assay: TR-FRET|U3KMH2|TRANSCRIPTION INITIATION FACTOR TFIID SUBUNIT 1|8.0|IC=0.010uM|IC50|=|0.01|uM|10|nM
5Y6E|1.80|2018|8PO|ligand is compound 12|Q9K2N0|BETA-LACTAMASE CLASS B VIM-2|7.86|IC=0.0137uM|IC50|=|0.0137|uM|13.700000000000001|nM
6CKX|2.80|2018|8M1|ligand is compound 29; Binding assay is LANCE Ultra assay|Q9NYV4|CYCLIN-DEPENDENT KINASE 12|7.89|IC=0.013uM|IC50|=|0.013|uM|13|nM
6FGQ|2.37|2018|D9N|ligand is compound 23|P51449|NUCLEAR RECEPTOR ROR-GAMMA|7.85|IC=0.014uM|IC50|=|0.014|uM|14|nM
5YG3|2.40|2018|8UC|[Different protein in assay: Protein in binding assay is Plasmodium falciparum] ligand is compound (+)-57,IC50=0.014+/-0.002uM|A5K8L9|SERINE HYDROXYMETHYLTRANSFERASE|7.85|IC=0.014uM|IC50|=|0.014|uM|14|nM
5KPM|2.69|2018|6VM|IC50 = 0.015 +/- 0.011 uM. ligand is BRD3731|P49841|GLYCOGEN SYNTHASE KINASE-3 BETA|7.82|IC=0.015uM|IC50|=|0.015|uM|15|nM
5NIB|1.82|2018|8Y5|ligand is compound 25|P51449|NUCLEAR RECEPTOR ROR-GAMMA|7.72|IC=0.019uM|IC50|=|0.019|uM|19|nM
6DO4|2.20|2018|6-mer|[Incomplete ligand] [Different ligand in assay: ] ligand is peptide SelS(GPSSGG). AlphaScreen competition assay, IC50 = 0.019-0.024uM (95% CI)|Q9Y2U9|KELCH DOMAIN-CONTAINING PROTEIN 2|7.68|IC=0.021uM|IC50|=|0.021|uM|21|nM
6F3I|2.14|2018|CKN|ligand is compound 33|Q9NWZ3|INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE 4|7.68|IC=0.021uM|IC50|=|0.021|uM|21|nM
6DF4|1.30|2018|G9Y|Ligand is compound 8; bingind assay: TR-FRET|U3KMH2|TRANSCRIPTION INITIATION FACTOR TFIID SUBUNIT 1|7.64|IC=0.023uM|IC50|=|0.023|uM|23|nM
5OWC|1.75|2018|AYZ|[Nonstandard assay: Temp 37] ligand is compound 31|O15496|GROUP 10 SECRETORY PHOSPHOLIPASE A2|7.59|IC=0.026uM|IC50|=|0.026|uM|26|nM
6HVJ|2.28|2018|GV8|ligand is compound 70|Q16875|6-PHOSPHOFRUCTO-2-KINASE/FRUCTOSE-2,6-BISPHOSPHATASE 3|7.55|IC=0.028uM|IC50|=|0.028|uM|28|nM
6BBU|2.08|2018|D7D|[Nonstandard assay: 1 mM ATP] ligand is compound 25|P23458|TYROSINE-PROTEIN KINASE JAK1|7.54|IC=0.029uM|IC50|=|0.029|uM|29|nM
6FEX|1.29|2018|D6Z|ligand is compound 2.45|Q08345|EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1|7.54|IC=0.029uM|IC50|=|0.029|uM|29|nM
5NI8|1.94|2018|8Y2|ligand is compound 10|P51449|NUCLEAR RECEPTOR ROR-GAMMA|7.7|IC=0.02uM|IC50|=|0.02|uM|20|nM
5NI7|2.45|2018|8Y8|ligand is compound 8|P51449|NUCLEAR RECEPTOR ROR-GAMMA|7.7|IC=0.02uM|IC50|=|0.02|uM|20|nM
6BFP|1.29|2018|DJY|enzymic inhibition assay, IC50(trypsin, BCX4161=0.02uM|P00760|CATIONIC TRYPSIN|7.7|IC=0.02uM|IC50|=|0.02|uM|20|nM
6F1X|1.90|2018|C9Q|ligand is compound 7|P36639|7,8-DIHYDRO-8-OXOGUANINE TRIPHOSPHATASE|7.7|IC=0.02uM|IC50|=|0.02|uM|20|nM
6GIN|2.20|2018|IR2|ligand is compound 16|Q04771|ACTIVIN RECEPTOR TYPE-1|7.49|IC=0.032uM|IC50|=|0.032|uM|32|nM
6CCK|1.61|2018|EXJ|ligand is compound 53|P0A6I6|PHOSPHOPANTETHEINE ADENYLYLTRANSFERASE|7.43|IC=0.037uM|IC50|=|0.037|uM|37|nM
6ED6|2.86|2018|J0P|[Nonstandard assay: ATP = 100 uM] ligand is compound 12|O75116|RHO-ASSOCIATED PROTEIN KINASE 2|7.43|IC=0.037uM|IC50|=|0.037|uM|37|nM
6BIR|2.30|2018|13-mer|[Nonstandard assay: Temp 37, PH=5.4] [Different protein in assay: protein in binding assay is HLA_DRB1*04:05] ligand is compound Vim424Cit|P01903|HLA CLASS II HISTOCOMPATIBILITY ANTIGEN, DR ALPHA CHAIN|7.52|IC=0.03uM|IC50|=|0.03|uM|30|nM
6FRF|2.10|2018|E3T|ligand is compound 18|Q92793|CREB-BINDING PROTEIN|7.4|IC=0.040uM|IC50|=|0.04|uM|40|nM
6GIP|2.17|2018|EUN|ligand is compound 21|Q04771|ACTIVIN RECEPTOR TYPE-1|7.38|IC=0.042uM|IC50|=|0.042|uM|42|nM
5OSY|2.06|2018|AJQ|IC50 = 0.0430 +/- 0.0080 uM, ligand is compound 15|Q96C86|M7GPPPX DIPHOSPHATASE|7.37|IC=0.0430uM|IC50|=|0.043|uM|43|nM
5YG4|2.30|2018|8UF|[Different protein in assay: Protein in binding assay is Plasmodium falciparum] ligand is (+)-59,IC50=0.043+/-0.002uM|A5K8L9|SERINE HYDROXYMETHYLTRANSFERASE|7.37|IC=0.043uM|IC50|=|0.043|uM|43|nM
6DZQ|2.25|2018|HJP|ligand is compound 1; IC50 = 0.043 +/- 0.009uM|C3W5S0|POLYMERASE ACIDIC PROTEIN|7.37|IC=0.043uM|IC50|=|0.043|uM|43|nM
6FT8|1.45|2018|E6T|ligand is compound 8g|P49759|DUAL SPECIFICITY PROTEIN KINASE CLK1|7.36|IC=0.044uM|IC50|=|0.044|uM|44|nM
6H1I|1.69|2018|FJH|ligand is compound 2|O00625|PIRIN|7.36|IC=0.044uM|IC50|=|0.044|uM|44|nM
6HVH|2.36|2018|GV2|ligand is compound 37|Q16875|6-PHOSPHOFRUCTO-2-KINASE/FRUCTOSE-2,6-BISPHOSPHATASE 3|7.33|IC=0.047uM|IC50|=|0.047|uM|47|nM
5QIN|1.57|2018|J2V|ligand is compound 2b|P37173|TGF-BETA RECEPTOR TYPE-2|10.4|IC=0.04nM|IC50|=|0.04|nM|0.04|nM
6EW3|2.14|2018|S3C|IC50 = 0.04 +/- 0.002 uM, ligand is ML302F|D1MEN9|METALLO-BETA-LACTAMASE VIM-2|7.4|IC=0.04uM|IC50|=|0.04|uM|40|nM
5YSO|2.50|2018|90C|compound is DN200434|P62508|ESTROGEN-RELATED RECEPTOR GAMMA|7.4|IC=0.04uM|IC50|=|0.04|uM|40|nM
6CCO|1.82|2018|EXV|ligand is compound 28|P0A6I6|PHOSPHOPANTETHEINE ADENYLYLTRANSFERASE|7.29|IC=0.051uM|IC50|=|0.051|uM|51|nM
5Y6D|2.10|2018|8PL|ligand is compound 11|Q9K2N0|BETA-LACTAMASE CLASS B VIM-2|7.26|IC=0.055uM|IC50|=|0.055|uM|55|nM
6CZ3|1.80|2018|FLJ|binding assay: mobility shift assay; ligand is compound 2c;IC50=0.056+/-0.004uM|Q13882|PROTEIN-TYROSINE KINASE 6|7.25|IC=0.056uM|IC50|=|0.056|uM|56|nM
6MR5|1.85|2018|W45|ligand is MCA|A7YT55|HDAC6 PROTEIN|7.3|IC=0.05uM|IC50|=|0.05|uM|50|nM
6FFS|1.86|2018|D8E|[Covalent complex] ligand is compound 4|P04936|3C PROTEASE|7.2|IC=0.063uM|IC50|=|0.063|uM|63|nM
6DCZ|2.89|2018|G5Y|ligand is compound 3; IC50 = 0.068 +/- 0.011uM|C3W5S0|POLYMERASE ACIDIC PROTEIN|7.17|IC=0.068uM|IC50|=|0.068|uM|68|nM
6DO5|2.50|2018|6-mer|[Incomplete ligand] [Different ligand in assay: ] ligand is peptide USP1(IGLLGG). AlphaScreen competition assay, IC50 = 0.0458-0.1053uM (95% CI)|Q9Y2U9|KELCH DOMAIN-CONTAINING PROTEIN 2|7.16|IC=0.0695uM|IC50|=|0.0695|uM|69.5|nM
6F3G|2.37|2018|CJN|ligand is compound 17|Q9NWZ3|INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE 4|7.16|IC=0.069uM|IC50|=|0.069|uM|69|nM
6BU1|1.58|2018|E9S|[Incomplete ligand] ligand is PDKA-substituent 2-Br-3-OH|A5U3K4|MALATE SYNTHASE G|7.22|IC=0.06uM|IC50|=|0.06|uM|60|nM
6CJE|3.36|2018|F4A|ligand is compound 1|Q9HBH9|MAP KINASE-INTERACTING SERINE/THREONINE-PROTEIN KINASE 2|7.22|IC=0.06uM|IC50|=|0.06|uM|60|nM
6F3E|2.67|2018|CJQ|ligand is compound 3|Q9NWZ3|INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE 4|7.15|IC=0.070uM|IC50|=|0.07|uM|70|nM
6H7Z|2.00|2018|FVW|[Nonstandard assay: Temp 37] IC50 = 0.075 +/- 0.005 nM; ligand is compound 13b|Q04609|GLUTAMATE CARBOXYPEPTIDASE 2|10.12|IC=0.075nM|IC50|=|0.075|nM|0.075|nM
6CGP|2.50|2018|F1Y|ligand is compound 4i; IC50 = 0.076+/-0.0036uM|A7YT55|HDAC6 PROTEIN|7.12|IC=0.076uM|IC50|=|0.076|uM|76|nM
6CZ4|1.50|2018|FKY|binding assay: mobility shift assay; ligand is compound PF-6683324;IC50=0.076+/-0.001uM|Q13882|PROTEIN-TYROSINE KINASE 6|7.12|IC=0.076uM|IC50|=|0.076|uM|76|nM
5WGD|1.80|2018|13-mer|ligand is peptide SRC2-LP1|P03372|ESTROGEN RECEPTOR|7.11|IC=0.078uM|IC50|=|0.078|uM|78|nM
6GGN|2.00|2018|EYH|ligand is compound 15a|Q00987|E3 UBIQUITIN-PROTEIN LIGASE MDM2|10.1|IC=0.08nM|IC50|=|0.08|nM|0.08|nM
5UX4|2.81|2018|3UT|ligand is compound 4|P24268|CATHEPSIN D|7.05|IC=0.09uM|IC50|=|0.09|uM|90|nM
6F5H|2.16|2018|CQ5|ligand is compound 46|Q93009|UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 7|7.05|IC=0.09uM|IC50|=|0.09|uM|90|nM
5WZU|2.20|2018|7W3|ligand is compound 24|Q9NZK7|GROUP IIE SECRETORY PHOSPHOLIPASE A2|7.0|IC=0.10uM|IC50|=|0.1|uM|100|nM
5T31|2.85|2018|75F|IC50 = 0.110 +/- 0.001 uM. ligand is BRD0705|P49841|GLYCOGEN SYNTHASE KINASE-3 BETA|6.96|IC=0.110uM|IC50|=|0.11|uM|110|nM
5LH4|1.37|2018|6W4|[Different protein in assay: Protein in binding assay is human cationic trypsin] ligand is compound 1|P00760|TRYPSIN|6.96|IC=0.11uM|IC50|=|0.11|uM|110|nM
5NCQ|3.00|2018|8T8|IC50 = 0.11 +/- 0.06 uM. ligand is compound 7|P04191|SARCOPLASMIC/ENDOPLASMIC RETICULUM CALCIUM ATPASE 1|6.96|IC=0.11uM|IC50|=|0.11|uM|110|nM
5WDJ|2.40|2018|AEY|ligand is compound 6|P05164|MYELOPEROXIDASE|6.96|IC=0.11uM|IC50|=|0.11|uM|110|nM
6FT9|1.87|2018|E6W|ligand is compound 16|P49759|DUAL SPECIFICITY PROTEIN KINASE CLK1|6.96|IC=0.11uM|IC50|=|0.11|uM|110|nM
6Q73|2.21|2018|HKK|ligand is compound 11|O35904|PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE CATALYTIC|6.9|IC=0.126uM|IC50|=|0.126|uM|126|nM
6BSK|2.57|2018|MVG|ligand is compound 12b|P11309|SERINE/THREONINE-PROTEIN KINASE PIM-1|6.92|IC=0.12uM|IC50|=|0.12|uM|120|nM
6CIS|1.51|2018|X26|Ligand is compound JWG-047;IC50 = 0.135+/-0.004uM, AlphaScreen Binding Assay|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|6.87|IC=0.135uM|IC50|=|0.135|uM|135|nM
6HKZ|2.09|2018|GBZ|[Nonstandard assay: Temp 37] IC50 = 0.13 +/- 0.01 nM. ligand is compound 22b|Q04609|GLUTAMATE CARBOXYPEPTIDASE 2|9.89|IC=0.13nM|IC50|=|0.13|nM|0.13|nM
6FQO|1.35|2018|E2T|ligand is compound 16|Q92793|CREB-BINDING PROTEIN|6.85|IC=0.140uM|IC50|=|0.14|uM|140|nM
6EP9|2.01|2018|BNB|Lanthascreen assay, compound 9|Q06187|TYROSINE-PROTEIN KINASE BTK|6.84|IC=0.145uM|IC50|=|0.145|uM|145|nM
6FR0|1.50|2018|E3H|ligand is compound 17|Q92793|CREB-BINDING PROTEIN|6.84|IC=0.146uM|IC50|=|0.146|uM|146|nM
5X02|2.40|2018|F6M|[Covalent complex] Mobility shift assay: IC50=0.14nM, kinase inhibition assay: IC50=2.0nM|P36888|RECEPTOR-TYPE TYROSINE-PROTEIN KINASE FLT3|9.85|IC=0.14nM|IC50|=|0.14|nM|0.14|nM
5W8I|1.95|2018|9YD|[Nonstandard assay: without EDTA] IC50 = 0.150 +/- 0.001 uM. ligand is compound 27|P00338|L-LACTATE DEHYDROGENASE A CHAIN|6.82|IC=0.150uM|IC50|=|0.15|uM|150|nM
5MWA|1.55|2018|8S9|IC50(22d)=0.15+/-0.04uM|P34913|BIFUNCTIONAL EPOXIDE HYDROLASE 2|6.82|IC=0.15uM|IC50|=|0.15|uM|150|nM
6APZ|2.25|2018|BQ4|[Incomplete ligand] [Different ligand in assay: tautomer] ligand is PDKA-substituent 3-OH|A5U3K4|MALATE SYNTHASE G|6.82|IC=0.15uM|IC50|=|0.15|uM|150|nM
5Y8C|1.42|2018|8P9|ligand is 6m, IC50 = 0.16 +/- 0.04 uM|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|6.8|IC=0.16uM|IC50|=|0.16|uM|160|nM
6C7D|1.79|2018|EOJ|Ligand is compound 23; pIC50 = 9.77; Binding assay is IMAP assay|O00408|CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE|9.77|IC=0.17nM|IC50|=|0.17|nM|0.17|nM
6GI6|1.98|2018|EZB|ligand is compound 11|Q04771|ACTIVIN RECEPTOR TYPE-1|6.71|IC=0.194uM|IC50|=|0.194|uM|194|nM
6ETJ|2.51|2018|BWW|Ligand is compound KAN0438241; IC50 = 0.19+/-0.04uM; Bingind assay: ADP-GLO|Q16875|6-PHOSPHOFRUCTO-2-KINASE/FRUCTOSE-2,6-BISPHOSPHATASE 3|6.72|IC=0.19uM|IC50|=|0.19|uM|190|nM
6HDQ|1.70|2018|FZE|ligand is compound 26|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|7.0|IC=0.1uM|IC50|=|0.1|uM|100|nM
6CIY|1.68|2018|F3J|Ligand is compound JWG-069;IC50 = 0.201+/-0.007uM, AlphaScreen Binding Assay|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|6.7|IC=0.201uM|IC50|=|0.201|uM|201|nM
5WZV|2.20|2018|7W0|ligand is compound Me-indoxam|Q9NZK7|GROUP IIE SECRETORY PHOSPHOLIPASE A2|6.68|IC=0.21uM|IC50|=|0.21|uM|210|nM
5G6U|1.84|2018|YJM|IC50 = 0.22 +/- 0.03 uM, ligand is GlcNS6S|Q9UJ71|LANGERIN|6.66|IC=0.22uM|IC50|=|0.22|uM|220|nM
5WZT|2.40|2018|7W6|ligand is compound 14|Q9NZK7|GROUP IIE SECRETORY PHOSPHOLIPASE A2|6.66|IC=0.22uM|IC50|=|0.22|uM|220|nM
6BIY|2.05|2018|13-mer|[Nonstandard assay: Temp 37, PH=5.4] ligand is compound His2B|P01903|HLA CLASS II HISTOCOMPATIBILITY ANTIGEN, DR ALPHA CHAIN|6.66|IC=0.22uM|IC50|=|0.22|uM|220|nM
6GIU|1.39|2018|L69|IC50 = 0.22 +/- 0.01 uM|P29218|INOSITOL MONOPHOSPHATASE 1|6.66|IC=0.22uM|IC50|=|0.22|uM|220|nM
6FT4|1.34|2018|E5W|alpha screen assay|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|6.63|IC=0.235uM|IC50|=|0.235|uM|235|nM
5Y8W|1.76|2018|8PU|ligand is 6a, IC50 = 0.23 +/- 0.01 uM|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|6.64|IC=0.23uM|IC50|=|0.23|uM|230|nM
6CZV|1.88|2018|FOY|[Covalent complex] [Incomplete ligand] AlphaScreen assay; Liand is compound 1|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|6.64|IC=0.23uM|IC50|=|0.23|uM|230|nM
6CMR|2.21|2018|5OD|ligand is compound SHP099; IC50 = 0.246+/-0.009uM|Q06124|TYROSINE-PROTEIN PHOSPHATASE, NON-RECEPTOR TYPE 11|6.61|IC=0.246uM|IC50|=|0.246|uM|246|nM
6C7F|1.82|2018|EOS|Ligand is compound 39; pIC50 = 9.61; Binding assay is IMAP assay|O00408|CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE|9.62|IC=0.24nM|IC50|=|0.24|nM|0.24|nM
6C2Y|2.74|2018|EJS|ligand is compound 33; IC50 = 0.25+/-0.07uM|P25098|BETA-ADRENERGIC RECEPTOR KINASE 1|6.6|IC=0.25uM|IC50|=|0.25|uM|250|nM
6CCQ|1.92|2018|EX7|ligand is compound 20|P0A6I6|PHOSPHOPANTETHEINE ADENYLYLTRANSFERASE|6.6|IC=0.25uM|IC50|=|0.25|uM|250|nM
6G4M|2.63|2018|DQ5|[Different protein in assay: X-ray(Tetronarce californica), IC50(human)] ligand is compound 1; IC50 = 0.25 +/- 0.02 uM|P04058|ACETYLCHOLINESTERASE|6.6|IC=0.25uM|IC50|=|0.25|uM|250|nM
6HDO|2.61|2018|FZH|ligand is compound 27|Q6PL18|ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 2|6.6|IC=0.25uM|IC50|=|0.25|uM|250|nM
6BIZ|2.10|2018|15-mer|[Nonstandard assay: Temp 37, PH=5.4] ligand is compound His2BCit|P01903|HLA CLASS II HISTOCOMPATIBILITY ANTIGEN, DR ALPHA CHAIN|6.57|IC=0.27uM|IC50|=|0.27|uM|270|nM
6CW8|1.90|2018|FGY|IC50=0.27+/-0.01uM|A7YT55|HDAC6 PROTEIN|6.57|IC=0.27uM|IC50|=|0.27|uM|270|nM
5WZS|2.30|2018|7W9|ligand is compound 8|Q9NZK7|GROUP IIE SECRETORY PHOSPHOLIPASE A2|6.55|IC=0.28uM|IC50|=|0.28|uM|280|nM
6E9W|2.96|2018|J0P|[Nonstandard assay: ATP = 100 uM] ligand is compound 12|Q13464|RHO-ASSOCIATED PROTEIN KINASE 1|6.55|IC=0.28uM|IC50|=|0.28|uM|280|nM
5ZH2|2.66|2018|9CU|ligand is compound 16, IC50 = 0.29 +/- 0.04 uM|W7JP72|LYSINE-TRNA LIGASE|6.54|IC=0.29uM|IC50|=|0.29|uM|290|nM
6G6W|2.72|2018|EO5|ligand is compound 39|O00329|PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC|9.7|IC=0.2nM|IC50|=|0.2|nM|0.2|nM
6F2N|1.15|2018|CF8|IC50 = 0.2 +/- 0.03 uM, ligand is 6c|P04190|BETA-LACTAMASE 2|6.7|IC=0.2uM|IC50|=|0.2|uM|200|nM
5YZD|2.64|2018|4-mer|ligand is FIP|Q786F3|GLYCOPROTEIN F2|6.7|IC=0.2uM|IC50|=|0.2|uM|200|nM
6C8P|1.64|2018|EQA|[Incomplete ligand] ligand is PDKA-substituent 2-F|A5U3K4|MALATE SYNTHASE G|6.7|IC=0.2uM|IC50|=|0.2|uM|200|nM
6G5J|1.85|2018|EM8|ligand is compound (R)-12|O15496|GROUP 10 SECRETORY PHOSPHOLIPASE A2|6.7|IC=0.2uM|IC50|=|0.2|uM|200|nM
6BIV|2.90|2018|13-mer|[Nonstandard assay: Temp 37, PH=5.4] ligand is compound LL37_Cit91|P01903|HLA CLASS II HISTOCOMPATIBILITY ANTIGEN, DR ALPHA CHAIN|6.52|IC=0.30uM|IC50|=|0.3|uM|300|nM
6BIX|2.20|2018|13-mer|[Nonstandard assay: Temp 37, PH=5.4] ligand is compound LL37_Cit91|P01903|HLA CLASS II HISTOCOMPATIBILITY ANTIGEN, DR ALPHA CHAIN|6.51|IC=0.31uM|IC50|=|0.31|uM|310|nM
6DQB|1.79|2018|HZM|[Different protein in assay: protein in binding assay is KDM5A(1-1090)] ligand is compound N71; AlphaLISA, IC50 = 0.32+/-0.02uM|P29375|LINKED KDM5A JMJ DOMAIN|6.49|IC=0.32uM|IC50|=|0.32|uM|320|nM
5Z9E|1.80|2018|27K|[Nonstandard assay: Temp 30] lligand is compound 37|P0AES6|DNA GYRASE SUBUNIT B|3.48|IC=0.33mM|IC50|=|0.33|mM|330000|nM
5WGQ|2.30|2018|13-mer|ligand is peptide SRC2-LP1|P03372|ESTROGEN RECEPTOR|6.48|IC=0.33uM|IC50|=|0.33|uM|330|nM
5YVE|3.40|2018|AF9|ligand is AF-219,IC50=0.33+/-0.07uM|P56373|P2X PURINOCEPTOR 3|6.48|IC=0.33uM|IC50|=|0.33|uM|330|nM
6BX6|2.90|2018|EDJ|ligand is compound SBI-0206965; IC50 = 0.33+/-0.07uM|P54646|5'-AMP-ACTIVATED PROTEIN KINASE CATALYTIC SUBUNIT ALPHA-2|6.48|IC=0.33uM|IC50|=|0.33|uM|330|nM
6H7Y|1.81|2018|FVZ|[Nonstandard assay: Temp 37] IC50 = 0.35 +/- 0.01 nM; ligand is compound 11a|Q04609|GLUTAMATE CARBOXYPEPTIDASE 2|9.46|IC=0.35nM|IC50|=|0.35|nM|0.35|nM
6DQA|1.89|2018|H6V|[Different protein in assay: protein in binding assay is KDM5A(1-1090)] ligand is compound N70; AlphaLISA, IC50 = 0.36+/-0.01uM|P29375|LINKED KDM5A JMJ DOMAIN|6.44|IC=0.36uM|IC50|=|0.36|uM|360|nM
6FT3|1.28|2018|E5T|alpha screen assay|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|6.42|IC=0.377uM|IC50|=|0.377|uM|377|nM
6MX8|1.96|2018|6GY|ligand is compound 11q (Brigatinib)|Q9UM73|ALK TYROSINE KINASE RECEPTOR|9.43|IC=0.37nM|IC50|=|0.37|nM|0.37|nM
6HVI|1.96|2018|GV5|ligand is compound 38|Q16875|6-PHOSPHOFRUCTO-2-KINASE/FRUCTOSE-2,6-BISPHOSPHATASE 3|6.42|IC=0.380uM|IC50|=|0.38|uM|380|nM
6C7I|1.71|2018|EP7|Ligand is compound 31; pIC50 = 9.42; Binding assay is IMAP assay|O00408|CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE|9.42|IC=0.38nM|IC50|=|0.38|nM|0.38|nM
6ACB|2.80|2018|9T9|ligand is compound 17c,IC50=0.39+/-0.05nM|O76074|CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE|9.41|IC=0.39nM|IC50|=|0.39|nM|0.39|nM
6I8L|1.58|2018|H7Q||Q9Y657|SPINDLIN-1|6.41|IC=0.39uM|IC50|=|0.39|uM|390|nM
6EUM|1.18|2018|BY5|IC50 = 0.3 +/- 0.01 uM, ligand is 6k|P04190|BETA-LACTAMASE 2|6.52|IC=0.3uM|IC50|=|0.3|uM|300|nM
5O7N|1.50|2018|9NK|IC50=0.3+/-0.09uM|------|BETA-LACTAMASE VIM-2|6.52|IC=0.3uM|IC50|=|0.3|uM|300|nM
6FKP|2.00|2018|10-mer|ligand is H3 10-mer peptide(ARTKQTARKS); Binding assay: AlphaLISA competition assay|Q9UIF9|BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN PROTEIN 2A|6.52|IC=0.3uM|IC50|=|0.3|uM|300|nM
5YLT|1.69|2018|C7N|[Nonstandard assay: pH 8.8] ligand is 2n,IC50=0.41+/-0.14uM|Q8WTS6|HISTONE-LYSINE N-METHYLTRANSFERASE SETD7|6.39|IC=0.41uM|IC50|=|0.41|uM|410|nM
5Y0Z|2.00|2018|8K9|ligand is NPD11033,IC50=0.46+/-0.056uM|Q8IXJ6|NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-2|6.34|IC=0.46uM|IC50|=|0.46|uM|460|nM
6BIN|2.50|2018|13-mer|[Nonstandard assay: Temp 37, PH=5.4] [Different protein in assay: protein in binding assay is HLA_DRB1*04:01] ligand is compound CII1240|P01903|HLA CLASS II HISTOCOMPATIBILITY ANTIGEN, DR ALPHA CHAIN|6.34|IC=0.46uM|IC50|=|0.46|uM|460|nM
6FFH|2.65|2018|D7W|ligand is compound 4(fenobam)|P41594|METABOTROPIC GLUTAMATE RECEPTOR 5, ENDOLYSIN|6.34|IC=0.46uM|IC50|=|0.46|uM|460|nM
6CZU|1.47|2018|FP7|[Covalent complex] [Incomplete ligand] AlphaScreen assay; Liand is compound 1A, and Epoxypropyl in the ligand is opened|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|6.32|IC=0.48uM|IC50|=|0.48|uM|480|nM
5X27|2.95|2018|7XR|ligand is SKLB5; IC50=0.4+/-0.3nM|P00533|EPIDERMAL GROWTH FACTOR RECEPTOR|9.4|IC=0.4nM|IC50|=|0.4|nM|0.4|nM
5L9H|2.25|2018|CVL|ligand is compound NPD-340(2)|Q8WQX9|PHOSPHODIESTERASE|6.4|IC=0.4uM|IC50|=|0.4|uM|400|nM
6GY1|2.10|2018|FGQ|[Different protein in assay: X-ray(Rattus norvegicus), IC50(human)] ligand is compound 21|P22734|CATECHOL O-METHYLTRANSFERASE|6.3|IC=0.50uM|IC50|=|0.5|uM|500|nM
5KPL|2.60|2018|6VL|IC50 = 0.515 +/- 0.257uM. ligand is BRD0705|P49841|GLYCOGEN SYNTHASE KINASE-3 BETA|6.29|IC=0.515uM|IC50|=|0.515|uM|515|nM
6BJO|1.75|2018|DUY|ligand is compound BIO124|Q9NRD5|PRKCA-BINDING PROTEIN|6.29|IC=0.51uM|IC50|=|0.51|uM|510|nM
5Z4O|1.73|2018|HX8|[Nonstandard assay: Temp 30] lligand is compound 36|P0AES6|DNA GYRASE SUBUNIT B|3.28|IC=0.53mM|IC50|=|0.53|mM|530000|nM
6D4O|2.90|2018|FUV|[Different ligand in assay: Ligand in binding assay is subtrate] Ligand is compound Amoxapine-GlcA ; IC50 = 0.53+/-0.01uM|------|BETA-GLUCURONIDASE|6.28|IC=0.53uM|IC50|=|0.53|uM|530|nM
6AR4|1.69|2018|BQA|ligand is 1o|Q9NRD5|PRKCA-BINDING PROTEIN|6.24|IC=0.573uM|IC50|=|0.573|uM|573|nM
6BIL|2.40|2018|13-mer|[Nonstandard assay: Temp 37, PH=5.4] [Different protein in assay: protein in binding assay is HLA_DRB1*04:01] ligand is compound Fib74cit|P01903|HLA CLASS II HISTOCOMPATIBILITY ANTIGEN, DR ALPHA CHAIN|6.24|IC=0.58uM|IC50|=|0.58|uM|580|nM
6AXB|1.80|2018|C0V|[Incomplete ligand] [Different ligand in assay: tautomer] ligand is PDKA-substituent naphthyl|A5U3K4|MALATE SYNTHASE G|6.3|IC=0.5uM|IC50|=|0.5|uM|500|nM
5Y8Z|1.84|2018|8Q3|ligand is 5t, IC50 = 0.62 +/- 0.09 uM|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|6.21|IC=0.62uM|IC50|=|0.62|uM|620|nM
5ZUN|1.35|2018|9JX|ligand is compound 31|Q99685|MONOGLYCERIDE LIPASE|9.19|IC=0.64nM|IC50|=|0.64|nM|0.64|nM
6F5L|1.63|2018|CQB|IC50(7)=0.65+/-0.11nM|Q04609|GLUTAMATE CARBOXYPEPTIDASE 2|9.19|IC=0.65nM|IC50|=|0.65|nM|0.65|nM
5ZZ4|2.90|2018|9M3|[Nonstandard assay: unactivated form of BTK, BTK[U]] ligand is 2e,IC50=0.67nM,unactivated conformation of BTK (BTK[U])|Q06187|TYROSINE-PROTEIN KINASE BTK|9.17|IC=0.67nM|IC50|=|0.67|nM|0.67|nM
6H1H|1.54|2018|FJE|ligand is compound 7|O00625|PIRIN|6.17|IC=0.67uM|IC50|=|0.67|uM|670|nM
6IIL|2.20|2018|A8F|ligand is compound IU1-47|P54578|UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 14|6.17|IC=0.68uM|IC50|=|0.68|uM|680|nM
6AAK|2.67|2018|9T6|ligand is peficitinib,IC50=0.71(0.38-1.4)nM|P52333|TYROSINE-PROTEIN KINASE JAK3|9.15|IC=0.71nM|IC50|=|0.71|nM|0.71|nM
6GOP|2.90|2018|F6K|[Multiple sites: site 1: IC50=0.7 +/- 0.04 nM(chymotrypsin-like activity); site 2: IC50=144 +/- 12 nM(caspase-like activity); site 3: IC50=118 +/- 28 nM(trypsin-like activity)] ligand is HomoSalA IC50 = 0 ? +/- 0.04 nM|P23639|PROTEASOME SUBUNIT ALPHA TYPE-2|9.15|IC=0.7nM|IC50|=|0.7|nM|0.7|nM
5WKL|1.85|2018|AVY/B3J|[Covalent complex] ligand is compound 10c, protein source is Middle East respiratory syndrome-related coronavirus|------|ORF1A PROTEIN|6.15|IC=0.7uM|IC50|=|0.7|uM|700|nM
6BBV|1.80|2018|D7D|[Nonstandard assay: 1 mM ATP] ligand is compound 25|O60674|TYROSINE-PROTEIN KINASE JAK2|6.1|IC=0.803uM|IC50|=|0.803|uM|803|nM
5YQO|1.48|2018|L5C|ligand is compound 24a|Q8IXJ6|NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-2|6.09|IC=0.815uM|IC50|=|0.815|uM|815|nM
5O7I|2.38|2018|9N8|compound 46, IC50=0.82+/-0.1uM|Q13164|MITOGEN-ACTIVATED PROTEIN KINASE 7|6.09|IC=0.82uM|IC50|=|0.82|uM|820|nM
6IIN|2.53|2018|A8O|ligand is compound IU1-248|P54578|UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 14|6.08|IC=0.83uM|IC50|=|0.83|uM|830|nM
6E4F|1.15|2018|HRA|ligand is compound ARQ 531|Q06187|TYROSINE-PROTEIN KINASE BTK|9.07|IC=0.85nM|IC50|=|0.85|nM|0.85|nM
6AUM|2.95|2018|BXV|ligand is t-TUCB|P34913|BIFUNCTIONAL EPOXIDE HYDROLASE 2|9.1|IC=0.8nM|IC50|=|0.8|nM|0.8|nM
5Y86|1.90|2018|HRM|ligand is harmine|O43781|DUAL SPECIFICITY TYROSINE-PHOSPHORYLATION-REGULATED KINASE|6.1|IC=0.8uM|IC50|=|0.8|uM|800|nM
6F8U|2.10|2018|CZQ|ligand is GEBR-20b; IC50 = 0.8 +/- 0.2 uM|Q08499|CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D|6.1|IC=0.8uM|IC50|=|0.8|uM|800|nM
6BIJ|2.10|2018|13-mer|[Nonstandard assay: Temp 37, PH=5.4] [Different protein in assay: protein in binding assay is HLA_DRB1*04:01] ligand is compound FIb72,74Cit|P01903|HLA CLASS II HISTOCOMPATIBILITY ANTIGEN, DR ALPHA CHAIN|6.05|IC=0.90uM|IC50|=|0.9|uM|900|nM
6E9L|2.80|2018|J0P|[Nonstandard assay: ATP = 100 uM] ligand is compound 12|P00517|CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA|6.04|IC=0.92uM|IC50|=|0.92|uM|920|nM
5OKT|2.13|2018|9XK|[Different protein in assay: Protein in binding assay is rat] IC50 = 0.93 +/- 0.15 uM. ligand is IWP-2|P48730|CASEIN KINASE I ISOFORM DELTA|6.03|IC=0.93uM|IC50|=|0.93|uM|930|nM
5W0E|1.41|2018|9U4|ligand is compound 3|Q92793|CREB-BINDING PROTEIN|9.03|IC=0.94nM|IC50|=|0.94|nM|0.94|nM
5Z4H|2.00|2018|A8K|[Nonstandard assay: Temp 30] lligand is compound 7|P0AES6|DNA GYRASE SUBUNIT B|3.02|IC=0.95mM|IC50|=|0.95|mM|950000|nM
5NR7|2.35|2018|YUI|IC50 = 0.95 +/- 0.08 uM. ligand is compound 43|P9WKE1|THYMIDYLATE KINASE|6.02|IC=0.95uM|IC50|=|0.95|uM|950|nM
6CYB|1.62|2018|FKV|Ligand is compound 11|O00408|CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE|9.02|IC=0.96nM|IC50|=|0.96|nM|0.96|nM
6HKJ|2.09|2018|G8W|[Nonstandard assay: Temp 37] IC50 = 0.99 +/- 0.05nM. ligand is compound 13a|Q04609|GLUTAMATE CARBOXYPEPTIDASE 2|9.0|IC=0.99nM|IC50|=|0.99|nM|0.99|nM
5XGH|2.97|2018|84U|HTRF assay, IC50=1.02+/-0.005uM|P42336|PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC|5.99|IC=1.02uM|IC50|=|1.02|uM|1020|nM
6CK6|3.32|2018|N45|ligand is compound 23|Q9HBH9|MAP KINASE-INTERACTING SERINE/THREONINE-PROTEIN KINASE 2|9.0|IC=1.0nM|IC50|=|1|nM|1|nM
6DL9|1.80|2018|GXD|[Incomplete ligand] [Different ligand in assay: tautomer] ligand is PDKA-substituent 2,6-Cl|A5U3K4|MALATE SYNTHASE G|6.0|IC=1.0uM|IC50|=|1|uM|1000|nM
6E99|1.88|2018|J0G|[Nonstandard assay: ATP = 100 uM] ligand is compound 47|P00517|CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA|6.0|IC=1.0uM|IC50|=|1|uM|1000|nM
5ZWE|2.72|2018|9K0|[Covalent complex] ligand is compound 1,IC50=1.1+/-0.06nM|P13053|VITAMIN D3 RECEPTOR|8.96|IC=1.1nM|IC50|=|1.1|nM|1.1|nM
5ZOB|2.00|2018|5-mer|[Nonstandard assay: Temp 37] ligand is compound 3,IC50=1.1+/-0.07uM|Q32ZE1|SERINE PROTEASE SUBUNIT NS2B|5.96|IC=1.1uM|IC50|=|1.1|uM|1100|nM
6AU9|2.10|2018|BXS|[Incomplete ligand] [Different ligand in assay: tautomer] ligand is PDKA-substituent dioxine|A5U3K4|MALATE SYNTHASE G|5.96|IC=1.1uM|IC50|=|1.1|uM|1100|nM
5WZW|1.95|2018|U8D|ligand is compound LY311727|Q9NZK7|GROUP IIE SECRETORY PHOSPHOLIPASE A2|5.91|IC=1.23uM|IC50|=|1.23|uM|1230|nM
5ZFI|1.80|2018|9C9|ligand is 22g|Q91VE3|KALLIKREIN-7|5.92|IC=1.2uM|IC50|=|1.2|uM|1200|nM
6C7J|1.85|2018|EPV|Ligand is compound 46; pIC50 = 8.88; Binding assay is IMAP assay|O00408|CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE|8.88|IC=1.32nM|IC50|=|1.32|nM|1.32|nM
6BKH|1.79|2018|DVD|Lanthascreen assay, compound 10|Q06187|TYROSINE-PROTEIN KINASE BTK|8.89|IC=1.3nM|IC50|=|1.3|nM|1.3|nM
6HMX|2.53|2018|GEZ|ligand is compound 7|O43353|RECEPTOR-INTERACTING SERINE/THREONINE-PROTEIN KINASE 2|8.89|IC=1.3nM|IC50|=|1.3|nM|1.3|nM
6G3Y|2.51|2018|ELB|ligand is TH5675|O08760|N-GLYCOSYLASE/DNA LYASE|5.89|IC=1.3uM|IC50|=|1.3|uM|1300|nM
5ZZ2|2.60|2018|9M0|ligand is compound 11b,IC50=1.41+/-0.30nM|O76074|CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE|8.85|IC=1.41nM|IC50|=|1.41|nM|1.41|nM
6FEW|1.44|2018|D6W|ligand is compound 2a|Q08345|EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1|5.85|IC=1.41uM|IC50|=|1.41|uM|1410|nM
6FIL|1.73|2018|D6W|ligand is compound 2a|Q08345|EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1|5.85|IC=1.41uM|IC50|=|1.41|uM|1410|nM
6G8N|3.00|2018|EQB|ligand is compound 2; IC50 = 1.430 +/- 0.089 uM|P23639|PROTEASOME SUBUNIT ALPHA TYPE-2|5.84|IC=1.430uM|IC50|=|1.43|uM|1430|nM
5W0I|1.43|2018|9UA|ligand is compound 8|P45481|CREB-BINDING PROTEIN|8.85|IC=1.4nM|IC50|=|1.4|nM|1.4|nM
6BQA|1.03|2018|67C|compound 5|Q9H8M2|BROMODOMAIN-CONTAINING PROTEIN 9|5.85|IC=1.4uM|IC50|=|1.4|uM|1400|nM
5VIL|2.64|2018|9E1|[Nonstandard assay: ATP = 1mM] [Different protein in assay: Protein in binding assay is full length] IC50 = 1.5 +/- 0.87 nM, ligand is compound 18|Q99683|MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 5|8.82|IC=1.5nM|IC50|=|1.5|nM|1.5|nM
5ZEQ|1.90|2018|9B3|[Uncommon element] ligand is compound 1|P09955|CARBOXYPEPTIDASE B|8.82|IC=1.5nM|IC50|=|1.5|nM|1.5|nM
5YOF|1.51|2018|7HS|[Incomplete ligand] [Different protein in assay: Protein in binding assay is WT] ligand is compound 1|------|NS2B COFACTOR|5.82|IC=1.5uM|IC50|=|1.5|uM|1500|nM
6C7B|2.13|2018|ENY|[Incomplete ligand] [Different ligand in assay: tautomer] ligand is PDKA-substituent methoxynaphthyl|A5U3K4|MALATE SYNTHASE G|5.82|IC=1.5uM|IC50|=|1.5|uM|1500|nM
6BLN|1.30|2018|DY4|Lanthascreen assay, compound 12|Q06187|TYROSINE-PROTEIN KINASE BTK|8.8|IC=1.6nM|IC50|=|1.6|nM|1.6|nM
6DKO|1.56|2018|GXG|[Incomplete ligand] [Different ligand in assay: tautomer] ligand is PDKA-substituent 2,6-F|A5U3K4|MALATE SYNTHASE G|5.8|IC=1.6uM|IC50|=|1.6|uM|1600|nM
6BIB|1.95|2018|DW7|[Covalent complex] inhibitor 1|Q83883|3C-LIKE PROTEASE|5.8|IC=1.6uM|IC50|=|1.6|uM|1600|nM
5MWG|1.50|2018|WGX|ligand is compound 16|P55201|PEREGRIN|5.77|IC=1.7uM|IC50|=|1.7|uM|1700|nM
6HJJ|2.13|2018|G7T|IC50 = 1.7 +/- 0.4 uM; ligand is compound ASDO6|O14965|AURORA KINASE A|5.77|IC=1.7uM|IC50|=|1.7|uM|1700|nM
5WG8|1.65|2018|LB1|[Nonstandard assay: substrate: DiFMUP] phosphatase assay|P53041|SERINE/THREONINE-PROTEIN PHOSPHATASE 5|5.74|IC=1.82uM|IC50|=|1.82|uM|1820|nM
5ZWF|2.10|2018|9KR|[Covalent complex] ligand is compound 2,IC50=1.8+/-0.06nM|P13053|VITAMIN D3 RECEPTOR|8.74|IC=1.8nM|IC50|=|1.8|nM|1.8|nM
5YJF|2.49|2018|8WO|[Nonstandard assay: Tem 37 C] ligand is JBSNF-000088,IC50=1.8uM|P40261|NICOTINAMIDE N-METHYLTRANSFERASE|5.74|IC=1.8uM|IC50|=|1.8|uM|1800|nM
6CJW|3.38|2018|FYV|ligand is compound 2|Q9HBH9|MAP KINASE-INTERACTING SERINE/THREONINE-PROTEIN KINASE 2|5.74|IC=1.8uM|IC50|=|1.8|uM|1800|nM
6EV0|2.30|2018|BYK|[Different ligand in assay: ligand in binding assay is racemic] ligand is compound 11; Both R and S form of 11 appear in complex structure|P22262|LISTERIOLYSIN REGULATORY PROTEIN|5.74|IC=1.8uM|IC50|=|1.8|uM|1800|nM
5ZWH|2.38|2018|9N9|[Covalent complex] ligand is compound 3,IC50=1.9+/-0.04nM|P13053|VITAMIN D3 RECEPTOR|8.72|IC=1.9nM|IC50|=|1.9|nM|1.9|nM
6BR2|3.18|2018|E3S|ligand is compound 2|P51449|NUCLEAR RECEPTOR ROR-GAMMA|8.72|IC=1.9nM|IC50|=|1.9|nM|1.9|nM
6BR3|3.00|2018|E3V|ligand is compound 10; IC50 = 1.9+/-0.3nM|P51449|NUCLEAR RECEPTOR ROR-GAMMA|8.72|IC=1.9nM|IC50|=|1.9|nM|1.9|nM
5MXQ|2.00|2018|U8K|ligand is ANT-090 (32)|Q9K2N0|BETA-LACTAMASE VIM-2|5.72|IC=1.9uM|IC50|=|1.9|uM|1900|nM
6G7F|2.70|2018|EPW|ligand is Cystargolide B|P23639|PROTEASOME SUBUNIT ALPHA TYPE-2|5.0|IC=10.1uM|IC50|=|10.1|uM|10100|nM
6H7U|2.80|2018|FVT|ligand is 5-aminolevulinic acid|------|PEPTIDE ABC TRANSPORTER PERMEASE|1.98|IC=10.4mM|IC50|=|10.4|mM|10400000|nM
5XPN|1.96|2018|8BO|ligand is 4a,IC50=102+/-0.50nM|P13053|VITAMIN D3 RECEPTOR|6.99|IC=102nM|IC50|=|102|nM|102|nM
6C0U|2.65|2018|EE4|ligand is compound N46; IC50 = 1030+/-43nM|P17612|CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA|5.99|IC=1030nM|IC50|=|1030|nM|1030|nM
6C5T|2.75|2018|EKP|Ligand is compound SR11023|P37231|PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA|6.97|IC=108nM|IC50|=|108|nM|108|nM
5NWD|1.45|2018|9C8|ligand is compound 32|Q9H2K2|TANKYRASE-2|8.0|IC=10nM|IC50|=|10|nM|10|nM
5OWS|1.80|2018|KC8|ligand is compound 9, Structure of ligand in PDB is wrong, and the name is compound 8|Q9H2K2|TANKYRASE-2|8.0|IC=10nM|IC50|=|10|nM|10|nM
5W0Q|1.70|2018|9U7|ligand is compound 10|Q92793|CREB-BINDING PROTEIN|8.0|IC=10nM|IC50|=|10|nM|10|nM
6GN1|2.60|2018|F4N|ligand is PIK-75|P49841|GLYCOGEN SYNTHASE KINASE-3 BETA|8.0|IC=10nM|IC50|=|10|nM|10|nM
5NQ5|2.85|2018|952|IC50 = 10 +/- 2 uM. ligand is compound 1|P9WKE1|THYMIDYLATE KINASE|5.0|IC=10uM|IC50|=|10|uM|10000|nM
5WI1|1.99|2018|AOY|ligand is compound 5|P43490|NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE|5.0|IC=10uM|IC50|=|10|uM|10000|nM
5YFZ|2.16|2018|8UO|[Different protein in assay: Protein in binding assay is Plasmodium falciparum] ligand is compound (+)-65|A5K8L9|SERINE HYDROXYMETHYLTRANSFERASE|6.96|IC=110nM|IC50|=|110|nM|110|nM
6BL1|2.02|2018|DWG|[Covalent complex] ligand is compound 13|O75874|ISOCITRATE DEHYDROGENASE [NADP] CYTOPLASMIC|6.96|IC=110nM|IC50|=|110|nM|110|nM
6FDQ|2.30|2018|2UQ|ligand is compound 5|B0B9A0|DEUBIQUITINASE AND DENEDDYLASE DUB1|3.95|IC=113uM|IC50|=|113|uM|113000|nM
5YJY|3.40|2018|8WF|ligand is compound AC0-12|P32340|ROTENONE-INSENSITIVE NADH-UBIQUINONE OXIDOREDUCTASE|6.94|IC=115nM|IC50|=|115|nM|115|nM
6HSZ|2.37|2018|GOW|ligand is compound 2; IC50 = 116 +/- 38 nM|A5H660|HISTONE DEACETYLASE|6.94|IC=116nM|IC50|=|116|nM|116|nM
5XV7|2.32|2018|EMH|ligand is Alectinib|------|SERINE-ARGININE (SR) PROTEIN KINASE 1|7.96|IC=11nM|IC50|=|11|nM|11|nM
6DVL|2.10|2018|HBG|Ligand is compound 1|A7YT55|HDAC6 PROTEIN|7.96|IC=11nM|IC50|=|11|nM|11|nM
6EQM|1.35|2018|BUH|Ligand is compound CNP520; IC50 = 11+/-0.4nM|P56817|BETA-SECRETASE 1|7.96|IC=11nM|IC50|=|11|nM|11|nM
6FYV|2.46|2018|3NG|ligand is CX-4945|Q9HAZ1|DUAL SPECIFICITY PROTEIN KINASE CLK4|7.96|IC=11nM|IC50|=|11|nM|11|nM
6G93|1.67|2018|EU2|ligand is compound 11|P28482|MITOGEN-ACTIVATED PROTEIN KINASE 1|7.96|IC=11nM|IC50|=|11|nM|11|nM
6GL3|2.77|2018|EMW|ligand is compound 44|Q9UBF8|PHOSPHATIDYLINOSITOL 4-KINASE BETA,PHOSPHATIDYLINOSITOL 4|7.96|IC=11nM|IC50|=|11|nM|11|nM
6H3K|2.48|2018|FMW|ligand is BOS172722|P33981|DUAL SPECIFICITY PROTEIN KINASE TTK|7.96|IC=11nM|IC50|=|11|nM|11|nM
6FR2|2.26|2018|E3N|ligand is compound 22; IC50 = 12.0 +/- 1.9 nM|P34913|BIFUNCTIONAL EPOXIDE HYDROLASE 2|7.92|IC=12.0nM|IC50|=|12|nM|12|nM
6IIK|1.97|2018|IU1|ligand is compound IU1|P54578|UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 14|4.91|IC=12.25uM|IC50|=|12.25|uM|12250|nM
6E2N|2.10|2018|KK8|ligand is compound 2|Q99683|MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 5|7.9|IC=12.5nM|IC50|=|12.5|nM|12.5|nM
5WFC|2.28|2018|A97|ligand is GSK343|G0S8H7|POLYCOMB PROTEIN EED|4.9|IC=12.5uM|IC50|=|12.5|uM|12500|nM
6FNX|1.19|2018|DYZ|ligand is F1p; Bingding assay: HTRF|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|4.9|IC=12.6uM|IC50|=|12.6|uM|12600|nM
6HU0|1.75|2018|T86|ligand is compound 9; IC50 = 122 +/- 19 nM|A5H660|HISTONE DEACETYLASE|6.91|IC=122nM|IC50|=|122|nM|122|nM
5NRA|1.27|2018|95K|IC50 = 123 +/- 47 nM, ligand is 7g|Q13231|CHITOTRIOSIDASE-1|6.91|IC=123nM|IC50|=|123|nM|123|nM
6BY8|1.90|2018|FNV|IC50(FP)=123+/-21nM|O00255|MENIN|6.91|IC=123nM|IC50|=|123|nM|123|nM
6HU2|1.99|2018|T34|ligand is compound 11; IC50 = 1260 +/- 170 nM|A5H660|HISTONE DEACETYLASE|5.9|IC=1260nM|IC50|=|1260|nM|1260|nM
5NZM|2.35|2018|9ET|ligand is murrayamine-I|Q4QDU3|UDP-GLUCOSE PYROPHOSPHORYLASE|3.9|IC=127uM|IC50|=|127|uM|127000|nM
5NUT|1.60|2018|9A8|ligand is compound 34|Q9H2K2|TANKYRASE-2|7.92|IC=12nM|IC50|=|12|nM|12|nM
5WH6|1.60|2018|AKJ|S_Zl-n-91|Q08499|CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D|7.92|IC=12nM|IC50|=|12|nM|12|nM
6BG3|1.05|2018|DOJ|ligand is compound 34|P00720|ENDOLYSIN, DCN1-LIKE PROTEIN 1 CHIMERA|4.92|IC=12uM|IC50|=|12|uM|12000|nM
6FUL|1.65|2018|E7Z|ligand is compound 8|O15550|LYSINE-SPECIFIC DEMETHYLASE 6A|4.92|IC=12uM|IC50|=|12|uM|12000|nM
6FO7|2.59|2018|LX3|[Different protein in assay: X-ray(Danio rerio); IC50(human)] ligand is compound 2c|Q9PTN2|VITAMIN D3 RECEPTOR A|7.87|IC=13.6nM|IC50|=|13.6|nM|13.6|nM
5W2P|2.00|2018|6U5|EC50(DG-167)=130.9+/-18.2nM, microscale thermophoresis assay|H8ESN0|3-OXOACYL-[ACYL-CARRIER-PROTEIN] SYNTHASE 1|6.88|IC=130.9nM|IC50|=|130.9|nM|130.9|nM
5W2Q|1.80|2018|6U5|EC50(DG-167)=130.9+/-18.2nM, microscale thermophoresis assay|H8ESN0|3-OXOACYL-[ACYL-CARRIER-PROTEIN] SYNTHASE 1|6.88|IC=130.9nM|IC50|=|130.9|nM|130.9|nM
5YG2|2.20|2018|N05|[Different protein in assay: Protein in binding assay is Plasmodium falciparum] [Different ligand in assay: in binding assay is racemic,in PDB is single conformation] ligand is compound (+)-66|A5K8L9|SERINE HYDROXYMETHYLTRANSFERASE|6.89|IC=130nM|IC50|=|130|nM|130|nM
5MZG|1.85|2018|2GE|[Nonstandard assay: pH=8] IC50 = 138 +/- 2.8 nM, ligand is TH588|P53368|7,8-DIHYDRO-8-OXOGUANINE TRIPHOSPHATASE|6.86|IC=138nM|IC50|=|138|nM|138|nM
5OLB|1.82|2018|6ZO|IC50 = 13 +/- 3.1 nM, mATX+ PF-8380 (2)|Q9R1E6|ECTONUCLEOTIDE PYROPHOSPHATASE/PHOSPHODIESTERASE|7.89|IC=13nM|IC50|=|13|nM|13|nM
5XYX|2.61|2018|FTZ|ligand is compound 1, IC50=14.445+/-1.211uM|Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|4.84|IC=14.445uM|IC50|=|14.445|uM|14445|nM
6EOX|1.30|2018|BKW|ligand is compound 2b|P39900|MACROPHAGE METALLOELASTASE|6.85|IC=140nM|IC50|=|140|nM|140|nM
6FYP|2.29|2018|3NG|ligand is CX-4945|P49761|DUAL SPECIFICITY PROTEIN KINASE CLK3|6.84|IC=143nM|IC50|=|143|nM|143|nM
6CYC|1.54|2018|FKJ|Ligand is compound 9|O00408|CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE|7.85|IC=14nM|IC50|=|14|nM|14|nM
6DVN|2.20|2018|HB7|Ligand is compound 3|A7YT55|HDAC6 PROTEIN|7.85|IC=14nM|IC50|=|14|nM|14|nM
6CQ4|3.20|2018|F8P|Ligand is compound 131; IC50 = 14+/-3.8uM|Q9UHD2|SERINE/THREONINE-PROTEIN KINASE TBK1|4.85|IC=14uM|IC50|=|14|uM|14000|nM
6DXG|1.91|2018|HGJ|ligand is compound 1; IC50 = 14+/-2uM|Q86WV6|STIMULATOR OF INTERFERON GENES PROTEIN|4.85|IC=14uM|IC50|=|14|uM|14000|nM
6AS6|1.40|2018|BSV|[Incomplete ligand] ligand is PDKA-substituent 3-Prop-6-Me|A5U3K4|MALATE SYNTHASE G|4.82|IC=15.2uM|IC50|=|15.2|uM|15200|nM
5NVH|1.60|2018|9B2|ligand is compound 30|Q9H2K2|TANKYRASE-2|7.82|IC=15nM|IC50|=|15|nM|15|nM
5OCJ|1.80|2018|9SW|IC50 = 15 +/- 5 uM, ligand is CyC8beta|P9WQN9|DIACYLGLYCEROL ACYLTRANSFERASE/MYCOLYLTRANSFERASE AG85C|4.82|IC=15uM|IC50|=|15|uM|15000|nM
6EZ9|1.61|2018|C68|[Different protein in assay: E424M inactive mutant] IC50(5)=16.9+/-7.2nM|Q04609|GLUTAMATE CARBOXYPEPTIDASE 2|7.77|IC=16.9nM|IC50|=|16.9|nM|16.9|nM
6BSM|2.33|2018|E7D|ligand is compound 4|P13497|BONE MORPHOGENETIC PROTEIN 1|6.8|IC=160nM|IC50|=|160|nM|160|nM
5NRF|1.45|2018|95Q|IC50 = 163 +/- 70 nM, ligand is 7i|Q13231|CHITOTRIOSIDASE-1|6.79|IC=163nM|IC50|=|163|nM|163|nM
6G2A|1.80|2018|A3R|ligand is compound ADP-HPM|P54922|[PROTEIN ADP-RIBOSYLARGININE] HYDROLASE|3.79|IC=164uM|IC50|=|164|uM|164000|nM
6CHO|1.85|2018|F14|ligand is compound 7|P0A6I6|PHOSPHOPANTETHEINE ADENYLYLTRANSFERASE|6.78|IC=167nM|IC50|=|167|nM|167|nM
5NVF|1.55|2018|9AW|ligand is compound 29|Q9H2K2|TANKYRASE-2|7.8|IC=16nM|IC50|=|16|nM|16|nM
5NWB|1.60|2018|9C5|ligand is compound 33|Q9H2K2|TANKYRASE-2|7.8|IC=16nM|IC50|=|16|nM|16|nM
5UZ0|1.79|2018|8US|IC50 = 16 +/- 11 nM. ligand is compound 28a|P31939|BIFUNCTIONAL PURINE BIOSYNTHESIS PROTEIN PURH|7.8|IC=16nM|IC50|=|16|nM|16|nM
5W0F|1.60|2018|9U7|ligand is compound 3|Q92793|CREB-BINDING PROTEIN|7.8|IC=16nM|IC50|=|16|nM|16|nM
6F6U|1.83|2018|CV8|ligand is GEBR-7b; IC50 = 16 +/- 2.2 uM|Q08499|CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D|4.8|IC=16uM|IC50|=|16|uM|16000|nM
6F8V|1.85|2018|D0B|ligand is GEBR-18b; IC50 = 16 +/- 5 uM|Q08499|CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D|4.8|IC=16uM|IC50|=|16|uM|16000|nM
6C2X|2.60|2018|EHV|[Incomplete ligand] [Different ligand in assay: tautomer] ligand is PDKA-substituent 2-Br-6-Me|A5U3K4|MALATE SYNTHASE G|4.76|IC=17.4uM|IC50|=|17.4|uM|17400|nM
6FO9|2.70|2018|E0E|[Different protein in assay: X-ray(Danio rerio); IC50(human)] ligand is compound 2b|Q9PTN2|VITAMIN D3 RECEPTOR A|7.75|IC=17.6nM|IC50|=|17.6|nM|17.6|nM
5Y5U|2.14|2018|8OU|ligand is SKI-G-618|P43405|TYROSINE-PROTEIN KINASE SYK|7.75|IC=17.7nM|IC50|=|17.7|nM|17.7|nM
5YZ7|1.90|2018|94X|[Incomplete ligand] [Nonstandard assay: Temp 30] [Different ligand in assay: ligand in binding assay is racemic,in PDB is single form] ligand is 7'carba-4BD,IC50=17.8+/- 5.2uM|Q10QA5|STRIGOLACTONE ESTERASE D14|4.75|IC=17.8uM|IC50|=|17.8|uM|17800|nM
5NR8|1.35|2018|95N|IC50 = 175 +/- 7.1 nM, ligand is 7a|Q13231|CHITOTRIOSIDASE-1|6.76|IC=175nM|IC50|=|175|nM|175|nM
5NT4|1.90|2018|97Z|ligand is compound 31|Q9H2K2|TANKYRASE-2|7.77|IC=17nM|IC50|=|17|nM|17|nM
6F8X|1.95|2018|D08|ligand is GEBR-26g; IC50 = 17 +/- 5 uM|Q08499|CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D|4.77|IC=17uM|IC50|=|17|uM|17000|nM
6C7G|1.68|2018|EOY|Ligand is compound 43; pIC50 = 7.74; Binding assay is IMAP assay|O00408|CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE|7.74|IC=18.20nM|IC50|=|18.2|nM|18.2|nM
6FO8|2.30|2018|DZT|[Different protein in assay: X-ray(Danio rerio); IC50(human)] ligand is compound 2d|Q9PTN2|VITAMIN D3 RECEPTOR A|7.74|IC=18.4nM|IC50|=|18.4|nM|18.4|nM
5ZMQ|1.99|2018|4-mer|[Nonstandard assay: Temp 37] ligand is compound 1B,IC50=18.4+/-1.9uM|Q32ZE1|SERINE PROTEASE SUBUNIT NS2B|4.74|IC=18.4uM|IC50|=|18.4|uM|18400|nM
6BMX|2.42|2018|DYV|[Multiple sites: Src Homology 2 domains:IC50=18.9uM; phosphatese domain IC50 > 100uM] ligand is compound 8|Q06124|TYROSINE-PROTEIN PHOSPHATASE, NON-RECEPTOR TYPE 11|4.72|IC=18.9uM|IC50|=|18.9|uM|18900|nM
6DI1|1.10|2018|GJD|Ligand is compound 7; binding assay: microfluidic, off-chip mobility shift kinase assay|Q06187|TYROSINE-PROTEIN KINASE BTK|6.74|IC=180nM|IC50|=|180|nM|180|nM
6CEF|1.80|2018|EYJ|ligand is compound 2; IC50 = 180+/-52uM|Q9UBN7|HISTONE DEACETYLASE 6|3.74|IC=180uM|IC50|=|180|uM|180000|nM
6GXU|1.92|2018|FG8|ligand is compound 33c, IC50 = 180 +/- 30 uM (schistosoma mansoni)|A5H660|HISTONE DEACETYLASE|3.74|IC=180uM|IC50|=|180|uM|180000|nM
6HTZ|1.84|2018|GRK|ligand is compound 8; IC50 = 183 +/- 39 nM|A5H660|HISTONE DEACETYLASE|6.74|IC=183nM|IC50|=|183|nM|183|nM
5W0L|1.55|2018|9U7|ligand is compound 17|Q92793|CREB-BINDING PROTEIN|4.74|IC=18uM|IC50|=|18|uM|18000|nM
6BUV|1.86|2018|E9A|IC50(N2-8)=18+/-2uM, enzyme inhibition assay|P9WJJ5|NICOTINATE MONONUCLEOTIDE ADENYLYLTRANSFERASE NADD|4.74|IC=18uM|IC50|=|18|uM|18000|nM
6HT8|2.50|2018|GQE|ligand is compound 3; IC50 = 190 +/- 54 nM|A5H660|HISTONE DEACETYLASE|6.72|IC=190nM|IC50|=|190|nM|190|nM
6HU1|2.00|2018|GT2|ligand is compound 10; IC50 = 191 +/- 17 nM|A5H660|HISTONE DEACETYLASE|6.72|IC=191nM|IC50|=|191|nM|191|nM
6FTN|2.00|2018|E78|ligand is compound 9|O35904|PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE|6.7|IC=199.5nM|IC50|=|199.5|nM|199.5|nM
6CHM|2.28|2018|F1V|ligand is compound 5|P0A6I6|PHOSPHOPANTETHEINE ADENYLYLTRANSFERASE|3.7|IC=199uM|IC50|=|199|uM|199000|nM
6BQK|1.97|2018|Z1E|[Different protein in assay: protein in binding assay is genotype-1a] ligand is compound 18|A8DG50|NS3 PROTEASE|9.0|IC=1nM|IC50|=|1|nM|1|nM
6BG5|1.10|2018|DQD|ligand is compound 45|P00720|ENDOLYSIN, DCN1-LIKE PROTEIN 1 CHIMERA|6.0|IC=1uM|IC50|=|1|uM|1000|nM
6Q6Y|2.03|2018|HKQ|ligand is compound 14|O35904|PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE CATALYTIC|6.0|IC=1uM|IC50|=|1|uM|1000|nM
6H9B|2.75|2018|FWH|ligand is compound 4f; IC50=2.0+/-0.5uM|P63043|TUBULIN ALPHA CHAIN|5.7|IC=2.0uM|IC50|=|2|uM|2000|nM
6GE0|1.82|2018|EVQ|ligand is compound 21|P28482|MITOGEN-ACTIVATED PROTEIN KINASE 1|8.68|IC=2.1nM|IC50|=|2.1|nM|2.1|nM
6BT0|2.60|2018|E7V|[Nonstandard assay: Temp 30] ligand is compund NR1|Q15382|GTP-BINDING PROTEIN RHEB|5.68|IC=2.1uM|IC50|=|2.1|uM|2100|nM
6ES0|2.38|2018|BW8|ligand is compound CSR35; IC50=2.26+/-0.11uM|O43353|RECEPTOR-INTERACTING SERINE/THREONINE-PROTEIN KINASE 2|5.65|IC=2.26uM|IC50|=|2.26|uM|2260|nM
5Y93|1.62|2018|8Q9|ligand is 6f, IC50 = 2.27 +/- 1.24 uM|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|5.64|IC=2.27uM|IC50|=|2.27|uM|2270|nM
6DS0|3.19|2018|H8M|Ligand is compound LY266097|P41595|5HT2B RECEPTOR, BRIL CHIMERA|8.66|IC=2.2nM|IC50|=|2.2|nM|2.2|nM
6FQU|1.43|2018|E3B|ligand is compound 15|Q92793|CREB-BINDING PROTEIN|5.66|IC=2.2uM|IC50|=|2.2|uM|2200|nM
5OF0|1.48|2018|9TB|[Nonstandard assay: Temp 37] IC50 = 2.32 +/- 0.55 nM. ligand is compound 7a|Q04609|GLUTAMATE CARBOXYPEPTIDASE 2|8.63|IC=2.32nM|IC50|=|2.32|nM|2.32|nM
5ZWI|2.40|2018|9KX|[Covalent complex] ligand is compound 4,IC50=2.3+/-0.05nM|P13053|VITAMIN D3 RECEPTOR|8.64|IC=2.3nM|IC50|=|2.3|nM|2.3|nM
6FDC|1.45|2018|DD5|[Different ligand in assay: ligand is tautomeric mixtures] ligand is GEBR-32a; IC50 = 2.3 +/- 0.7 uM|Q08499|CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D|5.64|IC=2.3uM|IC50|=|2.3|uM|2300|nM
6G4N|2.90|2018|E2W|[Different protein in assay: X-ray(Tetronarce californica), IC50(human)] ligand is compound 2; IC50 = 2.3 +/- 0.2 uM|P04058|ACETYLCHOLINESTERASE|5.64|IC=2.3uM|IC50|=|2.3|uM|2300|nM
6G1U|1.79|2018|E1K|[Covalent complex] [Different protein in assay: X-ray(TcAChE); IC50(hAChE)] ligand is compound 5; IC50 = 2.45 +/- 0.28 uM|P04058|ACETYLCHOLINESTERASE|5.61|IC=2.45uM|IC50|=|2.45|uM|2450|nM
5VIO|2.84|2018|9E4|[Nonstandard assay: ATP = 1mM] [Different protein in assay: Protein in binding assay is full length] IC50 = 2.4 +/- 1.3 nM, ligand is compound 19|Q99683|MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 5|8.62|IC=2.4nM|IC50|=|2.4|nM|2.4|nM
6BIC|2.25|2018|5LH|[Covalent complex] inhibitor 2|Q83883|3C-LIKE PROTEASE|5.62|IC=2.4uM|IC50|=|2.4|uM|2400|nM
6C7E|1.43|2018|EOG|Ligand is compound 19; pIC50 = 8.55; Binding assay is IMAP assay|O00408|CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE|8.55|IC=2.82nM|IC50|=|2.82|nM|2.82|nM
6DLJ|2.60|2018|GXM|[Incomplete ligand] [Different ligand in assay: tautomer] ligand is PDKA-substituent 2-Nitro|A5U3K4|MALATE SYNTHASE G|5.55|IC=2.8uM|IC50|=|2.8|uM|2800|nM
6BID|1.15|2018|DW4|[Covalent complex] inhibitor 3|Q83883|3C-LIKE PROTEASE|5.54|IC=2.9uM|IC50|=|2.9|uM|2900|nM
6EW7|1.60|2018|C1W|ligand is compound 2|P41182|B-CELL LYMPHOMA 6 PROTEIN|5.54|IC=2.9uM|IC50|=|2.9|uM|2900|nM
6EZG|2.20|2018|C6K|[Different protein in assay: X-ray(Tetronarce californica); IC50(human)] ligand is compound 6b; IC50 = 20.4 +/- 0.8 nM|P04058|ACETYLCHOLINESTERASE|7.69|IC=20.4nM|IC50|=|20.4|nM|20.4|nM
5YOV|1.45|2018|8XR|IC50=20.9+/-1.1nM|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|7.68|IC=20.9nM|IC50|=|20.9|nM|20.9|nM
6FYI|2.60|2018|EAE|ligand is TG003; IC50 = 200 nM (published); IC50 = 260 +/- 2 nM (in house)|P49760|DUAL SPECIFICITY PROTEIN KINASE CLK2|6.7|IC=200nM|IC50|=|200|nM|200|nM
6FDU|2.30|2018|D5W|ligand is compound 3|B0B9A0|DEUBIQUITINASE AND DENEDDYLASE DUB1|3.69|IC=204uM|IC50|=|204|uM|204000|nM
6GMD|1.66|2018|A8Q|ligand is compound 3|P68400|CASEIN KINASE II, SUBUNIT ALPHA|3.69|IC=205uM|IC50|=|205|uM|205000|nM
5XPL|2.05|2018|8C9|ligand is 5b,IC50=20+/-0.55nM|P13053|VITAMIN D3 RECEPTOR|7.7|IC=20nM|IC50|=|20|nM|20|nM
5NAT|1.17|2018|8RT||P00746|COMPLEMENT FACTOR D|4.7|IC=20uM|IC50|=|20|uM|20000|nM
5O48|1.69|2018|9K2|ligand is IMP-72|A5K1A2|GLYCYLPEPTIDE N-TETRADECANOYLTRANSFERASE|4.7|IC=20uM|IC50|=|20|uM|20000|nM
6F8R|1.83|2018|CZK|ligand is GEBR-54; IC50 = 20 +/- 3 uM|Q08499|CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D|4.7|IC=20uM|IC50|=|20|uM|20000|nM
5ZH3|2.86|2018|9CF|ligand is compound 17,IC50=21.3+/-2uM|W7JP72|LYSINE-TRNA LIGASE|4.67|IC=21.3uM|IC50|=|21.3|uM|21300|nM
5Y5T|1.80|2018|8OR|ligand is SKI-O-85|P43405|TYROSINE-PROTEIN KINASE SYK|6.68|IC=211nM|IC50|=|211|nM|211|nM
6FZU|1.80|2018|EE8|ligand is compound 1; IC50 = 216 +/- 15 uM|P51449|NUCLEAR RECEPTOR ROR-GAMMA|3.67|IC=216uM|IC50|=|216|uM|216000|nM
5WVD|3.00|2018|7UX|[Different protein in assay: Protein in binding assay is full length and inactive (unphosphorylated)] ligand is DS12881479|B5BUJ6|MAP KINASE INTERACTING SERINE/THREONINE KINASE 1|7.68|IC=21nM|IC50|=|21|nM|21|nM
6G9A|1.91|2018|ESQ|ligand is compound 14|P28482|MITOGEN-ACTIVATED PROTEIN KINASE 1|7.68|IC=21nM|IC50|=|21|nM|21|nM
6BMV|2.05|2018|DZS|[Different protein in assay: Src Homology 2 domains:IC50=21uM; phosphatese domain IC50 > 100uM] ligand is compound 9|Q06124|TYROSINE-PROTEIN PHOSPHATASE, NON-RECEPTOR TYPE 11|4.68|IC=21uM|IC50|=|21|uM|21000|nM
6E2M|2.25|2018|KK7|ligand is compound 1|Q99683|MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 5|5.66|IC=2200nM|IC50|=|2200|nM|2200|nM
6C5Q|2.40|2018|EKS|Ligand is compound SR10171|P37231|PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA|6.66|IC=220nM|IC50|=|220|nM|220|nM
6HTT|1.75|2018|GQZ|ligand is compound 7; IC50 = 220 +/- 4 nM|A5H660|HISTONE DEACETYLASE|6.66|IC=220nM|IC50|=|220|nM|220|nM
5O1S|1.90|2018|9HB|[Covalent complex] IC50app = 225 uM. ligand is DMF|P18654|RIBOSOMAL PROTEIN S6 KINASE ALPHA-3|3.65|IC=225uM|IC50|=|225|uM|225000|nM
6G28|1.23|2018|AR6|ligand is ADPr|P54922|[PROTEIN ADP-RIBOSYLARGININE] HYDROLASE|3.64|IC=228uM|IC50|=|228|uM|228000|nM
5QIK|1.58|2018|J2M|ligand is compound 1|P36897|TGF-BETA RECEPTOR TYPE-1|7.66|IC=22nM|IC50|=|22|nM|22|nM
5W8H|1.80|2018|9Y1|[Nonstandard assay: without EDTA] IC50 = 23.4 +/- 5.7 uM. ligand is compound 15|P00338|L-LACTATE DEHYDROGENASE A CHAIN|4.63|IC=23.4uM|IC50|=|23.4|uM|23400|nM
6FOB|2.75|2018|DZW|[Different protein in assay: X-ray(Danio rerio); IC50(human)] ligand is compound 2e|Q9PTN2|VITAMIN D3 RECEPTOR A|7.63|IC=23.5nM|IC50|=|23.5|nM|23.5|nM
6DXX|2.70|2018|WTF|Ligand is compound ARN19702, crystalized in presence of Triton X-100|Q02083|N-ACYLETHANOLAMINE-HYDROLYZING ACID AMIDASE SUBUNIT ALPHA|6.64|IC=230nM|IC50|=|230|nM|230|nM
6CCS|2.06|2018|EXD|ligand is compound 5|P0A6I6|PHOSPHOPANTETHEINE ADENYLYLTRANSFERASE|3.64|IC=230uM|IC50|=|230|uM|230000|nM
5XPM|2.20|2018|8C0|[Different ligand in assay: Ligand in binding assay is racemic.] ligand is 4b,IC50=23+/-0.72nM.|P13053|VITAMIN D3 RECEPTOR|7.64|IC=23nM|IC50|=|23|nM|23|nM
6CJY|3.05|2018|F4J|ligand is compound 8|Q9HBH9|MAP KINASE-INTERACTING SERINE/THREONINE-PROTEIN KINASE 2|7.64|IC=23nM|IC50|=|23|nM|23|nM
6F8W|1.60|2018|D0E|ligand is GEBR-18a; IC50 = 23 +/- 4 uM|Q08499|CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D|4.64|IC=23uM|IC50|=|23|uM|23000|nM
5WJJ|1.60|2018|AQY|ligand is compound 1|Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|6.62|IC=240nM|IC50|=|240|nM|240|nM
5O9H|2.70|2018|9P2|ligand is NDT9513727|P21730|C5A ANAPHYLATOXIN CHEMOTACTIC RECEPTOR 1|6.62|IC=241nM|IC50|=|241|nM|241|nM
6FGL|2.10|2018|UO1|ligand is compound 8|Q9UIF9|BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN PROTEIN 2A|4.62|IC=24uM|IC50|=|24|uM|24000|nM
5OAE|2.70|2018|SVF|IC50 = 25.11 + 0.98 uM, ligand is compound 3|B2ZB02|TYROSINASE|4.6|IC=25.11uM|IC50|=|25.11|uM|25110|nM
6ARY|2.26|2018|BT7|[Covalent complex] ligand is PRC1214,IC50=25.1+/-1.2nM|Q869C3|ACETYLCHOLINESTERASE|7.6|IC=25.1nM|IC50|=|25.1|nM|25.1|nM
5YQL|1.60|2018|A2I|ligand is compound 1|Q8IXJ6|NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-2|4.59|IC=25.9uM|IC50|=|25.9|uM|25900|nM
6GX3|2.10|2018|FF2|ligand is compound 9b, IC50 = 250 +/- 20 uM (schistosoma mansoni)|A5H660|HISTONE DEACETYLASE|3.6|IC=250uM|IC50|=|250|uM|250000|nM
6DUD|1.66|2018|HB4|[Covalent complex] ligand is compound 12|P52333|TYROSINE-PROTEIN KINASE JAK3|6.59|IC=256nM|IC50|=|256|nM|256|nM
6HJK|2.40|2018|G7W|IC50 = 25 +/- 2 nM; ligand is ligand ASDO2|O14965|AURORA KINASE A|7.6|IC=25nM|IC50|=|25|nM|25|nM
5WFD|2.65|2018|A9G|ligand is GSK126|G0S8H7|POLYCOMB PROTEIN EED|4.58|IC=26.2uM|IC50|=|26.2|uM|26200|nM
6ELA|1.49|2018|B9Z|ligand is compound 3a|P39900|MACROPHAGE METALLOELASTASE|7.59|IC=26nM|IC50|=|26|nM|26|nM
6BKY|2.17|2018|K32|[Covalent complex] ligand is compound 2|O75874|ISOCITRATE DEHYDROGENASE [NADP] CYTOPLASMIC|6.57|IC=270nM|IC50|=|270|nM|270|nM
6CCL|1.77|2018|EXG|ligand is compound 4|P0A6I6|PHOSPHOPANTETHEINE ADENYLYLTRANSFERASE|3.56|IC=273uM|IC50|=|273|uM|273000|nM
5XST|2.30|2018|8E6|[Nonstandard assay: Temp 37, PH=8.0] ligand is compound 15|P09874|POLY [ADP-RIBOSE] POLYMERASE 1|7.57|IC=27nM|IC50|=|27|nM|27|nM
6G07|1.66|2018|EEZ|ligand is compound 10; IC50 = 27 +/- 2 uM|P51449|NUCLEAR RECEPTOR ROR-GAMMA|4.57|IC=27uM|IC50|=|27|uM|27000|nM
5WG6|3.90|2018|A9G|ligand is GSK126|Q15910|HISTONE-LYSINE N-METHYLTRANSFERASE EZH2,POLYCOMB PROTEIN|4.54|IC=28.6uM|IC50|=|28.6|uM|28600|nM
5NT0|1.75|2018|97H|ligand is compound 13|Q9H2K2|TANKYRASE-2|6.55|IC=280nM|IC50|=|280|nM|280|nM
6FN9|2.27|2018|DW8|ligand is compound Mov2; IC50 = 284 +/- 60 uM|P63104|14-3-3 PROTEIN ZETA/DELTA|3.55|IC=284uM|IC50|=|284|uM|284000|nM
6MRG|2.77|2018|JXV|[Different protein in assay: X-ray(Rattus norvegicus); IC50(human)] IC50 = 28 +/- 8 nM|P97612|FATTY-ACID AMIDE HYDROLASE 1|7.55|IC=28nM|IC50|=|28|nM|28|nM
6ESM|1.10|2018|B9Z|ligand is compound 3a|P14780|MATRIX METALLOPROTEINASE-9 (MMP-9)|5.53|IC=2960nM|IC50|=|2960|nM|2960|nM
5NWH|2.60|2018|9CH|ligand is TH5427|Q9UKK9|ADP-SUGAR PYROPHOSPHATASE|7.54|IC=29nM|IC50|=|29|nM|29|nM
6CYD|1.69|2018|FKG|Ligand is compound 4|O00408|CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE|8.7|IC=2nM|IC50|=|2|nM|2|nM
6G9N|1.76|2018|ESN|ligand is compound 27|P28482|MITOGEN-ACTIVATED PROTEIN KINASE 1|8.52|IC=3.0nM|IC50|=|3|nM|3|nM
5YZC|2.33|2018|95C|ligand is AS-48|Q786F3|GLYCOPROTEIN F2|5.52|IC=3.0uM|IC50|=|3|uM|3000|nM
6EXM|1.60|2018|QQH|[Different ligand in assay: ligand in binding assay is racemic] ligand is compound 17|Q4TVQ0|LISTERIOLYSIN POSITIVE REGULATORY FACTOR A|5.52|IC=3.0uM|IC50|=|3|uM|3000|nM
6HM6|2.10|2018|GDK|ligand is compound 20|P43405|SPLEEN TYROSINE KINASE|5.5|IC=3.16uM|IC50|=|3.16|uM|3160|nM
6EWE|1.46|2018|C0W|IC50 = 3.1 +/- 0.3 uM, ligand is 6c|P04190|BETA-LACTAMASE 2|5.51|IC=3.1uM|IC50|=|3.1|uM|3100|nM
5X33|3.70|2018|7Y9|[Different ligand in assay: ] ligand is BIIL260,ligand in PDB is neutral,but in binding assay is positively charged.|Q9WTK1|LTB4 RECEPTOR,LYSOZYME,LTB4 RECEPTOR|8.49|IC=3.2nM|IC50|=|3.2|nM|3.2|nM
6CEN|1.61|2018|7-mer|ligand is peptide PTD2|Q9BZ95|HISTONE-LYSINE N-METHYLTRANSFERASE NSD3|5.49|IC=3.2uM|IC50|=|3.2|uM|3200|nM
6B41|2.61|2018|CJV|[Incomplete ligand] ligand is compound 10,IC50=3.3+/-0.4nM|O00255|MENIN|8.48|IC=3.3nM|IC50|=|3.3|nM|3.3|nM
5OHI|1.66|2018|9V8|IC50 = 3.4 +/- 2.1 nM, Autotaxin/BI-2545 (19) complex|Q9R1E6|ECTONUCLEOTIDE PYROPHOSPHATASE/PHOSPHODIESTERASE|8.47|IC=3.4nM|IC50|=|3.4|nM|3.4|nM
5O4S|1.75|2018|9KW|ligand is compound 26|P55201|PEREGRIN|5.47|IC=3.4uM|IC50|=|3.4|uM|3400|nM
5XAG|2.56|2018|93X|[Nonstandard assay: Tem 37 C] ligand is 14b,IC50=3.5+/-0.1uM|P81947|TUBULIN ALPHA-1B CHAIN|5.46|IC=3.5uM|IC50|=|3.5|uM|3500|nM
6DCY|2.08|2018|G5V|ligand is compound 2; IC50 = 3.5 +/- 0.6uM|C3W5S0|POLYMERASE ACIDIC PROTEIN|5.46|IC=3.5uM|IC50|=|3.5|uM|3500|nM
6B31|3.18|2018|CFJ|[Different ligand in assay: Ligand in binding assay is Racemic,in PDB is S form] ligand is 18h|P51449|NUCLEAR RECEPTOR ROR-GAMMA|8.44|IC=3.6nM|IC50|=|3.6|nM|3.6|nM
6CJH|3.60|2018|ET8|ligand is compound 3|Q9HBH9|MAP KINASE-INTERACTING SERINE/THREONINE-PROTEIN KINASE 2|5.42|IC=3.8uM|IC50|=|3.8|uM|3800|nM
6AAH|1.83|2018|9T6|ligand is peficitinib,IC50=3.9(2.1-7.2)nM|P23458|TYROSINE-PROTEIN KINASE JAK1|8.41|IC=3.9nM|IC50|=|3.9|nM|3.9|nM
6EJI|2.30|2018|UD2|ligand is compound UDP-CH2-GalNAc; IC50=303+/-24uM|O86151|WLAC PROTEIN|3.52|IC=303uM|IC50|=|303|uM|303000|nM
6CCN|1.87|2018|EXS|ligand is compound 29|P0A6I6|PHOSPHOPANTETHEINE ADENYLYLTRANSFERASE|4.52|IC=30uM|IC50|=|30|uM|30000|nM
6FU5|3.26|2018|E7N|ligand is compound CSLP18; IC50 = 31.6 +/- 8.7 nM|O43353|RECEPTOR-INTERACTING SERINE/THREONINE-PROTEIN KINASE 2|7.5|IC=31.6nM|IC50|=|31.6|nM|31.6|nM
6ALC|1.39|2018|BKD|TR-FRET assay|Q92793|CREB-BINDING PROTEIN|7.51|IC=31nM|IC50|=|31|nM|31|nM
6C0R|2.05|2018|K5C|K103N/Y181C mutant; ligand is compound 25a; IC50 = 31+/-0.83nM|P03366|REVERSE TRANSCRIPTASE/RIBONUCLEASE H|7.51|IC=31nM|IC50|=|31|nM|31|nM
6G91|1.80|2018|EQW|ligand is compound 10|P28482|MITOGEN-ACTIVATED PROTEIN KINASE 1|5.49|IC=3200nM|IC50|=|3200|nM|3200|nM
6EHH|2.40|2018|2GE|[Nonstandard assay: pH=8] IC50 = 32 +/- 15 nM, ligand is TH588|P53368|7,8-DIHYDRO-8-OXOGUANINE TRIPHOSPHATASE|7.49|IC=32nM|IC50|=|32|nM|32|nM
6EK3|1.60|2018|OUL|ligand is compound 1|Q460N3|POLY [ADP-RIBOSE] POLYMERASE 15|6.48|IC=330nM|IC50|=|330|nM|330|nM
6GH9|2.09|2018|MIX|ligand is mitoxantrone; IC50 = 33 +/- 11 uM|Q9Y4E8|UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 15|4.48|IC=33uM|IC50|=|33|uM|33000|nM
6D8E|2.54|2018|FZP|[Covalent complex] ligand is compound 2b; IC50 = 340+/-42nM|P00533|EPIDERMAL GROWTH FACTOR RECEPTOR|6.47|IC=340nM|IC50|=|340|nM|340|nM
5YE7|2.31|2018|8U0|ligand is compound 11|Q13093|PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE|5.46|IC=3431nM|IC50|=|3431|nM|3431|nM
5YE9|1.88|2018|8U6|ligand is compound 14a|Q13093|PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE|6.45|IC=355nM|IC50|=|355|nM|355|nM
5NVE|1.50|2018|9AQ|ligand is compound 35|Q9H2K2|TANKYRASE-2|7.46|IC=35nM|IC50|=|35|nM|35|nM
6CQ0|3.19|2018|F8M|Ligand is compound 114; IC50 = 35+/-2.2uM|Q9UHD2|SERINE/THREONINE-PROTEIN KINASE TBK1|4.46|IC=35uM|IC50|=|35|uM|35000|nM
5WI0|2.05|2018|AQ1|ligand is compound 2|P43490|NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE|3.44|IC=360uM|IC50|=|360|uM|360000|nM
6EKD|2.10|2018|B9K|Ligand is compound 44; IC50 = 363+/-34nM|P53779|MITOGEN-ACTIVATED PROTEIN KINASE 10|6.44|IC=363nM|IC50|=|363|nM|363|nM
5XPP|2.85|2018|8BF|[Different ligand in assay: Ligand in binding assay is recemic] ligand is 3a,IC50=36+/-016nM,|P13053|VITAMIN D3 RECEPTOR|7.44|IC=36nM|IC50|=|36|nM|36|nM
6DUH|2.00|2018|K5C|Y181I mutant; ligand is compound 25a; IC50 = 38+/-1.1nM|P03366|P66 RT|7.42|IC=38nM|IC50|=|38|nM|38|nM
6CE8|1.55|2018|EYV|ligand is compound 22; IC50 = 390+/-160uM|Q9UBN7|HISTONE DEACETYLASE 6|3.41|IC=390uM|IC50|=|390|uM|390000|nM
6DVM|1.47|2018|HBJ|Ligand is compound 2|A7YT55|HDAC6 PROTEIN|8.52|IC=3nM|IC50|=|3|nM|3|nM
6FYK|2.39|2018|EAZ|ligand is Indazole1|P49760|DUAL SPECIFICITY PROTEIN KINASE CLK2|8.52|IC=3nM|IC50|=|3|nM|3|nM
5YUN|2.67|2018|MYC|ligand is Myricetin|P40947|SINGLE-STRANDED DNA-BINDING PROTEIN|5.52|IC=3uM|IC50|=|3|uM|3000|nM
6G9H|1.73|2018|ERW|ligand is compound 16|P28482|MITOGEN-ACTIVATED PROTEIN KINASE 1|8.4|IC=4.0nM|IC50|=|4|nM|4|nM
6G8M|2.70|2018|EQE|ligand is compound 1|P23639|PROTEASOME SUBUNIT ALPHA TYPE-2|5.38|IC=4.18uM|IC50|=|4.18|uM|4180|nM
6G9J|1.98|2018|ERK|ligand is compound 18|P28482|MITOGEN-ACTIVATED PROTEIN KINASE 1|8.39|IC=4.1nM|IC50|=|4.1|nM|4.1|nM
6G97|1.90|2018|EQZ|ligand is compound 13|P28482|MITOGEN-ACTIVATED PROTEIN KINASE 1|8.38|IC=4.2nM|IC50|=|4.2|nM|4.2|nM
6C0N|2.00|2018|K5C|ligand is compound 25a; IC50 = 4.3+/-0.08nM|P03366|REVERSE TRANSCRIPTASE/RIBONUCLEASE H|8.37|IC=4.3nM|IC50|=|4.3|nM|4.3|nM
6G9D|1.80|2018|ER8|ligand is compound 15|P28482|MITOGEN-ACTIVATED PROTEIN KINASE 1|8.37|IC=4.3nM|IC50|=|4.3|nM|4.3|nM
6CHQ|1.79|2018|F0V|ligand is compound 28|P0A6I6|PHOSPHOPANTETHEINE ADENYLYLTRANSFERASE|5.36|IC=4.4uM|IC50|=|4.4|uM|4400|nM
6CD4|1.23|2018|EX1|Ligand is compound JWG-046;IC50 = 4.59+/-0.14uM, AlphaScreen Binding Assay|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|5.34|IC=4.59uM|IC50|=|4.59|uM|4590|nM
6BKE|1.95|2018|DVJ|Lanthascreen assay, compound 11|Q06187|TYROSINE-PROTEIN KINASE BTK|8.35|IC=4.5nM|IC50|=|4.5|nM|4.5|nM
6CQF|2.25|2018|F97|ligand is compound GNE-1858|Q92918|MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE KINASE 1|8.35|IC=4.5nM|IC50|=|4.5|nM|4.5|nM
5ZH5|3.08|2018|9CX|ligand is compound 13, IC50 = 4.64 +/- 0.5 uM|W7JP72|LYSINE-TRNA LIGASE|5.33|IC=4.64uM|IC50|=|4.64|uM|4640|nM
6AAM|1.98|2018|9T6|ligand is peficitinib,IC50=4.8nM|P29597|NON-RECEPTOR TYROSINE-PROTEIN KINASE TYK2|8.32|IC=4.8nM|IC50|=|4.8|nM|4.8|nM
6ENM|1.59|2018|LPW|ligand is compound 1b|P39900|MACROPHAGE METALLOELASTASE|8.32|IC=4.8nM|IC50|=|4.8|nM|4.8|nM
5NSX|1.80|2018|97K|ligand is compound 20|Q9H2K2|TANKYRASE-2|6.4|IC=400nM|IC50|=|400|nM|400|nM
6G9K|1.94|2018|ESK|ligand is compound 23|P28482|MITOGEN-ACTIVATED PROTEIN KINASE 1|7.4|IC=40nM|IC50|=|40|nM|40|nM
6BKX|1.65|2018|DWP|[Covalent complex] ligand is compound 1|O75874|ISOCITRATE DEHYDROGENASE [NADP] CYTOPLASMIC|6.39|IC=410nM|IC50|=|410|nM|410|nM
6BL2|1.92|2018|DWS|[Covalent complex] ligand is compound 15|O75874|ISOCITRATE DEHYDROGENASE [NADP] CYTOPLASMIC|7.39|IC=41nM|IC50|=|41|nM|41|nM
5XIG|2.41|2018|87F|[Nonstandard assay: Temp 37] ligand is In-1,IC50=420+/-37.5nM|S8G8I1|PROLYL-TRNA SYNTHETASE (PRORS)|6.38|IC=420nM|IC50|=|420|nM|420|nM
6DGT|2.60|2018|GFJ|ligand is compound (P)-28|O35904|PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE CATALYTIC|7.38|IC=42nM|IC50|=|42|nM|42|nM
6C0T|1.98|2018|EE4|ligand is compound N46; IC50 = 43.1+/-1.5nM|Q13976|CGMP-DEPENDENT PROTEIN KINASE 1|7.37|IC=43.1nM|IC50|=|43.1|nM|43.1|nM
6FER|2.87|2018|D6Q|ligand is compound 2.38|Q16832|DISCOIDIN DOMAIN-CONTAINING RECEPTOR 2|4.36|IC=44.1uM|IC50|=|44.1|uM|44100|nM
6GXW|2.07|2018|FGN|ligand is compound 31c, IC50 = 440 +/- 40 uM (schistosoma mansoni)|A5H660|HISTONE DEACETYLASE|3.36|IC=440uM|IC50|=|440|uM|440000|nM
6GIH|1.96|2018|EZN|ligand is compound 7|P68400|CASEIN KINASE II, SUBUNIT ALPHA|4.36|IC=44uM|IC50|=|44|uM|44000|nM
6DA4|2.90|2018|G4V|[Covalent complex] ligand is compound 10|P52333|TYROSINE-PROTEIN KINASE JAK3|6.34|IC=456nM|IC50|=|456|nM|456|nM
6CK3|2.90|2018|F67|ligand is compound 9|Q9HBH9|MAP KINASE-INTERACTING SERINE/THREONINE-PROTEIN KINASE 2|7.35|IC=45nM|IC50|=|45|nM|45|nM
6CEC|1.55|2018|EY7|ligand is compound 24; IC50 = 45+/-8uM|Q9UBN7|HISTONE DEACETYLASE 6|4.35|IC=45uM|IC50|=|45|uM|45000|nM
6ARV|2.00|2018|BW7|ligand is compound 2, IC50 = 46 +/- 9 nM.|Q86X55|HISTONE-ARGININE METHYLTRANSFERASE CARM1|7.34|IC=46nM|IC50|=|46|nM|46|nM
6BQ0|2.00|2018|E3A|[Covalent complex] ligand is compound 10|Q99685|MONOGLYCERIDE LIPASE|7.34|IC=46nM|IC50|=|46|nM|46|nM
6DB4|1.66|2018|G4Y|ligand is compound 34|P52333|TYROSINE-PROTEIN KINASE JAK3|7.31|IC=49nM|IC50|=|49|nM|49|nM
5X28|2.95|2018|7XU|ligand is SKLB6; IC50=4+/-2nM|P00533|EPIDERMAL GROWTH FACTOR RECEPTOR|8.4|IC=4nM|IC50|=|4|nM|4|nM
6AAJ|2.37|2018|9T6|ligand is peficitinib,IC50=5.0(3.7-6.9)nM|O60674|TYROSINE-PROTEIN KINASE JAK2|8.3|IC=5.0nM|IC50|=|5|nM|5|nM
6CN6|2.45|2018|F7J|Ligand is compound 36|P51449|NUCLEAR RECEPTOR ROR-GAMMA|8.3|IC=5.0nM|IC50|=|5|nM|5|nM
5YJI|1.99|2018|8WO|[Nonstandard assay: Tem 37 C] ligand is JBSNF-000088,IC50=5.0uM|O55239|NICOTINAMIDE N-METHYLTRANSFERASE|5.3|IC=5.0uM|IC50|=|5|uM|5000|nM
6EI4|2.00|2018|B5N|IC50 = 5.25 + 1.60 uM, ligand is compound 16.|B2ZB02|TYROSINASE|5.28|IC=5.25uM|IC50|=|5.25|uM|5250|nM
6G0W|2.34|2018|EGW|ligand is compound 8b|Q460N5|POLY [ADP-RIBOSE] POLYMERASE 14|5.28|IC=5.2uM|IC50|=|5.2|uM|5200|nM
6CJ1|1.53|2018|F2S|Ligand is compound JWG-071;IC50 = 5.42+/-0.18uM, AlphaScreen Binding Assay|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|5.27|IC=5.42uM|IC50|=|5.42|uM|5420|nM
6ANL|2.00|2018|T75|ligand is compound 15a|Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|8.27|IC=5.4nM|IC50|=|5.4|nM|5.4|nM
6DUG|2.23|2018|K5C|K101P mutant; ligand is compound 25a; IC50 = 5.4+/-0.16nM|P03366|P66 RT|8.27|IC=5.4nM|IC50|=|5.4|nM|5.4|nM
6F6R|1.80|2018|CVE|[Uncommon element] [Incomplete ligand] ligand is compound 10; IC50 (concentration of substrate is Km )|P29466|CASPASE-1|8.25|IC=5.6nM|IC50|=|5.6|nM|5.6|nM
6CCM|1.79|2018|EXP|ligand is compound 30|P0A6I6|PHOSPHOPANTETHEINE ADENYLYLTRANSFERASE|5.25|IC=5.6uM|IC50|=|5.6|uM|5600|nM
5ZMS|1.80|2018|4-mer|[Nonstandard assay: Temp 37] ligand is compound 2B,IC50=5.9+/-0.55uM|Q32ZE1|SERINE PROTEASE SUBUNIT NS2B|5.23|IC=5.9uM|IC50|=|5.9|uM|5900|nM
6HDN|1.90|2018|FZB|ligand is compound 9|Q6PL18|ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 2|4.3|IC=50.12uM|IC50|=|50.12|uM|50120|nM
6HU3|1.66|2018|GRZ|ligand is compound 12; IC50 = 504 +/- 46 nM;|A5H660|HISTONE DEACETYLASE|6.3|IC=504nM|IC50|=|504|nM|504|nM
5XIJ|2.50|2018|873|ligand is In-9,IC50=50+/-3.5nM|S8G8I1|PROLYL-TRNA SYNTHETASE (PRORS)|7.3|IC=50nM|IC50|=|50|nM|50|nM
6EY7|2.90|2018|C3W|ligand is compound 2|P16732|UL89 HCMV TERMINASE|4.3|IC=50uM|IC50|=|50|uM|50000|nM
6EKN|1.20|2018|B9N|ligand is compound 3b|P39900|MACROPHAGE METALLOELASTASE|6.29|IC=510nM|IC50|=|510|nM|510|nM
5W6O|2.35|2018|9X1|[Nonstandard assay: Temp 37] IC50 = 520 +/- 150 nM. ligand is TCD-717|P35790|CHOLINE KINASE ALPHA|6.28|IC=520nM|IC50|=|520|nM|520|nM
6E06|2.50|2018|CTP|crystals grown in citrate precipitant|P9WPQ5|ATP-DEPENDENT DETHIOBIOTIN SYNTHETASE BIOD|4.26|IC=54.4uM|IC50|=|54.4|uM|54400|nM
6E05|2.50|2018|CTP|crystals grown in sulfate precipitant|P9WPQ5|ATP-DEPENDENT DETHIOBIOTIN SYNTHETASE BIOD|4.26|IC=54.4uM|IC50|=|54.4|uM|54400|nM
6DB3|1.97|2018|G54|ligand is compound 23|P52333|TYROSINE-PROTEIN KINASE JAK3|7.25|IC=56nM|IC50|=|56|nM|56|nM
6CKI|2.95|2018|FZJ|ligand is compound 12|Q9HBH9|MAP KINASE-INTERACTING SERINE/THREONINE-PROTEIN KINASE 2|7.24|IC=57nM|IC50|=|57|nM|57|nM
6CQ5|3.35|2018|F8S|Ligand is compound 150; IC50 = 57+/-4.1uM|Q9UHD2|SERINE/THREONINE-PROTEIN KINASE TBK1|4.24|IC=57uM|IC50|=|57|uM|57000|nM
6G1V|1.82|2018|E1N|[Covalent complex] [Different protein in assay: X-ray(TcAChE); IC50(hAChE)] ligand is compound 6; IC50 = 59.2 +/- 5.7 nM|P04058|ACETYLCHOLINESTERASE|7.23|IC=59.2nM|IC50|=|59.2|nM|59.2|nM
5W5K|2.70|2018|K70|IC50(7i)=5+/-1nM|A7YT55|HISTONE DEACETYLASE 6|8.3|IC=5nM|IC50|=|5|nM|5|nM
5X26|2.95|2018|7XO|ligand is SKLB3; IC50=5+/-2nM|P00533|EPIDERMAL GROWTH FACTOR RECEPTOR|8.3|IC=5nM|IC50|=|5|nM|5|nM
5YEA|1.81|2018|8U9|ligand is compound 41|Q13093|PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE|8.3|IC=5nM|IC50|=|5|nM|5|nM
5ZTN|2.50|2018|CUR|ligand is curcumin|Q92630|DUAL SPECIFICITY TYROSINE-PHOSPHORYLATION-REGULATED KINASE|8.3|IC=5nM|IC50|=|5|nM|5|nM
6BKW|1.50|2018|DXM|Lanthascreen assay, compound 13|Q06187|TYROSINE-PROTEIN KINASE BTK|8.3|IC=5nM|IC50|=|5|nM|5|nM
6CMJ|2.40|2018|F6J|ligand is compound 1b|Q96RR4|CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE KINASE 2|8.3|IC=5nM|IC50|=|5|nM|5|nM
6EN4|3.08|2018|BGZ|ligand is compound PB; Crystal is human SF3B core in complex with PB|Q15393|SPLICING FACTOR 3B SUBUNIT 3|8.3|IC=5nM|IC50|=|5|nM|5|nM
6C42|2.00|2018|85M|competitive assay, IC50(OP-1156)=6.13+/-0.06nM|P03372|ESTROGEN RECEPTOR|8.21|IC=6.13nM|IC50|=|6.13|nM|6.13|nM
6ASU|2.32|2018|BVS|[Incomplete ligand] [Different ligand in assay: tautomer] ligand is PDKA-substituent 4-Me|A5U3K4|MALATE SYNTHASE G|5.21|IC=6.1uM|IC50|=|6.1|uM|6100|nM
5MXR|1.75|2018|JTY|ligand is ANT-330 (62)|Q9K2N0|BETA-LACTAMASE VIM-2|5.21|IC=6.2uM|IC50|=|6.2|uM|6200|nM
6F8B|1.30|2018|CXH|ligand is compound 27; IC50 = 6.2 +/- 0.3 uM|I6R951|ELASTASE|5.21|IC=6.2uM|IC50|=|6.2|uM|6200|nM
5NUU|2.50|2018|9A5|[Different protein in assay: protein in binding assay is from human] S-K1035|P04058|ACETYLCHOLINESTERASE|8.2|IC=6.3nM|IC50|=|6.3|nM|6.3|nM
6Q74|2.48|2018|HKN|ligand is compound 16|O35904|PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE CATALYTIC|8.2|IC=6.3nM|IC50|=|6.3|nM|6.3|nM
6BIK|1.90|2018|DTJ|Lanthascreen assay, compound 7|Q06187|TYROSINE-PROTEIN KINASE BTK|8.19|IC=6.4nM|IC50|=|6.4|nM|6.4|nM
6CJ5|2.80|2018|F4G|ligand is compound 4|Q9HBH9|MAP KINASE-INTERACTING SERINE/THREONINE-PROTEIN KINASE 2|5.19|IC=6.4uM|IC50|=|6.4|uM|6400|nM
6DNP|1.71|2018|GZV|[Incomplete ligand] [Different ligand in assay: tautomer] ligand is PDKA-substituent 2-F-3-Me-6-F|A5U3K4|MALATE SYNTHASE G|5.18|IC=6.6uM|IC50|=|6.6|uM|6600|nM
5OWT|2.20|2018|F37|ligand is compound 8|Q9H2K2|TANKYRASE-2|8.17|IC=6.7nM|IC50|=|6.7|nM|6.7|nM
6HF5|1.80|2018|G1N|ligand is ANT-431 (76)|Q9K2N0|BETA-LACTAMASE CLASS B VIM-2|5.17|IC=6.7uM|IC50|=|6.7|uM|6700|nM
5OW8|1.90|2018|AYN|[Nonstandard assay: Temp 37] ligand is compound 1|O15496|GROUP 10 SECRETORY PHOSPHOLIPASE A2|5.16|IC=6.9uM|IC50|=|6.9|uM|6900|nM
6B30|2.69|2018|CFG|[Different ligand in assay: Ligand in binding assay is racemic] ligand is compound 19|P51449|NUCLEAR RECEPTOR ROR-GAMMA|7.22|IC=60nM|IC50|=|60|nM|60|nM
6DVO|1.98|2018|HBV|Ligand is compound 4|A7YT55|HDAC6 PROTEIN|7.22|IC=60nM|IC50|=|60|nM|60|nM
6BMR|2.21|2018|DZV|[Multiple sites: Src Homology 2 domains:IC50=60uM; phosphatese domain IC50 > 100uM] ligand is compound 2|Q06124|TYROSINE-PROTEIN PHOSPHATASE, NON-RECEPTOR TYPE 11|4.22|IC=60uM|IC50|=|60|uM|60000|nM
6GXA|2.10|2018|TB8|ligand is compound 13c, IC50 = 60 +/- 20 uM (schistosoma mansoni)|A5H660|HISTONE DEACETYLASE|4.22|IC=60uM|IC50|=|60|uM|60000|nM
6EUZ|1.95|2018|C8Q|[Different ligand in assay: ligand in binding assay is racemic] ligand is compound 5|Q4TVQ0|LISTERIOLYSIN POSITIVE REGULATORY FACTOR A|4.18|IC=65.6uM|IC50|=|65.6|uM|65600|nM
5NVC|1.60|2018|9AN|ligand is compound 15|Q9H2K2|TANKYRASE-2|6.19|IC=650nM|IC50|=|650|nM|650|nM
5WH5|1.80|2018|R91|(R)-Zl-n-91|Q08499|CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D|7.19|IC=65nM|IC50|=|65|nM|65|nM
6CEE|1.55|2018|EYM|ligand is compound 33; IC50 = 65+/-9.7uM|Q9UBN7|HISTONE DEACETYLASE 6|4.19|IC=65uM|IC50|=|65|uM|65000|nM
5NWG|1.40|2018|9CB|ligand is compound 41|Q9H2K2|TANKYRASE-2|6.18|IC=660nM|IC50|=|660|nM|660|nM
5YJO|2.14|2018|8W0|[Covalent complex] compound 21, IC50=67+/-17nM|Q9H7B4|HISTONE-LYSINE N-METHYLTRANSFERASE SMYD3|7.17|IC=67nM|IC50|=|67|nM|67|nM
6AY5|1.44|2018|C3V|ligand is compound 17|Q92793|CREB-BINDING PROTEIN|7.16|IC=69nM|IC50|=|69|nM|69|nM
6AX4|1.45|2018|5-mer|[Incomplete ligand] ligand is 5b,IC50=6+/-0.5nM|P53350|SERINE/THREONINE-PROTEIN KINASE PLK1|8.22|IC=6nM|IC50|=|6|nM|6|nM
6F4N|2.54|2018|AKG|[Uncommon element] ligand is 2OG and Manganese (II) ION; IC50 = 6 +/- 1.4 uM|Q8N371|JMJC DOMAIN-CONTAINING PROTEIN 5|5.22|IC=6uM|IC50|=|6|uM|6000|nM
6FZX|2.10|2018|EEK|ligand is compound 7; IC50 = 7.0 +/- 0.2 nM|E3ULB4|KERATINASE KP2|8.15|IC=7.0nM|IC50|=|7|nM|7|nM
6FOD|2.50|2018|E05|[Different protein in assay: X-ray(Danio rerio); IC50(human)] ligand is compound 2a|Q9PTN2|VITAMIN D3 RECEPTOR A|8.15|IC=7.11nM|IC50|=|7.11|nM|7.11|nM
6G1W|1.90|2018|E0Z|[Covalent complex] [Different protein in assay: X-ray(TcAChE); IC50(hAChE)] ligand is compound 16; IC50 = 7.18 +/- 0.29 nM|P04058|ACETYLCHOLINESTERASE|8.14|IC=7.18nM|IC50|=|7.18|nM|7.18|nM
5ZH4|2.60|2018|9CC|ligand is compound 18,IC50=7.25+/-0.5uM|W7JP72|LYSINE-TRNA LIGASE|5.14|IC=7.25uM|IC50|=|7.25|uM|7250|nM
6MVX|3.46|2018|K4D|ligand is Flecainide; IC50 = 7.2 +/- 0.4uM|A8EVM5|ION TRANSPORT PROTEIN|5.14|IC=7.2uM|IC50|=|7.2|uM|7200|nM
6DUF|1.96|2018|K5C|mutant V106A/F227L; ligand is compound 25a; IC50 = 7.3+/-0.23nM|P03366|P66 RT|8.14|IC=7.3nM|IC50|=|7.3|nM|7.3|nM
6GZ9|3.10|2018|TXC|ligand is valacyclovir|------|PEPTIDE ABC TRANSPORTER PERMEASE|2.13|IC=7.4mM|IC50|=|7.4|mM|7400000|nM
6B33|2.48|2018|CF7|compound 43|P51449|NUCLEAR RECEPTOR ROR-GAMMA|8.12|IC=7.5nM|IC50|=|7.5|nM|7.5|nM
5WKM|2.25|2018|N02/B6Y|[Covalent complex] ligand is compound 10e, protein source is Middle East respiratory syndrome-related coronavirus|------|ORF1A PROTEIN|5.12|IC=7.5uM|IC50|=|7.5|uM|7500|nM
6BH8|3.85|2018|RDF|Ligand is compound phosphoramidon; IC50 = 7.6+/-1.1uM at [S] = 40uM|O75844|CAAX PRENYL PROTEASE 1 HOMOLOG|5.12|IC=7.6uM|IC50|=|7.6|uM|7600|nM
6G9M|1.86|2018|ESW|ligand is compound 20|P28482|MITOGEN-ACTIVATED PROTEIN KINASE 1|8.1|IC=7.9nM|IC50|=|7.9|nM|7.9|nM
6MU1|4.10|2018|JYP|IC50 = 7.9 +/- 2 nM|P29994|INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR TYPE 1|8.1|IC=7.9nM|IC50|=|7.9|nM|7.9|nM
5NWC|1.50|2018|9CE|ligand is compound 14|Q9H2K2|TANKYRASE-2|6.15|IC=700nM|IC50|=|700|nM|700|nM
5NQR|2.20|2018|958|ligand is TH1713|Q9UKK9|ADP-SUGAR PYROPHOSPHATASE|7.15|IC=70nM|IC50|=|70|nM|70|nM
5XIH|2.20|2018|86U|[Nonstandard assay: Temp 37] ligand is In-5,IC50=70+/-5.5nM|S8G8I1|PROLYL-TRNA SYNTHETASE (PRORS)|7.15|IC=70nM|IC50|=|70|nM|70|nM
6AFR|2.00|2018|9E3|ligand is compound 38,IC50=70+/-19nM|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|7.15|IC=70nM|IC50|=|70|nM|70|nM
6FGY|1.54|2018|D9W|ligand is compound 4|P56817|BETA-SECRETASE 1|7.15|IC=70nM|IC50|=|70|nM|70|nM
6MX3|1.36|2018|K5P|[Different ligand in assay: X-ray structure of 1 in STING protein is a symmetrical dimer] ligand is compound 1|Q86WV6|STIMULATOR OF INTERFERON GENES PROTEIN|5.14|IC=7300nM|IC50|=|7300|nM|7300|nM
5XII|2.17|2018|86X|[Nonstandard assay: Temp 37] ligand is In-6,IC50=75+/-6nM|S8G8I1|PROLYL-TRNA SYNTHETASE (PRORS)|7.12|IC=75nM|IC50|=|75|nM|75|nM
6HTH|1.95|2018|GQN|ligand is compound 5; IC50 = 75 +/- 25 nM|A5H660|HISTONE DEACETYLASE|7.12|IC=75nM|IC50|=|75|nM|75|nM
6G92|1.99|2018|ERZ|ligand is compound 5|P28482|MITOGEN-ACTIVATED PROTEIN KINASE 1|4.12|IC=76000nM|IC50|=|76000|nM|76000|nM
5VM6|1.50|2018|9EG|[Multiple sites: ] ligand is TCC|------|SINGLE DOMAIN CAMELID NANOBODY VHH T10|7.11|IC=78nM|IC50|=|78|nM|78|nM
6HM7|1.64|2018|GDH|ligand is compound 44|P43405|TYROSINE-PROTEIN KINASE SYK|7.1|IC=79.4nM|IC50|=|79.4|nM|79.4|nM
6F6D|1.82|2018|17-mer|ligand is peptide H3(17-33)A21M; IC50 = 79.4 +/- 0.1 uM|O15054|LYSINE-SPECIFIC DEMETHYLASE 6B|4.1|IC=79.4uM|IC50|=|79.4|uM|79400|nM
6B5J|2.97|2018|CV4|ligand is compound 4|Q59H18|SERINE/THREONINE-PROTEIN KINASE TNNI3K|7.1|IC=79nM|IC50|=|79|nM|79|nM
6DCG|1.45|2018|G67|ligand is compound 20(MK-8353);|P63086|MITOGEN-ACTIVATED PROTEIN KINASE 1|8.15|IC=7nM|IC50|=|7|nM|7|nM
6FYL|1.95|2018|3NG|ligand is CX-4945|P49760|DUAL SPECIFICITY PROTEIN KINASE CLK2|8.15|IC=7nM|IC50|=|7|nM|7|nM
6F8T|1.80|2018|CZT|ligand is GEBR-4a; IC50 = 7 +/- 2 uM|Q08499|CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D|5.15|IC=7uM|IC50|=|7|uM|7000|nM
6E0Q|2.35|2018|HKD|ligand is compound 33; IC50 = 8.0 +/- 1.1 nM|C3W5S0|POLYMERASE ACIDIC PROTEIN|8.1|IC=8.0nM|IC50|=|8|nM|8|nM
6ETY|1.68|2018|BXK|IC50(8)=8.9+/-0.1nM|Q04609|GLUTAMATE CARBOXYPEPTIDASE 2|8.05|IC=8.9nM|IC50|=|8.9|nM|8.9|nM
6BO6|2.80|2018|E0V|in vitro inhibition assay, IC50(UNC4917)=80+/-1nM|C4Z6Z2|GLYCOSIDE HYDROLASE FAMILY 2 CANDIDATE B-GLUCURONIDASE|7.1|IC=80nM|IC50|=|80|nM|80|nM
6EMH|1.76|2018|BGE|Ligand is compound 38; IC50 = 833+/-139nM|P53779|MITOGEN-ACTIVATED PROTEIN KINASE 10|6.08|IC=833nM|IC50|=|833|nM|833|nM
5XPO|2.28|2018|8BL|ligand is 5a,IC50=84+/-0.50nM|P13053|VITAMIN D3 RECEPTOR|7.08|IC=84nM|IC50|=|84|nM|84|nM
6FFI|2.20|2018|D8B|ligand is compound 3 (M-MPEP); IC50= 8 +/- 2 nM|P41594|METABOTROPIC GLUTAMATE RECEPTOR 5, ENDOLYSIN|8.1|IC=8nM|IC50|=|8|nM|8|nM
5W6E|1.90|2018|0NY|IC50 = 9.1 +/- 0.5 nM. ligand is compound (S)-3|Q01064|CALCIUM/CALMODULIN-DEPENDENT 3',5'-CYCLIC NUCLEOTIDE|8.04|IC=9.1nM|IC50|=|9.1|nM|9.1|nM
5XYY|1.70|2018|P0F|ligand is compound 3, IC50=9.221+/-0.455uM|Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|5.04|IC=9.221uM|IC50|=|9.221|uM|9221|nM
6AY3|1.39|2018|C3J|ligand is compound 16|Q92793|CREB-BINDING PROTEIN|8.02|IC=9.5nM|IC50|=|9.5|nM|9.5|nM
5YGI|2.18|2018|T93|inhibition assay|P14324|FARNESYL PYROPHOSPHATE SYNTHASE|7.05|IC=90nM|IC50|=|90|nM|90|nM
6I3S|1.77|2018|H28|ligand is compound 13|Q00987|E3 UBIQUITIN-PROTEIN LIGASE MDM2|7.05|IC=90nM|IC50|=|90|nM|90|nM
6EZH|2.60|2018|C6H|[Different protein in assay: X-ray(Tetronarce californica); IC50(human)] ligand is compound 6a; IC50 = 91.4 +/- 12.7 nM|P04058|ACETYLCHOLINESTERASE|7.04|IC=91.4nM|IC50|=|91.4|nM|91.4|nM
5YQN|1.60|2018|L55|ligand is compound 24b|Q8IXJ6|NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-2|4.03|IC=93.7uM|IC50|=|93.7|uM|93700|nM
6HSK|2.10|2018|GOK|ligand is Quisinostat; IC50 = 93 +/- 8 nM|Q9BY41|HISTONE DEACETYLASE 8|7.03|IC=93nM|IC50|=|93|nM|93|nM
6EX0|2.78|2018|C1Z|ligand is compound pppGpp; IC50=94+/-26uM|W8U368|GTP PYROPHOSPHOKINASE|4.03|IC=94uM|IC50|=|94|uM|94000|nM
6HTI|1.69|2018|GQW|ligand is compound 6; IC50 = 97 +/- 16 nM|A5H660|HISTONE DEACETYLASE|7.01|IC=97nM|IC50|=|97|nM|97|nM
5WF7|2.50|2018|A9G|ligand is GSK126|G0S8H7|POLYCOMB PROTEIN EED|4.01|IC=98.5uM|IC50|=|98.5|uM|98500|nM
6AXQ|1.30|2018|C2Y|ligand is compound 6|Q92793|CREB-BINDING PROTEIN|4.0|IC=99000nM|IC50|=|99000|nM|99000|nM
6BTO|2.05|2018|E8P|ligand is compound 9|P13497|BONE MORPHOGENETIC PROTEIN 1|5.0|IC>10000nM|IC50|>|10000|nM|10000|nM
6BQJ|1.69|2018|Z1B|[Different protein in assay: protein in binding assay is genotype-1a] ligand is compound 16|A8DG50|NS3 PROTEASE|6.0|IC>1000nM|IC50|>|1000|nM|1000|nM
6FH6|2.08|2018|D8Q|ligand is compound 1|Q9UIF8|BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN PROTEIN 2B|3.0|IC>1000uM|IC50|>|1000|uM|1000000|nM
6FH7|2.10|2018|EN2|ligand is compound 2|Q9UIF8|BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN PROTEIN 2B|3.0|IC>1000uM|IC50|>|1000|uM|1000000|nM
6FT7|2.02|2018|E6Q|ligand is compound 8a|P49761|DUAL SPECIFICITY PROTEIN KINASE CLK3|5.0|IC>10uM|IC50|>|10|uM|10000|nM
5YP6|2.20|2018|4CX|ligand is 6, pIC50<4.6|P51449|NUCLEAR RECEPTOR ROR-GAMMA|4.6|IC>25uM|IC50|>|25|uM|25000|nM
5YP5|2.65|2018|4CZ|ligand is 5d, pIC50<4.6|P51449|NUCLEAR RECEPTOR ROR-GAMMA|4.6|IC>25uM|IC50|>|25|uM|25000|nM
6GQM|2.00|2018|F8H|ligand is compound 44|P10721|MAST/STEM CELL GROWTH FACTOR RECEPTOR KIT|4.48|IC>33.3uM|IC50|>|33.3|uM|33300|nM
5O4T|1.50|2018|9KT|ligand is compound 9|P55201|PEREGRIN|3.4|IC>400uM|IC50|>|400|uM|400000|nM
6BSX|1.65|2018|E7S|ligand is compund 1|Q15382|GTP-BINDING PROTEIN RHEB|3.3|IC>500uM|IC50|>|500|uM|500000|nM
6DI0|1.30|2018|GJG|Ligand is compound 6; binding assay: microfluidic, off-chip mobility shift kinase assay|Q06187|TYROSINE-PROTEIN KINASE BTK|5.22|IC>6000nM|IC50|>|6000|nM|6000|nM
5O5H|1.85|2018|9LK|ligand is compound 43|P55201|PEREGRIN|4.12|IC>75uM|IC50|>|75|uM|75000|nM
6F5M|2.70|2018|CQH||P08246|NEUTROPHIL ELASTASE|6.3|IC~0.5uM|IC50|~|0.5|uM|500|nM
6BOY|3.33|2018|RN6|ligand is compound dBET6(4)|Q16531|DNA DAMAGE-BINDING PROTEIN 1|5.74|IC~1.8uM|IC50|~|1.8|uM|1800|nM
5YE8|1.85|2018|8U3|ligand is compound 10|Q13093|PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE|3.0|IC~1mM|IC50|~|1|mM|1000000|nM
5UQ9|3.00|2018|8HS|enzymic assay|P52209|6-PHOSPHOGLUCONATE DEHYDROGENASE, DECARBOXYLATING|6.15|IC~700nM|IC50|~|700|nM|700|nM
6B5M|1.79|2018|15-mer|ligand is petide 21|------|CIS43 FAB HEAVY CHAIN|12.0|Kd<0.001nM|Kd|<|0.001|nM|0.001|nM
6D59|1.70|2018|FVJ|ligand is compound 58; Binding assay: FPA|P01112|GTPASE HRAS|7.0|Kd<0.10uM|Kd|<|0.1|uM|100|nM
6FEL|2.84|2018|8-mer|ligand is peptide pepS511|P61981|14-3-3 PROTEIN GAMMA|6.4|Kd<0.4uM|Kd|<|0.4|uM|400|nM
5ZO7|2.60|2018|5C5|ligand is PVEI0138|P52732|KINESIN-LIKE PROTEIN KIF11|9.0|Kd<1nM|Kd|<|1|nM|1|nM
6FS0|2.25|2018|E4W|ligand is compound (Ra)-7|Q07820|INDUCED MYELOID LEUKEMIA CELL DIFFERENTIATION PROTEIN MCL-1|9.77|Kd=0.00017uM|Kd|=|0.00017|uM|0.17|nM
5MPK|1.90|2018|0BC|ligand is compound 13|Q92793|CREB-BINDING PROTEIN|8.52|Kd=0.003uM|Kd|=|0.003|uM|3|nM
6MA3|2.00|2018|JAJ|ligand is compound 2a; Kd = 0.005 +/- 0.001uM|O15294|UDP-N-ACETYLGLUCOSAMINE--PEPTIDE N|8.3|Kd=0.005uM|Kd|=|0.005|uM|5|nM
6MA5|2.00|2018|J9V|ligand is compound 4a; Kd = 0.008 +/- 0.001uM|O15294|UDP-N-ACETYLGLUCOSAMINE--PEPTIDE N|8.1|Kd=0.008uM|Kd|=|0.008|uM|8|nM
6MA1|2.75|2018|JA4|ligand is compound 4a; Kd = 0.008 +/- 0.001uM|O15294|UDP-N-ACETYLGLUCOSAMINE--PEPTIDE N|8.1|Kd=0.008uM|Kd|=|0.008|uM|8|nM
6D56|1.68|2018|FVM|ligand is compound 65; Binding assay: FPA; Kd = 0.009+/-0.0017uM|P01112|GTPASE HRAS|8.05|Kd=0.009uM|Kd|=|0.009|uM|9|nM
6EQ8|2.19|2018|BQZ|Kd = 0.010+/-0.001uM|------|PERIPLASMIC ALPHA-GALACTOSIDE-BINDING PROTEIN|8.0|Kd=0.010uM|Kd|=|0.01|uM|10|nM
6CUS|NMR|2018|IHP|ligand is compound IP6; Kd = 0.013+/-0.001 mM|P03354|MATRIX PROTEIN P19|4.89|Kd=0.013mM|Kd|=|0.013|mM|13000|nM
6CKS|1.72|2018|F5Y|ligand is compound 35|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|7.82|Kd=0.015uM|Kd|=|0.015|uM|15|nM
5NLK|1.80|2018|92E|ligand is compound 16|Q92793|CREB-BINDING PROTEIN|7.46|Kd=0.035uM|Kd|=|0.035|uM|35|nM
6EOL|1.50|2018|BKH|ligand is compound 2h; Kd=0.037+/-0.0010 uM|P17931|GALECTIN-3|7.43|Kd=0.037uM|Kd|=|0.037|uM|37|nM
6FA3|1.82|2018|D1Z|ligand is Abd-6|P01116|GTPASE KRAS|7.42|Kd=0.038uM|Kd|=|0.038|uM|38|nM
6FYZ|2.15|2018|EBE|ligand is compound 16|P56524|HISTONE DEACETYLASE 4|7.41|Kd=0.039uM|Kd|=|0.039|uM|39|nM
6D55|1.68|2018|FWA|ligand is compound 64; binding assay: FPA; Kd = 0.044+/-0.0067uM|P01112|GTPASE HRAS|7.36|Kd=0.044uM|Kd|=|0.044|uM|44|nM
6MA4|2.00|2018|JA7|ligand is compound 3a; Kd = 0.045 +/- 0.02uM|O15294|UDP-N-ACETYLGLUCOSAMINE--PEPTIDE N|7.35|Kd=0.045uM|Kd|=|0.045|uM|45|nM
6FA4|2.02|2018|D1W|ligand is Abd-7|P01116|GTPASE KRAS|7.29|Kd=0.051uM|Kd|=|0.051|uM|51|nM
5YGD|1.55|2018|11-mer|[Nonstandard assay: Tem 20,PH=8.0] ligand is Piwi-R10me2s,Kd=0.054+/-0.018uM|Q9VQ91|GH18329P|7.27|Kd=0.054uM|Kd|=|0.054|uM|54|nM
6CKR|1.62|2018|F5V|ligand is compound 32|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|7.3|Kd=0.05uM|Kd|=|0.05|uM|50|nM
6BH1|1.93|2018|DQG|[Different protein in assay] ligand is compound N52; Kd = 0.06+/-0.01 uM|P29375|LYSINE-SPECIFIC DEMETHYLASE 5A, LINKED KDM5A JMJ DOMAIN|7.22|Kd=0.06uM|Kd|=|0.06|uM|60|nM
6EPZ|1.80|2018|MLB|Kd = 0.072+/-0.004uM|------|PERIPLASMIC ALPHA-GALACTOSIDE-BINDING PROTEIN|7.14|Kd=0.072uM|Kd|=|0.072|uM|72|nM
6CHP|1.94|2018|F0Y|ligand is compound 11|P0A6I6|PHOSPHOPANTETHEINE ADENYLYLTRANSFERASE|10.12|Kd=0.075nM|Kd|=|0.075|nM|0.075|nM
6HT1|2.10|2018|GQ5|ligand is compound 92|Q03111|PROTEIN ENL|7.11|Kd=0.077uM|Kd|=|0.077|uM|77|nM
5MPN|1.23|2018|YE5|ligand is compound 19|Q92793|CREB-BINDING PROTEIN|7.07|Kd=0.085uM|Kd|=|0.085|uM|85|nM
6AS8|2.10|2018|BTG|bio-layer interferometry experiment, Kd=0.089+/-0.4uM|Q1RBS0|FML FIMBRIAL ADHESIN FMLD|7.05|Kd=0.089uM|Kd|=|0.089|uM|89|nM
5YPO|2.29|2018|15-mer|[Nonstandard assay: PH=8] ligand is pSAPAP1-R2,Kd=0.08+/-0.01uM|P31016|DISKS LARGE HOMOLOG 4|7.1|Kd=0.08uM|Kd|=|0.08|uM|80|nM
6B2C|2.00|2018|C9Y|ligand is 4b,Ki=0.090uM|P14174|MACROPHAGE MIGRATION INHIBITORY FACTOR|7.03|Kd=0.094uM|Kd|=|0.094|uM|94|nM
5UNP|2.92|2018|8FY|ligand is T-025|P49760|DUAL SPECIFICITY PROTEIN KINASE CLK2|10.02|Kd=0.096nM|Kd|=|0.096|nM|0.096|nM
6FS1|1.60|2018|E4Q|ligand is compound 4|Q07820|INDUCED MYELOID LEUKEMIA CELL DIFFERENTIATION PROTEIN MCL|7.01|Kd=0.098uM|Kd|=|0.098|uM|98|nM
5YJ8|1.76|2018|8W9|ligand is compound 1,Kd=0.104+/-0.002mM|Q9H7E2|TUDOR DOMAIN-CONTAINING PROTEIN 3|3.98|Kd=0.104mM|Kd|=|0.104|mM|104000|nM
6AFL|1.60|2018|73H|[Covalent complex] ligand is 15,Kd=0.10+/-0.01uM(ITC),Kd=0.064+/-0.001uM(SPR)|Q99497|PROTEIN/NUCLEIC ACID DEGLYCASE DJ-1|7.0|Kd=0.10uM|Kd|=|0.1|uM|100|nM
6B1C|2.16|2018|C9J|ligand is 4a,Ki=0.075uM|P14174|MACROPHAGE MIGRATION INHIBITORY FACTOR|6.95|Kd=0.111uM|Kd|=|0.111|uM|111|nM
5YMX|1.35|2018|GDP|Kd=0.12+/-0.03uM|Q1DB04|MUTUAL GLIDING-MOTILITY PROTEIN MGLA|6.92|Kd=0.12uM|Kd|=|0.12|uM|120|nM
6D5H|1.80|2018|FV7|ligand is compound 38; binding assay: FPA; Kd = 0.12+/-0.034uM|P01112|GTPASE HRAS|6.92|Kd=0.12uM|Kd|=|0.12|uM|120|nM
5YWX|1.74|2018|93C|ligand is F092,Kd=0.14+/-0.010nM|O60760|HEMATOPOIETIC PROSTAGLANDIN D SYNTHASE|9.85|Kd=0.14nM|Kd|=|0.14|nM|0.14|nM
6H7O|2.80|2018|P32|[Incomplete ligand] [Different ligand in assay: Ligand in binding assay is racemic mixture] ligand is cyanopindolol|P0AA25|THIOREDOXIN 1|9.85|Kd=0.14nM|Kd|=|0.14|nM|0.14|nM
6D5E|1.75|2018|FVG|ligand is compound 47; binding assay: FPA; Kd = 0.14+/-0.009uM|P01112|GTPASE HRAS|6.85|Kd=0.14uM|Kd|=|0.14|uM|140|nM
6BGY|1.22|2018|DLJ|[Different protein in assay] ligand is compound N46; Kd = 0.15+/-0.01 uM|P29375|LYSINE-SPECIFIC DEMETHYLASE 5A, LINKED KDM5A JMJ DOMAIN|6.82|Kd=0.15uM|Kd|=|0.15|uM|150|nM
6AJJ|2.79|2018|J9E|microscale thermophoresis assay, Kd(ICA38)=0.16+/-0.02uM|I7G2R2|DRUG EXPORTERS OF THE RND SUPERFAMILY-LIKE PROTEIN|6.8|Kd=0.16uM|Kd|=|0.16|uM|160|nM
6CVE|2.20|2018|CTP|ligand is CTP; Kd = 0.16 +/- 0.01 uM|P9WPQ5|ATP-DEPENDENT DETHIOBIOTIN SYNTHETASE BIOD|6.8|Kd=0.16uM|Kd|=|0.16|uM|160|nM
6BGV|1.59|2018|DQG|[Different protein in assay] ligand is compound N40; Kd = 0.18+/-0.02 uM|P29375|LYSINE-SPECIFIC DEMETHYLASE 5A, LINKED KDM5A JMJ DOMAIN|6.74|Kd=0.18uM|Kd|=|0.18|uM|180|nM
6GHH|1.90|2018|TDA|ligand is C13, Kd = 0.193 +/- 0.031 uM|P02754|BETA-LACTOGLOBULIN|6.71|Kd=0.193uM|Kd|=|0.193|uM|193|nM
5YA5|1.89|2018|6TD|ligand is HL-11|P08581|HEPATOCYTE GROWTH FACTOR RECEPTOR|6.72|Kd=0.19uM|Kd|=|0.19|uM|190|nM
6FO5|.95|2018|DZH|ligand is compound 17; Kd = 0.19 +/- 0.07 uM|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|6.72|Kd=0.19uM|Kd|=|0.19|uM|190|nM
6MSY|2.00|2018|4-mer||P0DOX7|ANTIBODY FAB 2G12, LIGHT CHAIN|7.0|Kd=0.1uM|Kd|=|0.1|uM|100|nM
6MUB|2.50|2018|5-mer||P0DOX7|ANTIBODY FAB 2G12, LIGHT CHAIN|7.0|Kd=0.1uM|Kd|=|0.1|uM|100|nM
6EQ7|1.50|2018|BS8|compound 11|P36639|7,8-DIHYDRO-8-OXOGUANINE TRIPHOSPHATASE|7.0|Kd=0.1uM|Kd|=|0.1|uM|100|nM
6B1K|1.17|2018|C9G|ligand is 3a,Ki=0.363uM|P14174|MACROPHAGE MIGRATION INHIBITORY FACTOR|6.67|Kd=0.213uM|Kd|=|0.213|uM|213|nM
6BGW|1.64|2018|DKS|[Different protein in assay] ligand is compound N41; Kd = 0.21+/-0.02 uM|P29375|LYSINE-SPECIFIC DEMETHYLASE 5A, LINKED KDM5A JMJ DOMAIN|6.68|Kd=0.21uM|Kd|=|0.21|uM|210|nM
6FA2|2.60|2018|D2W|ligand is Abd-5|P01116|GTPASE KRAS|6.66|Kd=0.220uM|Kd|=|0.22|uM|220|nM
6BH0|1.99|2018|DO1|[Different protein in assay] ligand is compound N51; Kd = 0.22+/-0.03 uM|P29375|LYSINE-SPECIFIC DEMETHYLASE 5A, LINKED KDM5A JMJ DOMAIN|6.66|Kd=0.22uM|Kd|=|0.22|uM|220|nM
6CQZ|2.22|2018|_VX|[Covalent complex] Ligand in binding assay is P(R/S) form|P22303|ACETYLCHOLINESTERASE|9.64|Kd=0.23nM|Kd|=|0.23|nM|0.23|nM
6CQT|2.27|2018|_VX|[Covalent complex] Ligand in binding assay is P(S) form|P22303|ACETYLCHOLINESTERASE|9.64|Kd=0.23nM|Kd|=|0.23|nM|0.23|nM
6FSY|1.34|2018|E5Q|Kd(ITC)=0.247+/-0.08uM|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|6.61|Kd=0.247uM|Kd|=|0.247|uM|247|nM
5Y97|3.05|2018|LAT|ligand is lactose, ITC Kb = 4x1000 M-1|U3KRF8|SEED LECTIN|3.6|Kd=0.25mM|Kd|=|0.25|mM|250000|nM
5Z7J|1.98|2018|36J|ligand is alpha-ZOL|------|LACTONASE FOR PROTEIN|6.6|Kd=0.25uM|Kd|=|0.25|uM|250|nM
6BH5|1.65|2018|DNY|[Different protein in assay] ligand is compound N48; Kd = 0.25+/-0.02 uM|P29375|LYSINE-SPECIFIC DEMETHYLASE 5A, LINKED KDM5A JMJ DOMAIN|6.6|Kd=0.25uM|Kd|=|0.25|uM|250|nM
6D5G|1.92|2018|FVD|ligand is compound 43; binding assay: FPA; Kd = 0.25+/-0.057uM|P01112|GTPASE HRAS|6.6|Kd=0.25uM|Kd|=|0.25|uM|250|nM
6DQ8|1.46|2018|H6S|[Different ligand in assay: Ligand in binding assay is racemic, both R and S form can bind with protein] ligand is compound N49; Kd = 0.26+/-0.03 uM|P29375|LINKED KDM5A JMJ DOMAIN|6.59|Kd=0.26uM|Kd|=|0.26|uM|260|nM
6DF1|2.30|2018|3-mer|Biolayer Interferometry assay, ligand is pY peptide|------|ANTI-PHOSPHOTYROSINE ANTIBODY 4G10-4D5 HEAVY CHAIN|6.56|Kd=0.277uM|Kd|=|0.277|uM|277|nM
6BNT|3.20|2018|15-mer|AP2M1: YMPMpS|Q96CW1|AP-2 COMPLEX SUBUNIT MU|6.55|Kd=0.28uM|Kd|=|0.28|uM|280|nM
6GFS|2.00|2018|F15|ligand is C15, Kd = 0.291 +/- 0.117 uM|P02754|BETA-LACTOGLOBULIN|6.54|Kd=0.291uM|Kd|=|0.291|uM|291|nM
6F5U|2.07|2018|CQN|[Nonstandard assay: pH = 5.2] ligand is bepridil ; Kd=0.29 +/- 0.06 mM|Q05320|ENVELOPE GLYCOPROTEIN 1|3.54|Kd=0.29mM|Kd|=|0.29|mM|290000|nM
6AJH|2.82|2018|9ZF|microscale thermophoresis assay, Kd(AU1235)=0.29+/-0.04uM|I7G2R2|DRUG EXPORTERS OF THE RND SUPERFAMILY-LIKE PROTEIN|6.54|Kd=0.29uM|Kd|=|0.29|uM|290|nM
6NAO|3.23|2018|8ZP|ligand is compound PF-06928215|Q8N884|CYCLIC GMP-AMP SYNTHASE|6.7|Kd=0.2uM|Kd|=|0.2|uM|200|nM
5XHZ|1.32|2018|11-mer|ligand is ARAP1; Kd=0.32 +/- 0.03 uM|Q8R550|SH3 DOMAIN-CONTAINING KINASE-BINDING PROTEIN 1|6.49|Kd=0.32uM|Kd|=|0.32|uM|320|nM
5YYF|1.90|2018|7-mer|ligand is XL-07i|P42568|PROTEIN AF-9|6.48|Kd=0.33uM|Kd|=|0.33|uM|330|nM
6EPY|2.04|2018|RAF|Kd = 0.347+/-0.42uM|------|PERIPLASMIC ALPHA-GALACTOSIDE-BINDING PROTEIN|6.46|Kd=0.347uM|Kd|=|0.347|uM|347|nM
5W4E|2.18|2018|16-mer|[Incomplete ligand] Kd(FP)=0.349+/-0.036uM|P52293|IMPORTIN SUBUNIT ALPHA-1,IMPORTIN SUBUNIT ALPHA-1|6.46|Kd=0.349uM|Kd|=|0.349|uM|349|nM
5V37|1.42|2018|8WD|kon=6.1E+5, koff=2.1E-4|Q9H7B4|HISTONE-LYSINE N-METHYLTRANSFERASE SMYD3|9.47|Kd=0.34nM|Kd|=|0.34|nM|0.34|nM
5Y21|1.77|2018|14-mer|Kd=0.34+/-0.08uM|Q9SRM4|PHD FINGER PROTEIN ALFIN-LIKE 2|6.47|Kd=0.34uM|Kd|=|0.34|uM|340|nM
5UC4|2.05|2018|83S|Kd = 0.35 +/- 0.13 uM. ligand is compound 4|P08238|HEAT SHOCK PROTEIN HSP90-BETA|6.46|Kd=0.35uM|Kd|=|0.35|uM|350|nM
6F7T|2.60|2018|12-mer|Kd = 0.36 +/- 0.04 nM|O31774|FAB RY79-90, LIGHT CHAIN|9.44|Kd=0.36nM|Kd|=|0.36|nM|0.36|nM
6AR2|1.55|2018|10-mer|[Incomplete ligand] [Nonstandard assay: Temp 20 C] ligand is pT378-MST|Q14BN4|SARCOLEMMAL MEMBRANE-ASSOCIATED PROTEIN|6.41|Kd=0.393uM|Kd|=|0.393|uM|393|nM
5ZIA|2.60|2018|9-mer|ligand is V1088-7|------|HEAVY CHAIN OF CBTAU-24.1 ANTIBODY|6.52|Kd=0.3uM|Kd|=|0.3|uM|300|nM
6FBV|3.50|2018|FI8|ligand is Lpm|P9WGZ1|DNA-DIRECTED RNA POLYMERASE SUBUNIT ALPHA|6.52|Kd=0.3uM|Kd|=|0.3|uM|300|nM
6GF9|2.10|2018|X90|ligand is C17, Kd = 0.411 +/- 0.129 uM|P02754|BETA-LACTOGLOBULIN|6.39|Kd=0.411uM|Kd|=|0.411|uM|411|nM
6BGZ|1.69|2018|DNV|[Different protein in assay] ligand is compound N47; Kd = 0.41+/-0.03 uM|P29375|LYSINE-SPECIFIC DEMETHYLASE 5A, LINKED KDM5A JMJ DOMAIN|6.39|Kd=0.41uM|Kd|=|0.41|uM|410|nM
5XJM|3.20|2018|8-mer|[Nonstandard assay: with Fab4A03] ligand is s-AngII, Kd=0.43+/-0.06nM|P50052|TYPE-2 ANGIOTENSIN II RECEPTOR,SOLUBLE CYTOCHROME B562|9.37|Kd=0.43nM|Kd|=|0.43|nM|0.43|nM
5Y53|1.60|2018|18-mer|Kd=0.43+/-0.06uM|Q9SRM4|PHD FINGER PROTEIN ALFIN-LIKE 2|6.37|Kd=0.43uM|Kd|=|0.43|uM|430|nM
6GHP|1.95|2018|EZ5|ligand is compound 3a|P31947|14-3-3 PROTEIN SIGMA|9.36|Kd=0.44nM|Kd|=|0.44|nM|0.44|nM
5UCJ|1.69|2018|KU3|Kd = 0.44 +/- 0.56 uM. ligand is compound 6b|P08238|HEAT SHOCK PROTEIN HSP90-BETA|6.36|Kd=0.44uM|Kd|=|0.44|uM|440|nM
5XO7|1.88|2018|36J|ligand is alpha-ZOL|------|LACTONASE FOR PROTEIN|6.36|Kd=0.44uM|Kd|=|0.44|uM|440|nM
6CVF|2.30|2018|CDP|Kd = 0.45+/-0.05uM; ligand is cytidine diphosphate|P9WPQ5|ATP-DEPENDENT DETHIOBIOTIN SYNTHETASE BIOD|6.35|Kd=0.45uM|Kd|=|0.45|uM|450|nM
6D5J|1.75|2018|FV4|ligand is compound 29; binding assay: FPA; Kd = 0.46+/-0.078uM|P01112|GTPASE HRAS|6.34|Kd=0.46uM|Kd|=|0.46|uM|460|nM
6BGX|1.88|2018|DKV|[Different protein in assay] ligand is compound N42; Kd = 0.47+/-0.05 uM|P29375|LYSINE-SPECIFIC DEMETHYLASE 5A, LINKED KDM5A JMJ DOMAIN|6.33|Kd=0.47uM|Kd|=|0.47|uM|470|nM
6BNY|3.34|2018|E0M|IC50 = 0.4 +/- 0.05uM. ligand is compound 9|Q9UHD2|SERINE/THREONINE-PROTEIN KINASE TBK1|6.4|Kd=0.4uM|Kd|=|0.4|uM|400|nM
6COJ|1.40|2018|F8G|[Different protein in assay: Protein in binding assay is E105AA] ligand is COCHEA-CoA; Kd = 0.4+/-0.2 uM|Q0S7P9|PROBABLE COA-TRANSFERASE ALPHA SUBUNIT|6.4|Kd=0.4uM|Kd|=|0.4|uM|400|nM
6GVZ|1.54|2018|CHO|ligand is GCDCA|J9XXB7|CAPSID PROTEIN VP1|6.4|Kd=0.4uM|Kd|=|0.4|uM|400|nM
5YF1|2.40|2018|8V0|ligand is carnosine,the binding assay is tested in the present of SFG.|Q8N4J0|CARNOSINE N-METHYLTRANSFERASE|3.28|Kd=0.52mM|Kd|=|0.52|mM|520000|nM
6AFJ|1.48|2018|73G|[Covalent complex] ligand is 13,Kd=0.52+/-0.02uM(ITC)|Q99497|PROTEIN/NUCLEIC ACID DEGLYCASE DJ-1|6.28|Kd=0.52uM|Kd|=|0.52|uM|520|nM
6BGU|1.68|2018|DKP|ligand is compound N9; Kd = 0.53+/-0.06 uM|P29375|LYSINE-SPECIFIC DEMETHYLASE 5A, LINKED KDM5A JMJ DOMAIN|6.28|Kd=0.53uM|Kd|=|0.53|uM|530|nM
6E8M|1.61|2018|13-mer|ligand is peptide DnaJ-A1-pTyr381; fluorescence polarization assay, Kd = 0.53+/-0.08uM|D3HJY4|LESH (LLO2327)|6.28|Kd=0.53uM|Kd|=|0.53|uM|530|nM
5OXL|2.66|2018|2-mer|Kd = 0.56 + 0.08 mM, ligand is Ala-Leu|Q5M4H8|DI-OR TRIPEPTIDE:H+ SYMPORTER|3.25|Kd=0.56mM|Kd|=|0.56|mM|560000|nM
6CZI|2.30|2018|38E|ligand is compound DFHBI; Kd = 0.56+/-0.07uM|------|MFAP1|6.25|Kd=0.56uM|Kd|=|0.56|uM|560|nM
6ER3|1.37|2018|2-mer|[Incomplete ligand] ligand is compound 3'SL; ligand in the crystal is Sia-Gal; Kd=0.57+/-0.05mM|A7B557|BNR/ASP-BOX REPEAT PROTEIN|3.24|Kd=0.57mM|Kd|=|0.57|mM|570000|nM
6DRX|3.10|2018|H8G|Ligand is compound LSD|P41595|5HT2B RECEPTOR, BRIL CHIMERA|9.24|Kd=0.58nM|Kd|=|0.58|nM|0.58|nM
6CE2|2.15|2018|SVR|ligand is suramin; Kd = 0.5+/-0.2uM( ratio of MjTX-I/suramin = 1:1)|P82114|BASIC PHOSPHOLIPASE A2 HOMOLOG 1|6.3|Kd=0.5uM|Kd|=|0.5|uM|500|nM
5VYY|1.79|2018|9QY|Kd = 0.62 +/- 0.13 uM. ligand is compound 1|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|6.21|Kd=0.62uM|Kd|=|0.62|uM|620|nM
5YGF|1.70|2018|9-mer|[Nonstandard assay: Tem 20,PH=8.0] ligand is Piwi-unme,Kd=0.62+/-0.07uM|Q9VQ91|GH18329P|6.21|Kd=0.62uM|Kd|=|0.62|uM|620|nM
6MWE|2.05|2018|919|ligand is rebastinib; IC50 = 0.63 +/- 0.08 nM|Q02763|ANGIOPOIETIN-1 RECEPTOR|9.2|Kd=0.63nM|Kd|=|0.63|nM|0.63|nM
6AFI|1.65|2018|73D|[Covalent complex] ligand is 11,Kd=0.63+/-0.02uM(ITC),Kd=0.48+/-0.08uM(SPR)|Q99497|PROTEIN/NUCLEIC ACID DEGLYCASE DJ-1|6.2|Kd=0.63uM|Kd|=|0.63|uM|630|nM
6F6I|2.40|2018|8PR|[Nonstandard assay: pH = 5.2] ligand is paroxetine; Kd = 0.65 +/- 0.07mM|Q05320|ENVELOPE GLYCOPROTEIN 1|3.19|Kd=0.65mM|Kd|=|0.65|mM|650000|nM
6C91|2.90|2018|EQD|Kd = 0.65+/- 0.02 uM. ligand is compound 3|P41148|ENDOPLASMIN|6.19|Kd=0.65uM|Kd|=|0.65|uM|650|nM
6GJN|1.70|2018|F0Q|ligand is compound 15; Kd = 0.6 +/- 0.4 uM|P62937|PEPTIDYL-PROLYL CIS-TRANS ISOMERASE A|6.22|Kd=0.6uM|Kd|=|0.6|uM|600|nM
6AFH|1.65|2018|73F|[Covalent complex] ligand is 10,Kd=0.75+/-0.02uM(ITC),Kd=0.46+/-0.10uM(SPR)|Q99497|PROTEIN/NUCLEIC ACID DEGLYCASE DJ-1|6.12|Kd=0.75uM|Kd|=|0.75|uM|750|nM
6E5X|1.50|2018|15-mer|[Different protein in assay: peptide used for bioassay is 549-571.] Kd(ITC)=0.75+/-0.095uM, peptide used for crystallization is 556-568|Q77DJ5|MINOR NUCLEOPROTEIN VP30|6.12|Kd=0.75uM|Kd|=|0.75|uM|750|nM
6FMJ|2.45|2018|DV5|ligand is compound 3; Kd = 0.76 +/- 0.02 uM (ITC)|Q15370|TRANSCRIPTION ELONGATION FACTOR B POLYPEPTIDE 2|6.12|Kd=0.76uM|Kd|=|0.76|uM|760|nM
6DKB|2.68|2018|FKY|ligand is compound 10b|P04629|HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR|9.15|Kd=0.7nM|Kd|=|0.7|nM|0.7|nM
6MU3|2.33|2018|4-mer|ligand is synthetic oligomannoses 7|P0DOX7|ANTIBODY FAB 2G12, LIGHT CHAIN|6.15|Kd=0.7uM|Kd|=|0.7|uM|700|nM
6EQ3|1.80|2018|BU5|compound 9|P36639|7,8-DIHYDRO-8-OXOGUANINE TRIPHOSPHATASE|6.15|Kd=0.7uM|Kd|=|0.7|uM|700|nM
6CDM|2.41|2018|8-mer|protein is vFP7.04, ligand is Fusion peptide|------|VFP7.04 ANTIBODY FAB HEAVY CHAIN|9.09|Kd=0.805nM|Kd|=|0.805|nM|0.805|nM
6CKW|2.06|2018|F6D|ligand is compound 51|P0A6I6|PHOSPHOPANTETHEINE ADENYLYLTRANSFERASE|9.08|Kd=0.83nM|Kd|=|0.83|nM|0.83|nM
6GE7|2.30|2018|EW8|ligand is C19, Kd = 0.867 +/- 0.184 uM|P02754|BETA-LACTOGLOBULIN|6.06|Kd=0.867uM|Kd|=|0.867|uM|867|nM
5Y6K|2.86|2018|8R6|[Uncommon element] ligand is Fe-tracer,Kd=0.68 +/- 0.11 uM|P02787|SEROTRANSFERRIN|6.07|Kd=0.86uM|Kd|=|0.86|uM|860|nM
5NWZ|2.37|2018|9CT|[Covalent complex] Kd = 0.8 +/- 0.2 nM. ligand is compound 8|P22455|FIBROBLAST GROWTH FACTOR RECEPTOR 4|9.1|Kd=0.8nM|Kd|=|0.8|nM|0.8|nM
5W5V|3.65|2018|ANW|IC50 = 0.8 +/- 0.1 uM. ligand is Amlexanox (1)|Q9UHD2|SERINE/THREONINE-PROTEIN KINASE TBK1|6.1|Kd=0.8uM|Kd|=|0.8|uM|800|nM
5MUC|2.60|2018|AH2|ligand is compound 4|P08191|PROTEIN FIMH|6.04|Kd=0.913uM|Kd|=|0.913|uM|913|nM
6E8K|1.71|2018|13-mer|ligand is peptide IL2Rbeta-pTyr387; fluorescence polarization assay, Kd = 0.91+/-0.06uM|D3HJY4|LESH (LLO2327)|6.04|Kd=0.91uM|Kd|=|0.91|uM|910|nM
6AFC|1.45|2018|72R|[Covalent complex] ligand is 4,Kd=0.93+/-0.05uM(ITC),Kd=0.46+/-0.14uM(SPR)|Q99497|PROTEIN/NUCLEIC ACID DEGLYCASE DJ-1|6.03|Kd=0.93uM|Kd|=|0.93|uM|930|nM
6F6N|2.15|2018|SRE|[Nonstandard assay: pH = 5.2] ligand is sertraline; Kd = 0.95 +/- 0.25 mM|Q05320|ENVELOPE GLYCOPROTEIN 1|3.02|Kd=0.95mM|Kd|=|0.95|mM|950000|nM
5OHT|1.87|2018|9VH|Kd=0.96+/-0.12uM|P32138|SULFOQUINOVOSIDASE|6.02|Kd=0.96uM|Kd|=|0.96|uM|960|nM
5UCH|2.65|2018|871|Kd = 0.97 +/- 0.03 uM. ligand is compound 2|P08238|HEAT SHOCK PROTEIN HSP90-BETA|6.01|Kd=0.97uM|Kd|=|0.97|uM|970|nM
5XWR|2.69|2018|12-mer|ligand is SALL4,Kd=1.04+/-0.06uM|Q09028|HISTONE-BINDING PROTEIN RBBP4|5.98|Kd=1.04uM|Kd|=|1.04|uM|1040|nM
6CDO|2.10|2018|8-mer|protein is vFP16.02, ligand is Fusion peptide|------|VFP16.02 FAB HEAVY CHAIN|8.97|Kd=1.06nM|Kd|=|1.06|nM|1.06|nM
6F09|1.59|2018|13-mer|Kd = 1.07 +/- 0.03 uM|P63104|14-3-3 PROTEIN ZETA/DELTA|5.97|Kd=1.07uM|Kd|=|1.07|uM|1070|nM
6EPA|1.82|2018|BNQ|ligand is compound IGS-1.76; Kd = 1.13 +/- 0.35uM|Q9VWX8|FI18190P1|5.95|Kd=1.13uM|Kd|=|1.13|uM|1130|nM
5OVC|1.55|2018|7-mer|Kd = 1.1 +/- 0.05 uM, ligand is CKAP|Q9JLU4|SH3 AND MULTIPLE ANKYRIN REPEAT DOMAINS PROTEIN 3|5.96|Kd=1.1uM|Kd|=|1.1|uM|1100|nM
5UMX|1.59|2018|RBF|Kd = 59.5 +/- 8.6 uM, ligand is riboflavin, protein is TnmS3|------|GLYOXALASE/BLEOMYCIN RESISANCE PROTEIN/DIOXYGENASE|5.96|Kd=1.1uM|Kd|=|1.1|uM|1100|nM
6B5I|2.60|2018|CU4|[Nonstandard assay: Tem 30 C] ligand is CM121,Kd=1.1+/-0.28uM,IC50=0.54+/-0.15uM|O94788|RETINAL DEHYDROGENASE 2|5.96|Kd=1.1uM|Kd|=|1.1|uM|1100|nM
6BU0|2.43|2018|IHP|ligand is compound InsP6; Kd = 1.1+/-0.2uM|O00443|PHOSPHATIDYLINOSITOL 4-PHOSPHATE 3-KINASE C2 DOMAIN|5.96|Kd=1.1uM|Kd|=|1.1|uM|1100|nM
6EY9|2.00|2018|C4N|ligand is compound 40; Kd = 1.24+/-0.14uM|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|5.91|Kd=1.24uM|Kd|=|1.24|uM|1240|nM
5UGM|2.10|2018|8A7|Kd(Edaglitazone)=1.26uM, Kd(Edaglitazone+C9)=0.63uM|P37231|PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA|5.9|Kd=1.26uM|Kd|=|1.26|uM|1260|nM
6F7C|2.00|2018|CVT|compound 12|P81947|TUBULIN ALPHA-1B CHAIN|5.9|Kd=1.26uM|Kd|=|1.26|uM|1260|nM
5YVX|1.59|2018|9-mer|[Nonstandard assay: Temp 20, PH=8] ligand is H3K4me1,Kd=1.29+/-0.15uM|Q2LAE1|HISTONE-LYSINE N-METHYLTRANSFERASE ASHH2|5.89|Kd=1.29uM|Kd|=|1.29|uM|1290|nM
6FV4|1.97|2018|16G|ligand is GlcNAc6P; Kd = 1.2 +/- 0.05 mM|A0QU89|N-ACETYLGLUCOSAMINE-6-PHOSPHATE DEACETYLASE|2.92|Kd=1.2mM|Kd|=|1.2|mM|1200000|nM
6GW4|2.30|2018|CHO|ligand is GCDCA|A0ZNP3|CAPSID PROTEIN|5.92|Kd=1.2uM|Kd|=|1.2|uM|1200|nM
6F6S|2.29|2018|CXQ|[Nonstandard assay: pH = 5.2] ligand is benztropine; Kd= 1.30 +/- 0.43 mM|Q05320|ENVELOPE GLYCOPROTEIN 1|2.89|Kd=1.30mM|Kd|=|1.3|mM|1300000|nM
6FMC|.90|2018|DUE|ligand is compound 1; Kd = 1.32 +/- 0.08 uM|O14786|NEUROPILIN-1|5.88|Kd=1.32uM|Kd|=|1.32|uM|1320|nM
6FMF|2.81|2018|DUE|ligand is compound 1; Kd = 1.32 +/- 0.08 uM|O14786|NEUROPILIN-1|5.88|Kd=1.32uM|Kd|=|1.32|uM|1320|nM
5WMT|2.75|2018|9QY|Kd = 1.38 +/- 0.11 uM. ligand is compound 1|P41148|ENDOPLASMIN|5.86|Kd=1.38uM|Kd|=|1.38|uM|1380|nM
5ZK8|3.00|2018|3C0|ligand is NMS; Kd=1.3+/-0.9nM|P08172|MUSCARINIC ACETYLCHOLINE RECEPTOR M2,REDESIGNED APO|8.89|Kd=1.3nM|Kd|=|1.3|nM|1.3|nM
6F7B|2.00|2018|CVQ|Kd(kPCA)=1.3+/-0.94nM, kon=4.1E+5, koff=2.2E-4|O43683|MITOTIC CHECKPOINT SERINE/THREONINE-PROTEIN KINASE BUB1|8.89|Kd=1.3nM|Kd|=|1.3|nM|1.3|nM
6MNF|2.76|2018|7-mer||P0DOX7|ANTIBODY FAB 2G12, LIGHT CHAIN|5.89|Kd=1.3uM|Kd|=|1.3|uM|1300|nM
5VB9|1.70|2018|15-mer|[Nonstandard assay: Temp = 8] ligand is 18-902|Q16552|INTERLEUKIN-17A|5.89|Kd=1.3uM|Kd|=|1.3|uM|1300|nM
5Z68|3.00|2018|ATP|ligand is ATP,Kd=1.3+/-0.2uM|Q8RDL3|DNA REPLICATION AND REPAIR PROTEIN RECF|5.89|Kd=1.3uM|Kd|=|1.3|uM|1300|nM
6EQ2|1.80|2018|BU8|compound 6|P36639|7,8-DIHYDRO-8-OXOGUANINE TRIPHOSPHATASE|5.89|Kd=1.3uM|Kd|=|1.3|uM|1300|nM
6BM5|1.50|2018|SAM|ligand is compound AdoMet; Kd = 1.43+/-0.05uM|P13009|METHIONINE SYNTHASE|5.84|Kd=1.43uM|Kd|=|1.43|uM|1430|nM
6EY8|2.16|2018|C4T|ligand is compound 38; Kd = 1.55+/-0.052uM|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|5.81|Kd=1.55uM|Kd|=|1.55|uM|1550|nM
5OWF|1.91|2018|GLN|[Nonstandard assay: Temp 20, pH=8.0] Kd = 1.59 +/- 0.23 uM. Protein is L117K mutant|P02911|LYSINE,ARGININE,ORNITHINE-BINDING PROTEIN|5.8|Kd=1.59uM|Kd|=|1.59|uM|1590|nM
6MJ7|1.41|2018|ARG||Q13501|SEQUESTOSOME-1|2.82|Kd=1.5mM|Kd|=|1.5|mM|1500000|nM
6FTP|1.80|2018|DM2|ligand is doxorubicin, Kd for S-conformation|P01011|ALPHA-1-ANTICHYMOTRYPSIN|5.82|Kd=1.5uM|Kd|=|1.5|uM|1500|nM
6CED|1.70|2018|EYA|ligand is compound 31|Q9UBN7|HISTONE DEACETYLASE 6|5.82|Kd=1.5uM|Kd|=|1.5|uM|1500|nM
6CMS|2.68|2018|5OD|ligand is compound SHP099; Kd = 1.5+/-0.23 uM|Q06124|TYROSINE-PROTEIN PHOSPHATASE, NON-RECEPTOR TYPE 11|5.82|Kd=1.5uM|Kd|=|1.5|uM|1500|nM
5VM0|1.79|2018|9EG|[Multiple sites: site 1: Kd = 1.60 nM, site 2: Kd = 1.10 nM.] ligand is TCC|------|CAMELID NANOBODY VHH T9|8.8|Kd=1.60nM|Kd|=|1.6|nM|1.6|nM
6EOG|1.20|2018|BKK|ligand is compound 1c; Kd=1.60+/-0.078 uM|P17931|GALECTIN-3|5.8|Kd=1.60uM|Kd|=|1.6|uM|1600|nM
5Y80|2.50|2018|IRE|[Multiple sites: two ligands in two binding sites respectively in the PDB structure] ligand is gefitinib,Kd=1.62nM(site1),Kd=285nM(site2)|O14976|CYCLIN-G-ASSOCIATED KINASE|8.79|Kd=1.62nM|Kd|=|1.62|nM|1.62|nM
6CDP|2.46|2018|8-mer|protein is vFP20.01, ligand is Fusion peptide|------|VFP20.01 ANTIBODY FAB HEAVY CHAIN|8.79|Kd=1.64nM|Kd|=|1.64|nM|1.64|nM
6AJG|2.60|2018|3RX|microscale thermophoresis assay, Kd(SQ109)=1.65+/-0.20uM|I7G2R2|DRUG EXPORTERS OF THE RND SUPERFAMILY-LIKE PROTEIN|5.78|Kd=1.65uM|Kd|=|1.65|uM|1650|nM
6B5R|1.78|2018|15-mer|ligand is petide 21|------|CIS42 FAB HEAVY CHAIN|8.77|Kd=1.69nM|Kd|=|1.69|nM|1.69|nM
5UN1|3.60|2018|BMK|Kd = 1.6 +/- 0.3 uM. ligand is MK-801|C0KD15|N-METHYL-D-ASPARTATE RECEPTOR SUBUNIT NR1-3A|5.8|Kd=1.6uM|Kd|=|1.6|uM|1600|nM
6CZF|1.95|2018|G4P|[Nonstandard assay: Mg2+]|P0AG16|AMIDOPHOSPHORIBOSYLTRANSFERASE|5.8|Kd=1.6uM|Kd|=|1.6|uM|1600|nM
6DXL|2.45|2018|HG4|ligand is compound 2; Kd is apparent dissociation constant|Q86WV6|STIMULATOR OF INTERFERON GENES PROTEIN|5.8|Kd=1.6uM|Kd|=|1.6|uM|1600|nM
6ER4|1.30|2018|3-mer|[Incomplete ligand] ligand is compound 6'SL; ligand in the crystal is SIA-GAL-BGC; Kd = 1.70+/-0.14mM|A7B557|BNR/ASP-BOX REPEAT PROTEIN|2.77|Kd=1.70mM|Kd|=|1.7|mM|1700000|nM
5OYD|2.10|2018|7-mer|[Covalent complex] Ki = 1.78 +/- 0.17 mM|B3PD52|CELLULASE, PUTATIVE, CEL5D|2.75|Kd=1.78mM|Kd|=|1.78|mM|1780000|nM
5ZA2|1.50|2018|NXL|[Covalent complex] ligand is avibactam,ki(app)=3.4+/-0.2uM|Q9L387|BETA-LACTAMASE|5.77|Kd=1.7uM|Kd|=|1.7|uM|1700|nM
5ZK3|2.60|2018|QNB|ligand is QNB,Kd=1.8+/-0.6nM|P08172|MUSCARINIC ACETYLCHOLINE RECEPTOR M2,APO-CYTOCHROME B562|8.74|Kd=1.8nM|Kd|=|1.8|nM|1.8|nM
5MWH|1.65|2018|UWX|ligand is compound 21|P55201|PEREGRIN|5.74|Kd=1.8uM|Kd|=|1.8|uM|1800|nM
5OM7|1.73|2018|DM2|ligand is doxorubicin, Kd for S-conformation|P01011|ALPHA-1-ANTICHYMOTRYPSIN|5.74|Kd=1.8uM|Kd|=|1.8|uM|1800|nM
6AVI|2.29|2018|KNA||P37231|PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA|5.71|Kd=1.94uM|Kd|=|1.94|uM|1940|nM
6B1H|1.80|2018|C8Y|[Covalent complex] ligand is compound 3,Kd=1.9+/-0.2nM,KPC-2-cocrystallized 3|Q9F663|CARBAPENEM-HYDROLYZING BETA-LACTAMASE KPC|8.72|Kd=1.9nM|Kd|=|1.9|nM|1.9|nM
6B1F|1.44|2018|C8Y|[Covalent complex] ligand is compound 3,Kd=1.9+/-0.2nM,KPC-2-soaked 3|Q9F663|CARBAPENEM-HYDROLYZING BETA-LACTAMASE KPC|8.72|Kd=1.9nM|Kd|=|1.9|nM|1.9|nM
5MTW|1.84|2018|13-mer|Kd(ITC)=1.9+/-0.2uM|P95257|SECB-LIKE CHAPERONE RV1957|5.72|Kd=1.9uM|Kd|=|1.9|uM|1900|nM
6CDG|1.60|2018|6-mer|ligand is peptide PGLWKS; Kd = 1.9+/-0.1uM|Q8IVV7|GLUCOSE-INDUCED DEGRADATION PROTEIN 4 HOMOLOG|5.72|Kd=1.9uM|Kd|=|1.9|uM|1900|nM
6EYT|2.21|2018|UDP|[Uncommon element] Kd = 1.9 +/- 0.5 uM; the ligand contains a Mn atom|------|TYPE III SECRETION SYSTEM EFFECTOR PROTEIN|5.72|Kd=1.9uM|Kd|=|1.9|uM|1900|nM
5O3R|1.90|2018|AMP|[Multiple sites: site 1: Kd = 10.1 +/- 1.1 uM; site 2: Kd = 7.4 +/- 0.3 uM; site 3: Kd = 244.9 +/- 9.8 uM.] Kd = 10.1 +/- 1.1 uM. ligand is AMP|P73954|MEMBRANE-ASSOCIATED PROTEIN SLR1513|5.0|Kd=10.1uM|Kd|=|10.1|uM|10100|nM
6GNW|1.75|2018|F52|ligand is compound 2,4,5-T|Q9PTT3|TRANSTHYRETIN|4.99|Kd=10.20uM|Kd|=|10.2|uM|10200|nM
6AOY|1.80|2018|145|bio-layer interferometry experiment, Kd=10.6+/-4.6uM|Q1RBS0|FML FIMBRIAL ADHESIN FMLD|4.97|Kd=10.6uM|Kd|=|10.6|uM|10600|nM
6ARM|1.50|2018|145|bio-layer interferometry experiment, Kd=10.6+/-4.6uM|Q1RBS0|F9 PILUS ADHESIN FMLH|4.97|Kd=10.6uM|Kd|=|10.6|uM|10600|nM
6DRT|2.12|2018|13-mer|Ligand is peptide KKEPEGLDFLFDA, Kd = 10.7+/-3.2uM|P04525|DNA POLYMERASE CLAMP|4.97|Kd=10.7uM|Kd|=|10.7|uM|10700|nM
6F4X|1.69|2018|FMC|[Incomplete ligand] [Multiple sites: site 1: Kd=10.7 +/-7.9 uM; site 2: Kd= 95.2 +/- 60.4 uM; site 3: Kd=3.10 +/- 6.22 mM] ligand is FA covalent with Pi|P56463|PURINE NUCLEOSIDE PHOSPHORYLASE DEOD-TYPE|4.97|Kd=10.7uM|Kd|=|10.7|uM|10700|nM
5OXN|2.20|2018|2-mer|Kd = 10.95 + 2.22 mM, ligand is Phe-Ala|Q5M4H8|DI-OR TRIPEPTIDE:H+ SYMPORTER|1.96|Kd=10.95mM|Kd|=|10.95|mM|10950000|nM
6FTZ|1.67|2018|E7E|ligand is compound 6|P00746|COMPLEMENT FACTOR D|3.0|Kd=1000uM|Kd|=|1000|uM|1000000|nM
6CT7|1.90|2018|11-mer|ligand is peptide N-terminal acetylated alpha-syn|------|BIIB054 FAB LIGHT CHAIN|7.0|Kd=100nM|Kd|=|100|nM|100|nM
5QAP|1.79|2018|AV7|ligand is compound 21a|Q6XEC0|BETA-LACTAMASE|4.0|Kd=100uM|Kd|=|100|uM|100000|nM
5QAM|1.87|2018|GA6|ligand is compound 17|Q6XEC0|BETA-LACTAMASE|4.0|Kd=100uM|Kd|=|100|uM|100000|nM
6BNK|3.20|2018|AGH|ligand is compound KRN7000; Kd=102+/-16nM|P01887|ANTIGEN-PRESENTING GLYCOPROTEIN CD1D1|6.99|Kd=102nM|Kd|=|102|nM|102|nM
6BEF|3.21|2018|3YI|ligand is compound 3-formyl rifamycin|P68440|SCAFFOLD PROTEIN D13|3.98|Kd=104uM|Kd|=|104|uM|104000|nM
5OS8|1.55|2018|J27|ligand is compound 11|P68400|CASEIN KINASE II, ALPHA SUBUNIT|3.98|Kd=105uM|Kd|=|105|uM|105000|nM
6FX1|2.10|2018|8-mer|ligand is N-glycan 1|------|LECTIN|3.98|Kd=105uM|Kd|=|105|uM|105000|nM
5UMY|1.78|2018|TNN|Kd = 108 +/- 13 nM, ligand is TNM A, protein is TnmS3|------|GLYOXALASE/BLEOMYCIN RESISANCE PROTEIN/DIOXYGENASE|6.97|Kd=108nM|Kd|=|108|nM|108|nM
5YVT|2.40|2018|NAI|IDH3 in complex with Mg(2+) and NADH|P50213|ISOCITRATE DEHYDROGENASE [NAD] SUBUNIT ALPHA|3.96|Kd=109uM|Kd|=|109|uM|109000|nM
5O22|2.10|2018|C3R||P24186|BIFUNCTIONAL PROTEIN FOLD|8.0|Kd=10nM|Kd|=|10|nM|10|nM
6FKQ|3.07|2018|19-mer|[Different ligand in assay: Ligand in binding assay is hDraxin-22. 22-aa] ligand is hDraxin-22 peptide|O95631|NETRIN-1|8.0|Kd=10nM|Kd|=|10|nM|10|nM
5ZW6|2.05|2018|6-mer|Kd=10+/-2.2nM|O64094|AIMR TRANSCRIPTIONAL REGULATOR|8.0|Kd=10nM|Kd|=|10|nM|10|nM
5YFT|2.21|2018|RI2|[Nonstandard assay: PH=8] ligand is R15P,protein is D204N mutant|O57947|RIBOSE 1,5-BISPHOSPHATE ISOMERASE|5.0|Kd=10uM|Kd|=|10|uM|10000|nM
5XIW|2.90|2018|LOC|ligand is colchicine; Kd=11.03+/-2.57uM|Q2XVP4|TUBULIN ALPHA-1B CHAIN|4.96|Kd=11.03uM|Kd|=|11.03|uM|11030|nM
5NAP|2.17|2018|DZ7|Kd = 11.12 +/- 2.88 nM. Ki = dissociation constant in lecture|P04058|ACETYLCHOLINESTERASE|7.95|Kd=11.12nM|Kd|=|11.12|nM|11.12|nM
5YZ2|1.75|2018|AMP|[Nonstandard assay: pH 8.0] ligand is AMP,Kd=13.2uM in SPR|P0AE78|MAGNESIUM AND COBALT EFFLUX PROTEIN CORC|4.95|Kd=11.3uM|Kd|=|11.3|uM|11300|nM
6B5A|1.62|2018|CQS|[Different protein in assay: Protein in binding assay is CA IX] ligand is compound 29|P00918|CARBONIC ANHYDRASE 2|7.94|Kd=11.4nM|Kd|=|11.4|nM|11.4|nM
5YC2|2.70|2018|18-mer|[Different ligand in assay: Ligand in binding assay is Rap1 479-527] ligand is Rap1,Kd=11.4+/-1.2uM,IC50=50.9uM (Rap1 479-527)|Q12306|UBIQUITIN-LIKE PROTEIN SMT3,BOUQUET FORMATION PROTEIN 4|4.94|Kd=11.4uM|Kd|=|11.4|uM|11400|nM
6HMG|1.27|2018|2-mer|ligand is compound 4; Kd = 11.5 +/- 0.9 uM|D6D1V7|GLYCOSYL HYDROLASE FAMILY 71|4.94|Kd=11.5uM|Kd|=|11.5|uM|11500|nM
6HAI|2.20|2018|FWW|ligand is compound 3|Q8KRS7|ALBICIDIN RESISTANCE PROTEIN|7.94|Kd=11.6nM|Kd|=|11.6|nM|11.6|nM
5YQX|1.82|2018|E0K||O60885|BROMODOMAIN-CONTAINING PROTEIN 4|6.96|Kd=110nM|Kd|=|110|nM|110|nM
6BNL|2.60|2018|QWV|ligand is compound AH10-7; Kd=110+/-13nM|P01887|ANTIGEN-PRESENTING GLYCOPROTEIN CD1D1|6.96|Kd=110nM|Kd|=|110|nM|110|nM
5QA7|1.82|2018|IQQ|ligand is compound 4b|Q6XEC0|BETA-LACTAMASE|3.96|Kd=110uM|Kd|=|110|uM|110000|nM
5QAN|2.30|2018|M8Q|ligand is compound 19a|Q6XEC0|BETA-LACTAMASE|3.96|Kd=110uM|Kd|=|110|uM|110000|nM
6FGF|2.80|2018|EN2|ligand is compound 2|Q9UIF9|BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN PROTEIN 2A|3.96|Kd=110uM|Kd|=|110|uM|110000|nM
5O1C|1.32|2018|9GZ|ligand is compound 34|P04637|CELLULAR TUMOR ANTIGEN P53|3.95|Kd=113uM|Kd|=|113|uM|113000|nM
5O1G|1.35|2018|9GK|ligand is compound 55|P04637|CELLULAR TUMOR ANTIGEN P53|3.94|Kd=116uM|Kd|=|116|uM|116000|nM
6G9I|2.19|2018|CXX|ligand is clomipramine; Kd = 118 +/- 40 uM|Q05320|ENVELOPE GLYCOPROTEIN 1|3.93|Kd=118uM|Kd|=|118|uM|118000|nM
6CHN|2.03|2018|F1D|ligand is compound 9|P0A6I6|PHOSPHOPANTETHEINE ADENYLYLTRANSFERASE|7.96|Kd=11nM|Kd|=|11|nM|11|nM
5NN0|2.10|2018|92H|[Nonstandard assay: pH = 8] Ki = 11.1 +/- 0.46 pM. ligand is (+)-3|P06276|CHOLINESTERASE|10.96|Kd=11pM|Kd|=|11|pM|0.011|nM
5YC4|2.70|2018|9-mer|ligand is H3K4me3|Q9M2B4|PHD FINGER PROTEIN ALFIN-LIKE 3|4.92|Kd=12.1uM|Kd|=|12.1|uM|12100|nM
5NKN|2.20|2018|LOC|[Different protein in assay: Protein in binding assay is D6.2] Kd = 120 +/- 20 pM, ligand is colchicine|P80188|NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN|9.92|Kd=120pM|Kd|=|120|pM|0.12|nM
5QAA|1.95|2018|EAJ|ligand is compound 6a|Q6XEC0|BETA-LACTAMASE|3.91|Kd=123uM|Kd|=|123|uM|123000|nM
6MIN|1.90|2018|8-mer|Kd = 124 +/- 41 uM|P35189|TRANSCRIPTION INITIATION FACTOR TFIID SUBUNIT 14|3.91|Kd=124uM|Kd|=|124|uM|124000|nM
6GLB|2.00|2018|F48|ligand is compound 20; IC50 = 129 +/- 13 nM|P52333|TYROSINE-PROTEIN KINASE JAK3|6.89|Kd=129nM|Kd|=|129|nM|129|nM
6GFX|1.83|2018|19-mer|ligand is compound 13a; Kd = 12 +/- 2 nM|Q15370|ELONGIN-B|7.92|Kd=12nM|Kd|=|12|nM|12|nM
5OTR|1.52|2018|AU8|ligand is compound 14|P68400|CASEIN KINASE II, ALPHA SUBUNIT|4.92|Kd=12uM|Kd|=|12|uM|12000|nM
5YTU|1.90|2018|5FW|[Incomplete ligand] ligand is isoproterenol|P00441|SUPEROXIDE DISMUTASE|4.92|Kd=12uM|Kd|=|12|uM|12000|nM
6DQ4|1.39|2018|K0I|ligand is compound GSK-J1; Kd = 12+/-2 uM|P29375|LINKED KDM5A JMJ DOMAIN|4.92|Kd=12uM|Kd|=|12|uM|12000|nM
5O9O|1.90|2018|9PB|Kd = 13.00 +/- 0.01 uM. ligand is compound 7|Q06135|1,3-BETA-GLUCANOSYLTRANSFERASE GAS2|4.89|Kd=13.00uM|Kd|=|13|uM|13000|nM
6CLV|2.30|2018|6MB|[Incomplete ligand] [Different protein in assay: Protein in binding assay is wild type] ligand is compound SMX + pterin; Kd = 13.3 +/-3.5uM|O05701|DIHYDROPTEROATE SYNTHASE|4.88|Kd=13.3uM|Kd|=|13.3|uM|13300|nM
6E4U|3.27|2018|HU7|ligand is compound M2; Kd = 13.6+/-0.4nM|P54645|5'-AMP-ACTIVATED PROTEIN KINASE CATALYTIC SUBUNIT A|7.87|Kd=13.6nM|Kd|=|13.6|nM|13.6|nM
6AFG|1.50|2018|72V|[Covalent complex] ligand is 9,Kd=13.7+/-0.7uM(ITC)|Q99497|PROTEIN/NUCLEIC ACID DEGLYCASE DJ-1|4.86|Kd=13.7uM|Kd|=|13.7|uM|13700|nM
6GY5|1.09|2018|11-mer|[Incomplete ligand] ligand is DAPK1 peptide|Q9Y2M5|KELCH-LIKE PROTEIN 20|4.86|Kd=13.7uM|Kd|=|13.7|uM|13700|nM
5YFS|2.30|2018|RI2|[Nonstandard assay: PH=8] ligand is R15P, protein is C135S mutant|O57947|RIBOSE 1,5-BISPHOSPHATE ISOMERASE|4.86|Kd=13.8uM|Kd|=|13.8|uM|13800|nM
6CFD|2.57|2018|EZA|ligand is compound ADEP4|------|ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT|7.86|Kd=13.9nM|Kd|=|13.9|nM|13.9|nM
5XGL|3.44|2018|17-mer|[Incomplete ligand] [Nonstandard assay: PH=5.0] ligand is alpha-conotoxin LvIA|Q8WSF8|ACETYLCHOLINE RECEPTOR|6.88|Kd=131.6nM|Kd|=|131.6|nM|131.6|nM
5NWE|2.00|2018|G39|Kd = 13200 +/- 600 nM, ligand is oseltamivir carboxylate|C9EKP8|NEURAMINIDASE|4.88|Kd=13200nM|Kd|=|13200|nM|13200|nM
5Z99|1.49|2018|SLB|[Nonstandard assay: pH 8.0] ligand is Neu5Ac,Kd=133+/-22nM|Q7VL18|PUTATIVE ABC TRANSPORTER PERIPLASMIC BINDING PROTEIN|6.88|Kd=133nM|Kd|=|133|nM|133|nM
6EL5|1.67|2018|PU1|ligand is compound 68; Kd = 133+/-4.1nM|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|6.88|Kd=133nM|Kd|=|133|nM|133|nM
6GL9|1.70|2018|F3W|ligand is compound 10; IC50 = 135 +/- 3 nM|P52333|TYROSINE-PROTEIN KINASE JAK3|6.87|Kd=135nM|Kd|=|135|nM|135|nM
6GJI|1.60|2018|F1E|ligand is compound 8; Kd = 135 +/ -6 uM|P62937|PEPTIDYL-PROLYL CIS-TRANS ISOMERASE A|3.87|Kd=135uM|Kd|=|135|uM|135000|nM
5YLJ|2.70|2018|8X0|ligand is MIL, Kd=139.3+/-34.76uM|Q2XVP4|TUBULIN ALPHA-1B CHAIN|3.86|Kd=139.3uM|Kd|=|139.3|uM|139300|nM
6GJL|1.16|2018|F1Q|ligand is compound 10; Kd = 139 +/- 4 uM|P62937|PEPTIDYL-PROLYL CIS-TRANS ISOMERASE A|3.86|Kd=139uM|Kd|=|139|uM|139000|nM
6FNF|1.56|2018|DXH|ligand is NVP|P29317|EPHRIN TYPE-A RECEPTOR 2|7.89|Kd=13nM|Kd|=|13|nM|13|nM
5OHA|1.55|2018|9UW|Ki = 13 +/- 1.3 uM, ligand is 2-Thiohydantoin|A4TVL0|CEREBLON ISOFORM 4|4.89|Kd=13uM|Kd|=|13|uM|13000|nM
6AM8|1.83|2018|TRP|Kd = 13 +/- 1 uM. ligand is L-Trp|Q8U093|TRYPTOPHAN SYNTHASE BETA CHAIN 1|4.89|Kd=13uM|Kd|=|13|uM|13000|nM
5Z7B|2.10|2018|VNL|[Nonstandard assay: pH 8.0 ] ligand is vanillate,Kd=13+/-1uM|------|PADR FAMILY TRANSCRIPTIONAL REGULATOR|4.89|Kd=13uM|Kd|=|13|uM|13000|nM
5YC3|2.60|2018|9-mer|ligand is H3K4me2|Q9M2B4|PHD FINGER PROTEIN ALFIN-LIKE 3|4.85|Kd=14.2uM|Kd|=|14.2|uM|14200|nM
6EQA|3.16|2018|9-mer|A2-AAG|P01892|HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA CHAIN|4.85|Kd=14.2uM|Kd|=|14.2|uM|14200|nM
5QAT|1.90|2018|T7O|ligand is compound 24|Q6XEC0|BETA-LACTAMASE|3.85|Kd=140uM|Kd|=|140|uM|140000|nM
5Y6F|2.30|2018|C2E|c-di-GMP, Kd=141+/-24nM|P76010|FLAGELLAR BRAKE PROTEIN YCGR|6.85|Kd=141nM|Kd|=|141|nM|141|nM
6FNJ|1.24|2018|DWT|ligand is NVPiso|P54760|EPHRIN TYPE-B RECEPTOR 4|6.85|Kd=142nM|Kd|=|142|nM|142|nM
5MO2|1.50|2018|D86|Kd = 143 +/- 11 uM. ligand is N-amidinopiperidine, direct ITC, Neutron diffraction (295K)|P00760|CATIONIC TRYPSIN|3.84|Kd=143uM|Kd|=|143|uM|143000|nM
5MNN|.86|2018|MRZ|Kd = 143 +/- 11 uM. ligand is N-amidinopiperidine, direct ITC, X-ray diffraction (100K)|P00760|TRYPSIN|3.84|Kd=143uM|Kd|=|143|uM|143000|nM
5MNO|.96|2018|MRZ|Kd = 143 +/- 11 uM. ligand is N-amidinopiperidine, direct ITC, X-ray diffraction (295K)|P00760|CATIONIC TRYPSIN|3.84|Kd=143uM|Kd|=|143|uM|143000|nM
6CSR|1.62|2018|BHO|ligand is compound 1|A7YT55|HDAC6 PROTEIN|6.84|Kd=144nM|Kd|=|144|nM|144|nM
5QAH|1.95|2018|EFX|ligand is compound 9b|Q6XEC0|BETA-LACTAMASE|3.84|Kd=144uM|Kd|=|144|uM|144000|nM
6F5W|1.91|2018|KG1|ligand is compound 5; Kd = 149 +/- 16 uM|C7BLE4|LECTIN PHL|3.83|Kd=149uM|Kd|=|149|uM|149000|nM
5O1H|1.32|2018|9GN|ligand is compound 60|P04637|CELLULAR TUMOR ANTIGEN P53|4.85|Kd=14uM|Kd|=|14|uM|14000|nM
6H2T|1.67|2018|GLU|ligand is GLU; Kd = 15.2 +/- 5.7 uM|P96257|PROBABLE GLUTAMINE-BINDING LIPOPROTEIN GLNH (GLNBP)|4.82|Kd=15.2uM|Kd|=|15.2|uM|15200|nM
5Y7Z|2.80|2018|IRE|[Multiple sites: ] ligand is gefitinib, 1:1 binding model|O14976|CYCLIN-G-ASSOCIATED KINASE|7.81|Kd=15.4nM|Kd|=|15.4|nM|15.4|nM
6BCY|2.30|2018|13-mer|Kd(site3, T360)=15.5+/-6.6uM|Q3SZI4|14-3-3 PROTEIN THETA|4.81|Kd=15.5uM|Kd|=|15.5|uM|15500|nM
5QAI|1.90|2018|VM7|ligand is compound 12a|Q6XEC0|BETA-LACTAMASE|3.82|Kd=150uM|Kd|=|150|uM|150000|nM
6GU7|2.75|2018|FB8|[Different protein in assay: protein in binding assay is CDK1-Cks2] Kd = 1560 +/- 220 nM; ligand is compound AZD5438|P06493|CYCLIN-DEPENDENT KINASE 1|5.81|Kd=1560nM|Kd|=|1560|nM|1560|nM
5QB0|1.95|2018|AVA|ligand is compound 35|Q6XEC0|BETA-LACTAMASE|3.8|Kd=159uM|Kd|=|159|uM|159000|nM
6AOX|2.10|2018|TF0|bio-layer interferometry experiment, Kd=15+/-0.8uM|Q1RBS0|FML FIMBRIAL ADHESIN FMLD|4.82|Kd=15uM|Kd|=|15|uM|15000|nM
6EQ6|2.00|2018|EV2|compound 1|P36639|7,8-DIHYDRO-8-OXOGUANINE TRIPHOSPHATASE|4.82|Kd=15uM|Kd|=|15|uM|15000|nM
6G36|1.46|2018|EKH|ligand is 5-chlorotubercidin; Kd = 16.3 +/ - 0.9 nM|Q8TF76|SERINE/THREONINE-PROTEIN KINASE HASPIN|7.79|Kd=16.3nM|Kd|=|16.3|nM|16.3|nM
5ZUJ|2.60|2018|15-mer|[Different ligand in assay: ligand in binding assay is TIFA protein] ligand is TIFA mutant,Kd=16.5+/-0.7uM|Q9Y4K3|TNF RECEPTOR-ASSOCIATED FACTOR 6|4.78|Kd=16.5uM|Kd|=|16.5|uM|16500|nM
6BD1|2.35|2018|14-mer|Kd(site4, S366)=16.5+/-8.1uM|Q3SZI4|14-3-3 PROTEIN THETA|4.78|Kd=16.5uM|Kd|=|16.5|uM|16500|nM
6CZC|2.30|2018|TTP|ligand is TTP; Kd = 16.5+/-0.7uM|P9WPQ5|ATP-DEPENDENT DETHIOBIOTIN SYNTHETASE BIOD|4.78|Kd=16.5uM|Kd|=|16.5|uM|16500|nM
6FBW|1.45|2018|8-mer|[Covalent complex] ligand is 4.2f-2; Kd = 16.5 +/- 2 uM|P31947|14-3-3 PROTEIN SIGMA|4.78|Kd=16.5uM|Kd|=|16.5|uM|16500|nM
5YBA|2.06|2018|8-mer|[Nonstandard assay: NaCl=50mM ] ligand is Myb1,Kd=16.81+/-0.58uM|A2DT06|MYB1 PEPTIDE|4.77|Kd=16.81uM|Kd|=|16.81|uM|16810|nM
5O0J|1.81|2018|8BR|[Nonstandard assay: Temp 37] Kd = 16.85 +/- 4.12 uM. ligand is 8-Br-AMP|O58328|ADP-DEPENDENT GLUCOKINASE|4.77|Kd=16.85uM|Kd|=|16.85|uM|16850|nM
6GU2|2.00|2018|F9Z|[Different protein in assay: protein in binding assay is CDK1-CyclinB] Kd=1600+/-300 nM; ligand is compound Alvocidib|P06493|CYCLIN-DEPENDENT KINASE 1|5.8|Kd=1600nM|Kd|=|1600|nM|1600|nM
5QAX|2.31|2018|Q92|ligand is compound 28|Q6XEC0|BETA-LACTAMASE|3.8|Kd=160uM|Kd|=|160|uM|160000|nM
5MOS|0.96|2018|D86|Kd = 143 +/- 11 uM. ligand is N-amidinopiperidine, direct ITC, Joint X-ray/neutron diffraction (295K)|P00760|CATIONIC TRYPSIN|3.79|Kd=163uM|Kd|=|163|uM|163000|nM
5Y94|2.00|2018|8QC|ligand is 6j|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|6.79|Kd=164nM|Kd|=|164|nM|164|nM
6G0V|1.09|2018|EGZ|ligand is TF mimetic 2|P17931|GALECTIN-3|3.78|Kd=166uM|Kd|=|166|uM|166000|nM
5YH8|2.12|2018|8UX|[Uncommon element] ligand is Staphylopine.containing Ni2+|------|NICKEL ABC TRANSPORTER SUBSTRATE-BINDING PROTEIN|6.78|Kd=167.8nM|Kd|=|167.8|nM|167.8|nM
6CNK|3.70|2018|NCT|Kd = 10.2-26.6nM; Receptor plus Fab|P43681|NEURONAL ACETYLCHOLINE RECEPTOR SUBUNIT ALPHA-4|7.77|Kd=17.0nM|Kd|=|17|nM|17|nM
6G35|1.55|2018|EKK|ligand is 5-bromotubercidin; Kd = 17.5 +/- 1.3 nM|Q8TF76|SERINE/THREONINE-PROTEIN KINASE HASPIN|7.76|Kd=17.5nM|Kd|=|17.5|nM|17.5|nM
5QA8|2.50|2018|JSX|ligand is compound 4c|Q6XEC0|BETA-LACTAMASE|3.77|Kd=170uM|Kd|=|170|uM|170000|nM
5QAR|2.10|2018|QIU|ligand is compound 23a|Q6XEC0|BETA-LACTAMASE|3.77|Kd=170uM|Kd|=|170|uM|170000|nM
5QA4|1.95|2018|TI7|ligand is compound 3a|Q6XEC0|BETA-LACTAMASE|3.77|Kd=170uM|Kd|=|170|uM|170000|nM
5QAD|1.75|2018|WVV|ligand is compound 8a|Q6XEC0|BETA-LACTAMASE|3.77|Kd=170uM|Kd|=|170|uM|170000|nM
6FUH|1.37|2018|E88|ligand is compound 8|P00746|COMPLEMENT FACTOR D|3.77|Kd=170uM|Kd|=|170|uM|170000|nM
5QA6|1.95|2018|AUV|ligand is compound 4a|Q6XEC0|BETA-LACTAMASE|3.76|Kd=175uM|Kd|=|175|uM|175000|nM
6FAA|1.97|2018|ADP|ligand is ADP|G0SEG4|PUTATIVE MRNA SPLICING FACTOR|6.75|Kd=179nM|Kd|=|179|nM|179|nM
6FA5|2.30|2018|ADP|ligand is ADP; same as 6faa|G0SEG4|PUTATIVE MRNA SPLICING FACTOR|6.75|Kd=179nM|Kd|=|179|nM|179|nM
6FAC|2.05|2018|ADP|ligand is ADP; same as 6faa|G0SEG4|PUTATIVE MRNA SPLICING FACTOR|6.75|Kd=179nM|Kd|=|179|nM|179|nM
5O5A|1.60|2018|9LN|ligand is compound 2|P55201|PEREGRIN|4.77|Kd=17uM|Kd|=|17|uM|17000|nM
5ORJ|1.99|2018|A4Q|ligand is compound 3|P68400|CASEIN KINASE II, ALPHA SUBUNIT|4.77|Kd=17uM|Kd|=|17|uM|17000|nM
5VKF|2.75|2018|NPY|Kd(Naphthalene)=17+/-1.4uM|Q54436|TETRABRACHION|4.77|Kd=17uM|Kd|=|17|uM|17000|nM
6BJ3|1.90|2018|9-mer|ligand is peptide IPLTEEAEL(B35-HIV)|P30685|HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-35 ALPHA CHAIN|4.77|Kd=17uM|Kd|=|17|uM|17000|nM
6FGG|1.10|2018|D9B|ligand is compound 5|Q9UIF9|BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN PROTEIN 2A|4.77|Kd=17uM|Kd|=|17|uM|17000|nM
5OD5|1.90|2018|95B|[Uncommon element] Kd = 18.3 +/- 4.9 nM, ligand is [FeIII(11)Cp*IrIII]|------|ENTEROCHELIN ABC TRANSPORTER SUBSTRATE-BINDING PROTEIN|7.74|Kd=18.3nM|Kd|=|18.3|nM|18.3|nM
5NYH|1.65|2018|9EK|Kd = 18.7 +/- 0.5 nM. ligand is compound 2b|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|7.73|Kd=18.7nM|Kd|=|18.7|nM|18.7|nM
5ZOP|2.70|2018|12-mer||P56524|HISTONE DEACETYLASE 4|4.73|Kd=18.8uM|Kd|=|18.8|uM|18800|nM
5WEW|3.18|2018|A81|Kd(FosA,KP)=180+/-30nM|W8UNW6|FOSFOMYCIN RESISTANCE PROTEIN|6.74|Kd=180nM|Kd|=|180|nM|180|nM
5XSU|2.40|2018|8E3|[Nonstandard assay: ] ligand is compound 31,Kd=180+/-44nM,IC50=244nM|P09874|POLY [ADP-RIBOSE] POLYMERASE 1|6.74|Kd=180nM|Kd|=|180|nM|180|nM
6I8Y|1.52|2018|2OD|ligand is 35|Q9Y657|SPINDLIN-1|6.74|Kd=180nM|Kd|=|180|nM|180|nM
6GU6|2.33|2018|1QK|[Different protein in assay: protein in binding assay is CDK1-Cks2] Kd = 1810 +/- 150 nM; ligand is compound Dinaciclib|P06493|CYCLIN-DEPENDENT KINASE 1|5.74|Kd=1810nM|Kd|=|1810|nM|1810|nM
6GJR|1.69|2018|F0W|ligand is compound 9; Kd = 184 +/- 13 uM|P62937|PEPTIDYL-PROLYL CIS-TRANS ISOMERASE A|3.74|Kd=184uM|Kd|=|184|uM|184000|nM
5YHL|4.20|2018|8VL|ligand is ONO-AE3-208-Br. Protein is EP4-i3d (A62L/G106R). Complex is EP4-Fab001-ligand|P35408|PROSTAGLANDIN E2 RECEPTOR EP4 SUBTYPE|7.74|Kd=18nM|Kd|=|18|nM|18|nM
5OV8|1.80|2018|AXN|ligand is compound 13|P55201|PEREGRIN|4.74|Kd=18uM|Kd|=|18|uM|18000|nM
6DUB|1.20|2018|6-mer|ligand is peptide SPKRIA|Q5VVY1|ALPHA N-TERMINAL PROTEIN METHYLTRANSFERASE 1B|4.74|Kd=18uM|Kd|=|18|uM|18000|nM
6EQ5|1.80|2018|AX7|compound 4|P36639|7,8-DIHYDRO-8-OXOGUANINE TRIPHOSPHATASE|4.74|Kd=18uM|Kd|=|18|uM|18000|nM
6FSE|2.70|2018|E5K|[Different protein in assay: X-ray(Mus musculus); IC50(human)] ligand is compound 15|P21836|ACETYLCHOLINESTERASE|4.74|Kd=18uM|Kd|=|18|uM|18000|nM
6CD8|1.60|2018|4-mer|ligand is peptide PSRV; Kd = 19.4+/-1.2uM|Q8IVV7|GLUCOSE-INDUCED DEGRADATION PROTEIN 4 HOMOLOG|4.71|Kd=19.4uM|Kd|=|19.4|uM|19400|nM
5NNE|1.15|2018|11-mer|[Different ligand in assay: Ligand in binding assasy is TOP2A] ligand is TOP2A|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|4.71|Kd=19.5uM|Kd|=|19.5|uM|19500|nM
6EVN|1.48|2018|9-mer|Ligand is peptide PPG-PAG-PPG; Kd = 19.7+/-0.7uM|O15460|PROLYL 4-HYDROXYLASE SUBUNIT ALPHA-2|4.71|Kd=19.7uM|Kd|=|19.7|uM|19700|nM
6FBA|2.00|2018|D48|ligand is 2,3-naphthalenediol; Kd = 19.9+/- 4.7 uM; Binding assay: Microscale Thermophoresis|O15804|ASPARTATE TRANSCARBAMOYLASE|4.7|Kd=19.9uM|Kd|=|19.9|uM|19900|nM
5QAS|1.90|2018|CVF|ligand is compound 23b|Q6XEC0|BETA-LACTAMASE|3.72|Kd=190uM|Kd|=|190|uM|190000|nM
5WA5|1.17|2018|4K4|Kd(XMD11-50)=192+/-28nM|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|6.72|Kd=192nM|Kd|=|192|nM|192|nM
5ODX|1.82|2018|9RZ|Kd = 195 +/- 78 nM. ligand is compound 3b|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|6.71|Kd=195nM|Kd|=|195|nM|195|nM
5Z89|1.42|2018|EGC|[Incomplete ligand] [Nonstandard assay: incubation 2.5h] ligand is Triton,Kd=195+/-21nM, Protein is S95C|------|HYPOSENSITIVE TO LIGHT 7|6.71|Kd=195nM|Kd|=|195|nM|195|nM
6BVB|2.00|2018|19-mer|Ligand is peptide HIF-2alphaOH;Kd = 196+/-17nM|P40337|VON HIPPEL-LINDAU DISEASE TUMOR SUPPRESSOR|6.71|Kd=196nM|Kd|=|196|nM|196|nM
6E4W|3.35|2018|HUG|ligand is compound M3; Kd =197.8+/-3.5nM|P54645|5'-AMP-ACTIVATED PROTEIN KINASE CATALYTIC SUBUNIT A|6.7|Kd=197.8nM|Kd|=|197.8|nM|197.8|nM
6E49|2.90|2018|17-mer|PCNA-Pif1815 -831;+/- 0.5|P15873|PROLIFERATING CELL NUCLEAR ANTIGEN|4.72|Kd=19uM|Kd|=|19|uM|19000|nM
6BED|2.75|2018|RFP|ligand is compound rifampicin; Kd = 19+/-5uM|P68440|SCAFFOLD PROTEIN D13|4.72|Kd=19uM|Kd|=|19|uM|19000|nM
5OLK|2.45|2018|DTP|Kd = 1 +/- 0.2 uM. ligand is dATP. binding stoichiometry = 2|A3XHF9|RIBONUCLEOSIDE-DIPHOSPHATE REDUCTASE, BETA SUBUNIT 1|6.0|Kd=1uM|Kd|=|1|uM|1000|nM
6BDY|1.51|2018|SFG|ligand is compound sinefungin; Kd = 2.04+/-0.07uM|P13009|METHIONINE SYNTHASE|5.69|Kd=2.04uM|Kd|=|2.04|uM|2040|nM
6MIM|2.53|2018|10-mer|Kd = 2.0 +/- 0.3 uM; ligand is peptide H3K9cr|P42568|PROTEIN AF-9|5.7|Kd=2.0uM|Kd|=|2|uM|2000|nM
6HM4|1.77|2018|15-mer|Kd = 2.12 + 0.64 uM|P32372|S-M CHECKPOINT CONTROL PROTEIN RAD4|5.67|Kd=2.12uM|Kd|=|2.12|uM|2120|nM
6AQF|2.51|2018|ZMA|ligand is ZM241385,Kd=2.14+/-0.75nM|P29274|ADENOSINE RECEPTOR A2A,SOLUBLE CYTOCHROME B562,ADENOSINE|8.67|Kd=2.14nM|Kd|=|2.14|nM|2.14|nM
6E59|3.40|2018|L76|Ligand is compound L760735; Kd = 2.15+/-0.22nM|P25103|SUBSTANCE-P RECEPTOR, GLGA GLYCOGEN SYNTHASE, SUBSTANCE-P|8.67|Kd=2.15nM|Kd|=|2.15|nM|2.15|nM
6GON|1.65|2018|8PF|ligand is compound PFOA|Q9PTT3|TRANSTHYRETIN|5.67|Kd=2.16uM|Kd|=|2.16|uM|2160|nM
6GOO|1.80|2018|8PF|ligand is compound PFOA; same as 6gon|Q9PTT3|TRANSTHYRETIN|5.67|Kd=2.16uM|Kd|=|2.16|uM|2160|nM
6H96|1.55|2018|FWE|ligand is compound 1|Q8KRS7|ALBICIDIN RESISTANCE PROTEIN|8.68|Kd=2.1nM|Kd|=|2.1|nM|2.1|nM
5O3Q|1.75|2018|CMP|[Multiple sites: site 1: Kd = 2.1 +/- 0.6 uM; site 2: Kd = 12.6 +/- 2.5 uM; site 3: Kd = 76.2 +/- 11.9 uM.] Kd = 2.1 +/- 0.6 uM. ligand is CAMP|P73954|MEMBRANE-ASSOCIATED PROTEIN SLR1513|5.68|Kd=2.1uM|Kd|=|2.1|uM|2100|nM
6B5T|2.22|2018|15-mer|ligand is petide 29|------|PFCSP PEPTIDE 29: ALA-ASN-PRO-ASN-ALA-ASN-PRO-ASN-ALA-ASN|8.66|Kd=2.21nM|Kd|=|2.21|nM|2.21|nM
5ZOO|1.85|2018|14-mer|ligand is SP1|P56524|HISTONE DEACETYLASE 4|5.65|Kd=2.23uM|Kd|=|2.23|uM|2230|nM
6FI4|2.00|2018|8-mer|[Covalent complex] ligand is 3.2e(the Sequence Length of peptide in Literature is different from that in PDB ); Kd = 2.2 +/- 0.7uM|P31947|14-3-3 PROTEIN SIGMA|5.66|Kd=2.2uM|Kd|=|2.2|uM|2200|nM
6FHU|2.00|2018|3-mer|ligand is compound H3 3-mer|Q9UIF9|BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN PROTEIN 2A|2.64|Kd=2.3mM|Kd|=|2.3|mM|2300000|nM
6DKI|2.11|2018|GOD|ligand is compound 19|P04629|HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR|8.64|Kd=2.3nM|Kd|=|2.3|nM|2.3|nM
6GL8|1.40|2018|F3Q|ligand is S55746|P10415|APOPTOSIS REGULATOR BCL-2|8.61|Kd=2.47nM|Kd|=|2.47|nM|2.47|nM
5ZVW|2.29|2018|6-mer|Kd=2.4+/-0.3nM|P0DOE3|AIMR TRANSCRIPTIONAL REGULATOR|8.62|Kd=2.4nM|Kd|=|2.4|nM|2.4|nM
6BH2|1.45|2018|90V|[Different protein in assay] ligand is compound N54; Kd = 2.4+/-0.4 uM|P29375|LYSINE-SPECIFIC DEMETHYLASE 5A, LINKED KDM5A JMJ DOMAIN|5.62|Kd=2.4uM|Kd|=|2.4|uM|2400|nM
6C99|2.00|2018|EQY|[Different ligand in assay: ] ligand is compound UCB-303|P55899|IGG RECEPTOR FCRN LARGE SUBUNIT P51|5.62|Kd=2.4uM|Kd|=|2.4|uM|2400|nM
6EQ4|1.40|2018|BSW|compound 8|P36639|7,8-DIHYDRO-8-OXOGUANINE TRIPHOSPHATASE|5.62|Kd=2.4uM|Kd|=|2.4|uM|2400|nM
6CDC|1.75|2018|4-mer|ligand is peptide PGLW; Kd = 2.5+/-0.1uM|Q8IVV7|GLUCOSE-INDUCED DEGRADATION PROTEIN 4 HOMOLOG|5.6|Kd=2.5uM|Kd|=|2.5|uM|2500|nM
5OUA|1.67|2018|18-mer|Kd=2.67+/-0.35uM|P25321|CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA|5.57|Kd=2.67uM|Kd|=|2.67|uM|2670|nM
6EGW|1.74|2018|18-mer|Kd(18-mer)=2.67+/-0.35uM, microscale thermophoresis assay|P25321|CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA|5.57|Kd=2.67uM|Kd|=|2.67|uM|2670|nM
6DKG|2.53|2018|GO7|ligand is compound 13b|P04629|HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR|8.59|Kd=2.6nM|Kd|=|2.6|nM|2.6|nM
5VZU|2.70|2018|17-mer|Kd = 2.7 +/- 0.4 uM, ligand is Cyclin D1|P63208|S-PHASE KINASE-ASSOCIATED PROTEIN 1|5.57|Kd=2.7uM|Kd|=|2.7|uM|2700|nM
6CHH|2.30|2018|F0P|[Nonstandard assay: PH=8.0] [Different ligand in assay: ] ligand is compound 6,Kd = 2.7+/-0.2 uM,Entry 6CHH supersedes 6B1A|P40261|NICOTINAMIDE N-METHYLTRANSFERASE|5.57|Kd=2.7uM|Kd|=|2.7|uM|2700|nM
6FAW|1.40|2018|8-mer|[Covalent complex] [Different ligand in assay: ] ligand is 4.2c-1|P31947|14-3-3 PROTEIN SIGMA|5.57|Kd=2.7uM|Kd|=|2.7|uM|2700|nM
6F4W|2.29|2018|FMC|[Multiple sites: site 1: Kd=2.95 +/- 0.98 uM; site 2: Kd=163.7 +/- 34.2 uM; site 3: Kd=5.23 +/- 1.22 mM] ligand is formycin A (FA)|P56463|PURINE NUCLEOSIDE PHOSPHORYLASE DEOD-TYPE|5.53|Kd=2.95uM|Kd|=|2.95|uM|2950|nM
6E2O|2.39|2018|S0L|ligand is compound 3(GS-444217); Kd = 2.9+/-0.8nM|Q99683|MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 5|8.54|Kd=2.9nM|Kd|=|2.9|nM|2.9|nM
6BOE|3.60|2018|E0S|IC50 = 2.9 +/- 0.5 uM. ligand is compound 5a|Q9UHD2|SERINE/THREONINE-PROTEIN KINASE TBK1|5.54|Kd=2.9uM|Kd|=|2.9|uM|2900|nM
5XSR|2.30|2018|8EC|ligand is compound 13,Kd=20.3+/-3.0nM,IC50=17nM|P09874|POLY [ADP-RIBOSE] POLYMERASE 1|7.69|Kd=20.3nM|Kd|=|20.3|nM|20.3|nM
5ZNP|2.80|2018|15-mer|ligand is H3K4me3|B9H0V2|SHORT LIFE FAMILY PROTEIN|4.69|Kd=20.6uM|Kd|=|20.6|uM|20600|nM
5MOQ|.93|2018|BAM|Kd = 20.7 +/- 2.8 uM. ligand is Benzamidine, direct ITC, Joint X-ray/neutron diffraction (295K)|P00760|CATIONIC TRYPSIN|4.68|Kd=20.7uM|Kd|=|20.7|uM|20700|nM
5MNG|.86|2018|BAM|Kd = 20.7 +/- 2.8 uM. ligand is Benzamidine, direct ITC, X-ray diffraction (100K)|P00760|CATIONIC TRYPSIN|4.68|Kd=20.7uM|Kd|=|20.7|uM|20700|nM
5MNH|.93|2018|BAM|Kd = 20.7 +/- 2.8 uM. ligand is Benzamidine, direct ITC, X-ray diffraction (295K)|P00760|CATIONIC TRYPSIN|4.68|Kd=20.7uM|Kd|=|20.7|uM|20700|nM
5MO0|1.50|2018|BAM|Kd = 20.7 +/- 2.8 uM. ligand is Benzamidine, direct ITC, same as 5MNG, Neutron diffraction|P00760|CATIONIC TRYPSIN|4.68|Kd=20.7uM|Kd|=|20.7|uM|20700|nM
6BM6|1.50|2018|SAH|ligand is compound AdoHcy; Kd = 20.8+/-0.2uM|P13009|METHIONINE SYNTHASE|4.68|Kd=20.8uM|Kd|=|20.8|uM|20800|nM
6D28|1.75|2018|NEC||P41148|ENDOPLASMIN|6.7|Kd=200nM|Kd|=|200|nM|200|nM
5QAG|2.30|2018|Q2R|ligand is compound 9a|Q6XEC0|BETA-LACTAMASE|3.7|Kd=200uM|Kd|=|200|uM|200000|nM
6GJJ|1.38|2018|L36|ligand is compound 2; Kd = 200 +/- 5 uM|P62937|PEPTIDYL-PROLYL CIS-TRANS ISOMERASE A|3.7|Kd=200uM|Kd|=|200|uM|200000|nM
5YHE|2.47|2018|8UX|ligand is Staphylopine,containing Co2+|------|NICKEL ABC TRANSPORTER SUBSTRATE-BINDING PROTEIN|6.69|Kd=203.3nM|Kd|=|203.3|nM|203.3|nM
6B3V|1.60|2018|7DQ|[Nonstandard assay: ATP:Mg2+ = 1 mM] ligand is compound PZ-2891,Kd=203+/-0.05pM|Q9H999|PANTOTHENATE KINASE 3|9.69|Kd=203pM|Kd|=|203|pM|0.203|nM
5OS7|1.66|2018|A8Q|ligand is compound 4|P68400|CASEIN KINASE II, ALPHA SUBUNIT|3.69|Kd=205uM|Kd|=|205|uM|205000|nM
5O55|1.45|2018|9L5|ligand is compound 8|P55201|PEREGRIN|4.7|Kd=20uM|Kd|=|20|uM|20000|nM
5O1B|1.43|2018|9H2|ligand is compound 13|P04637|CELLULAR TUMOR ANTIGEN P53|4.7|Kd=20uM|Kd|=|20|uM|20000|nM
5QB1|1.80|2018|F1C|ligand is compound 36|Q6XEC0|BETA-LACTAMASE|4.7|Kd=20uM|Kd|=|20|uM|20000|nM
6FUT|1.50|2018|E82|ligand is compound 13b|P00746|COMPLEMENT FACTOR D|4.7|Kd=20uM|Kd|=|20|uM|20000|nM
5ZT1|3.11|2018|AGS|[Nonstandard assay: PH=8.0] ligand is ATP gammaS,Kd=21.23+/-0.80uM|P0A1C1|PROBABLE ATP SYNTHASE SPAL/MXIB|4.67|Kd=21.23uM|Kd|=|21.23|uM|21230|nM
5ZNR|3.20|2018|17-mer|ligand is H3K27me3|B9H0V2|SHORT LIFE FAMILY PROTEIN|4.67|Kd=21.3uM|Kd|=|21.3|uM|21300|nM
6FMK|2.75|2018|DV8|ligand is compound 4; Kd = 21.6 +/- 0.8 uM (ITC)|Q15370|ELONGIN-B|4.67|Kd=21.6uM|Kd|=|21.6|uM|21600|nM
6CFC|2.04|2018|BLG|Kd = 210 +/-28uM;ligand is Cj0843|------|LYTIC TRANSGLYCOSYLASE|3.68|Kd=210uM|Kd|=|210|uM|210000|nM
6BBX|2.20|2018|D77|Kd = 215 +/- 27 nM, ligand is TNM C, protein is TnmS3|------|GLYOXALASE/BLEOMYCIN RESISANCE PROTEIN/DIOXYGENASE|6.67|Kd=215nM|Kd|=|215|nM|215|nM
6HKE|2.11|2018|MLT|ligand is D-malate; Kd = 21 +/- 2 nM|Q6N446|POSSIBLE TCTC SUBUNIT OF THE TRIPARTITE TRICARBOXYLATE|7.68|Kd=21nM|Kd|=|21|nM|21|nM
6DK1|3.12|2018|GM4|Ligand is compound (+)-pentazocine; Kd = 22.5+/-10.8nM|Q99720|SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1|7.65|Kd=22.5nM|Kd|=|22.5|nM|22.5|nM
6G6Y|1.80|2018|EOK|[Different ligand in assay: ligand is a tautomer] ligand is K858-1, Kd = 220.0 +/- 4.21 nM|P52732|KINESIN-LIKE PROTEIN KIF11|6.66|Kd=220nM|Kd|=|220|nM|220|nM
6G6Z|2.80|2018|EOK|[Different ligand in assay: ligand is a tautomer] ligand is K858-1, Kd = 220.0 +/- 4.21 nM|P52732|KINESIN-LIKE PROTEIN KIF11|6.66|Kd=220nM|Kd|=|220|nM|220|nM
5QAK|1.90|2018|AV4|ligand is compound 14|Q6XEC0|BETA-LACTAMASE|3.66|Kd=220uM|Kd|=|220|uM|220000|nM
6GUF|2.65|2018|23D|Kd = 224 +/- 14 nM; ligand is compound CGP74514A|P24941|CYCLIN-DEPENDENT KINASE 2|6.65|Kd=224nM|Kd|=|224|nM|224|nM
6CWN|1.53|2018|6LA|Ligand is compound 4,6-Pyr-beta-D-ManNAcOMe|C1JZ07|SURFACE (S-) LAYER GLYCOPROTEIN|6.65|Kd=226nM|Kd|=|226|nM|226|nM
5QAB|2.15|2018|XEV|ligand is compound 6b|Q6XEC0|BETA-LACTAMASE|3.65|Kd=226uM|Kd|=|226|uM|226000|nM
5NDB|2.38|2018|8TW|[Different protein in assay: Protein in binding assay is Y58C] Kd = 22 +/-7 uM|Q8G9Q0|BETA-LACTAMASE IMP-1|4.66|Kd=22uM|Kd|=|22|uM|22000|nM
5O1D|1.36|2018|9GW|ligand is compound 50|P04637|CELLULAR TUMOR ANTIGEN P53|4.66|Kd=22uM|Kd|=|22|uM|22000|nM
6BEE|3.11|2018|RXM|ligand is compound rifaximin|P68440|SCAFFOLD PROTEIN D13|4.66|Kd=22uM|Kd|=|22|uM|22000|nM
5QA9|1.90|2018|QKU|ligand is compound 5|Q6XEC0|BETA-LACTAMASE|3.64|Kd=230uM|Kd|=|230|uM|230000|nM
5ORK|2.14|2018|A4T|ligand is compound 6|P68400|CASEIN KINASE II, ALPHA SUBUNIT|3.63|Kd=234uM|Kd|=|234|uM|234000|nM
6ELP|1.85|2018|BA8|ligand is compound 14; Kd = 236+/-19nM|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|6.63|Kd=236nM|Kd|=|236|nM|236|nM
6G38|1.47|2018|TBN|ligand is tubercidin; kd is 239.2 +/- 10.0 nM|Q8TF76|SERINE/THREONINE-PROTEIN KINASE HASPIN|6.62|Kd=239.2nM|Kd|=|239.2|nM|239.2|nM
6GUB|2.52|2018|F9Z|Kd = 23 +/- 3 nM; ligand is compound Alvocidib|P24941|CYCLIN-DEPENDENT KINASE 2|7.64|Kd=23nM|Kd|=|23|nM|23|nM
5UXN|2.20|2018|TYR|Kd = 23 +/- 1 uM, ligand is Tyr|Q9I000|PHOSPHO-2-DEHYDRO-3-DEOXYHEPTONATE ALDOLASE|4.64|Kd=23uM|Kd|=|23|uM|23000|nM
6G0Q|1.40|2018|11-mer|[Different ligand in assay: Ligand in binding assasy is GATA1] ligand is GATA1|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|4.61|Kd=24.6uM|Kd|=|24.6|uM|24600|nM
6EQ1|2.10|2018|STW|Kd = 24.6+/-2.4uM|------|PERIPLASMIC ALPHA-GALACTOSIDE-BINDING PROTEIN|4.61|Kd=24.6uM|Kd|=|24.6|uM|24600|nM
5QAE|2.10|2018|Q4G|ligand is compound 8b|Q6XEC0|BETA-LACTAMASE|3.62|Kd=240uM|Kd|=|240|uM|240000|nM
5QAO|2.00|2018|Z8R|ligand is compound 19b|Q6XEC0|BETA-LACTAMASE|3.62|Kd=240uM|Kd|=|240|uM|240000|nM
6GFY|2.70|2018|EXH|ligand is compound 14a; Kd = 244 +/- 6 nM|Q15370|ELONGIN-B|6.61|Kd=244nM|Kd|=|244|nM|244|nM
5OQU|2.32|2018|A4B|ligand is compound 5|P68400|CASEIN KINASE II, ALPHA SUBUNIT|3.61|Kd=244uM|Kd|=|244|uM|244000|nM
5O87|2.20|2018|NCT|Kd=245+/-20nM|Q8WSF8|ACETYLCHOLINE RECEPTOR|6.61|Kd=245nM|Kd|=|245|nM|245|nM
6BEB|2.55|2018|RFV|ligand is compound rifamycin SV|P68440|SCAFFOLD PROTEIN D13|3.61|Kd=246uM|Kd|=|246|uM|246000|nM
6F1J|1.25|2018|EDG|ligand is AraDNJ; Kd = 24+/-0.4 uM|------|PROTEIN|4.62|Kd=24uM|Kd|=|24|uM|24000|nM
5QAC|2.00|2018|U4J|ligand is compound 6c|Q6XEC0|BETA-LACTAMASE|3.6|Kd=250uM|Kd|=|250|uM|250000|nM
6AHI|1.90|2018|MET|Kd=252+/-55uM|P56067|CYSTEINE SYNTHASE|3.6|Kd=252uM|Kd|=|252|uM|252000|nM
6CSS|1.70|2018|FBJ|ligand is compound 4|A7YT55|HDAC6 PROTEIN|7.6|Kd=25nM|Kd|=|25|nM|25|nM
6GUC|2.00|2018|SU9|Kd = 25 +/- 5 nM; ligand is compound SU9516|P24941|CYCLIN-DEPENDENT KINASE 2|7.6|Kd=25nM|Kd|=|25|nM|25|nM
5N1P|1.45|2018|8GK|[Different ligand in assay: ligand in binding assay is Zn-binding] ligand is comound 1|Q81EJ6|PEPTIDOGLYCAN N-ACETYLGLUCOSAMINE DEACETYLASE|4.6|Kd=25uM|Kd|=|25|uM|25000|nM
6EGS|2.70|2018|UD2|ligand is compound UDP-GalNac;Kd = 260+/-50uM|Q10471|POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 2|3.59|Kd=260uM|Kd|=|260|uM|260000|nM
6GJM|1.35|2018|L36|ligand is compound 4; Kd = 266 +/- 3 uM|P62937|PEPTIDYL-PROLYL CIS-TRANS ISOMERASE A|3.58|Kd=266uM|Kd|=|266|uM|266000|nM
6GUH|1.50|2018|FB8|Kd = 26 +/- 3 nM; ligand is compound AZD5438|P24941|CYCLIN-DEPENDENT KINASE 2|7.59|Kd=26nM|Kd|=|26|nM|26|nM
6FNQ|1.75|2018|AVJ|ligand is TMH; Kd = 26 +/- 4 uM|------|HISTIDINE N-ALPHA-METHYLTRANSFERASE|4.59|Kd=26uM|Kd|=|26|uM|26000|nM
5OST|2.10|2018|AEZ|[Nonstandard assay: pH=6.8] Kd = 27.3 +/- 0.4 uM, ligand is compound 6|F6BL85|GLUCOSYLCERAMIDASE|4.56|Kd=27.3uM|Kd|=|27.3|uM|27300|nM
5OAJ|2.47|2018|TKT|Kd=275+/-15nM, T53F, Q74R, Y110A, I135S, G162E mutant|Q8WSF8|ACETYLCHOLINE RECEPTOR|6.56|Kd=275nM|Kd|=|275|nM|275|nM
5YYB|2.48|2018|NGE|[Nonstandard assay: pH 8.0] ligand is Neu5Gc,Kd=277+/-58nM|Q7VL18|PUTATIVE ABC TRANSPORTER PERIPLASMIC BINDING PROTEIN|6.56|Kd=277nM|Kd|=|277|nM|277|nM
6CO4|NMR|2018|18-mer||Q16186|PROTEASOMAL UBIQUITIN RECEPTOR ADRM1|7.57|Kd=27nM|Kd|=|27|nM|27|nM
5OAX|1.20|2018|9Q5|Kd = 27 +/- 3 nM, ligand is compound 36|P17931|GALECTIN-3|7.57|Kd=27nM|Kd|=|27|nM|27|nM
5WJ6|2.45|2018|B4A|[Nonstandard assay: pH = 8.5] [Different protein in assay: Protein in binding assay is F327W] Kd = 27 +/- 2 nM. ligand is UPGL00004|O94925|GLUTAMINASE KIDNEY ISOFORM, MITOCHONDRIAL|7.57|Kd=27nM|Kd|=|27|nM|27|nM
6GLA|1.92|2018|F4B|ligand is compound 11; IC50 = 27 +/- 1 nM|P52333|TYROSINE-PROTEIN KINASE JAK3|7.57|Kd=27nM|Kd|=|27|nM|27|nM
5OSS|1.70|2018|AEZ|[Nonstandard assay: pH=6.8] Kd = 28.3 +/- 6.9 uM, ligand is compound 6|Q08638|BETA-GLUCOSIDASE A|4.55|Kd=28.3uM|Kd|=|28.3|uM|28300|nM
6GNP|2.02|2018|F4Z|ligand is compound TC2P|Q9PTT3|TRANSTHYRETIN|4.55|Kd=28.41uM|Kd|=|28.41|uM|28410|nM
6HSH|1.55|2018|GOK|ligand is Quisinostat(QSN); Kd = 28.4 +/- 3.3 nM|A5H660|HISTONE DEACETYLASE|7.55|Kd=28.4nM|Kd|=|28.4|nM|28.4|nM
5Z95|1.20|2018|EGC|[Incomplete ligand] ligand is Triton,Kd=284+/-22nM|------|HYPOSENSITIVE TO LIGHT 7|6.55|Kd=284nM|Kd|=|284|nM|284|nM
6MIQ|1.75|2018|8-mer|Kd = 28 +/- 2 uM; ligand is peptide H3K9bu|P35189|TRANSCRIPTION INITIATION FACTOR TFIID SUBUNIT 14|4.55|Kd=28uM|Kd|=|28|uM|28000|nM
6EVP|1.68|2018|9-mer|Ligand is peptide PPG-PEG-PPG; Kd = 29.2 +/- 0.7 uM|O15460|PROLYL 4-HYDROXYLASE SUBUNIT ALPHA-2|4.53|Kd=29.2uM|Kd|=|29.2|uM|29200|nM
6AJI|2.90|2018|AY6|microscale thermophoresis assay, Kd(rimonabant)=29.5+/-3.4uM|I7G2R2|DRUG EXPORTERS OF THE RND SUPERFAMILY-LIKE PROTEIN|4.53|Kd=29.5uM|Kd|=|29.5|uM|29500|nM
5O0E|1.50|2018|18-mer|Kd=29.6+/-10.0uM|P25321|CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA|4.53|Kd=29.6uM|Kd|=|29.6|uM|29600|nM
6EM7|1.24|2018|18-mer|microscale thermophoresis assay, Kd(18-mer)=29.6+/-10.0uM|P25321|CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA|4.53|Kd=29.6uM|Kd|=|29.6|uM|29600|nM
6EMA|1.88|2018|18-mer|microscale thermophoresis assay, Kd(18-mer)=29.6+/-10.0uM|P25321|CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA|4.53|Kd=29.6uM|Kd|=|29.6|uM|29600|nM
6ERU|2.15|2018|18-mer|microscale thermophoresis assay, Kd(18-mer)=29.6+/-10.0uM|P25321|CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA|4.53|Kd=29.6uM|Kd|=|29.6|uM|29600|nM
6ESA|1.31|2018|18-mer|microscale thermophoresis assay, Kd(18-mer)=29.6+/-10.0uM|P25321|CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA|4.53|Kd=29.6uM|Kd|=|29.6|uM|29600|nM
5NAU|2.25|2018|DZ0|Kd = 29.86 +/- 1.12 nM. Ki = dissociation constant in lecture|P04058|ACETYLCHOLINESTERASE|7.52|Kd=29.86nM|Kd|=|29.86|nM|29.86|nM
5QAQ|2.40|2018|S1C|ligand is compound 21b|Q6XEC0|BETA-LACTAMASE|3.54|Kd=290uM|Kd|=|290|uM|290000|nM
6CWI|2.16|2018|6LA|Ligand is compound 4,6-Pyr-beta-D-ManNAcOMe; Solving co-crystal structure in C2 space group; same as 6cwh|C1JZ07|SURFACE (S-) LAYER GLYCOPROTEIN|7.54|Kd=29nM|Kd|=|29|nM|29|nM
6CWH|2.00|2018|6LA|Ligand is compound 4,6-Pyr-beta-D-ManNAcOMe; Solving co-crystal structure in P1 space group|C1JZ07|SURFACE (S-) LAYER GLYCOPROTEIN|7.54|Kd=29nM|Kd|=|29|nM|29|nM
6CWF|2.25|2018|6LA|Ligand is compound 4,6-Pyr-beta-D-ManNAcOMe; same as 6cwh|C1JZ07|SURFACE (S-) LAYER GLYCOPROTEIN|7.54|Kd=29nM|Kd|=|29|nM|29|nM
6GGV|2.69|2018|ARG|ligand is ARG|Q9WZ62|AMINO ACID ABC TRANSPORTER, PERIPLASMIC AMINO ACID-BINDING|7.54|Kd=29nM|Kd|=|29|nM|29|nM
6E83|NMR|2018|12-mer|Binding assay: microscale thermophoresis; Ligand is peptide H3; Kd = 29+/-7uM|Q8IYH5|ZZ-TYPE ZINC FINGER-CONTAINING PROTEIN 3|4.54|Kd=29uM|Kd|=|29|uM|29000|nM
6F9G|2.39|2018|PUT|ligand is putrescine; Kd = 2 +/- 1 uM|Q88NI1|METHYL-ACCEPTING CHEMOTAXIS PROTEIN MCPU|5.7|Kd=2uM|Kd|=|2|uM|2000|nM
6HD6|2.30|2018|FYH|ligand is compound 6;|P00520|TYROSINE-PROTEIN KINASE ABL1|5.7|Kd=2uM|Kd|=|2|uM|2000|nM
6FI5|1.70|2018|8-mer|[Covalent complex] ligand is 3.2d(the Sequence Length of peptide in Literature is different from that in PDB ); Kd = 3.0 +/- 0.6uM|P31947|14-3-3 PROTEIN SIGMA|5.52|Kd=3.0uM|Kd|=|3|uM|3000|nM
5OA6|1.94|2018|9PT|Kd = 3.10 +/- 0.02uM. ligand is compound 12|Q06135|1,3-BETA-GLUCANOSYLTRANSFERASE GAS2|5.51|Kd=3.10uM|Kd|=|3.1|uM|3100|nM
6HPG|2.00|2018|8-mer|ligand is Hsp90; Kd = 3.17 +/- 2.09 uM|F4KCL7|OUTER ENVELOPE PROTEIN 64|5.5|Kd=3.17uM|Kd|=|3.17|uM|3170|nM
6GR7|1.40|2018|F52|[Different protein in assay: X-ray(Sparus aurata), Kd(human)] ligand is compound 2,4,5-T|P02766|TRANSTHYRETIN|5.5|Kd=3.19uM|Kd|=|3.19|uM|3190|nM
5ZU0|2.76|2018|SAH|ligand is SAH,Kd=3.1+/-0.2uM|Q54S83|PROTEIN ARGININE METHYLTRANSFERASE NDUFAF7 HOMOLOG|5.51|Kd=3.1uM|Kd|=|3.1|uM|3100|nM
5ZZW|2.60|2018|SAH|ligand is SAH,Kd=3.1+/-0.2uM|Q54S83|PROTEIN ARGININE METHYLTRANSFERASE NDUFAF7 HOMOLOG|5.51|Kd=3.1uM|Kd|=|3.1|uM|3100|nM
6G14|1.80|2018|G4P|ligand is compound ppGpp|------|RIBOSOME BIOGENESIS GTPASE A|5.49|Kd=3.26uM|Kd|=|3.26|uM|3260|nM
5XVW|1.85|2018|14-mer|Kd=3.29+/-0.34uM|Q9SRM4|PHD FINGER PROTEIN ALFIN-LIKE 2|5.48|Kd=3.29uM|Kd|=|3.29|uM|3290|nM
6AF9|1.39|2018|ISN|[Covalent complex] ligand is compound 1(high concentration),Kd=3.2+/-0.08uM(ITC),Kd=2.0+/-0.5uM(SPR)|Q99497|PROTEIN/NUCLEIC ACID DEGLYCASE DJ-1|5.49|Kd=3.2uM|Kd|=|3.2|uM|3200|nM
6AFA|1.65|2018|ISN|[Covalent complex] ligand is compound 1(low concentration),Kd=3.2+/-0.08uM(ITC),Kd=2.0+/-0.5uM(SPR)|Q99497|PROTEIN/NUCLEIC ACID DEGLYCASE DJ-1|5.49|Kd=3.2uM|Kd|=|3.2|uM|3200|nM
6GRP|1.60|2018|F4Z|[Different protein in assay: X-ray(Sparus aurata), Kd(human)] ligand is compound TC2P|P02766|TRANSTHYRETIN|5.48|Kd=3.34uM|Kd|=|3.34|uM|3340|nM
6FE1|1.95|2018|V14|ligand is VD11-4-2|Q16790|CARBONIC ANHYDRASE 9|8.48|Kd=3.3nM|Kd|=|3.3|nM|3.3|nM
6FHQ|1.95|2018|DE5|ligand is compound Fr21; Kd = 3.4 +/- 0.5 mM|Q9UIF8|BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN PROTEIN 2B|2.47|Kd=3.4mM|Kd|=|3.4|mM|3400000|nM
6H7N|2.50|2018|FVK|[Different ligand in assay: Ligand in binding assay is racemic mixture] ligand is xamoterol|P0AA25|THIOREDOXIN 1|8.46|Kd=3.5nM|Kd|=|3.5|nM|3.5|nM
6EKQ|1.65|2018|B0H|ligand is compound 42|P55201|PEREGRIN|5.46|Kd=3.5uM|Kd|=|3.5|uM|3500|nM
5OWA|1.95|2018|B0H|ligand is compound 42, same as 6ekq|P55201|PEREGRIN|5.46|Kd=3.5uM|Kd|=|3.5|uM|3500|nM
6GNR|1.40|2018|6J3|ligand is compound Clonixin|Q9PTT3|TRANSTHYRETIN|5.44|Kd=3.61uM|Kd|=|3.61|uM|3610|nM
5UXM|1.54|2018|TRP|Kd = 3.6 +/- 0.8 uM, ligand is Trp|Q9I000|PHOSPHO-2-DEHYDRO-3-DEOXYHEPTONATE ALDOLASE|5.44|Kd=3.6uM|Kd|=|3.6|uM|3600|nM
6FAU|1.25|2018|8-mer|[Covalent complex] ligand is 4.2e-1; Kd = 3.6 +/- 0.6 uM|P31947|14-3-3 PROTEIN SIGMA|5.44|Kd=3.6uM|Kd|=|3.6|uM|3600|nM
5VL2|1.90|2018|9EG|[Multiple sites: site 1: Kd = 3.77 nM, site 2: Kd = 0.98 nM.] ligand is TCC|------|T4 NANOBODY|8.42|Kd=3.77nM|Kd|=|3.77|nM|3.77|nM
6A6W|2.60|2018|17-mer|ligand is Sad1,Kd=3.7+/-0.3uM|O60158|BOUQUET FORMATION PROTEIN 4|5.43|Kd=3.7uM|Kd|=|3.7|uM|3700|nM
6AFD|1.48|2018|72S|[Covalent complex] ligand is 6,Kd=3.7+/-0.1uM(ITC)|Q99497|PROTEIN/NUCLEIC ACID DEGLYCASE DJ-1|5.43|Kd=3.7uM|Kd|=|3.7|uM|3700|nM
5XS8|1.95|2018|2-mer|[Incomplete ligand] ligand is Cdelta4S6S,Kd=3.86+/-0.243uM,ligand in PDB is incomplete|D1AWE0|EXTRACELLULAR SOLUTE-BINDING PROTEIN FAMILY 1|5.41|Kd=3.86uM|Kd|=|3.86|uM|3860|nM
5YV5|2.10|2018|18-mer|ligand is aP1,Kd=3.9+/-0.3uM|I6V0C7|ATPASE RIL|5.41|Kd=3.9uM|Kd|=|3.9|uM|3900|nM
6AFF|1.60|2018|72U|[Covalent complex] ligand is 8,Kd=3.9+/-0.2uM(ITC)|Q99497|PROTEIN/NUCLEIC ACID DEGLYCASE DJ-1|5.41|Kd=3.9uM|Kd|=|3.9|uM|3900|nM
6MIL|1.93|2018|19-mer|Kd = 3.9 +/- 0.5 uM; ligand is peptide H3K9bu|P42568|PROTEIN AF-9|5.41|Kd=3.9uM|Kd|=|3.9|uM|3900|nM
5Y20|2.41|2018|7-mer|[Incomplete ligand] ligand is H3K4me3|Q9FFF5|PHD FINGER PROTEIN ALFIN-LIKE 1|4.52|Kd=30.4uM|Kd|=|30.4|uM|30400|nM
5QA5|1.95|2018|L5D|ligand is compound 3b|Q6XEC0|BETA-LACTAMASE|3.52|Kd=300uM|Kd|=|300|uM|300000|nM
6GFZ|2.30|2018|EXE|ligand is compound 13b; Kd = 3080 +/- 10 nM|Q15370|TRANSCRIPTION ELONGATION FACTOR B POLYPEPTIDE 2|5.51|Kd=3080nM|Kd|=|3080|nM|3080|nM
5O1F|1.38|2018|9GQ|ligand is compound 52|P04637|CELLULAR TUMOR ANTIGEN P53|4.52|Kd=30uM|Kd|=|30|uM|30000|nM
5O1A|1.44|2018|9H5|ligand is compound 11|P04637|CELLULAR TUMOR ANTIGEN P53|4.52|Kd=30uM|Kd|=|30|uM|30000|nM
5VH0|2.06|2018|8P0|Kd(pyrene)=30+/-2.0uM|Q54436|TETRABRACHION|4.52|Kd=30uM|Kd|=|30|uM|30000|nM
6AMI|1.97|2018|TRP|Kd = 30 +/- 4 uM. ligand is L-Trp|Q8U093|TRYPTOPHAN SYNTHASE BETA CHAIN 1|4.52|Kd=30uM|Kd|=|30|uM|30000|nM
6FHK|1.66|2018|ADP||P0DMV8|HEAT SHOCK 70 KDA PROTEIN 1A|7.51|Kd=31.15nM|Kd|=|31.15|nM|31.15|nM
5YL2|2.09|2018|8WU|ligand is SKLB028, Kd=31.69+/-5.26uM|Q2XVP4|TUBULIN ALPHA-1B CHAIN|4.5|Kd=31.69uM|Kd|=|31.69|uM|31690|nM
5QAF|2.15|2018|S1D|ligand is compound 8c|Q6XEC0|BETA-LACTAMASE|3.51|Kd=312uM|Kd|=|312|uM|312000|nM
5YQW|1.36|2018|CBS|[Nonstandard assay: PH=8.0,Temp=4 C] Kd=31+/-8.3nM|D0XC84|PEPTIDE ABC TRANSPORTER, PERIPLASMIC PEPTIDE-BINDING|7.51|Kd=31nM|Kd|=|31|nM|31|nM
6BAU|3.80|2018|CYS|[Nonstandard assay: 100 mM Na+] ligand is cys,Kd=31+/-3uM|O59010|GLUTAMATE TRANSPORTER HOMOLOG|4.51|Kd=31uM|Kd|=|31|uM|31000|nM
6G86|1.74|2018|16-mer||Q00684|TYROSINE-PROTEIN PHOSPHATASE CDC14|4.49|Kd=32.2uM|Kd|=|32.2|uM|32200.000000000004|nM
5YBI|2.27|2018|ANP|ligand is AMPPNP,Kd=322.48+/-12.60uM|P0A1C1|PROBABLE ATP SYNTHASE SPAL/MXIB|3.49|Kd=322.48uM|Kd|=|322.48|uM|322480|nM
5VQE|1.89|2018|G2F|[Covalent complex] ligand is 2FGlc|------|BETA-GLUCOSIDE PHOSPHORYLASE BGLX|1.49|Kd=32mM|Kd|=|32|mM|32000000|nM
5NUD|2.50|2018|99K|[Covalent complex] Kd = 32 +/- 11 nM. ligand is compound 9|P22455|FIBROBLAST GROWTH FACTOR RECEPTOR 4|7.49|Kd=32nM|Kd|=|32|nM|32|nM
6FE0|1.91|2018|V90|ligand is VD12-09|Q16790|CARBONIC ANHYDRASE 9|6.48|Kd=330nM|Kd|=|330|nM|330|nM
5QAJ|2.00|2018|VBC|ligand is compound 13|Q6XEC0|BETA-LACTAMASE|3.48|Kd=330uM|Kd|=|330|uM|330000|nM
6EYA|2.10|2018|C4K|ligand is compound 35; Kd = 33+/-3.1nM|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|7.48|Kd=33nM|Kd|=|33|nM|33|nM
6H7B|1.89|2018|14-mer||E9AFX7|POLYADENYLATE-BINDING PROTEIN|7.48|Kd=33nM|Kd|=|33|nM|33|nM
5O1E|1.30|2018|9GT|ligand is compound 51|P04637|CELLULAR TUMOR ANTIGEN P53|4.48|Kd=33uM|Kd|=|33|uM|33000|nM
5OVV|1.40|2018|7-mer|Kd = 33 +/- 2.0 uM, ligand is ProSAPiP1|Q8K1Q4|SH3 AND MULTIPLE ANKYRIN REPEAT DOMAINS PROTEIN 3|4.48|Kd=33uM|Kd|=|33|uM|33000|nM
5YTO|1.90|2018|946|[Incomplete ligand] ligand is SBL-1|P00441|SUPEROXIDE DISMUTASE|4.48|Kd=33uM|Kd|=|33|uM|33000|nM
6HOY|1.70|2018|TSN|Kd = 33 +/- 6 uM|Q8N6T7|NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-6|4.48|Kd=33uM|Kd|=|33|uM|33000|nM
5OGB|1.80|2018|9U5|Kd(DC360)=34+/-2.5nM|P29373|CELLULAR RETINOIC ACID-BINDING PROTEIN 2|7.47|Kd=34nM|Kd|=|34|nM|34|nM
6CCU|1.75|2018|4-mer|ligand is peptide PHRV; Kd = 35.2+/-5.3uM|Q8IVV7|GLUCOSE-INDUCED DEGRADATION PROTEIN 4 HOMOLOG|4.45|Kd=35.2uM|Kd|=|35.2|uM|35200|nM
6Q3Q|2.00|2018|8-mer|ligand is Hsp90; Kd = 35.2 +/- 6.85 uM|F4KCL7|OUTER ENVELOPE PROTEIN 64|4.45|Kd=35.2uM|Kd|=|35.2|uM|35200|nM
5QAL|1.95|2018|TVZ|ligand is compound 11b|Q6XEC0|BETA-LACTAMASE|3.46|Kd=350uM|Kd|=|350|uM|350000|nM
5MSB|1.30|2018|V13|ligand is compound 10|O43570|CARBONIC ANHYDRASE 12|7.46|Kd=35nM|Kd|=|35|nM|35|nM
6FUI|1.38|2018|E7W|ligand is compound 9|P00746|COMPLEMENT FACTOR D|4.46|Kd=35uM|Kd|=|35|uM|35000|nM
6HQY|2.50|2018|GKW|ligand is PCI-34051; Kd = 367 +/- 40.7 nM|A5H660|HISTONE DEACETYLASE|6.44|Kd=367nM|Kd|=|367|nM|367|nM
6MDQ|2.15|2018|TES|ligand is testosterone|P35747|SERUM ALBUMIN|3.44|Kd=367uM|Kd|=|367|uM|367000|nM
6H8S|1.77|2018|FSZ||P54830|TYROSINE-PROTEIN PHOSPHATASE NON-RECEPTOR TYPE 5|4.42|Kd=37.7uM|Kd|=|37.7|uM|37700|nM
5W8J|1.55|2018|9Y7|[Nonstandard assay: in the presence of NADH] ligand is compound 33|P00338|L-LACTATE DEHYDROGENASE A CHAIN|6.43|Kd=370nM|Kd|=|370|nM|370|nM
5YY4|1.59|2018|9-mer|[Nonstandard assay: Temp 25] ligand is pep1,Kd=370+/-5.6nM|P51681|SCFV 4B08|6.43|Kd=370nM|Kd|=|370|nM|370|nM
6G9U|1.75|2018|ETK|ligand is VR16-10|Q16790|CARBONIC ANHYDRASE 9|6.43|Kd=370nM|Kd|=|370|nM|370|nM
5OSL|1.95|2018|A9K|ligand is compound 7|P68400|CASEIN KINASE II, ALPHA SUBUNIT|3.43|Kd=375uM|Kd|=|375|uM|375000|nM
6EI5|2.20|2018|B5Q|ligand is compound 62; Kd = 38.3+/-9.4nM|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|7.42|Kd=38.3nM|Kd|=|38.3|nM|38.3|nM
6CD9|1.55|2018|4-mer|ligand is peptide PSRW; Kd = 38.3+/-2.1uM|Q8IVV7|GLUCOSE-INDUCED DEGRADATION PROTEIN 4 HOMOLOG|4.42|Kd=38.3uM|Kd|=|38.3|uM|38300|nM
5YIJ|3.18|2018|NAI|MST assay, ligand is NAD+|Q6RCR0|SDEA|3.42|Kd=381uM|Kd|=|381|uM|381000|nM
6BYK|3.00|2018|12-mer|Kd=390+/-13uM|P31946|14-3-3 PROTEIN BETA/ALPHA|3.41|Kd=390uM|Kd|=|390|uM|390000|nM
6HK6|2.35|2018|G8H|ligand is 9|Q9BVS4|SERINE/THREONINE-PROTEIN KINASE RIO2|6.41|Kd=393nM|Kd|=|393|nM|393|nM
6CSP|1.24|2018|FBM|ligand is compound 2|A7YT55|HDAC6 PROTEIN|8.52|Kd=3nM|Kd|=|3|nM|3|nM
6F08|1.90|2018|13-mer|ligand is SOS1pSer peptide; Kd = 4.06 +/- 0.17 uM; Fluorescence polarization assay|P63104|14-3-3 PROTEIN ZETA/DELTA|5.39|Kd=4.06uM|Kd|=|4.06|uM|4059.9999999999995|nM
5O9R|1.70|2018|9PK|Kd = 4.09 +/- 0.04 uM. ligand is compound 9|Q06135|1,3-BETA-GLUCANOSYLTRANSFERASE GAS2|5.39|Kd=4.09uM|Kd|=|4.09|uM|4090|nM
5ODY|1.15|2018|9SK|Kd = 4.0 +/- 0.4, ligand is compound 37|P17931|GALECTIN-3|8.4|Kd=4.0nM|Kd|=|4|nM|4|nM
6C3U|1.85|2018|NY2|Kd(FosA,KP)=4.0+/-0.6uM|------|FOSA FAMILY FOSFOMYCIN RESISTANCE GLUTATHIONE TRANSFERASE|5.4|Kd=4.0uM|Kd|=|4|uM|4000|nM
6MA2|2.10|2018|J9S|ligand is compound ent-1a; Kd = 4.1 +/- 3.0uM|O15294|UDP-N-ACETYLGLUCOSAMINE--PEPTIDE N|5.39|Kd=4.1uM|Kd|=|4.1|uM|4100|nM
6EYB|1.90|2018|C3Z|ligand is compound 41; Kd = 4.22+/-0.097uM|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|5.37|Kd=4.22uM|Kd|=|4.22|uM|4220|nM
5UCI|2.70|2018|874|Kd = 4.27 +/- 0.95 uM. ligand is compound 5|P08238|HEAT SHOCK PROTEIN HSP90-BETA|5.37|Kd=4.27uM|Kd|=|4.27|uM|4270|nM
6G3A|1.43|2018|5ID|ligand is 5-iTU; Kd = 4.2 +/- 0.4 nM|Q8TF76|SERINE/THREONINE-PROTEIN KINASE HASPIN|8.38|Kd=4.2nM|Kd|=|4.2|nM|4.2|nM
6BAW|2.70|2018|D57|Kd = 4.2 +/- 0.22 uM. ligand is compound 2|P41148|ENDOPLASMIN|5.38|Kd=4.2uM|Kd|=|4.2|uM|4200|nM
6G15|1.65|2018|C1Z|ligand is compound pppGpp|------|RIBOSOME BIOGENESIS GTPASE A|5.37|Kd=4.31uM|Kd|=|4.31|uM|4310|nM
5OL3|1.58|2018|18-mer|Kd(18-mer)=4.32+/-0.89uM|P25321|CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA|5.36|Kd=4.32uM|Kd|=|4.32|uM|4320|nM
6ERV|2.06|2018|18-mer|microscale thermophoresis assay, Kd(18-mer)=4.32+/-0.89uM|P25321|CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA|5.36|Kd=4.32uM|Kd|=|4.32|uM|4320|nM
6ERW|1.89|2018|18-mer|microscale thermophoresis assay, Kd(18-mer)=4.32+/-0.89uM|P25321|CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA|5.36|Kd=4.32uM|Kd|=|4.32|uM|4320|nM
6CER|2.69|2018|TDP|[Covalent complex] ligand is compound ThDP; Kd = 4.39+/-0.23uM|P08559|PYRUVATE DEHYDROGENASE E1 COMPONENT SUBUNIT ALPHA, SOMATIC|5.36|Kd=4.39uM|Kd|=|4.39|uM|4390|nM
6AP6|1.65|2018|TLF|[Nonstandard assay: PH=8] [Different protein in assay: Protein in binding assay is WT] ligand is Tolfenamic acid,Kd=4.3+/-0.5uM,Ki=0.12+/-0.02uM|J9U5U9|PROBABLE STRIGOLACTONE ESTERASE DAD2|5.37|Kd=4.3uM|Kd|=|4.3|uM|4300|nM
6AFE|1.50|2018|72T|[Covalent complex] ligand is 7,Kd=4.4+/-0.3uM(ITC)|Q99497|PROTEIN/NUCLEIC ACID DEGLYCASE DJ-1|5.36|Kd=4.4uM|Kd|=|4.4|uM|4400|nM
6AN1|2.69|2018|BKY|[Incomplete ligand] ligand is AM-879,Kd=4.5+/-0.6uM,ligand in PDB is wrong|P37231|PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA|5.35|Kd=4.5uM|Kd|=|4.5|uM|4500|nM
5O9Y|1.57|2018|9PN|Kd = 4.60 +/- 0.03 uM. ligand is compound 11|Q06135|1,3-BETA-GLUCANOSYLTRANSFERASE GAS2|5.34|Kd=4.60uM|Kd|=|4.6|uM|4600|nM
6B5O|2.19|2018|15-mer|ligand is petide 29|------|CIS43 FAB HEAVY CHAIN|8.33|Kd=4.66nM|Kd|=|4.66|nM|4.66|nM
5Y24|1.92|2018|6-mer|[Nonstandard assay: PH=8.0] Kd=4.6+/-1.4nM|O64094|AIMR TRANSCRIPTIONAL REGULATOR|8.34|Kd=4.6nM|Kd|=|4.6|nM|4.6|nM
6G39|1.45|2018|5ID|ligand is 5-iTU; Kd = 4.6 +/- 0.3 nM|Q8TF76|SERINE/THREONINE-PROTEIN KINASE HASPIN|8.34|Kd=4.6nM|Kd|=|4.6|nM|4.6|nM
6AP7|1.51|2018|BNY|[Nonstandard assay: PH=8] [Different protein in assay: Protein in binding assay is WT] ligand is MNAB,Kd=4.6+/-0.5uM,Ki=0.16+/-0.02uM|J9U5U9|PROBABLE STRIGOLACTONE ESTERASE DAD2|5.34|Kd=4.6uM|Kd|=|4.6|uM|4600|nM
6FAV|1.40|2018|8-mer|[Different ligand in assay: ] ligand is 4.2f-1; Kd = 4.7 +/- 0.6 uM|P31947|14-3-3 PROTEIN SIGMA|5.33|Kd=4.7uM|Kd|=|4.7|uM|4700|nM
6G0Z|2.15|2018|GDP||------|RIBOSOME BIOGENESIS GTPASE A|5.32|Kd=4.84uM|Kd|=|4.84|uM|4840|nM
6H1U|1.68|2018|ASP|ligand is ASP; Kd = 4.8 +/- 0.6 uM|P96257|PROBABLE GLUTAMINE-BINDING LIPOPROTEIN GLNH (GLNBP)|5.32|Kd=4.8uM|Kd|=|4.8|uM|4800|nM
5OAH|1.80|2018|95B|[Uncommon element] Kd = 4.9 +/- 0.4 nM, Ligand is [FeIII(AZOTO)]2-|------|ENTEROCHELIN ABC TRANSPORTER SUBSTRATE-BINDING PROTEIN|8.31|Kd=4.9nM|Kd|=|4.9|nM|4.9|nM
6EZI|1.50|2018|10-mer|Kd = 4.9 +/- 0.2 uM|Q5T2W1|NA(+)/H(+) EXCHANGE REGULATORY COFACTOR NHE-RF3|5.31|Kd=4.9uM|Kd|=|4.9|uM|4900|nM
5QAZ|2.20|2018|Q2S|ligand is compound 34|Q6XEC0|BETA-LACTAMASE|3.4|Kd=400uM|Kd|=|400|uM|400000|nM
5QAW|2.20|2018|TVC|ligand is compound 27|Q6XEC0|BETA-LACTAMASE|3.4|Kd=400uM|Kd|=|400|uM|400000|nM
6B1X|1.45|2018|C9D|[Covalent complex] ligand is compound 1,Kd=40+/-7nM,KPC-2-soaked 1|Q9F663|CARBAPENEM-HYDROLYZING BETA-LACTAMASE KPC|7.4|Kd=40nM|Kd|=|40|nM|40|nM
6B1Y|1.80|2018|CD7|[Covalent complex] ligand is compound 1,Kd=40+/-7nM,KPC-2-cocrystallized 1|Q9F663|CARBAPENEM-HYDROLYZING BETA-LACTAMASE KPC|7.4|Kd=40nM|Kd|=|40|nM|40|nM
5NZE|1.69|2018|G39|Kd = 410 +/- 20 nM, ligand is oseltamivir carboxylate|W5R8B8|NEURAMINIDASE|6.39|Kd=410nM|Kd|=|410|nM|410|nM
6CSQ|2.03|2018|F9P|ligand is compound 3|A7YT55|HDAC6 PROTEIN|6.39|Kd=410nM|Kd|=|410|nM|410|nM
5ORH|1.75|2018|A4N|ligand is compound 2|P68400|CASEIN KINASE II, ALPHA SUBUNIT|4.39|Kd=41uM|Kd|=|41|uM|41000|nM
6EU6|1.98|2018|NH4|ligand is NH4+; Kd=41+/-24uM;Binding assay method is MST|Q1Q357|AMMONIUM TRANSPORTER|4.39|Kd=41uM|Kd|=|41|uM|41000|nM
6G37|1.48|2018|FTU|ligand is 5-fluorotubercidin; Kd = 42.7 +/- 2.8 nM|Q8TF76|SERINE/THREONINE-PROTEIN KINASE HASPIN|7.37|Kd=42.7nM|Kd|=|42.7|nM|42.7|nM
6B22|1.93|2018|C8Y|[Covalent complex] ligand is compound 3,Kd=42+/-6nM,OXA-24/40-cocrystallized 3|Q8RLA6|BETA-LACTAMASE|7.38|Kd=42nM|Kd|=|42|nM|42|nM
6B1W|1.73|2018|C8V|[Covalent complex] ligand is compound 2,Kd=43+/-5nM,KPC-2-cocrystallized 2|Q9F663|CARBAPENEM-HYDROLYZING BETA-LACTAMASE KPC|7.37|Kd=43nM|Kd|=|43|nM|43|nM
6B1J|1.60|2018|C8V|[Covalent complex] ligand is compound 2,Kd=43+/-5nM,KPC-2-soaked 2|Q9F663|CARBAPENEM-HYDROLYZING BETA-LACTAMASE KPC|7.37|Kd=43nM|Kd|=|43|nM|43|nM
6GU3|2.65|2018|FB8|[Different protein in assay: protein in binding assay is CDK1-CyclinB] Kd=4400+/-3200 nM; ligand is compound AZD5438|P06493|CYCLIN-DEPENDENT KINASE 1|5.36|Kd=4400nM|Kd|=|4400|nM|4400|nM
5WEP|3.50|2018|A81|Kd(WT)=440+/-50nM|D7UQM0|FOSA3|6.36|Kd=440nM|Kd|=|440|nM|440|nM
6E4A|1.26|2018|HRY|Ligand is compound 48(CN750); Binding assay: BROMOscan assay|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|7.36|Kd=44nM|Kd|=|44|nM|44|nM
6H77|2.10|2018|ATP||Q9GZZ9|UBIQUITIN-LIKE MODIFIER-ACTIVATING ENZYME 5|7.33|Kd=46.3nM|Kd|=|46.3|nM|46.3|nM
6H78|2.70|2018|ATP||Q9GZZ9|UBIQUITIN-LIKE MODIFIER-ACTIVATING ENZYME 5|7.33|Kd=46.3nM|Kd|=|46.3|nM|46.3|nM
5W2S|2.40|2018|KMG|Kd(5g)=46.5+/-18.7nM|H8ESN0|3-OXOACYL-[ACYL-CARRIER-PROTEIN] SYNTHASE 1|7.33|Kd=46.5nM|Kd|=|46.5|nM|46.5|nM
6HLY|1.40|2018|G9Z|ligand is agropinic acid; Kd = 47 +/- 5.6 nM (fluorescence)|W8FRA6|AGROPINE PERMEASE|7.33|Kd=47nM|Kd|=|47|nM|47|nM
6HLZ|1.89|2018|G9Z|ligand is agropinic acid; Kd = 47 +/- 5.6 nM (fluorescence); same as 6hly|W8FRA6|AGROPINE PERMEASE|7.33|Kd=47nM|Kd|=|47|nM|47|nM
6HM2|1.74|2018|G9Z|ligand is agropinic acid; Kd = 47 +/- 5.6 nM (fluorescence); same as 6hly|W8FRA6|AGROPINE PERMEASE|7.33|Kd=47nM|Kd|=|47|nM|47|nM
5ODS|3.09|2018|18-mer|Kd = 47 +/- 2 uM|Q68FD5|CLATHRIN HEAVY CHAIN 1|4.33|Kd=47uM|Kd|=|47|uM|47000|nM
6EXJ|1.80|2018|7-mer|Kd = 47 +/- 2.5 uM, ligand is SSRL2|Q9JLU4|SH3 AND MULTIPLE ANKYRIN REPEAT DOMAINS PROTEIN 3|4.33|Kd=47uM|Kd|=|47|uM|47000|nM
6CZB|2.40|2018|UTP|ligand is UTP; Kd = 47+/-1uM|P9WPQ5|ATP-DEPENDENT DETHIOBIOTIN SYNTHETASE BIOD|4.33|Kd=47uM|Kd|=|47|uM|47000|nM
5WIJ|2.04|2018|AQG|Kd(NU6140)=488+/-26nM|O60674|TYROSINE-PROTEIN KINASE JAK2|6.31|Kd=488nM|Kd|=|488|nM|488|nM
6F20|2.00|2018|C9E|ligand is compound 1|P36639|7,8-DIHYDRO-8-OXOGUANINE TRIPHOSPHATASE|4.31|Kd=49.5uM|Kd|=|49.5|uM|49500|nM
5QB3|2.00|2018|AVM|ligand is compound 40|Q6XEC0|BETA-LACTAMASE|4.31|Kd=49uM|Kd|=|49|uM|49000|nM
6GUE|1.99|2018|FB8|Kd = 4 +/- 1 nM; ligand is compound AZD5438|P24941|CYCLIN-DEPENDENT KINASE 2|8.4|Kd=4nM|Kd|=|4|nM|4|nM
5O1I|1.40|2018|9GH|ligand is compound 70|P04637|CELLULAR TUMOR ANTIGEN P53|5.4|Kd=4uM|Kd|=|4|uM|4000|nM
6BJ2|3.35|2018|9-mer|ligand is peptide IPLTEEAEL(B35-HIV)|Q6IRV4|TCR 589 ALPHA CHAIN|5.4|Kd=4uM|Kd|=|4|uM|4000|nM
6GMQ|2.76|2018|F4K|Kd = 5.0 +/- 0.4 mM; Compound is MB756|Q15370|ELONGIN-B|2.3|Kd=5.0mM|Kd|=|5|mM|5000000|nM
5VNB|2.40|2018|10-mer|[Different protein in assay: Protein in binding assay is full-length] Kd = 5.0 +/- 2.8 uM|O95619|YEATS DOMAIN-CONTAINING PROTEIN 4|5.3|Kd=5.0uM|Kd|=|5|uM|5000|nM
5YLS|3.00|2018|Y50|ligand is SKLB050,Kd=5.13+/-0.62uM|Q2XVP4|TUBULIN ALPHA-1B CHAIN|5.29|Kd=5.13uM|Kd|=|5.13|uM|5130|nM
5TKK|1.55|2018|8-mer|protein is vFP5.01, ligand is Fusion peptide|------|HIV-1 FUSION PEPTIDE RESIDUE 512-519|8.28|Kd=5.29nM|Kd|=|5.29|nM|5.29|nM
5XPI|2.20|2018|8C3|ligand is NV01, Kd=5.2+/-1.2uM|Q96T88|E3 UBIQUITIN-PROTEIN LIGASE UHRF1|5.28|Kd=5.2uM|Kd|=|5.2|uM|5200|nM
6GZH|3.17|2018|LCI|ligand is compound A86|P50750|CYCLIN-DEPENDENT KINASE 9|8.27|Kd=5.4nM|Kd|=|5.4|nM|5.4|nM
6GZM|1.59|2018|LCI|ligand is compound A86|P48730|CASEIN KINASE I ISOFORM DELTA|8.26|Kd=5.5nM|Kd|=|5.5|nM|5.5|nM
6BCR|1.99|2018|14-mer|Kd(site 2, T340)=5.5+/-1.8uM|P27348|14-3-3 PROTEIN THETA|5.26|Kd=5.5uM|Kd|=|5.5|uM|5500|nM
6BW5|3.10|2018|TUM|[Nonstandard assay: without MgCl2] Kd = 5.6+/-1.3nM|Q9H3H5|UDP-N-ACETYLGLUCOSAMINE--DOLICHYL-PHOSPHATE N|8.25|Kd=5.6nM|Kd|=|5.6|nM|5.6|nM
6CPW|1.85|2018|F8V|ligand is compound 27|P63086|MITOGEN-ACTIVATED PROTEIN KINASE 1|8.25|Kd=5.6nM|Kd|=|5.6|nM|5.6|nM
6ET8|1.70|2018|BWH|ligand is compound albicidin; Kd = 5.6+/-0.2nM|Q8KRS7|ALBICIDIN RESISTANCE PROTEIN|8.25|Kd=5.6nM|Kd|=|5.6|nM|5.6|nM
6FC6|1.80|2018|11-mer|ligand is peptide ETF; Kd = 5.6 +/- 0.8 uM|P11709|NUCLEAR FUSION PROTEIN BIK1|5.25|Kd=5.6uM|Kd|=|5.6|uM|5600|nM
6B5Q|2.16|2018|5-mer|[Nonstandard assay: Temp 30] ligand is compound 38,Kd=5.7+/-2.0nM|Q96GG9|DCN1-LIKE PROTEIN 1|8.24|Kd=5.7nM|Kd|=|5.7|nM|5.7|nM
6G34|1.76|2018|5ID|ligand is 5-ITU; Kd = 5.7 +/- 0.5 nM|Q8TF76|SERINE/THREONINE-PROTEIN KINASE HASPIN|8.24|Kd=5.7nM|Kd|=|5.7|nM|5.7|nM
5OT3|2.04|2018|9LQ,18-mer|[Uncommon element] Kd(9LQ)=5.86+/-2.75uM,Kd(18-mer)>100uM|P25321|CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA|5.23|Kd=5.86uM|Kd|=|5.86|uM|5860|nM
6ERT|1.80|2018|BVZ|[Uncommon element] microscale thermophoresis assay, Kd(BVZ)=5.86+/-2.75uM|P25321|CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA|5.23|Kd=5.86uM|Kd|=|5.86|uM|5860|nM
6BHV|2.30|2018|DQV|ligand is compound BAD; Kd=5.87+/-0.62uM|P09874|POLY [ADP-RIBOSE] POLYMERASE 1|5.23|Kd=5.87uM|Kd|=|5.87|uM|5870|nM
6CF6|1.93|2018|13-mer|ligand is compound RNF146; Kd = 5.8+/-0.6uM|Q6PFX9|TANKYRASE-1|5.24|Kd=5.8uM|Kd|=|5.8|uM|5800|nM
5ZLA|1.70|2018|9F3|[Different protein in assay: Protein in binding assay is C387A/E210A] ligand is DFA-III,Kd=50.1+/-7.2uM|B8HDZ1|DFA-IIIASE C387A MUTANT|4.3|Kd=50.1uM|Kd|=|50.1|uM|50100|nM
5ZKU|2.32|2018|9F3|[Different protein in assay: Protein in binding assay is E210A mutant] ligand is DFA-III,Kd=50.5+/-7.1uM; same as 5zla|B8HDZ1|DFA-IIIASE|4.3|Kd=50.5uM|Kd|=|50.5|uM|50500|nM
6FDT|NMR|2018|9-mer|Kd = 50.5 +/- 5.0 uM|Q9H6T3|RNA POLYMERASE II-ASSOCIATED PROTEIN 3|4.3|Kd=50.5uM|Kd|=|50.5|uM|50500|nM
6FUG|2.21|2018|E85|ligand is compound 7|P00746|COMPLEMENT FACTOR D|4.3|Kd=50uM|Kd|=|50|uM|50000|nM
6FUJ|2.25|2018|E8B|ligand is compound 10|P00746|COMPLEMENT FACTOR D|4.3|Kd=50uM|Kd|=|50|uM|50000|nM
6ELO|1.80|2018|BAW|ligand is compound 7; Kd =514+/-6nM|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|6.29|Kd=514nM|Kd|=|514|nM|514|nM
5NZ4|1.36|2018|G39|Kd = 520 +/- 30 nM, ligand is oseltamivir carboxylate|C6KQL9|NEURAMINIDASE|6.28|Kd=520nM|Kd|=|520|nM|520|nM
6GNM|2.24|2018|27M|ligand is compound BP2|Q9PTT3|TRANSTHYRETIN|4.26|Kd=54.61uM|Kd|=|54.61|uM|54610|nM
6F1N|2.09|2018|C8W|ligand is compound 6; Kd = 547+/-7.3 nM|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|6.26|Kd=547nM|Kd|=|547|nM|547|nM
6BOD|3.20|2018|E0P|IC50 = 55 +/- 29 uM. ligand is compound 3|Q9UHD2|SERINE/THREONINE-PROTEIN KINASE TBK1|4.26|Kd=55uM|Kd|=|55|uM|55000|nM
6MXE|2.47|2018|K5S|[Different ligand in assay: Ligand in binding assay is a symmetrical dimer] ligand is compound 18; Kd = 55+/- 30 uM(first)|Q86WV6|STIMULATOR OF INTERFERON GENES PROTEIN|4.26|Kd=55uM|Kd|=|55|uM|55000|nM
6DF2|2.60|2018|3-mer|Biolayer Interferometry assay, ligand is pY peptide|------|ANTI-PHOSPHOTYROSINE ANTIBODY C310-4D5 HEAVY CHAIN|7.24|Kd=57.2nM|Kd|=|57.2|nM|57.2|nM
6FJM|2.10|2018|DKN|Kd = 576 +/- 49 nM; ligand is Disorazole Z|P81947|TUBULIN ALPHA-1B CHAIN|6.24|Kd=576nM|Kd|=|576|nM|576|nM
5XMX|2.00|2018|89L|ligand is compound 18, Kd=57+/-1nM|Q03181|PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR DELTA|7.24|Kd=57nM|Kd|=|57|nM|57|nM
6FSD|2.70|2018|E5H|[Different protein in assay: X-ray(Mus musculus); IC50(human)] ligand is compound 10|P21836|ACETYLCHOLINESTERASE|4.24|Kd=57uM|Kd|=|57|uM|57000|nM
6G9B|2.26|2018|IXX|ligand is imipramine; Kd = 582 +/- 256 uM|Q05320|ENVELOPE GLYCOPROTEIN 1|3.24|Kd=582uM|Kd|=|582|uM|582000|nM
5UMW|2.27|2018|RBF|Kd = 59.5 +/- 8.6 uM, ligand is riboflavin, protein is TnmS2|------|GLYOXALASE/BLEOMYCIN RESISANCE PROTEIN/DIOXYGENASE|4.23|Kd=59.5uM|Kd|=|59.5|uM|59500|nM
5QAY|1.70|2018|X6P|ligand is compound 32|Q6XEC0|BETA-LACTAMASE|3.23|Kd=590uM|Kd|=|590|uM|590000|nM
5YWY|3.20|2018|7UR|ligand is ONO-AE3-208. Protein is EP4-i3d (A62L/G106R). Complex is EP4-Fab001-ligand|P35408|PROSTAGLANDIN E2 RECEPTOR EP4 SUBTYPE|7.23|Kd=59nM|Kd|=|59|nM|59|nM
5V3H|2.69|2018|8WG|kon=5E+5, koff=0.003|Q9NRG4|N-LYSINE METHYLTRANSFERASE SMYD2|8.3|Kd=5nM|Kd|=|5|nM|5|nM
6ATV|1.75|2018|15-mer|[Nonstandard assay: pH 6.1, NaCl = 80mM] NaCl = 80mM:Kd=6.0+/-2.0nM,NaCl = 1M:Kd=1.0+/-0.3uM|P46108|ADAPTER MOLECULE CRK|8.22|Kd=6.0nM|Kd|=|6|nM|6|nM
5WMG|1.19|2018|6JF||O60885|BROMODOMAIN-CONTAINING PROTEIN 4|8.21|Kd=6.1nM|Kd|=|6.1|nM|6.1|nM
6D6U|3.80|2018|FYP|Kd = 6.1 +/- 1.1 nM; Conformation A|P47870|GAMMA-AMINOBUTYRIC ACID RECEPTOR SUBUNIT BETA-2,GAMMA|8.21|Kd=6.1nM|Kd|=|6.1|nM|6.1|nM
6D6T|3.80|2018|FYP|Kd = 6.1 +/- 1.1 nM; Conformation B|P47870|GAMMA-AMINOBUTYRIC ACID RECEPTOR SUBUNIT BETA-2,GAMMA|8.21|Kd=6.1nM|Kd|=|6.1|nM|6.1|nM
6G85|1.53|2018|16-mer||Q00684|TYROSINE-PROTEIN PHOSPHATASE CDC14|5.21|Kd=6.1uM|Kd|=|6.1|uM|6100|nM
6G84|2.47|2018|16-mer|Kd = 6.1 +/- 0.3 uM|Q00684|TYROSINE-PROTEIN PHOSPHATASE CDC14|5.21|Kd=6.1uM|Kd|=|6.1|uM|6100|nM
5O9Q|1.40|2018|9PH|Kd = 6.2 +/- 0.1 uM. ligand is compound 6|Q06135|1,3-BETA-GLUCANOSYLTRANSFERASE GAS2|5.21|Kd=6.2uM|Kd|=|6.2|uM|6200|nM
5ZO8|2.20|2018|4C5|ligand is PVEI0021,Kd=6.3+/-1.8nM|P52732|KINESIN-LIKE PROTEIN KIF11|8.2|Kd=6.3nM|Kd|=|6.3|nM|6.3|nM
5ZO9|2.70|2018|4C5|Kd=6.3+/-1.8nM,5zo8 and 5zo9 are same complex with different crystal structrue|P52732|KINESIN-LIKE PROTEIN KIF11|8.2|Kd=6.3nM|Kd|=|6.3|nM|6.3|nM
6D1X|2.30|2018|PA7|compound is NPCA, Kd=6.3+/-0.1uM|P41148|ENDOPLASMIN|5.2|Kd=6.3uM|Kd|=|6.3|uM|6300|nM
5ZKC|2.30|2018|3C0|ligand is NMS; Kd=6.4+/-0.1nM|P08172|MUSCARINIC ACETYLCHOLINE RECEPTOR M2,APO-CYTOCHROME B562|8.19|Kd=6.4nM|Kd|=|6.4|nM|6.4|nM
5YC8|2.50|2018|3C0|ligand is NMS; Kd=6.4+/-0.1nM; same as 5zkc|P08172|MUSCARINIC ACETYLCHOLINE RECEPTOR M2,REDESIGNED APO|8.19|Kd=6.4nM|Kd|=|6.4|nM|6.4|nM
6DQ5|1.89|2018|H6G|ligand is compound N43; Kd = 6.4+/-1.6uM|P29375|LINKED KDM5A JMJ DOMAIN|5.19|Kd=6.4uM|Kd|=|6.4|uM|6400|nM
5OTZ|1.46|2018|AUT|ligand is compound 15|P68400|CASEIN KINASE II, ALPHA SUBUNIT|5.19|Kd=6.5uM|Kd|=|6.5|uM|6500|nM
6ARN|1.25|2018|BQY|bio-layer interferometry experiment, Kd=6.5+/-1.4uM|Q1RBS0|PUTATIVE FML FIMBRIAL ADHESIN FMLD|5.19|Kd=6.5uM|Kd|=|6.5|uM|6500|nM
6G47|1.50|2018|SIA|ligand is 52SFK; Kd = 6.60 +/- 0.43 mM|A0MK70|FIBER-1|2.18|Kd=6.60mM|Kd|=|6.6|mM|6600000|nM
6GMX|2.53|2018|F7B|Kd = 6.7 +/- 0.8 mM; Compound is MB1200|Q15370|ELONGIN-B|2.17|Kd=6.7mM|Kd|=|6.7|mM|6700000|nM
5OXK|2.38|2018|2-mer|Kd = 6.82 + 1.33 mM, ligand is Ala-Gln|Q5M4H8|DI-OR TRIPEPTIDE:H+ SYMPORTER|2.17|Kd=6.82mM|Kd|=|6.82|mM|6820000|nM
6MJF|2.20|2018|SAH|Kd = 6.88 +/- 1.13 uM; ligand is compound SAH|------|DBOPHM|5.16|Kd=6.88uM|Kd|=|6.88|uM|6880|nM
6GHJ|2.26|2018|3-mer|Kd = 6.89 +/- 1.35 mM|Q5M4H8|DI-OR TRIPEPTIDE:H+ SYMPORTER|2.16|Kd=6.89mM|Kd|=|6.89|mM|6890000|nM
6FJF|2.40|2018|DKE|Kd = 6.8 +/- 0.8 nM; ligand is FcMaytansine ?binding assay: fluorescence anisotrop|P81947|TUBULIN ALPHA-1B CHAIN|8.17|Kd=6.8nM|Kd|=|6.8|nM|6.8|nM
5OHY|1.77|2018|9VH|Kd=6.8+/-0.2uM|------|ALPHA-GLUCOSIDASE YIHQ|5.17|Kd=6.8uM|Kd|=|6.8|uM|6800|nM
6EVO|1.55|2018|9-mer|Ligand is peptide PPG-PRG-PPG; Kd = 6.8+/-1.0uM|O15460|PROLYL 4-HYDROXYLASE SUBUNIT ALPHA-2|5.17|Kd=6.8uM|Kd|=|6.8|uM|6800|nM
5NIY|1.70|2018|GNP|[Different protein in assay: Protein in binding assay is FtsY deltaN1 (aa.220-493)] ligand is GMPPNP|P10121|SIGNAL RECOGNITION PARTICLE RECEPTOR FTSY|4.22|Kd=60uM|Kd|=|60|uM|60000|nM
5WIK|2.60|2018|584|Kd(BI-D1870)=620+/-36nM|O60674|TYROSINE-PROTEIN KINASE JAK2|6.21|Kd=620nM|Kd|=|620|nM|620|nM
6FU4|2.45|2018|HSM|Kd = 639 +/- 27 nM; ligand is histamine|Q9I0I4|PROBABLE CHEMOTAXIS TRANSDUCER|6.19|Kd=639nM|Kd|=|639|nM|639|nM
6F8G|2.03|2018|12-mer|Kd = 65.5 +/- 9.6 uM|O43791|SPECKLE-TYPE POZ PROTEIN|4.18|Kd=65.5uM|Kd|=|65.5|uM|65500|nM
5YYZ|1.80|2018|13-mer|[Nonstandard assay: Tem 15] ligand is PT318,Kd=66.2+/-9.0uM|P24719|MEIOSIS-SPECIFIC SERINE/THREONINE-PROTEIN KINASE MEK1|4.18|Kd=66.2uM|Kd|=|66.2|uM|66200|nM
5WOU|1.55|2018|8-mer|ligand is Gukh peptide; Kd=664+/-129nM|Q7KRY7|PROTEIN LAP4|6.18|Kd=664nM|Kd|=|664|nM|664|nM
6HLX|1.65|2018|G9Z|ligand is agropinic acid; Kd = 67 +/- 10.6 nM (fluorescence)|O50260|AGAA|7.17|Kd=67nM|Kd|=|67|nM|67|nM
6HTG|1.94|2018|T61|ligand is compound 4; IC50 = 67 +/- 10 nM|A5H660|HISTONE DEACETYLASE|7.17|Kd=67nM|Kd|=|67|nM|67|nM
6C28|2.09|2018|WCA|ligand is compound pCC;Kd = 68+/-8uM;binding assay method: DSF|Q6N8V9|TRANSCRIPTIONAL REGULATOR, MARR FAMILY|4.17|Kd=68uM|Kd|=|68|uM|68000|nM
6CKC|2.80|2018|F5J|ligand is compound 1; Kd = 6+/-2nM|O14744|PROTEIN ARGININE N-METHYLTRANSFERASE 5|8.22|Kd=6nM|Kd|=|6|nM|6|nM
6FNI|1.47|2018|DXH|ligand is NVP|P54760|EPHRIN TYPE-B RECEPTOR 4|8.22|Kd=6nM|Kd|=|6|nM|6|nM
5Y2F|2.53|2018|8L9|ligand is compound MDL-801|Q8N6T7|NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-6|5.15|Kd=7.0uM|Kd|=|7|uM|7000|nM
5TKJ|2.12|2018|8-mer|protein is vFP1.01, ligand is Fusion peptide|------|VFP1.01 ANTIBODY FAB HEAVY CHAIN|8.15|Kd=7.15nM|Kd|=|7.15|nM|7.15|nM
6FAP|2.70|2018|D3H|ligand is compound Fr23; Kd = 7.1 +/- 1.9 mM|Q9UIF9|BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN PROTEIN 2A|2.15|Kd=7.1mM|Kd|=|7.1|mM|7100000|nM
6FI1|2.70|2018|D3H|ligand is compound Fr23; Kd = 7.1 +/- 1.9 mM|Q9UIF8|BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN PROTEIN 2B|2.15|Kd=7.1mM|Kd|=|7.1|mM|7100000|nM
5MWZ|1.25|2018|KGU|ligand is compound 36|P55201|PEREGRIN|5.15|Kd=7.1uM|Kd|=|7.1|uM|7100|nM
6ARO|1.20|2018|BS7|bio-layer interferometry experiment, Kd=7.1+/-2.3uM|Q1RBS0|F9 PILUS ADHESIN FMLH|5.15|Kd=7.1uM|Kd|=|7.1|uM|7100|nM
6GW1|1.90|2018|CHO|ligand is GCDCA|Q5F4T5|CAPSID PROTEIN|5.14|Kd=7.2uM|Kd|=|7.2|uM|7200|nM
5XBT|2.50|2018|C2E|Kd(FP)=7.3+/-0.5uM|Q9HUT5|PROBABLE TRANSCRIPTIONAL REGULATOR|5.14|Kd=7.3uM|Kd|=|7.3|uM|7300|nM
6GZL|1.95|2018|17-mer||P63167|DYNEIN LIGHT CHAIN 1|5.14|Kd=7.3uM|Kd|=|7.3|uM|7300|nM
5Y1U|2.14|2018|12-mer|ligand is AEBP2,Kd=7.6+/-0.6umol/L|Q09028|HISTONE-BINDING PROTEIN RBBP4|5.12|Kd=7.6uM|Kd|=|7.6|uM|7600|nM
6CNJ|3.40|2018|NCT|Kd = 6.9-8.6nM; Receptor alone|P43681|NEURONAL ACETYLCHOLINE RECEPTOR SUBUNIT ALPHA-4|8.11|Kd=7.7nM|Kd|=|7.7|nM|7.7|nM
6GWR|2.07|2018|FEW|ligand is compound 5n|Q08345|EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1|8.1|Kd=7.9nM|Kd|=|7.9|nM|7.9|nM
5QAV|1.72|2018|L43|ligand is compound 26b|Q6XEC0|BETA-LACTAMASE|4.15|Kd=70uM|Kd|=|70|uM|70000|nM
5QB2|1.75|2018|U3M|ligand is compound 38|Q6XEC0|BETA-LACTAMASE|4.15|Kd=70uM|Kd|=|70|uM|70000|nM
5QAU|1.75|2018|V7V|ligand is compound 26a|Q6XEC0|BETA-LACTAMASE|4.15|Kd=70uM|Kd|=|70|uM|70000|nM
6H0B|1.80|2018|16-mer|Kd = 70 +/- 15 uM; ligand is glycopeptide 6|Q8N4A0|POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 4|4.15|Kd=70uM|Kd|=|70|uM|70000|nM
6G98|2.47|2018|ER5|ligand is VR16-09|Q16790|CARBONIC ANHYDRASE 9|6.15|Kd=710nM|Kd|=|710|nM|710|nM
6GUK|1.30|2018|FC8|Kd = 715 +/- 15 nM; ligand is compound CGP74514A|P24941|CYCLIN-DEPENDENT KINASE 2|6.15|Kd=715nM|Kd|=|715|nM|715|nM
5V5O|2.24|2018|19-mer|Kd=72.4+/-10.0uM|P52293|IMPORTIN SUBUNIT ALPHA-1|4.14|Kd=72.4uM|Kd|=|72.4|uM|72400|nM
6CCT|2.40|2018|4-mer|ligand is peptide PTLV; Kd = 72.5+/-1.7uM|Q8IVV7|GLUCOSE-INDUCED DEGRADATION PROTEIN 4 HOMOLOG|4.14|Kd=72.5uM|Kd|=|72.5|uM|72500|nM
6FNG|1.04|2018|DWT|ligand is NVPiso|P29317|EPHRIN TYPE-A RECEPTOR 2|7.14|Kd=73nM|Kd|=|73|nM|73|nM
5O8T|2.20|2018|SY9|Kd=74.1+/-22.6nM; redundant to 5obg|Q8WSF8|ACETYLCHOLINE RECEPTOR|7.13|Kd=74.1nM|Kd|=|74.1|nM|74.1|nM
5OBG|2.00|2018|SY9|Kd=74.1+/-22.6nM|Q8WSF8|ACETYLCHOLINE RECEPTOR|7.13|Kd=74.1nM|Kd|=|74.1|nM|74.1|nM
6CVV|2.41|2018|ATP|ligand is ATP; Kd = 75+/-3uM|P9WPQ5|ATP-DEPENDENT DETHIOBIOTIN SYNTHETASE BIOD|4.12|Kd=75uM|Kd|=|75|uM|75000|nM
6H7F|2.26|2018|FV8|[Uncommon element] ligand is preacinetobactin|Q76HJ9|BAUA|6.12|Kd=763nM|Kd|=|763|nM|763|nM
5VRL|2.65|2018|9JA|Kd = 77 +/- 31 nM. ligand is AN12855|P9WGR0|ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTASE [NADH|7.11|Kd=77nM|Kd|=|77|nM|77|nM
5OM3|2.00|2018|DXT|ligand is doxycycline, Kd for S-conformation|P01011|ALPHA-1-ANTICHYMOTRYPSIN|4.1|Kd=79.2uM|Kd|=|79.2|uM|79200|nM
6C4U|2.60|2018|9-mer|ligand is peptide Myc-pTBD; Kd = 798+/-60nM|------|FORKHEAD-ASSOCIATED 1|6.1|Kd=798nM|Kd|=|798|nM|798|nM
5O9P|1.75|2018|9P8|Kd = 8.06 +/- 0.07 uM. ligand is compound 10|Q06135|1,3-BETA-GLUCANOSYLTRANSFERASE GAS2|5.09|Kd=8.06uM|Kd|=|8.06|uM|8060.000000000001|nM
6AP8|1.27|2018|BNY|[Nonstandard assay: PH=8] [Different protein in assay: Protein in binding assay is WT] ligand is MNAB,Kd=8.0+/-0.4uM,Ki=2.40+/-0.42uM|Q10QA5|STRIGOLACTONE ESTERASE D14|5.1|Kd=8.0uM|Kd|=|8|uM|8000|nM
6E86|NMR|2018|8-mer|Binding assay: microscale thermophoresis; Ligand is peptide H3K4ac; Kd = 8.2+/-2.4uM|Q8IYH5|ZZ-TYPE ZINC FINGER-CONTAINING PROTEIN 3|5.09|Kd=8.2uM|Kd|=|8.2|uM|8200|nM
6DIK|1.93|2018|GKP|ligand is compound CA; Kd = 8.47+/-1.26uM|Q90249|BASIC PHOSPHOLIPASE A2 HOMOLOG BOTHROPSTOXIN-1|5.07|Kd=8.47uM|Kd|=|8.47|uM|8470|nM
6DQ6|1.59|2018|H6J|ligand is compound N44; Kd = 8.5+/-1.7 uM|P29375|LINKED KDM5A JMJ DOMAIN|5.07|Kd=8.5uM|Kd|=|8.5|uM|8500|nM
5OK6|1.30|2018|14-mer|[Different ligand in assay: ] IC50=8.86+/-1.13uM|G5E9A6|UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 11|5.05|Kd=8.86uM|Kd|=|8.86|uM|8860|nM
6E4T|3.40|2018|HTV|ligand is compound 1; Kd = 8.96+/-0.11nM|P54645|5'-AMP-ACTIVATED PROTEIN KINASE CATALYTIC SUBUNIT A|8.05|Kd=8.96nM|Kd|=|8.96|nM|8.96|nM
6B67|2.20|2018|7-mer|ligand is MpSIpYVA,Kd = 8.9+/-0.3uM|P35813|PROTEIN PHOSPHATASE 1A|5.05|Kd=8.9uM|Kd|=|8.9|uM|8900|nM
6HPW|1.90|2018|GKT|ligand is compound 20|Q03111|PROTEIN ENL|6.09|Kd=807nM|Kd|=|807|nM|807|nM
5W7X|2.01|2018|9-mer|APLF FHA/XRCC1pSpT-9 complex|Q8IW19|APRATAXIN AND PNK-LIKE FACTOR|4.1|Kd=80uM|Kd|=|80|uM|80000|nM
6HRQ|1.85|2018|GM5|ligand is NCC-149; Kd = 81.7 +/- 7.0 nM|A5H660|HISTONE DEACETYLASE|7.09|Kd=81.7nM|Kd|=|81.7|nM|81.7|nM
5VAR|1.83|2018|92Y|Kd = 81.7 +/- 7.1 uM. ligand is compound 1a.|O75164|LYSINE-SPECIFIC DEMETHYLASE 4A|4.09|Kd=81.7uM|Kd|=|81.7|uM|81700|nM
5Y8Y|1.87|2018|8PX|ligand is 6i|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|7.09|Kd=82nM|Kd|=|82|nM|82|nM
6BEH|3.00|2018|RPT|ligand is compound rifapentin|P68440|SCAFFOLD PROTEIN D13|4.09|Kd=82uM|Kd|=|82|uM|82000|nM
6AGG|2.71|2018|AG2|[Nonstandard assay: Temp 20, PH=7.9] ligand is Agmatine,Kd=85+/-5.7uM|O28025|TRNA(ILE2) 2-AGMATINYLCYTIDINE SYNTHETASE TIAS|4.07|Kd=85uM|Kd|=|85|uM|85000|nM
5OM2|1.47|2018|DXT|ligand is doxycycline, Kd for S-conformation|P01011|ALPHA-1-ANTICHYMOTRYPSIN|4.06|Kd=86.7uM|Kd|=|86.7|uM|86700|nM
6CE6|1.60|2018|EYP|ligand is compound 1|Q9UBN7|HISTONE DEACETYLASE 6|5.1|Kd=8uM|Kd|=|8|uM|8000|nM
5XHS|2.19|2018|3-mer|[Incomplete ligand] [Nonstandard assay: PH=8.0] ligand is 6b, PHQ-SLL-MCM|Q9NXA8|NAD-DEPENDENT DEACYLASE SIRTUIN-5|5.05|Kd=9.01uM|Kd|=|9.01|uM|9010|nM
5OCI|1.62|2018|9R8|Kd = 9.0 +/- 3.9 nM. ligand is compound 1g|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|8.05|Kd=9.0nM|Kd|=|9|nM|9|nM
6CHL|2.20|2018|EXJ|ligand is compound 3|P0A6I6|PHOSPHOPANTETHEINE ADENYLYLTRANSFERASE|8.05|Kd=9.0nM|Kd|=|9|nM|9|nM
5YY9|2.65|2018|13-mer|Kd=9.1+/-3.8nM|Q96T88|E3 UBIQUITIN-PROTEIN LIGASE UHRF1|8.04|Kd=9.1nM|Kd|=|9.1|nM|9.1|nM
5OVP|1.50|2018|7-mer|Kd = 9.1 +/- 0.5 uM, ligand is CIRL|Q9JLU4|SH3 AND MULTIPLE ANKYRIN REPEAT DOMAINS PROTEIN 3|5.04|Kd=9.1uM|Kd|=|9.1|uM|9100|nM
6FBY|1.50|2018|8-mer|[Covalent complex] ligand is 4.2b; Kd = 9.3 +/- 2.0 uM|P31947|14-3-3 PROTEIN SIGMA|5.03|Kd=9.3uM|Kd|=|9.3|uM|9300|nM
6EMU|2.30|2018|SAM|[Different protein in assay: Protein in binding assay is wild type] Kd = 9.4+/-1.2uM|Q5JD38|TRNA (GUANINE(9)-/ADENINE(9)-N1)-METHYLTRANSFERASE|5.03|Kd=9.4uM|Kd|=|9.4|uM|9400|nM
6FMI|2.80|2018|DV2|ligand is compound 2; Kd = 9.4 +/- 0.3 uM|Q15370|ELONGIN-B|5.03|Kd=9.4uM|Kd|=|9.4|uM|9400|nM
6FII|2.41|2018|SG9|Kd = 9.5 +/- 1.9 nM; ligand is spongistatin-1|P81947|TUBULIN ALPHA-1B CHAIN|8.02|Kd=9.5nM|Kd|=|9.5|nM|9.5|nM
5OA2|2.15|2018|9PW|Kd = 9.80 +/- 0.07 uM. ligand is compound 8|Q06135|1,3-BETA-GLUCANOSYLTRANSFERASE GAS2|5.01|Kd=9.80uM|Kd|=|9.8|uM|9800|nM
6GZD|2.28|2018|LCI|ligand is compound A86|P48729|CASEIN KINASE I ISOFORM ALPHA|8.01|Kd=9.8nM|Kd|=|9.8|nM|9.8|nM
6I8B|1.76|2018|H7T|ligand is 35|Q9Y657|SPINDLIN-1|8.0|Kd=9.9nM|Kd|=|9.9|nM|9.9|nM
6ELN|1.60|2018|P4A|ligand is compound 10; Kd = 900+/-17nM|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|6.05|Kd=900nM|Kd|=|900|nM|900|nM
6H41|2.75|2018|18-mer|Kd = 90 +/- 4.5 nM|Q01344|INTERLEUKIN-5 RECEPTOR SUBUNIT ALPHA|7.05|Kd=90nM|Kd|=|90|nM|90|nM
6CZE|2.30|2018|ITT|ligand is Inosine triphosphate; Kd = 93+/-8 uM|P9WPQ5|ATP-DEPENDENT DETHIOBIOTIN SYNTHETASE BIOD|4.03|Kd=93uM|Kd|=|93|uM|93000|nM
6FNS|1.85|2018|DY8|[Different ligand in assay: ligand is racemic] ligand is compound 3; Ki = 93 +/- 11 uM|------|HISTIDINE N-ALPHA-METHYLTRANSFERASE|4.03|Kd=93uM|Kd|=|93|uM|93000|nM
5WIN|2.38|2018|SKE|Kd(JNJ7706621)=94+/-1nM|O60674|TYROSINE-PROTEIN KINASE JAK2|7.03|Kd=94nM|Kd|=|94|nM|94|nM
5YHG|2.03|2018|8UX|[Uncommon element] ligand is Staphylopine.containing Zn2+|------|NICKEL ABC TRANSPORTER SUBSTRATE-BINDING PROTEIN|6.02|Kd=952.3nM|Kd|=|952.3|nM|952.3|nM
6FAM|1.13|2018|2-mer|[Incomplete ligand] [Different protein in assay: Protein in binding assay is BtGH99, which is closely related to BtGH99.] ligand is compound 1; Kd = 97.7 +/- 4.9 uM;|D6D1V7|GLYCOSYL HYDROLASE FAMILY 71|4.01|Kd=97.7uM|Kd|=|97.7|uM|97700|nM
6BEC|2.91|2018|RBT|ligand is compound rifabutin|P68440|SCAFFOLD PROTEIN D13|4.01|Kd=98uM|Kd|=|98|uM|98000|nM
5Y6G|2.30|2018|C2E|PilZ domain|P76010|FLAGELLAR BRAKE PROTEIN YCGR|7.0|Kd=99nM|Kd|=|99|nM|99|nM
6BXY|1.82|2018|EEV|Biolayer interferometry, Kd=9nM|------|MENIN|8.05|Kd=9nM|Kd|=|9|nM|9|nM
6BMI|3.90|2018|SER|[Nonstandard assay: 100 mM Na+] ligand is serine,Kd=9+/-1uM|O59010|GLUTAMATE TRANSPORTER HOMOLOG|5.05|Kd=9uM|Kd|=|9|uM|9000|nM
6D50|2.50|2018|GCB|Kd = 9+/-2uM|A0A078|GLYCOSYL HYDROLASES FAMILY 2, SUGAR BINDING DOMAIN PROTEIN|5.05|Kd=9uM|Kd|=|9|uM|9000|nM
6EXI|1.92|2018|ADN|ligand is Ado|------|ADENOSYLHOMOCYSTEINASE|5.05|Kd=9uM|Kd|=|9|uM|9000|nM
6GJY|1.29|2018|F1Z|ligand is compound 5|P62937|PEPTIDYL-PROLYL CIS-TRANS ISOMERASE A|3.0|Kd>1000uM|Kd|>|1000|uM|1000000|nM
5NW8|2.09|2018|18-mer||P25321|CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA|4.0|Kd>100uM|Kd|>|100|uM|100000|nM
5OUS|2.21|2018|18-mer||P25321|CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA|4.0|Kd>100uM|Kd|>|100|uM|100000|nM
6EH2|1.76|2018|18-mer|microscale thermophoresis assay|P25321|CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA|4.0|Kd>100uM|Kd|>|100|uM|100000|nM
6EM6|1.64|2018|18-mer|microscale thermophoresis assay|P25321|CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA|4.0|Kd>100uM|Kd|>|100|uM|100000|nM
6BH3|1.70|2018|DQJ|[Different protein in assay] ligand is compound N55|P29375|LYSINE-SPECIFIC DEMETHYLASE 5A, LINKED KDM5A JMJ DOMAIN|4.92|Kd>12uM|Kd|>|12|uM|12000|nM
6EVM|2.00|2018|9-mer|Ligand is peptide (P)9|O15460|PROLYL 4-HYDROXYLASE SUBUNIT ALPHA-2|2.82|Kd>1500uM|Kd|>|1500|uM|1500000|nM
6GU4|2.73|2018|FC8|[Different protein in assay: protein in binding assay is CDK1-CyclinB] Kd>20000 nM; ligand is compound CGP74514A|P06493|CYCLIN-DEPENDENT KINASE 1|4.7|Kd>20000nM|Kd|>|20000|nM|20000|nM
6FTY|1.67|2018|E7H|ligand is compound 5|P00746|COMPLEMENT FACTOR D|2.7|Kd>2000uM|Kd|>|2000|uM|2000000|nM
6CEX|2.57|2018|NHE|ligand is compound NCT|Q91MA7|HEMAGGLUTININ|1.7|Kd>20mM|Kd|>|20|mM|20000000|nM
6CF5|2.04|2018|NHE|ligand is compound NCT|Q5EP31|HEMAGGLUTININ|1.7|Kd>20mM|Kd|>|20|mM|20000000|nM
5OK3|1.59|2018|18-mer|peptide 9, MST assay|P25321|CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA|3.52|Kd>300uM|Kd|>|300|uM|300000|nM
6FG6|2.40|2018|D8Q|ligand is compound 1|Q9UIF9|BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN PROTEIN 2A|3.4|Kd>400uM|Kd|>|400|uM|400000|nM
5OUL|1.34|2018|AWE|ligand is compound 9|P68400|CASEIN KINASE II, SUBUNIT ALPHA|3.3|Kd>500uM|Kd|>|500|uM|500000|nM
5OXM|2.30|2018|2-mer|Kd > 50 mM, ligand is Asp-Glu|Q5M4H8|DI-OR TRIPEPTIDE:H+ SYMPORTER|1.3|Kd>50mM|Kd|>|50|mM|50000000|nM
5O5F|1.30|2018|9LT|ligand is compound 7|P55201|PEREGRIN|4.3|Kd>50uM|Kd|>|50|uM|50000|nM
6CEA|1.60|2018|EYY|ligand is compound 23|Q9UBN7|HISTONE DEACETYLASE 6|3.14|Kd>720uM|Kd|>|720|uM|720000|nM
6EW6|1.39|2018|C0H|ligand is compound 1|P41182|B-CELL LYMPHOMA 6 PROTEIN|3.08|Kd>829uM|Kd|>|829|uM|829000|nM
5V1D|2.80|2018|12-mer|ligand is P16 peptide|A5D791|EIF2AK3 PROTEIN|6.7|Kd~0.2uM|Kd|~|0.2|uM|200|nM
6CVD|1.78|2018|4ME|ligand is compound fragment1; Kd ~ 100+/-20uM|P10121|SIGNAL RECOGNITION PARTICLE RECEPTOR FTSY|4.0|Kd~100uM|Kd|~|100|uM|100000|nM
6DRG|NMR|2018|2VN||P07148|FATTY ACID-BINDING PROTEIN, LIVER|6.92|Kd~120nM|Kd|~|120|nM|120|nM
5YPP|1.90|2018|VAL|crystal form 1a|P0ADF8|ACETOLACTATE SYNTHASE ISOZYME 1 SMALL SUBUNIT|4.64|Kd~23uM|Kd|~|23|uM|23000|nM
5YPW|2.30|2018|VAL|crystal form 1b|P0ADG0|ACETOLACTATE SYNTHASE ISOZYME 1 SMALL SUBUNIT|4.64|Kd~23uM|Kd|~|23|uM|23000|nM
5YPY|1.97|2018|VAL|crystal form 1c|P0ADF8|ACETOLACTATE SYNTHASE ISOZYME 1 SMALL SUBUNIT|4.64|Kd~23uM|Kd|~|23|uM|23000|nM
5NP8|1.90|2018|93T|compound is CRT0063465|P00558|PHOSPHOGLYCERATE KINASE 1|4.62|Kd~24uM|Kd|~|24|uM|24000|nM
5NX9|2.30|2018|AMP||------|ADENYLOSUCCINATE LYASE|4.6|Kd~25uM|Kd|~|25|uM|25000|nM
6B4H|2.17|2018|IHP|ligand is IP6|G0S381|NUCLEOPORIN AMO1|8.52|Kd~3nM|Kd|~|3|nM|3|nM
6DLX|1.85|2018|GXY|ligand is compound fragment1; Kd ~ 480+/-20uM|P10121|SIGNAL RECOGNITION PARTICLE RECEPTOR FTSY|3.32|Kd~480uM|Kd|~|480|uM|480000|nM
5W19|2.10|2018|9TD|ligand is OIA|P28796|TRYPTOPHANASE|5.3|Kd~5uM|Kd|~|5|uM|5000|nM
6G33|2.05|2018|5ID|ligand is 5-iTU|P49759|DUAL SPECIFICITY PROTEIN KINASE CLK1|8.15|Kd~7nM|Kd|~|7|nM|7|nM
6C98|1.85|2018|ER7|[Different ligand in assay: Ligand in binding assay is R/S form] ligand is compound UCB-84|P55899|IGG RECEPTOR FCRN LARGE SUBUNIT P51|4.1|Kd~80uM|Kd|~|80|uM|80000|nM
6BW8|2.90|2018|ECM|[Nonstandard assay:] ligand is compound 35;TR-FRET, Ki = 1.6+/-0.10nM in the presence of 1% FBS|Q07820|INDUCED MYELOID LEUKEMIA CELL DIFFERENTIATION PROTEIN MCL|9.0|Ki<1.0nM|Ki|<|1|nM|1|nM
6B2P|3.01|2018|CJJ|ligand is compound 38|P9WI80|SERINE/THREONINE-PROTEIN KINASE PKNB|8.89|Ki<1.3nM|Ki|<|1.3|nM|1.3|nM
6C7R|1.50|2018|EO4|ligand is compound 28|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|9.0|Ki<1nM|Ki|<|1|nM|1|nM
6DH3|1.91|2018|017|ligand is compound DRV|Q6B6C5|HIV-1 PROTEASE|11.3|Ki<5pM|Ki|<|5|pM|0.005|nM
6DGX|2.00|2018|017|ligand is compound DRV; same as 6dh3|Q8ULI9|HIV-1 PROTEASE|11.3|Ki<5pM|Ki|<|5|pM|0.005|nM
6DGZ|1.99|2018|A60|ligand is compound UMass6|Q8ULI9|HIV-1 PROTEASE|11.3|Ki<5pM|Ki|<|5|pM|0.005|nM
6DH5|2.01|2018|A60|ligand is compound UMass6|Q6B6C5|HIV-1 PROTEASE|11.3|Ki<5pM|Ki|<|5|pM|0.005|nM
6DGY|1.95|2018|K13|ligand is compound UMass1|Q8ULI9|HIV-1 PROTEASE|11.3|Ki<5pM|Ki|<|5|pM|0.005|nM
6DH4|1.94|2018|K13|ligand is compound UMass1|Q6B6C5|HIV-1 PROTEASE|11.3|Ki<5pM|Ki|<|5|pM|0.005|nM
6E9A|1.22|2018|J0S|binding assay: Continuous Fluorometric Assay; ligand is compound 4a|Q5RZ08|HIV-1 PROTEASE|11.92|Ki=0.0012nM|Ki|=|0.0012|nM|0.0012|nM
6CDJ|1.13|2018|GR8|ligand is compound 5d|Q5RZ08|HIV-1 PROTEASE|11.7|Ki=0.002nM|Ki|=|0.002|nM|0.002|nM
5XVG|2.10|2018|8FX|[Nonstandard assay: Tem 22 C] ligand is compound 31,Ki=0.009uM|O96013|SERINE/THREONINE-PROTEIN KINASE PAK 4|8.05|Ki=0.009uM|Ki|=|0.009|uM|9|nM
6CDL|1.25|2018|GR5|ligand is compound 5c|Q5RZ08|HIV-1 PROTEASE|10.92|Ki=0.012nM|Ki|=|0.012|nM|0.012|nM
6H5X|1.80|2018|FT8|ligand is Omapatrilat; Ki = 0.015 +/- 0.001 nM|P12821|ANGIOTENSIN-CONVERTING ENZYME|10.82|Ki=0.015nM|Ki|=|0.015|nM|0.015|nM
6H5W|1.37|2018|FT8|ligand is Omapatrilat; Ki = 0.016 +/- 0.004 nM|P12821|ANGIOTENSIN-CONVERTING ENZYME|10.8|Ki=0.016nM|Ki|=|0.016|nM|0.016|nM
6DIF|1.20|2018|TPV|ligand is compound 3|Q5RZ08|HIV-1 PROTEASE|10.72|Ki=0.019nM|Ki|=|0.019|nM|0.019|nM
5WEB|2.25|2018|KU5|Ki = 0.01 +/- 0.04 uM, ligand is compound 10e|C3W5S0|POLYMERASE ACIDIC PROTEIN|8.0|Ki=0.01uM|Ki|=|0.01|uM|10|nM
6GBX|1.72|2018|S77|ligand is SEN177|Q16769|GLUTAMINYL-PEPTIDE CYCLOTRANSFERASE|7.7|Ki=0.020uM|Ki|=|0.02|uM|20|nM
5W92|2.30|2018|KU0|Ki = 0.02 +/- 0.02 uM, ligand is compound 8e|C3W5S0|POLYMERASE ACIDIC PROTEIN|7.7|Ki=0.02uM|Ki|=|0.02|uM|20|nM
6CN5|2.30|2018|F7M|Ligand is compound 8b|P51449|NUCLEAR RECEPTOR ROR-GAMMA|7.7|Ki=0.02uM|Ki|=|0.02|uM|20|nM
6DJ1|1.26|2018|AB1|ligand is compound 2|Q5RZ08|HIV-1 PROTEASE|10.51|Ki=0.031nM|Ki|=|0.031|nM|0.031|nM
5XVA|1.85|2018|8FU|[Nonstandard assay: Tem 22 C] ligand is compound 30,Ki=0.051uM|O96013|SERINE/THREONINE-PROTEIN KINASE PAK 4|7.29|Ki=0.051uM|Ki|=|0.051|uM|51|nM
5WB3|2.20|2018|GYA|Ki = 0.06 +/- 0.05 uM, ligand is compound 10j|C3W5S0|POLYMERASE ACIDIC PROTEIN|7.22|Ki=0.06uM|Ki|=|0.06|uM|60|nM
5YKP|1.68|2018|OVA|[Covalent complex] Ki=0.09+/-0.01uM,|P53582|METHIONINE AMINOPEPTIDASE 1|7.05|Ki=0.09uM|Ki|=|0.09|uM|90|nM
6APV|1.99|2018|3L4|[Nonstandard assay: pH 8.4] ligand is compound 2,Ki=0.11+/-0.008uM,ligand is wring in PDB.|Q07010|HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE|6.96|Ki=0.11uM|Ki|=|0.11|uM|110|nM
6BBS|2.00|2018|BZ1|ligand is BZM|P00918|CARBONIC ANHYDRASE 2|9.89|Ki=0.13nM|Ki|=|0.13|nM|0.13|nM
6CZD|2.40|2018|ADP||P9WPQ5|ATP-DEPENDENT DETHIOBIOTIN SYNTHETASE BIOD|3.85|Ki=0.14mM|Ki|=|0.14|mM|140000|nM
6BQH|2.70|2018|E2J|ligand is compound RIT(ritaneserin)|P28335|5-HYDROXYTRYPTAMINE RECEPTOR 2C,SOLUBLE CYTOCHROME B562|9.8|Ki=0.16nM|Ki|=|0.16|nM|0.16|nM
6DRZ|3.10|2018|H8J|Ligand is compound methysergide|P41595|5HT2B RECEPTOR, BRIL CHIMERA|9.8|Ki=0.16nM|Ki|=|0.16|nM|0.16|nM
6G4Z|2.84|2018|ELW|ligand is compound 2f; Ki = 0.17 +/- 0.13 nM|Q9WUL6|MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 14|9.77|Ki=0.17nM|Ki|=|0.17|nM|0.17|nM
5YR5|1.60|2018|OVA|[Covalent complex] Ki=0.18+/-0.022uM,|P53582|METHIONINE AMINOPEPTIDASE 1|6.74|Ki=0.18uM|Ki|=|0.18|uM|180|nM
6DGE|1.91|2018|GBG|[Covalent complex] ligand is compound CI-NIL; Ki = 0.19+/-0.04uM|O94760|N(G),N(G)-DIMETHYLARGININE DIMETHYLAMINOHYDROLASE 1|6.72|Ki=0.19uM|Ki|=|0.19|uM|190|nM
5Y0G|1.54|2018|8JL|[Incomplete ligand][Nonstandard assay: Temp 30] ligand is 16do,Ki=0.20+/-0.01uM|P15090|FATTY ACID-BINDING PROTEIN, ADIPOCYTE|6.7|Ki=0.20uM|Ki|=|0.2|uM|200|nM
6EBE|1.88|2018|J3V|ligand is compound 15; binding assay: Stopped Flow CO2 Hydrase Assay|P00918|CARBONIC ANHYDRASE 2|6.7|Ki=0.20uM|Ki|=|0.2|uM|200|nM
6EDA|1.88|2018|J3V|ligand is compound 15; binding assay: Stopped Flow CO2 Hydrase Assay; same as 6ebe|P00918|CARBONIC ANHYDRASE 2|6.7|Ki=0.20uM|Ki|=|0.2|uM|200|nM
6DAR|1.88|2018|G2J|ligand is compound 4q|P61964|WD REPEAT-CONTAINING PROTEIN 5|6.66|Ki=0.219uM|Ki|=|0.219|uM|219|nM
5Y0F|1.54|2018|8JO|[Incomplete ligand][Nonstandard assay: Temp 30] ligand is 16dk,Ki=0.21+/-0.01uM|P15090|FATTY ACID-BINDING PROTEIN, ADIPOCYTE|6.68|Ki=0.21uM|Ki|=|0.21|uM|210|nM
6B8Y|1.65|2018|D0A|ligand is compound 22,IC50=0.00055uM Ki app =0.22 nM|P36897|TGF-BETA RECEPTOR TYPE-1|9.66|Ki=0.22nM|Ki|=|0.22|nM|0.22|nM
6APS|1.76|2018|SV2|[Nonstandard assay: pH 8.4] ligand is compound 6,Ki=0.22+/-0.03uM|Q07010|HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE|6.66|Ki=0.22uM|Ki|=|0.22|uM|220|nM
5VJA|2.46|2018|DUK|ligand is HS38|O43293|DEATH-ASSOCIATED PROTEIN KINASE 3|6.59|Ki=0.260uM|Ki|=|0.26|uM|260|nM
6ECZ|2.21|2018|J4D|ligand is compound 17; binding assay: Stopped Flow CO2 Hydrase Assay|P00918|CARBONIC ANHYDRASE 2|6.57|Ki=0.27uM|Ki|=|0.27|uM|270|nM
6AQQ|2.71|2018|BVY|[Different ligand in assay: although the ligand author wrote in literiture is 4c,actual ligand is 5c according to PDB] the ki data of 5c is 0.28+/-0.02uM|------|BIFUNCTIONAL LIGASE/REPRESSOR BIRA|6.55|Ki=0.28uM|Ki|=|0.28|uM|280|nM
6BU3|1.15|2018|3GK|ligand is compound 1; Ki = 0.28+/-0.09uM|B5LY47|BETA-LACTAMASE|6.55|Ki=0.28uM|Ki|=|0.28|uM|280|nM
5WDW|2.30|2018|8KU|Ki = 0.29 +/- 0.05 uM, ligand is compound 10k|C3W5S0|POLYMERASE ACIDIC PROTEIN|6.54|Ki=0.29uM|Ki|=|0.29|uM|290|nM
6EEH|1.63|2018|J4D|ligand is compound 17; binding assay: Stopped Flow CO2 Hydrase Assay|P00918|CARBONIC ANHYDRASE 2|6.54|Ki=0.29uM|Ki|=|0.29|uM|290|nM
6E7J|1.30|2018|HWY|binding assay: Continuous Fluorometric Assay; ligand is compound 4e|Q5RZ08|HIV-1 PROTEASE|9.48|Ki=0.33nM|Ki|=|0.33|nM|0.33|nM
5W44|2.10|2018|GY6|Ki = 0.36 +/- 0.03 uM, ligand is compound 7a|C3W5S0|POLYMERASE ACIDIC PROTEIN|6.44|Ki=0.36uM|Ki|=|0.36|uM|360|nM
6BC9|1.80|2018|ETS|ligand is DZM|P00918|CARBONIC ANHYDRASE 2|9.43|Ki=0.37nM|Ki|=|0.37|nM|0.37|nM
6DRY|2.92|2018|H8D|Ligand is compound methylergonovine|P41595|5HT2B RECEPTOR, BRIL CHIMERA|9.43|Ki=0.37nM|Ki|=|0.37|nM|0.37|nM
6EEO|1.72|2018|J6V|ligand is compound 16; binding assay: Stopped Flow CO2 Hydrase Assay|P00918|CARBONIC ANHYDRASE 2|6.43|Ki=0.37uM|Ki|=|0.37|uM|370|nM
5WFM|2.25|2018|KU5|Ki =0.3 +/- 0.5 uM, ligand is compound 9k, protein is E119D|C3W5S0|POLYMERASE ACIDIC PROTEIN|6.52|Ki=0.3uM|Ki|=|0.3|uM|300|nM
5WAP|2.20|2018|KU9|Ki = 0.3 +/- 0.1 uM, ligand is compound 10i|C3W5S0|POLYMERASE ACIDIC PROTEIN|6.52|Ki=0.3uM|Ki|=|0.3|uM|300|nM
5N9N|1.84|2018|8QK|[Incomplete ligand] [Nonstandard assay: Temp 37] Kiapp = 0.41 +/- 0.02 nM, ligand is compound 4a, the ligand ID and structure in PDB is wrong|P68400|CASEIN KINASE II, SUBUNIT ALPHA|9.39|Ki=0.41nM|Ki|=|0.41|nM|0.41|nM
5WA6|2.25|2018|KU7|Ki(FP)=0.44+/-0.03uM|C3W5S0|POLYMERASE ACIDIC PROTEIN|6.36|Ki=0.44uM|Ki|=|0.44|uM|440|nM
6H36|1.85|2018|FKE|ligand is compound 7a|P43166|CARBONIC ANHYDRASE 7|9.35|Ki=0.45nM|Ki|=|0.45|nM|0.45|nM
5N9K|1.64|2018|8QK|[Nonstandard assay: Temp 37] Kiapp = 0.46 +/- 0.09 nM, ligand is compound 5|P68400|CASEIN KINASE II, SUBUNIT ALPHA|9.34|Ki=0.46nM|Ki|=|0.46|nM|0.46|nM
5YR4|1.82|2018|TN4|[Covalent complex] Ki=0.46+/-0.04uM,|P53582|METHIONINE AMINOPEPTIDASE 1|6.34|Ki=0.46uM|Ki|=|0.46|uM|460|nM
6GOT|1.56|2018|F6W|ligand is compound 5b|P00918|CARBONIC ANHYDRASE 2|9.4|Ki=0.4nM|Ki|=|0.4|nM|0.4|nM
5WDC|2.10|2018|G2K|Ki = 0.4 +/- 0.2 uM, ligand is compound 9e|C3W5S0|POLYMERASE ACIDIC PROTEIN|6.4|Ki=0.4uM|Ki|=|0.4|uM|400|nM
5WA7|2.20|2018|KU4|Ki = 0.4 +/- 0.2 uM, ligand is compound 9b|C3W5S0|POLYMERASE ACIDIC PROTEIN|6.4|Ki=0.4uM|Ki|=|0.4|uM|400|nM
6F92|1.90|2018|MVL|ligand is Manl|Q8A0Q6|PUTATIVE ALPHA-1,2-MANNOSIDASE|6.4|Ki=0.4uM|Ki|=|0.4|uM|400|nM
6CBH|2.00|2018|EWJ|ligand is compound 8n|P14174|MACROPHAGE MIGRATION INHIBITORY FACTOR|6.29|Ki=0.51uM|Ki|=|0.51|uM|510|nM
6G3O|2.27|2018|EL8|ligand is compound 37|Q92769|HISTONE DEACETYLASE 2|9.24|Ki=0.58nM|Ki|=|0.58|nM|0.58|nM
6HH3|1.82|2018|A1R|Ki = 0.58 +/- 0.12 uM; ligand is compound ADP-HPD|H3BCW1|ADP-RIBOSYLHYDROLASE LIKE 2|6.24|Ki=0.58uM|Ki|=|0.58|uM|580|nM
5Y12|1.75|2018|8JX|[Nonstandard assay: Temp 30] ligand is 16d,Ki=0.59+/-0.03uM|P15090|FATTY ACID-BINDING PROTEIN, ADIPOCYTE|6.23|Ki=0.59uM|Ki|=|0.59|uM|590|nM
6H2Z|1.94|2018|FKE|ligand is compound 7a|P00918|CARBONIC ANHYDRASE 2|9.3|Ki=0.5nM|Ki|=|0.5|nM|0.5|nM
6H34|1.55|2018|FKK|ligand is compound 8b|P00918|CARBONIC ANHYDRASE 2|9.3|Ki=0.5nM|Ki|=|0.5|nM|0.5|nM
6C8X|1.61|2018|BVR|[Uncommon element] ligand is compound boronic acid 1; Ki = 0.5 +/- 0.3 pM|Q5RZ08|HIV-1 PROTEASE|12.3|Ki=0.5pM|Ki|=|0.5|pM|0.0005|nM
5W73|2.20|2018|GY9|Ki = 0.5 +/- 0.2 uM, ligand is compound 9f|C3W5S0|POLYMERASE ACIDIC PROTEIN|6.3|Ki=0.5uM|Ki|=|0.5|uM|500|nM
5OU3|1.60|2018|AUN|[Nonstandard assay: Temp 37] Ki = 0.61 +/- 0.05 uM. ligand is compound 3|G7CNL4|INOSINE-5'-MONOPHOSPHATE DEHYDROGENASE,INOSINE-5|6.21|Ki=0.61uM|Ki|=|0.61|uM|610|nM
5LAQ|2.40|2018|6M5|pKi = 9.2, ligand is compound NPD-001(1)|Q07343|CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B|9.2|Ki=0.63nM|Ki|=|0.63|nM|0.63|nM
6EEA|1.63|2018|J3V|ligand is compound 15; binding assay: Stopped Flow CO2 Hydrase Assay|P00918|CARBONIC ANHYDRASE 2|6.2|Ki=0.63uM|Ki|=|0.63|uM|630|nM
6AYS|1.70|2018|HT6|kinetic inhibition assay, Ki=0.65+/-0.17nM (calculated from the time-equilibrated rates)|------|5'-METHYLTHIOADENOSINE/S-ADENOSYLHOMOCYSTEINE NUCLEOSIDASE|9.19|Ki=0.65nM|Ki|=|0.65|nM|0.65|nM
6APW|2.61|2018|BTV|ligand is 5o,Ki=0.67+/-0.06uM|------|BIFUNCTIONAL LIGASE/REPRESSOR BIRA|6.17|Ki=0.67uM|Ki|=|0.67|uM|670|nM
6H33|1.58|2018|FKQ|ligand is compound 7b|P00918|CARBONIC ANHYDRASE 2|9.22|Ki=0.6nM|Ki|=|0.6|nM|0.6|nM
6EIZ|1.85|2018|FOH|ligand is compound 6; Ki = 0.6+/-0.2uM|------|CC-HEX2|6.22|Ki=0.6uM|Ki|=|0.6|uM|600|nM
5XVF|2.66|2018|8FR|[Nonstandard assay: Tem 22 C] ligand is compound 10a,Ki=0.710uM|O96013|SERINE/THREONINE-PROTEIN KINASE PAK 4|6.15|Ki=0.710uM|Ki|=|0.71|uM|710|nM
6AQO|2.64|2018|45T|[Nonstandard assay: pH 8.4] ligand is compound 7,Ki=0.77+/-0.06uM|Q38CA1|HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE|6.11|Ki=0.77uM|Ki|=|0.77|uM|770|nM
6B4D|1.20|2018|53X|ligand is 1d,Ki=0.78+/-0.009uM|P00918|CARBONIC ANHYDRASE 2|6.11|Ki=0.78uM|Ki|=|0.78|uM|780|nM
6BVH|1.93|2018|14-mer|binding data cited from other reference|P00760|CATIONIC TRYPSIN|9.15|Ki=0.7nM|Ki|=|0.7|nM|0.7|nM
6C7Q|1.51|2018|EO1|ligand is compound 12; Ki = 0.7+/-0.3nM|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|9.15|Ki=0.7nM|Ki|=|0.7|nM|0.7|nM
5KW2|2.76|2018|6XQ|ligand is compound 1|O14842|FREE FATTY ACID RECEPTOR 1,LYSOZYME,FREE FATTY ACID|9.09|Ki=0.81nM|Ki|=|0.81|nM|0.81|nM
5OU1|1.78|2018|AUQ|[Nonstandard assay: Temp 37] Ki = 0.86 +/- 0.03 uM. ligand is compound 1|G7CNL4|INOSINE-5'-MONOPHOSPHATE DEHYDROGENASE,INOSINE-5|6.07|Ki=0.86uM|Ki|=|0.86|uM|860|nM
6APT|1.80|2018|45T|[Nonstandard assay: pH 8.4] ligand is compound 7,Ki=0.89+/-0.07uM|Q07010|HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE|6.05|Ki=0.89uM|Ki|=|0.89|uM|890|nM
5WFW|2.29|2018|GYA|Ki = 0.8 +/- 0.4 uM, ligand is compound 10j, protein is E119D|C3W5S0|POLYMERASE ACIDIC PROTEIN|6.1|Ki=0.8uM|Ki|=|0.8|uM|800|nM
6C4D|2.52|2018|EJP|ligand is compound 22|Q13546|RECEPTOR-INTERACTING SERINE/THREONINE-PROTEIN KINASE 1|9.04|Ki=0.912nM|Ki|=|0.912|nM|0.912|nM
6B7H|2.82|2018|CWY|ligand is 8p,Ki=0.927+/-0.225nM|Q14832|METABOTROPIC GLUTAMATE RECEPTOR 3|9.03|Ki=0.927nM|Ki|=|0.927|nM|0.927|nM
6H7L|2.70|2018|Y00|[Incomplete ligand] ligand is dobutamine|P0AA25|THIOREDOXIN 1|8.97|Ki=1.07nM|Ki|=|1.07|nM|1.07|nM
6HGZ|1.86|2018|AR6|[Different protein in assay: X-ray(Latimeria chalumnae);Ki and IC50(human)] Ki = 1.08 +/- 0.08 uM; ligand is compound ADPr|H3BCW1|ADP-RIBOSYLHYDROLASE LIKE 2|5.97|Ki=1.08uM|Ki|=|1.08|uM|1080|nM
6F7Q|2.60|2018|CWQ|ligand is compound 11; Ki = 1.09 +/- 0.12 nM|P06276|CHOLINESTERASE|8.96|Ki=1.09nM|Ki|=|1.09|nM|1.09|nM
6F90|2.40|2018|MVL|ligand is Manl|------|ALPHA-1,2-MANNOSIDASE, PUTATIVE|6.0|Ki=1.0uM|Ki|=|1|uM|1000|nM
5MGI|1.50|2018|6YV|[Covalent complex] [Uncommon element] [Incomplete ligand] competitive assay, IC50=4.72uM|Q848S6|CARBAPENEM-HYDROLYZING BETA-LACTAMASE KPC|5.95|Ki=1.13uM|Ki|=|1.13|uM|1130|nM
5Y13|1.75|2018|8K0|[Nonstandard assay: Temp 30] ligand is 16c,Ki=1.16+/-0.07uM|P15090|FATTY ACID-BINDING PROTEIN, ADIPOCYTE|5.94|Ki=1.16uM|Ki|=|1.16|uM|1160|nM
6BQG|3.00|2018|ERM|ligand is compound ERG(Ergotamine)|P28335|5-HYDROXYTRYPTAMINE RECEPTOR 2C,SOLUBLE CYTOCHROME B562|8.93|Ki=1.17nM|Ki|=|1.17|nM|1.17|nM
5OD1|1.34|2018|9RQ|Ki=1.1+/-0.1uM|------|MID1SC10|5.96|Ki=1.1uM|Ki|=|1.1|uM|1100|nM
6BT6|1.05|2018|3GK|ligand is compound 1; Ki = 1.23+/-0.27uM|Q9L5C8|BETA-LACTAMASE|5.91|Ki=1.23uM|Ki|=|1.23|uM|1230|nM
5OWH|2.30|2018|B0K|ligand is compound 8b, same as 5owl|P68400|CASEIN KINASE II, SUBUNIT ALPHA|5.92|Ki=1.2uM|Ki|=|1.2|uM|1200|nM
5OWL|2.23|2018|B0K|ligand is compound 8b, the crystallization conditions are different|P68400|CASEIN KINASE II, ALPHA SUBUNIT|5.92|Ki=1.2uM|Ki|=|1.2|uM|1200|nM
5Z1C|1.45|2018|ZXI|[Nonstandard assay: Temp 37] ligand is IBA,Ki=1.38+/-0.09mM|P00749|UROKINASE-TYPE PLASMINOGEN ACTIVATOR|2.86|Ki=1.38mM|Ki|=|1.38|mM|1380000|nM
5NPS|1.68|2018|9-mer|Ki = 1.3 +/- 0.8 uM. ligand is peptide 1|O15294|UDP-N-ACETYLGLUCOSAMINE--PEPTIDE N|5.89|Ki=1.3uM|Ki|=|1.3|uM|1300|nM
5YIC|1.90|2018|8VO|[Nonstandard assay: pH 5.0] ligand is KNI-10333, Ki = 1.3 +/- 0.18 uM|Q8I6V3|PLASMEPSIN II|5.89|Ki=1.3uM|Ki|=|1.3|uM|1300|nM
6DPX|1.90|2018|H7G|enzyme inhibition assay|P00811|BETA-LACTAMASE|5.89|Ki=1.3uM|Ki|=|1.3|uM|1300|nM
6AYT|1.85|2018|4EH|kinetic inhibition assay, Ki=1.4+/-0.2nM (calculated from the time-equilibrated rates)|------|5'-METHYLTHIOADENOSINE/S-ADENOSYLHOMOCYSTEINE NUCLEOSIDASE|8.85|Ki=1.4nM|Ki|=|1.4|nM|1.4|nM
5WF3|2.25|2018|KU2|Ki =1.4 +/- 0.7 uM, ligand is compound 9k, protein is E119D|C3W5S0|POLYMERASE ACIDIC PROTEIN|5.85|Ki=1.4uM|Ki|=|1.4|uM|1400|nM
6G4Y|2.65|2018|ELZ|ligand is compound 1a|Q9WUL6|MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 14|8.82|Ki=1.5nM|Ki|=|1.5|nM|1.5|nM
5NW7|1.85|2018|9C2|ligand is 5PAHz|P34948|MANNOSE-6-PHOSPHATE ISOMERASE|5.77|Ki=1.7uM|Ki|=|1.7|uM|1700|nM
6GDG|4.11|2018|NEC|ligand is NECA; Ki = 1.8 +/- 1.2 nM|Q14F07|TRXA,ADENOSINE RECEPTOR A2A|8.74|Ki=1.8nM|Ki|=|1.8|nM|1.8|nM
6DJ7|1.31|2018|G10|ligand is compound 5; Ki = 1.9+/-0.7nM|Q5RZ08|HIV-1 PROTEASE|8.72|Ki=1.9nM|Ki|=|1.9|nM|1.9|nM
5NXP|1.25|2018|9DH|Ki = 10.2 +/- 1.0 nM. ligand is compound 5|P00918|CARBONIC ANHYDRASE 2|7.99|Ki=10.2nM|Ki|=|10.2|nM|10.2|nM
6F9R|1.85|2018|D0W|[Covalent complex] ligand is compound SamAsp; Ki = 10.6 +/- 0.3 uM|P12821|ANGIOTENSIN-CONVERTING ENZYME|4.97|Ki=10.6uM|Ki|=|10.6|uM|10600|nM
6DHC|2.85|2018|GHJ|ligand is compound 3a|P56817|BETA-SECRETASE 1|7.96|Ki=10.9nM|Ki|=|10.9|nM|10.9|nM
5L8C|2.01|2018|908|pKi = 7, ligand is compound NPD-039(9)|Q8WQX9|PHOSPHODIESTERASE|7.0|Ki=100nM|Ki|=|100|nM|100|nM
5MWY|1.75|2018|YNU|pKi = 7.0 +/- 0.1, ligand is eplerenone|P08235|MINERALOCORTICOID RECEPTOR|7.0|Ki=100nM|Ki|=|100|nM|100|nM
6EIF|2.22|2018|B5T|ligand is compound AC12|Q13627|DUAL SPECIFICITY TYROSINE-PHOSPHORYLATION-REGULATED KINASE|6.98|Ki=104nM|Ki|=|104|nM|104|nM
5ZAG|1.95|2018|94I|ligand is compound 25,Ki=108+/-17nM|P00749|UROKINASE-TYPE PLASMINOGEN ACTIVATOR CHAIN B|6.97|Ki=108nM|Ki|=|108|nM|108|nM
6EN6|1.80|2018|BJ2|[Multiple sites: N-domain:Ki=11.45+/-1.37nM; C-domain:Ki=961.02+/-153.00nM] ligand is compound 16; same as 6en5|P12821|ANGIOTENSIN-CONVERTING ENZYME|7.94|Ki=11.45nM|Ki|=|11.45|nM|11.45|nM
6CBG|2.00|2018|EWG|ligand is compound 5|P14174|MACROPHAGE MIGRATION INHIBITORY FACTOR|3.95|Ki=113uM|Ki|=|113|uM|113000|nM
6DH6|1.97|2018|017|ligand is compound DRV; Ki = 117.2+/-5.8 pM|Q8ULI3|HIV-1 PROTEASE|9.93|Ki=117.2pM|Ki|=|117.2|pM|0.1172|nM
6EJ3|1.94|2018|B7T|ligand is compound 23; Ki = 1179+/-374nM|P56817|BETA-SECRETASE 1|5.93|Ki=1179nM|Ki|=|1179|nM|1179|nM
6IIU|2.50|2018|A8X|ligand is Ramatroban; Ki = 11 +/- 4nM|P0ABE7|SOLUBLE CYTOCHROME B562,THROMBOXANE A2 RECEPTOR,RUBREDOXIN|7.96|Ki=11nM|Ki|=|11|nM|11|nM
5NPR|1.85|2018|9-mer|Ki = 12.5 +/- 7 uM. ligand is peptide 6|O15294|UDP-N-ACETYLGLUCOSAMINE--PEPTIDE N|4.9|Ki=12.5uM|Ki|=|12.5|uM|12500|nM
6DH2|1.98|2018|A60|ligand is compound UMass6; Ki = 12.8+/-3.1 pM|Q7ZCI0|HIV-1 PROTEASE|10.89|Ki=12.8pM|Ki|=|12.8|pM|0.0128|nM
6MVU|1.49|2018|K4V|[Different protein in assay: Protein in binding assay is C295A mutant] Ki = 1290 +/- 270 uM; ligand is pNPA|------|ALDEHYDE DEHYDROGENASE|2.89|Ki=1290uM|Ki|=|1290|uM|1290000|nM
6APU|1.84|2018|3L6|[Incomplete ligand] [Nonstandard assay: pH 8.4] ligand is compound 1,Ki=13.46+/-0.83uM,ligand is wrong in PDB|Q07010|HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE|4.87|Ki=13.46uM|Ki|=|13.46|uM|13460|nM
5NY6|1.10|2018|R92|Ki = 13.5 +/- 1.1 nM. ligand is compound 3|P00918|CARBONIC ANHYDRASE 2|7.87|Ki=13.5nM|Ki|=|13.5|nM|13.5|nM
6F9T|1.60|2018|D0Z|[Covalent complex] ligand is compound Sampatrilat; Ki = 13.8 +/- 0.2 nM|P12821|ANGIOTENSIN-CONVERTING ENZYME|7.86|Ki=13.8nM|Ki|=|13.8|nM|13.8|nM
6DH7|2.00|2018|K13|ligand is compound UMass1; Ki = 131.3+/-8.2 pM|Q8ULI3|HIV-1 PROTEASE|9.88|Ki=131.3pM|Ki|=|131.3|pM|0.13130000000000003|nM
5ZA7|1.70|2018|HMX|ligand is compound 5,Ki=1356+/-183nM|P00749|UROKINASE-TYPE PLASMINOGEN ACTIVATOR CHAIN B|5.87|Ki=1356nM|Ki|=|1356|nM|1356|nM
5OH3|2.10|2018|9V2|Ki = 136 +/- 11.6 uM, ligand is Ethosuximide|A4TVL0|CEREBLON ISOFORM 4|3.87|Ki=136uM|Ki|=|136|uM|136000|nM
6EE3|1.82|2018|J4V|[Different ligand in assay: Ligand in binding assay is R/S form] ligand is compound 6k; Ki=137+/-11nM|O96935|M1 FAMILY AMINOPEPTIDASE|6.86|Ki=137nM|Ki|=|137|nM|137|nM
5OH9|1.65|2018|9UT|Ki = 137 +/- 15.9 uM, ligand is Thiazolidine-2,4-dione|A4TVL0|CEREBLON ISOFORM 4|3.86|Ki=137uM|Ki|=|137|uM|137000|nM
5WF6|2.90|2018|UKA|Ki = 14.7 +/- 0.7 nM. ligand is UK432097|P29274|HUMAN A2A ADENOSINE RECEPTOR T4L CHIMERA|7.83|Ki=14.7nM|Ki|=|14.7|nM|14.7|nM
6IIV|3.00|2018|A90|ligand is Ramatroban; Ki = 140 +/- 24nM|P0ABE7|SOLUBLE CYTOCHROME B562,THROMBOXANE A2 RECEPTOR,RUBREDOXIN|6.85|Ki=140nM|Ki|=|140|nM|140|nM
6DH8|1.95|2018|A60|ligand is compound UMass6; Ki = 146.2+/-10.7 pM|Q8ULI3|HIV-1 PROTEASE|9.84|Ki=146.2pM|Ki|=|146.2|pM|0.1462|nM
6G2M|1.37|2018|O84|ligand is compound 6; Ki = 15.1 +/- 5.6 nM|Q9NPB1|5'(3')-DEOXYRIBONUCLEOTIDASE|7.82|Ki=15.1nM|Ki|=|15.1|nM|15.1|nM
6H7M|2.76|2018|68H|[Different ligand in assay: Ligand in binding assay is racemic mixture] ligand is salbutamol|P0AA25|THIOREDOXIN 1|7.8|Ki=15.8nM|Ki|=|15.8|nM|15.8|nM
5YLV|2.80|2018|8WX|[Nonstandard assay: Tem 37] ligand is SCH28080,Ki=150+/-10nM|P19156|POTASSIUM-TRANSPORTING ATPASE ALPHA CHAIN 1|6.82|Ki=150nM|Ki|=|150|nM|150|nM
5WLT|1.57|2018|86B|ligand is compound 23|P00918|CARBONIC ANHYDRASE 2|6.81|Ki=155.5nM|Ki|=|155.5|nM|155.5|nM
5ZAE|1.73|2018|EAU|ligand is compound 22,Ki=156+/-20nM|P00749|UROKINASE-TYPE PLASMINOGEN ACTIVATOR CHAIN B|6.81|Ki=156nM|Ki|=|156|nM|156|nM
6EJ4|2.88|2018|B7W|ligand is compound AC15|Q13627|DUAL SPECIFICITY TYROSINE-PHOSPHORYLATION-REGULATED KINASE|6.8|Ki=158nM|Ki|=|158|nM|158|nM
5N9L|1.79|2018|8QH|[Nonstandard assay: Temp 37] ligand is compound 4b|P68400|CASEIN KINASE II, SUBUNIT ALPHA|7.82|Ki=15nM|Ki|=|15|nM|15|nM
5UZJ|3.30|2018|8UV|[Nonstandard assay: Temp 30] ligand is compound 8|Q13464|RHO-ASSOCIATED PROTEIN KINASE 1|6.78|Ki=165nM|Ki|=|165|nM|165|nM
5ZAF|1.65|2018|28I|ligand is compound 23,Ki=166+/-34nM|P00749|UROKINASE-TYPE PLASMINOGEN ACTIVATOR CHAIN B|6.78|Ki=166nM|Ki|=|166|nM|166|nM
6EIJ|2.42|2018|B5Z|ligand is compound AC20|Q13627|DUAL SPECIFICITY TYROSINE-PHOSPHORYLATION-REGULATED KINASE|5.77|Ki=1680nM|Ki|=|1680|nM|1680|nM
6EUC|2.22|2018|RM0|reverse inhibition assay, Ki(17)=168+/-23uM|P04058|ACETYLCHOLINESTERASE|3.77|Ki=168uM|Ki|=|168|uM|168000|nM
6EWK|2.22|2018|RM0|reverse inhibition assay, Ki(17)=168+/-23uM; redundant to 6euc|P04058|ACETYLCHOLINESTERASE|3.77|Ki=168uM|Ki|=|168|uM|168000|nM
6EJ2|1.46|2018|B7E|ligand is compound 28; Ki = 16+/-7.6nM|P56817|BETA-SECRETASE 1|7.8|Ki=16nM|Ki|=|16|nM|16|nM
6F9V|1.69|2018|D0Z|ligand is compound Sampatrilat; Ki = 171.9 +/- 32.2 nM|P12821|ANGIOTENSIN-CONVERTING ENZYME|6.76|Ki=171.9nM|Ki|=|171.9|nM|171.9|nM
5NXX|2.20|2018|3Q7|[Uncommon element] Ki = 17 +/- 2 uM, ligand is Arsenobetaine. uncommon atom is As|------|GLYCINE BETAINE ABC TRANSPORT SYSTEM GLYCINE BETAINE|4.77|Ki=17uM|Ki|=|17|uM|17000|nM
5UZK|2.30|2018|504|ligand is compound 35|P17612|CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA|6.74|Ki=180nM|Ki|=|180|nM|180|nM
5ZA9|1.62|2018|50I|ligand is compound 18,Ki=183+/-10nM|P00749|UROKINASE-TYPE PLASMINOGEN ACTIVATOR CHAIN B|6.74|Ki=183nM|Ki|=|183|nM|183|nM
6G46|2.40|2018|ELH|[Nonstandard assay: pH=4.9] ligand is compound 4f; Ki = 185 +/- 75 uM|P80366|FE(3+)-ZN(2+) PURPLE ACID PHOSPHATASE|3.73|Ki=185uM|Ki|=|185|uM|185000|nM
6M9T|2.50|2018|J9P|[Multiple sites: site 1(high):Ki=0.02 nM ; site2(low):Ki= 19.9 nM] ligand is misoprostol-FA|P43115|PROSTAGLANDIN E2 RECEPTOR EP3 SUBTYPE, ENDOLYSIN CHIMERA|7.7|Ki=19.9nM|Ki|=|19.9|nM|19.9|nM
6EE2|2.10|2018|J1V|[Different ligand in assay: Ligand in binding assay is racemic mixture] ligand is compound 6i; Ki=195+/-11nM|W4I9J7|PF-M17|6.71|Ki=195nM|Ki|=|195|nM|195|nM
5G5V|1.80|2018|8Z4|pKi = 6.7, ligand is compound NPD-038(22)|Q8WQX9|PHOSPHODIESTERASE B1|6.7|Ki=199nM|Ki|=|199|nM|199|nM
5ZKB|2.95|2018|82F|ligand is AF-DX 384, pKi = 8.70 +/- 0.05|P08172|MUSCARINIC ACETYLCHOLINE RECEPTOR M2,APO-CYTOCHROME B562|8.7|Ki=2.0nM|Ki|=|2|nM|2|nM
6F28|2.40|2018|CG8|ligand is compound 5c; Ki = 2.15 +/- 0.10 uM|P42264|GLUTAMATE RECEPTOR, IONOTROPIC KAINATE 3|5.67|Ki=2.15uM|Ki|=|2.15|uM|2150|nM
6HX5|1.44|2018|GXE|[Uncommon element] ligand is compound 2a; Se-containing ligand|P00918|CARBONIC ANHYDRASE 2|5.66|Ki=2.2uM|Ki|=|2.2|uM|2200|nM
5LL7|1.40|2018|6YV|[Covalent complex] [Uncommon element] competitive assay, IC50=10.1uM|------|BETA-LACTAMASE|5.61|Ki=2.43uM|Ki|=|2.43|uM|2430|nM
5YLU|2.80|2018|HKT|[Nonstandard assay: Temp 37] ligand is Vonoprazan,Ki=2.4+/-2.3nM|P19156|POTASSIUM-TRANSPORTING ATPASE ALPHA CHAIN 1|8.62|Ki=2.4nM|Ki|=|2.4|nM|2.4|nM
6H7J|2.80|2018|5FW|[Different ligand in assay: Ligand in binding assay is racemic mixture] ligand is isoprenaline|P0AA25|THIOREDOXIN 1|8.62|Ki=2.4nM|Ki|=|2.4|nM|2.4|nM
6H29|1.46|2018|FK8|ligand is compound 1|P00918|CARBONIC ANHYDRASE 2|5.62|Ki=2.4uM|Ki|=|2.4|uM|2400|nM
6H37|1.90|2018|FKQ|ligand is compound 7b|P43166|CARBONIC ANHYDRASE 7|8.59|Ki=2.6nM|Ki|=|2.6|nM|2.6|nM
5WG9|2.30|2018|KU4|Ki = 2.6 +/- 1.3 uM, ligand is compound 9b, protein is E119D|C3W5S0|POLYMERASE ACIDIC PROTEIN|5.59|Ki=2.6uM|Ki|=|2.6|uM|2600|nM
6FNR|1.83|2018|DYT|ligand is compound 8; Ki = 2.6 +/- 0.4 uM|------|HISTIDINE N-ALPHA-METHYLTRANSFERASE|5.59|Ki=2.6uM|Ki|=|2.6|uM|2600|nM
5NXG|1.20|2018|RA1|Ki = 2.8 +/- 0.3 nM. ligand is compound 6|P00918|CARBONIC ANHYDRASE 2|8.55|Ki=2.8nM|Ki|=|2.8|nM|2.8|nM
6EIP|2.56|2018|B7B|ligand is compound AC23|Q13627|DUAL SPECIFICITY TYROSINE-PHOSPHORYLATION-REGULATED KINASE|5.7|Ki=2015nM|Ki|=|2015|nM|2015|nM
6EE4|1.58|2018|J4S|[Different ligand in assay: Ligand in binding assay is R/S form] ligand is compound 6m; Ki=202+/-27nM|O96935|M1 FAMILY AMINOPEPTIDASE|6.69|Ki=202nM|Ki|=|202|nM|202|nM
6GG4|2.46|2018|PHE|ligand is PHE|P14618|PYRUVATE KINASE PKM|3.69|Ki=205uM|Ki|=|205|uM|205000|nM
5WXO|1.64|2018|12-mer|[Nonstandard assay: Temp 37] [Different protein in assay: Protein in binding assay is full length] ligand is upain-2-6-W3A,Ki=207+/-14uM|P00749|UROKINASE-TYPE PLASMINOGEN ACTIVATOR CHAIN B|3.68|Ki=207uM|Ki|=|207|uM|207000|nM
6EE6|1.50|2018|J4P|[Different ligand in assay: Ligand in binding assay is R/S form] ligand is compound 6o; Ki=216+/-12nM|O96935|M1 FAMILY AMINOPEPTIDASE|6.67|Ki=216nM|Ki|=|216|nM|216|nM
5NXI|1.16|2018|9DE|Ki = 217.4 +/- 15.7 nM. ligand is compound 4|P00918|CARBONIC ANHYDRASE 2|6.66|Ki=217.4nM|Ki|=|217.4|nM|217.4|nM
6BW2|2.75|2018|ECY|ligand is compound 28|Q07820|INDUCED MYELOID LEUKEMIA CELL DIFFERENTIATION PROTEIN MCL|7.68|Ki=21nM|Ki|=|21|nM|21|nM
6CVX|1.78|2018|FH4|ligand is compound 12c; Ki = 21+/-2.6nM|A8DG50|NS3 PROTEASE|7.68|Ki=21nM|Ki|=|21|nM|21|nM
6FNT|1.90|2018|AVO|[Different ligand in assay: ] ligand is compound 2; Ki = 21 +/- 3 uM|------|HISTIDINE N-ALPHA-METHYLTRANSFERASE|4.68|Ki=21uM|Ki|=|21|uM|21000|nM
5WF5|2.60|2018|UKA|Ki = 22.4 +/- 2.5 nM. ligand is UK432097|P29274|HUMAN A2A ADENOSINE RECEPTOR T4L CHIMERA|7.65|Ki=22.4nM|Ki|=|22.4|nM|22.4|nM
6EQW|1.99|2018|5-mer|ligand is compound I3|P09958|FURIN|10.65|Ki=22.4pM|Ki|=|22.4|pM|0.0224|nM
5NZN|1.73|2018|G39|Kd = 220000 +/- 4000 nM, ligand is oseltamivir carboxylate|W5R8B8|NEURAMINIDASE|3.66|Ki=220000nM|Ki|=|220000|nM|220000|nM
6CJV|1.55|2018|G2Y|ligand is Sucralose|P00918|CARBONIC ANHYDRASE 2|5.66|Ki=2200nM|Ki|=|2200|nM|2200|nM
6GG5|3.20|2018|TRP|ligand is TRP|P14618|PYRUVATE KINASE PKM|3.65|Ki=222uM|Ki|=|222|uM|222000|nM
5YUM|2.43|2018|ILE||P0ADF8|ACETOLACTATE SYNTHASE ISOZYME 1 SMALL SUBUNIT|3.65|Ki=223uM|Ki|=|223|uM|223000|nM
6FMP|2.92|2018|8-mer|ligand is peptide 1(Ac-Asp-Glu-Glu-Thr-Gly-Glu-Phe-OH)|Q14145|KELCH-LIKE ECH-ASSOCIATED PROTEIN 1|5.64|Ki=2265nM|Ki|=|2265|nM|2265|nM
6DJC|1.46|2018|CF6|ligand is compound MS645|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|6.63|Ki=232.8nM|Ki|=|232.8|nM|232.8|nM
6EQV|1.90|2018|5-mer|ligand is compound I2|P09958|FURIN|6.62|Ki=238nM|Ki|=|238|nM|238|nM
6FCL|1.50|2018|AMP|ligand is compound AMP; Ki = 23 +/- 6 uM|P07741|ADENINE PHOSPHORIBOSYLTRANSFERASE|4.64|Ki=23uM|Ki|=|23|uM|23000|nM
5WGP|1.53|2018|AUD|CA IX (mimic) in complex with Ace K|P00918|CARBONIC ANHYDRASE 2|5.62|Ki=2400nM|Ki|=|2400|nM|2400|nM
6DH0|1.90|2018|017|ligand is DRV; Ki=25.6+/-5.6pM|Q7ZCI0|HIV-1 PROTEASE|10.59|Ki=25.6pM|Ki|=|25.6|pM|0.0256|nM
6EIS|2.36|2018|B6N|ligand is compound AC27|Q13627|DUAL SPECIFICITY TYROSINE-PHOSPHORYLATION-REGULATED KINASE|6.6|Ki=252nM|Ki|=|252|nM|252|nM
6FAG|1.79|2018|EON|in vitro enzyme assay|P00915|CARBONIC ANHYDRASE 1|6.59|Ki=255.1nM|Ki|=|255.1|nM|255.1|nM
6EA1|1.82|2018|J0Y|[Different ligand in assay: Ligand in binding assay is a racemic mixture] ligand is compound 6d-a; Ki=257+/-14nM|O96935|M1 FAMILY AMINOPEPTIDASE|6.59|Ki=257nM|Ki|=|257|nM|257|nM
6DPZ|1.50|2018|H7D|enzyme inhibition assay|P00811|BETA-LACTAMASE|3.59|Ki=259uM|Ki|=|259|uM|259000|nM
6ARJ|1.92|2018|BW4|ligand is EZM2302,IC50=6 +/ -3 nM,Ki=25+/-3nM|Q86X55|HISTONE-ARGININE METHYLTRANSFERASE CARM1|7.6|Ki=25nM|Ki|=|25|nM|25|nM
6DH1|1.97|2018|K13|ligand is compound UMass1; Ki = 26.1+/-3.7 pM|Q7ZCI0|HIV-1 PROTEASE|10.58|Ki=26.1pM|Ki|=|26.1|pM|0.0261|nM
6G22|1.85|2018|2O2|[Incomplete ligand] ligand is compound 4; Ki = 27.7 +/- 2.7nM; ligand is not consistent with the descriptions in reference|Q9NPB1|5'(3')-DEOXYRIBONUCLEOTIDASE|7.56|Ki=27.7nM|Ki|=|27.7|nM|27.7|nM
6F3B|1.40|2018|CJK|ligand is compound 5|P00915|CARBONIC ANHYDRASE 1|6.56|Ki=273.3nM|Ki|=|273.3|nM|273.3|nM
6EDR|2.40|2018|ZNA|ligand is compound S-NAD+; Ki=28.5+/-3.1uM|P28907|ADP-RIBOSYL CYCLASE/CYCLIC ADP-RIBOSE HYDROLASE 1|4.55|Ki=28.5uM|Ki|=|28.5|uM|28500|nM
6EEE|2.30|2018|J4V|[Different ligand in assay: Ligand in binding assay is R/S form] ligand is compound 6k; Ki=28.9+/-4.4nM|Q8IL11|M17 LEUCYL AMINOPEPTIDASE|7.54|Ki=28.9nM|Ki|=|28.9|nM|28.9|nM
6EA2|1.35|2018|J1G|[Different ligand in assay: Ligand in binding assay is racemic mixture] ligand is compound 6h; Ki=285+/-40nM|O96935|M1 FAMILY AMINOPEPTIDASE|6.55|Ki=285nM|Ki|=|285|nM|285|nM
6AQS|1.57|2018|IM5|ligand is DADMe-ImmG,Ki=28+/-1nM|Q8T9Z7|PURINE NUCLEOSIDE PHOSPHORYLASE|7.55|Ki=28nM|Ki|=|28|nM|28|nM
5OH4|2.30|2018|9UZ|Ki = 28 +/- 5.0 uM, ligand is Glutarimide|A4TVL0|CEREBLON ISOFORM 4|4.55|Ki=28uM|Ki|=|28|uM|28000|nM
5YJB|2.96|2018|8WC|ligand is congpound 1, a reversible LSD1 inhibitor with a Ki of 29 nM|O60341|LYSINE-SPECIFIC HISTONE DEMETHYLASE 1A|7.54|Ki=29nM|Ki|=|29|nM|29|nM
6MI6|2.95|2018|JSJ|Ligand is compond ADP-beta-S-SL; Ki = 29 +/- 6 uM|Q56310|CHEMOTAXIS PROTEIN CHEA|4.54|Ki=29uM|Ki|=|29|uM|29000|nM
5WLV|1.40|2018|42G|ligand is compound 12|P00918|CARBONIC ANHYDRASE 2|8.52|Ki=3.0nM|Ki|=|3|nM|3|nM
5YIA|2.00|2018|8V9|ligand is KNI-10343, Ki = 3.0 +/- 0.33 uM|Q8I6V3|PLASMEPSIN II|5.52|Ki=3.0uM|Ki|=|3|uM|3000|nM
6F29|2.60|2018|CGW|ligand is compound 2; ki = 3.25 +/- 0.30 uM|P42264|GLUTAMATE RECEPTOR, IONOTROPIC KAINATE 3|5.49|Ki=3.25uM|Ki|=|3.25|uM|3250|nM
5V6Y|2.80|2018|16-mer|pKi = 8.47 +/- 0.21. ligand is S45W/K46L/Q50W/Y52F (AMmut)|P0AEY0|MALTOSE-BINDING PERIPLASMIC PROTEIN,RECEPTOR ACTIVITY|8.47|Ki=3.39nM|Ki|=|3.39|nM|3.39|nM
5YIB|2.15|2018|8VC|[Nonstandard assay: pH 5.0] ligand is KNI-10743, Ki = 3.3 +/- 0.35 uM|Q8I6V3|PLASMEPSIN II|5.48|Ki=3.3uM|Ki|=|3.3|uM|3300|nM
5NXV|1.10|2018|9E2|Ki = 3.5 +/- 0.3 nM. ligand is compound 7|P00918|CARBONIC ANHYDRASE 2|8.46|Ki=3.5nM|Ki|=|3.5|nM|3.5|nM
6D1U|2.05|2018|20-mer|ligand is peptide AM2/IMD(29-47), peptide sequence is GPAGRQDSAPVDPSSPHSY; pKi = 5.44+/-0.06|P0AEY0|MALTOSE-BINDING PERIPLASMIC PROTEIN,RECEPTOR ACTIVITY|5.44|Ki=3.63uM|Ki|=|3.63|uM|3630|nM
6BUU|2.40|2018|10-mer|Ligand is peptide GRPRTTSFAE|P31749|RAC-ALPHA SERINE/THREONINE-PROTEIN KINASE|5.44|Ki=3.6uM|Ki|=|3.6|uM|3600|nM
6CVY|1.80|2018|FHD|ligand is compound 12d; Ki = 3.9+/-0.7nM|A8DG50|NS3 PROTEASE|8.41|Ki=3.9nM|Ki|=|3.9|nM|3.9|nM
6FLG|2.50|2018|8-mer|ligand is compound 33.2; Ki = 30.1 +/- 6.1 nM|Q6DHI5|NAD-DEPENDENT PROTEIN DEACYLASE SIRTUIN-5|7.52|Ki=30.1nM|Ki|=|30.1|nM|30.1|nM
6FAF|1.99|2018|D3B|ligand is compound 15|P00915|CARBONIC ANHYDRASE 1|6.51|Ki=306.1nM|Ki|=|306.1|nM|306.1|nM
5MWP|1.82|2018|ECV|pKi = 7.5 +/- 0.1, ligand is AZD9977|P08235|MINERALOCORTICOID RECEPTOR|7.5|Ki=31.6nM|Ki|=|31.6|nM|31.6|nM
6FKY|2.98|2018|8-mer|[Different ligand in assay: compound 15 is a diastereomer; compound 15.1:Ki = 320nM; compound 15.2: Ki=170 nM] ligand is compound 15|Q6DHI5|NAD-DEPENDENT PROTEIN DEACYLASE SIRTUIN-5|6.49|Ki=320nM|Ki|=|320|nM|320|nM
6D9X|1.83|2018|FZM|ligand is compound F-1|P61964|WD REPEAT-CONTAINING PROTEIN 5|3.49|Ki=323uM|Ki|=|323|uM|323000|nM
6DNE|2.96|2018|H1V|ligand is compound MS660|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|7.48|Ki=33.3nM|Ki|=|33.3|nM|33.3|nM
6EQX|1.99|2018|6-mer|ligand is compound I1|P09958|FURIN|10.47|Ki=33.7pM|Ki|=|33.7|pM|0.0337|nM
5NY3|1.40|2018|9E8|Ki = 33.9 +/- 2.7 nM. ligand is compound 9|P00918|CARBONIC ANHYDRASE 2|7.47|Ki=33.9nM|Ki|=|33.9|nM|33.9|nM
5WXF|1.46|2018|12-mer|[Nonstandard assay: Temp 37] [Different protein in assay: Protein in binding assay is full length] ligand is upain-2-6,Ki=33+/-10uM|P00749|UROKINASE-TYPE PLASMINOGEN ACTIVATOR CHAIN B|4.48|Ki=33uM|Ki|=|33|uM|33000|nM
6C5F|1.40|2018|7L9|ligand is 4-CPPC; Ki = 33+/-0.7uM|P30046|D-DOPACHROME DECARBOXYLASE|4.48|Ki=33uM|Ki|=|33|uM|33000|nM
6C7W|1.28|2018|LMS|ligand is compound 1|P00918|CARBONIC ANHYDRASE 2|5.47|Ki=3410nM|Ki|=|3410|nM|3410|nM
6F05|2.20|2018|GTS|ligand is GSO3|O80852|GLUTATHIONE S-TRANSFERASE F9|4.47|Ki=34uM|Ki|=|34|uM|34000|nM
6CEH|1.43|2018|EZ1|ligand is compound 5e; Binding assay:Stopped flow CO2 hydrase assay|P00918|CARBONIC ANHYDRASE 2|7.44|Ki=36.5nM|Ki|=|36.5|nM|36.5|nM
6EXS|2.50|2018|C3H|IC50 = 362 +/- 21.8 uM|------|PEPTIDE ABC TRANSPORTER PERMEASE|3.44|Ki=362uM|Ki|=|362|uM|362000|nM
5NY1|1.10|2018|9E5|Ki = 366.7 +/- 46.5 nM. ligand is compound 10|P00918|CARBONIC ANHYDRASE 2|6.44|Ki=366.7nM|Ki|=|366.7|nM|366.7|nM
6EIQ|2.30|2018|B6Z|ligand is compound AC24|Q13627|DUAL SPECIFICITY TYROSINE-PHOSPHORYLATION-REGULATED KINASE|6.42|Ki=383nM|Ki|=|383|nM|383|nM
5L8Y|2.14|2018|CVA|pKi = 6.4, ligand is compound NPD-937(16)|Q8WQX9|PHOSPHODIESTERASE|6.4|Ki=398nM|Ki|=|398|nM|398|nM
5OH1|1.70|2018|9UQ|[Different ligand in assay: ligand in binding assay is DL-aminoglutethimide] Ki = 39 +/- 3.8, ligand is Aminoglutethimide|A4TVL0|CEREBLON ISOFORM 4|4.41|Ki=39uM|Ki|=|39|uM|39000|nM
6C1S|2.31|2018|EFV|ligand is compound 6|P48736|PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE|8.52|Ki=3nM|Ki|=|3|nM|3|nM
5YID|2.10|2018|K95|ligand is KNI-10395, Ki = 4.0 +/- 0.29 uM|Q8I6V3|PLASMEPSIN II|5.4|Ki=4.0uM|Ki|=|4|uM|4000|nM
6AYR|1.95|2018|BIG|ligand is BTDIA,Ki=4.1+/-1.0nM,Ki*=0.75+/-0.20nM|------|5'-METHYLTHIOADENOSINE/S-ADENOSYLHOMOCYSTEINE NUCLEOSIDASE|8.39|Ki=4.1nM|Ki|=|4.1|nM|4.1|nM
6CB5|1.78|2018|EV7|ligand is compound 8g|P14174|MACROPHAGE MIGRATION INHIBITORY FACTOR|5.37|Ki=4.3uM|Ki|=|4.3|uM|4300|nM
5YR6|1.75|2018|TN4|Ki=4.57+/-0.34uM,|P53582|METHIONINE AMINOPEPTIDASE 1|5.34|Ki=4.57uM|Ki|=|4.57|uM|4570|nM
6DAS|1.80|2018|G2D|ligand is compound 6b; Ki = 4.94+/-0.79nM|P61964|WD REPEAT-CONTAINING PROTEIN 5|8.31|Ki=4.94nM|Ki|=|4.94|nM|4.94|nM
5NXO|1.20|2018|9HK|Ki = 4.9 +/- 0.6 nM. ligand is compound 2|P00918|CARBONIC ANHYDRASE 2|8.31|Ki=4.9nM|Ki|=|4.9|nM|4.9|nM
5NYA|1.20|2018|FB2|Ki = 415.6 +/- 56.5 nM. ligand is compound 1|P00918|CARBONIC ANHYDRASE 2|6.38|Ki=415.6nM|Ki|=|415.6|nM|415.6|nM
6M8Y|1.10|2018|4-mer|covalent complex|P42790|SEDOLISIN|6.38|Ki=415nM|Ki|=|415|nM|415|nM
5ZAJ|1.65|2018|32I|ligand is compound 27,Ki=42+/-2nM|P00749|UROKINASE-TYPE PLASMINOGEN ACTIVATOR CHAIN B|7.38|Ki=42nM|Ki|=|42|nM|42|nM
6EAB|1.85|2018|J2D|[Different ligand in assay: Ligand in binding assay is racemic mixture] ligand is compound 6j; Ki=431+/-10nM|O96935|M1 FAMILY AMINOPEPTIDASE|6.37|Ki=431nM|Ki|=|431|nM|431|nM
5OH7|1.85|2018|HYN|Ki = 43 +/- 10.7 uM, ligand is Hydantoin|A4TVL0|CEREBLON ISOFORM 4|4.37|Ki=43uM|Ki|=|43|uM|43000|nM
5WXP|1.75|2018|4-mer|[Incomplete ligand] [Nonstandard assay: Temp 37] [Different protein in assay: Protein in binding assay is full length] ligand is upain-2-12-W3A,Ki=443+/-51uM|P00749|UROKINASE-TYPE PLASMINOGEN ACTIVATOR CHAIN B|3.35|Ki=443uM|Ki|=|443|uM|443000|nM
6M9D|2.00|2018|3-mer|covalent complex; incomplete ligand structure|P42790|SEDOLISIN|7.35|Ki=45nM|Ki|=|45|nM|45|nM
6EX1|1.60|2018|N19|ligand is compound (S)-12; Ki(hCA IX) = 83.7nM|P00915|CARBONIC ANHYDRASE 1|7.31|Ki=49.4nM|Ki|=|49.4|nM|49.4|nM
6AYO|1.67|2018|C1Y|ligand is PDIA,Ki=5.1+/-0.6nM,Ki*=1.4+/-0.1nM. Ki = determined from the initial rates|------|5'-METHYLTHIOADENOSINE/S-ADENOSYLHOMOCYSTEINE NUCLEOSIDASE|8.29|Ki=5.1nM|Ki|=|5.1|nM|5.1|nM
5YIE|2.10|2018|8VF|ligand is KNI-10343, Ki = 5.6 +/- 0.60 uM|Q8I6V3|PLASMEPSIN II|5.25|Ki=5.6uM|Ki|=|5.6|uM|5600|nM
6ISD|2.40|2018|5BQ|ligand is sulcotrione|P93836|4-HYDROXYPHENYLPYRUVATE DIOXYGENASE|8.24|Ki=5.79nM|Ki|=|5.79|nM|5.79|nM
5ZA8|1.90|2018|27I|ligand is compound 14,Ki=508+/-9nM|P00749|UROKINASE-TYPE PLASMINOGEN ACTIVATOR CHAIN B|6.29|Ki=508nM|Ki|=|508|nM|508|nM
6DM8|2.70|2018|6AK|ligand is compound 2; Ki = 52+/- 9nM|P0AEX9|INDUCED MYELOID LEUKEMIA CELL DIFFERENTIATION PROTEIN MCL-1|7.28|Ki=52nM|Ki|=|52|nM|52|nM
5ZAH|2.98|2018|30I|ligand is compound 26,Ki=53+/-5nM|P00749|UROKINASE-TYPE PLASMINOGEN ACTIVATOR CHAIN B|7.28|Ki=53nM|Ki|=|53|nM|53|nM
6HH5|1.95|2018|A3R|Ki = 54.2 +/- 4uM; ligand is compound ADP-HPM|H3BCW1|ADP-RIBOSYLHYDROLASE LIKE 2|4.27|Ki=54.2uM|Ki|=|54.2|uM|54200|nM
6M9C|1.80|2018|3-mer|covalent complex|P42790|SEDOLISIN|7.25|Ki=56nM|Ki|=|56|nM|56|nM
5NXW|1.10|2018|RA9|Ki = 57.4 +/- 7.7 nM. ligand is compound 8|P00918|CARBONIC ANHYDRASE 2|7.24|Ki=57.4nM|Ki|=|57.4|nM|57.4|nM
6G3Q|1.01|2018|FO9|ligand is famotidine|P00918|CARBONIC ANHYDRASE 2|7.24|Ki=57.9nM|Ki|=|57.9|nM|57.9|nM
6EIR|2.40|2018|B6H|ligand is compound AC25|Q13627|DUAL SPECIFICITY TYROSINE-PHOSPHORYLATION-REGULATED KINASE|6.24|Ki=575nM|Ki|=|575|nM|575|nM
5OH2|1.90|2018|BAQ|Ki = 57 +/-11.6, ligand is gamma-Butyrolactam|A4TVL0|CEREBLON ISOFORM 4|4.24|Ki=57uM|Ki|=|57|uM|57000|nM
5V3R|1.91|2018|18-mer|Ki = 5 +/- 1 uM. ligand is peptide CHMP4CA232|Q8WUM4|PROGRAMMED CELL DEATH 6-INTERACTING PROTEIN|5.3|Ki=5uM|Ki|=|5|uM|5000|nM
6D2O|1.90|2018|4MZ|ligand is compound 4MI; An Applied Photophysics stopped-flow instrument was used for binding assay|------|CARBONIC ANHYDRASE|5.3|Ki=5uM|Ki|=|5|uM|5000|nM
5OJE|1.58|2018|VSK|Ki = 6.1 +/- 0.4 uM. ligand is compound (S)-2|P11838|ENDOTHIAPEPSIN|5.21|Ki=6.1uM|Ki|=|6.1|uM|6100|nM
6D1M|1.21|2018|FQY|ligand is compound 3f|P00918|CARBONIC ANHYDRASE 2|8.2|Ki=6.3nM|Ki|=|6.3|nM|6.3|nM
6AR9|2.28|2018|3L4|ligand is compound 2,Ki=6.54+/-0.2uM|Q38CA1|HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE, PUTATIVE|5.18|Ki=6.54uM|Ki|=|6.54|uM|6540|nM
6AYQ|1.42|2018|TDI|ligand is MTDIA,Ki=6.5+/-0.6nM,Ki*=2.9+/-0.1nM. Ki = determined from the initial rates|------|5'-METHYLTHIOADENOSINE/S-ADENOSYLHOMOCYSTEINE NUCLEOSIDASE|8.19|Ki=6.5nM|Ki|=|6.5|nM|6.5|nM
6HWZ|1.64|2018|GXE|[Uncommon element] ligand is compound 2a; Se-containing ligand|P00915|CARBONIC ANHYDRASE 1|5.17|Ki=6.7uM|Ki|=|6.7|uM|6700|nM
5Z5F|2.10|2018|FUB|ligand is arabinose,Ki=6.8+/-0.6mM|Q2I2N4|BETA-XYLOSIDASE|2.17|Ki=6.8mM|Ki|=|6.8|mM|6800000|nM
6CBF|2.30|2018|EWD|ligand is compound 8a|P14174|MACROPHAGE MIGRATION INHIBITORY FACTOR|5.17|Ki=6.8uM|Ki|=|6.8|uM|6800|nM
6M8W|1.10|2018|4-mer|covalent complex|P42790|SEDOLISIN|6.22|Ki=600nM|Ki|=|600|nM|600|nM
5OU2|1.45|2018|36Y|[Nonstandard assay: Temp 37] Ki = 609 +/- 3 uM. ligand is compound 2|G7CNL4|INOSINE-5'-MONOPHOSPHATE DEHYDROGENASE,INOSINE-5|3.22|Ki=609uM|Ki|=|609|uM|609000|nM
5TIG|2.70|2018|7DH|Ki = 60 +/- 10 uM, ligand is compound 9|Q01468|2-HYDROXYMUCONATE TAUTOMERASE|4.22|Ki=60uM|Ki|=|60|uM|60000|nM
6C3E|2.60|2018|EJY|ligand is compound 10|Q13546|RECEPTOR-INTERACTING SERINE/THREONINE-PROTEIN KINASE 1|7.2|Ki=63.1nM|Ki|=|63.1|nM|63.1|nM
6C7X|1.50|2018|EO7|ligand is compound 2|P00918|CARBONIC ANHYDRASE 2|7.19|Ki=65.2nM|Ki|=|65.2|nM|65.2|nM
5WA1|1.87|2018|18-mer|Ki = 67 +/- 13 uM. ligand is peptide CHMP4CT232|Q8WUM4|PROGRAMMED CELL DEATH 6-INTERACTING PROTEIN|4.17|Ki=67uM|Ki|=|67|uM|67000|nM
5WDL|2.63|2018|R33|[Covalent complex] Ki(GR-AOMK)=683+/-36nM|A6LE66|AMINOPEPTIDASE C|6.17|Ki=683nM|Ki|=|683|nM|683|nM
6G2L|1.48|2018|EJ8|ligand is compound 5; Ki=68+/-22nM|Q9NPB1|5'(3')-DEOXYRIBONUCLEOTIDASE|7.17|Ki=68nM|Ki|=|68|nM|68|nM
6M9F|1.30|2018|4-mer|covalent complex|P42790|SEDOLISIN|8.22|Ki=6nM|Ki|=|6|nM|6|nM
6CVW|1.78|2018|FH1|ligand is compound 12b; Ki=7.1+/-1.1nM|A8DG50|NS3 PROTEASE|8.15|Ki=7.1nM|Ki|=|7.1|nM|7.1|nM
6B95|1.95|2018|D0P|[Covalent complex] [Incomplete ligand] ligand is compound 2, Ki=7.1+/-1.1uM|P18031|TYROSINE-PROTEIN PHOSPHATASE, NON-RECEPTOR TYPE 1|5.15|Ki=7.1uM|Ki|=|7.1|uM|7100|nM
6DAK|1.60|2018|G1Y|ligand is compound 4a|P61964|WD REPEAT-CONTAINING PROTEIN 5|5.14|Ki=7.21uM|Ki|=|7.21|uM|7210|nM
6DJ5|1.75|2018|G52|ligand is compound 4; Ki=7.2+/-1.4nM|Q5RZ08|HIV-1 PROTEASE|8.14|Ki=7.2nM|Ki|=|7.2|nM|7.2|nM
6F9U|1.90|2018|D0W|ligand is compound SamAsp; Ki = 7.4 +/- 0.3 uM|P12821|ANGIOTENSIN-CONVERTING ENZYME|5.13|Ki=7.4uM|Ki|=|7.4|uM|7400|nM
6D1L|1.40|2018|FQV|ligand is compound 3e|P00918|CARBONIC ANHYDRASE 2|8.12|Ki=7.6nM|Ki|=|7.6|nM|7.6|nM
6DJ2|1.36|2018|AB1|ligand is compound 3; Ki = 7.6+/-0.3nM|Q5RZ08|HIV-1 PROTEASE|8.12|Ki=7.6nM|Ki|=|7.6|nM|7.6|nM
6DIL|1.48|2018|TPV|ligand is compound 3; Ki = 7.6+/-0.3nM|Q5RZ08|HIV-1 PROTEASE|8.12|Ki=7.6nM|Ki|=|7.6|nM|7.6|nM
5Y0X|1.60|2018|8JR|[Incomplete ligand][Nonstandard assay: Temp 30] ligand is 16di,Ki=7.75+/-0.09uM|P15090|FATTY ACID-BINDING PROTEIN, ADIPOCYTE|5.11|Ki=7.75uM|Ki|=|7.75|uM|7750|nM
6H38|1.70|2018|FKK|ligand is compound 8b|P43166|CARBONIC ANHYDRASE 7|8.11|Ki=7.8nM|Ki|=|7.8|nM|7.8|nM
6G2N|1.40|2018|O84|ligand is compound 6; Ki = 72.0 +/- 6.4nM|Q8TCD5|5'(3')-DEOXYRIBONUCLEOTIDASE, CYTOSOLIC TYPE|7.14|Ki=72.0nM|Ki|=|72|nM|72|nM
6DPT|1.79|2018|H7M|enzyme inhibition assay|P00811|BETA-LACTAMASE|7.11|Ki=77nM|Ki|=|77|nM|77|nM
6B59|1.64|2018|CQS|ligand is compound 29|P00918|CARBONIC ANHYDRASE 2|8.09|Ki=8.2nM|Ki|=|8.2|nM|8.2|nM
6EVR|1.50|2018|BZW|ligand is compound (S)-17; Ki(hCA IX) = 104nM|P00915|CARBONIC ANHYDRASE 1|8.06|Ki=8.8nM|Ki|=|8.8|nM|8.8|nM
6DPY|1.91|2018|H7A|enzyme inhibition assay|P00811|BETA-LACTAMASE|4.1|Ki=80uM|Ki|=|80|uM|80000|nM
6EED|1.50|2018|J6A|ligand is compound 6o; Ki=812+/-64nM|O96935|M1 FAMILY AMINOPEPTIDASE|6.09|Ki=812nM|Ki|=|812|nM|812|nM
6EAA|1.65|2018|J1V|[Different ligand in assay: Ligand in binding assay is racemic mixture] ligand is compound 6i; Ki=818+/-45nM|O96935|M1 FAMILY AMINOPEPTIDASE|6.09|Ki=818nM|Ki|=|818|nM|818|nM
6DAI|1.63|2018|G2V|ligand is compound 3h|P61964|WD REPEAT-CONTAINING PROTEIN 5|4.07|Ki=85.2uM|Ki|=|85.2|uM|85200|nM
5ZC5|1.90|2018|09I|ligand is compound 19,Ki=88+/-33nM|P00749|UROKINASE-TYPE PLASMINOGEN ACTIVATOR CHAIN B|7.06|Ki=88nM|Ki|=|88|nM|88|nM
6C0S|2.35|2018|EEJ|ligand is compound 17|P03951|COAGULATION FACTOR XI|7.05|Ki=89nM|Ki|=|89|nM|89|nM
6FKZ|3.30|2018|8-mer|[Different ligand in assay: compound 2 is a diastereomer; compound 2.1:Ki = 900nM; compound 2.2: Ki=135 nM] ligand is compound 2|Q6DHI5|NAD-DEPENDENT PROTEIN DEACYLASE SIRTUIN-5|6.05|Ki=900nM|Ki|=|900|nM|900|nM
6G3V|1.69|2018|FO9|ligand is famotidine|P00915|CARBONIC ANHYDRASE 1|6.04|Ki=922.4nM|Ki|=|922.4|nM|922.4|nM
5NZF|1.75|2018|G39|Ki = 94000 +/- 7000 nM, ligand is oseltamivir carboxylate|W5R8B8|NEURAMINIDASE|4.03|Ki=94000nM|Ki|=|94000|nM|94000|nM
6B2Q|2.88|2018|CJJ|ligand is compound 38|A5TY85|SERINE/THREONINE-PROTEIN KINASE PKNA|8.05|Ki=9nM|Ki|=|9|nM|9|nM
5NXY|1.90|2018|1Y8|[Uncommon element] Ki = 9 +/- 2 uM, ligand is Arsenocholine. uncommon atom is As|------|OSMOTICALLY ACTIVATED L-CARNITINE/CHOLINE ABC TRANSPORTER|5.05|Ki=9uM|Ki|=|9|uM|9000|nM
5WG7|1.45|2018|AUD|CA II in complex with Ace K|P00918|CARBONIC ANHYDRASE 2|4.7|Ki>20000nM|Ki|>|20000|nM|20000|nM
6EIL|2.47|2018|B6B|ligand is compound AC22|Q13627|DUAL SPECIFICITY TYROSINE-PHOSPHORYLATION-REGULATED KINASE|5.55|Ki>2800nM|Ki|>|2800|nM|2800|nM
6B0V|1.29|2018|C8G|[Covalent complex] [Incomplete ligand] ligand is ARS-107|P01116|GTPASE KRAS|3.49|Ki>320uM|Ki|>|320|uM|320000|nM
6B0Y|1.43|2018|8ZG|[Covalent complex] [Incomplete ligand] ligand is ARS-917|P01116|GTPASE KRAS|4.19|Ki>64uM|Ki|>|64|uM|64000|nM
6OI8|2.50|2019|MQV|ligand is compound 14a|P43873|BIOTIN CARBOXYLASE|7.82|IC<15nM|IC50|<|15|nM|15|nM
6HRP|1.12|2019|GMQ|ligand is compound 2|Q06187|TYROSINE-PROTEIN KINASE BTK|9.0|IC<1nM|IC50|<|1|nM|1|nM
6HRT|1.36|2019|GMW|ligand is compound 3|Q06187|TYROSINE-PROTEIN KINASE BTK|9.0|IC<1nM|IC50|<|1|nM|1|nM
6E3N|3.19|2019|HNS|ligand is compound 7|C3W5S0|POLYMERASE ACIDIC PROTEIN|8.7|IC<2nM|IC50|<|2|nM|2|nM
6E3O|3.19|2019|HNY|ligand is compound 13|C3W5S0|POLYMERASE ACIDIC PROTEIN|8.7|IC<2nM|IC50|<|2|nM|2|nM
6E3P|2.80|2019|HO1|ligand is compound 20|C3W5S0|POLYMERASE ACIDIC PROTEIN|8.7|IC<2nM|IC50|<|2|nM|2|nM
6PZ4|1.85|2019|P6J|ligand is compound 20(AM-6494)|P56817|BETA-SECRETASE 1|9.4|IC=0.0004uM|IC50|=|0.0004|uM|0.4|nM
6N6O|2.60|2019|KE7|ligand is compound 20|P33981|DUAL SPECIFICITY PROTEIN KINASE TTK|9.15|IC=0.0007uM|IC50|=|0.0007|uM|0.7|nM
6NZF|2.39|2019|L91|ligand is compound 23; IC50 = 0.00092 +/- 0.0004 uM; Binding assay is HTRF|P29597|NON-RECEPTOR TYROSINE-PROTEIN KINASE TYK2|9.04|IC=0.00092uM|IC50|=|0.00092|uM|0.92|nM
6NZE|1.96|2019|L8Y|ligand is compound 5; IC50 = 0.0013 +/- 0.0005 uM; Binding assay is HTRF|P29597|NON-RECEPTOR TYROSINE-PROTEIN KINASE TYK2|8.89|IC=0.0013uM|IC50|=|0.0013|uM|1.3|nM
6NZH|2.73|2019|L9A|ligand is compound 40; IC50 = 0.0013 +/- 0.0007 uM; Binding assay is HTRF|P29597|NON-RECEPTOR TYROSINE-PROTEIN KINASE TYK2|8.8|IC=0.0016uM|IC50|=|0.0016|uM|1.6|nM
6NZM|1.72|2019|L9S|ligand is compound 50|Q06187|TYROSINE-PROTEIN KINASE BTK|9.0|IC=0.001uM|IC50|=|0.001|uM|1|nM
6OCZ|2.65|2019|M6Y|ligand is compound A86; IC50 = 0.003 +/- 0.001 uM|P9WHU1|PROTEASOME SUBUNIT ALPHA|8.52|IC=0.003uM|IC50|=|0.003|uM|3|nM
6RFJ|2.61|2019|K1E|ligand is compound 13|Q9NWZ3|INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE 4|8.4|IC=0.004uM|IC50|=|0.004|uM|4|nM
6GVA|2.15|2019|FCQ|ligand is 4.35; with a fragment of cyclin A2|P24941|CYCLIN-DEPENDENT KINASE 2|8.22|IC=0.006uM|IC50|=|0.006|uM|6|nM
6OCW|2.60|2019|M6M|ligand is compound A85; IC50 = 0.007 +/- 0.003 uM|P9WHU1|PROTEASOME SUBUNIT ALPHA|8.15|IC=0.007uM|IC50|=|0.007|uM|7|nM
6ODE|2.90|2019|M9G|ligand is compound B6; IC50 = 0.008 +/- 0.002 uM|P9WHU1|PROTEASOME SUBUNIT ALPHA|8.1|IC=0.008uM|IC50|=|0.008|uM|8|nM
6MJW|2.41|2019|JUJ|ligand is G150|Q8N884|CYCLIC GMP-AMP SYNTHASE|7.99|IC=0.0102uM|IC50|=|0.0102|uM|10.200000000000001|nM
6MCK|3.77|2019|JDP|[Different protein in assay: Protein in binding assay is a truncation of p97 containing only D1 and D2 domains.] ligand is CB-5083|P55072|TRANSITIONAL ENDOPLASMIC RETICULUM ATPASE|7.92|IC=0.012uM|IC50|=|0.012|uM|12|nM
6QMR|2.00|2019|J6T|ligand is compound 12; Binding assay is TR-FRET|P00746|COMPLEMENT FACTOR D|7.92|IC=0.012uM|IC50|=|0.012|uM|12|nM
6R0K|1.15|2019|JNN|ligand is compound SS-208; IC50 = 0.012 +/- 0.002 uM|F8W4B7|HISTONE DEACETYLASE 6|7.92|IC=0.012uM|IC50|=|0.012|uM|12|nM
6S90|1.82|2019|L0Z|ligand is compound 3|Q06187|TYROSINE-PROTEIN KINASE BTK|7.89|IC=0.013uM|IC50|=|0.013|uM|13|nM
6PLG|2.93|2019|ONS|ligand is compound 15|O43175|D-3-PHOSPHOGLYCERATE DEHYDROGENASE|7.82|IC=0.015uM|IC50|=|0.015|uM|15|nM
6OIR|2.03|2019|MNJ|[Nonstandard assay: Concentration of Ac-CoA is 0.4uM;] ligand is compound 62|Q9H7Z6|HISTONE ACETYLTRANSFERASE KAT8|7.77|IC=0.017uM|IC50|=|0.017|uM|17|nM
6SFJ|1.95|2019|LBB|ligand is compound 77|Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|7.74|IC=0.018uM|IC50|=|0.018|uM|18|nM
6G9S|2.00|2019|ET5|ligand is CPD4|P0AD65|PEPTIDOGLYCAN D,D-TRANSPEPTIDASE MRDA|8.0|IC=0.01uM|IC50|=|0.01|uM|10|nM
6OQN|1.70|2019|N0P|ligand is compound 7|Q07820|INDUCED MYELOID LEUKEMIA CELL DIFFERENTIATION PROTEIN MCL|8.0|IC=0.01uM|IC50|=|0.01|uM|10|nM
6RMF|1.51|2019|K9B|[Uncommon element] ligand is VNRX-5133, two different forms; contain B element|C7C422|METALLO-BETA-LACTAMASE TYPE 2|8.0|IC=0.01uM|IC50|=|0.01|uM|10|nM
6UWV|1.47|2019|QK7|ligand is compound 34|P56817|BETA-SECRETASE 1|8.0|IC=0.01uM|IC50|=|0.01|uM|10|nM
6K1S|2.60|2019|CUX|[Covalent complex] ligand is 10|O14744|PROTEIN ARGININE N-METHYLTRANSFERASE 5|7.7|IC=0.020uM|IC50|=|0.02|uM|20|nM
6NZG|2.43|2019|L9D|[Covalent complex] ligand is compound 2; Covalently bound|------|BETA-GALACTOSIDASE|7.7|IC=0.020uM|IC50|=|0.02|uM|20|nM
6H4Z|2.30|2019|FQ5|ligand is 16a|Q9UGL1|LYSINE-SPECIFIC DEMETHYLASE 5B,LYSINE-SPECIFIC DEMETHYLASE|7.64|IC=0.023uM|IC50|=|0.023|uM|23|nM
6NCJ|2.00|2019|KJJ|ligand is 24|F2WR52|INTEGRASE|7.62|IC=0.024uM|IC50|=|0.024|uM|24|nM
6SFI|1.60|2019|LB5|ligand is compound 75|Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|7.59|IC=0.026uM|IC50|=|0.026|uM|26|nM
6MJU|2.45|2019|JUM|ligand is G108|Q8N884|CYCLIC GMP-AMP SYNTHASE|7.56|IC=0.0275uM|IC50|=|0.0275|uM|27.5|nM
6UWP|1.29|2019|QKA|ligand is compound 32|P56817|BETA-SECRETASE 1|7.55|IC=0.028uM|IC50|=|0.028|uM|28|nM
6MDC|2.14|2019|JEA|ligand is 1|Q06124|TYROSINE-PROTEIN PHOSPHATASE NON-RECEPTOR TYPE 11|7.44|IC=0.036uM|IC50|=|0.036|uM|36|nM
6RFI|2.31|2019|K1H|ligand is compound 4|Q9NWZ3|INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE 4|7.43|IC=0.037uM|IC50|=|0.037|uM|37|nM
6H4S|2.45|2019|FQE|ligand is 16m|O75164|LYSINE-SPECIFIC DEMETHYLASE 4A|7.42|IC=0.038uM|IC50|=|0.038|uM|38|nM
6UL8|2.68|2019|Q9J|ligand is compound 11|O43353|RECEPTOR-INTERACTING SERINE/THREONINE-PROTEIN KINASE 2|7.52|IC=0.03uM|IC50|=|0.03|uM|30|nM
6N0Q|2.04|2019|K7S|ligand is 10|P15056|SERINE/THREONINE-PROTEIN KINASE B-RAF|7.4|IC=0.04uM|IC50|=|0.04|uM|40|nM
6O6F|1.60|2019|LOD|ligand is compound 5|Q07820|INDUCED MYELOID LEUKEMIA CELL DIFFERENTIATION PROTEIN MCL|7.4|IC=0.04uM|IC50|=|0.04|uM|40|nM
6HKN|2.33|2019|G9E|ligand is 35|Q13164|MITOGEN-ACTIVATED PROTEIN KINASE 7|7.29|IC=0.051uM|IC50|=|0.051|uM|51|nM
6MT0|2.20|2019|JYG|ligand is 28|P11309|SERINE/THREONINE-PROTEIN KINASE PIM-1|10.3|IC=0.05nM|IC50|=|0.05|nM|0.05|nM
6HRO|2.30|2019|GKZ|ligand is 118a|Q05320|ENVELOPE GLYCOPROTEIN,ENVELOPE GLYCOPROTEIN,ENVELOPE|7.3|IC=0.05uM|IC50|=|0.05|uM|50|nM
6QEG|2.08|2019|K4K|ligand is compound S-11a; IC50 = 0.05+/-0.006 uM|P50579|METHIONINE AMINOPEPTIDASE 2|7.3|IC=0.05uM|IC50|=|0.05|uM|50|nM
6H52|2.14|2019|FQN|ligand is 34g|Q9UGL1|LYSINE-SPECIFIC DEMETHYLASE 5B,LYSINE-SPECIFIC DEMETHYLASE|7.17|IC=0.068uM|IC50|=|0.068|uM|68|nM
6AKW|2.20|2019|8S3|HPLC-based assay, IC50(FB23)=0.06+/-0.04uM|Q9C0B1|ALPHA-KETOGLUTARATE-DEPENDENT DIOXYGENASE FTO|7.22|IC=0.06uM|IC50|=|0.06|uM|60|nM
6QEF|1.79|2019|HZW|ligand is compound 11r; IC50 = 0.06+/-0.006uM|P50579|METHIONINE AMINOPEPTIDASE 2|7.22|IC=0.06uM|IC50|=|0.06|uM|60|nM
6SFK|1.80|2019|LB8|ligand is compound 81|Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|7.15|IC=0.071uM|IC50|=|0.071|uM|71|nM
6QED|1.80|2019|HZK|ligand is compound 21|P50579|METHIONINE AMINOPEPTIDASE 2|7.13|IC=0.074uM|IC50|=|0.074|uM|74|nM
6H4Y|2.38|2019|FO8|ligand is 17e|O75164|LYSINE-SPECIFIC DEMETHYLASE 4A|7.11|IC=0.077uM|IC50|=|0.077|uM|77|nM
6HGX|2.16|2019|G3T|ligand is Morpholino-Talinolol|P34913|BIFUNCTIONAL EPOXIDE HYDROLASE 2|7.11|IC=0.077uM|IC50|=|0.077|uM|77|nM
6R8R|1.27|2019|JV8|ligand is compound 45|Q6P988|PALMITOLEOYL-PROTEIN CARBOXYLESTERASE NOTUM|7.07|IC=0.085uM|IC50|=|0.085|uM|85|nM
6QFE|1.67|2019|J08|ligand is GSK144|Q9Y337|KALLIKREIN-5|7.1|IC=0.08uM|IC50|=|0.08|uM|80|nM
6K9U|2.35|2019|D4L|ligand is 3g|Q9QYJ6|CAMP AND CAMP-INHIBITED CGMP 3',5'-CYCLIC PHOSPHODIESTERASE|10.05|IC=0.090nM|IC50|=|0.09|nM|0.09|nM
6H4R|2.14|2019|FQB|ligand is 17f|O75164|LYSINE-SPECIFIC DEMETHYLASE 4A|7.03|IC=0.093uM|IC50|=|0.093|uM|93|nM
6ST3|2.43|2019|LUW|[Nonstandard assay: With HIF-1 alpha NODD substrates] ligand is compound 8; IC50 = 0.094 +/- 0.042 uM|Q9GZT9|EGL NINE HOMOLOG 1|7.03|IC=0.094uM|IC50|=|0.094|uM|94|nM
6OIM|1.65|2019|MOV|[Covalent complex] ligand is compound AMG 510; covalent complex|P01116|GTPASE KRAS|7.05|IC=0.09uM|IC50|=|0.09|uM|90|nM
6H4T|2.38|2019|FOW|ligand is 19a|O75164|LYSINE-SPECIFIC DEMETHYLASE 4A|7.0|IC=0.100uM|IC50|=|0.1|uM|100|nM
6PGP|1.50|2019|OHY|[Covalent complex] ligand is compound 9; covalently bound|P01116|GTPASE KRAS|7.0|IC=0.101uM|IC50|=|0.101|uM|101|nM
6H4P|2.19|2019|FQ5|ligand is 16a|O75164|LYSINE-SPECIFIC DEMETHYLASE 4A|6.99|IC=0.102uM|IC50|=|0.102|uM|102|nM
6H4W|2.81|2019|FQQ|ligand is 19d|O75164|LYSINE-SPECIFIC DEMETHYLASE 4A|6.97|IC=0.107uM|IC50|=|0.107|uM|107|nM
6O8I|1.42|2019|LTJ|Ligand is compound 5a;IC50 = 0.10+/-0.05nM|Q06187|TYROSINE-PROTEIN KINASE BTK|10.0|IC=0.10nM|IC50|=|0.1|nM|0.1|nM
6Q96|1.80|2019|HRE|ligand is compound 12; Binding assay is TR-FRET|Q00987|E3 UBIQUITIN-PROTEIN LIGASE MDM2|10.0|IC=0.10nM|IC50|=|0.1|nM|0.1|nM
6TEL|2.19|2019|N4Z|ligand is compound 10|Q8TEK3|HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-79 SPECIFIC|9.96|IC=0.11nM|IC50|=|0.11|nM|0.11|nM
6QMT|1.80|2019|J7B|ligand is compound 3; Binding assay is TR-FRET|P00746|COMPLEMENT FACTOR D|6.92|IC=0.120uM|IC50|=|0.12|uM|120|nM
6H4O|2.25|2019|FQH|ligand is 18a|O75164|LYSINE-SPECIFIC DEMETHYLASE 4A|6.89|IC=0.128uM|IC50|=|0.128|uM|128|nM
6D4T|1.54|2019|FWS|ligand is 45; IC50=0.12+/-0.02uM|G7CNL4|INOSINE-5'-MONOPHOSPHATE DEHYDROGENASE,INOSINE-5|6.92|IC=0.12uM|IC50|=|0.12|uM|120|nM
6OIP|1.80|2019|MLS|[Nonstandard assay: Concentration of Ac-CoA is 0.4uM;] ligand is compound 34|Q9H7Z6|HISTONE ACETYLTRANSFERASE KAT8|6.92|IC=0.12uM|IC50|=|0.12|uM|120|nM
6R8Q|1.50|2019|JV5|ligand is compound 39|Q6P988|PALMITOLEOYL-PROTEIN CARBOXYLESTERASE NOTUM|6.92|IC=0.12uM|IC50|=|0.12|uM|120|nM
6H4X|2.34|2019|FNQ|ligand is 17b|O75164|LYSINE-SPECIFIC DEMETHYLASE 4A|6.88|IC=0.131uM|IC50|=|0.131|uM|131|nM
6H51|2.21|2019|FQK|ligand is 34f|Q9UGL1|LYSINE-SPECIFIC DEMETHYLASE 5B,LYSINE-SPECIFIC DEMETHYLASE|6.87|IC=0.134uM|IC50|=|0.134|uM|134|nM
6HCW|1.46|2019|FYB|ligand is compound 5, kinase-glo assay|Q5CR27|LYSINE--TRNA LIGASE|6.89|IC=0.13uM|IC50|=|0.13|uM|130|nM
6RRM|1.64|2019|9JT|[Covalent complex] ligand is ebselen; IC50 = 0.143 +/- 0.014 uM|O53223|L,D-TRANSPEPTIDASE 2|6.84|IC=0.143uM|IC50|=|0.143|uM|143|nM
6P3P|1.61|2019|NQJ|ligand is compound 65; Binding assay is FP|Q07820|INDUCED MYELOID LEUKEMIA CELL DIFFERENTIATION PROTEIN MCL|6.84|IC=0.145uM|IC50|=|0.145|uM|145|nM
6Q7W|2.82|2019|HLQ|ligand is compound 20; IC50 = 0.14 +/- 0.04 uM|Q9I4X0|TRANSCRIPTIONAL REGULATOR MVFR|6.85|IC=0.14uM|IC50|=|0.14|uM|140|nM
6H50|2.19|2019|FO2|ligand is 34a|Q9UGL1|LYSINE-SPECIFIC DEMETHYLASE 5B,LYSINE-SPECIFIC DEMETHYLASE|6.81|IC=0.156uM|IC50|=|0.156|uM|156|nM
6NPV|1.86|2019|KWP|ligand is compound 51|P00519|TYROSINE-PROTEIN KINASE ABL1|6.8|IC=0.16uM|IC50|=|0.16|uM|160|nM
6QM7|2.80|2019|J6E|[Different protein in assay: Protein in binding assay is from L.donovani] ligand is compound 8; IC50 = 0.16+/-0.01uM|------|PROTEASOME ALPHA1 CHAIN|6.8|IC=0.16uM|IC50|=|0.16|uM|160|nM
6TEN|2.21|2019|N5K|ligand is compound 11|Q8TEK3|HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-79 SPECIFIC|9.77|IC=0.17nM|IC50|=|0.17|nM|0.17|nM
6H0U|2.30|2019|FKB|[Covalent complex] [Incomplete ligand] ligand is 12|P49841|GLYCOGEN SYNTHASE KINASE-3 BETA|6.77|IC=0.17uM|IC50|=|0.17|uM|170|nM
6MHB|2.75|2019|JR7|[Covalent complex] ligand is 18|P78417|GLUTATHIONE S-TRANSFERASE OMEGA-1|6.77|IC=0.17uM|IC50|=|0.17|uM|170|nM
6MD7|1.96|2019|JE1|ligand is compound 7|Q06124|TYROSINE-PROTEIN PHOSPHATASE NON-RECEPTOR TYPE 11|6.74|IC=0.181uM|IC50|=|0.181|uM|181|nM
6OKO|2.10|2019|1FN|ligand is compound 9; Binding assay is HTRF|Q9QZL0|RECEPTOR-INTERACTING SERINE/THREONINE-PROTEIN KINASE 3|6.74|IC=0.18uM|IC50|=|0.18|uM|180|nM
6RJ2|2.00|2019|K52|ligand is compound 40|O43175|D-3-PHOSPHOGLYCERATE DEHYDROGENASE|7.0|IC=0.1uM|IC50|=|0.1|uM|100|nM
6T6A|2.80|2019|MLW|ligand is compound 11|Q13627|DUAL SPECIFICITY TYROSINE-PHOSPHORYLATION-REGULATED KINASE|6.7|IC=0.20uM|IC50|=|0.2|uM|200|nM
6MO2|2.80|2019|JVM|ligand is compound 5|Q91H74|FLAVIVIRUS_NS2B/PEPTIDASE S7|6.68|IC=0.21uM|IC50|=|0.21|uM|210|nM
6K4X|1.17|2019|D0U|ligand is ASB|G5ELM3|METALLO-BETA-LACTAMASE|6.66|IC=0.22uM|IC50|=|0.22|uM|220|nM
6P14|1.93|2019|NKY|ligand is compound 4|Q8I0P1|SPASTIN|6.66|IC=0.22uM|IC50|=|0.22|uM|220|nM
6RTN|2.17|2019|KJK|[Uncommon element] ligand is VNRX-5133, bicyclic form; Binding assay is fluorogenic assay|P14489|BETA-LACTAMASE OXA-10|6.63|IC=0.234uM|IC50|=|0.234|uM|234|nM
6D4V|2.02|2019|FWM|IC50(compound 22)=0.23+/-0.02uM|G7CNL4|INOSINE-5'-MONOPHOSPHATE DEHYDROGENASE,INOSINE-5|6.64|IC=0.23uM|IC50|=|0.23|uM|230|nM
6IND|1.87|2019|AKO|ligand is compound 16|Q08499|CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D|6.62|IC=0.24uM|IC50|=|0.24|uM|240|nM
6IMT|1.48|2019|AK0|ligand is compound 15|Q08499|CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D|6.6|IC=0.25uM|IC50|=|0.25|uM|250|nM
6SAL|1.61|2019|L3E|ligand is compound 25 (allosteric ligand FM26)|P51449|NUCLEAR RECEPTOR ROR-GAMMA|6.58|IC=0.264uM|IC50|=|0.264|uM|264|nM
6DUK|2.20|2019|JBJ|compound is JBJ-04-125-02, HTRF assay|P00533|EPIDERMAL GROWTH FACTOR RECEPTOR|9.59|IC=0.26nM|IC50|=|0.26|nM|0.26|nM
6HKM|2.47|2019|G92|ligand is 1|Q13164|MITOGEN-ACTIVATED PROTEIN KINASE 7|6.57|IC=0.27uM|IC50|=|0.27|uM|270|nM
6INK|1.70|2019|AKU|ligand is 2|Q08499|CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D|6.57|IC=0.27uM|IC50|=|0.27|uM|270|nM
6OIQ|1.75|2019|MLV|[Nonstandard assay: Concentration of Ac-CoA is 0.4uM;] ligand is compound 63|Q9H7Z6|HISTONE ACETYLTRANSFERASE KAT8|6.57|IC=0.27uM|IC50|=|0.27|uM|270|nM
6TE6|1.98|2019|N4W|ligand is compound 3|Q8TEK3|HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-79 SPECIFIC|6.57|IC=0.27uM|IC50|=|0.27|uM|270|nM
6MO1|3.00|2019|I16|ligand is 8|B3RFT3|FLAVIVIRUS_NS2B/PEPTIDASE S7|6.54|IC=0.29uM|IC50|=|0.29|uM|290|nM
6OIO|1.70|2019|ML7|[Nonstandard assay: Concentration of Ac-CoA is 0.4uM;] ligand is compound 60|Q9H7Z6|HISTONE ACETYLTRANSFERASE KAT8|6.54|IC=0.29uM|IC50|=|0.29|uM|290|nM
6NZP|2.35|2019|LB7|ligand is compound 11; Binding assay is HTRF|P29597|NON-RECEPTOR TYROSINE-PROTEIN KINASE TYK2|9.7|IC=0.2nM|IC50|=|0.2|nM|0.2|nM
6P5V|1.40|2019|O37|ligand is compound 27; IC50 = 0.2 +/- 0.1 uM|D9IEF7|LYSOZYME,DCN1-LIKE PROTEIN 1 FUSION|6.7|IC=0.2uM|IC50|=|0.2|uM|200|nM
6HX1|2.14|2019|GXK|[Multiple sites: ] ligand is 2; site 2(ATP-site): IC50 = 1.60 +/- 0.91 uM; site 3(RNase activity): IC50 = 8.9 +/- 0.21 uM|O75460|SERINE/THREONINE-PROTEIN KINASE/ENDORIBONUCLEASE IRE1|6.52|IC=0.303uM|IC50|=|0.303|uM|303|nM
6J6M|1.25|2019|BA0|[Covalent complex] ligand is 31a|Q06187|TYROSINE-PROTEIN KINASE BTK|9.52|IC=0.30nM|IC50|=|0.3|nM|0.3|nM
6ILZ|3.26|2019|AFU|ligand is 19|P41743|PROTEIN KINASE C IOTA TYPE|6.47|IC=0.34uM|IC50|=|0.34|uM|340|nM
6MHC|2.00|2019|JRM|[Covalent complex] ligand is 37|P78417|GLUTATHIONE S-TRANSFERASE OMEGA-1|6.43|IC=0.37uM|IC50|=|0.37|uM|370|nM
6MO5|1.85|2019|JWP|ligand is 19|P47205|UDP-3-O-ACYL-N-ACETYLGLUCOSAMINE DEACETYLASE|9.52|IC=0.3nM|IC50|=|0.3|nM|0.3|nM
6NZQ|2.11|2019|LB4|ligand is compound 29; Binding assay is HTRF|P29597|NON-RECEPTOR TYROSINE-PROTEIN KINASE TYK2|9.52|IC=0.3nM|IC50|=|0.3|nM|0.3|nM
6O6G|2.40|2019|LOJ|ligand is compound 4|Q07820|INDUCED MYELOID LEUKEMIA CELL DIFFERENTIATION PROTEIN MCL|6.52|IC=0.3uM|IC50|=|0.3|uM|300|nM
6OVC|NMR|2019|N8J|ligand is compound 6|Q07820|INDUCED MYELOID LEUKEMIA CELL DIFFERENTIATION PROTEIN MCL|6.52|IC=0.3uM|IC50|=|0.3|uM|300|nM
6RJ5|1.89|2019|K5N|ligand is compound 39|O43175|D-3-PHOSPHOGLYCERATE DEHYDROGENASE|6.52|IC=0.3uM|IC50|=|0.3|uM|300|nM
6RNI|1.54|2019|KAQ|ligand is compound 10; pIC50 = 9.4|P53634|DIPEPTIDYL PEPTIDASE 1|9.4|IC=0.40nM|IC50|=|0.4|nM|0.4|nM
6SUO|1.74|2019|LVH|ligand is compound 6; pIC50 = 9.4|P03372|ESTROGEN RECEPTOR|9.4|IC=0.40nM|IC50|=|0.4|nM|0.4|nM
6NPU|2.33|2019|KWV|ligand is compound 29|P00519|TYROSINE-PROTEIN KINASE ABL1|6.4|IC=0.40uM|IC50|=|0.4|uM|400|nM
6BQD|2.14|2019|69G|compound 4|P21675|TRANSCRIPTION INITIATION FACTOR TFIID SUBUNIT 1|6.39|IC=0.41uM|IC50|=|0.41|uM|410|nM
6OHD|2.50|2019|MKP|ligand is compound 25, T-3220137|Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|9.38|IC=0.42nM|IC50|=|0.42|nM|0.42|nM
6IJI|2.70|2019|AEL|ligand is 2b|Q9Y233|CAMP AND CAMP-INHIBITED CGMP 3',5'-CYCLIC PHOSPHODIESTERASE|9.36|IC=0.44nM|IC50|=|0.44|nM|0.44|nM
6ILQ|2.41|2019|AE0|ligand is 2|P37231|PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA|6.36|IC=0.44uM|IC50|=|0.44|uM|440|nM
6AA4|1.90|2019|MKS|IC50(alpha-mangostin)=0.47+/-0.033uM|P36639|7,8-DIHYDRO-8-OXOGUANINE TRIPHOSPHATASE|6.33|IC=0.47uM|IC50|=|0.47|uM|470|nM
6EB2|2.49|2019|J3P|LEDGF/p75 Independent Integration Assays, IC50(6l)=0.48+/-0.01uM|F2WR52|INTEGRASE|6.32|IC=0.48uM|IC50|=|0.48|uM|480|nM
6OA3|1.90|2019|M0M|ligand is JA2131|Q86W56|POLY(ADP-RIBOSE) GLYCOHYDROLASE|6.4|IC=0.4uM|IC50|=|0.4|uM|400|nM
6RJ3|1.42|2019|K58|ligand is compound 15|O43175|D-3-PHOSPHOGLYCERATE DEHYDROGENASE|6.4|IC=0.4uM|IC50|=|0.4|uM|400|nM
6FE5|1.52|2019|D6E|[Different protein in assay: E424M inactive mutant] IC50(ZJ-43)=0.50+/-0.11nM|Q04609|GLUTAMATE CARBOXYPEPTIDASE 2|9.3|IC=0.50nM|IC50|=|0.5|nM|0.5|nM
6NPE|2.15|2019|KWD|ligand is compound 6; pIC50=6.3|P00519|TYROSINE-PROTEIN KINASE ABL1|6.3|IC=0.50uM|IC50|=|0.5|uM|500|nM
6QHB|1.84|2019|J2W|[Different protein in assay: Protein KLK5/KLK1 was used in binding assay;But all structures were based on KLK6] Ligand is compound 5|Q92876|KALLIKREIN-6|6.3|IC=0.50uM|IC50|=|0.5|uM|500|nM
6INM|2.00|2019|AKU|ligand is 1|Q08499|CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D|6.29|IC=0.51uM|IC50|=|0.51|uM|510|nM
6N83|2.00|2019|YL6|ligand is (R)-6g|P14324|FARNESYL PYROPHOSPHATE SYNTHASE|6.27|IC=0.54uM|IC50|=|0.54|uM|540|nM
6G9F|2.35|2019|NXL|avibactam|P0AD67|PEPTIDOGLYCAN D,D-TRANSPEPTIDASE MRDA|6.23|IC=0.59uM|IC50|=|0.59|uM|590|nM
6MO0|2.70|2019|JVJ|ligand is 9|Q91H74|FLAVIVIRUS_NS2B/PEPTIDASE S7|6.23|IC=0.59uM|IC50|=|0.59|uM|590|nM
6NZR|2.56|2019|LAJ|ligand is compound 12; IC50 = 0.3 +/- 0.2 nM; Binding assay is HTRF|P29597|NON-RECEPTOR TYROSINE-PROTEIN KINASE TYK2|9.3|IC=0.5nM|IC50|=|0.5|nM|0.5|nM
6H4V|2.15|2019|FQN|ligand is 34g|O75164|LYSINE-SPECIFIC DEMETHYLASE 4A|6.21|IC=0.613uM|IC50|=|0.613|uM|613|nM
6P8Y|2.31|2019|O5Y|[Covalent complex] ligand is compound 6; covalently bound|P01116|GTPASE KRAS|6.2|IC=0.638uM|IC50|=|0.638|uM|638|nM
5Z1T|1.42|2019|EFN|Alpha Screen|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|6.2|IC=0.63uM|IC50|=|0.63|uM|630|nM
6IMO|1.55|2019|AJL|ligand is 7|Q08499|CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D|6.19|IC=0.65uM|IC50|=|0.65|uM|650|nM
5Y7K|2.51|2019|8VU||P27487|DIPEPTIDYL PEPTIDASE 4|9.18|IC=0.666nM|IC50|=|0.666|nM|0.666|nM
6S88|1.59|2019|L0K|ligand is compound 16l; IC50 = 0.67 +/- 0.03 uM|------|FUMARATE HYDRATASE CLASS II|6.17|IC=0.67uM|IC50|=|0.67|uM|670|nM
6H4U|2.21|2019|FO2|ligand is 34b|O75164|LYSINE-SPECIFIC DEMETHYLASE 4A|6.16|IC=0.693uM|IC50|=|0.693|uM|693|nM
5Z1S|1.42|2019|EFM|Alpha Screen|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|6.16|IC=0.69uM|IC50|=|0.69|uM|690|nM
6GCX|1.55|2019|EUW|[Covalent complex] ADP Glo kinase assay, IC50(5)=0.6+/-0.04nM|Q00944|FOCAL ADHESION KINASE 1|9.22|IC=0.6nM|IC50|=|0.6|nM|0.6|nM
6I3U|2.09|2019|H2E|ligand is 33,|Q8NEB9|PHOSPHATIDYLINOSITOL 3-KINASE CATALYTIC SUBUNIT TYPE 3|9.22|IC=0.6nM|IC50|=|0.6|nM|0.6|nM
6MOD|1.85|2019|JWV|ligand is 26|B7UZI4|UDP-3-O-ACYL-N-ACETYLGLUCOSAMINE DEACETYLASE|9.15|IC=0.71nM|IC50|=|0.71|nM|0.71|nM
5ZHM|2.76|2019|9D3|compound 11, IC50=0.73+/-0.13uM|Q02RL6|TRNA (GUANINE-N(1)-)-METHYLTRANSFERASE|6.14|IC=0.73uM|IC50|=|0.73|uM|730|nM
6DHU|1.63|2019|GHM|compound 1(cocktail soak)|Q9NUW8|TYROSYL-DNA PHOSPHODIESTERASE 1|3.13|IC=0.74mM|IC50|=|0.74|mM|740000|nM
6DIE|1.78|2019|GHM|compound 1, same as PDB 6dhu(single soak))|Q9NUW8|TDP1 CATALYTIC DOMAIN (RESIDUES 149-609)|3.13|IC=0.74mM|IC50|=|0.74|mM|740000|nM
6SQ0|1.77|2019|LRQ|ligand is compound 8; pIC50 = 9.1|P03372|ESTROGEN RECEPTOR|9.1|IC=0.79nM|IC50|=|0.79|nM|0.79|nM
6FFE|1.76|2019|D7Q|pIC50=6.1+/-0.04|P25440|BROMODOMAIN-CONTAINING PROTEIN 2|6.1|IC=0.79uM|IC50|=|0.79|uM|790|nM
5ZXI|2.10|2019|9LU|transactivation assay, EC50=0.7+/-0.2nM|Q03181|PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR DELTA|9.15|IC=0.7nM|IC50|=|0.7|nM|0.7|nM
6AEJ|2.80|2019|7YC|enzymic inhibition assay, IC50(cpd-7)=0.7+/-0.3uM|Q9C0B1|ALPHA-KETOGLUTARATE-DEPENDENT DIOXYGENASE FTO,ALPHA|6.15|IC=0.7uM|IC50|=|0.7|uM|700|nM
6D4Q|1.71|2019|FWG|IC50(compound 14)=0.83+/-0.04uM|G7CNL4|INOSINE-5'-MONOPHOSPHATE DEHYDROGENASE,INOSINE-5|6.08|IC=0.83uM|IC50|=|0.83|uM|830|nM
6I0X|1.60|2019|BFB|[Covalent complex] [Incomplete ligand] ligand is Cl-amidine|Q9RQJ2|PEPTIDYLARGININE DEIMINASE|6.07|IC=0.86uM|IC50|=|0.86|uM|860|nM
6GJ7|1.67|2019|F0B|ligand is 22|P01116|GTPASE KRAS|6.06|IC=0.87uM|IC50|=|0.87|uM|870|nM
6NPP|1.35|2019|KWG|ligand is compound VK-0497|P03211|EPSTEIN-BARR NUCLEAR ANTIGEN 1|6.05|IC=0.89uM|IC50|=|0.89|uM|890|nM
6FZM|2.67|2019|EE5|IC50=0.917+/-0.086uM|Q460N5|POLY [ADP-RIBOSE] POLYMERASE 14|6.04|IC=0.917uM|IC50|=|0.917|uM|917|nM
6K4T|1.39|2019|JKE|ligand is TSA|G5ELM3|METALLO-BETA-LACTAMASE|6.02|IC=0.95uM|IC50|=|0.95|uM|950|nM
6N19|1.50|2019|K8V|compound 11|Q9NUW8|TYROSYL-DNA PHOSPHODIESTERASE 1|3.02|IC=0.96mM|IC50|=|0.96|mM|960000|nM
6QXD|2.32|2019|JKB|ligand is compound 25; IC50 = 0.96 +/- 0.21 uM|B2ZB02|TYROSINASE|6.02|IC=0.96uM|IC50|=|0.96|uM|960|nM
6UVY|1.71|2019|QJP|ligand is compound 18|P56817|BETA-SECRETASE 1|6.0|IC=0.99uM|IC50|=|0.99|uM|990|nM
6D4S|1.63|2019|FWV|IC50(compound 37)=0.9+/-0.06uM|G7CNL4|INOSINE-5'-MONOPHOSPHATE DEHYDROGENASE,INOSINE-5|6.05|IC=0.9uM|IC50|=|0.9|uM|900|nM
6O9X|1.70|2019|M0S|ligand is JA2-4|Q86W56|POLY(ADP-RIBOSE) GLYCOHYDROLASE|6.05|IC=0.9uM|IC50|=|0.9|uM|900|nM
6P11|2.15|2019|SKE|ligand is compound 1; IC50 = 0.9 +/- 0.1 uM|Q8I0P1|DROSOPHILA MELANOGASTER SPASTIN AAA DOMAIN|6.05|IC=0.9uM|IC50|=|0.9|uM|900|nM
6N17|1.64|2019|K8Y|compound 10|Q9NUW8|TYROSYL-DNA PHOSPHODIESTERASE 1|3.0|IC=1.01mM|IC50|=|1.01|mM|1010000|nM
6FV1|2.30|2019|E8E|compound 11n, IC50=1.08+/-0.09uM|P0C6X5|REPLICASE POLYPROTEIN 1AB|5.97|IC=1.08uM|IC50|=|1.08|uM|1080|nM
6OIN|1.70|2019|MQJ|[Nonstandard assay: Concentration of Ac-CoA is 0.4uM;] ligand is compound CTX-0124143|Q9H7Z6|HISTONE ACETYLTRANSFERASE KAT8|6.0|IC=1.0uM|IC50|=|1|uM|1000|nM
6P12|1.94|2019|NKY|ligand is compound 4|Q8I0P1|DROSOPHILA MELANOGASTER SPASTIN AAA DOMAIN|5.95|IC=1.11uM|IC50|=|1.11|uM|1110|nM
6RJP|2.57|2019|17-mer|ligand is peptide 138C7; dissociation-enhanced lanthanide fluorescence immunoassay|Q16548|BCL-2-RELATED PROTEIN A1|8.96|IC=1.1nM|IC50|=|1.1|nM|1.1|nM
6D4R|1.34|2019|FWY|IC50(compound 18)=1.1+/-0.1uM|G7CNL4|INOSINE-5'-MONOPHOSPHATE DEHYDROGENASE,INOSINE-5|5.96|IC=1.1uM|IC50|=|1.1|uM|1100|nM
6HTC|2.80|2019|GQK|ligand is ONX-0914|P23639|PROTEASOME SUBUNIT ALPHA TYPE-2|5.96|IC=1.1uM|IC50|=|1.1|uM|1100|nM
6M88|1.90|2019|MYC|ligand is 1|Q8NFU5|INOSITOL POLYPHOSPHATE MULTIKINASE,INOSITOL POLYPHOSPHATE|5.96|IC=1.1uM|IC50|=|1.1|uM|1100|nM
6N82|2.00|2019|YF7|ligand is (S)-6g|P14324|FARNESYL PYROPHOSPHATE SYNTHASE|5.96|IC=1.1uM|IC50|=|1.1|uM|1100|nM
6C67|2.11|2019|5ID|enzymic inhibition assay, compound 2|P9WID5|ADENOSINE KINASE|5.92|IC=1.2uM|IC50|=|1.2|uM|1200|nM
6QFH|1.65|2019|J08|ligand is GSK144; Protein is KLK6 TM (triple mutation)|Q92876|KALLIKREIN-6|5.86|IC=1.38uM|IC50|=|1.38|uM|1380|nM
6HX8|2.40|2019|GXN|ligand is 10 (STX3451)|P81947|TUBULIN ALPHA-1B CHAIN|5.89|IC=1.3uM|IC50|=|1.3|uM|1300|nM
6Q5B|2.22|2019|NXL|ligand is compound avibactam; IC50 = 1.3 +/- 0.3uM;|Q6XEC0|BETA-LACTAMASE|5.89|IC=1.3uM|IC50|=|1.3|uM|1300|nM
6JJM|2.05|2019|4-mer|[Incomplete ligand] ligand is GM2-GS|Q9WAF5|HN PROTEIN|2.85|IC=1.40mM|IC50|=|1.4|mM|1400000|nM
6I1R|2.80|2019|C5P|ligand is CMP|B4FZ94|CMP-SIALIC ACID TRANSPORTER 1|5.84|IC=1.45uM|IC50|=|1.45|uM|1450|nM
6NSS|1.97|2019|L0M|ligand is compound 6|P04629|HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR|8.85|IC=1.4nM|IC50|=|1.4|nM|1.4|nM
5ZEE|1.74|2019|HAR|IC50(L-NOHA)=1.57+/-0.06mM|C4LSS0|ARGINASE|2.8|IC=1.57mM|IC50|=|1.57|mM|1570000|nM
6RNE|1.65|2019|KA8|ligand is compound 8; pIC50 = 8.8|P53634|DIPEPTIDYL PEPTIDASE 1|8.8|IC=1.58nM|IC50|=|1.58|nM|1.58|nM
6MNY|2.80|2019|JVP|ligand is 9a|Q7TMU1|TYROSINE-PROTEIN KINASE|8.82|IC=1.5nM|IC50|=|1.5|nM|1.5|nM
6AHS|1.75|2019|9YO|compound 24|Q91VE3|KALLIKREIN-7|5.82|IC=1.5uM|IC50|=|1.5|uM|1500|nM
6OAH|2.20|2019|M2V|ligand is (R)-6f|P14324|FARNESYL PYROPHOSPHATE SYNTHASE|5.82|IC=1.5uM|IC50|=|1.5|uM|1500|nM
6SZJ|2.53|2019|M5W|ligand is compound 2a|O43353|RECEPTOR-INTERACTING SERINE/THREONINE-PROTEIN KINASE 2|5.82|IC=1.5uM|IC50|=|1.5|uM|1500|nM
6J5L|2.30|2019|B9C|ligand is 10e|P04629|HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR|8.8|IC=1.6nM|IC50|=|1.6|nM|1.6|nM
6JIB|2.25|2019|BQF|ligand is 41|P13995|BIFUNCTIONAL METHYLENETETRAHYDROFOLATE|5.8|IC=1.6uM|IC50|=|1.6|uM|1600|nM
5ZNL|2.80|2019|9G6||Q9Y233|CAMP AND CAMP-INHIBITED CGMP 3',5'-CYCLIC PHOSPHODIESTERASE|8.77|IC=1.7nM|IC50|=|1.7|nM|1.7|nM
6JSE|2.00|2019|C6R|ligand is 16|P56817|BETA-SECRETASE 1|8.77|IC=1.7nM|IC50|=|1.7|nM|1.7|nM
6QXA|3.41|2019|GQB|ligand is compound 1, ATC|Q9S5X0|K(+)-STIMULATED PYROPHOSPHATE-ENERGIZED SODIUM PUMP|5.77|IC=1.7uM|IC50|=|1.7|uM|1700|nM
6D4U|1.70|2019|FWP|IC50(compound 27)=1.98+/-0.1uM|G7CNL4|INOSINE-5'-MONOPHOSPHATE DEHYDROGENASE,INOSINE-5|5.7|IC=1.98uM|IC50|=|1.98|uM|1980|nM
5Z1R|1.62|2019|EFL|Alpha Screen|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|5.7|IC=1.99uM|IC50|=|1.99|uM|1990|nM
6DIH|1.78|2019|GJS|compound 3|Q9NUW8|TYROSYL-DNA PHOSPHODIESTERASE 1|2.72|IC=1.9mM|IC50|=|1.9|mM|1900000|nM
5ZQR|1.75|2019|9H9||Q9H2K2|TANKYRASE-2|7.97|IC=10.6nM|IC50|=|10.6|nM|10.6|nM
6ITJ|1.99|2019|AXU|[Covalent complex] ligand is 9|P11362|FIBROBLAST GROWTH FACTOR RECEPTOR 1|7.97|IC=10.8nM|IC50|=|10.8|nM|10.8|nM
6JWA|1.78|2019|5ID|ligand is 5-iodotubercidin|P68400|CASEIN KINASE II SUBUNIT ALPHA|4.96|IC=10.9uM|IC50|=|10.9|uM|10900|nM
6NJJ|2.30|2019|KR7|ligand is compound 28; IC50 = 1018+/-239nM|Q08499|CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D|5.99|IC=1018nM|IC50|=|1018|nM|1018|nM
6NJI|2.45|2019|KR4|ligand is compound 5|Q08499|CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D|6.99|IC=102nM|IC50|=|102|nM|102|nM
6OYH|2.95|2019|NK4|ligand is carbacaprazamycin|O66465|MRAYAA NANOBODY|6.98|IC=104nM|IC50|=|104|nM|104|nM
6HTD|3.00|2019|GQH|ligand is 4(LU-002c)|P23639|PROTEASOME SUBUNIT ALPHA TYPE-2|8.0|IC=10nM|IC50|=|10|nM|10|nM
6IB2|2.10|2019|862|[Covalent complex] ligand is 4a|O14733|DUAL SPECIFICITY MITOGEN-ACTIVATED PROTEIN KINASE KINASE 7|8.0|IC=10nM|IC50|=|10|nM|10|nM
6PYU|2.54|2019|P5V|ligand is compound 4-2|O00329|PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC|8.0|IC=10nM|IC50|=|10|nM|10|nM
6UDX|1.70|2019|Q57|ligand is compound 7|Q07820|INDUCED MYELOID LEUKEMIA CELL DIFFERENTIATION PROTEIN MCL|8.0|IC=10nM|IC50|=|10|nM|10|nM
6G8L|1.37|2019|11-mer|betaYAP5|P31947|14-3-3 PROTEIN SIGMA|5.0|IC=10uM|IC50|=|10|uM|10000|nM
6QH9|2.27|2019|J2N|[Different protein in assay: Protein KLK5/KLK1 was used in binding assay;But all structures were based on KLK6] Ligand is compound 13; Ligand is racemer|Q92876|KALLIKREIN-6|5.0|IC=10uM|IC50|=|10|uM|10000|nM
6NVH|1.90|2019|XL6|[Covalent complex] ligand is compound 1|P22455|FIBROBLAST GROWTH FACTOR RECEPTOR 4|7.95|IC=11.1nM|IC50|=|11.1|nM|11.1|nM
6NVL|2.70|2019|XL6|[Covalent complex] ligand is compound 1|P11362|FIBROBLAST GROWTH FACTOR RECEPTOR 1|7.95|IC=11.1nM|IC50|=|11.1|nM|11.1|nM
6MSN|1.59|2019|JYD|[Different ligand in assay: ligand in binding assay is racemic mixture] ligand is RS-2-thiomalate|E9AE57|FUMARATE HYDRATASE|4.95|IC=11.3uM|IC50|=|11.3|uM|11300|nM
6KZC|2.00|2019|DZC|ligand is 9c|Q16288|NT-3 GROWTH FACTOR RECEPTOR|7.94|IC=11.46nM|IC50|=|11.46|nM|11.46|nM
6IJL|2.35|2019|A8U|[Covalent complex] compound 29, IC50=11.7+/-10.9nM|Q9H7B4|HISTONE-LYSINE N-METHYLTRANSFERASE SMYD3|7.93|IC=11.7nM|IC50|=|11.7|nM|11.7|nM
6E6W|2.35|2019|HWJ|compound 22, IC50=110+/-10pM|C3W5S0|POLYMERASE ACIDIC PROTEIN|9.96|IC=110pM|IC50|=|110|pM|0.11|nM
6NPM|1.60|2019|KVD|ligand is compound VK-0044|P03211|EPSTEIN-BARR NUCLEAR ANTIGEN 1|3.96|IC=110uM|IC50|=|110|uM|110000|nM
6F1W|1.86|2019|CG5|kinase inhibition assay, IC50(31a)=11+/-1nM|P48730|CASEIN KINASE I ISOFORM DELTA|7.96|IC=11nM|IC50|=|11|nM|11|nM
6HTR|2.60|2019|GQT|ligand is 13|P23639|PROTEASOME SUBUNIT ALPHA TYPE-2|7.96|IC=11nM|IC50|=|11|nM|11|nM
6NEL|2.00|2019|KKV|ligand is compound 11; Binding assay is endonuclease assay|C6H0Y9|POLYMERASE ACIDIC PROTEIN|7.96|IC=11nM|IC50|=|11|nM|11|nM
6PF5|2.39|2019|OED|ligand is compound 23; IC50 = 11 +/- 1 uM|P04818|THYMIDYLATE SYNTHASE|4.96|IC=11uM|IC50|=|11|uM|11000|nM
6UHV|2.53|2019|XS6|ligand is compound 5; IC50 = 120 +/- 20 nM; acetylpolyamine hydrolysis assay|F1QCV2|POLYAMINE DEACETYLASE HDAC10|6.92|IC=120nM|IC50|=|120|nM|120|nM
6E4C|2.35|2019|HRJ|compound 24, IC50=120+/-10pM|C3W5S0|POLYMERASE ACIDIC PROTEIN|9.92|IC=120pM|IC50|=|120|pM|0.12|nM
6G3C|1.60|2019|EKT|compound 2|Q506Q0|TYROSINE-PROTEIN KINASE|6.91|IC=123nM|IC50|=|123|nM|123|nM
6Q6M|2.35|2019|HJW|ligand is compound 1|P51449|NUCLEAR RECEPTOR ROR-GAMMA|6.89|IC=128nM|IC50|=|128|nM|128|nM
6NEM|1.95|2019|KKS|ligand is compound 29; Binding assay is endonuclease assay|C6H0Y9|POLYMERASE ACIDIC PROTEIN|7.92|IC=12nM|IC50|=|12|nM|12|nM
6Q9U|2.40|2019|HRE|ligand is compound 12; Binding assay is TR-FRET|O15151|PROTEIN MDM4|5.89|IC=1300nM|IC50|=|1300|nM|1300|nM
6CKL|2.68|2019|DAN|IC50=130+/-10uM|P0A0Z8|N-ACYLNEURAMINATE CYTIDYLYLTRANSFERASE|3.89|IC=130uM|IC50|=|130|uM|130000|nM
6N5F|1.93|2019|KJ1|ligand is 3|------|EPOXIDE HYDROLASE TREH|6.86|IC=138.8nM|IC50|=|138.8|nM|138.8|nM
6HMP|2.04|2019|GEW|ligand is 3|P48730|CASEIN KINASE I ISOFORM DELTA|6.86|IC=138nM|IC50|=|138|nM|138|nM
6K0J|2.35|2019|CQO|[Nonstandard assay: in presence of 50uM ATP] ligand is LDN192960|Q92630|DUAL SPECIFICITY TYROSINE-PHOSPHORYLATION-REGULATED KINASE|7.89|IC=13nM|IC50|=|13|nM|13|nM
6I0K|1.64|2019|GZ8|[Different protein in assay: EcNadA] ligand is 4MP|Q9X1X7|QUINOLINATE SYNTHASE A|4.89|IC=13uM|IC50|=|13|uM|13000|nM
6I0C|2.68|2019|GZ5|R-K1035|P06276|CHOLINESTERASE|6.85|IC=140nM|IC50|=|140|nM|140|nM
5OVF|2.01|2019|AWT|KRASG12C CSOS1cat interaction assay , compound 17|Q07889|SON OF SEVENLESS HOMOLOG 1|6.85|IC=140nM|IC50|=|140|nM|140|nM
6M95|1.80|2019|J8S|ligand is 1|Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|6.85|IC=140nM|IC50|=|140|nM|140|nM
6MO8|1.80|2019|JWD|ligand is 12|P25440|BROMODOMAIN-CONTAINING PROTEIN 2|5.84|IC=1430nM|IC50|=|1430|nM|1430|nM
6Q9Q|2.10|2019|HUE|ligand is compound 13; Binding assay is TR-FRET|O15151|PROTEIN MDM4|6.84|IC=145nM|IC50|=|145|nM|145|nM
6HMR|1.78|2019|GE5|ligand is 2|P48730|CASEIN KINASE I ISOFORM DELTA|6.83|IC=147nM|IC50|=|147|nM|147|nM
6QG7|2.10|2019|6HL|ligand is compound 1k; IC50 = 149 +/- 30nM|O14733|DUAL SPECIFICITY MITOGEN-ACTIVATED PROTEIN KINASE KINASE 7|6.83|IC=149nM|IC50|=|149|nM|149|nM
6F7I|2.43|2019|CW5|compound MLT-747|Q9UDY8|MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION|7.85|IC=14nM|IC50|=|14|nM|14|nM
6Q39|2.21|2019|HDQ|ligand is compound 49|P78540|ARGINASE-2, MITOCHONDRIAL|7.85|IC=14nM|IC50|=|14|nM|14|nM
6QAD|2.50|2019|HUZ|ligand is compound 13; IC50 = 14+/-1 nM|P06276|CHOLINESTERASE|7.85|IC=14nM|IC50|=|14|nM|14|nM
6M8E|2.00|2019|J8G|ligand is 11|Q8NFU5|INOSITOL POLYPHOSPHATE MULTIKINASE,INOSITOL POLYPHOSPHATE|4.85|IC=14uM|IC50|=|14|uM|14000|nM
6QRI|2.40|2019|CV9|ligand is chivoA|P68135|ACTIN, ALPHA SKELETAL MUSCLE|4.82|IC=15.21uM|IC50|=|15.21|uM|15210|nM
6I8Z|1.99|2019|H82|ligand is BI-4464|Q05397|FOCAL ADHESION KINASE 1|7.8|IC=15.8nM|IC50|=|15.8|nM|15.8|nM
6PYA|1.71|2019|P57|ligand is compound IPI; IC50 = 150 +/- 16 nM|P04278|SEX HORMONE-BINDING GLOBULIN|6.82|IC=150nM|IC50|=|150|nM|150|nM
6MO9|1.80|2019|JVY|ligand is 16|P25440|BROMODOMAIN-CONTAINING PROTEIN 2|5.81|IC=1542nM|IC50|=|1542|nM|1542|nM
6IRT|3.50|2019|AUU|ligand is BCH|J3KPF3|4F2 CELL-SURFACE ANTIGEN HEAVY CHAIN|3.81|IC=155.10uM|IC50|=|155.1|uM|155100|nM
6SKD|2.26|2019|LH2|ligand is compound 12; pIC50=5.8; contain uncommon B element|Q92876|KALLIKREIN-6|5.8|IC=1585nM|IC50|=|1585|nM|1585|nM
6RN6|2.40|2019|K9Q|ligand is compound 3; pIC50 = 6.8|P53634|DIPEPTIDYL PEPTIDASE 1|6.8|IC=158nM|IC50|=|158|nM|158|nM
6HCU|1.62|2019|FYB|compound 5, kinase-glo assay|Q8IDJ8|LYSINE--TRNA LIGASE|7.82|IC=15nM|IC50|=|15|nM|15|nM
6IBY|2.51|2019|HAT|[Different ligand in assay: ligand in binding asssay is racemic mixture] ligand is 7|Q16875|6-PHOSPHOFRUCTO-2-KINASE/FRUCTOSE-2,6-BISPHOSPHATASE 3|7.82|IC=15nM|IC50|=|15|nM|15|nM
6IC6|1.90|2019|H9B||P53634|DIPEPTIDYL PEPTIDASE 1|7.82|IC=15nM|IC50|=|15|nM|15|nM
6IUO|2.30|2019|AWX|[Covalent complex] ligand is 11|P22455|FIBROBLAST GROWTH FACTOR RECEPTOR 4|7.79|IC=16.3nM|IC50|=|16.3|nM|16.3|nM
6C9N|2.10|2019|SGV|enzymic inhibition assay, compound 3|A5U4N0|ADENOSINE KINASE|4.78|IC=16.5uM|IC50|=|16.5|uM|16500|nM
6HTP|3.00|2019|GQQ|ligand is 7|P23639|PROTEASOME SUBUNIT ALPHA TYPE-2|6.8|IC=160nM|IC50|=|160|nM|160|nM
6PI1|1.70|2019|B3N|ligand is compound 7; IC50 = 160 +/- 90 uM|------|ACETYLPOLYAMINE AMIDOHYDROLASE|3.8|IC=160uM|IC50|=|160|uM|160000|nM
6EGA|2.51|2019|J8A|kinase binding assay, IC50(HG-12-6, unphosphorylated IRAK4)=165.1+/-2.52nM|Q9NWZ3|INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE 4|6.78|IC=165.1nM|IC50|=|165.1|nM|165.1|nM
6OHU|3.53|2019|CTX|ligand is compound tamoxifen; IC50 = 165 +/- 13 nM|Q15125|3-BETA-HYDROXYSTEROID-DELTA(8),DELTA(7)-ISOMERASE|6.78|IC=165nM|IC50|=|165|nM|165|nM
6S9D|2.67|2019|L3Z|[Different protein in assay: Protein in binding assay is EGFR L858R T790M C797S] ligand is compound 6|P00533|EPIDERMAL GROWTH FACTOR RECEPTOR|7.8|IC=16nM|IC50|=|16|nM|16|nM
6PF4|2.85|2019|OF7|ligand is compound 5; IC50 = 16 +/- 1 uM|P04818|THYMIDYLATE SYNTHASE|4.8|IC=16uM|IC50|=|16|uM|16000|nM
6G8J|1.47|2019|11-mer|betaYAP3|P31947|14-3-3 PROTEIN SIGMA|4.76|IC=17.2uM|IC50|=|17.2|uM|17200|nM
6E3Z|1.94|2019|HRV||P56817|BETA-SECRETASE 1|7.76|IC=17.4nM|IC50|=|17.4|nM|17.4|nM
5ZEF|2.01|2019|NVA|IC50(L-Norvaline)=17.9+/-0.2mM|C4LSS0|ARGINASE|1.75|IC=17.9mM|IC50|=|17.9|mM|17900000|nM
6QMD|1.94|2019|J6N|ligand is compound (R)-7|Q9Z2X8|KELCH-LIKE ECH-ASSOCIATED PROTEIN 1|3.77|IC=170uM|IC50|=|170|uM|170000|nM
6E6V|2.25|2019|HWA|compound 1, IC50=17+/-3nM|C3W5S0|POLYMERASE ACIDIC PROTEIN|7.77|IC=17nM|IC50|=|17|nM|17|nM
6Q9S|2.40|2019|HRN|ligand is compound 14; Binding assay is TR-FRET|O15151|PROTEIN MDM4|7.77|IC=17nM|IC50|=|17|nM|17|nM
6S7S|1.70|2019|KZ8|ligand is compound 16h; IC50 = 17 +/- 3 uM|------|FUMARATE HYDRATASE CLASS II|4.77|IC=17uM|IC50|=|17|uM|17000|nM
5ZQP|1.99|2019|9H3||Q9H2K2|TANKYRASE-2|7.74|IC=18.3nM|IC50|=|18.3|nM|18.3|nM
5Y7H|3.00|2019|8O3||P27487|DIPEPTIDYL PEPTIDASE 4|7.73|IC=18.7nM|IC50|=|18.7|nM|18.7|nM
6UIM|2.75|2019|Q7Y|ligand is compound 8; IC50 =180 +/- 20 nM; acetylpolyamine hydrolysis assay|F1QCV2|POLYAMINE DEACETYLASE HDAC10|6.74|IC=180nM|IC50|=|180|nM|180|nM
6OYZ|3.62|2019|NKM|ligand is capuramycin|O66465|MRAYAA NANOBODY|6.73|IC=185nM|IC50|=|185|nM|185|nM
6NRF|2.00|2019|KYV|[Incomplete ligand] ligand is compound 103, UTT103; ligand structure double bond in different form|P09874|POLY [ADP-RIBOSE] POLYMERASE 1|7.74|IC=18nM|IC50|=|18|nM|18|nM
6NWC|2.35|2019|L6P|ligand is compound 3CB|Q8H1R0|ABSCISIC ACID RECEPTOR PYL10|7.74|IC=18nM|IC50|=|18|nM|18|nM
6Q8P|3.00|2019|HQB|Ligand is compound 9m|P49759|DUAL SPECIFICITY PROTEIN KINASE CLK1|7.74|IC=18nM|IC50|=|18|nM|18|nM
6PF6|2.50|2019|OEJ|ligand is compound 15; IC50 = 18 +/- 2 uM|P04818|THYMIDYLATE SYNTHASE,THYMIDYLATE SYNTHASE|4.74|IC=18uM|IC50|=|18|uM|18000|nM
6PK7|3.10|2019|CTP|assay at CTPS2 concentration = 300 nM|Q9NRF8|CTP SYNTHASE 2|4.72|IC=19.2uM|IC50|=|19.2|uM|19200|nM
5ZQO|2.06|2019|9GX||Q9H2K2|TANKYRASE-2|7.71|IC=19.4nM|IC50|=|19.4|nM|19.4|nM
6SKB|1.84|2019|LH5|[Uncommon element] [Different ligand in assay: ligand in binding assay is enantiomer] ligand is compound 17; pIC50=7.7; contain uncommon B element|Q92876|KALLIKREIN-6|7.7|IC=19.9nM|IC50|=|19.9|nM|19.9|nM
6C9R|2.10|2019|ERJ|enzymic inhibition assay, compound 6, IC50=196.5+/-20.3nM|A5U4N0|ADENOSINE KINASE|6.71|IC=196.5nM|IC50|=|196.5|nM|196.5|nM
6F96|2.50|2019|D0K|compound 2|P0AES7|DNA GYRASE SUBUNIT B|7.72|IC=19nM|IC50|=|19|nM|19|nM
6QHR|2.52|2019|J3N|ligand is compound 1m; IC50 = 19 +/- 9 nM|O14733|DUAL SPECIFICITY MITOGEN-ACTIVATED PROTEIN KINASE KINASE 7|7.72|IC=19nM|IC50|=|19|nM|19|nM
6G8Q|1.85|2019|11-mer|betaYAP3.2|P31947|14-3-3 PROTEIN SIGMA|4.72|IC=19uM|IC50|=|19|uM|19000|nM
6O1G|2.20|2019|7SD|compound 1|P03952|PLASMA KALLIKREIN|9.0|IC=1nM|IC50|=|1|nM|1|nM
6OW7|1.45|2019|N9Y|ligand is compound 9|Q939R9|PEPTIDE DEFORMYLASE|9.0|IC=1nM|IC50|=|1|nM|1|nM
6PYR|2.21|2019|P5J|ligand is compound 2-10|O00329|PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC|9.0|IC=1nM|IC50|=|1|nM|1|nM
6HRW|2.45|2019|GNK|ligand is 1|O53623|PROBABLE TRANSCRIPTIONAL REGULATORY PROTEIN|6.0|IC=1uM|IC50|=|1|uM|1000|nM
6QFF|1.64|2019|J08|ligand is GSK144; Protein is KLK6 WT|Q92876|KALLIKREIN-6|5.69|IC=2.04uM|IC50|=|2.04|uM|2040|nM
6H4Q|2.31|2019|FO2|ligand is 34a|O75164|LYSINE-SPECIFIC DEMETHYLASE 4A|5.69|IC=2.06uM|IC50|=|2.06|uM|2060|nM
6EDL|2.80|2019|J4M|compound 1, HTRF assay|Q9UM73|ALK TYROSINE KINASE RECEPTOR|8.7|IC=2.0nM|IC50|=|2|nM|2|nM
6JUT|2.10|2019|C9O|ligand is 6k|Q9NYL2|MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE MLT|8.68|IC=2.1nM|IC50|=|2.1|nM|2.1|nM
6DHA|1.88|2019|GFV|[Nonstandard assay: FITC-TRAP220 peptide] EC50=2.1+/-0.05uM, using FITC-TRAP220 peptide|P37231|PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA|5.68|IC=2.1uM|IC50|=|2.1|uM|2100|nM
6E5B|2.77|2019|HUJ|[Covalent complex] [Uncommon element] IC50(compd 5, B5i)=2.2+/-2.4nM|P25787|PROTEASOME SUBUNIT ALPHA TYPE-2|8.66|IC=2.2nM|IC50|=|2.2|nM|2.2|nM
6M8C|1.80|2019|IRH|ligand is 6|Q8NFU5|INOSITOL POLYPHOSPHATE MULTIKINASE,INOSITOL POLYPHOSPHATE|5.66|IC=2.2uM|IC50|=|2.2|uM|2200|nM
6S7Z|1.85|2019|KZN|ligand is compound 16j; IC50 = 2.2 +/- 0.2 uM|------|FUMARATE HYDRATASE CLASS II|5.66|IC=2.2uM|IC50|=|2.2|uM|2200|nM
6E3M|2.65|2019|HOG|compound 18, IC50=2.3+/-0.4nM|C3W5S0|POLYMERASE ACIDIC PROTEIN|8.64|IC=2.3nM|IC50|=|2.3|nM|2.3|nM
6GCW|2.00|2019|EUQ|ADP Glo kinase assay, IC50(7)=2.3+/-0.3nM|Q00944|FOCAL ADHESION KINASE 1|8.64|IC=2.3nM|IC50|=|2.3|nM|2.3|nM
6C9P|2.00|2019|MTP|enzymic inhibition assay, compound 4|A5U4N0|ADENOSINE KINASE|5.64|IC=2.3uM|IC50|=|2.3|uM|2300|nM
6M89|1.85|2019|QUE|ligand is 2|Q8NFU5|INOSITOL POLYPHOSPHATE MULTIKINASE,INOSITOL POLYPHOSPHATE|5.64|IC=2.3uM|IC50|=|2.3|uM|2300|nM
6UFN|2.70|2019|Q6M|ligand is compound 2; IC50 = 2.3 +/- 0.2 uM; acetylpolyamine hydrolysis assay|F1QCV2|POLYAMINE DEACETYLASE HDAC10|5.64|IC=2.3uM|IC50|=|2.3|uM|2300|nM
6N3O|2.40|2019|KA7|ligand is 6e|Q9P2K8|EIF-2-ALPHA KINASE GCN2|8.62|IC=2.4nM|IC50|=|2.4|nM|2.4|nM
6R7D|2.35|2019|JUQ|ligand is 1S,2S-12, AZ13690257|Q16873|LEUKOTRIENE C4 SYNTHASE|8.62|IC=2.4nM|IC50|=|2.4|nM|2.4|nM
6EBW|2.46|2019|J3Y|compound 9, HTRF assay|Q9UM73|ALK TYROSINE KINASE RECEPTOR|8.6|IC=2.5nM|IC50|=|2.5|nM|2.5|nM
6QCJ|2.01|2019|XEG|ligand is compound catechin gallate; IC50 = 2.5 +/- 0.1 uM|Q8N6T7|NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-6|5.6|IC=2.5uM|IC50|=|2.5|uM|2500|nM
6JMF|2.00|2019|9FC|ligand is 4|P07332|TYROSINE-PROTEIN KINASE FES/FPS|8.59|IC=2.6nM|IC50|=|2.6|nM|2.6|nM
6NVI|2.12|2019|XL7|[Covalent complex] ligand is compound 3|P22455|FIBROBLAST GROWTH FACTOR RECEPTOR 4|8.59|IC=2.6nM|IC50|=|2.6|nM|2.6|nM
6HYS|2.60|2019|ADP||Q14562|ATP-DEPENDENT RNA HELICASE DHX8|5.59|IC=2.6uM|IC50|=|2.6|uM|2600|nM
6Q7V|2.56|2019|HLK|ligand is compound 11; IC50 = 2.6 +/- 0.8 uM|Q9I4X0|TRANSCRIPTIONAL REGULATOR MVFR|5.59|IC=2.6uM|IC50|=|2.6|uM|2600|nM
6P8X|2.11|2019|O5V|[Covalent complex] ligand is compound 5; covalently bound|P01116|GTPASE KRAS|5.56|IC=2.78uM|IC50|=|2.78|uM|2780|nM
6PEB|2.46|2019|OE4|ligand is compound 3, NVP-LTM976|P43490|NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE|8.57|IC=2.7nM|IC50|=|2.7|nM|2.7|nM
6HGV|2.00|2019|G3Q|ligand is talinolol|P34913|BIFUNCTIONAL EPOXIDE HYDROLASE 2|5.55|IC=2.8uM|IC50|=|2.8|uM|2800|nM
6HVW|3.00|2019|GVW|ligand is 43|P23639|PROTEASOME SUBUNIT ALPHA TYPE-2|5.55|IC=2.8uM|IC50|=|2.8|uM|2800|nM
6N7Z|2.55|2019|KF7|ligand is (S)-6d|P14324|FARNESYL PYROPHOSPHATE SYNTHASE|5.55|IC=2.8uM|IC50|=|2.8|uM|2800|nM
6KZD|1.71|2019|DZ6|ligand is 9o|Q16288|NT-3 GROWTH FACTOR RECEPTOR|8.53|IC=2.95nM|IC50|=|2.95|nM|2.95|nM
6KDZ|3.10|2019|D79|ligand is 2; binding assay method is HTRF|Q9Y233|CAMP AND CAMP-INHIBITED CGMP 3',5'-CYCLIC PHOSPHODIESTERASE|8.54|IC=2.9nM|IC50|=|2.9|nM|2.9|nM
6RZ6|2.43|2019|KNW|ligand is compound 11a, ONO-2570366; HTRF assay|Q9NS75|CYSTEINYL LEUKOTRIENE RECEPTOR 2,SOLUBLE CYTOCHROME B562|8.54|IC=2.9nM|IC50|=|2.9|nM|2.9|nM
6PGO|1.60|2019|OJ1|[Covalent complex] ligand is compound 2; covalently bound|P01116|GTPASE KRAS|4.7|IC=20.1uM|IC50|=|20.1|uM|20100|nM
6IM6|1.70|2019|AH3|ligand is 5|Q08499|CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D|4.68|IC=20.7uM|IC50|=|20.7|uM|20700|nM
6NJH|2.15|2019|KRD|ligand is compound 6|Q08499|CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D|3.69|IC=203uM|IC50|=|203|uM|203000|nM
6JSZ|1.53|2019|C7O|ligand is 22|Q9Y5Z0|BETA-SECRETASE 2|5.68|IC=2090nM|IC50|=|2090|nM|2090|nM
6E0R|2.30|2019|HKJ|compound 7, HTRF assay|Q9UM73|ALK TYROSINE KINASE RECEPTOR|7.7|IC=20nM|IC50|=|20|nM|20|nM
6R5F|3.25|2019|JSW|ligand is compound 77|Q13546|RECEPTOR-INTERACTING SERINE/THREONINE-PROTEIN KINASE 1|7.7|IC=20nM|IC50|=|20|nM|20|nM
6M7H|1.60|2019|KN9|ligand is KN95|P0DP23|CALMODULIN-1|4.7|IC=20uM|IC50|=|20|uM|20000|nM
6ETG|1.28|2019|BWT|compound 6, FDH assay|Q6B0I6|LYSINE-SPECIFIC DEMETHYLASE 4D|4.66|IC=21.8uM|IC50|=|21.8|uM|21800|nM
5ZQQ|2.29|2019|9H6||Q9H2K2|TANKYRASE-2|7.66|IC=21.9nM|IC50|=|21.9|nM|21.9|nM
6S9B|3.25|2019|L1H|[Different protein in assay: Protein in binding assay is EGFR L858R T790M C797S] ligand is compound 1|P00533|EPIDERMAL GROWTH FACTOR RECEPTOR|5.68|IC=2100nM|IC50|=|2100|nM|2100|nM
6PRT|1.30|2019|OWA|ligand is compound R-10; IC50 = 2120 +/- 270 uM|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|2.67|IC=2120uM|IC50|=|2120|uM|2120000|nM
6HVV|2.70|2019|GT8|ligand is 39|P23639|PROTEASOME SUBUNIT ALPHA TYPE-2|6.67|IC=215nM|IC50|=|215|nM|215|nM
5ZCU|2.41|2019|PYV|IC50 for pyrabactin with RCAR3:PP2C complex, Phosphatase activity assay|Q6L5H6|PROBABLE PROTEIN PHOSPHATASE 2C 50|5.67|IC=2160nM|IC50|=|2160|nM|2160|nM
5OVI|2.20|2019|AXH|KRASG12C CSOS1cat interaction assay , compound 23|Q07889|SON OF SEVENLESS HOMOLOG 1|7.68|IC=21nM|IC50|=|21|nM|21|nM
5QJ2|2.82|2019|JXS|compound 20, The Amplex Red (AR) assay to measure the inhibition of MPO peroxidase activity|P05164|MYELOPEROXIDASE|7.68|IC=21nM|IC50|=|21|nM|21|nM
6MSC|2.36|2019|JY7|ligand is 23|Q9Y233|CAMP AND CAMP-INHIBITED CGMP 3',5'-CYCLIC PHOSPHODIESTERASE|7.68|IC=21nM|IC50|=|21|nM|21|nM
6Q7H|2.30|2019|HL8|ligand is compound 9|P51449|NUCLEAR RECEPTOR ROR-GAMMA|7.68|IC=21nM|IC50|=|21|nM|21|nM
6GJD|1.58|2019|F0E|ligand is SCH-TCO|P28482|MITOGEN-ACTIVATED PROTEIN KINASE 1|7.66|IC=22nM|IC50|=|22|nM|22|nM
6IC0|2.60|2019|HAK|[Different ligand in assay: ] ligand is 21; the code in literature and PDB are inconsistent(6ico & 6ic0)|Q16875|6-PHOSPHOFRUCTO-2-KINASE/FRUCTOSE-2,6-BISPHOSPHATASE 3|7.66|IC=22nM|IC50|=|22|nM|22|nM
6IBZ|2.44|2019|HAW|[Different ligand in assay: ligand in binding asssay is racemic mixture] ligand is 15|Q16875|6-PHOSPHOFRUCTO-2-KINASE/FRUCTOSE-2,6-BISPHOSPHATASE 3|7.66|IC=22nM|IC50|=|22|nM|22|nM
6QAA|1.90|2019|HUN|ligand is compound 6; IC50 = 22 +/- 6 nM|P06276|CHOLINESTERASE|7.66|IC=22nM|IC50|=|22|nM|22|nM
6IUP|2.00|2019|AX0|[Covalent complex] ligand is 10|P22455|FIBROBLAST GROWTH FACTOR RECEPTOR 4|7.64|IC=23.1nM|IC50|=|23.1|nM|23.1|nM
6NYW|2.19|2019|L8M|ligand is compound 4|Q8I0P1|SPASTIN|6.64|IC=230nM|IC50|=|230|nM|230|nM
6QW9|1.04|2019|MK7|ligand is relebactam|Q9F663|CARBAPENEM-HYDROLYZING BETA-LACTAMASE KPC|6.64|IC=230nM|IC50|=|230|nM|230|nM
5QJ3|2.76|2019|JXP|compound 24, The Amplex Red (AR) assay to measure the inhibition of MPO peroxidase activity|P05164|MYELOPEROXIDASE|7.62|IC=24nM|IC50|=|24|nM|24|nM
6F26|1.83|2019|C9Z|kinase inhibition assay, IC50(31b)=24+/-4nM|P48730|CASEIN KINASE I ISOFORM DELTA|7.62|IC=24nM|IC50|=|24|nM|24|nM
6PS9|1.21|2019|Y17|ligand is compound 17; IC50 = 24 +/- 2 uM|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|4.62|IC=24uM|IC50|=|24|uM|24000|nM
6IAR|1.84|2019|H8W|ligand is 4|P03372|ESTROGEN RECEPTOR|7.6|IC=25.1nM|IC50|=|25.1|nM|25.1|nM
6OA1|1.80|2019|M0P|ligand is JA2120|Q86W56|POLY(ADP-RIBOSE) GLYCOHYDROLASE|4.59|IC=25.7uM|IC50|=|25.7|uM|25700|nM
6N3Z|2.24|2019|KC4|ligand is 4|------|EPOXIDE HYDROLASE TREH|6.59|IC=259.3nM|IC50|=|259.3|nM|259.3|nM
6IMI|1.46|2019|AH6|ligand is 6|Q08499|CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D|4.58|IC=26.1uM|IC50|=|26.1|uM|26100|nM
6HVU|2.90|2019|GTW|ligand is 29|P23639|PROTEASOME SUBUNIT ALPHA TYPE-2|6.59|IC=260nM|IC50|=|260|nM|260|nM
6QWA|1.06|2019|MK7|ligand is relebactam|Q93DC4|BETA-LACTAMASE|6.59|IC=260nM|IC50|=|260|nM|260|nM
6S9C|2.73|2019|L1K|ligand is compound 5|P00533|EPIDERMAL GROWTH FACTOR RECEPTOR|6.57|IC=267nM|IC50|=|267|nM|267|nM
6HUC|3.00|2019|GRT|ligand is 18|P23639|PROTEASOME SUBUNIT ALPHA TYPE-2|7.59|IC=26nM|IC50|=|26|nM|26|nM
6ND3|2.36|2019|BTL|[Covalent complex] ligand is betaine aldehyde; covalent interaction;|Q30W70|CHOLINE TRIMETHYLAMINE-LYASE|4.59|IC=26uM|IC50|=|26|uM|26000|nM
6HV0|2.73|2019|GUK|[Multiple sites: IC50 = 736 nM] ligand is 33|O75460|SERINE/THREONINE-PROTEIN KINASE/ENDORIBONUCLEASE IRE1|6.56|IC=276nM|IC50|=|276|nM|276|nM
6N3L|2.61|2019|KAV|ligand is 5|Q9P2K8|EIF-2-ALPHA KINASE GCN2,EIF-2-ALPHA KINASE GCN2|7.57|IC=27nM|IC50|=|27|nM|27|nM
6NRI|2.20|2019|KYM|[Incomplete ligand] ligand is compound 83, UTT83; IC50 = 7.57+/-0.05|P09874|POLY [ADP-RIBOSE] POLYMERASE 1|7.57|IC=27nM|IC50|=|27|nM|27|nM
6UDY|1.70|2019|Q54|ligand is compound 5|Q07820|INDUCED MYELOID LEUKEMIA CELL DIFFERENTIATION PROTEIN MCL|7.57|IC=27nM|IC50|=|27|nM|27|nM
5OVH|2.30|2019|AWW|KRASG12C CSOS1cat interaction assay , compound 21|Q07889|SON OF SEVENLESS HOMOLOG 1|6.55|IC=280nM|IC50|=|280|nM|280|nM
6KNH|1.76|2019|CIT|ligand is citrate|------|PROBABLE DIAMINOPIMELATE DECARBOXYLASE PROTEIN|3.55|IC=280uM|IC50|=|280|uM|280000|nM
5Z5V|1.66|2019|96X|alpha screen assay|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|6.54|IC=287nM|IC50|=|287|nM|287|nM
6KE0|2.95|2019|D7C|ligand is 5l; binding assay method is HTRF|Q9Y233|CAMP AND CAMP-INHIBITED CGMP 3',5'-CYCLIC PHOSPHODIESTERASE|7.55|IC=28nM|IC50|=|28|nM|28|nM
6PF3|2.39|2019|OE7|ligand is compound 14; IC50 = 28 +/- 6 uM|P04818|THYMIDYLATE SYNTHASE|4.55|IC=28uM|IC50|=|28|uM|28000|nM
6HWU|2.30|2019|GE5|ligand is 2|Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|7.54|IC=29.1nM|IC50|=|29.1|nM|29.1|nM
6Q8K|2.29|2019|FG9|Ligand is compound 10i|P49759|DUAL SPECIFICITY PROTEIN KINASE CLK1|6.54|IC=290nM|IC50|=|290|nM|290|nM
6KDX|2.44|2019|D6X|ligand is 4a; binding assay method is HTRF|Q9Y233|CAMP AND CAMP-INHIBITED CGMP 3',5'-CYCLIC PHOSPHODIESTERASE|6.53|IC=294nM|IC50|=|294|nM|294|nM
6M9L|2.45|2019|J9G|ligand is 10|Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|7.54|IC=29nM|IC50|=|29|nM|29|nM
6MHM|2.74|2019|JRY|[Covalent complex] [Incomplete ligand] ligand is carmofur|Q13510|ACID CERAMIDASE SUBUNIT ALPHA|7.54|IC=29nM|IC50|=|29|nM|29|nM
6N3K|2.20|2019|K9V|ligand is 1|------|EPOXIDE HYDROLASE|7.54|IC=29nM|IC50|=|29|nM|29|nM
6Q6O|2.30|2019|HKE|ligand is compound 2|P51449|NUCLEAR RECEPTOR ROR-GAMMA|7.54|IC=29nM|IC50|=|29|nM|29|nM
6IBX|2.11|2019|H9Z|[Different ligand in assay: ligand in binding asssay is racemic mixture] ligand is 29|Q16875|6-PHOSPHOFRUCTO-2-KINASE/FRUCTOSE-2,6-BISPHOSPHATASE 3|8.7|IC=2nM|IC50|=|2|nM|2|nM
6P1L|2.80|2019|9LL|ligand is EAI045; crystal use EGFR(T790M/ V948R); assay use EGFR L858R/T790M|P00533|EPIDERMAL GROWTH FACTOR RECEPTOR|8.7|IC=2nM|IC50|=|2|nM|2|nM
6NPI|1.50|2019|60Q|ligand is compound VK-0064|P03211|EPSTEIN-BARR NUCLEAR ANTIGEN 1|5.7|IC=2uM|IC50|=|2|uM|2000|nM
6QFG|1.68|2019|J08|ligand is GSK144; Protein is KLK6 SM (single mutation)|Q92876|KALLIKREIN-6|5.52|IC=3.01uM|IC50|=|3.01|uM|3010|nM
6QAE|2.49|2019|HUK|ligand is compound 12; IC50 = 3.0 +/- 0.2 nM|P06276|CHOLINESTERASE|8.52|IC=3.0nM|IC50|=|3|nM|3|nM
6RPG|2.70|2019|KDW|Ligand is compound 2b; IC50 = 3.0 +/-0.1nM; Binding assay is HTRF|Q9NZQ7|PROGRAMMED CELL DEATH 1 LIGAND 1|8.52|IC=3.0nM|IC50|=|3|nM|3|nM
5ZMA|3.18|2019|9FX|Phosphatase assay, IC50(9987)=3.0+/-0.3uM|O00167|EYES ABSENT HOMOLOG 2|5.52|IC=3.0uM|IC50|=|3|uM|3000|nM
6HS0|1.45|2019|GNW|ligand is 5|O53623|PROBABLE TRANSCRIPTIONAL REGULATORY PROTEIN|5.5|IC=3.16uM|IC50|=|3.16|uM|3160|nM
6IZQ|2.45|2019|XJ2|[Different ligand in assay: Ligand in binding assay is racemic mixture] ligand is 10|Q86X55|HISTONE-ARGININE METHYLTRANSFERASE CARM1|5.5|IC=3.19uM|IC50|=|3.19|uM|3190|nM
6DJI|1.75|2019|GOG|compound 4|Q9NUW8|TYROSYL-DNA PHOSPHODIESTERASE 1|2.51|IC=3.1mM|IC50|=|3.1|mM|3100000|nM
6HS4|2.05|2019|GON|ligand is 118|Q05320|ENVELOPE GLYCOPROTEIN,GP1,ENVELOPE GLYCOPROTEIN|5.51|IC=3.1uM|IC50|=|3.1|uM|3100|nM
6JSF|2.30|2019|C7X|ligand is 17|P56817|BETA-SECRETASE 1|8.48|IC=3.3nM|IC50|=|3.3|nM|3.3|nM
6Q9O|1.21|2019|HU8|ligand is compound 10; Binding assay is TR-FRET|Q00987|E3 UBIQUITIN-PROTEIN LIGASE MDM2|8.47|IC=3.4nM|IC50|=|3.4|nM|3.4|nM
6AK4|2.80|2019|PD9|enzymic inhibition assay, IC50(entacapone)=3.5+/-0.8uM|Q9C0B1|ALPHA-KETOGLUTARATE-DEPENDENT DIOXYGENASE FTO,ALPHA|5.46|IC=3.5uM|IC50|=|3.5|uM|3500|nM
6OAG|2.30|2019|M2Y|ligand is (S)-6f|P14324|FARNESYL PYROPHOSPHATE SYNTHASE|5.43|IC=3.7uM|IC50|=|3.7|uM|3700|nM
6JSN|2.60|2019|C7O|ligand is 22|P56817|BETA-SECRETASE 1|8.42|IC=3.8nM|IC50|=|3.8|nM|3.8|nM
6MSO|2.05|2019|JYD|ligand is RS-2-thiomalate|Q4QAU9|FUMARATE HYDRATASE|5.42|IC=3.8uM|IC50|=|3.8|uM|3800|nM
6MUM|3.06|2019|K47|ligand is 2q, binding assay method is HTRF|Q3UDT3|PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC|8.41|IC=3.9nM|IC50|=|3.9|nM|3.9|nM
6MZW|2.20|2019|TZ0|[Covalent complex] ligand i s TAS-120|P11362|FIBROBLAST GROWTH FACTOR RECEPTOR 1|8.41|IC=3.9nM|IC50|=|3.9|nM|3.9|nM
6MZQ|2.00|2019|TZ0|ligand i s TAS-120|P11362|FIBROBLAST GROWTH FACTOR RECEPTOR 1|8.41|IC=3.9nM|IC50|=|3.9|nM|3.9|nM
6Q9L|1.13|2019|HTZ|ligand is compound 9; Binding assay is TR-FRET|Q00987|E3 UBIQUITIN-PROTEIN LIGASE MDM2|8.41|IC=3.9nM|IC50|=|3.9|nM|3.9|nM
6NKP|2.03|2019|13-mer|Ligand is bA-WLA-YSKbio peptide|P29317|EPHRIN TYPE-A RECEPTOR 2|6.52|IC=300nM|IC50|=|300|nM|300|nM
6HV5|3.00|2019|GQH|ligand is 4 (LU-002c)|P23639|PROTEASOME SUBUNIT ALPHA TYPE-2|6.49|IC=325nM|IC50|=|325|nM|325|nM
6HVR|2.70|2019|GRW|ligand is 16|P23639|PROTEASOME SUBUNIT ALPHA TYPE-2|6.48|IC=330nM|IC50|=|330|nM|330|nM
6R8P|1.45|2019|JVB|ligand is compound 3|Q6P988|PALMITOLEOYL-PROTEIN CARBOXYLESTERASE NOTUM|4.48|IC=33uM|IC50|=|33|uM|33000|nM
6GCL|1.95|2019|EUE|ligand is inhibitor 3a (F020)|O76290|PTERIDINE REDUCTASE|4.47|IC=34.2uM|IC50|=|34.2|uM|34200|nM
6UFO|2.68|2019|Q6P|ligand is compound 3; IC50 = 35.0 +/- 0.1 uM; acetylpolyamine hydrolysis assay|F1QCV2|POLYAMINE DEACETYLASE HDAC10|4.46|IC=35.0uM|IC50|=|35|uM|35000|nM
6G8K|1.25|2019|11-mer|betaYAP4|P31947|14-3-3 PROTEIN SIGMA|4.45|IC=35.4uM|IC50|=|35.4|uM|35400|nM
6PHZ|2.00|2019|FKS|ligand is compound 2; IC50 = 350 +/- 100 uM|------|ACETYLPOLYAMINE AMIDOHYDROLASE|3.46|IC=350uM|IC50|=|350|uM|350000|nM
6OHT|3.20|2019|MKM|ligand is compound U18666A; IC50 = 351 +/- 12 nM|Q15125|3-BETA-HYDROXYSTEROID-DELTA(8),DELTA(7)-ISOMERASE|6.45|IC=351nM|IC50|=|351|nM|351|nM
6N5H|1.72|2019|AUB|ligand is 5|------|EPOXIDE HYDROLASE TREH|6.45|IC=357.9nM|IC50|=|357.9|nM|357.9|nM
6A6K|2.90|2019|9S6|ligand is compound 35.|P62508|ESTROGEN-RELATED RECEPTOR GAMMA|7.46|IC=35nM|IC50|=|35|nM|35|nM
6HUU|2.80|2019|GTW|ligand is 29|P23639|PROTEASOME SUBUNIT ALPHA TYPE-2|7.46|IC=35nM|IC50|=|35|nM|35|nM
6K1Q|2.70|2019|D2U|ligand is IRL2500|P24530|ENDOTHELIN B RECEPTOR,ENDOLYSIN,ENDOTHELIN B RECEPTOR|7.46|IC=35nM|IC50|=|35|nM|35|nM
6QFT|2.70|2019|J0B|ligand is compound 1b; IC50 = 35 +/- 3nM|O14733|DUAL SPECIFICITY MITOGEN-ACTIVATED PROTEIN KINASE KINASE 7|7.46|IC=35nM|IC50|=|35|nM|35|nM
6NRJ|1.65|2019|KYJ|[Incomplete ligand] ligand is compound 93, UTT93|P09874|POLY [ADP-RIBOSE] POLYMERASE 1|7.44|IC=36nM|IC50|=|36|nM|36|nM
6Q9Y|1.20|2019|HRQ|ligand is compound 16; Binding assay is TR-FRET|O15151|PROTEIN MDM4|5.43|IC=3700nM|IC50|=|3700|nM|3700|nM
6UII|2.65|2019|SS9|ligand is compound 6; IC50 = 370 +/- 20 nM; acetylpolyamine hydrolysis assay|F1QCV2|POLYAMINE DEACETYLASE HDAC10|6.43|IC=370nM|IC50|=|370|nM|370|nM
6N5C|1.95|2019|KDJ|ligand is 1|O43314|INOSITOL HEXAKISPHOSPHATE AND DIPHOSPHOINOSITOL|6.43|IC=375nM|IC50|=|375|nM|375|nM
6F86|1.90|2019|CWW|compound 5|P0AES7|DNA GYRASE SUBUNIT B|7.43|IC=37nM|IC50|=|37|nM|37|nM
6S9X|2.60|2019|L1W|[Covalent complex] ligand is compound 15c; IC50 = 381 +/- 116 nM; No Ki data|P31749|RAC-ALPHA SERINE/THREONINE-PROTEIN KINASE|6.42|IC=381nM|IC50|=|381|nM|381|nM
6R7J|1.84|2019|JUN|ligand is compound 14|P51449|NUCLEAR RECEPTOR ROR-GAMMA|7.4|IC=39.8nM|IC50|=|39.8|nM|39.8|nM
6PHT|1.80|2019|OKP|ligand is compound 1; IC50 = 390 +/- 100uM|------|ACETYLPOLYAMINE AMIDOHYDROLASE|3.41|IC=390uM|IC50|=|390|uM|390000|nM
6P1D|2.40|2019|NQ1|ligand is DDC4002; crystal use EGFR(T790M/ V948R); assay use EGFR L858R/T790M|P00533|EPIDERMAL GROWTH FACTOR RECEPTOR|7.41|IC=39nM|IC50|=|39|nM|39|nM
6HGY|2.20|2019|G4B|ligand is 1|P43235|CATHEPSIN K|8.52|IC=3nM|IC50|=|3|nM|3|nM
6NY4|2.33|2019|Z3A|ligand is compound 22; IC50 = 3 +/- 1 nM|P52333|TYROSINE-PROTEIN KINASE JAK3|8.52|IC=3nM|IC50|=|3|nM|3|nM
6OW2|1.70|2019|NB4|ligand is compound 1|Q939R9|PEPTIDE DEFORMYLASE|8.52|IC=3nM|IC50|=|3|nM|3|nM
6PL3|3.00|2019|OOD|ligand is compound 2a; Only IC50 data, no Kd|P04629|HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR|8.52|IC=3nM|IC50|=|3|nM|3|nM
6RJ6|1.98|2019|K5K|ligand is compound BI-4924|O43175|D-3-PHOSPHOGLYCERATE DEHYDROGENASE|8.52|IC=3nM|IC50|=|3|nM|3|nM
6FNE|2.50|2019|DY5|compound is bragsin1, Liposomes and flotation assay|Q6DN90|IQ MOTIF AND SEC7 DOMAIN-CONTAINING PROTEIN 1|5.52|IC=3uM|IC50|=|3|uM|3000|nM
6S43|1.42|2019|KUE|ligand is compound 16b; IC50 = 4.0 +/- 0.1 uM|------|FUMARATE HYDRATASE CLASS II|5.4|IC=4.0uM|IC50|=|4|uM|4000|nM
6E5G|2.43|2019|HUY|[Covalent complex] FP inhibition: EC50=4.3+/-0.6uM|Q15562|TRANSCRIPTIONAL ENHANCER FACTOR TEF-4|5.37|IC=4.3uM|IC50|=|4.3|uM|4300|nM
6IMR|1.50|2019|AJX|ligand is 8|Q08499|CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D|5.37|IC=4.3uM|IC50|=|4.3|uM|4300|nM
6TLD|1.61|2019|NK5|ligand is compound 2b; IC50 = 4.44 +/- 1.52 uM|A5H660|HISTONE DEACETYLASE|5.35|IC=4.44uM|IC50|=|4.44|uM|4440|nM
6FU1|1.55|2019|E7Q|IC50=4.4+/-0.17uM|A5H660|HISTONE DEACETYLASE|5.36|IC=4.4uM|IC50|=|4.4|uM|4400|nM
6M8B|1.80|2019|KMP|ligand is 4|Q8NFU5|INOSITOL POLYPHOSPHATE MULTIKINASE,INOSITOL POLYPHOSPHATE|5.36|IC=4.4uM|IC50|=|4.4|uM|4400|nM
6DTX|3.33|2019|H9Y|state RT kinetic assay, IC50(WT, compound 1)=4.5+/-1.2nM|P03366|REVERSE TRANSCRIPTASE/RIBONUCLEASE H|8.35|IC=4.5nM|IC50|=|4.5|nM|4.5|nM
6EB1|2.20|2019|J3M|LEDGF/p75 Independent Integration Assays, IC50(6b)=4.65+/-1.3uM|F2WR52|INTEGRASE|5.33|IC=4.65uM|IC50|=|4.65|uM|4650|nM
6JSG|2.30|2019|C6U|ligand is 8|P56817|BETA-SECRETASE 1|8.34|IC=4.6nM|IC50|=|4.6|nM|4.6|nM
6MO4|1.84|2019|JWM|ligand is 17|P47205|UDP-3-O-ACYL-N-ACETYLGLUCOSAMINE DEACETYLASE|8.34|IC=4.6nM|IC50|=|4.6|nM|4.6|nM
6GCR|2.30|2019|EUW|ADP Glo kinase assay, IC50(6)=4.7+/-0.5nM|Q00944|FOCAL ADHESION KINASE 1|8.33|IC=4.7nM|IC50|=|4.7|nM|4.7|nM
6OE3|2.90|2019|M9A|ligand is compound Cmpd I; IC50 = 4.8+/-1.1nM|P03366|HIV-1 REVERSE TRANSCRIPTASE, P66 SUBUNIT|8.32|IC=4.8nM|IC50|=|4.8|nM|4.8|nM
6HOT|1.50|2019|CIY|ligand is Ferulic aldehyde|P68400|CASEIN KINASE II SUBUNIT ALPHA|4.4|IC=40.1uM|IC50|=|40.1|uM|40100|nM
5OVG|2.30|2019|AWZ|KRASG12C CSOS1cat interaction assay , compound 18|Q07889|SON OF SEVENLESS HOMOLOG 1|6.4|IC=400nM|IC50|=|400|nM|400|nM
6QW8|1.10|2019|MK7|ligand is relebactam|G3G192|BETA-LACTAMASE|6.4|IC=400nM|IC50|=|400|nM|400|nM
6UHU|2.80|2019|Q7V|ligand is compound 4; IC50 = 400 +/- 70 uM; acetylpolyamine hydrolysis assay|F1QCV2|POLYAMINE DEACETYLASE HDAC10|3.4|IC=400uM|IC50|=|400|uM|400000|nM
6IB0|2.60|2019|H8Z|[Covalent complex] ligand is 3a|O14733|DUAL SPECIFICITY MITOGEN-ACTIVATED PROTEIN KINASE KINASE 7|7.4|IC=40nM|IC50|=|40|nM|40|nM
6I0P|1.90|2019|QAS|ligand is 6MPDC|Q9X1X7|QUINOLINATE SYNTHASE A|4.4|IC=40uM|IC50|=|40|uM|40000|nM
6PIC|2.03|2019|6XA|ligand is compound 4; IC50 = 410 +/- 100|------|ACETYLPOLYAMINE AMIDOHYDROLASE|3.39|IC=410uM|IC50|=|410|uM|410000|nM
6KEB|3.20|2019|D6C|ligand is Diltiazem|A8EVM5|ION TRANSPORT PROTEIN|4.39|IC=41uM|IC50|=|41|uM|41000|nM
6PYB|1.80|2019|P5G|ligand is compound DVT; IC50 = 4200 +/- 790 nM|P04278|SEX HORMONE-BINDING GLOBULIN|5.38|IC=4200nM|IC50|=|4200|nM|4200|nM
6PDJ|1.81|2019|ODJ|ligand is compound 11|P06239|TYROSINE-PROTEIN KINASE LCK|7.38|IC=42nM|IC50|=|42|nM|42|nM
6NSP|2.31|2019|L0P|ligand is compound 9|P04629|HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR|7.36|IC=44.1nM|IC50|=|44.1|nM|44.1|nM
6Q37|2.21|2019|HE8|ligand is compound 23|P78540|ARGINASE-2, MITOCHONDRIAL|6.36|IC=440nM|IC50|=|440|nM|440|nM
6J10|2.30|2019|B4O|ligand is Ciclopirox|P03147|CAPSID PROTEIN|6.35|IC=445nM|IC50|=|445|nM|445|nM
6E3G|2.10|2019|HOJ|ligand is compound 3a. Displacement assay of boron-dipyrromethene (BODIPY)-labeled with apo ROR t|P51449|NUCLEAR RECEPTOR ROR-GAMMA|7.36|IC=44nM|IC50|=|44|nM|44|nM
6QME|1.81|2019|J6Q|ligand is compound 12|Q9Z2X8|KELCH-LIKE ECH-ASSOCIATED PROTEIN 1|4.36|IC=44uM|IC50|=|44|uM|44000|nM
6MEP|2.89|2019|9VS|ligand is 7|Q12866|TYROSINE-PROTEIN KINASE MER|7.35|IC=45nM|IC50|=|45|nM|45|nM
6I0R|2.10|2019|QAT|ligand is 5MPDC|Q9X1X7|QUINOLINATE SYNTHASE A|4.35|IC=45uM|IC50|=|45|uM|45000|nM
6QW7|1.78|2019|MK7|ligand is relebactam|Q9RBQ1|BETA-LACTAMASE|6.33|IC=470nM|IC50|=|470|nM|470|nM
6OCO|2.58|2019|M5V|ligand is compound 6; HTRF assay|O00329|PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC|6.32|IC=474nM|IC50|=|474|nM|474|nM
6MDD|2.05|2019|JE7|ligand is 24|Q06124|TYROSINE-PROTEIN PHOSPHATASE NON-RECEPTOR TYPE 11|4.33|IC=47uM|IC50|=|47|uM|47000|nM
6AGT|1.95|2019|9X0|compound 2, kinase-glo assay|W7JP72|LYSINE--TRNA LIGASE|8.4|IC=4nM|IC50|=|4|nM|4|nM
6N9P|2.23|2019|KHD|[Covalent complex] [Incomplete ligand] ligand is 6|Q06187|TYROSINE-PROTEIN KINASE BTK|8.4|IC=4nM|IC50|=|4|nM|4|nM
6OYW|2.60|2019|NKJ|ligand is compound 11|Q99683|MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 5|8.4|IC=4nM|IC50|=|4|nM|4|nM
6QHA|1.82|2019|J2Q|[Different protein in assay: Protein KLK5/KLK1 was used in binding assay;But all structures were based on KLK6] Ligand is compound 6|Q92876|KALLIKREIN-6|5.3|IC=5.01uM|IC50|=|5.01|uM|5010|nM
6JT3|2.40|2019|C83|ligand is 5; binding assay method is HTRF|P56817|BETA-SECRETASE 1|8.3|IC=5.0nM|IC50|=|5|nM|5|nM
6P5W|1.69|2019|O0A|ligand is compound 1; IC50 = 5.1 +/- 0.6 uM|D9IEF7|LYSOZYME,DCN1-LIKE PROTEIN 1 CHIMERA|5.29|IC=5.1uM|IC50|=|5.1|uM|5100|nM
6A84|1.98|2019|9SU||Q9H2K2|TANKYRASE-2|8.28|IC=5.3nM|IC50|=|5.3|nM|5.3|nM
6NVJ|2.30|2019|XL5|[Covalent complex] ligand is compound 4|P22455|FIBROBLAST GROWTH FACTOR RECEPTOR 4|8.28|IC=5.3nM|IC50|=|5.3|nM|5.3|nM
6DTW|2.74|2019|H9Y|steady state RT kinetic assay, IC50(Y181C, compound 1)=5.5+/-1.1nM|P03366|REVERSE TRANSCRIPTASE/RIBONUCLEASE H|8.26|IC=5.5nM|IC50|=|5.5|nM|5.5|nM
6HZU|2.20|2019|GYQ||P23458|TYROSINE-PROTEIN KINASE JAK1|8.26|IC=5.5nM|IC50|=|5.5|nM|5.5|nM
6M8A|1.75|2019|LU2|ligand is 3|Q8NFU5|INOSITOL POLYPHOSPHATE MULTIKINASE,INOSITOL POLYPHOSPHATE|5.26|IC=5.5uM|IC50|=|5.5|uM|5500|nM
6HP9|1.96|2019|GKB|ligand is 7c|Q08345|EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1|8.25|IC=5.6nM|IC50|=|5.6|nM|5.6|nM
6D4W|1.80|2019|FWJ|[Different ligand in assay: ligand structure is incorrect] IC50(compound 35)=5.6+/-0.2uM, ligand in crystal structure is compound 29, IC50=0.68+/-0.05uM|G7CNL4|INOSINE-5'-MONOPHOSPHATE DEHYDROGENASE,INOSINE-5|5.25|IC=5.6uM|IC50|=|5.6|uM|5600|nM
6OYT|2.82|2019|NJV|ligand is compound 4, GS-4997|Q99683|MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 5|8.23|IC=5.9nM|IC50|=|5.9|nM|5.9|nM
6FFF|1.67|2019|D7H|pIC50=7.3+/-0.21|P25440|BROMODOMAIN-CONTAINING PROTEIN 2|7.3|IC=50.1nM|IC50|=|50.1|nM|50.1|nM
6R7K|1.54|2019|JUH|ligand is compound 22|P51449|NUCLEAR RECEPTOR ROR-GAMMA|7.3|IC=50.1nM|IC50|=|50.1|nM|50.1|nM
6RN7|1.66|2019|K9W|ligand is compound 5; pIC50 = 7.3|P53634|DIPEPTIDYL PEPTIDASE 1|7.3|IC=50.1nM|IC50|=|50.1|nM|50.1|nM
6HY2|1.60|2019|12-mer|ligand is CR20|P0A722|ACYL-[ACYL-CARRIER-PROTEIN]--UDP-N-ACETYLGLUCOSAMINE O|7.3|IC=50nM|IC50|=|50|nM|50|nM
5Y7J|2.52|2019|8OL||P27487|DIPEPTIDYL PEPTIDASE 4|7.29|IC=51.7nM|IC50|=|51.7|nM|51.7|nM
6HVA|2.90|2019|GQT|ligand is 13|P23639|PROTEASOME SUBUNIT ALPHA TYPE-2|6.28|IC=525nM|IC50|=|525|nM|525|nM
6AA5|1.90|2019|MKU|IC50(3-isomangostin)=52+/-1.2nM|P36639|7,8-DIHYDRO-8-OXOGUANINE TRIPHOSPHATASE|7.28|IC=52nM|IC50|=|52|nM|52|nM
6OZ6|3.70|2019|NKD|ligand is 3'-hydroxymureidomycin A|O66465|MRAYAA NANOBODY|7.28|IC=52nM|IC50|=|52|nM|52|nM
6HV2|1.71|2019|5-mer||P45452|COLLAGENASE 3|4.28|IC=52uM|IC50|=|52|uM|52000|nM
6HOU|1.80|2019|V55|ligand is Vanillin|P68400|CASEIN KINASE II SUBUNIT ALPHA|4.27|IC=53.4uM|IC50|=|53.4|uM|53400|nM
6NRH|1.50|2019|KYP|[Incomplete ligand] ligand is compound 63, UTT63; ligand structure lack one double bond|P09874|POLY [ADP-RIBOSE] POLYMERASE 1|7.26|IC=55nM|IC50|=|55|nM|55|nM
6KLA|2.11|2019|DJX|ligand is 15a|P10721|MAST/STEM CELL GROWTH FACTOR RECEPTOR KIT|7.25|IC=56nM|IC50|=|56|nM|56|nM
6NRG|1.70|2019|KYY|[Incomplete ligand] ligand is compound 55, UTT57; ligand structure lack one double bond|P09874|POLY [ADP-RIBOSE] POLYMERASE 1|7.25|IC=56nM|IC50|=|56|nM|56|nM
6S7K|1.55|2019|KYZ|ligand is compound 16a; IC50 = 57 +/- 3 uM|------|FUMARATE HYDRATASE CLASS II|4.24|IC=57uM|IC50|=|57|uM|57000|nM
6IMB|1.55|2019|AH9|ligand is 4|Q08499|CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D|4.23|IC=58.5uM|IC50|=|58.5|uM|58500|nM
6Q9W|1.55|2019|HRT|ligand is compound 15; Binding assay is TR-FRET|O15151|PROTEIN MDM4|6.24|IC=580nM|IC50|=|580|nM|580|nM
6HVS|3.10|2019|GRT|ligand is 18|P23639|PROTEASOME SUBUNIT ALPHA TYPE-2|5.23|IC=5900nM|IC50|=|5900|nM|5900|nM
6HV4|3.00|2019|GQK|ligand is ONX-0914|P23639|PROTEASOME SUBUNIT ALPHA TYPE-2|6.23|IC=590nM|IC50|=|590|nM|590|nM
5Z1E|2.30|2019|95U|[Covalent complex] kinase activity assay, C218S mutant|O14733|DUAL SPECIFICITY MITOGEN-ACTIVATED PROTEIN KINASE KINASE 7|8.3|IC=5nM|IC50|=|5|nM|5|nM
5Z1D|2.28|2019|95U|[Covalent complex] kinase activity assay, C276S mutant|O14733|DUAL SPECIFICITY MITOGEN-ACTIVATED PROTEIN KINASE KINASE 7|8.3|IC=5nM|IC50|=|5|nM|5|nM
6HCV|2.20|2019|FYE|compound 4, kinase-glo assay|Q8IDJ8|LYSINE--TRNA LIGASE|8.3|IC=5nM|IC50|=|5|nM|5|nM
6Q7A|2.20|2019|HKZ|ligand is compound 4|P51449|NUCLEAR RECEPTOR ROR-GAMMA|8.3|IC=5nM|IC50|=|5|nM|5|nM
6RNA|2.62|2019|KA2|ligand is compound 5; Binding assay is FP|O43353|RECEPTOR-INTERACTING SERINE/THREONINE-PROTEIN KINASE 2|8.3|IC=5nM|IC50|=|5|nM|5|nM
6P10|2.30|2019|SKE|ligand is compound 1; IC50 = 6.0 +/- 1.0 uM|Q8I0P1|DROSOPHILA MELANOGASTER SPASTIN AAA DOMAIN|5.22|IC=6.0uM|IC50|=|6|uM|6000|nM
6OD6|2.00|2019|M7D|ligand is compound 13; pIC50 = 8.21|P56817|BETA-SECRETASE 1|8.21|IC=6.16nM|IC50|=|6.16|nM|6.16|nM
6JPJ|2.64|2019|FGF|ligand is FGF401|P22455|FIBROBLAST GROWTH FACTOR RECEPTOR 4|8.21|IC=6.2nM|IC50|=|6.2|nM|6.2|nM
6QAB|2.49|2019|HUQ|ligand is compound 10; IC50 = 6.2+/-3.4 nM|P06276|CHOLINESTERASE|8.21|IC=6.2nM|IC50|=|6.2|nM|6.2|nM
6QAC|2.77|2019|HUT|ligand is compound 8; IC50 = 6.2+/-0.4 nM|P06276|CHOLINESTERASE|8.21|IC=6.2nM|IC50|=|6.2|nM|6.2|nM
6MUL|3.09|2019|K4A|ligand is 1, binding assay method is HTRF|Q3UDT3|PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC|8.2|IC=6.3nM|IC50|=|6.3|nM|6.3|nM
6RLN|2.87|2019|K8K|ligand is compound 6; uses Promega ADP-Glo kinase kit to measure kinase activity|Q13546|RECEPTOR-INTERACTING SERINE/THREONINE-PROTEIN KINASE 1|8.2|IC=6.3nM|IC50|=|6.3|nM|6.3|nM
6RN9|1.90|2019|K9Z|ligand is compound 6; pIC50 = 8.2|P53634|DIPEPTIDYL PEPTIDASE 1|8.2|IC=6.3nM|IC50|=|6.3|nM|6.3|nM
6QHC|1.87|2019|135|[Different protein in assay: Protein KLK5/KLK1 was used in binding assay;But all structures were based on KLK6] Ligand is compound 1; Ligand is racemer|Q92876|KALLIKREIN-6|5.2|IC=6.3uM|IC50|=|6.3|uM|6300|nM
6UVV|1.63|2019|QJV|ligand is compound 17|P56817|BETA-SECRETASE 1|5.18|IC=6.64uM|IC50|=|6.64|uM|6640|nM
6HBN|1.59|2019|FXB|ligand is THN27|P68400|CASEIN KINASE II SUBUNIT ALPHA|6.22|IC=607nM|IC50|=|607|nM|607|nM
6G8P|1.90|2019|11-mer|betaYAP2.2|P31947|14-3-3 PROTEIN SIGMA|4.21|IC=61.2uM|IC50|=|61.2|uM|61200|nM
6D5W|2.48|2019|FVV|Ras:SOS1:Ras complex|P01112|GTPASE HRAS|4.2|IC=63.0uM|IC50|=|63|uM|63000|nM
6FFG|1.59|2019|D7B|pIC50=7.2+/-0.07|P25440|BROMODOMAIN-CONTAINING PROTEIN 2|7.2|IC=63.1nM|IC50|=|63.1|nM|63.1|nM
6QHO|2.70|2019|J3H|ligand is compound 1a; IC50 = 631 +/- 87nM|O14733|DUAL SPECIFICITY MITOGEN-ACTIVATED PROTEIN KINASE KINASE 7|6.2|IC=631nM|IC50|=|631|nM|631|nM
6S55|2.09|2019|KW5|ligand is compound 36; pIC50 = 6.2 +/- 0.03|Q6PL18|ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 2|6.2|IC=631nM|IC50|=|631|nM|631|nM
6OI9|2.06|2019|MQM|ligand is 13f|------|BIOTIN CARBOXYLASE|7.19|IC=64nM|IC50|=|64|nM|64|nM
6HOR|1.80|2019|GJK|ligand is Feruloylmethane|P68400|CASEIN KINASE II SUBUNIT ALPHA|4.18|IC=65.5uM|IC50|=|65.5|uM|65500|nM
6HV7|3.40|2019|GQQ|ligand is 7|P23639|PROTEASOME SUBUNIT ALPHA TYPE-2|5.19|IC=6500nM|IC50|=|6500|nM|6500|nM
6EG9|2.41|2019|0LI|kinase binding assay, IC50(ponatinib, unphosphorylated IRAK4)=66.9+/-2.37nM|Q9NWZ3|INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE 4|7.17|IC=66.9nM|IC50|=|66.9|nM|66.9|nM
6NPT|2.19|2019|KWY|ligand is compound 1|P04629|HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR|7.17|IC=68.3nM|IC50|=|68.3|nM|68.3|nM
6IJH|2.60|2019|AEO|ligand is AF-399/14387019|Q9Y233|CAMP AND CAMP-INHIBITED CGMP 3',5'-CYCLIC PHOSPHODIESTERASE|7.17|IC=68nM|IC50|=|68|nM|68|nM
6HZV|2.46|2019|GYW||P52333|TYROSINE-PROTEIN KINASE JAK3|8.22|IC=6nM|IC50|=|6|nM|6|nM
6IC5|2.00|2019|HB5||P53634|DIPEPTIDYL PEPTIDASE 1|8.22|IC=6nM|IC50|=|6|nM|6|nM
6QXU|1.20|2019|JKN|ligand is compound 5k|O95271|POLY [ADP-RIBOSE] POLYMERASE TANKYRASE-1|8.15|IC=7.0nM|IC50|=|7|nM|7|nM
6DIM|1.81|2019|GJP|compound 2(cocktail soak)|Q9NUW8|TYROSYL-DNA PHOSPHODIESTERASE 1|2.14|IC=7.2mM|IC50|=|7.2|mM|7200000|nM
6DJD|1.78|2019|GJP|compound 2, same as PDB 6dim(single soak)|Q9NUW8|TYROSYL-DNA PHOSPHODIESTERASE 1|2.14|IC=7.2mM|IC50|=|7.2|mM|7200000|nM
6M8D|2.00|2019|J8D|ligand is 7|Q8NFU5|INOSITOL POLYPHOSPHATE MULTIKINASE,INOSITOL POLYPHOSPHATE|5.14|IC=7.2uM|IC50|=|7.2|uM|7200|nM
6N7Y|2.00|2019|KFA|ligand is (R)-6d|P14324|FARNESYL PYROPHOSPHATE SYNTHASE|5.11|IC=7.7uM|IC50|=|7.7|uM|7700|nM
6Q9H|2.00|2019|HRH|ligand is compound 11; Binding assay is TR-FRET|Q00987|E3 UBIQUITIN-PROTEIN LIGASE MDM2|8.11|IC=7.8nM|IC50|=|7.8|nM|7.8|nM
6HRX|1.87|2019|GO8|ligand is 2|O53623|PROBABLE TRANSCRIPTIONAL REGULATORY PROTEIN|5.1|IC=7.9uM|IC50|=|7.9|uM|7900|nM
6PYS|2.19|2019|P5J|ligand is compound 2-10; selectivity(alpha/delta) = 70|P42336|PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC|7.15|IC=70nM|IC50|=|70|nM|70|nM
6HUQ|3.00|2019|GT5|ligand is 20|P23639|PROTEASOME SUBUNIT ALPHA TYPE-2|7.14|IC=72nM|IC50|=|72|nM|72|nM
6UF0|1.96|2019|Q5V|ligand is compound 13a; IC50 = 66 - 91nM;binding assay fluorescence anisotropy|Q14145|KELCH-LIKE ECH-ASSOCIATED PROTEIN 1|7.14|IC=73nM|IC50|=|73|nM|73|nM
6IC7|2.00|2019|H9H||P53634|DIPEPTIDYL PEPTIDASE 1|7.11|IC=78nM|IC50|=|78|nM|78|nM
6SKC|2.18|2019|LH8|[Uncommon element] ligand is compound 10; pIC50=7.1; contain uncommon B element|Q92876|KALLIKREIN-6|7.1|IC=79.4nM|IC50|=|79.4|nM|79.4|nM
6PSB|1.59|2019|Y18|ligand is compound 18; IC50 = 79 +/- 3 uM|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|4.1|IC=79uM|IC50|=|79|uM|79000|nM
6A1C|1.68|2019|9NX|kinase assay|P68400|CASEIN KINASE II SUBUNIT ALPHA|8.15|IC=7nM|IC50|=|7|nM|7|nM
6MOB|1.80|2019|JWY|ligand is DP-2976|P10721|MAST/STEM CELL GROWTH FACTOR RECEPTOR KIT|8.15|IC=7nM|IC50|=|7|nM|7|nM
6C9Q|1.95|2019|5N5|enzymic inhibition assay, compound 5|A5U4N0|ADENOSINE KINASE|5.1|IC=8.0uM|IC50|=|8|uM|8000|nM
6N4T|1.95|2019|KD7|[Covalent complex] ligand is cpd-8|Q9Y5Y6|SUPPRESSOR OF TUMORIGENICITY 14 PROTEIN|8.09|IC=8.1nM|IC50|=|8.1|nM|8.1|nM
6JID|2.50|2019|BQC|ligand is 1|P13995|BIFUNCTIONAL METHYLENETETRAHYDROFOLATE|5.08|IC=8.3uM|IC50|=|8.3|uM|8300|nM
6FYM|2.15|2019|EBB|IC50=8.55+/-0.8uM|Q460N5|POLY [ADP-RIBOSE] POLYMERASE 14|5.07|IC=8.55uM|IC50|=|8.55|uM|8550|nM
6S8A|2.60|2019|L0N|[Different protein in assay: Protein in binding assay is L858R/T790M/C797S mutant] ligand is 19h; binding assay method is HTRF|P00533|EPIDERMAL GROWTH FACTOR RECEPTOR|8.07|IC=8.5nM|IC50|=|8.5|nM|8.5|nM
6NVG|1.99|2019|XL8|[Covalent complex] ligand is compound 5|P22455|FIBROBLAST GROWTH FACTOR RECEPTOR 4|8.07|IC=8.5nM|IC50|=|8.5|nM|8.5|nM
6S89|2.70|2019|L0Q|[Covalent complex] [Different protein in assay: Protein in binding assay is L858R/T790M/C797S mutant] ligand is 19g; binding assay method is HTRF|P00533|EPIDERMAL GROWTH FACTOR RECEPTOR|8.07|IC=8.6nM|IC50|=|8.6|nM|8.6|nM
6QG4|2.30|2019|J0E|ligand is compound 1h; IC50 = 8.6 +/- 2.9 nM|O14733|DUAL SPECIFICITY MITOGEN-ACTIVATED PROTEIN KINASE KINASE 7|8.07|IC=8.6nM|IC50|=|8.6|nM|8.6|nM
6A3N|2.60|2019|9Q9|compound 2, IC50=8.7+/-0.3nM, enzymic assay|O76083|HIGH AFFINITY CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE|8.06|IC=8.7nM|IC50|=|8.7|nM|8.7|nM
6UIL|2.85|2019|FKS|ligand is compound 1; IC50 = 80 +/- 10 nM; acetylpolyamine hydrolysis assay|F1QCV2|POLYAMINE DEACETYLASE HDAC10|7.1|IC=80nM|IC50|=|80|nM|80|nM
6DJJ|1.74|2019|GM7|compound 5|Q9NUW8|TYROSYL-DNA PHOSPHODIESTERASE 1|4.1|IC=80uM|IC50|=|80|uM|80000|nM
6SZE|2.94|2019|M2B|ligand is compound 1|O43353|RECEPTOR-INTERACTING SERINE/THREONINE-PROTEIN KINASE 2|4.1|IC=80uM|IC50|=|80|uM|80000|nM
6HWV|1.70|2019|GEW|ligand is 3|Q16539|MITOGEN-ACTIVATED PROTEIN KINASE 14|7.08|IC=83.2nM|IC50|=|83.2|nM|83.2|nM
6MOA|1.27|2019|JW4|ligand is 42|P25440|BROMODOMAIN-CONTAINING PROTEIN 2|7.08|IC=83nM|IC50|=|83|nM|83|nM
6MSA|2.06|2019|JY4|ligand is 17|Q9Y233|CAMP AND CAMP-INHIBITED CGMP 3',5'-CYCLIC PHOSPHODIESTERASE|7.08|IC=84nM|IC50|=|84|nM|84|nM
6F8J|1.95|2019|CZ5|compound 4|P0AES7|DNA GYRASE SUBUNIT B|7.07|IC=86nM|IC50|=|86|nM|86|nM
6R49|2.21|2019|JSB|ligand is compound 39|O14965|AURORA KINASE A|2.1|IC=8mM|IC50|=|8|mM|8000000|nM
6E6J|2.44|2019|HWV|compound is ABBV-744, BD2 domain|P25440|BROMODOMAIN-CONTAINING PROTEIN 2|8.1|IC=8nM|IC50|=|8|nM|8|nM
6GJB|1.82|2019|F0H|ligand is TCO-GDC-2|P28482|MITOGEN-ACTIVATED PROTEIN KINASE 1|8.1|IC=8nM|IC50|=|8|nM|8|nM
6NSQ|3.05|2019|KZP|ligand is compound 2l; IC50 = 8+/-1 nM|P15056|SERINE/THREONINE-PROTEIN KINASE B-RAF|8.1|IC=8nM|IC50|=|8|nM|8|nM
6I0B|2.38|2019|9A5|S-K1035|P06276|CHOLINESTERASE|8.04|IC=9.1nM|IC50|=|9.1|nM|9.1|nM
6N4E|1.65|2019|KCD|ligand is 1bv|O60760|HEMATOPOIETIC PROSTAGLANDIN D SYNTHASE|8.0|IC=9.9nM|IC50|=|9.9|nM|9.9|nM
6QWB|1.04|2019|MK7|ligand is relebactam|B1PL86|BETA-LACTAMASE|6.04|IC=910nM|IC50|=|910|nM|910|nM
6MO7|1.85|2019|JWA|ligand is 10|P25440|BROMODOMAIN-CONTAINING PROTEIN 2|5.03|IC=9376nM|IC50|=|9376|nM|9376|nM
5ZR3|2.50|2019|9J0|alphascreen competitive assay, IC50(16d)=98+/-10nM|P07900|HEAT SHOCK PROTEIN HSP 90-ALPHA|7.01|IC=98nM|IC50|=|98|nM|98|nM
6F94|2.35|2019|D0H|compound 10|P0AES7|DNA GYRASE SUBUNIT B|7.0|IC=99nM|IC50|=|99|nM|99|nM
6N5G|2.60|2019|KDS|ligand is 2|------|EPOXIDE HYDROLASE TREH|7.0|IC=99nM|IC50|=|99|nM|99|nM
6I5I|1.60|2019|H3E|ligand is 12h|P49759|DUAL SPECIFICITY PROTEIN KINASE CLK1|8.05|IC=9nM|IC50|=|9|nM|9|nM
6HRZ|1.57|2019|GO2|ligand is 4|O53623|PROBABLE TRANSCRIPTIONAL REGULATORY PROTEIN|4.0|IC>100uM|IC50|>|100|uM|100000|nM
6HRY|1.84|2019|GOE|ligand is 3|O53623|PROBABLE TRANSCRIPTIONAL REGULATORY PROTEIN|4.0|IC>100uM|IC50|>|100|uM|100000|nM
6UVP|1.56|2019|QJJ|ligand is compound 3|P56817|BETA-SECRETASE 1|4.0|IC>100uM|IC50|>|100|uM|100000|nM
6HUV|3.10|2019|GT8|ligand is 39|P23639|PROTEASOME SUBUNIT ALPHA TYPE-2|5.0|IC>10uM|IC50|>|10|uM|10000|nM
6HVT|2.90|2019|GT5|ligand is 20|P23639|PROTEASOME SUBUNIT ALPHA TYPE-2|6.0|IC>1uM|IC50|>|1|uM|1000|nM
6N69|2.00|2019|KDV|ligand is 1a|O35543|HEMATOPOIETIC PROSTAGLANDIN D SYNTHASE|4.3|IC>50000nM|IC50|>|50000|nM|50000|nM
6FV2|2.95|2019|D03|compound 11a|P0C6X5|REPLICASE POLYPROTEIN 1AB|4.3|IC>50uM|IC50|>|50|uM|50000|nM
6RNU|2.40|2019|KBH|[Covalent complex] ligand is compound 2; TR-FRET assay|Q07817|BCL-2-LIKE PROTEIN 1|4.0|IC>99.2uM|IC50|>|99.2|uM|99200|nM
5ZLF|2.85|2019|B29|compound 69 for EcOPPS|P0AD57|OCTAPRENYL DIPHOSPHATE SYNTHASE|3.48|IC~330uM|IC50|~|330|uM|330000|nM
5ZE6|2.50|2019|HJX|compound 70 for EcOPPS|P0AD57|OCTAPRENYL DIPHOSPHATE SYNTHASE|3.35|IC~450uM|IC50|~|450|uM|450000|nM
6SD9|2.35|2019|88Z|ligand is foretinib; pKd>9.1, then Kd<0.8nM|P08581|HEPATOCYTE GROWTH FACTOR RECEPTOR|9.1|Kd<0.8nM|Kd|<|0.8|nM|0.8|nM
6SDC|1.67|2019|88Z|ligand is foretinib; pKd>8.9, then Kd<1.26nM|P08581|HEPATOCYTE GROWTH FACTOR RECEPTOR|8.9|Kd<1.26nM|Kd|<|1.26|nM|1.26|nM
6UN3|1.90|2019|XT8|[Covalent complex] ligand is ticarcillin; FPA assay, Kd = Koff / Kon; covalently bound|Q51504|PEPTIDOGLYCAN D,D-TRANSPEPTIDASE FTSI|8.64|Kd<2.3nM|Kd|<|2.3|nM|2.3|nM
6N9H|1.04|2019|308|ligand is amantadine|------|AMANTADINE-BINDING PROTEIN|4.26|Kd<55uM|Kd|<|55|uM|55000|nM
6NAF|1.92|2019|308|ligand is amantadine; Expression System is different from 6N9H|------|AMANTADINE-BINDING PROTEIN|4.26|Kd<55uM|Kd|<|55|uM|55000|nM
6QGJ|1.90|2019|J1T|ligand is compound 14; SPR Kd=0.001uM, FP Ki=0.02uM|P10415|APOPTOSIS REGULATOR BCL-2,BCL-2-LIKE PROTEIN 1,APOPTOSIS|9.0|Kd=0.001uM|Kd|=|0.001|uM|1|nM
6MQE|2.46|2019|8-mer||------|DFPHA.15 ANTIBODY FAB LIGHT CHAIN|11.29|Kd=0.0051nM|Kd|=|0.0051|nM|0.0051|nM
6R8O|1.36|2019|JV2|ligand is compound 14|P30405|PEPTIDYL-PROLYL CIS-TRANS ISOMERASE F|8.22|Kd=0.006uM|Kd|=|0.006|uM|6|nM
6H4D|2.90|2019|GDP||Q9HUL3|SMALL RIBOSOMAL SUBUNIT BIOGENESIS GTPASE RSGA|7.96|Kd=0.011uM|Kd|=|0.011|uM|11|nM
6I8M|2.10|2019|H7W|ligand is (S)-13|P26446|POLY [ADP-RIBOSE] POLYMERASE 1|7.8|Kd=0.016uM|Kd|=|0.016|uM|16|nM
6QYN|2.50|2019|JL8|ligand is compound 10d|P0AEY0|MALTOSE/MALTODEXTRIN-BINDING PERIPLASMIC PROTEIN,INDUCED|7.62|Kd=0.024uM|Kd|=|0.024|uM|24|nM
6QZ8|2.15|2019|JL8|ligand is compound 10d|Q07820|INDUCED MYELOID LEUKEMIA CELL DIFFERENTIATION PROTEIN MCL|7.62|Kd=0.024uM|Kd|=|0.024|uM|24|nM
6DYV|1.62|2019|OS3|Kd(HpMTAN, 16)=0.026+/-0.006nM|------|5'-METHYLTHIOADENOSINE/S-ADENOSYLHOMOCYSTEINE NUCLEOSIDASE|10.59|Kd=0.026nM|Kd|=|0.026|nM|0.026|nM
6DYY|1.61|2019|OS6|Kd(HpMTAN, 30)=0.028+/-0.010nM|------|5'-METHYLTHIOADENOSINE/S-ADENOSYLHOMOCYSTEINE NUCLEOSIDASE|10.55|Kd=0.028nM|Kd|=|0.028|nM|0.028|nM
6H76|1.50|2019|SLB|[Different protein in assay: ] ligand is Neu5Gc|P44542|SIALIC ACID-BINDING PERIPLASMIC PROTEIN SIAP|7.52|Kd=0.030uM|Kd|=|0.03|uM|30|nM
6QYO|2.10|2019|JLH|ligand is compound 18a|P0AEY0|MALTOSE/MALTODEXTRIN-BINDING PERIPLASMIC PROTEIN,INDUCED|7.52|Kd=0.030uM|Kd|=|0.03|uM|30|nM
6MAJ|2.14|2019|JAV|ligand is WM-3835|O95251|HISTONE ACETYLTRANSFERASE KAT7|7.47|Kd=0.034uM|Kd|=|0.034|uM|34|nM
6QMK|1.72|2019|J8H|ligand is compound 21; has ITC Kd data|Q9Z2X8|KELCH-LIKE ECH-ASSOCIATED PROTEIN 1|7.46|Kd=0.035uM|Kd|=|0.035|uM|35|nM
6DYW|1.45|2019|OS5|Kd(HpMTAN, 32)=0.036+/-0.010nM|------|5'-METHYLTHIOADENOSINE/S-ADENOSYLHOMOCYSTEINE NUCLEOSIDASE|10.44|Kd=0.036nM|Kd|=|0.036|nM|0.036|nM
6QMJ|1.86|2019|J6K|ligand is compound 20; has ITC Kd data|Q9Z2X8|KELCH-LIKE ECH-ASSOCIATED PROTEIN 1|7.36|Kd=0.044uM|Kd|=|0.044|uM|44|nM
6DYU|1.60|2019|OS2|Kd(HpMTAN, 15)=0.055+/-0.025nM|------|5'-METHYLTHIOADENOSINE/S-ADENOSYLHOMOCYSTEINE NUCLEOSIDASE|10.26|Kd=0.055nM|Kd|=|0.055|nM|0.055|nM
6JB0|1.63|2019|TRE||Q5SLD7|ABC TRANSPORTER, PERIPLASMIC SUBSTRATE-BINDING PROTEIN|7.24|Kd=0.058uM|Kd|=|0.058|uM|58|nM
6SLG|1.33|2019|LHZ|ligand is compound 15, AZD0364; SPR pKd=10.3 for phosphorylated ERK2|P28482|MITOGEN-ACTIVATED PROTEIN KINASE 1|10.3|Kd=0.05nM|Kd|=|0.05|nM|0.05|nM
5ZYJ|1.90|2019|9ML|Kd=0.061+/-0.005uM, kon=7.78E+5, koff=4.82E-2, E16A(1S,2R)|Q9Y5P4|LIPID-TRANSFER PROTEIN CERT|7.21|Kd=0.061uM|Kd|=|0.061|uM|61|nM
6U5Y|1.53|2019|Q0M|ligand is compound 7k; Kd = 0.069 +/- 0.034 uM; Binding assay is FPA|P61964|WD REPEAT-CONTAINING PROTEIN 5|7.16|Kd=0.069uM|Kd|=|0.069|uM|69|nM
6QYP|2.20|2019|JL5|ligand is compound 13|Q07820|INDUCED MYELOID LEUKEMIA CELL DIFFERENTIATION PROTEIN MCL|7.15|Kd=0.070uM|Kd|=|0.07|uM|70|nM
6NFH|1.40|2019|KLM|ligand is compound 1; binding assay is ThermoFluor|Q06187|TYROSINE-PROTEIN KINASE BTK|7.15|Kd=0.07uM|Kd|=|0.07|uM|70|nM
6RR0|2.18|2019|12-mer|ligand is Ubp10 pT123 peptide|P11978|REGULATORY PROTEIN SIR4|7.15|Kd=0.07uM|Kd|=|0.07|uM|70|nM
6QSZ|2.50|2019|16-mer|ligand is peptide Esc1-pS1450|P11978|REGULATORY PROTEIN SIR4|7.15|Kd=0.07uM|Kd|=|0.07|uM|70|nM
5ZYI|1.90|2019|9ML|[Different ligand in assay: ] Kd=0.086+/-0.003uM, kon=8.73E+4, koff=7.54E-3|Q9Y5P4|LIPID-TRANSFER PROTEIN CERT|7.07|Kd=0.086uM|Kd|=|0.086|uM|86|nM
5ZYL|1.80|2019|9MC|Kd=0.088+/-0.002uM, kon=1.63E+5, koff=1.43E-2, E25A(1S,2R)|Q9Y5P4|LIPID-TRANSFER PROTEIN CERT|7.06|Kd=0.088uM|Kd|=|0.088|uM|88|nM
6P83|1.70|2019|O3Y|ligand is compound 1o|Q0P6M7|UDP-3-O-(3-HYDROXYMYRISTOYL)GLUCOSAMINE N-ACYLTRANSFERASE|7.1|Kd=0.08uM|Kd|=|0.08|uM|80|nM
6QFQ|1.60|2019|J3E|ligand is compound 3; ITC Kd data|Q07820|INDUCED MYELOID LEUKEMIA CELL DIFFERENTIATION PROTEIN MCL|7.1|Kd=0.08uM|Kd|=|0.08|uM|80|nM
6NFI|2.41|2019|KLP|ligand is compound 5; binding assay is ThermoFluor|Q06187|TYROSINE-PROTEIN KINASE BTK|7.05|Kd=0.09uM|Kd|=|0.09|uM|90|nM
6PI5|1.67|2019|GUN|ligand is guanine; Kd = 0.11 +/- 0.02 uM|Q936X6|ATRAZINE PERIPLASMIC BINDING PROTEIN|6.96|Kd=0.11uM|Kd|=|0.11|uM|110|nM
6PII|1.87|2019|GUN|ligand is guanine; Kd = 0.11 +/- 0.02 uM; redundant to 6pi5|Q936X6|ATRAZINE PERIPLASMIC BINDING PROTEIN|6.96|Kd=0.11uM|Kd|=|0.11|uM|110|nM
6U8L|1.57|2019|Q1P|ligand is compound 6g; Kd = 0.122 +/- 0.04 uM; Binding assay is FPA|P61964|WD REPEAT-CONTAINING PROTEIN 5|6.91|Kd=0.122uM|Kd|=|0.122|uM|122|nM
6QR0|1.59|2019|JFB|ligand is compound 26l; Kd = 0.12+/-0.02uM|B1MDI3|TRNA (GUANINE-N(1)-)-METHYLTRANSFERASE|6.92|Kd=0.12uM|Kd|=|0.12|uM|120|nM
6FZF|1.95|2019|14-mer|microscale thermophoresis, Kd(T475M,in presence of GW1929)=0.15+/-0.04uM|P37231|PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA|6.82|Kd=0.15uM|Kd|=|0.15|uM|150|nM
6EFK|1.50|2019|6-mer|Ac-IEEVD, pKd=6.8|Q9UNE7|E3 UBIQUITIN-PROTEIN LIGASE CHIP|6.8|Kd=0.16uM|Kd|=|0.16|uM|160|nM
6FVL|1.98|2019|6-mer|Kd(EcwtSC)=0.16+/-0.05uM|P0A988|BETA SLIDING CLAMP|6.8|Kd=0.16uM|Kd|=|0.16|uM|160|nM
6NP2|1.20|2019|SIS|ligand is compound sisomicin; Kd = 0.16 +/- 0.01 uM|Q47030|AMINOGLYCOSIDE N(3)-ACETYLTRANSFERASE|6.8|Kd=0.16uM|Kd|=|0.16|uM|160|nM
5ZYK|1.55|2019|9MC|[Different ligand in assay: ] Kd=0.18+/-0.006uM, kon=8.66E+4, koff=2.07E-2|Q9Y5P4|LIPID-TRANSFER PROTEIN CERT|6.74|Kd=0.18uM|Kd|=|0.18|uM|180|nM
6AI9|2.09|2019|PAZ|[Different protein in assay: protein in binding assay is WT] Kd(Cab2,PPA)=0.18+/-0.01uM|P40506|PHOSPHOPANTOTHENATE--CYSTEINE LIGASE CAB2|6.74|Kd=0.18uM|Kd|=|0.18|uM|180|nM
6QQZ|1.70|2019|JEB|ligand is compound 26g; Kd = 0.18 +/- 0.06 uM|B1MDI3|TRNA (GUANINE-N(1)-)-METHYLTRANSFERASE|6.74|Kd=0.18uM|Kd|=|0.18|uM|180|nM
5ZHL|2.25|2019|9D0|compound 15, koff=0.12, kon=6.45E+5|P9WFY6|TRNA (GUANINE-N(1)-)-METHYLTRANSFERASE|6.72|Kd=0.19uM|Kd|=|0.19|uM|190|nM
6KDI|2.70|2019|2-mer|Ka=5.2x10 E6 M-1, ligand is dT(6-4)T DNA|------|ANTI-(6-4) PHOTOPRODUCT ANTIBODY 64M-5 FAB (LIGHT CHAIN)|6.72|Kd=0.19uM|Kd|=|0.19|uM|190|nM
6E23|1.66|2019|HLJ|compound is C6|P61964|WD REPEAT-CONTAINING PROTEIN 5|10.0|Kd=0.1nM|Kd|=|0.1|nM|0.1|nM
6IPH|1.65|2019|DTP|[Nonstandard assay: in presence of Mn2+]|Q9NP87|DNA-DIRECTED DNA/RNA POLYMERASE MU|6.66|Kd=0.22uM|Kd|=|0.22|uM|220|nM
6IDG|2.00|2019|2-mer|ligand is dT(6-4)T|------|ANTI-(6-4) PHOTOPRODUCT ANTIBODY 64M-5 FAB (LIGHT CHAIN)|6.66|Kd=0.22uM|Kd|=|0.22|uM|220|nM
6FVM|1.63|2019|6-mer|Kd(EcM1SC)=0.25+/-0.09uM|P0A990|BETA SLIDING CLAMP|6.6|Kd=0.25uM|Kd|=|0.25|uM|250|nM
6I17|1.56|2019|GZW|ligand is 24|Q16658|FASCIN|6.6|Kd=0.25uM|Kd|=|0.25|uM|250|nM
6MQM|3.48|2019|7-mer||------|ANTIBODY FAB HEAVY CHAIN|9.57|Kd=0.269nM|Kd|=|0.269|nM|0.269|nM
6U8O|1.60|2019|Q1G|ligand is compound 5n; Kd = 0.289 +/- 0.19 uM; Binding assay is FPA|P61964|WD REPEAT-CONTAINING PROTEIN 5|6.54|Kd=0.289uM|Kd|=|0.289|uM|289|nM
6FZG|2.10|2019|EDK|[Nonstandard assay: binding affinity for PPAR gamma and its peptide in the presence of EDK] microscale thermophoresis, peptide is not solved in the crystal structure. Kd(I290M,in presence of GW1929)=0.28/-0.09uM|P37231|PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA|6.55|Kd=0.28uM|Kd|=|0.28|uM|280|nM
6OJA|1.55|2019|MET|L-methionine|Q9JPG4|LIPOPROTEIN|9.7|Kd=0.2nM|Kd|=|0.2|nM|0.2|nM
6N9L|2.01|2019|ADP||Q9WYV0|UVRABC SYSTEM PROTEIN A|6.7|Kd=0.2uM|Kd|=|0.2|uM|200|nM
6PHR|1.65|2019|SS9|ligand is compound 3|------|ACETYLPOLYAMINE AMIDOHYDROLASE|6.7|Kd=0.2uM|Kd|=|0.2|uM|200|nM
6QGK|1.80|2019|J1Q|ligand is compound 2; SPR Kd=0.2uM, ITC Kd=0.2uM, FP Ki=1.3uM|P10415|APOPTOSIS REGULATOR BCL-2,BCL-2-LIKE PROTEIN 1,APOPTOSIS|6.7|Kd=0.2uM|Kd|=|0.2|uM|200|nM
6IDZ|2.71|2019|3-mer|ligand is alpha 2-3|R4NN21|HEMAGGLUTININ HA1 CHAIN|6.51|Kd=0.31uM|Kd|=|0.31|uM|310|nM
6IF0|1.80|2019|A59|ligand is D16|Q9Y5P4|LIPID-TRANSFER PROTEIN CERT|6.51|Kd=0.31uM|Kd|=|0.31|uM|310|nM
6QZ6|1.90|2019|JLE|ligand is compound 8b|Q07820|INDUCED MYELOID LEUKEMIA CELL DIFFERENTIATION PROTEIN MCL|6.49|Kd=0.32uM|Kd|=|0.32|uM|320|nM
6QZ7|2.20|2019|JLE|ligand is compound 8b|P0AEY0|MALTOSE/MALTODEXTRIN-BINDING PERIPLASMIC PROTEIN,INDUCED|6.49|Kd=0.32uM|Kd|=|0.32|uM|320|nM
6PXC|1.60|2019|14-mer|ligand is peptide p190RhoGAP phosphotyrosine; ITC Kd1=0.43uM, Kd2=0.24uM, we use mean value|P20936|RAS GTPASE-ACTIVATING PROTEIN 1|6.47|Kd=0.335uM|Kd|=|0.335|uM|335|nM
6NP3|1.15|2019|LLL|ligand is compound gentamicin; Kd = 0.34 +/- 0.01 uM|Q47030|AMINOGLYCOSIDE N(3)-ACETYLTRANSFERASE|6.47|Kd=0.34uM|Kd|=|0.34|uM|340|nM
6NTJ|1.90|2019|LLL|ligand is compound gentamicin; redundant to 6np3|C4NV15|AMINOGLYCOSIDE N(3)-ACETYLTRANSFERASE|6.47|Kd=0.34uM|Kd|=|0.34|uM|340|nM
6QZB|2.00|2019|JLK|ligand is compound 8d|Q07820|INDUCED MYELOID LEUKEMIA CELL DIFFERENTIATION PROTEIN MCL|6.47|Kd=0.34uM|Kd|=|0.34|uM|340|nM
6G2R|2.10|2019|EJK|compound 6|P08191|TYPE 1 FIMBRIN D-MANNOSE SPECIFIC ADHESIN|9.46|Kd=0.35nM|Kd|=|0.35|nM|0.35|nM
6QI7|2.50|2019|PLM|ligand is palmitic acid; Kd = 0.35 +/- 0.09 uM|P02754|BETA-LACTOGLOBULIN|6.46|Kd=0.35uM|Kd|=|0.35|uM|350|nM
6QR3|1.61|2019|JE8|ligand is compound 26o; Kd = 0.36+/-0.05uM|B1MDI3|TRNA (GUANINE-N(1)-)-METHYLTRANSFERASE|6.44|Kd=0.36uM|Kd|=|0.36|uM|360|nM
6FZP|2.30|2019|14-mer|microscale thermophoresis, Kd(WT,in presence of GW1929)=0.38/-0.09uM|P37231|PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA|6.42|Kd=0.38uM|Kd|=|0.38|uM|380|nM
6PFJ|2.08|2019|C2E|ligand is ci-di-GMP; Kd = 0.39 +/- 0.05 uM; FP assay|F2RFR7|AMFC PROTEIN|6.41|Kd=0.39uM|Kd|=|0.39|uM|390|nM
6MOM|2.10|2019|JX4|ligand is NCGC1481|Q9NWZ3|INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE 4|9.52|Kd=0.3nM|Kd|=|0.3|nM|0.3|nM
6N7D|1.78|2019|KF4|ligand is 54|P23458|TYROSINE-PROTEIN KINASE JAK1|9.52|Kd=0.3nM|Kd|=|0.3|nM|0.3|nM
6IEZ|1.90|2019|A50|ligand is B16|Q9Y5P4|LIPID-TRANSFER PROTEIN CERT|6.52|Kd=0.3uM|Kd|=|0.3|uM|300|nM
6PEK|4.20|2019|10-mer|ligand is peptide (EY)5; Kd = 0.3 +/- 0.1 uM; FP assay|Q9UBP0|SPASTIN|6.52|Kd=0.3uM|Kd|=|0.3|uM|300|nM
6R4S|2.75|2019|ATP|ligand is ATP; assay in the precense of Mn2+|P49642|DNA PRIMASE SMALL SUBUNIT|6.39|Kd=0.41uM|Kd|=|0.41|uM|410|nM
6C8C|1.50|2019|EQ7|compound is JH-RE-06|Q9QUG2|CHIMERIC PROTEIN OF THE POL KAPPA RIR HELIX AND THE REV1 C|6.38|Kd=0.42uM|Kd|=|0.42|uM|420|nM
6U8B|1.26|2019|Q1M|ligand is compound 6b; Kd = 0.431 +/- 0.08 uM; Binding assay is FPA|P61964|WD REPEAT-CONTAINING PROTEIN 5|6.37|Kd=0.431uM|Kd|=|0.431|uM|431|nM
6SY7|2.75|2019|AMP|ligand is AMP|O15648|ATP-DEPENDENT 6-PHOSPHOFRUCTOKINASE|3.33|Kd=0.47mM|Kd|=|0.47|mM|470000|nM
6FZJ|2.01|2019|14-mer|microscale thermophoresis, Kd(M280I,in presence of GW1929)=0.47+/-0.08uM|P37231|PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA|6.33|Kd=0.47uM|Kd|=|0.47|uM|470|nM
6R7R|2.80|2019|DAS|ligand is compound D-ASPARTIC ACID; Kd in presence of 300 mM NaCl; no D-aspartate binding in absence of NaCl|Q5JID0|PROTON/GLUTAMATE SYMPORTER, SDF FAMILY|6.33|Kd=0.47uM|Kd|=|0.47|uM|470|nM
6IDB|2.50|2019|3-mer|ligand is alpha 2-6|R4NN21|HEMAGGLUTININ HA1 CHAIN|6.4|Kd=0.4uM|Kd|=|0.4|uM|400|nM
6U5M|1.80|2019|Q0S|ligand is compound 7t; Kd = 0.511 +/- 0.050 uM; Binding assay is FPA|P61964|WD REPEAT-CONTAINING PROTEIN 5|6.29|Kd=0.511uM|Kd|=|0.511|uM|511|nM
6J81|1.80|2019|B8X|ligand is E14 (this code is belong to literature 6iez )|Q9Y5P4|LIPID-TRANSFER PROTEIN CERT|6.29|Kd=0.51uM|Kd|=|0.51|uM|510|nM
6OP9|2.50|2019|DB8|Bosutinib; Kd=0.52+/-0.06nM|P21860|RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3|9.28|Kd=0.52nM|Kd|=|0.52|nM|0.52|nM
5ZYS|1.78|2019|10-mer||Q6RHR9|MEMBRANE-ASSOCIATED GUANYLATE KINASE, WW AND PDZ DOMAIN|6.27|Kd=0.54uM|Kd|=|0.54|uM|540|nM
6P3W|2.54|2019|7-mer|[Different protein in assay: Assay use Cyclin A, crystal use Cyclin A-CDK2] ligand is ORC1(233-240) peptide|P24941|CYCLIN-DEPENDENT KINASE 2|6.26|Kd=0.55uM|Kd|=|0.55|uM|550|nM
6O3X|1.99|2019|12-mer|ligand is peptide Sen1 NIM2; Kd = 0.56 +/- 0.05 uM|P53617|PROTEIN NRD1|6.25|Kd=0.56uM|Kd|=|0.56|uM|560|nM
6QR4|1.52|2019|JD8|ligand is compound 26n; Kd = 0.59+/-0.23uM|B1MDI3|TRNA (GUANINE-N(1)-)-METHYLTRANSFERASE|6.23|Kd=0.59uM|Kd|=|0.59|uM|590|nM
6NAD|2.90|2019|KHY|ligand is 25|P51449|NUCLEAR RECEPTOR ROR-GAMMA|9.3|Kd=0.5nM|Kd|=|0.5|nM|0.5|nM
6DYZ|1.62|2019|OS2|Kd(HsMTAP, 15)=0.63+/-0.08nM|Q13126|S-METHYL-5'-THIOADENOSINE PHOSPHORYLASE|9.2|Kd=0.63nM|Kd|=|0.63|nM|0.63|nM
6R8L|1.64|2019|JUZ|ligand is compound 16|P30405|PEPTIDYL-PROLYL CIS-TRANS ISOMERASE F|6.17|Kd=0.670uM|Kd|=|0.67|uM|670|nM
6MKQ|1.90|2019|NXL|[Covalent complex] ligand is avibactam|------|BETA-LACTAMASE|6.16|Kd=0.686uM|Kd|=|0.686|uM|686|nM
6PI7|2.80|2019|16-mer|ligand is compound PIWIL1-based peptide; Kd = 0.68+/-0.06 uM|Q9Y2W6|TUDOR AND KH DOMAIN-CONTAINING PROTEIN|6.17|Kd=0.68uM|Kd|=|0.68|uM|680|nM
6MD4|2.24|2019|BRL|two ligands: Rosiglitazone and OA, Kd(Rosiglitazone)=1.28uM|P37231|PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA|6.16|Kd=0.69uM|Kd|=|0.69|uM|690|nM
6HGI|1.52|2019|C0R|ligand is Corticosterone|P01011|ALPHA-1-ANTICHYMOTRYPSIN|6.22|Kd=0.6uM|Kd|=|0.6|uM|600|nM
6AEC|1.72|2019|ATP|[Nonstandard assay: in presence of Mn2+] Kd(MnrATP)=0.71+/-0.21uM|Q9NP87|DNA-DIRECTED DNA/RNA POLYMERASE MU|6.15|Kd=0.71uM|Kd|=|0.71|uM|710|nM
6J72|2.20|2019|GTP||I7FE16|ISONIAZID INDUCIBLE GENE PROTEIN INIA|6.13|Kd=0.74uM|Kd|=|0.74|uM|740|nM
6AK5|1.70|2019|GTP|[Nonstandard assay: in presence of Mn2+] Kd(MnrGTP)=0.75+/-0.16uM|Q9NP87|DNA-DIRECTED DNA/RNA POLYMERASE MU|6.12|Kd=0.75uM|Kd|=|0.75|uM|750|nM
6HQ7|2.46|2019|PCG|dimer has two active binding site(positive co-operativity)|Q6MLN6|EAL ENZYME BD1971|6.11|Kd=0.769uM|Kd|=|0.769|uM|769|nM
6HQ3|2.79|2019|CMP|dimer has two active binding site(negative co-operativity)|Q6MLN6|EAL ENZYME BD1971|6.11|Kd=0.775uM|Kd|=|0.775|uM|775|nM
6A87|2.41|2019|2-mer|fucose(alpha1-6)GlcNAc, Kd=0.7+/-0.14mM|A0A384|LECTIN|3.15|Kd=0.7mM|Kd|=|0.7|mM|700000|nM
6OIE|2.08|2019|19-mer|ligand is peptide H3K14cr; Kd = 0.7 +/- 0.1 uM|Q8WYB5|HISTONE ACETYLTRANSFERASE KAT6B|6.15|Kd=0.7uM|Kd|=|0.7|uM|700|nM
6P7P|1.67|2019|3-mer|ligand is 3-mer nucleic acid cAAA|D7Y2H5|E. COLI MS115-1 NUCC 2-241|6.15|Kd=0.7uM|Kd|=|0.7|uM|700|nM
6DSP|1.37|2019|PAV|Kd=0.81+/-0.13uM|U5MRH9|AUTOINDUCER 2-BINDING PROTEIN LSRB|6.09|Kd=0.81uM|Kd|=|0.81|uM|810|nM
6QYL|2.20|2019|JLE|ligand is compound 8a|P0AEY0|MALTOSE/MALTODEXTRIN-BINDING PERIPLASMIC PROTEIN,INDUCED|6.08|Kd=0.83uM|Kd|=|0.83|uM|830|nM
6QZ5|2.00|2019|JLE|ligand is compound 8a|Q07820|INDUCED MYELOID LEUKEMIA CELL DIFFERENTIATION PROTEIN MCL|6.08|Kd=0.83uM|Kd|=|0.83|uM|830|nM
6HTN|1.55|2019|MFU|ligand is methyl-a-L-fucoside|------|FUCOSE-BINDING LECTIN|6.07|Kd=0.86uM|Kd|=|0.86|uM|860|nM
6MLO|1.72|2019|ARG||P02911|LYSINE/ARGININE/ORNITHINE-BINDING PERIPLASMIC PROTEIN|6.1|Kd=0.8uM|Kd|=|0.8|uM|800|nM
6N3F|2.10|2019|4-mer|[Incomplete ligand] ligand is ULM5|O43719|HIV TAT-SPECIFIC FACTOR 1|6.1|Kd=0.8uM|Kd|=|0.8|uM|800|nM
6HM1|1.54|2019|AO3|ligand is Allosamidin|A8GFD6|GLYCOSIDE HYDROLASE FAMILY 18|6.04|Kd=0.91uM|Kd|=|0.91|uM|910|nM
6DZ0|1.62|2019|OS3|Kd(HsMTAP, 16)=0.94+/-0.12nM|Q13126|S-METHYL-5'-THIOADENOSINE PHOSPHORYLASE|9.03|Kd=0.94nM|Kd|=|0.94|nM|0.94|nM
6R8I|1.52|2019|19-mer|ligand is FxxP motif model peptide SLPFTFKVPAPPPSLPPS|Q6IN85|SERINE/THREONINE-PROTEIN PHOSPHATASE 4 REGULATORY SUBUNIT|6.03|Kd=0.94uM|Kd|=|0.94|uM|940|nM
6JBB|1.95|2019|SUC||Q5SLD7|ABC TRANSPORTER, PERIPLASMIC SUBSTRATE-BINDING PROTEIN|5.99|Kd=1.03uM|Kd|=|1.03|uM|1030|nM
6JB4|1.63|2019|MAL||Q5SLD7|ABC TRANSPORTER, PERIPLASMIC SUBSTRATE-BINDING PROTEIN|5.98|Kd=1.04uM|Kd|=|1.04|uM|1040|nM
6MLE|1.86|2019|ARG||P02911|LYSINE/ARGININE/ORNITHINE-BINDING PERIPLASMIC PROTEIN|9.0|Kd=1.0nM|Kd|=|1|nM|1|nM
6QGF|1.34|2019|J0T|Ligand is compound R; Kd = 1.0+/-0.03 uM|P17931|GALECTIN-3|6.0|Kd=1.0uM|Kd|=|1|uM|1000|nM
6UYX|1.70|2019|17-mer|ligand is peptide DAXX-SIM-PO4; Kd = 1.0 +/- 0.2 uM|P63165|SMALL UBIQUITIN-RELATED MODIFIER 1|6.0|Kd=1.0uM|Kd|=|1|uM|1000|nM
6MBO|1.59|2019|JDG|[Different protein in assay: protein in binding assay is G9a] ligand is 12a in space group P212121|Q9H9B1|HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1|5.95|Kd=1.13uM|Kd|=|1.13|uM|1130|nM
6MBP|1.95|2019|JDG|[Different protein in assay: protein in binding assay is G9a] ligand is 12a in space group P3121|Q9H9B1|HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1|5.95|Kd=1.13uM|Kd|=|1.13|uM|1130|nM
6PKA|2.25|2019|7-mer|compound 16, Kd=1.19+/-0.1uM|Q2G036|ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT|5.92|Kd=1.19uM|Kd|=|1.19|uM|1190|nM
6R9X|1.66|2019|JW2|ligand is compound 8|P30405|PEPTIDYL-PROLYL CIS-TRANS ISOMERASE F|2.96|Kd=1.1mM|Kd|=|1.1|mM|1100000|nM
6D9S|2.11|2019|G4P|compound is (p)ppGpp|------|HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE|5.96|Kd=1.1uM|Kd|=|1.1|uM|1100|nM
6OS6|1.33|2019|TRP|ligand is L-Trp; binding to CymD prenyltransferase-DMSPP|A8M6W6|CYMD PRENYLTRANSFERASE|5.96|Kd=1.1uM|Kd|=|1.1|uM|1100|nM
6A80|1.56|2019|CYS|[Different ligand in assay: ligand in binding assay is L-cystine (S)] ligand in crystal structure is different from the literature|C6XGT2|PUTATIVE AMINO ACID-BINDING PERIPLASMIC ABC TRANSPORTER|5.9|Kd=1.26uM|Kd|=|1.26|uM|1260|nM
6MD0|1.95|2019|OLA||P37231|PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA|5.9|Kd=1.27uM|Kd|=|1.27|uM|1270|nM
6MH1|1.60|2019|JQP|ligand is compound V|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|5.92|Kd=1.2uM|Kd|=|1.2|uM|1200|nM
6N48|3.20|2019|KBY|ligand is Cmpd-6FA|P07550|ENDOLYSIN,BETA-2 ADRENERGIC RECEPTOR,BETA-2 ADRENERGIC|5.92|Kd=1.2uM|Kd|=|1.2|uM|1200|nM
6R8W|1.40|2019|JVH|ligand is compound 40|P30405|PEPTIDYL-PROLYL CIS-TRANS ISOMERASE F|5.92|Kd=1.2uM|Kd|=|1.2|uM|1200|nM
6IYV|1.50|2019|2RG|[Covalent complex] ligand is ertapenem|I6Y9J2|L,D-TRANSPEPTIDASE 2|5.88|Kd=1.32uM|Kd|=|1.32|uM|1320|nM
6GJ8|1.65|2019|F0K|ligand is BI2852|P01116|GTPASE KRAS|5.87|Kd=1.36uM|Kd|=|1.36|uM|1360|nM
6E22|1.60|2019|HLS|compound is C3|P61964|WD REPEAT-CONTAINING PROTEIN 5|8.89|Kd=1.3nM|Kd|=|1.3|nM|1.3|nM
6DZ3|1.91|2019|OS6|Kd(HsMTAP, 30)=1.3+/-0.1nM|Q13126|S-METHYL-5'-THIOADENOSINE PHOSPHORYLASE|8.89|Kd=1.3nM|Kd|=|1.3|nM|1.3|nM
6N0P|2.37|2019|K81|ligand is 15|P15056|SERINE/THREONINE-PROTEIN KINASE B-RAF|8.89|Kd=1.3nM|Kd|=|1.3|nM|1.3|nM
6K4R|3.11|2019|AMP|binding assay method is microscale thermophoresis|Q5ZTK6|SIDJ|5.84|Kd=1.45uM|Kd|=|1.45|uM|1450|nM
6DZ2|1.99|2019|OS5|Kd(HsMTAP, 32)=1.4+/-0.1nM|Q13126|S-METHYL-5'-THIOADENOSINE PHOSPHORYLASE|8.85|Kd=1.4nM|Kd|=|1.4|nM|1.4|nM
6E1A|3.10|2019|HL7|compound is 42 (M-89), Biolayer Interferometry assay, Kd=1.4+/-0.6nM, koff=2.9E-4, kon=2.3E+5|O00255|MENIN|8.85|Kd=1.4nM|Kd|=|1.4|nM|1.4|nM
6I5J|2.80|2019|11-mer|ligand is GHR2_pY595|O14508|SUPPRESSOR OF CYTOKINE SIGNALING 2|5.85|Kd=1.4uM|Kd|=|1.4|uM|1400|nM
6I5N|1.98|2019|11-mer|ligand is GHR2_pY595|O14508|SUPPRESSOR OF CYTOKINE SIGNALING 2|5.85|Kd=1.4uM|Kd|=|1.4|uM|1400|nM
6N3W|1.75|2019|KBJ|ligand is 2|P49773|HISTIDINE TRIAD NUCLEOTIDE-BINDING PROTEIN 1|5.81|Kd=1.56uM|Kd|=|1.56|uM|1560|nM
6BS3|2.30|2019|ADP|Kd(BagAB, ADP)=1.5uM|P9WKX5|PUTATIVE ATPASE RV3679|5.82|Kd=1.5uM|Kd|=|1.5|uM|1500|nM
6I14|1.73|2019|GZN|ligand is 9|Q16658|FASCIN|5.82|Kd=1.5uM|Kd|=|1.5|uM|1500|nM
6N0M|3.30|2019|K94|ligand is NV-5138|P58004|SESTRIN-2|5.82|Kd=1.5uM|Kd|=|1.5|uM|1500|nM
6RML|2.81|2019|15-mer|ligand is peptide 53BP1 pT670 phosphopeptide; Kd = 1.5 +/- 0.2uM; Binding assay is Fluorescence polarisation|Q92547|DNA TOPOISOMERASE 2-BINDING PROTEIN 1|5.82|Kd=1.5uM|Kd|=|1.5|uM|1500|nM
6JAN|1.77|2019|MAL||Q5SLD7|ABC TRANSPORTER, PERIPLASMIC SUBSTRATE-BINDING PROTEIN|5.79|Kd=1.61uM|Kd|=|1.61|uM|1610|nM
6AAD|1.44|2019|9TU|compound is mTmdZLys|Q8PWY1|PYRROLYSINE--TRNA LIGASE|2.79|Kd=1.62mM|Kd|=|1.62|mM|1620000|nM
6IPJ|1.98|2019|TTP|[Nonstandard assay: in presence of Mn2+]|Q9NP87|DNA-DIRECTED DNA/RNA POLYMERASE MU,DNA-DIRECTED DNA/RNA|5.79|Kd=1.62uM|Kd|=|1.62|uM|1620|nM
6RQK|1.85|2019|MVL|ligand is compound mannoimidazole|Q8XNB2|ALPHA-1,6-MANNOSIDASE|2.8|Kd=1.6mM|Kd|=|1.6|mM|1600000|nM
5ZHN|2.65|2019|9D0|compound 15, koff=2.18E-2, kon=1.35E+7|Q02RL6|TRNA (GUANINE-N(1)-)-METHYLTRANSFERASE|8.8|Kd=1.6nM|Kd|=|1.6|nM|1.6|nM
6STL|1.30|2019|TAU|ligand is taurine|Q47537|TAURINE-BINDING PERIPLASMIC PROTEIN|8.8|Kd=1.6nM|Kd|=|1.6|nM|1.6|nM
6INZ|2.29|2019|2-mer|[Incomplete ligand] ligand is deltaHA|D1AWE0|EXTRACELLULAR SOLUTE-BINDING PROTEIN FAMILY 1|5.8|Kd=1.6uM|Kd|=|1.6|uM|1600|nM
6MNC|2.40|2019|J3Z|ligand is E1|P14061|ESTRADIOL 17-BETA-DEHYDROGENASE 1|5.8|Kd=1.6uM|Kd|=|1.6|uM|1600|nM
6R4V|2.20|2019|BFQ|ligand is compound ibandronate; Kd = 1.74 +/- 0.22 uM|O95749|GERANYLGERANYL PYROPHOSPHATE SYNTHASE|5.76|Kd=1.74uM|Kd|=|1.74|uM|1740|nM
6AAN|1.51|2019|9TX|compound is mEtZLys|Q8PWY1|PYRROLYSINE--TRNA LIGASE|2.75|Kd=1.76mM|Kd|=|1.76|mM|1760000|nM
6I8T|2.10|2019|H7Z|ligand is (R)-13|P26446|POLY [ADP-RIBOSE] POLYMERASE 1|5.75|Kd=1.76uM|Kd|=|1.76|uM|1760|nM
6AEH|1.64|2019|UTP|[Nonstandard assay: in presence of Mn2+] Kd(MnrUTP)=1.77+/-0.60uM|Q9NP87|DNA-DIRECTED DNA/RNA POLYMERASE MU|5.75|Kd=1.77uM|Kd|=|1.77|uM|1770|nM
5ZDB|1.97|2019|AR6|Kd=1.78+/-0.05uM, crystal P21|Q9RZM4|POLY ADP-RIBOSE GLYCOHYDROLASE|5.75|Kd=1.78uM|Kd|=|1.78|uM|1780|nM
5ZDD|2.73|2019|AR6|Kd=1.78+/-0.05uM, crystal P212121; redundant to 5zdb|Q9RZM4|POLY ADP-RIBOSE GLYCOHYDROLASE|5.75|Kd=1.78uM|Kd|=|1.78|uM|1780|nM
5ZDC|1.98|2019|AR6|Kd=1.78+/-0.05uM, crystal P32; redundant to 5zdb|Q9RZM4|POLY ADP-RIBOSE GLYCOHYDROLASE|5.75|Kd=1.78uM|Kd|=|1.78|uM|1780|nM
5ZDE|2.80|2019|AR6|Kd=1.78+/-0.05uM, crystal P3221; redundant to 5zdb|Q9RZM4|POLY ADP-RIBOSE GLYCOHYDROLASE|5.75|Kd=1.78uM|Kd|=|1.78|uM|1780|nM
5ZYM|1.90|2019|9M6|Kd=1.7+/-0.6uM, kon=1.01E+5, koff=1.68E-1, E25B(1R,2S)|Q9Y5P4|LIPID-TRANSFER PROTEIN CERT|5.77|Kd=1.7uM|Kd|=|1.7|uM|1700|nM
6GGE|1.25|2019|EYE||P04637|CELLULAR TUMOR ANTIGEN P53|5.77|Kd=1.7uM|Kd|=|1.7|uM|1700|nM
6A9C|1.98|2019|9-mer|P2|C4LUC7|UNCONVENTIONAL MYOSIN IB|2.74|Kd=1.8mM|Kd|=|1.8|mM|1800000|nM
6D78|2.35|2019|9-mer|alpha-D26Y, beta-L98W, Kd=1.8+/-0.3nM|P01892|HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA CHAIN|8.74|Kd=1.8nM|Kd|=|1.8|nM|1.8|nM
6MH7|1.74|2019|JQY|ligand is compound IV|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|5.74|Kd=1.8uM|Kd|=|1.8|uM|1800|nM
6IPI|1.80|2019|DCP|[Nonstandard assay: in presence of Mn2+]|Q9NP87|DNA-DIRECTED DNA/RNA POLYMERASE MU|5.71|Kd=1.95uM|Kd|=|1.95|uM|1950|nM
5ZDF|2.50|2019|AR6|T267K, Kd=1.98+/-0.02uM|Q9RZM4|POLY ADP-RIBOSE GLYCOHYDROLASE|5.7|Kd=1.98uM|Kd|=|1.98|uM|1980|nM
6HOL|1.40|2019|15-mer|ligand is LIR peptide of ATG14|Q9H0R8|GAMMA-AMINOBUTYRIC ACID RECEPTOR-ASSOCIATED PROTEIN-LIKE 1|5.72|Kd=1.9uM|Kd|=|1.9|uM|1900|nM
6UYY|1.60|2019|17-mer|ligand is peptide DAXX-SIM-PO4; Kd = 1.9 +/- 0.3 uM|P63165|SMALL UBIQUITIN-RELATED MODIFIER 1|5.72|Kd=1.9uM|Kd|=|1.9|uM|1900|nM
5ZHJ|1.75|2019|SAH|koff=7.75E-2, kon=7.7E+3|P9WFY7|TRNA (GUANINE-N(1)-)-METHYLTRANSFERASE|5.0|Kd=10.1uM|Kd|=|10.1|uM|10100|nM
6O68|2.78|2019|LO4|compound is cioglitazone|P37231|PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA|4.99|Kd=10.3uM|Kd|=|10.3|uM|10300|nM
6P85|1.90|2019|O4V|ligand is compound 3|Q0P6M7|UDP-3-O-(3-HYDROXYMYRISTOYL)GLUCOSAMINE N-ACYLTRANSFERASE|4.99|Kd=10.3uM|Kd|=|10.3|uM|10300|nM
6JOF|2.20|2019|BWR|AZ51, koff=0.21, kon=2.01E+4|P9WFY7|TRNA (GUANINE-N(1)-)-METHYLTRANSFERASE|4.98|Kd=10.4uM|Kd|=|10.4|uM|10400|nM
6HAJ|1.50|2019|EVB|ligand is sclx8 which is bidentate-ligand model|B6HWK0|PC24G00380 PROTEIN|4.97|Kd=10.6uM|Kd|=|10.6|uM|10600|nM
6KJF|2.40|2019|SIM|ligand is simvastatin|B6H6L7|PC15G00720 PROTEIN|4.97|Kd=10.8uM|Kd|=|10.8|uM|10800|nM
6HAZ|1.31|2019|FX5||P51531|PROBABLE GLOBAL TRANSCRIPTION ACTIVATOR SNF2L2|7.0|Kd=100nM|Kd|=|100|nM|100|nM
6QL3|1.35|2019|V14|ligand is compound 25|P00918|CARBONIC ANHYDRASE 2|7.0|Kd=100nM|Kd|=|100|nM|100|nM
6QRD|1.75|2019|JEH|ligand is compound 29e; Kd = 100 +/- 24nM|B1MDI3|TRNA (GUANINE-N(1)-)-METHYLTRANSFERASE|7.0|Kd=100nM|Kd|=|100|nM|100|nM
6J3P|1.60|2019|B8O|ligand is (R,R)-36n|Q92830|HISTONE ACETYLTRANSFERASE KAT2A|6.98|Kd=105nM|Kd|=|105|nM|105|nM
6RIH|2.15|2019|K4T|ligand is compound 9|O43175|D-3-PHOSPHOGLYCERATE DEHYDROGENASE|3.98|Kd=105uM|Kd|=|105|uM|105000|nM
6HA4|1.33|2019|T3Y|ligand is sclx4|B6HWK0|PC24G00380 PROTEIN|3.97|Kd=107uM|Kd|=|107|uM|107000|nM
6QRG|1.84|2019|JET|ligand is compound 8; Kd = 10 +/- 1 uM|B1MDI3|TRNA (GUANINE-N(1)-)-METHYLTRANSFERASE|5.0|Kd=10uM|Kd|=|10|uM|10000|nM
6PIA|1.75|2019|XS6|ligand is compound 6|------|ACETYLPOLYAMINE AMIDOHYDROLASE|4.96|Kd=11.0uM|Kd|=|11|uM|11000|nM
5ZBZ|1.31|2019|SAU|N-terminal domain, microscale thermophoresis assay, Kd=11.1+/-0.9uM|P60842|EUKARYOTIC INITIATION FACTOR 4A-I|4.95|Kd=11.1uM|Kd|=|11.1|uM|11100|nM
6ABK|1.58|2019|9VF|compound is TeocLys|------|PYRROLYSINE--TRNA LIGASE|1.95|Kd=11.3mM|Kd|=|11.3|mM|11300000|nM
6J0O|1.80|2019|XAF|ligand is SC1(this code is belong to literature 6iez)|Q9Y5P4|LIPID-TRANSFER PROTEIN CERT|4.92|Kd=11.9uM|Kd|=|11.9|uM|11900|nM
6JAQ|1.95|2019|GLC||Q5SLD7|ABC TRANSPORTER, PERIPLASMIC SUBSTRATE-BINDING PROTEIN|3.95|Kd=111.23uM|Kd|=|111.23|uM|111230|nM
6FMN|1.36|2019|E4E|microsomal stability assay, Kd(compound 2)=1120+/-110nM|P28720|QUEUINE TRNA-RIBOSYLTRANSFERASE|5.95|Kd=1120nM|Kd|=|1120|nM|1120|nM
6D49|1.80|2019|FVP|Kd(P22)=118+/-41uM, crystal 1|P20138|MYELOID CELL SURFACE ANTIGEN CD33|3.93|Kd=118uM|Kd|=|118|uM|118000|nM
6D4A|1.75|2019|FVP|Kd(P22)=118+/-41uM, crystal 1|P20138|MYELOID CELL SURFACE ANTIGEN CD33|3.93|Kd=118uM|Kd|=|118|uM|118000|nM
6GJW|1.90|2019|F2H|ligand is 5a|P98170|E3 UBIQUITIN-PROTEIN LIGASE XIAP|4.96|Kd=11uM|Kd|=|11|uM|11000|nM
6I77|1.22|2019|H5Q|[Different ligand in assay: ligand in binding asssay is racemic mixture] ligand is 5|P17931|GALECTIN-3|4.96|Kd=11uM|Kd|=|11|uM|11000|nM
6PG5|1.99|2019|OHV|ligand is compound 35; Kd = 11 +/- 1 uM|P61964|WD REPEAT-CONTAINING PROTEIN 5|4.96|Kd=11uM|Kd|=|11|uM|11000|nM
6NV7|2.13|2019|L3J|ligand is inhibitor 2; Kd = 12.1 +/- 5.8 nM|P56817|BETA-SECRETASE 1|7.92|Kd=12.1nM|Kd|=|12.1|nM|12.1|nM
6CF7|2.72|2019|EZ7|JNJ4796|A7Y8I1|HEMAGGLUTININ|7.91|Kd=12.2nM|Kd|=|12.2|nM|12.2|nM
6DGR|2.15|2019|GDY|compound is CAY10638|P37231|PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA|4.91|Kd=12.3uM|Kd|=|12.3|uM|12300|nM
6I4X|2.69|2019|11-mer|ligand is EpoR_pY426|Q15370|ELONGIN-B|4.9|Kd=12.5uM|Kd|=|12.5|uM|12500|nM
6A05|2.20|2019|1YD|MST assay, Kd(3',3'-cGAMP)=12.8+/-1.1uM|B8XX90|STIMULATOR OF INTERFERON GENES PROTEIN|4.89|Kd=12.8uM|Kd|=|12.8|uM|12800|nM
6A30|2.79|2019|6-mer|[Different protein in assay: peptide used in binding assay is syb2(29-96)] Kd(syb2(29-96))=12.9+/-1.8uM|Q62768|PROTEIN UNC-13 HOMOLOG A|4.89|Kd=12.9uM|Kd|=|12.9|uM|12900|nM
6E7U|2.27|2019|HX7|[Nonstandard assay: PH=7.6] Kd(PH=7.6)=121+/-5.1nM, Kd(PH=6.5)=78+/-3.0nM, chain BD: 363|Q00960|GLUTAMATE RECEPTOR IONOTROPIC, NMDA 1|6.92|Kd=121nM|Kd|=|121|nM|121|nM
6CJJ|1.74|2019|ADP||P46598|HEAT SHOCK PROTEIN 90 HOMOLOG|3.9|Kd=125uM|Kd|=|125|uM|125000|nM
6E7T|2.31|2019|HYY|[Nonstandard assay: PH=7.6] Kd(PH=7.6)=129+/-9.3nM, Kd(PH=6.5)+116+/-2.2nM, Chain BD: 363|Q00960|GLUTAMATE RECEPTOR IONOTROPIC, NMDA 1|6.89|Kd=129nM|Kd|=|129|nM|129|nM
6ME1|1.97|2019|16-mer||P03375|VRC34.01 FAB HEAVY CHAIN|7.92|Kd=12nM|Kd|=|12|nM|12|nM
6PG9|1.75|2019|OH1|ligand is compound 30; Kd = 12 +/- 1 uM|P61964|WD REPEAT-CONTAINING PROTEIN 5|4.92|Kd=12uM|Kd|=|12|uM|12000|nM
6QQV|1.71|2019|JEW|ligand is compound 24d; Kd = 12 +/- 2 uM|B1MDI3|TRNA (GUANINE-N(1)-)-METHYLTRANSFERASE|4.92|Kd=12uM|Kd|=|12|uM|12000|nM
6UN1|2.26|2019|TJ7|[Covalent complex] ligand is temocillin; FPA assay, Kd = Koff / Kon; covalently bound|Q51504|PEPTIDOGLYCAN D,D-TRANSPEPTIDASE FTSI|7.89|Kd=13.0nM|Kd|=|13|nM|13|nM
6JON|2.34|2019|DTP|ligand is dATP|M5AAG8|PRIMASE|4.88|Kd=13.2uM|Kd|=|13.2|uM|13200|nM
6MJQ|3.00|2019|JUD|ligand is 15p|K7N5M3|T CELL RECEPTOR ALPHA VARIABLE 11,T CELL RECEPTOR ALPHA|7.88|Kd=13.3nM|Kd|=|13.3|nM|13.3|nM
6G6X|1.13|2019|11-mer|betaYAP2|P31947|14-3-3 PROTEIN SIGMA|4.88|Kd=13.3uM|Kd|=|13.3|uM|13300|nM
6N55|3.09|2019|UZ0|[Incomplete ligand] ligand is 2 AzUd|Q9BZX2|URIDINE-CYTIDINE KINASE 2|7.87|Kd=13.4nM|Kd|=|13.4|nM|13.4|nM
6N53|2.70|2019|UZR|[Incomplete ligand] ligand is 2 AzUd|Q9BZX2|URIDINE-CYTIDINE KINASE 2|7.87|Kd=13.4nM|Kd|=|13.4|nM|13.4|nM
6MAX|1.42|2019|9TF|[Incomplete ligand] ligand is Purpurin|Q9X1H4|RIBONUCLEASE P PROTEIN COMPONENT|4.87|Kd=13.6uM|Kd|=|13.6|uM|13600|nM
6OP0|2.55|2019|A7A|ligand is UCB-9260; Biopore assay|P01375|TUMOR NECROSIS FACTOR|7.86|Kd=13.8nM|Kd|=|13.8|nM|13.8|nM
6TYZ|1.51|2019|16-mer|ligand is peptide hsAPLF KBM; Kd = 131 +/- 12nM; FP assay|------|X-RAY REPAIR CROSS-COMPLEMENTING PROTEIN 5|6.88|Kd=131nM|Kd|=|131|nM|131|nM
6MT6|1.31|2019|9-mer||P18463|HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-37 ALPHA CHAIN|3.88|Kd=133.0uM|Kd|=|133|uM|133000|nM
6KLK|1.76|2019|URF|ligand is 5-FU|Q9I676|D-HYDANTOINASE/DIHYDROPYRIMIDINASE|3.88|Kd=133.2uM|Kd|=|133.2|uM|133200|nM
6DQL|3.30|2019|8-mer|SIP-WT|D3KVD8|REGULATOR OF PROTEINASE B ROPB|7.89|Kd=13nM|Kd|=|13|nM|13|nM
6I68|1.85|2019|9-mer|[Different protein in assay: ] ligand is BRD3 fragment|O43791|SPECKLE-TYPE POZ PROTEIN|4.89|Kd=13uM|Kd|=|13|uM|13000|nM
6JDL|2.25|2019|AGS|ligand is ATPgS|Q51460|NITROGEN ASSIMILATION REGULATORY PROTEIN|4.89|Kd=13uM|Kd|=|13|uM|13000|nM
6QRC|1.73|2019|JFE|ligand is compound 24b; Kd = 13 +/- 2 uM|B1MDI3|TRNA (GUANINE-N(1)-)-METHYLTRANSFERASE|4.89|Kd=13uM|Kd|=|13|uM|13000|nM
6MJA|2.35|2019|JTJ|ligand is 15o|K7N5M3|T CELL RECEPTOR ALPHA VARIABLE 11,T CELL RECEPTOR ALPHA|7.85|Kd=14.1nM|Kd|=|14.1|nM|14.1|nM
6GGA|1.55|2019|EY2|ligand is PK9284|P04637|CELLULAR TUMOR ANTIGEN P53|4.85|Kd=14.2uM|Kd|=|14.2|uM|14200|nM
6MJJ|1.93|2019|JU4|ligand is 15m|K7N5M3|T CELL RECEPTOR ALPHA VARIABLE 11,T CELL RECEPTOR ALPHA|7.84|Kd=14.3nM|Kd|=|14.3|nM|14.3|nM
6JFK|2.00|2019|GDP||O95140|MITOFUSIN-2,CDNA FLJ57997, HIGHLY SIMILAR TO TRANSMEMBRANE|4.84|Kd=14.4uM|Kd|=|14.4|uM|14400|nM
6PG8|1.67|2019|OGY|ligand is compound 16; Kd = 140 +/- 30 uM|P61964|WD REPEAT-CONTAINING PROTEIN 5|3.85|Kd=140uM|Kd|=|140|uM|140000|nM
6E7R|2.10|2019|HYS|[Nonstandard assay: PH=7.6] Kd(PH=7.6)=147+/-5.0nM, Kd(PH=6.5)=170+/-4.8nM, chain BD: 363|Q00960|GLUTAMATE RECEPTOR IONOTROPIC, NMDA 1|6.83|Kd=147nM|Kd|=|147|nM|147|nM
6QFW|1.20|2019|JR8|[Uncommon element] ligand is cofactor 9; inculde uncommon Ir element|P00918|CARBONIC ANHYDRASE 2|6.83|Kd=149nM|Kd|=|149|nM|149|nM
6QK8|2.92|2019|8-mer|ligand is peptide pS481;Kd = 14 +/- 2 uM|P29311|PROTEIN BMH1|4.85|Kd=14uM|Kd|=|14|uM|14000|nM
6QRE|1.93|2019|JCQ|ligand is compound 7; Kd = 14+/-1uM|B1MDI3|TRNA (GUANINE-N(1)-)-METHYLTRANSFERASE|4.85|Kd=14uM|Kd|=|14|uM|14000|nM
6HAH|1.45|2019|FWQ|ligand is sclx6|B6HWK0|PC24G00380 PROTEIN|4.81|Kd=15.4uM|Kd|=|15.4|uM|15400|nM
6P84|1.70|2019|O3V|ligand is compound 2o|Q0P6M7|UDP-3-O-(3-HYDROXYMYRISTOYL)GLUCOSAMINE N-ACYLTRANSFERASE|4.81|Kd=15.6uM|Kd|=|15.6|uM|15600|nM
6NSV|1.31|2019|6-mer|Ac-LWWPD, pKd=7.8|Q9UNE7|E3 UBIQUITIN-PROTEIN LIGASE CHIP|7.8|Kd=15.8nM|Kd|=|15.8|nM|15.8|nM
6MT4|1.55|2019|9-mer||P18463|HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-37 ALPHA CHAIN|3.82|Kd=150.5uM|Kd|=|150.5|uM|150500|nM
6Q4Q|1.45|2019|8-mer|ligand is Stapled Peptide P2-C4|P68400|CASEIN KINASE II SUBUNIT ALPHA|6.82|Kd=150nM|Kd|=|150|nM|150|nM
6E1Z|1.10|2019|HLP|compound is C4|P61964|WD REPEAT-CONTAINING PROTEIN 5|3.82|Kd=150uM|Kd|=|150|uM|150000|nM
6IPL|1.64|2019|DTP|[Nonstandard assay: in presence of Mg2+]|Q9NP87|DNA-DIRECTED DNA/RNA POLYMERASE MU|3.82|Kd=153uM|Kd|=|153|uM|153000|nM
6CD5|1.58|2019|R4L|Kd(XMD17-26)=156+/-12nM|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|6.81|Kd=156nM|Kd|=|156|nM|156|nM
6PYD|2.00|2019|P4S|ligand is compound MBG|------|3E9 ANTI-MARINOBUFAGENIN ANTIBODY FAB HEAVY CHAIN, RECLONED|6.81|Kd=156nM|Kd|=|156|nM|156|nM
6I62|1.65|2019|27N|ligand is Hydroxychlor (HPTE)|P62508|ESTROGEN-RELATED RECEPTOR GAMMA|6.8|Kd=157.5nM|Kd|=|157.5|nM|157.5|nM
6NLJ|1.65|2019|KTV|ligand is analog 12; Kd = 11 +/- 1 uM|Q9HY79|FERROXIDASE|4.82|Kd=15uM|Kd|=|15|uM|15000|nM
6QLR|0.97|2019|J4N|ligand is compound 6; Kd = 15+/-0.3 uM; Binding assay is fluorescence polarization|P17931|GALECTIN-3|4.82|Kd=15uM|Kd|=|15|uM|15000|nM
6JAP|1.77|2019|SUC||Q5SLD7|ABC TRANSPORTER, PERIPLASMIC SUBSTRATE-BINDING PROTEIN|4.8|Kd=16.02uM|Kd|=|16.02|uM|16020|nM
6KMJ|1.40|2019|17-mer|ligand is H3K14Ac|P32597|NUCLEAR PROTEIN STH1/NPS1|4.79|Kd=16.3uM|Kd|=|16.3|uM|16300|nM
6QXJ|1.70|2019|JKQ|ligand is compound 6a|P0AEY0|MALTOSE-BINDING PERIPLASMIC PROTEIN,INDUCED MYELOID|4.79|Kd=16.4uM|Kd|=|16.4|uM|16400|nM
6G2B|1.61|2019|EH8|Kd(compd 8)=160+/-26uM|Q9BZ95|HISTONE-LYSINE N-METHYLTRANSFERASE NSD3|3.8|Kd=160uM|Kd|=|160|uM|160000|nM
6E3S|3.00|2019|79A|microscale thermophoresis, compound is PT2385|P53762|ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR|6.78|Kd=167nM|Kd|=|167|nM|167|nM
6G7A|1.42|2019|EOQ|Kd(9, FTSA)=167nM|O43570|CARBONIC ANHYDRASE 12|6.78|Kd=167nM|Kd|=|167|nM|167|nM
6NFZ|2.97|2019|B49|ligand is compound sunitinib; Protein in crystal is at active state|Q92918|MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE KINASE 1|7.8|Kd=16nM|Kd|=|16|nM|16|nM
6NFY|2.17|2019|B49|ligand is compound sunitinib; Protein in crystal is at inactive state|Q92918|MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE KINASE 1|7.8|Kd=16nM|Kd|=|16|nM|16|nM
6QTS|1.11|2019|9-mer|ligand is peptide UVR8; Kd = 16+/- 1uM|P43254|E3 UBIQUITIN-PROTEIN LIGASE COP1|4.8|Kd=16uM|Kd|=|16|uM|16000|nM
6T1L|2.00|2019|M7N|ligand is compound 3|Q03111|PROTEIN ENL|4.77|Kd=17.1uM|Kd|=|17.1|uM|17100|nM
6OM2|2.77|2019|11-mer|ligand is proTGF-beta1 ligand peptide; assay use TGF-beta3 ligand peptide|P06756|INTEGRIN ALPHA-V|7.75|Kd=17.7nM|Kd|=|17.7|nM|17.7|nM
6N54|2.42|2019|KEA|[Incomplete ligand] ligand is 2 AzCd|Q9BZX2|URIDINE-CYTIDINE KINASE 2|7.75|Kd=17.8nM|Kd|=|17.8|nM|17.8|nM
6G24|2.10|2019|EH2|Kd(compd 3)=1700+/-700uM|Q9BZ95|HISTONE-LYSINE N-METHYLTRANSFERASE NSD3|2.77|Kd=1700uM|Kd|=|1700|uM|1700000|nM
6G2O|1.81|2019|EJE|Kd(compd BI-9321)=170+/-3nM|Q9BZ95|HISTONE-LYSINE N-METHYLTRANSFERASE NSD3|6.77|Kd=170nM|Kd|=|170|nM|170|nM
6E7X|2.58|2019|T97|[Nonstandard assay: PH=7.6] Kd(PH=7.6)=175+/-5.6nM, Kd(PH=6.5)=186+/-11nM, chain BD: 363|Q00960|GLUTAMATE RECEPTOR IONOTROPIC, NMDA 1|6.76|Kd=175nM|Kd|=|175|nM|175|nM
6QL2|1.30|2019|EZL|ligand is EZA|P00918|CARBONIC ANHYDRASE 2|7.77|Kd=17nM|Kd|=|17|nM|17|nM
6MKW|2.32|2019|HIS||P02911|LYSINE/ARGININE/ORNITHINE TRANSPORT PROTEIN|4.77|Kd=17uM|Kd|=|17|uM|17000|nM
6QAS|1.75|2019|34W|Ligand is compound PF-03814735|O75385|SERINE/THREONINE-PROTEIN KINASE ULK1|7.74|Kd=18.1nM|Kd|=|18.1|nM|18.1|nM
6T1J|1.97|2019|M7T|ligand is compound 2|Q03111|PROTEIN ENL|4.74|Kd=18.1uM|Kd|=|18.1|uM|18100|nM
6MIY|2.75|2019|JTV|ligand is 15a|K7N5M3|T CELL RECEPTOR ALPHA VARIABLE 11,T CELL RECEPTOR ALPHA|7.73|Kd=18.5nM|Kd|=|18.5|nM|18.5|nM
6N3E|1.89|2019|7-mer|[Incomplete ligand] ligand is ULM4|O43719|HIV TAT-SPECIFIC FACTOR 1|4.72|Kd=18.9uM|Kd|=|18.9|uM|18900|nM
6I66|1.60|2019|H4Q|ligand is 4-sec-butylphenol|P62508|ESTROGEN-RELATED RECEPTOR GAMMA|6.74|Kd=182.5nM|Kd|=|182.5|nM|182.5|nM
6IOU|2.10|2019|SER|ligand is L-serine|------|METHYL-ACCEPTING CHEMOTAXIS PROTEIN|3.73|Kd=184.2uM|Kd|=|184.2|uM|184200|nM
6I78|1.15|2019|H5H|[Different ligand in assay: ligand in binding asssay is racemic mixture] ligand is 8|P17931|GALECTIN-3|4.74|Kd=18uM|Kd|=|18|uM|18000|nM
6MJ4|2.00|2019|JTG|ligand is 15w|K7N5M3|T CELL RECEPTOR ALPHA VARIABLE 11,T CELL RECEPTOR ALPHA|7.72|Kd=19.1nM|Kd|=|19.1|nM|19.1|nM
6UEG|2.00|2019|Q5G|ligand is compound 2|A6V1E4|ACYL-[ACYL-CARRIER-PROTEIN]--UDP-N-ACETYLGLUCOSAMINE O|4.71|Kd=19.5uM|Kd|=|19.5|uM|19500|nM
6JBE|1.75|2019|GLC||Q5SLD7|ABC TRANSPORTER, PERIPLASMIC SUBSTRATE-BINDING PROTEIN|4.7|Kd=19.80uM|Kd|=|19.8|uM|19800|nM
6QR9|2.42|2019|JEE|ligand is compound 29c; Kd = 190 +/- 23nM|B1MDI3|TRNA (GUANINE-N(1)-)-METHYLTRANSFERASE|6.72|Kd=190nM|Kd|=|190|nM|190|nM
6QTQ|1.30|2019|9-mer|ligand is peptide UVR8; Kd = 190 +/- 40 uM|P43254|E3 UBIQUITIN-PROTEIN LIGASE COP1|3.72|Kd=190uM|Kd|=|190|uM|190000|nM
5ZK7|2.12|2019|14-mer|Kd=195.2+/-49.7nM, kon=3.4+/-1.6E+5, koff=5.8+/-1.4E-2|P06730|EUKARYOTIC TRANSLATION INITIATION FACTOR 4E|6.71|Kd=195.2nM|Kd|=|195.2|nM|195.2|nM
6POH|1.67|2019|OVG|ligand is compound 21; Kd = 1970 +/- 640 uM|P0AEG4|THIOL:DISULFIDE INTERCHANGE PROTEIN DSBA|2.71|Kd=1970uM|Kd|=|1970|uM|1970000|nM
6PRG|2.35|2019|4-mer|ligand is stachyose; Kd = 198.5+/-23.0 uM|------|ABC TRANSPORTER SUGAR-BINDING PROTEIN|3.7|Kd=198.5uM|Kd|=|198.5|uM|198500|nM
6QQW|1.80|2019|JDQ|ligand is compound 24c; Kd = 19+/-1uM|B1MDI3|TRNA (GUANINE-N(1)-)-METHYLTRANSFERASE|4.72|Kd=19uM|Kd|=|19|uM|19000|nM
6QUV|1.48|2019|JJN|ligand is compound 15R|P01116|GTPASE KRAS|3.0|Kd=1mM|Kd|=|1|mM|1000000|nM
6R0X|3.13|2019|8-mer|ligand is heparin, a kind of oligosaccharide; Kd = 2.00 +/- 1.17 nM|O95866|ANTIBODY FAB FRAGMENT HEAVY CHAIN|8.7|Kd=2.00nM|Kd|=|2|nM|2|nM
6BS5|3.10|2019|ANP|Kd(BagAB, AMPPNP)=2.0uM|P9WKX5|PUTATIVE ATPASE RV3679|5.7|Kd=2.0uM|Kd|=|2|uM|2000|nM
6N8X|1.49|2019|KFY|ligand is PU-11-trans|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|5.7|Kd=2.0uM|Kd|=|2|uM|2000|nM
6QGE|1.16|2019|J1E|ligand is compound S; Kd = 2.1+/-0.1uM|P17931|GALECTIN-3|5.68|Kd=2.1uM|Kd|=|2.1|uM|2100|nM
6IIW|1.70|2019|10-mer|ligand is PAF152-11|Q96T88|E3 UBIQUITIN-PROTEIN LIGASE UHRF1|5.66|Kd=2.2uM|Kd|=|2.2|uM|2200|nM
6N87|1.59|2019|13-mer||Q1PBJ5|APICAL MEMBRANE ANTIGEN-1|5.66|Kd=2.2uM|Kd|=|2.2|uM|2200|nM
6PI6|1.65|2019|OKM|ligand is 2-Hydroxyatrazine; Kd =2.2 +/- 0.2 uM|Q936X6|ATRAZINE PERIPLASMIC BINDING PROTEIN|5.66|Kd=2.2uM|Kd|=|2.2|uM|2200|nM
6JJZ|1.65|2019|18-mer|ligand is Dendrin peptide|Q9WVQ1|MEMBRANE-ASSOCIATED GUANYLATE KINASE, WW AND PDZ DOMAIN|8.64|Kd=2.3nM|Kd|=|2.3|nM|2.3|nM
6J0G|1.60|2019|H6P|HMBPP, R351H, structure 1|O00478|BUTYROPHILIN SUBFAMILY 3 MEMBER A3|5.64|Kd=2.3uM|Kd|=|2.3|uM|2300|nM
6J0K|2.00|2019|H6P|HMBPP, R351H, structure 2; redundant to 6j0g|O00478|BUTYROPHILIN SUBFAMILY 3 MEMBER A3|5.64|Kd=2.3uM|Kd|=|2.3|uM|2300|nM
6ETS|1.33|2019|I1L|compound 1, Kd=2.3+/-0.9uM|Q6B0I6|LYSINE-SPECIFIC DEMETHYLASE 4D|5.64|Kd=2.3uM|Kd|=|2.3|uM|2300|nM
6N3V|1.45|2019|KB7|ligand is 1|P49773|HISTIDINE TRIAD NUCLEOTIDE-BINDING PROTEIN 1|5.61|Kd=2.45uM|Kd|=|2.45|uM|2450|nM
6J3O|2.11|2019|B4L|ligand is 12|Q92831|HISTONE ACETYLTRANSFERASE KAT2B|5.62|Kd=2.4uM|Kd|=|2.4|uM|2400|nM
6CSE|3.24|2019|ALA||Q6LX42|MONOCLONAL ANTIBODY FAB HEAVY CHAIN|5.6|Kd=2.5uM|Kd|=|2.5|uM|2500|nM
6H1D|1.94|2019|SAH|ligand is SAH complex with TRMT112|Q9Y5N5|HEMK METHYLTRANSFERASE FAMILY MEMBER 2|5.6|Kd=2.5uM|Kd|=|2.5|uM|2500|nM
6AGK|2.80|2019|9WR|compound is 4v|Q2XVP4|TUBULIN ALPHA-1B CHAIN|5.58|Kd=2.66uM|Kd|=|2.66|uM|2660|nM
6GGD|1.40|2019|EYB||P04637|CELLULAR TUMOR ANTIGEN P53|5.59|Kd=2.6uM|Kd|=|2.6|uM|2600|nM
6T1O|1.90|2019|M82|ligand is compound 6|Q03111|PROTEIN ENL|5.59|Kd=2.6uM|Kd|=|2.6|uM|2600|nM
6AK6|1.75|2019|CTP|[Nonstandard assay: in presence of Mn2+] Kd(MnrCTP)=2.76+/-0.47uM|Q9NP87|DNA-DIRECTED DNA/RNA POLYMERASE MU|5.56|Kd=2.76uM|Kd|=|2.76|uM|2760|nM
6IKM|3.40|2019|SPD|ligand Spermidine|------|POLYAMINE TRANSPORT PROTEIN|8.57|Kd=2.7nM|Kd|=|2.7|nM|2.7|nM
5ZYH|1.95|2019|9N0|[Different ligand in assay: ] Kd=2.7+/-0.5uM, kon=7.17E+3, koff=1.94E-2|Q9Y5P4|LIPID-TRANSFER PROTEIN CERT|5.57|Kd=2.7uM|Kd|=|2.7|uM|2700|nM
6I12|1.65|2019|H08|ligand is 5|Q16658|FASCIN|5.57|Kd=2.7uM|Kd|=|2.7|uM|2700|nM
6HK4|2.50|2019|G8E|ligand is 4|P49841|GLYCOGEN SYNTHASE KINASE-3 BETA|8.55|Kd=2.81nM|Kd|=|2.81|nM|2.81|nM
6FVO|2.69|2019|6-mer|Kd(MtM1SC)=2.84+/-0.7uM|P9WNU0|BETA SLIDING CLAMP|5.55|Kd=2.84uM|Kd|=|2.84|uM|2840|nM
6BS4|2.50|2019|AGS|Kd(BagAB, ATPgammaS)=2.8uM|P9WKX5|PUTATIVE ATPASE RV3679|5.55|Kd=2.8uM|Kd|=|2.8|uM|2800|nM
6MG5|1.80|2019|6ZW|ligand is 1|------|LIGHT CHAIN JTO|4.69|Kd=20.3uM|Kd|=|20.3|uM|20300|nM
6ITQ|1.53|2019|HCY|[Nonstandard assay: pH = 10.5] ligand is cortisol|------|ANTI-CORTISOL CAMELID ANTIBODY|4.69|Kd=20.5uM|Kd|=|20.5|uM|20500|nM
6N93|1.70|2019|KGA|ligand is 8|P52045|METHYLMALONYL-COA DECARBOXYLASE|4.69|Kd=20.6uM|Kd|=|20.6|uM|20600|nM
6RMM|3.53|2019|15-mer|ligand is peptide 53BP1 pS366; Kd = 20.6 +/- 1.9 uM; Binding assay is Fluorescence polarisation|Q92547|DNA TOPOISOMERASE 2-BINDING PROTEIN 1|4.69|Kd=20.6uM|Kd|=|20.6|uM|20600|nM
6OCQ|2.79|2019|M5J|ligand is compound 11; Binding assay is fluorescence polarization|Q13546|RECEPTOR-INTERACTING SERINE/THREONINE-PROTEIN KINASE 1|6.7|Kd=200nM|Kd|=|200|nM|200|nM
6PG6|1.68|2019|OH7|ligand is compound 29; Kd = 200 +/- 10 uM|P61964|WD REPEAT-CONTAINING PROTEIN 5|3.7|Kd=200uM|Kd|=|200|uM|200000|nM
6I67|1.75|2019|H42|ligand is tetrahydro-2-naphtol|P62508|ESTROGEN-RELATED RECEPTOR GAMMA|6.7|Kd=201.4nM|Kd|=|201.4|nM|201.4|nM
5Z66|1.80|2019|VDM|microscale thermophoresis, Kd=206+/10nM|------|PERIPLASMIC TREHALASE|6.69|Kd=206nM|Kd|=|206|nM|206|nM
6IPM|1.72|2019|DCP|[Nonstandard assay: in presence of Mg2+]|Q9NP87|DNA-DIRECTED DNA/RNA POLYMERASE MU|3.69|Kd=206uM|Kd|=|206|uM|206000|nM
6G6T|1.12|2019|ENN|Kd(9, FTSA)=20nM|P00918|CARBONIC ANHYDRASE 2|7.7|Kd=20nM|Kd|=|20|nM|20|nM
6NFN|2.63|2019|BCG|ligand is benzoylecgonine|------|FAB H2E2 LIGHT CHAIN|7.7|Kd=20nM|Kd|=|20|nM|20|nM
6QFX|1.32|2019|JR3|[Uncommon element] ligand is cofactor 10; inculde uncommon Ir element|P00918|CARBONIC ANHYDRASE 2|7.7|Kd=20nM|Kd|=|20|nM|20|nM
6GJ6|1.76|2019|EZZ|ligand is 18|P01116|GTPASE KRAS|4.7|Kd=20uM|Kd|=|20|uM|20000|nM
6IAE|2.49|2019|GTP||Q381A3|INTRAFLAGELLAR TRANSPORT PROTEIN 22|4.7|Kd=20uM|Kd|=|20|uM|20000|nM
6P86|1.80|2019|O4S|ligand is compound 4.1|Q0P6M7|UDP-3-O-(3-HYDROXYMYRISTOYL)GLUCOSAMINE N-ACYLTRANSFERASE|4.7|Kd=20uM|Kd|=|20|uM|20000|nM
6P8Z|1.65|2019|O5S|[Covalent complex] ligand is lead compound 1; non-covalent bound; NMR Kd data|P01116|GTPASE KRAS|4.7|Kd=20uM|Kd|=|20|uM|20000|nM
6I96|1.85|2019|0UE|[Uncommon element] ligand is B-FoxA|------|FERRIC HYDROXAMATE UPTAKE|6.68|Kd=210nM|Kd|=|210|nM|210|nM
6DYR|2.45|2019|HJD||A4GK78|EBONY|3.66|Kd=218.6uM|Kd|=|218.6|uM|218600|nM
6CQ1|1.70|2019|F8J|Kd(15a, NMR)=219+/-32uM|P41182|B-CELL LYMPHOMA 6 PROTEIN|3.66|Kd=219uM|Kd|=|219|uM|219000|nM
6IFT|1.90|2019|SAM||P37468|RIBOSOMAL RNA SMALL SUBUNIT METHYLTRANSFERASE A|4.68|Kd=21uM|Kd|=|21|uM|21000|nM
6NW3|2.35|2019|L4J|ligand is inhibitor 1; Kd = 22.1 +/- 9.5 nM|P56817|BETA-SECRETASE 1|7.66|Kd=22.1nM|Kd|=|22.1|nM|22.1|nM
6PL1|2.03|2019|OOJ|ligand is compound 1b; SPR assay|P04629|HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR|7.65|Kd=22.2nM|Kd|=|22.2|nM|22.2|nM
6HQ4|2.63|2019|CMP|dimer has two active binding site(negative co-operativity)|Q6MLN6|EAL ENZYME BD1971|4.65|Kd=22.4uM|Kd|=|22.4|uM|22400|nM
6ITP|1.57|2019|HCY|[Nonstandard assay: pH = 3.8] ligand is cortisol|------|ANTI-CORTISOL CAMELID ANTIBODY|4.65|Kd=22.4uM|Kd|=|22.4|uM|22400|nM
6H9V|1.52|2019|MFU|IAS373|B5BTR7|VP1|0.66|Kd=220mM|Kd|=|220|mM|220000000|nM
6NK1|1.55|2019|14-mer|Ligand is bA-WLA-YRPKbio peptide|P29317|EPHRIN TYPE-A RECEPTOR 2|6.66|Kd=220nM|Kd|=|220|nM|220|nM
6E7M|2.70|2019|RET|[Covalent complex] [Nonstandard assay: ] M5, Kd=221+/-18.0|P50120|RETINOL-BINDING PROTEIN 2|6.66|Kd=221nM|Kd|=|221|nM|221|nM
6NSX|2.00|2019|6-mer|ligand is peptide HSH155 ULM; Kd = 229 +/- 57 nM|O43719|HIV TAT-SPECIFIC FACTOR 1|6.64|Kd=229nM|Kd|=|229|nM|229|nM
6E1Y|1.22|2019|HLM|compound is C2|P61964|WD REPEAT-CONTAINING PROTEIN 5|7.66|Kd=22nM|Kd|=|22|nM|22|nM
6G2C|1.76|2019|EHT|Kd(compd 9)=22+/-2.2uM|Q9BZ95|HISTONE-LYSINE N-METHYLTRANSFERASE NSD3|4.66|Kd=22uM|Kd|=|22|uM|22000|nM
6OOY|2.50|2019|A7M|ligand is UCB-6876|P01375|TUMOR NECROSIS FACTOR|4.66|Kd=22uM|Kd|=|22|uM|22000|nM
6PG7|2.45|2019|OH4|ligand is compound 17; Kd = 22 +/- 6 uM|P61964|WD REPEAT-CONTAINING PROTEIN 5|4.66|Kd=22uM|Kd|=|22|uM|22000|nM
6QLN|1.00|2019|J5Q|ligand is compound 3; Kd = 22+/-0.7 uM; Binding assay is fluorescence polarization|P17931|GALECTIN-3|4.66|Kd=22uM|Kd|=|22|uM|22000|nM
6JNO|2.65|2019|WY5|ligand is 10|P19793|RETINOIC ACID RECEPTOR RXR-ALPHA|6.63|Kd=233nM|Kd|=|233|nM|233|nM
6I75|1.17|2019|H5T|[Different ligand in assay: ligand in binding asssay is racemic mixture] ligand is 2|P17931|GALECTIN-3|4.64|Kd=23uM|Kd|=|23|uM|23000|nM
6QLU|1.10|2019|J62|ligand is compound 7; Kd = 23+/-1.0 uM; Binding assay is fluorescence polarization|P17931|GALECTIN-3|4.64|Kd=23uM|Kd|=|23|uM|23000|nM
6QTR|1.37|2019|12-mer|ligand is peptide HY5; Kd = 23 +/- 10uM|P43254|E3 UBIQUITIN-PROTEIN LIGASE COP1|4.64|Kd=23uM|Kd|=|23|uM|23000|nM
6QTO|1.27|2019|12-mer|ligand is peptide HY5; Kd = 23 +/- 7uM|P43254|E3 UBIQUITIN-PROTEIN LIGASE COP1|4.64|Kd=23uM|Kd|=|23|uM|23000|nM
6E91|1.80|2019|J04|[Different protein in assay: protein binding assay is CA IX] compound is STX2484|P00918|CARBONIC ANHYDRASE 2|6.62|Kd=240nM|Kd|=|240|nM|240|nM
6PGE|1.76|2019|OJM|ligand is compound 24; Kd = 240 +/- 10 uM|P61964|WD REPEAT-CONTAINING PROTEIN 5|3.62|Kd=240uM|Kd|=|240|uM|240000|nM
6NJ0|1.83|2019|KOY|ligand is analogue 5|P37353|2-SUCCINYLBENZOATE--COA LIGASE|6.61|Kd=244nM|Kd|=|244|nM|244|nM
6MMC|1.42|2019|ADP|[Nonstandard assay: Temp 25, pH = 8, NaCl = 20 mM, HEPES = 20 mM]|B5II98|CARBON REGULATORY PII-LIKE PROTEIN SBTB|3.61|Kd=244uM|Kd|=|244|uM|244000|nM
6G5L|1.21|2019|EM5|Kd(7a, ITC)=24nM|O43570|CARBONIC ANHYDRASE 12|7.62|Kd=24nM|Kd|=|24|nM|24|nM
6ISO|2.95|2019|7-mer|ligand is H3K4Cr peptide; Kd=25.1+/-2.5uM|Q9NTG7|NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-3, MITOCHONDRIAL|4.6|Kd=25.1uM|Kd|=|25.1|uM|25100|nM
6P87|1.90|2019|O4P|ligand is compound 5|Q0P6M7|UDP-3-O-(3-HYDROXYMYRISTOYL)GLUCOSAMINE N-ACYLTRANSFERASE|4.6|Kd=25.4uM|Kd|=|25.4|uM|25400|nM
6P8A|1.80|2019|O4D|ligand is compound 8.1|Q0P6M7|UDP-3-O-(3-HYDROXYMYRISTOYL)GLUCOSAMINE N-ACYLTRANSFERASE|3.59|Kd=255uM|Kd|=|255|uM|255000|nM
6J06|2.65|2019|99C|HMBPP-08|O00481|BUTYROPHILIN SUBFAMILY 3 MEMBER A1|6.59|Kd=256nM|Kd|=|256|nM|256|nM
6N5X|2.05|2019|JEF|ligand is CI-MPR|Q9Y5X3|SORTING NEXIN-5,CATION-INDEPENDENT MANNOSE-6-PHOSPHATE|4.6|Kd=25uM|Kd|=|25|uM|25000|nM
6PGB|1.73|2019|OJG|ligand is compound 31; Kd = 25 +/- 3 uM|P61964|WD REPEAT-CONTAINING PROTEIN 5|4.6|Kd=25uM|Kd|=|25|uM|25000|nM
6QE0|1.39|2019|HZ2|ligand is BA2; Kd = 25+/-3uM|------|RIBOSOMAL RNA LARGE SUBUNIT METHYLTRANSFERASE J|4.6|Kd=25uM|Kd|=|25|uM|25000|nM
6PG4|1.60|2019|OHG|ligand is compound 2; Kd = 260 +/- 20 uM|P61964|WD REPEAT-CONTAINING PROTEIN 5|3.59|Kd=260uM|Kd|=|260|uM|260000|nM
6POQ|1.80|2019|OVJ|ligand is compound 16; Kd = 2700 +/- 920 uM|P0AEG4|THIOL:DISULFIDE INTERCHANGE PROTEIN DSBA|2.57|Kd=2700uM|Kd|=|2700|uM|2700000|nM
6NP5|1.35|2019|9CS|ligand is compound kanamycin B; Kd = 27 +/- 0.5uM|Q47030|AMINOGLYCOSIDE N(3)-ACETYLTRANSFERASE|4.57|Kd=27uM|Kd|=|27|uM|27000|nM
6NTI|2.30|2019|9CS|ligand is compound kanamycin B; redundant to 6np5|C4NV15|AMINOGLYCOSIDE N(3)-ACETYLTRANSFERASE|4.57|Kd=27uM|Kd|=|27|uM|27000|nM
6O9C|2.45|2019|9-mer|ligand is S45F beta-catenin peptide|P04439|HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-3 ALPHA CHAIN|7.55|Kd=28.5nM|Kd|=|28.5|nM|28.5|nM
6PGA|2.45|2019|OGM|ligand is compound 32; Kd = 28.9 +/- 0.5 uM|P61964|WD REPEAT-CONTAINING PROTEIN 5|4.54|Kd=28.9uM|Kd|=|28.9|uM|28900|nM
6PID|1.55|2019|OKS|ligand is compound 5|------|ACETYLPOLYAMINE AMIDOHYDROLASE|4.54|Kd=29.0uM|Kd|=|29|uM|29000|nM
6MM5|1.95|2019|12-mer||P05132|CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA|4.54|Kd=29.1uM|Kd|=|29.1|uM|29100|nM
6I11|1.67|2019|H0H|ligand is 3|Q16658|FASCIN|4.53|Kd=29.3uM|Kd|=|29.3|uM|29300|nM
6I10|2.10|2019|GZK|ligand is 2|Q16658|FASCIN|4.53|Kd=29.5uM|Kd|=|29.5|uM|29500|nM
5ZNC|1.66|2019|QI9||Q8T9Z7|PURINE NUCLEOSIDE PHOSPHORYLASE|7.52|Kd=29.9nM|Kd|=|29.9|nM|29.9|nM
6MLN|1.72|2019|ARG||P02911|LYSINE/ARGININE/ORNITHINE-BINDING PERIPLASMIC PROTEIN|7.54|Kd=29nM|Kd|=|29|nM|29|nM
5ZJF|2.60|2019|9G9|compound is MA|P00338|L-LACTATE DEHYDROGENASE A CHAIN|4.54|Kd=29uM|Kd|=|29|uM|29000|nM
6O5G|1.89|2019|LMJ|Kd(isomalbrancheamide D )=2+/-1uM|P0DP23|CALMODULIN-1|5.7|Kd=2uM|Kd|=|2|uM|2000|nM
6IA7|2.30|2019|GTP||Q381A3|INTRAFLAGELLAR TRANSPORT PROTEIN 22|5.7|Kd=2uM|Kd|=|2|uM|2000|nM
6DGL|1.95|2019|GEV|compound is darglitazone|P37231|PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA|5.52|Kd=3.05uM|Kd|=|3.05|uM|3050|nM
6DGQ|2.45|2019|GBV|compound is CAY10506|P37231|PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA|5.51|Kd=3.09uM|Kd|=|3.09|uM|3090|nM
6QTW|1.39|2019|11-mer|ligand is peptide CRY1; Kd = 3.0 +/- 0.3uM|P43254|E3 UBIQUITIN-PROTEIN LIGASE COP1|5.52|Kd=3.0uM|Kd|=|3|uM|3000|nM
6A5E|2.77|2019|15-mer||Q9SCZ4|RECEPTOR-LIKE PROTEIN KINASE FERONIA|5.49|Kd=3.21uM|Kd|=|3.21|uM|3210|nM
6C3N|2.53|2019|EHY|Kd(7CC5, NMR)=3.2+/-0.1mM|P41182|B-CELL LYMPHOMA 6 PROTEIN|2.49|Kd=3.2mM|Kd|=|3.2|mM|3200000|nM
6QR2|1.55|2019|JQB|ligand is compound 26j: Kd = 3.2+/-0.3uM|B1MDI3|TRNA (GUANINE-N(1)-)-METHYLTRANSFERASE|5.49|Kd=3.2uM|Kd|=|3.2|uM|3200|nM
6DGO|3.10|2019|GD4|compound is troglitazone|P37231|PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA|5.47|Kd=3.36uM|Kd|=|3.36|uM|3360|nM
5ZXK|1.96|2019|H6P|HMBPP|O00481|BUTYROPHILIN SUBFAMILY 3 MEMBER A1|5.48|Kd=3.3uM|Kd|=|3.3|uM|3300|nM
6FGC|1.50|2019|D95|[Nonstandard assay: displacement titration of the GephE-artesunate complex with the GlyR beta dimer peptide]|Q03555|GEPHYRIN|5.48|Kd=3.3uM|Kd|=|3.3|uM|3300|nM
6A06|1.79|2019|1SY|MST assay, Kd(2',3'-cGAMP)=3.4+/-0.07nM|B8XX90|STIMULATOR OF INTERFERON GENES PROTEIN|8.47|Kd=3.4nM|Kd|=|3.4|nM|3.4|nM
6GFM|2.77|2019|0O2|ligand is pppGpp|P0ADR8|PYRIMIDINE/PURINE NUCLEOTIDE 5'-MONOPHOSPHATE NUCLEOSIDASE|5.47|Kd=3.4uM|Kd|=|3.4|uM|3400|nM
6I74|0.96|2019|H5Z|[Different ligand in assay: ligand in binding asssay is racemic mixture] ligand is 3|P17931|GALECTIN-3|5.47|Kd=3.4uM|Kd|=|3.4|uM|3400|nM
6OM4|1.70|2019|7-mer|Peptide sequence is MRTGNAN; Competition FP binding assay|Q47506|MCCB PROTEIN|5.45|Kd=3.58uM|Kd|=|3.58|uM|3580|nM
6DZX|1.68|2019|MED|D-methionine|C6S9R8|LIPOPROTEIN|5.46|Kd=3.5uM|Kd|=|3.5|uM|3500|nM
6GDY|2.04|2019|AKG|[Nonstandard assay: in presence of Fe2+] Kd(2OG)=3.5+/-2.1uM|Q6NYC1|BIFUNCTIONAL ARGININE DEMETHYLASE AND LYSYL-HYDROXYLASE|5.46|Kd=3.5uM|Kd|=|3.5|uM|3500|nM
6T1N|1.95|2019|M7Z|ligand is compound 5|Q03111|PROTEIN ENL|5.46|Kd=3.5uM|Kd|=|3.5|uM|3500|nM
6N3Y|1.80|2019|HHJ|ligand is TrpGc|P49773|HISTIDINE TRIAD NUCLEOTIDE-BINDING PROTEIN 1|5.44|Kd=3.65uM|Kd|=|3.65|uM|3650|nM
6CSF|3.30|2019|DAL||Q6LX42|MONOCLONAL ANTIBODY FAB HEAVY CHAIN|5.44|Kd=3.6uM|Kd|=|3.6|uM|3600|nM
6R1B|2.27|2019|CH5|ligand is compound GPC; Kd = 3.6 +/- 0.5 uM|------|PUTATIVE SN-GLYCEROL-3-PHOSPHATE-BINDING LIPOPROTEIN UGPB|5.44|Kd=3.6uM|Kd|=|3.6|uM|3600|nM
5ZDG|2.59|2019|AR6|T267R, Kd=3.76+/-0.47uM|Q9RZM4|POLY APD-RIBOSE GLYCOHYDROLASE|5.42|Kd=3.76uM|Kd|=|3.76|uM|3760|nM
6D8V|2.80|2019|PBE||Q92SH9|PROBABLE CHEMORECEPTOR (METHYL-ACCEPTING CHEMOTAXIS)|5.42|Kd=3.8uM|Kd|=|3.8|uM|3800|nM
6HGG|1.79|2019|HCY|ligand is cortisol|P01011|ALPHA-1-ANTICHYMOTRYPSIN|5.42|Kd=3.8uM|Kd|=|3.8|uM|3800|nM
6OTT|2.55|2019|N7Y|ligand is ppApp|P0AG16|AMIDOPHOSPHORIBOSYLTRANSFERASE, PURF|5.42|Kd=3.8uM|Kd|=|3.8|uM|3800|nM
6MM2|1.04|2019|ATP|[Uncommon element] ligand is ATP|B5II98|CARBON REGULATORY PII-LIKE PROTEIN SBTB|5.41|Kd=3.92uM|Kd|=|3.92|uM|3920|nM
6AAQ|1.55|2019|9U9|compound is BCNLys|Q8PWY1|PYRROLYSINE--TRNA LIGASE|2.41|Kd=3.9mM|Kd|=|3.9|mM|3900000|nM
6QZR|2.30|2019|11-mer|ligand is FOXO1 pT24 peptide; Kd = 30.0 +/- 3.0 nM|P31947|14-3-3 PROTEIN SIGMA|7.52|Kd=30.0nM|Kd|=|30|nM|30|nM
6P88|1.70|2019|O4G|ligand is compound 6|Q0P6M7|UDP-3-O-(3-HYDROXYMYRISTOYL)GLUCOSAMINE N-ACYLTRANSFERASE|4.52|Kd=30.2uM|Kd|=|30.2|uM|30200|nM
6SGE|1.50|2019|GTP|RHOB-GTP in complex with nanobody B6|P62745|RHO-RELATED GTP-BINDING PROTEIN RHOB|7.51|Kd=30.8nM|Kd|=|30.8|nM|30.8|nM
6G25|1.43|2019|EHQ|Kd(compd 4)=300+/-21uM|Q9BZ95|HISTONE-LYSINE N-METHYLTRANSFERASE NSD3|3.52|Kd=300uM|Kd|=|300|uM|300000|nM
6E7W|2.67|2019|HXM|[Nonstandard assay: PH=7.6] Kd(PH=7.6)=305+/-18nM, Kd(PH=6.5)=147+/-5.6nM, chain BD: 363|Q00960|GLUTAMATE RECEPTOR IONOTROPIC, NMDA 1|6.52|Kd=305nM|Kd|=|305|nM|305|nM
6Q9T|2.68|2019|15-mer|ligand is 4|P00918|CARBONIC ANHYDRASE 2|7.52|Kd=30nM|Kd|=|30|nM|30|nM
6NCO|1.71|2019|KQP|ligand is 3|P02649|APOLIPOPROTEIN E|4.52|Kd=30uM|Kd|=|30|uM|30000|nM
6QDX|2.10|2019|HY8|ligand is BA4; Kd = 30+/-4uM|------|RIBOSOMAL RNA LARGE SUBUNIT METHYLTRANSFERASE J|4.52|Kd=30uM|Kd|=|30|uM|30000|nM
6NU1|2.25|2019|CYS|ligand is cysteine; assay in presence of FBP ligand|P14618|PYRUVATE KINASE PKM|4.51|Kd=31.2uM|Kd|=|31.2|uM|31200|nM
6HK3|2.35|2019|G8B|ligand is 5|P49841|GLYCOGEN SYNTHASE KINASE-3 BETA|7.5|Kd=31.4nM|Kd|=|31.4|nM|31.4|nM
6J7L|1.85|2019|TYD|ligand is TDP|Q9HZZ1|PSEUDOMONAS AERUGINOSA EARP|4.5|Kd=31.4uM|Kd|=|31.4|uM|31400|nM
6NYV|2.43|2019|LBD|ligand is compound 1; Kd = 312+/-300nM|Q8I0P1|SPASTIN|6.51|Kd=312nM|Kd|=|312|nM|312|nM
6QLQ|1.08|2019|J4E|ligand is compound 4; Kd = 31+/-1.3 uM; Binding assay is fluorescence polarization|P17931|GALECTIN-3|4.51|Kd=31uM|Kd|=|31|uM|31000|nM
6MT5|1.55|2019|9-mer||P18463|HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-37 ALPHA CHAIN|4.49|Kd=32.3uM|Kd|=|32.3|uM|32299.999999999996|nM
6QAU|2.48|2019|1FV|Ligand is compound MRT67307|Q8IYT8|SERINE/THREONINE-PROTEIN KINASE ULK2|7.48|Kd=32.9nM|Kd|=|32.9|nM|32.9|nM
6FPU|1.36|2019|E48|microsomal stability assay, Kd(compound 4)=321+/-193nM|P28720|QUEUINE TRNA-RIBOSYLTRANSFERASE|6.49|Kd=321nM|Kd|=|321|nM|321|nM
6POI|1.77|2019|OVS|ligand is compound 25; Kd = 326 +/- 65 uM|P0AEG4|THIOL:DISULFIDE INTERCHANGE PROTEIN DSBA|3.49|Kd=326uM|Kd|=|326|uM|326000|nM
6DN5|2.40|2019|7-mer|Kd=32+/-4nM, kon=8.4E+5, koff=2.6E-2|Q99619|SPRY DOMAIN-CONTAINING SOCS BOX PROTEIN 2|7.49|Kd=32nM|Kd|=|32|nM|32|nM
6HHP|1.80|2019|8-mer|with molecule 1|P31947|14-3-3 PROTEIN SIGMA|7.49|Kd=32nM|Kd|=|32|nM|32|nM
6DYO|2.84|2019|LDP||A4GK78|EBONY|4.49|Kd=32uM|Kd|=|32|uM|32000|nM
6QL1|1.42|2019|V50|ligand is compound 14; Kd = 330 +/- 140 nM|P00918|CARBONIC ANHYDRASE 2|6.48|Kd=330nM|Kd|=|330|nM|330|nM
6E7V|2.60|2019|T88|[Nonstandard assay: PH=7.6] Kd(PH=7.6)=331+/-29nM, Kd(PH=6.5)=171+/-6.6nM, chain BD: 363|Q00960|GLUTAMATE RECEPTOR IONOTROPIC, NMDA 1|6.48|Kd=331nM|Kd|=|331|nM|331|nM
6QRF|1.86|2019|JF5|ligand is compound 3; Kd = 33+/-2 uM|B1MDI3|TRNA (GUANINE-N(1)-)-METHYLTRANSFERASE|4.48|Kd=33uM|Kd|=|33|uM|33000|nM
6PVZ|1.99|2019|OZM|ligand is compound 28; Kd = 341 +/- 47 uM|P0AEG4|THIOL:DISULFIDE INTERCHANGE PROTEIN DSBA|3.47|Kd=341uM|Kd|=|341|uM|341000|nM
6PYC|3.60|2019|P4S|ligand is compound MBG|------|KOH BODY FAB HEAVY CHAIN|7.45|Kd=35.8nM|Kd|=|35.8|nM|35.8|nM
6Q4E|1.06|2019|HH5|ligand is compound 33|P24941|CYCLIN-DEPENDENT KINASE 2|3.46|Kd=350uM|Kd|=|350|uM|350000|nM
6E92|1.77|2019|HZY|[Different protein in assay: protein binding assay is CA IX] compound is STX2845|P00918|CARBONIC ANHYDRASE 2|7.46|Kd=35nM|Kd|=|35|nM|35|nM
6QFU|1.80|2019|J0K|[Uncommon element] ligand is cofactor 7; inculde uncommon Ir element|P00918|CARBONIC ANHYDRASE 2|7.46|Kd=35nM|Kd|=|35|nM|35|nM
6DKP|2.97|2019|10-mer|alpha-D26Y, alpha-Y50A,beta-L98W, Kd=36.4+/-7.1nM|P01892|HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA CHAIN|7.44|Kd=36.4nM|Kd|=|36.4|nM|36.4|nM
6E5S|2.06|2019|RET|[Covalent complex] M2, Kd=367+/-14.7nM|P50120|RETINOL-BINDING PROTEIN 2|6.44|Kd=367nM|Kd|=|367|nM|367|nM
6C3L|1.46|2019|EGP|Kd(15f, ITC)=36+/-5 uM, Kd(15f, NMR)=44+/-16uM|P41182|B-CELL LYMPHOMA 6 PROTEIN|4.44|Kd=36uM|Kd|=|36|uM|36000|nM
6NP4|1.15|2019|TOY|ligand is compound tobramycin; Kd = 36 +/- 0.3 uM|Q47030|AMINOGLYCOSIDE N(3)-ACETYLTRANSFERASE|4.44|Kd=36uM|Kd|=|36|uM|36000|nM
6M8Q|2.49|2019|JBG|ligand is 2; binding assay method is SEC CTID|Q9UKF6|CLEAVAGE AND POLYADENYLATION SPECIFICITY FACTOR SUBUNIT 3|6.43|Kd=370nM|Kd|=|370|nM|370|nM
6RTW|1.90|2019|Y01|ligand is cholesterol-hemisuccinate(HS)|Q13635|PROTEIN PATCHED HOMOLOG 1|6.43|Kd=370nM|Kd|=|370|nM|370|nM
6U80|1.55|2019|Q1J|ligand is compound 5g; Binding assay is FPA|P61964|WD REPEAT-CONTAINING PROTEIN 5|4.43|Kd=37uM|Kd|=|37|uM|37000|nM
6O3Y|2.80|2019|13-mer|ligand is peptide Sen1 NIM3; Kd = 38.4+/-5.0uM|P53617|PROTEIN NRD1|4.42|Kd=38.4uM|Kd|=|38.4|uM|38400|nM
6J1L|2.30|2019|B6L|ligand is 27|P51449|NUCLEAR RECEPTOR ROR-GAMMA|6.42|Kd=380nM|Kd|=|380|nM|380|nM
6PY0|2.20|2019|RTL|ligand is retinol, Kd = 386 +/- 143 nM|P04918|SERUM AMYLOID A-3 PROTEIN|6.41|Kd=386nM|Kd|=|386|nM|386|nM
6QAF|1.61|2019|XC3|[Uncommon element] [Incomplete ligand] ligand is compound CB-1158; Crystal in PH=9.0, Kd in PH=7.4|P05089|ARGINASE-1|7.42|Kd=38nM|Kd|=|38|nM|38|nM
6I65|1.50|2019|H3Z|ligand is 4-iso-propylphenol|P62508|ESTROGEN-RELATED RECEPTOR GAMMA|6.41|Kd=390.4nM|Kd|=|390.4|nM|390.4|nM
6G5U|1.70|2019|ENN|Kd(9, FTSA)=395nM|Q8N1Q1|CARBONIC ANHYDRASE 13|6.4|Kd=395nM|Kd|=|395|nM|395|nM
6QTX|1.95|2019|10-mer|ligand is peptide COL3; Kd = 39 +/- 0.4uM|P43254|E3 UBIQUITIN-PROTEIN LIGASE COP1|4.41|Kd=39uM|Kd|=|39|uM|39000|nM
6QZH|2.10|2019|JLW|ligand is cmp2105|P32248|C-C CHEMOKINE RECEPTOR TYPE 7,SIALIDASE A,C-C CHEMOKINE|8.52|Kd=3nM|Kd|=|3|nM|3|nM
6G2S|2.20|2019|EJN|compound 5|P08191|FIMH PROTEIN|8.4|Kd=4.01nM|Kd|=|4.01|nM|4.01|nM
6GGB|1.32|2019|EXQ|ligand is PK9318|P04637|CELLULAR TUMOR ANTIGEN P53|5.39|Kd=4.1uM|Kd|=|4.1|uM|4100|nM
6GGF|1.32|2019|EXQ|ligand is PK9318|P04637|CELLULAR TUMOR ANTIGEN P53|5.39|Kd=4.1uM|Kd|=|4.1|uM|4100|nM
6AEE|3.30|2019|9-mer|Kd(D1-D4)=4.28+/-1.53uM, Kd(D1D2)=3.84+/-0.38uM|P17693|HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, ALPHA CHAIN G|5.37|Kd=4.28uM|Kd|=|4.28|uM|4280|nM
6HZX|2.91|2019|10-mer|ligand is 2|P00918|CARBONIC ANHYDRASE 2|8.38|Kd=4.2nM|Kd|=|4.2|nM|4.2|nM
6N8Y|1.55|2019|KFY|ligand is PU-11-trans; redundant to 6olx|P08238|HEAT SHOCK PROTEIN HSP90-BETA|5.38|Kd=4.2uM|Kd|=|4.2|uM|4200|nM
6OLX|1.44|2019|KFY|ligand is PU-11-trans|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|5.38|Kd=4.2uM|Kd|=|4.2|uM|4200|nM
6N0J|1.79|2019|K8S|ligand is CCG-222740|O00625|PIRIN|5.37|Kd=4.3uM|Kd|=|4.3|uM|4300|nM
6OS5|1.66|2019|TRP|ligand is L-Trp; Kd = 4.4 +/- 0.4 uM|A8M6W6|CYMD PRENYLTRANSFERASE|5.36|Kd=4.4uM|Kd|=|4.4|uM|4400|nM
6P7Q|1.66|2019|2-mer|ligand is compound 5'-pApA|D7Y2H5|E. COLI MS115-1 NUCC|5.36|Kd=4.4uM|Kd|=|4.4|uM|4400|nM
6UYZ|1.40|2019|17-mer|ligand is peptide DAXX-SIM-PO4; Kd = 4.4 +/- 0.2 uM|P63165|SMALL UBIQUITIN-RELATED MODIFIER 1|5.36|Kd=4.4uM|Kd|=|4.4|uM|4400|nM
6PGC|1.81|2019|OJJ|ligand is compound 37; Kd = 4.5 +/- 0.3 uM|P61964|WD REPEAT-CONTAINING PROTEIN 5|5.35|Kd=4.5uM|Kd|=|4.5|uM|4500|nM
6QLS|1.05|2019|HRK|ligand is compound 9; Kd = 4.5+/-0.2 uM; Binding assay is fluorescence polarization|P17931|GALECTIN-3|5.35|Kd=4.5uM|Kd|=|4.5|uM|4500|nM
6U6W|1.20|2019|Q0Y|ligand is compound 1; Kd = 4.71 +/- 1.59 uM; Binding assay is FPA|P61964|WD REPEAT-CONTAINING PROTEIN 5|5.33|Kd=4.71uM|Kd|=|4.71|uM|4710|nM
6QMU|1.98|2019|ZCQ|[Covalent complex] ligand is compound 4-nitrocatechol; Kd = 4.8 +/- 0.04 uM|P80188|NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN|5.32|Kd=4.8uM|Kd|=|4.8|uM|4800|nM
6FVN|3.14|2019|6-mer|Kd(MtwtSC)=4.99+/-3.97uM|P9WNU0|BETA SLIDING CLAMP|5.3|Kd=4.99uM|Kd|=|4.99|uM|4990|nM
6QAV|2.05|2019|HVH|Ligand is compound MRT68921|Q8IYT8|SERINE/THREONINE-PROTEIN KINASE ULK2|8.31|Kd=4.9nM|Kd|=|4.9|nM|4.9|nM
5ZNI|2.30|2019|YMZ||Q8T9Z7|PURINE NUCLEOSIDE PHOSPHORYLASE|4.39|Kd=40.3uM|Kd|=|40.3|uM|40300|nM
6DZV|4.20|2019|HJM|[Nonstandard assay: without the 15B8 Fab] [Different protein in assay: protein in crystal structure is dN72/C13 SERT] compound is ibogaine|P31645|SODIUM-DEPENDENT SEROTONIN TRANSPORTER|6.4|Kd=400nM|Kd|=|400|nM|400|nM
6IM4|1.93|2019|6-mer|ligand is AimP|O64094|AIMR TRANSCRIPTIONAL REGULATOR|7.4|Kd=40nM|Kd|=|40|nM|40|nM
6S07|1.04|2019|17-mer|ligand is peptide Abz-ATTPLCGPSRASILSGR; Kd = 40 +/- 10 nM|D1A7C3|FORMYLGLYCINE-GENERATING ENZYME|7.4|Kd=40nM|Kd|=|40|nM|40|nM
6U9V|2.90|2019|GDP|ligand is compound GDP; Kd = 40 +/- 10 nM|Q64663|P2X PURINOCEPTOR 7|7.4|Kd=40nM|Kd|=|40|nM|40|nM
6HGJ|1.83|2019|AS4|ligand is Aldosterone|P01011|ALPHA-1-ANTICHYMOTRYPSIN|4.38|Kd=41.6uM|Kd|=|41.6|uM|41600|nM
6Q38|1.74|2019|9-mer|ligand is Stapled Peptide P1-C4|P68400|CASEIN KINASE II SUBUNIT ALPHA|6.38|Kd=420nM|Kd|=|420|nM|420|nM
6H4A|2.65|2019|FNB|compound MLT-748, kon=2.8E+4, koff=1.1E-3|Q9UDY8|MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION|7.38|Kd=42nM|Kd|=|42|nM|42|nM
6H75|1.45|2019|SLB|[Different protein in assay: Protein in binding assay is A11N mutant] ligand is Neu5Gc|P44542|SIALIC ACID-BINDING PERIPLASMIC PROTEIN SIAP|4.38|Kd=42uM|Kd|=|42|uM|42000|nM
6MLA|1.58|2019|ARG||P02911|LYSINE/ARGININE/ORNITHINE-BINDING PERIPLASMIC PROTEIN|4.38|Kd=42uM|Kd|=|42|uM|42000|nM
6O5U|1.40|2019|KAN|ligand is compound kanamycin A; Kd = 42 +/- 0.2uM|Q47030|AMINOGLYCOSIDE N(3)-ACETYLTRANSFERASE|4.38|Kd=42uM|Kd|=|42|uM|42000|nM
6K2N|1.80|2019|3-mer|ligand is glycan|E2EA82|OUTER CAPSID PROTEIN VP4|1.36|Kd=43.4mM|Kd|=|43.4|mM|43400000|nM
6QI4|1.78|2019|FKW|ligand is compound 3b; Kd = 43 +/- 6 uM|P62166|NEURONAL CALCIUM SENSOR 1|4.37|Kd=43uM|Kd|=|43|uM|43000|nM
6GJ5|1.50|2019|F0N|ligand is 15|P01116|GTPASE KRAS|3.36|Kd=440uM|Kd|=|440|uM|440000|nM
6Q6F|3.30|2019|HJQ|ligand is HMS 101; MST assay|O75874|ISOCITRATE DEHYDROGENASE [NADP] CYTOPLASMIC|3.35|Kd=445.9uM|Kd|=|445.9|uM|445900|nM
6MMO|1.86|2019|AMP|[Nonstandard assay: Temp 25, pH = 8, NaCl = 20 mM, HEPES = 20 mM]|B5II98|CARBON REGULATORY PII-LIKE PROTEIN SBTB|3.35|Kd=447uM|Kd|=|447|uM|447000|nM
6Q3Z|2.00|2019|HG8|ligand is compound 16k|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|7.36|Kd=44nM|Kd|=|44|nM|44|nM
6HK7|3.20|2019|G8N|ligand is 6|P49841|GLYCOGEN SYNTHASE KINASE-3 BETA|7.34|Kd=45.9nM|Kd|=|45.9|nM|45.9|nM
5OVE|1.85|2019|AXE|compound 1|Q07889|SON OF SEVENLESS HOMOLOG 1|6.35|Kd=450nM|Kd|=|450|nM|450|nM
6HKX|2.80|2019|GCE|ligand is Arry-520|P52732|KINESIN-LIKE PROTEIN KIF11|9.34|Kd=456.3pM|Kd|=|456.3|pM|0.45630000000000004|nM
6HKY|2.75|2019|GCE|ligand is Arry-520|P52732|KINESIN-LIKE PROTEIN KIF11|9.34|Kd=456.3pM|Kd|=|456.3|pM|0.45630000000000004|nM
6AJZ|1.30|2019|LOC||O60885|BROMODOMAIN-CONTAINING PROTEIN 4|4.34|Kd=46uM|Kd|=|46|uM|46000|nM
6QAT|2.77|2019|FE7|Ligand is compound hesperadin|Q8IYT8|SERINE/THREONINE-PROTEIN KINASE ULK2|7.33|Kd=47.3nM|Kd|=|47.3|nM|47.3|nM
6GY0|2.55|2019|FGE|ligand is AZ3|O35904|PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC|7.32|Kd=47.9nM|Kd|=|47.9|nM|47.9|nM
6PHX|2.00|2019|3-mer|ligand is raffinose|A0A0H2|ALPHA-GALACTOSIDASE|3.32|Kd=478.6uM|Kd|=|478.6|uM|478600|nM
6G29|1.70|2019|EHK|Kd(compd 6)=47+/-11uM|Q9BZ95|HISTONE-LYSINE N-METHYLTRANSFERASE NSD3|4.33|Kd=47uM|Kd|=|47|uM|47000|nM
6AJR|1.34|2019|URA|compound is uracil|A0QP43|URACIL DNA GLYCOSYLASE SUPERFAMILY PROTEIN|4.31|Kd=48.5uM|Kd|=|48.5|uM|48500|nM
6I64|1.91|2019|H48|ligand is bisphenol-E|P62508|ESTROGEN-RELATED RECEPTOR GAMMA|7.31|Kd=48.7nM|Kd|=|48.7|nM|48.7|nM
6PG3|2.04|2019|OHJ|ligand is compound 1; Kd = 480 +/- 30 uM|P61964|WD REPEAT-CONTAINING PROTEIN 5|3.32|Kd=480uM|Kd|=|480|uM|480000|nM
6OH3|2.75|2019|NCC|ligand is compound CMP-Sia; Kd = 482+/-147uM|Q61420|CMP-SIALIC ACID TRANSPORTER|3.32|Kd=482uM|Kd|=|482|uM|482000|nM
6I5P|1.81|2019|9-mer|[Different protein in assay: ] ligand is BRD3 fragment|O43791|SPECKLE-TYPE POZ PROTEIN|4.32|Kd=48uM|Kd|=|48|uM|48000|nM
6IOR|2.50|2019|ASN|ligand is L-Asparagine|------|METHYL-ACCEPTING CHEMOTAXIS PROTEIN|4.31|Kd=49.5uM|Kd|=|49.5|uM|49500|nM
6NZK|2.80|2019|MJJ|ligand is compound (9-O-Ac-Me-Sia); Kd = 49.7 +/- 10.7 uM|Q696P8|SPIKE SURFACE GLYCOPROTEIN|4.3|Kd=49.7uM|Kd|=|49.7|uM|49700|nM
6QFV|1.45|2019|J0N|[Uncommon element] ligand is cofactor 8; inculde uncommon Ir element|P00918|CARBONIC ANHYDRASE 2|7.31|Kd=49nM|Kd|=|49|nM|49|nM
6SDD|1.93|2019|353|ligand is BMS-777607; pKd=8.4, then Kd=4nM|P08581|HEPATOCYTE GROWTH FACTOR RECEPTOR|8.4|Kd=4nM|Kd|=|4|nM|4|nM
6QQU|1.59|2019|JF8|ligand is compound 25; Kd = 5.0+/-2.1 uM|B1MDI3|TRNA (GUANINE-N(1)-)-METHYLTRANSFERASE|5.3|Kd=5.0uM|Kd|=|5|uM|5000|nM
6MQC|1.99|2019|8-mer||------|0PV-C.01 ANTIBODY FAB HEAVY CHAIN|8.28|Kd=5.22nM|Kd|=|5.22|nM|5.22|nM
6QLP|1.08|2019|J3Q|ligand is compound 8; Kd = 5.2+/-0.3 uM; Binding assay is fluorescence polarization|P17931|GALECTIN-3|5.28|Kd=5.2uM|Kd|=|5.2|uM|5200|nM
6SFC|2.00|2019|L9T|ligand is compound 3; Kd = 5.2 +/- 1.8 uM|O75530|POLYCOMB PROTEIN EED|5.28|Kd=5.2uM|Kd|=|5.2|uM|5200|nM
6AJY|1.60|2019|A0R|Kd(ISL 4-methyl ester)=5.3uM, ligand structure is inconsistent with the literature|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|5.28|Kd=5.3uM|Kd|=|5.3|uM|5300|nM
6QTM|3.00|2019|17-mer|ligand is Ty5 pS1095 peptide|P11978|REGULATORY PROTEIN SIR4|5.25|Kd=5.57uM|Kd|=|5.57|uM|5570|nM
6T1I|1.80|2019|M7W|ligand is compound 1|Q03111|PROTEIN ENL|5.26|Kd=5.5uM|Kd|=|5.5|uM|5500|nM
6A03|2.60|2019|2BA|MST assay, Kd(c-diAMP)=5.67+/-0.49uM|B8XX90|STIMULATOR OF INTERFERON GENES PROTEIN|5.25|Kd=5.67uM|Kd|=|5.67|uM|5670|nM
6A9O|2.50|2019|6B3|microscale thermophoresis assay, Kd=5.7+/-1.3uM|P00441|SUPEROXIDE DISMUTASE [CU-ZN|5.24|Kd=5.7uM|Kd|=|5.7|uM|5700|nM
6GXG|1.60|2019|FFN||O77404|TRYPAREDOXIN|5.24|Kd=5.7uM|Kd|=|5.7|uM|5700|nM
6GXY|1.80|2019|FFN||O77404|TRYPAREDOXIN|5.24|Kd=5.7uM|Kd|=|5.7|uM|5700|nM
6IOT|2.70|2019|ARG|ligand is L-arginine|------|METHYL-ACCEPTING CHEMOTAXIS PROTEIN|5.24|Kd=5.7uM|Kd|=|5.7|uM|5700|nM
6PU3|1.80|2019|4-mer|ligand is peptide STSA; Kd = 5.85 +/- 0.56 uM|------|HEME-BINDING PROTEIN A|5.23|Kd=5.85uM|Kd|=|5.85|uM|5850|nM
6JAM|1.63|2019|TRE||Q5SLD7|ABC TRANSPORTER, PERIPLASMIC SUBSTRATE-BINDING PROTEIN|5.23|Kd=5.95uM|Kd|=|5.95|uM|5950|nM
6E4V|2.00|2019|HWS|Kd(coprogen)=508+/-110nM|P16869|FHUE RECEPTOR|6.29|Kd=508nM|Kd|=|508|nM|508|nM
6Q4G|0.98|2019|HJK|ligand is compound 37|P24941|CYCLIN-DEPENDENT KINASE 2|4.3|Kd=50uM|Kd|=|50|uM|50000|nM
6MJI|2.30|2019|JTD|ligand is 15s|K7N5M3|T CELL RECEPTOR ALPHA VARIABLE 11,T CELL RECEPTOR ALPHA|7.29|Kd=51.5nM|Kd|=|51.5|nM|51.5|nM
6GHV|2.10|2019|EZ8|ligand is 16|Q9NNX6|CD209 ANTIGEN|4.28|Kd=52.0uM|Kd|=|52|uM|52000|nM
6K5R|NMR|2019|12-mer|ligand is IE2-SIM1|P55854|SMALL UBIQUITIN-RELATED MODIFIER 3|4.27|Kd=53.5uM|Kd|=|53.5|uM|53500|nM
6HP5|2.28|2019|6-mer|ligand is AimP|O31927|SPBC2 PROPHAGE-DERIVED UNCHARACTERIZED PROTEIN YOPK|7.27|Kd=53.8nM|Kd|=|53.8|nM|53.8|nM
6HKS|2.19|2019|11-mer||P26045|TYROSINE-PROTEIN PHOSPHATASE NON-RECEPTOR TYPE 3|4.28|Kd=53uM|Kd|=|53|uM|53000|nM
6Q3Y|1.20|2019|HG5|ligand is compound 16i|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|7.27|Kd=54nM|Kd|=|54|nM|54|nM
6MLJ|1.60|2019|ARG||P02911|LYSINE/ARGININE/ORNITHINE TRANSPORT PROTEIN|7.26|Kd=55nM|Kd|=|55|nM|55|nM
6I7A|2.20|2019|9-mer|[Different protein in assay: Protein in binding assay is D140N mutant] ligand is BRD3 fragment|O43791|SPECKLE-TYPE POZ PROTEIN|4.26|Kd=55uM|Kd|=|55|uM|55000|nM
6DYS|2.30|2019|HJ1||A4GK78|EBONY|4.25|Kd=56.4uM|Kd|=|56.4|uM|56400|nM
6I61|1.65|2019|H3W|ligand is Bisphenol-B|P62508|ESTROGEN-RELATED RECEPTOR GAMMA|6.24|Kd=569.0nM|Kd|=|569|nM|569|nM
6HMY|1.60|2019|6-mer|[Different protein in assay: Protein in binding assay is B-pentamer] ligand is hexaose|Q57193|CHOLERA ENTEROTOXIN B-SUBUNIT|7.24|Kd=57.7nM|Kd|=|57.7|nM|57.7|nM
6QC0|3.50|2019|14-mer|ligand is Cdt2 C-terminal PIP-box peptide; sequence is SSMRKICTYFHRKS;|P12004|PROLIFERATING CELL NUCLEAR ANTIGEN|7.24|Kd=57nM|Kd|=|57|nM|57|nM
6IYW|1.60|2019|IM2|[Covalent complex] ligand is imipenem|I6Y9J2|L,D-TRANSPEPTIDASE 2|7.23|Kd=58.8nM|Kd|=|58.8|nM|58.8|nM
6NNG|2.40|2019|DJ9|ligand is compound DJ95|Q2XVP4|TUBULIN ALPHA-1B CHAIN|4.23|Kd=59.4uM|Kd|=|59.4|uM|59400|nM
6QQT|1.67|2019|JCH|ligand is compound 24a; Kd = 59 +/- 17 uM|B1MDI3|TRNA (GUANINE-N(1)-)-METHYLTRANSFERASE|4.23|Kd=59uM|Kd|=|59|uM|59000|nM
6EEB|1.96|2019|J6P|Kd(malbrancheamide)=5+/-1uM|P0DP23|CALMODULIN-1|5.3|Kd=5uM|Kd|=|5|uM|5000|nM
6ML9|1.69|2019|ARG||P02911|LYSINE/ARGININE/ORNITHINE-BINDING PERIPLASMIC PROTEIN|5.3|Kd=5uM|Kd|=|5|uM|5000|nM
6MS1|1.35|2019|8-mer||Q14160|PROTEIN SCRIBBLE HOMOLOG|5.22|Kd=6.0uM|Kd|=|6|uM|6000|nM
6A04|1.90|2019|C2E|MST assay, Kd(c-diGMP)=6.18+/-0.76uM|B8XX90|STIMULATOR OF INTERFERON GENES PROTEIN|5.21|Kd=6.18uM|Kd|=|6.18|uM|6180|nM
6T1M|1.85|2019|M8K|ligand is compound 4|Q03111|PROTEIN ENL|5.21|Kd=6.1uM|Kd|=|6.1|uM|6100|nM
5ZYG|1.80|2019|9N3|Kd=6.2+/-2.7uM, kon=5.45E+4, koff=3.0E-1|Q9Y5P4|LIPID-TRANSFER PROTEIN CERT|5.21|Kd=6.2uM|Kd|=|6.2|uM|6200|nM
6IHT|1.57|2019|3-mer|ligand is His12|Q9RL81|PHOSPHORYLATED PROTEIN PHOSPHATASE|5.21|Kd=6.2uM|Kd|=|6.2|uM|6200|nM
6OH2|2.58|2019|C5P|ligand is compound CMP; Kd = 6.3+/-1.2uM|Q61420|CMP-SIALIC ACID TRANSPORTER|5.2|Kd=6.3uM|Kd|=|6.3|uM|6300|nM
6J63|2.62|2019|NTD|ligand is NTBC (this code is belong to literature 6isd )|P93836|4-HYDROXYPHENYLPYRUVATE DIOXYGENASE|8.19|Kd=6.43nM|Kd|=|6.43|nM|6.43|nM
6NV9|2.13|2019|L3M|ligand is inhibitor 3; Kd = 6.4 +/- 2.9 nM|P56817|BETA-SECRETASE 1|8.19|Kd=6.4nM|Kd|=|6.4|nM|6.4|nM
6I97|3.35|2019|0UE|[Uncommon element] ligand is B-FoxA|------|TONB-DEPENDENT RECEPTOR|8.18|Kd=6.6nM|Kd|=|6.6|nM|6.6|nM
6O2P|3.30|2019|VX7|ligand is compound ivacaftor; Kd = 6.6+/-1.2 nM|P13569|CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR|8.18|Kd=6.6nM|Kd|=|6.6|nM|6.6|nM
6G8I|1.60|2019|11-mer|betaYAP7|P31947|14-3-3 PROTEIN SIGMA|5.17|Kd=6.71uM|Kd|=|6.71|uM|6710|nM
6IPK|2.15|2019|8DG|[Nonstandard assay: in presence of Mn2+]|Q9NP87|DNA-DIRECTED DNA/RNA POLYMERASE MU|5.17|Kd=6.7uM|Kd|=|6.7|uM|6700|nM
6QQQ|1.85|2019|JDE|ligand is compound 14; Kd = 6.7 +/- 0.6 uM|B1MDI3|TRNA (GUANINE-N(1)-)-METHYLTRANSFERASE|5.17|Kd=6.7uM|Kd|=|6.7|uM|6700|nM
6PEG|2.00|2019|4FQ|ligand is compound L2-4048; allosteric inhibitor|P14174|MACROPHAGE MIGRATION INHIBITORY FACTOR|5.16|Kd=6.86uM|Kd|=|6.86|uM|6860|nM
6G2F|1.74|2019|EHW|Kd(compd 16)=6.8+/-2.6uM|Q9BZ95|HISTONE-LYSINE N-METHYLTRANSFERASE NSD3|5.17|Kd=6.8uM|Kd|=|6.8|uM|6800|nM
6K3L|2.09|2019|3NG||J9VNH4|CMGC/CK2 PROTEIN KINASE|7.22|Kd=60.1nM|Kd|=|60.1|nM|60.1|nM
6E8X|1.60|2019|J0A|[Different protein in assay: protein binding assay is CA IX] compound is STX140|P00918|CARBONIC ANHYDRASE 2|6.22|Kd=605nM|Kd|=|605|nM|605|nM
6MTU|2.14|2019|8-mer|ligand is pMCC|Q14160|PROTEIN SCRIBBLE HOMOLOG|5.22|Kd=6083nM|Kd|=|6083|nM|6083|nM
6I41|1.90|2019|9-mer|ligand is BRD3 fragment|O43791|SPECKLE-TYPE POZ PROTEIN|4.21|Kd=61uM|Kd|=|61|uM|61000|nM
6CN8|1.40|2019|7-mer|Kd(rufomucin 1)=63.4+/-6.0nM, koff=1.08E-1, kon=1.71E+6|P9WPC9|ATP-DEPENDENT CLP PROTEASE ATP-BINDING SUBUNIT CLPC1|7.2|Kd=63.4nM|Kd|=|63.4|nM|63.4|nM
6DYN|2.10|2019|HSM||A4GK78|EBONY|3.19|Kd=638.9uM|Kd|=|638.9|uM|638900|nM
6PVY|1.74|2019|OZG|ligand is compound 26; Kd = 639 +/- 87 uM|P0AEG4|THIOL:DISULFIDE INTERCHANGE PROTEIN DSBA|3.19|Kd=639uM|Kd|=|639|uM|639000|nM
6SDE|2.49|2019|V0L|ligand is savolitinib; pKd=10.2, then Kd=63pM|P08581|HEPATOCYTE GROWTH FACTOR RECEPTOR|10.2|Kd=63pM|Kd|=|63|pM|0.063|nM
6SSY|1.62|2019|P7I|ligand is 2-AEP|Q47537|TAURINE-BINDING PERIPLASMIC PROTEIN|3.19|Kd=649uM|Kd|=|649|uM|649000|nM
6V1C|1.55|2019|4A4|ligand is GlcNAc-alpha-1,4-Gal disaccharide|Q07654|TREFOIL FACTOR 3|4.19|Kd=65uM|Kd|=|65|uM|65000|nM
6DY7|1.90|2019|HH7|compound is C1|P61964|WD REPEAT-CONTAINING PROTEIN 5|4.18|Kd=66.2uM|Kd|=|66.2|uM|66200|nM
6E7S|2.72|2019|HZ4|[Nonstandard assay: PH=7.6] Kd(PH=7.6)=66.3+/-3.2nM, Kd(PH=6.5)=70.7+/-2.0nM, chain BD: 363|Q00960|GLUTAMATE RECEPTOR IONOTROPIC, NMDA 1|7.18|Kd=66.3nM|Kd|=|66.3|nM|66.3|nM
5ZDP|2.71|2019|9AU|koff=0.0914, kon=1.372E+6|Q26710|ALTERNATIVE OXIDASE, MITOCHONDRIAL|7.18|Kd=66.62nM|Kd|=|66.62|nM|66.62|nM
6CYG|1.50|2019|N5O|compound is NEoCA, Kd=67.5+/-3.5uM|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|4.17|Kd=67.5uM|Kd|=|67.5|uM|67500|nM
6P9E|2.00|2019|O6D|kd = 67.6+/-5.98 nM; ligand is compound A-552|Q9NZH8|INTERLEUKIN-36 GAMMA|7.17|Kd=67.6nM|Kd|=|67.6|nM|67.6|nM
6DYA|2.56|2019|HHM|compound is C5|P61964|WD REPEAT-CONTAINING PROTEIN 5|6.17|Kd=681nM|Kd|=|681|nM|681|nM
6DET|1.75|2019|ARG||S3MDF0|TV2483|8.22|Kd=6nM|Kd|=|6|nM|6|nM
6NU5|1.60|2019|CYS|ligand is cysteine; Kd = 7.04 +/- 1.83 uM|P14618|PYRUVATE KINASE PKM|5.15|Kd=7.04uM|Kd|=|7.04|uM|7040|nM
6NTB|1.90|2019|ATP|ligand is ATP. Kd = 3.92 uM with 7mM CaCl2|B5II98|SBTB7001, PII-LIKE PROTEIN|5.15|Kd=7.07uM|Kd|=|7.07|uM|7070|nM
5ZQU|2.60|2019|9HF|Kd(CBt-PMN)=7.0+/-1.2uM|P19793|RETINOIC ACID RECEPTOR RXR-ALPHA|5.15|Kd=7.0uM|Kd|=|7|uM|7000|nM
6N7Q|2.10|2019|13-mer||Q1PBJ5|APICAL MEMBRANE ANTIGEN-1|5.15|Kd=7.0uM|Kd|=|7|uM|7000|nM
6R9S|2.00|2019|JVN|ligand is compound 3|P30405|PEPTIDYL-PROLYL CIS-TRANS ISOMERASE F, MITOCHONDRIAL|2.15|Kd=7.1mM|Kd|=|7.1|mM|7100000|nM
6MIV|2.05|2019|JU1|ligand is 15q|K7N5M3|T CELL RECEPTOR ALPHA VARIABLE 11,T CELL RECEPTOR ALPHA|8.15|Kd=7.1nM|Kd|=|7.1|nM|7.1|nM
6J9W|1.80|2019|TRE||Q5SLD7|ABC TRANSPORTER, PERIPLASMIC SUBSTRATE-BINDING PROTEIN|5.13|Kd=7.46uM|Kd|=|7.46|uM|7460|nM
6R9U|1.26|2019|JVQ|ligand is compound 4|P30405|PEPTIDYL-PROLYL CIS-TRANS ISOMERASE F|2.12|Kd=7.5mM|Kd|=|7.5|mM|7500000|nM
6QE5|1.61|2019|SAH|ligand is SAH; Kd = 7.5+/-0.9uM|------|RIBOSOMAL RNA LARGE SUBUNIT METHYLTRANSFERASE J|5.12|Kd=7.5uM|Kd|=|7.5|uM|7500|nM
6O3W|2.10|2019|14-mer|ligand is peptide Sen1 NIM1; Kd = 7.65+/-0.89uM|Q00416|HELICASE SEN1|5.12|Kd=7.65uM|Kd|=|7.65|uM|7650|nM
6I13|1.79|2019|H0Q|ligand is 7|Q16658|FASCIN|5.12|Kd=7.6uM|Kd|=|7.6|uM|7600|nM
6AAO|1.40|2019|9U0|compound is TCO*Lys|Q8PWY1|PYRROLYSINE--TRNA LIGASE|2.11|Kd=7.8mM|Kd|=|7.8|mM|7800000|nM
5ZML|1.80|2019|16-mer|Kd=7.8+/-1.9nM, kon=2.2+/-0.3E+6, koff=1.6+/-0.3E-2|P06730|EUKARYOTIC TRANSLATION INITIATION FACTOR 4E|8.11|Kd=7.8nM|Kd|=|7.8|nM|7.8|nM
6JDI|1.95|2019|AGS|ligand is ATPgS|Q51460|NITROGEN ASSIMILATION REGULATORY PROTEIN|5.11|Kd=7.8uM|Kd|=|7.8|uM|7800|nM
6HOI|1.14|2019|10-mer|ligand is LIR peptide of BECN1|Q9H0R8|GAMMA-AMINOBUTYRIC ACID RECEPTOR-ASSOCIATED PROTEIN-LIKE 1|5.1|Kd=7.95uM|Kd|=|7.95|uM|7950|nM
6CYH|1.49|2019|N5A|compound is NEaCA, Kd=708+/-88uM|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|3.15|Kd=708uM|Kd|=|708|uM|708000|nM
6MKU|1.73|2019|ARG||P02911|LYSINE/ARGININE/ORNITHINE-BINDING PERIPLASMIC PROTEIN|7.15|Kd=70nM|Kd|=|70|nM|70|nM
6QR7|2.03|2019|JEK|ligand is compound 29b; Kd = 70 +/- 29 nM|B1MDI3|TRNA (GUANINE-N(1)-)-METHYLTRANSFERASE|7.15|Kd=70nM|Kd|=|70|nM|70|nM
6N9T|2.58|2019|13-mer|ligand is 7a|Q6MZV7|IMMUNOGLOBULIN G1 FC|4.15|Kd=70uM|Kd|=|70|uM|70000|nM
6FCJ|2.49|2019|D4W|Kd=71.1+/-4.33nM, kon=4.79E+5, koff=3.38E-2|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|7.15|Kd=71.1nM|Kd|=|71.1|nM|71.1|nM
6QRA|1.71|2019|JDK|ligand is compound 31b; Kd = 710 +/- 90nM|B1MDI3|TRNA (GUANINE-N(1)-)-METHYLTRANSFERASE|6.15|Kd=710nM|Kd|=|710|nM|710|nM
6QCG|3.40|2019|14-mer|ligand is Cdt1 N-terminal PIP-box peptide; sequence is MEQRRVTDFFARRR; Kd = 7200+/-200nM|P12004|PROLIFERATING CELL NUCLEAR ANTIGEN|5.14|Kd=7200nM|Kd|=|7200|nM|7200|nM
6G27|1.65|2019|EHE|Kd(compd 5)=731+/-308uM|Q9BZ95|HISTONE-LYSINE N-METHYLTRANSFERASE NSD3|3.14|Kd=731uM|Kd|=|731|uM|731000|nM
6QHG|1.48|2019|MGT|ligand is m7-GTP; Kd = 737 +/- 47 uM|F4ZDJ0|POLYMERASE|3.13|Kd=737uM|Kd|=|737|uM|737000|nM
6ST0|1.50|2019|LUQ|ligand is ACES|Q47537|TAURINE-BINDING PERIPLASMIC PROTEIN|5.13|Kd=7463nM|Kd|=|7463|nM|7463|nM
6MTV|2.60|2019|8-mer|ligand is MCC|Q14160|PROTEIN SCRIBBLE HOMOLOG|5.11|Kd=7715nM|Kd|=|7715|nM|7715|nM
6GXQ|1.96|2019|FFZ|ligand is 37|Q8WQX9|PHOSPHODIESTERASE|7.1|Kd=79.4nM|Kd|=|79.4|nM|79.4|nM
6IOS|2.35|2019|PRO|ligand is L-proline|------|METHYL-ACCEPTING CHEMOTAXIS PROTEIN|4.1|Kd=79.4uM|Kd|=|79.4|uM|79400|nM
6Q92|1.50|2019|ABH|[Uncommon element] ligand is compound ABH; PH=7.4; B element contained|P05089|ARGINASE-1|6.1|Kd=797nM|Kd|=|797|nM|797|nM
6DN6|1.59|2019|5-mer|Kd=7+/-2nM, kon=5E+5, koff=3.2E-3|Q99619|SPRY DOMAIN-CONTAINING SOCS BOX PROTEIN 2|8.15|Kd=7nM|Kd|=|7|nM|7|nM
5OAI|2.00|2019|B5K|[Different protein in assay: protein in binding assay is MDM2(1-118)] MST assay for compound (R)-6a|Q00987|E3 UBIQUITIN-PROTEIN LIGASE MDM2|5.15|Kd=7uM|Kd|=|7|uM|7000|nM
6N3X|1.10|2019|KBD|ligand is 3|P49773|HISTIDINE TRIAD NUCLEOTIDE-BINDING PROTEIN 1|5.09|Kd=8.09uM|Kd|=|8.09|uM|8090|nM
6J9Y|1.63|2019|MAL||Q5SLD7|ABC TRANSPORTER, PERIPLASMIC SUBSTRATE-BINDING PROTEIN|5.07|Kd=8.54uM|Kd|=|8.54|uM|8540|nM
6NNR|1.05|2019|UMC|ligand is dUMP; Kd = 8.5 +/- 0.9 uM(without Mg2+)|P0A884|THYMIDYLATE SYNTHASE|5.07|Kd=8.5uM|Kd|=|8.5|uM|8500|nM
6I76|1.20|2019|H5N|[Different ligand in assay: ligand in binding asssay is racemic mixture] ligand is 4|P17931|GALECTIN-3|5.07|Kd=8.5uM|Kd|=|8.5|uM|8500|nM
6QR1|1.67|2019|JFT|ligand is compound 27g; Kd = 8.5 +/- 1.0 uM|B1MDI3|TRNA (GUANINE-N(1)-)-METHYLTRANSFERASE|5.07|Kd=8.5uM|Kd|=|8.5|uM|8500|nM
6N0K|1.46|2019|K8M|ligand is CCG-257081|O00625|PIRIN|5.07|Kd=8.6uM|Kd|=|8.6|uM|8600|nM
6PL2|2.59|2019|OOM|ligand is compound 1a|P04629|HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR|8.06|Kd=8.74nM|Kd|=|8.74|nM|8.74|nM
6KQI|3.25|2019|9GF|[Different protein in assay: Protein in binding assay is wild type] ligand is CP55940|P21554|CANNABINOID RECEPTOR 1,GLGA GLYCOGEN SYNTHASE,CANNABINOID|8.06|Kd=8.7nM|Kd|=|8.7|nM|8.7|nM
6QLO|1.18|2019|J5E|ligand is compound 5; Kd = 8.8+/-0.3 uM; Binding assay is fluorescence polarization|P17931|GALECTIN-3|5.06|Kd=8.8uM|Kd|=|8.8|uM|8800|nM
6KJD|2.30|2019|LVA|ligand is lovastatin|B6H6L7|PC15G00720 PROTEIN|5.05|Kd=8.9uM|Kd|=|8.9|uM|8900|nM
6PML|2.00|2019|OR4|ligand is compound 23; Kd = 820 +/- 140 uM|P0AEG4|THIOL:DISULFIDE INTERCHANGE PROTEIN DSBA|3.09|Kd=820uM|Kd|=|820|uM|820000|nM
6FH3|1.85|2019|RPI|Kd(pArg)=850+/-400uM|P0DMM5|PROTEIN-ARGININE KINASE|3.07|Kd=850uM|Kd|=|850|uM|850000|nM
6I18|1.49|2019|H0N|ligand is BDP-13176|Q16658|FASCIN|4.07|Kd=85uM|Kd|=|85|uM|85000|nM
6NM4|2.58|2019|KS7|ligand is compound MRK-740|Q9NQV7|HISTONE-LYSINE N-METHYLTRANSFERASE PRDM9|7.06|Kd=87nM|Kd|=|87|nM|87|nM
6FTF|1.09|2019|7CI|Kd(7-CN-7-C-Ino)=8+/-2nM|Q4DSV5|PROTEIN KINASE A REGULATORY SUBUNIT, PUTATIVE|8.1|Kd=8nM|Kd|=|8|nM|8|nM
6M87|2.61|2019|2M9|ligand is MPTS|------|FAB 10A6 LIGHT CHAIN|8.1|Kd=8nM|Kd|=|8|nM|8|nM
6MD6|1.68|2019|JSV|ligand is G6SG-OMe|Q9XEI3|BETA-D-GLUCAN EXOHYDROLASE ISOENZYME EXOI|5.1|Kd=8uM|Kd|=|8|uM|8000|nM
6S57|1.82|2019|KVT|ligand is compound 15; SPR pKd=5.1|Q6PL18|ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 2|5.1|Kd=8uM|Kd|=|8|uM|8000|nM
6S56|2.01|2019|KVZ|ligand is compound 9; SPR pKd=5.1|Q6PL18|ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 2|5.1|Kd=8uM|Kd|=|8|uM|8000|nM
6AJV|1.45|2019|HCC|Kd(ISL)=9.1uM, +DMSO in crystal structure|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|5.04|Kd=9.1uM|Kd|=|9.1|uM|9100|nM
6AJX|1.89|2019|HCC|Kd(ISL)=9.1uM, -DMSO in crystal structure; redundant to 6ajv|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|5.04|Kd=9.1uM|Kd|=|9.1|uM|9100|nM
6CYI|1.76|2019|N5O|compound is NEoCA, Kd=9.1+/-0.3uM|P41148|ENDOPLASMIN|5.04|Kd=9.1uM|Kd|=|9.1|uM|9100|nM
6J7E|2.40|2019|AGS|ligand is ATPgS|Q51460|NITROGEN ASSIMILATION REGULATORY PROTEIN|5.04|Kd=9.2uM|Kd|=|9.2|uM|9200|nM
6HGF|1.65|2019|HCY|ligand is cortisol|P01011|ALPHA-1-ANTICHYMOTRYPSIN|5.02|Kd=9.6uM|Kd|=|9.6|uM|9600|nM
6P89|1.40|2019|O4A|ligand is compound 7|Q0P6M7|UDP-3-O-(3-HYDROXYMYRISTOYL)GLUCOSAMINE N-ACYLTRANSFERASE|5.01|Kd=9.77uM|Kd|=|9.77|uM|9770|nM
6G2E|1.85|2019|EHH|Kd(compd 13)=9.7+/-2.3uM|Q9BZ95|HISTONE-LYSINE N-METHYLTRANSFERASE NSD3|5.01|Kd=9.7uM|Kd|=|9.7|uM|9700|nM
6NCN|1.82|2019|KJM|ligand is 1|P02649|APOLIPOPROTEIN E|3.05|Kd=900uM|Kd|=|900|uM|900000|nM
6JOE|2.21|2019|BWR|AZ51, koff=1.17E-2, kon=1.28E+5|Q02RL6|TRNA (GUANINE-N(1)-)-METHYLTRANSFERASE|7.04|Kd=91nM|Kd|=|91|nM|91|nM
6QPL|1.60|2019|JC5|ligand is compound 3; Kd = 91 +/- 4 nM|Q9Y657|SPINDLIN-1|7.04|Kd=91nM|Kd|=|91|nM|91|nM
6HMT|1.10|2019|8-mer|with molecule 2|P31947|14-3-3 PROTEIN SIGMA|7.04|Kd=92nM|Kd|=|92|nM|92|nM
6I0Z|1.77|2019|GZQ|ligand is 1|Q16658|FASCIN|4.04|Kd=92uM|Kd|=|92|uM|92000|nM
6QLT|1.15|2019|J5W|ligand is compound 2; Kd = 92+/-5 uM; Binding assay is fluorescence polarization|P17931|GALECTIN-3|4.04|Kd=92uM|Kd|=|92|uM|92000|nM
6HNI|1.35|2019|TYR||Q18A65|ABC-TYPE TRANSPORT SYSTEM, SUGAR-FAMILY EXTRACELLULAR|4.03|Kd=94uM|Kd|=|94|uM|94000|nM
6I63|2.23|2019|2OH|ligand is bisphenol-A|P62508|ESTROGEN-RELATED RECEPTOR GAMMA|7.01|Kd=98.6nM|Kd|=|98.6|nM|98.6|nM
6NJZ|1.90|2019|17-mer|ligand is YSA-GSGSK-bio peptide|P29317|EPHRIN TYPE-A RECEPTOR 2|5.01|Kd=9800nM|Kd|=|9800|nM|9800|nM
6HAY|2.24|2019|FX8|ligand is PROTAC 1, ternary complex VHL and PROTAC 1 with SMARCA2|P51531|PROBABLE GLOBAL TRANSCRIPTION ACTIVATOR SNF2L2|7.01|Kd=98nM|Kd|=|98|nM|98|nM
6HHR|2.00|2019|G5E|ligand is 7|P07900|HEAT SHOCK PROTEIN HSP90-ALPHA|7.01|Kd=98nM|Kd|=|98|nM|98|nM
6RK4|1.43|2019|K5T|ligand is P4-G5; high-resolution set crystal|P10547|LYSOSTAPHIN|4.01|Kd=98uM|Kd|=|98|uM|98000|nM
6AFK|2.75|2019|9WO|compound 32, kon=2.11E+5, koff=0.211|Q02RL6|TRNA (GUANINE-N(1)-)-METHYLTRANSFERASE|6.0|Kd=999nM|Kd|=|999|nM|999|nM
6OOZ|2.80|2019|A6Y|ligand is UCB-5307; Biopore assay|P01375|TUMOR NECROSIS FACTOR|8.05|Kd=9nM|Kd|=|9|nM|9|nM
6MLG|1.89|2019|ARG||P02911|LYSINE/ARGININE/ORNITHINE-BINDING PERIPLASMIC PROTEIN|5.05|Kd=9uM|Kd|=|9|uM|9000|nM
6QUW|1.24|2019|JJQ|ligand is compound 9b|P01116|GTPASE KRAS|2.82|Kd>1.5mM|Kd|>|1.5|mM|1500000|nM
6I15|1.91|2019|GZT|ligand is 11|Q16658|FASCIN|4.0|Kd>100uM|Kd|>|100|uM|100000|nM
6I16|2.00|2019|H0B|ligand is 15|Q16658|FASCIN|4.0|Kd>100uM|Kd|>|100|uM|100000|nM
6RA1|2.00|2019|JVQ|ligand is compound 7|P30405|PEPTIDYL-PROLYL CIS-TRANS ISOMERASE F, MITOCHONDRIAL|2.0|Kd>10mM|Kd|>|10|mM|10000000|nM
6OXL|3.50|2019|7-mer|ligand is peptide NECAP; Binding assay is pulldown depletion assays.|Q9DBG3|AP-2 COMPLEX SUBUNIT ALPHA-2|5.52|Kd>3000nM|Kd|>|3000|nM|3000|nM
6O9B|2.20|2019|9-mer|ligand is beta-catenin peptide|P04439|HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-3 ALPHA CHAIN|6.4|Kd>400nM|Kd|>|400|nM|400|nM
6GZY|2.15|2019|FHH|ligand is 5|Q96EP0|E3 UBIQUITIN-PROTEIN LIGASE RNF31|3.4|Kd>400uM|Kd|>|400|uM|400000|nM
6HOV|1.85|2019|FER|ligand is Ferulic acid; binding assay method is BROMOscan assay|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|3.3|Kd>500uM|Kd|>|500|uM|500000|nM
6OB0|2.81|2019|M3D|ligand is compound 2|P06858|LIPOPROTEIN LIPASE|4.96|Kd~11uM|Kd|~|11|uM|11000|nM
6E13|2.35|2019|HKS|[Nonstandard assay: in presence of excess Zn2+] Cys-DOPA|Q88QV5|COENZYME PQQ SYNTHESIS PROTEIN B|6.7|Kd~200nM|Kd|~|200|nM|200|nM
6HCK|2.70|2019|LEU||P22262|LISTERIOLYSIN REGULATORY PROTEIN|4.6|Kd~25uM|Kd|~|25|uM|25000|nM
6OMU|1.41|2019|MZJ|ligand is compound evobrutinib|Q06187|TYROSINE-PROTEIN KINASE BTK|8.7|Kd~2nM|Kd|~|2|nM|2|nM
6OOS|1.90|2019|017|ligand is compound DRV (darunavir)|Q3HWC9|NL4-3 PROTEASE|11.3|Ki<0.005nM|Ki|<|0.005|nM|0.005|nM
6OOT|1.82|2019|017|ligand is compound DRV(darunavir)|Q3HWC9|NL4-3 PROTEASE|11.3|Ki<0.005nM|Ki|<|0.005|nM|0.005|nM
6OOU|2.13|2019|017|ligand is compound DRV(darunavir)|Q7ZCR0|NL4-3 PROTEASE|11.3|Ki<0.005nM|Ki|<|0.005|nM|0.005|nM
6C2T|1.73|2019|EGJ||O14965|AURORA KINASE A|9.05|Ki<0.9nM|Ki|<|0.9|nM|0.9|nM
6OXQ|1.89|2019|F53|[Different protein in assay: Protein in binding assay is I84V mutant] ligand is compound 4; Ki = 0.005 +/- 0.002 nM|Q8ULI9|PROTEASE NL4-3|11.3|Ki=0.005nM|Ki|=|0.005|nM|0.005|nM
6NG0|2.05|2019|B49|ligand is compound sunitinib; Ki = 0.0064+/-0.0034uM at ATP=300 uM|Q92918|MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE KINASE 1|8.19|Ki=0.0064uM|Ki|=|0.0064|uM|6.4|nM
6QGH|2.00|2019|1XJ|ligand is compound 13, ABT-263; FP Ki data|P10415|APOPTOSIS REGULATOR BCL-2,BCL-2-LIKE PROTEIN 1|8.15|Ki=0.007uM|Ki|=|0.007|uM|7|nM
6OXP|1.97|2019|K2A|[Different protein in assay: Protein in binding assay is I84V mutant] ligand is compound 3; Ki = 0.010 +/- 0.03 nM|Q8ULI9|PROTEASE NL4-3|11.0|Ki=0.010nM|Ki|=|0.01|nM|0.01|nM
6O0K|1.62|2019|LBM|ligand is venetoclax; Ki = 0.018+/-0.014 nM|P10415|APOPTOSIS REGULATOR BCL-2|10.74|Ki=0.018nM|Ki|=|0.018|nM|0.018|nM
5ZG1|1.32|2019|9C0||P42262|GLUTAMATE RECEPTOR 2|7.72|Ki=0.019uM|Ki|=|0.019|uM|19|nM
6OXV|1.99|2019|NF4|[Different protein in assay: Protein in binding assay is I84V mutant] ligand is compound 16; Ki = 0.020 +/- 0.002 nM|Q8ULI9|PROTEASE NL4-3|10.7|Ki=0.020nM|Ki|=|0.02|nM|0.02|nM
6OXW|1.98|2019|NFJ|[Different protein in assay: Protein in binding assay is I84V mutant] ligand is compound 17; Ki = 0.028 +/- 0.003 nM|Q8ULI9|PROTEASE NL4-3|10.55|Ki=0.028nM|Ki|=|0.028|nM|0.028|nM
6NE5|1.85|2019|KJP|ligand is compound 42; Ki = 0.030+/-0.02nM|Q07820|INDUCED MYELOID LEUKEMIA CELL DIFFERENTIATION PROTEIN MCL|10.52|Ki=0.03nM|Ki|=|0.03|nM|0.03|nM
6NO9|1.71|2019|KUV|ligand is compound 16|P11309|SERINE/THREONINE-PROTEIN KINASE PIM-1|10.52|Ki=0.03nM|Ki|=|0.03|nM|0.03|nM
6OXR|2.04|2019|NJA|[Different protein in assay: Protein in binding assay is I84V mutant] ligand is compound 12; Ki = 0.048 +/- 0.04 nM|Q8ULI9|PROTEASE NL4-3|10.32|Ki=0.048nM|Ki|=|0.048|nM|0.048|nM
6P3T|2.50|2019|NRS|ligand is compound 1, inhibitor SGT449; Ki = 0.048 +/- 0.003 uM|P9WFK7|N-ACETYLTRANSFERASE EIS|7.32|Ki=0.048uM|Ki|=|0.048|uM|48|nM
6OQC|1.80|2019|N0S|ligand is compound 9|Q07820|INDUCED MYELOID LEUKEMIA CELL DIFFERENTIATION PROTEIN MCL|10.4|Ki=0.04nM|Ki|=|0.04|nM|0.04|nM
6D3X|1.80|2019|14-mer|Ki=0.051+/-0.007nM,|P00747|PLASMINOGEN|10.29|Ki=0.051nM|Ki|=|0.051|nM|0.051|nM
6UDV|1.35|2019|Q51|ligand is compound 3|Q07820|INDUCED MYELOID LEUKEMIA CELL DIFFERENTIATION PROTEIN MCL|10.29|Ki=0.051nM|Ki|=|0.051|nM|0.051|nM
6HLB|2.00|2019|9-mer|ligand is 10|P09958|FURIN|10.27|Ki=0.0538nM|Ki|=|0.0538|nM|0.0538|nM
6OY1|2.00|2019|NJ1|[Different protein in assay: Protein in binding assay is I84V mutant] ligand is compound 26; Ki = 0.057 +/- 0.004 nM|Q8ULI9|PROTEASE NL4-3|10.24|Ki=0.057nM|Ki|=|0.057|nM|0.057|nM
6OQB|1.60|2019|N0J|ligand is compound 10 (AM-8621); Some data are Ki, some are IC50|Q07820|INDUCED MYELOID LEUKEMIA CELL DIFFERENTIATION PROTEIN MCL|10.3|Ki=0.05nM|Ki|=|0.05|nM|0.05|nM
5ZG3|1.65|2019|9C6||P42262|GLUTAMATE RECEPTOR 2|7.21|Ki=0.061uM|Ki|=|0.061|uM|61|nM
6UD2|1.70|2019|Q4D|ligand is compound 1|Q07820|INDUCED MYELOID LEUKEMIA CELL DIFFERENTIATION PROTEIN MCL|10.21|Ki=0.062nM|Ki|=|0.062|nM|0.062|nM
6NZT|1.40|2019|L9P|ligand is compound 36, voxilaprevir;|S4UY05|HCV NS3/4A PROTEASE|10.2|Ki=0.063nM|Ki|=|0.063|nM|0.063|nM
6NDL|2.00|2019|BQX|ligand is compound 7; Ki = 0.065 +/- 0.03 nM|------|BIOTIN PROTEIN LIGASE|7.19|Ki=0.065uM|Ki|=|0.065|uM|65|nM
6NZV|1.55|2019|L9J|ligand is compound 12|S4UY05|HCV NS3/4A PROTEASE|10.17|Ki=0.067nM|Ki|=|0.067|nM|0.067|nM
6PVX|1.55|2019|U5F|ligand is compound p5U; Ki = 0.068 +/- 0.007 uM|P61823|RIBONUCLEASE PANCREATIC|7.17|Ki=0.068uM|Ki|=|0.068|uM|68|nM
5ZTY|2.80|2019|9JU||P34972|G PROTEIN COUPLED RECEPTOR,T4 LYSOZYME,G PROTEIN COUPLED|10.12|Ki=0.075nM|Ki|=|0.075|nM|0.075|nM
6JN6|1.60|2019|BY0|[Incomplete ligand] ligand is MS19|Q9K2N0|BETA-LACTAMASE CLASS B VIM-2|7.15|Ki=0.07uM|Ki|=|0.07|uM|70|nM
5ZG0|1.58|2019|9C3||P42262|GLUTAMATE RECEPTOR 2|7.09|Ki=0.082uM|Ki|=|0.082|uM|82|nM
6OXU|1.86|2019|NE7|[Different protein in assay: Protein in binding assay is I84V mutant] ligand is compound 15; Ki = 0.095 +/- 0.005 nM|Q8ULI9|PROTEASE NL4-3|10.02|Ki=0.095nM|Ki|=|0.095|nM|0.095|nM
6P3U|2.55|2019|NRY|ligand is compound 2; Ki = 0.095 +/- 0.005 uM|P9WFK7|N-ACETYLTRANSFERASE EIS|7.02|Ki=0.095uM|Ki|=|0.095|uM|95|nM
6P3V|2.50|2019|NRV|ligand is compound 3; Ki = 0.096 +/- 0.010 uM|P9WFK7|N-ACETYLTRANSFERASE EIS|7.02|Ki=0.096uM|Ki|=|0.096|uM|96|nM
6N4B|3.00|2019|KCA|ligand is FUB|P63096|GUANINE NUCLEOTIDE-BINDING PROTEIN G(I) SUBUNIT ALPHA-1|10.01|Ki=0.098nM|Ki|=|0.098|nM|0.098|nM
6OXX|1.96|2019|NF7|[Different protein in assay: Protein in binding assay is I84V mutant] ligand is compound 22; Ki = 0.098 +/- 0.008 nM|Q8ULI9|PROTEASE NL4-3|10.01|Ki=0.098nM|Ki|=|0.098|nM|0.098|nM
6OXS|1.99|2019|NJ4|[Different protein in assay: Protein in binding assay is I84V mutant] ligand is compound 13; Ki = 0.109 +/- 0.007 nM|Q8ULI9|PROTEASE NL4-3|9.96|Ki=0.109nM|Ki|=|0.109|nM|0.109|nM
6UDI|1.94|2019|Q4S|ligand is compound 20; Ki = 0.10 +/- 0.01 nM|Q07820|INDUCED MYELOID LEUKEMIA CELL DIFFERENTIATION PROTEIN MCL|10.0|Ki=0.10nM|Ki|=|0.1|nM|0.1|nM
6OXT|1.86|2019|NEJ|[Different protein in assay: Protein in binding assay is I84V mutant] ligand is compound 14; Ki = 0.111 +/- 0.008 nM|Q8ULI9|PROTEASE NL4-3|9.95|Ki=0.111nM|Ki|=|0.111|nM|0.111|nM
6PS0|3.40|2019|CAU|ligand is carazolol|P07550|FUSION PROTEIN OF BETA-2 ADRENERGIC RECEPTOR AND T4|9.94|Ki=0.114nM|Ki|=|0.114|nM|0.114|nM
6O0P|1.80|2019|LBM|ligand is venetoclax; Ki = 0.11 +/- 0.03 nM|P10415|APOPTOSIS REGULATOR BCL-2|9.96|Ki=0.11nM|Ki|=|0.11|nM|0.11|nM
6ME4|3.20|2019|ML2|ligand is 2-iodomelatonin|P48039|CHIMERA PROTEIN OF MELATONIN RECEPTOR TYPE 1A AND GLGA|9.92|Ki=0.12nM|Ki|=|0.12|nM|0.12|nM
6OY2|1.99|2019|NJJ|[Different protein in assay: Protein in binding assay is I84V mutant] ligand is compound 27; Ki = 0.134 +/- 0.007 nM|Q8ULI9|PROTEASE NL4-3|9.87|Ki=0.134nM|Ki|=|0.134|nM|0.134|nM
6PS4|2.60|2019|JRZ|ligand is ICI-118551|P07550|FUSION PROTEIN OF BETA-2 ADRENERGIC RECEPTOR AND T4|9.89|Ki=0.13nM|Ki|=|0.13|nM|0.13|nM
6D40|1.43|2019|14-mer|Ki=0.14+/-0.02nM|P00747|PLASMINOGEN|9.85|Ki=0.14nM|Ki|=|0.14|nM|0.14|nM
6Q89|2.21|2019|LSS|[Incomplete ligand]|------|LEUCINE--TRNA LIGASE|9.85|Ki=0.14nM|Ki|=|0.14|nM|0.14|nM
6OQD|1.48|2019|N0M|ligand is compound 8|Q07820|INDUCED MYELOID LEUKEMIA CELL DIFFERENTIATION PROTEIN MCL|9.85|Ki=0.14nM|Ki|=|0.14|nM|0.14|nM
6PS3|2.50|2019|CVD|ligand is carvedilol|P07550|FUSION PROTEIN OF BETA-2 ADRENERGIC RECEPTOR AND T4|9.78|Ki=0.166nM|Ki|=|0.166|nM|0.166|nM
6SBT|2.30|2019|L5H|Ligand is compound 11; Ki = 0.166+/-0.011uM|P22756|GLUTAMATE RECEPTOR, IONOTROPIC KAINATE 1|6.78|Ki=0.166uM|Ki|=|0.166|uM|166|nM
6IXD|1.00|2019|B0F|ligand is 2|Q5RZ08|HIV-1 PROTEASE|9.8|Ki=0.16nM|Ki|=|0.16|nM|0.16|nM
6H9X|2.10|2019|SSA|[Incomplete ligand] ligand is 15|W9BNU9|SERINE--TRNA LIGASE|9.74|Ki=0.18nM|Ki|=|0.18|nM|0.18|nM
6I9A|1.20|2019|H8E|ligand is KYT-36|Q51817|LYS-GINGIPAIN W83|10.0|Ki=0.1nM|Ki|=|0.1|nM|0.1|nM
6UDT|1.50|2019|Q4V|ligand is compound 10|Q07820|INDUCED MYELOID LEUKEMIA CELL DIFFERENTIATION PROTEIN MCL|10.0|Ki=0.1nM|Ki|=|0.1|nM|0.1|nM
6PS1|3.20|2019|TIM|ligand is timolol|P07550|FUSION PROTEIN OF BETA-2 ADRENERGIC RECEPTOR AND T4|9.7|Ki=0.201nM|Ki|=|0.201|nM|0.201|nM
6PS6|2.70|2019|TIM|ligand is timolol|P07550|FUSION PROTEIN OF BETA-2 ADRENERGIC RECEPTOR AND T4|9.7|Ki=0.201nM|Ki|=|0.201|nM|0.201|nM
6CJS|1.90|2019|2GJ|AUY922|P46598|HEAT SHOCK PROTEIN 90 HOMOLOG|9.7|Ki=0.20nM|Ki|=|0.2|nM|0.2|nM
6OXZ|1.96|2019|NJG|[Different protein in assay: Protein in binding assay is I84V mutant] ligand is compound 24; Ki = 0.216 +/- 0.011 nM|Q8ULI9|PROTEASE NL4-3|9.67|Ki=0.216nM|Ki|=|0.216|nM|0.216|nM
6N78|1.83|2019|KEP|ligand is 21|P23458|TYROSINE-PROTEIN KINASE JAK1|9.68|Ki=0.21nM|Ki|=|0.21|nM|0.21|nM
6N79|2.27|2019|KES|ligand is 20|P23458|TYROSINE-PROTEIN KINASE JAK1|9.68|Ki=0.21nM|Ki|=|0.21|nM|0.21|nM
6JIJ|2.65|2019|6-mer|[Covalent complex] ligand is N3|Q66WN6|REPLICATIVE POLYPROTEIN 1AB|6.64|Ki=0.23uM|Ki|=|0.23|uM|230|nM
6SAF|2.05|2019|L2Q|ligand is compound 25|Q13451|PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5|6.64|Ki=0.23uM|Ki|=|0.23|uM|230|nM
6D19|1.45|2019|YKG|compound 9, Ki=0.246+/-0.047uM|Q9F663|CARBAPENEM-HYDROLYZING BETA-LACTAMASE KPC|6.61|Ki=0.246uM|Ki|=|0.246|uM|246|nM
6OXY|1.96|2019|NG4|[Different protein in assay: Protein in binding assay is I84V mutant] ligand is compound 23; Ki = 0.283 +/- 0.024 nM|Q8ULI9|PROTEASE NL4-3|9.55|Ki=0.283nM|Ki|=|0.283|nM|0.283|nM
6CJR|1.80|2019|E0G|SNX-2112|P46598|HEAT SHOCK PROTEIN 90 HOMOLOG|9.52|Ki=0.30nM|Ki|=|0.3|nM|0.3|nM
6O5T|2.10|2019|L8J|compound 16, Ki=0.316+/-0.015uM|Q9K2N0|BETA-LACTAMASE CLASS B VIM-2|6.5|Ki=0.316uM|Ki|=|0.316|uM|316|nM
6FTW|2.16|2019|E6Z|pKi(8b)=6.5+/-0.2|Q08499|CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D|6.49|Ki=0.32uM|Ki|=|0.32|uM|320|nM
6Q54|1.40|2019|HJ8|ligand is compound 6b; Ki = 0.32+/-0.03uM|P19491|GLUTAMATE RECEPTOR 2|6.49|Ki=0.32uM|Ki|=|0.32|uM|320|nM
6PT3|3.30|2019|OWY|ligand is DPI-287|------|DELTA OPIOID RECEPTOR|9.41|Ki=0.39nM|Ki|=|0.39|nM|0.39|nM
6HOQ|1.55|2019|FER|ligand is ferulic acid|P68400|CASEIN KINASE II, ALPHA SUBUNIT|6.39|Ki=0.41uM|Ki|=|0.41|uM|410|nM
6ME3|2.90|2019|JEY|ligand is 2-pmt|P48039|CHIMERA PROTEIN OF MELATONIN RECEPTOR TYPE 1A AND GLGA|9.38|Ki=0.42nM|Ki|=|0.42|nM|0.42|nM
6IQL|3.50|2019|L74|ligand is L745870|P51436|D(4) DOPAMINE RECEPTOR,SOLUBLE CYTOCHROME B562,D(4)|9.37|Ki=0.43nM|Ki|=|0.43|nM|0.43|nM
6ME2|2.80|2019|JEV|ligand is ramelteon|P48039|CHIMERA PROTEIN OF MELATONIN RECEPTOR TYPE 1A AND GLGA|9.37|Ki=0.43nM|Ki|=|0.43|nM|0.43|nM
6O0M|1.75|2019|LBM|ligand is venetoclax; Ki = 0.46 +/- 0.12 nM|P10415|APOPTOSIS REGULATOR BCL-2|9.34|Ki=0.46nM|Ki|=|0.46|nM|0.46|nM
6PVW|1.60|2019|OZV|ligand is compound cp4pA; Ki = 0.48 +/- 0.03 uM|P61823|RIBONUCLEASE|6.32|Ki=0.48uM|Ki|=|0.48|uM|480|nM
6HLE|1.99|2019|6-mer|ligand is 5|P09958|FURIN|9.31|Ki=0.491nM|Ki|=|0.491|nM|0.491|nM
6IBL|2.70|2019|H98|[Different ligand in assay: Ligand in binding assay is racemic mixture] ligand is formoterol|P0AA25|THIOREDOXIN 1, BETA-1 ADRENERGIC RECEPTOR|9.31|Ki=0.49nM|Ki|=|0.49|nM|0.49|nM
6HZA|1.90|2019|5-mer|ligand is 2|P09958|FURIN|9.3|Ki=0.504nM|Ki|=|0.504|nM|0.504|nM
6OY0|2.00|2019|NJ7|[Different protein in assay: Protein in binding assay is I84V mutant] ligand is compound 25; Ki = 0.504 +/- 0.039 nM|Q8ULI9|PROTEASE NL4-3|9.3|Ki=0.504nM|Ki|=|0.504|nM|0.504|nM
6N77|1.64|2019|KEJ|ligand is 15|P23458|TYROSINE-PROTEIN KINASE JAK1|9.24|Ki=0.57nM|Ki|=|0.57|nM|0.57|nM
6ORR|2.25|2019|N37|ligand is compound 10, Inhibitor NS1; pKi = 9.30 +/- 0.07|Q6FH49|NNMT PROTEIN|9.3|Ki=0.5nM|Ki|=|0.5|nM|0.5|nM
6UDU|1.75|2019|Q4Y|ligand is compound 8|Q07820|INDUCED MYELOID LEUKEMIA CELL DIFFERENTIATION PROTEIN MCL|9.3|Ki=0.5nM|Ki|=|0.5|nM|0.5|nM
6QGG|1.50|2019|J1H|ligand is compound 1; FP Ki data|P10415|APOPTOSIS REGULATOR BCL-2,BCL-2-LIKE PROTEIN 1|6.3|Ki=0.5uM|Ki|=|0.5|uM|500|nM
6HLD|2.10|2019|7-mer|ligand is 12|P09958|FURIN|9.21|Ki=0.618nM|Ki|=|0.618|nM|0.618|nM
6PGX|1.36|2019|OJ4|ligand is compound 8; Binding assay is stopped flow CO2 hydrase assay|P00918|CARBONIC ANHYDRASE 2|9.21|Ki=0.62nM|Ki|=|0.62|nM|0.62|nM
6GGG|1.71|2019|EYN|the order is wrong, this code appears in the first literature.(same as 6gev 6gg8)|P08235|MINERALOCORTICOID RECEPTOR|9.2|Ki=0.63nM|Ki|=|0.63|nM|0.63|nM
6N7C|1.69|2019|KF1|ligand is 56|P23458|TYROSINE-PROTEIN KINASE JAK1|9.17|Ki=0.67nM|Ki|=|0.67|nM|0.67|nM
6HZD|1.90|2019|6-mer|ligand is 4|P09958|FURIN|9.17|Ki=0.68nM|Ki|=|0.68|nM|0.68|nM
6N7B|1.81|2019|KEY|ligand is 38|P23458|TYROSINE-PROTEIN KINASE JAK1|9.22|Ki=0.6nM|Ki|=|0.6|nM|0.6|nM
6J8R|1.58|2019|BHU|[Incomplete ligand] ligand is MS01|Q9K2N0|BETA-LACTAMASE CLASS B VIM-2|6.12|Ki=0.76uM|Ki|=|0.76|uM|760|nM
6GG8|1.80|2019|EY8|pKi=9.1, compound is (R)-36|P08235|MINERALOCORTICOID RECEPTOR|9.1|Ki=0.79nM|Ki|=|0.79|nM|0.79|nM
6ODZ|1.30|2019|M8J|ligand is compound 5a; Binding assay is stopped flow CO2 hydrase assay|P00918|CARBONIC ANHYDRASE 2|9.15|Ki=0.7nM|Ki|=|0.7|nM|0.7|nM
6C2R|1.96|2019|EG7||O14965|SERINE/THREONINE-PROTEIN KINASE 6|9.1|Ki=0.8nM|Ki|=|0.8|nM|0.8|nM
6HZB|1.90|2019|5-mer|ligand is 3|P09958|FURIN|8.98|Ki=1.05nM|Ki|=|1.05|nM|1.05|nM
6FZ4|1.85|2019|EC8|Ki(37)=1.12+/-0.14uM|P22756|GLUTAMATE RECEPTOR, IONOTROPIC KAINATE 1|5.95|Ki=1.12uM|Ki|=|1.12|uM|1120|nM
6HZC|1.90|2019|6-mer|ligand is 7|P09958|FURIN|8.93|Ki=1.17nM|Ki|=|1.17|nM|1.17|nM
6PIT|2.25|2019|12-mer|ligand is SRC2 peptide 6a; Ki = 1.19 +/- 0.041 uM; FP assay|P03372|ESTROGEN RECEPTOR|5.92|Ki=1.19uM|Ki|=|1.19|uM|1190|nM
6D3Z|2.00|2019|14-mer|Ki=1.2+/-0.2nM|P00747|PLASMINOGEN|8.92|Ki=1.2nM|Ki|=|1.2|nM|1.2|nM
6OE0|1.30|2019|M8S|ligand is compound 5c; Binding assay is stopped flow CO2 hydrase assay|P00918|CARBONIC ANHYDRASE 2|8.92|Ki=1.2nM|Ki|=|1.2|nM|1.2|nM
6PEU|1.95|2019|12-mer|[Different ligand in assay: ligand in binding assay is MBP-SGSLESTSLRLGFYGYDLQDAAALEHHHHHH] ligand is peptide GRLGFYGYDLQD; Ki = 1.3+/-0.1 uM; Binding assay is fluorescence polarization|Q58494|UNCHARACTERIZED PROTEIN MJ1094|5.89|Ki=1.3uM|Ki|=|1.3|uM|1300|nM
6S1S|1.78|2019|KRT|ligand is compound 3|Q541D8|BETA-LACTAMASE|5.84|Ki=1.45uM|Ki|=|1.45|uM|1450|nM
6D18|1.35|2019|GTV|compound 6, Ki=1.4+/-0.2uM|Q9F663|CARBAPENEM-HYDROLYZING BETA-LACTAMASE KPC|5.85|Ki=1.4uM|Ki|=|1.4|uM|1400|nM
6NPF|2.57|2019|KVM|compound is KSF|B7MLA0|ENOLASE|5.85|Ki=1.4uM|Ki|=|1.4|uM|1400|nM
6PVV|1.65|2019|5FA|ligand is compound p5A; Ki = 1.4 +/- 0.06 uM|P61823|RIBONUCLEASE|5.85|Ki=1.4uM|Ki|=|1.4|uM|1400|nM
6NT2|2.48|2019|KZS|ligand is compound GSK3368715|Q99873|PROTEIN ARGININE N-METHYLTRANSFERASE 1|8.82|Ki=1.5nM|Ki|=|1.5|nM|1.5|nM
6ME5|3.20|2019|AWY|ligand is agomelatine|P48039|CHIMERA PROTEIN OF MELATONIN RECEPTOR TYPE 1A AND GLGA|8.78|Ki=1.67nM|Ki|=|1.67|nM|1.67|nM
6JAV|1.44|2019|BC0|ligand is PT|------|GROUP II CHITINASE|5.76|Ki=1.72uM|Ki|=|1.72|uM|1720|nM
6MQ3|3.57|2019|J22|compound 63|P14735|INSULIN-DEGRADING ENZYME|8.77|Ki=1.7nM|Ki|=|1.7|nM|1.7|nM
6EDS|3.18|2019|J22|compound 63, in complex with glucagon|P14735|INSULIN-DEGRADING ENZYME|8.77|Ki=1.7nM|Ki|=|1.7|nM|1.7|nM
6O94|1.98|2019|LRS|ligand is compound 17; Ki = 1.8+/-0.9nM|Q9NWZ3|INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE 4|8.74|Ki=1.8nM|Ki|=|1.8|nM|1.8|nM
6Q60|1.55|2019|HJH|ligand is compound 7a; Ki = 1.97+/-0.17uM|P19491|GLUTAMATE RECEPTOR 2|5.71|Ki=1.97uM|Ki|=|1.97|uM|1970|nM
6JAY|1.50|2019|JUK|ligand is DP|------|GROUP II CHITINASE|5.7|Ki=1.99uM|Ki|=|1.99|uM|1990|nM
6HHJ|2.30|2019|G4H|[Covalent complex] ligand is 24b|P31749|RAC-ALPHA SERINE/THREONINE-PROTEIN KINASE|7.97|Ki=10.7nM|Ki|=|10.7|nM|10.7|nM
6N92|1.70|2019|KFV|ligand is 7|P52045|METHYLMALONYL-COA DECARBOXYLASE|4.97|Ki=10.8uM|Ki|=|10.8|uM|10800|nM
6HR2|1.76|2019|FWZ|ligand is PROTAC 2, ternary complex VHL and PROTAC 2 with SMARCA4|P51532|TRANSCRIPTION ACTIVATOR BRG1|7.0|Ki=100nM|Ki|=|100|nM|100|nM
6U26|1.53|2019|063|ligand is compound 16; FP assay|Q8NBP7|PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9|6.97|Ki=107nM|Ki|=|107|nM|107|nM
6OAC|3.15|2019|M1J|ligand is compound 6(PQR530); Binding assay is LanthaScreen technology|P42336|PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC|7.95|Ki=11.1nM|Ki|=|11.1|nM|11.1|nM
6S4T|2.00|2019|KVB|ligand is WAY-254011; pKi=7.95|P55055|OXYSTEROLS RECEPTOR LXR-BETA|7.95|Ki=11.2nM|Ki|=|11.2|nM|11.2|nM
6RVL|1.72|2019|KKE|[Uncommon element] [Incomplete ligand] ligand is compound 3a; ligand is hydroxylation|P00918|CARBONIC ANHYDRASE 2|5.94|Ki=1148nM|Ki|=|1148|nM|1148|nM
6IBS|1.37|2019|HB8|[Uncommon element] [Incomplete ligand] ligand is 6|C7C422|METALLO-BETA-LACTAMASE TYPE 2|4.96|Ki=11uM|Ki|=|11|uM|11000|nM
6R0V|1.60|2019|JO2|ligand is compound 4b; Ki = 11+/-1.8 uM|A4TVL0|CEREBLON ISOFORM 4|4.96|Ki=11uM|Ki|=|11|uM|11000|nM
6C9V|1.70|2019|ERS|enzymic inhibition assay, compound 7, Ki=120.2+/-0.9nM|A5U4N0|ADENOSINE KINASE|6.92|Ki=120.2nM|Ki|=|120.2|nM|120.2|nM
6G9X|2.30|2019|JKE|Microscale thermophoresis binding assay, compound is TSA|A0LNN5|MAJOR FACILITATOR SUPERFAMILY MFS_1|3.92|Ki=120uM|Ki|=|120|uM|120000|nM
6HZY|1.70|2019|GYZ|ligand is 39|Q8A3I4|ALPHA-L-FUCOSIDASE|3.92|Ki=121uM|Ki|=|121|uM|121000|nM
6D1B|1.25|2019|FUJ|compound 2, Ki=123.7+/-3.6uM|C7C422|METALLO-BETA-LACTAMASE TYPE 2|3.91|Ki=123.7uM|Ki|=|123.7|uM|123700|nM
6C85|2.40|2019|PLQ|enzyme assay, Ki=126+/-14uM|C5GC63|ASPARTATE-SEMIALDEHYDE DEHYDROGENASE|3.9|Ki=126uM|Ki|=|126|uM|126000|nM
6HP0|1.88|2019|GJT|ligand is 17|C6KP13|NEURAMINIDASE|4.92|Ki=12uM|Ki|=|12|uM|12000|nM
6R11|1.75|2019|JOB|ligand is compound 5b; Ki = 12 +/- 0.7 uM|A4TVL0|CEREBLON ISOFORM 4|4.92|Ki=12uM|Ki|=|12|uM|12000|nM
6R18|1.35|2019|JOQ|ligand is compound 11a; Ki = 12 +/- 1.7 uM|A4TVL0|CEREBLON ISOFORM 4|4.92|Ki=12uM|Ki|=|12|uM|12000|nM
6R1C|1.50|2019|JOW|ligand is compound 12a; Ki = 12 +/- 2.0 uM|A4TVL0|CEREBLON ISOFORM 4|4.92|Ki=12uM|Ki|=|12|uM|12000|nM
6I5G|2.00|2019|PTG|ligand is 15d-PGJ2|P34913|BIFUNCTIONAL EPOXIDE HYDROLASE 2|4.89|Ki=13.03uM|Ki|=|13.03|uM|13030|nM
6H14|1.86|2019|FW8|[Different protein in assay: The source of protein in binding assay is human] [Different ligand in assay: Ligand in binding assay is racemic mixture] ligand is compound 6|P04058|ACETYLCHOLINESTERASE|7.86|Ki=13.7nM|Ki|=|13.7|nM|13.7|nM
6RW1|1.70|2019|KL5|[Uncommon element] [Incomplete ligand] ligand is compound 3b; ligand is hydroxylation|P00918|CARBONIC ANHYDRASE 2|5.88|Ki=1305nM|Ki|=|1305|nM|1305|nM
6GF3|2.40|2019|EX5|ligand is 34|P81947|TUBULIN ALPHA-1B CHAIN|4.84|Ki=14.3uM|Ki|=|14.3|uM|14300|nM
6IAM|1.51|2019|12-mer|[Incomplete ligand] ligand is 4|P61964|WD REPEAT-CONTAINING PROTEIN 5|6.85|Ki=140nM|Ki|=|140|nM|140|nM
6OVZ|2.02|2019|N9M|[Covalent complex] [Incomplete ligand] ligand is compound 1 and as a substrate of NDM-1, after a substitute it lose a phenyl and form a covalent bond with the protein|E5KIY2|BETA-LACTAMASE|3.85|Ki=140uM|Ki|=|140|uM|140000|nM
6HB5|1.88|2019|YSC|[Incomplete ligand]|------|TYROSINE--TRNA LIGASE|5.83|Ki=1484nM|Ki|=|1484|nM|1484|nM
6HB7|1.90|2019|Y3U|[Incomplete ligand]|------|TYROSINE--TRNA LIGASE|6.83|Ki=149nM|Ki|=|149|nM|149|nM
6OX0|1.76|2019|SFG|ligand is sinefungin; Ki = 14 +/- 1uM|P60709|ACTIN PEPTIDE|4.85|Ki=14uM|Ki|=|14|uM|14000|nM
6A8N|2.49|2019|10-mer|Ki(muPA-SPD, IG-2)=15.3+/-0.5nM|P06869|UROKINASE-TYPE PLASMINOGEN ACTIVATOR B|7.82|Ki=15.3nM|Ki|=|15.3|nM|15.3|nM
6D17|1.45|2019|VKE|compound 3, Ki=15.3+/-2.5uM|Q9F663|CARBAPENEM-HYDROLYZING BETA-LACTAMASE KPC|4.82|Ki=15.3uM|Ki|=|15.3|uM|15300|nM
6U7O|1.33|2019|Q1D|ligand is compound 6|Q5RZ08|PROTEASE|10.81|Ki=15.5pM|Ki|=|15.5|pM|0.0155|nM
6GVI|2.90|2019|FDW|ligand is 3j|P42336|PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC|6.82|Ki=150nM|Ki|=|150|nM|150|nM
6Q35|1.40|2019|HD5|[Uncommon element] [Incomplete ligand] ligand is 3|Q09HD0|BETA-LACTAMASE|4.82|Ki=15uM|Ki|=|15|uM|15000|nM
6S4N|1.90|2019|KUW|ligand is AZ6; pKi=6.79|P55055|OXYSTEROLS RECEPTOR LXR-BETA|6.79|Ki=162nM|Ki|=|162|nM|162|nM
6S4U|2.81|2019|KVK|ligand is AZ3; pKi=7.76|P55055|OXYSTEROLS RECEPTOR LXR-BETA|7.76|Ki=17.4nM|Ki|=|17.4|nM|17.4|nM
6HHG|2.30|2019|G4T|[Covalent complex] [Incomplete ligand] ligand is 27|P31749|RAC-ALPHA SERINE/THREONINE-PROTEIN KINASE|7.76|Ki=17.5nM|Ki|=|17.5|nM|17.5|nM
6HGS|1.55|2019|5GP|ligand is GMP|P07741|ADENINE PHOSPHORIBOSYLTRANSFERASE|3.77|Ki=170uM|Ki|=|170|uM|170000|nM
6E6M|1.55|2019|8CB|compound CBDO at 350nm|P09455|RETINOL-BINDING PROTEIN 1|5.75|Ki=1786.5nM|Ki|=|1786.5|nM|1786.5|nM
5QQO|2.00|2019|NRJ|compound 10|P03951|COAGULATION FACTOR XI|7.77|Ki=17nM|Ki|=|17|nM|17|nM
6MLW|1.90|2019|JVA|ligand is 8|Q8PGN7|PHOSPHOGLUCOMUTASE|3.74|Ki=184uM|Ki|=|184|uM|184000|nM
6SZP|1.76|2019|M3B|ligand is compound 8a; Ki = 18 +/- 6 uM;|O94760|N(G),N(G)-DIMETHYLARGININE DIMETHYLAMINOHYDROLASE 1|4.74|Ki=18uM|Ki|=|18|uM|18000|nM
6UGZ|1.31|2019|Q71|ligand is compound 2h, SB4-208|P00918|CARBONIC ANHYDRASE IX-MIMIC|7.72|Ki=19.1nM|Ki|=|19.1|nM|19.1|nM
6N94|1.75|2019|KGJ|ligand is 9|P52045|METHYLMALONYL-COA DECARBOXYLASE|4.7|Ki=19.8uM|Ki|=|19.8|uM|19800|nM
6D1H|1.25|2019|KED|compound 11, Ki=190.2+/-22.6uM|C7C422|METALLO-BETA-LACTAMASE TYPE 2|3.72|Ki=190.2uM|Ki|=|190.2|uM|190200|nM
6MNP|2.20|2019|1CE|[Different ligand in assay: ligand structure is different from that reported in the literature] Ki(compound 7)=195+/-44uM, -Lactamase Inhibition Assay|Q9F663|CARBAPENEM-HYDROLYZING BETA-LACTAMASE KPC|3.71|Ki=195uM|Ki|=|195|uM|195000|nM
6RFN|2.29|2019|K3W|ligand is 40|Q8WQX9|PHOSPHODIESTERASE|6.7|Ki=199.5nM|Ki|=|199.5|nM|199.5|nM
6GEV|1.54|2019|EWN|pKi=8.7, compound is (S)-13|P08235|MINERALOCORTICOID RECEPTOR|8.7|Ki=2.00nM|Ki|=|2|nM|2|nM
6NMB|2.30|2019|AMH|ligand is compound TXA;Ki = 2.01+/-0.09mM|P00749|UROKINASE-TYPE PLASMINOGEN ACTIVATOR|2.7|Ki=2.01mM|Ki|=|2.01|mM|2009999.9999999998|nM
6JN4|1.90|2019|BX9|[Incomplete ligand] ligand is MS22|Q93LQ9|SERINE BETA-LACTAMASE KPC-2|5.69|Ki=2.02uM|Ki|=|2.02|uM|2020|nM
6D3Y|1.32|2019|14-mer|Ki=2.0+/-0.3nM|P00747|PLASMINOGEN|8.7|Ki=2.0nM|Ki|=|2|nM|2|nM
6JAW|1.98|2019|BBO|ligand is NI|------|GROUP II CHITINASE|5.66|Ki=2.18uM|Ki|=|2.18|uM|2180|nM
6U7P|1.13|2019|B4R|ligand is compound 7|Q5RZ08|PROTEASE|11.68|Ki=2.1pM|Ki|=|2.1|pM|0.0021000000000000003|nM
6PRF|1.21|2019|7OA|ligand is compound 2, GRL-14213A; Ki = 2.5 +/- 0.5 nM|P03366|HIV-1 PROTEASE|8.6|Ki=2.5nM|Ki|=|2.5|nM|2.5|nM
6MXC|1.99|2019|5GP||Q38CA1|HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE|5.56|Ki=2.73uM|Ki|=|2.73|uM|2730|nM
6HY7|2.26|2019|13-mer|ligand is RgIA|Q9UGM1|NEURONAL ACETYLCHOLINE RECEPTOR SUBUNIT ALPHA-9|5.57|Ki=2.7uM|Ki|=|2.7|uM|2700|nM
6J8Q|1.79|2019|BHU|[Incomplete ligand] ligand is MS01|Q93LQ9|SERINE BETA-LACTAMASE KPC-2|5.57|Ki=2.7uM|Ki|=|2.7|uM|2700|nM
6O50|2.35|2019|EBW|[Different protein in assay: assay use mouse AChE, crystal use human AChE] ligand is compound BW284c51;|P22303|ACETYLCHOLINESTERASE|8.55|Ki=2.8nM|Ki|=|2.8|nM|2.8|nM
6OUV|1.94|2019|TDK|ligand is MAP; Ki = 2.8 +/- 0.2 uM|Q9RUB5|1-DEOXY-D-XYLULOSE-5-PHOSPHATE SYNTHASE|5.55|Ki=2.8uM|Ki|=|2.8|uM|2800|nM
6QYK|2.30|2019|JLB|ligand is compound 7a; FP binding assay|P0AEY0|MALTOSE/MALTODEXTRIN-BINDING PERIPLASMIC PROTEIN,INDUCED|5.55|Ki=2.8uM|Ki|=|2.8|uM|2800|nM
6I5Y|1.90|2019|YSA|[Incomplete ligand]|------|TYROSINE--TRNA LIGASE|8.54|Ki=2.9nM|Ki|=|2.9|nM|2.9|nM
6H12|2.20|2019|FJK|[Different protein in assay: The source of protein in binding assay is human] [Different ligand in assay: Ligand in binding assay is racemic mixture] ligand is compound 2|P04058|ACETYLCHOLINESTERASE|7.68|Ki=20.8nM|Ki|=|20.8|nM|20.8|nM
6Q8C|2.31|2019|LSU|[Incomplete ligand]|------|LEUCINE--TRNA LIGASE|7.68|Ki=20.8nM|Ki|=|20.8|nM|20.8|nM
6NWK|1.65|2019|DEX|ligand is DEX|Q9UBK2|GLUCOCORTICOID RECEPTOR|7.7|Ki=20nM|Ki|=|20|nM|20|nM
6D3G|2.40|2019|NXL|[Covalent complex] compound is avibactam|A2RP81|BETA-LACTAMASE|4.7|Ki=20uM|Ki|=|20|uM|20000|nM
6R13|1.65|2019|JOK|ligand is compound 7f; Ki = 20+/-2.6uM|A4TVL0|CEREBLON ISOFORM 4|4.7|Ki=20uM|Ki|=|20|uM|20000|nM
6MLH|1.65|2019|GPM|ligand is 7|Q8PGN7|PHOSPHOGLUCOMUTASE|3.67|Ki=213uM|Ki|=|213|uM|213000|nM
6PLF|1.70|2019|ONV|ligand is compound 1; Ki = 214 +/- 26 nM|O43175|D-3-PHOSPHOGLYCERATE DEHYDROGENASE|6.67|Ki=214nM|Ki|=|214|nM|214|nM
6NYH|2.10|2019|L8D|ligand is compound GNE684; Binding assay is RIP1-catalyzed hydrolysis.|Q13546|RECEPTOR-INTERACTING SERINE/THREONINE-PROTEIN KINASE 1|7.68|Ki=21nM|Ki|=|21|nM|21|nM
6DD1|1.70|2019|M3Q|compound 14, Ki=22.3+/-1.3uM|Q9K2N0|BETA-LACTAMASE CLASS B VIM-2|4.65|Ki=22.3uM|Ki|=|22.3|uM|22300|nM
6O5X|1.70|2019|0Q4|ligand is CA-p2; Ki = 22+/-3.4nM|I7BFC3|HIV-1 PROTEASE PR-S17|7.66|Ki=22nM|Ki|=|22|nM|22|nM
6MLL|1.86|2019|N1G|Ki(compound 7)=239+/-23uM, -Lactamase Inhibition Assay|Q9F663|CARBAPENEM-HYDROLYZING BETA-LACTAMASE KPC|3.62|Ki=239uM|Ki|=|239|uM|239000|nM
5YY6|2.40|2019|94L|compound is Y13161, Ki=24.16+/-1.01nM|P93836|4-HYDROXYPHENYLPYRUVATE DIOXYGENASE|7.62|Ki=24.16nM|Ki|=|24.16|nM|24.16|nM
6QS1|1.80|2019|11-mer|ligand is peptide BPPb;|P12821|ANGIOTENSIN-CONVERTING ENZYME|5.61|Ki=2430nM|Ki|=|2430|nM|2430|nM
6G02|1.84|2019|EF8|[Nonstandard assay: PH=6.15] Ki(kinetic assay)=24+/-5nM|C3W6G3|NEURAMINIDASE|7.62|Ki=24nM|Ki|=|24|nM|24|nM
6GVX|2.24|2019|TAK|ligand is dorsomorphin|Q14680|MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE|7.62|Ki=24nM|Ki|=|24|nM|24|nM
6UGO|1.46|2019|Q77|ligand is compound 2d|P00918|CARBONIC ANHYDRASE IX-MIMIC|7.59|Ki=25.8nM|Ki|=|25.8|nM|25.8|nM
6MIA|1.40|2019|1CE|[Different ligand in assay: ligand structure is different from that reported in the literature] Ki(compound 6)=2540+/-410uM, -Lactamase Inhibition Assay|H6UQI0|BETA-LACTAMASE|2.6|Ki=2540uM|Ki|=|2540|uM|2540000|nM
6HAX|2.35|2019|FWZ|ligand is PROTAC 2, ternary complex VHL and PROTAC 2 with SMARCA2|P51531|PROBABLE GLOBAL TRANSCRIPTION ACTIVATOR SNF2L2|7.59|Ki=26nM|Ki|=|26|nM|26|nM
6MXB|2.19|2019|XMP||Q38CA1|HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE, PUTATIVE|4.59|Ki=26uM|Ki|=|26|uM|26000|nM
6K05|1.94|2019|CQF|ligand is 40|P25440|BROMODOMAIN-CONTAINING PROTEIN 2|6.56|Ki=275nM|Ki|=|275|nM|275|nM
6UGQ|1.31|2019|Q7A|ligand is compound 2i, SB4-206|P00918|CARBONIC ANHYDRASE IX-MIMIC|7.55|Ki=28.2nM|Ki|=|28.2|nM|28.2|nM
6P5O|1.49|2019|O2Y|ligand is compound CMP; Ki = 28.6 +/- 8.8 uM|P07379|PHOSPHOENOLPYRUVATE CARBOXYKINASE|4.54|Ki=28.6uM|Ki|=|28.6|uM|28600|nM
6E5T|1.55|2019|HVJ|compound abn-CBDO, at 350nm|P09455|RETINOL-BINDING PROTEIN 1|6.55|Ki=285nM|Ki|=|285|nM|285|nM
6GVF|2.50|2019|FE5|ligand is 1|P42336|PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC|7.55|Ki=28nM|Ki|=|28|nM|28|nM
6JIO|2.60|2019|BQ3|ligand is 3|P55055|OXYSTEROLS RECEPTOR LXR-BETA|4.55|Ki=28uM|Ki|=|28|uM|28000|nM
6Q8B|2.20|2019|L3U|[Incomplete ligand]|------|LEUCINE--TRNA LIGASE|7.53|Ki=29.5nM|Ki|=|29.5|nM|29.5|nM
6O9D|2.51|2019|LTY|ligand is compound 5; Ki = 2+/-0.71nM|Q9NWZ3|INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE 4|8.7|Ki=2nM|Ki|=|2|nM|2|nM
6S0E|1.90|2019|DAN|ligand is compound DANA. Ki = 3.17 +/- 0.41 uM|------|EXOSIALIDASE FROM UNCULTURED BACTERIUM PG7|5.5|Ki=3.17uM|Ki|=|3.17|uM|3170|nM
6OE1|1.45|2019|M8V|ligand is compound 5b; Binding assay is stopped flow CO2 hydrase assay|P00918|CARBONIC ANHYDRASE 2|8.51|Ki=3.1nM|Ki|=|3.1|nM|3.1|nM
6H7D|2.40|2019|BGC|[Nonstandard assay: pH = 5.5] ligand is glucose|Q9LT15|SUGAR TRANSPORT PROTEIN 10|5.49|Ki=3.2uM|Ki|=|3.2|uM|3200|nM
6DD0|1.50|2019|P9T|compound 8, Ki=3.3+/-0.1uM|Q9K2N0|BETA-LACTAMASE CLASS B VIM-2|5.48|Ki=3.3uM|Ki|=|3.3|uM|3300|nM
6O21|1.15|2019|14-mer|ligand is cycle peptide SFTI-FCQR(Asn14)[1,14]; Ki = 3.48+/-0.35nM|------|KALLIKREIN 4 (PROSTASE, ENAMEL MATRIX, PROSTATE), ISOFORM|8.46|Ki=3.48nM|Ki|=|3.48|nM|3.48|nM
5QTT|2.23|2019|QEY|compound is 17|P03951|COAGULATION FACTOR XI|8.47|Ki=3.4nM|Ki|=|3.4|nM|3.4|nM
6D3Q|2.24|2019|4NG|compound is SF2312|B7MLA0|ENOLASE|8.47|Ki=3.4nM|Ki|=|3.4|nM|3.4|nM
6O4W|2.35|2019|E20|[Different protein in assay: assay use mouse AChE, crystal use human AChE] ligand is compound Donepezil;|P22303|ACETYLCHOLINESTERASE|8.47|Ki=3.4nM|Ki|=|3.4|nM|3.4|nM
6GBW|1.45|2019|EU5|compound 6|P00734|PROTHROMBIN|8.45|Ki=3.51nM|Ki|=|3.51|nM|3.51|nM
6NXZ|1.75|2019|D49|ligand is compound 3; Ki = 3.5+/-1.7 uM|P00383|DIHYDROFOLATE REDUCTASE TYPE 2|5.46|Ki=3.5uM|Ki|=|3.5|uM|3500|nM
6PS5|2.90|2019|SNP|ligand is propranolol|P07550|FUSION PROTEIN OF BETA-2 ADRENERGIC RECEPTOR AND T4|8.43|Ki=3.69nM|Ki|=|3.69|nM|3.69|nM
6TL2|3.80|2019|NJZ|ligand is compound Br-BIT; Ki = 3.6 +/- 0.7 uM|E4KPW4|DIVALENT METAL CATION TRANSPORTER MNTH|5.44|Ki=3.6uM|Ki|=|3.6|uM|3600|nM
6N96|1.70|2019|LCV|ligand is 5|P52045|METHYLMALONYL-COA DECARBOXYLASE|5.42|Ki=3.8uM|Ki|=|3.8|uM|3800|nM
6OTG|1.50|2019|4UY|ligand is compound 1; Ki = 31.4 +/- 3.9nM|Q7SSI0|HIV-1 PROTEASE|7.5|Ki=31.4nM|Ki|=|31.4|nM|31.4|nM
6RFW|2.18|2019|K1Q|ligand is 41|Q8WQX9|PHOSPHODIESTERASE|6.5|Ki=316nM|Ki|=|316|nM|316|nM
6D15|1.30|2019|TWB|compound 1, Ki=32.9+/-3.3uM|Q9F663|CARBAPENEM-HYDROLYZING BETA-LACTAMASE KPC|4.48|Ki=32.9uM|Ki|=|32.9|uM|32900|nM
6D1D|1.40|2019|GTV|compound 6, Ki=33.8+/-3.8uM|C7C422|METALLO-BETA-LACTAMASE TYPE 2|4.47|Ki=33.8uM|Ki|=|33.8|uM|33800|nM
6DL2|1.47|2019|GUJ|Ki(FP, 3)=33+/-4nM|O60885|BROMODOMAIN-CONTAINING PROTEIN 4|7.48|Ki=33nM|Ki|=|33|nM|33|nM
6D1G|1.15|2019|YKG|compound 9, Ki=34.2+/-8.0uM|C7C422|METALLO-BETA-LACTAMASE TYPE 2|4.47|Ki=34.2uM|Ki|=|34.2|uM|34200|nM
6HGR|1.52|2019|IMP|ligand is IMP|P07741|ADENINE PHOSPHORIBOSYLTRANSFERASE|3.46|Ki=350uM|Ki|=|350|uM|350000|nM
6GXB|1.35|2019|FF5|ligand is compound 1|P00918|CARBONIC ANHYDRASE 2|7.46|Ki=35nM|Ki|=|35|nM|35|nM
6O0O|2.00|2019|F3Q|ligand is S55746; Ki = 36 +/- 12 nM|P10415|APOPTOSIS REGULATOR BCL-2|7.44|Ki=36nM|Ki|=|36|nM|36|nM
6PPY|2.00|2019|OVY|ligand is compound NeuNAC oxime; Ki = 36 +/- 12 uM|H2VFG5|N-ACETYLNEURAMINATE SYNTHASE|4.44|Ki=36uM|Ki|=|36|uM|36000|nM
6JAX|1.70|2019|8-mer|ligand is (GlcN)8|------|GROUP II CHITINASE|4.42|Ki=38.43uM|Ki|=|38.43|uM|38430|nM
6M7I|1.70|2019|J84|Ki(compound 3)=386+/-33uM, -Lactamase Inhibition Assay|Q9F663|CARBAPENEM-HYDROLYZING BETA-LACTAMASE KPC|3.41|Ki=386uM|Ki|=|386|uM|386000|nM
6G01|1.61|2019|EEW|[Nonstandard assay: PH=6.15] Ki(kinetic assay)=39+/-1nM|C6KP13|NEURAMINIDASE|7.41|Ki=39nM|Ki|=|39|nM|39|nM
6DZY|4.10|2019|HJM|[Nonstandard assay: in presence of 15B8 Fab and 8B6 ScFv] compound is ibogaine|P31645|SODIUM-DEPENDENT SEROTONIN TRANSPORTER|5.52|Ki=3uM|Ki|=|3|uM|3000|nM
6Q30|1.50|2019|HCH|[Uncommon element] [Incomplete ligand] ligand is 5|C7C422|METALLO-BETA-LACTAMASE TYPE 2|5.52|Ki=3uM|Ki|=|3|uM|3000|nM
6NY0|1.40|2019|LBA|ligand is compound 1; Ki = 3.5+/-1.7 uM|P00383|DIHYDROFOLATE REDUCTASE TYPE 2|5.4|Ki=4.0uM|Ki|=|4|uM|4000|nM
5QTU|2.53|2019|QEV|compound is 17|P03951|COAGULATION FACTOR XI|8.39|Ki=4.1nM|Ki|=|4.1|nM|4.1|nM
6BYZ|2.96|2019|J18|compound 37|P14735|INSULIN-DEGRADING ENZYME|8.37|Ki=4.3nM|Ki|=|4.3|nM|4.3|nM
6N7A|1.33|2019|KEV|ligand is 39|P23458|TYROSINE-PROTEIN KINASE JAK1|8.37|Ki=4.3nM|Ki|=|4.3|nM|4.3|nM
5YWG|2.60|2019|92L|inhibition kinetic assay, Ki=4.56+/-0.82nM|P93836|4-HYDROXYPHENYLPYRUVATE DIOXYGENASE|8.34|Ki=4.56nM|Ki|=|4.56|nM|4.56|nM
6OF5|2.30|2019|MFJ|ligand is compound 1; Ki = 4.5 +/- 1.9 uM|P80366|FE(3+)-ZN(2+) PURPLE ACID PHOSPHATASE|5.35|Ki=4.5uM|Ki|=|4.5|uM|4500|nM
6PNO|1.82|2019|ORM|ligand is compound 3f|P78417|GLUTATHIONE S-TRANSFERASE OMEGA-1|5.32|Ki=4.8uM|Ki|=|4.8|uM|4800|nM
6A94|2.90|2019|ZOT|compound is zotepine|P28223|5-HYDROXYTRYPTAMINE RECEPTOR 2A,SOLUBLE CYTOCHROME B562|7.4|Ki=40nM|Ki|=|40|nM|40|nM
6O4X|2.30|2019|AA|[Different protein in assay: assay use mouse AChE, crystal use human AChE] ligand is compound 9-aminoacridine|P22303|ACETYLCHOLINESTERASE|7.4|Ki=40nM|Ki|=|40|nM|40|nM
6MD8|1.40|2019|J84|Ki(compound 3)=4200+/-300uM, -Lactamase Inhibition Assay|------|BETA-LACTAMASE CTX-M-14|2.38|Ki=4200uM|Ki|=|4200|uM|4200000|nM
6MNV|1.65|2019|JVS|ligand is 3|------|PHOSPHOMANNOMUTASE/PHOSPHOGLUCOMUTASE|3.37|Ki=428uM|Ki|=|428|uM|428000|nM
6HB6|1.92|2019|YSU|[Incomplete ligand]|------|TYROSINE--TRNA LIGASE|7.36|Ki=43.4nM|Ki|=|43.4|nM|43.4|nM
6RVK|1.58|2019|R29|[Uncommon element] [Incomplete ligand] ligand is compound 2b; ligand is hydroxylation|P00918|CARBONIC ANHYDRASE 2|6.36|Ki=439nM|Ki|=|439|nM|439|nM
6NWL|1.60|2019|HCY|ligand is HCY|Q9UBK2|GLUCOCORTICOID RECEPTOR|7.37|Ki=43nM|Ki|=|43|nM|43|nM
6PVE|2.30|2019|OZP|ligand is compound 1a, inhibitor LL319; Ki = 43 +/- 5.0 nM|Q6FH49|NNMT PROTEIN|7.37|Ki=43nM|Ki|=|43|nM|43|nM
6D1A|1.25|2019|TWB|compound 1, Ki=44.3+/-7.3uM|C7C422|METALLO-BETA-LACTAMASE TYPE 2|4.35|Ki=44.3uM|Ki|=|44.3|uM|44300|nM
6R1A|1.54|2019|JP8|ligand is compound 20b; Ki = 45 +/- 15.7 uM|A4TVL0|CEREBLON ISOFORM 4|4.35|Ki=45uM|Ki|=|45|uM|45000|nM
6S5K|1.60|2019|KWE|ligand is AZ8; pKi=7.32|P55055|OXYSTEROLS RECEPTOR LXR-BETA|7.32|Ki=47.9nM|Ki|=|47.9|nM|47.9|nM
6EFJ|1.65|2019|O5E|Ki(compound 9)=477+/-40uM, -Lactamase Inhibition Assay|C7C422|METALLO-BETA-LACTAMASE TYPE 2|3.32|Ki=477uM|Ki|=|477|uM|477000|nM
6MEY|1.42|2019|O5E|Ki(compound 9)=479+/-41uM, -Lactamase Inhibition Assay|Q9F663|CARBAPENEM-HYDROLYZING BETA-LACTAMASE KPC|3.32|Ki=479uM|Ki|=|479|uM|479000|nM
6ROT|1.34|2019|KDQ|compound 4|P00734|PROTHROMBIN|6.32|Ki=483.63nM|Ki|=|483.63|nM|483.63|nM
6C9S|2.23|2019|ERP|enzymic inhibition assay, compound 17, Ki=48+/-0.6nM|A5U4N0|ADENOSINE KINASE|7.32|Ki=48nM|Ki|=|48|nM|48|nM
6R1D|1.10|2019|JP5|ligand is compound 7d; Ki = 4 +/- 0.4 uM|A4TVL0|CEREBLON ISOFORM 4|5.4|Ki=4uM|Ki|=|4|uM|4000|nM
6R1W|1.35|2019|JPW|ligand is compound 16b; Ki = 5.0 +/- 0.5 uM|A4TVL0|CEREBLON ISOFORM 4|5.3|Ki=5.0uM|Ki|=|5|uM|5000|nM
6O95|1.77|2019|LSV|ligand is compound 41; Ki = 5.1+/-1.2nM|Q9NWZ3|INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE 4|8.29|Ki=5.1nM|Ki|=|5.1|nM|5.1|nM
5QQP|2.08|2019|NR7|compound 13|P03951|COAGULATION FACTOR XI|8.28|Ki=5.3nM|Ki|=|5.3|nM|5.3|nM
6O8U|1.80|2019|LS7|ligand is compound 23; Ki = 5.3+/-2.1nM|Q9NWZ3|INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE 4|8.28|Ki=5.3nM|Ki|=|5.3|nM|5.3|nM
6Q2Y|1.00|2019|HCQ|[Uncommon element] [Incomplete ligand] ligand is 3|C7C422|METALLO-BETA-LACTAMASE TYPE 2|5.26|Ki=5.5uM|Ki|=|5.5|uM|5500|nM
6MXD|2.96|2019|IMP||Q38CA1|HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE, PUTATIVE|5.23|Ki=5.83uM|Ki|=|5.83|uM|5830|nM
6IBV|1.40|2019|H9E|[Uncommon element] [Incomplete ligand] ligand is 1|C7C422|METALLO-BETA-LACTAMASE TYPE 2|5.23|Ki=5.9uM|Ki|=|5.9|uM|5900|nM
6IBK|1.99|2019|YTW|ligand is 4|P06280|ALPHA-GALACTOSIDASE A|3.29|Ki=509uM|Ki|=|509|uM|509000|nM
6O57|1.71|2019|2NC|ligand is compound p2-NC; crystal in space group P41; redundant to 6o5a|I7BFC3|HIV-1 PROTEASE|6.29|Ki=514nM|Ki|=|514|nM|514|nM
6O5A|1.67|2019|2NC|ligand is compound p2-NC; crystal in space group P61|I7BFC3|HIV-1 PROTEASE|6.29|Ki=514nM|Ki|=|514|nM|514|nM
6QWI|2.85|2019|JJW|ligand is compound 4|P22073|BETA-GLUCOSIDASE A|4.29|Ki=51uM|Ki|=|51|uM|51000|nM
6UGR|1.31|2019|Q71|ligand is compound 2h, SB4-208|P00918|CARBONIC ANHYDRASE 2|6.27|Ki=533.6nM|Ki|=|533.6|nM|533.6|nM
6MLF|1.75|2019|JV4|ligand is 9|Q8PGN7|PHOSPHOGLUCOMUTASE|4.28|Ki=53uM|Ki|=|53|uM|53000|nM
6D1J|1.15|2019|7SX|compound 13, Ki=56.2+/-4.3uM|C7C422|METALLO-BETA-LACTAMASE TYPE 2|4.25|Ki=56.2uM|Ki|=|56.2|uM|56200|nM
6MDU|1.15|2019|N1G|Ki(compound 7)=56+/-8uM, -Lactamase Inhibition Assay|C7C422|METALLO-BETA-LACTAMASE TYPE 2|4.25|Ki=56uM|Ki|=|56|uM|56000|nM
6H13|2.80|2019|FJN|[Different protein in assay: The source of protein in binding assay is human] [Different ligand in assay: Ligand in binding assay is racemic mixture] ligand is compound 3|P04058|ACETYLCHOLINESTERASE|7.23|Ki=58.6nM|Ki|=|58.6|nM|58.6|nM
6S9W|2.30|2019|L1Z|[Covalent complex] ligand is compound 16a; Ki = 59 +/- 4 nM|P31749|RAC-ALPHA SERINE/THREONINE-PROTEIN KINASE|7.23|Ki=59nM|Ki|=|59|nM|59|nM
6PVU|1.49|2019|P0S|ligand is compound cP6i; Ki = 6.2 +/- 0.1 uM|P61823|RIBONUCLEASE PANCREATIC|5.21|Ki=6.2uM|Ki|=|6.2|uM|6200|nM
6PNM|1.82|2019|XX0|ligand is compound 3d|P78417|GLUTATHIONE S-TRANSFERASE OMEGA-1|5.17|Ki=6.7uM|Ki|=|6.7|uM|6700|nM
6JN3|2.22|2019|BX6|[Incomplete ligand] ligand is MS05|Q93LQ9|SERINE BETA-LACTAMASE KPC-2|5.16|Ki=6.85uM|Ki|=|6.85|uM|6850|nM
6HHI|2.70|2019|G4N|[Covalent complex] [Incomplete ligand] ligand is 3b|P31749|RAC-ALPHA SERINE/THREONINE-PROTEIN KINASE|8.17|Ki=6.8nM|Ki|=|6.8|nM|6.8|nM
6PVS|2.58|2019|P0V|ligand is compound 2a, inhibitor LL320; Ki = 6.8 +/- 2.3 nM|Q6FH49|NNMT PROTEIN|8.17|Ki=6.8nM|Ki|=|6.8|nM|6.8|nM
6A93|3.00|2019|8NU|compound is risperidone|P28223|5-HYDROXYTRYPTAMINE RECEPTOR 2A,SOLUBLE CYTOCHROME B562|8.16|Ki=6.9nM|Ki|=|6.9|nM|6.9|nM
6OM8|2.45|2019|UDX|ligand is compound UDP-xyl; Ki = 6.9 +/- 0.6 uM|Q19905|UDP-GLUCOSE 6-DEHYDROGENASE|5.16|Ki=6.9uM|Ki|=|6.9|uM|6900|nM
6PNN|2.10|2019|OR7|ligand is compound 3b; IC50 = 0.16 +/- 0.02 uM|P78417|GLUTATHIONE S-TRANSFERASE OMEGA-1|5.16|Ki=6.9uM|Ki|=|6.9|uM|6900|nM
6GG3|3.72|2019|ALA||P14618|PYRUVATE KINASE PKM|4.21|Ki=62uM|Ki|=|62|uM|62000|nM
6E5L|1.17|2019|HVD|compound abn-CBD, at 350nm|P09455|RETINOL-BINDING PROTEIN 1|7.18|Ki=66.7nM|Ki|=|66.7|nM|66.7|nM
6HHH|2.70|2019|G4Q|[Incomplete ligand] ligand is 30|P31749|RAC-ALPHA SERINE/THREONINE-PROTEIN KINASE|7.17|Ki=67.1nM|Ki|=|67.1|nM|67.1|nM
6UGP|1.31|2019|Q7A|ligand is compound 2i, SB4-206|P00918|CARBONIC ANHYDRASE 2|6.16|Ki=685.5nM|Ki|=|685.5|nM|685.5|nM
6JN5|1.97|2019|BXU|[Incomplete ligand] ligand is MS23|Q93LQ9|SERINE BETA-LACTAMASE KPC-2|5.15|Ki=7.08uM|Ki|=|7.08|uM|7080|nM
6O0H|3.67|2019|LBG|ligand is compound NDI-091143; Ki = 7.0+/-0.8nM|P53396|ATP-CITRATE SYNTHASE|8.15|Ki=7.0nM|Ki|=|7|nM|7|nM
6ABX|1.70|2019|FLC|citrate|A4YGX6|CITRATE SYNTHASE|2.14|Ki=7.19mM|Ki|=|7.19|mM|7190000|nM
6N97|1.75|2019|KGP|[Different ligand in assay: Ligand in binding assay is racemic mixture] ligand is 6|P52045|METHYLMALONYL-COA DECARBOXYLASE|5.15|Ki=7.1uM|Ki|=|7.1|uM|7100|nM
6N95|1.80|2019|YXS|ligand is 4|P52045|METHYLMALONYL-COA DECARBOXYLASE|5.12|Ki=7.5uM|Ki|=|7.5|uM|7500|nM
6CJP|2.60|2019|F5S|CMLD013075|P46598|HEAT SHOCK PROTEIN 90 HOMOLOG|8.11|Ki=7.7nM|Ki|=|7.7|nM|7.7|nM
6PM9|2.86|2019|OQ1|ligand is compound 42, MK-8719|O60502|O-GLCNACASE TIM-BARREL DOMAIN|8.1|Ki=7.9nM|Ki|=|7.9|nM|7.9|nM
6H3Q|1.31|2019|FMH|ligand is 7c|P00918|CARBONIC ANHYDRASE 2|7.14|Ki=73.2nM|Ki|=|73.2|nM|73.2|nM
6RVF|2.07|2019|KKH|[Uncommon element] [Incomplete ligand] ligand is compound 2a; ligand is hydroxylation in PDB|P00918|CARBONIC ANHYDRASE 2|6.14|Ki=730nM|Ki|=|730|nM|730|nM
6D1K|1.20|2019|M3Q|compound 14, Ki=741.3+/-53.1uM|C7C422|METALLO-BETA-LACTAMASE TYPE 2|3.13|Ki=741.3uM|Ki|=|741.3|uM|741300|nM
6QXS|2.88|2019|UFP|ligand is compound FdUMP|Q834R3|THYMIDYLATE SYNTHASE|7.13|Ki=74nM|Ki|=|74|nM|74|nM
6O48|1.46|2019|0Q4|ligand is CA-p2|Q5RZ08|HIV-1 PROTEASE|7.12|Ki=75nM|Ki|=|75|nM|75|nM
6UGN|1.41|2019|Q77|ligand is compound 2d, SB4-205|P00918|CARBONIC ANHYDRASE 2|6.12|Ki=763.5nM|Ki|=|763.5|nM|763.5|nM
6DO1|2.90|2019|8-mer|logKi(S1l8)=-8.08|P30556|TYPE-1 ANGIOTENSIN II RECEPTOR,SOLUBLE CYTOCHROME B562 BRIL|8.08|Ki=8.32nM|Ki|=|8.32|nM|8.32|nM
6JTC|2.39|2019|C8O||B2RID1|ASP/GLU-SPECIFIC DIPEPTIDYL-PEPTIDASE|5.07|Ki=8.45uM|Ki|=|8.45|uM|8450|nM
6D16|1.40|2019|FUJ|compound 2, Ki=8.4+/-0.4uM|Q9F663|CARBAPENEM-HYDROLYZING BETA-LACTAMASE KPC|5.08|Ki=8.4uM|Ki|=|8.4|uM|8400|nM
6R4K|2.13|2019|JSK|ligand is compound 10|P22073|BETA-GLUCOSIDASE A|5.07|Ki=8.5uM|Ki|=|8.5|uM|8500|nM
6D1I|1.10|2019|T6Z|compound 12, Ki=81+/-12.8uM|C7C422|METALLO-BETA-LACTAMASE TYPE 2|4.09|Ki=81uM|Ki|=|81|uM|81000|nM
6UH0|1.31|2019|PX7|ligand is compound 2o, SB4-202|P00918|CARBONIC ANHYDRASE 2|6.07|Ki=853.1nM|Ki|=|853.1|nM|853.1|nM
6R1K|1.94|2019|JPB|ligand is compound 7c; Ki=9.0+/-1.5uM|A4TVL0|CEREBLON ISOFORM 4|5.05|Ki=9.0uM|Ki|=|9|uM|9000|nM
6K04|1.25|2019|CQF|ligand is 40|P25440|BROMODOMAIN-CONTAINING PROTEIN 2|8.04|Ki=9.1nM|Ki|=|9.1|nM|9.1|nM
6Q8A|2.11|2019|HQ5|[Incomplete ligand]|B4RNT1|LEUCINE--TRNA LIGASE|8.01|Ki=9.8nM|Ki|=|9.8|nM|9.8|nM
6IC2|1.15|2019|BBJ|ligand is EPA|P00918|CARBONIC ANHYDRASE 2|6.04|Ki=917.4nM|Ki|=|917.4|nM|917.4|nM
6GVH|2.74|2019|FDH|ligand is 3e|P42336|PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC|6.04|Ki=920nM|Ki|=|920|nM|920|nM
6GVG|3.00|2019|FCZ|ligand is 3a|P42336|PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC|6.0|Ki=990nM|Ki|=|990|nM|990|nM
6GXE|1.30|2019|FFH|ligand is compound 2|P00918|CARBONIC ANHYDRASE 2|8.05|Ki=9nM|Ki|=|9|nM|9|nM
6R0U|1.70|2019|JO5|ligand is compound 5a|A4TVL0|CEREBLON ISOFORM 4|4.4|Ki>40uM|Ki|>|40|uM|40000|nM
6R0S|1.55|2019|JOH|ligand is compound 4a|A4TVL0|CEREBLON ISOFORM 4|4.4|Ki>40uM|Ki|>|40|uM|40000|nM
6R12|1.74|2019|JOT|ligand is compound 7b|A4TVL0|CEREBLON ISOFORM 4|4.4|Ki>40uM|Ki|>|40|uM|40000|nM
6R1X|1.80|2019|JPQ|ligand is compound 7a|A4TVL0|CEREBLON ISOFORM 4|4.4|Ki>40uM|Ki|>|40|uM|40000|nM
